Citrus Sinensis ID: 009340

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------
Protein Sequence
MLARYTYQGLTTCQALLGQNYFDAPNITIGAQVMIPLRCACPTANQIDKGVSYLLAYMAAKGDTISSIGYKFGVDQQSILEANMLSKADSIFPFAPLLIPLKNGSCSANPENFFCHCKNGFLVDGKLEGLHCKPDGKKFPVKLVALLGLGIGLGFLSVVVVGCYLYRFFKDKRNRMLKEKLFKQNGGYLLQQQLSSCGSSERAKVFTADELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRSQRCLEMCQVNQLLADEISLADNLMQERNLDFLLS
Secondary Structure (PSIPRED)
cccccccccccHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEccccccccccccccccccccccccccccccccEEEccccccEEcccccccccccccccccccccccccccEEEEEHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccHHHHHHHccccccccEEccHHHHHHHHcccccccccccccccEEEEEEcccccEEEEEEcccccHHHHHHHHHHHHHHHHccccccccEEcEEcccccEEEEEEEcccccHHHHHcccccHHHHHHHcccccccHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccEEcccccccccccccccEEEEEcccccccccHHHHcccccccccccccHHHHHHHHHHcccccccccccccccHHHHHHHHHHHccccccccHHHHHcccHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHHHHHHHHHHHcccccccHHccccccccccccccccc
Secondary Structure Prediction (SSPRO)
ccEEEEEccccccccHcccccccEEccccccEccccccccccccccccccHHccHHHHHHcccccccccEEEccccEcccccccccccccEEEEcccEcccccccEEEEcccccEEEEcccccccccccccccccccccccHHHEEEHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccEcHHHHHHHHccccHHccccccccccEEEcEcccccEEEEEEEcccccccHHHHHHHHHHHHHHHHHHHHHHHEEEcccccEEEEEEEcccccHHHHHccccHHHHHHHccccccccHHHHHHHHHHHHHHHHHHHHccccEEEcccccHHHEEEcccccEEEccccccEEcccccEEcccccccccccccHHHHHHcEEcHHHHHHHHHHHHHHHHccccccccccccccccHHHHHHHHHHcccHHHHccHHHcccccHHHHHHHHHHHHHHHcccHcccccHHHHHHHHccccccccccccccccccccccccccccccccccEEEEEc
Coil and Loop (DISEMBL)
MLARYTYQGLTTCQALLgqnyfdapnitigaqvmiplrcacptanqiDKGVSYLLAYMAAKGDTISSIGYKFGVDQQSILEANMlskadsifpfaplliplkngscsanpenffchckngflvdgkleglhckpdgkkfPVKLVALLGLGIGLGFLSVVVVGCYLYRFFKDKRNRMLKEKLFKQNGGYLLQQqlsscgsserakvftADELQRATdnynqsrflgqggfgtvykgmlpdgsivavkrskeiDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISsgtlshhihdhQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYmhssasipifhrdikssnillddkfsakvsdfgisrsipndkthltttiqgtfgyldpeyfqssqftdksdvySFGVVLLELLtgkkpicfaRVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRlnskkrptmKQVSMELEGLRRSQRCLEMCQVNQLLADEISLADNLMQERNLDFLLS
Flexible Loop (DISEMBL)
MLARYTYQGLTTCQALLGQNYFDAPNITIGAQVMIPLRCACPTANQIDKGVSYLLAYMAAKGDTISSIGYKFGVDQQSILEANMLSKADSIFPFAPLLIPLKNGSCSANPENFFCHCKNGFLVDGKLEGLHCKPDGKKFPVKLVALLGLGIGLGFLSVVVVGCYLYRFFKDKRNRMLKEKLFKQNGGYLLQQQLSSCGSSERAKVFTADELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFgisrsipndkthlTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRClrlnskkrptmkqVSMELEGLRRSQRCLEMCQVNQLLADEISLADNLMQERNLDFLLS
Low Complexity Region (SEG)
MLARYTYQGLTTCQALLGQNYFDAPNITIGAQVMIPLRCACPTANQIDKGVSYLLAYMAAKGDTISSIGYKFGVDQQSILEANMLSKADSIFPFAPLLIPLKNGSCSANPENFFCHCKNGFLVDGKLEGLHCKPDGKKFPvklvallglgiglgflsvvvvgCYLYRFFKDKRNRMLKEKLFKQNggyllqqqlsscgssERAKVFTADELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHqqqqeqkqkqeLSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRSQRCLEMCQVNQLLADEISLADNLMQERNLDFLLS
Disordered region (IsUnstruct)
***RYTYQGLTTCQALLGQNYFDAPNITIGAQVMIPLRCACPTANQIDKGVSYLLAYMAAKGDTISSIGYKFGVDQQSILEANMLSKADSIFPFAPLLIPLKNGSCSANPENFFCHCKNGFLVDGKLEGLHCKPDGKKFPVKLVALLGLGIGLGFLSVVVVGCYLYRFFKDKRNRMLKEKLFKQNGGYLLQQQL**********VFTADELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSH********************SWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRL*********************QRCLEMCQVNQLLADEISLADNL***********
Disordered Region (DISOPRED)
***RYTYQGLTTCQALLGQNYFDAPNITIGAQVMIPLRCACPTANQIDKGVSYLLAYMAAKGDTISSIGYKFGVDQQSILEANMLSKADSIFPFAPLLIPLKNGSCSANPENFFCHCKNGFLVDGK***************KLVALLGLGIGLGFLSVVVVGCYLYRF*************************************FTADELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEG**************************************
Disordered Region (DISEMBL)
MLARYTYQGLTTCQALLGQNYFDAPNITIGAQVMIPLRCACPTANQIDKGVSYLLAYMAAKGDTISSIGYKFGVDQQSILEANMLSKADSIFPFAPLLIPLKNGSCSANPENFFCHCKNGFLVDGKLEGLHCKPDGKKFPVKLVALLGLGIGLGFLSVVVVGCYLYRFFKDKRNRMLKEKLFKQNGGYLLQQQ*********AKVFTADELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLS*******************SLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRSQRCLEMCQVNQLLADEISLADNLMQERNLDFLLS
Disordered Region (DISPRO)
MLARYTYQGLTTCQALLGQNYFDAPNITIGAQVMIPLRCACPTANQIDKGVSYLLAYMAAKGDTISSIGYKFGVDQQSILEANMLSKADSIFPFAPLLIPLKNGSCSANPENFFCHCKNGFLVDGKLEGLH******KFPVKLVALLGLGIGLGFLSVVVVGCYLYRFFKDKR***************************ERAKVFTADELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGL*************************************
Transmembrane Helix (TMHMM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MLARYTYQGLTTCQALLGQNYFDAPNITIGAQVMIPLRCACPTANQIDKGVSYLLAYMAAKGDTISSIGYKFGVDQQSILEANMLSKADSIFPFAPLLIPLKNGSCSANPENFFCHCKNGFLVDGKLEGLHCKPDGKKFPVKLVALLGLGIGLGFLSVVVVGCYLYRFFKDKRNRMLKEKLFKQNGGYLLQQQLSSCGSSERAKVFTADELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRSQRCLEMCQVNQLLADEISLADNLMQERNLDFLLS
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	537	2.2.26 [Sep-21-2011]
Q9C9L5	792	Wall-associated receptor	yes	no	0.646	0.438	0.569	1e-114
Q9S9M5	730	Wall-associated receptor	no	no	0.716	0.527	0.532	1e-112
Q7X8C5	748	Wall-associated receptor	no	no	0.674	0.483	0.524	1e-111
Q9LMN6	738	Wall-associated receptor	no	no	0.726	0.528	0.488	1e-109
Q9LMN7	733	Wall-associated receptor	no	no	0.718	0.526	0.496	1e-109
Q8RY17	751	Wall-associated receptor	no	no	0.642	0.459	0.557	1e-109
Q9S9M2	761	Wall-associated receptor	no	no	0.696	0.491	0.511	1e-109
Q9S9M3	730	Wall-associated receptor	no	no	0.631	0.464	0.551	1e-107
Q9LN59	788	Putative wall-associated	no	no	0.655	0.446	0.542	1e-107
Q8VYA3	769	Wall-associated receptor	no	no	0.700	0.488	0.503	1e-107

>sp|Q9C9L5|WAKLH_ARATH Wall-associated receptor kinase-like 9 OS=Arabidopsis thaliana GN=WAKL9 PE=2 SV=1

 Score =  410 bits (1055), Expect = e-114,   Method: Compositional matrix adjust.
 Identities = 204/358 (56%), Positives = 270/358 (75%), Gaps = 11/358 (3%)

Query: 147 LGLGIGLGFLSVV-VVGCYL-YRFFKDKRNRMLKEKLFKQNGGYLLQQQL-SSCGSSERA 203
           L +G+G  F S++ VVG YL Y+F K +R    K+K FK+NGG LLQQQL S+ G  E+ 
Sbjct: 373 LAIGLGASFGSLIFVVGIYLLYKFIKKQRKLNQKKKFFKRNGGLLLQQQLISTVGMVEKT 432

Query: 204 KVFTADELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEV 263
            VF++ EL++AT+N++ +R LGQGG GTVYKGML DG IVAVK+SK +D+ ++ +FINEV
Sbjct: 433 IVFSSRELEKATENFSSNRILGQGGQGTVYKGMLVDGRIVAVKKSKVVDEDKLEEFINEV 492

Query: 264 VILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSW 323
           VILSQINHR+IVKLLGCCLET+VPVLVYE+I +G L  H+HD        +  E    +W
Sbjct: 493 VILSQINHRNIVKLLGCCLETKVPVLVYEFIPNGNLFEHLHD--------EFDENIMATW 544

Query: 324 ENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTH 383
             R+R+A ++AGA++Y+HSSAS PI+HRD+KS+NI+LD+K+ AKVSDFG SR++  D TH
Sbjct: 545 NIRLRIAIDIAGALSYLHSSASSPIYHRDVKSTNIMLDEKYRAKVSDFGTSRTVTVDHTH 604

Query: 384 LTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACF 443
           LTT + GT GY+DPEYFQSSQFTDKSDVYSFGVVL+EL+TG+K I F R +E R L   F
Sbjct: 605 LTTVVSGTVGYMDPEYFQSSQFTDKSDVYSFGVVLVELITGEKSISFLRSQENRTLATYF 664

Query: 444 ISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLR 501
           I   KEN+L +I+DAR+        + A A++A +CL L  +KRP+M++VSMEL+ +R
Sbjct: 665 ILAMKENKLFDIIDARIRDGCMLSQVTATAKVARKCLNLKGRKRPSMREVSMELDSIR 722

Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: -

>sp|Q9S9M5|WAKLA_ARATH Wall-associated receptor kinase-like 1 OS=Arabidopsis thaliana GN=WAKL1 PE=1 SV=1

 Score =  404 bits (1038), Expect = e-112,   Method: Compositional matrix adjust.
 Identities = 211/396 (53%), Positives = 285/396 (71%), Gaps = 11/396 (2%)

Query: 132 CKPDGK-KFPVKLVALLGLGIGLGFLSVVVVGCYLYRFFKDKRNRMLKEKLFKQNGGYLL 190
           C+P+ K   P K   L G+ IGL  L   V   +L++  K +RN    +K FK+NGG LL
Sbjct: 341 CRPNPKITKPTKPPVLQGILIGLSGLVFFVGLFWLFKLIKKRRNINRSKKFFKRNGGLLL 400

Query: 191 QQQLSSC-GSSERAKVFTADELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSK 249
           +QQL++  G+ E +K+F++ EL++ATDN++  R LGQGG GTVYKGML DGSIVAVKRSK
Sbjct: 401 KQQLTTKDGNVEMSKIFSSKELRKATDNFSIDRVLGQGGQGTVYKGMLVDGSIVAVKRSK 460

Query: 250 EIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQ 309
            +D+ ++ +FINE+V+LSQINHR+IVKLLGCCLETEVP+LVYEYI +G L   +HD    
Sbjct: 461 VVDEDKMEEFINEIVLLSQINHRNIVKLLGCCLETEVPILVYEYIPNGDLFKRLHDESDD 520

Query: 310 QEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVS 369
                     +++WE R+R+A E+AGA+ YMHS+AS PIFHRDIK++NILLD+K+ AKVS
Sbjct: 521 Y---------TMTWEVRLRIAIEIAGALTYMHSAASFPIFHRDIKTTNILLDEKYRAKVS 571

Query: 370 DFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPIC 429
           DFG SRS+  D+THLTT + GTFGY+DPEYF SSQ+T KSDVYSFGVVL+EL+TG+KP+ 
Sbjct: 572 DFGTSRSVTLDQTHLTTLVAGTFGYMDPEYFLSSQYTHKSDVYSFGVVLVELITGEKPLS 631

Query: 430 FARVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPT 489
             R EE R L   F+   KEN++++I+D R+  E++ E + A+A+LA +CL    K RP 
Sbjct: 632 RVRSEEGRGLATHFLEAMKENRVIDIIDIRIKDESKLEQVMAVAKLARKCLNRKGKNRPN 691

Query: 490 MKQVSMELEGLRRSQRCLEMCQVNQLLADEISLADN 525
           MK+VS ELE +R S   L++   N+   ++  +A N
Sbjct: 692 MKEVSNELERIRSSPEDLDVRTENEDEEEDQPMAIN 727

Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q7X8C5|WAKLB_ARATH Wall-associated receptor kinase-like 2 OS=Arabidopsis thaliana GN=WAKL2 PE=2 SV=1

 Score =  401 bits (1030), Expect = e-111,   Method: Compositional matrix adjust.
 Identities = 196/374 (52%), Positives = 273/374 (72%), Gaps = 12/374 (3%)

Query: 132 CKPDGKKFPVKLVALLGLGIGLGFLSVVVVGCYLYRFFKDKRNRMLKEKLFKQNGGYLLQ 191
           C+P   +   +++  + +G  L   +  + G  LY+F + +R  +   K F++NGG LL+
Sbjct: 331 CQPKKPEQLKRVIQGVLIGSALLLFAFGIFG--LYKFVQKRRKLIRMRKFFRRNGGMLLK 388

Query: 192 QQLSSC-GSSERAKVFTADELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKE 250
           QQL+   G+ E +++F++ EL++ATDN+N++R LGQGG GTVYKGML DG IVAVKRSK 
Sbjct: 389 QQLARKEGNVEMSRIFSSHELEKATDNFNKNRVLGQGGQGTVYKGMLVDGRIVAVKRSKA 448

Query: 251 IDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQ 310
           +D+ ++ +FINEVV+L+QINHR+IVKLLGCCLETEVPVLVYE++ +G L   +HD     
Sbjct: 449 VDEDRVEEFINEVVVLAQINHRNIVKLLGCCLETEVPVLVYEFVPNGDLCKRLHDESDDY 508

Query: 311 EQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSD 370
                    +++WE R+ +A E+AGA++Y+HS+AS PI+HRDIK++NILLD++  AKVSD
Sbjct: 509 ---------TMTWEVRLHIAIEIAGALSYLHSAASFPIYHRDIKTTNILLDERNRAKVSD 559

Query: 371 FGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICF 430
           FG SRS+  D+THLTT + GTFGY+DPEYFQSS+FT+KSDVYSFGVVL+ELLTG+KP   
Sbjct: 560 FGTSRSVTIDQTHLTTQVAGTFGYVDPEYFQSSKFTEKSDVYSFGVVLVELLTGEKPSSR 619

Query: 431 ARVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTM 490
            R EE R L A F+   KEN++L+I+D R+  E   + + ++A LA RCL    KKRP M
Sbjct: 620 VRSEENRGLAAHFVEAVKENRVLDIVDDRIKDECNMDQVMSVANLARRCLNRKGKKRPNM 679

Query: 491 KQVSMELEGLRRSQ 504
           ++VS+ELE +R S 
Sbjct: 680 REVSIELEMIRSSH 693

Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9LMN6|WAK4_ARATH Wall-associated receptor kinase 4 OS=Arabidopsis thaliana GN=WAK4 PE=2 SV=1

 Score =  397 bits (1020), Expect = e-109,   Method: Compositional matrix adjust.
 Identities = 200/409 (48%), Positives = 283/409 (69%), Gaps = 19/409 (4%)

Query: 100 PLKNGSCSANP--EN----FFCHCKNGFLVDGKLEGLHCKPDGKKFPVKLVALLGLGIGL 153
           P+   +CS +   EN    F C+C++ + ++       CKP G    V+   ++ LG  +
Sbjct: 288 PIHKHNCSGDSTCENKLGHFRCNCRSRYELNTTTN--TCKPKGNPEYVEWTTIV-LGTTI 344

Query: 154 GFLSVVVVGCYLYRFFKDKRNRMLKEKLFKQNGGYLLQQQLSSCGSSE-RAKVFTADELQ 212
           GFL +++    +    K+ ++  L+++ F+QNGG +L Q+LS  G S    K+FT + ++
Sbjct: 345 GFLVILLAISCIEHKMKNTKDTELRQQFFEQNGGGMLMQRLSGAGPSNVDVKIFTEEGMK 404

Query: 213 RATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHR 272
            ATD Y+++R LGQGG GTVYKG+LPD SIVA+K+++  D +Q+ QFINEV++LSQINHR
Sbjct: 405 EATDGYDENRILGQGGQGTVYKGILPDNSIVAIKKARLGDNSQVEQFINEVLVLSQINHR 464

Query: 273 HIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACE 332
           ++VKLLGCCLETEVP+LVYE+ISSGTL  H+H              SSL+WE+R+R+A E
Sbjct: 465 NVVKLLGCCLETEVPLLVYEFISSGTLFDHLHGSMFD---------SSLTWEHRLRMAVE 515

Query: 333 VAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTF 392
           +AG +AY+HSSASIPI HRDIK++NILLD+  +AKV+DFG SR IP DK  L T +QGT 
Sbjct: 516 IAGTLAYLHSSASIPIIHRDIKTANILLDENLTAKVADFGASRLIPMDKEDLATMVQGTL 575

Query: 393 GYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQL 452
           GYLDPEY+ +    +KSDVYSFGVVL+ELL+G+K +CF R +  +++V+ F S  KEN+L
Sbjct: 576 GYLDPEYYNTGLLNEKSDVYSFGVVLMELLSGQKALCFERPQTSKHIVSYFASATKENRL 635

Query: 453 LEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLR 501
            EI+D +V  E  + +I   A +A+ C RL  ++RP MK+V+ ELE LR
Sbjct: 636 HEIIDGQVMNENNQREIQKAARIAVECTRLTGEERPGMKEVAAELEALR 684

Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Binding to pectin may have significance in the control of cell expansion, morphogenesis and development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9LMN7|WAK5_ARATH Wall-associated receptor kinase 5 OS=Arabidopsis thaliana GN=WAK5 PE=2 SV=1

 Score =  395 bits (1016), Expect = e-109,   Method: Compositional matrix adjust.
 Identities = 198/399 (49%), Positives = 278/399 (69%), Gaps = 13/399 (3%)

Query: 105 SCSANPENFFCHCKNGFLVDGKLEGLHCKPDGKKFPVKL-VALLGLGIGLGFLSVVVVGC 163
           +C     +F C C +G   D     + C    K+ P  L    + LG  +GFL +++   
Sbjct: 295 TCENTLGSFHCQCPSG--SDLNTTTMSCIDTPKEEPKYLGWTTVLLGTTIGFLIILLTIS 352

Query: 164 YLYRFFKDKRNRMLKEKLFKQNGGYLLQQQLSSCGSSE-RAKVFTADELQRATDNYNQSR 222
           Y+ +  + ++N  L+++ F+QNGG +L Q+LS  G S    K+FT + ++ ATD YN+SR
Sbjct: 353 YIQQKMRHRKNTELRQQFFEQNGGGMLIQRLSGAGPSNVDVKIFTEEGMKEATDGYNESR 412

Query: 223 FLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCL 282
            LGQGG GTVYKG+L D SIVA+K+++  D++Q+ QFINEV++LSQINHR++VKLLGCCL
Sbjct: 413 ILGQGGQGTVYKGILQDNSIVAIKKARLGDRSQVEQFINEVLVLSQINHRNVVKLLGCCL 472

Query: 283 ETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHS 342
           ETEVP+LVYE+ISSGTL  H+H              SSL+WE+R+R+A EVAG +AY+HS
Sbjct: 473 ETEVPLLVYEFISSGTLFDHLHGSMFD---------SSLTWEHRLRIAIEVAGTLAYLHS 523

Query: 343 SASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQS 402
            ASIPI HRD+K++NILLD+  +AKV+DFG SR IP D+  LTT +QGT GYLDPEY+ +
Sbjct: 524 YASIPIIHRDVKTANILLDENLTAKVADFGASRLIPMDQEQLTTMVQGTLGYLDPEYYNT 583

Query: 403 SQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEILDARVAK 462
               +KSDVYSFGVVL+ELL+G+K +CF R +  ++LV+ F+S  KEN+L EI+D +V  
Sbjct: 584 GLLNEKSDVYSFGVVLMELLSGEKALCFERPQSSKHLVSYFVSAMKENRLHEIIDGQVMN 643

Query: 463 EAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLR 501
           E  + +I   A +A+ C R+  ++RP+MK+V+ ELE LR
Sbjct: 644 EYNQREIQESARIAVECTRIMGEERPSMKEVAAELEALR 682

Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Binding to pectin may have significance in the control of cell expansion, morphogenesis and development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q8RY17|WAKLI_ARATH Wall-associated receptor kinase-like 22 OS=Arabidopsis thaliana GN=WAKL22 PE=2 SV=1

 Score =  395 bits (1014), Expect = e-109,   Method: Compositional matrix adjust.
 Identities = 199/357 (55%), Positives = 272/357 (76%), Gaps = 12/357 (3%)

Query: 150 GIGLGF-LSVVVVGCY-LYRFFKDKRNRMLKEKLFKQNGGYLLQQQLSSCGSS-ERAKVF 206
           G+ LGF L  +V+G + L +F K +R  + K   FK+NGG LL+QQL++ G + + +K+F
Sbjct: 350 GLVLGFPLLFLVLGIWGLIKFVKKRRKIIRKRMFFKRNGGLLLKQQLTTRGGNVQSSKIF 409

Query: 207 TADELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVIL 266
           ++ EL++ATDN+N +R LGQGG GTVYKGML DG IVAVKRSK +D+ ++ +FINEV +L
Sbjct: 410 SSKELEKATDNFNMNRVLGQGGQGTVYKGMLVDGRIVAVKRSKVLDEDKVEEFINEVGVL 469

Query: 267 SQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENR 326
           SQINHR+IVKL+GCCLETEVP+LVYE+I +G L   +H               +++W+ R
Sbjct: 470 SQINHRNIVKLMGCCLETEVPILVYEHIPNGDLFKRLHHDSDDY---------TMTWDVR 520

Query: 327 VRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTT 386
           +R++ E+AGA+AY+HS+AS P++HRD+K++NILLD+K+ AKVSDFG SRSI  D+THLTT
Sbjct: 521 LRISVEIAGALAYLHSAASTPVYHRDVKTTNILLDEKYRAKVSDFGTSRSINVDQTHLTT 580

Query: 387 TIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISL 446
            + GTFGYLDPEYFQ+SQFTDKSDVYSFGVVL+EL+TG+KP    R EE R LV+ F   
Sbjct: 581 LVAGTFGYLDPEYFQTSQFTDKSDVYSFGVVLVELITGEKPFSVMRPEENRGLVSHFNEA 640

Query: 447 AKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRS 503
            K+N++L+I+D+R+ +    E + A+A+LA RCL L  KKRP M++VS+ELE +R S
Sbjct: 641 MKQNRVLDIVDSRIKEGCTLEQVLAVAKLARRCLSLKGKKRPNMREVSVELERIRSS 697

Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Required during plant's response to pathogen infection.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9S9M2|WAKLD_ARATH Wall-associated receptor kinase-like 4 OS=Arabidopsis thaliana GN=WAKL4 PE=2 SV=2

 Score =  394 bits (1013), Expect = e-109,   Method: Compositional matrix adjust.
 Identities = 206/403 (51%), Positives = 276/403 (68%), Gaps = 29/403 (7%)

Query: 102 KNGSCSANPENFFCHCKNGFLVDGKLEGLHCKPDGKKFPVKLVALLGLGIGLGFLSVVVV 161
           K+ SC   P  F C  K              KP G+  PV    L+G  + L   +  + 
Sbjct: 326 KDQSCVNKPGWFTCEPK--------------KP-GQIKPVFQGVLIGSALLL--FAFGIF 368

Query: 162 GCYLYRFFKDKRNRMLKEKLFKQNGGYLLQQQLSSC-GSSERAKVFTADELQRATDNYNQ 220
           G  LY+F K +R        F++NGG LL+QQL+   G+ E +K+F+++EL++ATDN+N 
Sbjct: 369 G--LYKFIKKQRRSSRMRVFFRRNGGMLLKQQLARKEGNVEMSKIFSSNELEKATDNFNT 426

Query: 221 SRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGC 280
           +R LGQGG GTVYKGML DG IVAVKRSK +D+ ++ +FINEVV+L+QINHR+IVKLLGC
Sbjct: 427 NRVLGQGGQGTVYKGMLVDGRIVAVKRSKAMDEDKVEEFINEVVVLAQINHRNIVKLLGC 486

Query: 281 CLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYM 340
           CLETEVPVLVYE++ +G L   + D               ++WE R+ +A E+AGA++Y+
Sbjct: 487 CLETEVPVLVYEFVPNGDLCKRLRDECDDY---------IMTWEVRLHIAIEIAGALSYL 537

Query: 341 HSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYF 400
           HS+AS PI+HRDIK++NILLD+K+  KVSDFG SRS+  D+THLTT + GTFGY+DPEYF
Sbjct: 538 HSAASFPIYHRDIKTTNILLDEKYQVKVSDFGTSRSVTIDQTHLTTQVAGTFGYVDPEYF 597

Query: 401 QSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEILDARV 460
           QSS+FTDKSDVYSFGVVL+EL+TGK P    + EE R   A F++  KEN+ L+I+D R+
Sbjct: 598 QSSKFTDKSDVYSFGVVLVELITGKNPSSRVQSEENRGFAAHFVAAVKENRFLDIVDERI 657

Query: 461 AKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRS 503
             E   + + A+A+LA RCL    KKRP M++VS+ELE +R S
Sbjct: 658 KDECNLDQVMAVAKLAKRCLNRKGKKRPNMREVSVELERIRSS 700

Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Plays a role in plant mineral nutrients response.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9S9M3|WAKLC_ARATH Wall-associated receptor kinase-like 3 OS=Arabidopsis thaliana GN=WAKL3 PE=2 SV=2

 Score =  389 bits (998), Expect = e-107,   Method: Compositional matrix adjust.
 Identities = 194/352 (55%), Positives = 265/352 (75%), Gaps = 13/352 (3%)

Query: 160 VVGCY-LYRFFKDKRNRMLKEKLFKQNGGYLLQQQLSSC-GSSERAKVFTADELQRATDN 217
           V+G + LY+F + +R  +   K FK+NGG LL+QQL++  GS E +K+F++ EL++ATDN
Sbjct: 368 VIGIFGLYKFIRKRRRIIRSMKFFKRNGGLLLKQQLTTKDGSVEMSKIFSSRELEKATDN 427

Query: 218 YNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKL 277
           ++  R LGQGG GTVYK ML DGSIVAVKRSK +D+ ++ +FINE+V+LSQINHR+IVKL
Sbjct: 428 FSIDRVLGQGGQGTVYKRMLVDGSIVAVKRSKVVDEDKMEEFINEIVLLSQINHRNIVKL 487

Query: 278 LGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAV 337
           LGCCLETEVP+LVYEYI +G L   +HD               ++WE R+R+A E+AGA+
Sbjct: 488 LGCCLETEVPILVYEYIPNGDLFKRLHDEYDDY---------MMTWEVRLRIAVEIAGAL 538

Query: 338 AYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDP 397
           +YMHS+AS PIFHRDIK++NILLD+K+ AK+SDFG SRS+  D+THLTT + GTFGY+DP
Sbjct: 539 SYMHSAASFPIFHRDIKTTNILLDEKYRAKISDFGTSRSVATDQTHLTTLVAGTFGYMDP 598

Query: 398 EYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEILD 457
           EYF SSQ+T KSDVYSFGVVL+EL+TG+KP+   R EE   L   F+   KEN+ ++I+D
Sbjct: 599 EYFLSSQYTHKSDVYSFGVVLVELITGEKPMSRVRSEEGIGLATYFLEAMKENRAVDIID 658

Query: 458 ARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRSQRCLEM 509
            R+  E+++  + A+A+LA RCL     KRP M++VS++LE +R S + L++
Sbjct: 659 IRIKDESKQ--VMAVAKLARRCLNRKGNKRPNMREVSIKLERIRSSPKDLDV 708

Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9LN59|WAKLK_ARATH Putative wall-associated receptor kinase-like 11 OS=Arabidopsis thaliana GN=WAKL11 PE=3 SV=2

 Score =  389 bits (998), Expect = e-107,   Method: Compositional matrix adjust.
 Identities = 197/363 (54%), Positives = 261/363 (71%), Gaps = 11/363 (3%)

Query: 144 VALLGLGIGLGFLSVVVVGCYLYRFFKDKRNRMLKEKLFKQNGGYLLQQQLSSC-GSSER 202
           V ++G+G   G L +VV   +L +F K +R    K K FK+NGG LLQQQL++  G+ E+
Sbjct: 376 VTMIGVGSAFGILVLVVGIWWLRKFLKKRRMSKRKRKFFKRNGGLLLQQQLNTNKGNVEK 435

Query: 203 AKVFTADELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINE 262
            ++F++ EL++ATDN+++SR LGQGG GTVYKGML DG  VAVK+SK +D+ ++ +FINE
Sbjct: 436 TRIFSSRELEKATDNFSESRILGQGGQGTVYKGMLVDGRTVAVKKSKVVDEDKLEEFINE 495

Query: 263 VVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLS 322
           VVILSQINHRH+VKLLGCCLETEVP LVYE+I +G L  HIH+      +         +
Sbjct: 496 VVILSQINHRHVVKLLGCCLETEVPTLVYEFIPNGNLFQHIHEESDDYTK---------T 546

Query: 323 WENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKT 382
           W  R+R+A ++AGA++Y+HS+AS PI+HRDIKS+NILLD+K+  KVSDFG SRS+  D T
Sbjct: 547 WGMRLRIAVDIAGALSYLHSAASSPIYHRDIKSTNILLDEKYRTKVSDFGTSRSVTIDHT 606

Query: 383 HLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP-ICFARVEEERNLVA 441
           H TT I GT GY+DPEY+ SSQ+TDKSDVYSFGVVL+EL+TG+KP I  +  +E R L  
Sbjct: 607 HWTTVISGTVGYVDPEYYGSSQYTDKSDVYSFGVVLVELITGEKPVITVSNSQEIRGLAD 666

Query: 442 CFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLR 501
            F    KEN+  EI+DAR+    + E + A+A LA RCL    KKRP M++V  +LE + 
Sbjct: 667 HFRVAMKENRFFEIMDARIRDGCKPEQVMAVANLARRCLNSKGKKRPCMRKVFTDLEKIL 726

Query: 502 RSQ 504
            SQ
Sbjct: 727 ASQ 729

Putative serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q8VYA3|WAKLJ_ARATH Wall-associated receptor kinase-like 10 OS=Arabidopsis thaliana GN=WAKL10 PE=2 SV=1

 Score =  387 bits (995), Expect = e-107,   Method: Compositional matrix adjust.
 Identities = 209/415 (50%), Positives = 285/415 (68%), Gaps = 39/415 (9%)

Query: 115 CHCKNGFLVDGKLEGLHCKP--------DGKKFPV----KLVALLG-------------L 149
           C C +GF  +  + G  CK         DG   PV    K V LLG             +
Sbjct: 305 CSCASGFEGNPYIPG-ECKDINECVRGIDGN--PVCTAGKCVNLLGGYTCEYTNHRPLVI 361

Query: 150 GIGLGFLSVVVVGC--YLYRFFKDKRNRMLKEKLFKQNGGYLLQQQLSSC-GSSERAKVF 206
           G+   F ++V +G   +LY+F + +R    K+K FK+NGG LLQQQL++  G+ +  +VF
Sbjct: 362 GLSTSFSTLVFIGGIYWLYKFIRRQRRLNQKKKFFKRNGGLLLQQQLTTTEGNVDSTRVF 421

Query: 207 TADELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVIL 266
            + EL++AT+N++ +R LG+GG GTVYKGML DG IVAVK+SK +D+ ++ +FINEVVIL
Sbjct: 422 NSRELEKATENFSLTRILGEGGQGTVYKGMLVDGRIVAVKKSKVVDEDKLEEFINEVVIL 481

Query: 267 SQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENR 326
           SQINHR+IVKLLGCCLET+VP+LVYE+I +G L  H+HD           + +  +WE R
Sbjct: 482 SQINHRNIVKLLGCCLETDVPILVYEFIPNGNLFEHLHD--------DSDDYTMTTWEVR 533

Query: 327 VRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTT 386
           +R+A ++AGA++Y+HS+AS PI+HRDIKS+NI+LD+K  AKVSDFG SR++  D THLTT
Sbjct: 534 LRIAVDIAGALSYLHSAASSPIYHRDIKSTNIMLDEKHRAKVSDFGTSRTVTVDHTHLTT 593

Query: 387 TIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISL 446
            + GT GY+DPEYFQSSQFTDKSDVYSFGVVL EL+TG+K + F R +E R L   F   
Sbjct: 594 VVSGTVGYMDPEYFQSSQFTDKSDVYSFGVVLAELITGEKSVSFLRSQEYRTLATYFTLA 653

Query: 447 AKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLR 501
            KEN+L +I+DAR+    +   + A A++A +CL +  +KRP+M+QVSMELE +R
Sbjct: 654 MKENRLSDIIDARIRDGCKLNQVTAAAKIARKCLNMKGRKRPSMRQVSMELEKIR 708

Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	537
87162779	684	Protein kinase; Peptidoglycan-binding Ly	0.945	0.742	0.634	0.0
357507639	776	Wall-associated receptor kinase-like pro	0.945	0.654	0.634	0.0
356531931	666	PREDICTED: wall-associated receptor kina	0.949	0.765	0.616	0.0
290490602	678	LysM type receptor kinase [Lotus japonic	0.932	0.738	0.626	0.0
356566933	667	PREDICTED: wall-associated receptor kina	0.925	0.745	0.625	0.0
290490588	678	LysM type receptor kinase [Lotus japonic	0.932	0.738	0.624	0.0
357507635	679	Wall-associated receptor kinase-like pro	0.929	0.734	0.603	1e-180
255547606	594	kinase, putative [Ricinus communis] gi|2	0.895	0.809	0.594	1e-180
255547604	541	conserved hypothetical protein [Ricinus	0.817	0.811	0.568	1e-162
359483710	751	PREDICTED: wall-associated receptor kina	0.731	0.523	0.560	1e-125

>gi|87162779|gb|ABD28574.1| Protein kinase; Peptidoglycan-binding LysM [Medicago truncatula]

 Score =  679 bits (1753), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 333/525 (63%), Positives = 404/525 (76%), Gaps = 17/525 (3%)

Query: 2   LARYTYQGLTTCQALLGQNYFDAPNITIGAQVMIPLRCACPTANQIDKGVSYLLAYMAAK 61
           L   TYQ LTTCQAL GQNY+ + NI IGA+V +P+ CACPT  Q+ KG++ LL Y+   
Sbjct: 146 LVNETYQSLTTCQALKGQNYYASENIAIGAEVTVPVLCACPTTTQMAKGITSLLVYIVNY 205

Query: 62  GDTISSIGYKFGVDQQSILEANMLSKADS----IFPFAPLLIPLKNGSCSANPENFFCHC 117
           G+T+ SIG  +GVD+QSILEAN L  +++    +F   P+L+PL+  SC  +P++F+C C
Sbjct: 206 GETVKSIGEAYGVDEQSILEANELQPSENRSVILFALTPILLPLRGKSCKEDPDSFYCTC 265

Query: 118 KNGFLVDGKLEGLHCKPDGKKFPVKLVALLGLGIGLGFLSVVVVGCYLYRFFKDKRNRML 177
             G L DG     H    G+KFP KLVA LG+GIG GFL + ++   LY++ K KR  + 
Sbjct: 266 SQGRLADGSCNESH----GQKFPAKLVAALGVGIGAGFLVLFLLSYRLYQYIKKKRASIR 321

Query: 178 KEKLFKQNGGYLLQQQLSSCGSSERAKVFTADELQRATDNYNQSRFLGQGGFGTVYKGML 237
           KEKLF+QNGGYLLQ++LSS G+ E AK+FTA+ELQRATD+YNQSRFLGQGG+GTVYKGML
Sbjct: 322 KEKLFRQNGGYLLQEKLSSYGNGEMAKLFTAEELQRATDDYNQSRFLGQGGYGTVYKGML 381

Query: 238 PDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSG 297
           PDG+IVAVK+SK +D+ QI  F+NEVVILSQINHR+IVKLLGCCLETE P+LVYEYI SG
Sbjct: 382 PDGTIVAVKKSKHLDRNQIETFVNEVVILSQINHRNIVKLLGCCLETETPLLVYEYIHSG 441

Query: 298 TLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSN 357
           TLS HIH          K   SSLSWE+R+R+ACEVAGAV YMH SASIPIFHRDIK SN
Sbjct: 442 TLSQHIHG---------KDRDSSLSWESRLRIACEVAGAVTYMHFSASIPIFHRDIKPSN 492

Query: 358 ILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVV 417
           ILLD+ +SAKVSDFG SRSIP DKTHLTT + GTFGY+DPEYFQSSQFTDKSDVYSFGVV
Sbjct: 493 ILLDNNYSAKVSDFGTSRSIPLDKTHLTTAVGGTFGYMDPEYFQSSQFTDKSDVYSFGVV 552

Query: 418 LLELLTGKKPICFARVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAM 477
           L+EL+TG+KPI F   +E +N+ A FIS+ KENQL +ILD  +  EAR++DI A+A LAM
Sbjct: 553 LVELITGRKPITFNDEDEGQNMTAHFISVMKENQLPQILDNALVNEARKDDILAIANLAM 612

Query: 478 RCLRLNSKKRPTMKQVSMELEGLRRSQRCLEMCQVNQLLADEISL 522
           RCLRLN KKRPTMK+VSMELE LR+ Q  L +    +  +DE SL
Sbjct: 613 RCLRLNGKKRPTMKEVSMELEALRKVQSSLHIKDDQESPSDEQSL 657

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357507639|ref|XP_003624108.1| Wall-associated receptor kinase-like protein [Medicago truncatula] gi|355499123|gb|AES80326.1| Wall-associated receptor kinase-like protein [Medicago truncatula]

 Score =  677 bits (1748), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 333/525 (63%), Positives = 404/525 (76%), Gaps = 17/525 (3%)

Query: 2   LARYTYQGLTTCQALLGQNYFDAPNITIGAQVMIPLRCACPTANQIDKGVSYLLAYMAAK 61
           L   TYQ LTTCQAL GQNY+ + NI IGA+V +P+ CACPT  Q+ KG++ LL Y+   
Sbjct: 146 LVNETYQSLTTCQALKGQNYYASENIAIGAEVTVPVLCACPTTTQMAKGITSLLVYIVNY 205

Query: 62  GDTISSIGYKFGVDQQSILEANMLSKADS----IFPFAPLLIPLKNGSCSANPENFFCHC 117
           G+T+ SIG  +GVD+QSILEAN L  +++    +F   P+L+PL+  SC  +P++F+C C
Sbjct: 206 GETVKSIGEAYGVDEQSILEANELQPSENRSVILFALTPILLPLRGKSCKEDPDSFYCTC 265

Query: 118 KNGFLVDGKLEGLHCKPDGKKFPVKLVALLGLGIGLGFLSVVVVGCYLYRFFKDKRNRML 177
             G L DG     H    G+KFP KLVA LG+GIG GFL + ++   LY++ K KR  + 
Sbjct: 266 SQGRLADGSCNESH----GQKFPAKLVAALGVGIGAGFLVLFLLSYRLYQYIKKKRASIR 321

Query: 178 KEKLFKQNGGYLLQQQLSSCGSSERAKVFTADELQRATDNYNQSRFLGQGGFGTVYKGML 237
           KEKLF+QNGGYLLQ++LSS G+ E AK+FTA+ELQRATD+YNQSRFLGQGG+GTVYKGML
Sbjct: 322 KEKLFRQNGGYLLQEKLSSYGNGEMAKLFTAEELQRATDDYNQSRFLGQGGYGTVYKGML 381

Query: 238 PDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSG 297
           PDG+IVAVK+SK +D+ QI  F+NEVVILSQINHR+IVKLLGCCLETE P+LVYEYI SG
Sbjct: 382 PDGTIVAVKKSKHLDRNQIETFVNEVVILSQINHRNIVKLLGCCLETETPLLVYEYIHSG 441

Query: 298 TLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSN 357
           TLS HIH          K   SSLSWE+R+R+ACEVAGAV YMH SASIPIFHRDIK SN
Sbjct: 442 TLSQHIHG---------KDRDSSLSWESRLRIACEVAGAVTYMHFSASIPIFHRDIKPSN 492

Query: 358 ILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVV 417
           ILLD+ +SAKVSDFG SRSIP DKTHLTT + GTFGY+DPEYFQSSQFTDKSDVYSFGVV
Sbjct: 493 ILLDNNYSAKVSDFGTSRSIPLDKTHLTTAVGGTFGYMDPEYFQSSQFTDKSDVYSFGVV 552

Query: 418 LLELLTGKKPICFARVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAM 477
           L+EL+TG+KPI F   +E +N+ A FIS+ KENQL +ILD  +  EAR++DI A+A LAM
Sbjct: 553 LVELITGRKPITFNDEDEGQNMTAHFISVMKENQLPQILDNALVNEARKDDILAIANLAM 612

Query: 478 RCLRLNSKKRPTMKQVSMELEGLRRSQRCLEMCQVNQLLADEISL 522
           RCLRLN KKRPTMK+VSMELE LR+ Q  L +    +  +DE SL
Sbjct: 613 RCLRLNGKKRPTMKEVSMELEALRKVQSSLHIKDDQESPSDEQSL 657

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356531931|ref|XP_003534529.1| PREDICTED: wall-associated receptor kinase-like 2-like [Glycine max]

 Score =  667 bits (1722), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 330/535 (61%), Positives = 408/535 (76%), Gaps = 25/535 (4%)

Query: 2   LARYTYQGLTTCQALLGQNYFDAPNITIGAQVMIPLRCACPTANQIDKGVSYLLAYMAAK 61
           L + T+QGLTTCQA++G+NY+   NI IGA++ +P  CACPT NQ  +G++ LL Y+   
Sbjct: 133 LVKETFQGLTTCQAMMGRNYYAPVNIVIGAELTVPKLCACPTENQTARGITSLLVYLVNY 192

Query: 62  GDTISSIGYKFGVDQQSILEANMLSKADS------IFPFAPLLIPLKNGSCSANPENFFC 115
           GDTI SIG  +GVD+QS+LEAN L++  S      +F   P+L+PL   SC  NP+ F+C
Sbjct: 193 GDTIKSIGRAYGVDEQSVLEANKLAEPQSSNRSMDLFALTPILVPLIGKSCKENPDKFYC 252

Query: 116 HCKNGFLVDGKLEGLHC-KPDGKKFPVKLVALLGLGIGLGFLSVVVVGCYLYRFFKDKRN 174
            C      DG L+G  C + DG+KFP KLVA LG+GIG GFL + ++G   Y++ + KR 
Sbjct: 253 RCYQA--PDGILKGPFCGESDGQKFPAKLVAGLGVGIGAGFLCLFLLGYKSYQYIQKKRE 310

Query: 175 RMLKEKLFKQNGGYLLQQQLSSCGSSERAKVFTADELQRATDNYNQSRFLGQGGFGTVYK 234
            +LKEKLF+QNGGYLLQ++LS  G+ E AK+FTA+ELQRATDNYN+SRFLGQGG+GTVYK
Sbjct: 311 SILKEKLFRQNGGYLLQEKLSY-GNGEMAKLFTAEELQRATDNYNRSRFLGQGGYGTVYK 369

Query: 235 GMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI 294
           GMLPDG+IVAVK+SKEI++ QI  F+NEVVILSQINHR+IVKLLGCCLETE P+LVYE+I
Sbjct: 370 GMLPDGTIVAVKKSKEIERNQIKTFVNEVVILSQINHRNIVKLLGCCLETETPILVYEFI 429

Query: 295 SSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIK 354
            + TLSHHIH    +          SLSW +R+R+ACEVAGAV YMH SASIPIFHRDIK
Sbjct: 430 PNETLSHHIHRRDNE---------PSLSWVSRLRIACEVAGAVTYMHFSASIPIFHRDIK 480

Query: 355 SSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSF 414
            +NILLD  +SAKVSDFG SRS+P DKTHLTT + GTFGY+DPEYFQSSQF+DKSDVYSF
Sbjct: 481 PTNILLDSNYSAKVSDFGTSRSVPLDKTHLTTAVGGTFGYIDPEYFQSSQFSDKSDVYSF 540

Query: 415 GVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAE 474
           GVVL+EL+TG+KPI F   +E +NLVA FISL K+NQ+ EI DARV K+AR++DI A+A 
Sbjct: 541 GVVLVELITGRKPISFLYEDEGQNLVAQFISLMKKNQVSEIFDARVLKDARKDDILAVAN 600

Query: 475 LAMRCLRLNSKKRPTMKQVSMELEGLRRSQRCLEMCQVNQLLADEISLADNLMQE 529
           LAMRCLRLN KKRPTMK+VS ELE LR++Q  L+M        D      N++QE
Sbjct: 601 LAMRCLRLNGKKRPTMKEVSAELEALRKAQSSLQMSH------DHEHTTSNIVQE 649

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|290490602|dbj|BAI79288.1| LysM type receptor kinase [Lotus japonicus]

 Score =  665 bits (1715), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 324/517 (62%), Positives = 401/517 (77%), Gaps = 16/517 (3%)

Query: 1   MLARYTYQGLTTCQALLGQNYFDAPNITIGAQVMIPLRCACPTANQIDKGVSYLLAYMAA 60
           ML + TYQGLTTCQA++GQNY+ A +I +GA++ +P+ CACPT+N I KGVS+LL +M  
Sbjct: 132 MLVKTTYQGLTTCQAMMGQNYYAAVSIAVGAELTVPVLCACPTSNLIAKGVSFLLVHMVR 191

Query: 61  KGDTISSIGYKFGVDQQSILEANMLSKADS-------IFPFAPLLIPLKNGSCSANPENF 113
            G+ ++SIG  +GVD+QS+ EAN L    S       +    P+L+PL+  SC  NP+ F
Sbjct: 192 DGEMVNSIGEAYGVDEQSMREANGLPVVPSSANNSVTLNALTPILVPLRGQSCKENPDKF 251

Query: 114 FCHCKNGFLVDGKLEGLHC-KPDGKKFPVKLVALLGLGIGLGFLSVVVVGCYLYRFFKDK 172
           +C C    L DG  +GL C + DG+KFP KLV  LG+GIG GFL + V G  LY++ + K
Sbjct: 252 YCKCSQA-LHDGSSKGLFCNESDGQKFPAKLVVPLGVGIGAGFLCLFVSGYKLYQYIQKK 310

Query: 173 RNRMLKEKLFKQNGGYLLQQQLSSCGSSERAKVFTADELQRATDNYNQSRFLGQGGFGTV 232
           R R+  EKLF+QNGGYLLQ++ S  G+ E+AK+FTA+ELQRATDNYN+SRFLGQGG+G V
Sbjct: 311 RKRIHTEKLFRQNGGYLLQEKFSLYGNGEKAKLFTAEELQRATDNYNRSRFLGQGGYGMV 370

Query: 233 YKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE 292
           YKGMLPDG+IVAVKRSKEI+++QI  F+NEVVILSQINHR+IVKLLGCCLETE P+LVYE
Sbjct: 371 YKGMLPDGTIVAVKRSKEIERSQIDTFVNEVVILSQINHRNIVKLLGCCLETETPLLVYE 430

Query: 293 YISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRD 352
           +I +GTLS HIH        K  +  SSL WE+R+R+ACEVAGA+AYMH SASIPIFHRD
Sbjct: 431 FIPNGTLSQHIH-------MKNYESSSSLPWESRLRIACEVAGALAYMHFSASIPIFHRD 483

Query: 353 IKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVY 412
           IK +NILLD  F AKVSDFG S+S+P DKTHLTT ++GTFGY+DPEYFQS QFTDKSDVY
Sbjct: 484 IKPTNILLDSNFCAKVSDFGTSKSVPQDKTHLTTNVKGTFGYIDPEYFQSCQFTDKSDVY 543

Query: 413 SFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAM 472
           SFGVVL+EL+TGK+PI F   +E +NLV  FISL KE+QL +ILDA V KEAR +DI ++
Sbjct: 544 SFGVVLVELITGKRPISFFYEDEGQNLVGEFISLMKEDQLSQILDAVVVKEARIDDILSI 603

Query: 473 AELAMRCLRLNSKKRPTMKQVSMELEGLRRSQRCLEM 509
           A LA RCLRLN KKRPTMK+VS ELE LR+ Q  L++
Sbjct: 604 ASLARRCLRLNGKKRPTMKEVSAELEALRKVQNTLQI 640

Source: Lotus japonicus

Species: Lotus japonicus

Genus: Lotus

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356566933|ref|XP_003551679.1| PREDICTED: wall-associated receptor kinase-like 2-like [Glycine max]

 Score =  664 bits (1712), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 322/515 (62%), Positives = 402/515 (78%), Gaps = 18/515 (3%)

Query: 2   LARYTYQGLTTCQALLGQNYFDAPNITIGAQVMIPLRCACPTANQIDKGVSYLLAYMAAK 61
           L + T+QGLTTCQA++GQNY+ + NI IGA++ +P+ CACPT NQ  +GV+ LL ++   
Sbjct: 133 LVKETFQGLTTCQAMMGQNYYASINIAIGAELTVPMLCACPTENQTARGVTSLLVHLVNY 192

Query: 62  GDTISSIGYKFGVDQQSILEANMLSKADS------IFPFAPLLIPLKNGSCSANPENFFC 115
           GDTI SIG  +GVD+QS+LEAN L+ + S      +    P+++PL   SC  NP+ F+C
Sbjct: 193 GDTIKSIGRAYGVDEQSVLEANKLAVSQSKNSSMDLLALTPIIVPLIGKSCKENPDKFYC 252

Query: 116 HCKNGFLVDGKLEGLHC-KPDGKKFPVKLVALLGLGIGLGFLSVVVVGCYLYRFFKDKRN 174
            C      DG  +G  C + DG+KFP KLVA LG+GIG GFL + ++G   Y++ + KR 
Sbjct: 253 RCYQA--PDGSSKGPFCDESDGQKFPAKLVAGLGVGIGAGFLCLFLLGYKSYQYIQKKRE 310

Query: 175 RMLKEKLFKQNGGYLLQQQLSSCGSSERAKVFTADELQRATDNYNQSRFLGQGGFGTVYK 234
            +LKEKLF+QNGGYLLQ++LSS G+ E AK+FTA+ELQRATDNYN+SRFLGQGG+GTVYK
Sbjct: 311 TILKEKLFRQNGGYLLQEKLSSYGNGEMAKLFTAEELQRATDNYNRSRFLGQGGYGTVYK 370

Query: 235 GMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI 294
           GML DG+IVAVK+SKEI++ QI  F+NEVV+LSQINHR+IVKLLGCCLETE P+LVYE+I
Sbjct: 371 GMLLDGTIVAVKKSKEIERNQIQTFVNEVVVLSQINHRNIVKLLGCCLETETPILVYEFI 430

Query: 295 SSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIK 354
            +GTLSHHIH    +          S SW +R+R+ACEVAGAVAYMH +ASI IFHRDIK
Sbjct: 431 PNGTLSHHIHRRDNE---------PSPSWISRLRIACEVAGAVAYMHFAASISIFHRDIK 481

Query: 355 SSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSF 414
            +NILLD  +SAKVSDFG SRS+P DKTHLTT + GTFGY+DPEYFQSSQF+DKSDVYSF
Sbjct: 482 PTNILLDSNYSAKVSDFGTSRSVPLDKTHLTTAVGGTFGYIDPEYFQSSQFSDKSDVYSF 541

Query: 415 GVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAE 474
           GVVL+EL+TG+KPI F   +E +NL+A FISL KENQ+ EILDA + KEAR++DI A+A 
Sbjct: 542 GVVLVELITGRKPISFLYEDEGQNLIAQFISLMKENQVFEILDASLLKEARKDDILAIAN 601

Query: 475 LAMRCLRLNSKKRPTMKQVSMELEGLRRSQRCLEM 509
           LAMRCLRLN KKRPTMK+VS ELE LR++Q  L+M
Sbjct: 602 LAMRCLRLNGKKRPTMKEVSTELEALRKAQSSLQM 636

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|290490588|dbj|BAI79281.1| LysM type receptor kinase [Lotus japonicus]

 Score =  662 bits (1709), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 323/517 (62%), Positives = 400/517 (77%), Gaps = 16/517 (3%)

Query: 1   MLARYTYQGLTTCQALLGQNYFDAPNITIGAQVMIPLRCACPTANQIDKGVSYLLAYMAA 60
           ML + TYQGLTTCQA++GQNY+ A +I +GA++ +P+ CACPT+N I KGVS+LL +M  
Sbjct: 132 MLVKTTYQGLTTCQAMMGQNYYAAVSIAVGAELTVPVLCACPTSNLIAKGVSFLLVHMVR 191

Query: 61  KGDTISSIGYKFGVDQQSILEANMLSKADS-------IFPFAPLLIPLKNGSCSANPENF 113
            G+ ++SIG  +GVD+QS+ EAN L    S       +    P+L+PL+  SC  NP+ F
Sbjct: 192 DGEMVNSIGEAYGVDEQSMREANGLPVVPSSANNSVTLNALTPILVPLRGQSCKENPDKF 251

Query: 114 FCHCKNGFLVDGKLEGLHC-KPDGKKFPVKLVALLGLGIGLGFLSVVVVGCYLYRFFKDK 172
           +C C    L DG  +GL C + DG+KFP KLV  LG+GIG GFL + V G  LY++ + K
Sbjct: 252 YCKCSQA-LHDGSSKGLFCNESDGQKFPAKLVVPLGVGIGAGFLCLFVSGYKLYQYIQKK 310

Query: 173 RNRMLKEKLFKQNGGYLLQQQLSSCGSSERAKVFTADELQRATDNYNQSRFLGQGGFGTV 232
           R R+  EKLF+QNGGYLLQ++ S  G+ E+AK+FTA+ELQRATDNYN+SRFLGQGG+G V
Sbjct: 311 RKRIHTEKLFRQNGGYLLQEKFSLYGNGEKAKLFTAEELQRATDNYNRSRFLGQGGYGMV 370

Query: 233 YKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE 292
           YKGMLPDG+IVAVKRSKEI+++QI  F+NEVVILSQINHR+IVKLLGCCLETE P+LVYE
Sbjct: 371 YKGMLPDGTIVAVKRSKEIERSQIDTFVNEVVILSQINHRNIVKLLGCCLETETPLLVYE 430

Query: 293 YISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRD 352
           +I +GTLS HIH        K  +  SSL WE+R+R+ACEVAGA+AYMH SASIPIFHRD
Sbjct: 431 FIPNGTLSQHIH-------MKNYESSSSLPWESRLRIACEVAGALAYMHFSASIPIFHRD 483

Query: 353 IKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVY 412
           IK +NILLD  F AKVSDFG S+S+P DKTHLTT ++GTFGY+DPEYFQS QFTDKSDVY
Sbjct: 484 IKPTNILLDSNFCAKVSDFGTSKSVPQDKTHLTTNVKGTFGYIDPEYFQSCQFTDKSDVY 543

Query: 413 SFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAM 472
           SFGVVL+EL+TGK+PI F   +E +NLV  FISL KE+QL +ILD  V KEAR +DI ++
Sbjct: 544 SFGVVLVELITGKRPISFFYEDEGQNLVGEFISLMKEDQLSQILDPVVVKEARIDDILSI 603

Query: 473 AELAMRCLRLNSKKRPTMKQVSMELEGLRRSQRCLEM 509
           A LA RCLRLN KKRPTMK+VS ELE LR+ Q  L++
Sbjct: 604 ASLARRCLRLNGKKRPTMKEVSAELEALRKVQNTLQI 640

Source: Lotus japonicus

Species: Lotus japonicus

Genus: Lotus

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357507635|ref|XP_003624106.1| Wall-associated receptor kinase-like protein [Medicago truncatula] gi|87162780|gb|ABD28575.1| Protein kinase [Medicago truncatula] gi|355499121|gb|AES80324.1| Wall-associated receptor kinase-like protein [Medicago truncatula]

 Score =  638 bits (1645), Expect = e-180,   Method: Compositional matrix adjust.
 Identities = 311/515 (60%), Positives = 392/515 (76%), Gaps = 16/515 (3%)

Query: 2   LARYTYQGLTTCQALLGQNYFDAPNITIGAQVMIPLRCACPTANQIDKGVSYLLAYMAAK 61
           L + TYQGLTTCQAL+GQNY+   +I + A++ +P+ CACPTAN   KGV+ LL +M   
Sbjct: 132 LVKETYQGLTTCQALMGQNYYAPVSIQLDAELTVPILCACPTANLTAKGVTSLLVHMVNY 191

Query: 62  GDTISSIGYKFGVDQQSILEANMLSKADS------IFPFAPLLIPLKNGSCSANPENFFC 115
           G+T+ SIG  +GVD+ S+ EAN LS   S      +F   P+L+PL+  +C  N + F+C
Sbjct: 192 GETVKSIGEAYGVDEHSMREANELSGLQSANSSVILFASTPILVPLRRKNCKENSDRFYC 251

Query: 116 HCKNGFLVDGKLEGLHC-KPDGKKFPVKLVALLGLGIGLGFLSVVVVGCYLYRFFKDKRN 174
            C      D   +G++C +   +K P KLVA  G+GIG   L + ++ C LY+  K +R 
Sbjct: 252 KCSEALHGDESSKGIYCDESPRRKVPAKLVAASGMGIGTVLLCLFLLSCKLYQHIKKRRA 311

Query: 175 RMLKEKLFKQNGGYLLQQQLSSCGSSERAKVFTADELQRATDNYNQSRFLGQGGFGTVYK 234
              KEKLF+QNGGYLLQ++LSS G+ E AK+FTA+ELQRATDNYN+SRFLGQGG+GTVYK
Sbjct: 312 STHKEKLFRQNGGYLLQEKLSSYGNGEMAKLFTAEELQRATDNYNRSRFLGQGGYGTVYK 371

Query: 235 GMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI 294
           GMLPDG+IVAVK+SKE+++ QI  F+NEVVILSQINHR+IVKLLGCCLETE P+LVYE+I
Sbjct: 372 GMLPDGTIVAVKKSKELERNQIETFVNEVVILSQINHRNIVKLLGCCLETETPLLVYEFI 431

Query: 295 SSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIK 354
            +GTLS HIH   Q+         SSLSWENR+R+ACEVAGAVAYMH SASIPIFHRDIK
Sbjct: 432 PNGTLSQHIHMKDQE---------SSLSWENRLRIACEVAGAVAYMHFSASIPIFHRDIK 482

Query: 355 SSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSF 414
            +NILLD  FSAKVSDFG SRSIP DKTHLTT + GT+GY+DPEYFQS+QFT+KSDVYSF
Sbjct: 483 PTNILLDSNFSAKVSDFGTSRSIPLDKTHLTTFVGGTYGYIDPEYFQSNQFTNKSDVYSF 542

Query: 415 GVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAE 474
           GVVL+EL+T +KPI F   ++ +NL+A FIS+ KENQ+ +I+DAR+ KEA ++ I A++ 
Sbjct: 543 GVVLVELITSRKPISFYDEDDGQNLIAHFISVMKENQVSQIIDARLQKEAGKDTILAISS 602

Query: 475 LAMRCLRLNSKKRPTMKQVSMELEGLRRSQRCLEM 509
           LA RCLRLN KKRPTMK+VS ELE LR++Q   E+
Sbjct: 603 LARRCLRLNHKKRPTMKEVSAELETLRKAQSSFEI 637

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255547606|ref|XP_002514860.1| kinase, putative [Ricinus communis] gi|223545911|gb|EEF47414.1| kinase, putative [Ricinus communis]

 Score =  637 bits (1643), Expect = e-180,   Method: Compositional matrix adjust.
 Identities = 319/537 (59%), Positives = 391/537 (72%), Gaps = 56/537 (10%)

Query: 2   LARYTYQGLTTCQALLGQNYFDAPNITIGAQVMIPLRCACPTANQIDKGVSYLLAYMAAK 61
           +A  TYQGLTTCQAL GQNY+D  ++ +G ++M+PLRCACP+ NQ   GV  LL YM   
Sbjct: 100 IANNTYQGLTTCQALTGQNYYDPEHLQVGMELMVPLRCACPSRNQTADGVISLLMYMVTW 159

Query: 62  GDTISSIGYKFGVDQQSILEANMLSKADSIFPFAPLLIPLKNGSCSANPENFFCHCKNGF 121
           GDT+SSIG  FG D  SILEAN LS+   IFPF P+L+PL+   C A+PENFFC C  G 
Sbjct: 160 GDTLSSIGQAFGADAASILEANRLSQNSIIFPFTPILVPLRRERCMADPENFFCQCPKG- 218

Query: 122 LVDGKLEGLHCKPDGKKFPVKLVALLGLGIGLGFLSVVVVGCYLYRFFKDKRNRMLKEKL 181
                + GL+C+ D KKFP KL+ LLG GIG+G L + +    L+ F K++RNR+ KE+L
Sbjct: 219 ----GVGGLNCRQDSKKFPTKLIILLGTGIGMGLLCLFLFSYKLFHFLKERRNRIRKERL 274

Query: 182 FKQNGGYLLQQQLSSCGSSERAKVFTADELQRATDNYNQSRFLGQGGFGTVYKGMLPDGS 241
           F+QNGG+LLQQ+LSSCG  ++AK+FTA+ELQRATDNYNQSRFLGQGG+GTV+KGMLPDGS
Sbjct: 275 FEQNGGFLLQQKLSSCGGGKKAKLFTAEELQRATDNYNQSRFLGQGGYGTVFKGMLPDGS 334

Query: 242 IVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSH 301
           IVAVKRSK ID+TQI QFINEVVILSQINHR+IVKLLGCCLETE+P+LVYE+I +G LS+
Sbjct: 335 IVAVKRSKTIDRTQIAQFINEVVILSQINHRNIVKLLGCCLETELPLLVYEFIPNGNLSN 394

Query: 302 HIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD 361
           HIH+  Q+         SS  WE R+R+A EVAGAVAYMHSSAS PIFHRDIKSSNILLD
Sbjct: 395 HIHEQDQE---------SSFPWELRLRIASEVAGAVAYMHSSASSPIFHRDIKSSNILLD 445

Query: 362 DKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLEL 421
           DK+SAKVSDFG SR+IP D+THLTT +QGTFG                            
Sbjct: 446 DKYSAKVSDFGTSRAIPFDRTHLTTAVQGTFGN--------------------------- 478

Query: 422 LTGKKPICFARVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLR 481
                       E+ER+LVA FIS  KE++LL+ILD RVA+EAR ED+ A+A+LA  C+R
Sbjct: 479 ------------EDERSLVAHFISSMKEDRLLQILDPRVAREARREDMHAIAKLATSCVR 526

Query: 482 LNSKKRPTMKQVSMELEGLRRSQRCLEMCQVNQLLADEISL---ADNLMQERNLDFL 535
           LN KKRPTM++V+MEL+GLR+S+RCL++ Q   LL D+ S    AD   QE   D++
Sbjct: 527 LNGKKRPTMREVAMELDGLRKSERCLQIDQELSLLRDDPSFAHRADEPGQESTEDYI 583

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255547604|ref|XP_002514859.1| conserved hypothetical protein [Ricinus communis] gi|223545910|gb|EEF47413.1| conserved hypothetical protein [Ricinus communis]

 Score =  577 bits (1487), Expect = e-162,   Method: Compositional matrix adjust.
 Identities = 287/505 (56%), Positives = 361/505 (71%), Gaps = 66/505 (13%)

Query: 2   LARYTYQGLTTCQALLGQNYFDAPNITIGAQVMIPLRCACPTANQIDKGVSYLLAYMAAK 61
           +A  TYQGLTTCQA++ QN + +  + +G+++++PLRCACPT NQ + GV  LL +M   
Sbjct: 79  IANNTYQGLTTCQAIMDQNNYPSQGLPVGSELIVPLRCACPTQNQTENGVISLLVHMVTW 138

Query: 62  GDTISSIGYKFGVDQQSILEANMLSKADSIFPFAPLLIPLKNGSCSANPE-NFFCHCKNG 120
           GDTI+SI   FGVD+ SIL AN LS+  +I+PF P+L+PL N +   NP  NF C   NG
Sbjct: 139 GDTIASIANSFGVDEASILAANKLSENSTIYPFTPILVPLTNENRLTNPAANFSCQYPNG 198

Query: 121 FLVDGKLEGLHCKPDGKKFPVKLVALLGLGIGLGFLSVVVVGCYLYRFFKDKRNRMLKEK 180
            +  G ++G++C              +G+GIGL     V +  +L               
Sbjct: 199 SVAVGGVDGMYCTSRS----------VGIGIGL----TVFIPVHL--------------- 229

Query: 181 LFKQNGGYLLQQQLSSCGSSERAKVFTADELQRATDNYNQSRFLGQGGFGTVYKGMLPDG 240
                                       +ELQRATDNY+QSRFLGQGGF TVYKGMLPDG
Sbjct: 230 ---------------------------QEELQRATDNYSQSRFLGQGGFSTVYKGMLPDG 262

Query: 241 SIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLS 300
           SIVAVKRSK ID+TQI QFINEVVILSQINHR+IVKLLGCCLETE P+LVYE+IS+GTLS
Sbjct: 263 SIVAVKRSKTIDRTQIEQFINEVVILSQINHRNIVKLLGCCLETEFPLLVYEFISNGTLS 322

Query: 301 HHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILL 360
            HI++  Q+         SSL WE+R R+A EVAGA+AYMHS+AS PIFHRDIKS+NILL
Sbjct: 323 QHIYNQDQE---------SSLPWEHRFRIASEVAGALAYMHSAASFPIFHRDIKSANILL 373

Query: 361 DDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLE 420
           DDK+SAKVSDFG SRSIP D+THLTT +QGTFGYLDPEYF +SQFT+KSDVYSFGVVL+E
Sbjct: 374 DDKYSAKVSDFGTSRSIPFDRTHLTTVVQGTFGYLDPEYFYTSQFTEKSDVYSFGVVLIE 433

Query: 421 LLTGKKPICFARVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCL 480
           L TG+KPI   R E+ERNLVA FIS+AKEN+LL++LDARVAKEAR ED+ ++A+L ++C+
Sbjct: 434 LFTGEKPISSTRAEDERNLVAHFISMAKENRLLDLLDARVAKEARREDVYSIAKLVIKCV 493

Query: 481 RLNSKKRPTMKQVSMELEGLRRSQR 505
           R N K RP++++V+MEL+G+ +S +
Sbjct: 494 RSNGKNRPSIREVAMELDGIMKSHQ 518

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359483710|ref|XP_002265582.2| PREDICTED: wall-associated receptor kinase 5-like [Vitis vinifera]

 Score =  453 bits (1166), Expect = e-125,   Method: Compositional matrix adjust.
 Identities = 227/405 (56%), Positives = 295/405 (72%), Gaps = 12/405 (2%)

Query: 106 CSANPENFFCHCKNGFLVDGKLEGLHCKPDGKKFPVKLVALLGLGIGLGFLSVVVVGCYL 165
           CS  P ++ C C  G+  DGK  G  C P  +K  + LV  LG+GI +  L ++  G +L
Sbjct: 312 CSNIPGSYSCTCPAGYHGDGKTNGTGCIPGKRKHLLALVFSLGVGITVVPLILIATGLWL 371

Query: 166 YRFFKDKRNRMLKEKLFKQNGGYLLQQQLSSCGSS-ERAKVFTADELQRATDNYNQSRFL 224
           YR  K++  + +K++ FK+NGG LLQQQ+SS   S E+ K+++ +EL+RATD +N SR +
Sbjct: 372 YRRLKEREKKKIKQEFFKKNGGLLLQQQISSSKESVEKTKLYSVEELERATDGFNSSRVI 431

Query: 225 GQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLET 284
           G+GG GTVYKGML DGSIVA+K+S  +D+ Q+ QF+NEV ILSQINHRHIV+LLGCCLET
Sbjct: 432 GKGGLGTVYKGMLSDGSIVAIKKSNTVDEKQLDQFVNEVFILSQINHRHIVRLLGCCLET 491

Query: 285 EVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSA 344
           EVP+LVYEY+S+GTL HH+H         ++   S+LSW+NR+R+  E+AGA+AY+HS A
Sbjct: 492 EVPLLVYEYVSNGTLFHHLH---------EEGHASTLSWKNRLRIGSEIAGALAYLHSYA 542

Query: 345 SIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQ 404
           SI I HRDIKS NILLD+   A VSDFG+SRSIP DKTHLT  +QGTFGYLDP+YF S Q
Sbjct: 543 SIAICHRDIKSRNILLDENLRAVVSDFGLSRSIPLDKTHLTALVQGTFGYLDPDYFHSGQ 602

Query: 405 FTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEILDARVAKEA 464
           FTDKSDVY+FGVVL ELLTG++ I   R   E+ L   F S  K+N+L EILD +V  E 
Sbjct: 603 FTDKSDVYAFGVVLAELLTGEQAISSDR--SEQGLANHFRSAMKQNRLFEILDNQVVNEG 660

Query: 465 REEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRSQRCLEM 509
           ++E+I A+A+LA RCL+LN KKRPTMKQ+ ++L+ L R Q  L  
Sbjct: 661 QKEEIFAVAKLAKRCLKLNGKKRPTMKQIDIDLQQLGRFQEQLSF 705

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	537
TAIR|locus:2019893	751	RFO1 "RESISTANCE TO FUSARIUM O	0.668	0.478	0.513	4.2e-98
TAIR|locus:2200552	730	WAKL1 "wall associated kinase-	0.657	0.483	0.526	8.4e-97
TAIR|locus:2205040	792	AT1G69730 [Arabidopsis thalian	0.638	0.433	0.526	3.3e-95
TAIR|locus:2200562	748	WAKL2 "wall associated kinase-	0.614	0.441	0.538	4.2e-95
TAIR|locus:2014952	738	WAK4 "wall associated kinase 4	0.720	0.524	0.457	2.1e-94
TAIR|locus:2019843	769	WAKL10 "WALL ASSOCIATED KINASE	0.668	0.466	0.502	1e-93
TAIR|locus:2014962	733	WAK5 "wall associated kinase 5	0.718	0.526	0.461	8.1e-92
TAIR|locus:2014902	735	WAK1 "cell wall-associated kin	0.709	0.518	0.462	1.1e-91
TAIR|locus:2014912	732	WAK2 "wall-associated kinase 2	0.720	0.528	0.466	5.7e-91
TAIR|locus:2016377	788	AT1G19390 [Arabidopsis thalian	0.618	0.421	0.527	2.5e-90

TAIR|locus:2019893 RFO1 "RESISTANCE TO FUSARIUM OXYSPORUM 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 954 (340.9 bits), Expect = 4.2e-98, Sum P(2) = 4.2e-98
 Identities = 190/370 (51%), Positives = 264/370 (71%)

Query:   165 LYRFFKDKRNRMLKEKLFKQNXXXXXXXXXXXXXXX-ERAKVFTADELQRATDNYNQSRF 223
             L +F K +R  + K   FK+N                + +K+F++ EL++ATDN+N +R 
Sbjct:   367 LIKFVKKRRKIIRKRMFFKRNGGLLLKQQLTTRGGNVQSSKIFSSKELEKATDNFNMNRV 426

Query:   224 LGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLE 283
             LGQGG GTVYKGML DG IVAVKRSK +D+ ++ +FINEV +LSQINHR+IVKL+GCCLE
Sbjct:   427 LGQGGQGTVYKGMLVDGRIVAVKRSKVLDEDKVEEFINEVGVLSQINHRNIVKLMGCCLE 486

Query:   284 TEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYMHSS 343
             TEVP+LVYE+I +G L   +H H             +++W+ R+R++ E+AGA+AY+HS+
Sbjct:   487 TEVPILVYEHIPNGDLFKRLH-HDSDDY--------TMTWDVRLRISVEIAGALAYLHSA 537

Query:   344 ASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSS 403
             AS P++HRD+K++NILLD+K+ AKVSDFG SRSI  D+THLTT + GTFGYLDPEYFQ+S
Sbjct:   538 ASTPVYHRDVKTTNILLDEKYRAKVSDFGTSRSINVDQTHLTTLVAGTFGYLDPEYFQTS 597

Query:   404 QFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEILDARVAKE 463
             QFTDKSDVYSFGVVL+EL+TG+KP    R EE R LV+ F    K+N++L+I+D+R+ + 
Sbjct:   598 QFTDKSDVYSFGVVLVELITGEKPFSVMRPEENRGLVSHFNEAMKQNRVLDIVDSRIKEG 657

Query:   464 AREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRSQRCLEMCQVNQLLADEISLA 523
                E + A+A+LA RCL L  KKRP M++VS+ELE +R S   LE+  + +   +E ++ 
Sbjct:   658 CTLEQVLAVAKLARRCLSLKGKKRPNMREVSVELERIRSSPEDLEL-HIEEEDEEECAME 716

Query:   524 DNLMQERNLD 533
              N+    ++D
Sbjct:   717 INMDDSWSVD 726

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005618 "cell wall" evidence=ISS

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016021 "integral to membrane" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009620 "response to fungus" evidence=IMP

TAIR|locus:2200552 WAKL1 "wall associated kinase-like 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 962 (343.7 bits), Expect = 8.4e-97, P = 8.4e-97
 Identities = 191/363 (52%), Positives = 258/363 (71%)

Query:   164 YLYRFFKDKRNRMLKEKLFKQNXXXXXXXXXXXXXXX-ERAKVFTADELQRATDNYNQSR 222
             +L++  K +RN    +K FK+N                E +K+F++ EL++ATDN++  R
Sbjct:   374 WLFKLIKKRRNINRSKKFFKRNGGLLLKQQLTTKDGNVEMSKIFSSKELRKATDNFSIDR 433

Query:   223 FLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCL 282
              LGQGG GTVYKGML DGSIVAVKRSK +D+ ++ +FINE+V+LSQINHR+IVKLLGCCL
Sbjct:   434 VLGQGGQGTVYKGMLVDGSIVAVKRSKVVDEDKMEEFINEIVLLSQINHRNIVKLLGCCL 493

Query:   283 ETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYMHS 342
             ETEVP+LVYEYI +G L   +HD              +++WE R+R+A E+AGA+ YMHS
Sbjct:   494 ETEVPILVYEYIPNGDLFKRLHDESDDY---------TMTWEVRLRIAIEIAGALTYMHS 544

Query:   343 SASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQS 402
             +AS PIFHRDIK++NILLD+K+ AKVSDFG SRS+  D+THLTT + GTFGY+DPEYF S
Sbjct:   545 AASFPIFHRDIKTTNILLDEKYRAKVSDFGTSRSVTLDQTHLTTLVAGTFGYMDPEYFLS 604

Query:   403 SQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEILDARVAK 462
             SQ+T KSDVYSFGVVL+EL+TG+KP+   R EE R L   F+   KEN++++I+D R+  
Sbjct:   605 SQYTHKSDVYSFGVVLVELITGEKPLSRVRSEEGRGLATHFLEAMKENRVIDIIDIRIKD 664

Query:   463 EAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRSQRCLEMCQVNQLLADEISL 522
             E++ E + A+A+LA +CL    K RP MK+VS ELE +R S   L++   N+   ++  +
Sbjct:   665 ESKLEQVMAVAKLARKCLNRKGKNRPNMKEVSNELERIRSSPEDLDVRTENEDEEEDQPM 724

Query:   523 ADN 525
             A N
Sbjct:   725 AIN 727

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005618 "cell wall" evidence=ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016021 "integral to membrane" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2205040 AT1G69730 [Arabidopsis thaliana (taxid:3702)]

 Score = 947 (338.4 bits), Expect = 3.3e-95, P = 3.3e-95
 Identities = 187/355 (52%), Positives = 253/355 (71%)

Query:   165 LYRFFKDKRNRMLKEKLFKQNXXXXXXXXXXXXXXX-ERAKVFTADELQRATDNYNQSRF 223
             LY+F K +R    K+K FK+N                E+  VF++ EL++AT+N++ +R 
Sbjct:   393 LYKFIKKQRKLNQKKKFFKRNGGLLLQQQLISTVGMVEKTIVFSSRELEKATENFSSNRI 452

Query:   224 LGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLE 283
             LGQGG GTVYKGML DG IVAVK+SK +D+ ++ +FINEVVILSQINHR+IVKLLGCCLE
Sbjct:   453 LGQGGQGTVYKGMLVDGRIVAVKKSKVVDEDKLEEFINEVVILSQINHRNIVKLLGCCLE 512

Query:   284 TEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYMHSS 343
             T+VPVLVYE+I +G L  H+HD                +W  R+R+A ++AGA++Y+HSS
Sbjct:   513 TKVPVLVYEFIPNGNLFEHLHDEFDENIMA--------TWNIRLRIAIDIAGALSYLHSS 564

Query:   344 ASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSS 403
             AS PI+HRD+KS+NI+LD+K+ AKVSDFG SR++  D THLTT + GT GY+DPEYFQSS
Sbjct:   565 ASSPIYHRDVKSTNIMLDEKYRAKVSDFGTSRTVTVDHTHLTTVVSGTVGYMDPEYFQSS 624

Query:   404 QFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEILDARVAKE 463
             QFTDKSDVYSFGVVL+EL+TG+K I F R +E R L   FI   KEN+L +I+DAR+   
Sbjct:   625 QFTDKSDVYSFGVVLVELITGEKSISFLRSQENRTLATYFILAMKENKLFDIIDARIRDG 684

Query:   464 AREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRSQRCLEMCQVNQLLAD 518
                  + A A++A +CL L  +KRP+M++VSMEL+ +R    C +M Q+ + +++
Sbjct:   685 CMLSQVTATAKVARKCLNLKGRKRPSMREVSMELDSIRMP--CGDM-QLQECVSE 736

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016021 "integral to membrane" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2200562 WAKL2 "wall associated kinase-like 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 946 (338.1 bits), Expect = 4.2e-95, P = 4.2e-95
 Identities = 183/340 (53%), Positives = 248/340 (72%)

Query:   165 LYRFFKDKRNRMLKEKLFKQNXXXXXXXXXXXXXXX-ERAKVFTADELQRATDNYNQSRF 223
             LY+F + +R  +   K F++N                E +++F++ EL++ATDN+N++R 
Sbjct:   362 LYKFVQKRRKLIRMRKFFRRNGGMLLKQQLARKEGNVEMSRIFSSHELEKATDNFNKNRV 421

Query:   224 LGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLE 283
             LGQGG GTVYKGML DG IVAVKRSK +D+ ++ +FINEVV+L+QINHR+IVKLLGCCLE
Sbjct:   422 LGQGGQGTVYKGMLVDGRIVAVKRSKAVDEDRVEEFINEVVVLAQINHRNIVKLLGCCLE 481

Query:   284 TEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYMHSS 343
             TEVPVLVYE++ +G L   +HD              +++WE R+ +A E+AGA++Y+HS+
Sbjct:   482 TEVPVLVYEFVPNGDLCKRLHDESDDY---------TMTWEVRLHIAIEIAGALSYLHSA 532

Query:   344 ASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSS 403
             AS PI+HRDIK++NILLD++  AKVSDFG SRS+  D+THLTT + GTFGY+DPEYFQSS
Sbjct:   533 ASFPIYHRDIKTTNILLDERNRAKVSDFGTSRSVTIDQTHLTTQVAGTFGYVDPEYFQSS 592

Query:   404 QFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEILDARVAKE 463
             +FT+KSDVYSFGVVL+ELLTG+KP    R EE R L A F+   KEN++L+I+D R+  E
Sbjct:   593 KFTEKSDVYSFGVVLVELLTGEKPSSRVRSEENRGLAAHFVEAVKENRVLDIVDDRIKDE 652

Query:   464 AREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRS 503
                + + ++A LA RCL    KKRP M++VS+ELE +R S
Sbjct:   653 CNMDQVMSVANLARRCLNRKGKKRPNMREVSIELEMIRSS 692

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016021 "integral to membrane" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0010200 "response to chitin" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2014952 WAK4 "wall associated kinase 4" [Arabidopsis thaliana (taxid:3702)]

 Score = 912 (326.1 bits), Expect = 2.1e-94, Sum P(2) = 2.1e-94
 Identities = 183/400 (45%), Positives = 258/400 (64%)

Query:   103 NGSCSANPENFFCHCKNGFLVDGKLEGLHCKPDGKKFPXXXXXXXXXXXXXXXXXXXXXX 162
             + +C     +F C+C++ + ++       CKP G                          
Sbjct:   297 DSTCENKLGHFRCNCRSRYELNTTTNT--CKPKGNPEYVEWTTIVLGTTIGFLVILLAIS 354

Query:   163 CYLYRFFKDKRNRMLKEKLFKQNXXXXXXXXXXXXXXXE-RAKVFTADELQRATDNYNQS 221
             C  ++  K+ ++  L+++ F+QN                   K+FT + ++ ATD Y+++
Sbjct:   355 CIEHKM-KNTKDTELRQQFFEQNGGGMLMQRLSGAGPSNVDVKIFTEEGMKEATDGYDEN 413

Query:   222 RFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCC 281
             R LGQGG GTVYKG+LPD SIVA+K+++  D +Q+ QFINEV++LSQINHR++VKLLGCC
Sbjct:   414 RILGQGGQGTVYKGILPDNSIVAIKKARLGDNSQVEQFINEVLVLSQINHRNVVKLLGCC 473

Query:   282 LETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYMH 341
             LETEVP+LVYE+ISSGTL  H+H              SSL+WE+R+R+A E+AG +AY+H
Sbjct:   474 LETEVPLLVYEFISSGTLFDHLHGSMFD---------SSLTWEHRLRMAVEIAGTLAYLH 524

Query:   342 SSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQ 401
             SSASIPI HRDIK++NILLD+  +AKV+DFG SR IP DK  L T +QGT GYLDPEY+ 
Sbjct:   525 SSASIPIIHRDIKTANILLDENLTAKVADFGASRLIPMDKEDLATMVQGTLGYLDPEYYN 584

Query:   402 SSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEILDARVA 461
             +    +KSDVYSFGVVL+ELL+G+K +CF R +  +++V+ F S  KEN+L EI+D +V 
Sbjct:   585 TGLLNEKSDVYSFGVVLMELLSGQKALCFERPQTSKHIVSYFASATKENRLHEIIDGQVM 644

Query:   462 KEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLR 501
              E  + +I   A +A+ C RL  ++RP MK+V+ ELE LR
Sbjct:   645 NENNQREIQKAARIAVECTRLTGEERPGMKEVAAELEALR 684

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0009826 "unidimensional cell growth" evidence=IMP

GO:0048527 "lateral root development" evidence=RCA;IMP

GO:0048589 "developmental growth" evidence=RCA

GO:0048765 "root hair cell differentiation" evidence=RCA

TAIR|locus:2019843 WAKL10 "WALL ASSOCIATED KINASE (WAK)-LIKE 10" [Arabidopsis thaliana (taxid:3702)]

 Score = 933 (333.5 bits), Expect = 1.0e-93, P = 1.0e-93
 Identities = 187/372 (50%), Positives = 255/372 (68%)

Query:   164 YLYRFFKDKRNRMLKEKLFKQNXXXXXXXXXXXXXXX-ERAKVFTADELQRATDNYNQSR 222
             +LY+F + +R    K+K FK+N                +  +VF + EL++AT+N++ +R
Sbjct:   378 WLYKFIRRQRRLNQKKKFFKRNGGLLLQQQLTTTEGNVDSTRVFNSRELEKATENFSLTR 437

Query:   223 FLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCL 282
              LG+GG GTVYKGML DG IVAVK+SK +D+ ++ +FINEVVILSQINHR+IVKLLGCCL
Sbjct:   438 ILGEGGQGTVYKGMLVDGRIVAVKKSKVVDEDKLEEFINEVVILSQINHRNIVKLLGCCL 497

Query:   283 ETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYMHS 342
             ET+VP+LVYE+I +G L  H+HD                +WE R+R+A ++AGA++Y+HS
Sbjct:   498 ETDVPILVYEFIPNGNLFEHLHDDSDDYTMT--------TWEVRLRIAVDIAGALSYLHS 549

Query:   343 SASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQS 402
             +AS PI+HRDIKS+NI+LD+K  AKVSDFG SR++  D THLTT + GT GY+DPEYFQS
Sbjct:   550 AASSPIYHRDIKSTNIMLDEKHRAKVSDFGTSRTVTVDHTHLTTVVSGTVGYMDPEYFQS 609

Query:   403 SQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEILDARVAK 462
             SQFTDKSDVYSFGVVL EL+TG+K + F R +E R L   F    KEN+L +I+DAR+  
Sbjct:   610 SQFTDKSDVYSFGVVLAELITGEKSVSFLRSQEYRTLATYFTLAMKENRLSDIIDARIRD 669

Query:   463 EAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLR---RSQRCLEMCQVNQLLADE 519
               +   + A A++A +CL +  +KRP+M+QVSMELE +R      +  E    N+    E
Sbjct:   670 GCKLNQVTAAAKIARKCLNMKGRKRPSMRQVSMELEKIRSYSEDMQPYEYASENEEEKKE 729

Query:   520 ISLADNLMQERN 531
              +L D  ++ RN
Sbjct:   730 -TLVDVNVESRN 740

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016021 "integral to membrane" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004383 "guanylate cyclase activity" evidence=IDA

GO:0006182 "cGMP biosynthetic process" evidence=IDA

GO:0006952 "defense response" evidence=IEP

GO:0009617 "response to bacterium" evidence=IEP

GO:0009620 "response to fungus" evidence=IEP

GO:0009751 "response to salicylic acid stimulus" evidence=IEP

GO:0009723 "response to ethylene stimulus" evidence=RCA

TAIR|locus:2014962 WAK5 "wall associated kinase 5" [Arabidopsis thaliana (taxid:3702)]

 Score = 915 (327.2 bits), Expect = 8.1e-92, P = 8.1e-92
 Identities = 184/399 (46%), Positives = 257/399 (64%)

Query:   105 SCSANPENFFCHCKNGFLVDGKLEGLHCKPDGKKFPXXXX-XXXXXXXXXXXXXXXXXXC 163
             +C     +F C C +G   D     + C    K+ P                        
Sbjct:   295 TCENTLGSFHCQCPSGS--DLNTTTMSCIDTPKEEPKYLGWTTVLLGTTIGFLIILLTIS 352

Query:   164 YLYRFFKDKRNRMLKEKLFKQNXXXXXXXXXXXXXXXE-RAKVFTADELQRATDNYNQSR 222
             Y+ +  + ++N  L+++ F+QN                   K+FT + ++ ATD YN+SR
Sbjct:   353 YIQQKMRHRKNTELRQQFFEQNGGGMLIQRLSGAGPSNVDVKIFTEEGMKEATDGYNESR 412

Query:   223 FLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCL 282
              LGQGG GTVYKG+L D SIVA+K+++  D++Q+ QFINEV++LSQINHR++VKLLGCCL
Sbjct:   413 ILGQGGQGTVYKGILQDNSIVAIKKARLGDRSQVEQFINEVLVLSQINHRNVVKLLGCCL 472

Query:   283 ETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYMHS 342
             ETEVP+LVYE+ISSGTL  H+H              SSL+WE+R+R+A EVAG +AY+HS
Sbjct:   473 ETEVPLLVYEFISSGTLFDHLHGSMFD---------SSLTWEHRLRIAIEVAGTLAYLHS 523

Query:   343 SASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQS 402
              ASIPI HRD+K++NILLD+  +AKV+DFG SR IP D+  LTT +QGT GYLDPEY+ +
Sbjct:   524 YASIPIIHRDVKTANILLDENLTAKVADFGASRLIPMDQEQLTTMVQGTLGYLDPEYYNT 583

Query:   403 SQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEILDARVAK 462
                 +KSDVYSFGVVL+ELL+G+K +CF R +  ++LV+ F+S  KEN+L EI+D +V  
Sbjct:   584 GLLNEKSDVYSFGVVLMELLSGEKALCFERPQSSKHLVSYFVSAMKENRLHEIIDGQVMN 643

Query:   463 EAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLR 501
             E  + +I   A +A+ C R+  ++RP+MK+V+ ELE LR
Sbjct:   644 EYNQREIQESARIAVECTRIMGEERPSMKEVAAELEALR 682

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2014902 WAK1 "cell wall-associated kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 887 (317.3 bits), Expect = 1.1e-91, Sum P(2) = 1.1e-91
 Identities = 184/398 (46%), Positives = 253/398 (63%)

Query:   105 SCSANPENFFCHCKNGFLVDGKLEGLHCKPDGKKFPXXXXXXXXXXXXXXXXXXXXXXCY 164
             +C      F+C C++G+ +D     + CK   K+F                       C 
Sbjct:   302 TCRNKVGGFYCKCQSGYRLDTTT--MSCKR--KEF--AWTTILLVTTIGFLVILLGVACI 355

Query:   165 LYRFFKDKRNRMLKEKLFKQNXXXXXXXXXXXXXXXE-RAKVFTADELQRATDNYNQSRF 223
               R  K  ++  L+E+ F+QN                   K+FT D +++AT+ Y +SR 
Sbjct:   356 QQRM-KHLKDTKLREQFFEQNGGGMLTQRLSGAGPSNVDVKIFTEDGMKKATNGYAESRI 414

Query:   224 LGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLE 283
             LGQGG GTVYKG+LPD SIVA+K+++  D +Q+ QFINEV++LSQINHR++VKLLGCCLE
Sbjct:   415 LGQGGQGTVYKGILPDNSIVAIKKARLGDSSQVEQFINEVLVLSQINHRNVVKLLGCCLE 474

Query:   284 TEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYMHSS 343
             TEVP+LVYE+I++GTL  H+H              SSL+WE+R+++A EVAG +AY+HSS
Sbjct:   475 TEVPLLVYEFITNGTLFDHLHGSMID---------SSLTWEHRLKIAIEVAGTLAYLHSS 525

Query:   344 ASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSS 403
             ASIPI HRDIK++NILLD   +AKV+DFG SR IP DK  L T +QGT GYLDPEY+ + 
Sbjct:   526 ASIPIIHRDIKTANILLDVNLTAKVADFGASRLIPMDKEELETMVQGTLGYLDPEYYNTG 585

Query:   404 QFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEILDARVAKE 463
                +KSDVYSFGVVL+ELL+G+K +CF R +  ++LV+ F +  KEN+L EI+   V  E
Sbjct:   586 LLNEKSDVYSFGVVLMELLSGQKALCFKRPQSSKHLVSYFATATKENRLDEIIGGEVMNE 645

Query:   464 AREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLR 501
                ++I   A +A  C RL  ++RP MK+V+ +LE LR
Sbjct:   646 DNLKEIQEAARIAAECTRLMGEERPRMKEVAAKLEALR 683

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISS;IDA

GO:0005515 "protein binding" evidence=IPI

GO:0007166 "cell surface receptor signaling pathway" evidence=IPI

GO:0005773 "vacuole" evidence=IDA

GO:0009751 "response to salicylic acid stimulus" evidence=IEP

GO:0009615 "response to virus" evidence=IEP

GO:0050832 "defense response to fungus" evidence=RCA;IMP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0009814 "defense response, incompatible interaction" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0009505 "plant-type cell wall" evidence=IDA

TAIR|locus:2014912 WAK2 "wall-associated kinase 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 907 (324.3 bits), Expect = 5.7e-91, P = 5.7e-91
 Identities = 187/401 (46%), Positives = 256/401 (63%)

Query:   102 KNGSCSANPENFFCHCKNGFLVDGKLEGLHCKPDGKKFPXXXXXXXXXXXXXXXXXXXXX 161
             ++ +C     +F C+C +G+  D  L     K   + F                      
Sbjct:   291 EHSTCENTKGSFNCNCPSGYRKDS-LNSCTRKVRPEYF--RWTQIFLGTTIGFSVIMLGI 347

Query:   162 XCYLYRFFKDKRNRMLKEKLFKQNXXXXXXXXXXXXXXXE-RAKVFTADELQRATDNYNQ 220
              C L +  K ++N  L++K F+QN                   K+FT   ++ AT+ Y++
Sbjct:   348 SC-LQQKIKHRKNTELRQKFFEQNGGGMLIQRVSGAGPSNVDVKIFTEKGMKEATNGYHE 406

Query:   221 SRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGC 280
             SR LGQGG GTVYKG+LPD SIVA+K+++  +++Q+ QFINEV++LSQINHR++VK+LGC
Sbjct:   407 SRILGQGGQGTVYKGILPDNSIVAIKKARLGNRSQVEQFINEVLVLSQINHRNVVKVLGC 466

Query:   281 CLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYM 340
             CLETEVP+LVYE+I+SGTL  H+H              SSL+WE+R+R+A EVAG++AY+
Sbjct:   467 CLETEVPLLVYEFINSGTLFDHLHGSLYD---------SSLTWEHRLRIATEVAGSLAYL 517

Query:   341 HSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYF 400
             HSSASIPI HRDIK++NILLD   +AKV+DFG SR IP DK  LTT +QGT GYLDPEY+
Sbjct:   518 HSSASIPIIHRDIKTANILLDKNLTAKVADFGASRLIPMDKEQLTTIVQGTLGYLDPEYY 577

Query:   401 QSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEILDARV 460
              +    +KSDVYSFGVVL+ELL+G+K +CF R    +NLV+CF S  K N+  EI+D +V
Sbjct:   578 NTGLLNEKSDVYSFGVVLMELLSGQKALCFERPHCPKNLVSCFASATKNNRFHEIIDGQV 637

Query:   461 AKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLR 501
               E  + +I   A +A  C RL  ++RP MK+V+ ELE LR
Sbjct:   638 MNEDNQREIQEAARIAAECTRLMGEERPRMKEVAAELEALR 678

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0009751 "response to salicylic acid stimulus" evidence=IDA

GO:0009311 "oligosaccharide metabolic process" evidence=IMP

GO:0009826 "unidimensional cell growth" evidence=IMP

GO:0009992 "cellular water homeostasis" evidence=IMP;IDA

GO:0009793 "embryo development ending in seed dormancy" evidence=RCA

GO:0010027 "thylakoid membrane organization" evidence=RCA

GO:0010228 "vegetative to reproductive phase transition of meristem" evidence=RCA

GO:0016226 "iron-sulfur cluster assembly" evidence=RCA

GO:0019761 "glucosinolate biosynthetic process" evidence=RCA

GO:0048481 "ovule development" evidence=RCA

TAIR|locus:2016377 AT1G19390 [Arabidopsis thaliana (taxid:3702)]

 Score = 901 (322.2 bits), Expect = 2.5e-90, P = 2.5e-90
 Identities = 181/343 (52%), Positives = 237/343 (69%)

Query:   164 YLYRFFKDKRNRMLKEKLFKQNXXXXXXXXXXXXXXX-ERAKVFTADELQRATDNYNQSR 222
             +L +F K +R    K K FK+N                E+ ++F++ EL++ATDN+++SR
Sbjct:   396 WLRKFLKKRRMSKRKRKFFKRNGGLLLQQQLNTNKGNVEKTRIFSSRELEKATDNFSESR 455

Query:   223 FLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCL 282
              LGQGG GTVYKGML DG  VAVK+SK +D+ ++ +FINEVVILSQINHRH+VKLLGCCL
Sbjct:   456 ILGQGGQGTVYKGMLVDGRTVAVKKSKVVDEDKLEEFINEVVILSQINHRHVVKLLGCCL 515

Query:   283 ETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYMHS 342
             ETEVP LVYE+I +G L  HIH+                +W  R+R+A ++AGA++Y+HS
Sbjct:   516 ETEVPTLVYEFIPNGNLFQHIHEESDDYTK---------TWGMRLRIAVDIAGALSYLHS 566

Query:   343 SASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQS 402
             +AS PI+HRDIKS+NILLD+K+  KVSDFG SRS+  D TH TT I GT GY+DPEY+ S
Sbjct:   567 AASSPIYHRDIKSTNILLDEKYRTKVSDFGTSRSVTIDHTHWTTVISGTVGYVDPEYYGS 626

Query:   403 SQFTDKSDVYSFGVVLLELLTGKKP-ICFARVEEERNLVACFISLAKENQLLEILDARVA 461
             SQ+TDKSDVYSFGVVL+EL+TG+KP I  +  +E R L   F    KEN+  EI+DAR+ 
Sbjct:   627 SQYTDKSDVYSFGVVLVELITGEKPVITVSNSQEIRGLADHFRVAMKENRFFEIMDARIR 686

Query:   462 KEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRSQ 504
                + E + A+A LA RCL    KKRP M++V  +LE +  SQ
Sbjct:   687 DGCKPEQVMAVANLARRCLNSKGKKRPCMRKVFTDLEKILASQ 729

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016021 "integral to membrane" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.691

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input:
	atpE	SubName- Full=Chromosome chr10 scaffold_50, whole genome shotgun sequence;; Produces ATP from ADP in the presence of a proton gradient across the membrane (By similarity) (766 aa)
		(Vitis vinifera)
Predicted Functional Partners:
	atpB	SubName- Full=Chromosome undetermined scaffold_79, whole genome shotgun sequence;; Produces ATP [...] (271 aa)						•			0.540
	atpF	SubName- Full=Chromosome undetermined scaffold_79, whole genome shotgun sequence;; F(1)F(0) ATP [...] (81 aa)						•			0.540
	atpA	RecName- Full=ATP synthase subunit alpha; Short=ATPase subunit alpha; EC=3.6.3.14; AltName- Ful [...] (507 aa)						•			0.540
	atpI	ATP synthase CF0 A subunit ; Key component of the proton channel; it plays a direct role in the [...] (247 aa)						•			0.540

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	537
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	9e-54
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	4e-51
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-50
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	6e-50
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	1e-49
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	8e-48
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	2e-47
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	2e-45
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	2e-39
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	7e-38
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	3e-36
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	7e-34
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-31
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	2e-31
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	1e-30
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-30
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	6e-30
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	7e-30
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-29
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	2e-29
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	1e-28
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	2e-28
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	5e-28
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	6e-28
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	2e-27
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	2e-27
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	3e-27
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	5e-27
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	7e-27
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	8e-27
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	2e-26
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-26
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	3e-26
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	5e-26
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	1e-25
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-25
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	3e-25
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	3e-25
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	4e-25
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	5e-25
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	5e-25
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	5e-25
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	5e-25
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	6e-25
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	8e-25
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	8e-25
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	1e-24
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	1e-24
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	1e-24
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	1e-24
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-24
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	3e-24
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	3e-24
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	3e-24
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	7e-24
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	7e-24
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	7e-24
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	3e-23
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	3e-23
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	4e-23
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	4e-23
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	6e-23
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	7e-23
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	7e-23
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	8e-23
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	1e-22
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	2e-22
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	3e-22
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	5e-22
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	1e-21
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	1e-21
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	1e-21
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-21
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-21
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	3e-21
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	4e-21
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	4e-21
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	5e-21
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	5e-21
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	6e-21
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	7e-21
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	7e-21
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	9e-21
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-20
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-20
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	2e-20
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-20
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	3e-20
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	3e-20
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	3e-20
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	3e-20
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	4e-20
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	4e-20
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	7e-20
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	9e-20
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	9e-20
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	1e-19
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	2e-19
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	2e-19
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	2e-19
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-19
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	3e-19
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	4e-19
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	4e-19
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	5e-19
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	5e-19
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	5e-19
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	8e-19
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	1e-18
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	1e-18
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	3e-18
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	3e-18
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	4e-18
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	4e-18
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	4e-18
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	6e-18
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	8e-18
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	1e-17
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-17
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-17
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	1e-17
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	1e-17
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	2e-17
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-17
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-17
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-17
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	2e-17
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-17
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	3e-17
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	3e-17
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	3e-17
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	3e-17
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	4e-17
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	4e-17
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	4e-17
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	4e-17
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	5e-17
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	5e-17
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	5e-17
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	6e-17
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	7e-17
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	8e-17
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	9e-17
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	9e-17
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-16
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-16
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-16
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	2e-16
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	3e-16
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	3e-16
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	3e-16
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	4e-16
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	4e-16
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	5e-16
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	5e-16
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	6e-16
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	7e-16
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	7e-16
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	9e-16
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	9e-16
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	9e-16
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	1e-15
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	2e-15
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	3e-15
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	3e-15
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	3e-15
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	4e-15
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	4e-15
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	4e-15
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	4e-15
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	5e-15
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	6e-15
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	7e-15
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	7e-15
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	8e-15
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	9e-15
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	1e-14
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	1e-14
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	2e-14
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-14
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	2e-14
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	2e-14
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	3e-14
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	3e-14
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	4e-14
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	4e-14
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	4e-14
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	5e-14
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	7e-14
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	8e-14
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	9e-14
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-13
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	1e-13
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	1e-13
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	1e-13
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-13
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	2e-13
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	2e-13
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	2e-13
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-13
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-13
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-13
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	3e-13
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	4e-13
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	7e-13
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	8e-13
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	8e-13
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	9e-13
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	9e-13
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	9e-13
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-12
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-12
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	1e-12
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	2e-12
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	3e-12
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	3e-12
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	3e-12
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	4e-12
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	4e-12
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	5e-12
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	5e-12
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	5e-12
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	5e-12
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	7e-12
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	7e-12
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	8e-12
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	1e-11
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-11
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	1e-11
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	2e-11
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	2e-11
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-11
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-11
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	2e-11
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	3e-11
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	3e-11
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	3e-11
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	3e-11
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	4e-11
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	4e-11
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	4e-11
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	4e-11
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	4e-11
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	5e-11
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	5e-11
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	5e-11
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	5e-11
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	8e-11
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	9e-11
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	1e-10
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	1e-10
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	2e-10
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-10
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	2e-10
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	2e-10
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	3e-10
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	4e-10
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	5e-10
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	6e-10
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	9e-10
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	2e-09
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	2e-09
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	2e-09
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	4e-09
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	6e-09
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	7e-09
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	7e-09
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	9e-09
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	2e-08
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	2e-08
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-08
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	2e-08
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	3e-08
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	3e-08
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	3e-08
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	4e-08
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	6e-08
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	6e-08
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	7e-08
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	9e-08
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	1e-07
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	2e-07
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	2e-07
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	3e-07
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	3e-07
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	3e-07
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	5e-07
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	5e-07
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	7e-07
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	7e-07
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	1e-06
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	1e-06
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	1e-06
pfam01476	43	pfam01476, LysM, LysM domain	2e-06
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	5e-06
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	6e-06
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	6e-06
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	8e-06
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	1e-05
smart00257	44	smart00257, LysM, Lysin motif	2e-05
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	3e-05
cd00118	45	cd00118, LysM, Lysine Motif is a small domain invo	3e-05
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	4e-05
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	7e-05
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	7e-05
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	7e-05
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	9e-05
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	2e-04
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	4e-04
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	0.001
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	0.001
PRK11198	147	PRK11198, PRK11198, LysM domain/BON superfamily pr	0.002
TIGR02899	44	TIGR02899, spore_safA, spore coat assembly protein	0.003

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  181 bits (463), Expect = 9e-54
 Identities = 81/279 (29%), Positives = 125/279 (44%), Gaps = 34/279 (12%)

Query: 218 YNQSRFLGQGGFGTVYKGM-LPDGSIVAVKR-SKEIDKTQIHQFINEVVILSQINHRHIV 275
           Y     LG+G FG VY       G +VA+K   K+  K    + + E+ IL ++ H +IV
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 276 KLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVR-VACEVA 334
           +L     + +   LV EY   G L   +                 LS E+  R    ++ 
Sbjct: 61  RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRG------------RLS-EDEARFYLRQIL 107

Query: 335 GAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGY 394
            A+ Y+H   S  I HRD+K  NILLD+    K++DFG++R +  D     TT  GT  Y
Sbjct: 108 SALEYLH---SKGIVHRDLKPENILLDEDGHVKLADFGLARQL--DPGEKLTTFVGTPEY 162

Query: 395 LDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLE 454
           + PE      +    D++S GV+L ELLTGK P  F     +  L+  F  + K      
Sbjct: 163 MAPEVLLGKGYGKAVDIWSLGVILYELLTGKPP--F---PGDDQLLELFKKIGKPKPPFP 217

Query: 455 ILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQV 493
             +  ++ EA+        +L  + L  + +KR T ++ 
Sbjct: 218 PPEWDISPEAK--------DLIRKLLVKDPEKRLTAEEA 248

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  175 bits (446), Expect = 4e-51
 Identities = 89/285 (31%), Positives = 141/285 (49%), Gaps = 35/285 (12%)

Query: 224 LGQGGFGTVYKGMLPDGS----IVAVKRSKEI-DKTQIHQFINEVVILSQINHRHIVKLL 278
           LG+G FG VYKG L         VAVK  KE   + +   F+ E  ++ ++ H ++V+LL
Sbjct: 3   LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLL 62

Query: 279 GCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVA 338
           G C E E   LV EY+  G L  ++   ++ +      E S+LS ++ +  A ++A  + 
Sbjct: 63  GVCTEEEPLYLVLEYMEGGDLLDYL---RKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119

Query: 339 YMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTF--GYLD 396
           Y+    S    HRD+ + N L+ +    K+SDFG+SR + +D  +   T  G     ++ 
Sbjct: 120 YLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKT-GGKLPIRWMA 175

Query: 397 PEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQLLEI 455
           PE  +   FT KSDV+SFGV+L E+ T G  P               +  L+ E ++LE 
Sbjct: 176 PESLKDGIFTSKSDVWSFGVLLWEIFTLGATP---------------YPGLSNE-EVLEY 219

Query: 456 LDA--RVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELE 498
           L    R+ K     D   + EL + C +L+ + RPT  ++   LE
Sbjct: 220 LRKGYRLPKPEYCPD--ELYELMLSCWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  171 bits (436), Expect = 2e-50
 Identities = 78/274 (28%), Positives = 125/274 (45%), Gaps = 67/274 (24%)

Query: 224 LGQGGFGTVYKGM-LPDGSIVAVKR-SKEIDKTQIHQFINEVVILSQINHRHIVKLLGCC 281
           LG+GGFGTVY       G  VA+K   KE   + + + + E+ IL ++NH +IVKL G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 282 LETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMH 341
            +     LV EY   G+L   + +++ +           LS +  +R+  ++   + Y+H
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENEGK-----------LSEDEILRILLQILEGLEYLH 109

Query: 342 SSASIPIFHRDIKSSNILLD-DKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPE-Y 399
              S  I HRD+K  NILLD D    K++DFG+S+ + +DK  L  TI GT  Y+ PE  
Sbjct: 110 ---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDK-SLLKTIVGTPAYMAPEVL 165

Query: 400 FQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEILDAR 459
                +++KSD++S GV+L EL                                      
Sbjct: 166 LGKGYYSEKSDIWSLGVILYEL-------------------------------------- 187

Query: 460 VAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQV 493
                       + +L  + L+ + +KRP+ K++
Sbjct: 188 ----------PELKDLIRKMLQKDPEKRPSAKEI 211

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  171 bits (437), Expect = 6e-50
 Identities = 80/277 (28%), Positives = 133/277 (48%), Gaps = 37/277 (13%)

Query: 224 LGQGGFGTVYKGML----PDGSI-VAVKRSKEI-DKTQIHQFINEVVILSQINHRHIVKL 277
           LG+G FG VYKG L        + VAVK  KE   + QI +F+ E  I+ +++H ++VKL
Sbjct: 7   LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66

Query: 278 LGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAV 337
           LG C E E   +V EY+  G L  ++  ++             LS  + +  A ++A  +
Sbjct: 67  LGVCTEEEPLYIVMEYMEGGDLLSYLRKNR-----------PKLSLSDLLSFALQIARGM 115

Query: 338 AYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDP 397
            Y+    S    HRD+ + N L+ +    K+SDFG+SR + +D  +     +    ++ P
Sbjct: 116 EYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAP 172

Query: 398 EYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQLLEIL 456
           E  +  +FT KSDV+SFGV+L E+ T G++P  +  +  E       +   K    L   
Sbjct: 173 ESLKEGKFTSKSDVWSFGVLLWEIFTLGEQP--YPGMSNEE-----VLEYLKNGYRLPQP 225

Query: 457 DARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQV 493
                     E    + +L ++C   + + RPT  ++
Sbjct: 226 P-----NCPPE----LYDLMLQCWAEDPEDRPTFSEL 253

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  171 bits (435), Expect = 1e-49
 Identities = 80/277 (28%), Positives = 135/277 (48%), Gaps = 36/277 (12%)

Query: 224 LGQGGFGTVYKGMLPDGSI-----VAVKRSKEI-DKTQIHQFINEVVILSQINHRHIVKL 277
           LG+G FG VYKG L          VAVK  KE   + QI +F+ E  I+ +++H +IVKL
Sbjct: 7   LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66

Query: 278 LGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAV 337
           LG C E E  ++V EY+  G L  ++  ++ +           LS  + +  A ++A  +
Sbjct: 67  LGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPK----------ELSLSDLLSFALQIARGM 116

Query: 338 AYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDP 397
            Y+    S    HRD+ + N L+ +    K+SDFG+SR + +D  +     +    ++ P
Sbjct: 117 EYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAP 173

Query: 398 EYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQLLEIL 456
           E  +  +FT KSDV+SFGV+L E+ T G++P               +  ++   ++LE L
Sbjct: 174 ESLKEGKFTSKSDVWSFGVLLWEIFTLGEEP---------------YPGMSNA-EVLEYL 217

Query: 457 DARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQV 493
                          + +L ++C   + + RPT  ++
Sbjct: 218 KKGYRLPKPPNCPPELYKLMLQCWAEDPEDRPTFSEL 254

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  166 bits (423), Expect = 8e-48
 Identities = 86/280 (30%), Positives = 131/280 (46%), Gaps = 30/280 (10%)

Query: 218 YNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSK--EIDKTQIHQFINEVVILSQINHRHI 274
           Y   R LG G FGTVYK      G IVAVK  K       +      E+ IL +++H +I
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60

Query: 275 VKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVA 334
           V+L+    + +   LV EY   G L  ++                 LS +   ++A ++ 
Sbjct: 61  VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGG------------PLSEDEAKKIALQIL 108

Query: 335 GAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGY 394
             + Y+HS     I HRD+K  NILLD+    K++DFG+++ +    + L TT  GT  Y
Sbjct: 109 RGLEYLHS---NGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSL-TTFVGTPWY 164

Query: 395 LDPE-YFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLL 453
           + PE     + +  K DV+S GV+L ELLTGK P  F+       L      L    +  
Sbjct: 165 MAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPP--FSGENILDQLQLIRRILGPPLEFD 222

Query: 454 EILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQV 493
           E   +  ++EA+        +L  +CL  +  KRPT +++
Sbjct: 223 EPKWSSGSEEAK--------DLIKKCLNKDPSKRPTAEEI 254

Length = 260

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  164 bits (419), Expect = 2e-47
 Identities = 84/284 (29%), Positives = 139/284 (48%), Gaps = 42/284 (14%)

Query: 224 LGQGGFGTVYKGML-PDGS----IVAVKRSKEI-DKTQIHQFINEVVILSQINHRHIVKL 277
           LG+G FG VYKG L  DG      VAVK  KE   + +  +F+ E  I+ +++H +IV+L
Sbjct: 7   LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66

Query: 278 LGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAV 337
           LG C + E   +V EY+  G L   +  H +            L+ ++ +++A ++A  +
Sbjct: 67  LGVCTQGEPLYIVTEYMPGGDLLDFLRKHGE-----------KLTLKDLLQMALQIAKGM 115

Query: 338 AYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFG---Y 394
            Y+    S    HRD+ + N L+ +    K+SDFG+SR I  D  +      G      +
Sbjct: 116 EYLE---SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRG--GGKLPIKW 170

Query: 395 LDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQLL 453
           + PE  +  +FT KSDV+SFGV+L E+ T G++P      EE        + L ++   L
Sbjct: 171 MAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE-------VLELLEDGYRL 223

Query: 454 EILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMEL 497
              +        +E    + EL ++C   + + RPT  ++  +L
Sbjct: 224 PRPE-----NCPDE----LYELMLQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  159 bits (405), Expect = 2e-45
 Identities = 78/275 (28%), Positives = 136/275 (49%), Gaps = 37/275 (13%)

Query: 222 RFLGQGGFGTVYKGMLPD-GSIVAVK--RSKEIDKTQIHQFINEVVILSQINHRHIVKLL 278
             LG+G FG+VY  +  D G ++AVK        + ++     E+ ILS + H +IV+  
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 279 GCCLETEVPVL-VY-EYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRV-ACEVAG 335
           G   + E   L ++ EY+S G+LS  +         K+  +L     E  +R    ++  
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLL---------KKFGKLP----EPVIRKYTRQILE 112

Query: 336 AVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIP-NDKTHLTTTIQGTFGY 394
            +AY+HS+    I HRDIK +NIL+D     K++DFG ++ +   +    T +++GT  +
Sbjct: 113 GLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYW 169

Query: 395 LDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLE 454
           + PE  +  ++   +D++S G  ++E+ TGK P       E  N +A    +    +  E
Sbjct: 170 MAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPW-----SELGNPMAALYKIGSSGEPPE 224

Query: 455 ILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPT 489
           I    +++EA+        +   +CLR + KKRPT
Sbjct: 225 I-PEHLSEEAK--------DFLRKCLRRDPKKRPT 250

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  143 bits (364), Expect = 2e-39
 Identities = 85/285 (29%), Positives = 128/285 (44%), Gaps = 41/285 (14%)

Query: 217 NYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKR-----SKEIDKTQIHQFINEVVILSQIN 270
            Y   + +G+G FG VY      DG +  +K        E ++      +NEV IL ++N
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDA---LNEVKILKKLN 57

Query: 271 HRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVA 330
           H +I+K      E     +V EY   G LS  I        +KQK+E      E  +   
Sbjct: 58  HPNIIKYYESFEEKGKLCIVMEYADGGDLSQKI--------KKQKKEGKPFPEEQILDWF 109

Query: 331 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQG 390
            ++  A+ Y+HS     I HRDIK  NI L      K+ DFGIS+ + +    L  T+ G
Sbjct: 110 VQLCLALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVL-SSTVDLAKTVVG 165

Query: 391 TFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKE- 449
           T  YL PE  Q+  +  KSD++S G VL EL T K P  F    E  NL    + LA + 
Sbjct: 166 TPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHP--F----EGENL----LELALKI 215

Query: 450 -NQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQV 493
                  + ++ + E        +  L    L+ + ++RP++ Q+
Sbjct: 216 LKGQYPPIPSQYSSE--------LRNLVSSLLQKDPEERPSIAQI 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  139 bits (352), Expect = 7e-38
 Identities = 67/209 (32%), Positives = 100/209 (47%), Gaps = 25/209 (11%)

Query: 224 LGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCL 282
           +G+GGFG VYK      G  VA+K  K   K +  + INE+ IL +  H +IVK  G  L
Sbjct: 8   IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67

Query: 283 ETEVPVLVYEYISSGTLSHHIHDHQQQ-QEQKQKQELSSLSWENRVRVAC---EVAGAVA 338
           + +   +V E+ S G+L   +    Q   E +               +A    E+   + 
Sbjct: 68  KKDELWIVMEFCSGGSLKDLLKSTNQTLTESQ---------------IAYVCKELLKGLE 112

Query: 339 YMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPE 398
           Y+H   S  I HRDIK++NILL      K+ DFG+S  +    T    T+ GT  ++ PE
Sbjct: 113 YLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQL--SDTKARNTMVGTPYWMAPE 167

Query: 399 YFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
                 +  K+D++S G+  +EL  GK P
Sbjct: 168 VINGKPYDYKADIWSLGITAIELAEGKPP 196

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  138 bits (348), Expect = 3e-36
 Identities = 79/289 (27%), Positives = 125/289 (43%), Gaps = 31/289 (10%)

Query: 217 NYNQSRFLGQGGFGTVYKGMLPDGSIVAVKR---SKEIDKTQIHQFINEVVILSQINH-R 272
           +Y   R LG+G FG VY     D  +VA+K      E    ++ +F+ E+ IL+ +NH  
Sbjct: 1   SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58

Query: 273 HIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACE 332
           +IVKL     +     LV EY+  G+L   +    ++           LS    + +  +
Sbjct: 59  NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRK---------GPLSESEALFILAQ 109

Query: 333 VAGAVAYMHSSASIPIFHRDIKSSNILLD-DKFSAKVSDFGISRSIPNDKTH-----LTT 386
           +  A+ Y+HS     I HRDIK  NILLD D    K+ DFG+++ +P+  +      L +
Sbjct: 110 ILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPS 166

Query: 387 TIQGTFGYLDPEYFQSSQF---TDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACF 443
           T  GT GY+ PE          +  SD++S G+ L ELLTG  P    +     +     
Sbjct: 167 TSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKI 226

Query: 444 ISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQ 492
           I       L   L     +   +      ++L  + L  + K R +   
Sbjct: 227 ILELPTPSLASPLSPSNPELISKA----ASDLLKKLLAKDPKNRLSSSS 271

Length = 384

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  129 bits (326), Expect = 7e-34
 Identities = 68/217 (31%), Positives = 108/217 (49%), Gaps = 14/217 (6%)

Query: 222 RFLGQGGFGTVYKG----MLPDGS--IVAVKRSKEIDKTQIHQ-FINEVVILSQINHRHI 274
           R LG+G FG V+ G    + P+    +VAVK  KE       + F  E  +L+   H +I
Sbjct: 11  RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENI 70

Query: 275 VKLLGCCLETEVPVLVYEYISSGTLSHHI--HDHQQQQEQKQKQELSSLSWENRVRVACE 332
           VK  G C E + P++V+EY+  G L+  +  H       +     +  L+    +++A +
Sbjct: 71  VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130

Query: 333 VAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI-PNDKTHLTTTIQGT 391
           +A  + Y+   AS    HRD+ + N L+      K+ DFG+SR +   D   +       
Sbjct: 131 IASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLP 187

Query: 392 FGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
             ++ PE     +FT +SDV+SFGVVL E+ T GK+P
Sbjct: 188 IRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  121 bits (307), Expect = 2e-31
 Identities = 66/217 (30%), Positives = 109/217 (50%), Gaps = 25/217 (11%)

Query: 217 NYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKR--SKEIDKTQIHQFINEVVILSQINHRH 273
           NY     +G+G FG VYKG+ L  G  VA+K+   ++I +  +   + E+ +L  + H +
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 274 IVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVAC-- 331
           IVK +G    ++   ++ EY  +G+L   I       E        SL       VA   
Sbjct: 61  IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPE--------SL-------VAVYV 105

Query: 332 -EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQG 390
            +V   +AY+H      + HRDIK++NIL       K++DFG++  + ND +    ++ G
Sbjct: 106 YQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKL-NDVSKDDASVVG 161

Query: 391 TFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
           T  ++ PE  + S  +  SD++S G  ++ELLTG  P
Sbjct: 162 TPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPP 198

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  121 bits (307), Expect = 2e-31
 Identities = 76/276 (27%), Positives = 120/276 (43%), Gaps = 37/276 (13%)

Query: 223 FLGQGGFGTVYKGML-PDGSIVAVKRSKE-IDKTQIHQFINEVVILSQINHRHIVKLLGC 280
            LGQG  G VYK    P G I A+K+     D+    Q + E+  L      ++VK  G 
Sbjct: 8   VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67

Query: 281 CLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYM 340
             +     +V EY+  G+L     D  ++  +  +  L+         +A ++   + Y+
Sbjct: 68  FYKEGEISIVLEYMDGGSL----ADLLKKVGKIPEPVLAY--------IARQILKGLDYL 115

Query: 341 HSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYF 400
           H+   I   HRDIK SN+L++ K   K++DFGIS+ + N       T  GT  Y+ PE  
Sbjct: 116 HTKRHI--IHRDIKPSNLLINSKGEVKIADFGISKVLENTLD-QCNTFVGTVTYMSPERI 172

Query: 401 QSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEILD--- 457
           Q   ++  +D++S G+ LLE   GK P               F  L     +  I D   
Sbjct: 173 QGESYSYAADIWSLGLTLLECALGKFPFLPPG-------QPSFFEL-----MQAICDGPP 220

Query: 458 -ARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQ 492
            +  A+E   E      +    CL+ + KKRP+  +
Sbjct: 221 PSLPAEEFSPE----FRDFISACLQKDPKKRPSAAE 252

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  119 bits (300), Expect = 1e-30
 Identities = 78/281 (27%), Positives = 129/281 (45%), Gaps = 35/281 (12%)

Query: 217 NYNQSRFLGQGGFG--TVYKGMLPDGSIVAVKRS--KEIDKTQIHQFINEVVILSQINHR 272
           +Y   R LG+G FG  T+Y+    D S+V  K      + + +    +NE+VILS + H 
Sbjct: 1   HYIPIRVLGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHP 59

Query: 273 HIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACE 332
           +I+      ++    ++  EY + GTL   I   Q+ Q  +++  L  L          +
Sbjct: 60  NIIAYYNHFMDDNTLLIEMEYANGGTLYDKI-VRQKGQLFEEEMVLWYLF---------Q 109

Query: 333 VAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTF 392
           +  AV+Y+H      I HRDIK+ NI L      K+ DFGIS+ I   +  +  T+ GT 
Sbjct: 110 IVSAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLGDFGISK-ILGSEYSMAETVVGTP 165

Query: 393 GYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQL 452
            Y+ PE  Q  ++  KSD+++ G VL ELL         R  +  N +   + + + N  
Sbjct: 166 YYMSPELCQGVKYNFKSDIWALGCVLYELL------TLKRTFDATNPLNLVVKIVQGNY- 218

Query: 453 LEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQV 493
              + +  + E        +  L    L+ + +KRPT  +V
Sbjct: 219 -TPVVSVYSSE--------LISLVHSLLQQDPEKRPTADEV 250

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  119 bits (299), Expect = 2e-30
 Identities = 70/273 (25%), Positives = 126/273 (46%), Gaps = 43/273 (15%)

Query: 224 LGQGGFGTVYKGMLP-DGSIVAVKRS--KEIDKTQIHQFINEVVILSQINHRHIVKLLGC 280
           +G+G FG V+K +   D  + A+K+    ++++ +  + I+E  +L++++  +I++    
Sbjct: 8   IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYES 67

Query: 281 CLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYM 340
            L+     +V EY  +G L   +            Q    L  +   R   ++   +A++
Sbjct: 68  FLDKGKLNIVMEYAENGDLHKLLK----------MQRGRPLPEDQVWRFFIQILLGLAHL 117

Query: 341 HSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYF 400
           HS     I HRDIKS N+ LD   + K+ D G+++ + +D T+   TI GT  YL PE  
Sbjct: 118 HSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLL-SDNTNFANTIVGTPYYLSPELC 173

Query: 401 QSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEILDARV 460
           +   + +KSDV++ GVVL E  TGK P       +  N  A  + + +            
Sbjct: 174 EDKPYNEKSDVWALGVVLYECCTGKHPF------DANNQGALILKIIR------------ 215

Query: 461 AKEAREEDIGAM-----AELAMRCLRLNSKKRP 488
                   +  M     A+L  +CL  + ++RP
Sbjct: 216 ---GVFPPVSQMYSQQLAQLIDQCLTKDYRQRP 245

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  117 bits (295), Expect = 6e-30
 Identities = 74/210 (35%), Positives = 105/210 (50%), Gaps = 24/210 (11%)

Query: 224 LGQGGFGTVYKGMLPD-GSIVAVK---RSKEIDKTQIHQFINEVVILSQINHRHIVKLLG 279
           LG+G FG V      D G + A+K   + K I + ++   + E  ILS+INH  IVKL  
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59

Query: 280 CCLETEVPV-LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRV-ACEVAGAV 337
              +TE  + LV EY   G L  H+             +    S E R R  A E+  A+
Sbjct: 60  YAFQTEEKLYLVLEYAPGGELFSHL------------SKEGRFS-EERARFYAAEIVLAL 106

Query: 338 AYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDP 397
            Y+HS     I +RD+K  NILLD     K++DFG+++ + ++ +  T T  GT  YL P
Sbjct: 107 EYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSR-TNTFCGTPEYLAP 162

Query: 398 EYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
           E      +    D +S GV+L E+LTGK P
Sbjct: 163 EVLLGKGYGKAVDWWSLGVLLYEMLTGKPP 192

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  118 bits (297), Expect = 7e-30
 Identities = 73/252 (28%), Positives = 117/252 (46%), Gaps = 34/252 (13%)

Query: 221 SRFLGQGGFGTVYKGMLP-----DGSIVAVKRSK-EIDKTQIHQFINEVVILSQINHRHI 274
            + LG+G FG V            G  VAVK      ++     F  E+ IL  ++H +I
Sbjct: 9   IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENI 68

Query: 275 VKLLGCCLET--EVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACE 332
           VK  G C +       L+ EY+ SG+L  ++  H+ Q   K+            +  + +
Sbjct: 69  VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKR-----------LLLFSSQ 117

Query: 333 VAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQG-- 390
           +   + Y+ S   I   HRD+ + NIL++ +   K+SDFG+++ +P DK +      G  
Sbjct: 118 ICKGMDYLGSQRYI---HRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGES 174

Query: 391 -TFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPIC-----FARV---EEERNLVA 441
             F Y  PE  ++S+F+  SDV+SFGV L EL T   P       F R+    + + +V 
Sbjct: 175 PIFWY-APECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVT 233

Query: 442 CFISLAKENQLL 453
             + L KE + L
Sbjct: 234 RLLELLKEGERL 245

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  116 bits (294), Expect = 1e-29
 Identities = 78/281 (27%), Positives = 126/281 (44%), Gaps = 40/281 (14%)

Query: 223 FLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQI-----HQFINEVVILSQINHRHIVK 276
            +G+G FGTV K     DG I+     KEID   +      Q ++EV IL ++ H +IV+
Sbjct: 7   TIGKGSFGTVRKVRRKSDGKILV---WKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVR 63

Query: 277 LLGCCL--ETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVA 334
                +    +   +V EY   G L+  I        QK K+E   +  E   R+  ++ 
Sbjct: 64  YYDRIIDRSNQTLYIVMEYCEGGDLAQLI--------QKCKKERKYIEEEFIWRILTQLL 115

Query: 335 GAVAYMH--SSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTF 392
            A+   H  S     + HRD+K +NI LD   + K+ DFG+++ + +D +    T  GT 
Sbjct: 116 LALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHD-SSFAKTYVGTP 174

Query: 393 GYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICF-ARVEEERNLVACFISLAKENQ 451
            Y+ PE      + +KSD++S G ++ EL     P  F AR + +        S  KE +
Sbjct: 175 YYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP--FTARNQLQ------LASKIKEGK 226

Query: 452 LLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQ 492
              I   R + E          E+    L ++  KRP+ ++
Sbjct: 227 FRRI-PYRYSSELN--------EVIKSMLNVDPDKRPSTEE 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score =  117 bits (293), Expect = 2e-29
 Identities = 67/215 (31%), Positives = 107/215 (49%), Gaps = 14/215 (6%)

Query: 224 LGQGGFGTVY----KGMLP--DGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKL 277
           LG+G FG V+      +LP  D  +VAVK  KE  ++    F  E  +L+ + H+HIV+ 
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 278 LGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQ---EQKQKQELSSLSWENRVRVACEVA 334
            G C E    ++V+EY+  G L+  +  H          +      L+    + +A ++A
Sbjct: 73  YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132

Query: 335 GAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI-PNDKTHLTTTIQGTFG 393
             + Y+   AS+   HRD+ + N L+      K+ DFG+SR I   D   +         
Sbjct: 133 SGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189

Query: 394 YLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
           ++ PE     +FT +SD++SFGVVL E+ T GK+P
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  114 bits (286), Expect = 1e-28
 Identities = 75/279 (26%), Positives = 131/279 (46%), Gaps = 42/279 (15%)

Query: 224 LGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLE 283
           +G+G FG V  G    G  VAVK  K+ D T    F+ E  +++ + H ++V+LLG  L+
Sbjct: 14  IGKGEFGDVMLGDY-RGQKVAVKCLKD-DSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71

Query: 284 TEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSS 343
                +V EY++ G+L  ++          + +  + ++   ++  A +V   + Y+   
Sbjct: 72  GNPLYIVTEYMAKGSLVDYL----------RSRGRAVITLAQQLGFALDVCEGMEYLEEK 121

Query: 344 ASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSS 403
                 HRD+ + N+L+ +   AKVSDFG+++     +      ++ T     PE  +  
Sbjct: 122 N---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT----APEALREK 174

Query: 404 QFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEILDARVAK- 462
           +F+ KSDV+SFG++L E+ +      F RV   R      I L       +++   V K 
Sbjct: 175 KFSTKSDVWSFGILLWEIYS------FGRVPYPR------IPLK------DVVPH-VEKG 215

Query: 463 ---EAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELE 498
              EA E     + ++   C  L+  KRPT KQ+  +L 
Sbjct: 216 YRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLA 254

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  113 bits (284), Expect = 2e-28
 Identities = 67/211 (31%), Positives = 103/211 (48%), Gaps = 23/211 (10%)

Query: 222 RFLGQGGFGTVYKGMLPD-GSIVAVK---RSKEIDKTQIHQFINEVVILSQINHRHIVKL 277
           R +G+G FG V      D   + A+K   + K ++K  +   +NE  IL ++NH  +V L
Sbjct: 6   RVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNL 65

Query: 278 LGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRV-ACEVAGA 336
                + E   LV + +  G L +H+     Q+ +           E +V+   CE+  A
Sbjct: 66  WYSFQDEENMYLVVDLLLGGDLRYHL----SQKVKFS---------EEQVKFWICEIVLA 112

Query: 337 VAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLD 396
           + Y+HS     I HRDIK  NILLD++    ++DF I+  +  D   LTT+  GT GY+ 
Sbjct: 113 LEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--LTTSTSGTPGYMA 167

Query: 397 PEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
           PE      ++   D +S GV   E L GK+P
Sbjct: 168 PEVLCRQGYSVAVDWWSLGVTAYECLRGKRP 198

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score =  112 bits (283), Expect = 5e-28
 Identities = 79/295 (26%), Positives = 137/295 (46%), Gaps = 36/295 (12%)

Query: 210 ELQRATDNYNQSRFLGQGGFGTVYKGM---LPDGSI---VAVKRSKEIDK-TQIHQFINE 262
           EL R  +     R LGQG FG VY+G+   +  G     VA+K   E     +  +F+NE
Sbjct: 2   ELPR--EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNE 59

Query: 263 VVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLS 322
             ++ + N  H+V+LLG     +  ++V E ++ G L  ++   + + E          +
Sbjct: 60  ASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGL--GPPT 117

Query: 323 WENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKT 382
            +  +++A E+A  +AY+   A+    HRD+ + N ++ +  + K+ DFG++R I  +  
Sbjct: 118 LQKFIQMAAEIADGMAYL---AAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDI-YETD 173

Query: 383 HLTTTIQGTFG--YLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNL 439
           +     +G     ++ PE  +   FT KSDV+SFGVVL E+ T  ++P            
Sbjct: 174 YYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQP------------ 221

Query: 440 VACFISLAKENQLLEILDARVAKEARE-EDIGAMAELAMRCLRLNSKKRPTMKQV 493
              +  L+ E  L  ++D           D   + EL   C + N K RPT  ++
Sbjct: 222 ---YQGLSNEEVLKFVIDGGHLDLPENCPDK--LLELMRMCWQYNPKMRPTFLEI 271

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  112 bits (281), Expect = 6e-28
 Identities = 66/207 (31%), Positives = 109/207 (52%), Gaps = 15/207 (7%)

Query: 222 RFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCC 281
           R LG G FG V++G+  +   VA+K  K  D  +   F  EV  L ++ H+H++ L   C
Sbjct: 12  RKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVC 71

Query: 282 LETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMH 341
              E   ++ E +  G+L   +        + Q   ++SL     + +AC+VA  +AY+ 
Sbjct: 72  SVGEPVYIITELMEKGSLLAFLRS-----PEGQVLPVASL-----IDMACQVAEGMAYLE 121

Query: 342 SSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQ 401
              SI   HRD+ + NIL+ +    KV+DFG++R I  D  +L++  +  + +  PE   
Sbjct: 122 EQNSI---HRDLAARNILVGEDLVCKVADFGLARLIKED-VYLSSDKKIPYKWTAPEAAS 177

Query: 402 SSQFTDKSDVYSFGVVLLELLT-GKKP 427
              F+ KSDV+SFG++L E+ T G+ P
Sbjct: 178 HGTFSTKSDVWSFGILLYEMFTYGQVP 204

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score =  111 bits (279), Expect = 2e-27
 Identities = 77/299 (25%), Positives = 135/299 (45%), Gaps = 42/299 (14%)

Query: 224 LGQGGFGTVYKGM------LPDGSIVAVKRSKE-IDKTQIHQFINEVVILSQINHRHIVK 276
           LG+G FG V K            + VAVK  KE    +++   ++E  +L Q+NH H++K
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67

Query: 277 LLGCCLETEVPVLVYEYISSGTLSHHIH------------DHQQQQEQKQKQELSSLSWE 324
           L G C +    +L+ EY   G+L   +             D  +        +  +L+  
Sbjct: 68  LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127

Query: 325 NRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHL 384
           + +  A +++  + Y+   A + + HRD+ + N+L+ +    K+SDFG+SR +  + +++
Sbjct: 128 DLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184

Query: 385 TTTIQGTF--GYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVA 441
             + +G     ++  E      +T +SDV+SFGV+L E++T G  P              
Sbjct: 185 KRS-KGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP-------------- 229

Query: 442 CFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGL 500
            +  +A E  L  +L      E  E     M  L + C +    KRPT   +S ELE +
Sbjct: 230 -YPGIAPER-LFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM 286

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score =  110 bits (278), Expect = 2e-27
 Identities = 74/234 (31%), Positives = 115/234 (49%), Gaps = 27/234 (11%)

Query: 210 ELQRATDNYNQSRFLGQGGFGTVYKG--MLPDGSI--VAVKRSK-EIDKTQIHQFINEVV 264
           E+QR  ++    R +G+G FG VY+G  M P+     VAVK  K     +   +F+ E  
Sbjct: 2   EIQR--EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAY 59

Query: 265 ILSQINHRHIVKLLGCCLETEVPV-LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSW 323
           I+ Q +H HIVKL+G    TE PV +V E    G L  ++        Q  K  L   S 
Sbjct: 60  IMRQFDHPHIVKLIGVI--TENPVWIVMELAPLGELRSYL--------QVNKYSLDLASL 109

Query: 324 ENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTH 383
              +  + +++ A+AY+ S       HRDI + N+L+      K+ DFG+SR + ++  +
Sbjct: 110 ---ILYSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYY 163

Query: 384 LTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEE 436
             +  +    ++ PE     +FT  SDV+ FGV + E+L  G KP  F  V+  
Sbjct: 164 KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKP--FQGVKNN 215

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  110 bits (277), Expect = 3e-27
 Identities = 66/218 (30%), Positives = 105/218 (48%), Gaps = 26/218 (11%)

Query: 220 QSRFLGQGGFGTVYKGM-LPDGSIVAVK--RSKEIDKTQIHQFINEVVILSQINHRHIVK 276
           +   +G G FG VY  + L  G ++AVK  R ++ D   I +  +E+ +L  + H ++VK
Sbjct: 4   RGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVK 63

Query: 277 LLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRV-ACEVAG 335
             G  +  E   +  EY S GTL              +  E   +  E+ +RV   ++  
Sbjct: 64  YYGVEVHREKVYIFMEYCSGGTLE-------------ELLEHGRILDEHVIRVYTLQLLE 110

Query: 336 AVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFG-- 393
            +AY+HS     I HRDIK +NI LD     K+ DFG +  + N+ T +   +Q   G  
Sbjct: 111 GLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTP 167

Query: 394 -YLDPEYFQSSQFTDK---SDVYSFGVVLLELLTGKKP 427
            Y+ PE     +       +D++S G V+LE+ TGK+P
Sbjct: 168 AYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  109 bits (275), Expect = 5e-27
 Identities = 67/212 (31%), Positives = 108/212 (50%), Gaps = 24/212 (11%)

Query: 224 LGQGGFGTVYKG--MLPDGSI--VAVKR-SKEIDKTQIHQFINEVVILSQINHRHIVKLL 278
           LG G FG+V KG  ++  G    VAVK   +E       +F+ E  +++Q++H  IV+L+
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 279 GCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVA 338
           G C   E  +LV E    G L  ++   ++      K+            +A +VA  +A
Sbjct: 63  GVCKG-EPLMLVMELAPLGPLLKYLKKRREIPVSDLKE------------LAHQVAMGMA 109

Query: 339 YMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTF--GYLD 396
           Y+ S   +   HRD+ + N+LL ++  AK+SDFG+SR++     +   T  G +   +  
Sbjct: 110 YLESKHFV---HRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYA 166

Query: 397 PEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
           PE     +F+ KSDV+S+GV L E  + G KP
Sbjct: 167 PECINYGKFSSKSDVWSYGVTLWEAFSYGAKP 198

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score =  109 bits (273), Expect = 7e-27
 Identities = 71/219 (32%), Positives = 112/219 (51%), Gaps = 31/219 (14%)

Query: 222 RFLGQGGFGTVYKGML--PDGSIV--AVKRSKEI-DKTQIHQFINEVVILSQINHRHIVK 276
           R +G+G FG VY G L   DG  +  AVK    I D  ++ QF+ E +I+   +H +++ 
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60

Query: 277 LLGCCLETE-VPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAG 335
           LLG CL +E  P++V  Y+  G L + I         K           + +    +VA 
Sbjct: 61  LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVK-----------DLIGFGLQVAK 109

Query: 336 AVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI-------PNDKTHLTTTI 388
            + Y+   AS    HRD+ + N +LD+ F+ KV+DFG++R I        ++ T     +
Sbjct: 110 GMEYL---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPV 166

Query: 389 QGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
           +    ++  E  Q+ +FT KSDV+SFGV+L EL+T   P
Sbjct: 167 K----WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 201

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  108 bits (273), Expect = 8e-27
 Identities = 68/212 (32%), Positives = 105/212 (49%), Gaps = 25/212 (11%)

Query: 222 RFLGQGGFGTVYKGMLPDGSIVAVKRSKE--IDKTQIHQFINEVVILSQINHRHIVKLLG 279
           R LG G FG V+ G     + VAVK  K   +       F+ E  I+ ++ H  +V+L  
Sbjct: 12  RKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEA---FLQEAQIMKKLRHDKLVQLYA 68

Query: 280 CCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAY 339
            C E E   +V EY+S G+L   +             E   L     V +A ++A  +AY
Sbjct: 69  VCSEEEPIYIVTEYMSKGSLLDFLKS----------GEGKKLRLPQLVDMAAQIAEGMAY 118

Query: 340 MHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGT---FGYLD 396
           + S   I   HRD+ + NIL+ +    K++DFG++R I +D+    T  +G      +  
Sbjct: 119 LESRNYI---HRDLAARNILVGENLVCKIADFGLARLIEDDE---YTAREGAKFPIKWTA 172

Query: 397 PEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
           PE     +FT KSDV+SFG++L E++T G+ P
Sbjct: 173 PEAANYGRFTIKSDVWSFGILLTEIVTYGRVP 204

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  107 bits (270), Expect = 2e-26
 Identities = 58/203 (28%), Positives = 101/203 (49%), Gaps = 16/203 (7%)

Query: 224 LGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQ-FINEVVILSQINHRHIVKLLGCCL 282
           +G+G FG VYKG+L   + VAVK  +      + + F+ E  IL Q +H +IVKL+G C+
Sbjct: 3   IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV 62

Query: 283 ETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHS 342
           + +   +V E +  G+L   +   + +   K+  ++S            + A  + Y+ S
Sbjct: 63  QKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSL-----------DAAAGMEYLES 111

Query: 343 SASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTT-TIQGTFGYLDPEYFQ 401
              I   HRD+ + N L+ +    K+SDFG+SR        ++    Q    +  PE   
Sbjct: 112 KNCI---HRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALN 168

Query: 402 SSQFTDKSDVYSFGVVLLELLTG 424
             ++T +SDV+S+G++L E  + 
Sbjct: 169 YGRYTSESDVWSYGILLWETFSL 191

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score =  108 bits (272), Expect = 2e-26
 Identities = 69/229 (30%), Positives = 113/229 (49%), Gaps = 31/229 (13%)

Query: 212 QRATDNYNQSRFLGQGGFGTVYKGM---LPDGSI---VAVKRSKEIDKTQIHQ-FINEVV 264
           +   D+    R LG G FG VY+G+       ++   VAVK   E    Q    F+ E +
Sbjct: 2   EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEAL 61

Query: 265 ILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWE 324
           I+S+ NH++IV+L+G   E     ++ E ++ G L   + +++ + E+      SSL+ +
Sbjct: 62  IMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERP-----SSLTMK 116

Query: 325 NRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFS---AKVSDFGISRSI---- 377
           + +  A +VA    Y+  +  I   HRDI + N LL  K     AK++DFG++R I    
Sbjct: 117 DLLFCARDVAKGCKYLEENHFI---HRDIAARNCLLTCKGPGRVAKIADFGMARDIYRAS 173

Query: 378 ---PNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT 423
                 +  L         ++ PE F    FT K+DV+SFGV+L E+ +
Sbjct: 174 YYRKGGRAMLPIK------WMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  107 bits (269), Expect = 3e-26
 Identities = 59/216 (27%), Positives = 109/216 (50%), Gaps = 31/216 (14%)

Query: 224 LGQGGFGTVYKGMLPDGS----IVAVK--RSKEIDKTQIHQFINEVVILSQINHRHIVKL 277
           +G G FG V +G L         VA+K  ++   DK ++  F+ E  I+ Q +H +I++L
Sbjct: 12  IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRL-DFLTEASIMGQFDHPNIIRL 70

Query: 278 LGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAV 337
            G   ++   +++ EY+ +G+L   + ++  +            +    V +   +A  +
Sbjct: 71  EGVVTKSRPVMIITEYMENGSLDKFLRENDGK-----------FTVGQLVGMLRGIASGM 119

Query: 338 AYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT-----IQGTF 392
            Y+   + +   HRD+ + NIL++     KVSDFG+SR + + +   TT      I+ T 
Sbjct: 120 KYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWT- 175

Query: 393 GYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
               PE     +FT  SDV+SFG+V+ E+++ G++P
Sbjct: 176 ---APEAIAYRKFTSASDVWSFGIVMWEVMSYGERP 208

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  106 bits (267), Expect = 5e-26
 Identities = 65/219 (29%), Positives = 120/219 (54%), Gaps = 30/219 (13%)

Query: 224 LGQGGFGTVYKGM-LPDGSIVAVKR---------SKEIDKTQIHQFINEVVILSQINHRH 273
           +G G FG+VY GM    G ++AVK+         SK+  ++ +     E+ +L ++ H +
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 274 IVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEV 333
           IV+ LG  L+ +   +  EY+  G+++  ++++   +E   +         N VR   ++
Sbjct: 68  IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVR---------NFVR---QI 115

Query: 334 AGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTT-----TI 388
              + Y+H+     I HRDIK +NIL+D+K   K+SDFGIS+ +  +     T     ++
Sbjct: 116 LKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSL 172

Query: 389 QGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
           QG+  ++ PE  + + +T K+D++S G +++E+LTGK P
Sbjct: 173 QGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score =  105 bits (264), Expect = 1e-25
 Identities = 75/286 (26%), Positives = 121/286 (42%), Gaps = 45/286 (15%)

Query: 224 LGQGGFGTVYKG--MLPDGSI--VAVKRSKEIDKTQIHQ-FINEVVILSQINHRHIVKLL 278
           LG G FG V +G      G +  VAVK  K    + I   F+ E  I+  ++H ++++L 
Sbjct: 3   LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62

Query: 279 GCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVA 338
           G  L T   ++V E    G+L   +              L           A ++A  + 
Sbjct: 63  GVVL-THPLMMVTELAPLGSLLDRLRKDA----------LGHFLISTLCDYAVQIANGMR 111

Query: 339 YMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGT--FGYLD 396
           Y+ S   I   HRD+ + NILL      K+ DFG+ R++P ++ H          F +  
Sbjct: 112 YLESKRFI---HRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCA 168

Query: 397 PEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQLLEI 455
           PE  ++  F+  SDV+ FGV L E+ T G++P               +  L+   Q+L+ 
Sbjct: 169 PESLRTRTFSHASDVWMFGVTLWEMFTYGEEP---------------WAGLSGS-QILKK 212

Query: 456 LDARVAK----EAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMEL 497
           +D    +    EA  +DI  +    ++C   N   RPT   +   L
Sbjct: 213 IDKEGERLERPEACPQDIYNV---MLQCWAHNPADRPTFAALREFL 255

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  105 bits (264), Expect = 2e-25
 Identities = 79/288 (27%), Positives = 135/288 (46%), Gaps = 34/288 (11%)

Query: 224 LGQGGFGTVYKG--MLPDG----SIVAVKRSKEIDKTQIHQ-FINEVVILSQINHRHIVK 276
           LG+G FG VYKG    P+     + VA+K  KE  + ++ Q F  E  ++S + H +IV 
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72

Query: 277 LLGCCLETEVPVLVYEYISSGTL-----SHHIHDHQQQQEQKQKQELSSLSWENRVRVAC 331
           LLG C + +   +++EY++ G L      +  H     +   +  + SSL   + + +A 
Sbjct: 73  LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVK-SSLDCSDFLHIAI 131

Query: 332 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI-PNDKTHLTTTIQG 390
           ++A  + Y+   +S    HRD+ + N L+ +  + K+SDFG+SR I   D   + +    
Sbjct: 132 QIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLL 188

Query: 391 TFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKE 449
              ++ PE     +FT +SD++SFGVVL E+ + G +P      +E        I + + 
Sbjct: 189 PVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE-------VIEMIRS 241

Query: 450 NQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMEL 497
            QLL            E+    +  L + C      +RP  K +   L
Sbjct: 242 RQLL---------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRL 280

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  104 bits (262), Expect = 3e-25
 Identities = 61/207 (29%), Positives = 102/207 (49%), Gaps = 15/207 (7%)

Query: 222 RFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCC 281
           R LG G FG V++G+  + + VAVK  K         F+ E  I+ ++ H  +++L   C
Sbjct: 12  RKLGAGQFGEVWEGLWNNTTPVAVKTLKP-GTMDPKDFLAEAQIMKKLRHPKLIQLYAVC 70

Query: 282 LETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMH 341
              E   +V E +  G+L           E  Q     +L     + +A +VA  +AY+ 
Sbjct: 71  TLEEPIYIVTELMKYGSL----------LEYLQGGAGRALKLPQLIDMAAQVASGMAYLE 120

Query: 342 SSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQ 401
           +   I   HRD+ + N+L+ +    KV+DFG++R I  D        +    +  PE   
Sbjct: 121 AQNYI---HRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAAL 177

Query: 402 SSQFTDKSDVYSFGVVLLELLT-GKKP 427
            ++F+ KSDV+SFG++L E++T G+ P
Sbjct: 178 YNRFSIKSDVWSFGILLTEIVTYGRMP 204

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  104 bits (261), Expect = 3e-25
 Identities = 66/227 (29%), Positives = 112/227 (49%), Gaps = 27/227 (11%)

Query: 222 RFLGQGGFGTVYK-GMLPDGSIVAVKRSK--EIDKTQIHQFINEVVILSQINHRHIVK-- 276
           + LG+G +G+VYK   L D    A+K      + + +    +NE+ IL+ +NH +I+   
Sbjct: 6   KKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYK 65

Query: 277 ---LLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEV 333
              L G  L      +V EY   G LS  I   +++++   +QE+    W    R+  ++
Sbjct: 66  EAFLDGNKL-----CIVMEYAPFGDLSKAISKRKKKRKLIPEQEI----W----RIFIQL 112

Query: 334 AGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFG 393
              +  +H      I HRD+KS+NILL      K+ D GIS+ +   K ++  T  GT  
Sbjct: 113 LRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVL---KKNMAKTQIGTPH 166

Query: 394 YLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLV 440
           Y+ PE ++   ++ KSD++S G +L E+ T   P     +++ R  V
Sbjct: 167 YMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKV 213

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  104 bits (262), Expect = 4e-25
 Identities = 61/219 (27%), Positives = 110/219 (50%), Gaps = 37/219 (16%)

Query: 224 LGQGGFGTVYKGM-LPDGS----IVAVKRSKE-IDKTQIHQFINEVVILSQINHRHIVKL 277
           LG G FGTVYKG+ +P+G      VA+K  +E        + ++E  +++ ++H H+V+L
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74

Query: 278 LGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSS---LSWENRVRVACEVA 334
           LG CL +    L+ + +  G L  ++ +H        K  + S   L+W        ++A
Sbjct: 75  LGICL-SSQVQLITQLMPLGCLLDYVRNH--------KDNIGSQYLLNW------CVQIA 119

Query: 335 GAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT-----IQ 389
             ++Y+       + HRD+ + N+L+      K++DFG+++ +  D+           I+
Sbjct: 120 KGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIK 176

Query: 390 GTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
               ++  E      +T KSDV+S+GV + EL+T G KP
Sbjct: 177 ----WMALESILHRIYTHKSDVWSYGVTVWELMTFGAKP 211

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score =  104 bits (260), Expect = 5e-25
 Identities = 82/293 (27%), Positives = 144/293 (49%), Gaps = 38/293 (12%)

Query: 214 ATDNYNQSRFLGQGGFGTVY----KGMLPDG--SIVAVKRSKEIDKTQIH-QFINEVVIL 266
           A +    SR LGQG FG VY    KG++ D   + VA+K   E    +   +F+NE  ++
Sbjct: 4   AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 63

Query: 267 SQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENR 326
            + N  H+V+LLG   + +  +++ E ++ G L  ++   + + E    Q   SL     
Sbjct: 64  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLK--KM 121

Query: 327 VRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTT 386
           +++A E+A  +AY++++  +   HRD+ + N ++ + F+ K+ DFG++R I     +   
Sbjct: 122 IQMAGEIADGMAYLNANKFV---HRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR-- 176

Query: 387 TIQGTFG-----YLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLV 440
             +G  G     ++ PE  +   FT  SDV+SFGVVL E+ T  ++P  +  +  E+ L 
Sbjct: 177 --KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP--YQGMSNEQVL- 231

Query: 441 ACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQV 493
                   E  LL+       K     D+  + EL   C + N K RP+  ++
Sbjct: 232 ----RFVMEGGLLD-------KPDNCPDM--LFELMRMCWQYNPKMRPSFLEI 271

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  104 bits (260), Expect = 5e-25
 Identities = 74/279 (26%), Positives = 134/279 (48%), Gaps = 41/279 (14%)

Query: 222 RFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQ-----IHQFINEVVILSQINHRHIV 275
             LG G FG+VY+G+ L DG   AVK     D  Q     + Q   E+ +LS++ H +IV
Sbjct: 6   ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65

Query: 276 KLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACE-VA 334
           + LG   E +   +  E +  G+L+            K  ++  S   E  +R+    + 
Sbjct: 66  QYLGTEREEDNLYIFLELVPGGSLA------------KLLKKYGSFP-EPVIRLYTRQIL 112

Query: 335 GAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGY 394
             + Y+H   ++   HRDIK +NIL+D     K++DFG+++ +   +     + +G+  +
Sbjct: 113 LGLEYLHDRNTV---HRDIKGANILVDTNGVVKLADFGMAKQV--VEFSFAKSFKGSPYW 167

Query: 395 LDPEYF-QSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLL 453
           + PE   Q   +   +D++S G  +LE+ TGK P  ++++E     VA    + +  +L 
Sbjct: 168 MAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPP--WSQLEG----VAAVFKIGRSKELP 221

Query: 454 EILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQ 492
            I D  ++ EA+        +  ++CL+ +   RPT  +
Sbjct: 222 PIPD-HLSDEAK--------DFILKCLQRDPSLRPTAAE 251

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  103 bits (259), Expect = 5e-25
 Identities = 64/208 (30%), Positives = 115/208 (55%), Gaps = 22/208 (10%)

Query: 224 LGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLE 283
           LG G FG V+ G       VA+K  +E   ++   FI E  ++ +++H ++V+L G C +
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSE-DDFIEEAKVMMKLSHPNLVQLYGVCTK 70

Query: 284 TEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSS 343
                +V EY+++G L +++   ++++ +   + L        + +  +V  A+ Y+ S+
Sbjct: 71  QRPIFIVTEYMANGCLLNYL---RERKGKLGTEWL--------LDMCSDVCEAMEYLESN 119

Query: 344 ASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGT---FGYLDPEYF 400
             I   HRD+ + N L+ +    KVSDFG++R + +D+    T+ QGT     +  PE F
Sbjct: 120 GFI---HRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY---TSSQGTKFPVKWAPPEVF 173

Query: 401 QSSQFTDKSDVYSFGVVLLELLT-GKKP 427
             S+F+ KSDV+SFGV++ E+ + GK P
Sbjct: 174 DYSRFSSKSDVWSFGVLMWEVFSEGKMP 201

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  103 bits (260), Expect = 5e-25
 Identities = 60/208 (28%), Positives = 106/208 (50%), Gaps = 24/208 (11%)

Query: 224 LGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCL 282
           LG+G +G+VYK +    G +VA+K    ++   + + I E+ IL Q +  +IVK  G   
Sbjct: 11  LGEGSYGSVYKAIHKETGQVVAIK-VVPVE-EDLQEIIKEISILKQCDSPYIVKYYGSYF 68

Query: 283 ETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAV---AY 339
           +     +V EY  +G++S  +    +   +++              +A  +   +    Y
Sbjct: 69  KNTDLWIVMEYCGAGSVSDIMKITNKTLTEEE--------------IAAILYQTLKGLEY 114

Query: 340 MHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEY 399
           +HS+  I   HRDIK+ NILL+++  AK++DFG+S     D      T+ GT  ++ PE 
Sbjct: 115 LHSNKKI---HRDIKAGNILLNEEGQAKLADFGVS-GQLTDTMAKRNTVIGTPFWMAPEV 170

Query: 400 FQSSQFTDKSDVYSFGVVLLELLTGKKP 427
            Q   + +K+D++S G+  +E+  GK P
Sbjct: 171 IQEIGYNNKADIWSLGITAIEMAEGKPP 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score =  103 bits (258), Expect = 6e-25
 Identities = 74/276 (26%), Positives = 126/276 (45%), Gaps = 30/276 (10%)

Query: 223 FLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIH-QFINEVVILSQINHRHIVKLLGCC 281
            LG+G FG V+KG L D + VAVK  KE    ++  +F++E  IL Q +H +IVKL+G C
Sbjct: 2   LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61

Query: 282 LETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMH 341
            + +   +V E +  G     +        +K+K EL +   +  V+ A + A  +AY+ 
Sbjct: 62  TQRQPIYIVMELVPGGDFLSFL--------RKKKDELKT---KQLVKFALDAAAGMAYLE 110

Query: 342 SSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQ 401
           S   I   HRD+ + N L+ +    K+SDFG+SR   +     +   Q    +  PE   
Sbjct: 111 SKNCI---HRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALN 167

Query: 402 SSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEILDARVA 461
             +++ +SDV+S+G++L E  +               L  C        Q  E ++    
Sbjct: 168 YGRYSSESDVWSYGILLWETFS---------------LGVCPYPGMTNQQAREQVEKGYR 212

Query: 462 KEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMEL 497
               ++    + ++  RC     + RP   ++  EL
Sbjct: 213 MSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKEL 248

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  103 bits (260), Expect = 8e-25
 Identities = 60/205 (29%), Positives = 98/205 (47%), Gaps = 17/205 (8%)

Query: 224 LGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCL 282
           +G+G  G VYK      G  VA+K+ + + K      INE++I+    H +IV      L
Sbjct: 27  IGEGASGEVYKATDRATGKEVAIKKMR-LRKQNKELIINEILIMKDCKHPNIVDYYDSYL 85

Query: 283 ETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHS 342
             +   +V EY+  G+L+  I            Q    ++      V  EV   + Y+HS
Sbjct: 86  VGDELWVVMEYMDGGSLTDII-----------TQNFVRMNEPQIAYVCREVLQGLEYLHS 134

Query: 343 SASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQS 402
              I   HRDIKS NILL    S K++DFG +  +  +K+    ++ GT  ++ PE  + 
Sbjct: 135 QNVI---HRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSK-RNSVVGTPYWMAPEVIKR 190

Query: 403 SQFTDKSDVYSFGVVLLELLTGKKP 427
             +  K D++S G++ +E+  G+ P
Sbjct: 191 KDYGPKVDIWSLGIMCIEMAEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  103 bits (259), Expect = 8e-25
 Identities = 70/219 (31%), Positives = 107/219 (48%), Gaps = 20/219 (9%)

Query: 216 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDK--TQIHQFINEVVILSQINHR 272
           D+Y     +G G    VY  + LP+   VA+KR  +++K  T + +   EV  +SQ NH 
Sbjct: 1   DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRI-DLEKCQTSVDELRKEVQAMSQCNHP 59

Query: 273 HIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACE 332
           ++VK     +  +   LV  Y+S G+L   +         K       L       V  E
Sbjct: 60  NVVKYYTSFVVGDELWLVMPYLSGGSLLDIM---------KSSYPRGGLDEAIIATVLKE 110

Query: 333 VAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI--PNDKTHLT-TTIQ 389
           V   + Y+HS+  I   HRDIK+ NILL +  S K++DFG+S S+    D+T     T  
Sbjct: 111 VLKGLEYLHSNGQI---HRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFV 167

Query: 390 GTFGYLDPEYFQSSQ-FTDKSDVYSFGVVLLELLTGKKP 427
           GT  ++ PE  +    +  K+D++SFG+  +EL TG  P
Sbjct: 168 GTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAP 206

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  103 bits (258), Expect = 1e-24
 Identities = 79/281 (28%), Positives = 126/281 (44%), Gaps = 48/281 (17%)

Query: 224 LGQGGFGTVYKGML--PDGSIVAVKRSK-EIDKTQIHQFINEVVILSQINHRHIVKLLGC 280
           LG G  G V K +L  P G I+AVK  + EI++    Q + E+ IL + N  +IV   G 
Sbjct: 9   LGAGNSGVVSK-VLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGA 67

Query: 281 CL-ETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAY 339
                ++  +  EY+  G+L     D   ++ Q +  E   L      ++A  V   + Y
Sbjct: 68  FYNNGDI-SICMEYMDGGSL-----DKILKEVQGRIPE-RILG-----KIAVAVLKGLTY 115

Query: 340 MHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEY 399
           +H    I   HRD+K SNIL++ +   K+ DFG+S  + N    L  T  GT  Y+ PE 
Sbjct: 116 LHEKHKI--IHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS---LAKTFVGTSSYMAPER 170

Query: 400 FQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQ----LLEI 455
            Q + ++ KSD++S G+ L+EL TG+ P                     EN     + E+
Sbjct: 171 IQGNDYSVKSDIWSLGLSLIELATGRFPY------------------PPENDPPDGIFEL 212

Query: 456 LDARVAKEA----REEDIGAMAELAMRCLRLNSKKRPTMKQ 492
           L   V +        +      +    CL  + ++RP+ K+
Sbjct: 213 LQYIVNEPPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKE 253

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score =  103 bits (258), Expect = 1e-24
 Identities = 76/298 (25%), Positives = 137/298 (45%), Gaps = 49/298 (16%)

Query: 222 RFLGQGGFGTVYKGML--PDGSI--VAVKRSK--EIDKTQIHQFINEVVILSQINHRHIV 275
           + LG+G FG+V +G L   DGS   VAVK  K      ++I +F++E   +   +H +++
Sbjct: 5   KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVM 64

Query: 276 KLLGCCLETE------VPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRV 329
           KL+G C E         P+++  ++  G L H    + +     +K  L +L     ++ 
Sbjct: 65  KLIGVCFEASSLQKIPKPMVILPFMKHGDL-HSFLLYSRLGGLPEKLPLQTL-----LKF 118

Query: 330 ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTI- 388
             ++A  + Y+ +   I   HRD+ + N +L +  +  V+DFG+S+ I +   +    I 
Sbjct: 119 MVDIALGMEYLSNRNFI---HRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIA 175

Query: 389 QGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLA 447
           +    ++  E      +T KSDV++FGV + E+ T G+ P  +  VE             
Sbjct: 176 KMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP--YPGVENH----------- 222

Query: 448 KENQLLEILD-----ARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGL 500
                 EI D      R+ +   E+ +  + +L   C R + K RPT  ++   LE +
Sbjct: 223 ------EIYDYLRHGNRLKQP--EDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  102 bits (256), Expect = 1e-24
 Identities = 63/205 (30%), Positives = 109/205 (53%), Gaps = 16/205 (7%)

Query: 224 LGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLE 283
           +G G FG V+ G   +   VA+K  +E   ++   FI E  ++ +++H  +V+L G C E
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSE-EDFIEEAQVMMKLSHPKLVQLYGVCTE 70

Query: 284 TEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSS 343
                LV+E++  G LS ++           + +    S E  + +  +V   +AY+ SS
Sbjct: 71  RSPICLVFEFMEHGCLSDYL-----------RAQRGKFSQETLLGMCLDVCEGMAYLESS 119

Query: 344 ASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSS 403
             I   HRD+ + N L+ +    KVSDFG++R + +D+   +T  +    +  PE F  S
Sbjct: 120 NVI---HRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFS 176

Query: 404 QFTDKSDVYSFGVVLLELLT-GKKP 427
           +++ KSDV+SFGV++ E+ + GK P
Sbjct: 177 KYSSKSDVWSFGVLMWEVFSEGKTP 201

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  102 bits (257), Expect = 1e-24
 Identities = 62/218 (28%), Positives = 109/218 (50%), Gaps = 18/218 (8%)

Query: 215 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSK---EIDKTQIHQFINEVVILSQIN 270
             N+   + +G+G F  VYK + L DG +VA+K+ +    +D       + E+ +L Q++
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 271 HRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLS-WENRVRV 329
           H +++K L   +E     +V E   +G LS  I     +  +KQK+ +   + W+  V  
Sbjct: 61  HPNVIKYLASFIENNELNIVLELADAGDLSRMI-----KHFKKQKRLIPERTIWKYFV-- 113

Query: 330 ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQ 389
             ++  A+ +MHS     I HRDIK +N+ +      K+ D G+ R   + KT    ++ 
Sbjct: 114 --QLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGR-FFSSKTTAAHSLV 167

Query: 390 GTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
           GT  Y+ PE    + +  KSD++S G +L E+   + P
Sbjct: 168 GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  102 bits (256), Expect = 2e-24
 Identities = 69/287 (24%), Positives = 124/287 (43%), Gaps = 54/287 (18%)

Query: 224 LGQGGFGTVYKGM-LPDGSIVAVK----------RSKEIDKTQIHQFINEVVILSQINHR 272
           +G+G +G VY  + +  G ++AVK          R     K  +    +E+  L  ++H 
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68

Query: 273 HIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQK----QELSSLSWENRVR 328
           +IV+ LG     E   +  EY+  G++   +  + + +EQ  +    Q L  L       
Sbjct: 69  NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGL------- 121

Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHL-TTT 387
                    AY+HS     I HRD+K+ N+L+D     K+SDFGIS+   +   +    +
Sbjct: 122 ---------AYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMS 169

Query: 388 IQGTFGYLDPEYFQSSQ--FTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFIS 445
           +QG+  ++ PE   S    ++ K D++S G V+LE+  G++P  ++  E     +A    
Sbjct: 170 MQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP--WSDEEA----IAAMFK 223

Query: 446 LAKENQ---LLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPT 489
           L  +     +   +   ++  A         +    C  +N   RPT
Sbjct: 224 LGNKRSAPPIPPDVSMNLSPVAL--------DFLNACFTINPDNRPT 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score =  101 bits (254), Expect = 3e-24
 Identities = 65/216 (30%), Positives = 109/216 (50%), Gaps = 22/216 (10%)

Query: 220 QSRFLGQGGFGTVYKGMLP----DGSIVAVKRSKE-IDKTQIHQFINEVVILSQINHRHI 274
           + + +G G FG V++G+L         VA+K  K    + Q   F++E  I+ Q +H +I
Sbjct: 9   KQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNI 68

Query: 275 VKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVA 334
           ++L G   + +  +++ EY+ +G L  ++ DH          E SS      +R      
Sbjct: 69  IRLEGVVTKFKPAMIITEYMENGALDKYLRDHDG--------EFSSYQLVGMLR------ 114

Query: 335 GAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFG- 393
           G  A M   + +   HRD+ + NIL++     KVSDFG+SR + +D     TT  G    
Sbjct: 115 GIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPI 174

Query: 394 -YLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
            +  PE     +FT  SDV+SFG+V+ E+++ G++P
Sbjct: 175 RWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERP 210

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score =  101 bits (254), Expect = 3e-24
 Identities = 68/208 (32%), Positives = 115/208 (55%), Gaps = 22/208 (10%)

Query: 224 LGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLE 283
           LG G FG V  G       VA+K  KE   ++  +FI E  ++ +++H  +V+L G C  
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMKLSHEKLVQLYGVC-T 69

Query: 284 TEVPV-LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHS 342
            + P+ +V EY+S+G L +++ +H ++ +  Q  E+             +V   +AY+ S
Sbjct: 70  KQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCK-----------DVCEGMAYLES 118

Query: 343 SASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTF--GYLDPEYF 400
              I   HRD+ + N L+DD+   KVSDFG+SR + +D+   T+++   F   +  PE  
Sbjct: 119 KQFI---HRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE--YTSSVGSKFPVRWSPPEVL 173

Query: 401 QSSQFTDKSDVYSFGVVLLELLT-GKKP 427
             S+F+ KSDV++FGV++ E+ + GK P
Sbjct: 174 LYSKFSSKSDVWAFGVLMWEVYSLGKMP 201

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score =  102 bits (255), Expect = 3e-24
 Identities = 67/231 (29%), Positives = 117/231 (50%), Gaps = 22/231 (9%)

Query: 216 DNYNQSRFLGQGGFGTVYK----GMLP--DGSIVAVKRSKEIDKTQIH-QFINEVVILSQ 268
           +N    R +GQG FG V++    G+LP    ++VAVK  KE     +   F  E  ++++
Sbjct: 5   NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 64

Query: 269 INHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHD----------HQQQQEQKQKQEL 318
            +H +IVKLLG C   +   L++EY++ G L+  +            H     +K     
Sbjct: 65  FDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNP 124

Query: 319 SSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI- 377
             LS   ++ +A +VA  +AY+     +   HRD+ + N L+ +    K++DFG+SR+I 
Sbjct: 125 LPLSCTEQLCIAKQVAAGMAYLSERKFV---HRDLATRNCLVGENMVVKIADFGLSRNIY 181

Query: 378 PNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
             D    +        ++ PE    +++T +SDV+++GVVL E+ + G +P
Sbjct: 182 SADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQP 232

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score =  101 bits (253), Expect = 7e-24
 Identities = 66/218 (30%), Positives = 106/218 (48%), Gaps = 15/218 (6%)

Query: 222 RFLGQGGFGTVY----KGMLP--DGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIV 275
           R LG+G FG V+      + P  D  +VAVK  K+        F  E  +L+ + H HIV
Sbjct: 11  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 70

Query: 276 KLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQ----EQKQKQELSSLSWENRVRVAC 331
           K  G C + +  ++V+EY+  G L+  +  H        + + +Q    L     + +A 
Sbjct: 71  KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 130

Query: 332 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI-PNDKTHLTTTIQG 390
           ++A  + Y+   AS    HRD+ + N L+      K+ DFG+SR +   D   +      
Sbjct: 131 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 187

Query: 391 TFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
              ++ PE     +FT +SDV+SFGV+L E+ T GK+P
Sbjct: 188 PIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  100 bits (251), Expect = 7e-24
 Identities = 80/287 (27%), Positives = 132/287 (45%), Gaps = 42/287 (14%)

Query: 217 NYNQSRFLGQGGFGTVYKGMLPD-GSIVAVKR------SKEIDKTQIHQFINEVVILSQI 269
           N+ + + LGQG FG VY     D G  +AVK+      S E  K +++    E+ +L  +
Sbjct: 3   NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKK-EVNALECEIQLLKNL 61

Query: 270 NHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVR- 328
            H  IV+  GC  + E   +  EY+  G++   +         K    L+    E   R 
Sbjct: 62  QHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQL---------KAYGALT----ETVTRK 108

Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLT--T 386
              ++   V Y+HS+    I HRDIK +NIL D   + K+ DFG S+ +    +  T   
Sbjct: 109 YTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMK 165

Query: 387 TIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISL 446
           ++ GT  ++ PE      +  K+DV+S G  ++E+LT K P  +A  E     +A    +
Sbjct: 166 SVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPP--WAEFEA----MAAIFKI 219

Query: 447 AKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQV 493
           A +    + L + V+ +AR            R    N+KKRP+ +++
Sbjct: 220 ATQPTNPQ-LPSHVSPDAR--------NFLRRTFVENAKKRPSAEEL 257

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score =  101 bits (252), Expect = 7e-24
 Identities = 66/215 (30%), Positives = 106/215 (49%), Gaps = 12/215 (5%)

Query: 222 RFLGQGGFGTVY----KGMLP--DGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIV 275
           R LG+G FG V+      + P  D  +VAVK  K+        F  E  +L+ + H HIV
Sbjct: 11  RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIV 70

Query: 276 KLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQE-QKQKQELSSLSWENRVRVACEVA 334
           K  G C+E +  ++V+EY+  G L+  +  H        +    + L+    + +A ++A
Sbjct: 71  KFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIA 130

Query: 335 GAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI-PNDKTHLTTTIQGTFG 393
             + Y+   AS    HRD+ + N L+ +    K+ DFG+SR +   D   +         
Sbjct: 131 AGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 187

Query: 394 YLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
           ++ PE     +FT +SDV+S GVVL E+ T GK+P
Sbjct: 188 WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 99.5 bits (249), Expect = 3e-23
 Identities = 59/217 (27%), Positives = 94/217 (43%), Gaps = 30/217 (13%)

Query: 218 YNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSK-EIDKTQIHQ-FINEVVILSQINHRHI 274
           Y +   LG+G +G VYK      G IVA+K+ + + ++  I    + E+ +L ++ H +I
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNI 60

Query: 275 VKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQ-----KQELSSLSWENRVRV 329
           VKLL          LV+EY     L  ++                 Q L           
Sbjct: 61  VKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLR---------- 109

Query: 330 ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQ 389
                  +AY HS     I HRD+K  NIL++     K++DFG++R+        T  + 
Sbjct: 110 ------GLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV 160

Query: 390 GTFGYLDPEYFQSSQFTDKS-DVYSFGVVLLELLTGK 425
            T  Y  PE    S+    + D++S G +  E++TGK
Sbjct: 161 -TLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 99.1 bits (247), Expect = 3e-23
 Identities = 68/283 (24%), Positives = 129/283 (45%), Gaps = 29/283 (10%)

Query: 224 LGQGGFGTVYKGMLP------DGSIVAVKRSKEIDKTQIHQ-FINEVVILSQINHRHIVK 276
           LG+G FG V+             ++V VK  ++     +   F  E+ +  +++H+++V+
Sbjct: 13  LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72

Query: 277 LLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGA 336
           LLG C E E   ++ EY   G L   +   + + E+ +   LS+   + +V +  ++A  
Sbjct: 73  LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLST---KQKVALCTQIALG 129

Query: 337 VAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLD 396
           + ++ ++  +   HRD+ + N L+  +   KVS   +S+ + N + +          +L 
Sbjct: 130 MDHLSNARFV---HRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLA 186

Query: 397 PEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQLLEI 455
           PE  Q   F+ KSDV+SFGV++ E+ T G+ P               F  L+ E  L  +
Sbjct: 187 PEAVQEDDFSTKSDVWSFGVLMWEVFTQGELP---------------FYGLSDEEVLNRL 231

Query: 456 LDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELE 498
              ++     E     + +L  RC  +N K RP+  ++   L 
Sbjct: 232 QAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 99.1 bits (247), Expect = 4e-23
 Identities = 79/297 (26%), Positives = 137/297 (46%), Gaps = 43/297 (14%)

Query: 224 LGQGGFGTVYK---GMLPD--GSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLL 278
           LG+G FG+V       L D  G +VAVK+ +      +  F  E+ IL  + H +IVK  
Sbjct: 12  LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71

Query: 279 GCCLETEVP--VLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGA 336
           G C         LV EY+  G+L  ++  H+++ + ++    +S           ++   
Sbjct: 72  GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYAS-----------QICKG 120

Query: 337 VAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQG---TFG 393
           + Y+ S   +   HRD+ + NIL++ +   K+ DFG+++ +P DK +      G    F 
Sbjct: 121 MEYLGSKRYV---HRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFW 177

Query: 394 YLDPEYFQSSQFTDKSDVYSFGVVLLELLT-----GKKPICFARV---EEERNLVAC-FI 444
           Y  PE    S+F+  SDV+SFGVVL EL T        P  F R+   +++  ++    I
Sbjct: 178 YA-PESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLI 236

Query: 445 SLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLR 501
            L K N  L       A+         +  +   C   +  +RP+  ++++++E +R
Sbjct: 237 ELLKNNGRLPAPPGCPAE---------IYAIMKECWNNDPSQRPSFSELALQVEAIR 284

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 98.8 bits (246), Expect = 4e-23
 Identities = 71/222 (31%), Positives = 109/222 (49%), Gaps = 25/222 (11%)

Query: 222 RFLGQGGFGTVYKGMLPD------GSI-VAVK--RSKEIDKTQIHQFINEVVILSQINHR 272
            FLG G FG VY+G   D      G I VAVK  R    D+ +  +F+ E  ++S  NH 
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKK-EFLKEAHLMSNFNHP 59

Query: 273 HIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACE 332
           +IVKLLG CL  E   ++ E +  G L  ++ D + ++       L  L     + +  +
Sbjct: 60  NIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKEL-----LDICLD 114

Query: 333 VAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA-----KVSDFGISRSI-PNDKTHLTT 386
           VA    Y+     I   HRD+ + N L+ +K        K+ DFG++R I  +D      
Sbjct: 115 VAKGCVYLEQMHFI---HRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEG 171

Query: 387 TIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
                  ++ PE     +FT +SDV+SFGV++ E+LT G++P
Sbjct: 172 EGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 98.0 bits (244), Expect = 6e-23
 Identities = 72/279 (25%), Positives = 134/279 (48%), Gaps = 32/279 (11%)

Query: 224 LGQGGFGTVYKGMLPD-GSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCL 282
           LG G +G VY+G+       VAVK  KE D  ++ +F+ E  ++ +I H ++V+LLG C 
Sbjct: 14  LGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 72

Query: 283 ETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHS 342
                 ++ E+++ G L  ++ +         +QE++++     + +A +++ A+ Y+  
Sbjct: 73  REPPFYIITEFMTYGNLLDYLRE-------CNRQEVNAVVL---LYMATQISSAMEYLEK 122

Query: 343 SASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQS 402
              I   HRD+ + N L+ +    KV+DFG+SR +  D        +    +  PE    
Sbjct: 123 KNFI---HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 179

Query: 403 SQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQLLEILDARVA 461
           ++F+ KSDV++FGV+L E+ T G  P  +  ++               +Q+ E+L+    
Sbjct: 180 NKFSIKSDVWAFGVLLWEIATYGMSP--YPGID--------------LSQVYELLEKGYR 223

Query: 462 KEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGL 500
            E  E     + EL   C + N   RP+  ++    E +
Sbjct: 224 MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 99.0 bits (246), Expect = 7e-23
 Identities = 69/232 (29%), Positives = 122/232 (52%), Gaps = 30/232 (12%)

Query: 204 KVFTADELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIV----AVKRSKEIDKTQIH- 257
           ++    EL+R        + LG G FGTVYKG+ +P+G  V    A+K   E    + + 
Sbjct: 2   RILKETELKRV-------KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANV 54

Query: 258 QFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQE 317
           +F++E +I++ ++H H+V+LLG CL   +  LV + +  G L  ++H+H   ++    Q 
Sbjct: 55  EFMDEALIMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLDYVHEH---KDNIGSQL 110

Query: 318 LSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI 377
           L  L+W        ++A  + Y+       + HRD+ + N+L+      K++DFG++R +
Sbjct: 111 L--LNW------CVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLL 159

Query: 378 PND-KTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
             D K +     +    ++  E     +FT +SDV+S+GV + EL+T G KP
Sbjct: 160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKP 211

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 98.0 bits (245), Expect = 7e-23
 Identities = 59/231 (25%), Positives = 94/231 (40%), Gaps = 45/231 (19%)

Query: 224 LGQGGFGTVYKGML-PDGSIVAVKRSKEIDKTQI------HQFINEVVILSQIN-HRHIV 275
           +G+G F TV            A+K    +DK Q+           E  +L+++N H  I+
Sbjct: 9   IGEGSFSTVVLAKEKETNKEYAIKI---LDKRQLIKEKKVKYVKIEKEVLTRLNGHPGII 65

Query: 276 KLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAG 335
           KL     + E    V EY  +G L  +I  +             SL  +     A E+  
Sbjct: 66  KLYYTFQDEENLYFVLEYAPNGELLQYIRKY------------GSLDEKCTRFYAAEILL 113

Query: 336 AVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQ------ 389
           A+ Y+HS     I HRD+K  NILLD     K++DFG ++ +  + +  +          
Sbjct: 114 ALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDS 170

Query: 390 -------------GTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
                        GT  Y+ PE          SD+++ G ++ ++LTGK P
Sbjct: 171 QIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 98.4 bits (245), Expect = 8e-23
 Identities = 78/299 (26%), Positives = 153/299 (51%), Gaps = 42/299 (14%)

Query: 224 LGQGGFGTVY----KGMLP-------------DGSIVAVKRSKE-IDKTQIHQFINEVVI 265
           LG+G FG V+    +GM                  +VAVK  +E  +K   + F+ E+ I
Sbjct: 13  LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72

Query: 266 LSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWEN 325
           +S++   +I++LL  C+ ++   ++ EY+ +G L+  +  H + QE  +K ++ ++S+  
Sbjct: 73  MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRH-EPQEAAEKADVVTISYST 131

Query: 326 RVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLT 385
            + +A ++A  + Y+   +S+   HRD+ + N L+   ++ K++DFG+SR++ +   +  
Sbjct: 132 LIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYY-- 186

Query: 386 TTIQG----TFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEER---N 438
             IQG       ++  E     +FT  SDV++FGV L E+LT  K   ++++ +E+   N
Sbjct: 187 -RIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIEN 245

Query: 439 LVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMEL 497
               F    ++  L         K A   D  ++ +L + C R N+K+RP+ +++   L
Sbjct: 246 TGEFFRDQGRQVYLP--------KPALCPD--SLYKLMLSCWRRNAKERPSFQEIHATL 294

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 98.1 bits (244), Expect = 1e-22
 Identities = 77/305 (25%), Positives = 145/305 (47%), Gaps = 50/305 (16%)

Query: 219 NQSRF---LGQGGFGTV----------YKGMLPDG-----SIVAVKRSK-EIDKTQIHQF 259
            Q R    LG+G FG V          + G           +VAVK  + ++ KT  + F
Sbjct: 5   QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDF 64

Query: 260 INEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELS 319
           + E+ I+S++ + +I++LLG C+  +   ++ EY+ +G L+  +   + +        + 
Sbjct: 65  LKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIP 124

Query: 320 SLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPN 379
           S+S  N + +A ++A  + Y+   AS+   HRD+ + N L+ + ++ K++DFG+SR++ +
Sbjct: 125 SVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYS 181

Query: 380 DKTHLTTTIQG----TFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEE 435
              +    IQG       ++  E     +FT  SDV++FGV L E+ T    +C    +E
Sbjct: 182 GDYY---RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT----LC----KE 230

Query: 436 ERNLVACFISLAKENQLLEILDARVAKEAREEDI-------GAMAELAMRCLRLNSKKRP 488
           +        SL  + Q++E        + R+  +         + +L MRC   + K RP
Sbjct: 231 QP------YSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRP 284

Query: 489 TMKQV 493
           T  ++
Sbjct: 285 TFNKI 289

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 97.2 bits (243), Expect = 2e-22
 Identities = 60/220 (27%), Positives = 102/220 (46%), Gaps = 40/220 (18%)

Query: 224 LGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQ---IHQFINEVVILSQINHRHIVKLLG 279
           +G+G +G VYK      G +VA+K+ +  ++ +   I   I E+ +L ++ H +IV+L  
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPI-TAIREIKLLQKLRHPNIVRLKE 65

Query: 280 CCLETEVP--VLVYEYIS---SGTLSHHIHDHQQQQEQKQ-----KQELSSLSWENRVRV 329
                      +V+EY+    +G L       + +  + Q     KQ L           
Sbjct: 66  IVTSKGKGSIYMVFEYMDHDLTGLLDSP----EVKFTESQIKCYMKQLLE---------- 111

Query: 330 ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQ 389
                  + Y+HS+    I HRDIK SNIL+++    K++DFG++R      +   T   
Sbjct: 112 ------GLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRV 162

Query: 390 GTFGYLDPE-YFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
            T  Y  PE    ++++  + D++S G +L EL  G KPI
Sbjct: 163 ITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLG-KPI 201

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 95.7 bits (238), Expect = 3e-22
 Identities = 79/281 (28%), Positives = 134/281 (47%), Gaps = 35/281 (12%)

Query: 217 NYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKR--SKEIDKTQIHQFINEVVILSQINHRH 273
            Y + R +G+G FG V+      D  +V +K+   +++ K +     NE  +L  ++H +
Sbjct: 1   KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60

Query: 274 IVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEV 333
           I++     LE +  ++V EY   GTL+ +I        QK+   L  L  +  +    ++
Sbjct: 61  IIEYYENFLEDKALMIVMEYAPGGTLAEYI--------QKRCNSL--LDEDTILHFFVQI 110

Query: 334 AGAVAYMHSSASIPIFHRDIKSSNILLDD-KFSAKVSDFGISRSIPNDKTHLTTTIQGTF 392
             A+ ++H+     I HRD+K+ NILLD  K   K+ DFGIS+ I + K+   T + GT 
Sbjct: 111 LLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISK-ILSSKSKAYTVV-GTP 165

Query: 393 GYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQL 452
            Y+ PE  +   +  KSD+++ G VL EL + K      R  E  NL A  + +      
Sbjct: 166 CYISPELCEGKPYNQKSDIWALGCVLYELASLK------RAFEAANLPALVLKIMSGTF- 218

Query: 453 LEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQV 493
              +  R + + R        +L +  L L+  KRP + Q+
Sbjct: 219 -APISDRYSPDLR--------QLILSMLNLDPSKRPQLSQI 250

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 96.3 bits (240), Expect = 5e-22
 Identities = 74/305 (24%), Positives = 134/305 (43%), Gaps = 54/305 (17%)

Query: 224 LGQGGFGTVY------------KGMLPDGS-----IVAVKRSKE-IDKTQIHQFINEVVI 265
           LG+G FG V+            K    + +     +VAVK  +          F+ EV I
Sbjct: 13  LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKI 72

Query: 266 LSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWEN 325
           LS+++  +I +LLG C       ++ EY+ +G L+  +  H   +         SLS+  
Sbjct: 73  LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKH-VAETSGLACNSKSLSFST 131

Query: 326 RVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI-PNDKTHL 384
            + +A ++A  + Y+    S+   HRD+ + N L+   ++ K++DFG+SR++  +D    
Sbjct: 132 LLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYR- 187

Query: 385 TTTIQGT----FGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLV 440
              +QG       ++  E     +FT KSDV++FGV L E+LT        R +      
Sbjct: 188 ---VQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT------LCREQP----- 233

Query: 441 ACFISLAKENQLLEILDARVAKEAREEDIGAMA--------ELAMRCLRLNSKKRPTMKQ 492
             +  L  + Q++E       ++   +              EL + C R + + RPT ++
Sbjct: 234 --YEHLTDQ-QVIENA-GHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFRE 289

Query: 493 VSMEL 497
           + + L
Sbjct: 290 IHLFL 294

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 94.3 bits (234), Expect = 1e-21
 Identities = 67/206 (32%), Positives = 107/206 (51%), Gaps = 18/206 (8%)

Query: 224 LGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLE 283
           LG G FG V+ G     + VAVK  K         F+ E  I+ ++ H  +V+L      
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAVKTLKP-GTMSPESFLEEAQIMKKLRHDKLVQLYAVV-- 70

Query: 284 TEVPV-LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHS 342
           +E P+ +V EY+S G+L   + D + +          +L   N V +A +VA  +AY+  
Sbjct: 71  SEEPIYIVTEYMSKGSLLDFLKDGEGR----------ALKLPNLVDMAAQVAAGMAYIER 120

Query: 343 SASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQS 402
              I   HRD++S+NIL+ D    K++DFG++R I +++       +    +  PE    
Sbjct: 121 MNYI---HRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY 177

Query: 403 SQFTDKSDVYSFGVVLLELLT-GKKP 427
            +FT KSDV+SFG++L EL+T G+ P
Sbjct: 178 GRFTIKSDVWSFGILLTELVTKGRVP 203

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 95.2 bits (237), Expect = 1e-21
 Identities = 81/290 (27%), Positives = 133/290 (45%), Gaps = 35/290 (12%)

Query: 224 LGQGGFGTVYKGML------PDGSIVAVKRSKEIDKTQ--IHQFINEVVILSQI-NHRHI 274
           LG+G FG V K          + S VAVK  K+ D T+  +   ++E+ ++  I  H++I
Sbjct: 20  LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKD-DATEKDLSDLVSEMEMMKMIGKHKNI 78

Query: 275 VKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSS----LSWENRVRVA 330
           + LLG C +     +V EY + G L   +   +   E     +       L+ ++ V  A
Sbjct: 79  INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138

Query: 331 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPN-DKTHLTTTIQ 389
            +VA  + ++   AS    HRD+ + N+L+ +    K++DFG++R I + D    TT  +
Sbjct: 139 YQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGR 195

Query: 390 GTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAK 448
               ++ PE      +T +SDV+SFGV+L E+ T G  P     VEE          L K
Sbjct: 196 LPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE-------LFKLLK 248

Query: 449 ENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELE 498
           E   +E    +     +E     +  L   C      +RPT KQ+  +L+
Sbjct: 249 EGYRME----KPQNCTQE-----LYHLMRDCWHEVPSQRPTFKQLVEDLD 289

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 94.3 bits (234), Expect = 1e-21
 Identities = 80/288 (27%), Positives = 140/288 (48%), Gaps = 38/288 (13%)

Query: 224 LGQGGFGTVYKGML-PDGSI--VAVKRSKE--IDKTQIHQFINEVVILSQINHRHIVKLL 278
           LG+G FG+V +G L  D SI  VAVK  K     ++++  F++E V + + +H ++++L+
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 279 GCCLETE------VPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACE 332
           G CL+T        PV++  ++  G L H    + +  +  Q      L  +  V+   +
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDL-HSFLLYSRLGDCPQ-----YLPTQMLVKFMTD 120

Query: 333 VAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTI-QGT 391
           +A  + Y+ S + I   HRD+ + N +L++  +  V+DFG+S+ I N   +    I +  
Sbjct: 121 IASGMEYLSSKSFI---HRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMP 177

Query: 392 FGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKEN 450
             ++  E      +T KSDV+SFGV + E+ T G+ P  +  VE        +  L + N
Sbjct: 178 VKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTP--YPGVENSE----IYDYLRQGN 231

Query: 451 QLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELE 498
           +L +  D           +  +  L   C  LN K RP+ + +  ELE
Sbjct: 232 RLKQPPDC----------LDGLYSLMSSCWLLNPKDRPSFETLRCELE 269

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 93.4 bits (232), Expect = 2e-21
 Identities = 67/287 (23%), Positives = 126/287 (43%), Gaps = 40/287 (13%)

Query: 218 YNQSRFLGQGGFGTVYKGMLPDGSIVAVKR------SKEIDKTQIHQFINEVVILSQINH 271
           + +   LG+G +GTVY G+   G ++AVK+      +    + +  +   EV +L  + H
Sbjct: 2   WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61

Query: 272 RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVAC 331
            +IV+ LG CL+     +  E++  G++S  +                 L      +   
Sbjct: 62  VNIVQYLGTCLDDNTISIFMEFVPGGSISSIL------------NRFGPLPEPVFCKYTK 109

Query: 332 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIP-----NDKTHLTT 386
           ++   VAY+H++  +   HRDIK +N++L      K+ DFG +R +         +++  
Sbjct: 110 QILDGVAYLHNNCVV---HRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLK 166

Query: 387 TIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISL 446
           ++ GT  ++ PE    S +  KSD++S G  + E+ TGK P   A ++     +A    +
Sbjct: 167 SMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPP--LASMDR----LAAMFYI 220

Query: 447 AKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQV 493
                L+  L    +         A  +    CL  +  +RP+  Q+
Sbjct: 221 GAHRGLMPRLPDSFS--------AAAIDFVTSCLTRDQHERPSALQL 259

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 94.2 bits (235), Expect = 2e-21
 Identities = 57/221 (25%), Positives = 96/221 (43%), Gaps = 33/221 (14%)

Query: 217 NYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQFIN-----EVVILSQIN 270
            Y + + LG+G +  VYK      G IVA+K+ K  ++ +    IN     E+ +L ++ 
Sbjct: 1   RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60

Query: 271 HRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQ---QQQEQKQ--KQELSSLSWEN 325
           H +I+ LL          LV+E++ +  L   I D        + K      L       
Sbjct: 61  HPNIIGLLDVFGHKSNINLVFEFMET-DLEKVIKDKSIVLTPADIKSYMLMTLR------ 113

Query: 326 RVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLT 385
                      + Y+HS+    I HRD+K +N+L+      K++DFG++RS  +    +T
Sbjct: 114 ----------GLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMT 160

Query: 386 TTIQGTFGYLDPE-YFQSSQFTDKSDVYSFGVVLLELLTGK 425
             +  T  Y  PE  F +  +    D++S G +  ELL   
Sbjct: 161 HQVV-TRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRV 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 93.5 bits (232), Expect = 3e-21
 Identities = 76/304 (25%), Positives = 141/304 (46%), Gaps = 39/304 (12%)

Query: 214 ATDNYNQSRFLGQGGFGTVYKGMLPD------GSIVAVKRSKEIDKTQIH-QFINEVVIL 266
           + +     R LGQG FG VY+G   D       + VAVK   E    +   +F+NE  ++
Sbjct: 4   SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVM 63

Query: 267 SQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENR 326
                 H+V+LLG   + +  ++V E ++ G L  ++   + + E    +   +L  +  
Sbjct: 64  KGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL--QEM 121

Query: 327 VRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTT 386
           +++A E+A  +AY+++   +   HRD+ + N ++   F+ K+ DFG++R I     +   
Sbjct: 122 IQMAAEIADGMAYLNAKKFV---HRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYR-- 176

Query: 387 TIQGTFG-----YLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLV 440
             +G  G     ++ PE  +   FT  SD++SFGVVL E+ +  ++P             
Sbjct: 177 --KGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP------------- 221

Query: 441 ACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQ-VSMELEG 499
             +  L+ E  L  ++D     +  +     + +L   C + N K RPT  + V++  + 
Sbjct: 222 --YQGLSNEQVLKFVMDGGYLDQP-DNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278

Query: 500 LRRS 503
           L  S
Sbjct: 279 LHPS 282

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 93.1 bits (232), Expect = 4e-21
 Identities = 58/212 (27%), Positives = 98/212 (46%), Gaps = 19/212 (8%)

Query: 217 NYNQSRFLGQGGFGTVYK-GMLPDGSIVAVKR--SKEIDKTQIHQFINEVVILSQINHRH 273
            Y     +G+G  G V+K      G  VA+K+   + ++    +Q + E+  L    H +
Sbjct: 1   RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPY 60

Query: 274 IVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEV 333
           +VKLL         VLV EY+ S  LS  + D ++   + Q +           R+  + 
Sbjct: 61  VVKLLDVFPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQVKSYM--------RMLLK- 110

Query: 334 AGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFG 393
              VAYMH++    I HRD+K +N+L+      K++DFG++R    ++  L +    T  
Sbjct: 111 --GVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRW 165

Query: 394 YLDPEYFQSSQFTDKS-DVYSFGVVLLELLTG 424
           Y  PE    ++  D   D+++ G +  ELL G
Sbjct: 166 YRAPELLYGARKYDPGVDLWAVGCIFAELLNG 197

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 93.0 bits (231), Expect = 4e-21
 Identities = 68/213 (31%), Positives = 102/213 (47%), Gaps = 28/213 (13%)

Query: 222 RFLGQGGFGTV----YKGMLPD-GSIVAVKRSKEIDKTQIHQ-FINEVVILSQINHRHIV 275
           R LG+G FG V    Y       G +VAVK  K     Q    +  E+ IL  + H +IV
Sbjct: 10  RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69

Query: 276 KLLGCCLET--EVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEV 333
           K  GCC E   +   L+ EY+  G+L  ++  H              L+    +  A ++
Sbjct: 70  KYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKH-------------KLNLAQLLLFAQQI 116

Query: 334 AGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQG--- 390
              +AY+HS   I   HRD+ + N+LLD+    K+ DFG+++++P    +      G   
Sbjct: 117 CEGMAYLHSQHYI---HRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP 173

Query: 391 TFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT 423
            F Y   E  + ++F+  SDV+SFGV L ELLT
Sbjct: 174 VFWYA-VECLKENKFSYASDVWSFGVTLYELLT 205

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 93.1 bits (231), Expect = 5e-21
 Identities = 76/308 (24%), Positives = 149/308 (48%), Gaps = 46/308 (14%)

Query: 203 AKVFTADELQRATDNYNQSRFLGQGGFGTVYKGM-LPDG-SI---VAVKRSKEIDKTQ-I 256
           A++    EL++        + LG G FGTV+KG+ +P+G SI   VA+K  ++    Q  
Sbjct: 1   ARILKETELRKL-------KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTF 53

Query: 257 HQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQ 316
            +  + ++ +  ++H +IV+LLG C    +  LV +    G+L  H+   +Q ++    Q
Sbjct: 54  QEITDHMLAMGSLDHAYIVRLLGICPGASLQ-LVTQLSPLGSLLDHV---RQHRDSLDPQ 109

Query: 317 ELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS 376
            L  L+W        ++A  + Y+     +   HR++ + NILL      +++DFG++  
Sbjct: 110 RL--LNW------CVQIAKGMYYLEEHRMV---HRNLAARNILLKSDSIVQIADFGVADL 158

Query: 377 I-PNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVE 434
           + P+DK +  +  +    ++  E     ++T +SDV+S+GV + E+++ G +P    R  
Sbjct: 159 LYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH 218

Query: 435 EERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVS 494
           E  +L+     LA+  Q+  I                +  + ++C  ++   RPT K+++
Sbjct: 219 EVPDLLEKGERLAQP-QICTI---------------DVYMVMVKCWMIDENVRPTFKELA 262

Query: 495 MELEGLRR 502
            E   + R
Sbjct: 263 NEFTRMAR 270

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 92.9 bits (231), Expect = 5e-21
 Identities = 73/277 (26%), Positives = 127/277 (45%), Gaps = 33/277 (11%)

Query: 224 LGQGGFGTVYK-GMLPDGSIVAVKRSKEID-KTQIH-QFINEVVILSQINHRHIVKLLGC 280
           LG G  G+V K   +P G+++A K+   I  K+ +  Q + E+ I+ +    +IV   G 
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMA-KKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGA 71

Query: 281 CLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYM 340
            L      +  E++  G+L             +  ++   +  E   ++A  V   + Y+
Sbjct: 72  FLNENNICMCMEFMDCGSLD------------RIYKKGGPIPVEILGKIAVAVVEGLTYL 119

Query: 341 HSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYF 400
           ++   I   HRDIK SNIL++ +   K+ DFG+S  + N    +  T  GT  Y+ PE  
Sbjct: 120 YNVHRI--MHRDIKPSNILVNSRGQIKLCDFGVSGELINS---IADTFVGTSTYMSPERI 174

Query: 401 QSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEILDARV 460
           Q  ++T KSDV+S G+ ++EL  GK P  FA    + +     +       +L++L   V
Sbjct: 175 QGGKYTVKSDVWSLGISIIELALGKFP--FAFSNIDDDGQDDPMG------ILDLLQQIV 226

Query: 461 AKEA---REEDIGA-MAELAMRCLRLNSKKRPTMKQV 493
            +        D    + +    CL  +  +RPT +Q+
Sbjct: 227 QEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQL 263

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 92.2 bits (229), Expect = 6e-21
 Identities = 57/206 (27%), Positives = 105/206 (50%), Gaps = 18/206 (8%)

Query: 224 LGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLE 283
           LG G FG V+ G     + VA+K  K+        F+ E  ++ Q+ H  +V+L      
Sbjct: 14  LGAGQFGEVWMGYYNGHTKVAIKSLKQ-GSMSPEAFLAEANLMKQLQHPRLVRLYAVV-- 70

Query: 284 TEVPV-LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHS 342
           T+ P+ ++ EY+ +G+L   +          +  E   L+    + +A ++A  +A++  
Sbjct: 71  TQEPIYIITEYMENGSLVDFL----------KTPEGIKLTINKLIDMAAQIAEGMAFIER 120

Query: 343 SASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQS 402
              I   HRD++++NIL+ +    K++DFG++R I +++       +    +  PE    
Sbjct: 121 KNYI---HRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY 177

Query: 403 SQFTDKSDVYSFGVVLLELLT-GKKP 427
             FT KSDV+SFG++L E++T G+ P
Sbjct: 178 GTFTIKSDVWSFGILLTEIVTYGRIP 203

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 91.6 bits (227), Expect = 7e-21
 Identities = 75/279 (26%), Positives = 126/279 (45%), Gaps = 36/279 (12%)

Query: 224 LGQGGFGTVYKGML-PDGSIVAVKRSKEIDKTQIH-QFINEVVILSQINHRHIVKLLGCC 281
           +G+G FG V+ G L  D + VAVK  +E     +  +F+ E  IL Q +H +IV+L+G C
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62

Query: 282 LETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMH 341
            + +   +V E +  G     +           + E   L  +  +++    A  + Y+ 
Sbjct: 63  TQKQPIYIVMELVQGGDFLTFL-----------RTEGPRLKVKELIQMVENAAAGMEYLE 111

Query: 342 SSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTT--TIQGTFGYLDPEY 399
           S   I   HRD+ + N L+ +K   K+SDFG+SR    D  + +T    Q    +  PE 
Sbjct: 112 SKHCI---HRDLAARNCLVTEKNVLKISDFGMSRE-EEDGVYASTGGMKQIPVKWTAPEA 167

Query: 400 FQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQLLEILDA 458
               +++ +SDV+SFG++L E  + G  P               + +L+ + Q  E ++ 
Sbjct: 168 LNYGRYSSESDVWSFGILLWEAFSLGAVP---------------YANLSNQ-QTREAIEQ 211

Query: 459 RVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMEL 497
            V     E    A+  L  RC   +  +RP+   V  EL
Sbjct: 212 GVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQEL 250

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 91.9 bits (228), Expect = 7e-21
 Identities = 71/219 (32%), Positives = 101/219 (46%), Gaps = 26/219 (11%)

Query: 217 NYNQSRFLGQGGFGTVY--KGMLPDGSIVAVKRSKEIDKTQI-----HQFINEVVILSQI 269
            Y   + +G+G FG +Y  K        V     KEID T++          EV++L+++
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAKSDSEHCVI----KEIDLTKMPVKEKEASKKEVILLAKM 56

Query: 270 NHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRV 329
            H +IV       E     +V EY   G L   I     +Q      E   LSW      
Sbjct: 57  KHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRI----NRQRGVLFSEDQILSW------ 106

Query: 330 ACEVAGAVAYMHSSASIPIFHRDIKSSNILLD-DKFSAKVSDFGISRSIPNDKTHLTTTI 388
             +++  + ++H      I HRDIKS NI L  +   AK+ DFGI+R + ND   L  T 
Sbjct: 107 FVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQL-NDSMELAYTC 162

Query: 389 QGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
            GT  YL PE  Q+  + +K+D++S G VL EL T K P
Sbjct: 163 VGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHP 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 92.2 bits (230), Expect = 9e-21
 Identities = 66/220 (30%), Positives = 98/220 (44%), Gaps = 31/220 (14%)

Query: 216 DNYNQSRFLGQGGFGTVYKGML----PDGSIVAVKR-SKE--IDKTQIHQFINEVVILSQ 268
           D++   + LG G FG V   ML      G   A+K  SK   +   Q+   +NE  IL  
Sbjct: 1   DDFEFIKTLGTGSFGRV---MLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQS 57

Query: 269 INHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVR 328
           I H  +V L G   +     LV EY+  G L  H+         ++         E   R
Sbjct: 58  IRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHL---------RKSGRFP----EPVAR 104

Query: 329 V-ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
             A +V  A+ Y+HS     I +RD+K  N+LLD     K++DFG ++ +       T T
Sbjct: 105 FYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR----TYT 157

Query: 388 IQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
           + GT  YL PE   S  +    D ++ G+++ E+L G  P
Sbjct: 158 LCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 91.9 bits (228), Expect = 1e-20
 Identities = 60/212 (28%), Positives = 106/212 (50%), Gaps = 20/212 (9%)

Query: 218 YNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVK 276
           Y +   +GQG  GTVY  + +  G  VA+K+     + +    INE++++ +  H +IV 
Sbjct: 21  YTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVN 80

Query: 277 LLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVAC-EVAG 335
            L   L  +   +V EY++ G+L+  + +                  E ++   C E   
Sbjct: 81  YLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD--------------EGQIAAVCRECLQ 126

Query: 336 AVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYL 395
           A+ ++HS+  I   HRDIKS NILL    S K++DFG    I  +++  +T + GT  ++
Sbjct: 127 ALEFLHSNQVI---HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWM 182

Query: 396 DPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
            PE      +  K D++S G++ +E++ G+ P
Sbjct: 183 APEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 91.2 bits (226), Expect = 1e-20
 Identities = 55/207 (26%), Positives = 102/207 (49%), Gaps = 15/207 (7%)

Query: 222 RFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCC 281
           + LG G FG V+ G   + + VAVK  K      +  F+ E  ++  + H  +V+L    
Sbjct: 12  KKLGAGQFGEVWMGYYNNSTKVAVKTLKP-GTMSVQAFLEEANLMKTLQHDKLVRLYAVV 70

Query: 282 LETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMH 341
            + E   ++ EY++ G+L   +          +  E   +     +  + ++A  +AY+ 
Sbjct: 71  TKEEPIYIITEYMAKGSLLDFL----------KSDEGGKVLLPKLIDFSAQIAEGMAYIE 120

Query: 342 SSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQ 401
               I   HRD++++N+L+ +    K++DFG++R I +++       +    +  PE   
Sbjct: 121 RKNYI---HRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAIN 177

Query: 402 SSQFTDKSDVYSFGVVLLELLT-GKKP 427
              FT KSDV+SFG++L E++T GK P
Sbjct: 178 FGSFTIKSDVWSFGILLYEIVTYGKIP 204

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 91.1 bits (226), Expect = 2e-20
 Identities = 66/288 (22%), Positives = 133/288 (46%), Gaps = 38/288 (13%)

Query: 217 NYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQ------FINEVVILSQI 269
            + + + LG G F + Y+   +  G+++AVK+   +  T   Q         E+ +++++
Sbjct: 1   EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60

Query: 270 NHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRV 329
           NH HI+++LG   E     L  E+++ G++SH +  +   +E        ++     +  
Sbjct: 61  NHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKE--------AVI----INY 108

Query: 330 ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK-FSAKVSDFGISRSIPNDKT---HLT 385
             ++   ++Y+H +    I HRD+K +N+L+D      +++DFG +  +    T      
Sbjct: 109 TEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQ 165

Query: 386 TTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFIS 445
             + GT  ++ PE  +  Q+    DV+S G V++E+ T K P      E+  N +A    
Sbjct: 166 GQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP---WNAEKHSNHLAL--- 219

Query: 446 LAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQV 493
                 + +I  A  A    E     + ++ +RCL L  + RP  +++
Sbjct: 220 ------IFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSREL 261

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 94.9 bits (236), Expect = 2e-20
 Identities = 86/362 (23%), Positives = 155/362 (42%), Gaps = 47/362 (12%)

Query: 153 LGFLSVVVVGCYLYRFFKDKRNRMLKEKLFKQNGGYLLQQQLSSCGSSERAKVFTADELQ 212
           LG   V+ +  + + F + + N  LK ++  ++G + LQ        S+ +K  T +++ 
Sbjct: 636 LGAFLVLALVAFGFVFIRGRNNLELK-RVENEDGTWELQ-----FFDSKVSKSITINDIL 689

Query: 213 RATDNYNQSRFLGQGGFGTVYKGMLPDGSI-VAVKRSKEIDKTQIHQFINEVVILSQINH 271
            +    N    + +G  G  YKG      +   VK   +++        +E+  + ++ H
Sbjct: 690 SSLKEEN---VISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPS----SEIADMGKLQH 742

Query: 272 RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVAC 331
            +IVKL+G C   +   L++EYI    LS               + L +LSWE R ++A 
Sbjct: 743 PNIVKLIGLCRSEKGAYLIHEYIEGKNLS---------------EVLRNLSWERRRKIAI 787

Query: 332 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGT 391
            +A A+ ++H   S  +   ++    I++D K    +    +   +  D     ++    
Sbjct: 788 GIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISS---- 842

Query: 392 FGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERN--LVA----CFIS 445
             Y+ PE  ++   T+KSD+Y FG++L+ELLTGK P   A  E   +  +V     C+  
Sbjct: 843 -AYVAPETRETKDITEKSDIYGFGLILIELLTGKSP---ADAEFGVHGSIVEWARYCYSD 898

Query: 446 LAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEG-LRRSQ 504
              +  +   +   V+    E  I  +  LA+ C   +   RP    V   LE   R S 
Sbjct: 899 CHLDMWIDPSIRGDVSVNQNE--IVEVMNLALHCTATDPTARPCANDVLKTLESASRSSS 956

Query: 505 RC 506
            C
Sbjct: 957 SC 958

Length = 968

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 90.4 bits (225), Expect = 3e-20
 Identities = 65/218 (29%), Positives = 97/218 (44%), Gaps = 32/218 (14%)

Query: 224 LGQGGFGTVY---KGMLPDGSIVAVK---RSKEIDKTQIHQFINEVVILSQINHRHIVKL 277
           + +G +G V+   K     G I A+K   ++  I K Q+ Q + E  ILSQ    ++VKL
Sbjct: 1   ISKGAYGRVFLAKKKST--GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL 58

Query: 278 LGCCLETEVPV-LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGA 336
                + +  + LV EY+  G L+  + +            + SL  +       E+  A
Sbjct: 59  Y-YSFQGKKNLYLVMEYLPGGDLASLLEN------------VGSLDEDVARIYIAEIVLA 105

Query: 337 VAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGIS------RSI-PNDKTHLTTTIQ 389
           + Y+HS     I HRD+K  NIL+D     K++DFG+S      R I  ND       I 
Sbjct: 106 LEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIV 162

Query: 390 GTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
           GT  Y+ PE       +   D +S G +L E L G  P
Sbjct: 163 GTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPP 200

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 90.0 bits (223), Expect = 3e-20
 Identities = 63/212 (29%), Positives = 109/212 (51%), Gaps = 24/212 (11%)

Query: 224 LGQGGFGTVYKG---MLPDGSIVAVK--RSKEIDKTQIHQFINEVVILSQINHRHIVKLL 278
           LG G FGTV KG   M      VAVK  ++   D     + + E  ++ Q+++ +IV+++
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 279 GCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVA 338
           G C E E  +LV E    G L+  +   Q+ +   +K         N   +  +V+  + 
Sbjct: 63  GIC-EAESWMLVMELAELGPLNKFL---QKNKHVTEK---------NITELVHQVSMGMK 109

Query: 339 YMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTF--GYLD 396
           Y+  +  +   HRD+ + N+LL  +  AK+SDFG+S+++  D+ +      G +   +  
Sbjct: 110 YLEETNFV---HRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYA 166

Query: 397 PEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
           PE     +F+ KSDV+SFGV++ E  + G+KP
Sbjct: 167 PECMNYYKFSSKSDVWSFGVLMWEAFSYGQKP 198

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 90.3 bits (224), Expect = 3e-20
 Identities = 63/230 (27%), Positives = 99/230 (43%), Gaps = 33/230 (14%)

Query: 210 ELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSI-VAVKRSKEIDKTQIHQFINEVVILSQ 268
           E +   D   +   LG+G +G VY        + +A+K   E D   +     E+ + S 
Sbjct: 2   EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSY 61

Query: 269 INHRHIVKLLGCCLETEVPVLVYEYISSGTLSH-------HIHDHQQQQEQKQKQELSSL 321
           + HR+IV+ LG   E     +  E +  G+LS         + D++Q      KQ L  L
Sbjct: 62  LKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGL 121

Query: 322 SWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA--KVSDFGISRSIPN 379
                            Y+H +    I HRDIK  N+L+ + +S   K+SDFG S+ +  
Sbjct: 122 K----------------YLHDNQ---IVHRDIKGDNVLV-NTYSGVVKISDFGTSKRLAG 161

Query: 380 DKTHLTTTIQGTFGYLDPEYFQSSQ--FTDKSDVYSFGVVLLELLTGKKP 427
                T T  GT  Y+ PE        +   +D++S G  ++E+ TGK P
Sbjct: 162 INP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPP 210

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 90.4 bits (224), Expect = 3e-20
 Identities = 75/288 (26%), Positives = 132/288 (45%), Gaps = 34/288 (11%)

Query: 224 LGQGGFGTVYKGML-----PDGSIVAVKRSKEIDKTQ-IHQFINEVVILSQINHRHIVKL 277
           LG+  FG +YKG L         +VA+K  K+I+  Q   +F  E  ++++++H +IV L
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72

Query: 278 LGCCLETEVPVLVYEYISSGTLSHHI-----HDHQQQQEQKQKQELSSLSWENRVRVACE 332
           LG   + +   +++EY++ G L   +     H        +     SSL   + + +A +
Sbjct: 73  LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132

Query: 333 VAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI-PNDKTHLTTTIQGT 391
           +A  + Y+ S   +   H+D+ + NIL+ ++   K+SD G+SR I   D   +       
Sbjct: 133 IAAGMEYLSSHFFV---HKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189

Query: 392 FGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPIC-FARVEEERNLVACFISLAKE 449
             ++ PE     +F+  SD++SFGVVL E+ + G +P   F+  E         I + ++
Sbjct: 190 IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE--------VIEMVRK 241

Query: 450 NQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMEL 497
            QLL            E+    M  L   C +    +RP  K +   L
Sbjct: 242 RQLL---------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRL 280

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 89.9 bits (223), Expect = 4e-20
 Identities = 62/207 (29%), Positives = 111/207 (53%), Gaps = 16/207 (7%)

Query: 222 RFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCC 281
           + LG G FG V+ G       VA+K   E   ++   FI E  ++ +++H  +V+L G C
Sbjct: 10  KELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSE-EDFIEEAKVMMKLSHPKLVQLYGVC 68

Query: 282 LETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMH 341
            + +   +V E++ +G L +++   +Q+Q +  K  L S+  +      CE    + Y+ 
Sbjct: 69  TQQKPLYIVTEFMENGCLLNYL---RQRQGKLSKDMLLSMCQD-----VCE---GMEYLE 117

Query: 342 SSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQ 401
            ++ I   HRD+ + N L+      KVSDFG++R + +D+   ++  +    +  PE F 
Sbjct: 118 RNSFI---HRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFN 174

Query: 402 SSQFTDKSDVYSFGVVLLELLT-GKKP 427
            S+++ KSDV+SFGV++ E+ T GK P
Sbjct: 175 FSKYSSKSDVWSFGVLMWEVFTEGKMP 201

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 90.5 bits (225), Expect = 4e-20
 Identities = 56/212 (26%), Positives = 101/212 (47%), Gaps = 20/212 (9%)

Query: 218 YNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQFIN--EVVILSQINHRHI 274
           Y +   +G+G +G VYK      G IVA+K+ K   +++        E+ +L ++NH +I
Sbjct: 1   YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60

Query: 275 VKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVA 334
           +KLL          LV+E++ +  L   I D Q+   +     + S  ++        + 
Sbjct: 61  IKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESL---IKSYLYQ--------LL 108

Query: 335 GAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGY 394
             +A+ HS     I HRD+K  N+L++ +   K++DFG++RS  +     T  +  T  Y
Sbjct: 109 QGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYV-VTRWY 164

Query: 395 LDPE-YFQSSQFTDKSDVYSFGVVLLELLTGK 425
             PE       ++   D++S G +  ELL+ +
Sbjct: 165 RAPELLLGDKGYSTPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 89.9 bits (223), Expect = 7e-20
 Identities = 79/296 (26%), Positives = 140/296 (47%), Gaps = 44/296 (14%)

Query: 216 DNYNQSRFLGQGGFGTVYK----GMLPDGSI--VAVKRSKEI-DKTQIHQFINEVVILSQ 268
           +N +  + LG G FG V +    G+    ++  VAVK  K     ++    ++E+ I+S 
Sbjct: 35  NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94

Query: 269 I-NHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRV 327
           + NH +IV LLG C      +++ EY   G L + +          +K+E S L+ E+ +
Sbjct: 95  LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLR---------RKRE-SFLTLEDLL 144

Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
             + +VA  +A++ S   I   HRD+ + N+LL      K+ DFG++R I ND  ++   
Sbjct: 145 SFSYQVAKGMAFLASKNCI---HRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYV--- 198

Query: 388 IQGT----FGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVAC 442
           ++G       ++ PE   +  +T +SDV+S+G++L E+ + G  P     V+ +      
Sbjct: 199 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK------ 252

Query: 443 FISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELE 498
           F  L KE         R+A+         + ++   C   +  KRPT KQ+   + 
Sbjct: 253 FYKLIKEG-------YRMAQPEHAPA--EIYDIMKTCWDADPLKRPTFKQIVQLIG 299

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 88.8 bits (221), Expect = 9e-20
 Identities = 59/212 (27%), Positives = 100/212 (47%), Gaps = 27/212 (12%)

Query: 224 LGQGGFGTVYKGM-LPDGSIVAVKRSKEID----KTQIHQFINEVVILSQINHRHIVKLL 278
           +G+G FG VYK +      +VA+K    ID    + +I     E+  LSQ    +I K  
Sbjct: 9   IGKGSFGEVYKAIDKRTNQVVAIK---VIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYY 65

Query: 279 GCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVAC-EVAGAV 337
           G  L+     ++ EY   G+    +             +   L  E  +     EV   +
Sbjct: 66  GSFLKGSKLWIIMEYCGGGSCLDLL-------------KPGKLD-ETYIAFILREVLLGL 111

Query: 338 AYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDP 397
            Y+H    I   HRDIK++NILL ++   K++DFG+S  + +  +   T + GT  ++ P
Sbjct: 112 EYLHEEGKI---HRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFWMAP 167

Query: 398 EYFQSSQFTDKSDVYSFGVVLLELLTGKKPIC 429
           E  + S + +K+D++S G+  +EL  G+ P+ 
Sbjct: 168 EVIKQSGYDEKADIWSLGITAIELAKGEPPLS 199

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 90.1 bits (223), Expect = 9e-20
 Identities = 60/218 (27%), Positives = 115/218 (52%), Gaps = 23/218 (10%)

Query: 218 YNQSRFLGQGGFGTVYKGM-LPDGS----IVAVKRSKEIDKTQIHQFI-NEVVILSQINH 271
           + + + LG G FGTVYKG+ +P+G      VA+K  +E    + ++ I +E  +++ +++
Sbjct: 9   FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68

Query: 272 RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVAC 331
            H+ +LLG CL + V  L+ + +  G L  ++ +H+   +    Q L  L+W        
Sbjct: 69  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHK---DNIGSQYL--LNW------CV 116

Query: 332 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPND-KTHLTTTIQG 390
           ++A  + Y+       + HRD+ + N+L+      K++DFG+++ +  D K +     + 
Sbjct: 117 QIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKV 173

Query: 391 TFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
              ++  E      +T +SDV+S+GV + EL+T G KP
Sbjct: 174 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 211

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 88.2 bits (218), Expect = 1e-19
 Identities = 75/281 (26%), Positives = 131/281 (46%), Gaps = 42/281 (14%)

Query: 224 LGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLE 283
           LGQG FG V+ G     + VA+K  K         F+ E  ++ ++ H  +V+L      
Sbjct: 14  LGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-- 70

Query: 284 TEVPV-LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHS 342
           +E P+ +V EY+S G+L   +          + +    L     V +A ++A  +AY+  
Sbjct: 71  SEEPIYIVTEYMSKGSLLDFL----------KGEMGKYLRLPQLVDMAAQIASGMAYVER 120

Query: 343 SASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQS 402
              +   HRD++++NIL+ +    KV+DFG++R I +++       +    +  PE    
Sbjct: 121 MNYV---HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY 177

Query: 403 SQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQLLEILDARVA 461
            +FT KSDV+SFG++L EL T G+ P               +  +       E+LD +V 
Sbjct: 178 GRFTIKSDVWSFGILLTELTTKGRVP---------------YPGMVNR----EVLD-QVE 217

Query: 462 KEAR----EEDIGAMAELAMRCLRLNSKKRPTMKQVSMELE 498
           +  R     E   ++ +L  +C R   ++RPT + +   LE
Sbjct: 218 RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 258

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 88.1 bits (218), Expect = 2e-19
 Identities = 73/278 (26%), Positives = 139/278 (50%), Gaps = 40/278 (14%)

Query: 224 LGQGGFGTVYKGMLPD--GSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCC 281
           +G+G FG V   ML D  G+ VAVK  K     Q   F+ E  +++Q+ H ++V+LLG  
Sbjct: 14  IGKGEFGDV---MLGDYRGNKVAVKCIKNDATAQ--AFLAEASVMTQLRHSNLVQLLGVI 68

Query: 282 LETEVPV-LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYM 340
           +E +  + +V EY++ G+L  ++    +          S L  +  ++ + +V  A+ Y+
Sbjct: 69  VEEKGGLYIVTEYMAKGSLVDYLRSRGR----------SVLGGDCLLKFSLDVCEAMEYL 118

Query: 341 HSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYF 400
            ++  +   HRD+ + N+L+ +   AKVSDFG+++   + +      ++ T     PE  
Sbjct: 119 EANNFV---HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEAL 171

Query: 401 QSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEILDARV 460
           +  +F+ KSDV+SFG++L E+ +      F RV   R      I L     ++  ++   
Sbjct: 172 REKKFSTKSDVWSFGILLWEIYS------FGRVPYPR------IPL---KDVVPRVEKGY 216

Query: 461 AKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELE 498
             +A +     + ++  +C  L++  RP+  Q+  +LE
Sbjct: 217 KMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLE 254

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 88.8 bits (220), Expect = 2e-19
 Identities = 69/279 (24%), Positives = 131/279 (46%), Gaps = 55/279 (19%)

Query: 242 IVAVKRSK-EIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLS 300
           +VAVK  + + +K   + F+ EV ILS++   +I++LLG C++ +   ++ EY+ +G L+
Sbjct: 48  LVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLN 107

Query: 301 HHIHDHQQQQEQK-------QKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDI 353
             +  H    +++           L ++S+ + + VA ++A  + Y+   +S+   HRD+
Sbjct: 108 QFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDL 164

Query: 354 KSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQG----TFGYLDPEYFQSSQFTDKS 409
            + N L+ +  + K++DFG+SR++     +    IQG       ++  E     +FT  S
Sbjct: 165 ATRNCLVGENLTIKIADFGMSRNLYAGDYY---RIQGRAVLPIRWMAWECILMGKFTTAS 221

Query: 410 DVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEILDARVAKEARE--E 467
           DV++FGV L E+L                       L KE    E+ D +V + A E   
Sbjct: 222 DVWAFGVTLWEIL----------------------MLCKEQPYGELTDEQVIENAGEFFR 259

Query: 468 DIG-------------AMAELAMRCLRLNSKKRPTMKQV 493
           D G              + EL ++C   + ++RP+   +
Sbjct: 260 DQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDI 298

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 87.7 bits (218), Expect = 2e-19
 Identities = 59/216 (27%), Positives = 90/216 (41%), Gaps = 35/216 (16%)

Query: 224 LGQGGFGTVYKG-MLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCL 282
           +G G +G VYK   +  G +VA+K  K            E+ +L +  H +IV   G  L
Sbjct: 11  IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70

Query: 283 ETEVPVLVYEYISSGTLS--HHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYM 340
             +   +V EY   G+L   + +                 LS      V  E    +AY+
Sbjct: 71  RRDKLWIVMEYCGGGSLQDIYQVTRG-------------PLSELQIAYVCRETLKGLAYL 117

Query: 341 HSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQ------GTFGY 394
           H +  I   HRDIK +NILL +    K++DFG+S         LT TI       GT  +
Sbjct: 118 HETGKI---HRDIKGANILLTEDGDVKLADFGVS-------AQLTATIAKRKSFIGTPYW 167

Query: 395 LDPEYFQ---SSQFTDKSDVYSFGVVLLELLTGKKP 427
           + PE         +  K D+++ G+  +EL   + P
Sbjct: 168 MAPEVAAVERKGGYDGKCDIWALGITAIELAELQPP 203

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 88.5 bits (219), Expect = 2e-19
 Identities = 76/293 (25%), Positives = 137/293 (46%), Gaps = 33/293 (11%)

Query: 224 LGQGGFGTVYKGMLP-DGSIV--AVKRSKEIDKTQIHQ-FINEVVILSQI-NHRHIVKLL 278
           +G+G FG V + M+  DG  +  A+K  KE      H+ F  E+ +L ++ +H +I+ LL
Sbjct: 10  IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69

Query: 279 GCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQ----KQKQELSSLSWENRVRVACEVA 334
           G C       +  EY   G L   +   +  +      K+    S+L+ +  ++ A +VA
Sbjct: 70  GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVA 129

Query: 335 GAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTI-QGTFG 393
             + Y+     I   HRD+ + N+L+ +  ++K++DFG+SR    ++ ++  T+ +    
Sbjct: 130 TGMQYLSEKQFI---HRDLAARNVLVGENLASKIADFGLSRG---EEVYVKKTMGRLPVR 183

Query: 394 YLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQL 452
           ++  E    S +T KSDV+SFGV+L E+++ G  P C     E                L
Sbjct: 184 WMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE----------------L 227

Query: 453 LEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRSQR 505
            E L      E        + EL  +C R    +RP   Q+S++L  +  +++
Sbjct: 228 YEKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARK 280

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 87.3 bits (216), Expect = 3e-19
 Identities = 74/278 (26%), Positives = 130/278 (46%), Gaps = 42/278 (15%)

Query: 224 LGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLE 283
           +G+G FG V +G    G  VAVK  K  D T    F+ E  ++++++H+++V+LLG  L 
Sbjct: 14  IGEGEFGAVLQGEYT-GQKVAVKNIK-CDVTA-QAFLEETAVMTKLHHKNLVRLLGVILH 70

Query: 284 TEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSS 343
             + + V E +S G L + +    +          + +S    ++ + +VA  + Y+ S 
Sbjct: 71  NGLYI-VMELMSKGNLVNFLRTRGR----------ALVSVIQLLQFSLDVAEGMEYLESK 119

Query: 344 ASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPN--DKTHLTTTIQGTFGYLDPEYFQ 401
               + HRD+ + NIL+ +   AKVSDFG++R      D + L         +  PE  +
Sbjct: 120 K---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK------WTAPEALK 170

Query: 402 SSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQLLEILDARV 460
             +F+ KSDV+S+GV+L E+ + G+ P     ++E                + E ++   
Sbjct: 171 HKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE----------------VKECVEKGY 214

Query: 461 AKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELE 498
             E  E     +  L   C     KKRP+  ++  +LE
Sbjct: 215 RMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLE 252

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 87.5 bits (217), Expect = 4e-19
 Identities = 59/211 (27%), Positives = 110/211 (52%), Gaps = 16/211 (7%)

Query: 226 QGGFGTVYKGMLPDGSI-----VAVKRSKE-IDKTQIHQFINEVVILSQINHRHIVKLLG 279
           +G FG ++ G+L D        V VK  K+   + Q+   + E  +L  ++H++I+ +L 
Sbjct: 16  EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILH 75

Query: 280 CCLE-TEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVA 338
            C+E  E P ++Y Y++ G L   +    QQ    +     +LS +  V +A ++A  ++
Sbjct: 76  VCIEDGEPPFVLYPYMNWGNLKLFL----QQCRLGEANNPQALSTQQLVHMAIQIACGMS 131

Query: 339 YMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI-PNDKTHLTTTIQGTFGYLDP 397
           Y+H      + H+DI + N ++D++   K++D  +SR + P D   L         ++  
Sbjct: 132 YLHKRG---VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMAL 188

Query: 398 EYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
           E   + +++  SDV+SFGV+L EL+T G+ P
Sbjct: 189 ESLVNKEYSSASDVWSFGVLLWELMTLGQTP 219

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 87.4 bits (216), Expect = 4e-19
 Identities = 61/214 (28%), Positives = 117/214 (54%), Gaps = 23/214 (10%)

Query: 222 RFLGQGGFGTVYKGM-LPDGS----IVAVKRSKEIDKTQIH-QFINEVVILSQINHRHIV 275
           + LG G FGTVYKG+ +PDG      VA+K  +E    + + + ++E  +++ +   ++ 
Sbjct: 13  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVC 72

Query: 276 KLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAG 335
           +LLG CL + V  LV + +  G L  ++ +++   ++   Q+L  L+W        ++A 
Sbjct: 73  RLLGICLTSTVQ-LVTQLMPYGCLLDYVRENK---DRIGSQDL--LNW------CVQIAK 120

Query: 336 AVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKT-HLTTTIQGTFGY 394
            ++Y+     + + HRD+ + N+L+      K++DFG++R +  D+T +     +    +
Sbjct: 121 GMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKW 177

Query: 395 LDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
           +  E     +FT +SDV+S+GV + EL+T G KP
Sbjct: 178 MALESILHRRFTHQSDVWSYGVTVWELMTFGAKP 211

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 87.2 bits (217), Expect = 5e-19
 Identities = 59/211 (27%), Positives = 104/211 (49%), Gaps = 30/211 (14%)

Query: 224 LGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQF-----INEVVILSQIN-HRHIVK 276
           LG G FG+VY       G +VA+K+ K     + + +     + EV  L ++N H +IVK
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIKKMK----KKFYSWEECMNLREVKSLRKLNEHPNIVK 62

Query: 277 LLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVR-VACEVAG 335
           L     E +    V+EY+  G L      +Q  +++K K      S E+ +R +  ++  
Sbjct: 63  LKEVFRENDELYFVFEYME-GNL------YQLMKDRKGKP----FS-ESVIRSIIYQILQ 110

Query: 336 AVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYL 395
            +A++H       FHRD+K  N+L+      K++DFG++R I +   +  T    T  Y 
Sbjct: 111 GLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY--TDYVSTRWYR 165

Query: 396 DPEYF-QSSQFTDKSDVYSFGVVLLELLTGK 425
            PE   +S+ ++   D+++ G ++ EL T +
Sbjct: 166 APEILLRSTSYSSPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 86.5 bits (214), Expect = 5e-19
 Identities = 61/211 (28%), Positives = 110/211 (52%), Gaps = 22/211 (10%)

Query: 224 LGQGGFGTVYKG---MLPDGSIVAVKRSK-EIDKTQIHQFINEVVILSQINHRHIVKLLG 279
           LG G FG V KG   M      VA+K  K E +K+   + + E  I+ Q+++ +IV+++G
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62

Query: 280 CCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAY 339
            C E E  +LV E  S G L+  +   + +           ++  N V +  +V+  + Y
Sbjct: 63  VC-EAEALMLVMEMASGGPLNKFLSGKKDE-----------ITVSNVVELMHQVSMGMKY 110

Query: 340 MHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTF--GYLDP 397
           +     +   HRD+ + N+LL ++  AK+SDFG+S+++  D ++      G +   +  P
Sbjct: 111 LEGKNFV---HRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAP 167

Query: 398 EYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
           E     +F+ +SDV+S+G+ + E  + G+KP
Sbjct: 168 ECINFRKFSSRSDVWSYGITMWEAFSYGQKP 198

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 86.9 bits (215), Expect = 5e-19
 Identities = 79/294 (26%), Positives = 137/294 (46%), Gaps = 39/294 (13%)

Query: 222 RFLGQGGFGTVYKGMLP--DGSI--VAVKRSKE--IDKTQIHQFINEVVILSQINHRHIV 275
           R LG+G FG+V +  L   DGS   VAVK  K      + I +F+ E   + + +H +++
Sbjct: 5   RMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVI 64

Query: 276 KLLGCCLETE------VPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRV 329
           KL+G  L +       +P+++  ++  G L      H      +  +E  +L  +  VR 
Sbjct: 65  KLIGVSLRSRAKGRLPIPMVILPFMKHGDL------HTFLLMSRIGEEPFTLPLQTLVRF 118

Query: 330 ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI-PNDKTHLTTTI 388
             ++A  + Y+ S   I   HRD+ + N +L++  +  V+DFG+S+ I   D        
Sbjct: 119 MIDIASGMEYLSSKNFI---HRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCAS 175

Query: 389 QGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLA 447
           +    +L  E    + +T  SDV++FGV + E++T G+ P  +A VE        +  L 
Sbjct: 176 KLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP--YAGVENSE----IYNYLI 229

Query: 448 KENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLR 501
           K N+L +  D         ED+    EL  +C     K RP+ + +  +LE + 
Sbjct: 230 KGNRLKQPPDCL-------EDV---YELMCQCWSPEPKCRPSFQHLRDQLELIW 273

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 86.3 bits (214), Expect = 8e-19
 Identities = 61/224 (27%), Positives = 108/224 (48%), Gaps = 35/224 (15%)

Query: 218 YNQSRFLGQGGFGTVYKGM-LPDGSIVAVK----RSKEIDKTQIHQFINEVVILSQINH- 271
           Y +   +G+G +G VY+G  +P G +VA+K     + + D + I +   EV +LSQ+   
Sbjct: 3   YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQR---EVALLSQLRQS 59

Query: 272 --RHIVKLLGCCLETEVPVLVYEYISSG---TLSHHIHDHQQQQEQKQKQELSSLSWENR 326
              +I K  G  L+     ++ EY   G   TL          +     ++  S+     
Sbjct: 60  QPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLM---------KAGPIAEKYISV----- 105

Query: 327 VRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTT 386
             +  EV  A+ Y+H      + HRDIK++NIL+ +  + K+ DFG++  + N  +   +
Sbjct: 106 --IIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALL-NQNSSKRS 159

Query: 387 TIQGTFGYLDPEYFQSSQFTD-KSDVYSFGVVLLELLTGKKPIC 429
           T  GT  ++ PE     ++ D K+D++S G+ + E+ TG  P  
Sbjct: 160 TFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYS 203

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 85.9 bits (213), Expect = 1e-18
 Identities = 67/239 (28%), Positives = 108/239 (45%), Gaps = 47/239 (19%)

Query: 206 FTADELQRATDNYNQSRFLGQGGFGTVYKGML--PDGSIVAVKR-SKEIDKTQIHQFINE 262
           FTA++L+   +       +G+G FGTV K ML  P G+I+AVKR    +D+ +  + + +
Sbjct: 1   FTAEDLKDLGE-------IGRGAFGTVNK-MLHKPSGTIMAVKRIRSTVDEKEQKRLLMD 52

Query: 263 V-VILSQINHRHIVKLLGCCLETEVPVLVYEY--ISSGTLSHHIHDHQQQQEQKQKQELS 319
           + V++   +  +IVK  G         +  E   IS      ++++  +           
Sbjct: 53  LDVVMRSSDCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKS---------- 102

Query: 320 SLSWENRVRVACEVAGAVAYM------HSSASIPIFHRDIKSSNILLDDKFSAKVSDFGI 373
                    +  E+ G +A        +    + I HRD+K SNILLD   + K+ DFGI
Sbjct: 103 --------VIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGI 154

Query: 374 SRSIPND--KTHLTTTIQGTFGYLDPEYFQSSQ---FTDKSDVYSFGVVLLELLTGKKP 427
           S  + +   KT       G   Y+ PE    S    +  +SDV+S G+ L E+ TGK P
Sbjct: 155 SGQLVDSIAKTRDA----GCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFP 209

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 85.3 bits (211), Expect = 1e-18
 Identities = 61/215 (28%), Positives = 105/215 (48%), Gaps = 24/215 (11%)

Query: 222 RFLGQGGFGTVYKGMLPDGS----IVAVKRSKE--IDKTQIHQFINEVVILSQINHRHIV 275
           + +G G FG V  G L         VA+K  K    +K Q   F++E  I+ Q +H +I+
Sbjct: 10  KVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEK-QRRDFLSEASIMGQFDHPNII 68

Query: 276 KLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAG 335
            L G   +++  ++V EY+ +G+L   +  H  Q                 +++   + G
Sbjct: 69  HLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQF--------------TVIQLVGMLRG 114

Query: 336 AVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFG-- 393
             + M   + +   HRD+ + NIL++     KVSDFG+SR + +D     TT  G     
Sbjct: 115 IASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 174

Query: 394 YLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
           +  PE     +FT  SDV+S+G+V+ E+++ G++P
Sbjct: 175 WTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 209

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 84.7 bits (209), Expect = 3e-18
 Identities = 74/286 (25%), Positives = 124/286 (43%), Gaps = 33/286 (11%)

Query: 223 FLGQGGFGTVYKGMLPDGSI---VAVKRSKEIDKTQIHQ-FINEVVILSQINHR-HIVKL 277
            +G+G FG V K  +    +    A+KR KE      H+ F  E+ +L ++ H  +I+ L
Sbjct: 2   VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61

Query: 278 LGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQ----KQKQELSSLSWENRVRVACEV 333
           LG C       L  EY   G L   +   +  +            S+LS +  +  A +V
Sbjct: 62  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121

Query: 334 AGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTI-QGTF 392
           A  + Y+     I   HRD+ + NIL+ + + AK++DFG+SR     + ++  T+ +   
Sbjct: 122 ARGMDYLSQKQFI---HRDLAARNILVGENYVAKIADFGLSRG---QEVYVKKTMGRLPV 175

Query: 393 GYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQ 451
            ++  E    S +T  SDV+S+GV+L E+++ G  P C     E                
Sbjct: 176 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---------------- 219

Query: 452 LLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMEL 497
           L E L      E        + +L  +C R    +RP+  Q+ + L
Sbjct: 220 LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 265

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 84.3 bits (208), Expect = 3e-18
 Identities = 63/206 (30%), Positives = 105/206 (50%), Gaps = 18/206 (8%)

Query: 224 LGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLE 283
           LGQG FG V+ G     + VA+K  K         F+ E  I+ ++ H  +V L      
Sbjct: 14  LGQGCFGEVWMGTWNGTTKVAIKTLKP-GTMMPEAFLQEAQIMKKLRHDKLVPLYAVV-- 70

Query: 284 TEVPV-LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHS 342
           +E P+ +V E++  G+L     D  ++ + K       L     V +A ++A  +AY+  
Sbjct: 71  SEEPIYIVTEFMGKGSLL----DFLKEGDGKY------LKLPQLVDMAAQIADGMAYIER 120

Query: 343 SASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQS 402
              I   HRD++++NIL+ D    K++DFG++R I +++       +    +  PE    
Sbjct: 121 MNYI---HRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY 177

Query: 403 SQFTDKSDVYSFGVVLLELLT-GKKP 427
            +FT KSDV+SFG++L EL+T G+ P
Sbjct: 178 GRFTIKSDVWSFGILLTELVTKGRVP 203

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 83.8 bits (207), Expect = 4e-18
 Identities = 70/232 (30%), Positives = 108/232 (46%), Gaps = 31/232 (13%)

Query: 224 LGQGGFGTVYKGMLPDGSIVAVKRSK--------EIDKTQIHQFINEVVILSQINHRHIV 275
           LG+G FGTVY  ++ D   VA +R K        E++  +  Q   E  +LS+++H  IV
Sbjct: 8   LGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65

Query: 276 KLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRV-RVACEVA 334
           K     LE +   ++ EY     L   +      +E K   +  S   EN+V     ++ 
Sbjct: 66  KFHASFLERDAFCIITEYCEGRDLDCKL------EELKHTGKTLS---ENQVCEWFIQLL 116

Query: 335 GAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGY 394
             V YMH      I HRD+K+ NI L +    K+ DFG+SR +      L TT  GT  Y
Sbjct: 117 LGVHYMHQRR---ILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMG-SCDLATTFTGTPYY 171

Query: 395 LDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISL 446
           + PE  +   +  KSD++S G +L E+       C A   E +N ++  + +
Sbjct: 172 MSPEALKHQGYDSKSDIWSLGCILYEM------CCLAHAFEGQNFLSVVLRI 217

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 84.4 bits (209), Expect = 4e-18
 Identities = 60/219 (27%), Positives = 107/219 (48%), Gaps = 33/219 (15%)

Query: 216 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQFI-NEVVILSQINHRH 273
           DN+ +   +G+G  G V        G  VAVK+  ++ K Q  + + NEVVI+    H +
Sbjct: 22  DNFVK---IGEGSTGIVCIATDKSTGRQVAVKK-MDLRKQQRRELLFNEVVIMRDYQHPN 77

Query: 274 IVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACE- 332
           IV++    L  +   +V E++  G L+  +   +  +EQ              +   C  
Sbjct: 78  IVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQ--------------IATVCLA 123

Query: 333 VAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG----ISRSIPNDKTHLTTTI 388
           V  A++++H+   I   HRDIKS +ILL      K+SDFG    +S+ +P  K     ++
Sbjct: 124 VLKALSFLHAQGVI---HRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRK-----SL 175

Query: 389 QGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
            GT  ++ PE      +  + D++S G++++E++ G+ P
Sbjct: 176 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 84.2 bits (208), Expect = 4e-18
 Identities = 61/212 (28%), Positives = 96/212 (45%), Gaps = 36/212 (16%)

Query: 224 LGQGGFGTVYKGM-LPDGSIVAVKR-----SKEIDKTQIHQFINEVVILSQINHRHIVKL 277
           LG G  GTVYK   L    I+AVK      + E+ K    Q ++E+ IL + +  +I+  
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQK----QIMSELEILYKCDSPYIIGF 64

Query: 278 LGCCLETEVPVLVYEYISSGTLSHH--IHDHQQQQEQKQKQELSSLSWENRVRVACEVAG 335
            G         +  E++  G+L  +  I +H                     R+A  V  
Sbjct: 65  YGAFFVENRISICTEFMDGGSLDVYRKIPEHVLG------------------RIAVAVVK 106

Query: 336 AVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYL 395
            + Y+    S+ I HRD+K SN+L++ +   K+ DFG+S  + N    +  T  GT  Y+
Sbjct: 107 GLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---IAKTYVGTNAYM 160

Query: 396 DPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
            PE     Q+   SDV+S G+  +EL  G+ P
Sbjct: 161 APERISGEQYGIHSDVWSLGISFMELALGRFP 192

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 84.0 bits (208), Expect = 6e-18
 Identities = 66/212 (31%), Positives = 100/212 (47%), Gaps = 24/212 (11%)

Query: 224 LGQGGFGTVYKGMLPD-GSIVAVKRSKEIDKTQIH-QFINEVVILSQINHRHIVKLLGCC 281
           LG+G  G+V K  L + G I A+K         +  Q + E+ I       +IVK  G  
Sbjct: 9   LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAF 68

Query: 282 L---ETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRV--RVACEVAGA 336
           L    + + + + EY   G+L     D   ++ +K+   +       +V  ++A  V   
Sbjct: 69  LDESSSSIGIAM-EYCEGGSL-----DSIYKKVKKRGGRIGE-----KVLGKIAESVLKG 117

Query: 337 VAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLD 396
           ++Y+HS     I HRDIK SNILL  K   K+ DFG+S  + N    L  T  GT  Y+ 
Sbjct: 118 LSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS---LAGTFTGTSFYMA 171

Query: 397 PEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
           PE  Q   ++  SDV+S G+ LLE+   + P 
Sbjct: 172 PERIQGKPYSITSDVWSLGLTLLEVAQNRFPF 203

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 83.3 bits (206), Expect = 8e-18
 Identities = 59/210 (28%), Positives = 98/210 (46%), Gaps = 23/210 (10%)

Query: 224 LGQGGFGTVYKGMLPD-GSIVAVKR--SKEIDKTQIHQF-INEVVILSQINHRHIVKLLG 279
           LG+GGFG V    +   G + A K+   K + K +  Q  +NE  IL +++ R IV L  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59

Query: 280 CCLETEVPV-LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRV-ACEVAGAV 337
              ET+  + LV   ++ G L +HI++  +               E R    A ++   +
Sbjct: 60  YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFP-----------EARAIFYAAQIICGL 108

Query: 338 AYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDP 397
            ++H      I +RD+K  N+LLDD  + ++SD G++  +   K        GT GY+ P
Sbjct: 109 EHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK--IKGRAGTPGYMAP 163

Query: 398 EYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
           E  Q   +    D ++ G  L E++ G+ P
Sbjct: 164 EVLQGEVYDFSVDWFALGCTLYEMIAGRSP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 83.4 bits (206), Expect = 1e-17
 Identities = 66/215 (30%), Positives = 104/215 (48%), Gaps = 30/215 (13%)

Query: 222 RFLGQGGFGTV----YKGMLPDG----SIVAVKRSK-EIDKTQIHQFINEVVILSQINHR 272
           R LG+G FG V    Y    P+G      VAVK  K E     I     E+ IL  + H 
Sbjct: 10  RDLGEGHFGKVELCRYD---PEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHE 66

Query: 273 HIVKLLGCCLET--EVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVA 330
           +IVK  G C E       L+ E++ SG+L  ++  ++ +   KQ+           ++ A
Sbjct: 67  NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQ-----------LKYA 115

Query: 331 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT--I 388
            ++   + Y+ S   +   HRD+ + N+L++ +   K+ DFG++++I  DK + T    +
Sbjct: 116 VQICKGMDYLGSRQYV---HRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDL 172

Query: 389 QGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT 423
                +  PE    S+F   SDV+SFGV L ELLT
Sbjct: 173 DSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 84.0 bits (208), Expect = 1e-17
 Identities = 57/213 (26%), Positives = 96/213 (45%), Gaps = 25/213 (11%)

Query: 222 RFLGQGGFGTV----YKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKL 277
           + LG+G FG V     KG     ++  +K+   +    +   + E  +L+       +  
Sbjct: 1   KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60

Query: 278 LGCCLETEVPV-LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRV-ACEVAG 335
           L  C +T+  +  V EY++ G L  HI     Q+  +          E R R  A E+  
Sbjct: 61  LHSCFQTKDRLFFVMEYVNGGDLMFHI-----QRSGRFD--------EPRARFYAAEIVL 107

Query: 336 AVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISR-SIPNDKTHLTTTIQGTFGY 394
            + ++H      I +RD+K  N+LLD +   K++DFG+ +  I    T  T+T  GT  Y
Sbjct: 108 GLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TSTFCGTPDY 162

Query: 395 LDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
           + PE      +    D ++ GV+L E+L G+ P
Sbjct: 163 IAPEILSYQPYGPAVDWWALGVLLYEMLAGQSP 195

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 82.8 bits (204), Expect = 1e-17
 Identities = 58/208 (27%), Positives = 102/208 (49%), Gaps = 23/208 (11%)

Query: 224 LGQGGFGTVYKGMLPDGSIVAVKRSKEID----KTQIHQFINEVVILSQINHRHIVKLLG 279
           +G+G FG V+KG+  D     V   K ID    + +I     E+ +LSQ +  ++ K  G
Sbjct: 12  IGKGSFGEVFKGI--DNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69

Query: 280 CCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAY 339
             L+     ++ EY+  G+      D  +     + Q  + L          E+   + Y
Sbjct: 70  SYLKGTKLWIIMEYLGGGSAL----DLLRAGPFDEFQIATMLK---------EILKGLDY 116

Query: 340 MHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEY 399
           +HS   I   HRDIK++N+LL ++   K++DFG++  + + +    T + GT  ++ PE 
Sbjct: 117 LHSEKKI---HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEV 172

Query: 400 FQSSQFTDKSDVYSFGVVLLELLTGKKP 427
            Q S +  K+D++S G+  +EL  G+ P
Sbjct: 173 IQQSAYDSKADIWSLGITAIELAKGEPP 200

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 82.8 bits (205), Expect = 1e-17
 Identities = 60/209 (28%), Positives = 89/209 (42%), Gaps = 27/209 (12%)

Query: 224 LGQGGFGTVYKGMLPD-GSIVAVKRSKEIDKTQ-IHQFI-NEVVILSQINHRHIVKLLGC 280
           +G+G +G V K      G IVA+K+ KE +  + + +    EV +L Q+ H +IV L   
Sbjct: 9   VGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEA 68

Query: 281 CLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQK----QELSSLSWENRVRVACEVAGA 336
                   LV+EY+    L        +  E          + S  W+        +  A
Sbjct: 69  FRRKGRLYLVFEYVERTLL--------ELLEASPGGLPPDAVRSYIWQ--------LLQA 112

Query: 337 VAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLD 396
           +AY HS     I HRDIK  NIL+ +    K+ DFG +R++        T    T  Y  
Sbjct: 113 IAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRA 169

Query: 397 PEYFQSSQFTDKS-DVYSFGVVLLELLTG 424
           PE         K  DV++ G ++ ELL G
Sbjct: 170 PELLVGDTNYGKPVDVWAIGCIMAELLDG 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 82.8 bits (204), Expect = 1e-17
 Identities = 58/212 (27%), Positives = 106/212 (50%), Gaps = 20/212 (9%)

Query: 218 YNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVK 276
           Y +   +GQG  GTVY  + +  G  VA+K+     + +    INE++++ +  + +IV 
Sbjct: 21  YTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVN 80

Query: 277 LLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVAC-EVAG 335
            L   L  +   +V EY++ G+L+  + +                  E ++   C E   
Sbjct: 81  YLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD--------------EGQIAAVCRECLQ 126

Query: 336 AVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYL 395
           A+ ++HS+    + HRDIKS NILL    S K++DFG    I  +++  +T + GT  ++
Sbjct: 127 ALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWM 182

Query: 396 DPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
            PE      +  K D++S G++ +E++ G+ P
Sbjct: 183 APEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 82.3 bits (204), Expect = 2e-17
 Identities = 63/209 (30%), Positives = 94/209 (44%), Gaps = 23/209 (11%)

Query: 224 LGQGGFGTVYKGML-PDGSIVAVKRSKE---IDKTQIHQFINEVVILSQINHRHIVKLLG 279
           LG GGFG V    +       A+K  K+   ++  Q     +E  IL + NH  IVKL  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 280 CCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAY 339
              + +   ++ EY   G L   + D     E           +  R  +AC V  A  Y
Sbjct: 61  TFKDKKYIYMLMEYCLGGELWTILRDRGLFDE-----------YTARFYIAC-VVLAFEY 108

Query: 340 MHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPN-DKTHLTTTIQGTFGYLDPE 398
           +H+     I +RD+K  N+LLD     K+ DFG ++ + +  KT    T  GT  Y+ PE
Sbjct: 109 LHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTW---TFCGTPEYVAPE 162

Query: 399 YFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
              +  +    D +S G++L ELLTG+ P
Sbjct: 163 IILNKGYDFSVDYWSLGILLYELLTGRPP 191

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 82.0 bits (202), Expect = 2e-17
 Identities = 59/215 (27%), Positives = 105/215 (48%), Gaps = 16/215 (7%)

Query: 217 NYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSK---EIDKTQIHQFINEVVILSQINHR 272
           N+   + +G+G F  VY+   L DG  VA+K+ +    +D       I E+ +L Q+NH 
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62

Query: 273 HIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACE 332
           +++K     +E     +V E   +G LS  I   ++Q+    ++ +    W+  V    +
Sbjct: 63  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTV----WKYFV----Q 114

Query: 333 VAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTF 392
           +  A+ +MHS     + HRDIK +N+ +      K+ D G+ R   + KT    ++ GT 
Sbjct: 115 LCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFF-SSKTTAAHSLVGTP 170

Query: 393 GYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
            Y+ PE    + +  KSD++S G +L E+   + P
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 82.2 bits (203), Expect = 2e-17
 Identities = 75/289 (25%), Positives = 136/289 (47%), Gaps = 50/289 (17%)

Query: 224 LGQGGFGTVYKGMLPDG--SIVAVKR-----------SKEIDKTQIHQFINEVVIL-SQI 269
           LG G FG VYK    +   +++A+K             +E DK+ I   ++EV I+  Q+
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKS-IGDIVSEVTIIKEQL 66

Query: 270 NHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRV-R 328
            H +IV+     LE +   +V + I    L  H       +E+KQ+        E R+  
Sbjct: 67  RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHF---NSLKEKKQRFT------EERIWN 117

Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI-PNDKTHLTTT 387
           +  ++  A+ Y+H    I   HRD+  +NI+L +     ++DFG+++   P  K    T+
Sbjct: 118 IFVQMVLALRYLHKEKRI--VHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESK---LTS 172

Query: 388 IQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLA 447
           + GT  Y  PE  ++  + +K+DV++FG +L ++ T + P     +          +SLA
Sbjct: 173 VVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM----------LSLA 222

Query: 448 KENQLLEILDARVAKEAREEDIGA--MAELAMRCLRLNSKKRPTMKQVS 494
                 +I++A    E   E + +  + ++   CL  +++ RP + QVS
Sbjct: 223 -----TKIVEAVY--EPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVS 264

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 82.0 bits (202), Expect = 2e-17
 Identities = 57/208 (27%), Positives = 106/208 (50%), Gaps = 18/208 (8%)

Query: 222 RFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCC 281
           + LG G FG V+       + VAVK  K      +  F+ E  ++  + H  +VKL    
Sbjct: 12  KKLGAGQFGEVWMATYNKHTKVAVKTMKP-GSMSVEAFLAEANVMKTLQHDKLVKLHAVV 70

Query: 282 LETEVPV-LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYM 340
             T+ P+ ++ E+++ G+L   +     + ++  KQ L  L     +  + ++A  +A++
Sbjct: 71  --TKEPIYIITEFMAKGSLLDFL-----KSDEGSKQPLPKL-----IDFSAQIAEGMAFI 118

Query: 341 HSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYF 400
                I   HRD++++NIL+      K++DFG++R I +++       +    +  PE  
Sbjct: 119 EQRNYI---HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAI 175

Query: 401 QSSQFTDKSDVYSFGVVLLELLT-GKKP 427
               FT KSDV+SFG++L+E++T G+ P
Sbjct: 176 NFGSFTIKSDVWSFGILLMEIVTYGRIP 203

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 82.2 bits (203), Expect = 2e-17
 Identities = 61/216 (28%), Positives = 106/216 (49%), Gaps = 28/216 (12%)

Query: 224 LGQGGFGTVYKGML-PDG---SIVAVKRSKE-IDKTQIHQFINEVVILSQINHRHIVKLL 278
           +G G FG V +G L   G     VA+K  K    + Q   F++E  I+ Q +H +I+ L 
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71

Query: 279 GCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVA 338
           G   ++   +++ E++ +G L   +   +Q   Q    +L  +           + G  A
Sbjct: 72  GVVTKSRPVMIITEFMENGALDSFL---RQNDGQFTVIQLVGM-----------LRGIAA 117

Query: 339 YMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFG----- 393
            M   + +   HRD+ + NIL++     KVSDFG+SR + +D +  T T   + G     
Sbjct: 118 GMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYT--SSLGGKIPI 175

Query: 394 -YLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
            +  PE     +FT  SDV+S+G+V+ E+++ G++P
Sbjct: 176 RWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 211

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 82.4 bits (203), Expect = 2e-17
 Identities = 62/214 (28%), Positives = 102/214 (47%), Gaps = 19/214 (8%)

Query: 218 YNQSRFLGQGGFGTVYKGML-PDGSIVAVKR--SKEIDKTQIHQF-INEVVILSQINHRH 273
           + Q R LG+GGFG V    +   G + A K+   K I K +     +NE  IL ++N R 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61

Query: 274 IVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEV 333
           +V L       +   LV   ++ G L  HI+ H  +   ++ +          V  A E+
Sbjct: 62  VVSLAYAYETKDALCLVLTLMNGGDLKFHIY-HMGEAGFEEGRA---------VFYAAEI 111

Query: 334 AGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFG 393
              +  +H      I +RD+K  NILLDD    ++SD G++  +P  +T       GT G
Sbjct: 112 CCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRVGTVG 166

Query: 394 YLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
           Y+ PE  ++ ++T   D ++ G +L E++ G+ P
Sbjct: 167 YMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 82.5 bits (204), Expect = 3e-17
 Identities = 68/221 (30%), Positives = 101/221 (45%), Gaps = 33/221 (14%)

Query: 218 YNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQF---INEVVILSQINHRH 273
           +   R +G G FG VY    +    +VA+K+     K    ++   I EV  L Q+ H +
Sbjct: 17  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76

Query: 274 IVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEV 333
            ++  GC L      LV EY   G+ S  +  H+     K  QE         V +A   
Sbjct: 77  TIEYKGCYLREHTAWLVMEY-CLGSASDILEVHK-----KPLQE---------VEIAAIC 121

Query: 334 AGAV---AYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQG 390
            GA+   AY+HS   I   HRDIK+ NILL +  + K++DFG S S+ +       +  G
Sbjct: 122 HGALQGLAYLHSHERI---HRDIKAGNILLTEPGTVKLADFG-SASLVSP----ANSFVG 173

Query: 391 TFGYLDPEY---FQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
           T  ++ PE        Q+  K DV+S G+  +EL   K P+
Sbjct: 174 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 82.6 bits (204), Expect = 3e-17
 Identities = 70/231 (30%), Positives = 107/231 (46%), Gaps = 28/231 (12%)

Query: 222 RFLGQGGFGTVYKG-MLPDGSIVAVKRSKE---IDKTQIHQFINEVVILS-QINHRHIVK 276
           R LG+G FG V    +   G + AVK  K+   +    +   + E  ILS   NH  + +
Sbjct: 1   RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60

Query: 277 LLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRV-ACEVAG 335
           L  C    +    V E+++ G L  HI        QK ++       E R R  A E+  
Sbjct: 61  LYCCFQTPDRLFFVMEFVNGGDLMFHI--------QKSRR-----FDEARARFYAAEITS 107

Query: 336 AVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS-IPNDKTHLTTTIQGTFGY 394
           A+ ++H      I +RD+K  N+LLD +   K++DFG+ +  I N KT  T+T  GT  Y
Sbjct: 108 ALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT--TSTFCGTPDY 162

Query: 395 LDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFIS 445
           + PE  Q   +    D ++ GV+L E+L G  P      E E +L    ++
Sbjct: 163 IAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPF---EAENEDDLFEAILN 210

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 82.0 bits (202), Expect = 3e-17
 Identities = 81/303 (26%), Positives = 134/303 (44%), Gaps = 43/303 (14%)

Query: 216 DNYNQSRFLGQGGFGTVY--------KGMLPDGSIVAVKRSKEIDKTQ--IHQFINEVVI 265
           D     + LG+G FG V         K    +   VAVK  K+ D T+  +   ++E+ +
Sbjct: 15  DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKD-DATEKDLSDLVSEMEM 73

Query: 266 LSQI-NHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQ----KQELSS 320
           +  I  H++I+ LLG C +     ++ EY S G L  ++   +    +      +     
Sbjct: 74  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQ 133

Query: 321 LSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPN- 379
           +++++ V    +VA  + Y+ S   I   HRD+ + N+L+ +    K++DFG++R + N 
Sbjct: 134 MTFKDLVSCTYQVARGMEYLASQKCI---HRDLAARNVLVTENNVMKIADFGLARDVNNI 190

Query: 380 DKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERN 438
           D    TT  +    ++ PE      +T +SDV+SFGV++ E+ T G  P     VEE   
Sbjct: 191 DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--- 247

Query: 439 LVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMR---CLRLNSKKRPTMKQVSM 495
                  L KE         R+ K A         EL M    C       RPT KQ+  
Sbjct: 248 ----LFKLLKEGH-------RMDKPA-----NCTNELYMMMRDCWHAIPSHRPTFKQLVE 291

Query: 496 ELE 498
           +L+
Sbjct: 292 DLD 294

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 81.2 bits (200), Expect = 3e-17
 Identities = 65/222 (29%), Positives = 105/222 (47%), Gaps = 27/222 (12%)

Query: 217 NYNQSRFLGQGGFGTVYKGMLPD-GSIVAVKR------SKEIDKTQIHQFINEVVILSQI 269
           N+   + LG+G FG VY     D G  +AVK+      S+E  K +++    E+ +L  +
Sbjct: 3   NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSK-EVNALECEIQLLKNL 61

Query: 270 NHRHIVKLLGCCLETEVPVL--VYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRV 327
            H  IV+  GC  + E   L    EY+  G++            + Q +   +L+     
Sbjct: 62  RHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSI------------KDQLKAYGALTENVTR 109

Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLT-- 385
           R   ++   V+Y+HS+    I HRDIK +NIL D   + K+ DFG S+ I       T  
Sbjct: 110 RYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGI 166

Query: 386 TTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
            ++ GT  ++ PE      +  K+DV+S    ++E+LT K P
Sbjct: 167 KSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 82.0 bits (203), Expect = 4e-17
 Identities = 65/235 (27%), Positives = 104/235 (44%), Gaps = 54/235 (22%)

Query: 213 RATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKR---SKEIDKTQIHQFINEVVILSQ 268
           R+   + +   +G+G +G VY+      G IVA+K+     E D   I   + E+ +L  
Sbjct: 4   RSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISS-LREITLLLN 62

Query: 269 INHRHIVKLLGCCLETEVPV--------LVYEYISSGTLSHHIHDHQQQQEQKQKQELSS 320
           + H +IV+L       EV V        LV EY                     +Q+L+S
Sbjct: 63  LRHPNIVELK------EVVVGKHLDSIFLVMEYC--------------------EQDLAS 96

Query: 321 LSWENRVR------VAC---EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF 371
           L  +N         V C   ++   + Y+H +    I HRD+K SN+LL DK   K++DF
Sbjct: 97  L-LDNMPTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADF 152

Query: 372 GISRSIPNDKTHLTTTIQGTFGYLDPE-YFQSSQFTDKSDVYSFGVVLLELLTGK 425
           G++R+       +T  +  T  Y  PE     + +T   D+++ G +L ELL  K
Sbjct: 153 GLARTYGLPAKPMTPKVV-TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 81.7 bits (201), Expect = 4e-17
 Identities = 55/212 (25%), Positives = 107/212 (50%), Gaps = 20/212 (9%)

Query: 218 YNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVK 276
           Y +   +GQG  GTV+  + +  G  VA+K+     + +    INE++++ ++ + +IV 
Sbjct: 21  YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVN 80

Query: 277 LLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVAC-EVAG 335
            L   L  +   +V EY++ G+L+  + +    + Q              +   C E   
Sbjct: 81  FLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQ--------------IAAVCRECLQ 126

Query: 336 AVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYL 395
           A+ ++H++    + HRDIKS N+LL    S K++DFG    I  +++  +T + GT  ++
Sbjct: 127 ALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWM 182

Query: 396 DPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
            PE      +  K D++S G++ +E++ G+ P
Sbjct: 183 APEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 82.6 bits (204), Expect = 4e-17
 Identities = 84/316 (26%), Positives = 134/316 (42%), Gaps = 60/316 (18%)

Query: 195 SSCGSSERAKVFTADELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKR-SKEID 252
           SS  SS  +   +A    ++     +   +G G  GTVYK +  P G + A+K      +
Sbjct: 53  SSSSSSSSSASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHE 112

Query: 253 KTQIHQFINEVVILSQINHRHIVKLLGCCLET-----EVPVLVYEYISSGTLS-HHIHDH 306
            T   Q   E+ IL  +NH ++VK    C +      E+ VL+ E++  G+L   HI D 
Sbjct: 113 DTVRRQICREIEILRDVNHPNVVK----CHDMFDHNGEIQVLL-EFMDGGSLEGTHIADE 167

Query: 307 QQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA 366
           Q   +                 VA ++   +AY+H      I HRDIK SN+L++   + 
Sbjct: 168 QFLAD-----------------VARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNV 207

Query: 367 KVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTD---------KSDVYSFGVV 417
           K++DFG+SR I         +  GT  Y+ PE       TD           D++S GV 
Sbjct: 208 KIADFGVSR-ILAQTMDPCNSSVGTIAYMSPERIN----TDLNHGAYDGYAGDIWSLGVS 262

Query: 418 LLELLTGKKPICFARVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAM 477
           +LE   G+ P    R  +  +L+ C I +++  +      A  ++E R            
Sbjct: 263 ILEFYLGRFPFGVGRQGDWASLM-CAICMSQPPE----APATASREFR--------HFIS 309

Query: 478 RCLRLNSKKRPTMKQV 493
            CL+    KR +  Q+
Sbjct: 310 CCLQREPAKRWSAMQL 325

Length = 353

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 81.2 bits (201), Expect = 4e-17
 Identities = 63/227 (27%), Positives = 100/227 (44%), Gaps = 42/227 (18%)

Query: 224 LGQGGFGTVYKGM-LPDGSIVAVK--RSKEIDKTQIHQFINEVVILSQINHRHIVKLLGC 280
           +G+G +G VYK      G +VA+K     E ++ +I +  N +   S  NH +I    G 
Sbjct: 14  IGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYS--NHPNIATFYGA 71

Query: 281 CLETEVPV------LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVAC-EV 333
            ++   P       LV E    G+++  +     +  +K+ + L     E  +     E 
Sbjct: 72  FIKKNPPGNDDQLWLVMELCGGGSVTDLV-----KGLRKKGKRLK----EEWIAYILRET 122

Query: 334 AGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQ---- 389
              +AY+H +  I   HRDIK  NILL      K+ DFG+S         L +T+     
Sbjct: 123 LRGLAYLHENKVI---HRDIKGQNILLTKNAEVKLVDFGVSA-------QLDSTLGRRNT 172

Query: 390 --GTFGYLDPEYFQSSQFTD-----KSDVYSFGVVLLELLTGKKPIC 429
             GT  ++ PE     +  D     +SDV+S G+  +EL  GK P+C
Sbjct: 173 FIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLC 219

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 80.8 bits (199), Expect = 5e-17
 Identities = 59/215 (27%), Positives = 105/215 (48%), Gaps = 16/215 (7%)

Query: 217 NYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSK---EIDKTQIHQFINEVVILSQINHR 272
           N+   + +G+G F  VY+   L D   VA+K+ +    +D       + E+ +L Q+NH 
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62

Query: 273 HIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACE 332
           +++K L   +E     +V E   +G LS  I   ++Q+    ++ +    W+  V    +
Sbjct: 63  NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTV----WKYFV----Q 114

Query: 333 VAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTF 392
           +  AV +MHS     + HRDIK +N+ +      K+ D G+ R   + KT    ++ GT 
Sbjct: 115 LCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFF-SSKTTAAHSLVGTP 170

Query: 393 GYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
            Y+ PE    + +  KSD++S G +L E+   + P
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 82.0 bits (203), Expect = 5e-17
 Identities = 78/280 (27%), Positives = 117/280 (41%), Gaps = 59/280 (21%)

Query: 224 LGQGGFGTV----YKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQIN---HRHIVK 276
           LG+G FG V    YK      +I A+K+   I + ++   + E  I    N   H  +V 
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66

Query: 277 LLGCCLETEVPV-LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAG 335
           L   C +TE  V  V EY + G L  HIH     + +                 A  V  
Sbjct: 67  LF-ACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAV-------------FYAACVVL 112

Query: 336 AVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS--IPNDKTHLTTTIQGTFG 393
            + Y+H +    I +RD+K  N+LLD +   K++DFG+ +      D+T   +T  GT  
Sbjct: 113 GLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRT---STFCGTPE 166

Query: 394 YLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLL 453
           +L PE    + +T   D +  GV++ E+L G+ P  F   +EE                 
Sbjct: 167 FLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESP--FPGDDEE----------------- 207

Query: 454 EILDARVAKEAR------EEDIGAMAELAMRCLRLNSKKR 487
           E+ D+ V  E R       E I  M  L    LR N ++R
Sbjct: 208 EVFDSIVNDEVRYPRFLSREAISIMRRL----LRRNPERR 243

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 81.3 bits (200), Expect = 5e-17
 Identities = 58/212 (27%), Positives = 106/212 (50%), Gaps = 20/212 (9%)

Query: 218 YNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVK 276
           Y +   +GQG  GTVY  M +  G  VA+++     + +    INE++++ +  + +IV 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81

Query: 277 LLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVAC-EVAG 335
            L   L  +   +V EY++ G+L+  + +                  E ++   C E   
Sbjct: 82  YLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD--------------EGQIAAVCRECLQ 127

Query: 336 AVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYL 395
           A+ ++HS+    + HRDIKS NILL    S K++DFG    I  +++  +T + GT  ++
Sbjct: 128 ALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWM 183

Query: 396 DPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
            PE      +  K D++S G++ +E++ G+ P
Sbjct: 184 APEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 81.2 bits (200), Expect = 6e-17
 Identities = 85/310 (27%), Positives = 142/310 (45%), Gaps = 47/310 (15%)

Query: 210 ELQRATDNYNQSRFLGQGGFGTVYK----GMLPDG----SIVAVKRSKEIDKTQ--IHQF 259
           E+ R  D     + LG+G FG V      G+  +     + VAVK  K  D T+  +   
Sbjct: 14  EVPR--DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKS-DATEKDLSDL 70

Query: 260 INEVVILSQI-NHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIH-------DHQQQQE 311
           I+E+ ++  I  H++I+ LLG C +     ++ EY S G L  ++        ++     
Sbjct: 71  ISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPT 130

Query: 312 QKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF 371
           Q  +++LS    ++ V  A +VA  + Y+ S   I   HRD+ + N+L+ +    K++DF
Sbjct: 131 QVPEEQLSF---KDLVSCAYQVARGMEYLASKKCI---HRDLAARNVLVTEDNVMKIADF 184

Query: 372 GISRSIPN-DKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPIC 429
           G++R I + D    TT  +    ++ PE      +T +SDV+SFGV+L E+ T G  P  
Sbjct: 185 GLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 244

Query: 430 FARVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMR-CLRLNSKKRP 488
              VEE          L KE   ++          +  +      + MR C      +RP
Sbjct: 245 GVPVEE-------LFKLLKEGHRMD----------KPSNCTNELYMMMRDCWHAVPSQRP 287

Query: 489 TMKQVSMELE 498
           T KQ+  +L+
Sbjct: 288 TFKQLVEDLD 297

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 81.2 bits (200), Expect = 7e-17
 Identities = 79/298 (26%), Positives = 133/298 (44%), Gaps = 44/298 (14%)

Query: 224 LGQGGFGTVYK----GMLPD----GSIVAVKRSKE--IDKTQIHQFINEVVILSQIN-HR 272
           LG+G FG V +    G+          VAVK  K+   DK  +   I+E+ ++  I  H+
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDK-DLADLISEMELMKLIGKHK 78

Query: 273 HIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQ------KQKQELSSLSWENR 326
           +I+ LLG C +     ++ EY + G L   +   +           K  +E   LS+++ 
Sbjct: 79  NIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQ--LSFKDL 136

Query: 327 VRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPN-DKTHLT 385
           V  A +VA  + Y+ S   I   HRD+ + N+L+ +    K++DFG++R + + D    T
Sbjct: 137 VSCAYQVARGMEYLESRRCI---HRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKT 193

Query: 386 TTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFI 444
           +  +    ++ PE      +T +SDV+SFG+++ E+ T G  P     VEE         
Sbjct: 194 SNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE-------LF 246

Query: 445 SLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRR 502
            L +E   ++            E    M E    C      +RPT KQ+   +E L +
Sbjct: 247 KLLREGHRMD-----KPSNCTHELYMLMRE----CWHAVPTQRPTFKQL---VEALDK 292

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 81.2 bits (200), Expect = 8e-17
 Identities = 87/313 (27%), Positives = 137/313 (43%), Gaps = 49/313 (15%)

Query: 224 LGQGGFGTVY--------KGMLPDGSIVAVKRSKE--IDKTQIHQFINEVVILSQI-NHR 272
           LG+G FG V         K        VAVK  K+   DK  +   ++E+ ++  I  H+
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDK-DLSDLVSEMEMMKMIGKHK 78

Query: 273 HIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQ----KQELSSLSWENRVR 328
           +I+ LLG C +     ++ EY S G L  ++   +           K     L++++ V 
Sbjct: 79  NIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVS 138

Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPN-DKTHLTTT 387
            A +VA  + Y+ S   I   HRD+ + N+L+ +    K++DFG++R + N D    TT 
Sbjct: 139 CAYQVARGMEYLASQKCI---HRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTN 195

Query: 388 IQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISL 446
            +    ++ PE      +T +SDV+SFGV+L E+ T G  P     VEE          L
Sbjct: 196 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE-------LFKL 248

Query: 447 AKENQLLEILDARVAKEAREEDIGAMAELAM---RCLRLNSKKRPTMKQVSMELEGLRRS 503
            KE         R+ K A         EL M    C      +RPT KQ+  +L+     
Sbjct: 249 LKEGH-------RMDKPA-----NCTHELYMIMRECWHAVPSQRPTFKQLVEDLD----- 291

Query: 504 QRCLEMCQVNQLL 516
            R L +   ++ L
Sbjct: 292 -RVLTVTSTDEYL 303

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 81.3 bits (201), Expect = 9e-17
 Identities = 61/217 (28%), Positives = 95/217 (43%), Gaps = 25/217 (11%)

Query: 224 LGQGGFGTVYKGMLPD-GSIVAVKR-SKEI--DKTQIHQFINEVVILSQINHRHIVKLLG 279
           +GQGG+G V+     D G IVA+KR  K +     ++   + E  IL+      +VKLL 
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68

Query: 280 CCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRV-ACEVAGAVA 338
              + E   L  EY+  G     +++            L  LS E+  R    E+  AV 
Sbjct: 69  AFQDDEYLYLAMEYVPGGDFRTLLNN------------LGVLS-EDHARFYMAEMFEAVD 115

Query: 339 YMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPE 398
            +H    +   HRD+K  N L+D     K++DFG+S+ I         ++ G+  Y+ PE
Sbjct: 116 ALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----YANSVVGSPDYMAPE 168

Query: 399 YFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEE 435
             +   +    D +S G +L E L G  P   +   E
Sbjct: 169 VLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE 205

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 80.8 bits (199), Expect = 9e-17
 Identities = 77/291 (26%), Positives = 126/291 (43%), Gaps = 45/291 (15%)

Query: 224 LGQGGFGTVYKGMLPDGSI---VAVKRSKEIDKTQIHQ-FINEVVILSQIN-HRHIVKLL 278
           +G+G FG V K  +    +    A+KR KE      H+ F  E+ +L ++  H +I+ LL
Sbjct: 15  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74

Query: 279 GCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQ----KQELSSLSWENRVRVACEVA 334
           G C       L  EY   G L   +   +  +            S+LS +  +  A +VA
Sbjct: 75  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 134

Query: 335 GAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFG- 393
             + Y+     I   HRD+ + NIL+ + + AK++DFG+SR            ++ T G 
Sbjct: 135 RGMDYLSQKQFI---HRDLAARNILVGENYVAKIADFGLSRG-------QEVYVKKTMGR 184

Query: 394 ----YLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAK 448
               ++  E    S +T  SDV+S+GV+L E+++ G  P C     E             
Sbjct: 185 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------------- 231

Query: 449 ENQLLEILDA--RVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMEL 497
              L E L    R+ K    +D   + +L  +C R    +RP+  Q+ + L
Sbjct: 232 ---LYEKLPQGYRLEKPLNCDD--EVYDLMRQCWREKPYERPSFAQILVSL 277

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 79.3 bits (195), Expect = 2e-16
 Identities = 62/222 (27%), Positives = 104/222 (46%), Gaps = 27/222 (12%)

Query: 217 NYNQSRFLGQGGFGTVYKGMLPD-GSIVAVKR------SKEIDKTQIHQFINEVVILSQI 269
           N+   + LGQG FG VY     D G  +AVK+      S E  K +++    E+ +L  +
Sbjct: 3   NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSK-EVNALECEIQLLKNL 61

Query: 270 NHRHIVKLLGCCLETEVPVL--VYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRV 327
            H  IV+  GC  +     L    E++  G++            + Q +   +L+     
Sbjct: 62  LHERIVQYYGCLRDPMERTLSIFMEHMPGGSI------------KDQLKSYGALTENVTR 109

Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLT-- 385
           +   ++   V+Y+HS+    I HRDIK +NIL D   + K+ DFG S+ +       T  
Sbjct: 110 KYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGM 166

Query: 386 TTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
            ++ GT  ++ PE      +  K+D++S G  ++E+LT K P
Sbjct: 167 KSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 79.4 bits (195), Expect = 2e-16
 Identities = 69/286 (24%), Positives = 124/286 (43%), Gaps = 39/286 (13%)

Query: 224 LGQGGFGTVYKGMLPDGSIVAVKRSKEID----KTQIHQFINEVVILSQINHRHIVKLLG 279
           +G+G FG V+KG+  D     V   K ID    + +I     E+ +LSQ +  ++ K  G
Sbjct: 12  IGKGSFGEVFKGI--DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69

Query: 280 CCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAY 339
             L+     ++ EY+  G+    +             E   L       +  E+   + Y
Sbjct: 70  SYLKDTKLWIIMEYLGGGSALDLL-------------EPGPLDETQIATILREILKGLDY 116

Query: 340 MHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEY 399
           +HS   I   HRDIK++N+LL +    K++DFG++  + + +    T + GT  ++ PE 
Sbjct: 117 LHSEKKI---HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEV 172

Query: 400 FQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEILDAR 459
            + S +  K+D++S G+  +EL  G+ P        E + +     + K N     L+  
Sbjct: 173 IKQSAYDSKADIWSLGITAIELAKGEPP------HSELHPMKVLFLIPKNNP--PTLEGN 224

Query: 460 VAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRSQR 505
            +K         + E    CL      RPT K++      +R +++
Sbjct: 225 YSK--------PLKEFVEACLNKEPSFRPTAKELLKHKFIVRFAKK 262

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 79.6 bits (196), Expect = 2e-16
 Identities = 61/224 (27%), Positives = 103/224 (45%), Gaps = 22/224 (9%)

Query: 218 YNQSRFLGQGGFGTVYKGML-PDGSIVAVKR--SKEIDKTQIHQF-INEVVILSQINHRH 273
           + Q R LG+GGFG V    +   G + A KR   K I K +     +NE  IL ++N + 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61

Query: 274 IVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEV 333
           +V L       +   LV   ++ G L  HI++      ++          E  +  A E+
Sbjct: 62  VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEE----------ERALFYAAEI 111

Query: 334 AGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFG 393
              +  +H   ++   +RD+K  NILLDD    ++SD G++  IP  +        GT G
Sbjct: 112 LCGLEDLHRENTV---YRDLKPENILLDDYGHIRISDLGLAVKIP--EGESIRGRVGTVG 166

Query: 394 YLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEER 437
           Y+ PE   + ++T   D +  G ++ E++ G+ P    R  +E+
Sbjct: 167 YMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPF---RGRKEK 207

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 79.3 bits (195), Expect = 2e-16
 Identities = 55/206 (26%), Positives = 101/206 (49%), Gaps = 19/206 (9%)

Query: 224 LGQGGFGTVYKGMLP-DGSIVAVKR-SKEIDKTQIHQFINEVVILSQINHRHIVKLLGCC 281
           +G+G FG VYKG+      +VA+K    E  + +I     E+ +LSQ +  +I +  G  
Sbjct: 12  IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71

Query: 282 LETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMH 341
           L+     ++ EY+  G+    +             +   L       +  E+   + Y+H
Sbjct: 72  LKGTKLWIIMEYLGGGSALDLL-------------KPGPLEETYIATILREILKGLDYLH 118

Query: 342 SSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQ 401
           S   I   HRDIK++N+LL ++   K++DFG++  + + +    T + GT  ++ PE  +
Sbjct: 119 SERKI---HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIK 174

Query: 402 SSQFTDKSDVYSFGVVLLELLTGKKP 427
            S +  K+D++S G+  +EL  G+ P
Sbjct: 175 QSAYDFKADIWSLGITAIELAKGEPP 200

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 79.7 bits (196), Expect = 3e-16
 Identities = 61/215 (28%), Positives = 104/215 (48%), Gaps = 19/215 (8%)

Query: 216 DNYNQSRFLGQGGFGTVYK-GMLPDGSIVAVKRSK-EIDKTQIHQFINEVVILSQINHRH 273
           D++ +   LG G  G V K    P G I+A K    EI     +Q I E+ +L + N  +
Sbjct: 5   DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64

Query: 274 IVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEV 333
           IV   G         +  E++  G+L     D   ++ ++  +E+         +V+  V
Sbjct: 65  IVGFYGAFYSDGEISICMEHMDGGSL-----DQVLKEAKRIPEEILG-------KVSIAV 112

Query: 334 AGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFG 393
              +AY+     I   HRD+K SNIL++ +   K+ DFG+S  + +    +  +  GT  
Sbjct: 113 LRGLAYLREKHQI--MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRS 167

Query: 394 YLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
           Y+ PE  Q + ++ +SD++S G+ L+EL  G+ PI
Sbjct: 168 YMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPI 202

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 79.4 bits (196), Expect = 3e-16
 Identities = 66/211 (31%), Positives = 97/211 (45%), Gaps = 25/211 (11%)

Query: 224 LGQGGFGTVYKGMLP-DGSIVAVK-RSKEI---DKTQIHQFINEVVILSQINHRHIVKLL 278
           +G+G FG V       DG   AVK   K+     K Q H      V+L  + H  +V L 
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 279 GCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRV-ACEVAGAV 337
                 +    V +Y++ G L  H+        Q+++        E R R  A E+A A+
Sbjct: 63  YSFQTADKLYFVLDYVNGGELFFHL--------QRERSFP-----EPRARFYAAEIASAL 109

Query: 338 AYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISR-SIPNDKTHLTTTIQGTFGYLD 396
            Y+HS   + I +RD+K  NILLD +    ++DFG+ +  I + KT  T+T  GT  YL 
Sbjct: 110 GYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT--TSTFCGTPEYLA 164

Query: 397 PEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
           PE  +   +    D +  G VL E+L G  P
Sbjct: 165 PEVLRKQPYDRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 78.7 bits (194), Expect = 3e-16
 Identities = 62/217 (28%), Positives = 101/217 (46%), Gaps = 25/217 (11%)

Query: 218 YNQSRFLGQGGFGTVYKGML-PDGSIVAVKR--SKEIDKTQIHQF-INEVVILSQINHRH 273
           +   R LG+GGFG V    +   G + A K+   K I K +     +NE  IL ++N R 
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61

Query: 274 IVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEV 333
           +V L       +   LV   ++ G L  HI++       +++           V  A E+
Sbjct: 62  VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERA----------VFYAAEI 111

Query: 334 AGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQ---G 390
              +  +H      I +RD+K  NILLDD    ++SD G++  IP  +     TI+   G
Sbjct: 112 TCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE-----TIRGRVG 163

Query: 391 TFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
           T GY+ PE  ++ ++T   D +  G ++ E++ GK P
Sbjct: 164 TVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 78.5 bits (193), Expect = 4e-16
 Identities = 63/231 (27%), Positives = 109/231 (47%), Gaps = 23/231 (9%)

Query: 217 NYNQSRF---LGQGGFGTVYKGML------PDGSIVAVKRSKEIDKTQI---HQFINEVV 264
           N +  RF   LG+  FG VYKG L           VA+K  K  DK +     +F +E +
Sbjct: 3   NLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLK--DKAEGPLREEFKHEAM 60

Query: 265 ILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQE----QKQKQELSS 320
           + S++ H +IV LLG   + +   +++ Y S   L   +       +       K   S+
Sbjct: 61  MRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKST 120

Query: 321 LSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI-PN 379
           L   + V +  ++A  + ++ S     + H+D+ + N+L+ DK + K+SD G+ R +   
Sbjct: 121 LEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKISDLGLFREVYAA 177

Query: 380 DKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPIC 429
           D   L         ++ PE     +F+  SD++S+GVVL E+ + G +P C
Sbjct: 178 DYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYC 228

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 78.5 bits (193), Expect = 4e-16
 Identities = 57/194 (29%), Positives = 98/194 (50%), Gaps = 29/194 (14%)

Query: 240 GSIVAVKRSKEIDKTQIHQFI-NEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGT 298
           G  VAVK   ++ K Q  + + NEVVI+    H+++V++    L  E   ++ E++  G 
Sbjct: 46  GRQVAVKM-MDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104

Query: 299 LSHHIHDHQQQQEQKQKQELSSLSWENRVRVACE-VAGAVAYMHSSASIPIFHRDIKSSN 357
           L+  +   +  +EQ              +   CE V  A+ Y+HS   I   HRDIKS +
Sbjct: 105 LTDIVSQTRLNEEQ--------------IATVCESVLQALCYLHSQGVI---HRDIKSDS 147

Query: 358 ILLDDKFSAKVSDFG----ISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYS 413
           ILL      K+SDFG    IS+ +P  K     ++ GT  ++ PE    + +  + D++S
Sbjct: 148 ILLTLDGRVKLSDFGFCAQISKDVPKRK-----SLVGTPYWMAPEVISRTPYGTEVDIWS 202

Query: 414 FGVVLLELLTGKKP 427
            G++++E++ G+ P
Sbjct: 203 LGIMVIEMVDGEPP 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 78.5 bits (193), Expect = 5e-16
 Identities = 61/212 (28%), Positives = 102/212 (48%), Gaps = 25/212 (11%)

Query: 224 LGQGGFGTVYKGMLPD-GSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCL 282
           LG G FG VYK    + G++ A K  +   + ++  ++ E+ IL+  NH +IVKLLG   
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79

Query: 283 ETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVAC-EVAGAVAYMH 341
                 ++ E+   G +   +             EL     E +++V C ++  A+ Y+H
Sbjct: 80  WDGKLWIMIEFCPGGAVDAIM------------LELDRGLTEPQIQVICRQMLEALQYLH 127

Query: 342 SSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKT-HLTTTIQGTFGYLDPEYF 400
           S   + I HRD+K+ N+LL      K++DFG+S    N KT     +  GT  ++ PE  
Sbjct: 128 S---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAK--NVKTLQRRDSFIGTPYWMAPEVV 182

Query: 401 QSSQFTD-----KSDVYSFGVVLLELLTGKKP 427
                 D     K+D++S G+ L+E+   + P
Sbjct: 183 MCETMKDTPYDYKADIWSLGITLIEMAQIEPP 214

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 78.7 bits (194), Expect = 5e-16
 Identities = 65/213 (30%), Positives = 98/213 (46%), Gaps = 33/213 (15%)

Query: 224 LGQGGFGTV----YKGMLPDGSIVAVK--RSKEIDKT-QIHQFINEVVILSQINHRHIVK 276
           LG G FG V    +KG    G   A+K  + +EI K  Q+     E  IL +++H  IV 
Sbjct: 26  LGTGSFGRVRIAKHKG---TGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVN 82

Query: 277 LLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVR--VACEVA 334
           ++    +      + E++  G L  H+                +  + N V      E+ 
Sbjct: 83  MMCSFQDENRVYFLLEFVVGGELFTHLR--------------KAGRFPNDVAKFYHAELV 128

Query: 335 GAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGY 394
            A  Y+HS     I +RD+K  N+LLD+K   KV+DFG ++ +P D+T    T+ GT  Y
Sbjct: 129 LAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVP-DRTF---TLCGTPEY 181

Query: 395 LDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
           L PE  QS       D ++ GV+L E + G  P
Sbjct: 182 LAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214

Length = 329

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 78.5 bits (194), Expect = 6e-16
 Identities = 60/250 (24%), Positives = 102/250 (40%), Gaps = 64/250 (25%)

Query: 214 ATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQF----INEVVILSQ 268
              +Y     LG+G FG VYK   +  G +VA+K  K +   +   F    + E+ IL +
Sbjct: 6   KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALK--KILMHNEKDGFPITALREIKILKK 63

Query: 269 INHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQK---------QKQELS 319
           + H ++V L+          +  E               + + ++            +LS
Sbjct: 64  LKHPNVVPLID---------MAVER------------PDKSKRKRGSVYMVTPYMDHDLS 102

Query: 320 SLSWENRVRVACEVAGA----------VAYMHSSASIPIFHRDIKSSNILLDDKFSAKVS 369
            L     V++    +            + Y+H +    I HRDIK++NIL+D++   K++
Sbjct: 103 GLLENPSVKL--TESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIA 157

Query: 370 DFGISR----SIPNDK------THLTTTIQGTFGYLDPEY-FQSSQFTDKSDVYSFGVVL 418
           DFG++R      PN K      T   T +  T  Y  PE      ++T   D++  G V 
Sbjct: 158 DFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVF 217

Query: 419 LELLTGKKPI 428
            E+ T  +PI
Sbjct: 218 AEMFTR-RPI 226

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 78.3 bits (193), Expect = 7e-16
 Identities = 75/242 (30%), Positives = 112/242 (46%), Gaps = 40/242 (16%)

Query: 212 QRATDNYNQSRFLGQGGFGTVYKGMLPD-GSIVAVKRSK---EIDKTQIHQFINEVVILS 267
           +R  D ++    +G+G +G VYK    D G +VA+K+ +   E +   I   I E+ IL 
Sbjct: 3   KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITA-IREIKILR 61

Query: 268 QINHRHIVKLLGCCLETEVPV----------LVYEYISS---GTL-SHHIHDHQQQQEQK 313
           Q+NHR+IV L     + +  +          LV+EY+     G L S  +H  +   +  
Sbjct: 62  QLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSF 121

Query: 314 QKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGI 373
            KQ L  L+                Y H        HRDIK SNILL++K   K++DFG+
Sbjct: 122 MKQLLEGLN----------------YCHKKN---FLHRDIKCSNILLNNKGQIKLADFGL 162

Query: 374 SRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQ-FTDKSDVYSFGVVLLELLTGKKPICFAR 432
           +R   ++++   T    T  Y  PE     + +    DV+S G +L EL T KKPI  A 
Sbjct: 163 ARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKPIFQAN 221

Query: 433 VE 434
            E
Sbjct: 222 QE 223

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 77.9 bits (192), Expect = 7e-16
 Identities = 60/211 (28%), Positives = 96/211 (45%), Gaps = 23/211 (10%)

Query: 224 LGQGGFGTVYKGMLPDGSIVAVKRSKEI-DKTQIHQFINEVVILSQINHRHIVKLLGCCL 282
           LG G FG VYK    +  + A  +  +I  + ++  F+ E+ ILS+  H +IV L     
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 283 ETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVAC-EVAGAVAYMH 341
                 ++ E+   G L   +             EL     E ++R  C ++  A+ ++H
Sbjct: 73  YENKLWILIEFCDGGALDSIM------------LELERGLTEPQIRYVCRQMLEALNFLH 120

Query: 342 SSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQ 401
           S   I   HRD+K+ NILL      K++DFG+S    +      T I GT  ++ PE   
Sbjct: 121 SHKVI---HRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI-GTPYWMAPEVVA 176

Query: 402 SSQFTD-----KSDVYSFGVVLLELLTGKKP 427
              F D     K+D++S G+ L+EL   + P
Sbjct: 177 CETFKDNPYDYKADIWSLGITLIELAQMEPP 207

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 77.3 bits (190), Expect = 9e-16
 Identities = 60/216 (27%), Positives = 101/216 (46%), Gaps = 28/216 (12%)

Query: 222 RFLGQGGFGTVYKGMLPDGS----IVAVK--RSKEIDKTQIHQFINEVVILSQINHRHIV 275
           R LG G FG + +G L   S     VA+   R+   DK +   F+ E + L Q +H +IV
Sbjct: 11  RILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRR-GFLAEALTLGQFDHSNIV 69

Query: 276 KLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAG 335
           +L G        ++V EY+S+G L   +  H+ Q    Q   +              + G
Sbjct: 70  RLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGM--------------LPG 115

Query: 336 AVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTH-LTTTIQGTFGY 394
             + M   + +   H+ + +  +L++     K+S F   R +  DK+  + TT+ G    
Sbjct: 116 LASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGF---RRLQEDKSEAIYTTMSGKSPV 172

Query: 395 L--DPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
           L   PE  Q   F+  SDV+SFG+V+ E+++ G++P
Sbjct: 173 LWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERP 208

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 77.9 bits (192), Expect = 9e-16
 Identities = 70/217 (32%), Positives = 111/217 (51%), Gaps = 32/217 (14%)

Query: 222 RFLGQGGFGTVY---KGMLPD-GSIVAVKRSKEI-----DKTQIHQFINEVVILSQINHR 272
           + LGQG FG V+   K   PD G + A+K  K+      D+ +      E  IL+++NH 
Sbjct: 2   KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTK---MERDILAEVNHP 58

Query: 273 HIVKLLGCCLETEVPV-LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVAC 331
            IVKL     +TE  + L+ +++  G L   +       E+  K  L+            
Sbjct: 59  FIVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA------------ 105

Query: 332 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISR-SIPNDKTHLTTTIQG 390
           E+A A+ ++HS   + I +RD+K  NILLD++   K++DFG+S+ SI ++K     +  G
Sbjct: 106 ELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK--AYSFCG 160

Query: 391 TFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
           T  Y+ PE       T  +D +SFGV++ E+LTG  P
Sbjct: 161 TVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLP 197

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 77.0 bits (189), Expect = 9e-16
 Identities = 72/289 (24%), Positives = 131/289 (45%), Gaps = 45/289 (15%)

Query: 217 NYNQSRFLGQGGFGTVYKGMLPD-GSIVAVKR------SKEIDKTQIHQFINEVVILSQI 269
           N+ + + LGQG FG VY     D G  +A K+      S E  K ++     E+ +L  +
Sbjct: 3   NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSK-EVSALECEIQLLKNL 61

Query: 270 NHRHIVKLLGCCLE--TEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRV 327
            H  IV+  GC  +   +   +  EY+  G++            + Q +   +L+     
Sbjct: 62  QHERIVQYYGCLRDRAEKTLTIFMEYMPGGSV------------KDQLKAYGALTESVTR 109

Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLT-- 385
           +   ++   ++Y+HS+    I HRDIK +NIL D   + K+ DFG S+ +       T  
Sbjct: 110 KYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGI 166

Query: 386 TTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACF-I 444
            ++ GT  ++ PE      +  K+DV+S G  ++E+LT K P       E   + A F I
Sbjct: 167 RSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWA-----EYEAMAAIFKI 221

Query: 445 SLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQV 493
           +    N  L    + +++ AR+          + C+ + ++ RP+ +++
Sbjct: 222 ATQPTNPQLP---SHISEHARD---------FLGCIFVEARHRPSAEEL 258

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 76.8 bits (189), Expect = 1e-15
 Identities = 65/219 (29%), Positives = 99/219 (45%), Gaps = 33/219 (15%)

Query: 218 YNQSRFLGQGGFGTVYKGML----PDGSIVAVK-------RSKEIDKTQIHQFINEVVIL 266
           Y + + +G+G FG   K +L     DG    +K         KE ++++      EV +L
Sbjct: 2   YVKVKKIGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESR-----KEVAVL 53

Query: 267 SQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENR 326
           S + H +IV+      E     +V +Y   G L   I+     Q      E   L W   
Sbjct: 54  SNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKIN----AQRGVLFPEDQILDW--- 106

Query: 327 VRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTT 386
                ++  A+ ++H      I HRDIKS NI L    + K+ DFGI+R + N    L  
Sbjct: 107 ---FVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVL-NSTVELAR 159

Query: 387 TIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGK 425
           T  GT  YL PE  ++  + +KSD+++ G VL E+ T K
Sbjct: 160 TCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLK 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 77.4 bits (190), Expect = 2e-15
 Identities = 59/215 (27%), Positives = 100/215 (46%), Gaps = 19/215 (8%)

Query: 216 DNYNQSRFLGQGGFGTVYK-GMLPDGSIVAVKRSK-EIDKTQIHQFINEVVILSQINHRH 273
           D++ +   LG G  G V+K    P G I+A K    EI     +Q I E+ +L + N  +
Sbjct: 5   DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64

Query: 274 IVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEV 333
           IV   G         +  E++  G+L   +    +  EQ               +V+  V
Sbjct: 65  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG------------KVSIAV 112

Query: 334 AGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFG 393
              + Y+     I   HRD+K SNIL++ +   K+ DFG+S  + +    +  +  GT  
Sbjct: 113 IKGLTYLREKHKI--MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRS 167

Query: 394 YLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
           Y+ PE  Q + ++ +SD++S G+ L+E+  G+ PI
Sbjct: 168 YMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPI 202

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 76.7 bits (189), Expect = 3e-15
 Identities = 56/232 (24%), Positives = 96/232 (41%), Gaps = 45/232 (19%)

Query: 223 FLGQGGFGTVYKGM-LPDGSIVAVKRSKEI----DKTQIHQFIN----------EVVILS 267
            LG+G +G V K      G IVA+K+ K I    D T+  Q +           E+ I++
Sbjct: 16  HLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMN 75

Query: 268 QINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRV 327
           +I H +I+ L+   +E +   LV + ++S  L   +    +  E + K  L         
Sbjct: 76  EIKHENIMGLVDVYVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCILL-------- 126

Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
               ++   +  +H        HRD+  +NI ++ K   K++DFG++R         T +
Sbjct: 127 ----QILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLS 179

Query: 388 IQG-------------TFGYLDPE-YFQSSQFTDKSDVYSFGVVLLELLTGK 425
                           T  Y  PE    + ++    D++S G +  ELLTGK
Sbjct: 180 KDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 78.7 bits (194), Expect = 3e-15
 Identities = 62/210 (29%), Positives = 94/210 (44%), Gaps = 30/210 (14%)

Query: 240 GSIVAVKRSKEIDKTQIHQ---FINEVVILSQINHRHIVKLL--GCCLETEVPVLVYEYI 294
           G  VA+K  +     + HQ   F  E  + +++ H +IV LL  G      +   V+EY+
Sbjct: 3   GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYV 61

Query: 295 SSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIK 354
              TL   +                +L      R+  +V  A+A  H+     I HRD+K
Sbjct: 62  PGRTLREVL------------AADGALPAGETGRLMLQVLDALACAHNQG---IVHRDLK 106

Query: 355 SSNILL---DDKFSAKVSDFGISRSIPN----DKTHLTTTIQ--GTFGYLDPEYFQSSQF 405
             NI++     +  AKV DFGI   +P     D   LT T +  GT  Y  PE  +    
Sbjct: 107 PQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPV 166

Query: 406 TDKSDVYSFGVVLLELLTGKKPICFARVEE 435
           T  SD+Y++G++ LE LTG++ +  A V E
Sbjct: 167 TPNSDLYAWGLIFLECLTGQRVVQGASVAE 196

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 75.8 bits (186), Expect = 3e-15
 Identities = 59/214 (27%), Positives = 98/214 (45%), Gaps = 19/214 (8%)

Query: 218 YNQSRFLGQGGFGTVYKGML-PDGSIVAVKR--SKEIDKTQIHQF-INEVVILSQINHRH 273
           +   R LG+GGFG V    +   G + A K+   K I K +     +NE  IL ++N R 
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61

Query: 274 IVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEV 333
           +V L       +   LV   ++ G L  HI++       +Q+           +  A E+
Sbjct: 62  VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRA----------IFYAAEL 111

Query: 334 AGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFG 393
              +  +       I +RD+K  NILLDD+   ++SD G++  IP  +T       GT G
Sbjct: 112 CCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRV--GTVG 166

Query: 394 YLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
           Y+ PE   + ++T   D +  G ++ E++ G+ P
Sbjct: 167 YMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 76.2 bits (187), Expect = 4e-15
 Identities = 69/213 (32%), Positives = 101/213 (47%), Gaps = 25/213 (11%)

Query: 222 RFLGQGGFGTVYKGMLP-DGSIVAVK--RSKEI--DKTQIHQFINEVVILSQINHRHIVK 276
           + +G+G FG V       DGS  AVK  + K I   K Q H      V+L  + H  +V 
Sbjct: 1   KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60

Query: 277 LLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRV-ACEVAG 335
           L       E    V +Y++ G L  H+        Q+++  L     E R R  A EVA 
Sbjct: 61  LHYSFQTAEKLYFVLDYVNGGELFFHL--------QRERCFL-----EPRARFYAAEVAS 107

Query: 336 AVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS-IPNDKTHLTTTIQGTFGY 394
           A+ Y+HS   + I +RD+K  NILLD +    ++DFG+ +  +  ++T  T+T  GT  Y
Sbjct: 108 AIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET--TSTFCGTPEY 162

Query: 395 LDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
           L PE  +   +    D +  G VL E+L G  P
Sbjct: 163 LAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 75.8 bits (186), Expect = 4e-15
 Identities = 59/218 (27%), Positives = 108/218 (49%), Gaps = 31/218 (14%)

Query: 216 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEIDKTQIHQFI-NEVVILSQINHRH 273
           DN+ +   +G+G  G V    +   G +VAVK+  ++ K Q  + + NEVVI+    H +
Sbjct: 23  DNFIK---IGEGSTGIVCIATVKSSGKLVAVKK-MDLRKQQRRELLFNEVVIMRDYQHEN 78

Query: 274 IVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEV 333
           +V++    L  +   +V E++  G L+  +   +  +EQ     L+ L            
Sbjct: 79  VVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLK----------- 127

Query: 334 AGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG----ISRSIPNDKTHLTTTIQ 389
             A++ +H+   I   HRDIKS +ILL      K+SDFG    +S+ +P  K     ++ 
Sbjct: 128 --ALSVLHAQGVI---HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK-----SLV 177

Query: 390 GTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
           GT  ++ PE      +  + D++S G++++E++ G+ P
Sbjct: 178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 76.4 bits (188), Expect = 4e-15
 Identities = 86/337 (25%), Positives = 139/337 (41%), Gaps = 78/337 (23%)

Query: 224 LGQGGFGTVYK------GMLPDGSIVAVKRSKEIDKTQIHQ-FINEVVILSQI-NHRHIV 275
           LG+G FG V +              VAVK  KE      ++  + E+ IL  I +H ++V
Sbjct: 15  LGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVV 74

Query: 276 KLLGCCLETEVPVLV-YEYISSGTLSHHIHDHQ-----------QQQEQKQ----KQELS 319
            LLG C +   P++V  EY   G LS+++   +           +++E KQ    KQ L 
Sbjct: 75  NLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLD 134

Query: 320 S----------------------------------LSWENRVRVACEVAGAVAYMHSSAS 345
           S                                  L+ E+ +  + +VA  + ++ S   
Sbjct: 135 SVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKC 194

Query: 346 IPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTT-TIQGTFGYLDPEYFQSSQ 404
           I   HRD+ + NILL +    K+ DFG++R I  D  ++     +    ++ PE      
Sbjct: 195 I---HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKV 251

Query: 405 FTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQLLEILDARVAKE 463
           +T +SDV+SFGV+L E+ + G  P    +++EE      F    KE   +     R  + 
Sbjct: 252 YTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE------FCRRLKEGTRM-----RAPEY 300

Query: 464 AREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGL 500
           A  E    M    + C   N + RPT  ++   L  L
Sbjct: 301 ATPEIYSIM----LDCWHNNPEDRPTFSELVEILGDL 333

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 76.2 bits (187), Expect = 4e-15
 Identities = 66/212 (31%), Positives = 96/212 (45%), Gaps = 23/212 (10%)

Query: 222 RFLGQGGFGTVYKGMLP-DGSIVAVK-RSKEI---DKTQIHQFINEVVILSQINHRHIVK 276
           + +G+G FG V       DG   AVK   K+I    K Q H      V+L  + H  +V 
Sbjct: 1   KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 277 LLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGA 336
           L      TE    V ++++ G L  H+   +   E + +              A E+A A
Sbjct: 61  LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRAR------------FYAAEIASA 108

Query: 337 VAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS-IPNDKTHLTTTIQGTFGYL 395
           + Y+HS   I I +RD+K  NILLD +    ++DFG+ +  I    T  TTT  GT  YL
Sbjct: 109 LGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT--TTTFCGTPEYL 163

Query: 396 DPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
            PE  +   + +  D +  G VL E+L G  P
Sbjct: 164 APEVIRKQPYDNTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 75.5 bits (186), Expect = 5e-15
 Identities = 61/209 (29%), Positives = 103/209 (49%), Gaps = 23/209 (11%)

Query: 224 LGQGGFGTVYKGM-LPDGSIVAVKRSK-EIDKTQIHQFINEVVILSQINHRHIVKLLGCC 281
           LG G  G V K +  P G I+A K    EI     +Q I E+ +L + N  +IV   G  
Sbjct: 9   LGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAF 68

Query: 282 L-ETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRV-RVACEVAGAVAY 339
             + E+ + + E++  G+L          Q  K+   +     EN + +++  V   + Y
Sbjct: 69  YSDGEISICM-EHMDGGSLD---------QVLKKAGRIP----ENILGKISIAVLRGLTY 114

Query: 340 MHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEY 399
           +     I   HRD+K SNIL++ +   K+ DFG+S  + +    +  +  GT  Y+ PE 
Sbjct: 115 LREKHKI--MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPER 169

Query: 400 FQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
            Q + +T +SD++S G+ L+E+  G+ PI
Sbjct: 170 LQGTHYTVQSDIWSLGLSLVEMAIGRYPI 198

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 75.3 bits (186), Expect = 6e-15
 Identities = 66/234 (28%), Positives = 109/234 (46%), Gaps = 47/234 (20%)

Query: 213 RATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQF----INEVVILS 267
           R+ D Y +   + +G +G VY+      G IVA+K+ K ++K +   F    + E+ IL 
Sbjct: 2   RSVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLK-MEK-EKEGFPITSLREINILL 59

Query: 268 QINHRHIVKLLGCCLETEVPV--------LVYEYISSG--TLSHHIHDHQQQQEQK--QK 315
           ++ H +IV +       EV V        +V EY+     +L   +     Q E K    
Sbjct: 60  KLQHPNIVTV------KEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLML 113

Query: 316 QELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISR 375
           Q LS                 VA++H +    I HRD+K+SN+LL+++   K+ DFG++R
Sbjct: 114 QLLS----------------GVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAR 154

Query: 376 SIPNDKTHLTTTIQGTFGYLDPE-YFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
              +     T  +  T  Y  PE    + +++   D++S G +  ELLT KKP+
Sbjct: 155 EYGSPLKPYTQLVV-TLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLT-KKPL 206

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 74.8 bits (184), Expect = 7e-15
 Identities = 67/234 (28%), Positives = 108/234 (46%), Gaps = 31/234 (13%)

Query: 217 NYNQSRFLGQGGFGTVY----KGMLPDGSIVAVKRSKEID-----KTQIHQFINEVVILS 267
           N+   R LG G +G V+     G    G + A+K  K+       KT  H    E  +L 
Sbjct: 1   NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHT-RTERQVLE 59

Query: 268 QINHRHIVKLLGCCLETEVPV-LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENR 326
            +     +  L    +T+  + L+ +Y++ G L  H++       Q++    S    E R
Sbjct: 60  AVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLY-------QREHFTES----EVR 108

Query: 327 VRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTT 386
           V +A E+  A+ ++H    + I +RDIK  NILLD +    ++DFG+S+    ++     
Sbjct: 109 VYIA-EIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAY 164

Query: 387 TIQGTFGYLDPEYFQ--SSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERN 438
           +  GT  Y+ PE  +  S       D +S GV+  ELLTG  P  F  V+ E+N
Sbjct: 165 SFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASP--FT-VDGEQN 215

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 74.8 bits (184), Expect = 7e-15
 Identities = 58/218 (26%), Positives = 99/218 (45%), Gaps = 27/218 (12%)

Query: 216 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKR---SKEIDKTQIHQFINEVVILSQINH 271
           D+  + + +G G FG V+           A+K     + I   Q     NE  +L +++H
Sbjct: 1   DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60

Query: 272 RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRV-- 329
             I++L     +     ++ EY+  G L  ++               +S  + N   +  
Sbjct: 61  PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLR--------------NSGRFSNSTGLFY 106

Query: 330 ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQ 389
           A E+  A+ Y+HS     I +RD+K  NILLD +   K++DFG ++ +  D+T    T+ 
Sbjct: 107 ASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKL-RDRTW---TLC 159

Query: 390 GTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
           GT  YL PE  QS       D ++ G+++ E+L G  P
Sbjct: 160 GTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 75.1 bits (184), Expect = 8e-15
 Identities = 74/240 (30%), Positives = 108/240 (45%), Gaps = 40/240 (16%)

Query: 201 ERAKVFTADELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQ- 258
           E A +F  D+ +      ++   +G G FG VY         +VAVK+     K Q ++ 
Sbjct: 9   EIADLFYKDDPEEIFVGLHE---IGHGSFGAVYFATNSHTNEVVAVKKMSYSGK-QTNEK 64

Query: 259 ---FINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQK 315
               I EV  L Q+ H + ++  GC L+     LV EY   G+ S  +  H+     K  
Sbjct: 65  WQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY-CLGSASDLLEVHK-----KPL 118

Query: 316 QELSSLSWENRVRVACEVAGAV---AYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG 372
           QE         V +A    GA+   AY+HS   I   HRDIK+ NILL +    K++DFG
Sbjct: 119 QE---------VEIAAITHGALQGLAYLHSHNMI---HRDIKAGNILLTEPGQVKLADFG 166

Query: 373 -ISRSIPNDKTHLTTTIQGTFGYLDPEY---FQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
             S+S P        +  GT  ++ PE        Q+  K DV+S G+  +EL   K P+
Sbjct: 167 SASKSSP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 220

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 74.2 bits (182), Expect = 9e-15
 Identities = 69/286 (24%), Positives = 125/286 (43%), Gaps = 41/286 (14%)

Query: 224 LGQGGFGTVYKGMLPDGSIVAVKRSKEIDKT----QIHQFINEVVILSQINHRHIVKLLG 279
           +G G FG V  G    G   A    KE+  +    +   F+ EV    ++NH ++++ LG
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62

Query: 280 CCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAY 339
            C+E+   +LV E+   G L +++  ++    Q  ++++         R+ACEVA  + +
Sbjct: 63  QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDV-------LQRMACEVASGLLW 115

Query: 340 MHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS-IPNDKTHLTTTIQGTFG--YLD 396
           +H +  I   H D+   N  L    S K+ D+G++    P D  +  T         +L 
Sbjct: 116 LHQADFI---HSDLALRNCQLTADLSVKIGDYGLALEQYPED--YYITKDCHAVPLRWLA 170

Query: 397 PEYFQSSQ-------FTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAK 448
           PE  +           T KS+++S GV + EL T   +P  +  + +E+ L         
Sbjct: 171 PELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQP--YPDLSDEQVL--------- 219

Query: 449 ENQLLEILDARVAKEAREEDIGAM-AELAMRCLRLNSKKRPTMKQV 493
             Q++   D ++ K   +        E+   C  L+ + RPT ++V
Sbjct: 220 -KQVVREQDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEV 263

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 75.0 bits (184), Expect = 1e-14
 Identities = 66/234 (28%), Positives = 111/234 (47%), Gaps = 32/234 (13%)

Query: 217 NYNQSRFLGQGGFGTVY---KGMLPD-GSIVAVKRSKEI-----DKTQIHQFINEVVILS 267
           N+   + LG G +G V+   K    D G + A+K  ++       KT  H    E  +L 
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTR-TERNVLE 59

Query: 268 QINHRHIVKLLGCCLETEVPV-LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENR 326
            +     +  L    +TE  + L+ +Y+S G +  H++         Q+   S    E+ 
Sbjct: 60  HVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLY---------QRDNFS----EDE 106

Query: 327 VRV-ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLT 385
           VR  + E+  A+ ++H    + I +RDIK  NILLD +    ++DFG+S+   +++   T
Sbjct: 107 VRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERT 163

Query: 386 TTIQGTFGYLDPEYFQSSQFTDKS-DVYSFGVVLLELLTGKKPICFARVEEERN 438
            +  GT  Y+ PE  +      K+ D +S G+++ ELLTG  P     +E ERN
Sbjct: 164 YSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFT---LEGERN 214

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 74.4 bits (183), Expect = 1e-14
 Identities = 57/216 (26%), Positives = 102/216 (47%), Gaps = 35/216 (16%)

Query: 224 LGQGGFGTVYKGMLPDG----SIVAVKRS-----KEIDKTQIHQFINEVVILSQINHRHI 274
           LG+G FG V    L       +I A+K+       +++ T + +    V+ L+   H  +
Sbjct: 3   LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVER---RVLALAW-EHPFL 58

Query: 275 VKLLGCCLETEVPVL-VYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRV-ACE 332
             L  C  +T+  +  V EY++ G L  HI       +   + + +      R R  A E
Sbjct: 59  THLF-CTFQTKEHLFFVMEYLNGGDLMFHI-------QSSGRFDEA------RARFYAAE 104

Query: 333 VAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISR-SIPNDKTHLTTTIQGT 391
           +   + ++H    I   +RD+K  N+LLD     K++DFG+ + ++  +     +T  GT
Sbjct: 105 IICGLQFLHKKGII---YRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK--ASTFCGT 159

Query: 392 FGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
             Y+ PE  +  ++ +  D +SFGV+L E+L G+ P
Sbjct: 160 PDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 73.7 bits (181), Expect = 2e-14
 Identities = 59/212 (27%), Positives = 102/212 (48%), Gaps = 22/212 (10%)

Query: 224 LGQGGFGTVYKGM-LPDGSIVAVKRSK-EIDKTQIHQFINEVVILSQINHRHIVKLLGCC 281
           LG+G +G+VYK +  P G  +A+K  + E+D+++ +Q I E+ IL +    +IV   G  
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68

Query: 282 LETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMH 341
                  +  EY+ +G+L   ++      E   +  L         R+   V   + ++ 
Sbjct: 69  FIEGAVYMCMEYMDAGSLD-KLYAGGVATEGIPEDVLR--------RITYAVVKGLKFLK 119

Query: 342 SSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQ 401
              +  I HRD+K +N+L++     K+ DFG+S    N    L  T  G   Y+ PE  +
Sbjct: 120 EEHN--IIHRDVKPTNVLVNGNGQVKLCDFGVS---GNLVASLAKTNIGCQSYMAPERIK 174

Query: 402 S------SQFTDKSDVYSFGVVLLELLTGKKP 427
           S        +T +SDV+S G+ +LE+  G+ P
Sbjct: 175 SGGPNQNPTYTVQSDVWSLGLSILEMALGRYP 206

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 73.9 bits (181), Expect = 2e-14
 Identities = 64/220 (29%), Positives = 103/220 (46%), Gaps = 41/220 (18%)

Query: 224 LGQGGFGTVYKGMLPDGSIVAVKRSKEID---KTQIHQFINEVVILSQINHRHIVKLLGC 280
           LG G FG VYK    +  ++A   +K ID   + ++  ++ E+ IL+  +H +IVKLL  
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAA--AKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 70

Query: 281 CL-ETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVAC-EVAGAVA 338
              E  + +L+ E+ + G +   +             EL     E ++RV C +   A+ 
Sbjct: 71  FYYENNLWILI-EFCAGGAVDAVM------------LELERPLTEPQIRVVCKQTLEALN 117

Query: 339 YMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQ------GTF 392
           Y+H +    I HRD+K+ NIL       K++DFG+S          T TIQ      GT 
Sbjct: 118 YLHENK---IIHRDLKAGNILFTLDGDIKLADFGVS-------AKNTRTIQRRDSFIGTP 167

Query: 393 GYLDPEYFQSSQFTD-----KSDVYSFGVVLLELLTGKKP 427
            ++ PE        D     K+DV+S G+ L+E+   + P
Sbjct: 168 YWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPP 207

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 73.9 bits (181), Expect = 2e-14
 Identities = 55/193 (28%), Positives = 97/193 (50%), Gaps = 27/193 (13%)

Query: 240 GSIVAVKRSKEIDKTQIHQFI-NEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGT 298
           G  VAVK+  ++ K Q  + + NEVVI+   +H ++V +    L  +   +V E++  G 
Sbjct: 47  GKQVAVKK-MDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGA 105

Query: 299 LSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNI 358
           L+  +   +  +EQ     LS L              A++Y+H+   I   HRDIKS +I
Sbjct: 106 LTDIVTHTRMNEEQIATVCLSVLR-------------ALSYLHNQGVI---HRDIKSDSI 149

Query: 359 LLDDKFSAKVSDFG----ISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSF 414
           LL      K+SDFG    +S+ +P  K     ++ GT  ++ PE      +  + D++S 
Sbjct: 150 LLTSDGRIKLSDFGFCAQVSKEVPKRK-----SLVGTPYWMAPEVISRLPYGTEVDIWSL 204

Query: 415 GVVLLELLTGKKP 427
           G++++E++ G+ P
Sbjct: 205 GIMVIEMIDGEPP 217

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 73.9 bits (181), Expect = 2e-14
 Identities = 65/213 (30%), Positives = 100/213 (46%), Gaps = 25/213 (11%)

Query: 222 RFLGQGGFGTVYKGM-LPDGSIVAVK--RSKEI--DKTQIHQFINEVVILSQINHRHIVK 276
           + +G+G FG V       +    AVK  + K I   K + H      V+L  + H  +V 
Sbjct: 1   KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60

Query: 277 LLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRV-ACEVAG 335
           L       +    V +YI+ G L +H+        Q+++  L     E R R  A E+A 
Sbjct: 61  LHFSFQTADKLYFVLDYINGGELFYHL--------QRERCFL-----EPRARFYAAEIAS 107

Query: 336 AVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISR-SIPNDKTHLTTTIQGTFGY 394
           A+ Y+HS   + I +RD+K  NILLD +    ++DFG+ + +I ++ T  T+T  GT  Y
Sbjct: 108 ALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGT--TSTFCGTPEY 162

Query: 395 LDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
           L PE      +    D +  G VL E+L G  P
Sbjct: 163 LAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 73.7 bits (181), Expect = 3e-14
 Identities = 64/213 (30%), Positives = 101/213 (47%), Gaps = 25/213 (11%)

Query: 222 RFLGQGGFGTVY----KGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKL 277
           + LG+G FG V     KG     +I  +K+   +    +   + E  IL+       +  
Sbjct: 1   KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60

Query: 278 LGCCLETEVPVL-VYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRV-ACEVAG 335
           L CC +T+  +  V EY++ G L   I     Q+ +K          E R R  A EV  
Sbjct: 61  LHCCFQTKDRLFFVMEYVNGGDLMFQI-----QRSRKFD--------EPRSRFYAAEVTL 107

Query: 336 AVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISR-SIPNDKTHLTTTIQGTFGY 394
           A+ ++H    I   +RD+K  NILLD +   K++DFG+ +  I N  T  TTT  GT  Y
Sbjct: 108 ALMFLHRHGVI---YRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT--TTTFCGTPDY 162

Query: 395 LDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
           + PE  Q  ++    D ++ GV++ E++ G+ P
Sbjct: 163 IAPEILQELEYGPSVDWWALGVLMYEMMAGQPP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 73.7 bits (181), Expect = 3e-14
 Identities = 66/220 (30%), Positives = 107/220 (48%), Gaps = 29/220 (13%)

Query: 217 NYNQSRFLGQGGFGTVYKGMLPD--GS--IVAVKRSKE---IDKTQIHQFINEVVILSQI 269
           ++N    LG+G FG V   ML +  G+  + A+K  K+   I    +   + E  +L+  
Sbjct: 1   DFNFLMVLGKGSFGKV---MLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALP 57

Query: 270 NHRHIVKLLGCCLETEVPV-LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVR 328
                +  L  C +T   +  V EY++ G L +HI     QQ  K K+  +       V 
Sbjct: 58  GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI-----QQVGKFKEPHA-------VF 105

Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISR-SIPNDKTHLTTT 387
            A E+A  + ++HS     I +RD+K  N++LD +   K++DFG+ + +I   KT  T T
Sbjct: 106 YAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT--TRT 160

Query: 388 IQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
             GT  Y+ PE      +    D ++FGV+L E+L G+ P
Sbjct: 161 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPP 200

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 72.1 bits (177), Expect = 4e-14
 Identities = 63/224 (28%), Positives = 90/224 (40%), Gaps = 32/224 (14%)

Query: 226 QGGFGTVY---KGMLPDG-SIVAVKRSKEIDKTQIHQFINEVVIL-SQINHRHIVKLLGC 280
           +G FG+VY   K    D  +I  +K+S  I K Q+     E  I+  Q    ++ KL   
Sbjct: 6   KGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYS 65

Query: 281 CLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYM 340
               +   LV EY++ G  +  I            + L  L  +   +   EV   V  +
Sbjct: 66  FQSKDYLYLVMEYLNGGDCASLI------------KTLGGLPEDWAKQYIAEVVLGVEDL 113

Query: 341 HSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYF 400
           H      I HRDIK  N+L+D     K++DFG+SR+   +K        GT  YL PE  
Sbjct: 114 HQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENK-----KFVGTPDYLAPETI 165

Query: 401 QSSQFTDKSDVYSFGVVLLELLTGKKPI-------CFARVEEER 437
                   SD +S G V+ E L G  P         F  +   R
Sbjct: 166 LGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRR 209

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 72.5 bits (178), Expect = 4e-14
 Identities = 58/216 (26%), Positives = 102/216 (47%), Gaps = 30/216 (13%)

Query: 224 LGQGGFGTVYKGML--PDGSIVAVKRSK-EIDKTQIHQFINEV-VILSQINHRHIVKLLG 279
           LG+G +G V K M   P G+I+AVKR +  ++  +  + + ++ + +  ++  + V   G
Sbjct: 9   LGRGAYGVVDK-MRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYG 67

Query: 280 CCLETEVPVLVYEYISSGTLSH---HIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGA 336
             L  E  V +   +   +L      ++D      +        L      ++A  +  A
Sbjct: 68  A-LFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPE------DILG-----KIAVSIVKA 115

Query: 337 VAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQ-GTFGYL 395
           + Y+HS  S+   HRD+K SN+L++     K+ DFGIS  + +    +  TI  G   Y+
Sbjct: 116 LEYLHSKLSV--IHRDVKPSNVLINRNGQVKLCDFGISGYLVDS---VAKTIDAGCKPYM 170

Query: 396 DPEYF----QSSQFTDKSDVYSFGVVLLELLTGKKP 427
            PE          +  KSDV+S G+ ++EL TG+ P
Sbjct: 171 APERINPELNQKGYDVKSDVWSLGITMIELATGRFP 206

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 71.9 bits (176), Expect = 4e-14
 Identities = 58/213 (27%), Positives = 94/213 (44%), Gaps = 16/213 (7%)

Query: 217 NYNQSRFLGQGGFGT--VYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHI 274
            YN  R +G+G FG   + + +  D      +       + +     E V+L+++ H +I
Sbjct: 1   QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNI 60

Query: 275 VKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVA 334
           V             +V EY   G L   I    + Q  K   E + L W        ++ 
Sbjct: 61  VAFKESFEADGHLYIVMEYCDGGDLMQKI----KLQRGKLFPEDTILQW------FVQMC 110

Query: 335 GAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGY 394
             V ++H      + HRDIKS NI L      K+ DFG +R + +   +  T + GT  Y
Sbjct: 111 LGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYY 166

Query: 395 LDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
           + PE +++  + +KSD++S G +L EL T K P
Sbjct: 167 VPPEIWENMPYNNKSDIWSLGCILYELCTLKHP 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 72.8 bits (178), Expect = 5e-14
 Identities = 69/238 (28%), Positives = 109/238 (45%), Gaps = 36/238 (15%)

Query: 201 ERAKVFTADELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKR---SKEIDKTQI 256
           E A++F  ++ ++    +   R +G G FG VY    +    +VA+K+   S +    + 
Sbjct: 13  EIAELFFKEDPEKL---FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKW 69

Query: 257 HQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQ 316
              I EV  L +I H + ++  GC L      LV EY   G+ S  +  H++  ++    
Sbjct: 70  QDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY-CLGSASDLLEVHKKPLQE---- 124

Query: 317 ELSSLSWENRVRVACEVAGAV---AYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGI 373
                     V +A    GA+   AY+HS   I   HRDIK+ NILL +    K++DFG 
Sbjct: 125 ----------VEIAAITHGALQGLAYLHSHNMI---HRDIKAGNILLTEPGQVKLADFG- 170

Query: 374 SRSIPNDKTHLTTTIQGTFGYLDPEY---FQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
           S SI +       +  GT  ++ PE        Q+  K DV+S G+  +EL   K P+
Sbjct: 171 SASIASP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 224

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 72.3 bits (177), Expect = 7e-14
 Identities = 57/209 (27%), Positives = 96/209 (45%), Gaps = 22/209 (10%)

Query: 224 LGQGGFGTVYKGMLPDGSIV----AVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLG 279
           +G+G FG V +    D   +     ++++  + ++++   + E  +L+Q+N   IV L  
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 280 CCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRV-ACEVAGAVA 338
                E   LV  +I+ G L HH+     Q+E +           +R R    E+  A+ 
Sbjct: 61  SFQSPEKLYLVLAFINGGELFHHL-----QREGRFD--------LSRARFYTAELLCALE 107

Query: 339 YMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPE 398
            +H      + +RD+K  NILLD +    + DFG+ + +       T T  GT  YL PE
Sbjct: 108 NLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCK-LNMKDDDKTNTFCGTPEYLAPE 163

Query: 399 YFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
                 +T   D ++ GV+L E+LTG  P
Sbjct: 164 LLLGHGYTKAVDWWTLGVLLYEMLTGLPP 192

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 71.4 bits (175), Expect = 8e-14
 Identities = 54/209 (25%), Positives = 99/209 (47%), Gaps = 18/209 (8%)

Query: 224 LGQGGFGTVYK-GMLPDGSIVAVKR--SKEIDKTQIHQ-FINEVVILSQINHRHIVKLLG 279
           LG+GGFG V    M   G + A K+   K + K + ++  + E  IL++++ R IV L  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSL-A 59

Query: 280 CCLETEVPV-LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVA 338
              +T+  + LV   ++ G L +HI++          +E              ++   + 
Sbjct: 60  YAFQTKTDLCLVMTIMNGGDLRYHIYN--------VDEENPGFPEPRACFYTAQIISGLE 111

Query: 339 YMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPE 398
           ++H      I +RD+K  N+LLD+  + ++SD G++  +  D    T    GT G++ PE
Sbjct: 112 HLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVEL-KDGQSKTKGYAGTPGFMAPE 167

Query: 399 YFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
             Q  ++    D ++ GV L E++  + P
Sbjct: 168 LLQGEEYDFSVDYFALGVTLYEMIAARGP 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 72.3 bits (177), Expect = 9e-14
 Identities = 69/282 (24%), Positives = 113/282 (40%), Gaps = 64/282 (22%)

Query: 216 DNYNQSRFLGQGGFGTVYKGML------PDGSIVAVKRSKEIDKTQIHQ-FINEVVILSQ 268
           D     + LG G FG V +            + VAVK  KE      H+  ++E+ IL  
Sbjct: 7   DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIH 66

Query: 269 I-NHRHIVKLLGCCLETEVPVLV-YEYISSGTLS-------------------------- 300
           I NH ++V LLG C +   P++V  E+   G LS                          
Sbjct: 67  IGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRA 126

Query: 301 ----------------------HHIHDHQQQQEQKQKQEL--SSLSWENRVRVACEVAGA 336
                                             ++  +L  S L+ E+ +  + +VA  
Sbjct: 127 MVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARG 186

Query: 337 VAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTT-TIQGTFGYL 395
           + ++ S   I   HRD+ + NILL +    K+ DFG++R I  D  ++   + +    ++
Sbjct: 187 MEFLASRKCI---HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWM 243

Query: 396 DPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEE 436
            PE      +T +SDV+SFGV+L E+ + G  P    ++ EE
Sbjct: 244 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE 285

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 73.7 bits (181), Expect = 1e-13
 Identities = 61/232 (26%), Positives = 97/232 (41%), Gaps = 27/232 (11%)

Query: 218 YNQSRFLGQGGFGTVYKGMLPDGS-IVAVKRSKE--IDKTQIH-QFINEVVILSQINHRH 273
           Y+  R +G+GG G VY    P  S  VA+K+ +E   +   +  +F+ E  I + + H  
Sbjct: 4   YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPG 63

Query: 274 IVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEV 333
           IV +   C + +       YI   TL   +     Q+E   K+     S    + +  ++
Sbjct: 64  IVPVYSICSDGDPVYYTMPYIEGYTLKS-LLKSVWQKESLSKELAEKTSVGAFLSIFHKI 122

Query: 334 AGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKV-SDFG--------------ISRSIP 378
              + Y+HS     + HRD+K  NILL   F   V  D+G              I     
Sbjct: 123 CATIEYVHSKG---VLHRDLKPDNILLG-LFGEVVILDWGAAIFKKLEEEDLLDIDVDER 178

Query: 379 NDKTHLTTT---IQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
           N      T    I GT  Y+ PE       ++ +D+Y+ GV+L ++LT   P
Sbjct: 179 NICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230

Length = 932

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 71.1 bits (174), Expect = 1e-13
 Identities = 56/212 (26%), Positives = 107/212 (50%), Gaps = 27/212 (12%)

Query: 224 LGQGGFGTVYKGMLPD-GSIVAVKRSKEIDKTQIHQFINEVV------ILSQINHRHIVK 276
           LG+GGFG V    + + G + A K+   +DK ++ +   E +      IL ++N   IV 
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKK---LDKKRLKKKSGEKMALLEKEILEKVNSPFIVN 57

Query: 277 LLGCCLETEVPV-LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAG 335
           L     E++  + LV   ++ G L +HI++  ++           L  E  +  + ++  
Sbjct: 58  L-AYAFESKTHLCLVMSLMNGGDLKYHIYNVGER----------GLEMERVIHYSAQITC 106

Query: 336 AVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYL 395
            + ++HS   + I +RD+K  N+LLDD+ + ++SD G++  + + KT   T   GT GY+
Sbjct: 107 GILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRAGTNGYM 161

Query: 396 DPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
            PE  +   ++   D ++ G  + E++ G+ P
Sbjct: 162 APEILKEEPYSYPVDWFAMGCSIYEMVAGRTP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 71.5 bits (175), Expect = 1e-13
 Identities = 65/221 (29%), Positives = 103/221 (46%), Gaps = 25/221 (11%)

Query: 222 RFLGQGGFGTVY----KGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKL 277
           + LG+G FG V+    KG     +I A+K+   +    +   + E  +LS       +  
Sbjct: 1   KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60

Query: 278 LGCCLET-EVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGA 336
           L C  +T E    V EY++ G L  HI       +   K +L   ++      A E+   
Sbjct: 61  LYCTFQTKENLFFVMEYLNGGDLMFHI-------QSCHKFDLPRATF-----YAAEIICG 108

Query: 337 VAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISR-SIPNDKTHLTTTIQGTFGYL 395
           + ++HS     I +RD+K  NILLD     K++DFG+ + ++  D    T T  GT  Y+
Sbjct: 109 LQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK--TCTFCGTPDYI 163

Query: 396 DPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEE 436
            PE     ++    D +SFGV+L E+L G+ P  F   +EE
Sbjct: 164 APEILLGQKYNTSVDWWSFGVLLYEMLIGQSP--FHGHDEE 202

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 71.5 bits (175), Expect = 1e-13
 Identities = 63/213 (29%), Positives = 101/213 (47%), Gaps = 25/213 (11%)

Query: 222 RFLGQGGFGTVYKGMLP-DGSIVAVKRSKE----IDKTQIHQFINEVVILSQINHRHIVK 276
           + LG+G FG V    L   G   AVK  K+    ID   +   + E  +L+       + 
Sbjct: 1   KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDD-DVECTMVEKRVLALAWENPFLT 59

Query: 277 LLGCCLET-EVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAG 335
            L C  +T E    V E+++ G L  HI D       K + +L   ++      A E+  
Sbjct: 60  HLYCTFQTKEHLFFVMEFLNGGDLMFHIQD-------KGRFDLYRATF-----YAAEIVC 107

Query: 336 AVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISR-SIPNDKTHLTTTIQGTFGY 394
            + ++HS   I   +RD+K  N++LD     K++DFG+ + ++  D     +T  GT  Y
Sbjct: 108 GLQFLHSKGII---YRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR--ASTFCGTPDY 162

Query: 395 LDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
           + PE  Q  ++T   D +SFGV+L E+L G+ P
Sbjct: 163 IAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 70.9 bits (174), Expect = 1e-13
 Identities = 58/212 (27%), Positives = 107/212 (50%), Gaps = 25/212 (11%)

Query: 224 LGQGGFGTVYKGM-LPDGSIVAVKRSK-EIDKTQI-HQFINEVVILSQINHRHIVKLLGC 280
           +G+G +G VYKG     G IVA+K+ + E ++  +    I E+ +L ++ H +IV L   
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67

Query: 281 CLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYM 340
            ++     L++E++S   L  ++ D   + +    + + S  ++        +   + + 
Sbjct: 68  LMQESRLYLIFEFLSM-DLKKYL-DSLPKGQYMDAELVKSYLYQ--------ILQGILFC 117

Query: 341 HSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS--IP-NDKTHLTTTIQGTFGYLDP 397
           HS     + HRD+K  N+L+D+K   K++DFG++R+  IP    TH   T+     Y  P
Sbjct: 118 HSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLW----YRAP 170

Query: 398 EYFQSSQ-FTDKSDVYSFGVVLLELLTGKKPI 428
           E    S  ++   D++S G +  E+ T KKP+
Sbjct: 171 EVLLGSPRYSTPVDIWSIGTIFAEMAT-KKPL 201

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 71.0 bits (174), Expect = 2e-13
 Identities = 57/224 (25%), Positives = 100/224 (44%), Gaps = 31/224 (13%)

Query: 216 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSK-EIDKTQI-HQFINEVVILSQINHR 272
           D Y +   +G+G +G VYK      G +VA+K+++ E+D+  I    + E+ +L  ++  
Sbjct: 1   DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60

Query: 273 -HIVKLLGCCLETEVPV------LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWEN 325
            +IV+LL      E         LV+EY+ S        + +        + + S  ++ 
Sbjct: 61  IYIVRLL-DVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQ- 118

Query: 326 RVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD-DKFSAKVSDFGISR--SIPNDK- 381
                  +   VA+ H      + HRD+K  N+L+D  K   K++D G+ R  SIP    
Sbjct: 119 -------LLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSY 168

Query: 382 THLTTTIQGTFGYLDPE-YFQSSQFTDKSDVYSFGVVLLELLTG 424
           TH   T+     Y  PE    S+ ++   D++S G +  E+   
Sbjct: 169 THEIVTLW----YRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 71.4 bits (176), Expect = 2e-13
 Identities = 57/233 (24%), Positives = 101/233 (43%), Gaps = 55/233 (23%)

Query: 218 YNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIH--QFINEVVILSQINHRHI 274
           Y   + +G G +G V   +    G  VA+K+   +    I   + + E+ +L  + H +I
Sbjct: 2   YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENI 61

Query: 275 VKLLGCCLETEVPV-----------LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSW 323
           + LL      ++             +V E + +  L   I         K  Q L+    
Sbjct: 62  IGLL------DILRPPSPEDFNDVYIVTELMET-DLHKVI---------KSPQPLT---- 101

Query: 324 ENRVR-VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI---PN 379
           ++ ++    ++   + Y+HS+  I   HRD+K SNIL++     K+ DFG++R +    +
Sbjct: 102 DDHIQYFLYQILRGLKYLHSANVI---HRDLKPSNILVNSNCDLKICDFGLARGVDPDED 158

Query: 380 DKTHLTTTIQGTFGYL------DPE-YFQSSQFTDKSDVYSFGVVLLELLTGK 425
           +K  LT        Y+       PE    SS++T   D++S G +  ELLT K
Sbjct: 159 EKGFLT-------EYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 72.6 bits (178), Expect = 2e-13
 Identities = 77/247 (31%), Positives = 106/247 (42%), Gaps = 57/247 (23%)

Query: 218 YNQSRFLGQGGFGTV-YKGMLPDGSIVAVK-------RSKEIDKTQIHQFINEVVILSQI 269
           Y  SR LG G  GTV     + DG   AVK          + ++ Q      EV  L   
Sbjct: 34  YWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQ-----AEVCCLLNC 88

Query: 270 NHRHIVKLLGCCLE--------TEVPV----LVYEYISSGTLSHHIHDHQQQQEQKQKQE 317
           +   IVK    C E            V    LV +Y ++G L               +QE
Sbjct: 89  DFFSIVK----CHEDFAKKDPRNPENVLMIALVLDYANAGDL---------------RQE 129

Query: 318 LSSLSWENRVRVACEVAG--------AVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVS 369
           + S +  NR     E AG        AV ++HS   I   HRDIKS+NILL      K+ 
Sbjct: 130 IKSRAKTNRTFREHE-AGLLFIQVLLAVHHVHSKHMI---HRDIKSANILLCSNGLVKLG 185

Query: 370 DFGISRSIPNDKT-HLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
           DFG S+      +  +  T  GT  Y+ PE ++   ++ K+D++S GV+L ELLT K+P 
Sbjct: 186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPF 245

Query: 429 CFARVEE 435
               +EE
Sbjct: 246 DGENMEE 252

Length = 496

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 71.2 bits (175), Expect = 2e-13
 Identities = 62/246 (25%), Positives = 96/246 (39%), Gaps = 47/246 (19%)

Query: 216 DNYNQSRFLGQGGFGTVYKG-MLPDGSIVAVKR-SKE--IDKTQIHQFINEVVILSQINH 271
           D++   + +G+G FG V+       G + A+K   K   I + QI     E  IL+  + 
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60

Query: 272 RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVAC 331
             IVKL     + E   LV EY+  G L + +       E+             R  +A 
Sbjct: 61  PWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEE-----------TARFYIA- 108

Query: 332 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQ-- 389
           E+  A+  +H    I   HRDIK  NIL+D     K++DFG+ + +   K          
Sbjct: 109 ELVLALDSVHKLGFI---HRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSH 165

Query: 390 --------------------------GTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT 423
                                     GT  Y+ PE  + + +  + D +S GV+L E+L 
Sbjct: 166 NLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLY 225

Query: 424 GKKPIC 429
           G  P  
Sbjct: 226 GFPPFY 231

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 70.8 bits (173), Expect = 2e-13
 Identities = 67/238 (28%), Positives = 108/238 (45%), Gaps = 36/238 (15%)

Query: 201 ERAKVFTADELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKR---SKEIDKTQI 256
           + A++F  D+ ++    ++  R +G G FG VY    + +  +VA+K+   S +    + 
Sbjct: 3   DVAELFFKDDPEKL---FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKW 59

Query: 257 HQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQ 316
              I EV  L ++ H + ++  GC L      LV EY   G+ S  +  H++  ++    
Sbjct: 60  QDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY-CLGSASDLLEVHKKPLQE---- 114

Query: 317 ELSSLSWENRVRVACEVAGAV---AYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGI 373
                     V +A    GA+   AY+HS   I   HRD+K+ NILL +    K+ DFG 
Sbjct: 115 ----------VEIAAVTHGALQGLAYLHSHNMI---HRDVKAGNILLSEPGLVKLGDFG- 160

Query: 374 SRSIPNDKTHLTTTIQGTFGYLDPEY---FQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
           S SI            GT  ++ PE        Q+  K DV+S G+  +EL   K P+
Sbjct: 161 SASIMAP----ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 71.1 bits (175), Expect = 2e-13
 Identities = 79/333 (23%), Positives = 128/333 (38%), Gaps = 116/333 (34%)

Query: 222 RFLGQGGFGTVYKGMLPD---GSIVAVKRSKEID----KTQIHQFINEVVILSQI-NHRH 273
           + LG+G +G V+K +  D     +VA+K  K  D     T   +   E++ L ++ +H +
Sbjct: 13  QKLGKGAYGIVWKAI--DRRTKEVVALK--KIFDAFRNATDAQRTFREIMFLQELGDHPN 68

Query: 274 IVKLLGCCLETEVPV----------LVYEY--------ISSGTLSHHIHDHQQQQEQKQK 315
           IVKLL         V          LV+EY        I +  L           E   K
Sbjct: 69  IVKLLN--------VIKAENDKDIYLVFEYMETDLHAVIRANIL-----------EDVHK 109

Query: 316 QELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISR 375
           +            +  ++  A+ Y+HS   I   HRD+K SNILL+     K++DFG++R
Sbjct: 110 R-----------YIMYQLLKALKYIHSGNVI---HRDLKPSNILLNSDCRVKLADFGLAR 155

Query: 376 SIPNDKTHLTTTIQ----GTFGYLDPE-YFQSSQFTDKSDVYSFGVVLLELLTGKKPICF 430
           S+   + +    +      T  Y  PE    S+++T   D++S G +L E+L GK     
Sbjct: 156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK----- 210

Query: 431 ARVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAM------------------ 472
                       F   +  NQL +I++  V      EDI ++                  
Sbjct: 211 ----------PLFPGTSTLNQLEKIIE--VIGPPSAEDIESIKSPFAATMLDSLPSRPRK 258

Query: 473 -------------AELAMRCLRLNSKKRPTMKQ 492
                         +L  + L  N  KR T ++
Sbjct: 259 PLDELLPKASDDALDLLKKLLVFNPNKRLTAEE 291

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 70.1 bits (172), Expect = 3e-13
 Identities = 59/213 (27%), Positives = 95/213 (44%), Gaps = 27/213 (12%)

Query: 224 LGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQFI---NEVVILSQINHRHIVKLLG 279
           +G G  G VYK      G ++AVK+ +     + ++ I    +VV+ S  +  +IVK  G
Sbjct: 23  IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSH-DCPYIVKCYG 81

Query: 280 CCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRV-RVACEVAGAVA 338
               T+  V +   + S  L             K  + +     E+ + ++   +  A+ 
Sbjct: 82  Y-FITDSDVFICMELMSTCL------------DKLLKRIQGPIPEDILGKMTVAIVKALH 128

Query: 339 YMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPE 398
           Y+     +   HRD+K SNILLD   + K+ DFGIS  + + K    T   G   Y+ PE
Sbjct: 129 YLKEKHGV--IHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK--TRSAGCAAYMAPE 184

Query: 399 YFQSSQFTDK----SDVYSFGVVLLELLTGKKP 427
                    K    +DV+S G+ L+EL TG+ P
Sbjct: 185 RIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 69.6 bits (170), Expect = 4e-13
 Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 26/212 (12%)

Query: 224 LGQGGFGTVYKGMLPD-GSIVAVK--RSKEIDKTQIHQF-INEVVILSQINHRHIVKLLG 279
           +G+GGFG VY     D G + A+K    K I   Q     +NE ++LS ++      ++ 
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61

Query: 280 CCLETEVP---VLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGA 336
                  P     + + ++ G L +H+  H    E++ +              A E+   
Sbjct: 62  MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMR------------FYATEIILG 109

Query: 337 VAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLD 396
           + +MH+     + +RD+K +NILLD+    ++SD G++      K H +    GT GY+ 
Sbjct: 110 LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMA 163

Query: 397 PEYFQSSQFTDKS-DVYSFGVVLLELLTGKKP 427
           PE  Q     D S D +S G +L +LL G  P
Sbjct: 164 PEVLQKGTAYDSSADWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 69.3 bits (169), Expect = 7e-13
 Identities = 60/219 (27%), Positives = 102/219 (46%), Gaps = 27/219 (12%)

Query: 217 NYNQSRFLGQGGFGTVYKGMLPD----GSIVAVKRSKE---IDKTQIHQFINEVVILSQI 269
           ++N    LG+G FG V   ML +      + A+K  K+   I    +   + E  +L+  
Sbjct: 1   DFNFLMVLGKGSFGKV---MLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQ 57

Query: 270 NHRHIVKLLGCCLET-EVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVR 328
           +    +  L  C +T +    V EY++ G L +HI   QQ  + K+ Q          V 
Sbjct: 58  DKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHI---QQVGKFKEPQA---------VF 105

Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTI 388
            A E++  + ++H      I +RD+K  N++LD +   K++DFG+ +    D    T T 
Sbjct: 106 YAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV-TTRTF 161

Query: 389 QGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
            GT  Y+ PE      +    D +++GV+L E+L G+ P
Sbjct: 162 CGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPP 200

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 69.0 bits (168), Expect = 8e-13
 Identities = 60/215 (27%), Positives = 103/215 (47%), Gaps = 25/215 (11%)

Query: 216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVK--RSKEIDKTQIHQFINEVVILSQINHR 272
           D+Y +   LG+G + TVYKG    +G +VA+K  R +E + T     I E  +L  + H 
Sbjct: 5   DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTA-IREASLLKGLKHA 63

Query: 273 HIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACE 332
           +IV L       E   LV+EY+ +  L  ++  H              L  EN      +
Sbjct: 64  NIVLLHDIIHTKETLTLVFEYVHT-DLCQYMDKHP-----------GGLHPENVKLFLFQ 111

Query: 333 VAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISR--SIPNDKTHLTTTIQG 390
           +   ++Y+H      I HRD+K  N+L+ D    K++DFG++R  S+P   +H  +    
Sbjct: 112 LLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVP---SHTYSNEVV 165

Query: 391 TFGYLDPE-YFQSSQFTDKSDVYSFGVVLLELLTG 424
           T  Y  P+    S++++   D++  G + +E++ G
Sbjct: 166 TLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 69.3 bits (169), Expect = 8e-13
 Identities = 55/211 (26%), Positives = 94/211 (44%), Gaps = 22/211 (10%)

Query: 222 RFLGQGGFGTVY----KGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKL 277
           + LG+G FG V     K      ++  +K+   I K ++   + E  +L    H  +  L
Sbjct: 1   KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60

Query: 278 LGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRV-ACEVAGA 336
                  +    V EY++ G L  H+           ++ + S   E+R R    E+  A
Sbjct: 61  KYSFQTKDRLCFVMEYVNGGELFFHL----------SRERVFS---EDRTRFYGAEIVSA 107

Query: 337 VAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLD 396
           + Y+HS     I +RD+K  N++LD     K++DFG+ +    D   + T   GT  YL 
Sbjct: 108 LDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT-FCGTPEYLA 163

Query: 397 PEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
           PE  + + +    D +  GVV+ E++ G+ P
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 68.5 bits (167), Expect = 9e-13
 Identities = 73/291 (25%), Positives = 125/291 (42%), Gaps = 57/291 (19%)

Query: 217 NYNQSRFLGQGGFGTVY---------------KGMLPDGSIVAVKRSKEIDKTQIHQFIN 261
           N+   + LG G +G V+                 +L   +IV   ++ E  +T       
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRT------- 53

Query: 262 EVVILSQINHRHIVKLLGCCLETEVPV-LVYEYISSGTLSHHIHDHQQQQEQKQKQELSS 320
           E  +L  I     +  L    +T+  + L+ +YI+ G L  H+     Q+E+ ++QE+  
Sbjct: 54  ERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHL----SQRERFKEQEVQI 109

Query: 321 LSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPND 380
            S E        +  A+ ++H    + I +RDIK  NILLD      ++DFG+S+    D
Sbjct: 110 YSGE--------IVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHED 158

Query: 381 KTHLTTTIQGTFGYLDPEYFQSSQFT-DKS-DVYSFGVVLLELLTGKKPICFARVEEERN 438
           +     +  GT  Y+ P+  +      DK+ D +S GV++ ELLTG  P           
Sbjct: 159 EVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP----------- 207

Query: 439 LVACFISLAKENQLLEILDARVAKE-AREEDIGAMA-ELAMRCLRLNSKKR 487
               F    ++N   EI    +  E    +++ A+A ++  R L  + KKR
Sbjct: 208 ----FTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDIIQRLLMKDPKKR 254

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 68.5 bits (167), Expect = 9e-13
 Identities = 61/222 (27%), Positives = 110/222 (49%), Gaps = 23/222 (10%)

Query: 224 LGQGGFGTVYKGMLP-DGSIVAVKRSK-EIDKTQIHQFINEVVILSQINHRHIVKLLGCC 281
           LG+G + TV+KG      ++VA+K  + E ++      I EV +L  + H +IV L    
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72

Query: 282 LETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMH 341
                  LV+EY+ S  L  ++ D+            + +S  N      ++   ++Y H
Sbjct: 73  HTERCLTLVFEYLDS-DLKQYL-DNCG----------NLMSMHNVKIFMFQLLRGLSYCH 120

Query: 342 SSASIPIFHRDIKSSNILLDDKFSAKVSDFGISR--SIPNDKTHLTTTIQGTFGYLDPE- 398
                 I HRD+K  N+L+++K   K++DFG++R  S+P  KT+    +  T  Y  P+ 
Sbjct: 121 KRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPT-KTYSNEVV--TLWYRPPDV 174

Query: 399 YFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLV 440
              S++++   D++  G +L E+ TG+     + V+EE +L+
Sbjct: 175 LLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLI 216

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 68.4 bits (167), Expect = 9e-13
 Identities = 58/212 (27%), Positives = 95/212 (44%), Gaps = 26/212 (12%)

Query: 224 LGQGGFGTVYKGMLPD-GSIVAVK--RSKEIDKTQIHQF-INEVVILSQINHRHIVKLLG 279
           +G+GGFG VY     D G + A+K    K I   Q     +NE ++LS ++      ++ 
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61

Query: 280 CCLETEVP---VLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGA 336
                  P     + + ++ G L +H+  H    E + +              A E+   
Sbjct: 62  MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMR------------FYAAEIILG 109

Query: 337 VAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLD 396
           + +MH+     + +RD+K +NILLD+    ++SD G++      K H +    GT GY+ 
Sbjct: 110 LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMA 163

Query: 397 PEYFQSSQFTDKS-DVYSFGVVLLELLTGKKP 427
           PE  Q     D S D +S G +L +LL G  P
Sbjct: 164 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 68.2 bits (166), Expect = 1e-12
 Identities = 58/221 (26%), Positives = 101/221 (45%), Gaps = 30/221 (13%)

Query: 223 FLGQGGFGTVYKGM-LPDGSIVAVKRSKEI--DKTQIHQFINEVVILSQINHRHIVKLLG 279
            +G G +G VYKG  +  G + A+K       ++ +I Q IN +   S  +HR+I    G
Sbjct: 13  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYS--HHRNIATYYG 70

Query: 280 CCLETEVP------VLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEV 333
             ++   P       LV E+  +G+++  I + +           ++L  E    +  E+
Sbjct: 71  AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG----------NTLKEEWIAYICREI 120

Query: 334 AGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFG 393
              ++++H      + HRDIK  N+LL +    K+ DFG+S  +        T I GT  
Sbjct: 121 LRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPY 176

Query: 394 YLDPEYFQSSQFTD-----KSDVYSFGVVLLELLTGKKPIC 429
           ++ PE     +  D     KSD++S G+  +E+  G  P+C
Sbjct: 177 WMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLC 217

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 68.1 bits (166), Expect = 1e-12
 Identities = 58/221 (26%), Positives = 104/221 (47%), Gaps = 32/221 (14%)

Query: 224 LGQGGFGTVYKGM-LPDGSIVAVK--RSKEIDKTQIHQFINEVVILSQINHRHIVKLLGC 280
           +G G +G VYKG  +  G + A+K     E ++ +I   IN +   S  +HR+I    G 
Sbjct: 24  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYS--HHRNIATYYGA 81

Query: 281 CLETEVP------VLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVA 334
            ++   P       LV E+  +G+++  +          +  + ++L  +    +  E+ 
Sbjct: 82  FIKKSPPGHDDQLWLVMEFCGAGSVTDLV----------KNTKGNALKEDWIAYICREIL 131

Query: 335 GAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKT-HLTTTIQGTFG 393
             +A++H+   I   HRDIK  N+LL +    K+ DFG+S  +  D+T     T  GT  
Sbjct: 132 RGLAHLHAHKVI---HRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTFIGTPY 186

Query: 394 YLDPEYFQSSQFTD-----KSDVYSFGVVLLELLTGKKPIC 429
           ++ PE     +  D     +SD++S G+  +E+  G  P+C
Sbjct: 187 WMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLC 227

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 68.5 bits (167), Expect = 1e-12
 Identities = 58/216 (26%), Positives = 97/216 (44%), Gaps = 21/216 (9%)

Query: 217 NYNQSRFLGQGGFGTVY----KGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHR 272
           ++N    LG+G FG V     KG     +I  +K+   I    +   + E  +L+     
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60

Query: 273 HIVKLLGCCLET-EVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVAC 331
             +  L  C +T +    V EY++ G L + I            Q++      + V  A 
Sbjct: 61  PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQI------------QQVGRFKEPHAVFYAA 108

Query: 332 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGT 391
           E+A  + ++HS     I +RD+K  N++LD +   K++DFG+ +    D    T T  GT
Sbjct: 109 EIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV-TTKTFCGT 164

Query: 392 FGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
             Y+ PE      +    D ++FGV+L E+L G+ P
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 200

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 67.7 bits (166), Expect = 2e-12
 Identities = 59/235 (25%), Positives = 98/235 (41%), Gaps = 52/235 (22%)

Query: 216 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQ-FINEVVILSQINHRH 273
             Y    ++G+G +G V      P G  VA+K+    +     Q  + E+ IL +  H +
Sbjct: 5   PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHEN 64

Query: 274 IVKLLG-----------------CCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQ 316
           I+ +L                    +ET++    Y+ I +  LS+   DH Q        
Sbjct: 65  IIGILDIIRPPSFESFNDVYIVQELMETDL----YKLIKTQHLSN---DHIQY------- 110

Query: 317 ELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS 376
                          ++   + Y+HS+    + HRD+K SN+LL+     K+ DFG++R 
Sbjct: 111 ------------FLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI 155

Query: 377 I-PN-DKTHLTTTIQGTFGYLDPE-YFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
             P  D T   T    T  Y  PE    S  +T   D++S G +L E+L+  +P+
Sbjct: 156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN-RPL 209

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 67.3 bits (165), Expect = 3e-12
 Identities = 69/308 (22%), Positives = 118/308 (38%), Gaps = 67/308 (21%)

Query: 218 YNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSK-EIDKTQIHQF-INEVVILSQI---NH 271
           Y +   +G+G +GTVYK   L  G  VA+K+ +  + +  I    + E+ +L Q+    H
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60

Query: 272 RHIVKLLGCC----LETEVPV-LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENR 326
            +IV+LL  C     + E+ + LV+E++            Q       K     L  E  
Sbjct: 61  PNIVRLLDVCHGPRTDRELKLTLVFEHV-----------DQDLATYLSKCPKPGLPPETI 109

Query: 327 VRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTT 386
             +  ++   V ++HS     I HRD+K  NIL+      K++DFG++R          T
Sbjct: 110 KDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIY--SFEMALT 164

Query: 387 TIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISL 446
           ++  T  Y  PE    S +    D++S G +  EL                     F   
Sbjct: 165 SVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELF---------------RRRPLFRGT 209

Query: 447 AKENQLLEILD------------------------ARVAKEAREEDIGAMA-ELAMRCLR 481
           ++ +QL +I D                           + ++   +I     +L  + L 
Sbjct: 210 SEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLT 269

Query: 482 LNSKKRPT 489
            N  KR +
Sbjct: 270 FNPHKRIS 277

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 67.5 bits (165), Expect = 3e-12
 Identities = 59/265 (22%), Positives = 108/265 (40%), Gaps = 50/265 (18%)

Query: 218 YNQSRFLGQGGFGTVYKGMLPD-GSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVK 276
           Y   R LG G  G V+  +  D    VAVK+    D   +   + E+ I+ +++H +IVK
Sbjct: 7   YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 66

Query: 277 LLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSS---------------- 320
                        VYE +               ++     EL+S                
Sbjct: 67  -------------VYEVLGPSG-------SDLTEDVGSLTELNSVYIVQEYMETDLANVL 106

Query: 321 ----LSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD-DKFSAKVSDFGISR 375
               LS E+      ++   + Y+HS+    + HRD+K +N+ ++ +    K+ DFG++R
Sbjct: 107 EQGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLAR 163

Query: 376 SIPND---KTHLTTTIQGTFGYLDPE-YFQSSQFTDKSDVYSFGVVLLELLTGKKPICFA 431
            +      K +L+  +   + Y  P      + +T   D+++ G +  E+LTGK     A
Sbjct: 164 IVDPHYSHKGYLSEGLVTKW-YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGA 222

Query: 432 RVEEERNLVACFISLAKENQLLEIL 456
              E+  L+   + + +E    E+L
Sbjct: 223 HELEQMQLILESVPVVREEDRNELL 247

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 67.3 bits (164), Expect = 3e-12
 Identities = 58/218 (26%), Positives = 95/218 (43%), Gaps = 26/218 (11%)

Query: 216 DNYNQSRFLGQGGFGTV----YK-GMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQIN 270
           +++N  R LG G FG V    YK    P  +I   ++SK I + Q+    +E  IL+ IN
Sbjct: 30  EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN 89

Query: 271 HRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVA 330
           H   V L G   +     LV E++  G     +  +++                    V 
Sbjct: 90  HPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPND----------------VG 133

Query: 331 CEVAGAVAYMHSS-ASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQ 389
           C  A  +  +     S+ I +RD+K  N+LLD     K++DFG ++ +       T T+ 
Sbjct: 134 CFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR----TYTLC 189

Query: 390 GTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
           GT  Y+ PE   +      +D ++ G+ + E+L G  P
Sbjct: 190 GTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPP 227

Length = 340

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 66.9 bits (163), Expect = 4e-12
 Identities = 71/269 (26%), Positives = 111/269 (41%), Gaps = 46/269 (17%)

Query: 224 LGQGGFGTVYKGMLPD-GSIVAVKR-SKE--IDKTQIHQFINEVVILSQINHRHIVKLLG 279
           +G+G FG VY+    D   I A+K  SK+  + K ++   I E  IL +        ++G
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 280 CCLETEVPV---LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGA 336
                +      LV +Y+S G L  H+    +  E + K  ++            E+  A
Sbjct: 61  LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIA------------ELVLA 108

Query: 337 VAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPN-DKTHLTTTIQGTFGYL 395
           + ++H      I +RD+K  NILLD      + DFG+S+   N      T T  GT  YL
Sbjct: 109 LEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYL 163

Query: 396 DPE-YFQSSQFTDKSDVYSFGVVLLELLTGKKP------------ICFARV--------E 434
            PE       +T   D +S GV++ E+  G  P            I F +V        +
Sbjct: 164 APEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSD 223

Query: 435 EERNLVACFISLAKENQLLEILDARVAKE 463
           E R  V   ++   +++L    DA   KE
Sbjct: 224 EGRQFVKGLLNRNPQHRLGAHRDAVELKE 252

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 66.3 bits (162), Expect = 4e-12
 Identities = 73/294 (24%), Positives = 134/294 (45%), Gaps = 54/294 (18%)

Query: 224 LGQGGFGTVYKGMLPD-GSIVAVKR--SKEIDKTQIHQFINEVVILSQINHRHIVKLLGC 280
           +G+G +G V K    + G IVA+K+    E DK      + E+ +L Q+ H ++V L+  
Sbjct: 9   VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEV 68

Query: 281 CLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVR-VACEVAGAVAY 339
               +   LV+E++      H + D  ++              E+RVR    ++   + +
Sbjct: 69  FRRKKRLYLVFEFVD-----HTVLDDLEKYPNGLD--------ESRVRKYLFQILRGIEF 115

Query: 340 MHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI--PNDKTHLTTTIQGTFGYLDP 397
            HS     I HRDIK  NIL+      K+ DFG +R++  P +   + T    T  Y  P
Sbjct: 116 CHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE---VYTDYVATRWYRAP 169

Query: 398 EYF-QSSQFTDKSDVYSFGVVLLELLTGKKPICF---ARVEEERNLVACFISLAKENQLL 453
           E     +++    D+++ G ++ E+LTG +P+ F   + +++  +++ C  +L   +Q +
Sbjct: 170 ELLVGDTKYGRAVDIWAVGCLVTEMLTG-EPL-FPGDSDIDQLYHIIKCLGNLIPRHQEI 227

Query: 454 ------------------EILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPT 489
                             E L+ R  K +     G + +LA +CLR++   RP+
Sbjct: 228 FQKNPLFAGMRLPEVKEIEPLEKRFPKLS-----GLVLDLAKQCLRIDPDDRPS 276

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 66.6 bits (162), Expect = 5e-12
 Identities = 60/223 (26%), Positives = 109/223 (48%), Gaps = 25/223 (11%)

Query: 224 LGQGGFGTVYKG--MLPDGSIVAVKRSK-EIDKTQIHQFINEVVILSQINHRHIVKLLGC 280
           LG+G + TVYKG   L D ++VA+K  + E ++      I EV +L  + H +IV L   
Sbjct: 14  LGEGTYATVYKGRSKLTD-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 281 CLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYM 340
               +   LV+EY+    L  ++ D             +S++  N      ++   + Y 
Sbjct: 73  IHTEKSLTLVFEYLDK-DLKQYLDDCG-----------NSINMHNVKLFLFQLLRGLNYC 120

Query: 341 HSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISR--SIPNDKTHLTTTIQGTFGYLDPE 398
           H      + HRD+K  N+L++++   K++DFG++R  SIP  KT+    +  T  Y  P+
Sbjct: 121 HRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT-KTYSNEVV--TLWYRPPD 174

Query: 399 -YFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLV 440
               S+ ++ + D++  G +  E+ TG+     + VEE+ + +
Sbjct: 175 ILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFI 217

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 67.0 bits (163), Expect = 5e-12
 Identities = 54/213 (25%), Positives = 97/213 (45%), Gaps = 25/213 (11%)

Query: 222 RFLGQGGFGTVYKGMLPDG----SIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKL 277
           R +G+G +  V    L       ++  VK+    D   I     E  +  Q +    +  
Sbjct: 1   RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60

Query: 278 LGCCLETEVPV-LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGA 336
           L  C +T   + LV EY++ G L  H+     Q+++K  +E +          A E+  A
Sbjct: 61  LHSCFQTTSRLFLVIEYVNGGDLMFHM-----QRQRKLPEEHARF-------YAAEICIA 108

Query: 337 VAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS--IPNDKTHLTTTIQGTFGY 394
           + ++H      I +RD+K  N+LLD     K++D+G+ +    P D T   +T  GT  Y
Sbjct: 109 LNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT---STFCGTPNY 162

Query: 395 LDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
           + PE  +  ++    D ++ GV++ E++ G+ P
Sbjct: 163 IAPEILRGEEYGFSVDWWALGVLMFEMMAGRSP 195

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 66.6 bits (162), Expect = 5e-12
 Identities = 59/223 (26%), Positives = 111/223 (49%), Gaps = 25/223 (11%)

Query: 224 LGQGGFGTVYKG--MLPDGSIVAVKRSK-EIDKTQIHQFINEVVILSQINHRHIVKLLGC 280
           LG+G + TV+KG   L + ++VA+K  + E ++      I EV +L  + H +IV L   
Sbjct: 14  LGEGTYATVFKGRSKLTE-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 281 CLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYM 340
               +   LV+EY+    L  ++ D             + +S  N      ++   +AY 
Sbjct: 73  VHTDKSLTLVFEYLDK-DLKQYMDDCG-----------NIMSMHNVKIFLYQILRGLAYC 120

Query: 341 HSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISR--SIPNDKTHLTTTIQGTFGYLDPE 398
           H      + HRD+K  N+L++++   K++DFG++R  S+P  KT+    +  T  Y  P+
Sbjct: 121 HRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPT-KTYSNEVV--TLWYRPPD 174

Query: 399 -YFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLV 440
               SS+++ + D++  G +  E+ +G+     + VE+E +L+
Sbjct: 175 VLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLI 217

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 66.7 bits (163), Expect = 5e-12
 Identities = 64/222 (28%), Positives = 98/222 (44%), Gaps = 36/222 (16%)

Query: 222 RFLGQGGFGTVYKGMLPDGS----IVAVKRSKEI-----DKTQIHQFINEVVILSQINHR 272
           + LG+GG+G V++     G+    I A+K  K+       K   H    E  IL  + H 
Sbjct: 2   KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKA-ERNILEAVKHP 60

Query: 273 HIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVAC- 331
            IV L+          L+ EY+S G L  H+             E   +  E+    AC 
Sbjct: 61  FIVDLIYAFQTGGKLYLILEYLSGGELFMHL-------------EREGIFMED---TACF 104

Query: 332 ---EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISR-SIPNDKTHLTTT 387
              E++ A+ ++H      I +RD+K  NILLD +   K++DFG+ + SI      +T T
Sbjct: 105 YLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT--VTHT 159

Query: 388 IQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPIC 429
             GT  Y+ PE    S      D +S G ++ ++LTG  P  
Sbjct: 160 FCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFT 201

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 66.2 bits (161), Expect = 7e-12
 Identities = 54/213 (25%), Positives = 99/213 (46%), Gaps = 25/213 (11%)

Query: 222 RFLGQGGFGTVYKGMLPDG----SIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKL 277
           R +G+G +  V    L       ++  VK+    D   I     E  +  Q ++   +  
Sbjct: 1   RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60

Query: 278 LGCCLETEVPVL-VYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGA 336
           L  C +TE  +  V EY++ G L  H+     Q+++K  +E +          + E++ A
Sbjct: 61  LHSCFQTESRLFFVIEYVNGGDLMFHM-----QRQRKLPEEHARF-------YSAEISLA 108

Query: 337 VAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS--IPNDKTHLTTTIQGTFGY 394
           + Y+H      I +RD+K  N+LLD +   K++D+G+ +    P D T   +T  GT  Y
Sbjct: 109 LNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---STFCGTPNY 162

Query: 395 LDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
           + PE  +   +    D ++ GV++ E++ G+ P
Sbjct: 163 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 195

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 65.6 bits (160), Expect = 7e-12
 Identities = 71/294 (24%), Positives = 122/294 (41%), Gaps = 58/294 (19%)

Query: 224 LGQGGFGTVYKGML-PDGSIVAVKRSKEIDKTQIH----------QFINEVVILSQINHR 272
           LGQG F  +YKG+L     +  V   +E     +            F     ++SQ++H+
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQE-VSVVLKVLGSDHRDSLAFFETASLMSQLSHK 61

Query: 273 HIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACE 332
           H+VKL G C+  E  ++V EY+  G L   +H        ++K  + SL W  ++ VA +
Sbjct: 62  HLVKLYGVCVRDEN-IMVEEYVKFGPLDVFLH--------REKNNV-SLHW--KLDVAKQ 109

Query: 333 VAGAVAYMHSSASIPIFHRDIKSSNILL---DDKFS----AKVSDFGISRSIPNDKTHLT 385
           +A A+ Y+     +   H ++   NIL+             K+SD GI  ++ + +    
Sbjct: 110 LASALHYLEDKKLV---HGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS-REERV 165

Query: 386 TTIQGTFGYLDPEYFQ--SSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACF 443
             I     ++ PE  +   +  T  +D +SFG  LLE       IC    EE  +     
Sbjct: 166 ERIP----WIAPECIRNGQASLTIAADKWSFGTTLLE-------ICS-NGEEPLS----- 208

Query: 444 ISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMEL 497
            +L+   +     D          D   +A L  +C   +  KRP+ + +  +L
Sbjct: 209 -TLSSSEKERFYQDQHRLPMP---DCAELANLINQCWTYDPTKRPSFRAILRDL 258

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 66.2 bits (162), Expect = 8e-12
 Identities = 61/229 (26%), Positives = 105/229 (45%), Gaps = 33/229 (14%)

Query: 218 YNQSRFLGQGGFGTVYKGML---PDGSIVAVKRSKEIDKTQIHQF----INEVVILSQIN 270
           Y     +G+G +G VYK       DG   A+K+ K  DK Q          E+ +L ++ 
Sbjct: 2   YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKG-DKEQYTGISQSACREIALLRELK 60

Query: 271 HRHIVKLLGCCLE-TEVPV-LVYEYISSGTLSHHIHDHQQ-QQEQKQKQELSSLSWENRV 327
           H ++V L+   LE  +  V L+++Y +   L   I  H+Q ++       + SL W+   
Sbjct: 61  HENVVSLVEVFLEHADKSVYLLFDY-AEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQ--- 116

Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILL----DDKFSAKVSDFGISRSIPNDKTH 383
                +   V Y+HS+    + HRD+K +NIL+     ++   K+ D G++R + N    
Sbjct: 117 -----ILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLAR-LFNAPLK 167

Query: 384 LTTTIQG---TFGYLDPEYFQSSQ-FTDKSDVYSFGVVLLELLTGKKPI 428
               +     T  Y  PE    ++ +T   D+++ G +  ELLT  +PI
Sbjct: 168 PLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-LEPI 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 66.6 bits (162), Expect = 1e-11
 Identities = 51/177 (28%), Positives = 89/177 (50%), Gaps = 12/177 (6%)

Query: 252 DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQE 311
           D+ Q     +E+  L+  +H  IVK        +  +L+ EY S G L+  I    ++  
Sbjct: 105 DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHL 164

Query: 312 QKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF 371
             Q+ E+  L ++        +  A+  +HS     + HRD+KS+NI L      K+ DF
Sbjct: 165 PFQEYEVGLLFYQ--------IVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDF 213

Query: 372 GISRSIPNDKT-HLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
           G S+   +  +  + ++  GT  YL PE ++  +++ K+D++S GV+L ELLT  +P
Sbjct: 214 GFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRP 270

Length = 478

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 65.4 bits (159), Expect = 1e-11
 Identities = 62/232 (26%), Positives = 104/232 (44%), Gaps = 25/232 (10%)

Query: 209 DELQRATDNYNQSRFLGQGGFGTVYK-GMLPDGSIVAVKRSKEIDKTQIHQFINEVVILS 267
           + L   TD +     +G+G +G VYK     DGS+ AVK    I      +   E  IL 
Sbjct: 15  ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIEAEYNILQ 73

Query: 268 QI-NHRHIVKLLGCCLETEVPV-----LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSL 321
            + NH ++VK  G   + +  V     LV E  + G+++  +       ++  +  +S +
Sbjct: 74  SLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYI 133

Query: 322 SWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDK 381
            +           GA+  +    +  I HRD+K +NILL  +   K+ DFG+S  + + +
Sbjct: 134 LY-----------GALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR 182

Query: 382 THLTTTIQGTFGYLDPEYFQSSQFTDKS-----DVYSFGVVLLELLTGKKPI 428
               T++ GT  ++ PE     Q  D S     DV+S G+  +EL  G  P+
Sbjct: 183 LRRNTSV-GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 64.5 bits (157), Expect = 1e-11
 Identities = 59/214 (27%), Positives = 90/214 (42%), Gaps = 29/214 (13%)

Query: 224 LGQGGFGTVYKGMLPDGSIVAVKRSKEID-----KTQIHQFINEVVILSQINHRHIVKLL 278
           +G G FG V    +   + VA    KE+      K Q ++F+ +      + H +I++ L
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQ-NEFLQQGDPYRILQHPNILQCL 61

Query: 279 GCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVA 338
           G C+E    +LV+EY   G L  ++   Q  +   Q   L         R+ACE+A  V 
Sbjct: 62  GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQ--------RMACEIAAGVT 113

Query: 339 YMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFG---YL 395
           +MH        H D+   N  L    + KV D+GI  S    K     T         +L
Sbjct: 114 HMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPS--RYKEDYIETEDDKCVPLRWL 168

Query: 396 DPEY---FQ----SSQFTDKSDVYSFGVVLLELL 422
            PE    F     +++ T  S+V++ GV L EL 
Sbjct: 169 APELVGEFHGGLITAEQTKPSNVWALGVTLWELF 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 65.2 bits (159), Expect = 2e-11
 Identities = 48/185 (25%), Positives = 88/185 (47%), Gaps = 24/185 (12%)

Query: 245 VKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIH 304
           V   ++ID  Q  + + E    +  NH  +V L  C         V E++S G L  H+ 
Sbjct: 33  VNDDEDIDWVQTEKHVFE----TASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHM- 87

Query: 305 DHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF 364
               Q+++K  +E +          + E++ A+ ++H      I +RD+K  N+LLD + 
Sbjct: 88  ----QRQRKLPEEHARF-------YSAEISLALNFLHERG---IIYRDLKLDNVLLDAEG 133

Query: 365 SAKVSDFGISRS--IPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELL 422
             K++D+G+ +    P D    T+T  GT  Y+ PE  +   +    D ++ GV++ E++
Sbjct: 134 HIKLTDYGMCKEGIRPGD---TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMM 190

Query: 423 TGKKP 427
            G+ P
Sbjct: 191 AGRSP 195

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 64.8 bits (158), Expect = 2e-11
 Identities = 54/278 (19%), Positives = 114/278 (41%), Gaps = 47/278 (16%)

Query: 232 VYKGMLPDGSIV--AVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVP-- 287
           +YKG+  +  ++    K+  +  K  I    NE+  L +I+  +I+K+ G  ++      
Sbjct: 36  IYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLP 95

Query: 288 --VLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSAS 345
              L+ EY + G L   +   +             LS++ ++ +A +    +  ++   +
Sbjct: 96  RLSLILEYCTRGYLREVLDKEKD------------LSFKTKLDMAIDCCKGLYNLYKYTN 143

Query: 346 IPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQS--S 403
            P  ++++ S + L+ + +  K+   G+ + + +        +     Y   +      S
Sbjct: 144 KP--YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFM----VYFSYKMLNDIFS 197

Query: 404 QFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEILDARVAKE 463
           ++T K D+YS GVVL E+ TGK P      +E  +L      +  +N  L++        
Sbjct: 198 EYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDL------IINKNNSLKL-------- 243

Query: 464 AREEDIGAMAEL---AMRCLRLNSKKRPTMKQVSMELE 498
                +    E+      C   +S KRP +K++   L 
Sbjct: 244 ----PLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLS 277

Length = 283

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 64.3 bits (157), Expect = 2e-11
 Identities = 57/213 (26%), Positives = 96/213 (45%), Gaps = 20/213 (9%)

Query: 216 DNYNQSRFLGQGGFGTVYKGMLPD-GSIVAVKRSKEI-DKTQIHQF-INEVVILSQINHR 272
           + Y +   +G+G +G V+K    + G IVA+K+  E  D   I +  + E+ +L Q+ H 
Sbjct: 1   EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHP 60

Query: 273 HIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACE 332
           ++V L+          LV+EY    T+ + +  + +      +  +  + W+        
Sbjct: 61  NLVNLIEVFRRKRKLHLVFEYCDH-TVLNELEKNPRGVP---EHLIKKIIWQ-------- 108

Query: 333 VAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTF 392
              AV + H    I   HRD+K  NIL+  +   K+ DFG +R +       T  +  T 
Sbjct: 109 TLQAVNFCHKHNCI---HRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYV-ATR 164

Query: 393 GYLDPEYF-QSSQFTDKSDVYSFGVVLLELLTG 424
            Y  PE     +Q+    DV++ G V  ELLTG
Sbjct: 165 WYRAPELLVGDTQYGPPVDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 64.6 bits (157), Expect = 2e-11
 Identities = 58/224 (25%), Positives = 96/224 (42%), Gaps = 30/224 (13%)

Query: 222 RFLGQGGFGTVY------KGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIV 275
           + LG+G FG V        G      I+  ++   I K ++   + E  +L    H  + 
Sbjct: 1   KLLGKGTFGKVILVREKATGRYYAMKIL--RKEVIIAKDEVAHTVTESRVLQNTRHPFLT 58

Query: 276 KLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRV-ACEVA 334
            L       +    V EY + G L  H+           ++ + +   E R R    E+ 
Sbjct: 59  ALKYAFQTHDRLCFVMEYANGGELFFHL----------SRERVFT---EERARFYGAEIV 105

Query: 335 GAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS-IPNDKTHLTTTIQGTFG 393
            A+ Y+HS     + +RDIK  N++LD     K++DFG+ +  I +  T    T  GT  
Sbjct: 106 SALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPE 160

Query: 394 YLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEER 437
           YL PE  + + +    D +  GVV+ E++ G+ P  F   + ER
Sbjct: 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDHER 202

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 65.3 bits (159), Expect = 2e-11
 Identities = 68/283 (24%), Positives = 120/283 (42%), Gaps = 77/283 (27%)

Query: 216 DNYNQSRFLGQGGFGTVYK----GMLPDGSI--VAVKRSK-EIDKTQIHQFINEVVILSQ 268
           DN    + LG G FG V +    G+  + ++  VAVK  K      +    ++E+ ILS 
Sbjct: 38  DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSH 97

Query: 269 I-NHRHIVKLLG--------------CCL-----------ETEV-PVLVYEYISSGTLSH 301
           +  H++IV LLG              CC            ET +  V+    IS  +  +
Sbjct: 98  LGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDY 157

Query: 302 -HIH-------------------------------DHQQQQEQKQKQELSSLSWENRVRV 329
            +I                                     ++++  ++   L  ++ +R 
Sbjct: 158 KNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRF 217

Query: 330 ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQ 389
           + +VA  + ++ S   I   HRD+ + N+LL D   AK+ DFG++R I ND  ++   ++
Sbjct: 218 SSQVAQGMDFLASKNCI---HRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV---VK 271

Query: 390 GT----FGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
           G       ++ PE      +T +SDV+S+G++L E+ + GK P
Sbjct: 272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 63.5 bits (154), Expect = 3e-11
 Identities = 58/233 (24%), Positives = 103/233 (44%), Gaps = 31/233 (13%)

Query: 262 EVVILSQINHRHIVKLLGCCL-ETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSS 320
           E  +LSQ+ H +IV        E  +  +V  +   G L H +    ++Q+ K   E   
Sbjct: 49  EAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKL----KEQKGKLLPENQV 104

Query: 321 LSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPND 380
           + W        ++A A+ Y+H      I HRD+K+ N+ L      KV D GI+R + N 
Sbjct: 105 VEW------FVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN- 154

Query: 381 KTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLV 440
           +  + +T+ GT  Y+ PE F +  +  KSDV++ G  + E+ T               L 
Sbjct: 155 QCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMAT---------------LK 199

Query: 441 ACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQV 493
             F +    + +  I++ ++    ++     + EL    L    +KRP++K +
Sbjct: 200 HAFNAKDMNSLVYRIIEGKLPPMPKDYS-PELGELIATMLSKRPEKRPSVKSI 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 63.7 bits (155), Expect = 3e-11
 Identities = 60/228 (26%), Positives = 111/228 (48%), Gaps = 47/228 (20%)

Query: 224 LGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQI--------HQ-----FINEVVILSQIN 270
           LGQG F  ++KG+  +     V    E+ KT++        H+     F     ++SQ++
Sbjct: 3   LGQGTFTKIFKGIRRE-----VGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLS 57

Query: 271 HRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVA 330
           H+H+V   G C+  +  ++V EY+  G+L  ++         K+ + L ++SW  ++ VA
Sbjct: 58  HKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYL---------KKNKNLINISW--KLEVA 106

Query: 331 CEVAGAVAYMHSSASIPIFHRDIKSSNILL----DDKFSA----KVSDFGISRSIPNDKT 382
            ++A A+ ++       + H ++ + N+LL    D K       K+SD GIS ++   K 
Sbjct: 107 KQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITV-LPKE 162

Query: 383 HLTTTIQGTFGYLDPEYFQSSQ-FTDKSDVYSFGVVLLELLTG-KKPI 428
            L   I     ++ PE  ++ Q  +  +D +SFG  L E+ +G  KP+
Sbjct: 163 ILLERIP----WVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPL 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 63.9 bits (156), Expect = 3e-11
 Identities = 60/214 (28%), Positives = 102/214 (47%), Gaps = 30/214 (14%)

Query: 224 LGQGGFGTVYKGM-LPDGSIVAVK--RSKEIDKTQIHQFINEVVILSQINHRHIVKLLGC 280
           +G+G +G VYK      G IVA+K  R +  D+      I E+ +L ++NH +IV+LL  
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66

Query: 281 CLETEVPVLVYEYISSGTLSHHI--HDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVA 338
                   LV+E++    L  ++             K  L  L           + G +A
Sbjct: 67  VHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQL-----------LQG-IA 113

Query: 339 YMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS--IP-NDKTHLTTTIQGTFGYL 395
           Y HS     + HRD+K  N+L+D + + K++DFG++R+  +P    TH   T+     Y 
Sbjct: 114 YCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLW----YR 166

Query: 396 DPE-YFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
            PE    S Q++   D++S G +  E++  ++P+
Sbjct: 167 APEILLGSRQYSTPVDIWSIGCIFAEMVN-RRPL 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 64.0 bits (156), Expect = 3e-11
 Identities = 61/247 (24%), Positives = 115/247 (46%), Gaps = 38/247 (15%)

Query: 217 NYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSK-EIDKTQIHQFINEVVILSQINHRHI 274
           N+ Q   LG+G + TVYKG     G IVA+K    + ++      I E+ ++ ++ H +I
Sbjct: 1   NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60

Query: 275 VKLLGCCLETEVP-VLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEV 333
           V+L    + TE   +LV+EY+    L  ++  H  +        + S +++        +
Sbjct: 61  VRLHDV-IHTENKLMLVFEYMD-KDLKKYMDTHGVRGALDPNT-VKSFTYQ--------L 109

Query: 334 AGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS--IPNDKTHLTTTIQGT 391
              +A+ H +    + HRD+K  N+L++ +   K++DFG++R+  IP +          T
Sbjct: 110 LKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV---T 163

Query: 392 FGYLDPEYFQSSQ-FTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKEN 450
             Y  P+    S+ ++   D++S G ++ E++TG+                 F     E+
Sbjct: 164 LWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR---------------PLFPGTNNED 208

Query: 451 QLLEILD 457
           QLL+I  
Sbjct: 209 QLLKIFR 215

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 63.7 bits (155), Expect = 4e-11
 Identities = 52/220 (23%), Positives = 105/220 (47%), Gaps = 33/220 (15%)

Query: 217 NYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKR------SKEIDKTQIHQFINEVVILSQI 269
           N+ +   +G+G +G VYK      G +VA+K+      ++ +  T I     E+ +L ++
Sbjct: 1   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR----EISLLKEL 56

Query: 270 NHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRV 329
           NH +IVKLL          LV+E++          D ++  +      +     ++ +  
Sbjct: 57  NHPNIVKLLDVIHTENKLYLVFEFLH--------QDLKKFMDASPLSGIPLPLIKSYLF- 107

Query: 330 ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS--IP-NDKTHLTT 386
             ++   +A+ HS     + HRD+K  N+L++ + + K++DFG++R+  +P    TH   
Sbjct: 108 --QLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV 162

Query: 387 TIQGTFGYLDPEYFQSSQF-TDKSDVYSFGVVLLELLTGK 425
           T+     Y  PE     ++ +   D++S G +  E++T +
Sbjct: 163 TLW----YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 64.3 bits (156), Expect = 4e-11
 Identities = 59/252 (23%), Positives = 100/252 (39%), Gaps = 53/252 (21%)

Query: 216 DNYNQSRFLGQGGFGTVYKGMLPD-GSIVAVK---RSKEIDKTQIHQFINEVVILSQINH 271
           D++   + +G+G FG V      D G I A+K   ++  ++K Q+     E  IL + + 
Sbjct: 1   DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60

Query: 272 RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVAC 331
             +VK+     +     L+ E++  G +   +       E+  +  ++            
Sbjct: 61  AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIA------------ 108

Query: 332 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI-------------- 377
           E   A+  +H    I   HRDIK  N+LLD K   K+SDFG+   +              
Sbjct: 109 ETVLAIDAIHQLGFI---HRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTH 165

Query: 378 --PND------------------KTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVV 417
             P+D                  +  L  +  GT  Y+ PE F  + +    D +S GV+
Sbjct: 166 NPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVI 225

Query: 418 LLELLTGKKPIC 429
           + E+L G  P C
Sbjct: 226 MYEMLIGYPPFC 237

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 64.1 bits (156), Expect = 4e-11
 Identities = 56/224 (25%), Positives = 97/224 (43%), Gaps = 28/224 (12%)

Query: 216 DNYNQSRFLGQGGFGTVYKGMLPD---GSIVAVKRSKE---IDKTQIHQFINEVVILSQI 269
            +++    +G+G FG V   ++ +   G I A+K  K+   + +  +  F  E  ILS  
Sbjct: 1   KDFDVKSLVGRGHFGEVQ--VVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSIS 58

Query: 270 NHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRV 329
           N   I +L     + +   LV EY   G L   ++ ++ Q +            E+  + 
Sbjct: 59  NSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFD------------EDMAQF 106

Query: 330 ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQ 389
              +A  V  +HS   +   HRDIK  N+L+D     K++DFG +  +  +K   +    
Sbjct: 107 Y--LAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPV 164

Query: 390 GTFGYLDPEYFQSSQFTDKS------DVYSFGVVLLELLTGKKP 427
           GT  Y+ PE   +     K       D +S GV+  E++ G+ P
Sbjct: 165 GTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP 208

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 64.1 bits (156), Expect = 4e-11
 Identities = 58/215 (26%), Positives = 96/215 (44%), Gaps = 30/215 (13%)

Query: 222 RFLGQGGFGTVYKGML----PDGSIVAVKRSKE---IDKTQIHQFINEVVILSQINHRHI 274
           + LG+G FG V   +L      G   A+K  K+   I K ++   + E  +L    H  +
Sbjct: 1   KLLGKGTFGKV---ILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFL 57

Query: 275 VKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRV-ACEV 333
             L       +    V EY + G L  H+           ++ + S   E+R R    E+
Sbjct: 58  TALKYSFQTHDRLCFVMEYANGGELFFHL----------SRERVFS---EDRARFYGAEI 104

Query: 334 AGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS-IPNDKTHLTTTIQGTF 392
             A+ Y+HS     + +RD+K  N++LD     K++DFG+ +  I +  T    T  GT 
Sbjct: 105 VSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTP 159

Query: 393 GYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
            YL PE  + + +    D +  GVV+ E++ G+ P
Sbjct: 160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 64.2 bits (157), Expect = 4e-11
 Identities = 56/221 (25%), Positives = 95/221 (42%), Gaps = 33/221 (14%)

Query: 216 DNYNQSRFLGQGGFGTVYKGMLPDGSI-VAVKRSKEIDKTQIH--QFINEVVILSQINHR 272
           D Y     +G G +G V           VA+K+     ++ IH  +   E+ +L  ++H 
Sbjct: 15  DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHE 74

Query: 273 HIVKLLGC-----CLETEVPV-LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENR 326
           +++ LL        LE    V LV   +  G   ++I   Q+            LS ++ 
Sbjct: 75  NVIGLLDVFTPASSLEDFQDVYLVTHLM--GADLNNIVKCQK------------LS-DDH 119

Query: 327 VRV-ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLT 385
           ++    ++   + Y+HS+    I HRD+K SNI +++    K+ DFG++R          
Sbjct: 120 IQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARH----TDDEM 172

Query: 386 TTIQGTFGYLDPE-YFQSSQFTDKSDVYSFGVVLLELLTGK 425
           T    T  Y  PE       +    D++S G ++ ELLTGK
Sbjct: 173 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 63.9 bits (155), Expect = 5e-11
 Identities = 79/343 (23%), Positives = 135/343 (39%), Gaps = 84/343 (24%)

Query: 224 LGQGGFGTVYKG------MLPDGSIVAVKRSKEIDKTQIHQ-FINEVVILSQINHR-HIV 275
           LG+G FG V +              VAVK  KE      H+  ++E+ IL  I H  ++V
Sbjct: 15  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 74

Query: 276 KLLGCCLETEVPVLV-YEYISSGTLSHHIHDHQQQ------------------------- 309
            LLG C +   P++V  E+   G LS+++   + +                         
Sbjct: 75  NLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDL 134

Query: 310 ---------------------------QEQKQKQE---LSSLSWENRVRVACEVAGAVAY 339
                                      +E++ +QE      L+ E+ +  + +VA  + +
Sbjct: 135 KRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEF 194

Query: 340 MHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTT-TIQGTFGYLDPE 398
           + S   I   HRD+ + NILL +    K+ DFG++R I  D  ++     +    ++ PE
Sbjct: 195 LASRKCI---HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 251

Query: 399 YFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQLLEILD 457
                 +T +SDV+SFGV+L E+ + G  P    +++EE      F    KE   +    
Sbjct: 252 TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE------FCRRLKEGTRM---- 301

Query: 458 ARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGL 500
                 A +     M +  + C      +RPT  ++   L  L
Sbjct: 302 -----RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 339

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 63.1 bits (153), Expect = 5e-11
 Identities = 57/217 (26%), Positives = 94/217 (43%), Gaps = 22/217 (10%)

Query: 217 NYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIV 275
           +Y   + +G G +G VYK   L  G + AVK  K            E+ ++ +  H +IV
Sbjct: 10  DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIV 69

Query: 276 KLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVAC-EVA 334
              G  L  E   +  EY   G+L    H             ++    E ++   C E  
Sbjct: 70  AYFGSYLSREKLWICMEYCGGGSLQDIYH-------------VTGPLSELQIAYVCRETL 116

Query: 335 GAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGY 394
             +AY+HS   +   HRDIK +NILL D    K++DFG++  I        + I GT  +
Sbjct: 117 QGLAYLHSKGKM---HRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI-GTPYW 172

Query: 395 LDPEYF---QSSQFTDKSDVYSFGVVLLELLTGKKPI 428
           + PE     ++  +    D+++ G+  +EL   + P+
Sbjct: 173 MAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPM 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 65.1 bits (158), Expect = 5e-11
 Identities = 75/320 (23%), Positives = 137/320 (42%), Gaps = 70/320 (21%)

Query: 209 DELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKE-----------IDKTQIH 257
           D+ +   + Y   + +G G FG V+        +V  KR++E           + + +  
Sbjct: 6   DDGESRLNEYEVIKKIGNGRFGEVF--------LVKHKRTQEFFCWKAISYRGLKEREKS 57

Query: 258 QFINEVVILSQINHRHIVKLLGCCLE--TEVPVLVYEYISSGTLSHHIHDHQQQQEQKQK 315
           Q + EV ++ ++ H++IV+ +   L    +   ++ E+  +G LS +I        QK  
Sbjct: 58  QLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNI--------QKCY 109

Query: 316 QELSSLSWENRVRVACEVAGAVAYMHSSASIP----IFHRDIKSSNILLDDKFS------ 365
           +    +     V +  ++  A+AY H+    P    + HRD+K  NI L           
Sbjct: 110 KMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169

Query: 366 -----------AKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYF--QSSQFTDKSDVY 412
                      AK+ DFG+S++I  +   +  +  GT  Y  PE    ++  + DKSD++
Sbjct: 170 AQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMW 227

Query: 413 SFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAM 472
           + G ++ EL +GK P        + N  +  IS  K    L I       +++E +I   
Sbjct: 228 ALGCIIYELCSGKTPF------HKANNFSQLISELKRGPDLPI-----KGKSKELNI--- 273

Query: 473 AELAMRCLRLNSKKRPTMKQ 492
             L    L L++K+RP+  Q
Sbjct: 274 --LIKNLLNLSAKERPSALQ 291

Length = 1021

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 63.3 bits (154), Expect = 5e-11
 Identities = 58/221 (26%), Positives = 104/221 (47%), Gaps = 27/221 (12%)

Query: 216 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK--RSKEIDKTQIHQFINEVVILSQINHR 272
           D Y +   +G+G +G VYK         +A+K  R ++ D+      I E+ +L ++ H 
Sbjct: 2   DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61

Query: 273 HIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACE 332
           +IV+L       +   LV+EY+    L    H        K  + + +  ++        
Sbjct: 62  NIVRLQDVVHSEKRLYLVFEYLD---LDLKKHMDSSPDFAKNPRLIKTYLYQ-------- 110

Query: 333 VAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA-KVSDFGISRS--IP-NDKTHLTTTI 388
           +   +AY HS     + HRD+K  N+L+D + +A K++DFG++R+  IP    TH   T+
Sbjct: 111 ILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTL 167

Query: 389 QGTFGYLDPE-YFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
                Y  PE    S  ++   D++S G +  E++  +KP+
Sbjct: 168 W----YRAPEILLGSRHYSTPVDIWSVGCIFAEMVN-QKPL 203

Length = 294

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 62.7 bits (152), Expect = 8e-11
 Identities = 60/240 (25%), Positives = 112/240 (46%), Gaps = 29/240 (12%)

Query: 203 AKVFTADELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK---RSKEIDKTQIHQ 258
            K    D     +D +     +G+G +G V+K +   +GS  AVK      +ID+ +I  
Sbjct: 5   GKTIIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDE-EIEA 63

Query: 259 FINEVVILSQINHRHIVKLLGCCLETEVPV-----LVYEYISSGTLSHHIHDHQQQQEQK 313
             N +  LS  +H ++VK  G   + +V       LV E  + G+++  +    ++ E+ 
Sbjct: 64  EYNILKALS--DHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERM 121

Query: 314 QKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGI 373
           ++  ++         +  E    + ++H + +I   HRD+K +NILL  +   K+ DFG+
Sbjct: 122 EEPIIAY--------ILHEALMGLQHLHVNKTI---HRDVKGNNILLTTEGGVKLVDFGV 170

Query: 374 SRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKS-----DVYSFGVVLLELLTGKKPI 428
           S  + + +    T++ GT  ++ PE     Q  D +     DV+S G+  +EL  G  P+
Sbjct: 171 SAQLTSTRLRRNTSV-GTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL 229

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 62.7 bits (152), Expect = 9e-11
 Identities = 60/218 (27%), Positives = 95/218 (43%), Gaps = 29/218 (13%)

Query: 224 LGQGGFGTVYKGMLPD-GSIVAVK--RSKEIDKTQIHQFINEVVIL---SQINHRHIVKL 277
           +G G +GTVYK   P  G  VA+K  R +  +       + EV +L      +H +IV+L
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 278 LGCCL------ETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVAC 331
           +  C       ET+V  LV+E           H  Q  +    K     L  E    +  
Sbjct: 68  MDVCATSRTDRETKV-TLVFE-----------HVDQDLRTYLDKVPPPGLPAETIKDLMR 115

Query: 332 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGT 391
           +    + ++H++    I HRD+K  NIL+      K++DFG++R I + +  LT  +  T
Sbjct: 116 QFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLAR-IYSCQMALTPVVV-T 170

Query: 392 FGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPIC 429
             Y  PE    S +    D++S G +  E+   K   C
Sbjct: 171 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFC 208

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 61.6 bits (149), Expect = 1e-10
 Identities = 53/209 (25%), Positives = 87/209 (41%), Gaps = 20/209 (9%)

Query: 224 LGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCL 282
           +G G +G VYK   +  G + A+K  K            E++++    H +IV   G  L
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76

Query: 283 ETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHS 342
             +   +  E+   G+L    H                LS      V+ E    + Y+HS
Sbjct: 77  RRDKLWICMEFCGGGSLQDIYH------------VTGPLSESQIAYVSRETLQGLYYLHS 124

Query: 343 SASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYF-- 400
              +   HRDIK +NILL D    K++DFG+S  I        + I GT  ++ PE    
Sbjct: 125 KGKM---HRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI-GTPYWMAPEVAAV 180

Query: 401 -QSSQFTDKSDVYSFGVVLLELLTGKKPI 428
            +   +    D+++ G+  +EL   + P+
Sbjct: 181 ERKGGYNQLCDIWAVGITAIELAELQPPM 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 62.8 bits (152), Expect = 1e-10
 Identities = 61/252 (24%), Positives = 103/252 (40%), Gaps = 53/252 (21%)

Query: 216 DNYNQSRFLGQGGFGTVYKGMLPD-GSIVAVK---RSKEIDKTQIHQFINEVVILSQINH 271
           +++   + +G+G FG V      D G + A+K   ++  ++K Q+     E  IL + + 
Sbjct: 1   EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60

Query: 272 RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVAC 331
             +VK+     +     L+ E++  G +   +       E+           E +  +A 
Sbjct: 61  LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEE-----------ETQFYIA- 108

Query: 332 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGI----------------SR 375
           E   A+  +H    I   HRDIK  N+LLD K   K+SDFG+                + 
Sbjct: 109 ETVLAIDSIHQLGFI---HRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNH 165

Query: 376 SIPNDKT------------------HLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVV 417
           S+P+D T                   L  +  GT  Y+ PE F  + +    D +S GV+
Sbjct: 166 SLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVI 225

Query: 418 LLELLTGKKPIC 429
           + E+L G  P C
Sbjct: 226 MYEMLIGYPPFC 237

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 62.4 bits (152), Expect = 2e-10
 Identities = 64/259 (24%), Positives = 97/259 (37%), Gaps = 76/259 (29%)

Query: 222 RFLGQGGFGTVYKGMLPD-GSIVAVKR---SKEIDKTQIHQFINEVVILSQINHRHIVKL 277
           + +G+G FG V      D G I A+K+   S+ ++K Q+     E  IL++ ++  +VKL
Sbjct: 7   KVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKL 66

Query: 278 LGCCLETEVPVLVYEYISSG----------TLSHHIHDHQQQQEQKQKQELSSLSWENRV 327
                +     L+ EY+  G          T +                       E R 
Sbjct: 67  YYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEE---------------------ETRF 105

Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISR------------ 375
            +A E   A+  +H    I   HRDIK  N+LLD K   K+SDFG+              
Sbjct: 106 YIA-ETILAIDSIHKLGYI---HRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYR 161

Query: 376 --------------SIPNDKTHLTTTIQ-----------GTFGYLDPEYFQSSQFTDKSD 410
                         S P        T +           GT  Y+ PE F  + +  + D
Sbjct: 162 ILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECD 221

Query: 411 VYSFGVVLLELLTGKKPIC 429
            +S GV++ E+L G  P C
Sbjct: 222 WWSLGVIMYEMLVGYPPFC 240

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 61.5 bits (150), Expect = 2e-10
 Identities = 56/220 (25%), Positives = 91/220 (41%), Gaps = 52/220 (23%)

Query: 224 LGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQFINEVVILSQIN-------HRHIV 275
           +G+G F  V K      G   A+K  K     +  + + +V  L +I        H +I+
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKCMK-----KHFKSLEQVNNLREIQALRRLSPHPNIL 61

Query: 276 KLLGCCLETEVPVL----------VYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWEN 325
           +L+    + +   L          +YE I                 + +K+ L     E 
Sbjct: 62  RLIEVLFDRKTGRLALVFELMDMNLYELI-----------------KGRKRPLP----EK 100

Query: 326 RVR-VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHL 384
           RV+    ++  ++ +MH +    IFHRDIK  NIL+ D    K++DFG  R I   K   
Sbjct: 101 RVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKDD-ILKLADFGSCRGI-YSKPPY 155

Query: 385 TTTIQGTFGYLDPEYFQSSQF-TDKSDVYSFGVVLLELLT 423
           T  I  T  Y  PE   +  +   K D+++ G V  E+L+
Sbjct: 156 TEYI-STRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 62.1 bits (151), Expect = 2e-10
 Identities = 61/226 (26%), Positives = 100/226 (44%), Gaps = 24/226 (10%)

Query: 210 ELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIV-AVKR-SKE--IDKTQIHQFINEVVI 265
           +L+   ++++  + +G+G FG V          V A+K  SK   I ++    F  E  I
Sbjct: 37  KLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDI 96

Query: 266 LSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWEN 325
           ++  N   IV+L     + +   +V EY+  G L + + ++   ++           W  
Sbjct: 97  MAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEK-----------WA- 144

Query: 326 RVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLT 385
           R   A EV  A+  +HS   I   HRD+K  N+LLD     K++DFG    +  +     
Sbjct: 145 RFYTA-EVVLALDAIHSMGFI---HRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRC 200

Query: 386 TTIQGTFGYLDPEYFQS----SQFTDKSDVYSFGVVLLELLTGKKP 427
            T  GT  Y+ PE  +S      +  + D +S GV L E+L G  P
Sbjct: 201 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 61.6 bits (149), Expect = 2e-10
 Identities = 53/211 (25%), Positives = 94/211 (44%), Gaps = 21/211 (9%)

Query: 222 RFLGQGGFGTVY----KGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKL 277
           + LG+G FG V     K      ++  +K+   + K ++   + E  +L    H  +  L
Sbjct: 1   KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60

Query: 278 LGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRV-ACEVAGA 336
                  +    V EY + G L  H+           ++ + S   E+R R    E+  A
Sbjct: 61  KYSFQTHDRLCFVMEYANGGELFFHL----------SRERVFS---EDRARFYGAEIVSA 107

Query: 337 VAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLD 396
           + Y+HS  ++   +RD+K  N++LD     K++DFG+ +    D   + T   GT  YL 
Sbjct: 108 LDYLHSEKNV--VYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYLA 164

Query: 397 PEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
           PE  + + +    D +  GVV+ E++ G+ P
Sbjct: 165 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 60.8 bits (147), Expect = 3e-10
 Identities = 57/217 (26%), Positives = 99/217 (45%), Gaps = 23/217 (10%)

Query: 214 ATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKR-SKEIDKTQIHQFINEVVILSQINH 271
           A  +Y     LG+G + TVYKG+   +G +VA+K  S + ++      I E  +L  + H
Sbjct: 3   AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKH 62

Query: 272 RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVAC 331
            +IV L       E    V+EY+                 Q   Q    L   N      
Sbjct: 63  ANIVLLHDIIHTKETLTFVFEYM------------HTDLAQYMIQHPGGLHPYNVRLFMF 110

Query: 332 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISR--SIPNDKTHLTTTIQ 389
           ++   +AY+H      I HRD+K  N+L+      K++DFG++R  SIP+ +T+ +  + 
Sbjct: 111 QLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPS-QTYSSEVV- 165

Query: 390 GTFGYLDPEYFQ-SSQFTDKSDVYSFGVVLLELLTGK 425
            T  Y  P+    ++ ++   D++  G + +E+L G+
Sbjct: 166 -TLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 61.2 bits (148), Expect = 4e-10
 Identities = 66/281 (23%), Positives = 118/281 (41%), Gaps = 39/281 (13%)

Query: 211 LQRATDNYNQSRFLGQGGFGTV----YKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVIL 266
           LQ   ++Y+  + +G+G FG V    +K      ++  + + + I ++    F  E  I+
Sbjct: 38  LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIM 97

Query: 267 SQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENR 326
           +  N   +V+L     + +   +V EY+  G L + + ++   ++           W   
Sbjct: 98  AFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEK-----------WAKF 146

Query: 327 VRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTT 386
                EV  A+  +HS   I   HRD+K  N+LLD     K++DFG    +         
Sbjct: 147 Y--TAEVVLALDAIHSMGLI---HRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCD 201

Query: 387 TIQGTFGYLDPEYFQSS----QFTDKSDVYSFGVVLLELLTGKKPI-------CFARVEE 435
           T  GT  Y+ PE  +S      +  + D +S GV L E+L G  P         ++++ +
Sbjct: 202 TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMD 261

Query: 436 ERNLVACF-----ISLAKENQLLEILDARVAKEARE--EDI 469
            +N +  F     IS   +N +   L  R  +  R   E+I
Sbjct: 262 HKNSL-NFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEI 301

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 60.1 bits (146), Expect = 5e-10
 Identities = 52/222 (23%), Positives = 101/222 (45%), Gaps = 32/222 (14%)

Query: 217 NYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSK-EIDKTQIHQF-INEVVILSQINHRH 273
            Y +   +G+G +GTV+K        IVA+KR + + D   +    + E+ +L ++ H++
Sbjct: 1   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 60

Query: 274 IVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVA--- 330
           IV+L       +   LV+EY                 +Q  K+   S + +    +    
Sbjct: 61  IVRLYDVLHSDKKLTLVFEYC----------------DQDLKKYFDSCNGDIDPEIVKSF 104

Query: 331 -CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS--IPNDKTHLTTT 387
             ++   +A+ HS     + HRD+K  N+L++     K++DFG++R+  IP  + +    
Sbjct: 105 MFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-RCYSAEV 160

Query: 388 IQGTFGYLDPEYFQSSQFTDKS-DVYSFGVVLLELLTGKKPI 428
           +  T  Y  P+    ++    S D++S G +  EL    +P+
Sbjct: 161 V--TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 60.8 bits (147), Expect = 6e-10
 Identities = 57/226 (25%), Positives = 99/226 (43%), Gaps = 24/226 (10%)

Query: 210 ELQRATDNYNQSRFLGQGGFGTV----YKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVI 265
           +L+   ++Y   + +G+G FG V    +K      ++  + + + I ++    F  E  I
Sbjct: 37  DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDI 96

Query: 266 LSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWEN 325
           ++  N   +V+L     +     +V EY+  G L + + ++   ++           W  
Sbjct: 97  MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK-----------WA- 144

Query: 326 RVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLT 385
           R   A EV  A+  +HS   I   HRD+K  N+LLD     K++DFG    +  +     
Sbjct: 145 RFYTA-EVVLALDAIHSMGFI---HRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRC 200

Query: 386 TTIQGTFGYLDPEYFQSS----QFTDKSDVYSFGVVLLELLTGKKP 427
            T  GT  Y+ PE  +S      +  + D +S GV L E+L G  P
Sbjct: 201 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 59.7 bits (145), Expect = 9e-10
 Identities = 56/206 (27%), Positives = 97/206 (47%), Gaps = 23/206 (11%)

Query: 224 LGQGGFGTVYKGMLP-DGSIVAVKR-SKEIDKTQIHQFINEVVILSQINHRHIVKLLGCC 281
           LG+G + TVYKG     G +VA+K    E ++      I E  +L  + H +IV L    
Sbjct: 13  LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDII 72

Query: 282 LETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMH 341
              +   LV+EY+ +  L  ++ D               LS  N      ++   +AY H
Sbjct: 73  HTKKTLTLVFEYLDT-DLKQYMDDCG-----------GGLSMHNVRLFLFQLLRGLAYCH 120

Query: 342 SSASIPIFHRDIKSSNILLDDKFSAKVSDFGISR--SIPNDKTHLTTTIQGTFGYLDPE- 398
                 + HRD+K  N+L+ ++   K++DFG++R  S+P+ KT+    +  T  Y  P+ 
Sbjct: 121 QRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPS-KTYSNEVV--TLWYRPPDV 174

Query: 399 YFQSSQFTDKSDVYSFGVVLLELLTG 424
              S++++   D++  G +  E+ TG
Sbjct: 175 LLGSTEYSTSLDMWGVGCIFYEMATG 200

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 59.7 bits (144), Expect = 2e-09
 Identities = 41/179 (22%), Positives = 75/179 (41%), Gaps = 20/179 (11%)

Query: 258 QFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQE 317
           Q  NE++ L ++NH +I+K+     E  +      Y+ +      ++     +    K  
Sbjct: 209 QLENEILALGRLNHENILKI-----EEILRSEANTYMITQKYDFDLYSFMYDEAFDWKD- 262

Query: 318 LSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI 377
              L  + R  +  ++  AV Y+H      + HRDIK  NI L+      + DFG +   
Sbjct: 263 -RPLLKQTR-AIMKQLLCAVEYIHDKK---LIHRDIKLENIFLNCDGKIVLGDFGTAMPF 317

Query: 378 PNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT---------GKKP 427
             ++        GT     PE      + + +D++S G++LL++L+         G KP
Sbjct: 318 EKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKP 376

Length = 501

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 58.9 bits (142), Expect = 2e-09
 Identities = 61/231 (26%), Positives = 101/231 (43%), Gaps = 33/231 (14%)

Query: 205 VFTADELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIH--QFIN 261
           V  AD        Y Q + +G G  G V        G  VAVK+     + Q H  +   
Sbjct: 10  VQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYR 69

Query: 262 EVVILSQINHRHIVKLLGC-----CLETEVPVLVYEYISSGTLSHHIH---DHQQQQEQK 313
           E+V+L  +NH++I+ LL        LE    V +   +    L   IH   DH++     
Sbjct: 70  ELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHER----- 124

Query: 314 QKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGI 373
               +S L ++    + C     + ++HS+    I HRD+K SNI++    + K+ DFG+
Sbjct: 125 ----MSYLLYQ----MLC----GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 169

Query: 374 SRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTG 424
           +R+   +   + T    T  Y  PE      + +  D++S G ++ EL+ G
Sbjct: 170 ARTACTN--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 59.1 bits (143), Expect = 2e-09
 Identities = 48/184 (26%), Positives = 87/184 (47%), Gaps = 26/184 (14%)

Query: 320 SLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPN 379
           +L  E+ +  + +VA  ++++ S   I   HRD+ + NILL      K+ DFG++R I N
Sbjct: 210 ALDTEDLLSFSYQVAKGMSFLASKNCI---HRDLAARNILLTHGRITKICDFGLARDIRN 266

Query: 380 DKTHLTTTIQGT----FGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVE 434
           D  ++   ++G       ++ PE   +  +T +SDV+S+G++L E+ + G  P     V+
Sbjct: 267 DSNYV---VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD 323

Query: 435 EERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVS 494
            +      F  + KE   +          + E     M ++   C   +  KRPT KQ+ 
Sbjct: 324 SK------FYKMIKEGYRM---------LSPECAPSEMYDIMKSCWDADPLKRPTFKQIV 368

Query: 495 MELE 498
             +E
Sbjct: 369 QLIE 372

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 58.2 bits (140), Expect = 4e-09
 Identities = 56/222 (25%), Positives = 107/222 (48%), Gaps = 18/222 (8%)

Query: 224 LGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIH-QFINEVVILSQINHRHIVKLLGCCL 282
           +G+G +G VYK    DG        K+I+ T I      E+ +L ++ H +++ L    L
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68

Query: 283 -ETEVPV-LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYM 340
             ++  V L+++Y +   L H I  H+  +  K+  +L     ++ +    ++   + Y+
Sbjct: 69  SHSDRKVWLLFDY-AEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLY---QILDGIHYL 124

Query: 341 HSSASIPIFHRDIKSSNILL----DDKFSAKVSDFGISRSIPNDKTHLT--TTIQGTFGY 394
           H++    + HRD+K +NIL+     ++   K++D G +R   +    L     +  TF Y
Sbjct: 125 HANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 181

Query: 395 LDPEYFQSSQ-FTDKSDVYSFGVVLLELLTGKKPICFARVEE 435
             PE    ++ +T   D+++ G +  ELLT  +PI   R E+
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQED 222

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 57.5 bits (139), Expect = 6e-09
 Identities = 34/94 (36%), Positives = 50/94 (53%), Gaps = 7/94 (7%)

Query: 336 AVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPND--KTHLTTTIQGTFG 393
           A+ Y+H++    +FHRD+K  NIL +     K+ DFG++R   ND       T    T  
Sbjct: 115 ALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW 171

Query: 394 YLDPEYFQS--SQFTDKSDVYSFGVVLLELLTGK 425
           Y  PE   S  S++T   D++S G +  E+LTGK
Sbjct: 172 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 57.4 bits (139), Expect = 7e-09
 Identities = 57/234 (24%), Positives = 99/234 (42%), Gaps = 47/234 (20%)

Query: 217 NYNQSRFLGQGGFGTV----YKGMLPDGSIVAVKR-----SKEIDKTQIHQFINEVVILS 267
            Y   + LGQG +G V          +   VA+K+     SK+I      + + E+ +L 
Sbjct: 1   RYELIKELGQGAYGIVCSARNAET-SEEETVAIKKITNVFSKKI---LAKRALRELKLLR 56

Query: 268 QI-NHRHIVKLLGCCLETEVP-------VLVYEYISSGTLSHHIHDHQQQQEQKQKQELS 319
               H++I     C  + ++        + +YE +    L   I   Q   +   +  + 
Sbjct: 57  HFRGHKNIT----CLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFI- 111

Query: 320 SLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPN 379
                   ++ C     + Y+HS+  +   HRD+K  N+L++     K+ DFG++R    
Sbjct: 112 -------YQILC----GLKYIHSANVL---HRDLKPGNLLVNADCELKICDFGLARGFSE 157

Query: 380 DKT----HLTTTIQGTFGYLDPEYFQSSQ-FTDKSDVYSFGVVLLELLTGKKPI 428
           +       +T  +  T  Y  PE   S Q +T   DV+S G +L ELL G+KP+
Sbjct: 158 NPGENAGFMTEYV-ATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPV 209

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 57.0 bits (138), Expect = 7e-09
 Identities = 59/232 (25%), Positives = 99/232 (42%), Gaps = 39/232 (16%)

Query: 216 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKR---SKEIDKTQIHQFINEVVILSQINH 271
             Y +   +GQG FG V+K        IVA+K+     E +   I   + E+ IL  + H
Sbjct: 12  SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITA-LREIKILQLLKH 70

Query: 272 RHIVKLLGCCLETEVP--------VLVYEYIS---SGTLSHHIHDHQQQQEQKQKQELSS 320
            ++V L+  C     P         LV+E+     +G LS+        + +K  + L +
Sbjct: 71  ENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLN 130

Query: 321 LSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISR--SIP 378
                           + Y+H +    I HRD+K++NIL+      K++DFG++R  S+ 
Sbjct: 131 ---------------GLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLARAFSLS 172

Query: 379 -NDKTHLTTTIQGTFGYLDPE-YFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
            N K +  T    T  Y  PE       +    D++  G ++ E+ T + PI
Sbjct: 173 KNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT-RSPI 223

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 56.6 bits (137), Expect = 9e-09
 Identities = 52/220 (23%), Positives = 89/220 (40%), Gaps = 32/220 (14%)

Query: 222 RFLGQGGFGTVYKGMLPDGSIVAVKR------SKEIDKTQIHQFINEVVILSQINHRHIV 275
           +         + K   P  ++VAVK+      SKE D   + Q   E++   Q+ H +I+
Sbjct: 8   KCFEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKE-DLKLLQQ---EIITSRQLQHPNIL 62

Query: 276 KLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAG 335
             +   +      +V   ++ G+    +  H         + L  L+    ++   +V  
Sbjct: 63  PYVTSFIVDSELYVVSPLMAYGSCEDLLKTHF-------PEGLPELAIAFILK---DVLN 112

Query: 336 AVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS-IPNDKTH-----LTTTIQ 389
           A+ Y+HS   I   HR +K+S+ILL       +S    S S I + K          +  
Sbjct: 113 ALDYIHSKGFI---HRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSV 169

Query: 390 GTFGYLDPEYFQSS--QFTDKSDVYSFGVVLLELLTGKKP 427
               +L PE  Q +   + +KSD+YS G+   EL  G  P
Sbjct: 170 KNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVP 209

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 56.2 bits (136), Expect = 2e-08
 Identities = 34/91 (37%), Positives = 52/91 (57%), Gaps = 6/91 (6%)

Query: 339 YMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPE 398
           Y+HS+    + HRD+K SN+LL+     K+ DFG++R+  ++K    T    T  Y  PE
Sbjct: 123 YIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLART-TSEKGDFMTEYVVTRWYRAPE 178

Query: 399 -YFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
                S++T   DV+S G +  ELL G+KP+
Sbjct: 179 LLLNCSEYTTAIDVWSVGCIFAELL-GRKPL 208

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 55.8 bits (134), Expect = 2e-08
 Identities = 56/222 (25%), Positives = 106/222 (47%), Gaps = 18/222 (8%)

Query: 224 LGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIH-QFINEVVILSQINHRHIVKLLGCCL 282
           +G+G +G VYK    DG        K+I+ T I      E+ +L ++ H +++ L    L
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68

Query: 283 -ETEVPV-LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYM 340
              +  V L+++Y +   L H I  H+  +  K+  +L     ++ +    ++   + Y+
Sbjct: 69  SHADRKVWLLFDY-AEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLY---QILDGIHYL 124

Query: 341 HSSASIPIFHRDIKSSNILL----DDKFSAKVSDFGISRSIPNDKTHLT--TTIQGTFGY 394
           H++    + HRD+K +NIL+     ++   K++D G +R   +    L     +  TF Y
Sbjct: 125 HANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 181

Query: 395 LDPEYFQSSQ-FTDKSDVYSFGVVLLELLTGKKPICFARVEE 435
             PE    ++ +T   D+++ G +  ELLT  +PI   R E+
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQED 222

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 56.2 bits (135), Expect = 2e-08
 Identities = 32/100 (32%), Positives = 51/100 (51%), Gaps = 5/100 (5%)

Query: 333 VAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTF 392
           +A  V  +HS   +   HRDIK  N+LLD     +++DFG    +  D T  ++   GT 
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTP 167

Query: 393 GYLDPEYFQS-----SQFTDKSDVYSFGVVLLELLTGKKP 427
            Y+ PE  Q+      ++  + D +S GV + E+L G+ P
Sbjct: 168 DYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 56.2 bits (135), Expect = 2e-08
 Identities = 48/184 (26%), Positives = 86/184 (46%), Gaps = 24/184 (13%)

Query: 321 LSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPND 380
           LS+ + V  + +VA  + ++ S   +   HRD+ + N+L+ +    K+ DFG++R I  D
Sbjct: 236 LSYMDLVGFSYQVANGMEFLASKNCV---HRDLAARNVLICEGKLVKICDFGLARDIMRD 292

Query: 381 KTHLTTTIQGTF---GYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEE 436
             +++     TF    ++ PE   ++ +T  SDV+SFG++L E+ T G  P     + E+
Sbjct: 293 SNYISKG--STFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ 350

Query: 437 RNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSME 496
                 F +  K          R+AK A   D   + E+  +C     + RP   Q+   
Sbjct: 351 ------FYNAIKRGY-------RMAKPAHASD--EIYEIMQKCWEEKFEIRPDFSQLVHL 395

Query: 497 LEGL 500
           +  L
Sbjct: 396 VGDL 399

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 55.7 bits (134), Expect = 3e-08
 Identities = 33/161 (20%), Positives = 70/161 (43%), Gaps = 17/161 (10%)

Query: 262 EVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSL 321
           E ++L  +NH  ++++    +   +  +V  + SS   ++              +    L
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTY------------LTKRSRPL 154

Query: 322 SWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDK 381
             +  + +  ++   + Y+H+     I HRD+K+ NI ++D     + D G ++      
Sbjct: 155 PIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP 211

Query: 382 THLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELL 422
             L   + GT     PE     ++  K+D++S G+VL E+L
Sbjct: 212 AFL--GLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250

Length = 357

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 55.8 bits (134), Expect = 3e-08
 Identities = 64/259 (24%), Positives = 116/259 (44%), Gaps = 35/259 (13%)

Query: 182 FKQNGGYLLQQQLS----SCGSSERAKVFTADELQRATDNYNQSRFLGQGGFGTVYKGML 237
           F+ N   L +++ S    +    +  K+   D  +    +Y     +G G FG VY+ + 
Sbjct: 28  FEMNDKKLDEEERSHNNNAGEDEDEEKMIDNDINRSPNKSYKLGNIIGNGSFGVVYEAIC 87

Query: 238 PDGS-IVAVKRSKEIDKTQIHQFIN-EVVILSQINHRHIVKL-----LGCCLETEVPV-- 288
            D S  VA+K+       Q  Q+ N E++I+  +NH +I+ L       C  + E  +  
Sbjct: 88  IDTSEKVAIKKV-----LQDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFL 142

Query: 289 -LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIP 347
            +V E+I      H    H  +        L  L        + ++  A+AY+HS     
Sbjct: 143 NVVMEFIPQTV--HKYMKHYARNNHALPLFLVKL-------YSYQLCRALAYIHSKF--- 190

Query: 348 IFHRDIKSSNILLDDK-FSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPE-YFQSSQF 405
           I HRD+K  N+L+D    + K+ DFG ++++   +  + + I   F Y  PE    ++ +
Sbjct: 191 ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSV-SYICSRF-YRAPELMLGATNY 248

Query: 406 TDKSDVYSFGVVLLELLTG 424
           T   D++S G ++ E++ G
Sbjct: 249 TTHIDLWSLGCIIAEMILG 267

Length = 440

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 54.6 bits (131), Expect = 3e-08
 Identities = 52/218 (23%), Positives = 94/218 (43%), Gaps = 31/218 (14%)

Query: 224 LGQGGFGTVYKG--MLPDGSIVAVKRSK--EIDKTQIHQFINEVVILSQIN---HRHIVK 276
           +G+G +G V+K   +   G  VA+KR +    ++      I EV +L  +    H ++V+
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68

Query: 277 LLGCCL------ETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVA 330
           L   C       ET++  LV+E++            Q       K     +  E    + 
Sbjct: 69  LFDVCTVSRTDRETKL-TLVFEHVD-----------QDLTTYLDKVPEPGVPTETIKDMM 116

Query: 331 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQG 390
            ++   + ++HS     + HRD+K  NIL+      K++DFG++R          T++  
Sbjct: 117 FQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM--ALTSVVV 171

Query: 391 TFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
           T  Y  PE    S +    D++S G +  E+   +KP+
Sbjct: 172 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 208

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 54.6 bits (132), Expect = 4e-08
 Identities = 55/229 (24%), Positives = 95/229 (41%), Gaps = 38/229 (16%)

Query: 216 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKR-SKEIDK-TQIHQFINEVVILSQINHR 272
             Y     +G G +G V   +    G  VA+K+     D  T   + + E+ IL    H 
Sbjct: 5   SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHD 64

Query: 273 HIVKLLGCCLETEVPV-----LVYEYISSGTLSHHIHDHQQQQEQKQK----QELSSLSW 323
           +I+ +    L           +V + + S  L H IH  Q   E+  +    Q L  L  
Sbjct: 65  NIIAIRDI-LRPPGADFKDVYVVMDLMES-DLHHIIHSDQPLTEEHIRYFLYQLLRGLK- 121

Query: 324 ENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI---PND 380
                          Y+HS+    + HRD+K SN+L+++    ++ DFG++R +   P +
Sbjct: 122 ---------------YIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTE 163

Query: 381 KTHLTTTIQGTFGYLDPE-YFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
             +  T    T  Y  PE      ++T   D++S G +  E+L G++ +
Sbjct: 164 HKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 54.4 bits (131), Expect = 6e-08
 Identities = 55/216 (25%), Positives = 94/216 (43%), Gaps = 26/216 (12%)

Query: 215 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQI--HQFINEVVILSQINH 271
           T+ Y   + +G G FG V        G  VA+K+  +   T +   +   E+ +L  + H
Sbjct: 9   TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68

Query: 272 RHIVKLLGCCLE-TEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVA 330
            +I+ L    +   E    V E +  GT  H +          +KQ +    ++      
Sbjct: 69  ENIISLSDIFISPLEDIYFVTELL--GTDLHRL----LTSRPLEKQFIQYFLYQ------ 116

Query: 331 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQG 390
             +   + Y+HS+  +   HRD+K SNIL+++    K+ DFG++R    D     T    
Sbjct: 117 --ILRGLKYVHSAGVV---HRDLKPSNILINENCDLKICDFGLAR--IQD--PQMTGYVS 167

Query: 391 TFGYLDPEYFQSSQ-FTDKSDVYSFGVVLLELLTGK 425
           T  Y  PE   + Q +  + D++S G +  E+L GK
Sbjct: 168 TRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 53.8 bits (129), Expect = 6e-08
 Identities = 64/287 (22%), Positives = 124/287 (43%), Gaps = 35/287 (12%)

Query: 224 LGQGGFGTVYKGMLPDG---SIVAVKRSKEIDKTQIH-QFINEVVILSQINHRHIVKLLG 279
           +G G FG V  G +  G   + V VK  +     Q   +F+ E      + H ++++ LG
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62

Query: 280 CCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAY 339
            C E    +LV E+   G L  ++     ++ +    + ++L      R+ACE+A  + +
Sbjct: 63  QCTEVTPYLLVMEFCPLGDLKGYL--RSCRKAELMTPDPTTLQ-----RMACEIALGLLH 115

Query: 340 MHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTT-TIQGTFGYLDPE 398
           +H +  I   H D+   N LL    + K+ D+G+S +   +  ++T   +     ++ PE
Sbjct: 116 LHKNNFI---HSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPE 172

Query: 399 YFQS-------SQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKEN 450
                         T +S+V+S GV + EL   G +P    R   +  ++   +   +E 
Sbjct: 173 LVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPY---RHLSDEQVLTYTV---REQ 226

Query: 451 QLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMEL 497
           QL      ++ K   +  +       M+   L  ++RP+ ++V + L
Sbjct: 227 QL------KLPKPRLKLPLSDRWYEVMQFCWLQPEQRPSAEEVHLLL 267

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 54.9 bits (132), Expect = 7e-08
 Identities = 47/155 (30%), Positives = 73/155 (47%), Gaps = 21/155 (13%)

Query: 226 QGGFGTVYKGMLPDGS----IVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCC 281
           +G FG VY G   + S    +  VK++  I+K  +HQ   E   L+      IV L    
Sbjct: 14  RGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLY-YS 72

Query: 282 LETEVPV-LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYM 340
           L++   V LV EY+  G +   +H +    E            E  V+   EVA A+ Y+
Sbjct: 73  LQSANNVYLVMEYLIGGDVKSLLHIYGYFDE------------EMAVKYISEVALALDYL 120

Query: 341 HSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISR 375
           H      I HRD+K  N+L+ ++   K++DFG+S+
Sbjct: 121 HRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 54.1 bits (130), Expect = 9e-08
 Identities = 41/168 (24%), Positives = 70/168 (41%), Gaps = 17/168 (10%)

Query: 262 EVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSL 321
           E+ IL  I+HR I+ L+          +V        +  +  D     ++        L
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMV--------MPKYKCDLFTYVDRS-----GPL 182

Query: 322 SWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGIS-RSIPND 380
             E  + +   +  A+AY+H      I HRD+K+ NI LD+  +A + DFG + +   + 
Sbjct: 183 PLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239

Query: 381 KTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
            T       GT     PE      +  K+D++S G+VL E+      +
Sbjct: 240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287

Length = 392

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 53.6 bits (129), Expect = 1e-07
 Identities = 30/91 (32%), Positives = 50/91 (54%), Gaps = 6/91 (6%)

Query: 337 VAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISR-SIPNDKTHLTTTIQGTFGYL 395
           + Y+HS+    I HRDIK  N+L++     K+ DFG++R   P++  H+T  +   + Y 
Sbjct: 116 LKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY-YR 171

Query: 396 DPEYFQSSQ-FTDKSDVYSFGVVLLELLTGK 425
            PE    S+ +T   D++S G +  ELL  +
Sbjct: 172 APEILMGSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 52.9 bits (127), Expect = 2e-07
 Identities = 61/264 (23%), Positives = 98/264 (37%), Gaps = 65/264 (24%)

Query: 216 DNYNQSRFLGQGGFGTV-YKGMLPDGSIVAVK---RSKEIDKTQIHQFINEVVILSQINH 271
           ++++  + +G+G FG V        G I A+K   +S+   K Q+     E  +L++ + 
Sbjct: 1   EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60

Query: 272 RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVAC 331
             +V L     + +   L+ E++  G L   +  +    E              R  +A 
Sbjct: 61  PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDV-----------TRFYMA- 108

Query: 332 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGIS----------------- 374
           E   A+  +H    I   HRDIK  NIL+D     K+SDFG+S                 
Sbjct: 109 ECVLAIEAVHKLGFI---HRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQ 165

Query: 375 -----------RSIPNDKTHLTT----TIQ--------------GTFGYLDPEYFQSSQF 405
                       S+  D  +LT      I               GT  Y+ PE F    +
Sbjct: 166 GKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY 225

Query: 406 TDKSDVYSFGVVLLELLTGKKPIC 429
             + D +S G ++ E L G  P C
Sbjct: 226 GQECDWWSLGAIMFECLIGWPPFC 249

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 52.4 bits (125), Expect = 2e-07
 Identities = 31/100 (31%), Positives = 50/100 (50%), Gaps = 5/100 (5%)

Query: 333 VAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTF 392
           +A  V  + S   +   HRDIK  NIL+D     +++DFG    +  D T  ++   GT 
Sbjct: 108 LAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTP 167

Query: 393 GYLDPEYFQS-----SQFTDKSDVYSFGVVLLELLTGKKP 427
            Y+ PE  Q+      ++  + D +S GV + E+L G+ P
Sbjct: 168 DYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 52.4 bits (126), Expect = 3e-07
 Identities = 56/222 (25%), Positives = 99/222 (44%), Gaps = 39/222 (17%)

Query: 218 YNQSRFLGQGGFGTV---YKGMLPDGSIVAVKRSKEIDKTQIH--QFINEVVILSQINHR 272
           Y   + +G G  G V   Y  +   G  VA+K+     +   H  +   E+V++  +NH+
Sbjct: 18  YQNLKPIGSGAQGIVCAAYDTVT--GQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHK 75

Query: 273 HIVKLLGC-----CLETEVPV-LVYEYISSGTLSHHIH---DHQQQQEQKQKQELSSLSW 323
           +I+ LL        LE    V LV E + +  L   I    DH++         +S L +
Sbjct: 76  NIIGLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQMDLDHER---------MSYLLY 125

Query: 324 ENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTH 383
           +    + C     + ++HS+    I HRD+K SNI++    + K+ DFG++R+       
Sbjct: 126 Q----MLC----GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--F 172

Query: 384 LTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGK 425
           + T    T  Y  PE      + +  D++S G ++ E++ G 
Sbjct: 173 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 52.1 bits (125), Expect = 3e-07
 Identities = 60/244 (24%), Positives = 101/244 (41%), Gaps = 44/244 (18%)

Query: 216 DNYNQSRFLGQGGFGTVY----KGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINH 271
           +++   + +  G +G VY    K      ++  + +   I + QI Q   E  IL+   +
Sbjct: 1   EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAEN 60

Query: 272 RHIVKLLGCCLETEVPV-LVYEYISSG---TLSHHIHDHQQQQEQKQKQELSSLSWE-NR 326
             +V +  C  ET+  + +V EY+  G   TL  +I                +L  +  R
Sbjct: 61  PFVVSMF-CSFETKRHLCMVMEYVEGGDCATLLKNI---------------GALPVDMAR 104

Query: 327 VRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISR----------- 375
           +  A E   A+ Y+H+     I HRD+K  N+L+      K++DFG+S+           
Sbjct: 105 MYFA-ETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY 160

Query: 376 --SIPND-KTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFAR 432
              I  D +  L   + GT  Y+ PE      +    D ++ G++L E L G  P  F  
Sbjct: 161 EGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPF-FGD 219

Query: 433 VEEE 436
             EE
Sbjct: 220 TPEE 223

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 52.0 bits (124), Expect = 3e-07
 Identities = 50/213 (23%), Positives = 95/213 (44%), Gaps = 21/213 (9%)

Query: 218 YNQSRFLGQGGFGTV---YKGMLPDGSIVAVKRSKEIDKTQIH--QFINEVVILSQINHR 272
           Y   + +G G  G V   Y  +L     VA+K+     + Q H  +   E+V++  +NH+
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76

Query: 273 HIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACE 332
           +I+ LL        P    E      L   + D    Q  + + +   +S+     +  +
Sbjct: 77  NIISLL----NVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSY-----LLYQ 127

Query: 333 VAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTF 392
           +   + ++HS+    I HRD+K SNI++    + K+ DFG++R+     + + T    T 
Sbjct: 128 MLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTR 182

Query: 393 GYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGK 425
            Y  PE      + +  D++S G ++ E++  K
Sbjct: 183 YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 51.4 bits (123), Expect = 5e-07
 Identities = 49/216 (22%), Positives = 91/216 (42%), Gaps = 28/216 (12%)

Query: 218 YNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQI--HQFINEVVILSQINHRHI 274
           Y   + +G G +G+V   +    G  VA+K+     +++I   +   E+ +L  + H ++
Sbjct: 17  YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENV 76

Query: 275 VKLLGCCLETEVPVLVYEYISSGTLSHHIHDH----QQQQEQKQKQELSSLSWENRVRVA 330
           + LL             +  +S        D        Q   QK     LS +    + 
Sbjct: 77  IGLL-------------DVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLV 123

Query: 331 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQG 390
            ++   + Y+HS+    I HRD+K  N+ +++    K+ DFG++R    + T    T   
Sbjct: 124 YQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRW- 179

Query: 391 TFGYLDPEYFQS-SQFTDKSDVYSFGVVLLELLTGK 425
              Y  PE   +   +    D++S G ++ E+LTGK
Sbjct: 180 ---YRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 51.6 bits (123), Expect = 5e-07
 Identities = 58/240 (24%), Positives = 106/240 (44%), Gaps = 35/240 (14%)

Query: 200 SERAKVFTADELQRAT----DNYNQSRFLGQGGFGTV---YKGMLPDGSIVAVKRSKEID 252
           S+R   F + E+  +T      Y   + +G G  G V   Y  +L     VA+K+     
Sbjct: 4   SKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPF 61

Query: 253 KTQIH--QFINEVVILSQINHRHIVKLLGC-----CLETEVPVLVYEYISSGTLSHHIHD 305
           + Q H  +   E+V++  +NH++I+ LL        LE    V +   +    L   I  
Sbjct: 62  QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVI-- 119

Query: 306 HQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFS 365
               Q +   + +S L ++    + C     + ++HS+    I HRD+K SNI++    +
Sbjct: 120 ----QMELDHERMSYLLYQ----MLC----GIKHLHSAG---IIHRDLKPSNIVVKSDCT 164

Query: 366 AKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGK 425
            K+ DFG++R+     + + T    T  Y  PE      + +  D++S G ++ E++ G 
Sbjct: 165 LKILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 50.9 bits (122), Expect = 7e-07
 Identities = 31/100 (31%), Positives = 49/100 (49%), Gaps = 5/100 (5%)

Query: 333 VAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTF 392
           +A  V  + S   +   HRDIK  N+LLD     +++DFG    +  D T  +    GT 
Sbjct: 108 LAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTP 167

Query: 393 GYLDPEYFQS-----SQFTDKSDVYSFGVVLLELLTGKKP 427
            Y+ PE  Q+      ++  + D +S GV + E+L G+ P
Sbjct: 168 DYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 50.3 bits (120), Expect = 7e-07
 Identities = 53/249 (21%), Positives = 109/249 (43%), Gaps = 48/249 (19%)

Query: 259 FINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQEL 318
           F     ++ Q++H+HIV L G C+     ++V E++  G L   +H         +K ++
Sbjct: 51  FFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMH---------RKSDV 101

Query: 319 SSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILL-----DDKFSA--KVSDF 371
            +  W  + +VA ++A A++Y+       + H ++ + NILL     D +     K+SD 
Sbjct: 102 LTTPW--KFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156

Query: 372 GISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQ-FTDKSDVYSFGVVLLEL-LTGKKPIC 429
           GI  ++ + +  +         ++ PE  + S+  +  +D +SFG  L E+   G+ P+ 
Sbjct: 157 GIPITVLSRQECVE-----RIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLK 211

Query: 430 FARV-EEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRP 488
              + E+ER      + +               KE        +A+L   C+  +  +RP
Sbjct: 212 DKTLAEKERFYEGQCMLVTPS-----------CKE--------LADLMTHCMNYDPNQRP 252

Query: 489 TMKQVSMEL 497
             + +  ++
Sbjct: 253 FFRAIMRDI 261

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 50.4 bits (120), Expect = 1e-06
 Identities = 54/229 (23%), Positives = 100/229 (43%), Gaps = 23/229 (10%)

Query: 205 VFTADELQRAT----DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIH-- 257
            F   EL +      + Y     +G G +G+V        G  VAVK+     ++ IH  
Sbjct: 2   TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK 61

Query: 258 QFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQE 317
           +   E+ +L  + H +++ LL    +   P    E  +   L  H+         K ++ 
Sbjct: 62  RTYRELRLLKHMKHENVIGLL----DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK- 116

Query: 318 LSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI 377
              L+ ++   +  ++   + Y+HS+    I HRD+K SN+ +++    K+ DFG++R  
Sbjct: 117 ---LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHT 170

Query: 378 PNDKTHLTTTIQGTFGYLDPEYFQS-SQFTDKSDVYSFGVVLLELLTGK 425
            ++ T    T      Y  PE   +   +    D++S G ++ ELLTG+
Sbjct: 171 DDEMTGYVATRW----YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 50.0 bits (119), Expect = 1e-06
 Identities = 50/206 (24%), Positives = 90/206 (43%), Gaps = 20/206 (9%)

Query: 224 LGQGGFGTVYKGMLPD-GSIVAVKRSKEIDKTQ--IHQFINEVVILSQINHRHIVKLLGC 280
           +G+G +G V K    +   IVA+K+ K+ ++ +      + E+ +L  +   +IV+L   
Sbjct: 9   VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68

Query: 281 CLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVAC-EVAGAVAY 339
                   LV+EY+    L             +  +E+ +     +VR    ++  A+ +
Sbjct: 69  FRRRGKLYLVFEYVEKNML-------------ELLEEMPNGVPPEKVRSYIYQLIKAIHW 115

Query: 340 MHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEY 399
            H +    I HRDIK  N+L+      K+ DFG +R++        T    T  Y  PE 
Sbjct: 116 CHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPEL 172

Query: 400 FQSSQFTDKSDVYSFGVVLLELLTGK 425
              + +    D++S G +L EL  G+
Sbjct: 173 LLGAPYGKAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 50.4 bits (120), Expect = 1e-06
 Identities = 46/215 (21%), Positives = 93/215 (43%), Gaps = 33/215 (15%)

Query: 299 LSHHIHDHQQQQEQKQKQELSS---------LSWENRVRVACEVAGAVAYMHSSASIPIF 349
           +    +D     +     E+ +         L+  + +    +VA  + ++ S   +   
Sbjct: 203 IQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCV--- 259

Query: 350 HRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTF---GYLDPEYFQSSQFT 406
           HRD+ + N+LL      K+ DFG++R I +D  +++     TF    ++ PE    + +T
Sbjct: 260 HRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKG--STFLPVKWMAPESIFDNLYT 317

Query: 407 DKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQLLEILDARVAKEAR 465
             SDV+S+G++L E+ + G  P     V+      + F +  K          R+AK   
Sbjct: 318 TLSDVWSYGILLWEIFSLGGTPYPGMIVD------STFYNKIKSGY-------RMAKP-- 362

Query: 466 EEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGL 500
           +     + ++ ++C     +KRP+   +S  +E L
Sbjct: 363 DHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL 397

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|144899 pfam01476, LysM, LysM domain

 Score = 44.3 bits (106), Expect = 2e-06
 Identities = 16/44 (36%), Positives = 26/44 (59%), Gaps = 1/44 (2%)

Query: 57  YMAAKGDTISSIGYKFGVDQQSILEANMLSKADSIFPFAPLLIP 100
           Y   KGDT+SSI  ++G+  + + E N LS + +++    L IP
Sbjct: 1   YTVKKGDTLSSIAKRYGITVEELAELNGLS-SPNLYVGQKLKIP 43

The LysM (lysin motif) domain is about 40 residues long. It is found in a variety of enzymes involved in bacterial cell wall degradation. This domain may have a general peptidoglycan binding function. The structure of this domain is known. Length = 43

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 48.0 bits (115), Expect = 5e-06
 Identities = 59/242 (24%), Positives = 96/242 (39%), Gaps = 49/242 (20%)

Query: 222 RFLGQGGFGTVYKGMLPD-GSIVAVK---RSKEIDKTQIHQFINEVVILSQINHRHIVKL 277
           + LG+G  G V+   L   G + A+K   + + I + ++ + + E  IL+ ++H  +  L
Sbjct: 7   KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66

Query: 278 LGCCLETEVPV-LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRV-ACEVAG 335
                +TE  + LV +Y   G L   +          Q+Q    LS E   R  A EV  
Sbjct: 67  Y-ASFQTETYLCLVMDYCPGGELFRLL----------QRQPGKCLS-EEVARFYAAEVLL 114

Query: 336 AVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGIS-----------------RSIP 378
           A+ Y+H      I +RD+K  NILL +     +SDF +S                     
Sbjct: 115 ALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRS 171

Query: 379 NDKTHLTTTIQ-----------GTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
           +  +  + T             GT  Y+ PE           D ++ G++L E+L G  P
Sbjct: 172 SVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP 231

Query: 428 IC 429
             
Sbjct: 232 FK 233

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 48.3 bits (115), Expect = 6e-06
 Identities = 60/253 (23%), Positives = 100/253 (39%), Gaps = 63/253 (24%)

Query: 222 RFLGQGGFGTVYKGMLPDGSIV-AVK--RSKE-IDKTQIHQFINEVVILSQINHRHIVKL 277
           + +G G FG V      D + + A+K  R  + + + Q      E  IL++ ++  +VKL
Sbjct: 7   KTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKL 66

Query: 278 LGCCLETEVPVLVYEYISSGTL-SHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGA 336
                + +    V +YI  G + S  I      +    +++L+      R  +A E+  A
Sbjct: 67  YYSFQDKDNLYFVMDYIPGGDMMSLLI------RLGIFEEDLA------RFYIA-ELTCA 113

Query: 337 VAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGI----------------------S 374
           +  +H    I   HRDIK  NIL+D     K++DFG+                      S
Sbjct: 114 IESVHKMGFI---HRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDS 170

Query: 375 RSIPN-----DKTHLTT---------------TIQGTFGYLDPEYFQSSQFTDKSDVYSF 414
                     D+  L                 ++ GT  Y+ PE    + +T   D +S 
Sbjct: 171 MEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 230

Query: 415 GVVLLELLTGKKP 427
           GV+L E+L G+ P
Sbjct: 231 GVILYEMLVGQPP 243

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 48.1 bits (114), Expect = 6e-06
 Identities = 60/254 (23%), Positives = 98/254 (38%), Gaps = 65/254 (25%)

Query: 224 LGQGGFGTVYKGMLPD-GSIVAVK--RSKEI-DKTQIHQFINEVVILSQINHRHIVKLLG 279
           LG G FG V      D  ++ A+K  R K++ ++ Q+     E  IL++ ++  +VKL  
Sbjct: 9   LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68

Query: 280 CCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAY 339
              + +    V +YI  G +   +   +   E   +  ++ L+             A+  
Sbjct: 69  SFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTL------------AIES 116

Query: 340 MHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI---------------------P 378
           +H    I   HRDIK  NIL+D     K++DFG+                         P
Sbjct: 117 VHKMGFI---HRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEP 173

Query: 379 ND----------------------KTH---LTTTIQGTFGYLDPEYFQSSQFTDKSDVYS 413
           +D                      K H   L  ++ GT  Y+ PE      +T   D +S
Sbjct: 174 SDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWS 233

Query: 414 FGVVLLELLTGKKP 427
            GV+L E+L G+ P
Sbjct: 234 VGVILFEMLVGQPP 247

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 46.8 bits (111), Expect = 8e-06
 Identities = 41/157 (26%), Positives = 64/157 (40%), Gaps = 27/157 (17%)

Query: 273 HIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACE 332
           ++V L    +  +   LV ++   G L  HI       E+  K+      W      A E
Sbjct: 46  NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKR------W------AAE 93

Query: 333 VAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG----ISRSIPNDKTHLTTTI 388
           +  A+  +H      I  RD+  +NILLDD+   +++ F     +  S   +        
Sbjct: 94  MVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM--- 147

Query: 389 QGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGK 425
                Y  PE    S+ T+  D +S G +L ELLTGK
Sbjct: 148 -----YCAPEVGGISEETEACDWWSLGAILFELLTGK 179

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 47.3 bits (112), Expect = 1e-05
 Identities = 29/104 (27%), Positives = 56/104 (53%), Gaps = 9/104 (8%)

Query: 324 ENRVR-VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKT 382
           E+R++ +  ++   + Y+H++    I HRD+K  N+ +++    K+ DFG++R   ++ T
Sbjct: 117 EDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMT 173

Query: 383 HLTTTIQGTFGYLDPEYFQS-SQFTDKSDVYSFGVVLLELLTGK 425
               T      Y  PE   +   +T   D++S G ++ E+LTGK
Sbjct: 174 GYVVTRW----YRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|197609 smart00257, LysM, Lysin motif

 Score = 41.3 bits (98), Expect = 2e-05
 Identities = 15/43 (34%), Positives = 23/43 (53%)

Query: 57 YMAAKGDTISSIGYKFGVDQQSILEANMLSKADSIFPFAPLLI 99
          Y   KGDT+SSI  ++G+    +LE N +   D++     L I
Sbjct: 2  YTVKKGDTLSSIARRYGISVSDLLELNNILDPDNLQVGQKLKI 44

Length = 44

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 46.0 bits (109), Expect = 3e-05
 Identities = 30/98 (30%), Positives = 44/98 (44%), Gaps = 14/98 (14%)

Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGI------SRSIPNDKT 382
           VA ++  A+ Y+H      I HRDIK+ N+L++      + DFG       S S P    
Sbjct: 265 VARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP---- 317

Query: 383 HLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLE 420
                I GT     PE      +T   D++S G+V+ E
Sbjct: 318 -FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|212030 cd00118, LysM, Lysine Motif is a small domain involved in binding peptidoglycan

 Score = 40.9 bits (97), Expect = 3e-05
 Identities = 17/43 (39%), Positives = 22/43 (51%)

Query: 57 YMAAKGDTISSIGYKFGVDQQSILEANMLSKADSIFPFAPLLI 99
          Y    GDT+ SI  K+GV  + +  AN L   D I+P   L I
Sbjct: 3  YTVKPGDTLWSIAKKYGVTVEELAAANPLINPDCIYPGQKLKI 45

LysM, a small globular domain with approximately 40 amino acids, is a widespread protein module involved in binding peptidoglycan in bacteria and chitin in eukaryotes. The domain was originally identified in enzymes that degrade bacterial cell walls, but proteins involved in many other biological functions also contain this domain. It has been reported that the LysM domain functions as a signal for specific plant-bacteria recognition in bacterial pathogenesis. Many of these enzymes are modular and are composed of catalytic units linked to one or several repeats of LysM domains. LysM domains are found in bacteria and eukaryotes. Length = 45

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 45.8 bits (108), Expect = 4e-05
 Identities = 27/88 (30%), Positives = 46/88 (52%), Gaps = 8/88 (9%)

Query: 339 YMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPE 398
           Y+HS+    I HRD+K SN+ +++    ++ DFG++R   ++ T    T      Y  PE
Sbjct: 133 YIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATRW----YRAPE 185

Query: 399 YFQS-SQFTDKSDVYSFGVVLLELLTGK 425
              +   +    D++S G ++ ELL GK
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 45.0 bits (106), Expect = 7e-05
 Identities = 41/167 (24%), Positives = 64/167 (38%), Gaps = 18/167 (10%)

Query: 260 INEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELS 319
             E  IL  INH  I++L G           Y   +   L  +  D       K+   + 
Sbjct: 131 ATEAHILRAINHPSIIQLKG--------TFTYNKFTCLILPRYKTDLYCYLAAKRNIAIC 182

Query: 320 SLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPN 379
            +     + +   V  A+ Y+H +    I HRDIK+ NI ++      + DFG +   P 
Sbjct: 183 DI-----LAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAA-CFPV 233

Query: 380 DKT-HLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGK 425
           D   +      GT     PE      +    D++S G+VL E+ T  
Sbjct: 234 DINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 42.8 bits (101), Expect = 7e-05
 Identities = 29/141 (20%), Positives = 50/141 (35%), Gaps = 31/141 (21%)

Query: 259 FINEVVILSQINHRHIVKLL-----GCCLETEVPVL------------VYEYI----SSG 297
             N V +L   +  +++K+      G   E EV +L            V         S 
Sbjct: 10  LTNRVYLLGTKDEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGESDGWSY 69

Query: 298 TLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSN 357
            L   I              L  +S E +  +A ++A  +A +H    + + H D+   N
Sbjct: 70  LLMEWIEGE----------TLDEVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGN 119

Query: 358 ILLDDKFSAKVSDFGISRSIP 378
           IL+DD     + D+  +   P
Sbjct: 120 ILVDDGKILGIIDWEYAGYGP 140

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 45.0 bits (106), Expect = 7e-05
 Identities = 57/254 (22%), Positives = 95/254 (37%), Gaps = 65/254 (25%)

Query: 224 LGQGGFGTVYKGMLPD-GSIVAVKRSKEID---KTQIHQFINEVVILSQINHRHIVKLLG 279
           LG G FG V      D  ++ A+K  ++ D   + Q+     E  IL++ ++  +V+L  
Sbjct: 9   LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYY 68

Query: 280 CCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAY 339
              + +    V +YI  G +   +       E   +  ++ L+        C    AV  
Sbjct: 69  SFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELT--------C----AVES 116

Query: 340 MHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGIS------------------------- 374
           +H    I   HRDIK  NIL+D     K++DFG+                          
Sbjct: 117 VHKMGFI---HRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDF 173

Query: 375 ---------------------RSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYS 413
                                R+    +  L  ++ GT  Y+ PE    + +T   D +S
Sbjct: 174 SNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWS 233

Query: 414 FGVVLLELLTGKKP 427
            GV+L E+L G+ P
Sbjct: 234 VGVILYEMLVGQPP 247

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 44.1 bits (105), Expect = 9e-05
 Identities = 42/159 (26%), Positives = 68/159 (42%), Gaps = 21/159 (13%)

Query: 270 NHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRV 329
           ++ + +KL       +  VL+ +YI  G L   +         K++ +LS    +  +R 
Sbjct: 67  DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLL---------KKEGKLSEAEVKKIIRQ 117

Query: 330 ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD-KFSAKVSDFGISRSIPNDKTHLTTTI 388
             E   A+  +H      I H DIK  N+L D  K    + D+G+ + I        +  
Sbjct: 118 LVE---ALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKII-----GTPSCY 166

Query: 389 QGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
            GT  Y  PE  +   +    D ++ GV+  ELLTGK P
Sbjct: 167 DGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHP 205

Length = 267

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 44.0 bits (104), Expect = 2e-04
 Identities = 80/348 (22%), Positives = 130/348 (37%), Gaps = 106/348 (30%)

Query: 216 DNYNQSRFLGQGGFGTVYKGML------PDGSIVAVKRSKEIDKTQIHQFINEVVILSQI 269
           D++   + LG+G FG VYK  L       +G  V +K++ E    +I  ++NE V  +  
Sbjct: 132 DDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYV-LKKATEYGAVEI--WMNERVRRACP 188

Query: 270 NHRHIVKLLGCCLET-----EVPV-LVYEYISSGTLSHHIHDHQQQQE----------QK 313
           N       +   LE      E    LV+ Y    TL+    D  Q +E           K
Sbjct: 189 N--SCADFVYGFLEPVSSKKEDEYWLVWRYEGESTLA----DLMQSKEFPYNVEPYLLGK 242

Query: 314 QKQELSSLSWENRV--RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF-SAKVSD 370
            +     L  EN++   +  ++  A+  +HS+    I HRD+K  NI+  +   S K+ D
Sbjct: 243 VQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQNIIFSEGSGSFKIID 299

Query: 371 FGIS---RS----IPNDKTHLTTTIQGTFGYLDP------EYFQSSQ------------- 404
            G +   R     IP +           F  LDP      +Y  S+Q             
Sbjct: 300 LGAAADLRVGINYIPKE-----------F-LLDPRYAAPEQYIMSTQTPSAPSAPVATAL 347

Query: 405 --------FTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVA-------CFISLAKE 449
                     D+ D+YS G++ L++        F  +  + NL+            L   
Sbjct: 348 SPVLWQLNLPDRFDIYSAGLIFLQM-------AFPNLRSDSNLIQFNRQLKRNDYDLVAW 400

Query: 450 NQLLEILDARVAKEARE------EDIGAMAELAMRCLRLNSKKRPTMK 491
            +L+E    R + + R        D GA  EL    +R   ++R + K
Sbjct: 401 RKLVE---PRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAK 445

Length = 566

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 42.2 bits (99), Expect = 4e-04
 Identities = 54/250 (21%), Positives = 111/250 (44%), Gaps = 50/250 (20%)

Query: 259 FINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQEL 318
           F     ++SQ++H H+  + G C+     ++V E++  G L   +        +K+K  +
Sbjct: 63  FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCL--------RKEKGRV 114

Query: 319 SSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA-------KVSDF 371
             ++W  ++ VA ++A A++Y+       + H ++ + NILL     A       K+SD 
Sbjct: 115 -PVAW--KITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDP 168

Query: 372 GISRSIPNDKTHLTTTIQGTFGYLDPEYFQS-SQFTDKSDVYSFGVVLLEL-LTGKKPIC 429
           G+S +  + +  +         ++ PE     +  +  +D +SFG  LLE+   G+ P+ 
Sbjct: 169 GVSFTALSREERVE-----RIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPL- 222

Query: 430 FARVEEERNLVACFISLAKENQLLEILDARVAKEAR--EEDIGAMAELAMRCLRLNSKKR 487
                +ER       + +++ +  E       K+ R  E     +A L  +CL     +R
Sbjct: 223 -----KER-------TPSEKERFYE-------KKHRLPEPSCKELATLISQCLTYEPTQR 263

Query: 488 PTMKQVSMEL 497
           P+ + +  +L
Sbjct: 264 PSFRTILRDL 273

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 41.2 bits (96), Expect = 0.001
 Identities = 32/109 (29%), Positives = 54/109 (49%), Gaps = 12/109 (11%)

Query: 222 RFLGQGGFGTVYKGMLPDGS------IVAVKRSKEIDKTQIHQ-FINEVVILSQIN-HRH 273
           R LG G FG V +G     S       VAVK  K   ++   Q  ++E+ I++ +  H +
Sbjct: 43  RILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLN 102

Query: 274 IVKLLGCCLETEVPVLVYEYISSGTLSHHIHDH----QQQQEQKQKQEL 318
           IV LLG C ++    ++ EY   G L +++H +      +  +K K++L
Sbjct: 103 IVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDL 151

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 40.7 bits (95), Expect = 0.001
 Identities = 30/108 (27%), Positives = 48/108 (44%), Gaps = 18/108 (16%)

Query: 332 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPN------------ 379
           +   A+ Y H+   + + H D+K  NIL++   S  V D   +R++P             
Sbjct: 239 QTGVALDYFHTE--LHLMHTDLKPENILMET--SDTVVDPVTNRALPPDPCRVRICDLGG 294

Query: 380 --DKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGK 425
             D+ H  T I  T  Y  PE      +   +D++S G ++ EL TGK
Sbjct: 295 CCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGK 342

Length = 467

>gnl|CDD|236880 PRK11198, PRK11198, LysM domain/BON superfamily protein; Provisional

 Score = 38.7 bits (91), Expect = 0.002
 Identities = 19/49 (38%), Positives = 22/49 (44%), Gaps = 5/49 (10%)

Query: 57  YMAAKGDTISSIGYKF---GVDQQSILEAN--MLSKADSIFPFAPLLIP 100
           Y    GDT+S+I  K          I EAN  ML   D I+P   L IP
Sbjct: 98  YTVKSGDTLSAIAKKVYGNANKYNKIFEANKPMLKSPDKIYPGQVLRIP 146

Length = 147

>gnl|CDD|131945 TIGR02899, spore_safA, spore coat assembly protein SafA

 Score = 35.5 bits (82), Expect = 0.003
 Identities = 17/41 (41%), Positives = 25/41 (60%), Gaps = 1/41 (2%)

Query: 61  KGDTISSIGYKFGVDQQSILEAN-MLSKADSIFPFAPLLIP 100
           KGDT+  I  K+GVD   +++AN  LS  + I+P   + IP
Sbjct: 3   KGDTLWKIAKKYGVDFDELIQANPQLSNPNLIYPGMKIKIP 43

SafA (YrbB) (SafA) of Bacillus subtilis is a protein found at the interface of the spore cortex and spore coat, and is dependent on SpoVID for its localization. This model is based on the N-terminal LysM (lysin motif) domain (see pfam01476) of SafA and, from several other spore-forming species, the protein with the most similar N-terminal region. However, this set of proteins differs greatly in C-terminal of the LysM domaim; blocks of 12-residue and 13-residue repeats are found in the Bacillus cereus group, tandem LysM domains in Thermoanaerobacter tengcongensis MB4, etc. in which one of which is found in most examples of endospore-forming bacteria. Lysin motifs are repeated in many proteins [Cellular processes, Sporulation and germination]. Length = 44

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	537
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.98
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.98
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.98
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.98
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.97
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.97
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.97
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.97
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.97
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.97
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.97
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.97
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.96
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.96
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.96
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.95
KOG1152	772	consensus Signal transduction serine/threonine kin	99.95
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.95
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.94
PLN00181	793	protein SPA1-RELATED; Provisional	99.94
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.94
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.93
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.93
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.93
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.92
PRK09188	365	serine/threonine protein kinase; Provisional	99.91
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.89
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.88
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.88
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.86
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.85
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.85
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.85
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.83
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.82
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.82
PRK12274	218	serine/threonine protein kinase; Provisional	99.81
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.79
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.79
PRK10345	210	hypothetical protein; Provisional	99.78
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.76
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.76
PRK14879	211	serine/threonine protein kinase; Provisional	99.75
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.74
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.74
smart00090	237	RIO RIO-like kinase.	99.73
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.72
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.71
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.63
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.63
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.61
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.59
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.54
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.5
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.44
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.35
KOG1243	690	consensus Protein kinase [General function predict	99.31
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.29
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.27
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.18
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.18
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.17
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.16
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.16
KOG3087	229	consensus Serine/threonine protein kinase [General	99.11
PRK10783	456	mltD membrane-bound lytic murein transglycosylase	98.99
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.92
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.91
PRK06347	592	autolysin; Reviewed	98.9
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.87
COG4248	637	Uncharacterized protein with protein kinase and he	98.87
PF01476	44	LysM: LysM domain; InterPro: IPR018392 This domain	98.76
PRK09902	216	hypothetical protein; Provisional	98.66
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.63
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.6
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.56
COG1388	124	LytE FOG: LysM repeat [Cell envelope biogenesis, o	98.56
PRK06347	592	autolysin; Reviewed	98.55
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.45
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.36
PRK14125	103	cell division suppressor protein YneA; Provisional	98.32
TIGR02899	44	spore_safA spore coat assembly protein SafA. in wh	98.29
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.27
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.2
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.19
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.17
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.15
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.11
cd00118	46	LysM Lysin domain, found in a variety of enzymes i	98.06
PF01636	239	APH: Phosphotransferase enzyme family This family	98.05
PLN02876	822	acyl-CoA dehydrogenase	97.99
PRK10871	319	nlpD lipoprotein NlpD; Provisional	97.96
TIGR02907	338	spore_VI_D stage VI sporulation protein D. SpoVID,	97.93
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.83
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.78
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.77
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.67
PRK10593	297	hypothetical protein; Provisional	97.67
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.65
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.65
smart00257	44	LysM Lysin motif.	97.64
PRK10783	456	mltD membrane-bound lytic murein transglycosylase	97.63
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.62
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.56
PRK13914	481	invasion associated secreted endopeptidase; Provis	97.54
PRK05231	319	homoserine kinase; Provisional	97.52
PRK11198	147	LysM domain/BON superfamily protein; Provisional	97.46
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.3
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.29
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.16
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	97.11
PRK13914	481	invasion associated secreted endopeptidase; Provis	97.08
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.05
COG3858	423	Predicted glycosyl hydrolase [General function pre	96.97
PLN02236	344	choline kinase	96.79
KOG2268	465	consensus Serine/threonine protein kinase [Signal	96.75
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.65
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	96.48
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.03

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-61  Score=486.32  Aligned_cols=290  Identities=49%  Similarity=0.834  Sum_probs=259.1

Q ss_pred             cccccCHHHHHHHhcCCccccccCcCCceEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEE
Q 009340          202 RAKVFTADELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCC  281 (537)
Q Consensus       202 ~~~~~~~~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~  281 (537)
                      ....|+++|++.||++|+..++||+|+||.||+|.+.+|..||||++.....+...+|.+|+.++++++|||+|+|+|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            56789999999999999999999999999999999999999999988765443145699999999999999999999999


Q ss_pred             eeCC-ccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEE
Q 009340          282 LETE-VPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILL  360 (537)
Q Consensus       282 ~~~~-~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll  360 (537)
                      .+.+ ..+||||||++|||.++|+....         . .|+|..|++||.++|+||+|||+...++|+||||||+||||
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~---------~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILL  210 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKG---------E-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILL  210 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCC---------C-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeE
Confidence            9999 49999999999999999998543         1 78999999999999999999999999999999999999999


Q ss_pred             CCCCcEEEeeccCccccCC-CCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccH
Q 009340          361 DDKFSAKVSDFGISRSIPN-DKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNL  439 (537)
Q Consensus       361 ~~~~~~ki~Dfgla~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~  439 (537)
                      |+++++||+|||+|+..+. .... .+...||.+|+|||++..+..|.|+|||||||+|+||+||+++.+.........+
T Consensus       211 D~~~~aKlsDFGLa~~~~~~~~~~-~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l  289 (361)
T KOG1187|consen  211 DEDFNAKLSDFGLAKLGPEGDTSV-STTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSL  289 (361)
T ss_pred             CCCCCEEccCccCcccCCccccce-eeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccH
Confidence            9999999999999977654 2222 1111799999999999999999999999999999999999999887665566679


Q ss_pred             HHHHHHHHhhchhhhhhcHHhh-ccccH-HHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHH
Q 009340          440 VACFISLAKENQLLEILDARVA-KEARE-EDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRR  502 (537)
Q Consensus       440 ~~~~~~~~~~~~~~~~~d~~~~-~~~~~-~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~  502 (537)
                      ..|.+..+..+.+.+++|+.+. ..++. .....+..++.+|++.+|.+||+|.||+++|+.+..
T Consensus       290 ~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~  354 (361)
T KOG1187|consen  290 VEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS  354 (361)
T ss_pred             HHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence            9999999999999999999987 55554 688889999999999999999999999999966654

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-52  Score=415.65  Aligned_cols=254  Identities=31%  Similarity=0.489  Sum_probs=226.4

Q ss_pred             ccccccCcCCceEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecCCCCC
Q 009340          219 NQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGT  298 (537)
Q Consensus       219 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs  298 (537)
                      ...+.||+|.||.||.|.++....||+|.++... ...+.|.+|+++|.+++|+|||+++|+|..++..+||||||++|+
T Consensus       209 ~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~Gs  287 (468)
T KOG0197|consen  209 KLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGS  287 (468)
T ss_pred             HHHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCc
Confidence            3467899999999999999877799999998752 335789999999999999999999999999889999999999999


Q ss_pred             hhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCccccC
Q 009340          299 LSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIP  378 (537)
Q Consensus       299 L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~  378 (537)
                      |.++|....          ...+...+.+.++.|||+||+||++++   +|||||.++||||+++..+||+|||||+...
T Consensus       288 Ll~yLr~~~----------~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~  354 (468)
T KOG0197|consen  288 LLDYLRTRE----------GGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIG  354 (468)
T ss_pred             HHHHhhhcC----------CCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccC
Confidence            999998732          346899999999999999999999999   9999999999999999999999999999766


Q ss_pred             CCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHHHHHhhchhhhhhc
Q 009340          379 NDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQLLEILD  457 (537)
Q Consensus       379 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  457 (537)
                      ++.+.......-+..|+|||.+..+.||.|||||||||+||||+| |+.|+......                .+.+.++
T Consensus       355 d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~----------------ev~~~le  418 (468)
T KOG0197|consen  355 DDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE----------------EVLELLE  418 (468)
T ss_pred             CCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHH----------------HHHHHHh
Confidence            666666666677899999999999999999999999999999999 88887554332                2455677


Q ss_pred             HHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHH
Q 009340          458 ARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRR  502 (537)
Q Consensus       458 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~  502 (537)
                      ...+.+.|..|+..+++||..||+.+|++|||+..+...|+.+..
T Consensus       419 ~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~  463 (468)
T KOG0197|consen  419 RGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT  463 (468)
T ss_pred             ccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence            788888999999999999999999999999999999999988765

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-50  Score=402.71  Aligned_cols=256  Identities=34%  Similarity=0.567  Sum_probs=214.3

Q ss_pred             ccccCcCCceEEEEEEcCCCCEEEEEEccCCC--hHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCC-ccEEEEecCCCC
Q 009340          221 SRFLGQGGFGTVYKGMLPDGSIVAVKRSKEID--KTQIHQFINEVVILSQINHRHIVKLLGCCLETE-VPVLVYEYISSG  297 (537)
Q Consensus       221 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lV~e~~~~g  297 (537)
                      .+.||.|+||+||+|.++....||||++....  ....++|.+|+.+|++++|||||+|+|+|.+.. ...+||||+++|
T Consensus        46 ~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~G  125 (362)
T KOG0192|consen   46 EEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGG  125 (362)
T ss_pred             hhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCC
Confidence            45599999999999999644449999987633  223668999999999999999999999999887 789999999999


Q ss_pred             ChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCC-cEEEeeccCccc
Q 009340          298 TLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF-SAKVSDFGISRS  376 (537)
Q Consensus       298 sL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~-~~ki~Dfgla~~  376 (537)
                      +|.++++...          ...++|..+++||.|||+||.|||+.+.  ||||||||+|||++.++ ++||+|||+++.
T Consensus       126 sL~~~l~~~~----------~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~  193 (362)
T KOG0192|consen  126 SLSVLLHKKR----------KRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSRE  193 (362)
T ss_pred             cHHHHHhhcc----------cCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCcccee
Confidence            9999998741          2479999999999999999999999885  99999999999999997 999999999987


Q ss_pred             cCCCCCceeeeccccccccCccccc--CCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchhhh
Q 009340          377 IPNDKTHLTTTIQGTFGYLDPEYFQ--SSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLE  454 (537)
Q Consensus       377 ~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  454 (537)
                      ..... ...+...||+.|||||.+.  ...|+.|+|||||||+||||+||+.||.......       .        ...
T Consensus       194 ~~~~~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~-------~--------~~~  257 (362)
T KOG0192|consen  194 KVISK-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQ-------V--------ASA  257 (362)
T ss_pred             ecccc-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHH-------H--------HHH
Confidence            64332 2234467999999999999  5699999999999999999999999997544311       0        111


Q ss_pred             hhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHHhh
Q 009340          455 ILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRSQ  504 (537)
Q Consensus       455 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~  504 (537)
                      +.....+...+..+...+..|+.+||+.||+.||++.+|+.+|+.+....
T Consensus       258 v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~  307 (362)
T KOG0192|consen  258 VVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHI  307 (362)
T ss_pred             HHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhh
Confidence            12223334445557788999999999999999999999999999988743

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=2.5e-50  Score=421.86  Aligned_cols=270  Identities=29%  Similarity=0.493  Sum_probs=229.8

Q ss_pred             cCCccccccCcCCceEEEEEEcC------CCCEEEEEEccCCChH-HHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP------DGSIVAVKRSKEIDKT-QIHQFINEVVILSQINHRHIVKLLGCCLETEVPV  288 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  288 (537)
                      .+....+.||+|.||.||+|...      +...||||.++..... ..++|.+|++++..++|||||+|+|+|.+++..+
T Consensus       486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~  565 (774)
T KOG1026|consen  486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC  565 (774)
T ss_pred             hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence            44555778999999999999843      3457999999976554 7889999999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhhhhhhhHHHHhh-hc-cCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcE
Q 009340          289 LVYEYISSGTLSHHIHDHQQQQEQKQK-QE-LSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA  366 (537)
Q Consensus       289 lV~e~~~~gsL~~~l~~~~~~~~~~~~-~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~  366 (537)
                      +|+|||..|+|.+||..+.....-... +. ..+|+..+.+.||.|||.||+||-++.   +|||||..+|+||.++..+
T Consensus       566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~V  642 (774)
T KOG1026|consen  566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLVV  642 (774)
T ss_pred             EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceEE
Confidence            999999999999999876553222211 11 345999999999999999999999999   9999999999999999999


Q ss_pred             EEeeccCccccCCCCCceee-eccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHH
Q 009340          367 KVSDFGISRSIPNDKTHLTT-TIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFI  444 (537)
Q Consensus       367 ki~Dfgla~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~  444 (537)
                      ||+||||++.....+++... ...-+++||+||.+..++||++||||||||+|||++| |+.|++....++       +.
T Consensus       643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E-------VI  715 (774)
T KOG1026|consen  643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE-------VI  715 (774)
T ss_pred             EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH-------HH
Confidence            99999999998777766554 5567899999999999999999999999999999999 999987665544       33


Q ss_pred             HHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHHhh
Q 009340          445 SLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRSQ  504 (537)
Q Consensus       445 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~  504 (537)
                      ....++++         -+.|..++.++++|+..||+.+|.+||+++||-..|+......
T Consensus       716 e~i~~g~l---------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s  766 (774)
T KOG1026|consen  716 ECIRAGQL---------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS  766 (774)
T ss_pred             HHHHcCCc---------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence            33444333         3578889999999999999999999999999999999876643

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-49  Score=409.05  Aligned_cols=275  Identities=25%  Similarity=0.469  Sum_probs=234.2

Q ss_pred             ccCHHHHHHHhcCC---------ccccccCcCCceEEEEEEcC----CCCEEEEEEccCC-ChHHHHHHHHHHHHHHhcC
Q 009340          205 VFTADELQRATDNY---------NQSRFLGQGGFGTVYKGMLP----DGSIVAVKRSKEI-DKTQIHQFINEVVILSQIN  270 (537)
Q Consensus       205 ~~~~~el~~~~~~~---------~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~  270 (537)
                      .+++++--.|...|         .+.++||.|.||.||+|+++    ....||||.++.. ...+..+|+.|+.||.++.
T Consensus       609 P~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFd  688 (996)
T KOG0196|consen  609 PHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFD  688 (996)
T ss_pred             CccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCC
Confidence            45555544444333         34678999999999999975    2357999999974 4566788999999999999


Q ss_pred             CCCcceEeeEEeeCCccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeee
Q 009340          271 HRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFH  350 (537)
Q Consensus       271 H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH  350 (537)
                      ||||++|.|+.......++|+|||+||+|+.||+.+..           .++|.++.-|..+||.||.||-+.+   +||
T Consensus       689 HPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DG-----------qftviQLVgMLrGIAsGMkYLsdm~---YVH  754 (996)
T KOG0196|consen  689 HPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDG-----------QFTVIQLVGMLRGIASGMKYLSDMN---YVH  754 (996)
T ss_pred             CCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCC-----------ceEeehHHHHHHHHHHHhHHHhhcC---chh
Confidence            99999999999999999999999999999999988654           5999999999999999999999999   999


Q ss_pred             cCCCCCCEEECCCCcEEEeeccCccccCCCCCceeeec--cccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCC
Q 009340          351 RDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTI--QGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP  427 (537)
Q Consensus       351 ~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~--~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p  427 (537)
                      |||.++|||++.+..+||+||||++.+.++.....+..  .-+.+|.|||.+..+++|.+|||||||||+||.++ |.+|
T Consensus       755 RDLAARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERP  834 (996)
T KOG0196|consen  755 RDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP  834 (996)
T ss_pred             hhhhhhheeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCc
Confidence            99999999999999999999999998755543322332  23679999999999999999999999999999998 9999


Q ss_pred             CCccchhhhccHHHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHHhhHHH
Q 009340          428 ICFARVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRSQRCL  507 (537)
Q Consensus       428 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~~~~  507 (537)
                      +......+                +...++..++-+.|.+|+..|.+||+.||++|..+||.+.+|+.+|+++.++...+
T Consensus       835 YWdmSNQd----------------VIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~SL  898 (996)
T KOG0196|consen  835 YWDMSNQD----------------VIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNSL  898 (996)
T ss_pred             ccccchHH----------------HHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchhh
Confidence            76544332                33445566777889999999999999999999999999999999999999877666


Q ss_pred             hh
Q 009340          508 EM  509 (537)
Q Consensus       508 ~~  509 (537)
                      ..
T Consensus       899 k~  900 (996)
T KOG0196|consen  899 KT  900 (996)
T ss_pred             cc
Confidence            43

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-47  Score=365.59  Aligned_cols=254  Identities=30%  Similarity=0.439  Sum_probs=211.1

Q ss_pred             cCHHHHHHHhcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccC-CChHHHHHHHHHHHHHHhcCCCCcceEeeEEee
Q 009340          206 FTADELQRATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKE-IDKTQIHQFINEVVILSQINHRHIVKLLGCCLE  283 (537)
Q Consensus       206 ~~~~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~  283 (537)
                      .+..|++.       .+.||+|..|+|||++++ +++.+|+|.+.. .+....+++.+|++++++.+||+||+++|.|..
T Consensus        76 i~~~dle~-------~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~  148 (364)
T KOG0581|consen   76 ISLSDLER-------LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYS  148 (364)
T ss_pred             cCHHHhhh-------hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEe
Confidence            45555543       568999999999999975 688999999854 455667889999999999999999999999999


Q ss_pred             CCc-cEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeecCCCCCCEEEC
Q 009340          284 TEV-PVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHS-SASIPIFHRDIKSSNILLD  361 (537)
Q Consensus       284 ~~~-~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-~~~~~ivH~Dlk~~NIll~  361 (537)
                      ... ..++||||++|||++++...            +.+++...-+|+.++++||.|||+ ++   ||||||||+|||++
T Consensus       149 ~~~~isI~mEYMDgGSLd~~~k~~------------g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvN  213 (364)
T KOG0581|consen  149 NGEEISICMEYMDGGSLDDILKRV------------GRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVN  213 (364)
T ss_pred             CCceEEeehhhcCCCCHHHHHhhc------------CCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeec
Confidence            984 99999999999999999763            359999999999999999999996 66   99999999999999


Q ss_pred             CCCcEEEeeccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHH
Q 009340          362 DKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVA  441 (537)
Q Consensus       362 ~~~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~  441 (537)
                      .+|++||||||.++.+.+.   ...+.+||..|||||.+.+..|+.++||||||+.++|+.+|+.|+...... ...   
T Consensus       214 skGeVKicDFGVS~~lvnS---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~-~~~---  286 (364)
T KOG0581|consen  214 SKGEVKICDFGVSGILVNS---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPP-YLD---  286 (364)
T ss_pred             cCCCEEeccccccHHhhhh---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCC-CCC---
Confidence            9999999999999987544   456788999999999999999999999999999999999999998653110 011   


Q ss_pred             HHHHHHhhchhhhhhcHHhhccccH-HHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          442 CFISLAKENQLLEILDARVAKEARE-EDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       442 ~~~~~~~~~~~~~~~d~~~~~~~~~-~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      ++.      .+..+++. .....|. .+++++..++..||++||.+|||+.|+++
T Consensus       287 ~~~------Ll~~Iv~~-ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~  334 (364)
T KOG0581|consen  287 IFE------LLCAIVDE-PPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ  334 (364)
T ss_pred             HHH------HHHHHhcC-CCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            111      11122221 1112344 37889999999999999999999999875

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-46  Score=360.78  Aligned_cols=204  Identities=33%  Similarity=0.563  Sum_probs=184.3

Q ss_pred             hcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCC--ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEE
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI--DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY  291 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  291 (537)
                      ..+|...+.||.|.|++||+|+++ ++..||||.+...  .+...+.+..|+.+|+.++|||||++++++..++..||||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM   88 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM   88 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence            467888889999999999999965 6899999988654  5666777889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCC------Cc
Q 009340          292 EYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK------FS  365 (537)
Q Consensus       292 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~------~~  365 (537)
                      |||.+|+|.+|++..            +.+++.....+..|+|.||++||+++   ||||||||.||||+.+      -.
T Consensus        89 EyC~gGDLs~yi~~~------------~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~  153 (429)
T KOG0595|consen   89 EYCNGGDLSDYIRRR------------GRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPV  153 (429)
T ss_pred             EeCCCCCHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCce
Confidence            999999999999874            35999999999999999999999999   9999999999999865      56


Q ss_pred             EEEeeccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhh
Q 009340          366 AKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEE  435 (537)
Q Consensus       366 ~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~  435 (537)
                      +||+|||+|+.+...  ....+.+|++-|||||++...+|+.|+|+||+|++||++++|+.||......+
T Consensus       154 LKIADFGfAR~L~~~--~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~e  221 (429)
T KOG0595|consen  154 LKIADFGFARFLQPG--SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKE  221 (429)
T ss_pred             EEecccchhhhCCch--hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHH
Confidence            899999999998643  34567889999999999999999999999999999999999999998665544

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.6e-47  Score=350.36  Aligned_cols=259  Identities=26%  Similarity=0.435  Sum_probs=212.0

Q ss_pred             cCCccccccCcCCceEEEEEE-cCCCCEEEEEEcc--CCChHHHHHHHHHHHHHHhcCCCCcceEee-EEeeCC-ccEEE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSK--EIDKTQIHQFINEVVILSQINHRHIVKLLG-CCLETE-VPVLV  290 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~H~niv~l~g-~~~~~~-~~~lV  290 (537)
                      .+|...++||.|.||+|||+. +.+|..||.|.++  ..+....+....|+.+|++++|||||++++ .+.++. ..+||
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            356678899999999999998 5689999999876  345666788999999999999999999998 444444 48999


Q ss_pred             EecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCC-CCeeecCCCCCCEEECCCCcEEEe
Q 009340          291 YEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSAS-IPIFHRDIKSSNILLDDKFSAKVS  369 (537)
Q Consensus       291 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~-~~ivH~Dlk~~NIll~~~~~~ki~  369 (537)
                      |||++.|+|...++..+..        .+.+++..+++++.|++.||..+|+.-. ..|+||||||.||+|+++|.+|++
T Consensus        99 mE~c~~GDLsqmIk~~K~q--------kr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLG  170 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQ--------KRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLG  170 (375)
T ss_pred             HHhhcccCHHHHHHHHHhc--------cccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeec
Confidence            9999999999999876542        4579999999999999999999999321 239999999999999999999999


Q ss_pred             eccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhh
Q 009340          370 DFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKE  449 (537)
Q Consensus       370 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  449 (537)
                      ||||++.+..... .....+|||.||+||.+.+..|+.||||||+||++|||..-+.||......+       +.....+
T Consensus       171 DfGL~r~l~s~~t-fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~-------L~~KI~q  242 (375)
T KOG0591|consen  171 DFGLGRFLSSKTT-FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLS-------LCKKIEQ  242 (375)
T ss_pred             cchhHhHhcchhH-HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHH-------HHHHHHc
Confidence            9999999866543 3566789999999999999999999999999999999999999997652211       2222222


Q ss_pred             chhhhhhcHHhhcccc-HHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHH
Q 009340          450 NQLLEILDARVAKEAR-EEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEG  499 (537)
Q Consensus       450 ~~~~~~~d~~~~~~~~-~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  499 (537)
                      +..         .+.| .-++..+.+|+..|+..||+.||+...++..+..
T Consensus       243 gd~---------~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~  284 (375)
T KOG0591|consen  243 GDY---------PPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS  284 (375)
T ss_pred             CCC---------CCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence            221         2234 5567889999999999999999996555555543

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.4e-46  Score=375.06  Aligned_cols=247  Identities=28%  Similarity=0.467  Sum_probs=213.7

Q ss_pred             cCCccccccCcCCceEEEEEEc-CCCCEEEEEEccC---CChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKE---IDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY  291 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  291 (537)
                      ..|...+.||+|||..+|.++. ..|+.||+|++..   ....+.+...+|++|.++|+|||||+++++|++.+..|+|.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            4688899999999999999996 7899999998865   23456778899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeec
Q 009340          292 EYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF  371 (537)
Q Consensus       292 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Df  371 (537)
                      |+|++++|..+++.            .+++++.++..+..||+.||.|||+++   |+|||||..|+||++++++||+||
T Consensus        98 ELC~~~sL~el~Kr------------rk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDF  162 (592)
T KOG0575|consen   98 ELCHRGSLMELLKR------------RKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDF  162 (592)
T ss_pred             EecCCccHHHHHHh------------cCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEeccc
Confidence            99999999999974            457999999999999999999999999   999999999999999999999999


Q ss_pred             cCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhch
Q 009340          372 GISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQ  451 (537)
Q Consensus       372 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  451 (537)
                      |||..+..+. ....+.+||+.|+|||++.....+..+||||+||++|.|+.|++||+.....+.      +... .   
T Consensus       163 GLAt~le~~~-Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vket------y~~I-k---  231 (592)
T KOG0575|consen  163 GLATQLEYDG-ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKET------YNKI-K---  231 (592)
T ss_pred             ceeeeecCcc-cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHH------HHHH-H---
Confidence            9999886443 345678999999999999988899999999999999999999999987654432      1111 1   


Q ss_pred             hhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          452 LLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       452 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      ..+       ...|...+.+..+|+.++|+.||.+|||+.+|+.
T Consensus       232 ~~~-------Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  232 LNE-------YSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             hcC-------cccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            111       1234455667889999999999999999999974

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-46  Score=406.07  Aligned_cols=268  Identities=28%  Similarity=0.516  Sum_probs=225.1

Q ss_pred             cCCccccccCcCCceEEEEEEcCC--CC----EEEEEEccCC-ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLPD--GS----IVAVKRSKEI-DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPV  288 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~~--g~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  288 (537)
                      .+.+..+.||+|.||.||.|.+.+  |.    .||||.++.. +.+...+|++|..+|++++|||||+++|+|.+....+
T Consensus       692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~  771 (1025)
T KOG1095|consen  692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL  771 (1025)
T ss_pred             hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence            455567889999999999999653  43    4999999864 5667889999999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEE
Q 009340          289 LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKV  368 (537)
Q Consensus       289 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki  368 (537)
                      +++|||++|+|..||++.+.....     ...|+..+.+.++.|||+|+.||++++   +|||||.++|+||+....+||
T Consensus       772 i~leyM~gGDL~sflr~~r~~~~~-----~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKI  843 (1025)
T KOG1095|consen  772 ILLEYMEGGDLLSFLRESRPAPFQ-----PSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKI  843 (1025)
T ss_pred             EEehhcccCcHHHHHHhcccccCC-----CCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEE
Confidence            999999999999999987543221     346999999999999999999999999   999999999999999999999


Q ss_pred             eeccCccccCCCCCceeeec-cccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHHHH
Q 009340          369 SDFGISRSIPNDKTHLTTTI-QGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISL  446 (537)
Q Consensus       369 ~Dfgla~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~  446 (537)
                      +|||||+.+....++..... .-+.+|||||.+..+.||.|+|||||||+|||++| |..|+...+..+.      +...
T Consensus       844 aDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v------~~~~  917 (1025)
T KOG1095|consen  844 ADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEV------LLDV  917 (1025)
T ss_pred             cccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHH------HHHH
Confidence            99999997766666555443 45679999999999999999999999999999999 8888765433221      1111


Q ss_pred             HhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHHhhHHH
Q 009340          447 AKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRSQRCL  507 (537)
Q Consensus       447 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~~~~  507 (537)
                      ...+          +.+.|..|+..+++||.+||+.+|++||++..|++++..+.....--
T Consensus       918 ~~gg----------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~  968 (1025)
T KOG1095|consen  918 LEGG----------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGT  968 (1025)
T ss_pred             HhCC----------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccC
Confidence            1212          34567788899999999999999999999999999999888754433

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.3e-45  Score=352.07  Aligned_cols=251  Identities=27%  Similarity=0.413  Sum_probs=203.7

Q ss_pred             HhcCCccccccCcCCceEEEEEEc-CCCCEEEEEEccCC-----Ch--HHHHHHHHHHHHHHhcCCCCcceEeeEEeeCC
Q 009340          214 ATDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEI-----DK--TQIHQFINEVVILSQINHRHIVKLLGCCLETE  285 (537)
Q Consensus       214 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~-----~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~  285 (537)
                      ..+.|...+.||+|+||.|-+|.. ++|+.||||+++..     +.  .......+|+++|++++|||||++.+++...+
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            346677789999999999999994 57999999988642     11  11223469999999999999999999999999


Q ss_pred             ccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCC--
Q 009340          286 VPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK--  363 (537)
Q Consensus       286 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~--  363 (537)
                      ..|+|+||+++|.|.+++-.+.            .+.+..-..++.|++.|+.|||+.|   |+||||||+|||+..+  
T Consensus       250 s~YmVlE~v~GGeLfd~vv~nk------------~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e  314 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVVANK------------YLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAE  314 (475)
T ss_pred             ceEEEEEEecCccHHHHHHhcc------------ccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCc
Confidence            9999999999999999998754            4666667889999999999999999   9999999999999766  


Q ss_pred             -CcEEEeeccCccccCCCCCceeeeccccccccCcccccCCCC---CcchhHHHHHHHHHHHHhCCCCCCccchhhhccH
Q 009340          364 -FSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQF---TDKSDVYSFGVVLLELLTGKKPICFARVEEERNL  439 (537)
Q Consensus       364 -~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~  439 (537)
                       ..+||+|||+|+..+  ....+.+.+||+.|.|||++.+..+   ..|+|+||+||+||-+++|..||........   
T Consensus       315 ~~llKItDFGlAK~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s---  389 (475)
T KOG0615|consen  315 DCLLKITDFGLAKVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS---  389 (475)
T ss_pred             ceEEEecccchhhccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc---
Confidence             889999999999875  3455788999999999999977543   3488999999999999999999965433210   


Q ss_pred             HHHHHHHHhhchhhhhhcHHhh--ccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          440 VACFISLAKENQLLEILDARVA--KEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       440 ~~~~~~~~~~~~~~~~~d~~~~--~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                         ...        ++...++.  .......+.+..+|+.+||..||++|||+.|+++
T Consensus       390 ---l~e--------QI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  390 ---LKE--------QILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             ---HHH--------HHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence               111        11111211  1233456678899999999999999999999875

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-44  Score=367.05  Aligned_cols=259  Identities=30%  Similarity=0.516  Sum_probs=215.6

Q ss_pred             cCCccccccCcCCceEEEEEEcCC--C--CE-EEEEEccC---CChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCcc
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLPD--G--SI-VAVKRSKE---IDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVP  287 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~~--g--~~-vavK~~~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~  287 (537)
                      ++....++||+|+||.||+|++..  +  .. ||||..+.   ....+..+|++|+++|++++|||||+++|++......
T Consensus       157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl  236 (474)
T KOG0194|consen  157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL  236 (474)
T ss_pred             cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence            444556899999999999999653  2  23 89999885   4577889999999999999999999999999999999


Q ss_pred             EEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEE
Q 009340          288 VLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK  367 (537)
Q Consensus       288 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~k  367 (537)
                      ++|||+|.+|+|.++|.....           .++..+++.++.++|.||+|||+.+   ++||||.++|+|++.++.+|
T Consensus       237 ~ivmEl~~gGsL~~~L~k~~~-----------~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vK  302 (474)
T KOG0194|consen  237 MLVMELCNGGSLDDYLKKNKK-----------SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVK  302 (474)
T ss_pred             EEEEEecCCCcHHHHHHhCCC-----------CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEE
Confidence            999999999999999987542           5999999999999999999999999   99999999999999999999


Q ss_pred             EeeccCccccCCCCCceee-eccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHHH
Q 009340          368 VSDFGISRSIPNDKTHLTT-TIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFIS  445 (537)
Q Consensus       368 i~Dfgla~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~  445 (537)
                      |+||||++...  ...... ...-+.+|+|||.+..+.||.++|||||||++||+++ |..|+......+       ...
T Consensus       303 ISDFGLs~~~~--~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~-------v~~  373 (474)
T KOG0194|consen  303 ISDFGLSRAGS--QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYE-------VKA  373 (474)
T ss_pred             eCccccccCCc--ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHH-------HHH
Confidence            99999987643  111111 2245789999999999999999999999999999999 888986543321       111


Q ss_pred             HHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHHhhH
Q 009340          446 LAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRSQR  505 (537)
Q Consensus       446 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~~  505 (537)
                              .++....+...+...+..+..++.+||..+|++||+|.++.+.|+.+.....
T Consensus       374 --------kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~  425 (474)
T KOG0194|consen  374 --------KIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE  425 (474)
T ss_pred             --------HHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence                    1112233344455667788899999999999999999999999999887543

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-44  Score=364.24  Aligned_cols=283  Identities=27%  Similarity=0.490  Sum_probs=220.9

Q ss_pred             cCHHHHHHHhcCCccccccCcCCceEEEEEEcCCCCEEEEEEccC--CChHHHHHHHHHHHHHHhcCCCCcceEeeEEee
Q 009340          206 FTADELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKE--IDKTQIHQFINEVVILSQINHRHIVKLLGCCLE  283 (537)
Q Consensus       206 ~~~~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~  283 (537)
                      .+.++++...+.+.....||+|.||+||+|.|. |. ||||.++.  -..++.+.|.+|+..+++-+|.||+-|.|+|..
T Consensus       382 ~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh-Gd-VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~  459 (678)
T KOG0193|consen  382 DSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWH-GD-VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN  459 (678)
T ss_pred             ccccccccCHHHhhccceeccccccceeecccc-cc-eEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC
Confidence            344666666677778899999999999999995 43 99999875  345678999999999999999999999999998


Q ss_pred             CCccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCC
Q 009340          284 TEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK  363 (537)
Q Consensus       284 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~  363 (537)
                      ... .+|+.+|++-+|..++|....           .++..+.++||.|||+||.|||.++   |||||||+.||||.++
T Consensus       460 p~~-AIiTqwCeGsSLY~hlHv~et-----------kfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~  524 (678)
T KOG0193|consen  460 PPL-AIITQWCEGSSLYTHLHVQET-----------KFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHED  524 (678)
T ss_pred             Cce-eeeehhccCchhhhhccchhh-----------hhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccC
Confidence            877 999999999999999997643           6889999999999999999999999   9999999999999999


Q ss_pred             CcEEEeeccCccccCC-CCCceeeeccccccccCcccccC---CCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccH
Q 009340          364 FSAKVSDFGISRSIPN-DKTHLTTTIQGTFGYLDPEYFQS---SQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNL  439 (537)
Q Consensus       364 ~~~ki~Dfgla~~~~~-~~~~~~~~~~gt~~y~aPE~~~~---~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~  439 (537)
                      +.|||+||||+..-.. ..........|...|||||++..   .+|+.++||||||+|+|||++|..|+.....+..   
T Consensus       525 ~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqI---  601 (678)
T KOG0193|consen  525 LKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQI---  601 (678)
T ss_pred             CcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhhe---
Confidence            9999999999864311 11111223447889999999864   4799999999999999999999999862221110   


Q ss_pred             HHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHHhhHHHhh-hhhhhhhc
Q 009340          440 VACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRSQRCLEM-CQVNQLLA  517 (537)
Q Consensus       440 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~~~~~~-~~~~~~l~  517 (537)
                          .-+...+    .+.+++. .....+..+|.+|+..||..++++||.+.+|+.+|+.+..+...++. +..|.++.
T Consensus       602 ----ifmVGrG----~l~pd~s-~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~pki~RS~S~P~~~~  671 (678)
T KOG0193|consen  602 ----IFMVGRG----YLMPDLS-KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSLPKINRSASEPVLLR  671 (678)
T ss_pred             ----EEEeccc----ccCccch-hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcccccccCcCccchhh
Confidence                0000111    0111111 12345667899999999999999999999999999988875433333 33444433

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-44  Score=361.13  Aligned_cols=263  Identities=25%  Similarity=0.442  Sum_probs=229.5

Q ss_pred             HHHHHhcCCccccccCcCCceEEEEEEcCC-CCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccE
Q 009340          210 ELQRATDNYNQSRFLGQGGFGTVYKGMLPD-GSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPV  288 (537)
Q Consensus       210 el~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  288 (537)
                      +++--..+....++||.|.||.||-|+|+. .-.||||.+++. ....++|+.|+.+|+.++|||+|+|+|+|..+...|
T Consensus       261 kWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFY  339 (1157)
T KOG4278|consen  261 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFY  339 (1157)
T ss_pred             hhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeE
Confidence            333334455667899999999999999874 567999999874 345789999999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEE
Q 009340          289 LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKV  368 (537)
Q Consensus       289 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki  368 (537)
                      +|+|||.+|+|.++|+....          ..++--..+.||.||+.||+||..++   +|||||.++|+|+.++..+||
T Consensus       340 IiTEfM~yGNLLdYLRecnr----------~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKv  406 (1157)
T KOG4278|consen  340 IITEFMCYGNLLDYLRECNR----------SEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKV  406 (1157)
T ss_pred             EEEecccCccHHHHHHHhch----------hhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEe
Confidence            99999999999999988654          34777788999999999999999999   999999999999999999999


Q ss_pred             eeccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHHHHH
Q 009340          369 SDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLA  447 (537)
Q Consensus       369 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~  447 (537)
                      +||||++++..+.+.......-++.|.|||.+....++.|+|||+|||+||||.| |..|+..-+.              
T Consensus       407 ADFGLsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl--------------  472 (1157)
T KOG4278|consen  407 ADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--------------  472 (1157)
T ss_pred             eccchhhhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH--------------
Confidence            9999999998776655555666889999999999999999999999999999999 8888753321              


Q ss_pred             hhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHH
Q 009340          448 KENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRR  502 (537)
Q Consensus       448 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~  502 (537)
                        .++-+++...++.+.+..|++.+++|+.+||+++|.+||++.||-+.++.+-.
T Consensus       473 --SqVY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~  525 (1157)
T KOG4278|consen  473 --SQVYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS  525 (1157)
T ss_pred             --HHHHHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence              22445667788888999999999999999999999999999999999987754

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-43  Score=342.70  Aligned_cols=268  Identities=25%  Similarity=0.378  Sum_probs=201.4

Q ss_pred             CCccccccCcCCceEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHHHHhc--CCCCcceEeeEEeeCC----ccEEE
Q 009340          217 NYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQI--NHRHIVKLLGCCLETE----VPVLV  290 (537)
Q Consensus       217 ~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~H~niv~l~g~~~~~~----~~~lV  290 (537)
                      .....++||+|+||.||||++. ++.||||++..   +..+.|.+|-.|.+..  +|+||++|++.-....    ..+||
T Consensus       211 pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV  286 (534)
T KOG3653|consen  211 PLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV  286 (534)
T ss_pred             chhhHHHhhcCccceeehhhcc-CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence            3445678999999999999995 68999999985   4456788888887764  8999999999865444    78999


Q ss_pred             EecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhc------CCCCeeecCCCCCCEEECCCC
Q 009340          291 YEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSS------ASIPIFHRDIKSSNILLDDKF  364 (537)
Q Consensus       291 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~------~~~~ivH~Dlk~~NIll~~~~  364 (537)
                      +||.++|||.+||..+             .++|....+|+..+++||+|||+.      .+|+|+|||||++||||.+|+
T Consensus       287 t~fh~kGsL~dyL~~n-------------tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~Dl  353 (534)
T KOG3653|consen  287 TEFHPKGSLCDYLKAN-------------TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDL  353 (534)
T ss_pred             eeeccCCcHHHHHHhc-------------cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCC
Confidence            9999999999999864             699999999999999999999974      357899999999999999999


Q ss_pred             cEEEeeccCccccCCCCCc-eeeeccccccccCcccccCCC-CC-----cchhHHHHHHHHHHHHhCCCCCCccchhh-h
Q 009340          365 SAKVSDFGISRSIPNDKTH-LTTTIQGTFGYLDPEYFQSSQ-FT-----DKSDVYSFGVVLLELLTGKKPICFARVEE-E  436 (537)
Q Consensus       365 ~~ki~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-~t-----~ksDV~S~Gvll~el~tg~~p~~~~~~~~-~  436 (537)
                      ++.|+|||||..+...... .....+||.+|||||++.+.. +.     .+.||||+|.|||||+++...++.....+ .
T Consensus       354 TccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yq  433 (534)
T KOG3653|consen  354 TCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQ  433 (534)
T ss_pred             cEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCccc
Confidence            9999999999887544332 223467999999999987532 22     37999999999999999766553211111 1


Q ss_pred             cc---------HHHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHHhh
Q 009340          437 RN---------LVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRSQ  504 (537)
Q Consensus       437 ~~---------~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~  504 (537)
                      ..         -.+..+...-..+.+..+-.....   ......+.+.+..||..||+.|.|+.=|-+++.++....
T Consensus       434 lpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~---h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~  507 (534)
T KOG3653|consen  434 LPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRK---HAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW  507 (534)
T ss_pred             CchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhc---CccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence            11         111111111111111111111111   134567889999999999999999999999888777643

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=3.3e-43  Score=357.55  Aligned_cols=271  Identities=28%  Similarity=0.452  Sum_probs=209.7

Q ss_pred             HhcCCccccccCcCCceEEEEEEc------CCCCEEEEEEccCCC-hHHHHHHHHHHHHHHhc-CCCCcceEeeEEeeCC
Q 009340          214 ATDNYNQSRFLGQGGFGTVYKGML------PDGSIVAVKRSKEID-KTQIHQFINEVVILSQI-NHRHIVKLLGCCLETE  285 (537)
Q Consensus       214 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~  285 (537)
                      ..++|...++||+|+||.||+|..      .+++.||||+++... ....+.+.+|+.++.++ +||||++++++|...+
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (338)
T cd05102           5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN   84 (338)
T ss_pred             chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence            346788899999999999999973      235689999987532 34456789999999999 8999999999987654


Q ss_pred             -ccEEEEecCCCCChhhhhhhhhhhHHH--------------------------------------------------Hh
Q 009340          286 -VPVLVYEYISSGTLSHHIHDHQQQQEQ--------------------------------------------------KQ  314 (537)
Q Consensus       286 -~~~lV~e~~~~gsL~~~l~~~~~~~~~--------------------------------------------------~~  314 (537)
                       ..++||||+++|+|.+++.........                                                  ..
T Consensus        85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (338)
T cd05102          85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD  164 (338)
T ss_pred             CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence             578999999999999999764321000                                                  00


Q ss_pred             hhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCccccCCCCCc-eeeecccccc
Q 009340          315 KQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTH-LTTTIQGTFG  393 (537)
Q Consensus       315 ~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~-~~~~~~gt~~  393 (537)
                      ......+++..++.++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||+++........ ......++..
T Consensus       165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~  241 (338)
T cd05102         165 DLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK  241 (338)
T ss_pred             ccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence            001235889999999999999999999998   999999999999999999999999999865433222 1223456788


Q ss_pred             ccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHHHHHhhchhhhhhcHHhhccccHHHHHHH
Q 009340          394 YLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAM  472 (537)
Q Consensus       394 y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l  472 (537)
                      |+|||++.+..++.++||||||+++|||++ |..||......+.      +......+.         ....+...+..+
T Consensus       242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~------~~~~~~~~~---------~~~~~~~~~~~l  306 (338)
T cd05102         242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE------FCQRLKDGT---------RMRAPENATPEI  306 (338)
T ss_pred             ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH------HHHHHhcCC---------CCCCCCCCCHHH
Confidence            999999999999999999999999999997 9999865332211      111111111         011123345678


Q ss_pred             HHHHHHhcccCCCCCCCHhhHHHHHHHHHH
Q 009340          473 AELAMRCLRLNSKKRPTMKQVSMELEGLRR  502 (537)
Q Consensus       473 ~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~  502 (537)
                      .+|+.+||+.||++|||+.+++++|+.+..
T Consensus       307 ~~li~~cl~~dp~~RPs~~el~~~l~~~~~  336 (338)
T cd05102         307 YRIMLACWQGDPKERPTFSALVEILGDLLQ  336 (338)
T ss_pred             HHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            899999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-43  Score=351.46  Aligned_cols=264  Identities=27%  Similarity=0.429  Sum_probs=217.1

Q ss_pred             hcCCccccccCcCCceEEEEEEcCCCCEEEEEEccCCC-hHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEec
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEID-KTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY  293 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  293 (537)
                      .......++||+|.||.|.......+..||||+++... +....+|.+|+++|.+++||||++++|+|..++..++|+||
T Consensus       537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY  616 (807)
T KOG1094|consen  537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY  616 (807)
T ss_pred             hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence            34555678999999999999999778999999999754 44568999999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccC
Q 009340          294 ISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGI  373 (537)
Q Consensus       294 ~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgl  373 (537)
                      |++|+|.+|+..+..          ..+.-..-.+|+.|||.||+||.+.+   +|||||.++|+|+|.++++||+|||+
T Consensus       617 mEnGDLnqFl~ahea----------pt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgm  683 (807)
T KOG1094|consen  617 MENGDLNQFLSAHEL----------PTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGM  683 (807)
T ss_pred             HhcCcHHHHHHhccC----------cccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCccc
Confidence            999999999987643          12345566789999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCCcee-eeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh--CCCCCCccchhhhccHHHHHHHHHhhc
Q 009340          374 SRSIPNDKTHLT-TTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT--GKKPICFARVEEERNLVACFISLAKEN  450 (537)
Q Consensus       374 a~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t--g~~p~~~~~~~~~~~~~~~~~~~~~~~  450 (537)
                      ++.+..+.++.. ...+-+++|||||.+..+++|++||||+|||.+||+++  ...|+.....+..   ++..-.+....
T Consensus       684 sR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~v---ven~~~~~~~~  760 (807)
T KOG1094|consen  684 SRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQV---VENAGEFFRDQ  760 (807)
T ss_pred             ccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHH---HHhhhhhcCCC
Confidence            998866666544 45667899999999999999999999999999999876  7778765433321   11111111111


Q ss_pred             hhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHH
Q 009340          451 QLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGL  500 (537)
Q Consensus       451 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i  500 (537)
                            ........|.-++..+++++.+||+.+..+||+++++...|+..
T Consensus       761 ------~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  761 ------GRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             ------CcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence                  01112234667788999999999999999999999999888754

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.3e-42  Score=344.23  Aligned_cols=260  Identities=20%  Similarity=0.335  Sum_probs=207.4

Q ss_pred             ccccCHHHHHHHhcCCccccccCcCCceEEEEEEcCCCCEEEEEEccCCCh---HHHHHHHHHHHHHHhcCCCCcceEee
Q 009340          203 AKVFTADELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDK---TQIHQFINEVVILSQINHRHIVKLLG  279 (537)
Q Consensus       203 ~~~~~~~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g  279 (537)
                      .+.++.+++.     ......||+|++|.||+|.+ +|+.||||+++....   ...+.|.+|+.+|++++||||++++|
T Consensus        12 ~~~i~~~~i~-----~~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g   85 (283)
T PHA02988         12 IKCIESDDID-----KYTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYG   85 (283)
T ss_pred             ceecCHHHcC-----CCCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEee
Confidence            3445556652     22245799999999999999 688999999875432   22577889999999999999999999


Q ss_pred             EEee----CCccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeeecCCC
Q 009340          280 CCLE----TEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSS-ASIPIFHRDIK  354 (537)
Q Consensus       280 ~~~~----~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~-~~~~ivH~Dlk  354 (537)
                      ++.+    ....++||||+++|+|.+++...            ..++|...++++.+++.||.|||+. +   ++|||||
T Consensus        86 ~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~------------~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlk  150 (283)
T PHA02988         86 FIIDIVDDLPRLSLILEYCTRGYLREVLDKE------------KDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLT  150 (283)
T ss_pred             eEEecccCCCceEEEEEeCCCCcHHHHHhhC------------CCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCC
Confidence            9977    34678999999999999999753            3589999999999999999999985 6   7799999


Q ss_pred             CCCEEECCCCcEEEeeccCccccCCCCCceeeeccccccccCcccccC--CCCCcchhHHHHHHHHHHHHhCCCCCCccc
Q 009340          355 SSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQS--SQFTDKSDVYSFGVVLLELLTGKKPICFAR  432 (537)
Q Consensus       355 ~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~ksDV~S~Gvll~el~tg~~p~~~~~  432 (537)
                      |+|||+++++.+||+|||+++......    ....++..|+|||.+.+  ..++.++|||||||++|||++|+.||....
T Consensus       151 p~nill~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~  226 (283)
T PHA02988        151 SVSFLVTENYKLKIICHGLEKILSSPP----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT  226 (283)
T ss_pred             hhhEEECCCCcEEEcccchHhhhcccc----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCC
Confidence            999999999999999999998654322    23457899999999976  689999999999999999999999997543


Q ss_pred             hhhhccHHHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHH
Q 009340          433 VEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRR  502 (537)
Q Consensus       433 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~  502 (537)
                      ..+.      +......         ......+..++..+.+++.+||+.||++|||+.++++.|+.+..
T Consensus       227 ~~~~------~~~i~~~---------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~  281 (283)
T PHA02988        227 TKEI------YDLIINK---------NNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF  281 (283)
T ss_pred             HHHH------HHHHHhc---------CCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence            2211      1111111         11112233456678999999999999999999999999998763

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-43  Score=340.47  Aligned_cols=293  Identities=23%  Similarity=0.350  Sum_probs=218.9

Q ss_pred             hhhhhcccCCCccccccCHHHHHHHhcCCccccccCcCCceEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHHHHhc
Q 009340          190 LQQQLSSCGSSERAKVFTADELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQI  269 (537)
Q Consensus       190 ~~~~~~~~~~~~~~~~~~~~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l  269 (537)
                      +...+.....+.+...+.+--.+....+....+.||+|.||.||+|.|+ |+.||||++...++   ..+.+|.+|.+.+
T Consensus       185 l~Dll~~~~tSGSGSGlplLVQRTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE---~SWfrEtEIYqTv  260 (513)
T KOG2052|consen  185 LKDLLDDLETSGSGSGLPLLVQRTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDE---RSWFRETEIYQTV  260 (513)
T ss_pred             HHHHHHhhccCCCCCCchhHhHHhhhheeEEEEEecCccccceeecccc-CCceEEEEecccch---hhhhhHHHHHHHH
Confidence            3333333334444445555555666778888999999999999999995 88999999986443   4677888888875


Q ss_pred             --CCCCcceEeeEEeeCC----ccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh--
Q 009340          270 --NHRHIVKLLGCCLETE----VPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMH--  341 (537)
Q Consensus       270 --~H~niv~l~g~~~~~~----~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH--  341 (537)
                        +|+||+.|++.-..+.    .+|||++|.++|||.|||..             ..++-...++++..+|.||++||  
T Consensus       261 mLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r-------------~tv~~~~ml~LalS~AsGLaHLH~e  327 (513)
T KOG2052|consen  261 MLRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNR-------------NTVTTEGMLKLALSIASGLAHLHME  327 (513)
T ss_pred             HhccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhh-------------ccCCHHHHHHHHHHHhhhHHHHHHH
Confidence              9999999998865443    57999999999999999975             36899999999999999999999  


Q ss_pred             ---hcCCCCeeecCCCCCCEEECCCCcEEEeeccCccccCCCCCc---eeeeccccccccCcccccCCC----CC--cch
Q 009340          342 ---SSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTH---LTTTIQGTFGYLDPEYFQSSQ----FT--DKS  409 (537)
Q Consensus       342 ---~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~----~t--~ks  409 (537)
                         .+++|.|.|||||+.|||++.++++.|+|+|||.....+...   .....+||.+|||||++.+..    |.  ..+
T Consensus       328 I~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~A  407 (513)
T KOG2052|consen  328 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRA  407 (513)
T ss_pred             HhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHH
Confidence               468899999999999999999999999999999876544322   235678999999999986532    22  379


Q ss_pred             hHHHHHHHHHHHHhC----------CCCCCccchhhhccHHHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHh
Q 009340          410 DVYSFGVVLLELLTG----------KKPICFARVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRC  479 (537)
Q Consensus       410 DV~S~Gvll~el~tg----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c  479 (537)
                      ||||||.|+||+.-+          +.||+...+.+. + ........-..+++..+..+.   ...++...+.++++.|
T Consensus       408 DIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DP-s-~eeMrkVVCv~~~RP~ipnrW---~s~~~l~~m~klMkeC  482 (513)
T KOG2052|consen  408 DIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDP-S-FEEMRKVVCVQKLRPNIPNRW---KSDPALRVMAKLMKEC  482 (513)
T ss_pred             HHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCC-C-HHHHhcceeecccCCCCCccc---ccCHHHHHHHHHHHHh
Confidence            999999999999742          244443222211 0 000111111111221111111   2356678899999999


Q ss_pred             cccCCCCCCCHhhHHHHHHHHHHhh
Q 009340          480 LRLNSKKRPTMKQVSMELEGLRRSQ  504 (537)
Q Consensus       480 l~~~p~~RPs~~ev~~~L~~i~~~~  504 (537)
                      |..||.-|-|+-.|.+.|.++.++.
T Consensus       483 W~~Np~aRltALriKKtl~~l~~~~  507 (513)
T KOG2052|consen  483 WYANPAARLTALRIKKTLAKLSNSD  507 (513)
T ss_pred             hcCCchhhhHHHHHHHHHHHHhcCh
Confidence            9999999999999999999988644

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=2e-43  Score=327.78  Aligned_cols=276  Identities=24%  Similarity=0.353  Sum_probs=210.2

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCC--ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEe
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI--DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE  292 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e  292 (537)
                      +.|+...++|+|+||.|||.+.+ +|+.||||++.+.  ++...+-.++|+++|++++|+|+|.++++|.....++||+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            35677789999999999999966 6999999998753  34445567899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeecc
Q 009340          293 YISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG  372 (537)
Q Consensus       293 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfg  372 (537)
                      |++..-| +-|....           .-++.....+++.|+++|+.|+|+++   ++||||||+|||++.++.+||||||
T Consensus        82 ~~dhTvL-~eLe~~p-----------~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFG  146 (396)
T KOG0593|consen   82 YCDHTVL-HELERYP-----------NGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFG  146 (396)
T ss_pred             ecchHHH-HHHHhcc-----------CCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccch
Confidence            9988444 4443322           24888999999999999999999999   9999999999999999999999999


Q ss_pred             CccccCCCCCceeeeccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHH--------HH
Q 009340          373 ISRSIPNDKTHLTTTIQGTFGYLDPEYFQS-SQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVA--------CF  443 (537)
Q Consensus       373 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~--------~~  443 (537)
                      +|+.+.. .....+..+.|.+|.|||.+.+ .+|...+||||+||++.||++|.+-|...++-+...++.        ..
T Consensus       147 FAR~L~~-pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prh  225 (396)
T KOG0593|consen  147 FARTLSA-PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRH  225 (396)
T ss_pred             hhHhhcC-CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHH
Confidence            9998864 2233466778999999999877 789999999999999999999999887655443322111        11


Q ss_pred             HHHHhhc------hhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH--HHHHHHHhhHHH
Q 009340          444 ISLAKEN------QLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM--ELEGLRRSQRCL  507 (537)
Q Consensus       444 ~~~~~~~------~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~--~L~~i~~~~~~~  507 (537)
                      .+.+...      .+.+.-++.-.+..-...+..+.+++..||+.||++|++-++++.  .++.+.......
T Consensus       226 q~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~~er~~~~  297 (396)
T KOG0593|consen  226 QSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGFIERELKA  297 (396)
T ss_pred             HHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHHHHHHHHH
Confidence            1111111      111111111111112334557889999999999999999999874  234444433333

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-44  Score=356.24  Aligned_cols=243  Identities=26%  Similarity=0.474  Sum_probs=206.1

Q ss_pred             cccccCcCCceEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecCCCCCh
Q 009340          220 QSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTL  299 (537)
Q Consensus       220 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL  299 (537)
                      ..+.||.|+.|.||+|++. ++.||||+++....       .+|+.|++|+|+||+.|.|+|......++|||||..|.|
T Consensus       128 ELeWlGSGaQGAVF~Grl~-netVAVKKV~elkE-------TdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL  199 (904)
T KOG4721|consen  128 ELEWLGSGAQGAVFLGRLH-NETVAVKKVRELKE-------TDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQL  199 (904)
T ss_pred             hhhhhccCcccceeeeecc-CceehhHHHhhhhh-------hhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccH
Confidence            3567999999999999995 67899999875322       478899999999999999999999999999999999999


Q ss_pred             hhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCccccCC
Q 009340          300 SHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPN  379 (537)
Q Consensus       300 ~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~  379 (537)
                      ...|+..            ..++-.....+..+||.||.|||.+.   |||||||+=||||+.+..+||+|||-++....
T Consensus       200 ~~VLka~------------~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~  264 (904)
T KOG4721|consen  200 YEVLKAG------------RPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSD  264 (904)
T ss_pred             HHHHhcc------------CccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhh
Confidence            9999873            46888889999999999999999999   99999999999999999999999999987644


Q ss_pred             CCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchhhhhhcHH
Q 009340          380 DKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEILDAR  459 (537)
Q Consensus       380 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  459 (537)
                      -  .......||..|||||++.+.+.++|+||||||||||||+||..|+..-....               -+..+-...
T Consensus       265 ~--STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA---------------IIwGVGsNs  327 (904)
T KOG4721|consen  265 K--STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA---------------IIWGVGSNS  327 (904)
T ss_pred             h--hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe---------------eEEeccCCc
Confidence            3  33456789999999999999999999999999999999999999974322110               011111122


Q ss_pred             hhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHH
Q 009340          460 VAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRR  502 (537)
Q Consensus       460 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~  502 (537)
                      +.-+.|..++..+.-|+++||+..|.+||++++|+.-|+-...
T Consensus       328 L~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~p  370 (904)
T KOG4721|consen  328 LHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASP  370 (904)
T ss_pred             ccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCH
Confidence            3345677888889999999999999999999999999985443

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.8e-43  Score=347.49  Aligned_cols=264  Identities=26%  Similarity=0.361  Sum_probs=209.5

Q ss_pred             cCCccccccCcCCceEEEEEE-cCCCCEEEEEEccCCC--hHHHHHHHHHHHHHHhcCCCCcceEeeEEeeC--CccEEE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEID--KTQIHQFINEVVILSQINHRHIVKLLGCCLET--EVPVLV  290 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV  290 (537)
                      +.|+..++||+|.||.||+|+ ..+|+.||+|+++...  ........+||.||++|+||||++|.+...+.  ...|||
T Consensus       117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV  196 (560)
T KOG0600|consen  117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV  196 (560)
T ss_pred             HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence            567777899999999999999 5689999999987533  33445567999999999999999999999887  578999


Q ss_pred             EecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEee
Q 009340          291 YEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSD  370 (537)
Q Consensus       291 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~D  370 (537)
                      +|||+. +|.-++....           -.++..++..++.|+++||+|+|+.+   |+|||||.+|||||++|.+||+|
T Consensus       197 FeYMdh-DL~GLl~~p~-----------vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaD  261 (560)
T KOG0600|consen  197 FEYMDH-DLSGLLSSPG-----------VKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIAD  261 (560)
T ss_pred             Eecccc-hhhhhhcCCC-----------cccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEecc
Confidence            999988 8888886542           36999999999999999999999999   99999999999999999999999


Q ss_pred             ccCccccCCCCCceeeeccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHH-----
Q 009340          371 FGISRSIPNDKTHLTTTIQGTFGYLDPEYFQS-SQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFI-----  444 (537)
Q Consensus       371 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~-----  444 (537)
                      ||||++.........+..+-|..|.|||.+.+ ..|+.++|+||.||||.||+.|++.+.....-+....+..+-     
T Consensus       262 FGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e  341 (560)
T KOG0600|consen  262 FGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTE  341 (560)
T ss_pred             ccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCCh
Confidence            99999887666665677788999999999876 479999999999999999999999987665444322221110     


Q ss_pred             HHHhhchhh--hhh------cHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          445 SLAKENQLL--EIL------DARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       445 ~~~~~~~~~--~~~------d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      ..|...++.  ..+      ...+. +.....+....+|+..+|..||++|.|+.++++
T Consensus       342 ~~W~~~kLP~~~~~kp~~~y~r~l~-E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  342 DYWPVSKLPHATIFKPQQPYKRRLR-ETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             hccccccCCcccccCCCCcccchHH-HHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence            001100111  011      11111 112334567889999999999999999998864

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-43  Score=350.75  Aligned_cols=264  Identities=28%  Similarity=0.476  Sum_probs=228.8

Q ss_pred             CCccccccCcCCceEEEEEEcCC---C--CEEEEEEccC-CChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEE
Q 009340          217 NYNQSRFLGQGGFGTVYKGMLPD---G--SIVAVKRSKE-IDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLV  290 (537)
Q Consensus       217 ~~~~~~~lg~G~~g~Vy~~~~~~---g--~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  290 (537)
                      .....++||+|.||.||+|++.+   |  -.||||..+. ......+.|++|..+|++++||||++++|+|.+. ..|+|
T Consensus       390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wiv  468 (974)
T KOG4257|consen  390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIV  468 (974)
T ss_pred             hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEE
Confidence            33445789999999999999643   2  2699999886 4556688899999999999999999999999865 45999


Q ss_pred             EecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEee
Q 009340          291 YEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSD  370 (537)
Q Consensus       291 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~D  370 (537)
                      ||.++.|.|..||...+.           .|+......++.||..+|+|||+..   +|||||.++|||+...--+|++|
T Consensus       469 mEL~~~GELr~yLq~nk~-----------sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaD  534 (974)
T KOG4257|consen  469 MELAPLGELREYLQQNKD-----------SLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLAD  534 (974)
T ss_pred             EecccchhHHHHHHhccc-----------cchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecc
Confidence            999999999999987654           6888999999999999999999999   99999999999999999999999


Q ss_pred             ccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHHHHHhh
Q 009340          371 FGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKE  449 (537)
Q Consensus       371 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  449 (537)
                      |||++.+..+.++..+...-++.|||||.+.-..+|.+||||.|||.+||+++ |..||..-...+              
T Consensus       535 FGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD--------------  600 (974)
T KOG4257|consen  535 FGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD--------------  600 (974)
T ss_pred             cchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc--------------
Confidence            99999998888877777777899999999999999999999999999999998 999987543322              


Q ss_pred             chhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHHhhHHHhhhh
Q 009340          450 NQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRSQRCLEMCQ  511 (537)
Q Consensus       450 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~~~~~~~~  511 (537)
                        +...+...-+.+.|+.|++.++.|+.+||..+|.+||.+.++...|+.+.+..+...+.+
T Consensus       601 --VI~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qeek~~~~Eq  660 (974)
T KOG4257|consen  601 --VIGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEEKINSSEQ  660 (974)
T ss_pred             --eEEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHhhhhhHHH
Confidence              223344455567889999999999999999999999999999999999998666555444

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-43  Score=334.56  Aligned_cols=243  Identities=29%  Similarity=0.446  Sum_probs=203.4

Q ss_pred             hcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCC---ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEE
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI---DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLV  290 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  290 (537)
                      .++|+..++||+|+||.||.++.+ .++.+|+|.++..   .....+...+|..+|.+++||.||++.-.+.+.+.+|||
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence            468999999999999999999854 6899999998752   334566788999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEee
Q 009340          291 YEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSD  370 (537)
Q Consensus       291 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~D  370 (537)
                      +||+.||.|..+|...            ..+++..+..++..|+.||.|||+.+   ||||||||+|||||++|.++|+|
T Consensus       104 ld~~~GGeLf~hL~~e------------g~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtD  168 (357)
T KOG0598|consen  104 LDYLNGGELFYHLQRE------------GRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTD  168 (357)
T ss_pred             EeccCCccHHHHHHhc------------CCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEec
Confidence            9999999999999764            35889989999999999999999999   99999999999999999999999


Q ss_pred             ccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhc
Q 009340          371 FGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKEN  450 (537)
Q Consensus       371 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  450 (537)
                      |||++..-.. ...+.+.+||+.|||||++....|+..+|.||+|+++|||++|.+||...+...      ....... +
T Consensus       169 FgL~k~~~~~-~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~------~~~~I~~-~  240 (357)
T KOG0598|consen  169 FGLCKEDLKD-GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKK------MYDKILK-G  240 (357)
T ss_pred             cccchhcccC-CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHH------HHHHHhc-C
Confidence            9999865333 223456899999999999999999999999999999999999999997654322      1111111 1


Q ss_pred             hhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCC
Q 009340          451 QLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPT  489 (537)
Q Consensus       451 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs  489 (537)
                      +         ....+.-.+.+..+++...|+.||++|-.
T Consensus       241 k---------~~~~p~~ls~~ardll~~LL~rdp~~RLg  270 (357)
T KOG0598|consen  241 K---------LPLPPGYLSEEARDLLKKLLKRDPRQRLG  270 (357)
T ss_pred             c---------CCCCCccCCHHHHHHHHHHhccCHHHhcC
Confidence            1         11122234567889999999999999964

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-43  Score=340.99  Aligned_cols=255  Identities=29%  Similarity=0.474  Sum_probs=205.7

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCC--ccEEEEe
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETE--VPVLVYE  292 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lV~e  292 (537)
                      .++...+.||+|.||+||++... +|...|||.+...+....+.+.+|+.+|++++|||||+++|......  ..+++||
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE   96 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME   96 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence            45667889999999999999965 48999999887654333667889999999999999999999855554  5899999


Q ss_pred             cCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECC-CCcEEEeec
Q 009340          293 YISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD-KFSAKVSDF  371 (537)
Q Consensus       293 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~-~~~~ki~Df  371 (537)
                      |+++|||.+++.....           .|++..+.+++.||++||.|||+++   |||+||||+|||++. ++.+||+||
T Consensus        97 y~~~GsL~~~~~~~g~-----------~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDF  162 (313)
T KOG0198|consen   97 YAPGGSLSDLIKRYGG-----------KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADF  162 (313)
T ss_pred             ccCCCcHHHHHHHcCC-----------CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccC
Confidence            9999999999987532           6999999999999999999999999   999999999999999 799999999


Q ss_pred             cCccccCC--CCCceeeeccccccccCcccccCCCC-CcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHh
Q 009340          372 GISRSIPN--DKTHLTTTIQGTFGYLDPEYFQSSQF-TDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAK  448 (537)
Q Consensus       372 gla~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  448 (537)
                      |+++....  ..........||+.|||||++.++.. ..++|||||||++.||+||+.||...     .....+......
T Consensus       163 G~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~  237 (313)
T KOG0198|consen  163 GLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGR  237 (313)
T ss_pred             ccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhc
Confidence            99987753  22223445789999999999986433 35999999999999999999998642     011111111111


Q ss_pred             hchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHH
Q 009340          449 ENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELE  498 (537)
Q Consensus       449 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~  498 (537)
                      .         ......+...+....+++.+|++.||+.|||+.++++.--
T Consensus       238 ~---------~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf  278 (313)
T KOG0198|consen  238 E---------DSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPF  278 (313)
T ss_pred             c---------CCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence            1         1112445556678889999999999999999999987554

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=5.4e-42  Score=336.59  Aligned_cols=255  Identities=23%  Similarity=0.400  Sum_probs=206.6

Q ss_pred             cCCccccccCcCCceEEEEEEcC----CCCEEEEEEccCC-ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP----DGSIVAVKRSKEI-DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLV  290 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  290 (537)
                      ++|...+.||+|+||.||+|.++    .+..||+|.++.. .......|.+|+..+++++||||++++|++...+..++|
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   84 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV   84 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence            46778899999999999999853    3568999998764 334456789999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEee
Q 009340          291 YEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSD  370 (537)
Q Consensus       291 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~D  370 (537)
                      |||+++|+|.+++....           ..++|..++.++.|++.||+|||+.+   ++||||||+|||++.++.+|++|
T Consensus        85 ~e~~~~~~L~~~l~~~~-----------~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~d  150 (266)
T cd05064          85 TEYMSNGALDSFLRKHE-----------GQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISG  150 (266)
T ss_pred             EEeCCCCcHHHHHHhCC-----------CCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECC
Confidence            99999999999986532           25899999999999999999999999   99999999999999999999999


Q ss_pred             ccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHHHHHhh
Q 009340          371 FGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKE  449 (537)
Q Consensus       371 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  449 (537)
                      ||.+...............++..|+|||.+.+..++.++||||||+++||+++ |+.||......+       .......
T Consensus       151 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~-------~~~~~~~  223 (266)
T cd05064         151 FRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD-------VIKAVED  223 (266)
T ss_pred             CcccccccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH-------HHHHHHC
Confidence            99876543222221222345678999999999999999999999999999876 999986543221       1111111


Q ss_pred             chhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHH
Q 009340          450 NQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGL  500 (537)
Q Consensus       450 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i  500 (537)
                      .         ...+.+..++..+.+++.+||+.+|++||++.+|.+.|+++
T Consensus       224 ~---------~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         224 G---------FRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             C---------CCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence            1         11122344556789999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-42  Score=354.16  Aligned_cols=255  Identities=25%  Similarity=0.498  Sum_probs=217.2

Q ss_pred             cccccCcCCceEEEEEEc-CCCC----EEEEEEccC-CChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEec
Q 009340          220 QSRFLGQGGFGTVYKGML-PDGS----IVAVKRSKE-IDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY  293 (537)
Q Consensus       220 ~~~~lg~G~~g~Vy~~~~-~~g~----~vavK~~~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  293 (537)
                      ..++||+|+||+||+|.| ..|+    +||+|.+.. ...+...++++|+-+|.+++|+|+++|+|+|..+. ..||++|
T Consensus       700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~  778 (1177)
T KOG1025|consen  700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQL  778 (1177)
T ss_pred             hhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHh
Confidence            357899999999999996 3443    689998765 44556789999999999999999999999998776 7899999


Q ss_pred             CCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccC
Q 009340          294 ISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGI  373 (537)
Q Consensus       294 ~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgl  373 (537)
                      ++.|+|.+|++.++.           .+.-...+.|..|||+||.|||.+.   +|||||.++|||+..-..+||+|||+
T Consensus       779 mP~G~LlDyvr~hr~-----------~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgl  844 (1177)
T KOG1025|consen  779 MPLGCLLDYVREHRD-----------NIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGL  844 (1177)
T ss_pred             cccchHHHHHHHhhc-----------cccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecch
Confidence            999999999998754           6888889999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCCce-eeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHHHHHhhch
Q 009340          374 SRSIPNDKTHL-TTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQ  451 (537)
Q Consensus       374 a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  451 (537)
                      ++.+..+.... .....-.+.|||-|.+....||+++|||||||.+||++| |..|++....++                
T Consensus       845 a~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e----------------  908 (1177)
T KOG1025|consen  845 AKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE----------------  908 (1177)
T ss_pred             hhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH----------------
Confidence            99986554432 333445789999999999999999999999999999999 999987655444                


Q ss_pred             hhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHHhhH
Q 009340          452 LLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRSQR  505 (537)
Q Consensus       452 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~~  505 (537)
                      +.+++....+-+.|..+..+++.++.+||..|+..||+++++...+.++.+...
T Consensus       909 I~dlle~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardpq  962 (1177)
T KOG1025|consen  909 IPDLLEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDPQ  962 (1177)
T ss_pred             hhHHHhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCcc
Confidence            223333344455688889999999999999999999999999999987765443

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-42  Score=332.47  Aligned_cols=261  Identities=24%  Similarity=0.376  Sum_probs=208.6

Q ss_pred             hcCCccccccCcCCceEEEEEEc-CCCCEEEEEEccCC-ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEe
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEI-DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE  292 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e  292 (537)
                      .+.|+..+.||.|..++||+|+. +.++.||||++... .....+.+.+|+..|+.++||||++++.+|..+..+|+||.
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp  104 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP  104 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence            36788899999999999999994 56799999998743 23346889999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeecc
Q 009340          293 YISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG  372 (537)
Q Consensus       293 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfg  372 (537)
                      ||.+||+.+.++..-.          ..+++..+..|..++++||.|||.+|   .||||||+.||||+.+|.+||+|||
T Consensus       105 fMa~GS~ldIik~~~~----------~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFg  171 (516)
T KOG0582|consen  105 FMAGGSLLDIIKTYYP----------DGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFG  171 (516)
T ss_pred             hhcCCcHHHHHHHHcc----------ccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCce
Confidence            9999999999987643          35899999999999999999999999   9999999999999999999999999


Q ss_pred             CccccCCCCCce--e-eeccccccccCcccccC--CCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHH
Q 009340          373 ISRSIPNDKTHL--T-TTIQGTFGYLDPEYFQS--SQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLA  447 (537)
Q Consensus       373 la~~~~~~~~~~--~-~~~~gt~~y~aPE~~~~--~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~  447 (537)
                      .+..+.......  . ...+||++|||||.+..  ..|+.|+||||||+...||.+|+.||....+-.      .+...+
T Consensus       172 vsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmk------vLl~tL  245 (516)
T KOG0582|consen  172 VSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMK------VLLLTL  245 (516)
T ss_pred             eeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHH------HHHHHh
Confidence            987664333211  1 45689999999999644  468999999999999999999999986543211      111111


Q ss_pred             hhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          448 KENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       448 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      .. ......-..+..+........+.+++..||+.||+.|||++++++
T Consensus       246 qn-~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  246 QN-DPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             cC-CCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            11 000000111222233445568999999999999999999999875

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-42  Score=348.41  Aligned_cols=249  Identities=24%  Similarity=0.448  Sum_probs=212.4

Q ss_pred             cCCccccccCcCCceEEEEEE-cCCCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecC
Q 009340          216 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI  294 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  294 (537)
                      ..|....+||+|.-|.||.+. ...++.||||++........+-+++|+.+|+..+|+|||++++.+...+..|.|||||
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym  352 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM  352 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence            456667899999999999998 4578899999998766666677899999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCc
Q 009340          295 SSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGIS  374 (537)
Q Consensus       295 ~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla  374 (537)
                      ++|+|.+.+..             ..+++.++..|+.++++||+|||.++   |+|||||+.|||++.++.+||+|||++
T Consensus       353 ~ggsLTDvVt~-------------~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFc  416 (550)
T KOG0578|consen  353 EGGSLTDVVTK-------------TRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFC  416 (550)
T ss_pred             CCCchhhhhhc-------------ccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeee
Confidence            99999999965             35899999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchhhh
Q 009340          375 RSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLE  454 (537)
Q Consensus       375 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  454 (537)
                      ..+..... ...+.+||+.|||||.+....|..|+||||||++++||+-|.+||....+-      .....+...+.   
T Consensus       417 aqi~~~~~-KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Pl------rAlyLIa~ng~---  486 (550)
T KOG0578|consen  417 AQISEEQS-KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPL------RALYLIATNGT---  486 (550)
T ss_pred             eccccccC-ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChH------HHHHHHhhcCC---
Confidence            88866554 355678999999999999999999999999999999999999998653221      11111111111   


Q ss_pred             hhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          455 ILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       455 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                         +.  ...+...+..+.+++.+||+.|+++||++.|+++
T Consensus       487 ---P~--lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  487 ---PK--LKNPEKLSPELKDFLDRCLVVDVEQRASAKELLE  522 (550)
T ss_pred             ---CC--cCCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence               11  1235566788999999999999999999999975

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-43  Score=344.17  Aligned_cols=261  Identities=25%  Similarity=0.380  Sum_probs=206.7

Q ss_pred             hcCCccccccCcCCceEEEEEEc-CCCCEEEEEEccCCChHHHHH--HHHHHHHHHhcC-CCCcceEeeEEeeCC-ccEE
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEIDKTQIHQ--FINEVVILSQIN-HRHIVKLLGCCLETE-VPVL  289 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~--~~~E~~~l~~l~-H~niv~l~g~~~~~~-~~~l  289 (537)
                      .++|...++||.|.||.||+|+- ..|+.||||+++..-.. .++  -++|+.-|++++ ||||+++.+++.+.+ .+++
T Consensus         9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f   87 (538)
T KOG0661|consen    9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF   87 (538)
T ss_pred             HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence            46788889999999999999994 47899999999863322 222  368999999998 999999999999888 8999


Q ss_pred             EEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEe
Q 009340          290 VYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVS  369 (537)
Q Consensus       290 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~  369 (537)
                      |||||+. +|.+.+++.           ...+++..+..|+.||++||+|+|.+|   +.|||+||+|||+..+..+||+
T Consensus        88 VfE~Md~-NLYqLmK~R-----------~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKia  152 (538)
T KOG0661|consen   88 VFEFMDC-NLYQLMKDR-----------NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIA  152 (538)
T ss_pred             eHHhhhh-hHHHHHhhc-----------CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEec
Confidence            9999976 999999875           347999999999999999999999999   9999999999999998999999


Q ss_pred             eccCccccCCCCCceeeeccccccccCcccc-cCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHh
Q 009340          370 DFGISRSIPNDKTHLTTTIQGTFGYLDPEYF-QSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAK  448 (537)
Q Consensus       370 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  448 (537)
                      |||||+.......  .+..+.|..|.|||++ .++.|+.+.|+|++|||++|+.+-++-|.....-+...   ..-..+.
T Consensus       153 DFGLARev~SkpP--YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~---KIc~VLG  227 (538)
T KOG0661|consen  153 DFGLAREVRSKPP--YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIY---KICEVLG  227 (538)
T ss_pred             ccccccccccCCC--cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHH---HHHHHhC
Confidence            9999998865443  3566789999999986 56889999999999999999999998886554322211   1111111


Q ss_pred             hc---------hhhhhhcHHh-------hccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHH
Q 009340          449 EN---------QLLEILDARV-------AKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSME  496 (537)
Q Consensus       449 ~~---------~~~~~~d~~~-------~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~  496 (537)
                      .+         .+...+.-++       ....-..++.+..+|+.+|+++||++|||+.+.++.
T Consensus       228 tP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  228 TPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             CCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence            11         1111111000       011112367889999999999999999999999764

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=4e-42  Score=336.22  Aligned_cols=249  Identities=36%  Similarity=0.576  Sum_probs=196.4

Q ss_pred             cccccCcCCceEEEEEEcC-----CCCEEEEEEccCC-ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEec
Q 009340          220 QSRFLGQGGFGTVYKGMLP-----DGSIVAVKRSKEI-DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY  293 (537)
Q Consensus       220 ~~~~lg~G~~g~Vy~~~~~-----~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  293 (537)
                      ..+.||.|.||.||+|.+.     .+..|+||.++.. .....+.|.+|++.+++++||||++++|+|...+..++|+||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            3568999999999999986     2568999999753 444578999999999999999999999999988889999999


Q ss_pred             CCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccC
Q 009340          294 ISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGI  373 (537)
Q Consensus       294 ~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgl  373 (537)
                      +++|+|.++|....          ...+++..++.|+.||++||.|||+.+   ++|+||+++||++++++.+||+|||+
T Consensus        83 ~~~g~L~~~L~~~~----------~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~  149 (259)
T PF07714_consen   83 CPGGSLDDYLKSKN----------KEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGL  149 (259)
T ss_dssp             -TTEBHHHHHHHTC----------TTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTT
T ss_pred             cccccccccccccc----------ccccccccccccccccccccccccccc---cccccccccccccccccccccccccc
Confidence            99999999998752          236999999999999999999999998   99999999999999999999999999


Q ss_pred             ccccCCCCCc-eeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHHHHHhhch
Q 009340          374 SRSIPNDKTH-LTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQ  451 (537)
Q Consensus       374 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  451 (537)
                      +......... ..........|+|||.+.+..++.++||||||+++|||++ |+.|+......+       +........
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~-------~~~~~~~~~  222 (259)
T PF07714_consen  150 SRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE-------IIEKLKQGQ  222 (259)
T ss_dssp             GEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH-------HHHHHHTTE
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-------ccccccccc
Confidence            9877332222 2233457789999999998889999999999999999999 678875432211       111111111


Q ss_pred             hhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHH
Q 009340          452 LLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMEL  497 (537)
Q Consensus       452 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L  497 (537)
                               ....+..++..+.+++.+||+.+|++||||.+|+++|
T Consensus       223 ---------~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  223 ---------RLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             ---------ETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             ---------cceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence                     1122334456788999999999999999999999887

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=3.3e-41  Score=337.61  Aligned_cols=271  Identities=24%  Similarity=0.425  Sum_probs=205.6

Q ss_pred             cCCccccccCcCCceEEEEEEcCC-----------------CCEEEEEEccCC-ChHHHHHHHHHHHHHHhcCCCCcceE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLPD-----------------GSIVAVKRSKEI-DKTQIHQFINEVVILSQINHRHIVKL  277 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~~-----------------g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l  277 (537)
                      ++|...++||+|+||.||++.+++                 +..||+|.+... ......+|.+|+.++.+++|+||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            567888999999999999998532                 336999998754 34456679999999999999999999


Q ss_pred             eeEEeeCCccEEEEecCCCCChhhhhhhhhhhHHHHh-------hhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeee
Q 009340          278 LGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQ-------KQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFH  350 (537)
Q Consensus       278 ~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~-------~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH  350 (537)
                      ++++.+.+..++||||+++|+|.+++...........       ......++|..+++++.|++.||.|||+.+   |+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH  161 (304)
T cd05096          85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH  161 (304)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence            9999999999999999999999999865321110000       011235899999999999999999999999   999


Q ss_pred             cCCCCCCEEECCCCcEEEeeccCccccCCCCCc-eeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh--CCCC
Q 009340          351 RDIKSSNILLDDKFSAKVSDFGISRSIPNDKTH-LTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT--GKKP  427 (537)
Q Consensus       351 ~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t--g~~p  427 (537)
                      |||||+|||++.++.+||+|||+++........ ......++..|+|||.+.++.++.++||||||+++|||++  +..|
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p  241 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP  241 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence            999999999999999999999999866433322 2233456789999999998899999999999999999997  4556


Q ss_pred             CCccchhhhccHHHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHH
Q 009340          428 ICFARVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELE  498 (537)
Q Consensus       428 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~  498 (537)
                      +......+   ..............      ......+..++..+.+++.+||+.+|++|||+.+|.+.|+
T Consensus       242 ~~~~~~~~---~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         242 YGELTDEQ---VIENAGEFFRDQGR------QVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             CCcCCHHH---HHHHHHHHhhhccc------cccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence            65432211   11111111111000      0001112234567899999999999999999999998886

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=9.3e-41  Score=384.59  Aligned_cols=270  Identities=26%  Similarity=0.441  Sum_probs=215.9

Q ss_pred             cCHHHHHHHhcCCccccccCcCCceEEEEEEc-CCCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeC
Q 009340          206 FTADELQRATDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLET  284 (537)
Q Consensus       206 ~~~~el~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~  284 (537)
                      ++.+++   ...|...+.||+|+||.||+|+. .+|..||||+++.....    ..+|++.+++++||||++++|+|.+.
T Consensus       683 ~~~~~~---~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~  755 (968)
T PLN00113        683 ITINDI---LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSE  755 (968)
T ss_pred             hhHHHH---HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcC
Confidence            444444   34577788999999999999996 47899999998754322    12468899999999999999999999


Q ss_pred             CccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCC
Q 009340          285 EVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF  364 (537)
Q Consensus       285 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~  364 (537)
                      +..++||||+++|+|.++++               .++|..+.+|+.|+|+||+|||+...++|+||||||+||+++.++
T Consensus       756 ~~~~lv~Ey~~~g~L~~~l~---------------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~  820 (968)
T PLN00113        756 KGAYLIHEYIEGKNLSEVLR---------------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKD  820 (968)
T ss_pred             CCCEEEEeCCCCCcHHHHHh---------------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCC
Confidence            99999999999999999984               389999999999999999999977666699999999999999999


Q ss_pred             cEEEeeccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHH
Q 009340          365 SAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFI  444 (537)
Q Consensus       365 ~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~  444 (537)
                      .+++. ||.......+     ....+|..|+|||++.+..++.|+|||||||++|||+||+.|++.... .......|..
T Consensus       821 ~~~~~-~~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~  893 (968)
T PLN00113        821 EPHLR-LSLPGLLCTD-----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWAR  893 (968)
T ss_pred             ceEEE-eccccccccC-----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHH
Confidence            88886 6665433221     223578999999999999999999999999999999999999853322 2234444544


Q ss_pred             HHHhhchhhhhhcHHhhc--cccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHHhh
Q 009340          445 SLAKENQLLEILDARVAK--EAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRSQ  504 (537)
Q Consensus       445 ~~~~~~~~~~~~d~~~~~--~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~  504 (537)
                      ..........++|+.+..  ..+.....++.+++.+||+.||++||||.||+++|+++.+..
T Consensus       894 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~  955 (968)
T PLN00113        894 YCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSS  955 (968)
T ss_pred             HhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhccc
Confidence            444444455556655533  234566678899999999999999999999999999887643

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=2.6e-41  Score=330.54  Aligned_cols=255  Identities=24%  Similarity=0.442  Sum_probs=208.9

Q ss_pred             cCCccccccCcCCceEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecCC
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYIS  295 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  295 (537)
                      ++|+..++||+|+||.||+|...++..||+|.+.... ...+.+.+|+.++++++|+|++++++++.+.+..++||||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   84 (261)
T cd05072           6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA   84 (261)
T ss_pred             HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence            5788889999999999999998888899999987533 235788999999999999999999999999999999999999


Q ss_pred             CCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCcc
Q 009340          296 SGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISR  375 (537)
Q Consensus       296 ~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~  375 (537)
                      +|+|.+++....          ...+++..++.++.|+++||+|||+.+   ++||||||+||+++.++.++|+|||++.
T Consensus        85 ~~~L~~~l~~~~----------~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~  151 (261)
T cd05072          85 KGSLLDFLKSDE----------GGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLAR  151 (261)
T ss_pred             CCcHHHHHHHhc----------CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccce
Confidence            999999997532          246899999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHHHHHhhchhhh
Q 009340          376 SIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQLLE  454 (537)
Q Consensus       376 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  454 (537)
                      ..............++..|+|||++..+.++.++||||||+++|||++ |+.||......+       ........    
T Consensus       152 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~-------~~~~~~~~----  220 (261)
T cd05072         152 VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD-------VMSALQRG----  220 (261)
T ss_pred             ecCCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH-------HHHHHHcC----
Confidence            764433222233446778999999998899999999999999999998 999986433221       11111111    


Q ss_pred             hhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHH
Q 009340          455 ILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGL  500 (537)
Q Consensus       455 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i  500 (537)
                           ...+.....+..+.+++.+||+.+|++||++.++.+.|+.+
T Consensus       221 -----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         221 -----YRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             -----CCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence                 01111223345788999999999999999999999999853

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=2.6e-41  Score=348.04  Aligned_cols=267  Identities=27%  Similarity=0.431  Sum_probs=207.4

Q ss_pred             hcCCccccccCcCCceEEEEEEc------CCCCEEEEEEccCC-ChHHHHHHHHHHHHHHhc-CCCCcceEeeEEeeCCc
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGML------PDGSIVAVKRSKEI-DKTQIHQFINEVVILSQI-NHRHIVKLLGCCLETEV  286 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~  286 (537)
                      .++|+..+.||+|+||.||++++      ..+..||||+++.. .....+.+.+|+.++..+ +||||++++++|.+.+.
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~  113 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP  113 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence            45688889999999999999973      24568999998753 234456788999999999 89999999999999999


Q ss_pred             cEEEEecCCCCChhhhhhhhhhhH--------------------------------------------------------
Q 009340          287 PVLVYEYISSGTLSHHIHDHQQQQ--------------------------------------------------------  310 (537)
Q Consensus       287 ~~lV~e~~~~gsL~~~l~~~~~~~--------------------------------------------------------  310 (537)
                      .++||||+++|+|.+++.......                                                        
T Consensus       114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (375)
T cd05104         114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS  193 (375)
T ss_pred             ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence            999999999999999997543100                                                        


Q ss_pred             -------HHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCccccCCCCCc
Q 009340          311 -------EQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTH  383 (537)
Q Consensus       311 -------~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~  383 (537)
                             ..........++|..+++++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||+++........
T Consensus       194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  270 (375)
T cd05104         194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY  270 (375)
T ss_pred             ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence                   0000011235899999999999999999999998   999999999999999999999999999876443322


Q ss_pred             e-eeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHHHHHhhchhhhhhcHHhh
Q 009340          384 L-TTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQLLEILDARVA  461 (537)
Q Consensus       384 ~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  461 (537)
                      . .....++..|+|||.+.+..++.++||||||+++|||++ |..||.......      .+......+         ..
T Consensus       271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~------~~~~~~~~~---------~~  335 (375)
T cd05104         271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS------KFYKMIKEG---------YR  335 (375)
T ss_pred             cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH------HHHHHHHhC---------cc
Confidence            1 222345678999999999999999999999999999998 888875432211      111111111         11


Q ss_pred             ccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHH
Q 009340          462 KEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEG  499 (537)
Q Consensus       462 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  499 (537)
                      ...+...+.++.+|+.+||+.||++|||+.+|+++|++
T Consensus       336 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~  373 (375)
T cd05104         336 MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ  373 (375)
T ss_pred             CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence            11122234578899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=9.9e-42  Score=311.58  Aligned_cols=262  Identities=25%  Similarity=0.322  Sum_probs=207.0

Q ss_pred             cCCccccccCcCCceEEEEEE-cCCCCEEEEEEccCCChH--HHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEe
Q 009340          216 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKT--QIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE  292 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e  292 (537)
                      ++|...++||+|.||.||+|+ ..+|+.||||+++.....  -....++|++.|+.++|+||+.+++++...+..-||+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            457778899999999999999 457999999998754322  23457899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeecc
Q 009340          293 YISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG  372 (537)
Q Consensus       293 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfg  372 (537)
                      ||+. +|+..+++..           ..++-.++..++.++++|++|||++.   |+||||||.|+|++++|.+||+|||
T Consensus        82 fm~t-dLe~vIkd~~-----------i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFG  146 (318)
T KOG0659|consen   82 FMPT-DLEVVIKDKN-----------IILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFG  146 (318)
T ss_pred             eccc-cHHHHhcccc-----------cccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeeccc
Confidence            9987 8999998753           36888999999999999999999999   9999999999999999999999999


Q ss_pred             CccccCCCCCceeeeccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhc-
Q 009340          373 ISRSIPNDKTHLTTTIQGTFGYLDPEYFQS-SQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKEN-  450 (537)
Q Consensus       373 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-  450 (537)
                      +++.+....... +..+-|..|.|||.+.+ ..|+..+|+||.||++.||+-|.+-|...++-+.  +...| +.+..+ 
T Consensus       147 LAr~f~~p~~~~-~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQ--L~~If-~~LGTP~  222 (318)
T KOG0659|consen  147 LARFFGSPNRIQ-THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQ--LSKIF-RALGTPT  222 (318)
T ss_pred             chhccCCCCccc-ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHH--HHHHH-HHcCCCC
Confidence            999986554433 33367999999998876 5799999999999999999998876654433222  11112 111111 


Q ss_pred             --------hhhhhhcHH-----hhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHH
Q 009340          451 --------QLLEILDAR-----VAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSME  496 (537)
Q Consensus       451 --------~~~~~~d~~-----~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~  496 (537)
                              .+.+...-.     ........++....+|+..++..||.+|+|+.|++++
T Consensus       223 ~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  223 PDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             cccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence                    111111111     1111334556677999999999999999999999765

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.6e-41  Score=349.41  Aligned_cols=269  Identities=27%  Similarity=0.450  Sum_probs=208.9

Q ss_pred             hcCCccccccCcCCceEEEEEEc------CCCCEEEEEEccCC-ChHHHHHHHHHHHHHHhc-CCCCcceEeeEEeeCCc
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGML------PDGSIVAVKRSKEI-DKTQIHQFINEVVILSQI-NHRHIVKLLGCCLETEV  286 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~  286 (537)
                      .++|...+.||+|+||.||+++.      .++..||||+++.. .....+.+.+|+.+++.+ +|+||++++++|.+.+.
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~  116 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP  116 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence            45788899999999999999873      23457999998753 344456788999999999 89999999999999999


Q ss_pred             cEEEEecCCCCChhhhhhhhhhhH--------------------------------------------------------
Q 009340          287 PVLVYEYISSGTLSHHIHDHQQQQ--------------------------------------------------------  310 (537)
Q Consensus       287 ~~lV~e~~~~gsL~~~l~~~~~~~--------------------------------------------------------  310 (537)
                      .++||||+++|+|.++++......                                                        
T Consensus       117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (374)
T cd05106         117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD  196 (374)
T ss_pred             eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence            999999999999999997543210                                                        


Q ss_pred             --HHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCccccCCCCCc-eeee
Q 009340          311 --EQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTH-LTTT  387 (537)
Q Consensus       311 --~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~-~~~~  387 (537)
                        ..........+++..+++++.|+++||+|||+.+   |+||||||+|||+++++.+||+|||+++........ ....
T Consensus       197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~  273 (374)
T cd05106         197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN  273 (374)
T ss_pred             ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence              0000111235899999999999999999999998   999999999999999999999999999865433222 1222


Q ss_pred             ccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHHHHHhhchhhhhhcHHhhccccH
Q 009340          388 IQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQLLEILDARVAKEARE  466 (537)
Q Consensus       388 ~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  466 (537)
                      ..++..|+|||++.+..++.++|||||||++|||++ |+.||........      +......         ......+.
T Consensus       274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~------~~~~~~~---------~~~~~~~~  338 (374)
T cd05106         274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK------FYKMVKR---------GYQMSRPD  338 (374)
T ss_pred             CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH------HHHHHHc---------ccCccCCC
Confidence            345678999999999999999999999999999997 9999864322110      1111111         11111122


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHH
Q 009340          467 EDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLR  501 (537)
Q Consensus       467 ~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~  501 (537)
                      ..+.++.+++.+||+.||++|||+.+|+++|+++.
T Consensus       339 ~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         339 FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence            23467889999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=3e-41  Score=329.23  Aligned_cols=252  Identities=25%  Similarity=0.394  Sum_probs=204.2

Q ss_pred             cCCccccccCcCCceEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecCC
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYIS  295 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  295 (537)
                      ++|+..+.||+|+||.||++.++++..+|+|.+..... ....|.+|+.++++++||||+++++++.+.+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   82 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAM-SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME   82 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCc-cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence            35777889999999999999998888999998764332 24578899999999999999999999999999999999999


Q ss_pred             CCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCcc
Q 009340          296 SGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISR  375 (537)
Q Consensus       296 ~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~  375 (537)
                      +|+|.++++...           ..++|..++.++.|+++||.|||+.+   ++||||||+||++++++.+||+|||+++
T Consensus        83 ~~~L~~~~~~~~-----------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~  148 (256)
T cd05114          83 NGCLLNYLRQRQ-----------GKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTR  148 (256)
T ss_pred             CCcHHHHHHhCc-----------cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCcc
Confidence            999999987532           25899999999999999999999999   9999999999999999999999999998


Q ss_pred             ccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHHHHHhhchhhh
Q 009340          376 SIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQLLE  454 (537)
Q Consensus       376 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  454 (537)
                      ..............++..|+|||.+.+..++.++||||||+++|||++ |+.||......+.      +.. ...+.   
T Consensus       149 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~------~~~-i~~~~---  218 (256)
T cd05114         149 YVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEV------VEM-ISRGF---  218 (256)
T ss_pred             ccCCCceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHH------HHH-HHCCC---
Confidence            664333222223345678999999988889999999999999999999 8889864432111      111 11110   


Q ss_pred             hhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHH
Q 009340          455 ILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELE  498 (537)
Q Consensus       455 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~  498 (537)
                            ....+......+.+++.+||+.+|++||++.+++++|.
T Consensus       219 ------~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~  256 (256)
T cd05114         219 ------RLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT  256 (256)
T ss_pred             ------CCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                  00112223457899999999999999999999998873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=5.6e-41  Score=328.72  Aligned_cols=255  Identities=26%  Similarity=0.448  Sum_probs=208.6

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecC
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI  294 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  294 (537)
                      .+|...++||+|+||.||+|... .++.||+|.++... ....++.+|+.++++++|+|++++++++...+..++||||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   84 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence            35777889999999999999965 58899999987543 34567899999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCc
Q 009340          295 SSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGIS  374 (537)
Q Consensus       295 ~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla  374 (537)
                      ++++|.+++....          ...+++..++.++.|+++||+|||+.+   ++||||||+||++++++.+||+|||++
T Consensus        85 ~~~~L~~~~~~~~----------~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~  151 (263)
T cd05052          85 TYGNLLDYLRECN----------RQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLS  151 (263)
T ss_pred             CCCcHHHHHHhCC----------CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccc
Confidence            9999999986532          235899999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHHHHHhhchhh
Q 009340          375 RSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQLL  453 (537)
Q Consensus       375 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  453 (537)
                      ...............++..|+|||.+.+..++.++||||||+++|||++ |..|+......+       .......    
T Consensus       152 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~-------~~~~~~~----  220 (263)
T cd05052         152 RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLEK----  220 (263)
T ss_pred             cccccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHHC----
Confidence            8765433222223334678999999998999999999999999999998 888876433221       1111111    


Q ss_pred             hhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHH
Q 009340          454 EILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGL  500 (537)
Q Consensus       454 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i  500 (537)
                           ....+.+...+..+.+++.+||+.+|++|||+.+++++|+.+
T Consensus       221 -----~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         221 -----GYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             -----CCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence                 111122334456789999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=2.1e-41  Score=331.13  Aligned_cols=258  Identities=27%  Similarity=0.484  Sum_probs=214.4

Q ss_pred             HHhcCCccccccCcCCceEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEe
Q 009340          213 RATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE  292 (537)
Q Consensus       213 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e  292 (537)
                      ++..+|...++||.|+||.||+|...+++.+|+|.+..........+.+|+.+++.++|+|++++++++.+.+..++|||
T Consensus         3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   82 (261)
T cd05148           3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE   82 (261)
T ss_pred             CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence            34567888999999999999999988899999999987666566789999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeecc
Q 009340          293 YISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG  372 (537)
Q Consensus       293 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfg  372 (537)
                      |+++|+|.+++....          ...+++..++.++.|+++||.|||+.+   ++|+||+|+||++++++.+||+|||
T Consensus        83 ~~~~~~L~~~~~~~~----------~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g  149 (261)
T cd05148          83 LMEKGSLLAFLRSPE----------GQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFG  149 (261)
T ss_pred             ecccCCHHHHHhcCC----------CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEcccc
Confidence            999999999997643          235899999999999999999999998   9999999999999999999999999


Q ss_pred             CccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHHHHHhhch
Q 009340          373 ISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQ  451 (537)
Q Consensus       373 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  451 (537)
                      ++......... .....++..|+|||.+.+..++.++||||||+++|+|++ |+.||......+.      +..      
T Consensus       150 ~~~~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~------~~~------  216 (261)
T cd05148         150 LARLIKEDVYL-SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEV------YDQ------  216 (261)
T ss_pred             chhhcCCcccc-ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHH------HHH------
Confidence            99876433222 223446778999999998899999999999999999998 8888854332110      111      


Q ss_pred             hhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHH
Q 009340          452 LLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGL  500 (537)
Q Consensus       452 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i  500 (537)
                          +......+.+..++..+.+++.+||+.||++|||+.++++.|+.+
T Consensus       217 ----~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         217 ----ITAGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             ----HHhCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence                111111223344556789999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.5e-41  Score=327.78  Aligned_cols=255  Identities=25%  Similarity=0.419  Sum_probs=208.3

Q ss_pred             hcCCccccccCcCCceEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecC
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI  294 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  294 (537)
                      .++|+..+.||+|++|.||+|...+++.||+|.++... ...++|.+|+.++++++|+|++++++++...+..++||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM   83 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence            45688889999999999999998778899999987543 23567889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCc
Q 009340          295 SSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGIS  374 (537)
Q Consensus       295 ~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla  374 (537)
                      ++++|.+++....          ...++|..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++
T Consensus        84 ~~~~L~~~~~~~~----------~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~  150 (261)
T cd05068          84 KYGSLLEYLQGGA----------GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLA  150 (261)
T ss_pred             cCCcHHHHHhccC----------CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceE
Confidence            9999999997532          236899999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHHHHHhhchhh
Q 009340          375 RSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQLL  453 (537)
Q Consensus       375 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  453 (537)
                      ................+..|+|||++.+..++.++||||||+++|||++ |+.||.......       ......     
T Consensus       151 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-------~~~~~~-----  218 (261)
T cd05068         151 RVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE-------VLQQVD-----  218 (261)
T ss_pred             EEccCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHH-----
Confidence            8765332221222233568999999998899999999999999999999 898885432211       111111     


Q ss_pred             hhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHH
Q 009340          454 EILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEG  499 (537)
Q Consensus       454 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  499 (537)
                          .......+...+..+.+++.+||+.+|++||++.+++++|+.
T Consensus       219 ----~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         219 ----QGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             ----cCCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence                111112233445678999999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=7.4e-41  Score=337.04  Aligned_cols=258  Identities=23%  Similarity=0.468  Sum_probs=207.3

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCC----EEEEEEccCC-ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGS----IVAVKRSKEI-DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVL  289 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  289 (537)
                      .+|+..+.||+|+||.||+|++. +|+    .||+|.++.. .....++|.+|+.+++.++|+||++++|+|... ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            46888999999999999999864 343    3899998753 345567899999999999999999999999864 5689


Q ss_pred             EEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEe
Q 009340          290 VYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVS  369 (537)
Q Consensus       290 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~  369 (537)
                      |+||+++|+|.+++....           ..+++..++.++.|+++||+|||+.+   |+||||||+|||+++++.+||+
T Consensus        86 v~e~~~~g~l~~~l~~~~-----------~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~  151 (316)
T cd05108          86 ITQLMPFGCLLDYVREHK-----------DNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKIT  151 (316)
T ss_pred             eeecCCCCCHHHHHHhcc-----------ccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEc
Confidence            999999999999997642           25889999999999999999999999   9999999999999999999999


Q ss_pred             eccCccccCCCCCcee-eeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHHHHH
Q 009340          370 DFGISRSIPNDKTHLT-TTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLA  447 (537)
Q Consensus       370 Dfgla~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~  447 (537)
                      |||+++.......... ....++..|+|||.+.+..++.++||||||+++|||++ |+.|+......+       +....
T Consensus       152 DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~-------~~~~~  224 (316)
T cd05108         152 DFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-------ISSIL  224 (316)
T ss_pred             cccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHH
Confidence            9999987654333221 22334678999999999999999999999999999998 999986432221       11111


Q ss_pred             hhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHHhh
Q 009340          448 KENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRSQ  504 (537)
Q Consensus       448 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~  504 (537)
                      ...         .....+..+...+.+++.+||+.+|++||++.+++..|..+....
T Consensus       225 ~~~---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~  272 (316)
T cd05108         225 EKG---------ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP  272 (316)
T ss_pred             hCC---------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence            111         111112234457889999999999999999999999998887643

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-40  Score=326.69  Aligned_cols=255  Identities=25%  Similarity=0.458  Sum_probs=207.9

Q ss_pred             cCCccccccCcCCceEEEEEEcCC----CCEEEEEEccCC-ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLPD----GSIVAVKRSKEI-DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLV  290 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  290 (537)
                      ++|+..+.||+|+||.||+|.+..    ...||||.++.. ......+|.+|+.++++++|+||+++++++.+.+..++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   83 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII   83 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence            578889999999999999999742    457999998753 344566799999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEee
Q 009340          291 YEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSD  370 (537)
Q Consensus       291 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~D  370 (537)
                      |||+++++|.+++....           ..++|..+++++.|++.||+|||+.+   |+||||||+||++++++.++|+|
T Consensus        84 ~e~~~~~~L~~~~~~~~-----------~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~d  149 (266)
T cd05033          84 TEYMENGSLDKFLREND-----------GKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSD  149 (266)
T ss_pred             EEcCCCCCHHHHHHhcc-----------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECc
Confidence            99999999999997532           26899999999999999999999998   99999999999999999999999


Q ss_pred             ccCccccCCCCC-ceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHHHHHh
Q 009340          371 FGISRSIPNDKT-HLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAK  448 (537)
Q Consensus       371 fgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~  448 (537)
                      ||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |..|+......+       ......
T Consensus       150 fg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~-------~~~~~~  222 (266)
T cd05033         150 FGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD-------VIKAVE  222 (266)
T ss_pred             cchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH-------HHHHHH
Confidence            999987752222 12223345678999999999999999999999999999998 999985432221       111111


Q ss_pred             hchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHH
Q 009340          449 ENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGL  500 (537)
Q Consensus       449 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i  500 (537)
                      ..         ...+.+..++..+.+++.+||+.+|++||++.+|++.|+++
T Consensus       223 ~~---------~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         223 DG---------YRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             cC---------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            11         11112234456788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1e-40  Score=330.36  Aligned_cols=265  Identities=28%  Similarity=0.485  Sum_probs=210.2

Q ss_pred             cCCccccccCcCCceEEEEEEcCC------CCEEEEEEccCCC-hHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLPD------GSIVAVKRSKEID-KTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPV  288 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~~------g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  288 (537)
                      ++|+..+.||+|+||.||+|....      ...||+|.++... .....+|.+|+.++++++|+||+++++++.+....+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            467788999999999999998642      2579999987533 344567899999999999999999999999888999


Q ss_pred             EEEecCCCCChhhhhhhhhhhHHHHh----hhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCC
Q 009340          289 LVYEYISSGTLSHHIHDHQQQQEQKQ----KQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF  364 (537)
Q Consensus       289 lV~e~~~~gsL~~~l~~~~~~~~~~~----~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~  364 (537)
                      ++|||+++|+|.+++...........    ......+++..++.++.|+++||.|||+.+   ++||||||+||++++++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence            99999999999999976432110000    000145899999999999999999999999   99999999999999999


Q ss_pred             cEEEeeccCccccCCCCC-ceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHH
Q 009340          365 SAKVSDFGISRSIPNDKT-HLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVAC  442 (537)
Q Consensus       365 ~~ki~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~  442 (537)
                      .+||+|||+++....... .......+++.|+|||.+.++.++.++|||||||++|||++ |..||......+       
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~-------  234 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE-------  234 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH-------
Confidence            999999999986543322 22334456889999999998999999999999999999998 999986543221       


Q ss_pred             HHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHH
Q 009340          443 FISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEG  499 (537)
Q Consensus       443 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  499 (537)
                      ......         .......+..++.++.+|+.+||+.||++||++.+|++.|+.
T Consensus       235 ~~~~i~---------~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         235 VIEMIR---------SRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             HHHHHH---------cCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence            111111         111122344566789999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-41  Score=335.40  Aligned_cols=249  Identities=27%  Similarity=0.388  Sum_probs=207.0

Q ss_pred             hcCCccccccCcCCceEEEEEEc-CCCCEEEEEEccCC---ChHHHHHHHHHHHHHHhc-CCCCcceEeeEEeeCCccEE
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEI---DKTQIHQFINEVVILSQI-NHRHIVKLLGCCLETEVPVL  289 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l  289 (537)
                      ..+|...+.||+|.|++|++|+. ..++.+|||++...   .....+-...|-..|.+| .||.|++|+-.|.++..+|+
T Consensus        72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYF  151 (604)
T KOG0592|consen   72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYF  151 (604)
T ss_pred             hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEE
Confidence            46788899999999999999994 46899999988641   122234456788999999 89999999999999999999


Q ss_pred             EEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEe
Q 009340          290 VYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVS  369 (537)
Q Consensus       290 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~  369 (537)
                      |+||+++|+|.++|+..            +.+++.....++.+|+.||+|||+.|   ||||||||+|||||+||.+||+
T Consensus       152 vLe~A~nGdll~~i~K~------------Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikIT  216 (604)
T KOG0592|consen  152 VLEYAPNGDLLDLIKKY------------GSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKIT  216 (604)
T ss_pred             EEEecCCCcHHHHHHHh------------CcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEe
Confidence            99999999999999874            46899999999999999999999999   9999999999999999999999


Q ss_pred             eccCccccCCCCCc------------eeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhc
Q 009340          370 DFGISRSIPNDKTH------------LTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEER  437 (537)
Q Consensus       370 Dfgla~~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~  437 (537)
                      |||-|+.++.....            .....+||..|.+||.+.++..+..+|+|+|||+||+|+.|++||.....-   
T Consensus       217 DFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney---  293 (604)
T KOG0592|consen  217 DFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY---  293 (604)
T ss_pred             eccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH---
Confidence            99999987432211            124578999999999999999999999999999999999999999654321   


Q ss_pred             cHHHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          438 NLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       438 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                         .-|..         +++  +..+.+...++...+|+.+.|..||.+|+|..+|.+
T Consensus       294 ---liFqk---------I~~--l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~  337 (604)
T KOG0592|consen  294 ---LIFQK---------IQA--LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA  337 (604)
T ss_pred             ---HHHHH---------HHH--hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence               11222         111  122345555678889999999999999999977754

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1.1e-40  Score=330.78  Aligned_cols=251  Identities=25%  Similarity=0.376  Sum_probs=201.3

Q ss_pred             CCccccccCcCCceEEEEEEc-CCCCEEEEEEccCCC---hHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEe
Q 009340          217 NYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEID---KTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE  292 (537)
Q Consensus       217 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e  292 (537)
                      .|+..+.||+|+||.||++.. .+|+.||+|.+....   ......+.+|+.++++++|+|++++.+++.+.+..++|+|
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            367788999999999999985 478999999876422   2233467899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeecc
Q 009340          293 YISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG  372 (537)
Q Consensus       293 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfg  372 (537)
                      |+++|+|.+++....          ...+++..++.++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||
T Consensus        81 ~~~~g~L~~~~~~~~----------~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg  147 (285)
T cd05631          81 IMNGGDLKFHIYNMG----------NPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLG  147 (285)
T ss_pred             ecCCCcHHHHHHhhC----------CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCC
Confidence            999999998886432          235899999999999999999999999   9999999999999999999999999


Q ss_pred             CccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchh
Q 009340          373 ISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQL  452 (537)
Q Consensus       373 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  452 (537)
                      ++........  .....||..|+|||.+.+..++.++|||||||++|||++|+.||........   .........    
T Consensus       148 ~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~---~~~~~~~~~----  218 (285)
T cd05631         148 LAVQIPEGET--VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK---REEVDRRVK----  218 (285)
T ss_pred             CcEEcCCCCe--ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh---HHHHHHHhh----
Confidence            9987543222  2345689999999999999999999999999999999999999975432111   000111000    


Q ss_pred             hhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCC-----HhhHHH
Q 009340          453 LEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPT-----MKQVSM  495 (537)
Q Consensus       453 ~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~ev~~  495 (537)
                            ......+...+..+.+|+.+||+.||++||+     +.++++
T Consensus       219 ------~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         219 ------EDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             ------cccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence                  0011233345567889999999999999997     666654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.1e-40  Score=330.98  Aligned_cols=265  Identities=21%  Similarity=0.276  Sum_probs=202.2

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCC--ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEe
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI--DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE  292 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e  292 (537)
                      ++|+..+.||+|+||.||+++.+ +++.||+|+++..  .....+.+.+|+.+++.++|+||+++++++.+.+..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            46888999999999999999975 6789999988643  23345678899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeecc
Q 009340          293 YISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG  372 (537)
Q Consensus       293 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfg  372 (537)
                      |++++++..+...            ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||
T Consensus        81 ~~~~~~l~~~~~~------------~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg  145 (287)
T cd07848          81 YVEKNMLELLEEM------------PNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFG  145 (287)
T ss_pred             cCCCCHHHHHHhc------------CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeecc
Confidence            9998777554322            235899999999999999999999998   9999999999999999999999999


Q ss_pred             CccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHH---------
Q 009340          373 ISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACF---------  443 (537)
Q Consensus       373 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~---------  443 (537)
                      ++...............|++.|+|||++.+..++.++|||||||++|||++|+.||......+........         
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  225 (287)
T cd07848         146 FARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQM  225 (287)
T ss_pred             CcccccccccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHH
Confidence            99876443332233456899999999999888999999999999999999999998754332211000000         


Q ss_pred             HHHHhhchhhhhhcHHh------hccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          444 ISLAKENQLLEILDARV------AKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       444 ~~~~~~~~~~~~~d~~~------~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      ..............+..      ........+..+.+|+.+||+.||++|||+.++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         226 KLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             HhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            00000000000000000      00011123567899999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.5e-40  Score=324.44  Aligned_cols=252  Identities=27%  Similarity=0.426  Sum_probs=203.7

Q ss_pred             cCCccccccCcCCceEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecCC
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYIS  295 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  295 (537)
                      ++|...+.||+|+||.||+|.+.++..||+|.++.... ..++|.+|+.++.+++||||+++++++.+.+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS   82 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence            35667789999999999999987777899998875432 34678999999999999999999999998888999999999


Q ss_pred             CCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCcc
Q 009340          296 SGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISR  375 (537)
Q Consensus       296 ~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~  375 (537)
                      +|+|.+++....           ..++|..++.++.|++.||+|||+.+   ++|+||||+||++++++.+||+|||+++
T Consensus        83 ~~~l~~~i~~~~-----------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~  148 (256)
T cd05113          83 NGCLLNYLREHG-----------KRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSR  148 (256)
T ss_pred             CCcHHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccce
Confidence            999999986532           25899999999999999999999999   9999999999999999999999999988


Q ss_pred             ccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHHHHHhhchhhh
Q 009340          376 SIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQLLE  454 (537)
Q Consensus       376 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  454 (537)
                      ..............++..|+|||.+.+..++.++||||||+++|||++ |+.||......+       .........   
T Consensus       149 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~-------~~~~~~~~~---  218 (256)
T cd05113         149 YVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE-------TVEKVSQGL---  218 (256)
T ss_pred             ecCCCceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH-------HHHHHhcCC---
Confidence            664433222223345678999999998889999999999999999999 999986433221       111111110   


Q ss_pred             hhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHH
Q 009340          455 ILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELE  498 (537)
Q Consensus       455 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~  498 (537)
                            ....+...+..+.+++.+||+.+|++||++.+|++.|+
T Consensus       219 ------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         219 ------RLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             ------CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence                  11112223467899999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1.9e-40  Score=343.11  Aligned_cols=270  Identities=25%  Similarity=0.401  Sum_probs=210.5

Q ss_pred             hcCCccccccCcCCceEEEEEEcC------CCCEEEEEEccCC-ChHHHHHHHHHHHHHHhcC-CCCcceEeeEEeeCCc
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLP------DGSIVAVKRSKEI-DKTQIHQFINEVVILSQIN-HRHIVKLLGCCLETEV  286 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~  286 (537)
                      .++|...++||+|+||.||+|+..      .+..||||+++.. .....+.|.+|+.+++++. ||||++++++|.+...
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~  115 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP  115 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence            467888899999999999999842      2346999999753 3344567999999999996 9999999999999999


Q ss_pred             cEEEEecCCCCChhhhhhhhhhhHH-------------------------------------------------------
Q 009340          287 PVLVYEYISSGTLSHHIHDHQQQQE-------------------------------------------------------  311 (537)
Q Consensus       287 ~~lV~e~~~~gsL~~~l~~~~~~~~-------------------------------------------------------  311 (537)
                      .++||||+++|+|.++++.......                                                       
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (400)
T cd05105         116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK  195 (400)
T ss_pred             eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence            9999999999999999976432100                                                       


Q ss_pred             -----------------------------HHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECC
Q 009340          312 -----------------------------QKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD  362 (537)
Q Consensus       312 -----------------------------~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~  362 (537)
                                                   .........++|..++.++.|+++||.|||+.+   |+||||||+|||++.
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~  272 (400)
T cd05105         196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQ  272 (400)
T ss_pred             hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeC
Confidence                                         000011235899999999999999999999998   999999999999999


Q ss_pred             CCcEEEeeccCccccCCCCCc-eeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHH
Q 009340          363 KFSAKVSDFGISRSIPNDKTH-LTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLV  440 (537)
Q Consensus       363 ~~~~ki~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~  440 (537)
                      ++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||........    
T Consensus       273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~----  348 (400)
T cd05105         273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST----  348 (400)
T ss_pred             CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH----
Confidence            999999999999865433222 1223456788999999999999999999999999999997 8889764322110    


Q ss_pred             HHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHH
Q 009340          441 ACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRR  502 (537)
Q Consensus       441 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~  502 (537)
                        +......+         .....+...+..+.+++.+||+.+|++|||+.+|.++|+++.+
T Consensus       349 --~~~~~~~~---------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~  399 (400)
T cd05105         349 --FYNKIKSG---------YRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP  399 (400)
T ss_pred             --HHHHHhcC---------CCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence              11111111         1112233445678999999999999999999999999997643

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.5e-40  Score=329.29  Aligned_cols=263  Identities=27%  Similarity=0.496  Sum_probs=205.7

Q ss_pred             cCCccccccCcCCceEEEEEEc-----CCCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeC--CccE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGML-----PDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLET--EVPV  288 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~  288 (537)
                      .+|...+.||+|+||.||++..     .++..||+|.++.......+.|.+|+.+++.++|+|++++.+++...  ...+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            4677889999999999999974     25789999999877777778899999999999999999999987543  4678


Q ss_pred             EEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEE
Q 009340          289 LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKV  368 (537)
Q Consensus       289 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki  368 (537)
                      +|+||+++|+|.+++....           ..++|..++.++.|+++||+|||+.+   ++||||||+||++++++.+||
T Consensus        84 lv~e~~~~~~L~~~l~~~~-----------~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l  149 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKHR-----------ERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKI  149 (284)
T ss_pred             EEEEecCCCCHHHHHHhcC-----------cCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEE
Confidence            9999999999999986532           35899999999999999999999999   999999999999999999999


Q ss_pred             eeccCccccCCCCCcee--eeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHH
Q 009340          369 SDFGISRSIPNDKTHLT--TTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISL  446 (537)
Q Consensus       369 ~Dfgla~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~  446 (537)
                      +|||++...........  ....++..|+|||.+.+..++.++||||||+++|||++|..++......        +...
T Consensus       150 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~--------~~~~  221 (284)
T cd05081         150 GDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE--------FMRM  221 (284)
T ss_pred             CCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh--------hhhh
Confidence            99999987654332211  1222345699999999889999999999999999999987765322110        0000


Q ss_pred             Hhhc--------hhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHH
Q 009340          447 AKEN--------QLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGL  500 (537)
Q Consensus       447 ~~~~--------~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i  500 (537)
                      ....        .+.+.+......+.+...+..+.+++.+||+.+|++|||+.+|++.|+.+
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         222 MGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             cccccccccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            0000        01111111111122233456789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-40  Score=335.55  Aligned_cols=256  Identities=28%  Similarity=0.393  Sum_probs=210.7

Q ss_pred             HHhcCCccccccCcCCceEEEEEEc-CCCCEEEEEEccCC----Ch-HHHHHHHHHHHHHHhcC-CCCcceEeeEEeeCC
Q 009340          213 RATDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEI----DK-TQIHQFINEVVILSQIN-HRHIVKLLGCCLETE  285 (537)
Q Consensus       213 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~  285 (537)
                      ...++|...+.||+|.||.|+.|.. .+|..||+|.....    .. ...+.+.+|+.++++++ ||||++++.++....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            3457889999999999999999984 46899999976542    11 23445668999999998 999999999999999


Q ss_pred             ccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCC-C
Q 009340          286 VPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK-F  364 (537)
Q Consensus       286 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~-~  364 (537)
                      ..++||||+.+|+|.+++...            ..+.+.....++.|++.|++|+|+++   |+||||||+|||+|.+ +
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~~------------g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~  158 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVNK------------GRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEG  158 (370)
T ss_pred             eEEEEEEecCCccHHHHHHHc------------CCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCC
Confidence            999999999999999999872            36888999999999999999999999   9999999999999999 9


Q ss_pred             cEEEeeccCccccCCCCCceeeeccccccccCcccccCCC-CC-cchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHH
Q 009340          365 SAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQ-FT-DKSDVYSFGVVLLELLTGKKPICFARVEEERNLVAC  442 (537)
Q Consensus       365 ~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~t-~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~  442 (537)
                      ++||+|||++.... .......+.+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+......      -
T Consensus       159 ~~Kl~DFG~s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~------l  231 (370)
T KOG0583|consen  159 NLKLSDFGLSAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPN------L  231 (370)
T ss_pred             CEEEeccccccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHH------H
Confidence            99999999998874 2233456788999999999999877 76 78999999999999999999997632211      1


Q ss_pred             HHHHHhhchhhhhhcHHhhccccHHH-HHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHH
Q 009340          443 FISLAKENQLLEILDARVAKEAREED-IGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRR  502 (537)
Q Consensus       443 ~~~~~~~~~~~~~~d~~~~~~~~~~~-~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~  502 (537)
                      +.. ..        ...+  .++... +.++..|+.+|+..||..|+|+.+|+ .-.-++.
T Consensus       232 ~~k-i~--------~~~~--~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~-~h~w~~~  280 (370)
T KOG0583|consen  232 YRK-IR--------KGEF--KIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL-EHPWFQK  280 (370)
T ss_pred             HHH-Hh--------cCCc--cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh-hChhhcc
Confidence            111 11        1111  123333 77889999999999999999999998 6665554

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=4.1e-40  Score=327.09  Aligned_cols=269  Identities=27%  Similarity=0.477  Sum_probs=212.8

Q ss_pred             cCCccccccCcCCceEEEEEEc------CCCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGML------PDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVL  289 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  289 (537)
                      ++|...+.||+|+||.||++..      .++..+|+|.+..........+.+|+.++++++|+|++++++++...+..++
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   84 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            5778889999999999999984      2345699999987666667789999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhhhhhhhHHHHh-hhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEE
Q 009340          290 VYEYISSGTLSHHIHDHQQQQEQKQ-KQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKV  368 (537)
Q Consensus       290 V~e~~~~gsL~~~l~~~~~~~~~~~-~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki  368 (537)
                      ||||+++++|.+++........... ......++|..++.++.|++.||+|||+.+   ++||||||+||++++++.+||
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl  161 (288)
T cd05093          85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI  161 (288)
T ss_pred             EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEe
Confidence            9999999999999975432110000 001235999999999999999999999999   999999999999999999999


Q ss_pred             eeccCccccCCCCCc-eeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHHHH
Q 009340          369 SDFGISRSIPNDKTH-LTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISL  446 (537)
Q Consensus       369 ~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~  446 (537)
                      +|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+       ....
T Consensus       162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~-------~~~~  234 (288)
T cd05093         162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE-------VIEC  234 (288)
T ss_pred             ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHH
Confidence            999999866433221 1223345778999999998899999999999999999998 888876443221       1111


Q ss_pred             HhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHHh
Q 009340          447 AKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRS  503 (537)
Q Consensus       447 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~  503 (537)
                      ...+...         ..+...+..+.+++.+||+.||.+|||+.++.+.|+.+...
T Consensus       235 i~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~  282 (288)
T cd05093         235 ITQGRVL---------QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA  282 (288)
T ss_pred             HHcCCcC---------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence            1111110         11122345789999999999999999999999999988863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=3.7e-40  Score=327.92  Aligned_cols=268  Identities=26%  Similarity=0.465  Sum_probs=213.2

Q ss_pred             cCCccccccCcCCceEEEEEEcC------CCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP------DGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVL  289 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  289 (537)
                      .+|...+.||+|+||.||++...      ++..+++|.++.......+.+.+|+.++++++|+||+++++++.+.+..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            45777889999999999999742      355799999987666667789999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhhhhhhhHHH----HhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCc
Q 009340          290 VYEYISSGTLSHHIHDHQQQQEQ----KQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFS  365 (537)
Q Consensus       290 V~e~~~~gsL~~~l~~~~~~~~~----~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~  365 (537)
                      ||||+++++|.+++.........    ........++|..++.++.|++.||+|||+.+   ++||||||+|||++.++.
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence            99999999999999764321000    00011235899999999999999999999999   999999999999999999


Q ss_pred             EEEeeccCccccCCCCC-ceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHH
Q 009340          366 AKVSDFGISRSIPNDKT-HLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACF  443 (537)
Q Consensus       366 ~ki~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~  443 (537)
                      ++|+|||++........ .......++..|+|||++.+..++.++||||||+++|||++ |+.||......+       .
T Consensus       162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-------~  234 (291)
T cd05094         162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE-------V  234 (291)
T ss_pred             EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------H
Confidence            99999999976543322 12233456788999999999999999999999999999999 999986543322       1


Q ss_pred             HHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHH
Q 009340          444 ISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRR  502 (537)
Q Consensus       444 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~  502 (537)
                      ......+..         ...+...+..+.+++.+||+.+|++|||+.+|+++|+.+..
T Consensus       235 ~~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~  284 (291)
T cd05094         235 IECITQGRV---------LERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK  284 (291)
T ss_pred             HHHHhCCCC---------CCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence            111111111         11122345678899999999999999999999999999866

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=2.4e-40  Score=327.09  Aligned_cols=264  Identities=28%  Similarity=0.487  Sum_probs=209.2

Q ss_pred             cCCccccccCcCCceEEEEEEcCC------CCEEEEEEccCCChH-HHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLPD------GSIVAVKRSKEIDKT-QIHQFINEVVILSQINHRHIVKLLGCCLETEVPV  288 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~~------g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  288 (537)
                      ++|...+.||+|+||.||+|...+      +..||||.++..... ..+.|.+|+++++.++|+|++++++++......+
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   84 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI   84 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence            467778899999999999998633      478999998764433 5678999999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhhhhhhhHHHH--hhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcE
Q 009340          289 LVYEYISSGTLSHHIHDHQQQQEQK--QKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA  366 (537)
Q Consensus       289 lV~e~~~~gsL~~~l~~~~~~~~~~--~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~  366 (537)
                      +||||+++|+|.+++..........  .......+++..+..++.|++.|+.|||+.+   ++||||||+||+++.++.+
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence            9999999999999997653211111  0111345899999999999999999999999   9999999999999999999


Q ss_pred             EEeeccCccccCCCCCc-eeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHH
Q 009340          367 KVSDFGISRSIPNDKTH-LTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFI  444 (537)
Q Consensus       367 ki~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~  444 (537)
                      ||+|||++......... ......+++.|+|||++.+..++.++||||||+++|||++ |+.||......+.       .
T Consensus       162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~-------~  234 (280)
T cd05049         162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEV-------I  234 (280)
T ss_pred             EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH-------H
Confidence            99999999765332221 1233345788999999999999999999999999999998 9999865433221       1


Q ss_pred             HHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHH
Q 009340          445 SLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELE  498 (537)
Q Consensus       445 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~  498 (537)
                      .....+.         ....+...+..+.+++.+||+.||++||++.||+++|+
T Consensus       235 ~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         235 ECITQGR---------LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             HHHHcCC---------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence            1111111         11122334567899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.6e-41  Score=339.34  Aligned_cols=248  Identities=26%  Similarity=0.469  Sum_probs=212.1

Q ss_pred             cccccCcCCceEEEEEEcC--CCC--EEEEEEccCCChH-HHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecC
Q 009340          220 QSRFLGQGGFGTVYKGMLP--DGS--IVAVKRSKEIDKT-QIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI  294 (537)
Q Consensus       220 ~~~~lg~G~~g~Vy~~~~~--~g~--~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  294 (537)
                      ..++||+|.||.|++|.|.  +|+  .||||.++..... ...+|++|+.+|.+|+|+|+++|+|+..+ ....+|+|.+
T Consensus       114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa  192 (1039)
T KOG0199|consen  114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA  192 (1039)
T ss_pred             HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence            3578999999999999986  344  5999999876544 67899999999999999999999999988 6678999999


Q ss_pred             CCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCc
Q 009340          295 SSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGIS  374 (537)
Q Consensus       295 ~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla  374 (537)
                      +.|||.+.|+...          ...|-......++.|||.||.||.+++   +|||||.++|+||-..-.+||+||||.
T Consensus       193 plGSLldrLrka~----------~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLm  259 (1039)
T KOG0199|consen  193 PLGSLLDRLRKAK----------KAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLM  259 (1039)
T ss_pred             ccchHHHHHhhcc----------ccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccce
Confidence            9999999998722          346888999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCCc-ee-eeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHHHHHhhch
Q 009340          375 RSIPNDKTH-LT-TTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQ  451 (537)
Q Consensus       375 ~~~~~~~~~-~~-~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  451 (537)
                      +.++....+ .+ ....-++.|+|||.+..+.|+.+||||+|||.+|||+| |..||.....                ..
T Consensus       260 RaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g----------------~q  323 (1039)
T KOG0199|consen  260 RALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG----------------IQ  323 (1039)
T ss_pred             eccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH----------------HH
Confidence            988544332 22 23445778999999999999999999999999999999 8888754322                13


Q ss_pred             hhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHH
Q 009340          452 LLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMEL  497 (537)
Q Consensus       452 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L  497 (537)
                      +.+.+|.+-+-+.+..|+++++++++.||..+|++|||+..|.+.+
T Consensus       324 IL~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~  369 (1039)
T KOG0199|consen  324 ILKNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL  369 (1039)
T ss_pred             HHHhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence            4455666666677889999999999999999999999999997544

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.8e-40  Score=322.45  Aligned_cols=250  Identities=26%  Similarity=0.427  Sum_probs=203.0

Q ss_pred             CCccccccCcCCceEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecCCC
Q 009340          217 NYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISS  296 (537)
Q Consensus       217 ~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  296 (537)
                      +|+..+.||+|+||.||++.++++..+|+|.+..... ....|.+|+.++++++|+|++++++++.+.+..++|+||+++
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN   83 (256)
T ss_pred             HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence            4677889999999999999987777899998865322 235688999999999999999999999999999999999999


Q ss_pred             CChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCccc
Q 009340          297 GTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS  376 (537)
Q Consensus       297 gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~  376 (537)
                      ++|.+++....           ..++|..++.++.|+++||+|||+.+   ++||||||+||++++++.+||+|||+++.
T Consensus        84 ~~L~~~l~~~~-----------~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~  149 (256)
T cd05059          84 GCLLNYLRERK-----------GKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARY  149 (256)
T ss_pred             CCHHHHHHhcc-----------cCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCccccee
Confidence            99999987532           25899999999999999999999999   99999999999999999999999999986


Q ss_pred             cCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHHHHHhhchhhhh
Q 009340          377 IPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQLLEI  455 (537)
Q Consensus       377 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  455 (537)
                      .............++..|+|||.+.+..++.++||||||+++|||++ |+.||......+.       ......      
T Consensus       150 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~-------~~~~~~------  216 (256)
T cd05059         150 VLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEV-------VESVSA------  216 (256)
T ss_pred             cccccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHH-------HHHHHc------
Confidence            64332222222334568999999999999999999999999999999 7888864332211       111110      


Q ss_pred             hcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHH
Q 009340          456 LDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMEL  497 (537)
Q Consensus       456 ~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L  497 (537)
                         ......+...+..+.+++.+||+.+|++|||+.+++++|
T Consensus       217 ---~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         217 ---GYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             ---CCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence               111122233556799999999999999999999999887

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=6.8e-41  Score=333.33  Aligned_cols=246  Identities=27%  Similarity=0.454  Sum_probs=210.0

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCC--ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEe
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI--DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE  292 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e  292 (537)
                      ++|...+.||+|.||.||||+-+ +.+.||+|.+.+.  .....+.+.+|++|++.++||||+.++++++...+.++|+|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            47888899999999999999954 6889999987653  34456778999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeecc
Q 009340          293 YISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG  372 (537)
Q Consensus       293 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfg  372 (537)
                      |+.+ +|..+|...            ..++++.+..|+.+++.||.|||+.+   |.|||+||+|||++.++.+|++|||
T Consensus        82 ~a~g-~L~~il~~d------------~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg  145 (808)
T KOG0597|consen   82 YAVG-DLFTILEQD------------GKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFG  145 (808)
T ss_pred             hhhh-hHHHHHHhc------------cCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhh
Confidence            9977 999999764            46999999999999999999999999   9999999999999999999999999


Q ss_pred             CccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchh
Q 009340          373 ISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQL  452 (537)
Q Consensus       373 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  452 (537)
                      +|+.... .....+.+.||+-|||||.+.+..|+..+|.||+||++||+.+|++||.......      -...+..++  
T Consensus       146 ~Ar~m~~-~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~------Lv~~I~~d~--  216 (808)
T KOG0597|consen  146 LARAMST-NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQ------LVKSILKDP--  216 (808)
T ss_pred             hhhhccc-CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHH------HHHHHhcCC--
Confidence            9998765 3455677889999999999999999999999999999999999999997543211      111111111  


Q ss_pred             hhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          453 LEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       453 ~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                               ...+...+..+..++...|.+||..|.|-.+++.
T Consensus       217 ---------v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  217 ---------VKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             ---------CCCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence                     1134567788999999999999999999887753

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=6.5e-40  Score=332.31  Aligned_cols=262  Identities=26%  Similarity=0.379  Sum_probs=205.0

Q ss_pred             hcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCC-ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEe
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI-DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE  292 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e  292 (537)
                      .++|+..+.||+|+||.||+++.. +|..||+|.+... .....+.+.+|++++++++|+||+++++++.+.+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            368889999999999999999965 6889999988753 33445679999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeecc
Q 009340          293 YISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG  372 (537)
Q Consensus       293 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfg  372 (537)
                      |+++|+|.+++...            ..+++..+..++.|++.||.|||+.+.  |+||||||+|||++.++.+||+|||
T Consensus        84 ~~~~~~L~~~l~~~------------~~~~~~~~~~~~~~i~~~l~~lH~~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg  149 (331)
T cd06649          84 HMDGGSLDQVLKEA------------KRIPEEILGKVSIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFG  149 (331)
T ss_pred             cCCCCcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHhhcCC--EEcCCCChhhEEEcCCCcEEEccCc
Confidence            99999999998652            358899999999999999999998532  9999999999999999999999999


Q ss_pred             CccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHh----
Q 009340          373 ISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAK----  448 (537)
Q Consensus       373 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~----  448 (537)
                      ++.......   .....||..|+|||.+.+..++.++|||||||++|||++|+.||......+.   ...+.....    
T Consensus       150 ~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~---~~~~~~~~~~~~~  223 (331)
T cd06649         150 VSGQLIDSM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKEL---EAIFGRPVVDGEE  223 (331)
T ss_pred             ccccccccc---cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHhccccccccc
Confidence            997653321   2345689999999999999999999999999999999999999864332211   000000000    


Q ss_pred             --------------------------hchhhhhhcH---Hhhccc-cHHHHHHHHHHHHHhcccCCCCCCCHhhHHHH
Q 009340          449 --------------------------ENQLLEILDA---RVAKEA-REEDIGAMAELAMRCLRLNSKKRPTMKQVSME  496 (537)
Q Consensus       449 --------------------------~~~~~~~~d~---~~~~~~-~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~  496 (537)
                                                .....+..+.   ...... ......++.+|+.+||+.||++|||+.++++.
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h  301 (331)
T cd06649         224 GEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH  301 (331)
T ss_pred             CCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                                      0000000010   000000 11345678999999999999999999999764

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=6.2e-40  Score=324.33  Aligned_cols=256  Identities=24%  Similarity=0.445  Sum_probs=202.7

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCC----EEEEEEccCCC-hHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGS----IVAVKRSKEID-KTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVL  289 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  289 (537)
                      ++|+..+.||+|+||.||+|.+. +++    .|++|.+.... .....++..|+..+++++|+||+++++++.. ...++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence            35667789999999999999964 344    47888876432 3345678889999999999999999999864 45689


Q ss_pred             EEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEe
Q 009340          290 VYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVS  369 (537)
Q Consensus       290 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~  369 (537)
                      ++||+++|+|.+++....           ..++|..++.++.|+++||.|||+.+   ++||||||+|||+++++.+||+
T Consensus        86 i~e~~~~gsL~~~l~~~~-----------~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~  151 (279)
T cd05111          86 VTQLSPLGSLLDHVRQHR-----------DSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIA  151 (279)
T ss_pred             EEEeCCCCcHHHHHHhcc-----------cCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEc
Confidence            999999999999997532           36899999999999999999999998   9999999999999999999999


Q ss_pred             eccCccccCCCCC-ceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHHHHH
Q 009340          370 DFGISRSIPNDKT-HLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLA  447 (537)
Q Consensus       370 Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~  447 (537)
                      |||+++....... .......++..|+|||.+.++.++.++||||||+++|||++ |+.|+.......       .....
T Consensus       152 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~-------~~~~~  224 (279)
T cd05111         152 DFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE-------VPDLL  224 (279)
T ss_pred             CCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHH
Confidence            9999987643322 22234457789999999999999999999999999999998 999986443221       11111


Q ss_pred             hhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHH
Q 009340          448 KENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRR  502 (537)
Q Consensus       448 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~  502 (537)
                      ..+.         ....+..+...+.+++.+||..+|++|||+.|+++.|..+.+
T Consensus       225 ~~~~---------~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~  270 (279)
T cd05111         225 EKGE---------RLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR  270 (279)
T ss_pred             HCCC---------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence            1111         111112234567889999999999999999999999988664

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=3e-40  Score=326.12  Aligned_cols=264  Identities=27%  Similarity=0.473  Sum_probs=206.4

Q ss_pred             HhcCCccccccCcCCceEEEEEEcC------CCCEEEEEEccCC-ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCc
Q 009340          214 ATDNYNQSRFLGQGGFGTVYKGMLP------DGSIVAVKRSKEI-DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEV  286 (537)
Q Consensus       214 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~  286 (537)
                      .+++|+..+.||+|+||.||+|...      .+..||||.+... ......+|.+|+.+++.++|+||+++++++.+...
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4578999999999999999998753      3567999988643 33445678999999999999999999999998889


Q ss_pred             cEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcE
Q 009340          287 PVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA  366 (537)
Q Consensus       287 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~  366 (537)
                      .++||||+++|+|.+++..........  .....++|..++.++.|+++||.|||+.+   ++||||||+||++++++.+
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~  158 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENN--PVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTV  158 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCcccccc--ccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCE
Confidence            999999999999999997643211000  00235789999999999999999999998   9999999999999999999


Q ss_pred             EEeeccCccccCCCCCcee-eeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHH
Q 009340          367 KVSDFGISRSIPNDKTHLT-TTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFI  444 (537)
Q Consensus       367 ki~Dfgla~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~  444 (537)
                      +|+|||+++.......... ....++..|+|||++.++.++.++||||||+++|||++ |..||.......       ..
T Consensus       159 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~-------~~  231 (277)
T cd05062         159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ-------VL  231 (277)
T ss_pred             EECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-------HH
Confidence            9999999976543322211 22345778999999998899999999999999999999 688875432221       11


Q ss_pred             HHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHH
Q 009340          445 SLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELE  498 (537)
Q Consensus       445 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~  498 (537)
                      ........         ...+...+..+.+++.+||+.+|++|||+.|+++.|+
T Consensus       232 ~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         232 RFVMEGGL---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             HHHHcCCc---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence            11111111         1112234457899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-40  Score=328.37  Aligned_cols=244  Identities=25%  Similarity=0.329  Sum_probs=200.5

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCC---ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI---DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY  291 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  291 (537)
                      ++|...+.||+|+||.||++... +|+.||+|.+...   .....+.+.+|+.++++++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            36888899999999999999965 6899999998642   2234566889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeec
Q 009340          292 EYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF  371 (537)
Q Consensus       292 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Df  371 (537)
                      ||+++|+|.+++...            ..+++..+..++.|+++||+|||+.+   |+||||||+|||++.++.+||+||
T Consensus        81 e~~~~~~L~~~~~~~------------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Df  145 (291)
T cd05612          81 EYVPGGELFSYLRNS------------GRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDF  145 (291)
T ss_pred             eCCCCCCHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEec
Confidence            999999999998653            35899999999999999999999999   999999999999999999999999


Q ss_pred             cCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhch
Q 009340          372 GISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQ  451 (537)
Q Consensus       372 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  451 (537)
                      |+++.....    .....||+.|+|||.+.+..++.++|||||||++|||++|+.||......+.      ... .....
T Consensus       146 g~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~------~~~-i~~~~  214 (291)
T cd05612         146 GFAKKLRDR----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGI------YEK-ILAGK  214 (291)
T ss_pred             CcchhccCC----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHH-HHhCC
Confidence            999866432    1234689999999999988899999999999999999999999865432210      111 11110


Q ss_pred             hhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCC-----HhhHHH
Q 009340          452 LLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPT-----MKQVSM  495 (537)
Q Consensus       452 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~ev~~  495 (537)
                                ...+......+.+|+.+||+.||.+||+     +.++++
T Consensus       215 ----------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  253 (291)
T cd05612         215 ----------LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN  253 (291)
T ss_pred             ----------cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence                      1122233557889999999999999995     666654

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-40  Score=336.61  Aligned_cols=253  Identities=25%  Similarity=0.395  Sum_probs=204.6

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCC---ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI---DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY  291 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  291 (537)
                      ++|+..+.||+|+||.||+|+.. +++.||||+++..   .......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            36888999999999999999975 5889999998642   2234567889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeec
Q 009340          292 EYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF  371 (537)
Q Consensus       292 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Df  371 (537)
                      ||+++|+|.+++...            ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+||
T Consensus        81 e~~~g~~L~~~l~~~------------~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Df  145 (333)
T cd05600          81 EYVPGGDFRTLLNNL------------GVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDF  145 (333)
T ss_pred             eCCCCCCHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeC
Confidence            999999999999652            35899999999999999999999999   999999999999999999999999


Q ss_pred             cCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhch
Q 009340          372 GISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQ  451 (537)
Q Consensus       372 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  451 (537)
                      |++.....    ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.      +....... 
T Consensus       146 g~a~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~------~~~i~~~~-  214 (333)
T cd05600         146 GLSKGIVT----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET------WENLKYWK-  214 (333)
T ss_pred             cCCccccc----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHH------HHHHHhcc-
Confidence            99976533    23345689999999999999999999999999999999999999975443221      11111000 


Q ss_pred             hhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHH
Q 009340          452 LLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSME  496 (537)
Q Consensus       452 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~  496 (537)
                        ..+............+.++.+++.+||+.+|++||++.++++.
T Consensus       215 --~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         215 --ETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             --ccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence              0000000000012345678899999999999999999999864

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=1.2e-39  Score=316.62  Aligned_cols=247  Identities=28%  Similarity=0.452  Sum_probs=200.9

Q ss_pred             cccCcCCceEEEEEEcCCCCEEEEEEccCCC-hHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecCCCCChh
Q 009340          222 RFLGQGGFGTVYKGMLPDGSIVAVKRSKEID-KTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLS  300 (537)
Q Consensus       222 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~  300 (537)
                      ++||+|+||.||+|...+++.||+|..+... ......|.+|+.+++.++|+|++++++++...+..++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            3699999999999998889999999987543 334457899999999999999999999999999999999999999999


Q ss_pred             hhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCccccCCC
Q 009340          301 HHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPND  380 (537)
Q Consensus       301 ~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~  380 (537)
                      +++....           ..++|..++.++.|++++|.|||+.+   ++||||||+||+++.++.+||+|||++......
T Consensus        81 ~~~~~~~-----------~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~  146 (250)
T cd05085          81 SFLRKKK-----------DELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDG  146 (250)
T ss_pred             HHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceecccc
Confidence            9986432           25899999999999999999999998   999999999999999999999999998765333


Q ss_pred             CCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHHHHHhhchhhhhhcHH
Q 009340          381 KTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQLLEILDAR  459 (537)
Q Consensus       381 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  459 (537)
                      .........++..|+|||++.++.++.++||||||+++|||++ |..||.......       .......         .
T Consensus       147 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~-------~~~~~~~---------~  210 (250)
T cd05085         147 IYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ-------AREQVEK---------G  210 (250)
T ss_pred             ccccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH-------HHHHHHc---------C
Confidence            2222222345678999999998999999999999999999999 998986443221       1111111         1


Q ss_pred             hhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHH
Q 009340          460 VAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELE  498 (537)
Q Consensus       460 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~  498 (537)
                      .....+...+..+.+++.+||+.+|++||++.+++++|.
T Consensus       211 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         211 YRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            111122334567899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=6.5e-40  Score=320.51  Aligned_cols=253  Identities=29%  Similarity=0.458  Sum_probs=204.9

Q ss_pred             cCCccccccCcCCceEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecCC
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYIS  295 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  295 (537)
                      ++|...++||+|+||.||++...++..||+|.++.... ..+.|.+|+.++++++|+|++++++++. ....+++|||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~   83 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS   83 (260)
T ss_pred             HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence            46778899999999999999988888899999875332 2457899999999999999999999885 456799999999


Q ss_pred             CCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCcc
Q 009340          296 SGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISR  375 (537)
Q Consensus       296 ~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~  375 (537)
                      +++|.+++....          ...+++..++.++.+++.||.|||+.+   ++||||||+||++++++.++|+|||++.
T Consensus        84 ~~~L~~~~~~~~----------~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~  150 (260)
T cd05070          84 KGSLLDFLKDGE----------GRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLAR  150 (260)
T ss_pred             CCcHHHHHHhcC----------CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeee
Confidence            999999997532          235899999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHHHHHhhchhhh
Q 009340          376 SIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQLLE  454 (537)
Q Consensus       376 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  454 (537)
                      ..............++..|+|||.+.+..++.++||||||+++|||++ |+.||......+       .....       
T Consensus       151 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~-------~~~~~-------  216 (260)
T cd05070         151 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE-------VLEQV-------  216 (260)
T ss_pred             eccCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHH-------
Confidence            764433222223345678999999988899999999999999999999 888885432211       01111       


Q ss_pred             hhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHH
Q 009340          455 ILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEG  499 (537)
Q Consensus       455 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  499 (537)
                        ......+.+...+..+.+++.+||+.+|++|||+.++.+.|+.
T Consensus       217 --~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         217 --ERGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             --HcCCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence              1111112334455678999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=3.5e-40  Score=333.06  Aligned_cols=241  Identities=24%  Similarity=0.366  Sum_probs=197.2

Q ss_pred             cccCcCCceEEEEEEc-CCCCEEEEEEccCC---ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecCCCC
Q 009340          222 RFLGQGGFGTVYKGML-PDGSIVAVKRSKEI---DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSG  297 (537)
Q Consensus       222 ~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g  297 (537)
                      +.||+|+||.||++.. .+|+.||+|.++..   .......+.+|+.++++++||||+++++++.+.+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            3699999999999985 47899999988742   2334567889999999999999999999999999999999999999


Q ss_pred             ChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCcccc
Q 009340          298 TLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI  377 (537)
Q Consensus       298 sL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~  377 (537)
                      +|.+++...            ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        81 ~L~~~l~~~------------~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~  145 (323)
T cd05571          81 ELFFHLSRE------------RVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEG  145 (323)
T ss_pred             cHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCccc
Confidence            999888652            35899999999999999999999999   999999999999999999999999998754


Q ss_pred             CCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchhhhhhc
Q 009340          378 PNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEILD  457 (537)
Q Consensus       378 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  457 (537)
                      .... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.......       .........      
T Consensus       146 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~-------~~~~~~~~~------  211 (323)
T cd05571         146 ISDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-------LFELILMEE------  211 (323)
T ss_pred             ccCC-CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH-------HHHHHHcCC------
Confidence            2221 12334568999999999999999999999999999999999999986543221       011111000      


Q ss_pred             HHhhccccHHHHHHHHHHHHHhcccCCCCCC-----CHhhHHH
Q 009340          458 ARVAKEAREEDIGAMAELAMRCLRLNSKKRP-----TMKQVSM  495 (537)
Q Consensus       458 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~  495 (537)
                          ...+......+.+++.+||+.||++||     ++.++++
T Consensus       212 ----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         212 ----IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             ----CCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence                112334456788999999999999999     7888764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=5.1e-40  Score=333.65  Aligned_cols=270  Identities=28%  Similarity=0.452  Sum_probs=208.5

Q ss_pred             hcCCccccccCcCCceEEEEEEcC------CCCEEEEEEccCCC-hHHHHHHHHHHHHHHhc-CCCCcceEeeEEeeC-C
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLP------DGSIVAVKRSKEID-KTQIHQFINEVVILSQI-NHRHIVKLLGCCLET-E  285 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~-~  285 (537)
                      .++|...+.||+|+||.||+|...      .++.||+|+++... ....+.+.+|+.++.++ +|+||++++++|... .
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~   85 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG   85 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence            357888999999999999999742      24789999987532 34456788999999999 899999999988754 4


Q ss_pred             ccEEEEecCCCCChhhhhhhhhhhH-------------------------------------------------HHHhhh
Q 009340          286 VPVLVYEYISSGTLSHHIHDHQQQQ-------------------------------------------------EQKQKQ  316 (537)
Q Consensus       286 ~~~lV~e~~~~gsL~~~l~~~~~~~-------------------------------------------------~~~~~~  316 (537)
                      ..++++||+++|+|.+++.......                                                 ......
T Consensus        86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (337)
T cd05054          86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL  165 (337)
T ss_pred             CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence            6789999999999999986532100                                                 000000


Q ss_pred             ccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCccccCCCCCce-eeecccccccc
Q 009340          317 ELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHL-TTTIQGTFGYL  395 (537)
Q Consensus       317 ~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~-~~~~~gt~~y~  395 (537)
                      ....++|..+.+++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||++..+....... .....++..|+
T Consensus       166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~  242 (337)
T cd05054         166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM  242 (337)
T ss_pred             hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence            1236899999999999999999999998   9999999999999999999999999998764333222 23345677899


Q ss_pred             CcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHH
Q 009340          396 DPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAE  474 (537)
Q Consensus       396 aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~  474 (537)
                      |||++.+..++.++|||||||++|||++ |..||......+.      +.......         .....+.....++.+
T Consensus       243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~------~~~~~~~~---------~~~~~~~~~~~~~~~  307 (337)
T cd05054         243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE------FCRRLKEG---------TRMRAPEYATPEIYS  307 (337)
T ss_pred             CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH------HHHHHhcc---------CCCCCCccCCHHHHH
Confidence            9999999999999999999999999998 9999864322111      11111111         111122334567899


Q ss_pred             HHHHhcccCCCCCCCHhhHHHHHHHHHH
Q 009340          475 LAMRCLRLNSKKRPTMKQVSMELEGLRR  502 (537)
Q Consensus       475 l~~~cl~~~p~~RPs~~ev~~~L~~i~~  502 (537)
                      ++.+||+.+|++||++.+|++.|+++.+
T Consensus       308 l~~~cl~~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         308 IMLDCWHNNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             HHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            9999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=9.1e-40  Score=317.88  Aligned_cols=247  Identities=28%  Similarity=0.461  Sum_probs=198.6

Q ss_pred             cccCcCCceEEEEEEcC-CCCEEEEEEccCC-ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecCCCCCh
Q 009340          222 RFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI-DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTL  299 (537)
Q Consensus       222 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL  299 (537)
                      +.||+|+||.||+|+.. +++.||+|..... .......|.+|+.++++++|+||+++++++......++|+||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            46999999999999964 7889999987643 344567799999999999999999999999999999999999999999


Q ss_pred             hhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCccccCC
Q 009340          300 SHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPN  379 (537)
Q Consensus       300 ~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~  379 (537)
                      .+++....           ..++|..++.++.|+++||+|||+.+   ++||||||+||+++.++.+||+|||++.....
T Consensus        81 ~~~~~~~~-----------~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~  146 (252)
T cd05084          81 LTFLRTEG-----------PRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEED  146 (252)
T ss_pred             HHHHHhCC-----------CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCccccc
Confidence            99986432           35899999999999999999999999   99999999999999999999999999876533


Q ss_pred             CCCcee-eeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHHHHHhhchhhhhhc
Q 009340          380 DKTHLT-TTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQLLEILD  457 (537)
Q Consensus       380 ~~~~~~-~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  457 (537)
                      ...... .....+..|+|||.+.++.++.++||||||+++|||++ |..|+.......       ....         +.
T Consensus       147 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~-------~~~~---------~~  210 (252)
T cd05084         147 GVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ-------TREA---------IE  210 (252)
T ss_pred             ccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH-------HHHH---------HH
Confidence            211111 11123467999999999999999999999999999998 888875432211       0111         11


Q ss_pred             HHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHH
Q 009340          458 ARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELE  498 (537)
Q Consensus       458 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~  498 (537)
                      .......+...+..+.+++.+||+.+|++|||+.++.++|+
T Consensus       211 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         211 QGVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             cCCCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            11111223344567899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=9e-40  Score=324.95  Aligned_cols=267  Identities=28%  Similarity=0.460  Sum_probs=208.9

Q ss_pred             CCccccccCcCCceEEEEEEcC------CCCEEEEEEccCC-ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEE
Q 009340          217 NYNQSRFLGQGGFGTVYKGMLP------DGSIVAVKRSKEI-DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVL  289 (537)
Q Consensus       217 ~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  289 (537)
                      +|...+.||+|+||.||+|+..      ....+++|.+... .......+.+|+.+++.++||||+++++++...+..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            4677889999999999999852      2357999988653 33446779999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhhhhhhhHHH------------HhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCC
Q 009340          290 VYEYISSGTLSHHIHDHQQQQEQ------------KQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSN  357 (537)
Q Consensus       290 V~e~~~~gsL~~~l~~~~~~~~~------------~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~N  357 (537)
                      |+||+++|+|.+++.........            ........+++..++.++.|++.||.|||+.+   ++||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence            99999999999998753221000            00011235899999999999999999999998   9999999999


Q ss_pred             EEECCCCcEEEeeccCccccCCCCCce-eeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhh
Q 009340          358 ILLDDKFSAKVSDFGISRSIPNDKTHL-TTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEE  435 (537)
Q Consensus       358 Ill~~~~~~ki~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~  435 (537)
                      ||+++++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~  237 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER  237 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence            999999999999999998653332221 222345678999999988889999999999999999998 998885433221


Q ss_pred             hccHHHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHH
Q 009340          436 ERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRR  502 (537)
Q Consensus       436 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~  502 (537)
                             ......         .....+.+...+..+.+++.+||+.+|++||++.++++.|+++..
T Consensus       238 -------~~~~~~---------~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~  288 (290)
T cd05045         238 -------LFNLLK---------TGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV  288 (290)
T ss_pred             -------HHHHHh---------CCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence                   111111         111112233445678899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=1.2e-39  Score=325.36  Aligned_cols=269  Identities=26%  Similarity=0.451  Sum_probs=209.2

Q ss_pred             cCCccccccCcCCceEEEEEEcCC-CC--EEEEEEccC-CChHHHHHHHHHHHHHHhc-CCCCcceEeeEEeeCCccEEE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLPD-GS--IVAVKRSKE-IDKTQIHQFINEVVILSQI-NHRHIVKLLGCCLETEVPVLV  290 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~~-g~--~vavK~~~~-~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV  290 (537)
                      ++|+..+.||+|+||.||+|...+ +.  .+++|.++. ......+.|.+|+.+++++ +|||++++++++.+.+..++|
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            578888999999999999998753 33  478998875 3344567799999999999 799999999999999999999


Q ss_pred             EecCCCCChhhhhhhhhhhHHHH----hhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcE
Q 009340          291 YEYISSGTLSHHIHDHQQQQEQK----QKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA  366 (537)
Q Consensus       291 ~e~~~~gsL~~~l~~~~~~~~~~----~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~  366 (537)
                      +||+++|+|.+++..........    .......+++..++.++.|++.||+|||+.+   ++||||||+|||+++++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence            99999999999997643211000    0001235899999999999999999999998   9999999999999999999


Q ss_pred             EEeeccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHHH
Q 009340          367 KVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFIS  445 (537)
Q Consensus       367 ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~  445 (537)
                      ||+|||++......  ........+..|+|||.+.+..++.++|||||||++|||++ |+.||......+       ...
T Consensus       159 kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~-------~~~  229 (297)
T cd05089         159 KIADFGLSRGEEVY--VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE-------LYE  229 (297)
T ss_pred             EECCcCCCccccce--eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHH
Confidence            99999998643211  11111223567999999988889999999999999999998 999986543221       111


Q ss_pred             HHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHHhhH
Q 009340          446 LAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRSQR  505 (537)
Q Consensus       446 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~~  505 (537)
                      ..         ........+...+..+.+++.+||+.+|.+||++.++++.|+.+....+
T Consensus       230 ~~---------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~  280 (297)
T cd05089         230 KL---------PQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARK  280 (297)
T ss_pred             HH---------hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence            11         1111112233345678899999999999999999999999998887653

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1.2e-39  Score=319.16  Aligned_cols=254  Identities=28%  Similarity=0.422  Sum_probs=204.8

Q ss_pred             cCCccccccCcCCceEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecCC
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYIS  295 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  295 (537)
                      .+|...++||+|+||.||+|...+...||+|.++.... ..++|.+|+.++++++|+|++++++++. ....++||||++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~   83 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS   83 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCC
Confidence            56888999999999999999987777899999875332 2457899999999999999999999875 456799999999


Q ss_pred             CCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCcc
Q 009340          296 SGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISR  375 (537)
Q Consensus       296 ~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~  375 (537)
                      +|+|.+++....          ...++|..++.++.|+++||+|||+.+   ++||||||+||++++++.++|+|||++.
T Consensus        84 ~~~L~~~~~~~~----------~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~  150 (262)
T cd05071          84 KGSLLDFLKGEM----------GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLAR  150 (262)
T ss_pred             CCcHHHHHhhcc----------ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCcee
Confidence            999999997532          235899999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHHHHHhhchhhh
Q 009340          376 SIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQLLE  454 (537)
Q Consensus       376 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  454 (537)
                      ..............++..|+|||+..+..++.++||||||+++|||++ |+.||......+       .......     
T Consensus       151 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~-------~~~~~~~-----  218 (262)
T cd05071         151 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-------VLDQVER-----  218 (262)
T ss_pred             eccccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH-------HHHHHhc-----
Confidence            764433322233446778999999988899999999999999999999 777875432211       0111100     


Q ss_pred             hhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHH
Q 009340          455 ILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGL  500 (537)
Q Consensus       455 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i  500 (537)
                          ......+...+..+.+++.+||+.+|++||++.+++++|+..
T Consensus       219 ----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         219 ----GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             ----CCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence                011112334556788999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1.4e-39  Score=317.61  Aligned_cols=245  Identities=29%  Similarity=0.458  Sum_probs=198.1

Q ss_pred             ccCcCCceEEEEEEc---CCCCEEEEEEccCC--ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecCCCC
Q 009340          223 FLGQGGFGTVYKGML---PDGSIVAVKRSKEI--DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSG  297 (537)
Q Consensus       223 ~lg~G~~g~Vy~~~~---~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g  297 (537)
                      .||+|+||.||+|.+   .++..||+|+++..  .....+++.+|+.+++.++|+||+++++++. .+..++||||+++|
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            589999999999975   35788999988643  3345678999999999999999999999985 45679999999999


Q ss_pred             ChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCcccc
Q 009340          298 TLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI  377 (537)
Q Consensus       298 sL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~  377 (537)
                      +|.+++...            ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++...
T Consensus        81 ~L~~~l~~~------------~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~  145 (257)
T cd05116          81 PLNKFLQKN------------KHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKAL  145 (257)
T ss_pred             cHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCcccccc
Confidence            999998642            35899999999999999999999999   999999999999999999999999999876


Q ss_pred             CCCCCcee--eeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHHHHHhhchhhh
Q 009340          378 PNDKTHLT--TTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQLLE  454 (537)
Q Consensus       378 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  454 (537)
                      ........  ....++..|+|||.+....++.++||||||+++|||++ |+.||......+       .......     
T Consensus       146 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-------~~~~i~~-----  213 (257)
T cd05116         146 GADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE-------VTQMIES-----  213 (257)
T ss_pred             CCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHC-----
Confidence            44433211  12234578999999988889999999999999999998 999986443221       1111111     


Q ss_pred             hhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHH
Q 009340          455 ILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEG  499 (537)
Q Consensus       455 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  499 (537)
                          ....+.+...+..+.+++.+||+.||++||++.+|.++|+.
T Consensus       214 ----~~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~  254 (257)
T cd05116         214 ----GERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN  254 (257)
T ss_pred             ----CCCCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence                11112333455678999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=9.2e-40  Score=346.67  Aligned_cols=252  Identities=25%  Similarity=0.298  Sum_probs=205.4

Q ss_pred             CCccccccCcCCceEEEEEEcC-C-CCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecC
Q 009340          217 NYNQSRFLGQGGFGTVYKGMLP-D-GSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI  294 (537)
Q Consensus       217 ~~~~~~~lg~G~~g~Vy~~~~~-~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  294 (537)
                      .|...+.||+|+||.||++... + ++.||+|............+.+|+.+++.++||||+++++++...+..++||||+
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~  147 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG  147 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence            4888899999999999999843 3 6789999876655666667889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCc
Q 009340          295 SSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGIS  374 (537)
Q Consensus       295 ~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla  374 (537)
                      ++|+|.+++.....        ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       148 ~gg~L~~~l~~~~~--------~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla  216 (478)
T PTZ00267        148 SGGDLNKQIKQRLK--------EHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFS  216 (478)
T ss_pred             CCCCHHHHHHHHHh--------ccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCc
Confidence            99999999865322        1346899999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCC-ceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchhh
Q 009340          375 RSIPNDKT-HLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLL  453 (537)
Q Consensus       375 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  453 (537)
                      +....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+      .+..... +.  
T Consensus       217 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~------~~~~~~~-~~--  287 (478)
T PTZ00267        217 KQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE------IMQQVLY-GK--  287 (478)
T ss_pred             eecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHh-CC--
Confidence            87643322 12344568999999999999999999999999999999999999986432211      0111110 00  


Q ss_pred             hhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          454 EILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       454 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                             ....+...+..+.+++.+||+.||++||++.+++.
T Consensus       288 -------~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        288 -------YDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             -------CCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence                   01122334567899999999999999999999864

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=4.1e-40  Score=333.45  Aligned_cols=243  Identities=26%  Similarity=0.387  Sum_probs=199.9

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCC---ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI---DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY  291 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  291 (537)
                      ++|...+.||+|+||.||+++.. +|+.||+|.++..   .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            57888899999999999999965 6889999988642   2234567889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeec
Q 009340          292 EYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF  371 (537)
Q Consensus       292 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Df  371 (537)
                      ||+++|+|.+++...            ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+||
T Consensus        98 e~~~~~~L~~~l~~~------------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Df  162 (329)
T PTZ00263         98 EFVVGGELFTHLRKA------------GRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDF  162 (329)
T ss_pred             cCCCCChHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeec
Confidence            999999999998753            35888999999999999999999999   999999999999999999999999


Q ss_pred             cCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhch
Q 009340          372 GISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQ  451 (537)
Q Consensus       372 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  451 (537)
                      |+++......    ....||+.|+|||.+.+..++.++|||||||++|||++|+.||.......       .......+.
T Consensus       163 g~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-------~~~~i~~~~  231 (329)
T PTZ00263        163 GFAKKVPDRT----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR-------IYEKILAGR  231 (329)
T ss_pred             cCceEcCCCc----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHH-------HHHHHhcCC
Confidence            9998764322    23468999999999999999999999999999999999999986433211       111111111


Q ss_pred             hhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCC-----HhhHH
Q 009340          452 LLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPT-----MKQVS  494 (537)
Q Consensus       452 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~ev~  494 (537)
                              .  ..+......+.+|+.+||+.||.+||+     +.+++
T Consensus       232 --------~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll  269 (329)
T PTZ00263        232 --------L--KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVK  269 (329)
T ss_pred             --------c--CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHh
Confidence                    0  112223456789999999999999997     56665

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=5e-40  Score=304.67  Aligned_cols=236  Identities=28%  Similarity=0.424  Sum_probs=202.7

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCC---ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI---DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY  291 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  291 (537)
                      ++|+..+.||.|+||+|.+.+.+ +|..+|+|.++..   ...+.+...+|..+|+.+.||.++++.+.+.+.+..++||
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm  123 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM  123 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence            45677889999999999999965 6889999998753   3345667789999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeec
Q 009340          292 EYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF  371 (537)
Q Consensus       292 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Df  371 (537)
                      ||.++|.|..+++..            ..++.+....+|.+|+.||+|||+.+   |++|||||+|||||.+|.+||+||
T Consensus       124 eyv~GGElFS~Lrk~------------~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDF  188 (355)
T KOG0616|consen  124 EYVPGGELFSYLRKS------------GRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDF  188 (355)
T ss_pred             eccCCccHHHHHHhc------------CCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEec
Confidence            999999999999874            36999999999999999999999999   999999999999999999999999


Q ss_pred             cCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhch
Q 009340          372 GISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQ  451 (537)
Q Consensus       372 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  451 (537)
                      |+|+.....    +-+.+||+.|+|||.+....+..++|.|||||++|||+.|..||.....-.      -+        
T Consensus       189 GFAK~v~~r----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~------iY--------  250 (355)
T KOG0616|consen  189 GFAKRVSGR----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQ------IY--------  250 (355)
T ss_pred             cceEEecCc----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHH------HH--------
Confidence            999987543    567899999999999999999999999999999999999999998654311      11        


Q ss_pred             hhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCC
Q 009340          452 LLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKR  487 (537)
Q Consensus       452 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~R  487 (537)
                       ..++...+  ..|.-.+.++.+|+...|+.|-..|
T Consensus       251 -~KI~~~~v--~fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  251 -EKILEGKV--KFPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             -HHHHhCcc--cCCcccCHHHHHHHHHHHhhhhHhh
Confidence             11222222  2455566778899999999999988

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=9.8e-40  Score=319.27  Aligned_cols=254  Identities=25%  Similarity=0.427  Sum_probs=206.7

Q ss_pred             hcCCccccccCcCCceEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecC
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI  294 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  294 (537)
                      .++|...++||+|+||.||+|...+++.||+|.+..... ..+.|.+|+.++++++|+|++++++++. .+..+++|||+
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   82 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM   82 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence            457888899999999999999988899999999875433 3467899999999999999999999874 45689999999


Q ss_pred             CCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCc
Q 009340          295 SSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGIS  374 (537)
Q Consensus       295 ~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla  374 (537)
                      ++|+|.+++....          ...+++.+++.++.|++.||+|||+.+   ++||||||+||++++++.++|+|||++
T Consensus        83 ~~~~L~~~~~~~~----------~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~  149 (260)
T cd05067          83 ENGSLVDFLKTPE----------GIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLA  149 (260)
T ss_pred             CCCCHHHHHHhcC----------CCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcce
Confidence            9999999986532          236899999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHHHHHhhchhh
Q 009340          375 RSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQLL  453 (537)
Q Consensus       375 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  453 (537)
                      ...............++..|+|||.+....++.++||||||+++|||++ |+.||......+       ......     
T Consensus       150 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~-----  217 (260)
T cd05067         150 RLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE-------VIQNLE-----  217 (260)
T ss_pred             eecCCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH-------HHHHHH-----
Confidence            8765333322233446788999999998889999999999999999999 999986433221       111111     


Q ss_pred             hhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHH
Q 009340          454 EILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEG  499 (537)
Q Consensus       454 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  499 (537)
                          .....+.+...+.++.+++.+||+.+|++||++.++.+.|+.
T Consensus       218 ----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         218 ----RGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             ----cCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence                111112223344679999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=8.8e-40  Score=323.78  Aligned_cols=267  Identities=27%  Similarity=0.408  Sum_probs=204.9

Q ss_pred             CccccccCcCCceEEEEEEc-----CCCCEEEEEEccCCC-hHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCC--ccEE
Q 009340          218 YNQSRFLGQGGFGTVYKGML-----PDGSIVAVKRSKEID-KTQIHQFINEVVILSQINHRHIVKLLGCCLETE--VPVL  289 (537)
Q Consensus       218 ~~~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~~l  289 (537)
                      |...+.||+|+||.||++.+     .+++.||+|..+... ......|.+|+.++++++|+||+++++++...+  ..++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL   85 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence            37788999999999988653     357889999987543 344567889999999999999999999987643  5789


Q ss_pred             EEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEe
Q 009340          290 VYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVS  369 (537)
Q Consensus       290 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~  369 (537)
                      ||||+++|+|.+++..             ..++|.+++.++.|+++||.|||+.+   ++||||||+|||+++++.+||+
T Consensus        86 v~e~~~~~~l~~~~~~-------------~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~  149 (283)
T cd05080          86 IMEYVPLGSLRDYLPK-------------HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIG  149 (283)
T ss_pred             EecCCCCCCHHHHHHH-------------cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEe
Confidence            9999999999999854             25899999999999999999999998   9999999999999999999999


Q ss_pred             eccCccccCCCCCce--eeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHH
Q 009340          370 DFGISRSIPNDKTHL--TTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLA  447 (537)
Q Consensus       370 Dfgla~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~  447 (537)
                      |||+++.........  .....++..|+|||.+.+..++.++||||||+++|||++|+.|+....... ...........
T Consensus       150 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~  228 (283)
T cd05080         150 DFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-EEMIGPKQGQM  228 (283)
T ss_pred             ecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh-hhhhccccccc
Confidence            999998764332211  122335667999999998899999999999999999999999975432110 00000000000


Q ss_pred             hhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHH
Q 009340          448 KENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLR  501 (537)
Q Consensus       448 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~  501 (537)
                      ....+.+.++.....+.+...+..+.+++.+||+.+|++|||+++|+++|+.+.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         229 TVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             chhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            111112222222222233445578999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=5.7e-40  Score=326.14  Aligned_cols=264  Identities=23%  Similarity=0.332  Sum_probs=199.5

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCC-hHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEec
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEID-KTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY  293 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  293 (537)
                      ++|...++||+|+||.||+|... +++.||+|.++... ......+.+|+.++++++|+||+++++++.+.+..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            46888999999999999999864 68899999886432 22345678999999999999999999999998899999999


Q ss_pred             CCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccC
Q 009340          294 ISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGI  373 (537)
Q Consensus       294 ~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgl  373 (537)
                      +++ +|.+++....           ..+++..+..++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        85 ~~~-~l~~~l~~~~-----------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~  149 (288)
T cd07871          85 LDS-DLKQYLDNCG-----------NLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGL  149 (288)
T ss_pred             CCc-CHHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcc
Confidence            975 8988886432           25789999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCCceeeeccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHH-----HH
Q 009340          374 SRSIPNDKTHLTTTIQGTFGYLDPEYFQS-SQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFIS-----LA  447 (537)
Q Consensus       374 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~-----~~  447 (537)
                      ++....... ......+++.|+|||.+.+ ..++.++||||+||++|||++|+.||......+..........     .+
T Consensus       150 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  228 (288)
T cd07871         150 ARAKSVPTK-TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETW  228 (288)
T ss_pred             eeeccCCCc-cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHh
Confidence            976533221 1233457899999998865 5689999999999999999999999975543332111110000     00


Q ss_pred             h----hchhhhhhcHHhhc----cccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          448 K----ENQLLEILDARVAK----EAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       448 ~----~~~~~~~~d~~~~~----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      .    .........+....    ........++.+|+.+||+.||.+|||+.|+++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         229 PGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             hccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            0    00000111111000    001122456789999999999999999999974

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.6e-39  Score=319.12  Aligned_cols=255  Identities=27%  Similarity=0.496  Sum_probs=206.1

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CC---CEEEEEEccCC-ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DG---SIVAVKRSKEI-DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLV  290 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  290 (537)
                      ++|+..+.||+|+||.||+|+.. ++   ..+|+|..+.. .....+.+.+|+.++++++|+|++++.+++.+.+..++|
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII   84 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence            46778899999999999999964 33   37999998754 344567799999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEee
Q 009340          291 YEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSD  370 (537)
Q Consensus       291 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~D  370 (537)
                      |||+++++|.+++....           ..++|..+..++.|++.||+|||+.+   ++||||||+||++++++.+||+|
T Consensus        85 ~e~~~~~~L~~~~~~~~-----------~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~d  150 (268)
T cd05063          85 TEYMENGALDKYLRDHD-----------GEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSD  150 (268)
T ss_pred             EEcCCCCCHHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECC
Confidence            99999999999986532           35899999999999999999999998   99999999999999999999999


Q ss_pred             ccCccccCCCCCceee--eccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHHHHH
Q 009340          371 FGISRSIPNDKTHLTT--TIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLA  447 (537)
Q Consensus       371 fgla~~~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~  447 (537)
                      ||++............  ....+..|+|||++.+..++.++||||||+++|||++ |+.||......+       .....
T Consensus       151 fg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~-------~~~~i  223 (268)
T cd05063         151 FGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE-------VMKAI  223 (268)
T ss_pred             CccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH-------HHHHH
Confidence            9999866433222111  1223567999999998899999999999999999998 999986433211       11111


Q ss_pred             hhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHH
Q 009340          448 KENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGL  500 (537)
Q Consensus       448 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i  500 (537)
                      ..         ....+.+...+..+.+++.+||+.+|++||++.+|++.|+++
T Consensus       224 ~~---------~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         224 ND---------GFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             hc---------CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            11         111122233456789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1.8e-39  Score=321.02  Aligned_cols=265  Identities=25%  Similarity=0.449  Sum_probs=210.7

Q ss_pred             hcCCccccccCcCCceEEEEEEcCC-----CCEEEEEEccCC-ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeC-Ccc
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLPD-----GSIVAVKRSKEI-DKTQIHQFINEVVILSQINHRHIVKLLGCCLET-EVP  287 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-~~~  287 (537)
                      .++|...+.||+|+||.||+|...+     +..|++|++... .....+.+.+|+.++++++|+|++++++++... ...
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   84 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP   84 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence            4678888999999999999999765     688999988753 345567789999999999999999999998764 578


Q ss_pred             EEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEE
Q 009340          288 VLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK  367 (537)
Q Consensus       288 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~k  367 (537)
                      ++++||+++|+|.+++.......    ......+++..++.++.|++.||+|||+.+   ++||||||+||++++++.+|
T Consensus        85 ~~~~~~~~~~~L~~~l~~~~~~~----~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~k  157 (280)
T cd05043          85 FVLYPYMNWGNLKLFLQQCRLGE----ANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVK  157 (280)
T ss_pred             EEEEEcCCCCcHHHHHHhccccc----cccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEE
Confidence            99999999999999987643210    001246999999999999999999999998   99999999999999999999


Q ss_pred             EeeccCccccCCCCCce-eeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHHH
Q 009340          368 VSDFGISRSIPNDKTHL-TTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFIS  445 (537)
Q Consensus       368 i~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~  445 (537)
                      |+|||+++.+....... .....++..|+|||.+.+..++.++||||||+++||+++ |+.||......+       ...
T Consensus       158 l~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------~~~  230 (280)
T cd05043         158 ITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE-------MAA  230 (280)
T ss_pred             ECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH-------HHH
Confidence            99999998664333221 223345778999999998889999999999999999999 999986433211       111


Q ss_pred             HHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHH
Q 009340          446 LAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRR  502 (537)
Q Consensus       446 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~  502 (537)
                      ....+         .....+..++..+.+++.+||+.+|++|||+.++++.|+.+..
T Consensus       231 ~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~  278 (280)
T cd05043         231 YLKDG---------YRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA  278 (280)
T ss_pred             HHHcC---------CCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            11111         1111122334678999999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1.4e-39  Score=322.27  Aligned_cols=265  Identities=26%  Similarity=0.475  Sum_probs=206.2

Q ss_pred             cCCccccccCcCCceEEEEEEc-----CCCCEEEEEEccCC-ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGML-----PDGSIVAVKRSKEI-DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVL  289 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  289 (537)
                      ++|+..+.||+|+||.||+|.+     .++..||+|.++.. .......|.+|+.++++++|+||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            4577788999999999999984     25678999998753 34445778999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhhhhhhhHHH-----HhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCC
Q 009340          290 VYEYISSGTLSHHIHDHQQQQEQ-----KQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF  364 (537)
Q Consensus       290 V~e~~~~gsL~~~l~~~~~~~~~-----~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~  364 (537)
                      ||||+++|+|.+++.........     ........+++.+.+.++.|++.||.|||+.+   ++||||||+|||+++++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence            99999999999998643210000     00001235899999999999999999999998   99999999999999999


Q ss_pred             cEEEeeccCccccCCCCC-ceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHH
Q 009340          365 SAKVSDFGISRSIPNDKT-HLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVAC  442 (537)
Q Consensus       365 ~~ki~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~  442 (537)
                      .+||+|||+++....... .......++..|+|||++.+..++.++||||||+++|||++ |..||.......       
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~-------  234 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE-------  234 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH-------
Confidence            999999999986533222 22233445778999999988889999999999999999999 888875432211       


Q ss_pred             HHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHH
Q 009340          443 FISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEG  499 (537)
Q Consensus       443 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  499 (537)
                      .........         ....+......+.+++.+||+.||++||++.+|.++|..
T Consensus       235 ~~~~~~~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         235 VIEMVRKRQ---------LLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             HHHHHHcCC---------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            111111111         111233345678899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.8e-40  Score=328.96  Aligned_cols=241  Identities=26%  Similarity=0.363  Sum_probs=195.6

Q ss_pred             cCcCCceEEEEEEcC-CCCEEEEEEccCC---ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecCCCCCh
Q 009340          224 LGQGGFGTVYKGMLP-DGSIVAVKRSKEI---DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTL  299 (537)
Q Consensus       224 lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL  299 (537)
                      ||+|+||.||++... +++.||+|.++..   .......+.+|+.++.+++||||+++++++.+.+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            799999999999965 5889999988642   334456788999999999999999999999999999999999999999


Q ss_pred             hhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCccccCC
Q 009340          300 SHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPN  379 (537)
Q Consensus       300 ~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~  379 (537)
                      .+++...            ..+++..+..++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        81 ~~~l~~~------------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~  145 (312)
T cd05585          81 FHHLQRE------------GRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMK  145 (312)
T ss_pred             HHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCcc
Confidence            9998652            35899999999999999999999999   99999999999999999999999999976432


Q ss_pred             CCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchhhhhhcHH
Q 009340          380 DKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEILDAR  459 (537)
Q Consensus       380 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  459 (537)
                      .. .......||+.|+|||.+.+..++.++|||||||++|||++|+.||......+      .+......         .
T Consensus       146 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~------~~~~~~~~---------~  209 (312)
T cd05585         146 DD-DKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE------MYRKILQE---------P  209 (312)
T ss_pred             CC-CccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHH------HHHHHHcC---------C
Confidence            22 22344568999999999999999999999999999999999999986543221      11111110         0


Q ss_pred             hhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHH
Q 009340          460 VAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMEL  497 (537)
Q Consensus       460 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L  497 (537)
                        ...+......+.+++.+||+.||++||++..+.+.|
T Consensus       210 --~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l  245 (312)
T cd05585         210 --LRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIK  245 (312)
T ss_pred             --CCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence              112334456788999999999999998754444433

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=2e-39  Score=316.67  Aligned_cols=247  Identities=27%  Similarity=0.459  Sum_probs=197.9

Q ss_pred             ccCcCCceEEEEEEcC---CCCEEEEEEccCCC-hHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecCCCCC
Q 009340          223 FLGQGGFGTVYKGMLP---DGSIVAVKRSKEID-KTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGT  298 (537)
Q Consensus       223 ~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs  298 (537)
                      .||+|+||.||+|.+.   .+..||+|.+.... ....+.|.+|+.++++++|+||+++++++. ....++||||+++|+
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence            3899999999999864   35579999987643 344567999999999999999999999985 456799999999999


Q ss_pred             hhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCccccC
Q 009340          299 LSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIP  378 (537)
Q Consensus       299 L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~  378 (537)
                      |.+++....           ..+++..+++++.|+++||.|||+.+   ++||||||+||+++.++.+||+|||++....
T Consensus        81 L~~~l~~~~-----------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~  146 (257)
T cd05115          81 LNKFLSGKK-----------DEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALG  146 (257)
T ss_pred             HHHHHHhCC-----------CCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCcccccc
Confidence            999986532           36899999999999999999999998   9999999999999999999999999998654


Q ss_pred             CCCCcee--eeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHHHHHhhchhhhh
Q 009340          379 NDKTHLT--TTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQLLEI  455 (537)
Q Consensus       379 ~~~~~~~--~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  455 (537)
                      .......  ....++..|+|||.+....++.++||||||+++|||++ |+.||......+       .......      
T Consensus       147 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~------  213 (257)
T cd05115         147 ADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE-------VMSFIEQ------  213 (257)
T ss_pred             CCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH-------HHHHHHC------
Confidence            4332211  12223578999999988889999999999999999997 999986443221       1111111      


Q ss_pred             hcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHH
Q 009340          456 LDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGL  500 (537)
Q Consensus       456 ~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i  500 (537)
                         ......+..++.++.+++.+||..+|++||++.+|.+.|+.+
T Consensus       214 ---~~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         214 ---GKRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             ---CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence               111223344567888999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=5.4e-40  Score=348.80  Aligned_cols=260  Identities=28%  Similarity=0.351  Sum_probs=207.5

Q ss_pred             HHHHHhcCCccccccCcCCceEEEEEEc-CCCCEEEEEEccC--CChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCC-
Q 009340          210 ELQRATDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKE--IDKTQIHQFINEVVILSQINHRHIVKLLGCCLETE-  285 (537)
Q Consensus       210 el~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-  285 (537)
                      +.....++|...+.||+|+||+||++.. .+|+.||||.+..  ........+.+|+..+..++|+|++++.+.+...+ 
T Consensus        26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~  105 (496)
T PTZ00283         26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP  105 (496)
T ss_pred             cccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence            3344557999999999999999999985 4789999998864  34455667889999999999999999988775432 


Q ss_pred             -------ccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCE
Q 009340          286 -------VPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNI  358 (537)
Q Consensus       286 -------~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NI  358 (537)
                             ..++||||+++|+|.+++.....        ....+++..+..++.|++.||.|||+.+   |+||||||+||
T Consensus       106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~--------~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NI  174 (496)
T PTZ00283        106 RNPENVLMIALVLDYANAGDLRQEIKSRAK--------TNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANI  174 (496)
T ss_pred             cCcccceEEEEEEeCCCCCcHHHHHHHhhc--------cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHE
Confidence                   25799999999999999975432        1346899999999999999999999998   99999999999


Q ss_pred             EECCCCcEEEeeccCccccCCCCC-ceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhc
Q 009340          359 LLDDKFSAKVSDFGISRSIPNDKT-HLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEER  437 (537)
Q Consensus       359 ll~~~~~~ki~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~  437 (537)
                      |++.++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+  
T Consensus       175 Ll~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~--  252 (496)
T PTZ00283        175 LLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE--  252 (496)
T ss_pred             EEeCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--
Confidence            999999999999999987643221 22334578999999999999999999999999999999999999986543221  


Q ss_pred             cHHHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHH
Q 009340          438 NLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSME  496 (537)
Q Consensus       438 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~  496 (537)
                          .+.... .+.         ....+...+..+.+++.+||+.||++||++.+++..
T Consensus       253 ----~~~~~~-~~~---------~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        253 ----VMHKTL-AGR---------YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             ----HHHHHh-cCC---------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence                111111 010         112233455678999999999999999999999763

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-41  Score=328.23  Aligned_cols=248  Identities=26%  Similarity=0.414  Sum_probs=208.4

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCCEEEEEEccC-CChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEec
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKE-IDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY  293 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  293 (537)
                      ..|...+.||+|.||.||+|... .++.||+|.+.. ..+...++..+|+.++.+++++||.+++|.+.....++++|||
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey   92 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY   92 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence            35666788999999999999954 688999999875 3455678889999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccC
Q 009340          294 ISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGI  373 (537)
Q Consensus       294 ~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgl  373 (537)
                      +.+|++.+.|...            ..+.+....-|..++..||.|||+++   .+|||||+.|||+..+|.+|++|||.
T Consensus        93 ~~gGsv~~lL~~~------------~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgV  157 (467)
T KOG0201|consen   93 CGGGSVLDLLKSG------------NILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGV  157 (467)
T ss_pred             hcCcchhhhhccC------------CCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecce
Confidence            9999999999753            23577778889999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchhh
Q 009340          374 SRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLL  453 (537)
Q Consensus       374 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  453 (537)
                      +..+....... .+.+||+.|||||++....|+.|+||||||++.+||.+|.+|+....+-                +..
T Consensus       158 a~ql~~~~~rr-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm----------------rvl  220 (467)
T KOG0201|consen  158 AGQLTNTVKRR-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM----------------RVL  220 (467)
T ss_pred             eeeeechhhcc-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcc----------------eEE
Confidence            98886655443 6788999999999999889999999999999999999999997543321                111


Q ss_pred             hhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          454 EILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       454 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      -++-+.........++..+.+++..||..||+.||++.++++
T Consensus       221 flIpk~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  221 FLIPKSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK  262 (467)
T ss_pred             EeccCCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence            111111112223356677999999999999999999999976

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=8.5e-40  Score=332.30  Aligned_cols=264  Identities=25%  Similarity=0.403  Sum_probs=196.4

Q ss_pred             CCccccccCcCCceEEEEEEcC-CCCEEEEEEccCC--ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCC-----ccE
Q 009340          217 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI--DKTQIHQFINEVVILSQINHRHIVKLLGCCLETE-----VPV  288 (537)
Q Consensus       217 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~  288 (537)
                      +|+..++||+|+||.||+|+.. +|+.||||+++..  .......+.+|+.++++++||||+++++++....     ..+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            4777899999999999999954 6899999988642  2234457889999999999999999999986432     479


Q ss_pred             EEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEE
Q 009340          289 LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKV  368 (537)
Q Consensus       289 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki  368 (537)
                      +||||++ ++|.+++...            ..+++..+..++.|+++||.|||+.+   |+||||||+|||++.++.+||
T Consensus        81 lv~e~~~-~~L~~~l~~~------------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL  144 (338)
T cd07859          81 VVFELME-SDLHQVIKAN------------DDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKI  144 (338)
T ss_pred             EEEecCC-CCHHHHHHhc------------ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEE
Confidence            9999996 6898888642            35899999999999999999999999   999999999999999999999


Q ss_pred             eeccCccccCCCCCc--eeeeccccccccCcccccC--CCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHH-
Q 009340          369 SDFGISRSIPNDKTH--LTTTIQGTFGYLDPEYFQS--SQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACF-  443 (537)
Q Consensus       369 ~Dfgla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~-  443 (537)
                      +|||+++........  ......||+.|+|||++.+  ..++.++|||||||++|||++|+.||............... 
T Consensus       145 ~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~  224 (338)
T cd07859         145 CDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLL  224 (338)
T ss_pred             ccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHh
Confidence            999999865322211  1234568999999999875  67899999999999999999999998654322111100000 


Q ss_pred             -------HHHHhhchhhhhhc---HHhhcc---ccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHH
Q 009340          444 -------ISLAKENQLLEILD---ARVAKE---AREEDIGAMAELAMRCLRLNSKKRPTMKQVSME  496 (537)
Q Consensus       444 -------~~~~~~~~~~~~~d---~~~~~~---~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~  496 (537)
                             ............+.   ......   ........+.+++.+||+.||++|||+.|+++.
T Consensus       225 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         225 GTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             CCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence                   00000000000000   000000   001224567899999999999999999999853

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=2.6e-39  Score=317.40  Aligned_cols=261  Identities=24%  Similarity=0.393  Sum_probs=209.6

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCCEEEEEEccC---CChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKE---IDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY  291 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  291 (537)
                      ++|...+.||+|+||.||+|+.. +++.||||.++.   ........+.+|+.+++.++|||++++++++.+.+..++|+
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            57888999999999999999954 789999998753   23445567899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeec
Q 009340          292 EYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF  371 (537)
Q Consensus       292 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Df  371 (537)
                      ||+++|+|.+++......        ...+++..++.++.|+++||.|||+.+   ++|+||||+||+++.++.++|+||
T Consensus        82 e~~~~~~L~~~~~~~~~~--------~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~  150 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQ--------KRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDL  150 (267)
T ss_pred             EecCCCcHHHHHHHhhhc--------cCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECcc
Confidence            999999999988643221        235889999999999999999999998   999999999999999999999999


Q ss_pred             cCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhch
Q 009340          372 GISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQ  451 (537)
Q Consensus       372 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  451 (537)
                      |++........ ......++..|+|||.+.+..++.++|+||||+++|||++|+.|+.......    .. +........
T Consensus       151 g~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~----~~-~~~~~~~~~  224 (267)
T cd08228         151 GLGRFFSSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL----FS-LCQKIEQCD  224 (267)
T ss_pred             ccceeccchhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH----HH-HHHHHhcCC
Confidence            99887643322 1223457889999999988889999999999999999999999985432111    11 111111100


Q ss_pred             hhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHH
Q 009340          452 LLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLR  501 (537)
Q Consensus       452 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~  501 (537)
                              ............+.+++.+||+.+|++||++.+|++.|++++
T Consensus       225 --------~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         225 --------YPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             --------CCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence                    001112234567899999999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.3e-39  Score=318.55  Aligned_cols=258  Identities=24%  Similarity=0.469  Sum_probs=203.9

Q ss_pred             CccccccCcCCceEEEEEEcCC----CCEEEEEEccCC--ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCc-----
Q 009340          218 YNQSRFLGQGGFGTVYKGMLPD----GSIVAVKRSKEI--DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEV-----  286 (537)
Q Consensus       218 ~~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-----  286 (537)
                      |...+.||+|+||.||+|....    +..||+|+++..  .......+.+|+..++.++|+|++++++++...+.     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            4567899999999999998642    367999998743  34456789999999999999999999999876554     


Q ss_pred             -cEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCc
Q 009340          287 -PVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFS  365 (537)
Q Consensus       287 -~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~  365 (537)
                       .++|+||+++|+|..++.......      ....+++..++.++.|++.||.|||+.+   ++||||||+||++++++.
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~------~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~  151 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGG------LPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMT  151 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccC------CcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCe
Confidence             799999999999999986543210      1236899999999999999999999998   999999999999999999


Q ss_pred             EEEeeccCccccCCCCCcee-eeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHH
Q 009340          366 AKVSDFGISRSIPNDKTHLT-TTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACF  443 (537)
Q Consensus       366 ~ki~Dfgla~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~  443 (537)
                      +||+|||+++.......... ....++..|+|||.+.+..++.++||||||+++|||++ |..||......+   .   +
T Consensus       152 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~---~---~  225 (273)
T cd05035         152 VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE---I---Y  225 (273)
T ss_pred             EEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH---H---H
Confidence            99999999987644332222 22335678999999988899999999999999999999 888875432211   1   1


Q ss_pred             HHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHH
Q 009340          444 ISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGL  500 (537)
Q Consensus       444 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i  500 (537)
                       .....+         .....+......+.+++.+||+.||++|||+.++++.|+++
T Consensus       226 -~~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         226 -DYLRHG---------NRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             -HHHHcC---------CCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence             111111         11122334556789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-39  Score=324.27  Aligned_cols=272  Identities=24%  Similarity=0.420  Sum_probs=204.8

Q ss_pred             hcCCccccccCcCCceEEEEEEcCC---------------CCEEEEEEccCC-ChHHHHHHHHHHHHHHhcCCCCcceEe
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLPD---------------GSIVAVKRSKEI-DKTQIHQFINEVVILSQINHRHIVKLL  278 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~~---------------g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~  278 (537)
                      .++|...+.||+|+||.||++...+               ...||+|.++.. .......|.+|++++++++|+|+++++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~   83 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL   83 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence            3578888999999999999987532               235899998753 344556799999999999999999999


Q ss_pred             eEEeeCCccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCE
Q 009340          279 GCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNI  358 (537)
Q Consensus       279 g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NI  358 (537)
                      +++...+..++||||+++++|.+++.................++|..++.++.|+++||+|||+.+   ++||||||+||
T Consensus        84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Ni  160 (295)
T cd05097          84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNC  160 (295)
T ss_pred             EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhE
Confidence            999999999999999999999999965321110000111235789999999999999999999999   99999999999


Q ss_pred             EECCCCcEEEeeccCccccCCCCCc-eeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh--CCCCCCccchhh
Q 009340          359 LLDDKFSAKVSDFGISRSIPNDKTH-LTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT--GKKPICFARVEE  435 (537)
Q Consensus       359 ll~~~~~~ki~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t--g~~p~~~~~~~~  435 (537)
                      ++++++.+||+|||++......... ......++..|+|||.+.++.++.++||||||+++|||++  |..||......+
T Consensus       161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~  240 (295)
T cd05097         161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ  240 (295)
T ss_pred             EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence            9999999999999999765433222 1223345778999999998899999999999999999998  555665432221


Q ss_pred             hccHHHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHH
Q 009340          436 ERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELE  498 (537)
Q Consensus       436 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~  498 (537)
                      .   ...........      ........+...+..+.+|+.+||+.+|++|||+.+|++.|+
T Consensus       241 ~---~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         241 V---IENTGEFFRNQ------GRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             H---HHHHHHhhhhc------cccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence            1   11111111100      000001112223467999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=7.8e-40  Score=325.76  Aligned_cols=269  Identities=29%  Similarity=0.457  Sum_probs=210.8

Q ss_pred             HhcCCccccccCcCCceEEEEEEcC------CCCEEEEEEccCC-ChHHHHHHHHHHHHHHhc-CCCCcceEeeEEeeCC
Q 009340          214 ATDNYNQSRFLGQGGFGTVYKGMLP------DGSIVAVKRSKEI-DKTQIHQFINEVVILSQI-NHRHIVKLLGCCLETE  285 (537)
Q Consensus       214 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~  285 (537)
                      ..++|+..+.||+|+||.||++...      ....+|+|.+... ......++.+|+.++.++ +|+||+++++++...+
T Consensus        10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~   89 (293)
T cd05053          10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG   89 (293)
T ss_pred             CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence            3457888899999999999999863      2367999988753 334556789999999999 7999999999999999


Q ss_pred             ccEEEEecCCCCChhhhhhhhhhhHHHHh----hhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEC
Q 009340          286 VPVLVYEYISSGTLSHHIHDHQQQQEQKQ----KQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD  361 (537)
Q Consensus       286 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~----~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~  361 (537)
                      ..+++|||+++|+|.+++...........    ......++|..+++++.|++.||.|||+.+   |+||||||+||+++
T Consensus        90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~  166 (293)
T cd05053          90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVT  166 (293)
T ss_pred             CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEc
Confidence            99999999999999999975421100000    011346999999999999999999999998   99999999999999


Q ss_pred             CCCcEEEeeccCccccCCCCCce-eeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccH
Q 009340          362 DKFSAKVSDFGISRSIPNDKTHL-TTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNL  439 (537)
Q Consensus       362 ~~~~~ki~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~  439 (537)
                      +++.+||+|||+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..|+......+    
T Consensus       167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~----  242 (293)
T cd05053         167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE----  242 (293)
T ss_pred             CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH----
Confidence            99999999999998764433221 222345678999999998999999999999999999998 888876433221    


Q ss_pred             HHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHH
Q 009340          440 VACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLR  501 (537)
Q Consensus       440 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~  501 (537)
                         .......         ......+......+.+|+.+||+.+|++|||+.++++.|+.+.
T Consensus       243 ---~~~~~~~---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         243 ---LFKLLKE---------GYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             ---HHHHHHc---------CCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence               1111111         1111223344567889999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-39  Score=316.13  Aligned_cols=250  Identities=26%  Similarity=0.479  Sum_probs=207.1

Q ss_pred             cCCccccccCcCCceEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecCC
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYIS  295 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  295 (537)
                      ++|+..+.||+|+||.||++... |+.||+|.++.... ..+++.+|+.++++++|+|++++++++.+.+..++||||++
T Consensus         6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   83 (256)
T cd05039           6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA   83 (256)
T ss_pred             hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence            46778899999999999999974 78999999986544 56789999999999999999999999998889999999999


Q ss_pred             CCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCcc
Q 009340          296 SGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISR  375 (537)
Q Consensus       296 ~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~  375 (537)
                      +++|.+++....          ...++|..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++
T Consensus        84 ~~~L~~~~~~~~----------~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~  150 (256)
T cd05039          84 KGSLVDYLRSRG----------RAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAK  150 (256)
T ss_pred             CCcHHHHHHhcC----------CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEccccccc
Confidence            999999987532          126899999999999999999999999   9999999999999999999999999998


Q ss_pred             ccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHHHHHhhchhhh
Q 009340          376 SIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQLLE  454 (537)
Q Consensus       376 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  454 (537)
                      .......    ....+..|+|||++..+.++.++||||||+++|||++ |+.||......+       .......     
T Consensus       151 ~~~~~~~----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~~-----  214 (256)
T cd05039         151 EASQGQD----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-------VVPHVEK-----  214 (256)
T ss_pred             ccccccc----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHhc-----
Confidence            7632221    2335678999999998899999999999999999998 999986443221       1111111     


Q ss_pred             hhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHH
Q 009340          455 ILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGL  500 (537)
Q Consensus       455 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i  500 (537)
                          ......+...+..+.+++.+||+.+|++|||+.+++++|+.+
T Consensus       215 ----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         215 ----GYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             ----CCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence                111112233456788999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=2.6e-39  Score=316.32  Aligned_cols=253  Identities=27%  Similarity=0.418  Sum_probs=204.0

Q ss_pred             cCCccccccCcCCceEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecCC
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYIS  295 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  295 (537)
                      ++|...+.||+|+||.||++...++..+|+|.+..... ..+.|.+|+.++++++|+|++++++++. .+..++||||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~   83 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM-MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG   83 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc-cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence            45778889999999999999987777899998865332 3467889999999999999999999875 456799999999


Q ss_pred             CCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCcc
Q 009340          296 SGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISR  375 (537)
Q Consensus       296 ~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~  375 (537)
                      +|+|.+++....          ...++|..+..++.|+++||.|||+.+   ++|+||||+||++++++.++|+|||++.
T Consensus        84 ~~~L~~~~~~~~----------~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~  150 (260)
T cd05069          84 KGSLLDFLKEGD----------GKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLAR  150 (260)
T ss_pred             CCCHHHHHhhCC----------CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccce
Confidence            999999997532          235899999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHHHHHhhchhhh
Q 009340          376 SIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQLLE  454 (537)
Q Consensus       376 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  454 (537)
                      ..............++..|+|||...+..++.++||||||+++|||++ |+.||......+       .......     
T Consensus       151 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-------~~~~~~~-----  218 (260)
T cd05069         151 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE-------VLEQVER-----  218 (260)
T ss_pred             EccCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHc-----
Confidence            664333222223346778999999998899999999999999999999 888886432211       1111111     


Q ss_pred             hhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHH
Q 009340          455 ILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEG  499 (537)
Q Consensus       455 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  499 (537)
                          ......+...+..+.+++.+||+.||++||++.+|+++|+.
T Consensus       219 ----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         219 ----GYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             ----CCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence                01112233445678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=4.3e-39  Score=315.53  Aligned_cols=260  Identities=25%  Similarity=0.426  Sum_probs=210.8

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCCEEEEEEccC---CChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKE---IDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY  291 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  291 (537)
                      ++|+..+.||+|+||.||+|... +|+.||+|.++.   ......+.+.+|++++++++|+|++++++++.+.+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57888999999999999999976 789999998753   23344678899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeec
Q 009340          292 EYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF  371 (537)
Q Consensus       292 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Df  371 (537)
                      ||+++|+|.+++......        ...+++.+++.++.++++||.|||+.+   ++||||+|+||+++.++.++|+||
T Consensus        82 e~~~~~~L~~~l~~~~~~--------~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~  150 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQ--------KRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDL  150 (267)
T ss_pred             ecCCCCCHHHHHHHhccc--------CCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEecc
Confidence            999999999998653221        235899999999999999999999999   999999999999999999999999


Q ss_pred             cCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhch
Q 009340          372 GISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQ  451 (537)
Q Consensus       372 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  451 (537)
                      |++......... .....++..|+|||.+.+..++.++||||||+++|||++|+.|+......    ... .......  
T Consensus       151 ~~~~~~~~~~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~-~~~~~~~--  222 (267)
T cd08224         151 GLGRFFSSKTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYS-LCKKIEK--  222 (267)
T ss_pred             ceeeeccCCCcc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc----HHH-HHhhhhc--
Confidence            998765433221 23345788999999999888999999999999999999999998543211    111 0111111  


Q ss_pred             hhhhhcHHhhccccH-HHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHH
Q 009340          452 LLEILDARVAKEARE-EDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLR  501 (537)
Q Consensus       452 ~~~~~d~~~~~~~~~-~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~  501 (537)
                             ....+.+. .....+.+++.+||..+|++|||+.+|+++|+.+.
T Consensus       223 -------~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         223 -------CDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             -------CCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence                   11111222 44567889999999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.2e-39  Score=329.06  Aligned_cols=241  Identities=25%  Similarity=0.361  Sum_probs=196.1

Q ss_pred             cccCcCCceEEEEEEcC-CCCEEEEEEccCC---ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecCCCC
Q 009340          222 RFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI---DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSG  297 (537)
Q Consensus       222 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g  297 (537)
                      +.||+|+||.||++... +|+.||+|.++..   .......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            36999999999999854 6899999998642   2344567788999999999999999999999999999999999999


Q ss_pred             ChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCcccc
Q 009340          298 TLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI  377 (537)
Q Consensus       298 sL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~  377 (537)
                      +|..++...            ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        81 ~L~~~l~~~------------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~  145 (323)
T cd05595          81 ELFFHLSRE------------RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEG  145 (323)
T ss_pred             cHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccc
Confidence            998888642            35899999999999999999999999   999999999999999999999999998754


Q ss_pred             CCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchhhhhhc
Q 009340          378 PNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEILD  457 (537)
Q Consensus       378 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  457 (537)
                      .... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........      ...... ..      
T Consensus       146 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~------~~~~~~-~~------  211 (323)
T cd05595         146 ISDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL------FELILM-EE------  211 (323)
T ss_pred             cCCC-CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHH------HHHHhc-CC------
Confidence            2221 122345689999999999999999999999999999999999999865432211      111110 00      


Q ss_pred             HHhhccccHHHHHHHHHHHHHhcccCCCCCC-----CHhhHHH
Q 009340          458 ARVAKEAREEDIGAMAELAMRCLRLNSKKRP-----TMKQVSM  495 (537)
Q Consensus       458 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~  495 (537)
                          ...+...+..+.+++.+||+.||++||     ++.++++
T Consensus       212 ----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         212 ----IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             ----CCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence                012233456788999999999999998     7777764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1.5e-39  Score=321.08  Aligned_cols=260  Identities=28%  Similarity=0.449  Sum_probs=205.3

Q ss_pred             hcCCccccccCcCCceEEEEEEcCC------CCEEEEEEccCCC-hHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCcc
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLPD------GSIVAVKRSKEID-KTQIHQFINEVVILSQINHRHIVKLLGCCLETEVP  287 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~~------g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~  287 (537)
                      +++|...+.||+|+||.||+|.+.+      +..||+|...... ......|.+|+.++++++|+||+++++++.+.+..
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   84 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR   84 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence            4678889999999999999999753      5689999887533 33456799999999999999999999999999999


Q ss_pred             EEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCC---
Q 009340          288 VLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF---  364 (537)
Q Consensus       288 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~---  364 (537)
                      ++||||+++++|.+++........     ....++|..+++++.||+.||+|||+.+   ++||||||+||+++.++   
T Consensus        85 ~lv~e~~~g~~L~~~i~~~~~~~~-----~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~  156 (277)
T cd05036          85 FILLELMAGGDLKSFLRENRPRPE-----RPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGR  156 (277)
T ss_pred             EEEEecCCCCCHHHHHHHhCCCCC-----CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCc
Confidence            999999999999999976532110     1235899999999999999999999998   99999999999998754   


Q ss_pred             cEEEeeccCccccCCCCCce-eeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHH
Q 009340          365 SAKVSDFGISRSIPNDKTHL-TTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVAC  442 (537)
Q Consensus       365 ~~ki~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~  442 (537)
                      .+||+|||+++......... ......+..|+|||++.+..++.++|||||||++|||++ |+.||......+.      
T Consensus       157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~------  230 (277)
T cd05036         157 VAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEV------  230 (277)
T ss_pred             ceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH------
Confidence            69999999998763322211 112233568999999999999999999999999999997 9999865433221      


Q ss_pred             HHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHH
Q 009340          443 FISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELE  498 (537)
Q Consensus       443 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~  498 (537)
                       .....         .......+...+..+.+++.+||+.+|++|||+.+|++.|+
T Consensus       231 -~~~~~---------~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         231 -MEFVT---------GGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             -HHHHH---------cCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence             11111         11111223334567889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-40  Score=299.63  Aligned_cols=264  Identities=23%  Similarity=0.365  Sum_probs=213.2

Q ss_pred             hcCCccccccCcCCceEEEEEE-cCCCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCC-----ccE
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETE-----VPV  288 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~  288 (537)
                      .++|...+.||+|||+.||.++ +.+++.+|+|++.-...++.+..++|++..++++|||++++++++..+.     ..|
T Consensus        20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y   99 (302)
T KOG2345|consen   20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY   99 (302)
T ss_pred             CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence            4688889999999999999998 6688999999998777788889999999999999999999999986543     489


Q ss_pred             EEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEE
Q 009340          289 LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKV  368 (537)
Q Consensus       289 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki  368 (537)
                      |+++|...|||.+.+.....        ....+++.+.+.|+.++.+||.+||+..+ |+.||||||.|||+.+.+.+++
T Consensus       100 ll~Pyy~~Gsl~d~i~~~k~--------kg~~~sE~~iL~if~gic~gL~~lH~~~~-~yAH~DiKP~NILls~~~~~vl  170 (302)
T KOG2345|consen  100 LLLPYYKRGSLLDEIERLKI--------KGNFVSEAQILWIFLGICRGLEALHEKEP-PYAHRDIKPANILLSDSGLPVL  170 (302)
T ss_pred             EEeehhccccHHHHHHHHhh--------cCCccCHHHHHHHHHHHHHHHHHHhccCC-cccccCCCcceeEecCCCceEE
Confidence            99999999999999976543        24579999999999999999999999884 6999999999999999999999


Q ss_pred             eeccCccccCCCCCcee--------eeccccccccCccccc---CCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhc
Q 009340          369 SDFGISRSIPNDKTHLT--------TTIQGTFGYLDPEYFQ---SSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEER  437 (537)
Q Consensus       369 ~Dfgla~~~~~~~~~~~--------~~~~gt~~y~aPE~~~---~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~  437 (537)
                      .|||.+...+-.-....        .....|..|.|||.+.   +...++++|||||||+||+|+.|..||+..-.... 
T Consensus       171 ~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~Gg-  249 (302)
T KOG2345|consen  171 MDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGG-  249 (302)
T ss_pred             EeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCC-
Confidence            99999875532111100        1123688999999985   45678999999999999999999999864322110 


Q ss_pred             cHHHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHH
Q 009340          438 NLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGL  500 (537)
Q Consensus       438 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i  500 (537)
                                  .....+..+.+..+.....+..+.+++.+|++.||.+||++.+++..++.+
T Consensus       250 ------------SlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L  300 (302)
T KOG2345|consen  250 ------------SLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL  300 (302)
T ss_pred             ------------eEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence                        011122222333233334778899999999999999999999999998865

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=2.3e-39  Score=320.39  Aligned_cols=264  Identities=26%  Similarity=0.437  Sum_probs=208.2

Q ss_pred             cCCccccccCcCCceEEEEEEcC------CCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP------DGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVL  289 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  289 (537)
                      .+|...++||+|+||.||++...      ++..+|+|.++.........|.+|+.+++.++|+||+++++++.+.+..++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            46677889999999999999632      356899999887777777889999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhhhhhhhHHHHh---hhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcE
Q 009340          290 VYEYISSGTLSHHIHDHQQQQEQKQ---KQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA  366 (537)
Q Consensus       290 V~e~~~~gsL~~~l~~~~~~~~~~~---~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~  366 (537)
                      ++||+++|+|.+++...........   ......+++..++.++.|++.||+|||+.+   ++||||||+|||+++++.+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~  161 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV  161 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence            9999999999999976542111100   011235899999999999999999999999   9999999999999999999


Q ss_pred             EEeeccCccccCCCCCce-eeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHH
Q 009340          367 KVSDFGISRSIPNDKTHL-TTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFI  444 (537)
Q Consensus       367 ki~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~  444 (537)
                      ||+|||++.......... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+.      . 
T Consensus       162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~------~-  234 (280)
T cd05092         162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA------I-  234 (280)
T ss_pred             EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH------H-
Confidence            999999997654322211 222345788999999999999999999999999999998 8888754332211      0 


Q ss_pred             HHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHH
Q 009340          445 SLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELE  498 (537)
Q Consensus       445 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~  498 (537)
                      ......         .....+...+..+.+++.+||+.||++||++.+|.+.|+
T Consensus       235 ~~~~~~---------~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         235 ECITQG---------RELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             HHHHcC---------ccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence            000000         011122234467889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=3.6e-39  Score=317.27  Aligned_cols=257  Identities=27%  Similarity=0.481  Sum_probs=200.0

Q ss_pred             ccccccCcCCceEEEEEEcCC-CC--EEEEEEccCC--ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeC------Ccc
Q 009340          219 NQSRFLGQGGFGTVYKGMLPD-GS--IVAVKRSKEI--DKTQIHQFINEVVILSQINHRHIVKLLGCCLET------EVP  287 (537)
Q Consensus       219 ~~~~~lg~G~~g~Vy~~~~~~-g~--~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~  287 (537)
                      ...++||+|+||.||+|++.+ +.  .||+|.++..  .....+.|.+|+.+++.++|+||+++++++...      ...
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   81 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP   81 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence            456889999999999999754 33  5999987653  355567899999999999999999999988532      246


Q ss_pred             EEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEE
Q 009340          288 VLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK  367 (537)
Q Consensus       288 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~k  367 (537)
                      ++++||+++|+|.+++......      .....++|...+.++.|+++||+|||+.+   |+||||||+|||+++++.+|
T Consensus        82 ~~v~e~~~~~~l~~~~~~~~~~------~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~k  152 (272)
T cd05075          82 VVILPFMKHGDLHSFLLYSRLG------DCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVC  152 (272)
T ss_pred             EEEEEeCCCCcHHHHHHHhccc------CCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEE
Confidence            8999999999999988543210      01235899999999999999999999998   99999999999999999999


Q ss_pred             EeeccCccccCCCCCcee-eeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHHH
Q 009340          368 VSDFGISRSIPNDKTHLT-TTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFIS  445 (537)
Q Consensus       368 i~Dfgla~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~  445 (537)
                      |+|||+++.......... ....+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+       ...
T Consensus       153 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-------~~~  225 (272)
T cd05075         153 VADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE-------IYD  225 (272)
T ss_pred             ECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHH
Confidence            999999987643332211 22345678999999999999999999999999999999 788875432211       111


Q ss_pred             HHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHH
Q 009340          446 LAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGL  500 (537)
Q Consensus       446 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i  500 (537)
                      ....+..         ...+......+.+++.+||+.+|++|||+.++++.|+.+
T Consensus       226 ~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         226 YLRQGNR---------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             HHHcCCC---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            1111111         011223445688999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=3.2e-39  Score=327.35  Aligned_cols=263  Identities=25%  Similarity=0.410  Sum_probs=202.4

Q ss_pred             hcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCC-ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEe
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI-DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE  292 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e  292 (537)
                      .++|+..++||+|+||.||++... ++..+|+|.++.. .....+.+.+|++++++++|+||+++++++.+.+..++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            368889999999999999999965 6888999987753 33445678999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeeecCCCCCCEEECCCCcEEEeec
Q 009340          293 YISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSS-ASIPIFHRDIKSSNILLDDKFSAKVSDF  371 (537)
Q Consensus       293 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~-~~~~ivH~Dlk~~NIll~~~~~~ki~Df  371 (537)
                      |+++|+|.+++...            ..+++.....++.++++||.|||+. +   ++||||||+|||++.++.+||+||
T Consensus        84 ~~~~~~L~~~l~~~------------~~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Df  148 (333)
T cd06650          84 HMDGGSLDQVLKKA------------GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDF  148 (333)
T ss_pred             cCCCCcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeC
Confidence            99999999998652            3588999999999999999999975 5   999999999999999999999999


Q ss_pred             cCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHH---------
Q 009340          372 GISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVAC---------  442 (537)
Q Consensus       372 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~---------  442 (537)
                      |++.......   .....|+..|+|||.+.+..++.++|||||||++|||++|+.||..............         
T Consensus       149 g~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  225 (333)
T cd06650         149 GVSGQLIDSM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAES  225 (333)
T ss_pred             Ccchhhhhhc---cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCcccc
Confidence            9987653221   2334689999999999988899999999999999999999999864432111000000         


Q ss_pred             ------------HHHHHhh----chhhhhhcHHhhcc---cc-HHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          443 ------------FISLAKE----NQLLEILDARVAKE---AR-EEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       443 ------------~~~~~~~----~~~~~~~d~~~~~~---~~-~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                                  .......    .......+......   .+ .....++.+|+.+||+.||++|||+.|+++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~  298 (333)
T cd06650         226 ETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV  298 (333)
T ss_pred             ccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence                        0000000    00000001000000   00 113456889999999999999999999964

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1.4e-39  Score=332.81  Aligned_cols=247  Identities=26%  Similarity=0.370  Sum_probs=193.5

Q ss_pred             CCccccccCcCCceEEEEEEcC-CCCEEEEEEccCC-ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecC
Q 009340          217 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI-DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI  294 (537)
Q Consensus       217 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  294 (537)
                      +|+..++||+|+||.||+++.. +|+.||||.+... .....+.+.+|+.+++.++|+||+++++++.+.+..++||||+
T Consensus        75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  154 (353)
T PLN00034         75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM  154 (353)
T ss_pred             HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence            3445678999999999999964 6899999998653 3344567899999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCc
Q 009340          295 SSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGIS  374 (537)
Q Consensus       295 ~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla  374 (537)
                      ++|+|.+..                ...+..+..++.|+++||.|||+.+   |+||||||+|||+++++.+||+|||++
T Consensus       155 ~~~~L~~~~----------------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~  215 (353)
T PLN00034        155 DGGSLEGTH----------------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVS  215 (353)
T ss_pred             CCCcccccc----------------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccc
Confidence            999986432                3556778899999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCCceeeeccccccccCcccccC-----CCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhh
Q 009340          375 RSIPNDKTHLTTTIQGTFGYLDPEYFQS-----SQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKE  449 (537)
Q Consensus       375 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  449 (537)
                      +....... ......||..|+|||.+..     ...+.++|||||||++|||++|+.||......+...    .......
T Consensus       216 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~----~~~~~~~  290 (353)
T PLN00034        216 RILAQTMD-PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWAS----LMCAICM  290 (353)
T ss_pred             eecccccc-cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHH----HHHHHhc
Confidence            87643221 2234568999999998743     223468999999999999999999987332221100    0000000


Q ss_pred             chhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHH
Q 009340          450 NQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSME  496 (537)
Q Consensus       450 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~  496 (537)
                               ......+......+.+|+.+||+.||++|||+.|+++.
T Consensus       291 ---------~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        291 ---------SQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             ---------cCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                     00111233445678999999999999999999999763

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=3.4e-39  Score=316.77  Aligned_cols=255  Identities=27%  Similarity=0.462  Sum_probs=205.7

Q ss_pred             cCCccccccCcCCceEEEEEEcC-C---CCEEEEEEccCCC-hHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-D---GSIVAVKRSKEID-KTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLV  290 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~---g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  290 (537)
                      .+|...+.||+|+||.||+|... +   +..+|+|.++... ....+.|.+|+.++++++||||+++++++.+.+..++|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            46778899999999999999863 2   3379999987532 34466889999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEee
Q 009340          291 YEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSD  370 (537)
Q Consensus       291 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~D  370 (537)
                      |||+++++|.+++....           ..+++.+++.++.|++.||.|||+.+   ++||||||+|||++.++.++|+|
T Consensus        84 ~e~~~~~~L~~~~~~~~-----------~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~d  149 (267)
T cd05066          84 TEYMENGSLDAFLRKHD-----------GQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSD  149 (267)
T ss_pred             EEcCCCCCHHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCC
Confidence            99999999999996532           35899999999999999999999999   99999999999999999999999


Q ss_pred             ccCccccCCCCCceee--eccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHHHHH
Q 009340          371 FGISRSIPNDKTHLTT--TIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLA  447 (537)
Q Consensus       371 fgla~~~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~  447 (537)
                      ||++............  ...++..|+|||.+.+..++.++||||||+++||+++ |+.||......+       .....
T Consensus       150 fg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~-------~~~~~  222 (267)
T cd05066         150 FGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD-------VIKAI  222 (267)
T ss_pred             CCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH-------HHHHH
Confidence            9999876543332222  1223568999999998899999999999999999887 999986543221       11111


Q ss_pred             hhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHH
Q 009340          448 KENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGL  500 (537)
Q Consensus       448 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i  500 (537)
                      ...         ...+.+...+..+.+++.+||+.+|++||+|.++++.|+++
T Consensus       223 ~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         223 EEG---------YRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             hCC---------CcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence            111         01112233456788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.9e-39  Score=335.59  Aligned_cols=271  Identities=26%  Similarity=0.402  Sum_probs=210.1

Q ss_pred             HHhcCCccccccCcCCceEEEEEEcC------CCCEEEEEEccCCC-hHHHHHHHHHHHHHHhcC-CCCcceEeeEEeeC
Q 009340          213 RATDNYNQSRFLGQGGFGTVYKGMLP------DGSIVAVKRSKEID-KTQIHQFINEVVILSQIN-HRHIVKLLGCCLET  284 (537)
Q Consensus       213 ~~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~  284 (537)
                      ...++|...++||+|+||.||+|++.      .+..||||+++... ....+.+.+|+.++.++. |+||++++++|...
T Consensus        34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~  113 (401)
T cd05107          34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG  113 (401)
T ss_pred             ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC
Confidence            33456777899999999999999853      24579999997542 333457899999999997 99999999999998


Q ss_pred             CccEEEEecCCCCChhhhhhhhhhhHHH----------------------------------------------------
Q 009340          285 EVPVLVYEYISSGTLSHHIHDHQQQQEQ----------------------------------------------------  312 (537)
Q Consensus       285 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~----------------------------------------------------  312 (537)
                      +..++|+||+++|+|.++++........                                                    
T Consensus       114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (401)
T cd05107         114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ  193 (401)
T ss_pred             CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence            9999999999999999999764321000                                                    


Q ss_pred             ----------------------------------HhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCE
Q 009340          313 ----------------------------------KQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNI  358 (537)
Q Consensus       313 ----------------------------------~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NI  358 (537)
                                                        ........++|..++.++.|++.||.|||+.+   ++||||||+||
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~Ni  270 (401)
T cd05107         194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNV  270 (401)
T ss_pred             cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceE
Confidence                                              00011235889999999999999999999988   99999999999


Q ss_pred             EECCCCcEEEeeccCccccCCCCCc-eeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhh
Q 009340          359 LLDDKFSAKVSDFGISRSIPNDKTH-LTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEE  436 (537)
Q Consensus       359 ll~~~~~~ki~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~  436 (537)
                      |+++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |+.|+......+.
T Consensus       271 Ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~  350 (401)
T cd05107         271 LICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ  350 (401)
T ss_pred             EEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH
Confidence            9999999999999999865332221 1223456789999999998889999999999999999998 8888754322110


Q ss_pred             ccHHHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHH
Q 009340          437 RNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLR  501 (537)
Q Consensus       437 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~  501 (537)
                            .....         ........+...+..+.+++.+||+.+|++||++++|++.|+++.
T Consensus       351 ------~~~~~---------~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         351 ------FYNAI---------KRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             ------HHHHH---------HcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence                  11111         111111223334568899999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=3.4e-39  Score=317.28  Aligned_cols=257  Identities=26%  Similarity=0.443  Sum_probs=207.7

Q ss_pred             cCCccccccCcCCceEEEEEEcCC----CCEEEEEEccCCC-hHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLPD----GSIVAVKRSKEID-KTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLV  290 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  290 (537)
                      ++|...++||+|+||.||+|...+    ...||||...... ....+.|.+|+.++++++|+|++++++++.+ +..++|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv   84 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV   84 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence            457778899999999999998643    2469999887644 5566789999999999999999999999875 456899


Q ss_pred             EecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEee
Q 009340          291 YEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSD  370 (537)
Q Consensus       291 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~D  370 (537)
                      |||+++|+|.+++....           ..+++..++.++.+++.||.|||+.+   ++||||||+||+++.++.+||+|
T Consensus        85 ~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d  150 (270)
T cd05056          85 MELAPLGELRSYLQVNK-----------YSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGD  150 (270)
T ss_pred             EEcCCCCcHHHHHHhCC-----------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEcc
Confidence            99999999999996532           25899999999999999999999998   99999999999999999999999


Q ss_pred             ccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHHHHHhh
Q 009340          371 FGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKE  449 (537)
Q Consensus       371 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  449 (537)
                      ||+++..............++..|+|||.+....++.++||||||+++|||++ |+.||......+.      ... ...
T Consensus       151 ~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~------~~~-~~~  223 (270)
T cd05056         151 FGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV------IGR-IEN  223 (270)
T ss_pred             CceeeecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH------HHH-HHc
Confidence            99998765443333333345678999999988889999999999999999997 9999864432211      111 111


Q ss_pred             chhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHHh
Q 009340          450 NQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRS  503 (537)
Q Consensus       450 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~  503 (537)
                      ..         ....+...+..+.+++.+|+..+|++|||+.++++.|+.+...
T Consensus       224 ~~---------~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~  268 (270)
T cd05056         224 GE---------RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE  268 (270)
T ss_pred             CC---------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            10         1112334456789999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.7e-39  Score=328.75  Aligned_cols=241  Identities=25%  Similarity=0.362  Sum_probs=196.9

Q ss_pred             cccCcCCceEEEEEEcC-CCCEEEEEEccCC---ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecCCCC
Q 009340          222 RFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI---DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSG  297 (537)
Q Consensus       222 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g  297 (537)
                      +.||+|+||.||++... +|+.||+|.+...   .......+.+|+.+++.++||||+++.+++.+.+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            36999999999999854 6899999998642   2344567889999999999999999999999999999999999999


Q ss_pred             ChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCcccc
Q 009340          298 TLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI  377 (537)
Q Consensus       298 sL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~  377 (537)
                      +|.+++...            ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        81 ~L~~~l~~~------------~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~  145 (328)
T cd05593          81 ELFFHLSRE------------RVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEG  145 (328)
T ss_pred             CHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccC
Confidence            999888652            35899999999999999999999999   999999999999999999999999998754


Q ss_pred             CCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchhhhhhc
Q 009340          378 PNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEILD  457 (537)
Q Consensus       378 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  457 (537)
                      .... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||......+.      ...... .       
T Consensus       146 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~------~~~~~~-~-------  210 (328)
T cd05593         146 ITDA-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL------FELILM-E-------  210 (328)
T ss_pred             CCcc-cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHH------HHHhcc-C-------
Confidence            2221 122345689999999999999999999999999999999999999865432211      111000 0       


Q ss_pred             HHhhccccHHHHHHHHHHHHHhcccCCCCCC-----CHhhHHH
Q 009340          458 ARVAKEAREEDIGAMAELAMRCLRLNSKKRP-----TMKQVSM  495 (537)
Q Consensus       458 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~  495 (537)
                         ....+...+..+.+++.+||+.||++||     ++.++++
T Consensus       211 ---~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  250 (328)
T cd05593         211 ---DIKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR  250 (328)
T ss_pred             ---CccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence               0012233456788999999999999997     7888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=3.1e-39  Score=323.87  Aligned_cols=270  Identities=28%  Similarity=0.423  Sum_probs=210.1

Q ss_pred             hcCCccccccCcCCceEEEEEEcC--------CCCEEEEEEccCC-ChHHHHHHHHHHHHHHhc-CCCCcceEeeEEeeC
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLP--------DGSIVAVKRSKEI-DKTQIHQFINEVVILSQI-NHRHIVKLLGCCLET  284 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~  284 (537)
                      .++|...+.||+|+||.||++...        ++..+|+|.++.. ......++.+|+.+++.+ +|+||+++++++...
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            357888999999999999999742        2357999998753 234456788999999999 799999999999999


Q ss_pred             CccEEEEecCCCCChhhhhhhhhhhHHHH----hhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEE
Q 009340          285 EVPVLVYEYISSGTLSHHIHDHQQQQEQK----QKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILL  360 (537)
Q Consensus       285 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~----~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll  360 (537)
                      +..++||||+++|+|.+++..........    .......++|.++++++.|++.||+|||+.+   ++||||||+||++
T Consensus        97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill  173 (307)
T cd05098          97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV  173 (307)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence            99999999999999999997643210000    0001235899999999999999999999998   9999999999999


Q ss_pred             CCCCcEEEeeccCccccCCCCCce-eeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhcc
Q 009340          361 DDKFSAKVSDFGISRSIPNDKTHL-TTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERN  438 (537)
Q Consensus       361 ~~~~~~ki~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~  438 (537)
                      +.++.+||+|||++.......... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+   
T Consensus       174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~---  250 (307)
T cd05098         174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---  250 (307)
T ss_pred             cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH---
Confidence            999999999999987654322111 122234578999999998899999999999999999998 888875433211   


Q ss_pred             HHHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHHh
Q 009340          439 LVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRS  503 (537)
Q Consensus       439 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~  503 (537)
                          +.......         ...+.+.....++.+++.+||+.+|++|||+.+|++.|+++...
T Consensus       251 ----~~~~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~  302 (307)
T cd05098         251 ----LFKLLKEG---------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL  302 (307)
T ss_pred             ----HHHHHHcC---------CCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence                11111111         11122334456888999999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=3.2e-39  Score=323.27  Aligned_cols=269  Identities=26%  Similarity=0.435  Sum_probs=210.3

Q ss_pred             hcCCccccccCcCCceEEEEEEcC--------CCCEEEEEEccCC-ChHHHHHHHHHHHHHHhc-CCCCcceEeeEEeeC
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLP--------DGSIVAVKRSKEI-DKTQIHQFINEVVILSQI-NHRHIVKLLGCCLET  284 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~  284 (537)
                      .++|...+.||+|+||.||+++..        ++..||+|.++.. .....+++.+|+.+++.+ +|+||+++++++...
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   93 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   93 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence            457778899999999999999731        3457999988753 344567789999999999 899999999999999


Q ss_pred             CccEEEEecCCCCChhhhhhhhhhhHHHH----hhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEE
Q 009340          285 EVPVLVYEYISSGTLSHHIHDHQQQQEQK----QKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILL  360 (537)
Q Consensus       285 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~----~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll  360 (537)
                      ...++||||+++|+|.+++..........    .......++|..++.++.|+++||.|||+.+   ++||||||+||++
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili  170 (304)
T cd05101          94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLV  170 (304)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEE
Confidence            99999999999999999997643210000    0001235899999999999999999999998   9999999999999


Q ss_pred             CCCCcEEEeeccCccccCCCCCce-eeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhcc
Q 009340          361 DDKFSAKVSDFGISRSIPNDKTHL-TTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERN  438 (537)
Q Consensus       361 ~~~~~~ki~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~  438 (537)
                      ++++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..|+......+   
T Consensus       171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---  247 (304)
T cd05101         171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---  247 (304)
T ss_pred             cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH---
Confidence            999999999999998764433221 223345678999999998889999999999999999998 777875432221   


Q ss_pred             HHHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHH
Q 009340          439 LVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRR  502 (537)
Q Consensus       439 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~  502 (537)
                          ........         .....+..++..+.+++.+||+.+|++|||+.++++.|+++..
T Consensus       248 ----~~~~~~~~---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~  298 (304)
T cd05101         248 ----LFKLLKEG---------HRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT  298 (304)
T ss_pred             ----HHHHHHcC---------CcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence                11111111         1111223445678899999999999999999999999998876

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=3.8e-39  Score=318.55  Aligned_cols=257  Identities=25%  Similarity=0.449  Sum_probs=204.8

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCC----EEEEEEccC-CChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGS----IVAVKRSKE-IDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVL  289 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~----~vavK~~~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  289 (537)
                      ++|+..++||+|+||+||+|.+. +|+    .||+|.++. ......+++.+|+.++..++|+|++++++++... ..++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l   85 (279)
T cd05109           7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQL   85 (279)
T ss_pred             hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEE
Confidence            56778899999999999999853 444    489999875 3444567789999999999999999999999754 5689


Q ss_pred             EEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEe
Q 009340          290 VYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVS  369 (537)
Q Consensus       290 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~  369 (537)
                      ++||+++|+|.++++...           ..+++..++.++.|+++||+|||+.+   ++||||||+|||+++++.+||+
T Consensus        86 ~~~~~~~g~l~~~l~~~~-----------~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~  151 (279)
T cd05109          86 VTQLMPYGCLLDYVRENK-----------DRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKIT  151 (279)
T ss_pred             EEEcCCCCCHHHHHhhcc-----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEEC
Confidence            999999999999987532           25899999999999999999999999   9999999999999999999999


Q ss_pred             eccCccccCCCCCce-eeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHHHHH
Q 009340          370 DFGISRSIPNDKTHL-TTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLA  447 (537)
Q Consensus       370 Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~  447 (537)
                      |||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||.......       .....
T Consensus       152 dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-------~~~~~  224 (279)
T cd05109         152 DFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE-------IPDLL  224 (279)
T ss_pred             CCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHH
Confidence            999998764332211 122335678999999998999999999999999999998 888875432211       11111


Q ss_pred             hhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHHh
Q 009340          448 KENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRS  503 (537)
Q Consensus       448 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~  503 (537)
                      ...         ...+.+...+..+.+++.+||+.||++||++.++++.|+.+...
T Consensus       225 ~~~---------~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~  271 (279)
T cd05109         225 EKG---------ERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD  271 (279)
T ss_pred             HCC---------CcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence            111         11112233456788999999999999999999999999877653

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.5e-39  Score=323.22  Aligned_cols=261  Identities=21%  Similarity=0.353  Sum_probs=194.9

Q ss_pred             cCCccccccCcCCceEEEEEEcC--CCCEEEEEEccCCC--hHHHHHHHHHHHHHHhc---CCCCcceEeeEEee-----
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP--DGSIVAVKRSKEID--KTQIHQFINEVVILSQI---NHRHIVKLLGCCLE-----  283 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~--~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~-----  283 (537)
                      .+|...+.||+|+||.||++...  +|+.||+|.++...  ......+.+|+.+++.+   +||||++++++|..     
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            36888899999999999999852  46889999876422  22234566777777765   69999999999863     


Q ss_pred             CCccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCC
Q 009340          284 TEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK  363 (537)
Q Consensus       284 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~  363 (537)
                      ....++||||++ ++|.+++....          ...+++..+..++.|+++||.|||+.+   |+||||||+|||++.+
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~----------~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~  146 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVP----------EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSS  146 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCC----------CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCC
Confidence            345799999996 58998886532          235899999999999999999999999   9999999999999999


Q ss_pred             CcEEEeeccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHH
Q 009340          364 FSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACF  443 (537)
Q Consensus       364 ~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~  443 (537)
                      +.+||+|||+++.....  .......||+.|+|||.+.+..++.++|||||||++|||++|+.||......+.   ....
T Consensus       147 ~~~kl~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~---~~~i  221 (290)
T cd07862         147 GQIKLADFGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ---LGKI  221 (290)
T ss_pred             CCEEEccccceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHH---HHHH
Confidence            99999999999865433  223445689999999999988999999999999999999999999875433221   1111


Q ss_pred             HHHHh---hchhh-------hhhcHHh---hccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          444 ISLAK---ENQLL-------EILDARV---AKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       444 ~~~~~---~~~~~-------~~~d~~~---~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      .....   .....       ..+....   ...........+.+++.+||+.||++|||+.++++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         222 LDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             HHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            11100   00000       0000000   00011123456789999999999999999999974

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=4e-39  Score=322.28  Aligned_cols=258  Identities=28%  Similarity=0.459  Sum_probs=206.8

Q ss_pred             hcCCccccccCcCCceEEEEEEc------CCCCEEEEEEccCC-ChHHHHHHHHHHHHHHhc-CCCCcceEeeEEeeCCc
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGML------PDGSIVAVKRSKEI-DKTQIHQFINEVVILSQI-NHRHIVKLLGCCLETEV  286 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~  286 (537)
                      .++|...+.||+|+||.||++..      ..+..||||.++.. .....+.+.+|+.+++++ +|+||+++++++...+.
T Consensus        34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  113 (302)
T cd05055          34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP  113 (302)
T ss_pred             HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence            35788899999999999999973      13457999988754 234456789999999999 79999999999999999


Q ss_pred             cEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcE
Q 009340          287 PVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA  366 (537)
Q Consensus       287 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~  366 (537)
                      .++||||+++|+|.++++....          ..+++.++..++.|++.||.|||+.+   ++|+||||+|||++.++.+
T Consensus       114 ~~lv~e~~~~~~L~~~i~~~~~----------~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~  180 (302)
T cd05055         114 ILVITEYCCYGDLLNFLRRKRE----------SFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIV  180 (302)
T ss_pred             eEEEEEcCCCCcHHHHHHhCCC----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeE
Confidence            9999999999999999975321          24899999999999999999999998   9999999999999999999


Q ss_pred             EEeeccCccccCCCCCc-eeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHH
Q 009340          367 KVSDFGISRSIPNDKTH-LTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFI  444 (537)
Q Consensus       367 ki~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~  444 (537)
                      +++|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |+.||......+.      +.
T Consensus       181 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~------~~  254 (302)
T cd05055         181 KICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK------FY  254 (302)
T ss_pred             EECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH------HH
Confidence            99999999866433221 1222345778999999999999999999999999999998 9999764332111      11


Q ss_pred             HHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHH
Q 009340          445 SLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGL  500 (537)
Q Consensus       445 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i  500 (537)
                      .....+         .....+...+..+.+++.+||..+|++|||+.++++.|+++
T Consensus       255 ~~~~~~---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         255 KLIKEG---------YRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             HHHHcC---------CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence            111111         11111222345789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=3e-39  Score=323.31  Aligned_cols=273  Identities=26%  Similarity=0.444  Sum_probs=209.5

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCC--EEEEEEccCC-ChHHHHHHHHHHHHHHhc-CCCCcceEeeEEeeCCccEEE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGS--IVAVKRSKEI-DKTQIHQFINEVVILSQI-NHRHIVKLLGCCLETEVPVLV  290 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV  290 (537)
                      ++|+..+.||+|+||.||+|... ++.  .+|+|.++.. .......+.+|+.++.++ +|+||+++++++.+.+..++|
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv   86 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   86 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence            57788899999999999999964 444  4688877653 344566788999999999 899999999999999999999


Q ss_pred             EecCCCCChhhhhhhhhhhHHHH----hhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcE
Q 009340          291 YEYISSGTLSHHIHDHQQQQEQK----QKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA  366 (537)
Q Consensus       291 ~e~~~~gsL~~~l~~~~~~~~~~----~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~  366 (537)
                      +||+++|+|.++++.........    .......+++..++.++.|+++||+|||+.+   ++||||||+|||++.++.+
T Consensus        87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~  163 (303)
T cd05088          87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  163 (303)
T ss_pred             EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence            99999999999997643211000    0001235899999999999999999999998   9999999999999999999


Q ss_pred             EEeeccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHHH
Q 009340          367 KVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFIS  445 (537)
Q Consensus       367 ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~  445 (537)
                      ||+|||++......  .......++..|+|||++.+..++.++||||||+++|||+| |..||......+      .+..
T Consensus       164 kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------~~~~  235 (303)
T cd05088         164 KIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------LYEK  235 (303)
T ss_pred             EeCccccCcccchh--hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH------HHHH
Confidence            99999998643211  11112234678999999988889999999999999999998 999986433221      1111


Q ss_pred             HHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHHhhHHHhh
Q 009340          446 LAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRSQRCLEM  509 (537)
Q Consensus       446 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~~~~~~  509 (537)
                       ...         ....+.+...+..+.+|+.+||+.+|++||++.+++.+|+++....+....
T Consensus       236 -~~~---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~~~~~  289 (303)
T cd05088         236 -LPQ---------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVN  289 (303)
T ss_pred             -Hhc---------CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhhhhhh
Confidence             111         011112223345788999999999999999999999999988776544433

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5e-39  Score=332.20  Aligned_cols=258  Identities=19%  Similarity=0.244  Sum_probs=197.2

Q ss_pred             cCCccccccCcCCceEEEEEEc-CCCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecC
Q 009340          216 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI  294 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  294 (537)
                      .+|...+.||+|+||.||++.. .+++.||+|....      ..+.+|+.++++++||||+++++++......++|+|++
T Consensus        92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~  165 (391)
T PHA03212         92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY  165 (391)
T ss_pred             CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence            5799999999999999999985 4688999997542      35678999999999999999999999999999999998


Q ss_pred             CCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCc
Q 009340          295 SSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGIS  374 (537)
Q Consensus       295 ~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla  374 (537)
                      . ++|.+++...            ..+++..++.++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       166 ~-~~L~~~l~~~------------~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a  229 (391)
T PHA03212        166 K-TDLYCYLAAK------------RNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAA  229 (391)
T ss_pred             C-CCHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcc
Confidence            5 6888887542            35899999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhh----ccHHHHHHHHHhh-
Q 009340          375 RSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEE----RNLVACFISLAKE-  449 (537)
Q Consensus       375 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~----~~~~~~~~~~~~~-  449 (537)
                      +..............||+.|+|||++.+..++.++|||||||++|||++|+.|+........    ............. 
T Consensus       230 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~  309 (391)
T PHA03212        230 CFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTH  309 (391)
T ss_pred             cccccccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCC
Confidence            75433222223445799999999999999999999999999999999999988754321110    0011111110000 


Q ss_pred             ---------chhhhhh---------cHHhhc--cccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          450 ---------NQLLEIL---------DARVAK--EAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       450 ---------~~~~~~~---------d~~~~~--~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                               ..+.+..         .+....  ......+.++.+|+.+||+.||++|||+.|+++
T Consensus       310 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        310 PNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             hhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence                     0000000         000000  001123457889999999999999999999974

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.9e-39  Score=315.93  Aligned_cols=255  Identities=28%  Similarity=0.455  Sum_probs=208.2

Q ss_pred             hcCCccccccCcCCceEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecC
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI  294 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  294 (537)
                      .++|...++||+|+||.||++..++++.||||.+..... ..+++.+|+.++++++|+|++++++++......++||||+
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   83 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM   83 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence            467888999999999999999988888999999875332 3467899999999999999999999999888999999999


Q ss_pred             CCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCc
Q 009340          295 SSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGIS  374 (537)
Q Consensus       295 ~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla  374 (537)
                      ++++|.+++....          ...+++..+..++.+++.||.|||+.+   ++|+||||+||++++++.+||+|||++
T Consensus        84 ~~~~L~~~i~~~~----------~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~  150 (261)
T cd05034          84 SKGSLLDFLKSGE----------GKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLA  150 (261)
T ss_pred             CCCCHHHHHhccc----------cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccc
Confidence            9999999997643          236899999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHHHHHhhchhh
Q 009340          375 RSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQLL  453 (537)
Q Consensus       375 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  453 (537)
                      ................+..|+|||.+.+..++.++||||||+++|||++ |+.||.......   ...   . ..     
T Consensus       151 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~~---~-~~-----  218 (261)
T cd05034         151 RLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE---VLE---Q-VE-----  218 (261)
T ss_pred             eeccchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH---H-HH-----
Confidence            8765432222223335678999999998889999999999999999999 999985432211   111   1 10     


Q ss_pred             hhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHH
Q 009340          454 EILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEG  499 (537)
Q Consensus       454 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  499 (537)
                          .......+...+..+.+++.+||+.+|++||++.++.+.|+.
T Consensus       219 ----~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         219 ----RGYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             ----cCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence                011111222335678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=3.7e-39  Score=316.82  Aligned_cols=254  Identities=25%  Similarity=0.468  Sum_probs=203.5

Q ss_pred             CCccccccCcCCceEEEEEEcCC-C---CEEEEEEccCC-ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEE
Q 009340          217 NYNQSRFLGQGGFGTVYKGMLPD-G---SIVAVKRSKEI-DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY  291 (537)
Q Consensus       217 ~~~~~~~lg~G~~g~Vy~~~~~~-g---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  291 (537)
                      .|+..+.||+|+||.||+|.... +   ..||||.++.. ......+|..|+.+++.++|||++++.+++.+....++||
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   84 (269)
T cd05065           5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT   84 (269)
T ss_pred             HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence            46778899999999999999642 3   36999998754 4555678999999999999999999999999989999999


Q ss_pred             ecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeec
Q 009340          292 EYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF  371 (537)
Q Consensus       292 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Df  371 (537)
                      ||+++|+|.+++....           ..+++.+++.++.|++.||.|||+.+   ++|+||||+||+++.++.+||+||
T Consensus        85 e~~~~~~L~~~l~~~~-----------~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~df  150 (269)
T cd05065          85 EFMENGALDSFLRQND-----------GQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDF  150 (269)
T ss_pred             ecCCCCcHHHHHhhCC-----------CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCC
Confidence            9999999999986532           35899999999999999999999998   999999999999999999999999


Q ss_pred             cCccccCCCCCce--eeecc--ccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHHHH
Q 009340          372 GISRSIPNDKTHL--TTTIQ--GTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISL  446 (537)
Q Consensus       372 gla~~~~~~~~~~--~~~~~--gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~  446 (537)
                      |++..........  .....  .+..|+|||++....++.++||||||+++|||++ |+.||......+       +...
T Consensus       151 g~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~-------~~~~  223 (269)
T cd05065         151 GLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD-------VINA  223 (269)
T ss_pred             ccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH-------HHHH
Confidence            9987654322211  11111  2457999999999999999999999999999987 999986433221       1111


Q ss_pred             HhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHH
Q 009340          447 AKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGL  500 (537)
Q Consensus       447 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i  500 (537)
                      ...         ....+.+.+++..+.+++.+||+.+|++||++.+|+.+|+.+
T Consensus       224 i~~---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         224 IEQ---------DYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             HHc---------CCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            110         011112234456788999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=5e-39  Score=315.32  Aligned_cols=261  Identities=23%  Similarity=0.384  Sum_probs=209.3

Q ss_pred             cCCccccccCcCCceEEEEEEc-CCCCEEEEEEccCC---ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEI---DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY  291 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  291 (537)
                      ++|+..+.||+|+||.||++.. .+++.+|||.+...   ......++.+|+.+++.++|+|++++++++.+.+..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            4677888999999999999995 47899999987542   3344568899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeec
Q 009340          292 EYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF  371 (537)
Q Consensus       292 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Df  371 (537)
                      ||+++++|.+++.....        ....++|..++.++.|+++||.|||+.+   ++|+||||+||+++.++.++|+||
T Consensus        82 e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df  150 (267)
T cd08229          82 ELADAGDLSRMIKHFKK--------QKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDL  150 (267)
T ss_pred             EecCCCCHHHHHHHhhc--------cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcc
Confidence            99999999999864321        1246899999999999999999999999   999999999999999999999999


Q ss_pred             cCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhch
Q 009340          372 GISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQ  451 (537)
Q Consensus       372 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  451 (537)
                      |++........ ......++..|+|||.+.+..++.++||||||+++|||++|..||.......    .. ......   
T Consensus       151 g~~~~~~~~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----~~-~~~~~~---  221 (267)
T cd08229         151 GLGRFFSSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL----YS-LCKKIE---  221 (267)
T ss_pred             hhhhccccCCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchH----HH-Hhhhhh---
Confidence            99876643322 1233458899999999988889999999999999999999999985432210    00 000000   


Q ss_pred             hhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHH
Q 009340          452 LLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLR  501 (537)
Q Consensus       452 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~  501 (537)
                        ....   ...........+.+++.+||+.+|++||||.+|+++++++.
T Consensus       222 --~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         222 --QCDY---PPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             --cCCC---CCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence              0000   00112235567899999999999999999999999998763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.6e-39  Score=330.15  Aligned_cols=245  Identities=24%  Similarity=0.338  Sum_probs=200.4

Q ss_pred             cCCccccccCcCCceEEEEEEcCC--CCEEEEEEccCC---ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLPD--GSIVAVKRSKEI---DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLV  290 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~~--g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  290 (537)
                      ++|...+.||+|+||.||+|...+  +..||+|++...   .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv  109 (340)
T PTZ00426         30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV  109 (340)
T ss_pred             hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence            568889999999999999998543  368999987542   233456788999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEee
Q 009340          291 YEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSD  370 (537)
Q Consensus       291 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~D  370 (537)
                      |||+++|+|.+++...            ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|
T Consensus       110 ~Ey~~~g~L~~~i~~~------------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~D  174 (340)
T PTZ00426        110 LEFVIGGEFFTFLRRN------------KRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTD  174 (340)
T ss_pred             EeCCCCCcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEec
Confidence            9999999999998753            35899999999999999999999999   99999999999999999999999


Q ss_pred             ccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhc
Q 009340          371 FGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKEN  450 (537)
Q Consensus       371 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  450 (537)
                      ||++......    .....||+.|+|||++.+..++.++|||||||++|||++|+.||........      .... ...
T Consensus       175 FG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~------~~~i-~~~  243 (340)
T PTZ00426        175 FGFAKVVDTR----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLI------YQKI-LEG  243 (340)
T ss_pred             CCCCeecCCC----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHH------HHHH-hcC
Confidence            9999875432    2345689999999999988899999999999999999999999975432110      1111 111


Q ss_pred             hhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCC-----CHhhHHHH
Q 009340          451 QLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRP-----TMKQVSME  496 (537)
Q Consensus       451 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~~  496 (537)
                      .          ...+......+.+++.+||+.||++|+     ++.++++.
T Consensus       244 ~----------~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        244 I----------IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             C----------CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence            0          012223345678999999999999995     78887653

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=6.3e-39  Score=312.36  Aligned_cols=249  Identities=27%  Similarity=0.426  Sum_probs=205.1

Q ss_pred             CCccccccCcCCceEEEEEEcC-CCCEEEEEEccC--CChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEec
Q 009340          217 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKE--IDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY  293 (537)
Q Consensus       217 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  293 (537)
                      +|+..+.||+|++|.||++... +++.|++|.+..  .......++.+|++++++++|+|++++++++.+.+..++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            4677889999999999999964 688999998763  3445667899999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccC
Q 009340          294 ISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGI  373 (537)
Q Consensus       294 ~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgl  373 (537)
                      +++++|.+++....          ...+++..++.++.+++.||.|||+.+   ++|+||+|+||+++.++.++|+|||+
T Consensus        81 ~~~~~L~~~l~~~~----------~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~  147 (256)
T cd08529          81 AENGDLHKLLKMQR----------GRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGV  147 (256)
T ss_pred             CCCCcHHHHHHHhc----------CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEccccc
Confidence            99999999997642          236899999999999999999999998   99999999999999999999999999


Q ss_pred             ccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchhh
Q 009340          374 SRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLL  453 (537)
Q Consensus       374 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  453 (537)
                      ++........ .....+++.|+|||++.+..++.++|+||||+++|||++|+.||.......       ........   
T Consensus       148 ~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~---  216 (256)
T cd08529         148 AKLLSDNTNF-ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA-------LILKIIRG---  216 (256)
T ss_pred             ceeccCccch-hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHcC---
Confidence            8876443222 233457889999999999999999999999999999999999986543211       11111111   


Q ss_pred             hhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          454 EILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       454 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                            .....+......+.+++.+||+.+|++||++.++++
T Consensus       217 ------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  252 (256)
T cd08529         217 ------VFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR  252 (256)
T ss_pred             ------CCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence                  111122244567899999999999999999999976

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=4.7e-39  Score=314.52  Aligned_cols=254  Identities=24%  Similarity=0.433  Sum_probs=206.7

Q ss_pred             hcCCccccccCcCCceEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecC
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI  294 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  294 (537)
                      .++|...++||+|+||.||++...++..+|+|.++.. ....+.|.+|+.+++.++|+|++++.+++.+ ...+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~   82 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM   82 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence            4678889999999999999999877888999988753 3345678999999999999999999999887 7789999999


Q ss_pred             CCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCc
Q 009340          295 SSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGIS  374 (537)
Q Consensus       295 ~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla  374 (537)
                      ++|+|.+++....          ...++|..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||++
T Consensus        83 ~~~~L~~~~~~~~----------~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~  149 (260)
T cd05073          83 AKGSLLDFLKSDE----------GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLA  149 (260)
T ss_pred             CCCcHHHHHHhCC----------ccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcce
Confidence            9999999997532          235899999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHHHHHhhchhh
Q 009340          375 RSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQLL  453 (537)
Q Consensus       375 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  453 (537)
                      ...............++..|+|||++..+.++.++|+||||+++|||++ |+.||.......       ........   
T Consensus       150 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~-------~~~~~~~~---  219 (260)
T cd05073         150 RVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE-------VIRALERG---  219 (260)
T ss_pred             eeccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHhCC---
Confidence            8764433322233445678999999998889999999999999999999 888886432211       11111111   


Q ss_pred             hhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHH
Q 009340          454 EILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEG  499 (537)
Q Consensus       454 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  499 (537)
                            ...+.+...+..+.+++.+||+.+|++||++.++.+.|+.
T Consensus       220 ------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         220 ------YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             ------CCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence                  1111223344678899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.8e-39  Score=321.56  Aligned_cols=264  Identities=25%  Similarity=0.420  Sum_probs=205.2

Q ss_pred             CCccccccCcCCceEEEEEEcC------CCCEEEEEEccCCC-hHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEE
Q 009340          217 NYNQSRFLGQGGFGTVYKGMLP------DGSIVAVKRSKEID-KTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVL  289 (537)
Q Consensus       217 ~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  289 (537)
                      +|...+.||+|+||.||+|...      ++..||+|+++... ....+.|.+|+.+++.++|+||+++++++.+....++
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~   85 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM   85 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence            4566788999999999999853      25789999987543 3345678899999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhhhhhhhHHH----HhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCc
Q 009340          290 VYEYISSGTLSHHIHDHQQQQEQ----KQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFS  365 (537)
Q Consensus       290 V~e~~~~gsL~~~l~~~~~~~~~----~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~  365 (537)
                      ++||+++++|.+++.........    ........+++..+++++.|+++||.|||+.+   ++||||||+||++++++.
T Consensus        86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~  162 (283)
T cd05091          86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLN  162 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCc
Confidence            99999999999998643211000    00011235899999999999999999999999   999999999999999999


Q ss_pred             EEEeeccCccccCCCCC-ceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHH
Q 009340          366 AKVSDFGISRSIPNDKT-HLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACF  443 (537)
Q Consensus       366 ~ki~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~  443 (537)
                      +||+|||+++....... .......+++.|+|||.+.++.++.++||||||+++|||++ |..|+......+       .
T Consensus       163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-------~  235 (283)
T cd05091         163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD-------V  235 (283)
T ss_pred             eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH-------H
Confidence            99999999886643322 12233446789999999988899999999999999999998 777875432211       1


Q ss_pred             HHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHH
Q 009340          444 ISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEG  499 (537)
Q Consensus       444 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  499 (537)
                      ........         ....+..++..+.+++.+||+.+|++||++.+|+..|+.
T Consensus       236 ~~~i~~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         236 IEMIRNRQ---------VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             HHHHHcCC---------cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            11111111         112234456678999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=4.9e-39  Score=321.79  Aligned_cols=263  Identities=22%  Similarity=0.353  Sum_probs=197.8

Q ss_pred             hcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCCh-HHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEe
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDK-TQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE  292 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e  292 (537)
                      .++|...+.||+|+||.||+|... +++.||||.++.... .....+.+|+.+++.++|+||+++++++.+.+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            468899999999999999999965 688999999864322 223457789999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeecc
Q 009340          293 YISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG  372 (537)
Q Consensus       293 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfg  372 (537)
                      |++ ++|.+++....           ..+++..+..++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        84 ~~~-~~l~~~~~~~~-----------~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg  148 (303)
T cd07869          84 YVH-TDLCQYMDKHP-----------GGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFG  148 (303)
T ss_pred             CCC-cCHHHHHHhCC-----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCC
Confidence            996 58888776432           35889999999999999999999999   9999999999999999999999999


Q ss_pred             CccccCCCCCceeeeccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhch
Q 009340          373 ISRSIPNDKTHLTTTIQGTFGYLDPEYFQS-SQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQ  451 (537)
Q Consensus       373 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  451 (537)
                      ++....... .......+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||.......  ..............
T Consensus       149 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~  225 (303)
T cd07869         149 LARAKSVPS-HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ--DQLERIFLVLGTPN  225 (303)
T ss_pred             cceeccCCC-ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHH--HHHHHHHHHhCCCC
Confidence            987543222 12234567899999999865 458899999999999999999999996532211  11111111110000


Q ss_pred             hh--------hhhcHH---------hhccc-cHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          452 LL--------EILDAR---------VAKEA-REEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       452 ~~--------~~~d~~---------~~~~~-~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      ..        ...++.         +.... ....+..+.+|+.+||+.||++|||+.|+++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         226 EDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             hhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence            00        000000         00000 0012246789999999999999999999975

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.6e-39  Score=318.11  Aligned_cols=263  Identities=28%  Similarity=0.468  Sum_probs=208.5

Q ss_pred             hcCCccccccCcCCceEEEEEEcCC------CCEEEEEEccCCC-hHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCcc
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLPD------GSIVAVKRSKEID-KTQIHQFINEVVILSQINHRHIVKLLGCCLETEVP  287 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~~------g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~  287 (537)
                      .++|...+.||+|+||.||+|...+      +..||+|.+.... ......+.+|+.++..++|+|++++++++......
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            3578888999999999999998642      3689999987543 34456789999999999999999999999999999


Q ss_pred             EEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEE
Q 009340          288 VLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK  367 (537)
Q Consensus       288 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~k  367 (537)
                      ++||||+++|+|.+++.........  ......++|..++.++.|++.||.|||+.+   ++||||||+||+++.++.+|
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~--~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~k  159 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAEN--NPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVK  159 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhh--ccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEE
Confidence            9999999999999999764321110  011235899999999999999999999998   99999999999999999999


Q ss_pred             EeeccCccccCCCCCc-eeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHHH
Q 009340          368 VSDFGISRSIPNDKTH-LTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFIS  445 (537)
Q Consensus       368 i~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~  445 (537)
                      |+|||+++........ ......++..|+|||.+.++.++.++||||||+++|||++ |+.|+......+       +..
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-------~~~  232 (277)
T cd05032         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE-------VLK  232 (277)
T ss_pred             ECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH-------HHH
Confidence            9999999865433221 2233456789999999998899999999999999999998 888875433222       111


Q ss_pred             HHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHH
Q 009340          446 LAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELE  498 (537)
Q Consensus       446 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~  498 (537)
                      ....+.         ....+...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus       233 ~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         233 FVIDGG---------HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             HHhcCC---------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence            111111         11123334568899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=8.7e-39  Score=314.51  Aligned_cols=259  Identities=27%  Similarity=0.457  Sum_probs=199.4

Q ss_pred             cccCcCCceEEEEEEcCC-CC--EEEEEEccCC-ChHHHHHHHHHHHHHHhc-CCCCcceEeeEEeeCCccEEEEecCCC
Q 009340          222 RFLGQGGFGTVYKGMLPD-GS--IVAVKRSKEI-DKTQIHQFINEVVILSQI-NHRHIVKLLGCCLETEVPVLVYEYISS  296 (537)
Q Consensus       222 ~~lg~G~~g~Vy~~~~~~-g~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~  296 (537)
                      +.||+|+||.||+|...+ +.  .+++|.++.. .....+.+.+|+.+++++ +|||++++++++...+..++||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            369999999999999753 43  5789988753 345566889999999999 799999999999999999999999999


Q ss_pred             CChhhhhhhhhhhHHHH----hhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeecc
Q 009340          297 GTLSHHIHDHQQQQEQK----QKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG  372 (537)
Q Consensus       297 gsL~~~l~~~~~~~~~~----~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfg  372 (537)
                      |+|.+++..........    .......+++..++.++.|++.||+|||+.+   ++||||||+||++++++.+||+|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence            99999997643210000    0001235899999999999999999999998   9999999999999999999999999


Q ss_pred             CccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHHHHHhhch
Q 009340          373 ISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQ  451 (537)
Q Consensus       373 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  451 (537)
                      ++......  ........+..|+|||++....++.++||||||+++|||++ |+.||......+       .......  
T Consensus       158 l~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~-------~~~~~~~--  226 (270)
T cd05047         158 LSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-------LYEKLPQ--  226 (270)
T ss_pred             Cccccchh--hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH-------HHHHHhC--
Confidence            98633211  11111223567999999988889999999999999999997 999985432211       1111111  


Q ss_pred             hhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHH
Q 009340          452 LLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLR  501 (537)
Q Consensus       452 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~  501 (537)
                             ....+.+......+.+++.+||+.+|.+|||+.+++..|++|.
T Consensus       227 -------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         227 -------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             -------CCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence                   1111122234457889999999999999999999999998774

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=2.6e-39  Score=328.03  Aligned_cols=251  Identities=23%  Similarity=0.335  Sum_probs=198.5

Q ss_pred             CCccccccCcCCceEEEEEEc----CCCCEEEEEEccCC----ChHHHHHHHHHHHHHHhc-CCCCcceEeeEEeeCCcc
Q 009340          217 NYNQSRFLGQGGFGTVYKGML----PDGSIVAVKRSKEI----DKTQIHQFINEVVILSQI-NHRHIVKLLGCCLETEVP  287 (537)
Q Consensus       217 ~~~~~~~lg~G~~g~Vy~~~~----~~g~~vavK~~~~~----~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~  287 (537)
                      +|+..+.||+|+||.||+++.    .+++.||+|.+...    .....+.+.+|+.++.++ +|+||+++++++.+.+..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            477889999999999999874    35789999988642    223345678899999999 599999999999999999


Q ss_pred             EEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEE
Q 009340          288 VLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK  367 (537)
Q Consensus       288 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~k  367 (537)
                      ++||||+++|+|.+++...            ..+++..+..++.|+++||.|||+.+   |+||||||+|||++.++.+|
T Consensus        81 ~lv~e~~~~g~L~~~l~~~------------~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~k  145 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQR------------DNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVV  145 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEE
Confidence            9999999999999998652            35899999999999999999999999   99999999999999999999


Q ss_pred             EeeccCccccCCCCCceeeeccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHH
Q 009340          368 VSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSS-QFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISL  446 (537)
Q Consensus       368 i~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~  446 (537)
                      |+|||+++..............||+.|+|||.+.+. .++.++|||||||++|||++|+.||........   ...+...
T Consensus       146 l~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~---~~~~~~~  222 (332)
T cd05614         146 LTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT---QSEVSRR  222 (332)
T ss_pred             EeeCcCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC---HHHHHHH
Confidence            999999986544333333456799999999998765 478899999999999999999999864322111   1111111


Q ss_pred             HhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCC-----CHhhHHH
Q 009340          447 AKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRP-----TMKQVSM  495 (537)
Q Consensus       447 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~  495 (537)
                      ...      .+    ...+......+.+++.+||+.||++||     ++.++++
T Consensus       223 ~~~------~~----~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         223 ILK------CD----PPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             Hhc------CC----CCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence            100      01    112233456788999999999999999     5556654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=4.6e-39  Score=313.55  Aligned_cols=251  Identities=27%  Similarity=0.471  Sum_probs=202.7

Q ss_pred             cCCccccccCcCCceEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecCC
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYIS  295 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  295 (537)
                      .+|...+.||+|+||.||++.+.++..+|+|.++.... ...+|.+|+.++++++|+|++++++++......++|+||++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME   82 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence            35677889999999999999987788999998875332 23578899999999999999999999999999999999999


Q ss_pred             CCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCcc
Q 009340          296 SGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISR  375 (537)
Q Consensus       296 ~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~  375 (537)
                      +++|.+++....           ..++|..++.++.+++.||+|||+.+   ++|+||||+||+++.++.+||+|||++.
T Consensus        83 ~~~L~~~~~~~~-----------~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~  148 (256)
T cd05112          83 HGCLSDYLRAQR-----------GKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTR  148 (256)
T ss_pred             CCcHHHHHHhCc-----------cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCccee
Confidence            999999986532           25899999999999999999999998   9999999999999999999999999987


Q ss_pred             ccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHHHHHhhchhhh
Q 009340          376 SIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQLLE  454 (537)
Q Consensus       376 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  454 (537)
                      ..............++.+|+|||.+.++.++.++||||||+++|||++ |+.||......+       .......+    
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~----  217 (256)
T cd05112         149 FVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE-------VVETINAG----  217 (256)
T ss_pred             ecccCcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH-------HHHHHhCC----
Confidence            654332222223335678999999998899999999999999999998 899986433221       11111110    


Q ss_pred             hhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHH
Q 009340          455 ILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMEL  497 (537)
Q Consensus       455 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L  497 (537)
                           .....+...+..+.+|+.+||+.+|++|||+.+++++|
T Consensus       218 -----~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         218 -----FRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             -----CCCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence                 00011122346789999999999999999999999887

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=3.8e-39  Score=319.44  Aligned_cols=262  Identities=26%  Similarity=0.402  Sum_probs=204.4

Q ss_pred             cCCccccccCcCCceEEEEEEc-----CCCCEEEEEEccCC-ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeC--Ccc
Q 009340          216 DNYNQSRFLGQGGFGTVYKGML-----PDGSIVAVKRSKEI-DKTQIHQFINEVVILSQINHRHIVKLLGCCLET--EVP  287 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~  287 (537)
                      ..|...+.||+|+||.||++.+     .++..||+|.++.. .......+.+|+.+++.++|+|++++.+++.+.  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            3567788999999999999974     35788999998754 344557799999999999999999999999875  467


Q ss_pred             EEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEE
Q 009340          288 VLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK  367 (537)
Q Consensus       288 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~k  367 (537)
                      ++||||+++++|.+++....           ..++|..++.++.|++.||+|||+.+   ++||||||+||++++++.++
T Consensus        84 ~lv~e~~~g~~L~~~l~~~~-----------~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~  149 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRNK-----------NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVK  149 (284)
T ss_pred             EEEEEccCCCCHHHHHHhcc-----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEE
Confidence            99999999999999986432           25899999999999999999999999   99999999999999999999


Q ss_pred             EeeccCccccCCCCCc--eeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhh--------hc
Q 009340          368 VSDFGISRSIPNDKTH--LTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEE--------ER  437 (537)
Q Consensus       368 i~Dfgla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~--------~~  437 (537)
                      |+|||++.........  ......++..|+|||.+.+..++.++||||||+++|||++++.|........        ..
T Consensus       150 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~  229 (284)
T cd05079         150 IGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQ  229 (284)
T ss_pred             ECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhccccccc
Confidence            9999999876433221  1223456778999999988899999999999999999999877643211000        00


Q ss_pred             cHHHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHH
Q 009340          438 NLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGL  500 (537)
Q Consensus       438 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i  500 (537)
                      ...........         .....+.+...+..+.+|+.+||+.+|++|||+.++++.|+.+
T Consensus       230 ~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         230 MTVTRLVRVLE---------EGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             ccHHHHHHHHH---------cCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            00000111111         1111112333557899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=4.8e-39  Score=319.46  Aligned_cols=266  Identities=25%  Similarity=0.432  Sum_probs=206.5

Q ss_pred             HhcCCccccccCcCCceEEEEEEcC------CCCEEEEEEccCCC-hHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCc
Q 009340          214 ATDNYNQSRFLGQGGFGTVYKGMLP------DGSIVAVKRSKEID-KTQIHQFINEVVILSQINHRHIVKLLGCCLETEV  286 (537)
Q Consensus       214 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~  286 (537)
                      ..++|+..++||+|+||.||+|..+      .+..||+|.++... ......+.+|+.+++.++|+|++++++++.+.+.
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP   83 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4578889999999999999999753      24579999876433 3344568899999999999999999999998889


Q ss_pred             cEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcE
Q 009340          287 PVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA  366 (537)
Q Consensus       287 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~  366 (537)
                      .++||||+++|+|.+++.........  ......+++..+..++.|++.||.|||+.+   ++||||||+||++++++.+
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~  158 (288)
T cd05061          84 TLVVMELMAHGDLKSYLRSLRPEAEN--NPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTV  158 (288)
T ss_pred             cEEEEeCCCCCCHHHHHHHhcccccc--CCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcE
Confidence            99999999999999999764321110  011235688899999999999999999998   9999999999999999999


Q ss_pred             EEeeccCccccCCCCCce-eeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHH
Q 009340          367 KVSDFGISRSIPNDKTHL-TTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFI  444 (537)
Q Consensus       367 ki~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~  444 (537)
                      +|+|||+++......... .....++..|+|||.+.++.++.++||||||+++|||++ |..||......+       ..
T Consensus       159 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~-------~~  231 (288)
T cd05061         159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ-------VL  231 (288)
T ss_pred             EECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HH
Confidence            999999998654322211 122345678999999999999999999999999999999 777875432221       11


Q ss_pred             HHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHH
Q 009340          445 SLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGL  500 (537)
Q Consensus       445 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i  500 (537)
                      .....+..         ...+......+.+++.+||+.+|++|||+.++++.|+..
T Consensus       232 ~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~  278 (288)
T cd05061         232 KFVMDGGY---------LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD  278 (288)
T ss_pred             HHHHcCCC---------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence            11111100         111223346799999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.6e-39  Score=311.71  Aligned_cols=248  Identities=29%  Similarity=0.470  Sum_probs=198.7

Q ss_pred             cccCcCCceEEEEEEcCC----CCEEEEEEccCCCh-HHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecCCC
Q 009340          222 RFLGQGGFGTVYKGMLPD----GSIVAVKRSKEIDK-TQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISS  296 (537)
Q Consensus       222 ~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  296 (537)
                      ++||+|+||.||+|++..    +..+|+|....... ...+++.+|+.+++.+.|+|++++++++. .+..++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            469999999999998532    26899999875433 34567899999999999999999999876 4467999999999


Q ss_pred             CChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCccc
Q 009340          297 GTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS  376 (537)
Q Consensus       297 gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~  376 (537)
                      |+|.+++...            ..+++..++.++.|++.||+|||+.+   ++||||||+|||++.++.+||+|||+++.
T Consensus        80 ~~L~~~l~~~------------~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~  144 (257)
T cd05060          80 GPLLKYLKKR------------REIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRA  144 (257)
T ss_pred             CcHHHHHHhC------------CCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccce
Confidence            9999999753            25899999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCCCceee--eccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHHHHHhhchhh
Q 009340          377 IPNDKTHLTT--TIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQLL  453 (537)
Q Consensus       377 ~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  453 (537)
                      ..........  ...++..|+|||.+.+..++.++||||||+++|||++ |+.||......+       +........  
T Consensus       145 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~-------~~~~~~~~~--  215 (257)
T cd05060         145 LGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE-------VIAMLESGE--  215 (257)
T ss_pred             eecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH-------HHHHHHcCC--
Confidence            6443322211  2224568999999998999999999999999999998 999986443211       111111111  


Q ss_pred             hhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHH
Q 009340          454 EILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLR  501 (537)
Q Consensus       454 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~  501 (537)
                             ..+.+...+..+.+++.+||+.+|++||++.++++.|+.+.
T Consensus       216 -------~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         216 -------RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             -------cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence                   11223334567889999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-39  Score=340.57  Aligned_cols=260  Identities=25%  Similarity=0.352  Sum_probs=218.0

Q ss_pred             hcCCccccccCcCCceEEEEEEcCCC-CEEEEEEccCCChHHHHHHHHHHHHHHhcC-CCCcceEee-EEeeC------C
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLPDG-SIVAVKRSKEIDKTQIHQFINEVVILSQIN-HRHIVKLLG-CCLET------E  285 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~~g-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g-~~~~~------~  285 (537)
                      ..++.+.+.|.+|||+.||.+....+ ..+|+|++-..++...+...+|+++|+.|. |+|||.+++ .....      -
T Consensus        36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~  115 (738)
T KOG1989|consen   36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW  115 (738)
T ss_pred             CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence            34666788999999999999997665 999999998778889999999999999996 999999999 33321      2


Q ss_pred             ccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCc
Q 009340          286 VPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFS  365 (537)
Q Consensus       286 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~  365 (537)
                      +.+|.||||.+|+|-|++.....          ..|++.++++|+.|+++|+++||... +||||||||-+||||+.++.
T Consensus       116 EvllLmEyC~gg~Lvd~mn~Rlq----------~~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~  184 (738)
T KOG1989|consen  116 EVLLLMEYCKGGSLVDFMNTRLQ----------TRLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGN  184 (738)
T ss_pred             EEEeehhhccCCcHHHHHHHHHh----------ccCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCC
Confidence            56899999999999999987554          24999999999999999999999986 66999999999999999999


Q ss_pred             EEEeeccCccccCCCC--Cceee------eccccccccCcccc---cCCCCCcchhHHHHHHHHHHHHhCCCCCCccchh
Q 009340          366 AKVSDFGISRSIPNDK--THLTT------TIQGTFGYLDPEYF---QSSQFTDKSDVYSFGVVLLELLTGKKPICFARVE  434 (537)
Q Consensus       366 ~ki~Dfgla~~~~~~~--~~~~~------~~~gt~~y~aPE~~---~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~  434 (537)
                      .||||||-+.-.-...  .....      ...-|+.|.|||.+   .+..+++|+|||+|||+||-|+....||+...  
T Consensus       185 ~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg--  262 (738)
T KOG1989|consen  185 YKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG--  262 (738)
T ss_pred             EEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc--
Confidence            9999999986432111  10000      12358899999986   56789999999999999999999999996432  


Q ss_pred             hhccHHHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHHhh
Q 009340          435 EERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRSQ  504 (537)
Q Consensus       435 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~  504 (537)
                                       ...|++..+..+....++..|..||..||+.||++||++-+|++.+-+|....
T Consensus       263 -----------------~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~  315 (738)
T KOG1989|consen  263 -----------------KLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP  315 (738)
T ss_pred             -----------------ceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence                             23566666766666788999999999999999999999999999999888743

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.8e-40  Score=333.59  Aligned_cols=252  Identities=25%  Similarity=0.371  Sum_probs=204.2

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCC---ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI---DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY  291 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  291 (537)
                      ++|...+.||+|+||.||++... +|+.||||+++..   .......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            46888999999999999999965 6899999998642   2234567889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeec
Q 009340          292 EYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF  371 (537)
Q Consensus       292 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Df  371 (537)
                      ||+++|+|.+++...            ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+||
T Consensus        81 e~~~~~~L~~~l~~~------------~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Df  145 (350)
T cd05573          81 EYMPGGDLMNLLIRK------------DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADF  145 (350)
T ss_pred             cCCCCCCHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecC
Confidence            999999999999753            35899999999999999999999998   999999999999999999999999


Q ss_pred             cCccccCCCC----------------------------CceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh
Q 009340          372 GISRSIPNDK----------------------------THLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT  423 (537)
Q Consensus       372 gla~~~~~~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t  423 (537)
                      |++.......                            ........||+.|+|||.+.+..++.++|||||||++|||++
T Consensus       146 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~  225 (350)
T cd05573         146 GLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLY  225 (350)
T ss_pred             CCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhcc
Confidence            9998764432                            112234568999999999999999999999999999999999


Q ss_pred             CCCCCCccchhhhccHHHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCC-HhhHHHH
Q 009340          424 GKKPICFARVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPT-MKQVSME  496 (537)
Q Consensus       424 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-~~ev~~~  496 (537)
                      |+.||........      ........       ..+..+.....+..+.+++.+|++ +|.+||+ +.++++.
T Consensus       226 g~~Pf~~~~~~~~------~~~i~~~~-------~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         226 GFPPFYSDTLQET------YNKIINWK-------ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             CCCCCCCCCHHHH------HHHHhccC-------CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            9999875432211      11111100       001111111145678899999997 9999999 9999864

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=6.1e-39  Score=312.93  Aligned_cols=249  Identities=27%  Similarity=0.474  Sum_probs=201.4

Q ss_pred             cCCccccccCcCCceEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEee-CCccEEEEecC
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLE-TEVPVLVYEYI  294 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lV~e~~  294 (537)
                      ++|...+.||+|+||.||++... |..||+|..+...  ..+.|.+|+.++++++|+|++++++++.. .+..++|+||+
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~   82 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   82 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence            46778899999999999999874 7889999987533  34678999999999999999999998654 45689999999


Q ss_pred             CCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCc
Q 009340          295 SSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGIS  374 (537)
Q Consensus       295 ~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla  374 (537)
                      ++|+|.+++....          ...++|..++.++.|++.||+|||+++   ++||||||+||++++++.+||+|||++
T Consensus        83 ~~~~L~~~~~~~~----------~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~  149 (256)
T cd05082          83 AKGSLVDYLRSRG----------RSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLT  149 (256)
T ss_pred             CCCcHHHHHHhcC----------CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccc
Confidence            9999999987532          235899999999999999999999998   999999999999999999999999998


Q ss_pred             cccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHHHHHhhchhh
Q 009340          375 RSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQLL  453 (537)
Q Consensus       375 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  453 (537)
                      .......    .....+..|+|||++.+..++.++||||||+++|||++ |+.|+......+       .......    
T Consensus       150 ~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~-------~~~~~~~----  214 (256)
T cd05082         150 KEASSTQ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-------VVPRVEK----  214 (256)
T ss_pred             eeccccC----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHhc----
Confidence            7653221    22334678999999998899999999999999999998 888875432211       1111111    


Q ss_pred             hhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHH
Q 009340          454 EILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGL  500 (537)
Q Consensus       454 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i  500 (537)
                           ......+...+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus       215 -----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         215 -----GYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             -----CCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence                 111122234456788999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=3.7e-39  Score=332.11  Aligned_cols=261  Identities=22%  Similarity=0.306  Sum_probs=199.9

Q ss_pred             CCccccccCcCCceEEEEEEc-CCCCEEEEEEccCC--ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCC-----ccE
Q 009340          217 NYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEI--DKTQIHQFINEVVILSQINHRHIVKLLGCCLETE-----VPV  288 (537)
Q Consensus       217 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~  288 (537)
                      +|+..++||+|+||.||++.. .+|+.||||++...  .....+++.+|+.+++.++|+||+++++++...+     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            477889999999999999995 47899999998642  3344567889999999999999999999998776     789


Q ss_pred             EEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEE
Q 009340          289 LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKV  368 (537)
Q Consensus       289 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki  368 (537)
                      +|+||+. ++|.+++..            ...+++..+..++.|+++||.|||+.+   ++||||||+|||++.++.+||
T Consensus        81 lv~e~~~-~~l~~~~~~------------~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL  144 (372)
T cd07853          81 VVTELMQ-SDLHKIIVS------------PQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKI  144 (372)
T ss_pred             EEeeccc-cCHHHHHhc------------CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEe
Confidence            9999997 578777754            236899999999999999999999999   999999999999999999999


Q ss_pred             eeccCccccCCCCCceeeeccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHH
Q 009340          369 SDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSS-QFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLA  447 (537)
Q Consensus       369 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~  447 (537)
                      +|||+++..............++..|+|||.+.+. .++.++|||||||++|||++|+.||...........   .....
T Consensus       145 ~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~---i~~~~  221 (372)
T cd07853         145 CDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDL---ITDLL  221 (372)
T ss_pred             ccccceeecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHH---HHHHc
Confidence            99999986543333333445678999999998764 578999999999999999999999975543221111   11100


Q ss_pred             hhch----------hhhhhcHH-h-------hccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHH
Q 009340          448 KENQ----------LLEILDAR-V-------AKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSME  496 (537)
Q Consensus       448 ~~~~----------~~~~~d~~-~-------~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~  496 (537)
                      ....          ....+... .       ..........++.+|+.+||+.||++|||+.|+++.
T Consensus       222 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         222 GTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             CCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence            0000          00000000 0       001112234678899999999999999999999763

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=2.1e-39  Score=322.98  Aligned_cols=246  Identities=26%  Similarity=0.385  Sum_probs=202.6

Q ss_pred             HhcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCC---ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEE
Q 009340          214 ATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI---DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVL  289 (537)
Q Consensus       214 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  289 (537)
                      ..++|+....||+|+||.||+++-+ +|+.+|+|+++..   ...+.+..+.|-.+|...+++.||+|+-.|.+.+.+||
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL  218 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL  218 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence            4578999999999999999999955 6999999999863   34566778899999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEe
Q 009340          290 VYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVS  369 (537)
Q Consensus       290 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~  369 (537)
                      ||||+++|++..+|...            ..|+.......+.+++-|+.-||+.|   +|||||||+|+|||..|.+||+
T Consensus       219 iMEylPGGD~mTLL~~~------------~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLS  283 (550)
T KOG0605|consen  219 IMEYLPGGDMMTLLMRK------------DTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLS  283 (550)
T ss_pred             EEEecCCccHHHHHHhc------------CcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeec
Confidence            99999999999999763            46999999999999999999999999   9999999999999999999999


Q ss_pred             eccCccccCC-----------------------CCC----ce-------------------eeeccccccccCcccccCC
Q 009340          370 DFGISRSIPN-----------------------DKT----HL-------------------TTTIQGTFGYLDPEYFQSS  403 (537)
Q Consensus       370 Dfgla~~~~~-----------------------~~~----~~-------------------~~~~~gt~~y~aPE~~~~~  403 (537)
                      ||||+.-+..                       +..    ..                   ....+|||.|||||++.+.
T Consensus       284 DFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~k  363 (550)
T KOG0605|consen  284 DFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGK  363 (550)
T ss_pred             cccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcC
Confidence            9999853210                       000    00                   1124599999999999999


Q ss_pred             CCCcchhHHHHHHHHHHHHhCCCCCCccchhhhc-cHHHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhccc
Q 009340          404 QFTDKSDVYSFGVVLLELLTGKKPICFARVEEER-NLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRL  482 (537)
Q Consensus       404 ~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~  482 (537)
                      .|+..+|.||+|||+|||+.|.+||....+.+.- .+..|-.              .+..+.....+.+..+||.+|+. 
T Consensus       364 gY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~--------------~l~fP~~~~~s~eA~DLI~rll~-  428 (550)
T KOG0605|consen  364 GYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRE--------------TLKFPEEVDLSDEAKDLITRLLC-  428 (550)
T ss_pred             CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhh--------------hccCCCcCcccHHHHHHHHHHhc-
Confidence            9999999999999999999999999877665421 1111111              11112222334678899999998 


Q ss_pred             CCCCCCC
Q 009340          483 NSKKRPT  489 (537)
Q Consensus       483 ~p~~RPs  489 (537)
                      ||+.|-.
T Consensus       429 d~~~RLG  435 (550)
T KOG0605|consen  429 DPENRLG  435 (550)
T ss_pred             CHHHhcC
Confidence            9999976

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=5e-39  Score=324.67  Aligned_cols=241  Identities=26%  Similarity=0.391  Sum_probs=194.6

Q ss_pred             cccCcCCceEEEEEEc----CCCCEEEEEEccCC----ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEec
Q 009340          222 RFLGQGGFGTVYKGML----PDGSIVAVKRSKEI----DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY  293 (537)
Q Consensus       222 ~~lg~G~~g~Vy~~~~----~~g~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  293 (537)
                      +.||+|+||.||++..    .+++.||||.++..    .......+.+|+.+++.++||||+++++++...+..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            5799999999999984    35789999998642    223345678899999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccC
Q 009340          294 ISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGI  373 (537)
Q Consensus       294 ~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgl  373 (537)
                      +++|+|.+++...            ..+.+..+..++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        82 ~~~~~L~~~~~~~------------~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~  146 (323)
T cd05584          82 LSGGELFMHLERE------------GIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGL  146 (323)
T ss_pred             CCCchHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcC
Confidence            9999999988653            35788889999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchhh
Q 009340          374 SRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLL  453 (537)
Q Consensus       374 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  453 (537)
                      ++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......      ....... .   
T Consensus       147 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~------~~~~~~~-~---  215 (323)
T cd05584         147 CKESIHEGT-VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK------TIDKILK-G---  215 (323)
T ss_pred             CeecccCCC-cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH------HHHHHHc-C---
Confidence            875432221 2234568999999999998889999999999999999999999986543211      1111111 1   


Q ss_pred             hhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCC-----CHhhHHH
Q 009340          454 EILDARVAKEAREEDIGAMAELAMRCLRLNSKKRP-----TMKQVSM  495 (537)
Q Consensus       454 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~  495 (537)
                           .  ...+......+.+++.+||+.+|++||     ++.++++
T Consensus       216 -----~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         216 -----K--LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             -----C--CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence                 0  112333456788999999999999999     6777655

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-39  Score=331.26  Aligned_cols=244  Identities=29%  Similarity=0.421  Sum_probs=207.6

Q ss_pred             HHhcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCC---ChHHHHHHHHHHHHHHhc-CCCCcceEeeEEeeCCcc
Q 009340          213 RATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI---DKTQIHQFINEVVILSQI-NHRHIVKLLGCCLETEVP  287 (537)
Q Consensus       213 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~  287 (537)
                      ...++|...++||+|.||.|+++.++ +++.+|||.++..   .....+..+.|.+++... +||.|++++.++.+.++.
T Consensus       365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l  444 (694)
T KOG0694|consen  365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL  444 (694)
T ss_pred             ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence            34478999999999999999999976 6789999999863   345567788899998888 599999999999999999


Q ss_pred             EEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEE
Q 009340          288 VLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK  367 (537)
Q Consensus       288 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~k  367 (537)
                      |.||||..+|++..+.+.             ..+++..+..+|..++.||+|||+++   ||+||||.+|||||.+|.+|
T Consensus       445 ~fvmey~~Ggdm~~~~~~-------------~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~k  508 (694)
T KOG0694|consen  445 FFVMEYVAGGDLMHHIHT-------------DVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVK  508 (694)
T ss_pred             EEEEEecCCCcEEEEEec-------------ccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEE
Confidence            999999999996666543             36999999999999999999999999   99999999999999999999


Q ss_pred             EeeccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHH
Q 009340          368 VSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLA  447 (537)
Q Consensus       368 i~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~  447 (537)
                      |+||||++..-... ..+.+.+||+.|||||++.+..||..+|.|||||+||||+.|..||...+.++.      |..+.
T Consensus       509 iADFGlcKe~m~~g-~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~------FdsI~  581 (694)
T KOG0694|consen  509 IADFGLCKEGMGQG-DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEV------FDSIV  581 (694)
T ss_pred             ecccccccccCCCC-CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHH------HHHHh
Confidence            99999998753222 256788999999999999999999999999999999999999999976544331      22222


Q ss_pred             hhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCH
Q 009340          448 KENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTM  490 (537)
Q Consensus       448 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~  490 (537)
                      .+         .  ..+|...+.+...++.++|..+|+.|-.+
T Consensus       582 ~d---------~--~~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  582 ND---------E--VRYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             cC---------C--CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence            11         1  12566677888999999999999999877

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-38  Score=311.46  Aligned_cols=251  Identities=27%  Similarity=0.431  Sum_probs=202.7

Q ss_pred             cCCccccccCcCCceEEEEEEc-CCCCEEEEEEccCCC-----hHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEID-----KTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVL  289 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  289 (537)
                      ++|...+.||+|++|.||++.. .+++.||+|.+....     ......+.+|+.++++++|+||+++++++.+.+..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            5788899999999999999985 468999999875421     2234578899999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEe
Q 009340          290 VYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVS  369 (537)
Q Consensus       290 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~  369 (537)
                      |+||+++++|.+++...            ..+++..+..++.|++.||.|||+.+   ++||||+|+||++++++.++|+
T Consensus        82 v~e~~~~~~l~~~~~~~------------~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~  146 (263)
T cd06625          82 FMEYMPGGSVKDQLKAY------------GALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLG  146 (263)
T ss_pred             EEEECCCCcHHHHHHHh------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEe
Confidence            99999999999988652            35889999999999999999999999   9999999999999999999999


Q ss_pred             eccCccccCCCCCcee--eeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHH
Q 009340          370 DFGISRSIPNDKTHLT--TTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLA  447 (537)
Q Consensus       370 Dfgla~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~  447 (537)
                      |||+++..........  ....++..|+|||.+.+..++.++||||||+++|||++|+.||........      .....
T Consensus       147 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~~~~~  220 (263)
T cd06625         147 DFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA------IFKIA  220 (263)
T ss_pred             ecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHH------HHHHh
Confidence            9999976533221111  234578899999999998899999999999999999999999854321110      11110


Q ss_pred             hhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHH
Q 009340          448 KENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSME  496 (537)
Q Consensus       448 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~  496 (537)
                               ........+......+.+++.+||..+|++|||+.++++.
T Consensus       221 ---------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         221 ---------TQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             ---------ccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence                     0111112333455678899999999999999999999763

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=7.2e-39  Score=318.09  Aligned_cols=266  Identities=26%  Similarity=0.442  Sum_probs=207.9

Q ss_pred             hcCCccccccCcCCceEEEEEEcC------CCCEEEEEEccCC-ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCcc
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLP------DGSIVAVKRSKEI-DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVP  287 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~  287 (537)
                      .++|+..+.||+|+||.||++...      ++..||+|.+... ......+|.+|+.++++++|+|++++++++.+.+..
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            467888999999999999999853      4678999998754 334456799999999999999999999999998899


Q ss_pred             EEEEecCCCCChhhhhhhhhhhHHHHh----------hhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCC
Q 009340          288 VLVYEYISSGTLSHHIHDHQQQQEQKQ----------KQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSN  357 (537)
Q Consensus       288 ~lV~e~~~~gsL~~~l~~~~~~~~~~~----------~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~N  357 (537)
                      ++|+||+++|+|.+++...........          ......+++..++.++.|++.||+|||+.+   ++||||||+|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence            999999999999999975432111000          011235889999999999999999999998   9999999999


Q ss_pred             EEECCCCcEEEeeccCccccCCCCCc-eeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhh
Q 009340          358 ILLDDKFSAKVSDFGISRSIPNDKTH-LTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEE  435 (537)
Q Consensus       358 Ill~~~~~~ki~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~  435 (537)
                      |++++++.++|+|||++......... .......+..|+|||.+.+..++.++|||||||++|||++ |..||......+
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~  240 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE  240 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            99999999999999998765332211 1222334678999999998899999999999999999998 888875432221


Q ss_pred             hccHHHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHH
Q 009340          436 ERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEG  499 (537)
Q Consensus       436 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  499 (537)
                             .......+..         ...+...+..+.+++.+||+.+|++|||+.|+++.|++
T Consensus       241 -------~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         241 -------VIYYVRDGNV---------LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             -------HHHHHhcCCC---------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence                   1111111111         11223345678999999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.2e-38  Score=313.05  Aligned_cols=256  Identities=24%  Similarity=0.414  Sum_probs=204.8

Q ss_pred             HHHHhcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEE
Q 009340          211 LQRATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVL  289 (537)
Q Consensus       211 l~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  289 (537)
                      ++.+++++.....||+|+||.||+|... ++..||+|.+........+.+.+|+.++++++|+||+++++++...+..++
T Consensus         3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   82 (268)
T cd06624           3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI   82 (268)
T ss_pred             cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence            4556778888889999999999999954 678899999887666677889999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhhhhhhhHHHHhhhccCCC--CHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECC-CCcE
Q 009340          290 VYEYISSGTLSHHIHDHQQQQEQKQKQELSSL--SWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD-KFSA  366 (537)
Q Consensus       290 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l--~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~-~~~~  366 (537)
                      |+||+++++|.+++....           ..+  ++..+..++.|+++||+|||+.+   |+||||||+||+++. ++.+
T Consensus        83 v~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~  148 (268)
T cd06624          83 FMEQVPGGSLSALLRSKW-----------GPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVV  148 (268)
T ss_pred             EEecCCCCCHHHHHHHhc-----------ccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeE
Confidence            999999999999997532           234  78889999999999999999998   999999999999976 6799


Q ss_pred             EEeeccCccccCCCCCceeeeccccccccCcccccCCC--CCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHH
Q 009340          367 KVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQ--FTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFI  444 (537)
Q Consensus       367 ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~  444 (537)
                      +|+|||++........ ......++..|+|||++....  ++.++||||||+++|||++|+.|+.........     ..
T Consensus       149 ~l~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~-----~~  222 (268)
T cd06624         149 KISDFGTSKRLAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA-----MF  222 (268)
T ss_pred             EEecchhheecccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh-----Hh
Confidence            9999999876533221 122345789999999986643  788999999999999999999998543211100     00


Q ss_pred             HHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          445 SLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       445 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      ..   .      ........+......+.+++.+||+.+|++|||+.+++.
T Consensus       223 ~~---~------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         223 KV---G------MFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             hh---h------hhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence            00   0      000111233345567889999999999999999999875

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=9.9e-39  Score=325.22  Aligned_cols=270  Identities=27%  Similarity=0.427  Sum_probs=206.1

Q ss_pred             hcCCccccccCcCCceEEEEEEc------CCCCEEEEEEccCCC-hHHHHHHHHHHHHHHhc-CCCCcceEeeEEeeCC-
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGML------PDGSIVAVKRSKEID-KTQIHQFINEVVILSQI-NHRHIVKLLGCCLETE-  285 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~-  285 (537)
                      .++|...+.||+|+||.||+|..      .+++.||||+++... ......+.+|+.++.++ +|+||+++++++...+ 
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   85 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence            35788899999999999999973      357789999987532 34456788999999999 7899999999887554 


Q ss_pred             ccEEEEecCCCCChhhhhhhhhhhH-------------------------------------------------------
Q 009340          286 VPVLVYEYISSGTLSHHIHDHQQQQ-------------------------------------------------------  310 (537)
Q Consensus       286 ~~~lV~e~~~~gsL~~~l~~~~~~~-------------------------------------------------------  310 (537)
                      ..++||||+++|+|.++++......                                                       
T Consensus        86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (343)
T cd05103          86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  165 (343)
T ss_pred             ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence            5789999999999999997532100                                                       


Q ss_pred             HHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCccccCCCCCc-eeeecc
Q 009340          311 EQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTH-LTTTIQ  389 (537)
Q Consensus       311 ~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~-~~~~~~  389 (537)
                      ..........++|..+..++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||++......... ......
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  242 (343)
T cd05103         166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR  242 (343)
T ss_pred             hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence            0000001235899999999999999999999998   999999999999999999999999999865332221 122334


Q ss_pred             ccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHHHHHhhchhhhhhcHHhhccccHHH
Q 009340          390 GTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQLLEILDARVAKEAREED  468 (537)
Q Consensus       390 gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  468 (537)
                      ++..|+|||.+.+..++.++||||||+++|||++ |..|+.......      .+......+.         ....+...
T Consensus       243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~------~~~~~~~~~~---------~~~~~~~~  307 (343)
T cd05103         243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE------EFCRRLKEGT---------RMRAPDYT  307 (343)
T ss_pred             CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH------HHHHHHhccC---------CCCCCCCC
Confidence            5678999999988899999999999999999997 888875432211      0111111111         11112223


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHH
Q 009340          469 IGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRR  502 (537)
Q Consensus       469 ~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~  502 (537)
                      ...+.+++.+||+.+|++|||+.+|++.|+.+.+
T Consensus       308 ~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~  341 (343)
T cd05103         308 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  341 (343)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            3568899999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.7e-39  Score=334.02  Aligned_cols=254  Identities=22%  Similarity=0.330  Sum_probs=201.8

Q ss_pred             HhcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCC---ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEE
Q 009340          214 ATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI---DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVL  289 (537)
Q Consensus       214 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  289 (537)
                      ..++|+..++||+|+||.||+++.. +++.||+|.+...   .......+.+|+.+++.++||||+++++++.+.+..++
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l  120 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM  120 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence            3568888999999999999999964 6889999998642   22334557889999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEe
Q 009340          290 VYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVS  369 (537)
Q Consensus       290 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~  369 (537)
                      ||||+++|+|.+++..             ..++...+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+
T Consensus       121 v~Ey~~gg~L~~~l~~-------------~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~  184 (370)
T cd05596         121 VMEYMPGGDLVNLMSN-------------YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLA  184 (370)
T ss_pred             EEcCCCCCcHHHHHHh-------------cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEE
Confidence            9999999999998854             24778888999999999999999999   9999999999999999999999


Q ss_pred             eccCccccCCCCCceeeeccccccccCcccccCC----CCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHH
Q 009340          370 DFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSS----QFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFIS  445 (537)
Q Consensus       370 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~  445 (537)
                      |||++...............||+.|+|||.+.+.    .++.++|||||||++|||++|+.||.......      .+..
T Consensus       185 DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~------~~~~  258 (370)
T cd05596         185 DFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG------TYSK  258 (370)
T ss_pred             eccceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH------HHHH
Confidence            9999987644333233456799999999998653    47899999999999999999999997543221      1111


Q ss_pred             HHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCC--CCCHhhHHHH
Q 009340          446 LAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKK--RPTMKQVSME  496 (537)
Q Consensus       446 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~--RPs~~ev~~~  496 (537)
                      ......       .+..+.....+..+.+++.+||+.+|++  |||+.++++.
T Consensus       259 i~~~~~-------~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         259 IMDHKN-------SLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             HHcCCC-------cCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence            111000       0111111134567889999999999987  9999999653

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.1e-39  Score=330.58  Aligned_cols=252  Identities=23%  Similarity=0.312  Sum_probs=203.1

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCC---ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI---DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY  291 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  291 (537)
                      ++|...+.||+|+||.||++... +|+.||+|.++..   .....+.+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            46888999999999999999854 6889999998752   2234566889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeec
Q 009340          292 EYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF  371 (537)
Q Consensus       292 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Df  371 (537)
                      ||+++|+|.+++....           ..+++..+..++.|+++||.|||+.+   |+||||||+|||++.++.+||+||
T Consensus        81 e~~~~~~L~~~l~~~~-----------~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Df  146 (330)
T cd05601          81 EYQPGGDLLSLLNRYE-----------DQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADF  146 (330)
T ss_pred             CCCCCCCHHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccC
Confidence            9999999999997642           36899999999999999999999999   999999999999999999999999


Q ss_pred             cCccccCCCCCceeeeccccccccCccccc------CCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHH
Q 009340          372 GISRSIPNDKTHLTTTIQGTFGYLDPEYFQ------SSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFIS  445 (537)
Q Consensus       372 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~  445 (537)
                      |++...............||+.|+|||++.      ...++.++|||||||++|||++|+.||.......      .+..
T Consensus       147 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~------~~~~  220 (330)
T cd05601         147 GSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK------TYNN  220 (330)
T ss_pred             CCCeECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH------HHHH
Confidence            999876544433334457899999999986      4567899999999999999999999986543221      1111


Q ss_pred             HHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          446 LAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       446 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      ........       ..+.....+..+.+|+..|++ +|++|||+.+++.
T Consensus       221 i~~~~~~~-------~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         221 IMNFQRFL-------KFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             HHcCCCcc-------CCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence            11111100       001111234668899999997 9999999999874

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7e-39  Score=317.82  Aligned_cols=251  Identities=26%  Similarity=0.384  Sum_probs=201.2

Q ss_pred             CCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCC---hHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEe
Q 009340          217 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEID---KTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE  292 (537)
Q Consensus       217 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e  292 (537)
                      +|+..++||+|+||.||++... +++.||+|.+....   ......+.+|+.++++++|+||+++++++.+.+..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            4777899999999999999964 68899999886422   2223457889999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeecc
Q 009340          293 YISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG  372 (537)
Q Consensus       293 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfg  372 (537)
                      |+++|+|.+++....          ...+++..+..++.|++.||.|||+.+   ++||||||+||++++++.++|+|||
T Consensus        81 ~~~~~~L~~~~~~~~----------~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg  147 (285)
T cd05605          81 LMNGGDLKFHIYNMG----------NPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLG  147 (285)
T ss_pred             ccCCCcHHHHHHhcC----------cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCC
Confidence            999999998886432          235899999999999999999999999   9999999999999999999999999


Q ss_pred             CccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchh
Q 009340          373 ISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQL  452 (537)
Q Consensus       373 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  452 (537)
                      ++........  .....|+..|+|||.+.+..++.++||||||+++|||++|+.||........   ...+...      
T Consensus       148 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~---~~~~~~~------  216 (285)
T cd05605         148 LAVEIPEGET--IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVK---REEVERR------  216 (285)
T ss_pred             CceecCCCCc--cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhH---HHHHHHH------
Confidence            9987543222  2334689999999999988999999999999999999999999975332111   0001110      


Q ss_pred             hhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCC-----CHhhHHH
Q 009340          453 LEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRP-----TMKQVSM  495 (537)
Q Consensus       453 ~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~  495 (537)
                         +. ......+...+..+.+|+.+||+.||++||     ++.++++
T Consensus       217 ---~~-~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05605         217 ---VK-EDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA  260 (285)
T ss_pred             ---hh-hcccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence               00 011123344566788999999999999999     6777754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-38  Score=309.08  Aligned_cols=247  Identities=26%  Similarity=0.465  Sum_probs=200.7

Q ss_pred             cccCcCCceEEEEEEcCCCCEEEEEEccCCCh-HHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecCCCCChh
Q 009340          222 RFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDK-TQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLS  300 (537)
Q Consensus       222 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~  300 (537)
                      ++||+|+||.||++...+++.||+|..+.... .....+.+|+.++++++|+||+++++++.+....++|+||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            46999999999999987799999998876433 35678999999999999999999999999999999999999999999


Q ss_pred             hhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCccccCCC
Q 009340          301 HHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPND  380 (537)
Q Consensus       301 ~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~  380 (537)
                      +++....           ..+++..++.++.+++.||.|||+.+   ++||||+|+||+++.++.+||+|||++......
T Consensus        81 ~~l~~~~-----------~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~  146 (251)
T cd05041          81 TFLRKKK-----------NRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGG  146 (251)
T ss_pred             HHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCC
Confidence            9986532           25889999999999999999999999   999999999999999999999999999865422


Q ss_pred             CCcee-eeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHHHHHhhchhhhhhcH
Q 009340          381 KTHLT-TTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQLLEILDA  458 (537)
Q Consensus       381 ~~~~~-~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  458 (537)
                      ..... .....+..|+|||.+.++.++.++|+||||+++|||++ |..||.......       .....         ..
T Consensus       147 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~-------~~~~~---------~~  210 (251)
T cd05041         147 IYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ-------TRERI---------ES  210 (251)
T ss_pred             cceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH-------HHHHH---------hc
Confidence            22111 12234667999999998899999999999999999999 788875433211       01111         11


Q ss_pred             HhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHH
Q 009340          459 RVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELE  498 (537)
Q Consensus       459 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~  498 (537)
                      ......+...+..+.+++.+||+.+|++|||+.|+++.|+
T Consensus       211 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         211 GYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             CCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            1111223344567899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1e-39  Score=325.99  Aligned_cols=251  Identities=25%  Similarity=0.394  Sum_probs=215.8

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCC--ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCc-cEEEE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI--DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEV-PVLVY  291 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-~~lV~  291 (537)
                      ++|...+++|+|+||.++..+.+ +++.+++|++...  .....+...+|+.++++++|||||.+.+.+.+++. .++||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            57888899999999999988754 6778999987642  33344567899999999999999999999999998 99999


Q ss_pred             ecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeec
Q 009340          292 EYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF  371 (537)
Q Consensus       292 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Df  371 (537)
                      +|+++|+|.+.+...+.          ..++++.++.++.|++.|+.|||+..   |+|||||++|||++.+..+||+||
T Consensus        84 ~Y~eGg~l~~~i~~~k~----------~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDf  150 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQKG----------VLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDF  150 (426)
T ss_pred             eecCCCCHHHHHHHHhh----------ccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecch
Confidence            99999999999987652          46899999999999999999999888   999999999999999999999999


Q ss_pred             cCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhch
Q 009340          372 GISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQ  451 (537)
Q Consensus       372 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  451 (537)
                      |+|+.+..+.. ...+..||+.||.||.+.+.+|..|+|||||||++|||.+-+++|...+...-               
T Consensus       151 GlaK~l~~~~~-~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~L---------------  214 (426)
T KOG0589|consen  151 GLAKILNPEDS-LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSEL---------------  214 (426)
T ss_pred             hhhhhcCCchh-hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHH---------------
Confidence            99999876652 45667899999999999999999999999999999999999999976544321               


Q ss_pred             hhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHH
Q 009340          452 LLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSME  496 (537)
Q Consensus       452 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~  496 (537)
                       ..-+-.....+.+..++.++..++..|++.+|..||++.+++.+
T Consensus       215 -i~ki~~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  215 -ILKINRGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             -HHHHhhccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence             11111122345677888899999999999999999999999988

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.3e-38  Score=317.45  Aligned_cols=271  Identities=25%  Similarity=0.417  Sum_probs=207.2

Q ss_pred             hcCCccccccCcCCceEEEEEEcCC-----------------CCEEEEEEccCC-ChHHHHHHHHHHHHHHhcCCCCcce
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLPD-----------------GSIVAVKRSKEI-DKTQIHQFINEVVILSQINHRHIVK  276 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----------------g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~  276 (537)
                      ..+|+..+.||+|+||.||++...+                 +..||+|.+... .....+.+.+|+.++++++|+|+++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            3578889999999999999988532                 246899998753 3455678999999999999999999


Q ss_pred             EeeEEeeCCccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCC
Q 009340          277 LLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSS  356 (537)
Q Consensus       277 l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~  356 (537)
                      +++++...+..++|+||+++++|.+++.......... ......+++..++.++.|+++||+|||+.+   ++||||||+
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~  159 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGL-ACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATR  159 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccc-cccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchh
Confidence            9999999999999999999999999997643211000 001236899999999999999999999998   999999999


Q ss_pred             CEEECCCCcEEEeeccCccccCCCCCc-eeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh--CCCCCCccch
Q 009340          357 NILLDDKFSAKVSDFGISRSIPNDKTH-LTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT--GKKPICFARV  433 (537)
Q Consensus       357 NIll~~~~~~ki~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t--g~~p~~~~~~  433 (537)
                      ||+++.++.++|+|||+++........ ......++..|+|||.+.++.++.++||||||+++|||++  |..|+.....
T Consensus       160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~  239 (296)
T cd05051         160 NCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD  239 (296)
T ss_pred             ceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence            999999999999999999865433222 2234456789999999988889999999999999999998  5667643322


Q ss_pred             hhhccHHHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHH
Q 009340          434 EEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELE  498 (537)
Q Consensus       434 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~  498 (537)
                      ..   .............      .....+.+...+.++.+++.+||+.||++|||+.+|++.|+
T Consensus       240 ~~---~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         240 QQ---VIENAGHFFRDDG------RQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             HH---HHHHHHhcccccc------ccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence            11   1111111111100      01111112234467899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.6e-38  Score=310.90  Aligned_cols=251  Identities=29%  Similarity=0.492  Sum_probs=195.0

Q ss_pred             cccCcCCceEEEEEEcC----CCCEEEEEEccC-CChHHHHHHHHHHHHHHhcCCCCcceEeeEEee-CCccEEEEecCC
Q 009340          222 RFLGQGGFGTVYKGMLP----DGSIVAVKRSKE-IDKTQIHQFINEVVILSQINHRHIVKLLGCCLE-TEVPVLVYEYIS  295 (537)
Q Consensus       222 ~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lV~e~~~  295 (537)
                      +.||+|+||.||+|...    ++..||+|++.. ......+.+.+|+.+++.++|+|++++++++.. +...++|+||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            46899999999999853    245799999864 334556788999999999999999999998764 456799999999


Q ss_pred             CCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCcc
Q 009340          296 SGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISR  375 (537)
Q Consensus       296 ~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~  375 (537)
                      +|+|.+++....           ..+++..++.++.|+++||+|||+.+   ++||||||+|||+++++.+||+|||+++
T Consensus        81 ~~~L~~~~~~~~-----------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~  146 (262)
T cd05058          81 HGDLRNFIRSET-----------HNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLAR  146 (262)
T ss_pred             CCCHHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccc
Confidence            999999997532           24688888999999999999999998   9999999999999999999999999997


Q ss_pred             ccCCCCCc---eeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCC-CCCccchhhhccHHHHHHHHHhhch
Q 009340          376 SIPNDKTH---LTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKK-PICFARVEEERNLVACFISLAKENQ  451 (537)
Q Consensus       376 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~-p~~~~~~~~~~~~~~~~~~~~~~~~  451 (537)
                      ........   ......++..|+|||.+.+..++.++||||||+++|||++|+. |+......+   ...    ....+.
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~---~~~----~~~~~~  219 (262)
T cd05058         147 DIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD---ITV----YLLQGR  219 (262)
T ss_pred             cccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHH----HHhcCC
Confidence            65332211   1123345778999999988899999999999999999999654 543221111   111    111000


Q ss_pred             hhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHH
Q 009340          452 LLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRR  502 (537)
Q Consensus       452 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~  502 (537)
                               ....+...+..+.+++.+||+.+|++||++.+|++.|+.+..
T Consensus       220 ---------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~  261 (262)
T cd05058         220 ---------RLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS  261 (262)
T ss_pred             ---------CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence                     011122234578899999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=7.2e-39  Score=324.31  Aligned_cols=243  Identities=23%  Similarity=0.384  Sum_probs=193.1

Q ss_pred             cccCcCCceEEEEEEcC-CCCEEEEEEccCC---ChHHHHHHHHHHHHHHhc-CCCCcceEeeEEeeCCccEEEEecCCC
Q 009340          222 RFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI---DKTQIHQFINEVVILSQI-NHRHIVKLLGCCLETEVPVLVYEYISS  296 (537)
Q Consensus       222 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~  296 (537)
                      +.||+|+||.||++... +++.||+|.++..   .......+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999964 6889999998752   233455688899999998 799999999999999999999999999


Q ss_pred             CChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCccc
Q 009340          297 GTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS  376 (537)
Q Consensus       297 gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~  376 (537)
                      |+|.+++...            ..+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||+++.
T Consensus        81 g~L~~~~~~~------------~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~  145 (329)
T cd05588          81 GDLMFHMQRQ------------RKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKE  145 (329)
T ss_pred             CCHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccc
Confidence            9998888642            36999999999999999999999999   99999999999999999999999999875


Q ss_pred             cCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhh--hccHHHHHHHHHhhchhhh
Q 009340          377 IPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEE--ERNLVACFISLAKENQLLE  454 (537)
Q Consensus       377 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~  454 (537)
                      ..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+  ......+........    
T Consensus       146 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~----  220 (329)
T cd05588         146 GIRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEK----  220 (329)
T ss_pred             cccCC-CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcC----
Confidence            32211 12334578999999999999999999999999999999999999996432211  111111111111111    


Q ss_pred             hhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCH
Q 009340          455 ILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTM  490 (537)
Q Consensus       455 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~  490 (537)
                          ..  ..+...+..+.+++.+||+.||.+||++
T Consensus       221 ----~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~  250 (329)
T cd05588         221 ----QI--RIPRSLSVKASSVLKGFLNKDPKERLGC  250 (329)
T ss_pred             ----CC--CCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence                11  1223345678899999999999999983

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.4e-40  Score=294.85  Aligned_cols=247  Identities=28%  Similarity=0.426  Sum_probs=207.4

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCC---hHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEID---KTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY  291 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  291 (537)
                      ++|+..+.||+|-||.||.|+.+ ++-.||+|.+....   .+...++.+|+++-+.++||||+++++++.++...||++
T Consensus        22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil  101 (281)
T KOG0580|consen   22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL  101 (281)
T ss_pred             hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence            57888999999999999999965 67899999986532   122456889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeec
Q 009340          292 EYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF  371 (537)
Q Consensus       292 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Df  371 (537)
                      ||...|+|...|.+...          ..++......++.|+|.||.|+|..+   ++||||||+|+|++.++..||+||
T Consensus       102 Eya~~gel~k~L~~~~~----------~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdf  168 (281)
T KOG0580|consen  102 EYAPRGELYKDLQEGRM----------KRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADF  168 (281)
T ss_pred             EecCCchHHHHHHhccc----------ccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCC
Confidence            99999999999985432          45888888999999999999999999   999999999999999999999999


Q ss_pred             cCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhch
Q 009340          372 GISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQ  451 (537)
Q Consensus       372 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  451 (537)
                      |.+..-+   .....+.+||..|.+||...+...+.++|+|++|++.||++.|.+||.....++-      +.+...   
T Consensus       169 GwsV~~p---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~et------YkrI~k---  236 (281)
T KOG0580|consen  169 GWSVHAP---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSET------YKRIRK---  236 (281)
T ss_pred             CceeecC---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHH------HHHHHH---
Confidence            9987643   3345677899999999999999999999999999999999999999975542221      111111   


Q ss_pred             hhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          452 LLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       452 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                       .++       ..|...+....+++.+|+..+|.+|.+..|+++
T Consensus       237 -~~~-------~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~  272 (281)
T KOG0580|consen  237 -VDL-------KFPSTISGGAADLISRLLVKNPIERLALTEVMD  272 (281)
T ss_pred             -ccc-------cCCcccChhHHHHHHHHhccCccccccHHHHhh
Confidence             111       223445567889999999999999999999865

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=6e-39  Score=331.48  Aligned_cols=251  Identities=22%  Similarity=0.328  Sum_probs=196.9

Q ss_pred             CCccccccCcCCceEEEEEEc-CCCCEEEEEEccCC---ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEe
Q 009340          217 NYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEI---DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE  292 (537)
Q Consensus       217 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e  292 (537)
                      .|...+.||+|+||+||+|+. .+++.||||++...   .......+.+|+.++.+++|+||+++++++.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            578889999999999999985 46889999998642   23445678999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeecc
Q 009340          293 YISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG  372 (537)
Q Consensus       293 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfg  372 (537)
                      |+++|+|.+++...            ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        82 ~~~gg~L~~~l~~~------------~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFG  146 (381)
T cd05626          82 YIPGGDMMSLLIRM------------EVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFG  146 (381)
T ss_pred             cCCCCcHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCc
Confidence            99999999998653            35889999999999999999999999   9999999999999999999999999


Q ss_pred             CccccCCCCC----------------------------------------------ceeeeccccccccCcccccCCCCC
Q 009340          373 ISRSIPNDKT----------------------------------------------HLTTTIQGTFGYLDPEYFQSSQFT  406 (537)
Q Consensus       373 la~~~~~~~~----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~t  406 (537)
                      ++..+.....                                              .......||+.|+|||.+.+..++
T Consensus       147 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~  226 (381)
T cd05626         147 LCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT  226 (381)
T ss_pred             CCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCC
Confidence            9764311000                                              001234699999999999988899


Q ss_pred             cchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHH--hcccCC
Q 009340          407 DKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMR--CLRLNS  484 (537)
Q Consensus       407 ~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~--cl~~~p  484 (537)
                      .++|||||||++|||++|+.||......+.      .......       ...+..+.....+.++.+++.+  |+..+|
T Consensus       227 ~~~DiwSlG~il~elltG~~Pf~~~~~~~~------~~~i~~~-------~~~~~~~~~~~~s~~~~dli~~ll~~~~~~  293 (381)
T cd05626         227 QLCDWWSVGVILFEMLVGQPPFLAPTPTET------QLKVINW-------ENTLHIPPQVKLSPEAVDLITKLCCSAEER  293 (381)
T ss_pred             CccceeehhhHHHHHHhCCCCCcCCCHHHH------HHHHHcc-------ccccCCCCCCCCCHHHHHHHHHHccCcccc
Confidence            999999999999999999999975433221      0011000       0001111111234567778877  556667


Q ss_pred             CCCCCHhhHHH
Q 009340          485 KKRPTMKQVSM  495 (537)
Q Consensus       485 ~~RPs~~ev~~  495 (537)
                      ..||++.+++.
T Consensus       294 ~~R~~~~~~l~  304 (381)
T cd05626         294 LGRNGADDIKA  304 (381)
T ss_pred             cCCCCHHHHhc
Confidence            77999999976

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=3.2e-39  Score=326.38  Aligned_cols=241  Identities=25%  Similarity=0.366  Sum_probs=195.5

Q ss_pred             cccCcCCceEEEEEEc-CCCCEEEEEEccCC---ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecCCCC
Q 009340          222 RFLGQGGFGTVYKGML-PDGSIVAVKRSKEI---DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSG  297 (537)
Q Consensus       222 ~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g  297 (537)
                      +.||+|+||.||++.. .+|+.||+|.++..   .......+.+|+.++..++|+||+++.+++.+.+..++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            3699999999999985 47899999998642   2334567788999999999999999999999999999999999999


Q ss_pred             ChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeecCCCCCCEEECCCCcEEEeeccCccc
Q 009340          298 TLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHS-SASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS  376 (537)
Q Consensus       298 sL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~  376 (537)
                      +|.+++...            ..+++..+..++.|++.||.|||+ .+   |+||||||+|||++.++.+||+|||+++.
T Consensus        81 ~L~~~l~~~------------~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~  145 (325)
T cd05594          81 ELFFHLSRE------------RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKE  145 (325)
T ss_pred             cHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCee
Confidence            999888642            358999999999999999999997 67   99999999999999999999999999875


Q ss_pred             cCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchhhhhh
Q 009340          377 IPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEIL  456 (537)
Q Consensus       377 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  456 (537)
                      ...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||........      . .......     
T Consensus       146 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~------~-~~i~~~~-----  212 (325)
T cd05594         146 GIKDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL------F-ELILMEE-----  212 (325)
T ss_pred             cCCCCc-ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHH------H-HHHhcCC-----
Confidence            432221 22345689999999999999999999999999999999999999865432211      0 1110000     


Q ss_pred             cHHhhccccHHHHHHHHHHHHHhcccCCCCCC-----CHhhHHH
Q 009340          457 DARVAKEAREEDIGAMAELAMRCLRLNSKKRP-----TMKQVSM  495 (537)
Q Consensus       457 d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~  495 (537)
                           ...+......+.+++.+||+.||++|+     ++.++++
T Consensus       213 -----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  251 (325)
T cd05594         213 -----IRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ  251 (325)
T ss_pred             -----CCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence                 012233456788999999999999996     8888874

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=5.8e-39  Score=317.60  Aligned_cols=270  Identities=26%  Similarity=0.417  Sum_probs=207.5

Q ss_pred             cCCccccccCcCCceEEEEEEcC-----CCCEEEEEEccCCChH-HHHHHHHHHHHHHhcCCCCcceEeeEEee--CCcc
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-----DGSIVAVKRSKEIDKT-QIHQFINEVVILSQINHRHIVKLLGCCLE--TEVP  287 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-----~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~  287 (537)
                      +.|...+.||+|+||.||++.+.     ++..||||.++..... ..+.|.+|+++++.++|+|++++++++..  ....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            35666789999999999999853     3678999998765443 56789999999999999999999999987  4578


Q ss_pred             EEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEE
Q 009340          288 VLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK  367 (537)
Q Consensus       288 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~k  367 (537)
                      ++||||+++++|.+++....           ..++|..++.++.|++.||+|||+.+   ++|+||||+||+++.++.++
T Consensus        84 ~lv~e~~~~~~l~~~l~~~~-----------~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~  149 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRHR-----------DQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVK  149 (284)
T ss_pred             EEEEecCCCCCHHHHHHhCc-----------cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEE
Confidence            99999999999999997643           25999999999999999999999998   99999999999999999999


Q ss_pred             EeeccCccccCCCCCce--eeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHH
Q 009340          368 VSDFGISRSIPNDKTHL--TTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFIS  445 (537)
Q Consensus       368 i~Dfgla~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~  445 (537)
                      |+|||++..........  .....++..|+|||.+.+..++.++||||||+++|||++|+.|+............. ...
T Consensus       150 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~-~~~  228 (284)
T cd05038         150 ISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGI-AQG  228 (284)
T ss_pred             EcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccccc-ccc
Confidence            99999998775332211  112345667999999988899999999999999999999999875432211000000 000


Q ss_pred             HHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHH
Q 009340          446 LAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGL  500 (537)
Q Consensus       446 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i  500 (537)
                      ......+.+.+........+..+..++.+++.+||+.+|++||||.||+++|+.+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         229 QMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             cccHHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            0000011111111111222334456799999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.4e-38  Score=320.20  Aligned_cols=269  Identities=26%  Similarity=0.437  Sum_probs=208.3

Q ss_pred             hcCCccccccCcCCceEEEEEEcC--------CCCEEEEEEccCC-ChHHHHHHHHHHHHHHhc-CCCCcceEeeEEeeC
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLP--------DGSIVAVKRSKEI-DKTQIHQFINEVVILSQI-NHRHIVKLLGCCLET  284 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~  284 (537)
                      .++|...++||+|+||.||++...        ....||+|.++.. ......++.+|+.+++++ +|+||+++++++.+.
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE   90 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence            357778899999999999999742        2457999988753 344566789999999999 699999999999998


Q ss_pred             CccEEEEecCCCCChhhhhhhhhhhHHHH----hhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEE
Q 009340          285 EVPVLVYEYISSGTLSHHIHDHQQQQEQK----QKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILL  360 (537)
Q Consensus       285 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~----~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll  360 (537)
                      +..++|+||+++|+|.+++..........    .......++|..+.+++.|++.||.|||+.+   ++||||||+|||+
T Consensus        91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill  167 (314)
T cd05099          91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLV  167 (314)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEE
Confidence            88999999999999999997643210000    0001235899999999999999999999998   9999999999999


Q ss_pred             CCCCcEEEeeccCccccCCCCCce-eeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhcc
Q 009340          361 DDKFSAKVSDFGISRSIPNDKTHL-TTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERN  438 (537)
Q Consensus       361 ~~~~~~ki~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~  438 (537)
                      +.++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||......+   
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~---  244 (314)
T cd05099         168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE---  244 (314)
T ss_pred             cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH---
Confidence            999999999999998664322211 112234567999999998899999999999999999999 888875433221   


Q ss_pred             HHHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHH
Q 009340          439 LVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRR  502 (537)
Q Consensus       439 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~  502 (537)
                          +........         ..+.+..++..+.+++.+||+.+|++|||+.++++.|+++..
T Consensus       245 ----~~~~~~~~~---------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~  295 (314)
T cd05099         245 ----LFKLLREGH---------RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA  295 (314)
T ss_pred             ----HHHHHHcCC---------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence                111111111         111233345578899999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=9.7e-39  Score=323.30  Aligned_cols=243  Identities=25%  Similarity=0.390  Sum_probs=192.7

Q ss_pred             cccCcCCceEEEEEEcC-CCCEEEEEEccCC---ChHHHHHHHHHHHHHHhc-CCCCcceEeeEEeeCCccEEEEecCCC
Q 009340          222 RFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI---DKTQIHQFINEVVILSQI-NHRHIVKLLGCCLETEVPVLVYEYISS  296 (537)
Q Consensus       222 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~  296 (537)
                      +.||+|+||.||++... +++.||+|.++..   .......+.+|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46999999999999964 6789999998742   334455678899988877 899999999999999999999999999


Q ss_pred             CChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCccc
Q 009340          297 GTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS  376 (537)
Q Consensus       297 gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~  376 (537)
                      |+|..++...            ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++.
T Consensus        81 ~~L~~~~~~~------------~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~  145 (329)
T cd05618          81 GDLMFHMQRQ------------RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKE  145 (329)
T ss_pred             CCHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCcccc
Confidence            9998887642            35899999999999999999999999   99999999999999999999999999875


Q ss_pred             cCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhh--hccHHHHHHHHHhhchhhh
Q 009340          377 IPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEE--ERNLVACFISLAKENQLLE  454 (537)
Q Consensus       377 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~  454 (537)
                      ...... ......||..|+|||++.+..++.++||||||+++|||++|+.||.......  ......+.........   
T Consensus       146 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~---  221 (329)
T cd05618         146 GLRPGD-TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ---  221 (329)
T ss_pred             ccCCCC-ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC---
Confidence            422211 2234568999999999999999999999999999999999999986322111  1111111111111111   


Q ss_pred             hhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCH
Q 009340          455 ILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTM  490 (537)
Q Consensus       455 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~  490 (537)
                             ...+......+.+++.+||+.||++||++
T Consensus       222 -------~~~p~~~~~~~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         222 -------IRIPRSLSVKAASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             -------CCCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence                   11233445678899999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.2e-38  Score=315.42  Aligned_cols=247  Identities=23%  Similarity=0.352  Sum_probs=195.0

Q ss_pred             cCcCCceEEEEEEcC-CCCEEEEEEccCCC---hHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecCCCCCh
Q 009340          224 LGQGGFGTVYKGMLP-DGSIVAVKRSKEID---KTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTL  299 (537)
Q Consensus       224 lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL  299 (537)
                      ||+|+||+||++... +|+.||+|.+....   ....+.+..|+.+++.++|+|++++.+++......++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            799999999999854 68899999886422   22345678899999999999999999999999999999999999999


Q ss_pred             hhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCccccCC
Q 009340          300 SHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPN  379 (537)
Q Consensus       300 ~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~  379 (537)
                      .+++.....        ....+++..++.++.|+++||.|||+.+   |+||||||+||+++.++.+||+|||++.....
T Consensus        81 ~~~~~~~~~--------~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~  149 (280)
T cd05608          81 RYHIYNVDE--------ENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKD  149 (280)
T ss_pred             HHHHHhccc--------cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCC
Confidence            988754321        1246899999999999999999999999   99999999999999999999999999976643


Q ss_pred             CCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchhhhhhcHH
Q 009340          380 DKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEILDAR  459 (537)
Q Consensus       380 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  459 (537)
                      ... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.........   .....        ......
T Consensus       150 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~---~~~~~--------~~~~~~  217 (280)
T cd05608         150 GQS-KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN---KELKQ--------RILNDS  217 (280)
T ss_pred             CCc-cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH---HHHHH--------hhcccC
Confidence            322 223456899999999999999999999999999999999999998653321100   00000        001100


Q ss_pred             hhccccHHHHHHHHHHHHHhcccCCCCCC-----CHhhHHH
Q 009340          460 VAKEAREEDIGAMAELAMRCLRLNSKKRP-----TMKQVSM  495 (537)
Q Consensus       460 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~  495 (537)
                        ...+...+..+.+++.+||+.||++||     ++.++++
T Consensus       218 --~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         218 --VTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             --CCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence              112334556788999999999999999     4555543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-39  Score=331.14  Aligned_cols=251  Identities=24%  Similarity=0.402  Sum_probs=199.3

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCC---ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI---DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY  291 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  291 (537)
                      ++|+..+.||+|+||.||+++.. +|+.||||+++..   .......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            46888999999999999999964 6899999998642   2334566789999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeec
Q 009340          292 EYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF  371 (537)
Q Consensus       292 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Df  371 (537)
                      ||+++|+|.+++...            ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+||
T Consensus        81 E~~~~g~L~~~l~~~------------~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Df  145 (364)
T cd05599          81 EYLPGGDMMTLLMKK------------DTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDF  145 (364)
T ss_pred             CCCCCcHHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeec
Confidence            999999999998652            35899999999999999999999999   999999999999999999999999


Q ss_pred             cCccccCCCCCc-------------------------------------eeeeccccccccCcccccCCCCCcchhHHHH
Q 009340          372 GISRSIPNDKTH-------------------------------------LTTTIQGTFGYLDPEYFQSSQFTDKSDVYSF  414 (537)
Q Consensus       372 gla~~~~~~~~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~  414 (537)
                      |++..+......                                     ......||+.|+|||++....++.++|||||
T Consensus       146 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  225 (364)
T cd05599         146 GLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSL  225 (364)
T ss_pred             ccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecc
Confidence            998754321100                                     0112458999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCC---Hh
Q 009340          415 GVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPT---MK  491 (537)
Q Consensus       415 Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs---~~  491 (537)
                      ||++|||++|+.||......+.      ........       ..+..+.....+..+.+++.+|+. +|.+|++   +.
T Consensus       226 G~il~el~~G~~Pf~~~~~~~~------~~~i~~~~-------~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~  291 (364)
T cd05599         226 GVIMYEMLVGYPPFCSDNPQET------YRKIINWK-------ETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVN  291 (364)
T ss_pred             hhHHHHhhcCCCCCCCCCHHHH------HHHHHcCC-------CccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHH
Confidence            9999999999999965432211      11111100       000001111234567889999996 9999998   77


Q ss_pred             hHHH
Q 009340          492 QVSM  495 (537)
Q Consensus       492 ev~~  495 (537)
                      ++++
T Consensus       292 ~ll~  295 (364)
T cd05599         292 EIKS  295 (364)
T ss_pred             HHhc
Confidence            7765

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.9e-38  Score=316.49  Aligned_cols=271  Identities=25%  Similarity=0.437  Sum_probs=206.3

Q ss_pred             hcCCccccccCcCCceEEEEEEcC-----------------CCCEEEEEEccCC-ChHHHHHHHHHHHHHHhcCCCCcce
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLP-----------------DGSIVAVKRSKEI-DKTQIHQFINEVVILSQINHRHIVK  276 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~-----------------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~  276 (537)
                      .++|+..++||+|+||.||++...                 ++..||+|.++.. .......|.+|+.+++.++|+||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~   83 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR   83 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence            357888999999999999998532                 2446999998753 3445678999999999999999999


Q ss_pred             EeeEEeeCCccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCC
Q 009340          277 LLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSS  356 (537)
Q Consensus       277 l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~  356 (537)
                      +++++...+..++||||+++|+|.+++.......... ......+++..++.++.|++.||+|||+.+   ++||||||+
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~  159 (296)
T cd05095          84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAE-KADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATR  159 (296)
T ss_pred             EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccc-cccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChh
Confidence            9999999999999999999999999997643211100 111235889999999999999999999999   999999999


Q ss_pred             CEEECCCCcEEEeeccCccccCCCCCce-eeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh--CCCCCCccch
Q 009340          357 NILLDDKFSAKVSDFGISRSIPNDKTHL-TTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT--GKKPICFARV  433 (537)
Q Consensus       357 NIll~~~~~~ki~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t--g~~p~~~~~~  433 (537)
                      |||++.++.++|+|||+++......... .....++..|+|||....+.++.++||||||+++|||++  |..|+.....
T Consensus       160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~  239 (296)
T cd05095         160 NCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD  239 (296)
T ss_pred             eEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh
Confidence            9999999999999999998664332221 222344678999999888889999999999999999998  6677754332


Q ss_pred             hhhccHHHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHH
Q 009340          434 EEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELE  498 (537)
Q Consensus       434 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~  498 (537)
                      .+.   ............      .....+.+..++..+.+++.+||+.||++||++.+|.+.|+
T Consensus       240 ~~~---~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         240 EQV---IENTGEFFRDQG------RQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL  295 (296)
T ss_pred             HHH---HHHHHHHHhhcc------ccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            221   111111111000      00011112334467889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.2e-38  Score=312.74  Aligned_cols=253  Identities=25%  Similarity=0.366  Sum_probs=201.2

Q ss_pred             cCCccccccCcCCceEEEEEEc-CCCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecC
Q 009340          216 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI  294 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  294 (537)
                      ++|+..+.||+|+||.||+|+. .+++.||+|++..........+.+|+.++++++|+|++++++++...+..++|+||+
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~   88 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC   88 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence            5788899999999999999995 478899999987654445567889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCc
Q 009340          295 SSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGIS  374 (537)
Q Consensus       295 ~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla  374 (537)
                      ++++|.++++..            ..+++..+..++.|+++||.|||+.+   |+||||+|+||+++.++.+||+|||++
T Consensus        89 ~~~~L~~~~~~~------------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~  153 (267)
T cd06646          89 GGGSLQDIYHVT------------GPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVA  153 (267)
T ss_pred             CCCcHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccc
Confidence            999999998642            35899999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCCceeeeccccccccCccccc---CCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhch
Q 009340          375 RSIPNDKTHLTTTIQGTFGYLDPEYFQ---SSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQ  451 (537)
Q Consensus       375 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  451 (537)
                      ........ ......++..|+|||.+.   ...++.++||||||+++|||++|+.|+......+...      . .....
T Consensus       154 ~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~------~-~~~~~  225 (267)
T cd06646         154 AKITATIA-KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF------L-MSKSN  225 (267)
T ss_pred             eeeccccc-ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe------e-eecCC
Confidence            86632221 123345788999999874   4457889999999999999999999985332211100      0 00000


Q ss_pred             hhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHH
Q 009340          452 LLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSME  496 (537)
Q Consensus       452 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~  496 (537)
                         ...+...  .....+..+.+++.+||+.+|++|||+.++++.
T Consensus       226 ---~~~~~~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  265 (267)
T cd06646         226 ---FQPPKLK--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTH  265 (267)
T ss_pred             ---CCCCCCc--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence               0000000  112234678899999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=2e-38  Score=309.22  Aligned_cols=255  Identities=33%  Similarity=0.528  Sum_probs=205.1

Q ss_pred             cccCcCCceEEEEEEcCC----CCEEEEEEccCCChH-HHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecCCC
Q 009340          222 RFLGQGGFGTVYKGMLPD----GSIVAVKRSKEIDKT-QIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISS  296 (537)
Q Consensus       222 ~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  296 (537)
                      +.||+|+||.||++....    +..|++|.++..... ..+.+.+|+..++.++|+|++++++++.+....++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            469999999999999753    788999998764433 367889999999999999999999999998899999999999


Q ss_pred             CChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCccc
Q 009340          297 GTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS  376 (537)
Q Consensus       297 gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~  376 (537)
                      ++|.+++.......   .......+++..++.++.|+++||+|||+.+   ++||||+|+||++++++.+||+|||.+..
T Consensus        81 ~~L~~~l~~~~~~~---~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~  154 (262)
T cd00192          81 GDLLDYLRKSRPVF---PSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRD  154 (262)
T ss_pred             CcHHHHHhhccccc---cccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEcccccccc
Confidence            99999997642100   0000146999999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCCC-ceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHHHHHhhchhhh
Q 009340          377 IPNDKT-HLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQLLE  454 (537)
Q Consensus       377 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  454 (537)
                      ...... .......++..|+|||.+....++.++||||||++++||++ |..||......+       +......     
T Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~~-----  222 (262)
T cd00192         155 VYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE-------VLEYLRK-----  222 (262)
T ss_pred             cccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHHc-----
Confidence            754332 22234557889999999988899999999999999999999 688886542221       1111111     


Q ss_pred             hhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHH
Q 009340          455 ILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELE  498 (537)
Q Consensus       455 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~  498 (537)
                          ......+...+.++.+++.+||+.+|++|||+.++++.|+
T Consensus       223 ----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         223 ----GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             ----CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                1111233444678999999999999999999999998874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.7e-38  Score=312.43  Aligned_cols=256  Identities=25%  Similarity=0.465  Sum_probs=205.9

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCC----EEEEEEccCCC-hHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGS----IVAVKRSKEID-KTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVL  289 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  289 (537)
                      .+|...+.||+|+||.||+|... +|+    .||+|...... .....++.+|+.++++++|+|+++++++|.. ...++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            45677889999999999999964 333    58999887543 4456789999999999999999999999987 77899


Q ss_pred             EEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEe
Q 009340          290 VYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVS  369 (537)
Q Consensus       290 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~  369 (537)
                      |+||+++|+|.+++....           ..+++..++.++.|+++||+|||+.+   ++||||||+||++++++.+||+
T Consensus        86 v~e~~~~g~L~~~l~~~~-----------~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~  151 (279)
T cd05057          86 ITQLMPLGCLLDYVRNHK-----------DNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKIT  151 (279)
T ss_pred             EEecCCCCcHHHHHHhcc-----------CCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEEC
Confidence            999999999999997542           25899999999999999999999988   9999999999999999999999


Q ss_pred             eccCccccCCCCCcee-eeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHHHHH
Q 009340          370 DFGISRSIPNDKTHLT-TTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLA  447 (537)
Q Consensus       370 Dfgla~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~  447 (537)
                      |||+++.......... ....++..|+|||.+....++.++|+||||+++|||++ |+.||......+       +....
T Consensus       152 dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~  224 (279)
T cd05057         152 DFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE-------IPDLL  224 (279)
T ss_pred             CCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH-------HHHHH
Confidence            9999987653332221 12224578999999988899999999999999999999 999986543221       11111


Q ss_pred             hhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHH
Q 009340          448 KENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRR  502 (537)
Q Consensus       448 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~  502 (537)
                      ....         ....+..+...+.+++.+||..+|++||++.++++.|+.+.+
T Consensus       225 ~~~~---------~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05057         225 EKGE---------RLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR  270 (279)
T ss_pred             hCCC---------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            1110         111122334568899999999999999999999999998755

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1.1e-38  Score=321.04  Aligned_cols=238  Identities=25%  Similarity=0.386  Sum_probs=190.7

Q ss_pred             cccCcCCceEEEEEEcC-CCCEEEEEEccCC---ChHHHHHHHHHHHHHHhc-CCCCcceEeeEEeeCCccEEEEecCCC
Q 009340          222 RFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI---DKTQIHQFINEVVILSQI-NHRHIVKLLGCCLETEVPVLVYEYISS  296 (537)
Q Consensus       222 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~  296 (537)
                      +.||+|+||.||+|... +++.||+|.++..   .....+.+..|..++... +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999964 5789999988642   223344566677777654 899999999999999999999999999


Q ss_pred             CChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCccc
Q 009340          297 GTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS  376 (537)
Q Consensus       297 gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~  376 (537)
                      |+|.+++...            ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        81 g~L~~~~~~~------------~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~  145 (316)
T cd05592          81 GDLMFHIQSS------------GRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKE  145 (316)
T ss_pred             CcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeE
Confidence            9999888653            35889999999999999999999998   99999999999999999999999999976


Q ss_pred             cCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchhhhhh
Q 009340          377 IPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEIL  456 (537)
Q Consensus       377 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  456 (537)
                      ..... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||......+      .+.....        
T Consensus       146 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~------~~~~i~~--------  210 (316)
T cd05592         146 NMNGE-GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE------LFDSILN--------  210 (316)
T ss_pred             CCCCC-CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH------HHHHHHc--------
Confidence            53322 22344568999999999999899999999999999999999999986543221      0111110        


Q ss_pred             cHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhh
Q 009340          457 DARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQ  492 (537)
Q Consensus       457 d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  492 (537)
                         .....+......+.+++.+||+.||++||++.+
T Consensus       211 ---~~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~  243 (316)
T cd05592         211 ---DRPHFPRWISKEAKDCLSKLFERDPTKRLGVDG  243 (316)
T ss_pred             ---CCCCCCCCCCHHHHHHHHHHccCCHHHcCCChH
Confidence               011123334456789999999999999999864

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=5.2e-39  Score=330.10  Aligned_cols=255  Identities=22%  Similarity=0.337  Sum_probs=200.2

Q ss_pred             HHhcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccC---CChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccE
Q 009340          213 RATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKE---IDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPV  288 (537)
Q Consensus       213 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  288 (537)
                      ...++|+..+.||+|+||.||++... +++.||+|.+..   ........+.+|+.+++.++||||+++++++.+.+..+
T Consensus        40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~  119 (370)
T cd05621          40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY  119 (370)
T ss_pred             CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence            34578999999999999999999965 588999998853   12233456789999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEE
Q 009340          289 LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKV  368 (537)
Q Consensus       289 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki  368 (537)
                      +||||+++|+|.+++..             ..+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||
T Consensus       120 lv~Ey~~gg~L~~~l~~-------------~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL  183 (370)
T cd05621         120 MVMEYMPGGDLVNLMSN-------------YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKL  183 (370)
T ss_pred             EEEcCCCCCcHHHHHHh-------------cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEE
Confidence            99999999999999854             24788899999999999999999999   999999999999999999999


Q ss_pred             eeccCccccCCCCCceeeeccccccccCcccccCC----CCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHH
Q 009340          369 SDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSS----QFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFI  444 (537)
Q Consensus       369 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~  444 (537)
                      +|||++...............||+.|+|||.+...    .++.++|||||||++|||++|+.||.......      .+.
T Consensus       184 ~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~------~~~  257 (370)
T cd05621         184 ADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVG------TYS  257 (370)
T ss_pred             EecccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHH------HHH
Confidence            99999987644333333456799999999998653    37889999999999999999999996543221      111


Q ss_pred             HHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCC--CCCHhhHHHH
Q 009340          445 SLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKK--RPTMKQVSME  496 (537)
Q Consensus       445 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~--RPs~~ev~~~  496 (537)
                      .......       .+..+.....+..+.+++..|+..++.+  ||++.++++.
T Consensus       258 ~i~~~~~-------~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         258 KIMDHKN-------SLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             HHHhCCc-------ccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence            1111100       0111111233566778999999755543  8899988764

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=1.3e-38  Score=326.93  Aligned_cols=253  Identities=23%  Similarity=0.381  Sum_probs=195.4

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCC---ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI---DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY  291 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  291 (537)
                      ++|+..+.||+|+||+||++... +++.||+|.++..   .......+.+|+.++.+++|+||+++++++.+....++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            46888999999999999999854 6889999998652   2233456788999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeec
Q 009340          292 EYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF  371 (537)
Q Consensus       292 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Df  371 (537)
                      ||+++|+|.+++...            ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+||
T Consensus        81 E~~~gg~L~~~l~~~------------~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DF  145 (363)
T cd05628          81 EFLPGGDMMTLLMKK------------DTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDF  145 (363)
T ss_pred             cCCCCCcHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeec
Confidence            999999999998752            35899999999999999999999999   999999999999999999999999


Q ss_pred             cCccccCCCCC----------------------------------ceeeeccccccccCcccccCCCCCcchhHHHHHHH
Q 009340          372 GISRSIPNDKT----------------------------------HLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVV  417 (537)
Q Consensus       372 gla~~~~~~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvl  417 (537)
                      |+++.......                                  .......||+.|+|||++.+..++.++|||||||+
T Consensus       146 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvi  225 (363)
T cd05628         146 GLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVI  225 (363)
T ss_pred             cCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHH
Confidence            99875432110                                  00123469999999999999999999999999999


Q ss_pred             HHHHHhCCCCCCccchhhhccHHHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcc--cCCCCCCCHhhHHH
Q 009340          418 LLELLTGKKPICFARVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLR--LNSKKRPTMKQVSM  495 (537)
Q Consensus       418 l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~--~~p~~RPs~~ev~~  495 (537)
                      +|||++|+.||......+.      +.......       ..+..+.....+..+.+++.+++.  .++..||++.||++
T Consensus       226 l~ell~G~~Pf~~~~~~~~------~~~i~~~~-------~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~  292 (363)
T cd05628         226 MYEMLIGYPPFCSETPQET------YKKVMNWK-------ETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKT  292 (363)
T ss_pred             HHHHHhCCCCCCCCCHHHH------HHHHHcCc-------CcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhC
Confidence            9999999999965432221      11111100       000000001123455667666443  33445789999977


Q ss_pred             H
Q 009340          496 E  496 (537)
Q Consensus       496 ~  496 (537)
                      .
T Consensus       293 h  293 (363)
T cd05628         293 N  293 (363)
T ss_pred             C
Confidence            4

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.3e-38  Score=321.81  Aligned_cols=240  Identities=28%  Similarity=0.397  Sum_probs=191.5

Q ss_pred             CccccccCcCCceEEEEEEcC-CCCEEEEEEccCC---ChHHHHHHHHHHHHH---HhcCCCCcceEeeEEeeCCccEEE
Q 009340          218 YNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI---DKTQIHQFINEVVIL---SQINHRHIVKLLGCCLETEVPVLV  290 (537)
Q Consensus       218 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l---~~l~H~niv~l~g~~~~~~~~~lV  290 (537)
                      |...+.||+|+||.||++... +|+.||||.++..   .....+.+.+|+.++   +.++||||+++++++.+.+..++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            556789999999999999864 6899999998742   223345566676655   566899999999999999999999


Q ss_pred             EecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEee
Q 009340          291 YEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSD  370 (537)
Q Consensus       291 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~D  370 (537)
                      |||+++|+|..++..             ..+++..++.++.|++.||.|||+.+   ++||||||+|||++.++.+||+|
T Consensus        81 ~E~~~~~~L~~~~~~-------------~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~D  144 (324)
T cd05589          81 MEYAAGGDLMMHIHT-------------DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIAD  144 (324)
T ss_pred             EcCCCCCcHHHHhhc-------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCc
Confidence            999999999888753             35899999999999999999999999   99999999999999999999999


Q ss_pred             ccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhc
Q 009340          371 FGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKEN  450 (537)
Q Consensus       371 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  450 (537)
                      ||+++...... .......|++.|+|||.+.+..++.++|||||||++|||++|+.||......+.      +..... .
T Consensus       145 fg~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~------~~~i~~-~  216 (324)
T cd05589         145 FGLCKEGMGFG-DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEV------FDSIVN-D  216 (324)
T ss_pred             ccCCccCCCCC-CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHH------HHHHHh-C
Confidence            99987542222 223345689999999999999999999999999999999999999865432211      111111 0


Q ss_pred             hhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHh
Q 009340          451 QLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMK  491 (537)
Q Consensus       451 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~  491 (537)
                              .  ...+...+..+.+++.+||+.||++||++.
T Consensus       217 --------~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~  247 (324)
T cd05589         217 --------E--VRYPRFLSREAISIMRRLLRRNPERRLGSG  247 (324)
T ss_pred             --------C--CCCCCCCCHHHHHHHHHHhhcCHhHcCCCC
Confidence                    0  012233456788999999999999999543

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=2e-38  Score=309.21  Aligned_cols=248  Identities=27%  Similarity=0.470  Sum_probs=200.8

Q ss_pred             cccCcCCceEEEEEEcCC--C--CEEEEEEccCCCh-HHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecCCC
Q 009340          222 RFLGQGGFGTVYKGMLPD--G--SIVAVKRSKEIDK-TQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISS  296 (537)
Q Consensus       222 ~~lg~G~~g~Vy~~~~~~--g--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  296 (537)
                      ++||+|++|.||+|.+.+  +  ..||||.++.... ...+.|.+|+.++++++|+||+++++++.+ ...++|+||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999999643  3  3699999887555 567789999999999999999999999988 888999999999


Q ss_pred             CChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCccc
Q 009340          297 GTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS  376 (537)
Q Consensus       297 gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~  376 (537)
                      |+|.+++.....          ..++|...+.++.|+++||+|||+.+   ++|+||+|+||+++.++.+||+|||++..
T Consensus        80 ~~L~~~l~~~~~----------~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~  146 (257)
T cd05040          80 GSLLDRLRKDAL----------GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRA  146 (257)
T ss_pred             CcHHHHHHhccc----------ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccc
Confidence            999999976421          35899999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCCCce--eeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHHHHHhhchhh
Q 009340          377 IPNDKTHL--TTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQLL  453 (537)
Q Consensus       377 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  453 (537)
                      ........  .....++..|+|||++.+..++.++||||||+++|||++ |+.|+......+.      ........   
T Consensus       147 ~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~------~~~~~~~~---  217 (257)
T cd05040         147 LPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQI------LKKIDKEG---  217 (257)
T ss_pred             ccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH------HHHHHhcC---
Confidence            74432221  123456789999999998899999999999999999999 9999854332211      11111000   


Q ss_pred             hhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHH
Q 009340          454 EILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELE  498 (537)
Q Consensus       454 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~  498 (537)
                            .....+...+..+.+++.+||+.+|++||++.++++.|.
T Consensus       218 ------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         218 ------ERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             ------CcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence                  001112234567889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-39  Score=308.81  Aligned_cols=266  Identities=23%  Similarity=0.343  Sum_probs=206.3

Q ss_pred             HhcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccC--CChHHHHHHHHHHHHHHhcCCCCcceEeeEEee-----CC
Q 009340          214 ATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKE--IDKTQIHQFINEVVILSQINHRHIVKLLGCCLE-----TE  285 (537)
Q Consensus       214 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-----~~  285 (537)
                      ....|...+.||+|+||.|+.+... +|+.||||++..  ......++-++|+++|++++|+||+.+++.+..     -.
T Consensus        20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~   99 (359)
T KOG0660|consen   20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN   99 (359)
T ss_pred             ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence            3456666788999999999999954 789999999873  455667888999999999999999999999875     24


Q ss_pred             ccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCc
Q 009340          286 VPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFS  365 (537)
Q Consensus       286 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~  365 (537)
                      ..|+|+|+|+. +|...++..            ..|+......+..|+++||.|+|+.+   ++||||||+|+|++.+..
T Consensus       100 DvYiV~elMet-DL~~iik~~------------~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~  163 (359)
T KOG0660|consen  100 DVYLVFELMET-DLHQIIKSQ------------QDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCD  163 (359)
T ss_pred             eeEEehhHHhh-HHHHHHHcC------------ccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCC
Confidence            67999999954 898888763            34999999999999999999999999   999999999999999999


Q ss_pred             EEEeeccCccccCCC-CCceeeeccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHH
Q 009340          366 AKVSDFGISRSIPND-KTHLTTTIQGTFGYLDPEYFQS-SQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACF  443 (537)
Q Consensus       366 ~ki~Dfgla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~  443 (537)
                      .||+|||||+..... .....+..+.|..|.|||++.+ ..||.+.||||.||++.||++|+.-|...+.-+...+....
T Consensus       164 lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~  243 (359)
T KOG0660|consen  164 LKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILEL  243 (359)
T ss_pred             EEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHh
Confidence            999999999987542 1223456678999999998754 67999999999999999999999998766543333222222


Q ss_pred             HH--------HHhhchhhhhhcHHhh------ccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          444 IS--------LAKENQLLEILDARVA------KEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       444 ~~--------~~~~~~~~~~~d~~~~------~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      ..        ..........+..-..      ........+...+|+.+||..||.+|+|++|.++
T Consensus       244 lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~  309 (359)
T KOG0660|consen  244 LGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA  309 (359)
T ss_pred             cCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence            11        1111111111110000      0111234567889999999999999999999875

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.4e-38  Score=313.79  Aligned_cols=239  Identities=23%  Similarity=0.393  Sum_probs=189.2

Q ss_pred             ccCcCCceEEEEEEcCC-------------------------CCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceE
Q 009340          223 FLGQGGFGTVYKGMLPD-------------------------GSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKL  277 (537)
Q Consensus       223 ~lg~G~~g~Vy~~~~~~-------------------------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l  277 (537)
                      +||+|+||.||+|.+..                         ...|++|.+.........+|.+|+.+++.++|+||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            69999999999998521                         13589999876555556789999999999999999999


Q ss_pred             eeEEeeCCccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCC
Q 009340          278 LGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSN  357 (537)
Q Consensus       278 ~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~N  357 (537)
                      +++|.+....++||||+++|+|..++....           ..+++..++.++.|+++||+|||+.+   |+||||||+|
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~-----------~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~N  147 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK-----------GRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKN  147 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCccc
Confidence            999999999999999999999999886532           35899999999999999999999998   9999999999


Q ss_pred             EEECCCC-------cEEEeeccCccccCCCCCceeeeccccccccCcccccC-CCCCcchhHHHHHHHHHHHH-hCCCCC
Q 009340          358 ILLDDKF-------SAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQS-SQFTDKSDVYSFGVVLLELL-TGKKPI  428 (537)
Q Consensus       358 Ill~~~~-------~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~el~-tg~~p~  428 (537)
                      ||++..+       .+|++|||++......     ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.|+
T Consensus       148 ill~~~~~~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~  222 (274)
T cd05076         148 ILLARLGLAEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPL  222 (274)
T ss_pred             EEEeccCcccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCc
Confidence            9997643       3899999988644221     12346788999998875 56899999999999999995 688888


Q ss_pred             CccchhhhccHHHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHH
Q 009340          429 CFARVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELE  498 (537)
Q Consensus       429 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~  498 (537)
                      ......+.       .....         ...  ..+......+.+++.+||+.+|++|||+.+|++.|+
T Consensus       223 ~~~~~~~~-------~~~~~---------~~~--~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         223 KERTPSEK-------ERFYE---------KKH--RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             cccChHHH-------HHHHH---------hcc--CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence            64432211       00000         000  011112346889999999999999999999998873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1.1e-38  Score=321.63  Aligned_cols=237  Identities=26%  Similarity=0.393  Sum_probs=192.1

Q ss_pred             cccCcCCceEEEEEEcC-CCCEEEEEEccCC---ChHHHHHHHHHHHHHHhc-CCCCcceEeeEEeeCCccEEEEecCCC
Q 009340          222 RFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI---DKTQIHQFINEVVILSQI-NHRHIVKLLGCCLETEVPVLVYEYISS  296 (537)
Q Consensus       222 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~  296 (537)
                      +.||+|+||.||++... +++.||||.++..   .....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999965 5889999988642   223456678899888877 699999999999999999999999999


Q ss_pred             CChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCccc
Q 009340          297 GTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS  376 (537)
Q Consensus       297 gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~  376 (537)
                      |+|.+++...            ..+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||+++.
T Consensus        81 g~L~~~i~~~------------~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~  145 (320)
T cd05590          81 GDLMFHIQKS------------RRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKE  145 (320)
T ss_pred             chHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCee
Confidence            9999888653            35899999999999999999999999   99999999999999999999999999875


Q ss_pred             cCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchhhhhh
Q 009340          377 IPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEIL  456 (537)
Q Consensus       377 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  456 (537)
                      ..... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||......+.      ..... ...     
T Consensus       146 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~------~~~i~-~~~-----  212 (320)
T cd05590         146 GIFNG-KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDL------FEAIL-NDE-----  212 (320)
T ss_pred             cCcCC-CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH------HHHHh-cCC-----
Confidence            42221 123345689999999999999999999999999999999999999965432211      11111 110     


Q ss_pred             cHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHh
Q 009340          457 DARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMK  491 (537)
Q Consensus       457 d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~  491 (537)
                           ...+......+.+++.+||+.||++||++.
T Consensus       213 -----~~~~~~~~~~~~~li~~~L~~dP~~R~~~~  242 (320)
T cd05590         213 -----VVYPTWLSQDAVDILKAFMTKNPTMRLGSL  242 (320)
T ss_pred             -----CCCCCCCCHHHHHHHHHHcccCHHHCCCCC
Confidence                 011223445788999999999999999983

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.1e-38  Score=321.84  Aligned_cols=241  Identities=25%  Similarity=0.368  Sum_probs=194.1

Q ss_pred             cccCcCCceEEEEEEcC-CCCEEEEEEccCC---ChHHHHHHHHHHHHHHhc-CCCCcceEeeEEeeCCccEEEEecCCC
Q 009340          222 RFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI---DKTQIHQFINEVVILSQI-NHRHIVKLLGCCLETEVPVLVYEYISS  296 (537)
Q Consensus       222 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~  296 (537)
                      ++||+|+||.||+|+.. +++.||+|.++..   .....+.+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46999999999999965 5789999998652   233455678899998876 799999999999999999999999999


Q ss_pred             CChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCccc
Q 009340          297 GTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS  376 (537)
Q Consensus       297 gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~  376 (537)
                      |+|..++...            ..+++..+..++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||++..
T Consensus        81 ~~L~~~l~~~------------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~  145 (321)
T cd05591          81 GDLMFQIQRS------------RKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKE  145 (321)
T ss_pred             CcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeeccccee
Confidence            9999888653            35899999999999999999999999   99999999999999999999999999875


Q ss_pred             cCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchhhhhh
Q 009340          377 IPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEIL  456 (537)
Q Consensus       377 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  456 (537)
                      ..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+.      +.......      
T Consensus       146 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~------~~~i~~~~------  212 (321)
T cd05591         146 GILNG-VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDL------FESILHDD------  212 (321)
T ss_pred             cccCC-ccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHH------HHHHHcCC------
Confidence            43222 123345689999999999998999999999999999999999999975432211      11111100      


Q ss_pred             cHHhhccccHHHHHHHHHHHHHhcccCCCCCC-------CHhhHHH
Q 009340          457 DARVAKEAREEDIGAMAELAMRCLRLNSKKRP-------TMKQVSM  495 (537)
Q Consensus       457 d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-------s~~ev~~  495 (537)
                         .  ..+...+..+.+++.+||+.||++||       ++.++++
T Consensus       213 ---~--~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~  253 (321)
T cd05591         213 ---V--LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ  253 (321)
T ss_pred             ---C--CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence               0  11222345788999999999999999       6666653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=3.6e-38  Score=308.75  Aligned_cols=239  Identities=23%  Similarity=0.416  Sum_probs=190.1

Q ss_pred             cccCcCCceEEEEEEcCC-------------CCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccE
Q 009340          222 RFLGQGGFGTVYKGMLPD-------------GSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPV  288 (537)
Q Consensus       222 ~~lg~G~~g~Vy~~~~~~-------------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  288 (537)
                      +.||+|+||.||+|.+.+             ...|++|.+..........|.+|+.+++.++||||+++++++......+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            468999999999998532             2258999887655555668899999999999999999999999998999


Q ss_pred             EEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCc---
Q 009340          289 LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFS---  365 (537)
Q Consensus       289 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~---  365 (537)
                      +||||+++|+|..++....           ..+++..+++++.||++||+|||+.+   |+||||||+|||++.++.   
T Consensus        81 lv~e~~~~~~l~~~~~~~~-----------~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~  146 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRKS-----------DVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGE  146 (262)
T ss_pred             EEEecccCCCHHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCC
Confidence            9999999999988876432           35899999999999999999999998   999999999999987664   


Q ss_pred             ----EEEeeccCccccCCCCCceeeeccccccccCccccc-CCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccH
Q 009340          366 ----AKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQ-SSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNL  439 (537)
Q Consensus       366 ----~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~  439 (537)
                          ++++|||++......     ....++..|+|||.+. +..++.++||||||+++|||++ |+.|+......+.   
T Consensus       147 ~~~~~~l~d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~---  218 (262)
T cd05077         147 CGPFIKLSDPGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK---  218 (262)
T ss_pred             CCceeEeCCCCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH---
Confidence                899999998755322     2345788899999886 4668999999999999999985 7777654322111   


Q ss_pred             HHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHH
Q 009340          440 VACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMEL  497 (537)
Q Consensus       440 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L  497 (537)
                          ..... ..        ..  ........+.+|+.+||+.||++||++.+|++.|
T Consensus       219 ----~~~~~-~~--------~~--~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         219 ----ERFYE-GQ--------CM--LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             ----HHHHh-cC--------cc--CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence                01000 00        00  0111235688999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1.7e-38  Score=320.95  Aligned_cols=241  Identities=25%  Similarity=0.358  Sum_probs=194.7

Q ss_pred             CCccccccCcCCceEEEEEEcC-CCCEEEEEEccCC---ChHHHHHHHHHHHHHHhcCC-CCcceEeeEEeeCCccEEEE
Q 009340          217 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI---DKTQIHQFINEVVILSQINH-RHIVKLLGCCLETEVPVLVY  291 (537)
Q Consensus       217 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~  291 (537)
                      +|+..+.||+|+||.||+|+.. +++.||||.++..   .....+.+..|..++..++| ++|+++.+++.+.+..++||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            4778899999999999999965 5789999988642   23445678889999999976 56888999999889999999


Q ss_pred             ecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeec
Q 009340          292 EYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF  371 (537)
Q Consensus       292 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Df  371 (537)
                      ||+++|+|.+++...            ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+||
T Consensus        81 E~~~~g~L~~~~~~~------------~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Df  145 (324)
T cd05587          81 EYVNGGDLMYHIQQV------------GKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADF  145 (324)
T ss_pred             cCCCCCcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeec
Confidence            999999999888652            35899999999999999999999998   999999999999999999999999


Q ss_pred             cCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhch
Q 009340          372 GISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQ  451 (537)
Q Consensus       372 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  451 (537)
                      |++........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.      +..... . 
T Consensus       146 g~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~------~~~i~~-~-  216 (324)
T cd05587         146 GMCKENIFGGK-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL------FQSIME-H-  216 (324)
T ss_pred             CcceecCCCCC-ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH------HHHHHc-C-
Confidence            99875322211 23345689999999999999999999999999999999999999865432211      111110 0 


Q ss_pred             hhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCH
Q 009340          452 LLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTM  490 (537)
Q Consensus       452 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~  490 (537)
                               ....+...+..+.+++.+||+.||.+|++.
T Consensus       217 ---------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         217 ---------NVSYPKSLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             ---------CCCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence                     011233345678899999999999999987

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=2.4e-38  Score=315.76  Aligned_cols=249  Identities=26%  Similarity=0.449  Sum_probs=203.9

Q ss_pred             cCCccccccCcCCceEEEEEEc-CCCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecC
Q 009340          216 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI  294 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  294 (537)
                      .+|...+.||+|+||.||+|+. .+++.||+|.+........+.+.+|+.+++.++|+|++++++++......++||||+
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~   99 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence            5788888999999999999985 468899999987655555677899999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCc
Q 009340          295 SSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGIS  374 (537)
Q Consensus       295 ~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla  374 (537)
                      ++++|.+++..             ..+++.++..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++
T Consensus       100 ~~~~L~~~~~~-------------~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~  163 (296)
T cd06654         100 AGGSLTDVVTE-------------TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFC  163 (296)
T ss_pred             CCCCHHHHHHh-------------cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccc
Confidence            99999998853             24889999999999999999999999   999999999999999999999999998


Q ss_pred             cccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchhhh
Q 009340          375 RSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLE  454 (537)
Q Consensus       375 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  454 (537)
                      ......... .....+++.|+|||.+.+..++.++|||||||++|||++|+.||........      ........    
T Consensus       164 ~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~------~~~~~~~~----  232 (296)
T cd06654         164 AQITPEQSK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA------LYLIATNG----  232 (296)
T ss_pred             hhccccccc-cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh------HHHHhcCC----
Confidence            765332211 2234588999999999988899999999999999999999999865432110      00000000    


Q ss_pred             hhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          455 ILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       455 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                          ......+......+.+++.+||..+|++||++.++++
T Consensus       233 ----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         233 ----TPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             ----CCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence                0000112334467889999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=2.5e-38  Score=312.58  Aligned_cols=248  Identities=23%  Similarity=0.338  Sum_probs=195.0

Q ss_pred             cCcCCceEEEEEEcC-CCCEEEEEEccCCC---hHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecCCCCCh
Q 009340          224 LGQGGFGTVYKGMLP-DGSIVAVKRSKEID---KTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTL  299 (537)
Q Consensus       224 lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL  299 (537)
                      ||+|+||.||++... +|+.||+|.+....   ......+..|+.++++++||||+++.+++.+....++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            799999999999864 68999999886421   12234556799999999999999999999999999999999999999


Q ss_pred             hhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCccccCC
Q 009340          300 SHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPN  379 (537)
Q Consensus       300 ~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~  379 (537)
                      .+++....          ...+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.++|+|||++.....
T Consensus        81 ~~~~~~~~----------~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~  147 (277)
T cd05607          81 KYHIYNVG----------ERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKD  147 (277)
T ss_pred             HHHHHhcc----------ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCC
Confidence            98886532          235899999999999999999999999   99999999999999999999999999987643


Q ss_pred             CCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchhhhhhcHH
Q 009340          380 DKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEILDAR  459 (537)
Q Consensus       380 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  459 (537)
                      ..  ......|+..|+|||++.+..++.++|||||||++|||++|+.||.......  .........         +...
T Consensus       148 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~--~~~~~~~~~---------~~~~  214 (277)
T cd05607         148 GK--TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV--AKEELKRRT---------LEDE  214 (277)
T ss_pred             Cc--eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh--hHHHHHHHh---------hccc
Confidence            32  2234568999999999999889999999999999999999999986432211  000000000         0000


Q ss_pred             hhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHH
Q 009340          460 VAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELE  498 (537)
Q Consensus       460 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~  498 (537)
                      .. ......+.++.+|+.+||+.||++||++.|+++.+.
T Consensus       215 ~~-~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~  252 (277)
T cd05607         215 VK-FEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPR  252 (277)
T ss_pred             cc-cccccCCHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence            00 001133556889999999999999999988764443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1.8e-38  Score=321.11  Aligned_cols=244  Identities=24%  Similarity=0.365  Sum_probs=194.6

Q ss_pred             cccCcCCceEEEEEEcC-CCCEEEEEEccCC---ChHHHHHHHHHHHHHHhc-CCCCcceEeeEEeeCCccEEEEecCCC
Q 009340          222 RFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI---DKTQIHQFINEVVILSQI-NHRHIVKLLGCCLETEVPVLVYEYISS  296 (537)
Q Consensus       222 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~  296 (537)
                      +.||+|+||.||++... +++.||+|.++..   .....+.+.+|+.++.++ +|+||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999964 6789999998752   233456688999999888 699999999999999999999999999


Q ss_pred             CChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCccc
Q 009340          297 GTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS  376 (537)
Q Consensus       297 gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~  376 (537)
                      |+|.+++...            ..+++..+..++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        81 ~~L~~~~~~~------------~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~  145 (327)
T cd05617          81 GDLMFHMQRQ------------RKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKE  145 (327)
T ss_pred             CcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEecccccee
Confidence            9999888642            35999999999999999999999999   99999999999999999999999999875


Q ss_pred             cCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchhhhhh
Q 009340          377 IPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEIL  456 (537)
Q Consensus       377 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  456 (537)
                      ..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......................     
T Consensus       146 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-----  219 (327)
T cd05617         146 GLGPG-DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP-----  219 (327)
T ss_pred             ccCCC-CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCC-----
Confidence            32221 123345689999999999999999999999999999999999999964433222222222222211110     


Q ss_pred             cHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHh
Q 009340          457 DARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMK  491 (537)
Q Consensus       457 d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~  491 (537)
                           ...+...+..+.+++.+||+.||++||++.
T Consensus       220 -----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~  249 (327)
T cd05617         220 -----IRIPRFLSVKASHVLKGFLNKDPKERLGCQ  249 (327)
T ss_pred             -----CCCCCCCCHHHHHHHHHHhccCHHHcCCCC
Confidence                 112333445678999999999999999864

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.7e-38  Score=320.76  Aligned_cols=241  Identities=24%  Similarity=0.358  Sum_probs=194.9

Q ss_pred             CCccccccCcCCceEEEEEEcC-CCCEEEEEEccCC---ChHHHHHHHHHHHHHHhc-CCCCcceEeeEEeeCCccEEEE
Q 009340          217 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI---DKTQIHQFINEVVILSQI-NHRHIVKLLGCCLETEVPVLVY  291 (537)
Q Consensus       217 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~  291 (537)
                      +|...+.||+|+||.||++... +++.||+|.++..   .....+.+..|..++..+ +|++|+++.+++.+.+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            4778899999999999999865 5789999988642   223345567788888887 5899999999999999999999


Q ss_pred             ecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeec
Q 009340          292 EYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF  371 (537)
Q Consensus       292 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Df  371 (537)
                      ||+++|+|.+++...            ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+||
T Consensus        81 E~~~~g~L~~~~~~~------------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~Df  145 (323)
T cd05616          81 EYVNGGDLMYQIQQV------------GRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADF  145 (323)
T ss_pred             cCCCCCCHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccC
Confidence            999999999888652            35899999999999999999999998   999999999999999999999999


Q ss_pred             cCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhch
Q 009340          372 GISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQ  451 (537)
Q Consensus       372 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  451 (537)
                      |+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........      +..... . 
T Consensus       146 G~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~------~~~i~~-~-  216 (323)
T cd05616         146 GMCKENMWDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL------FQSIME-H-  216 (323)
T ss_pred             CCceecCCCCC-ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHH------HHHHHh-C-
Confidence            99975432221 23345689999999999999999999999999999999999999965432211      111111 0 


Q ss_pred             hhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCH
Q 009340          452 LLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTM  490 (537)
Q Consensus       452 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~  490 (537)
                             .  ...+...+.++.+++.+||+.+|++|++.
T Consensus       217 -------~--~~~p~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         217 -------N--VAYPKSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             -------C--CCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence                   0  11233445678899999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=4.6e-39  Score=324.25  Aligned_cols=238  Identities=27%  Similarity=0.348  Sum_probs=193.6

Q ss_pred             cccCcCCceEEEEEEc----CCCCEEEEEEccCCC--hHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecCC
Q 009340          222 RFLGQGGFGTVYKGML----PDGSIVAVKRSKEID--KTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYIS  295 (537)
Q Consensus       222 ~~lg~G~~g~Vy~~~~----~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  295 (537)
                      +.||+|+||.||++..    .+|+.||+|+++...  ......+.+|+.++++++|+||+++++++.+.+..++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            5799999999999874    368899999987532  2234557789999999999999999999999999999999999


Q ss_pred             CCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCcc
Q 009340          296 SGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISR  375 (537)
Q Consensus       296 ~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~  375 (537)
                      +|+|.+++...            ..+++..+..++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        82 ~~~L~~~l~~~------------~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~  146 (318)
T cd05582          82 GGDLFTRLSKE------------VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSK  146 (318)
T ss_pred             CCcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCc
Confidence            99999988642            35899999999999999999999999   9999999999999999999999999997


Q ss_pred             ccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchhhhh
Q 009340          376 SIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEI  455 (537)
Q Consensus       376 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  455 (537)
                      ....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+.      ...... ..    
T Consensus       147 ~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~------~~~i~~-~~----  214 (318)
T cd05582         147 ESIDHEK-KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKET------MTMILK-AK----  214 (318)
T ss_pred             ccCCCCC-ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHH------HHHHHc-CC----
Confidence            6533321 23345689999999999988899999999999999999999999865432110      111111 00    


Q ss_pred             hcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhh
Q 009340          456 LDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQ  492 (537)
Q Consensus       456 ~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  492 (537)
                            ...+...+..+.+++.+||+.||++||++.+
T Consensus       215 ------~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         215 ------LGMPQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             ------CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence                  1122334567889999999999999999766

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.9e-38  Score=319.71  Aligned_cols=241  Identities=24%  Similarity=0.365  Sum_probs=194.5

Q ss_pred             cccCcCCceEEEEEEcC-CCCEEEEEEccCC---ChHHHHHHHHHHHHHHhc-CCCCcceEeeEEeeCCccEEEEecCCC
Q 009340          222 RFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI---DKTQIHQFINEVVILSQI-NHRHIVKLLGCCLETEVPVLVYEYISS  296 (537)
Q Consensus       222 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~  296 (537)
                      +.||+|+||.||++... +++.||||.++..   .......+..|..++..+ +|+||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999965 5789999998742   233455677899999888 799999999999999999999999999


Q ss_pred             CChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCccc
Q 009340          297 GTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS  376 (537)
Q Consensus       297 gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~  376 (537)
                      |+|.+++...            ..+++..+..++.|+++||.|||+.+   |+||||||+|||+++++.+||+|||+++.
T Consensus        81 ~~L~~~~~~~------------~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~  145 (318)
T cd05570          81 GDLMFHIQRS------------GRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKE  145 (318)
T ss_pred             CCHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCee
Confidence            9999888653            35899999999999999999999999   99999999999999999999999999875


Q ss_pred             cCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchhhhhh
Q 009340          377 IPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEIL  456 (537)
Q Consensus       377 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  456 (537)
                      ...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.......       ........      
T Consensus       146 ~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~-------~~~~i~~~------  211 (318)
T cd05570         146 GILGGV-TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE-------LFQSILED------  211 (318)
T ss_pred             cCcCCC-cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH-------HHHHHHcC------
Confidence            322211 1233468999999999999999999999999999999999999986443211       11111110      


Q ss_pred             cHHhhccccHHHHHHHHHHHHHhcccCCCCCCCH-----hhHHH
Q 009340          457 DARVAKEAREEDIGAMAELAMRCLRLNSKKRPTM-----KQVSM  495 (537)
Q Consensus       457 d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~-----~ev~~  495 (537)
                        .  ...+...+..+.+++.+||+.||++||++     .++++
T Consensus       212 --~--~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         212 --E--VRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             --C--CCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence              0  01223345678899999999999999999     66654

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=6.4e-39  Score=301.62  Aligned_cols=264  Identities=22%  Similarity=0.281  Sum_probs=202.5

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCChHH--HHHHHHHHHHHHhcCCCCcceEeeEEeeC--CccEEE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKTQ--IHQFINEVVILSQINHRHIVKLLGCCLET--EVPVLV  290 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV  290 (537)
                      +.|+..+.|++|.||.||+|+.+ +++.||+|+++......  --..++|+.+|.+.+|||||.+-.+....  +..|+|
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V  155 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV  155 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence            46777889999999999999954 78899999987532211  12357899999999999999999988754  468999


Q ss_pred             EecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEee
Q 009340          291 YEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSD  370 (537)
Q Consensus       291 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~D  370 (537)
                      |||++. +|..++.....           ++...+..-+..|+++|+.|||.+.   |+|||||++|+|++..|.+||+|
T Consensus       156 Me~~Eh-DLksl~d~m~q-----------~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaD  220 (419)
T KOG0663|consen  156 MEYVEH-DLKSLMETMKQ-----------PFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIAD  220 (419)
T ss_pred             HHHHHh-hHHHHHHhccC-----------CCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecc
Confidence            999988 89999887542           6888999999999999999999999   99999999999999999999999


Q ss_pred             ccCccccCCCCCceeeeccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhh
Q 009340          371 FGISRSIPNDKTHLTTTIQGTFGYLDPEYFQS-SQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKE  449 (537)
Q Consensus       371 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  449 (537)
                      ||||+..+.... ..+..+-|..|.|||.+.+ ..|++..|+||+|||+.||+++++-|.....-+..+.+-.......+
T Consensus       221 FGLAR~ygsp~k-~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte  299 (419)
T KOG0663|consen  221 FGLAREYGSPLK-PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSE  299 (419)
T ss_pred             cchhhhhcCCcc-cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCcc
Confidence            999998865533 3456678999999999876 46999999999999999999999888655433221111111000000


Q ss_pred             c--------------hhhhhhcHHhhccccHH-HHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          450 N--------------QLLEILDARVAKEAREE-DIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       450 ~--------------~~~~~~d~~~~~~~~~~-~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      .              .........++..+... .+..-++|+..++..||.+|.|+.|.++
T Consensus       300 ~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~  360 (419)
T KOG0663|consen  300 AIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK  360 (419)
T ss_pred             ccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence            0              01111111222222222 3467789999999999999999999875

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-39  Score=314.65  Aligned_cols=258  Identities=25%  Similarity=0.359  Sum_probs=203.3

Q ss_pred             HHHHHhcCCccccccCcCCceEEEEEEc-CCCCEEEEEEccCCCh--------------HHHHHHHHHHHHHHhcCCCCc
Q 009340          210 ELQRATDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEIDK--------------TQIHQFINEVVILSQINHRHI  274 (537)
Q Consensus       210 el~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~H~ni  274 (537)
                      +-....++|.....||+|.||.|-+|+. .+++.||||++.....              ...+...+|+.+|++++|+||
T Consensus        91 ~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nV  170 (576)
T KOG0585|consen   91 QDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNV  170 (576)
T ss_pred             ccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCe
Confidence            3344568999999999999999999994 4789999998754111              113578899999999999999


Q ss_pred             ceEeeEEeeC--CccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCC-CCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 009340          275 VKLLGCCLET--EVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSS-LSWENRVRVACEVAGAVAYMHSSASIPIFHR  351 (537)
Q Consensus       275 v~l~g~~~~~--~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~-l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~  351 (537)
                      |+|+++..+.  +..|||+|||..|.+...-.             .+. ++..+.++++.++..||+|||.++   |+||
T Consensus       171 V~LiEvLDDP~s~~~YlVley~s~G~v~w~p~-------------d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHR  234 (576)
T KOG0585|consen  171 VKLIEVLDDPESDKLYLVLEYCSKGEVKWCPP-------------DKPELSEQQARKYLRDVVLGLEYLHYQG---IIHR  234 (576)
T ss_pred             eEEEEeecCcccCceEEEEEeccCCccccCCC-------------CcccccHHHHHHHHHHHHHHHHHHHhcC---eecc
Confidence            9999998754  57899999999988743322             223 899999999999999999999999   9999


Q ss_pred             CCCCCCEEECCCCcEEEeeccCccccCCCCCc----eeeeccccccccCcccccCCC----CCcchhHHHHHHHHHHHHh
Q 009340          352 DIKSSNILLDDKFSAKVSDFGISRSIPNDKTH----LTTTIQGTFGYLDPEYFQSSQ----FTDKSDVYSFGVVLLELLT  423 (537)
Q Consensus       352 Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~----~t~ksDV~S~Gvll~el~t  423 (537)
                      ||||+|+||+++|++||+|||.+...+.....    ......||+.|+|||...++.    .+.+.||||+||.||.|+.
T Consensus       235 DIKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllf  314 (576)
T KOG0585|consen  235 DIKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLF  314 (576)
T ss_pred             ccchhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhh
Confidence            99999999999999999999999876322111    123367999999999987743    3468999999999999999


Q ss_pred             CCCCCCccchhhhccHHHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHH
Q 009340          424 GKKPICFARVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELE  498 (537)
Q Consensus       424 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~  498 (537)
                      |+.||.....-+               ....++...+..+...+....+.+|++++|++||+.|.+..+|..-.-
T Consensus       315 G~~PF~~~~~~~---------------l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw  374 (576)
T KOG0585|consen  315 GQLPFFDDFELE---------------LFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPW  374 (576)
T ss_pred             ccCCcccchHHH---------------HHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecce
Confidence            999986432111               112233333333334456678899999999999999999999876554

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=6.3e-38  Score=309.95  Aligned_cols=250  Identities=24%  Similarity=0.367  Sum_probs=198.2

Q ss_pred             CCccccccCcCCceEEEEEEc-CCCCEEEEEEccCC-ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecC
Q 009340          217 NYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEI-DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI  294 (537)
Q Consensus       217 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  294 (537)
                      +|...++||+|+||.||+|+. .+++.||+|..... ......++.+|+.++++++|+|++++++++...+..++||||+
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   81 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM   81 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence            567788999999999999985 47889999988643 3445567999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCc
Q 009340          295 SSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGIS  374 (537)
Q Consensus       295 ~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla  374 (537)
                      ++++|..+.                .+++..+..++.|++.||.|||+.+   |+|+||||+|||++.++.++|+|||++
T Consensus        82 ~~~~l~~~~----------------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~  142 (279)
T cd06619          82 DGGSLDVYR----------------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVS  142 (279)
T ss_pred             CCCChHHhh----------------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcc
Confidence            999996442                4778888999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchhhh
Q 009340          375 RSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLE  454 (537)
Q Consensus       375 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  454 (537)
                      .......   .....++..|+|||.+.+..++.++||||||+++|||++|+.||.......................   
T Consensus       143 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---  216 (279)
T cd06619         143 TQLVNSI---AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED---  216 (279)
T ss_pred             eeccccc---ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC---
Confidence            7653321   2335689999999999998999999999999999999999999864322111110000000000000   


Q ss_pred             hhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHH
Q 009340          455 ILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSME  496 (537)
Q Consensus       455 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~  496 (537)
                        .+.+   .......++.+++.+||+.+|++||++.++++.
T Consensus       217 --~~~~---~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         217 --PPVL---PVGQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             --CCCC---CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence              0000   111234568899999999999999999999765

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.7e-38  Score=318.74  Aligned_cols=264  Identities=24%  Similarity=0.371  Sum_probs=199.1

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCC-hHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEec
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEID-KTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY  293 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  293 (537)
                      ++|...++||+|+||.||+|+.. +++.||+|.++... ......+.+|+.++++++|+||+++++++...+..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            56888899999999999999864 67889999886432 22334677899999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccC
Q 009340          294 ISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGI  373 (537)
Q Consensus       294 ~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgl  373 (537)
                      +++ +|.+++....           ..+++..+..++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        86 ~~~-~l~~~~~~~~-----------~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~  150 (309)
T cd07872          86 LDK-DLKQYMDDCG-----------NIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGL  150 (309)
T ss_pred             CCC-CHHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcccc
Confidence            975 8888775432           25889999999999999999999998   99999999999999999999999999


Q ss_pred             ccccCCCCCceeeeccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchh
Q 009340          374 SRSIPNDKTHLTTTIQGTFGYLDPEYFQS-SQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQL  452 (537)
Q Consensus       374 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  452 (537)
                      +........ ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+.................
T Consensus       151 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  229 (309)
T cd07872         151 ARAKSVPTK-TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETW  229 (309)
T ss_pred             ceecCCCcc-ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence            976533221 1223457899999998865 56889999999999999999999999765443321111110000000000


Q ss_pred             hhh------hcHHhhc-------cccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          453 LEI------LDARVAK-------EAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       453 ~~~------~d~~~~~-------~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      ..+      .+.....       ......+.++.+++.+||+.||.+|||+.|+++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         230 PGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             hhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence            000      0000000       001123456789999999999999999999976

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=8.2e-38  Score=307.33  Aligned_cols=255  Identities=24%  Similarity=0.403  Sum_probs=193.7

Q ss_pred             cccCcCCceEEEEEEcCC---CCEEEEEEccCCC-hHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecCCCC
Q 009340          222 RFLGQGGFGTVYKGMLPD---GSIVAVKRSKEID-KTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSG  297 (537)
Q Consensus       222 ~~lg~G~~g~Vy~~~~~~---g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g  297 (537)
                      +.||+|+||.||+|.+.+   +..+|+|.++... ......|.+|+.++++++|+|++++++++.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            359999999999998643   4579999887543 334457889999999999999999999999988999999999999


Q ss_pred             ChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCcccc
Q 009340          298 TLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI  377 (537)
Q Consensus       298 sL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~  377 (537)
                      +|.+++......       ....+++..++.++.|+++||+|||+.+   ++||||||+||+++.++++||+|||+++..
T Consensus        81 ~L~~~l~~~~~~-------~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~  150 (269)
T cd05087          81 DLKGYLRSCRKA-------ELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNK  150 (269)
T ss_pred             cHHHHHHHhhhc-------ccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccc
Confidence            999999764321       0235678888999999999999999999   999999999999999999999999999765


Q ss_pred             CCCCCce-eeeccccccccCcccccCC-------CCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHHHHHh
Q 009340          378 PNDKTHL-TTTIQGTFGYLDPEYFQSS-------QFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAK  448 (537)
Q Consensus       378 ~~~~~~~-~~~~~gt~~y~aPE~~~~~-------~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~  448 (537)
                      ....... .....++..|+|||++.+.       .++.++||||||+++|||++ |+.||......+.   ...   ...
T Consensus       151 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~---~~~---~~~  224 (269)
T cd05087         151 YKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV---LTY---TVR  224 (269)
T ss_pred             cCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH---HHH---Hhh
Confidence            4332221 1234567889999998642       35789999999999999997 9999864432221   000   000


Q ss_pred             hchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHH
Q 009340          449 ENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELE  498 (537)
Q Consensus       449 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~  498 (537)
                       .......++..    .......+.+++..|| .+|++|||+.+|+..|+
T Consensus       225 -~~~~~~~~~~~----~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         225 -EQQLKLPKPRL----KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             -cccCCCCCCcc----CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence             11111111111    1123345778999999 68999999999998875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=2.5e-38  Score=316.68  Aligned_cols=257  Identities=26%  Similarity=0.498  Sum_probs=202.9

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCC----EEEEEEccCCC-hHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGS----IVAVKRSKEID-KTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVL  289 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  289 (537)
                      ++|+..+.||+|+||.||+|... +|.    .||+|.+.... .....++.+|+.+++.++|+||++++|+|... ..++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~   85 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL   85 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence            45677889999999999999863 444    57999887543 33445789999999999999999999999754 4679


Q ss_pred             EEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEe
Q 009340          290 VYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVS  369 (537)
Q Consensus       290 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~  369 (537)
                      ++||+++|+|.+++....           ..+++..++.++.|++.||.|||+.+   |+||||||+||++++++.+||+
T Consensus        86 v~e~~~~g~l~~~~~~~~-----------~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~  151 (303)
T cd05110          86 VTQLMPHGCLLDYVHEHK-----------DNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKIT  151 (303)
T ss_pred             eehhcCCCCHHHHHHhcc-----------cCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEc
Confidence            999999999999987542           25899999999999999999999998   9999999999999999999999


Q ss_pred             eccCccccCCCCCc-eeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHHHHH
Q 009340          370 DFGISRSIPNDKTH-LTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLA  447 (537)
Q Consensus       370 Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~  447 (537)
                      |||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |+.|+......+       .....
T Consensus       152 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~-------~~~~~  224 (303)
T cd05110         152 DFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE-------IPDLL  224 (303)
T ss_pred             cccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHH
Confidence            99999876433221 1223345778999999998899999999999999999998 888985432211       11111


Q ss_pred             hhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHHh
Q 009340          448 KENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRS  503 (537)
Q Consensus       448 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~  503 (537)
                      ....         ....+..+...+.+++.+||..+|++||++.++++.|+.+...
T Consensus       225 ~~~~---------~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~  271 (303)
T cd05110         225 EKGE---------RLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD  271 (303)
T ss_pred             HCCC---------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            1110         0111222345688999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.9e-39  Score=325.68  Aligned_cols=247  Identities=26%  Similarity=0.373  Sum_probs=208.1

Q ss_pred             cCCccccccCcCCceEEEEEEc-CCCCEEEEEEccCC---ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEI---DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY  291 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  291 (537)
                      .-|+..+.||.|+-|.|-.|+. .+|+.+|||.+...   .......+.+|+-+|+-+.|||+++++++.++...+|||.
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl   91 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL   91 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence            3466788899999999999995 47999999988653   2233445678999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeec
Q 009340          292 EYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF  371 (537)
Q Consensus       292 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Df  371 (537)
                      ||+++|-|.+++...            ++++..+..+++.||+.|+.|+|..+   |+||||||+|+|||.++++||+||
T Consensus        92 Eyv~gGELFdylv~k------------G~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADF  156 (786)
T KOG0588|consen   92 EYVPGGELFDYLVRK------------GPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADF  156 (786)
T ss_pred             EecCCchhHHHHHhh------------CCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeecc
Confidence            999999999999874            36999999999999999999999999   999999999999999999999999


Q ss_pred             cCccccCCCCCceeeeccccccccCcccccCCCCC-cchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhc
Q 009340          372 GISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFT-DKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKEN  450 (537)
Q Consensus       372 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t-~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  450 (537)
                      |+|.....+  ....+.+|++.|.|||++++..|. .++||||.|||||.|+||+.||+......       +......+
T Consensus       157 GMAsLe~~g--klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~-------LLlKV~~G  227 (786)
T KOG0588|consen  157 GMASLEVPG--KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRV-------LLLKVQRG  227 (786)
T ss_pred             ceeecccCC--ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHH-------HHHHHHcC
Confidence            999875443  345667899999999999999886 68999999999999999999997432211       11111111


Q ss_pred             hhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHH
Q 009340          451 QLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSME  496 (537)
Q Consensus       451 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~  496 (537)
                      .          .+.|...+.+..+|+.+|+..||+.|.|+.||++-
T Consensus       228 ~----------f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH  263 (786)
T KOG0588|consen  228 V----------FEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH  263 (786)
T ss_pred             c----------ccCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence            1          23455666788999999999999999999999874

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=3.7e-38  Score=306.93  Aligned_cols=249  Identities=26%  Similarity=0.453  Sum_probs=204.0

Q ss_pred             cCCccccccCcCCceEEEEEEcCC-CCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecC
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLPD-GSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI  294 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  294 (537)
                      ++|+..+.||+|+||.||+|...+ ++.+++|.++....  .+++.+|++++++++|+|++++++++.+....++++||+
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~   80 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC   80 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence            678889999999999999999764 78999999875432  678999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCc
Q 009340          295 SSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGIS  374 (537)
Q Consensus       295 ~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla  374 (537)
                      ++++|.+++....           ..++|..+..++.|+++||.|||+.+   ++||||+|+||++++++.++|+|||++
T Consensus        81 ~~~~L~~~l~~~~-----------~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~  146 (256)
T cd06612          81 GAGSVSDIMKITN-----------KTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVS  146 (256)
T ss_pred             CCCcHHHHHHhCc-----------cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccc
Confidence            9999999986532           36899999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchhhh
Q 009340          375 RSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLE  454 (537)
Q Consensus       375 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  454 (537)
                      ........ ......++..|+|||++.+..++.++||||||+++|||++|+.|+........      . ......    
T Consensus       147 ~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~------~-~~~~~~----  214 (256)
T cd06612         147 GQLTDTMA-KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA------I-FMIPNK----  214 (256)
T ss_pred             hhcccCcc-ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh------h-hhhccC----
Confidence            87643321 22334578899999999988999999999999999999999999864322110      0 000000    


Q ss_pred             hhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          455 ILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       455 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                       ..+  ....+......+.+++.+||+.+|++|||+.+|++
T Consensus       215 -~~~--~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         215 -PPP--TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             -CCC--CCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence             000  01112334467889999999999999999999975

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=3.4e-38  Score=317.48  Aligned_cols=240  Identities=25%  Similarity=0.391  Sum_probs=192.0

Q ss_pred             cccCcCCceEEEEEEcC-CCCEEEEEEccCCC---hHHHHHHHHHHHHHHhc-CCCCcceEeeEEeeCCccEEEEecCCC
Q 009340          222 RFLGQGGFGTVYKGMLP-DGSIVAVKRSKEID---KTQIHQFINEVVILSQI-NHRHIVKLLGCCLETEVPVLVYEYISS  296 (537)
Q Consensus       222 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~  296 (537)
                      +.||+|+||.||+|... +++.||||.++...   ......+..|..++... +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            36999999999999965 57899999887521   23345567788888765 899999999999999999999999999


Q ss_pred             CChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCccc
Q 009340          297 GTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS  376 (537)
Q Consensus       297 gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~  376 (537)
                      |+|.+++...            ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        81 g~L~~~l~~~------------~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~  145 (316)
T cd05619          81 GDLMFHIQSC------------HKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKE  145 (316)
T ss_pred             CcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceE
Confidence            9999998652            35899999999999999999999998   99999999999999999999999999875


Q ss_pred             cCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchhhhhh
Q 009340          377 IPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEIL  456 (537)
Q Consensus       377 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  456 (537)
                      ...... ......||..|+|||.+.+..++.++|||||||++|||++|+.||......+       ........      
T Consensus       146 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~-------~~~~i~~~------  211 (316)
T cd05619         146 NMLGDA-KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE-------LFQSIRMD------  211 (316)
T ss_pred             CCCCCC-ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhC------
Confidence            422211 2334568999999999999899999999999999999999999986543221       11111100      


Q ss_pred             cHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHh-hHH
Q 009340          457 DARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMK-QVS  494 (537)
Q Consensus       457 d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~-ev~  494 (537)
                      .    ...+......+.+++.+||+.||++||++. ++.
T Consensus       212 ~----~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05619         212 N----PCYPRWLTREAKDILVKLFVREPERRLGVKGDIR  246 (316)
T ss_pred             C----CCCCccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence            0    011223445678999999999999999997 553

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=3.7e-38  Score=344.32  Aligned_cols=270  Identities=23%  Similarity=0.361  Sum_probs=207.9

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCC---ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI---DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY  291 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  291 (537)
                      ++|...++||+|+||.||+|+.. +|+.||+|+++..   .....++|.+|+.++++++||||+++++++.+.+..++||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            57888999999999999999964 5899999998642   2334567999999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeec
Q 009340          292 EYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF  371 (537)
Q Consensus       292 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Df  371 (537)
                      ||+++|+|.+++........ ........+++..+++++.|+++||+|||+.+   |+||||||+|||++.++.+||+||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~-l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDF  157 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKES-LSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDW  157 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccc-cchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEec
Confidence            99999999999975322110 00011235788899999999999999999998   999999999999999999999999


Q ss_pred             cCccccCCCCC-----------------ceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchh
Q 009340          372 GISRSIPNDKT-----------------HLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVE  434 (537)
Q Consensus       372 gla~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~  434 (537)
                      |+++.......                 .......||+.|+|||.+.+..++.++|||||||++|||+||+.||......
T Consensus       158 GLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~  237 (932)
T PRK13184        158 GAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR  237 (932)
T ss_pred             CcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence            99986521110                 0112346899999999999999999999999999999999999998653221


Q ss_pred             hhccHHHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCC-CHhhHHHHHHHHHHh
Q 009340          435 EERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRP-TMKQVSMELEGLRRS  503 (537)
Q Consensus       435 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-s~~ev~~~L~~i~~~  503 (537)
                      ..          ....   ...++... ......+..+.+++.+||+.||++|| ++.++.+.|+...+.
T Consensus       238 ki----------~~~~---~i~~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~  293 (932)
T PRK13184        238 KI----------SYRD---VILSPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG  293 (932)
T ss_pred             hh----------hhhh---hccChhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence            10          0000   00011000 00123345688999999999999995 677788888876553

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.1e-39  Score=308.38  Aligned_cols=246  Identities=28%  Similarity=0.444  Sum_probs=206.7

Q ss_pred             cCCccccccCcCCceEEEEEEc-CCCCEEEEEEccC---CChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKE---IDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY  291 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  291 (537)
                      .+|++.+.||+|.||.|-++.. ..|+.||||.++.   .+++..-.+.+|++||+.++||||+.++.+|.+.+...+||
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM  132 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM  132 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence            4677788999999999999985 6799999998765   35566677889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeec
Q 009340          292 EYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF  371 (537)
Q Consensus       292 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Df  371 (537)
                      ||..+|.|.+++...            ..|++.+...++.||.+|+.|+|.++   ++|||||.+|||||+|+++||+||
T Consensus       133 EYaS~GeLYDYiSer------------~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADF  197 (668)
T KOG0611|consen  133 EYASGGELYDYISER------------GSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADF  197 (668)
T ss_pred             EecCCccHHHHHHHh------------ccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeecc
Confidence            999999999999774            46999999999999999999999999   999999999999999999999999


Q ss_pred             cCccccCCCCCceeeeccccccccCcccccCCCCC-cchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhc
Q 009340          372 GISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFT-DKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKEN  450 (537)
Q Consensus       372 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t-~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  450 (537)
                      ||+..+....  ..++.+|++-|.+||++.+..|. +.+|-||+||+||.|+.|..||+..+...       +.+     
T Consensus       198 GLSNly~~~k--fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~-------lvr-----  263 (668)
T KOG0611|consen  198 GLSNLYADKK--FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKR-------LVR-----  263 (668)
T ss_pred             chhhhhcccc--HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHH-------HHH-----
Confidence            9998764432  34678899999999999998885 78999999999999999999997643321       111     


Q ss_pred             hhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHH
Q 009340          451 QLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSME  496 (537)
Q Consensus       451 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~  496 (537)
                         ++-...++.+   ..+....-|+.+||..||++|-|+.+|..-
T Consensus       264 ---QIs~GaYrEP---~~PSdA~gLIRwmLmVNP~RRATieDiAsH  303 (668)
T KOG0611|consen  264 ---QISRGAYREP---ETPSDASGLIRWMLMVNPERRATIEDIASH  303 (668)
T ss_pred             ---HhhcccccCC---CCCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence               1111112211   122345579999999999999999999764

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=4.3e-38  Score=315.76  Aligned_cols=261  Identities=26%  Similarity=0.404  Sum_probs=202.4

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCC-ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEec
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI-DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY  293 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  293 (537)
                      ++|+..+.||+|+||.||++... ++..+|+|.++.. ......++.+|++++++++|+||+++++++.+.+..++|+||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            36888999999999999999964 6788999988653 334456788999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeecCCCCCCEEECCCCcEEEeecc
Q 009340          294 ISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHS-SASIPIFHRDIKSSNILLDDKFSAKVSDFG  372 (537)
Q Consensus       294 ~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfg  372 (537)
                      +++++|.+++...            ..+++..+..++.|+++||.|||+ .+   ++||||||+|||++.++.+||+|||
T Consensus        81 ~~~~~L~~~l~~~------------~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg  145 (308)
T cd06615          81 MDGGSLDQVLKKA------------GRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFG  145 (308)
T ss_pred             cCCCcHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCC
Confidence            9999999999653            358899999999999999999998 46   9999999999999999999999999


Q ss_pred             CccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhc--
Q 009340          373 ISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKEN--  450 (537)
Q Consensus       373 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--  450 (537)
                      ++.......   .....++..|+|||.+.+..++.++||||||+++|||++|+.||........   ...+.......  
T Consensus       146 ~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~~~  219 (308)
T cd06615         146 VSGQLIDSM---ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKEL---EAMFGRPVSEGEA  219 (308)
T ss_pred             Ccccccccc---cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhH---HHhhcCccccccc
Confidence            987653221   2334688999999999888899999999999999999999999864332111   00000000000  


Q ss_pred             ------------------hhhhhhcHHhh---cccc-HHHHHHHHHHHHHhcccCCCCCCCHhhHHHHH
Q 009340          451 ------------------QLLEILDARVA---KEAR-EEDIGAMAELAMRCLRLNSKKRPTMKQVSMEL  497 (537)
Q Consensus       451 ------------------~~~~~~d~~~~---~~~~-~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L  497 (537)
                                        ...+..+....   ...+ ......+.+++.+||+.+|++|||+.+|++..
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~  288 (308)
T cd06615         220 KESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP  288 (308)
T ss_pred             cCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence                              00000000000   0000 12445789999999999999999999997763

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=4.4e-38  Score=306.60  Aligned_cols=250  Identities=24%  Similarity=0.345  Sum_probs=203.4

Q ss_pred             CCccccccCcCCceEEEEEEcC-CCCEEEEEEccC-CChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecC
Q 009340          217 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKE-IDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI  294 (537)
Q Consensus       217 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  294 (537)
                      +|+..+.||+|+||.||++... +++.+|+|.++. ......+.+.+|+.+++.++|+|++++++++.+.+..++||||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            4677889999999999999954 688999998754 23445677889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCc
Q 009340          295 SSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGIS  374 (537)
Q Consensus       295 ~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla  374 (537)
                      ++|+|.+++....          ...+++...+.++.|+++||.|||+.+   ++|+||||+||++++++.++++|||++
T Consensus        81 ~~~~l~~~~~~~~----------~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~  147 (255)
T cd08219          81 DGGDLMQKIKLQR----------GKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSA  147 (255)
T ss_pred             CCCcHHHHHHhcc----------CCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcc
Confidence            9999999886432          235789999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchhhh
Q 009340          375 RSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLE  454 (537)
Q Consensus       375 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  454 (537)
                      ........ ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||........      ... ...+.   
T Consensus       148 ~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~------~~~-~~~~~---  216 (255)
T cd08219         148 RLLTSPGA-YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL------ILK-VCQGS---  216 (255)
T ss_pred             eeeccccc-ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH------HHH-HhcCC---
Confidence            76643322 22345688899999999988899999999999999999999999864332110      111 11111   


Q ss_pred             hhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHH
Q 009340          455 ILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSME  496 (537)
Q Consensus       455 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~  496 (537)
                            ....+...+..+.+++.+||+.||++|||+.+++..
T Consensus       217 ------~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         217 ------YKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             ------CCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence                  111223344568899999999999999999999764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=3.9e-38  Score=319.75  Aligned_cols=270  Identities=27%  Similarity=0.423  Sum_probs=209.2

Q ss_pred             cCCccccccCcCCceEEEEEEcC--------CCCEEEEEEccCC-ChHHHHHHHHHHHHHHhc-CCCCcceEeeEEeeCC
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP--------DGSIVAVKRSKEI-DKTQIHQFINEVVILSQI-NHRHIVKLLGCCLETE  285 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~--------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~  285 (537)
                      .+|...+.||+|+||.||++...        .+..||+|..+.. .....+++.+|+.+++++ +|+||++++++|...+
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   91 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence            46788899999999999999742        1236999988753 344567899999999999 7999999999999999


Q ss_pred             ccEEEEecCCCCChhhhhhhhhhhHHH----HhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEC
Q 009340          286 VPVLVYEYISSGTLSHHIHDHQQQQEQ----KQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD  361 (537)
Q Consensus       286 ~~~lV~e~~~~gsL~~~l~~~~~~~~~----~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~  361 (537)
                      ..++++||+++|+|.+++.........    ........++|..++.++.|+++||+|||+.+   ++||||||+|||++
T Consensus        92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~  168 (334)
T cd05100          92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVT  168 (334)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEc
Confidence            999999999999999999764321000    00001235899999999999999999999998   99999999999999


Q ss_pred             CCCcEEEeeccCccccCCCCCce-eeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccH
Q 009340          362 DKFSAKVSDFGISRSIPNDKTHL-TTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNL  439 (537)
Q Consensus       362 ~~~~~ki~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~  439 (537)
                      .++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||......+    
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~----  244 (334)
T cd05100         169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE----  244 (334)
T ss_pred             CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH----
Confidence            99999999999998664322211 122334568999999999999999999999999999998 888875433222    


Q ss_pred             HHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHHhh
Q 009340          440 VACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRSQ  504 (537)
Q Consensus       440 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~  504 (537)
                         +.......         ...+.+......+.+++.+||+.+|++|||+.++++.|+.+....
T Consensus       245 ---~~~~~~~~---------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~  297 (334)
T cd05100         245 ---LFKLLKEG---------HRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT  297 (334)
T ss_pred             ---HHHHHHcC---------CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence               11111111         111223344567889999999999999999999999999887543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=2.7e-38  Score=331.75  Aligned_cols=267  Identities=21%  Similarity=0.320  Sum_probs=196.6

Q ss_pred             HhcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeC--------
Q 009340          214 ATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLET--------  284 (537)
Q Consensus       214 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--------  284 (537)
                      ...+|...++||+|+||.||+|+.. +++.||||++....    ....+|+.+++.++|+||+++++++...        
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~  139 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN  139 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence            3467999999999999999999964 68899999886432    2234799999999999999999886432        


Q ss_pred             CccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCC
Q 009340          285 EVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF  364 (537)
Q Consensus       285 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~  364 (537)
                      ...++||||+++ +|.+++.....        ....+++..+..++.|+++||+|||+.+   |+||||||+|||++.++
T Consensus       140 ~~l~lvmE~~~~-~l~~~~~~~~~--------~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~  207 (440)
T PTZ00036        140 IFLNVVMEFIPQ-TVHKYMKHYAR--------NNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNT  207 (440)
T ss_pred             eEEEEEEecCCc-cHHHHHHHHhh--------cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCC
Confidence            135689999985 78777754321        1346899999999999999999999999   99999999999999664


Q ss_pred             -cEEEeeccCccccCCCCCceeeeccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHH
Q 009340          365 -SAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQS-SQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVAC  442 (537)
Q Consensus       365 -~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~  442 (537)
                       .+||+|||+++.......  .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+.   ...
T Consensus       208 ~~vkL~DFGla~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~---~~~  282 (440)
T PTZ00036        208 HTLKLCDFGSAKNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQ---LVR  282 (440)
T ss_pred             CceeeeccccchhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HHH
Confidence             799999999987643322  233467999999999865 4689999999999999999999999875433221   111


Q ss_pred             HHHHHhhch---h------------hhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH--HHHHHH
Q 009340          443 FISLAKENQ---L------------LEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM--ELEGLR  501 (537)
Q Consensus       443 ~~~~~~~~~---~------------~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~--~L~~i~  501 (537)
                      .........   +            ..+....+....+...+.++.+|+.+||+.||.+|||+.|+++  .++.++
T Consensus       283 i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~  358 (440)
T PTZ00036        283 IIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR  358 (440)
T ss_pred             HHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhh
Confidence            111110000   0            0000111111222234567899999999999999999999973  444443

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=2.9e-38  Score=311.43  Aligned_cols=262  Identities=26%  Similarity=0.438  Sum_probs=206.1

Q ss_pred             cCCccccccCcCCceEEEEEEcC------CCCEEEEEEccCCChH-HHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP------DGSIVAVKRSKEIDKT-QIHQFINEVVILSQINHRHIVKLLGCCLETEVPV  288 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  288 (537)
                      ++|.....||+|+||.||+|+..      +.+.|++|.+...... ..+++.+|+.++++++|+|++++++++.+.+..+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            56788889999999999999953      3467999988754433 5678999999999999999999999999988999


Q ss_pred             EEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEE
Q 009340          289 LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKV  368 (537)
Q Consensus       289 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki  368 (537)
                      +||||+++|+|.+++.........   .....+++..++.++.|+++||.|||+.+   |+||||||+||+++.++.+++
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~---~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l  158 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEK---LKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKV  158 (275)
T ss_pred             EEEEecCCCcHHHHHHhccccccc---ccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEE
Confidence            999999999999999764421000   00125899999999999999999999999   999999999999999999999


Q ss_pred             eeccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHHHHH
Q 009340          369 SDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLA  447 (537)
Q Consensus       369 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~  447 (537)
                      +|||++...............++..|+|||.+.+..++.++||||||+++|||++ |..||.......       +....
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~-------~~~~~  231 (275)
T cd05046         159 SLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE-------VLNRL  231 (275)
T ss_pred             cccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH-------HHHHH
Confidence            9999987654333333334456788999999988888999999999999999999 777875322211       11111


Q ss_pred             hhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHH
Q 009340          448 KENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELE  498 (537)
Q Consensus       448 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~  498 (537)
                      .....        ....+...+..+.+++.+||+.+|++|||+.+++++|+
T Consensus       232 ~~~~~--------~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         232 QAGKL--------ELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             HcCCc--------CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            11111        11112234457889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=3.5e-38  Score=309.66  Aligned_cols=253  Identities=28%  Similarity=0.474  Sum_probs=199.6

Q ss_pred             cccCcCCceEEEEEEcCC-------CCEEEEEEccCCC-hHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEec
Q 009340          222 RFLGQGGFGTVYKGMLPD-------GSIVAVKRSKEID-KTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY  293 (537)
Q Consensus       222 ~~lg~G~~g~Vy~~~~~~-------g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  293 (537)
                      +.||+|+||.||+|...+       +..+|+|.+.... .....+|.+|+.+++.++|+||+++++++...+..++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            369999999999998642       2579999876432 34567899999999999999999999999998999999999


Q ss_pred             CCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCC-----cEEE
Q 009340          294 ISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF-----SAKV  368 (537)
Q Consensus       294 ~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~-----~~ki  368 (537)
                      +++|+|.+++.......     .....++|..++.++.|+++||.|||+.+   ++|+||||+||+++.+.     .+++
T Consensus        81 ~~~~~L~~~l~~~~~~~-----~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l  152 (269)
T cd05044          81 MEGGDLLSYLRDARVER-----FGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKI  152 (269)
T ss_pred             cCCCcHHHHHHHhhhcc-----cCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEE
Confidence            99999999997643210     01235899999999999999999999998   99999999999999887     8999


Q ss_pred             eeccCccccCCCCCce-eeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHHHH
Q 009340          369 SDFGISRSIPNDKTHL-TTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISL  446 (537)
Q Consensus       369 ~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~  446 (537)
                      +|||++.......... .....++..|+|||.+.++.++.++||||||+++|||++ |+.||......+   .   . ..
T Consensus       153 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~---~---~-~~  225 (269)
T cd05044         153 GDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE---V---L-QH  225 (269)
T ss_pred             CCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH---H---H-HH
Confidence            9999997654332211 122345678999999999999999999999999999998 999986432211   0   1 11


Q ss_pred             HhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHH
Q 009340          447 AKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELE  498 (537)
Q Consensus       447 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~  498 (537)
                      ...         ......+...+..+.+++.+||+.+|++||++.+|++.|+
T Consensus       226 ~~~---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         226 VTA---------GGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             Hhc---------CCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            111         1111223344567889999999999999999999999886

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=7.9e-38  Score=307.28  Aligned_cols=254  Identities=24%  Similarity=0.408  Sum_probs=202.3

Q ss_pred             CCccccccCcCCceEEEEEEcCC--CCEEEEEEccC----------CChHHHHHHHHHHHHHHh-cCCCCcceEeeEEee
Q 009340          217 NYNQSRFLGQGGFGTVYKGMLPD--GSIVAVKRSKE----------IDKTQIHQFINEVVILSQ-INHRHIVKLLGCCLE  283 (537)
Q Consensus       217 ~~~~~~~lg~G~~g~Vy~~~~~~--g~~vavK~~~~----------~~~~~~~~~~~E~~~l~~-l~H~niv~l~g~~~~  283 (537)
                      +|+..+.||+|+||.||+|....  ++.+|+|.+..          .......++.+|+.++.+ ++|+|++++++++.+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47778899999999999999754  68899997653          223345667889988875 799999999999999


Q ss_pred             CCccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeecCCCCCCEEECC
Q 009340          284 TEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHS-SASIPIFHRDIKSSNILLDD  362 (537)
Q Consensus       284 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-~~~~~ivH~Dlk~~NIll~~  362 (537)
                      .+..++||||+++++|.+++......        ...+++..++.++.|++.||.|||+ .+   ++|+||+|+||+++.
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~--------~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~  149 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEK--------KQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGE  149 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhc--------cCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECC
Confidence            99999999999999999988643221        3468999999999999999999996 56   999999999999999


Q ss_pred             CCcEEEeeccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHH
Q 009340          363 KFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVAC  442 (537)
Q Consensus       363 ~~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~  442 (537)
                      ++.+||+|||++.......  ......++..|+|||.+.++.++.++||||||+++|||++|+.||........      
T Consensus       150 ~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~------  221 (269)
T cd08528         150 DDKVTITDFGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSL------  221 (269)
T ss_pred             CCcEEEecccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHH------
Confidence            9999999999998764432  23445688999999999998899999999999999999999999864322110      


Q ss_pred             HHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHH
Q 009340          443 FISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELE  498 (537)
Q Consensus       443 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~  498 (537)
                      .. ......        ............+.+++.+||+.||++||++.|+..+++
T Consensus       222 ~~-~~~~~~--------~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         222 AT-KIVEAV--------YEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             HH-HHhhcc--------CCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            00 011111        010011123467889999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1.8e-38  Score=312.19  Aligned_cols=253  Identities=24%  Similarity=0.426  Sum_probs=199.1

Q ss_pred             HHhcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCChHHHHHHHHHHHHHHhc-CCCCcceEeeEEeeC------
Q 009340          213 RATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKTQIHQFINEVVILSQI-NHRHIVKLLGCCLET------  284 (537)
Q Consensus       213 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~------  284 (537)
                      .+++.|+..+.||+|+||.||+|... +++.||+|.+.... .....+.+|+.++.++ +|+|++++++++...      
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            45678888999999999999999864 68899999986543 2345788999999998 799999999998753      


Q ss_pred             CccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCC
Q 009340          285 EVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF  364 (537)
Q Consensus       285 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~  364 (537)
                      ...++||||+++|+|.+++....          ...++|..+..++.|++.||+|||+.+   |+|+||+|+||++++++
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~~----------~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~  148 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNTK----------GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENA  148 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhcc----------CCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCC
Confidence            35789999999999999987532          235899999999999999999999998   99999999999999999


Q ss_pred             cEEEeeccCccccCCCCCceeeeccccccccCccccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccH
Q 009340          365 SAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQ-----SSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNL  439 (537)
Q Consensus       365 ~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~  439 (537)
                      .++|+|||++....... .......|+..|+|||++.     +..++.++|||||||++|||++|+.||........   
T Consensus       149 ~~~l~Dfg~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~---  224 (272)
T cd06637         149 EVKLVDFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA---  224 (272)
T ss_pred             CEEEccCCCceeccccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHH---
Confidence            99999999998653322 1223456889999999986     34578899999999999999999999854322110   


Q ss_pred             HHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          440 VACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       440 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                        .. .. ....     .   ........+..+.+|+.+||..+|.+|||+.++++
T Consensus       225 --~~-~~-~~~~-----~---~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         225 --LF-LI-PRNP-----A---PRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             --HH-HH-hcCC-----C---CCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence              00 00 0000     0   00111223456889999999999999999999875

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-38  Score=328.24  Aligned_cols=252  Identities=23%  Similarity=0.358  Sum_probs=196.7

Q ss_pred             cCCccccccCcCCceEEEEEEc-CCCCEEEEEEccCC---ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEI---DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY  291 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  291 (537)
                      ++|...++||+|+||.||++.. .+|+.||||.+...   .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            4688889999999999999985 47899999987642   2334567889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeec
Q 009340          292 EYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF  371 (537)
Q Consensus       292 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Df  371 (537)
                      ||+++|+|.+++...            ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+||
T Consensus        81 E~~~gg~L~~~l~~~------------~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~Df  145 (377)
T cd05629          81 EFLPGGDLMTMLIKY------------DTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDF  145 (377)
T ss_pred             eCCCCCcHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeec
Confidence            999999999998652            35889999999999999999999999   999999999999999999999999


Q ss_pred             cCccccCCCCC------------c----------------------------------eeeeccccccccCcccccCCCC
Q 009340          372 GISRSIPNDKT------------H----------------------------------LTTTIQGTFGYLDPEYFQSSQF  405 (537)
Q Consensus       372 gla~~~~~~~~------------~----------------------------------~~~~~~gt~~y~aPE~~~~~~~  405 (537)
                      |+++.......            .                                  ......||+.|+|||.+.+..+
T Consensus       146 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  225 (377)
T cd05629         146 GLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY  225 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCC
Confidence            99863311000            0                                  0012468999999999999999


Q ss_pred             CcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCC
Q 009340          406 TDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSK  485 (537)
Q Consensus       406 t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~  485 (537)
                      +.++|||||||++|||++|+.||......+.      +........       .+..+.....+..+.+++.+|++ +|.
T Consensus       226 ~~~~DiwSlGvil~elltG~~Pf~~~~~~~~------~~~i~~~~~-------~~~~p~~~~~s~~~~dli~~lL~-~~~  291 (377)
T cd05629         226 GQECDWWSLGAIMFECLIGWPPFCSENSHET------YRKIINWRE-------TLYFPDDIHLSVEAEDLIRRLIT-NAE  291 (377)
T ss_pred             CCceeeEecchhhhhhhcCCCCCCCCCHHHH------HHHHHccCC-------ccCCCCCCCCCHHHHHHHHHHhc-CHh
Confidence            9999999999999999999999965432211      111111000       00000111234567899999997 666


Q ss_pred             CC---CCHhhHHHH
Q 009340          486 KR---PTMKQVSME  496 (537)
Q Consensus       486 ~R---Ps~~ev~~~  496 (537)
                      +|   +++.+++..
T Consensus       292 ~r~~r~~~~~~l~h  305 (377)
T cd05629         292 NRLGRGGAHEIKSH  305 (377)
T ss_pred             hcCCCCCHHHHhcC
Confidence            65   588888764

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=5.9e-38  Score=310.54  Aligned_cols=249  Identities=24%  Similarity=0.357  Sum_probs=199.6

Q ss_pred             CccccccCcCCceEEEEEEcC-CCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecCCC
Q 009340          218 YNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISS  296 (537)
Q Consensus       218 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  296 (537)
                      |+..+.||+|+||.||+|... ++..+++|.+........+.+.+|+.+++.++|+|++++++++...+..++|+||+++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~   86 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   86 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence            455678999999999999965 5778999998776666778899999999999999999999999999999999999999


Q ss_pred             CChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCccc
Q 009340          297 GTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS  376 (537)
Q Consensus       297 gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~  376 (537)
                      |+|..++...           ...++|..+..++.|+++||.|||+.+   ++||||||+||+++.++.+||+|||++..
T Consensus        87 ~~l~~~~~~~-----------~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~  152 (282)
T cd06643          87 GAVDAVMLEL-----------ERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAK  152 (282)
T ss_pred             CcHHHHHHhc-----------CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccc
Confidence            9998887642           236899999999999999999999998   99999999999999999999999999876


Q ss_pred             cCCCCCceeeeccccccccCccccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhch
Q 009340          377 IPNDKTHLTTTIQGTFGYLDPEYFQ-----SSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQ  451 (537)
Q Consensus       377 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  451 (537)
                      ..... .......++..|+|||.+.     +..++.++|||||||++|||++|+.||......+.      ....... .
T Consensus       153 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~------~~~~~~~-~  224 (282)
T cd06643         153 NTRTI-QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV------LLKIAKS-E  224 (282)
T ss_pred             ccccc-cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH------HHHHhhc-C
Confidence            53221 1223346889999999984     34578899999999999999999999864322110      1111100 0


Q ss_pred             hhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          452 LLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       452 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                           .+.  ...+...+..+.+++.+||+.+|++||++.++++
T Consensus       225 -----~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  261 (282)
T cd06643         225 -----PPT--LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ  261 (282)
T ss_pred             -----CCC--CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                 000  0112234467889999999999999999998864

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=7.4e-38  Score=304.90  Aligned_cols=250  Identities=33%  Similarity=0.538  Sum_probs=203.0

Q ss_pred             ccccccCcCCceEEEEEEcCC-----CCEEEEEEccCCChH-HHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEe
Q 009340          219 NQSRFLGQGGFGTVYKGMLPD-----GSIVAVKRSKEIDKT-QIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE  292 (537)
Q Consensus       219 ~~~~~lg~G~~g~Vy~~~~~~-----g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e  292 (537)
                      ...+.||.|+||.||+++..+     +..||+|.++..... ..+.+.+|+.++..++|+|++++++++.+.+..+++||
T Consensus         2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e   81 (258)
T smart00219        2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME   81 (258)
T ss_pred             cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence            456789999999999999753     378999999765433 56789999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeecc
Q 009340          293 YISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG  372 (537)
Q Consensus       293 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfg  372 (537)
                      |+++++|.+++.....          ..+++..+..++.|++.||+|||+.+   ++|+||+|+||++++++.++|+|||
T Consensus        82 ~~~~~~l~~~~~~~~~----------~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg  148 (258)
T smart00219       82 YMEGGDLLDYLRKNRP----------KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFG  148 (258)
T ss_pred             ccCCCCHHHHHHhhhh----------ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccC
Confidence            9999999999976432          12899999999999999999999998   9999999999999999999999999


Q ss_pred             CccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHHHHHhhch
Q 009340          373 ISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQ  451 (537)
Q Consensus       373 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  451 (537)
                      ++...............++..|+|||.+.+..++.++||||+|++++||++ |+.|+.......       .........
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~-------~~~~~~~~~  221 (258)
T smart00219      149 LSRDLYDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEE-------VLEYLKKGY  221 (258)
T ss_pred             CceecccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHhcCC
Confidence            998775543333223347789999999988889999999999999999999 778875432211       111111111


Q ss_pred             hhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHH
Q 009340          452 LLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMEL  497 (537)
Q Consensus       452 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L  497 (537)
                               ....+...+..+.+++.+||..+|++|||+.++++.|
T Consensus       222 ---------~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      222 ---------RLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             ---------CCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence                     1112223456788999999999999999999998864

Phosphotransferases. Tyrosine-specific kinase subfamily.

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-38  Score=343.55  Aligned_cols=275  Identities=27%  Similarity=0.432  Sum_probs=221.3

Q ss_pred             HHHHHhcCCccccccCcCCceEEEEEEcC----C----CCEEEEEEccC-CChHHHHHHHHHHHHHHhc-CCCCcceEee
Q 009340          210 ELQRATDNYNQSRFLGQGGFGTVYKGMLP----D----GSIVAVKRSKE-IDKTQIHQFINEVVILSQI-NHRHIVKLLG  279 (537)
Q Consensus       210 el~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~----g~~vavK~~~~-~~~~~~~~~~~E~~~l~~l-~H~niv~l~g  279 (537)
                      .++...++....+.||+|.||.|++|...    .    ...||||.++. ....+.+.+..|+.+|+.+ +|+|++.++|
T Consensus       290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG  369 (609)
T KOG0200|consen  290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG  369 (609)
T ss_pred             ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence            34444555566679999999999999843    1    45799999986 3345678899999999999 6999999999


Q ss_pred             EEeeCCccEEEEecCCCCChhhhhhhhhhhHHHHhh--hcc--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCC
Q 009340          280 CCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQK--QEL--SSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKS  355 (537)
Q Consensus       280 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~--~~~--~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~  355 (537)
                      +|..++..++|+||+..|+|.++|+..+........  ...  ..++..+.+.++.|||.||+||++..   +|||||.+
T Consensus       370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAa  446 (609)
T KOG0200|consen  370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAA  446 (609)
T ss_pred             eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhh
Confidence            999988999999999999999999987610000000  001  24899999999999999999999998   99999999


Q ss_pred             CCEEECCCCcEEEeeccCccccCCCCCceeeecc--ccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccc
Q 009340          356 SNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQ--GTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFAR  432 (537)
Q Consensus       356 ~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~  432 (537)
                      +|||++++..+||+|||+++.......+......  -+..|||||.+....||.|||||||||+||||+| |..|+..-.
T Consensus       447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~  526 (609)
T KOG0200|consen  447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP  526 (609)
T ss_pred             hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence            9999999999999999999987666666544333  3567999999999999999999999999999999 888875321


Q ss_pred             hhhhccHHHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHH
Q 009340          433 VEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRR  502 (537)
Q Consensus       433 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~  502 (537)
                      ...               .+.+.+....+.+.|..+..+++++++.||+.+|++||++.++++.++.+..
T Consensus       527 ~~~---------------~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~  581 (609)
T KOG0200|consen  527 PTE---------------ELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ  581 (609)
T ss_pred             cHH---------------HHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence            111               1122333444556677888999999999999999999999999999998543

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=3.8e-38  Score=317.22  Aligned_cols=240  Identities=24%  Similarity=0.377  Sum_probs=191.9

Q ss_pred             cccCcCCceEEEEEEcC-CCCEEEEEEccCCC---hHHHHHHHHHHHHHHhc-CCCCcceEeeEEeeCCccEEEEecCCC
Q 009340          222 RFLGQGGFGTVYKGMLP-DGSIVAVKRSKEID---KTQIHQFINEVVILSQI-NHRHIVKLLGCCLETEVPVLVYEYISS  296 (537)
Q Consensus       222 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~  296 (537)
                      +.||+|+||.||++... +|+.||+|.++...   ....+.+..|..++... +|+||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999965 68899999986421   22345567788888765 899999999999999999999999999


Q ss_pred             CChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCccc
Q 009340          297 GTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS  376 (537)
Q Consensus       297 gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~  376 (537)
                      |+|.+++...            ..+++..+..++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        81 g~L~~~i~~~------------~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~  145 (316)
T cd05620          81 GDLMFHIQDK------------GRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKE  145 (316)
T ss_pred             CcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCee
Confidence            9999888652            35889999999999999999999999   99999999999999999999999999875


Q ss_pred             cCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchhhhhh
Q 009340          377 IPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEIL  456 (537)
Q Consensus       377 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  456 (537)
                      ..... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||......+       ........      
T Consensus       146 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~-------~~~~~~~~------  211 (316)
T cd05620         146 NVFGD-NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE-------LFESIRVD------  211 (316)
T ss_pred             cccCC-CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhC------
Confidence            32221 12344568999999999999999999999999999999999999996543221       11111100      


Q ss_pred             cHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHh-hHH
Q 009340          457 DARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMK-QVS  494 (537)
Q Consensus       457 d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~-ev~  494 (537)
                          ....+.....++.+++.+||+.||++||++. ++.
T Consensus       212 ----~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         212 ----TPHYPRWITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             ----CCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence                0112223445788999999999999999985 454

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-38  Score=304.21  Aligned_cols=272  Identities=24%  Similarity=0.384  Sum_probs=224.4

Q ss_pred             HHHHHHHhcCCccccccCcCCceEEEEEEcC------CCCEEEEEEccC-CChHHHHHHHHHHHHHHhcCCCCcceEeeE
Q 009340          208 ADELQRATDNYNQSRFLGQGGFGTVYKGMLP------DGSIVAVKRSKE-IDKTQIHQFINEVVILSQINHRHIVKLLGC  280 (537)
Q Consensus       208 ~~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~g~  280 (537)
                      ..++.....++....++-+|.||.||+|.|+      +.+.|-||.++. .+.-+...++.|--++..+.|||+..+.++
T Consensus       276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V  355 (563)
T KOG1024|consen  276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV  355 (563)
T ss_pred             HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence            4455556677888889999999999999764      345688898875 556678889999999999999999999999


Q ss_pred             EeeCC-ccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEE
Q 009340          281 CLETE-VPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNIL  359 (537)
Q Consensus       281 ~~~~~-~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIl  359 (537)
                      +.++. .++.+|.++.-|+|..||...+....    .....++-.+...++.|++.|++|||+++   +||.||.++|++
T Consensus       356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~----~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCv  428 (563)
T KOG1024|consen  356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDP----SYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCV  428 (563)
T ss_pred             EeeccCcceEEEeccCcchHHHHHHHhccCCC----ccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcce
Confidence            98764 67899999999999999985442111    11346888899999999999999999999   999999999999


Q ss_pred             ECCCCcEEEeeccCccccCCCCCce-eeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhc
Q 009340          360 LDDKFSAKVSDFGISRSIPNDKTHL-TTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEER  437 (537)
Q Consensus       360 l~~~~~~ki~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~  437 (537)
                      +|+..++||+|-.|++.+-..+++- ......+..||+||.+.+..|++++|||||||+||||+| |+.|+..-++.+  
T Consensus       429 Idd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE--  506 (563)
T KOG1024|consen  429 IDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE--  506 (563)
T ss_pred             ehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH--
Confidence            9999999999999999875555443 334456789999999999999999999999999999999 999976544333  


Q ss_pred             cHHHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHH
Q 009340          438 NLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRR  502 (537)
Q Consensus       438 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~  502 (537)
                                    +...+....+-..|-+|+.+++.++.-||+..|++||++.|++.-|+++..
T Consensus       507 --------------m~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~  557 (563)
T KOG1024|consen  507 --------------MEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHT  557 (563)
T ss_pred             --------------HHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHH
Confidence                          223333444555677888999999999999999999999999999987654

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.6e-38  Score=328.47  Aligned_cols=250  Identities=22%  Similarity=0.325  Sum_probs=194.6

Q ss_pred             CCccccccCcCCceEEEEEEc-CCCCEEEEEEccCC---ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEe
Q 009340          217 NYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEI---DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE  292 (537)
Q Consensus       217 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e  292 (537)
                      .|...++||+|+||.||+|+. .+++.||+|.+...   .......+.+|+.++++++|+||+++++++.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            578889999999999999995 46889999998642   23345678899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeecc
Q 009340          293 YISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG  372 (537)
Q Consensus       293 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfg  372 (537)
                      |+++|+|.+++...            ..+++.....++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        82 ~~~gg~L~~~l~~~------------~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFG  146 (382)
T cd05625          82 YIPGGDMMSLLIRM------------GIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFG  146 (382)
T ss_pred             CCCCCcHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECC
Confidence            99999999998653            35888899999999999999999999   9999999999999999999999999


Q ss_pred             CccccCCCC----------------------------------------------CceeeeccccccccCcccccCCCCC
Q 009340          373 ISRSIPNDK----------------------------------------------THLTTTIQGTFGYLDPEYFQSSQFT  406 (537)
Q Consensus       373 la~~~~~~~----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~t  406 (537)
                      ++..+....                                              ........||+.|+|||++.+..++
T Consensus       147 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~  226 (382)
T cd05625         147 LCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT  226 (382)
T ss_pred             CCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCC
Confidence            975321000                                              0001234689999999999999999


Q ss_pred             cchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCC
Q 009340          407 DKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKK  486 (537)
Q Consensus       407 ~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~  486 (537)
                      .++|||||||++|||++|+.||......+.      .......       ......+.....+.++.+++.+|+ .+|.+
T Consensus       227 ~~~DiwSlGvil~elltG~~Pf~~~~~~~~------~~~i~~~-------~~~~~~p~~~~~s~~~~~li~~l~-~~p~~  292 (382)
T cd05625         227 QLCDWWSVGVILYEMLVGQPPFLAQTPLET------QMKVINW-------QTSLHIPPQAKLSPEASDLIIKLC-RGPED  292 (382)
T ss_pred             CeeeEEechHHHHHHHhCCCCCCCCCHHHH------HHHHHcc-------CCCcCCCCcccCCHHHHHHHHHHc-cCHhH
Confidence            999999999999999999999975433211      1111000       001111111223456677777765 59999


Q ss_pred             CCC---HhhHHH
Q 009340          487 RPT---MKQVSM  495 (537)
Q Consensus       487 RPs---~~ev~~  495 (537)
                      |++   +.+++.
T Consensus       293 R~~~~~~~ei~~  304 (382)
T cd05625         293 RLGKNGADEIKA  304 (382)
T ss_pred             cCCCCCHHHHhc
Confidence            997   666653

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=2.5e-38  Score=325.27  Aligned_cols=260  Identities=22%  Similarity=0.330  Sum_probs=203.5

Q ss_pred             HHHHHHHhcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCC---ChHHHHHHHHHHHHHHhcCCCCcceEeeEEee
Q 009340          208 ADELQRATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI---DKTQIHQFINEVVILSQINHRHIVKLLGCCLE  283 (537)
Q Consensus       208 ~~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~  283 (537)
                      ..++....++|...+.||+|+||.||++... +++.||+|.+...   .......+.+|+.+++.++||||+++++++.+
T Consensus        35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~  114 (371)
T cd05622          35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  114 (371)
T ss_pred             HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence            4455556689999999999999999999965 6889999987531   22334567889999999999999999999999


Q ss_pred             CCccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCC
Q 009340          284 TEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK  363 (537)
Q Consensus       284 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~  363 (537)
                      ....++||||+++|+|.+++..             ..++...+..++.|++.||.|||+.+   |+||||||+|||++.+
T Consensus       115 ~~~~~lv~Ey~~gg~L~~~~~~-------------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~  178 (371)
T cd05622         115 DRYLYMVMEYMPGGDLVNLMSN-------------YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKS  178 (371)
T ss_pred             CCEEEEEEcCCCCCcHHHHHHh-------------cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCC
Confidence            9999999999999999998854             24788888999999999999999999   9999999999999999


Q ss_pred             CcEEEeeccCccccCCCCCceeeeccccccccCcccccCC----CCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccH
Q 009340          364 FSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSS----QFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNL  439 (537)
Q Consensus       364 ~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~  439 (537)
                      +.+||+|||++...............||+.|+|||.+.+.    .++.++|||||||++|||++|+.||.......    
T Consensus       179 ~~ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~----  254 (371)
T cd05622         179 GHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG----  254 (371)
T ss_pred             CCEEEEeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHH----
Confidence            9999999999987654433333456799999999998653    37899999999999999999999997543221    


Q ss_pred             HHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCC--CCCHhhHHHH
Q 009340          440 VACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKK--RPTMKQVSME  496 (537)
Q Consensus       440 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~--RPs~~ev~~~  496 (537)
                        .+...........       .+.....+..+.+++.+|+..++.+  ||++.++++.
T Consensus       255 --~~~~i~~~~~~~~-------~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h  304 (371)
T cd05622         255 --TYSKIMNHKNSLT-------FPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  304 (371)
T ss_pred             --HHHHHHcCCCccc-------CCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence              1111111111001       1111234566789999999844433  7788888764

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=7e-38  Score=305.57  Aligned_cols=252  Identities=32%  Similarity=0.520  Sum_probs=199.9

Q ss_pred             CccccccCcCCceEEEEEEcC-CCCEEEEEEccCCChHHH--HHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecC
Q 009340          218 YNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKTQI--HQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI  294 (537)
Q Consensus       218 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  294 (537)
                      |+..+.||+|+||+||+++.. +++.||+|.+........  ....+|+.++++++|+||+++++++.+....++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            456789999999999999965 566899999887554333  23456999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCc
Q 009340          295 SSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGIS  374 (537)
Q Consensus       295 ~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla  374 (537)
                      ++++|.+++..            ...+++..++.++.|+++||.+||+.+   ++|+||||+||++++++.++|+|||.+
T Consensus        81 ~~~~L~~~l~~------------~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~  145 (260)
T PF00069_consen   81 PGGSLQDYLQK------------NKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSS  145 (260)
T ss_dssp             TTEBHHHHHHH------------HSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTT
T ss_pred             ccccccccccc------------ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccc
Confidence            99999999973            246899999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCCceeeeccccccccCccccc-CCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchhh
Q 009340          375 RSIPNDKTHLTTTIQGTFGYLDPEYFQ-SSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLL  453 (537)
Q Consensus       375 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  453 (537)
                      .... ..........++..|+|||.+. +..++.++||||+|+++|+|++|+.|+......+...   .+.......   
T Consensus       146 ~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~---~~~~~~~~~---  218 (260)
T PF00069_consen  146 VKLS-ENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLE---IIEKILKRP---  218 (260)
T ss_dssp             EEST-STTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHH---HHHHHHHTH---
T ss_pred             cccc-ccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhh---hhhhccccc---
Confidence            7642 2222344566899999999998 7889999999999999999999999987542211111   111111100   


Q ss_pred             hhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          454 EILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       454 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                        ......  ........+.+++.+||+.||++||++.++++
T Consensus       219 --~~~~~~--~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  219 --LPSSSQ--QSREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             --HHHHTT--SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             --cccccc--ccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence              000000  00011267899999999999999999999875

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=7.8e-38  Score=305.20  Aligned_cols=238  Identities=27%  Similarity=0.479  Sum_probs=190.1

Q ss_pred             cccCcCCceEEEEEEcCCCC-----------EEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEE
Q 009340          222 RFLGQGGFGTVYKGMLPDGS-----------IVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLV  290 (537)
Q Consensus       222 ~~lg~G~~g~Vy~~~~~~g~-----------~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  290 (537)
                      +.||+|+||.||+|...+..           .|++|.+...... ...|.+|+.+++.++|+|++++++++.. ...++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            46999999999999976433           5888877654333 6788999999999999999999999988 778999


Q ss_pred             EecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCC------
Q 009340          291 YEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF------  364 (537)
Q Consensus       291 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~------  364 (537)
                      +||+++|+|.+++....           ..+++..++.++.|++.||+|||+.+   |+||||||+|||++.++      
T Consensus        79 ~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~  144 (259)
T cd05037          79 EEYVKFGPLDVFLHREK-----------NNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYV  144 (259)
T ss_pred             EEcCCCCcHHHHHHhhc-----------cCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCc
Confidence            99999999999997642           25899999999999999999999998   99999999999999888      


Q ss_pred             -cEEEeeccCccccCCCCCceeeeccccccccCcccccCC--CCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHH
Q 009340          365 -SAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSS--QFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLV  440 (537)
Q Consensus       365 -~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~  440 (537)
                       .+||+|||++.....     .....++..|+|||++...  .++.++||||||+++|||++ |..|+......+.    
T Consensus       145 ~~~kl~Dfg~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~----  215 (259)
T cd05037         145 PFIKLSDPGIPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK----  215 (259)
T ss_pred             eeEEeCCCCccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhH----
Confidence             799999999986543     1223467789999999876  78999999999999999999 5666654322111    


Q ss_pred             HHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHH
Q 009340          441 ACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELE  498 (537)
Q Consensus       441 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~  498 (537)
                         .........           .+......+.+++.+||..+|++|||+.+|++.|+
T Consensus       216 ---~~~~~~~~~-----------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         216 ---ERFYQDQHR-----------LPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             ---HHHHhcCCC-----------CCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence               000100000           01111167889999999999999999999998873

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=4.4e-38  Score=306.46  Aligned_cols=247  Identities=28%  Similarity=0.463  Sum_probs=199.5

Q ss_pred             cCCccccccCcCCceEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecCC
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYIS  295 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  295 (537)
                      ++|...+.||+|+||.||++.. +++.||+|..+...  ..+.+.+|+.++++++|+|++++++++... ..++||||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~   81 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS   81 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence            4577889999999999999986 67889999987532  346788999999999999999999998754 4799999999


Q ss_pred             CCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCcc
Q 009340          296 SGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISR  375 (537)
Q Consensus       296 ~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~  375 (537)
                      +|+|.+++....          ...+++..++.++.|+++||.|||+.+   ++||||||+||+++.++.+||+|||++.
T Consensus        82 ~~~L~~~l~~~~----------~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~  148 (254)
T cd05083          82 KGNLVNFLRTRG----------RALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLAR  148 (254)
T ss_pred             CCCHHHHHHhcC----------cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccce
Confidence            999999997532          235899999999999999999999998   9999999999999999999999999987


Q ss_pred             ccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHHHHHhhchhhh
Q 009340          376 SIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQLLE  454 (537)
Q Consensus       376 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  454 (537)
                      ......    .....+..|+|||.+.++.++.++|+||||+++|||++ |+.||......+       .......     
T Consensus       149 ~~~~~~----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~-----  212 (254)
T cd05083         149 VGSMGV----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE-------VKECVEK-----  212 (254)
T ss_pred             eccccC----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH-------HHHHHhC-----
Confidence            643221    12234568999999998899999999999999999998 898886443221       1111111     


Q ss_pred             hhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHH
Q 009340          455 ILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEG  499 (537)
Q Consensus       455 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  499 (537)
                          ....+.+...+..+.+++.+||+.+|++||++.++++.|+.
T Consensus       213 ----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         213 ----GYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             ----CCCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence                11111223345678899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.2e-38  Score=328.73  Aligned_cols=251  Identities=22%  Similarity=0.339  Sum_probs=196.2

Q ss_pred             CCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCC---hHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEe
Q 009340          217 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEID---KTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE  292 (537)
Q Consensus       217 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e  292 (537)
                      +|+..+.||+|+||.||+++.. +++.||||.+....   ......+.+|+.++++++|+||+++++.+.+.+..++|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E   81 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence            6888999999999999999954 68899999986421   2334568899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeecc
Q 009340          293 YISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG  372 (537)
Q Consensus       293 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfg  372 (537)
                      |+++|+|.+++...            ..+++.....++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        82 ~~~~g~L~~~i~~~------------~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG  146 (376)
T cd05598          82 YIPGGDMMSLLIRL------------GIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFG  146 (376)
T ss_pred             CCCCCcHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCC
Confidence            99999999999652            35888889999999999999999999   9999999999999999999999999


Q ss_pred             CccccCCCC------------------------------------------CceeeeccccccccCcccccCCCCCcchh
Q 009340          373 ISRSIPNDK------------------------------------------THLTTTIQGTFGYLDPEYFQSSQFTDKSD  410 (537)
Q Consensus       373 la~~~~~~~------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~t~ksD  410 (537)
                      ++..+....                                          ........||+.|+|||++.+..++.++|
T Consensus       147 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D  226 (376)
T cd05598         147 LCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCD  226 (376)
T ss_pred             CCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCccee
Confidence            975331000                                          00012346899999999999999999999


Q ss_pred             HHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCC--
Q 009340          411 VYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRP--  488 (537)
Q Consensus       411 V~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP--  488 (537)
                      ||||||++|||++|+.||......+.      .......       ......+.....+..+.+++.+|+ .+|.+|+  
T Consensus       227 iwSlGvilyell~G~~Pf~~~~~~~~------~~~i~~~-------~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~  292 (376)
T cd05598         227 WWSVGVILYEMLVGQPPFLADTPAET------QLKVINW-------ETTLHIPSQAKLSREASDLILRLC-CGAEDRLGK  292 (376)
T ss_pred             eeeccceeeehhhCCCCCCCCCHHHH------HHHHhcc-------CccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCC
Confidence            99999999999999999975443221      0000000       000111111223456677888876 5999999  


Q ss_pred             -CHhhHHHH
Q 009340          489 -TMKQVSME  496 (537)
Q Consensus       489 -s~~ev~~~  496 (537)
                       ++.++++.
T Consensus       293 ~t~~ell~h  301 (376)
T cd05598         293 NGADEIKAH  301 (376)
T ss_pred             CCHHHHhCC
Confidence             78888654

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=3.2e-38  Score=318.86  Aligned_cols=238  Identities=26%  Similarity=0.400  Sum_probs=189.7

Q ss_pred             cccCcCCceEEEEEEcC-CCCEEEEEEccCC---ChHHHHHHHHHHH-HHHhcCCCCcceEeeEEeeCCccEEEEecCCC
Q 009340          222 RFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI---DKTQIHQFINEVV-ILSQINHRHIVKLLGCCLETEVPVLVYEYISS  296 (537)
Q Consensus       222 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  296 (537)
                      +.||+|+||.||+++.. +|+.||+|.+...   ......++..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            36999999999999964 6899999998642   1223345555554 56789999999999999999999999999999


Q ss_pred             CChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCccc
Q 009340          297 GTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS  376 (537)
Q Consensus       297 gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~  376 (537)
                      |+|.+++...            ..+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        81 g~L~~~l~~~------------~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~  145 (323)
T cd05575          81 GELFFHLQRE------------RSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKE  145 (323)
T ss_pred             CCHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcc
Confidence            9999888652            35889999999999999999999999   99999999999999999999999999875


Q ss_pred             cCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchhhhhh
Q 009340          377 IPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEIL  456 (537)
Q Consensus       377 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  456 (537)
                      ..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+      .+..... .      
T Consensus       146 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~------~~~~i~~-~------  211 (323)
T cd05575         146 GIEHS-KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE------MYDNILN-K------  211 (323)
T ss_pred             cccCC-CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHH------HHHHHHc-C------
Confidence            42221 22334568999999999999999999999999999999999999986543221      1111111 0      


Q ss_pred             cHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhh
Q 009340          457 DARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQ  492 (537)
Q Consensus       457 d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  492 (537)
                        ..  ..+...+..+.+++.+||+.||++||++.+
T Consensus       212 --~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~  243 (323)
T cd05575         212 --PL--RLKPNISVSARHLLEGLLQKDRTKRLGAKD  243 (323)
T ss_pred             --CC--CCCCCCCHHHHHHHHHHhhcCHHhCCCCCC
Confidence              00  112223567889999999999999999863

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=6.1e-38  Score=310.65  Aligned_cols=263  Identities=23%  Similarity=0.329  Sum_probs=197.9

Q ss_pred             CCccccccCcCCceEEEEEEcC-CCCEEEEEEccCC--ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEec
Q 009340          217 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI--DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY  293 (537)
Q Consensus       217 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  293 (537)
                      +|+..+.||+|++|.||+|+.. +++.||+|.++..  .......+.+|+.++++++|+|++++++++.+.+..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            4677889999999999999964 6899999987643  222346788999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccC
Q 009340          294 ISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGI  373 (537)
Q Consensus       294 ~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgl  373 (537)
                      ++ ++|.+++.....         ...+++..++.++.|+++||.|||+.+   ++||||+|+||+++.++.+||+|||+
T Consensus        81 ~~-~~l~~~~~~~~~---------~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~  147 (285)
T cd07861          81 LS-MDLKKYLDSLPK---------GQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGL  147 (285)
T ss_pred             CC-CCHHHHHhcCCC---------CCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccc
Confidence            97 689888865322         246899999999999999999999998   99999999999999999999999999


Q ss_pred             ccccCCCCCceeeeccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHH------
Q 009340          374 SRSIPNDKTHLTTTIQGTFGYLDPEYFQSS-QFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISL------  446 (537)
Q Consensus       374 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~------  446 (537)
                      +....... .......+++.|+|||.+.+. .++.++||||||+++|||++|+.||......+.  ....+...      
T Consensus       148 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~--~~~~~~~~~~~~~~  224 (285)
T cd07861         148 ARAFGIPV-RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQ--LFRIFRILGTPTED  224 (285)
T ss_pred             eeecCCCc-ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHHhCCCChh
Confidence            97653322 112234568899999988654 578999999999999999999999865432211  00000000      


Q ss_pred             -Hhh----chhhhhhcH---HhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          447 -AKE----NQLLEILDA---RVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       447 -~~~----~~~~~~~d~---~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                       +..    .........   ..........+.++.+++.+||+.||++|||+.+|++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         225 VWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             hhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence             000    000000000   0000111123567789999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=6.7e-38  Score=312.52  Aligned_cols=249  Identities=25%  Similarity=0.454  Sum_probs=203.9

Q ss_pred             cCCccccccCcCCceEEEEEEc-CCCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecC
Q 009340          216 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI  294 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  294 (537)
                      .+|...+.||.|+||.||+|+. .+|+.||+|.+........+.+.+|+.+++.++|+|++++++++...+..++|+||+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            4688889999999999999984 478999999887655555677899999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCc
Q 009340          295 SSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGIS  374 (537)
Q Consensus       295 ~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla  374 (537)
                      ++++|.+++..             ..+++.++..++.+++.||+|||+.+   ++||||||+||+++.++.+||+|||++
T Consensus        99 ~~~~L~~~~~~-------------~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~  162 (296)
T cd06655          99 AGGSLTDVVTE-------------TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFC  162 (296)
T ss_pred             CCCcHHHHHHh-------------cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccc
Confidence            99999998853             25899999999999999999999999   999999999999999999999999998


Q ss_pred             cccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchhhh
Q 009340          375 RSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLE  454 (537)
Q Consensus       375 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  454 (537)
                      ......... .....++..|+|||.+.+..++.++|||||||++|+|++|+.||........      ........ .  
T Consensus       163 ~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~------~~~~~~~~-~--  232 (296)
T cd06655         163 AQITPEQSK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA------LYLIATNG-T--  232 (296)
T ss_pred             hhccccccc-CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhcC-C--
Confidence            865433221 2334688899999999988899999999999999999999999865433211      00000000 0  


Q ss_pred             hhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          455 ILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       455 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                         +.  ...+......+.+++.+||+.+|++||++.++++
T Consensus       233 ---~~--~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         233 ---PE--LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             ---cc--cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence               00  0112334457889999999999999999999863

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.3e-38  Score=309.36  Aligned_cols=240  Identities=22%  Similarity=0.436  Sum_probs=191.2

Q ss_pred             cccCcCCceEEEEEEcCC--------CCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEec
Q 009340          222 RFLGQGGFGTVYKGMLPD--------GSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY  293 (537)
Q Consensus       222 ~~lg~G~~g~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  293 (537)
                      +.||+|+||.||+|....        ...||+|.+........+.+.+|+.+++.++|+|++++++++......++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            469999999999998532        234888988765556667899999999999999999999999998899999999


Q ss_pred             CCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCc--------
Q 009340          294 ISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFS--------  365 (537)
Q Consensus       294 ~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~--------  365 (537)
                      +++|+|.+++....           ..++|..++.++.|++.||+|||+.+   |+||||||+||+++.++.        
T Consensus        81 ~~~g~L~~~l~~~~-----------~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~  146 (258)
T cd05078          81 VKFGSLDTYLKKNK-----------NLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPF  146 (258)
T ss_pred             CCCCcHHHHHhcCC-----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCce
Confidence            99999999997542           25899999999999999999999999   999999999999987765        


Q ss_pred             EEEeeccCccccCCCCCceeeeccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCC-CCCCccchhhhccHHHHH
Q 009340          366 AKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSS-QFTDKSDVYSFGVVLLELLTGK-KPICFARVEEERNLVACF  443 (537)
Q Consensus       366 ~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvll~el~tg~-~p~~~~~~~~~~~~~~~~  443 (537)
                      ++++|||++......     ....++..|+|||.+.+. .++.++||||||+++|||++|. .|+........       
T Consensus       147 ~~l~d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~-------  214 (258)
T cd05078         147 IKLSDPGISITVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK-------  214 (258)
T ss_pred             EEecccccccccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH-------
Confidence            699999988654321     234578899999999864 5789999999999999999985 44432221110       


Q ss_pred             HHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHH
Q 009340          444 ISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELE  498 (537)
Q Consensus       444 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~  498 (537)
                      .....         .  ....+.....++.+++.+||+.+|++|||+.++++.|+
T Consensus       215 ~~~~~---------~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         215 LQFYE---------D--RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             HHHHH---------c--cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            00000         0  01122223356889999999999999999999998873

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=6.7e-38  Score=316.39  Aligned_cols=242  Identities=24%  Similarity=0.366  Sum_probs=195.0

Q ss_pred             CCccccccCcCCceEEEEEEcC-CCCEEEEEEccCC---ChHHHHHHHHHHHHHHhcC-CCCcceEeeEEeeCCccEEEE
Q 009340          217 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI---DKTQIHQFINEVVILSQIN-HRHIVKLLGCCLETEVPVLVY  291 (537)
Q Consensus       217 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~  291 (537)
                      +|+..+.||+|+||.||++... +|+.||+|.++..   .....+.+..|..++..+. |++|+++.+++.+.+..++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            4677889999999999999854 6889999988642   2234456788999998885 578888999999989999999


Q ss_pred             ecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeec
Q 009340          292 EYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF  371 (537)
Q Consensus       292 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Df  371 (537)
                      ||+++|+|.+++...            ..+++.+++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+||
T Consensus        81 Ey~~~g~L~~~i~~~------------~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Df  145 (323)
T cd05615          81 EYVNGGDLMYHIQQV------------GKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADF  145 (323)
T ss_pred             cCCCCCcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEecc
Confidence            999999999988652            35899999999999999999999999   999999999999999999999999


Q ss_pred             cCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhch
Q 009340          372 GISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQ  451 (537)
Q Consensus       372 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  451 (537)
                      |+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......   .   ......   
T Consensus       146 g~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~---~---~~~i~~---  215 (323)
T cd05615         146 GMCKEHMVDGV-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE---L---FQSIME---  215 (323)
T ss_pred             ccccccCCCCc-cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH---H---HHHHHh---
Confidence            99875432221 2234568999999999999899999999999999999999999986543221   0   111111   


Q ss_pred             hhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHh
Q 009340          452 LLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMK  491 (537)
Q Consensus       452 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~  491 (537)
                            ..  ...+...+..+.+++.+||+.+|.+|++..
T Consensus       216 ------~~--~~~p~~~~~~~~~li~~~l~~~p~~R~~~~  247 (323)
T cd05615         216 ------HN--VSYPKSLSKEAVSICKGLMTKHPSKRLGCG  247 (323)
T ss_pred             ------CC--CCCCccCCHHHHHHHHHHcccCHhhCCCCC
Confidence                  00  112333456788999999999999999864

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=1e-37  Score=309.46  Aligned_cols=246  Identities=25%  Similarity=0.378  Sum_probs=196.3

Q ss_pred             CccccccCcCCceEEEEEEcC-CCCEEEEEEccCCC---hHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEec
Q 009340          218 YNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEID---KTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY  293 (537)
Q Consensus       218 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  293 (537)
                      |...+.||+|+||+||++... +++.||+|.+....   ......+.+|+.++++++|+|++++.+++...+..++||||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            566788999999999999864 68899999886432   22344578899999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccC
Q 009340          294 ISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGI  373 (537)
Q Consensus       294 ~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgl  373 (537)
                      +++++|.+++....          ...+++..+..++.|++.||.|||+.+   |+||||||+||++++++.+||+|||+
T Consensus        82 ~~~~~L~~~~~~~~----------~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~  148 (285)
T cd05632          82 MNGGDLKFHIYNMG----------NPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGL  148 (285)
T ss_pred             ccCccHHHHHHHhc----------CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCc
Confidence            99999998886532          235999999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchhh
Q 009340          374 SRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLL  453 (537)
Q Consensus       374 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  453 (537)
                      +........  .....|+..|+|||.+.+..++.++|+||||+++|||++|+.||..........   .........   
T Consensus       149 ~~~~~~~~~--~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~---~~~~~~~~~---  220 (285)
T cd05632         149 AVKIPEGES--IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKRE---EVDRRVLET---  220 (285)
T ss_pred             ceecCCCCc--ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHhhhcc---
Confidence            976543221  234568999999999998899999999999999999999999986543221100   000000000   


Q ss_pred             hhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHh
Q 009340          454 EILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMK  491 (537)
Q Consensus       454 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~  491 (537)
                             ....+......+.+|+..||+.||++||++.
T Consensus       221 -------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~  251 (285)
T cd05632         221 -------EEVYSAKFSEEAKSICKMLLTKDPKQRLGCQ  251 (285)
T ss_pred             -------ccccCccCCHHHHHHHHHHccCCHhHcCCCc
Confidence                   0112233445678999999999999999943

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=8.2e-38  Score=310.17  Aligned_cols=250  Identities=28%  Similarity=0.414  Sum_probs=199.4

Q ss_pred             CccccccCcCCceEEEEEEcC-CCCEEEEEEccCCC---hHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEec
Q 009340          218 YNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEID---KTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY  293 (537)
Q Consensus       218 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  293 (537)
                      |+..+.||+|+||.||++... +++.||+|.+....   ......+.+|+.++++++|+|++++.+.+.+.+..++||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            667788999999999999964 68899999876421   22345678899999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccC
Q 009340          294 ISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGI  373 (537)
Q Consensus       294 ~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgl  373 (537)
                      +++|+|.+++....          ...+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.++|+|||+
T Consensus        82 ~~g~~L~~~l~~~~----------~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~  148 (285)
T cd05630          82 MNGGDLKFHIYHMG----------EAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGL  148 (285)
T ss_pred             cCCCcHHHHHHHhc----------ccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccc
Confidence            99999999886432          235899999999999999999999998   99999999999999999999999999


Q ss_pred             ccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchhh
Q 009340          374 SRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLL  453 (537)
Q Consensus       374 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  453 (537)
                      +........  .....|+..|+|||.+.+..++.++||||||+++|||++|+.||..........   .......     
T Consensus       149 ~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~---~~~~~~~-----  218 (285)
T cd05630         149 AVHVPEGQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE---EVERLVK-----  218 (285)
T ss_pred             eeecCCCcc--ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHH---HHHhhhh-----
Confidence            876543322  223468999999999999999999999999999999999999986532211000   0000000     


Q ss_pred             hhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCC-----HhhHHH
Q 009340          454 EILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPT-----MKQVSM  495 (537)
Q Consensus       454 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~ev~~  495 (537)
                           ......+......+.+|+.+||+.||++|||     +.|+++
T Consensus       219 -----~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         219 -----EVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             -----hhhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence                 0011122334456889999999999999999     777765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1.8e-37  Score=304.90  Aligned_cols=254  Identities=24%  Similarity=0.381  Sum_probs=191.4

Q ss_pred             ccCcCCceEEEEEEcCC---CCEEEEEEccCC-ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecCCCCC
Q 009340          223 FLGQGGFGTVYKGMLPD---GSIVAVKRSKEI-DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGT  298 (537)
Q Consensus       223 ~lg~G~~g~Vy~~~~~~---g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs  298 (537)
                      .||+|+||.||+|...+   ...+|+|.+... .......|.+|+.+++.++|+||+++++++.+....++||||+++|+
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD   81 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence            59999999999997543   357899987643 33445678999999999999999999999999999999999999999


Q ss_pred             hhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCccccC
Q 009340          299 LSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIP  378 (537)
Q Consensus       299 L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~  378 (537)
                      |.+++.......       ....++...+.++.|++.||+|||+.+   |+||||||+|||+++++++||+|||++....
T Consensus        82 L~~~l~~~~~~~-------~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~  151 (269)
T cd05042          82 LKNYLRSNRGMV-------AQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQY  151 (269)
T ss_pred             HHHHHHhccccc-------cccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccc
Confidence            999997653210       123578888999999999999999998   9999999999999999999999999987543


Q ss_pred             CCCCce-eeeccccccccCcccccC-------CCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHHHHHhh
Q 009340          379 NDKTHL-TTTIQGTFGYLDPEYFQS-------SQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKE  449 (537)
Q Consensus       379 ~~~~~~-~~~~~gt~~y~aPE~~~~-------~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  449 (537)
                      ...... .....++..|+|||++..       ..++.++||||||+++|||++ |..||......+   .   .......
T Consensus       152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~---~---~~~~~~~  225 (269)
T cd05042         152 PEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ---V---LKQVVRE  225 (269)
T ss_pred             cchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH---H---HHHHhhc
Confidence            332211 223345778999998743       356789999999999999999 777775432211   0   1111111


Q ss_pred             chhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHH
Q 009340          450 NQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELE  498 (537)
Q Consensus       450 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~  498 (537)
                      . ......+.    .+......+.+++..|| .||++|||+++|++.|.
T Consensus       226 ~-~~~~~~~~----~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         226 Q-DIKLPKPQ----LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             c-CccCCCCc----ccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            1 01111111    12234456778889998 59999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-37  Score=303.35  Aligned_cols=254  Identities=25%  Similarity=0.400  Sum_probs=205.9

Q ss_pred             hcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEec
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY  293 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  293 (537)
                      .++|+..+.||+|+||.||++... +++.+++|.+........+.+.+|+.++++++|+|++++++++.+....+++|||
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~   81 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY   81 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence            367888999999999999999964 5788999998866555678899999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccC
Q 009340          294 ISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGI  373 (537)
Q Consensus       294 ~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgl  373 (537)
                      +++++|.+++....           ..+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||+
T Consensus        82 ~~~~~l~~~~~~~~-----------~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~  147 (262)
T cd06613          82 CGGGSLQDIYQVTR-----------GPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGV  147 (262)
T ss_pred             CCCCcHHHHHHhhc-----------cCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECcccc
Confidence            99999999886532           36899999999999999999999998   99999999999999999999999999


Q ss_pred             ccccCCCCCceeeeccccccccCcccccCC---CCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhc
Q 009340          374 SRSIPNDKTHLTTTIQGTFGYLDPEYFQSS---QFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKEN  450 (537)
Q Consensus       374 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  450 (537)
                      +........ ......++..|+|||.+.+.   .++.++||||||+++|||++|+.|+.........      .. ....
T Consensus       148 ~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~------~~-~~~~  219 (262)
T cd06613         148 SAQLTATIA-KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRAL------FL-ISKS  219 (262)
T ss_pred             chhhhhhhh-ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH------HH-HHhc
Confidence            876543221 22344678899999999776   8899999999999999999999998654322110      00 0000


Q ss_pred             hhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          451 QLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       451 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      ..   .....  ......+..+.+++.+||+.+|.+|||+.+|+.
T Consensus       220 ~~---~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         220 NF---PPPKL--KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             cC---CCccc--cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            00   00000  112344567899999999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=1.7e-37  Score=308.94  Aligned_cols=251  Identities=24%  Similarity=0.362  Sum_probs=202.4

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecC
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI  294 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  294 (537)
                      +.|+..++||+|+||.||+|... +++.|++|.+........+.+.+|+.+++.++|+|++++++++...+..++||||+
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   91 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC   91 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence            56778889999999999999965 58899999998777777788999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCc
Q 009340          295 SSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGIS  374 (537)
Q Consensus       295 ~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla  374 (537)
                      ++++|..++....           ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++
T Consensus        92 ~~~~l~~~~~~~~-----------~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~  157 (292)
T cd06644          92 PGGAVDAIMLELD-----------RGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVS  157 (292)
T ss_pred             CCCcHHHHHHhhc-----------CCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccc
Confidence            9999988876432           35899999999999999999999998   999999999999999999999999998


Q ss_pred             cccCCCCCceeeeccccccccCccccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhh
Q 009340          375 RSIPNDKTHLTTTIQGTFGYLDPEYFQ-----SSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKE  449 (537)
Q Consensus       375 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  449 (537)
                      ....... .......++..|+|||++.     ...++.++|||||||++|||++|+.|+.......      .+......
T Consensus       158 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~------~~~~~~~~  230 (292)
T cd06644         158 AKNVKTL-QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR------VLLKIAKS  230 (292)
T ss_pred             eeccccc-cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH------HHHHHhcC
Confidence            7543221 1123445788999999984     3457889999999999999999999986432211      11111110


Q ss_pred             chhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          450 NQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       450 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                       .     .+.  ...+...+..+.+++.+||+.+|++||++.++++
T Consensus       231 -~-----~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         231 -E-----PPT--LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             -C-----Ccc--CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence             0     000  0112234456889999999999999999999965

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=5.9e-38  Score=309.73  Aligned_cols=247  Identities=25%  Similarity=0.421  Sum_probs=200.5

Q ss_pred             CCccccccCcCCceEEEEEEcC-CCCEEEEEEccCC-ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecC
Q 009340          217 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI-DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI  294 (537)
Q Consensus       217 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  294 (537)
                      .|+..+.||+|+||.||+|... +++.||+|.++.. .....+.+.+|+.++++++|+||+++++++......++|+||+
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence            3555678999999999999854 5789999988643 2445667899999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCc
Q 009340          295 SSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGIS  374 (537)
Q Consensus       295 ~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla  374 (537)
                      ++++|.+++..             ..+++..+..++.|+++|+.|||+.+   ++|+||+|+||++++++.++++|||++
T Consensus        85 ~~~~L~~~~~~-------------~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~  148 (277)
T cd06642          85 GGGSALDLLKP-------------GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVA  148 (277)
T ss_pred             CCCcHHHHhhc-------------CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEcccccc
Confidence            99999998853             25889999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchhhh
Q 009340          375 RSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLE  454 (537)
Q Consensus       375 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  454 (537)
                      ........ ......++..|+|||++.+..++.++||||||+++|||++|+.|+........      .. .        
T Consensus       149 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~------~~-~--------  212 (277)
T cd06642         149 GQLTDTQI-KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV------LF-L--------  212 (277)
T ss_pred             ccccCcch-hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH------Hh-h--------
Confidence            76643221 12234578899999999998999999999999999999999999753321110      00 0        


Q ss_pred             hhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHH
Q 009340          455 ILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSME  496 (537)
Q Consensus       455 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~  496 (537)
                       +............+..+.+++.+||+.+|++||+|.++++.
T Consensus       213 -~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         213 -IPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             -hhcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence             00011111222345678899999999999999999999884

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=7.8e-38  Score=312.18  Aligned_cols=249  Identities=26%  Similarity=0.438  Sum_probs=204.0

Q ss_pred             cCCccccccCcCCceEEEEEEc-CCCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecC
Q 009340          216 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI  294 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  294 (537)
                      .+|...+.||+|+||.||++.. .+++.||+|.+........+.+.+|+.+++.++|+|++++++++...+..++||||+
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~   98 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   98 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence            6788889999999999999995 478999999987655555677889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCc
Q 009340          295 SSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGIS  374 (537)
Q Consensus       295 ~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla  374 (537)
                      ++++|.+++..             ..+++.++..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++
T Consensus        99 ~~~~L~~~~~~-------------~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~  162 (297)
T cd06656          99 AGGSLTDVVTE-------------TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFC  162 (297)
T ss_pred             CCCCHHHHHHh-------------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccc
Confidence            99999998853             25889999999999999999999998   999999999999999999999999998


Q ss_pred             cccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchhhh
Q 009340          375 RSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLE  454 (537)
Q Consensus       375 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  454 (537)
                      ......... .....+++.|+|||.+.+..++.++||||||+++|+|++|+.||..........      .....+    
T Consensus       163 ~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~------~~~~~~----  231 (297)
T cd06656         163 AQITPEQSK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------LIATNG----  231 (297)
T ss_pred             eEccCCccC-cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee------eeccCC----
Confidence            765433221 233457889999999999889999999999999999999999986433211100      000000    


Q ss_pred             hhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          455 ILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       455 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                          ......+......+.+++.+||+.+|++||++.++++
T Consensus       232 ----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         232 ----TPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             ----CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                0000112334456789999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=8.3e-38  Score=309.85  Aligned_cols=256  Identities=25%  Similarity=0.411  Sum_probs=203.6

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCC-hHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEec
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEID-KTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY  293 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  293 (537)
                      ++|+..+.||+|+||+||++... +|+.||+|.+.... ....+.+.+|+++++.++|+||+++++++......++||||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            46777889999999999999964 68899999876432 34467889999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeecCCCCCCEEECCCCcEEEeecc
Q 009340          294 ISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHS-SASIPIFHRDIKSSNILLDDKFSAKVSDFG  372 (537)
Q Consensus       294 ~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfg  372 (537)
                      +++|+|.+++...            ..+++..+..++.+++.||.|||+ .+   ++||||+|+||++++++.++|+|||
T Consensus        85 ~~~~~L~~~~~~~------------~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~g  149 (284)
T cd06620          85 MDCGSLDRIYKKG------------GPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFG  149 (284)
T ss_pred             CCCCCHHHHHHhc------------cCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCC
Confidence            9999999988652            358999999999999999999997 46   9999999999999999999999999


Q ss_pred             CccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhh-----ccHHHHHHHHH
Q 009340          373 ISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEE-----RNLVACFISLA  447 (537)
Q Consensus       373 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~-----~~~~~~~~~~~  447 (537)
                      ++.......   .....|+..|+|||.+.+..++.++|||||||++|||++|+.||......+.     ......+....
T Consensus       150 l~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  226 (284)
T cd06620         150 VSGELINSI---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIV  226 (284)
T ss_pred             cccchhhhc---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHh
Confidence            987543221   2234689999999999888999999999999999999999999875433211     00111111111


Q ss_pred             hhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHH
Q 009340          448 KENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELE  498 (537)
Q Consensus       448 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~  498 (537)
                      .         ...........+..+.+++.+||+.||++|||+.|++++.-
T Consensus       227 ~---------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~  268 (284)
T cd06620         227 Q---------EPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPP  268 (284)
T ss_pred             h---------ccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence            0         00000011224567889999999999999999999998643

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1.3e-37  Score=305.16  Aligned_cols=250  Identities=25%  Similarity=0.476  Sum_probs=200.8

Q ss_pred             CCccccccCcCCceEEEEEEcCCCCEEEEEEccCCC------hHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEE
Q 009340          217 NYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEID------KTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLV  290 (537)
Q Consensus       217 ~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  290 (537)
                      +|...+.||+|+||.||+|...+|+.+|+|.++...      ......+.+|+.++++++|+||+++.+++.+.+..++|
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            466788999999999999998889999999876421      22345688999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEee
Q 009340          291 YEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSD  370 (537)
Q Consensus       291 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~D  370 (537)
                      +||+++++|.+++...            ..+++..+..++.|++.||+|||+.+   ++|+||+|+||++++++.++|+|
T Consensus        81 ~e~~~~~~L~~~l~~~------------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~d  145 (265)
T cd06631          81 MEFVPGGSISSILNRF------------GPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLID  145 (265)
T ss_pred             EecCCCCcHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEecc
Confidence            9999999999999652            35889999999999999999999998   99999999999999999999999


Q ss_pred             ccCccccCCCC-----CceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHH
Q 009340          371 FGISRSIPNDK-----THLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFIS  445 (537)
Q Consensus       371 fgla~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~  445 (537)
                      ||++.......     ........++..|+|||.+.+..++.++||||||+++|||++|+.||........      ...
T Consensus       146 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~------~~~  219 (265)
T cd06631         146 FGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA------MFY  219 (265)
T ss_pred             chhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH------HHH
Confidence            99987653211     1112234588999999999988899999999999999999999999864322110      000


Q ss_pred             HHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          446 LAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       446 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      .....        ......+......+.+++.+||+.+|++||++.++++
T Consensus       220 ~~~~~--------~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         220 IGAHR--------GLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             hhhcc--------CCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            00000        0011123334567889999999999999999999864

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1.3e-37  Score=303.31  Aligned_cols=250  Identities=28%  Similarity=0.412  Sum_probs=204.5

Q ss_pred             CCccccccCcCCceEEEEEEc-CCCCEEEEEEccCC--ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEec
Q 009340          217 NYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEI--DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY  293 (537)
Q Consensus       217 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  293 (537)
                      +|+..+.||+|+||.||.++. .+++.+++|.+...  ......++.+|+.++++++|+|++++++++.+.+..+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            477889999999999998884 46889999987642  345567889999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccC
Q 009340          294 ISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGI  373 (537)
Q Consensus       294 ~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgl  373 (537)
                      +++|+|.+++....          ...+++..+..++.|+++||.|||+.+   ++|+||+|+||++++++.+||+|||+
T Consensus        81 ~~~~~L~~~~~~~~----------~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~  147 (256)
T cd08221          81 ANGGTLYDKIVRQK----------GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGI  147 (256)
T ss_pred             cCCCcHHHHHHhcc----------ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcc
Confidence            99999999987532          135899999999999999999999998   99999999999999999999999999


Q ss_pred             ccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchhh
Q 009340          374 SRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLL  453 (537)
Q Consensus       374 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  453 (537)
                      +........ ......+++.|+|||.+.+..++.++||||||+++|||++|+.||......+      ..... ..+.. 
T Consensus       148 ~~~~~~~~~-~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~------~~~~~-~~~~~-  218 (256)
T cd08221         148 SKILGSEYS-MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN------LVVKI-VQGNY-  218 (256)
T ss_pred             eEEcccccc-cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHH------HHHHH-HcCCC-
Confidence            987644332 2234568999999999988889999999999999999999999986433211      11111 11111 


Q ss_pred             hhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHH
Q 009340          454 EILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSME  496 (537)
Q Consensus       454 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~  496 (537)
                              ...+...+..+.+++.+||+.+|++||++.++++.
T Consensus       219 --------~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~  253 (256)
T cd08221         219 --------TPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ  253 (256)
T ss_pred             --------CCCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence                    11123345678899999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.9e-38  Score=317.92  Aligned_cols=255  Identities=22%  Similarity=0.339  Sum_probs=197.3

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCCEEEEEEccC---CChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKE---IDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY  291 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  291 (537)
                      ++|+..+.||+|+||.||+++.. +++.||+|.+..   ......+.|.+|+.++..++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            46888999999999999999964 688999999864   22234456889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeec
Q 009340          292 EYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF  371 (537)
Q Consensus       292 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Df  371 (537)
                      ||+++|+|.+++....           ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+||
T Consensus        81 e~~~g~~L~~~l~~~~-----------~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Df  146 (331)
T cd05597          81 DYYVGGDLLTLLSKFE-----------DRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADF  146 (331)
T ss_pred             ecCCCCcHHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEEC
Confidence            9999999999996532           35889999999999999999999999   999999999999999999999999


Q ss_pred             cCccccCCCCCceeeeccccccccCcccccC-----CCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHH
Q 009340          372 GISRSIPNDKTHLTTTIQGTFGYLDPEYFQS-----SQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISL  446 (537)
Q Consensus       372 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~  446 (537)
                      |++...............||+.|+|||++..     ..++.++|||||||++|||++|+.||......+      .....
T Consensus       147 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~------~~~~i  220 (331)
T cd05597         147 GSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE------TYGKI  220 (331)
T ss_pred             CceeecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHH------HHHHH
Confidence            9987664433333334568999999999863     457889999999999999999999986533221      11111


Q ss_pred             HhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCC--CCCCCHhhHHHH
Q 009340          447 AKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNS--KKRPTMKQVSME  496 (537)
Q Consensus       447 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p--~~RPs~~ev~~~  496 (537)
                      ........+      .......+..+.+++.+|+..++  ..||++.++++.
T Consensus       221 ~~~~~~~~~------~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         221 MNHKEHFQF------PPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             HcCCCcccC------CCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            111100000      00111234567788888775533  347888888765

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=3.4e-38  Score=318.94  Aligned_cols=242  Identities=27%  Similarity=0.398  Sum_probs=191.4

Q ss_pred             cccCcCCceEEEEEEcC-CCCEEEEEEccCC---ChHHHHHHHHHHH-HHHhcCCCCcceEeeEEeeCCccEEEEecCCC
Q 009340          222 RFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI---DKTQIHQFINEVV-ILSQINHRHIVKLLGCCLETEVPVLVYEYISS  296 (537)
Q Consensus       222 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  296 (537)
                      +.||+|+||.||++... +|+.||+|.+...   .......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46999999999999854 6899999988642   2233445566655 46778999999999999999999999999999


Q ss_pred             CChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCccc
Q 009340          297 GTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS  376 (537)
Q Consensus       297 gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~  376 (537)
                      |+|..++...            ..+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        81 ~~L~~~l~~~------------~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~  145 (325)
T cd05604          81 GELFFHLQRE------------RSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKE  145 (325)
T ss_pred             CCHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCccc
Confidence            9998888642            36899999999999999999999999   99999999999999999999999999875


Q ss_pred             cCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchhhhhh
Q 009340          377 IPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEIL  456 (537)
Q Consensus       377 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  456 (537)
                      ..... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||......+      .+..... .      
T Consensus       146 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~------~~~~~~~-~------  211 (325)
T cd05604         146 GIAQS-DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE------MYDNILH-K------  211 (325)
T ss_pred             CCCCC-CCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH------HHHHHHc-C------
Confidence            42221 12334568999999999999999999999999999999999999986543221      1111111 0      


Q ss_pred             cHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHH
Q 009340          457 DARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSME  496 (537)
Q Consensus       457 d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~  496 (537)
                        ..  ..+...+..+.+++.+|++.+|.+||++.+.++.
T Consensus       212 --~~--~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~  247 (325)
T cd05604         212 --PL--VLRPGASLTAWSILEELLEKDRQRRLGAKEDFLE  247 (325)
T ss_pred             --Cc--cCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHH
Confidence              00  0112234567899999999999999998754443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=5.4e-38  Score=313.94  Aligned_cols=261  Identities=23%  Similarity=0.373  Sum_probs=199.2

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCC-hHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEec
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEID-KTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY  293 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  293 (537)
                      ++|...+.||+|+||.||+|... +++.||+|.++... ......+.+|+.++++++|+||+++++++.+.+..++|+||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            56888899999999999999864 67899999886432 22344677899999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccC
Q 009340          294 ISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGI  373 (537)
Q Consensus       294 ~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgl  373 (537)
                      ++ ++|.+++....           ..+++..+..++.|+++||.|||+.+   ++|+||||+||++++++.+||+|||+
T Consensus        86 ~~-~~l~~~l~~~~-----------~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~  150 (301)
T cd07873          86 LD-KDLKQYLDDCG-----------NSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGL  150 (301)
T ss_pred             cc-cCHHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcc
Confidence            97 58988886532           35889999999999999999999998   99999999999999999999999999


Q ss_pred             ccccCCCCCceeeeccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHh---h
Q 009340          374 SRSIPNDKTHLTTTIQGTFGYLDPEYFQS-SQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAK---E  449 (537)
Q Consensus       374 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~---~  449 (537)
                      +........ ......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||......+.   ...+.....   .
T Consensus       151 ~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~---~~~~~~~~~~~~~  226 (301)
T cd07873         151 ARAKSIPTK-TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQ---LHFIFRILGTPTE  226 (301)
T ss_pred             hhccCCCCC-cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCCh
Confidence            976533221 1223456889999998865 4578899999999999999999999975543221   111111110   0


Q ss_pred             chhhhhhc---------HHhhc----cccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          450 NQLLEILD---------ARVAK----EAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       450 ~~~~~~~d---------~~~~~----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      .....+++         +....    .........+.+|+.+||+.||.+|||+.|+++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         227 ETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             hhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            00011110         00000    011123456789999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.5e-37  Score=318.24  Aligned_cols=191  Identities=21%  Similarity=0.369  Sum_probs=164.7

Q ss_pred             hcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEec
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY  293 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  293 (537)
                      ..+|...+.||+|+||.||+|... +++.||+|.....      ....|+.++++++|+||+++++++.+....++|+||
T Consensus        65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  138 (357)
T PHA03209         65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPH  138 (357)
T ss_pred             hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEc
Confidence            457999999999999999999965 5678999975432      234699999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccC
Q 009340          294 ISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGI  373 (537)
Q Consensus       294 ~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgl  373 (537)
                      +. ++|.+++...           ...++|..++.|+.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus       139 ~~-~~l~~~l~~~-----------~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~  203 (357)
T PHA03209        139 YS-SDLYTYLTKR-----------SRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGA  203 (357)
T ss_pred             cC-CcHHHHHHhc-----------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCcc
Confidence            95 6888888643           236899999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 009340          374 SRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI  428 (537)
Q Consensus       374 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~  428 (537)
                      ++......  ......||..|+|||++.+..++.++|||||||++|||+++..++
T Consensus       204 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        204 AQFPVVAP--AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             ccccccCc--ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence            97543221  123456899999999999999999999999999999999966654

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-37  Score=306.64  Aligned_cols=247  Identities=26%  Similarity=0.413  Sum_probs=202.6

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCC-hHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEec
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEID-KTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY  293 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  293 (537)
                      ++|+..+.||.|+||.||+|+.. +++.||+|.+.... ......+.+|+.+++.++|+|++++.+++.+....++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            36778889999999999999965 68899999886532 44556788999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccC
Q 009340          294 ISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGI  373 (537)
Q Consensus       294 ~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgl  373 (537)
                      +++++|.+++...             .+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||+
T Consensus        81 ~~~~~L~~~~~~~-------------~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~  144 (274)
T cd06609          81 CGGGSCLDLLKPG-------------KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGV  144 (274)
T ss_pred             eCCCcHHHHHhhc-------------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccccc
Confidence            9999999998642             5899999999999999999999998   99999999999999999999999999


Q ss_pred             ccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchhh
Q 009340          374 SRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLL  453 (537)
Q Consensus       374 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  453 (537)
                      +........ ......++..|+|||.+.+..++.++||||||+++|||++|+.||.......       ........   
T Consensus       145 ~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~-------~~~~~~~~---  213 (274)
T cd06609         145 SGQLTSTMS-KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR-------VLFLIPKN---  213 (274)
T ss_pred             ceeeccccc-ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH-------HHHHhhhc---
Confidence            987654321 2233457889999999998889999999999999999999999986432211       00111111   


Q ss_pred             hhhcHHhhccccHH-HHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          454 EILDARVAKEAREE-DIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       454 ~~~d~~~~~~~~~~-~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                            ........ .+..+.+++.+||..+|++|||+.++++
T Consensus       214 ------~~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         214 ------NPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             ------CCCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence                  00111111 4557889999999999999999999976

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.5e-37  Score=302.79  Aligned_cols=247  Identities=24%  Similarity=0.452  Sum_probs=201.3

Q ss_pred             CCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCC-----hHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEE
Q 009340          217 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEID-----KTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLV  290 (537)
Q Consensus       217 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  290 (537)
                      +|...+.||+|+||.||+|... +++.|++|.+....     ....+.+.+|+.+++.++|+|++++++++.+....++|
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            3667788999999999999976 78999999875432     34567899999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEee
Q 009340          291 YEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSD  370 (537)
Q Consensus       291 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~D  370 (537)
                      +||+++++|.+++...            ..+++..++.++.|+++||.|||+.+   ++|+||+|+||+++.++.+||+|
T Consensus        81 ~e~~~~~~L~~~~~~~------------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d  145 (258)
T cd06632          81 LELVPGGSLAKLLKKY------------GSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLAD  145 (258)
T ss_pred             EEecCCCcHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcc
Confidence            9999999999998652            35889999999999999999999998   99999999999999999999999


Q ss_pred             ccCccccCCCCCceeeeccccccccCcccccCCC-CCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhh
Q 009340          371 FGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQ-FTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKE  449 (537)
Q Consensus       371 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  449 (537)
                      ||++.......  ......++..|+|||.+.... ++.++|+||||+++|+|++|+.||.......      ........
T Consensus       146 ~~~~~~~~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~------~~~~~~~~  217 (258)
T cd06632         146 FGMAKQVVEFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA------AVFKIGRS  217 (258)
T ss_pred             Cccceeccccc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH------HHHHHHhc
Confidence            99988764332  223456889999999987776 8999999999999999999999986432111      01111110


Q ss_pred             chhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          450 NQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       450 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      ..         ....+......+.+++.+||+.+|++||++.+++.
T Consensus       218 ~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         218 KE---------LPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             cc---------CCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence            00         11122334567889999999999999999999875

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=3.3e-37  Score=304.45  Aligned_cols=248  Identities=24%  Similarity=0.406  Sum_probs=203.9

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCC-ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEec
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI-DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY  293 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  293 (537)
                      ..|+..+.||+|+||.||+|... +++.||+|.++.. .......+.+|+.++++++|+|++++++++.+....++||||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            35666788999999999999964 5889999988743 345567899999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccC
Q 009340          294 ISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGI  373 (537)
Q Consensus       294 ~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgl  373 (537)
                      +++|+|.+++..             ..+++.+...++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||+
T Consensus        84 ~~~~~L~~~i~~-------------~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~  147 (277)
T cd06640          84 LGGGSALDLLRA-------------GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGV  147 (277)
T ss_pred             CCCCcHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEccccc
Confidence            999999998853             25888999999999999999999998   99999999999999999999999999


Q ss_pred             ccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchhh
Q 009340          374 SRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLL  453 (537)
Q Consensus       374 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  453 (537)
                      +........ ......++..|+|||++.+..++.++|+||||+++|||++|+.|+........       .         
T Consensus       148 ~~~~~~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-------~---------  210 (277)
T cd06640         148 AGQLTDTQI-KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV-------L---------  210 (277)
T ss_pred             ceeccCCcc-ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH-------h---------
Confidence            977643322 12334578899999999888899999999999999999999999864332110       0         


Q ss_pred             hhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHH
Q 009340          454 EILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSME  496 (537)
Q Consensus       454 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~  496 (537)
                      ..+............+..+.+++.+||+.+|++||++.++++.
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         211 FLIPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             hhhhcCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            0001111122344566788999999999999999999999765

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=2.5e-37  Score=301.43  Aligned_cols=249  Identities=25%  Similarity=0.388  Sum_probs=200.9

Q ss_pred             CCccccccCcCCceEEEEEEcC-CCCEEEEEEccCC--ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCC-ccEEEEe
Q 009340          217 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI--DKTQIHQFINEVVILSQINHRHIVKLLGCCLETE-VPVLVYE  292 (537)
Q Consensus       217 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lV~e  292 (537)
                      +|+..+.||+|++|.||++... +++.||+|++...  .....+.+.+|+.++++++|+|++++.+.+...+ ..++|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            4778899999999999999954 5789999988642  3345567889999999999999999999876444 5789999


Q ss_pred             cCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeecc
Q 009340          293 YISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG  372 (537)
Q Consensus       293 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfg  372 (537)
                      |+++++|.+++....          ...+++.+++.++.+++.|++|||+.+   ++||||+|+||+++.++.++|+|||
T Consensus        81 ~~~~~~l~~~l~~~~----------~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~  147 (257)
T cd08223          81 FCEGGDLYHKLKEQK----------GKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLG  147 (257)
T ss_pred             ccCCCcHHHHHHHhc----------CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEeccc
Confidence            999999999997532          235899999999999999999999999   9999999999999999999999999


Q ss_pred             CccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchh
Q 009340          373 ISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQL  452 (537)
Q Consensus       373 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  452 (537)
                      ++........ ......+++.|+|||.+.+..++.++||||||++++||++|+.||.......      ..... ..+. 
T Consensus       148 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~------~~~~~-~~~~-  218 (257)
T cd08223         148 IARVLENQCD-MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNS------LVYRI-IEGK-  218 (257)
T ss_pred             ceEEecccCC-ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH------HHHHH-HhcC-
Confidence            9986643322 2234457899999999999999999999999999999999999986433211      01111 1111 


Q ss_pred             hhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          453 LEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       453 ~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                              ....+......+.+++.+||+.+|++|||+.++++
T Consensus       219 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  253 (257)
T cd08223         219 --------LPPMPKDYSPELGELIATMLSKRPEKRPSVKSILR  253 (257)
T ss_pred             --------CCCCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence                    11223345567889999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.2e-37  Score=319.41  Aligned_cols=260  Identities=23%  Similarity=0.335  Sum_probs=197.3

Q ss_pred             HhcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCC--ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCC-----
Q 009340          214 ATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI--DKTQIHQFINEVVILSQINHRHIVKLLGCCLETE-----  285 (537)
Q Consensus       214 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----  285 (537)
                      ..++|...+.||+|+||.||++... +|+.||||.+...  .......+.+|+.+++.++|+||+++++++...+     
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            3578999999999999999999854 6889999998642  3344667889999999999999999999986543     


Q ss_pred             -ccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCC
Q 009340          286 -VPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF  364 (537)
Q Consensus       286 -~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~  364 (537)
                       ..++||||+++ +|.+.++.              .+++..+..++.|+++||.|||+.+   |+||||||+|||++.++
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~~--------------~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~  160 (359)
T cd07876          99 QDVYLVMELMDA-NLCQVIHM--------------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDC  160 (359)
T ss_pred             ceeEEEEeCCCc-CHHHHHhc--------------cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCC
Confidence             46999999975 56665532              4788889999999999999999999   99999999999999999


Q ss_pred             cEEEeeccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHH
Q 009340          365 SAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFI  444 (537)
Q Consensus       365 ~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~  444 (537)
                      .+||+|||+++.....  .......||..|+|||.+.+..++.++|||||||++|||++|+.||......+.   .....
T Consensus       161 ~~kl~Dfg~a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~---~~~~~  235 (359)
T cd07876         161 TLKILDFGLARTACTN--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQ---WNKVI  235 (359)
T ss_pred             CEEEecCCCccccccC--ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHH
Confidence            9999999999764322  122345689999999999999999999999999999999999999975432211   00010


Q ss_pred             HHHhhc----------hhhhhhcHH--------------hh----ccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHH
Q 009340          445 SLAKEN----------QLLEILDAR--------------VA----KEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSME  496 (537)
Q Consensus       445 ~~~~~~----------~~~~~~d~~--------------~~----~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~  496 (537)
                      ......          .........              ..    ..........+.+|+.+||+.||++|||+.|+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  315 (359)
T cd07876         236 EQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH  315 (359)
T ss_pred             HhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence            000000          000000000              00    00111224568899999999999999999999873

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=2.8e-37  Score=303.07  Aligned_cols=249  Identities=24%  Similarity=0.427  Sum_probs=195.2

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCC-----ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeC--Ccc
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI-----DKTQIHQFINEVVILSQINHRHIVKLLGCCLET--EVP  287 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~  287 (537)
                      .+|...+.||+|+||.||++... ++..||+|++...     .....+.+.+|+.++++++|+||+++++++.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            47888999999999999999864 6889999987532     223456788999999999999999999998753  467


Q ss_pred             EEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEE
Q 009340          288 VLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK  367 (537)
Q Consensus       288 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~k  367 (537)
                      ++++||+++++|.+++...            ..+++...+.++.|+++||+|||+.+   ++||||+|+||+++.++.+|
T Consensus        82 ~l~~e~~~~~~L~~~l~~~------------~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~  146 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAY------------GALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVK  146 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEE
Confidence            8999999999999999652            35889999999999999999999998   99999999999999999999


Q ss_pred             EeeccCccccCCCCCc--eeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHH
Q 009340          368 VSDFGISRSIPNDKTH--LTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFIS  445 (537)
Q Consensus       368 i~Dfgla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~  445 (537)
                      |+|||++.........  ......++..|+|||.+.+..++.++||||||+++|||++|+.||.......      ....
T Consensus       147 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~------~~~~  220 (266)
T cd06651         147 LGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA------AIFK  220 (266)
T ss_pred             EccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH------HHHH
Confidence            9999999765322111  1123457889999999998889999999999999999999999986432111      0101


Q ss_pred             HHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          446 LAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       446 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      ....         ......+......+..++ +||..+|++||+++||++
T Consensus       221 ~~~~---------~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         221 IATQ---------PTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             HhcC---------CCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence            0000         001122333344566666 788899999999999964

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=2.5e-37  Score=303.85  Aligned_cols=253  Identities=25%  Similarity=0.376  Sum_probs=190.0

Q ss_pred             ccCcCCceEEEEEEcCCC---CEEEEEEccCCC-hHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecCCCCC
Q 009340          223 FLGQGGFGTVYKGMLPDG---SIVAVKRSKEID-KTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGT  298 (537)
Q Consensus       223 ~lg~G~~g~Vy~~~~~~g---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs  298 (537)
                      .||+|+||.||+|...++   ..+++|.++... ....+.|.+|+.+++.++|||+++++++|.+....++||||+++|+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            599999999999975433   356677766432 3456789999999999999999999999999989999999999999


Q ss_pred             hhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCccccC
Q 009340          299 LSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIP  378 (537)
Q Consensus       299 L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~  378 (537)
                      |.+++......        ...+++..+..++.|+++||+|||+.+   ++||||||+|||++.++.+||+|||++....
T Consensus        82 L~~~l~~~~~~--------~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~  150 (268)
T cd05086          82 LKSYLSQEQWH--------RRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRY  150 (268)
T ss_pred             HHHHHHhhhcc--------cccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccC
Confidence            99999764321        234677888999999999999999998   9999999999999999999999999986432


Q ss_pred             CCC-CceeeeccccccccCcccccC-------CCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHHHHHhh
Q 009340          379 NDK-THLTTTIQGTFGYLDPEYFQS-------SQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKE  449 (537)
Q Consensus       379 ~~~-~~~~~~~~gt~~y~aPE~~~~-------~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  449 (537)
                      ... ........++..|+|||++..       ..++.++||||||+++|||++ |..|+......+      .+......
T Consensus       151 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~------~~~~~~~~  224 (268)
T cd05086         151 KEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE------VLNHVIKD  224 (268)
T ss_pred             cchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHhh
Confidence            211 111234457889999998743       245789999999999999998 566764332211      11111111


Q ss_pred             chhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHH
Q 009340          450 NQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELE  498 (537)
Q Consensus       450 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~  498 (537)
                       ......++.+..    .....+.+++..|| .+|++||++.+|++.|.
T Consensus       225 -~~~~~~~~~~~~----~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         225 -QQVKLFKPQLEL----PYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             -cccccCCCccCC----CCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence             111122222221    23456788999999 67999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2e-37  Score=303.98  Aligned_cols=248  Identities=26%  Similarity=0.512  Sum_probs=199.3

Q ss_pred             CCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCCh---------HHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCc
Q 009340          217 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDK---------TQIHQFINEVVILSQINHRHIVKLLGCCLETEV  286 (537)
Q Consensus       217 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~  286 (537)
                      +|.....||+|+||.||+|... +++.||+|.+.....         ...+.+.+|+.++++++|+||+++++++.+.+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            3566789999999999999854 578999998754211         223568899999999999999999999999999


Q ss_pred             cEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcE
Q 009340          287 PVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA  366 (537)
Q Consensus       287 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~  366 (537)
                      .++|+||+++++|.+++...            ..+++..+..++.|++.||+|||+.+   ++||||+|+||++++++.+
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~------------~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~  145 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNY------------GAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGI  145 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhc------------cCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCE
Confidence            99999999999999999653            35889999999999999999999998   9999999999999999999


Q ss_pred             EEeeccCccccCCCCCc-----eeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHH
Q 009340          367 KVSDFGISRSIPNDKTH-----LTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVA  441 (537)
Q Consensus       367 ki~Dfgla~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~  441 (537)
                      +|+|||+++........     ......|+..|+|||.+.+..++.++||||||+++|||++|+.||.......      
T Consensus       146 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------  219 (267)
T cd06628         146 KISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ------  219 (267)
T ss_pred             EecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH------
Confidence            99999999876422111     1122357889999999998899999999999999999999999986432111      


Q ss_pred             HHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          442 CFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       442 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      ......      .    ......+......+.+++.+||+.+|++||++.+|++
T Consensus       220 ~~~~~~------~----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         220 AIFKIG------E----NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             HHHHHh------c----cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence            000000      0    1111223344567889999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.8e-37  Score=324.80  Aligned_cols=259  Identities=22%  Similarity=0.301  Sum_probs=195.9

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecC
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI  294 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  294 (537)
                      .+|...+.||+|+||.||++... .++.||||....      ..+.+|+.++++++|+||+++++++...+..++|||++
T Consensus       169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~  242 (461)
T PHA03211        169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY  242 (461)
T ss_pred             CCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc
Confidence            46888899999999999999965 578899996432      34568999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCc
Q 009340          295 SSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGIS  374 (537)
Q Consensus       295 ~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla  374 (537)
                      . ++|.+++...           ...++|.+++.++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       243 ~-~~L~~~l~~~-----------~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla  307 (461)
T PHA03211        243 R-SDLYTYLGAR-----------LRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAA  307 (461)
T ss_pred             C-CCHHHHHHhc-----------CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCc
Confidence            5 6888887543           236999999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCCc-eeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchh-hhccHHHHHHHHHhhchh
Q 009340          375 RSIPNDKTH-LTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVE-EERNLVACFISLAKENQL  452 (537)
Q Consensus       375 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~  452 (537)
                      +........ ......||..|+|||++.+..++.++|||||||++|||++|..++...... ........+.........
T Consensus       308 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~  387 (461)
T PHA03211        308 CFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQV  387 (461)
T ss_pred             eecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhcc
Confidence            866432221 223456999999999999999999999999999999999988765432211 111111111111111000


Q ss_pred             -----hhhhcHHh------------hcc--cc-----HHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          453 -----LEILDARV------------AKE--AR-----EEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       453 -----~~~~d~~~------------~~~--~~-----~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                           .......+            ...  .+     ......+.+|+.+||+.||++|||+.|+++
T Consensus       388 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~  454 (461)
T PHA03211        388 HVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLR  454 (461)
T ss_pred             ccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhh
Confidence                 00000000            000  00     012346889999999999999999999986

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=6.3e-38  Score=317.88  Aligned_cols=255  Identities=21%  Similarity=0.314  Sum_probs=198.3

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCC---ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI---DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY  291 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  291 (537)
                      ++|...++||+|+||.||++..+ +++.+|+|.+...   .......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            46888999999999999999965 5778999988542   2233445888999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeec
Q 009340          292 EYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF  371 (537)
Q Consensus       292 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Df  371 (537)
                      ||+++|+|.+++....           ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+||
T Consensus        81 ey~~~g~L~~~l~~~~-----------~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~Df  146 (332)
T cd05623          81 DYYVGGDLLTLLSKFE-----------DRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADF  146 (332)
T ss_pred             eccCCCcHHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeec
Confidence            9999999999997532           35899999999999999999999999   999999999999999999999999


Q ss_pred             cCccccCCCCCceeeeccccccccCccccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHH
Q 009340          372 GISRSIPNDKTHLTTTIQGTFGYLDPEYFQ-----SSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISL  446 (537)
Q Consensus       372 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~  446 (537)
                      |++...............||+.|+|||++.     ...++.++|||||||++|||++|+.||......+      .+...
T Consensus       147 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~------~~~~i  220 (332)
T cd05623         147 GSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE------TYGKI  220 (332)
T ss_pred             chheecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHH------HHHHH
Confidence            999765443333334457999999999986     3468899999999999999999999996543221      11111


Q ss_pred             HhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCC--CCCCHhhHHHH
Q 009340          447 AKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSK--KRPTMKQVSME  496 (537)
Q Consensus       447 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~--~RPs~~ev~~~  496 (537)
                      ........      ........+..+.+|+.+|+..+++  .|+++.++++.
T Consensus       221 ~~~~~~~~------~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         221 MNHKERFQ------FPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             hCCCcccc------CCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence            11110000      0011123456778899998865444  36888888765

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.3e-37  Score=305.29  Aligned_cols=252  Identities=24%  Similarity=0.386  Sum_probs=200.4

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecC
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI  294 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  294 (537)
                      ++|...+.||+|+||.||++... +++.||+|.++.........+.+|+.+++.++|+|++++++++.+.+..++|+||+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~   88 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC   88 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence            46777889999999999999854 68899999987655555667889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCc
Q 009340          295 SSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGIS  374 (537)
Q Consensus       295 ~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla  374 (537)
                      ++++|.+++...            ..+++.+++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++
T Consensus        89 ~~~~L~~~~~~~------------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~  153 (267)
T cd06645          89 GGGSLQDIYHVT------------GPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVS  153 (267)
T ss_pred             CCCcHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceee
Confidence            999999998642            35899999999999999999999999   999999999999999999999999998


Q ss_pred             cccCCCCCceeeeccccccccCccccc---CCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhch
Q 009340          375 RSIPNDKTHLTTTIQGTFGYLDPEYFQ---SSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQ  451 (537)
Q Consensus       375 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  451 (537)
                      ....... .......|+..|+|||.+.   ...++.++|||||||++|||++|+.|+........      ........ 
T Consensus       154 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~------~~~~~~~~-  225 (267)
T cd06645         154 AQITATI-AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA------LFLMTKSN-  225 (267)
T ss_pred             eEccCcc-cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh------HHhhhccC-
Confidence            7654322 1223446899999999874   45688999999999999999999999854322111      00000000 


Q ss_pred             hhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          452 LLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       452 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      .   ..+....  ....+..+.+++.+||+.+|++||++.+|++
T Consensus       226 ~---~~~~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         226 F---QPPKLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             C---CCCcccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence            0   0000000  0122346789999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=3.6e-38  Score=302.19  Aligned_cols=265  Identities=23%  Similarity=0.316  Sum_probs=201.5

Q ss_pred             cCCccccccCcCCceEEEEEEc-CCCCEEEEEEccCCCh--HHHHHHHHHHHHHHhcCCCC-cceEeeEEeeCC------
Q 009340          216 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEIDK--TQIHQFINEVVILSQINHRH-IVKLLGCCLETE------  285 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~------  285 (537)
                      ..|...++||+|.||+||+|+. .+|+.||+|+++....  ..-....+|+.++++++|+| |+++.+++...+      
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            4566677899999999999994 4789999999875433  23345679999999999999 999999999877      


Q ss_pred             ccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCc
Q 009340          286 VPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFS  365 (537)
Q Consensus       286 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~  365 (537)
                      ..++|+||++. +|..++.......        ..++-..+..+..||++||+|||+++   |+||||||.|||++++|.
T Consensus        91 ~l~lvfe~~d~-DL~~ymd~~~~~~--------~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~  158 (323)
T KOG0594|consen   91 KLYLVFEFLDR-DLKKYMDSLPKKP--------QGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGV  158 (323)
T ss_pred             eEEEEEEeecc-cHHHHHHhccccc--------cCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCc
Confidence            78999999977 8999997754310        24666889999999999999999999   999999999999999999


Q ss_pred             EEEeeccCccccCCCCCceeeeccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHH
Q 009340          366 AKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSS-QFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFI  444 (537)
Q Consensus       366 ~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~  444 (537)
                      +||+|||+|+...-... ..+..++|..|.|||.+.+. .|+...||||+||++.||++++.-|......+.  +.. ..
T Consensus       159 lKlaDFGlAra~~ip~~-~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~q--l~~-If  234 (323)
T KOG0594|consen  159 LKLADFGLARAFSIPMR-TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQ--LFR-IF  234 (323)
T ss_pred             EeeeccchHHHhcCCcc-cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHH--HHH-HH
Confidence            99999999996643322 24556789999999998876 799999999999999999998888765544221  111 11


Q ss_pred             HHHhhc---hhhhhh---cH--Hhhccc-c-------HHHHHHHHHHHHHhcccCCCCCCCHhhHHHH
Q 009340          445 SLAKEN---QLLEIL---DA--RVAKEA-R-------EEDIGAMAELAMRCLRLNSKKRPTMKQVSME  496 (537)
Q Consensus       445 ~~~~~~---~~~~~~---d~--~~~~~~-~-------~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~  496 (537)
                      +.+..+   .+....   +-  ...... +       ........+++.+||+.+|..|.|++.++..
T Consensus       235 ~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  235 RLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             HHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            111111   111100   00  000000 1       1112478899999999999999999999875

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=7.8e-38  Score=315.71  Aligned_cols=237  Identities=27%  Similarity=0.412  Sum_probs=188.4

Q ss_pred             cccCcCCceEEEEEEcC-CCCEEEEEEccCC---ChHHHHHHHHHHH-HHHhcCCCCcceEeeEEeeCCccEEEEecCCC
Q 009340          222 RFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI---DKTQIHQFINEVV-ILSQINHRHIVKLLGCCLETEVPVLVYEYISS  296 (537)
Q Consensus       222 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  296 (537)
                      ++||+|+||.||+++.. +|+.||+|.+...   .......+.+|.. +++.++|+||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999964 6889999988642   1223344555554 67889999999999999999999999999999


Q ss_pred             CChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCccc
Q 009340          297 GTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS  376 (537)
Q Consensus       297 gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~  376 (537)
                      |+|..++...            ..+++..+..++.||++||.|||+.+   |+||||||+||+++.++.+||+|||+++.
T Consensus        81 ~~L~~~l~~~------------~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~  145 (321)
T cd05603          81 GELFFHLQRE------------RCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKE  145 (321)
T ss_pred             CCHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCcc
Confidence            9998887542            35888889999999999999999998   99999999999999999999999999875


Q ss_pred             cCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchhhhhh
Q 009340          377 IPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEIL  456 (537)
Q Consensus       377 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  456 (537)
                      ..... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.......      .......        
T Consensus       146 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------~~~~i~~--------  210 (321)
T cd05603         146 GVEPE-ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ------MYDNILH--------  210 (321)
T ss_pred             CCCCC-CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHH------HHHHHhc--------
Confidence            32221 12334568999999999999899999999999999999999999986543211      1111111        


Q ss_pred             cHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHh
Q 009340          457 DARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMK  491 (537)
Q Consensus       457 d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~  491 (537)
                       ..  ...+......+.+++.+||+.+|.+||++.
T Consensus       211 -~~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         211 -KP--LQLPGGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             -CC--CCCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence             00  112233455788999999999999999875

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-37  Score=307.51  Aligned_cols=253  Identities=24%  Similarity=0.374  Sum_probs=204.6

Q ss_pred             hcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEec
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY  293 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  293 (537)
                      .++|...+.||+|+||.||++... ++..||+|..+.......+.|.+|+.++++++|+|++++++++.+....++||||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF   83 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence            456888899999999999999964 6889999998876667778899999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccC
Q 009340          294 ISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGI  373 (537)
Q Consensus       294 ~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgl  373 (537)
                      +++++|.+++....           ..+++..+..++.|++.||.|||+.+   |+|+||+|+||+++.++.++|+|||+
T Consensus        84 ~~~~~L~~~~~~~~-----------~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~  149 (280)
T cd06611          84 CDGGALDSIMLELE-----------RGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGV  149 (280)
T ss_pred             cCCCcHHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCcc
Confidence            99999999986532           36899999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCCceeeeccccccccCccccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHh
Q 009340          374 SRSIPNDKTHLTTTIQGTFGYLDPEYFQ-----SSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAK  448 (537)
Q Consensus       374 a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  448 (537)
                      +........ ......++..|+|||.+.     ...++.++||||||+++|||++|+.||.......      ..... .
T Consensus       150 ~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~------~~~~~-~  221 (280)
T cd06611         150 SAKNKSTLQ-KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR------VLLKI-L  221 (280)
T ss_pred             chhhccccc-ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH------HHHHH-h
Confidence            876533222 223445889999999874     3457789999999999999999999986432211      01111 1


Q ss_pred             hchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHH
Q 009340          449 ENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSME  496 (537)
Q Consensus       449 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~  496 (537)
                      ....     +.+  ..+...+..+.+++.+||+.+|++||++.++++.
T Consensus       222 ~~~~-----~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         222 KSEP-----PTL--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             cCCC-----CCc--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence            0000     000  1122344678899999999999999999999763

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=8.6e-38  Score=315.96  Aligned_cols=242  Identities=26%  Similarity=0.386  Sum_probs=190.3

Q ss_pred             cccCcCCceEEEEEEcC-CCCEEEEEEccCCC---hHHHHHHHHHH-HHHHhcCCCCcceEeeEEeeCCccEEEEecCCC
Q 009340          222 RFLGQGGFGTVYKGMLP-DGSIVAVKRSKEID---KTQIHQFINEV-VILSQINHRHIVKLLGCCLETEVPVLVYEYISS  296 (537)
Q Consensus       222 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~-~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  296 (537)
                      +.||+|+||.||+++.. +++.||+|.+....   ......+..|. .+++.++|+||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            36999999999999965 57889999886421   12233444454 456788999999999999999999999999999


Q ss_pred             CChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCccc
Q 009340          297 GTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS  376 (537)
Q Consensus       297 gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~  376 (537)
                      |+|.+++...            ..+.+.....++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        81 ~~L~~~~~~~------------~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~  145 (325)
T cd05602          81 GELFYHLQRE------------RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKE  145 (325)
T ss_pred             CcHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcc
Confidence            9999988653            35778888899999999999999999   99999999999999999999999999975


Q ss_pred             cCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchhhhhh
Q 009340          377 IPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEIL  456 (537)
Q Consensus       377 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  456 (537)
                      ..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.      +......       
T Consensus       146 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~------~~~i~~~-------  211 (325)
T cd05602         146 NIEHN-GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM------YDNILNK-------  211 (325)
T ss_pred             cccCC-CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHH------HHHHHhC-------
Confidence            42222 123445689999999999999999999999999999999999999975432211      1111110       


Q ss_pred             cHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHH
Q 009340          457 DARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSME  496 (537)
Q Consensus       457 d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~  496 (537)
                        ..  ..+...+..+.+++.+||+.+|.+||++.+.+..
T Consensus       212 --~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~  247 (325)
T cd05602         212 --PL--QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFME  247 (325)
T ss_pred             --Cc--CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHH
Confidence              00  1122344568899999999999999998865443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.1e-37  Score=319.10  Aligned_cols=263  Identities=21%  Similarity=0.326  Sum_probs=198.5

Q ss_pred             HHhcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCC--ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCC----
Q 009340          213 RATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI--DKTQIHQFINEVVILSQINHRHIVKLLGCCLETE----  285 (537)
Q Consensus       213 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----  285 (537)
                      ...++|...+.||+|+||.||++... .++.||||++...  .......+.+|+.+++.++|+||+++++++....    
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   93 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE   93 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence            34578999999999999999999854 6889999998642  3344567889999999999999999999986432    


Q ss_pred             --ccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCC
Q 009340          286 --VPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK  363 (537)
Q Consensus       286 --~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~  363 (537)
                        ..++||||+++ +|.+.+..              .+++..+..++.|+++||.|||+.+   |+||||||+|||++.+
T Consensus        94 ~~~~~lv~e~~~~-~l~~~~~~--------------~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~  155 (355)
T cd07874          94 FQDVYLVMELMDA-NLCQVIQM--------------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSD  155 (355)
T ss_pred             cceeEEEhhhhcc-cHHHHHhh--------------cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCC
Confidence              46999999975 66666532              4888999999999999999999999   9999999999999999


Q ss_pred             CcEEEeeccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhcc-HHH-
Q 009340          364 FSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERN-LVA-  441 (537)
Q Consensus       364 ~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~-~~~-  441 (537)
                      +.+||+|||+++.....  .......||..|+|||.+.+..++.++|||||||++|||++|+.||......+... ... 
T Consensus       156 ~~~kl~Dfg~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~  233 (355)
T cd07874         156 CTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ  233 (355)
T ss_pred             CCEEEeeCcccccCCCc--cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence            99999999999865332  22234568999999999999899999999999999999999999996543221100 000 


Q ss_pred             ------HHHHHHhhchhhhhhc----------HHh-----h---ccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHH
Q 009340          442 ------CFISLAKENQLLEILD----------ARV-----A---KEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSME  496 (537)
Q Consensus       442 ------~~~~~~~~~~~~~~~d----------~~~-----~---~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~  496 (537)
                            .+..... ......++          +..     .   ...+......+.+|+.+||+.||++|||+.|+++.
T Consensus       234 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         234 LGTPCPEFMKKLQ-PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             hCCCCHHHHHhhc-HHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence                  0000000 00000000          000     0   00111224567899999999999999999999874

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=2.9e-37  Score=312.37  Aligned_cols=261  Identities=21%  Similarity=0.279  Sum_probs=196.5

Q ss_pred             cccccCcC--CceEEEEEEc-CCCCEEEEEEccCC--ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecC
Q 009340          220 QSRFLGQG--GFGTVYKGML-PDGSIVAVKRSKEI--DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI  294 (537)
Q Consensus       220 ~~~~lg~G--~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  294 (537)
                      ..++||+|  +|++||++.. .+|+.||+|+++..  .....+.+.+|+.+++.++||||+++++++...+..++|+||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            35689999  7899999986 47899999998753  2334456778999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCc
Q 009340          295 SSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGIS  374 (537)
Q Consensus       295 ~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla  374 (537)
                      ++|+|.+++.....          ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.++++||+..
T Consensus        82 ~~~~l~~~~~~~~~----------~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~  148 (327)
T cd08227          82 AYGSAKDLICTHFM----------DGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSN  148 (327)
T ss_pred             CCCcHHHHHHhhcc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchh
Confidence            99999999965322          35899999999999999999999999   999999999999999999999999875


Q ss_pred             cccCCCCCc------eeeeccccccccCcccccC--CCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHH
Q 009340          375 RSIPNDKTH------LTTTIQGTFGYLDPEYFQS--SQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISL  446 (537)
Q Consensus       375 ~~~~~~~~~------~~~~~~gt~~y~aPE~~~~--~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~  446 (537)
                      .........      ......++..|+|||++.+  ..++.++|||||||++|||++|+.||........  ...    .
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~----~  222 (327)
T cd08227         149 LSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLE----K  222 (327)
T ss_pred             hccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH--HHH----H
Confidence            443211110      0122346778999999876  4588999999999999999999999864322110  000    0


Q ss_pred             Hhhchhhhhhc------------------------------------HHhhccccHHHHHHHHHHHHHhcccCCCCCCCH
Q 009340          447 AKENQLLEILD------------------------------------ARVAKEAREEDIGAMAELAMRCLRLNSKKRPTM  490 (537)
Q Consensus       447 ~~~~~~~~~~d------------------------------------~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~  490 (537)
                      .. ......++                                    .....+........+.+++.+||+.||++|||+
T Consensus       223 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~  301 (327)
T cd08227         223 LN-GTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSA  301 (327)
T ss_pred             hc-CCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCH
Confidence            00 00000000                                    000011222345678999999999999999999


Q ss_pred             hhHHH--HHHHH
Q 009340          491 KQVSM--ELEGL  500 (537)
Q Consensus       491 ~ev~~--~L~~i  500 (537)
                      .++++  .+.++
T Consensus       302 ~ell~~p~f~~~  313 (327)
T cd08227         302 STLLNHSFFKQI  313 (327)
T ss_pred             HHHhcChhhhhc
Confidence            99986  34443

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=7.5e-38  Score=317.16  Aligned_cols=254  Identities=21%  Similarity=0.328  Sum_probs=197.6

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCC---ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI---DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY  291 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  291 (537)
                      ++|...+.||+|+||.||+++.. +++.||+|.+...   .......+.+|..++..++|+||+++++++.+.+..++||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47888999999999999999964 6789999988642   2233455788999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeec
Q 009340          292 EYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF  371 (537)
Q Consensus       292 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Df  371 (537)
                      ||+++|+|.+++....           ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+||
T Consensus        81 Ey~~gg~L~~~l~~~~-----------~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~Df  146 (331)
T cd05624          81 DYYVGGDLLTLLSKFE-----------DRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADF  146 (331)
T ss_pred             eCCCCCcHHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEec
Confidence            9999999999997532           25889999999999999999999999   999999999999999999999999


Q ss_pred             cCccccCCCCCceeeeccccccccCcccccC-----CCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHH
Q 009340          372 GISRSIPNDKTHLTTTIQGTFGYLDPEYFQS-----SQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISL  446 (537)
Q Consensus       372 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~  446 (537)
                      |++...............||+.|+|||++.+     +.++.++|||||||++|||++|+.||......+      .+...
T Consensus       147 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~------~~~~i  220 (331)
T cd05624         147 GSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE------TYGKI  220 (331)
T ss_pred             cceeeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHH------HHHHH
Confidence            9998765443333334569999999999875     567889999999999999999999986543221      11111


Q ss_pred             HhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCC--CCCHhhHHH
Q 009340          447 AKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKK--RPTMKQVSM  495 (537)
Q Consensus       447 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~--RPs~~ev~~  495 (537)
                      ........     + .......+..+.+++.+|+..++++  |+++.++++
T Consensus       221 ~~~~~~~~-----~-p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~  265 (331)
T cd05624         221 MNHEERFQ-----F-PSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK  265 (331)
T ss_pred             HcCCCccc-----C-CCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence            11100000     0 0011123467888999999865544  467777764

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=2.1e-37  Score=301.89  Aligned_cols=249  Identities=24%  Similarity=0.378  Sum_probs=203.0

Q ss_pred             CCccccccCcCCceEEEEEEc-CCCCEEEEEEccC--CChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEec
Q 009340          217 NYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKE--IDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY  293 (537)
Q Consensus       217 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  293 (537)
                      +|+..+.||+|+||.||++.. .+|+.||+|++..  ......+++.+|+.++++++|+|++++.+++.+.+..++|+||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            477889999999999999985 4688999998764  2344556889999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccC
Q 009340          294 ISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGI  373 (537)
Q Consensus       294 ~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgl  373 (537)
                      +++++|.+++.....          ..+++..+++++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||+
T Consensus        81 ~~~~~l~~~~~~~~~----------~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~  147 (256)
T cd08218          81 CEGGDLYKKINAQRG----------VLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGI  147 (256)
T ss_pred             CCCCcHHHHHHhccC----------CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccc
Confidence            999999998875321          25789999999999999999999998   99999999999999999999999999


Q ss_pred             ccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchhh
Q 009340          374 SRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLL  453 (537)
Q Consensus       374 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  453 (537)
                      +........ ......+++.|+|||++.+..++.++|+||||+++++|++|+.|+......+      ....... +.  
T Consensus       148 ~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~------~~~~~~~-~~--  217 (256)
T cd08218         148 ARVLNSTVE-LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN------LVLKIIR-GS--  217 (256)
T ss_pred             eeecCcchh-hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHH------HHHHHhc-CC--
Confidence            976543221 1223457889999999998899999999999999999999999986433221      1111110 00  


Q ss_pred             hhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          454 EILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       454 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                             ....+......+.+++.+||+.+|++||++.+|++
T Consensus       218 -------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         218 -------YPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             -------CCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence                   11123344567899999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=2.7e-37  Score=304.09  Aligned_cols=258  Identities=26%  Similarity=0.479  Sum_probs=200.4

Q ss_pred             CccccccCcCCceEEEEEEcC----CCCEEEEEEccCC--ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCC------
Q 009340          218 YNQSRFLGQGGFGTVYKGMLP----DGSIVAVKRSKEI--DKTQIHQFINEVVILSQINHRHIVKLLGCCLETE------  285 (537)
Q Consensus       218 ~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------  285 (537)
                      |...+.||+|+||.||+|.+.    .++.||||.++..  .....+++.+|+.+++.++|||++++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            456788999999999999853    3678999988642  3445677899999999999999999999986542      


Q ss_pred             ccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCc
Q 009340          286 VPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFS  365 (537)
Q Consensus       286 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~  365 (537)
                      ..++++||+++|+|.+++......      .....+++...++++.|++.||+|||+.+   |+||||||+||++++++.
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~------~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~  151 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIG------EEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMT  151 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhccc------CCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCC
Confidence            247899999999999888643211      01235899999999999999999999998   999999999999999999


Q ss_pred             EEEeeccCccccCCCCCce-eeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHH
Q 009340          366 AKVSDFGISRSIPNDKTHL-TTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACF  443 (537)
Q Consensus       366 ~ki~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~  443 (537)
                      +||+|||+++......... .....++..|++||.+.+..++.++||||||+++|||++ |+.|+......+   ...  
T Consensus       152 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~---~~~--  226 (273)
T cd05074         152 VCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE---IYN--  226 (273)
T ss_pred             EEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH---HHH--
Confidence            9999999998764332211 123345678999999998889999999999999999999 888875432211   111  


Q ss_pred             HHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHH
Q 009340          444 ISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGL  500 (537)
Q Consensus       444 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i  500 (537)
                       ........          ..+......+.+++.+||+.+|++|||+.++++.|+.+
T Consensus       227 -~~~~~~~~----------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         227 -YLIKGNRL----------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             -HHHcCCcC----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence             11110000          11123446789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1e-38  Score=305.37  Aligned_cols=266  Identities=24%  Similarity=0.323  Sum_probs=200.2

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCC-----ccEE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETE-----VPVL  289 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~l  289 (537)
                      -.|...+++|.|.||.||+|++. +++.||||+.-...+..    -+|+.+|+.+.|||||+++-++....     ...|
T Consensus        24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k----nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl   99 (364)
T KOG0658|consen   24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK----NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL   99 (364)
T ss_pred             EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC----cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence            45667889999999999999965 46899999875432211    26999999999999999998886433     3467


Q ss_pred             EEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCC-CcEEE
Q 009340          290 VYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK-FSAKV  368 (537)
Q Consensus       290 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~-~~~ki  368 (537)
                      |||||+. +|.++++.....        ...++...+.-+..||.+||.|||+.+   |+||||||+|+|+|.+ |.+||
T Consensus       100 VleymP~-tL~~~~r~~~~~--------~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKi  167 (364)
T KOG0658|consen  100 VLEYMPE-TLYRVIRHYTRA--------NQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKI  167 (364)
T ss_pred             HHHhchH-HHHHHHHHHhhc--------CCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEe
Confidence            9999998 899998763221        235777778889999999999999998   9999999999999976 99999


Q ss_pred             eeccCccccCCCCCceeeeccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHH
Q 009340          369 SDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQS-SQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLA  447 (537)
Q Consensus       369 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~  447 (537)
                      ||||-|+.+..+...  .....|..|.|||.+.+ ..||.+.||||.|||+.||+-|+.-|...+..+..   ......+
T Consensus       168 cDFGSAK~L~~~epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL---~eIik~l  242 (364)
T KOG0658|consen  168 CDFGSAKVLVKGEPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQL---VEIIKVL  242 (364)
T ss_pred             ccCCcceeeccCCCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHH---HHHHHHh
Confidence            999999988554432  34456889999999876 57999999999999999999999988765443322   1122222


Q ss_pred             hhchhhhh----------hcHHhhc-----cccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH--HHHHHHH
Q 009340          448 KENQLLEI----------LDARVAK-----EAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM--ELEGLRR  502 (537)
Q Consensus       448 ~~~~~~~~----------~d~~~~~-----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~--~L~~i~~  502 (537)
                      ..+...++          -.+.+..     -......++..+|+.++++.+|.+|.++.|++.  ..+.++.
T Consensus       243 G~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~  314 (364)
T KOG0658|consen  243 GTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRD  314 (364)
T ss_pred             CCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhC
Confidence            21111111          1111111     122344578899999999999999999999874  4555554

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.2e-37  Score=307.06  Aligned_cols=252  Identities=25%  Similarity=0.408  Sum_probs=201.2

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCC-ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEec
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI-DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY  293 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  293 (537)
                      ++|+..+.||+|+||.||++... +|..||+|.++.. .......+.+|+.++++++|+|++++++++...+..++|+||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            35777889999999999999975 7899999987643 344457899999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeeecCCCCCCEEECCCCcEEEeecc
Q 009340          294 ISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSS-ASIPIFHRDIKSSNILLDDKFSAKVSDFG  372 (537)
Q Consensus       294 ~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~-~~~~ivH~Dlk~~NIll~~~~~~ki~Dfg  372 (537)
                      +++++|..++.....         ...+++..+..++.++++||.|||+. +   ++||||||+||+++.++.+||+|||
T Consensus        81 ~~~~~l~~~~~~~~~---------~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg  148 (286)
T cd06622          81 MDAGSLDKLYAGGVA---------TEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFG  148 (286)
T ss_pred             cCCCCHHHHHHhccc---------cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecC
Confidence            999999998865321         23689999999999999999999974 6   9999999999999999999999999


Q ss_pred             CccccCCCCCceeeeccccccccCcccccCC------CCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHH
Q 009340          373 ISRSIPNDKTHLTTTIQGTFGYLDPEYFQSS------QFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISL  446 (537)
Q Consensus       373 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~  446 (537)
                      ++.......   .....++..|+|||.+.+.      .++.++|||||||++|||++|+.||.......   ....+   
T Consensus       149 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~---  219 (286)
T cd06622         149 VSGNLVASL---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN---IFAQL---  219 (286)
T ss_pred             CcccccCCc---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh---HHHHH---
Confidence            987653221   2334578899999998554      35789999999999999999999986432211   00100   


Q ss_pred             HhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          447 AKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       447 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                            ..+.+. .....+......+.+++.+||+.+|++||++.+++.
T Consensus       220 ------~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         220 ------SAIVDG-DPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             ------HHHhhc-CCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence                  111110 111233446677889999999999999999999876

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.9e-37  Score=321.36  Aligned_cols=261  Identities=21%  Similarity=0.265  Sum_probs=198.9

Q ss_pred             hcCCccccccCcCCceEEEEEEcC---CCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEE
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLP---DGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY  291 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  291 (537)
                      ..+|...+.||+|+||.||++...   .+..||+|.+...     ..+.+|+.++++++|+||+++++++......++||
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~  165 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM  165 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence            357999999999999999999753   3578999988653     23457999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeec
Q 009340          292 EYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF  371 (537)
Q Consensus       292 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Df  371 (537)
                      |++. ++|.+++..            ...++|..++.++.|++.||.|||+.+   |+||||||+|||++.++.++|+||
T Consensus       166 e~~~-~~l~~~l~~------------~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~Df  229 (392)
T PHA03207        166 PKYK-CDLFTYVDR------------SGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDF  229 (392)
T ss_pred             hhcC-CCHHHHHHh------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccC
Confidence            9986 588888843            236999999999999999999999999   999999999999999999999999


Q ss_pred             cCccccCCCCCc-eeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhc
Q 009340          372 GISRSIPNDKTH-LTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKEN  450 (537)
Q Consensus       372 gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  450 (537)
                      |++......... ......||+.|+|||++....++.++|||||||++|||++|+.||......................
T Consensus       230 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~  309 (392)
T PHA03207        230 GAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVH  309 (392)
T ss_pred             ccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccC
Confidence            999766433222 2234568999999999999999999999999999999999999986543322111111111111100


Q ss_pred             h----------hhhh---hcHHhhccc--c-----HHHHHHHHHHHHHhcccCCCCCCCHhhHHHH
Q 009340          451 Q----------LLEI---LDARVAKEA--R-----EEDIGAMAELAMRCLRLNSKKRPTMKQVSME  496 (537)
Q Consensus       451 ~----------~~~~---~d~~~~~~~--~-----~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~  496 (537)
                      .          +...   .........  +     ......+.+++.+||+.||++|||+.+++..
T Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        310 PLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             ccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence            0          0000   000000000  0     1123567889999999999999999999764

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=4.5e-37  Score=300.42  Aligned_cols=252  Identities=26%  Similarity=0.420  Sum_probs=203.2

Q ss_pred             CCccccccCcCCceEEEEEEc-CCCCEEEEEEccC--CChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeC--CccEEEE
Q 009340          217 NYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKE--IDKTQIHQFINEVVILSQINHRHIVKLLGCCLET--EVPVLVY  291 (537)
Q Consensus       217 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~  291 (537)
                      +|+..+.||.|+||.||++.. .+++.||+|.+..  ......+.+.+|+.++++++|+|++++++++...  ...+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            467788999999999999985 4688999998864  3445567789999999999999999999988643  4578999


Q ss_pred             ecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh-----hcCCCCeeecCCCCCCEEECCCCcE
Q 009340          292 EYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMH-----SSASIPIFHRDIKSSNILLDDKFSA  366 (537)
Q Consensus       292 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH-----~~~~~~ivH~Dlk~~NIll~~~~~~  366 (537)
                      ||+++++|.+++.....        ....+++..++.++.++++||.|||     +.+   ++|+||+|+||++++++.+
T Consensus        81 e~~~~~~L~~~l~~~~~--------~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~  149 (265)
T cd08217          81 EYCEGGDLAQLIQKCKK--------ERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNV  149 (265)
T ss_pred             hhccCCCHHHHHHHHhh--------cccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCE
Confidence            99999999999976422        1346999999999999999999999     555   9999999999999999999


Q ss_pred             EEeeccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHH
Q 009340          367 KVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISL  446 (537)
Q Consensus       367 ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~  446 (537)
                      ||+|||++......... .....++..|+|||.+.+..++.++||||||+++|+|++|+.|+.......       +...
T Consensus       150 kl~d~g~~~~~~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-------~~~~  221 (265)
T cd08217         150 KLGDFGLAKILGHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ-------LASK  221 (265)
T ss_pred             EEecccccccccCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH-------HHHH
Confidence            99999999876543321 233468999999999999889999999999999999999999986543211       1111


Q ss_pred             HhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHH
Q 009340          447 AKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSME  496 (537)
Q Consensus       447 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~  496 (537)
                      ...         ......+...+..+.+++.+||+.+|++||++.+|++.
T Consensus       222 ~~~---------~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         222 IKE---------GKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             Hhc---------CCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence            111         11112334455788999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.2e-37  Score=309.15  Aligned_cols=260  Identities=24%  Similarity=0.373  Sum_probs=192.4

Q ss_pred             CCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCC--hHHHHHHHHHHHHHHhc---CCCCcceEeeEEeeC-----C
Q 009340          217 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEID--KTQIHQFINEVVILSQI---NHRHIVKLLGCCLET-----E  285 (537)
Q Consensus       217 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~~-----~  285 (537)
                      +|...+.||+|+||.||++... +|+.||+|.++...  ......+.+|+.+++.+   +|+||+++++++...     .
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4777889999999999999865 68899999886421  11223455677766655   799999999998643     3


Q ss_pred             ccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCc
Q 009340          286 VPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFS  365 (537)
Q Consensus       286 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~  365 (537)
                      ..++||||+++ +|.+++....          ...+++..+..++.|++.||.|||+.+   ++||||||+|||+++++.
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~----------~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~  146 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVP----------PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQ  146 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcC----------CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCC
Confidence            47899999985 8888886532          235899999999999999999999999   999999999999999999


Q ss_pred             EEEeeccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHH
Q 009340          366 AKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFIS  445 (537)
Q Consensus       366 ~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~  445 (537)
                      +||+|||++.......  ......+|..|+|||.+.+..++.++|||||||++|||++|+.||......+.   ......
T Consensus       147 ~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~---~~~~~~  221 (288)
T cd07863         147 VKLADFGLARIYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ---LGKIFD  221 (288)
T ss_pred             EEECccCccccccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHH---HHHHHH
Confidence            9999999998664322  12334678999999999988999999999999999999999999865432211   111111


Q ss_pred             HHhhc---hhhh-------hhcHHh---hccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          446 LAKEN---QLLE-------ILDARV---AKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       446 ~~~~~---~~~~-------~~d~~~---~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      .....   ....       ...+..   ...........+.+++.+||+.||++|||+.+++.
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         222 LIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             HhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            11000   0000       000000   00111233456789999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-37  Score=307.92  Aligned_cols=265  Identities=26%  Similarity=0.362  Sum_probs=202.4

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCC--ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEe
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI--DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE  292 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e  292 (537)
                      ++|+..+.||+|+||.||+|... +++.||+|.++..  .....+.+.+|++++++++|+||+++++++.+.+..++|||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            36888899999999999999965 5889999988642  33345678999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeecc
Q 009340          293 YISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG  372 (537)
Q Consensus       293 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfg  372 (537)
                      |++++.+..+...            ...+++..+..++.|+++||.|||+.+   ++|+||+|+||++++++.+||+|||
T Consensus        81 ~~~~~~l~~~~~~------------~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g  145 (288)
T cd07833          81 YVERTLLELLEAS------------PGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFG  145 (288)
T ss_pred             cCCCCHHHHHHhc------------CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeee
Confidence            9998777655433            235899999999999999999999998   9999999999999999999999999


Q ss_pred             CccccCCCCCceeeeccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHH-------
Q 009340          373 ISRSIPNDKTHLTTTIQGTFGYLDPEYFQSS-QFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFI-------  444 (537)
Q Consensus       373 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~-------  444 (537)
                      ++...............++..|+|||++.+. .++.++||||||+++|||++|+.||......+.........       
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  225 (288)
T cd07833         146 FARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSH  225 (288)
T ss_pred             cccccCCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            9987754433223345678899999999887 88999999999999999999999986443221100000000       


Q ss_pred             -HHHh-hc-----hhhhhhcHH-hhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          445 -SLAK-EN-----QLLEILDAR-VAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       445 -~~~~-~~-----~~~~~~d~~-~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                       ..+. ..     ...+..++. .....+...+..+.+++.+||..+|++|||+.++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         226 QELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             hhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence             0000 00     000000000 001122233678999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=6.9e-38  Score=321.19  Aligned_cols=247  Identities=25%  Similarity=0.397  Sum_probs=193.9

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCC---ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI---DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY  291 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  291 (537)
                      ++|+..+.||+|+||.||++... +++.||+|.++..   .......+.+|+.++..++|+|++++++.+.+.+..++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46888899999999999999864 6889999998642   2334567888999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeec
Q 009340          292 EYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF  371 (537)
Q Consensus       292 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Df  371 (537)
                      ||+++|+|.+++...            ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+||
T Consensus        81 E~~~gg~L~~~l~~~------------~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~Df  145 (360)
T cd05627          81 EFLPGGDMMTLLMKK------------DTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDF  145 (360)
T ss_pred             eCCCCccHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeec
Confidence            999999999998653            35899999999999999999999999   999999999999999999999999


Q ss_pred             cCccccCCCCC----------------------------------ceeeeccccccccCcccccCCCCCcchhHHHHHHH
Q 009340          372 GISRSIPNDKT----------------------------------HLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVV  417 (537)
Q Consensus       372 gla~~~~~~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvl  417 (537)
                      |++........                                  .......||+.|+|||++.+..++.++|||||||+
T Consensus       146 G~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvi  225 (360)
T cd05627         146 GLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVI  225 (360)
T ss_pred             cCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccce
Confidence            99875422110                                  00123468999999999999999999999999999


Q ss_pred             HHHHHhCCCCCCccchhhhccHHHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHh
Q 009340          418 LLELLTGKKPICFARVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMK  491 (537)
Q Consensus       418 l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~  491 (537)
                      +|||++|+.||......+.      +.......       ..+..+.....+.++.+++.+|+ .||.+|++..
T Consensus       226 lyel~tG~~Pf~~~~~~~~------~~~i~~~~-------~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~  285 (360)
T cd05627         226 MYEMLIGYPPFCSETPQET------YRKVMNWK-------ETLVFPPEVPISEKAKDLILRFC-TDSENRIGSN  285 (360)
T ss_pred             eeecccCCCCCCCCCHHHH------HHHHHcCC-------CceecCCCCCCCHHHHHHHHHhc-cChhhcCCCC
Confidence            9999999999975433221      11111100       00000001113456777888876 4999998643

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=2.3e-37  Score=308.05  Aligned_cols=247  Identities=23%  Similarity=0.382  Sum_probs=199.5

Q ss_pred             ccccccCcCCceEEEEEEcC-CCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecCCCC
Q 009340          219 NQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSG  297 (537)
Q Consensus       219 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g  297 (537)
                      .....||+|+||.||++... ++..||||.+........+.+.+|+.+++.++|+|++++++.+...+..++||||++++
T Consensus        25 ~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~  104 (292)
T cd06658          25 DSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGG  104 (292)
T ss_pred             hhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCC
Confidence            33467999999999999854 68899999987655566677899999999999999999999999999999999999999


Q ss_pred             ChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCcccc
Q 009340          298 TLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI  377 (537)
Q Consensus       298 sL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~  377 (537)
                      +|.+++..             ..+++..++.++.|++.||.|||+.+   ++||||||+||++++++.++|+|||++...
T Consensus       105 ~L~~~~~~-------------~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~  168 (292)
T cd06658         105 ALTDIVTH-------------TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQV  168 (292)
T ss_pred             cHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhc
Confidence            99998743             25889999999999999999999998   999999999999999999999999998765


Q ss_pred             CCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchhhhhhc
Q 009340          378 PNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEILD  457 (537)
Q Consensus       378 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  457 (537)
                      ..... ......++..|+|||.+.+..++.++||||||+++|||++|+.||........      +.. ..     ..+.
T Consensus       169 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~------~~~-~~-----~~~~  235 (292)
T cd06658         169 SKEVP-KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA------MRR-IR-----DNLP  235 (292)
T ss_pred             ccccc-cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHH-HH-----hcCC
Confidence            43222 12335688999999999888899999999999999999999999864322110      110 00     0111


Q ss_pred             HHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHH
Q 009340          458 ARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSME  496 (537)
Q Consensus       458 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~  496 (537)
                      ....  ........+.+++.+||+.||.+|||+.++++.
T Consensus       236 ~~~~--~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         236 PRVK--DSHKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             Cccc--cccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            1111  111234567899999999999999999999863

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=7.5e-37  Score=299.73  Aligned_cols=249  Identities=24%  Similarity=0.394  Sum_probs=197.2

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCC-----ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeC--Ccc
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI-----DKTQIHQFINEVVILSQINHRHIVKLLGCCLET--EVP  287 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~  287 (537)
                      .+|+..++||+|+||.||+|... +|+.||+|.+...     .....+.+.+|+.++++++|+||+++++++.+.  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            47888999999999999999964 5889999987521     223456788999999999999999999998764  457


Q ss_pred             EEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEE
Q 009340          288 VLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK  367 (537)
Q Consensus       288 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~k  367 (537)
                      ++||||+++++|.+++...            ..+++...++++.|++.||.|||+.+   ++|+||||+||+++.++.++
T Consensus        82 ~~v~e~~~~~~L~~~l~~~------------~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~  146 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSY------------GALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVK  146 (265)
T ss_pred             EEEEEecCCCcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEE
Confidence            8999999999999988642            35788899999999999999999999   99999999999999999999


Q ss_pred             EeeccCccccCCCCC--ceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHH
Q 009340          368 VSDFGISRSIPNDKT--HLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFIS  445 (537)
Q Consensus       368 i~Dfgla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~  445 (537)
                      |+|||++........  .......++..|+|||.+.+..++.++||||||+++|||++|+.||.......      ....
T Consensus       147 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~------~~~~  220 (265)
T cd06652         147 LGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA------AIFK  220 (265)
T ss_pred             ECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH------HHHH
Confidence            999999876532111  11223458889999999988889999999999999999999999986432111      0111


Q ss_pred             HHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          446 LAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       446 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      ...         .......+......+.+++.+|+. +|++||++.+|++
T Consensus       221 ~~~---------~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         221 IAT---------QPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             Hhc---------CCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence            000         001112344555678889999994 9999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=6.7e-37  Score=314.43  Aligned_cols=262  Identities=21%  Similarity=0.321  Sum_probs=197.8

Q ss_pred             HhcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCC--ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeC------
Q 009340          214 ATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI--DKTQIHQFINEVVILSQINHRHIVKLLGCCLET------  284 (537)
Q Consensus       214 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------  284 (537)
                      ..++|...+.||+|+||.||++... .++.||||++...  .......+.+|+.+++.++|+||+++++++...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            3578999999999999999999854 6889999998642  334456788999999999999999999987643      


Q ss_pred             CccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCC
Q 009340          285 EVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF  364 (537)
Q Consensus       285 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~  364 (537)
                      ...++||||+++ +|.+++..              .+++..+..++.|+++||+|||+.+   |+||||||+|||++.++
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~~--------------~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~  163 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQM--------------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDC  163 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHHh--------------cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCC
Confidence            246999999975 67766632              4788999999999999999999999   99999999999999999


Q ss_pred             cEEEeeccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHH---
Q 009340          365 SAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVA---  441 (537)
Q Consensus       365 ~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~---  441 (537)
                      .+||+|||+++......  ......+|..|+|||++.+..++.++|||||||++|||++|+.||......+......   
T Consensus       164 ~~kL~DfG~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~  241 (364)
T cd07875         164 TLKILDFGLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQL  241 (364)
T ss_pred             cEEEEeCCCccccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence            99999999998653322  2234568999999999999999999999999999999999999997544322110000   


Q ss_pred             -----HHHHHHhhchhhhhhcH--------------Hhh----ccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHH
Q 009340          442 -----CFISLAKENQLLEILDA--------------RVA----KEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSME  496 (537)
Q Consensus       442 -----~~~~~~~~~~~~~~~d~--------------~~~----~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~  496 (537)
                           .+...... .....+..              ...    ..........+.+|+.+||+.||++|||+.++++.
T Consensus       242 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         242 GTPCPEFMKKLQP-TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             CCCCHHHHHhhhH-HHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence                 00000000 00000000              000    00111123567899999999999999999999763

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=3.2e-37  Score=306.69  Aligned_cols=264  Identities=24%  Similarity=0.363  Sum_probs=206.2

Q ss_pred             ccCHHHHHHHhcCCccccccCcCCceEEEEEEc-CCCCEEEEEEccCCChHHHHHHHHHHHHHHhc-CCCCcceEeeEEe
Q 009340          205 VFTADELQRATDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEIDKTQIHQFINEVVILSQI-NHRHIVKLLGCCL  282 (537)
Q Consensus       205 ~~~~~el~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~  282 (537)
                      .++..++..++++|...+.||+|+||.||++.. .+++.+|+|.+.... .....+.+|+.++.++ +|+|++++++++.
T Consensus        11 ~~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~   89 (291)
T cd06639          11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFY   89 (291)
T ss_pred             hhhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence            356677777889999999999999999999996 468899999886532 2245677899999999 8999999999987


Q ss_pred             eCC-----ccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCC
Q 009340          283 ETE-----VPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSN  357 (537)
Q Consensus       283 ~~~-----~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~N  357 (537)
                      ..+     ..++|+||+++|+|.++++....        ....++|..++.++.|++.||.|||+.+   ++||||||+|
T Consensus        90 ~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~--------~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~n  158 (291)
T cd06639          90 KADKLVGGQLWLVLELCNGGSVTELVKGLLI--------CGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNN  158 (291)
T ss_pred             eccccCCCeeEEEEEECCCCcHHHHHHHhhh--------cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHH
Confidence            543     57999999999999998865321        1346899999999999999999999998   9999999999


Q ss_pred             EEECCCCcEEEeeccCccccCCCCCceeeeccccccccCcccccCC-----CCCcchhHHHHHHHHHHHHhCCCCCCccc
Q 009340          358 ILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSS-----QFTDKSDVYSFGVVLLELLTGKKPICFAR  432 (537)
Q Consensus       358 Ill~~~~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~t~ksDV~S~Gvll~el~tg~~p~~~~~  432 (537)
                      |+++.++.+||+|||++......... .....++..|+|||.+...     .++.++|||||||++|||++|+.||....
T Consensus       159 ili~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~  237 (291)
T cd06639         159 ILLTTEGGVKLVDFGVSAQLTSTRLR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMH  237 (291)
T ss_pred             EEEcCCCCEEEeecccchhccccccc-ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCc
Confidence            99999999999999998865432211 2234578899999998643     36889999999999999999999986432


Q ss_pred             hhhhccHHHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          433 VEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       433 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      ....      ...... ....     .+  ..+......+.+++.+||+.+|++||++.++++
T Consensus       238 ~~~~------~~~~~~-~~~~-----~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         238 PVKT------LFKIPR-NPPP-----TL--LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             HHHH------HHHHhc-CCCC-----CC--CcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            2110      111110 0000     00  112234457889999999999999999999975

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.8e-37  Score=307.48  Aligned_cols=264  Identities=23%  Similarity=0.368  Sum_probs=204.2

Q ss_pred             cCHHHHHHHhcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCChHHHHHHHHHHHHHHhc-CCCCcceEeeEEee
Q 009340          206 FTADELQRATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKTQIHQFINEVVILSQI-NHRHIVKLLGCCLE  283 (537)
Q Consensus       206 ~~~~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~  283 (537)
                      +.++.+..+.++|+..+.||+|+||.||++... +++.+|+|..+... ....++.+|+.+++.+ +|+|++++++++..
T Consensus         8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   86 (286)
T cd06638           8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK   86 (286)
T ss_pred             EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence            445667778899999999999999999999864 68899999876532 2235678899999999 69999999999853


Q ss_pred             -----CCccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCE
Q 009340          284 -----TEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNI  358 (537)
Q Consensus       284 -----~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NI  358 (537)
                           .+..++||||+++++|.+++......        ...+++..+..++.|+++||.|||+.+   ++||||||+||
T Consensus        87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~--------~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~ni  155 (286)
T cd06638          87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKR--------GERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNI  155 (286)
T ss_pred             cccCCCCeEEEEEeecCCCCHHHHHHHhhcc--------CccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhE
Confidence                 34679999999999999988643211        236889999999999999999999998   99999999999


Q ss_pred             EECCCCcEEEeeccCccccCCCCCceeeeccccccccCcccccC-----CCCCcchhHHHHHHHHHHHHhCCCCCCccch
Q 009340          359 LLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQS-----SQFTDKSDVYSFGVVLLELLTGKKPICFARV  433 (537)
Q Consensus       359 ll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~  433 (537)
                      +++.++.+||+|||++........ ......|+..|+|||++..     ..++.++|||||||++|||++|+.|+.....
T Consensus       156 li~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~  234 (286)
T cd06638         156 LLTTEGGVKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP  234 (286)
T ss_pred             EECCCCCEEEccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCch
Confidence            999999999999999886643221 2234468999999999853     4578899999999999999999999864322


Q ss_pred             hhhccHHHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHH
Q 009340          434 EEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSME  496 (537)
Q Consensus       434 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~  496 (537)
                      ...      .... ....     .+..  ..+......+.+++.+||+.+|++|||+.||++.
T Consensus       235 ~~~------~~~~-~~~~-----~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         235 MRA------LFKI-PRNP-----PPTL--HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             hHH------Hhhc-cccC-----CCcc--cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence            110      0000 0000     0000  0111233568899999999999999999999864

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1.3e-37  Score=308.57  Aligned_cols=264  Identities=25%  Similarity=0.414  Sum_probs=199.3

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCC--ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEe
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI--DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE  292 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e  292 (537)
                      ++|+..++||+|+||.||++... +++.||+|++...  .....+.+.+|+++++.++|+|++++++++.+.+..++|+|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            36788899999999999999975 5899999987642  22235678899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeecc
Q 009340          293 YISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG  372 (537)
Q Consensus       293 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfg  372 (537)
                      |+++++|.++...            ...++|..++.++.|+++||+|||+.+   ++|+||+|+||++++++.++|+|||
T Consensus        81 ~~~~~~l~~~~~~------------~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg  145 (286)
T cd07846          81 FVDHTVLDDLEKY------------PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFG  145 (286)
T ss_pred             cCCccHHHHHHhc------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeee
Confidence            9999988877653            225899999999999999999999998   9999999999999999999999999


Q ss_pred             CccccCCCCCceeeeccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCccchhhh-ccHHHHHHH-----
Q 009340          373 ISRSIPNDKTHLTTTIQGTFGYLDPEYFQS-SQFTDKSDVYSFGVVLLELLTGKKPICFARVEEE-RNLVACFIS-----  445 (537)
Q Consensus       373 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~-~~~~~~~~~-----  445 (537)
                      ++....... .......++..|+|||++.+ ..++.++||||||+++|||++|+.||......+. .........     
T Consensus       146 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  224 (286)
T cd07846         146 FARTLAAPG-EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRH  224 (286)
T ss_pred             eeeeccCCc-cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhh
Confidence            998764332 22233457889999999875 4578899999999999999999988864332111 000000000     


Q ss_pred             --HHhhchhh-hhhcHHhh-----ccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          446 --LAKENQLL-EILDARVA-----KEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       446 --~~~~~~~~-~~~d~~~~-----~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                        ........ ....+...     .......+..+.+++.+||+.+|++||++.++++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         225 QEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             HHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence              00000000 00000000     0011233567899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=3e-37  Score=305.73  Aligned_cols=264  Identities=22%  Similarity=0.321  Sum_probs=199.3

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCC--hHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEe
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEID--KTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE  292 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e  292 (537)
                      ++|+..+.||+|+||.||+|+.. +|+.||+|++....  ....+.+.+|+.++++++|+|++++++++......++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            46788899999999999999975 68999999876432  2234567899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeecc
Q 009340          293 YISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG  372 (537)
Q Consensus       293 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfg  372 (537)
                      |+++++|..++..            ...++|..++.++.|+++||+|||+.+   ++||||||+||+++.++.++|+|||
T Consensus        81 ~~~~~~l~~~~~~------------~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg  145 (286)
T cd07847          81 YCDHTVLNELEKN------------PRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFG  145 (286)
T ss_pred             ccCccHHHHHHhC------------CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccc
Confidence            9999888877643            235899999999999999999999998   9999999999999999999999999


Q ss_pred             CccccCCCCCceeeeccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHH-HHHH-----
Q 009340          373 ISRSIPNDKTHLTTTIQGTFGYLDPEYFQS-SQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVA-CFIS-----  445 (537)
Q Consensus       373 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~-~~~~-----  445 (537)
                      ++........ ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+...... ....     
T Consensus       146 ~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  224 (286)
T cd07847         146 FARILTGPGD-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRH  224 (286)
T ss_pred             cceecCCCcc-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHH
Confidence            9987644321 1223347889999999876 567899999999999999999999986543322110000 0000     


Q ss_pred             --HHhhchh-hhhhcHHhhc-----cccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          446 --LAKENQL-LEILDARVAK-----EAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       446 --~~~~~~~-~~~~d~~~~~-----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                        .+..... .....+....     ......+..+.+++.+||+.+|++||++.+++.
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         225 QQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             hhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence              0000000 0000000000     001123467889999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=5.3e-37  Score=300.19  Aligned_cols=251  Identities=28%  Similarity=0.454  Sum_probs=201.2

Q ss_pred             CCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCCh--HHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEec
Q 009340          217 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDK--TQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY  293 (537)
Q Consensus       217 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  293 (537)
                      +|...+.||+|+||.||+|... +++.|++|.++....  ...+.+.+|+.++++++|+||+++++++.+.+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            4777889999999999999864 688999999875433  4677899999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccC
Q 009340          294 ISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGI  373 (537)
Q Consensus       294 ~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgl  373 (537)
                      +++++|.+++...            ..+++..+..++.++++||.|||+.+   ++|+||+|+||++++++.+||+|||+
T Consensus        81 ~~~~~L~~~~~~~------------~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~  145 (264)
T cd06626          81 CSGGTLEELLEHG------------RILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGC  145 (264)
T ss_pred             CCCCcHHHHHhhc------------CCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccccc
Confidence            9999999998752            24889999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCCceee---eccccccccCcccccCCC---CCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHH
Q 009340          374 SRSIPNDKTHLTT---TIQGTFGYLDPEYFQSSQ---FTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLA  447 (537)
Q Consensus       374 a~~~~~~~~~~~~---~~~gt~~y~aPE~~~~~~---~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~  447 (537)
                      +............   ...++..|+|||++....   ++.++||||||+++|||++|+.||.......     .......
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~-----~~~~~~~  220 (264)
T cd06626         146 AVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF-----QIMFHVG  220 (264)
T ss_pred             ccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH-----HHHHHHh
Confidence            9876443332211   345788999999998766   8899999999999999999999986432111     0000000


Q ss_pred             hhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          448 KENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       448 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      . ..     .+.+  +........+.+++.+||+.+|++|||+.+++.
T Consensus       221 ~-~~-----~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         221 A-GH-----KPPI--PDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             c-CC-----CCCC--CcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            0 00     0000  011122566789999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.8e-37  Score=328.84  Aligned_cols=266  Identities=19%  Similarity=0.262  Sum_probs=193.8

Q ss_pred             HHHHHHhcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCChHHHHHHHHHHHHHHhcCC------CCcceEeeEE
Q 009340          209 DELQRATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKTQIHQFINEVVILSQINH------RHIVKLLGCC  281 (537)
Q Consensus       209 ~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H------~niv~l~g~~  281 (537)
                      +++...+++|...++||+|+||+||++... .++.||||+++... ....++..|+.++..++|      .+++++++++
T Consensus       122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~  200 (467)
T PTZ00284        122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF  200 (467)
T ss_pred             CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence            344455788999999999999999999854 57889999986532 223455667777777754      4588899988


Q ss_pred             eeC-CccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeecCCCCCCEE
Q 009340          282 LET-EVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHS-SASIPIFHRDIKSSNIL  359 (537)
Q Consensus       282 ~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-~~~~~ivH~Dlk~~NIl  359 (537)
                      ... ...++|||++ +++|.+++...            ..+++..+..|+.||+.||.|||+ .+   |+||||||+|||
T Consensus       201 ~~~~~~~~iv~~~~-g~~l~~~l~~~------------~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NIL  264 (467)
T PTZ00284        201 QNETGHMCIVMPKY-GPCLLDWIMKH------------GPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENIL  264 (467)
T ss_pred             EcCCceEEEEEecc-CCCHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEE
Confidence            765 4678899987 66888888652            359999999999999999999998 47   999999999999


Q ss_pred             ECCCC----------------cEEEeeccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh
Q 009340          360 LDDKF----------------SAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT  423 (537)
Q Consensus       360 l~~~~----------------~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t  423 (537)
                      ++.++                .+||+|||++.....    ......||+.|+|||++.+..++.++|||||||++|||++
T Consensus       265 l~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~ellt  340 (467)
T PTZ00284        265 METSDTVVDPVTNRALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYT  340 (467)
T ss_pred             EecCCcccccccccccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHh
Confidence            98765                499999998764322    2334678999999999999999999999999999999999


Q ss_pred             CCCCCCccchhhhccHHHHH--------HHHHhhchhhhh----------hcHHhh----ccc---cHHHHHHHHHHHHH
Q 009340          424 GKKPICFARVEEERNLVACF--------ISLAKENQLLEI----------LDARVA----KEA---REEDIGAMAELAMR  478 (537)
Q Consensus       424 g~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~----------~d~~~~----~~~---~~~~~~~l~~l~~~  478 (537)
                      |+.||......+........        ..........++          .++...    ...   .......+.+|+.+
T Consensus       341 G~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~  420 (467)
T PTZ00284        341 GKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYG  420 (467)
T ss_pred             CCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHH
Confidence            99999754432211111110        000000000000          011000    000   00123567899999


Q ss_pred             hcccCCCCCCCHhhHHH
Q 009340          479 CLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       479 cl~~~p~~RPs~~ev~~  495 (537)
                      ||+.||++|||+.|+++
T Consensus       421 mL~~dP~~R~ta~e~L~  437 (467)
T PTZ00284        421 LLHYDRQKRLNARQMTT  437 (467)
T ss_pred             hCCcChhhCCCHHHHhc
Confidence            99999999999999986

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=5.7e-37  Score=298.58  Aligned_cols=248  Identities=27%  Similarity=0.438  Sum_probs=200.9

Q ss_pred             CCccccccCcCCceEEEEEEc-CCCCEEEEEEccCC--ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEec
Q 009340          217 NYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEI--DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY  293 (537)
Q Consensus       217 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  293 (537)
                      +|...+.||+|+||.||++.. .+++.+|+|.+...  .......+.+|+.+++.++|+|++++++.+...+..++|+||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            477889999999999999885 36889999987643  334567899999999999999999999999988999999999


Q ss_pred             CCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCC-CcEEEeecc
Q 009340          294 ISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK-FSAKVSDFG  372 (537)
Q Consensus       294 ~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~-~~~ki~Dfg  372 (537)
                      +++++|.+++....          ...+++..+.+++.++++||.|||+++   ++|+||+|+||+++++ +.+||+|||
T Consensus        81 ~~~~~L~~~~~~~~----------~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~  147 (256)
T cd08220          81 APGGTLAEYIQKRC----------NSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFG  147 (256)
T ss_pred             CCCCCHHHHHHHhc----------ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCC
Confidence            99999999997632          235899999999999999999999998   9999999999999854 468999999


Q ss_pred             CccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchh
Q 009340          373 ISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQL  452 (537)
Q Consensus       373 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  452 (537)
                      ++........  .....++..|+|||.+.+..++.++||||||+++|+|++|+.||.......      ....... .. 
T Consensus       148 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~------~~~~~~~-~~-  217 (256)
T cd08220         148 ISKILSSKSK--AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA------LVLKIMS-GT-  217 (256)
T ss_pred             CceecCCCcc--ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH------HHHHHHh-cC-
Confidence            9987643321  223457889999999998889999999999999999999999986433211      0111110 00 


Q ss_pred             hhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          453 LEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       453 ~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                              ....+......+.+++.+||+.+|++|||+.+++.
T Consensus       218 --------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         218 --------FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             --------CCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence                    11122234567889999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.5e-37  Score=314.99  Aligned_cols=259  Identities=21%  Similarity=0.323  Sum_probs=195.1

Q ss_pred             HHhcCCccccccCcCCceEEEEEEc-CCCCEEEEEEccCCC--hHHHHHHHHHHHHHHhcCCCCcceEeeEEeeC-----
Q 009340          213 RATDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEID--KTQIHQFINEVVILSQINHRHIVKLLGCCLET-----  284 (537)
Q Consensus       213 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----  284 (537)
                      ...++|...+.||+|+||.||++.. .+++.||||++....  ....+.+.+|+.++++++|+||+++++++...     
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN   91 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence            3457888999999999999999985 468899999986532  23445678999999999999999999988643     


Q ss_pred             -CccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCC
Q 009340          285 -EVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK  363 (537)
Q Consensus       285 -~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~  363 (537)
                       ...++++|++ +++|.+++..             ..+++..+..++.|+++||.|||+.+   |+||||||+|||++++
T Consensus        92 ~~~~~~~~~~~-~~~l~~~~~~-------------~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~  154 (343)
T cd07878          92 FNEVYLVTNLM-GADLNNIVKC-------------QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNED  154 (343)
T ss_pred             cCcEEEEeecC-CCCHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCC
Confidence             3468999987 6788877742             35899999999999999999999999   9999999999999999


Q ss_pred             CcEEEeeccCccccCCCCCceeeeccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHH
Q 009340          364 FSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQS-SQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVAC  442 (537)
Q Consensus       364 ~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~  442 (537)
                      +.+||+|||+++.....    .....||..|+|||.+.+ ..++.++|||||||++|||++|+.||......+.   ...
T Consensus       155 ~~~kl~Dfg~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~  227 (343)
T cd07878         155 CELRILDFGLARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQ---LKR  227 (343)
T ss_pred             CCEEEcCCccceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH---HHH
Confidence            99999999999865432    233468999999999876 5688999999999999999999999865432211   000


Q ss_pred             HHHHHhh-----------chhhhhhcH--Hhh----ccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          443 FISLAKE-----------NQLLEILDA--RVA----KEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       443 ~~~~~~~-----------~~~~~~~d~--~~~----~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      .......           ......+..  ...    ........+.+.+|+.+||+.||++|||+.|++.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~  297 (343)
T cd07878         228 IMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA  297 (343)
T ss_pred             HHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            1000000           000000000  000    0000112345789999999999999999999985

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=2.9e-37  Score=310.93  Aligned_cols=202  Identities=23%  Similarity=0.388  Sum_probs=161.7

Q ss_pred             ccccCcCCceEEEEEEcC---CCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeC--CccEEEEecCC
Q 009340          221 SRFLGQGGFGTVYKGMLP---DGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLET--EVPVLVYEYIS  295 (537)
Q Consensus       221 ~~~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~e~~~  295 (537)
                      .++||+|+||.||+|+..   +++.||+|.+.....  ...+.+|+.++++++||||+++++++...  ...++|+||+.
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            468999999999999854   467899999875322  34567899999999999999999998643  45789999986


Q ss_pred             CCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEE----CCCCcEEEeec
Q 009340          296 SGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILL----DDKFSAKVSDF  371 (537)
Q Consensus       296 ~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll----~~~~~~ki~Df  371 (537)
                      + +|.+++........   ......+++..+..++.|++.||.|||+.+   |+||||||+|||+    +.++.+||+||
T Consensus        84 ~-~l~~~~~~~~~~~~---~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~Df  156 (317)
T cd07868          84 H-DLWHIIKFHRASKA---NKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADM  156 (317)
T ss_pred             C-CHHHHHHhcccccc---cCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeec
Confidence            5 88887754322100   001235899999999999999999999999   9999999999999    46678999999


Q ss_pred             cCccccCCCCCc--eeeeccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCcc
Q 009340          372 GISRSIPNDKTH--LTTTIQGTFGYLDPEYFQS-SQFTDKSDVYSFGVVLLELLTGKKPICFA  431 (537)
Q Consensus       372 gla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~el~tg~~p~~~~  431 (537)
                      |+++........  ......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||...
T Consensus       157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~  219 (317)
T cd07868         157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             CceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence            999876433221  2234568999999999876 45899999999999999999999998643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=8e-37  Score=299.76  Aligned_cols=252  Identities=24%  Similarity=0.488  Sum_probs=201.7

Q ss_pred             CCccccccCcCCceEEEEEEc-CCCCEEEEEEccCCC------hHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEE
Q 009340          217 NYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEID------KTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVL  289 (537)
Q Consensus       217 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  289 (537)
                      +|+..+.||+|+||.||++.. .+++.||+|.+....      ....+.+.+|+.++++++|+|++++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            477788999999999999985 578999999886422      2235678999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCC-cEEE
Q 009340          290 VYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF-SAKV  368 (537)
Q Consensus       290 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~-~~ki  368 (537)
                      |+||+++++|.+++...            ..+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++ .+||
T Consensus        81 v~e~~~~~~L~~~l~~~------------~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l  145 (268)
T cd06630          81 FVEWMAGGSVSHLLSKY------------GAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRI  145 (268)
T ss_pred             EEeccCCCcHHHHHHHh------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEE
Confidence            99999999999998642            35889999999999999999999999   99999999999998775 6999


Q ss_pred             eeccCccccCCCCCc---eeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHH
Q 009340          369 SDFGISRSIPNDKTH---LTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFIS  445 (537)
Q Consensus       369 ~Dfgla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~  445 (537)
                      +|||++.........   ......++..|+|||.+.+..++.++||||+|+++++|++|+.||........   ......
T Consensus       146 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~---~~~~~~  222 (268)
T cd06630         146 ADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH---LALIFK  222 (268)
T ss_pred             cccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch---HHHHHH
Confidence            999999776433211   12234578999999999888899999999999999999999999854322111   000000


Q ss_pred             HHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          446 LAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       446 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                               ..........+......+.+++.+||+.+|++||++.++++
T Consensus       223 ---------~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         223 ---------IASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             ---------HhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence                     00001112334455677889999999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-38  Score=316.27  Aligned_cols=244  Identities=27%  Similarity=0.437  Sum_probs=199.9

Q ss_pred             CCccccccCcCCceEEEEEEc-CCCCEEEEEEccCCCh---HHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEe
Q 009340          217 NYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEIDK---TQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE  292 (537)
Q Consensus       217 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e  292 (537)
                      .|...+.||.|+||.||.++. ++.+.||||++.-..+   ....+++.|++.|++++|||.+.+.||+..+...|||||
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME  106 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME  106 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence            455567899999999999994 4788999999875433   346678999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeecc
Q 009340          293 YISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG  372 (537)
Q Consensus       293 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfg  372 (537)
                      ||- ||-.|.+.-++           +++-...+..|+.+.+.||+|||+++   .||||||+.||||++.|.+|++|||
T Consensus       107 YCl-GSAsDlleVhk-----------KplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFG  171 (948)
T KOG0577|consen  107 YCL-GSASDLLEVHK-----------KPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFG  171 (948)
T ss_pred             HHh-ccHHHHHHHHh-----------ccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeecccc
Confidence            995 58888876654           37889999999999999999999999   9999999999999999999999999


Q ss_pred             CccccCCCCCceeeeccccccccCccccc---CCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhh
Q 009340          373 ISRSIPNDKTHLTTTIQGTFGYLDPEYFQ---SSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKE  449 (537)
Q Consensus       373 la~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  449 (537)
                      .+......     ...+||+.|||||++.   .|.|+-|+||||+|+...||.-.++|......      ...+..+...
T Consensus       172 SAsi~~PA-----nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA------MSALYHIAQN  240 (948)
T KOG0577|consen  172 SASIMAPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQN  240 (948)
T ss_pred             chhhcCch-----hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH------HHHHHHHHhc
Confidence            98776433     4568999999999874   68999999999999999999999999754321      1111111111


Q ss_pred             chhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          450 NQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       450 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                            -.|.+.   ..+.+..+..++..||+.-|.+|||..++++
T Consensus       241 ------esPtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~  277 (948)
T KOG0577|consen  241 ------ESPTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLK  277 (948)
T ss_pred             ------CCCCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence                  011111   3455678899999999999999999988764

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-38  Score=319.27  Aligned_cols=244  Identities=27%  Similarity=0.452  Sum_probs=205.7

Q ss_pred             ccCcCCceEEEEEEcCC-CCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecCCCCChhh
Q 009340          223 FLGQGGFGTVYKGMLPD-GSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSH  301 (537)
Q Consensus       223 ~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~  301 (537)
                      +||+|.||+||.|+..+ ...+|||.+...+....+-+..|+.+.++++|.|||+++|+|.+.+..-+.||-.++|||.+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            69999999999999654 55799999988777777889999999999999999999999999999899999999999999


Q ss_pred             hhhhhhhhHHHHhhhccCCC--CHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEC-CCCcEEEeeccCccccC
Q 009340          302 HIHDHQQQQEQKQKQELSSL--SWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD-DKFSAKVSDFGISRSIP  378 (537)
Q Consensus       302 ~l~~~~~~~~~~~~~~~~~l--~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~-~~~~~ki~Dfgla~~~~  378 (537)
                      +|+...+           ++  ++...-....||++||.|||+..   |||||||-.|||++ -.|.+||+|||-++.+.
T Consensus       662 LLrskWG-----------PlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLA  727 (1226)
T KOG4279|consen  662 LLRSKWG-----------PLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLA  727 (1226)
T ss_pred             HHHhccC-----------CCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhc
Confidence            9987654           45  67778889999999999999999   99999999999995 68899999999998874


Q ss_pred             CCCCceeeeccccccccCcccccCCC--CCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchhhhhh
Q 009340          379 NDKTHLTTTIQGTFGYLDPEYFQSSQ--FTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEIL  456 (537)
Q Consensus       379 ~~~~~~~~~~~gt~~y~aPE~~~~~~--~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  456 (537)
                      . -+..+.+..||.-|||||++..|+  |..++|||||||.+.||.||++||.......        ..+++-+.     
T Consensus       728 g-inP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq--------AAMFkVGm-----  793 (1226)
T KOG4279|consen  728 G-INPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ--------AAMFKVGM-----  793 (1226)
T ss_pred             c-CCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh--------Hhhhhhcc-----
Confidence            3 334456678999999999998764  8899999999999999999999996543221        01111110     


Q ss_pred             cHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          457 DARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       457 d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                       -..-.+.|.+.+.+...++.+|+.++|.+||+++++++
T Consensus       794 -yKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  794 -YKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             -eecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence             01224567888899999999999999999999999975

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=4e-37  Score=304.48  Aligned_cols=260  Identities=22%  Similarity=0.414  Sum_probs=203.6

Q ss_pred             cCHHHHHHHhcCCccccccCcCCceEEEEEEc-CCCCEEEEEEccCCChHHHHHHHHHHHHHHhc-CCCCcceEeeEEee
Q 009340          206 FTADELQRATDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEIDKTQIHQFINEVVILSQI-NHRHIVKLLGCCLE  283 (537)
Q Consensus       206 ~~~~el~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~  283 (537)
                      .+..++..+.+.|+..+.||+|+||.||+|.. .+++.||+|...... ....++..|+.++.++ +|+|++++++++..
T Consensus         6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   84 (282)
T cd06636           6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIK   84 (282)
T ss_pred             hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence            45666667788999999999999999999996 468899999876543 3345688899999999 79999999999863


Q ss_pred             ------CCccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCC
Q 009340          284 ------TEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSN  357 (537)
Q Consensus       284 ------~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~N  357 (537)
                            .+..+++|||+++|+|.+++.....          ..+++..++.++.|+++||.|||+.+   ++|+||+|+|
T Consensus        85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~----------~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~n  151 (282)
T cd06636          85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKG----------NALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQN  151 (282)
T ss_pred             ccccCCCCEEEEEEEeCCCCcHHHHHHHccC----------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHH
Confidence                  3467999999999999999865332          35888899999999999999999999   9999999999


Q ss_pred             EEECCCCcEEEeeccCccccCCCCCceeeeccccccccCccccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCccc
Q 009340          358 ILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQ-----SSQFTDKSDVYSFGVVLLELLTGKKPICFAR  432 (537)
Q Consensus       358 Ill~~~~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~  432 (537)
                      |++++++.++|+|||++........ ......|+..|+|||.+.     ...++.++|||||||++|||++|+.||....
T Consensus       152 ili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~  230 (282)
T cd06636         152 VLLTENAEVKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMH  230 (282)
T ss_pred             EEECCCCCEEEeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccC
Confidence            9999999999999999876532211 123345889999999875     3467889999999999999999999986432


Q ss_pred             hhhhccHHHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          433 VEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       433 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      ....      ......         ...........+..+.+++.+||+.||.+|||+.|+++
T Consensus       231 ~~~~------~~~~~~---------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         231 PMRA------LFLIPR---------NPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             HHhh------hhhHhh---------CCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence            2111      000000         00000111234567899999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=6.1e-37  Score=303.57  Aligned_cols=261  Identities=24%  Similarity=0.306  Sum_probs=201.2

Q ss_pred             CCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCC--hHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEec
Q 009340          217 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEID--KTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY  293 (537)
Q Consensus       217 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  293 (537)
                      +|+..+.||+|+||.||+|... +|+.||+|++....  ......+.+|+.++++++|+|++++++++.+....++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            4677889999999999999964 68999999987543  33456789999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccC
Q 009340          294 ISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGI  373 (537)
Q Consensus       294 ~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgl  373 (537)
                      + +++|.+++....           ..+++.+++.++.|+++||+|||+.+   ++|+||||+||+++.++.++|+|||+
T Consensus        81 ~-~~~L~~~~~~~~-----------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~  145 (286)
T cd07832          81 M-PSDLSEVLRDEE-----------RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGL  145 (286)
T ss_pred             c-CCCHHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeee
Confidence            9 999999986532           36899999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCCceeeeccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhch-
Q 009340          374 SRSIPNDKTHLTTTIQGTFGYLDPEYFQSS-QFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQ-  451 (537)
Q Consensus       374 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~-  451 (537)
                      +...............++..|+|||.+.+. .++.++||||+|++++||++|+.+|......+   ............. 
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~---~~~~~~~~~~~~~~  222 (286)
T cd07832         146 ARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIE---QLAIVFRTLGTPNE  222 (286)
T ss_pred             cccccCCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHH---HHHHHHHHcCCCCh
Confidence            987654432223345688999999998654 46899999999999999999977775433211   1111111110000 


Q ss_pred             -----------hhhhhcHH----hhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          452 -----------LLEILDAR----VAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       452 -----------~~~~~d~~----~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                                 ...+..+.    .......+....+.+++.+||+.+|++|||+++++.
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~  281 (286)
T cd07832         223 ETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR  281 (286)
T ss_pred             HHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence                       00000000    000111123478899999999999999999999875

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.6e-37  Score=307.73  Aligned_cols=252  Identities=24%  Similarity=0.363  Sum_probs=200.9

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCCh---HHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDK---TQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY  291 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  291 (537)
                      ++|...+.||+|+||.||++... +++.||+|.+.....   ...+.+.+|+.+++.++|+||+++++++.+....++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            36888899999999999999965 489999998865322   34567889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeec
Q 009340          292 EYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF  371 (537)
Q Consensus       292 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Df  371 (537)
                      ||+.+++|.+++....          ...+++..+..++.|+++||+|||+.+   ++|+||||+||+++.++.++|+||
T Consensus        81 e~~~~~~L~~~~~~~~----------~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~df  147 (316)
T cd05574          81 DYCPGGELFRLLQRQP----------GKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDF  147 (316)
T ss_pred             EecCCCCHHHHHHhCC----------CCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeec
Confidence            9999999999986432          236899999999999999999999998   999999999999999999999999


Q ss_pred             cCccccCCCCCc----------------------------eeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh
Q 009340          372 GISRSIPNDKTH----------------------------LTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT  423 (537)
Q Consensus       372 gla~~~~~~~~~----------------------------~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t  423 (537)
                      |++.........                            ......|+..|+|||.+.+..++.++||||||+++|+|++
T Consensus       148 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~  227 (316)
T cd05574         148 DLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLY  227 (316)
T ss_pred             chhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhh
Confidence            998755322110                            0112357889999999998889999999999999999999


Q ss_pred             CCCCCCccchhhhccHHHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCC----HhhHHH
Q 009340          424 GKKPICFARVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPT----MKQVSM  495 (537)
Q Consensus       424 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs----~~ev~~  495 (537)
                      |+.||........      +..         +.+...........+..+.+++.+||+.+|++|||    +.+++.
T Consensus       228 g~~pf~~~~~~~~------~~~---------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         228 GTTPFKGSNRDET------FSN---------ILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             CCCCCCCCchHHH------HHH---------HhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            9999864432211      111         11111111111124578999999999999999999    555544

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1e-36  Score=298.57  Aligned_cols=256  Identities=27%  Similarity=0.422  Sum_probs=204.8

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCC-hHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEec
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEID-KTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY  293 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  293 (537)
                      ++|+..+.||.|+||+||+|... ++..+|+|++.... ......+.+|+.+++.++|+|++++++.+...+..++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            46888999999999999999954 67899999986432 33567889999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccC
Q 009340          294 ISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGI  373 (537)
Q Consensus       294 ~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgl  373 (537)
                      +++++|.+++.....         ...+++.....++.|++.||.|||+.+   ++||||+|+||++++++.++|+|||+
T Consensus        81 ~~~~~l~~~~~~~~~---------~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~  148 (267)
T cd06610          81 LSGGSLLDIMKSSYP---------RGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGV  148 (267)
T ss_pred             cCCCcHHHHHHHhcc---------cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccch
Confidence            999999999975422         236899999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCCc---eeeeccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhh
Q 009340          374 SRSIPNDKTH---LTTTIQGTFGYLDPEYFQSS-QFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKE  449 (537)
Q Consensus       374 a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  449 (537)
                      +.........   ......++..|+|||++... .++.++|+||||+++|||++|+.||.......      .+......
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~------~~~~~~~~  222 (267)
T cd06610         149 SASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK------VLMLTLQN  222 (267)
T ss_pred             HHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh------hHHHHhcC
Confidence            8776443322   22334688999999998877 78999999999999999999999986432211      11111111


Q ss_pred             chhhhhhcHHhhccc-cHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          450 NQLLEILDARVAKEA-REEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       450 ~~~~~~~d~~~~~~~-~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      .      .+.+.... ....+..+.+++.+||+.||++||++.++++
T Consensus       223 ~------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         223 D------PPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             C------CCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            0      00111110 1234567889999999999999999999875

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1e-36  Score=299.91  Aligned_cols=253  Identities=24%  Similarity=0.446  Sum_probs=197.7

Q ss_pred             CCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCC----------hHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCC
Q 009340          217 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEID----------KTQIHQFINEVVILSQINHRHIVKLLGCCLETE  285 (537)
Q Consensus       217 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~  285 (537)
                      +|...+.||+|+||.||+|... +|+.||+|.++...          ....+.+.+|+.+++.++|+|++++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            4667789999999999999854 68899999875311          112356888999999999999999999999999


Q ss_pred             ccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCc
Q 009340          286 VPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFS  365 (537)
Q Consensus       286 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~  365 (537)
                      ..++|+||+++|+|.+++...            ..+++..+..++.|++.||.|||+.+   ++||||+|+||+++.++.
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~------------~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~  146 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTY------------GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGI  146 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhc------------cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCe
Confidence            999999999999999998753            35899999999999999999999998   999999999999999999


Q ss_pred             EEEeeccCccccCCCCCc-eeeeccccccccCcccccCCC--CCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHH
Q 009340          366 AKVSDFGISRSIPNDKTH-LTTTIQGTFGYLDPEYFQSSQ--FTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVAC  442 (537)
Q Consensus       366 ~ki~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~  442 (537)
                      ++|+|||+++........ ......++..|+|||.+....  ++.++|+||||+++|||++|+.|+......+      .
T Consensus       147 ~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~------~  220 (272)
T cd06629         147 CKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA------A  220 (272)
T ss_pred             EEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHH------H
Confidence            999999999765322111 123346789999999987654  7899999999999999999999985322111      0


Q ss_pred             HHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          443 FISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       443 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      ....... .....+.    .......+..+.+++.+||+.+|++|||+.+|++
T Consensus       221 ~~~~~~~-~~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (272)
T cd06629         221 MFKLGNK-RSAPPIP----PDVSMNLSPVALDFLNACFTINPDNRPTARELLQ  268 (272)
T ss_pred             HHHhhcc-ccCCcCC----ccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence            1111000 0000111    1111234567889999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=4.4e-37  Score=309.50  Aligned_cols=202  Identities=23%  Similarity=0.389  Sum_probs=161.6

Q ss_pred             ccccCcCCceEEEEEEcC---CCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEee--CCccEEEEecCC
Q 009340          221 SRFLGQGGFGTVYKGMLP---DGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLE--TEVPVLVYEYIS  295 (537)
Q Consensus       221 ~~~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~e~~~  295 (537)
                      ..+||+|+||.||+|+..   ++..||+|.++....  ...+.+|+.++++++|+||+++++++..  ....++|+||++
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE   83 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence            357999999999999964   357899998875332  3457789999999999999999999864  446789999987


Q ss_pred             CCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEE----CCCCcEEEeec
Q 009340          296 SGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILL----DDKFSAKVSDF  371 (537)
Q Consensus       296 ~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll----~~~~~~ki~Df  371 (537)
                      + +|.+++........   ......+++..+..++.|+++||.|||+.+   |+||||||+|||+    +.++.+||+||
T Consensus        84 ~-~l~~~~~~~~~~~~---~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~Df  156 (317)
T cd07867          84 H-DLWHIIKFHRASKA---NKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADM  156 (317)
T ss_pred             C-cHHHHHHhhhcccc---CCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeec
Confidence            5 78777754321100   001235899999999999999999999999   9999999999999    56779999999


Q ss_pred             cCccccCCCCCc--eeeeccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCcc
Q 009340          372 GISRSIPNDKTH--LTTTIQGTFGYLDPEYFQS-SQFTDKSDVYSFGVVLLELLTGKKPICFA  431 (537)
Q Consensus       372 gla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~el~tg~~p~~~~  431 (537)
                      |+++........  ......+|+.|+|||.+.+ ..++.++|||||||++|||+||+.||...
T Consensus       157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~  219 (317)
T cd07867         157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             cceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence            999876433221  1234568999999999876 45899999999999999999999998643

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=2.5e-37  Score=306.20  Aligned_cols=261  Identities=21%  Similarity=0.313  Sum_probs=196.2

Q ss_pred             CCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCC--hHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEec
Q 009340          217 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEID--KTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY  293 (537)
Q Consensus       217 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  293 (537)
                      +|+..+.||+|+||.||+++.. +|+.||+|+++...  ......+.+|+.++++++|+|++++++++.+....++|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            4777889999999999999964 68999999886422  22235677899999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccC
Q 009340          294 ISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGI  373 (537)
Q Consensus       294 ~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgl  373 (537)
                      ++ ++|.+++...           ...+++..++.++.||++||.|||+.+   ++||||||+||+++.++.+||+|||+
T Consensus        81 ~~-~~l~~~~~~~-----------~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~  145 (284)
T cd07839          81 CD-QDLKKYFDSC-----------NGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGL  145 (284)
T ss_pred             CC-CCHHHHHHhc-----------CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccch
Confidence            97 5788877543           235899999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCCceeeeccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhc--
Q 009340          374 SRSIPNDKTHLTTTIQGTFGYLDPEYFQSS-QFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKEN--  450 (537)
Q Consensus       374 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--  450 (537)
                      ++........ .....++..|+|||.+.+. .++.++||||||+++|||++|+.|+........  ............  
T Consensus       146 ~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~  222 (284)
T cd07839         146 ARAFGIPVRC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLLGTPTE  222 (284)
T ss_pred             hhccCCCCCC-cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHH--HHHHHHHHhCCCCh
Confidence            9865432211 2234578899999998764 478999999999999999999998653322110  011111100000  


Q ss_pred             ----hhhhhhcHHhh---------ccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          451 ----QLLEILDARVA---------KEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       451 ----~~~~~~d~~~~---------~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                          ......+....         .......+.++.+++.+||+.||.+|||+.++++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         223 ESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             HHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence                00000000000         0111234567889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1.6e-36  Score=304.20  Aligned_cols=246  Identities=26%  Similarity=0.427  Sum_probs=196.8

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCC---ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI---DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY  291 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  291 (537)
                      ..|...+.||+|+||.||+|... +|+.||+|.+...   .....+++.+|+.+++.++|+|++++.++|.+.+..++|+
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            45778889999999999999964 6899999987632   2344567899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeec
Q 009340          292 EYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF  371 (537)
Q Consensus       292 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Df  371 (537)
                      ||++ |+|.+++....           ..+++..+..++.|++.||.|||+.+   ++||||+|+||+++.++.++|+||
T Consensus        95 e~~~-g~l~~~~~~~~-----------~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~df  159 (307)
T cd06607          95 EYCL-GSASDILEVHK-----------KPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADF  159 (307)
T ss_pred             HhhC-CCHHHHHHHcc-----------cCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeec
Confidence            9997 57777765322           35899999999999999999999998   999999999999999999999999


Q ss_pred             cCccccCCCCCceeeeccccccccCccccc---CCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHh
Q 009340          372 GISRSIPNDKTHLTTTIQGTFGYLDPEYFQ---SSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAK  448 (537)
Q Consensus       372 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  448 (537)
                      |++......     ....++..|+|||.+.   .+.++.++||||||+++|||++|+.|+........      ......
T Consensus       160 g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~------~~~~~~  228 (307)
T cd06607         160 GSASLVSPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIAQ  228 (307)
T ss_pred             CcceecCCC-----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH------HHHHhc
Confidence            998765332     2345788999999874   45688999999999999999999999864322110      000000


Q ss_pred             hchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHH
Q 009340          449 ENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSME  496 (537)
Q Consensus       449 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~  496 (537)
                       ..        ............+.+++.+||+.+|++||++.+|+..
T Consensus       229 -~~--------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         229 -ND--------SPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             -CC--------CCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence             00        0001122345678999999999999999999999874

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3.7e-37  Score=337.76  Aligned_cols=257  Identities=25%  Similarity=0.406  Sum_probs=199.9

Q ss_pred             HHhcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccC--CChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeC--Ccc
Q 009340          213 RATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKE--IDKTQIHQFINEVVILSQINHRHIVKLLGCCLET--EVP  287 (537)
Q Consensus       213 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~  287 (537)
                      ...++|...++||+|+||+||++... .+..||+|.+..  ........|..|+.++++++||||+++++++.+.  ...
T Consensus        10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l   89 (1021)
T PTZ00266         10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL   89 (1021)
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence            34578999999999999999999964 577899998764  2344567789999999999999999999988654  468


Q ss_pred             EEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCC----CCeeecCCCCCCEEECC-
Q 009340          288 VLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSAS----IPIFHRDIKSSNILLDD-  362 (537)
Q Consensus       288 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~----~~ivH~Dlk~~NIll~~-  362 (537)
                      |+||||+++|+|.++|......        ...+++..++.|+.||+.||.|||+.+.    .+||||||||+||||+. 
T Consensus        90 yIVMEY~~gGSL~~lL~k~~~~--------~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~  161 (1021)
T PTZ00266         90 YILMEFCDAGDLSRNIQKCYKM--------FGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTG  161 (1021)
T ss_pred             EEEEeCCCCCcHHHHHHHHhhc--------cCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecC
Confidence            9999999999999999754321        2469999999999999999999998542    33999999999999964 


Q ss_pred             ----------------CCcEEEeeccCccccCCCCCceeeeccccccccCcccccC--CCCCcchhHHHHHHHHHHHHhC
Q 009340          363 ----------------KFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQS--SQFTDKSDVYSFGVVLLELLTG  424 (537)
Q Consensus       363 ----------------~~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~ksDV~S~Gvll~el~tg  424 (537)
                                      ...+||+|||++.......  ......||+.|+|||++.+  ..++.++|||||||+||||++|
T Consensus       162 ~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTG  239 (1021)
T PTZ00266        162 IRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSG  239 (1021)
T ss_pred             ccccccccccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHC
Confidence                            3459999999998764322  2234568999999999854  4588999999999999999999


Q ss_pred             CCCCCccchhhhccHHHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          425 KKPICFARVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       425 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      +.||.......      .+........       .+   .....+..+.+|+..||+.+|.+||++.+++.
T Consensus       240 k~PF~~~~~~~------qli~~lk~~p-------~l---pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        240 KTPFHKANNFS------QLISELKRGP-------DL---PIKGKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             CCCCCcCCcHH------HHHHHHhcCC-------CC---CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            99986432111      1111111100       00   01123467889999999999999999999984

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.5e-37  Score=284.72  Aligned_cols=251  Identities=26%  Similarity=0.394  Sum_probs=204.9

Q ss_pred             HHhcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCC--------ChHHHHHHHHHHHHHHhc-CCCCcceEeeEEe
Q 009340          213 RATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI--------DKTQIHQFINEVVILSQI-NHRHIVKLLGCCL  282 (537)
Q Consensus       213 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--------~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~  282 (537)
                      ..-..|...+.||.|..+.|-+...+ .|+..|+|++...        .....++-.+|+.||+++ .||+|+++.+++.
T Consensus        14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye   93 (411)
T KOG0599|consen   14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE   93 (411)
T ss_pred             hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence            33467788889999999999887754 6788999976431        122345567899999999 6999999999999


Q ss_pred             eCCccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECC
Q 009340          283 ETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD  362 (537)
Q Consensus       283 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~  362 (537)
                      .+.-.++|+|.|+.|.|.|+|...            -.++++...+|+.|+.+|++|||..+   ||||||||+|||+|+
T Consensus        94 s~sF~FlVFdl~prGELFDyLts~------------VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILldd  158 (411)
T KOG0599|consen   94 SDAFVFLVFDLMPRGELFDYLTSK------------VTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDD  158 (411)
T ss_pred             CcchhhhhhhhcccchHHHHhhhh------------eeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeecc
Confidence            999999999999999999999763            36999999999999999999999999   999999999999999


Q ss_pred             CCcEEEeeccCccccCCCCCceeeeccccccccCcccccC------CCCCcchhHHHHHHHHHHHHhCCCCCCccchhhh
Q 009340          363 KFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQS------SQFTDKSDVYSFGVVLLELLTGKKPICFARVEEE  436 (537)
Q Consensus       363 ~~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~  436 (537)
                      +.++||+|||+++.+..+.  .....+||++|+|||.+..      ..|+..+|+|+.||++|.|+.|.+||.....   
T Consensus       159 n~~i~isDFGFa~~l~~Ge--kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ---  233 (411)
T KOG0599|consen  159 NMNIKISDFGFACQLEPGE--KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ---  233 (411)
T ss_pred             ccceEEeccceeeccCCch--hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH---
Confidence            9999999999999886543  3456789999999998853      3578899999999999999999999864211   


Q ss_pred             ccHHHHHHHHHhhchhhhhhcHHh--hccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          437 RNLVACFISLAKENQLLEILDARV--AKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       437 ~~~~~~~~~~~~~~~~~~~~d~~~--~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                                  .-.++-++...+  ..+...+.+....+|+.+||+.||..|.|++|++.
T Consensus       234 ------------mlMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  234 ------------MLMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             ------------HHHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence                        001122222222  22334556678899999999999999999999975

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=1.2e-36  Score=297.54  Aligned_cols=252  Identities=27%  Similarity=0.419  Sum_probs=206.6

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCCh-HHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEec
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDK-TQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY  293 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  293 (537)
                      ++|+..+.||+|++|.||+++.. +++.|+||++..... .....+.+|+..+++++|+|++++++++......++|+||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            36788899999999999999976 589999999876443 4567899999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeecCCCCCCEEECCCCcEEEeecc
Q 009340          294 ISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHS-SASIPIFHRDIKSSNILLDDKFSAKVSDFG  372 (537)
Q Consensus       294 ~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfg  372 (537)
                      +++++|.+++...            ..+++..++.++.|+++||.|||+ .+   ++||||+|+||+++.++.++|+|||
T Consensus        81 ~~~~~L~~~l~~~------------~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~  145 (264)
T cd06623          81 MDGGSLADLLKKV------------GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFG  145 (264)
T ss_pred             cCCCcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCc
Confidence            9999999999753            368999999999999999999999 88   9999999999999999999999999


Q ss_pred             CccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchh
Q 009340          373 ISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQL  452 (537)
Q Consensus       373 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  452 (537)
                      ++......... .....++..|+|||.+.+..++.++||||||+++|||++|+.|+...........   ......    
T Consensus       146 ~~~~~~~~~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~---~~~~~~----  217 (264)
T cd06623         146 ISKVLENTLDQ-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFEL---MQAICD----  217 (264)
T ss_pred             cceecccCCCc-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHH---HHHHhc----
Confidence            99876443322 2244578899999999999999999999999999999999999865432111111   111110    


Q ss_pred             hhhhcHHhhccccHH-HHHHHHHHHHHhcccCCCCCCCHhhHHHH
Q 009340          453 LEILDARVAKEAREE-DIGAMAELAMRCLRLNSKKRPTMKQVSME  496 (537)
Q Consensus       453 ~~~~d~~~~~~~~~~-~~~~l~~l~~~cl~~~p~~RPs~~ev~~~  496 (537)
                            ......+.. .+..+.+++.+||+.+|++||++.++++.
T Consensus       218 ------~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         218 ------GPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             ------CCCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence                  011112222 45678999999999999999999999863

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-37  Score=314.67  Aligned_cols=236  Identities=26%  Similarity=0.346  Sum_probs=184.6

Q ss_pred             cCcCCceEEEEEEcC-CCCEEEEEEccCC---ChHHHHHHHHHHHHHHhc---CCCCcceEeeEEeeCCccEEEEecCCC
Q 009340          224 LGQGGFGTVYKGMLP-DGSIVAVKRSKEI---DKTQIHQFINEVVILSQI---NHRHIVKLLGCCLETEVPVLVYEYISS  296 (537)
Q Consensus       224 lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~~~~~~lV~e~~~~  296 (537)
                      ||+|+||.||+++.. +++.||||++...   .......+..|..++...   +||||+++++++.+.+..++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            799999999999864 6899999998642   122334456677777665   699999999999999999999999999


Q ss_pred             CChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCccc
Q 009340          297 GTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS  376 (537)
Q Consensus       297 gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~  376 (537)
                      |+|.+++...            ..+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||++..
T Consensus        81 g~L~~~l~~~------------~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~  145 (330)
T cd05586          81 GELFWHLQKE------------GRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKA  145 (330)
T ss_pred             ChHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcC
Confidence            9999888642            35899999999999999999999999   99999999999999999999999999875


Q ss_pred             cCCCCCceeeeccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchhhhh
Q 009340          377 IPNDKTHLTTTIQGTFGYLDPEYFQSS-QFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEI  455 (537)
Q Consensus       377 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  455 (537)
                      ...... ......||..|+|||.+.+. .++.++|||||||++|||++|+.||......+       .......+..   
T Consensus       146 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~-------~~~~i~~~~~---  214 (330)
T cd05586         146 NLTDNK-TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ-------MYRNIAFGKV---  214 (330)
T ss_pred             CCCCCC-CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH-------HHHHHHcCCC---
Confidence            432221 23345689999999998764 47899999999999999999999986543221       1111111110   


Q ss_pred             hcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHh
Q 009340          456 LDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMK  491 (537)
Q Consensus       456 ~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~  491 (537)
                         .+.   .......+.+++.+||+.||++||++.
T Consensus       215 ---~~~---~~~~~~~~~~li~~~L~~~P~~R~~~~  244 (330)
T cd05586         215 ---RFP---KNVLSDEGRQFVKGLLNRNPQHRLGAH  244 (330)
T ss_pred             ---CCC---CccCCHHHHHHHHHHcCCCHHHCCCCC
Confidence               000   112345678999999999999999644

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.2e-36  Score=304.84  Aligned_cols=255  Identities=23%  Similarity=0.324  Sum_probs=201.5

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCC---hHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEID---KTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY  291 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  291 (537)
                      ++|+..+.||+|+||.||++... .++.||+|.+....   ......+.+|+.+++.++|+||+++++.+.+.+..++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            46888899999999999999964 57899999886532   234567889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeec
Q 009340          292 EYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF  371 (537)
Q Consensus       292 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Df  371 (537)
                      ||+++++|.+++...            ..+++..+..++.|+++||.|||+.+   ++||||||+||+++.++.+||+||
T Consensus        81 e~~~g~~L~~~l~~~------------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~df  145 (305)
T cd05609          81 EYVEGGDCATLLKNI------------GALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDF  145 (305)
T ss_pred             ecCCCCcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeC
Confidence            999999999999652            35899999999999999999999998   999999999999999999999999


Q ss_pred             cCccccCCCC--------------CceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhc
Q 009340          372 GISRSIPNDK--------------THLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEER  437 (537)
Q Consensus       372 gla~~~~~~~--------------~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~  437 (537)
                      |+++......              ........++..|+|||.+.+..++.++|+||||+++|||++|+.||......+  
T Consensus       146 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~--  223 (305)
T cd05609         146 GLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE--  223 (305)
T ss_pred             CCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--
Confidence            9986421100              001112357889999999988889999999999999999999999986432211  


Q ss_pred             cHHHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHH
Q 009340          438 NLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEG  499 (537)
Q Consensus       438 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  499 (537)
                          .+..... ..   ...+.    .....+..+.+++.+||+.+|++||++.++.+.|+.
T Consensus       224 ----~~~~~~~-~~---~~~~~----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         224 ----LFGQVIS-DD---IEWPE----GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             ----HHHHHHh-cc---cCCCC----ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence                0111110 00   00000    111344568899999999999999998877777764

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=7e-37  Score=305.29  Aligned_cols=245  Identities=24%  Similarity=0.389  Sum_probs=198.0

Q ss_pred             ccccCcCCceEEEEEEcC-CCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecCCCCCh
Q 009340          221 SRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTL  299 (537)
Q Consensus       221 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL  299 (537)
                      ...||+|+||.||++... +++.||+|.+........+.+.+|+.++..++|||++++++++...+..++|+||+++++|
T Consensus        26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L  105 (297)
T cd06659          26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL  105 (297)
T ss_pred             hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence            457999999999999864 6889999998654444556788999999999999999999999999999999999999999


Q ss_pred             hhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCccccCC
Q 009340          300 SHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPN  379 (537)
Q Consensus       300 ~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~  379 (537)
                      .+++..             ..+++..++.++.|++.||+|||+.+   ++||||+|+||+++.++.+||+|||++.....
T Consensus       106 ~~~~~~-------------~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~  169 (297)
T cd06659         106 TDIVSQ-------------TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISK  169 (297)
T ss_pred             HHHHhh-------------cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccc
Confidence            887743             25899999999999999999999999   99999999999999999999999999876543


Q ss_pred             CCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchhhhhhcHH
Q 009340          380 DKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEILDAR  459 (537)
Q Consensus       380 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  459 (537)
                      ... ......++..|+|||++.+..++.++||||||+++|||++|+.||......+.      ... .....     ...
T Consensus       170 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~------~~~-~~~~~-----~~~  236 (297)
T cd06659         170 DVP-KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA------MKR-LRDSP-----PPK  236 (297)
T ss_pred             ccc-cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHH-HhccC-----CCC
Confidence            322 12335688999999999988899999999999999999999999864432211      111 11000     000


Q ss_pred             hhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHH
Q 009340          460 VAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSME  496 (537)
Q Consensus       460 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~  496 (537)
                      .  .........+.+++.+||+.+|++||++.++++.
T Consensus       237 ~--~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         237 L--KNAHKISPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             c--cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            0  0111233567899999999999999999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=2e-36  Score=298.85  Aligned_cols=247  Identities=24%  Similarity=0.413  Sum_probs=200.6

Q ss_pred             CCccccccCcCCceEEEEEEc-CCCCEEEEEEccCC-ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecC
Q 009340          217 NYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEI-DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI  294 (537)
Q Consensus       217 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  294 (537)
                      -|...+.||+|+||.||+|.. .+++.||+|..... .......+.+|+.++++++|+|++++++++.+....++||||+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL   84 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence            356678899999999999985 46889999987643 2344567889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCc
Q 009340          295 SSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGIS  374 (537)
Q Consensus       295 ~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla  374 (537)
                      ++++|.+++..             ..+++..+..++.+++.|+.|||+.+   ++|+||+|+||+++.++.++|+|||++
T Consensus        85 ~~~~l~~~i~~-------------~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~  148 (277)
T cd06641          85 GGGSALDLLEP-------------GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVA  148 (277)
T ss_pred             CCCcHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccc
Confidence            99999998853             25899999999999999999999998   999999999999999999999999998


Q ss_pred             cccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchhhh
Q 009340          375 RSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLE  454 (537)
Q Consensus       375 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  454 (537)
                      ........ ......++..|+|||.+.+..++.++|+||||+++|||++|..|+.......      .... ..      
T Consensus       149 ~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~------~~~~-~~------  214 (277)
T cd06641         149 GQLTDTQI-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK------VLFL-IP------  214 (277)
T ss_pred             eecccchh-hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH------HHHH-Hh------
Confidence            76543221 1223457889999999998889999999999999999999999985432111      0000 00      


Q ss_pred             hhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHH
Q 009340          455 ILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSME  496 (537)
Q Consensus       455 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~  496 (537)
                         .......+...+..+.+++.+||+.+|++||++.++++.
T Consensus       215 ---~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         215 ---KNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             ---cCCCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence               001111223345678899999999999999999999884

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=9.8e-37  Score=301.97  Aligned_cols=260  Identities=22%  Similarity=0.334  Sum_probs=197.0

Q ss_pred             CCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCC--hHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEec
Q 009340          217 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEID--KTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY  293 (537)
Q Consensus       217 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  293 (537)
                      +|+..+.||+|++|.||+|+.. +|+.||||+++...  ......+.+|++++++++|+||+++++++.+.+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4778899999999999999864 68999999886432  22345788999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccC
Q 009340          294 ISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGI  373 (537)
Q Consensus       294 ~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgl  373 (537)
                      +. ++|.+++....          ...+++..+..++.|+++||+|||+.+   ++||||+|+||+++.++.+||+|||+
T Consensus        81 ~~-~~l~~~~~~~~----------~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~  146 (284)
T cd07860          81 LH-QDLKKFMDASP----------LSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGL  146 (284)
T ss_pred             cc-cCHHHHHHhCC----------CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccc
Confidence            96 68988886532          236899999999999999999999998   99999999999999999999999999


Q ss_pred             ccccCCCCCceeeeccccccccCcccccCCC-CCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhc--
Q 009340          374 SRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQ-FTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKEN--  450 (537)
Q Consensus       374 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--  450 (537)
                      +........ ......++..|+|||.+.+.. ++.++||||||+++|||+||+.||......+  .....+. .....  
T Consensus       147 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~--~~~~~~~-~~~~~~~  222 (284)
T cd07860         147 ARAFGVPVR-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--QLFRIFR-TLGTPDE  222 (284)
T ss_pred             hhhcccCcc-ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHH-HhCCCCh
Confidence            876533221 122334688999999886644 6889999999999999999999986543221  1111110 00000  


Q ss_pred             --------------hhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          451 --------------QLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       451 --------------~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                                    .......... ..........+.+++.+||+.||++|||+.++++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         223 VVWPGVTSLPDYKPSFPKWARQDF-SKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             hhhhhhhHHHHHHhhcccccccCH-HHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence                          0000000000 0011123456789999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=6.8e-37  Score=299.74  Aligned_cols=252  Identities=27%  Similarity=0.404  Sum_probs=202.8

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCC-hHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEec
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEID-KTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY  293 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  293 (537)
                      ++|+..+.||+|+||.||++... +++.||+|++.... ....+++.+|+.++++++|+||+++++++......++++||
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            35777889999999999999975 68899999887543 34567789999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeecCCCCCCEEECCCCcEEEeecc
Q 009340          294 ISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHS-SASIPIFHRDIKSSNILLDDKFSAKVSDFG  372 (537)
Q Consensus       294 ~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfg  372 (537)
                      +++++|.+++....           ..+++..+..++.|+++||+|||+ .+   ++|+||+|+||++++++.++|+|||
T Consensus        81 ~~~~~L~~~~~~~~-----------~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g  146 (265)
T cd06605          81 MDGGSLDKILKEVQ-----------GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFG  146 (265)
T ss_pred             cCCCcHHHHHHHcc-----------CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecc
Confidence            99999999987532           368899999999999999999999 77   9999999999999999999999999


Q ss_pred             CccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchh
Q 009340          373 ISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQL  452 (537)
Q Consensus       373 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  452 (537)
                      .+........   ....++..|+|||.+.+..++.++||||||+++|+|++|+.|+....... ..............  
T Consensus       147 ~~~~~~~~~~---~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~--  220 (265)
T cd06605         147 VSGQLVNSLA---KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP-DGIFELLQYIVNEP--  220 (265)
T ss_pred             cchhhHHHHh---hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc-ccHHHHHHHHhcCC--
Confidence            9876532221   12567889999999999899999999999999999999999986432111 11111111111100  


Q ss_pred             hhhhcHHhhccccHH-HHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          453 LEILDARVAKEAREE-DIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       453 ~~~~d~~~~~~~~~~-~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                              ....+.. .+..+.+++.+||..+|++|||+.+++.
T Consensus       221 --------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         221 --------PPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             --------CCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence                    0011122 5567889999999999999999999874

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.7e-36  Score=299.54  Aligned_cols=261  Identities=27%  Similarity=0.340  Sum_probs=201.5

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCC-ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCC--ccEEEE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI-DKTQIHQFINEVVILSQINHRHIVKLLGCCLETE--VPVLVY  291 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lV~  291 (537)
                      ++|...+.||.|++|.||++... +++.+|+|.+... ......++.+|++++++++|+||+++++++.+..  ..++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            46788899999999999999974 6889999988753 2345677999999999999999999999986543  679999


Q ss_pred             ecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeec
Q 009340          292 EYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF  371 (537)
Q Consensus       292 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Df  371 (537)
                      ||+++++|.+++.....        ....+++..+..++.|+++||.|||+.+   ++|+||+|+||+++.++.++|+||
T Consensus        81 e~~~~~~L~~~l~~~~~--------~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~df  149 (287)
T cd06621          81 EYCEGGSLDSIYKKVKK--------RGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDF  149 (287)
T ss_pred             EecCCCCHHHHHHHHHh--------cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeec
Confidence            99999999998764322        1345899999999999999999999999   999999999999999999999999


Q ss_pred             cCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhch
Q 009340          372 GISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQ  451 (537)
Q Consensus       372 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  451 (537)
                      |++.......   .....++..|+|||.+.+..++.++||||||+++|||++|+.|+........ .... .........
T Consensus       150 g~~~~~~~~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~~-~~~~~~~~~  224 (287)
T cd06621         150 GVSGELVNSL---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPL-GPIE-LLSYIVNMP  224 (287)
T ss_pred             cccccccccc---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCC-ChHH-HHHHHhcCC
Confidence            9987653221   1234578899999999999999999999999999999999999875432100 1111 111111100


Q ss_pred             hhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          452 LLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       452 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      ... +....  .........+.+++.+||+.+|++|||+.|+++
T Consensus       225 ~~~-~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         225 NPE-LKDEP--GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             chh-hccCC--CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence            000 00000  001223567899999999999999999999987

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1.9e-36  Score=300.39  Aligned_cols=253  Identities=25%  Similarity=0.430  Sum_probs=205.5

Q ss_pred             HHhcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEE
Q 009340          213 RATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY  291 (537)
Q Consensus       213 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  291 (537)
                      ..+++|+..+.||+|+||.||++... +++.|++|.+..... ..+.+.+|+++++.++|+|++++++++...+..++|+
T Consensus        16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   94 (286)
T cd06614          16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM   94 (286)
T ss_pred             CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence            34567888889999999999999976 688999999876544 5667889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeec
Q 009340          292 EYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF  371 (537)
Q Consensus       292 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Df  371 (537)
                      ||+++++|.+++....           ..+++..+..++.+++.||.|||+.+   ++|+||+|+||+++.++.++|+||
T Consensus        95 e~~~~~~L~~~l~~~~-----------~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~  160 (286)
T cd06614          95 EYMDGGSLTDIITQNF-----------VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADF  160 (286)
T ss_pred             eccCCCcHHHHHHHhc-----------cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECcc
Confidence            9999999999997642           26999999999999999999999988   999999999999999999999999


Q ss_pred             cCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhch
Q 009340          372 GISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQ  451 (537)
Q Consensus       372 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  451 (537)
                      |++........ ......++..|+|||.+.+..++.++||||||+++|+|++|+.|+........      ...... ..
T Consensus       161 ~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~------~~~~~~-~~  232 (286)
T cd06614         161 GFAAQLTKEKS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA------LFLITT-KG  232 (286)
T ss_pred             chhhhhccchh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHh-cC
Confidence            99876543221 12234578899999999888899999999999999999999999864322211      111000 00


Q ss_pred             hhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          452 LLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       452 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      ...       ..........+.+++.+||+.+|.+||++.+|++
T Consensus       233 ~~~-------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         233 IPP-------LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             CCC-------CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            000       0011224467889999999999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1.2e-36  Score=303.00  Aligned_cols=250  Identities=26%  Similarity=0.445  Sum_probs=203.6

Q ss_pred             cCCccccccCcCCceEEEEEEc-CCCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecC
Q 009340          216 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI  294 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  294 (537)
                      ++|...+.||+|+||.||++.. .+++.||+|.+........+.+.+|+.+++.++|||++++++++...+..++|+||+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~   98 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL   98 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence            6788889999999999999985 467899999987555555677899999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCc
Q 009340          295 SSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGIS  374 (537)
Q Consensus       295 ~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla  374 (537)
                      ++++|.+++..             ..+++..+..++.|++.||.|||+.+   ++||||+|+||+++.++.+||+|||++
T Consensus        99 ~~~~L~~~~~~-------------~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~  162 (293)
T cd06647          99 AGGSLTDVVTE-------------TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFC  162 (293)
T ss_pred             CCCcHHHHHhh-------------cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcce
Confidence            99999999864             24789999999999999999999999   999999999999999999999999998


Q ss_pred             cccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchhhh
Q 009340          375 RSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLE  454 (537)
Q Consensus       375 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  454 (537)
                      ......... .....+++.|+|||.+....++.++||||||+++|||++|+.||..........      .....+    
T Consensus       163 ~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~------~~~~~~----  231 (293)
T cd06647         163 AQITPEQSK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------LIATNG----  231 (293)
T ss_pred             ecccccccc-cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee------ehhcCC----
Confidence            765433221 233458889999999988889999999999999999999999986543221100      000000    


Q ss_pred             hhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHH
Q 009340          455 ILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSME  496 (537)
Q Consensus       455 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~  496 (537)
                          ......+......+.+++.+||+.+|++||++.+++..
T Consensus       232 ----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         232 ----TPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             ----CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                00011122334568899999999999999999999754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=2.6e-36  Score=292.38  Aligned_cols=249  Identities=31%  Similarity=0.480  Sum_probs=204.4

Q ss_pred             CCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecCC
Q 009340          217 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYIS  295 (537)
Q Consensus       217 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  295 (537)
                      .|+..+.||+|++|.||++... +++.+++|++........+.+.+|+..++.++|+|++++++++......++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            3667889999999999999975 688999999987655567789999999999999999999999999999999999999


Q ss_pred             CCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCcc
Q 009340          296 SGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISR  375 (537)
Q Consensus       296 ~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~  375 (537)
                      +++|.+++....           ..+++..+..++.+++++|.|||+.+   ++||||+|+||++++++.++|+|||.+.
T Consensus        81 ~~~L~~~~~~~~-----------~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~  146 (253)
T cd05122          81 GGSLKDLLKSTN-----------QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSA  146 (253)
T ss_pred             CCcHHHHHhhcC-----------CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeeccccc
Confidence            999999987532           36899999999999999999999988   9999999999999999999999999998


Q ss_pred             ccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchhhhh
Q 009340          376 SIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEI  455 (537)
Q Consensus       376 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  455 (537)
                      .......  .....++..|+|||.+.+..++.++||||||+++++|++|+.|+........      ... .........
T Consensus       147 ~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~------~~~-~~~~~~~~~  217 (253)
T cd05122         147 QLSDTKA--RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKA------LFK-IATNGPPGL  217 (253)
T ss_pred             ccccccc--ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHH------HHH-HHhcCCCCc
Confidence            7654432  3345688999999999888899999999999999999999999864322110      000 000000000


Q ss_pred             hcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          456 LDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       456 ~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                             .........+.+++.+||+.||++|||+.++++
T Consensus       218 -------~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         218 -------RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             -------CcccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                   011112467889999999999999999999875

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-36  Score=301.35  Aligned_cols=260  Identities=24%  Similarity=0.345  Sum_probs=199.3

Q ss_pred             CccccccCcCCceEEEEEEcC-CCCEEEEEEccCCC--hHHHHHHHHHHHHHHhcCCCCcceEeeEEeeC--CccEEEEe
Q 009340          218 YNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEID--KTQIHQFINEVVILSQINHRHIVKLLGCCLET--EVPVLVYE  292 (537)
Q Consensus       218 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~e  292 (537)
                      |+..+.||+|+||.||+|+.. +|+.+|+|++....  ......+.+|+.+++.++|+|++++++++.+.  +..++|+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            556788999999999999965 58899999987642  33456788999999999999999999999988  78999999


Q ss_pred             cCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeecc
Q 009340          293 YISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG  372 (537)
Q Consensus       293 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfg  372 (537)
                      |+++ +|.+++....           ..+++..++.++.|+++||+|||+.+   ++|+||+|+||++++++.+||+|||
T Consensus        81 ~~~~-~l~~~~~~~~-----------~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g  145 (287)
T cd07840          81 YMDH-DLTGLLDSPE-----------VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFG  145 (287)
T ss_pred             cccc-cHHHHHhccC-----------CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEcccc
Confidence            9975 8888886531           36899999999999999999999998   9999999999999999999999999


Q ss_pred             CccccCCCCCceeeeccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhh--
Q 009340          373 ISRSIPNDKTHLTTTIQGTFGYLDPEYFQS-SQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKE--  449 (537)
Q Consensus       373 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--  449 (537)
                      ++...............++..|+|||.+.+ ..++.++||||||+++|||++|+.||..........   ........  
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~---~~~~~~~~~~  222 (287)
T cd07840         146 LARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLE---KIFELCGSPT  222 (287)
T ss_pred             ceeeccCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH---HHHHHhCCCc
Confidence            998765443222334456888999998764 467899999999999999999999986544322111   11110000  


Q ss_pred             -ch--------------hhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          450 -NQ--------------LLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       450 -~~--------------~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                       ..              ........+.......++..+.+++.+||+.+|++||++.++++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         223 DENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             hhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence             00              00000011111111113567899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.9e-36  Score=300.28  Aligned_cols=247  Identities=23%  Similarity=0.384  Sum_probs=200.5

Q ss_pred             CccccccCcCCceEEEEEEc-CCCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecCCC
Q 009340          218 YNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISS  296 (537)
Q Consensus       218 ~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  296 (537)
                      |...+.||+|++|.||++.. .+++.+++|++........+.+.+|+.+++.++|+|++++++++...+..++|+||+++
T Consensus        21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~  100 (285)
T cd06648          21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG  100 (285)
T ss_pred             hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence            44457899999999999985 47889999998765555567789999999999999999999999999999999999999


Q ss_pred             CChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCccc
Q 009340          297 GTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS  376 (537)
Q Consensus       297 gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~  376 (537)
                      ++|.+++..             ..+++..+..++.|++.||+|||+.+   ++||||+|+||+++.++.++|+|||++..
T Consensus       101 ~~L~~~~~~-------------~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~  164 (285)
T cd06648         101 GALTDIVTH-------------TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQ  164 (285)
T ss_pred             CCHHHHHHh-------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchh
Confidence            999998864             25889999999999999999999999   99999999999999999999999999876


Q ss_pred             cCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchhhhhh
Q 009340          377 IPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEIL  456 (537)
Q Consensus       377 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  456 (537)
                      ...... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||.......      .... ....     .
T Consensus       165 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~------~~~~-~~~~-----~  231 (285)
T cd06648         165 VSKEVP-RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQ------AMKR-IRDN-----L  231 (285)
T ss_pred             hccCCc-ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHH------HHHH-HHhc-----C
Confidence            543322 1233458899999999988889999999999999999999999986432211      1111 1100     0


Q ss_pred             cHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          457 DARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       457 d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      .+...  .+......+.+++.+||+.+|++||++.++++
T Consensus       232 ~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         232 PPKLK--NLHKVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             CCCCc--ccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence            00010  11124467899999999999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=2.6e-36  Score=304.04  Aligned_cols=251  Identities=27%  Similarity=0.415  Sum_probs=198.8

Q ss_pred             CCccccccCcCCceEEEEEEcC-CCCEEEEEEccCC---ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEe
Q 009340          217 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI---DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE  292 (537)
Q Consensus       217 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e  292 (537)
                      .|...+.||+|+||.||+++.. ++..||+|.+...   .......+.+|+.++++++|+|++++++++.+.+..++|||
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  105 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME  105 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence            3666788999999999999954 6889999988642   23445678899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeecc
Q 009340          293 YISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG  372 (537)
Q Consensus       293 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfg  372 (537)
                      |+. |+|.+.+...           ...++|.++..++.+++.||.|||+.+   ++||||+|+||+++.++.++|+|||
T Consensus       106 ~~~-g~l~~~~~~~-----------~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg  170 (317)
T cd06635         106 YCL-GSASDLLEVH-----------KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFG  170 (317)
T ss_pred             CCC-CCHHHHHHHh-----------cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCC
Confidence            997 5887777543           236899999999999999999999999   9999999999999999999999999


Q ss_pred             CccccCCCCCceeeeccccccccCccccc---CCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhh
Q 009340          373 ISRSIPNDKTHLTTTIQGTFGYLDPEYFQ---SSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKE  449 (537)
Q Consensus       373 la~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  449 (537)
                      ++......     ....++..|+|||++.   .+.++.++|||||||++|||++|+.||........      .......
T Consensus       171 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~------~~~~~~~  239 (317)
T cd06635         171 SASIASPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIAQN  239 (317)
T ss_pred             CccccCCc-----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH------HHHHHhc
Confidence            98754322     2345788999999973   46788999999999999999999999864321110      0000000


Q ss_pred             chhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHH
Q 009340          450 NQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRR  502 (537)
Q Consensus       450 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~  502 (537)
                               .............+.+++.+||+.+|.+||++.+|++.+-.+..
T Consensus       240 ---------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~  283 (317)
T cd06635         240 ---------ESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRE  283 (317)
T ss_pred             ---------cCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhcc
Confidence                     00011122344568899999999999999999999986654443

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=9.2e-37  Score=303.34  Aligned_cols=262  Identities=24%  Similarity=0.381  Sum_probs=196.0

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCCh-HHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEec
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDK-TQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY  293 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  293 (537)
                      ++|+..+.||+|++|.||+|..+ +++.||+|.+..... .....+.+|+.++++++|+||+++++++.+.+..++||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            57888899999999999999965 688999998864321 2234567899999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccC
Q 009340          294 ISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGI  373 (537)
Q Consensus       294 ~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgl  373 (537)
                      +++ +|.+++....           ..+++.....++.|+++||.|||+.+   ++||||||+||+++.++.+||+|||+
T Consensus        85 ~~~-~L~~~~~~~~-----------~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~  149 (291)
T cd07844          85 LDT-DLKQYMDDCG-----------GGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGL  149 (291)
T ss_pred             CCC-CHHHHHHhCC-----------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECcccc
Confidence            985 8998886532           25889999999999999999999998   99999999999999999999999999


Q ss_pred             ccccCCCCCceeeeccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhh---
Q 009340          374 SRSIPNDKTHLTTTIQGTFGYLDPEYFQS-SQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKE---  449 (537)
Q Consensus       374 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---  449 (537)
                      ++....... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||........  ...........   
T Consensus       150 ~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~  226 (291)
T cd07844         150 ARAKSVPSK-TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVED--QLHKIFRVLGTPTE  226 (291)
T ss_pred             ccccCCCCc-cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH--HHHHHHHhcCCCCh
Confidence            875432211 1122346889999999865 4588999999999999999999999864431110  01101110000   


Q ss_pred             chhhhh-------------h-cHHhhccc-cHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          450 NQLLEI-------------L-DARVAKEA-REEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       450 ~~~~~~-------------~-d~~~~~~~-~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      ......             . ...+.... .......+.+++.+||+.+|++|||+.+++.
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         227 ETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             hhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence            000000             0 00000000 0111256789999999999999999999864

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1.4e-36  Score=300.61  Aligned_cols=252  Identities=24%  Similarity=0.386  Sum_probs=193.8

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCC-hHHHHHHHHHHHH-HHhcCCCCcceEeeEEeeCCccEEEEe
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEID-KTQIHQFINEVVI-LSQINHRHIVKLLGCCLETEVPVLVYE  292 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~H~niv~l~g~~~~~~~~~lV~e  292 (537)
                      ++|+..+.||+|+||.||+++.. +|+.||+|+++... .....++..|+.+ ++..+|+|++++++++...+..++|||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            46888899999999999999965 68999999887532 2233456667665 566689999999999999999999999


Q ss_pred             cCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeeecCCCCCCEEECCCCcEEEeec
Q 009340          293 YISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSS-ASIPIFHRDIKSSNILLDDKFSAKVSDF  371 (537)
Q Consensus       293 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~-~~~~ivH~Dlk~~NIll~~~~~~ki~Df  371 (537)
                      |++ |+|.+++......        ...+++..++.++.|++.||+|||++ +   ++||||||+||+++.++.+||+||
T Consensus        81 ~~~-~~l~~~l~~~~~~--------~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~df  148 (283)
T cd06617          81 VMD-TSLDKFYKKVYDK--------GLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDF  148 (283)
T ss_pred             hhc-ccHHHHHHHhccC--------CCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeec
Confidence            997 6888888653221        24689999999999999999999987 6   999999999999999999999999


Q ss_pred             cCccccCCCCCceeeeccccccccCcccccC----CCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHH
Q 009340          372 GISRSIPNDKTHLTTTIQGTFGYLDPEYFQS----SQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLA  447 (537)
Q Consensus       372 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~  447 (537)
                      |++.......  ......++..|+|||.+.+    ..++.++|+||||+++|||++|+.||......     ........
T Consensus       149 g~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~  221 (283)
T cd06617         149 GISGYLVDSV--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP-----FQQLKQVV  221 (283)
T ss_pred             cccccccccc--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC-----HHHHHHHH
Confidence            9998653321  1233457889999998865    45688999999999999999999998532111     01111111


Q ss_pred             hhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          448 KENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       448 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      ..      ..+.+   .....+..+.+++.+||..+|++||++.++++
T Consensus       222 ~~------~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         222 EE------PSPQL---PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             hc------CCCCC---CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            10      00000   01123467889999999999999999999976

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1e-36  Score=296.92  Aligned_cols=249  Identities=25%  Similarity=0.412  Sum_probs=200.3

Q ss_pred             CCccccccCcCCceEEEEEEcC-CCCEEEEEEccCC--ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEec
Q 009340          217 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI--DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY  293 (537)
Q Consensus       217 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  293 (537)
                      +|+..+.||+|+||.||++... +|..||+|.+...  .....+.+.+|+.+++.++|+|++++++++.+.+..++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            4777889999999999999965 5889999987642  223456788999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCC-cEEEeecc
Q 009340          294 ISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF-SAKVSDFG  372 (537)
Q Consensus       294 ~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~-~~ki~Dfg  372 (537)
                      +++++|.+++....          ...++|..+..++.|+++||.|||+.+   ++|+||+|+||++++++ .+||+|||
T Consensus        81 ~~~~~L~~~~~~~~----------~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~  147 (257)
T cd08225          81 CDGGDLMKRINRQR----------GVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFG  147 (257)
T ss_pred             CCCCcHHHHHHhcc----------CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccc
Confidence            99999999996532          225899999999999999999999998   99999999999999885 56999999


Q ss_pred             CccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchh
Q 009340          373 ISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQL  452 (537)
Q Consensus       373 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  452 (537)
                      .+........ ......|++.|+|||.+.+..++.++||||||+++|||++|+.|+......+      ....... ...
T Consensus       148 ~~~~~~~~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~-~~~  219 (257)
T cd08225         148 IARQLNDSME-LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ------LVLKICQ-GYF  219 (257)
T ss_pred             cchhccCCcc-cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH------HHHHHhc-ccC
Confidence            9987643322 2233458899999999988889999999999999999999999986432211      1111111 110


Q ss_pred             hhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          453 LEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       453 ~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                               ..........+.+++.+||+.+|++|||+.++++
T Consensus       220 ---------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  253 (257)
T cd08225         220 ---------APISPNFSRDLRSLISQLFKVSPRDRPSITSILK  253 (257)
T ss_pred             ---------CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence                     1112233457889999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-36  Score=298.20  Aligned_cols=256  Identities=26%  Similarity=0.439  Sum_probs=201.4

Q ss_pred             HHhcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCChHHHHHHHHHHHHHHhc-CCCCcceEeeEEeeCC-----
Q 009340          213 RATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKTQIHQFINEVVILSQI-NHRHIVKLLGCCLETE-----  285 (537)
Q Consensus       213 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~-----  285 (537)
                      .++++|+..+.||+|+||.||+|... +++.+++|.+..... ..+.+.+|+.+++++ +|+|++++++++.+..     
T Consensus         3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (275)
T cd06608           3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND   81 (275)
T ss_pred             CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence            35689999999999999999999974 678999998876443 346789999999999 7999999999997654     


Q ss_pred             -ccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCC
Q 009340          286 -VPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF  364 (537)
Q Consensus       286 -~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~  364 (537)
                       ..++||||+++++|.+++......        ...+++..+..++.|+++||.|||+.+   ++|+||+|+||++++++
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~--------~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~  150 (275)
T cd06608          82 DQLWLVMELCGGGSVTDLVKGLRKK--------GKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNA  150 (275)
T ss_pred             eEEEEEEEcCCCCcHHHHHHHHhhc--------CCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCC
Confidence             379999999999999998654310        246899999999999999999999999   99999999999999999


Q ss_pred             cEEEeeccCccccCCCCCceeeeccccccccCcccccC-----CCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccH
Q 009340          365 SAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQS-----SQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNL  439 (537)
Q Consensus       365 ~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~  439 (537)
                      .+||+|||++........ ......++..|+|||.+..     ..++.++||||||++++||++|+.||........   
T Consensus       151 ~~~l~d~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---  226 (275)
T cd06608         151 EVKLVDFGVSAQLDSTLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA---  226 (275)
T ss_pred             eEEECCCccceecccchh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHH---
Confidence            999999999876533221 2233458899999998753     3467899999999999999999999864321110   


Q ss_pred             HHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          440 VACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       440 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                         ...... ..     .+.  ...+......+.+++.+||..||++|||+.++++
T Consensus       227 ---~~~~~~-~~-----~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         227 ---LFKIPR-NP-----PPT--LKSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             ---HHHhhc-cC-----CCC--CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence               111110 00     000  1112234567889999999999999999999975

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1.2e-36  Score=303.64  Aligned_cols=260  Identities=24%  Similarity=0.325  Sum_probs=198.0

Q ss_pred             CCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCCh-----HHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEE
Q 009340          217 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDK-----TQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLV  290 (537)
Q Consensus       217 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  290 (537)
                      +|+..+.||+|+||.||+|... +|+.||||.++....     .....+..|+.++++++|+|++++++++.+.+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            4677889999999999999964 689999999875432     2345677899999999999999999999998899999


Q ss_pred             EecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEee
Q 009340          291 YEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSD  370 (537)
Q Consensus       291 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~D  370 (537)
                      |||+ +|+|.+++....           ..+++..++.++.|+++||.|||+.+   ++|+||+|+||+++.++.++|+|
T Consensus        81 ~e~~-~~~L~~~i~~~~-----------~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~d  145 (298)
T cd07841          81 FEFM-ETDLEKVIKDKS-----------IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLAD  145 (298)
T ss_pred             Eccc-CCCHHHHHhccC-----------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEcc
Confidence            9999 899999996532           25999999999999999999999999   99999999999999999999999


Q ss_pred             ccCccccCCCCCceeeeccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhh
Q 009340          371 FGISRSIPNDKTHLTTTIQGTFGYLDPEYFQS-SQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKE  449 (537)
Q Consensus       371 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  449 (537)
                      ||++......... .....++..|+|||.+.+ ..++.++||||||+++|||++|..+|......+.   ..........
T Consensus       146 fg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~---~~~~~~~~~~  221 (298)
T cd07841         146 FGLARSFGSPNRK-MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQ---LGKIFEALGT  221 (298)
T ss_pred             ceeeeeccCCCcc-ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHH---HHHHHHHcCC
Confidence            9999876443221 223346788999998865 4678999999999999999999777654332111   0000000000


Q ss_pred             ---------chhhhhhcHHhhc-----cccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          450 ---------NQLLEILDARVAK-----EAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       450 ---------~~~~~~~d~~~~~-----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                               .............     ......+..+.+++.+||+.+|++|||+.|+++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~  281 (298)
T cd07841         222 PTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE  281 (298)
T ss_pred             CchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence                     0000000000000     011233567889999999999999999999987

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=2.1e-36  Score=300.77  Aligned_cols=243  Identities=27%  Similarity=0.392  Sum_probs=199.4

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCC---ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI---DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY  291 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  291 (537)
                      ++|...+.||+|+||.||++... +++.||+|.+...   .....+.+.+|++++++++|+||+++++++.+....++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            36788899999999999999965 6899999988642   2334567889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeec
Q 009340          292 EYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF  371 (537)
Q Consensus       292 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Df  371 (537)
                      ||+++++|.+++...            ..+++..+..++.|+++||.|||+.+   ++|+||+|+||+++.++.+||+||
T Consensus        81 e~~~~~~L~~~~~~~------------~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~df  145 (290)
T cd05580          81 EYVPGGELFSHLRKS------------GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDF  145 (290)
T ss_pred             ecCCCCCHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeC
Confidence            999999999998653            35899999999999999999999998   999999999999999999999999


Q ss_pred             cCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhch
Q 009340          372 GISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQ  451 (537)
Q Consensus       372 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  451 (537)
                      |++......    .....+++.|+|||.+.+...+.++||||||+++|+|++|+.||.......      ...... .+ 
T Consensus       146 g~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~-~~-  213 (290)
T cd05580         146 GFAKRVKGR----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ------IYEKIL-EG-  213 (290)
T ss_pred             CCccccCCC----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHh-cC-
Confidence            999876443    233458899999999988889999999999999999999999986443211      000100 00 


Q ss_pred             hhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCC-----CHhhHH
Q 009340          452 LLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRP-----TMKQVS  494 (537)
Q Consensus       452 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~  494 (537)
                               ....+......+.+++.+||+.||.+||     ++.|++
T Consensus       214 ---------~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~  252 (290)
T cd05580         214 ---------KVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK  252 (290)
T ss_pred             ---------CccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence                     0112223356788999999999999998     555554

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=1.9e-36  Score=301.44  Aligned_cols=261  Identities=23%  Similarity=0.312  Sum_probs=198.9

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCCh--HHHHHHHHHHHHHHhcCCCCcceEeeEEeeC--CccEEE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDK--TQIHQFINEVVILSQINHRHIVKLLGCCLET--EVPVLV  290 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV  290 (537)
                      ++|+..+.||+|+||.||+|... +++.+|+|.++....  .....+.+|+.++.+++|+||+++++++...  ...++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            47888899999999999999975 588999998864322  2234567899999999999999999999877  789999


Q ss_pred             EecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEee
Q 009340          291 YEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSD  370 (537)
Q Consensus       291 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~D  370 (537)
                      +||+++ +|.+++....           ..+++..++.++.|+++||+|||+.+   ++|+||||+||+++.++.+||+|
T Consensus        85 ~e~~~~-~L~~~~~~~~-----------~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d  149 (293)
T cd07843          85 MEYVEH-DLKSLMETMK-----------QPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICD  149 (293)
T ss_pred             ehhcCc-CHHHHHHhcc-----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEee
Confidence            999974 8988886532           25899999999999999999999999   99999999999999999999999


Q ss_pred             ccCccccCCCCCceeeeccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhh
Q 009340          371 FGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSS-QFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKE  449 (537)
Q Consensus       371 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  449 (537)
                      ||++........ ......++..|+|||.+.+. .++.++|+||||+++|||++|+.||......+...   ........
T Consensus       150 ~g~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~---~~~~~~~~  225 (293)
T cd07843         150 FGLAREYGSPLK-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLN---KIFKLLGT  225 (293)
T ss_pred             cCceeeccCCcc-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH---HHHHHhCC
Confidence            999987644321 12334578899999998754 46899999999999999999999987543322110   00000000


Q ss_pred             -----------------chhhhhhcHHhhccccHH-HHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          450 -----------------NQLLEILDARVAKEAREE-DIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       450 -----------------~~~~~~~d~~~~~~~~~~-~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                                       ..........+....+.. ....+.+++.+||+.+|++|||+.|++.
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         226 PTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             CchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence                             000000111111112221 3567889999999999999999999975

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-36  Score=298.38  Aligned_cols=247  Identities=25%  Similarity=0.450  Sum_probs=198.7

Q ss_pred             CCccccccCcCCceEEEEEEc-CCCCEEEEEEccCC-ChHHHHHHHHHHHHHHhcC---CCCcceEeeEEeeCCccEEEE
Q 009340          217 NYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEI-DKTQIHQFINEVVILSQIN---HRHIVKLLGCCLETEVPVLVY  291 (537)
Q Consensus       217 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV~  291 (537)
                      .|+..+.||+|+||.||+|.. .+++.||+|.++.. ......++.+|+.++++++   |+|++++++++.+....++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            467788999999999999996 47899999988643 3445567889999999996   999999999999999999999


Q ss_pred             ecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeec
Q 009340          292 EYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF  371 (537)
Q Consensus       292 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Df  371 (537)
                      ||+++++|.+++..             ..+++...+.++.|+++||.|||+.+   ++|+||+|+||+++.++.++|+||
T Consensus        82 e~~~~~~L~~~~~~-------------~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~df  145 (277)
T cd06917          82 EYAEGGSVRTLMKA-------------GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDF  145 (277)
T ss_pred             ecCCCCcHHHHHHc-------------cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccC
Confidence            99999999988753             25899999999999999999999999   999999999999999999999999


Q ss_pred             cCccccCCCCCceeeeccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhc
Q 009340          372 GISRSIPNDKTHLTTTIQGTFGYLDPEYFQSS-QFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKEN  450 (537)
Q Consensus       372 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  450 (537)
                      |++......... .....|+..|+|||.+.++ .++.++||||||+++|+|++|+.||........      .. .....
T Consensus       146 g~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~------~~-~~~~~  217 (277)
T cd06917         146 GVAALLNQNSSK-RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA------MM-LIPKS  217 (277)
T ss_pred             CceeecCCCccc-cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh------hh-ccccC
Confidence            999876443321 2334688899999998764 468999999999999999999999864322110      00 00000


Q ss_pred             hhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          451 QLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       451 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                           ..+.+..   ......+.+++.+||+.||++||++.++++
T Consensus       218 -----~~~~~~~---~~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         218 -----KPPRLED---NGYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             -----CCCCCCc---ccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence                 0011110   114457889999999999999999999976

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-36  Score=306.31  Aligned_cols=251  Identities=29%  Similarity=0.406  Sum_probs=211.2

Q ss_pred             HhcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCCh---HHHHHHHHHHHHHHhcC-CCCcceEeeEEeeCCccE
Q 009340          214 ATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDK---TQIHQFINEVVILSQIN-HRHIVKLLGCCLETEVPV  288 (537)
Q Consensus       214 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~  288 (537)
                      ....|...+.||.|.||.||+++.+ +|+.+|+|.+.....   ...+.+.+|+.+|+++. |||+|.+.+.+.+....+
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~  112 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY  112 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence            3467888899999999999999976 499999998865322   24567889999999998 999999999999999999


Q ss_pred             EEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCC----C
Q 009340          289 LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK----F  364 (537)
Q Consensus       289 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~----~  364 (537)
                      +|||++.+|.|.+.+...             .+++.....++.|+++++.|||+.+   |+||||||+|+|+...    +
T Consensus       113 lvmEL~~GGeLfd~i~~~-------------~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~  176 (382)
T KOG0032|consen  113 LVMELCEGGELFDRIVKK-------------HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSG  176 (382)
T ss_pred             EEEEecCCchHHHHHHHc-------------cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCC
Confidence            999999999999999652             2889999999999999999999999   9999999999999543    5


Q ss_pred             cEEEeeccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHH
Q 009340          365 SAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFI  444 (537)
Q Consensus       365 ~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~  444 (537)
                      .+|++|||++.....  .......+||+.|+|||.+....|+..+||||+||++|.|++|..||........      +.
T Consensus       177 ~ik~~DFGla~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~------~~  248 (382)
T KOG0032|consen  177 RIKLIDFGLAKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEI------FL  248 (382)
T ss_pred             cEEEeeCCCceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHH------HH
Confidence            799999999998765  4456788999999999999999999999999999999999999999986553321      11


Q ss_pred             HHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          445 SLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       445 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                       ....+..      .+..+.....+....+++..|+..||..|+|+.++++
T Consensus       249 -~i~~~~~------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~  292 (382)
T KOG0032|consen  249 -AILRGDF------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ  292 (382)
T ss_pred             -HHHcCCC------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence             1111111      2233344556778889999999999999999999988

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=3.2e-36  Score=299.54  Aligned_cols=264  Identities=22%  Similarity=0.313  Sum_probs=196.2

Q ss_pred             HhcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCC-hHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEE
Q 009340          214 ATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEID-KTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY  291 (537)
Q Consensus       214 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  291 (537)
                      ++++|...+.||+|+||.||+|... +|+.||+|.++... ......+.+|+.+++.++|+||+++.+++.+.+..++|+
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            3578889999999999999999854 68899999986432 222346778999999999999999999999988999999


Q ss_pred             ecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeec
Q 009340          292 EYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF  371 (537)
Q Consensus       292 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Df  371 (537)
                      ||+. ++|.+++....           ..+++..+..++.|+++||.|||+.+   ++|+||||+||+++.++.+||+||
T Consensus        83 e~~~-~~l~~~~~~~~-----------~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Df  147 (291)
T cd07870          83 EYMH-TDLAQYMIQHP-----------GGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADF  147 (291)
T ss_pred             eccc-CCHHHHHHhCC-----------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEecc
Confidence            9996 67777765421           25788889999999999999999998   999999999999999999999999


Q ss_pred             cCccccCCCCCceeeeccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhc
Q 009340          372 GISRSIPNDKTHLTTTIQGTFGYLDPEYFQSS-QFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKEN  450 (537)
Q Consensus       372 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  450 (537)
                      |+++....... ......++..|+|||.+.+. .++.++||||||+++|||++|+.||.......  ......+......
T Consensus       148 g~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~--~~~~~~~~~~~~~  224 (291)
T cd07870         148 GLARAKSIPSQ-TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVF--EQLEKIWTVLGVP  224 (291)
T ss_pred             ccccccCCCCC-CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHH--HHHHHHHHHcCCC
Confidence            99876432221 12234568899999998754 57889999999999999999999986543211  1111111110000


Q ss_pred             ------------h-hhhhhcHHhhcc-----ccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          451 ------------Q-LLEILDARVAKE-----AREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       451 ------------~-~~~~~d~~~~~~-----~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                                  . ..+.........     ........+.+++.+|++.||++|||+.|++.
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         225 TEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             ChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence                        0 000000000000     00012356789999999999999999999864

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=3.5e-36  Score=292.86  Aligned_cols=249  Identities=24%  Similarity=0.385  Sum_probs=205.0

Q ss_pred             CCccccccCcCCceEEEEEEcC-CCCEEEEEEccCC--ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEec
Q 009340          217 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI--DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY  293 (537)
Q Consensus       217 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  293 (537)
                      +|+..++||+|+||.||++... +++.+|+|.+...  ......++.+|+.++++++|+||+++.+++.+....++|+||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            4777889999999999999854 6889999988643  344566788999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccC
Q 009340          294 ISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGI  373 (537)
Q Consensus       294 ~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgl  373 (537)
                      +++++|.+++......        ...+++..++.++.|+++||.|||+.+   ++|+||+|+||++++++.+|++|||+
T Consensus        81 ~~~~~L~~~~~~~~~~--------~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~  149 (256)
T cd08530          81 APFGDLSKAISKRKKK--------RKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGI  149 (256)
T ss_pred             cCCCCHHHHHHHHHhh--------cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccc
Confidence            9999999998763221        246899999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchhh
Q 009340          374 SRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLL  453 (537)
Q Consensus       374 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  453 (537)
                      +......   ......++..|+|||.+.+..++.++|+||||+++|||++|+.||......+       +......    
T Consensus       150 ~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~-------~~~~~~~----  215 (256)
T cd08530         150 SKVLKKN---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD-------LRYKVQR----  215 (256)
T ss_pred             hhhhccC---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHhc----
Confidence            9876543   2223457889999999999999999999999999999999999986543221       1111111    


Q ss_pred             hhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          454 EILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       454 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                           ......+......+.+++.+||+.+|++||++.++++
T Consensus       216 -----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         216 -----GKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             -----CCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                 1111233355677899999999999999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=4.3e-36  Score=297.27  Aligned_cols=262  Identities=23%  Similarity=0.346  Sum_probs=199.3

Q ss_pred             CCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCCh-HHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecC
Q 009340          217 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDK-TQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI  294 (537)
Q Consensus       217 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  294 (537)
                      +|+..+.||+|++|.||+|+.. +|+.||||.++.... ...+.+.+|+.++++++|+|++++++++.+.+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            5788899999999999999975 688999998875432 23456778999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCc
Q 009340          295 SSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGIS  374 (537)
Q Consensus       295 ~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla  374 (537)
                      ++ +|.+++.....         ...+++..+..++.|+++||.|||+.+   ++||||+|+||++++++.++|+|||++
T Consensus        81 ~~-~l~~~~~~~~~---------~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~  147 (284)
T cd07836          81 DK-DLKKYMDTHGV---------RGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLA  147 (284)
T ss_pred             Cc-cHHHHHHhcCC---------CCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchh
Confidence            85 88888865432         236899999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCCceeeeccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhh---c
Q 009340          375 RSIPNDKTHLTTTIQGTFGYLDPEYFQSS-QFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKE---N  450 (537)
Q Consensus       375 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---~  450 (537)
                      ........ ......++..|++||.+.+. .++.++||||||+++|||++|+.||......+...   ........   .
T Consensus       148 ~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~---~~~~~~~~~~~~  223 (284)
T cd07836         148 RAFGIPVN-TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLL---KIFRIMGTPTES  223 (284)
T ss_pred             hhhcCCcc-ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHH---HHHHHhCCCChh
Confidence            76533221 12234568899999988654 56889999999999999999999986543322111   01000000   0


Q ss_pred             hhhhhh-----cH-------HhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          451 QLLEIL-----DA-------RVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       451 ~~~~~~-----d~-------~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      ....+.     ..       ..........+..+.+++.+||+.||++||++.++++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         224 TWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             hHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            000000     00       0001111233567889999999999999999999874

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=2.3e-36  Score=302.11  Aligned_cols=264  Identities=27%  Similarity=0.359  Sum_probs=198.4

Q ss_pred             HHhcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCC--hHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCC----
Q 009340          213 RATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEID--KTQIHQFINEVVILSQINHRHIVKLLGCCLETE----  285 (537)
Q Consensus       213 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----  285 (537)
                      ...++|+..+.||+|+||.||+|... +|+.||+|.++...  ......+.+|+.++++++|||++++++++.+..    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            45678999999999999999999975 58899999986432  223356778999999999999999999987655    


Q ss_pred             ------ccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEE
Q 009340          286 ------VPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNIL  359 (537)
Q Consensus       286 ------~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIl  359 (537)
                            ..++|+||+++ +|.+.+...           ...+++..+..++.|++.||+|||+.+   |+||||+|+||+
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~-----------~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nil  148 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESG-----------LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNIL  148 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEE
Confidence                  68999999986 777766542           235899999999999999999999998   999999999999


Q ss_pred             ECCCCcEEEeeccCccccCCCCCceeeeccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhcc
Q 009340          360 LDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQS-SQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERN  438 (537)
Q Consensus       360 l~~~~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~  438 (537)
                      +++++.+||+|||++...............++..|+|||.+.+ ..++.++|||||||++|||++|+.||......+.  
T Consensus       149 i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~--  226 (302)
T cd07864         149 LNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQ--  226 (302)
T ss_pred             ECCCCcEEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHH--
Confidence            9999999999999998764433222223346788999998865 4578999999999999999999999865432211  


Q ss_pred             HHHHHHHHHhhc---hhhhhhc--------------HHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          439 LVACFISLAKEN---QLLEILD--------------ARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       439 ~~~~~~~~~~~~---~~~~~~d--------------~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                       ...+.......   ...++..              ..... .....+..+.+++.+||+.+|++||++.+++.
T Consensus       227 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         227 -LELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLRE-EFSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             -HHHHHHHhCCCChhhcccccccccccccccccccccchhh-hcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence             11111111000   0000000              00000 01123467899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=7.8e-36  Score=290.27  Aligned_cols=250  Identities=28%  Similarity=0.478  Sum_probs=205.4

Q ss_pred             CCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCC--hHHHHHHHHHHHHHHhcCCCCcceEeeEEeeC--CccEEEE
Q 009340          217 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEID--KTQIHQFINEVVILSQINHRHIVKLLGCCLET--EVPVLVY  291 (537)
Q Consensus       217 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~  291 (537)
                      +|...+.||+|++|.||+|... +++.|++|......  ....+.+.+|+.++++++|+|++++++++.+.  ...++|+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4677889999999999999976 68899999886543  35577899999999999999999999999988  7899999


Q ss_pred             ecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeec
Q 009340          292 EYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF  371 (537)
Q Consensus       292 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Df  371 (537)
                      ||+++++|.+++...            ..++|..++.++.++++||+|||+.+   ++|+||+|+||+++.++.++|+||
T Consensus        81 e~~~~~~L~~~~~~~------------~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~  145 (260)
T cd06606          81 EYVSGGSLSSLLKKF------------GKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADF  145 (260)
T ss_pred             EecCCCcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccc
Confidence            999999999998653            26999999999999999999999988   999999999999999999999999


Q ss_pred             cCccccCCCCCc-eeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhc
Q 009340          372 GISRSIPNDKTH-LTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKEN  450 (537)
Q Consensus       372 gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  450 (537)
                      |.+......... ......++..|+|||.+.....+.++||||||+++++|++|+.||.....     .........   
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~---  217 (260)
T cd06606         146 GCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN-----PMAALYKIG---  217 (260)
T ss_pred             ccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-----hHHHHHhcc---
Confidence            999876544321 12345678899999999888899999999999999999999999865431     111111111   


Q ss_pred             hhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          451 QLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       451 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                            ........+......+.+++.+|++.+|++||++.+++.
T Consensus       218 ------~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         218 ------SSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             ------ccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence                  111111233344678999999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=4.2e-36  Score=299.16  Aligned_cols=265  Identities=22%  Similarity=0.300  Sum_probs=195.9

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCC--hHHHHHHHHHHHHHHhcC-CCCcceEeeEEeeCCc-----
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEID--KTQIHQFINEVVILSQIN-HRHIVKLLGCCLETEV-----  286 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~-----  286 (537)
                      ++|+..+.||+|+||.||+|... +|+.||+|..+...  ......+.+|+.+++.++ |+|++++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            46888899999999999999964 68999999876432  223456888999999995 6999999999987665     


Q ss_pred             cEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECC-CCc
Q 009340          287 PVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD-KFS  365 (537)
Q Consensus       287 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~-~~~  365 (537)
                      .++||||+++ +|.+++......       ....+++..++.++.||++||.|||+.+   ++||||+|+||+++. ++.
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~-------~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~  149 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRG-------PGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGL  149 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhccc-------CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCe
Confidence            7999999985 898888653220       0235899999999999999999999998   999999999999998 899


Q ss_pred             EEEeeccCccccCCCCCceeeeccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHH
Q 009340          366 AKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQS-SQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFI  444 (537)
Q Consensus       366 ~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~  444 (537)
                      +||+|||++......... .....+++.|+|||++.+ ..++.++||||||+++|||++|+.||......+.  +.. +.
T Consensus       150 ~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~--~~~-~~  225 (295)
T cd07837         150 LKIADLGLGRAFSIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQ--LLH-IF  225 (295)
T ss_pred             EEEeecccceecCCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH--HHH-HH
Confidence            999999998765332111 122346788999998865 4578999999999999999999999865432211  000 00


Q ss_pred             HHHhhchhh---hhh-----------cHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          445 SLAKENQLL---EIL-----------DARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       445 ~~~~~~~~~---~~~-----------d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      .........   ...           .+.............+.+++.+||+.||++||++.|++.
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         226 KLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             HHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            100000000   000           000000011234567889999999999999999999874

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=5.9e-36  Score=300.96  Aligned_cols=268  Identities=22%  Similarity=0.324  Sum_probs=197.7

Q ss_pred             CCccccccCcCCceEEEEEEcC---CCCEEEEEEccCCC---hHHHHHHHHHHHHHHhcCCCCcceEeeEEeeC--CccE
Q 009340          217 NYNQSRFLGQGGFGTVYKGMLP---DGSIVAVKRSKEID---KTQIHQFINEVVILSQINHRHIVKLLGCCLET--EVPV  288 (537)
Q Consensus       217 ~~~~~~~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~  288 (537)
                      .|+..++||+|+||.||+|...   +++.||+|.+....   ....+.+.+|+.++++++|||++++++++.+.  ...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            3677889999999999999964   47899999987632   33456778899999999999999999999988  7899


Q ss_pred             EEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECC----CC
Q 009340          289 LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD----KF  364 (537)
Q Consensus       289 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~----~~  364 (537)
                      +||||+++ +|.+++......       ....+++..+..++.|++.||.|||+.+   ++||||||+||+++.    ++
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~-------~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~  149 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQA-------KRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERG  149 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccC-------CCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccc
Confidence            99999975 677776543321       0136889999999999999999999999   999999999999999    99


Q ss_pred             cEEEeeccCccccCCCCC--ceeeeccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhcc---
Q 009340          365 SAKVSDFGISRSIPNDKT--HLTTTIQGTFGYLDPEYFQS-SQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERN---  438 (537)
Q Consensus       365 ~~ki~Dfgla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~---  438 (537)
                      .+||+|||++........  .......++..|+|||.+.+ ..++.++||||||++++||++|+.||..........   
T Consensus       150 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~  229 (316)
T cd07842         150 VVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPF  229 (316)
T ss_pred             eEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchh
Confidence            999999999987643322  11234467889999998866 457899999999999999999999986543322000   


Q ss_pred             ---HHHHHHHHHhh------------chhhhhhcH---------HhhccccH--HHHHHHHHHHHHhcccCCCCCCCHhh
Q 009340          439 ---LVACFISLAKE------------NQLLEILDA---------RVAKEARE--EDIGAMAELAMRCLRLNSKKRPTMKQ  492 (537)
Q Consensus       439 ---~~~~~~~~~~~------------~~~~~~~d~---------~~~~~~~~--~~~~~l~~l~~~cl~~~p~~RPs~~e  492 (537)
                         ....+...+..            .......+.         .+......  .....+.+++.+||+.||++|||+.|
T Consensus       230 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~e  309 (316)
T cd07842         230 QRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEE  309 (316)
T ss_pred             HHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHH
Confidence               00000000000            000000000         00000001  33457889999999999999999999


Q ss_pred             HHH
Q 009340          493 VSM  495 (537)
Q Consensus       493 v~~  495 (537)
                      +++
T Consensus       310 il~  312 (316)
T cd07842         310 ALE  312 (316)
T ss_pred             Hhc
Confidence            875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=7.4e-36  Score=292.08  Aligned_cols=237  Identities=28%  Similarity=0.359  Sum_probs=192.9

Q ss_pred             cCcCCceEEEEEEcC-CCCEEEEEEccCC---ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecCCCCCh
Q 009340          224 LGQGGFGTVYKGMLP-DGSIVAVKRSKEI---DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTL  299 (537)
Q Consensus       224 lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL  299 (537)
                      ||.|+||.||+++.. +++.||+|.+...   .....+.+.+|+.+++.++|+|++++++++.+....++|+||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            699999999999975 4889999988642   223456789999999999999999999999999999999999999999


Q ss_pred             hhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCccccCC
Q 009340          300 SHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPN  379 (537)
Q Consensus       300 ~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~  379 (537)
                      .+++...            ..+++..+..++.|+++||.|||+.+   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 ~~~l~~~------------~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~  145 (262)
T cd05572          81 WTILRDR------------GLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKS  145 (262)
T ss_pred             HHHHhhc------------CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCc
Confidence            9999753            24889999999999999999999998   99999999999999999999999999987654


Q ss_pred             CCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchhhhhhcHH
Q 009340          380 DKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEILDAR  459 (537)
Q Consensus       380 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  459 (537)
                      ..  ......++..|+|||.+.+..++.++|+||||+++|||++|+.|+.....+.    ......         +....
T Consensus       146 ~~--~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~~~---------~~~~~  210 (262)
T cd05572         146 GQ--KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP----MEIYND---------ILKGN  210 (262)
T ss_pred             cc--ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH----HHHHHH---------HhccC
Confidence            32  2233467889999999988889999999999999999999999986543211    011111         11101


Q ss_pred             hhccccHHHHHHHHHHHHHhcccCCCCCCCH
Q 009340          460 VAKEAREEDIGAMAELAMRCLRLNSKKRPTM  490 (537)
Q Consensus       460 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~  490 (537)
                      .....+......+.+++.+||+.+|++||++
T Consensus       211 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~  241 (262)
T cd05572         211 GKLEFPNYIDKAAKDLIKQLLRRNPEERLGN  241 (262)
T ss_pred             CCCCCCcccCHHHHHHHHHHccCChhhCcCC
Confidence            1112233335688999999999999999993

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-36  Score=307.00  Aligned_cols=268  Identities=24%  Similarity=0.377  Sum_probs=200.2

Q ss_pred             hcCCccccccCcCCceEEEEEEc-CCCCEEEEEEccCC-ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCC-----cc
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEI-DKTQIHQFINEVVILSQINHRHIVKLLGCCLETE-----VP  287 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~  287 (537)
                      .++|...++||+|+||.||+|+. .+|+.||+|.++.. .......+.+|+.++++++|+||+++++++....     ..
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            46899999999999999999985 46899999998643 2334567889999999999999999999876543     47


Q ss_pred             EEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEE
Q 009340          288 VLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK  367 (537)
Q Consensus       288 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~k  367 (537)
                      ++|+||+++ +|.+++..             ..+++..+..++.|+++||+|||+.+   |+||||||+||+++.++.+|
T Consensus        84 ~lv~e~~~~-~l~~~~~~-------------~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~k  146 (336)
T cd07849          84 YIVQELMET-DLYKLIKT-------------QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLK  146 (336)
T ss_pred             EEEehhccc-CHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEE
Confidence            999999975 77776643             35899999999999999999999999   99999999999999999999


Q ss_pred             EeeccCccccCCCCCc--eeeeccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHH
Q 009340          368 VSDFGISRSIPNDKTH--LTTTIQGTFGYLDPEYFQS-SQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFI  444 (537)
Q Consensus       368 i~Dfgla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~  444 (537)
                      |+|||++.........  ......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||........   .....
T Consensus       147 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~---~~~~~  223 (336)
T cd07849         147 ICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQ---LNLIL  223 (336)
T ss_pred             ECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHH
Confidence            9999999765432221  1123467899999998754 5688999999999999999999999864332111   11111


Q ss_pred             HHHhh---chhhhhhcHHh---------hcc-----ccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHH--HHHHHH
Q 009340          445 SLAKE---NQLLEILDARV---------AKE-----AREEDIGAMAELAMRCLRLNSKKRPTMKQVSME--LEGLRR  502 (537)
Q Consensus       445 ~~~~~---~~~~~~~d~~~---------~~~-----~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~--L~~i~~  502 (537)
                      .....   .....+.+...         ...     .....+..+.+++.+||+.+|++|||+.++++.  ++....
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~  300 (336)
T cd07849         224 GVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD  300 (336)
T ss_pred             HHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence            11110   00111111000         000     011234678899999999999999999999876  555443

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=4.6e-36  Score=296.97  Aligned_cols=261  Identities=24%  Similarity=0.342  Sum_probs=196.3

Q ss_pred             CccccccCcCCceEEEEEEcC-CCCEEEEEEccCCC--hHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecC
Q 009340          218 YNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEID--KTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI  294 (537)
Q Consensus       218 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  294 (537)
                      |+..+.||.|++|.||+|... +|+.||+|++....  ......+.+|+.++++++|+|++++++++.+.+..+++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            566788999999999999864 79999999886432  223457889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCc
Q 009340          295 SSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGIS  374 (537)
Q Consensus       295 ~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla  374 (537)
                      + ++|.+++.....          ..+++..++.++.|+++||+|||+.+   ++||||+|+||+++.++.++|+|||++
T Consensus        81 ~-~~l~~~~~~~~~----------~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~  146 (283)
T cd07835          81 D-LDLKKYMDSSPL----------TGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLA  146 (283)
T ss_pred             C-cCHHHHHhhCCC----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccc
Confidence            5 689998865321          25899999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCCceeeeccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhc---
Q 009340          375 RSIPNDKTHLTTTIQGTFGYLDPEYFQSS-QFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKEN---  450 (537)
Q Consensus       375 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---  450 (537)
                      ......... .....++..|+|||.+.+. .++.++||||||+++|||++|+.||........  +...+.......   
T Consensus       147 ~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~  223 (283)
T cd07835         147 RAFGVPVRT-YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ--LFRIFRTLGTPDEDV  223 (283)
T ss_pred             cccCCCccc-cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCChHH
Confidence            765322211 1223468899999988654 578999999999999999999999865432211  111000000000   


Q ss_pred             -----hhhhhhcH------HhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          451 -----QLLEILDA------RVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       451 -----~~~~~~d~------~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                           .+.+....      ..........+..+.+++.+||+.+|++|||+.|+++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         224 WPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             hhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence                 00000000      0000111223357889999999999999999999974

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=7e-36  Score=295.33  Aligned_cols=257  Identities=23%  Similarity=0.284  Sum_probs=192.8

Q ss_pred             CccccccCcCCceEEEEEEcC-CCCEEEEEEccCCC-hHHHHHHHHHHHHHHhcC-CCCcceEeeEEeeC--CccEEEEe
Q 009340          218 YNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEID-KTQIHQFINEVVILSQIN-HRHIVKLLGCCLET--EVPVLVYE  292 (537)
Q Consensus       218 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~--~~~~lV~e  292 (537)
                      |+..++||+|+||.||+|... +++.||+|+++... ........+|+.++.++. |+|++++++++.+.  +..++|+|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            456788999999999999954 68899999887532 222234567899999885 99999999999987  78999999


Q ss_pred             cCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeecc
Q 009340          293 YISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG  372 (537)
Q Consensus       293 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfg  372 (537)
                      |++ |+|.+++....           ..++|..++.++.|++.||.|||+.+   ++||||+|+||+++. +.+||+|||
T Consensus        81 ~~~-~~l~~~l~~~~-----------~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg  144 (282)
T cd07831          81 LMD-MNLYELIKGRK-----------RPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFG  144 (282)
T ss_pred             cCC-ccHHHHHHhcc-----------CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecc
Confidence            997 58888876532           36899999999999999999999998   999999999999999 999999999


Q ss_pred             CccccCCCCCceeeeccccccccCccccc-CCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHh---
Q 009340          373 ISRSIPNDKTHLTTTIQGTFGYLDPEYFQ-SSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAK---  448 (537)
Q Consensus       373 la~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~---  448 (537)
                      ++.........  ....++..|+|||.+. ++.++.++|||||||++|||++|+.||......+.   .........   
T Consensus       145 ~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~---~~~~~~~~~~~~  219 (282)
T cd07831         145 SCRGIYSKPPY--TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQ---IAKIHDVLGTPD  219 (282)
T ss_pred             cccccccCCCc--CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHH---HHHHHHHcCCCC
Confidence            99876433221  2345788999999764 45678899999999999999999999865433221   111111100   


Q ss_pred             --------hchhhhhhcHHh----hccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          449 --------ENQLLEILDARV----AKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       449 --------~~~~~~~~d~~~----~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                              .........+..    ........+..+.+++.+||+.+|++||++.++++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         220 AEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             HHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence                    000000000000    00011234678999999999999999999999875

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=2.5e-36  Score=294.79  Aligned_cols=247  Identities=28%  Similarity=0.381  Sum_probs=202.0

Q ss_pred             CCccccccCcCCceEEEEEEcC-CCCEEEEEEccCC---ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEe
Q 009340          217 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI---DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE  292 (537)
Q Consensus       217 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e  292 (537)
                      +|...+.||+|+||.||++... +++.||+|.+...   .....+.+.+|+.++++++|||++++++++.+....++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            5778899999999999999975 5899999988642   23456789999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeecc
Q 009340          293 YISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG  372 (537)
Q Consensus       293 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfg  372 (537)
                      |+++++|.+++...            ..+++..+..++.|+++||.|||+.+   ++|+||+|+||++++++.++|+|||
T Consensus        81 ~~~~~~L~~~l~~~------------~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~  145 (258)
T cd05578          81 LLLGGDLRYHLSQK------------VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFN  145 (258)
T ss_pred             CCCCCCHHHHHHhc------------CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecc
Confidence            99999999998653            25889999999999999999999998   9999999999999999999999999


Q ss_pred             CccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchh
Q 009340          373 ISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQL  452 (537)
Q Consensus       373 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  452 (537)
                      ++.......  ......++..|+|||.+.+..++.++|+||||+++|+|++|+.|+.......    ...+......   
T Consensus       146 ~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~~---  216 (258)
T cd05578         146 IATKVTPDT--LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI----RDQIRAKQET---  216 (258)
T ss_pred             cccccCCCc--cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH----HHHHHHHhcc---
Confidence            988764432  1234557889999999988889999999999999999999999987543321    1111111110   


Q ss_pred             hhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCH--hhHH
Q 009340          453 LEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTM--KQVS  494 (537)
Q Consensus       453 ~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~--~ev~  494 (537)
                             .....+...+..+.+++.+||+.||.+||++  +|++
T Consensus       217 -------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         217 -------ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             -------ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence                   1112233345788899999999999999999  5543

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-36  Score=297.36  Aligned_cols=247  Identities=26%  Similarity=0.377  Sum_probs=210.4

Q ss_pred             cCCccccccCcCCceEEEEEEc-CCCCEEEEEEccCC--ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEe
Q 009340          216 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEI--DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE  292 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e  292 (537)
                      .-|...+.||+|.|..|-+++. -.|..||||.+...  +.-....+++|++.|+-++|||||+|+++.......|||.|
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE   97 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE   97 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence            4577778899999999988873 37999999998753  33345568899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEE-CCCCcEEEeec
Q 009340          293 YISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILL-DDKFSAKVSDF  371 (537)
Q Consensus       293 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll-~~~~~~ki~Df  371 (537)
                      .-++|+|.+|+-.+..           -+.+....+++.||+.|+.|+|+..   +|||||||+||.+ ..-|-+|++||
T Consensus        98 LGD~GDl~DyImKHe~-----------Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDF  163 (864)
T KOG4717|consen   98 LGDGGDLFDYIMKHEE-----------GLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDF  163 (864)
T ss_pred             ecCCchHHHHHHhhhc-----------cccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeec
Confidence            9999999999987654           5899999999999999999999999   9999999999976 45678999999


Q ss_pred             cCccccCCCCCceeeeccccccccCcccccCCCCC-cchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhc
Q 009340          372 GISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFT-DKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKEN  450 (537)
Q Consensus       372 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t-~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  450 (537)
                      |++..+..+.  ..++.+|+..|.|||++.+..|+ +++||||+|||||-|++|+.||+.....+               
T Consensus       164 GFSNkf~PG~--kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE---------------  226 (864)
T KOG4717|consen  164 GFSNKFQPGK--KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE---------------  226 (864)
T ss_pred             cccccCCCcc--hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh---------------
Confidence            9997764433  34567899999999999999887 68999999999999999999997665433               


Q ss_pred             hhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          451 QLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       451 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      .+..++|-.+  ..|.-.+.++.+||..||..||.+|-+.++|+.
T Consensus       227 TLTmImDCKY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  227 TLTMIMDCKY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS  269 (864)
T ss_pred             hhhhhhcccc--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence            2344555433  357778889999999999999999999999865

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=5e-36  Score=293.06  Aligned_cols=243  Identities=29%  Similarity=0.403  Sum_probs=196.9

Q ss_pred             cCcCCceEEEEEEcC-CCCEEEEEEccCCCh---HHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecCCCCCh
Q 009340          224 LGQGGFGTVYKGMLP-DGSIVAVKRSKEIDK---TQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTL  299 (537)
Q Consensus       224 lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL  299 (537)
                      ||+|+||.||++... +|+.+++|.+.....   ...+.+.+|+.++++++|+|++++++++......++|+||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999976 489999999865332   4566789999999999999999999999999999999999999999


Q ss_pred             hhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCccccCC
Q 009340          300 SHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPN  379 (537)
Q Consensus       300 ~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~  379 (537)
                      .+++...            ..+++..+..++.|+++||+|||+.+   ++|+||+|+||++++++.++|+|||++.....
T Consensus        81 ~~~l~~~------------~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~  145 (265)
T cd05579          81 ASLLENV------------GSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLV  145 (265)
T ss_pred             HHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhccc
Confidence            9998652            35899999999999999999999998   99999999999999999999999999876533


Q ss_pred             CCC-------ceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchh
Q 009340          380 DKT-------HLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQL  452 (537)
Q Consensus       380 ~~~-------~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  452 (537)
                      ...       .......++..|+|||.......+.++||||||+++|||++|+.||......+      .+..... .. 
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~------~~~~~~~-~~-  217 (265)
T cd05579         146 RRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE------IFQNILN-GK-  217 (265)
T ss_pred             CcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHhc-CC-
Confidence            321       12233457889999999988889999999999999999999999986543221      1111110 00 


Q ss_pred             hhhhcHHhhccccHH--HHHHHHHHHHHhcccCCCCCCCHhhHHHHHH
Q 009340          453 LEILDARVAKEAREE--DIGAMAELAMRCLRLNSKKRPTMKQVSMELE  498 (537)
Q Consensus       453 ~~~~d~~~~~~~~~~--~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~  498 (537)
                             .  ..+..  ....+.+++.+||+.+|++|||+.++.+.|+
T Consensus       218 -------~--~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~  256 (265)
T cd05579         218 -------I--EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN  256 (265)
T ss_pred             -------c--CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence                   0  11111  2567889999999999999999977766554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=4.3e-36  Score=305.12  Aligned_cols=266  Identities=27%  Similarity=0.391  Sum_probs=198.6

Q ss_pred             HhcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccC--CChHHHHHHHHHHHHHHhc-CCCCcceEeeEEeeCC--cc
Q 009340          214 ATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKE--IDKTQIHQFINEVVILSQI-NHRHIVKLLGCCLETE--VP  287 (537)
Q Consensus       214 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~--~~  287 (537)
                      ..++|+..+.||+|+||.||+|... +|+.||+|++..  ........+.+|+.+++++ +|+||+++++++...+  ..
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            4567888899999999999999965 688999998754  2334456678899999999 9999999999986543  57


Q ss_pred             EEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEE
Q 009340          288 VLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK  367 (537)
Q Consensus       288 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~k  367 (537)
                      ++||||++ ++|.+++..             ..++|..+..++.|++.||.|||+.+   |+||||||+||+++.++.+|
T Consensus        85 ~lv~e~~~-~~L~~~~~~-------------~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~k  147 (337)
T cd07852          85 YLVFEYME-TDLHAVIRA-------------NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVK  147 (337)
T ss_pred             EEEecccc-cCHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEE
Confidence            99999997 589888754             25889999999999999999999998   99999999999999999999


Q ss_pred             EeeccCccccCCCCCc----eeeeccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHH
Q 009340          368 VSDFGISRSIPNDKTH----LTTTIQGTFGYLDPEYFQS-SQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVAC  442 (537)
Q Consensus       368 i~Dfgla~~~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~  442 (537)
                      |+|||++.........    ......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||......+.......
T Consensus       148 l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~  227 (337)
T cd07852         148 LADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIE  227 (337)
T ss_pred             EeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence            9999999876433221    2233468899999998765 5678899999999999999999999864432221000000


Q ss_pred             H--------HHHHhhchhhhhhcH---Hhh---ccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHH
Q 009340          443 F--------ISLAKENQLLEILDA---RVA---KEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSME  496 (537)
Q Consensus       443 ~--------~~~~~~~~~~~~~d~---~~~---~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~  496 (537)
                      .        ...+........++.   .-.   .......+..+.+++.+||+.+|++|||+.++++.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         228 VIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence            0        000000000011110   000   00111235678999999999999999999999864

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=1.1e-35  Score=289.27  Aligned_cols=251  Identities=30%  Similarity=0.442  Sum_probs=205.9

Q ss_pred             CCccccccCcCCceEEEEEEcC-CCCEEEEEEccCC--ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEec
Q 009340          217 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI--DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY  293 (537)
Q Consensus       217 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  293 (537)
                      +|...+.||.|+||.||++... +++.|++|++...  ......++.+|+++++.++|+|++++.+.+...+..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            4777889999999999999965 6889999998754  235667789999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccC
Q 009340          294 ISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGI  373 (537)
Q Consensus       294 ~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgl  373 (537)
                      +++++|.+++.....        ....+++..+..++.++++||.|||+.+   ++|+||+|+||+++.++.++|+|||+
T Consensus        81 ~~~~~L~~~l~~~~~--------~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~  149 (258)
T cd08215          81 ADGGDLSQKIKKQKK--------EGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGI  149 (258)
T ss_pred             cCCCcHHHHHHHhhc--------cCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccc
Confidence            999999999976431        0246999999999999999999999998   99999999999999999999999999


Q ss_pred             ccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchhh
Q 009340          374 SRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLL  453 (537)
Q Consensus       374 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  453 (537)
                      +....... .......+++.|+|||.+.+..++.++||||||+++++|++|+.|+......+      .... .....  
T Consensus       150 ~~~~~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~------~~~~-~~~~~--  219 (258)
T cd08215         150 SKVLSSTV-DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE------LALK-ILKGQ--  219 (258)
T ss_pred             eeecccCc-ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH------HHHH-HhcCC--
Confidence            98764433 22334568889999999988889999999999999999999999986443211      0111 11111  


Q ss_pred             hhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          454 EILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       454 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                             ....+......+.+++.+||..+|++|||+.++++
T Consensus       220 -------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         220 -------YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             -------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                   11122344567889999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-38  Score=293.22  Aligned_cols=249  Identities=24%  Similarity=0.401  Sum_probs=207.9

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecC
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI  294 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  294 (537)
                      +-|....+||+|.||+||++..+ .|+.||||++...  ...+++..|+.+|++...+++|+++|.+.....+|+|||||
T Consensus        33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC  110 (502)
T KOG0574|consen   33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC  110 (502)
T ss_pred             HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence            34667789999999999999965 6999999998763  45788999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCc
Q 009340          295 SSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGIS  374 (537)
Q Consensus       295 ~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla  374 (537)
                      .-||..+.++..           .++|++.++..+..+.++||+|||...   -+|||||+.||||+-+|.+|++|||.+
T Consensus       111 GAGSiSDI~R~R-----------~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVA  176 (502)
T KOG0574|consen  111 GAGSISDIMRAR-----------RKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVA  176 (502)
T ss_pred             CCCcHHHHHHHh-----------cCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhcccc
Confidence            999999999765           358999999999999999999999988   789999999999999999999999999


Q ss_pred             cccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchhhh
Q 009340          375 RSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLE  454 (537)
Q Consensus       375 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  454 (537)
                      ..+.... ....++.||+.|||||++..-.|+.++||||+|+...||.-|++|+..-.+-.         ..   ..+..
T Consensus       177 GQLTDTM-AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMR---------AI---FMIPT  243 (502)
T KOG0574|consen  177 GQLTDTM-AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMR---------AI---FMIPT  243 (502)
T ss_pred             chhhhhH-HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccc---------ee---EeccC
Confidence            8764332 23456789999999999999999999999999999999999999975321100         00   00000


Q ss_pred             hhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          455 ILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       455 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      ...+.+  ..|...+.++.++++.||-.+|++|-|+-++++
T Consensus       244 ~PPPTF--~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~  282 (502)
T KOG0574|consen  244 KPPPTF--KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE  282 (502)
T ss_pred             CCCCCC--CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence            011111  235666788999999999999999999988865

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=5.4e-36  Score=297.33  Aligned_cols=256  Identities=26%  Similarity=0.372  Sum_probs=194.4

Q ss_pred             CCccccccCcCCceEEEEEEcC-CCCEEEEEEccCC-ChHHHHHHHHHHHHHHhcC-CCCcceEeeEEeeCCccEEEEec
Q 009340          217 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI-DKTQIHQFINEVVILSQIN-HRHIVKLLGCCLETEVPVLVYEY  293 (537)
Q Consensus       217 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~  293 (537)
                      +|...+.||+|+||.||++... +++.||+|.+... .......+.+|+.++.++. |+||+++++++......+++|||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            4445678999999999999964 6899999988643 2344567889999999996 99999999999988889999999


Q ss_pred             CCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeeecCCCCCCEEECCCCcEEEeecc
Q 009340          294 ISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSS-ASIPIFHRDIKSSNILLDDKFSAKVSDFG  372 (537)
Q Consensus       294 ~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~-~~~~ivH~Dlk~~NIll~~~~~~ki~Dfg  372 (537)
                      +.. +|.++......       .....+++..+.+++.++++||+|||+. +   ++||||||+||+++.++.+||+|||
T Consensus        85 ~~~-~l~~l~~~~~~-------~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg  153 (288)
T cd06616          85 MDI-SLDKFYKYVYE-------VLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFG  153 (288)
T ss_pred             ccC-CHHHHHHHHHH-------hhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecc
Confidence            864 66554422110       0124689999999999999999999975 6   9999999999999999999999999


Q ss_pred             CccccCCCCCceeeeccccccccCcccccCC---CCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhh
Q 009340          373 ISRSIPNDKTHLTTTIQGTFGYLDPEYFQSS---QFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKE  449 (537)
Q Consensus       373 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  449 (537)
                      ++........  .....++..|+|||.+.+.   .++.++||||||+++|||++|+.||....     ........... 
T Consensus       154 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~~~-  225 (288)
T cd06616         154 ISGQLVDSIA--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLTQVVK-  225 (288)
T ss_pred             hhHHhccCCc--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHHhhhcC-
Confidence            9976543221  2233578899999998776   68999999999999999999999985432     01111111100 


Q ss_pred             chhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHH
Q 009340          450 NQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSME  496 (537)
Q Consensus       450 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~  496 (537)
                      .     ..+.+....+...+..+.+|+.+||+.+|++|||+.+|++.
T Consensus       226 ~-----~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         226 G-----DPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             C-----CCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0     01111112223355678999999999999999999999764

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.2e-36  Score=289.80  Aligned_cols=250  Identities=26%  Similarity=0.344  Sum_probs=205.7

Q ss_pred             CCccccccCcCCceEEEEEEcCC-CCEEEEEEccCC---ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEe
Q 009340          217 NYNQSRFLGQGGFGTVYKGMLPD-GSIVAVKRSKEI---DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE  292 (537)
Q Consensus       217 ~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e  292 (537)
                      .|+..+.||+|.-|+||++.+++ +...|+|.+...   ......+...|-+||+.++||.++.|++.+..++..+||||
T Consensus        78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me  157 (459)
T KOG0610|consen   78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME  157 (459)
T ss_pred             HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence            45566789999999999999864 589999998753   23345567789999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeecc
Q 009340          293 YISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG  372 (537)
Q Consensus       293 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfg  372 (537)
                      ||++|+|...++...          .+.++...+..++..++-||+|||-.|   ||.|||||+||||-++|.+.|+||.
T Consensus       158 yCpGGdL~~LrqkQp----------~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFD  224 (459)
T KOG0610|consen  158 YCPGGDLHSLRQKQP----------GKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFD  224 (459)
T ss_pred             cCCCccHHHHHhhCC----------CCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeecc
Confidence            999999998887654          357999999999999999999999999   9999999999999999999999999


Q ss_pred             CccccCCC----------------------------------C---------------------CceeeeccccccccCc
Q 009340          373 ISRSIPND----------------------------------K---------------------THLTTTIQGTFGYLDP  397 (537)
Q Consensus       373 la~~~~~~----------------------------------~---------------------~~~~~~~~gt~~y~aP  397 (537)
                      |+......                                  .                     .......+||..|+||
T Consensus       225 LS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAP  304 (459)
T KOG0610|consen  225 LSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAP  304 (459)
T ss_pred             ccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccc
Confidence            98643110                                  0                     0011234699999999


Q ss_pred             ccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHH
Q 009340          398 EYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAM  477 (537)
Q Consensus       398 E~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~  477 (537)
                      |++.+...+.++|.|+|||++|||+.|..||.....++               .+..++...+..+.....+..+.+||.
T Consensus       305 EvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~---------------Tl~NIv~~~l~Fp~~~~vs~~akDLIr  369 (459)
T KOG0610|consen  305 EVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKE---------------TLRNIVGQPLKFPEEPEVSSAAKDLIR  369 (459)
T ss_pred             eeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchh---------------hHHHHhcCCCcCCCCCcchhHHHHHHH
Confidence            99999999999999999999999999999997654332               234444444443334466678899999


Q ss_pred             HhcccCCCCCCC----HhhHH
Q 009340          478 RCLRLNSKKRPT----MKQVS  494 (537)
Q Consensus       478 ~cl~~~p~~RPs----~~ev~  494 (537)
                      +.|.+||.+|..    +.||.
T Consensus       370 ~LLvKdP~kRlg~~rGA~eIK  390 (459)
T KOG0610|consen  370 KLLVKDPSKRLGSKRGAAEIK  390 (459)
T ss_pred             HHhccChhhhhccccchHHhh
Confidence            999999999988    66663

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=4.1e-36  Score=305.31  Aligned_cols=268  Identities=22%  Similarity=0.343  Sum_probs=202.3

Q ss_pred             hcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCC--ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCC-----c
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI--DKTQIHQFINEVVILSQINHRHIVKLLGCCLETE-----V  286 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~  286 (537)
                      .++|...+.||+|+||.||+++.. +++.||||.+...  .......+.+|+.+++.++|+|++++++++....     .
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            457888999999999999999954 6899999987642  2334556788999999999999999999886542     4


Q ss_pred             cEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcE
Q 009340          287 PVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA  366 (537)
Q Consensus       287 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~  366 (537)
                      .++|+||+. ++|.+++...            ..+++..+..++.|+++||.|||+.+   ++||||||+||+++.++.+
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~------------~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~  147 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRSS------------QTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDL  147 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhcC------------CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCE
Confidence            799999996 6888887642            35899999999999999999999998   9999999999999999999


Q ss_pred             EEeeccCccccCCCCCceeeeccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHH
Q 009340          367 KVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQS-SQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFIS  445 (537)
Q Consensus       367 ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~  445 (537)
                      ||+|||++....... .......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||........   ......
T Consensus       148 kL~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~~~~  223 (337)
T cd07858         148 KICDFGLARTTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQ---LKLITE  223 (337)
T ss_pred             EECcCccccccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHH---HHHHHH
Confidence            999999998764332 11233457889999998865 4688999999999999999999999865432211   111111


Q ss_pred             HHh-----------hchhhhhhc-------HHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHH--HHHHHHh
Q 009340          446 LAK-----------ENQLLEILD-------ARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSME--LEGLRRS  503 (537)
Q Consensus       446 ~~~-----------~~~~~~~~d-------~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~--L~~i~~~  503 (537)
                      ...           .......+.       .... ......+..+.+++.+||+.+|++|||+.++++.  ++.+...
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~  300 (337)
T cd07858         224 LLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDP  300 (337)
T ss_pred             HhCCCChHHhhhcCchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCc
Confidence            100           000000000       0000 1112345678999999999999999999999876  6655443

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-35  Score=289.50  Aligned_cols=249  Identities=25%  Similarity=0.399  Sum_probs=198.1

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCCEEEEEEccC-----CChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeC--Ccc
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKE-----IDKTQIHQFINEVVILSQINHRHIVKLLGCCLET--EVP  287 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~-----~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~  287 (537)
                      .+|...+.||+|+||.||+|... +++.||+|.+..     ........+.+|+.++++++|+||+++++++.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            47888999999999999999954 689999998642     1234456788999999999999999999998764  357


Q ss_pred             EEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEE
Q 009340          288 VLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK  367 (537)
Q Consensus       288 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~k  367 (537)
                      ++|+||+++++|.+++...            ..+++....+++.|+++||.|||+.+   ++|+||||+||+++.++.++
T Consensus        82 ~~v~e~~~~~~L~~~~~~~------------~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~  146 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAY------------GALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVK  146 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEE
Confidence            8999999999999998642            35889999999999999999999999   99999999999999999999


Q ss_pred             EeeccCccccCCCCC--ceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHH
Q 009340          368 VSDFGISRSIPNDKT--HLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFIS  445 (537)
Q Consensus       368 i~Dfgla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~  445 (537)
                      |+|||+++.......  .......++..|+|||.+.+..++.++|+||||+++|||++|+.||.......      .+..
T Consensus       147 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~  220 (264)
T cd06653         147 LGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA------AIFK  220 (264)
T ss_pred             ECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH------HHHH
Confidence            999999986532111  11223458899999999998889999999999999999999999986432111      0111


Q ss_pred             HHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          446 LAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       446 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      .         .........+......+.+++.+||+ +|..||+..+++.
T Consensus       221 ~---------~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         221 I---------ATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             H---------HcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence            1         11111122344556778999999998 5799999998764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.2e-35  Score=293.57  Aligned_cols=242  Identities=25%  Similarity=0.383  Sum_probs=187.2

Q ss_pred             ccCcCCceEEEEEEcC-CCCEEEEEEccCCC---hHHHHHHHHHHHHHH---hcCCCCcceEeeEEeeCCccEEEEecCC
Q 009340          223 FLGQGGFGTVYKGMLP-DGSIVAVKRSKEID---KTQIHQFINEVVILS---QINHRHIVKLLGCCLETEVPVLVYEYIS  295 (537)
Q Consensus       223 ~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~---~l~H~niv~l~g~~~~~~~~~lV~e~~~  295 (537)
                      .||+|+||.||++... +++.+|+|.+....   ......+.+|..+++   ..+|+|++.+.+++...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999964 68899999875421   122233445544433   3479999999999999899999999999


Q ss_pred             CCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCcc
Q 009340          296 SGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISR  375 (537)
Q Consensus       296 ~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~  375 (537)
                      +|+|.+++...            ..++|..+..++.|++.||.|||+.+   ++||||||+|||+++++.++|+|||++.
T Consensus        81 ~~~L~~~i~~~------------~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~  145 (279)
T cd05633          81 GGDLHYHLSQH------------GVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLAC  145 (279)
T ss_pred             CCCHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcce
Confidence            99999988652            35999999999999999999999999   9999999999999999999999999987


Q ss_pred             ccCCCCCceeeeccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchhhh
Q 009340          376 SIPNDKTHLTTTIQGTFGYLDPEYFQS-SQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLE  454 (537)
Q Consensus       376 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  454 (537)
                      ......   .....|+..|+|||.+.+ ..++.++|||||||++|||++|+.||.........    ......       
T Consensus       146 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~----~~~~~~-------  211 (279)
T cd05633         146 DFSKKK---PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH----EIDRMT-------  211 (279)
T ss_pred             eccccC---ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH----HHHHHh-------
Confidence            653322   123458999999999864 55889999999999999999999998643322110    011100       


Q ss_pred             hhcHHhhccccHHHHHHHHHHHHHhcccCCCCCC-----CHhhHHHH
Q 009340          455 ILDARVAKEAREEDIGAMAELAMRCLRLNSKKRP-----TMKQVSME  496 (537)
Q Consensus       455 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~~  496 (537)
                         .......+...+..+.+++.+||+.||++||     |+.++++.
T Consensus       212 ---~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         212 ---LTVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             ---hcCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence               0011123344556788999999999999999     58888763

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-37  Score=281.37  Aligned_cols=249  Identities=27%  Similarity=0.407  Sum_probs=200.8

Q ss_pred             hcCCccccccCcCCceEEEEEEc-CCCCEEEEEEccC--CChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEE
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKE--IDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY  291 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  291 (537)
                      +++|+..+.||+|.|+.||+... ..|+.+|+|.+..  ......+++.+|++|-+.++||||++|.....+....|+|+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF   89 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   89 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence            46777788999999999998874 4688888886542  23346778889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECC---CCcEEE
Q 009340          292 EYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD---KFSAKV  368 (537)
Q Consensus       292 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~---~~~~ki  368 (537)
                      |+|.+++|-.-+-..            ...++...-..+.||+++|.|.|..+   |||||+||.|+||-.   .--+|+
T Consensus        90 e~m~G~dl~~eIV~R------------~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL  154 (355)
T KOG0033|consen   90 DLVTGGELFEDIVAR------------EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKL  154 (355)
T ss_pred             ecccchHHHHHHHHH------------HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceee
Confidence            999999997666543            13677778889999999999999999   999999999999943   345999


Q ss_pred             eeccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHh
Q 009340          369 SDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAK  448 (537)
Q Consensus       369 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  448 (537)
                      +|||++..+.  .........||++|||||++...+|+..+|||+.||+||-|+.|..||+..+...   +   +.+   
T Consensus       155 ~~FGvAi~l~--~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~r---l---ye~---  223 (355)
T KOG0033|consen  155 ADFGLAIEVN--DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR---L---YEQ---  223 (355)
T ss_pred             cccceEEEeC--CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHH---H---HHH---
Confidence            9999999887  3344567789999999999999999999999999999999999999997633221   1   111   


Q ss_pred             hchhhhhhcHHh--hccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          449 ENQLLEILDARV--AKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       449 ~~~~~~~~d~~~--~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                            ++...+  ..+.....+++..+|+.+||..||.+|.|+.|.++
T Consensus       224 ------I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  224 ------IKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             ------HhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence                  111111  11122344567889999999999999999988764

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=1.5e-35  Score=295.01  Aligned_cols=244  Identities=23%  Similarity=0.389  Sum_probs=197.3

Q ss_pred             ccccCcCCceEEEEEEcC-CCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecCCCCCh
Q 009340          221 SRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTL  299 (537)
Q Consensus       221 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL  299 (537)
                      ..+||+|+||.||++... +|+.||||++..........+.+|+.+++.++|+|++++++++...+..++||||+++++|
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  104 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL  104 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence            357999999999999864 7899999998765555567789999999999999999999999999999999999999999


Q ss_pred             hhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCccccCC
Q 009340          300 SHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPN  379 (537)
Q Consensus       300 ~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~  379 (537)
                      .+++..             ..+++.....++.|++.||+|||+.+   ++||||+|+||+++.++.++|+|||++.....
T Consensus       105 ~~~~~~-------------~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~  168 (292)
T cd06657         105 TDIVTH-------------TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK  168 (292)
T ss_pred             HHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccc
Confidence            987743             25889999999999999999999998   99999999999999999999999999876543


Q ss_pred             CCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchhhhhhcHH
Q 009340          380 DKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEILDAR  459 (537)
Q Consensus       380 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  459 (537)
                      ... ......++..|+|||.+.+..++.++|+||||+++|||++|+.||........       ......     .....
T Consensus       169 ~~~-~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~-------~~~~~~-----~~~~~  235 (292)
T cd06657         169 EVP-RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA-------MKMIRD-----NLPPK  235 (292)
T ss_pred             ccc-cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHh-----hCCcc
Confidence            321 12334578999999999888899999999999999999999999864322111       011110     00011


Q ss_pred             hhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          460 VAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       460 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      +.  ........+.+++.+||+.+|.+||++.++++
T Consensus       236 ~~--~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         236 LK--NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             cC--CcccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence            10  11123456789999999999999999999876

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=2e-35  Score=294.38  Aligned_cols=257  Identities=18%  Similarity=0.245  Sum_probs=183.3

Q ss_pred             cCCccccccCcCCceEEEEEEcCC----CCEEEEEEccCCChHH-----------HHHHHHHHHHHHhcCCCCcceEeeE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLPD----GSIVAVKRSKEIDKTQ-----------IHQFINEVVILSQINHRHIVKLLGC  280 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~H~niv~l~g~  280 (537)
                      ++|...++||+|+||.||+|...+    +..+|+|.........           ......+...+..++|+|+++++++
T Consensus        12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~   91 (294)
T PHA02882         12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC   91 (294)
T ss_pred             CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence            578889999999999999999654    3456676543221111           0112234445566789999999998


Q ss_pred             EeeCC----ccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCC
Q 009340          281 CLETE----VPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSS  356 (537)
Q Consensus       281 ~~~~~----~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~  356 (537)
                      +....    ..++++|+... ++.+.+..            ....++..+..++.|+++||+|||+.+   |+||||||+
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~------------~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~  155 (294)
T PHA02882         92 GSFKRCRMYYRFILLEKLVE-NTKEIFKR------------IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPE  155 (294)
T ss_pred             eeEecCCceEEEEEEehhcc-CHHHHHHh------------hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHH
Confidence            76554    23667776643 55555533            123678889999999999999999998   999999999


Q ss_pred             CEEECCCCcEEEeeccCccccCCCCCc------eeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCc
Q 009340          357 NILLDDKFSAKVSDFGISRSIPNDKTH------LTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICF  430 (537)
Q Consensus       357 NIll~~~~~~ki~Dfgla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~  430 (537)
                      |||++.++.++|+|||+++........      ......||+.|+|||...+..++.++|||||||++|||++|+.||..
T Consensus       156 Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~  235 (294)
T PHA02882        156 NIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKG  235 (294)
T ss_pred             HEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCc
Confidence            999999999999999999876322211      11234689999999999999999999999999999999999999975


Q ss_pred             cchhhhccHHHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHH
Q 009340          431 ARVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMEL  497 (537)
Q Consensus       431 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L  497 (537)
                      ......  ...    ....+....+......   .......+.+++..|++.+|++||++.++.+.|
T Consensus       236 ~~~~~~--~~~----~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        236 FGHNGN--LIH----AAKCDFIKRLHEGKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             cccchH--HHH----HhHHHHHHHhhhhhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence            422211  000    0000000111111111   112346788999999999999999999999876

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=1.1e-35  Score=304.00  Aligned_cols=260  Identities=21%  Similarity=0.321  Sum_probs=198.3

Q ss_pred             HhcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccC--CChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCC-----
Q 009340          214 ATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKE--IDKTQIHQFINEVVILSQINHRHIVKLLGCCLETE-----  285 (537)
Q Consensus       214 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----  285 (537)
                      ..++|+..+.||+|+||.||++... +|+.||+|.+..  .......++.+|+.++++++|+|++++++++....     
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            4578999999999999999999954 789999999864  23344567889999999999999999999986432     


Q ss_pred             -ccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCC
Q 009340          286 -VPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF  364 (537)
Q Consensus       286 -~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~  364 (537)
                       ..++||||+.+ +|.+.+..              .+++..+..++.|++.||+|||+.+   ++||||||+||+++.++
T Consensus        94 ~~~~lv~e~~~~-~l~~~~~~--------------~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~  155 (353)
T cd07850          94 QDVYLVMELMDA-NLCQVIQM--------------DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDC  155 (353)
T ss_pred             CcEEEEEeccCC-CHHHHHhh--------------cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCC
Confidence             46999999964 88877743              3788899999999999999999998   99999999999999999


Q ss_pred             cEEEeeccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHH
Q 009340          365 SAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFI  444 (537)
Q Consensus       365 ~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~  444 (537)
                      .+||+|||+++.......  .....++..|+|||.+.+..++.++||||||+++|+|++|+.||........   .....
T Consensus       156 ~~kL~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~---~~~~~  230 (353)
T cd07850         156 TLKILDFGLARTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQ---WNKII  230 (353)
T ss_pred             CEEEccCccceeCCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHH---HHHHH
Confidence            999999999987643221  2334578899999999999999999999999999999999999865432111   00000


Q ss_pred             HHHhhc--h-----------------------hhhhhcHHh----hccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          445 SLAKEN--Q-----------------------LLEILDARV----AKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       445 ~~~~~~--~-----------------------~~~~~d~~~----~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      ......  .                       ..+......    ....+......+.+++.+||+.||++|||+.|++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~  310 (353)
T cd07850         231 EQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ  310 (353)
T ss_pred             HhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            000000  0                       000000000    00001234567889999999999999999999975


Q ss_pred             H
Q 009340          496 E  496 (537)
Q Consensus       496 ~  496 (537)
                      .
T Consensus       311 ~  311 (353)
T cd07850         311 H  311 (353)
T ss_pred             C
Confidence            3

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=8.4e-36  Score=317.59  Aligned_cols=270  Identities=20%  Similarity=0.258  Sum_probs=190.2

Q ss_pred             HhcCCccccccCcCCceEEEEEEcCC--CCEEEEE------------------EccCCChHHHHHHHHHHHHHHhcCCCC
Q 009340          214 ATDNYNQSRFLGQGGFGTVYKGMLPD--GSIVAVK------------------RSKEIDKTQIHQFINEVVILSQINHRH  273 (537)
Q Consensus       214 ~~~~~~~~~~lg~G~~g~Vy~~~~~~--g~~vavK------------------~~~~~~~~~~~~~~~E~~~l~~l~H~n  273 (537)
                      ..++|...+.||+|+||.||++.++.  +..+++|                  .+. ........+.+|+.++++++|+|
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hpn  224 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHEN  224 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCC
Confidence            45789999999999999999987532  2222222                  111 12233456889999999999999


Q ss_pred             cceEeeEEeeCCccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCC
Q 009340          274 IVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDI  353 (537)
Q Consensus       274 iv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dl  353 (537)
                      |+++++++.+.+..++|+|++. ++|.+++......       ............++.|++.||.|||+.+   |+||||
T Consensus       225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~-------~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDL  293 (501)
T PHA03210        225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFD-------WKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDI  293 (501)
T ss_pred             cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhcccc-------ccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence            9999999999999999999985 4777776543210       0112345667889999999999999999   999999


Q ss_pred             CCCCEEECCCCcEEEeeccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCc-cc
Q 009340          354 KSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICF-AR  432 (537)
Q Consensus       354 k~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~-~~  432 (537)
                      ||+|||++.++.+||+|||+++.+............||..|+|||.+.+..++.++|||||||++|||++|..++.. ..
T Consensus       294 KP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~  373 (501)
T PHA03210        294 KLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGG  373 (501)
T ss_pred             CHHHEEECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCC
Confidence            99999999999999999999987754443334456799999999999999999999999999999999998754332 21


Q ss_pred             hhhhccHHHHHHHHH--hh------chhhhhhcHHhhcccc---------HHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          433 VEEERNLVACFISLA--KE------NQLLEILDARVAKEAR---------EEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       433 ~~~~~~~~~~~~~~~--~~------~~~~~~~d~~~~~~~~---------~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      ......+........  ..      ..+.+.++.......+         ......+.+++.+||+.||.+|||+.|++.
T Consensus       374 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~  453 (501)
T PHA03210        374 GKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA  453 (501)
T ss_pred             CCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence            111111111110000  00      0111111110000000         011245678899999999999999999976

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-35  Score=286.78  Aligned_cols=247  Identities=26%  Similarity=0.470  Sum_probs=202.9

Q ss_pred             CCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCCh--HHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEec
Q 009340          217 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDK--TQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY  293 (537)
Q Consensus       217 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  293 (537)
                      +|+..+.||+|++|.||+++.. +++.|++|.+.....  ...+.+.+|++++++++|+|++++++++.+.+..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            4677889999999999999865 678999999876543  4567899999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccC
Q 009340          294 ISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGI  373 (537)
Q Consensus       294 ~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgl  373 (537)
                      +++++|.+++...            ..+++..+..++.|++.||.|||+.+   ++||||+|+||+++.++.++|+|||+
T Consensus        81 ~~~~~L~~~~~~~------------~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~  145 (254)
T cd06627          81 AENGSLRQIIKKF------------GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGV  145 (254)
T ss_pred             CCCCcHHHHHHhc------------cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEecccc
Confidence            9999999998653            36899999999999999999999998   99999999999999999999999999


Q ss_pred             ccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchhh
Q 009340          374 SRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLL  453 (537)
Q Consensus       374 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  453 (537)
                      +......... .....++..|+|||......++.++||||+|+++|+|++|+.|+.......      ....... .   
T Consensus       146 ~~~~~~~~~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~------~~~~~~~-~---  214 (254)
T cd06627         146 ATKLNDVSKD-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMA------ALFRIVQ-D---  214 (254)
T ss_pred             ceecCCCccc-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHH------HHHHHhc-c---
Confidence            9876543322 233457889999999988888999999999999999999999986432111      0111100 0   


Q ss_pred             hhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          454 EILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       454 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                            .....+......+.+++.+||..+|++|||+.+++.
T Consensus       215 ------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         215 ------DHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             ------CCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence                  011122334567889999999999999999999874

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=9.3e-36  Score=298.59  Aligned_cols=266  Identities=22%  Similarity=0.321  Sum_probs=194.2

Q ss_pred             hcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCC--hHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCc-----
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEID--KTQIHQFINEVVILSQINHRHIVKLLGCCLETEV-----  286 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-----  286 (537)
                      .++|+..++||+|+||.||++... +++.||||.+....  ......+.+|+.++++++|||+++++++|...+.     
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            357888999999999999999964 68999999875422  2223456789999999999999999999876543     


Q ss_pred             ---cEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCC
Q 009340          287 ---PVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK  363 (537)
Q Consensus       287 ---~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~  363 (537)
                         .++||||+.+ +|.+++...           ...+++..++.++.|+++||.|||+++   ++|+||||+||+++.+
T Consensus        91 ~~~~~lv~e~~~~-~l~~~l~~~-----------~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~  155 (310)
T cd07865          91 KGSFYLVFEFCEH-DLAGLLSNK-----------NVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKD  155 (310)
T ss_pred             CceEEEEEcCCCc-CHHHHHHhc-----------ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCC
Confidence               4999999975 787777542           225899999999999999999999998   9999999999999999


Q ss_pred             CcEEEeeccCccccCCCCCc---eeeeccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccH
Q 009340          364 FSAKVSDFGISRSIPNDKTH---LTTTIQGTFGYLDPEYFQSS-QFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNL  439 (537)
Q Consensus       364 ~~~ki~Dfgla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~  439 (537)
                      +.+||+|||++.........   ......++..|+|||.+.+. .++.++||||||+++|||++|+.||...........
T Consensus       156 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~  235 (310)
T cd07865         156 GILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTL  235 (310)
T ss_pred             CcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            99999999999766332211   11234578899999988664 478899999999999999999999865433221111


Q ss_pred             HHHHHHHHhhchh-----hhhhcH---------Hhhcc-ccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          440 VACFISLAKENQL-----LEILDA---------RVAKE-AREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       440 ~~~~~~~~~~~~~-----~~~~d~---------~~~~~-~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      ...+.........     .+..+.         ..... .+......+.+++.+||+.||++|||+.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         236 ISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             HHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence            1111100000000     000000         00000 00012345679999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=7.8e-36  Score=299.44  Aligned_cols=262  Identities=24%  Similarity=0.322  Sum_probs=196.1

Q ss_pred             hcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCC--hHHHHHHHHHHHHHHhcCCCCcceEeeEEeeC--CccEE
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEID--KTQIHQFINEVVILSQINHRHIVKLLGCCLET--EVPVL  289 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~l  289 (537)
                      .++|+..+.||+|+||.||+|... +|+.||+|.++...  ......+.+|+.++++++|+|++++++++.+.  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            467889999999999999999964 68999999886432  12233566899999999999999999998765  45799


Q ss_pred             EEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEe
Q 009340          290 VYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVS  369 (537)
Q Consensus       290 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~  369 (537)
                      ||||+++ +|.+++....           ..+++.++..++.|+++||+|||+.+   ++||||||+||++++++.+||+
T Consensus        86 v~e~~~~-~l~~~l~~~~-----------~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~  150 (309)
T cd07845          86 VMEYCEQ-DLASLLDNMP-----------TPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIA  150 (309)
T ss_pred             EEecCCC-CHHHHHHhcc-----------cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEC
Confidence            9999975 8888876532           36899999999999999999999999   9999999999999999999999


Q ss_pred             eccCccccCCCCCceeeeccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHh
Q 009340          370 DFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQS-SQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAK  448 (537)
Q Consensus       370 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  448 (537)
                      |||++......... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+.   .........
T Consensus       151 dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~---~~~~~~~~~  226 (309)
T cd07845         151 DFGLARTYGLPAKP-MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQ---LDLIIQLLG  226 (309)
T ss_pred             ccceeeecCCccCC-CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhcC
Confidence            99999876433211 222345788999999865 4578999999999999999999999865433221   111111110


Q ss_pred             hc--hhh-h--------h--hcHHhhc---cccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          449 EN--QLL-E--------I--LDARVAK---EAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       449 ~~--~~~-~--------~--~d~~~~~---~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      ..  ... .        .  +......   ......+..+.+++.+||+.||++|||+.+++.
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~  289 (309)
T cd07845         227 TPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE  289 (309)
T ss_pred             CCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            00  000 0        0  0000000   000113567789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-35  Score=293.80  Aligned_cols=259  Identities=24%  Similarity=0.315  Sum_probs=199.6

Q ss_pred             CccccccCcCCceEEEEEEcC-CCCEEEEEEccCCCh--HHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecC
Q 009340          218 YNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDK--TQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI  294 (537)
Q Consensus       218 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  294 (537)
                      |+..+.||+|++|.||++... +++.+++|+++....  .....+.+|+.++++++|+|++++++++.+.+..++|+||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            456678999999999999964 688999998865322  34567889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCc
Q 009340          295 SSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGIS  374 (537)
Q Consensus       295 ~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla  374 (537)
                      ++ +|.+++....           ..+++..++.++.|+++||.|||+.+   ++|+||+|+||+++.++.++|+|||.+
T Consensus        81 ~~-~l~~~l~~~~-----------~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~  145 (283)
T cd05118          81 DT-DLYKLIKDRQ-----------RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLA  145 (283)
T ss_pred             CC-CHHHHHHhhc-----------ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeee
Confidence            75 8888876532           36899999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCCceeeeccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhh---c
Q 009340          375 RSIPNDKTHLTTTIQGTFGYLDPEYFQSS-QFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKE---N  450 (537)
Q Consensus       375 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---~  450 (537)
                      ....... .......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||......+..   .........   .
T Consensus       146 ~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~---~~~~~~~~~~~~~  221 (283)
T cd05118         146 RSFGSPV-RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQL---FKIFRTLGTPDPE  221 (283)
T ss_pred             EecCCCc-ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHcCCCchH
Confidence            8765443 112234578889999998876 7899999999999999999999998654332210   000000000   0


Q ss_pred             hhhhhhc-----------HH--hhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          451 QLLEILD-----------AR--VAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       451 ~~~~~~d-----------~~--~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      ......+           ..  .........+..+.+++.+||+.||.+||++.+++.
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         222 VWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             hcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence            0000000           00  001112345678999999999999999999999975

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=1.5e-35  Score=294.18  Aligned_cols=256  Identities=22%  Similarity=0.305  Sum_probs=202.0

Q ss_pred             CCccccccCcCCceEEEEEEc----CCCCEEEEEEccCCC----hHHHHHHHHHHHHHHhc-CCCCcceEeeEEeeCCcc
Q 009340          217 NYNQSRFLGQGGFGTVYKGML----PDGSIVAVKRSKEID----KTQIHQFINEVVILSQI-NHRHIVKLLGCCLETEVP  287 (537)
Q Consensus       217 ~~~~~~~lg~G~~g~Vy~~~~----~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~  287 (537)
                      +|+..+.||+|+||.||++..    .+++.||||.++...    ....+.+.+|+.++.++ +|+|++++++++......
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            367788999999999999884    357889999886422    22345688999999999 599999999999988899


Q ss_pred             EEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEE
Q 009340          288 VLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK  367 (537)
Q Consensus       288 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~k  367 (537)
                      ++||||+++|+|.+++...            ..+++..+..++.|+++||.|||+.+   ++||||+|+||+++.++.++
T Consensus        81 ~lv~e~~~~~~L~~~~~~~------------~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~  145 (288)
T cd05583          81 HLILDYVNGGELFTHLYQR------------EHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVV  145 (288)
T ss_pred             EEEEecCCCCcHHHHHhhc------------CCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEE
Confidence            9999999999999998642            35889999999999999999999988   99999999999999999999


Q ss_pred             EeeccCccccCCCCCceeeeccccccccCcccccCCC--CCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHH
Q 009340          368 VSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQ--FTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFIS  445 (537)
Q Consensus       368 i~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~  445 (537)
                      |+|||+++..............++..|+|||.+.+..  .+.++||||||+++|||++|..||.......   ....+..
T Consensus       146 l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~---~~~~~~~  222 (288)
T cd05583         146 LTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN---SQSEISR  222 (288)
T ss_pred             EEECccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc---hHHHHHH
Confidence            9999999876544333333456889999999987655  7889999999999999999999985322110   0011111


Q ss_pred             HHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHH
Q 009340          446 LAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGL  500 (537)
Q Consensus       446 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i  500 (537)
                      ..        ..  ...+.+......+.+++.+||+.+|++|||+.++.+.|+..
T Consensus       223 ~~--------~~--~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~  267 (288)
T cd05583         223 RI--------LK--SKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP  267 (288)
T ss_pred             HH--------Hc--cCCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence            00        00  01122333456788999999999999999999998877654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.6e-35  Score=294.98  Aligned_cols=262  Identities=23%  Similarity=0.317  Sum_probs=195.7

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCC--hHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEe
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEID--KTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE  292 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e  292 (537)
                      ++|+..+.||+|++|.||+|... +|+.||+|.+....  ....+.+.+|+.++++++|+|++++++++.+....++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            46888899999999999999965 68899999886432  2334578899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECC-CCcEEEeec
Q 009340          293 YISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD-KFSAKVSDF  371 (537)
Q Consensus       293 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~-~~~~ki~Df  371 (537)
                      |++ ++|.+++....          ...+++.....++.|++.||+|||+.+   ++||||+|+||+++. ++.+||+||
T Consensus        82 ~~~-~~l~~~~~~~~----------~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~df  147 (294)
T PLN00009         82 YLD-LDLKKHMDSSP----------DFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADF  147 (294)
T ss_pred             ccc-ccHHHHHHhCC----------CCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEccc
Confidence            996 57877775432          124678888999999999999999998   999999999999985 567999999


Q ss_pred             cCccccCCCCCceeeeccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhc
Q 009340          372 GISRSIPNDKTHLTTTIQGTFGYLDPEYFQS-SQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKEN  450 (537)
Q Consensus       372 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  450 (537)
                      |++........ ......+++.|+|||.+.+ ..++.++||||||+++|+|+||+.||......+.   ...........
T Consensus       148 g~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~---~~~~~~~~~~~  223 (294)
T PLN00009        148 GLARAFGIPVR-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDE---LFKIFRILGTP  223 (294)
T ss_pred             ccccccCCCcc-ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCC
Confidence            99976533211 1223456889999998866 4578999999999999999999999865433211   00011100000


Q ss_pred             ---h------hhhhhc--HH----hhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          451 ---Q------LLEILD--AR----VAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       451 ---~------~~~~~d--~~----~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                         .      +.+...  +.    .........+..+.+++.+|++.+|++||++.++++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        224 NEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             ChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence               0      000000  00    000011223456889999999999999999999986

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=5.7e-36  Score=303.87  Aligned_cols=266  Identities=21%  Similarity=0.344  Sum_probs=198.6

Q ss_pred             hcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCC--hHHHHHHHHHHHHHHhcCCCCcceEeeEEee----CCcc
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEID--KTQIHQFINEVVILSQINHRHIVKLLGCCLE----TEVP  287 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~  287 (537)
                      .++|+..+.||+|+||.||++... +|+.||+|++....  ......+.+|+.++++++|+||+++.+++..    ....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            468888999999999999999954 68999999986532  2345677889999999999999999998763    3457


Q ss_pred             EEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEE
Q 009340          288 VLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK  367 (537)
Q Consensus       288 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~k  367 (537)
                      ++|+||+. |+|.+++...            ..+++..+..++.|+++||.|||+.+   ++||||||+||++++++.+|
T Consensus        84 ~lv~e~~~-~~l~~~~~~~------------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~k  147 (334)
T cd07855          84 YVVMDLME-SDLHHIIHSD------------QPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELR  147 (334)
T ss_pred             EEEEehhh-hhHHHHhccC------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEE
Confidence            99999996 6898888642            35899999999999999999999998   99999999999999999999


Q ss_pred             EeeccCccccCCCCCc---eeeeccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHH-
Q 009340          368 VSDFGISRSIPNDKTH---LTTTIQGTFGYLDPEYFQS-SQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVAC-  442 (537)
Q Consensus       368 i~Dfgla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~-  442 (537)
                      |+|||++.........   ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||.............. 
T Consensus       148 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~  227 (334)
T cd07855         148 IGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSV  227 (334)
T ss_pred             ecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHH
Confidence            9999999765332211   1223468889999999865 4688999999999999999999999965432211000000 


Q ss_pred             -------HHHHHhhchhhhhhcHH-hhcc-----ccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHH
Q 009340          443 -------FISLAKENQLLEILDAR-VAKE-----AREEDIGAMAELAMRCLRLNSKKRPTMKQVSME  496 (537)
Q Consensus       443 -------~~~~~~~~~~~~~~d~~-~~~~-----~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~  496 (537)
                             +.............+.. ....     .....+..+.+++.+||+.+|++|||+.+++..
T Consensus       228 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  294 (334)
T cd07855         228 LGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH  294 (334)
T ss_pred             hCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence                   00000000111111100 0000     112245778999999999999999999998763

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-35  Score=287.44  Aligned_cols=243  Identities=26%  Similarity=0.330  Sum_probs=189.6

Q ss_pred             cccCcCCceEEEEEEcC-CCCEEEEEEccCCCh---HHHHHHHHHHHHH-HhcCCCCcceEeeEEeeCCccEEEEecCCC
Q 009340          222 RFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDK---TQIHQFINEVVIL-SQINHRHIVKLLGCCLETEVPVLVYEYISS  296 (537)
Q Consensus       222 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l-~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  296 (537)
                      +.||+|+||.||+|... +|+.||+|.++....   .....+..|..++ ...+|+|++++++++...+..++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            46999999999999864 688999999865322   2233445555444 445899999999999999999999999999


Q ss_pred             CChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCccc
Q 009340          297 GTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS  376 (537)
Q Consensus       297 gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~  376 (537)
                      ++|.+++...            ..+++..+..++.|+++||.|||+.+   ++||||+|+||++++++.+||+|||++..
T Consensus        82 ~~L~~~l~~~------------~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~  146 (260)
T cd05611          82 GDCASLIKTL------------GGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRN  146 (260)
T ss_pred             CCHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeeccccee
Confidence            9999998652            35889999999999999999999998   99999999999999999999999999876


Q ss_pred             cCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchhhhhh
Q 009340          377 IPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEIL  456 (537)
Q Consensus       377 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  456 (537)
                      ...     .....++..|+|||.+.+..++.++||||||+++|||++|..||.......       ..........    
T Consensus       147 ~~~-----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~~----  210 (260)
T cd05611         147 GLE-----NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA-------VFDNILSRRI----  210 (260)
T ss_pred             ccc-----cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHhccc----
Confidence            433     223457889999999988889999999999999999999999986433221       1111111100    


Q ss_pred             cHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHH
Q 009340          457 DARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMEL  497 (537)
Q Consensus       457 d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L  497 (537)
                        ..........+..+.+++.+||+.+|++||++.++.+.|
T Consensus       211 --~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l  249 (260)
T cd05611         211 --NWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK  249 (260)
T ss_pred             --CCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence              001111223456789999999999999999887775544

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=2.2e-35  Score=296.09  Aligned_cols=250  Identities=26%  Similarity=0.389  Sum_probs=196.9

Q ss_pred             CCccccccCcCCceEEEEEEcC-CCCEEEEEEccC---CChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEe
Q 009340          217 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKE---IDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE  292 (537)
Q Consensus       217 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e  292 (537)
                      .|+..+.||+|+||.||+|+.. +++.||+|.+..   .......++.+|+.+++.++|+|++++.+++......++|+|
T Consensus        16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   95 (308)
T cd06634          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (308)
T ss_pred             HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence            4666788999999999999964 678899998753   233445678899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeecc
Q 009340          293 YISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG  372 (537)
Q Consensus       293 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfg  372 (537)
                      |+. |+|.+++...           ...+++..+..++.|++.||.|||+.+   ++||||+|+||+++.++.++|+|||
T Consensus        96 ~~~-~~l~~~~~~~-----------~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg  160 (308)
T cd06634          96 YCL-GSASDLLEVH-----------KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFG  160 (308)
T ss_pred             ccC-CCHHHHHHHc-----------CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcc
Confidence            996 6888777543           235899999999999999999999998   9999999999999999999999999


Q ss_pred             CccccCCCCCceeeeccccccccCccccc---CCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhh
Q 009340          373 ISRSIPNDKTHLTTTIQGTFGYLDPEYFQ---SSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKE  449 (537)
Q Consensus       373 la~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  449 (537)
                      ++......     ....++..|+|||.+.   .+.++.++|||||||++|||++|+.|+......+.      ... ...
T Consensus       161 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~~~-~~~  228 (308)
T cd06634         161 SASIMAPA-----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYH-IAQ  228 (308)
T ss_pred             cceeecCc-----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHH------HHH-Hhh
Confidence            98765432     2345788999999974   45688899999999999999999999754321110      000 000


Q ss_pred             chhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHH
Q 009340          450 NQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLR  501 (537)
Q Consensus       450 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~  501 (537)
                      ...        ...........+.+++.+||+.+|++||++.++++.-.-+.
T Consensus       229 ~~~--------~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~  272 (308)
T cd06634         229 NES--------PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR  272 (308)
T ss_pred             cCC--------CCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence            000        00112234567889999999999999999999987654333

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.3e-36  Score=305.21  Aligned_cols=243  Identities=24%  Similarity=0.438  Sum_probs=192.0

Q ss_pred             ccccCcCCceEEEEEEcC-CCCEEEEEEccC----CChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCc--cEEEEec
Q 009340          221 SRFLGQGGFGTVYKGMLP-DGSIVAVKRSKE----IDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEV--PVLVYEY  293 (537)
Q Consensus       221 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~----~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~--~~lV~e~  293 (537)
                      ..+||+|.|-+||||... +|-.||=-.++.    .+....++|..|+.+|+.|+|+||++++.+..+...  ..+|+|.
T Consensus        45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL  124 (632)
T KOG0584|consen   45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL  124 (632)
T ss_pred             hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence            467999999999999964 465665332221    244567899999999999999999999999887665  7889999


Q ss_pred             CCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCC-CcEEEeecc
Q 009340          294 ISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK-FSAKVSDFG  372 (537)
Q Consensus       294 ~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~-~~~ki~Dfg  372 (537)
                      +..|+|..|+...+            .++.+....|+.||++||.|||++. |||+|||||-.||||+.+ |.+||+|+|
T Consensus       125 ~TSGtLr~Y~kk~~------------~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLG  191 (632)
T KOG0584|consen  125 FTSGTLREYRKKHR------------RVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLG  191 (632)
T ss_pred             ccCCcHHHHHHHhc------------cCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchh
Confidence            99999999998754            4888899999999999999999987 679999999999999764 899999999


Q ss_pred             CccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchh
Q 009340          373 ISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQL  452 (537)
Q Consensus       373 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  452 (537)
                      ||.......   ...+.|||.|||||.+. ..|++.+||||||+.++||+|+..|+..-.     +..+.+. ....+..
T Consensus       192 LAtl~r~s~---aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~-----n~AQIYK-KV~SGiK  261 (632)
T KOG0584|consen  192 LATLLRKSH---AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECT-----NPAQIYK-KVTSGIK  261 (632)
T ss_pred             HHHHhhccc---cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhC-----CHHHHHH-HHHcCCC
Confidence            999875432   23478999999999987 789999999999999999999999974321     1111111 1111211


Q ss_pred             hhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          453 LEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       453 ~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      .+.+.        .-..+++.++|.+|+.. .++|||+.|+++
T Consensus       262 P~sl~--------kV~dPevr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  262 PAALS--------KVKDPEVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             HHHhh--------ccCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence            11111        11125688999999999 999999999975

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=5.2e-35  Score=294.08  Aligned_cols=260  Identities=19%  Similarity=0.263  Sum_probs=194.3

Q ss_pred             ccccCcCCceEEEEEEcCCCCEEEEEEccCC--ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecCCCCC
Q 009340          221 SRFLGQGGFGTVYKGMLPDGSIVAVKRSKEI--DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGT  298 (537)
Q Consensus       221 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs  298 (537)
                      .+.+|.|+++.||++.. +++.||||+++..  .....+.+.+|+.+++.++|+||+++++++.+.+..+++|||+++|+
T Consensus         7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~   85 (314)
T cd08216           7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS   85 (314)
T ss_pred             hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence            34456666666676666 6899999998653  44566789999999999999999999999999999999999999999


Q ss_pred             hhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCccccC
Q 009340          299 LSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIP  378 (537)
Q Consensus       299 L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~  378 (537)
                      |.+++.....          ..+++.....++.|+++||+|||+.+   |+||||||+||+++.++.+||+|||.+....
T Consensus        86 l~~~l~~~~~----------~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~  152 (314)
T cd08216          86 CEDLLKTHFP----------EGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMI  152 (314)
T ss_pred             HHHHHHHhcc----------cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeec
Confidence            9999976432          35888999999999999999999999   9999999999999999999999999887553


Q ss_pred             CCCC------ceeeeccccccccCcccccC--CCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHH----
Q 009340          379 NDKT------HLTTTIQGTFGYLDPEYFQS--SQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISL----  446 (537)
Q Consensus       379 ~~~~------~~~~~~~gt~~y~aPE~~~~--~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~----  446 (537)
                      ....      .......++..|+|||.+..  ..++.++||||||+++|||++|+.||.......  .........    
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~  230 (314)
T cd08216         153 KHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKVRGTVPCL  230 (314)
T ss_pred             cccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhccCccc
Confidence            2211      11223456788999999876  358899999999999999999999986533211  111100000    


Q ss_pred             Hhh-------chhhh----hhcH----HhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHH
Q 009340          447 AKE-------NQLLE----ILDA----RVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSME  496 (537)
Q Consensus       447 ~~~-------~~~~~----~~d~----~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~  496 (537)
                      ...       .....    ..++    .............+.+++.+||+.||++|||+.++++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  295 (314)
T cd08216         231 LDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH  295 (314)
T ss_pred             cccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence            000       00000    0000    01111233445678899999999999999999999763

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=2.6e-35  Score=292.84  Aligned_cols=244  Identities=25%  Similarity=0.355  Sum_probs=192.8

Q ss_pred             CCccccccCcCCceEEEEEEc----CCCCEEEEEEccCCC----hHHHHHHHHHHHHHHhc-CCCCcceEeeEEeeCCcc
Q 009340          217 NYNQSRFLGQGGFGTVYKGML----PDGSIVAVKRSKEID----KTQIHQFINEVVILSQI-NHRHIVKLLGCCLETEVP  287 (537)
Q Consensus       217 ~~~~~~~lg~G~~g~Vy~~~~----~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~  287 (537)
                      +|+..+.||+|+||.||++..    .+|+.||+|+++...    ....+.+.+|+.+++++ +|+||+++++++......
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            467788999999999999885    368899999987532    22346678899999999 599999999999988889


Q ss_pred             EEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEE
Q 009340          288 VLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK  367 (537)
Q Consensus       288 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~k  367 (537)
                      ++|+||+++++|.+++...            ..+++..+..++.|+++||.|||+.+   ++||||+|+|||+++++.+|
T Consensus        81 ~lv~e~~~~~~L~~~l~~~------------~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~k  145 (290)
T cd05613          81 HLILDYINGGELFTHLSQR------------ERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVV  145 (290)
T ss_pred             EEEEecCCCCcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEE
Confidence            9999999999999998652            35889999999999999999999998   99999999999999999999


Q ss_pred             EeeccCccccCCCCCceeeeccccccccCcccccCC--CCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHH
Q 009340          368 VSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSS--QFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFIS  445 (537)
Q Consensus       368 i~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~  445 (537)
                      |+|||++...............|+..|+|||.+.+.  .++.++||||||+++|+|++|+.|+.......  ........
T Consensus       146 l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~--~~~~~~~~  223 (290)
T cd05613         146 LTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN--SQAEISRR  223 (290)
T ss_pred             EeeCccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc--cHHHHHHH
Confidence            999999987644333323345688999999998753  46789999999999999999999986432211  11110111


Q ss_pred             HHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCC
Q 009340          446 LAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRP  488 (537)
Q Consensus       446 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP  488 (537)
                      ...           ...+.+......+.+++.+||+.+|++||
T Consensus       224 ~~~-----------~~~~~~~~~~~~~~~ll~~~l~~~p~~R~  255 (290)
T cd05613         224 ILK-----------SEPPYPQEMSALAKDIIQRLLMKDPKKRL  255 (290)
T ss_pred             hhc-----------cCCCCCccCCHHHHHHHHHHhcCCHHHhc
Confidence            000           01112334456788999999999999997

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8.9e-36  Score=301.84  Aligned_cols=270  Identities=24%  Similarity=0.360  Sum_probs=204.5

Q ss_pred             CCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCC--hHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCC-----ccE
Q 009340          217 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEID--KTQIHQFINEVVILSQINHRHIVKLLGCCLETE-----VPV  288 (537)
Q Consensus       217 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~  288 (537)
                      +|...+.||+|+||.||+++.. +++.||||++....  ....+.+.+|+.+++.++|+||+++.+++....     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            4777899999999999999965 48999999887533  445567899999999999999999999998775     789


Q ss_pred             EEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEE
Q 009340          289 LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKV  368 (537)
Q Consensus       289 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki  368 (537)
                      +||||+++ +|.+++...            ..+++..++.++.++++||.|||+.+   ++||||||+|||++.++.++|
T Consensus        81 lv~e~~~~-~l~~~l~~~------------~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L  144 (330)
T cd07834          81 IVTELMET-DLHKVIKSP------------QPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKI  144 (330)
T ss_pred             EEecchhh-hHHHHHhCC------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEE
Confidence            99999984 888888642            36999999999999999999999999   999999999999999999999


Q ss_pred             eeccCccccCCCCC--ceeeeccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHH-
Q 009340          369 SDFGISRSIPNDKT--HLTTTIQGTFGYLDPEYFQSS-QFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFI-  444 (537)
Q Consensus       369 ~Dfgla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~-  444 (537)
                      +|||++........  .......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||......+......... 
T Consensus       145 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~  224 (330)
T cd07834         145 CDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLG  224 (330)
T ss_pred             cccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcC
Confidence            99999987644321  112334578899999999887 78999999999999999999999987654322111000000 


Q ss_pred             -------HHHhhchhhhhhcH------HhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHH--HHHHHH
Q 009340          445 -------SLAKENQLLEILDA------RVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSME--LEGLRR  502 (537)
Q Consensus       445 -------~~~~~~~~~~~~d~------~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~--L~~i~~  502 (537)
                             .........+.+..      .-........+..+.+++.+||+.+|++||++.+++..  ++.+..
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~  297 (330)
T cd07834         225 TPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD  297 (330)
T ss_pred             CCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence                   00000000001000      00000112245678899999999999999999999873  555444

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.7e-36  Score=298.14  Aligned_cols=250  Identities=26%  Similarity=0.401  Sum_probs=202.7

Q ss_pred             cCCccccccCcCCceEEEEEEcCCCCEEEEEEcc--CCChHHHHHHHHHHHHHHhc-CCCCcceEeeEEeeCCccEEEEe
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSK--EIDKTQIHQFINEVVILSQI-NHRHIVKLLGCCLETEVPVLVYE  292 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~--~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e  292 (537)
                      ..|+..++||+||.+.||++...+.+.+|+|++.  ..+.+...-|.+|+.+|.++ .|.+|++|++|-..++..|+|||
T Consensus       361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE  440 (677)
T KOG0596|consen  361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME  440 (677)
T ss_pred             chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence            4677889999999999999998888889999764  46677788899999999999 59999999999999999999999


Q ss_pred             cCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeecc
Q 009340          293 YISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG  372 (537)
Q Consensus       293 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfg  372 (537)
                      |-+. +|..+|.....          ....| .+..+..|++.++.++|.++   |||.||||.|.|+-.. .+||+|||
T Consensus       441 ~Gd~-DL~kiL~k~~~----------~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVkG-~LKLIDFG  504 (677)
T KOG0596|consen  441 CGDI-DLNKILKKKKS----------IDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVKG-RLKLIDFG  504 (677)
T ss_pred             cccc-cHHHHHHhccC----------CCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEee-eEEeeeec
Confidence            8754 99999987543          23445 78889999999999999999   9999999999998764 89999999


Q ss_pred             CccccCCCCCce-eeeccccccccCcccccCCC-----------CCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHH
Q 009340          373 ISRSIPNDKTHL-TTTIQGTFGYLDPEYFQSSQ-----------FTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLV  440 (537)
Q Consensus       373 la~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~-----------~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~  440 (537)
                      +|..+..+.... ....+||+.||+||.+....           .+.+|||||+|||||+|+.|+.||...     .+  
T Consensus       505 IA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~-----~n--  577 (677)
T KOG0596|consen  505 IANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI-----IN--  577 (677)
T ss_pred             hhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH-----HH--
Confidence            999887665543 34567999999999985432           457899999999999999999997421     11  


Q ss_pred             HHHHHHHhhchhhhhhcHHhhccccHHHH-HHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          441 ACFISLAKENQLLEILDARVAKEAREEDI-GAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       441 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~-~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                             ...++..+.++....+++.--. .++.++++.||+.||++|||..++++
T Consensus       578 -------~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  578 -------QIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             -------HHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence                   1123455666644333332111 23899999999999999999999975

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=2.7e-35  Score=290.80  Aligned_cols=241  Identities=25%  Similarity=0.384  Sum_probs=191.3

Q ss_pred             cCcCCceEEEEEEcC-CCCEEEEEEccCCC---hHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecCCCCCh
Q 009340          224 LGQGGFGTVYKGMLP-DGSIVAVKRSKEID---KTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTL  299 (537)
Q Consensus       224 lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL  299 (537)
                      ||+|+||+||++... +|+.||+|.+....   ......+.+|+.+++.++|+|++++++++...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            689999999999854 68899999876421   22345677899999999999999999999999999999999999999


Q ss_pred             hhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCccccCC
Q 009340          300 SHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPN  379 (537)
Q Consensus       300 ~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~  379 (537)
                      .+++.....          ..+++..++.++.|++.||.|||+.+   ++||||+|+||++++++.++|+|||++.....
T Consensus        81 ~~~l~~~~~----------~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~  147 (277)
T cd05577          81 KYHIYNVGE----------PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKG  147 (277)
T ss_pred             HHHHHHcCc----------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhcc
Confidence            999975432          25899999999999999999999999   99999999999999999999999999876543


Q ss_pred             CCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchhhhhhcHH
Q 009340          380 DKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEILDAR  459 (537)
Q Consensus       380 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  459 (537)
                      ..  ......++..|+|||.+.++.++.++||||||+++++|++|+.||..........   ....    .    ..  .
T Consensus       148 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---~~~~----~----~~--~  212 (277)
T cd05577         148 GK--KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE---ELKR----R----TL--E  212 (277)
T ss_pred             CC--ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHH---HHHh----c----cc--c
Confidence            21  1233457889999999988889999999999999999999999986443211000   0000    0    00  0


Q ss_pred             hhccccHHHHHHHHHHHHHhcccCCCCCCCHhh
Q 009340          460 VAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQ  492 (537)
Q Consensus       460 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  492 (537)
                      .....+......+.+++.+||+.+|++||++.+
T Consensus       213 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~  245 (277)
T cd05577         213 MAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRG  245 (277)
T ss_pred             ccccCCccCCHHHHHHHHHHccCChhHccCCCc
Confidence            011223334667889999999999999995555

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2e-35  Score=300.77  Aligned_cols=263  Identities=21%  Similarity=0.360  Sum_probs=196.2

Q ss_pred             hcCCccccccCcCCceEEEEEEc-CCCCEEEEEEccCC--ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCC------
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEI--DKTQIHQFINEVVILSQINHRHIVKLLGCCLETE------  285 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------  285 (537)
                      .++|...+.||+|+||.||+|+. .+|+.||||++...  .......+.+|+.+++.++|+||+++++++....      
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            37898999999999999999995 46899999988642  2223456889999999999999999999987543      


Q ss_pred             ccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCc
Q 009340          286 VPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFS  365 (537)
Q Consensus       286 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~  365 (537)
                      ..++|+||+.. +|..++.              ..+++..+..++.|+++||+|||+.+   ++||||||+||+++.++.
T Consensus        94 ~~~lv~e~~~~-~l~~~~~--------------~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~  155 (342)
T cd07879          94 DFYLVMPYMQT-DLQKIMG--------------HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCE  155 (342)
T ss_pred             eEEEEeccccc-CHHHHHc--------------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCC
Confidence            45899999864 6665542              25889999999999999999999999   999999999999999999


Q ss_pred             EEEeeccCccccCCCCCceeeeccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHH
Q 009340          366 AKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQS-SQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFI  444 (537)
Q Consensus       366 ~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~  444 (537)
                      +||+|||+++.....    .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||........   .....
T Consensus       156 ~kL~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~---~~~~~  228 (342)
T cd07879         156 LKILDFGLARHADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ---LTQIL  228 (342)
T ss_pred             EEEeeCCCCcCCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHH
Confidence            999999998765322    123456888999999876 4688999999999999999999999975432111   11111


Q ss_pred             HH-----------HhhchhhhhhcH--Hh-hcc---ccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH--HHHHHHH
Q 009340          445 SL-----------AKENQLLEILDA--RV-AKE---AREEDIGAMAELAMRCLRLNSKKRPTMKQVSM--ELEGLRR  502 (537)
Q Consensus       445 ~~-----------~~~~~~~~~~d~--~~-~~~---~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~--~L~~i~~  502 (537)
                      ..           ............  .. ...   ........+.+++.+||+.||++||++.+++.  .++..+.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~  305 (342)
T cd07879         229 KVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD  305 (342)
T ss_pred             HhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence            10           000000000000  00 000   00123456889999999999999999999984  4766654

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=2.7e-35  Score=293.69  Aligned_cols=252  Identities=24%  Similarity=0.398  Sum_probs=194.3

Q ss_pred             cCCccccccCcCCceEEEEEEcCC-CCEEEEEEccCCC-hHHHHHHHHHHHHHHhcC-CCCcceEeeEEeeCCccEEEEe
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLPD-GSIVAVKRSKEID-KTQIHQFINEVVILSQIN-HRHIVKLLGCCLETEVPVLVYE  292 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e  292 (537)
                      ++|+..+.||+|+||.||+|...+ ++.||||.++... .....++..|+.++.+.. |+||+++++++.+....++|||
T Consensus        15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   94 (296)
T cd06618          15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME   94 (296)
T ss_pred             chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence            567788999999999999999864 8999999987532 334556777888777775 9999999999999999999999


Q ss_pred             cCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeecCCCCCCEEECCCCcEEEeec
Q 009340          293 YISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHS-SASIPIFHRDIKSSNILLDDKFSAKVSDF  371 (537)
Q Consensus       293 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-~~~~~ivH~Dlk~~NIll~~~~~~ki~Df  371 (537)
                      |+.+ +|.+++...           ...+++..+..++.|+++||+|||+ .+   |+||||+|+||++++++.+||+||
T Consensus        95 ~~~~-~l~~l~~~~-----------~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~df  159 (296)
T cd06618          95 LMST-CLDKLLKRI-----------QGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDF  159 (296)
T ss_pred             ccCc-CHHHHHHHh-----------cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECcc
Confidence            9854 776666442           2368999999999999999999997 46   999999999999999999999999


Q ss_pred             cCccccCCCCCceeeeccccccccCcccccCCC----CCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHH
Q 009340          372 GISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQ----FTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLA  447 (537)
Q Consensus       372 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~  447 (537)
                      |++........  .....++..|+|||.+....    ++.++||||||+++|||++|+.||.......     .......
T Consensus       160 g~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-----~~~~~~~  232 (296)
T cd06618         160 GISGRLVDSKA--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF-----EVLTKIL  232 (296)
T ss_pred             ccchhccCCCc--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH-----HHHHHHh
Confidence            99876643222  12335788999999987553    7889999999999999999999985422110     0011111


Q ss_pred             hhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHH
Q 009340          448 KENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMEL  497 (537)
Q Consensus       448 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L  497 (537)
                      ... ..     ..  +.......++.+++.+||+.||++||++.++++.-
T Consensus       233 ~~~-~~-----~~--~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~  274 (296)
T cd06618         233 QEE-PP-----SL--PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP  274 (296)
T ss_pred             cCC-CC-----CC--CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence            110 00     00  01112345789999999999999999999997653

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=1.7e-35  Score=302.71  Aligned_cols=198  Identities=30%  Similarity=0.396  Sum_probs=171.3

Q ss_pred             CCccccccCcCCceEEEEEEc-CCCCEEEEEEccCCChHHHHHHHHHHHHHHhcC-C-----CCcceEeeEEeeCCccEE
Q 009340          217 NYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEIDKTQIHQFINEVVILSQIN-H-----RHIVKLLGCCLETEVPVL  289 (537)
Q Consensus       217 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H-----~niv~l~g~~~~~~~~~l  289 (537)
                      +|...+.||+|.||.|-++.. .+++.||||+++.. +....+-..|+.+|..|+ |     -|+|++++++..+++.+|
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci  265 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI  265 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence            788899999999999999995 46999999999864 334556678999999997 4     389999999999999999


Q ss_pred             EEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECC--CCcEE
Q 009340          290 VYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD--KFSAK  367 (537)
Q Consensus       290 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~--~~~~k  367 (537)
                      |+|.++. +|.++|+.+.-          ..++...+..|+.||+.||.+||+.+   |||+||||+||||.+  ...+|
T Consensus       266 VfELL~~-NLYellK~n~f----------~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vK  331 (586)
T KOG0667|consen  266 VFELLST-NLYELLKNNKF----------RGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIK  331 (586)
T ss_pred             eehhhhh-hHHHHHHhcCC----------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCcee
Confidence            9999966 99999988653          46999999999999999999999999   999999999999964  34799


Q ss_pred             EeeccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccch
Q 009340          368 VSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARV  433 (537)
Q Consensus       368 i~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~  433 (537)
                      |+|||.+......-    .....+..|.|||++.+.+|+.+.||||||||+.||++|.+-|.....
T Consensus       332 VIDFGSSc~~~q~v----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne  393 (586)
T KOG0667|consen  332 VIDFGSSCFESQRV----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNE  393 (586)
T ss_pred             EEecccccccCCcc----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCH
Confidence            99999998754322    145568899999999999999999999999999999999776655443

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=1e-34  Score=287.70  Aligned_cols=259  Identities=24%  Similarity=0.360  Sum_probs=194.8

Q ss_pred             CccccccCcCCceEEEEEEcC-CCCEEEEEEccCC--ChHHHHHHHHHHHHHHhc---CCCCcceEeeEEeeCCc-----
Q 009340          218 YNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI--DKTQIHQFINEVVILSQI---NHRHIVKLLGCCLETEV-----  286 (537)
Q Consensus       218 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~~~~-----  286 (537)
                      |+..+.||+|+||.||+|..+ +++.||+|+++..  .......+.+|+.++.++   +|+|++++++++.+.+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            566789999999999999976 4899999998642  222234566788777766   59999999999988776     


Q ss_pred             cEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcE
Q 009340          287 PVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA  366 (537)
Q Consensus       287 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~  366 (537)
                      .+++|||+.+ +|.+++.....          ..++|..++.++.|+++||.|||+.+   ++|+||+|+||+++.++.+
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~~----------~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~  146 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCPK----------PGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQV  146 (287)
T ss_pred             eEEEehhccc-CHHHHHHHccC----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCE
Confidence            8999999974 89888865321          25899999999999999999999998   9999999999999999999


Q ss_pred             EEeeccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHH
Q 009340          367 KVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISL  446 (537)
Q Consensus       367 ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~  446 (537)
                      ||+|||++........  .....++..|+|||.+.+..++.++||||||+++|||++|+.||......+.  . ..+...
T Consensus       147 ~l~dfg~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~--~-~~~~~~  221 (287)
T cd07838         147 KIADFGLARIYSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQ--L-DKIFDV  221 (287)
T ss_pred             EEeccCcceeccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHH--H-HHHHHH
Confidence            9999999977643322  1233478899999999999999999999999999999999988865433221  1 111110


Q ss_pred             Hhh-chh---------hhhhcHHhh---ccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          447 AKE-NQL---------LEILDARVA---KEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       447 ~~~-~~~---------~~~~d~~~~---~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      ... ...         .........   ..........+.+++.+||+.||++||++.+++.
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         222 IGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             cCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence            000 000         000000000   1111234567789999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=9.5e-35  Score=292.16  Aligned_cols=244  Identities=26%  Similarity=0.416  Sum_probs=192.9

Q ss_pred             CccccccCcCCceEEEEEEcC-CCCEEEEEEccCC---ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEec
Q 009340          218 YNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI---DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY  293 (537)
Q Consensus       218 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  293 (537)
                      |...+.||+|+||.||+|+.. +|+.|++|.+...   .......+.+|+.+++.++|+|++++++++.+.+..++||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            555677999999999999854 6889999988642   334456788999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccC
Q 009340          294 ISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGI  373 (537)
Q Consensus       294 ~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgl  373 (537)
                      +. |+|.+++...           ...++|..++.++.|++.+|.|||+.+   ++|+||+|+||+++.++.+||+|||+
T Consensus       103 ~~-~~l~~~l~~~-----------~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~  167 (313)
T cd06633         103 CL-GSASDLLEVH-----------KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGS  167 (313)
T ss_pred             CC-CCHHHHHHhc-----------CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCC
Confidence            96 5787777543           236899999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCCceeeeccccccccCccccc---CCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhc
Q 009340          374 SRSIPNDKTHLTTTIQGTFGYLDPEYFQ---SSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKEN  450 (537)
Q Consensus       374 a~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  450 (537)
                      +.....     .....|+..|+|||.+.   .+.++.++||||||+++|||++|+.|+........      ....... 
T Consensus       168 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~------~~~~~~~-  235 (313)
T cd06633         168 ASKSSP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIAQN-  235 (313)
T ss_pred             CcccCC-----CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHHhc-
Confidence            864322     22346788999999984   46688999999999999999999999864322110      1111100 


Q ss_pred             hhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHH
Q 009340          451 QLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSME  496 (537)
Q Consensus       451 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~  496 (537)
                      ...     .   .........+.+++.+||+.+|.+||++.+++..
T Consensus       236 ~~~-----~---~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         236 DSP-----T---LQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             CCC-----C---CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            000     0   0111223468899999999999999999999853

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=6.2e-35  Score=295.51  Aligned_cols=266  Identities=19%  Similarity=0.280  Sum_probs=195.9

Q ss_pred             cccCcC--CceEEEEEEcC-CCCEEEEEEccCC--ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecCCC
Q 009340          222 RFLGQG--GFGTVYKGMLP-DGSIVAVKRSKEI--DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISS  296 (537)
Q Consensus       222 ~~lg~G--~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  296 (537)
                      ..||+|  +||+||++... +|+.||+|.+...  .....+.+.+|+.+++.++|+||+++++++...+..++|+||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            356766  89999999864 7899999997642  334457788999999999999999999999999999999999999


Q ss_pred             CChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCccc
Q 009340          297 GTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS  376 (537)
Q Consensus       297 gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~  376 (537)
                      |+|.+++.....          ..+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.++++||+.+..
T Consensus        84 ~~l~~~l~~~~~----------~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~  150 (328)
T cd08226          84 GSANSLLKTYFP----------EGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYS  150 (328)
T ss_pred             CCHHHHHHhhcc----------cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhh
Confidence            999999876432          25889999999999999999999998   99999999999999999999999986543


Q ss_pred             cCCCCCce------eeeccccccccCcccccCC--CCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHH----
Q 009340          377 IPNDKTHL------TTTIQGTFGYLDPEYFQSS--QFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFI----  444 (537)
Q Consensus       377 ~~~~~~~~------~~~~~gt~~y~aPE~~~~~--~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~----  444 (537)
                      ........      .....++..|+|||++.+.  .++.++||||||+++|||++|+.||........  ......    
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~  228 (328)
T cd08226         151 LVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM--LLQKLKGPPY  228 (328)
T ss_pred             hhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH--HHHHhcCCCC
Confidence            32111110      0112346679999998763  478999999999999999999999864322110  000000    


Q ss_pred             ------------HHHhh----------------chhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH-
Q 009340          445 ------------SLAKE----------------NQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM-  495 (537)
Q Consensus       445 ------------~~~~~----------------~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~-  495 (537)
                                  .....                .......+..+..+....+...+.+|+.+||+.||++|||+.++++ 
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~  308 (328)
T cd08226         229 SPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH  308 (328)
T ss_pred             CCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence                        00000                0000011111122223456678999999999999999999999964 


Q ss_pred             -HHHHHHH
Q 009340          496 -ELEGLRR  502 (537)
Q Consensus       496 -~L~~i~~  502 (537)
                       .+..+.+
T Consensus       309 ~~~~~~~~  316 (328)
T cd08226         309 AFFKQVKE  316 (328)
T ss_pred             HHHHHHHH
Confidence             4444444

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.2e-34  Score=284.58  Aligned_cols=248  Identities=23%  Similarity=0.301  Sum_probs=190.7

Q ss_pred             HHHHHhcCCcccccc--CcCCceEEEEEEcC-CCCEEEEEEccCCChHHHHHHHHHHHHHHhc-CCCCcceEeeEEeeCC
Q 009340          210 ELQRATDNYNQSRFL--GQGGFGTVYKGMLP-DGSIVAVKRSKEIDKTQIHQFINEVVILSQI-NHRHIVKLLGCCLETE  285 (537)
Q Consensus       210 el~~~~~~~~~~~~l--g~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~  285 (537)
                      +.....++|+..+.+  |+|+||.||++... ++..+|+|..........     |+.....+ +|+|++++++++...+
T Consensus         8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~   82 (267)
T PHA03390          8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLK   82 (267)
T ss_pred             HHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCC
Confidence            334445677776666  99999999999854 688899998764321111     22222222 7999999999999999


Q ss_pred             ccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCC-
Q 009340          286 VPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF-  364 (537)
Q Consensus       286 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~-  364 (537)
                      ..++||||+++|+|.+++...            ..++|..+..++.|+++||.|||+.+   ++||||||+||+++.++ 
T Consensus        83 ~~~iv~e~~~~~~L~~~l~~~------------~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~  147 (267)
T PHA03390         83 GHVLIMDYIKDGDLFDLLKKE------------GKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKD  147 (267)
T ss_pred             eeEEEEEcCCCCcHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCC
Confidence            999999999999999999653            26899999999999999999999999   99999999999999998 


Q ss_pred             cEEEeeccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHH
Q 009340          365 SAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFI  444 (537)
Q Consensus       365 ~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~  444 (537)
                      .++|+|||++.......     ...++..|+|||.+.+..++.++||||||+++|||++|+.||......+ .....+..
T Consensus       148 ~~~l~dfg~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~~  221 (267)
T PHA03390        148 RIYLCDYGLCKIIGTPS-----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLLK  221 (267)
T ss_pred             eEEEecCccceecCCCc-----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHHH
Confidence            99999999987654322     2357899999999999899999999999999999999999987432211 11111111


Q ss_pred             HHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCC-HhhHHH
Q 009340          445 SLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPT-MKQVSM  495 (537)
Q Consensus       445 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-~~ev~~  495 (537)
                      ..          ..  ........+..+.+++.+||+.+|.+||+ ++++++
T Consensus       222 ~~----------~~--~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        222 RQ----------QK--KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             hh----------cc--cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence            00          00  00122245567899999999999999996 588763

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.8e-35  Score=298.32  Aligned_cols=267  Identities=21%  Similarity=0.315  Sum_probs=200.3

Q ss_pred             cCHHHHHHHhcCCccccccCcCCceEEEEEEc-CCCCEEEEEEccCC--ChHHHHHHHHHHHHHHhcCCCCcceEeeEEe
Q 009340          206 FTADELQRATDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEI--DKTQIHQFINEVVILSQINHRHIVKLLGCCL  282 (537)
Q Consensus       206 ~~~~el~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~  282 (537)
                      ....++...+++|...+.||+|+||.||++.. .+|+.||+|++...  .....+.+.+|+.++++++|+||+++.+++.
T Consensus         7 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~   86 (345)
T cd07877           7 ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT   86 (345)
T ss_pred             hHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeee
Confidence            44566777889999999999999999999984 47899999998653  2333567889999999999999999999886


Q ss_pred             eC------CccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCC
Q 009340          283 ET------EVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSS  356 (537)
Q Consensus       283 ~~------~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~  356 (537)
                      ..      ...+++++++ +++|.+++..             ..+++..+..++.|+++||+|||+.+   ++||||||+
T Consensus        87 ~~~~~~~~~~~~lv~~~~-~~~L~~~~~~-------------~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~  149 (345)
T cd07877          87 PARSLEEFNDVYLVTHLM-GADLNNIVKC-------------QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPS  149 (345)
T ss_pred             ecccccccccEEEEehhc-ccCHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChH
Confidence            43      2357788876 6789887753             25899999999999999999999999   999999999


Q ss_pred             CEEECCCCcEEEeeccCccccCCCCCceeeeccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCccchhh
Q 009340          357 NILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQS-SQFTDKSDVYSFGVVLLELLTGKKPICFARVEE  435 (537)
Q Consensus       357 NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~  435 (537)
                      ||++++++.+||+|||++......    .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||.......
T Consensus       150 NIll~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~  225 (345)
T cd07877         150 NLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID  225 (345)
T ss_pred             HEEEcCCCCEEEeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            999999999999999998765322    223457889999998866 568899999999999999999999986433221


Q ss_pred             hccHHHHHHHHH-----------hhchhhhhh---cHHhh---ccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHH
Q 009340          436 ERNLVACFISLA-----------KENQLLEIL---DARVA---KEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSME  496 (537)
Q Consensus       436 ~~~~~~~~~~~~-----------~~~~~~~~~---d~~~~---~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~  496 (537)
                      .   ........           ........+   .....   .+........+.+++.+|++.||.+||++.+++..
T Consensus       226 ~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         226 Q---LKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             H---HHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence            1   00010000           000000000   00000   00001234568899999999999999999988754

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=2.9e-35  Score=290.30  Aligned_cols=247  Identities=25%  Similarity=0.390  Sum_probs=201.8

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCC---ChHHHHHHHHHHHHHHhcC-CCCcceEeeEEeeCCccEEE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI---DKTQIHQFINEVVILSQIN-HRHIVKLLGCCLETEVPVLV  290 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV  290 (537)
                      ++|...+.||+|+||.||++... +|+.||+|.....   .....+.+.+|+.++++++ |+||+++++++.+.+..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            36788899999999999999965 7899999987642   2334567889999999998 99999999999999999999


Q ss_pred             EecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEee
Q 009340          291 YEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSD  370 (537)
Q Consensus       291 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~D  370 (537)
                      |||+++++|.+++...            ..+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++++|
T Consensus        81 ~e~~~~~~L~~~l~~~------------~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~d  145 (280)
T cd05581          81 LEYAPNGELLQYIRKY------------GSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITD  145 (280)
T ss_pred             EcCCCCCcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecC
Confidence            9999999999998653            36999999999999999999999999   99999999999999999999999


Q ss_pred             ccCccccCCCCC-------------------ceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCcc
Q 009340          371 FGISRSIPNDKT-------------------HLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFA  431 (537)
Q Consensus       371 fgla~~~~~~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~  431 (537)
                      ||++........                   .......++..|+|||.+....++.++||||||++++++++|+.|+...
T Consensus       146 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~  225 (280)
T cd05581         146 FGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGS  225 (280)
T ss_pred             CccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCc
Confidence            999986643321                   1122345788999999998888999999999999999999999998654


Q ss_pred             chhhhccHHHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCH----hhHH
Q 009340          432 RVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTM----KQVS  494 (537)
Q Consensus       432 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~----~ev~  494 (537)
                      ....      .+....           ......+......+.+++.+||+.+|++||++    .+++
T Consensus       226 ~~~~------~~~~~~-----------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll  275 (280)
T cd05581         226 NEYL------TFQKIL-----------KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELK  275 (280)
T ss_pred             cHHH------HHHHHH-----------hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHh
Confidence            3111      111111           01112233345678899999999999999999    6654

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.5e-35  Score=299.14  Aligned_cols=271  Identities=20%  Similarity=0.313  Sum_probs=200.9

Q ss_pred             HHHhcCCccccccCcCCceEEEEEEc-CCCCEEEEEEccCC--ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCC---
Q 009340          212 QRATDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEI--DKTQIHQFINEVVILSQINHRHIVKLLGCCLETE---  285 (537)
Q Consensus       212 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~---  285 (537)
                      ....++|...+.||+|+||.||++.. .+|+.||||++...  .......+.+|+.++++++|+||+++++++....   
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07880          11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD   90 (343)
T ss_pred             hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence            34567899999999999999999984 47899999988542  2334556889999999999999999999987554   


Q ss_pred             ---ccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECC
Q 009340          286 ---VPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD  362 (537)
Q Consensus       286 ---~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~  362 (537)
                         ..++||||+ +++|.+++..             ..+++..++.++.|+++||+|||+.+   |+||||||+||++++
T Consensus        91 ~~~~~~lv~e~~-~~~l~~~~~~-------------~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~  153 (343)
T cd07880          91 RFHDFYLVMPFM-GTDLGKLMKH-------------EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNE  153 (343)
T ss_pred             ccceEEEEEecC-CCCHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcC
Confidence               348999998 6688887753             25899999999999999999999999   999999999999999


Q ss_pred             CCcEEEeeccCccccCCCCCceeeeccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhcc-H-
Q 009340          363 KFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQS-SQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERN-L-  439 (537)
Q Consensus       363 ~~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~-~-  439 (537)
                      ++.++|+|||++.......    ....++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.......... . 
T Consensus       154 ~~~~kl~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~  229 (343)
T cd07880         154 DCELKILDFGLARQTDSEM----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIM  229 (343)
T ss_pred             CCCEEEeecccccccccCc----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            9999999999998653321    23356889999999876 458899999999999999999999986543211100 0 


Q ss_pred             ------HHHHHHHHhhchhhhhhcH--Hh----hccccHHHHHHHHHHHHHhcccCCCCCCCHhhHH--HHHHHHHHh
Q 009340          440 ------VACFISLAKENQLLEILDA--RV----AKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVS--MELEGLRRS  503 (537)
Q Consensus       440 ------~~~~~~~~~~~~~~~~~d~--~~----~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~--~~L~~i~~~  503 (537)
                            ...+...............  ..    ...........+.+++.+|++.||++|||+.+++  ..++.....
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~  307 (343)
T cd07880         230 KVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDP  307 (343)
T ss_pred             HhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCc
Confidence                  0000000000000000000  00    0001122345688999999999999999999998  455555443

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=1.1e-34  Score=286.54  Aligned_cols=241  Identities=24%  Similarity=0.381  Sum_probs=186.6

Q ss_pred             ccCcCCceEEEEEEc-CCCCEEEEEEccCCC---hHHHHHHHHHHH---HHHhcCCCCcceEeeEEeeCCccEEEEecCC
Q 009340          223 FLGQGGFGTVYKGML-PDGSIVAVKRSKEID---KTQIHQFINEVV---ILSQINHRHIVKLLGCCLETEVPVLVYEYIS  295 (537)
Q Consensus       223 ~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~---~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  295 (537)
                      .||+|+||.||++.. .+++.||+|.+....   ......+..|..   .++..+|+|++++.+++.+.+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            489999999999985 468899999876421   122223444444   3444579999999999999999999999999


Q ss_pred             CCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCcc
Q 009340          296 SGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISR  375 (537)
Q Consensus       296 ~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~  375 (537)
                      +|+|.+++...            ..++|..+..++.|+++||.|||+.+   ++||||||+||+++.++.+||+|||++.
T Consensus        81 g~~L~~~l~~~------------~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~  145 (278)
T cd05606          81 GGDLHYHLSQH------------GVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLAC  145 (278)
T ss_pred             CCcHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCcc
Confidence            99999888542            36999999999999999999999998   9999999999999999999999999987


Q ss_pred             ccCCCCCceeeeccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchhhh
Q 009340          376 SIPNDKTHLTTTIQGTFGYLDPEYFQSS-QFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLE  454 (537)
Q Consensus       376 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  454 (537)
                      ......   .....|+..|+|||.+.++ .++.++||||||+++|||++|+.||..........    ......      
T Consensus       146 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~----~~~~~~------  212 (278)
T cd05606         146 DFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE----IDRMTL------  212 (278)
T ss_pred             ccCccC---CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH----HHHHhh------
Confidence            653322   2234689999999998755 68999999999999999999999986542211100    000000      


Q ss_pred             hhcHHhhccccHHHHHHHHHHHHHhcccCCCCCC-----CHhhHHH
Q 009340          455 ILDARVAKEAREEDIGAMAELAMRCLRLNSKKRP-----TMKQVSM  495 (537)
Q Consensus       455 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~  495 (537)
                          ......+...+..+.+++.+|+..+|++||     ++.++++
T Consensus       213 ----~~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         213 ----TMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             ----ccCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence                001112233456788999999999999999     8888874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=7.4e-35  Score=288.25  Aligned_cols=259  Identities=27%  Similarity=0.368  Sum_probs=195.2

Q ss_pred             CccccccCcCCceEEEEEEcC-CCCEEEEEEccCCCh-HHHHHHHHHHHHHHhcC-CCCcceEeeEEeeCCccEEEEecC
Q 009340          218 YNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDK-TQIHQFINEVVILSQIN-HRHIVKLLGCCLETEVPVLVYEYI  294 (537)
Q Consensus       218 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~  294 (537)
                      |+..+.||+|+||+||+|+.. +++.|+||++..... .......+|+..+++++ |+|++++++++.+.+..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            556788999999999999975 578899998865322 22234567999999998 999999999999999999999999


Q ss_pred             CCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCc
Q 009340          295 SSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGIS  374 (537)
Q Consensus       295 ~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla  374 (537)
                       +|+|.+++....          ...++|..++.++.|++++|.|||+.+   ++|+||+|+||+++.++.++|+|||++
T Consensus        81 -~~~l~~~~~~~~----------~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~  146 (283)
T cd07830          81 -EGNLYQLMKDRK----------GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLA  146 (283)
T ss_pred             -CCCHHHHHHhcc----------cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccc
Confidence             889998887543          136899999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCCceeeeccccccccCccccc-CCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhh----
Q 009340          375 RSIPNDKTHLTTTIQGTFGYLDPEYFQ-SSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKE----  449 (537)
Q Consensus       375 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~----  449 (537)
                      ........  .....++..|+|||.+. +..++.++|+||||+++|||++|+.||......+..   .........    
T Consensus       147 ~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~---~~~~~~~~~~~~~  221 (283)
T cd07830         147 REIRSRPP--YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQL---YKICSVLGTPTKQ  221 (283)
T ss_pred             eeccCCCC--cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHH---HHHHHhcCCCChh
Confidence            86643322  12345788999999875 456789999999999999999999998654322110   000000000    


Q ss_pred             ----c-hhhhhhcHHh-------hccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          450 ----N-QLLEILDARV-------AKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       450 ----~-~~~~~~d~~~-------~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                          . .+...++...       ...........+.+++.+||+.+|++|||+.|++.
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         222 DWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             hhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence                0 0000000000       00011112467889999999999999999999875

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=6.6e-35  Score=285.02  Aligned_cols=250  Identities=26%  Similarity=0.370  Sum_probs=195.2

Q ss_pred             CCccccccCcCCceEEEEEEcC-CCCEEEEEEccCC-----ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEE
Q 009340          217 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI-----DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLV  290 (537)
Q Consensus       217 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  290 (537)
                      +|...+.||+|+||.||++... .+..+++|.++..     ......++..|+.++++++|||++++++++.+....++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            4677889999999999999864 3444555655431     223344577899999999999999999999998899999


Q ss_pred             EecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEee
Q 009340          291 YEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSD  370 (537)
Q Consensus       291 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~D  370 (537)
                      +||+++++|.+++......        ...+++..++.++.|+++||.|||+.+   ++|+||+|+||+++++ .++|+|
T Consensus        81 ~e~~~~~~l~~~~~~~~~~--------~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~~-~~~l~d  148 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHT--------GKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKNN-LLKIGD  148 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhc--------ccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeecC-CEeecc
Confidence            9999999999998753221        346999999999999999999999998   9999999999999864 699999


Q ss_pred             ccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhc
Q 009340          371 FGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKEN  450 (537)
Q Consensus       371 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  450 (537)
                      ||++....... .......++..|+|||.+.+..++.++|+||||+++|+|++|+.|+.......      ....... .
T Consensus       149 ~g~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~------~~~~~~~-~  220 (260)
T cd08222         149 FGVSRLLMGSC-DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLS------VVLRIVE-G  220 (260)
T ss_pred             cCceeecCCCc-ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH------HHHHHHc-C
Confidence            99987664322 12234457889999999988888999999999999999999999985332111      1111100 0


Q ss_pred             hhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          451 QLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       451 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                               .....+...+..+.+++.+||+.+|++||++.++++
T Consensus       221 ---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         221 ---------PTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             ---------CCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence                     111123455568899999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=6.9e-35  Score=288.10  Aligned_cols=259  Identities=25%  Similarity=0.341  Sum_probs=198.1

Q ss_pred             CccccccCcCCceEEEEEEcC-CCCEEEEEEccCCC--hHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecC
Q 009340          218 YNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEID--KTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI  294 (537)
Q Consensus       218 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  294 (537)
                      |+..+.||+|++|.||+|+.. +++.||+|.+....  ....+.+.+|+.++++++|+|++++++++.+.+..++|+||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            456678999999999999975 58999999887642  333567889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCc
Q 009340          295 SSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGIS  374 (537)
Q Consensus       295 ~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla  374 (537)
                      + ++|.+++....           ..+++..++.++.++++||.|||+.+   ++||||+|+||++++++.++|+|||++
T Consensus        81 ~-~~l~~~i~~~~-----------~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~  145 (282)
T cd07829          81 D-MDLKKYLDKRP-----------GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLA  145 (282)
T ss_pred             C-cCHHHHHHhhc-----------cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcc
Confidence            8 58999997642           25899999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCCceeeeccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhc---
Q 009340          375 RSIPNDKTHLTTTIQGTFGYLDPEYFQSS-QFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKEN---  450 (537)
Q Consensus       375 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---  450 (537)
                      ........ ......++..|+|||.+.+. .++.++||||||+++|||++|+.||......+.   ...........   
T Consensus       146 ~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~  221 (282)
T cd07829         146 RAFGIPLR-TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQ---LFKIFQILGTPTEE  221 (282)
T ss_pred             cccCCCcc-ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH---HHHHHHHhCCCcHH
Confidence            87643322 12233457789999998776 789999999999999999999998865432211   11111110000   


Q ss_pred             hhhhh-----hcHHh-------hccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          451 QLLEI-----LDARV-------AKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       451 ~~~~~-----~d~~~-------~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      ....+     .+...       ...........+.+++.+||+.+|++||++.+++.
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         222 SWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             HHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence            00000     00000       00001122467899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=4.6e-35  Score=293.70  Aligned_cols=262  Identities=24%  Similarity=0.326  Sum_probs=193.7

Q ss_pred             hcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCC--hHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCC------
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEID--KTQIHQFINEVVILSQINHRHIVKLLGCCLETE------  285 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------  285 (537)
                      .++|+..++||+|+||.||+|... +++.||+|++....  ......+.+|+.+++.++|+||+++++++.+..      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            478999999999999999999964 68899999875422  122345678999999999999999999876543      


Q ss_pred             --ccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCC
Q 009340          286 --VPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK  363 (537)
Q Consensus       286 --~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~  363 (537)
                        ..++|+||+.. +|...+...           ...+++..+..++.|+++||.|||+.+   ++|+||||+||+++++
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~-----------~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~  151 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENP-----------SVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQ  151 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhcc-----------ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCC
Confidence              35999999975 676666542           236999999999999999999999999   9999999999999999


Q ss_pred             CcEEEeeccCccccCCCCCc----------eeeeccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCccc
Q 009340          364 FSAKVSDFGISRSIPNDKTH----------LTTTIQGTFGYLDPEYFQSS-QFTDKSDVYSFGVVLLELLTGKKPICFAR  432 (537)
Q Consensus       364 ~~~ki~Dfgla~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvll~el~tg~~p~~~~~  432 (537)
                      +.++|+|||++.........          ..+...+++.|+|||.+.+. .++.++||||||+++|||++|+.||....
T Consensus       152 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~  231 (311)
T cd07866         152 GILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKS  231 (311)
T ss_pred             CCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCC
Confidence            99999999999765332211          11234568889999987654 58899999999999999999999986543


Q ss_pred             hhhhccHHHHHHHHHhh---c------hhhhhh--------cHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          433 VEEERNLVACFISLAKE---N------QLLEIL--------DARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       433 ~~~~~~~~~~~~~~~~~---~------~~~~~~--------d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      .......   .......   .      .+....        .+.+. .........+.+++.+||+.||++|||+.+++.
T Consensus       232 ~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         232 DIDQLHL---IFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLE-ERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             HHHHHHH---HHHHhCCCChhhchhhhhcccccccccCCCCCccHH-HHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            3221111   1111000   0      000000        00000 001122357889999999999999999999864

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-35  Score=289.63  Aligned_cols=245  Identities=27%  Similarity=0.412  Sum_probs=205.5

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCC---ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI---DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY  291 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  291 (537)
                      +.|..-++||+||||.||-.+.+ +|+.+|.|++...   .+....-.++|-.+|.+++.+.||.+--.+.+.+.++||+
T Consensus       185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL  264 (591)
T KOG0986|consen  185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL  264 (591)
T ss_pred             cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence            56777899999999999998865 6999999987532   1223345678999999999999999988889999999999


Q ss_pred             ecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeec
Q 009340          292 EYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF  371 (537)
Q Consensus       292 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Df  371 (537)
                      ..|.+|+|.-+|.+...          ..+++...+..|.+|+-||++||...   ||.||+||+|||||+.|.++|+|+
T Consensus       265 tlMNGGDLkfHiyn~g~----------~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDL  331 (591)
T KOG0986|consen  265 TLMNGGDLKFHIYNHGN----------PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDL  331 (591)
T ss_pred             EeecCCceeEEeeccCC----------CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeecc
Confidence            99999999999987653          36999999999999999999999999   999999999999999999999999


Q ss_pred             cCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhch
Q 009340          372 GISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQ  451 (537)
Q Consensus       372 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  451 (537)
                      |||..++.....  ...+||.+|||||++.++.|+...|.||+||+||||+.|+.||.......                
T Consensus       332 GLAvei~~g~~~--~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKv----------------  393 (591)
T KOG0986|consen  332 GLAVEIPEGKPI--RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKV----------------  393 (591)
T ss_pred             ceEEecCCCCcc--ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhh----------------
Confidence            999988766543  44589999999999999999999999999999999999999985432211                


Q ss_pred             hhhhhcHHh---hccccHHHHHHHHHHHHHhcccCCCCCCCHh
Q 009340          452 LLEILDARV---AKEAREEDIGAMAELAMRCLRLNSKKRPTMK  491 (537)
Q Consensus       452 ~~~~~d~~~---~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~  491 (537)
                      ..+-+|.+.   ..+++...+++...+....|+.||.+|-.-.
T Consensus       394 k~eEvdrr~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr  436 (591)
T KOG0986|consen  394 KREEVDRRTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR  436 (591)
T ss_pred             hHHHHHHHHhcchhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence            111223222   2246677788889999999999999997554

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=1.2e-34  Score=293.23  Aligned_cols=265  Identities=21%  Similarity=0.308  Sum_probs=197.6

Q ss_pred             HHHHhcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccC--CChHHHHHHHHHHHHHHhcCCCCcceEeeEEee-CCc
Q 009340          211 LQRATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKE--IDKTQIHQFINEVVILSQINHRHIVKLLGCCLE-TEV  286 (537)
Q Consensus       211 l~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~  286 (537)
                      +...+++|+..+.||+|+||.||++... +++.||+|++..  ......+.+.+|+.+++.++|||++++.+++.. ...
T Consensus         5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   84 (328)
T cd07856           5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED   84 (328)
T ss_pred             eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence            3456789999999999999999999854 789999998753  222345678899999999999999999999875 457


Q ss_pred             cEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcE
Q 009340          287 PVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA  366 (537)
Q Consensus       287 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~  366 (537)
                      .++|+||+ +++|.+++..             ..+++.....++.|+++||.|||+.+   ++||||+|+||++++++.+
T Consensus        85 ~~lv~e~~-~~~L~~~~~~-------------~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~  147 (328)
T cd07856          85 IYFVTELL-GTDLHRLLTS-------------RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDL  147 (328)
T ss_pred             EEEEeehh-ccCHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCE
Confidence            89999998 4588887753             25788888999999999999999999   9999999999999999999


Q ss_pred             EEeeccCccccCCCCCceeeeccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHH---
Q 009340          367 KVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQS-SQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVAC---  442 (537)
Q Consensus       367 ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~---  442 (537)
                      +|+|||++......    .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||..............   
T Consensus       148 ~l~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~  223 (328)
T cd07856         148 KICDFGLARIQDPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLG  223 (328)
T ss_pred             EeCccccccccCCC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            99999998754321    123356888999998766 5689999999999999999999999865432111000000   


Q ss_pred             -----HHHHHhhchhhhhhcH-Hhhcccc-----HHHHHHHHHHHHHhcccCCCCCCCHhhHHHH
Q 009340          443 -----FISLAKENQLLEILDA-RVAKEAR-----EEDIGAMAELAMRCLRLNSKKRPTMKQVSME  496 (537)
Q Consensus       443 -----~~~~~~~~~~~~~~d~-~~~~~~~-----~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~  496 (537)
                           +..........+.+.. ......+     ......+.+++.+||+.+|++|||+.+++..
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         224 TPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             CCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                 0000000000011000 0000111     1234678999999999999999999988543

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=1.2e-34  Score=294.39  Aligned_cols=260  Identities=23%  Similarity=0.333  Sum_probs=194.3

Q ss_pred             cCCcc-ccccCcCCceEEEEEEcC-CCCEEEEEEccCCChHH--------------HHHHHHHHHHHHhcCCCCcceEee
Q 009340          216 DNYNQ-SRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKTQ--------------IHQFINEVVILSQINHRHIVKLLG  279 (537)
Q Consensus       216 ~~~~~-~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~H~niv~l~g  279 (537)
                      ++|.. .+.||+|+||.||+|... +++.||||.++......              ...+.+|++++++++|+|++++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            45543 467999999999999954 68999999876432211              124778999999999999999999


Q ss_pred             EEeeCCccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEE
Q 009340          280 CCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNIL  359 (537)
Q Consensus       280 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIl  359 (537)
                      ++...+..++||||++ |+|.+++...            ..+++.....++.|+++||.|||+.+   ++|+||+|+||+
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~------------~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nil  151 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVDRK------------IRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIF  151 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeE
Confidence            9999999999999997 6898888542            35899999999999999999999999   999999999999


Q ss_pred             ECCCCcEEEeeccCccccCCCC-------------CceeeeccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCC
Q 009340          360 LDDKFSAKVSDFGISRSIPNDK-------------THLTTTIQGTFGYLDPEYFQSS-QFTDKSDVYSFGVVLLELLTGK  425 (537)
Q Consensus       360 l~~~~~~ki~Dfgla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvll~el~tg~  425 (537)
                      ++.++.++|+|||++.......             ........++..|+|||.+.+. .++.++||||||+++|||++|+
T Consensus       152 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~  231 (335)
T PTZ00024        152 INSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK  231 (335)
T ss_pred             ECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCC
Confidence            9999999999999997654111             0111223467889999998764 4689999999999999999999


Q ss_pred             CCCCccchhhhccHHHHHHHHHhhch---hhhhh------------cHHhhccccHHHHHHHHHHHHHhcccCCCCCCCH
Q 009340          426 KPICFARVEEERNLVACFISLAKENQ---LLEIL------------DARVAKEAREEDIGAMAELAMRCLRLNSKKRPTM  490 (537)
Q Consensus       426 ~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~------------d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~  490 (537)
                      .||......+.   ............   ..+..            ..... ......+..+.+++.+||+.+|++|||+
T Consensus       232 ~p~~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~s~  307 (335)
T PTZ00024        232 PLFPGENEIDQ---LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLK-TIFPNASDDAIDLLQSLLKLNPLERISA  307 (335)
T ss_pred             CCCCCCCHHHH---HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHH-HhCcCCChHHHHHHHHHcCCCchhccCH
Confidence            99865443221   111111111000   00000            00000 0111234678899999999999999999


Q ss_pred             hhHHH
Q 009340          491 KQVSM  495 (537)
Q Consensus       491 ~ev~~  495 (537)
                      .|++.
T Consensus       308 ~~~l~  312 (335)
T PTZ00024        308 KEALK  312 (335)
T ss_pred             HHHhc
Confidence            99975

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=1.8e-34  Score=292.55  Aligned_cols=260  Identities=22%  Similarity=0.330  Sum_probs=191.6

Q ss_pred             CCccccccCcCCceEEEEEEcC-C--CCEEEEEEccCC--ChHHHHHHHHHHHHHHhc-CCCCcceEeeEEeeC----Cc
Q 009340          217 NYNQSRFLGQGGFGTVYKGMLP-D--GSIVAVKRSKEI--DKTQIHQFINEVVILSQI-NHRHIVKLLGCCLET----EV  286 (537)
Q Consensus       217 ~~~~~~~lg~G~~g~Vy~~~~~-~--g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~----~~  286 (537)
                      +|+..+.||+|+||.||++... .  +..||+|++...  .....+.+.+|+.+++++ +|+||+++++++...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            4677889999999999999964 3  778999987642  223356788999999999 599999999976433    34


Q ss_pred             cEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcE
Q 009340          287 PVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA  366 (537)
Q Consensus       287 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~  366 (537)
                      .++++||+. ++|.+++..            ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+
T Consensus        81 ~~~~~e~~~-~~L~~~l~~------------~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~  144 (332)
T cd07857          81 LYLYEELME-ADLHQIIRS------------GQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCEL  144 (332)
T ss_pred             EEEEEeccc-CCHHHHHhc------------CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCE
Confidence            688888886 589888854            236899999999999999999999999   9999999999999999999


Q ss_pred             EEeeccCccccCCCCCc---eeeeccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHH
Q 009340          367 KVSDFGISRSIPNDKTH---LTTTIQGTFGYLDPEYFQS-SQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVAC  442 (537)
Q Consensus       367 ki~Dfgla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~  442 (537)
                      ||+|||+++........   ......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||........   ...
T Consensus       145 kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~---~~~  221 (332)
T cd07857         145 KICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQ---LNQ  221 (332)
T ss_pred             EeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHH---HHH
Confidence            99999999865432211   1223468899999998765 4688999999999999999999999865432211   010


Q ss_pred             HHHHHh---hchhhhhhcHH-------h----h---ccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          443 FISLAK---ENQLLEILDAR-------V----A---KEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       443 ~~~~~~---~~~~~~~~d~~-------~----~---~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      ......   ...+..+..+.       .    .   ..........+.+++.+||+.||++|||+.++++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         222 ILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             HHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            000000   00000000000       0    0   0001112457889999999999999999999863

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=6.9e-35  Score=296.87  Aligned_cols=260  Identities=24%  Similarity=0.374  Sum_probs=193.6

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeC----------
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLET----------  284 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~----------  284 (537)
                      .+|...+.||.|+||.||+|... +|+.||+|.+........+.+.+|+.+++.++|+||+++++++...          
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS   84 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence            67888999999999999999964 6889999998765556667788999999999999999999876544          


Q ss_pred             ----CccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEE
Q 009340          285 ----EVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILL  360 (537)
Q Consensus       285 ----~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll  360 (537)
                          ...++|+||++ ++|.+++..             ..+++.....++.|+++||.|||+.+   ++||||||+||++
T Consensus        85 ~~~~~~~~lv~e~~~-~~L~~~~~~-------------~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili  147 (342)
T cd07854          85 LTELNSVYIVQEYME-TDLANVLEQ-------------GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFI  147 (342)
T ss_pred             ccccceEEEEeeccc-ccHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEE
Confidence                34689999997 588877743             25889999999999999999999999   9999999999999


Q ss_pred             C-CCCcEEEeeccCccccCCCCCce--eeeccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCccchhhh
Q 009340          361 D-DKFSAKVSDFGISRSIPNDKTHL--TTTIQGTFGYLDPEYFQS-SQFTDKSDVYSFGVVLLELLTGKKPICFARVEEE  436 (537)
Q Consensus       361 ~-~~~~~ki~Dfgla~~~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~  436 (537)
                      + .++.+|++|||++..........  .....++..|+|||.+.. ..++.++|||||||++|||++|+.||......+.
T Consensus       148 ~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~  227 (342)
T cd07854         148 NTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQ  227 (342)
T ss_pred             cCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            7 45678999999997653321111  122357889999998754 5678899999999999999999999965432211


Q ss_pred             ccHHHHHHHHHh------hchhhhhhcHHhh----------ccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          437 RNLVACFISLAK------ENQLLEILDARVA----------KEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       437 ~~~~~~~~~~~~------~~~~~~~~d~~~~----------~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      ...   ......      .............          .........++.+++.+||+.||++|||+.+++.
T Consensus       228 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         228 MQL---ILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             HHH---HHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence            000   000000      0000000000000          0011123467889999999999999999999974

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-35  Score=300.05  Aligned_cols=273  Identities=26%  Similarity=0.408  Sum_probs=205.4

Q ss_pred             CCccccccCcCCceEEEEEEc-CCCCEEEEEEccCC-ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeC------CccE
Q 009340          217 NYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEI-DKTQIHQFINEVVILSQINHRHIVKLLGCCLET------EVPV  288 (537)
Q Consensus       217 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~~  288 (537)
                      .+...+.||+|+||.||+|+. ..|+.||||.++.. .....+...+|+++|++++|+|||+++++=.+.      ....
T Consensus        14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v   93 (732)
T KOG4250|consen   14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV   93 (732)
T ss_pred             ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence            344567899999999999994 57999999988763 344567788999999999999999999986543      3578


Q ss_pred             EEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEC----CCC
Q 009340          289 LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD----DKF  364 (537)
Q Consensus       289 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~----~~~  364 (537)
                      +|||||.+|||...|.+...         ..-|+..+.+.+..+++.||.|||+++   |+||||||.||++-    ..-
T Consensus        94 lvmEyC~gGsL~~~L~~PEN---------~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~  161 (732)
T KOG4250|consen   94 LVMEYCSGGSLRKVLNSPEN---------AYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQS  161 (732)
T ss_pred             EEEeecCCCcHHHHhcCccc---------ccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCce
Confidence            99999999999999987655         346999999999999999999999999   99999999999983    333


Q ss_pred             cEEEeeccCccccCCCCCceeeeccccccccCccccc-CCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHH
Q 009340          365 SAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQ-SSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACF  443 (537)
Q Consensus       365 ~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~  443 (537)
                      --||+|||.|+.+..+.  .....+||..|++||.+. .+.|+..+|.|||||++||.+||..||.............|.
T Consensus       162 IyKLtDfG~Arel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~  239 (732)
T KOG4250|consen  162 IYKLTDFGAARELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWH  239 (732)
T ss_pred             EEeeecccccccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhh
Confidence            58999999999886544  577889999999999998 488999999999999999999999999654333211112222


Q ss_pred             HHHHhhchhhhhhcHHhh--------ccc----cHHHHHHHHHHHHHhcccCCCCCC--CHhhHHHHHHHHHHh
Q 009340          444 ISLAKENQLLEILDARVA--------KEA----REEDIGAMAELAMRCLRLNSKKRP--TMKQVSMELEGLRRS  503 (537)
Q Consensus       444 ~~~~~~~~~~~~~d~~~~--------~~~----~~~~~~~l~~l~~~cl~~~p~~RP--s~~ev~~~L~~i~~~  503 (537)
                      ...-+..-..-..+....        .+.    .......+-..+..+|..+|++|=  .+.+....+..|...
T Consensus       240 ~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~  313 (732)
T KOG4250|consen  240 IITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNL  313 (732)
T ss_pred             hhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhh
Confidence            111111100000011000        011    122334556677778888888887  777777777666553

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-36  Score=300.11  Aligned_cols=250  Identities=24%  Similarity=0.393  Sum_probs=201.1

Q ss_pred             CCccccccCcCCceEEEEEEcCCCC-EEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecCC
Q 009340          217 NYNQSRFLGQGGFGTVYKGMLPDGS-IVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYIS  295 (537)
Q Consensus       217 ~~~~~~~lg~G~~g~Vy~~~~~~g~-~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  295 (537)
                      .|.+...||.|+||.||+++.++.. ..|-|.+.-.+....++|+-|++||+...||+||+|++.+...+.+++..|||.
T Consensus        33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~  112 (1187)
T KOG0579|consen   33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG  112 (1187)
T ss_pred             HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence            3444567999999999999976533 456677766677888999999999999999999999999999999999999999


Q ss_pred             CCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCcc
Q 009340          296 SGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISR  375 (537)
Q Consensus       296 ~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~  375 (537)
                      +|-.+..+....           ..|+..++.-++.|++.||.|||++.   |+|||||+.|||++-+|.++++|||.+.
T Consensus       113 GGAVDaimlEL~-----------r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSA  178 (1187)
T KOG0579|consen  113 GGAVDAIMLELG-----------RVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSA  178 (1187)
T ss_pred             CchHhHHHHHhc-----------cccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccc
Confidence            999998887643           47999999999999999999999999   9999999999999999999999999975


Q ss_pred             ccCCCCCceeeeccccccccCccccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhc
Q 009340          376 SIPNDKTHLTTTIQGTFGYLDPEYFQ-----SSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKEN  450 (537)
Q Consensus       376 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  450 (537)
                      ..... ........||+.|||||+..     ..+|+.++||||||+.|.||..+.+|.....      ....+...... 
T Consensus       179 Kn~~t-~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHheln------pMRVllKiaKS-  250 (1187)
T KOG0579|consen  179 KNKST-RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELN------PMRVLLKIAKS-  250 (1187)
T ss_pred             cchhH-HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccc------hHHHHHHHhhc-
Confidence            43221 22345678999999999864     4679999999999999999999999954321      11111111110 


Q ss_pred             hhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          451 QLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       451 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                           -.|.+.  .|...+..+.+++.+||..||+.||++.++++
T Consensus       251 -----ePPTLl--qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  251 -----EPPTLL--QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             -----CCCccc--CcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence                 011122  24445667889999999999999999999874

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.3e-34  Score=294.99  Aligned_cols=258  Identities=23%  Similarity=0.356  Sum_probs=196.9

Q ss_pred             HhcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCC--ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCc----
Q 009340          214 ATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI--DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEV----  286 (537)
Q Consensus       214 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~----  286 (537)
                      ..++|...+.||+|+||.||+|+.. +++.||+|++...  .......+.+|+.+++.++|+|++++.+++...+.    
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            4578999999999999999999975 5789999988642  23345667889999999999999999998876554    


Q ss_pred             --cEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCC
Q 009340          287 --PVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF  364 (537)
Q Consensus       287 --~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~  364 (537)
                        .++|+||+ +++|.+++..             ..+++..+..++.|+++||.|||+.+   ++||||+|+||++++++
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~~-------------~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~  155 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVKC-------------QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDC  155 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCC
Confidence              79999998 5689888853             25899999999999999999999998   99999999999999999


Q ss_pred             cEEEeeccCccccCCCCCceeeeccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHH
Q 009340          365 SAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQS-SQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACF  443 (537)
Q Consensus       365 ~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~  443 (537)
                      .++|+|||++......    .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+.   ....
T Consensus       156 ~~kL~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~---~~~i  228 (343)
T cd07851         156 ELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQ---LKRI  228 (343)
T ss_pred             CEEEcccccccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH---HHHH
Confidence            9999999999865432    233457888999999865 3678999999999999999999999864432211   1111


Q ss_pred             HHHH-----------hhchhhhhhcHHh---hc---cccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          444 ISLA-----------KENQLLEILDARV---AK---EAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       444 ~~~~-----------~~~~~~~~~d~~~---~~---~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      ....           ........+....   ..   ......+..+.+++.+||+.+|++|||+.+|+.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         229 MNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             HHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence            1100           0000000000000   00   001123567899999999999999999999875

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-36  Score=323.51  Aligned_cols=252  Identities=27%  Similarity=0.406  Sum_probs=199.6

Q ss_pred             HHhcCCccccccCcCCceEEEEEE-cCCCCEEEEEEccC--CChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEE
Q 009340          213 RATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKE--IDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVL  289 (537)
Q Consensus       213 ~~~~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  289 (537)
                      ..+-++....+||.|.||.||.+. ..+|+..|+|.++.  ..........+|+.++..++|||+|+++|+=.+++..+|
T Consensus      1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred             cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHH
Confidence            344566778899999999999998 56799999997654  333445667899999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEe
Q 009340          290 VYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVS  369 (537)
Q Consensus       290 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~  369 (537)
                      .||||++|+|.+.+...+            ..++.....+..|++.|++|||+++   ||||||||.||+|+.+|.+|.+
T Consensus      1312 FMEyC~~GsLa~ll~~gr------------i~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~ 1376 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEHGR------------IEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYG 1376 (1509)
T ss_pred             HHHHhccCcHHHHHHhcc------------hhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEee
Confidence            999999999999997632            3566666778899999999999999   9999999999999999999999


Q ss_pred             eccCccccCCCCCc---eeeeccccccccCcccccCCC---CCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHH
Q 009340          370 DFGISRSIPNDKTH---LTTTIQGTFGYLDPEYFQSSQ---FTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACF  443 (537)
Q Consensus       370 Dfgla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~---~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~  443 (537)
                      |||.|..+......   ......||+-|||||.+.+..   ..-++||||+|||++||+||++||...+.+-   .   .
T Consensus      1377 DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~---a---I 1450 (1509)
T KOG4645|consen 1377 DFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEW---A---I 1450 (1509)
T ss_pred             cccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchh---H---H
Confidence            99999877544211   123567999999999997643   3458999999999999999999985432210   0   0


Q ss_pred             HHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHH
Q 009340          444 ISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVS  494 (537)
Q Consensus       444 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~  494 (537)
                      .-....+.         ....|...+.+-.+++.+||+.||++|=++.|++
T Consensus      1451 My~V~~gh---------~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qll 1492 (1509)
T KOG4645|consen 1451 MYHVAAGH---------KPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLL 1492 (1509)
T ss_pred             HhHHhccC---------CCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHH
Confidence            11111111         2234555677888999999999999997666554

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=9.8e-35  Score=294.28  Aligned_cols=248  Identities=29%  Similarity=0.408  Sum_probs=206.3

Q ss_pred             hcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCC--ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEE
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI--DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY  291 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  291 (537)
                      ...|.....||+|.|+.|.+++.. .|..||||.+.+.  +......+.+|+++|..++|||||+++.+......+|+||
T Consensus        55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~  134 (596)
T KOG0586|consen   55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM  134 (596)
T ss_pred             ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence            568888999999999999999954 6899999988763  3344456899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeec
Q 009340          292 EYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF  371 (537)
Q Consensus       292 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Df  371 (537)
                      ||+.+|.+.+++..+..            +.......++.|+.++++|+|+++   |||||||++||||+.+.++||+||
T Consensus       135 eya~~ge~~~yl~~~gr------------~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDf  199 (596)
T KOG0586|consen  135 EYASGGELFDYLVKHGR------------MKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADF  199 (596)
T ss_pred             EeccCchhHHHHHhccc------------chhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeecc
Confidence            99999999999988643            556788899999999999999999   999999999999999999999999


Q ss_pred             cCccccCCCCCceeeeccccccccCcccccCCCC-CcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhc
Q 009340          372 GISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQF-TDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKEN  450 (537)
Q Consensus       372 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  450 (537)
                      |++..+..  .....+.+|++.|.|||++.+..| ++++|+||+|++||-|++|..||+.....+...            
T Consensus       200 gfS~~~~~--~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~------------  265 (596)
T KOG0586|consen  200 GFSTFFDY--GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRP------------  265 (596)
T ss_pred             ccceeecc--cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccc------------
Confidence            99988753  344567789999999999998776 479999999999999999999997554332110            


Q ss_pred             hhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHH
Q 009340          451 QLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSME  496 (537)
Q Consensus       451 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~  496 (537)
                         ..+-..++  .+.-.+.++-++++++|-.+|.+|+++++|.+-
T Consensus       266 ---rvl~gk~r--Ip~~ms~dce~lLrk~lvl~Pskr~~~dqim~~  306 (596)
T KOG0586|consen  266 ---RVLRGKYR--IPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD  306 (596)
T ss_pred             ---hheeeeec--ccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence               01111111  122223457789999999999999999999654

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.2e-34  Score=276.17  Aligned_cols=236  Identities=32%  Similarity=0.420  Sum_probs=193.2

Q ss_pred             cCcCCceEEEEEEcC-CCCEEEEEEccCCC---hHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecCCCCCh
Q 009340          224 LGQGGFGTVYKGMLP-DGSIVAVKRSKEID---KTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTL  299 (537)
Q Consensus       224 lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL  299 (537)
                      ||+|+||.||++... +++.+|+|.+....   ......+.+|+.++++++|+|++++++.+......++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            699999999999965 58899999876532   23456789999999999999999999999999999999999999999


Q ss_pred             hhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCccccCC
Q 009340          300 SHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPN  379 (537)
Q Consensus       300 ~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~  379 (537)
                      .+++...            ..+++..+..++.|+++||.|||+.+   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 ~~~l~~~------------~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~  145 (250)
T cd05123          81 FSHLSKE------------GRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSS  145 (250)
T ss_pred             HHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceeccc
Confidence            9998653            25899999999999999999999988   99999999999999999999999999987643


Q ss_pred             CCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchhhhhhcHH
Q 009340          380 DKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEILDAR  459 (537)
Q Consensus       380 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  459 (537)
                      .. .......++..|+|||...+...+.++|+||||+++|||++|+.||.......      .......           
T Consensus       146 ~~-~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~------~~~~~~~-----------  207 (250)
T cd05123         146 EG-SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE------IYEKILK-----------  207 (250)
T ss_pred             CC-CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH------HHHHHhc-----------
Confidence            32 12234557889999999988889999999999999999999999986443211      0111100           


Q ss_pred             hhccccHHHHHHHHHHHHHhcccCCCCCCCHhh
Q 009340          460 VAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQ  492 (537)
Q Consensus       460 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  492 (537)
                      .....+......+.+++.+||..||++||++.+
T Consensus       208 ~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         208 DPLRFPEFLSPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             CCCCCCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence            011223333567889999999999999999965

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=5.8e-35  Score=314.00  Aligned_cols=255  Identities=26%  Similarity=0.438  Sum_probs=187.3

Q ss_pred             HHHhcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCC-ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeC-----
Q 009340          212 QRATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI-DKTQIHQFINEVVILSQINHRHIVKLLGCCLET-----  284 (537)
Q Consensus       212 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----  284 (537)
                      .+-..+|+..+.||+||||.||+++.+ ||+.+|||++... +........+|+..+++|+|||||+++....+.     
T Consensus       475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~  554 (1351)
T KOG1035|consen  475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT  554 (1351)
T ss_pred             hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence            456678999999999999999999955 8999999998653 445567788999999999999999986532110     


Q ss_pred             --------------------------------------------------------------------------------
Q 009340          285 --------------------------------------------------------------------------------  284 (537)
Q Consensus       285 --------------------------------------------------------------------------------  284 (537)
                                                                                                      
T Consensus       555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS  634 (1351)
T KOG1035|consen  555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS  634 (1351)
T ss_pred             cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence                                                                                            


Q ss_pred             ----------------------------------CccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHH
Q 009340          285 ----------------------------------EVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVA  330 (537)
Q Consensus       285 ----------------------------------~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~  330 (537)
                                                        ...|+=||||+..+|.++++.+.-.           -.-...++++
T Consensus       635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~-----------~~~d~~wrLF  703 (1351)
T KOG1035|consen  635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN-----------SQRDEAWRLF  703 (1351)
T ss_pred             ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc-----------hhhHHHHHHH
Confidence                                              0125667777776666666543210           0345678999


Q ss_pred             HHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCccccC-----------------CCCCceeeecccccc
Q 009340          331 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIP-----------------NDKTHLTTTIQGTFG  393 (537)
Q Consensus       331 ~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~-----------------~~~~~~~~~~~gt~~  393 (537)
                      .+|++||.|+|+.+   ||||||||.||+||++..+||+|||++....                 .......+..+||.-
T Consensus       704 reIlEGLaYIH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTal  780 (1351)
T KOG1035|consen  704 REILEGLAYIHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTAL  780 (1351)
T ss_pred             HHHHHHHHHHHhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceee
Confidence            99999999999999   9999999999999999999999999998621                 011112355679999


Q ss_pred             ccCcccccCC---CCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchhhhhhcHHhhccccHHHHH
Q 009340          394 YLDPEYFQSS---QFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIG  470 (537)
Q Consensus       394 y~aPE~~~~~---~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~  470 (537)
                      |+|||.+.+.   .|+.|+|+||+|||++||+.   ||......-     . ....++.+.+..-      ........+
T Consensus       781 YvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa-----~-iL~~LR~g~iP~~------~~f~~~~~~  845 (1351)
T KOG1035|consen  781 YVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERA-----S-ILTNLRKGSIPEP------ADFFDPEHP  845 (1351)
T ss_pred             eecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCchHHHH-----H-HHHhcccCCCCCC------cccccccch
Confidence            9999999765   49999999999999999986   454332211     0 1111122222111      111223334


Q ss_pred             HHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          471 AMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       471 ~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      .-..++.++++.||++|||+.|++.
T Consensus       846 ~e~slI~~Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  846 EEASLIRWLLSHDPSKRPTATELLN  870 (1351)
T ss_pred             HHHHHHHHHhcCCCccCCCHHHHhh
Confidence            5568999999999999999999874

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=7.8e-35  Score=267.00  Aligned_cols=246  Identities=23%  Similarity=0.374  Sum_probs=194.8

Q ss_pred             ccccCcCCceEEEEEEcC-CCCEEEEEEccC-CChHHHHHHHHHHHHHHhcC-CCCcceEeeEEeeCCccEEEEecCCCC
Q 009340          221 SRFLGQGGFGTVYKGMLP-DGSIVAVKRSKE-IDKTQIHQFINEVVILSQIN-HRHIVKLLGCCLETEVPVLVYEYISSG  297 (537)
Q Consensus       221 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~~g  297 (537)
                      ...||.|..|.||+.+.+ .|...|||.+.. .+++..++++..++++..-+ .|.||+.+|||..+...++.||.|.. 
T Consensus        97 l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~-  175 (391)
T KOG0983|consen   97 LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMST-  175 (391)
T ss_pred             HHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHH-
Confidence            456999999999999975 589999999876 45677788888998888775 89999999999999999999998854 


Q ss_pred             ChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCcccc
Q 009340          298 TLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI  377 (537)
Q Consensus       298 sL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~  377 (537)
                      .++.++...           ..++++..+=++...+.+||.||.+++.  |+|||+||+|||+|+.|++|+||||++-.+
T Consensus       176 C~ekLlkri-----------k~piPE~ilGk~tva~v~AL~YLKeKH~--viHRDvKPSNILlDe~GniKlCDFGIsGrl  242 (391)
T KOG0983|consen  176 CAEKLLKRI-----------KGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGNIKLCDFGISGRL  242 (391)
T ss_pred             HHHHHHHHh-----------cCCchHHhhhhhHHHHHHHHHHHHHhcc--eeecccCccceEEccCCCEEeeccccccee
Confidence            455555543           2368888888999999999999988764  999999999999999999999999999877


Q ss_pred             CCCCCceeeeccccccccCcccccC---CCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchhhh
Q 009340          378 PNDKTHLTTTIQGTFGYLDPEYFQS---SQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLE  454 (537)
Q Consensus       378 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  454 (537)
                      -++..  .+...|.+.|||||.+.-   ..|+-++||||||+.|+||.||+.|+..-..+-+      .....-+     
T Consensus       243 vdSkA--htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe------~ltkvln-----  309 (391)
T KOG0983|consen  243 VDSKA--HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFE------VLTKVLN-----  309 (391)
T ss_pred             ecccc--cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHH------HHHHHHh-----
Confidence            55433  345568999999999864   4688999999999999999999999865332211      1111110     


Q ss_pred             hhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          455 ILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       455 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      ..-+.+.  .....++.+.+++..||+.|+.+||...++++
T Consensus       310 ~ePP~L~--~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~  348 (391)
T KOG0983|consen  310 EEPPLLP--GHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE  348 (391)
T ss_pred             cCCCCCC--cccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence            0011121  12336788999999999999999999988865

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-34  Score=268.08  Aligned_cols=267  Identities=24%  Similarity=0.356  Sum_probs=203.2

Q ss_pred             CHHHHHHHhcCCccccccCcCCceEEEEEE-cCCCCEEEEEEccCCChHHHHHHHHHHHHHHhcC-CCCcceEeeEEeeC
Q 009340          207 TADELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQFINEVVILSQIN-HRHIVKLLGCCLET  284 (537)
Q Consensus       207 ~~~el~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~  284 (537)
                      ++.++.+.|     .+.||+|+|+.|-..+ +.+|..+|||++.........+..+|++++.+.+ |+||+.|+++++++
T Consensus        74 ~F~d~YkLt-----~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd  148 (463)
T KOG0607|consen   74 KFEDMYKLT-----SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD  148 (463)
T ss_pred             hHHHHHHhH-----HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence            467777777     4679999999998877 6689999999998876677888999999999994 99999999999999


Q ss_pred             CccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCC
Q 009340          285 EVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF  364 (537)
Q Consensus       285 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~  364 (537)
                      ...|||||.|.+|+|..+++..            ..+++.++.++..+||.||.|||.++   |.|||+||+|||.....
T Consensus       149 ~~FYLVfEKm~GGplLshI~~~------------~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn  213 (463)
T KOG0607|consen  149 TRFYLVFEKMRGGPLLSHIQKR------------KHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPN  213 (463)
T ss_pred             ceEEEEEecccCchHHHHHHHh------------hhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCC
Confidence            9999999999999999999874            46999999999999999999999999   99999999999996543


Q ss_pred             ---cEEEeeccCccccC--CCCC----ceeeeccccccccCccccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCc
Q 009340          365 ---SAKVSDFGISRSIP--NDKT----HLTTTIQGTFGYLDPEYFQ-----SSQFTDKSDVYSFGVVLLELLTGKKPICF  430 (537)
Q Consensus       365 ---~~ki~Dfgla~~~~--~~~~----~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~S~Gvll~el~tg~~p~~~  430 (537)
                         -+||+||.|.....  .+-+    ....+.+|+..|||||+..     ...|+.+.|.||+|||||-|++|..||..
T Consensus       214 ~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG  293 (463)
T KOG0607|consen  214 KVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVG  293 (463)
T ss_pred             CcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccC
Confidence               48999999976442  1111    1123456888999999863     23588899999999999999999999975


Q ss_pred             cchhhhccHHHHHHHHHhhchhhhhhcHHhhccccHH----HHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          431 ARVEEERNLVACFISLAKENQLLEILDARVAKEAREE----DIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       431 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~----~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      ....+-.--....-+.- +..+.+.+..... ++|..    .+.+..+++...+..++.+|-++.+++.
T Consensus       294 ~Cg~dCGWdrGe~Cr~C-Q~~LFesIQEGkY-eFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  294 HCGADCGWDRGEVCRVC-QNKLFESIQEGKY-EFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             ccCCcCCccCCCccHHH-HHHHHHHHhccCC-cCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence            43321000000000000 0112222221111 22322    3455668888889999999999998876

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=3e-34  Score=267.48  Aligned_cols=205  Identities=25%  Similarity=0.390  Sum_probs=171.7

Q ss_pred             hcCCccccccCcCCceEEEEEEcC---C--CCEEEEEEccCCCh--HHHHHHHHHHHHHHhcCCCCcceEeeEEee-CCc
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLP---D--GSIVAVKRSKEIDK--TQIHQFINEVVILSQINHRHIVKLLGCCLE-TEV  286 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~---~--g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~  286 (537)
                      ...|+...+||+|.||.||+++-.   +  ...+|+|+++....  .......+|+.+++.++|+|++.|..++.+ +..
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~  102 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK  102 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence            357788889999999999999733   2  23689999876422  223456789999999999999999999987 778


Q ss_pred             cEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCC---
Q 009340          287 PVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK---  363 (537)
Q Consensus       287 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~---  363 (537)
                      .+|++||.+. +|...++-+....       ...++-..+..|..||+.|+.|||++-   |+||||||.|||+..+   
T Consensus       103 v~l~fdYAEh-DL~~II~fHr~~~-------~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgpe  171 (438)
T KOG0666|consen  103 VWLLFDYAEH-DLWHIIKFHRASK-------AKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPE  171 (438)
T ss_pred             EEEEehhhhh-hHHHHHHHhccch-------hccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCc
Confidence            9999999988 8999998776532       246888999999999999999999999   9999999999999887   


Q ss_pred             -CcEEEeeccCccccCCCCCce--eeeccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCc
Q 009340          364 -FSAKVSDFGISRSIPNDKTHL--TTTIQGTFGYLDPEYFQS-SQFTDKSDVYSFGVVLLELLTGKKPICF  430 (537)
Q Consensus       364 -~~~ki~Dfgla~~~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~el~tg~~p~~~  430 (537)
                       |.+||+|||+++.+.+.-...  ...++-|+.|.|||.+.+ ..||.+.|||+.||++.||+|-++-|..
T Consensus       172 rG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g  242 (438)
T KOG0666|consen  172 RGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG  242 (438)
T ss_pred             cCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence             999999999999885543332  345678999999999876 5699999999999999999998877754

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=5.5e-33  Score=305.03  Aligned_cols=145  Identities=30%  Similarity=0.451  Sum_probs=130.8

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCC---ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI---DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY  291 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  291 (537)
                      ++|...++||+|+||.||+|... +++.||||+++..   .......+.+|+.++..++|+||+++++++......++||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            57888999999999999999975 6889999998642   2344567889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeec
Q 009340          292 EYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF  371 (537)
Q Consensus       292 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Df  371 (537)
                      ||+++++|.+++...            ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+||
T Consensus        84 Ey~~g~~L~~li~~~------------~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DF  148 (669)
T cd05610          84 EYLIGGDVKSLLHIY------------GYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDF  148 (669)
T ss_pred             eCCCCCCHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeC
Confidence            999999999998652            35889999999999999999999998   999999999999999999999999


Q ss_pred             cCcc
Q 009340          372 GISR  375 (537)
Q Consensus       372 gla~  375 (537)
                      |+++
T Consensus       149 Gls~  152 (669)
T cd05610         149 GLSK  152 (669)
T ss_pred             CCCc
Confidence            9985

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-34  Score=267.22  Aligned_cols=240  Identities=26%  Similarity=0.389  Sum_probs=199.6

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCCEEEEEEccC---CChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKE---IDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY  291 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  291 (537)
                      ++|+..++||+|.||.|-+.+-+ .|+.+|+|+++.   ..+.....-+.|-++|+..+||.+..+.-.+...+..++||
T Consensus       168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM  247 (516)
T KOG0690|consen  168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM  247 (516)
T ss_pred             chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence            68889999999999999999854 789999999986   34445555677889999999999999988889999999999


Q ss_pred             ecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeec
Q 009340          292 EYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF  371 (537)
Q Consensus       292 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Df  371 (537)
                      ||..+|.|.-+|...            ..+++......-..|..||.|||+.+   ||.||||.+|.|||.+|.+||+||
T Consensus       248 eyanGGeLf~HLsre------------r~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDF  312 (516)
T KOG0690|consen  248 EYANGGELFFHLSRE------------RVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDF  312 (516)
T ss_pred             EEccCceEeeehhhh------------hcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeec
Confidence            999999999888763            35788888889999999999999998   999999999999999999999999


Q ss_pred             cCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhch
Q 009340          372 GISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQ  451 (537)
Q Consensus       372 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  451 (537)
                      ||++.--.. ...+.+.+||+.|+|||++....|..++|.|.+||++|||++|+.||+..+.+.-      |.-+     
T Consensus       313 GLCKE~I~~-g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kL------FeLI-----  380 (516)
T KOG0690|consen  313 GLCKEEIKY-GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKL------FELI-----  380 (516)
T ss_pred             ccchhcccc-cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHH------HHHH-----
Confidence            999854222 2345678999999999999999999999999999999999999999986543321      1111     


Q ss_pred             hhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCC
Q 009340          452 LLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRP  488 (537)
Q Consensus       452 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP  488 (537)
                          +-..+  ..|...+++...|+...|..||.+|.
T Consensus       381 ----l~ed~--kFPr~ls~eAktLLsGLL~kdP~kRL  411 (516)
T KOG0690|consen  381 ----LMEDL--KFPRTLSPEAKTLLSGLLKKDPKKRL  411 (516)
T ss_pred             ----Hhhhc--cCCccCCHHHHHHHHHHhhcChHhhc
Confidence                11111  13445556778899999999999995

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=6.9e-33  Score=290.09  Aligned_cols=274  Identities=20%  Similarity=0.223  Sum_probs=186.1

Q ss_pred             HhcCCccccccCcCCceEEEEEEc-----------------CCCCEEEEEEccCCChHHHHHHH--------------HH
Q 009340          214 ATDNYNQSRFLGQGGFGTVYKGML-----------------PDGSIVAVKRSKEIDKTQIHQFI--------------NE  262 (537)
Q Consensus       214 ~~~~~~~~~~lg~G~~g~Vy~~~~-----------------~~g~~vavK~~~~~~~~~~~~~~--------------~E  262 (537)
                      ..++|+..++||+|+||.||+|.+                 ..++.||||++........++|.              .|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            367899999999999999999964                 23568999998754433333343              46


Q ss_pred             HHHHHhcCCCCc-----ceEeeEEee--------CCccEEEEecCCCCChhhhhhhhhhhHH-----H-------Hhhhc
Q 009340          263 VVILSQINHRHI-----VKLLGCCLE--------TEVPVLVYEYISSGTLSHHIHDHQQQQE-----Q-------KQKQE  317 (537)
Q Consensus       263 ~~~l~~l~H~ni-----v~l~g~~~~--------~~~~~lV~e~~~~gsL~~~l~~~~~~~~-----~-------~~~~~  317 (537)
                      +.++.+++|.++     ++++++|..        .+..+|||||+++|+|.++++.......     .       .....
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            777777766554     778888763        3467999999999999999986422100     0       00001


Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCccccCCCCCceeeeccccccccCc
Q 009340          318 LSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDP  397 (537)
Q Consensus       318 ~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aP  397 (537)
                      ...++|..+..++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||++...............+|+.|+||
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP  379 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP  379 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence            234688999999999999999999998   99999999999999999999999999976543322222223457899999


Q ss_pred             ccccCCCC----------------------CcchhHHHHHHHHHHHHhCCC-CCCccchh-hhccHHHHHHHHHhhchhh
Q 009340          398 EYFQSSQF----------------------TDKSDVYSFGVVLLELLTGKK-PICFARVE-EERNLVACFISLAKENQLL  453 (537)
Q Consensus       398 E~~~~~~~----------------------t~ksDV~S~Gvll~el~tg~~-p~~~~~~~-~~~~~~~~~~~~~~~~~~~  453 (537)
                      |.+.....                      ..+.||||+||+++||++|.. |+...... ............+.     
T Consensus       380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r-----  454 (507)
T PLN03224        380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWR-----  454 (507)
T ss_pred             hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHH-----
Confidence            98754321                      135799999999999999875 55321110 00000000000000     


Q ss_pred             hhhcHHhhccccHHHHHHHHHHHHHhcccCC---CCCCCHhhHHH
Q 009340          454 EILDARVAKEAREEDIGAMAELAMRCLRLNS---KKRPTMKQVSM  495 (537)
Q Consensus       454 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p---~~RPs~~ev~~  495 (537)
                      .+.......+..........+|+.++|..+|   .+|+|+.|+++
T Consensus       455 ~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        455 MYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             hhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence            0000111111223345678899999999766   68999999874

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=4.4e-33  Score=268.55  Aligned_cols=222  Identities=22%  Similarity=0.216  Sum_probs=177.6

Q ss_pred             CCceEEEEEEcC-CCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecCCCCChhhhhhh
Q 009340          227 GGFGTVYKGMLP-DGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHD  305 (537)
Q Consensus       227 G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~  305 (537)
                      |.||.||++... +++.||+|+++...     .+.+|...+....|||++++++++.+.+..++||||+++|+|.+++..
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            889999999954 78899999987532     233455555666799999999999999999999999999999999865


Q ss_pred             hhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCccccCCCCCcee
Q 009340          306 HQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLT  385 (537)
Q Consensus       306 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~  385 (537)
                      .            ..+++..+..++.|+++||.|||+.+   ++||||||+||+++.++.++++|||++......    .
T Consensus        79 ~------------~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~  139 (237)
T cd05576          79 F------------LNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----C  139 (237)
T ss_pred             h------------cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc----c
Confidence            2            25899999999999999999999998   999999999999999999999999987655332    1


Q ss_pred             eeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchhhhhhcHHhhcccc
Q 009340          386 TTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEILDARVAKEAR  465 (537)
Q Consensus       386 ~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  465 (537)
                      ....++..|+|||.+....++.++||||+|+++|||++|+.|+.......            ..         ......+
T Consensus       140 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------------~~---------~~~~~~~  198 (237)
T cd05576         140 DGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------------NT---------HTTLNIP  198 (237)
T ss_pred             ccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------------cc---------ccccCCc
Confidence            22345678999999988889999999999999999999998764321100            00         0001122


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHhhH
Q 009340          466 EEDIGAMAELAMRCLRLNSKKRPTMKQV  493 (537)
Q Consensus       466 ~~~~~~l~~l~~~cl~~~p~~RPs~~ev  493 (537)
                      ......+.+++.+||+.||++||++.+.
T Consensus       199 ~~~~~~~~~li~~~l~~dp~~R~~~~~~  226 (237)
T cd05576         199 EWVSEEARSLLQQLLQFNPTERLGAGVA  226 (237)
T ss_pred             ccCCHHHHHHHHHHccCCHHHhcCCCcc
Confidence            3344678899999999999999998544

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=1.2e-32  Score=264.81  Aligned_cols=238  Identities=29%  Similarity=0.416  Sum_probs=192.6

Q ss_pred             CceEEEEEEcC-CCCEEEEEEccCCChHH-HHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecCCCCChhhhhhh
Q 009340          228 GFGTVYKGMLP-DGSIVAVKRSKEIDKTQ-IHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHD  305 (537)
Q Consensus       228 ~~g~Vy~~~~~-~g~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~  305 (537)
                      +||.||+|+.. +|+.+|+|++....... .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999976 48999999987654433 67899999999999999999999999999999999999999999999865


Q ss_pred             hhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCccccCCCCCcee
Q 009340          306 HQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLT  385 (537)
Q Consensus       306 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~  385 (537)
                      .            ..+++..++.++.++++++.|||+.+   ++|+||+|+||++++++.++|+|||.+.......  ..
T Consensus        81 ~------------~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~  143 (244)
T smart00220       81 R------------GRLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LL  143 (244)
T ss_pred             c------------cCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc--cc
Confidence            2            23889999999999999999999998   9999999999999999999999999998765432  23


Q ss_pred             eeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchhhhhhcHHhhcccc
Q 009340          386 TTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEILDARVAKEAR  465 (537)
Q Consensus       386 ~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  465 (537)
                      ....++..|++||.+....++.++||||||+++++|++|..|+......+  .    ...........       .....
T Consensus       144 ~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~--~----~~~~~~~~~~~-------~~~~~  210 (244)
T smart00220      144 TTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL--E----LFKKIGKPKPP-------FPPPE  210 (244)
T ss_pred             ccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH--H----HHHHHhccCCC-------Ccccc
Confidence            34557889999999998889999999999999999999999986521111  0    11111111000       00000


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          466 EEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       466 ~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      ......+.+++.+||..+|++||++.++++
T Consensus       211 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      211 WKISPEAKDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             ccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence            004467889999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-34  Score=264.65  Aligned_cols=262  Identities=26%  Similarity=0.341  Sum_probs=197.2

Q ss_pred             cccCHHHHHHHhcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCCh-HHHHHHHHHHHHHHhc-CCCCcceEeeE
Q 009340          204 KVFTADELQRATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDK-TQIHQFINEVVILSQI-NHRHIVKLLGC  280 (537)
Q Consensus       204 ~~~~~~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g~  280 (537)
                      ..|+.+.|+.       ...||.|.||+|+|-..+ .|+..|||+++.... ...++++.|.+...+- +.||||+++|.
T Consensus        59 ~~F~~~~Lqd-------lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa  131 (361)
T KOG1006|consen   59 HTFTSDNLQD-------LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGA  131 (361)
T ss_pred             cccccchHHH-------HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhh
Confidence            4466666554       457999999999998864 799999999886443 5567788888765554 78999999999


Q ss_pred             EeeCCccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEE
Q 009340          281 CLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILL  360 (537)
Q Consensus       281 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll  360 (537)
                      +..++..|+.||.|+- ||+.+...--...       ...+++.-.-.|+...+.||.||.+.-.  |+|||+||+||||
T Consensus       132 ~F~EGdcWiCMELMd~-SlDklYk~vy~vq-------~~~ipE~Ilg~ItvatV~AL~yLK~~lk--iIHRDvKPSNILl  201 (361)
T KOG1006|consen  132 LFSEGDCWICMELMDI-SLDKLYKRVYSVQ-------KSRIPENILGHITVATVDALDYLKEELK--IIHRDVKPSNILL  201 (361)
T ss_pred             hhcCCceeeeHHHHhh-hHHHHHHHHHHHH-------hccCcHhhhhheeeeehhHHHHHHHHhh--hhhccCChhheEE
Confidence            9999999999999965 7765544322211       2468888888999999999999987653  9999999999999


Q ss_pred             CCCCcEEEeeccCccccCCCCCceeeeccccccccCcccccCC--CCCcchhHHHHHHHHHHHHhCCCCCCccchhhhcc
Q 009340          361 DDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSS--QFTDKSDVYSFGVVLLELLTGKKPICFARVEEERN  438 (537)
Q Consensus       361 ~~~~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~  438 (537)
                      |..|.+|+||||.+-.+..  +...+...|...|||||.+...  .|+-+|||||+|+.|+|+.||+.|+.....     
T Consensus       202 dr~G~vKLCDFGIcGqLv~--SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----  274 (361)
T KOG1006|consen  202 DRHGDVKLCDFGICGQLVD--SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----  274 (361)
T ss_pred             ecCCCEeeecccchHhHHH--HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----
Confidence            9999999999999977633  2334556688999999998643  488999999999999999999999743211     


Q ss_pred             HHHHHHHHHhhchhhhhhcHH-hhcc-ccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHH
Q 009340          439 LVACFISLAKENQLLEILDAR-VAKE-AREEDIGAMAELAMRCLRLNSKKRPTMKQVSME  496 (537)
Q Consensus       439 ~~~~~~~~~~~~~~~~~~d~~-~~~~-~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~  496 (537)
                      +.+.+.....       -|+. +..+ -....+..+..++.-|+.+|.++||...++.++
T Consensus       275 vfeql~~Vv~-------gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  275 VFEQLCQVVI-------GDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             HHHHHHHHHc-------CCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence            1111111111       1111 1111 113456789999999999999999999998654

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-33  Score=241.03  Aligned_cols=263  Identities=21%  Similarity=0.326  Sum_probs=196.5

Q ss_pred             CCccccccCcCCceEEEEEEc-CCCCEEEEEEccCC--ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEec
Q 009340          217 NYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEI--DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY  293 (537)
Q Consensus       217 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  293 (537)
                      +|...++||+|.||+||+|+. ..++.||+|+++..  +...-...++|+-+++.++|+|||+++++...+...-||+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            455668899999999999994 46889999987643  333456678999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccC
Q 009340          294 ISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGI  373 (537)
Q Consensus       294 ~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgl  373 (537)
                      |+. +|..+.....           ..++......++.|+++||.|.|+++   +.|||+||.|.|++.+|+.|++|||+
T Consensus        83 cdq-dlkkyfdsln-----------g~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfgl  147 (292)
T KOG0662|consen   83 CDQ-DLKKYFDSLN-----------GDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGL  147 (292)
T ss_pred             hhH-HHHHHHHhcC-----------CcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccch
Confidence            976 7888776543           36888999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCCceeeeccccccccCcccccCC-CCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHHHHHhhch
Q 009340          374 SRSIPNDKTHLTTTIQGTFGYLDPEYFQSS-QFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQ  451 (537)
Q Consensus       374 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  451 (537)
                      ++.++-.-.. ....+-|..|.+|..+.+. .|+...|+||-||++.|+.. |++-|...+..+....+-+......++.
T Consensus       148 arafgipvrc-ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~  226 (292)
T KOG0662|consen  148 ARAFGIPVRC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQ  226 (292)
T ss_pred             hhhcCCceEe-eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCcccc
Confidence            9987543221 2344579999999998764 58899999999999999998 5555544433332211111111111111


Q ss_pred             ---hhhhhcHHhhcccc---------HHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          452 ---LLEILDARVAKEAR---------EEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       452 ---~~~~~d~~~~~~~~---------~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                         +....|-.....++         +.....-.+|+...+.-+|..|.++++.++
T Consensus       227 wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  227 WPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             CCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence               11112211111111         112234567888899999999999987754

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-33  Score=299.72  Aligned_cols=259  Identities=23%  Similarity=0.341  Sum_probs=211.3

Q ss_pred             CHHHHHHHhcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccC---CChHHHHHHHHHHHHHHhcCCCCcceEeeEEe
Q 009340          207 TADELQRATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKE---IDKTQIHQFINEVVILSQINHRHIVKLLGCCL  282 (537)
Q Consensus       207 ~~~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~  282 (537)
                      ...+++...++|.+.++||+|+||.|...+.+ .++.+|.|++..   .......-|..|-.+|..-+.+-|+.+.-.|.
T Consensus        66 ~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQ  145 (1317)
T KOG0612|consen   66 KVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQ  145 (1317)
T ss_pred             HHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhc
Confidence            44566666789999999999999999999975 588999999876   22334556888999999999999999999999


Q ss_pred             eCCccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECC
Q 009340          283 ETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD  362 (537)
Q Consensus       283 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~  362 (537)
                      +...+|+|||||+||+|..++...            ..++...+..++..|+-||.-||+.|   +|||||||.|||||.
T Consensus       146 D~~~LYlVMdY~pGGDlltLlSk~------------~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~  210 (1317)
T KOG0612|consen  146 DERYLYLVMDYMPGGDLLTLLSKF------------DRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDK  210 (1317)
T ss_pred             CccceEEEEecccCchHHHHHhhc------------CCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecc
Confidence            999999999999999999999763            35889999999999999999999999   999999999999999


Q ss_pred             CCcEEEeeccCccccCCCCCceeeeccccccccCccccc----C-CCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhc
Q 009340          363 KFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQ----S-SQFTDKSDVYSFGVVLLELLTGKKPICFARVEEER  437 (537)
Q Consensus       363 ~~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~  437 (537)
                      .|.+|++|||-+..+..++.-.....+|||.|++||++.    + +.|+..+|.||+||++|||+.|..||+....-   
T Consensus       211 ~GHikLADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslv---  287 (1317)
T KOG0612|consen  211 SGHIKLADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLV---  287 (1317)
T ss_pred             cCcEeeccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHH---
Confidence            999999999999888877777778889999999999984    2 57889999999999999999999999864332   


Q ss_pred             cHHHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCC---HhhHH
Q 009340          438 NLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPT---MKQVS  494 (537)
Q Consensus       438 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs---~~ev~  494 (537)
                         .-+..++.......+       +...+.+....+||.+.+ -+|+.|-.   +.++.
T Consensus       288 ---eTY~KIm~hk~~l~F-------P~~~~VSeeakdLI~~ll-~~~e~RLgrngiedik  336 (1317)
T KOG0612|consen  288 ---ETYGKIMNHKESLSF-------PDETDVSEEAKDLIEALL-CDREVRLGRNGIEDIK  336 (1317)
T ss_pred             ---HHHHHHhchhhhcCC-------CcccccCHHHHHHHHHHh-cChhhhcccccHHHHH
Confidence               222222222111111       111335667788888888 56778877   66664

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=4.3e-32  Score=290.99  Aligned_cols=267  Identities=21%  Similarity=0.278  Sum_probs=173.3

Q ss_pred             HhcCCccccccCcCCceEEEEEEcC-C----CCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeE------Ee
Q 009340          214 ATDNYNQSRFLGQGGFGTVYKGMLP-D----GSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGC------CL  282 (537)
Q Consensus       214 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~----g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~------~~  282 (537)
                      ..++|...++||+|+||.||+|+.. +    +..||||++.....  .+.+..|  .+.+..+.++..++..      +.
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            4578999999999999999999975 4    68999998765322  1112221  1222222333322211      23


Q ss_pred             eCCccEEEEecCCCCChhhhhhhhhhhHHHHh--------hhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCC
Q 009340          283 ETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQ--------KQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIK  354 (537)
Q Consensus       283 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~--------~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk  354 (537)
                      .....++||||+++++|.+++...........        ........+..+..++.|+++||.|||+.+   |+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence            45678999999999999999875421100000        000011223456689999999999999998   9999999


Q ss_pred             CCCEEECC-CCcEEEeeccCccccCCCCCceeeeccccccccCcccccCC----------------------CCCcchhH
Q 009340          355 SSNILLDD-KFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSS----------------------QFTDKSDV  411 (537)
Q Consensus       355 ~~NIll~~-~~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~t~ksDV  411 (537)
                      |+|||++. ++.+||+|||+++.+............+++.|+|||.+...                      .++.++||
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV  362 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI  362 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence            99999986 57999999999987655444444566789999999965322                      23456799


Q ss_pred             HHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhc-----hhhhhhcHHhhc------cccHHHHHHHHHHHHHhc
Q 009340          412 YSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKEN-----QLLEILDARVAK------EAREEDIGAMAELAMRCL  480 (537)
Q Consensus       412 ~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~d~~~~~------~~~~~~~~~l~~l~~~cl  480 (537)
                      |||||+||||+++..+.....        ..+...+...     .+...+.+....      +..........+|+.+||
T Consensus       363 wSlGviL~el~~~~~~~~~~~--------~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL  434 (566)
T PLN03225        363 YSAGLIFLQMAFPNLRSDSNL--------IQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMM  434 (566)
T ss_pred             HHHHHHHHHHHhCcCCCchHH--------HHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHc
Confidence            999999999999776643210        0011111100     001111111000      000111234568999999


Q ss_pred             ccCCCCCCCHhhHHH
Q 009340          481 RLNSKKRPTMKQVSM  495 (537)
Q Consensus       481 ~~~p~~RPs~~ev~~  495 (537)
                      +.||++|||+.++++
T Consensus       435 ~~dP~kR~ta~e~L~  449 (566)
T PLN03225        435 RFKGRQRISAKAALA  449 (566)
T ss_pred             cCCcccCCCHHHHhC
Confidence            999999999999986

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-33  Score=270.86  Aligned_cols=254  Identities=29%  Similarity=0.464  Sum_probs=195.7

Q ss_pred             CCccccccCcCCceEEEEEE-cCCCCEEEEEEccC--CChH-----HHHHHHHHHHHHHhcCCCCcceEeeEEe-eCCcc
Q 009340          217 NYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKE--IDKT-----QIHQFINEVVILSQINHRHIVKLLGCCL-ETEVP  287 (537)
Q Consensus       217 ~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~--~~~~-----~~~~~~~E~~~l~~l~H~niv~l~g~~~-~~~~~  287 (537)
                      +|-..++||+|||+.||++. +...+.||||+-..  ...+     ..+...+|.+|.+.+.||.||++++++. +.+..
T Consensus       464 RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsF  543 (775)
T KOG1151|consen  464 RYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSF  543 (775)
T ss_pred             HHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccc
Confidence            45556789999999999998 44678999997432  1111     2344678999999999999999999987 45678


Q ss_pred             EEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECC---CC
Q 009340          288 VLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD---KF  364 (537)
Q Consensus       288 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~---~~  364 (537)
                      +-|.||+++.+|+-+|..++            .++++++..|+.||+.||.||.+.. +||+|-||||.||||-+   -|
T Consensus       544 CTVLEYceGNDLDFYLKQhk------------lmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacG  610 (775)
T KOG1151|consen  544 CTVLEYCEGNDLDFYLKQHK------------LMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACG  610 (775)
T ss_pred             eeeeeecCCCchhHHHHhhh------------hhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccc
Confidence            88999999999999998754            5899999999999999999999875 67999999999999954   57


Q ss_pred             cEEEeeccCccccCCCCCc------eeeeccccccccCcccccC----CCCCcchhHHHHHHHHHHHHhCCCCCCccchh
Q 009340          365 SAKVSDFGISRSIPNDKTH------LTTTIQGTFGYLDPEYFQS----SQFTDKSDVYSFGVVLLELLTGKKPICFARVE  434 (537)
Q Consensus       365 ~~ki~Dfgla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~----~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~  434 (537)
                      .+||+||||++.+..+.+.      .+....||.+|++||.+.-    ...+.|+||||.||++|..+.|++||......
T Consensus       611 eIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ  690 (775)
T KOG1151|consen  611 EIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ  690 (775)
T ss_pred             eeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH
Confidence            8999999999988554432      3445679999999998743    35788999999999999999999999754322


Q ss_pred             hhccHHHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHH
Q 009340          435 EERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVS  494 (537)
Q Consensus       435 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~  494 (537)
                      .         .++....+...-.  ...+.-+..+.+...++.+||++.-++|....++.
T Consensus       691 Q---------dILqeNTIlkAtE--VqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA  739 (775)
T KOG1151|consen  691 Q---------DILQENTILKATE--VQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA  739 (775)
T ss_pred             H---------HHHhhhchhccee--ccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence            1         1122222111111  11122234456778899999999999998877764

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.98  E-value=1.6e-32  Score=279.68  Aligned_cols=239  Identities=24%  Similarity=0.336  Sum_probs=191.9

Q ss_pred             hcCCccccccCcCCceEEEEEEc-CCCCEEEEEEccCCChHHHHHHHHHHHHHHhc-CCCCcceEeeEEeeCCccEEEEe
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEIDKTQIHQFINEVVILSQI-NHRHIVKLLGCCLETEVPVLVYE  292 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e  292 (537)
                      ++.|.....+|.|+|+.|-++.. ..++..+||++.....    +-.+|+.++... +|+|++++.+.+.+....|+|||
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e  396 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME  396 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence            56777788899999999988885 4678899999876411    223567666655 79999999999999999999999


Q ss_pred             cCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEE-CCCCcEEEeec
Q 009340          293 YISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILL-DDKFSAKVSDF  371 (537)
Q Consensus       293 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll-~~~~~~ki~Df  371 (537)
                      .+.++-|.+.+.....            .. ..+..|+.+|+.++.|||+++   +|||||||+|||+ ++.++++|+||
T Consensus       397 ~l~g~ell~ri~~~~~------------~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyF  460 (612)
T KOG0603|consen  397 LLDGGELLRRIRSKPE------------FC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYF  460 (612)
T ss_pred             hccccHHHHHHHhcch------------hH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEe
Confidence            9999988877765322            22 677789999999999999999   9999999999999 58999999999


Q ss_pred             cCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhch
Q 009340          372 GISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQ  451 (537)
Q Consensus       372 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  451 (537)
                      |.++....+    ..+.+-|..|.|||.+....||+++|+||||++||+|++|+.||.....+.      ........  
T Consensus       461 G~a~~~~~~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~------ei~~~i~~--  528 (612)
T KOG0603|consen  461 GFWSELERS----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGI------EIHTRIQM--  528 (612)
T ss_pred             chhhhCchh----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchH------HHHHhhcC--
Confidence            999887554    233356889999999999999999999999999999999999987543321      01111111  


Q ss_pred             hhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          452 LLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       452 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                                .......+....+|+.+||+.||.+||+|.++..
T Consensus       529 ----------~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  529 ----------PKFSECVSDEAKDLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             ----------CccccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence                      1222455667889999999999999999999854

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=1e-32  Score=265.68  Aligned_cols=240  Identities=26%  Similarity=0.376  Sum_probs=197.2

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCC---ChHHHHHHHHHHHHHHhc-CCCCcceEeeEEeeCCccEEE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI---DKTQIHQFINEVVILSQI-NHRHIVKLLGCCLETEVPVLV  290 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV  290 (537)
                      .+|....+||+|+||.|.++.-+ ..+.+|||+++..   .....+--+.|-++|.-. +-|.++++..++..-+.+|.|
T Consensus       349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV  428 (683)
T KOG0696|consen  349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV  428 (683)
T ss_pred             cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence            47888999999999999999865 4567999998763   222233345677777766 568899999999999999999


Q ss_pred             EecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEee
Q 009340          291 YEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSD  370 (537)
Q Consensus       291 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~D  370 (537)
                      |||+.+|+|--++++.            ..+.++.+...|..||-||-+||+++   |+.||||..||+||.+|.+||+|
T Consensus       429 MEyvnGGDLMyhiQQ~------------GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~D  493 (683)
T KOG0696|consen  429 MEYVNGGDLMYHIQQV------------GKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIAD  493 (683)
T ss_pred             EEEecCchhhhHHHHh------------cccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeee
Confidence            9999999999998764            45888899999999999999999999   99999999999999999999999


Q ss_pred             ccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhc
Q 009340          371 FGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKEN  450 (537)
Q Consensus       371 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  450 (537)
                      ||+++.--.+. ..+.+.+||+.|+|||++...+|+..+|.|||||+||||+.|+.||+..+.++.      |.      
T Consensus       494 FGmcKEni~~~-~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~el------F~------  560 (683)
T KOG0696|consen  494 FGMCKENIFDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL------FQ------  560 (683)
T ss_pred             cccccccccCC-cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHH------HH------
Confidence            99998543222 235678999999999999999999999999999999999999999976544331      21      


Q ss_pred             hhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCC
Q 009340          451 QLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRP  488 (537)
Q Consensus       451 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP  488 (537)
                         .+.+...  .+|...+.+...+....+...|..|.
T Consensus       561 ---aI~ehnv--syPKslSkEAv~ickg~ltK~P~kRL  593 (683)
T KOG0696|consen  561 ---AIMEHNV--SYPKSLSKEAVAICKGLLTKHPGKRL  593 (683)
T ss_pred             ---HHHHccC--cCcccccHHHHHHHHHHhhcCCcccc
Confidence               2222222  35667777888899999999999994

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.98  E-value=3.7e-32  Score=284.18  Aligned_cols=261  Identities=21%  Similarity=0.406  Sum_probs=210.4

Q ss_pred             cCHHHHHHHhcCCccccccCcCCceEEEEEE-cCCCCEEEEEEccCCChHHHHHHHHHHHHHHhc-CCCCcceEeeEEee
Q 009340          206 FTADELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQFINEVVILSQI-NHRHIVKLLGCCLE  283 (537)
Q Consensus       206 ~~~~el~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~  283 (537)
                      ..++.+...++.|++.+.||.|.+|.||+++ .++|+.+|+|++..... ..++...|..+++.. +|||++.++|++..
T Consensus         9 ~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k   87 (953)
T KOG0587|consen    9 IDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIK   87 (953)
T ss_pred             cchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence            4455556677899999999999999999999 45789999998875432 335666788888888 79999999999864


Q ss_pred             -----CCccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCE
Q 009340          284 -----TEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNI  358 (537)
Q Consensus       284 -----~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NI  358 (537)
                           .+.+|||||||.+||..|+++....          ..+.|..+..|+..++.|+.+||...   ++|||||-.||
T Consensus        88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g----------~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~Ni  154 (953)
T KOG0587|consen   88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTKG----------NRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNV  154 (953)
T ss_pred             ecCCCCCeEEEEeeccCCccHHHHHhhhcc----------cchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceE
Confidence                 4678999999999999999987653          46999999999999999999999999   99999999999


Q ss_pred             EECCCCcEEEeeccCccccCCCCCceeeeccccccccCcccccCC-----CCCcchhHHHHHHHHHHHHhCCCCCCccch
Q 009340          359 LLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSS-----QFTDKSDVYSFGVVLLELLTGKKPICFARV  433 (537)
Q Consensus       359 ll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~t~ksDV~S~Gvll~el~tg~~p~~~~~~  433 (537)
                      |++.++.+|+.|||++..+.... ....+..||+.|||||++...     .|+.++|+||+|++..||--|.+|+....+
T Consensus       155 LLT~e~~VKLvDFGvSaQldsT~-grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP  233 (953)
T KOG0587|consen  155 LLTENAEVKLVDFGVSAQLDSTV-GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP  233 (953)
T ss_pred             EEeccCcEEEeeeeeeeeeeccc-ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch
Confidence            99999999999999998775433 334566799999999998643     477899999999999999999999754322


Q ss_pred             hhhccHHHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          434 EEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       434 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      -.         .++   .+....-+.+  ..+..-+.++.+++..||..|-..||++.++++
T Consensus       234 mr---------aLF---~IpRNPPPkL--krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  234 MR---------ALF---LIPRNPPPKL--KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             hh---------hhc---cCCCCCCccc--cchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence            10         000   0111111122  235677789999999999999999999998864

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.98  E-value=1.7e-32  Score=254.79  Aligned_cols=250  Identities=23%  Similarity=0.314  Sum_probs=195.7

Q ss_pred             hcCCccc-cccCcCCceEEEEEEcC-CCCEEEEEEccCCChHHHHHHHHHHHHHHhc-CCCCcceEeeEEee----CCcc
Q 009340          215 TDNYNQS-RFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKTQIHQFINEVVILSQI-NHRHIVKLLGCCLE----TEVP  287 (537)
Q Consensus       215 ~~~~~~~-~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~----~~~~  287 (537)
                      +++|... ++||-|-.|.|-....+ .|+.+|+|.+....     ...+|+++.-.. .|+|||.+++++.+    ...+
T Consensus        60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~-----KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL  134 (400)
T KOG0604|consen   60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP-----KARREVELHWMASGHPHIVSIIDVYENSYQGRKCL  134 (400)
T ss_pred             hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH-----HHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence            4455443 57999999999887754 68899999987532     345788876665 69999999999865    3467


Q ss_pred             EEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECC---CC
Q 009340          288 VLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD---KF  364 (537)
Q Consensus       288 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~---~~  364 (537)
                      ++|||+|++|.|...+.+.+.          ..+++.++-.|..||+.|+.|||+.+   |.||||||+|+|...   |-
T Consensus       135 LiVmE~meGGeLfsriq~~g~----------~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na  201 (400)
T KOG0604|consen  135 LIVMECMEGGELFSRIQDRGD----------QAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNA  201 (400)
T ss_pred             EeeeecccchHHHHHHHHccc----------ccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCc
Confidence            899999999999999987654          46999999999999999999999999   999999999999964   55


Q ss_pred             cEEEeeccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHH
Q 009340          365 SAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFI  444 (537)
Q Consensus       365 ~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~  444 (537)
                      .+|++|||+|+....  .....+.+-|+.|.|||++....|+...|+||+||++|-|++|.+||+......   +..-..
T Consensus       202 ~lKLtDfGFAK~t~~--~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a---ispgMk  276 (400)
T KOG0604|consen  202 PLKLTDFGFAKETQE--PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA---ISPGMK  276 (400)
T ss_pred             ceEecccccccccCC--CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc---CChhHH
Confidence            799999999987543  233455678999999999999999999999999999999999999998654321   001111


Q ss_pred             HHHhhchhhhhhcHHhh--ccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          445 SLAKENQLLEILDARVA--KEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       445 ~~~~~~~~~~~~d~~~~--~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      +        .+....+.  .+-....++...++++.+|+.+|.+|.|+.+++.
T Consensus       277 ~--------rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~  321 (400)
T KOG0604|consen  277 R--------RIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD  321 (400)
T ss_pred             h--------HhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence            1        11111111  1122345677789999999999999999999865

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=2.3e-33  Score=254.51  Aligned_cols=264  Identities=22%  Similarity=0.357  Sum_probs=192.5

Q ss_pred             CCccccccCcCCceEEEEEEcC-CCCEEEEEEccC-CC-hHHHHHHHHHHHHHHhcCCCCcceEeeEEeeC--------C
Q 009340          217 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKE-ID-KTQIHQFINEVVILSQINHRHIVKLLGCCLET--------E  285 (537)
Q Consensus       217 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~-~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--------~  285 (537)
                      .|....+||+|.||.||+++.+ .|+.||+|+.-- .. ..--...++|+++|..+.|+|++.+++.|...        .
T Consensus        18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~   97 (376)
T KOG0669|consen   18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA   97 (376)
T ss_pred             HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence            4455678999999999999965 577899986532 11 12234567899999999999999999998642        3


Q ss_pred             ccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCc
Q 009340          286 VPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFS  365 (537)
Q Consensus       286 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~  365 (537)
                      ..|+|+++|+. +|...|....           ..++..++.++..++..||.|+|...   |+|||+|+.|+|++.++.
T Consensus        98 t~ylVf~~ceh-DLaGlLsn~~-----------vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgi  162 (376)
T KOG0669|consen   98 TFYLVFDFCEH-DLAGLLSNRK-----------VRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGI  162 (376)
T ss_pred             eeeeeHHHhhh-hHHHHhcCcc-----------ccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCce
Confidence            47999999987 7877776542           25888999999999999999999998   999999999999999999


Q ss_pred             EEEeeccCccccCCCCCc---eeeeccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHH
Q 009340          366 AKVSDFGISRSIPNDKTH---LTTTIQGTFGYLDPEYFQS-SQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVA  441 (537)
Q Consensus       366 ~ki~Dfgla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~  441 (537)
                      +||+|||+++.+......   ..+..+-|..|.+||.+.+ ..|+++.|||.-||++.||++|.+-+..........++.
T Consensus       163 lklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is  242 (376)
T KOG0669|consen  163 LKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLIS  242 (376)
T ss_pred             EEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHH
Confidence            999999999876433322   2345567999999998876 579999999999999999999998876554433222222


Q ss_pred             HHHHHHhhc--------hhhhhhcHH-hhc-c--ccHHH------HHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          442 CFISLAKEN--------QLLEILDAR-VAK-E--AREED------IGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       442 ~~~~~~~~~--------~~~~~~d~~-~~~-~--~~~~~------~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      .+-.....+        .+.+.+... +.. .  .-.+.      ..+.++|+.+++..||..|+++++++.
T Consensus       243 ~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln  314 (376)
T KOG0669|consen  243 QLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN  314 (376)
T ss_pred             HHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence            221111100        111111000 000 0  00011      236779999999999999999888753

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.97  E-value=5.1e-32  Score=267.76  Aligned_cols=266  Identities=25%  Similarity=0.323  Sum_probs=204.6

Q ss_pred             ccccCcCCceEEEEEEcC-CCCEEEEEEccC--CChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecCCCC
Q 009340          221 SRFLGQGGFGTVYKGMLP-DGSIVAVKRSKE--IDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSG  297 (537)
Q Consensus       221 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g  297 (537)
                      .+.||+|.||+||-|+.+ +|+.||||.+.+  ....+...+.+|+.||++++||.||.+.-.|+..+..+.|||.+.+ 
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G-  647 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG-  647 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-
Confidence            578999999999999954 799999998764  2334457788999999999999999999999999999999999965 


Q ss_pred             ChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCC---CcEEEeeccCc
Q 009340          298 TLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK---FSAKVSDFGIS  374 (537)
Q Consensus       298 sL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~---~~~ki~Dfgla  374 (537)
                      +..+.+....          ...|+...-..+..||+.||.|||.++   |||.||||+||||.+.   -++||||||+|
T Consensus       648 DMLEMILSsE----------kgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfA  714 (888)
T KOG4236|consen  648 DMLEMILSSE----------KGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFA  714 (888)
T ss_pred             hHHHHHHHhh----------cccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccce
Confidence            4444443322          246888888999999999999999999   9999999999999543   57999999999


Q ss_pred             cccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchhhh
Q 009340          375 RSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLE  454 (537)
Q Consensus       375 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  454 (537)
                      +.+++..  ....++||+.|+|||++.+..|...-|+||.||++|--++|..||.....-.     +    ....   ..
T Consensus       715 RiIgEks--FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIn-----d----QIQN---Aa  780 (888)
T KOG4236|consen  715 RIIGEKS--FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIN-----D----QIQN---AA  780 (888)
T ss_pred             eecchhh--hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchh-----H----Hhhc---cc
Confidence            9986543  3567889999999999999999999999999999999999999986432111     0    0000   00


Q ss_pred             hhcHHhhcccc-HHHHHHHHHHHHHhcccCCCCCCCHhhHHHHH----HHHHHhhHHHhhhhhhhhhcc
Q 009340          455 ILDARVAKEAR-EEDIGAMAELAMRCLRLNSKKRPTMKQVSMEL----EGLRRSQRCLEMCQVNQLLAD  518 (537)
Q Consensus       455 ~~d~~~~~~~~-~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L----~~i~~~~~~~~~~~~~~~l~~  518 (537)
                      ++    ..+-| .+.+....+|+...|+..=..|-|...-+..-    .+.....++++..-.++++..
T Consensus       781 FM----yPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~yq~w~DLRelE~~igeRyiTh  845 (888)
T KOG4236|consen  781 FM----YPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDYQTWLDLRELEVRIGERYITH  845 (888)
T ss_pred             cc----cCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcchHHHHHHHHHHhhCcceecC
Confidence            11    11112 33446677899999999888998887665432    133344455666666666653

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.97  E-value=3.1e-32  Score=283.42  Aligned_cols=256  Identities=26%  Similarity=0.390  Sum_probs=193.0

Q ss_pred             CCccccccCcCCceE-EEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHHHHhc-CCCCcceEeeEEeeCCccEEEEecC
Q 009340          217 NYNQSRFLGQGGFGT-VYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQI-NHRHIVKLLGCCLETEVPVLVYEYI  294 (537)
Q Consensus       217 ~~~~~~~lg~G~~g~-Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~  294 (537)
                      -|...+.+|.|..|+ ||+|.+ +|+.||||++-..   ......+|+..|+.- +|||||++++.-.++.-.|+..|.|
T Consensus       510 ~~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC  585 (903)
T KOG1027|consen  510 FFSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC  585 (903)
T ss_pred             eeccHHHcccCCCCcEEEEEee-CCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence            455567889999887 799999 6899999998642   233456899999988 6999999998888888899999999


Q ss_pred             CCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECC-----CCcEEEe
Q 009340          295 SSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD-----KFSAKVS  369 (537)
Q Consensus       295 ~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~-----~~~~ki~  369 (537)
                      .. +|.+++..... .       .....-...+.+..|+++||++||+.+   ||||||||.||||+.     ..+++|+
T Consensus       586 ~~-sL~dlie~~~~-d-------~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iS  653 (903)
T KOG1027|consen  586 AC-SLQDLIESSGL-D-------VEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKIS  653 (903)
T ss_pred             hh-hHHHHHhcccc-c-------hhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEec
Confidence            66 99999987511 0       001111345778899999999999988   999999999999975     3689999


Q ss_pred             eccCccccCCCCCcee--eeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHHHH
Q 009340          370 DFGISRSIPNDKTHLT--TTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISL  446 (537)
Q Consensus       370 Dfgla~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~  446 (537)
                      |||+++.+..+.....  ....||-||+|||++....-+.++||||+|||+|..++ |++||......+.        .+
T Consensus       654 DfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~--------NI  725 (903)
T KOG1027|consen  654 DFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA--------NI  725 (903)
T ss_pred             ccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh--------hh
Confidence            9999999876655433  45679999999999999888889999999999999999 5999864322110        00


Q ss_pred             HhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHH---------HHHHHHHHhh
Q 009340          447 AKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVS---------MELEGLRRSQ  504 (537)
Q Consensus       447 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~---------~~L~~i~~~~  504 (537)
                      ....     .+-....+ ..++  +..+||.+|++++|..||++.+|+         ++|+-+++..
T Consensus       726 l~~~-----~~L~~L~~-~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ekrL~Fl~dvS  784 (903)
T KOG1027|consen  726 LTGN-----YTLVHLEP-LPDC--EAKDLISRMLNPDPQLRPSATDVLNHPLFWDSEKRLSFLRDVS  784 (903)
T ss_pred             hcCc-----cceeeecc-CchH--HHHHHHHHhcCCCcccCCCHHHHhCCCccCChHHHHHHHHhhh
Confidence            0000     00000011 1111  667999999999999999999997         4555555543

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=7.7e-32  Score=265.77  Aligned_cols=241  Identities=25%  Similarity=0.318  Sum_probs=198.8

Q ss_pred             CCccccccCcCCceEEEEEEcCCCC-EEEEEEccC---CChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEe
Q 009340          217 NYNQSRFLGQGGFGTVYKGMLPDGS-IVAVKRSKE---IDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE  292 (537)
Q Consensus       217 ~~~~~~~lg~G~~g~Vy~~~~~~g~-~vavK~~~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e  292 (537)
                      ++.....||-||||.|-+...++.. .+|+|.++.   .+..+.+....|-.+|...+.+.||+++--+.+....|+.||
T Consensus       421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmE  500 (732)
T KOG0614|consen  421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLME  500 (732)
T ss_pred             hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHH
Confidence            3444557999999999998876443 378888764   345556778899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeecc
Q 009340          293 YISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG  372 (537)
Q Consensus       293 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfg  372 (537)
                      -|-+|.|+..|++.            ..++......++..+.+|++|||+++   ||.|||||+|.+||.+|-+||.|||
T Consensus       501 aClGGElWTiLrdR------------g~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFG  565 (732)
T KOG0614|consen  501 ACLGGELWTILRDR------------GSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFG  565 (732)
T ss_pred             hhcCchhhhhhhhc------------CCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehh
Confidence            99999999999874            45888888999999999999999999   9999999999999999999999999


Q ss_pred             CccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchh
Q 009340          373 ISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQL  452 (537)
Q Consensus       373 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  452 (537)
                      +|+.+..+.  .+-+.+||+.|.|||++.+...+.++|.||+|+++|||++|++||...++-...+      ..+.-   
T Consensus       566 FAKki~~g~--KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn------~ILkG---  634 (732)
T KOG0614|consen  566 FAKKIGSGR--KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYN------LILKG---  634 (732)
T ss_pred             hHHHhccCC--ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHH------HHHhh---
Confidence            999886543  4567899999999999999999999999999999999999999997654322111      11111   


Q ss_pred             hhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCC
Q 009340          453 LEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPT  489 (537)
Q Consensus       453 ~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs  489 (537)
                            --..+.|........+|+++..+.+|.+|..
T Consensus       635 ------id~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG  665 (732)
T KOG0614|consen  635 ------IDKIEFPRRITKTATDLIKKLCRDNPTERLG  665 (732)
T ss_pred             ------hhhhhcccccchhHHHHHHHHHhcCcHhhhc
Confidence                  0111234444556778999999999999976

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=4.2e-32  Score=248.84  Aligned_cols=264  Identities=22%  Similarity=0.341  Sum_probs=199.7

Q ss_pred             CccccccCcCCceEEEEEEc-CCCCEEEEEEccCC--ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeC-----CccEE
Q 009340          218 YNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEI--DKTQIHQFINEVVILSQINHRHIVKLLGCCLET-----EVPVL  289 (537)
Q Consensus       218 ~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~~l  289 (537)
                      .+..+-||.|+||.||..+. ++|+.||+|++...  +-...+.+.+|+++|+.++|.|++..++...-.     .+.|.
T Consensus        55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV  134 (449)
T KOG0664|consen   55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV  134 (449)
T ss_pred             CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence            34567899999999998885 48999999998753  334567899999999999999999998876543     25678


Q ss_pred             EEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEe
Q 009340          290 VYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVS  369 (537)
Q Consensus       290 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~  369 (537)
                      ++|.|.. +|...+-.            ...|+-..+.-+..||++||.|||+.+   |.||||||.|.|++.|...|||
T Consensus       135 ~TELmQS-DLHKIIVS------------PQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKIC  198 (449)
T KOG0664|consen  135 LTELMQS-DLHKIIVS------------PQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKIC  198 (449)
T ss_pred             HHHHHHh-hhhheecc------------CCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEec
Confidence            8888865 78777765            235888888889999999999999999   9999999999999999999999


Q ss_pred             eccCccccCCCCCceeeeccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHH----
Q 009340          370 DFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQS-SQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFI----  444 (537)
Q Consensus       370 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~----  444 (537)
                      |||+++....+....++..+-|..|.|||++++ ..|+.+.||||.||++.||+..+.-|....+-+...++..+.    
T Consensus       199 DFGLARvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs  278 (449)
T KOG0664|consen  199 DFGLARTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPS  278 (449)
T ss_pred             ccccccccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCc
Confidence            999999876555555666778999999999987 469999999999999999999888887665544433333221    


Q ss_pred             ----HHHhhchhhhhhcHHhhc---------cccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHH
Q 009340          445 ----SLAKENQLLEILDARVAK---------EAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMEL  497 (537)
Q Consensus       445 ----~~~~~~~~~~~~d~~~~~---------~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L  497 (537)
                          +..-++....++......         ..+.....+-..+..+++..||+.|.+..+.+.-+
T Consensus       279 ~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~  344 (449)
T KOG0664|consen  279 QEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR  344 (449)
T ss_pred             HHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence                111111111111111111         11122334556778888999999999988876654

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.97  E-value=3.9e-31  Score=253.72  Aligned_cols=262  Identities=22%  Similarity=0.307  Sum_probs=199.9

Q ss_pred             hcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCChHHHHHHHHHHHHHHhcC-C-C----CcceEeeEEeeCCcc
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKTQIHQFINEVVILSQIN-H-R----HIVKLLGCCLETEVP  287 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H-~----niv~l~g~~~~~~~~  287 (537)
                      +++|.....+|+|.||.|-....+ .+..||||+++...+ ..+..+-|+++++++. + |    -++.+.+++.-.+..
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k-YreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi  166 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK-YREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI  166 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH-HhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence            678999999999999999887743 478999999987543 3456677999999994 2 2    377888889999999


Q ss_pred             EEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECC-----
Q 009340          288 VLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD-----  362 (537)
Q Consensus       288 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~-----  362 (537)
                      ++|+|.+ +-|+.++|..+.-          .+++..++..|+.|++++++|||+..   ++|-||||+|||+.+     
T Consensus       167 Civfell-G~S~~dFlk~N~y----------~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~  232 (415)
T KOG0671|consen  167 CIVFELL-GLSTFDFLKENNY----------IPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFK  232 (415)
T ss_pred             EEEEecc-ChhHHHHhccCCc----------cccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEE
Confidence            9999988 4489999987543          47899999999999999999999999   999999999999932     


Q ss_pred             ---------------CCcEEEeeccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCC
Q 009340          363 ---------------KFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP  427 (537)
Q Consensus       363 ---------------~~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p  427 (537)
                                     +..+||+|||-|.......    ...+.|..|.|||++.+-.++..+||||+||||.|+.+|..-
T Consensus       233 ~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~L  308 (415)
T KOG0671|consen  233 TYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETL  308 (415)
T ss_pred             EeccCCccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeecccee
Confidence                           3468999999998754433    456789999999999999999999999999999999999999


Q ss_pred             CCccchhhhccHHHHHH--------HH------Hhhchh-----------hhhhc---H-HhhccccHHHHHHHHHHHHH
Q 009340          428 ICFARVEEERNLVACFI--------SL------AKENQL-----------LEILD---A-RVAKEAREEDIGAMAELAMR  478 (537)
Q Consensus       428 ~~~~~~~~~~~~~~~~~--------~~------~~~~~~-----------~~~~d---~-~~~~~~~~~~~~~l~~l~~~  478 (537)
                      |+.....+.....+...        ..      ...+.+           ....+   + .........+...|.+|+.+
T Consensus       309 FqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~  388 (415)
T KOG0671|consen  309 FQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRR  388 (415)
T ss_pred             cccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHH
Confidence            87655333211111110        00      000000           00000   0 00011223455679999999


Q ss_pred             hcccCCCCCCCHhhHHH
Q 009340          479 CLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       479 cl~~~p~~RPs~~ev~~  495 (537)
                      ||..||.+|+|+.|++.
T Consensus       389 mL~fDP~~RiTl~EAL~  405 (415)
T KOG0671|consen  389 MLEFDPARRITLREALS  405 (415)
T ss_pred             HHccCccccccHHHHhc
Confidence            99999999999999874

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.2e-30  Score=245.34  Aligned_cols=248  Identities=23%  Similarity=0.380  Sum_probs=201.1

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCCEEEEEEccC---CChHHHHHHHHHHHHHHhc-CCCCcceEeeEEeeCCccEEE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKE---IDKTQIHQFINEVVILSQI-NHRHIVKLLGCCLETEVPVLV  290 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~---~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV  290 (537)
                      .+|...++||.|+|..|-.+++. ..+.+|+|.++.   .+.+.......|-.+..+- +||.+|.+..|+..+..+++|
T Consensus       250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv  329 (593)
T KOG0695|consen  250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV  329 (593)
T ss_pred             ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence            57888999999999999999864 578899998864   2333344455677776666 799999999999999999999


Q ss_pred             EecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEee
Q 009340          291 YEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSD  370 (537)
Q Consensus       291 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~D  370 (537)
                      .||.++|+|--+++..            ..|+++.+......|.-||.|||+.+   |+.||||..|||+|..|.+|++|
T Consensus       330 ieyv~ggdlmfhmqrq------------rklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltd  394 (593)
T KOG0695|consen  330 IEYVNGGDLMFHMQRQ------------RKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTD  394 (593)
T ss_pred             EEEecCcceeeehhhh------------hcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecc
Confidence            9999999998888663            35999999999999999999999999   99999999999999999999999


Q ss_pred             ccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccch-hhhccHHHHHHHHHhh
Q 009340          371 FGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARV-EEERNLVACFISLAKE  449 (537)
Q Consensus       371 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~  449 (537)
                      +|+++.--. ....+.+.+||+.|+|||++.+..|...+|.|++||+++||+.|+.||+.... ..+.+..+++.+..-+
T Consensus       395 ygmcke~l~-~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvile  473 (593)
T KOG0695|consen  395 YGMCKEGLG-PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILE  473 (593)
T ss_pred             cchhhcCCC-CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhh
Confidence            999986422 22346678999999999999999999999999999999999999999975433 2334444444443332


Q ss_pred             chhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCC
Q 009340          450 NQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPT  489 (537)
Q Consensus       450 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs  489 (537)
                              +.++  .|...+.....+++.-|..||.+|..
T Consensus       474 --------kqir--iprslsvkas~vlkgflnkdp~erlg  503 (593)
T KOG0695|consen  474 --------KQIR--IPRSLSVKASHVLKGFLNKDPKERLG  503 (593)
T ss_pred             --------hccc--ccceeehhhHHHHHHhhcCCcHHhcC
Confidence                    2222  23344455678889999999999954

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.97  E-value=6.1e-31  Score=232.38  Aligned_cols=203  Identities=25%  Similarity=0.399  Sum_probs=166.3

Q ss_pred             hcCCccccccCcCCceEEEEEEc-CCCCEEEEEEccCC-ChHHHHHHHHHHHHHHhc-CCCCcceEeeEEeeCCccEEEE
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEI-DKTQIHQFINEVVILSQI-NHRHIVKLLGCCLETEVPVLVY  291 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~  291 (537)
                      .+.......||+|++|.|-+-++ .+|+..|+|+++.. ..+..++.++|+.+..+- .+|.+|.++|........++.|
T Consensus        45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcM  124 (282)
T KOG0984|consen   45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICM  124 (282)
T ss_pred             hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeH
Confidence            34445567799999999987774 47999999998753 344556778888876655 7999999999988888999999


Q ss_pred             ecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeec
Q 009340          292 EYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF  371 (537)
Q Consensus       292 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Df  371 (537)
                      |.|+. ||+.+-..-..        ....+++..+=+||..+.+||.|||++-+  ++|||+||+|||++.+|++|||||
T Consensus       125 E~M~t-Sldkfy~~v~~--------~g~~ipE~vlGkIa~Svv~al~~L~~kL~--vIHRDvKPsNiLIn~~GqVKiCDF  193 (282)
T KOG0984|consen  125 ELMDT-SLDKFYRKVLK--------KGGTIPEDVLGKIAVSVVHALEFLHSKLS--VIHRDVKPSNILINYDGQVKICDF  193 (282)
T ss_pred             HHhhh-hHHHHHHHHHh--------cCCcCchHHhhHhHHHHHHHHHHHHHHhh--hhhccCCcceEEEccCCcEEEccc
Confidence            99966 88877655333        24578999999999999999999999764  999999999999999999999999


Q ss_pred             cCccccCCCCCceeeeccccccccCcccccC----CCCCcchhHHHHHHHHHHHHhCCCCCCc
Q 009340          372 GISRSIPNDKTHLTTTIQGTFGYLDPEYFQS----SQFTDKSDVYSFGVVLLELLTGKKPICF  430 (537)
Q Consensus       372 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~t~ksDV~S~Gvll~el~tg~~p~~~  430 (537)
                      |.+-.+.++-  ..+...|...|||||.+..    ..|+-||||||+|+.+.||.+++.|+..
T Consensus       194 GIsG~L~dSi--Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~  254 (282)
T KOG0984|consen  194 GISGYLVDSI--AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES  254 (282)
T ss_pred             ccceeehhhh--HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence            9997764322  2233457889999998753    4689999999999999999999999754

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=5.4e-29  Score=233.36  Aligned_cols=210  Identities=37%  Similarity=0.637  Sum_probs=183.4

Q ss_pred             cCcCCceEEEEEEcCC-CCEEEEEEccCCChH-HHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecCCCCChhh
Q 009340          224 LGQGGFGTVYKGMLPD-GSIVAVKRSKEIDKT-QIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSH  301 (537)
Q Consensus       224 lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~  301 (537)
                      ||+|.+|.||++...+ ++.+++|........ ..+.+.+|+..++.++|++++++++++......++++||+++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999999754 899999998865432 35678999999999999999999999999899999999999999999


Q ss_pred             hhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECC-CCcEEEeeccCccccCCC
Q 009340          302 HIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD-KFSAKVSDFGISRSIPND  380 (537)
Q Consensus       302 ~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~-~~~~ki~Dfgla~~~~~~  380 (537)
                      ++....           ..+++..+..++.++++++.+||+.+   ++|+||+|.||+++. ++.++|+|||.+......
T Consensus        81 ~~~~~~-----------~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~  146 (215)
T cd00180          81 LLKENE-----------GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSD  146 (215)
T ss_pred             HHHhcc-----------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCC
Confidence            986531           25899999999999999999999998   999999999999999 899999999999876443


Q ss_pred             CCceeeeccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchhhhhhcHH
Q 009340          381 KTHLTTTIQGTFGYLDPEYFQSS-QFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEILDAR  459 (537)
Q Consensus       381 ~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  459 (537)
                      .. ......+...|++||.+... ..+.++|+|++|+++++|                                      
T Consensus       147 ~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------  187 (215)
T cd00180         147 KS-LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------  187 (215)
T ss_pred             cc-hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------------
Confidence            21 12334578889999999887 888999999999999999                                      


Q ss_pred             hhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHH
Q 009340          460 VAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSME  496 (537)
Q Consensus       460 ~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~  496 (537)
                                ..+.+++.+|++.+|++||++.++++.
T Consensus       188 ----------~~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         188 ----------PELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             ----------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence                      457789999999999999999999864

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=8.3e-30  Score=256.96  Aligned_cols=205  Identities=25%  Similarity=0.400  Sum_probs=174.0

Q ss_pred             cCCccccccCcCCceEEEEEEc-CCCCEEEEEEccCCC---hHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEID---KTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY  291 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  291 (537)
                      .-|-..+.||-|+||.|.++.. +....+|.|.++..+   ..+......|-+||..-..+-||+|+-.|.+.+.+|+||
T Consensus       629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM  708 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM  708 (1034)
T ss_pred             cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence            4677788999999999999884 445678999887643   344556778999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeec
Q 009340          292 EYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF  371 (537)
Q Consensus       292 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Df  371 (537)
                      +|+++|++-.+|-..            .-+.+..+..++..+..|+++.|..|   +|||||||.|||||.+|.+||+||
T Consensus       709 dYIPGGDmMSLLIrm------------gIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDF  773 (1034)
T KOG0608|consen  709 DYIPGGDMMSLLIRM------------GIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDF  773 (1034)
T ss_pred             eccCCccHHHHHHHh------------ccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeec
Confidence            999999999988764            35788888889999999999999999   999999999999999999999999


Q ss_pred             cCccccCC---CCC--------------------------------------ceeeeccccccccCcccccCCCCCcchh
Q 009340          372 GISRSIPN---DKT--------------------------------------HLTTTIQGTFGYLDPEYFQSSQFTDKSD  410 (537)
Q Consensus       372 gla~~~~~---~~~--------------------------------------~~~~~~~gt~~y~aPE~~~~~~~t~ksD  410 (537)
                      ||+.-+..   ..+                                      ......+||..|+|||++....++.-+|
T Consensus       774 GLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cd  853 (1034)
T KOG0608|consen  774 GLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCD  853 (1034)
T ss_pred             cccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccch
Confidence            99864420   000                                      0012346999999999999999999999


Q ss_pred             HHHHHHHHHHHHhCCCCCCccchhh
Q 009340          411 VYSFGVVLLELLTGKKPICFARVEE  435 (537)
Q Consensus       411 V~S~Gvll~el~tg~~p~~~~~~~~  435 (537)
                      .||.|||||||+.|+.||......+
T Consensus       854 wws~gvil~em~~g~~pf~~~tp~~  878 (1034)
T KOG0608|consen  854 WWSVGVILYEMLVGQPPFLADTPGE  878 (1034)
T ss_pred             hhHhhHHHHHHhhCCCCccCCCCCc
Confidence            9999999999999999998766544

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.96  E-value=6.3e-29  Score=222.79  Aligned_cols=258  Identities=22%  Similarity=0.368  Sum_probs=195.5

Q ss_pred             hcCCccccccCcCCceEEEEEE-cCCCCEEEEEEccCCChHHHHHHHHHHHHHHhcC-CCCcceEeeEEeeC--CccEEE
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQFINEVVILSQIN-HRHIVKLLGCCLET--EVPVLV  290 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~--~~~~lV  290 (537)
                      .++|+..+++|.|.++.||-|. ..+.+.++||.++...   .+.+.+|+.||..+. ||||+++++...+.  ..+.||
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi  113 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI  113 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence            4688889999999999999998 4578889999998643   456789999999996 99999999998765  467899


Q ss_pred             EecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCC-CcEEEe
Q 009340          291 YEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK-FSAKVS  369 (537)
Q Consensus       291 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~-~~~ki~  369 (537)
                      +||+.+.+.....               ..|+...+...+.++++||.|+|+.|   |+|||+||.|+++|.. -..+|+
T Consensus       114 FE~v~n~Dfk~ly---------------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlI  175 (338)
T KOG0668|consen  114 FEYVNNTDFKQLY---------------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLI  175 (338)
T ss_pred             hhhhccccHHHHh---------------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeee
Confidence            9999997765544               25788888999999999999999999   9999999999999965 469999


Q ss_pred             eccCccccCCCCCceeeeccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhcc----------
Q 009340          370 DFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQS-SQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERN----------  438 (537)
Q Consensus       370 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~----------  438 (537)
                      |+|||.+......+  ...+.+..|--||.+-+ ..|+..-|+|||||+|..|+..+.||.......++.          
T Consensus       176 DWGLAEFYHp~~eY--nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~  253 (338)
T KOG0668|consen  176 DWGLAEFYHPGKEY--NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTD  253 (338)
T ss_pred             ecchHhhcCCCcee--eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChH
Confidence            99999887554432  33456778889999866 457889999999999999999999997654432211          


Q ss_pred             -HHHHHHHHH--hhchhhhhhcHHhhcc-------cc-HHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          439 -LVACFISLA--KENQLLEILDARVAKE-------AR-EEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       439 -~~~~~~~~~--~~~~~~~~~d~~~~~~-------~~-~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                       +..++....  -+.+..+++....+..       .. .-..++..+++...|..|-.+|||++|...
T Consensus       254 el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  254 ELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             HHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence             111111100  0112222222111110       01 112478899999999999999999999854

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.96  E-value=4e-28  Score=230.93  Aligned_cols=199  Identities=37%  Similarity=0.543  Sum_probs=172.6

Q ss_pred             CccccccCcCCceEEEEEEcCC-CCEEEEEEccCCChH-HHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecCC
Q 009340          218 YNQSRFLGQGGFGTVYKGMLPD-GSIVAVKRSKEIDKT-QIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYIS  295 (537)
Q Consensus       218 ~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  295 (537)
                      |+..+.||+|++|.||++...+ ++.+|+|........ ..+.+.+|++.+.+++|+|++++++++......++++||++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            4567889999999999999764 889999998765444 56788999999999999999999999999899999999999


Q ss_pred             CCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCcc
Q 009340          296 SGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISR  375 (537)
Q Consensus       296 ~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~  375 (537)
                      +++|.+++.....           .+++..+..++.++++++.+||+.+   ++|+||+++||+++.++.++|+|||.+.
T Consensus        81 ~~~L~~~~~~~~~-----------~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~  146 (225)
T smart00221       81 GGDLFDYLRKKGG-----------KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLAR  146 (225)
T ss_pred             CCCHHHHHHhccc-----------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceee
Confidence            9999999875321           2889999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCCCceeeeccccccccCcccc-cCCCCCcchhHHHHHHHHHHHHhCCCCCCc
Q 009340          376 SIPNDKTHLTTTIQGTFGYLDPEYF-QSSQFTDKSDVYSFGVVLLELLTGKKPICF  430 (537)
Q Consensus       376 ~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~t~ksDV~S~Gvll~el~tg~~p~~~  430 (537)
                      ..............++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      147 FIHRDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             EecCcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            7754421122334577889999998 667788899999999999999999999854

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.95  E-value=6.1e-28  Score=226.76  Aligned_cols=259  Identities=22%  Similarity=0.331  Sum_probs=189.9

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCCEEEEEEccC--CChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCC------c
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKE--IDKTQIHQFINEVVILSQINHRHIVKLLGCCLETE------V  286 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------~  286 (537)
                      .+|-....+|.|.- .|-.+... .++.||+|++..  ......++..+|+.++..++|+|+++++.+++-..      .
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e   95 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE   95 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence            35556677888877 55544422 578899998753  23344567788999999999999999999987443      5


Q ss_pred             cEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcE
Q 009340          287 PVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA  366 (537)
Q Consensus       287 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~  366 (537)
                      .|+|||+|.. +|...++-              .++-.....|..|+..|+.|||+.+   |+||||||+||++..+..+
T Consensus        96 ~y~v~e~m~~-nl~~vi~~--------------elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~l  157 (369)
T KOG0665|consen   96 VYLVMELMDA-NLCQVILM--------------ELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTL  157 (369)
T ss_pred             HHHHHHhhhh-HHHHHHHH--------------hcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhhe
Confidence            6999999955 89888863              3667778899999999999999999   9999999999999999999


Q ss_pred             EEeeccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhh--------cc
Q 009340          367 KVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEE--------RN  438 (537)
Q Consensus       367 ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~--------~~  438 (537)
                      ||.|||+++.-..+  ...+..+.|..|.|||++.+..+.+.+||||.||++.||++|+.-|.....-+.        +.
T Consensus       158 Ki~dfg~ar~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgt  235 (369)
T KOG0665|consen  158 KILDFGLARTEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGT  235 (369)
T ss_pred             eeccchhhcccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcC
Confidence            99999999865433  456778889999999999988899999999999999999999988754322111        00


Q ss_pred             HHHHHHHHHhh--------------chhhhhh-cHHhhc--cccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          439 LVACFISLAKE--------------NQLLEIL-DARVAK--EAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       439 ~~~~~~~~~~~--------------~~~~~~~-d~~~~~--~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      ....|...+..              -...+.+ |..+..  +.+........+++.+||-.||++|.++.+++.
T Consensus       236 pd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~  309 (369)
T KOG0665|consen  236 PDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR  309 (369)
T ss_pred             CCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence            00111111100              0000000 100000  111223445779999999999999999999875

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.95  E-value=3.9e-28  Score=243.15  Aligned_cols=196  Identities=22%  Similarity=0.360  Sum_probs=165.4

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCCh--------HHHHHHHHHHHHHHhcC---CCCcceEeeEEee
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDK--------TQIHQFINEVVILSQIN---HRHIVKLLGCCLE  283 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~  283 (537)
                      ..|...+.+|+|+||.|+.+..+ +...|+||.+++..-        ...-..-.|+.||..++   |+||++++++|++
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            35777889999999999999976 456899997754211        01112446999999997   9999999999999


Q ss_pred             CCccEEEEecCC-CCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECC
Q 009340          284 TEVPVLVYEYIS-SGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD  362 (537)
Q Consensus       284 ~~~~~lV~e~~~-~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~  362 (537)
                      ++..||+||-.. +-+|.+++..+            +.+++++...|+.|++.|+++||+++   |||||||-+||.+|.
T Consensus       641 dd~yyl~te~hg~gIDLFd~IE~k------------p~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~  705 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFIEFK------------PRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDS  705 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhhhcc------------CccchHHHHHHHHHHHhccccccccC---ceecccccccEEEec
Confidence            999999999764 45888888653            35999999999999999999999999   999999999999999


Q ss_pred             CCcEEEeeccCccccCCCCCceeeeccccccccCcccccCCCCC-cchhHHHHHHHHHHHHhCCCCCC
Q 009340          363 KFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFT-DKSDVYSFGVVLLELLTGKKPIC  429 (537)
Q Consensus       363 ~~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t-~ksDV~S~Gvll~el~tg~~p~~  429 (537)
                      +|-+||+|||-+.....+.   ....+||.+|.|||.+.+..|- ..-|||++|++||.++....|++
T Consensus       706 ~g~~klidfgsaa~~ksgp---fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  706 NGFVKLIDFGSAAYTKSGP---FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             CCeEEEeeccchhhhcCCC---cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            9999999999987654432   3456799999999999988774 56899999999999999988875

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.95  E-value=8.6e-29  Score=251.66  Aligned_cols=254  Identities=26%  Similarity=0.366  Sum_probs=202.5

Q ss_pred             HhcCCccccccCcCCceEEEEEEc-CCCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEe
Q 009340          214 ATDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE  292 (537)
Q Consensus       214 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e  292 (537)
                      ..++|+....+|.|.+|.|||++. ..++..|||.++........-..+|+.+++..+|+||+.++|.+..++..++.||
T Consensus        13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME   92 (829)
T KOG0576|consen   13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME   92 (829)
T ss_pred             CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence            457888899999999999999995 4789999999887655556667789999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeecc
Q 009340          293 YISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG  372 (537)
Q Consensus       293 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfg  372 (537)
                      |+.+|+|.+.-+..            .++++.++...+....+||.|||+.+   -+|||||-.|||+++.+.+|++|||
T Consensus        93 ycgggslQdiy~~T------------gplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfg  157 (829)
T KOG0576|consen   93 YCGGGSLQDIYHVT------------GPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFG  157 (829)
T ss_pred             ecCCCcccceeeec------------ccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccC
Confidence            99999999988763            46899999999999999999999999   6799999999999999999999999


Q ss_pred             CccccCCCCCceeeeccccccccCcccc---cCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhh
Q 009340          373 ISRSIPNDKTHLTTTIQGTFGYLDPEYF---QSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKE  449 (537)
Q Consensus       373 la~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  449 (537)
                      .+..+...-. ......||+.|||||+.   ..+.|..++|||+.|+...|+---+.|.....+-.       ..-++..
T Consensus       158 vsaqitati~-KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr-------~l~LmTk  229 (829)
T KOG0576|consen  158 VSAQITATIA-KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMR-------ALFLMTK  229 (829)
T ss_pred             chhhhhhhhh-hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHH-------HHHHhhc
Confidence            9876643222 23456799999999975   45778999999999999999988887753321110       0000000


Q ss_pred             chhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          450 NQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       450 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                          ..+++.-. .-...-.+.+.++++.|+-.+|+.||++..++.
T Consensus       230 ----S~~qpp~l-kDk~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  230 ----SGFQPPTL-KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             ----cCCCCCcc-cCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence                00111101 112334567889999999999999999987654

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=4.6e-26  Score=224.56  Aligned_cols=131  Identities=25%  Similarity=0.402  Sum_probs=110.8

Q ss_pred             cCCccccccCcCCceEEEEEEc-CCCCEEEEEEccCCChHHHHHHHHHHHHHHhcC-----C---CCcceEeeEEeeC--
Q 009340          216 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEIDKTQIHQFINEVVILSQIN-----H---RHIVKLLGCCLET--  284 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----H---~niv~l~g~~~~~--  284 (537)
                      .+|...++||.|.|++||++.. .+.+.||+|+.+.. ....+..+.||++|++++     |   ..||+|++.|...  
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp  156 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP  156 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence            6788899999999999999985 35778999999863 344567889999999983     3   3699999999754  


Q ss_pred             --CccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEE
Q 009340          285 --EVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILL  360 (537)
Q Consensus       285 --~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll  360 (537)
                        .+.++|+|++ +.+|..+|....          .+-++...+.+|+.|++.||.|||....  |+|-||||+|||+
T Consensus       157 NG~HVCMVfEvL-GdnLLklI~~s~----------YrGlpl~~VK~I~~qvL~GLdYLH~ecg--IIHTDlKPENvLl  221 (590)
T KOG1290|consen  157 NGQHVCMVFEVL-GDNLLKLIKYSN----------YRGLPLSCVKEICRQVLTGLDYLHRECG--IIHTDLKPENVLL  221 (590)
T ss_pred             CCcEEEEEehhh-hhHHHHHHHHhC----------CCCCcHHHHHHHHHHHHHHHHHHHHhcC--ccccCCCcceeee
Confidence              4689999998 458888887643          3469999999999999999999999874  9999999999999

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.94  E-value=1.8e-27  Score=267.62  Aligned_cols=195  Identities=20%  Similarity=0.208  Sum_probs=138.5

Q ss_pred             hcCC-CCcceEeeEE-------eeCCccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHH
Q 009340          268 QINH-RHIVKLLGCC-------LETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAY  339 (537)
Q Consensus       268 ~l~H-~niv~l~g~~-------~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~y  339 (537)
                      .++| +||.+++++|       .+....+.++||+ .++|.++|...           ...+++.+++.++.||++||.|
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-----------~~~~~~~~~~~i~~qi~~al~~   95 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-----------DRSVDAFECFHVFRQIVEIVNA   95 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-----------cccccHHHHHHHHHHHHHHHHH
Confidence            3455 6888888887       2334567888987 55999999643           2359999999999999999999


Q ss_pred             HhhcCCCCeeecCCCCCCEEECC-------------------CCcEEEeeccCccccCCCC---------------Ccee
Q 009340          340 MHSSASIPIFHRDIKSSNILLDD-------------------KFSAKVSDFGISRSIPNDK---------------THLT  385 (537)
Q Consensus       340 LH~~~~~~ivH~Dlk~~NIll~~-------------------~~~~ki~Dfgla~~~~~~~---------------~~~~  385 (537)
                      ||+++   |+||||||+||||+.                   ++.+|++|||+++......               ....
T Consensus        96 lH~~g---IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (793)
T PLN00181         96 AHSQG---IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQ  172 (793)
T ss_pred             HHhCC---eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccc
Confidence            99999   999999999999955                   4455666666665321100               0001


Q ss_pred             eeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchhhhhhcHHhhcccc
Q 009340          386 TTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEILDARVAKEAR  465 (537)
Q Consensus       386 ~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  465 (537)
                      ....||+.|||||++.+..++.++|||||||+||||++|..|+....     ..   +.. ..    ...+.+..     
T Consensus       173 ~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~-----~~---~~~-~~----~~~~~~~~-----  234 (793)
T PLN00181        173 ILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS-----RT---MSS-LR----HRVLPPQI-----  234 (793)
T ss_pred             cccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH-----HH---HHH-HH----HhhcChhh-----
Confidence            12357889999999999999999999999999999999888753210     00   000 00    00111111     


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          466 EEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       466 ~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      .........++.+||+.+|.+||+|.||++
T Consensus       235 ~~~~~~~~~~~~~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        235 LLNWPKEASFCLWLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             hhcCHHHHHHHHHhCCCChhhCcChHHHhh
Confidence            112334568889999999999999999975

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.94  E-value=2.7e-26  Score=210.57  Aligned_cols=171  Identities=21%  Similarity=0.230  Sum_probs=128.0

Q ss_pred             CChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCccc
Q 009340          297 GTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS  376 (537)
Q Consensus       297 gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~  376 (537)
                      |||.+++....           ..++|.+++.++.|+++||.|||+.+         ||+|||++.++.+|+  ||++..
T Consensus         1 GsL~~~l~~~~-----------~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~   58 (176)
T smart00750        1 VSLADILEVRG-----------RPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAF   58 (176)
T ss_pred             CcHHHHHHHhC-----------CCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEe
Confidence            68888887532           36999999999999999999999876         999999999999999  999887


Q ss_pred             cCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchhhhhh
Q 009340          377 IPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEIL  456 (537)
Q Consensus       377 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  456 (537)
                      .....      ..||+.|+|||++.+..++.++|||||||++|||++|+.||.......  .............      
T Consensus        59 ~~~~~------~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~--~~~~~~~~~~~~~------  124 (176)
T smart00750       59 KTPEQ------SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS--AILEILLNGMPAD------  124 (176)
T ss_pred             ecccc------CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc--HHHHHHHHHhccC------
Confidence            54322      257899999999999999999999999999999999999985432111  0011111000000      


Q ss_pred             cHHhhccccHHHHH--HHHHHHHHhcccCCCCCCCHhhHHHHHHHHHHhh
Q 009340          457 DARVAKEAREEDIG--AMAELAMRCLRLNSKKRPTMKQVSMELEGLRRSQ  504 (537)
Q Consensus       457 d~~~~~~~~~~~~~--~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~  504 (537)
                      ++.. ...+.....  .+.+++.+||+.+|++||++.++++.+..+..+.
T Consensus       125 ~~~~-~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~~  173 (176)
T smart00750      125 DPRD-RSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAET  173 (176)
T ss_pred             Cccc-cccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHHH
Confidence            0000 001122222  6899999999999999999999999998776543

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.93  E-value=3.2e-26  Score=222.98  Aligned_cols=200  Identities=27%  Similarity=0.406  Sum_probs=165.5

Q ss_pred             HHhcCCccccccCcCCceEEEEEEcC----CCCEEEEEEccCCChHHHHHHHHHHHHHHhc-CCCCcceEeeEEeeCCcc
Q 009340          213 RATDNYNQSRFLGQGGFGTVYKGMLP----DGSIVAVKRSKEIDKTQIHQFINEVVILSQI-NHRHIVKLLGCCLETEVP  287 (537)
Q Consensus       213 ~~~~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~  287 (537)
                      ...+.|...++||+|.|++||++.+.    ..+.||+|.+...+.  .....+|+++|..+ .+.||+++.+++...+..
T Consensus        33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v  110 (418)
T KOG1167|consen   33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQV  110 (418)
T ss_pred             hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccCCee
Confidence            34467888999999999999999954    367899999876443  34678999999999 599999999999999999


Q ss_pred             EEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECC-CCcE
Q 009340          288 VLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD-KFSA  366 (537)
Q Consensus       288 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~-~~~~  366 (537)
                      .+|+||++...-.++..               .++...+...+..+..||.++|+.|   ||||||||+|+|.+. .+.-
T Consensus       111 ~ivlp~~~H~~f~~l~~---------------~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg  172 (418)
T KOG1167|consen  111 AIVLPYFEHDRFRDLYR---------------SLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRG  172 (418)
T ss_pred             EEEecccCccCHHHHHh---------------cCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCc
Confidence            99999999988888875               3778889999999999999999999   999999999999975 4678


Q ss_pred             EEeeccCccccC-----------------C--C--------------CCc-e---------eeeccccccccCcccccC-
Q 009340          367 KVSDFGISRSIP-----------------N--D--------------KTH-L---------TTTIQGTFGYLDPEYFQS-  402 (537)
Q Consensus       367 ki~Dfgla~~~~-----------------~--~--------------~~~-~---------~~~~~gt~~y~aPE~~~~-  402 (537)
                      .|.||||+....                 .  +              ..+ .         .....||+||.|||++.. 
T Consensus       173 ~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~  252 (418)
T KOG1167|consen  173 VLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRC  252 (418)
T ss_pred             eEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhc
Confidence            899999997210                 0  0              000 0         112459999999999865 


Q ss_pred             CCCCcchhHHHHHHHHHHHHhCCCCCCccc
Q 009340          403 SQFTDKSDVYSFGVVLLELLTGKKPICFAR  432 (537)
Q Consensus       403 ~~~t~ksDV~S~Gvll~el~tg~~p~~~~~  432 (537)
                      ..-|+++||||-|||++-+++++.||....
T Consensus       253 ~~QttaiDiws~GVI~Lslls~~~PFf~a~  282 (418)
T KOG1167|consen  253 PRQTTAIDIWSAGVILLSLLSRRYPFFKAK  282 (418)
T ss_pred             cCcCCccceeeccceeehhhccccccccCc
Confidence            456889999999999999999999986543

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.93  E-value=4.1e-26  Score=226.03  Aligned_cols=266  Identities=21%  Similarity=0.267  Sum_probs=200.5

Q ss_pred             HHhcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCChHHHHHHHHHHHHHHhcC------CCCcceEeeEEeeCC
Q 009340          213 RATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKTQIHQFINEVVILSQIN------HRHIVKLLGCCLETE  285 (537)
Q Consensus       213 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------H~niv~l~g~~~~~~  285 (537)
                      ....+|......|+|-|++|-+|... -|+.||||++.... ..-+.=+.|+++|.+|+      .-++++|+-.|...+
T Consensus       429 ~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hkn  507 (752)
T KOG0670|consen  429 LLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKN  507 (752)
T ss_pred             hhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcc
Confidence            34568888889999999999999854 47899999998642 23345578999999995      348999999999999


Q ss_pred             ccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCC-C
Q 009340          286 VPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK-F  364 (537)
Q Consensus       286 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~-~  364 (537)
                      +++||+|-+.- +|.++|...+.         ..-|....+..++.|+.-||..|...+   |+|.||||.|||+.+. .
T Consensus       508 HLClVFE~Lsl-NLRevLKKyG~---------nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~  574 (752)
T KOG0670|consen  508 HLCLVFEPLSL-NLREVLKKYGR---------NVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKN  574 (752)
T ss_pred             eeEEEehhhhc-hHHHHHHHhCc---------ccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcc
Confidence            99999998744 89999987654         345888899999999999999999999   9999999999999864 5


Q ss_pred             cEEEeeccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHH
Q 009340          365 SAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFI  444 (537)
Q Consensus       365 ~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~  444 (537)
                      .+||||||-|........   +...-+..|.|||++.+..|+...|+||.||.||||.||+..|..........+...+.
T Consensus       575 iLKLCDfGSA~~~~enei---tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~K  651 (752)
T KOG0670|consen  575 ILKLCDFGSASFASENEI---TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELK  651 (752)
T ss_pred             eeeeccCccccccccccc---cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhc
Confidence            789999999987644321   22334567999999999999999999999999999999999987655443222221110


Q ss_pred             H-----HHhhch---------------------------hhhhhcH------Hhh-----ccccHHHHHHHHHHHHHhcc
Q 009340          445 S-----LAKENQ---------------------------LLEILDA------RVA-----KEAREEDIGAMAELAMRCLR  481 (537)
Q Consensus       445 ~-----~~~~~~---------------------------~~~~~d~------~~~-----~~~~~~~~~~l~~l~~~cl~  481 (537)
                      .     ++..+.                           +...+.|      .+.     .+-.......+.+|+..|+.
T Consensus       652 Gk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~  731 (752)
T KOG0670|consen  652 GKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLI  731 (752)
T ss_pred             CCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhc
Confidence            0     000000                           0001111      010     11123345678899999999


Q ss_pred             cCCCCCCCHhhHHH
Q 009340          482 LNSKKRPTMKQVSM  495 (537)
Q Consensus       482 ~~p~~RPs~~ev~~  495 (537)
                      .||+.|.|..+.++
T Consensus       732 LdP~KRit~nqAL~  745 (752)
T KOG0670|consen  732 LDPEKRITVNQALK  745 (752)
T ss_pred             cChhhcCCHHHHhc
Confidence            99999999998864

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.93  E-value=1.6e-26  Score=212.27  Aligned_cols=248  Identities=21%  Similarity=0.312  Sum_probs=193.5

Q ss_pred             ccccCcCCceEEEEEEcCCCCEEEEEEccC--CChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecCCCCC
Q 009340          221 SRFLGQGGFGTVYKGMLPDGSIVAVKRSKE--IDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGT  298 (537)
Q Consensus       221 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs  298 (537)
                      ..+|.+...|..|+|+|. |..+++|++..  ......++|-.|.-.|+-+.||||+.++|.|.....+.++..||+.||
T Consensus       195 ~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs  273 (448)
T KOG0195|consen  195 ITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS  273 (448)
T ss_pred             hhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence            457888889999999995 66677787653  333345678889888999999999999999999999999999999999


Q ss_pred             hhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCccccC
Q 009340          299 LSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIP  378 (537)
Q Consensus       299 L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~  378 (537)
                      |...|++...          -.++-.+..+++.++|+|++|||+.... |----|.+..+++|++.+++|+= +-.++. 
T Consensus       274 lynvlhe~t~----------vvvd~sqav~faldiargmaflhslep~-ipr~~lns~hvmidedltarism-ad~kfs-  340 (448)
T KOG0195|consen  274 LYNVLHEQTS----------VVVDHSQAVRFALDIARGMAFLHSLEPM-IPRFYLNSKHVMIDEDLTARISM-ADTKFS-  340 (448)
T ss_pred             HHHHHhcCcc----------EEEecchHHHHHHHHHhhHHHHhhcchh-hhhhhcccceEEecchhhhheec-ccceee-
Confidence            9999998543          2477889999999999999999998742 44456899999999999998852 111111 


Q ss_pred             CCCCceeeeccccccccCcccccCCCCC---cchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchhhhh
Q 009340          379 NDKTHLTTTIQGTFGYLDPEYFQSSQFT---DKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEI  455 (537)
Q Consensus       379 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t---~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  455 (537)
                          .......-.+.||+||.++..+-+   .++|+|||.+++|||.|...||....+-+-             +  ..+
T Consensus       341 ----fqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmec-------------g--mki  401 (448)
T KOG0195|consen  341 ----FQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMEC-------------G--MKI  401 (448)
T ss_pred             ----eeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhh-------------h--hhh
Confidence                111122346789999999876543   479999999999999999999864432111             0  111


Q ss_pred             hcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHH
Q 009340          456 LDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLR  501 (537)
Q Consensus       456 ~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~  501 (537)
                      .-..++..+|+..+..+.+|+.-|+..||.+||.+..|+-.|+++.
T Consensus       402 aleglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  402 ALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             hhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence            1224455677788889999999999999999999999999999864

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.92  E-value=1.6e-25  Score=205.82  Aligned_cols=257  Identities=22%  Similarity=0.331  Sum_probs=186.0

Q ss_pred             hcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCChHHHHHHHHHHHHHHhc-CCCCcceEeeE-EeeCCccEEEE
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKTQIHQFINEVVILSQI-NHRHIVKLLGC-CLETEVPVLVY  291 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~-~~~~~~~~lV~  291 (537)
                      .+.|.+.+.||+|.||.+-++..+ ..+.+++|.+... .....+|.+|...--.+ .|.||+.-++. +...+..++++
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q  101 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ  101 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence            367888899999999999999976 4678999988653 23457888988766666 58999987765 44556677899


Q ss_pred             ecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEE-C-CCCcEEEe
Q 009340          292 EYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILL-D-DKFSAKVS  369 (537)
Q Consensus       292 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll-~-~~~~~ki~  369 (537)
                      ||++.|+|..-+...             .+.+..-.+++.|+++||.|+|+.+   +||||||.+|||+ + +..++|+|
T Consensus       102 E~aP~gdL~snv~~~-------------GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlc  165 (378)
T KOG1345|consen  102 EFAPRGDLRSNVEAA-------------GIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLC  165 (378)
T ss_pred             ccCccchhhhhcCcc-------------cccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEee
Confidence            999999998877653             3666777889999999999999999   9999999999999 3 34589999


Q ss_pred             eccCccccCCCCCceeeeccccccccCcccccC---C--CCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHH
Q 009340          370 DFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQS---S--QFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFI  444 (537)
Q Consensus       370 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~--~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~  444 (537)
                      |||+.+..+..    .....-+..|.+||....   +  ...+.+|||.||++++.++||+.|+......+ ...+.|. 
T Consensus       166 DFG~t~k~g~t----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d-~~Y~~~~-  239 (378)
T KOG1345|consen  166 DFGLTRKVGTT----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMD-KPYWEWE-  239 (378)
T ss_pred             ecccccccCce----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccC-chHHHHH-
Confidence            99998754321    223334667999997643   2  34678999999999999999999998443322 2222221 


Q ss_pred             HHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHH
Q 009340          445 SLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLR  501 (537)
Q Consensus       445 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~  501 (537)
                       .+.........      ......++.+..+.++-+..++++|--..++.++-....
T Consensus       240 -~w~~rk~~~~P------~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w  289 (378)
T KOG1345|consen  240 -QWLKRKNPALP------KKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLW  289 (378)
T ss_pred             -HHhcccCccCc------hhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHH
Confidence             12211111100      011223456778888999999999977777766654433

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.91  E-value=3.5e-24  Score=215.52  Aligned_cols=169  Identities=20%  Similarity=0.210  Sum_probs=131.5

Q ss_pred             HHHHHHhcCCccccccCcCCceEEEEEEcC--CCCEEEEEEccCC-----ChHHHHHHHHHHHHHHhcCCCCcce-EeeE
Q 009340          209 DELQRATDNYNQSRFLGQGGFGTVYKGMLP--DGSIVAVKRSKEI-----DKTQIHQFINEVVILSQINHRHIVK-LLGC  280 (537)
Q Consensus       209 ~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~g~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~-l~g~  280 (537)
                      +......++|...+.||+|+||.||+|...  +++.||||+....     .....+.|.+|+++|++++|+|+++ +++ 
T Consensus        11 ~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~-   89 (365)
T PRK09188         11 DQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA-   89 (365)
T ss_pred             cccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE-
Confidence            334455678999999999999999999864  5788899986432     2334567899999999999999985 443 


Q ss_pred             EeeCCccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCC-CCCCEE
Q 009340          281 CLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDI-KSSNIL  359 (537)
Q Consensus       281 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dl-k~~NIl  359 (537)
                         .+..++||||+++++|... ..               ..   ...++.+++++|.|||+.+   |+|||| ||+|||
T Consensus        90 ---~~~~~LVmE~~~G~~L~~~-~~---------------~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NIL  144 (365)
T PRK09188         90 ---TGKDGLVRGWTEGVPLHLA-RP---------------HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWL  144 (365)
T ss_pred             ---cCCcEEEEEccCCCCHHHh-Cc---------------cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEE
Confidence               2457999999999999622 10               00   1357889999999999999   999999 999999


Q ss_pred             ECCCCcEEEeeccCccccCCCCCc-------eeeeccccccccCcccccCC
Q 009340          360 LDDKFSAKVSDFGISRSIPNDKTH-------LTTTIQGTFGYLDPEYFQSS  403 (537)
Q Consensus       360 l~~~~~~ki~Dfgla~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~  403 (537)
                      ++.++.+||+|||+++.+......       ..+...+++.|+|||++...
T Consensus       145 v~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        145 MGPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             EcCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            999999999999999876433211       11356688899999998653

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.89  E-value=1.7e-23  Score=214.16  Aligned_cols=244  Identities=23%  Similarity=0.397  Sum_probs=178.3

Q ss_pred             HHhcCCCCcceEeeEEeeCCccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 009340          266 LSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSAS  345 (537)
Q Consensus       266 l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~  345 (537)
                      |+.+.|.|+.+++|.+.+....+.|.+|+..|+|.|.+....           ..++|.....+..+|+.||.|||+..-
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~-----------~~~d~~F~~s~~rdi~~Gl~ylh~s~i   69 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED-----------IKLDYFFILSFIRDISKGLAYLHNSPI   69 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc-----------cCccHHHHHHHHHHHHHHHHHHhcCcc
Confidence            356899999999999999999999999999999999998732           369999999999999999999998762


Q ss_pred             CCeeecCCCCCCEEECCCCcEEEeeccCccccCCC-CCceeeeccccccccCcccccCC-------CCCcchhHHHHHHH
Q 009340          346 IPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPND-KTHLTTTIQGTFGYLDPEYFQSS-------QFTDKSDVYSFGVV  417 (537)
Q Consensus       346 ~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~-------~~t~ksDV~S~Gvl  417 (537)
                        ..|+.++++|+++|..+.+||+|||+....... .........-..-|.|||.+...       ..+.++||||||++
T Consensus        70 --~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii  147 (484)
T KOG1023|consen   70 --GYHGALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGII  147 (484)
T ss_pred             --eeeeeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHH
Confidence              299999999999999999999999998776421 11111112234569999998763       25678999999999


Q ss_pred             HHHHHhCCCCCCccchhhhccHHHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHH
Q 009340          418 LLELLTGKKPICFARVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMEL  497 (537)
Q Consensus       418 l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L  497 (537)
                      ++|+++.+.||.........   ......... .....+-|.+...  .+..+++..++.+||..+|++||++.+|-..+
T Consensus       148 ~~ei~~r~~~~~~~~~~~~~---~eii~~~~~-~~~~~~rP~i~~~--~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~  221 (484)
T KOG1023|consen  148 MYEILFRSGPFDLRNLVEDP---DEIILRVKK-GGSNPFRPSIELL--NELPPELLLLVARCWEEIPEKRPSIEQIRSKL  221 (484)
T ss_pred             HHHHHhccCccccccccCCh---HHHHHHHHh-cCCCCcCcchhhh--hhcchHHHHHHHHhcccChhhCccHHHHHhhh
Confidence            99999999999765433321   111111111 0011111111110  13334789999999999999999999999999


Q ss_pred             HHHHHhhHHHhhhhhhhhhccchhhhcccccc
Q 009340          498 EGLRRSQRCLEMCQVNQLLADEISLADNLMQE  529 (537)
Q Consensus       498 ~~i~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  529 (537)
                      +.+..... -...-.+.++.-.+++++|+|..
T Consensus       222 ~~~~~~~~-~~~nl~D~m~~~le~Y~~nLe~~  252 (484)
T KOG1023|consen  222 LTINKGGS-SKGNLMDSLFRMLESYADNLEKL  252 (484)
T ss_pred             hhhccccc-ccchhHHHHHHHHHHHHhhhHHH
Confidence            98887543 11133444555556777777653

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.88  E-value=3e-21  Score=193.19  Aligned_cols=261  Identities=30%  Similarity=0.440  Sum_probs=196.2

Q ss_pred             CccccccCcCCceEEEEEEcCCCCEEEEEEccCCCh---HHHHHHHHHHHHHHhcCCC-CcceEeeEEeeCCccEEEEec
Q 009340          218 YNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDK---TQIHQFINEVVILSQINHR-HIVKLLGCCLETEVPVLVYEY  293 (537)
Q Consensus       218 ~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~-niv~l~g~~~~~~~~~lV~e~  293 (537)
                      |.....||.|+||.||++...  ..+++|.+.....   .....|.+|+.+++.+.|+ +++++.+++......++++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            556778999999999999986  7899998865322   2467899999999999988 799999999777778999999


Q ss_pred             CCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCC-cEEEeecc
Q 009340          294 ISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF-SAKVSDFG  372 (537)
Q Consensus       294 ~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~-~~ki~Dfg  372 (537)
                      +.++++.+++......         ..+.......+..|++.++.|+|+.+   ++|||+||+||+++... .++++|||
T Consensus        80 ~~~~~l~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg  147 (384)
T COG0515          80 VDGGSLEDLLKKIGRK---------GPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFG  147 (384)
T ss_pred             CCCCcHHHHHHhcccc---------cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccC
Confidence            9999999666543210         25888999999999999999999999   99999999999999998 79999999


Q ss_pred             CccccCCCCCc-----eeeeccccccccCcccccC---CCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHH
Q 009340          373 ISRSIPNDKTH-----LTTTIQGTFGYLDPEYFQS---SQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFI  444 (537)
Q Consensus       373 la~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~---~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~  444 (537)
                      ++.........     ......|+..|+|||.+.+   ..++...|+||+|++++++++|..|+......   .......
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~---~~~~~~~  224 (384)
T COG0515         148 LAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS---SATSQTL  224 (384)
T ss_pred             cceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc---ccHHHHH
Confidence            99865443322     2356679999999999987   57889999999999999999999996544321   0000111


Q ss_pred             HHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHH
Q 009340          445 SLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSME  496 (537)
Q Consensus       445 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~  496 (537)
                      ......... .................+.+++..|+..+|..|.++.+....
T Consensus       225 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         225 KIILELPTP-SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             HHHHhcCCc-ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            111111000 000000000001223567789999999999999999987765

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.88  E-value=3.1e-21  Score=194.35  Aligned_cols=262  Identities=21%  Similarity=0.270  Sum_probs=193.2

Q ss_pred             CCccccccCcCCceEEEEEEcCCC--CEEEEEEccCCChHHHHHHHHHHHHHHhcCC----CCcceEeeEE-eeCCccEE
Q 009340          217 NYNQSRFLGQGGFGTVYKGMLPDG--SIVAVKRSKEIDKTQIHQFINEVVILSQINH----RHIVKLLGCC-LETEVPVL  289 (537)
Q Consensus       217 ~~~~~~~lg~G~~g~Vy~~~~~~g--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H----~niv~l~g~~-~~~~~~~l  289 (537)
                      +|...++||+|+||.||++...+.  ..+|+|............+..|..++..+.+    +++..+++.. ......++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            799999999999999999996543  4788887665333222266788888888863    5888888888 46667899


Q ss_pred             EEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCC-----C
Q 009340          290 VYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK-----F  364 (537)
Q Consensus       290 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~-----~  364 (537)
                      ||+.. +.+|.++.....          ...++..+.++|+.|++.+|.+||+.+   ++||||||.|+++...     .
T Consensus        99 VM~l~-G~sL~dl~~~~~----------~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~  164 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNP----------PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVR  164 (322)
T ss_pred             EEecc-CccHHHHHHhCC----------CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccc
Confidence            99987 559999775443          246899999999999999999999999   9999999999999765     4


Q ss_pred             cEEEeeccCcc--ccCCCCC-----ce--eeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhh
Q 009340          365 SAKVSDFGISR--SIPNDKT-----HL--TTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEE  435 (537)
Q Consensus       365 ~~ki~Dfgla~--~~~~~~~-----~~--~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~  435 (537)
                      .+.+.|||+++  .......     ..  .....||..|+++....+...+.+.|+||++-++.|+..|..|+.......
T Consensus       165 ~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~  244 (322)
T KOG1164|consen  165 TLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTD  244 (322)
T ss_pred             eEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccc
Confidence            69999999998  3321211     11  123459999999999999999999999999999999999999985433221


Q ss_pred             hccHHHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHHhh
Q 009340          436 ERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRSQ  504 (537)
Q Consensus       436 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~  504 (537)
                      .   ...+........    ...     ........+.++...+-..+..++|....+...|+......
T Consensus       245 ~---~~~~~~~~~~~~----~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~  301 (322)
T KOG1164|consen  245 L---KSKFEKDPRKLL----TDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE  301 (322)
T ss_pred             h---HHHHHHHhhhhc----ccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence            1   111111111100    000     11122345556666666689999999999999988776644

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.86  E-value=1.8e-22  Score=216.27  Aligned_cols=253  Identities=22%  Similarity=0.275  Sum_probs=187.2

Q ss_pred             cccccCcCCceEEEEEEc-CCCCEEEEEEcc-----CCC-hHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEe
Q 009340          220 QSRFLGQGGFGTVYKGML-PDGSIVAVKRSK-----EID-KTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE  292 (537)
Q Consensus       220 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~-----~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e  292 (537)
                      ..+.+|.|.+|.|+.... ...+..+.|...     ... ......+..|+.+-..++|+|++..+..+.+....+-+||
T Consensus       322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE  401 (601)
T KOG0590|consen  322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME  401 (601)
T ss_pred             ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence            467899999997776663 233334444322     111 1222236678888888999999888888777776666699


Q ss_pred             cCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeecc
Q 009340          293 YISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG  372 (537)
Q Consensus       293 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfg  372 (537)
                      |++. +|..++...            ..++-.++..++.|+..|+.|||+.+   |.|||+|++|++++.++.+||+|||
T Consensus       402 ~~~~-Dlf~~~~~~------------~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg  465 (601)
T KOG0590|consen  402 YCPY-DLFSLVMSN------------GKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFG  465 (601)
T ss_pred             cccH-HHHHHHhcc------------cccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecC
Confidence            9999 999988653            25788889999999999999999999   9999999999999999999999999


Q ss_pred             CccccCCCCC---ceeeeccccccccCcccccCCCCCc-chhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHh
Q 009340          373 ISRSIPNDKT---HLTTTIQGTFGYLDPEYFQSSQFTD-KSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAK  448 (537)
Q Consensus       373 la~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~t~-ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  448 (537)
                      .+..+..+..   .......|+..|+|||.+....|.+ ..||||.|+++..|++|+.||......+...     .....
T Consensus       466 ~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-----~~~~~  540 (601)
T KOG0590|consen  466 AASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-----KTNNY  540 (601)
T ss_pred             cceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-----hhhcc
Confidence            9987644333   4556788999999999999999986 5899999999999999999987654433211     00000


Q ss_pred             hchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHH
Q 009340          449 ENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSME  496 (537)
Q Consensus       449 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~  496 (537)
                      .........   ........+.+...++.++|+.+|..|-|+.+|++.
T Consensus       541 ~~~~~~~~~---~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d  585 (601)
T KOG0590|consen  541 SDQRNIFEG---PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND  585 (601)
T ss_pred             ccccccccC---hHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence            000000000   011223445677889999999999999999999753

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.85  E-value=6.4e-21  Score=176.49  Aligned_cols=139  Identities=18%  Similarity=0.128  Sum_probs=107.9

Q ss_pred             ccccCcCCceEEEEEEcCCCCEEEEEEccCCChH--H-------HHH-----------------HHHHHHHHHhcCCCCc
Q 009340          221 SRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKT--Q-------IHQ-----------------FINEVVILSQINHRHI  274 (537)
Q Consensus       221 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~--~-------~~~-----------------~~~E~~~l~~l~H~ni  274 (537)
                      ...||+|+||.||+|...+|+.||||.++.....  .       ...                 ...|+..+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            3579999999999999888999999998653210  0       112                 2349999999988776


Q ss_pred             ceEeeEEeeCCccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHH-hhcCCCCeeecCC
Q 009340          275 VKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYM-HSSASIPIFHRDI  353 (537)
Q Consensus       275 v~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yL-H~~~~~~ivH~Dl  353 (537)
                      .....+.  ....++||||++++++......            ...+++....+++.|++.+|.|+ |+.+   |+||||
T Consensus        82 ~~p~~~~--~~~~~iVmE~i~g~~l~~~~~~------------~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDl  144 (190)
T cd05147          82 PCPEPIL--LKSHVLVMEFIGDDGWAAPRLK------------DAPLSESKARELYLQVIQIMRILYQDCR---LVHADL  144 (190)
T ss_pred             CCCcEEE--ecCCEEEEEEeCCCCCcchhhh------------cCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCC
Confidence            4433322  2234899999998877654322            13588999999999999999999 6888   999999


Q ss_pred             CCCCEEECCCCcEEEeeccCcccc
Q 009340          354 KSSNILLDDKFSAKVSDFGISRSI  377 (537)
Q Consensus       354 k~~NIll~~~~~~ki~Dfgla~~~  377 (537)
                      ||+|||+++ +.++|+|||++...
T Consensus       145 kP~NIli~~-~~v~LiDFG~a~~~  167 (190)
T cd05147         145 SEYNLLYHD-GKLYIIDVSQSVEH  167 (190)
T ss_pred             CHHHEEEEC-CcEEEEEccccccC
Confidence            999999984 68999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.85  E-value=2.7e-21  Score=181.22  Aligned_cols=172  Identities=15%  Similarity=0.135  Sum_probs=133.0

Q ss_pred             HHhcCCccccccCcCCceEEEEEEcCCCCEEEEEEccCCCh---HHHHH------HHHHHHHHHhcCCCCcceEeeEEee
Q 009340          213 RATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDK---TQIHQ------FINEVVILSQINHRHIVKLLGCCLE  283 (537)
Q Consensus       213 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~---~~~~~------~~~E~~~l~~l~H~niv~l~g~~~~  283 (537)
                      -..++|...+.+|.|+||.||.... ++..+|||.+.....   ...+.      +.+|+..+.+++|++|..+..++..
T Consensus        28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~  106 (232)
T PRK10359         28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL  106 (232)
T ss_pred             HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence            3457999999999999999999666 577899999875322   22222      5789999999999999999988664


Q ss_pred             C--------CccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCC
Q 009340          284 T--------EVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKS  355 (537)
Q Consensus       284 ~--------~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~  355 (537)
                      .        ...+|||||+++.+|.++..                ++.    ....+++.+|..+|..+   ++|||++|
T Consensus       107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----------------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp  163 (232)
T PRK10359        107 AERKTLRYAHTYIMLIEYIEGVELNDMPE----------------ISE----DVKAKIKASIESLHQHG---MVSGDPHK  163 (232)
T ss_pred             cccccccccCCeEEEEEEECCccHHHhhh----------------ccH----HHHHHHHHHHHHHHHcC---CccCCCCh
Confidence            3        35799999999999977732                221    24558999999999999   99999999


Q ss_pred             CCEEECCCCcEEEeeccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHH
Q 009340          356 SNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELL  422 (537)
Q Consensus       356 ~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~  422 (537)
                      +||+++.++ ++|+|||.......+...             ..++....+..++|+||||+.+.-..
T Consensus       164 ~Nili~~~g-i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        164 GNFIVSKNG-LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             HHEEEeCCC-EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence            999999988 999999988755322111             11344455667999999999876553

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.85  E-value=1.1e-21  Score=210.15  Aligned_cols=248  Identities=22%  Similarity=0.305  Sum_probs=182.5

Q ss_pred             CCccccccCcCCceEEEEEEcCCCCEEEEEEccCCC-hHHHHHHHH---HHHHHHhcCCCCcceEeeEEeeCCccEEEEe
Q 009340          217 NYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEID-KTQIHQFIN---EVVILSQINHRHIVKLLGCCLETEVPVLVYE  292 (537)
Q Consensus       217 ~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~-~~~~~~~~~---E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e  292 (537)
                      ++...+.||.+.|=.|.+++.+.|. |+||.+-..+ .-..+.|.+   |++ ...++|||++++.-+-......|||-+
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq  101 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ  101 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence            6777889999999999999998887 8888764322 233344444   444 555689999999888777778899999


Q ss_pred             cCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeecc
Q 009340          293 YISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG  372 (537)
Q Consensus       293 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfg  372 (537)
                      |..+ +|.|.+..            +..|..-+..-|+.|++.||..+|..+   |+|||||.+|||++.-.-+.|+||.
T Consensus       102 yvkh-nLyDRlST------------RPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFA  165 (1431)
T KOG1240|consen  102 YVKH-NLYDRLST------------RPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFA  165 (1431)
T ss_pred             HHhh-hhhhhhcc------------chHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhccc
Confidence            9876 89888865            335777788889999999999999999   9999999999999999999999998


Q ss_pred             Ccccc--CCCCC----ceeeeccccccccCcccccCC-----------CCCcchhHHHHHHHHHHHHh-CCCCCCccchh
Q 009340          373 ISRSI--PNDKT----HLTTTIQGTFGYLDPEYFQSS-----------QFTDKSDVYSFGVVLLELLT-GKKPICFARVE  434 (537)
Q Consensus       373 la~~~--~~~~~----~~~~~~~gt~~y~aPE~~~~~-----------~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~  434 (537)
                      -.+..  +++..    +...+...-.+|+|||.+...           ..+++.||||+||++.||++ |+++|..... 
T Consensus       166 sFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL-  244 (1431)
T KOG1240|consen  166 SFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQL-  244 (1431)
T ss_pred             ccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHH-
Confidence            76543  22222    222333445689999987431           26789999999999999999 7888753211 


Q ss_pred             hhccHHHHHHH--HHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHH
Q 009340          435 EERNLVACFIS--LAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGL  500 (537)
Q Consensus       435 ~~~~~~~~~~~--~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i  500 (537)
                           ..+-..  ...+..+.++-|            ..+.+++..|++.||+.|-++++.++.-+++
T Consensus       245 -----~aYr~~~~~~~e~~Le~Ied------------~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~  295 (1431)
T KOG1240|consen  245 -----LAYRSGNADDPEQLLEKIED------------VSLRNLILSMIQRDPSKRLSAEDYLQKYRGL  295 (1431)
T ss_pred             -----HhHhccCccCHHHHHHhCcC------------ccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence                 110000  000011111112            2467899999999999999999999885543

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.83  E-value=9.7e-20  Score=169.12  Aligned_cols=141  Identities=18%  Similarity=0.145  Sum_probs=110.5

Q ss_pred             ccccCcCCceEEEEEEcCCCCEEEEEEccCCChH--------------------------HHHHHHHHHHHHHhcCCCCc
Q 009340          221 SRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKT--------------------------QIHQFINEVVILSQINHRHI  274 (537)
Q Consensus       221 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~--------------------------~~~~~~~E~~~l~~l~H~ni  274 (537)
                      ...||+|+||.||+|...+|+.||||.++.....                          ....+..|...+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            4579999999999999878999999987653210                          01224578999999999987


Q ss_pred             ceEeeEEeeCCccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeecCC
Q 009340          275 VKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHS-SASIPIFHRDI  353 (537)
Q Consensus       275 v~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-~~~~~ivH~Dl  353 (537)
                      .....+...  ..+|||||++++++......            ...++.....+++.+++.++.+||+ .+   |+||||
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~------------~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDl  144 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLK------------DVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDL  144 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhhh------------hccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCC
Confidence            554444332  34899999998865433211            1247778899999999999999999 88   999999


Q ss_pred             CCCCEEECCCCcEEEeeccCccccCC
Q 009340          354 KSSNILLDDKFSAKVSDFGISRSIPN  379 (537)
Q Consensus       354 k~~NIll~~~~~~ki~Dfgla~~~~~  379 (537)
                      ||+|||++ ++.++|+|||++.....
T Consensus       145 kP~NIll~-~~~~~liDFG~a~~~~~  169 (190)
T cd05145         145 SEYNILYH-DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             ChhhEEEE-CCCEEEEEcccceecCC
Confidence            99999999 78999999999987643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.82  E-value=8.4e-20  Score=165.59  Aligned_cols=261  Identities=20%  Similarity=0.284  Sum_probs=195.5

Q ss_pred             hcCCccccccCcCCceEEEEEE-cCCCCEEEEEEccCCChHHHHHHHHHHHHHHhcCC-CCcceEeeEEeeCCccEEEEe
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINH-RHIVKLLGCCLETEVPVLVYE  292 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~e  292 (537)
                      ...|...++||.|+||.+|.|. ..+|+.||||.-+....  -.++.-|.++...++| ..|..+..+..+...-.+||+
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd   91 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD   91 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence            3688999999999999999998 56899999998654222  2345678899999976 688888888888888999999


Q ss_pred             cCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECC---CCcEEEe
Q 009340          293 YISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD---KFSAKVS  369 (537)
Q Consensus       293 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~---~~~~ki~  369 (537)
                      .. +-||++++.-...           .++.++.+-+|-|++.-++|+|.++   ++||||||+|.|..-   ...+.++
T Consensus        92 LL-GPsLEdLfnfC~R-----------~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LI  156 (341)
T KOG1163|consen   92 LL-GPSLEDLFNFCSR-----------RFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLI  156 (341)
T ss_pred             cc-CccHHHHHHHHhh-----------hhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEE
Confidence            88 5599988865433           5889999999999999999999999   999999999999863   3468899


Q ss_pred             eccCccccCCCCCc------eeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHH
Q 009340          370 DFGISRSIPNDKTH------LTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACF  443 (537)
Q Consensus       370 Dfgla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~  443 (537)
                      |||||+...+-...      ......||.+|.+--...+-.-+.+-|+=|+|-+|..+--|..||..........     
T Consensus       157 DFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~Q-----  231 (341)
T KOG1163|consen  157 DFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQ-----  231 (341)
T ss_pred             eccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHH-----
Confidence            99999876432221      1234568999988877776677788999999999999999999997644322111     


Q ss_pred             HHHHhhchhhhhhcHHhhc---cccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHHhh
Q 009340          444 ISLAKENQLLEILDARVAK---EAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRSQ  504 (537)
Q Consensus       444 ~~~~~~~~~~~~~d~~~~~---~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~  504 (537)
                             +...+......-   ..-...+.++.-.+.-|-..--++-|+-.-+-+.+..+....
T Consensus       232 -------KyEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~l  288 (341)
T KOG1163|consen  232 -------KYEKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTL  288 (341)
T ss_pred             -------HHHHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhc
Confidence                   011111111111   111223456777778888888888888888777777665543

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.82  E-value=6.4e-19  Score=166.87  Aligned_cols=200  Identities=21%  Similarity=0.332  Sum_probs=166.1

Q ss_pred             cCCccccccCcCCceEEEEEE-cCCCCEEEEEEccCCChHHHHHHHHHHHHHHhcC-CCCcceEeeEEeeCCccEEEEec
Q 009340          216 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQFINEVVILSQIN-HRHIVKLLGCCLETEVPVLVYEY  293 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~  293 (537)
                      -+|...++||+|.||..+.|+ +-+++.||||.-...  ...-++..|.+..+.|. .++|...+-+..+...-.||+|.
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL  105 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL  105 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence            478899999999999999999 457999999975432  22345667888888774 68999888887777788999998


Q ss_pred             CCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECC-----CCcEEE
Q 009340          294 ISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD-----KFSAKV  368 (537)
Q Consensus       294 ~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~-----~~~~ki  368 (537)
                      + +-||+|++.-..           ..++.++++.+|.|+..-++|+|++.   +|.|||||+|.||..     ...+-|
T Consensus       106 L-GPSLEDLFD~Cg-----------R~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~Ihi  170 (449)
T KOG1165|consen  106 L-GPSLEDLFDLCG-----------RRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHI  170 (449)
T ss_pred             h-CcCHHHHHHHhc-----------CcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEE
Confidence            8 558998886653           37999999999999999999999999   999999999999953     346899


Q ss_pred             eeccCccccCCCCCc------eeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccc
Q 009340          369 SDFGISRSIPNDKTH------LTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFAR  432 (537)
Q Consensus       369 ~Dfgla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~  432 (537)
                      .|||+|+...+....      ......||.+||+--...+.+-+.+-|.=|+|-+++..+-|..||....
T Consensus       171 iDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLK  240 (449)
T KOG1165|consen  171 IDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK  240 (449)
T ss_pred             EeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccccc
Confidence            999999977544322      2345679999999998888888999999999999999999999997543

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.81  E-value=4.8e-19  Score=162.54  Aligned_cols=187  Identities=13%  Similarity=0.059  Sum_probs=139.4

Q ss_pred             ccccccCcCCceEEEEEEcCCCCEEEEEEccCCChH----HHHHHHHHHHHHHhcC-CCCcceEeeEEeeCCccEEEEec
Q 009340          219 NQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKT----QIHQFINEVVILSQIN-HRHIVKLLGCCLETEVPVLVYEY  293 (537)
Q Consensus       219 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~----~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~  293 (537)
                      .....|++|+||+||.+.- .+..++.+.+.....-    ....|.+|+++|++++ |+++++++++    +..+++|||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey   79 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY   79 (218)
T ss_pred             ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence            3467899999999997666 6778888877653321    1235789999999995 5889999886    346999999


Q ss_pred             CCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCC-CCCCEEECCCCcEEEeecc
Q 009340          294 ISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDI-KSSNILLDDKFSAKVSDFG  372 (537)
Q Consensus       294 ~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dl-k~~NIll~~~~~~ki~Dfg  372 (537)
                      +.+.+|.+.+..                   ....++.+++++|.++|+++   |+|||| ||+|||++.++.++|+|||
T Consensus        80 I~G~~L~~~~~~-------------------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG  137 (218)
T PRK12274         80 LAGAAMYQRPPR-------------------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQ  137 (218)
T ss_pred             ecCccHHhhhhh-------------------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECC
Confidence            999888644311                   01346789999999999999   999999 7999999999999999999


Q ss_pred             CccccCCCCCc----e--------eeeccccccccCcccccCC-CCC-cchhHHHHHHHHHHHHhCCCCCCccc
Q 009340          373 ISRSIPNDKTH----L--------TTTIQGTFGYLDPEYFQSS-QFT-DKSDVYSFGVVLLELLTGKKPICFAR  432 (537)
Q Consensus       373 la~~~~~~~~~----~--------~~~~~gt~~y~aPE~~~~~-~~t-~ksDV~S~Gvll~el~tg~~p~~~~~  432 (537)
                      ++.........    .        ......++.|++|+...-- ..+ ...+.++-|.-+|.++|++.+.....
T Consensus       138 ~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~  211 (218)
T PRK12274        138 LAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN  211 (218)
T ss_pred             CceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence            99865432210    0        0112357778888754321 223 46788999999999999998875443

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.79  E-value=3.2e-19  Score=194.99  Aligned_cols=198  Identities=23%  Similarity=0.297  Sum_probs=159.8

Q ss_pred             HHHhcCCccccccCcCCceEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHHHHhcC---CCCcceEeeEEeeCCccE
Q 009340          212 QRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQIN---HRHIVKLLGCCLETEVPV  288 (537)
Q Consensus       212 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~  288 (537)
                      +.--..|.+.+.||+|+||+||+|...+|+.||+|.-+....   -+|.=-.+++.+|+   -+.+..+..++.-.+..+
T Consensus       694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~---WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~  770 (974)
T KOG1166|consen  694 EVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNP---WEFYICLQVMERLKPQMLPSIMHISSAHVFQNASV  770 (974)
T ss_pred             eecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCc---eeeeehHHHHHhhchhhhcchHHHHHHHccCCcce
Confidence            334467778889999999999999988899999998876433   22332334444454   234555555566677789


Q ss_pred             EEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEC-------
Q 009340          289 LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD-------  361 (537)
Q Consensus       289 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~-------  361 (537)
                      ||+||.+.|||.+++..            .+.++|...+.++.|+++.++.||..+   ||||||||+|.||.       
T Consensus       771 lv~ey~~~Gtlld~~N~------------~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~  835 (974)
T KOG1166|consen  771 LVSEYSPYGTLLDLINT------------NKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADS  835 (974)
T ss_pred             eeeeccccccHHHhhcc------------CCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCC
Confidence            99999999999999984            346999999999999999999999999   99999999999993       


Q ss_pred             CCCcEEEeeccCccccCCC-CCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCC
Q 009340          362 DKFSAKVSDFGISRSIPND-KTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP  427 (537)
Q Consensus       362 ~~~~~ki~Dfgla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p  427 (537)
                      ++..++|+|||-+..+.-- ........++|-.+--+|...+..++.++|-|.++.+++-|+.|+..
T Consensus       836 ~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~  902 (974)
T KOG1166|consen  836 DSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM  902 (974)
T ss_pred             cccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence            3557999999998655211 12345667889999999999999999999999999999999999764

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.79  E-value=2.6e-19  Score=172.90  Aligned_cols=237  Identities=21%  Similarity=0.277  Sum_probs=151.0

Q ss_pred             CCccccccCcCCceEEEEEEcC-CCCEEEEEEccC---CChHHHHHHHHHHHHHHhcC----------CCCcceEeeEEe
Q 009340          217 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKE---IDKTQIHQFINEVVILSQIN----------HRHIVKLLGCCL  282 (537)
Q Consensus       217 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~----------H~niv~l~g~~~  282 (537)
                      .+...+.||.|+++.||.++.. .|+.+|||....   ......+++.+|.-....+.          |-.++..++...
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            3445678999999999999965 589999997542   22334666777765555532          222332222221


Q ss_pred             e---------C---C-----ccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 009340          283 E---------T---E-----VPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSAS  345 (537)
Q Consensus       283 ~---------~---~-----~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~  345 (537)
                      -         .   .     +.+++|+-+ .++|.+++..-......     ...+....++.+..|+++.+++||+.+ 
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~-----~~~l~~~arl~lT~Q~I~lvA~Lh~~G-  165 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQT-----HSPLAFAARLSLTVQMIRLVANLHSYG-  165 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTT-----SHHHHHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred             EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccc-----cchhHHHHHHHHHHHHHHHHHHHhhcc-
Confidence            1         1   1     236778777 45888776542221100     123556677888899999999999999 


Q ss_pred             CCeeecCCCCCCEEECCCCcEEEeeccCccccCCCCCceeeeccccccccCcccccC--------CCCCcchhHHHHHHH
Q 009340          346 IPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQS--------SQFTDKSDVYSFGVV  417 (537)
Q Consensus       346 ~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~t~ksDV~S~Gvl  417 (537)
                        +||+||+|+|++++.+|.+.|+||+.....+..   ... ...+..|.+||....        -.+|.+.|.|++|++
T Consensus       166 --lVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~---~~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~  239 (288)
T PF14531_consen  166 --LVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTR---YRC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGIT  239 (288)
T ss_dssp             --EEEST-SGGGEEE-TTS-EEE--GGGEEETTEE---EEG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHH
T ss_pred             --eEecccceeeEEEcCCCCEEEcChHHHeecCce---eec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHH
Confidence              999999999999999999999999877654321   111 345678999997643        247889999999999


Q ss_pred             HHHHHhCCCCCCccchhhhccHHHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCC
Q 009340          418 LLELLTGKKPICFARVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKR  487 (537)
Q Consensus       418 l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~R  487 (537)
                      +|.|++|+.||...........                    .-..+. +.++.+..|+..+|+.||.+|
T Consensus       240 ly~lWC~~lPf~~~~~~~~~~~--------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  240 LYSLWCGRLPFGLSSPEADPEW--------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHHHHHSS-STCCCGGGSTSGG--------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             HHHHHHccCCCCCCCccccccc--------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence            9999999999976543321110                    112344 667788999999999999988

>PRK10345 hypothetical protein; Provisional

Probab=99.78  E-value=2.3e-18  Score=161.02  Aligned_cols=137  Identities=15%  Similarity=0.149  Sum_probs=106.3

Q ss_pred             CccccccCcCCceEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHHHHhc-----CCCCcceEeeEEeeCC---c-cE
Q 009340          218 YNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQI-----NHRHIVKLLGCCLETE---V-PV  288 (537)
Q Consensus       218 ~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~H~niv~l~g~~~~~~---~-~~  288 (537)
                      ++..+.||+|+||.||. .-.++. .+||+.........+.+.+|+.+++.+     .||||++++|++.++.   . ..
T Consensus         4 L~~~~~LG~G~~~~Vy~-hp~~~~-k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~   81 (210)
T PRK10345          4 LSEQSPLGTGRHRKCYA-HPEDAQ-RCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD   81 (210)
T ss_pred             cCCcceecCCCceEEEE-CCCCcC-eEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence            34567899999999996 323444 479987754444567799999999999     5799999999998874   2 33


Q ss_pred             EEEec--CCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHH-HHHhhcCCCCeeecCCCCCCEEECC---
Q 009340          289 LVYEY--ISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAV-AYMHSSASIPIFHRDIKSSNILLDD---  362 (537)
Q Consensus       289 lV~e~--~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl-~yLH~~~~~~ivH~Dlk~~NIll~~---  362 (537)
                      +|+||  +++|+|.+++.+.             .+++.  ..++.+++.++ +|||+++   |+||||||+|||++.   
T Consensus        82 ~I~e~~G~~~~tL~~~l~~~-------------~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~  143 (210)
T PRK10345         82 VIADFDGKPSITLTEFAEQC-------------RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISE  143 (210)
T ss_pred             EEecCCCCcchhHHHHHHcc-------------cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCC
Confidence            78999  5589999999642             24444  35677888777 9999999   999999999999973   


Q ss_pred             -CCcEEEeeccCc
Q 009340          363 -KFSAKVSDFGIS  374 (537)
Q Consensus       363 -~~~~ki~Dfgla  374 (537)
                       +.+++|+||+.+
T Consensus       144 ~~~~~~LiDg~G~  156 (210)
T PRK10345        144 SEVIPVVCDNIGE  156 (210)
T ss_pred             CCCcEEEEECCCC
Confidence             348999995544

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.76  E-value=2.1e-19  Score=180.75  Aligned_cols=173  Identities=24%  Similarity=0.350  Sum_probs=132.2

Q ss_pred             ccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCc
Q 009340          286 VPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFS  365 (537)
Q Consensus       286 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~  365 (537)
                      ..|+.|+++...+|.+||.....         ....+|...+.++.|++.|+.|   ++   .+|+|+||.||+...+..
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~---------~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q  394 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRT---------GEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQ  394 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCc---------ccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchh
Confidence            46899999999999999976543         4468899999999999999999   66   899999999999999999


Q ss_pred             EEEeeccCccccCCCC-----CceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccH
Q 009340          366 AKVSDFGISRSIPNDK-----THLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNL  439 (537)
Q Consensus       366 ~ki~Dfgla~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~  439 (537)
                      +||.|||+........     ....+...||..||+||.+.+..|+.|+||||+|++|+||+. =..+++...       
T Consensus       395 ~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~-------  467 (516)
T KOG1033|consen  395 LKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIA-------  467 (516)
T ss_pred             hhhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHH-------
Confidence            9999999988765444     223455679999999999999999999999999999999997 333322110       


Q ss_pred             HHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhh
Q 009340          440 VACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQ  492 (537)
Q Consensus       440 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  492 (537)
                         ...-++    ..++++....+++     .=+.|+.+++.+.|.+||++.+
T Consensus       468 ---t~~d~r----~g~ip~~~~~d~p-----~e~~ll~~lls~~p~~RP~~~~  508 (516)
T KOG1033|consen  468 ---TLTDIR----DGIIPPEFLQDYP-----EEYTLLQQLLSPSPEERPSAIE  508 (516)
T ss_pred             ---hhhhhh----cCCCChHHhhcCc-----HHHHHHHHhcCCCcccCchHHH
Confidence               000011    1223333333344     3357899999999999994443

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.76  E-value=1.7e-19  Score=184.70  Aligned_cols=225  Identities=26%  Similarity=0.327  Sum_probs=174.6

Q ss_pred             ccCcCCceEEEEEE----cCCCCEEEEEEccCCChH--HHHHHHHHHHHHHhcC-CCCcceEeeEEeeCCccEEEEecCC
Q 009340          223 FLGQGGFGTVYKGM----LPDGSIVAVKRSKEIDKT--QIHQFINEVVILSQIN-HRHIVKLLGCCLETEVPVLVYEYIS  295 (537)
Q Consensus       223 ~lg~G~~g~Vy~~~----~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~  295 (537)
                      .+|+|.||.|+...    .+.|..+|.|.++.....  .......|..++..++ |+.++++.-.+..+...+++.+|..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            37899999998754    335777888876542111  1114556888888887 9999999999999999999999999


Q ss_pred             CCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCcc
Q 009340          296 SGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISR  375 (537)
Q Consensus       296 ~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~  375 (537)
                      +|.|...+....            .++..........+|-+++++|+.+   ++|||+|++||+++.+|.+++.|||+++
T Consensus        81 gg~lft~l~~~~------------~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglsk  145 (612)
T KOG0603|consen   81 GGDLFTRLSKEV------------MFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSK  145 (612)
T ss_pred             cchhhhccccCC------------chHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhh
Confidence            999988876532            3566666677788899999999999   9999999999999999999999999998


Q ss_pred             ccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchhhhh
Q 009340          376 SIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEI  455 (537)
Q Consensus       376 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  455 (537)
                      ..-.....     +||..|||||++.  .....+|.||||++.+||+||..||....          ...         +
T Consensus       146 e~v~~~~~-----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~~----------~~~---------I  199 (612)
T KOG0603|consen  146 EAVKEKIA-----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGDT----------MKR---------I  199 (612)
T ss_pred             HhHhhhhc-----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchHH----------HHH---------H
Confidence            76433221     7999999999998  45678999999999999999999986410          111         1


Q ss_pred             hcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCH
Q 009340          456 LDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTM  490 (537)
Q Consensus       456 ~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~  490 (537)
                      +.  .....+........+++.+++..+|..|-..
T Consensus       200 l~--~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  200 LK--AELEMPRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             hh--hccCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence            11  1112455666677788888888888888655

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.75  E-value=1.7e-17  Score=156.88  Aligned_cols=134  Identities=21%  Similarity=0.304  Sum_probs=113.4

Q ss_pred             cccCcCCceEEEEEEcCCCCEEEEEEccCCC---h-----HHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEec
Q 009340          222 RFLGQGGFGTVYKGMLPDGSIVAVKRSKEID---K-----TQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY  293 (537)
Q Consensus       222 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~---~-----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  293 (537)
                      +.||+|++|.||+|.. +|..|++|......   .     .....+.+|+.++..++|+++.....++.+.+..++||||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5799999999999998 67789999755321   1     1234578899999999999998888887777888999999


Q ss_pred             CCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccC
Q 009340          294 ISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGI  373 (537)
Q Consensus       294 ~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgl  373 (537)
                      +++++|.+++..               ..+ .+..++.+++.+|.+||+.+   ++|||++|.|||++ ++.++|+|||+
T Consensus        81 ~~G~~L~~~~~~---------------~~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~  140 (211)
T PRK14879         81 IEGEPLKDLINS---------------NGM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGL  140 (211)
T ss_pred             eCCcCHHHHHHh---------------ccH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCc
Confidence            999999988853               122 77899999999999999999   99999999999999 78999999998


Q ss_pred             ccc
Q 009340          374 SRS  376 (537)
Q Consensus       374 a~~  376 (537)
                      +..
T Consensus       141 a~~  143 (211)
T PRK14879        141 AEF  143 (211)
T ss_pred             ccC
Confidence            864

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.74  E-value=1.5e-17  Score=161.08  Aligned_cols=197  Identities=21%  Similarity=0.263  Sum_probs=140.2

Q ss_pred             CCCCcceEeeEEeeC---------------------------CccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCC
Q 009340          270 NHRHIVKLLGCCLET---------------------------EVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLS  322 (537)
Q Consensus       270 ~H~niv~l~g~~~~~---------------------------~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~  322 (537)
                      +|||||++.++|.++                           ...|+||.-.+. +|.+++...             ..+
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~-------------~~s  339 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR-------------HRS  339 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC-------------CCc
Confidence            599999999887542                           235888887765 888888642             455


Q ss_pred             HHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEE--CCC--CcEEEeeccCccccCCCC---Cc--eeeecccccc
Q 009340          323 WENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILL--DDK--FSAKVSDFGISRSIPNDK---TH--LTTTIQGTFG  393 (537)
Q Consensus       323 ~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll--~~~--~~~ki~Dfgla~~~~~~~---~~--~~~~~~gt~~  393 (537)
                      ...+.-|+.|+++|+.|||.++   |.|||+|+.|||+  |+|  -...|+|||.+--.....   .+  ......|...
T Consensus       340 ~r~~~~~laQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~  416 (598)
T KOG4158|consen  340 YRTGRVILAQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAK  416 (598)
T ss_pred             hHHHHHHHHHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcce
Confidence            6667778999999999999999   9999999999998  333  457899999875332211   01  1123446778


Q ss_pred             ccCcccccCCCC------CcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchhhhhhcHHhhccccHH
Q 009340          394 YLDPEYFQSSQF------TDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEILDARVAKEAREE  467 (537)
Q Consensus       394 y~aPE~~~~~~~------t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  467 (537)
                      -||||+....+-      -.|+|.|+.|.+.||+++...||+....   ..+..  .. ..+.         .....+..
T Consensus       417 lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGe---m~L~~--r~-Yqe~---------qLPalp~~  481 (598)
T KOG4158|consen  417 LMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGE---MLLDT--RT-YQES---------QLPALPSR  481 (598)
T ss_pred             ecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccch---heech--hh-hhhh---------hCCCCccc
Confidence            999999864321      2599999999999999999999975211   00000  00 1111         12234556


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHhhHHHHHH
Q 009340          468 DIGAMAELAMRCLRLNSKKRPTMKQVSMELE  498 (537)
Q Consensus       468 ~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~  498 (537)
                      +.+.+.+|+...|+.||++|++..-....|.
T Consensus       482 vpp~~rqlV~~lL~r~pskRvsp~iAANvl~  512 (598)
T KOG4158|consen  482 VPPVARQLVFDLLKRDPSKRVSPNIAANVLN  512 (598)
T ss_pred             CChHHHHHHHHHhcCCccccCCccHHHhHHH
Confidence            6678889999999999999998876655553

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.74  E-value=3.9e-17  Score=152.80  Aligned_cols=145  Identities=22%  Similarity=0.196  Sum_probs=111.8

Q ss_pred             HHHHHhcCCccccccCcCCceEEEEEEcCCCCEEEEEEccCCCh----------------------HHHHHHHHHHHHHH
Q 009340          210 ELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDK----------------------TQIHQFINEVVILS  267 (537)
Q Consensus       210 el~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~----------------------~~~~~~~~E~~~l~  267 (537)
                      ++......|...+.||+|+||.||++...+|+.||||+......                      .....+..|..++.
T Consensus         9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   88 (198)
T cd05144           9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK   88 (198)
T ss_pred             HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence            34444445777889999999999999988899999997653210                      01123567899999


Q ss_pred             hcCCCC--cceEeeEEeeCCccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 009340          268 QINHRH--IVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSAS  345 (537)
Q Consensus       268 ~l~H~n--iv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~  345 (537)
                      .+.|++  +...++.    ...++||||+++++|.+....                  .....++.++++++.++|+.+ 
T Consensus        89 ~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~------------------~~~~~~~~~i~~~l~~lh~~g-  145 (198)
T cd05144          89 ALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL------------------EDPEEVLDEILEEIVKAYKHG-  145 (198)
T ss_pred             HHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc------------------ccHHHHHHHHHHHHHHHHHCC-
Confidence            998874  4444442    455899999999998765421                  224578899999999999988 


Q ss_pred             CCeeecCCCCCCEEECCCCcEEEeeccCccccCC
Q 009340          346 IPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPN  379 (537)
Q Consensus       346 ~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~  379 (537)
                        ++||||+|+||++++++.++|+|||++.....
T Consensus       146 --i~H~Dl~p~Nill~~~~~~~liDfg~~~~~~~  177 (198)
T cd05144         146 --IIHGDLSEFNILVDDDEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             --CCcCCCCcccEEEcCCCcEEEEECCccccCCC
Confidence              99999999999999999999999999976543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>smart00090 RIO RIO-like kinase

Probab=99.73  E-value=3.4e-17  Score=156.86  Aligned_cols=142  Identities=17%  Similarity=0.130  Sum_probs=110.2

Q ss_pred             CCccccccCcCCceEEEEEE--cCCCCEEEEEEccCCChH------------------------HHHHHHHHHHHHHhcC
Q 009340          217 NYNQSRFLGQGGFGTVYKGM--LPDGSIVAVKRSKEIDKT------------------------QIHQFINEVVILSQIN  270 (537)
Q Consensus       217 ~~~~~~~lg~G~~g~Vy~~~--~~~g~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~  270 (537)
                      .|...+.||+|+||.||+|.  ..+|+.||+|.++.....                        ....+..|+.++.++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            46678899999999999998  568999999987642110                        1123568999999997


Q ss_pred             CC--CcceEeeEEeeCCccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 009340          271 HR--HIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPI  348 (537)
Q Consensus       271 H~--niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~i  348 (537)
                      +.  .+.+++++    ...++||||+++++|.......            ..+.......++.|+++++.+||+.+.  +
T Consensus       109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~------------~~~~~~~~~~i~~qi~~~l~~LH~~g~--i  170 (237)
T smart00090      109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD------------VEPEEEEEFELYDDILEEMRKLYKEGE--L  170 (237)
T ss_pred             hcCCCCCeeeEe----cCceEEEEEecCCccccccccc------------CCcchHHHHHHHHHHHHHHHHHHhcCC--E
Confidence            53  34445543    2358999999998887665321            134555678999999999999999874  9


Q ss_pred             eecCCCCCCEEECCCCcEEEeeccCcccc
Q 009340          349 FHRDIKSSNILLDDKFSAKVSDFGISRSI  377 (537)
Q Consensus       349 vH~Dlk~~NIll~~~~~~ki~Dfgla~~~  377 (537)
                      +||||||+||+++ ++.++|+|||.+...
T Consensus       171 iH~Dikp~NIli~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      171 VHGDLSEYNILVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             EeCCCChhhEEEE-CCCEEEEEChhhhcc
Confidence            9999999999999 789999999998754

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.72  E-value=9e-17  Score=150.42  Aligned_cols=130  Identities=21%  Similarity=0.324  Sum_probs=107.1

Q ss_pred             ccCcCCceEEEEEEcCCCCEEEEEEccCCC--------hHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecC
Q 009340          223 FLGQGGFGTVYKGMLPDGSIVAVKRSKEID--------KTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI  294 (537)
Q Consensus       223 ~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  294 (537)
                      .||+|+||.||+|.+ +|..|++|......        .....++.+|+.++..++|+++.....++...+..++||||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            489999999999997 57889999854311        112356788999999999887766666666677789999999


Q ss_pred             CCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCc
Q 009340          295 SSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGIS  374 (537)
Q Consensus       295 ~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla  374 (537)
                      ++++|.+++....             .      .++.+++++|.+||+.+   ++|||++|.||+++ ++.+++.|||++
T Consensus        80 ~g~~l~~~~~~~~-------------~------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a  136 (199)
T TIGR03724        80 EGKPLKDVIEEGN-------------D------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLG  136 (199)
T ss_pred             CCccHHHHHhhcH-------------H------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCC
Confidence            9999988875311             0      78999999999999999   99999999999999 789999999988


Q ss_pred             cc
Q 009340          375 RS  376 (537)
Q Consensus       375 ~~  376 (537)
                      ..
T Consensus       137 ~~  138 (199)
T TIGR03724       137 KY  138 (199)
T ss_pred             cC
Confidence            65

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.71  E-value=7.6e-17  Score=173.43  Aligned_cols=137  Identities=19%  Similarity=0.302  Sum_probs=111.7

Q ss_pred             hcCCccccccCcCCceEEEEEEcCCCCEEEEEE-ccC-C------ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCc
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKR-SKE-I------DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEV  286 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~-~~~-~------~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~  286 (537)
                      ...|...+.||+|+||.||+|.+.+.. +++|+ ... .      .....+++.+|++++..++|++++....++.+...
T Consensus       332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~  410 (535)
T PRK09605        332 KRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE  410 (535)
T ss_pred             ccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence            345566789999999999999985443 44443 221 1      11224568899999999999999998888888778


Q ss_pred             cEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcE
Q 009340          287 PVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA  366 (537)
Q Consensus       287 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~  366 (537)
                      .++||||+++++|.+++.                    ....++.+++++|.|||+.+   ++||||||+|||+ +++.+
T Consensus       411 ~~lv~E~~~g~~L~~~l~--------------------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~  466 (535)
T PRK09605        411 KTIVMEYIGGKDLKDVLE--------------------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRL  466 (535)
T ss_pred             CEEEEEecCCCcHHHHHH--------------------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcE
Confidence            899999999999988874                    23568999999999999999   9999999999999 57799


Q ss_pred             EEeeccCccc
Q 009340          367 KVSDFGISRS  376 (537)
Q Consensus       367 ki~Dfgla~~  376 (537)
                      +|+|||+++.
T Consensus       467 ~liDFGla~~  476 (535)
T PRK09605        467 YLIDFGLGKY  476 (535)
T ss_pred             EEEeCccccc
Confidence            9999999975

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.63  E-value=2.3e-15  Score=139.35  Aligned_cols=136  Identities=21%  Similarity=0.236  Sum_probs=98.5

Q ss_pred             ccccCcCCceEEEEEEcCCCCEEEEEEccCCChH--HHHHH----------------------HHHHHHHHhcCCC--Cc
Q 009340          221 SRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKT--QIHQF----------------------INEVVILSQINHR--HI  274 (537)
Q Consensus       221 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~--~~~~~----------------------~~E~~~l~~l~H~--ni  274 (537)
                      .+.||+|+||.||+|...+|+.||||..+.....  ....+                      ..|...+.++.+.  .+
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            4679999999999999888999999987642211  11111                      3466666666443  34


Q ss_pred             ceEeeEEeeCCccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeecCC
Q 009340          275 VKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHS-SASIPIFHRDI  353 (537)
Q Consensus       275 v~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-~~~~~ivH~Dl  353 (537)
                      .+.+++    ...++||||++++++........            ... .....++.+++.++.++|. .+   |+||||
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~------------~~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl  141 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV------------RLL-EDPEELYDQILELMRKLYREAG---LVHGDL  141 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhh------------hhc-ccHHHHHHHHHHHHHHHhhccC---cCcCCC
Confidence            445443    34589999999966432211110            011 5568899999999999999 87   999999


Q ss_pred             CCCCEEECCCCcEEEeeccCcccc
Q 009340          354 KSSNILLDDKFSAKVSDFGISRSI  377 (537)
Q Consensus       354 k~~NIll~~~~~~ki~Dfgla~~~  377 (537)
                      ||+||+++ ++.++++|||.+...
T Consensus       142 ~p~Nili~-~~~~~liDfg~a~~~  164 (187)
T cd05119         142 SEYNILVD-DGKVYIIDVPQAVEI  164 (187)
T ss_pred             ChhhEEEE-CCcEEEEECcccccc
Confidence            99999999 889999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.63  E-value=2.6e-16  Score=169.27  Aligned_cols=210  Identities=26%  Similarity=0.381  Sum_probs=143.6

Q ss_pred             hcCCccccccCcCCceEEEEEEcCC-CCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEec
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLPD-GSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY  293 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  293 (537)
                      ..+|+..+.|..|++|.||..+.+. .+..|.|.-+...            ++     +||..+      .+..+.|   
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~l------------il-----Rnilt~------a~npfvv---  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNL------------IL-----RNILTF------AGNPFVV---  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhcccccch------------hh-----hccccc------cCCccee---
Confidence            3688889999999999999998653 4567775433210            11     112111      1222333   


Q ss_pred             CCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccC
Q 009340          294 ISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGI  373 (537)
Q Consensus       294 ~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgl  373 (537)
                         |+-...+...            .+++.        +.+.+++|||+.+   |+|||+||.|.+++.-|.+|++|||+
T Consensus       136 ---gDc~tllk~~------------g~lPv--------dmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgL  189 (1205)
T KOG0606|consen  136 ---GDCATLLKNI------------GPLPV--------DMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGL  189 (1205)
T ss_pred             ---chhhhhcccC------------CCCcc--------hhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhh
Confidence               3333333321            12322        2378899999999   99999999999999999999999999


Q ss_pred             ccccCCCC--------------CceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccH
Q 009340          374 SRSIPNDK--------------THLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNL  439 (537)
Q Consensus       374 a~~~~~~~--------------~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~  439 (537)
                      ++......              ......++||+.|.|||++....|...+|.|++|+|+||.+-|..||.....++-   
T Consensus       190 sk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeel---  266 (1205)
T KOG0606|consen  190 SKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL---  266 (1205)
T ss_pred             hhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHH---
Confidence            87432110              1112356899999999999999999999999999999999999999987766542   


Q ss_pred             HHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCH
Q 009340          440 VACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTM  490 (537)
Q Consensus       440 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~  490 (537)
                         |...+.+.        ....+.......+..+++.+.|+.+|.+|--.
T Consensus       267 ---fg~visd~--------i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt  306 (1205)
T KOG0606|consen  267 ---FGQVISDD--------IEWPEEDEALPPEAQDLIEQLLRQNPLCRLGT  306 (1205)
T ss_pred             ---Hhhhhhhh--------ccccccCcCCCHHHHHHHHHHHHhChHhhccc
Confidence               11111111        11112233445678899999999999999433

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.61  E-value=9.2e-15  Score=129.63  Aligned_cols=135  Identities=23%  Similarity=0.222  Sum_probs=113.4

Q ss_pred             cccccCcCCceEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHHHHhcCC--CCcceEeeEEeeCCccEEEEecCCCC
Q 009340          220 QSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINH--RHIVKLLGCCLETEVPVLVYEYISSG  297 (537)
Q Consensus       220 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lV~e~~~~g  297 (537)
                      ..+.||+|.++.||++... +..+++|.......  ...+.+|+..+..++|  .++++++++....+..++++||++++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~-~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~   78 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTK-DEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE   78 (155)
T ss_pred             cceecccccccceEEEEec-CCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence            3567999999999999985 47899999876433  4578899999999976  58999999888778899999999987


Q ss_pred             ChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCccc
Q 009340          298 TLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS  376 (537)
Q Consensus       298 sL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~  376 (537)
                      ++..+                   ++.....++.++++++.+||......++|+|++|+||++++++.+++.|||.+..
T Consensus        79 ~~~~~-------------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          79 TLDEV-------------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             ecccC-------------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            77533                   3445577899999999999997545599999999999999989999999998864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.59  E-value=1.5e-14  Score=138.79  Aligned_cols=135  Identities=20%  Similarity=0.261  Sum_probs=105.0

Q ss_pred             ccccC-cCCceEEEEEEcCCCCEEEEEEccCC-------------ChHHHHHHHHHHHHHHhcCCCCc--ceEeeEEeeC
Q 009340          221 SRFLG-QGGFGTVYKGMLPDGSIVAVKRSKEI-------------DKTQIHQFINEVVILSQINHRHI--VKLLGCCLET  284 (537)
Q Consensus       221 ~~~lg-~G~~g~Vy~~~~~~g~~vavK~~~~~-------------~~~~~~~~~~E~~~l~~l~H~ni--v~l~g~~~~~  284 (537)
                      ...|| .||.|+||+.... +..++||+....             .......+.+|+.++.+++|+++  ++.+++....
T Consensus        36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            35687 8999999999884 677999977431             11233567889999999998875  7777775543


Q ss_pred             Cc----cEEEEecCCC-CChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEE
Q 009340          285 EV----PVLVYEYISS-GTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNIL  359 (537)
Q Consensus       285 ~~----~~lV~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIl  359 (537)
                      ..    .++|+|++++ .+|.+++...             .++..    .+.+++++|.+||+.+   |+||||||.|||
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~-------------~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NIL  174 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQEA-------------PLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNIL  174 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhcC-------------CCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEE
Confidence            32    3599999997 6888887531             23332    3568999999999999   999999999999


Q ss_pred             ECCCCcEEEeeccCccc
Q 009340          360 LDDKFSAKVSDFGISRS  376 (537)
Q Consensus       360 l~~~~~~ki~Dfgla~~  376 (537)
                      ++.++.++|+|||.+..
T Consensus       175 v~~~~~v~LIDfg~~~~  191 (239)
T PRK01723        175 LDPDGKFWLIDFDRGEL  191 (239)
T ss_pred             EcCCCCEEEEECCCccc
Confidence            99988999999998875

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.54  E-value=5.2e-16  Score=166.63  Aligned_cols=253  Identities=23%  Similarity=0.323  Sum_probs=187.2

Q ss_pred             hcCCccccccCcCCceEEEEEEcC--CCCEEEEEEccCCC--hHHHHHHHHHHHHHHhcC-CCCcceEeeEEeeCCccEE
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLP--DGSIVAVKRSKEID--KTQIHQFINEVVILSQIN-HRHIVKLLGCCLETEVPVL  289 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~--~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~l  289 (537)
                      ...|...+.||+|.|+.|-.....  ....+|+|......  ....+....|..+-..+. |+|++++++...+.+..++
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~   98 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL   98 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence            346667778999999999877643  34567777665432  233344445777777776 9999999999999999999


Q ss_pred             EEecCCCCChhhhh-hhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh-hcCCCCeeecCCCCCCEEECCCC-cE
Q 009340          290 VYEYISSGTLSHHI-HDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMH-SSASIPIFHRDIKSSNILLDDKF-SA  366 (537)
Q Consensus       290 V~e~~~~gsL~~~l-~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH-~~~~~~ivH~Dlk~~NIll~~~~-~~  366 (537)
                      +.+|..+|++.+.+ +...           ...+-...-..+.|+..++.|+| ..+   +.|+||||+|.+++.++ ..
T Consensus        99 ~~~~s~g~~~f~~i~~~~~-----------~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l  164 (601)
T KOG0590|consen   99 SLSYSDGGSLFSKISHPDS-----------TGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSAL  164 (601)
T ss_pred             ccCcccccccccccccCCc-----------cCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcc
Confidence            99999999998888 4322           13555667788999999999999 877   99999999999999999 99


Q ss_pred             EEeeccCccccCC--CCCceeeeccc-cccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHH
Q 009340          367 KVSDFGISRSIPN--DKTHLTTTIQG-TFGYLDPEYFQSS-QFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVAC  442 (537)
Q Consensus       367 ki~Dfgla~~~~~--~~~~~~~~~~g-t~~y~aPE~~~~~-~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~  442 (537)
                      +++|||+|.....  +.........| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+.........     
T Consensus       165 ~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~-----  239 (601)
T KOG0590|consen  165 KIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR-----  239 (601)
T ss_pred             cCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc-----
Confidence            9999999988765  33334455678 9999999998874 4457899999999999999999998755433211     


Q ss_pred             HHHHHhhchhhhhhcHHh--hccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          443 FISLAKENQLLEILDARV--AKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       443 ~~~~~~~~~~~~~~d~~~--~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                               ...+.....  .............++..+++..+|..|.+.+++..
T Consensus       240 ---------~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~  285 (601)
T KOG0590|consen  240 ---------YSSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL  285 (601)
T ss_pred             ---------ceeecccccccccCccccCChhhhhcccccccCCchhccccccccc
Confidence                     001111100  00111222334567888888899999999888743

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.50  E-value=2e-13  Score=142.29  Aligned_cols=141  Identities=23%  Similarity=0.237  Sum_probs=101.8

Q ss_pred             ccccCcCCceEEEEEEcCCCCEEEEEEccCCChHHH----------------------------------------HHHH
Q 009340          221 SRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQI----------------------------------------HQFI  260 (537)
Q Consensus       221 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~----------------------------------------~~~~  260 (537)
                      .+.||.|++|.||+|++++|+.||||..+.......                                        -+|.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            367999999999999999999999998765321110                                        0245


Q ss_pred             HHHHHHHhcC----CCCcceEeeEEe-eCCccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHH
Q 009340          261 NEVVILSQIN----HRHIVKLLGCCL-ETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAG  335 (537)
Q Consensus       261 ~E~~~l~~l~----H~niv~l~g~~~-~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~  335 (537)
                      +|+..+.+++    |.+-+.+-.++. .....+|||||+++++|.++......           ..   .+.+++..+++
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-----------~~---~~~~ia~~~~~  267 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-----------GL---DRKALAENLAR  267 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-----------CC---CHHHHHHHHHH
Confidence            5666665552    333333333333 23457999999999999887653211           12   23556777666


Q ss_pred             -HHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCccccC
Q 009340          336 -AVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIP  378 (537)
Q Consensus       336 -gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~  378 (537)
                       .+..+|..+   ++|+|++|.||+++.++++++.|||++..++
T Consensus       268 ~~l~ql~~~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       268 SFLNQVLRDG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             HHHHHHHhCC---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence             478889988   9999999999999999999999999997764

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.44  E-value=2.1e-13  Score=129.67  Aligned_cols=203  Identities=20%  Similarity=0.302  Sum_probs=138.1

Q ss_pred             HHHhcCCCCcceEeeEEeeC-----CccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHH
Q 009340          265 ILSQINHRHIVKLLGCCLET-----EVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAY  339 (537)
Q Consensus       265 ~l~~l~H~niv~l~g~~~~~-----~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~y  339 (537)
                      -|-++.|.|||++..|..+.     ....++.|||..|+|..+|+.....        ...+......+|+.||..||.|
T Consensus       120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~--------~~a~~~~~wkkw~tqIlsal~y  191 (458)
T KOG1266|consen  120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKN--------QKALFQKAWKKWCTQILSALSY  191 (458)
T ss_pred             HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHh--------hhhhhHHHHHHHHHHHHhhhhh
Confidence            34556799999999887654     3568899999999999999886553        3457777778999999999999


Q ss_pred             HhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCccccCCCC---CceeeeccccccccCcccccCCCCCcchhHHHHHH
Q 009340          340 MHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDK---THLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGV  416 (537)
Q Consensus       340 LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gv  416 (537)
                      ||+.. |+|+|+++.-+-|++..++-+||.----......-.   ........+-++|.|||+=.....+..+|||+||+
T Consensus       192 Lhs~~-PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgm  270 (458)
T KOG1266|consen  192 LHSCD-PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGM  270 (458)
T ss_pred             hhccC-CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhH
Confidence            99976 679999999999999999988885322111110000   00111223568999999877777888999999999


Q ss_pred             HHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          417 VLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       417 ll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      -.+||.-+..--......   -......    ..... .+...           .-+.++..|++..|..||+|++++.
T Consensus       271 cAlemailEiq~tnseS~---~~~ee~i----a~~i~-~len~-----------lqr~~i~kcl~~eP~~rp~ar~llf  330 (458)
T KOG1266|consen  271 CALEMAILEIQSTNSESK---VEVEENI----ANVII-GLENG-----------LQRGSITKCLEGEPNGRPDARLLLF  330 (458)
T ss_pred             HHHHHHHheeccCCCcce---eehhhhh----hhhee-eccCc-----------cccCcCcccccCCCCCCcchhhhhc
Confidence            999998765431110000   0000000    00000 00001           1135778999999999999998754

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.35  E-value=9.3e-13  Score=135.61  Aligned_cols=246  Identities=21%  Similarity=0.249  Sum_probs=176.3

Q ss_pred             CCccccccCc--CCceEEEEEEc---CCCCEEEEEEccC--CChHHHHHHHHHHHHHHhc-CCCCcceEeeEEeeCCccE
Q 009340          217 NYNQSRFLGQ--GGFGTVYKGML---PDGSIVAVKRSKE--IDKTQIHQFINEVVILSQI-NHRHIVKLLGCCLETEVPV  288 (537)
Q Consensus       217 ~~~~~~~lg~--G~~g~Vy~~~~---~~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~  288 (537)
                      .|.....+|.  |.+|.||.+..   .++..+|+|+.+.  ........=.+|+.....+ .|+|.++.......++..+
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf  194 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF  194 (524)
T ss_pred             hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence            4455677899  99999999986   3688899998543  1112222334566666667 4999999888888889999


Q ss_pred             EEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHH----HHHHHhhcCCCCeeecCCCCCCEEECCC-
Q 009340          289 LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAG----AVAYMHSSASIPIFHRDIKSSNILLDDK-  363 (537)
Q Consensus       289 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~----gl~yLH~~~~~~ivH~Dlk~~NIll~~~-  363 (537)
                      +-+|++. .+|..+.+....           .++....+....+..+    |+.++|+..   ++|-|+||.||+...+ 
T Consensus       195 iqtE~~~-~sl~~~~~~~~~-----------~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~  259 (524)
T KOG0601|consen  195 IQTELCG-ESLQSYCHTPCN-----------FLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDW  259 (524)
T ss_pred             eeecccc-chhHHhhhcccc-----------cCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheeccccc
Confidence            9999986 588888776433           3666666777777777    999999999   9999999999999999 


Q ss_pred             CcEEEeeccCccccCCCCCce----eeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccH
Q 009340          364 FSAKVSDFGISRSIPNDKTHL----TTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNL  439 (537)
Q Consensus       364 ~~~ki~Dfgla~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~  439 (537)
                      ..++++|||+...+.......    .....|...|++||.. ++.++.++|+|++|.+..|..++...........    
T Consensus       260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~----  334 (524)
T KOG0601|consen  260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKNSS----  334 (524)
T ss_pred             ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCCCC----
Confidence            899999999998886554221    1222577789999987 4567889999999999999999877654321111    


Q ss_pred             HHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHH
Q 009340          440 VACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVS  494 (537)
Q Consensus       440 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~  494 (537)
                          |...+..     .   +..++-..-..++..++.++++.+|..|++...+.
T Consensus       335 ----W~~~r~~-----~---ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~  377 (524)
T KOG0601|consen  335 ----WSQLRQG-----Y---IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILT  377 (524)
T ss_pred             ----ccccccc-----c---CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHh
Confidence                1101100     0   00011111123455588999999999999887664

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.31  E-value=3.2e-11  Score=125.49  Aligned_cols=166  Identities=17%  Similarity=0.240  Sum_probs=126.7

Q ss_pred             cCCCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecCCCCChhhhhhhhhhhHHHHhhh
Q 009340          237 LPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQ  316 (537)
Q Consensus       237 ~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~  316 (537)
                      ..++.+|.|...+.......+...+.++.|+.++||||++++.....++..|||+|-+.  .|..++..           
T Consensus        34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~-----------  100 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE-----------  100 (690)
T ss_pred             eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH-----------
Confidence            33678888888776555445567788899999999999999999999999999999875  46666654           


Q ss_pred             ccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCccccCCCCCceeeeccccccccC
Q 009340          317 ELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLD  396 (537)
Q Consensus       317 ~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~a  396 (537)
                          +.-......+.||+.||.|||+.+.  ++|++|.-+.|+++..|..||++|.++........ .......-..|..
T Consensus       101 ----l~~~~v~~Gl~qIl~AL~FL~~d~~--lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~  173 (690)
T KOG1243|consen  101 ----LGKEEVCLGLFQILAALSFLNDDCN--LVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDD  173 (690)
T ss_pred             ----hHHHHHHHHHHHHHHHHHHHhccCC--eeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccC
Confidence                2344556688999999999997664  99999999999999999999999998865422211 1112222334667


Q ss_pred             cccccCCCCCcchhHHHHHHHHHHHHhC
Q 009340          397 PEYFQSSQFTDKSDVYSFGVVLLELLTG  424 (537)
Q Consensus       397 PE~~~~~~~t~ksDV~S~Gvll~el~tg  424 (537)
                      |+.+....  -..|.|-||++++|++.|
T Consensus       174 P~~~~~s~--~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  174 PEEIDPSE--WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             hhhcCccc--cchhhhhHHHHHHHHhCc
Confidence            77554322  246999999999999999

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.29  E-value=1.7e-11  Score=111.34  Aligned_cols=130  Identities=20%  Similarity=0.132  Sum_probs=96.6

Q ss_pred             ccccCcCCceEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcc-eEeeEEeeCCccEEEEecCCCCCh
Q 009340          221 SRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIV-KLLGCCLETEVPVLVYEYISSGTL  299 (537)
Q Consensus       221 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lV~e~~~~gsL  299 (537)
                      .+.|+.|.++.||+.... +..|++|....... ....+..|+.++..+.+.+++ +++.+.  ....++||||+++.++
T Consensus         3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l   78 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL   78 (170)
T ss_pred             eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence            356889999999999875 77899998765322 123457899999988665544 455443  3345899999999887


Q ss_pred             hhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcC--CCCeeecCCCCCCEEECCCCcEEEeeccCcc
Q 009340          300 SHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSA--SIPIFHRDIKSSNILLDDKFSAKVSDFGISR  375 (537)
Q Consensus       300 ~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~--~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~  375 (537)
                      .+..                 .   ....++.+++++|+.||+.+  ...++|+|++|.||+++ ++.+++.|||.+.
T Consensus        79 ~~~~-----------------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          79 LTED-----------------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             cccc-----------------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            5430                 0   01235678999999999987  23369999999999999 5689999999875

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.27  E-value=5.8e-11  Score=125.42  Aligned_cols=148  Identities=18%  Similarity=0.193  Sum_probs=95.0

Q ss_pred             hcCCccccccCcCCceEEEEEEcCC-CCEEEEEEccCCChH------------------------------H----HH--
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLPD-GSIVAVKRSKEIDKT------------------------------Q----IH--  257 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~------------------------------~----~~--  257 (537)
                      ...|+. +.||+|++|.||+|++++ |+.||||..+..-..                              .    .+  
T Consensus       119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l  197 (537)
T PRK04750        119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL  197 (537)
T ss_pred             HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence            345666 789999999999999987 999999988643111                              0    11  


Q ss_pred             ----HHHHHHHHHHhcC----CCCcceEeeEEee-CCccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHH
Q 009340          258 ----QFINEVVILSQIN----HRHIVKLLGCCLE-TEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVR  328 (537)
Q Consensus       258 ----~~~~E~~~l~~l~----H~niv~l~g~~~~-~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~  328 (537)
                          +|.+|+..+.+++    +.+.+.+-.++.+ ....+|||||++++.+.++-.-.....      ....+.......
T Consensus       198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~------d~~~la~~~v~~  271 (537)
T PRK04750        198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGT------DMKLLAERGVEV  271 (537)
T ss_pred             HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCC------CHHHHHHHHHHH
Confidence                2344554454442    3344444444433 345689999999999987422110000      000122222223


Q ss_pred             HHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCC----cEEEeeccCccccCC
Q 009340          329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF----SAKVSDFGISRSIPN  379 (537)
Q Consensus       329 i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~----~~ki~Dfgla~~~~~  379 (537)
                      ++.|       ++..+   ++|+|++|.||+++.++    ++++.|||++..++.
T Consensus       272 ~~~Q-------if~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        272 FFTQ-------VFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             HHHH-------HHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            3333       34567   99999999999999988    999999999987754

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.18  E-value=6.3e-10  Score=102.37  Aligned_cols=135  Identities=17%  Similarity=0.153  Sum_probs=97.2

Q ss_pred             cccCcCCceEEEEEEcCC-------CCEEEEEEccCC-------------C---------hHHHHHHH----HHHHHHHh
Q 009340          222 RFLGQGGFGTVYKGMLPD-------GSIVAVKRSKEI-------------D---------KTQIHQFI----NEVVILSQ  268 (537)
Q Consensus       222 ~~lg~G~~g~Vy~~~~~~-------g~~vavK~~~~~-------------~---------~~~~~~~~----~E~~~l~~  268 (537)
                      ..||.|--+.||.|.-.+       +..+|||..+..             +         ....+.+.    +|.+.|++
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            468999999999998543       478999953210             0         01122233    79999999


Q ss_pred             cCC--CCcceEeeEEeeCCccEEEEecCCCCChhh-hhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHH-hhcC
Q 009340          269 INH--RHIVKLLGCCLETEVPVLVYEYISSGTLSH-HIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYM-HSSA  344 (537)
Q Consensus       269 l~H--~niv~l~g~~~~~~~~~lV~e~~~~gsL~~-~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yL-H~~~  344 (537)
                      +..  -++.+++++    ...+|||||+.++.+.. .+.+             ..++..+...+..+++.+|..| |..+
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-------------~~~~~~~~~~i~~~i~~~l~~l~H~~g  145 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-------------AKLNDEEMKNAYYQVLSMMKQLYKECN  145 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-------------cccCHHHHHHHHHHHHHHHHHHHHhCC
Confidence            953  467777765    45689999998754421 1211             1244455677889999999999 7888


Q ss_pred             CCCeeecCCCCCCEEECCCCcEEEeeccCcccc
Q 009340          345 SIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI  377 (537)
Q Consensus       345 ~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~  377 (537)
                         +|||||++.||++++ +.+.|+|||.+...
T Consensus       146 ---lVHGDLs~~NIL~~~-~~v~iIDF~qav~~  174 (197)
T cd05146         146 ---LVHADLSEYNMLWHD-GKVWFIDVSQSVEP  174 (197)
T ss_pred             ---eecCCCCHHHEEEEC-CcEEEEECCCceeC
Confidence               999999999999974 57999999988654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.18  E-value=1.7e-11  Score=126.48  Aligned_cols=261  Identities=19%  Similarity=0.221  Sum_probs=181.3

Q ss_pred             cccCHHH-HHHHhcCCccccccCcCCceEEEEEEcC--CCCEEEEEEccCCChHHHH--HHHHHHHHHHhc-CCCCcceE
Q 009340          204 KVFTADE-LQRATDNYNQSRFLGQGGFGTVYKGMLP--DGSIVAVKRSKEIDKTQIH--QFINEVVILSQI-NHRHIVKL  277 (537)
Q Consensus       204 ~~~~~~e-l~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~g~~vavK~~~~~~~~~~~--~~~~E~~~l~~l-~H~niv~l  277 (537)
                      .+|.-.+ ....+.+|..+..||.|.|+.|++...+  ++..+++|.+.........  .-+.|+.+...+ .|.++++.
T Consensus       252 ~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~  331 (524)
T KOG0601|consen  252 NIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGK  331 (524)
T ss_pred             heecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCC
Confidence            3444444 4455678999999999999999987744  6788999987653332222  234577777666 48888887


Q ss_pred             eeEEeeCCccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCC
Q 009340          278 LGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSN  357 (537)
Q Consensus       278 ~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~N  357 (537)
                      ..........|+=-||++++++.....-            ...++...++++..+++.++.++|+..   ++|+|+||+|
T Consensus       332 ~~~W~~~r~~~ip~e~~~~~s~~l~~~~------------~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psn  396 (524)
T KOG0601|consen  332 NSSWSQLRQGYIPLEFCEGGSSSLRSVT------------SQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSN  396 (524)
T ss_pred             CCCccccccccCchhhhcCcchhhhhHH------------HHhcCcchhhhhHHHHHhccccccchh---hhcccccccc
Confidence            6666666677888999999998776622            124777788999999999999999988   9999999999


Q ss_pred             EEECCC-CcEEEeeccCccccCCCCCceeeeccccccc-cCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhh
Q 009340          358 ILLDDK-FSAKVSDFGISRSIPNDKTHLTTTIQGTFGY-LDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEE  435 (537)
Q Consensus       358 Ill~~~-~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y-~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~  435 (537)
                      |++..+ +..++.|||....+.-..   ......+..| .+|+......+-.++|+||||.-+.|.+++..--.....  
T Consensus       397 i~i~~~~~~~~~~~~~~~t~~~~~~---~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~--  471 (524)
T KOG0601|consen  397 ILISNDGFFSKLGDFGCWTRLAFSS---GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ--  471 (524)
T ss_pred             eeeccchhhhhccccccccccceec---ccccccccccccchhhccccccccccccccccccccccccCcccCccccc--
Confidence            999886 889999999886432111   1111123334 356666677888999999999999999988654211100  


Q ss_pred             hccHHHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHH
Q 009340          436 ERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRR  502 (537)
Q Consensus       436 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~  502 (537)
                              +.....+.         ....+ .....+..+++.+...++..||.+.+.....+..+.
T Consensus       472 --------~~~i~~~~---------~p~~~-~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~~  520 (524)
T KOG0601|consen  472 --------SLTIRSGD---------TPNLP-GLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYRD  520 (524)
T ss_pred             --------ceeeeccc---------ccCCC-chHHhhhhhhhhhcCCccccchhhhhhcccchhhhh
Confidence                    00000010         00111 112456678888999999999999988777665554

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.17  E-value=6.2e-10  Score=112.56  Aligned_cols=177  Identities=23%  Similarity=0.286  Sum_probs=132.3

Q ss_pred             eEEEEEEc-CCCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEee----CCccEEEEecCCC-CChhhhh
Q 009340          230 GTVYKGML-PDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLE----TEVPVLVYEYISS-GTLSHHI  303 (537)
Q Consensus       230 g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lV~e~~~~-gsL~~~l  303 (537)
                      .+.||+.. .||..+.+|++..........-..-++.++++.|.|+|++..++..    +...++||+|.++ ++|.+.-
T Consensus       290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~  369 (655)
T KOG3741|consen  290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY  369 (655)
T ss_pred             ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence            57888884 4899999999954333322233456788999999999999998873    3467999999986 5787766


Q ss_pred             hhhhhhHHHH---hhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCccccCCC
Q 009340          304 HDHQQQQEQK---QKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPND  380 (537)
Q Consensus       304 ~~~~~~~~~~---~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~  380 (537)
                      ........+.   ........++..+|.++.|+..||.++|+.|   +..+-|.+++||++.+.+++|+..|....+..+
T Consensus       370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d  446 (655)
T KOG3741|consen  370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQED  446 (655)
T ss_pred             ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence            5544322000   0112335788999999999999999999999   888999999999999999999999888766544


Q ss_pred             CCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCC
Q 009340          381 KTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP  427 (537)
Q Consensus       381 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p  427 (537)
                      ..               |-+.+   -.+-|.=.||.+++.|.||...
T Consensus       447 ~~---------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  447 PT---------------EPLES---QQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             CC---------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence            31               11111   1367999999999999999765

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.16  E-value=3.8e-10  Score=107.10  Aligned_cols=142  Identities=22%  Similarity=0.286  Sum_probs=104.6

Q ss_pred             cccCcCCceEEEEEEcCCCCEEEEEEccCCCh-HHHHHHHHHHHHHHhcCC--CCcceEeeEEeeCC---ccEEEEecCC
Q 009340          222 RFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDK-TQIHQFINEVVILSQINH--RHIVKLLGCCLETE---VPVLVYEYIS  295 (537)
Q Consensus       222 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~---~~~lV~e~~~  295 (537)
                      +.|+.|..+.||++...+|+.+++|....... .....+..|+.+++.+++  .++.+++.+.....   ..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            56899999999999987778899998764322 134567899999999975  44677888776543   5689999999


Q ss_pred             CCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhc--------------------------------
Q 009340          296 SGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSS--------------------------------  343 (537)
Q Consensus       296 ~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~--------------------------------  343 (537)
                      +.++.+.+..             ..++..++..++.++++.|..||+.                                
T Consensus        84 G~~l~~~~~~-------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  150 (223)
T cd05154          84 GRVLRDRLLR-------------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASR  150 (223)
T ss_pred             CEecCCCCCC-------------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhc
Confidence            9988776531             1244555555666666666666632                                


Q ss_pred             ---------------------CCCCeeecCCCCCCEEECC--CCcEEEeeccCccc
Q 009340          344 ---------------------ASIPIFHRDIKSSNILLDD--KFSAKVSDFGISRS  376 (537)
Q Consensus       344 ---------------------~~~~ivH~Dlk~~NIll~~--~~~~ki~Dfgla~~  376 (537)
                                           ....++|+|+.+.||+++.  ++.+.|.||+.+..
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         151 TDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             ccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                                 1244899999999999998  66789999998763

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.16  E-value=5.8e-10  Score=99.15  Aligned_cols=131  Identities=23%  Similarity=0.312  Sum_probs=102.2

Q ss_pred             cccCcCCceEEEEEEcCCCCEEEEEE-ccCC-------ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEec
Q 009340          222 RFLGQGGFGTVYKGMLPDGSIVAVKR-SKEI-------DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY  293 (537)
Q Consensus       222 ~~lg~G~~g~Vy~~~~~~g~~vavK~-~~~~-------~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  293 (537)
                      ..+++|+-..+|.+.+. |..+++|. .++.       .+-..++-.+|+.++.+++--.|.-..-+..+.+...++|||
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            35789999999999875 44577773 2221       111234566899999999776666666667778888999999


Q ss_pred             CCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccC
Q 009340          294 ISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGI  373 (537)
Q Consensus       294 ~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgl  373 (537)
                      +++-.|.+.+...                   +..++..+-+-+.-||..+   |+|+||.++||++.++. +.++||||
T Consensus        81 I~G~~lkd~l~~~-------------------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGL  137 (204)
T COG3642          81 IEGELLKDALEEA-------------------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGL  137 (204)
T ss_pred             eCChhHHHHHHhc-------------------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCc
Confidence            9999888888642                   2456777888888999999   99999999999999884 99999999


Q ss_pred             ccc
Q 009340          374 SRS  376 (537)
Q Consensus       374 a~~  376 (537)
                      +..
T Consensus       138 g~~  140 (204)
T COG3642         138 GEF  140 (204)
T ss_pred             ccc
Confidence            975

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.11  E-value=1.2e-09  Score=96.68  Aligned_cols=143  Identities=21%  Similarity=0.264  Sum_probs=107.4

Q ss_pred             cccccCcCCceEEEEEEcCCCCEEEEEEc-cC-------CChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEE
Q 009340          220 QSRFLGQGGFGTVYKGMLPDGSIVAVKRS-KE-------IDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY  291 (537)
Q Consensus       220 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~-~~-------~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  291 (537)
                      ....|-+|+-+.|+++.+ .|+...||.- ..       ..+-...+-.+|++++.+++--.|.-..-++.+...-.|+|
T Consensus        11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            467899999999999999 5888788842 21       11122455678999999987666665555666777778999


Q ss_pred             ecCCC-CChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCC---cEE
Q 009340          292 EYISS-GTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF---SAK  367 (537)
Q Consensus       292 e~~~~-gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~---~~k  367 (537)
                      ||+++ .++.+++......          .........++..|-+.+.-||..+   |+||||..+||+|..++   .+-
T Consensus        90 E~~~g~~~vk~~i~~~~~~----------~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~  156 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMED----------ESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPI  156 (229)
T ss_pred             EeccchhHHHHHHHHHccC----------cccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceE
Confidence            99977 4788888765431          2222333678899999999999999   99999999999996543   458


Q ss_pred             EeeccCccc
Q 009340          368 VSDFGISRS  376 (537)
Q Consensus       368 i~Dfgla~~  376 (537)
                      +.|||++..
T Consensus       157 lIdfgls~~  165 (229)
T KOG3087|consen  157 LIDFGLSSV  165 (229)
T ss_pred             EEeecchhc
Confidence            999999864

>PRK10783 mltD membrane-bound lytic murein transglycosylase D; Provisional

Probab=98.99  E-value=4.1e-10  Score=116.98  Aligned_cols=88  Identities=22%  Similarity=0.305  Sum_probs=73.0

Q ss_pred             ccHHHHhhCCCCCCCCCCCCceeeecccccCCCCccccchhhhhhhhhcccccchhhhHhhhcCChHHHHHhhccCCCCc
Q 009340           11 TTCQALLGQNYFDAPNITIGAQVMIPLRCACPTANQIDKGVSYLLAYMAAKGDTISSIGYKFGVDQQSILEANMLSKADS   90 (537)
Q Consensus        11 ~t~~~l~~~N~~~~~~i~~g~~l~vp~~c~c~~~~~~~~~~~~~~~y~v~~gdtl~~ia~~f~~~~~~l~~~n~~~~~~~   90 (537)
                      +|.++|+++|.+..+.|.+||.|.||..|.|....    ......+|+|++||||++||++||+++++|+++|++.+. .
T Consensus       363 vs~~~L~~~N~l~~~~L~~Gq~L~Ip~~~~~~~~~----~~~~~~~Y~Vr~GDTL~sIA~kygVtv~~L~~~N~l~~~-~  437 (456)
T PRK10783        363 VSTKDLQQWNNLRGSKLKVGQTLTIGAGSSAQRLA----NNSDSITYRVRKGDSLSSIAKRHGVNIKDVMRWNSDTAK-N  437 (456)
T ss_pred             cCHHHHHHHcCCCcccCCCCCEEEecCCccccccc----ccccceeEEeCCCCCHHHHHHHhCCCHHHHHHhcCCCCC-c
Confidence            56799999998776889999999999776664211    122245899999999999999999999999999998654 8


Q ss_pred             ccccccccCCcCC
Q 009340           91 IFPFAPLLIPLKN  103 (537)
Q Consensus        91 i~~~~~l~vp~~~  103 (537)
                      +.||+.+.++++.
T Consensus       438 L~pGq~L~l~v~~  450 (456)
T PRK10783        438 LQPGDKLTLFVKN  450 (456)
T ss_pred             CCCCCEEEEecCC
Confidence            9999999998764

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.92  E-value=2.2e-10  Score=124.30  Aligned_cols=250  Identities=23%  Similarity=0.280  Sum_probs=168.0

Q ss_pred             HHHhcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccC---CChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCcc
Q 009340          212 QRATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKE---IDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVP  287 (537)
Q Consensus       212 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~  287 (537)
                      +...+.|...+-+-.|.++.++.+.-. .|...+.|....   ....+.+....+-.++-..+||-+++..--+.-....
T Consensus       800 rsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~  879 (1205)
T KOG0606|consen  800 RSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPL  879 (1205)
T ss_pred             cCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCc
Confidence            345567777778889999999876632 343344443322   1112222223333333334556666555455566788


Q ss_pred             EEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEE
Q 009340          288 VLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK  367 (537)
Q Consensus       288 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~k  367 (537)
                      +|+++|..+++|...|+...            ..+..-.......+...++|||+..   +.|+|++|.|+|...++..+
T Consensus       880 ~L~~~~~~~~~~~Skl~~~~------------~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~  944 (1205)
T KOG0606|consen  880 PLVGHYLNGGDLPSKLHNSG------------CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRP  944 (1205)
T ss_pred             chhhHHhccCCchhhhhcCC------------CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcc
Confidence            99999999999999988743            2333334445667788999999987   89999999999999999999


Q ss_pred             EeeccCccccCC------------------------------CCCceeeeccccccccCcccccCCCCCcchhHHHHHHH
Q 009340          368 VSDFGISRSIPN------------------------------DKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVV  417 (537)
Q Consensus       368 i~Dfgla~~~~~------------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvl  417 (537)
                      ++|||.......                              +.........+|+.|.|||...+......+|.|++|+.
T Consensus       945 l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~ 1024 (1205)
T KOG0606|consen  945 LTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVC 1024 (1205)
T ss_pred             cCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhh
Confidence            999984432210                              00011234568999999999999999999999999999


Q ss_pred             HHHHHhCCCCCCccchhhhccHHHHHHHHHhhchhhhhhcHHh-hccccHHHHHHHHHHHHHhcccCCCCCCCHh
Q 009340          418 LLELLTGKKPICFARVEEERNLVACFISLAKENQLLEILDARV-AKEAREEDIGAMAELAMRCLRLNSKKRPTMK  491 (537)
Q Consensus       418 l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~-~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~  491 (537)
                      ++|.++|..||........      |..         ++.... ....+........+++...+..+|..|-.|.
T Consensus      1025 l~e~l~g~pp~na~tpq~~------f~n---------i~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1025 LFEVLTGIPPFNAETPQQI------FEN---------ILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             hhhhhcCCCCCCCcchhhh------hhc---------cccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            9999999999875543321      111         111111 1123344456677888888899999997766

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.91  E-value=2.7e-08  Score=96.69  Aligned_cols=139  Identities=15%  Similarity=0.075  Sum_probs=100.1

Q ss_pred             cCcCCceEEEEEEcCCCCEEEEEEccCCChH-HHH----------HHHHHHHHHHhcCCCC--cceEeeEEee-----CC
Q 009340          224 LGQGGFGTVYKGMLPDGSIVAVKRSKEIDKT-QIH----------QFINEVVILSQINHRH--IVKLLGCCLE-----TE  285 (537)
Q Consensus       224 lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~-~~~----------~~~~E~~~l~~l~H~n--iv~l~g~~~~-----~~  285 (537)
                      +-......|.+..+ +|+.+.||+....... ..+          .+.+|...+.++...+  ..+++++...     ..
T Consensus        30 v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~  108 (268)
T PRK15123         30 FRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATR  108 (268)
T ss_pred             EecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccc
Confidence            33333345667766 6788999976543211 111          3778999998885443  4455666543     23


Q ss_pred             ccEEEEecCCCC-ChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECC--
Q 009340          286 VPVLVYEYISSG-TLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD--  362 (537)
Q Consensus       286 ~~~lV~e~~~~g-sL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~--  362 (537)
                      ..+||+|++++. +|.+++.....          ...+...+..++.++++.+.-||..+   |+|+|++++|||++.  
T Consensus       109 ~s~LVte~l~~~~sL~~~~~~~~~----------~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~  175 (268)
T PRK15123        109 TSFIITEDLAPTISLEDYCADWAT----------NPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPF  175 (268)
T ss_pred             eeEEEEeeCCCCccHHHHHHhhcc----------cCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccc
Confidence            468999999986 89888853211          13455677889999999999999999   999999999999975  


Q ss_pred             -----CCcEEEeeccCccc
Q 009340          363 -----KFSAKVSDFGISRS  376 (537)
Q Consensus       363 -----~~~~ki~Dfgla~~  376 (537)
                           +..+.++||+.+..
T Consensus       176 ~~~~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        176 PGREEDLKLSVIDLHRAQI  194 (268)
T ss_pred             cCCCCCceEEEEECCcccc
Confidence                 57899999998853

>PRK06347 autolysin; Reviewed

Probab=98.90  E-value=1.4e-09  Score=115.23  Aligned_cols=89  Identities=20%  Similarity=0.201  Sum_probs=70.2

Q ss_pred             ccHHHHhhCCCCCCCCCCCCceeeecccccCCCCcc-----ccchhhhhhhhhcccccchhhhHhhhcCChHHHHHhhcc
Q 009340           11 TTCQALLGQNYFDAPNITIGAQVMIPLRCACPTANQ-----IDKGVSYLLAYMAAKGDTISSIGYKFGVDQQSILEANML   85 (537)
Q Consensus        11 ~t~~~l~~~N~~~~~~i~~g~~l~vp~~c~c~~~~~-----~~~~~~~~~~y~v~~gdtl~~ia~~f~~~~~~l~~~n~~   85 (537)
                      +++++|+++|++..+.|.+||+|.||....-.....     ..+......+|+|++|||||+||++||+++++|+++|++
T Consensus       499 VSv~~L~~~N~l~s~~L~~GQ~L~Ip~~~~~s~~~t~~~s~~~~~~~~~~~Y~Vk~GDTL~sIA~KygvSv~~L~~~N~L  578 (592)
T PRK06347        499 VTIANLKSWNNLKSDFIYPGQKLKVSAGSTTNNTNTAKPSTNKPSNSTVKTYTVKKGDSLWAISRQYKTTVDNIKAWNKL  578 (592)
T ss_pred             CCHHHHHHhcCCCcccccCCcEEEEecCcccccccccCCccCCccCccceeeecCCCCcHHHHHHHhCCCHHHHHHhcCC
Confidence            899999999988778899999999997543221100     001111245799999999999999999999999999999


Q ss_pred             CCCCcccccccccCC
Q 009340           86 SKADSIFPFAPLLIP  100 (537)
Q Consensus        86 ~~~~~i~~~~~l~vp  100 (537)
                      .. +.|++|+.+.|+
T Consensus       579 ~~-~~L~~GQ~L~I~  592 (592)
T PRK06347        579 TS-NMIHVGQKLTIK  592 (592)
T ss_pred             Cc-ccCCCCCEEecC
Confidence            64 679999998774

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.87  E-value=1.8e-08  Score=92.42  Aligned_cols=126  Identities=27%  Similarity=0.279  Sum_probs=82.2

Q ss_pred             EEEEEEcCCCCEEEEEEccCC-------------------------C-hHHHHHHHHHHHHHHhcCCC--CcceEeeEEe
Q 009340          231 TVYKGMLPDGSIVAVKRSKEI-------------------------D-KTQIHQFINEVVILSQINHR--HIVKLLGCCL  282 (537)
Q Consensus       231 ~Vy~~~~~~g~~vavK~~~~~-------------------------~-~~~~~~~~~E~~~l~~l~H~--niv~l~g~~~  282 (537)
                      -||.|...+|..||||..+..                         . ........+|.+.|.++...  ++.+++++- 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            389999888999999953220                         0 01123466899999999765  566676552 


Q ss_pred             eCCccEEEEecCC--CCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHH-HhhcCCCCeeecCCCCCCEE
Q 009340          283 ETEVPVLVYEYIS--SGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAY-MHSSASIPIFHRDIKSSNIL  359 (537)
Q Consensus       283 ~~~~~~lV~e~~~--~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~y-LH~~~~~~ivH~Dlk~~NIl  359 (537)
                         .-.|||||++  +..+..+....              ++......++.+++..+.. +|..+   |+|+||.+.|||
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~~~--------------~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIl  139 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKDVD--------------LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNIL  139 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHHCG--------------GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEE
T ss_pred             ---CCEEEEEecCCCccchhhHHhcc--------------ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEE
Confidence               4489999998  54443333211              1123346677788886555 57888   999999999999


Q ss_pred             ECCCCcEEEeeccCccccC
Q 009340          360 LDDKFSAKVSDFGISRSIP  378 (537)
Q Consensus       360 l~~~~~~ki~Dfgla~~~~  378 (537)
                      ++++ .+.|+|||.+....
T Consensus       140 v~~~-~~~iIDf~qav~~~  157 (188)
T PF01163_consen  140 VDDG-KVYIIDFGQAVDSS  157 (188)
T ss_dssp             EETT-CEEE--GTTEEETT
T ss_pred             eecc-eEEEEecCcceecC
Confidence            9988 99999999887543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.87  E-value=3e-08  Score=98.12  Aligned_cols=270  Identities=19%  Similarity=0.193  Sum_probs=161.0

Q ss_pred             cccccCcCCceEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHHHHhc-CCCCcceEeeE----Ee--eCC-ccEEEE
Q 009340          220 QSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQI-NHRHIVKLLGC----CL--ETE-VPVLVY  291 (537)
Q Consensus       220 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~----~~--~~~-~~~lV~  291 (537)
                      ..+-||+|+.+.+|----- +..|| |+...-......   +.+..|... .||-+-.=+.+    ..  ++. ..-+.|
T Consensus        15 ~gr~LgqGgea~ly~l~e~-~d~VA-KIYh~Pppa~~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm   89 (637)
T COG4248          15 PGRPLGQGGEADLYTLGEV-RDQVA-KIYHAPPPAAQA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM   89 (637)
T ss_pred             CCccccCCccceeeecchh-hchhh-eeecCCCchHHH---HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence            3567999999999953211 22233 443321111111   122333333 45543321111    11  111 244566


Q ss_pred             ecCCCC-ChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEee
Q 009340          292 EYISSG-TLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSD  370 (537)
Q Consensus       292 e~~~~g-sL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~D  370 (537)
                      ..+++- -...++...      ..++.....+|...++.+..+|.+.+-||++|   .+-+|+.++|+|+++++.+.+.|
T Consensus        90 P~v~g~~pI~~~y~p~------tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVd  160 (637)
T COG4248          90 PKVSGKEPIHMIYSPA------TRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVD  160 (637)
T ss_pred             ccCCCccchhhhcCch------hhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEc
Confidence            666543 122222211      11233556899999999999999999999999   88899999999999999999998


Q ss_pred             ccCccccCCCCCceeeeccccccccCccccc-----CCCCCcchhHHHHHHHHHHHHhC-CCCCCccchh--hhccHHHH
Q 009340          371 FGISRSIPNDKTHLTTTIQGTFGYLDPEYFQ-----SSQFTDKSDVYSFGVVLLELLTG-KKPICFARVE--EERNLVAC  442 (537)
Q Consensus       371 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~S~Gvll~el~tg-~~p~~~~~~~--~~~~~~~~  442 (537)
                      -.-.....++  ......+|...|++||.-.     +..-+...|-|.+||++++++.| ++||..-...  ........
T Consensus       161 sDsfqi~~ng--~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~  238 (637)
T COG4248         161 SDSFQINANG--TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETD  238 (637)
T ss_pred             ccceeeccCC--ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhh
Confidence            6544333222  2233456888999999754     33456789999999999999985 9998643211  10011100


Q ss_pred             HHHHHhhchhhhhhcHH--hh---cccc-HHHHHHHHHHHHHhcccC--CCCCCCHhhHHHHHHHHHHhhHHHhh
Q 009340          443 FISLAKENQLLEILDAR--VA---KEAR-EEDIGAMAELAMRCLRLN--SKKRPTMKQVSMELEGLRRSQRCLEM  509 (537)
Q Consensus       443 ~~~~~~~~~~~~~~d~~--~~---~~~~-~~~~~~l~~l~~~cl~~~--p~~RPs~~ev~~~L~~i~~~~~~~~~  509 (537)
                      +.    .+.....-+.+  +.   .+.+ .-..+.+..|..+|+...  +.-|||++..+..|..++++...+.+
T Consensus       239 Ia----~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~C~v  309 (637)
T COG4248         239 IA----HGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKKCTV  309 (637)
T ss_pred             hh----cceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhhhhh
Confidence            10    01110000100  00   1112 223467788889998653  56899999999999999998776644

>PF01476 LysM: LysM domain; InterPro: IPR018392 This domain is about 40 residues long and is found in a variety of enzymes involved in bacterial cell wall degradation []

Probab=98.76  E-value=2.4e-09  Score=73.63  Aligned_cols=43  Identities=33%  Similarity=0.593  Sum_probs=34.9

Q ss_pred             hhcccccchhhhHhhhcCChHHHHHhh-ccCCCCcccccccccCC
Q 009340           57 YMAAKGDTISSIGYKFGVDQQSILEAN-MLSKADSIFPFAPLLIP  100 (537)
Q Consensus        57 y~v~~gdtl~~ia~~f~~~~~~l~~~n-~~~~~~~i~~~~~l~vp  100 (537)
                      |+|++|||+++||++|+++.++|+++| ++.. +.+.+|+.+.+|
T Consensus         1 y~V~~gDtl~~IA~~~~~~~~~l~~~N~~~~~-~~l~~G~~l~iP   44 (44)
T PF01476_consen    1 YTVQPGDTLWSIAKRYGISVDELMELNPNIDS-DNLQPGQKLCIP   44 (44)
T ss_dssp             EEE-TT--HHHHHHHTTS-HHHHHHHCCTTHG-GCGGTTEEEEEC
T ss_pred             CEECcCCcHHHHHhhhhhhHhHHHHhcCCCCc-ccCCCCCEEEeC
Confidence            899999999999999999999999999 6644 349999999887

This domain may have a general peptidoglycan binding function.; GO: 0016998 cell wall macromolecule catabolic process; PDB: 2DJP_A 3ZQD_A 1Y7M_B 4A52_A 2L9Y_A 1E0G_A.

>PRK09902 hypothetical protein; Provisional

Probab=98.66  E-value=5.4e-07  Score=83.25  Aligned_cols=139  Identities=21%  Similarity=0.129  Sum_probs=103.6

Q ss_pred             cCcCCceEEEEEEcCCCCEEEEEEccCCC------hHHHHHHHHHHHHHHhcCCC--CcceEeeEEeeC----CccEEEE
Q 009340          224 LGQGGFGTVYKGMLPDGSIVAVKRSKEID------KTQIHQFINEVVILSQINHR--HIVKLLGCCLET----EVPVLVY  291 (537)
Q Consensus       224 lg~G~~g~Vy~~~~~~g~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~H~--niv~l~g~~~~~----~~~~lV~  291 (537)
                      -|.||.+.|++-.+ +|+.+-+|+....-      +.....|.+|...+.++...  .+.+...+....    ...+||+
T Consensus        26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT  104 (216)
T PRK09902         26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT  104 (216)
T ss_pred             cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence            56789999999877 46689999865211      23456799999999999532  355555222221    2368999


Q ss_pred             ecCCC-CChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCc--EEE
Q 009340          292 EYISS-GTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFS--AKV  368 (537)
Q Consensus       292 e~~~~-gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~--~ki  368 (537)
                      |-+++ -+|.+++.+..          ..+.+...+..+..++++.+.-||..+   +.|+|+.+.||+++.++.  +++
T Consensus       105 e~L~g~~~L~~~l~~~~----------~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~l  171 (216)
T PRK09902        105 EDMAGFISIADWYAQHA----------VSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGF  171 (216)
T ss_pred             EeCCCCccHHHHHhcCC----------cCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEE
Confidence            97764 48888885532          234677778899999999999999999   999999999999986666  999


Q ss_pred             eeccCccc
Q 009340          369 SDFGISRS  376 (537)
Q Consensus       369 ~Dfgla~~  376 (537)
                      +||.-++.
T Consensus       172 IDlEk~r~  179 (216)
T PRK09902        172 LDLEKSRR  179 (216)
T ss_pred             EEhhccch
Confidence            99976653

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.63  E-value=8.3e-09  Score=108.22  Aligned_cols=149  Identities=23%  Similarity=0.289  Sum_probs=101.0

Q ss_pred             HHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCccccCCCCCcee--------eeccccccccCcccccC
Q 009340          331 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLT--------TTIQGTFGYLDPEYFQS  402 (537)
Q Consensus       331 ~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~--------~~~~gt~~y~aPE~~~~  402 (537)
                      .+++.||.|+|.+.+  +||++|.|++|.++.++..||+.|+.+........+..        .-..-...|.|||++.+
T Consensus       106 ~~v~dgl~flh~sAk--~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~  183 (700)
T KOG2137|consen  106 GNVADGLAFLHRSAK--VVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG  183 (700)
T ss_pred             hcccchhhhhccCcc--eeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence            345599999998664  99999999999999999999999998865533111111        11223457999999999


Q ss_pred             CCCCcchhHHHHHHHHHHHHhCCCCCC-ccchhhhccHHHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcc
Q 009340          403 SQFTDKSDVYSFGVVLLELLTGKKPIC-FARVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLR  481 (537)
Q Consensus       403 ~~~t~ksDV~S~Gvll~el~tg~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~  481 (537)
                      ...+.++|+||+|+++|.+..|..+.. .......    ..+.         ...+..-...+....+.++.+=+.+++.
T Consensus       184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~----~~~~---------~~~~~~~~~~~s~~~p~el~~~l~k~l~  250 (700)
T KOG2137|consen  184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLS----YSFS---------RNLLNAGAFGYSNNLPSELRESLKKLLN  250 (700)
T ss_pred             ccccccccceeeeeEEEEEecCCcchhhccCCcch----hhhh---------hcccccccccccccCcHHHHHHHHHHhc
Confidence            888999999999999999996555532 2111110    0000         0011111112234455677788888999


Q ss_pred             cCCCCCCCHhhHH
Q 009340          482 LNSKKRPTMKQVS  494 (537)
Q Consensus       482 ~~p~~RPs~~ev~  494 (537)
                      .++.-||++.++.
T Consensus       251 ~~~~~rp~~~~l~  263 (700)
T KOG2137|consen  251 GDSAVRPTLDLLL  263 (700)
T ss_pred             CCcccCcchhhhh
Confidence            9999999776654

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.60  E-value=6.3e-07  Score=84.79  Aligned_cols=133  Identities=23%  Similarity=0.203  Sum_probs=94.6

Q ss_pred             cccccCcCCceEEEEEEcCCCCEEEEEEccCC--------------------C--hHHHHHHHHHHHHHHhcCCC--Ccc
Q 009340          220 QSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEI--------------------D--KTQIHQFINEVVILSQINHR--HIV  275 (537)
Q Consensus       220 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~--------------------~--~~~~~~~~~E~~~l~~l~H~--niv  275 (537)
                      ..++||.|--+.||.|....|.++|||.-+..                    +  .-......+|.+.|.++.-.  .+.
T Consensus        95 iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~VP  174 (304)
T COG0478          95 IGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKVP  174 (304)
T ss_pred             hccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCCC
Confidence            35789999999999999999999999942110                    0  01123456799999999655  677


Q ss_pred             eEeeEEeeCCccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCC
Q 009340          276 KLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKS  355 (537)
Q Consensus       276 ~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~  355 (537)
                      +.+++    +...+||||+++--|...-                 ++-...-.++..|++-+.-+-..|   |||+|+.+
T Consensus       175 ~P~~~----nRHaVvMe~ieG~eL~~~r-----------------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSe  230 (304)
T COG0478         175 KPIAW----NRHAVVMEYIEGVELYRLR-----------------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSE  230 (304)
T ss_pred             Ccccc----ccceeeeehcccceeeccc-----------------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCch
Confidence            77654    4558999999886664332                 122223344445555444444667   99999999


Q ss_pred             CCEEECCCCcEEEeeccCccc
Q 009340          356 SNILLDDKFSAKVSDFGISRS  376 (537)
Q Consensus       356 ~NIll~~~~~~ki~Dfgla~~  376 (537)
                      -||+++++|.+.++||--+..
T Consensus       231 fNIlV~~dg~~~vIDwPQ~v~  251 (304)
T COG0478         231 FNILVTEDGDIVVIDWPQAVP  251 (304)
T ss_pred             heEEEecCCCEEEEeCccccc
Confidence            999999999999999976543

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.56  E-value=8e-07  Score=83.44  Aligned_cols=107  Identities=19%  Similarity=0.197  Sum_probs=84.8

Q ss_pred             HHHHHHHHHHHHhcCC--CCcceEeeEEeeCC----ccEEEEecCCCC-ChhhhhhhhhhhHHHHhhhccCCCCHHHHHH
Q 009340          256 IHQFINEVVILSQINH--RHIVKLLGCCLETE----VPVLVYEYISSG-TLSHHIHDHQQQQEQKQKQELSSLSWENRVR  328 (537)
Q Consensus       256 ~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~----~~~lV~e~~~~g-sL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~  328 (537)
                      .....+|...+..+..  -...+.+++.....    ..+||+|++++. +|.+++....            .++......
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~------------~~~~~~~~~  122 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE------------QLDPSQRRE  122 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc------------ccchhhHHH
Confidence            3457788888888853  34566777776543    358999999874 7988886522            245556788


Q ss_pred             HHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCC---cEEEeeccCcccc
Q 009340          329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF---SAKVSDFGISRSI  377 (537)
Q Consensus       329 i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~---~~ki~Dfgla~~~  377 (537)
                      ++.++++.+.-||..+   |+|+|+++.|||++.+.   .+.++||+-++..
T Consensus       123 ll~~l~~~i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  123 LLRALARLIAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHHHHHHHHHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            9999999999999999   99999999999999887   8999999987653

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG1388 LytE FOG: LysM repeat [Cell envelope biogenesis, outer membrane]

Probab=98.56  E-value=6.7e-08  Score=82.91  Aligned_cols=92  Identities=29%  Similarity=0.331  Sum_probs=70.9

Q ss_pred             CcccHHHHhhCCCCC--CCCCCCCceeeecccccCCC-Cccccchhh-------------hhhhhhcccccchhhhHhhh
Q 009340            9 GLTTCQALLGQNYFD--APNITIGAQVMIPLRCACPT-ANQIDKGVS-------------YLLAYMAAKGDTISSIGYKF   72 (537)
Q Consensus         9 ~l~t~~~l~~~N~~~--~~~i~~g~~l~vp~~c~c~~-~~~~~~~~~-------------~~~~y~v~~gdtl~~ia~~f   72 (537)
                      .=+++.+|+.+|.++  ++.+.+||.+.+|..-.-.. .........             ...+|+|+.||+|+.||++|
T Consensus         5 ~~~~v~~l~~~n~~~~~s~~i~~gq~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~V~~gdtL~~Ia~~~   84 (124)
T COG1388           5 YGVSVKALKKANALTGKSDAIKPGQVLKIPGDISSTVNAGQTLSSLSNKVSDSSSASKAPPVVTYTVKKGDTLSKIARKY   84 (124)
T ss_pred             ccccHHHHHHHhcccCCCCccccCceEEccCCcccccccccccccccceeeccccccccCCCceEEEecCCCHHHHHHHh
Confidence            347899999999877  88999999999996311111 011111111             13579999999999999999


Q ss_pred             cCChHHHHHhhccCCCCcccccccccCCc
Q 009340           73 GVDQQSILEANMLSKADSIFPFAPLLIPL  101 (537)
Q Consensus        73 ~~~~~~l~~~n~~~~~~~i~~~~~l~vp~  101 (537)
                      ++++..|+++|.+.+ +.+++|+.+.++.
T Consensus        85 ~~tv~~l~~~n~l~~-~~i~~gq~l~~~~  112 (124)
T COG1388          85 GVTVAELKQLNNLSS-DKIKVGQKLKLPV  112 (124)
T ss_pred             CCCHHHHHHHhccCC-CceecCcEEEEec
Confidence            999999999999966 4999999999886

>PRK06347 autolysin; Reviewed

Probab=98.55  E-value=7.1e-08  Score=102.52  Aligned_cols=92  Identities=22%  Similarity=0.208  Sum_probs=71.1

Q ss_pred             ccHHHHhhCCCCCCCCCCCCceeeecccccCCCC------cc-----ccchhhhhhhhhcccccchhhhHhhhcCChHHH
Q 009340           11 TTCQALLGQNYFDAPNITIGAQVMIPLRCACPTA------NQ-----IDKGVSYLLAYMAAKGDTISSIGYKFGVDQQSI   79 (537)
Q Consensus        11 ~t~~~l~~~N~~~~~~i~~g~~l~vp~~c~c~~~------~~-----~~~~~~~~~~y~v~~gdtl~~ia~~f~~~~~~l   79 (537)
                      +++.+|+.+|.+..+.|.+||.|.||..-.-...      ..     .........+|+|+.||||++||++||+++++|
T Consensus       425 VSv~~L~~~N~l~s~~L~~Gq~L~IP~~~~~~~~t~~~s~~~~~~k~~s~~~~~~~~YtVk~GDTL~sIAkkygVSv~~L  504 (592)
T PRK06347        425 VTIANLKSWNNLKSDFIYPGQKLKVSAGSTSNTNTSKPSTNTNTSKPSTNTNTNAKVYTVAKGDSLWRIANNNKVTIANL  504 (592)
T ss_pred             CCHHHHHHHhCCCcceeccCcEEEEecCCcccccccccccccccccccccccccceeeeecCCCCHHHHHHHHCCCHHHH
Confidence            7889999999877778999999999964211000      00     000111234799999999999999999999999


Q ss_pred             HHhhccCCCCcccccccccCCcCC
Q 009340           80 LEANMLSKADSIFPFAPLLIPLKN  103 (537)
Q Consensus        80 ~~~n~~~~~~~i~~~~~l~vp~~~  103 (537)
                      +++|++.+ +.|.+|+.+.+|...
T Consensus       505 ~~~N~l~s-~~L~~GQ~L~Ip~~~  527 (592)
T PRK06347        505 KSWNNLKS-DFIYPGQKLKVSAGS  527 (592)
T ss_pred             HHhcCCCc-ccccCCcEEEEecCc
Confidence            99999864 689999999999864

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.45  E-value=1.6e-06  Score=91.31  Aligned_cols=141  Identities=21%  Similarity=0.225  Sum_probs=93.5

Q ss_pred             cccCcCCceEEEEEEcCCCCEEEEEEccCCChHHH------------------------------H----------HHHH
Q 009340          222 RFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQI------------------------------H----------QFIN  261 (537)
Q Consensus       222 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~------------------------------~----------~~~~  261 (537)
                      +-|+.++-|.||+|++++|+.||||+.+..-....                              +          ++.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            56899999999999999999999997654211110                              1          2344


Q ss_pred             HHHHHHhcC----CCCcceEeeEEee-CCccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHH
Q 009340          262 EVVILSQIN----HRHIVKLLGCCLE-TEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGA  336 (537)
Q Consensus       262 E~~~l~~l~----H~niv~l~g~~~~-~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~g  336 (537)
                      |..-+.+++    +..-+++=.++++ .....|+|||++|-.+.+...-...           .++-   ..++..++++
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~-----------g~d~---k~ia~~~~~~  276 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSA-----------GIDR---KELAELLVRA  276 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhc-----------CCCH---HHHHHHHHHH
Confidence            555555542    2223333444443 4567999999999988888532221           2332   2333333332


Q ss_pred             -HHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCccccCC
Q 009340          337 -VAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPN  379 (537)
Q Consensus       337 -l~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~  379 (537)
                       +..+=..+   ++|.|..|.||+++.+++..+.|||+...++.
T Consensus       277 f~~q~~~dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         277 FLRQLLRDG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             HHHHHHhcC---ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence             23333356   99999999999999999999999999987654

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.36  E-value=8e-06  Score=77.74  Aligned_cols=148  Identities=16%  Similarity=0.147  Sum_probs=86.0

Q ss_pred             cccCcCCceEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCC--cceEeeEEeeCCccEEEEecCCCCC-
Q 009340          222 RFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRH--IVKLLGCCLETEVPVLVYEYISSGT-  298 (537)
Q Consensus       222 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~~~~~~~~~lV~e~~~~gs-  298 (537)
                      ..||+|..+.||+.   .|..+++|......  ......+|.++++.+..-.  +.+.++++...+...+|||++++.+ 
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~   81 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS   81 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence            57899999999983   24457788876533  2234578999999986443  4677888877777889999999863 


Q ss_pred             hhhhhhhhhhh----------HHHHhhh-ccCCCCHHHHHH-HHH----------HHHH-HHHHHhh-cCCCCeeecCCC
Q 009340          299 LSHHIHDHQQQ----------QEQKQKQ-ELSSLSWENRVR-VAC----------EVAG-AVAYMHS-SASIPIFHRDIK  354 (537)
Q Consensus       299 L~~~l~~~~~~----------~~~~~~~-~~~~l~~~~~~~-i~~----------~ia~-gl~yLH~-~~~~~ivH~Dlk  354 (537)
                      +...+......          ....... .........+.. +..          .+.+ ...+|.. ...+.++|+|+.
T Consensus        82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~  161 (226)
T TIGR02172        82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ  161 (226)
T ss_pred             hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence            32222111000          0000000 000111111000 000          0011 1222221 123347899999


Q ss_pred             CCCEEECCCCcEEEeeccCcc
Q 009340          355 SSNILLDDKFSAKVSDFGISR  375 (537)
Q Consensus       355 ~~NIll~~~~~~ki~Dfgla~  375 (537)
                      |.||++++++ +.|.||+.+.
T Consensus       162 ~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       162 IGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             CCcEEEcCCC-cEEEechhcC
Confidence            9999999987 9999999775

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PRK14125 cell division suppressor protein YneA; Provisional

Probab=98.32  E-value=3.4e-07  Score=74.59  Aligned_cols=49  Identities=18%  Similarity=0.268  Sum_probs=42.2

Q ss_pred             hhhhhcccccchhhhHhhhcCC--------hHHHHHhhccCCCCcccccccccCCcCC
Q 009340           54 LLAYMAAKGDTISSIGYKFGVD--------QQSILEANMLSKADSIFPFAPLLIPLKN  103 (537)
Q Consensus        54 ~~~y~v~~gdtl~~ia~~f~~~--------~~~l~~~n~~~~~~~i~~~~~l~vp~~~  103 (537)
                      ..+|+|++|||||+||++|+++        ++.|++.|++.+ +.|+||+.+.+|...
T Consensus        36 ~~~~tV~~GDTLW~IA~~y~~~~~l~~~~~v~~I~~~N~l~~-~~I~~Gq~L~IP~~~   92 (103)
T PRK14125         36 YVEITVQEGDTLWALADQYAGKHHMAKNEFIEWVEDVNNLPS-GHIKAGDKLVIPVLK   92 (103)
T ss_pred             cEEEEECCCCCHHHHHHHhCCCcCCCHHHHHHHHHHhcCCCC-CcCCCCCEEEEecCC
Confidence            3479999999999999999875        477888899865 579999999999875

>TIGR02899 spore_safA spore coat assembly protein SafA

Probab=98.29  E-value=6.1e-07  Score=61.37  Aligned_cols=42  Identities=40%  Similarity=0.646  Sum_probs=37.2

Q ss_pred             cccccchhhhHhhhcCChHHHHHhhc-cCCCCcccccccccCC
Q 009340           59 AAKGDTISSIGYKFGVDQQSILEANM-LSKADSIFPFAPLLIP  100 (537)
Q Consensus        59 v~~gdtl~~ia~~f~~~~~~l~~~n~-~~~~~~i~~~~~l~vp  100 (537)
                      |++|||+|+||++|+++.+.|.++|+ +.+.+.+++|+.+.+|
T Consensus         1 v~~gdtl~~IA~~~~~~~~~l~~~N~~~~~~~~~~~g~~l~ip   43 (44)
T TIGR02899         1 VQKGDTLWKIAKKYGVDFDELIQANPQLSNPNLIYPGMKIKIP   43 (44)
T ss_pred             CCCCCCHHHHHHHHCcCHHHHHHHhhcCCCCCCcCCCCEEecC
Confidence            68999999999999999999999997 4455679999999887

in which one of which is found in most examples of endospore-forming bacteria. Lysin motifs are repeated in many proteins.

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.27  E-value=1.7e-05  Score=73.73  Aligned_cols=137  Identities=18%  Similarity=0.223  Sum_probs=90.8

Q ss_pred             hcCCccccccCcCCceEEEEEEcCCCCEEEEEEccCCChHHHHHH---------HHHHHHHHhcC---CCCcceEeeEEe
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQF---------INEVVILSQIN---HRHIVKLLGCCL  282 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~---------~~E~~~l~~l~---H~niv~l~g~~~  282 (537)
                      ..+|...+++-......|.+-.. +|..+++|..+.......+.|         .+++..+.+++   -.....++.++.
T Consensus        30 ~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e  108 (229)
T PF06176_consen   30 DNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE  108 (229)
T ss_pred             hCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence            45777777777777677776666 578899998765433222222         23444444443   233333333333


Q ss_pred             e-----CCccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCC
Q 009340          283 E-----TEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSN  357 (537)
Q Consensus       283 ~-----~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~N  357 (537)
                      .     ....+++|||+++..|.+...                ++.    .++..+++.+.-||+.|   ++|+|..|.|
T Consensus       109 kk~~~~~~~~~ll~EYIeG~~l~d~~~----------------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgN  165 (229)
T PF06176_consen  109 KKIFRYTSSYVLLMEYIEGVELNDIED----------------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGN  165 (229)
T ss_pred             eeeccceeEEEEEEEEecCeecccchh----------------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCc
Confidence            2     234578999999988866542                221    24566778899999999   9999999999


Q ss_pred             EEECCCCcEEEeeccCccc
Q 009340          358 ILLDDKFSAKVSDFGISRS  376 (537)
Q Consensus       358 Ill~~~~~~ki~Dfgla~~  376 (537)
                      ++++++ .+++.||+..+.
T Consensus       166 Flv~~~-~i~iID~~~k~~  183 (229)
T PF06176_consen  166 FLVSNN-GIRIIDTQGKRM  183 (229)
T ss_pred             EEEECC-cEEEEECccccc
Confidence            999966 599999987653

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.20  E-value=3.1e-05  Score=72.75  Aligned_cols=151  Identities=20%  Similarity=0.199  Sum_probs=99.3

Q ss_pred             cCHHHHHHHhcCCccccc---cCcCCceEEEEEEcCCCCEEEEEEccCCChH-----------------------H-HHH
Q 009340          206 FTADELQRATDNYNQSRF---LGQGGFGTVYKGMLPDGSIVAVKRSKEIDKT-----------------------Q-IHQ  258 (537)
Q Consensus       206 ~~~~el~~~~~~~~~~~~---lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~-----------------------~-~~~  258 (537)
                      .+.+.+....++......   |+.|....||+|.-.++..||||+.+.....                       . ...
T Consensus        35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W  114 (268)
T COG1718          35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW  114 (268)
T ss_pred             HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence            455666666666555544   5677788899999888999999976531110                       0 011


Q ss_pred             HHHHHHHHHhcC--CCCcceEeeEEeeCCccEEEEecCCCCC-hhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHH
Q 009340          259 FINEVVILSQIN--HRHIVKLLGCCLETEVPVLVYEYISSGT-LSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAG  335 (537)
Q Consensus       259 ~~~E~~~l~~l~--H~niv~l~g~~~~~~~~~lV~e~~~~gs-L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~  335 (537)
                      ..+|..-|.++.  +-.+.+.+++.    .-.|||||+.... -.-.|.+             ..+.......+..++++
T Consensus       115 ~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkD-------------v~~e~~e~~~~~~~~v~  177 (268)
T COG1718         115 ARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKD-------------VPLELEEAEGLYEDVVE  177 (268)
T ss_pred             HHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCccc-------------CCcCchhHHHHHHHHHH
Confidence            235666677663  44555555553    2379999997641 1111111             12233356677778888


Q ss_pred             HHHHHhh-cCCCCeeecCCCCCCEEECCCCcEEEeeccCcccc
Q 009340          336 AVAYMHS-SASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI  377 (537)
Q Consensus       336 gl~yLH~-~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~  377 (537)
                      .+.-|-. .+   +||+||+.-|||+. ++.+.|+|||-|...
T Consensus       178 ~~~~l~~~a~---LVHgDLSEyNiL~~-~~~p~iID~~QaV~~  216 (268)
T COG1718         178 YMRRLYKEAG---LVHGDLSEYNILVH-DGEPYIIDVSQAVTI  216 (268)
T ss_pred             HHHHHHHhcC---cccccchhhheEEE-CCeEEEEECcccccc
Confidence            8877776 66   99999999999999 779999999988654

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.19  E-value=8.1e-06  Score=75.18  Aligned_cols=104  Identities=21%  Similarity=0.306  Sum_probs=83.4

Q ss_pred             HHHHHHHhcCC-CCcceEeeEEeeCCccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHH
Q 009340          261 NEVVILSQINH-RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAY  339 (537)
Q Consensus       261 ~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~y  339 (537)
                      +|.-+++.+++ +++.+++|+|-    .++|.||...+++...-....         .....+|..|.+||.++++.+.+
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~---------~~~~~~w~~R~~iA~~lL~~l~~   74 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLS---------QFLQSPWEQRAKIALQLLELLEE   74 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccc---------cccccCHHHHHHHHHHHHHHHHH
Confidence            58888888976 69999999994    378999999876643210000         01247999999999999999999


Q ss_pred             HhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCcccc
Q 009340          340 MHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI  377 (537)
Q Consensus       340 LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~  377 (537)
                      |++...-.+.-.|++++|+-+++++++|+.|...+...
T Consensus        75 l~~~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   75 LDHGPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             HhcCCCCcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            99866555889999999999999999999999877544

Proteins in this uncharacterised family are described as transmembrane proteins.

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.17  E-value=3e-07  Score=95.66  Aligned_cols=187  Identities=18%  Similarity=0.142  Sum_probs=134.5

Q ss_pred             cCCccccccCcCCceEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCC-cceEeeEEeeCCccEEEEecC
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRH-IVKLLGCCLETEVPVLVYEYI  294 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~lV~e~~  294 (537)
                      .-+..-+-+++|+++.++|.+-.-.+...++.+...     ....-++++|.+++||| .++.++-+..++..+++++++
T Consensus       242 kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~  316 (829)
T KOG0576|consen  242 KWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRIC  316 (829)
T ss_pred             cchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhh
Confidence            333344568899999999988433333445544432     34456889999999999 777777777778889999999


Q ss_pred             CCC-ChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccC
Q 009340          295 SSG-TLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGI  373 (537)
Q Consensus       295 ~~g-sL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgl  373 (537)
                      ..+ +-..-....           ...+...+...+...-+++++|||+..   =+|+|    ||+..+ ...|..||+.
T Consensus       317 s~~rs~~~~~~~s-----------e~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v  377 (829)
T KOG0576|consen  317 STGRSSALEMTVS-----------EIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAV  377 (829)
T ss_pred             cCCccccccCChh-----------hHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccC
Confidence            887 222211111           012444455667777789999999875   57999    887776 4899999998


Q ss_pred             ccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 009340          374 SRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI  428 (537)
Q Consensus       374 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~  428 (537)
                      ...+....  ......+|+.|+|||....+.+..+.|+|+.|+--.++--|-.|-
T Consensus       378 ~~~L~~~~--~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr  430 (829)
T KOG0576|consen  378 PPQLTRTM--KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR  430 (829)
T ss_pred             CcccCccc--ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence            87764432  345567899999999999999999999999998766776666553

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.15  E-value=4.6e-05  Score=73.51  Aligned_cols=75  Identities=11%  Similarity=0.014  Sum_probs=54.6

Q ss_pred             cCcCCc-eEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHHHHhcC-CCCcceEeeEEeeCCccEEEEecCCCCChhh
Q 009340          224 LGQGGF-GTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQIN-HRHIVKLLGCCLETEVPVLVYEYISSGTLSH  301 (537)
Q Consensus       224 lg~G~~-g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~  301 (537)
                      |..|.. ..||+.... +..+.||+.....   ...+.+|++++..+. +--+.+++++....+..++|||++++.+|..
T Consensus         6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~   81 (244)
T cd05150           6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA   81 (244)
T ss_pred             cCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence            444554 778998764 4778899876543   335667898888884 4456678888776667899999999988765


Q ss_pred             h
Q 009340          302 H  302 (537)
Q Consensus       302 ~  302 (537)
                      .
T Consensus        82 ~   82 (244)
T cd05150          82 L   82 (244)
T ss_pred             h
Confidence            4

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.11  E-value=4.2e-05  Score=80.53  Aligned_cols=141  Identities=18%  Similarity=0.210  Sum_probs=90.2

Q ss_pred             cccCcCCceEEEEEEcCCCCEEEEEEccCCChHHH-------------------------------------HHHHHHHH
Q 009340          222 RFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQI-------------------------------------HQFINEVV  264 (537)
Q Consensus       222 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~-------------------------------------~~~~~E~~  264 (537)
                      +-|+.-..|.||+|++++|+.||||..+..-+...                                     -+|.+|++
T Consensus       167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~  246 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK  246 (538)
T ss_pred             chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence            56999999999999999999999997654221110                                     12455554


Q ss_pred             HHHhc----CCCC---cceEeeEEee-CCccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHH
Q 009340          265 ILSQI----NHRH---IVKLLGCCLE-TEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGA  336 (537)
Q Consensus       265 ~l~~l----~H~n---iv~l~g~~~~-~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~g  336 (537)
                      -..+.    .|-+   -|++=.++++ .....|+|||++|..+.|.-.-..           ..++-..   ++..+.++
T Consensus       247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~-----------~gi~~~~---i~~~l~~~  312 (538)
T KOG1235|consen  247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDK-----------RGISPHD---ILNKLVEA  312 (538)
T ss_pred             hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHH-----------cCCCHHH---HHHHHHHH
Confidence            44443    4555   1222233332 345689999999998876632111           1244443   33333333


Q ss_pred             H-HHHhhcCCCCeeecCCCCCCEEEC----CCCcEEEeeccCccccCC
Q 009340          337 V-AYMHSSASIPIFHRDIKSSNILLD----DKFSAKVSDFGISRSIPN  379 (537)
Q Consensus       337 l-~yLH~~~~~~ivH~Dlk~~NIll~----~~~~~ki~Dfgla~~~~~  379 (537)
                      . .-|=..|   ++|.|=.|-||+++    .++++.+-|||+...+..
T Consensus       313 ~~~qIf~~G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  313 YLEQIFKTG---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             HHHHHHhcC---CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            1 2222345   89999999999998    477899999999886643

>cd00118 LysM Lysin domain, found in a variety of enzymes involved in bacterial cell wall degradation

Probab=98.06  E-value=2.8e-06  Score=58.03  Aligned_cols=45  Identities=38%  Similarity=0.582  Sum_probs=39.9

Q ss_pred             hhhcccccchhhhHhhhcCChHHHHHhhccCCCCcccccccccCC
Q 009340           56 AYMAAKGDTISSIGYKFGVDQQSILEANMLSKADSIFPFAPLLIP  100 (537)
Q Consensus        56 ~y~v~~gdtl~~ia~~f~~~~~~l~~~n~~~~~~~i~~~~~l~vp  100 (537)
                      +|+|++|||+++||.+|+++..++.++|+......+.+|+.+.+|
T Consensus         2 ~~~v~~gdt~~~ia~~~~~~~~~~~~~N~~~~~~~~~~g~~l~ip   46 (46)
T cd00118           2 TYTVKKGDTLSSIAQRYGISVEELLKLNGLSDPDNLQVGQKLKIP   46 (46)
T ss_pred             EEEECCCCCHHHHHHHHCcCHHHHHHHcCCCCccccCCCCEEecC
Confidence            589999999999999999999999999987555678888887765

This domain may have a general peptidoglycan binding function.

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.05  E-value=4.6e-05  Score=72.59  Aligned_cols=78  Identities=23%  Similarity=0.293  Sum_probs=57.5

Q ss_pred             ccccCcCCceEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCC--CcceEeeEEeeCC---ccEEEEecCC
Q 009340          221 SRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHR--HIVKLLGCCLETE---VPVLVYEYIS  295 (537)
Q Consensus       221 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~g~~~~~~---~~~lV~e~~~  295 (537)
                      .+.|+.|..+.||+....+ ..+++|.....  .....+.+|..+++.+...  .+.+++.++....   ..+++|++++
T Consensus         2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~   78 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP   78 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred             CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence            3568899999999999876 58999987654  4456777899998888533  3567777554332   4589999999


Q ss_pred             CCChhh
Q 009340          296 SGTLSH  301 (537)
Q Consensus       296 ~gsL~~  301 (537)
                      +.++..
T Consensus        79 g~~~~~   84 (239)
T PF01636_consen   79 GRPLDD   84 (239)
T ss_dssp             SEEHHH
T ss_pred             cccccc
Confidence            988877

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PLN02876 acyl-CoA dehydrogenase

Probab=97.99  E-value=9.3e-05  Score=84.02  Aligned_cols=80  Identities=14%  Similarity=0.271  Sum_probs=58.1

Q ss_pred             ccccCcCCceEEEEEEcCCC---CEEEEEEccCCC-hHHHHHHHHHHHHHHhcC-CCCc--ceEeeEEeeC---CccEEE
Q 009340          221 SRFLGQGGFGTVYKGMLPDG---SIVAVKRSKEID-KTQIHQFINEVVILSQIN-HRHI--VKLLGCCLET---EVPVLV  290 (537)
Q Consensus       221 ~~~lg~G~~g~Vy~~~~~~g---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~ni--v~l~g~~~~~---~~~~lV  290 (537)
                      .+.++.|.+..+|+....++   ..+++|+..... ......+.+|.++++.+. |.++  .+++++|.+.   +..|+|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            56789999999999876553   367777764322 122346789999999995 6665  7888888764   467999


Q ss_pred             EecCCCCChh
Q 009340          291 YEYISSGTLS  300 (537)
Q Consensus       291 ~e~~~~gsL~  300 (537)
                      |||+++..+.
T Consensus       123 ME~v~G~~~~  132 (822)
T PLN02876        123 MEYLEGRIFV  132 (822)
T ss_pred             EEecCCcccC
Confidence            9999986543

>PRK10871 nlpD lipoprotein NlpD; Provisional

Probab=97.96  E-value=4e-06  Score=82.11  Aligned_cols=47  Identities=23%  Similarity=0.251  Sum_probs=44.7

Q ss_pred             hhhcccccchhhhHhhhcCChHHHHHhhccCCCCcccccccccCCcC
Q 009340           56 AYMAAKGDTISSIGYKFGVDQQSILEANMLSKADSIFPFAPLLIPLK  102 (537)
Q Consensus        56 ~y~v~~gdtl~~ia~~f~~~~~~l~~~n~~~~~~~i~~~~~l~vp~~  102 (537)
                      +|+|++||||++||.+||+++.+|.++|++.++..|++||.|.+|..
T Consensus        62 ~y~Vk~GDTL~~IA~~~g~~~~~La~~N~l~~p~~I~~GQ~L~i~~~  108 (319)
T PRK10871         62 TYTVKKGDTLFYIAWITGNDFRDLAQRNNIQAPYSLNVGQTLQVGNA  108 (319)
T ss_pred             ceEECCCCHHHHHHHHHCcCHHHHHHhcCCCCCccccCCCEEEeCCC
Confidence            79999999999999999999999999999988899999999999865

>TIGR02907 spore_VI_D stage VI sporulation protein D

Probab=97.93  E-value=4.6e-06  Score=80.69  Aligned_cols=46  Identities=24%  Similarity=0.361  Sum_probs=42.5

Q ss_pred             hhhhhcccccchhhhHhhhcCChHHHHHhhccCCCCcccccccccCC
Q 009340           54 LLAYMAAKGDTISSIGYKFGVDQQSILEANMLSKADSIFPFAPLLIP  100 (537)
Q Consensus        54 ~~~y~v~~gdtl~~ia~~f~~~~~~l~~~n~~~~~~~i~~~~~l~vp  100 (537)
                      ..+|+|++||||++||+|||++++.|+++|++. .+.+.+|+.+++|
T Consensus       293 ~~~YiVq~GDTL~sIAkRYGVSV~~L~r~N~L~-~~~L~~GQ~L~IP  338 (338)
T TIGR02907       293 LRMCIVQEGDTIETIAERYEISVSQLIRHNQLE-DFEVNEGQILYIP  338 (338)
T ss_pred             cEEEEECCCCCHHHHHHHHCcCHHHHHHHhCCC-ccccCCCCEEEeC
Confidence            457999999999999999999999999999986 6789999999887

SpoVID, the stage VI sporulation protein D, is restricted to endospore-forming members of the bacteria, all of which are found among the Firmicutes. It is widely distributed but not quite universal in this group. Between well-conserved N-terminal and C-terminal domains is a poorly conserved, low-complexity region of variable length, rich enough in glutamic acid to cause spurious BLAST search results unless a filter is used. The seed alignment for this model was trimmed, in effect, by choosing member sequences in which these regions are relatively short. SpoVID is involved in spore coat assembly by the mother cell compartment late in the process of sporulation.

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.83  E-value=0.00054  Score=63.44  Aligned_cols=130  Identities=23%  Similarity=0.312  Sum_probs=89.8

Q ss_pred             ccccccCcCCceEEEEEEcCCCCEEEEEEccCCC----------------hHHHHHHHHHHHHHHhcC------CCCcce
Q 009340          219 NQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEID----------------KTQIHQFINEVVILSQIN------HRHIVK  276 (537)
Q Consensus       219 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~------H~niv~  276 (537)
                      +....||+|+.-.||.  .++.....||......                ....+++.+|+.-...+.      +..|.+
T Consensus         4 ~~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r   81 (199)
T PF10707_consen    4 SESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPR   81 (199)
T ss_pred             CCCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCccccccc
Confidence            3456799999999995  3445557888776544                223456667776666665      789999


Q ss_pred             EeeEEeeCCccEEEEecCCC--C----ChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeee
Q 009340          277 LLGCCLETEVPVLVYEYISS--G----TLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFH  350 (537)
Q Consensus       277 l~g~~~~~~~~~lV~e~~~~--g----sL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH  350 (537)
                      ++|+..++...-+|+|.+.+  |    +|.+++..             ..++. ...+   .+-+-..||-+++   |+.
T Consensus        82 ~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-------------~~~~~-~~~~---~L~~f~~~l~~~~---Iv~  141 (199)
T PF10707_consen   82 FYGFVETNLGLGLVVELIRDADGNISPTLEDYLKE-------------GGLTE-ELRQ---ALDEFKRYLLDHH---IVI  141 (199)
T ss_pred             EeEEEecCCceEEEEEEEECCCCCcCccHHHHHHc-------------CCccH-HHHH---HHHHHHHHHHHcC---Cee
Confidence            99999999999999998643  3    46666643             23444 3333   3334456777777   999


Q ss_pred             cCCCCCCEEECCCC----cEEEee
Q 009340          351 RDIKSSNILLDDKF----SAKVSD  370 (537)
Q Consensus       351 ~Dlk~~NIll~~~~----~~ki~D  370 (537)
                      +|++|.||++..+.    .+.|.|
T Consensus       142 ~dl~~~NIv~~~~~~~~~~lvlID  165 (199)
T PF10707_consen  142 RDLNPHNIVVQRRDSGEFRLVLID  165 (199)
T ss_pred             cCCCcccEEEEecCCCceEEEEEe
Confidence            99999999995332    466666

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.78  E-value=0.0003  Score=64.73  Aligned_cols=125  Identities=27%  Similarity=0.411  Sum_probs=91.2

Q ss_pred             cCCccccccCcCCc-eEEEEEEcCCCCEEEEEEccC---C---------C---h------HHHHHHHHHHHHHHhcC---
Q 009340          216 DNYNQSRFLGQGGF-GTVYKGMLPDGSIVAVKRSKE---I---------D---K------TQIHQFINEVVILSQIN---  270 (537)
Q Consensus       216 ~~~~~~~~lg~G~~-g~Vy~~~~~~g~~vavK~~~~---~---------~---~------~~~~~~~~E~~~l~~l~---  270 (537)
                      .+++..+.||.|.. |.||+..+ +|+.+|+|.++.   .         .   .      ....-|..|.+...+++   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~  115 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG  115 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence            78888999999999 99999999 588999998221   0         0   0      12345788998888874   


Q ss_pred             CCCc--ceEeeEEeeCC------------------ccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHH
Q 009340          271 HRHI--VKLLGCCLETE------------------VPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVA  330 (537)
Q Consensus       271 H~ni--v~l~g~~~~~~------------------~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~  330 (537)
                      +.++  |+.+||..-..                  .+.+|.||.+...                     .+    ..+-+
T Consensus       116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------------------~~----~~~~~  170 (207)
T PF13095_consen  116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------------------PL----QIRDI  170 (207)
T ss_pred             ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------------------cc----chhHH
Confidence            4566  89999974221                  1356777766532                     01    12335


Q ss_pred             HHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCc
Q 009340          331 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGIS  374 (537)
Q Consensus       331 ~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla  374 (537)
                      .+|.+-|..+|..+   |+-+|+++.|..     .-||+|||.+
T Consensus       171 ~~~~~dl~~~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  171 PQMLRDLKILHKLG---IVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHHHHHHHHHHCC---eeeccCcccccc-----CCEEEecccC
Confidence            56777888999999   999999999997     6789999854

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.77  E-value=0.00029  Score=67.57  Aligned_cols=75  Identities=19%  Similarity=0.228  Sum_probs=47.4

Q ss_pred             cccCcCCce-EEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCC---CcceEeeEEeeCC---ccEEEEecC
Q 009340          222 RFLGQGGFG-TVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHR---HIVKLLGCCLETE---VPVLVYEYI  294 (537)
Q Consensus       222 ~~lg~G~~g-~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~---niv~l~g~~~~~~---~~~lV~e~~  294 (537)
                      +.|+.||.. .||+.    +..+++|..+...  ....+.+|.+++..+...   -+.++++.....+   ..+++|+++
T Consensus         3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~~--~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i   76 (235)
T cd05155           3 EPVDSGGTDNATFRL----GDDMSVRLPSAAG--YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL   76 (235)
T ss_pred             eeccCCCcccceEEc----CCceEEEcCCccc--hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence            457777766 48874    2346778655422  244688899999888532   3444555443322   348899999


Q ss_pred             CCCChhhh
Q 009340          295 SSGTLSHH  302 (537)
Q Consensus       295 ~~gsL~~~  302 (537)
                      ++.++.+.
T Consensus        77 ~G~~l~~~   84 (235)
T cd05155          77 EGETATAA   84 (235)
T ss_pred             cCCCCCcc
Confidence            99887543

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.67  E-value=0.00028  Score=78.98  Aligned_cols=196  Identities=19%  Similarity=0.223  Sum_probs=136.1

Q ss_pred             HHHHHHHHHhcCCCCcceEeeEEeeCCcc----EEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHH
Q 009340          259 FINEVVILSQINHRHIVKLLGCCLETEVP----VLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVA  334 (537)
Q Consensus       259 ~~~E~~~l~~l~H~niv~l~g~~~~~~~~----~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia  334 (537)
                      ..-|+..+..+.|+|++.+++|..++...    .+..|++..-++...+..            ...++....+.+..++.
T Consensus       229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~------------v~~i~~~~~r~~~~~~~  296 (1351)
T KOG1035|consen  229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS------------VGSIPLETLRILHQKLL  296 (1351)
T ss_pred             HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh------------ccccCHHHHHHHHHHHh
Confidence            34467778888999999999998765432    234567777777766654            34688888899999999


Q ss_pred             HHHHHHhhcCCCCeeecCCCCC---CEEECCCCcEEEe--eccCccccCCCCCceeeeccccccccCcccccCCCCCc--
Q 009340          335 GAVAYMHSSASIPIFHRDIKSS---NILLDDKFSAKVS--DFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTD--  407 (537)
Q Consensus       335 ~gl~yLH~~~~~~ivH~Dlk~~---NIll~~~~~~ki~--Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~--  407 (537)
                      +||.|+|+..   ..|.-+..+   +--.+..+...++  ||+.++..+.....  ....-+..|.|||......++.  
T Consensus       297 ~GL~~~h~~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~--~~~~~~~~~~~~e~~~~~~~~~~r  371 (1351)
T KOG1035|consen  297 EGLAYLHSLS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS--FSDLLAEIRNADEDLKENTAKKSR  371 (1351)
T ss_pred             hhHHHHHHhc---cceeEEecccccccccCccceeecchhhhcccccCCCcccc--hhhcCccccccccccccccchhhh
Confidence            9999999986   666666655   5556777778877  99988776443322  1223456688888887666554  


Q ss_pred             chhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCC
Q 009340          408 KSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKR  487 (537)
Q Consensus       408 ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~R  487 (537)
                      ..|+|.+|.++..+..|..+-.....                  ...+++..     .   ...+.....+|+..++++|
T Consensus       372 ~~dL~~lgll~~~~~~~~~i~~~~~~------------------~~~~l~~~-----~---~~~~~d~~~~~~~~~~~~R  425 (1351)
T KOG1035|consen  372 LTDLWCLGLLLLQLSQGEDISEKSAV------------------PVSLLDVL-----S---TSELLDALPKCLDEDSEER  425 (1351)
T ss_pred             hhHHHHHHHHHhhhhhcCcccccccc------------------hhhhhccc-----c---chhhhhhhhhhcchhhhhc
Confidence            47999999999999988765321100                  00011100     0   0145677789999999999


Q ss_pred             CCHhhHHHHH
Q 009340          488 PTMKQVSMEL  497 (537)
Q Consensus       488 Ps~~ev~~~L  497 (537)
                      +++.+++...
T Consensus       426 l~~~~ll~~~  435 (1351)
T KOG1035|consen  426 LSALELLTHP  435 (1351)
T ss_pred             cchhhhhhch
Confidence            9999997654

>PRK10593 hypothetical protein; Provisional

Probab=97.67  E-value=0.00058  Score=67.88  Aligned_cols=76  Identities=11%  Similarity=0.112  Sum_probs=57.1

Q ss_pred             ccccCcCCceEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHHHHhcCC---CCcceEeeEEeeC---CccEEEEecC
Q 009340          221 SRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINH---RHIVKLLGCCLET---EVPVLVYEYI  294 (537)
Q Consensus       221 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H---~niv~l~g~~~~~---~~~~lV~e~~  294 (537)
                      .+.||+|..+.||+-...+++ +.+|..+...  ....|..|...|+.+.-   -.+.+++++|...   +..+||||++
T Consensus        19 ~~~i~~G~~~~vy~~~~~~~~-~~~k~~~~~~--~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i   95 (297)
T PRK10593         19 VECISEQPYAALWALYDSQGN-PMPLMARSFS--TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERL   95 (297)
T ss_pred             eeecCCccceeEEEEEcCCCC-EEEEEecccc--cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEecc
Confidence            457999999999998876564 6667654311  23477899999998853   3688899888643   5689999999


Q ss_pred             CCCCh
Q 009340          295 SSGTL  299 (537)
Q Consensus       295 ~~gsL  299 (537)
                      +++++
T Consensus        96 ~G~~~  100 (297)
T PRK10593         96 RGVSV  100 (297)
T ss_pred             CCEec
Confidence            98876

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.65  E-value=0.0005  Score=61.30  Aligned_cols=127  Identities=17%  Similarity=0.152  Sum_probs=86.6

Q ss_pred             ccccCcCCceEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcce-EeeEEeeCCccEEEEecCCCCCh
Q 009340          221 SRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVK-LLGCCLETEVPVLVYEYISSGTL  299 (537)
Q Consensus       221 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~-l~g~~~~~~~~~lV~e~~~~gsL  299 (537)
                      .+.|++|++|.||+|.+. |..+|+|.-+..+.  ...+..|+++|..+.-.++-+ ++.|-.    -++.|||+.+-.|
T Consensus        27 ~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds~--r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~G~~L   99 (201)
T COG2112          27 EKELAKGTTSVVYLGEWR-GGEVALKVRRRDSP--RRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYIDGRPL   99 (201)
T ss_pred             hhhhhcccccEEEEeecc-CceEEEEEecCCcc--hhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhcCcch
Confidence            567999999999999996 55899998776443  456788999999988766644 444432    2455999988787


Q ss_pred             hhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCC-CCEEECCCCcEEEeeccCccc
Q 009340          300 SHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKS-SNILLDDKFSAKVSDFGISRS  376 (537)
Q Consensus       300 ~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~-~NIll~~~~~~ki~Dfgla~~  376 (537)
                      .++-...               +    .+-...+++.---|...+   |-|+.|.- ...+|-++..+-|+||.-|+.
T Consensus       100 ~~~~~~~---------------~----rk~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112         100 GKLEIGG---------------D----RKHLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             hhhhhcc---------------c----HHHHHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            6655321               1    122334455544455556   88888864 444444444999999988764

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.65  E-value=0.00064  Score=65.08  Aligned_cols=74  Identities=20%  Similarity=0.162  Sum_probs=48.4

Q ss_pred             cccCcCCceEEEEEEcCC--CCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCC-cceEeeEEeeCCccEEEEecCCCCC
Q 009340          222 RFLGQGGFGTVYKGMLPD--GSIVAVKRSKEIDKTQIHQFINEVVILSQINHRH-IVKLLGCCLETEVPVLVYEYISSGT  298 (537)
Q Consensus       222 ~~lg~G~~g~Vy~~~~~~--g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~lV~e~~~~gs  298 (537)
                      +.|..|-...+|+....+  ++.|++|........ .-...+|+.++..+...+ ..++++.+.    ..+||||+++.+
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~   78 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT   78 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence            457778888999988764  678889976543221 112346888888885433 344544332    248999999877


Q ss_pred             hh
Q 009340          299 LS  300 (537)
Q Consensus       299 L~  300 (537)
                      +.
T Consensus        79 l~   80 (235)
T cd05157          79 LE   80 (235)
T ss_pred             CC
Confidence            64

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>smart00257 LysM Lysin motif

Probab=97.64  E-value=4.1e-05  Score=51.42  Aligned_cols=43  Identities=33%  Similarity=0.495  Sum_probs=35.6

Q ss_pred             hhhcccccchhhhHhhhcCChHHHHHhhccCCCCccccccccc
Q 009340           56 AYMAAKGDTISSIGYKFGVDQQSILEANMLSKADSIFPFAPLL   98 (537)
Q Consensus        56 ~y~v~~gdtl~~ia~~f~~~~~~l~~~n~~~~~~~i~~~~~l~   98 (537)
                      +|+|++||++++||.+|+++...+..+|+......+.+|+.+.
T Consensus         1 ~~~v~~gdt~~~ia~~~~~~~~~~~~~N~~~~~~~~~~g~~l~   43 (44)
T smart00257        1 TYTVKKGDTLSSIARRYGISVSDLLELNNILDPDNLQVGQKLK   43 (44)
T ss_pred             CeEeCCCCCHHHHHHHhCCCHHHHHHHcCCCCccccCCCCEEe
Confidence            3889999999999999999999999999854445677776553

>PRK10783 mltD membrane-bound lytic murein transglycosylase D; Provisional

Probab=97.63  E-value=7.2e-05  Score=78.18  Aligned_cols=91  Identities=19%  Similarity=0.206  Sum_probs=64.4

Q ss_pred             ccHHHHhhCCC-CCCCCCCC-C-ceeeecccccCC------CC-------cccc-chhhhhhhhhcccccchhhhHhhhc
Q 009340           11 TTCQALLGQNY-FDAPNITI-G-AQVMIPLRCACP------TA-------NQID-KGVSYLLAYMAAKGDTISSIGYKFG   73 (537)
Q Consensus        11 ~t~~~l~~~N~-~~~~~i~~-g-~~l~vp~~c~c~------~~-------~~~~-~~~~~~~~y~v~~gdtl~~ia~~f~   73 (537)
                      +++++|...|+ +....+.| | ..+.||....-.      ..       .... +......+|+|++|||+++||++||
T Consensus       283 vs~~eL~~LNP~~kr~~t~p~g~~~llvP~~~~~~f~~~l~~~~~~~~~p~~~~~~~~~~~~~y~Vk~GDTL~sIA~r~g  362 (456)
T PRK10783        283 MSLTKLKTFNAGYKRSTTAPSGPHYIMVPKKHADQLRESLASGEIAAVQSTLVADNTPLNSRSYKVRSGDTLSGIASRLN  362 (456)
T ss_pred             CCHHHHHHhCccccCCCcCCCCCeEEEecCchhhHHHHhhhhhhhhhcccccccccCcCCceEEEECCCCcHHHHHHHHC
Confidence            56889999995 55554443 4 677788632210      00       0000 0001234799999999999999999


Q ss_pred             CChHHHHHhhccCCCCcccccccccCCcC
Q 009340           74 VDQQSILEANMLSKADSIFPFAPLLIPLK  102 (537)
Q Consensus        74 ~~~~~l~~~n~~~~~~~i~~~~~l~vp~~  102 (537)
                      +++.+|.++|++.+ +.+.+|+.+.+|.+
T Consensus       363 vs~~~L~~~N~l~~-~~L~~Gq~L~Ip~~  390 (456)
T PRK10783        363 VSTKDLQQWNNLRG-SKLKVGQTLTIGAG  390 (456)
T ss_pred             cCHHHHHHHcCCCc-ccCCCCCEEEecCC
Confidence            99999999999866 78999999999965

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.62  E-value=0.00043  Score=67.30  Aligned_cols=146  Identities=15%  Similarity=0.101  Sum_probs=78.1

Q ss_pred             cCcCCceEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCc-ceEeeEEeeCCccEEEEecCCCCChhhh
Q 009340          224 LGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHI-VKLLGCCLETEVPVLVYEYISSGTLSHH  302 (537)
Q Consensus       224 lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~e~~~~gsL~~~  302 (537)
                      +..|-...+|+... +++.+++|........-.-...+|..+++.+....+ .++++.+.    .++|+||+++..+...
T Consensus         4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~   78 (256)
T TIGR02721         4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLD   78 (256)
T ss_pred             CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccc
Confidence            55677788998874 567788887554322111134678888888864433 34454432    3799999998776432


Q ss_pred             -------hhhhhhhHHHHhhh--ccCCCCHHHHH-HHHH---------HHHHHHHHHhhc-----CCCCeeecCCCCCCE
Q 009340          303 -------IHDHQQQQEQKQKQ--ELSSLSWENRV-RVAC---------EVAGAVAYMHSS-----ASIPIFHRDIKSSNI  358 (537)
Q Consensus       303 -------l~~~~~~~~~~~~~--~~~~l~~~~~~-~i~~---------~ia~gl~yLH~~-----~~~~ivH~Dlk~~NI  358 (537)
                             +..-.....+....  ...+++...++ ....         .+.+.+..+-..     ..+.++|+|+.|.||
T Consensus        79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni  158 (256)
T TIGR02721        79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL  158 (256)
T ss_pred             cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence                   10000000000000  01112221111 1111         111112222111     123489999999999


Q ss_pred             EECCCCcEEEeeccCcc
Q 009340          359 LLDDKFSAKVSDFGISR  375 (537)
Q Consensus       359 ll~~~~~~ki~Dfgla~  375 (537)
                      ++++++ +.|.||..+.
T Consensus       159 l~~~~~-~~lIDwE~a~  174 (256)
T TIGR02721       159 VVTPQG-LKLIDWEYAS  174 (256)
T ss_pred             EEeCCC-CEEEeccccC
Confidence            999876 7899998775

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.56  E-value=0.0013  Score=67.60  Aligned_cols=75  Identities=21%  Similarity=0.218  Sum_probs=54.4

Q ss_pred             cccCcCCceEEEEEEcCCC-CEEEEEEccCC-------ChHHHHHHHHHHHHHHhcC---CCCcceEeeEEeeCCccEEE
Q 009340          222 RFLGQGGFGTVYKGMLPDG-SIVAVKRSKEI-------DKTQIHQFINEVVILSQIN---HRHIVKLLGCCLETEVPVLV  290 (537)
Q Consensus       222 ~~lg~G~~g~Vy~~~~~~g-~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV  290 (537)
                      +.||.|.+..||+....+| +.|+||.-...       -.-..+++..|.+.|..+.   -.++.+++.+  +.+..++|
T Consensus        32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV  109 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV  109 (401)
T ss_pred             eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence            5699999999999998777 48999974321       0123456777888888763   2457777777  44567899


Q ss_pred             EecCCCCC
Q 009340          291 YEYISSGT  298 (537)
Q Consensus       291 ~e~~~~gs  298 (537)
                      |||+++..
T Consensus       110 ME~L~~~~  117 (401)
T PRK09550        110 MEDLSDHK  117 (401)
T ss_pred             EecCCCcc
Confidence            99998754

>PRK13914 invasion associated secreted endopeptidase; Provisional

Probab=97.54  E-value=4.3e-05  Score=78.53  Aligned_cols=46  Identities=28%  Similarity=0.328  Sum_probs=42.6

Q ss_pred             hhhcccccchhhhHhhhcCChHHHHHhhccCCCCcccccccccCCcC
Q 009340           56 AYMAAKGDTISSIGYKFGVDQQSILEANMLSKADSIFPFAPLLIPLK  102 (537)
Q Consensus        56 ~y~v~~gdtl~~ia~~f~~~~~~l~~~n~~~~~~~i~~~~~l~vp~~  102 (537)
                      +|+|++|||||+||++|++++++|+++|++. .+.|++|+.+.+|-.
T Consensus        29 tytVq~GDTLw~IA~~ygvtv~~I~~~N~l~-~~~I~~Gq~L~Ip~~   74 (481)
T PRK13914         29 TVVVEAGDTLWGIAQSKGTTVDAIKKANNLT-TDKIVPGQKLQVNEV   74 (481)
T ss_pred             eEEECCCCCHHHHHHHHCCCHHHHHHHhCCC-cccccCCCEEEeCCC
Confidence            6999999999999999999999999999985 478999999999854

>PRK05231 homoserine kinase; Provisional

Probab=97.52  E-value=0.004  Score=62.58  Aligned_cols=167  Identities=13%  Similarity=0.170  Sum_probs=85.8

Q ss_pred             ccCHHHHHHHhcCCcc-----ccccCcCCceEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCC--CcceE
Q 009340          205 VFTADELQRATDNYNQ-----SRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHR--HIVKL  277 (537)
Q Consensus       205 ~~~~~el~~~~~~~~~-----~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~--niv~l  277 (537)
                      .++.+++......|..     .+.|+.|....+|+....+| .+++|+.......   ....|+.++..+...  .+.+.
T Consensus         6 ~ls~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~~~---~l~~~~~~l~~L~~~glpvP~~   81 (319)
T PRK05231          6 DVSDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQG-EYVLTLFERLTAE---DLPFFLGLMQHLAARGVPVPAP   81 (319)
T ss_pred             cCCHHHHHHHHHhcCCchhhccchhccccccceEEEEeCCC-cEEEEEeccCChH---HhHHHHHHHHHHHHCCCCCCcc
Confidence            3455666555555644     34566777778999887655 5888887532222   233455555555321  23343


Q ss_pred             eeE------EeeCCccEEEEecCCCCChhhh----hhhhhhhHH---HHhhh------ccCCCCH-HHHHH---------
Q 009340          278 LGC------CLETEVPVLVYEYISSGTLSHH----IHDHQQQQE---QKQKQ------ELSSLSW-ENRVR---------  328 (537)
Q Consensus       278 ~g~------~~~~~~~~lV~e~~~~gsL~~~----l~~~~~~~~---~~~~~------~~~~l~~-~~~~~---------  328 (537)
                      +..      ....+..++++||+++..+...    ...-....-   .....      ....+.| .....         
T Consensus        82 i~~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (319)
T PRK05231         82 VARRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADE  161 (319)
T ss_pred             eeCCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChh
Confidence            321      1224557899999998754211    110000000   00000      0001212 11111         


Q ss_pred             ----HHHHHHHHHHHHhhc----CCCCeeecCCCCCCEEECCCCcEEEeeccCcc
Q 009340          329 ----VACEVAGAVAYMHSS----ASIPIFHRDIKSSNILLDDKFSAKVSDFGISR  375 (537)
Q Consensus       329 ----i~~~ia~gl~yLH~~----~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~  375 (537)
                          +...+...+..+.+.    -+..++|+|+.+.||+++++...-|.||+.+.
T Consensus       162 ~~~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        162 QAALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             HHHHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence                111111222333211    23359999999999999977666899999875

>PRK11198 LysM domain/BON superfamily protein; Provisional

Probab=97.46  E-value=6.8e-05  Score=65.94  Aligned_cols=45  Identities=40%  Similarity=0.521  Sum_probs=39.2

Q ss_pred             hhhcccccchhhhHhhhc---CChHHHHHhhc--cCCCCcccccccccCC
Q 009340           56 AYMAAKGDTISSIGYKFG---VDQQSILEANM--LSKADSIFPFAPLLIP  100 (537)
Q Consensus        56 ~y~v~~gdtl~~ia~~f~---~~~~~l~~~n~--~~~~~~i~~~~~l~vp  100 (537)
                      +|+|++|||||+||++|.   .....|.++|+  +.+++.|+||+.+.+|
T Consensus        97 ~y~Vk~GDTL~~IA~~~~g~~~~~~~I~~~N~~~l~~~~~I~pGq~L~IP  146 (147)
T PRK11198         97 FYTVKSGDTLSAIAKKVYGNANKYNKIFEANKPMLKSPDKIYPGQVLRIP  146 (147)
T ss_pred             EEEECCCCCHHHHHHHHcCChhhHHHHHHhhhhcCCCcCCcCcCCEEecC
Confidence            699999999999999975   34678999997  6777889999999887

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.30  E-value=0.0041  Score=62.22  Aligned_cols=167  Identities=14%  Similarity=0.171  Sum_probs=88.8

Q ss_pred             cCHHHHHHHhcCCcc-----ccccCcCCceEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCC--CcceEe
Q 009340          206 FTADELQRATDNYNQ-----SRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHR--HIVKLL  278 (537)
Q Consensus       206 ~~~~el~~~~~~~~~-----~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~  278 (537)
                      .+.++|...-..|..     .+.++.|....+|+....+| .+++|.......  ..+...|+.++..+...  .+.+++
T Consensus         7 ~~~~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~~--~~~i~~e~~~l~~L~~~g~pvp~~i   83 (307)
T TIGR00938         7 VSDEEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTDVG-RYILTLYEKRVK--AEELPFFLALTTHLAARGLPVPKPV   83 (307)
T ss_pred             CCHHHHHHHHHhcCCCCceeccccCCccccceEEEEeCCC-cEEEEEecCCCC--HHHHHHHHHHHHHHHHCCCCCCccc
Confidence            344555555555544     34566676678998876555 477887654211  22344566777776422  244444


Q ss_pred             eEE------eeCCccEEEEecCCCCChhhh----hhhhhhh---HHHHhhhc-------cCCCCHHHHH-----------
Q 009340          279 GCC------LETEVPVLVYEYISSGTLSHH----IHDHQQQ---QEQKQKQE-------LSSLSWENRV-----------  327 (537)
Q Consensus       279 g~~------~~~~~~~lV~e~~~~gsL~~~----l~~~~~~---~~~~~~~~-------~~~l~~~~~~-----------  327 (537)
                      ...      ...+..++++||+++.++...    .......   .-......       ...-.|....           
T Consensus        84 ~t~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~  163 (307)
T TIGR00938        84 KSRDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLE  163 (307)
T ss_pred             cCCCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccC
Confidence            422      123456899999988654311    1100000   00000000       0011222111           


Q ss_pred             -HHHHHHHHHHHHHhh----cCCCCeeecCCCCCCEEECCCCcEEEeeccCcc
Q 009340          328 -RVACEVAGAVAYMHS----SASIPIFHRDIKSSNILLDDKFSAKVSDFGISR  375 (537)
Q Consensus       328 -~i~~~ia~gl~yLH~----~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~  375 (537)
                       .....+.+.++++..    .....++|+|+.+.||++++++...|.||+.+.
T Consensus       164 ~~~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       164 AHMGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             HHHHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence             011223344555543    223459999999999999998777899999774

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.29  E-value=0.011  Score=58.83  Aligned_cols=151  Identities=15%  Similarity=0.182  Sum_probs=85.8

Q ss_pred             ccccCcCCceEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCC--CcceEeeEE------eeCCccEEEEe
Q 009340          221 SRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHR--HIVKLLGCC------LETEVPVLVYE  292 (537)
Q Consensus       221 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~g~~------~~~~~~~lV~e  292 (537)
                      .+.|..|....+|+....+ ..+++|......   ......|+.++..+.+.  .+.+++...      ...+..+.|++
T Consensus        19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~~~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~   94 (296)
T cd05153          19 FEGISAGIENTNYFVTTDS-GRYVLTLFEKVS---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE   94 (296)
T ss_pred             eecccCccccceEEEEeCC-CcEEEEEcCCCC---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence            4567777778899987654 468889876522   34456688888887533  244544321      22345689999


Q ss_pred             cCCCCChhh----hhhhhhhhHHHH---hh------hccCCCCHHHHHH----------HHHHHHHHHHHHhh----cCC
Q 009340          293 YISSGTLSH----HIHDHQQQQEQK---QK------QELSSLSWENRVR----------VACEVAGAVAYMHS----SAS  345 (537)
Q Consensus       293 ~~~~gsL~~----~l~~~~~~~~~~---~~------~~~~~l~~~~~~~----------i~~~ia~gl~yLH~----~~~  345 (537)
                      |+++.++..    .........-..   ..      .......|.....          ....+...+.++..    ...
T Consensus        95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~  174 (296)
T cd05153          95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP  174 (296)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence            999877643    111100000000   00      0001123322211          11123344455543    122


Q ss_pred             CCeeecCCCCCCEEECCCCcEEEeeccCcc
Q 009340          346 IPIFHRDIKSSNILLDDKFSAKVSDFGISR  375 (537)
Q Consensus       346 ~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~  375 (537)
                      ..++|+|+.|.||+++++..+.|.||+.+.
T Consensus       175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence            348999999999999998778899998775

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.16  E-value=0.0031  Score=62.92  Aligned_cols=75  Identities=25%  Similarity=0.309  Sum_probs=48.9

Q ss_pred             cccCcCCceEEEEEEcCC-------CCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCc-ceEeeEEeeCCccEEEEec
Q 009340          222 RFLGQGGFGTVYKGMLPD-------GSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHI-VKLLGCCLETEVPVLVYEY  293 (537)
Q Consensus       222 ~~lg~G~~g~Vy~~~~~~-------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~e~  293 (537)
                      +.+..|-...+|+....+       ++.+++|....... ......+|..++..+...++ .++++++.    -.+|+||
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~r~~E~~~~~~l~~~g~~P~~~~~~~----~~~v~e~   78 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE-LLIDRERELVVFARLSERNLGPKLYGIFP----NGRIEEF   78 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc-ceechHHHHHHHHHHHhCCCCCceEEEeC----CCchhhe
Confidence            345666667899888755       47899998665322 22345678888888853333 45565553    2468999


Q ss_pred             CCCCChhh
Q 009340          294 ISSGTLSH  301 (537)
Q Consensus       294 ~~~gsL~~  301 (537)
                      +++.++..
T Consensus        79 i~G~~l~~   86 (302)
T cd05156          79 IPSRTLTT   86 (302)
T ss_pred             eCCCcCCH
Confidence            99877754

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=97.11  E-value=0.0031  Score=62.07  Aligned_cols=73  Identities=19%  Similarity=0.230  Sum_probs=48.0

Q ss_pred             ccccCcCCceEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHHHHhcC---CCCcceEeeEEeeCCccEEEEecCCCC
Q 009340          221 SRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQIN---HRHIVKLLGCCLETEVPVLVYEYISSG  297 (537)
Q Consensus       221 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV~e~~~~g  297 (537)
                      .+.++.|....+|+.. .+++.+.||.-..   .....|..|..-|+.|.   --.+.+++++....+..+||+||++.+
T Consensus        22 ~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~   97 (288)
T PF03881_consen   22 IEPVSGGDINEAYRLD-TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG   97 (288)
T ss_dssp             EEEE--SSSSEEEEEE-TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred             eEecCCCChhheEEEE-CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence            4568889999999988 4688899998763   22345778888888873   456888999988877889999999877

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PRK13914 invasion associated secreted endopeptidase; Provisional

Probab=97.08  E-value=0.00028  Score=72.66  Aligned_cols=48  Identities=33%  Similarity=0.377  Sum_probs=43.6

Q ss_pred             hhhhcccccchhhhHhhhcCChHHHHHhhccCCCCcccccccccCCcCC
Q 009340           55 LAYMAAKGDTISSIGYKFGVDQQSILEANMLSKADSIFPFAPLLIPLKN  103 (537)
Q Consensus        55 ~~y~v~~gdtl~~ia~~f~~~~~~l~~~n~~~~~~~i~~~~~l~vp~~~  103 (537)
                      .+|+|++||+||+||++|++++++|.++|++.. +.+++|+.+.+|-..
T Consensus       200 ~tytVq~GDTL~sIAkrYgVtv~eI~~~N~l~s-~~L~pGQ~L~Ip~sa  247 (481)
T PRK13914        200 TTHAVKSGDTIWALSVKYGVSVQDIMSWNNLSS-SSIYVGQKLAIKQTA  247 (481)
T ss_pred             eEEEECCCCCHHHHHHHHCCCHHHHHHhcCCCc-cccCCCCEEEecCCC
Confidence            579999999999999999999999999999865 579999999998653

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.05  E-value=0.0091  Score=59.29  Aligned_cols=146  Identities=12%  Similarity=0.199  Sum_probs=81.1

Q ss_pred             eEEEEEEcCCCCEEEEEEcc-CCChHHHHHHHHHHHHHHhcCC--CCcceEeeEEeeCC--ccEEEEecCCCCChhhhhh
Q 009340          230 GTVYKGMLPDGSIVAVKRSK-EIDKTQIHQFINEVVILSQINH--RHIVKLLGCCLETE--VPVLVYEYISSGTLSHHIH  304 (537)
Q Consensus       230 g~Vy~~~~~~g~~vavK~~~-~~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~--~~~lV~e~~~~gsL~~~l~  304 (537)
                      -.+|..... ++.+++.+-. ...........+|..+|+.+.-  --+.+.+++|.++.  ..+.||+|.++..+.+.+.
T Consensus        39 n~t~~~~~~-~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~  117 (321)
T COG3173          39 NDTFRLGDT-GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALP  117 (321)
T ss_pred             cceEEEecC-CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCC
Confidence            334544443 6777777221 1233344555678888887743  34556788888777  7799999998854433332


Q ss_pred             hhhhh--HHH-H----h-----------h--------hccCCCCHHHHHHH--------HHHHHHHHHHHhhc-----CC
Q 009340          305 DHQQQ--QEQ-K----Q-----------K--------QELSSLSWENRVRV--------ACEVAGAVAYMHSS-----AS  345 (537)
Q Consensus       305 ~~~~~--~~~-~----~-----------~--------~~~~~l~~~~~~~i--------~~~ia~gl~yLH~~-----~~  345 (537)
                      .....  ... .    .           .        .....-.|...++.        .-....-..+|+.+     +.
T Consensus       118 ~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~  197 (321)
T COG3173         118 PESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGP  197 (321)
T ss_pred             cccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCC
Confidence            21110  000 0    0           0        00000112111110        01112223444433     23


Q ss_pred             CCeeecCCCCCCEEECCCCcEEEeeccCccc
Q 009340          346 IPIFHRDIKSSNILLDDKFSAKVSDFGISRS  376 (537)
Q Consensus       346 ~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~  376 (537)
                      +.++|||+.+.|++++.+.-+=|.||+++..
T Consensus       198 ~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l  228 (321)
T COG3173         198 PVLVHGDYRPGNLIIDPGRPTGVLDWELATL  228 (321)
T ss_pred             ceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence            5699999999999999998899999999875

>COG3858 Predicted glycosyl hydrolase [General function prediction only]

Probab=96.97  E-value=0.00052  Score=68.59  Aligned_cols=76  Identities=22%  Similarity=0.260  Sum_probs=58.0

Q ss_pred             HHHHhhCCCCCCCCCCCCceeeecccccCCCCccccchhhhhhhhhcccccchhhhHhhhcCChHHHHHhhccCCCCccc
Q 009340           13 CQALLGQNYFDAPNITIGAQVMIPLRCACPTANQIDKGVSYLLAYMAAKGDTISSIGYKFGVDQQSILEANMLSKADSIF   92 (537)
Q Consensus        13 ~~~l~~~N~~~~~~i~~g~~l~vp~~c~c~~~~~~~~~~~~~~~y~v~~gdtl~~ia~~f~~~~~~l~~~n~~~~~~~i~   92 (537)
                      ...|...|....+.|.+||.+.||..               --.|.|++||+++|||++|+++++++..+|....+..+-
T Consensus        23 ~~~i~~~~~~~~d~~~~~q~~~v~~~---------------~~~y~~~~~d~~~Sia~~~~vt~~~~~~m~~~~~~~~l~   87 (423)
T COG3858          23 NNRIVNGNDYTNDDLVDGQTFVVPPS---------------GHFYDVGPGDTLTSIARTVGVTQDSAAIMNFVICPGYLQ   87 (423)
T ss_pred             ccccccccccccccccCceeEEECCc---------------ceEEEecCCcchhhhhhhhcCCHHHHHhhccccccccee
Confidence            34456666443388999999999931               116999999999999999999999999999765555666


Q ss_pred             ccccccCCcCC
Q 009340           93 PFAPLLIPLKN  103 (537)
Q Consensus        93 ~~~~l~vp~~~  103 (537)
                      ++-.+.+|-..
T Consensus        88 ~~~~l~~P~~~   98 (423)
T COG3858          88 YGLNLYIPSAR   98 (423)
T ss_pred             eeeEEeccCCC
Confidence            66667776554

>PLN02236 choline kinase

Probab=96.79  E-value=0.015  Score=59.05  Aligned_cols=149  Identities=19%  Similarity=0.235  Sum_probs=79.6

Q ss_pred             ccCcCCceEEEEEEcCC-----CCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcc-eEeeEEeeCCccEEEEecCCC
Q 009340          223 FLGQGGFGTVYKGMLPD-----GSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIV-KLLGCCLETEVPVLVYEYISS  296 (537)
Q Consensus       223 ~lg~G~~g~Vy~~~~~~-----g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lV~e~~~~  296 (537)
                      .|..|-.-.+|+..+.+     ++.|.+|.......... .-.+|..++..+...++. ++++++...    .|+||+++
T Consensus        43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g  117 (344)
T PLN02236         43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFF-DRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHA  117 (344)
T ss_pred             EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeee-chHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCC
Confidence            45456667888877532     36788998765432222 225788888888544443 556665322    58999987


Q ss_pred             CChhhh-hhhhhh-----hHHHHhhh-c----cCCCCHHHHHHHHHH-----------------HHHHHHHH----hh-c
Q 009340          297 GTLSHH-IHDHQQ-----QQEQKQKQ-E----LSSLSWENRVRVACE-----------------VAGAVAYM----HS-S  343 (537)
Q Consensus       297 gsL~~~-l~~~~~-----~~~~~~~~-~----~~~l~~~~~~~i~~~-----------------ia~gl~yL----H~-~  343 (537)
                      .+|... +.+...     ........ .    .....|....++..+                 +..-+..|    .. .
T Consensus       118 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~  197 (344)
T PLN02236        118 RTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDD  197 (344)
T ss_pred             CCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccC
Confidence            676422 111000     00000000 0    001123322222211                 11112222    22 2


Q ss_pred             CCCCeeecCCCCCCEEECC-CCcEEEeeccCccc
Q 009340          344 ASIPIFHRDIKSSNILLDD-KFSAKVSDFGISRS  376 (537)
Q Consensus       344 ~~~~ivH~Dlk~~NIll~~-~~~~ki~Dfgla~~  376 (537)
                      ....++|+|+++.||++++ ++.+.++||..+..
T Consensus       198 ~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        198 QEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             CCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            2334899999999999986 46899999988753

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=96.75  E-value=0.0036  Score=61.23  Aligned_cols=146  Identities=15%  Similarity=0.154  Sum_probs=96.2

Q ss_pred             cCHHHHHHHhc---CCccccccCcCCceEEEEEEcCCCCEEEEEEccC--C--------C-------h---H--HHHHHH
Q 009340          206 FTADELQRATD---NYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKE--I--------D-------K---T--QIHQFI  260 (537)
Q Consensus       206 ~~~~el~~~~~---~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~--~--------~-------~---~--~~~~~~  260 (537)
                      +++-.|+....   -++..++||-|.-+-+|.+...+|++.++|.-+.  .        .       .   .  ..-...
T Consensus        79 yDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~  158 (465)
T KOG2268|consen   79 YDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAAT  158 (465)
T ss_pred             chHHHHHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHH
Confidence            44555544443   3456789999999999999998999999983111  0        0       0   0  111234


Q ss_pred             HHHHHHHhcC-C-CCcceEeeEEeeCCccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHH
Q 009340          261 NEVVILSQIN-H-RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVA  338 (537)
Q Consensus       261 ~E~~~l~~l~-H-~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~  338 (537)
                      +|...|+.+. | --+.+.+++    +..+.|||++.+-.|...-+-               .+.+   .+...+..-+-
T Consensus       159 kEfafmkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v---------------~d~~---~ly~~lm~~Iv  216 (465)
T KOG2268|consen  159 KEFAFMKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVRHV---------------EDPP---TLYDDLMGLIV  216 (465)
T ss_pred             HHHHHHHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeeeec---------------CChH---HHHHHHHHHHH
Confidence            6777788774 2 234455544    345889999988777554321               1122   23333344455


Q ss_pred             HHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCccc
Q 009340          339 YMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS  376 (537)
Q Consensus       339 yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~  376 (537)
                      -|..+|   +||+|..--||+++++..++++||--...
T Consensus       217 ~la~~G---lIHgDFNEFNimv~dd~~i~vIDFPQmvS  251 (465)
T KOG2268|consen  217 RLANHG---LIHGDFNEFNIMVKDDDKIVVIDFPQMVS  251 (465)
T ss_pred             HHHHcC---ceecccchheeEEecCCCEEEeechHhhc
Confidence            566778   99999999999999999999999976543

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.65  E-value=0.033  Score=54.73  Aligned_cols=31  Identities=19%  Similarity=0.416  Sum_probs=25.7

Q ss_pred             CCeeecCCCCCCEEECCCCc-EEEeeccCccc
Q 009340          346 IPIFHRDIKSSNILLDDKFS-AKVSDFGISRS  376 (537)
Q Consensus       346 ~~ivH~Dlk~~NIll~~~~~-~ki~Dfgla~~  376 (537)
                      +.++|+|+.+.|||++++++ .-|.||+.+..
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            45899999999999997555 56999998754

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=96.48  E-value=0.00042  Score=79.38  Aligned_cols=176  Identities=13%  Similarity=0.005  Sum_probs=118.1

Q ss_pred             EEEEccCCChHHHHH-----HHHHHHHHHhcCCCCcceEeeEEee--CCccEEEEecCCCCChhhhhhhhhhhHHHHhhh
Q 009340          244 AVKRSKEIDKTQIHQ-----FINEVVILSQINHRHIVKLLGCCLE--TEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQ  316 (537)
Q Consensus       244 avK~~~~~~~~~~~~-----~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~  316 (537)
                      -+|+.+..+-+...+     ...|...++...|+++.....-...  ....+.+++|+..|.+.+.+-.....       
T Consensus      1256 k~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee------- 1328 (2724)
T KOG1826|consen 1256 KFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEE------- 1328 (2724)
T ss_pred             EEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhcccc-------
Confidence            445555444333333     3344445555688887766554433  23568899999999999888664432       


Q ss_pred             ccCCCCHHHHHHHHHHHHHHHHHHhhcC--CCCeeecCCCCCCEEECCCCcEEEeeccCccccCCCCCceeeeccccccc
Q 009340          317 ELSSLSWENRVRVACEVAGAVAYMHSSA--SIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGY  394 (537)
Q Consensus       317 ~~~~l~~~~~~~i~~~ia~gl~yLH~~~--~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y  394 (537)
                       ...++..-....-.+......-+|+..  ....+|+++|+.|.++..+.++|++++|+.+...... ...+...+++.|
T Consensus      1329 -~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~-sf~Gl~l~sp~~ 1406 (2724)
T KOG1826|consen 1329 -SPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVL-SFFGLELCSPIY 1406 (2724)
T ss_pred             -CCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCchH-hhhhhhhCCHHH
Confidence             222333222222223244444444432  3447899999999999999999999999998433322 233455678899


Q ss_pred             cCcccccCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 009340          395 LDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI  428 (537)
Q Consensus       395 ~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~  428 (537)
                      ++|++...-.++.++|+|..|+.+|+.--|..+|
T Consensus      1407 v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1407 VLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred             HHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHH
Confidence            9999998889999999999999999998888775

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.03  E-value=0.025  Score=53.13  Aligned_cols=29  Identities=28%  Similarity=0.462  Sum_probs=20.7

Q ss_pred             eeecCCCCCCEEE-CCCCcEEEeeccCccc
Q 009340          348 IFHRDIKSSNILL-DDKFSAKVSDFGISRS  376 (537)
Q Consensus       348 ivH~Dlk~~NIll-~~~~~~ki~Dfgla~~  376 (537)
                      ++|+|+.+.|||+ +.++.++++||..+..
T Consensus       145 ~cHnDl~~~Nil~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  145 FCHNDLNPGNILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             EE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred             EeeccCccccEEeccCCCeEEEecHHHHhh
Confidence            7899999999999 8889999999998753

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	537
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		5e-52
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		4e-51
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		1e-50
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		2e-50
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		1e-34
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		2e-34
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		9e-34
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		3e-31
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		3e-26
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		5e-26
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		1e-25
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		2e-25
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		6e-25
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		5e-24
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		9e-24
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		1e-23
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		1e-23
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		1e-23
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		1e-23
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		1e-23
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		1e-23
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		1e-23
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		2e-23
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		4e-23
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		4e-23
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		5e-23
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		6e-23
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		7e-23
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		7e-23
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		1e-22
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-22
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-22
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		1e-22
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-22
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		1e-22
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		1e-22
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		1e-22
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		1e-22
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		1e-22
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		1e-22
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		1e-22
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-22
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		2e-22
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		2e-22
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		2e-22
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		2e-22
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-22
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		2e-22
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-21
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-21
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		2e-21
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-21
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		6e-21
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		7e-21
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		8e-21
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		1e-20
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		1e-20
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		1e-20
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		1e-20
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		1e-20
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-20
4h58_A	275	Braf In Complex With Compound 3 Length = 275		1e-20
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		1e-20
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		1e-20
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		1e-20
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		1e-20
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		2e-20
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		2e-20
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-20
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-20
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-20
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		2e-20
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-20
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		2e-20
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-20
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-20
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-20
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-20
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		2e-20
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-20
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-20
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		3e-20
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		3e-20
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		3e-20
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		3e-20
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		3e-20
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		3e-20
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-20
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		3e-20
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		4e-20
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-20
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		4e-20
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		4e-20
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		4e-20
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		4e-20
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		4e-20
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		5e-20
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		5e-20
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		5e-20
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		5e-20
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		5e-20
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		5e-20
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		5e-20
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		5e-20
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		5e-20
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		7e-20
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		8e-20
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		8e-20
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		8e-20
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		1e-19
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		1e-19
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		1e-19
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		1e-19
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		1e-19
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		1e-19
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		1e-19
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		1e-19
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		1e-19
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		1e-19
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		2e-19
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-19
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-19
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-19
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-19
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-19
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-19
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-19
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		2e-19
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-19
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-19
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-19
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-19
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		2e-19
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-19
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		2e-19
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		2e-19
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-19
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		2e-19
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		2e-19
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-19
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-19
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-19
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		3e-19
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		3e-19
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		3e-19
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-19
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		5e-19
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		5e-19
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		5e-19
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		7e-19
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		7e-19
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		8e-19
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		8e-19
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		8e-19
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		8e-19
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		9e-19
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-18
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		1e-18
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		1e-18
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-18
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		1e-18
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		1e-18
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		1e-18
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		1e-18
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		1e-18
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		1e-18
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		1e-18
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		1e-18
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		1e-18
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		1e-18
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		1e-18
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		1e-18
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		2e-18
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		2e-18
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		2e-18
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		2e-18
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-18
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-18
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-18
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		2e-18
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-18
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		3e-18
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		3e-18
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		3e-18
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		3e-18
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		3e-18
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		3e-18
2pl0_A	289	Lck Bound To Imatinib Length = 289		3e-18
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		4e-18
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		4e-18
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		4e-18
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		4e-18
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		4e-18
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		4e-18
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		4e-18
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		5e-18
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		5e-18
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		6e-18
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		6e-18
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		6e-18
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		6e-18
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		6e-18
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		7e-18
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		8e-18
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		8e-18
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		9e-18
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		1e-17
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		1e-17
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		1e-17
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-17
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		1e-17
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		1e-17
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		1e-17
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		1e-17
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		1e-17
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		1e-17
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-17
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		1e-17
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-17
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		1e-17
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		2e-17
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		2e-17
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-17
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		2e-17
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-17
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		2e-17
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		2e-17
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		2e-17
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		2e-17
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		2e-17
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		3e-17
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		3e-17
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-17
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		3e-17
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		3e-17
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		3e-17
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		3e-17
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		3e-17
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		3e-17
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		3e-17
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		3e-17
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		3e-17
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		3e-17
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		3e-17
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		3e-17
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		4e-17
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		4e-17
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		4e-17
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		4e-17
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		4e-17
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		4e-17
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		4e-17
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		4e-17
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		4e-17
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		4e-17
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		5e-17
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		5e-17
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		5e-17
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		5e-17
3a4o_X	286	Lyn Kinase Domain Length = 286		6e-17
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		6e-17
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		6e-17
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		6e-17
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		6e-17
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		7e-17
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		7e-17
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		7e-17
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		8e-17
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-16
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		1e-16
4fl3_A	635	Structural And Biophysical Characterization Of The		1e-16
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		1e-16
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		1e-16
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		1e-16
4fl2_A	636	Structural And Biophysical Characterization Of The		2e-16
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-16
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-16
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-16
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		2e-16
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		2e-16
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		2e-16
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		2e-16
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		2e-16
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		2e-16
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-16
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		3e-16
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		3e-16
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-16
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		3e-16
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		3e-16
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-16
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		3e-16
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		3e-16
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		3e-16
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-16
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		3e-16
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-16
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		4e-16
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		4e-16
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-16
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		4e-16
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		4e-16
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		4e-16
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		4e-16
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-16
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-16
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		5e-16
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		5e-16
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		5e-16
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		5e-16
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		5e-16
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		5e-16
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		5e-16
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		5e-16
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		6e-16
1fvr_A	327	Tie2 Kinase Domain Length = 327		6e-16
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		6e-16
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		6e-16
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-16
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		6e-16
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		6e-16
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		7e-16
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-16
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		7e-16
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-16
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		8e-16
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		8e-16
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		8e-16
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		8e-16
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		9e-16
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-16
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-16
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		9e-16
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		1e-15
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-15
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		1e-15
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-15
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		1e-15
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-15
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		1e-15
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-15
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		2e-15
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		2e-15
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-15
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		2e-15
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		2e-15
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-15
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		2e-15
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-15
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		2e-15
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-15
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-15
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-15
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		2e-15
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		2e-15
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		2e-15
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		2e-15
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		2e-15
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		2e-15
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		2e-15
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		2e-15
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		2e-15
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		2e-15
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		2e-15
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-15
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-15
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-15
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-15
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		3e-15
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		3e-15
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		3e-15
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		3e-15
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		3e-15
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-15
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		3e-15
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		4e-15
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		4e-15
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-15
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		4e-15
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		4e-15
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		4e-15
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		4e-15
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		4e-15
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-15
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		4e-15
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		5e-15
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		5e-15
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		5e-15
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		6e-15
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		6e-15
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		6e-15
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		6e-15
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		6e-15
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		7e-15
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		7e-15
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		7e-15
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		8e-15
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		9e-15
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		9e-15
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		9e-15
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		1e-14
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-14
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		1e-14
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		1e-14
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		1e-14
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		1e-14
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		1e-14
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		1e-14
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		1e-14
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		1e-14
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-14
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-14
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		1e-14
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		1e-14
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		1e-14
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		1e-14
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		1e-14
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-14
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		2e-14
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-14
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		2e-14
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		2e-14
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-14
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-14
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-14
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-14
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		2e-14
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		2e-14
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		3e-14
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		3e-14
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		3e-14
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		3e-14
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		3e-14
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		3e-14
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		4e-14
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		5e-14
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		6e-14
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		6e-14
3a7f_A	303	Human Mst3 Kinase Length = 303		7e-14
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		8e-14
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		8e-14
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		9e-14
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		9e-14
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		1e-13
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		1e-13
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		1e-13
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		1e-13
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		2e-13
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		2e-13
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-13
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		2e-13
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-13
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		2e-13
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-13
4fie_A	423	Full-Length Human Pak4 Length = 423		2e-13
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		2e-13
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		2e-13
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		2e-13
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		2e-13
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		2e-13
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		3e-13
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		4e-13
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		4e-13
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		5e-13
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		5e-13
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		7e-13
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		8e-13
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		8e-13
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		8e-13
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		8e-13
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		8e-13
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		8e-13
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		9e-13
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		9e-13
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		9e-13
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		9e-13
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		9e-13
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		9e-13
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		1e-12
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		1e-12
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		1e-12
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		1e-12
3g51_A	325	Structural Diversity Of The Active Conformation Of		1e-12
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		1e-12
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		1e-12
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-12
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		2e-12
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		2e-12
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-12
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-12
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		2e-12
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-12
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-12
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-12
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-12
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		2e-12
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		2e-12
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-12
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-12
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-12
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-12
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-12
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		3e-12
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		3e-12
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		3e-12
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		3e-12
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		3e-12
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		3e-12
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-12
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		3e-12
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		3e-12
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		4e-12
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		4e-12
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		4e-12
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		4e-12
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		4e-12
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		4e-12
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		4e-12
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		4e-12
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		5e-12
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		5e-12
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		5e-12
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		5e-12
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		5e-12
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		5e-12
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		6e-12
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		6e-12
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		6e-12
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		6e-12
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		6e-12
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		6e-12
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		6e-12
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		6e-12
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		6e-12
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		7e-12
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		7e-12
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		7e-12
4ae6_A	343	Structure And Function Of The Human Sperm-specific		7e-12
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		7e-12
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		8e-12
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		8e-12
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		8e-12
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		8e-12
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		9e-12
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		9e-12
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		9e-12
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		9e-12
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		1e-11
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		1e-11
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		1e-11
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-11
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-11
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		1e-11
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-11
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		1e-11
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		1e-11
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		1e-11
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-11
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-11
3kk8_A	284	Camkii Substrate Complex A Length = 284		2e-11
3kk9_A	282	Camkii Substrate Complex B Length = 282		2e-11
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-11
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		2e-11
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		2e-11
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		2e-11
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		2e-11
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-11
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		2e-11
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		2e-11
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		2e-11
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-11
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		2e-11
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		2e-11
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		2e-11
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-11
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		2e-11
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		2e-11
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-11
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		2e-11
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		2e-11
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		2e-11
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-11
4ae9_A	343	Structure And Function Of The Human Sperm-specific		3e-11
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		3e-11
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		3e-11
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		3e-11
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		3e-11
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		3e-11
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		3e-11
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		3e-11
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		3e-11
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-11
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		3e-11
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		4e-11
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		4e-11
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		4e-11
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		4e-11
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		4e-11
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		4e-11
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		4e-11
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		4e-11
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		4e-11
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		5e-11
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		5e-11
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		5e-11
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		5e-11
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		6e-11
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		6e-11
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		6e-11
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		6e-11
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		6e-11
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		6e-11
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		6e-11
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		6e-11
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		6e-11
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		6e-11
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		7e-11
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		7e-11
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		7e-11
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		7e-11
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		9e-11
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		1e-10
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		1e-10
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-10
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		1e-10
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		1e-10
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		1e-10
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		1e-10
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		1e-10
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		1e-10
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		1e-10
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		1e-10
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-10
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-10
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		2e-10
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		2e-10
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-10
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-10
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		2e-10
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		2e-10
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-10
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-10
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-10
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		2e-10
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		2e-10
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-10
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-10
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-10
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-10
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		2e-10
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-10
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		3e-10
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		3e-10
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		3e-10
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		3e-10
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		3e-10
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		3e-10
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		3e-10
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		3e-10
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		3e-10
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		3e-10
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-10
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		3e-10
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-10
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-10
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		3e-10
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		3e-10
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		3e-10
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		4e-10
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		5e-10
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		5e-10
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		6e-10
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		6e-10
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		7e-10
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		7e-10
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		7e-10
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		8e-10
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		8e-10
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		8e-10
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		9e-10
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		1e-09
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-09
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		1e-09
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		1e-09
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		1e-09
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		1e-09
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		1e-09
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-09
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		1e-09
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		1e-09
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-09
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		1e-09
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-09
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-09
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		1e-09
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		1e-09
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-09
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		1e-09
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-09
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		1e-09
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		1e-09
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-09
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		2e-09
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-09
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		2e-09
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		2e-09
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		2e-09
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		2e-09
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-09
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		2e-09
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-09
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		2e-09
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		2e-09
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-09
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		2e-09
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-09
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		2e-09
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		3e-09
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-09
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		3e-09
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		3e-09
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		3e-09
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		3e-09
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		3e-09
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		3e-09
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		3e-09
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-09
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		3e-09
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		3e-09
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-09
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		4e-09
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-09
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-09
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-09
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		4e-09
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		4e-09
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		5e-09
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		5e-09
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		5e-09
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		5e-09
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		5e-09
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		5e-09
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		5e-09
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		6e-09
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		6e-09
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		6e-09
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		6e-09
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		6e-09
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		6e-09
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		7e-09
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		7e-09
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		7e-09
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		7e-09
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		7e-09
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		7e-09
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		8e-09
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		8e-09
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		8e-09
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		9e-09
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		9e-09
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		9e-09
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		1e-08
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		1e-08
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		1e-08
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		1e-08
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		1e-08
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		1e-08
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		1e-08
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		1e-08
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		1e-08
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		1e-08
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		1e-08
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		1e-08
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		1e-08
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		1e-08
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		1e-08
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		1e-08
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		1e-08
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		1e-08
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		1e-08
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		1e-08
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		1e-08
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		1e-08
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		1e-08
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		2e-08
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		2e-08
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		2e-08
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		2e-08
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		2e-08
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-08
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-08
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-08
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-08
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-08
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		2e-08
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		2e-08
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		2e-08
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		2e-08
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		2e-08
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		2e-08
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		2e-08
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-08
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		2e-08
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-08
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-08
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-08
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		2e-08
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		3e-08
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		3e-08
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		3e-08
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		3e-08
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		3e-08
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-08
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		4e-08
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		4e-08
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		4e-08
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-08
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		4e-08
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		5e-08
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		5e-08
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		5e-08
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		5e-08
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		5e-08
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		6e-08
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		6e-08
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		6e-08
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		6e-08
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		7e-08
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		7e-08
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		7e-08
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		8e-08
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		8e-08
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		8e-08
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		8e-08
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		8e-08
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		9e-08
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		9e-08
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		9e-08
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		1e-07
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		1e-07
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		2e-07
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		2e-07
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		2e-07
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		2e-07
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		2e-07
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		2e-07
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		2e-07
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		2e-07
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		2e-07
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-07
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		2e-07
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		3e-07
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		3e-07
3soa_A	444	Full-Length Human Camkii Length = 444		3e-07
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		3e-07
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		4e-07
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		4e-07
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		4e-07
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		4e-07
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		5e-07
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		5e-07
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		5e-07
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		5e-07
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		5e-07
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		6e-07
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		8e-07
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		8e-07
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		9e-07
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		1e-06
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		1e-06
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		1e-06
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		1e-06
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		1e-06
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		1e-06
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		1e-06
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-06
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		2e-06
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		2e-06
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		2e-06
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-06
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		2e-06
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		2e-06
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-06
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		2e-06
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		2e-06
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		2e-06
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		2e-06
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		2e-06
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		2e-06
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		2e-06
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		2e-06
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		2e-06
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		2e-06
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		2e-06
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		2e-06
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		2e-06
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		2e-06
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		2e-06
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-06
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		2e-06
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		2e-06
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		3e-06
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-06
2oza_B	366	Structure Of P38alpha Complex Length = 366		3e-06
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		3e-06
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		3e-06
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		3e-06
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		3e-06
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		3e-06
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		3e-06
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		3e-06
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		3e-06
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		3e-06
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		3e-06
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		3e-06
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		3e-06
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		3e-06
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		3e-06
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		3e-06
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		3e-06
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		3e-06
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		3e-06
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		3e-06
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		3e-06
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		3e-06
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		3e-06
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		3e-06
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		3e-06
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		3e-06
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		3e-06
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		3e-06
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		3e-06
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		3e-06
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		3e-06
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		3e-06
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		3e-06
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		3e-06
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		3e-06
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		3e-06
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		3e-06
3hec_A	348	P38 In Complex With Imatinib Length = 348		3e-06
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		3e-06
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		3e-06
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		4e-06
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		4e-06
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		4e-06
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		4e-06
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		4e-06
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		4e-06
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		4e-06
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		4e-06
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		4e-06
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		4e-06
2oza_A	356	Structure Of P38alpha Complex Length = 356		4e-06
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		4e-06
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		4e-06
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		5e-06
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		5e-06
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		5e-06
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		5e-06
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		5e-06
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		5e-06
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		5e-06
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		5e-06
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		5e-06
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		5e-06
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		6e-06
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		6e-06
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		6e-06
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		6e-06
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		6e-06
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		6e-06
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-06
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		8e-06
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		9e-06
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		9e-06
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		1e-05
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		1e-05
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		1e-05
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		1e-05
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		1e-05
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		1e-05
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		2e-05
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		2e-05
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		2e-05
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		2e-05
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-05
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		2e-05
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		2e-05
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		2e-05
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-05
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		2e-05
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		2e-05
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		2e-05
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		2e-05
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		2e-05
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		3e-05
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-05
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		3e-05
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		4e-05

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  202 bits (513), Expect = 5e-52,   Method: Compositional matrix adjust.
 Identities = 115/299 (38%), Positives = 169/299 (56%), Gaps = 12/299 (4%)
Query: 210 ELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQI 269
           +L+ AT+N++    +G G FG VYKG+L DG+ VA+KR        I +F  E+  LS  
Sbjct: 33  DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFC 92
Query: 270 NHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRV 329
            H H+V L+G C E    +L+Y+Y+ +G L  H++               S+SWE R+ +
Sbjct: 93  RHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTM--------SMSWEQRLEI 144
Query: 330 ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPN-DKTHLTTTI 388
               A  + Y+H+ A   I HRD+KS NILLD+ F  K++DFGIS+     D+THL   +
Sbjct: 145 CIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVV 201
Query: 389 QGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAK 448
           +GT GY+DPEYF   + T+KSDVYSFGVVL E+L  +  I  +   E  NL    +    
Sbjct: 202 KGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN 261
Query: 449 ENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRSQRCL 507
             QL +I+D  +A + R E +    + A++CL L+S+ RP+M  V  +LE   R Q  +
Sbjct: 262 NGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQESV 320

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  199 bits (505), Expect = 4e-51,   Method: Compositional matrix adjust.
 Identities = 114/299 (38%), Positives = 168/299 (56%), Gaps = 12/299 (4%)
Query: 210 ELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQI 269
           +L+ AT+N++    +G G FG VYKG+L DG+ VA+KR        I +F  E+  LS  
Sbjct: 33  DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFC 92
Query: 270 NHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRV 329
            H H+V L+G C E    +L+Y+Y+ +G L  H++               S+SWE R+ +
Sbjct: 93  RHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTM--------SMSWEQRLEI 144
Query: 330 ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPN-DKTHLTTTI 388
               A  + Y+H+ A   I HRD+KS NILLD+ F  K++DFGIS+      +THL   +
Sbjct: 145 CIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVV 201
Query: 389 QGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAK 448
           +GT GY+DPEYF   + T+KSDVYSFGVVL E+L  +  I  +   E  NL    +    
Sbjct: 202 KGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN 261
Query: 449 ENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRSQRCL 507
             QL +I+D  +A + R E +    + A++CL L+S+ RP+M  V  +LE   R Q  +
Sbjct: 262 NGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQESV 320

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  197 bits (501), Expect = 1e-50,   Method: Compositional matrix adjust.
 Identities = 107/309 (34%), Positives = 182/309 (58%), Gaps = 13/309 (4%)
Query: 204 KVFTADELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIH--QFIN 261
           K F+  ELQ A+DN++    LG+GGFG VYKG L DG++VAVKR KE ++ Q    QF  
Sbjct: 26  KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKE-ERXQGGELQFQT 84
Query: 262 EVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSL 321
           EV ++S   HR++++L G C+     +LVY Y+++G+++  + +               L
Sbjct: 85  EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQ--------PPL 136
Query: 322 SWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDK 381
            W  R R+A   A  +AY+H      I HRD+K++NILLD++F A V DFG+++ +    
Sbjct: 137 DWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 196
Query: 382 THLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERN--L 439
            H+   ++GT G++ PEY  + + ++K+DV+ +GV+LLEL+TG++    AR+  + +  L
Sbjct: 197 XHVXXAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVML 256
Query: 440 VACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEG 499
           +     L KE +L  ++D  +    ++E++  + ++A+ C + +  +RP M +V   LEG
Sbjct: 257 LDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 316
Query: 500 LRRSQRCLE 508
              ++R  E
Sbjct: 317 DGLAERWEE 325

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  196 bits (499), Expect = 2e-50,   Method: Compositional matrix adjust.
 Identities = 107/309 (34%), Positives = 181/309 (58%), Gaps = 13/309 (4%)
Query: 204 KVFTADELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIH--QFIN 261
           K F+  ELQ A+DN+     LG+GGFG VYKG L DG +VAVKR KE ++TQ    QF  
Sbjct: 18  KRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKE-ERTQGGELQFQT 76
Query: 262 EVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSL 321
           EV ++S   HR++++L G C+     +LVY Y+++G+++  + +               L
Sbjct: 77  EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQ--------PPL 128
Query: 322 SWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDK 381
            W  R R+A   A  +AY+H      I HRD+K++NILLD++F A V DFG+++ +    
Sbjct: 129 DWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 188
Query: 382 THLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARV--EEERNL 439
            H+   ++G  G++ PEY  + + ++K+DV+ +GV+LLEL+TG++    AR+  +++  L
Sbjct: 189 XHVXXAVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVML 248
Query: 440 VACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEG 499
           +     L KE +L  ++D  +    ++E++  + ++A+ C + +  +RP M +V   LEG
Sbjct: 249 LDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308
Query: 500 LRRSQRCLE 508
              ++R  E
Sbjct: 309 DGLAERWEE 317

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  144 bits (363), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 99/312 (31%), Positives = 164/312 (52%), Gaps = 25/312 (8%)
Query: 202 RAKVFTADELQRATDNYNQSRF------LGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQ 255
           R   F+  EL+  T+N+++         +G+GGFG VYKG + + ++   K +  +D T 
Sbjct: 11  RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITT 70
Query: 256 ---IHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXX 312
                QF  E+ ++++  H ++V+LLG   + +   LVY Y+ +G+L   +         
Sbjct: 71  EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL--------- 121
Query: 313 XXXXXLSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG 372
                   LSW  R ++A   A  + ++H +  I   HRDIKS+NILLD+ F+AK+SDFG
Sbjct: 122 SCLDGTPPLSWHMRCKIAQGAANGINFLHENHHI---HRDIKSANILLDEAFTAKISDFG 178
Query: 373 ISRSIPN-DKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFA 431
           ++R+     +T + + I GT  Y+ PE  +  + T KSD+YSFGVVLLE++TG  P    
Sbjct: 179 LARASEKFAQTVMXSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITG-LPAVDE 236
Query: 432 RVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMK 491
             E +  L        +E  + + +D ++  +A    + AM  +A +CL     KRP +K
Sbjct: 237 HREPQLLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIK 295
Query: 492 QVSMELEGLRRS 503
           +V   L+ +  S
Sbjct: 296 KVQQLLQEMTAS 307

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  143 bits (361), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 99/312 (31%), Positives = 163/312 (52%), Gaps = 25/312 (8%)
Query: 202 RAKVFTADELQRATDNYNQSRF------LGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQ 255
           R   F+  EL+  T+N+++         +G+GGFG VYKG + + ++   K +  +D T 
Sbjct: 11  RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITT 70
Query: 256 ---IHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXX 312
                QF  E+ ++++  H ++V+LLG   + +   LVY Y+ +G+L   +         
Sbjct: 71  EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL--------- 121
Query: 313 XXXXXLSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG 372
                   LSW  R ++A   A  + ++H +  I   HRDIKS+NILLD+ F+AK+SDFG
Sbjct: 122 SCLDGTPPLSWHMRCKIAQGAANGINFLHENHHI---HRDIKSANILLDEAFTAKISDFG 178
Query: 373 ISRSIPN-DKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFA 431
           ++R+     +T +   I GT  Y+ PE  +  + T KSD+YSFGVVLLE++TG  P    
Sbjct: 179 LARASEKFAQTVMXXRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITG-LPAVDE 236
Query: 432 RVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMK 491
             E +  L        +E  + + +D ++  +A    + AM  +A +CL     KRP +K
Sbjct: 237 HREPQLLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIK 295
Query: 492 QVSMELEGLRRS 503
           +V   L+ +  S
Sbjct: 296 KVQQLLQEMTAS 307

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  141 bits (356), Expect = 9e-34,   Method: Compositional matrix adjust.
 Identities = 98/312 (31%), Positives = 162/312 (51%), Gaps = 25/312 (8%)
Query: 202 RAKVFTADELQRATDNYNQSRF------LGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQ 255
           R   F+  EL+  T+N+++         +G+GGFG VYKG + + ++   K +  +D T 
Sbjct: 5   RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITT 64
Query: 256 ---IHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXX 312
                QF  E+ ++++  H ++V+LLG   + +   LVY Y+ +G+L   +         
Sbjct: 65  EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL--------- 115
Query: 313 XXXXXLSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG 372
                   LSW  R ++A   A  + ++H +  I   HRDIKS+NILLD+ F+AK+SDFG
Sbjct: 116 SCLDGTPPLSWHMRCKIAQGAANGINFLHENHHI---HRDIKSANILLDEAFTAKISDFG 172
Query: 373 ISRSIPN-DKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFA 431
           ++R+     +  +   I GT  Y+ PE  +  + T KSD+YSFGVVLLE++TG  P    
Sbjct: 173 LARASEKFAQXVMXXRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITG-LPAVDE 230
Query: 432 RVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMK 491
             E +  L        +E  + + +D ++  +A    + AM  +A +CL     KRP +K
Sbjct: 231 HREPQLLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIK 289
Query: 492 QVSMELEGLRRS 503
           +V   L+ +  S
Sbjct: 290 KVQQLLQEMTAS 301

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  133 bits (334), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 96/307 (31%), Positives = 154/307 (50%), Gaps = 25/307 (8%)
Query: 202 RAKVFTADELQRATDNYNQSRF------LGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQ 255
           R   F+  EL+  T+N+++          G+GGFG VYKG + + ++   K +  +D T 
Sbjct: 2   RFHSFSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNNTTVAVKKLAAMVDITT 61
Query: 256 ---IHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXX 312
                QF  E+ + ++  H ++V+LLG   + +   LVY Y  +G+L   +         
Sbjct: 62  EELKQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRL--------- 112
Query: 313 XXXXXLSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG 372
                   LSW  R ++A   A  + ++H +  I   HRDIKS+NILLD+ F+AK+SDFG
Sbjct: 113 SCLDGTPPLSWHXRCKIAQGAANGINFLHENHHI---HRDIKSANILLDEAFTAKISDFG 169
Query: 373 ISRSIPNDKTHLTTT-IQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFA 431
           ++R+       +  + I GT  Y  PE  +  + T KSD+YSFGVVLLE++TG  P    
Sbjct: 170 LARASEKFAQXVXXSRIVGTTAYXAPEALR-GEITPKSDIYSFGVVLLEIITG-LPAVDE 227
Query: 432 RVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMK 491
             E +  L        +E  + + +D +   +A    + A   +A +CL     KRP +K
Sbjct: 228 HREPQLLLDIKEEIEDEEKTIEDYIDKK-XNDADSTSVEAXYSVASQCLHEKKNKRPDIK 286
Query: 492 QVSMELE 498
           +V   L+
Sbjct: 287 KVQQLLQ 293

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 72/206 (34%), Positives = 112/206 (54%), Gaps = 14/206 (6%)
Query: 224 LGQGGFGTVYKGMLPDGSIVAVKRSKEID--KTQIHQFINEVVILSQINHRHIVKLLGCC 281
           +G G FGTV++     GS VAVK   E D    ++++F+ EV I+ ++ H +IV  +G  
Sbjct: 45  IGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 282 LETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYMH 341
            +     +V EY+S G+L   +H                L    R+ +A +VA  + Y+H
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAR---------EQLDERRRLSMAYDVAKGMNYLH 154
Query: 342 SSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQ 401
           +  + PI HRD+KS N+L+D K++ KV DFG+SR +       +    GT  ++ PE  +
Sbjct: 155 NR-NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKASXFLXSKXAAGTPEWMAPEVLR 212
Query: 402 SSQFTDKSDVYSFGVVLLELLTGKKP 427
                +KSDVYSFGV+L EL T ++P
Sbjct: 213 DEPSNEKSDVYSFGVILWELATLQQP 238

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  115 bits (288), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 73/207 (35%), Positives = 115/207 (55%), Gaps = 16/207 (7%)
Query: 224 LGQGGFGTVYKGMLPDGSIVAVKRSKEID--KTQIHQFINEVVILSQINHRHIVKLLGCC 281
           +G G FGTV++     GS VAVK   E D    ++++F+ EV I+ ++ H +IV  +G  
Sbjct: 45  IGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 282 LETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYMH 341
            +     +V EY+S G+L   +H                L    R+ +A +VA  + Y+H
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAR---------EQLDERRRLSMAYDVAKGMNYLH 154
Query: 342 SSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTT-TIQGTFGYLDPEYF 400
           +  + PI HR++KS N+L+D K++ KV DFG+SR      T L++ +  GT  ++ PE  
Sbjct: 155 NR-NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTPEWMAPEVL 211
Query: 401 QSSQFTDKSDVYSFGVVLLELLTGKKP 427
           +     +KSDVYSFGV+L EL T ++P
Sbjct: 212 RDEPSNEKSDVYSFGVILWELATLQQP 238

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  114 bits (286), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 92/316 (29%), Positives = 149/316 (47%), Gaps = 57/316 (18%)
Query: 206 FTADELQRATDN-YNQSRFLGQGGFGTVYKG-MLPDGSIVAVK---------RSKEIDKT 254
           F    L    DN     + +G+GGFG V+KG ++ D S+VA+K          ++ I+K 
Sbjct: 8   FPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKF 67
Query: 255 QIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXX 314
           Q  +F  EV I+S +NH +IVKL G  L    P +V E++  G L H + D         
Sbjct: 68  Q--EFQREVFIMSNLNHPNIVKLYG--LMHNPPRMVMEFVPCGDLYHRLLDKA------- 116
Query: 315 XXXLSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILL-----DDKFSAKVS 369
                 + W  ++R+  ++A  + YM +    PI HRD++S NI L     +    AKV+
Sbjct: 117 ----HPIKWSVKLRLMLDIALGIEYMQNQNP-PIVHRDLRSPNIFLQSLDENAPVCAKVA 171
Query: 370 DFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQ--FTDKSDVYSFGVVLLELLTGKKP 427
           DFG+S+       H  + + G F ++ PE   + +  +T+K+D YSF ++L  +LTG+ P
Sbjct: 172 DFGLSQQ----SVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP 227
Query: 428 I---CFARVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNS 484
                + +++        FI++ +E  L   +        R      + EL   C   + 
Sbjct: 228 FDEYSYGKIK--------FINMIREEGLRPTIPEDCPPRLRN-----VIEL---CWSGDP 271
Query: 485 KKRPTMKQVSMELEGL 500
           KKRP    +  EL  L
Sbjct: 272 KKRPHFSYIVKELSEL 287

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 92/316 (29%), Positives = 148/316 (46%), Gaps = 57/316 (18%)
Query: 206 FTADELQRATDN-YNQSRFLGQGGFGTVYKG-MLPDGSIVAVK---------RSKEIDKT 254
           F    L    DN     + +G+GGFG V+KG ++ D S+VA+K          ++ I+K 
Sbjct: 8   FPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKF 67
Query: 255 QIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXX 314
           Q  +F  EV I+S +NH +IVKL G  L    P +V E++  G L H + D         
Sbjct: 68  Q--EFQREVFIMSNLNHPNIVKLYG--LMHNPPRMVMEFVPCGDLYHRLLDKA------- 116
Query: 315 XXXLSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILL-----DDKFSAKVS 369
                 + W  ++R+  ++A  + YM +    PI HRD++S NI L     +    AKV+
Sbjct: 117 ----HPIKWSVKLRLMLDIALGIEYMQNQNP-PIVHRDLRSPNIFLQSLDENAPVCAKVA 171
Query: 370 DFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQ--FTDKSDVYSFGVVLLELLTGKKP 427
           DFG S+       H  + + G F ++ PE   + +  +T+K+D YSF ++L  +LTG+ P
Sbjct: 172 DFGTSQQ----SVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP 227
Query: 428 I---CFARVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNS 484
                + +++        FI++ +E  L   +        R      + EL   C   + 
Sbjct: 228 FDEYSYGKIK--------FINMIREEGLRPTIPEDCPPRLRN-----VIEL---CWSGDP 271
Query: 485 KKRPTMKQVSMELEGL 500
           KKRP    +  EL  L
Sbjct: 272 KKRPHFSYIVKELSEL 287

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  112 bits (279), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 91/316 (28%), Positives = 148/316 (46%), Gaps = 57/316 (18%)
Query: 206 FTADELQRATDN-YNQSRFLGQGGFGTVYKG-MLPDGSIVAVK---------RSKEIDKT 254
           F    L    DN     + +G+GGFG V+KG ++ D S+VA+K          ++ I+K 
Sbjct: 8   FPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKF 67
Query: 255 QIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXX 314
           Q  +F  EV I+S +NH +IVKL G  L    P +V E++  G L H + D         
Sbjct: 68  Q--EFQREVFIMSNLNHPNIVKLYG--LMHNPPRMVMEFVPCGDLYHRLLDKA------- 116
Query: 315 XXXLSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILL-----DDKFSAKVS 369
                 + W  ++R+  ++A  + YM +    PI HRD++S NI L     +    AKV+
Sbjct: 117 ----HPIKWSVKLRLMLDIALGIEYMQNQNP-PIVHRDLRSPNIFLQSLDENAPVCAKVA 171
Query: 370 DFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQ--FTDKSDVYSFGVVLLELLTGKKP 427
           DF +S+       H  + + G F ++ PE   + +  +T+K+D YSF ++L  +LTG+ P
Sbjct: 172 DFSLSQQ----SVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP 227
Query: 428 I---CFARVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNS 484
                + +++        FI++ +E  L   +        R      + EL   C   + 
Sbjct: 228 FDEYSYGKIK--------FINMIREEGLRPTIPEDCPPRLRN-----VIEL---CWSGDP 271
Query: 485 KKRPTMKQVSMELEGL 500
           KKRP    +  EL  L
Sbjct: 272 KKRPHFSYIVKELSEL 287

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score =  109 bits (272), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 70/230 (30%), Positives = 120/230 (52%), Gaps = 15/230 (6%)
Query: 203 AKVFTADELQRATDNYNQSRFLGQGGFGTVY----KGMLPD--GSIVAVKRSKEIDKTQI 256
           A VF  DE + A +    SR LGQG FG VY    KG++ D   + VA+K   E    + 
Sbjct: 3   ADVFVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRE 62
Query: 257 H-QFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXX 315
             +F+NE  ++ + N  H+V+LLG   + +  +++ E ++ G L  ++            
Sbjct: 63  RIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPV 122
Query: 316 XXLSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISR 375
               SLS    +++A E+A  +AY++++  +   HRD+ + N ++ + F+ K+ DFG++R
Sbjct: 123 LAPPSLS--KMIQMAGEIADGMAYLNANKFV---HRDLAARNCMVAEDFTVKIGDFGMTR 177
Query: 376 SIPNDKTHLTTTIQGTFG--YLDPEYFQSSQFTDKSDVYSFGVVLLELLT 423
            I  +  +     +G     ++ PE  +   FT  SDV+SFGVVL E+ T
Sbjct: 178 DI-YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 226

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score =  108 bits (269), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 69/230 (30%), Positives = 120/230 (52%), Gaps = 15/230 (6%)
Query: 203 AKVFTADELQRATDNYNQSRFLGQGGFGTVY----KGMLPD--GSIVAVKRSKEIDKTQI 256
           A V+  DE + A +    SR LGQG FG VY    KG++ D   + VA+K   E    + 
Sbjct: 12  ADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRE 71
Query: 257 H-QFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXX 315
             +F+NE  ++ + N  H+V+LLG   + +  +++ E ++ G L  ++            
Sbjct: 72  RIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPV 131
Query: 316 XXLSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISR 375
               SLS    +++A E+A  +AY++++  +   HRD+ + N ++ + F+ K+ DFG++R
Sbjct: 132 LAPPSLS--KMIQMAGEIADGMAYLNANKFV---HRDLAARNCMVAEDFTVKIGDFGMTR 186
Query: 376 SIPNDKTHLTTTIQGTFG--YLDPEYFQSSQFTDKSDVYSFGVVLLELLT 423
            I  +  +     +G     ++ PE  +   FT  SDV+SFGVVL E+ T
Sbjct: 187 DI-YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score =  108 bits (269), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 69/230 (30%), Positives = 120/230 (52%), Gaps = 15/230 (6%)
Query: 203 AKVFTADELQRATDNYNQSRFLGQGGFGTVY----KGMLPD--GSIVAVKRSKEIDKTQI 256
           A V+  DE + A +    SR LGQG FG VY    KG++ D   + VA+K   E    + 
Sbjct: 5   ADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRE 64
Query: 257 H-QFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXX 315
             +F+NE  ++ + N  H+V+LLG   + +  +++ E ++ G L  ++            
Sbjct: 65  RIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPV 124
Query: 316 XXLSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISR 375
               SLS    +++A E+A  +AY++++  +   HRD+ + N ++ + F+ K+ DFG++R
Sbjct: 125 LAPPSLS--KMIQMAGEIADGMAYLNANKFV---HRDLAARNCMVAEDFTVKIGDFGMTR 179
Query: 376 SIPNDKTHLTTTIQGTFG--YLDPEYFQSSQFTDKSDVYSFGVVLLELLT 423
            I  +  +     +G     ++ PE  +   FT  SDV+SFGVVL E+ T
Sbjct: 180 DI-YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score =  108 bits (269), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 69/230 (30%), Positives = 120/230 (52%), Gaps = 15/230 (6%)
Query: 203 AKVFTADELQRATDNYNQSRFLGQGGFGTVY----KGMLPD--GSIVAVKRSKEIDKTQI 256
           A V+  DE + A +    SR LGQG FG VY    KG++ D   + VA+K   E    + 
Sbjct: 2   ADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRE 61
Query: 257 H-QFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXX 315
             +F+NE  ++ + N  H+V+LLG   + +  +++ E ++ G L  ++            
Sbjct: 62  RIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPV 121
Query: 316 XXLSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISR 375
               SLS    +++A E+A  +AY++++  +   HRD+ + N ++ + F+ K+ DFG++R
Sbjct: 122 LAPPSLS--KMIQMAGEIADGMAYLNANKFV---HRDLAARNCMVAEDFTVKIGDFGMTR 176
Query: 376 SIPNDKTHLTTTIQGTFG--YLDPEYFQSSQFTDKSDVYSFGVVLLELLT 423
            I  +  +     +G     ++ PE  +   FT  SDV+SFGVVL E+ T
Sbjct: 177 DI-YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 225

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score =  108 bits (269), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 69/230 (30%), Positives = 120/230 (52%), Gaps = 15/230 (6%)
Query: 203 AKVFTADELQRATDNYNQSRFLGQGGFGTVY----KGMLPD--GSIVAVKRSKEIDKTQI 256
           A V+  DE + A +    SR LGQG FG VY    KG++ D   + VA+K   E    + 
Sbjct: 12  ADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRE 71
Query: 257 H-QFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXX 315
             +F+NE  ++ + N  H+V+LLG   + +  +++ E ++ G L  ++            
Sbjct: 72  RIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPV 131
Query: 316 XXLSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISR 375
               SLS    +++A E+A  +AY++++  +   HRD+ + N ++ + F+ K+ DFG++R
Sbjct: 132 LAPPSLS--KMIQMAGEIADGMAYLNANKFV---HRDLAARNCMVAEDFTVKIGDFGMTR 186
Query: 376 SIPNDKTHLTTTIQGTFG--YLDPEYFQSSQFTDKSDVYSFGVVLLELLT 423
            I  +  +     +G     ++ PE  +   FT  SDV+SFGVVL E+ T
Sbjct: 187 DI-YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 69/230 (30%), Positives = 120/230 (52%), Gaps = 15/230 (6%)
Query: 203 AKVFTADELQRATDNYNQSRFLGQGGFGTVY----KGMLPD--GSIVAVKRSKEIDKTQI 256
           A V+  DE + A +    SR LGQG FG VY    KG++ D   + VA+K   E    + 
Sbjct: 5   ADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRE 64
Query: 257 H-QFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXX 315
             +F+NE  ++ + N  H+V+LLG   + +  +++ E ++ G L  ++            
Sbjct: 65  RIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPV 124
Query: 316 XXLSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISR 375
               SLS    +++A E+A  +AY++++  +   HRD+ + N ++ + F+ K+ DFG++R
Sbjct: 125 LAPPSLS--KMIQMAGEIADGMAYLNANKFV---HRDLAARNCMVAEDFTVKIGDFGMTR 179
Query: 376 SIPNDKTHLTTTIQGTFG--YLDPEYFQSSQFTDKSDVYSFGVVLLELLT 423
            I  +  +     +G     ++ PE  +   FT  SDV+SFGVVL E+ T
Sbjct: 180 DI-YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 70/233 (30%), Positives = 119/233 (51%), Gaps = 21/233 (9%)
Query: 203 AKVFTADELQRATDNYNQSRFLGQGGFGTVY----KGMLPD--GSIVAVKRSKEIDKTQI 256
           A V+  DE + A +    SR LGQG FG VY    KG++ D   + VA+K   E    + 
Sbjct: 6   ADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRE 65
Query: 257 H-QFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXX 315
             +F+NE  ++ + N  H+V+LLG   + +  +++ E ++ G L  ++            
Sbjct: 66  RIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPV 125
Query: 316 XXLSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISR 375
               SLS    +++A E+A  +AY++++  +   HRD+ + N ++ + F+ K+ DFG++R
Sbjct: 126 LAPPSLS--KMIQMAGEIADGMAYLNANKFV---HRDLAARNCMVAEDFTVKIGDFGMTR 180
Query: 376 SIPNDKTHLTTTIQGTFG-----YLDPEYFQSSQFTDKSDVYSFGVVLLELLT 423
            I           +G  G     ++ PE  +   FT  SDV+SFGVVL E+ T
Sbjct: 181 DI----XETDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 71/219 (32%), Positives = 107/219 (48%), Gaps = 33/219 (15%)
Query: 223 FLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFI----NEVVILSQINHRHIVKLL 278
            +G GGFG VY+     G  VAVK ++      I Q I     E  + + + H +I+ L 
Sbjct: 14  IIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72
Query: 279 GCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVA 338
           G CL+     LV E+   G L+  +                       V  A ++A  + 
Sbjct: 73  GVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDIL-------------VNWAVQIARGMN 119
Query: 339 YMHSSASIPIFHRDIKSSNILLDDKFS--------AKVSDFGISRSIPNDKTHLTTTIQ- 389
           Y+H  A +PI HRD+KSSNIL+  K           K++DFG++R     + H TT +  
Sbjct: 120 YLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR-----EWHRTTKMSA 174
Query: 390 -GTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
            G + ++ PE  ++S F+  SDV+S+GV+L ELLTG+ P
Sbjct: 175 AGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP 213

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 69/230 (30%), Positives = 120/230 (52%), Gaps = 15/230 (6%)
Query: 203 AKVFTADELQRATDNYNQSRFLGQGGFGTVY----KGMLPD--GSIVAVKRSKEIDKTQI 256
           A V+  DE + A +    SR LGQG FG VY    KG++ D   + VA+K   E    + 
Sbjct: 6   ADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRE 65
Query: 257 H-QFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXX 315
             +F+NE  ++ + N  H+V+LLG   + +  +++ E ++ G L  ++            
Sbjct: 66  RIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPV 125
Query: 316 XXLSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISR 375
               SLS    +++A E+A  +AY++++  +   HRD+ + N ++ + F+ K+ DFG++R
Sbjct: 126 LAPPSLS--KMIQMAGEIADGMAYLNANKFV---HRDLAARNCMVAEDFTVKIGDFGMTR 180
Query: 376 SIPNDKTHLTTTIQGTFG--YLDPEYFQSSQFTDKSDVYSFGVVLLELLT 423
            I  +  +     +G     ++ PE  +   FT  SDV+SFGVVL E+ T
Sbjct: 181 DI-YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 69/230 (30%), Positives = 120/230 (52%), Gaps = 15/230 (6%)
Query: 203 AKVFTADELQRATDNYNQSRFLGQGGFGTVY----KGMLPD--GSIVAVKRSKEIDKTQI 256
           A V+  DE + A +    SR LGQG FG VY    KG++ D   + VA+K   E    + 
Sbjct: 34  ADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRE 93
Query: 257 H-QFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXX 315
             +F+NE  ++ + N  H+V+LLG   + +  +++ E ++ G L  ++            
Sbjct: 94  RIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPV 153
Query: 316 XXLSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISR 375
               SLS    +++A E+A  +AY++++  +   HRD+ + N ++ + F+ K+ DFG++R
Sbjct: 154 LAPPSLS--KMIQMAGEIADGMAYLNANKFV---HRDLAARNCMVAEDFTVKIGDFGMTR 208
Query: 376 SIPNDKTHLTTTIQGTFG--YLDPEYFQSSQFTDKSDVYSFGVVLLELLT 423
            I  +  +     +G     ++ PE  +   FT  SDV+SFGVVL E+ T
Sbjct: 209 DI-YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 257

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score =  106 bits (264), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 86/287 (29%), Positives = 136/287 (47%), Gaps = 47/287 (16%)
Query: 224 LGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQ------FINEVVILSQINHRHIVKL 277
           +G+G FG V K         A  R+K++   QI        FI E+  LS++NH +IVKL
Sbjct: 17  VGRGAFGVVCK---------AKWRAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKL 67
Query: 278 LGCCLETEVPV-LVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGA 336
            G CL    PV LV EY   G+L + +H               ++SW        + +  
Sbjct: 68  YGACLN---PVCLVMEYAEGGSLYNVLHG---AEPLPYYTAAHAMSW------CLQCSQG 115
Query: 337 VAYMHSSASIPIFHRDIKSSNILLDDKFSA-KVSDFGISRSIPNDKTHLTTTIQGTFGYL 395
           VAY+HS     + HRD+K  N+LL    +  K+ DFG +  I   +TH+T   +G+  ++
Sbjct: 116 VAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI---QTHMTNN-KGSAAWM 171
Query: 396 DPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEI 455
            PE F+ S +++K DV+S+G++L E++T +KP       +E    A  I  A  N     
Sbjct: 172 APEVFEGSNYSEKCDVFSWGIILWEVITRRKPF------DEIGGPAFRIMWAVHNGTRPP 225
Query: 456 LDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRR 502
           L   + K         +  L  RC   +  +RP+M+++   +  L R
Sbjct: 226 LIKNLPK--------PIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR 264

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score =  106 bits (264), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 86/287 (29%), Positives = 136/287 (47%), Gaps = 47/287 (16%)
Query: 224 LGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQ------FINEVVILSQINHRHIVKL 277
           +G+G FG V K         A  R+K++   QI        FI E+  LS++NH +IVKL
Sbjct: 16  VGRGAFGVVCK---------AKWRAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKL 66
Query: 278 LGCCLETEVPV-LVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGA 336
            G CL    PV LV EY   G+L + +H               ++SW        + +  
Sbjct: 67  YGACLN---PVCLVMEYAEGGSLYNVLHG---AEPLPYYTAAHAMSW------CLQCSQG 114
Query: 337 VAYMHSSASIPIFHRDIKSSNILLDDKFSA-KVSDFGISRSIPNDKTHLTTTIQGTFGYL 395
           VAY+HS     + HRD+K  N+LL    +  K+ DFG +  I   +TH+T   +G+  ++
Sbjct: 115 VAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI---QTHMTNN-KGSAAWM 170
Query: 396 DPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEI 455
            PE F+ S +++K DV+S+G++L E++T +KP       +E    A  I  A  N     
Sbjct: 171 APEVFEGSNYSEKCDVFSWGIILWEVITRRKPF------DEIGGPAFRIMWAVHNGTRPP 224
Query: 456 LDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRR 502
           L   + K         +  L  RC   +  +RP+M+++   +  L R
Sbjct: 225 LIKNLPK--------PIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR 263

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score =  105 bits (263), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 69/215 (32%), Positives = 104/215 (48%), Gaps = 14/215 (6%)
Query: 224 LGQGGFGTVY----KGMLP--DGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKL 277
           LG+G FG V+      +LP  D  +VAVK  KE  ++    F  E  +L+ + H+HIV+ 
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 278 LGCCLETEVPVLVYEYISSGTLSHHIHDH---XXXXXXXXXXXLSSLSWENRVRVACEVA 334
            G C E    ++V+EY+  G L+  +  H                 L     + VA +VA
Sbjct: 86  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 145
Query: 335 GAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI-PNDKTHLTTTIQGTFG 393
             + Y+   A +   HRD+ + N L+      K+ DFG+SR I   D   +         
Sbjct: 146 AGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 202
Query: 394 YLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
           ++ PE     +FT +SDV+SFGVVL E+ T GK+P
Sbjct: 203 WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 237

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score =  105 bits (262), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 69/215 (32%), Positives = 104/215 (48%), Gaps = 14/215 (6%)
Query: 224 LGQGGFGTVY----KGMLP--DGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKL 277
           LG+G FG V+      +LP  D  +VAVK  KE  ++    F  E  +L+ + H+HIV+ 
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 278 LGCCLETEVPVLVYEYISSGTLSHHIHDH---XXXXXXXXXXXLSSLSWENRVRVACEVA 334
            G C E    ++V+EY+  G L+  +  H                 L     + VA +VA
Sbjct: 80  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 139
Query: 335 GAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI-PNDKTHLTTTIQGTFG 393
             + Y+   A +   HRD+ + N L+      K+ DFG+SR I   D   +         
Sbjct: 140 AGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 196
Query: 394 YLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
           ++ PE     +FT +SDV+SFGVVL E+ T GK+P
Sbjct: 197 WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 231

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score =  105 bits (261), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 69/215 (32%), Positives = 104/215 (48%), Gaps = 14/215 (6%)
Query: 224 LGQGGFGTVY----KGMLP--DGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKL 277
           LG+G FG V+      +LP  D  +VAVK  KE  ++    F  E  +L+ + H+HIV+ 
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 278 LGCCLETEVPVLVYEYISSGTLSHHIHDH---XXXXXXXXXXXLSSLSWENRVRVACEVA 334
            G C E    ++V+EY+  G L+  +  H                 L     + VA +VA
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 335 GAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI-PNDKTHLTTTIQGTFG 393
             + Y+   A +   HRD+ + N L+      K+ DFG+SR I   D   +         
Sbjct: 169 AGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 225
Query: 394 YLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
           ++ PE     +FT +SDV+SFGVVL E+ T GK+P
Sbjct: 226 WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score =  105 bits (261), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 118/228 (51%), Gaps = 15/228 (6%)
Query: 205 VFTADELQRATDNYNQSRFLGQGGFGTVY----KGMLPDG--SIVAVKRSKEIDKTQIH- 257
           V+  DE + A +    SR LGQG FG VY    KG++ D   + VA+K   E    +   
Sbjct: 1   VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 60
Query: 258 QFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXX 317
           +F+NE  ++ + N  H+V+LLG   + +  +++ E ++ G L  ++              
Sbjct: 61  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 120
Query: 318 LSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI 377
             SLS    +++A E+A  +AY++++  +   HRD+ + N  + + F+ K+ DFG++R I
Sbjct: 121 PPSLS--KMIQMAGEIADGMAYLNANKFV---HRDLAARNCXVAEDFTVKIGDFGMTRDI 175
Query: 378 PNDKTHLTTTIQGTFG--YLDPEYFQSSQFTDKSDVYSFGVVLLELLT 423
             +  +     +G     ++ PE  +   FT  SDV+SFGVVL E+ T
Sbjct: 176 -YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 70/213 (32%), Positives = 113/213 (53%), Gaps = 23/213 (10%)
Query: 224 LGQGGFGTVYKGML--PDGSIV--AVKRSKEI-DKTQIHQFINEVVILSQINHRHIVKLL 278
           +G+G FG VY G L   DG  +  AVK    I D  ++ QF+ E +I+   +H +++ LL
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 279 GCCLETE-VPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAV 337
           G CL +E  P++V  Y+  G L + I +                  ++ +    +VA  +
Sbjct: 99  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV-----------KDLIGFGLQVAKGM 147
Query: 338 AYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPN---DKTHLTTTIQGTFGY 394
            ++   AS    HRD+ + N +LD+KF+ KV+DFG++R + +   D  H  T  +    +
Sbjct: 148 KFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKW 204
Query: 395 LDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
           +  E  Q+ +FT KSDV+SFGV+L EL+T   P
Sbjct: 205 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 237

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 70/213 (32%), Positives = 113/213 (53%), Gaps = 23/213 (10%)
Query: 224 LGQGGFGTVYKGML--PDGSIV--AVKRSKEI-DKTQIHQFINEVVILSQINHRHIVKLL 278
           +G+G FG VY G L   DG  +  AVK    I D  ++ QF+ E +I+   +H +++ LL
Sbjct: 97  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 279 GCCLETE-VPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAV 337
           G CL +E  P++V  Y+  G L + I +                  ++ +    +VA  +
Sbjct: 157 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV-----------KDLIGFGLQVAKGM 205
Query: 338 AYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPN---DKTHLTTTIQGTFGY 394
            ++   AS    HRD+ + N +LD+KF+ KV+DFG++R + +   D  H  T  +    +
Sbjct: 206 KFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKW 262
Query: 395 LDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
           +  E  Q+ +FT KSDV+SFGV+L EL+T   P
Sbjct: 263 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 295

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 70/213 (32%), Positives = 113/213 (53%), Gaps = 23/213 (10%)
Query: 224 LGQGGFGTVYKGML--PDGSIV--AVKRSKEI-DKTQIHQFINEVVILSQINHRHIVKLL 278
           +G+G FG VY G L   DG  +  AVK    I D  ++ QF+ E +I+   +H +++ LL
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 279 GCCLETE-VPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAV 337
           G CL +E  P++V  Y+  G L + I +                  ++ +    +VA  +
Sbjct: 96  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV-----------KDLIGFGLQVAKGM 144
Query: 338 AYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPN---DKTHLTTTIQGTFGY 394
            ++   AS    HRD+ + N +LD+KF+ KV+DFG++R + +   D  H  T  +    +
Sbjct: 145 KFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKW 201
Query: 395 LDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
           +  E  Q+ +FT KSDV+SFGV+L EL+T   P
Sbjct: 202 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 234

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 70/213 (32%), Positives = 113/213 (53%), Gaps = 23/213 (10%)
Query: 224 LGQGGFGTVYKGML--PDGSIV--AVKRSKEI-DKTQIHQFINEVVILSQINHRHIVKLL 278
           +G+G FG VY G L   DG  +  AVK    I D  ++ QF+ E +I+   +H +++ LL
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 279 GCCLETE-VPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAV 337
           G CL +E  P++V  Y+  G L + I +                  ++ +    +VA  +
Sbjct: 99  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV-----------KDLIGFGLQVAKGM 147
Query: 338 AYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPN---DKTHLTTTIQGTFGY 394
            ++   AS    HRD+ + N +LD+KF+ KV+DFG++R + +   D  H  T  +    +
Sbjct: 148 KFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKW 204
Query: 395 LDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
           +  E  Q+ +FT KSDV+SFGV+L EL+T   P
Sbjct: 205 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 237

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 70/213 (32%), Positives = 113/213 (53%), Gaps = 23/213 (10%)
Query: 224 LGQGGFGTVYKGML--PDGSIV--AVKRSKEI-DKTQIHQFINEVVILSQINHRHIVKLL 278
           +G+G FG VY G L   DG  +  AVK    I D  ++ QF+ E +I+   +H +++ LL
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 279 GCCLETE-VPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAV 337
           G CL +E  P++V  Y+  G L + I +                  ++ +    +VA  +
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV-----------KDLIGFGLQVAKGM 146
Query: 338 AYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPN---DKTHLTTTIQGTFGY 394
            ++   AS    HRD+ + N +LD+KF+ KV+DFG++R + +   D  H  T  +    +
Sbjct: 147 KFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKW 203
Query: 395 LDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
           +  E  Q+ +FT KSDV+SFGV+L EL+T   P
Sbjct: 204 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 70/213 (32%), Positives = 113/213 (53%), Gaps = 23/213 (10%)
Query: 224 LGQGGFGTVYKGML--PDGSIV--AVKRSKEI-DKTQIHQFINEVVILSQINHRHIVKLL 278
           +G+G FG VY G L   DG  +  AVK    I D  ++ QF+ E +I+   +H +++ LL
Sbjct: 30  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 89
Query: 279 GCCLETE-VPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAV 337
           G CL +E  P++V  Y+  G L + I +                  ++ +    +VA  +
Sbjct: 90  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV-----------KDLIGFGLQVAKGM 138
Query: 338 AYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDK---THLTTTIQGTFGY 394
            Y+   AS    HRD+ + N +LD+KF+ KV+DFG++R + + +    H  T  +    +
Sbjct: 139 KYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW 195
Query: 395 LDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
           +  E  Q+ +FT KSDV+SFGV+L EL+T   P
Sbjct: 196 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 228

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 70/213 (32%), Positives = 113/213 (53%), Gaps = 23/213 (10%)
Query: 224 LGQGGFGTVYKGML--PDGSIV--AVKRSKEI-DKTQIHQFINEVVILSQINHRHIVKLL 278
           +G+G FG VY G L   DG  +  AVK    I D  ++ QF+ E +I+   +H +++ LL
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 279 GCCLETE-VPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAV 337
           G CL +E  P++V  Y+  G L + I +                  ++ +    +VA  +
Sbjct: 97  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV-----------KDLIGFGLQVAKGM 145
Query: 338 AYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDK---THLTTTIQGTFGY 394
            Y+   AS    HRD+ + N +LD+KF+ KV+DFG++R + + +    H  T  +    +
Sbjct: 146 KYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKW 202
Query: 395 LDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
           +  E  Q+ +FT KSDV+SFGV+L EL+T   P
Sbjct: 203 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 235

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 70/213 (32%), Positives = 113/213 (53%), Gaps = 23/213 (10%)
Query: 224 LGQGGFGTVYKGML--PDGSIV--AVKRSKEI-DKTQIHQFINEVVILSQINHRHIVKLL 278
           +G+G FG VY G L   DG  +  AVK    I D  ++ QF+ E +I+   +H +++ LL
Sbjct: 43  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 102
Query: 279 GCCLETE-VPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAV 337
           G CL +E  P++V  Y+  G L + I +                  ++ +    +VA  +
Sbjct: 103 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV-----------KDLIGFGLQVAKGM 151
Query: 338 AYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPN---DKTHLTTTIQGTFGY 394
            ++   AS    HRD+ + N +LD+KF+ KV+DFG++R + +   D  H  T  +    +
Sbjct: 152 KFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKW 208
Query: 395 LDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
           +  E  Q+ +FT KSDV+SFGV+L EL+T   P
Sbjct: 209 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 241

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 70/213 (32%), Positives = 113/213 (53%), Gaps = 23/213 (10%)
Query: 224 LGQGGFGTVYKGML--PDGSIV--AVKRSKEI-DKTQIHQFINEVVILSQINHRHIVKLL 278
           +G+G FG VY G L   DG  +  AVK    I D  ++ QF+ E +I+   +H +++ LL
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 279 GCCLETE-VPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAV 337
           G CL +E  P++V  Y+  G L + I +                  ++ +    +VA  +
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV-----------KDLIGFGLQVAKGM 146
Query: 338 AYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPN---DKTHLTTTIQGTFGY 394
            ++   AS    HRD+ + N +LD+KF+ KV+DFG++R + +   D  H  T  +    +
Sbjct: 147 KFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKW 203
Query: 395 LDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
           +  E  Q+ +FT KSDV+SFGV+L EL+T   P
Sbjct: 204 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 70/213 (32%), Positives = 113/213 (53%), Gaps = 23/213 (10%)
Query: 224 LGQGGFGTVYKGML--PDGSIV--AVKRSKEI-DKTQIHQFINEVVILSQINHRHIVKLL 278
           +G+G FG VY G L   DG  +  AVK    I D  ++ QF+ E +I+   +H +++ LL
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 279 GCCLETE-VPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAV 337
           G CL +E  P++V  Y+  G L + I +                  ++ +    +VA  +
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV-----------KDLIGFGLQVAKGM 146
Query: 338 AYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDK---THLTTTIQGTFGY 394
            Y+   AS    HRD+ + N +LD+KF+ KV+DFG++R + + +    H  T  +    +
Sbjct: 147 KYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW 203
Query: 395 LDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
           +  E  Q+ +FT KSDV+SFGV+L EL+T   P
Sbjct: 204 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 70/213 (32%), Positives = 113/213 (53%), Gaps = 23/213 (10%)
Query: 224 LGQGGFGTVYKGML--PDGSIV--AVKRSKEI-DKTQIHQFINEVVILSQINHRHIVKLL 278
           +G+G FG VY G L   DG  +  AVK    I D  ++ QF+ E +I+   +H +++ LL
Sbjct: 56  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 115
Query: 279 GCCLETE-VPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAV 337
           G CL +E  P++V  Y+  G L + I +                  ++ +    +VA  +
Sbjct: 116 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV-----------KDLIGFGLQVAKGM 164
Query: 338 AYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDK---THLTTTIQGTFGY 394
            Y+   AS    HRD+ + N +LD+KF+ KV+DFG++R + + +    H  T  +    +
Sbjct: 165 KYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW 221
Query: 395 LDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
           +  E  Q+ +FT KSDV+SFGV+L EL+T   P
Sbjct: 222 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 254

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 70/213 (32%), Positives = 113/213 (53%), Gaps = 23/213 (10%)
Query: 224 LGQGGFGTVYKGML--PDGSIV--AVKRSKEI-DKTQIHQFINEVVILSQINHRHIVKLL 278
           +G+G FG VY G L   DG  +  AVK    I D  ++ QF+ E +I+   +H +++ LL
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 94
Query: 279 GCCLETE-VPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAV 337
           G CL +E  P++V  Y+  G L + I +                  ++ +    +VA  +
Sbjct: 95  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV-----------KDLIGFGLQVAKGM 143
Query: 338 AYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDK---THLTTTIQGTFGY 394
            Y+   AS    HRD+ + N +LD+KF+ KV+DFG++R + + +    H  T  +    +
Sbjct: 144 KYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW 200
Query: 395 LDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
           +  E  Q+ +FT KSDV+SFGV+L EL+T   P
Sbjct: 201 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 233

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 70/213 (32%), Positives = 113/213 (53%), Gaps = 23/213 (10%)
Query: 224 LGQGGFGTVYKGML--PDGSIV--AVKRSKEI-DKTQIHQFINEVVILSQINHRHIVKLL 278
           +G+G FG VY G L   DG  +  AVK    I D  ++ QF+ E +I+   +H +++ LL
Sbjct: 57  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 116
Query: 279 GCCLETE-VPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAV 337
           G CL +E  P++V  Y+  G L + I +                  ++ +    +VA  +
Sbjct: 117 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV-----------KDLIGFGLQVAKGM 165
Query: 338 AYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDK---THLTTTIQGTFGY 394
            Y+   AS    HRD+ + N +LD+KF+ KV+DFG++R + + +    H  T  +    +
Sbjct: 166 KYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW 222
Query: 395 LDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
           +  E  Q+ +FT KSDV+SFGV+L EL+T   P
Sbjct: 223 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 255

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 68/227 (29%), Positives = 116/227 (51%), Gaps = 21/227 (9%)
Query: 209 DELQRATDNYNQSRFLGQGGFGTVY----KGMLPDG--SIVAVKRSKEIDKTQIH-QFIN 261
           DE + A +    SR LGQG FG VY    KG++ D   + VA+K   E    +   +F+N
Sbjct: 3   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 62
Query: 262 EVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSL 321
           E  ++ + N  H+V+LLG   + +  +++ E ++ G L  ++                SL
Sbjct: 63  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 122
Query: 322 SWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDK 381
           S    +++A E+A  +AY++++  +   HRD+ + N ++ + F+ K+ DFG++R I    
Sbjct: 123 S--KMIQMAGEIADGMAYLNANKFV---HRDLAARNCMVAEDFTVKIGDFGMTRDI---- 173
Query: 382 THLTTTIQGTFG-----YLDPEYFQSSQFTDKSDVYSFGVVLLELLT 423
                  +G  G     ++ PE  +   FT  SDV+SFGVVL E+ T
Sbjct: 174 XETDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 220

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 70/213 (32%), Positives = 113/213 (53%), Gaps = 23/213 (10%)
Query: 224 LGQGGFGTVYKGML--PDGSIV--AVKRSKEI-DKTQIHQFINEVVILSQINHRHIVKLL 278
           +G+G FG VY G L   DG  +  AVK    I D  ++ QF+ E +I+   +H +++ LL
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 279 GCCLETE-VPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAV 337
           G CL +E  P++V  Y+  G L + I +                  ++ +    +VA  +
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV-----------KDLIGFGLQVAKGM 146
Query: 338 AYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDK---THLTTTIQGTFGY 394
            Y+   AS    HRD+ + N +LD+KF+ KV+DFG++R + + +    H  T  +    +
Sbjct: 147 KYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW 203
Query: 395 LDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
           +  E  Q+ +FT KSDV+SFGV+L EL+T   P
Sbjct: 204 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 70/213 (32%), Positives = 113/213 (53%), Gaps = 23/213 (10%)
Query: 224 LGQGGFGTVYKGML--PDGSIV--AVKRSKEI-DKTQIHQFINEVVILSQINHRHIVKLL 278
           +G+G FG VY G L   DG  +  AVK    I D  ++ QF+ E +I+   +H +++ LL
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 279 GCCLETE-VPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAV 337
           G CL +E  P++V  Y+  G L + I +                  ++ +    +VA  +
Sbjct: 96  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV-----------KDLIGFGLQVAKGM 144
Query: 338 AYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDK---THLTTTIQGTFGY 394
            Y+   AS    HRD+ + N +LD+KF+ KV+DFG++R + + +    H  T  +    +
Sbjct: 145 KYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW 201
Query: 395 LDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
           +  E  Q+ +FT KSDV+SFGV+L EL+T   P
Sbjct: 202 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 234

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 70/213 (32%), Positives = 113/213 (53%), Gaps = 23/213 (10%)
Query: 224 LGQGGFGTVYKGML--PDGSIV--AVKRSKEI-DKTQIHQFINEVVILSQINHRHIVKLL 278
           +G+G FG VY G L   DG  +  AVK    I D  ++ QF+ E +I+   +H +++ LL
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 279 GCCLETE-VPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAV 337
           G CL +E  P++V  Y+  G L + I +                  ++ +    +VA  +
Sbjct: 97  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV-----------KDLIGFGLQVAKGM 145
Query: 338 AYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDK---THLTTTIQGTFGY 394
            Y+   AS    HRD+ + N +LD+KF+ KV+DFG++R + + +    H  T  +    +
Sbjct: 146 KYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW 202
Query: 395 LDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
           +  E  Q+ +FT KSDV+SFGV+L EL+T   P
Sbjct: 203 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 235

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 70/213 (32%), Positives = 113/213 (53%), Gaps = 23/213 (10%)
Query: 224 LGQGGFGTVYKGML--PDGSIV--AVKRSKEI-DKTQIHQFINEVVILSQINHRHIVKLL 278
           +G+G FG VY G L   DG  +  AVK    I D  ++ QF+ E +I+   +H +++ LL
Sbjct: 33  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 279 GCCLETE-VPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAV 337
           G CL +E  P++V  Y+  G L + I +                  ++ +    +VA  +
Sbjct: 93  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV-----------KDLIGFGLQVAKGM 141
Query: 338 AYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDK---THLTTTIQGTFGY 394
            Y+   AS    HRD+ + N +LD+KF+ KV+DFG++R + + +    H  T  +    +
Sbjct: 142 KYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW 198
Query: 395 LDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
           +  E  Q+ +FT KSDV+SFGV+L EL+T   P
Sbjct: 199 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 231

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 117/224 (52%), Gaps = 15/224 (6%)
Query: 209 DELQRATDNYNQSRFLGQGGFGTVY----KGMLPDG--SIVAVKRSKEIDKTQIH-QFIN 261
           DE + A +    SR LGQG FG VY    KG++ D   + VA+K   E    +   +F+N
Sbjct: 5   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 64
Query: 262 EVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSL 321
           E  ++ + N  H+V+LLG   + +  +++ E ++ G L  ++                SL
Sbjct: 65  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 124
Query: 322 SWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDK 381
           S    +++A E+A  +AY++++  +   HRD+ + N ++ + F+ K+ DFG++R I  + 
Sbjct: 125 S--KMIQMAGEIADGMAYLNANKFV---HRDLAARNCMVAEDFTVKIGDFGMTRDI-YET 178
Query: 382 THLTTTIQGTFG--YLDPEYFQSSQFTDKSDVYSFGVVLLELLT 423
            +     +G     ++ PE  +   FT  SDV+SFGVVL E+ T
Sbjct: 179 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 75/307 (24%), Positives = 139/307 (45%), Gaps = 46/307 (14%)
Query: 208 ADELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILS 267
           AD+ +         + +G G FGTVYKG       V +         Q+  F NEV +L 
Sbjct: 16  ADDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLR 75
Query: 268 QINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
           +  H +I+  +G     ++  +V ++    +L HH+H              +    +  +
Sbjct: 76  KTRHVNILLFMGYSTAPQL-AIVTQWCEGSSLYHHLH-----------ASETKFEMKKLI 123
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPN-DKTHLTT 386
            +A + A  + Y+H+ +   I HRD+KS+NI L +  + K+ DFG++        +H   
Sbjct: 124 DIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFE 180
Query: 387 TIQGTFGYLDPEYFQ---SSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACF 443
            + G+  ++ PE  +   S+ ++ +SDVY+FG+VL EL+TG+ P               +
Sbjct: 181 QLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP---------------Y 225
Query: 444 ISLAKENQLLEILDARVAKEAREEDIGA--------MAELAMRCLRLNSKKRPTMKQVSM 495
            ++   +Q++E+    V + +   D+          M  L   CL+    +RP+  ++  
Sbjct: 226 SNINNRDQIIEM----VGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281
Query: 496 ELEGLRR 502
           E+E L R
Sbjct: 282 EIEELAR 288

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 135/291 (46%), Gaps = 46/291 (15%)
Query: 224 LGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLE 283
           +G G FGTVYKG       V +         Q+  F NEV +L +  H +I+  +G   +
Sbjct: 32  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 91
Query: 284 TEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYMHSS 343
            ++ + V ++    +L HH+H              +    +  + +A + A  + Y+H+ 
Sbjct: 92  PQLAI-VTQWCEGSSLYHHLH-----------ASETKFEMKKLIDIARQTARGMDYLHAK 139
Query: 344 ASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPN-DKTHLTTTIQGTFGYLDPEYFQ- 401
           +   I HRD+KS+NI L +  + K+ DFG++        +H    + G+  ++ PE  + 
Sbjct: 140 S---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 196
Query: 402 --SSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEILDAR 459
             S+ ++ +SDVY+FG+VL EL+TG+ P               + ++   +Q++E+    
Sbjct: 197 QDSNPYSFQSDVYAFGIVLYELMTGQLP---------------YSNINNRDQIIEM---- 237
Query: 460 VAKEAREEDIGA--------MAELAMRCLRLNSKKRPTMKQVSMELEGLRR 502
           V + +   D+          M  L   CL+    +RP+  ++  E+E L R
Sbjct: 238 VGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 105/215 (48%), Gaps = 12/215 (5%)
Query: 222 RFLGQGGFGTVY----KGMLP--DGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIV 275
           R LG+G FG V+      + P  D  +VAVK  K+        F  E  +L+ + H HIV
Sbjct: 19  RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIV 78
Query: 276 KLLGCCLETEVPVLVYEYISSGTLSHHIHDHXX-XXXXXXXXXLSSLSWENRVRVACEVA 334
           K  G C+E +  ++V+EY+  G L+  +  H             + L+    + +A ++A
Sbjct: 79  KFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIA 138
Query: 335 GAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI-PNDKTHLTTTIQGTFG 393
             + Y+   AS    HRD+ + N L+ +    K+ DFG+SR +   D   +         
Sbjct: 139 AGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 195
Query: 394 YLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
           ++ PE     +FT +SDV+S GVVL E+ T GK+P
Sbjct: 196 WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 230

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 135/291 (46%), Gaps = 46/291 (15%)
Query: 224 LGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLE 283
           +G G FGTVYKG       V +         Q+  F NEV +L +  H +I+  +G   +
Sbjct: 20  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 79
Query: 284 TEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYMHSS 343
            ++ + V ++    +L HH+H              +    +  + +A + A  + Y+H+ 
Sbjct: 80  PQLAI-VTQWCEGSSLYHHLH-----------ASETKFEMKKLIDIARQTARGMDYLHAK 127
Query: 344 ASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPN-DKTHLTTTIQGTFGYLDPEYFQ- 401
           +   I HRD+KS+NI L +  + K+ DFG++        +H    + G+  ++ PE  + 
Sbjct: 128 S---IIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 184
Query: 402 --SSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEILDAR 459
             S+ ++ +SDVY+FG+VL EL+TG+ P               + ++   +Q++E+    
Sbjct: 185 QDSNPYSFQSDVYAFGIVLYELMTGQLP---------------YSNINNRDQIIEM---- 225
Query: 460 VAKEAREEDIGA--------MAELAMRCLRLNSKKRPTMKQVSMELEGLRR 502
           V + +   D+          M  L   CL+    +RP+  ++  E+E L R
Sbjct: 226 VGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 276

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 99.0 bits (245), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 118/232 (50%), Gaps = 30/232 (12%)
Query: 204 KVFTADELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIV----AVKRSKEIDKTQIH- 257
           ++    EL+R        + LG G FGTVYKG+ +P+G  V    A+K   E    + + 
Sbjct: 33  RILKETELKRV-------KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANV 85
Query: 258 QFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXX 317
           +F++E +I++ ++H H+V+LLG CL   +  LV + +  G L  ++H+H           
Sbjct: 86  EFMDEALIMASMDHPHLVRLLGVCLSPTI-QLVTQLMPHGCLLEYVHEHKDNIGSQLL-- 142
Query: 318 LSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI 377
              L+W        ++A  + Y+       + HRD+ + N+L+      K++DFG++R +
Sbjct: 143 ---LNW------CVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLL 190
Query: 378 PND-KTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
             D K +     +    ++  E     +FT +SDV+S+GV + EL+T G KP
Sbjct: 191 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKP 242

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 98.6 bits (244), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 73/284 (25%), Positives = 131/284 (46%), Gaps = 30/284 (10%)
Query: 224 LGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLE 283
           +G G FGTVYKG       V +         Q+  F NEV +L +  H +I+  +G   +
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 75
Query: 284 TEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYMHSS 343
            ++ + V ++    +L HH+H              +       + +A + A  + Y+H+ 
Sbjct: 76  PQLAI-VTQWCEGSSLYHHLH-----------IIETKFEMIKLIDIARQTAQGMDYLHAK 123
Query: 344 ASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPN-DKTHLTTTIQGTFGYLDPEYFQ- 401
           +   I HRD+KS+NI L +  + K+ DFG++        +H    + G+  ++ PE  + 
Sbjct: 124 S---IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 180
Query: 402 --SSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEILDAR 459
              + ++ +SDVY+FG+VL EL+TG+ P  ++ +   R+ +   +     +  L  + + 
Sbjct: 181 QDKNPYSFQSDVYAFGIVLYELMTGQLP--YSNI-NNRDQIIFMVGRGYLSPDLSKVRSN 237
Query: 460 VAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRS 503
             K        AM  L   CL+    +RP   Q+   +E L RS
Sbjct: 238 CPK--------AMKRLMAECLKKKRDERPLFPQILASIELLARS 273

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 98.6 bits (244), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 118/232 (50%), Gaps = 30/232 (12%)
Query: 204 KVFTADELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIV----AVKRSKEIDKTQIH- 257
           ++    EL+R        + LG G FGTVYKG+ +P+G  V    A+K   E    + + 
Sbjct: 10  RILKETELKRV-------KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANV 62
Query: 258 QFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXX 317
           +F++E +I++ ++H H+V+LLG CL   +  LV + +  G L  ++H+H           
Sbjct: 63  EFMDEALIMASMDHPHLVRLLGVCLSPTI-QLVTQLMPHGCLLEYVHEHKDNIGSQLL-- 119
Query: 318 LSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI 377
              L+W        ++A  + Y+       + HRD+ + N+L+      K++DFG++R +
Sbjct: 120 ---LNW------CVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLL 167
Query: 378 PND-KTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
             D K +     +    ++  E     +FT +SDV+S+GV + EL+T G KP
Sbjct: 168 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKP 219

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 106/205 (51%), Gaps = 16/205 (7%)
Query: 224 LGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLE 283
           +G G FG V+ G   +   VA+K  KE   ++   FI E  ++ +++H  +V+L G CLE
Sbjct: 35  IGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSE-DDFIEEAEVMMKLSHPKLVQLYGVCLE 93
Query: 284 TEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYMHSS 343
                LV+E++  G LS ++                    E  + +  +V   +AY+  +
Sbjct: 94  QAPICLVFEFMEHGCLSDYLRTQRGLFAA-----------ETLLGMCLDVCEGMAYLEEA 142
Query: 344 ASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSS 403
             I   HRD+ + N L+ +    KVSDFG++R + +D+   +T  +    +  PE F  S
Sbjct: 143 CVI---HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS 199
Query: 404 QFTDKSDVYSFGVVLLELLT-GKKP 427
           +++ KSDV+SFGV++ E+ + GK P
Sbjct: 200 RYSSKSDVWSFGVLMWEVFSEGKIP 224

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 107/205 (52%), Gaps = 16/205 (7%)
Query: 224 LGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLE 283
           +G G FG V+ G   +   VA+K  +E   ++   FI E  ++ +++H  +V+L G CLE
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYGVCLE 73
Query: 284 TEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYMHSS 343
                LV+E++  G LS ++                    E  + +  +V   +AY+  +
Sbjct: 74  QAPICLVFEFMEHGCLSDYLRTQRGLFAA-----------ETLLGMCLDVCEGMAYLEEA 122
Query: 344 ASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSS 403
           + I   HRD+ + N L+ +    KVSDFG++R + +D+   +T  +    +  PE F  S
Sbjct: 123 SVI---HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS 179
Query: 404 QFTDKSDVYSFGVVLLELLT-GKKP 427
           +++ KSDV+SFGV++ E+ + GK P
Sbjct: 180 RYSSKSDVWSFGVLMWEVFSEGKIP 204

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 73/284 (25%), Positives = 131/284 (46%), Gaps = 30/284 (10%)
Query: 224 LGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLE 283
           +G G FGTVYKG       V +         Q+  F NEV +L +  H +I+  +G   +
Sbjct: 36  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 95
Query: 284 TEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYMHSS 343
            ++ + V ++    +L HH+H              +       + +A + A  + Y+H+ 
Sbjct: 96  PQLAI-VTQWCEGSSLYHHLH-----------IIETKFEMIKLIDIARQTAQGMDYLHAK 143
Query: 344 ASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPN-DKTHLTTTIQGTFGYLDPEYFQ- 401
           +   I HRD+KS+NI L +  + K+ DFG++        +H    + G+  ++ PE  + 
Sbjct: 144 S---IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 200
Query: 402 --SSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEILDAR 459
              + ++ +SDVY+FG+VL EL+TG+ P  ++ +   R+ +   +     +  L  + + 
Sbjct: 201 QDKNPYSFQSDVYAFGIVLYELMTGQLP--YSNI-NNRDQIIFMVGRGYLSPDLSKVRSN 257
Query: 460 VAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRS 503
             K        AM  L   CL+    +RP   Q+   +E L RS
Sbjct: 258 CPK--------AMKRLMAECLKKKRDERPLFPQILASIELLARS 293

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 73/284 (25%), Positives = 131/284 (46%), Gaps = 30/284 (10%)
Query: 224 LGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLE 283
           +G G FGTVYKG       V +         Q+  F NEV +L +  H +I+  +G   +
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 103
Query: 284 TEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYMHSS 343
            ++ + V ++    +L HH+H              +       + +A + A  + Y+H+ 
Sbjct: 104 PQLAI-VTQWCEGSSLYHHLH-----------IIETKFEMIKLIDIARQTAQGMDYLHAK 151
Query: 344 ASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPN-DKTHLTTTIQGTFGYLDPEYFQ- 401
           +   I HRD+KS+NI L +  + K+ DFG++        +H    + G+  ++ PE  + 
Sbjct: 152 S---IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 208
Query: 402 --SSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEILDAR 459
              + ++ +SDVY+FG+VL EL+TG+ P  ++ +   R+ +   +     +  L  + + 
Sbjct: 209 QDKNPYSFQSDVYAFGIVLYELMTGQLP--YSNI-NNRDQIIFMVGRGYLSPDLSKVRSN 265
Query: 460 VAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRS 503
             K        AM  L   CL+    +RP   Q+   +E L RS
Sbjct: 266 CPK--------AMKRLMAECLKKKRDERPLFPQILASIELLARS 301

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 74/301 (24%), Positives = 137/301 (45%), Gaps = 30/301 (9%)
Query: 207 TADELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVIL 266
           ++D+ +         + +G G FGTVYKG       V +         Q+  F NEV +L
Sbjct: 4   SSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVL 63
Query: 267 SQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENR 326
            +  H +I+  +G   + ++ + V ++    +L HH+H              +       
Sbjct: 64  RKTRHVNILLFMGYSTKPQLAI-VTQWCEGSSLYHHLH-----------IIETKFEMIKL 111
Query: 327 VRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPN-DKTHLT 385
           + +A + A  + Y+H+ +   I HRD+KS+NI L +  + K+ DFG++        +H  
Sbjct: 112 IDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF 168
Query: 386 TTIQGTFGYLDPEYFQ---SSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVAC 442
             + G+  ++ PE  +    + ++ +SDVY+FG+VL EL+TG+ P  ++ +   R+ +  
Sbjct: 169 EQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP--YSNI-NNRDQIIF 225
Query: 443 FISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRR 502
            +     +  L  + +   K        AM  L   CL+    +RP   Q+   +E L R
Sbjct: 226 MVGRGYLSPDLSKVRSNCPK--------AMKRLMAECLKKKRDERPLFPQILASIELLAR 277
Query: 503 S 503
           S
Sbjct: 278 S 278

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 72/279 (25%), Positives = 129/279 (46%), Gaps = 32/279 (11%)
Query: 224 LGQGGFGTVYKGMLPDGSI-VAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCL 282
           LG G FG VY+G+    S+ VAVK  KE D  ++ +F+ E  ++ +I H ++V+LLG C 
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 283 ETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYMHS 342
                 ++ E+++ G L  ++ +                     + +A +++ A+ Y+  
Sbjct: 78  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVL----------LYMATQISSAMEYLEK 127
Query: 343 SASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQS 402
              I   HRD+ + N L+ +    KV+DFG+SR +  D        +    +  PE    
Sbjct: 128 KNFI---HRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAY 184
Query: 403 SQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQLLEILDARVA 461
           ++F+ KSDV++FGV+L E+ T G  P  +  ++               +Q+ E+L+    
Sbjct: 185 NKFSIKSDVWAFGVLLWEIATYGMSP--YPGID--------------PSQVYELLEKDYR 228
Query: 462 KEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGL 500
            E  E     + EL   C + N   RP+  ++    E +
Sbjct: 229 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 267

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 73/284 (25%), Positives = 131/284 (46%), Gaps = 30/284 (10%)
Query: 224 LGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLE 283
           +G G FGTVYKG       V +         Q+  F NEV +L +  H +I+  +G   +
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 75
Query: 284 TEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYMHSS 343
            ++ + V ++    +L HH+H              +       + +A + A  + Y+H+ 
Sbjct: 76  PQLAI-VTQWCEGSSLYHHLH-----------IIETKFEMIKLIDIARQTAQGMDYLHAK 123
Query: 344 ASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPN-DKTHLTTTIQGTFGYLDPEYFQ- 401
           +   I HRD+KS+NI L +  + K+ DFG++        +H    + G+  ++ PE  + 
Sbjct: 124 S---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 180
Query: 402 --SSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEILDAR 459
              + ++ +SDVY+FG+VL EL+TG+ P  ++ +   R+ +   +     +  L  + + 
Sbjct: 181 QDKNPYSFQSDVYAFGIVLYELMTGQLP--YSNI-NNRDQIIFMVGRGYLSPDLSKVRSN 237
Query: 460 VAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRS 503
             K        AM  L   CL+    +RP   Q+   +E L RS
Sbjct: 238 CPK--------AMKRLMAECLKKKRDERPLFPQILASIELLARS 273

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 106/205 (51%), Gaps = 16/205 (7%)
Query: 224 LGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLE 283
           +G G FG V+ G   +   VA+K  +E   ++   FI E  ++ +++H  +V+L G CLE
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYGVCLE 76
Query: 284 TEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYMHSS 343
                LV+E++  G LS ++                    E  + +  +V   +AY+  +
Sbjct: 77  QAPICLVFEFMEHGCLSDYLRTQRGLFAA-----------ETLLGMCLDVCEGMAYLEEA 125
Query: 344 ASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSS 403
             I   HRD+ + N L+ +    KVSDFG++R + +D+   +T  +    +  PE F  S
Sbjct: 126 CVI---HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS 182
Query: 404 QFTDKSDVYSFGVVLLELLT-GKKP 427
           +++ KSDV+SFGV++ E+ + GK P
Sbjct: 183 RYSSKSDVWSFGVLMWEVFSEGKIP 207

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 73/284 (25%), Positives = 131/284 (46%), Gaps = 30/284 (10%)
Query: 224 LGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLE 283
           +G G FGTVYKG       V +         Q+  F NEV +L +  H +I+  +G   +
Sbjct: 43  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 102
Query: 284 TEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYMHSS 343
            ++ + V ++    +L HH+H              +       + +A + A  + Y+H+ 
Sbjct: 103 PQLAI-VTQWCEGSSLYHHLH-----------IIETKFEMIKLIDIARQTAQGMDYLHAK 150
Query: 344 ASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPN-DKTHLTTTIQGTFGYLDPEYFQ- 401
           +   I HRD+KS+NI L +  + K+ DFG++        +H    + G+  ++ PE  + 
Sbjct: 151 S---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 207
Query: 402 --SSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEILDAR 459
              + ++ +SDVY+FG+VL EL+TG+ P  ++ +   R+ +   +     +  L  + + 
Sbjct: 208 QDKNPYSFQSDVYAFGIVLYELMTGQLP--YSNI-NNRDQIIFMVGRGYLSPDLSKVRSN 264
Query: 460 VAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRS 503
             K        AM  L   CL+    +RP   Q+   +E L RS
Sbjct: 265 CPK--------AMKRLMAECLKKKRDERPLFPQILASIELLARS 300

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 74/301 (24%), Positives = 137/301 (45%), Gaps = 30/301 (9%)
Query: 207 TADELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVIL 266
           ++D+ +         + +G G FGTVYKG       V +         Q+  F NEV +L
Sbjct: 4   SSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVL 63
Query: 267 SQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENR 326
            +  H +I+  +G   + ++ + V ++    +L HH+H              +       
Sbjct: 64  RKTRHVNILLFMGYSTKPQLAI-VTQWCEGSSLYHHLH-----------IIETKFEMIKL 111
Query: 327 VRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPN-DKTHLT 385
           + +A + A  + Y+H+ +   I HRD+KS+NI L +  + K+ DFG++        +H  
Sbjct: 112 IDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF 168
Query: 386 TTIQGTFGYLDPEYFQ---SSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVAC 442
             + G+  ++ PE  +    + ++ +SDVY+FG+VL EL+TG+ P  ++ +   R+ +  
Sbjct: 169 EQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP--YSNI-NNRDQIIF 225
Query: 443 FISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRR 502
            +     +  L  + +   K        AM  L   CL+    +RP   Q+   +E L R
Sbjct: 226 MVGRGYLSPDLSKVRSNCPK--------AMKRLMAECLKKKRDERPLFPQILASIELLAR 277
Query: 503 S 503
           S
Sbjct: 278 S 278

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 74/301 (24%), Positives = 137/301 (45%), Gaps = 30/301 (9%)
Query: 207 TADELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVIL 266
           ++D+ +         + +G G FGTVYKG       V +         Q+  F NEV +L
Sbjct: 1   SSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVL 60
Query: 267 SQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENR 326
            +  H +I+  +G   + ++ + V ++    +L HH+H              +       
Sbjct: 61  RKTRHVNILLFMGYSTKPQLAI-VTQWCEGSSLYHHLH-----------IIETKFEMIKL 108
Query: 327 VRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPN-DKTHLT 385
           + +A + A  + Y+H+ +   I HRD+KS+NI L +  + K+ DFG++        +H  
Sbjct: 109 IDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF 165
Query: 386 TTIQGTFGYLDPEYFQ---SSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVAC 442
             + G+  ++ PE  +    + ++ +SDVY+FG+VL EL+TG+ P  ++ +   R+ +  
Sbjct: 166 EQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP--YSNI-NNRDQIIF 222
Query: 443 FISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRR 502
            +     +  L  + +   K        AM  L   CL+    +RP   Q+   +E L R
Sbjct: 223 MVGRGYLSPDLSKVRSNCPK--------AMKRLMAECLKKKRDERPLFPQILASIELLAR 274
Query: 503 S 503
           S
Sbjct: 275 S 275

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 106/205 (51%), Gaps = 16/205 (7%)
Query: 224 LGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLE 283
           +G G FG V+ G   +   VA+K  +E   ++   FI E  ++ +++H  +V+L G CLE
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYGVCLE 73
Query: 284 TEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYMHSS 343
                LV+E++  G LS ++                    E  + +  +V   +AY+  +
Sbjct: 74  QAPICLVFEFMEHGCLSDYLRTQRGLFAA-----------ETLLGMCLDVCEGMAYLEEA 122
Query: 344 ASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSS 403
             I   HRD+ + N L+ +    KVSDFG++R + +D+   +T  +    +  PE F  S
Sbjct: 123 CVI---HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS 179
Query: 404 QFTDKSDVYSFGVVLLELLT-GKKP 427
           +++ KSDV+SFGV++ E+ + GK P
Sbjct: 180 RYSSKSDVWSFGVLMWEVFSEGKIP 204

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 106/205 (51%), Gaps = 16/205 (7%)
Query: 224 LGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLE 283
           +G G FG V+ G   +   VA+K  +E   ++   FI E  ++ +++H  +V+L G CLE
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYGVCLE 71
Query: 284 TEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYMHSS 343
                LV+E++  G LS ++                    E  + +  +V   +AY+  +
Sbjct: 72  QAPICLVFEFMEHGCLSDYLRTQRGLFAA-----------ETLLGMCLDVCEGMAYLEEA 120
Query: 344 ASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSS 403
             I   HRD+ + N L+ +    KVSDFG++R + +D+   +T  +    +  PE F  S
Sbjct: 121 CVI---HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS 177
Query: 404 QFTDKSDVYSFGVVLLELLT-GKKP 427
           +++ KSDV+SFGV++ E+ + GK P
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKIP 202

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 73/284 (25%), Positives = 131/284 (46%), Gaps = 30/284 (10%)
Query: 224 LGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLE 283
           +G G FGTVYKG       V +         Q+  F NEV +L +  H +I+  +G   +
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 103
Query: 284 TEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYMHSS 343
            ++ + V ++    +L HH+H              +       + +A + A  + Y+H+ 
Sbjct: 104 PQLAI-VTQWCEGSSLYHHLH-----------IIETKFEMIKLIDIARQTAQGMDYLHAK 151
Query: 344 ASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPN-DKTHLTTTIQGTFGYLDPEYFQ- 401
           +   I HRD+KS+NI L +  + K+ DFG++        +H    + G+  ++ PE  + 
Sbjct: 152 S---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 208
Query: 402 --SSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEILDAR 459
              + ++ +SDVY+FG+VL EL+TG+ P  ++ +   R+ +   +     +  L  + + 
Sbjct: 209 QDKNPYSFQSDVYAFGIVLYELMTGQLP--YSNI-NNRDQIIFMVGRGYLSPDLSKVRSN 265
Query: 460 VAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRS 503
             K        AM  L   CL+    +RP   Q+   +E L RS
Sbjct: 266 CPK--------AMKRLMAECLKKKRDERPLFPQILASIELLARS 301

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 73/284 (25%), Positives = 130/284 (45%), Gaps = 30/284 (10%)
Query: 224 LGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLE 283
           +G G FGTVYKG       V +         Q+  F NEV +L +  H +I+  +G    
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA 75
Query: 284 TEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYMHSS 343
            ++ + V ++    +L HH+H              +       + +A + A  + Y+H+ 
Sbjct: 76  PQLAI-VTQWCEGSSLYHHLH-----------IIETKFEMIKLIDIARQTAQGMDYLHAK 123
Query: 344 ASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPN-DKTHLTTTIQGTFGYLDPEYFQ- 401
           +   I HRD+KS+NI L +  + K+ DFG++        +H    + G+  ++ PE  + 
Sbjct: 124 S---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 180
Query: 402 --SSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEILDAR 459
              + ++ +SDVY+FG+VL EL+TG+ P  ++ +   R+ +   +     +  L  + + 
Sbjct: 181 QDKNPYSFQSDVYAFGIVLYELMTGQLP--YSNI-NNRDQIIFMVGRGYLSPDLSKVRSN 237
Query: 460 VAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRS 503
             K        AM  L   CL+    +RP   Q+   +E L RS
Sbjct: 238 CPK--------AMKRLMAECLKKKRDERPLFPQILASIELLARS 273

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 71/279 (25%), Positives = 129/279 (46%), Gaps = 32/279 (11%)
Query: 224 LGQGGFGTVYKGMLPDGSI-VAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCL 282
           LG G +G VY+G+    S+ VAVK  KE D  ++ +F+ E  ++ +I H ++V+LLG C 
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 283 ETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYMHS 342
                 ++ E+++ G L  ++ +                     + +A +++ A+ Y+  
Sbjct: 78  REPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVL----------LYMATQISSAMEYLEK 127
Query: 343 SASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQS 402
              I   HRD+ + N L+ +    KV+DFG+SR +  D        +    +  PE    
Sbjct: 128 KNFI---HRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAY 184
Query: 403 SQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQLLEILDARVA 461
           ++F+ KSDV++FGV+L E+ T G  P  +  ++               +Q+ E+L+    
Sbjct: 185 NKFSIKSDVWAFGVLLWEIATYGMSP--YPGID--------------PSQVYELLEKDYR 228
Query: 462 KEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGL 500
            E  E     + EL   C + N   RP+  ++    E +
Sbjct: 229 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 267

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 73/279 (26%), Positives = 128/279 (45%), Gaps = 32/279 (11%)
Query: 224 LGQGGFGTVYKGMLPDGSI-VAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCL 282
           LG G +G VY+G+    S+ VAVK  KE D  ++ +F+ E  ++ +I H ++V+LLG C 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 283 ETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYMHS 342
                 ++ E+++ G L  ++ +                     + +A +++ A+ Y+  
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL----------LYMATQISSAMEYLEK 134
Query: 343 SASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQS 402
              I   HRD+ + N L+ +    KV+DFG+SR +  D        +    +  PE    
Sbjct: 135 KNFI---HRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAY 191
Query: 403 SQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQLLEILDARVA 461
           ++F+ KSDV++FGV+L E+ T G  P                I L+   Q+ E+L+    
Sbjct: 192 NKFSIKSDVWAFGVLLWEIATYGMSPY-------------PGIDLS---QVYELLEKDYR 235
Query: 462 KEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGL 500
            E  E     + EL   C + N   RP+  ++    E +
Sbjct: 236 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 274

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 73/279 (26%), Positives = 128/279 (45%), Gaps = 32/279 (11%)
Query: 224 LGQGGFGTVYKGMLPDGSI-VAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCL 282
           LG G +G VY+G+    S+ VAVK  KE D  ++ +F+ E  ++ +I H ++V+LLG C 
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 80
Query: 283 ETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYMHS 342
                 ++ E+++ G L  ++ +                     + +A +++ A+ Y+  
Sbjct: 81  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL----------LYMATQISSAMEYLEK 130
Query: 343 SASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQS 402
              I   HRD+ + N L+ +    KV+DFG+SR +  D        +    +  PE    
Sbjct: 131 KNFI---HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAY 187
Query: 403 SQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQLLEILDARVA 461
           ++F+ KSDV++FGV+L E+ T G  P                I L+   Q+ E+L+    
Sbjct: 188 NKFSIKSDVWAFGVLLWEIATYGMSPY-------------PGIDLS---QVYELLEKDYR 231
Query: 462 KEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGL 500
            E  E     + EL   C + N   RP+  ++    E +
Sbjct: 232 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 270

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 73/279 (26%), Positives = 128/279 (45%), Gaps = 32/279 (11%)
Query: 224 LGQGGFGTVYKGMLPDGSI-VAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCL 282
           LG G +G VY+G+    S+ VAVK  KE D  ++ +F+ E  ++ +I H ++V+LLG C 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 283 ETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYMHS 342
                 ++ E+++ G L  ++ +                     + +A +++ A+ Y+  
Sbjct: 85  REPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVL----------LYMATQISSAMEYLEK 134
Query: 343 SASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQS 402
              I   HRD+ + N L+ +    KV+DFG+SR +  D        +    +  PE    
Sbjct: 135 KNFI---HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 191
Query: 403 SQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQLLEILDARVA 461
           ++F+ KSDV++FGV+L E+ T G  P                I L+   Q+ E+L+    
Sbjct: 192 NKFSIKSDVWAFGVLLWEIATYGMSPY-------------PGIDLS---QVYELLEKDYR 235
Query: 462 KEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGL 500
            E  E     + EL   C + N   RP+  ++    E +
Sbjct: 236 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 274

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 73/279 (26%), Positives = 128/279 (45%), Gaps = 32/279 (11%)
Query: 224 LGQGGFGTVYKGMLPDGSI-VAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCL 282
           LG G +G VY+G+    S+ VAVK  KE D  ++ +F+ E  ++ +I H ++V+LLG C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 283 ETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYMHS 342
                 ++ E+++ G L  ++ +                     + +A +++ A+ Y+  
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL----------LYMATQISSAMEYLEK 129
Query: 343 SASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQS 402
              I   HRD+ + N L+ +    KV+DFG+SR +  D        +    +  PE    
Sbjct: 130 KNFI---HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 186
Query: 403 SQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQLLEILDARVA 461
           ++F+ KSDV++FGV+L E+ T G  P                I L+   Q+ E+L+    
Sbjct: 187 NKFSIKSDVWAFGVLLWEIATYGMSPY-------------PGIDLS---QVYELLEKDYR 230
Query: 462 KEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGL 500
            E  E     + EL   C + N   RP+  ++    E +
Sbjct: 231 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 73/279 (26%), Positives = 128/279 (45%), Gaps = 32/279 (11%)
Query: 224 LGQGGFGTVYKGMLPDGSI-VAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCL 282
           LG G +G VY+G+    S+ VAVK  KE D  ++ +F+ E  ++ +I H ++V+LLG C 
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 83
Query: 283 ETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYMHS 342
                 ++ E+++ G L  ++ +                     + +A +++ A+ Y+  
Sbjct: 84  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL----------LYMATQISSAMEYLEK 133
Query: 343 SASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQS 402
              I   HRD+ + N L+ +    KV+DFG+SR +  D        +    +  PE    
Sbjct: 134 KNFI---HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 190
Query: 403 SQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQLLEILDARVA 461
           ++F+ KSDV++FGV+L E+ T G  P                I L+   Q+ E+L+    
Sbjct: 191 NKFSIKSDVWAFGVLLWEIATYGMSPY-------------PGIDLS---QVYELLEKDYR 234
Query: 462 KEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGL 500
            E  E     + EL   C + N   RP+  ++    E +
Sbjct: 235 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 73/279 (26%), Positives = 128/279 (45%), Gaps = 32/279 (11%)
Query: 224 LGQGGFGTVYKGMLPDGSI-VAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCL 282
           LG G +G VY+G+    S+ VAVK  KE D  ++ +F+ E  ++ +I H ++V+LLG C 
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 283 ETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYMHS 342
                 ++ E+++ G L  ++ +                     + +A +++ A+ Y+  
Sbjct: 82  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL----------LYMATQISSAMEYLEK 131
Query: 343 SASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQS 402
              I   HRD+ + N L+ +    KV+DFG+SR +  D        +    +  PE    
Sbjct: 132 KNFI---HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAY 188
Query: 403 SQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQLLEILDARVA 461
           ++F+ KSDV++FGV+L E+ T G  P                I L+   Q+ E+L+    
Sbjct: 189 NKFSIKSDVWAFGVLLWEIATYGMSPY-------------PGIDLS---QVYELLEKDYR 232
Query: 462 KEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGL 500
            E  E     + EL   C + N   RP+  ++    E +
Sbjct: 233 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 271

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 73/279 (26%), Positives = 128/279 (45%), Gaps = 32/279 (11%)
Query: 224 LGQGGFGTVYKGMLPDGSI-VAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCL 282
           LG G +G VY+G+    S+ VAVK  KE D  ++ +F+ E  ++ +I H ++V+LLG C 
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 80
Query: 283 ETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYMHS 342
                 ++ E+++ G L  ++ +                     + +A +++ A+ Y+  
Sbjct: 81  REPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVL----------LYMATQISSAMEYLEK 130
Query: 343 SASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQS 402
              I   HRD+ + N L+ +    KV+DFG+SR +  D        +    +  PE    
Sbjct: 131 KNFI---HRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAY 187
Query: 403 SQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQLLEILDARVA 461
           ++F+ KSDV++FGV+L E+ T G  P                I L+   Q+ E+L+    
Sbjct: 188 NKFSIKSDVWAFGVLLWEIATYGMSPY-------------PGIDLS---QVYELLEKDYR 231
Query: 462 KEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGL 500
            E  E     + EL   C + N   RP+  ++    E +
Sbjct: 232 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 270

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 73/279 (26%), Positives = 128/279 (45%), Gaps = 32/279 (11%)
Query: 224 LGQGGFGTVYKGMLPDGSI-VAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCL 282
           LG G +G VY+G+    S+ VAVK  KE D  ++ +F+ E  ++ +I H ++V+LLG C 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 283 ETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYMHS 342
                 ++ E+++ G L  ++ +                     + +A +++ A+ Y+  
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL----------LYMATQISSAMEYLEK 134
Query: 343 SASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQS 402
              I   HRD+ + N L+ +    KV+DFG+SR +  D        +    +  PE    
Sbjct: 135 KNFI---HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 191
Query: 403 SQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQLLEILDARVA 461
           ++F+ KSDV++FGV+L E+ T G  P                I L+   Q+ E+L+    
Sbjct: 192 NKFSIKSDVWAFGVLLWEIATYGMSPY-------------PGIDLS---QVYELLEKDYR 235
Query: 462 KEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGL 500
            E  E     + EL   C + N   RP+  ++    E +
Sbjct: 236 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 274

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 73/279 (26%), Positives = 128/279 (45%), Gaps = 32/279 (11%)
Query: 224 LGQGGFGTVYKGMLPDGSI-VAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCL 282
           LG G +G VY+G+    S+ VAVK  KE D  ++ +F+ E  ++ +I H ++V+LLG C 
Sbjct: 34  LGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 92
Query: 283 ETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYMHS 342
                 ++ E+++ G L  ++ +                     + +A +++ A+ Y+  
Sbjct: 93  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL----------LYMATQISSAMEYLEK 142
Query: 343 SASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQS 402
              I   HRD+ + N L+ +    KV+DFG+SR +  D        +    +  PE    
Sbjct: 143 KNFI---HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 199
Query: 403 SQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQLLEILDARVA 461
           ++F+ KSDV++FGV+L E+ T G  P                I L+   Q+ E+L+    
Sbjct: 200 NKFSIKSDVWAFGVLLWEIATYGMSPY-------------PGIDLS---QVYELLEKDYR 243
Query: 462 KEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGL 500
            E  E     + EL   C + N   RP+  ++    E +
Sbjct: 244 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 282

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 73/279 (26%), Positives = 128/279 (45%), Gaps = 32/279 (11%)
Query: 224 LGQGGFGTVYKGMLPDGSI-VAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCL 282
           LG G +G VY+G+    S+ VAVK  KE D  ++ +F+ E  ++ +I H ++V+LLG C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 283 ETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYMHS 342
                 ++ E+++ G L  ++ +                     + +A +++ A+ Y+  
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL----------LYMATQISSAMEYLEK 129
Query: 343 SASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQS 402
              I   HRD+ + N L+ +    KV+DFG+SR +  D        +    +  PE    
Sbjct: 130 KNFI---HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 186
Query: 403 SQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQLLEILDARVA 461
           ++F+ KSDV++FGV+L E+ T G  P                I L+   Q+ E+L+    
Sbjct: 187 NKFSIKSDVWAFGVLLWEIATYGMSPY-------------PGIDLS---QVYELLEKDYR 230
Query: 462 KEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGL 500
            E  E     + EL   C + N   RP+  ++    E +
Sbjct: 231 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 71/279 (25%), Positives = 127/279 (45%), Gaps = 32/279 (11%)
Query: 224 LGQGGFGTVYKGMLPDGSI-VAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCL 282
           LG G +G VY+G+    S+ VAVK  KE D  ++ +F+ E  ++ +I H ++V+LLG C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 283 ETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYMHS 342
                 ++ E+++ G L  ++ +                     + +A +++ A+ Y+  
Sbjct: 80  REPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVL----------LYMATQISSAMEYLEK 129
Query: 343 SASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQS 402
              I   HRD+ + N L+ +    KV+DFG+SR +  D        +    +  PE    
Sbjct: 130 KNFI---HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 186
Query: 403 SQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQLLEILDARVA 461
           ++F+ KSDV++FGV+L E+ T G  P     +                +Q+ E+L+    
Sbjct: 187 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL----------------SQVYELLEKDYR 230
Query: 462 KEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGL 500
            E  E     + EL   C + N   RP+  ++    E +
Sbjct: 231 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 71/279 (25%), Positives = 127/279 (45%), Gaps = 32/279 (11%)
Query: 224 LGQGGFGTVYKGMLPDGSI-VAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCL 282
           LG G +G VY+G+    S+ VAVK  KE D  ++ +F+ E  ++ +I H ++V+LLG C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 283 ETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYMHS 342
                 ++ E+++ G L  ++ +                     + +A +++ A+ Y+  
Sbjct: 80  REPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVL----------LYMATQISSAMEYLEK 129
Query: 343 SASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQS 402
              I   HRD+ + N L+ +    KV+DFG+SR +  D        +    +  PE    
Sbjct: 130 KNFI---HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 186
Query: 403 SQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQLLEILDARVA 461
           ++F+ KSDV++FGV+L E+ T G  P     +                +Q+ E+L+    
Sbjct: 187 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL----------------SQVYELLEKDYR 230
Query: 462 KEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGL 500
            E  E     + EL   C + N   RP+  ++    E +
Sbjct: 231 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 73/279 (26%), Positives = 128/279 (45%), Gaps = 32/279 (11%)
Query: 224 LGQGGFGTVYKGMLPDGSI-VAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCL 282
           LG G +G VY+G+    S+ VAVK  KE D  ++ +F+ E  ++ +I H ++V+LLG C 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 283 ETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYMHS 342
                 ++ E+++ G L  ++ +                     + +A +++ A+ Y+  
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVL----------LYMATQISSAMEYLEK 134
Query: 343 SASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQS 402
              I   HRD+ + N L+ +    KV+DFG+SR +  D        +    +  PE    
Sbjct: 135 KNFI---HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 191
Query: 403 SQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQLLEILDARVA 461
           ++F+ KSDV++FGV+L E+ T G  P                I L+   Q+ E+L+    
Sbjct: 192 NKFSIKSDVWAFGVLLWEIATYGMSPY-------------PGIDLS---QVYELLEKDYR 235
Query: 462 KEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGL 500
            E  E     + EL   C + N   RP+  ++    E +
Sbjct: 236 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 274

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 73/279 (26%), Positives = 128/279 (45%), Gaps = 32/279 (11%)
Query: 224 LGQGGFGTVYKGMLPDGSI-VAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCL 282
           LG G +G VY+G+    S+ VAVK  KE D  ++ +F+ E  ++ +I H ++V+LLG C 
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 283 ETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYMHS 342
                 ++ E+++ G L  ++ +                     + +A +++ A+ Y+  
Sbjct: 82  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL----------LYMATQISSAMEYLEK 131
Query: 343 SASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQS 402
              I   HRD+ + N L+ +    KV+DFG+SR +  D        +    +  PE    
Sbjct: 132 KNFI---HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 188
Query: 403 SQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQLLEILDARVA 461
           ++F+ KSDV++FGV+L E+ T G  P                I L+   Q+ E+L+    
Sbjct: 189 NKFSIKSDVWAFGVLLWEIATYGMSPY-------------PGIDLS---QVYELLEKDYR 232
Query: 462 KEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGL 500
            E  E     + EL   C + N   RP+  ++    E +
Sbjct: 233 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 271

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 71/279 (25%), Positives = 127/279 (45%), Gaps = 32/279 (11%)
Query: 224 LGQGGFGTVYKGMLPDGSI-VAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCL 282
           LG G +G VY+G+    S+ VAVK  KE D  ++ +F+ E  ++ +I H ++V+LLG C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 283 ETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYMHS 342
                 ++ E+++ G L  ++ +                     + +A +++ A+ Y+  
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVL----------LYMATQISSAMEYLEK 129
Query: 343 SASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQS 402
              I   HRD+ + N L+ +    KV+DFG+SR +  D        +    +  PE    
Sbjct: 130 KNFI---HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 186
Query: 403 SQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQLLEILDARVA 461
           ++F+ KSDV++FGV+L E+ T G  P     +                +Q+ E+L+    
Sbjct: 187 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL----------------SQVYELLEKDYR 230
Query: 462 KEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGL 500
            E  E     + EL   C + N   RP+  ++    E +
Sbjct: 231 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 73/279 (26%), Positives = 128/279 (45%), Gaps = 32/279 (11%)
Query: 224 LGQGGFGTVYKGMLPDGSI-VAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCL 282
           LG G +G VY+G+    S+ VAVK  KE D  ++ +F+ E  ++ +I H ++V+LLG C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 283 ETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYMHS 342
                 ++ E+++ G L  ++ +                     + +A +++ A+ Y+  
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVL----------LYMATQISSAMEYLEK 129
Query: 343 SASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQS 402
              I   HRD+ + N L+ +    KV+DFG+SR +  D        +    +  PE    
Sbjct: 130 KNFI---HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 186
Query: 403 SQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQLLEILDARVA 461
           ++F+ KSDV++FGV+L E+ T G  P                I L+   Q+ E+L+    
Sbjct: 187 NKFSIKSDVWAFGVLLWEIATYGMSPY-------------PGIDLS---QVYELLEKDYR 230
Query: 462 KEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGL 500
            E  E     + EL   C + N   RP+  ++    E +
Sbjct: 231 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 73/279 (26%), Positives = 128/279 (45%), Gaps = 32/279 (11%)
Query: 224 LGQGGFGTVYKGMLPDGSI-VAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCL 282
           LG G +G VY+G+    S+ VAVK  KE D  ++ +F+ E  ++ +I H ++V+LLG C 
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 283 ETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYMHS 342
                 ++ E+++ G L  ++ +                     + +A +++ A+ Y+  
Sbjct: 82  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL----------LYMATQISSAMEYLEK 131
Query: 343 SASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQS 402
              I   HRD+ + N L+ +    KV+DFG+SR +  D        +    +  PE    
Sbjct: 132 KNFI---HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 188
Query: 403 SQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQLLEILDARVA 461
           ++F+ KSDV++FGV+L E+ T G  P                I L+   Q+ E+L+    
Sbjct: 189 NKFSIKSDVWAFGVLLWEIATYGMSPY-------------PGIDLS---QVYELLEKDYR 232
Query: 462 KEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGL 500
            E  E     + EL   C + N   RP+  ++    E +
Sbjct: 233 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 271

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 73/279 (26%), Positives = 128/279 (45%), Gaps = 32/279 (11%)
Query: 224 LGQGGFGTVYKGMLPDGSI-VAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCL 282
           LG G +G VY+G+    S+ VAVK  KE D  ++ +F+ E  ++ +I H ++V+LLG C 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 283 ETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYMHS 342
                 ++ E+++ G L  ++ +                     + +A +++ A+ Y+  
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL----------LYMATQISSAMEYLEK 134
Query: 343 SASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQS 402
              I   HRD+ + N L+ +    KV+DFG+SR +  D        +    +  PE    
Sbjct: 135 KNFI---HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 191
Query: 403 SQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQLLEILDARVA 461
           ++F+ KSDV++FGV+L E+ T G  P                I L+   Q+ E+L+    
Sbjct: 192 NKFSIKSDVWAFGVLLWEIATYGMSPY-------------PGIDLS---QVYELLEKDYR 235
Query: 462 KEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGL 500
            E  E     + EL   C + N   RP+  ++    E +
Sbjct: 236 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 274

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 69/221 (31%), Positives = 103/221 (46%), Gaps = 22/221 (9%)
Query: 212 QRATDNYNQSRFLGQGGFGTVYKGMLPDGS-IVAVKR--SKEIDKTQI-HQFINEVVILS 267
           Q A +++   R LG+G FG VY         I+A+K     +++K  + HQ   EV I S
Sbjct: 5   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 64
Query: 268 QINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
            + H +I++L G   +     L+ EY   GT+   +              LS    +   
Sbjct: 65  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK------------LSKFDEQRTA 112
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
               E+A A++Y HS     + HRDIK  N+LL      K++DFG S   P+ +    TT
Sbjct: 113 TYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSCHAPSSRR---TT 166
Query: 388 IQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
           + GT  YL PE  +     +K D++S GV+  E L GK P 
Sbjct: 167 LSGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 207

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 71/279 (25%), Positives = 129/279 (46%), Gaps = 32/279 (11%)
Query: 224 LGQGGFGTVYKGMLPDGSI-VAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCL 282
           LG G +G VY+G+    S+ VAVK  KE D  ++ +F+ E  ++ +I H ++V+LLG C 
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 283 ETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYMHS 342
                 ++ E+++ G L  ++ +                     + +A +++ A+ Y+  
Sbjct: 78  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVL----------LYMATQISSAMEYLEK 127
Query: 343 SASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQS 402
              I   HRD+ + N L+ +    KV+DFG+SR +  D        +    +  PE    
Sbjct: 128 KNFI---HRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIKWTAPESLAY 184
Query: 403 SQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQLLEILDARVA 461
           ++F+ KSDV++FGV+L E+ T G  P  +  ++               +Q+ E+L+    
Sbjct: 185 NKFSIKSDVWAFGVLLWEIATYGMSP--YPGID--------------PSQVYELLEKDYR 228
Query: 462 KEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGL 500
            E  E     + EL   C + N   RP+  ++    E +
Sbjct: 229 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 267

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 69/221 (31%), Positives = 103/221 (46%), Gaps = 22/221 (9%)
Query: 212 QRATDNYNQSRFLGQGGFGTVYKGMLPDGS-IVAVKR--SKEIDKTQI-HQFINEVVILS 267
           Q A +++   R LG+G FG VY         I+A+K     +++K  + HQ   EV I S
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 268 QINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
            + H +I++L G   +     L+ EY   GT+   +              LS    +   
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK------------LSKFDEQRTA 114
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
               E+A A++Y HS     + HRDIK  N+LL      K++DFG S   P+ +    TT
Sbjct: 115 TYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TT 168
Query: 388 IQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
           + GT  YL PE  +     +K D++S GV+  E L GK P 
Sbjct: 169 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 209

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 69/221 (31%), Positives = 103/221 (46%), Gaps = 22/221 (9%)
Query: 212 QRATDNYNQSRFLGQGGFGTVYKGMLPDGS-IVAVKR--SKEIDKTQI-HQFINEVVILS 267
           Q A +++   R LG+G FG VY         I+A+K     +++K  + HQ   EV I S
Sbjct: 9   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 68
Query: 268 QINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
            + H +I++L G   +     L+ EY   GT+   +              LS    +   
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK------------LSKFDEQRTA 116
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
               E+A A++Y HS     + HRDIK  N+LL      K++DFG S   P+ +    TT
Sbjct: 117 TYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TT 170
Query: 388 IQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
           + GT  YL PE  +     +K D++S GV+  E L GK P 
Sbjct: 171 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 211

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 69/221 (31%), Positives = 103/221 (46%), Gaps = 22/221 (9%)
Query: 212 QRATDNYNQSRFLGQGGFGTVYKGMLPDGS-IVAVKR--SKEIDKTQI-HQFINEVVILS 267
           Q A +++   R LG+G FG VY         I+A+K     +++K  + HQ   EV I S
Sbjct: 21  QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 80
Query: 268 QINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
            + H +I++L G   +     L+ EY   GT+   +              LS    +   
Sbjct: 81  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK------------LSKFDEQRTA 128
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
               E+A A++Y HS     + HRDIK  N+LL      K++DFG S   P+ +    TT
Sbjct: 129 TYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TT 182
Query: 388 IQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
           + GT  YL PE  +     +K D++S GV+  E L GK P 
Sbjct: 183 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 223

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 69/221 (31%), Positives = 103/221 (46%), Gaps = 22/221 (9%)
Query: 212 QRATDNYNQSRFLGQGGFGTVYKGMLPDGS-IVAVKR--SKEIDKTQI-HQFINEVVILS 267
           Q A +++   R LG+G FG VY         I+A+K     +++K  + HQ   EV I S
Sbjct: 30  QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 89
Query: 268 QINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
            + H +I++L G   +     L+ EY   GT+   +              LS    +   
Sbjct: 90  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK------------LSKFDEQRTA 137
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
               E+A A++Y HS     + HRDIK  N+LL      K++DFG S   P+ +    TT
Sbjct: 138 TYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TT 191
Query: 388 IQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
           + GT  YL PE  +     +K D++S GV+  E L GK P 
Sbjct: 192 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 232

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 114/222 (51%), Gaps = 25/222 (11%)
Query: 214 ATDNYNQSRFLGQGGFGTVYKGMLPDGS----IVAVKRSKE---IDKTQIHQFINEVVIL 266
           A ++   +R LG+G FG VY+G+  +       VAVK  K+   +D  +  +F++E VI+
Sbjct: 6   AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKE--KFMSEAVIM 63
Query: 267 SQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENR 326
             ++H HIVKL+G  +E E   ++ E    G L H++  +            +SL     
Sbjct: 64  KNLDHPHIVKLIGI-IEEEPTWIIMELYPYGELGHYLERNK-----------NSLKVLTL 111
Query: 327 VRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTT 386
           V  + ++  A+AY+ S   I   HRDI   NIL+      K+ DFG+SR I ++  +  +
Sbjct: 112 VLYSLQICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKAS 168
Query: 387 TIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
             +    ++ PE     +FT  SDV+ F V + E+L+ GK+P
Sbjct: 169 VTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQP 210

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 70/221 (31%), Positives = 103/221 (46%), Gaps = 22/221 (9%)
Query: 212 QRATDNYNQSRFLGQGGFGTVYKGMLPDGS-IVAVKR--SKEIDKTQI-HQFINEVVILS 267
           Q A +++   R LG+G FG VY         I+A+K     +++K  + HQ   EV I S
Sbjct: 3   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 62
Query: 268 QINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
            + H +I++L G   +     L+ EY   GT+   +              LS    +   
Sbjct: 63  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK------------LSKFDEQRTA 110
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
               E+A A++Y HS   I   HRDIK  N+LL      K++DFG S   P+ +    TT
Sbjct: 111 TYITELANALSYCHSKRVI---HRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TT 164
Query: 388 IQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
           + GT  YL PE  +     +K D++S GV+  E L GK P 
Sbjct: 165 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 205

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 70/221 (31%), Positives = 103/221 (46%), Gaps = 22/221 (9%)
Query: 212 QRATDNYNQSRFLGQGGFGTVYKGMLPDGS-IVAVKR--SKEIDKTQI-HQFINEVVILS 267
           Q A +++   R LG+G FG VY         I+A+K     +++K  + HQ   EV I S
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 268 QINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
            + H +I++L G   +     L+ EY   GT+   +              LS    +   
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK------------LSKFDEQRTA 114
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
               E+A A++Y HS   I   HRDIK  N+LL      K++DFG S   P+ +    TT
Sbjct: 115 TYITELANALSYCHSKRVI---HRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TT 168
Query: 388 IQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
           + GT  YL PE  +     +K D++S GV+  E L GK P 
Sbjct: 169 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 209

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 107/218 (49%), Gaps = 23/218 (10%)
Query: 219 NQSRFLGQGGFGTVYKGMLPDGS-----IVAVKRSKE-IDKTQIHQFINEVVILSQINHR 272
            + + +G G FG VYKGML   S      VA+K  K    + Q   F+ E  I+ Q +H 
Sbjct: 47  TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHH 106
Query: 273 HIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACE 332
           +I++L G   + +  +++ EY+ +G L   + +             S L     +R    
Sbjct: 107 NIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE--------FSVLQLVGMLR---- 154
Query: 333 VAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTF 392
             G  A M   A++   HRD+ + NIL++     KVSDFG+SR + +D     TT  G  
Sbjct: 155 --GIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI 212
Query: 393 G--YLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
              +  PE     +FT  SDV+SFG+V+ E++T G++P
Sbjct: 213 PIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP 250

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 69/221 (31%), Positives = 103/221 (46%), Gaps = 22/221 (9%)
Query: 212 QRATDNYNQSRFLGQGGFGTVYKGMLPDGS-IVAVKR--SKEIDKTQI-HQFINEVVILS 267
           Q A +++   R LG+G FG VY         I+A+K     +++K  + HQ   EV I S
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 268 QINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
            + H +I++L G   +     L+ EY   GT+   +              LS    +   
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK------------LSKFDEQRTA 111
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
               E+A A++Y HS     + HRDIK  N+LL      K++DFG S   P+ +    TT
Sbjct: 112 TYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TT 165
Query: 388 IQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
           + GT  YL PE  +     +K D++S GV+  E L GK P 
Sbjct: 166 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 206

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 70/221 (31%), Positives = 103/221 (46%), Gaps = 22/221 (9%)
Query: 212 QRATDNYNQSRFLGQGGFGTVYKGMLPDGS-IVAVKR--SKEIDKTQI-HQFINEVVILS 267
           Q A +++   R LG+G FG VY         I+A+K     +++K  + HQ   EV I S
Sbjct: 8   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 67
Query: 268 QINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
            + H +I++L G   +     L+ EY   GT+   +              LS    +   
Sbjct: 68  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK------------LSKFDEQRTA 115
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
               E+A A++Y HS   I   HRDIK  N+LL      K++DFG S   P+ +    TT
Sbjct: 116 TYITELANALSYCHSKRVI---HRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TT 169
Query: 388 IQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
           + GT  YL PE  +     +K D++S GV+  E L GK P 
Sbjct: 170 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 210

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 114/222 (51%), Gaps = 25/222 (11%)
Query: 214 ATDNYNQSRFLGQGGFGTVYKGMLPDGS----IVAVKRSKE---IDKTQIHQFINEVVIL 266
           A ++   +R LG+G FG VY+G+  +       VAVK  K+   +D  +  +F++E VI+
Sbjct: 22  AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKE--KFMSEAVIM 79
Query: 267 SQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENR 326
             ++H HIVKL+G  +E E   ++ E    G L H++  +            +SL     
Sbjct: 80  KNLDHPHIVKLIGI-IEEEPTWIIMELYPYGELGHYLERNK-----------NSLKVLTL 127
Query: 327 VRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTT 386
           V  + ++  A+AY+ S   I   HRDI   NIL+      K+ DFG+SR I ++  +  +
Sbjct: 128 VLYSLQICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKAS 184
Query: 387 TIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
             +    ++ PE     +FT  SDV+ F V + E+L+ GK+P
Sbjct: 185 VTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQP 226

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 114/222 (51%), Gaps = 25/222 (11%)
Query: 214 ATDNYNQSRFLGQGGFGTVYKGMLPDGS----IVAVKRSKE---IDKTQIHQFINEVVIL 266
           A ++   +R LG+G FG VY+G+  +       VAVK  K+   +D  +  +F++E VI+
Sbjct: 10  AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKE--KFMSEAVIM 67
Query: 267 SQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENR 326
             ++H HIVKL+G  +E E   ++ E    G L H++  +            +SL     
Sbjct: 68  KNLDHPHIVKLIGI-IEEEPTWIIMELYPYGELGHYLERNK-----------NSLKVLTL 115
Query: 327 VRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTT 386
           V  + ++  A+AY+ S   I   HRDI   NIL+      K+ DFG+SR I ++  +  +
Sbjct: 116 VLYSLQICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKAS 172
Query: 387 TIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
             +    ++ PE     +FT  SDV+ F V + E+L+ GK+P
Sbjct: 173 VTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQP 214

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 105/205 (51%), Gaps = 16/205 (7%)
Query: 224 LGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLE 283
           +G G FG V+ G   +   VA+K  +E   ++   FI E  ++ +++H  +V+L G CLE
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYGVCLE 74
Query: 284 TEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYMHSS 343
                LV E++  G LS ++                    E  + +  +V   +AY+  +
Sbjct: 75  QAPICLVTEFMEHGCLSDYLRTQRGLFAA-----------ETLLGMCLDVCEGMAYLEEA 123
Query: 344 ASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSS 403
             I   HRD+ + N L+ +    KVSDFG++R + +D+   +T  +    +  PE F  S
Sbjct: 124 CVI---HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS 180
Query: 404 QFTDKSDVYSFGVVLLELLT-GKKP 427
           +++ KSDV+SFGV++ E+ + GK P
Sbjct: 181 RYSSKSDVWSFGVLMWEVFSEGKIP 205

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 69/221 (31%), Positives = 103/221 (46%), Gaps = 22/221 (9%)
Query: 212 QRATDNYNQSRFLGQGGFGTVYKGMLPDGS-IVAVKR--SKEIDKTQI-HQFINEVVILS 267
           Q A +++   R LG+G FG VY         I+A+K     +++K  + HQ   EV I S
Sbjct: 9   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 68
Query: 268 QINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
            + H +I++L G   +     L+ EY   GT+   +              LS    +   
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK------------LSKFDEQRTA 116
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
               E+A A++Y HS     + HRDIK  N+LL      K++DFG S   P+ +    TT
Sbjct: 117 TYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TT 170
Query: 388 IQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
           + GT  YL PE  +     +K D++S GV+  E L GK P 
Sbjct: 171 LCGTLDYLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGKPPF 211

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 76/308 (24%), Positives = 147/308 (47%), Gaps = 46/308 (14%)
Query: 203 AKVFTADELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEI--DKTQIHQF 259
           A++F   EL++        + LG G FGTV+KG+ +P+G  + +    ++  DK+    F
Sbjct: 25  ARIFKETELRKL-------KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSF 77
Query: 260 ---INEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXX 316
               + ++ +  ++H HIV+LLG C  + +  LV +Y+  G+L  H+  H          
Sbjct: 78  QAVTDHMLAIGSLDHAHIVRLLGLCPGSSL-QLVTQYLPLGSLLDHVRQHRGALGPQLL- 135
Query: 317 XLSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS 376
               L+W        ++A  + Y+     +   HR++ + N+LL      +V+DFG++  
Sbjct: 136 ----LNW------GVQIAKGMYYLEEHGMV---HRNLAARNVLLKSPSQVQVADFGVADL 182
Query: 377 IP-NDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVE 434
           +P +DK  L +  +    ++  E     ++T +SDV+S+GV + EL+T G +P    R+ 
Sbjct: 183 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA 242
Query: 435 EERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVS 494
           E  +L+     LA+    +  +D  +              + ++C  ++   RPT K+++
Sbjct: 243 EVPDLLEKGERLAQPQ--ICTIDVYM--------------VMVKCWMIDENIRPTFKELA 286
Query: 495 MELEGLRR 502
            E   + R
Sbjct: 287 NEFTRMAR 294

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 95.1 bits (235), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 102/218 (46%), Gaps = 15/218 (6%)
Query: 222 RFLGQGGFGTVYKG----MLP--DGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIV 275
           R LG+G FG V+      + P  D  +VAVK  K+        F  E  +L+ + H HIV
Sbjct: 21  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 276 KLLGCCLETEVPVLVYEYISSGTLSH----HIHDHXXXXXXXXXXXLSSLSWENRVRVAC 331
           K  G C + +  ++V+EY+  G L+     H  D               L     + +A 
Sbjct: 81  KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 332 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI-PNDKTHLTTTIQG 390
           ++A  + Y+   AS    HRD+ + N L+      K+ DFG+SR +   D   +      
Sbjct: 141 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 197
Query: 391 TFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
              ++ PE     +FT +SDV+SFGV+L E+ T GK+P
Sbjct: 198 PIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 95.1 bits (235), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 76/308 (24%), Positives = 147/308 (47%), Gaps = 46/308 (14%)
Query: 203 AKVFTADELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEI--DKTQIHQF 259
           A++F   EL++        + LG G FGTV+KG+ +P+G  + +    ++  DK+    F
Sbjct: 7   ARIFKETELRKL-------KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSF 59
Query: 260 ---INEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXX 316
               + ++ +  ++H HIV+LLG C  + +  LV +Y+  G+L  H+  H          
Sbjct: 60  QAVTDHMLAIGSLDHAHIVRLLGLCPGSSL-QLVTQYLPLGSLLDHVRQHRGALGPQLL- 117
Query: 317 XLSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS 376
               L+W        ++A  + Y+     +   HR++ + N+LL      +V+DFG++  
Sbjct: 118 ----LNW------GVQIAKGMYYLEEHGMV---HRNLAARNVLLKSPSQVQVADFGVADL 164
Query: 377 IP-NDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVE 434
           +P +DK  L +  +    ++  E     ++T +SDV+S+GV + EL+T G +P    R+ 
Sbjct: 165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA 224
Query: 435 EERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVS 494
           E  +L+     LA+    +  +D  +              + ++C  ++   RPT K+++
Sbjct: 225 EVPDLLEKGERLAQPQ--ICTIDVYM--------------VMVKCWMIDENIRPTFKELA 268
Query: 495 MELEGLRR 502
            E   + R
Sbjct: 269 NEFTRMAR 276

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 95.1 bits (235), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 70/221 (31%), Positives = 103/221 (46%), Gaps = 22/221 (9%)
Query: 212 QRATDNYNQSRFLGQGGFGTVYKGMLPDGS-IVAVKR--SKEIDKTQI-HQFINEVVILS 267
           Q A +++   R LG+G FG VY         I+A+K     +++K  + HQ   EV I S
Sbjct: 1   QWALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQS 60
Query: 268 QINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
            + H +I++L G   +     L+ EY   GT+   +              LS    +   
Sbjct: 61  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK------------LSKFDEQRTA 108
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
               E+A A++Y HS   I   HRDIK  N+LL      K++DFG S   P+ +    TT
Sbjct: 109 TYITELANALSYCHSKRVI---HRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TT 162
Query: 388 IQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
           + GT  YL PE  +     +K D++S GV+  E L GK P 
Sbjct: 163 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 203

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 82/300 (27%), Positives = 134/300 (44%), Gaps = 49/300 (16%)
Query: 224 LGQGGFGTV----YKGMLPD-GSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLL 278
           LG+G FG+V    Y  +  + G +VAVK+ +   +  +  F  E+ IL  + H +IVK  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 279 GCCLET--EVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGA 336
           G C         L+ EY+  G+L  ++  H           +  L + +++    E  G 
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDH-----IKLLQYTSQICKGMEYLGT 132
Query: 337 VAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQG---TFG 393
             Y+H         RD+ + NIL++++   K+ DFG+++ +P DK        G    F 
Sbjct: 133 KRYIH---------RDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFW 183
Query: 394 YLDPEYFQSSQFTDKSDVYSFGVVLLELLT-----GKKPICFARV----EEERNLVACFI 444
           Y  PE    S+F+  SDV+SFGVVL EL T        P  F R+    ++ + +V   I
Sbjct: 184 YA-PESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 242
Query: 445 SLAKENQLLEILDARVAKEAREEDIGAMAELAM---RCLRLNSKKRPTMKQVSMELEGLR 501
            L K N  L   D            G   E+ M    C   N  +RP+ + +++ ++ +R
Sbjct: 243 ELLKNNGRLPRPD------------GCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 290

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 68/221 (30%), Positives = 102/221 (46%), Gaps = 22/221 (9%)
Query: 212 QRATDNYNQSRFLGQGGFGTVYKGMLPDGS-IVAVKR--SKEIDKTQI-HQFINEVVILS 267
           Q A +++   R LG+G FG VY         I+A+K     +++K  + HQ   EV I S
Sbjct: 9   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 68
Query: 268 QINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
            + H +I++L G   +     L+ EY   G +   +              LS    +   
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQK------------LSKFDEQRTA 116
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
               E+A A++Y HS     + HRDIK  N+LL      K++DFG S   P+ +    TT
Sbjct: 117 TYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TT 170
Query: 388 IQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
           + GT  YL PE  +     +K D++S GV+  E L GK P 
Sbjct: 171 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 211

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 82/300 (27%), Positives = 134/300 (44%), Gaps = 49/300 (16%)
Query: 224 LGQGGFGTV----YKGMLPD-GSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLL 278
           LG+G FG+V    Y  +  + G +VAVK+ +   +  +  F  E+ IL  + H +IVK  
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 81
Query: 279 GCCLET--EVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGA 336
           G C         L+ EY+  G+L  ++  H           +  L + +++    E  G 
Sbjct: 82  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDH-----IKLLQYTSQICKGMEYLGT 136
Query: 337 VAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQG---TFG 393
             Y+H         RD+ + NIL++++   K+ DFG+++ +P DK        G    F 
Sbjct: 137 KRYIH---------RDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFW 187
Query: 394 YLDPEYFQSSQFTDKSDVYSFGVVLLELLT-----GKKPICFARV----EEERNLVACFI 444
           Y  PE    S+F+  SDV+SFGVVL EL T        P  F R+    ++ + +V   I
Sbjct: 188 YA-PESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 246
Query: 445 SLAKENQLLEILDARVAKEAREEDIGAMAELAM---RCLRLNSKKRPTMKQVSMELEGLR 501
            L K N  L   D            G   E+ M    C   N  +RP+ + +++ ++ +R
Sbjct: 247 ELLKNNGRLPRPD------------GCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 294

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 75/301 (24%), Positives = 138/301 (45%), Gaps = 32/301 (10%)
Query: 203 AKVFTADELQRATDNYNQSRFLGQGGFGTVYKGMLPD------GSIVAVKRSKEIDKTQI 256
           + VF  DE + + +     R LGQG FG VY+G   D       + VAVK   E    + 
Sbjct: 4   SSVFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRE 63
Query: 257 H-QFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXX 315
             +F+NE  ++      H+V+LLG   + +  ++V E ++ G L  ++            
Sbjct: 64  RIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPG 123
Query: 316 XXLSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISR 375
               +L  +  +++A E+A  +AY+++   +   HRD+ + N ++   F+ K+ DFG++R
Sbjct: 124 RPPPTL--QEMIQMAAEIADGMAYLNAKKFV---HRDLAARNCMVAHDFTVKIGDFGMTR 178
Query: 376 SIPNDKTHLTTTIQGTFG--YLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFAR 432
            I  +  +     +G     ++ PE  +   FT  SD++SFGVVL E+ +  ++P     
Sbjct: 179 DI-YETAYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP----- 232
Query: 433 VEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQ 492
                     +  L+ E  L  ++D     +  +     + +L   C + N K RPT  +
Sbjct: 233 ----------YQGLSNEQVLKFVMDGGYLDQP-DNCPERVTDLMRMCWQFNPKMRPTFLE 281
Query: 493 V 493
           +
Sbjct: 282 I 282

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 82/300 (27%), Positives = 134/300 (44%), Gaps = 49/300 (16%)
Query: 224 LGQGGFGTV----YKGMLPD-GSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLL 278
           LG+G FG+V    Y  +  + G +VAVK+ +   +  +  F  E+ IL  + H +IVK  
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 76
Query: 279 GCCLET--EVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGA 336
           G C         L+ EY+  G+L  ++  H           +  L + +++    E  G 
Sbjct: 77  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDH-----IKLLQYTSQICKGMEYLGT 131
Query: 337 VAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQG---TFG 393
             Y+H         RD+ + NIL++++   K+ DFG+++ +P DK        G    F 
Sbjct: 132 KRYIH---------RDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFW 182
Query: 394 YLDPEYFQSSQFTDKSDVYSFGVVLLELLT-----GKKPICFARV----EEERNLVACFI 444
           Y  PE    S+F+  SDV+SFGVVL EL T        P  F R+    ++ + +V   I
Sbjct: 183 YA-PESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 241
Query: 445 SLAKENQLLEILDARVAKEAREEDIGAMAELAM---RCLRLNSKKRPTMKQVSMELEGLR 501
            L K N  L   D            G   E+ M    C   N  +RP+ + +++ ++ +R
Sbjct: 242 ELLKNNGRLPRPD------------GCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 289

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 82/300 (27%), Positives = 134/300 (44%), Gaps = 49/300 (16%)
Query: 224 LGQGGFGTV----YKGMLPD-GSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLL 278
           LG+G FG+V    Y  +  + G +VAVK+ +   +  +  F  E+ IL  + H +IVK  
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 279 GCCLET--EVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGA 336
           G C         L+ EY+  G+L  ++  H           +  L + +++    E  G 
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDH-----IKLLQYTSQICKGMEYLGT 163
Query: 337 VAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQG---TFG 393
             Y+H         RD+ + NIL++++   K+ DFG+++ +P DK        G    F 
Sbjct: 164 KRYIH---------RDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFW 214
Query: 394 YLDPEYFQSSQFTDKSDVYSFGVVLLELLT-----GKKPICFARV----EEERNLVACFI 444
           Y  PE    S+F+  SDV+SFGVVL EL T        P  F R+    ++ + +V   I
Sbjct: 215 YA-PESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 273
Query: 445 SLAKENQLLEILDARVAKEAREEDIGAMAELAM---RCLRLNSKKRPTMKQVSMELEGLR 501
            L K N  L   D            G   E+ M    C   N  +RP+ + +++ ++ +R
Sbjct: 274 ELLKNNGRLPRPD------------GCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 321

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 82/300 (27%), Positives = 134/300 (44%), Gaps = 49/300 (16%)
Query: 224 LGQGGFGTV----YKGMLPD-GSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLL 278
           LG+G FG+V    Y  +  + G +VAVK+ +   +  +  F  E+ IL  + H +IVK  
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 279 GCCLET--EVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGA 336
           G C         L+ EY+  G+L  ++  H           +  L + +++    E  G 
Sbjct: 81  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDH-----IKLLQYTSQICKGMEYLGT 135
Query: 337 VAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQG---TFG 393
             Y+H         RD+ + NIL++++   K+ DFG+++ +P DK        G    F 
Sbjct: 136 KRYIH---------RDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFW 186
Query: 394 YLDPEYFQSSQFTDKSDVYSFGVVLLELLT-----GKKPICFARV----EEERNLVACFI 444
           Y  PE    S+F+  SDV+SFGVVL EL T        P  F R+    ++ + +V   I
Sbjct: 187 YA-PESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 245
Query: 445 SLAKENQLLEILDARVAKEAREEDIGAMAELAM---RCLRLNSKKRPTMKQVSMELEGLR 501
            L K N  L   D            G   E+ M    C   N  +RP+ + +++ ++ +R
Sbjct: 246 ELLKNNGRLPRPD------------GCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 293

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 68/221 (30%), Positives = 103/221 (46%), Gaps = 22/221 (9%)
Query: 212 QRATDNYNQSRFLGQGGFGTVYKGMLPDGS-IVAVKR--SKEIDKTQI-HQFINEVVILS 267
           Q A +++   R LG+G FG VY         I+A+K     +++K  + HQ   EV I S
Sbjct: 6   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 65
Query: 268 QINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
            + H +I++L G   +     L+ EY   GT+   +              LS    +   
Sbjct: 66  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK------------LSKFDEQRTA 113
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
               E+A A++Y HS     + HRDIK  N+LL      K+++FG S   P+ +    TT
Sbjct: 114 TYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRR---TT 167
Query: 388 IQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
           + GT  YL PE  +     +K D++S GV+  E L GK P 
Sbjct: 168 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 208

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 82/300 (27%), Positives = 134/300 (44%), Gaps = 49/300 (16%)
Query: 224 LGQGGFGTV----YKGMLPD-GSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLL 278
           LG+G FG+V    Y  +  + G +VAVK+ +   +  +  F  E+ IL  + H +IVK  
Sbjct: 23  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 82
Query: 279 GCCLET--EVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGA 336
           G C         L+ EY+  G+L  ++  H           +  L + +++    E  G 
Sbjct: 83  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDH-----IKLLQYTSQICKGMEYLGT 137
Query: 337 VAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQG---TFG 393
             Y+H         RD+ + NIL++++   K+ DFG+++ +P DK        G    F 
Sbjct: 138 KRYIH---------RDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFW 188
Query: 394 YLDPEYFQSSQFTDKSDVYSFGVVLLELLT-----GKKPICFARV----EEERNLVACFI 444
           Y  PE    S+F+  SDV+SFGVVL EL T        P  F R+    ++ + +V   I
Sbjct: 189 YA-PESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 247
Query: 445 SLAKENQLLEILDARVAKEAREEDIGAMAELAM---RCLRLNSKKRPTMKQVSMELEGLR 501
            L K N  L   D            G   E+ M    C   N  +RP+ + +++ ++ +R
Sbjct: 248 ELLKNNGRLPRPD------------GCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 295

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 82/300 (27%), Positives = 134/300 (44%), Gaps = 49/300 (16%)
Query: 224 LGQGGFGTV----YKGMLPD-GSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLL 278
           LG+G FG+V    Y  +  + G +VAVK+ +   +  +  F  E+ IL  + H +IVK  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 279 GCCLET--EVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGA 336
           G C         L+ EY+  G+L  ++  H           +  L + +++    E  G 
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDH-----IKLLQYTSQICKGMEYLGT 132
Query: 337 VAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQG---TFG 393
             Y+H         RD+ + NIL++++   K+ DFG+++ +P DK        G    F 
Sbjct: 133 KRYIH---------RDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFW 183
Query: 394 YLDPEYFQSSQFTDKSDVYSFGVVLLELLT-----GKKPICFARV----EEERNLVACFI 444
           Y  PE    S+F+  SDV+SFGVVL EL T        P  F R+    ++ + +V   I
Sbjct: 184 YA-PESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 242
Query: 445 SLAKENQLLEILDARVAKEAREEDIGAMAELAM---RCLRLNSKKRPTMKQVSMELEGLR 501
            L K N  L   D            G   E+ M    C   N  +RP+ + +++ ++ +R
Sbjct: 243 ELLKNNGRLPRPD------------GCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 290

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/221 (30%), Positives = 102/221 (46%), Gaps = 22/221 (9%)
Query: 212 QRATDNYNQSRFLGQGGFGTVYKGMLPDGS-IVAVKR--SKEIDKTQI-HQFINEVVILS 267
           Q A +++   R LG+G FG VY         I+A+K     +++K  + HQ   EV I S
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 268 QINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
            + H +I++L G   +     L+ EY   GT+   +              LS    +   
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK------------LSKFDEQRTA 111
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
               E+A A++Y HS     + HRDIK  N+LL      K++DFG S   P+ +    T 
Sbjct: 112 TYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TD 165
Query: 388 IQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
           + GT  YL PE  +     +K D++S GV+  E L GK P 
Sbjct: 166 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 206

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 82/300 (27%), Positives = 134/300 (44%), Gaps = 49/300 (16%)
Query: 224 LGQGGFGTV----YKGMLPD-GSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLL 278
           LG+G FG+V    Y  +  + G +VAVK+ +   +  +  F  E+ IL  + H +IVK  
Sbjct: 24  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 83
Query: 279 GCCLET--EVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGA 336
           G C         L+ EY+  G+L  ++  H           +  L + +++    E  G 
Sbjct: 84  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDH-----IKLLQYTSQICKGMEYLGT 138
Query: 337 VAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQG---TFG 393
             Y+H         RD+ + NIL++++   K+ DFG+++ +P DK        G    F 
Sbjct: 139 KRYIH---------RDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFW 189
Query: 394 YLDPEYFQSSQFTDKSDVYSFGVVLLELLT-----GKKPICFARV----EEERNLVACFI 444
           Y  PE    S+F+  SDV+SFGVVL EL T        P  F R+    ++ + +V   I
Sbjct: 190 YA-PESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 248
Query: 445 SLAKENQLLEILDARVAKEAREEDIGAMAELAM---RCLRLNSKKRPTMKQVSMELEGLR 501
            L K N  L   D            G   E+ M    C   N  +RP+ + +++ ++ +R
Sbjct: 249 ELLKNNGRLPRPD------------GCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 296

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 76/304 (25%), Positives = 137/304 (45%), Gaps = 38/304 (12%)
Query: 203 AKVFTADELQRATDNYNQSRFLGQGGFGTVYKGMLPD------GSIVAVKRSKEIDKTQI 256
           + VF  DE + + +     R LGQG FG VY+G   D       + VAVK   E    + 
Sbjct: 4   SSVFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRE 63
Query: 257 H-QFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXX 315
             +F+NE  ++      H+V+LLG   + +  ++V E ++ G L  ++            
Sbjct: 64  RIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPG 123
Query: 316 XXLSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISR 375
               +L  +  +++A E+A  +AY+++   +   HRD+ + N ++   F+ K+ DFG++R
Sbjct: 124 RPPPTL--QEMIQMAAEIADGMAYLNAKKFV---HRDLAARNCMVAHDFTVKIGDFGMTR 178
Query: 376 SIPNDKTHLTTTIQGTFG-----YLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPIC 429
            I           +G  G     ++ PE  +   FT  SD++SFGVVL E+ +  ++P  
Sbjct: 179 DI----XETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP-- 232
Query: 430 FARVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPT 489
                        +  L+ E  L  ++D     +  +     + +L   C + N K RPT
Sbjct: 233 -------------YQGLSNEQVLKFVMDGGYLDQP-DNCPERVTDLMRMCWQFNPKMRPT 278
Query: 490 MKQV 493
             ++
Sbjct: 279 FLEI 282

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 69/221 (31%), Positives = 103/221 (46%), Gaps = 22/221 (9%)
Query: 212 QRATDNYNQSRFLGQGGFGTVYKGMLPDGS-IVAVKR--SKEIDKTQI-HQFINEVVILS 267
           Q A +++   R LG+G FG VY         I+A+K     +++K  + HQ   EV I S
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 268 QINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
            + H +I++L G   +     L+ EY   GT+   +              LS    +   
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK------------LSKFDEQRTA 114
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
               E+A A++Y HS   I   HRDIK  N+LL      K+++FG S   P+ +    TT
Sbjct: 115 TYITELANALSYCHSKRVI---HRDIKPENLLLGSAGELKIANFGWSVHAPSSRR---TT 168
Query: 388 IQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
           + GT  YL PE  +     +K D++S GV+  E L GK P 
Sbjct: 169 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 209

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 75/301 (24%), Positives = 138/301 (45%), Gaps = 32/301 (10%)
Query: 203 AKVFTADELQRATDNYNQSRFLGQGGFGTVYKGMLPD------GSIVAVKRSKEIDKTQI 256
           + VF  DE + + +     R LGQG FG VY+G   D       + VAVK   E    + 
Sbjct: 4   SSVFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRE 63
Query: 257 H-QFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXX 315
             +F+NE  ++      H+V+LLG   + +  ++V E ++ G L  ++            
Sbjct: 64  RIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPG 123
Query: 316 XXLSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISR 375
               +L  +  +++A E+A  +AY+++   +   HRD+ + N ++   F+ K+ DFG++R
Sbjct: 124 RPPPTL--QEMIQMAAEIADGMAYLNAKKFV---HRDLAARNCMVAHDFTVKIGDFGMTR 178
Query: 376 SIPNDKTHLTTTIQGTFG--YLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFAR 432
            I  +  +     +G     ++ PE  +   FT  SD++SFGVVL E+ +  ++P     
Sbjct: 179 DI-YETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP----- 232
Query: 433 VEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQ 492
                     +  L+ E  L  ++D     +  +     + +L   C + N K RPT  +
Sbjct: 233 ----------YQGLSNEQVLKFVMDGGYLDQP-DNCPERVTDLMRMCWQFNPKMRPTFLE 281
Query: 493 V 493
           +
Sbjct: 282 I 282

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 82/300 (27%), Positives = 134/300 (44%), Gaps = 49/300 (16%)
Query: 224 LGQGGFGTV----YKGMLPD-GSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLL 278
           LG+G FG+V    Y  +  + G +VAVK+ +   +  +  F  E+ IL  + H +IVK  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 279 GCCLET--EVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGA 336
           G C         L+ EY+  G+L  ++  H           +  L + +++    E  G 
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDH-----IKLLQYTSQICKGMEYLGT 132
Query: 337 VAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQG---TFG 393
             Y+H         RD+ + NIL++++   K+ DFG+++ +P DK        G    F 
Sbjct: 133 KRYIH---------RDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFW 183
Query: 394 YLDPEYFQSSQFTDKSDVYSFGVVLLELLT-----GKKPICFARV----EEERNLVACFI 444
           Y  PE    S+F+  SDV+SFGVVL EL T        P  F R+    ++ + +V   I
Sbjct: 184 YA-PESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 242
Query: 445 SLAKENQLLEILDARVAKEAREEDIGAMAELAM---RCLRLNSKKRPTMKQVSMELEGLR 501
            L K N  L   D            G   E+ M    C   N  +RP+ + +++ ++ +R
Sbjct: 243 ELLKNNGRLPRPD------------GCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 290

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 82/300 (27%), Positives = 134/300 (44%), Gaps = 49/300 (16%)
Query: 224 LGQGGFGTV----YKGMLPD-GSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLL 278
           LG+G FG+V    Y  +  + G +VAVK+ +   +  +  F  E+ IL  + H +IVK  
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 84
Query: 279 GCCLET--EVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGA 336
           G C         L+ EY+  G+L  ++  H           +  L + +++    E  G 
Sbjct: 85  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDH-----IKLLQYTSQICKGMEYLGT 139
Query: 337 VAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQG---TFG 393
             Y+H         RD+ + NIL++++   K+ DFG+++ +P DK        G    F 
Sbjct: 140 KRYIH---------RDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFW 190
Query: 394 YLDPEYFQSSQFTDKSDVYSFGVVLLELLT-----GKKPICFARV----EEERNLVACFI 444
           Y  PE    S+F+  SDV+SFGVVL EL T        P  F R+    ++ + +V   I
Sbjct: 191 YA-PESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 249
Query: 445 SLAKENQLLEILDARVAKEAREEDIGAMAELAM---RCLRLNSKKRPTMKQVSMELEGLR 501
            L K N  L   D            G   E+ M    C   N  +RP+ + +++ ++ +R
Sbjct: 250 ELLKNNGRLPRPD------------GCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 297

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 82/300 (27%), Positives = 134/300 (44%), Gaps = 49/300 (16%)
Query: 224 LGQGGFGTV----YKGMLPD-GSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLL 278
           LG+G FG+V    Y  +  + G +VAVK+ +   +  +  F  E+ IL  + H +IVK  
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 279 GCCLET--EVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGA 336
           G C         L+ EY+  G+L  ++  H           +  L + +++    E  G 
Sbjct: 81  GVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDH-----IKLLQYTSQICKGMEYLGT 135
Query: 337 VAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQG---TFG 393
             Y+H         RD+ + NIL++++   K+ DFG+++ +P DK        G    F 
Sbjct: 136 KRYIH---------RDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFW 186
Query: 394 YLDPEYFQSSQFTDKSDVYSFGVVLLELLT-----GKKPICFARV----EEERNLVACFI 444
           Y  PE    S+F+  SDV+SFGVVL EL T        P  F R+    ++ + +V   I
Sbjct: 187 YA-PESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 245
Query: 445 SLAKENQLLEILDARVAKEAREEDIGAMAELAM---RCLRLNSKKRPTMKQVSMELEGLR 501
            L K N  L   D            G   E+ M    C   N  +RP+ + +++ ++ +R
Sbjct: 246 ELLKNNGRLPRPD------------GCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 293

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 103/205 (50%), Gaps = 16/205 (7%)
Query: 224 LGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLE 283
           LG G FG V+ G     + VA+K  K         F+ E  I+ ++ H  +V+L     E
Sbjct: 17  LGNGQFGEVWMGTWNGNTKVAIKTLKP-GTMSPESFLEEAQIMKKLKHDKLVQLYAVVSE 75
Query: 284 TEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYMHSS 343
             +  +V EY++ G+L   + D              +L   N V +A +VA  +AY+   
Sbjct: 76  EPI-YIVTEYMNKGSLLDFLKDGEG----------RALKLPNLVDMAAQVAAGMAYIERM 124
Query: 344 ASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSS 403
             I   HRD++S+NIL+ +    K++DFG++R I +++       +    +  PE     
Sbjct: 125 NYI---HRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYG 181
Query: 404 QFTDKSDVYSFGVVLLELLT-GKKP 427
           +FT KSDV+SFG++L EL+T G+ P
Sbjct: 182 RFTIKSDVWSFGILLTELVTKGRVP 206

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 82/297 (27%), Positives = 134/297 (45%), Gaps = 43/297 (14%)
Query: 224 LGQGGFGTV----YKGMLPD-GSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLL 278
           LG+G FG+V    Y  +  + G +VAVK+ +   +  +  F  E+ IL  + H +IVK  
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 279 GCCLET--EVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGA 336
           G C         L+ EY+  G+L  ++  H           +  L + +++    E  G 
Sbjct: 96  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDH-----IKLLQYTSQICKGMEYLGT 150
Query: 337 VAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQG---TFG 393
             Y+H         RD+ + NIL++++   K+ DFG+++ +P DK        G    F 
Sbjct: 151 KRYIH---------RDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFW 201
Query: 394 YLDPEYFQSSQFTDKSDVYSFGVVLLELLT-----GKKPICFARV----EEERNLVACFI 444
           Y  PE    S+F+  SDV+SFGVVL EL T        P  F R+    ++ + +V   I
Sbjct: 202 YA-PESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 260
Query: 445 SLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLR 501
            L K N  L   D        +E    M E    C   N  +RP+ + +++ ++ +R
Sbjct: 261 ELLKNNGRLPRPDG-----CPDEIYMIMTE----CWNNNVNQRPSFRDLALRVDQIR 308

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 82/300 (27%), Positives = 134/300 (44%), Gaps = 49/300 (16%)
Query: 224 LGQGGFGTV----YKGMLPD-GSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLL 278
           LG+G FG+V    Y  +  + G +VAVK+ +   +  +  F  E+ IL  + H +IVK  
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 75
Query: 279 GCCLET--EVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGA 336
           G C         L+ EY+  G+L  ++  H           +  L + +++    E  G 
Sbjct: 76  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDH-----IKLLQYTSQICKGMEYLGT 130
Query: 337 VAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQG---TFG 393
             Y+H         RD+ + NIL++++   K+ DFG+++ +P DK        G    F 
Sbjct: 131 KRYIH---------RDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFW 181
Query: 394 YLDPEYFQSSQFTDKSDVYSFGVVLLELLT-----GKKPICFARV----EEERNLVACFI 444
           Y  PE    S+F+  SDV+SFGVVL EL T        P  F R+    ++ + +V   I
Sbjct: 182 YA-PESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 240
Query: 445 SLAKENQLLEILDARVAKEAREEDIGAMAELAM---RCLRLNSKKRPTMKQVSMELEGLR 501
            L K N  L   D            G   E+ M    C   N  +RP+ + +++ ++ +R
Sbjct: 241 ELLKNNGRLPRPD------------GCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 288

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 82/302 (27%), Positives = 135/302 (44%), Gaps = 49/302 (16%)
Query: 222 RFLGQGGFGTV----YKGMLPD-GSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVK 276
           R LG+G FG+V    Y  +  + G +VAVK+ +   +  +  F  E+ IL  + H +IVK
Sbjct: 19  RQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 277 LLGCCLET--EVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVA 334
             G C         L+ E++  G+L  ++  H           +  L + +++    E  
Sbjct: 79  YKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDH-----IKLLQYTSQICKGMEYL 133
Query: 335 GAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQG---T 391
           G   Y+H         RD+ + NIL++++   K+ DFG+++ +P DK        G    
Sbjct: 134 GTKRYIH---------RDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI 184
Query: 392 FGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-----GKKPICFARV----EEERNLVAC 442
           F Y  PE    S+F+  SDV+SFGVVL EL T        P  F R+    ++ + +V  
Sbjct: 185 FWYA-PESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 243
Query: 443 FISLAKENQLLEILDARVAKEAREEDIGAMAELAM---RCLRLNSKKRPTMKQVSMELEG 499
            I L K N  L   D            G   E+ M    C   N  +RP+ + +++ ++ 
Sbjct: 244 LIELLKNNGRLPRPD------------GCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ 291
Query: 500 LR 501
           +R
Sbjct: 292 IR 293

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 76/304 (25%), Positives = 137/304 (45%), Gaps = 38/304 (12%)
Query: 203 AKVFTADELQRATDNYNQSRFLGQGGFGTVYKGMLPD------GSIVAVKRSKEIDKTQI 256
           + VF  DE + + +     R LGQG FG VY+G   D       + VAVK   E    + 
Sbjct: 1   SSVFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRE 60
Query: 257 H-QFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXX 315
             +F+NE  ++      H+V+LLG   + +  ++V E ++ G L  ++            
Sbjct: 61  RIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPG 120
Query: 316 XXLSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISR 375
               +L  +  +++A E+A  +AY+++   +   HRD+ + N ++   F+ K+ DFG++R
Sbjct: 121 RPPPTL--QEMIQMAAEIADGMAYLNAKKFV---HRDLAARNCMVAHDFTVKIGDFGMTR 175
Query: 376 SIPNDKTHLTTTIQGTFG-----YLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPIC 429
            I           +G  G     ++ PE  +   FT  SD++SFGVVL E+ +  ++P  
Sbjct: 176 DI----XETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP-- 229
Query: 430 FARVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPT 489
                        +  L+ E  L  ++D     +  +     + +L   C + N K RPT
Sbjct: 230 -------------YQGLSNEQVLKFVMDGGYLDQP-DNCPERVTDLMRMCWQFNPKMRPT 275
Query: 490 MKQV 493
             ++
Sbjct: 276 FLEI 279

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 69/221 (31%), Positives = 102/221 (46%), Gaps = 22/221 (9%)
Query: 212 QRATDNYNQSRFLGQGGFGTVYKGMLPDGS-IVAVKR--SKEIDKTQI-HQFINEVVILS 267
           Q A +++   R LG+G FG VY         I+A+K     +++K  + HQ   EV I S
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 268 QINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
            + H +I++L G   +     L+ EY   GT+   +              LS    +   
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK------------LSKFDEQRTA 111
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
               E+A A++Y HS   I   HRDIK  N+LL      K++DFG S   P+ +    T 
Sbjct: 112 TYITELANALSYCHSKRVI---HRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TX 165
Query: 388 IQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
           + GT  YL PE  +     +K D++S GV+  E L GK P 
Sbjct: 166 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 206

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/221 (30%), Positives = 102/221 (46%), Gaps = 22/221 (9%)
Query: 212 QRATDNYNQSRFLGQGGFGTVYKGMLPDGS-IVAVKR--SKEIDKTQI-HQFINEVVILS 267
           Q A +++   R LG+G FG VY         I+A+K     +++K  + HQ   EV I S
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 268 QINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
            + H +I++L G   +     L+ EY   GT+   +              LS    +   
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK------------LSKFDEQRTA 111
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
               E+A A++Y HS     + HRDIK  N+LL      K++DFG S   P+ +    T 
Sbjct: 112 TYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TD 165
Query: 388 IQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
           + GT  YL PE  +     +K D++S GV+  E L GK P 
Sbjct: 166 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 206

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/221 (30%), Positives = 102/221 (46%), Gaps = 22/221 (9%)
Query: 212 QRATDNYNQSRFLGQGGFGTVYKGMLPDGS-IVAVKR--SKEIDKTQI-HQFINEVVILS 267
           Q A +++   R LG+G FG VY         I+A+K     +++K  + HQ   EV I S
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 268 QINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
            + H +I++L G   +     L+ EY   GT+   +              LS    +   
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK------------LSKFDEQRTA 111
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
               E+A A++Y HS     + HRDIK  N+LL      K++DFG S   P+ +    T 
Sbjct: 112 TYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TE 165
Query: 388 IQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
           + GT  YL PE  +     +K D++S GV+  E L GK P 
Sbjct: 166 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 206

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 81/300 (27%), Positives = 135/300 (45%), Gaps = 49/300 (16%)
Query: 224 LGQGGFGTV----YKGMLPD-GSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLL 278
           LG+G FG+V    Y  +  + G +VAVK+ +   +  +  F  E+ IL  + H +IVK  
Sbjct: 19  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 78
Query: 279 GCCLET--EVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGA 336
           G C         L+ EY+  G+L  ++  H           +  L + +++    E  G 
Sbjct: 79  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDH-----IKLLQYTSQICKGMEYLGT 133
Query: 337 VAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQG---TFG 393
             Y+H         R++ + NIL++++   K+ DFG+++ +P DK +      G    F 
Sbjct: 134 KRYIH---------RNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFW 184
Query: 394 YLDPEYFQSSQFTDKSDVYSFGVVLLELLT-----GKKPICFARV----EEERNLVACFI 444
           Y  PE    S+F+  SDV+SFGVVL EL T        P  F R+    ++ + +V   I
Sbjct: 185 YA-PESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 243
Query: 445 SLAKENQLLEILDARVAKEAREEDIGAMAELAM---RCLRLNSKKRPTMKQVSMELEGLR 501
            L K N  L   D            G   E+ M    C   N  +RP+ + +++ ++ +R
Sbjct: 244 ELLKNNGRLPRPD------------GCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 291

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/221 (30%), Positives = 102/221 (46%), Gaps = 22/221 (9%)
Query: 212 QRATDNYNQSRFLGQGGFGTVYKGMLPDGS-IVAVKR--SKEIDKTQI-HQFINEVVILS 267
           Q A +++   R LG+G FG VY         I+A+K     +++K  + HQ   EV I S
Sbjct: 5   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 64
Query: 268 QINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
            + H +I++L G   +     L+ EY   GT+   +              LS    +   
Sbjct: 65  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK------------LSKFDEQRTA 112
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
               E+A A++Y HS     + HRDIK  N+LL      K++DFG S   P+ +     T
Sbjct: 113 TYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---DT 166
Query: 388 IQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
           + GT  YL PE  +     +K D++S GV+  E L GK P 
Sbjct: 167 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 207

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/221 (30%), Positives = 102/221 (46%), Gaps = 22/221 (9%)
Query: 212 QRATDNYNQSRFLGQGGFGTVYKGMLPDGS-IVAVKR--SKEIDKTQI-HQFINEVVILS 267
           Q A +++   R LG+G FG VY         I+A+K     +++K  + HQ   EV I S
Sbjct: 5   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 64
Query: 268 QINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
            + H +I++L G   +     L+ EY   GT+   +              LS    +   
Sbjct: 65  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK------------LSKFDEQRTA 112
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
               E+A A++Y HS     + HRDIK  N+LL      K++DFG S   P+ +    T 
Sbjct: 113 TYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TD 166
Query: 388 IQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
           + GT  YL PE  +     +K D++S GV+  E L GK P 
Sbjct: 167 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 207

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 102/214 (47%), Gaps = 31/214 (14%)
Query: 224 LGQGGFGTVYKGMLPDGSIVAVK----------RSKEIDKTQIHQFINEVVILSQINHRH 273
           LG GG  TVY   L + +I+ +K          R KE     + +F  EV   SQ++H++
Sbjct: 19  LGGGGMSTVY---LAEDTILNIKVAIKAIFIPPREKE---ETLKRFEREVHNSSQLSHQN 72
Query: 274 IVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEV 333
           IV ++    E +   LV EYI   TLS +I  H              LS +  +    ++
Sbjct: 73  IVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESH------------GPLSVDTAINFTNQI 120
Query: 334 AGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFG 393
              + + H    + I HRDIK  NIL+D   + K+ DFGI++++       T  + GT  
Sbjct: 121 LDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQ 177
Query: 394 YLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
           Y  PE  +     + +D+YS G+VL E+L G+ P
Sbjct: 178 YFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPP 211

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 82/297 (27%), Positives = 134/297 (45%), Gaps = 43/297 (14%)
Query: 224 LGQGGFGTV----YKGMLPD-GSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLL 278
           LG+G FG+V    Y  +  + G +VAVK+ +   +  +  F  E+ IL  + H +IVK  
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 279 GCCLET--EVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGA 336
           G C         L+ EY+  G+L  ++  H           +  L + +++    E  G 
Sbjct: 96  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDH-----IKLLQYTSQICKGMEYLGT 150
Query: 337 VAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQG---TFG 393
             Y+H         RD+ + NIL++++   K+ DFG+++ +P DK        G    F 
Sbjct: 151 KRYIH---------RDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFW 201
Query: 394 YLDPEYFQSSQFTDKSDVYSFGVVLLELLT-----GKKPICFARV----EEERNLVACFI 444
           Y  PE    S+F+  SDV+SFGVVL EL T        P  F R+    ++ + +V   I
Sbjct: 202 YA-PESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 260
Query: 445 SLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLR 501
            L K N  L   D        +E    M E    C   N  +RP+ + +++ ++ +R
Sbjct: 261 ELLKNNGRLPRPDG-----CPDEIYMIMTE----CWNNNVNQRPSFRDLALRVDQIR 308

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 72/279 (25%), Positives = 128/279 (45%), Gaps = 32/279 (11%)
Query: 224 LGQGGFGTVYKGMLPDGSI-VAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCL 282
           LG G +G VY+G+    S+ VAVK  KE D  ++ +F+ E  ++ +I H ++V+LLG C 
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 286
Query: 283 ETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYMHS 342
                 ++ E+++ G L  ++ +                     + +A +++ A+ Y+  
Sbjct: 287 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVL----------LYMATQISSAMEYLEK 336
Query: 343 SASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQS 402
              I   HR++ + N L+ +    KV+DFG+SR +  D        +    +  PE    
Sbjct: 337 KNFI---HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 393
Query: 403 SQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQLLEILDARVA 461
           ++F+ KSDV++FGV+L E+ T G  P                I L+   Q+ E+L+    
Sbjct: 394 NKFSIKSDVWAFGVLLWEIATYGMSPY-------------PGIDLS---QVYELLEKDYR 437
Query: 462 KEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGL 500
            E  E     + EL   C + N   RP+  ++    E +
Sbjct: 438 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 476

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/221 (30%), Positives = 102/221 (46%), Gaps = 22/221 (9%)
Query: 212 QRATDNYNQSRFLGQGGFGTVYKGMLPDGS-IVAVKR--SKEIDKTQI-HQFINEVVILS 267
           Q A +++   R LG+G FG VY         I+A+K     +++K  + HQ   EV I S
Sbjct: 9   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 68
Query: 268 QINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
            + H +I++L G   +     L+ EY   GT+   +              LS    +   
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK------------LSKFDEQRTA 116
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
               E+A A++Y HS     + HRDIK  N+LL      K++DFG S   P+ +    T 
Sbjct: 117 TYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TD 170
Query: 388 IQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
           + GT  YL PE  +     +K D++S GV+  E L GK P 
Sbjct: 171 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 211

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 80/289 (27%), Positives = 131/289 (45%), Gaps = 40/289 (13%)
Query: 224 LGQGGFGTVYKGMLPDGSIVAVKRSKEIDKT--QIHQFINEVVILSQINHRHIVKLLGCC 281
           +G G FGTVYKG       VAVK  K +D T  Q   F NEV +L +  H +I+  +G  
Sbjct: 44  IGSGSFGTVYKGKWHGD--VAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYM 101
Query: 282 LETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYMH 341
            +  + + V ++    +L  H+H                      + +A + A  + Y+H
Sbjct: 102 TKDNLAI-VTQWCEGSSLYKHLHVQETKFQMFQL-----------IDIARQTAQGMDYLH 149
Query: 342 SSASIPIFHRDIKSSNILLDDKFSAKVSDFGI----SRSIPNDKTHLTTTIQGTFGYLDP 397
           +     I HRD+KS+NI L +  + K+ DFG+    SR   + +    T   G+  ++ P
Sbjct: 150 AKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPT---GSVLWMAP 203
Query: 398 EYFQ---SSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLE 454
           E  +   ++ F+ +SDVYS+G+VL EL+TG+ P         R+ +   +     +  L 
Sbjct: 204 EVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHI---NNRDQIIFMVGRGYASPDLS 260
Query: 455 ILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRS 503
            L     K        AM  L   C++   ++RP   Q+   +E L+ S
Sbjct: 261 KLYKNCPK--------AMKRLVADCVKKVKEERPLFPQILSSIELLQHS 301

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 68/221 (30%), Positives = 103/221 (46%), Gaps = 22/221 (9%)
Query: 212 QRATDNYNQSRFLGQGGFGTVYKGMLPDGS-IVAVKR--SKEIDKTQI-HQFINEVVILS 267
           Q A +++   R LG+G FG VY     +   I+A+K     +++K  + HQ   EV I S
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 268 QINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
            + H +I++L G   ++    L+ EY   GT+   +              LS    +   
Sbjct: 64  HLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQK------------LSKFDEQRTA 111
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
               E+A A++Y HS   I   HRDIK  N+LL      K++DFG S   P+ +      
Sbjct: 112 TYITELANALSYCHSKKVI---HRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---AA 165
Query: 388 IQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
           + GT  YL PE  +     +K D++S GV+  E L GK P 
Sbjct: 166 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 206

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 72/279 (25%), Positives = 128/279 (45%), Gaps = 32/279 (11%)
Query: 224 LGQGGFGTVYKGMLPDGSI-VAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCL 282
           LG G +G VY+G+    S+ VAVK  KE D  ++ +F+ E  ++ +I H ++V+LLG C 
Sbjct: 267 LGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 325
Query: 283 ETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYMHS 342
                 ++ E+++ G L  ++ +                     + +A +++ A+ Y+  
Sbjct: 326 REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL----------LYMATQISSAMEYLEK 375
Query: 343 SASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQS 402
              I   HR++ + N L+ +    KV+DFG+SR +  D        +    +  PE    
Sbjct: 376 KNFI---HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 432
Query: 403 SQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQLLEILDARVA 461
           ++F+ KSDV++FGV+L E+ T G  P                I L+   Q+ E+L+    
Sbjct: 433 NKFSIKSDVWAFGVLLWEIATYGMSPY-------------PGIDLS---QVYELLEKDYR 476
Query: 462 KEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGL 500
            E  E     + EL   C + N   RP+  ++    E +
Sbjct: 477 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 515

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 101/221 (45%), Gaps = 22/221 (9%)
Query: 212 QRATDNYNQSRFLGQGGFGTVYKGMLPDGS-IVAVKR--SKEIDKTQI-HQFINEVVILS 267
           Q A +++   R LG+G FG VY         I+A+K     +++K  + HQ   EV I S
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 268 QINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
            + H +I++L G   +     L+ EY   GT+   +              LS    +   
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK------------LSKFDEQRTA 114
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
               E+A A++Y HS     + HRDIK  N+LL      K++DFG S   P+ +      
Sbjct: 115 TYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---AA 168
Query: 388 IQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
           + GT  YL PE  +     +K D++S GV+  E L GK P 
Sbjct: 169 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 209

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 68/221 (30%), Positives = 101/221 (45%), Gaps = 22/221 (9%)
Query: 212 QRATDNYNQSRFLGQGGFGTVYKGMLPDGS-IVAVKR--SKEIDKTQI-HQFINEVVILS 267
           Q A +++   R LG+G FG VY         I+A+K     +++K  + HQ   EV I S
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 268 QINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
            + H +I++L G   +     L+ EY   GT+   +              LS    +   
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK------------LSKFDEQRTA 111
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
               E+A A++Y HS   I   HRDIK  N+LL      K++DFG S   P+ +      
Sbjct: 112 TYITELANALSYCHSKRVI---HRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---AA 165
Query: 388 IQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
           + GT  YL PE  +     +K D++S GV+  E L GK P 
Sbjct: 166 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 206

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 78/318 (24%), Positives = 143/318 (44%), Gaps = 40/318 (12%)
Query: 202 RAKVFTADELQRATDNYNQS--RFLGQGGFGTVYKGMLPDGS----IVAVKRSK-EIDKT 254
           R    T  E  +  D  N S  + +G G FG V  G L   S     VA+K  K    + 
Sbjct: 17  RGSTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK 76
Query: 255 QIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXX 314
           Q   F+ E  I+ Q +H +I++L G   +++  ++V EY+ +G+L   +  H        
Sbjct: 77  QRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV-- 134
Query: 315 XXXLSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGIS 374
                       +++   + G  + M   + +   HRD+ + NIL++     KVSDFG+S
Sbjct: 135 ------------IQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLS 182
Query: 375 RSIPNDKTHLTTTIQGTFG--YLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFA 431
           R + +D     TT  G     +  PE     +FT  SDV+S+G+VL E+++ G++P    
Sbjct: 183 RVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP---- 238
Query: 432 RVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMK 491
                      +  ++ ++ +++ +D         +   A+ +L + C + +   RP  +
Sbjct: 239 -----------YWEMSNQD-VIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFE 286
Query: 492 QVSMELEGLRRSQRCLEM 509
           Q+   L+ L R+   L++
Sbjct: 287 QIVSILDKLIRNPGSLKI 304

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 92.0 bits (227), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 101/221 (45%), Gaps = 22/221 (9%)
Query: 212 QRATDNYNQSRFLGQGGFGTVYKGMLPDGS-IVAVKR--SKEIDKTQI-HQFINEVVILS 267
           Q A +++   R LG+G FG VY         I+A+K     +++K  + HQ   EV I S
Sbjct: 6   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 65
Query: 268 QINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
            + H +I++L G   +     L+ EY   GT+   +              LS    +   
Sbjct: 66  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK------------LSKFDEQRTA 113
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
               E+A A++Y HS     + HRDIK  N+LL      K++DFG S   P+ +      
Sbjct: 114 TYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---XX 167
Query: 388 IQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
           + GT  YL PE  +     +K D++S GV+  E L GK P 
Sbjct: 168 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 208

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 92.0 bits (227), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 68/221 (30%), Positives = 101/221 (45%), Gaps = 22/221 (9%)
Query: 212 QRATDNYNQSRFLGQGGFGTVYKGMLPDGS-IVAVKR--SKEIDKTQI-HQFINEVVILS 267
           Q A +++   R LG+G FG VY         I+A+K     +++K  + HQ   EV I S
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 268 QINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
            + H +I++L G   +     L+ EY   GT+   +              LS    +   
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK------------LSKFDEQRTA 114
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
               E+A A++Y HS   I   HRDIK  N+LL      K++DFG S   P+ +      
Sbjct: 115 TYITELANALSYCHSKRVI---HRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---XX 168
Query: 388 IQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
           + GT  YL PE  +     +K D++S GV+  E L GK P 
Sbjct: 169 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 209

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 92.0 bits (227), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 68/221 (30%), Positives = 101/221 (45%), Gaps = 22/221 (9%)
Query: 212 QRATDNYNQSRFLGQGGFGTVYKGMLPDGS-IVAVKR--SKEIDKTQI-HQFINEVVILS 267
           Q A +++   R LG+G FG VY         I+A+K     +++K  + HQ   EV I S
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 268 QINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
            + H +I++L G   +     L+ EY   GT+   +              LS    +   
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK------------LSKFDEQRTA 111
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
               E+A A++Y HS   I   HRDIK  N+LL      K++DFG S   P+ +      
Sbjct: 112 TYITELANALSYCHSKRVI---HRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---XX 165
Query: 388 IQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
           + GT  YL PE  +     +K D++S GV+  E L GK P 
Sbjct: 166 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 206

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 92.0 bits (227), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 77/313 (24%), Positives = 142/313 (45%), Gaps = 40/313 (12%)
Query: 207 TADELQRATDNYNQS--RFLGQGGFGTVYKGMLPDGS----IVAVKRSK-EIDKTQIHQF 259
           T  E  +  D  N S  + +G G FG V  G L   S     VA+K  K    + Q   F
Sbjct: 34  TVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF 93
Query: 260 INEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLS 319
           + E  I+ Q +H +I++L G   +++  ++V EY+ +G+L   +  H             
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV------- 146
Query: 320 SLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPN 379
                  +++   + G  + M   + +   HRD+ + NIL++     KVSDFG+SR + +
Sbjct: 147 -------IQLVGMLRGIASGMKYLSDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLED 199
Query: 380 DKTHLTTTIQGTFG--YLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEE 436
           D     TT  G     +  PE     +FT  SDV+S+G+VL E+++ G++P         
Sbjct: 200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP--------- 250
Query: 437 RNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSME 496
                 +  ++ ++ +++ +D         +   A+ +L + C + +   RP  +Q+   
Sbjct: 251 ------YWEMSNQD-VIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSI 303
Query: 497 LEGLRRSQRCLEM 509
           L+ L R+   L++
Sbjct: 304 LDKLIRNPGSLKI 316

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 92.0 bits (227), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 99/223 (44%), Gaps = 26/223 (11%)
Query: 212 QRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQI------HQFINEVVI 265
           Q   ++++  R LG+G FG VY         +     K + KTQ+      HQ   EV I
Sbjct: 8   QWTLEDFDIGRPLGKGKFGNVYLARERQSKFILA--LKVLFKTQLEKAGVEHQLRREVEI 65
Query: 266 LSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWEN 325
            S + H +I++L G   +     L+ EY   GT+   +              LS    + 
Sbjct: 66  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK------------LSRFDEQR 113
Query: 326 RVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLT 385
                 E+A A++Y HS   I   HRDIK  N+LL      K++DFG S   P+ +    
Sbjct: 114 TATYITELANALSYCHSKRVI---HRDIKPENLLLGSNGELKIADFGWSVHAPSSRR--- 167
Query: 386 TTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
           TT+ GT  YL PE  +     +K D++S GV+  E L G  P 
Sbjct: 168 TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPF 210

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 63/233 (27%), Positives = 112/233 (48%), Gaps = 21/233 (9%)
Query: 203 AKVFTADELQRATDNYNQSRFLGQGGFGTVYKGMLPD------GSIVAVKRSKEIDKTQI 256
           + V+  DE + + +     R LGQG FG VY+G   D       + VAVK   E    + 
Sbjct: 4   SSVYVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRE 63
Query: 257 H-QFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXX 315
             +F+NE  ++      H+V+LLG   + +  ++V E ++ G L  ++            
Sbjct: 64  RIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPG 123
Query: 316 XXLSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISR 375
               +L  +  +++A E+A  +AY+++   +   HRD+ + N ++   F+ K+ DFG++R
Sbjct: 124 RPPPTL--QEMIQMAAEIADGMAYLNAKKFV---HRDLAARNCMVAHDFTVKIGDFGMTR 178
Query: 376 SIPNDKTHLTTTIQGTFG-----YLDPEYFQSSQFTDKSDVYSFGVVLLELLT 423
            I           +G  G     ++ PE  +   FT  SD++SFGVVL E+ +
Sbjct: 179 DI----XETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 91.7 bits (226), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 101/221 (45%), Gaps = 22/221 (9%)
Query: 212 QRATDNYNQSRFLGQGGFGTVYKGMLPDGS-IVAVKR--SKEIDKTQI-HQFINEVVILS 267
           Q A +++   R LG+G FG VY         I+A+K     +++K  + HQ   EV I S
Sbjct: 30  QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 89
Query: 268 QINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
            + H +I++L G   +     L+ EY   GT+   +              LS    +   
Sbjct: 90  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK------------LSKFDEQRTA 137
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
               E+A A++Y HS     + HRDIK  N+LL      K++DFG S   P+ +      
Sbjct: 138 TYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---DD 191
Query: 388 IQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
           + GT  YL PE  +     +K D++S GV+  E L GK P 
Sbjct: 192 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 232

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 100/221 (45%), Gaps = 22/221 (9%)
Query: 212 QRATDNYNQSRFLGQGGFGTVYKGMLPDGS-IVAVKR--SKEIDKTQI-HQFINEVVILS 267
           Q A +++   R LG+G FG VY         I+A+K     +++K  + HQ   EV I S
Sbjct: 9   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 68
Query: 268 QINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
            + H +I++L G   +     L+ EY   G +   +              LS    +   
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQK------------LSKFDEQRTA 116
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
               E+A A++Y HS     + HRDIK  N+LL      K++DFG S   P+ +      
Sbjct: 117 TYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---XX 170
Query: 388 IQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
           + GT  YL PE  +     +K D++S GV+  E L GK P 
Sbjct: 171 LXGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 211

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 82/324 (25%), Positives = 145/324 (44%), Gaps = 42/324 (12%)
Query: 204 KVFTADELQRATDNYNQSRFLGQGGFGTVYKGML------PDGSIVAVKRSKE-IDKTQI 256
           K+    + +    N    + LG+G FG V K            + VAVK  KE    +++
Sbjct: 11  KILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSEL 70
Query: 257 HQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXX 316
              ++E  +L Q+NH H++KL G C +    +L+ EY   G+L   + +           
Sbjct: 71  RDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGS 130
Query: 317 XLS------------SLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF 364
             S            +L+  + +  A +++  + Y+   A + + HRD+ + NIL+ +  
Sbjct: 131 GGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGR 187
Query: 365 SAKVSDFGISRSIPNDKTHLTTTIQGTF--GYLDPEYFQSSQFTDKSDVYSFGVVLLELL 422
             K+SDFG+SR +  + +++  + QG     ++  E      +T +SDV+SFGV+L E++
Sbjct: 188 KMKISDFGLSRDVYEEDSYVKRS-QGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV 246
Query: 423 T-GKKPICFARVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLR 481
           T G  P  +  +  ER       +L K    +E  D        EE    M  L ++C +
Sbjct: 247 TLGGNP--YPGIPPER-----LFNLLKTGHRMERPD-----NCSEE----MYRLMLQCWK 290
Query: 482 LNSKKRPTMKQVSMELEGLRRSQR 505
               KRP    +S +LE +   +R
Sbjct: 291 QEPDKRPVFADISKDLEKMMVKRR 314

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 77/313 (24%), Positives = 142/313 (45%), Gaps = 40/313 (12%)
Query: 207 TADELQRATDNYNQS--RFLGQGGFGTVYKGMLPDGS----IVAVKRSK-EIDKTQIHQF 259
           T  E  +  D  N S  + +G G FG V  G L   S     VA+K  K    + Q   F
Sbjct: 5   TVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF 64
Query: 260 INEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLS 319
           + E  I+ Q +H +I++L G   +++  ++V EY+ +G+L   +  H             
Sbjct: 65  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV------- 117
Query: 320 SLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPN 379
                  +++   + G  + M   + +   HRD+ + NIL++     KVSDFG+SR + +
Sbjct: 118 -------IQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED 170
Query: 380 DKTHLTTTIQGTFG--YLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEE 436
           D     TT  G     +  PE     +FT  SDV+S+G+VL E+++ G++P         
Sbjct: 171 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP--------- 221
Query: 437 RNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSME 496
                 +  ++ ++ +++ +D         +   A+ +L + C + +   RP  +Q+   
Sbjct: 222 ------YWEMSNQD-VIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSI 274
Query: 497 LEGLRRSQRCLEM 509
           L+ L R+   L++
Sbjct: 275 LDKLIRNPGSLKI 287

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 77/313 (24%), Positives = 142/313 (45%), Gaps = 40/313 (12%)
Query: 207 TADELQRATDNYNQS--RFLGQGGFGTVYKGMLPDGS----IVAVKRSK-EIDKTQIHQF 259
           T  E  +  D  N S  + +G G FG V  G L   S     VA+K  K    + Q   F
Sbjct: 34  TVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF 93
Query: 260 INEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLS 319
           + E  I+ Q +H +I++L G   +++  ++V EY+ +G+L   +  H             
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV------- 146
Query: 320 SLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPN 379
                  +++   + G  + M   + +   HRD+ + NIL++     KVSDFG+SR + +
Sbjct: 147 -------IQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED 199
Query: 380 DKTHLTTTIQGTFG--YLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEE 436
           D     TT  G     +  PE     +FT  SDV+S+G+VL E+++ G++P         
Sbjct: 200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP--------- 250
Query: 437 RNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSME 496
                 +  ++ ++ +++ +D         +   A+ +L + C + +   RP  +Q+   
Sbjct: 251 ------YWEMSNQD-VIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSI 303
Query: 497 LEGLRRSQRCLEM 509
           L+ L R+   L++
Sbjct: 304 LDKLIRNPGSLKI 316

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 77/313 (24%), Positives = 142/313 (45%), Gaps = 40/313 (12%)
Query: 207 TADELQRATDNYNQS--RFLGQGGFGTVYKGMLPDGS----IVAVKRSK-EIDKTQIHQF 259
           T  E  +  D  N S  + +G G FG V  G L   S     VA+K  K    + Q   F
Sbjct: 34  TVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF 93
Query: 260 INEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLS 319
           + E  I+ Q +H +I++L G   +++  ++V EY+ +G+L   +  H             
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV------- 146
Query: 320 SLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPN 379
                  +++   + G  + M   + +   HRD+ + NIL++     KVSDFG+SR + +
Sbjct: 147 -------IQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED 199
Query: 380 DKTHLTTTIQGTFG--YLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEE 436
           D     TT  G     +  PE     +FT  SDV+S+G+VL E+++ G++P         
Sbjct: 200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP--------- 250
Query: 437 RNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSME 496
                 +  ++ ++ +++ +D         +   A+ +L + C + +   RP  +Q+   
Sbjct: 251 ------YWEMSNQD-VIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSI 303
Query: 497 LEGLRRSQRCLEM 509
           L+ L R+   L++
Sbjct: 304 LDKLIRNPGSLKI 316

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 77/313 (24%), Positives = 142/313 (45%), Gaps = 40/313 (12%)
Query: 207 TADELQRATDNYNQS--RFLGQGGFGTVYKGMLPDGS----IVAVKRSK-EIDKTQIHQF 259
           T  E  +  D  N S  + +G G FG V  G L   S     VA+K  K    + Q   F
Sbjct: 34  TVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF 93
Query: 260 INEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLS 319
           + E  I+ Q +H +I++L G   +++  ++V EY+ +G+L   +  H             
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV------- 146
Query: 320 SLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPN 379
                  +++   + G  + M   + +   HRD+ + NIL++     KVSDFG+SR + +
Sbjct: 147 -------IQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED 199
Query: 380 DKTHLTTTIQGTFG--YLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEE 436
           D     TT  G     +  PE     +FT  SDV+S+G+VL E+++ G++P         
Sbjct: 200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP--------- 250
Query: 437 RNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSME 496
                 +  ++ ++ +++ +D         +   A+ +L + C + +   RP  +Q+   
Sbjct: 251 ------YWEMSNQD-VIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSI 303
Query: 497 LEGLRRSQRCLEM 509
           L+ L R+   L++
Sbjct: 304 LDKLIRNPGSLKI 316

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 75/284 (26%), Positives = 130/284 (45%), Gaps = 34/284 (11%)
Query: 224 LGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLE 283
           LG G FG V  G       VAVK  KE   ++  +F  E   + +++H  +VK  G C  
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE-DEFFQEAQTMMKLSHPKLVKFYGVC-S 73
Query: 284 TEVPV-LVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYMHS 342
            E P+ +V EYIS+G L +++  H              L     + +  +V   +A++ S
Sbjct: 74  KEYPIYIVTEYISNGCLLNYLRSHG-----------KGLEPSQLLEMCYDVCEGMAFLES 122
Query: 343 SASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQS 402
              I   HRD+ + N L+D     KVSDFG++R + +D+   +   +    +  PE F  
Sbjct: 123 HQFI---HRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHY 179
Query: 403 SQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQLLEILDARVA 461
            +++ KSDV++FG+++ E+ + GK P          +L      + K +Q   +    +A
Sbjct: 180 FKYSSKSDVWAFGILMWEVFSLGKMPY---------DLYTNSEVVLKVSQGHRLYRPHLA 230
Query: 462 KEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRSQR 505
            +        + ++   C     +KRPT +Q+   +E LR   +
Sbjct: 231 SD-------TIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKDK 267

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 77/313 (24%), Positives = 142/313 (45%), Gaps = 40/313 (12%)
Query: 207 TADELQRATDNYNQS--RFLGQGGFGTVYKGMLPDGS----IVAVKRSK-EIDKTQIHQF 259
           T  E  +  D  N S  + +G G FG V  G L   S     VA+K  K    + Q   F
Sbjct: 32  TVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF 91
Query: 260 INEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLS 319
           + E  I+ Q +H +I++L G   +++  ++V EY+ +G+L   +  H             
Sbjct: 92  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV------- 144
Query: 320 SLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPN 379
                  +++   + G  + M   + +   HRD+ + NIL++     KVSDFG+SR + +
Sbjct: 145 -------IQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED 197
Query: 380 DKTHLTTTIQGTFG--YLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEE 436
           D     TT  G     +  PE     +FT  SDV+S+G+VL E+++ G++P         
Sbjct: 198 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP--------- 248
Query: 437 RNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSME 496
                 +  ++ ++ +++ +D         +   A+ +L + C + +   RP  +Q+   
Sbjct: 249 ------YWEMSNQD-VIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSI 301
Query: 497 LEGLRRSQRCLEM 509
           L+ L R+   L++
Sbjct: 302 LDKLIRNPGSLKI 314

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 77/313 (24%), Positives = 142/313 (45%), Gaps = 40/313 (12%)
Query: 207 TADELQRATDNYNQS--RFLGQGGFGTVYKGMLPDGS----IVAVKRSK-EIDKTQIHQF 259
           T  E  +  D  N S  + +G G FG V  G L   S     VA+K  K    + Q   F
Sbjct: 34  TVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF 93
Query: 260 INEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLS 319
           + E  I+ Q +H +I++L G   +++  ++V EY+ +G+L   +  H             
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV------- 146
Query: 320 SLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPN 379
                  +++   + G  + M   + +   HRD+ + NIL++     KVSDFG+SR + +
Sbjct: 147 -------IQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED 199
Query: 380 DKTHLTTTIQGTFG--YLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEE 436
           D     TT  G     +  PE     +FT  SDV+S+G+VL E+++ G++P         
Sbjct: 200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP--------- 250
Query: 437 RNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSME 496
                 +  ++ ++ +++ +D         +   A+ +L + C + +   RP  +Q+   
Sbjct: 251 ------YWEMSNQD-VIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSI 303
Query: 497 LEGLRRSQRCLEM 509
           L+ L R+   L++
Sbjct: 304 LDKLIRNPGSLKI 316

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 111/226 (49%), Gaps = 18/226 (7%)
Query: 204 KVFTADELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEV 263
           K +  DE +   +       LG G FG V+ G     + VAVK  K+        F+ E 
Sbjct: 10  KPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEA 68
Query: 264 VILSQINHRHIVKLLGCCLETEVPV-LVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLS 322
            ++ Q+ H+ +V+L      T+ P+ ++ EY+ +G+L   +                 L+
Sbjct: 69  NLMKQLQHQRLVRLYAVV--TQEPIYIITEYMENGSLVDFLKTPSGI----------KLT 116
Query: 323 WENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKT 382
               + +A ++A  +A++     I   HRD++++NIL+ D  S K++DFG++R I +++ 
Sbjct: 117 INKLLDMAAQIAEGMAFIEERNYI---HRDLRAANILVSDTLSCKIADFGLARLIEDNEX 173
Query: 383 HLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
                 +    +  PE      FT KSDV+SFG++L E++T G+ P
Sbjct: 174 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 219

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 68/221 (30%), Positives = 101/221 (45%), Gaps = 22/221 (9%)
Query: 212 QRATDNYNQSRFLGQGGFGTVYKGMLPDGS-IVAVKR--SKEIDKTQI-HQFINEVVILS 267
           Q A +++   R LG+G FG VY         I+A+K     +++K  + HQ   EV I S
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 268 QINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
            + H +I++L G   +     L+ EY   GT+   +              LS    +   
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK------------LSKFDEQRTA 114
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
               E+A A++Y HS   I   HRDIK  N+LL      K++DFG S   P+ +      
Sbjct: 115 TYITELANALSYCHSKRVI---HRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---DD 168
Query: 388 IQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
           + GT  YL PE  +     +K D++S GV+  E L GK P 
Sbjct: 169 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 209

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 111/226 (49%), Gaps = 18/226 (7%)
Query: 204 KVFTADELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEV 263
           K +  DE +   +       LG G FG V+ G     + VAVK  K+        F+ E 
Sbjct: 3   KPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEA 61
Query: 264 VILSQINHRHIVKLLGCCLETEVPV-LVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLS 322
            ++ Q+ H+ +V+L      T+ P+ ++ EY+ +G+L   +                 L+
Sbjct: 62  NLMKQLQHQRLVRLYAVV--TQEPIYIITEYMENGSLVDFLKTPSGI----------KLT 109
Query: 323 WENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKT 382
               + +A ++A  +A++     I   HRD++++NIL+ D  S K++DFG++R I +++ 
Sbjct: 110 INKLLDMAAQIAEGMAFIEERNYI---HRDLRAANILVSDTLSCKIADFGLARLIEDNEX 166
Query: 383 HLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
                 +    +  PE      FT KSDV+SFG++L E++T G+ P
Sbjct: 167 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 212

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 111/226 (49%), Gaps = 18/226 (7%)
Query: 204 KVFTADELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEV 263
           K +  DE +   +       LG G FG V+ G     + VAVK  K+        F+ E 
Sbjct: 1   KPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEA 59
Query: 264 VILSQINHRHIVKLLGCCLETEVPV-LVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLS 322
            ++ Q+ H+ +V+L      T+ P+ ++ EY+ +G+L   +                 L+
Sbjct: 60  NLMKQLQHQRLVRLYAVV--TQEPIYIITEYMENGSLVDFLKTPSGI----------KLT 107
Query: 323 WENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKT 382
               + +A ++A  +A++     I   HRD++++NIL+ D  S K++DFG++R I +++ 
Sbjct: 108 INKLLDMAAQIAEGMAFIEERNYI---HRDLRAANILVSDTLSCKIADFGLARLIEDNEX 164
Query: 383 HLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
                 +    +  PE      FT KSDV+SFG++L E++T G+ P
Sbjct: 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 210

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 104/214 (48%), Gaps = 22/214 (10%)
Query: 222 RFLGQGGFGTVYKGML--PDGSIVAVK-RSKEIDKT--QIHQFINEVVILSQINHRHIVK 276
           R +G G FG V  G L  P    VAV  ++ ++  T  Q   F+ E  I+ Q +H ++V 
Sbjct: 49  RVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVH 108
Query: 277 LLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGA 336
           L G     +  ++V E++ +G L   +  H                    +++   + G 
Sbjct: 109 LEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTV--------------IQLVGMLRGI 154
Query: 337 VAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFG--Y 394
            A M   A +   HRD+ + NIL++     KVSDFG+SR I +D   + TT  G     +
Sbjct: 155 AAGMRYLADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRW 214
Query: 395 LDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
             PE  Q  +FT  SDV+S+G+V+ E+++ G++P
Sbjct: 215 TAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP 248

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 111/226 (49%), Gaps = 18/226 (7%)
Query: 204 KVFTADELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEV 263
           K +  DE +   +       LG G FG V+ G     + VAVK  K+        F+ E 
Sbjct: 2   KPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEA 60
Query: 264 VILSQINHRHIVKLLGCCLETEVPV-LVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLS 322
            ++ Q+ H+ +V+L      T+ P+ ++ EY+ +G+L   +                 L+
Sbjct: 61  NLMKQLQHQRLVRLYAVV--TQEPIYIITEYMENGSLVDFLKTPSGI----------KLT 108
Query: 323 WENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKT 382
               + +A ++A  +A++     I   HRD++++NIL+ D  S K++DFG++R I +++ 
Sbjct: 109 INKLLDMAAQIAEGMAFIEERNYI---HRDLRAANILVSDTLSCKIADFGLARLIEDNEX 165
Query: 383 HLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
                 +    +  PE      FT KSDV+SFG++L E++T G+ P
Sbjct: 166 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 211

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 111/226 (49%), Gaps = 18/226 (7%)
Query: 204 KVFTADELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEV 263
           K +  DE +   +       LG G FG V+ G     + VAVK  K+        F+ E 
Sbjct: 1   KPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEA 59
Query: 264 VILSQINHRHIVKLLGCCLETEVPV-LVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLS 322
            ++ Q+ H+ +V+L      T+ P+ ++ EY+ +G+L   +                 L+
Sbjct: 60  NLMKQLQHQRLVRLYAVV--TQEPIYIITEYMENGSLVDFLKTPSGI----------KLT 107
Query: 323 WENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKT 382
               + +A ++A  +A++     I   HRD++++NIL+ D  S K++DFG++R I +++ 
Sbjct: 108 INKLLDMAAQIAEGMAFIEERNYI---HRDLRAANILVSDTLSCKIADFGLARLIEDNEX 164
Query: 383 HLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
                 +    +  PE      FT KSDV+SFG++L E++T G+ P
Sbjct: 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 210

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 71/279 (25%), Positives = 123/279 (44%), Gaps = 32/279 (11%)
Query: 224 LGQGGFGTVYKGMLPDGSI-VAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCL 282
           LG G +G VY G+    S+ VAVK  KE D  ++ +F+ E  ++ +I H ++V+LLG C 
Sbjct: 40  LGGGQYGEVYVGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 98
Query: 283 ETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYMHS 342
                 +V EY+  G L  ++ +                     + +A +++ A+ Y+  
Sbjct: 99  LEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVL----------LYMATQISSAMEYLEK 148
Query: 343 SASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQS 402
              I   HRD+ + N L+ +    KV+DFG+SR +  D        +    +  PE    
Sbjct: 149 KNFI---HRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 205
Query: 403 SQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQLLEILDARVA 461
           + F+ KSDV++FGV+L E+ T G  P     +                +Q+ ++L+    
Sbjct: 206 NTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL----------------SQVYDLLEKGYR 249
Query: 462 KEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGL 500
            E  E     + EL   C + +   RP+  +     E +
Sbjct: 250 MEQPEGCPPKVYELMRACWKWSPADRPSFAETHQAFETM 288

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 111/226 (49%), Gaps = 18/226 (7%)
Query: 204 KVFTADELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEV 263
           K +  DE +   +       LG G FG V+ G     + VAVK  K+        F+ E 
Sbjct: 9   KPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEA 67
Query: 264 VILSQINHRHIVKLLGCCLETEVPV-LVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLS 322
            ++ Q+ H+ +V+L      T+ P+ ++ EY+ +G+L   +                 L+
Sbjct: 68  NLMKQLQHQRLVRLYAVV--TQEPIYIITEYMENGSLVDFLKTPSGI----------KLT 115
Query: 323 WENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKT 382
               + +A ++A  +A++     I   HRD++++NIL+ D  S K++DFG++R I +++ 
Sbjct: 116 INKLLDMAAQIAEGMAFIEERNYI---HRDLRAANILVSDTLSCKIADFGLARLIEDNEX 172
Query: 383 HLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
                 +    +  PE      FT KSDV+SFG++L E++T G+ P
Sbjct: 173 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 218

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 111/226 (49%), Gaps = 18/226 (7%)
Query: 204 KVFTADELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEV 263
           K +  DE +   +       LG G FG V+ G     + VAVK  K+        F+ E 
Sbjct: 7   KPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEA 65
Query: 264 VILSQINHRHIVKLLGCCLETEVPV-LVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLS 322
            ++ Q+ H+ +V+L      T+ P+ ++ EY+ +G+L   +                 L+
Sbjct: 66  NLMKQLQHQRLVRLYAVV--TQEPIYIITEYMENGSLVDFLKTPSGI----------KLT 113
Query: 323 WENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKT 382
               + +A ++A  +A++     I   HRD++++NIL+ D  S K++DFG++R I +++ 
Sbjct: 114 INKLLDMAAQIAEGMAFIEERNYI---HRDLRAANILVSDTLSCKIADFGLARLIEDNEX 170
Query: 383 HLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
                 +    +  PE      FT KSDV+SFG++L E++T G+ P
Sbjct: 171 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 216

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 111/226 (49%), Gaps = 18/226 (7%)
Query: 204 KVFTADELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEV 263
           K +  DE +   +       LG G FG V+ G     + VAVK  K+        F+ E 
Sbjct: 1   KPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEA 59
Query: 264 VILSQINHRHIVKLLGCCLETEVPV-LVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLS 322
            ++ Q+ H+ +V+L      T+ P+ ++ EY+ +G+L   +                 L+
Sbjct: 60  NLMKQLQHQRLVRLYAVV--TQEPIYIITEYMENGSLVDFLKTPSGI----------KLT 107
Query: 323 WENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKT 382
               + +A ++A  +A++     I   HRD++++NIL+ D  S K++DFG++R I +++ 
Sbjct: 108 INKLLDMAAQIAEGMAFIEERNYI---HRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164
Query: 383 HLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
                 +    +  PE      FT KSDV+SFG++L E++T G+ P
Sbjct: 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 210

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 82/324 (25%), Positives = 144/324 (44%), Gaps = 42/324 (12%)
Query: 204 KVFTADELQRATDNYNQSRFLGQGGFGTVYKGML------PDGSIVAVKRSKE-IDKTQI 256
           K+    + +    N    + LG+G FG V K            + VAVK  KE    +++
Sbjct: 11  KILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSEL 70
Query: 257 HQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXX 316
              ++E  +L Q+NH H++KL G C +    +L+ EY   G+L   + +           
Sbjct: 71  RDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGS 130
Query: 317 XLS------------SLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF 364
             S            +L+  + +  A +++  + Y+   A + + HRD+ + NIL+ +  
Sbjct: 131 GGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMSLVHRDLAARNILVAEGR 187
Query: 365 SAKVSDFGISRSIPNDKTHLTTTIQGTF--GYLDPEYFQSSQFTDKSDVYSFGVVLLELL 422
             K+SDFG+SR +  + + +  + QG     ++  E      +T +SDV+SFGV+L E++
Sbjct: 188 KMKISDFGLSRDVYEEDSXVKRS-QGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV 246
Query: 423 T-GKKPICFARVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLR 481
           T G  P  +  +  ER       +L K    +E  D        EE    M  L ++C +
Sbjct: 247 TLGGNP--YPGIPPER-----LFNLLKTGHRMERPD-----NCSEE----MYRLMLQCWK 290
Query: 482 LNSKKRPTMKQVSMELEGLRRSQR 505
               KRP    +S +LE +   +R
Sbjct: 291 QEPDKRPVFADISKDLEKMMVKRR 314

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 76/313 (24%), Positives = 142/313 (45%), Gaps = 40/313 (12%)
Query: 207 TADELQRATDNYNQS--RFLGQGGFGTVYKGMLPDGS----IVAVKRSK-EIDKTQIHQF 259
           T  E  +  D  N S  + +G G FG V  G L   S     VA+K  K    + Q   F
Sbjct: 34  TVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF 93
Query: 260 INEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLS 319
           + E  I+ Q +H +I++L G   +++  ++V EY+ +G+L   +  H             
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV------- 146
Query: 320 SLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPN 379
                  +++   + G  + M   + +   HRD+ + NIL++     KVSDFG++R + +
Sbjct: 147 -------IQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLARVLED 199
Query: 380 DKTHLTTTIQGTFG--YLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEE 436
           D     TT  G     +  PE     +FT  SDV+S+G+VL E+++ G++P         
Sbjct: 200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP--------- 250
Query: 437 RNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSME 496
                 +  ++ ++ +++ +D         +   A+ +L + C + +   RP  +Q+   
Sbjct: 251 ------YWEMSNQD-VIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSI 303
Query: 497 LEGLRRSQRCLEM 509
           L+ L R+   L++
Sbjct: 304 LDKLIRNPGSLKI 316

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 111/226 (49%), Gaps = 18/226 (7%)
Query: 204 KVFTADELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEV 263
           K +  DE +   +       LG G FG V+ G     + VAVK  K+        F+ E 
Sbjct: 6   KPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEA 64
Query: 264 VILSQINHRHIVKLLGCCLETEVPV-LVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLS 322
            ++ Q+ H+ +V+L      T+ P+ ++ EY+ +G+L   +                 L+
Sbjct: 65  NLMKQLQHQRLVRLYAVV--TQEPIYIITEYMENGSLVDFLKTPSGI----------KLT 112
Query: 323 WENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKT 382
               + +A ++A  +A++     I   HRD++++NIL+ D  S K++DFG++R I +++ 
Sbjct: 113 INKLLDMAAQIAEGMAFIEERNYI---HRDLRAANILVSDTLSCKIADFGLARLIEDNEY 169
Query: 383 HLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
                 +    +  PE      FT KSDV+SFG++L E++T G+ P
Sbjct: 170 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 215

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 111/226 (49%), Gaps = 18/226 (7%)
Query: 204 KVFTADELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEV 263
           K +  DE +   +       LG G FG V+ G     + VAVK  K+        F+ E 
Sbjct: 7   KPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEA 65
Query: 264 VILSQINHRHIVKLLGCCLETEVPV-LVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLS 322
            ++ Q+ H+ +V+L      T+ P+ ++ EY+ +G+L   +                 L+
Sbjct: 66  NLMKQLQHQRLVRLYAVV--TQEPIYIITEYMENGSLVDFLKTPSGI----------KLT 113
Query: 323 WENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKT 382
               + +A ++A  +A++     I   HRD++++NIL+ D  S K++DFG++R I +++ 
Sbjct: 114 INKLLDMAAQIAEGMAFIEERNYI---HRDLRAANILVSDTLSCKIADFGLARLIEDNEY 170
Query: 383 HLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
                 +    +  PE      FT KSDV+SFG++L E++T G+ P
Sbjct: 171 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 216

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 82/324 (25%), Positives = 144/324 (44%), Gaps = 42/324 (12%)
Query: 204 KVFTADELQRATDNYNQSRFLGQGGFGTVYKGML------PDGSIVAVKRSKE-IDKTQI 256
           K+    + +    N    + LG+G FG V K            + VAVK  KE    +++
Sbjct: 11  KILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSEL 70
Query: 257 HQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXX 316
              ++E  +L Q+NH H++KL G C +    +L+ EY   G+L   + +           
Sbjct: 71  RDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGS 130
Query: 317 XLS------------SLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF 364
             S            +L+  + +  A +++  + Y+   A + + HRD+ + NIL+ +  
Sbjct: 131 GGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGR 187
Query: 365 SAKVSDFGISRSIPNDKTHLTTTIQGTF--GYLDPEYFQSSQFTDKSDVYSFGVVLLELL 422
             K+SDFG+SR +  + + +  + QG     ++  E      +T +SDV+SFGV+L E++
Sbjct: 188 KMKISDFGLSRDVYEEDSXVKRS-QGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV 246
Query: 423 T-GKKPICFARVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLR 481
           T G  P  +  +  ER       +L K    +E  D        EE    M  L ++C +
Sbjct: 247 TLGGNP--YPGIPPER-----LFNLLKTGHRMERPD-----NCSEE----MYRLMLQCWK 290
Query: 482 LNSKKRPTMKQVSMELEGLRRSQR 505
               KRP    +S +LE +   +R
Sbjct: 291 QEPDKRPVFADISKDLEKMMVKRR 314

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 73/292 (25%), Positives = 127/292 (43%), Gaps = 42/292 (14%)
Query: 224 LGQGGFGTVYKGMLPD-GSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCL 282
           LG+G FG   K    + G ++ +K     D+     F+ EV ++  + H +++K +G   
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 283 ETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYMHS 342
           + +    + EYI  GTL   I               S   W  RV  A ++A  +AY+HS
Sbjct: 78  KDKRLNFITEYIKGGTLRGIIKSMD-----------SQYPWSQRVSFAKDIASGMAYLHS 126
Query: 343 SASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTT-------------TIQ 389
              + I HRD+ S N L+ +  +  V+DFG++R + ++KT                 T+ 
Sbjct: 127 ---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVV 183
Query: 390 GTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKE 449
           G   ++ PE      + +K DV+SFG+VL E++         RV  + + +   +     
Sbjct: 184 GNPYWMAPEMINGRSYDEKVDVFSFGIVLCEII--------GRVNADPDYLPRTMDFGL- 234
Query: 450 NQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLR 501
             +   LD             +   + +RC  L+ +KRP+  ++   LE LR
Sbjct: 235 -NVRGFLDRYCPPNCPP----SFFPITVRCCDLDPEKRPSFVKLEHWLETLR 281

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 76/313 (24%), Positives = 141/313 (45%), Gaps = 40/313 (12%)
Query: 207 TADELQRATDNYNQS--RFLGQGGFGTVYKGMLPDGS----IVAVKRSK-EIDKTQIHQF 259
           T  E  +  D  N S  + +G G FG V  G L   S     VA+K  K    + Q   F
Sbjct: 34  TVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF 93
Query: 260 INEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLS 319
           + E  I+ Q +H +I++L G   +++  ++V EY+ +G+L   +  H             
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV------- 146
Query: 320 SLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPN 379
                  +++   + G  + M   + +   HRD+ + NIL++     KVSDFG+ R + +
Sbjct: 147 -------IQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLED 199
Query: 380 DKTHLTTTIQGTFG--YLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEE 436
           D     TT  G     +  PE     +FT  SDV+S+G+VL E+++ G++P         
Sbjct: 200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP--------- 250
Query: 437 RNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSME 496
                 +  ++ ++ +++ +D         +   A+ +L + C + +   RP  +Q+   
Sbjct: 251 ------YWEMSNQD-VIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSI 303
Query: 497 LEGLRRSQRCLEM 509
           L+ L R+   L++
Sbjct: 304 LDKLIRNPGSLKI 316

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 104/205 (50%), Gaps = 16/205 (7%)
Query: 224 LGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLE 283
           LG G FG V  G       VA+K  KE   ++  +FI E  ++  ++H  +V+L G C +
Sbjct: 16  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCTK 74
Query: 284 TEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYMHSS 343
                ++ EY+++G L +++ +                  +  + +  +V  A+ Y+ S 
Sbjct: 75  QRPIFIITEYMANGCLLNYLREMRHRFQT-----------QQLLEMCKDVCEAMEYLESK 123
Query: 344 ASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSS 403
                 HRD+ + N L++D+   KVSDFG+SR + +D+   +   +    +  PE    S
Sbjct: 124 Q---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYS 180
Query: 404 QFTDKSDVYSFGVVLLELLT-GKKP 427
           +F+ KSD+++FGV++ E+ + GK P
Sbjct: 181 KFSSKSDIWAFGVLMWEIYSLGKMP 205

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 107/207 (51%), Gaps = 20/207 (9%)
Query: 224 LGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLE 283
           LG G FG V  G       VA+K  KE   ++  +FI E  ++  ++H  +V+L G C +
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCTK 70
Query: 284 TEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYMHSS 343
                ++ EY+++G L +++ +                  +  + +  +V  A+ Y+ S 
Sbjct: 71  QRPIFIITEYMANGCLLNYLREMRHRFQT-----------QQLLEMCKDVCEAMEYLESK 119
Query: 344 ASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFG--YLDPEYFQ 401
                 HRD+ + N L++D+   KVSDFG+SR + +D+   T+++   F   +  PE   
Sbjct: 120 Q---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE--YTSSVGSKFPVRWSPPEVLM 174
Query: 402 SSQFTDKSDVYSFGVVLLELLT-GKKP 427
            S+F+ KSD+++FGV++ E+ + GK P
Sbjct: 175 YSKFSSKSDIWAFGVLMWEIYSLGKMP 201

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 107/207 (51%), Gaps = 20/207 (9%)
Query: 224 LGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLE 283
           LG G FG V  G       VA+K  KE   ++  +FI E  ++  ++H  +V+L G C +
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCTK 75
Query: 284 TEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYMHSS 343
                ++ EY+++G L +++ +                  +  + +  +V  A+ Y+ S 
Sbjct: 76  QRPIFIITEYMANGCLLNYLREMRHRFQT-----------QQLLEMCKDVCEAMEYLESK 124
Query: 344 ASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFG--YLDPEYFQ 401
                 HRD+ + N L++D+   KVSDFG+SR + +D+   T+++   F   +  PE   
Sbjct: 125 Q---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE--YTSSVGSKFPVRWSPPEVLM 179
Query: 402 SSQFTDKSDVYSFGVVLLELLT-GKKP 427
            S+F+ KSD+++FGV++ E+ + GK P
Sbjct: 180 YSKFSSKSDIWAFGVLMWEIYSLGKMP 206

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 104/205 (50%), Gaps = 16/205 (7%)
Query: 224 LGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLE 283
           LG G FG V  G       VA+K  KE   ++  +FI E  ++  ++H  +V+L G C +
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 284 TEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYMHSS 343
                ++ EY+++G L +++ +                  +  + +  +V  A+ Y+ S 
Sbjct: 91  QRPIFIITEYMANGCLLNYLREMRHRFQT-----------QQLLEMCKDVCEAMEYLESK 139
Query: 344 ASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSS 403
                 HRD+ + N L++D+   KVSDFG+SR + +D+   +   +    +  PE    S
Sbjct: 140 Q---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRWSPPEVLMYS 196
Query: 404 QFTDKSDVYSFGVVLLELLT-GKKP 427
           +F+ KSD+++FGV++ E+ + GK P
Sbjct: 197 KFSSKSDIWAFGVLMWEIYSLGKMP 221

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 111/226 (49%), Gaps = 18/226 (7%)
Query: 204 KVFTADELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEV 263
           K +  DE +   +       LG G FG V+ G     + VAVK  K+        F+ E 
Sbjct: 11  KPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEA 69
Query: 264 VILSQINHRHIVKLLGCCLETEVPV-LVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLS 322
            ++ Q+ H+ +V+L      T+ P+ ++ EY+ +G+L   +                 L+
Sbjct: 70  NLMKQLQHQRLVRLYAVV--TQEPIYIITEYMENGSLVDFLKTPSGI----------KLT 117
Query: 323 WENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKT 382
               + +A ++A  +A++     I   HRD++++NIL+ D  S K++DFG++R I +++ 
Sbjct: 118 INKLLDMAAQIAEGMAFIEERNYI---HRDLRAANILVSDTLSCKIADFGLARLIEDNEY 174
Query: 383 HLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
                 +    +  PE      FT KSDV+SFG++L E++T G+ P
Sbjct: 175 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 220

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 107/207 (51%), Gaps = 20/207 (9%)
Query: 224 LGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLE 283
           LG G FG V  G       VA+K  KE   ++  +FI E  ++  ++H  +V+L G C +
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 284 TEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYMHSS 343
                ++ EY+++G L +++ +                  +  + +  +V  A+ Y+ S 
Sbjct: 91  QRPIFIITEYMANGCLLNYLREMRHRFQT-----------QQLLEMCKDVCEAMEYLESK 139
Query: 344 ASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFG--YLDPEYFQ 401
                 HRD+ + N L++D+   KVSDFG+SR + +D+   T+++   F   +  PE   
Sbjct: 140 Q---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE--YTSSVGSKFPVRWSPPEVLM 194
Query: 402 SSQFTDKSDVYSFGVVLLELLT-GKKP 427
            S+F+ KSD+++FGV++ E+ + GK P
Sbjct: 195 YSKFSSKSDIWAFGVLMWEIYSLGKMP 221

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 98/223 (43%), Gaps = 26/223 (11%)
Query: 212 QRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQI------HQFINEVVI 265
           Q   ++++  R LG+G FG VY         +     K + KTQ+      HQ   EV I
Sbjct: 8   QWTLEDFDIGRPLGKGKFGNVYLARERQSKFILA--LKVLFKTQLEKAGVEHQLRREVEI 65
Query: 266 LSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWEN 325
            S + H +I++L G   +     L+ EY   GT+   +              LS    + 
Sbjct: 66  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK------------LSRFDEQR 113
Query: 326 RVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLT 385
                 E+A A++Y HS   I   HRDIK  N+LL      K++DFG S   P+ +    
Sbjct: 114 TATYITELANALSYCHSKRVI---HRDIKPENLLLGSNGELKIADFGWSVHAPSSRR--- 167
Query: 386 TTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
            T+ GT  YL PE  +     +K D++S GV+  E L G  P 
Sbjct: 168 DTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPF 210

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 107/207 (51%), Gaps = 20/207 (9%)
Query: 224 LGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLE 283
           LG G FG V  G       VA+K  KE   ++  +FI E  ++  ++H  +V+L G C +
Sbjct: 23  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCTK 81
Query: 284 TEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYMHSS 343
                ++ EY+++G L +++ +                  +  + +  +V  A+ Y+ S 
Sbjct: 82  QRPIFIITEYMANGCLLNYLREMRHRFQT-----------QQLLEMCKDVCEAMEYLESK 130
Query: 344 ASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFG--YLDPEYFQ 401
                 HRD+ + N L++D+   KVSDFG+SR + +D+   T+++   F   +  PE   
Sbjct: 131 Q---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE--YTSSVGSKFPVRWSPPEVLM 185
Query: 402 SSQFTDKSDVYSFGVVLLELLT-GKKP 427
            S+F+ KSD+++FGV++ E+ + GK P
Sbjct: 186 YSKFSSKSDIWAFGVLMWEIYSLGKMP 212

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 100/205 (48%), Gaps = 16/205 (7%)
Query: 224 LGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLE 283
           LGQG FG V+ G     + VA+K  K         F+ E  ++ ++ H  +V+L     E
Sbjct: 16  LGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 74
Query: 284 TEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYMHSS 343
             +  +V EY+S G+L   +                 L     V +A ++A  +AY+   
Sbjct: 75  EPI-XIVTEYMSKGSLLDFLKGETG----------KYLRLPQLVDMAAQIASGMAYVERM 123
Query: 344 ASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSS 403
             +   HRD++++NIL+ +    KV+DFG++R I +++       +    +  PE     
Sbjct: 124 NYV---HRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYG 180
Query: 404 QFTDKSDVYSFGVVLLELLT-GKKP 427
           +FT KSDV+SFG++L EL T G+ P
Sbjct: 181 RFTIKSDVWSFGILLTELTTKGRVP 205

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 100/205 (48%), Gaps = 16/205 (7%)
Query: 224 LGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLE 283
           LGQG FG V+ G     + VA+K  K         F+ E  ++ +I H  +V+L     E
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKIRHEKLVQLYAVVSE 84
Query: 284 TEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYMHSS 343
             +  +V EY+S G+L   +                 L     V +A ++A  +AY+   
Sbjct: 85  EPI-YIVTEYMSKGSLLDFLKGEMG----------KYLRLPQLVDMAAQIASGMAYVERM 133
Query: 344 ASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSS 403
             +   HRD++++NIL+ +    KV+DFG++R I +++       +    +  PE     
Sbjct: 134 NYV---HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 190
Query: 404 QFTDKSDVYSFGVVLLELLT-GKKP 427
           +FT KSDV+SFG++L EL T G+ P
Sbjct: 191 RFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 113/230 (49%), Gaps = 15/230 (6%)
Query: 203 AKVFTADELQRATDNYNQSRFLGQGGFGTVYKGMLPD------GSIVAVKRSKEIDKTQI 256
           + V+  DE + + +     R LGQG FG VY+G   D       + VAVK   E    + 
Sbjct: 4   SSVYVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRE 63
Query: 257 H-QFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXX 315
             +F+NE  ++      H+V+LLG   + +  ++V E ++ G L  ++            
Sbjct: 64  RIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPG 123
Query: 316 XXLSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISR 375
               +L  +  +++A E+A  +AY+++   +   HR++ + N ++   F+ K+ DFG++R
Sbjct: 124 RPPPTL--QEMIQMAAEIADGMAYLNAKKFV---HRNLAARNCMVAHDFTVKIGDFGMTR 178
Query: 376 SIPNDKTHLTTTIQGTFG--YLDPEYFQSSQFTDKSDVYSFGVVLLELLT 423
            I  +  +     +G     ++ PE  +   FT  SD++SFGVVL E+ +
Sbjct: 179 DI-YETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 113/230 (49%), Gaps = 15/230 (6%)
Query: 203 AKVFTADELQRATDNYNQSRFLGQGGFGTVYKGMLPD------GSIVAVKRSKEIDKTQI 256
           + V+  DE + + +     R LGQG FG VY+G   D       + VAVK   E    + 
Sbjct: 5   SSVYVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRE 64
Query: 257 H-QFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXX 315
             +F+NE  ++      H+V+LLG   + +  ++V E ++ G L  ++            
Sbjct: 65  RIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPG 124
Query: 316 XXLSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISR 375
               +L  +  +++A E+A  +AY+++   +   HR++ + N ++   F+ K+ DFG++R
Sbjct: 125 RPPPTL--QEMIQMAAEIADGMAYLNAKKFV---HRNLAARNCMVAHDFTVKIGDFGMTR 179
Query: 376 SIPNDKTHLTTTIQGTFG--YLDPEYFQSSQFTDKSDVYSFGVVLLELLT 423
            I  +  +     +G     ++ PE  +   FT  SD++SFGVVL E+ +
Sbjct: 180 DI-YETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 228

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 104/205 (50%), Gaps = 16/205 (7%)
Query: 224 LGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLE 283
           LG G FG V  G       VA+K  KE   ++  +FI E  ++  ++H  +V+L G C +
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCTK 75
Query: 284 TEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYMHSS 343
                ++ EY+++G L +++ +                  +  + +  +V  A+ Y+ S 
Sbjct: 76  QRPIFIITEYMANGCLLNYLREMRHRFQT-----------QQLLEMCKDVCEAMEYLESK 124
Query: 344 ASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSS 403
                 HRD+ + N L++D+   KVSDFG+SR + +D+   +   +    +  PE    S
Sbjct: 125 Q---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRWSPPEVLMYS 181
Query: 404 QFTDKSDVYSFGVVLLELLT-GKKP 427
           +F+ KSD+++FGV++ E+ + GK P
Sbjct: 182 KFSSKSDIWAFGVLMWEIYSLGKMP 206

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 100/205 (48%), Gaps = 16/205 (7%)
Query: 224 LGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLE 283
           LGQG FG V+ G     + VA+K  K         F+ E  ++ ++ H  +V+L     E
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 284 TEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYMHSS 343
             +  +V EY+S G+L   +                 L     V +A ++A  +AY+   
Sbjct: 85  EPI-YIVIEYMSKGSLLDFLKGEMG----------KYLRLPQLVDMAAQIASGMAYVERM 133
Query: 344 ASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSS 403
             +   HRD++++NIL+ +    KV+DFG++R I +++       +    +  PE     
Sbjct: 134 NYV---HRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYG 190
Query: 404 QFTDKSDVYSFGVVLLELLT-GKKP 427
           +FT KSDV+SFG++L EL T G+ P
Sbjct: 191 RFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 100/205 (48%), Gaps = 16/205 (7%)
Query: 224 LGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLE 283
           LGQG FG V+ G     + VA+K  K         F+ E  ++ ++ H  +V+L     E
Sbjct: 19  LGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 77
Query: 284 TEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYMHSS 343
             +  +V EY+S G+L   +                 L     V +A ++A  +AY+   
Sbjct: 78  EPI-YIVTEYMSKGSLLDFLKGETG----------KYLRLPQLVDMAAQIASGMAYVERM 126
Query: 344 ASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSS 403
             +   HRD++++NIL+ +    KV+DFG++R I +++       +    +  PE     
Sbjct: 127 NYV---HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 183
Query: 404 QFTDKSDVYSFGVVLLELLT-GKKP 427
           +FT KSDV+SFG++L EL T G+ P
Sbjct: 184 RFTIKSDVWSFGILLTELTTKGRVP 208

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 109/221 (49%), Gaps = 18/221 (8%)
Query: 209 DELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQ 268
           DE +   +       LG G FG V+ G     + VAVK  K+        F+ E  ++ Q
Sbjct: 1   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQ 59
Query: 269 INHRHIVKLLGCCLETEVPV-LVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
           + H+ +V+L      T+ P+ ++ EY+ +G+L   +                 L+    +
Sbjct: 60  LQHQRLVRLYAVV--TQEPIYIITEYMENGSLVDFLKTPSGI----------KLTINKLL 107
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
            +A ++A  +A++     I   HRD++++NIL+ D  S K++DFG++R I +++      
Sbjct: 108 DMAAQIAEGMAFIEERNYI---HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG 164
Query: 388 IQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
            +    +  PE      FT KSDV+SFG++L E++T G+ P
Sbjct: 165 AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 205

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 100/205 (48%), Gaps = 16/205 (7%)
Query: 224 LGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLE 283
           LGQG FG V+ G     + VA+K  K         F+ E  ++ ++ H  +V+L     E
Sbjct: 17  LGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 75
Query: 284 TEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYMHSS 343
             +  +V EY+S G+L   +                 L     V +A ++A  +AY+   
Sbjct: 76  EPI-YIVTEYMSKGSLLDFLKGEMG----------KYLRLPQLVDMAAQIASGMAYVERM 124
Query: 344 ASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSS 403
             +   HRD++++NIL+ +    KV+DFG++R I +++       +    +  PE     
Sbjct: 125 NYV---HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 181
Query: 404 QFTDKSDVYSFGVVLLELLT-GKKP 427
           +FT KSDV+SFG++L EL T G+ P
Sbjct: 182 RFTIKSDVWSFGILLTELTTKGRVP 206

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 80/306 (26%), Positives = 133/306 (43%), Gaps = 29/306 (9%)
Query: 206 FTADELQRATDNYNQSRFLGQGGFGTVYKG------MLPDGSIVAVKRSKEIDKTQIHQ- 258
           + A + +   D  N  + LG+G FG V +              VAVK  KE      H+ 
Sbjct: 17  YDASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRA 76
Query: 259 FINEVVILSQINHR-HIVKLLGCCLETEVPVLV-YEYISSGTLSHHIHDHXXXXXXXXXX 316
            ++E+ IL  I H  ++V LLG C +   P++V  E+   G LS ++             
Sbjct: 77  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDL 136
Query: 317 XLSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS 376
               L+ E+ +  + +VA  + ++ S   I   HRD+ + NILL +K   K+ DFG++R 
Sbjct: 137 YKDFLTLEHLIXYSFQVAKGMEFLASRKXI---HRDLAARNILLSEKNVVKIXDFGLARD 193
Query: 377 IPNDKTHLTT-TIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVE 434
           I  D  ++     +    ++ PE      +T +SDV+SFGV+L E+ + G  P    +++
Sbjct: 194 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 253
Query: 435 EERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVS 494
           EE      F    KE   +   D    +         M +  + C      +RPT  ++ 
Sbjct: 254 EE------FXRRLKEGTRMRAPDYTTPE---------MYQTMLDCWHGEPSQRPTFSELV 298
Query: 495 MELEGL 500
             L  L
Sbjct: 299 EHLGNL 304

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 100/205 (48%), Gaps = 16/205 (7%)
Query: 224 LGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLE 283
           LGQG FG V+ G     + VA+K  K         F+ E  ++ ++ H  +V+L     E
Sbjct: 15  LGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 73
Query: 284 TEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYMHSS 343
             +  +V EY+S G+L   +                 L     V +A ++A  +AY+   
Sbjct: 74  EPI-YIVTEYMSKGSLLDFLKGEMG----------KYLRLPQLVDMAAQIASGMAYVERM 122
Query: 344 ASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSS 403
             +   HRD++++NIL+ +    KV+DFG++R I +++       +    +  PE     
Sbjct: 123 NYV---HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 179
Query: 404 QFTDKSDVYSFGVVLLELLT-GKKP 427
           +FT KSDV+SFG++L EL T G+ P
Sbjct: 180 RFTIKSDVWSFGILLTELTTKGRVP 204

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 83/314 (26%), Positives = 142/314 (45%), Gaps = 46/314 (14%)
Query: 208 ADELQRATDN-------YNQSRFLGQGGFGTVYKGMLP--DGSIV--AVKRSKE--IDKT 254
           +DEL+   ++       +   R LG+G FG+V +  L   DGS V  AVK  K   I  +
Sbjct: 8   SDELKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASS 67
Query: 255 QIHQFINEVVILSQINHRHIVKLLGCCLETE------VPVLVYEYISSGTLSHHIHDHXX 308
            I +F+ E   + + +H H+ KL+G  L +       +P+++  ++  G L      H  
Sbjct: 68  DIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDL------HAF 121
Query: 309 XXXXXXXXXLSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKV 368
                      +L  +  VR   ++A  + Y+ S   I   HRD+ + N +L +  +  V
Sbjct: 122 LLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFI---HRDLAARNCMLAEDMTVCV 178
Query: 369 SDFGISRSI-PNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKK 426
           +DFG+SR I   D        +    +L  E    + +T  SDV++FGV + E++T G+ 
Sbjct: 179 ADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQT 238
Query: 427 PICFARVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKK 486
           P  +A +E        +  L   N+L      +   E  EE    + +L  +C   + K+
Sbjct: 239 P--YAGIEN----AEIYNYLIGGNRL------KQPPECMEE----VYDLMYQCWSADPKQ 282
Query: 487 RPTMKQVSMELEGL 500
           RP+   + MELE +
Sbjct: 283 RPSFTCLRMELENI 296

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 100/205 (48%), Gaps = 16/205 (7%)
Query: 224 LGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLE 283
           LGQG FG V+ G     + VA+K  K         F+ E  ++ ++ H  +V+L     E
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 284 TEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYMHSS 343
             +  +V EY+S G+L   +                 L     V +A ++A  +AY+   
Sbjct: 85  EPI-YIVIEYMSKGSLLDFLKGEMG----------KYLRLPQLVDMAAQIASGMAYVERM 133
Query: 344 ASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSS 403
             +   HRD++++NIL+ +    KV+DFG++R I +++       +    +  PE     
Sbjct: 134 NYV---HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 190
Query: 404 QFTDKSDVYSFGVVLLELLT-GKKP 427
           +FT KSDV+SFG++L EL T G+ P
Sbjct: 191 RFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 106/212 (50%), Gaps = 20/212 (9%)
Query: 218 YNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVK 276
           Y +   +GQG  GTVY  M +  G  VA+++     + +    INE++++ +  + +IV 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 277 LLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVAC-EVAG 335
            L   L  +   +V EY++ G+L+  + +                  E ++   C E   
Sbjct: 82  YLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD--------------EGQIAAVCRECLQ 127
Query: 336 AVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYL 395
           A+ ++HS+    + HRDIKS NILL    S K++DFG    I  +++  +T + GT  ++
Sbjct: 128 ALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWM 183
Query: 396 DPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
            PE      +  K D++S G++ +E++ G+ P
Sbjct: 184 APEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 100/205 (48%), Gaps = 16/205 (7%)
Query: 224 LGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLE 283
           LGQG FG V+ G     + VA+K  K         F+ E  ++ ++ H  +V+L     E
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 284 TEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYMHSS 343
             +  +V EY+S G+L   +                 L     V +A ++A  +AY+   
Sbjct: 85  EPI-YIVTEYMSKGSLLDFLKGEMG----------KYLRLPQLVDMAAQIASGMAYVERM 133
Query: 344 ASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSS 403
             +   HRD++++NIL+ +    KV+DFG++R I +++       +    +  PE     
Sbjct: 134 NYV---HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 190
Query: 404 QFTDKSDVYSFGVVLLELLT-GKKP 427
           +FT KSDV+SFG++L EL T G+ P
Sbjct: 191 RFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 73/269 (27%), Positives = 129/269 (47%), Gaps = 35/269 (13%)
Query: 216 DNYNQSRFLGQGGFGTVYK----GMLP--DGSIVAVKRSKEIDKTQIH-QFINEVVILSQ 268
           +N    R +G+G FG V++    G+LP    ++VAVK  KE     +   F  E  ++++
Sbjct: 47  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106
Query: 269 INHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHI------------HDHXXXXXXXXXX 316
            ++ +IVKLLG C   +   L++EY++ G L+  +            H            
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 317 XLSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS 376
               LS   ++ +A +VA  +AY+     +   HRD+ + N L+ +    K++DFG+SR+
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYLSERKFV---HRDLATRNCLVGENMVVKIADFGLSRN 223
Query: 377 IPN-DKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVE 434
           I + D             ++ PE    +++T +SDV+++GVVL E+ + G +P      E
Sbjct: 224 IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE 283
Query: 435 E------ERNLVACFISLAKENQLLEILD 457
           E      + N++AC      EN  LE+ +
Sbjct: 284 EVIYYVRDGNILAC-----PENCPLELYN 307

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 100/205 (48%), Gaps = 16/205 (7%)
Query: 224 LGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLE 283
           LGQG FG V+ G     + VA+K  K         F+ E  ++ ++ H  +V+L     E
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 284 TEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYMHSS 343
             +  +V EY+S G+L   +                 L     V +A ++A  +AY+   
Sbjct: 85  EPI-YIVCEYMSKGSLLDFLKGEMG----------KYLRLPQLVDMAAQIASGMAYVERM 133
Query: 344 ASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSS 403
             +   HRD++++NIL+ +    KV+DFG++R I +++       +    +  PE     
Sbjct: 134 NYV---HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 190
Query: 404 QFTDKSDVYSFGVVLLELLT-GKKP 427
           +FT KSDV+SFG++L EL T G+ P
Sbjct: 191 RFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 99/205 (48%), Gaps = 16/205 (7%)
Query: 224 LGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLE 283
           LGQG FG V+ G     + VA+K  K         F+ E  ++ ++ H  +V+L     E
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 284 TEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYMHSS 343
             +  +V EY+S G L   +                 L     V +A ++A  +AY+   
Sbjct: 85  EPI-YIVMEYMSKGCLLDFLKGEMG----------KYLRLPQLVDMAAQIASGMAYVERM 133
Query: 344 ASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSS 403
             +   HRD++++NIL+ +    KV+DFG++R I +++       +    +  PE     
Sbjct: 134 NYV---HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 190
Query: 404 QFTDKSDVYSFGVVLLELLT-GKKP 427
           +FT KSDV+SFG++L EL T G+ P
Sbjct: 191 RFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 76/313 (24%), Positives = 141/313 (45%), Gaps = 40/313 (12%)
Query: 207 TADELQRATDNYNQS--RFLGQGGFGTVYKGMLPDGS----IVAVKRSK-EIDKTQIHQF 259
           T  E  +  D  N S  + +G G FG V  G L   S     VA+K  K    + Q   F
Sbjct: 34  TVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF 93
Query: 260 INEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLS 319
           + E  I+ Q +H +I++L G   +++  ++V E + +G+L   +  H             
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTV------- 146
Query: 320 SLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPN 379
                  +++   + G  + M   + +   HRD+ + NIL++     KVSDFG+SR + +
Sbjct: 147 -------IQLVGMLRGIASGMKYLSDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLED 199
Query: 380 DKTHLTTTIQGTFG--YLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEE 436
           D     TT  G     +  PE     +FT  SDV+S+G+VL E+++ G++P         
Sbjct: 200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP--------- 250
Query: 437 RNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSME 496
                 +  ++ ++ +++ +D         +   A+ +L + C + +   RP  +Q+   
Sbjct: 251 ------YWEMSNQD-VIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSI 303
Query: 497 LEGLRRSQRCLEM 509
           L+ L R+   L++
Sbjct: 304 LDKLIRNPGSLKI 316

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 76/313 (24%), Positives = 141/313 (45%), Gaps = 40/313 (12%)
Query: 207 TADELQRATDNYNQS--RFLGQGGFGTVYKGMLPDGS----IVAVKRSK-EIDKTQIHQF 259
           T  E  +  D  N S  + +G G FG V  G L   S     VA+K  K    + Q   F
Sbjct: 5   TVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF 64
Query: 260 INEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLS 319
           + E  I+ Q +H +I++L G   +++  ++V E + +G+L   +  H             
Sbjct: 65  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTV------- 117
Query: 320 SLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPN 379
                  +++   + G  + M   + +   HRD+ + NIL++     KVSDFG+SR + +
Sbjct: 118 -------IQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED 170
Query: 380 DKTHLTTTIQGTFG--YLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEE 436
           D     TT  G     +  PE     +FT  SDV+S+G+VL E+++ G++P         
Sbjct: 171 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP--------- 221
Query: 437 RNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSME 496
                 +  ++ ++ +++ +D         +   A+ +L + C + +   RP  +Q+   
Sbjct: 222 ------YWEMSNQD-VIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSI 274
Query: 497 LEGLRRSQRCLEM 509
           L+ L R+   L++
Sbjct: 275 LDKLIRNPGSLKI 287

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 76/313 (24%), Positives = 141/313 (45%), Gaps = 40/313 (12%)
Query: 207 TADELQRATDNYNQS--RFLGQGGFGTVYKGMLPDGS----IVAVKRSK-EIDKTQIHQF 259
           T  E  +  D  N S  + +G G FG V  G L   S     VA+K  K    + Q   F
Sbjct: 34  TVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF 93
Query: 260 INEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLS 319
           + E  I+ Q +H +I++L G   +++  ++V E + +G+L   +  H             
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTV------- 146
Query: 320 SLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPN 379
                  +++   + G  + M   + +   HRD+ + NIL++     KVSDFG+SR + +
Sbjct: 147 -------IQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED 199
Query: 380 DKTHLTTTIQGTFG--YLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEE 436
           D     TT  G     +  PE     +FT  SDV+S+G+VL E+++ G++P         
Sbjct: 200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP--------- 250
Query: 437 RNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSME 496
                 +  ++ ++ +++ +D         +   A+ +L + C + +   RP  +Q+   
Sbjct: 251 ------YWEMSNQD-VIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSI 303
Query: 497 LEGLRRSQRCLEM 509
           L+ L R+   L++
Sbjct: 304 LDKLIRNPGSLKI 316

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/282 (25%), Positives = 130/282 (46%), Gaps = 32/282 (11%)
Query: 222 RFLGQGGFGTVYKGMLPD------GSIVAVKRSKEIDKTQIH-QFINEVVILSQINHRHI 274
           R LGQG FG VY+G   D       + VAVK   E    +   +F+NE  ++      H+
Sbjct: 22  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 81
Query: 275 VKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVA 334
           V+LLG   + +  ++V E ++ G L  ++                +L  +  +++A E+A
Sbjct: 82  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL--QEMIQMAAEIA 139
Query: 335 GAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFG- 393
             +AY+++   +   HRD+ + N ++   F+ K+ DFG++R I  +  +     +G    
Sbjct: 140 DGMAYLNAKKFV---HRDLAARNCMVAHDFTVKIGDFGMTRDI-YETDYYRKGGKGLLPV 195
Query: 394 -YLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQ 451
            ++ PE  +   FT  SD++SFGVVL E+ +  ++P               +  L+ E  
Sbjct: 196 RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP---------------YQGLSNEQV 240
Query: 452 LLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQV 493
           L  ++D     +  +     + +L   C + N K RPT  ++
Sbjct: 241 LKFVMDGGYLDQP-DNCPERVTDLMRMCWQFNPKMRPTFLEI 281

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 109/224 (48%), Gaps = 23/224 (10%)
Query: 210 ELQRATDNYNQSRFLGQGGFGTVYKG--MLPDGSI--VAVKRSKEIDKTQIHQ-FINEVV 264
           E+QR  +     R +G+G FG V++G  M P+     VA+K  K      + + F+ E +
Sbjct: 3   EIQR--ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 60
Query: 265 ILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWE 324
            + Q +H HIVKL+G   E  V +++ E  + G L   +                SL   
Sbjct: 61  TMRQFDHPHIVKLIGVITENPVWIIM-ELCTLGELRSFLQVRKY-----------SLDLA 108
Query: 325 NRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHL 384
           + +  A +++ A+AY+ S   +   HRDI + N+L+      K+ DFG+SR + +   + 
Sbjct: 109 SLILYAYQLSTALAYLESKRFV---HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK 165
Query: 385 TTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
            +  +    ++ PE     +FT  SDV+ FGV + E+L  G KP
Sbjct: 166 ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 209

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 79/305 (25%), Positives = 143/305 (46%), Gaps = 45/305 (14%)
Query: 205 VFTADELQRATDNYNQSRF-----LGQGGFGTVYKGMLPD--GSIVAVKRSKEIDKTQIH 257
           V   DE  R+    N         +G+G FG V   ML D  G+ VAVK  K     Q  
Sbjct: 177 VAAQDEFYRSGWALNMKELKLLQTIGKGEFGDV---MLGDYRGNKVAVKCIKNDATAQ-- 231
Query: 258 QFINEVVILSQINHRHIVKLLGCCLETEVPV-LVYEYISSGTLSHHIHDHXXXXXXXXXX 316
            F+ E  +++Q+ H ++V+LLG  +E +  + +V EY++ G+L  ++             
Sbjct: 232 AFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-------- 283
Query: 317 XLSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS 376
             S L  +  ++ + +V  A+ Y+  +  +   HRD+ + N+L+ +   AKVSDFG+++ 
Sbjct: 284 --SVLGGDCLLKFSLDVCEAMEYLEGNNFV---HRDLAARNVLVSEDNVAKVSDFGLTKE 338
Query: 377 IPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEE 436
             + +      ++ T     PE  +  +F+ KSDV+SFG++L E+ +      F RV   
Sbjct: 339 ASSTQDTGKLPVKWT----APEALREKKFSTKSDVWSFGILLWEIYS------FGRVPYP 388
Query: 437 RNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSME 496
           R  +   +   ++   ++  D             A+ ++   C  L++  RPT  Q+  +
Sbjct: 389 RIPLKDVVPRVEKGYKMDAPDGCPP---------AVYDVMKNCWHLDAATRPTFLQLREQ 439
Query: 497 LEGLR 501
           LE +R
Sbjct: 440 LEHIR 444

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 109/224 (48%), Gaps = 23/224 (10%)
Query: 210 ELQRATDNYNQSRFLGQGGFGTVYKG--MLPDGSI--VAVKRSKEIDKTQIHQ-FINEVV 264
           E+QR  +     R +G+G FG V++G  M P+     VA+K  K      + + F+ E +
Sbjct: 8   EIQR--ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 65
Query: 265 ILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWE 324
            + Q +H HIVKL+G   E  V +++ E  + G L   +                SL   
Sbjct: 66  TMRQFDHPHIVKLIGVITENPVWIIM-ELCTLGELRSFLQVRKY-----------SLDLA 113
Query: 325 NRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHL 384
           + +  A +++ A+AY+ S   +   HRDI + N+L+      K+ DFG+SR + +   + 
Sbjct: 114 SLILYAYQLSTALAYLESKRFV---HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK 170
Query: 385 TTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
            +  +    ++ PE     +FT  SDV+ FGV + E+L  G KP
Sbjct: 171 ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 214

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 80/306 (26%), Positives = 133/306 (43%), Gaps = 29/306 (9%)
Query: 206 FTADELQRATDNYNQSRFLGQGGFGTVYKG------MLPDGSIVAVKRSKEIDKTQIHQ- 258
           + A + +   D  N  + LG+G FG V +              VAVK  KE      H+ 
Sbjct: 17  YDASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRA 76
Query: 259 FINEVVILSQINHR-HIVKLLGCCLETEVPVLV-YEYISSGTLSHHIHDHXXXXXXXXXX 316
            ++E+ IL  I H  ++V LLG C +   P++V  E+   G LS ++             
Sbjct: 77  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDL 136
Query: 317 XLSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS 376
               L+ E+ +  + +VA  + ++ S   I   HRD+ + NILL +K   K+ DFG++R 
Sbjct: 137 YKDFLTLEHLICYSFQVAKGMEFLASRKXI---HRDLAARNILLSEKNVVKICDFGLARD 193
Query: 377 IPNDKTHLTT-TIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVE 434
           I  D  ++     +    ++ PE      +T +SDV+SFGV+L E+ + G  P    +++
Sbjct: 194 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 253
Query: 435 EERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVS 494
           EE      F    KE   +   D    +         M +  + C      +RPT  ++ 
Sbjct: 254 EE------FCRRLKEGTRMRAPDYTTPE---------MYQTMLDCWHGEPSQRPTFSELV 298
Query: 495 MELEGL 500
             L  L
Sbjct: 299 EHLGNL 304

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 109/224 (48%), Gaps = 23/224 (10%)
Query: 210 ELQRATDNYNQSRFLGQGGFGTVYKG--MLPDGSI--VAVKRSKEIDKTQIHQ-FINEVV 264
           E+QR  +     R +G+G FG V++G  M P+     VA+K  K      + + F+ E +
Sbjct: 11  EIQR--ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 68
Query: 265 ILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWE 324
            + Q +H HIVKL+G   E  V +++ E  + G L   +                SL   
Sbjct: 69  TMRQFDHPHIVKLIGVITENPVWIIM-ELCTLGELRSFLQVRKY-----------SLDLA 116
Query: 325 NRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHL 384
           + +  A +++ A+AY+ S   +   HRDI + N+L+      K+ DFG+SR + +   + 
Sbjct: 117 SLILYAYQLSTALAYLESKRFV---HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK 173
Query: 385 TTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
            +  +    ++ PE     +FT  SDV+ FGV + E+L  G KP
Sbjct: 174 ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 217

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 109/224 (48%), Gaps = 23/224 (10%)
Query: 210 ELQRATDNYNQSRFLGQGGFGTVYKG--MLPDGSI--VAVKRSKEIDKTQIHQ-FINEVV 264
           E+QR  +     R +G+G FG V++G  M P+     VA+K  K      + + F+ E +
Sbjct: 6   EIQR--ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEAL 63
Query: 265 ILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWE 324
            + Q +H HIVKL+G   E  V +++ E  + G L   +                SL   
Sbjct: 64  TMRQFDHPHIVKLIGVITENPVWIIM-ELCTLGELRSFLQVRKY-----------SLDLA 111
Query: 325 NRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHL 384
           + +  A +++ A+AY+ S   +   HRDI + N+L+      K+ DFG+SR + +   + 
Sbjct: 112 SLILYAYQLSTALAYLESKRFV---HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK 168
Query: 385 TTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
            +  +    ++ PE     +FT  SDV+ FGV + E+L  G KP
Sbjct: 169 ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 212

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 99/205 (48%), Gaps = 16/205 (7%)
Query: 224 LGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLE 283
           LGQG FG V+ G     + VA+K  K         F+ E  ++ ++ H  +V+L     E
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 284 TEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYMHSS 343
             +  +V EY+S G L   +                 L     V +A ++A  +AY+   
Sbjct: 85  EPI-YIVTEYMSKGCLLDFLKGEMG----------KYLRLPQLVDMAAQIASGMAYVERM 133
Query: 344 ASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSS 403
             +   HRD++++NIL+ +    KV+DFG++R I +++       +    +  PE     
Sbjct: 134 NYV---HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 190
Query: 404 QFTDKSDVYSFGVVLLELLT-GKKP 427
           +FT KSDV+SFG++L EL T G+ P
Sbjct: 191 RFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 109/224 (48%), Gaps = 23/224 (10%)
Query: 210 ELQRATDNYNQSRFLGQGGFGTVYKG--MLPDGSI--VAVKRSKEIDKTQIHQ-FINEVV 264
           E+QR  +     R +G+G FG V++G  M P+     VA+K  K      + + F+ E +
Sbjct: 6   EIQR--ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 63
Query: 265 ILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWE 324
            + Q +H HIVKL+G   E  V +++ E  + G L   +                SL   
Sbjct: 64  TMRQFDHPHIVKLIGVITENPVWIIM-ELCTLGELRSFLQVRKY-----------SLDLA 111
Query: 325 NRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHL 384
           + +  A +++ A+AY+ S   +   HRDI + N+L+      K+ DFG+SR + +   + 
Sbjct: 112 SLILYAYQLSTALAYLESKRFV---HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK 168
Query: 385 TTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
            +  +    ++ PE     +FT  SDV+ FGV + E+L  G KP
Sbjct: 169 ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 212

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 109/224 (48%), Gaps = 23/224 (10%)
Query: 210 ELQRATDNYNQSRFLGQGGFGTVYKG--MLPDGSI--VAVKRSKEIDKTQIHQ-FINEVV 264
           E+QR  +     R +G+G FG V++G  M P+     VA+K  K      + + F+ E +
Sbjct: 34  EIQR--ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 91
Query: 265 ILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWE 324
            + Q +H HIVKL+G   E  V +++ E  + G L   +                SL   
Sbjct: 92  TMRQFDHPHIVKLIGVITENPVWIIM-ELCTLGELRSFLQVRKY-----------SLDLA 139
Query: 325 NRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHL 384
           + +  A +++ A+AY+ S   +   HRDI + N+L+      K+ DFG+SR + +   + 
Sbjct: 140 SLILYAYQLSTALAYLESKRFV---HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK 196
Query: 385 TTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
            +  +    ++ PE     +FT  SDV+ FGV + E+L  G KP
Sbjct: 197 ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 240

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 109/224 (48%), Gaps = 23/224 (10%)
Query: 210 ELQRATDNYNQSRFLGQGGFGTVYKG--MLPDGSI--VAVKRSKEIDKTQIHQ-FINEVV 264
           E+QR  +     R +G+G FG V++G  M P+     VA+K  K      + + F+ E +
Sbjct: 9   EIQR--ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 66
Query: 265 ILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWE 324
            + Q +H HIVKL+G   E  V +++ E  + G L   +                SL   
Sbjct: 67  TMRQFDHPHIVKLIGVITENPVWIIM-ELCTLGELRSFLQVRKY-----------SLDLA 114
Query: 325 NRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHL 384
           + +  A +++ A+AY+ S   +   HRDI + N+L+      K+ DFG+SR + +   + 
Sbjct: 115 SLILYAYQLSTALAYLESKRFV---HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK 171
Query: 385 TTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
            +  +    ++ PE     +FT  SDV+ FGV + E+L  G KP
Sbjct: 172 ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 215

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 99/205 (48%), Gaps = 16/205 (7%)
Query: 224 LGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLE 283
           LGQG FG V+ G     + VA+K  K         F+ E  ++ ++ H  +V+L     E
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 284 TEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYMHSS 343
             +  +V EY+S G+L   +                 L     V +A ++A  +AY+   
Sbjct: 85  EPI-YIVTEYMSKGSLLDFLKGEMG----------KYLRLPQLVDMAAQIASGMAYVERM 133
Query: 344 ASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSS 403
             +   HRD+ ++NIL+ +    KV+DFG++R I +++       +    +  PE     
Sbjct: 134 NYV---HRDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 190
Query: 404 QFTDKSDVYSFGVVLLELLT-GKKP 427
           +FT KSDV+SFG++L EL T G+ P
Sbjct: 191 RFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 109/224 (48%), Gaps = 23/224 (10%)
Query: 210 ELQRATDNYNQSRFLGQGGFGTVYKG--MLPDGSI--VAVKRSKEIDKTQIHQ-FINEVV 264
           E+QR  +     R +G+G FG V++G  M P+     VA+K  K      + + F+ E +
Sbjct: 6   EIQR--ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEAL 63
Query: 265 ILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWE 324
            + Q +H HIVKL+G   E  V +++ E  + G L   +                SL   
Sbjct: 64  TMRQFDHPHIVKLIGVITENPVWIIM-ELCTLGELRSFLQVRKF-----------SLDLA 111
Query: 325 NRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHL 384
           + +  A +++ A+AY+ S   +   HRDI + N+L+      K+ DFG+SR + +   + 
Sbjct: 112 SLILYAYQLSTALAYLESKRFV---HRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYK 168
Query: 385 TTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
            +  +    ++ PE     +FT  SDV+ FGV + E+L  G KP
Sbjct: 169 ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 212

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 108/216 (50%), Gaps = 24/216 (11%)
Query: 220 QSRFLGQGGFGTVYKGMLP-----DGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHI 274
           + + LG G FGTV KG            V + +++  D     + + E  ++ Q+++ +I
Sbjct: 21  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80
Query: 275 VKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVA 334
           V+++G C E E  +LV E    G L+ ++  +                 +N + +  +V+
Sbjct: 81  VRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD------------KNIIELVHQVS 127
Query: 335 GAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTF-- 392
             + Y+  S  +   HRD+ + N+LL  +  AK+SDFG+S+++  D+ +      G +  
Sbjct: 128 MGMKYLEESNFV---HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV 184
Query: 393 GYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
            +  PE     +F+ KSDV+SFGV++ E  + G+KP
Sbjct: 185 KWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 220

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 108/216 (50%), Gaps = 24/216 (11%)
Query: 220 QSRFLGQGGFGTVYKGMLP-----DGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHI 274
           + + LG G FGTV KG            V + +++  D     + + E  ++ Q+++ +I
Sbjct: 9   EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 68
Query: 275 VKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVA 334
           V+++G C E E  +LV E    G L+ ++  +                 +N + +  +V+
Sbjct: 69  VRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD------------KNIIELVHQVS 115
Query: 335 GAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTF-- 392
             + Y+  S  +   HRD+ + N+LL  +  AK+SDFG+S+++  D+ +      G +  
Sbjct: 116 MGMKYLEESNFV---HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV 172
Query: 393 GYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
            +  PE     +F+ KSDV+SFGV++ E  + G+KP
Sbjct: 173 KWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 208

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 108/224 (48%), Gaps = 23/224 (10%)
Query: 210 ELQRATDNYNQSRFLGQGGFGTVYKG--MLPDGSI--VAVKRSKEIDKTQIHQ-FINEVV 264
           E+QR  +     R +G+G FG V++G  M P+     VA+K  K      + + F+ E +
Sbjct: 6   EIQR--ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEAL 63
Query: 265 ILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWE 324
            + Q +H HIVKL+G   E  V +++ E  + G L   +                SL   
Sbjct: 64  TMRQFDHPHIVKLIGVITENPVWIIM-ELCTLGELRSFLQVRKF-----------SLDLA 111
Query: 325 NRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHL 384
           + +  A +++ A+AY+ S   +   HRDI + N+L+      K+ DFG+SR + +     
Sbjct: 112 SLILYAYQLSTALAYLESKRFV---HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXK 168
Query: 385 TTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
            +  +    ++ PE     +FT  SDV+ FGV + E+L  G KP
Sbjct: 169 ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 212

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 100/205 (48%), Gaps = 16/205 (7%)
Query: 224 LGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLE 283
           LGQG FG V+ G     + VA+K  K         F+ E  ++ ++ H  +V+L     E
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 250
Query: 284 TEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYMHSS 343
             +  +V EY+S G+L   +                 L     V +A ++A  +AY+   
Sbjct: 251 EPI-YIVTEYMSKGSLLDFLKGETGKY----------LRLPQLVDMAAQIASGMAYVERM 299
Query: 344 ASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSS 403
             +   HRD++++NIL+ +    KV+DFG++R I +++       +    +  PE     
Sbjct: 300 NYV---HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 356
Query: 404 QFTDKSDVYSFGVVLLELLT-GKKP 427
           +FT KSDV+SFG++L EL T G+ P
Sbjct: 357 RFTIKSDVWSFGILLTELTTKGRVP 381

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 100/205 (48%), Gaps = 16/205 (7%)
Query: 224 LGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLE 283
           LGQG FG V+ G     + VA+K  K         F+ E  ++ ++ H  +V+L     E
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 250
Query: 284 TEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYMHSS 343
             +  +V EY+S G+L   +                 L     V +A ++A  +AY+   
Sbjct: 251 EPI-YIVTEYMSKGSLLDFLKGETGKY----------LRLPQLVDMAAQIASGMAYVERM 299
Query: 344 ASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSS 403
             +   HRD++++NIL+ +    KV+DFG++R I +++       +    +  PE     
Sbjct: 300 NYV---HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 356
Query: 404 QFTDKSDVYSFGVVLLELLT-GKKP 427
           +FT KSDV+SFG++L EL T G+ P
Sbjct: 357 RFTIKSDVWSFGILLTELTTKGRVP 381

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 101/205 (49%), Gaps = 16/205 (7%)
Query: 224 LGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLE 283
           LGQG FG V+ G     + VA+K  K  + +    F+ E  ++ ++ H  +V+L     E
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIKTLKPGNMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSE 251
Query: 284 TEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYMHSS 343
             +  +V EY+S G+L   +                 L     V +A ++A  +AY+   
Sbjct: 252 EPI-YIVTEYMSKGSLLDFLKGEMGKY----------LRLPQLVDMAAQIASGMAYVERM 300
Query: 344 ASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSS 403
             +   HRD++++NIL+ +    KV+DFG+ R I +++       +    +  PE     
Sbjct: 301 NYV---HRDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKWTAPEAALYG 357
Query: 404 QFTDKSDVYSFGVVLLELLT-GKKP 427
           +FT KSDV+SFG++L EL T G+ P
Sbjct: 358 RFTIKSDVWSFGILLTELTTKGRVP 382

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 108/216 (50%), Gaps = 24/216 (11%)
Query: 220 QSRFLGQGGFGTVYKGMLP-----DGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHI 274
           + + LG G FGTV KG            V + +++  D     + + E  ++ Q+++ +I
Sbjct: 11  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 275 VKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVA 334
           V+++G C E E  +LV E    G L+ ++  +                 +N + +  +V+
Sbjct: 71  VRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD------------KNIIELVHQVS 117
Query: 335 GAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTF-- 392
             + Y+  S  +   HRD+ + N+LL  +  AK+SDFG+S+++  D+ +      G +  
Sbjct: 118 MGMKYLEESNFV---HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV 174
Query: 393 GYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
            +  PE     +F+ KSDV+SFGV++ E  + G+KP
Sbjct: 175 KWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 210

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 108/216 (50%), Gaps = 24/216 (11%)
Query: 220 QSRFLGQGGFGTVYKGMLP-----DGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHI 274
           + + LG G FGTV KG            V + +++  D     + + E  ++ Q+++ +I
Sbjct: 15  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 74
Query: 275 VKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVA 334
           V+++G C E E  +LV E    G L+ ++  +                 +N + +  +V+
Sbjct: 75  VRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD------------KNIIELVHQVS 121
Query: 335 GAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTF-- 392
             + Y+  S  +   HRD+ + N+LL  +  AK+SDFG+S+++  D+ +      G +  
Sbjct: 122 MGMKYLEESNFV---HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV 178
Query: 393 GYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
            +  PE     +F+ KSDV+SFGV++ E  + G+KP
Sbjct: 179 KWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 214

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 108/216 (50%), Gaps = 24/216 (11%)
Query: 220 QSRFLGQGGFGTVYKGMLP-----DGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHI 274
           + + LG G FGTV KG            V + +++  D     + + E  ++ Q+++ +I
Sbjct: 31  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 90
Query: 275 VKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVA 334
           V+++G C E E  +LV E    G L+ ++  +                 +N + +  +V+
Sbjct: 91  VRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD------------KNIIELVHQVS 137
Query: 335 GAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTF-- 392
             + Y+  S  +   HRD+ + N+LL  +  AK+SDFG+S+++  D+ +      G +  
Sbjct: 138 MGMKYLEESNFV---HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV 194
Query: 393 GYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
            +  PE     +F+ KSDV+SFGV++ E  + G+KP
Sbjct: 195 KWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 230

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 108/216 (50%), Gaps = 24/216 (11%)
Query: 220 QSRFLGQGGFGTVYKGMLP-----DGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHI 274
           + + LG G FGTV KG            V + +++  D     + + E  ++ Q+++ +I
Sbjct: 31  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 90
Query: 275 VKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVA 334
           V+++G C E E  +LV E    G L+ ++  +                 +N + +  +V+
Sbjct: 91  VRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD------------KNIIELVHQVS 137
Query: 335 GAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTF-- 392
             + Y+  S  +   HRD+ + N+LL  +  AK+SDFG+S+++  D+ +      G +  
Sbjct: 138 MGMKYLEESNFV---HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV 194
Query: 393 GYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
            +  PE     +F+ KSDV+SFGV++ E  + G+KP
Sbjct: 195 KWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 230

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 100/205 (48%), Gaps = 16/205 (7%)
Query: 224 LGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLE 283
           LGQG FG V+ G     + VA+K  K         F+ E  ++ ++ H  +V+L     E
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 81
Query: 284 TEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYMHSS 343
             +  +V EY++ G+L   +                 L     V ++ ++A  +AY+   
Sbjct: 82  EPI-YIVTEYMNKGSLLDFLKGETG----------KYLRLPQLVDMSAQIASGMAYVERM 130
Query: 344 ASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSS 403
             +   HRD++++NIL+ +    KV+DFG++R I +++       +    +  PE     
Sbjct: 131 NYV---HRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKWTAPEAALYG 187
Query: 404 QFTDKSDVYSFGVVLLELLT-GKKP 427
           +FT KSDV+SFG++L EL T G+ P
Sbjct: 188 RFTIKSDVWSFGILLTELTTKGRVP 212

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 106/212 (50%), Gaps = 20/212 (9%)
Query: 218 YNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVK 276
           Y +   +GQG  GTVY  M +  G  VA+++     + +    INE++++ +  + +IV 
Sbjct: 23  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 82
Query: 277 LLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVAC-EVAG 335
            L   L  +   +V EY++ G+L+  + +                  E ++   C E   
Sbjct: 83  YLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD--------------EGQIAAVCRECLQ 128
Query: 336 AVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYL 395
           A+ ++HS+    + HR+IKS NILL    S K++DFG    I  +++  +T + GT  ++
Sbjct: 129 ALEFLHSNQ---VIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWM 184
Query: 396 DPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
            PE      +  K D++S G++ +E++ G+ P
Sbjct: 185 APEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 216

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 100/205 (48%), Gaps = 16/205 (7%)
Query: 224 LGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLE 283
           LGQG FG V+ G     + VA+K  K         F+ E  ++ ++ H  +V+L     E
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 250
Query: 284 TEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYMHSS 343
             +  +V EY+S G+L   +                 L     V +A ++A  +AY+   
Sbjct: 251 EPI-YIVGEYMSKGSLLDFLKGETGKY----------LRLPQLVDMAAQIASGMAYVERM 299
Query: 344 ASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSS 403
             +   HRD++++NIL+ +    KV+DFG++R I +++       +    +  PE     
Sbjct: 300 NYV---HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 356
Query: 404 QFTDKSDVYSFGVVLLELLT-GKKP 427
           +FT KSDV+SFG++L EL T G+ P
Sbjct: 357 RFTIKSDVWSFGILLTELTTKGRVP 381

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 105/212 (49%), Gaps = 20/212 (9%)
Query: 218 YNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVK 276
           Y +   +GQG  GTVY  M +  G  VA+++     + +    INE++++ +  + +IV 
Sbjct: 23  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 82
Query: 277 LLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVAC-EVAG 335
            L   L  +   +V EY++ G+L+  + +                  E ++   C E   
Sbjct: 83  YLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD--------------EGQIAAVCRECLQ 128
Query: 336 AVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYL 395
           A+ ++HS+    + HRDIKS NILL    S K++DFG    I  +++  +  + GT  ++
Sbjct: 129 ALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMV-GTPYWM 184
Query: 396 DPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
            PE      +  K D++S G++ +E++ G+ P
Sbjct: 185 APEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 216

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 105/206 (50%), Gaps = 18/206 (8%)
Query: 224 LGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLE 283
           LG G FG V+ G     + VAVK  K+        F+ E  ++ Q+ H+ +V+L      
Sbjct: 17  LGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYAVV-- 73
Query: 284 TEVPV-LVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYMHS 342
           T+ P+ ++ EY+ +G+L   +                 L+    + +A ++A  +A++  
Sbjct: 74  TQEPIYIITEYMENGSLVDFLKTPSGI----------KLTINKLLDMAAQIAEGMAFIEE 123
Query: 343 SASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQS 402
              I   HR+++++NIL+ D  S K++DFG++R I +++       +    +  PE    
Sbjct: 124 RNYI---HRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY 180
Query: 403 SQFTDKSDVYSFGVVLLELLT-GKKP 427
             FT KSDV+SFG++L E++T G+ P
Sbjct: 181 GTFTIKSDVWSFGILLTEIVTHGRIP 206

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 71/286 (24%), Positives = 129/286 (45%), Gaps = 34/286 (11%)
Query: 224 LGQGGFGTVYKGML-PDGSIVAVKRSKEIDKTQIH-QFINEVVILSQINHRHIVKLLGCC 281
           +G+G FG V+ G L  D ++VAVK  +E     +  +F+ E  IL Q +H +IV+L+G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 282 LETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYMH 341
            + +   +V E +  G     +               + L  +  +++  + A  + Y+ 
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEG-----------ARLRVKTLLQMVGDAAAGMEYLE 230
Query: 342 SSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTI-QGTFGYLDPEYF 400
           S   I   HRD+ + N L+ +K   K+SDFG+SR   +     +  + Q    +  PE  
Sbjct: 231 SKCCI---HRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEAL 287
Query: 401 QSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQLLEILDAR 459
              +++ +SDV+SFG++L E  + G  P               + +L+ + Q  E ++  
Sbjct: 288 NYGRYSSESDVWSFGILLWETFSLGASP---------------YPNLSNQ-QTREFVEKG 331
Query: 460 VAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRSQR 505
                 E    A+  L  +C      +RP+   +  EL+ +R+  R
Sbjct: 332 GRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKRHR 377

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 108/216 (50%), Gaps = 24/216 (11%)
Query: 220 QSRFLGQGGFGTVYKGMLP-----DGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHI 274
           + + LG G FGTV KG            V + +++  D     + + E  ++ Q+++ +I
Sbjct: 29  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 88
Query: 275 VKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVA 334
           V+++G C E E  +LV E    G L+ ++  +                 +N + +  +V+
Sbjct: 89  VRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD------------KNIIELVHQVS 135
Query: 335 GAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTF-- 392
             + Y+  S  +   HRD+ + N+LL  +  AK+SDFG+S+++  D+ +      G +  
Sbjct: 136 MGMKYLEESNFV---HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV 192
Query: 393 GYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
            +  PE     +F+ KSDV+SFGV++ E  + G+KP
Sbjct: 193 KWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 228

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 76/277 (27%), Positives = 122/277 (44%), Gaps = 42/277 (15%)
Query: 224 LGQGGFGTVYKGML--PDGSIVAV-----KRSKEIDKTQIHQFINEVVILSQINHRHIVK 276
           LG G FG V +G    P G  V+V     K         +  FI EV  +  ++HR++++
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 277 LLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGA 336
           L G  L T    +V E    G+L   +  H           L +LS     R A +VA  
Sbjct: 80  LYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFL------LGTLS-----RYAVQVAEG 127
Query: 337 VAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTH--LTTTIQGTFGY 394
           + Y+ S   I   HRD+ + N+LL  +   K+ DFG+ R++P +  H  +    +  F +
Sbjct: 128 MGYLESKRFI---HRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 184
Query: 395 LDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQLL 453
             PE  ++  F+  SD + FGV L E+ T G++P               +I L   +Q+L
Sbjct: 185 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP---------------WIGL-NGSQIL 228
Query: 454 EILDARVAKEAREEDIGA-MAELAMRCLRLNSKKRPT 489
             +D    +  R ED    +  + ++C     + RPT
Sbjct: 229 HKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPT 265

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 105/212 (49%), Gaps = 20/212 (9%)
Query: 218 YNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVK 276
           Y +   +GQG  GTVY  M +  G  VA+++     + +    INE++++ +  + +IV 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 277 LLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVAC-EVAG 335
            L   L  +   +V EY++ G+L+  + +                  E ++   C E   
Sbjct: 82  YLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD--------------EGQIAAVCRECLQ 127
Query: 336 AVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYL 395
           A+ ++HS+    + HRDIKS NILL    S K++DFG    I  +++  +  + GT  ++
Sbjct: 128 ALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMV-GTPYWM 183
Query: 396 DPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
            PE      +  K D++S G++ +E++ G+ P
Sbjct: 184 APEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 105/212 (49%), Gaps = 20/212 (9%)
Query: 218 YNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVK 276
           Y +   +GQG  GTVY  M +  G  VA+++     + +    INE++++ +  + +IV 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 277 LLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVAC-EVAG 335
            L   L  +   +V EY++ G+L+  + +                  E ++   C E   
Sbjct: 82  YLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD--------------EGQIAAVCRECLQ 127
Query: 336 AVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYL 395
           A+ ++HS+    + HRDIKS NILL    S K++DFG    I  +++  +  + GT  ++
Sbjct: 128 ALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMV-GTPYWM 183
Query: 396 DPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
            PE      +  K D++S G++ +E++ G+ P
Sbjct: 184 APEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 76/277 (27%), Positives = 122/277 (44%), Gaps = 42/277 (15%)
Query: 224 LGQGGFGTVYKGML--PDGSIVAV-----KRSKEIDKTQIHQFINEVVILSQINHRHIVK 276
           LG G FG V +G    P G  V+V     K         +  FI EV  +  ++HR++++
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 277 LLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGA 336
           L G  L T    +V E    G+L   +  H           L +LS     R A +VA  
Sbjct: 86  LYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFL------LGTLS-----RYAVQVAEG 133
Query: 337 VAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTH--LTTTIQGTFGY 394
           + Y+ S   I   HRD+ + N+LL  +   K+ DFG+ R++P +  H  +    +  F +
Sbjct: 134 MGYLESKRFI---HRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAW 190
Query: 395 LDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQLL 453
             PE  ++  F+  SD + FGV L E+ T G++P               +I L   +Q+L
Sbjct: 191 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP---------------WIGL-NGSQIL 234
Query: 454 EILDARVAKEAREEDIGA-MAELAMRCLRLNSKKRPT 489
             +D    +  R ED    +  + ++C     + RPT
Sbjct: 235 HKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPT 271

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 76/277 (27%), Positives = 122/277 (44%), Gaps = 42/277 (15%)
Query: 224 LGQGGFGTVYKGML--PDGSIVAV-----KRSKEIDKTQIHQFINEVVILSQINHRHIVK 276
           LG G FG V +G    P G  V+V     K         +  FI EV  +  ++HR++++
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 277 LLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGA 336
           L G  L T    +V E    G+L   +  H           L +LS     R A +VA  
Sbjct: 86  LYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFL------LGTLS-----RYAVQVAEG 133
Query: 337 VAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTH--LTTTIQGTFGY 394
           + Y+ S   I   HRD+ + N+LL  +   K+ DFG+ R++P +  H  +    +  F +
Sbjct: 134 MGYLESKRFI---HRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 190
Query: 395 LDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQLL 453
             PE  ++  F+  SD + FGV L E+ T G++P               +I L   +Q+L
Sbjct: 191 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP---------------WIGL-NGSQIL 234
Query: 454 EILDARVAKEAREEDIGA-MAELAMRCLRLNSKKRPT 489
             +D    +  R ED    +  + ++C     + RPT
Sbjct: 235 HKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPT 271

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 100/205 (48%), Gaps = 16/205 (7%)
Query: 224 LGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLE 283
           LGQG FG V+ G     + VA+K  K         F+ E  ++ ++ H  +V+L     E
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 81
Query: 284 TEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYMHSS 343
             +  +V EY++ G+L   +                 L     V ++ ++A  +AY+   
Sbjct: 82  EPI-YIVTEYMNKGSLLDFLKGETG----------KYLRLPQLVDMSAQIASGMAYVERM 130
Query: 344 ASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSS 403
             +   HRD++++NIL+ +    KV+DFG++R I +++       +    +  PE     
Sbjct: 131 NYV---HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 187
Query: 404 QFTDKSDVYSFGVVLLELLT-GKKP 427
           +FT KSDV+SFG++L EL T G+ P
Sbjct: 188 RFTIKSDVWSFGILLTELTTKGRVP 212

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 109/224 (48%), Gaps = 23/224 (10%)
Query: 210 ELQRATDNYNQSRFLGQGGFGTVYKG--MLPDGSI--VAVKRSKEIDKTQIHQ-FINEVV 264
           E+QR  +     R +G+G FG V++G  M P+     VA+K  K      + + F+ E +
Sbjct: 386 EIQR--ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEAL 443
Query: 265 ILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWE 324
            + Q +H HIVKL+G   E  V +++ E  + G L   +                SL   
Sbjct: 444 TMRQFDHPHIVKLIGVITENPVWIIM-ELCTLGELRSFLQVRKF-----------SLDLA 491
Query: 325 NRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHL 384
           + +  A +++ A+AY+ S   +   HRDI + N+L+      K+ DFG+SR + +   + 
Sbjct: 492 SLILYAYQLSTALAYLESKRFV---HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK 548
Query: 385 TTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
            +  +    ++ PE     +FT  SDV+ FGV + E+L  G KP
Sbjct: 549 ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 592

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 112/214 (52%), Gaps = 23/214 (10%)
Query: 222 RFLGQGGFGTVYKGM-LPDGS----IVAVKRSKEIDKTQIH-QFINEVVILSQINHRHIV 275
           + LG G FGTVYKG+ +PDG      VA+K  +E    + + + ++E  +++ +   ++ 
Sbjct: 23  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVS 82
Query: 276 KLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAG 335
           +LLG CL + V  LV + +  G L  H+ ++              L  ++ +    ++A 
Sbjct: 83  RLLGICLTSTVQ-LVTQLMPYGCLLDHVRENR-----------GRLGSQDLLNWCMQIAK 130
Query: 336 AVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKT-HLTTTIQGTFGY 394
            ++Y+     + + HRD+ + N+L+      K++DFG++R +  D+T +     +    +
Sbjct: 131 GMSYLED---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKW 187
Query: 395 LDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
           +  E     +FT +SDV+S+GV + EL+T G KP
Sbjct: 188 MALESILRRRFTHQSDVWSYGVTVWELMTFGAKP 221

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 75/277 (27%), Positives = 122/277 (44%), Gaps = 42/277 (15%)
Query: 224 LGQGGFGTVYKGML--PDGSIVAV-----KRSKEIDKTQIHQFINEVVILSQINHRHIVK 276
           LG G FG V +G    P G  V+V     K         +  FI EV  +  ++HR++++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 277 LLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGA 336
           L G  L   +  +V E    G+L   +  H           L +LS     R A +VA  
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFL------LGTLS-----RYAVQVAEG 123
Query: 337 VAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTH--LTTTIQGTFGY 394
           + Y+ S   I   HRD+ + N+LL  +   K+ DFG+ R++P +  H  +    +  F +
Sbjct: 124 MGYLESKRFI---HRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180
Query: 395 LDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQLL 453
             PE  ++  F+  SD + FGV L E+ T G++P               +I L   +Q+L
Sbjct: 181 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP---------------WIGL-NGSQIL 224
Query: 454 EILDARVAKEAREEDIGA-MAELAMRCLRLNSKKRPT 489
             +D    +  R ED    +  + ++C     + RPT
Sbjct: 225 HKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPT 261

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 109/222 (49%), Gaps = 31/222 (13%)
Query: 219 NQSRFLGQGGFGTVYKGMLPDGS-------IVAVKRSKEIDKTQIHQFINEVVILSQINH 271
           +  R +G+G FG VY G   D +       I ++ R  E+   Q+  F+ E +++  +NH
Sbjct: 24  HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQ--QVEAFLREGLLMRGLNH 81
Query: 272 RHIVKLLGCCLETE-VPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVA 330
            +++ L+G  L  E +P ++  Y+  G L   I                + + ++ +   
Sbjct: 82  PNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQ-----------RNPTVKDLISFG 130
Query: 331 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPND-----KTHLT 385
            +VA  + Y+   A     HRD+ + N +LD+ F+ KV+DFG++R I +      + H  
Sbjct: 131 LQVARGMEYL---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRH 187
Query: 386 TTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
             +   +  L  E  Q+ +FT KSDV+SFGV+L ELLT   P
Sbjct: 188 ARLPVKWTAL--ESLQTYRFTTKSDVWSFGVLLWELLTRGAP 227

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 71/286 (24%), Positives = 129/286 (45%), Gaps = 34/286 (11%)
Query: 224 LGQGGFGTVYKGML-PDGSIVAVKRSKEIDKTQIH-QFINEVVILSQINHRHIVKLLGCC 281
           +G+G FG V+ G L  D ++VAVK  +E     +  +F+ E  IL Q +H +IV+L+G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 282 LETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYMH 341
            + +   +V E +  G     +               + L  +  +++  + A  + Y+ 
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEG-----------ARLRVKTLLQMVGDAAAGMEYLE 230
Query: 342 SSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTI-QGTFGYLDPEYF 400
           S   I   HRD+ + N L+ +K   K+SDFG+SR   +     +  + Q    +  PE  
Sbjct: 231 SKCCI---HRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEAL 287
Query: 401 QSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQLLEILDAR 459
              +++ +SDV+SFG++L E  + G  P               + +L+ + Q  E ++  
Sbjct: 288 NYGRYSSESDVWSFGILLWETFSLGASP---------------YPNLSNQ-QTREFVEKG 331
Query: 460 VAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRSQR 505
                 E    A+  L  +C      +RP+   +  EL+ +R+  R
Sbjct: 332 GRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKRHR 377

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 100/205 (48%), Gaps = 16/205 (7%)
Query: 224 LGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLE 283
           LGQG FG V+ G     + VA+K  K         F+ E  ++ ++ H  +V+L     E
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 333
Query: 284 TEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYMHSS 343
             +  +V EY+S G+L   +                 L     V +A ++A  +AY+   
Sbjct: 334 EPI-YIVTEYMSKGSLLDFLKGETGKY----------LRLPQLVDMAAQIASGMAYVERM 382
Query: 344 ASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSS 403
             +   HRD++++NIL+ +    KV+DFG++R I +++       +    +  PE     
Sbjct: 383 NYV---HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 439
Query: 404 QFTDKSDVYSFGVVLLELLT-GKKP 427
           +FT KSDV+SFG++L EL T G+ P
Sbjct: 440 RFTIKSDVWSFGILLTELTTKGRVP 464

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 76/277 (27%), Positives = 122/277 (44%), Gaps = 42/277 (15%)
Query: 224 LGQGGFGTVYKGML--PDGSIVAV-----KRSKEIDKTQIHQFINEVVILSQINHRHIVK 276
           LG G FG V +G    P G  V+V     K         +  FI EV  +  ++HR++++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 277 LLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGA 336
           L G  L T    +V E    G+L   +  H           L +LS     R A +VA  
Sbjct: 76  LYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFL------LGTLS-----RYAVQVAEG 123
Query: 337 VAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTH--LTTTIQGTFGY 394
           + Y+ S   I   HRD+ + N+LL  +   K+ DFG+ R++P +  H  +    +  F +
Sbjct: 124 MGYLESKRFI---HRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180
Query: 395 LDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQLL 453
             PE  ++  F+  SD + FGV L E+ T G++P               +I L   +Q+L
Sbjct: 181 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP---------------WIGL-NGSQIL 224
Query: 454 EILDARVAKEAREEDIGA-MAELAMRCLRLNSKKRPT 489
             +D    +  R ED    +  + ++C     + RPT
Sbjct: 225 HKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPT 261

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 75/277 (27%), Positives = 122/277 (44%), Gaps = 42/277 (15%)
Query: 224 LGQGGFGTVYKGML--PDGSIVAV-----KRSKEIDKTQIHQFINEVVILSQINHRHIVK 276
           LG G FG V +G    P G  V+V     K         +  FI EV  +  ++HR++++
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 277 LLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGA 336
           L G  L   +  +V E    G+L   +  H           L +LS     R A +VA  
Sbjct: 80  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFL------LGTLS-----RYAVQVAEG 127
Query: 337 VAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTH--LTTTIQGTFGY 394
           + Y+ S   I   HRD+ + N+LL  +   K+ DFG+ R++P +  H  +    +  F +
Sbjct: 128 MGYLESKRFI---HRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 184
Query: 395 LDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQLL 453
             PE  ++  F+  SD + FGV L E+ T G++P               +I L   +Q+L
Sbjct: 185 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP---------------WIGL-NGSQIL 228
Query: 454 EILDARVAKEAREEDIGA-MAELAMRCLRLNSKKRPT 489
             +D    +  R ED    +  + ++C     + RPT
Sbjct: 229 HKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPT 265

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 75/277 (27%), Positives = 122/277 (44%), Gaps = 42/277 (15%)
Query: 224 LGQGGFGTVYKGML--PDGSIVAV-----KRSKEIDKTQIHQFINEVVILSQINHRHIVK 276
           LG G FG V +G    P G  V+V     K         +  FI EV  +  ++HR++++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 277 LLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGA 336
           L G  L   +  +V E    G+L   +  H           L +LS     R A +VA  
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFL------LGTLS-----RYAVQVAEG 123
Query: 337 VAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTH--LTTTIQGTFGY 394
           + Y+ S   I   HRD+ + N+LL  +   K+ DFG+ R++P +  H  +    +  F +
Sbjct: 124 MGYLESKRFI---HRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAW 180
Query: 395 LDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQLL 453
             PE  ++  F+  SD + FGV L E+ T G++P               +I L   +Q+L
Sbjct: 181 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP---------------WIGL-NGSQIL 224
Query: 454 EILDARVAKEAREEDIGA-MAELAMRCLRLNSKKRPT 489
             +D    +  R ED    +  + ++C     + RPT
Sbjct: 225 HKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPT 261

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 78/305 (25%), Positives = 143/305 (46%), Gaps = 45/305 (14%)
Query: 205 VFTADELQRATDNYNQSRF-----LGQGGFGTVYKGMLPD--GSIVAVKRSKEIDKTQIH 257
           V   DE  R+    N         +G+G FG V   ML D  G+ VAVK  K     Q  
Sbjct: 5   VAAQDEFYRSGWALNMKELKLLQTIGKGEFGDV---MLGDYRGNKVAVKCIKNDATAQ-- 59
Query: 258 QFINEVVILSQINHRHIVKLLGCCLETEVPV-LVYEYISSGTLSHHIHDHXXXXXXXXXX 316
            F+ E  +++Q+ H ++V+LLG  +E +  + +V EY++ G+L  ++             
Sbjct: 60  AFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-------- 111
Query: 317 XLSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS 376
             S L  +  ++ + +V  A+ Y+  +  +   HRD+ + N+L+ +   AKVSDFG+++ 
Sbjct: 112 --SVLGGDCLLKFSLDVCEAMEYLEGNNFV---HRDLAARNVLVSEDNVAKVSDFGLTKE 166
Query: 377 IPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEE 436
             + +      ++ T     PE  +  +F+ KSDV+SFG++L E+ +      F RV   
Sbjct: 167 ASSTQDTGKLPVKWT----APEALREKKFSTKSDVWSFGILLWEIYS------FGRVPYP 216
Query: 437 RNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSME 496
           R  +   +   ++   ++  D             A+ E+   C  L++  RP+  Q+  +
Sbjct: 217 RIPLKDVVPRVEKGYKMDAPDGCPP---------AVYEVMKNCWHLDAAMRPSFLQLREQ 267
Query: 497 LEGLR 501
           LE ++
Sbjct: 268 LEHIK 272

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 100/214 (46%), Gaps = 30/214 (14%)
Query: 222 RFLGQGGFGTVYKGMLPD-----GSIVAVKRSKEIDKTQIHQ--FINEVVILSQINHRHI 274
           R LG+G FG V            G +VAVK  K  D    H+  +  E+ IL  + H HI
Sbjct: 37  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALK-ADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 275 VKLLGCCLETEVPVL--VYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACE 332
           +K  GCC +     L  V EY+  G+L  ++  H             S+     +  A +
Sbjct: 96  IKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH-------------SIGLAQLLLFAQQ 142
Query: 333 VAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQG-- 390
           +   +AY+H+   I   HRD+ + N+LLD+    K+ DFG+++++P           G  
Sbjct: 143 ICEGMAYLHAQHYI---HRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDS 199
Query: 391 -TFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT 423
             F Y  PE  +  +F   SDV+SFGV L ELLT
Sbjct: 200 PVFWYA-PECLKEYKFYYASDVWSFGVTLYELLT 232

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 106/225 (47%), Gaps = 15/225 (6%)
Query: 204 KVFTADELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEV 263
           K +  D  +   ++    + LG G FG V+ G   + + VAVK  K      +  F+ E 
Sbjct: 1   KPWDKDAWEIPRESIKLVKRLGAGQFGEVWMGYYNNSTKVAVKTLKP-GTMSVQAFLEEA 59
Query: 264 VILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSW 323
            ++  + H  +V+L       E   ++ EY++ G+L   +              L  L  
Sbjct: 60  NLMKTLQHDKLVRLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVL-----LPKL-- 112
Query: 324 ENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTH 383
              +  + ++A  +AY+     I   HRD++++N+L+ +    K++DFG++R I +++  
Sbjct: 113 ---IDFSAQIAEGMAYIERKNYI---HRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 166
Query: 384 LTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
                +    +  PE      FT KSDV+SFG++L E++T GK P
Sbjct: 167 AREGAKFPIKWTAPEAINFGCFTIKSDVWSFGILLYEIVTYGKIP 211

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 107/211 (50%), Gaps = 22/211 (10%)
Query: 224 LGQGGFGTVYKG---MLPDGSIVAVKRSKE-IDKTQIHQFINEVVILSQINHRHIVKLLG 279
           LG G FG+V +G   M      VA+K  K+  +K    + + E  I+ Q+++ +IV+L+G
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 280 CCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAY 339
            C + E  +LV E    G L      H           +S     N   +  +V+  + Y
Sbjct: 78  VC-QAEALMLVMEMAGGGPL------HKFLVGKREEIPVS-----NVAELLHQVSMGMKY 125
Query: 340 MHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTF--GYLDP 397
           +     +   HRD+ + N+LL ++  AK+SDFG+S+++  D ++ T    G +   +  P
Sbjct: 126 LEEKNFV---HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAP 182
Query: 398 EYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
           E     +F+ +SDV+S+GV + E L+ G+KP
Sbjct: 183 ECINFRKFSSRSDVWSYGVTMWEALSYGQKP 213

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 107/216 (49%), Gaps = 24/216 (11%)
Query: 220 QSRFLGQGGFGTVYKGMLP-----DGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHI 274
           + + LG G FGTV KG            V + +++  D     + + E  ++ Q+++ +I
Sbjct: 15  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 74
Query: 275 VKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVA 334
           V+++G C E E  +LV E    G L+ ++  +                 +N + +  +V+
Sbjct: 75  VRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD------------KNIIELVHQVS 121
Query: 335 GAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTF-- 392
             + Y+  S  +   HRD+ + N+LL  +  AK+SDFG+S+++  D+        G +  
Sbjct: 122 MGMKYLEESNFV---HRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPV 178
Query: 393 GYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
            +  PE     +F+ KSDV+SFGV++ E  + G+KP
Sbjct: 179 KWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 214

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 109/224 (48%), Gaps = 23/224 (10%)
Query: 210 ELQRATDNYNQSRFLGQGGFGTVYKG--MLPDGSI--VAVKRSKEIDKTQIHQ-FINEVV 264
           E+QR  +     R +G+G FG V++G  M P+     VA+K  K      + + F+ E +
Sbjct: 386 EIQR--ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEAL 443
Query: 265 ILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWE 324
            + Q +H HIVKL+G   E  V +++ E  + G L   +                SL   
Sbjct: 444 TMRQFDHPHIVKLIGVITENPVWIIM-ELCTLGELRSFLQVRKF-----------SLDLA 491
Query: 325 NRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHL 384
           + +  A +++ A+AY+ S   +   HRDI + N+L+      K+ DFG+SR + +   + 
Sbjct: 492 SLILYAYQLSTALAYLESKRFV---HRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYK 548
Query: 385 TTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
            +  +    ++ PE     +FT  SDV+ FGV + E+L  G KP
Sbjct: 549 ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 592

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 71/213 (33%), Positives = 103/213 (48%), Gaps = 28/213 (13%)
Query: 222 RFLGQGGFGTVYKGMLPD-----GSIVAVKRSKEIDKTQIHQ-FINEVVILSQINHRHIV 275
           R LG+G FG V            G +VAVK  KE    Q+   +  E+ IL  + H HIV
Sbjct: 15  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIV 74
Query: 276 KLLGCCLET-EVPV-LVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEV 333
           K  GCC +  E  V LV EY+  G+L  ++  H           L+ L     +  A ++
Sbjct: 75  KYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVG--------LAQL-----LLFAQQI 121
Query: 334 AGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQG--- 390
              +AY+H+   I   HR + + N+LLD+    K+ DFG+++++P    +      G   
Sbjct: 122 CEGMAYLHAQHYI---HRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP 178
Query: 391 TFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT 423
            F Y  PE  +  +F   SDV+SFGV L ELLT
Sbjct: 179 VFWYA-PECLKECKFYYASDVWSFGVTLYELLT 210

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 101/205 (49%), Gaps = 18/205 (8%)
Query: 224 LGQGGFGTVYKGMLPD-GSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCL 282
           LG+G +G+VYK +  + G IVA+K+     ++ + + I E+ I+ Q +  H+VK  G   
Sbjct: 37  LGEGSYGSVYKAIHKETGQIVAIKQVPV--ESDLQEIIKEISIMQQCDSPHVVKYYGSYF 94
Query: 283 ETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYMHS 342
           +     +V EY  +G++S  I                +L+ +    +       + Y+H 
Sbjct: 95  KNTDLWIVMEYCGAGSVSDIIRLRN-----------KTLTEDEIATILQSTLKGLEYLHF 143
Query: 343 SASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQS 402
              I   HRDIK+ NILL+ +  AK++DFG++  +  D       + GT  ++ PE  Q 
Sbjct: 144 MRKI---HRDIKAGNILLNTEGHAKLADFGVAGQL-TDXMAKRNXVIGTPFWMAPEVIQE 199
Query: 403 SQFTDKSDVYSFGVVLLELLTGKKP 427
             +   +D++S G+  +E+  GK P
Sbjct: 200 IGYNCVADIWSLGITAIEMAEGKPP 224

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 71/213 (33%), Positives = 103/213 (48%), Gaps = 28/213 (13%)
Query: 222 RFLGQGGFGTVYKGMLPD-----GSIVAVKRSKEIDKTQIHQ-FINEVVILSQINHRHIV 275
           R LG+G FG V            G +VAVK  KE    Q+   +  E+ IL  + H HIV
Sbjct: 14  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIV 73
Query: 276 KLLGCCLET-EVPV-LVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEV 333
           K  GCC +  E  V LV EY+  G+L  ++  H           L+ L     +  A ++
Sbjct: 74  KYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVG--------LAQL-----LLFAQQI 120
Query: 334 AGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQG--- 390
              +AY+H+   I   HR + + N+LLD+    K+ DFG+++++P    +      G   
Sbjct: 121 CEGMAYLHAQHYI---HRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP 177
Query: 391 TFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT 423
            F Y  PE  +  +F   SDV+SFGV L ELLT
Sbjct: 178 VFWYA-PECLKECKFYYASDVWSFGVTLYELLT 209

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 73/281 (25%), Positives = 137/281 (48%), Gaps = 40/281 (14%)
Query: 224 LGQGGFGTVYKGMLPD--GSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCC 281
           +G+G FG V   ML D  G+ VAVK  K     Q   F+ E  +++Q+ H ++V+LLG  
Sbjct: 14  IGKGEFGDV---MLGDYRGNKVAVKCIKNDATAQ--AFLAEASVMTQLRHSNLVQLLGVI 68
Query: 282 LETEVPV-LVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYM 340
           +E +  + +V EY++ G+L  ++               S L  +  ++ + +V  A+ Y+
Sbjct: 69  VEEKGGLYIVTEYMAKGSLVDYLRSRGR----------SVLGGDCLLKFSLDVCEAMEYL 118
Query: 341 HSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYF 400
             +  +   HRD+ + N+L+ +   AKVSDFG+++   + +      ++ T     PE  
Sbjct: 119 EGNNFV---HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEAL 171
Query: 401 QSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEILDARV 460
           +  +F+ KSDV+SFG++L E+ +      F RV   R  +   +   ++   ++  D   
Sbjct: 172 REKKFSTKSDVWSFGILLWEIYS------FGRVPYPRIPLKDVVPRVEKGYKMDAPDGCP 225
Query: 461 AKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLR 501
                     A+ E+   C  L++  RP+  Q+  +LE ++
Sbjct: 226 P---------AVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 257

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 73/281 (25%), Positives = 137/281 (48%), Gaps = 40/281 (14%)
Query: 224 LGQGGFGTVYKGMLPD--GSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCC 281
           +G+G FG V   ML D  G+ VAVK  K     Q   F+ E  +++Q+ H ++V+LLG  
Sbjct: 20  IGKGEFGDV---MLGDYRGNKVAVKCIKNDATAQ--AFLAEASVMTQLRHSNLVQLLGVI 74
Query: 282 LETEVPV-LVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYM 340
           +E +  + +V EY++ G+L  ++               S L  +  ++ + +V  A+ Y+
Sbjct: 75  VEEKGGLYIVTEYMAKGSLVDYLRSRGR----------SVLGGDCLLKFSLDVCEAMEYL 124
Query: 341 HSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYF 400
             +  +   HRD+ + N+L+ +   AKVSDFG+++   + +      ++ T     PE  
Sbjct: 125 EGNNFV---HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEAL 177
Query: 401 QSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEILDARV 460
           + + F+ KSDV+SFG++L E+ +      F RV   R  +   +   ++   ++  D   
Sbjct: 178 REAAFSTKSDVWSFGILLWEIYS------FGRVPYPRIPLKDVVPRVEKGYKMDAPDGCP 231
Query: 461 AKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLR 501
                     A+ E+   C  L++  RP+  Q+  +LE ++
Sbjct: 232 P---------AVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 263

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 71/272 (26%), Positives = 117/272 (43%), Gaps = 40/272 (14%)
Query: 243 VAVKRSKE-IDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSH 301
           VA+K  K    + Q   F++E  I+ Q +H +I++L G      + ++V EY+ +G+L  
Sbjct: 80  VAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDT 139
Query: 302 HIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD 361
            +  H                    +++   + G  A M   + +   HRD+ + N+L+D
Sbjct: 140 FLRTHDGQFTI--------------MQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVD 185
Query: 362 DKFSAKVSDFGISRSIPNDKTHLTTTIQGTFG--YLDPEYFQSSQFTDKSDVYSFGVVLL 419
                KVSDFG+SR + +D     TT  G     +  PE      F+  SDV+SFGVV+ 
Sbjct: 186 SNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMW 245
Query: 420 ELLT-GKKPICFARVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIG---AMAEL 475
           E+L  G++P       +        IS  +E   L               +G   A+ +L
Sbjct: 246 EVLAYGERPYWNMTNRD-------VISSVEEGYRL------------PAPMGCPHALHQL 286
Query: 476 AMRCLRLNSKKRPTMKQVSMELEGLRRSQRCL 507
            + C   +  +RP   Q+   L+ L RS   L
Sbjct: 287 MLDCWHKDRAQRPRFSQIVSVLDALIRSPESL 318

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 84/306 (27%), Positives = 130/306 (42%), Gaps = 43/306 (14%)
Query: 215 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEI---DKTQIHQFINEVVILSQIN 270
           +D Y     LG GG   V+    L D   VAVK  +     D +   +F  E    + +N
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 271 HRHIVKLLGCCLETEVPV-----LVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWEN 325
           H  IV +     E E P      +V EY+   TL   +H                ++ + 
Sbjct: 71  HPAIVAVYDTG-EAETPAGPLPYIVMEYVDGVTLRDIVHTE------------GPMTPKR 117
Query: 326 RVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLT 385
            + V  +   A+ + H +    I HRD+K +NI++    + KV DFGI+R+I +    +T
Sbjct: 118 AIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVT 174
Query: 386 TT--IQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP--------ICFARVEE 435
            T  + GT  YL PE  +      +SDVYS G VL E+LTG+ P        + +  V E
Sbjct: 175 QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPDSVAYQHVRE 234
Query: 436 ERNLVACFISLAKENQLLEILDARVAK---EAREEDIGAMAELAMRCLRLNSKKRPTMKQ 492
           +          A+   L   LDA V K   +  E      AE+    +R+++ + P   +
Sbjct: 235 D-----PIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEAPK 289
Query: 493 VSMELE 498
           V  + E
Sbjct: 290 VLTDAE 295

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 108/216 (50%), Gaps = 24/216 (11%)
Query: 220 QSRFLGQGGFGTVYKGMLP-----DGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHI 274
           + + LG G FGTV KG            V + +++  D     + + E  ++ Q+++ +I
Sbjct: 373 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 432
Query: 275 VKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVA 334
           V+++G C E E  +LV E    G L+ ++  +                 +N + +  +V+
Sbjct: 433 VRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD------------KNIIELVHQVS 479
Query: 335 GAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTF-- 392
             + Y+  S  +   HRD+ + N+LL  +  AK+SDFG+S+++  D+ +      G +  
Sbjct: 480 MGMKYLEESNFV---HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV 536
Query: 393 GYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
            +  PE     +F+ KSDV+SFGV++ E  + G+KP
Sbjct: 537 KWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 572

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 103/206 (50%), Gaps = 18/206 (8%)
Query: 224 LGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLE 283
           LG G  G V+ G     + VAVK  K+        F+ E  ++ Q+ H+ +V+L      
Sbjct: 21  LGAGQAGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYAVV-- 77
Query: 284 TEVPV-LVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYMHS 342
           T+ P+ ++ EY+ +G+L   +                 L+    + +A ++A  +A++  
Sbjct: 78  TQEPIYIITEYMENGSLVDFLKTPSGI----------KLTINKLLDMAAQIAEGMAFIEE 127
Query: 343 SASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQS 402
              I   HRD++++NIL+ D  S K++DFG++R I + +       +    +  PE    
Sbjct: 128 RNYI---HRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAPEAINY 184
Query: 403 SQFTDKSDVYSFGVVLLELLT-GKKP 427
             FT KSDV+SFG++L E++T G+ P
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIP 210

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 103/213 (48%), Gaps = 19/213 (8%)
Query: 222 RFLGQGGFGTVYKGML------PDGSIVAVKRSKEIDKTQIH-QFINEVVILSQINHRHI 274
           R LG G FG VY+G +      P    VAVK   E+   Q    F+ E +I+S++NH++I
Sbjct: 51  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNI 110
Query: 275 VKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVA 334
           V+ +G  L++    ++ E ++ G L   + +             SSL+  + + VA ++A
Sbjct: 111 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQP-----SSLAMLDLLHVARDIA 165
Query: 335 GAVAYMHSSASIPIFHRDIKSSNILL---DDKFSAKVSDFGISRSIPNDKTHLTTTIQG- 390
               Y+  +  I   HRDI + N LL        AK+ DFG++R I     +        
Sbjct: 166 CGCQYLEENHFI---HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML 222
Query: 391 TFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT 423
              ++ PE F    FT K+D +SFGV+L E+ +
Sbjct: 223 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 84/306 (27%), Positives = 130/306 (42%), Gaps = 43/306 (14%)
Query: 215 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEI---DKTQIHQFINEVVILSQIN 270
           +D Y     LG GG   V+    L D   VAVK  +     D +   +F  E    + +N
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 271 HRHIVKLLGCCLETEVPV-----LVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWEN 325
           H  IV +     E E P      +V EY+   TL   +H                ++ + 
Sbjct: 71  HPAIVAVYDTG-EAETPAGPLPYIVMEYVDGVTLRDIVHTE------------GPMTPKR 117
Query: 326 RVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLT 385
            + V  +   A+ + H +    I HRD+K +NI++    + KV DFGI+R+I +    +T
Sbjct: 118 AIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVT 174
Query: 386 TT--IQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP--------ICFARVEE 435
            T  + GT  YL PE  +      +SDVYS G VL E+LTG+ P        + +  V E
Sbjct: 175 QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRE 234
Query: 436 ERNLVACFISLAKENQLLEILDARVAK---EAREEDIGAMAELAMRCLRLNSKKRPTMKQ 492
           +          A+   L   LDA V K   +  E      AE+    +R+++ + P   +
Sbjct: 235 D-----PIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEAPK 289
Query: 493 VSMELE 498
           V  + E
Sbjct: 290 VLTDAE 295

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 108/216 (50%), Gaps = 24/216 (11%)
Query: 220 QSRFLGQGGFGTVYKGMLP-----DGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHI 274
           + + LG G FGTV KG            V + +++  D     + + E  ++ Q+++ +I
Sbjct: 374 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 433
Query: 275 VKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVA 334
           V+++G C E E  +LV E    G L+ ++  +                 +N + +  +V+
Sbjct: 434 VRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD------------KNIIELVHQVS 480
Query: 335 GAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTF-- 392
             + Y+  S  +   HRD+ + N+LL  +  AK+SDFG+S+++  D+ +      G +  
Sbjct: 481 MGMKYLEESNFV---HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV 537
Query: 393 GYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
            +  PE     +F+ KSDV+SFGV++ E  + G+KP
Sbjct: 538 KWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 573

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/272 (26%), Positives = 117/272 (43%), Gaps = 40/272 (14%)
Query: 243 VAVKRSKE-IDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSH 301
           VA+K  K    + Q   F++E  I+ Q +H +I++L G      + ++V EY+ +G+L  
Sbjct: 80  VAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDT 139
Query: 302 HIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD 361
            +  H                    +++   + G  A M   + +   HRD+ + N+L+D
Sbjct: 140 FLRTHDGQFTI--------------MQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVD 185
Query: 362 DKFSAKVSDFGISRSIPNDKTHLTTTIQGTFG--YLDPEYFQSSQFTDKSDVYSFGVVLL 419
                KVSDFG+SR + +D     TT  G     +  PE      F+  SDV+SFGVV+ 
Sbjct: 186 SNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMW 245
Query: 420 ELLT-GKKPICFARVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIG---AMAEL 475
           E+L  G++P       +        IS  +E   L               +G   A+ +L
Sbjct: 246 EVLAYGERPYWNMTNRD-------VISSVEEGYRL------------PAPMGCPHALHQL 286
Query: 476 AMRCLRLNSKKRPTMKQVSMELEGLRRSQRCL 507
            + C   +  +RP   Q+   L+ L RS   L
Sbjct: 287 MLDCWHKDRAQRPRFSQIVSVLDALIRSPESL 318

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 102/214 (47%), Gaps = 30/214 (14%)
Query: 222 RFLGQGGFGTVYKGMLPD-----GSIVAVKRSKEIDKTQIHQ--FINEVVILSQINHRHI 274
           R LG+G FG V            G +VAVK  K  D    H+  +  E+ IL  + H HI
Sbjct: 20  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALK-ADCGPQHRSGWKQEIDILRTLYHEHI 78
Query: 275 VKLLGCCLET--EVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACE 332
           +K  GCC +   +   LV EY+  G+L  ++  H             S+     +  A +
Sbjct: 79  IKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRH-------------SIGLAQLLLFAQQ 125
Query: 333 VAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQG-- 390
           +   +AY+HS   I   HR++ + N+LLD+    K+ DFG+++++P    +      G  
Sbjct: 126 ICEGMAYLHSQHYI---HRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS 182
Query: 391 -TFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT 423
             F Y  PE  +  +F   SDV+SFGV L ELLT
Sbjct: 183 PVFWYA-PECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 103/218 (47%), Gaps = 19/218 (8%)
Query: 217 NYNQSRFLGQGGFGTVYKGML------PDGSIVAVKRSKEIDKTQIH-QFINEVVILSQI 269
           N    R LG G FG VY+G +      P    VAVK   E+   Q    F+ E +I+S+ 
Sbjct: 31  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 90
Query: 270 NHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRV 329
           NH++IV+ +G  L++    ++ E ++ G L   + +             SSL+  + + V
Sbjct: 91  NHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQP-----SSLAMLDLLHV 145
Query: 330 ACEVAGAVAYMHSSASIPIFHRDIKSSNILL---DDKFSAKVSDFGISRSIPNDKTHLTT 386
           A ++A    Y+  +  I   HRDI + N LL        AK+ DFG++R I     +   
Sbjct: 146 ARDIACGCQYLEENHFI---HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKG 202
Query: 387 TIQG-TFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT 423
                   ++ PE F    FT K+D +SFGV+L E+ +
Sbjct: 203 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 103/218 (47%), Gaps = 19/218 (8%)
Query: 217 NYNQSRFLGQGGFGTVYKGML------PDGSIVAVKRSKEIDKTQIH-QFINEVVILSQI 269
           N    R LG G FG VY+G +      P    VAVK   E+   Q    F+ E +I+S+ 
Sbjct: 31  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 90
Query: 270 NHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRV 329
           NH++IV+ +G  L++    ++ E ++ G L   + +             SSL+  + + V
Sbjct: 91  NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQP-----SSLAMLDLLHV 145
Query: 330 ACEVAGAVAYMHSSASIPIFHRDIKSSNILL---DDKFSAKVSDFGISRSIPNDKTHLTT 386
           A ++A    Y+  +  I   HRDI + N LL        AK+ DFG++R I     +   
Sbjct: 146 ARDIACGCQYLEENHFI---HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKG 202
Query: 387 TIQG-TFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT 423
                   ++ PE F    FT K+D +SFGV+L E+ +
Sbjct: 203 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 104/218 (47%), Gaps = 19/218 (8%)
Query: 217 NYNQSRFLGQGGFGTVYKGML------PDGSIVAVKRSKEIDKTQIH-QFINEVVILSQI 269
           N    R LG G FG VY+G +      P    VAVK   E+   Q    F+ E +I+S++
Sbjct: 32  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKL 91
Query: 270 NHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRV 329
           NH++IV+ +G  L++    ++ E ++ G L   + +             SSL+  + + V
Sbjct: 92  NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQP-----SSLAMLDLLHV 146
Query: 330 ACEVAGAVAYMHSSASIPIFHRDIKSSNILL---DDKFSAKVSDFGISRSIPNDKTHLTT 386
           A ++A    Y+  +  I   HRDI + N LL        AK+ DFG++R I     +   
Sbjct: 147 ARDIACGCQYLEENHFI---HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKG 203
Query: 387 TIQG-TFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT 423
                   ++ PE F    FT K+D +SFGV+L E+ +
Sbjct: 204 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 84/306 (27%), Positives = 129/306 (42%), Gaps = 43/306 (14%)
Query: 215 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEI---DKTQIHQFINEVVILSQIN 270
           +D Y     LG GG   V+    L D   VAVK  +     D +   +F  E    + +N
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 271 HRHIVKLLGCCLETEVPV-----LVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWEN 325
           H  IV +     E E P      +V EY+   TL   +H                ++ + 
Sbjct: 71  HPAIVAVYDTG-EAETPAGPLPYIVMEYVDGVTLRDIVHTE------------GPMTPKR 117
Query: 326 RVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHL- 384
            + V  +   A+ + H +    I HRD+K +NIL+    + KV DFGI+R+I +    + 
Sbjct: 118 AIEVIADACQALNFSHQNG---IIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVX 174
Query: 385 -TTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP--------ICFARVEE 435
            T  + GT  YL PE  +      +SDVYS G VL E+LTG+ P        + +  V E
Sbjct: 175 QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRE 234
Query: 436 ERNLVACFISLAKENQLLEILDARVAK---EAREEDIGAMAELAMRCLRLNSKKRPTMKQ 492
           +          A+   L   LDA V K   +  E      AE+    +R+++ + P   +
Sbjct: 235 D-----PIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEAPK 289
Query: 493 VSMELE 498
           V  + E
Sbjct: 290 VLTDAE 295

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 80/308 (25%), Positives = 132/308 (42%), Gaps = 31/308 (10%)
Query: 206 FTADELQRATDNYNQSRFLGQGGFGTVYKG------MLPDGSIVAVKRSKEIDKTQIHQ- 258
           + A + +   D     + LG+G FG V +              VAVK  KE      H+ 
Sbjct: 19  YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRA 78
Query: 259 FINEVVILSQINHR-HIVKLLGCCLETEVPVLV-YEYISSGTLSHHIHDHXXXXXXXXXX 316
            ++E+ IL  I H  ++V LLG C +   P++V  E+   G LS ++             
Sbjct: 79  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPE 138
Query: 317 XLSS--LSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGIS 374
            L    L+ E+ +  + +VA  + ++ S   I   HRD+ + NILL +K   K+ DFG++
Sbjct: 139 DLYKDFLTLEHLIXYSFQVAKGMEFLASRKXI---HRDLAARNILLSEKNVVKICDFGLA 195
Query: 375 RSIPNDKTHLTT-TIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFAR 432
           R I  D   +     +    ++ PE      +T +SDV+SFGV+L E+ + G  P    +
Sbjct: 196 RDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 255
Query: 433 VEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQ 492
           ++EE      F    KE   +   D    +         M +  + C      +RPT  +
Sbjct: 256 IDEE------FCRRLKEGTRMRAPDYTTPE---------MYQTMLDCWHGEPSQRPTFSE 300
Query: 493 VSMELEGL 500
           +   L  L
Sbjct: 301 LVEHLGNL 308

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 103/218 (47%), Gaps = 19/218 (8%)
Query: 217 NYNQSRFLGQGGFGTVYKGML------PDGSIVAVKRSKEIDKTQIH-QFINEVVILSQI 269
           N    R LG G FG VY+G +      P    VAVK   E+   Q    F+ E +I+S+ 
Sbjct: 23  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 82
Query: 270 NHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRV 329
           NH++IV+ +G  L++    ++ E ++ G L   + +             SSL+  + + V
Sbjct: 83  NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQP-----SSLAMLDLLHV 137
Query: 330 ACEVAGAVAYMHSSASIPIFHRDIKSSNILL---DDKFSAKVSDFGISRSIPNDKTHLTT 386
           A ++A    Y+  +  I   HRDI + N LL        AK+ DFG++R I     +   
Sbjct: 138 ARDIACGCQYLEENHFI---HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKG 194
Query: 387 TIQG-TFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT 423
                   ++ PE F    FT K+D +SFGV+L E+ +
Sbjct: 195 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 232

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 103/218 (47%), Gaps = 19/218 (8%)
Query: 217 NYNQSRFLGQGGFGTVYKGML------PDGSIVAVKRSKEIDKTQIH-QFINEVVILSQI 269
           N    R LG G FG VY+G +      P    VAVK   E+   Q    F+ E +I+S+ 
Sbjct: 48  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 107
Query: 270 NHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRV 329
           NH++IV+ +G  L++    ++ E ++ G L   + +             SSL+  + + V
Sbjct: 108 NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQP-----SSLAMLDLLHV 162
Query: 330 ACEVAGAVAYMHSSASIPIFHRDIKSSNILL---DDKFSAKVSDFGISRSIPNDKTHLTT 386
           A ++A    Y+  +  I   HRDI + N LL        AK+ DFG++R I     +   
Sbjct: 163 ARDIACGCQYLEENHFI---HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKG 219
Query: 387 TIQG-TFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT 423
                   ++ PE F    FT K+D +SFGV+L E+ +
Sbjct: 220 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 257

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 102/213 (47%), Gaps = 19/213 (8%)
Query: 222 RFLGQGGFGTVYKGML------PDGSIVAVKRSKEIDKTQIH-QFINEVVILSQINHRHI 274
           R LG G FG VY+G +      P    VAVK   E+   Q    F+ E +I+S+ NH++I
Sbjct: 51  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 110
Query: 275 VKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVA 334
           V+ +G  L++    ++ E ++ G L   + +             SSL+  + + VA ++A
Sbjct: 111 VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQP-----SSLAMLDLLHVARDIA 165
Query: 335 GAVAYMHSSASIPIFHRDIKSSNILL---DDKFSAKVSDFGISRSIPNDKTHLTTTIQG- 390
               Y+  +  I   HRDI + N LL        AK+ DFG++R I     +        
Sbjct: 166 CGCQYLEENHFI---HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML 222
Query: 391 TFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT 423
              ++ PE F    FT K+D +SFGV+L E+ +
Sbjct: 223 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 82/303 (27%), Positives = 133/303 (43%), Gaps = 43/303 (14%)
Query: 216 DNYNQSRFLGQGGFGTVY--------KGMLPDGSIVAVKRSKEIDKTQ--IHQFINEVVI 265
           D     + LG+G FG V         K    +   VAVK  K+ D T+  +   ++E+ +
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD-DATEKDLSDLVSEMEM 93
Query: 266 LSQIN-HRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXX----XXXLSS 320
           +  I  H++I+ LLG C +     ++ EY S G L  ++                     
Sbjct: 94  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQ 153
Query: 321 LSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPN- 379
           +++++ V    ++A  + Y+ S   I   HRD+ + N+L+ +    K++DFG++R I N 
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCI---HRDLAARNVLVTENNVMKIADFGLARDINNI 210
Query: 380 DKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERN 438
           D    TT  +    ++ PE      +T +SDV+SFGV++ E+ T G  P     VEE   
Sbjct: 211 DXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--- 267
Query: 439 LVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMR---CLRLNSKKRPTMKQVSM 495
                  L KE         R+ K A         EL M    C      +RPT KQ+  
Sbjct: 268 ----LFKLLKEGH-------RMDKPA-----NCTNELYMMMRDCWHAVPSQRPTFKQLVE 311
Query: 496 ELE 498
           +L+
Sbjct: 312 DLD 314

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 71/297 (23%), Positives = 136/297 (45%), Gaps = 40/297 (13%)
Query: 222 RFLGQGGFGTVYKG--MLPDGS--IVAVKRSKE-IDKTQIHQFINEVVILSQINHRHIVK 276
           + +G G FG V  G   LP      VA+K  K    + Q   F++E  I+ Q +H +++ 
Sbjct: 39  QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIH 98
Query: 277 LLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGA 336
           L G   ++   +++ E++ +G+L   +  +                    +++   + G 
Sbjct: 99  LEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTV--------------IQLVGMLRGI 144
Query: 337 VAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT--IQGTFG- 393
            A M   A +   HRD+ + NIL++     KVSDFG+SR + +D +  T T  + G    
Sbjct: 145 AAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPI 204
Query: 394 -YLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQ 451
            +  PE  Q  +FT  SDV+S+G+V+ E+++ G++P      ++  N      ++ ++ +
Sbjct: 205 RWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVIN------AIEQDYR 258
Query: 452 LLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRSQRCLE 508
           L   +D             A+ +L + C + +   RP   Q+   L+ + R+   L+
Sbjct: 259 LPPPMDCP----------SALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNPNSLK 305

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 102/213 (47%), Gaps = 19/213 (8%)
Query: 222 RFLGQGGFGTVYKGML------PDGSIVAVKRSKEIDKTQIH-QFINEVVILSQINHRHI 274
           R LG G FG VY+G +      P    VAVK   E+   Q    F+ E +I+S+ NH++I
Sbjct: 63  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 122
Query: 275 VKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVA 334
           V+ +G  L++    ++ E ++ G L   + +             SSL+  + + VA ++A
Sbjct: 123 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQP-----SSLAMLDLLHVARDIA 177
Query: 335 GAVAYMHSSASIPIFHRDIKSSNILLD---DKFSAKVSDFGISRSIPNDKTHLTTTIQG- 390
               Y+  +  I   HRDI + N LL        AK+ DFG++R I     +        
Sbjct: 178 CGCQYLEENHFI---HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML 234
Query: 391 TFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT 423
              ++ PE F    FT K+D +SFGV+L E+ +
Sbjct: 235 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 267

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 79/306 (25%), Positives = 129/306 (42%), Gaps = 43/306 (14%)
Query: 215 TDNYNQSRFLGQGGFGTVYKG----MLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQIN 270
           +D Y     LG GG   V+      +  D ++  ++     D +   +F  E    + +N
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 271 HRHIVKLLGCCLETEVPV-----LVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWEN 325
           H  IV +     E E P      +V EY+   TL   +H                ++ + 
Sbjct: 71  HPAIVAVYATG-EAETPAGPLPYIVMEYVDGVTLRDIVHTE------------GPMTPKR 117
Query: 326 RVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLT 385
            + V  +   A+ + H +    I HRD+K +NI++    + KV DFGI+R+I +    +T
Sbjct: 118 AIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVT 174
Query: 386 TT--IQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP--------ICFARVEE 435
            T  + GT  YL PE  +      +SDVYS G VL E+LTG+ P        + +  V E
Sbjct: 175 QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRE 234
Query: 436 ERNLVACFISLAKENQLLEILDARVAK---EAREEDIGAMAELAMRCLRLNSKKRPTMKQ 492
           +          A+   L   LDA V K   +  E      AE+    +R+++ + P   +
Sbjct: 235 D-----PIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEAPK 289
Query: 493 VSMELE 498
           V  + E
Sbjct: 290 VLTDAE 295

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 102/213 (47%), Gaps = 19/213 (8%)
Query: 222 RFLGQGGFGTVYKGML------PDGSIVAVKRSKEIDKTQIH-QFINEVVILSQINHRHI 274
           R LG G FG VY+G +      P    VAVK   E+   Q    F+ E +I+S+ NH++I
Sbjct: 51  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNI 110
Query: 275 VKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVA 334
           V+ +G  L++    ++ E ++ G L   + +             SSL+  + + VA ++A
Sbjct: 111 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQP-----SSLAMLDLLHVARDIA 165
Query: 335 GAVAYMHSSASIPIFHRDIKSSNILL---DDKFSAKVSDFGISRSIPNDKTHLTTTIQG- 390
               Y+  +  I   HRDI + N LL        AK+ DFG++R I     +        
Sbjct: 166 CGCQYLEENHFI---HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML 222
Query: 391 TFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT 423
              ++ PE F    FT K+D +SFGV+L E+ +
Sbjct: 223 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 102/213 (47%), Gaps = 19/213 (8%)
Query: 222 RFLGQGGFGTVYKGML------PDGSIVAVKRSKEIDKTQIH-QFINEVVILSQINHRHI 274
           R LG G FG VY+G +      P    VAVK   E+   Q    F+ E +I+S+ NH++I
Sbjct: 43  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 102
Query: 275 VKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVA 334
           V+ +G  L++    ++ E ++ G L   + +             SSL+  + + VA ++A
Sbjct: 103 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQP-----SSLAMLDLLHVARDIA 157
Query: 335 GAVAYMHSSASIPIFHRDIKSSNILL---DDKFSAKVSDFGISRSIPNDKTHLTTTIQG- 390
               Y+  +  I   HRDI + N LL        AK+ DFG++R I     +        
Sbjct: 158 CGCQYLEENHFI---HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML 214
Query: 391 TFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT 423
              ++ PE F    FT K+D +SFGV+L E+ +
Sbjct: 215 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 247

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 102/213 (47%), Gaps = 19/213 (8%)
Query: 222 RFLGQGGFGTVYKGML------PDGSIVAVKRSKEIDKTQIH-QFINEVVILSQINHRHI 274
           R LG G FG VY+G +      P    VAVK   E+   Q    F+ E +I+S+ NH++I
Sbjct: 54  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 113
Query: 275 VKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVA 334
           V+ +G  L++    ++ E ++ G L   + +             SSL+  + + VA ++A
Sbjct: 114 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQP-----SSLAMLDLLHVARDIA 168
Query: 335 GAVAYMHSSASIPIFHRDIKSSNILL---DDKFSAKVSDFGISRSIPNDKTHLTTTIQG- 390
               Y+  +  I   HRDI + N LL        AK+ DFG++R I     +        
Sbjct: 169 CGCQYLEENHFI---HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAML 225
Query: 391 TFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT 423
              ++ PE F    FT K+D +SFGV+L E+ +
Sbjct: 226 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 258

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 81/303 (26%), Positives = 132/303 (43%), Gaps = 43/303 (14%)
Query: 216 DNYNQSRFLGQGGFGTVY--------KGMLPDGSIVAVKRSKEIDKTQ--IHQFINEVVI 265
           D     + LG+G FG V         K    +   VAVK  K+ D T+  +   ++E+ +
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD-DATEKDLSDLVSEMEM 93
Query: 266 LSQIN-HRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXX----XXXLSS 320
           +  I  H++I+ LLG C +     ++ EY S G L  ++                     
Sbjct: 94  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 321 LSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPN- 379
           +++++ V    ++A  + Y+ S   I   HRD+ + N+L+ +    K++DFG++R I N 
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCI---HRDLAARNVLVTENNVMKIADFGLARDINNI 210
Query: 380 DKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERN 438
           D    TT  +    ++ PE      +T +SDV+SFGV++ E+ T G  P     VEE   
Sbjct: 211 DXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--- 267
Query: 439 LVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMR---CLRLNSKKRPTMKQVSM 495
                  L KE         R+ K A         EL M    C      +RPT KQ+  
Sbjct: 268 ----LFKLLKEGH-------RMDKPA-----NCTNELYMMMRDCWHAVPSQRPTFKQLVE 311
Query: 496 ELE 498
           +L+
Sbjct: 312 DLD 314

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 102/213 (47%), Gaps = 19/213 (8%)
Query: 222 RFLGQGGFGTVYKGML------PDGSIVAVKRSKEIDKTQIH-QFINEVVILSQINHRHI 274
           R LG G FG VY+G +      P    VAVK   E+   Q    F+ E +I+S+ NH++I
Sbjct: 77  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136
Query: 275 VKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVA 334
           V+ +G  L++    ++ E ++ G L   + +             SSL+  + + VA ++A
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQP-----SSLAMLDLLHVARDIA 191
Query: 335 GAVAYMHSSASIPIFHRDIKSSNILL---DDKFSAKVSDFGISRSIPNDKTHLTTTIQG- 390
               Y+  +  I   HRDI + N LL        AK+ DFG++R I     +        
Sbjct: 192 CGCQYLEENHFI---HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAML 248
Query: 391 TFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT 423
              ++ PE F    FT K+D +SFGV+L E+ +
Sbjct: 249 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 102/213 (47%), Gaps = 19/213 (8%)
Query: 222 RFLGQGGFGTVYKGML------PDGSIVAVKRSKEIDKTQIH-QFINEVVILSQINHRHI 274
           R LG G FG VY+G +      P    VAVK   E+   Q    F+ E +I+S+ NH++I
Sbjct: 37  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 96
Query: 275 VKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVA 334
           V+ +G  L++    ++ E ++ G L   + +             SSL+  + + VA ++A
Sbjct: 97  VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQP-----SSLAMLDLLHVARDIA 151
Query: 335 GAVAYMHSSASIPIFHRDIKSSNILL---DDKFSAKVSDFGISRSIPNDKTHLTTTIQG- 390
               Y+  +  I   HRDI + N LL        AK+ DFG++R I     +        
Sbjct: 152 CGCQYLEENHFI---HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML 208
Query: 391 TFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT 423
              ++ PE F    FT K+D +SFGV+L E+ +
Sbjct: 209 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 102/214 (47%), Gaps = 30/214 (14%)
Query: 222 RFLGQGGFGTVYKGMLPD-----GSIVAVKRSKEIDKTQIHQ--FINEVVILSQINHRHI 274
           R LG+G FG V            G +VAVK  K  D    H+  +  E+ IL  + H HI
Sbjct: 20  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALK-ADCGPQHRSGWKQEIDILRTLYHEHI 78
Query: 275 VKLLGCCLET--EVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACE 332
           +K  GCC +   +   LV EY+  G+L  ++  H             S+     +  A +
Sbjct: 79  IKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRH-------------SIGLAQLLLFAQQ 125
Query: 333 VAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQG-- 390
           +   +AY+H+   I   HR++ + N+LLD+    K+ DFG+++++P    +      G  
Sbjct: 126 ICEGMAYLHAQHYI---HRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS 182
Query: 391 -TFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT 423
             F Y  PE  +  +F   SDV+SFGV L ELLT
Sbjct: 183 PVFWYA-PECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 111/219 (50%), Gaps = 23/219 (10%)
Query: 217 NYNQSRFLGQGGFGTVYKGM-LPDGS----IVAVKRSKEIDKTQIH-QFINEVVILSQIN 270
            + + + LG G FGTVYKG+ +P+G      VA+K  +E    + + + ++E  +++ ++
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 76
Query: 271 HRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVA 330
           + H+ +LLG CL + V  L+ + +  G L  ++ +H              L+W       
Sbjct: 77  NPHVCRLLGICLTSTVQ-LIMQLMPFGXLLDYVREHKDNIGSQYL-----LNW------C 124
Query: 331 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI-PNDKTHLTTTIQ 389
            ++A  + Y+       + HRD+ + N+L+      K++DFG+++ +   +K +     +
Sbjct: 125 VQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 181
Query: 390 GTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
               ++  E      +T +SDV+S+GV + EL+T G KP
Sbjct: 182 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 220

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 103/214 (48%), Gaps = 22/214 (10%)
Query: 222 RFLGQGGFGTVYKGML--PDGS--IVAVKRSK-EIDKTQIHQFINEVVILSQINHRHIVK 276
           R +G G FG V  G L  P      VA+K  K    + Q   F+ E  I+ Q +H +I+ 
Sbjct: 28  RVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIH 87
Query: 277 LLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGA 336
           L G   +++  ++V EY+ +G+L   +  +                    +++   + G 
Sbjct: 88  LEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTV--------------IQLVGMLRGI 133
Query: 337 VAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFG--Y 394
            A M   + +   HRD+ + NIL++     KVSDFG+SR + +D     TT  G     +
Sbjct: 134 SAGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW 193
Query: 395 LDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
             PE     +FT  SDV+S+G+V+ E+++ G++P
Sbjct: 194 TAPEAIAFRKFTSASDVWSYGIVMWEVVSYGERP 227

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 98/210 (46%), Gaps = 25/210 (11%)
Query: 224 LGQGGFGTV----YKGMLPD-GSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLL 278
           LG+G FG+V    Y  +  + G++VAVK+ +     Q   F  E+ IL  ++   IVK  
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 74
Query: 279 GCCLETEVP--VLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGA 336
           G       P   LV EY+ SG L   +  H            SS           ++   
Sbjct: 75  GVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSS-----------QICKG 123
Query: 337 VAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQG---TFG 393
           + Y+ S   +   HRD+ + NIL++ +   K++DFG+++ +P DK        G    F 
Sbjct: 124 MEYLGSRRCV---HRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFW 180
Query: 394 YLDPEYFQSSQFTDKSDVYSFGVVLLELLT 423
           Y  PE    + F+ +SDV+SFGVVL EL T
Sbjct: 181 YA-PESLSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 90/328 (27%), Positives = 143/328 (43%), Gaps = 38/328 (11%)
Query: 207 TADELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIH-----QFI 260
           +ADE Q    NY   + +G+G F  V     +  G  VAVK    IDKTQ++     +  
Sbjct: 6   SADE-QPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKI---IDKTQLNSSSLQKLF 61
Query: 261 NEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSS 320
            EV I+  +NH +IVKL       +   LV EY S G +  ++  H              
Sbjct: 62  REVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEK-------- 113
Query: 321 LSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPND 380
              E R +   ++  AV Y H      I HRD+K+ N+LLD   + K++DFG S      
Sbjct: 114 ---EARAKFR-QIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFG 166
Query: 381 KTHLTTTIQGTFGYLDPEYFQSSQFTD-KSDVYSFGVVLLELLTGKKPICFARVEEERNL 439
                 T  G+  Y  PE FQ  ++   + DV+S GV+L  L++G  P     ++E R  
Sbjct: 167 NK--LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRER 224
Query: 440 V-------ACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQ 492
           V         ++S   EN L + L    +K    E I  M +  M     + + +P ++ 
Sbjct: 225 VLRGKYRIPFYMSTDCENLLKKFLILNPSKRGTLEQI--MKDRWMNVGHEDDELKPYVEP 282
Query: 493 VSMELEGLRRSQRCLEMCQVNQLLADEI 520
           +  + +  RR++  + M    + + D +
Sbjct: 283 LP-DYKDPRRTELMVSMGYTREEIQDSL 309

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 111/219 (50%), Gaps = 23/219 (10%)
Query: 217 NYNQSRFLGQGGFGTVYKGM-LPDGS----IVAVKRSKEIDKTQIH-QFINEVVILSQIN 270
            + + + LG G FGTVYKG+ +P+G      VA+K  +E    + + + ++E  +++ ++
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 271 HRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVA 330
           + H+ +LLG CL + V  L+ + +  G L  ++ +H              L+W       
Sbjct: 79  NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYL-----LNW------C 126
Query: 331 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI-PNDKTHLTTTIQ 389
            ++A  + Y+       + HRD+ + N+L+      K++DFG+++ +   +K +     +
Sbjct: 127 VQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 183
Query: 390 GTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
               ++  E      +T +SDV+S+GV + EL+T G KP
Sbjct: 184 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 222

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 79/306 (25%), Positives = 129/306 (42%), Gaps = 43/306 (14%)
Query: 215 TDNYNQSRFLGQGGFGTVYKG----MLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQIN 270
           +D Y     LG GG   V+      +  D ++  ++     D +   +F  E    + +N
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 271 HRHIVKLLGCCLETEVPV-----LVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWEN 325
           H  IV +     E E P      +V EY+   TL   +H                ++ + 
Sbjct: 71  HPAIVAVYDTG-EAETPAGPLPYIVMEYVDGVTLRDIVHTE------------GPMTPKR 117
Query: 326 RVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLT 385
            + V  +   A+ + H +    I HRD+K +NI++    + KV DFGI+R+I +    +T
Sbjct: 118 AIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVT 174
Query: 386 TT--IQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP--------ICFARVEE 435
            T  + GT  YL PE  +      +SDVYS G VL E+LTG+ P        + +  V E
Sbjct: 175 QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRE 234
Query: 436 ERNLVACFISLAKENQLLEILDARVAK---EAREEDIGAMAELAMRCLRLNSKKRPTMKQ 492
           +          A+   L   LDA V K   +  E      AE+    +R+++ + P   +
Sbjct: 235 D-----PIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEAPK 289
Query: 493 VSMELE 498
           V  + E
Sbjct: 290 VLTDAE 295

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 81/309 (26%), Positives = 136/309 (44%), Gaps = 32/309 (10%)
Query: 206 FTADELQRATDNYNQSRFLGQGGFGTVYK----GMLPDGS--IVAVKRSKEIDKTQIHQ- 258
           + A + +   D  N  + LG+G FG V +    G+    +   VAVK  KE      H+ 
Sbjct: 18  YDASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 77
Query: 259 FINEVVILSQINHR-HIVKLLGCCLETEVPVLV-YEYISSGTLSHHIH---DHXXXXXXX 313
            ++E+ IL  I H  ++V LLG C +   P++V  E+   G LS ++    +        
Sbjct: 78  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTP 137
Query: 314 XXXXLSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGI 373
                  L+ E+ +  + +VA  + ++ S   I   HRD+ + NILL +K   K+ DFG+
Sbjct: 138 EDLYKDFLTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILLSEKNVVKICDFGL 194
Query: 374 SRSIPNDKTHLTT-TIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFA 431
           +R I  D   +     +    ++ PE      +T +SDV+SFGV+L E+ + G  P    
Sbjct: 195 ARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 254
Query: 432 RVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMK 491
           +++EE      F    KE   +   D    +         M +  + C      +RPT  
Sbjct: 255 KIDEE------FCRRLKEGTRMRAPDYTTPE---------MYQTMLDCWHGEPSQRPTFS 299
Query: 492 QVSMELEGL 500
           ++   L  L
Sbjct: 300 ELVEHLGNL 308

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 111/219 (50%), Gaps = 23/219 (10%)
Query: 217 NYNQSRFLGQGGFGTVYKGM-LPDGS----IVAVKRSKEIDKTQIH-QFINEVVILSQIN 270
            + + + LG G FGTVYKG+ +P+G      VA+K  +E    + + + ++E  +++ ++
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 271 HRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVA 330
           + H+ +LLG CL + V  L+ + +  G L  ++ +H              L+W       
Sbjct: 78  NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYL-----LNW------C 125
Query: 331 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI-PNDKTHLTTTIQ 389
            ++A  + Y+       + HRD+ + N+L+      K++DFG+++ +   +K +     +
Sbjct: 126 VQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 182
Query: 390 GTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
               ++  E      +T +SDV+S+GV + EL+T G KP
Sbjct: 183 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 221

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 111/219 (50%), Gaps = 23/219 (10%)
Query: 217 NYNQSRFLGQGGFGTVYKGM-LPDGS----IVAVKRSKEIDKTQIH-QFINEVVILSQIN 270
            + + + LG G FGTVYKG+ +P+G      VA+K  +E    + + + ++E  +++ ++
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 76
Query: 271 HRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVA 330
           + H+ +LLG CL + V  L+ + +  G L  ++ +H              L+W       
Sbjct: 77  NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYL-----LNW------C 124
Query: 331 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI-PNDKTHLTTTIQ 389
            ++A  + Y+       + HRD+ + N+L+      K++DFG+++ +   +K +     +
Sbjct: 125 VQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 181
Query: 390 GTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
               ++  E      +T +SDV+S+GV + EL+T G KP
Sbjct: 182 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 220

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 111/219 (50%), Gaps = 23/219 (10%)
Query: 217 NYNQSRFLGQGGFGTVYKGM-LPDGS----IVAVKRSKEIDKTQIH-QFINEVVILSQIN 270
            + + + LG G FGTVYKG+ +P+G      VA+K  +E    + + + ++E  +++ ++
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 271 HRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVA 330
           + H+ +LLG CL + V  L+ + +  G L  ++ +H              L+W       
Sbjct: 76  NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYL-----LNW------C 123
Query: 331 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI-PNDKTHLTTTIQ 389
            ++A  + Y+       + HRD+ + N+L+      K++DFG+++ +   +K +     +
Sbjct: 124 VQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 180
Query: 390 GTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
               ++  E      +T +SDV+S+GV + EL+T G KP
Sbjct: 181 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 111/219 (50%), Gaps = 23/219 (10%)
Query: 217 NYNQSRFLGQGGFGTVYKGM-LPDGS----IVAVKRSKEIDKTQIH-QFINEVVILSQIN 270
            + + + LG G FGTVYKG+ +P+G      VA+K  +E    + + + ++E  +++ ++
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 271 HRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVA 330
           + H+ +LLG CL + V  L+ + +  G L  ++ +H              L+W       
Sbjct: 76  NPHVCRLLGICLTSTVQ-LITQLMPFGXLLDYVREHKDNIGSQYL-----LNW------C 123
Query: 331 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI-PNDKTHLTTTIQ 389
            ++A  + Y+       + HRD+ + N+L+      K++DFG+++ +   +K +     +
Sbjct: 124 VQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 180
Query: 390 GTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
               ++  E      +T +SDV+S+GV + EL+T G KP
Sbjct: 181 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 111/219 (50%), Gaps = 23/219 (10%)
Query: 217 NYNQSRFLGQGGFGTVYKGM-LPDGS----IVAVKRSKEIDKTQIH-QFINEVVILSQIN 270
            + + + LG G FGTVYKG+ +P+G      VA+K  +E    + + + ++E  +++ ++
Sbjct: 26  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 85
Query: 271 HRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVA 330
           + H+ +LLG CL + V  L+ + +  G L  ++ +H              L+W       
Sbjct: 86  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL-----LNW------C 133
Query: 331 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI-PNDKTHLTTTIQ 389
            ++A  + Y+       + HRD+ + N+L+      K++DFG+++ +   +K +     +
Sbjct: 134 VQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 190
Query: 390 GTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
               ++  E      +T +SDV+S+GV + EL+T G KP
Sbjct: 191 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 229

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 111/219 (50%), Gaps = 23/219 (10%)
Query: 217 NYNQSRFLGQGGFGTVYKGM-LPDGS----IVAVKRSKEIDKTQIH-QFINEVVILSQIN 270
            + + + LG G FGTVYKG+ +P+G      VA+K  +E    + + + ++E  +++ ++
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 271 HRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVA 330
           + H+ +LLG CL + V  L+ + +  G L  ++ +H              L+W       
Sbjct: 76  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL-----LNW------C 123
Query: 331 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI-PNDKTHLTTTIQ 389
            ++A  + Y+       + HRD+ + N+L+      K++DFG+++ +   +K +     +
Sbjct: 124 VQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 180
Query: 390 GTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
               ++  E      +T +SDV+S+GV + EL+T G KP
Sbjct: 181 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 75/241 (31%), Positives = 109/241 (45%), Gaps = 28/241 (11%)
Query: 207 TADELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIH-----QFI 260
           +ADE Q    NY   + +G+G F  V     +  G  VAVK    IDKTQ++     +  
Sbjct: 6   SADE-QPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKI---IDKTQLNSSSLQKLF 61
Query: 261 NEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSS 320
            EV I+  +NH +IVKL       +   LV EY S G +  ++  H              
Sbjct: 62  REVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEK-------- 113
Query: 321 LSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPND 380
              E R +   ++  AV Y H      I HRD+K+ N+LLD   + K++DFG S      
Sbjct: 114 ---EARAKFR-QIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFG 166
Query: 381 KTHLTTTIQGTFGYLDPEYFQSSQFTD-KSDVYSFGVVLLELLTGKKPICFARVEEERNL 439
                 T  G+  Y  PE FQ  ++   + DV+S GV+L  L++G  P     ++E R  
Sbjct: 167 NK--LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRER 224
Query: 440 V 440
           V
Sbjct: 225 V 225

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 107/211 (50%), Gaps = 22/211 (10%)
Query: 224 LGQGGFGTVYKG---MLPDGSIVAVKRSKE-IDKTQIHQFINEVVILSQINHRHIVKLLG 279
           LG G FG+V +G   M      VA+K  K+  +K    + + E  I+ Q+++ +IV+L+G
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 280 CCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAY 339
            C + E  +LV E    G L      H           +S     N   +  +V+  + Y
Sbjct: 404 VC-QAEALMLVMEMAGGGPL------HKFLVGKREEIPVS-----NVAELLHQVSMGMKY 451
Query: 340 MHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFG--YLDP 397
           +     +   HR++ + N+LL ++  AK+SDFG+S+++  D ++ T    G +   +  P
Sbjct: 452 LEEKNFV---HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAP 508
Query: 398 EYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
           E     +F+ +SDV+S+GV + E L+ G+KP
Sbjct: 509 ECINFRKFSSRSDVWSYGVTMWEALSYGQKP 539

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 111/219 (50%), Gaps = 23/219 (10%)
Query: 217 NYNQSRFLGQGGFGTVYKGM-LPDGS----IVAVKRSKEIDKTQIH-QFINEVVILSQIN 270
            + + + LG G FGTVYKG+ +P+G      VA+K  +E    + + + ++E  +++ ++
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 271 HRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVA 330
           + H+ +LLG CL + V  L+ + +  G L  ++ +H              L+W       
Sbjct: 79  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL-----LNW------C 126
Query: 331 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI-PNDKTHLTTTIQ 389
            ++A  + Y+       + HRD+ + N+L+      K++DFG+++ +   +K +     +
Sbjct: 127 VQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 183
Query: 390 GTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
               ++  E      +T +SDV+S+GV + EL+T G KP
Sbjct: 184 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 222

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 111/219 (50%), Gaps = 23/219 (10%)
Query: 217 NYNQSRFLGQGGFGTVYKGM-LPDGS----IVAVKRSKEIDKTQIH-QFINEVVILSQIN 270
            + + + LG G FGTVYKG+ +P+G      VA+K  +E    + + + ++E  +++ ++
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 79
Query: 271 HRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVA 330
           + H+ +LLG CL + V  L+ + +  G L  ++ +H              L+W       
Sbjct: 80  NPHVCRLLGICLTSTV-QLIMQLMPFGCLLDYVREHKDNIGSQYL-----LNW------C 127
Query: 331 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI-PNDKTHLTTTIQ 389
            ++A  + Y+       + HRD+ + N+L+      K++DFG+++ +   +K +     +
Sbjct: 128 VQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 184
Query: 390 GTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
               ++  E      +T +SDV+S+GV + EL+T G KP
Sbjct: 185 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 223

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 100/205 (48%), Gaps = 15/205 (7%)
Query: 224 LGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLE 283
           LG G FG V+ G   + + VAVK  K      +  F+ E  ++  + H  +V+L     +
Sbjct: 20  LGAGQFGEVWMGYYNNSTKVAVKTLKP-GTMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 78
Query: 284 TEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYMHSS 343
            E   ++ E+++ G+L   +              L  L     +  + ++A  +AY+   
Sbjct: 79  EEPIYIITEFMAKGSLLDFLKSDEGGKVL-----LPKL-----IDFSAQIAEGMAYIERK 128
Query: 344 ASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSS 403
             I   HRD++++N+L+ +    K++DFG++R I +++       +    +  PE     
Sbjct: 129 NYI---HRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFG 185
Query: 404 QFTDKSDVYSFGVVLLELLT-GKKP 427
            FT KS+V+SFG++L E++T GK P
Sbjct: 186 CFTIKSNVWSFGILLYEIVTYGKIP 210

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 111/219 (50%), Gaps = 23/219 (10%)
Query: 217 NYNQSRFLGQGGFGTVYKGM-LPDGS----IVAVKRSKEIDKTQIH-QFINEVVILSQIN 270
            + + + LG G FGTVYKG+ +P+G      VA+K  +E    + + + ++E  +++ ++
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 271 HRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVA 330
           + H+ +LLG CL + V  L+ + +  G L  ++ +H              L+W       
Sbjct: 79  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL-----LNW------C 126
Query: 331 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI-PNDKTHLTTTIQ 389
            ++A  + Y+       + HRD+ + N+L+      K++DFG+++ +   +K +     +
Sbjct: 127 VQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 183
Query: 390 GTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
               ++  E      +T +SDV+S+GV + EL+T G KP
Sbjct: 184 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 222

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 106/231 (45%), Gaps = 28/231 (12%)
Query: 217 NYNQSRF---LGQGGFGTVYKGMLPDGSI---VAVKRSKEIDKTQIHQ-FINEVVILSQI 269
           ++N  +F   +G+G FG V K  +    +    A+KR KE      H+ F  E+ +L ++
Sbjct: 23  DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKL 82
Query: 270 NHR-HIVKLLGCCLETEVPVLVYEYISSGTLSHHIHD----HXXXXXXXXXXXLSSLSWE 324
            H  +I+ LLG C       L  EY   G L   +                   S+LS +
Sbjct: 83  GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 142
Query: 325 NRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHL 384
             +  A +VA  + Y+     I   HRD+ + NIL+ + + AK++DFG+SR         
Sbjct: 143 QLLHFAADVARGMDYLSQKQFI---HRDLAARNILVGENYVAKIADFGLSRG-------Q 192
Query: 385 TTTIQGTFG-----YLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPIC 429
              ++ T G     ++  E    S +T  SDV+S+GV+L E+++ G  P C
Sbjct: 193 EVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC 243

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 111/219 (50%), Gaps = 23/219 (10%)
Query: 217 NYNQSRFLGQGGFGTVYKGM-LPDGS----IVAVKRSKEIDKTQIH-QFINEVVILSQIN 270
            + + + LG G FGTVYKG+ +P+G      VA+K  +E    + + + ++E  +++ ++
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 271 HRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVA 330
           + H+ +LLG CL + V  L+ + +  G L  ++ +H              L+W       
Sbjct: 79  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL-----LNW------C 126
Query: 331 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI-PNDKTHLTTTIQ 389
            ++A  + Y+       + HRD+ + N+L+      K++DFG+++ +   +K +     +
Sbjct: 127 VQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 183
Query: 390 GTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
               ++  E      +T +SDV+S+GV + EL+T G KP
Sbjct: 184 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 222

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 111/219 (50%), Gaps = 23/219 (10%)
Query: 217 NYNQSRFLGQGGFGTVYKGM-LPDGS----IVAVKRSKEIDKTQIH-QFINEVVILSQIN 270
            + + + LG G FGTVYKG+ +P+G      VA+K  +E    + + + ++E  +++ ++
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 271 HRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVA 330
           + H+ +LLG CL + V  L+ + +  G L  ++ +H              L+W       
Sbjct: 76  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL-----LNW------C 123
Query: 331 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI-PNDKTHLTTTIQ 389
            ++A  + Y+       + HRD+ + N+L+      K++DFG+++ +   +K +     +
Sbjct: 124 VQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 180
Query: 390 GTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
               ++  E      +T +SDV+S+GV + EL+T G KP
Sbjct: 181 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 81/303 (26%), Positives = 132/303 (43%), Gaps = 43/303 (14%)
Query: 216 DNYNQSRFLGQGGFGTVY--------KGMLPDGSIVAVKRSKEIDKTQ--IHQFINEVVI 265
           D     + LG+G FG V         K    +   VAVK  K+ D T+  +   ++E+ +
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD-DATEEDLSDLVSEMEM 93
Query: 266 LSQIN-HRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDH----XXXXXXXXXXXLSS 320
           +  I  H++I+ LLG C +     ++ EY S G L  ++                     
Sbjct: 94  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 321 LSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPN- 379
           +++++ V    ++A  + Y+ S   I   HRD+ + N+L+ +    K++DFG++R I N 
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCI---HRDLAARNVLVTENNVMKIADFGLARDINNI 210
Query: 380 DKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERN 438
           D    TT  +    ++ PE      +T +SDV+SFGV++ E+ T G  P     VEE   
Sbjct: 211 DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--- 267
Query: 439 LVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMR---CLRLNSKKRPTMKQVSM 495
                  L KE         R+ K A         EL M    C      +RPT KQ+  
Sbjct: 268 ----LFKLLKEGH-------RMDKPA-----NCTNELYMMMRDCWHAVPSQRPTFKQLVE 311
Query: 496 ELE 498
           +L+
Sbjct: 312 DLD 314

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 111/219 (50%), Gaps = 23/219 (10%)
Query: 217 NYNQSRFLGQGGFGTVYKGM-LPDGS----IVAVKRSKEIDKTQIH-QFINEVVILSQIN 270
            + + + LG G FGTVYKG+ +P+G      VA+K  +E    + + + ++E  +++ ++
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 271 HRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVA 330
           + H+ +LLG CL + V  L+ + +  G L  ++ +H              L+W       
Sbjct: 78  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL-----LNW------C 125
Query: 331 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI-PNDKTHLTTTIQ 389
            ++A  + Y+       + HRD+ + N+L+      K++DFG+++ +   +K +     +
Sbjct: 126 VQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 182
Query: 390 GTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
               ++  E      +T +SDV+S+GV + EL+T G KP
Sbjct: 183 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 221

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 111/219 (50%), Gaps = 23/219 (10%)
Query: 217 NYNQSRFLGQGGFGTVYKGM-LPDGS----IVAVKRSKEIDKTQIH-QFINEVVILSQIN 270
            + + + LG G FGTVYKG+ +P+G      VA+K  +E    + + + ++E  +++ ++
Sbjct: 23  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 271 HRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVA 330
           + H+ +LLG CL + V  L+ + +  G L  ++ +H              L+W       
Sbjct: 83  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL-----LNW------C 130
Query: 331 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI-PNDKTHLTTTIQ 389
            ++A  + Y+       + HRD+ + N+L+      K++DFG+++ +   +K +     +
Sbjct: 131 VQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 187
Query: 390 GTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
               ++  E      +T +SDV+S+GV + EL+T G KP
Sbjct: 188 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 226

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 106/231 (45%), Gaps = 28/231 (12%)
Query: 217 NYNQSRF---LGQGGFGTVYKGMLPDGSI---VAVKRSKEIDKTQIHQ-FINEVVILSQI 269
           ++N  +F   +G+G FG V K  +    +    A+KR KE      H+ F  E+ +L ++
Sbjct: 13  DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKL 72
Query: 270 NHR-HIVKLLGCCLETEVPVLVYEYISSGTLSHHIHD----HXXXXXXXXXXXLSSLSWE 324
            H  +I+ LLG C       L  EY   G L   +                   S+LS +
Sbjct: 73  GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 132
Query: 325 NRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHL 384
             +  A +VA  + Y+     I   HRD+ + NIL+ + + AK++DFG+SR         
Sbjct: 133 QLLHFAADVARGMDYLSQKQFI---HRDLAARNILVGENYVAKIADFGLSRG-------Q 182
Query: 385 TTTIQGTFG-----YLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPIC 429
              ++ T G     ++  E    S +T  SDV+S+GV+L E+++ G  P C
Sbjct: 183 EVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC 233

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 81/303 (26%), Positives = 132/303 (43%), Gaps = 43/303 (14%)
Query: 216 DNYNQSRFLGQGGFGTVY--------KGMLPDGSIVAVKRSKEIDKTQ--IHQFINEVVI 265
           D     + LG+G FG V         K    +   VAVK  K+ D T+  +   ++E+ +
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD-DATEKDLSDLVSEMEM 93
Query: 266 LSQIN-HRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXX----XXXLSS 320
           +  I  H++I+ LLG C +     ++ EY S G L  ++                     
Sbjct: 94  MKMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 321 LSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPN- 379
           +++++ V    ++A  + Y+ S   I   HRD+ + N+L+ +    K++DFG++R I N 
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCI---HRDLAARNVLVTENNVMKIADFGLARDINNI 210
Query: 380 DKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERN 438
           D    TT  +    ++ PE      +T +SDV+SFGV++ E+ T G  P     VEE   
Sbjct: 211 DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--- 267
Query: 439 LVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMR---CLRLNSKKRPTMKQVSM 495
                  L KE         R+ K A         EL M    C      +RPT KQ+  
Sbjct: 268 ----LFKLLKEGH-------RMDKPA-----NCTNELYMMMRDCWHAVPSQRPTFKQLVE 311
Query: 496 ELE 498
           +L+
Sbjct: 312 DLD 314

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 111/219 (50%), Gaps = 23/219 (10%)
Query: 217 NYNQSRFLGQGGFGTVYKGM-LPDGS----IVAVKRSKEIDKTQIH-QFINEVVILSQIN 270
            + + + LG G FGTVYKG+ +P+G      VA+K  +E    + + + ++E  +++ ++
Sbjct: 10  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 69
Query: 271 HRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVA 330
           + H+ +LLG CL + V  L+ + +  G L  ++ +H              L+W       
Sbjct: 70  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL-----LNW------C 117
Query: 331 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI-PNDKTHLTTTIQ 389
            ++A  + Y+       + HRD+ + N+L+      K++DFG+++ +   +K +     +
Sbjct: 118 VQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 174
Query: 390 GTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
               ++  E      +T +SDV+S+GV + EL+T G KP
Sbjct: 175 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 213

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 81/303 (26%), Positives = 132/303 (43%), Gaps = 43/303 (14%)
Query: 216 DNYNQSRFLGQGGFGTVY--------KGMLPDGSIVAVKRSKEIDKTQ--IHQFINEVVI 265
           D     + LG+G FG V         K    +   VAVK  K+ D T+  +   ++E+ +
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD-DATEKDLSDLVSEMEM 93
Query: 266 LSQIN-HRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDH----XXXXXXXXXXXLSS 320
           +  I  H++I+ LLG C +     ++ EY S G L  ++                     
Sbjct: 94  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 321 LSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPN- 379
           +++++ V    ++A  + Y+ S   I   HRD+ + N+L+ +    K++DFG++R I N 
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCI---HRDLAARNVLVTENNVMKIADFGLARDINNI 210
Query: 380 DKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERN 438
           D    TT  +    ++ PE      +T +SDV+SFGV++ E+ T G  P     VEE   
Sbjct: 211 DYYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--- 267
Query: 439 LVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMR---CLRLNSKKRPTMKQVSM 495
                  L KE         R+ K A         EL M    C      +RPT KQ+  
Sbjct: 268 ----LFKLLKEGH-------RMDKPA-----NCTNELYMMMRDCWHAVPSQRPTFKQLVE 311
Query: 496 ELE 498
           +L+
Sbjct: 312 DLD 314

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 111/219 (50%), Gaps = 23/219 (10%)
Query: 217 NYNQSRFLGQGGFGTVYKGM-LPDGS----IVAVKRSKEIDKTQIH-QFINEVVILSQIN 270
            + + + LG G FGTVYKG+ +P+G      VA+K  +E    + + + ++E  +++ ++
Sbjct: 41  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 100
Query: 271 HRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVA 330
           + H+ +LLG CL + V  L+ + +  G L  ++ +H              L+W       
Sbjct: 101 NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL-----LNW------C 148
Query: 331 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI-PNDKTHLTTTIQ 389
            ++A  + Y+       + HRD+ + N+L+      K++DFG+++ +   +K +     +
Sbjct: 149 VQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 205
Query: 390 GTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
               ++  E      +T +SDV+S+GV + EL+T G KP
Sbjct: 206 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 244

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 111/219 (50%), Gaps = 23/219 (10%)
Query: 217 NYNQSRFLGQGGFGTVYKGM-LPDGS----IVAVKRSKEIDKTQIH-QFINEVVILSQIN 270
            + + + LG G FGTVYKG+ +P+G      VA+K  +E    + + + ++E  +++ ++
Sbjct: 22  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 81
Query: 271 HRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVA 330
           + H+ +LLG CL + V  L+ + +  G L  ++ +H              L+W       
Sbjct: 82  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL-----LNW------C 129
Query: 331 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI-PNDKTHLTTTIQ 389
            ++A  + Y+       + HRD+ + N+L+      K++DFG+++ +   +K +     +
Sbjct: 130 VQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 186
Query: 390 GTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
               ++  E      +T +SDV+S+GV + EL+T G KP
Sbjct: 187 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 225

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 73/243 (30%), Positives = 109/243 (44%), Gaps = 27/243 (11%)
Query: 205 VFTADELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIH-----Q 258
           + +A + Q    NY   + +G+G F  V     +  G  VAVK    IDKTQ++     +
Sbjct: 4   ITSATDEQPHIGNYRLQKTIGKGNFAKVKLARHVLTGREVAVKI---IDKTQLNPTSLQK 60
Query: 259 FINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXL 318
              EV I+  +NH +IVKL       +   LV EY S G +  ++  H            
Sbjct: 61  LFREVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEK------ 114
Query: 319 SSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIP 378
                E R +   ++  AV Y H      I HRD+K+ N+LLD   + K++DFG S    
Sbjct: 115 -----EARAKFR-QIVSAVQYCHQKY---IVHRDLKAENLLLDGDMNIKIADFGFSNEFT 165
Query: 379 NDKTHLTTTIQGTFGYLDPEYFQSSQFTD-KSDVYSFGVVLLELLTGKKPICFARVEEER 437
                   T  G+  Y  PE FQ  ++   + DV+S GV+L  L++G  P     ++E R
Sbjct: 166 VGNK--LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELR 223
Query: 438 NLV 440
             V
Sbjct: 224 ERV 226

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 111/219 (50%), Gaps = 23/219 (10%)
Query: 217 NYNQSRFLGQGGFGTVYKGM-LPDGS----IVAVKRSKEIDKTQIH-QFINEVVILSQIN 270
            + + + LG G FGTVYKG+ +P+G      VA+K  +E    + + + ++E  +++ ++
Sbjct: 13  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 72
Query: 271 HRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVA 330
           + H+ +LLG CL + V  L+ + +  G L  ++ +H              L+W       
Sbjct: 73  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL-----LNW------C 120
Query: 331 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI-PNDKTHLTTTIQ 389
            ++A  + Y+       + HRD+ + N+L+      K++DFG+++ +   +K +     +
Sbjct: 121 VQIAEGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 177
Query: 390 GTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
               ++  E      +T +SDV+S+GV + EL+T G KP
Sbjct: 178 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 216

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 101/215 (46%), Gaps = 25/215 (11%)
Query: 224 LGQGGFGTVYKGMLPD-GSIVAVKRSK-EIDKTQIHQFINEVVILSQINHRHIVKL---- 277
           LG GGFG V + +  D G  VA+K+ + E+      ++  E+ I+ ++NH ++V      
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81
Query: 278 --LGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAG 335
             L      ++P+L  EY   G L  +++              + LS         +++ 
Sbjct: 82  DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLS---------DISS 132
Query: 336 AVAYMHSSASIPIFHRDIKSSNILLD---DKFSAKVSDFGISRSIPNDKTHLTTTIQGTF 392
           A+ Y+H +    I HRD+K  NI+L     +   K+ D G ++ +  D+  L T   GT 
Sbjct: 133 ALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQGELCTEFVGTL 187
Query: 393 GYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
            YL PE  +  ++T   D +SFG +  E +TG +P
Sbjct: 188 QYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRP 222

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 89/328 (27%), Positives = 143/328 (43%), Gaps = 38/328 (11%)
Query: 207 TADELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIH-----QFI 260
           +ADE Q    NY   + +G+G F  V     +  G  VAV+    IDKTQ++     +  
Sbjct: 6   SADE-QPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVRI---IDKTQLNSSSLQKLF 61
Query: 261 NEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSS 320
            EV I+  +NH +IVKL       +   LV EY S G +  ++  H              
Sbjct: 62  REVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEK-------- 113
Query: 321 LSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPND 380
              E R +   ++  AV Y H      I HRD+K+ N+LLD   + K++DFG S      
Sbjct: 114 ---EARAKFR-QIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFG 166
Query: 381 KTHLTTTIQGTFGYLDPEYFQSSQFTD-KSDVYSFGVVLLELLTGKKPICFARVEEERNL 439
                 T  G+  Y  PE FQ  ++   + DV+S GV+L  L++G  P     ++E R  
Sbjct: 167 NK--LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRER 224
Query: 440 V-------ACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQ 492
           V         ++S   EN L + L    +K    E I  M +  M     + + +P ++ 
Sbjct: 225 VLRGKYRIPFYMSTDCENLLKKFLILNPSKRGTLEQI--MKDRWMNVGHEDDELKPYVEP 282
Query: 493 VSMELEGLRRSQRCLEMCQVNQLLADEI 520
           +  + +  RR++  + M    + + D +
Sbjct: 283 LP-DYKDPRRTELMVSMGYTREEIQDSL 309

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 81/303 (26%), Positives = 132/303 (43%), Gaps = 43/303 (14%)
Query: 216 DNYNQSRFLGQGGFGTVY--------KGMLPDGSIVAVKRSKEIDKTQ--IHQFINEVVI 265
           D     + LG+G FG V         K    +   VAVK  K+ D T+  +   ++E+ +
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD-DATEKDLSDLVSEMEM 93
Query: 266 LSQIN-HRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXX----XXXLSS 320
           +  I  H++I+ LLG C +     ++ EY S G L  ++                     
Sbjct: 94  MKMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 321 LSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPN- 379
           +++++ V    ++A  + Y+ S   I   HRD+ + N+L+ +    K++DFG++R I N 
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCI---HRDLAARNVLVTENNVMKIADFGLARDINNI 210
Query: 380 DKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERN 438
           D    TT  +    ++ PE      +T +SDV+SFGV++ E+ T G  P     VEE   
Sbjct: 211 DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--- 267
Query: 439 LVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMR---CLRLNSKKRPTMKQVSM 495
                  L KE         R+ K A         EL M    C      +RPT KQ+  
Sbjct: 268 ----LFKLLKEGH-------RMDKPA-----NCTNELYMMMRDCWHAVPSQRPTFKQLVE 311
Query: 496 ELE 498
           +L+
Sbjct: 312 DLD 314

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 101/215 (46%), Gaps = 25/215 (11%)
Query: 224 LGQGGFGTVYKGMLPD-GSIVAVKRSK-EIDKTQIHQFINEVVILSQINHRHIVKL---- 277
           LG GGFG V + +  D G  VA+K+ + E+      ++  E+ I+ ++NH ++V      
Sbjct: 23  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 82
Query: 278 --LGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAG 335
             L      ++P+L  EY   G L  +++              + LS         +++ 
Sbjct: 83  DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLS---------DISS 133
Query: 336 AVAYMHSSASIPIFHRDIKSSNILLD---DKFSAKVSDFGISRSIPNDKTHLTTTIQGTF 392
           A+ Y+H +    I HRD+K  NI+L     +   K+ D G ++ +  D+  L T   GT 
Sbjct: 134 ALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQGELCTEFVGTL 188
Query: 393 GYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
            YL PE  +  ++T   D +SFG +  E +TG +P
Sbjct: 189 QYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRP 223

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 100/224 (44%), Gaps = 27/224 (12%)
Query: 215 TDNYNQSRFLGQGGFGTVYKG----MLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQIN 270
           +D Y     LG GG   V+      +  D ++  ++     D +   +F  E    + +N
Sbjct: 28  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 87
Query: 271 HRHIVKLLGCCLETEVPV-----LVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWEN 325
           H  IV +     E E P      +V EY+   TL   +H                ++ + 
Sbjct: 88  HPAIVAVYDTG-EAETPAGPLPYIVMEYVDGVTLRDIVHTE------------GPMTPKR 134
Query: 326 RVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLT 385
            + V  +   A+ + H +    I HRD+K +NI++    + KV DFGI+R+I +    +T
Sbjct: 135 AIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVT 191
Query: 386 TT--IQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
            T  + GT  YL PE  +      +SDVYS G VL E+LTG+ P
Sbjct: 192 QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 235

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 80/303 (26%), Positives = 132/303 (43%), Gaps = 43/303 (14%)
Query: 216 DNYNQSRFLGQGGFGTVY--------KGMLPDGSIVAVKRSKEIDKTQ--IHQFINEVVI 265
           D     + LG+G FG V         K    +   VAVK  K+ D T+  +   ++E+ +
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD-DATEKDLSDLVSEMEM 93
Query: 266 LSQIN-HRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXX----XXXLSS 320
           +  I  H++I+ LLG C +     ++ EY S G L  ++                     
Sbjct: 94  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 321 LSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPN- 379
           +++++ V    ++A  + Y+ S   I   HRD+ + N+L+ +    +++DFG++R I N 
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCI---HRDLAARNVLVTENNVMRIADFGLARDINNI 210
Query: 380 DKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERN 438
           D    TT  +    ++ PE      +T +SDV+SFGV++ E+ T G  P     VEE   
Sbjct: 211 DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--- 267
Query: 439 LVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMR---CLRLNSKKRPTMKQVSM 495
                  L KE         R+ K A         EL M    C      +RPT KQ+  
Sbjct: 268 ----LFKLLKEGH-------RMDKPA-----NCTNELYMMMRDCWHAVPSQRPTFKQLVE 311
Query: 496 ELE 498
           +L+
Sbjct: 312 DLD 314

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 87/321 (27%), Positives = 138/321 (42%), Gaps = 43/321 (13%)
Query: 217 NYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIH-----QFINEVVILSQIN 270
           NY   + +G+G F  V     +  G  VAVK    IDKTQ++     +   EV I+  +N
Sbjct: 8   NYRLLKTIGKGNFAKVKLARHILTGKEVAVKI---IDKTQLNSSSLQKLFREVRIMKVLN 64
Query: 271 HRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSW--ENRVR 328
           H +IVKL       +   LV EY S G +  ++  H                W  E   R
Sbjct: 65  HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAH---------------GWMKEKEAR 109
Query: 329 VAC-EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
               ++  AV Y H      I HRD+K+ N+LLD   + K++DFG S            T
Sbjct: 110 AKFRQIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK--LDT 164
Query: 388 IQGTFGYLDPEYFQSSQFTD-KSDVYSFGVVLLELLTGKKPICFARVEEERNLV------ 440
             G+  Y  PE FQ  ++   + DV+S GV+L  L++G  P     ++E R  V      
Sbjct: 165 FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYR 224
Query: 441 -ACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEG 499
              ++S   EN L + L    +K    E I  M +  M     + + +P ++ +  + + 
Sbjct: 225 IPFYMSTDCENLLKKFLILNPSKRGTLEQI--MKDRWMNVGHEDDELKPYVEPLP-DYKD 281
Query: 500 LRRSQRCLEMCQVNQLLADEI 520
            RR++  + M    + + D +
Sbjct: 282 PRRTELMVSMGYTREEIQDSL 302

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 80/292 (27%), Positives = 130/292 (44%), Gaps = 37/292 (12%)
Query: 224 LGQGGFGTVYK----GMLPDG----SIVAVKRSK-EIDKTQIHQFINEVVILSQIN-HRH 273
           LG+G FG V      G+  D     + VAVK  K +  +  +   I+E+ ++  I  H++
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 274 IVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXX----XXXXXLSSLSWENRVRV 329
           I+ LLG C +     ++ EY S G L  ++                     LS ++ V  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSC 155
Query: 330 ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPN-DKTHLTTTI 388
           A +VA  + Y+ S   I   HRD+ + N+L+ +    K++DFG++R I + D    TT  
Sbjct: 156 AYQVARGMEYLASKKCI---HRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNG 212
Query: 389 QGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLA 447
           +    ++ PE      +T +SDV+SFGV+L E+ T G  P     VEE          L 
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE-------LFKLL 265
Query: 448 KENQLLEILDARVAKEAREEDIGAMAELAMR-CLRLNSKKRPTMKQVSMELE 498
           KE   ++          +  +      + MR C      +RPT KQ+  +L+
Sbjct: 266 KEGHRMD----------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 307

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 102/213 (47%), Gaps = 19/213 (8%)
Query: 222 RFLGQGGFGTVYKGML------PDGSIVAVKRSKEIDKTQIH-QFINEVVILSQINHRHI 274
           R LG G FG VY+G +      P    VAVK   E+   Q    F+ E +I+S+ NH++I
Sbjct: 37  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 96
Query: 275 VKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVA 334
           V+ +G  L++    ++ E ++ G L   + +             SSL+  + + VA ++A
Sbjct: 97  VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQP-----SSLAMLDLLHVARDIA 151
Query: 335 GAVAYMHSSASIPIFHRDIKSSNILL---DDKFSAKVSDFGISRSIPNDKTHLTTTIQG- 390
               Y+  +  I   HRDI + N LL        AK+ DFG+++ I     +        
Sbjct: 152 CGCQYLEENHFI---HRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAML 208
Query: 391 TFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT 423
              ++ PE F    FT K+D +SFGV+L E+ +
Sbjct: 209 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 81/303 (26%), Positives = 132/303 (43%), Gaps = 43/303 (14%)
Query: 216 DNYNQSRFLGQGGFGTVY--------KGMLPDGSIVAVKRSKEIDKTQ--IHQFINEVVI 265
           D     + LG+G FG V         K    +   VAVK  K+ D T+  +   ++E+ +
Sbjct: 22  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD-DATEKDLSDLVSEMEM 80
Query: 266 LSQIN-HRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDH----XXXXXXXXXXXLSS 320
           +  I  H++I+ LLG C +     ++ EY S G L  ++                     
Sbjct: 81  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 140
Query: 321 LSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPN- 379
           +++++ V    ++A  + Y+ S   I   HRD+ + N+L+ +    K++DFG++R I N 
Sbjct: 141 MTFKDLVSCTYQLARGMEYLASQKCI---HRDLTARNVLVTENNVMKIADFGLARDINNI 197
Query: 380 DKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERN 438
           D    TT  +    ++ PE      +T +SDV+SFGV++ E+ T G  P     VEE   
Sbjct: 198 DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--- 254
Query: 439 LVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMR---CLRLNSKKRPTMKQVSM 495
                  L KE         R+ K A         EL M    C      +RPT KQ+  
Sbjct: 255 ----LFKLLKEGH-------RMDKPA-----NCTNELYMMMRDCWHAVPSQRPTFKQLVE 298
Query: 496 ELE 498
           +L+
Sbjct: 299 DLD 301

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 81/295 (27%), Positives = 133/295 (45%), Gaps = 43/295 (14%)
Query: 224 LGQGGFGTVYK----GMLPDG----SIVAVKRSK-EIDKTQIHQFINEVVILSQIN-HRH 273
           LG+G FG V      G+  D     + VAVK  K +  +  +   I+E+ ++  I  H++
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 274 IVKLLGCCLETEVPVLVYEYISSGTLSHHIH-------DHXXXXXXXXXXXLSSLSWENR 326
           I+ LLG C +     ++ EY S G L  ++        ++           LSS   ++ 
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS---KDL 193
Query: 327 VRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPN-DKTHLT 385
           V  A +VA  + Y+ S   I   HRD+ + N+L+ +    K++DFG++R I + D    T
Sbjct: 194 VSCAYQVARGMEYLASKKCI---HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 250
Query: 386 TTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFI 444
           T  +    ++ PE      +T +SDV+SFGV+L E+ T G  P     VEE         
Sbjct: 251 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE-------LF 303
Query: 445 SLAKENQLLEILDARVAKEAREEDIGAMAELAMR-CLRLNSKKRPTMKQVSMELE 498
            L KE   ++          +  +      + MR C      +RPT KQ+  +L+
Sbjct: 304 KLLKEGHRMD----------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 348

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 80/310 (25%), Positives = 137/310 (44%), Gaps = 33/310 (10%)
Query: 206 FTADELQRATDNYNQSRFLGQGGFGTVYK----GMLPDGS--IVAVKRSKEIDKTQIHQ- 258
           + A + +   D     + LG+G FG V +    G+    +   VAVK  KE      H+ 
Sbjct: 17  YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 76
Query: 259 FINEVVILSQINHR-HIVKLLGCCLETEVPVLV-YEYISSGTLSHHI----HDHXXXXXX 312
            ++E+ IL  I H  ++V LLG C +   P++V  E+   G LS ++    ++       
Sbjct: 77  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 136
Query: 313 XXXXXLSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG 372
                   L+ E+ +  + +VA  + ++ S   I   HRD+ + NILL +K   K+ DFG
Sbjct: 137 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILLSEKNVVKICDFG 193
Query: 373 ISRSIPNDKTHLTT-TIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICF 430
           ++R I  D  ++     +    ++ PE      +T +SDV+SFGV+L E+ + G  P   
Sbjct: 194 LARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253
Query: 431 ARVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTM 490
            +++EE      F    KE   +   D    +         M +  + C      +RPT 
Sbjct: 254 VKIDEE------FCRRLKEGTRMRAPDYTTPE---------MYQTMLDCWHGEPSQRPTF 298
Query: 491 KQVSMELEGL 500
            ++   L  L
Sbjct: 299 SELVEHLGNL 308

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 81/303 (26%), Positives = 132/303 (43%), Gaps = 43/303 (14%)
Query: 216 DNYNQSRFLGQGGFGTVY--------KGMLPDGSIVAVKRSKEIDKTQ--IHQFINEVVI 265
           D     + LG+G FG V         K    +   VAVK  K+ D T+  +   ++E+ +
Sbjct: 27  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD-DATEKDLSDLVSEMEM 85
Query: 266 LSQIN-HRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXX----XXXLSS 320
           +  I  H++I+ LLG C +     ++ EY S G L  ++                     
Sbjct: 86  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 145
Query: 321 LSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPN- 379
           +++++ V    ++A  + Y+ S   I   HRD+ + N+L+ +    K++DFG++R I N 
Sbjct: 146 MTFKDLVSCTYQLARGMEYLASQKCI---HRDLAARNVLVTENNVMKIADFGLARDINNI 202
Query: 380 DKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERN 438
           D    TT  +    ++ PE      +T +SDV+SFGV++ E+ T G  P     VEE   
Sbjct: 203 DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--- 259
Query: 439 LVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMR---CLRLNSKKRPTMKQVSM 495
                  L KE         R+ K A         EL M    C      +RPT KQ+  
Sbjct: 260 ----LFKLLKEGH-------RMDKPA-----NCTNELYMMMRDCWHAVPSQRPTFKQLVE 303
Query: 496 ELE 498
           +L+
Sbjct: 304 DLD 306

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 110/219 (50%), Gaps = 23/219 (10%)
Query: 217 NYNQSRFLGQGGFGTVYKGM-LPDGS----IVAVKRSKEIDKTQIH-QFINEVVILSQIN 270
            + + + LG G FGTVYKG+ +P+G      VA+K  +E    + + + ++E  +++ ++
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 271 HRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVA 330
           + H+ +LLG CL + V  L+ + +  G L  ++ +H              L+W       
Sbjct: 78  NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYL-----LNW------C 125
Query: 331 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI-PNDKTHLTTTIQ 389
            ++A  + Y+       + HRD+ + N+L+      K++DFG ++ +   +K +     +
Sbjct: 126 VQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGK 182
Query: 390 GTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
               ++  E      +T +SDV+S+GV + EL+T G KP
Sbjct: 183 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 221

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 80/310 (25%), Positives = 137/310 (44%), Gaps = 33/310 (10%)
Query: 206 FTADELQRATDNYNQSRFLGQGGFGTVYK----GMLPDGS--IVAVKRSKEIDKTQIHQ- 258
           + A + +   D     + LG+G FG V +    G+    +   VAVK  KE      H+ 
Sbjct: 19  YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 78
Query: 259 FINEVVILSQINHR-HIVKLLGCCLETEVPVLV-YEYISSGTLSHHI----HDHXXXXXX 312
            ++E+ IL  I H  ++V LLG C +   P++V  E+   G LS ++    ++       
Sbjct: 79  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEA 138
Query: 313 XXXXXLSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG 372
                   L+ E+ +  + +VA  + ++ S   I   HRD+ + NILL +K   K+ DFG
Sbjct: 139 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILLSEKNVVKICDFG 195
Query: 373 ISRSIPNDKTHLTT-TIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICF 430
           ++R I  D  ++     +    ++ PE      +T +SDV+SFGV+L E+ + G  P   
Sbjct: 196 LARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 255
Query: 431 ARVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTM 490
            +++EE      F    KE   +   D    +         M +  + C      +RPT 
Sbjct: 256 VKIDEE------FCRRLKEGTRMRAPDYTTPE---------MYQTMLDCWHGEPSQRPTF 300
Query: 491 KQVSMELEGL 500
            ++   L  L
Sbjct: 301 SELVEHLGNL 310

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 81/295 (27%), Positives = 133/295 (45%), Gaps = 43/295 (14%)
Query: 224 LGQGGFGTVYK----GMLPDG----SIVAVKRSK-EIDKTQIHQFINEVVILSQIN-HRH 273
           LG+G FG V      G+  D     + VAVK  K +  +  +   I+E+ ++  I  H++
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 274 IVKLLGCCLETEVPVLVYEYISSGTLSHHIH-------DHXXXXXXXXXXXLSSLSWENR 326
           I+ LLG C +     ++ EY S G L  ++        ++           LSS   ++ 
Sbjct: 88  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS---KDL 144
Query: 327 VRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPN-DKTHLT 385
           V  A +VA  + Y+ S   I   HRD+ + N+L+ +    K++DFG++R I + D    T
Sbjct: 145 VSCAYQVARGMEYLASKKCI---HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 201
Query: 386 TTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFI 444
           T  +    ++ PE      +T +SDV+SFGV+L E+ T G  P     VEE         
Sbjct: 202 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE-------LF 254
Query: 445 SLAKENQLLEILDARVAKEAREEDIGAMAELAMR-CLRLNSKKRPTMKQVSMELE 498
            L KE   ++          +  +      + MR C      +RPT KQ+  +L+
Sbjct: 255 KLLKEGHRMD----------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 299

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 81/303 (26%), Positives = 132/303 (43%), Gaps = 43/303 (14%)
Query: 216 DNYNQSRFLGQGGFGTVY--------KGMLPDGSIVAVKRSKEIDKTQ--IHQFINEVVI 265
           D     + LG+G FG V         K    +   VAVK  K+ D T+  +   ++E+ +
Sbjct: 24  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD-DATEKDLSDLVSEMEM 82
Query: 266 LSQIN-HRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXX----XXXLSS 320
           +  I  H++I+ LLG C +     ++ EY S G L  ++                     
Sbjct: 83  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 142
Query: 321 LSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPN- 379
           +++++ V    ++A  + Y+ S   I   HRD+ + N+L+ +    K++DFG++R I N 
Sbjct: 143 MTFKDLVSCTYQLARGMEYLASQKCI---HRDLAARNVLVTENNVMKIADFGLARDINNI 199
Query: 380 DKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERN 438
           D    TT  +    ++ PE      +T +SDV+SFGV++ E+ T G  P     VEE   
Sbjct: 200 DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--- 256
Query: 439 LVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMR---CLRLNSKKRPTMKQVSM 495
                  L KE         R+ K A         EL M    C      +RPT KQ+  
Sbjct: 257 ----LFKLLKEGH-------RMDKPA-----NCTNELYMMMRDCWHAVPSQRPTFKQLVE 300
Query: 496 ELE 498
           +L+
Sbjct: 301 DLD 303

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 81/295 (27%), Positives = 133/295 (45%), Gaps = 43/295 (14%)
Query: 224 LGQGGFGTVYK----GMLPDG----SIVAVKRSK-EIDKTQIHQFINEVVILSQIN-HRH 273
           LG+G FG V      G+  D     + VAVK  K +  +  +   I+E+ ++  I  H++
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 274 IVKLLGCCLETEVPVLVYEYISSGTLSHHIH-------DHXXXXXXXXXXXLSSLSWENR 326
           I+ LLG C +     ++ EY S G L  ++        ++           LSS   ++ 
Sbjct: 89  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS---KDL 145
Query: 327 VRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPN-DKTHLT 385
           V  A +VA  + Y+ S   I   HRD+ + N+L+ +    K++DFG++R I + D    T
Sbjct: 146 VSCAYQVARGMEYLASKKCI---HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 202
Query: 386 TTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFI 444
           T  +    ++ PE      +T +SDV+SFGV+L E+ T G  P     VEE         
Sbjct: 203 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE-------LF 255
Query: 445 SLAKENQLLEILDARVAKEAREEDIGAMAELAMR-CLRLNSKKRPTMKQVSMELE 498
            L KE   ++          +  +      + MR C      +RPT KQ+  +L+
Sbjct: 256 KLLKEGHRMD----------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 300

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 110/219 (50%), Gaps = 23/219 (10%)
Query: 217 NYNQSRFLGQGGFGTVYKGM-LPDGS----IVAVKRSKEIDKTQIH-QFINEVVILSQIN 270
            + + + LG G FGTVYKG+ +P+G      VA+K  +E    + + + ++E  +++ ++
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 79
Query: 271 HRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVA 330
           + H+ +LLG CL + V  L+ + +  G L  ++ +H              L+W       
Sbjct: 80  NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYL-----LNW------C 127
Query: 331 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI-PNDKTHLTTTIQ 389
            ++A  + Y+       + HRD+ + N+L+      K++DFG ++ +   +K +     +
Sbjct: 128 VQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGK 184
Query: 390 GTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
               ++  E      +T +SDV+S+GV + EL+T G KP
Sbjct: 185 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 223

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 81/295 (27%), Positives = 133/295 (45%), Gaps = 43/295 (14%)
Query: 224 LGQGGFGTVYK----GMLPDG----SIVAVKRSK-EIDKTQIHQFINEVVILSQIN-HRH 273
           LG+G FG V      G+  D     + VAVK  K +  +  +   I+E+ ++  I  H++
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 274 IVKLLGCCLETEVPVLVYEYISSGTLSHHIH-------DHXXXXXXXXXXXLSSLSWENR 326
           I+ LLG C +     ++ EY S G L  ++        ++           LSS   ++ 
Sbjct: 85  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS---KDL 141
Query: 327 VRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPN-DKTHLT 385
           V  A +VA  + Y+ S   I   HRD+ + N+L+ +    K++DFG++R I + D    T
Sbjct: 142 VSCAYQVARGMEYLASKKCI---HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 198
Query: 386 TTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFI 444
           T  +    ++ PE      +T +SDV+SFGV+L E+ T G  P     VEE         
Sbjct: 199 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE-------LF 251
Query: 445 SLAKENQLLEILDARVAKEAREEDIGAMAELAMR-CLRLNSKKRPTMKQVSMELE 498
            L KE   ++          +  +      + MR C      +RPT KQ+  +L+
Sbjct: 252 KLLKEGHRMD----------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 296

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 80/310 (25%), Positives = 137/310 (44%), Gaps = 33/310 (10%)
Query: 206 FTADELQRATDNYNQSRFLGQGGFGTVYK----GMLPDGS--IVAVKRSKEIDKTQIHQ- 258
           + A + +   D     + LG+G FG V +    G+    +   VAVK  KE      H+ 
Sbjct: 54  YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 113
Query: 259 FINEVVILSQINHR-HIVKLLGCCLETEVPVLV-YEYISSGTLSHHI----HDHXXXXXX 312
            ++E+ IL  I H  ++V LLG C +   P++V  E+   G LS ++    ++       
Sbjct: 114 LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 173
Query: 313 XXXXXLSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG 372
                   L+ E+ +  + +VA  + ++ S   I   HRD+ + NILL +K   K+ DFG
Sbjct: 174 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILLSEKNVVKICDFG 230
Query: 373 ISRSIPNDKTHLTT-TIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICF 430
           ++R I  D  ++     +    ++ PE      +T +SDV+SFGV+L E+ + G  P   
Sbjct: 231 LARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 290
Query: 431 ARVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTM 490
            +++EE      F    KE   +   D    +         M +  + C      +RPT 
Sbjct: 291 VKIDEE------FCRRLKEGTRMRAPDYTTPE---------MYQTMLDCWHGEPSQRPTF 335
Query: 491 KQVSMELEGL 500
            ++   L  L
Sbjct: 336 SELVEHLGNL 345

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 80/292 (27%), Positives = 130/292 (44%), Gaps = 37/292 (12%)
Query: 224 LGQGGFGTVYK----GMLPDG----SIVAVKRSK-EIDKTQIHQFINEVVILSQIN-HRH 273
           LG+G FG V      G+  D     + VAVK  K +  +  +   I+E+ ++  I  H++
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 274 IVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXX----XXXXXLSSLSWENRVRV 329
           I+ LLG C +     ++ EY S G L  ++                     LS ++ V  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 155
Query: 330 ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPN-DKTHLTTTI 388
           A +VA  + Y+ S   I   HRD+ + N+L+ +    K++DFG++R I + D    TT  
Sbjct: 156 AYQVARGMEYLASKKCI---HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 389 QGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLA 447
           +    ++ PE      +T +SDV+SFGV+L E+ T G  P     VEE          L 
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE-------LFKLL 265
Query: 448 KENQLLEILDARVAKEAREEDIGAMAELAMR-CLRLNSKKRPTMKQVSMELE 498
           KE   ++          +  +      + MR C      +RPT KQ+  +L+
Sbjct: 266 KEGHRMD----------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 307

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 80/310 (25%), Positives = 137/310 (44%), Gaps = 33/310 (10%)
Query: 206 FTADELQRATDNYNQSRFLGQGGFGTVYK----GMLPDGS--IVAVKRSKEIDKTQIHQ- 258
           + A + +   D     + LG+G FG V +    G+    +   VAVK  KE      H+ 
Sbjct: 8   YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 67
Query: 259 FINEVVILSQINHR-HIVKLLGCCLETEVPVLVY-EYISSGTLSHHI----HDHXXXXXX 312
            ++E+ IL  I H  ++V LLG C +   P++V  E+   G LS ++    ++       
Sbjct: 68  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVA 127
Query: 313 XXXXXLSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG 372
                   L+ E+ +  + +VA  + ++ S   I   HRD+ + NILL +K   K+ DFG
Sbjct: 128 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILLSEKNVVKICDFG 184
Query: 373 ISRSIPNDKTHLTT-TIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICF 430
           ++R I  D  ++     +    ++ PE      +T +SDV+SFGV+L E+ + G  P   
Sbjct: 185 LARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 244
Query: 431 ARVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTM 490
            +++EE      F    KE   +   D    +         M +  + C      +RPT 
Sbjct: 245 VKIDEE------FCRRLKEGTRMRAPDYTTPE---------MYQTMLDCWHGEPSQRPTF 289
Query: 491 KQVSMELEGL 500
            ++   L  L
Sbjct: 290 SELVEHLGNL 299

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 81/295 (27%), Positives = 133/295 (45%), Gaps = 43/295 (14%)
Query: 224 LGQGGFGTVYK----GMLPDG----SIVAVKRSK-EIDKTQIHQFINEVVILSQIN-HRH 273
           LG+G FG V      G+  D     + VAVK  K +  +  +   I+E+ ++  I  H++
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 274 IVKLLGCCLETEVPVLVYEYISSGTLSHHIH-------DHXXXXXXXXXXXLSSLSWENR 326
           I+ LLG C +     ++ EY S G L  ++        ++           LSS   ++ 
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS---KDL 152
Query: 327 VRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPN-DKTHLT 385
           V  A +VA  + Y+ S   I   HRD+ + N+L+ +    K++DFG++R I + D    T
Sbjct: 153 VSCAYQVARGMEYLASKKCI---HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 209
Query: 386 TTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFI 444
           T  +    ++ PE      +T +SDV+SFGV+L E+ T G  P     VEE         
Sbjct: 210 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE-------LF 262
Query: 445 SLAKENQLLEILDARVAKEAREEDIGAMAELAMR-CLRLNSKKRPTMKQVSMELE 498
            L KE   ++          +  +      + MR C      +RPT KQ+  +L+
Sbjct: 263 KLLKEGHRMD----------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 307

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 110/219 (50%), Gaps = 23/219 (10%)
Query: 217 NYNQSRFLGQGGFGTVYKGM-LPDGS----IVAVKRSKEIDKTQIH-QFINEVVILSQIN 270
            + + + LG G FGTVYKG+ +P+G      VA+K  +E    + + + ++E  +++ ++
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 271 HRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVA 330
           + H+ +LLG CL + V  L+ + +  G L  ++ +H              L+W       
Sbjct: 78  NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYL-----LNW------C 125
Query: 331 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI-PNDKTHLTTTIQ 389
            ++A  + Y+       + HRD+ + N+L+      K++DFG ++ +   +K +     +
Sbjct: 126 VQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGK 182
Query: 390 GTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
               ++  E      +T +SDV+S+GV + EL+T G KP
Sbjct: 183 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 221

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 106/231 (45%), Gaps = 28/231 (12%)
Query: 217 NYNQSRF---LGQGGFGTVYKGMLPDGSI---VAVKRSKEIDKTQIHQ-FINEVVILSQI 269
           ++N  +F   +G+G FG V K  +    +    A+KR KE      H+ F  E+ +L ++
Sbjct: 20  DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKL 79
Query: 270 NHR-HIVKLLGCCLETEVPVLVYEYISSGTLSHHIHD----HXXXXXXXXXXXLSSLSWE 324
            H  +I+ LLG C       L  EY   G L   +                   S+LS +
Sbjct: 80  GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 139
Query: 325 NRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHL 384
             +  A +VA  + Y+     I   HR++ + NIL+ + + AK++DFG+SR         
Sbjct: 140 QLLHFAADVARGMDYLSQKQFI---HRNLAARNILVGENYVAKIADFGLSRG-------Q 189
Query: 385 TTTIQGTFG-----YLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPIC 429
              ++ T G     ++  E    S +T  SDV+S+GV+L E+++ G  P C
Sbjct: 190 EVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC 240

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 81/295 (27%), Positives = 133/295 (45%), Gaps = 43/295 (14%)
Query: 224 LGQGGFGTVYK----GMLPDG----SIVAVKRSK-EIDKTQIHQFINEVVILSQIN-HRH 273
           LG+G FG V      G+  D     + VAVK  K +  +  +   I+E+ ++  I  H++
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 274 IVKLLGCCLETEVPVLVYEYISSGTLSHHIH-------DHXXXXXXXXXXXLSSLSWENR 326
           I+ LLG C +     ++ EY S G L  ++        ++           LSS   ++ 
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSS---KDL 152
Query: 327 VRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPN-DKTHLT 385
           V  A +VA  + Y+ S   I   HRD+ + N+L+ +    K++DFG++R I + D    T
Sbjct: 153 VSCAYQVARGMEYLASKKCI---HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 209
Query: 386 TTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFI 444
           T  +    ++ PE      +T +SDV+SFGV+L E+ T G  P     VEE         
Sbjct: 210 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE-------LF 262
Query: 445 SLAKENQLLEILDARVAKEAREEDIGAMAELAMR-CLRLNSKKRPTMKQVSMELE 498
            L KE   ++          +  +      + MR C      +RPT KQ+  +L+
Sbjct: 263 KLLKEGHRMD----------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 307

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 81/303 (26%), Positives = 132/303 (43%), Gaps = 43/303 (14%)
Query: 216 DNYNQSRFLGQGGFGTVY--------KGMLPDGSIVAVKRSKEIDKTQ--IHQFINEVVI 265
           D     + LG+G FG V         K    +   VAVK  K+ D T+  +   ++E+ +
Sbjct: 81  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD-DATEKDLSDLVSEMEM 139
Query: 266 LSQIN-HRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXX----XXXLSS 320
           +  I  H++I+ LLG C +     ++ EY S G L  ++                     
Sbjct: 140 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 199
Query: 321 LSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPN- 379
           +++++ V    ++A  + Y+ S   I   HRD+ + N+L+ +    K++DFG++R I N 
Sbjct: 200 MTFKDLVSCTYQLARGMEYLASQKCI---HRDLAARNVLVTENNVMKIADFGLARDINNI 256
Query: 380 DKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERN 438
           D    TT  +    ++ PE      +T +SDV+SFGV++ E+ T G  P     VEE   
Sbjct: 257 DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--- 313
Query: 439 LVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMR---CLRLNSKKRPTMKQVSM 495
                  L KE         R+ K A         EL M    C      +RPT KQ+  
Sbjct: 314 ----LFKLLKEGH-------RMDKPA-----NCTNELYMMMRDCWHAVPSQRPTFKQLVE 357
Query: 496 ELE 498
           +L+
Sbjct: 358 DLD 360

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 110/219 (50%), Gaps = 23/219 (10%)
Query: 217 NYNQSRFLGQGGFGTVYKGM-LPDGS----IVAVKRSKEIDKTQIH-QFINEVVILSQIN 270
            + + + LG G FGTVYKG+ +P+G      VA+K  +E    + + + ++E  +++ ++
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 271 HRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVA 330
           + H+ +LLG CL + V  L+ + +  G L  ++ +H              L+W       
Sbjct: 78  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL-----LNW------C 125
Query: 331 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI-PNDKTHLTTTIQ 389
            ++A  + Y+       + HRD+ + N+L+      K++DFG ++ +   +K +     +
Sbjct: 126 VQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGK 182
Query: 390 GTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
               ++  E      +T +SDV+S+GV + EL+T G KP
Sbjct: 183 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 221

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 110/219 (50%), Gaps = 23/219 (10%)
Query: 217 NYNQSRFLGQGGFGTVYKGM-LPDGS----IVAVKRSKEIDKTQIH-QFINEVVILSQIN 270
            + + + LG G FGTVYKG+ +P+G      VA+   +E    + + + ++E  +++ ++
Sbjct: 50  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVD 109
Query: 271 HRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVA 330
           + H+ +LLG CL + V  L+ + +  G L  ++ +H              L+W       
Sbjct: 110 NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL-----LNW------C 157
Query: 331 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI-PNDKTHLTTTIQ 389
            ++A  + Y+       + HRD+ + N+L+      K++DFG+++ +   +K +     +
Sbjct: 158 VQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 214
Query: 390 GTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
               ++  E      +T +SDV+S+GV + EL+T G KP
Sbjct: 215 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 253

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 80/292 (27%), Positives = 130/292 (44%), Gaps = 37/292 (12%)
Query: 224 LGQGGFGTVYK----GMLPDG----SIVAVKRSK-EIDKTQIHQFINEVVILSQIN-HRH 273
           LG+G FG V      G+  D     + VAVK  K +  +  +   I+E+ ++  I  H++
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 274 IVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXX----XXXXXLSSLSWENRVRV 329
           I+ LLG C +     ++ EY S G L  ++                     LS ++ V  
Sbjct: 81  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 140
Query: 330 ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPN-DKTHLTTTI 388
           A +VA  + Y+ S   I   HRD+ + N+L+ +    K++DFG++R I + D    TT  
Sbjct: 141 AYQVARGMEYLASKKCI---HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 197
Query: 389 QGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLA 447
           +    ++ PE      +T +SDV+SFGV+L E+ T G  P     VEE          L 
Sbjct: 198 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE-------LFKLL 250
Query: 448 KENQLLEILDARVAKEAREEDIGAMAELAMR-CLRLNSKKRPTMKQVSMELE 498
           KE   ++          +  +      + MR C      +RPT KQ+  +L+
Sbjct: 251 KEGHRMD----------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 292

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 82/295 (27%), Positives = 131/295 (44%), Gaps = 26/295 (8%)
Query: 224 LGQGGFGTV----YKGMLPD-GSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLL 278
           LG+G FG+V    Y  +  + G++VAVK+ +     Q   F  E+ IL  ++   IVK  
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 279 GCCLET--EVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGA 336
           G       +   LV EY+ SG L   +  H            SS           ++   
Sbjct: 91  GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSS-----------QICKG 139
Query: 337 VAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQG---TFG 393
           + Y+ S   +   HRD+ + NIL++ +   K++DFG+++ +P DK +      G    F 
Sbjct: 140 MEYLGSRRCV---HRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFW 196
Query: 394 YLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLL 453
           Y  PE    + F+ +SDV+SFGVVL EL T     C    E  R ++ C   +   ++LL
Sbjct: 197 YA-PESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLR-MMGCERDVPALSRLL 254
Query: 454 EILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRSQRCLE 508
           E+L+      A       + EL   C   + + RP+   +  +L+ L    R  E
Sbjct: 255 ELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCE 309

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 110/219 (50%), Gaps = 23/219 (10%)
Query: 217 NYNQSRFLGQGGFGTVYKGM-LPDGS----IVAVKRSKEIDKTQIH-QFINEVVILSQIN 270
            + + + LG G FGTVYKG+ +P+G      VA+K  +E    + + + ++E  +++ ++
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 271 HRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVA 330
           + H+ +LLG CL + V  L+ + +  G L  ++ +H              L+W       
Sbjct: 76  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL-----LNW------C 123
Query: 331 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI-PNDKTHLTTTIQ 389
            ++A  + Y+       + HRD+ + N+L+      K++DFG ++ +   +K +     +
Sbjct: 124 VQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGK 180
Query: 390 GTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
               ++  E      +T +SDV+S+GV + EL+T G KP
Sbjct: 181 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 110/219 (50%), Gaps = 23/219 (10%)
Query: 217 NYNQSRFLGQGGFGTVYKGM-LPDGS----IVAVKRSKEIDKTQIH-QFINEVVILSQIN 270
            + + + LG G FGTVYKG+ +P+G      VA+K  +E    + + + ++E  +++ ++
Sbjct: 23  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 271 HRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVA 330
           + H+ +LLG CL + V  L+ + +  G L  ++ +H              L+W       
Sbjct: 83  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL-----LNW------C 130
Query: 331 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI-PNDKTHLTTTIQ 389
            ++A  + Y+       + HRD+ + N+L+      K++DFG ++ +   +K +     +
Sbjct: 131 VQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGK 187
Query: 390 GTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
               ++  E      +T +SDV+S+GV + EL+T G KP
Sbjct: 188 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 226

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/297 (23%), Positives = 135/297 (45%), Gaps = 40/297 (13%)
Query: 222 RFLGQGGFGTVYKG--MLPDGS--IVAVKRSKE-IDKTQIHQFINEVVILSQINHRHIVK 276
           + +G G FG V  G   LP      VA+K  K    + Q   F++E  I+ Q +H +++ 
Sbjct: 13  QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIH 72
Query: 277 LLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGA 336
           L G   ++   +++ E++ +G+L   +  +                    +++   + G 
Sbjct: 73  LEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTV--------------IQLVGMLRGI 118
Query: 337 VAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT--IQGTFG- 393
            A M   A +   HR + + NIL++     KVSDFG+SR + +D +  T T  + G    
Sbjct: 119 AAGMKYLADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPI 178
Query: 394 -YLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQ 451
            +  PE  Q  +FT  SDV+S+G+V+ E+++ G++P      ++  N      ++ ++ +
Sbjct: 179 RWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVIN------AIEQDYR 232
Query: 452 LLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRSQRCLE 508
           L   +D             A+ +L + C + +   RP   Q+   L+ + R+   L+
Sbjct: 233 LPPPMDCP----------SALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNPNSLK 279

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 89/328 (27%), Positives = 141/328 (42%), Gaps = 38/328 (11%)
Query: 207 TADELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIH-----QFI 260
           +ADE Q    NY   + +G+G F  V     +  G  VAVK    IDKTQ++     +  
Sbjct: 6   SADE-QPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKI---IDKTQLNSSSLQKLF 61
Query: 261 NEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSS 320
            EV I+  +NH +IVKL       +   LV EY S G +  ++  H              
Sbjct: 62  REVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEK-------- 113
Query: 321 LSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPND 380
              E R +   ++  AV Y H      I HRD+K+ N+LLD   + K++DFG S      
Sbjct: 114 ---EARAKFR-QIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFG 166
Query: 381 KTHLTTTIQGTFGYLDPEYFQSSQFTD-KSDVYSFGVVLLELLTGKKPICFARVEEERNL 439
                    G   Y  PE FQ  ++   + DV+S GV+L  L++G  P     ++E R  
Sbjct: 167 NK--LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRER 224
Query: 440 V-------ACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQ 492
           V         ++S   EN L + L    +K    E I  M +  M     + + +P ++ 
Sbjct: 225 VLRGKYRIPFYMSTDCENLLKKFLILNPSKRGTLEQI--MKDRWMNVGHEDDELKPYVEP 282
Query: 493 VSMELEGLRRSQRCLEMCQVNQLLADEI 520
           +  + +  RR++  + M    + + D +
Sbjct: 283 LP-DYKDPRRTELMVSMGYTREEIQDSL 309

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 80/310 (25%), Positives = 136/310 (43%), Gaps = 33/310 (10%)
Query: 206 FTADELQRATDNYNQSRFLGQGGFGTVYK----GMLPDGS--IVAVKRSKEIDKTQIHQ- 258
           + A + +   D     + LG+G FG V +    G+    +   VAVK  KE      H+ 
Sbjct: 17  YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 76
Query: 259 FINEVVILSQINHR-HIVKLLGCCLETEVPVLV-YEYISSGTLSHHI----HDHXXXXXX 312
            ++E+ IL  I H  ++V LLG C +   P++V  E+   G LS ++    ++       
Sbjct: 77  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 136
Query: 313 XXXXXLSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG 372
                   L+ E+ +  + +VA  + ++ S   I   HRD+ + NILL +K   K+ DFG
Sbjct: 137 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILLSEKNVVKICDFG 193
Query: 373 ISRSIPNDKTHLTT-TIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICF 430
           ++R I  D   +     +    ++ PE      +T +SDV+SFGV+L E+ + G  P   
Sbjct: 194 LARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253
Query: 431 ARVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTM 490
            +++EE      F    KE   +   D    +         M +  + C      +RPT 
Sbjct: 254 VKIDEE------FCRRLKEGTRMRAPDYTTPE---------MYQTMLDCWHGEPSQRPTF 298
Query: 491 KQVSMELEGL 500
            ++   L  L
Sbjct: 299 SELVEHLGNL 308

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 80/310 (25%), Positives = 137/310 (44%), Gaps = 33/310 (10%)
Query: 206 FTADELQRATDNYNQSRFLGQGGFGTVYK----GMLPDGS--IVAVKRSKEIDKTQIHQ- 258
           + A + +   D     + LG+G FG V +    G+    +   VAVK  KE      H+ 
Sbjct: 8   YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 67
Query: 259 FINEVVILSQINHR-HIVKLLGCCLETEVPVLVY-EYISSGTLSHHI----HDHXXXXXX 312
            ++E+ IL  I H  ++V LLG C +   P++V  E+   G LS ++    ++       
Sbjct: 68  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVA 127
Query: 313 XXXXXLSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG 372
                   L+ E+ +  + +VA  + ++ S   I   HRD+ + NILL +K   K+ DFG
Sbjct: 128 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILLSEKNVVKICDFG 184
Query: 373 ISRSIPNDKTHLTT-TIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICF 430
           ++R I  D  ++     +    ++ PE      +T +SDV+SFGV+L E+ + G  P   
Sbjct: 185 LARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 244
Query: 431 ARVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTM 490
            +++EE      F    KE   +   D    +         M +  + C      +RPT 
Sbjct: 245 VKIDEE------FCRRLKEGTRMRAPDYTTPE---------MYQTMLDCWHGEPSQRPTF 289
Query: 491 KQVSMELEGL 500
            ++   L  L
Sbjct: 290 SELVEHLGNL 299

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 80/303 (26%), Positives = 131/303 (43%), Gaps = 43/303 (14%)
Query: 216 DNYNQSRFLGQGGFGTVY--------KGMLPDGSIVAVKRSKEIDKTQ--IHQFINEVVI 265
           D     + LG+G FG V         K    +   VAVK  K+ D T+  +   ++E+ +
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD-DATEKDLSDLVSEMEM 93
Query: 266 LSQIN-HRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXX----XXXLSS 320
           +  I  H++I+ LLG C +     ++  Y S G L  ++                     
Sbjct: 94  MKMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 321 LSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPN- 379
           +++++ V    ++A  + Y+ S   I   HRD+ + N+L+ +    K++DFG++R I N 
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCI---HRDLAARNVLVTENNVMKIADFGLARDINNI 210
Query: 380 DKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERN 438
           D    TT  +    ++ PE      +T +SDV+SFGV++ E+ T G  P     VEE   
Sbjct: 211 DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--- 267
Query: 439 LVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMR---CLRLNSKKRPTMKQVSM 495
                  L KE         R+ K A         EL M    C      +RPT KQ+  
Sbjct: 268 ----LFKLLKEGH-------RMDKPA-----NCTNELYMMMRDCWHAVPSQRPTFKQLVE 311
Query: 496 ELE 498
           +L+
Sbjct: 312 DLD 314

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 110/219 (50%), Gaps = 23/219 (10%)
Query: 217 NYNQSRFLGQGGFGTVYKGM-LPDGS----IVAVKRSKEIDKTQIH-QFINEVVILSQIN 270
            + + + L  G FGTVYKG+ +P+G      VA+K  +E    + + + ++E  +++ ++
Sbjct: 23  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 271 HRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVA 330
           + H+ +LLG CL + V  L+ + +  G L  ++ +H              L+W       
Sbjct: 83  NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYL-----LNW------C 130
Query: 331 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI-PNDKTHLTTTIQ 389
            ++A  + Y+       + HRD+ + N+L+      K++DFG+++ +   +K +     +
Sbjct: 131 VQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 187
Query: 390 GTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
               ++  E      +T +SDV+S+GV + EL+T G KP
Sbjct: 188 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 226

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 90/330 (27%), Positives = 146/330 (44%), Gaps = 42/330 (12%)
Query: 207 TADELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIH-----QFI 260
           +ADE Q    NY   + +G+G F  V     +  G  VAV+    IDKTQ++     +  
Sbjct: 6   SADE-QPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVRI---IDKTQLNSSSLQKLF 61
Query: 261 NEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSS 320
            EV I+  +NH +IVKL       +   LV EY S G +  ++  H              
Sbjct: 62  REVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEK-------- 113
Query: 321 LSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPND 380
              E R +   ++  AV Y H      I HRD+K+ N+LLD   + K++DFG S    N+
Sbjct: 114 ---EARAKFR-QIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFS----NE 162
Query: 381 KTHLTTTIQ--GTFGYLDPEYFQSSQFTD-KSDVYSFGVVLLELLTGKKPICFARVEEER 437
            T      +  G+  Y  PE FQ  ++   + DV+S GV+L  L++G  P     ++E R
Sbjct: 163 FTFGNKLDEFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELR 222
Query: 438 NLV-------ACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTM 490
             V         ++S   EN L + L    +K    E I  M +  M     + + +P +
Sbjct: 223 ERVLRGKYRIPFYMSTDCENLLKKFLILNPSKRGTLEQI--MKDRWMNVGHEDDELKPYV 280
Query: 491 KQVSMELEGLRRSQRCLEMCQVNQLLADEI 520
           + +  + +  RR++  + M    + + D +
Sbjct: 281 EPLP-DYKDPRRTELMVSMGYTREEIQDSL 309

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 99/210 (47%), Gaps = 25/210 (11%)
Query: 224 LGQGGFGTV----YKGMLPD-GSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLL 278
           LG+G FG+V    Y  +  + G++VAVK+ +     Q   F  E+ IL  ++   IVK  
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 78
Query: 279 GCCLET--EVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGA 336
           G       +   LV EY+ SG L   +  H            SS           ++   
Sbjct: 79  GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSS-----------QICKG 127
Query: 337 VAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQG---TFG 393
           + Y+ S   +   HRD+ + NIL++ +   K++DFG+++ +P DK +      G    F 
Sbjct: 128 MEYLGSRRCV---HRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFW 184
Query: 394 YLDPEYFQSSQFTDKSDVYSFGVVLLELLT 423
           Y  PE    + F+ +SDV+SFGVVL EL T
Sbjct: 185 YA-PESLSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 104/215 (48%), Gaps = 24/215 (11%)
Query: 222 RFLGQGGFGTVYKGMLPDGS----IVAVK--RSKEIDKTQIHQFINEVVILSQINHRHIV 275
           + +G G FG V  G L         VA+K  ++   DK Q   F++E  I+ Q +H +I+
Sbjct: 20  KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDK-QRRDFLSEASIMGQFDHPNII 78
Query: 276 KLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAG 335
            L G   + +  +++ EY+ +G+L   +  +                    +++   + G
Sbjct: 79  HLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTV--------------IQLVGMLRG 124
Query: 336 AVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFG-- 393
             + M   + +   HRD+ + NIL++     KVSDFG+SR + +D     TT  G     
Sbjct: 125 IGSGMKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIR 184
Query: 394 YLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
           +  PE     +FT  SDV+S+G+V+ E+++ G++P
Sbjct: 185 WTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 219

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 80/310 (25%), Positives = 136/310 (43%), Gaps = 33/310 (10%)
Query: 206 FTADELQRATDNYNQSRFLGQGGFGTVYK----GMLPDGS--IVAVKRSKEIDKTQIHQ- 258
           + A + +   D     + LG+G FG V +    G+    +   VAVK  KE      H+ 
Sbjct: 17  YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 76
Query: 259 FINEVVILSQINHR-HIVKLLGCCLETEVPVLV-YEYISSGTLSHHI----HDHXXXXXX 312
            ++E+ IL  I H  ++V LLG C +   P++V  E+   G LS ++    ++       
Sbjct: 77  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 136
Query: 313 XXXXXLSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG 372
                   L+ E+ +  + +VA  + ++ S   I   HRD+ + NILL +K   K+ DFG
Sbjct: 137 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILLSEKNVVKICDFG 193
Query: 373 ISRSIPNDKTHLTT-TIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICF 430
           ++R I  D   +     +    ++ PE      +T +SDV+SFGV+L E+ + G  P   
Sbjct: 194 LARDIYKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253
Query: 431 ARVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTM 490
            +++EE      F    KE   +   D    +         M +  + C      +RPT 
Sbjct: 254 VKIDEE------FCRRLKEGTRMRAPDYTTPE---------MYQTMLDCWHGEPSQRPTF 298
Query: 491 KQVSMELEGL 500
            ++   L  L
Sbjct: 299 SELVEHLGNL 308

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 80/310 (25%), Positives = 136/310 (43%), Gaps = 33/310 (10%)
Query: 206 FTADELQRATDNYNQSRFLGQGGFGTVYK----GMLPDGS--IVAVKRSKEIDKTQIHQ- 258
           + A + +   D     + LG+G FG V +    G+    +   VAVK  KE      H+ 
Sbjct: 8   YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 67
Query: 259 FINEVVILSQINHR-HIVKLLGCCLETEVPVLV-YEYISSGTLSHHI----HDHXXXXXX 312
            ++E+ IL  I H  ++V LLG C +   P++V  E+   G LS ++    ++       
Sbjct: 68  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 127
Query: 313 XXXXXLSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG 372
                   L+ E+ +  + +VA  + ++ S   I   HRD+ + NILL +K   K+ DFG
Sbjct: 128 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILLSEKNVVKICDFG 184
Query: 373 ISRSIPNDKTHLTT-TIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICF 430
           ++R I  D   +     +    ++ PE      +T +SDV+SFGV+L E+ + G  P   
Sbjct: 185 LARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 244
Query: 431 ARVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTM 490
            +++EE      F    KE   +   D    +         M +  + C      +RPT 
Sbjct: 245 VKIDEE------FCRRLKEGTRMRAPDYTTPE---------MYQTMLDCWHGEPSQRPTF 289
Query: 491 KQVSMELEGL 500
            ++   L  L
Sbjct: 290 SELVEHLGNL 299

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 110/219 (50%), Gaps = 23/219 (10%)
Query: 217 NYNQSRFLGQGGFGTVYKGM-LPDGS----IVAVKRSKEIDKTQIH-QFINEVVILSQIN 270
            + + + L  G FGTVYKG+ +P+G      VA+K  +E    + + + ++E  +++ ++
Sbjct: 16  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 271 HRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVA 330
           + H+ +LLG CL + V  L+ + +  G L  ++ +H              L+W       
Sbjct: 76  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL-----LNW------C 123
Query: 331 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI-PNDKTHLTTTIQ 389
            ++A  + Y+       + HRD+ + N+L+      K++DFG+++ +   +K +     +
Sbjct: 124 VQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 180
Query: 390 GTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
               ++  E      +T +SDV+S+GV + EL+T G KP
Sbjct: 181 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 99/210 (47%), Gaps = 25/210 (11%)
Query: 224 LGQGGFGTV----YKGMLPD-GSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLL 278
           LG+G FG+V    Y  +  + G++VAVK+ +     Q   F  E+ IL  ++   IVK  
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 77
Query: 279 GCCLET--EVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGA 336
           G       +   LV EY+ SG L   +  H            SS           ++   
Sbjct: 78  GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSS-----------QICKG 126
Query: 337 VAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQG---TFG 393
           + Y+ S   +   HRD+ + NIL++ +   K++DFG+++ +P DK +      G    F 
Sbjct: 127 MEYLGSRRCV---HRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFW 183
Query: 394 YLDPEYFQSSQFTDKSDVYSFGVVLLELLT 423
           Y  PE    + F+ +SDV+SFGVVL EL T
Sbjct: 184 YA-PESLSDNIFSRQSDVWSFGVVLYELFT 212

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 104/215 (48%), Gaps = 24/215 (11%)
Query: 222 RFLGQGGFGTVYKGMLPDGS----IVAVK--RSKEIDKTQIHQFINEVVILSQINHRHIV 275
           + +G G FG V  G L         VA+K  ++   DK Q   F++E  I+ Q +H +I+
Sbjct: 35  KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDK-QRRDFLSEASIMGQFDHPNII 93
Query: 276 KLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAG 335
            L G   + +  +++ EY+ +G+L   +  +                    +++   + G
Sbjct: 94  HLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTV--------------IQLVGMLRG 139
Query: 336 AVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFG-- 393
             + M   + +   HRD+ + NIL++     KVSDFG+SR + +D     TT  G     
Sbjct: 140 IGSGMKYLSDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIR 199
Query: 394 YLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
           +  PE     +FT  SDV+S+G+V+ E+++ G++P
Sbjct: 200 WTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 234

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 80/310 (25%), Positives = 136/310 (43%), Gaps = 33/310 (10%)
Query: 206 FTADELQRATDNYNQSRFLGQGGFGTVYK----GMLPDGS--IVAVKRSKEIDKTQIHQ- 258
           + A + +   D     + LG+G FG V +    G+    +   VAVK  KE      H+ 
Sbjct: 8   YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 67
Query: 259 FINEVVILSQINHR-HIVKLLGCCLETEVPVLVY-EYISSGTLSHHI----HDHXXXXXX 312
            ++E+ IL  I H  ++V LLG C +   P++V  E+   G LS ++    ++       
Sbjct: 68  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVA 127
Query: 313 XXXXXLSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG 372
                   L+ E+ +  + +VA  + ++ S   I   HRD+ + NILL +K   K+ DFG
Sbjct: 128 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILLSEKNVVKICDFG 184
Query: 373 ISRSIPNDKTHLTT-TIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICF 430
           ++R I  D   +     +    ++ PE      +T +SDV+SFGV+L E+ + G  P   
Sbjct: 185 LARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 244
Query: 431 ARVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTM 490
            +++EE      F    KE   +   D    +         M +  + C      +RPT 
Sbjct: 245 VKIDEE------FCRRLKEGTRMRAPDYTTPE---------MYQTMLDCWHGEPSQRPTF 289
Query: 491 KQVSMELEGL 500
            ++   L  L
Sbjct: 290 SELVEHLGNL 299

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 71/290 (24%), Positives = 128/290 (44%), Gaps = 34/290 (11%)
Query: 211 LQRATDNYNQSRFLGQGGFGTVYK-GMLPDGSIVAVKRSK-EIDKTQIHQFINEVVILSQ 268
           ++   D++ +   LG G  G V+K    P G ++A K    EI     +Q I E+ +L +
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 269 INHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVR 328
            N  +IV   G         +  E++  G+L   +                 +  +   +
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL------------KKAGRIPEQILGK 108
Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTI 388
           V+  V   + Y+     I   HRD+K SNIL++ +   K+ DFG+S  + +    +  + 
Sbjct: 109 VSIAVIKGLTYLREKHKI--MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSF 163
Query: 389 QGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEE-RNLVACFISLA 447
            GT  Y+ PE  Q + ++ +SD++S G+ L+E+  G+ PI     +E+ R  +A F    
Sbjct: 164 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEDSRPPMAIF---- 219
Query: 448 KENQLLEILDARVAKEAREEDIGAMA----ELAMRCLRLNSKKRPTMKQV 493
                 E+LD  V +   +   G  +    +   +CL  N  +R  +KQ+
Sbjct: 220 ------ELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 263

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 102/213 (47%), Gaps = 26/213 (12%)
Query: 222 RFLGQGGFGTVYKGML-PDG----SIVAVKRSK-EIDKTQIHQFINEVVILSQINHRHIV 275
           R LG+G FG V      P+G      VAVK  K E     I     E+ IL  + H +IV
Sbjct: 15  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 74
Query: 276 KLLGCCLET--EVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEV 333
           K  G C E       L+ E++ SG+L  ++  +            + ++ + +++ A ++
Sbjct: 75  KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNK-----------NKINLKQQLKYAVQI 123
Query: 334 AGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQ---G 390
              + Y+ S   +   HRD+ + N+L++ +   K+ DFG++++I  DK   T        
Sbjct: 124 CKGMDYLGSRQYV---HRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSP 180
Query: 391 TFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT 423
            F Y  PE    S+F   SDV+SFGV L ELLT
Sbjct: 181 VFWYA-PECLMQSKFYIASDVWSFGVTLHELLT 212

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 110/219 (50%), Gaps = 23/219 (10%)
Query: 217 NYNQSRFLGQGGFGTVYKGM-LPDGS----IVAVKRSKEIDKTQIH-QFINEVVILSQIN 270
            + + + L  G FGTVYKG+ +P+G      VA+K  +E    + + + ++E  +++ ++
Sbjct: 23  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 271 HRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVA 330
           + H+ +LLG CL + V  L+ + +  G L  ++ +H              L+W       
Sbjct: 83  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL-----LNW------C 130
Query: 331 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI-PNDKTHLTTTIQ 389
            ++A  + Y+       + HRD+ + N+L+      K++DFG+++ +   +K +     +
Sbjct: 131 VQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 187
Query: 390 GTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
               ++  E      +T +SDV+S+GV + EL+T G KP
Sbjct: 188 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 226

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 104/215 (48%), Gaps = 24/215 (11%)
Query: 222 RFLGQGGFGTVYKGMLPDGS----IVAVK--RSKEIDKTQIHQFINEVVILSQINHRHIV 275
           + +G G FG V  G L         VA+K  ++   DK Q   F++E  I+ Q +H +I+
Sbjct: 14  KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDK-QRRDFLSEASIMGQFDHPNII 72
Query: 276 KLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAG 335
            L G   + +  +++ EY+ +G+L   +  +                    +++   + G
Sbjct: 73  HLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTV--------------IQLVGMLRG 118
Query: 336 AVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFG-- 393
             + M   + +   HRD+ + NIL++     KVSDFG+SR + +D     TT  G     
Sbjct: 119 IGSGMKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIR 178
Query: 394 YLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
           +  PE     +FT  SDV+S+G+V+ E+++ G++P
Sbjct: 179 WTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 213

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 102/213 (47%), Gaps = 26/213 (12%)
Query: 222 RFLGQGGFGTVYKGML-PDGS----IVAVKRSK-EIDKTQIHQFINEVVILSQINHRHIV 275
           R LG+G FG V      P+G      VAVK  K E     I     E+ IL  + H +IV
Sbjct: 27  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 276 KLLGCCLET--EVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEV 333
           K  G C E       L+ E++ SG+L  ++  +            + ++ + +++ A ++
Sbjct: 87  KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNK-----------NKINLKQQLKYAVQI 135
Query: 334 AGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQ---G 390
              + Y+ S   +   HRD+ + N+L++ +   K+ DFG++++I  DK   T        
Sbjct: 136 CKGMDYLGSRQYV---HRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSP 192
Query: 391 TFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT 423
            F Y  PE    S+F   SDV+SFGV L ELLT
Sbjct: 193 VFWYA-PECLMQSKFYIASDVWSFGVTLHELLT 224

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 80/303 (26%), Positives = 131/303 (43%), Gaps = 43/303 (14%)
Query: 216 DNYNQSRFLGQGGFGTVY--------KGMLPDGSIVAVKRSKEIDKTQ--IHQFINEVVI 265
           D     + LG+G FG V         K    +   VAVK  K+ D T+  +   ++E+ +
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD-DATEKDLSDLVSEMEM 93
Query: 266 LSQIN-HRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXX----XXXLSS 320
           +  I  H++I+ LLG C +     ++  Y S G L  ++                     
Sbjct: 94  MKMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 321 LSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPN- 379
           +++++ V    ++A  + Y+ S   I   HRD+ + N+L+ +    K++DFG++R I N 
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCI---HRDLAARNVLVTENNVMKIADFGLARDINNI 210
Query: 380 DKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERN 438
           D    TT  +    ++ PE      +T +SDV+SFGV++ E+ T G  P     VEE   
Sbjct: 211 DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--- 267
Query: 439 LVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMR---CLRLNSKKRPTMKQVSM 495
                  L KE         R+ K A         EL M    C      +RPT KQ+  
Sbjct: 268 ----LFKLLKEGH-------RMDKPA-----NCTNELYMMMRDCWHAVPSQRPTFKQLVE 311
Query: 496 ELE 498
           +L+
Sbjct: 312 DLD 314

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 107/226 (47%), Gaps = 18/226 (7%)
Query: 204 KVFTADELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEV 263
           K +  D  +   ++    + LG G FG V+       + VAVK  K      +  F+ E 
Sbjct: 3   KPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKP-GSMSVEAFLAEA 61
Query: 264 VILSQINHRHIVKLLGCCLETEVPV-LVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLS 322
            ++  + H  +VKL      T+ P+ ++ E+++ G+L   +              L  L 
Sbjct: 62  NVMKTLQHDKLVKLHAVV--TKEPIYIITEFMAKGSLLDFLKSDEGSKQP-----LPKL- 113
Query: 323 WENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKT 382
               +  + ++A  +A++     I   HRD++++NIL+      K++DFG++R I +++ 
Sbjct: 114 ----IDFSAQIAEGMAFIEQRNYI---HRDLRAANILVSASLVCKIADFGLARVIEDNEY 166
Query: 383 HLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
                 +    +  PE      FT KSDV+SFG++L+E++T G+ P
Sbjct: 167 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIP 212

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 101/221 (45%), Gaps = 27/221 (12%)
Query: 215 TDNYNQSRFLGQGGFGTVYKGM------LPDGSIVAVKRSKEIDKTQIHQFINEVVILSQ 268
            ++++  + LG+G +G V   +           IV +KR+ +  +        E+ I   
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----IKKEIXINKM 61
Query: 269 INHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVR 328
           +NH ++VK  G   E  +  L  EY S G L   I                 +   +  R
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI------------GMPEPDAQR 109
Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIP-NDKTHLTTT 387
              ++   V Y+H    I I HRDIK  N+LLD++ + K+SDFG++     N++  L   
Sbjct: 110 FFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 166
Query: 388 IQGTFGYLDPEYFQSSQF-TDKSDVYSFGVVLLELLTGKKP 427
           + GT  Y+ PE  +  +F  +  DV+S G+VL  +L G+ P
Sbjct: 167 MXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 101/222 (45%), Gaps = 25/222 (11%)
Query: 214 ATDNYNQSRFLGQGGFGTVYKGMLPD-GSIVAVKRSKE---IDKTQIHQFINEVVILSQI 269
             DN+   R LG+G FG V    + + G + AVK  K+   +    +   + E  ILS  
Sbjct: 21  GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLA 80
Query: 270 NHRHIVKLLGCCLET-EVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVR 328
            +   +  L CC +T +    V E+++ G L  HI               S    E R R
Sbjct: 81  RNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQK-------------SRRFDEARAR 127
Query: 329 V-ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISR-SIPNDKTHLTT 386
             A E+  A+ ++H      I +RD+K  N+LLD +   K++DFG+ +  I N  T  T 
Sbjct: 128 FYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT--TA 182
Query: 387 TIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
           T  GT  Y+ PE  Q   +    D ++ GV+L E+L G  P 
Sbjct: 183 TFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPF 224

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 101/221 (45%), Gaps = 27/221 (12%)
Query: 215 TDNYNQSRFLGQGGFGTVYKGM------LPDGSIVAVKRSKEIDKTQIHQFINEVVILSQ 268
            ++++  + LG+G +G V   +           IV +KR+ +  +        E+ I   
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----IKKEICINKM 60
Query: 269 INHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVR 328
           +NH ++VK  G   E  +  L  EY S G L   I                 +   +  R
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI------------GMPEPDAQR 108
Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIP-NDKTHLTTT 387
              ++   V Y+H    I I HRDIK  N+LLD++ + K+SDFG++     N++  L   
Sbjct: 109 FFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 165
Query: 388 IQGTFGYLDPEYFQSSQF-TDKSDVYSFGVVLLELLTGKKP 427
           + GT  Y+ PE  +  +F  +  DV+S G+VL  +L G+ P
Sbjct: 166 MXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 100/213 (46%), Gaps = 27/213 (12%)
Query: 222 RFLGQGGFGTVYK-GMLPDGSIVAVKRSKE---IDKTQIHQFINEVVILSQINHRHIVKL 277
           R LG G FG V+      +G   A+K  K+   +   Q+    +E ++LS + H  I+++
Sbjct: 12  RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 71
Query: 278 LGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVR--VACEVAG 335
            G   + +   ++ +YI  G L   +                S  + N V    A EV  
Sbjct: 72  WGTFQDAQQIFMIMDYIEGGELFSLLR--------------KSQRFPNPVAKFYAAEVCL 117
Query: 336 AVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYL 395
           A+ Y+HS     I +RD+K  NILLD     K++DFG ++ +P+    +T  + GT  Y+
Sbjct: 118 ALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD----VTYXLCGTPDYI 170
Query: 396 DPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
            PE   +  +    D +SFG+++ E+L G  P 
Sbjct: 171 APEVVSTKPYNKSIDWWSFGILIYEMLAGYTPF 203

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 101/221 (45%), Gaps = 27/221 (12%)
Query: 215 TDNYNQSRFLGQGGFGTVYKGM------LPDGSIVAVKRSKEIDKTQIHQFINEVVILSQ 268
            ++++  + LG+G +G V   +           IV +KR+ +  +        E+ I   
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----IKKEIXINKM 60
Query: 269 INHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVR 328
           +NH ++VK  G   E  +  L  EY S G L   I                 +   +  R
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI------------GMPEPDAQR 108
Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIP-NDKTHLTTT 387
              ++   V Y+H    I I HRDIK  N+LLD++ + K+SDFG++     N++  L   
Sbjct: 109 FFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 165
Query: 388 IQGTFGYLDPEYFQSSQF-TDKSDVYSFGVVLLELLTGKKP 427
           + GT  Y+ PE  +  +F  +  DV+S G+VL  +L G+ P
Sbjct: 166 MXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 108/219 (49%), Gaps = 14/219 (6%)
Query: 216 DNYNQSRFLGQGGFGTVYK----GMLPDGSI--VAVKRSKEIDKT-QIHQFINEVVILSQ 268
           +N    + LG G FG V +    G+  + ++  VAVK  K      +    ++E+ I+S 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 269 IN-HRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXL--SSLSWEN 325
           +  H +IV LLG C      +++ EY   G L + +              +  S+LS  +
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRD 165
Query: 326 RVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLT 385
            +  + +VA  +A++ S   I   HRD+ + N+LL +   AK+ DFG++R I ND  ++ 
Sbjct: 166 LLHFSSQVAQGMAFLASKNCI---HRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 222
Query: 386 T-TIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT 423
               +    ++ PE      +T +SDV+S+G++L E+ +
Sbjct: 223 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 102/221 (46%), Gaps = 27/221 (12%)
Query: 215 TDNYNQSRFLGQGGFGTVYKGM------LPDGSIVAVKRSKEIDKTQIHQFINEVVILSQ 268
            ++++  + LG+G +G V   +           IV +KR+ +  +        E+ I + 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----IKKEICINAM 61
Query: 269 INHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVR 328
           +NH ++VK  G   E  +  L  EY S G L   I                 +   +  R
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI------------GMPEPDAQR 109
Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIP-NDKTHLTTT 387
              ++   V Y+H    I I HRDIK  N+LLD++ + K+SDFG++     N++  L   
Sbjct: 110 FFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 166
Query: 388 IQGTFGYLDPEYFQSSQF-TDKSDVYSFGVVLLELLTGKKP 427
           + GT  Y+ PE  +  +F  +  DV+S G+VL  +L G+ P
Sbjct: 167 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 101/221 (45%), Gaps = 27/221 (12%)
Query: 215 TDNYNQSRFLGQGGFGTVYKGM------LPDGSIVAVKRSKEIDKTQIHQFINEVVILSQ 268
            ++++  + LG+G +G V   +           IV +KR+ +  +        E+ I   
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----IKKEICINKM 60
Query: 269 INHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVR 328
           +NH ++VK  G   E  +  L  EY S G L   I                 +   +  R
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI------------GMPEPDAQR 108
Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIP-NDKTHLTTT 387
              ++   V Y+H    I I HRDIK  N+LLD++ + K+SDFG++     N++  L   
Sbjct: 109 FFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 165
Query: 388 IQGTFGYLDPEYFQSSQF-TDKSDVYSFGVVLLELLTGKKP 427
           + GT  Y+ PE  +  +F  +  DV+S G+VL  +L G+ P
Sbjct: 166 MXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 101/224 (45%), Gaps = 20/224 (8%)
Query: 210 ELQRATDN-YNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEIDKTQIH---QFINEVV 264
           E Q  T N + Q R LG+GGFG V    +   G + A K+ ++    +       +NE  
Sbjct: 177 ERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQ 236
Query: 265 ILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWE 324
           IL ++N R +V L       +   LV   ++ G L  HI+              +     
Sbjct: 237 ILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQ----------AGFPEA 286
Query: 325 NRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHL 384
             V  A E+   +  +H      I +RD+K  NILLDD    ++SD G++  +P  +T  
Sbjct: 287 RAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-- 341
Query: 385 TTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
                GT GY+ PE  ++ ++T   D ++ G +L E++ G+ P 
Sbjct: 342 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPF 385

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 101/221 (45%), Gaps = 27/221 (12%)
Query: 215 TDNYNQSRFLGQGGFGTVYKGM------LPDGSIVAVKRSKEIDKTQIHQFINEVVILSQ 268
            ++++  + LG+G +G V   +           IV +KR+ +  +        E+ I   
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----IKKEICINKM 60
Query: 269 INHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVR 328
           +NH ++VK  G   E  +  L  EY S G L   I                 +   +  R
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI------------GMPEPDAQR 108
Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIP-NDKTHLTTT 387
              ++   V Y+H    I I HRDIK  N+LLD++ + K+SDFG++     N++  L   
Sbjct: 109 FFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 165
Query: 388 IQGTFGYLDPEYFQSSQF-TDKSDVYSFGVVLLELLTGKKP 427
           + GT  Y+ PE  +  +F  +  DV+S G+VL  +L G+ P
Sbjct: 166 MXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 71/296 (23%), Positives = 131/296 (44%), Gaps = 38/296 (12%)
Query: 221 SRFLGQGGFGTVYKGMLP--DGSI--VAVKRSKEIDKTQ--IHQFINEVVILSQINHRHI 274
            + LG+G FG+V +G L   DG+   VAVK  K  + +Q  I +F++E   +   +H ++
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 275 VKLLGCCLETEV-----PVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRV 329
           ++LLG C+E        P+++  ++  G L      H              +  +  ++ 
Sbjct: 99  IRLLGVCIEMSSQGIPKPMVILPFMKYGDL------HTYLLYSRLETGPKHIPLQTLLKF 152
Query: 330 ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTI- 388
             ++A  + Y+ +       HRD+ + N +L D  +  V+DFG+S+ I +   +    I 
Sbjct: 153 MVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIA 209
Query: 389 QGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLA 447
           +    ++  E      +T KSDV++FGV + E+ T G  P    +  E  +         
Sbjct: 210 KMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDY-------- 261
Query: 448 KENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRS 503
                  +L     K+  E+ +  + E+   C R +   RPT   + ++LE L  S
Sbjct: 262 -------LLHGHRLKQP-EDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES 309

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 72/240 (30%), Positives = 108/240 (45%), Gaps = 28/240 (11%)
Query: 208 ADELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIH-----QFIN 261
           +DE Q    NY   + +G+G F  V     +  G  VA+K    IDKTQ++     +   
Sbjct: 5   SDE-QPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKI---IDKTQLNPTSLQKLFR 60
Query: 262 EVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSL 321
           EV I+  +NH +IVKL       +   L+ EY S G +  ++  H               
Sbjct: 61  EVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEK--------- 111
Query: 322 SWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDK 381
             E R +   ++  AV Y H      I HRD+K+ N+LLD   + K++DFG S       
Sbjct: 112 --EARSKFR-QIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG 165
Query: 382 THLTTTIQGTFGYLDPEYFQSSQFTD-KSDVYSFGVVLLELLTGKKPICFARVEEERNLV 440
                T  G+  Y  PE FQ  ++   + DV+S GV+L  L++G  P     ++E R  V
Sbjct: 166 K--LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERV 223

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 101/221 (45%), Gaps = 27/221 (12%)
Query: 215 TDNYNQSRFLGQGGFGTVYKGM------LPDGSIVAVKRSKEIDKTQIHQFINEVVILSQ 268
            ++++  + LG+G +G V   +           IV +KR+ +  +        E+ I   
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----IKKEICINKM 61
Query: 269 INHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVR 328
           +NH ++VK  G   E  +  L  EY S G L   I                 +   +  R
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI------------GMPEPDAQR 109
Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIP-NDKTHLTTT 387
              ++   V Y+H    I I HRDIK  N+LLD++ + K+SDFG++     N++  L   
Sbjct: 110 FFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 166
Query: 388 IQGTFGYLDPEYFQSSQF-TDKSDVYSFGVVLLELLTGKKP 427
           + GT  Y+ PE  +  +F  +  DV+S G+VL  +L G+ P
Sbjct: 167 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 101/221 (45%), Gaps = 27/221 (12%)
Query: 215 TDNYNQSRFLGQGGFGTVYKGM------LPDGSIVAVKRSKEIDKTQIHQFINEVVILSQ 268
            ++++  + LG+G +G V   +           IV +KR+ +  +        E+ I   
Sbjct: 4   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----IKKEICINKM 59
Query: 269 INHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVR 328
           +NH ++VK  G   E  +  L  EY S G L   I                 +   +  R
Sbjct: 60  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI------------GMPEPDAQR 107
Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIP-NDKTHLTTT 387
              ++   V Y+H    I I HRDIK  N+LLD++ + K+SDFG++     N++  L   
Sbjct: 108 FFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 164
Query: 388 IQGTFGYLDPEYFQSSQF-TDKSDVYSFGVVLLELLTGKKP 427
           + GT  Y+ PE  +  +F  +  DV+S G+VL  +L G+ P
Sbjct: 165 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 205

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 101/224 (45%), Gaps = 20/224 (8%)
Query: 210 ELQRATDN-YNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEIDKTQIH---QFINEVV 264
           E Q  T N + Q R LG+GGFG V    +   G + A K+ ++    +       +NE  
Sbjct: 177 ERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQ 236
Query: 265 ILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWE 324
           IL ++N R +V L       +   LV   ++ G L  HI+              +     
Sbjct: 237 ILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQ----------AGFPEA 286
Query: 325 NRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHL 384
             V  A E+   +  +H      I +RD+K  NILLDD    ++SD G++  +P  +T  
Sbjct: 287 RAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-- 341
Query: 385 TTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
                GT GY+ PE  ++ ++T   D ++ G +L E++ G+ P 
Sbjct: 342 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPF 385

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 101/221 (45%), Gaps = 27/221 (12%)
Query: 215 TDNYNQSRFLGQGGFGTVYKGM------LPDGSIVAVKRSKEIDKTQIHQFINEVVILSQ 268
            ++++  + LG+G +G V   +           IV +KR+ +  +        E+ I   
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----IKKEICINKM 60
Query: 269 INHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVR 328
           +NH ++VK  G   E  +  L  EY S G L   I                 +   +  R
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI------------GMPEPDAQR 108
Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIP-NDKTHLTTT 387
              ++   V Y+H    I I HRDIK  N+LLD++ + K+SDFG++     N++  L   
Sbjct: 109 FFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 165
Query: 388 IQGTFGYLDPEYFQSSQF-TDKSDVYSFGVVLLELLTGKKP 427
           + GT  Y+ PE  +  +F  +  DV+S G+VL  +L G+ P
Sbjct: 166 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/239 (25%), Positives = 109/239 (45%), Gaps = 45/239 (18%)
Query: 213 RATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKTQIHQFINEVVILSQINH 271
           R   ++ +   LGQG FG V K     D    A+K+ +  ++ ++   ++EV++L+ +NH
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEE-KLSTILSEVMLLASLNH 61
Query: 272 RHIVKLLGCCLETEVPV-------------LVYEYISSGTLSHHIHDHXXXXXXXXXXXL 318
           +++V+     LE    V             +  EY  +GTL   IH              
Sbjct: 62  QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEY--- 118
Query: 319 SSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGI----- 373
               W    R+  ++  A++Y+HS     I HRD+K  NI +D+  + K+ DFG+     
Sbjct: 119 ----W----RLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVH 167
Query: 374 ---------SRSIPNDKTHLTTTIQGTFGYLDPEYFQ-SSQFTDKSDVYSFGVVLLELL 422
                    S+++P    +LT+ I GT  Y+  E    +  + +K D+YS G++  E++
Sbjct: 168 RSLDILKLDSQNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/236 (25%), Positives = 106/236 (44%), Gaps = 26/236 (11%)
Query: 216 DNYNQSRFLGQGGFGTVYKGMLPDG----SIVAVKRSKEIDKTQIHQFINEVVILSQINH 271
           D++   R +G+G FG V      D     ++  + + K +++ ++     E+ I+  + H
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 272 RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRV-A 330
             +V L     + E   +V + +  G L +H+  +                 E  V++  
Sbjct: 75  PFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFK-------------EETVKLFI 121
Query: 331 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQG 390
           CE+  A+ Y+ +     I HRD+K  NILLD+     ++DF I+  +P +     TT+ G
Sbjct: 122 CELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ--ITTMAG 176
Query: 391 TFGYLDPEYFQSSQ---FTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACF 443
           T  Y+ PE F S +   ++   D +S GV   ELL G++P         + +V  F
Sbjct: 177 TKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTF 232

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 101/221 (45%), Gaps = 27/221 (12%)
Query: 215 TDNYNQSRFLGQGGFGTVYKGM------LPDGSIVAVKRSKEIDKTQIHQFINEVVILSQ 268
            ++++  + LG+G +G V   +           IV +KR+ +  +        E+ I   
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----IKKEICINKM 60
Query: 269 INHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVR 328
           +NH ++VK  G   E  +  L  EY S G L   I                 +   +  R
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI------------GMPEPDAQR 108
Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIP-NDKTHLTTT 387
              ++   V Y+H    I I HRDIK  N+LLD++ + K+SDFG++     N++  L   
Sbjct: 109 FFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 165
Query: 388 IQGTFGYLDPEYFQSSQF-TDKSDVYSFGVVLLELLTGKKP 427
           + GT  Y+ PE  +  +F  +  DV+S G+VL  +L G+ P
Sbjct: 166 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 101/221 (45%), Gaps = 27/221 (12%)
Query: 215 TDNYNQSRFLGQGGFGTVYKGM------LPDGSIVAVKRSKEIDKTQIHQFINEVVILSQ 268
            ++++  + LG+G +G V   +           IV +KR+ +  +        E+ I   
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----IKKEICINKM 60
Query: 269 INHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVR 328
           +NH ++VK  G   E  +  L  EY S G L   I                 +   +  R
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI------------GMPEPDAQR 108
Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIP-NDKTHLTTT 387
              ++   V Y+H    I I HRDIK  N+LLD++ + K+SDFG++     N++  L   
Sbjct: 109 FFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 165
Query: 388 IQGTFGYLDPEYFQSSQF-TDKSDVYSFGVVLLELLTGKKP 427
           + GT  Y+ PE  +  +F  +  DV+S G+VL  +L G+ P
Sbjct: 166 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 101/221 (45%), Gaps = 27/221 (12%)
Query: 215 TDNYNQSRFLGQGGFGTVYKGM------LPDGSIVAVKRSKEIDKTQIHQFINEVVILSQ 268
            ++++  + LG+G +G V   +           IV +KR+ +  +        E+ I   
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----IKKEICINKM 61
Query: 269 INHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVR 328
           +NH ++VK  G   E  +  L  EY S G L   I                 +   +  R
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI------------GMPEPDAQR 109
Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIP-NDKTHLTTT 387
              ++   V Y+H    I I HRDIK  N+LLD++ + K+SDFG++     N++  L   
Sbjct: 110 FFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 166
Query: 388 IQGTFGYLDPEYFQSSQF-TDKSDVYSFGVVLLELLTGKKP 427
           + GT  Y+ PE  +  +F  +  DV+S G+VL  +L G+ P
Sbjct: 167 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 101/221 (45%), Gaps = 27/221 (12%)
Query: 215 TDNYNQSRFLGQGGFGTVYKGM------LPDGSIVAVKRSKEIDKTQIHQFINEVVILSQ 268
            ++++  + LG+G +G V   +           IV +KR+ +  +        E+ I   
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----IKKEICINKM 60
Query: 269 INHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVR 328
           +NH ++VK  G   E  +  L  EY S G L   I                 +   +  R
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI------------GMPEPDAQR 108
Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIP-NDKTHLTTT 387
              ++   V Y+H    I I HRDIK  N+LLD++ + K+SDFG++     N++  L   
Sbjct: 109 FFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 165
Query: 388 IQGTFGYLDPEYFQSSQF-TDKSDVYSFGVVLLELLTGKKP 427
           + GT  Y+ PE  +  +F  +  DV+S G+VL  +L G+ P
Sbjct: 166 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 101/221 (45%), Gaps = 27/221 (12%)
Query: 215 TDNYNQSRFLGQGGFGTVYKGM------LPDGSIVAVKRSKEIDKTQIHQFINEVVILSQ 268
            ++++  + LG+G +G V   +           IV +KR+ +  +        E+ I   
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----IKKEICINKM 60
Query: 269 INHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVR 328
           +NH ++VK  G   E  +  L  EY S G L   I                 +   +  R
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI------------GMPEPDAQR 108
Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIP-NDKTHLTTT 387
              ++   V Y+H    I I HRDIK  N+LLD++ + K+SDFG++     N++  L   
Sbjct: 109 FFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 165
Query: 388 IQGTFGYLDPEYFQSSQF-TDKSDVYSFGVVLLELLTGKKP 427
           + GT  Y+ PE  +  +F  +  DV+S G+VL  +L G+ P
Sbjct: 166 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 101/211 (47%), Gaps = 29/211 (13%)
Query: 224 LGQGGFGTVYKGMLPDGSIVAVKRSKEID----KTQIHQFINEVVILSQINHRHIVKLLG 279
           +G+G FG V+KG+  D     V   K ID    + +I     E+ +LSQ +  ++ K  G
Sbjct: 31  IGKGSFGEVFKGI--DNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVTKYYG 88
Query: 280 CCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVAC---EVAGA 336
             L+     ++ EY+  G+                   L      +  ++A    E+   
Sbjct: 89  SYLKGSKLWIIMEYLGGGS----------------ALDLLRAGPFDEFQIATMLKEILKG 132
Query: 337 VAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLD 396
           + Y+HS   I   HRDIK++N+LL ++   K++DFG++  + + +    T + GT  ++ 
Sbjct: 133 LDYLHSEKKI---HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMA 188
Query: 397 PEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
           PE  Q S +  K+D++S G+  +EL  G+ P
Sbjct: 189 PEVIQQSAYDSKADIWSLGITAIELAKGEPP 219

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 101/221 (45%), Gaps = 27/221 (12%)
Query: 215 TDNYNQSRFLGQGGFGTVYKGM------LPDGSIVAVKRSKEIDKTQIHQFINEVVILSQ 268
            ++++  + LG+G +G V   +           IV +KR+ +  +        E+ I   
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----IKKEIXINKM 60
Query: 269 INHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVR 328
           +NH ++VK  G   E  +  L  EY S G L   I                 +   +  R
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI------------GMPEPDAQR 108
Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIP-NDKTHLTTT 387
              ++   V Y+H    I I HRDIK  N+LLD++ + K+SDFG++     N++  L   
Sbjct: 109 FFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 165
Query: 388 IQGTFGYLDPEYFQSSQF-TDKSDVYSFGVVLLELLTGKKP 427
           + GT  Y+ PE  +  +F  +  DV+S G+VL  +L G+ P
Sbjct: 166 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 103/229 (44%), Gaps = 19/229 (8%)
Query: 216 DNYNQSRFLGQGGFGTVYK-GMLPDGSIVAVKRSK-EIDKTQIHQFINEVVILSQINHRH 273
           D++ +   LG G  G V+K    P G ++A K    EI     +Q I E+ +L + N  +
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92
Query: 274 IVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEV 333
           IV   G         +  E++  G+L   +                 +  +   +V+  V
Sbjct: 93  IVGFYGAFYSDGEISICMEHMDGGSLDQVLK------------KAGRIPEQILGKVSIAV 140
Query: 334 AGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFG 393
              + Y+     I   HRD+K SNIL++ +   K+ DFG+S  + +    +  +  GT  
Sbjct: 141 IKGLTYLREKHKI--MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRS 195
Query: 394 YLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVAC 442
           Y+ PE  Q + ++ +SD++S G+ L+E+  G+ PI     +E   +  C
Sbjct: 196 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGC 244

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 100/215 (46%), Gaps = 19/215 (8%)
Query: 216 DNYNQSRFLGQGGFGTVYK-GMLPDGSIVAVKRSK-EIDKTQIHQFINEVVILSQINHRH 273
           D++ +   LG G  G V K    P G I+A K    EI     +Q I E+ +L + N  +
Sbjct: 16  DDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 75
Query: 274 IVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEV 333
           IV   G         +  E++  G+L   + +               +  E   +V+  V
Sbjct: 76  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKE------------AKRIPEEILGKVSIAV 123
Query: 334 AGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFG 393
              +AY+     I   HRD+K SNIL++ +   K+ DFG+S  + +    +  +  GT  
Sbjct: 124 LRGLAYLREKHQI--MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRS 178
Query: 394 YLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
           Y+ PE  Q + ++ +SD++S G+ L+EL  G+ PI
Sbjct: 179 YMAPERLQGTHYSVQSDIWSMGLSLVELAVGRYPI 213

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/274 (24%), Positives = 118/274 (43%), Gaps = 39/274 (14%)
Query: 224 LGQGGFGTVYKGMLPDGSIVAVKRSKEID----KTQIHQFINEVVILSQINHRHIVKLLG 279
           +G+G FG V+KG+  D     V   K ID    + +I     E+ +LSQ +  ++ K  G
Sbjct: 35  IGKGSFGEVFKGI--DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 92
Query: 280 CCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAY 339
             L+     ++ EY+  G+    +                 L       +  E+   + Y
Sbjct: 93  SYLKDTKLWIIMEYLGGGSALDLLEP-------------GPLDETQIATILREILKGLDY 139
Query: 340 MHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEY 399
           +HS   I   HRDIK++N+LL +    K++DFG++  + + +    T + GT  ++ PE 
Sbjct: 140 LHSEKKI---HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEV 195
Query: 400 FQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEILDAR 459
            + S +  K+D++S G+  +EL  G+ P        E + +     + K N     L+  
Sbjct: 196 IKQSAYDSKADIWSLGITAIELARGEPP------HSELHPMKVLFLIPKNNP--PTLEGN 247
Query: 460 VAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQV 493
            +K         + E    CL      RPT K++
Sbjct: 248 YSK--------PLKEFVEACLNKEPSFRPTAKEL 273

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 101/221 (45%), Gaps = 27/221 (12%)
Query: 215 TDNYNQSRFLGQGGFGTVYKGM------LPDGSIVAVKRSKEIDKTQIHQFINEVVILSQ 268
            ++++  + LG+G +G V   +           IV +KR+ +  +        E+ I   
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----IKKEICINKM 61
Query: 269 INHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVR 328
           +NH ++VK  G   E  +  L  EY S G L   I                 +   +  R
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI------------GMPEPDAQR 109
Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIP-NDKTHLTTT 387
              ++   V Y+H    I I HRDIK  N+LLD++ + K+SDFG++     N++  L   
Sbjct: 110 FFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 166
Query: 388 IQGTFGYLDPEYFQSSQF-TDKSDVYSFGVVLLELLTGKKP 427
           + GT  Y+ PE  +  +F  +  DV+S G+VL  +L G+ P
Sbjct: 167 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 101/221 (45%), Gaps = 27/221 (12%)
Query: 215 TDNYNQSRFLGQGGFGTVYKGM------LPDGSIVAVKRSKEIDKTQIHQFINEVVILSQ 268
            ++++  + LG+G +G V   +           IV +KR+ +  +        E+ I   
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----IKKEICINKM 61
Query: 269 INHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVR 328
           +NH ++VK  G   E  +  L  EY S G L   I                 +   +  R
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI------------GMPEPDAQR 109
Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIP-NDKTHLTTT 387
              ++   V Y+H    I I HRDIK  N+LLD++ + K+SDFG++     N++  L   
Sbjct: 110 FFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 166
Query: 388 IQGTFGYLDPEYFQSSQF-TDKSDVYSFGVVLLELLTGKKP 427
           + GT  Y+ PE  +  +F  +  DV+S G+VL  +L G+ P
Sbjct: 167 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 103/229 (44%), Gaps = 19/229 (8%)
Query: 216 DNYNQSRFLGQGGFGTVYK-GMLPDGSIVAVKRSK-EIDKTQIHQFINEVVILSQINHRH 273
           D++ +   LG G  G V+K    P G ++A K    EI     +Q I E+ +L + N  +
Sbjct: 68  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 127
Query: 274 IVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEV 333
           IV   G         +  E++  G+L   +                 +  +   +V+  V
Sbjct: 128 IVGFYGAFYSDGEISICMEHMDGGSLDQVLK------------KAGRIPEQILGKVSIAV 175
Query: 334 AGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFG 393
              + Y+     I   HRD+K SNIL++ +   K+ DFG+S  + +    +  +  GT  
Sbjct: 176 IKGLTYLREKHKI--MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRS 230
Query: 394 YLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVAC 442
           Y+ PE  Q + ++ +SD++S G+ L+E+  G+ PI     +E   +  C
Sbjct: 231 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGC 279

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 101/221 (45%), Gaps = 27/221 (12%)
Query: 215 TDNYNQSRFLGQGGFGTVYKGM------LPDGSIVAVKRSKEIDKTQIHQFINEVVILSQ 268
            ++++  + LG+G +G V   +           IV +KR+ +  +        E+ I   
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----IKKEICINKM 61
Query: 269 INHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVR 328
           +NH ++VK  G   E  +  L  EY S G L   I                 +   +  R
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI------------GMPEPDAQR 109
Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIP-NDKTHLTTT 387
              ++   V Y+H    I I HRDIK  N+LLD++ + K+SDFG++     N++  L   
Sbjct: 110 FFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 166
Query: 388 IQGTFGYLDPEYFQSSQF-TDKSDVYSFGVVLLELLTGKKP 427
           + GT  Y+ PE  +  +F  +  DV+S G+VL  +L G+ P
Sbjct: 167 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 72/240 (30%), Positives = 106/240 (44%), Gaps = 28/240 (11%)
Query: 208 ADELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIH-----QFIN 261
           ADE Q    NY   + +G+G F  V     +  G  VA+K    IDKTQ++     +   
Sbjct: 8   ADE-QPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKI---IDKTQLNPTSLQKLFR 63
Query: 262 EVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSL 321
           EV I+  +NH +IVKL       +   L+ EY S G +  ++  H               
Sbjct: 64  EVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEK--------- 114
Query: 322 SWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDK 381
             E R +   ++  AV Y H      I HRD+K+ N+LLD   + K++DFG S       
Sbjct: 115 --EARSKFR-QIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG 168
Query: 382 THLTTTIQGTFGYLDPEYFQSSQFTD-KSDVYSFGVVLLELLTGKKPICFARVEEERNLV 440
                   G   Y  PE FQ  ++   + DV+S GV+L  L++G  P     ++E R  V
Sbjct: 169 K--LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERV 226

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 70/298 (23%), Positives = 131/298 (43%), Gaps = 36/298 (12%)
Query: 204 KVFTADELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEV 263
           K +  D  +   ++    + LG G FG V+       + VAVK  K      +  F+ E 
Sbjct: 176 KPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKP-GSMSVEAFLAEA 234
Query: 264 VILSQINHRHIVKLLGCCLETEVPV-LVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLS 322
            ++  + H  +VKL      T+ P+ ++ E+++ G+L   +              L  L 
Sbjct: 235 NVMKTLQHDKLVKLHAVV--TKEPIYIITEFMAKGSLLDFLKSDEGSKQP-----LPKL- 286
Query: 323 WENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKT 382
               +  + ++A  +A++     I   HRD++++NIL+      K++DFG++R I +++ 
Sbjct: 287 ----IDFSAQIAEGMAFIEQRNYI---HRDLRAANILVSASLVCKIADFGLARVIEDNEY 339
Query: 383 HLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPI-CFARVEEERNLV 440
                 +    +  PE      FT KSDV+SFG++L+E++T G+ P    +  E  R L 
Sbjct: 340 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE 399
Query: 441 ACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELE 498
             +     EN   E+ +                 + MRC +   ++RPT + +   L+
Sbjct: 400 RGYRMPRPENCPEELYN-----------------IMMRCWKNRPEERPTFEYIQSVLD 440

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/274 (24%), Positives = 118/274 (43%), Gaps = 39/274 (14%)
Query: 224 LGQGGFGTVYKGMLPDGSIVAVKRSKEID----KTQIHQFINEVVILSQINHRHIVKLLG 279
           +G+G FG V+KG+  D     V   K ID    + +I     E+ +LSQ +  ++ K  G
Sbjct: 15  IGKGSFGEVFKGI--DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 72
Query: 280 CCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAY 339
             L+     ++ EY+  G+    +                 L       +  E+   + Y
Sbjct: 73  SYLKDTKLWIIMEYLGGGSALDLLEP-------------GPLDETQIATILREILKGLDY 119
Query: 340 MHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEY 399
           +HS   I   HRDIK++N+LL +    K++DFG++  + + +    T + GT  ++ PE 
Sbjct: 120 LHSEKKI---HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEV 175
Query: 400 FQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEILDAR 459
            + S +  K+D++S G+  +EL  G+ P        E + +     + K N     L+  
Sbjct: 176 IKQSAYDSKADIWSLGITAIELARGEPP------HSELHPMKVLFLIPKNNP--PTLEGN 227
Query: 460 VAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQV 493
            +K         + E    CL      RPT K++
Sbjct: 228 YSK--------PLKEFVEACLNKEPSFRPTAKEL 253

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 105/234 (44%), Gaps = 19/234 (8%)
Query: 211 LQRATDNYNQSRFLGQGGFGTVYK-GMLPDGSIVAVKRSK-EIDKTQIHQFINEVVILSQ 268
           ++   D++ +   LG G  G V+K    P G ++A K    EI     +Q I E+ +L +
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 269 INHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVR 328
            N  +IV   G         +  E++  G+L   +                 +  +   +
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK------------KAGRIPEQILGK 108
Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTI 388
           V+  V   + Y+     I   HRD+K SNIL++ +   K+ DFG+S  + +    +  + 
Sbjct: 109 VSIAVIKGLTYLREKHKI--MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSF 163
Query: 389 QGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVAC 442
            GT  Y+ PE  Q + ++ +SD++S G+ L+E+  G+ PI     +E   +  C
Sbjct: 164 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGC 217

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 105/234 (44%), Gaps = 19/234 (8%)
Query: 211 LQRATDNYNQSRFLGQGGFGTVYK-GMLPDGSIVAVKRSK-EIDKTQIHQFINEVVILSQ 268
           ++   D++ +   LG G  G V+K    P G ++A K    EI     +Q I E+ +L +
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 269 INHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVR 328
            N  +IV   G         +  E++  G+L   +                 +  +   +
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK------------KAGRIPEQILGK 108
Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTI 388
           V+  V   + Y+     I   HRD+K SNIL++ +   K+ DFG+S  + +    +  + 
Sbjct: 109 VSIAVIKGLTYLREKHKI--MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSF 163
Query: 389 QGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVAC 442
            GT  Y+ PE  Q + ++ +SD++S G+ L+E+  G+ PI     +E   +  C
Sbjct: 164 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGC 217

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 105/234 (44%), Gaps = 19/234 (8%)
Query: 211 LQRATDNYNQSRFLGQGGFGTVYK-GMLPDGSIVAVKRSK-EIDKTQIHQFINEVVILSQ 268
           ++   D++ +   LG G  G V+K    P G ++A K    EI     +Q I E+ +L +
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 269 INHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVR 328
            N  +IV   G         +  E++  G+L   +                 +  +   +
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL------------KKAGRIPEQILGK 108
Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTI 388
           V+  V   + Y+     I   HRD+K SNIL++ +   K+ DFG+S  + +    +  + 
Sbjct: 109 VSIAVIKGLTYLREKHKI--MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSF 163
Query: 389 QGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVAC 442
            GT  Y+ PE  Q + ++ +SD++S G+ L+E+  G+ PI     +E   +  C
Sbjct: 164 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGC 217

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/233 (27%), Positives = 116/233 (49%), Gaps = 24/233 (10%)
Query: 216 DNYNQSRFLGQGGFGTVYK----GMLPDG-SI-VAVKRSKE-IDKTQIHQFINEVVILSQ 268
           +N    + LG G FG V      G+   G SI VAVK  KE  D ++    ++E+ +++Q
Sbjct: 45  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104
Query: 269 I-NHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIH-----------DHXXXXXXXXXX 316
           + +H +IV LLG C  +    L++EY   G L +++            ++          
Sbjct: 105 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164
Query: 317 XLSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS 376
            L+ L++E+ +  A +VA  + ++   + +   HRD+ + N+L+      K+ DFG++R 
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFLEFKSCV---HRDLAARNVLVTHGKVVKICDFGLARD 221
Query: 377 IPNDKTHLTT-TIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
           I +D  ++     +    ++ PE      +T KSDV+S+G++L E+ + G  P
Sbjct: 222 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 75/241 (31%), Positives = 107/241 (44%), Gaps = 28/241 (11%)
Query: 207 TADELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIH-----QFI 260
           +ADE Q    NY   + +G+G F  V     +  G  VAVK    IDKTQ++     +  
Sbjct: 6   SADE-QPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKI---IDKTQLNSSSLQKLF 61
Query: 261 NEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSS 320
            EV I   +NH +IVKL       +   LV EY S G +  ++  H              
Sbjct: 62  REVRIXKVLNHPNIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEK-------- 113
Query: 321 LSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPND 380
              E R +   ++  AV Y H      I HRD+K+ N+LLD   + K++DFG S      
Sbjct: 114 ---EARAKFR-QIVSAVQYCHQKF---IVHRDLKAENLLLDADXNIKIADFGFSNEFTFG 166
Query: 381 KTHLTTTIQGTFGYLDPEYFQSSQFTD-KSDVYSFGVVLLELLTGKKPICFARVEEERNL 439
                    G   Y  PE FQ  ++   + DV+S GV+L  L++G  P     ++E R  
Sbjct: 167 NK--LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRER 224
Query: 440 V 440
           V
Sbjct: 225 V 225

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 105/234 (44%), Gaps = 19/234 (8%)
Query: 211 LQRATDNYNQSRFLGQGGFGTVYK-GMLPDGSIVAVKRSK-EIDKTQIHQFINEVVILSQ 268
           ++   D++ +   LG G  G V+K    P G ++A K    EI     +Q I E+ +L +
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 269 INHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVR 328
            N  +IV   G         +  E++  G+L   +                 +  +   +
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL------------KKAGRIPEQILGK 108
Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTI 388
           V+  V   + Y+     I   HRD+K SNIL++ +   K+ DFG+S  + +    +  + 
Sbjct: 109 VSIAVIKGLTYLREKHKI--MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSF 163
Query: 389 QGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVAC 442
            GT  Y+ PE  Q + ++ +SD++S G+ L+E+  G+ PI     +E   +  C
Sbjct: 164 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGC 217

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 99/215 (46%), Gaps = 16/215 (7%)
Query: 217 NYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSK---EIDKTQIHQFINEVVILSQINHR 272
           N+   + +G+G F  VY+   L DG  VA+K+ +    +D       I E+ +L Q+NH 
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92
Query: 273 HIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACE 332
           +++K     +E     +V E   +G LS  I              +    W+  V    +
Sbjct: 93  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTV----WKYFV----Q 144
Query: 333 VAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTF 392
           +  A+ +MHS     + HRDIK +N+ +      K+ D G+ R   + KT    ++ GT 
Sbjct: 145 LCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFF-SSKTTAAHSLVGTP 200
Query: 393 GYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
            Y+ PE    + +  KSD++S G +L E+   + P
Sbjct: 201 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 235

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 106/219 (48%), Gaps = 16/219 (7%)
Query: 224 LGQGGFGTVYKGML------PDGSIVAVKRSKEIDKTQI-HQFINEVVILSQINHRHIVK 276
           LG+  FG VYKG L           VA+K  K+  +  +  +F +E ++ +++ H ++V 
Sbjct: 34  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 93
Query: 277 LLGCCLETEVPVLVYEYISSGTLSHHI---HDHXXXXXXXXXXXL-SSLSWENRVRVACE 332
           LLG   + +   +++ Y S G L   +     H           + S+L   + V +  +
Sbjct: 94  LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 153
Query: 333 VAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI-PNDKTHLTTTIQGT 391
           +A  + Y+ S     + H+D+ + N+L+ DK + K+SD G+ R +   D   L       
Sbjct: 154 IAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLP 210
Query: 392 FGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPIC 429
             ++ PE     +F+  SD++S+GVVL E+ + G +P C
Sbjct: 211 IRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYC 249

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 107/219 (48%), Gaps = 14/219 (6%)
Query: 216 DNYNQSRFLGQGGFGTVYK----GMLPDGSI--VAVKRSKEIDKT-QIHQFINEVVILSQ 268
           +N    + LG G FG V +    G+  + ++  VAVK  K      +    ++E+ I+S 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 269 IN-HRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXL--SSLSWEN 325
           +  H +IV LLG C      +++ EY   G L + +              +  S+ S  +
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165
Query: 326 RVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLT 385
            +  + +VA  +A++ S   I   HRD+ + N+LL +   AK+ DFG++R I ND  ++ 
Sbjct: 166 LLHFSSQVAQGMAFLASKNCI---HRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 222
Query: 386 T-TIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT 423
               +    ++ PE      +T +SDV+S+G++L E+ +
Sbjct: 223 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 80/168 (47%), Gaps = 17/168 (10%)
Query: 262 EVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSL 321
           E+ I   +NH ++VK  G   E  +  L  EY S G L   I                 +
Sbjct: 54  EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI------------GM 101
Query: 322 SWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIP-ND 380
              +  R   ++   V Y+H    I I HRDIK  N+LLD++ + K+SDFG++     N+
Sbjct: 102 PEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 158
Query: 381 KTHLTTTIQGTFGYLDPEYFQSSQF-TDKSDVYSFGVVLLELLTGKKP 427
           +  L   + GT  Y+ PE  +  +F  +  DV+S G+VL  +L G+ P
Sbjct: 159 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 101/221 (45%), Gaps = 27/221 (12%)
Query: 215 TDNYNQSRFLGQGGFGTVYKGM------LPDGSIVAVKRSKEIDKTQIHQFINEVVILSQ 268
            ++++  + LG+G +G V   +           IV +KR+ +  +        E+ I   
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----IKKEICINKM 61
Query: 269 INHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVR 328
           +NH ++VK  G   E  +  L  EY S G L   I                 +   +  R
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI------------GMPEPDAQR 109
Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIP-NDKTHLTTT 387
              ++   V Y+H    I I HRDIK  N+LLD++ + K+SDFG++     N++  L   
Sbjct: 110 FFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 166
Query: 388 IQGTFGYLDPEYFQSSQF-TDKSDVYSFGVVLLELLTGKKP 427
           + GT  Y+ PE  +  +F  +  DV+S G+VL  +L G+ P
Sbjct: 167 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 106/219 (48%), Gaps = 16/219 (7%)
Query: 224 LGQGGFGTVYKGML------PDGSIVAVKRSKEIDKTQI-HQFINEVVILSQINHRHIVK 276
           LG+  FG VYKG L           VA+K  K+  +  +  +F +E ++ +++ H ++V 
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 277 LLGCCLETEVPVLVYEYISSGTLSHHI---HDHXXXXXXXXXXXL-SSLSWENRVRVACE 332
           LLG   + +   +++ Y S G L   +     H           + S+L   + V +  +
Sbjct: 77  LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 333 VAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI-PNDKTHLTTTIQGT 391
           +A  + Y+ S     + H+D+ + N+L+ DK + K+SD G+ R +   D   L       
Sbjct: 137 IAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLP 193
Query: 392 FGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPIC 429
             ++ PE     +F+  SD++S+GVVL E+ + G +P C
Sbjct: 194 IRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYC 232

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 101/221 (45%), Gaps = 27/221 (12%)
Query: 215 TDNYNQSRFLGQGGFGTVYKGM------LPDGSIVAVKRSKEIDKTQIHQFINEVVILSQ 268
            ++++  + LG+G +G V   +           IV +KR+ +  +        E+ I   
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----IKKEICINKM 60
Query: 269 INHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVR 328
           +NH ++VK  G   E  +  L  EY S G L   I                 +   +  R
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI------------GMPEPDAQR 108
Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIP-NDKTHLTTT 387
              ++   V Y+H    I I HRDIK  N+LLD++ + K+SDFG++     N++  L   
Sbjct: 109 FFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 165
Query: 388 IQGTFGYLDPEYFQSSQF-TDKSDVYSFGVVLLELLTGKKP 427
           + GT  Y+ PE  +  +F  +  DV+S G+VL  +L G+ P
Sbjct: 166 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 105/215 (48%), Gaps = 26/215 (12%)
Query: 224 LGQGGFGTVYKGMLP----DGSIVAVKRSKE-IDKTQIHQFINEVVILSQINHRHIVKLL 278
           +G G FG V +G L       S VA+K  K    + Q  +F++E  I+ Q  H +I++L 
Sbjct: 22  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLE 81
Query: 279 GCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVA 338
           G    +   +++ E++ +G L   +  +                    +++   + G  +
Sbjct: 82  GVVTNSMPVMILTEFMENGALDSFLRLNDGQFTV--------------IQLVGMLRGIAS 127
Query: 339 YMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI---PNDKTHLTTTIQGTFG-- 393
            M   A +   HRD+ + NIL++     KVSDFG+SR +    +D T+ T+++ G     
Sbjct: 128 GMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTY-TSSLGGKIPIR 186
Query: 394 YLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
           +  PE     +FT  SD +S+G+V+ E+++ G++P
Sbjct: 187 WTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERP 221

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 101/216 (46%), Gaps = 28/216 (12%)
Query: 224 LGQGGFGTVYKGMLP----DGSIVAVKRSKE-IDKTQIHQFINEVVILSQINHRHIVKLL 278
           +G G FG V +G L       S VA+K  K    + Q  +F++E  I+ Q  H +I++L 
Sbjct: 24  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLE 83
Query: 279 GCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVA 338
           G    +   +++ E++ +G L   +  +                    +++   + G  +
Sbjct: 84  GVVTNSMPVMILTEFMENGALDSFLRLNDGQFTV--------------IQLVGMLRGIAS 129
Query: 339 YMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISR------SIPNDKTHLTTTIQGTF 392
            M   A +   HRD+ + NIL++     KVSDFG+SR      S P + + L   I    
Sbjct: 130 GMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKI--PI 187
Query: 393 GYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
            +  PE     +FT  SD +S+G+V+ E+++ G++P
Sbjct: 188 RWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERP 223

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 99/215 (46%), Gaps = 19/215 (8%)
Query: 216 DNYNQSRFLGQGGFGTVYK-GMLPDGSIVAVKRSK-EIDKTQIHQFINEVVILSQINHRH 273
           D++ +   LG G  G V+K    P G ++A K    EI     +Q I E+ +L + N  +
Sbjct: 25  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 84
Query: 274 IVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEV 333
           IV   G         +  E++  G+L   +                 +  +   +V+  V
Sbjct: 85  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKK------------AGRIPEQILGKVSIAV 132
Query: 334 AGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFG 393
              + Y+     I   HRD+K SNIL++ +   K+ DFG+S  + +    +  +  GT  
Sbjct: 133 IKGLTYLREKHKI--MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRS 187
Query: 394 YLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
           Y+ PE  Q + ++ +SD++S G+ L+E+  G+ PI
Sbjct: 188 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 222

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 98/208 (47%), Gaps = 23/208 (11%)
Query: 224 LGQGGFGTVYKGMLPDGSIVAVKRSKEID----KTQIHQFINEVVILSQINHRHIVKLLG 279
           +G+G FG VYKG+  D     V   K ID    + +I     E+ +LSQ +  +I +  G
Sbjct: 27  IGKGSFGEVYKGI--DNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYFG 84
Query: 280 CCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAY 339
             L++    ++ EY+  G+                      L       +  E+   + Y
Sbjct: 85  SYLKSTKLWIIMEYLGGGS-------------ALDLLKPGPLEETYIATILREILKGLDY 131
Query: 340 MHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEY 399
           +HS   I   HRDIK++N+LL ++   K++DFG++  + + +      + GT  ++ PE 
Sbjct: 132 LHSERKI---HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFV-GTPFWMAPEV 187
Query: 400 FQSSQFTDKSDVYSFGVVLLELLTGKKP 427
            + S +  K+D++S G+  +EL  G+ P
Sbjct: 188 IKQSAYDFKADIWSLGITAIELAKGEPP 215

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 101/227 (44%), Gaps = 24/227 (10%)
Query: 207 TADELQR--ATDNYNQSRFLGQGGFGTVYKGMLPDGS-IVAVKR--SKEIDKTQI-HQFI 260
           T D L R    D++   R LG+G FG VY         IVA+K     +I+K  + HQ  
Sbjct: 12  TPDILTRHFTIDDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLR 71
Query: 261 NEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSS 320
            E+ I + ++H +I++L     +     L+ EY   G L   +                +
Sbjct: 72  REIEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKS------------CT 119
Query: 321 LSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPND 380
              +    +  E+A A+ Y H      + HRDIK  N+LL  K   K++DFG S   P+ 
Sbjct: 120 FDEQRTATIMEELADALMYCHGKK---VIHRDIKPENLLLGLKGELKIADFGWSVHAPSL 176
Query: 381 KTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
           +     T+ GT  YL PE  +     +K D++  GV+  ELL G  P
Sbjct: 177 RR---KTMCGTLDYLPPEMIEGRMHNEKVDLWCIGVLCYELLVGNPP 220

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 66/274 (24%), Positives = 117/274 (42%), Gaps = 39/274 (14%)
Query: 224 LGQGGFGTVYKGMLPDGSIVAVKRSKEID----KTQIHQFINEVVILSQINHRHIVKLLG 279
           +G+G FG V+KG+  D     V   K ID    + +I     E+ +LSQ +  ++ K  G
Sbjct: 30  IGKGSFGEVFKGI--DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 87
Query: 280 CCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAY 339
             L+     ++ EY+  G+    +                 L       +  E+   + Y
Sbjct: 88  SYLKDTKLWIIMEYLGGGSALDLLEP-------------GPLDETQIATILREILKGLDY 134
Query: 340 MHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEY 399
           +HS   I   HRDIK++N+LL +    K++DFG++  + + +      + GT  ++ PE 
Sbjct: 135 LHSEKKI---HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFV-GTPFWMAPEV 190
Query: 400 FQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEILDAR 459
            + S +  K+D++S G+  +EL  G+ P        E + +     + K N     L+  
Sbjct: 191 IKQSAYDSKADIWSLGITAIELARGEPP------HSELHPMKVLFLIPKNNP--PTLEGN 242
Query: 460 VAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQV 493
            +K         + E    CL      RPT K++
Sbjct: 243 YSK--------PLKEFVEACLNKEPSFRPTAKEL 268

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 66/274 (24%), Positives = 117/274 (42%), Gaps = 39/274 (14%)
Query: 224 LGQGGFGTVYKGMLPDGSIVAVKRSKEID----KTQIHQFINEVVILSQINHRHIVKLLG 279
           +G+G FG V+KG+  D     V   K ID    + +I     E+ +LSQ +  ++ K  G
Sbjct: 15  IGKGSFGEVFKGI--DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 72
Query: 280 CCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAY 339
             L+     ++ EY+  G+    +                 L       +  E+   + Y
Sbjct: 73  SYLKDTKLWIIMEYLGGGSALDLLEP-------------GPLDETQIATILREILKGLDY 119
Query: 340 MHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEY 399
           +HS   I   HRDIK++N+LL +    K++DFG++  + + +      + GT  ++ PE 
Sbjct: 120 LHSEKKI---HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFV-GTPFWMAPEV 175
Query: 400 FQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEILDAR 459
            + S +  K+D++S G+  +EL  G+ P        E + +     + K N     L+  
Sbjct: 176 IKQSAYDSKADIWSLGITAIELARGEPP------HSELHPMKVLFLIPKNNP--PTLEGN 227
Query: 460 VAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQV 493
            +K         + E    CL      RPT K++
Sbjct: 228 YSK--------PLKEFVEACLNKEPSFRPTAKEL 253

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 102/219 (46%), Gaps = 14/219 (6%)
Query: 216 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKR-SKEIDKTQIHQFINEVVILSQINHRH 273
           D+Y     +G G    V      P    VA+KR + E  +T + + + E+  +SQ +H +
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 274 IVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEV 333
           IV      +  +   LV + +S G++   I  H           L   +    +R   EV
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIK-HIVAKGEHKSGVLDESTIATILR---EV 130
Query: 334 AGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPN----DKTHLTTTIQ 389
              + Y+H +  I   HRD+K+ NILL +  S +++DFG+S  +       +  +  T  
Sbjct: 131 LEGLEYLHKNGQI---HRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV 187
Query: 390 GTFGYLDPEYFQSSQFTD-KSDVYSFGVVLLELLTGKKP 427
           GT  ++ PE  +  +  D K+D++SFG+  +EL TG  P
Sbjct: 188 GTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 226

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 60/239 (25%), Positives = 108/239 (45%), Gaps = 45/239 (18%)
Query: 213 RATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKTQIHQFINEVVILSQINH 271
           R   ++ +   LGQG FG V K     D    A+K+ +  ++ ++   ++EV++L+ +NH
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEE-KLSTILSEVMLLASLNH 61
Query: 272 RHIVKLLGCCLETEVPV-------------LVYEYISSGTLSHHIHDHXXXXXXXXXXXL 318
           +++V+     LE    V             +  EY  + TL   IH              
Sbjct: 62  QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEY--- 118
Query: 319 SSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGI----- 373
               W    R+  ++  A++Y+HS     I HRD+K  NI +D+  + K+ DFG+     
Sbjct: 119 ----W----RLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVH 167
Query: 374 ---------SRSIPNDKTHLTTTIQGTFGYLDPEYFQ-SSQFTDKSDVYSFGVVLLELL 422
                    S+++P    +LT+ I GT  Y+  E    +  + +K D+YS G++  E++
Sbjct: 168 RSLDILKLDSQNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 102/219 (46%), Gaps = 14/219 (6%)
Query: 216 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKR-SKEIDKTQIHQFINEVVILSQINHRH 273
           D+Y     +G G    V      P    VA+KR + E  +T + + + E+  +SQ +H +
Sbjct: 10  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 69
Query: 274 IVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEV 333
           IV      +  +   LV + +S G++   I  H           L   +    +R   EV
Sbjct: 70  IVSYYTSFVVKDELWLVMKLLSGGSVLDII-KHIVAKGEHKSGVLDESTIATILR---EV 125
Query: 334 AGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPND----KTHLTTTIQ 389
              + Y+H +  I   HRD+K+ NILL +  S +++DFG+S  +       +  +  T  
Sbjct: 126 LEGLEYLHKNGQI---HRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV 182
Query: 390 GTFGYLDPEYFQSSQFTD-KSDVYSFGVVLLELLTGKKP 427
           GT  ++ PE  +  +  D K+D++SFG+  +EL TG  P
Sbjct: 183 GTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 221

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 104/217 (47%), Gaps = 14/217 (6%)
Query: 216 DNYNQSRFLGQGGFGTVYK----GMLPDGSI--VAVKRSKEIDKT-QIHQFINEVVILSQ 268
           +N    + LG G FG V +    G+  + ++  VAVK  K      +    ++E+ I+S 
Sbjct: 38  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 97
Query: 269 IN-HRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
           +  H +IV LLG C      +++ EY   G L + +                 L   + +
Sbjct: 98  LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDG--RPLELRDLL 155
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTT- 386
             + +VA  +A++ S   I   HRD+ + N+LL +   AK+ DFG++R I ND  ++   
Sbjct: 156 HFSSQVAQGMAFLASKNCI---HRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKG 212
Query: 387 TIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT 423
             +    ++ PE      +T +SDV+S+G++L E+ +
Sbjct: 213 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 249

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 100/230 (43%), Gaps = 23/230 (10%)
Query: 216 DNYNQSRFLGQGGFGTVYKGMLPDGS-IVAVKR--SKEIDKTQI-HQFINEVVILSQINH 271
           D+++  R LG+G FG VY         I+A+K     +++K  + HQ   E+ I S + H
Sbjct: 15  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 74
Query: 272 RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVAC 331
            +I+++     + +   L+ E+   G L   +  H           +             
Sbjct: 75  PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFME------------ 122
Query: 332 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGT 391
           E+A A+ Y H    I   HRDIK  N+L+  K   K++DFG S   P+ +      + GT
Sbjct: 123 ELADALHYCHERKVI---HRDIKPENLLMGYKGELKIADFGWSVHAPSLR---RRXMCGT 176
Query: 392 FGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI-CFARVEEERNLV 440
             YL PE  +     +K D++  GV+  E L G  P    +  E  R +V
Sbjct: 177 LDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIV 226

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 104/217 (47%), Gaps = 14/217 (6%)
Query: 216 DNYNQSRFLGQGGFGTVYK----GMLPDGSI--VAVKRSKEIDKT-QIHQFINEVVILSQ 268
           +N    + LG G FG V +    G+  + ++  VAVK  K      +    ++E+ I+S 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 269 IN-HRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
           +  H +IV LLG C      +++ EY   G L + +                 L   + +
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDG--RPLELRDLL 163
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTT- 386
             + +VA  +A++ S   I   HRD+ + N+LL +   AK+ DFG++R I ND  ++   
Sbjct: 164 HFSSQVAQGMAFLASKNCI---HRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKG 220
Query: 387 TIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT 423
             +    ++ PE      +T +SDV+S+G++L E+ +
Sbjct: 221 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 257

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/194 (28%), Positives = 95/194 (48%), Gaps = 29/194 (14%)
Query: 240 GSIVAVKRSKEIDKTQIHQFI-NEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGT 298
           G  VAVK   ++ K Q  + + NEVVI+    H ++V++    L  E   ++ E++  G 
Sbjct: 70  GRQVAVK-MMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGA 128
Query: 299 LSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACE-VAGAVAYMHSSASIPIFHRDIKSSN 357
           L+  +                    E ++   CE V  A+AY+H+     + HRDIKS +
Sbjct: 129 LTDIVSQVRLN--------------EEQIATVCEAVLQALAYLHAQG---VIHRDIKSDS 171
Query: 358 ILLDDKFSAKVSDFG----ISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYS 413
           ILL      K+SDFG    IS+ +P  K      + GT  ++ PE    S +  + D++S
Sbjct: 172 ILLTLDGRVKLSDFGFCAQISKDVPKRK-----XLVGTPYWMAPEVISRSLYATEVDIWS 226
Query: 414 FGVVLLELLTGKKP 427
            G++++E++ G+ P
Sbjct: 227 LGIMVIEMVDGEPP 240

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 103/217 (47%), Gaps = 29/217 (13%)
Query: 216 DNYNQSRFLGQGGFGTV-YKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHI 274
           DN+ +   +G+G  G V    +   G +VAVK+     + +     NEVVI+    H ++
Sbjct: 23  DNFIK---IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 79
Query: 275 VKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVA 334
           V++    L  +   +V E++  G L+  I  H            + ++ E    V   V 
Sbjct: 80  VEMYNSYLVGDELWVVMEFLEGGALT-DIVTH------------TRMNEEQIAAVCLAVL 126
Query: 335 GAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG----ISRSIPNDKTHLTTTIQG 390
            A++ +H+     + HRDIKS +ILL      K+SDFG    +S+ +P  K      + G
Sbjct: 127 QALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK-----XLVG 178
Query: 391 TFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
           T  ++ PE      +  + D++S G++++E++ G+ P
Sbjct: 179 TPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 215

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 103/210 (49%), Gaps = 28/210 (13%)
Query: 224 LGQGGFGTV-YKGMLPDGSIVAVKRSKEIDKTQIHQFI-NEVVILSQINHRHIVKLLGCC 281
           +G+G  G V    +   G +VAVK+  ++ K Q  + + NEVVI+    H ++V++    
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKM-DLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 140
Query: 282 LETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYMH 341
           L  +   +V E++  G L+  I  H            + ++ E    V   V  A++ +H
Sbjct: 141 LVGDELWVVMEFLEGGALT-DIVTH------------TRMNEEQIAAVCLAVLQALSVLH 187
Query: 342 SSASIPIFHRDIKSSNILLDDKFSAKVSDFG----ISRSIPNDKTHLTTTIQGTFGYLDP 397
           +     + HRDIKS +ILL      K+SDFG    +S+ +P  K      + GT  ++ P
Sbjct: 188 AQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK-----XLVGTPYWMAP 239
Query: 398 EYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
           E      +  + D++S G++++E++ G+ P
Sbjct: 240 ELISRLPYGPEVDIWSLGIMVIEMVDGEPP 269

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 103/210 (49%), Gaps = 28/210 (13%)
Query: 224 LGQGGFGTV-YKGMLPDGSIVAVKRSKEIDKTQIHQFI-NEVVILSQINHRHIVKLLGCC 281
           +G+G  G V    +   G +VAVK+  ++ K Q  + + NEVVI+    H ++V++    
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKM-DLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 97
Query: 282 LETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYMH 341
           L  +   +V E++  G L+  I  H            + ++ E    V   V  A++ +H
Sbjct: 98  LVGDELWVVMEFLEGGALT-DIVTH------------TRMNEEQIAAVCLAVLQALSVLH 144
Query: 342 SSASIPIFHRDIKSSNILLDDKFSAKVSDFG----ISRSIPNDKTHLTTTIQGTFGYLDP 397
           +     + HRDIKS +ILL      K+SDFG    +S+ +P  K      + GT  ++ P
Sbjct: 145 AQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK-----XLVGTPYWMAP 196
Query: 398 EYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
           E      +  + D++S G++++E++ G+ P
Sbjct: 197 ELISRLPYGPEVDIWSLGIMVIEMVDGEPP 226

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 98/214 (45%), Gaps = 19/214 (8%)
Query: 216 DNYNQSRFLGQGGFGTVYK-GMLPDGSIVAVKRSK-EIDKTQIHQFINEVVILSQINHRH 273
           D++ +   LG G  G V+K    P G ++A K    EI     +Q I E+ +L + N  +
Sbjct: 9   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 68
Query: 274 IVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEV 333
           IV   G         +  E++  G+L   +                 +  +   +V+  V
Sbjct: 69  IVGFYGAFYSDGEISICMEHMDGGSLDQVL------------KKAGRIPEQILGKVSIAV 116
Query: 334 AGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFG 393
              + Y+     I   HRD+K SNIL++ +   K+ DFG+S  + ++   +     GT  
Sbjct: 117 IKGLTYLREKHKI--MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDE---MANEFVGTRS 171
Query: 394 YLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
           Y+ PE  Q + ++ +SD++S G+ L+E+  G+ P
Sbjct: 172 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 205

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 103/210 (49%), Gaps = 28/210 (13%)
Query: 224 LGQGGFGTV-YKGMLPDGSIVAVKRSKEIDKTQIHQFI-NEVVILSQINHRHIVKLLGCC 281
           +G+G  G V    +   G +VAVK+  ++ K Q  + + NEVVI+    H ++V++    
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKM-DLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 95
Query: 282 LETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYMH 341
           L  +   +V E++  G L+  I  H            + ++ E    V   V  A++ +H
Sbjct: 96  LVGDELWVVMEFLEGGALT-DIVTH------------TRMNEEQIAAVCLAVLQALSVLH 142
Query: 342 SSASIPIFHRDIKSSNILLDDKFSAKVSDFG----ISRSIPNDKTHLTTTIQGTFGYLDP 397
           +     + HRDIKS +ILL      K+SDFG    +S+ +P  K      + GT  ++ P
Sbjct: 143 AQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK-----XLVGTPYWMAP 194
Query: 398 EYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
           E      +  + D++S G++++E++ G+ P
Sbjct: 195 ELISRLPYGPEVDIWSLGIMVIEMVDGEPP 224

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 100/230 (43%), Gaps = 23/230 (10%)
Query: 216 DNYNQSRFLGQGGFGTVYKGMLPDGS-IVAVKR--SKEIDKTQI-HQFINEVVILSQINH 271
           D+++  R LG+G FG VY         I+A+K     +++K  + HQ   E+ I S + H
Sbjct: 14  DDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 272 RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVAC 331
            +I+++     + +   L+ E+   G L   +  H           +             
Sbjct: 74  PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFME------------ 121
Query: 332 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGT 391
           E+A A+ Y H    I   HRDIK  N+L+  K   K++DFG S   P+ +      + GT
Sbjct: 122 ELADALHYCHERKVI---HRDIKPENLLMGYKGELKIADFGWSVHAPSLR---RRXMCGT 175
Query: 392 FGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI-CFARVEEERNLV 440
             YL PE  +     +K D++  GV+  E L G  P    +  E  R +V
Sbjct: 176 LDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIV 225

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 103/210 (49%), Gaps = 28/210 (13%)
Query: 224 LGQGGFGTV-YKGMLPDGSIVAVKRSKEIDKTQIHQFI-NEVVILSQINHRHIVKLLGCC 281
           +G+G  G V    +   G +VAVK+  ++ K Q  + + NEVVI+    H ++V++    
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKM-DLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 217
Query: 282 LETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYMH 341
           L  +   +V E++  G L+  I  H            + ++ E    V   V  A++ +H
Sbjct: 218 LVGDELWVVMEFLEGGALT-DIVTH------------TRMNEEQIAAVCLAVLQALSVLH 264
Query: 342 SSASIPIFHRDIKSSNILLDDKFSAKVSDFG----ISRSIPNDKTHLTTTIQGTFGYLDP 397
           +     + HRDIKS +ILL      K+SDFG    +S+ +P  K      + GT  ++ P
Sbjct: 265 AQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK-----XLVGTPYWMAP 316
Query: 398 EYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
           E      +  + D++S G++++E++ G+ P
Sbjct: 317 ELISRLPYGPEVDIWSLGIMVIEMVDGEPP 346

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 108/224 (48%), Gaps = 22/224 (9%)
Query: 216 DNYNQSRFLGQGGFGTVYK----GMLPDGSI--VAVKRSKEIDKT-QIHQFINEVVILSQ 268
           +N    + LG G FG V +    G+  + ++  VAVK  K      +    ++E+ I+S 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 269 IN-HRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIH-------DHXXXXXXXXXXXLSS 320
           +  H +IV LLG C      +++ EY   G L + +        ++           LSS
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSS 165
Query: 321 LSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPND 380
               + +  + +VA  +A++ S   I   HRD+ + N+LL +   AK+ DFG++R I ND
Sbjct: 166 ---RDLLHFSSQVAQGMAFLASKNCI---HRDVAARNVLLTNGHVAKIGDFGLARDIMND 219
Query: 381 KTHLTT-TIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT 423
             ++     +    ++ PE      +T +SDV+S+G++L E+ +
Sbjct: 220 SNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 263

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 99/209 (47%), Gaps = 26/209 (12%)
Query: 224 LGQGGFGTV-YKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCL 282
           +G+G  G V    +   G +VAVK+     + +     NEVVI+    H ++V++    L
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 91
Query: 283 ETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYMHS 342
             +   +V E++  G L+  I  H            + ++ E    V   V  A++ +H+
Sbjct: 92  VGDELWVVMEFLEGGALT-DIVTH------------TRMNEEQIAAVCLAVLQALSVLHA 138
Query: 343 SASIPIFHRDIKSSNILLDDKFSAKVSDFG----ISRSIPNDKTHLTTTIQGTFGYLDPE 398
                + HRDIKS +ILL      K+SDFG    +S+ +P  K      + GT  ++ PE
Sbjct: 139 QG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK-----XLVGTPYWMAPE 190
Query: 399 YFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
                 +  + D++S G++++E++ G+ P
Sbjct: 191 LISRLPYGPEVDIWSLGIMVIEMVDGEPP 219

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 74/291 (25%), Positives = 128/291 (43%), Gaps = 34/291 (11%)
Query: 224 LGQGGFG-----TVYKGMLPDGSI-VAVKRSK-EIDKTQIHQFINEVVILSQI-NHRHIV 275
           LG G FG     T Y  +  D ++ VAVK  K     T+    ++E+ +LS + NH +IV
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 276 KLLGCCLETEVPVLVYEYISSGTLSHHIHDH------XXXXXXXXXXXLSSLSWENRVRV 329
            LLG C      +++ EY   G L + +                      +L  E+ +  
Sbjct: 91  NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 330 ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTT-TI 388
           + +VA  +A++ S   I   HRD+ + NILL      K+ DFG++R I ND  ++     
Sbjct: 151 SYQVAKGMAFLASKNCI---HRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 207
Query: 389 QGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLA 447
           +    ++ PE   +  +T +SDV+S+G+ L EL + G  P               +  + 
Sbjct: 208 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP---------------YPGMP 252
Query: 448 KENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELE 498
            +++  +++       + E     M ++   C   +  KRPT KQ+   +E
Sbjct: 253 VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 303

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 74/291 (25%), Positives = 128/291 (43%), Gaps = 34/291 (11%)
Query: 224 LGQGGFG-----TVYKGMLPDGSI-VAVKRSK-EIDKTQIHQFINEVVILSQI-NHRHIV 275
           LG G FG     T Y  +  D ++ VAVK  K     T+    ++E+ +LS + NH +IV
Sbjct: 49  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 108
Query: 276 KLLGCCLETEVPVLVYEYISSGTLSHHIHDH------XXXXXXXXXXXLSSLSWENRVRV 329
            LLG C      +++ EY   G L + +                      +L  E+ +  
Sbjct: 109 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 168
Query: 330 ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTT-TI 388
           + +VA  +A++ S   I   HRD+ + NILL      K+ DFG++R I ND  ++     
Sbjct: 169 SYQVAKGMAFLASKNCI---HRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 225
Query: 389 QGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLA 447
           +    ++ PE   +  +T +SDV+S+G+ L EL + G  P               +  + 
Sbjct: 226 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP---------------YPGMP 270
Query: 448 KENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELE 498
            +++  +++       + E     M ++   C   +  KRPT KQ+   +E
Sbjct: 271 VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 321

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 74/291 (25%), Positives = 128/291 (43%), Gaps = 34/291 (11%)
Query: 224 LGQGGFG-----TVYKGMLPDGSI-VAVKRSK-EIDKTQIHQFINEVVILSQI-NHRHIV 275
           LG G FG     T Y  +  D ++ VAVK  K     T+    ++E+ +LS + NH +IV
Sbjct: 47  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 106
Query: 276 KLLGCCLETEVPVLVYEYISSGTLSHHIHDH------XXXXXXXXXXXLSSLSWENRVRV 329
            LLG C      +++ EY   G L + +                      +L  E+ +  
Sbjct: 107 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 166
Query: 330 ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTT-TI 388
           + +VA  +A++ S   I   HRD+ + NILL      K+ DFG++R I ND  ++     
Sbjct: 167 SYQVAKGMAFLASKNCI---HRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 223
Query: 389 QGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLA 447
           +    ++ PE   +  +T +SDV+S+G+ L EL + G  P               +  + 
Sbjct: 224 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP---------------YPGMP 268
Query: 448 KENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELE 498
            +++  +++       + E     M ++   C   +  KRPT KQ+   +E
Sbjct: 269 VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 319

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 74/291 (25%), Positives = 128/291 (43%), Gaps = 34/291 (11%)
Query: 224 LGQGGFG-----TVYKGMLPDGSI-VAVKRSK-EIDKTQIHQFINEVVILSQI-NHRHIV 275
           LG G FG     T Y  +  D ++ VAVK  K     T+    ++E+ +LS + NH +IV
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 276 KLLGCCLETEVPVLVYEYISSGTLSHHIHDH------XXXXXXXXXXXLSSLSWENRVRV 329
            LLG C      +++ EY   G L + +                      +L  E+ +  
Sbjct: 114 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 173
Query: 330 ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTT-TI 388
           + +VA  +A++ S   I   HRD+ + NILL      K+ DFG++R I ND  ++     
Sbjct: 174 SYQVAKGMAFLASKNCI---HRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 230
Query: 389 QGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLA 447
           +    ++ PE   +  +T +SDV+S+G+ L EL + G  P               +  + 
Sbjct: 231 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP---------------YPGMP 275
Query: 448 KENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELE 498
            +++  +++       + E     M ++   C   +  KRPT KQ+   +E
Sbjct: 276 VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 326

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 74/291 (25%), Positives = 128/291 (43%), Gaps = 34/291 (11%)
Query: 224 LGQGGFG-----TVYKGMLPDGSI-VAVKRSK-EIDKTQIHQFINEVVILSQI-NHRHIV 275
           LG G FG     T Y  +  D ++ VAVK  K     T+    ++E+ +LS + NH +IV
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 276 KLLGCCLETEVPVLVYEYISSGTLSHHIHDH------XXXXXXXXXXXLSSLSWENRVRV 329
            LLG C      +++ EY   G L + +                      +L  E+ +  
Sbjct: 114 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 173
Query: 330 ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTT-TI 388
           + +VA  +A++ S   I   HRD+ + NILL      K+ DFG++R I ND  ++     
Sbjct: 174 SYQVAKGMAFLASKNCI---HRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVKGNA 230
Query: 389 QGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLA 447
           +    ++ PE   +  +T +SDV+S+G+ L EL + G  P               +  + 
Sbjct: 231 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP---------------YPGMP 275
Query: 448 KENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELE 498
            +++  +++       + E     M ++   C   +  KRPT KQ+   +E
Sbjct: 276 VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 326

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 96/223 (43%), Gaps = 36/223 (16%)
Query: 217 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIV 275
           ++ +   +G GGFG V+K     DG    +KR K  ++    +   EV  L++++H +IV
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE----KAEREVKALAKLDHVNIV 67
Query: 276 KLLGCC----------------LETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLS 319
              GC                  +T+   +  E+   GTL   I                
Sbjct: 68  HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLA--- 124
Query: 320 SLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPN 379
                  + +  ++   V Y+HS   I   +RD+K SNI L D    K+ DFG+  S+ N
Sbjct: 125 -------LELFEQITKGVDYIHSKKLI---NRDLKPSNIFLVDTKQVKIGDFGLVTSLKN 174
Query: 380 DKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELL 422
           D     +  +GT  Y+ PE   S  +  + D+Y+ G++L ELL
Sbjct: 175 DGKRXRS--KGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 99/220 (45%), Gaps = 29/220 (13%)
Query: 216 DNYNQSRFLGQGGFGTVYKGML----PDGSIVAVK---RSKEIDKTQIHQFINEVVILSQ 268
           D +++ + LG G FG V   ML      G+  A+K   + K +   QI   +NE  IL  
Sbjct: 62  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 118
Query: 269 INHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVR 328
           +N   +VKL     +     +V EY++ G +  H+              +   S  +   
Sbjct: 119 VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR------------RIGRFSEPHARF 166
Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTI 388
            A ++     Y+HS   + + +RD+K  N+L+D +   +V+DFG ++ +       T T+
Sbjct: 167 YAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----ATWTL 219
Query: 389 QGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
            GT  YL PE   S  +    D ++ GV++ E+  G  P 
Sbjct: 220 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 98/219 (44%), Gaps = 23/219 (10%)
Query: 213 RATDNYNQSRFLGQGGFGTVYK-GMLPDGSIVAVKRSKEID-----KTQIHQFINEVVIL 266
           RA D Y     +G G +G   K     DG I+  K   E+D     + +    ++EV +L
Sbjct: 4   RAED-YEVLYTIGTGSYGRCQKIRRKSDGKILVWK---ELDYGSMTEAEKQMLVSEVNLL 59
Query: 267 SQINHRHIVKLLGCCLETEVPVL--VYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWE 324
            ++ H +IV+     ++     L  V EY   G L+  I                 L  E
Sbjct: 60  RELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVI--------TKGTKERQYLDEE 111
Query: 325 NRVRVACEVAGAVAYMH--SSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKT 382
             +RV  ++  A+   H  S     + HRD+K +N+ LD K + K+ DFG++R I N  T
Sbjct: 112 FVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR-ILNHDT 170
Query: 383 HLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLEL 421
               T  GT  Y+ PE      + +KSD++S G +L EL
Sbjct: 171 SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 108/235 (45%), Gaps = 31/235 (13%)
Query: 224 LGQGGFGTVYKGMLPD-GSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCL 282
           LG G FG VYK    + G++ A K  +   + ++  +I E+ IL+  +H +IVKLLG   
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 78
Query: 283 ETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVAC-EVAGAVAYMH 341
                 ++ E+   G +                  L     E +++V C ++  A+ ++H
Sbjct: 79  HDGKLWIMIEFCPGGAVD------------AIMLELDRGLTEPQIQVVCRQMLEALNFLH 126
Query: 342 SSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKT-HLTTTIQGTFGYLDPEYF 400
           S     I HRD+K+ N+L+  +   +++DFG+S    N KT     +  GT  ++ PE  
Sbjct: 127 SKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAK--NLKTLQKRDSFIGTPYWMAPEVV 181
Query: 401 QSSQFTD-----KSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKEN 450
                 D     K+D++S G+ L+E+   + P        E N +   + +AK +
Sbjct: 182 MCETMKDTPYDYKADIWSLGITLIEMAQIEPP------HHELNPMRVLLKIAKSD 230

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 108/235 (45%), Gaps = 31/235 (13%)
Query: 224 LGQGGFGTVYKGMLPD-GSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCL 282
           LG G FG VYK    + G++ A K  +   + ++  +I E+ IL+  +H +IVKLLG   
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 283 ETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVAC-EVAGAVAYMH 341
                 ++ E+   G +                  L     E +++V C ++  A+ ++H
Sbjct: 87  HDGKLWIMIEFCPGGAVD------------AIMLELDRGLTEPQIQVVCRQMLEALNFLH 134
Query: 342 SSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKT-HLTTTIQGTFGYLDPEYF 400
           S     I HRD+K+ N+L+  +   +++DFG+S    N KT     +  GT  ++ PE  
Sbjct: 135 SKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAK--NLKTLQKRDSFIGTPYWMAPEVV 189
Query: 401 QSSQFTD-----KSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKEN 450
                 D     K+D++S G+ L+E+   + P        E N +   + +AK +
Sbjct: 190 MCETMKDTPYDYKADIWSLGITLIEMAQIEPP------HHELNPMRVLLKIAKSD 238

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 98/220 (44%), Gaps = 29/220 (13%)
Query: 216 DNYNQSRFLGQGGFGTVYKGML----PDGSIVAVK---RSKEIDKTQIHQFINEVVILSQ 268
           D +++ + LG G FG V   ML      G+  A+K   + K +   QI   +NE  IL  
Sbjct: 41  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 269 INHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVR 328
           +N   +VKL     +     +V EY++ G +  H+              +   S  +   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR------------RIGRFSEPHARF 145
Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTI 388
            A ++     Y+HS   + + +RD+K  N+L+D +   +V+DFG ++ +       T  +
Sbjct: 146 YAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXL 198
Query: 389 QGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
            GT  YL PE   S  +    D ++ GV++ E+  G  P 
Sbjct: 199 XGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 98/220 (44%), Gaps = 29/220 (13%)
Query: 216 DNYNQSRFLGQGGFGTVYKGML----PDGSIVAVK---RSKEIDKTQIHQFINEVVILSQ 268
           D +++ + LG G FG V   ML      G+  A+K   + K +   QI   +NE  IL  
Sbjct: 41  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 269 INHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVR 328
           +N   +VKL     +     +V EY++ G +  H+              +   S  +   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR------------RIGRFSEPHARF 145
Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTI 388
            A ++     Y+HS   + + +RD+K  N+L+D +   +V+DFG ++ +       T  +
Sbjct: 146 YAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXL 198
Query: 389 QGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
            GT  YL PE   S  +    D ++ GV++ E+  G  P 
Sbjct: 199 AGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 61/242 (25%), Positives = 109/242 (45%), Gaps = 26/242 (10%)
Query: 216 DNYNQSRFLGQGGFGTVYKGMLPD-GSIVAVK--RSKEIDKTQIHQF-INEVVILSQINH 271
           ++++  R +G+GGFG VY     D G + A+K    K I   Q     +NE ++LS ++ 
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 272 RHIVKLLGCCLETEVP---VLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVR 328
                ++        P     + + ++ G L +H+  H               S  +   
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH------------GVFSEADMRF 296
Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTI 388
            A E+   + +MH+     + +RD+K +NILLD+    ++SD G++      K H +   
Sbjct: 297 YAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-- 351
Query: 389 QGTFGYLDPEYFQSSQFTDKS-DVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLA 447
            GT GY+ PE  Q     D S D +S G +L +LL G  P    + +++  +    +++A
Sbjct: 352 -GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA 410
Query: 448 KE 449
            E
Sbjct: 411 VE 412

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 61/242 (25%), Positives = 109/242 (45%), Gaps = 26/242 (10%)
Query: 216 DNYNQSRFLGQGGFGTVYKGMLPD-GSIVAVK--RSKEIDKTQIHQF-INEVVILSQINH 271
           ++++  R +G+GGFG VY     D G + A+K    K I   Q     +NE ++LS ++ 
Sbjct: 188 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 247
Query: 272 RHIVKLLGCCLETEVP---VLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVR 328
                ++        P     + + ++ G L +H+  H               S  +   
Sbjct: 248 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH------------GVFSEADMRF 295
Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTI 388
            A E+   + +MH+     + +RD+K +NILLD+    ++SD G++      K H +   
Sbjct: 296 YAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-- 350
Query: 389 QGTFGYLDPEYFQSSQFTDKS-DVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLA 447
            GT GY+ PE  Q     D S D +S G +L +LL G  P    + +++  +    +++A
Sbjct: 351 -GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA 409
Query: 448 KE 449
            E
Sbjct: 410 VE 411

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 103/236 (43%), Gaps = 36/236 (15%)
Query: 203 AKVFTADELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKR---SKEIDKTQIHQ 258
           A++F  D+ ++    ++  R +G G FG VY    + +  +VA+K+   S +    +   
Sbjct: 44  AELFFKDDPEKL---FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQD 100
Query: 259 FINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXL 318
            I EV  L ++ H + ++  GC L      LV EY   G+ S  +  H            
Sbjct: 101 IIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY-CLGSASDLLEVHKKPL-------- 151
Query: 319 SSLSWENRVRVACEVAGAV---AYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISR 375
                   V +A    GA+   AY+HS   I   HRD+K+ NILL +    K+ DFG S 
Sbjct: 152 ------QEVEIAAVTHGALQGLAYLHSHNMI---HRDVKAGNILLSEPGLVKLGDFG-SA 201
Query: 376 SIPNDKTHLTTTIQGTFGYLDPEY---FQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
           SI            GT  ++ PE        Q+  K DV+S G+  +EL   K P+
Sbjct: 202 SI----MAPANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 253

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 96/217 (44%), Gaps = 23/217 (10%)
Query: 216 DNYNQSRFLGQGGFGTVY-KGMLPDGSIVAVK---RSKEIDKTQIHQFINEVVILSQINH 271
           D + + + LG G FG V     +  G+  A+K   + K +   QI   +NE  IL  +N 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 272 RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVAC 331
             +VKL     +     +V EY+  G +  H+              +   S  +    A 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLR------------RIGRFSEPHARFYAA 149
Query: 332 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGT 391
           ++     Y+HS   + + +RD+K  N+L+D +   +V+DFG ++ +       T T+ GT
Sbjct: 150 QIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWTLCGT 202
Query: 392 FGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
             YL PE   S  +    D ++ GV++ E+  G  P 
Sbjct: 203 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 61/242 (25%), Positives = 109/242 (45%), Gaps = 26/242 (10%)
Query: 216 DNYNQSRFLGQGGFGTVYKGMLPD-GSIVAVK--RSKEIDKTQIHQF-INEVVILSQINH 271
           ++++  R +G+GGFG VY     D G + A+K    K I   Q     +NE ++LS ++ 
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 272 RHIVKLLGCCLETEVP---VLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVR 328
                ++        P     + + ++ G L +H+  H               S  +   
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH------------GVFSEADMRF 296
Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTI 388
            A E+   + +MH+     + +RD+K +NILLD+    ++SD G++      K H +   
Sbjct: 297 YAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-- 351
Query: 389 QGTFGYLDPEYFQSSQFTDKS-DVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLA 447
            GT GY+ PE  Q     D S D +S G +L +LL G  P    + +++  +    +++A
Sbjct: 352 -GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA 410
Query: 448 KE 449
            E
Sbjct: 411 VE 412

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 61/242 (25%), Positives = 109/242 (45%), Gaps = 26/242 (10%)
Query: 216 DNYNQSRFLGQGGFGTVYKGMLPD-GSIVAVK--RSKEIDKTQIHQF-INEVVILSQINH 271
           ++++  R +G+GGFG VY     D G + A+K    K I   Q     +NE ++LS ++ 
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 272 RHIVKLLGCCLETEVP---VLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVR 328
                ++        P     + + ++ G L +H+  H               S  +   
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH------------GVFSEADMRF 296
Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTI 388
            A E+   + +MH+     + +RD+K +NILLD+    ++SD G++      K H +   
Sbjct: 297 YAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-- 351
Query: 389 QGTFGYLDPEYFQSSQFTDKS-DVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLA 447
            GT GY+ PE  Q     D S D +S G +L +LL G  P    + +++  +    +++A
Sbjct: 352 -GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA 410
Query: 448 KE 449
            E
Sbjct: 411 VE 412

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 64/236 (27%), Positives = 106/236 (44%), Gaps = 31/236 (13%)
Query: 216 DNYNQSRFLGQGGFGTVYKG-MLPDGSIVAVKRSKEIDKT------QIHQFINEVVILSQ 268
           +++     LG+G F  VY+   +  G  VA+K    IDK        + +  NEV I  Q
Sbjct: 11  EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKM---IDKKAMYKAGMVQRVQNEVKIHCQ 67
Query: 269 INHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVR 328
           + H  I++L     ++    LV E   +G ++ ++ +                  EN  R
Sbjct: 68  LKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFS------------ENEAR 115
Query: 329 -VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI--PNDKTHLT 385
               ++   + Y+HS     I HRD+  SN+LL    + K++DFG++  +  P++K +  
Sbjct: 116 HFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHY-- 170
Query: 386 TTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVA 441
            T+ GT  Y+ PE    S    +SDV+S G +   LL G+ P     V+   N V 
Sbjct: 171 -TLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVV 225

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 52/192 (27%), Positives = 92/192 (47%), Gaps = 25/192 (13%)
Query: 240 GSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTL 299
           G  VAVK+     + +     NEVVI+   +H ++V +    L  +   +V E++  G L
Sbjct: 70  GKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYLVGDELWVVMEFLEGGAL 129
Query: 300 SHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNIL 359
           +  I  H            + ++ E    V   V  A++Y+H+     + HRDIKS +IL
Sbjct: 130 TD-IVTH------------TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSIL 173
Query: 360 LDDKFSAKVSDFG----ISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFG 415
           L      K+SDFG    +S+ +P  K      + GT  ++ PE      +  + D++S G
Sbjct: 174 LTSDGRIKLSDFGFCAQVSKEVPKRK-----XLVGTPYWMAPEVISRLPYGTEVDIWSLG 228
Query: 416 VVLLELLTGKKP 427
           ++++E++ G+ P
Sbjct: 229 IMVIEMIDGEPP 240

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 96/217 (44%), Gaps = 23/217 (10%)
Query: 216 DNYNQSRFLGQGGFGTVY-KGMLPDGSIVAVK---RSKEIDKTQIHQFINEVVILSQINH 271
           D + + + LG G FG V     +  G+  A+K   + K +   QI   +NE  IL  +N 
Sbjct: 27  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 86
Query: 272 RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVAC 331
             +VKL     +     +V EY+  G +  H+              +   S  +    A 
Sbjct: 87  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLR------------RIGRFSEPHARFYAA 134
Query: 332 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGT 391
           ++     Y+HS   + + +RD+K  N+L+D +   +V+DFG ++ +       T T+ GT
Sbjct: 135 QIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWTLCGT 187
Query: 392 FGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
             YL PE   S  +    D ++ GV++ E+  G  P 
Sbjct: 188 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 224

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 103/236 (43%), Gaps = 36/236 (15%)
Query: 203 AKVFTADELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKR---SKEIDKTQIHQ 258
           A++F  D+ ++    ++  R +G G FG VY    + +  +VA+K+   S +    +   
Sbjct: 5   AELFFKDDPEKL---FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQD 61
Query: 259 FINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXL 318
            I EV  L ++ H + ++  GC L      LV EY   G+ S  +  H            
Sbjct: 62  IIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY-CLGSASDLLEVHKKPL-------- 112
Query: 319 SSLSWENRVRVACEVAGAV---AYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISR 375
                   V +A    GA+   AY+HS   I   HRD+K+ NILL +    K+ DFG S 
Sbjct: 113 ------QEVEIAAVTHGALQGLAYLHSHNMI---HRDVKAGNILLSEPGLVKLGDFG-SA 162
Query: 376 SIPNDKTHLTTTIQGTFGYLDPEY---FQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
           SI            GT  ++ PE        Q+  K DV+S G+  +EL   K P+
Sbjct: 163 SIMAPANXFV----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 106/218 (48%), Gaps = 32/218 (14%)
Query: 222 RFLGQGGFGTVYKGMLPDGS----IVAVKRSKEI-----DKTQIHQFINEVVILSQINHR 272
           + LGQG FG V+      GS    + A+K  K+      D+ +      E  IL ++NH 
Sbjct: 31  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM---ERDILVEVNHP 87
Query: 273 HIVKLLGCCLETEVPV-LVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVAC 331
            IVKL     +TE  + L+ +++  G L   +                  + E+      
Sbjct: 88  FIVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVM------------FTEEDVKFYLA 134
Query: 332 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISR-SIPNDKTHLTTTIQG 390
           E+A A+ ++HS   + I +RD+K  NILLD++   K++DFG+S+ SI ++K     +  G
Sbjct: 135 ELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK--AYSFCG 189
Query: 391 TFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
           T  Y+ PE       T  +D +SFGV++ E+LTG  P 
Sbjct: 190 TVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPF 227

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 106/218 (48%), Gaps = 32/218 (14%)
Query: 222 RFLGQGGFGTVYKGMLPDGS----IVAVKRSKEI-----DKTQIHQFINEVVILSQINHR 272
           + LGQG FG V+      GS    + A+K  K+      D+ +      E  IL ++NH 
Sbjct: 30  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM---ERDILVEVNHP 86
Query: 273 HIVKLLGCCLETEVPV-LVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVAC 331
            IVKL     +TE  + L+ +++  G L   +                  + E+      
Sbjct: 87  FIVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVM------------FTEEDVKFYLA 133
Query: 332 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISR-SIPNDKTHLTTTIQG 390
           E+A A+ ++HS   + I +RD+K  NILLD++   K++DFG+S+ SI ++K     +  G
Sbjct: 134 ELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK--AYSFCG 188
Query: 391 TFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
           T  Y+ PE       T  +D +SFGV++ E+LTG  P 
Sbjct: 189 TVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPF 226

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 106/218 (48%), Gaps = 32/218 (14%)
Query: 222 RFLGQGGFGTVYKGMLPDGS----IVAVKRSKEI-----DKTQIHQFINEVVILSQINHR 272
           + LGQG FG V+      GS    + A+K  K+      D+ +      E  IL ++NH 
Sbjct: 30  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM---ERDILVEVNHP 86
Query: 273 HIVKLLGCCLETEVPV-LVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVAC 331
            IVKL     +TE  + L+ +++  G L   +                  + E+      
Sbjct: 87  FIVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVM------------FTEEDVKFYLA 133
Query: 332 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISR-SIPNDKTHLTTTIQG 390
           E+A A+ ++HS   + I +RD+K  NILLD++   K++DFG+S+ SI ++K     +  G
Sbjct: 134 ELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK--AYSFCG 188
Query: 391 TFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
           T  Y+ PE       T  +D +SFGV++ E+LTG  P 
Sbjct: 189 TVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPF 226

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 99/220 (45%), Gaps = 29/220 (13%)
Query: 216 DNYNQSRFLGQGGFGTVYKGML----PDGSIVAVK---RSKEIDKTQIHQFINEVVILSQ 268
           D +++ + LG G FG V   ML      G+  A+K   + K +   QI   +NE  IL  
Sbjct: 28  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 84
Query: 269 INHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVR 328
           +N   +VKL     +     +V EY++ G +  H+              +   S  +   
Sbjct: 85  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR------------RIGRFSEPHARF 132
Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTI 388
            A ++     Y+HS   + + +RD+K  N+L+D++   +V+DFG ++ +       T  +
Sbjct: 133 YAAQIVLTFEYLHS---LDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGR----TWXL 185
Query: 389 QGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
            GT  YL PE   S  +    D ++ GV++ E+  G  P 
Sbjct: 186 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 225

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 94/216 (43%), Gaps = 33/216 (15%)
Query: 224 LGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCL 282
           LG+G +G VY G  L +   +A+K   E D         E+ +   + H++IV+ LG   
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 283 ETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSW----ENRVRVAC---EVAG 335
           E     +  E +  G+LS                 L    W    +N   +     ++  
Sbjct: 90  ENGFIKIFMEQVPGGSLS----------------ALLRSKWGPLKDNEQTIGFYTKQILE 133
Query: 336 AVAYMHSSASIPIFHRDIKSSNILLDDKFSA--KVSDFGISRSIPNDKTHLTTTIQGTFG 393
            + Y+H +    I HRDIK  N+L++  +S   K+SDFG S+ +       T T  GT  
Sbjct: 134 GLKYLHDNQ---IVHRDIKGDNVLIN-TYSGVLKISDFGTSKRLAGINP-CTETFTGTLQ 188
Query: 394 YLDPEYFQSSQ--FTDKSDVYSFGVVLLELLTGKKP 427
           Y+ PE        +   +D++S G  ++E+ TGK P
Sbjct: 189 YMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP 224

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/239 (24%), Positives = 105/239 (43%), Gaps = 45/239 (18%)
Query: 213 RATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKTQIHQFINEVVILSQINH 271
           R   ++ +   LGQG FG V K     D    A+K+ +  ++ ++   ++EV +L+ +NH
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEE-KLSTILSEVXLLASLNH 61
Query: 272 RHIVKLLGCCLETEVPV-------------LVYEYISSGTLSHHIHDHXXXXXXXXXXXL 318
           +++V+     LE    V             +  EY  + TL   IH              
Sbjct: 62  QYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEY--- 118
Query: 319 SSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGI----- 373
               W    R+  ++  A++Y+HS     I HR++K  NI +D+  + K+ DFG+     
Sbjct: 119 ----W----RLFRQILEALSYIHSQG---IIHRNLKPXNIFIDESRNVKIGDFGLAKNVH 167
Query: 374 ---------SRSIPNDKTHLTTTIQGTFGYLDPEYFQ-SSQFTDKSDVYSFGVVLLELL 422
                    S+++P    +LT+ I GT  Y+  E    +  + +K D YS G++  E +
Sbjct: 168 RSLDILKLDSQNLPGSSDNLTSAI-GTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 97/219 (44%), Gaps = 23/219 (10%)
Query: 213 RATDNYNQSRFLGQGGFGTVYK-GMLPDGSIVAVKRSKEID-----KTQIHQFINEVVIL 266
           RA D Y     +G G +G   K     DG I+  K   E+D     + +    ++EV +L
Sbjct: 4   RAED-YEVLYTIGTGSYGRCQKIRRKSDGKILVWK---ELDYGSMTEAEKQMLVSEVNLL 59
Query: 267 SQINHRHIVKLLGCCLETEVPVL--VYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWE 324
            ++ H +IV+     ++     L  V EY   G L+  I                 L  E
Sbjct: 60  RELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVI--------TKGTKERQYLDEE 111
Query: 325 NRVRVACEVAGAVAYMH--SSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKT 382
             +RV  ++  A+   H  S     + HRD+K +N+ LD K + K+ DFG++R I N  T
Sbjct: 112 FVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR-ILNHDT 170
Query: 383 HLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLEL 421
                  GT  Y+ PE      + +KSD++S G +L EL
Sbjct: 171 SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 94/216 (43%), Gaps = 33/216 (15%)
Query: 224 LGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCL 282
           LG+G +G VY G  L +   +A+K   E D         E+ +   + H++IV+ LG   
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 75
Query: 283 ETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSW----ENRVRVAC---EVAG 335
           E     +  E +  G+LS                 L    W    +N   +     ++  
Sbjct: 76  ENGFIKIFMEQVPGGSLS----------------ALLRSKWGPLKDNEQTIGFYTKQILE 119
Query: 336 AVAYMHSSASIPIFHRDIKSSNILLDDKFSA--KVSDFGISRSIPNDKTHLTTTIQGTFG 393
            + Y+H +    I HRDIK  N+L++  +S   K+SDFG S+ +       T T  GT  
Sbjct: 120 GLKYLHDNQ---IVHRDIKGDNVLIN-TYSGVLKISDFGTSKRLAGINP-CTETFTGTLQ 174
Query: 394 YLDPEYFQSSQ--FTDKSDVYSFGVVLLELLTGKKP 427
           Y+ PE        +   +D++S G  ++E+ TGK P
Sbjct: 175 YMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP 210

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/236 (25%), Positives = 95/236 (40%), Gaps = 49/236 (20%)
Query: 217 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIV 275
           ++ +   +G GGFG V+K     DG    ++R K        +   EV  L++++H +IV
Sbjct: 13  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVK----YNNEKAEREVKALAKLDHVNIV 68
Query: 276 KLLGCC-------------LE----------------TEVPVLVYEYISSGTLSHHIHDH 306
              GC              LE                T+   +  E+   GTL   I   
Sbjct: 69  HYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR 128
Query: 307 XXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA 366
                               + +  ++   V Y+HS     + HRD+K SNI L D    
Sbjct: 129 RGEKLDKVLA----------LELFEQITKGVDYIHSKK---LIHRDLKPSNIFLVDTKQV 175
Query: 367 KVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELL 422
           K+ DFG+  S+ ND     T  +GT  Y+ PE   S  +  + D+Y+ G++L ELL
Sbjct: 176 KIGDFGLVTSLKNDGKR--TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 229

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 98/220 (44%), Gaps = 29/220 (13%)
Query: 216 DNYNQSRFLGQGGFGTVYKGML----PDGSIVAVK---RSKEIDKTQIHQFINEVVILSQ 268
           D +++ + LG G FG V   ML      G+  A+K   + K +   QI   +NE  IL  
Sbjct: 42  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 269 INHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVR 328
           +N   +VKL     +     +V EY++ G +  H+              +   S  +   
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR------------RIGRFSEPHARF 146
Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTI 388
            A ++     Y+HS   + + +RD+K  N+L+D +   +V+DFG ++ +       T  +
Sbjct: 147 YAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXL 199
Query: 389 QGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
            GT  YL PE   S  +    D ++ GV++ E+  G  P 
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 104/228 (45%), Gaps = 23/228 (10%)
Query: 216 DNYNQSRFLGQGGFGTVYK----GMLPDGSI--VAVKRSKEIDKT-QIHQFINEVVILSQ 268
           +N    + LG G FG V +    G+  + ++  VAVK  K      +    ++E+ I+S 
Sbjct: 31  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 90
Query: 269 IN-HRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSS------- 320
           +  H +IV LLG C      +++ EY   G L + +                        
Sbjct: 91  LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKE 150
Query: 321 ----LSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS 376
               L   + +  + +VA  +A++ S   I   HRD+ + N+LL +   AK+ DFG++R 
Sbjct: 151 DGRPLELRDLLHFSSQVAQGMAFLASKNCI---HRDVAARNVLLTNGHVAKIGDFGLARD 207
Query: 377 IPNDKTHLTT-TIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT 423
           I ND  ++     +    ++ PE      +T +SDV+S+G++L E+ +
Sbjct: 208 IMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 255

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 98/220 (44%), Gaps = 29/220 (13%)
Query: 216 DNYNQSRFLGQGGFGTVYKGML----PDGSIVAVK---RSKEIDKTQIHQFINEVVILSQ 268
           D +++ + LG G FG V   ML      G+  A+K   + K +   QI   +NE  IL  
Sbjct: 41  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 269 INHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVR 328
           +N   +VKL     +     +V EY++ G +  H+              +   S  +   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR------------RIGRFSEPHARF 145
Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTI 388
            A ++     Y+HS   + + +RD+K  N+L+D +   +V+DFG ++ +       T  +
Sbjct: 146 YAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXL 198
Query: 389 QGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
            GT  YL PE   S  +    D ++ GV++ E+  G  P 
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 98/220 (44%), Gaps = 29/220 (13%)
Query: 216 DNYNQSRFLGQGGFGTVYKGML----PDGSIVAVK---RSKEIDKTQIHQFINEVVILSQ 268
           D +++ + LG G FG V   ML      G+  A+K   + K +   QI   +NE  IL  
Sbjct: 41  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 269 INHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVR 328
           +N   +VKL     +     +V EY++ G +  H+              +   S  +   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR------------RIGRFSEPHARF 145
Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTI 388
            A ++     Y+HS   + + +RD+K  N+L+D +   +V+DFG ++ +       T  +
Sbjct: 146 YAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXL 198
Query: 389 QGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
            GT  YL PE   S  +    D ++ GV++ E+  G  P 
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/298 (23%), Positives = 127/298 (42%), Gaps = 46/298 (15%)
Query: 204 KVFTADELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEV 263
           K +  D  +   ++    + LG G FG V+       + VAVK  K      +  F+ E 
Sbjct: 170 KPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKP-GSMSVEAFLAEA 228
Query: 264 VILSQINHRHIVKLLGCCLETEVPV-LVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLS 322
            ++  + H  +VKL      T+ P+ ++ E+++ G+L   +              L  L 
Sbjct: 229 NVMKTLQHDKLVKLHAVV--TKEPIYIITEFMAKGSLLDFLKSDEGSKQP-----LPKL- 280
Query: 323 WENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKT 382
               +  + ++A  +A++     I   HRD++++NIL+      K++DFG++R       
Sbjct: 281 ----IDFSAQIAEGMAFIEQRNYI---HRDLRAANILVSASLVCKIADFGLAR------- 326
Query: 383 HLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPI-CFARVEEERNLV 440
                 +    +  PE      FT KSDV+SFG++L+E++T G+ P    +  E  R L 
Sbjct: 327 ---VGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE 383
Query: 441 ACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELE 498
             +     EN   E+ +                 + MRC +   ++RPT + +   L+
Sbjct: 384 RGYRMPRPENCPEELYN-----------------IMMRCWKNRPEERPTFEYIQSVLD 424

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 98/220 (44%), Gaps = 29/220 (13%)
Query: 216 DNYNQSRFLGQGGFGTVYKGML----PDGSIVAVK---RSKEIDKTQIHQFINEVVILSQ 268
           D +++ + LG G FG V   ML      G+  A+K   + K +   QI   +NE  IL  
Sbjct: 41  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 269 INHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVR 328
           +N   +VKL     +     +V EY++ G +  H+              +   S  +   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR------------RIGRFSEPHARF 145
Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTI 388
            A ++     Y+HS   + + +RD+K  N+L+D +   +V+DFG ++ +       T  +
Sbjct: 146 YAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXL 198
Query: 389 QGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
            GT  YL PE   S  +    D ++ GV++ E+  G  P 
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 98/220 (44%), Gaps = 29/220 (13%)
Query: 216 DNYNQSRFLGQGGFGTVYKGML----PDGSIVAVK---RSKEIDKTQIHQFINEVVILSQ 268
           D +++ + LG G FG V   ML      G+  A+K   + K +   QI   +NE  IL  
Sbjct: 41  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 269 INHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVR 328
           +N   +VKL     +     +V EY++ G +  H+              +   S  +   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR------------RIGRFSEPHARF 145
Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTI 388
            A ++     Y+HS   + + +RD+K  N+L+D +   +V+DFG ++ +       T  +
Sbjct: 146 YAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXL 198
Query: 389 QGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
            GT  YL PE   S  +    D ++ GV++ E+  G  P 
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 97/220 (44%), Gaps = 29/220 (13%)
Query: 224 LGQGGFGTVYKGMLP-DGSIVAVKR----SKEIDKTQIHQFINEVVILSQINHRHIVKLL 278
           LG+GGFG V++     D    A+KR    ++E+ + ++   + EV  L+++ H  IV+  
Sbjct: 13  LGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKV---MREVKALAKLEHPGIVRYF 69
Query: 279 GCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVAC-----EV 333
              LE      +    SS  +  +I                  + E R R  C     ++
Sbjct: 70  NAWLEKNTTEKLQP--SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQI 127
Query: 334 AGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLT-------- 385
           A AV ++HS     + HRD+K SNI        KV DFG+  ++  D+   T        
Sbjct: 128 AEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAY 184
Query: 386 ---TTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELL 422
              T   GT  Y+ PE    + ++ K D++S G++L ELL
Sbjct: 185 ARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 98/220 (44%), Gaps = 29/220 (13%)
Query: 216 DNYNQSRFLGQGGFGTVYKGML----PDGSIVAVK---RSKEIDKTQIHQFINEVVILSQ 268
           D +++ + LG G FG V   ML      G+  A+K   + K +   QI   +NE  IL  
Sbjct: 41  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 269 INHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVR 328
           +N   +VKL     +     +V EY++ G +  H+              +   S  +   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR------------RIGRFSEPHARF 145
Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTI 388
            A ++     Y+HS   + + +RD+K  N+L+D +   +V+DFG ++ +       T  +
Sbjct: 146 YAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXL 198
Query: 389 QGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
            GT  YL PE   S  +    D ++ GV++ E+  G  P 
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 97/220 (44%), Gaps = 25/220 (11%)
Query: 215 TDNYNQSRFLGQGGFGTVY----KGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQIN 270
           +D Y   R LG+G FG V     K    + ++  + + +   KT     + EV +L Q++
Sbjct: 31  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 90
Query: 271 HRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVA 330
           H +I+KL     +     LV E  + G L   I                  S  +  R+ 
Sbjct: 91  HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEI------------ISRKRFSEVDAARII 138
Query: 331 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK---FSAKVSDFGISRSIPNDKTHLTTT 387
            +V   + YMH +    I HRD+K  N+LL+ K    + ++ DFG+S      K      
Sbjct: 139 RQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI 195
Query: 388 IQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
             GT  Y+ PE    + + +K DV+S GV+L  LL+G  P
Sbjct: 196 --GTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPP 232

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 99/220 (45%), Gaps = 25/220 (11%)
Query: 215 TDNYNQSRFLGQGGFGTVY----KGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQIN 270
           +D Y   R LG+G FG V     K    + ++  + + +   KT     + EV +L Q++
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 271 HRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVA 330
           H +I+KL     +     LV E  + G L   I                  S  +  R+ 
Sbjct: 85  HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEI------------ISRKRFSEVDAARII 132
Query: 331 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK---FSAKVSDFGISRSIPNDKTHLTTT 387
            +V   + YMH +    I HRD+K  N+LL+ K    + ++ DFG+S      K  +   
Sbjct: 133 RQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK-MKDK 188
Query: 388 IQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
           I GT  Y+ PE    + + +K DV+S GV+L  LL+G  P
Sbjct: 189 I-GTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPP 226

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/247 (25%), Positives = 114/247 (46%), Gaps = 29/247 (11%)
Query: 211 LQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSK--EIDKTQIHQFINEVVILSQ 268
            Q   + Y +   +G+G +G VYK     G IVA+KR +    D+      I E+ +L +
Sbjct: 16  FQGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKE 75
Query: 269 INHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVR 328
           ++H +IV L+          LV+E++    L   + ++                 +++++
Sbjct: 76  LHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQ------------DSQIK 122
Query: 329 VAC-EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS--IP-NDKTHL 384
           +   ++   VA+ H      I HRD+K  N+L++   + K++DFG++R+  IP    TH 
Sbjct: 123 IYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHE 179
Query: 385 TTTIQGTFGYLDPEYFQSS-QFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACF 443
             T+     Y  P+    S +++   D++S G +  E++TGK    F  V ++  L   F
Sbjct: 180 VVTLW----YRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKP--LFPGVTDDDQLPKIF 233
Query: 444 ISLAKEN 450
             L   N
Sbjct: 234 SILGTPN 240

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/247 (25%), Positives = 114/247 (46%), Gaps = 29/247 (11%)
Query: 211 LQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSK--EIDKTQIHQFINEVVILSQ 268
            Q   + Y +   +G+G +G VYK     G IVA+KR +    D+      I E+ +L +
Sbjct: 16  FQGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKE 75
Query: 269 INHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVR 328
           ++H +IV L+          LV+E++    L   + ++                 +++++
Sbjct: 76  LHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQ------------DSQIK 122
Query: 329 VAC-EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS--IP-NDKTHL 384
           +   ++   VA+ H      I HRD+K  N+L++   + K++DFG++R+  IP    TH 
Sbjct: 123 IYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHE 179
Query: 385 TTTIQGTFGYLDPEYFQSS-QFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACF 443
             T+     Y  P+    S +++   D++S G +  E++TGK    F  V ++  L   F
Sbjct: 180 VVTLW----YRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKP--LFPGVTDDDQLPKIF 233
Query: 444 ISLAKEN 450
             L   N
Sbjct: 234 SILGTPN 240

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 96/217 (44%), Gaps = 23/217 (10%)
Query: 216 DNYNQSRFLGQGGFGTVY-KGMLPDGSIVAVK---RSKEIDKTQIHQFINEVVILSQINH 271
           D + + + LG G FG V     +  G+  A+K   + K +   QI   +NE  IL  +N 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 272 RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVAC 331
             +VKL     +     +V EY++ G +  H+              +   S  +    A 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR------------RIGRFSEPHARFYAA 148
Query: 332 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGT 391
           ++     Y+HS   + + +RD+K  N+L+D +   +V+DFG ++ +       T  + GT
Sbjct: 149 QIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGT 201
Query: 392 FGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
             YL PE   S  +    D ++ GV++ E+  G  P 
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 71/300 (23%), Positives = 131/300 (43%), Gaps = 46/300 (15%)
Query: 213 RATDNYNQSRFLGQGGFGTVYKGMLPD-GSIVAVKRSKEIDKTQIHQFI--NEVVILSQI 269
           ++ + Y     +G+G +G V K    D G IVA+K+  E D  ++ + I   E+ +L Q+
Sbjct: 22  QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQL 81
Query: 270 NHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRV 329
            H ++V LL  C + +   LV+E++      H I D             + L ++   + 
Sbjct: 82  RHENLVNLLEVCKKKKRWYLVFEFVD-----HTILDDLELFP-------NGLDYQVVQKY 129
Query: 330 ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQ 389
             ++   + + HS     I HRDIK  NIL+      K+ DFG +R++          + 
Sbjct: 130 LFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEV- 185
Query: 390 GTFGYLDPEYFQSS-QFTDKSDVYSFGVVLLELLTGKKPI--CFARVEEERNLVACFISL 446
            T  Y  PE      ++    DV++ G ++ E+  G +P+    + +++  +++ C  +L
Sbjct: 186 ATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMG-EPLFPGDSDIDQLYHIMMCLGNL 244
Query: 447 AKENQLL------------------EILDARVAKEAREEDIGAMAELAMRCLRLNSKKRP 488
              +Q L                  E L+ R  K +       + +LA +CL ++  KRP
Sbjct: 245 IPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSE-----VVIDLAKKCLHIDPDKRP 299

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 100/225 (44%), Gaps = 35/225 (15%)
Query: 215 TDNYNQSRFLGQGGFGTVY----KGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQIN 270
           +D Y   R LG+G FG V     K    + ++  + + +   KT     + EV +L Q++
Sbjct: 48  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 107
Query: 271 HRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVA 330
           H +I+KL     +     LV E  + G L   I                  S  +  R+ 
Sbjct: 108 HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEI------------ISRKRFSEVDAARII 155
Query: 331 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK---FSAKVSDFGISRSIPNDKTHLTTT 387
            +V   + YMH +    I HRD+K  N+LL+ K    + ++ DFG+S       TH   +
Sbjct: 156 RQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLS-------THFEAS 205
Query: 388 IQ-----GTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
            +     GT  Y+ PE    + + +K DV+S GV+L  LL+G  P
Sbjct: 206 KKMKDKIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPP 249

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 107/229 (46%), Gaps = 26/229 (11%)
Query: 206 FTADELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKE-IDKTQIHQFINEV 263
           FTA++L+   +       +G+G +G+V K +  P G I+AVKR +  +D+ +  Q + ++
Sbjct: 19  FTAEDLKDLGE-------IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDL 71
Query: 264 -VILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLS 322
            V++   +  +IV+  G         +  E +S+     + + +           L  ++
Sbjct: 72  DVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKIT 131
Query: 323 WENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKT 382
                     +A   A  H   ++ I HRDIK SNILLD   + K+ DFGIS  + +  +
Sbjct: 132 ----------LATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD--S 179
Query: 383 HLTTTIQGTFGYLDPEYFQSSQ----FTDKSDVYSFGVVLLELLTGKKP 427
              T   G   Y+ PE    S     +  +SDV+S G+ L EL TG+ P
Sbjct: 180 IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFP 228

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 101/229 (44%), Gaps = 35/229 (15%)
Query: 215 TDNYNQSRFLGQGGFGTVY----KGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQIN 270
           +D Y   R LG+G FG V     K    + ++  + + +   KT     + EV +L Q++
Sbjct: 49  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 108
Query: 271 HRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVA 330
           H +I+KL     +     LV E  + G L   I                  S  +  R+ 
Sbjct: 109 HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEI------------ISRKRFSEVDAARII 156
Query: 331 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK---FSAKVSDFGISRSIPNDKTHLTTT 387
            +V   + YMH +    I HRD+K  N+LL+ K    + ++ DFG+S       TH   +
Sbjct: 157 RQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLS-------THFEAS 206
Query: 388 IQ-----GTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFA 431
            +     GT  Y+ PE    + + +K DV+S GV+L  LL+G  P   A
Sbjct: 207 KKMKDKIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPPFNGA 254

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 101/225 (44%), Gaps = 23/225 (10%)
Query: 210 ELQRATDNYNQSRFLGQGGFGTVYKGMLPDG----SIVAVKRSKEIDKTQIHQFINEVVI 265
           +++   +++   + LG+G FG V+           +I A+K+   +    +   + E  +
Sbjct: 12  QIKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV 71
Query: 266 LSQINHRHIVKLLGCCLET-EVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWE 324
           LS       +  + C  +T E    V EY++ G L +HI              LS  ++ 
Sbjct: 72  LSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ-------SCHKFDLSRATF- 123
Query: 325 NRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISR-SIPNDKTH 383
                A E+   + ++HS     I +RD+K  NILLD     K++DFG+ + ++  D   
Sbjct: 124 ----YAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK- 175
Query: 384 LTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
            T    GT  Y+ PE     ++    D +SFGV+L E+L G+ P 
Sbjct: 176 -TNEFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF 219

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 100/219 (45%), Gaps = 39/219 (17%)
Query: 224 LGQGGFGTVYKGMLPDGSIVAVKRSKEID---KTQIHQFINEVVILSQINHRHIVKLLGC 280
           LG G FG VYK    + S++A   +K ID   + ++  ++ E+ IL+  +H +IVKLL  
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAA--AKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 102
Query: 281 CLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVAC-EVAGAVAY 339
                   ++ E+ + G +                  L     E++++V C +   A+ Y
Sbjct: 103 FYYENNLWILIEFCAGGAVD------------AVMLELERPLTESQIQVVCKQTLDALNY 150
Query: 340 MHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQ------GTFG 393
           +H +    I HRD+K+ NIL       K++DFG+S          T TIQ      GT  
Sbjct: 151 LHDNK---IIHRDLKAGNILFTLDGDIKLADFGVS-------AKNTRTIQRRDSFIGTPY 200
Query: 394 YLDPEYFQSSQFTD-----KSDVYSFGVVLLELLTGKKP 427
           ++ PE        D     K+DV+S G+ L+E+   + P
Sbjct: 201 WMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP 239

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 95/217 (43%), Gaps = 23/217 (10%)
Query: 216 DNYNQSRFLGQGGFGTVY-KGMLPDGSIVAVK---RSKEIDKTQIHQFINEVVILSQINH 271
           D + + + +G G FG V     +  G+  A+K   + K +   QI   +NE  IL  +N 
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 272 RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVAC 331
             +VKL     +     +V EY+  G +  H+              +   S  +    A 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLR------------RIGRFSEPHARFYAA 148
Query: 332 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGT 391
           ++     Y+HS   + + +RD+K  N+L+D +   KV+DFG ++ +       T  + GT
Sbjct: 149 QIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR----TWXLCGT 201
Query: 392 FGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
             YL PE   S  +    D ++ GV++ E+  G  P 
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/218 (22%), Positives = 92/218 (42%), Gaps = 20/218 (9%)
Query: 216 DNYNQSRFLGQGGFGTVYKG----MLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINH 271
           +++   + LG+G F TV          + +I  +++   I + ++     E  ++S+++H
Sbjct: 37  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 96
Query: 272 RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVAC 331
              VKL  C  + E       Y  +G L  +I              + S           
Sbjct: 97  PFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRK------------IGSFDETCTRFYTA 144
Query: 332 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI-PNDKTHLTTTIQG 390
           E+  A+ Y+H      I HRD+K  NILL++    +++DFG ++ + P  K        G
Sbjct: 145 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 201
Query: 391 TFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
           T  Y+ PE          SD+++ G ++ +L+ G  P 
Sbjct: 202 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 239

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 95/217 (43%), Gaps = 23/217 (10%)
Query: 216 DNYNQSRFLGQGGFGTVY-KGMLPDGSIVAVK---RSKEIDKTQIHQFINEVVILSQINH 271
           D + + + LG G FG V     +  G+  A+K   + K +   QI   +NE  IL  +N 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 272 RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVAC 331
             +VKL     +     +V EY+  G +  H+              +   S  +    A 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLR------------RIGRFSEPHARFYAA 149
Query: 332 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGT 391
           ++     Y+HS   + + +RD+K  N+L+D +   +V+DFG ++ +       T  + GT
Sbjct: 150 QIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGT 202
Query: 392 FGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
             YL PE   S  +    D ++ GV++ E+  G  P 
Sbjct: 203 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 95/217 (43%), Gaps = 23/217 (10%)
Query: 216 DNYNQSRFLGQGGFGTVY-KGMLPDGSIVAVK---RSKEIDKTQIHQFINEVVILSQINH 271
           D + + + LG G FG V     +  G+  A+K   + K +   QI   +NE  IL  +N 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 272 RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVAC 331
             +VKL     +     +V EY+  G +  H+              +   S  +    A 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLR------------RIGRFSEPHARFYAA 148
Query: 332 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGT 391
           ++     Y+HS   + + +RD+K  N+L+D +   +V+DFG ++ +       T  + GT
Sbjct: 149 QIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGT 201
Query: 392 FGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
             YL PE   S  +    D ++ GV++ E+  G  P 
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 95/217 (43%), Gaps = 23/217 (10%)
Query: 216 DNYNQSRFLGQGGFGTVY-KGMLPDGSIVAVK---RSKEIDKTQIHQFINEVVILSQINH 271
           D + + + LG G FG V     +  G+  A+K   + K +   QI   +NE  IL  +N 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 272 RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVAC 331
             +VKL     +     +V EY+  G +  H+              +   S  +    A 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLR------------RIGRFSEPHARFYAA 148
Query: 332 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGT 391
           ++     Y+HS   + + +RD+K  N+L+D +   +V+DFG ++ +       T  + GT
Sbjct: 149 QIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGT 201
Query: 392 FGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
             YL PE   S  +    D ++ GV++ E+  G  P 
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 95/217 (43%), Gaps = 23/217 (10%)
Query: 216 DNYNQSRFLGQGGFGTVY-KGMLPDGSIVAVK---RSKEIDKTQIHQFINEVVILSQINH 271
           D + + + LG G FG V     +  G+  A+K   + K +   QI   +NE  IL  +N 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 272 RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVAC 331
             +VKL     +     +V EY+  G +  H+              +   S  +    A 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLR------------RIGRFSEPHARFYAA 148
Query: 332 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGT 391
           ++     Y+HS   + + +RD+K  N+L+D +   +V+DFG ++ +       T  + GT
Sbjct: 149 QIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGT 201
Query: 392 FGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
             YL PE   S  +    D ++ GV++ E+  G  P 
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 94/214 (43%), Gaps = 25/214 (11%)
Query: 222 RFLGQGGFGTVYKGMLPDGSI---VAVKRSKEI--DKTQIHQFINEVVILSQINHRHIVK 276
           + +G+G FG V         +   V V + K I   K + H      V+L  + H  +V 
Sbjct: 44  KVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 103
Query: 277 LLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRV-ACEVAG 335
           L       +    V +YI+ G L +H+                    E R R  A E+A 
Sbjct: 104 LHFSFQTADKLYFVLDYINGGELFYHLQRERCFL-------------EPRARFYAAEIAS 150
Query: 336 AVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISR-SIPNDKTHLTTTIQGTFGY 394
           A+ Y+HS   + I +RD+K  NILLD +    ++DFG+ + +I ++ T  T+T  GT  Y
Sbjct: 151 ALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST--TSTFCGTPEY 205
Query: 395 LDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
           L PE      +    D +  G VL E+L G  P 
Sbjct: 206 LAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPF 239

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 107/218 (49%), Gaps = 32/218 (14%)
Query: 222 RFLGQGGFGTVY---KGMLPD-GSIVAVKRSKEI-----DKTQIHQFINEVVILSQINHR 272
           + LGQG FG V+   K   PD G + A+K  K+      D+ +      E  IL+ +NH 
Sbjct: 34  KVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKM---ERDILADVNHP 90
Query: 273 HIVKLLGCCLETEVPV-LVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVAC 331
            +VKL     +TE  + L+ +++  G L   +                  + E+      
Sbjct: 91  FVVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVM------------FTEEDVKFYLA 137
Query: 332 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISR-SIPNDKTHLTTTIQG 390
           E+A  + ++HS   + I +RD+K  NILLD++   K++DFG+S+ +I ++K     +  G
Sbjct: 138 ELALGLDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKK--AYSFCG 192
Query: 391 TFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
           T  Y+ PE       +  +D +S+GV++ E+LTG  P 
Sbjct: 193 TVEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTGSLPF 230

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 98/220 (44%), Gaps = 29/220 (13%)
Query: 216 DNYNQSRFLGQGGFGTVYKGML----PDGSIVAVK---RSKEIDKTQIHQFINEVVILSQ 268
           D +++ + LG G FG V   ML      G+  A+K   + K +   QI   +NE  IL  
Sbjct: 41  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 269 INHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVR 328
           +N   +VKL     +     +V EY++ G +  H+              +   +  +   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR------------RIGRFAEPHARF 145
Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTI 388
            A ++     Y+HS   + + +RD+K  N+L+D +   +V+DFG ++ +       T  +
Sbjct: 146 YAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXL 198
Query: 389 QGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
            GT  YL PE   S  +    D ++ GV++ E+  G  P 
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 94/219 (42%), Gaps = 20/219 (9%)
Query: 213 RATDNYNQSRFLGQGGFGTVYKGMLPDGSIV----AVKRSKEIDKTQIHQFINEVVILSQ 268
           R    Y + RFLG+GGF   Y+    D   V     V +S  +   Q  +   E+ I   
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 98
Query: 269 INHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVR 328
           +++ H+V   G   + +   +V E     +L   +H              +    E R  
Sbjct: 99  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRK----------AVTEPEARYF 147
Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTI 388
           +   + G V Y+H++    + HRD+K  N+ L+D    K+ DFG++  I  D      T+
Sbjct: 148 MRQTIQG-VQYLHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER-KKTL 202
Query: 389 QGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
            GT  Y+ PE       + + D++S G +L  LL GK P
Sbjct: 203 CGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPP 241

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 98/220 (44%), Gaps = 29/220 (13%)
Query: 216 DNYNQSRFLGQGGFGTVYKGML----PDGSIVAVK---RSKEIDKTQIHQFINEVVILSQ 268
           D +++ + LG G FG V   ML      G+  A+K   + K +   QI   +NE  IL  
Sbjct: 41  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 269 INHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVR 328
           +N   +VKL     +     +V EY++ G +  H+              +   S  +   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR------------RIGRFSEPHARF 145
Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTI 388
            A ++     Y+HS   + + +RD+K  N+++D +   +V+DFG ++ +       T  +
Sbjct: 146 YAAQIVLTFEYLHS---LDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKGR----TWXL 198
Query: 389 QGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
            GT  YL PE   S  +    D ++ GV++ E+  G  P 
Sbjct: 199 CGTPEYLAPEIIISKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 100/221 (45%), Gaps = 30/221 (13%)
Query: 223 FLGQGGFGTVYKGM-LPDGSIVAVKRSKEI--DKTQIHQFINEVVILSQINHRHIVKLLG 279
            +G G +G VYKG  +  G + A+K       ++ +I Q IN +   S  +HR+I    G
Sbjct: 31  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYS--HHRNIATYYG 88
Query: 280 CCLETEVP------VLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEV 333
             ++   P       LV E+  +G+++  I +             ++L  E    +  E+
Sbjct: 89  AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG----------NTLKEEWIAYICREI 138
Query: 334 AGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFG 393
              ++++H      + HRDIK  N+LL +    K+ DFG+S  +        T I GT  
Sbjct: 139 LRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPY 194
Query: 394 YLDPEYFQSSQFTD-----KSDVYSFGVVLLELLTGKKPIC 429
           ++ PE     +  D     KSD++S G+  +E+  G  P+C
Sbjct: 195 WMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLC 235

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 95/217 (43%), Gaps = 23/217 (10%)
Query: 216 DNYNQSRFLGQGGFGTVY-KGMLPDGSIVAVK---RSKEIDKTQIHQFINEVVILSQINH 271
           D + + + +G G FG V     +  G+  A+K   + K +   QI   +NE  IL  +N 
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 272 RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVAC 331
             +VKL     +     +V EY+  G +  H+              +   S  +    A 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLR------------RIGRFSEPHARFYAA 148
Query: 332 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGT 391
           ++     Y+HS   + + +RD+K  N+L+D +   KV+DFG ++ +       T  + GT
Sbjct: 149 QIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR----TWXLCGT 201
Query: 392 FGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
             YL PE   S  +    D ++ GV++ E+  G  P 
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 95/217 (43%), Gaps = 23/217 (10%)
Query: 216 DNYNQSRFLGQGGFGTVY-KGMLPDGSIVAVK---RSKEIDKTQIHQFINEVVILSQINH 271
           D + + + +G G FG V     +  G+  A+K   + K +   QI   +NE  IL  +N 
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 272 RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVAC 331
             +VKL     +     +V EY+  G +  H+              +   S  +    A 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLR------------RIGRFSEPHARFYAA 148
Query: 332 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGT 391
           ++     Y+HS   + + +RD+K  N+L+D +   KV+DFG ++ +       T  + GT
Sbjct: 149 QIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR----TWXLCGT 201
Query: 392 FGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
             YL PE   S  +    D ++ GV++ E+  G  P 
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 98/220 (44%), Gaps = 29/220 (13%)
Query: 216 DNYNQSRFLGQGGFGTVYKGML----PDGSIVAVK---RSKEIDKTQIHQFINEVVILSQ 268
           D +++ + LG G FG V   ML      G+  A+K   + K +   QI   +NE  IL  
Sbjct: 41  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 269 INHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVR 328
           +N   +VKL     +     +V EY++ G +  H+              +   S  +   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR------------RIGRFSEPHARF 145
Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTI 388
            A ++     Y+HS   + + +RD+K  N+L+D +   +V+DFG ++ +       T  +
Sbjct: 146 YAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXL 198
Query: 389 QGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
            GT  YL PE   S  +    D ++ GV++ ++  G  P 
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYQMAAGYPPF 238

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 98/221 (44%), Gaps = 27/221 (12%)
Query: 213 RATDNYNQSRFLGQGGFG-TVYKGMLPDGSIVAVKR-------SKEIDKTQIHQFINEVV 264
           ++ + Y + + +G+G FG  +      DG    +K        SKE ++++      EV 
Sbjct: 21  QSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESR-----REVA 75
Query: 265 ILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWE 324
           +L+ + H +IV+      E     +V +Y   G L   I+                L W 
Sbjct: 76  VLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQI----LDW- 130
Query: 325 NRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHL 384
                  ++  A+ ++H      I HRDIKS NI L    + ++ DFGI+R + N    L
Sbjct: 131 -----FVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVL-NSTVEL 181
Query: 385 TTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGK 425
                GT  YL PE  ++  + +KSD+++ G VL EL T K
Sbjct: 182 ARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLK 222

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 96/220 (43%), Gaps = 29/220 (13%)
Query: 216 DNYNQSRFLGQGGFGTVYKGML----PDGSIVAVK---RSKEIDKTQIHQFINEVVILSQ 268
           D + + + LG G FG V   ML      G+  A+K   + K +   QI   +NE  IL  
Sbjct: 42  DQFERIKTLGTGSFGRV---MLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 269 INHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVR 328
           +N   +VKL     +     +V EY+  G +  H+              +   S  +   
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLR------------RIGRFSEPHARF 146
Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTI 388
            A ++     Y+HS   + + +RD+K  N+L+D +   +V+DFG ++ +       T  +
Sbjct: 147 YAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXL 199
Query: 389 QGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
            GT  YL PE   S  +    D ++ GV++ E+  G  P 
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 96/220 (43%), Gaps = 29/220 (13%)
Query: 216 DNYNQSRFLGQGGFGTVYKGML----PDGSIVAVK---RSKEIDKTQIHQFINEVVILSQ 268
           D + + + LG G FG V   ML      G+  A+K   + K +   QI   +NE  IL  
Sbjct: 41  DQFERIKTLGTGSFGRV---MLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 269 INHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVR 328
           +N   +VKL     +     +V EY+  G +  H+              +   S  +   
Sbjct: 98  VNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLR------------RIGRFSEPHARF 145
Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTI 388
            A ++     Y+HS   + + +RD+K  N+L+D +   +V+DFG ++ +       T  +
Sbjct: 146 YAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXL 198
Query: 389 QGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
            GT  YL PE   S  +    D ++ GV++ E+  G  P 
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 96/220 (43%), Gaps = 29/220 (13%)
Query: 216 DNYNQSRFLGQGGFGTVYKGML----PDGSIVAVK---RSKEIDKTQIHQFINEVVILSQ 268
           D + + + LG G FG V   ML      G+  A+K   + K +   QI   +NE  IL  
Sbjct: 41  DQFERIKTLGTGSFGRV---MLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 269 INHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVR 328
           +N   +VKL     +     +V EY+  G +  H+              +   S  +   
Sbjct: 98  VNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLR------------RIGRFSEPHARF 145
Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTI 388
            A ++     Y+HS   + + +RD+K  N+L+D +   +V+DFG ++ +       T  +
Sbjct: 146 YAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXL 198
Query: 389 QGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
            GT  YL PE   S  +    D ++ GV++ E+  G  P 
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 96/220 (43%), Gaps = 29/220 (13%)
Query: 216 DNYNQSRFLGQGGFGTVYKGML----PDGSIVAVK---RSKEIDKTQIHQFINEVVILSQ 268
           D + + + LG G FG V   ML      G+  A+K   + K +   QI   +NE  IL  
Sbjct: 42  DQFERIKTLGTGSFGRV---MLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 269 INHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVR 328
           +N   +VKL     +     +V EY+  G +  H+              +   S  +   
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLR------------RIGRFSEPHARF 146
Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTI 388
            A ++     Y+HS   + + +RD+K  N+L+D +   +V+DFG ++ +       T  +
Sbjct: 147 YAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXL 199
Query: 389 QGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
            GT  YL PE   S  +    D ++ GV++ E+  G  P 
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 97/220 (44%), Gaps = 29/220 (13%)
Query: 216 DNYNQSRFLGQGGFGTVYKGML----PDGSIVAVK---RSKEIDKTQIHQFINEVVILSQ 268
           D +++ + LG G FG V   ML      G+  A+K   + K +   QI   +NE  IL  
Sbjct: 41  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 269 INHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVR 328
           +N   +VKL     +     +V EY++ G +  H+              +      +   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR------------RIGRFXEPHARF 145
Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTI 388
            A ++     Y+HS   + + +RD+K  N+L+D +   +V+DFG ++ +       T  +
Sbjct: 146 YAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXL 198
Query: 389 QGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
            GT  YL PE   S  +    D ++ GV++ E+  G  P 
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 96/220 (43%), Gaps = 29/220 (13%)
Query: 216 DNYNQSRFLGQGGFGTVYKGML----PDGSIVAVK---RSKEIDKTQIHQFINEVVILSQ 268
           D + + + LG G FG V   ML      G+  A+K   + K +   QI   +NE  IL  
Sbjct: 41  DQFERIKTLGTGSFGRV---MLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 269 INHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVR 328
           +N   +VKL     +     +V EY+  G +  H+              +   S  +   
Sbjct: 98  VNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLR------------RIGRFSEPHARF 145
Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTI 388
            A ++     Y+HS   + + +RD+K  N+L+D +   +V+DFG ++ +       T  +
Sbjct: 146 YAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXL 198
Query: 389 QGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
            GT  YL PE   S  +    D ++ GV++ E+  G  P 
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 96/220 (43%), Gaps = 29/220 (13%)
Query: 216 DNYNQSRFLGQGGFGTVYKGML----PDGSIVAVK---RSKEIDKTQIHQFINEVVILSQ 268
           D + + + LG G FG V   ML      G+  A+K   + K +   QI   +NE  IL  
Sbjct: 42  DQFERIKTLGTGSFGRV---MLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 269 INHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVR 328
           +N   +VKL     +     +V EY+  G +  H+              +   S  +   
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLR------------RIGRFSEPHARF 146
Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTI 388
            A ++     Y+HS   + + +RD+K  N+L+D +   +V+DFG ++ +       T  +
Sbjct: 147 YAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXL 199
Query: 389 QGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
            GT  YL PE   S  +    D ++ GV++ E+  G  P 
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 101/232 (43%), Gaps = 23/232 (9%)
Query: 202 RAKVFTADELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSI---VAVKRSKEIDKTQIHQ 258
           R   F  +   + +DNY+    LG+G F  V + +     +     +  +K++      +
Sbjct: 15  RGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK 74
Query: 259 FINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXL 318
              E  I  ++ H +IV+L     E     LV++ ++ G L   I               
Sbjct: 75  LEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI------------VAR 122
Query: 319 SSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF---SAKVSDFGISR 375
              S  +      ++  ++AY HS+    I HR++K  N+LL  K    + K++DFG++ 
Sbjct: 123 EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAI 179
Query: 376 SIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
            + ND +       GT GYL PE  +   ++   D+++ GV+L  LL G  P
Sbjct: 180 EV-ND-SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 229

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 96/220 (43%), Gaps = 29/220 (13%)
Query: 216 DNYNQSRFLGQGGFGTVYKGML----PDGSIVAVK---RSKEIDKTQIHQFINEVVILSQ 268
           D + + + LG G FG V   ML      G+  A+K   + K +   QI   +NE  IL  
Sbjct: 62  DQFERIKTLGTGSFGRV---MLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 118
Query: 269 INHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVR 328
           +N   +VKL     +     +V EY+  G +  H+              +   S  +   
Sbjct: 119 VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLR------------RIGRFSEPHARF 166
Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTI 388
            A ++     Y+HS   + + +RD+K  N+L+D +   +V+DFG ++ +       T  +
Sbjct: 167 YAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXL 219
Query: 389 QGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
            GT  YL PE   S  +    D ++ GV++ E+  G  P 
Sbjct: 220 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 97/220 (44%), Gaps = 29/220 (13%)
Query: 216 DNYNQSRFLGQGGFGTVYKGML----PDGSIVAVK---RSKEIDKTQIHQFINEVVILSQ 268
           D +++ + LG G FG V   ML      G+  A+K   + K +   QI   +NE  IL  
Sbjct: 41  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 269 INHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVR 328
           +N   +VKL     +     +V EY++ G +  H+              +      +   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR------------RIGRFXEPHARF 145
Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTI 388
            A ++     Y+HS   + + +RD+K  N+L+D +   +V+DFG ++ +       T  +
Sbjct: 146 YAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXL 198
Query: 389 QGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
            GT  YL PE   S  +    D ++ GV++ E+  G  P 
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 97/220 (44%), Gaps = 29/220 (13%)
Query: 216 DNYNQSRFLGQGGFGTVYKGML----PDGSIVAVK---RSKEIDKTQIHQFINEVVILSQ 268
           D +++ + LG G FG V   ML      G+  A+K   + K +   QI   +NE  IL  
Sbjct: 41  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 269 INHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVR 328
           +N   +VKL     +     +V EY++ G +  H+              +      +   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR------------RIGRFXEPHARF 145
Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTI 388
            A ++     Y+HS   + + +RD+K  N+L+D +   +V+DFG ++ +       T  +
Sbjct: 146 YAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXL 198
Query: 389 QGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
            GT  YL PE   S  +    D ++ GV++ E+  G  P 
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 94/217 (43%), Gaps = 23/217 (10%)
Query: 216 DNYNQSRFLGQGGFGTVY-KGMLPDGSIVAVK---RSKEIDKTQIHQFINEVVILSQINH 271
           D + + + LG G FG V     +  G+  A+K   + K +   QI   +NE  IL  +N 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 272 RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVAC 331
             +VKL     +     +V EY   G +  H+              +   S  +    A 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLR------------RIGRFSEPHARFYAA 148
Query: 332 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGT 391
           ++     Y+HS   + + +RD+K  N+++D +   KV+DFG ++ +       T  + GT
Sbjct: 149 QIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXLCGT 201
Query: 392 FGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
             YL PE   S  +    D ++ GV++ E+  G  P 
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 96/220 (43%), Gaps = 29/220 (13%)
Query: 216 DNYNQSRFLGQGGFGTVYKGML----PDGSIVAVK---RSKEIDKTQIHQFINEVVILSQ 268
           D + + + LG G FG V   ML      G+  A+K   + K +   QI   +NE  IL  
Sbjct: 34  DQFERIKTLGTGSFGRV---MLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 90
Query: 269 INHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVR 328
           +N   +VKL     +     +V EY+  G +  H+              +   S  +   
Sbjct: 91  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLR------------RIGRFSEPHARF 138
Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTI 388
            A ++     Y+HS   + + +RD+K  N+L+D +   +V+DFG ++ +       T  +
Sbjct: 139 YAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXL 191
Query: 389 QGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
            GT  YL PE   S  +    D ++ GV++ E+  G  P 
Sbjct: 192 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 231

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 97/220 (44%), Gaps = 29/220 (13%)
Query: 216 DNYNQSRFLGQGGFGTVYKGML----PDGSIVAVK---RSKEIDKTQIHQFINEVVILSQ 268
           D +++ + LG G FG V   ML      G+  A+K   + K +   QI   +NE  IL  
Sbjct: 36  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 92
Query: 269 INHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVR 328
           +N   +VKL     +     +V EY++ G +  H+              +      +   
Sbjct: 93  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR------------RIGRFXEPHARF 140
Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTI 388
            A ++     Y+HS   + + +RD+K  N+L+D +   +V+DFG ++ +       T  +
Sbjct: 141 YAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXL 193
Query: 389 QGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
            GT  YL PE   S  +    D ++ GV++ E+  G  P 
Sbjct: 194 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 233

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 97/220 (44%), Gaps = 29/220 (13%)
Query: 216 DNYNQSRFLGQGGFGTVYKGML----PDGSIVAVK---RSKEIDKTQIHQFINEVVILSQ 268
           D +++ + LG G FG V   ML      G+  A+K   + K +   QI   +NE  IL  
Sbjct: 62  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 118
Query: 269 INHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVR 328
           +N   +VKL     +     +V EY++ G +  H+              +      +   
Sbjct: 119 VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR------------RIGRFXEPHARF 166
Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTI 388
            A ++     Y+HS   + + +RD+K  N+L+D +   +V+DFG ++ +       T  +
Sbjct: 167 YAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXL 219
Query: 389 QGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
            GT  YL PE   S  +    D ++ GV++ E+  G  P 
Sbjct: 220 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 101/225 (44%), Gaps = 23/225 (10%)
Query: 210 ELQRATDNYNQSRFLGQGGFGTVYKGMLPDG----SIVAVKRSKEIDKTQIHQFINEVVI 265
           +++   +++   + LG+G FG V+           +I A+K+   +    +   + E  +
Sbjct: 11  QIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV 70
Query: 266 LSQINHRHIVKLLGCCLET-EVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWE 324
           LS       +  + C  +T E    V EY++ G L +HI              LS  ++ 
Sbjct: 71  LSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ-------SCHKFDLSRATF- 122
Query: 325 NRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISR-SIPNDKTH 383
                A E+   + ++HS     I +RD+K  NILLD     K++DFG+ + ++  D   
Sbjct: 123 ----YAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK- 174
Query: 384 LTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
            T    GT  Y+ PE     ++    D +SFGV+L E+L G+ P 
Sbjct: 175 -TNXFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF 218

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 98/219 (44%), Gaps = 23/219 (10%)
Query: 213 RATDNYNQSRFLGQGGFGTVYK-GMLPDGSIVAVKRSKEID-----KTQIHQFINEVVIL 266
           RA D Y     +G G +G   K     DG I+  K   E+D     + +    ++EV +L
Sbjct: 4   RAED-YEVLYTIGTGSYGRCQKIRRKSDGKILVWK---ELDYGSMTEAEKQMLVSEVNLL 59
Query: 267 SQINHRHIVKLLGCCLETEVPVL--VYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWE 324
            ++ H +IV+     ++     L  V EY   G L+  I                 L  E
Sbjct: 60  RELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVI--------TKGTKERQYLDEE 111
Query: 325 NRVRVACEVAGAVAYMH--SSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKT 382
             +RV  ++  A+   H  S     + HRD+K +N+ LD K + K+ DFG++R + +D+ 
Sbjct: 112 FVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDED 171
Query: 383 HLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLEL 421
                  GT  Y+ PE      + +KSD++S G +L EL
Sbjct: 172 -FAKEFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 93/216 (43%), Gaps = 24/216 (11%)
Query: 222 RFLGQGGFGTVYK----GMLPDGSIVAVKRSKEI----DKTQIHQFINEVVILSQINHRH 273
           R LG+GG+G V++         G I A+K  K+     +         E  IL ++ H  
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 274 IVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEV 333
           IV L+          L+ EY+S G L   +              L+            E+
Sbjct: 83  IVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLA------------EI 130
Query: 334 AGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFG 393
           + A+ ++H      I +RD+K  NI+L+ +   K++DFG+ +   +D T +T T  GT  
Sbjct: 131 SMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT-VTHTFCGTIE 186
Query: 394 YLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPIC 429
           Y+ PE    S      D +S G ++ ++LTG  P  
Sbjct: 187 YMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFT 222

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 104/228 (45%), Gaps = 19/228 (8%)
Query: 216 DNYNQSRFLGQGGFGTVYK-GMLPDGSIVAVKRSKEIDKTQIHQFINEVV---ILSQINH 271
           D +   R LG+GGFG V+   M   G + A K+  +    +   +   +V   IL++++ 
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 272 RHIVKLLGCCLETEVPV-LVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVA 330
           R IV L     ET+  + LV   ++ G + +HI++                     +   
Sbjct: 245 RFIVSL-AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDN--------PGFQEPRAIFYT 295
Query: 331 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQG 390
            ++   + ++H      I +RD+K  N+LLDD  + ++SD G++  +   +T  T    G
Sbjct: 296 AQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAG 351
Query: 391 TFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERN 438
           T G++ PE     ++    D ++ GV L E++  + P   AR E+  N
Sbjct: 352 TPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFR-ARGEKVEN 398

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 104/228 (45%), Gaps = 19/228 (8%)
Query: 216 DNYNQSRFLGQGGFGTVYK-GMLPDGSIVAVKRSKEIDKTQIHQFINEVV---ILSQINH 271
           D +   R LG+GGFG V+   M   G + A K+  +    +   +   +V   IL++++ 
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 272 RHIVKLLGCCLETEVPV-LVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVA 330
           R IV L     ET+  + LV   ++ G + +HI++                     +   
Sbjct: 245 RFIVSL-AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDN--------PGFQEPRAIFYT 295
Query: 331 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQG 390
            ++   + ++H      I +RD+K  N+LLDD  + ++SD G++  +   +T  T    G
Sbjct: 296 AQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAG 351
Query: 391 TFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERN 438
           T G++ PE     ++    D ++ GV L E++  + P   AR E+  N
Sbjct: 352 TPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFR-ARGEKVEN 398

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 104/228 (45%), Gaps = 19/228 (8%)
Query: 216 DNYNQSRFLGQGGFGTVYK-GMLPDGSIVAVKRSKEIDKTQIHQFINEVV---ILSQINH 271
           D +   R LG+GGFG V+   M   G + A K+  +    +   +   +V   IL++++ 
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 272 RHIVKLLGCCLETEVPV-LVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVA 330
           R IV L     ET+  + LV   ++ G + +HI++                     +   
Sbjct: 245 RFIVSL-AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDN--------PGFQEPRAIFYT 295
Query: 331 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQG 390
            ++   + ++H      I +RD+K  N+LLDD  + ++SD G++  +   +T  T    G
Sbjct: 296 AQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAG 351
Query: 391 TFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERN 438
           T G++ PE     ++    D ++ GV L E++  + P   AR E+  N
Sbjct: 352 TPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFR-ARGEKVEN 398

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 104/228 (45%), Gaps = 19/228 (8%)
Query: 216 DNYNQSRFLGQGGFGTVYK-GMLPDGSIVAVKRSKEIDKTQIHQFINEVV---ILSQINH 271
           D +   R LG+GGFG V+   M   G + A K+  +    +   +   +V   IL++++ 
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 272 RHIVKLLGCCLETEVPV-LVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVA 330
           R IV L     ET+  + LV   ++ G + +HI++                     +   
Sbjct: 245 RFIVSL-AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDN--------PGFQEPRAIFYT 295
Query: 331 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQG 390
            ++   + ++H      I +RD+K  N+LLDD  + ++SD G++  +   +T  T    G
Sbjct: 296 AQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAG 351
Query: 391 TFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERN 438
           T G++ PE     ++    D ++ GV L E++  + P   AR E+  N
Sbjct: 352 TPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFR-ARGEKVEN 398

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 100/217 (46%), Gaps = 35/217 (16%)
Query: 224 LGQGGFGTVYKGMLPDGSIVAVKRSKEID---KTQIHQFINEVVILSQINHRHIVKLLGC 280
           LG G FG VYK    + S++A   +K ID   + ++  ++ E+ IL+  +H +IVKLL  
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAA--AKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 102
Query: 281 CLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVAC-EVAGAVAY 339
                   ++ E+ + G +                  L     E++++V C +   A+ Y
Sbjct: 103 FYYENNLWILIEFCAGGAVD------------AVMLELERPLTESQIQVVCKQTLDALNY 150
Query: 340 MHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGIS----RSIPNDKTHLTTTIQGTFGYL 395
           +H +    I HRD+K+ NIL       K++DFG+S    R I    + +     GT  ++
Sbjct: 151 LHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFI-----GTPYWM 202
Query: 396 DPEYFQSSQFTD-----KSDVYSFGVVLLELLTGKKP 427
            PE        D     K+DV+S G+ L+E+   + P
Sbjct: 203 APEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP 239

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 97/220 (44%), Gaps = 29/220 (13%)
Query: 216 DNYNQSRFLGQGGFGTVYKGML----PDGSIVAVK---RSKEIDKTQIHQFINEVVILSQ 268
           D +++ + LG G FG V   ML      G+  A+K   + K +   QI   +NE  IL  
Sbjct: 41  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 269 INHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVR 328
           +N   +VKL     +     +V EY++ G +  H+              +   S  +   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR------------RIGRFSEPHARF 145
Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTI 388
            A ++     Y+HS   + + +RD+K  N+L+D +   +V+DFG ++ +       T  +
Sbjct: 146 YAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXL 198
Query: 389 QGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
            GT  YL P    S  +    D ++ GV++ E+  G  P 
Sbjct: 199 CGTPEYLAPAIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 95/220 (43%), Gaps = 29/220 (13%)
Query: 216 DNYNQSRFLGQGGFGTVYKGML----PDGSIVAVK---RSKEIDKTQIHQFINEVVILSQ 268
           D + + + LG G FG V   ML      G+  A+K   + K +   QI   +NE  IL  
Sbjct: 42  DQFERIKTLGTGSFGRV---MLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 269 INHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVR 328
           +N   +VKL     +     +V EY   G +  H+              +   S  +   
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLR------------RIGRFSEPHARF 146
Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTI 388
            A ++     Y+HS   + + +RD+K  N+++D +   KV+DFG ++ +       T  +
Sbjct: 147 YAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXL 199
Query: 389 QGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
            GT  YL PE   S  +    D ++ GV++ E+  G  P 
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 95/217 (43%), Gaps = 23/217 (10%)
Query: 216 DNYNQSRFLGQGGFGTVY-KGMLPDGSIVAVK---RSKEIDKTQIHQFINEVVILSQINH 271
           D + + + LG G FG V     +  G+  A+K   + K +   +I   +NE  IL  +N 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF 100
Query: 272 RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVAC 331
             +VKL     +     +V EY   G +  H+              +   S  +    A 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLR------------RIGRFSEPHARFYAA 148
Query: 332 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGT 391
           ++     Y+HS   + + +RD+K  N+++D +   KV+DFG+++ +       T  + GT
Sbjct: 149 QIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGR----TWXLCGT 201
Query: 392 FGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
             YL PE   S  +    D ++ GV++ E+  G  P 
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 94/217 (43%), Gaps = 23/217 (10%)
Query: 216 DNYNQSRFLGQGGFGTVY-KGMLPDGSIVAVK---RSKEIDKTQIHQFINEVVILSQINH 271
           D + + + LG G FG V     +  G+  A+K   + K +   QI   +NE  IL  +N 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 272 RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVAC 331
             +VKL     +     +V EY+  G +  H+              +      +    A 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLR------------RIGRFXEPHARFYAA 149
Query: 332 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGT 391
           ++     Y+HS   + + +RD+K  N+L+D +   +V+DFG ++ +       T  + GT
Sbjct: 150 QIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGT 202
Query: 392 FGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
             YL PE   S  +    D ++ GV++ E+  G  P 
Sbjct: 203 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 95/217 (43%), Gaps = 21/217 (9%)
Query: 217 NYNQSRFLGQGGFGTVY----KGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHR 272
           ++N    LG+G FG V     KG     +I  +K+   I    +   + E  +L+ ++  
Sbjct: 20  DFNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKP 79
Query: 273 HIVKLLGCCLET-EVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVAC 331
             +  L  C +T +    V EY++ G L +HI              +        V  A 
Sbjct: 80  PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQ------------QVGKFKEPQAVFYAA 127
Query: 332 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGT 391
           E++  + ++H      I +RD+K  N++LD +   K++DFG+ +    D    T    GT
Sbjct: 128 EISIGLFFLHKRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGV-TTREFCGT 183
Query: 392 FGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
             Y+ PE      +    D +++GV+L E+L G+ P 
Sbjct: 184 PDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPF 220

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 94/217 (43%), Gaps = 23/217 (10%)
Query: 216 DNYNQSRFLGQGGFGTVY-KGMLPDGSIVAVK---RSKEIDKTQIHQFINEVVILSQINH 271
           D + + + LG G FG V     +  G+  A+K   + K +   QI   +NE  IL  +N 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 272 RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVAC 331
             +VKL     +     +V EY+  G +  H+              +      +    A 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLR------------RIGRFXEPHARFYAA 148
Query: 332 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGT 391
           ++     Y+HS   + + +RD+K  N+L+D +   +V+DFG ++ +       T  + GT
Sbjct: 149 QIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGT 201
Query: 392 FGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
             YL PE   S  +    D ++ GV++ E+  G  P 
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 94/220 (42%), Gaps = 29/220 (13%)
Query: 216 DNYNQSRFLGQGGFGTVYKGML----PDGSIVAVK---RSKEIDKTQIHQFINEVVILSQ 268
           D + + R LG G FG V   ML      G+  A+K   + K +   QI   +NE  I   
Sbjct: 42  DQFERIRTLGTGSFGRV---MLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQA 98
Query: 269 INHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVR 328
           +N   +VKL     +     +V EY   G +  H+              +   S  +   
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLR------------RIGRFSEPHARF 146
Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTI 388
            A ++     Y+HS   + + +RD+K  N+L+D +   KV+DFG ++ +       T  +
Sbjct: 147 YAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR----TWXL 199
Query: 389 QGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
            GT  YL PE   S  +    D ++ GV++ E+  G  P 
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 94/217 (43%), Gaps = 23/217 (10%)
Query: 216 DNYNQSRFLGQGGFGTVY-KGMLPDGSIVAVK---RSKEIDKTQIHQFINEVVILSQINH 271
           D + + + LG G FG V     +  G+  A+K   + K +   QI   +NE  IL  +N 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 272 RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVAC 331
             +VKL     +     +V EY+  G +  H+              +      +    A 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLR------------RIGRFXEPHARFYAA 148
Query: 332 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGT 391
           ++     Y+HS   + + +RD+K  N+L+D +   +V+DFG ++ +       T  + GT
Sbjct: 149 QIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGT 201
Query: 392 FGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
             YL PE   S  +    D ++ GV++ E+  G  P 
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 112/238 (47%), Gaps = 45/238 (18%)
Query: 218 YNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEI--DKTQIHQFINEVVILSQIN-HRH 273
           Y   + LG+G +G V+K +    G +VAVK+  +   + T   +   E++IL++++ H +
Sbjct: 11  YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHEN 70
Query: 274 IVKLLGCC-LETEVPV-LVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVAC 331
           IV LL     + +  V LV++Y+ +      +H              + L   ++  V  
Sbjct: 71  IVNLLNVLRADNDRDVYLVFDYMETD-----LH---------AVIRANILEPVHKQYVVY 116
Query: 332 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPN------------ 379
           ++   + Y+HS     + HRD+K SNILL+ +   KV+DFG+SRS  N            
Sbjct: 117 QLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSI 173
Query: 380 --------DKTHLTTTIQGTFGYLDPE-YFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
                   D   + T    T  Y  PE    S+++T   D++S G +L E+L G KPI
Sbjct: 174 NENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCG-KPI 230

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 93/219 (42%), Gaps = 20/219 (9%)
Query: 213 RATDNYNQSRFLGQGGFGTVYKGMLPDGSIV----AVKRSKEIDKTQIHQFINEVVILSQ 268
           R    Y + RFLG+GGF   Y+    D   V     V +S  +   Q  +   E+ I   
Sbjct: 23  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 82
Query: 269 INHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVR 328
           +++ H+V   G   + +   +V E     +L   +H              +    E R  
Sbjct: 83  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRK----------AVTEPEARYF 131
Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTI 388
           +   + G V Y+H++  I   HRD+K  N+ L+D    K+ DFG++  I  D       +
Sbjct: 132 MRQTIQG-VQYLHNNRVI---HRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER-KKDL 186
Query: 389 QGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
            GT  Y+ PE       + + D++S G +L  LL GK P
Sbjct: 187 CGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPP 225

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 99/219 (45%), Gaps = 39/219 (17%)
Query: 224 LGQGGFGTVYKGMLPDGSIVAVKRSKEID---KTQIHQFINEVVILSQINHRHIVKLLGC 280
           LG G FG VYK    + S++A   +K ID   + ++  ++ E+ IL+  +H +IVKLL  
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAA--AKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 102
Query: 281 CLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVAC-EVAGAVAY 339
                   ++ E+ + G +                  L     E++++V C +   A+ Y
Sbjct: 103 FYYENNLWILIEFCAGGAVD------------AVMLELERPLTESQIQVVCKQTLDALNY 150
Query: 340 MHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQ------GTFG 393
           +H +    I HRD+K+ NIL       K++DFG+S          T  IQ      GT  
Sbjct: 151 LHDNK---IIHRDLKAGNILFTLDGDIKLADFGVS-------AKNTRXIQRRDXFIGTPY 200
Query: 394 YLDPEYFQSSQFTD-----KSDVYSFGVVLLELLTGKKP 427
           ++ PE        D     K+DV+S G+ L+E+   + P
Sbjct: 201 WMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP 239

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 96/219 (43%), Gaps = 23/219 (10%)
Query: 215 TDNYNQSRFLGQGGFGTVYKGMLPDGSI---VAVKRSKEIDKTQIHQFINEVVILSQINH 271
           +DNY+    LG+G F  V + +     +     +  +K++      +   E  I  ++ H
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 272 RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVAC 331
            +IV+L     E     LV++ ++ G L   I              +             
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ------------ 112
Query: 332 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF---SAKVSDFGISRSIPNDKTHLTTTI 388
           ++  ++AY HS+    I HR++K  N+LL  K    + K++DFG++  + ND +      
Sbjct: 113 QILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV-ND-SEAWHGF 167
Query: 389 QGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
            GT GYL PE  +   ++   D+++ GV+L  LL G  P
Sbjct: 168 AGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 96/219 (43%), Gaps = 23/219 (10%)
Query: 215 TDNYNQSRFLGQGGFGTVYKGMLPDGSI---VAVKRSKEIDKTQIHQFINEVVILSQINH 271
           +DNY+    LG+G F  V + +     +     +  +K++      +   E  I  ++ H
Sbjct: 4   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 63
Query: 272 RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVAC 331
            +IV+L     E     LV++ ++ G L   I              +             
Sbjct: 64  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ------------ 111
Query: 332 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF---SAKVSDFGISRSIPNDKTHLTTTI 388
           ++  ++AY HS+    I HR++K  N+LL  K    + K++DFG++  + ND +      
Sbjct: 112 QILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV-ND-SEAWHGF 166
Query: 389 QGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
            GT GYL PE  +   ++   D+++ GV+L  LL G  P
Sbjct: 167 AGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 205

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 93/219 (42%), Gaps = 20/219 (9%)
Query: 213 RATDNYNQSRFLGQGGFGTVYKGMLPDGSIV----AVKRSKEIDKTQIHQFINEVVILSQ 268
           R    Y + RFLG+GGF   Y+    D   V     V +S  +   Q  +   E+ I   
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 98
Query: 269 INHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVR 328
           +++ H+V   G   + +   +V E     +L   +H              +    E R  
Sbjct: 99  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRK----------AVTEPEARYF 147
Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTI 388
           +   + G V Y+H++    + HRD+K  N+ L+D    K+ DFG++  I  D       +
Sbjct: 148 MRQTIQG-VQYLHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER-KKXL 202
Query: 389 QGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
            GT  Y+ PE       + + D++S G +L  LL GK P
Sbjct: 203 CGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPP 241

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/241 (26%), Positives = 109/241 (45%), Gaps = 27/241 (11%)
Query: 216 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVK--RSKEIDKTQIHQFINEVVILSQINHRH 273
           + Y+    +G+G +G VYK     G   A+K  R ++ D+      I E+ IL ++ H +
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 274 IVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEV 333
           IVKL       +  VLV+E         H+              L S++ ++ +    ++
Sbjct: 62  IVKLYDVIHTKKRLVLVFE---------HLDQDLKKLLDVCEGGLESVTAKSFL---LQL 109
Query: 334 AGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS--IPNDK-THLTTTIQG 390
              +AY H      + HRD+K  N+L++ +   K++DFG++R+  IP  K TH   T+  
Sbjct: 110 LNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLW- 165
Query: 391 TFGYLDPEYFQSS-QFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKE 449
              Y  P+    S +++   D++S G +  E++ G     F  V E   L+  F  L   
Sbjct: 166 ---YRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTP--LFPGVSEADQLMRIFRILGTP 220
Query: 450 N 450
           N
Sbjct: 221 N 221

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/241 (26%), Positives = 109/241 (45%), Gaps = 27/241 (11%)
Query: 216 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVK--RSKEIDKTQIHQFINEVVILSQINHRH 273
           + Y+    +G+G +G VYK     G   A+K  R ++ D+      I E+ IL ++ H +
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 274 IVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEV 333
           IVKL       +  VLV+E         H+              L S++ ++ +    ++
Sbjct: 62  IVKLYDVIHTKKRLVLVFE---------HLDQDLKKLLDVCEGGLESVTAKSFL---LQL 109
Query: 334 AGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS--IPNDK-THLTTTIQG 390
              +AY H      + HRD+K  N+L++ +   K++DFG++R+  IP  K TH   T+  
Sbjct: 110 LNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLW- 165
Query: 391 TFGYLDPEYFQSS-QFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKE 449
              Y  P+    S +++   D++S G +  E++ G     F  V E   L+  F  L   
Sbjct: 166 ---YRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGAP--LFPGVSEADQLMRIFRILGTP 220
Query: 450 N 450
           N
Sbjct: 221 N 221

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 97/219 (44%), Gaps = 23/219 (10%)
Query: 215 TDNYNQSRFLGQGGFGTVYKGMLPDGSI---VAVKRSKEIDKTQIHQFINEVVILSQINH 271
           +DNY+    LG+G F  V + +     +     +  +K++      +   E  I  ++ H
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 272 RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVAC 331
            +IV+L     E     LV++ ++ G L   I                  S  +      
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDI------------VAREFYSEADASHCIQ 112
Query: 332 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF---SAKVSDFGISRSIPNDKTHLTTTI 388
           ++  ++AY HS+    I HR++K  N+LL  K    + K++DFG++  + ND +      
Sbjct: 113 QILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV-ND-SEAWHGF 167
Query: 389 QGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
            GT GYL PE  +   ++   D+++ GV+L  LL G  P
Sbjct: 168 AGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 97/219 (44%), Gaps = 19/219 (8%)
Query: 222 RFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQI--HQFINEVVILSQINHRHIVKLLG 279
           R LG G FG V+        +  V ++   D++Q+   Q   E+ +L  ++H +I+K+  
Sbjct: 28  RKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFE 87
Query: 280 CCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAY 339
              +     +V E    G L   I                +LS      +  ++  A+AY
Sbjct: 88  VFEDYHNMYIVMETCEGGELLERI--------VSAQARGKALSEGYVAELMKQMMNALAY 139
Query: 340 MHSSASIPIFHRDIKSSNILLDD---KFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLD 396
            HS     + H+D+K  NIL  D       K+ DFG++    +D+   +T   GT  Y+ 
Sbjct: 140 FHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH--STNAAGTALYMA 194
Query: 397 PEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEE 435
           PE F+    T K D++S GVV+  LLTG  P     +EE
Sbjct: 195 PEVFKRD-VTFKCDIWSAGVVMYFLLTGCLPFTGTSLEE 232

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 93/219 (42%), Gaps = 20/219 (9%)
Query: 213 RATDNYNQSRFLGQGGFGTVYKGMLPDGSIV----AVKRSKEIDKTQIHQFINEVVILSQ 268
           R    Y + RFLG+GGF   Y+    D   V     V +S  +   Q  +   E+ I   
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 98
Query: 269 INHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVR 328
           +++ H+V   G   + +   +V E     +L   +H              +    E R  
Sbjct: 99  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRK----------AVTEPEARYF 147
Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTI 388
           +   + G V Y+H++    + HRD+K  N+ L+D    K+ DFG++  I  D       +
Sbjct: 148 MRQTIQG-VQYLHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER-KKDL 202
Query: 389 QGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
            GT  Y+ PE       + + D++S G +L  LL GK P
Sbjct: 203 CGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPP 241

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 94/217 (43%), Gaps = 23/217 (10%)
Query: 216 DNYNQSRFLGQGGFGTVY-KGMLPDGSIVAVK---RSKEIDKTQIHQFINEVVILSQINH 271
           D + + + LG G FG V     +  G+  A+K   + K +   QI   +NE  IL  +N 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 272 RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVAC 331
             +VKL     +     +V EY   G +  H+              +   S  +    A 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLR------------RIGRFSEPHARFYAA 148
Query: 332 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGT 391
           ++     Y+HS   + + +RD+K  N+++D +   +V+DFG ++ +       T  + GT
Sbjct: 149 QIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGR----TWXLCGT 201
Query: 392 FGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
             YL PE   S  +    D ++ GV++ E+  G  P 
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 98/213 (46%), Gaps = 31/213 (14%)
Query: 224 LGQGGFGTV-----YKGMLPDGSIVAVK--RSKEIDKTQIHQFIN-EVVILSQINHRHIV 275
           LG+G FG V     YK        VA+K    + + K+ +H  +  E+  L  + H HI+
Sbjct: 17  LGEGSFGKVKLATHYKTQ----QKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHII 72
Query: 276 KLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAG 335
           KL          V+V EY + G L  +I +               ++ +   R   ++  
Sbjct: 73  KLYDVITTPTDIVMVIEY-AGGELFDYIVEK------------KRMTEDEGRRFFQQIIC 119
Query: 336 AVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYL 395
           A+ Y H      I HRD+K  N+LLDD  + K++DFG+S +I  D   L T+  G+  Y 
Sbjct: 120 AIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLS-NIMTDGNFLKTSC-GSPNYA 174
Query: 396 DPEYFQSSQFT-DKSDVYSFGVVLLELLTGKKP 427
            PE      +   + DV+S G+VL  +L G+ P
Sbjct: 175 APEVINGKLYAGPEVDVWSCGIVLYVMLVGRLP 207

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 93/217 (42%), Gaps = 23/217 (10%)
Query: 216 DNYNQSRFLGQGGFGTVY-KGMLPDGSIVAVK---RSKEIDKTQIHQFINEVVILSQINH 271
           D + + + LG G FG V     +  G+  A+K   + K +   QI   +NE  IL  +N 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 272 RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVAC 331
             + KL     +     +V EY   G +  H+              +   S  +    A 
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLR------------RIGRFSEPHARFYAA 149
Query: 332 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGT 391
           ++     Y+HS   + + +RD+K  N+++D +   KV+DFG ++ +       T  + GT
Sbjct: 150 QIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXLCGT 202
Query: 392 FGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
             YL PE   S  +    D ++ GV++ E+  G  P 
Sbjct: 203 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 102/233 (43%), Gaps = 35/233 (15%)
Query: 213 RATDNYNQSRFLGQGGFGTVY----KGMLPDGSIVAVKRSK------EIDKTQIHQF--- 259
           +  ++Y + R LG G +G V     K    + +I  +K+S+        D   I +F   
Sbjct: 33  KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEE 92
Query: 260 -INEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXL 318
             NE+ +L  ++H +I+KL     + +   LV E+   G L   I +             
Sbjct: 93  IYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDEC------ 146
Query: 319 SSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK---FSAKVSDFGISR 375
                 +   +  ++   + Y+H      I HRDIK  NILL++K    + K+ DFG+S 
Sbjct: 147 ------DAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSS 197
Query: 376 SIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
               D  +      GT  Y+ PE  +  ++ +K DV+S GV++  LL G  P 
Sbjct: 198 FFSKD--YKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPF 247

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 93/217 (42%), Gaps = 23/217 (10%)
Query: 216 DNYNQSRFLGQGGFGTVY-KGMLPDGSIVAVK---RSKEIDKTQIHQFINEVVILSQINH 271
           D + + + LG G FG V     +  G+  A+K   + K +   QI   +NE  IL  +N 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 272 RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVAC 331
             + KL     +     +V EY   G +  H+              +   S  +    A 
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLR------------RIGRFSEPHARFYAA 149
Query: 332 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGT 391
           ++     Y+HS   + + +RD+K  N+++D +   KV+DFG ++ +       T  + GT
Sbjct: 150 QIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXLCGT 202
Query: 392 FGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
             YL PE   S  +    D ++ GV++ E+  G  P 
Sbjct: 203 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/218 (22%), Positives = 93/218 (42%), Gaps = 20/218 (9%)
Query: 216 DNYNQSRFLGQGGFGTVYKG----MLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINH 271
           +++   + LG+G F TV          + +I  +++   I + ++     E  ++S+++H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 272 RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVAC 331
              VKL     + E       Y  +G L  +I              + S           
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRK------------IGSFDETCTRFYTA 139
Query: 332 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI-PNDKTHLTTTIQG 390
           E+  A+ Y+H      I HRD+K  NILL++    +++DFG ++ + P  K     +  G
Sbjct: 140 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 196
Query: 391 TFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
           T  Y+ PE       +  SD+++ G ++ +L+ G  P 
Sbjct: 197 TAQYVSPELLTEKSASKSSDLWALGCIIYQLVAGLPPF 234

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 94/218 (43%), Gaps = 24/218 (11%)
Query: 216 DNYNQSRFLGQGGFGTVYK---GMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHR 272
           + YN    LG+G FG V K    +      V V              + EV +L +++H 
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 273 HIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACE 332
           +I+KL     ++    +V E  + G L   I                  S  +  R+  +
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGELFDEI------------IKRKRFSEHDAARIIKQ 129
Query: 333 VAGAVAYMHSSASIPIFHRDIKSSNILLDDKF---SAKVSDFGISRSIPNDKTHLTTTIQ 389
           V   + YMH      I HRD+K  NILL+ K      K+ DFG+S     + T +   I 
Sbjct: 130 VFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TKMKDRI- 184
Query: 390 GTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
           GT  Y+ PE  + + + +K DV+S GV+L  LL+G  P
Sbjct: 185 GTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPP 221

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/241 (26%), Positives = 109/241 (45%), Gaps = 27/241 (11%)
Query: 216 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVK--RSKEIDKTQIHQFINEVVILSQINHRH 273
           + Y+    +G+G +G VYK     G   A+K  R ++ D+      I E+ IL ++ H +
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 274 IVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEV 333
           IVKL       +  VLV+E         H+              L S++ ++ +    ++
Sbjct: 62  IVKLYDVIHTKKRLVLVFE---------HLDQDLKKLLDVCEGGLESVTAKSFL---LQL 109
Query: 334 AGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS--IPNDK-THLTTTIQG 390
              +AY H      + HRD+K  N+L++ +   K++DFG++R+  IP  K TH   T+  
Sbjct: 110 LNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLW- 165
Query: 391 TFGYLDPEYFQSS-QFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKE 449
              Y  P+    S +++   D++S G +  E++ G     F  V E   L+  F  L   
Sbjct: 166 ---YRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTP--LFPGVSEADQLMRIFRILGTP 220
Query: 450 N 450
           N
Sbjct: 221 N 221

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 93/213 (43%), Gaps = 20/213 (9%)
Query: 216 DNYNQSRFLGQGGFGTVYKGMLPD-GSIVAVKRSKEIDKTQIHQFI--NEVVILSQINHR 272
           + Y +   +G+G +G V+K    D G IVA+K+  E +   + + I   E+ +L Q+ H 
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 273 HIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACE 332
           ++V LL          LV+EY     L    H+            + S++W+        
Sbjct: 63  NLVNLLEVFRRKRRLHLVFEYCDHTVL----HELDRYQRGVPEHLVKSITWQT------- 111
Query: 333 VAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTF 392
              AV + H    I   HRD+K  NIL+      K+ DFG +R +     +    +  T 
Sbjct: 112 -LQAVNFCHKHNCI---HRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEV-ATR 166
Query: 393 GYLDPEYF-QSSQFTDKSDVYSFGVVLLELLTG 424
            Y  PE     +Q+    DV++ G V  ELL+G
Sbjct: 167 WYRSPELLVGDTQYGPPVDVWAIGCVFAELLSG 199

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 81/179 (45%), Gaps = 26/179 (14%)
Query: 262 EVVILSQI-NHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSS 320
           E  IL Q+  H HI+ L+     +    LV++ +  G L  ++ +            + S
Sbjct: 149 ETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRS 208
Query: 321 LSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI-PN 379
           L              AV+++H++    I HRD+K  NILLDD    ++SDFG S  + P 
Sbjct: 209 L------------LEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG 253
Query: 380 DKTHLTTTIQGTFGYLDPEYFQSSQ------FTDKSDVYSFGVVLLELLTGKKPICFAR 432
           +K      + GT GYL PE  + S       +  + D+++ GV+L  LL G  P    R
Sbjct: 254 EKLR---ELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR 309

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/237 (24%), Positives = 101/237 (42%), Gaps = 31/237 (13%)
Query: 207 TADELQRATDNYNQSRF----------LGQGGFGTVY----KGMLPDGSIVAVKRSKEID 252
           TA+ + +  +N N+ R           LG+G FG V     KG     ++  +K+   I 
Sbjct: 322 TANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQ 381
Query: 253 KTQIHQFINEVVILSQINHRHIVKLLGCCLET-EVPVLVYEYISSGTLSHHIHDHXXXXX 311
              +   + E  +L+       +  L  C +T +    V EY++ G L +HI        
Sbjct: 382 DDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQ------- 434
Query: 312 XXXXXXLSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF 371
                 +      + V  A E+A  + ++ S     I +RD+K  N++LD +   K++DF
Sbjct: 435 -----QVGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADF 486
Query: 372 GISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
           G+ +    D    T    GT  Y+ PE      +    D ++FGV+L E+L G+ P 
Sbjct: 487 GMCKENIWDGV-TTKXFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPF 542

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 97/220 (44%), Gaps = 29/220 (13%)
Query: 216 DNYNQSRFLGQGGFGTVYKGML----PDGSIVAVK---RSKEIDKTQIHQFINEVVILSQ 268
           D +++ + LG G FG V   ML      G+  A+K   + K +   QI   +NE  IL  
Sbjct: 41  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 269 INHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVR 328
           +N   +VKL     +     +V EY++ G +  H+              +   S  +   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR------------RIGRFSEPHARF 145
Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTI 388
            A ++     Y+HS   + + +RD+K  N+L+D +   +V+DFG ++ +       T  +
Sbjct: 146 YAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXL 198
Query: 389 QGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
            GT   L PE   S  +    D ++ GV++ E+  G  P 
Sbjct: 199 CGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 93/217 (42%), Gaps = 23/217 (10%)
Query: 216 DNYNQSRFLGQGGFGTVY-KGMLPDGSIVAVK---RSKEIDKTQIHQFINEVVILSQINH 271
           D + + + LG G FG V     +  G+  A+K   + K +   QI   +NE  IL  +N 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 272 RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVAC 331
             +VKL     +     +V EY   G +  H+              +      +    A 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLR------------RIGRFXEPHARFYAA 148
Query: 332 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGT 391
           ++     Y+HS   + + +RD+K  N+++D +   KV+DFG ++ +       T  + GT
Sbjct: 149 QIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXLCGT 201
Query: 392 FGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
             YL PE   S  +    D ++ GV++ E+  G  P 
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 93/218 (42%), Gaps = 22/218 (10%)
Query: 216 DNYNQSRFLGQGGFGTVY----KGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINH 271
           ++++  + LG+G FG V     K      ++  +++   I K ++   + E  +L    H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 272 RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRV-A 330
             +  L       +    V EY + G L  H+                    E R R   
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFT-------------EERARFYG 111
Query: 331 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQG 390
            E+  A+ Y+HS     + +RDIK  N++LD     K++DFG+ +   +D   +  T  G
Sbjct: 112 AEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM-KTFCG 167
Query: 391 TFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
           T  YL PE  + + +    D +  GVV+ E++ G+ P 
Sbjct: 168 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 205

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 95/220 (43%), Gaps = 29/220 (13%)
Query: 216 DNYNQSRFLGQGGFGTVYKGML----PDGSIVAVK---RSKEIDKTQIHQFINEVVILSQ 268
           D + + + LG G FG V   ML      G+  A+K   + K +   QI   +NE  IL  
Sbjct: 34  DQFERIKTLGTGSFGRV---MLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 90
Query: 269 INHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVR 328
           +N   +VKL     +     +V EY+  G +  H+              +      +   
Sbjct: 91  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLR------------RIGRFXEPHARF 138
Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTI 388
            A ++     Y+HS   + + +RD+K  N+L+D +   +V+DFG ++ +       T  +
Sbjct: 139 YAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXL 191
Query: 389 QGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
            GT  YL PE   S  +    D ++ GV++ E+  G  P 
Sbjct: 192 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 231

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 93/218 (42%), Gaps = 22/218 (10%)
Query: 216 DNYNQSRFLGQGGFGTVY----KGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINH 271
           ++++  + LG+G FG V     K      ++  +++   I K ++   + E  +L    H
Sbjct: 8   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 67
Query: 272 RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRV-A 330
             +  L       +    V EY + G L  H+                    E R R   
Sbjct: 68  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFT-------------EERARFYG 114
Query: 331 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQG 390
            E+  A+ Y+HS     + +RDIK  N++LD     K++DFG+ +   +D   +  T  G
Sbjct: 115 AEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM-KTFCG 170
Query: 391 TFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
           T  YL PE  + + +    D +  GVV+ E++ G+ P 
Sbjct: 171 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 208

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/222 (22%), Positives = 93/222 (41%), Gaps = 20/222 (9%)
Query: 212 QRATDNYNQSRFLGQGGFGTVYKG----MLPDGSIVAVKRSKEIDKTQIHQFINEVVILS 267
           ++  +++   + LG+G F TV          + +I  +++   I + ++     E  ++S
Sbjct: 4   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 268 QINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
           +++H   VKL     + E       Y  +G L  +I              + S       
Sbjct: 64  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK------------IGSFDETCTR 111
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI-PNDKTHLTT 386
               E+  A+ Y+H      I HRD+K  NILL++    +++DFG ++ + P  K     
Sbjct: 112 FYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN 168
Query: 387 TIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
              GT  Y+ PE          SD+++ G ++ +L+ G  P 
Sbjct: 169 XFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 210

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 94/218 (43%), Gaps = 24/218 (11%)
Query: 216 DNYNQSRFLGQGGFGTVYK---GMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHR 272
           + YN    LG+G FG V K    +      V V              + EV +L +++H 
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 273 HIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACE 332
           +I+KL     ++    +V E  + G L   I                  S  +  R+  +
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGELFDEI------------IKRKRFSEHDAARIIKQ 129
Query: 333 VAGAVAYMHSSASIPIFHRDIKSSNILLDDK---FSAKVSDFGISRSIPNDKTHLTTTIQ 389
           V   + YMH      I HRD+K  NILL+ K      K+ DFG+S     + T +   I 
Sbjct: 130 VFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TKMKDRI- 184
Query: 390 GTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
           GT  Y+ PE  + + + +K DV+S GV+L  LL+G  P
Sbjct: 185 GTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPP 221

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 94/218 (43%), Gaps = 24/218 (11%)
Query: 216 DNYNQSRFLGQGGFGTVYK---GMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHR 272
           + YN    LG+G FG V K    +      V V              + EV +L +++H 
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 273 HIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACE 332
           +I+KL     ++    +V E  + G L   I                  S  +  R+  +
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGELFDEI------------IKRKRFSEHDAARIIKQ 129
Query: 333 VAGAVAYMHSSASIPIFHRDIKSSNILLDDK---FSAKVSDFGISRSIPNDKTHLTTTIQ 389
           V   + YMH      I HRD+K  NILL+ K      K+ DFG+S     + T +   I 
Sbjct: 130 VFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TKMKDRI- 184
Query: 390 GTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
           GT  Y+ PE  + + + +K DV+S GV+L  LL+G  P
Sbjct: 185 GTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPP 221

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/222 (22%), Positives = 93/222 (41%), Gaps = 20/222 (9%)
Query: 212 QRATDNYNQSRFLGQGGFGTVYKG----MLPDGSIVAVKRSKEIDKTQIHQFINEVVILS 267
           ++  +++   + LG+G F TV          + +I  +++   I + ++     E  ++S
Sbjct: 6   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 65
Query: 268 QINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
           +++H   VKL     + E       Y  +G L  +I              + S       
Sbjct: 66  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK------------IGSFDETCTR 113
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI-PNDKTHLTT 386
               E+  A+ Y+H      I HRD+K  NILL++    +++DFG ++ + P  K     
Sbjct: 114 FYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN 170
Query: 387 TIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
              GT  Y+ PE          SD+++ G ++ +L+ G  P 
Sbjct: 171 XFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 212

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 93/218 (42%), Gaps = 22/218 (10%)
Query: 216 DNYNQSRFLGQGGFGTVY----KGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINH 271
           ++++  + LG+G FG V     K      ++  +++   I K ++   + E  +L    H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 272 RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRV-A 330
             +  L       +    V EY + G L  H+                    E R R   
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFT-------------EERARFYG 111
Query: 331 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQG 390
            E+  A+ Y+HS     + +RDIK  N++LD     K++DFG+ +   +D   +  T  G
Sbjct: 112 AEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM-KTFCG 167
Query: 391 TFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
           T  YL PE  + + +    D +  GVV+ E++ G+ P 
Sbjct: 168 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 205

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 92/216 (42%), Gaps = 24/216 (11%)
Query: 222 RFLGQGGFGTVYK----GMLPDGSIVAVKRSKEI----DKTQIHQFINEVVILSQINHRH 273
           R LG+GG+G V++         G I A+K  K+     +         E  IL ++ H  
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 274 IVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEV 333
           IV L+          L+ EY+S G L   +              L+            E+
Sbjct: 83  IVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLA------------EI 130
Query: 334 AGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFG 393
           + A+ ++H      I +RD+K  NI+L+ +   K++DFG+ +   +D T +T    GT  
Sbjct: 131 SMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT-VTHXFCGTIE 186
Query: 394 YLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPIC 429
           Y+ PE    S      D +S G ++ ++LTG  P  
Sbjct: 187 YMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFT 222

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 95/217 (43%), Gaps = 23/217 (10%)
Query: 216 DNYNQSRFLGQGGFGTVY-KGMLPDGSIVAVK---RSKEIDKTQIHQFINEVVILSQINH 271
           D + + + LG G FG V     +  G+  A+K   + K +   +I   +NE  IL  +N 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF 100
Query: 272 RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVAC 331
             +VKL     +     +V EY   G +  H+              +   S  +    A 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLR------------RIGRFSEPHARFYAA 148
Query: 332 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGT 391
           ++     Y+HS   + + +RD+K  N+++D +   +V+DFG+++ +       T  + GT
Sbjct: 149 QIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGR----TWXLCGT 201
Query: 392 FGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
             YL PE   S  +    D ++ GV++ E+  G  P 
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/222 (22%), Positives = 93/222 (41%), Gaps = 20/222 (9%)
Query: 212 QRATDNYNQSRFLGQGGFGTVYKG----MLPDGSIVAVKRSKEIDKTQIHQFINEVVILS 267
           ++  +++   + LG+G F TV          + +I  +++   I + ++     E  ++S
Sbjct: 5   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 64
Query: 268 QINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
           +++H   VKL     + E       Y  +G L  +I              + S       
Sbjct: 65  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK------------IGSFDETCTR 112
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI-PNDKTHLTT 386
               E+  A+ Y+H      I HRD+K  NILL++    +++DFG ++ + P  K     
Sbjct: 113 FYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN 169
Query: 387 TIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
              GT  Y+ PE          SD+++ G ++ +L+ G  P 
Sbjct: 170 XFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 211

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/222 (22%), Positives = 93/222 (41%), Gaps = 20/222 (9%)
Query: 212 QRATDNYNQSRFLGQGGFGTVYKG----MLPDGSIVAVKRSKEIDKTQIHQFINEVVILS 267
           ++  +++   + LG+G F TV          + +I  +++   I + ++     E  ++S
Sbjct: 3   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 62
Query: 268 QINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
           +++H   VKL     + E       Y  +G L  +I              + S       
Sbjct: 63  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK------------IGSFDETCTR 110
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI-PNDKTHLTT 386
               E+  A+ Y+H      I HRD+K  NILL++    +++DFG ++ + P  K     
Sbjct: 111 FYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN 167
Query: 387 TIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
              GT  Y+ PE          SD+++ G ++ +L+ G  P 
Sbjct: 168 XFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 209

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 94/217 (43%), Gaps = 21/217 (9%)
Query: 217 NYNQSRFLGQGGFGTVY----KGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHR 272
           ++N    LG+G FG V     KG     ++  +K+   I    +   + E  +L+     
Sbjct: 21  DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKP 80
Query: 273 HIVKLLGCCLET-EVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVAC 331
             +  L  C +T +    V EY++ G L +HI              +      + V  A 
Sbjct: 81  PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQ------------QVGRFKEPHAVFYAA 128
Query: 332 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGT 391
           E+A  + ++ S     I +RD+K  N++LD +   K++DFG+ +    D    T    GT
Sbjct: 129 EIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV-TTKXFCGT 184
Query: 392 FGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
             Y+ PE      +    D ++FGV+L E+L G+ P 
Sbjct: 185 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPF 221

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 97/219 (44%), Gaps = 25/219 (11%)
Query: 217 NYNQSRFLGQGGFGTVYKGMLPDGSIVAVKR--SKEI--DKTQIHQFINEVVILSQINHR 272
           +++  R +G+G +  V    L     +   R   KE+  D   I     E  +  Q ++ 
Sbjct: 53  DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNH 112
Query: 273 HIVKLLGCCLETEVPVL-VYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVAC 331
             +  L  C +TE  +  V EY++ G L  H+                 L  E+    + 
Sbjct: 113 PFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ------------RKLPEEHARFYSA 160
Query: 332 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS--IPNDKTHLTTTIQ 389
           E++ A+ Y+H      I +RD+K  N+LLD +   K++D+G+ +    P D T   +T  
Sbjct: 161 EISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---STFC 214
Query: 390 GTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
           GT  Y+ PE  +   +    D ++ GV++ E++ G+ P 
Sbjct: 215 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPF 253

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 95/220 (43%), Gaps = 25/220 (11%)
Query: 215 TDNYNQSRFLGQGGFGTVY----KGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQIN 270
           +D Y   R LG+G FG V     K    + ++  + + +   KT     + EV +L Q++
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 271 HRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVA 330
           H +I KL     +     LV E  + G L   I                  S  +  R+ 
Sbjct: 85  HPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEI------------ISRKRFSEVDAARII 132
Query: 331 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK---FSAKVSDFGISRSIPNDKTHLTTT 387
            +V   + Y H +    I HRD+K  N+LL+ K    + ++ DFG+S      K      
Sbjct: 133 RQVLSGITYXHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKI 189
Query: 388 IQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
             GT  Y+ PE    + + +K DV+S GV+L  LL+G  P
Sbjct: 190 --GTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPP 226

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 49/218 (22%), Positives = 92/218 (42%), Gaps = 20/218 (9%)
Query: 216 DNYNQSRFLGQGGFGTVYKG----MLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINH 271
           +++   + LG+G F TV          + +I  +++   I + ++     E  ++S+++H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 272 RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVAC 331
              VKL     + E       Y  +G L  +I              + S           
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK------------IGSFDETCTRFYTA 136
Query: 332 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI-PNDKTHLTTTIQG 390
           E+  A+ Y+H      I HRD+K  NILL++    +++DFG ++ + P  K     +  G
Sbjct: 137 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 193
Query: 391 TFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
           T  Y+ PE          SD+++ G ++ +L+ G  P 
Sbjct: 194 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 231

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 96/216 (44%), Gaps = 23/216 (10%)
Query: 217 NYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK--RSKEIDKTQIHQFIN-EVVILSQINHR 272
           NY   + LG+G FG V        G  VA+K    K + K+ +   I  E+  L  + H 
Sbjct: 15  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 74
Query: 273 HIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACE 332
           HI+KL       +  ++V EY  +    + +                 +S +   R   +
Sbjct: 75  HIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQR-------------DKMSEQEARRFFQQ 121
Query: 333 VAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTF 392
           +  AV Y H      I HRD+K  N+LLD+  + K++DFG+S +I  D   L T+  G+ 
Sbjct: 122 IISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLS-NIMTDGNFLKTSC-GSP 176
Query: 393 GYLDPEYFQSSQFTD-KSDVYSFGVVLLELLTGKKP 427
            Y  PE      +   + DV+S GV+L  +L  + P
Sbjct: 177 NYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLP 212

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 96/216 (44%), Gaps = 23/216 (10%)
Query: 217 NYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK--RSKEIDKTQIHQFIN-EVVILSQINHR 272
           NY   + LG+G FG V        G  VA+K    K + K+ +   I  E+  L  + H 
Sbjct: 5   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 64
Query: 273 HIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACE 332
           HI+KL       +  ++V EY  +    + +                 +S +   R   +
Sbjct: 65  HIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQR-------------DKMSEQEARRFFQQ 111
Query: 333 VAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTF 392
           +  AV Y H      I HRD+K  N+LLD+  + K++DFG+S +I  D   L T+  G+ 
Sbjct: 112 IISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLS-NIMTDGNFLKTSC-GSP 166
Query: 393 GYLDPEYFQSSQFT-DKSDVYSFGVVLLELLTGKKP 427
            Y  PE      +   + DV+S GV+L  +L  + P
Sbjct: 167 NYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLP 202

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 96/216 (44%), Gaps = 23/216 (10%)
Query: 217 NYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK--RSKEIDKTQIHQFIN-EVVILSQINHR 272
           NY   + LG+G FG V        G  VA+K    K + K+ +   I  E+  L  + H 
Sbjct: 14  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 73
Query: 273 HIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACE 332
           HI+KL       +  ++V EY  +    + +                 +S +   R   +
Sbjct: 74  HIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQR-------------DKMSEQEARRFFQQ 120
Query: 333 VAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTF 392
           +  AV Y H      I HRD+K  N+LLD+  + K++DFG+S +I  D   L T+  G+ 
Sbjct: 121 IISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLS-NIMTDGNFLKTSC-GSP 175
Query: 393 GYLDPEYFQSSQFTD-KSDVYSFGVVLLELLTGKKP 427
            Y  PE      +   + DV+S GV+L  +L  + P
Sbjct: 176 NYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLP 211

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 49/218 (22%), Positives = 92/218 (42%), Gaps = 20/218 (9%)
Query: 216 DNYNQSRFLGQGGFGTVYKG----MLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINH 271
           +++   + LG+G F TV          + +I  +++   I + ++     E  ++S+++H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 272 RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVAC 331
              VKL     + E       Y  +G L  +I              + S           
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK------------IGSFDETCTRFYTA 140
Query: 332 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI-PNDKTHLTTTIQG 390
           E+  A+ Y+H      I HRD+K  NILL++    +++DFG ++ + P  K     +  G
Sbjct: 141 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 197
Query: 391 TFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
           T  Y+ PE          SD+++ G ++ +L+ G  P 
Sbjct: 198 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 235

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/243 (23%), Positives = 110/243 (45%), Gaps = 16/243 (6%)
Query: 214 ATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSK-EIDKTQIHQFINEVVILSQINH 271
           ++  + Q   LG G + TVYKG+    G  VA+K  K + ++      I E+ ++ ++ H
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH 62
Query: 272 RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVAC 331
            +IV+L           LV+E++ +    +   D            L+ + +        
Sbjct: 63  ENIVRLYDVIHTENKLTLVFEFMDNDLKKYM--DSRTVGNTPRGLELNLVKY-----FQW 115
Query: 332 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGT 391
           ++   +A+ H +    I HRD+K  N+L++ +   K+ DFG++R+        ++ +  T
Sbjct: 116 QLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-T 171
Query: 392 FGYLDPEYFQSSQ-FTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKEN 450
             Y  P+    S+ ++   D++S G +L E++TGK    F    +E  L   F  +   N
Sbjct: 172 LWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKP--LFPGTNDEEQLKLIFDIMGTPN 229
Query: 451 QLL 453
           + L
Sbjct: 230 ESL 232

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 73/258 (28%), Positives = 109/258 (42%), Gaps = 29/258 (11%)
Query: 224 LGQGGFGTVYKGMLP-DGSIVAVK---RSKEIDKTQIHQFINEVVILSQINHRHIVKLLG 279
           LG G FG V  G     G  VAVK   R K      + +   E+  L    H HI+KL  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 280 CCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAY 339
                    +V EY+S G L  +I  H                 E R R+  ++  AV Y
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKHGRVE-----------EMEAR-RLFQQILSAVDY 126
Query: 340 MHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEY 399
            H      + HRD+K  N+LLD   +AK++DFG+S  + +D   L T+  G+  Y  PE 
Sbjct: 127 CHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMM-SDGEFLRTSC-GSPNYAAPEV 181
Query: 400 FQSSQFTD-KSDVYSFGVVLLELLTGKKPI-------CFARVEEERNLVACFISLAKENQ 451
                +   + D++S GV+L  LL G  P         F ++      +  +++ +    
Sbjct: 182 ISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATL 241
Query: 452 LLEILDARVAKEAREEDI 469
           L+ +L     K A  +DI
Sbjct: 242 LMHMLQVDPLKRATIKDI 259

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 49/218 (22%), Positives = 91/218 (41%), Gaps = 20/218 (9%)
Query: 216 DNYNQSRFLGQGGFGTVYKG----MLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINH 271
           +++   + LG+G F TV          + +I  +++   I + ++     E  ++S+++H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 272 RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVAC 331
              VKL     + E       Y  +G L  +I              + S           
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK------------IGSFDETCTRFYTA 137
Query: 332 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI-PNDKTHLTTTIQG 390
           E+  A+ Y+H      I HRD+K  NILL++    +++DFG ++ + P  K        G
Sbjct: 138 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVG 194
Query: 391 TFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
           T  Y+ PE          SD+++ G ++ +L+ G  P 
Sbjct: 195 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 232

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 96/216 (44%), Gaps = 23/216 (10%)
Query: 217 NYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK--RSKEIDKTQIHQFIN-EVVILSQINHR 272
           NY   + LG+G FG V        G  VA+K    K + K+ +   I  E+  L  + H 
Sbjct: 9   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 68
Query: 273 HIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACE 332
           HI+KL       +  ++V EY  +    + +                 +S +   R   +
Sbjct: 69  HIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQR-------------DKMSEQEARRFFQQ 115
Query: 333 VAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTF 392
           +  AV Y H      I HRD+K  N+LLD+  + K++DFG+S +I  D   L T+  G+ 
Sbjct: 116 IISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLS-NIMTDGNFLKTSC-GSP 170
Query: 393 GYLDPEYFQSSQFT-DKSDVYSFGVVLLELLTGKKP 427
            Y  PE      +   + DV+S GV+L  +L  + P
Sbjct: 171 NYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLP 206

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/257 (22%), Positives = 109/257 (42%), Gaps = 29/257 (11%)
Query: 216 DNYNQSRFLGQGGFGTVYKG----MLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINH 271
           +++   + LG+G F TV          + +I  +++   I + ++     E  ++S+++H
Sbjct: 35  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 94
Query: 272 RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVAC 331
              VKL     + E       Y  +G L  +I              + S           
Sbjct: 95  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK------------IGSFDETCTRFYTA 142
Query: 332 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI-PNDKTHLTTTIQG 390
           E+  A+ Y+H      I HRD+K  NILL++    +++DFG ++ + P  K        G
Sbjct: 143 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 199
Query: 391 TFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP-------ICFAR-VEEERNLVAC 442
           T  Y+ PE          SD+++ G ++ +L+ G  P       + F + ++ E +  A 
Sbjct: 200 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPAA 259
Query: 443 FISLAKE-NQLLEILDA 458
           F   A++  + L +LDA
Sbjct: 260 FFPKARDLVEKLLVLDA 276

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 98/234 (41%), Gaps = 22/234 (9%)
Query: 201 ERAKVFTADELQRATDN-YNQSRFLGQGGFGTVY----KGMLPDGSIVAVKRSKEIDKTQ 255
           E  +V  A    R T N +   + LG+G FG V     K      ++  +K+   + K +
Sbjct: 132 EEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDE 191
Query: 256 IHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXX 315
           +   + E  +L    H  +  L       +    V EY + G L  H+            
Sbjct: 192 VAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFS----- 246
Query: 316 XXLSSLSWENRVRV-ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGIS 374
                   E+R R    E+  A+ Y+HS  ++   +RD+K  N++LD     K++DFG+ 
Sbjct: 247 --------EDRARFYGAEIVSALDYLHSEKNV--VYRDLKLENLMLDKDGHIKITDFGLC 296
Query: 375 RSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
           +    D   + T   GT  YL PE  + + +    D +  GVV+ E++ G+ P 
Sbjct: 297 KEGIKDGATMKT-FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 349

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 49/218 (22%), Positives = 91/218 (41%), Gaps = 20/218 (9%)
Query: 216 DNYNQSRFLGQGGFGTVYKG----MLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINH 271
           +++   + LG+G F TV          + +I  +++   I + ++     E  ++S+++H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 272 RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVAC 331
              VKL     + E       Y  +G L  +I              + S           
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK------------IGSFDETCTRFYTA 139
Query: 332 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI-PNDKTHLTTTIQG 390
           E+  A+ Y+H      I HRD+K  NILL++    +++DFG ++ + P  K        G
Sbjct: 140 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 196
Query: 391 TFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
           T  Y+ PE          SD+++ G ++ +L+ G  P 
Sbjct: 197 TAQYVSPELLTEKSAXKSSDLWALGCIIYQLVAGLPPF 234

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 49/218 (22%), Positives = 91/218 (41%), Gaps = 20/218 (9%)
Query: 216 DNYNQSRFLGQGGFGTVYKG----MLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINH 271
           +++   + LG+G F TV          + +I  +++   I + ++     E  ++S+++H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 272 RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVAC 331
              VKL     + E       Y  +G L  +I              + S           
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK------------IGSFDETCTRFYTA 139
Query: 332 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI-PNDKTHLTTTIQG 390
           E+  A+ Y+H      I HRD+K  NILL++    +++DFG ++ + P  K        G
Sbjct: 140 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 196
Query: 391 TFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
           T  Y+ PE          SD+++ G ++ +L+ G  P 
Sbjct: 197 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 234

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 49/218 (22%), Positives = 91/218 (41%), Gaps = 20/218 (9%)
Query: 216 DNYNQSRFLGQGGFGTVYKG----MLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINH 271
           +++   + LG+G F TV          + +I  +++   I + ++     E  ++S+++H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 272 RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVAC 331
              VKL     + E       Y  +G L  +I              + S           
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK------------IGSFDETCTRFYTA 139
Query: 332 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI-PNDKTHLTTTIQG 390
           E+  A+ Y+H      I HRD+K  NILL++    +++DFG ++ + P  K        G
Sbjct: 140 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 196
Query: 391 TFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
           T  Y+ PE          SD+++ G ++ +L+ G  P 
Sbjct: 197 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 234

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 98/234 (41%), Gaps = 22/234 (9%)
Query: 201 ERAKVFTADELQRATDN-YNQSRFLGQGGFGTVY----KGMLPDGSIVAVKRSKEIDKTQ 255
           E  +V  A    R T N +   + LG+G FG V     K      ++  +K+   + K +
Sbjct: 135 EEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDE 194
Query: 256 IHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXX 315
           +   + E  +L    H  +  L       +    V EY + G L  H+            
Sbjct: 195 VAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFS----- 249
Query: 316 XXLSSLSWENRVRV-ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGIS 374
                   E+R R    E+  A+ Y+HS  ++   +RD+K  N++LD     K++DFG+ 
Sbjct: 250 --------EDRARFYGAEIVSALDYLHSEKNV--VYRDLKLENLMLDKDGHIKITDFGLC 299
Query: 375 RSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
           +    D   + T   GT  YL PE  + + +    D +  GVV+ E++ G+ P 
Sbjct: 300 KEGIKDGATMKT-FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 352

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 49/218 (22%), Positives = 91/218 (41%), Gaps = 20/218 (9%)
Query: 216 DNYNQSRFLGQGGFGTVYKG----MLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINH 271
           +++   + LG+G F TV          + +I  +++   I + ++     E  ++S+++H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 272 RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVAC 331
              VKL     + E       Y  +G L  +I              + S           
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK------------IGSFDETCTRFYTA 139
Query: 332 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI-PNDKTHLTTTIQG 390
           E+  A+ Y+H      I HRD+K  NILL++    +++DFG ++ + P  K        G
Sbjct: 140 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 196
Query: 391 TFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
           T  Y+ PE          SD+++ G ++ +L+ G  P 
Sbjct: 197 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 234

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 49/218 (22%), Positives = 91/218 (41%), Gaps = 20/218 (9%)
Query: 216 DNYNQSRFLGQGGFGTVYKG----MLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINH 271
           +++   + LG+G F TV          + +I  +++   I + ++     E  ++S+++H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 272 RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVAC 331
              VKL     + E       Y  +G L  +I              + S           
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK------------IGSFDETCTRFYTA 137
Query: 332 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI-PNDKTHLTTTIQG 390
           E+  A+ Y+H      I HRD+K  NILL++    +++DFG ++ + P  K        G
Sbjct: 138 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 194
Query: 391 TFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
           T  Y+ PE          SD+++ G ++ +L+ G  P 
Sbjct: 195 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 232

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 49/218 (22%), Positives = 91/218 (41%), Gaps = 20/218 (9%)
Query: 216 DNYNQSRFLGQGGFGTVYKG----MLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINH 271
           +++   + LG+G F TV          + +I  +++   I + ++     E  ++S+++H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 272 RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVAC 331
              VKL     + E       Y  +G L  +I              + S           
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK------------IGSFDETCTRFYTA 136
Query: 332 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI-PNDKTHLTTTIQG 390
           E+  A+ Y+H      I HRD+K  NILL++    +++DFG ++ + P  K        G
Sbjct: 137 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 193
Query: 391 TFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
           T  Y+ PE          SD+++ G ++ +L+ G  P 
Sbjct: 194 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 231

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 49/218 (22%), Positives = 91/218 (41%), Gaps = 20/218 (9%)
Query: 216 DNYNQSRFLGQGGFGTVYKG----MLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINH 271
           +++   + LG+G F TV          + +I  +++   I + ++     E  ++S+++H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 272 RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVAC 331
              VKL     + E       Y  +G L  +I              + S           
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK------------IGSFDETCTRFYTA 137
Query: 332 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI-PNDKTHLTTTIQG 390
           E+  A+ Y+H      I HRD+K  NILL++    +++DFG ++ + P  K        G
Sbjct: 138 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 194
Query: 391 TFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
           T  Y+ PE          SD+++ G ++ +L+ G  P 
Sbjct: 195 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 232

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 49/218 (22%), Positives = 91/218 (41%), Gaps = 20/218 (9%)
Query: 216 DNYNQSRFLGQGGFGTVYKG----MLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINH 271
           +++   + LG+G F TV          + +I  +++   I + ++     E  ++S+++H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 272 RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVAC 331
              VKL     + E       Y  +G L  +I              + S           
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK------------IGSFDETCTRFYTA 140
Query: 332 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI-PNDKTHLTTTIQG 390
           E+  A+ Y+H      I HRD+K  NILL++    +++DFG ++ + P  K        G
Sbjct: 141 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 197
Query: 391 TFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
           T  Y+ PE          SD+++ G ++ +L+ G  P 
Sbjct: 198 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 235

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 49/218 (22%), Positives = 91/218 (41%), Gaps = 20/218 (9%)
Query: 216 DNYNQSRFLGQGGFGTVYKG----MLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINH 271
           +++   + LG+G F TV          + +I  +++   I + ++     E  ++S+++H
Sbjct: 14  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 73
Query: 272 RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVAC 331
              VKL     + E       Y  +G L  +I              + S           
Sbjct: 74  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK------------IGSFDETCTRFYTA 121
Query: 332 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI-PNDKTHLTTTIQG 390
           E+  A+ Y+H      I HRD+K  NILL++    +++DFG ++ + P  K        G
Sbjct: 122 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 178
Query: 391 TFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
           T  Y+ PE          SD+++ G ++ +L+ G  P 
Sbjct: 179 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 216

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 49/218 (22%), Positives = 91/218 (41%), Gaps = 20/218 (9%)
Query: 216 DNYNQSRFLGQGGFGTVYKG----MLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINH 271
           +++   + LG+G F TV          + +I  +++   I + ++     E  ++S+++H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 272 RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVAC 331
              VKL     + E       Y  +G L  +I              + S           
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK------------IGSFDETCTRFYTA 139
Query: 332 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI-PNDKTHLTTTIQG 390
           E+  A+ Y+H      I HRD+K  NILL++    +++DFG ++ + P  K        G
Sbjct: 140 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 196
Query: 391 TFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
           T  Y+ PE          SD+++ G ++ +L+ G  P 
Sbjct: 197 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 234

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 63/249 (25%), Positives = 108/249 (43%), Gaps = 31/249 (12%)
Query: 202 RAKVFTADELQRATDNYNQSRFLGQGGFGTVYKGMLPDG-------SIVAVKRSKEIDKT 254
           R    T    +   +N+   + LG G +G V+      G       ++  +K++  + K 
Sbjct: 40  RTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKA 99
Query: 255 QIHQFI-NEVVILSQINHRHIVKLLGCCLETEVPV-LVYEYISSGTLSHHIHDHXXXXXX 312
           +  +    E  +L  I     +  L    +TE  + L+ +YI+ G L  H+         
Sbjct: 100 KTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFT-- 157
Query: 313 XXXXXLSSLSWENRVRV-ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF 371
                      E+ V++   E+  A+ ++H    + I +RDIK  NILLD      ++DF
Sbjct: 158 -----------EHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDF 203
Query: 372 GISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFT-DKS-DVYSFGVVLLELLTGKKPIC 429
           G+S+    D+T       GT  Y+ P+  +      DK+ D +S GV++ ELLTG  P  
Sbjct: 204 GLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFT 263
Query: 430 FARVEEERN 438
              V+ E+N
Sbjct: 264 ---VDGEKN 269

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 92/217 (42%), Gaps = 23/217 (10%)
Query: 216 DNYNQSRFLGQGGFGTVY-KGMLPDGSIVAVK---RSKEIDKTQIHQFINEVVILSQINH 271
           D + + + LG G FG V     +  G+  A+K   + K +   QI   +NE  IL  +N 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 272 RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVAC 331
             + KL     +     +V EY   G +  H+              +      +    A 
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLR------------RIGRFXEPHARFYAA 149
Query: 332 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGT 391
           ++     Y+HS   + + +RD+K  N+++D +   KV+DFG ++ +       T  + GT
Sbjct: 150 QIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXLCGT 202
Query: 392 FGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
             YL PE   S  +    D ++ GV++ E+  G  P 
Sbjct: 203 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 116/258 (44%), Gaps = 38/258 (14%)
Query: 219 NQSRFLGQGGFGTVYK------GMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHR 272
           +++  LG G FG V+K      G+     I+  +  K  DK ++    NE+ +++Q++H 
Sbjct: 92  SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMK--DKEEVK---NEISVMNQLDHA 146
Query: 273 HIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACE 332
           ++++L          VLV EY+  G L   I D            L+ L     ++  CE
Sbjct: 147 NLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDE--------SYNLTELDTILFMKQICE 198
Query: 333 VAGAVAYMHSSASIPIFHRDIKSSNILL--DDKFSAKVSDFGISRSI-PNDKTHLTTTIQ 389
               + +MH    + I H D+K  NIL    D    K+ DFG++R   P +K  +     
Sbjct: 199 ---GIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF--- 249
Query: 390 GTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFAR-VEEERNLVACFISLAK 448
           GT  +L PE       +  +D++S GV+   LL+G  P       E   N++AC   L  
Sbjct: 250 GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLED 309
Query: 449 ENQLLEILDARVAKEARE 466
           E    E  D  +++EA+E
Sbjct: 310 E----EFQD--ISEEAKE 321

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 100/218 (45%), Gaps = 38/218 (17%)
Query: 226 QGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLE-T 284
           +G FG V+K  L +   VAVK     DK Q  Q   EV  L  + H +I++ +G     T
Sbjct: 34  RGRFGCVWKAQLLN-EYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGT 91
Query: 285 EVPV---LVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYMH 341
            V V   L+  +   G+LS  +               + +SW     +A  +A  +AY+H
Sbjct: 92  SVDVDLWLITAFHEKGSLSDFL-------------KANVVSWNELCHIAETMARGLAYLH 138
Query: 342 SSASIP---------IFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQ-GT 391
               IP         I HRDIKS N+LL +  +A ++DFG++      K+   T  Q GT
Sbjct: 139 ED--IPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGT 196
Query: 392 FGYLDPEY------FQSSQFTDKSDVYSFGVVLLELLT 423
             Y+ PE       FQ   F  + D+Y+ G+VL EL +
Sbjct: 197 RRYMAPEVLEGAINFQRDAFL-RIDMYAMGLVLWELAS 233

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 92/218 (42%), Gaps = 22/218 (10%)
Query: 216 DNYNQSRFLGQGGFGTVY----KGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINH 271
           ++++  + LG+G FG V     K      ++  +++   I K ++   + E  +L    H
Sbjct: 10  NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 69
Query: 272 RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRV-A 330
             +  L       +    V EY + G L  H+                    E R R   
Sbjct: 70  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFT-------------EERARFYG 116
Query: 331 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQG 390
            E+  A+ Y+HS     + +RDIK  N++LD     K++DFG+ +   +D   +     G
Sbjct: 117 AEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM-KXFCG 172
Query: 391 TFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
           T  YL PE  + + +    D +  GVV+ E++ G+ P 
Sbjct: 173 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 210

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 90/218 (41%), Gaps = 20/218 (9%)
Query: 216 DNYNQSRFLGQGGFGT-VYKGMLPDGSIVAVK---RSKEIDKTQIHQFINEVVILSQINH 271
           +++   + LG+G F T V    L      A+K   +   I + ++     E  ++S+++H
Sbjct: 30  EDFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 272 RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVAC 331
              VKL     + E       Y  +G L  +I              + S           
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK------------IGSFDETCTRFYTA 137
Query: 332 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI-PNDKTHLTTTIQG 390
           E+  A+ Y+H      I HRD+K  NILL++    +++DFG ++ + P  K        G
Sbjct: 138 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 194
Query: 391 TFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
           T  Y+ PE          SD+++ G ++ +L+ G  P 
Sbjct: 195 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 232

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/239 (26%), Positives = 113/239 (47%), Gaps = 25/239 (10%)
Query: 224 LGQGGFGTVYKGM--LPDGSIVAVKRSK-EIDKTQIHQFINEVVILSQINHRHIVKLLGC 280
           LG+G + TVYKG   L D ++VA+K  + E ++      I EV +L  + H +IV L   
Sbjct: 10  LGEGTYATVYKGKSKLTD-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 68
Query: 281 CLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYM 340
               +   LV+EY+    L  ++ D             + ++  N      ++   +AY 
Sbjct: 69  IHTEKSLTLVFEYLDKD-LKQYLDDCG-----------NIINMHNVKLFLFQLLRGLAYC 116
Query: 341 HSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISR--SIPNDKTHLTTTIQGTFGYLDPE 398
           H      + HRD+K  N+L++++   K++DFG++R  SIP  KT+    +  T  Y  P+
Sbjct: 117 HRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT-KTYDNEVV--TLWYRPPD 170
Query: 399 -YFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEIL 456
               S+ ++ + D++  G +  E+ TG+     + VEE+ + +   +    E     IL
Sbjct: 171 ILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGIL 229

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/235 (25%), Positives = 104/235 (44%), Gaps = 34/235 (14%)
Query: 209 DELQ-RATDNYNQSRFL------GQGGFGTVYKGMLPDGSIVAVK---RSKEIDKTQIHQ 258
           +EL+ +A    N  RFL      G+G F TVYKG+  + ++       + +++ K++  +
Sbjct: 12  EELETKAVGXSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQR 71
Query: 259 FINEVVILSQINHRHIVKLLGCCLET----EVPVLVYEYISSGTLSHHIHDHXXXXXXXX 314
           F  E   L  + H +IV+       T    +  VLV E  +SGTL  ++           
Sbjct: 72  FKEEAEXLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKV- 130
Query: 315 XXXLSSLSWENRVRVAC-EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF-SAKVSDFG 372
                       +R  C ++   + ++H+    PI HRD+K  NI +     S K+ D G
Sbjct: 131 ------------LRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLG 177
Query: 373 ISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
           ++      +      + GT  +  PE ++  ++ +  DVY+FG   LE  T + P
Sbjct: 178 LATL---KRASFAKAVIGTPEFXAPEXYE-EKYDESVDVYAFGXCXLEXATSEYP 228

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 92/218 (42%), Gaps = 22/218 (10%)
Query: 216 DNYNQSRFLGQGGFGTVY----KGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINH 271
           ++++  + LG+G FG V     K      ++  +++   I K ++   + E  +L    H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 272 RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRV-A 330
             +  L       +    V EY + G L  H+                    E R R   
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFT-------------EERARFYG 111
Query: 331 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQG 390
            E+  A+ Y+HS     + +RDIK  N++LD     K++DFG+ +   +D   +     G
Sbjct: 112 AEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM-KXFCG 167
Query: 391 TFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
           T  YL PE  + + +    D +  GVV+ E++ G+ P 
Sbjct: 168 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 205

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 93/219 (42%), Gaps = 22/219 (10%)
Query: 215 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK--RSKEIDKTQIHQFINEVVILSQINH 271
           TD Y     LG+G F  V + M +P G   A K   +K++      +   E  I   + H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 272 RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVAC 331
            +IV+L     E     LV++ ++ G L   I                  S  +      
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDI------------VAREYYSEADASHCIQ 110
Query: 332 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDK---FSAKVSDFGISRSIPNDKTHLTTTI 388
           ++  +V + H +    I HRD+K  N+LL  K    + K++DFG++  +  D+       
Sbjct: 111 QILESVNHCHLNG---IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQ-QAWFGF 166
Query: 389 QGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
            GT GYL PE  +   +    D+++ GV+L  LL G  P
Sbjct: 167 AGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPP 205

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 93/219 (42%), Gaps = 22/219 (10%)
Query: 215 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK--RSKEIDKTQIHQFINEVVILSQINH 271
           TD Y     LG+G F  V + M +P G   A K   +K++      +   E  I   + H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 272 RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVAC 331
            +IV+L     E     LV++ ++ G L   I                  S  +      
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDI------------VAREYYSEADASHCIQ 110
Query: 332 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDK---FSAKVSDFGISRSIPNDKTHLTTTI 388
           ++  +V + H +    I HRD+K  N+LL  K    + K++DFG++  +  D+       
Sbjct: 111 QILESVNHCHLNG---IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQ-QAWFGF 166
Query: 389 QGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
            GT GYL PE  +   +    D+++ GV+L  LL G  P
Sbjct: 167 AGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPP 205

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 92/218 (42%), Gaps = 22/218 (10%)
Query: 216 DNYNQSRFLGQGGFGTVY----KGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINH 271
           ++++  + LG+G FG V     K      ++  +++   I K ++   + E  +L    H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 272 RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRV-A 330
             +  L       +    V EY + G L  H+                    E R R   
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFT-------------EERARFYG 111
Query: 331 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQG 390
            E+  A+ Y+HS     + +RDIK  N++LD     K++DFG+ +   +D   +     G
Sbjct: 112 AEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM-KXFCG 167
Query: 391 TFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
           T  YL PE  + + +    D +  GVV+ E++ G+ P 
Sbjct: 168 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 205

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 92/218 (42%), Gaps = 22/218 (10%)
Query: 216 DNYNQSRFLGQGGFGTVY----KGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINH 271
           ++++  + LG+G FG V     K      ++  +++   I K ++   + E  +L    H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 272 RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRV-A 330
             +  L       +    V EY + G L  H+                    E R R   
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFT-------------EERARFYG 111
Query: 331 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQG 390
            E+  A+ Y+HS     + +RDIK  N++LD     K++DFG+ +   +D   +     G
Sbjct: 112 AEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM-KXFCG 167
Query: 391 TFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
           T  YL PE  + + +    D +  GVV+ E++ G+ P 
Sbjct: 168 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 205

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/219 (23%), Positives = 96/219 (43%), Gaps = 25/219 (11%)
Query: 217 NYNQSRFLGQGGFGTVYKGMLPDG----SIVAVKRSKEIDKTQIHQFINEVVILSQINHR 272
           +++  R +G+G +  V    L       ++  VK+    D   I     E  +  Q ++ 
Sbjct: 21  DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNH 80
Query: 273 HIVKLLGCCLETEVPVL-VYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVAC 331
             +  L  C +TE  +  V EY++ G L  H+                 L  E+    + 
Sbjct: 81  PFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ------------RKLPEEHARFYSA 128
Query: 332 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS--IPNDKTHLTTTIQ 389
           E++ A+ Y+H      I +RD+K  N+LLD +   K++D+G+ +    P D T   +   
Sbjct: 129 EISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---SXFC 182
Query: 390 GTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
           GT  Y+ PE  +   +    D ++ GV++ E++ G+ P 
Sbjct: 183 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPF 221

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 92/209 (44%), Gaps = 24/209 (11%)
Query: 224 LGQGGFGTVY--KGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCC 281
           LG G F  V+  K  L  G + A+K  K+    +     NE+ +L +I H +IV L    
Sbjct: 17  LGSGAFSEVFLVKQRL-TGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 282 LETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYMH 341
             T    LV + +S G L   I +                  ++   V  +V  AV Y+H
Sbjct: 76  ESTTHYYLVMQLVSGGELFDRILERGVYTE------------KDASLVIQQVLSAVKYLH 123
Query: 342 SSASIPIFHRDIKSSNILL---DDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPE 398
            +    I HRD+K  N+L    ++     ++DFG+S+    ++  + +T  GT GY+ PE
Sbjct: 124 ENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKM---EQNGIMSTACGTPGYVAPE 177
Query: 399 YFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
                 ++   D +S GV+   LL G  P
Sbjct: 178 VLAQKPYSKAVDCWSIGVITYILLCGYPP 206

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 112/245 (45%), Gaps = 27/245 (11%)
Query: 216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKTQ--IHQFINEVVILSQINHR 272
           +N+ +   +G+G +G VYK      G +VA+K+ +   +T+      I E+ +L ++NH 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 273 HIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACE 332
           +IVKLL          LV+E++           H           L+ +          +
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFL-----------HQDLKKFMDASALTGIPLPLIKSYLFQ 118
Query: 333 VAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS--IP-NDKTHLTTTIQ 389
           +   +A+ HS     + HRD+K  N+L++ + + K++DFG++R+  +P    TH   T+ 
Sbjct: 119 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLW 175
Query: 390 GTFGYLDPEYFQSSQFTDKS-DVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAK 448
               Y  PE     ++   + D++S G +  E++T +    F    E   L   F +L  
Sbjct: 176 ----YRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRRA--LFPGDSEIDQLFRIFRTLGT 229
Query: 449 ENQLL 453
            ++++
Sbjct: 230 PDEVV 234

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 112/245 (45%), Gaps = 27/245 (11%)
Query: 216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKTQ--IHQFINEVVILSQINHR 272
           +N+ +   +G+G +G VYK      G +VA+K+ +   +T+      I E+ +L ++NH 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 273 HIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACE 332
           +IVKLL          LV+E++           H           L+ +          +
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-----------HQDLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 333 VAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS--IP-NDKTHLTTTIQ 389
           +   +A+ HS     + HRD+K  N+L++ + + K++DFG++R+  +P    TH   T+ 
Sbjct: 112 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLW 168
Query: 390 GTFGYLDPEYFQSSQFTDKS-DVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAK 448
               Y  PE     ++   + D++S G +  E++T +    F    E   L   F +L  
Sbjct: 169 ----YRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRRA--LFPGDSEIDQLFRIFRTLGT 222
Query: 449 ENQLL 453
            ++++
Sbjct: 223 PDEVV 227

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 96/220 (43%), Gaps = 28/220 (12%)
Query: 216 DNYNQSRFLGQGGFGTVYKGMLPDGS----IVAVK-RSKEIDKTQIHQFINEVVILSQIN 270
           D Y+    LG G F  V   +L +      +VA+K  +KE  + +     NE+ +L +I 
Sbjct: 18  DIYDFRDVLGTGAFSEV---ILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIK 74
Query: 271 HRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVA 330
           H +IV L           L+ + +S G L   I +                   +  R+ 
Sbjct: 75  HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTE------------RDASRLI 122
Query: 331 CEVAGAVAYMHSSASIPIFHRDIKSSNIL---LDDKFSAKVSDFGISRSIPNDKTHLTTT 387
            +V  AV Y+H    + I HRD+K  N+L   LD+     +SDFG+S+    D   + +T
Sbjct: 123 FQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLST 177
Query: 388 IQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
             GT GY+ PE      ++   D +S GV+   LL G  P
Sbjct: 178 ACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 72/258 (27%), Positives = 108/258 (41%), Gaps = 29/258 (11%)
Query: 224 LGQGGFGTVYKGMLP-DGSIVAVK---RSKEIDKTQIHQFINEVVILSQINHRHIVKLLG 279
           LG G FG V  G     G  VAVK   R K      + +   E+  L    H HI+KL  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 280 CCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAY 339
                    +V EY+S G L  +I  H                 E R R+  ++  AV Y
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKHGRVE-----------EMEAR-RLFQQILSAVDY 126
Query: 340 MHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEY 399
            H      + HRD+K  N+LLD   +AK++DFG+S  + +D   L  +  G+  Y  PE 
Sbjct: 127 CHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMM-SDGEFLRDSC-GSPNYAAPEV 181
Query: 400 FQSSQFTD-KSDVYSFGVVLLELLTGKKPI-------CFARVEEERNLVACFISLAKENQ 451
                +   + D++S GV+L  LL G  P         F ++      +  +++ +    
Sbjct: 182 ISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATL 241
Query: 452 LLEILDARVAKEAREEDI 469
           L+ +L     K A  +DI
Sbjct: 242 LMHMLQVDPLKRATIKDI 259

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 112/245 (45%), Gaps = 27/245 (11%)
Query: 216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKTQ--IHQFINEVVILSQINHR 272
           +N+ +   +G+G +G VYK      G +VA+K+ +   +T+      I E+ +L ++NH 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 273 HIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACE 332
           +IVKLL          LV+E++           H           L+ +          +
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFL-----------HQDLKKFMDASALTGIPLPLIKSYLFQ 118
Query: 333 VAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS--IP-NDKTHLTTTIQ 389
           +   +A+ HS     + HRD+K  N+L++ + + K++DFG++R+  +P    TH   T+ 
Sbjct: 119 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLW 175
Query: 390 GTFGYLDPEYFQSSQFTDKS-DVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAK 448
               Y  PE     ++   + D++S G +  E++T +    F    E   L   F +L  
Sbjct: 176 ----YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA--LFPGDSEIDQLFRIFRTLGT 229
Query: 449 ENQLL 453
            ++++
Sbjct: 230 PDEVV 234

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/186 (25%), Positives = 81/186 (43%), Gaps = 24/186 (12%)
Query: 245 VKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIH 304
           V   ++ID  Q  + + E       NH  +V L  C         V EY++ G L  H+ 
Sbjct: 47  VNDDEDIDWVQTEKHVFE----QASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQ 102
Query: 305 DHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF 364
                           L  E+    + E++ A+ Y+H      I +RD+K  N+LLD + 
Sbjct: 103 RQ------------RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEG 147
Query: 365 SAKVSDFGISRS--IPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELL 422
             K++D+G+ +    P D T   +   GT  Y+ PE  +   +    D ++ GV++ E++
Sbjct: 148 HIKLTDYGMCKEGLRPGDTT---SXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMM 204
Query: 423 TGKKPI 428
            G+ P 
Sbjct: 205 AGRSPF 210

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/219 (23%), Positives = 96/219 (43%), Gaps = 25/219 (11%)
Query: 217 NYNQSRFLGQGGFGTVYKGMLPDG----SIVAVKRSKEIDKTQIHQFINEVVILSQINHR 272
           +++  R +G+G +  V    L       ++  VK+    D   I     E  +  Q ++ 
Sbjct: 6   DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNH 65
Query: 273 HIVKLLGCCLETEVPVL-VYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVAC 331
             +  L  C +TE  +  V EY++ G L  H+                 L  E+    + 
Sbjct: 66  PFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ------------RKLPEEHARFYSA 113
Query: 332 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS--IPNDKTHLTTTIQ 389
           E++ A+ Y+H      I +RD+K  N+LLD +   K++D+G+ +    P D T   +   
Sbjct: 114 EISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---SXFC 167
Query: 390 GTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
           GT  Y+ PE  +   +    D ++ GV++ E++ G+ P 
Sbjct: 168 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPF 206

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 112/245 (45%), Gaps = 27/245 (11%)
Query: 216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKTQ--IHQFINEVVILSQINHR 272
           +N+ +   +G+G +G VYK      G +VA+K+ +   +T+      I E+ +L ++NH 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 273 HIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACE 332
           +IVKLL          LV+E++           H           L+ +          +
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-----------HQDLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 333 VAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS--IP-NDKTHLTTTIQ 389
           +   +A+ HS     + HRD+K  N+L++ + + K++DFG++R+  +P    TH   T+ 
Sbjct: 112 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLW 168
Query: 390 GTFGYLDPEYFQSSQFTDKS-DVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAK 448
               Y  PE     ++   + D++S G +  E++T +    F    E   L   F +L  
Sbjct: 169 ----YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA--LFPGDSEIDQLFRIFRTLGT 222
Query: 449 ENQLL 453
            ++++
Sbjct: 223 PDEVV 227

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/247 (23%), Positives = 113/247 (45%), Gaps = 27/247 (10%)
Query: 214 ATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKTQ--IHQFINEVVILSQIN 270
           + +N+ +   +G+G +G VYK      G +VA+K+ +   +T+      I E+ +L ++N
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 271 HRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVA 330
           H +IVKLL          LV+E++           H           L+ +         
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-----------HQDLKKFMDASALTGIPLPLIKSYL 110
Query: 331 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS--IP-NDKTHLTTT 387
            ++   +A+ HS     + HRD+K  N+L++ + + K++DFG++R+  +P    TH   T
Sbjct: 111 FQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVT 167
Query: 388 IQGTFGYLDPEYFQSSQFTDKS-DVYSFGVVLLELLTGKKPICFARVEEERNLVACFISL 446
           +     Y  PE     ++   + D++S G +  E++T +    F    E   L   F +L
Sbjct: 168 LW----YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA--LFPGDSEIDQLFRIFRTL 221
Query: 447 AKENQLL 453
              ++++
Sbjct: 222 GTPDEVV 228

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 112/245 (45%), Gaps = 27/245 (11%)
Query: 216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKTQ--IHQFINEVVILSQINHR 272
           +N+ +   +G+G +G VYK      G +VA+K+ +   +T+      I E+ +L ++NH 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 273 HIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACE 332
           +IVKLL          LV+E++           H           L+ +          +
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-----------HQDLKKFMDASALTGIPLPLIKSYLFQ 110
Query: 333 VAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS--IP-NDKTHLTTTIQ 389
           +   +A+ HS     + HRD+K  N+L++ + + K++DFG++R+  +P    TH   T+ 
Sbjct: 111 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLW 167
Query: 390 GTFGYLDPEYFQSSQFTDKS-DVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAK 448
               Y  PE     ++   + D++S G +  E++T +    F    E   L   F +L  
Sbjct: 168 ----YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA--LFPGDSEIDQLFRIFRTLGT 221
Query: 449 ENQLL 453
            ++++
Sbjct: 222 PDEVV 226

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 96/220 (43%), Gaps = 28/220 (12%)
Query: 216 DNYNQSRFLGQGGFGTVYKGMLPDGS----IVAVK-RSKEIDKTQIHQFINEVVILSQIN 270
           D Y+    LG G F  V   +L +      +VA+K  +KE  + +     NE+ +L +I 
Sbjct: 18  DIYDFRDVLGTGAFSEV---ILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIK 74
Query: 271 HRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVA 330
           H +IV L           L+ + +S G L   I +                   +  R+ 
Sbjct: 75  HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTE------------RDASRLI 122
Query: 331 CEVAGAVAYMHSSASIPIFHRDIKSSNIL---LDDKFSAKVSDFGISRSIPNDKTHLTTT 387
            +V  AV Y+H    + I HRD+K  N+L   LD+     +SDFG+S+    D   + +T
Sbjct: 123 FQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLST 177
Query: 388 IQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
             GT GY+ PE      ++   D +S GV+   LL G  P
Sbjct: 178 ACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 112/245 (45%), Gaps = 27/245 (11%)
Query: 216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKTQ--IHQFINEVVILSQINHR 272
           +N+ +   +G+G +G VYK      G +VA+K+ +   +T+      I E+ +L ++NH 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 273 HIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACE 332
           +IVKLL          LV+E++           H           L+ +          +
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-----------HQDLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 333 VAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS--IP-NDKTHLTTTIQ 389
           +   +A+ HS     + HRD+K  N+L++ + + K++DFG++R+  +P    TH   T+ 
Sbjct: 112 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLW 168
Query: 390 GTFGYLDPEYFQSSQFTDKS-DVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAK 448
               Y  PE     ++   + D++S G +  E++T +    F    E   L   F +L  
Sbjct: 169 ----YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA--LFPGDSEIDQLFRIFRTLGT 222
Query: 449 ENQLL 453
            ++++
Sbjct: 223 PDEVV 227

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 72/262 (27%), Positives = 106/262 (40%), Gaps = 34/262 (12%)
Query: 224 LGQGGFGTVYKGMLP-DGSIVAVK---RSKEIDKTQIHQFINEVVILSQINHRHIVKLLG 279
           LG G FG V  G     G  VAVK   R K      + +   E+  L    H HI+KL  
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 280 CCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAY 339
                    +V EY+S G L  +I  +              L  +   R+  ++   V Y
Sbjct: 84  VISTPSDIFMVMEYVSGGELFDYICKN------------GRLDEKESRRLFQQILSGVDY 131
Query: 340 MHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEY 399
            H      + HRD+K  N+LLD   +AK++DFG+S  + +D   L  +  G+  Y  PE 
Sbjct: 132 CHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMM-SDGEFLRXSC-GSPNYAAPEV 186
Query: 400 FQSSQFT-DKSDVYSFGVVLLELLTGKKP------------ICFARVEEERNLVACFISL 446
                +   + D++S GV+L  LL G  P            IC       + L    ISL
Sbjct: 187 ISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISL 246
Query: 447 AKENQLLEILDARVAKEAREED 468
            K    ++ +     K+ RE +
Sbjct: 247 LKHMLQVDPMKRATIKDIREHE 268

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 112/245 (45%), Gaps = 27/245 (11%)
Query: 216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKTQ--IHQFINEVVILSQINHR 272
           +N+ +   +G+G +G VYK      G +VA+K+ +   +T+      I E+ +L ++NH 
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 66
Query: 273 HIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACE 332
           +IVKLL          LV+E++           H           L+ +          +
Sbjct: 67  NIVKLLDVIHTENKLYLVFEFL-----------HQDLKKFMDASALTGIPLPLIKSYLFQ 115
Query: 333 VAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS--IP-NDKTHLTTTIQ 389
           +   +A+ HS     + HRD+K  N+L++ + + K++DFG++R+  +P    TH   T+ 
Sbjct: 116 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLW 172
Query: 390 GTFGYLDPEYFQSSQFTDKS-DVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAK 448
               Y  PE     ++   + D++S G +  E++T +    F    E   L   F +L  
Sbjct: 173 ----YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA--LFPGDSEIDQLFRIFRTLGT 226
Query: 449 ENQLL 453
            ++++
Sbjct: 227 PDEVV 231

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/245 (24%), Positives = 111/245 (45%), Gaps = 27/245 (11%)
Query: 216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKTQ--IHQFINEVVILSQINHR 272
           +N+ +   +G+G +G VYK      G +VA+K+ +   +T+      I E+ +L ++NH 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 273 HIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACE 332
           +IVKLL          LV+E           H H           L+ +          +
Sbjct: 62  NIVKLLDVIHTENKLYLVFE-----------HVHQDLKTFMDASALTGIPLPLIKSYLFQ 110
Query: 333 VAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS--IP-NDKTHLTTTIQ 389
           +   +A+ HS     + HRD+K  N+L++ + + K++DFG++R+  +P    TH   T+ 
Sbjct: 111 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLW 167
Query: 390 GTFGYLDPEYFQSSQFTDKS-DVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAK 448
               Y  PE     ++   + D++S G +  E++T +    F    E   L   F +L  
Sbjct: 168 ----YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA--LFPGDSEIDQLFRIFRTLGT 221
Query: 449 ENQLL 453
            ++++
Sbjct: 222 PDEVV 226

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 112/245 (45%), Gaps = 27/245 (11%)
Query: 216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKTQ--IHQFINEVVILSQINHR 272
           +N+ +   +G+G +G VYK      G +VA+K+ +   +T+      I E+ +L ++NH 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 273 HIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACE 332
           +IVKLL          LV+E++           H           L+ +          +
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-----------HQDLKKFMDASALTGIPLPLIKSYLFQ 110
Query: 333 VAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS--IP-NDKTHLTTTIQ 389
           +   +A+ HS     + HRD+K  N+L++ + + K++DFG++R+  +P    TH   T+ 
Sbjct: 111 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLW 167
Query: 390 GTFGYLDPEYFQSSQFTDKS-DVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAK 448
               Y  PE     ++   + D++S G +  E++T +    F    E   L   F +L  
Sbjct: 168 ----YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA--LFPGDSEIDQLFRIFRTLGT 221
Query: 449 ENQLL 453
            ++++
Sbjct: 222 PDEVV 226

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 96/220 (43%), Gaps = 28/220 (12%)
Query: 216 DNYNQSRFLGQGGFGTVYKGMLPDGS----IVAVK-RSKEIDKTQIHQFINEVVILSQIN 270
           D Y+    LG G F  V   +L +      +VA+K  +KE  + +     NE+ +L +I 
Sbjct: 18  DIYDFRDVLGTGAFSEV---ILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIK 74
Query: 271 HRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVA 330
           H +IV L           L+ + +S G L   I +                   +  R+ 
Sbjct: 75  HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTE------------RDASRLI 122
Query: 331 CEVAGAVAYMHSSASIPIFHRDIKSSNIL---LDDKFSAKVSDFGISRSIPNDKTHLTTT 387
            +V  AV Y+H    + I HRD+K  N+L   LD+     +SDFG+S+    D   + +T
Sbjct: 123 FQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLST 177
Query: 388 IQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
             GT GY+ PE      ++   D +S GV+   LL G  P
Sbjct: 178 ACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/246 (23%), Positives = 114/246 (46%), Gaps = 25/246 (10%)
Query: 214 ATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKTQ--IHQFINEVVILSQIN 270
           + +N+ +   +G+G +G VYK      G +VA+K+ +   +T+      I E+ +L ++N
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 271 HRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVA 330
           H +IVKLL          LV+E++           H           L+ +         
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-----------HQDLKKFMDASALTGIPLPLIKSYL 112
Query: 331 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS--IPNDKTHLTTTI 388
            ++   +A+ HS     + HRD+K  N+L++ + + K++DFG++R+  +P  +T+    +
Sbjct: 113 FQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYXHEVV 168
Query: 389 QGTFGYLDPEYFQSSQFTDKS-DVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLA 447
             T  Y  PE     ++   + D++S G +  E++T +    F    E   L   F +L 
Sbjct: 169 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA--LFPGDSEIDQLFRIFRTLG 224
Query: 448 KENQLL 453
             ++++
Sbjct: 225 TPDEVV 230

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/246 (23%), Positives = 114/246 (46%), Gaps = 25/246 (10%)
Query: 214 ATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKTQ--IHQFINEVVILSQIN 270
           + +N+ +   +G+G +G VYK      G +VA+K+ +   +T+      I E+ +L ++N
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 271 HRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVA 330
           H +IVKLL          LV+E++           H           L+ +         
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-----------HQDLKKFMDASALTGIPLPLIKSYL 111
Query: 331 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS--IPNDKTHLTTTI 388
            ++   +A+ HS     + HRD+K  N+L++ + + K++DFG++R+  +P  +T+    +
Sbjct: 112 FQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYXHEVV 167
Query: 389 QGTFGYLDPEYFQSSQFTDKS-DVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLA 447
             T  Y  PE     ++   + D++S G +  E++T +    F    E   L   F +L 
Sbjct: 168 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA--LFPGDSEIDQLFRIFRTLG 223
Query: 448 KENQLL 453
             ++++
Sbjct: 224 TPDEVV 229

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/246 (23%), Positives = 114/246 (46%), Gaps = 25/246 (10%)
Query: 214 ATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKTQ--IHQFINEVVILSQIN 270
           + +N+ +   +G+G +G VYK      G +VA+K+ +   +T+      I E+ +L ++N
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 271 HRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVA 330
           H +IVKLL          LV+E++           H           L+ +         
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-----------HQDLKKFMDASALTGIPLPLIKSYL 112
Query: 331 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS--IPNDKTHLTTTI 388
            ++   +A+ HS     + HRD+K  N+L++ + + K++DFG++R+  +P  +T+    +
Sbjct: 113 FQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYXHEVV 168
Query: 389 QGTFGYLDPEYFQSSQFTDKS-DVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLA 447
             T  Y  PE     ++   + D++S G +  E++T +    F    E   L   F +L 
Sbjct: 169 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA--LFPGDSEIDQLFRIFRTLG 224
Query: 448 KENQLL 453
             ++++
Sbjct: 225 TPDEVV 230

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 100/225 (44%), Gaps = 36/225 (16%)
Query: 215 TDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRS-KEIDKTQIH-----QFINEVVILSQ 268
           ++ Y + + LG G +G V   +L    +  V+R+ K I KT +      + + EV +L  
Sbjct: 36  SEMYQRVKKLGSGAYGEV---LLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKL 92
Query: 269 INHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVR 328
           ++H +I+KL     +     LV E    G L   I              +  + + N V 
Sbjct: 93  LDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEI--------------IHRMKF-NEVD 137
Query: 329 VAC---EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFS---AKVSDFGISRSIPNDKT 382
            A    +V   V Y+H      I HRD+K  N+LL+ K      K+ DFG+S    N K 
Sbjct: 138 AAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK 194
Query: 383 HLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
                  GT  Y+ PE  +  ++ +K DV+S GV+L  LL G  P
Sbjct: 195 MKERL--GTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPP 236

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/246 (23%), Positives = 114/246 (46%), Gaps = 25/246 (10%)
Query: 214 ATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKTQ--IHQFINEVVILSQIN 270
           + +N+ +   +G+G +G VYK      G +VA+K+ +   +T+      I E+ +L ++N
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 271 HRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVA 330
           H +IVKLL          LV+E++           H           L+ +         
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-----------HQDLKKFMDASALTGIPLPLIKSYL 109
Query: 331 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS--IPNDKTHLTTTI 388
            ++   +A+ HS     + HRD+K  N+L++ + + K++DFG++R+  +P  +T+    +
Sbjct: 110 FQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYXHEVV 165
Query: 389 QGTFGYLDPEYFQSSQFTDKS-DVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLA 447
             T  Y  PE     ++   + D++S G +  E++T +    F    E   L   F +L 
Sbjct: 166 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA--LFPGDSEIDQLFRIFRTLG 221
Query: 448 KENQLL 453
             ++++
Sbjct: 222 TPDEVV 227

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/244 (23%), Positives = 113/244 (46%), Gaps = 25/244 (10%)
Query: 216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKTQ--IHQFINEVVILSQINHR 272
           +N+ +   +G+G +G VYK      G +VA+K+ +   +T+      I E+ +L ++NH 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 273 HIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACE 332
           +IVKLL          LV+E++           H           L+ +          +
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-----------HQDLKKFMDASALTGIPLPLIKSYLFQ 110
Query: 333 VAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS--IPNDKTHLTTTIQG 390
           +   +A+ HS     + HRD+K  N+L++ + + K++DFG++R+  +P  +T+    +  
Sbjct: 111 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYXHEVV-- 164
Query: 391 TFGYLDPEYFQSSQFTDKS-DVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKE 449
           T  Y  PE     ++   + D++S G +  E++T +    F    E   L   F +L   
Sbjct: 165 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA--LFPGDSEIDQLFRIFRTLGTP 222
Query: 450 NQLL 453
           ++++
Sbjct: 223 DEVV 226

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/246 (23%), Positives = 114/246 (46%), Gaps = 25/246 (10%)
Query: 214 ATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKTQ--IHQFINEVVILSQIN 270
           + +N+ +   +G+G +G VYK      G +VA+K+ +   +T+      I E+ +L ++N
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 271 HRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVA 330
           H +IVKLL          LV+E++           H           L+ +         
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-----------HQDLKTFMDASALTGIPLPLIKSYL 112
Query: 331 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS--IPNDKTHLTTTI 388
            ++   +A+ HS     + HRD+K  N+L++ + + K++DFG++R+  +P  +T+    +
Sbjct: 113 FQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYXHEVV 168
Query: 389 QGTFGYLDPEYFQSSQFTDKS-DVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLA 447
             T  Y  PE     ++   + D++S G +  E++T +    F    E   L   F +L 
Sbjct: 169 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA--LFPGDSEIDQLFRIFRTLG 224
Query: 448 KENQLL 453
             ++++
Sbjct: 225 TPDEVV 230

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/246 (23%), Positives = 114/246 (46%), Gaps = 25/246 (10%)
Query: 214 ATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKTQ--IHQFINEVVILSQIN 270
           + +N+ +   +G+G +G VYK      G +VA+K+ +   +T+      I E+ +L ++N
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 64
Query: 271 HRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVA 330
           H +IVKLL          LV+E++           H           L+ +         
Sbjct: 65  HPNIVKLLDVIHTENKLYLVFEFL-----------HQDLKKFMDASALTGIPLPLIKSYL 113
Query: 331 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS--IPNDKTHLTTTI 388
            ++   +A+ HS     + HRD+K  N+L++ + + K++DFG++R+  +P  +T+    +
Sbjct: 114 FQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYXHEVV 169
Query: 389 QGTFGYLDPEYFQSSQFTDKS-DVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLA 447
             T  Y  PE     ++   + D++S G +  E++T +    F    E   L   F +L 
Sbjct: 170 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA--LFPGDSEIDQLFRIFRTLG 225
Query: 448 KENQLL 453
             ++++
Sbjct: 226 TPDEVV 231

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/246 (23%), Positives = 114/246 (46%), Gaps = 25/246 (10%)
Query: 214 ATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKTQ--IHQFINEVVILSQIN 270
           + +N+ +   +G+G +G VYK      G +VA+K+ +   +T+      I E+ +L ++N
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 271 HRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVA 330
           H +IVKLL          LV+E++           H           L+ +         
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-----------HQDLKKFMDASALTGIPLPLIKSYL 109
Query: 331 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS--IPNDKTHLTTTI 388
            ++   +A+ HS     + HRD+K  N+L++ + + K++DFG++R+  +P  +T+    +
Sbjct: 110 FQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYXHEVV 165
Query: 389 QGTFGYLDPEYFQSSQFTDKS-DVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLA 447
             T  Y  PE     ++   + D++S G +  E++T +    F    E   L   F +L 
Sbjct: 166 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA--LFPGDSEIDQLFRIFRTLG 221
Query: 448 KENQLL 453
             ++++
Sbjct: 222 TPDEVV 227

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/246 (23%), Positives = 114/246 (46%), Gaps = 25/246 (10%)
Query: 214 ATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKTQ--IHQFINEVVILSQIN 270
           + +N+ +   +G+G +G VYK      G +VA+K+ +   +T+      I E+ +L ++N
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 271 HRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVA 330
           H +IVKLL          LV+E++           H           L+ +         
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-----------HQDLKKFMDASALTGIPLPLIKSYL 110
Query: 331 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS--IPNDKTHLTTTI 388
            ++   +A+ HS     + HRD+K  N+L++ + + K++DFG++R+  +P  +T+    +
Sbjct: 111 FQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYXHEVV 166
Query: 389 QGTFGYLDPEYFQSSQFTDKS-DVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLA 447
             T  Y  PE     ++   + D++S G +  E++T +    F    E   L   F +L 
Sbjct: 167 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA--LFPGDSEIDQLFRIFRTLG 222
Query: 448 KENQLL 453
             ++++
Sbjct: 223 TPDEVV 228

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/246 (23%), Positives = 114/246 (46%), Gaps = 25/246 (10%)
Query: 214 ATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKTQ--IHQFINEVVILSQIN 270
           + +N+ +   +G+G +G VYK      G +VA+K+ +   +T+      I E+ +L ++N
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 271 HRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVA 330
           H +IVKLL          LV+E++           H           L+ +         
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-----------HQDLKKFMDASALTGIPLPLIKSYL 109
Query: 331 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS--IPNDKTHLTTTI 388
            ++   +A+ HS     + HRD+K  N+L++ + + K++DFG++R+  +P  +T+    +
Sbjct: 110 FQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYXHEVV 165
Query: 389 QGTFGYLDPEYFQSSQFTDKS-DVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLA 447
             T  Y  PE     ++   + D++S G +  E++T +    F    E   L   F +L 
Sbjct: 166 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA--LFPGDSEIDQLFRIFRTLG 221
Query: 448 KENQLL 453
             ++++
Sbjct: 222 TPDEVV 227

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/246 (23%), Positives = 114/246 (46%), Gaps = 25/246 (10%)
Query: 214 ATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKTQ--IHQFINEVVILSQIN 270
           + +N+ +   +G+G +G VYK      G +VA+K+ +   +T+      I E+ +L ++N
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 271 HRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVA 330
           H +IVKLL          LV+E++           H           L+ +         
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-----------HQDLKKFMDASALTGIPLPLIKSYL 111
Query: 331 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS--IPNDKTHLTTTI 388
            ++   +A+ HS     + HRD+K  N+L++ + + K++DFG++R+  +P  +T+    +
Sbjct: 112 FQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYXHEVV 167
Query: 389 QGTFGYLDPEYFQSSQFTDKS-DVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLA 447
             T  Y  PE     ++   + D++S G +  E++T +    F    E   L   F +L 
Sbjct: 168 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA--LFPGDSEIDQLFRIFRTLG 223
Query: 448 KENQLL 453
             ++++
Sbjct: 224 TPDEVV 229

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/246 (23%), Positives = 114/246 (46%), Gaps = 25/246 (10%)
Query: 214 ATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKTQ--IHQFINEVVILSQIN 270
           + +N+ +   +G+G +G VYK      G +VA+K+ +   +T+      I E+ +L ++N
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 271 HRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVA 330
           H +IVKLL          LV+E++           H           L+ +         
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-----------HQDLKKFMDASALTGIPLPLIKSYL 109
Query: 331 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS--IPNDKTHLTTTI 388
            ++   +A+ HS     + HRD+K  N+L++ + + K++DFG++R+  +P  +T+    +
Sbjct: 110 FQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYXHEVV 165
Query: 389 QGTFGYLDPEYFQSSQFTDKS-DVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLA 447
             T  Y  PE     ++   + D++S G +  E++T +    F    E   L   F +L 
Sbjct: 166 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA--LFPGDSEIDQLFRIFRTLG 221
Query: 448 KENQLL 453
             ++++
Sbjct: 222 TPDEVV 227

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/246 (23%), Positives = 114/246 (46%), Gaps = 25/246 (10%)
Query: 214 ATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKTQ--IHQFINEVVILSQIN 270
           + +N+ +   +G+G +G VYK      G +VA+K+ +   +T+      I E+ +L ++N
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 271 HRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVA 330
           H +IVKLL          LV+E++           H           L+ +         
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-----------HQDLKKFMDASALTGIPLPLIKSYL 111
Query: 331 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS--IPNDKTHLTTTI 388
            ++   +A+ HS     + HRD+K  N+L++ + + K++DFG++R+  +P  +T+    +
Sbjct: 112 FQLLQGLAFCHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPV-RTYXHEVV 167
Query: 389 QGTFGYLDPEYFQSSQFTDKS-DVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLA 447
             T  Y  PE     ++   + D++S G +  E++T +    F    E   L   F +L 
Sbjct: 168 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA--LFPGDSEIDQLFRIFRTLG 223
Query: 448 KENQLL 453
             ++++
Sbjct: 224 TPDEVV 229

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/246 (23%), Positives = 114/246 (46%), Gaps = 25/246 (10%)
Query: 214 ATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKTQ--IHQFINEVVILSQIN 270
           + +N+ +   +G+G +G VYK      G +VA+K+ +   +T+      I E+ +L ++N
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 271 HRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVA 330
           H +IVKLL          LV+E++           H           L+ +         
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-----------HQDLKKFMDASALTGIPLPLIKSYL 110
Query: 331 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS--IPNDKTHLTTTI 388
            ++   +A+ HS     + HRD+K  N+L++ + + K++DFG++R+  +P  +T+    +
Sbjct: 111 FQLLQGLAFCHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPV-RTYXHEVV 166
Query: 389 QGTFGYLDPEYFQSSQFTDKS-DVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLA 447
             T  Y  PE     ++   + D++S G +  E++T +    F    E   L   F +L 
Sbjct: 167 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA--LFPGDSEIDQLFRIFRTLG 222
Query: 448 KENQLL 453
             ++++
Sbjct: 223 TPDEVV 228

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/244 (23%), Positives = 113/244 (46%), Gaps = 25/244 (10%)
Query: 216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKTQ--IHQFINEVVILSQINHR 272
           +N+ +   +G+G +G VYK      G +VA+K+ +   +T+      I E+ +L ++NH 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 273 HIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACE 332
           +IVKLL          LV+E++           H           L+ +          +
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFL-----------HQDLKKFMDASALTGIPLPLIKSYLFQ 112
Query: 333 VAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS--IPNDKTHLTTTIQG 390
           +   +A+ HS     + HRD+K  N+L++ + + K++DFG++R+  +P  +T+    +  
Sbjct: 113 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYXHEVV-- 166
Query: 391 TFGYLDPEYFQSSQFTDKS-DVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKE 449
           T  Y  PE     ++   + D++S G +  E++T +    F    E   L   F +L   
Sbjct: 167 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA--LFPGDSEIDQLFRIFRTLGTP 224
Query: 450 NQLL 453
           ++++
Sbjct: 225 DEVV 228

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/244 (23%), Positives = 113/244 (46%), Gaps = 25/244 (10%)
Query: 216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKTQ--IHQFINEVVILSQINHR 272
           +N+ +   +G+G +G VYK      G +VA+K+ +   +T+      I E+ +L ++NH 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 273 HIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACE 332
           +IVKLL          LV+E++           H           L+ +          +
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-----------HQDLKKFMDASALTGIPLPLIKSYLFQ 110
Query: 333 VAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS--IPNDKTHLTTTIQG 390
           +   +A+ HS     + HRD+K  N+L++ + + K++DFG++R+  +P  +T+    +  
Sbjct: 111 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYXHEVV-- 164
Query: 391 TFGYLDPEYFQSSQFTDKS-DVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKE 449
           T  Y  PE     ++   + D++S G +  E++T +    F    E   L   F +L   
Sbjct: 165 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA--LFPGDSEIDQLFRIFRTLGTP 222
Query: 450 NQLL 453
           ++++
Sbjct: 223 DEVV 226

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/246 (23%), Positives = 114/246 (46%), Gaps = 25/246 (10%)
Query: 214 ATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKTQ--IHQFINEVVILSQIN 270
           + +N+ +   +G+G +G VYK      G +VA+K+ +   +T+      I E+ +L ++N
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 271 HRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVA 330
           H +IVKLL          LV+E++           H           L+ +         
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-----------HQDLKDFMDASALTGIPLPLIKSYL 109
Query: 331 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS--IPNDKTHLTTTI 388
            ++   +A+ HS     + HRD+K  N+L++ + + K++DFG++R+  +P  +T+    +
Sbjct: 110 FQLLQGLAFCHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPV-RTYXHEVV 165
Query: 389 QGTFGYLDPEYFQSSQFTDKS-DVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLA 447
             T  Y  PE     ++   + D++S G +  E++T +    F    E   L   F +L 
Sbjct: 166 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA--LFPGDSEIDQLFRIFRTLG 221
Query: 448 KENQLL 453
             ++++
Sbjct: 222 TPDEVV 227

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/236 (25%), Positives = 101/236 (42%), Gaps = 48/236 (20%)
Query: 216 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVI--LSQINHRH 273
           DN      +G+G +G VYKG L D   VAVK     ++     FINE  I  +  + H +
Sbjct: 13  DNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDN 68
Query: 274 IVKLLGCCLETEVP-----VLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVR 328
           I + +              +LV EY  +G+L  ++  H                W +  R
Sbjct: 69  IARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTS-------------DWVSSCR 115
Query: 329 VACEVAGAVAYMHSSASIP--------IFHRDIKSSNILLDDKFSAKVSDFGISRSI--- 377
           +A  V   +AY+H+   +P        I HRD+ S N+L+ +  +  +SDFG+S  +   
Sbjct: 116 LAHSVTRGLAYLHTE--LPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173
Query: 378 ----PNDKTHLTTTIQGTFGYLDPEYFQSS-------QFTDKSDVYSFGVVLLELL 422
               P ++ +   +  GT  Y+ PE  + +           + D+Y+ G++  E+ 
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 94/224 (41%), Gaps = 22/224 (9%)
Query: 211 LQRATDN-YNQSRFLGQGGFGTVY----KGMLPDGSIVAVKRSKEIDKTQIHQFINEVVI 265
           + R T N +   + LG+G FG V     K      ++  +K+   + K ++   + E  +
Sbjct: 3   MARVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRV 62
Query: 266 LSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWEN 325
           L    H  +  L       +    V EY + G L  H+                    E+
Sbjct: 63  LQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFS-------------ED 109
Query: 326 RVRV-ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHL 384
           R R    E+  A+ Y+HS  ++   +RD+K  N++LD     K++DFG+ +    D   +
Sbjct: 110 RARFYGAEIVSALDYLHSEKNV--VYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM 167
Query: 385 TTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
                GT  YL PE  + + +    D +  GVV+ E++ G+ P 
Sbjct: 168 KX-FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 210

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 70/305 (22%), Positives = 123/305 (40%), Gaps = 34/305 (11%)
Query: 211 LQRATDNYNQSRFLGQGGFGTV----YKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVIL 266
           LQ   ++Y+  + +G+G FG V    +K      ++  + + + I ++    F  E  I+
Sbjct: 70  LQMKAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIM 129
Query: 267 SQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENR 326
           +  N   +V+L     + +   +V EY+  G L + + ++                W   
Sbjct: 130 AFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPE-----------KWAKF 178
Query: 327 VRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTT 386
                EV  A+  +HS   I   HRD+K  N+LLD     K++DFG    +         
Sbjct: 179 Y--TAEVVLALDAIHSMGLI---HRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCD 233
Query: 387 TIQGTFGYLDPEYFQS----SQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVAC 442
           T  GT  Y+ PE  +S      +  + D +S GV L E+L G  P          +LV  
Sbjct: 234 TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFY------ADSLVGT 287
Query: 443 FISLAK-ENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNS---KKRPTMKQVSMELE 498
           +  +   +N L    DA ++K A+      + +  +R  R      K+ P  K      +
Sbjct: 288 YSKIMDHKNSLCFPEDAEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQWNWD 347
Query: 499 GLRRS 503
            +R +
Sbjct: 348 NIRET 352

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 57/245 (23%), Positives = 112/245 (45%), Gaps = 27/245 (11%)
Query: 216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKTQ--IHQFINEVVILSQINHR 272
           +N+ +   +G+G +G VYK      G +VA+K+ +   +T+      I E+ +L ++NH 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 273 HIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACE 332
           +IVKLL          LV+E++           H           L+ +          +
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-----------HQDLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 333 VAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS--IP-NDKTHLTTTIQ 389
           +   +++ HS     + HRD+K  N+L++ + + K++DFG++R+  +P    TH   T+ 
Sbjct: 112 LLQGLSFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLW 168
Query: 390 GTFGYLDPEYFQSSQFTDKS-DVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAK 448
               Y  PE     ++   + D++S G +  E++T +    F    E   L   F +L  
Sbjct: 169 ----YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA--LFPGDSEIDQLFRIFRTLGT 222
Query: 449 ENQLL 453
            ++++
Sbjct: 223 PDEVV 227

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/246 (23%), Positives = 116/246 (47%), Gaps = 25/246 (10%)
Query: 214 ATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKTQ--IHQFINEVVILSQIN 270
           + +N+ +   +G+G +G VYK      G +VA+K+ +   +T+      I E+ +L ++N
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 271 HRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVA 330
           H +IVKLL          LV+E+     LS  + D            L+ +         
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEF-----LSMDLKDFMDASA------LTGIPLPLIKSYL 112
Query: 331 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS--IPNDKTHLTTTI 388
            ++   +A+ HS     + HRD+K  N+L++ + + K++DFG++R+  +P  +T+    +
Sbjct: 113 FQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYXHEVV 168
Query: 389 QGTFGYLDPEYFQSSQFTDKS-DVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLA 447
             T  Y  PE     ++   + D++S G +  E++T +    F    E   L   F +L 
Sbjct: 169 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA--LFPGDSEIDQLFRIFRTLG 224
Query: 448 KENQLL 453
             ++++
Sbjct: 225 TPDEVV 230

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 57/246 (23%), Positives = 114/246 (46%), Gaps = 25/246 (10%)
Query: 214 ATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKTQ--IHQFINEVVILSQIN 270
           + +N+ +   +G+G +G VYK      G +VA+K+ +   +T+      I E+ +L ++N
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 271 HRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVA 330
           H +IVKLL          LV+E++S                      L+ +         
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLS-----------MDLKKFMDASALTGIPLPLIKSYL 112
Query: 331 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS--IPNDKTHLTTTI 388
            ++   +A+ HS     + HRD+K  N+L++ + + K++DFG++R+  +P  +T+    +
Sbjct: 113 FQLLQGLAFCHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPV-RTYXHEVV 168
Query: 389 QGTFGYLDPEYFQSSQFTDKS-DVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLA 447
             T  Y  PE     ++   + D++S G +  E++T +    F    E   L   F +L 
Sbjct: 169 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA--LFPGDSEIDQLFRIFRTLG 224
Query: 448 KENQLL 453
             ++++
Sbjct: 225 TPDEVV 230

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/246 (23%), Positives = 116/246 (47%), Gaps = 25/246 (10%)
Query: 214 ATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKTQ--IHQFINEVVILSQIN 270
           + +N+ +   +G+G +G VYK      G +VA+K+ +   +T+      I E+ +L ++N
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 271 HRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVA 330
           H +IVKLL          LV+E+     LS  + D            L+ +         
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEF-----LSMDLKDFMDASA------LTGIPLPLIKSYL 111
Query: 331 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS--IPNDKTHLTTTI 388
            ++   +A+ HS     + HRD+K  N+L++ + + K++DFG++R+  +P  +T+    +
Sbjct: 112 FQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYXHEVV 167
Query: 389 QGTFGYLDPEYFQSSQFTDKS-DVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLA 447
             T  Y  PE     ++   + D++S G +  E++T +    F    E   L   F +L 
Sbjct: 168 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA--LFPGDSEIDQLFRIFRTLG 223
Query: 448 KENQLL 453
             ++++
Sbjct: 224 TPDEVV 229

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 57/246 (23%), Positives = 114/246 (46%), Gaps = 25/246 (10%)
Query: 214 ATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKTQ--IHQFINEVVILSQIN 270
           + +N+ +   +G+G +G VYK      G +VA+K+ +   +T+      I E+ +L ++N
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 271 HRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVA 330
           H +IVKLL          LV+E++S                      L+ +         
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLS-----------MDLKKFMDASALTGIPLPLIKSYL 110
Query: 331 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS--IPNDKTHLTTTI 388
            ++   +A+ HS     + HRD+K  N+L++ + + K++DFG++R+  +P  +T+    +
Sbjct: 111 FQLLQGLAFCHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPV-RTYXHEVV 166
Query: 389 QGTFGYLDPEYFQSSQFTDKS-DVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLA 447
             T  Y  PE     ++   + D++S G +  E++T +    F    E   L   F +L 
Sbjct: 167 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA--LFPGDSEIDQLFRIFRTLG 222
Query: 448 KENQLL 453
             ++++
Sbjct: 223 TPDEVV 228

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 89/212 (41%), Gaps = 21/212 (9%)
Query: 222 RFLGQGGFGTVY----KGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKL 277
           + LG+G FG V     K      ++  +K+   + K ++   + E  +L    H  +  L
Sbjct: 16  KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 75
Query: 278 LGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRV-ACEVAGA 336
                  +    V EY + G L  H+                    E+R R    E+  A
Sbjct: 76  KYSFQTHDRLCFVMEYANGGELFFHLSRERVFS-------------EDRARFYGAEIVSA 122
Query: 337 VAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLD 396
           + Y+HS  ++   +RD+K  N++LD     K++DFG+ +    D   +     GT  YL 
Sbjct: 123 LDYLHSEKNV--VYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKX-FCGTPEYLA 179
Query: 397 PEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
           PE  + + +    D +  GVV+ E++ G+ P 
Sbjct: 180 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 211

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 93/222 (41%), Gaps = 22/222 (9%)
Query: 213 RATDN-YNQSRFLGQGGFGTVY----KGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILS 267
           R T N +   + LG+G FG V     K      ++  +K+   + K ++   + E  +L 
Sbjct: 4   RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ 63
Query: 268 QINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
              H  +  L       +    V EY + G L  H+                    E+R 
Sbjct: 64  NSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFS-------------EDRA 110
Query: 328 RV-ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTT 386
           R    E+  A+ Y+HS  ++   +RD+K  N++LD     K++DFG+ +    D   +  
Sbjct: 111 RFYGAEIVSALDYLHSEKNV--VYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKX 168
Query: 387 TIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
              GT  YL PE  + + +    D +  GVV+ E++ G+ P 
Sbjct: 169 -FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 209

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 75/170 (44%), Gaps = 20/170 (11%)
Query: 261 NEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSS 320
           NE+ +L +I H +IV L           L+ + +S G L   I +               
Sbjct: 65  NEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTE--------- 115
Query: 321 LSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNIL---LDDKFSAKVSDFGISRSI 377
               +  R+  +V  AV Y+H    + I HRD+K  N+L   LD+     +SDFG+S+  
Sbjct: 116 ---RDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM- 168
Query: 378 PNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
             D   + +T  GT GY+ PE      ++   D +S GV+   LL G  P
Sbjct: 169 -EDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 105/224 (46%), Gaps = 27/224 (12%)
Query: 208 ADELQRATDNYNQSRFLGQGGFGTVYKGMLPD-GSIVAVKRSKEIDKTQIHQFIN----- 261
           A +++     Y +  FLG+G F TVYK    +   IVA+K+ K   +++    IN     
Sbjct: 2   ALDVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALR 61
Query: 262 EVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSL 321
           E+ +L +++H +I+ LL          LV++++ +  L   I D+              +
Sbjct: 62  EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLM 120
Query: 322 SWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI--PN 379
           + +            + Y+H      I HRD+K +N+LLD+    K++DFG+++S   PN
Sbjct: 121 TLQ-----------GLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 166
Query: 380 DKTHLTTTIQGTFGYLDPE-YFQSSQFTDKSDVYSFGVVLLELL 422
            + +    +  T  Y  PE  F +  +    D+++ G +L ELL
Sbjct: 167 -RAYXHQVV--TRWYRAPELLFGARMYGVGVDMWAVGCILAELL 207

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 103/219 (47%), Gaps = 29/219 (13%)
Query: 217 NYNQSRFLGQGGFGTVYKGMLPD-GSIVAVKRSKEIDKTQIHQFIN-EVVILSQINHRHI 274
           +Y  ++ +G G FG VY+  L D G +VA+K+       Q  +F N E+ I+ +++H +I
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-----LQDKRFKNRELQIMRKLDHCNI 75
Query: 275 VKLLGCCLET-----EVPV-LVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVR 328
           V+L      +     EV + LV +Y+      + +  H              L      R
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETV--YRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLD-DKFSAKVSDFGISRSIPNDKTHLTTT 387
                  ++AY+HS     I HRDIK  N+LLD D    K+ DFG ++ +   + +++  
Sbjct: 134 -------SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXI 183
Query: 388 IQGTFGYLDPEY-FQSSQFTDKSDVYSFGVVLLELLTGK 425
                 Y  PE  F ++ +T   DV+S G VL ELL G+
Sbjct: 184 CSRY--YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/245 (23%), Positives = 111/245 (45%), Gaps = 27/245 (11%)
Query: 216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKTQ--IHQFINEVVILSQINHR 272
           +N+ +   +G+G +G VYK      G +VA+ + +   +T+      I E+ +L ++NH 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 273 HIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACE 332
           +IVKLL          LV+E++           H           L+ +          +
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-----------HQDLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 333 VAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS--IP-NDKTHLTTTIQ 389
           +   +A+ HS     + HRD+K  N+L++ + + K++DFG++R+  +P    TH   T+ 
Sbjct: 112 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLW 168
Query: 390 GTFGYLDPEYFQSSQFTDKS-DVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAK 448
               Y  PE     ++   + D++S G +  E++T +    F    E   L   F +L  
Sbjct: 169 ----YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA--LFPGDSEIDQLFRIFRTLGT 222
Query: 449 ENQLL 453
            ++++
Sbjct: 223 PDEVV 227

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/245 (23%), Positives = 111/245 (45%), Gaps = 27/245 (11%)
Query: 216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKTQ--IHQFINEVVILSQINHR 272
           +N+ +   +G+G +G VYK      G +VA+ + +   +T+      I E+ +L ++NH 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 273 HIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACE 332
           +IVKLL          LV+E++           H           L+ +          +
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-----------HQDLKKFMDASALTGIPLPLIKSYLFQ 110
Query: 333 VAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS--IP-NDKTHLTTTIQ 389
           +   +A+ HS     + HRD+K  N+L++ + + K++DFG++R+  +P    TH   T+ 
Sbjct: 111 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLW 167
Query: 390 GTFGYLDPEYFQSSQFTDKS-DVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAK 448
               Y  PE     ++   + D++S G +  E++T +    F    E   L   F +L  
Sbjct: 168 ----YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA--LFPGDSEIDQLFRIFRTLGT 221
Query: 449 ENQLL 453
            ++++
Sbjct: 222 PDEVV 226

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 103/219 (47%), Gaps = 29/219 (13%)
Query: 217 NYNQSRFLGQGGFGTVYKGMLPD-GSIVAVKRSKEIDKTQIHQFIN-EVVILSQINHRHI 274
           +Y  ++ +G G FG VY+  L D G +VA+K+       Q  +F N E+ I+ +++H +I
Sbjct: 25  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-----LQDKRFKNRELQIMRKLDHCNI 79
Query: 275 VKLLGCCLET-----EVPV-LVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVR 328
           V+L      +     EV + LV +Y+      + +  H              L      R
Sbjct: 80  VRLRYFFYSSGEKKDEVYLNLVLDYVPETV--YRVARHYSRAKQTLPVIYVKLYMYQLFR 137
Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLD-DKFSAKVSDFGISRSIPNDKTHLTTT 387
                  ++AY+HS     I HRDIK  N+LLD D    K+ DFG ++ +   + +++  
Sbjct: 138 -------SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXI 187
Query: 388 IQGTFGYLDPEY-FQSSQFTDKSDVYSFGVVLLELLTGK 425
                 Y  PE  F ++ +T   DV+S G VL ELL G+
Sbjct: 188 CSRY--YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 224

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 103/219 (47%), Gaps = 29/219 (13%)
Query: 217 NYNQSRFLGQGGFGTVYKGMLPD-GSIVAVKRSKEIDKTQIHQFIN-EVVILSQINHRHI 274
           +Y  ++ +G G FG VY+  L D G +VA+K+       Q  +F N E+ I+ +++H +I
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-----LQDKRFKNRELQIMRKLDHCNI 87
Query: 275 VKLLGCCLET-----EVPV-LVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVR 328
           V+L      +     EV + LV +Y+      + +  H              L      R
Sbjct: 88  VRLRYFFYSSGEKKDEVYLNLVLDYVPETV--YRVARHYSRAKQTLPVIYVKLYMYQLFR 145
Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLD-DKFSAKVSDFGISRSIPNDKTHLTTT 387
                  ++AY+HS     I HRDIK  N+LLD D    K+ DFG ++ +   + +++  
Sbjct: 146 -------SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXI 195
Query: 388 IQGTFGYLDPEY-FQSSQFTDKSDVYSFGVVLLELLTGK 425
                 Y  PE  F ++ +T   DV+S G VL ELL G+
Sbjct: 196 CSRY--YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/266 (24%), Positives = 111/266 (41%), Gaps = 33/266 (12%)
Query: 210 ELQRATDNYNQSRFLGQGGFGTV----YKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVI 265
           +L+   ++Y   + +G+G FG V    +K      ++  + + + I ++    F  E  I
Sbjct: 63  DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDI 122
Query: 266 LSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWEN 325
           ++  N   +V+L     +     +V EY+  G L + + ++                 E 
Sbjct: 123 MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVP--------------EK 168
Query: 326 RVRV-ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHL 384
             R    EV  A+  +HS   I   HRD+K  N+LLD     K++DFG    +  +    
Sbjct: 169 WARFYTAEVVLALDAIHSMGFI---HRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR 225
Query: 385 TTTIQGTFGYLDPEYFQS----SQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLV 440
             T  GT  Y+ PE  +S      +  + D +S GV L E+L G  P          +LV
Sbjct: 226 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY------ADSLV 279
Query: 441 ACFISLAK-ENQLLEILDARVAKEAR 465
             +  +   +N L    D  ++KEA+
Sbjct: 280 GTYSKIMNHKNSLTFPDDNDISKEAK 305

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/266 (24%), Positives = 111/266 (41%), Gaps = 33/266 (12%)
Query: 210 ELQRATDNYNQSRFLGQGGFGTV----YKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVI 265
           +L+   ++Y   + +G+G FG V    +K      ++  + + + I ++    F  E  I
Sbjct: 68  DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDI 127
Query: 266 LSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWEN 325
           ++  N   +V+L     +     +V EY+  G L + + ++                 E 
Sbjct: 128 MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVP--------------EK 173
Query: 326 RVRV-ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHL 384
             R    EV  A+  +HS   I   HRD+K  N+LLD     K++DFG    +  +    
Sbjct: 174 WARFYTAEVVLALDAIHSMGFI---HRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR 230
Query: 385 TTTIQGTFGYLDPEYFQS----SQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLV 440
             T  GT  Y+ PE  +S      +  + D +S GV L E+L G  P          +LV
Sbjct: 231 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY------ADSLV 284
Query: 441 ACFISLAK-ENQLLEILDARVAKEAR 465
             +  +   +N L    D  ++KEA+
Sbjct: 285 GTYSKIMNHKNSLTFPDDNDISKEAK 310

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 83/182 (45%), Gaps = 20/182 (10%)
Query: 321 LSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPND 380
           L+ E+ +  + +VA  + ++ S   I   HRD+ + NILL +K   K+ DFG++R I  D
Sbjct: 190 LTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILLSEKNVVKICDFGLARDIYKD 246
Query: 381 KTHLTT-TIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERN 438
             ++     +    ++ PE      +T +SDV+SFGV+L E+ + G  P    +++EE  
Sbjct: 247 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-- 304
Query: 439 LVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELE 498
               F    KE   +   D    +         M +  + C      +RPT  ++   L 
Sbjct: 305 ----FCRRLKEGTRMRAPDYTTPE---------MYQTMLDCWHGEPSQRPTFSELVEHLG 351
Query: 499 GL 500
            L
Sbjct: 352 NL 353

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 103/219 (47%), Gaps = 29/219 (13%)
Query: 217 NYNQSRFLGQGGFGTVYKGMLPD-GSIVAVKRSKEIDKTQIHQFIN-EVVILSQINHRHI 274
           +Y  ++ +G G FG VY+  L D G +VA+K+       Q  +F N E+ I+ +++H +I
Sbjct: 22  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-----LQDKRFKNRELQIMRKLDHCNI 76
Query: 275 VKLLGCCLET-----EVPV-LVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVR 328
           V+L      +     EV + LV +Y+      + +  H              L      R
Sbjct: 77  VRLRYFFYSSGEKKDEVYLNLVLDYVPETV--YRVARHYSRAKQTLPVIYVKLYMYQLFR 134
Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLD-DKFSAKVSDFGISRSIPNDKTHLTTT 387
                  ++AY+HS     I HRDIK  N+LLD D    K+ DFG ++ +   + +++  
Sbjct: 135 -------SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXI 184
Query: 388 IQGTFGYLDPEY-FQSSQFTDKSDVYSFGVVLLELLTGK 425
                 Y  PE  F ++ +T   DV+S G VL ELL G+
Sbjct: 185 CSRY--YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 221

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/266 (24%), Positives = 111/266 (41%), Gaps = 33/266 (12%)
Query: 210 ELQRATDNYNQSRFLGQGGFGTV----YKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVI 265
           +L+   ++Y   + +G+G FG V    +K      ++  + + + I ++    F  E  I
Sbjct: 68  DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDI 127
Query: 266 LSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWEN 325
           ++  N   +V+L     +     +V EY+  G L + + ++                 E 
Sbjct: 128 MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVP--------------EK 173
Query: 326 RVRV-ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHL 384
             R    EV  A+  +HS   I   HRD+K  N+LLD     K++DFG    +  +    
Sbjct: 174 WARFYTAEVVLALDAIHSMGFI---HRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR 230
Query: 385 TTTIQGTFGYLDPEYFQS----SQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLV 440
             T  GT  Y+ PE  +S      +  + D +S GV L E+L G  P          +LV
Sbjct: 231 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY------ADSLV 284
Query: 441 ACFISLAK-ENQLLEILDARVAKEAR 465
             +  +   +N L    D  ++KEA+
Sbjct: 285 GTYSKIMNHKNSLTFPDDNDISKEAK 310

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 83/182 (45%), Gaps = 20/182 (10%)
Query: 321 LSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPND 380
           L+ E+ +  + +VA  + ++ S   I   HRD+ + NILL +K   K+ DFG++R I  D
Sbjct: 197 LTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILLSEKNVVKICDFGLARDIYKD 253
Query: 381 KTHLTT-TIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERN 438
             ++     +    ++ PE      +T +SDV+SFGV+L E+ + G  P    +++EE  
Sbjct: 254 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-- 311
Query: 439 LVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELE 498
               F    KE   +   D    +         M +  + C      +RPT  ++   L 
Sbjct: 312 ----FCRRLKEGTRMRAPDYTTPE---------MYQTMLDCWHGEPSQRPTFSELVEHLG 358
Query: 499 GL 500
            L
Sbjct: 359 NL 360

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 83/182 (45%), Gaps = 20/182 (10%)
Query: 321 LSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPND 380
           L+ E+ +  + +VA  + ++ S   I   HRD+ + NILL +K   K+ DFG++R I  D
Sbjct: 195 LTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILLSEKNVVKICDFGLARDIYKD 251
Query: 381 KTHLTT-TIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERN 438
             ++     +    ++ PE      +T +SDV+SFGV+L E+ + G  P    +++EE  
Sbjct: 252 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-- 309
Query: 439 LVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELE 498
               F    KE   +   D    +         M +  + C      +RPT  ++   L 
Sbjct: 310 ----FCRRLKEGTRMRAPDYTTPE---------MYQTMLDCWHGEPSQRPTFSELVEHLG 356
Query: 499 GL 500
            L
Sbjct: 357 NL 358

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 83/182 (45%), Gaps = 20/182 (10%)
Query: 321 LSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPND 380
           L+ E+ +  + +VA  + ++ S   I   HRD+ + NILL +K   K+ DFG++R I  D
Sbjct: 188 LTLEHLICYSFQVAKGMEFLASRKCI---HRDLAARNILLSEKNVVKICDFGLARDIYKD 244
Query: 381 KTHLTT-TIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERN 438
             ++     +    ++ PE      +T +SDV+SFGV+L E+ + G  P    +++EE  
Sbjct: 245 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-- 302
Query: 439 LVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELE 498
               F    KE   +   D    +         M +  + C      +RPT  ++   L 
Sbjct: 303 ----FCRRLKEGTRMRAPDYTTPE---------MYQTMLDCWHGEPSQRPTFSELVEHLG 349
Query: 499 GL 500
            L
Sbjct: 350 NL 351

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 103/219 (47%), Gaps = 29/219 (13%)
Query: 217 NYNQSRFLGQGGFGTVYKGMLPD-GSIVAVKRSKEIDKTQIHQFIN-EVVILSQINHRHI 274
           +Y  ++ +G G FG VY+  L D G +VA+K+       Q  +F N E+ I+ +++H +I
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-----LQDKRFKNRELQIMRKLDHCNI 75
Query: 275 VKLLGCCLET-----EVPV-LVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVR 328
           V+L      +     EV + LV +Y+      + +  H              L      R
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETV--YRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLD-DKFSAKVSDFGISRSIPNDKTHLTTT 387
                  ++AY+HS     I HRDIK  N+LLD D    K+ DFG ++ +   + +++  
Sbjct: 134 -------SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXI 183
Query: 388 IQGTFGYLDPEY-FQSSQFTDKSDVYSFGVVLLELLTGK 425
                 Y  PE  F ++ +T   DV+S G VL ELL G+
Sbjct: 184 CSRY--YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 103/219 (47%), Gaps = 29/219 (13%)
Query: 217 NYNQSRFLGQGGFGTVYKGMLPD-GSIVAVKRSKEIDKTQIHQFIN-EVVILSQINHRHI 274
           +Y  ++ +G G FG VY+  L D G +VA+K+       Q  +F N E+ I+ +++H +I
Sbjct: 40  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-----LQDKRFKNRELQIMRKLDHCNI 94
Query: 275 VKLLGCCLET-----EVPV-LVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVR 328
           V+L      +     EV + LV +Y+      + +  H              L      R
Sbjct: 95  VRLRYFFYSSGEKKDEVYLNLVLDYVPETV--YRVARHYSRAKQTLPVIYVKLYMYQLFR 152
Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLD-DKFSAKVSDFGISRSIPNDKTHLTTT 387
                  ++AY+HS     I HRDIK  N+LLD D    K+ DFG ++ +   + +++  
Sbjct: 153 -------SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXI 202
Query: 388 IQGTFGYLDPEY-FQSSQFTDKSDVYSFGVVLLELLTGK 425
                 Y  PE  F ++ +T   DV+S G VL ELL G+
Sbjct: 203 CSRY--YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 239

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 95/229 (41%), Gaps = 35/229 (15%)
Query: 211 LQRATDNYNQSRFLGQGGFGTVY----KGMLPDGSIVAVKRSKEIDKTQIHQFINEVVIL 266
            Q  +D Y + + LG G +G V     K    + +I  +K+S     +     ++EV +L
Sbjct: 16  FQGLSDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVL 75
Query: 267 SQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENR 326
            Q++H +I+KL     +     LV E    G L   I                  S  + 
Sbjct: 76  KQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEI------------ILRQKFSEVDA 123
Query: 327 VRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFS---AKVSDFGISRSIPNDKTH 383
             +  +V     Y+H      I HRD+K  N+LL+ K      K+ DFG+S        H
Sbjct: 124 AVIMKQVLSGTTYLHKHN---IVHRDLKPENLLLESKSRDALIKIVDFGLS-------AH 173
Query: 384 LTTTIQ-----GTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
                +     GT  Y+ PE  +  ++ +K DV+S GV+L  LL G  P
Sbjct: 174 FEVGGKMKERLGTAYYIAPEVLR-KKYDEKCDVWSCGVILYILLCGYPP 221

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 103/219 (47%), Gaps = 29/219 (13%)
Query: 217 NYNQSRFLGQGGFGTVYKGMLPD-GSIVAVKRSKEIDKTQIHQFIN-EVVILSQINHRHI 274
           +Y  ++ +G G FG VY+  L D G +VA+K+       Q  +F N E+ I+ +++H +I
Sbjct: 29  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-----LQDKRFKNRELQIMRKLDHCNI 83
Query: 275 VKLLGCCLET-----EVPV-LVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVR 328
           V+L      +     EV + LV +Y+      + +  H              L      R
Sbjct: 84  VRLRYFFYSSGEKKDEVYLNLVLDYVPETV--YRVARHYSRAKQTLPVIYVKLYMYQLFR 141
Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLD-DKFSAKVSDFGISRSIPNDKTHLTTT 387
                  ++AY+HS     I HRDIK  N+LLD D    K+ DFG ++ +   + +++  
Sbjct: 142 -------SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXI 191
Query: 388 IQGTFGYLDPEY-FQSSQFTDKSDVYSFGVVLLELLTGK 425
                 Y  PE  F ++ +T   DV+S G VL ELL G+
Sbjct: 192 CSRY--YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 228

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 101/219 (46%), Gaps = 29/219 (13%)
Query: 217 NYNQSRFLGQGGFGTVYKGMLPD-GSIVAVKRSKEIDKTQIHQFIN-EVVILSQINHRHI 274
           +Y  ++ +G G FG VY+  L D G +VA+K+       Q  +F N E+ I+ +++H +I
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-----LQDKRFKNRELQIMRKLDHCNI 75
Query: 275 VKLL------GCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVR 328
           V+L       G   +     LV +Y+      + +  H              L      R
Sbjct: 76  VRLRYFFYSSGEKKDVVYLNLVLDYVPETV--YRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLD-DKFSAKVSDFGISRSIPNDKTHLTTT 387
                  ++AY+HS     I HRDIK  N+LLD D    K+ DFG ++ +   + +++  
Sbjct: 134 -------SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXI 183
Query: 388 IQGTFGYLDPEY-FQSSQFTDKSDVYSFGVVLLELLTGK 425
                 Y  PE  F ++ +T   DV+S G VL ELL G+
Sbjct: 184 CSRY--YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 103/219 (47%), Gaps = 29/219 (13%)
Query: 217 NYNQSRFLGQGGFGTVYKGMLPD-GSIVAVKRSKEIDKTQIHQFIN-EVVILSQINHRHI 274
           +Y  ++ +G G FG VY+  L D G +VA+K+       Q   F N E+ I+ +++H +I
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-----LQGKAFKNRELQIMRKLDHCNI 75
Query: 275 VKLLGCCLET-----EVPV-LVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVR 328
           V+L      +     EV + LV +Y+ +    + +  H              L      R
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPATV--YRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLD-DKFSAKVSDFGISRSIPNDKTHLTTT 387
                  ++AY+HS     I HRDIK  N+LLD D    K+ DFG ++ +   + +++  
Sbjct: 134 -------SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXI 183
Query: 388 IQGTFGYLDPEY-FQSSQFTDKSDVYSFGVVLLELLTGK 425
                 Y  PE  F ++ +T   DV+S G VL ELL G+
Sbjct: 184 CSRY--YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 103/219 (47%), Gaps = 29/219 (13%)
Query: 217 NYNQSRFLGQGGFGTVYKGMLPD-GSIVAVKRSKEIDKTQIHQFIN-EVVILSQINHRHI 274
           +Y  ++ +G G FG VY+  L D G +VA+K+       Q  +F N E+ I+ +++H +I
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-----LQDKRFKNRELQIMRKLDHCNI 87
Query: 275 VKLLGCCLET-----EVPV-LVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVR 328
           V+L      +     EV + LV +Y+      + +  H              L      R
Sbjct: 88  VRLRYFFYSSGEKKDEVYLNLVLDYVPETV--YRVARHYSRAKQTLPVIYVKLYMYQLFR 145
Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLD-DKFSAKVSDFGISRSIPNDKTHLTTT 387
                  ++AY+HS     I HRDIK  N+LLD D    K+ DFG ++ +   + +++  
Sbjct: 146 -------SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXI 195
Query: 388 IQGTFGYLDPEY-FQSSQFTDKSDVYSFGVVLLELLTGK 425
                 Y  PE  F ++ +T   DV+S G VL ELL G+
Sbjct: 196 CSRY--YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 102/219 (46%), Gaps = 29/219 (13%)
Query: 217 NYNQSRFLGQGGFGTVYKGMLPD-GSIVAVKRSKEIDKTQIHQFIN-EVVILSQINHRHI 274
           +Y  ++ +G G FG VY+  L D G +VA+K+       Q  +F N E+ I+ +++H +I
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-----LQDKRFKNRELQIMRKLDHCNI 109
Query: 275 VKL---LGCCLETEVPV---LVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVR 328
           V+L        E +  V   LV +Y+      + +  H              L      R
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDYVPETV--YRVARHYSRAKQTLPVIYVKLYMYQLFR 167
Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLD-DKFSAKVSDFGISRSIPNDKTHLTTT 387
                  ++AY+HS     I HRDIK  N+LLD D    K+ DFG ++ +   + +++  
Sbjct: 168 -------SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXI 217
Query: 388 IQGTFGYLDPEY-FQSSQFTDKSDVYSFGVVLLELLTGK 425
                 Y  PE  F ++ +T   DV+S G VL ELL G+
Sbjct: 218 CSRY--YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 90/209 (43%), Gaps = 22/209 (10%)
Query: 224 LGQGGFG-TVYKGMLPDGSIVAVK-RSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCC 281
           LG G F   V       G + AVK   K+  K +     NE+ +L +I H +IV L    
Sbjct: 30  LGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIVALEDIY 89
Query: 282 LETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYMH 341
                  LV + +S G L     D             S+L     +R   +V  AV Y+H
Sbjct: 90  ESPNHLYLVMQLVSGGEL----FDRIVEKGFYTEKDASTL-----IR---QVLDAVYYLH 137
Query: 342 SSASIPIFHRDIKSSNILL---DDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPE 398
               + I HRD+K  N+L    D++    +SDFG+S+     K  + +T  GT GY+ PE
Sbjct: 138 R---MGIVHRDLKPENLLYYSQDEESKIMISDFGLSKM--EGKGDVMSTACGTPGYVAPE 192
Query: 399 YFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
                 ++   D +S GV+   LL G  P
Sbjct: 193 VLAQKPYSKAVDCWSIGVIAYILLCGYPP 221

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 103/219 (47%), Gaps = 29/219 (13%)
Query: 217 NYNQSRFLGQGGFGTVYKGMLPD-GSIVAVKRSKEIDKTQIHQFIN-EVVILSQINHRHI 274
           +Y  ++ +G G FG VY+  L D G +VA+K+       Q  +F N E+ I+ +++H +I
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-----LQDKRFKNRELQIMRKLDHCNI 75
Query: 275 VKLLGCCLET-----EVPV-LVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVR 328
           V+L      +     EV + LV +Y+      + +  H              L      R
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETV--YRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLD-DKFSAKVSDFGISRSIPNDKTHLTTT 387
                  ++AY+HS     I HRDIK  N+LLD D    K+ DFG ++ +   + +++  
Sbjct: 134 -------SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI 183
Query: 388 IQGTFGYLDPEY-FQSSQFTDKSDVYSFGVVLLELLTGK 425
                 Y  PE  F ++ +T   DV+S G VL ELL G+
Sbjct: 184 CSRY--YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 92/219 (42%), Gaps = 22/219 (10%)
Query: 215 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK--RSKEIDKTQIHQFINEVVILSQINH 271
           TD Y     +G+G F  V + + L  G   A K   +K++      +   E  I   + H
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 272 RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVAC 331
            +IV+L     E     LV++ ++ G L   I                  S  +      
Sbjct: 63  SNIVRLHDSISEEGFHYLVFDLVTGGELFEDI------------VAREYYSEADASHCIQ 110
Query: 332 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDK---FSAKVSDFGISRSIPNDKTHLTTTI 388
           ++  AV + H    + + HRD+K  N+LL  K    + K++DFG++  +  D+       
Sbjct: 111 QILEAVLHCHQ---MGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQ-QAWFGF 166
Query: 389 QGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
            GT GYL PE  +   +    D+++ GV+L  LL G  P
Sbjct: 167 AGTPGYLSPEVLRKEAYGKPVDIWACGVILYILLVGYPP 205

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 103/219 (47%), Gaps = 29/219 (13%)
Query: 217 NYNQSRFLGQGGFGTVYKGMLPD-GSIVAVKRSKEIDKTQIHQFIN-EVVILSQINHRHI 274
           +Y  ++ +G G FG VY+  L D G +VA+K+       Q  +F N E+ I+ +++H +I
Sbjct: 34  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-----LQDKRFKNRELQIMRKLDHCNI 88
Query: 275 VKLLGCCLET-----EVPV-LVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVR 328
           V+L      +     EV + LV +Y+      + +  H              L      R
Sbjct: 89  VRLRYFFYSSGEKKDEVYLNLVLDYVPETV--YRVARHYSRAKQTLPVIYVKLYMYQLFR 146
Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLD-DKFSAKVSDFGISRSIPNDKTHLTTT 387
                  ++AY+HS     I HRDIK  N+LLD D    K+ DFG ++ +   + +++  
Sbjct: 147 -------SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI 196
Query: 388 IQGTFGYLDPEY-FQSSQFTDKSDVYSFGVVLLELLTGK 425
                 Y  PE  F ++ +T   DV+S G VL ELL G+
Sbjct: 197 CSRY--YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 233

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/251 (24%), Positives = 109/251 (43%), Gaps = 30/251 (11%)
Query: 214 ATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKTQIHQF-----INEVVILS 267
           AT  Y     +G G +GTVYK   P  G  VA+K  +  +            + EV +L 
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 268 QIN---HRHIVKLLGCC----LETEVPV-LVYEYISSGTLSHHIHDHXXXXXXXXXXXLS 319
           ++    H ++V+L+  C     + E+ V LV+E++          D            L 
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD--------QDLRTYLDKAPPPGLP 118
Query: 320 SLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPN 379
           + + ++ +R   +    + ++H++    I HRD+K  NIL+    + K++DFG++R I +
Sbjct: 119 AETIKDLMR---QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLAR-IYS 171
Query: 380 DKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNL 439
            +  LT  +  T  Y  PE    S +    D++S G +  E+   K   C     ++   
Sbjct: 172 YQMALTPVVV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGK 230
Query: 440 VACFISLAKEN 450
           +   I L  E+
Sbjct: 231 IFDLIGLPPED 241

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 103/219 (47%), Gaps = 29/219 (13%)
Query: 217 NYNQSRFLGQGGFGTVYKGMLPD-GSIVAVKRSKEIDKTQIHQFIN-EVVILSQINHRHI 274
           +Y  ++ +G G FG VY+  L D G +VA+K+       Q  +F N E+ I+ +++H +I
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-----LQDKRFKNRELQIMRKLDHCNI 109
Query: 275 VKLLGCCLET-----EVPV-LVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVR 328
           V+L      +     EV + LV +Y+      + +  H              L      R
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDYVPETV--YRVARHYSRAKQTLPVIYVKLYMYQLFR 167
Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLD-DKFSAKVSDFGISRSIPNDKTHLTTT 387
                  ++AY+HS     I HRDIK  N+LLD D    K+ DFG ++ +   + +++  
Sbjct: 168 -------SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI 217
Query: 388 IQGTFGYLDPEY-FQSSQFTDKSDVYSFGVVLLELLTGK 425
                 Y  PE  F ++ +T   DV+S G VL ELL G+
Sbjct: 218 CSRY--YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 89/209 (42%), Gaps = 20/209 (9%)
Query: 223 FLGQGGFGTVYKGMLPDGSIV----AVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLL 278
           FLG+GGF   ++    D   V     V +S  +   Q  +   E+ I   + H+H+V   
Sbjct: 28  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 87
Query: 279 GCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVA 338
           G   + +   +V E     +L   +H               +  +  ++ + C+      
Sbjct: 88  GFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEP-----EARYYLRQIVLGCQ------ 135
Query: 339 YMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPE 398
           Y+H +  I   HRD+K  N+ L++    K+ DFG++  +  D      T+ GT  Y+ PE
Sbjct: 136 YLHRNRVI---HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER-KKTLCGTPNYIAPE 191
Query: 399 YFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
                  + + DV+S G ++  LL GK P
Sbjct: 192 VLSKKGHSFEVDVWSIGCIMYTLLVGKPP 220

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/246 (22%), Positives = 113/246 (45%), Gaps = 25/246 (10%)
Query: 214 ATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKTQ--IHQFINEVVILSQIN 270
           + +N+ +   +G+G +G VYK      G +VA+K+ +   +T+      I E+ +L ++N
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 271 HRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVA 330
           H +IVKLL          LV+E++                       L+ +         
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEHVDQD-----------LKKFMDASALTGIPLPLIKSYL 112
Query: 331 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS--IPNDKTHLTTTI 388
            ++   +A+ HS     + HRD+K  N+L++ + + K++DFG++R+  +P  +T+    +
Sbjct: 113 FQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYXHEVV 168
Query: 389 QGTFGYLDPEYFQSSQFTDKS-DVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLA 447
             T  Y  PE     ++   + D++S G +  E++T +    F    E   L   F +L 
Sbjct: 169 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA--LFPGDSEIDQLFRIFRTLG 224
Query: 448 KENQLL 453
             ++++
Sbjct: 225 TPDEVV 230

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 103/219 (47%), Gaps = 29/219 (13%)
Query: 217 NYNQSRFLGQGGFGTVYKGMLPD-GSIVAVKRSKEIDKTQIHQFIN-EVVILSQINHRHI 274
           +Y  ++ +G G FG VY+  L D G +VA+K+       Q  +F N E+ I+ +++H +I
Sbjct: 26  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-----LQDKRFKNRELQIMRKLDHCNI 80
Query: 275 VKLLGCCLET-----EVPV-LVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVR 328
           V+L      +     EV + LV +Y+      + +  H              L      R
Sbjct: 81  VRLRYFFYSSGEKKDEVYLNLVLDYVPETV--YRVARHYSRAKQTLPVIYVKLYMYQLFR 138
Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLD-DKFSAKVSDFGISRSIPNDKTHLTTT 387
                  ++AY+HS     I HRDIK  N+LLD D    K+ DFG ++ +   + +++  
Sbjct: 139 -------SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI 188
Query: 388 IQGTFGYLDPEY-FQSSQFTDKSDVYSFGVVLLELLTGK 425
                 Y  PE  F ++ +T   DV+S G VL ELL G+
Sbjct: 189 CSRY--YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 225

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 89/209 (42%), Gaps = 20/209 (9%)
Query: 223 FLGQGGFGTVYKGMLPDGSIV----AVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLL 278
           FLG+GGF   ++    D   V     V +S  +   Q  +   E+ I   + H+H+V   
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 83
Query: 279 GCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVA 338
           G   + +   +V E     +L   +H               +  +  ++ + C+      
Sbjct: 84  GFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEP-----EARYYLRQIVLGCQ------ 131
Query: 339 YMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPE 398
           Y+H +  I   HRD+K  N+ L++    K+ DFG++  +  D      T+ GT  Y+ PE
Sbjct: 132 YLHRNRVI---HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER-KKTLCGTPNYIAPE 187
Query: 399 YFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
                  + + DV+S G ++  LL GK P
Sbjct: 188 VLSKKGHSFEVDVWSIGCIMYTLLVGKPP 216

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 102/219 (46%), Gaps = 29/219 (13%)
Query: 217 NYNQSRFLGQGGFGTVYKGMLPD-GSIVAVKRSKEIDKTQIHQFIN-EVVILSQINHRHI 274
           +Y  ++ +G G FG VY+  L D G +VA+K+       Q  +F N E+ I+ +++H +I
Sbjct: 57  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-----LQDKRFKNRELQIMRKLDHCNI 111
Query: 275 VKL---LGCCLETEVPV---LVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVR 328
           V+L        E +  V   LV +Y+      + +  H              L      R
Sbjct: 112 VRLRYFFYSSGEKKDEVYLNLVLDYVPETV--YRVARHYSRAKQTLPVIYVKLYMYQLFR 169
Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLD-DKFSAKVSDFGISRSIPNDKTHLTTT 387
                  ++AY+HS     I HRDIK  N+LLD D    K+ DFG ++ +   + +++  
Sbjct: 170 -------SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI 219
Query: 388 IQGTFGYLDPEY-FQSSQFTDKSDVYSFGVVLLELLTGK 425
                 Y  PE  F ++ +T   DV+S G VL ELL G+
Sbjct: 220 CSRY--YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 256

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 103/219 (47%), Gaps = 29/219 (13%)
Query: 217 NYNQSRFLGQGGFGTVYKGMLPD-GSIVAVKRSKEIDKTQIHQFIN-EVVILSQINHRHI 274
           +Y  ++ +G G FG VY+  L D G +VA+K+       Q  +F N E+ I+ +++H +I
Sbjct: 49  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-----LQDKRFKNRELQIMRKLDHCNI 103
Query: 275 VKLLGCCLET-----EVPV-LVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVR 328
           V+L      +     EV + LV +Y+      + +  H              L      R
Sbjct: 104 VRLRYFFYSSGEKKDEVYLNLVLDYVPETV--YRVARHYSRAKQTLPVIYVKLYMYQLFR 161
Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLD-DKFSAKVSDFGISRSIPNDKTHLTTT 387
                  ++AY+HS     I HRDIK  N+LLD D    K+ DFG ++ +   + +++  
Sbjct: 162 -------SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI 211
Query: 388 IQGTFGYLDPEY-FQSSQFTDKSDVYSFGVVLLELLTGK 425
                 Y  PE  F ++ +T   DV+S G VL ELL G+
Sbjct: 212 CSRY--YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 248

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 89/209 (42%), Gaps = 20/209 (9%)
Query: 223 FLGQGGFGTVYKGMLPDGSIV----AVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLL 278
           FLG+GGF   ++    D   V     V +S  +   Q  +   E+ I   + H+H+V   
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 83
Query: 279 GCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVA 338
           G   + +   +V E     +L   +H               +  +  ++ + C+      
Sbjct: 84  GFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEP-----EARYYLRQIVLGCQ------ 131
Query: 339 YMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPE 398
           Y+H +  I   HRD+K  N+ L++    K+ DFG++  +  D      T+ GT  Y+ PE
Sbjct: 132 YLHRNRVI---HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER-KKTLCGTPNYIAPE 187
Query: 399 YFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
                  + + DV+S G ++  LL GK P
Sbjct: 188 VLSKKGHSFEVDVWSIGCIMYTLLVGKPP 216

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/246 (24%), Positives = 107/246 (43%), Gaps = 39/246 (15%)
Query: 256 IHQFINEVVILSQINHRHIVKLLGCCLETEVP--VLVYEYISSGTLSHHIHDHXXXXXXX 313
           I Q   E+ IL +++H ++VKL+    +       +V+E ++ G +              
Sbjct: 80  IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME------------ 127
Query: 314 XXXXLSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGI 373
               L  LS +       ++   + Y+H      I HRDIK SN+L+ +    K++DFG+
Sbjct: 128 -VPTLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGV 183
Query: 374 SRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQ--FTDKS-DVYSFGVVLLELLTGKKPICF 430
           S         L+ T+ GT  ++ PE    ++  F+ K+ DV++ GV L   + G+ P   
Sbjct: 184 SNEFKGSDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242
Query: 431 ARVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGA-MAELAMRCLRLNSKKRPT 489
            R       + C  S  K +Q LE  D        + DI   + +L  R L  N + R  
Sbjct: 243 ER-------IMCLHSKIK-SQALEFPD--------QPDIAEDLKDLITRMLDKNPESRIV 286
Query: 490 MKQVSM 495
           + ++ +
Sbjct: 287 VPEIKL 292

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/248 (24%), Positives = 109/248 (43%), Gaps = 27/248 (10%)
Query: 214 ATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVK--RSKEIDKTQIHQFINEVVILSQIN 270
           AT  Y     +G G +GTVYK   P  G  VA+K  R    ++      + EV +L ++ 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 271 ---HRHIVKLLGCC----LETEVPV-LVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLS 322
              H ++V+L+  C     + E+ V LV+E++          D            L + +
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD--------QDLRTYLDKAPPPGLPAET 113
Query: 323 WENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKT 382
            ++ +R   +    + ++H++    I HRD+K  NIL+    + K++DFG++R I + + 
Sbjct: 114 IKDLMR---QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLAR-IYSYQM 166
Query: 383 HLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVAC 442
            L   +  T  Y  PE    S +    D++S G +  E+   K   C     ++   +  
Sbjct: 167 ALAPVVV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFD 225
Query: 443 FISLAKEN 450
            I L  E+
Sbjct: 226 LIGLPPED 233

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 103/219 (47%), Gaps = 29/219 (13%)
Query: 217 NYNQSRFLGQGGFGTVYKGMLPD-GSIVAVKRSKEIDKTQIHQFIN-EVVILSQINHRHI 274
           +Y  ++ +G G FG VY+  L D G +VA+K+       Q  +F N E+ I+ +++H +I
Sbjct: 59  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-----LQDKRFKNRELQIMRKLDHCNI 113
Query: 275 VKLLGCCLET-----EVPV-LVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVR 328
           V+L      +     EV + LV +Y+      + +  H              L      R
Sbjct: 114 VRLRYFFYSSGEKKDEVYLNLVLDYVPETV--YRVARHYSRAKQTLPVIYVKLYMYQLFR 171
Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLD-DKFSAKVSDFGISRSIPNDKTHLTTT 387
                  ++AY+HS     I HRDIK  N+LLD D    K+ DFG ++ +   + +++  
Sbjct: 172 -------SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI 221
Query: 388 IQGTFGYLDPEY-FQSSQFTDKSDVYSFGVVLLELLTGK 425
                 Y  PE  F ++ +T   DV+S G VL ELL G+
Sbjct: 222 CSRY--YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 258

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 94/230 (40%), Gaps = 25/230 (10%)
Query: 215 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIH-QFINEVVILSQINHR 272
           + ++     LG+G +G V      P G IVA+K+ +  DK     + + E+ IL    H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 273 HIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACE 332
           +I+ +               YI    +   +H                LS ++      +
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDLH---------RVISTQMLSDDHIQYFIYQ 120
Query: 333 VAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI---------PNDKTH 383
              AV  +H S  I   HRD+K SN+L++     KV DFG++R I         P  +  
Sbjct: 121 TLRAVKVLHGSNVI---HRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQS 177
Query: 384 LTTTIQGTFGYLDPE-YFQSSQFTDKSDVYSFGVVLLELLTGKKPICFAR 432
             T    T  Y  PE    S++++   DV+S G +L EL   ++PI   R
Sbjct: 178 GMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPIFPGR 226

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/248 (23%), Positives = 105/248 (42%), Gaps = 27/248 (10%)
Query: 214 ATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVK--RSKEIDKTQIHQFINEVVILSQIN 270
           AT  Y     +G G +GTVYK   P  G  VA+K  R    ++      + EV +L ++ 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 271 ---HRHIVKLLGCC----LETEVPV-LVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLS 322
              H ++V+L+  C     + E+ V LV+E++          D            L + +
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD--------QDLRTYLDKAPPPGLPAET 113
Query: 323 WENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKT 382
            ++ +R   +    + ++H++    I HRD+K  NIL+    + K++DFG++R       
Sbjct: 114 IKDLMR---QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA 167
Query: 383 HLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVAC 442
                +  T  Y  PE    S +    D++S G +  E+   K   C     ++   +  
Sbjct: 168 LFPVVV--TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFD 225
Query: 443 FISLAKEN 450
            I L  E+
Sbjct: 226 LIGLPPED 233

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 102/219 (46%), Gaps = 29/219 (13%)
Query: 217 NYNQSRFLGQGGFGTVYKGMLPD-GSIVAVKRSKEIDKTQIHQFIN-EVVILSQINHRHI 274
           +Y  ++ +G G FG VY+  L D G +VA+K+       Q   F N E+ I+ +++H +I
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-----LQGKAFKNRELQIMRKLDHCNI 75
Query: 275 VKLLGCCLET-----EVPV-LVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVR 328
           V+L      +     EV + LV +Y+      + +  H              L      R
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETV--YRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLD-DKFSAKVSDFGISRSIPNDKTHLTTT 387
                  ++AY+HS     I HRDIK  N+LLD D    K+ DFG ++ +   + +++  
Sbjct: 134 -------SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI 183
Query: 388 IQGTFGYLDPEY-FQSSQFTDKSDVYSFGVVLLELLTGK 425
                 Y  PE  F ++ +T   DV+S G VL ELL G+
Sbjct: 184 CSRY--YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 95/220 (43%), Gaps = 25/220 (11%)
Query: 216 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKR----SKEIDKTQIHQFINEVVILSQINH 271
           D Y+    LG G FG V++ +      V V +       +DK  +    NE+ I++Q++H
Sbjct: 51  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVK---NEISIMNQLHH 107
Query: 272 RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVAC 331
             ++ L     +    VL+ E++S G L   I              +S     N +R AC
Sbjct: 108 PKLINLHDAFEDKYEMVLILEFLSGGELFDRI--------AAEDYKMSEAEVINYMRQAC 159
Query: 332 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDK--FSAKVSDFGISRSIPNDKTHLTTTIQ 389
           E    + +MH  +   I H DIK  NI+ + K   S K+ DFG++  +  D+    TT  
Sbjct: 160 E---GLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTAT 213
Query: 390 GTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPIC 429
             F    PE          +D+++ GV+   LL+G  P  
Sbjct: 214 AEFA--APEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFA 251

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 103/219 (47%), Gaps = 29/219 (13%)
Query: 217 NYNQSRFLGQGGFGTVYKGMLPD-GSIVAVKRSKEIDKTQIHQFIN-EVVILSQINHRHI 274
           +Y  ++ +G G FG VY+  L D G +VA+K+       Q  +F N E+ I+ +++H +I
Sbjct: 100 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-----LQDKRFKNRELQIMRKLDHCNI 154
Query: 275 VKLLGCCLET-----EVPV-LVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVR 328
           V+L      +     EV + LV +Y+      + +  H              L      R
Sbjct: 155 VRLRYFFYSSGEKKDEVYLNLVLDYVPETV--YRVARHYSRAKQTLPVIYVKLYMYQLFR 212
Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLD-DKFSAKVSDFGISRSIPNDKTHLTTT 387
                  ++AY+HS     I HRDIK  N+LLD D    K+ DFG ++ +   + +++  
Sbjct: 213 -------SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI 262
Query: 388 IQGTFGYLDPEY-FQSSQFTDKSDVYSFGVVLLELLTGK 425
                 Y  PE  F ++ +T   DV+S G VL ELL G+
Sbjct: 263 CSRY--YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 299

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 94/230 (40%), Gaps = 25/230 (10%)
Query: 215 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIH-QFINEVVILSQINHR 272
           + ++     LG+G +G V      P G IVA+K+ +  DK     + + E+ IL    H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 273 HIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACE 332
           +I+ +               YI    +   +H                LS ++      +
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDLH---------RVISTQMLSDDHIQYFIYQ 120
Query: 333 VAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI---------PNDKTH 383
              AV  +H S  I   HRD+K SN+L++     KV DFG++R I         P  +  
Sbjct: 121 TLRAVKVLHGSNVI---HRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQS 177
Query: 384 LTTTIQGTFGYLDPE-YFQSSQFTDKSDVYSFGVVLLELLTGKKPICFAR 432
             T    T  Y  PE    S++++   DV+S G +L EL   ++PI   R
Sbjct: 178 GMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPIFPGR 226

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 94/223 (42%), Gaps = 31/223 (13%)
Query: 215 TDNYNQSRFLGQGGFGTVY----KGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQIN 270
           +D Y + + LG G +G V     K    + +I  +K+S     +     ++EV +L Q++
Sbjct: 3   SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLD 62
Query: 271 HRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVA 330
           H +I+KL     +     LV E    G L   I                  S  +   + 
Sbjct: 63  HPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEI------------ILRQKFSEVDAAVIM 110
Query: 331 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFS---AKVSDFGISRSIP---NDKTHL 384
            +V     Y+H      I HRD+K  N+LL+ K      K+ DFG+S         K  L
Sbjct: 111 KQVLSGTTYLHKH---NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERL 167
Query: 385 TTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
                GT  Y+ PE  +  ++ +K DV+S GV+L  LL G  P
Sbjct: 168 -----GTAYYIAPEVLR-KKYDEKCDVWSCGVILYILLCGYPP 204

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 101/221 (45%), Gaps = 31/221 (14%)
Query: 215 TDNYNQSRFLGQGGFGTVY----KGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQIN 270
           +D +     LG+G    VY    KG     ++  +K++  +DK  +     E+ +L +++
Sbjct: 52  SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT--VDKKIVR---TEIGVLLRLS 106
Query: 271 HRHIVKLLGCCLETEVPV-LVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRV 329
           H +I+KL     ET   + LV E ++ G L   I +                S  +    
Sbjct: 107 HPNIIKL-KEIFETPTEISLVLELVTGGELFDRIVEK------------GYYSERDAADA 153
Query: 330 ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFS---AKVSDFGISRSIPNDKTHLTT 386
             ++  AVAY+H +    I HRD+K  N+L          K++DFG+S+ +  +   L  
Sbjct: 154 VKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIV--EHQVLMK 208
Query: 387 TIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
           T+ GT GY  PE  +   +  + D++S G++   LL G +P
Sbjct: 209 TVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEP 249

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 102/219 (46%), Gaps = 29/219 (13%)
Query: 217 NYNQSRFLGQGGFGTVYKGMLPD-GSIVAVKRSKEIDKTQIHQFIN-EVVILSQINHRHI 274
           +Y  ++ +G G FG VY+  L D G +VA+K+       Q   F N E+ I+ +++H +I
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-----LQGKAFKNRELQIMRKLDHCNI 75
Query: 275 VKLLGCCLET-----EVPV-LVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVR 328
           V+L      +     EV + LV +Y+      + +  H              L      R
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETV--YRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLD-DKFSAKVSDFGISRSIPNDKTHLTTT 387
                  ++AY+HS     I HRDIK  N+LLD D    K+ DFG ++ +   + +++  
Sbjct: 134 -------SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI 183
Query: 388 IQGTFGYLDPEY-FQSSQFTDKSDVYSFGVVLLELLTGK 425
                 Y  PE  F ++ +T   DV+S G VL ELL G+
Sbjct: 184 CSRY--YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 72/302 (23%), Positives = 124/302 (41%), Gaps = 51/302 (16%)
Query: 203 AKVFTADELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQFIN 261
            K+    E +     Y     LG GGFG+VY G+ + D   VA+K  ++   +   +  N
Sbjct: 24  TKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN 83
Query: 262 ------EVVILSQINH--RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXX 313
                 EVV+L +++     +++LL      +  VL+ E          + D        
Sbjct: 84  GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEP---VQDLFDFITERGAL 140
Query: 314 XXXXLSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD-DKFSAKVSDFG 372
                 S  W        +V  AV + H+     + HRDIK  NIL+D ++   K+ DFG
Sbjct: 141 QEELARSFFW--------QVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG 189
Query: 373 ISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKS-DVYSFGVVLLELLTGKKPICFA 431
            S ++  D  +  T   GT  Y  PE+ +  ++  +S  V+S G++L +++ G  P    
Sbjct: 190 -SGALLKDTVY--TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF--- 243
Query: 432 RVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMK 491
             E +  ++   +   +          RV+ E +         L   CL L    RPT +
Sbjct: 244 --EHDEEIIGGQVFFRQ----------RVSSECQ--------HLIRWCLALRPSDRPTFE 283
Query: 492 QV 493
           ++
Sbjct: 284 EI 285

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 72/302 (23%), Positives = 124/302 (41%), Gaps = 51/302 (16%)
Query: 203 AKVFTADELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQFIN 261
            K+    E +     Y     LG GGFG+VY G+ + D   VA+K  ++   +   +  N
Sbjct: 23  TKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN 82
Query: 262 ------EVVILSQINH--RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXX 313
                 EVV+L +++     +++LL      +  VL+ E          + D        
Sbjct: 83  GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEP---VQDLFDFITERGAL 139
Query: 314 XXXXLSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD-DKFSAKVSDFG 372
                 S  W        +V  AV + H+     + HRDIK  NIL+D ++   K+ DFG
Sbjct: 140 QEELARSFFW--------QVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG 188
Query: 373 ISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKS-DVYSFGVVLLELLTGKKPICFA 431
            S ++  D  +  T   GT  Y  PE+ +  ++  +S  V+S G++L +++ G  P    
Sbjct: 189 -SGALLKDTVY--TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF--- 242
Query: 432 RVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMK 491
             E +  ++   +   +          RV+ E +         L   CL L    RPT +
Sbjct: 243 --EHDEEIIGGQVFFRQ----------RVSSECQ--------HLIRWCLALRPSDRPTFE 282
Query: 492 QV 493
           ++
Sbjct: 283 EI 284

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 72/302 (23%), Positives = 124/302 (41%), Gaps = 51/302 (16%)
Query: 203 AKVFTADELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQFIN 261
            K+    E +     Y     LG GGFG+VY G+ + D   VA+K  ++   +   +  N
Sbjct: 23  TKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN 82
Query: 262 ------EVVILSQINH--RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXX 313
                 EVV+L +++     +++LL      +  VL+ E          + D        
Sbjct: 83  GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEP---VQDLFDFITERGAL 139
Query: 314 XXXXLSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD-DKFSAKVSDFG 372
                 S  W        +V  AV + H+     + HRDIK  NIL+D ++   K+ DFG
Sbjct: 140 QEELARSFFW--------QVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG 188
Query: 373 ISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKS-DVYSFGVVLLELLTGKKPICFA 431
            S ++  D  +  T   GT  Y  PE+ +  ++  +S  V+S G++L +++ G  P    
Sbjct: 189 -SGALLKDTVY--TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF--- 242
Query: 432 RVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMK 491
             E +  ++   +   +          RV+ E +         L   CL L    RPT +
Sbjct: 243 --EHDEEIIGGQVFFRQ----------RVSSECQ--------HLIRWCLALRPSDRPTFE 282
Query: 492 QV 493
           ++
Sbjct: 283 EI 284

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 72/302 (23%), Positives = 124/302 (41%), Gaps = 51/302 (16%)
Query: 203 AKVFTADELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQFIN 261
            K+    E +     Y     LG GGFG+VY G+ + D   VA+K  ++   +   +  N
Sbjct: 24  TKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN 83
Query: 262 ------EVVILSQINH--RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXX 313
                 EVV+L +++     +++LL      +  VL+ E          + D        
Sbjct: 84  GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEP---VQDLFDFITERGAL 140
Query: 314 XXXXLSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD-DKFSAKVSDFG 372
                 S  W        +V  AV + H+     + HRDIK  NIL+D ++   K+ DFG
Sbjct: 141 QEELARSFFW--------QVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG 189
Query: 373 ISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKS-DVYSFGVVLLELLTGKKPICFA 431
            S ++  D  +  T   GT  Y  PE+ +  ++  +S  V+S G++L +++ G  P    
Sbjct: 190 -SGALLKDTVY--TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF--- 243
Query: 432 RVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMK 491
             E +  ++   +   +          RV+ E +         L   CL L    RPT +
Sbjct: 244 --EHDEEIIGGQVFFRQ----------RVSXECQ--------HLIRWCLALRPSDRPTFE 283
Query: 492 QV 493
           ++
Sbjct: 284 EI 285

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 72/302 (23%), Positives = 124/302 (41%), Gaps = 51/302 (16%)
Query: 203 AKVFTADELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQFIN 261
            K+    E +     Y     LG GGFG+VY G+ + D   VA+K  ++   +   +  N
Sbjct: 23  TKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN 82
Query: 262 ------EVVILSQINH--RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXX 313
                 EVV+L +++     +++LL      +  VL+ E          + D        
Sbjct: 83  GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEP---VQDLFDFITERGAL 139
Query: 314 XXXXLSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD-DKFSAKVSDFG 372
                 S  W        +V  AV + H+     + HRDIK  NIL+D ++   K+ DFG
Sbjct: 140 QEELARSFFW--------QVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG 188
Query: 373 ISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKS-DVYSFGVVLLELLTGKKPICFA 431
            S ++  D  +  T   GT  Y  PE+ +  ++  +S  V+S G++L +++ G  P    
Sbjct: 189 -SGALLKDTVY--TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF--- 242
Query: 432 RVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMK 491
             E +  ++   +   +          RV+ E +         L   CL L    RPT +
Sbjct: 243 --EHDEEIIGGQVFFRQ----------RVSXECQ--------HLIRWCLALRPSDRPTFE 282
Query: 492 QV 493
           ++
Sbjct: 283 EI 284

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/248 (24%), Positives = 109/248 (43%), Gaps = 27/248 (10%)
Query: 214 ATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVK--RSKEIDKTQIHQFINEVVILSQIN 270
           AT  Y     +G G +GTVYK   P  G  VA+K  R    ++      + EV +L ++ 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 271 ---HRHIVKLLGCC----LETEVPV-LVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLS 322
              H ++V+L+  C     + E+ V LV+E++          D            L + +
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD--------QDLRTYLDKAPPPGLPAET 113
Query: 323 WENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKT 382
            ++ +R   +    + ++H++    I HRD+K  NIL+    + K++DFG++R I + + 
Sbjct: 114 IKDLMR---QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLAR-IYSYQM 166
Query: 383 HLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVAC 442
            L   +  T  Y  PE    S +    D++S G +  E+   K   C     ++   +  
Sbjct: 167 ALDPVVV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFD 225
Query: 443 FISLAKEN 450
            I L  E+
Sbjct: 226 LIGLPPED 233

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 72/302 (23%), Positives = 124/302 (41%), Gaps = 51/302 (16%)
Query: 203 AKVFTADELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQFIN 261
            K+    E +     Y     LG GGFG+VY G+ + D   VA+K  ++   +   +  N
Sbjct: 24  TKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN 83
Query: 262 ------EVVILSQINH--RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXX 313
                 EVV+L +++     +++LL      +  VL+ E          + D        
Sbjct: 84  GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEP---VQDLFDFITERGAL 140
Query: 314 XXXXLSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD-DKFSAKVSDFG 372
                 S  W        +V  AV + H+     + HRDIK  NIL+D ++   K+ DFG
Sbjct: 141 QEELARSFFW--------QVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG 189
Query: 373 ISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKS-DVYSFGVVLLELLTGKKPICFA 431
            S ++  D  +  T   GT  Y  PE+ +  ++  +S  V+S G++L +++ G  P    
Sbjct: 190 -SGALLKDTVY--TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF--- 243
Query: 432 RVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMK 491
             E +  ++   +   +          RV+ E +         L   CL L    RPT +
Sbjct: 244 --EHDEEIIGGQVFFRQ----------RVSSECQ--------HLIRWCLALRPSDRPTFE 283
Query: 492 QV 493
           ++
Sbjct: 284 EI 285

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 72/302 (23%), Positives = 124/302 (41%), Gaps = 51/302 (16%)
Query: 203 AKVFTADELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQFIN 261
            K+    E +     Y     LG GGFG+VY G+ + D   VA+K  ++   +   +  N
Sbjct: 24  TKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN 83
Query: 262 ------EVVILSQINH--RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXX 313
                 EVV+L +++     +++LL      +  VL+ E          + D        
Sbjct: 84  GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEP---VQDLFDFITERGAL 140
Query: 314 XXXXLSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD-DKFSAKVSDFG 372
                 S  W        +V  AV + H+     + HRDIK  NIL+D ++   K+ DFG
Sbjct: 141 QEELARSFFW--------QVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG 189
Query: 373 ISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKS-DVYSFGVVLLELLTGKKPICFA 431
            S ++  D  +  T   GT  Y  PE+ +  ++  +S  V+S G++L +++ G  P    
Sbjct: 190 -SGALLKDTVY--TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF--- 243
Query: 432 RVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMK 491
             E +  ++   +   +          RV+ E +         L   CL L    RPT +
Sbjct: 244 --EHDEEIIGGQVFFRQ----------RVSXECQ--------HLIRWCLALRPSDRPTFE 283
Query: 492 QV 493
           ++
Sbjct: 284 EI 285

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 94/223 (42%), Gaps = 28/223 (12%)
Query: 216 DNYNQSRFLGQGGFGTVYK------GMLPDGSIVAVKRSKEIDKTQIHQFIN-EVVILSQ 268
           D Y+    LG G F  V K      G+      +  +R+K   +    + I  EV IL +
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 269 INHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVR 328
           I H +++ L          +L+ E ++ G L   + +              SL+ E    
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK------------ESLTEEEATE 118
Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD----KFSAKVSDFGISRSIPNDKTHL 384
              ++   V Y+HS   + I H D+K  NI+L D    K   K+ DFG++  I  D  + 
Sbjct: 119 FLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNE 173
Query: 385 TTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
              I GT  ++ PE         ++D++S GV+   LL+G  P
Sbjct: 174 FKNIFGTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 93/221 (42%), Gaps = 22/221 (9%)
Query: 213 RATDNYNQSRFLGQGGFGTVYKGM--LPDGSIVA-VKRSKEIDKTQIHQFINEVVILSQI 269
           R TD+Y     LG+G F  V + +   P     A +  +K++      +   E  I   +
Sbjct: 28  RFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLL 87
Query: 270 NHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRV 329
            H +IV+L     E     LV++ ++ G L   I                  S  +    
Sbjct: 88  KHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDI------------VAREYYSEADASHC 135
Query: 330 ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK---FSAKVSDFGISRSIPNDKTHLTT 386
             ++  +V ++H      I HRD+K  N+LL  K    + K++DFG++  +  ++     
Sbjct: 136 IHQILESVNHIHQH---DIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQ-QAWF 191
Query: 387 TIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
              GT GYL PE  +   +    D+++ GV+L  LL G  P
Sbjct: 192 GFAGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVGYPP 232

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 33/85 (38%), Positives = 48/85 (56%), Gaps = 7/85 (8%)
Query: 348 IFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTD 407
           + HRD+K SNILLD++   K+ DFGIS  + +DK    +   G   Y+ PE       T 
Sbjct: 146 VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSA--GCAAYMAPERIDPPDPTK 203
Query: 408 -----KSDVYSFGVVLLELLTGKKP 427
                ++DV+S G+ L+EL TG+ P
Sbjct: 204 PDYDIRADVWSLGISLVELATGQFP 228

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 72/302 (23%), Positives = 124/302 (41%), Gaps = 51/302 (16%)
Query: 203 AKVFTADELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQFIN 261
            K+    E +     Y     LG GGFG+VY G+ + D   VA+K  ++   +   +  N
Sbjct: 38  TKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN 97
Query: 262 ------EVVILSQINH--RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXX 313
                 EVV+L +++     +++LL      +  VL+ E          + D        
Sbjct: 98  GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEP---VQDLFDFITERGAL 154
Query: 314 XXXXLSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD-DKFSAKVSDFG 372
                 S  W        +V  AV + H+     + HRDIK  NIL+D ++   K+ DFG
Sbjct: 155 QEELARSFFW--------QVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG 203
Query: 373 ISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKS-DVYSFGVVLLELLTGKKPICFA 431
            S ++  D  +  T   GT  Y  PE+ +  ++  +S  V+S G++L +++ G  P    
Sbjct: 204 -SGALLKDTVY--TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF--- 257
Query: 432 RVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMK 491
             E +  ++   +   +          RV+ E +         L   CL L    RPT +
Sbjct: 258 --EHDEEIIRGQVFFRQ----------RVSSECQ--------HLIRWCLALRPSDRPTFE 297
Query: 492 QV 493
           ++
Sbjct: 298 EI 299

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 70/288 (24%), Positives = 121/288 (42%), Gaps = 51/288 (17%)
Query: 217 NYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQFIN------EVVILSQI 269
            Y     LG GGFG+VY G+ + D   VA+K  ++   +   +  N      EVV+L ++
Sbjct: 9   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 68
Query: 270 NH--RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
           +     +++LL      +  VL+ E +        + D              S  W    
Sbjct: 69  SSGFSGVIRLLDWFERPDSFVLILERMEP---VQDLFDFITERGALQEELARSFFW---- 121
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD-DKFSAKVSDFGISRSIPNDKTHLTT 386
               +V  AV + H+     + HRDIK  NIL+D ++   K+ DFG S ++  D  +  T
Sbjct: 122 ----QVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVY--T 171
Query: 387 TIQGTFGYLDPEYFQSSQFTDKS-DVYSFGVVLLELLTGKKPICFARVEEERNLVACFIS 445
              GT  Y  PE+ +  ++  +S  V+S G++L +++ G  P      E +  ++   + 
Sbjct: 172 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQVF 226
Query: 446 LAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQV 493
             +          RV+ E +         L   CL L    RPT +++
Sbjct: 227 FRQ----------RVSSECQ--------HLIRWCLALRPSDRPTFEEI 256

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 72/302 (23%), Positives = 124/302 (41%), Gaps = 51/302 (16%)
Query: 203 AKVFTADELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQFIN 261
            K+    E +     Y     LG GGFG+VY G+ + D   VA+K  ++   +   +  N
Sbjct: 11  TKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN 70
Query: 262 ------EVVILSQINH--RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXX 313
                 EVV+L +++     +++LL      +  VL+ E          + D        
Sbjct: 71  GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEP---VQDLFDFITERGAL 127
Query: 314 XXXXLSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD-DKFSAKVSDFG 372
                 S  W        +V  AV + H+     + HRDIK  NIL+D ++   K+ DFG
Sbjct: 128 QEELARSFFW--------QVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG 176
Query: 373 ISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKS-DVYSFGVVLLELLTGKKPICFA 431
            S ++  D  +  T   GT  Y  PE+ +  ++  +S  V+S G++L +++ G  P    
Sbjct: 177 -SGALLKDTVY--TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF--- 230
Query: 432 RVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMK 491
             E +  ++   +   +          RV+ E +         L   CL L    RPT +
Sbjct: 231 --EHDEEIIRGQVFFRQ----------RVSSECQ--------HLIRWCLALRPSDRPTFE 270
Query: 492 QV 493
           ++
Sbjct: 271 EI 272

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 72/302 (23%), Positives = 124/302 (41%), Gaps = 51/302 (16%)
Query: 203 AKVFTADELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQFIN 261
            K+    E +     Y     LG GGFG+VY G+ + D   VA+K  ++   +   +  N
Sbjct: 38  TKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN 97
Query: 262 ------EVVILSQINH--RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXX 313
                 EVV+L +++     +++LL      +  VL+ E          + D        
Sbjct: 98  GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEP---VQDLFDFITERGAL 154
Query: 314 XXXXLSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD-DKFSAKVSDFG 372
                 S  W        +V  AV + H+     + HRDIK  NIL+D ++   K+ DFG
Sbjct: 155 QEELARSFFW--------QVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG 203
Query: 373 ISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKS-DVYSFGVVLLELLTGKKPICFA 431
            S ++  D  +  T   GT  Y  PE+ +  ++  +S  V+S G++L +++ G  P    
Sbjct: 204 -SGALLKDTVY--TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF--- 257
Query: 432 RVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMK 491
             E +  ++   +   +          RV+ E +         L   CL L    RPT +
Sbjct: 258 --EHDEEIIRGQVFFRQ----------RVSXECQ--------HLIRWCLALRPSDRPTFE 297
Query: 492 QV 493
           ++
Sbjct: 298 EI 299

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 72/302 (23%), Positives = 124/302 (41%), Gaps = 51/302 (16%)
Query: 203 AKVFTADELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQFIN 261
            K+    E +     Y     LG GGFG+VY G+ + D   VA+K  ++   +   +  N
Sbjct: 10  TKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN 69
Query: 262 ------EVVILSQINH--RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXX 313
                 EVV+L +++     +++LL      +  VL+ E          + D        
Sbjct: 70  GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEP---VQDLFDFITERGAL 126
Query: 314 XXXXLSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD-DKFSAKVSDFG 372
                 S  W        +V  AV + H+     + HRDIK  NIL+D ++   K+ DFG
Sbjct: 127 QEELARSFFW--------QVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG 175
Query: 373 ISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKS-DVYSFGVVLLELLTGKKPICFA 431
            S ++  D  +  T   GT  Y  PE+ +  ++  +S  V+S G++L +++ G  P    
Sbjct: 176 -SGALLKDTVY--TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF--- 229
Query: 432 RVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMK 491
             E +  ++   +   +          RV+ E +         L   CL L    RPT +
Sbjct: 230 --EHDEEIIRGQVFFRQ----------RVSSECQ--------HLIRWCLALRPSDRPTFE 269
Query: 492 QV 493
           ++
Sbjct: 270 EI 271

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 72/302 (23%), Positives = 124/302 (41%), Gaps = 51/302 (16%)
Query: 203 AKVFTADELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQFIN 261
            K+    E +     Y     LG GGFG+VY G+ + D   VA+K  ++   +   +  N
Sbjct: 30  TKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN 89
Query: 262 ------EVVILSQINH--RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXX 313
                 EVV+L +++     +++LL      +  VL+ E          + D        
Sbjct: 90  GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEP---VQDLFDFITERGAL 146
Query: 314 XXXXLSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD-DKFSAKVSDFG 372
                 S  W        +V  AV + H+     + HRDIK  NIL+D ++   K+ DFG
Sbjct: 147 QEELARSFFW--------QVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG 195
Query: 373 ISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKS-DVYSFGVVLLELLTGKKPICFA 431
            S ++  D  +  T   GT  Y  PE+ +  ++  +S  V+S G++L +++ G  P    
Sbjct: 196 -SGALLKDTVY--TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF--- 249
Query: 432 RVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMK 491
             E +  ++   +   +          RV+ E +         L   CL L    RPT +
Sbjct: 250 --EHDEEIIRGQVFFRQ----------RVSSECQ--------HLIRWCLALRPSDRPTFE 289
Query: 492 QV 493
           ++
Sbjct: 290 EI 291

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 72/302 (23%), Positives = 124/302 (41%), Gaps = 51/302 (16%)
Query: 203 AKVFTADELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQFIN 261
            K+    E +     Y     LG GGFG+VY G+ + D   VA+K  ++   +   +  N
Sbjct: 11  TKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN 70
Query: 262 ------EVVILSQINH--RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXX 313
                 EVV+L +++     +++LL      +  VL+ E          + D        
Sbjct: 71  GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEP---VQDLFDFITERGAL 127
Query: 314 XXXXLSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD-DKFSAKVSDFG 372
                 S  W        +V  AV + H+     + HRDIK  NIL+D ++   K+ DFG
Sbjct: 128 QEELARSFFW--------QVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG 176
Query: 373 ISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKS-DVYSFGVVLLELLTGKKPICFA 431
            S ++  D  +  T   GT  Y  PE+ +  ++  +S  V+S G++L +++ G  P    
Sbjct: 177 -SGALLKDTVY--TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF--- 230
Query: 432 RVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMK 491
             E +  ++   +   +          RV+ E +         L   CL L    RPT +
Sbjct: 231 --EHDEEIIRGQVFFRQ----------RVSXECQ--------HLIRWCLALRPSDRPTFE 270
Query: 492 QV 493
           ++
Sbjct: 271 EI 272

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 72/302 (23%), Positives = 124/302 (41%), Gaps = 51/302 (16%)
Query: 203 AKVFTADELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQFIN 261
            K+    E +     Y     LG GGFG+VY G+ + D   VA+K  ++   +   +  N
Sbjct: 23  TKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN 82
Query: 262 ------EVVILSQINH--RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXX 313
                 EVV+L +++     +++LL      +  VL+ E          + D        
Sbjct: 83  GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEP---VQDLFDFITERGAL 139
Query: 314 XXXXLSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD-DKFSAKVSDFG 372
                 S  W        +V  AV + H+     + HRDIK  NIL+D ++   K+ DFG
Sbjct: 140 QEELARSFFW--------QVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG 188
Query: 373 ISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKS-DVYSFGVVLLELLTGKKPICFA 431
            S ++  D  +  T   GT  Y  PE+ +  ++  +S  V+S G++L +++ G  P    
Sbjct: 189 -SGALLKDTVY--TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF--- 242
Query: 432 RVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMK 491
             E +  ++   +   +          RV+ E +         L   CL L    RPT +
Sbjct: 243 --EHDEEIIRGQVFFRQ----------RVSSECQ--------HLIRWCLALRPSDRPTFE 282
Query: 492 QV 493
           ++
Sbjct: 283 EI 284

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 88/209 (42%), Gaps = 20/209 (9%)
Query: 223 FLGQGGFGTVYKGMLPDGSIV----AVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLL 278
           FLG+GGF   ++    D   V     V +S  +   Q  +   E+ I   + H+H+V   
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 279 GCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVA 338
           G   + +   +V E     +L   +H               +  +  ++ + C+      
Sbjct: 82  GFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEP-----EARYYLRQIVLGCQ------ 129
Query: 339 YMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPE 398
           Y+H +  I   HRD+K  N+ L++    K+ DFG++  +  D       + GT  Y+ PE
Sbjct: 130 YLHRNRVI---HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER-KKVLCGTPNYIAPE 185
Query: 399 YFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
                  + + DV+S G ++  LL GK P
Sbjct: 186 VLSKKGHSFEVDVWSIGCIMYTLLVGKPP 214

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 70/302 (23%), Positives = 138/302 (45%), Gaps = 59/302 (19%)
Query: 218 YNQSRFLGQGGFGTVYKGMLPD----GSI----VAVKRSKEIDKTQIHQFINEVVILSQI 269
           +N+S  LGQG F  ++KG+  +    G +    V +K   +  +     F     ++S++
Sbjct: 12  FNES--LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKL 69
Query: 270 NHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRV 329
           +H+H+V   G C+  +  +LV E++  G+L  ++  +             ++ W  ++ V
Sbjct: 70  SHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCI---------NILW--KLEV 118
Query: 330 ACEVAGAVAYMHSSASIPIFHRDIKSSNILL---DDKFSA-----KVSDFGISRSI-PND 380
           A ++A A+ ++  +  I   H ++ + NILL   +D+ +      K+SD GIS ++ P D
Sbjct: 119 AKQLAAAMHFLEENTLI---HGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD 175
Query: 381 KTHLTTTIQGTFGYLDPEYFQSSQFTD-KSDVYSFGVVLLELLT-GKKPICFARVEEERN 438
                  +Q    ++ PE  ++ +  +  +D +SFG  L E+ + G KP+  + ++ +R 
Sbjct: 176 ------ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPL--SALDSQRK 227
Query: 439 LVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELE 498
           L           Q  E      A +A E     +A L   C+      RP+ + +  +L 
Sbjct: 228 L-----------QFYEDRHQLPAPKAAE-----LANLINNCMDYEPDHRPSFRAIIRDLN 271
Query: 499 GL 500
            L
Sbjct: 272 SL 273

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 72/302 (23%), Positives = 124/302 (41%), Gaps = 51/302 (16%)
Query: 203 AKVFTADELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQFIN 261
            K+    E +     Y     LG GGFG+VY G+ + D   VA+K  ++   +   +  N
Sbjct: 43  TKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN 102
Query: 262 ------EVVILSQINH--RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXX 313
                 EVV+L +++     +++LL      +  VL+ E          + D        
Sbjct: 103 GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEP---VQDLFDFITERGAL 159
Query: 314 XXXXLSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD-DKFSAKVSDFG 372
                 S  W        +V  AV + H+     + HRDIK  NIL+D ++   K+ DFG
Sbjct: 160 QEELARSFFW--------QVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG 208
Query: 373 ISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKS-DVYSFGVVLLELLTGKKPICFA 431
            S ++  D  +  T   GT  Y  PE+ +  ++  +S  V+S G++L +++ G  P    
Sbjct: 209 -SGALLKDTVY--TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF--- 262
Query: 432 RVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMK 491
             E +  ++   +   +          RV+ E +         L   CL L    RPT +
Sbjct: 263 --EHDEEIIRGQVFFRQ----------RVSXECQ--------HLIRWCLALRPSDRPTFE 302
Query: 492 QV 493
           ++
Sbjct: 303 EI 304

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 93/230 (40%), Gaps = 25/230 (10%)
Query: 215 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIH-QFINEVVILSQINHR 272
           + ++     LG+G +G V      P G IVA+K+ +  DK     + + E+ IL    H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 273 HIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACE 332
           +I+ +               YI    +   +H                LS ++      +
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDLH---------RVISTQMLSDDHIQYFIYQ 120
Query: 333 VAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI---------PNDKTH 383
              AV  +H S  I   HRD+K SN+L++     KV DFG++R I         P  +  
Sbjct: 121 TLRAVKVLHGSNVI---HRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQS 177
Query: 384 LTTTIQGTFGYLDPE-YFQSSQFTDKSDVYSFGVVLLELLTGKKPICFAR 432
                  T  Y  PE    S++++   DV+S G +L EL   ++PI   R
Sbjct: 178 GMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPIFPGR 226

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 70/288 (24%), Positives = 120/288 (41%), Gaps = 51/288 (17%)
Query: 217 NYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQFIN------EVVILSQI 269
            Y     LG GGFG+VY G+ + D   VA+K  ++   +   +  N      EVV+L ++
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 270 NH--RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
           +     +++LL      +  VL+ E          + D              S  W    
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEP---VQDLFDFITERGALQEELARSFFW---- 117
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD-DKFSAKVSDFGISRSIPNDKTHLTT 386
               +V  AV + H+     + HRDIK  NIL+D ++   K+ DFG S ++  D  +  T
Sbjct: 118 ----QVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVY--T 167
Query: 387 TIQGTFGYLDPEYFQSSQFTDKS-DVYSFGVVLLELLTGKKPICFARVEEERNLVACFIS 445
              GT  Y  PE+ +  ++  +S  V+S G++L +++ G  P      E +  ++   + 
Sbjct: 168 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIGGQVF 222
Query: 446 LAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQV 493
             +          RV+ E +         L   CL L    RPT +++
Sbjct: 223 FRQ----------RVSSECQ--------HLIRWCLALRPSDRPTFEEI 252

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 72/302 (23%), Positives = 124/302 (41%), Gaps = 51/302 (16%)
Query: 203 AKVFTADELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQFIN 261
            K+    E +     Y     LG GGFG+VY G+ + D   VA+K  ++   +   +  N
Sbjct: 11  TKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN 70
Query: 262 ------EVVILSQINH--RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXX 313
                 EVV+L +++     +++LL      +  VL+ E          + D        
Sbjct: 71  GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEP---VQDLFDFITERGAL 127
Query: 314 XXXXLSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD-DKFSAKVSDFG 372
                 S  W        +V  AV + H+     + HRDIK  NIL+D ++   K+ DFG
Sbjct: 128 QEELARSFFW--------QVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG 176
Query: 373 ISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKS-DVYSFGVVLLELLTGKKPICFA 431
            S ++  D  +  T   GT  Y  PE+ +  ++  +S  V+S G++L +++ G  P    
Sbjct: 177 -SGALLKDTVY--TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF--- 230
Query: 432 RVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMK 491
             E +  ++   +   +          RV+ E +         L   CL L    RPT +
Sbjct: 231 --EHDEEIIRGQVFFRQ----------RVSXECQ--------HLIRWCLALRPXDRPTFE 270
Query: 492 QV 493
           ++
Sbjct: 271 EI 272

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 72/302 (23%), Positives = 124/302 (41%), Gaps = 51/302 (16%)
Query: 203 AKVFTADELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQFIN 261
            K+    E +     Y     LG GGFG+VY G+ + D   VA+K  ++   +   +  N
Sbjct: 10  TKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN 69
Query: 262 ------EVVILSQINH--RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXX 313
                 EVV+L +++     +++LL      +  VL+ E          + D        
Sbjct: 70  GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEP---VQDLFDFITERGAL 126
Query: 314 XXXXLSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD-DKFSAKVSDFG 372
                 S  W        +V  AV + H+     + HRDIK  NIL+D ++   K+ DFG
Sbjct: 127 QEELARSFFW--------QVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG 175
Query: 373 ISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKS-DVYSFGVVLLELLTGKKPICFA 431
            S ++  D  +  T   GT  Y  PE+ +  ++  +S  V+S G++L +++ G  P    
Sbjct: 176 -SGALLKDTVY--TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF--- 229
Query: 432 RVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMK 491
             E +  ++   +   +          RV+ E +         L   CL L    RPT +
Sbjct: 230 --EHDEEIIRGQVFFRQ----------RVSXECQ--------HLIRWCLALRPSDRPTFE 269
Query: 492 QV 493
           ++
Sbjct: 270 EI 271

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 64/299 (21%), Positives = 118/299 (39%), Gaps = 45/299 (15%)
Query: 223 FLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCL 282
            +G+G FG VY G       + +   +  ++ Q+  F  EV+   Q  H ++V  +G C+
Sbjct: 40  LIGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACM 99
Query: 283 ETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVR-VACEVAGAVAYMH 341
                 ++       TL   + D                   N+ R +A E+   + Y+H
Sbjct: 100 SPPHLAIITSLCKGRTLYSVVRDAKIVLDV------------NKTRQIAQEIVKGMGYLH 147
Query: 342 SSASIPIFHRDIKSSNILLDDKFSAKVSDFG---ISRSIPNDKTHLTTTIQ-GTFGYLDP 397
           +     I H+D+KS N+  D+     ++DFG   IS  +   +      IQ G   +L P
Sbjct: 148 AKG---ILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAP 203
Query: 398 EYFQSSQ---------FTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAK 448
           E  +            F+  SDV++ G +  EL   + P    + +    ++    +  K
Sbjct: 204 EIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPF---KTQPAEAIIWQMGTGMK 260
Query: 449 ENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRSQRCL 507
            N    +    + KE        ++++ + C     ++RPT  ++   LE L +  R L
Sbjct: 261 PN----LSQIGMGKE--------ISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRL 307

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 88/209 (42%), Gaps = 20/209 (9%)
Query: 223 FLGQGGFGTVYKGMLPDGSIV----AVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLL 278
           FLG+GGF   ++    D   V     V +S  +   Q  +   E+ I   + H+H+V   
Sbjct: 46  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 105
Query: 279 GCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVA 338
           G   + +   +V E     +L   +H               +  +  ++ + C+      
Sbjct: 106 GFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEP-----EARYYLRQIVLGCQ------ 153
Query: 339 YMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPE 398
           Y+H +  I   HRD+K  N+ L++    K+ DFG++  +  D       + GT  Y+ PE
Sbjct: 154 YLHRNRVI---HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER-KKVLCGTPNYIAPE 209
Query: 399 YFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
                  + + DV+S G ++  LL GK P
Sbjct: 210 VLSKKGHSFEVDVWSIGCIMYTLLVGKPP 238

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 97/219 (44%), Gaps = 37/219 (16%)
Query: 225 GQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLL-----G 279
            +G FG V+K  L +   VAVK     DK Q  Q   E+     + H ++++ +     G
Sbjct: 24  ARGRFGCVWKAQLMN-DFVAVKIFPLQDK-QSWQSEREIFSTPGMKHENLLQFIAAEKRG 81
Query: 280 CCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAY 339
             LE E+  L+  +   G+L+ ++  +              ++W     VA  ++  ++Y
Sbjct: 82  SNLEVEL-WLITAFHDKGSLTDYLKGNI-------------ITWNELCHVAETMSRGLSY 127
Query: 340 MHSSASI--------PIFHRDIKSSNILLDDKFSAKVSDFGIS-RSIPNDKTHLTTTIQG 390
           +H              I HRD KS N+LL    +A ++DFG++ R  P      T    G
Sbjct: 128 LHEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVG 187
Query: 391 TFGYLDPEY------FQSSQFTDKSDVYSFGVVLLELLT 423
           T  Y+ PE       FQ   F  + D+Y+ G+VL EL++
Sbjct: 188 TRRYMAPEVLEGAINFQRDAFL-RIDMYAMGLVLWELVS 225

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 88/209 (42%), Gaps = 20/209 (9%)
Query: 223 FLGQGGFGTVYKGMLPDGSIV----AVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLL 278
           FLG+GGF   ++    D   V     V +S  +   Q  +   E+ I   + H+H+V   
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 279 GCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVA 338
           G   + +   +V E     +L   +H               +  +  ++ + C+      
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEP-----EARYYLRQIVLGCQ------ 155
Query: 339 YMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPE 398
           Y+H +  I   HRD+K  N+ L++    K+ DFG++  +  D       + GT  Y+ PE
Sbjct: 156 YLHRNRVI---HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER-KKVLCGTPNYIAPE 211
Query: 399 YFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
                  + + DV+S G ++  LL GK P
Sbjct: 212 VLSKKGHSFEVDVWSIGCIMYTLLVGKPP 240

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 95/229 (41%), Gaps = 28/229 (12%)
Query: 212 QRATDNYNQSRFLGQGGFGTVYK------GMLPDGSIVAVKRSKEIDKTQIHQFIN-EVV 264
           +   D Y+    LG G F  V K      G+      +  +R+K   +    + I  EV 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 265 ILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWE 324
           IL +I H +++ L          +L+ E ++ G L   + +              SL+ E
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK------------ESLTEE 114
Query: 325 NRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD----KFSAKVSDFGISRSIPND 380
                  ++   V Y+HS   + I H D+K  NI+L D    K   K+ DFG++  I  D
Sbjct: 115 EATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--D 169
Query: 381 KTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPIC 429
             +    I GT  ++ PE         ++D++S GV+   LL+G  P  
Sbjct: 170 FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 218

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 94/223 (42%), Gaps = 28/223 (12%)
Query: 216 DNYNQSRFLGQGGFGTVYK------GMLPDGSIVAVKRSKEIDKTQIHQFIN-EVVILSQ 268
           D Y+    LG G F  V K      G+      +  +R+K   +    + I  EV IL +
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 269 INHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVR 328
           I H +++ L          +L+ E ++ G L   + +              SL+ E    
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK------------ESLTEEEATE 118
Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD----KFSAKVSDFGISRSIPNDKTHL 384
              ++   V Y+HS   + I H D+K  NI+L D    K   K+ DFG++  I  D  + 
Sbjct: 119 FLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNE 173
Query: 385 TTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
              I GT  ++ PE         ++D++S GV+   LL+G  P
Sbjct: 174 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 95/229 (41%), Gaps = 28/229 (12%)
Query: 212 QRATDNYNQSRFLGQGGFGTVYK------GMLPDGSIVAVKRSKEIDKTQIHQFIN-EVV 264
           +   D Y+    LG G F  V K      G+      +  +R+K   +    + I  EV 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 265 ILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWE 324
           IL +I H +++ L          +L+ E ++ G L   + +              SL+ E
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK------------ESLTEE 114
Query: 325 NRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD----KFSAKVSDFGISRSIPND 380
                  ++   V Y+HS   + I H D+K  NI+L D    K   K+ DFG++  I  D
Sbjct: 115 EATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--D 169
Query: 381 KTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPIC 429
             +    I GT  ++ PE         ++D++S GV+   LL+G  P  
Sbjct: 170 FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 218

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 95/229 (41%), Gaps = 28/229 (12%)
Query: 212 QRATDNYNQSRFLGQGGFGTVYK------GMLPDGSIVAVKRSKEIDKTQIHQFIN-EVV 264
           +   D Y+    LG G F  V K      G+      +  +R+K   +    + I  EV 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 265 ILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWE 324
           IL +I H +++ L          +L+ E ++ G L   + +              SL+ E
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK------------ESLTEE 114
Query: 325 NRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD----KFSAKVSDFGISRSIPND 380
                  ++   V Y+HS   + I H D+K  NI+L D    K   K+ DFG++  I  D
Sbjct: 115 EATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--D 169
Query: 381 KTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPIC 429
             +    I GT  ++ PE         ++D++S GV+   LL+G  P  
Sbjct: 170 FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 218

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 70/302 (23%), Positives = 137/302 (45%), Gaps = 59/302 (19%)
Query: 218 YNQSRFLGQGGFGTVYKGMLPD----GSI----VAVKRSKEIDKTQIHQFINEVVILSQI 269
           +N+S  LGQG F  ++KG+  +    G +    V +K   +  +     F     ++S++
Sbjct: 12  FNES--LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKL 69
Query: 270 NHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRV 329
           +H+H+V   G C   +  +LV E++  G+L  ++  +             ++ W  ++ V
Sbjct: 70  SHKHLVLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCI---------NILW--KLEV 118
Query: 330 ACEVAGAVAYMHSSASIPIFHRDIKSSNILL---DDKFSA-----KVSDFGISRSI-PND 380
           A ++A A+ ++  +  I   H ++ + NILL   +D+ +      K+SD GIS ++ P D
Sbjct: 119 AKQLAWAMHFLEENTLI---HGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD 175
Query: 381 KTHLTTTIQGTFGYLDPEYFQSSQFTD-KSDVYSFGVVLLELLT-GKKPICFARVEEERN 438
                  +Q    ++ PE  ++ +  +  +D +SFG  L E+ + G KP+  + ++ +R 
Sbjct: 176 ------ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPL--SALDSQRK 227
Query: 439 LVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELE 498
           L           Q  E      A +A E     +A L   C+      RP+ + +  +L 
Sbjct: 228 L-----------QFYEDRHQLPAPKAAE-----LANLINNCMDYEPDHRPSFRAIIRDLN 271
Query: 499 GL 500
            L
Sbjct: 272 SL 273

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 95/227 (41%), Gaps = 28/227 (12%)
Query: 212 QRATDNYNQSRFLGQGGFGTVYK------GMLPDGSIVAVKRSKEIDKTQIHQFIN-EVV 264
           +   D Y+    LG G F  V K      G+      +  +R+K   +    + I  EV 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 265 ILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWE 324
           IL +I H +++ L          +L+ E ++ G L   + +              SL+ E
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK------------ESLTEE 114
Query: 325 NRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD----KFSAKVSDFGISRSIPND 380
                  ++   V Y+HS   + I H D+K  NI+L D    K   K+ DFG++  I  D
Sbjct: 115 EATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--D 169
Query: 381 KTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
             +    I GT  ++ PE         ++D++S GV+   LL+G  P
Sbjct: 170 FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 95/229 (41%), Gaps = 28/229 (12%)
Query: 212 QRATDNYNQSRFLGQGGFGTVYK------GMLPDGSIVAVKRSKEIDKTQIHQFIN-EVV 264
           +   D Y+    LG G F  V K      G+      +  +R+K   +    + I  EV 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 265 ILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWE 324
           IL +I H +++ L          +L+ E ++ G L   + +              SL+ E
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK------------ESLTEE 114
Query: 325 NRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD----KFSAKVSDFGISRSIPND 380
                  ++   V Y+HS   + I H D+K  NI+L D    K   K+ DFG++  I  D
Sbjct: 115 EATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--D 169
Query: 381 KTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPIC 429
             +    I GT  ++ PE         ++D++S GV+   LL+G  P  
Sbjct: 170 FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 218

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 95/229 (41%), Gaps = 28/229 (12%)
Query: 212 QRATDNYNQSRFLGQGGFGTVYK------GMLPDGSIVAVKRSKEIDKTQIHQFIN-EVV 264
           +   D Y+    LG G F  V K      G+      +  +R+K   +    + I  EV 
Sbjct: 7   ENVDDYYDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 265 ILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWE 324
           IL +I H +++ L          +L+ E ++ G L   + +              SL+ E
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK------------ESLTEE 114
Query: 325 NRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD----KFSAKVSDFGISRSIPND 380
                  ++   V Y+HS   + I H D+K  NI+L D    K   K+ DFG++  I  D
Sbjct: 115 EATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--D 169
Query: 381 KTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPIC 429
             +    I GT  ++ PE         ++D++S GV+   LL+G  P  
Sbjct: 170 FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 218

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 52/100 (52%), Gaps = 7/100 (7%)
Query: 332 EVAGAVAYMHSSASIPIFHRDIKSSNILL---DDKFSAKVSDFGISRSIPNDKTHLTTTI 388
           ++  AV++MH    + + HRD+K  N+L    +D    K+ DFG +R  P D   L T  
Sbjct: 114 KLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC 170
Query: 389 QGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
             T  Y  PE    + + +  D++S GV+L  +L+G+ P 
Sbjct: 171 -FTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPF 209

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 76/295 (25%), Positives = 127/295 (43%), Gaps = 57/295 (19%)
Query: 217 NYNQSRFLGQGGFGTVYKG-MLPDGSIVAVK---RSKEIDKTQIHQFIN---EVVILSQI 269
            Y     LG+GGFGTV+ G  L D   VA+K   R++ +  + +   +    EV +L ++
Sbjct: 32  EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKV 91
Query: 270 N----HRHIVKLLGCCLETEVPVLVYEY-ISSGTLSHHIHDHXXXXXXXXXXXLSSLSWE 324
                H  +++LL      E  +LV E  + +  L  +I +                   
Sbjct: 92  GAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFG----- 146
Query: 325 NRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD-DKFSAKVSDFGISRSIPNDKTH 383
                  +V  A+ + HS     + HRDIK  NIL+D  +  AK+ DFG S ++ +D+ +
Sbjct: 147 -------QVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFG-SGALLHDEPY 195
Query: 384 LTTTIQGTFGYLDPEYFQSSQFTD-KSDVYSFGVVLLELLTGKKPICFARVEEERNLVAC 442
             T   GT  Y  PE+    Q+    + V+S G++L +++ G  P        ER+    
Sbjct: 196 --TDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPF-------ERD---- 242
Query: 443 FISLAKENQLLEILDARVAKEAR-EEDIGAMAELAMRCLRLNSKKRPTMKQVSME 496
                      EIL+A +   A    D  A   L  RCL      RP+++++ ++
Sbjct: 243 ----------QEILEAELHFPAHVSPDCCA---LIRRCLAPKPSSRPSLEEILLD 284

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/215 (23%), Positives = 95/215 (44%), Gaps = 21/215 (9%)
Query: 218 YNQSRFLGQGGFGTV---YKGMLPDGSIVAVKRSKEID-KTQIHQFINEVVILSQINHRH 273
           Y    ++G+G +G V   Y  +  +   VA+K+    + +T   + + E+ IL +  H +
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHEN 86
Query: 274 IVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEV 333
           I+ +        +  +   YI    +   ++                LS ++      ++
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDLMETDLY---------KLLKTQHLSNDHICYFLYQI 137
Query: 334 AGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTH--LTTTIQGT 391
              + Y+HS+    + HRD+K SN+LL+     K+ DFG++R    D  H    T    T
Sbjct: 138 LRGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVAT 194
Query: 392 FGYLDPEYFQSSQ-FTDKSDVYSFGVVLLELLTGK 425
             Y  PE   +S+ +T   D++S G +L E+L+ +
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 70/288 (24%), Positives = 120/288 (41%), Gaps = 51/288 (17%)
Query: 217 NYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQFIN------EVVILSQI 269
            Y     LG GGFG+VY G+ + D   VA+K  ++   +   +  N      EVV+L ++
Sbjct: 8   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 67
Query: 270 NH--RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
           +     +++LL      +  VL+ E          + D              S  W    
Sbjct: 68  SSGFSGVIRLLDWFERPDSFVLILERPEP---VQDLFDFITERGALQEELARSFFW---- 120
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD-DKFSAKVSDFGISRSIPNDKTHLTT 386
               +V  AV + H+     + HRDIK  NIL+D ++   K+ DFG S ++  D  +  T
Sbjct: 121 ----QVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVY--T 170
Query: 387 TIQGTFGYLDPEYFQSSQFTDKS-DVYSFGVVLLELLTGKKPICFARVEEERNLVACFIS 445
              GT  Y  PE+ +  ++  +S  V+S G++L +++ G  P      E +  ++   + 
Sbjct: 171 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQVF 225
Query: 446 LAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQV 493
             +          RV+ E +         L   CL L    RPT +++
Sbjct: 226 FRQ----------RVSSECQ--------HLIRWCLALRPSDRPTFEEI 255

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 70/288 (24%), Positives = 120/288 (41%), Gaps = 51/288 (17%)
Query: 217 NYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQFIN------EVVILSQI 269
            Y     LG GGFG+VY G+ + D   VA+K  ++   +   +  N      EVV+L ++
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 270 NH--RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
           +     +++LL      +  VL+ E          + D              S  W    
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEP---VQDLFDFITERGALQEELARSFFW---- 117
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD-DKFSAKVSDFGISRSIPNDKTHLTT 386
               +V  AV + H+     + HRDIK  NIL+D ++   K+ DFG S ++  D  +  T
Sbjct: 118 ----QVLEAVRHCHNXG---VLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVY--T 167
Query: 387 TIQGTFGYLDPEYFQSSQFTDKS-DVYSFGVVLLELLTGKKPICFARVEEERNLVACFIS 445
              GT  Y  PE+ +  ++  +S  V+S G++L +++ G  P      E +  ++   + 
Sbjct: 168 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQVF 222
Query: 446 LAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQV 493
             +          RV+ E +         L   CL L    RPT +++
Sbjct: 223 FRQ----------RVSXECQ--------HLIRWCLALRPSDRPTFEEI 252

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 95/229 (41%), Gaps = 28/229 (12%)
Query: 212 QRATDNYNQSRFLGQGGFGTVYK------GMLPDGSIVAVKRSKEIDKTQIHQFIN-EVV 264
           +   D Y+    LG G F  V K      G+      +  +R+K   +    + I  EV 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 265 ILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWE 324
           IL +I H +++ L          +L+ E ++ G L   + +              SL+ E
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK------------ESLTEE 114
Query: 325 NRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD----KFSAKVSDFGISRSIPND 380
                  ++   V Y+HS   + I H D+K  NI+L D    K   K+ DFG++  I  D
Sbjct: 115 EATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--D 169
Query: 381 KTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPIC 429
             +    I GT  ++ PE         ++D++S GV+   LL+G  P  
Sbjct: 170 FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 218

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 95/229 (41%), Gaps = 28/229 (12%)
Query: 212 QRATDNYNQSRFLGQGGFGTVYK------GMLPDGSIVAVKRSKEIDKTQIHQFIN-EVV 264
           +   D Y+    LG G F  V K      G+      +  +R+K   +    + I  EV 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 265 ILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWE 324
           IL +I H +++ L          +L+ E ++ G L   + +              SL+ E
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK------------ESLTEE 114
Query: 325 NRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD----KFSAKVSDFGISRSIPND 380
                  ++   V Y+HS   + I H D+K  NI+L D    K   K+ DFG++  I  D
Sbjct: 115 EATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--D 169
Query: 381 KTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPIC 429
             +    I GT  ++ PE         ++D++S GV+   LL+G  P  
Sbjct: 170 FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 218

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 70/288 (24%), Positives = 120/288 (41%), Gaps = 51/288 (17%)
Query: 217 NYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQFIN------EVVILSQI 269
            Y     LG GGFG+VY G+ + D   VA+K  ++   +   +  N      EVV+L ++
Sbjct: 10  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 69
Query: 270 NH--RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
           +     +++LL      +  VL+ E          + D              S  W    
Sbjct: 70  SSGFSGVIRLLDWFERPDSFVLILERPEP---VQDLFDFITERGALQEELARSFFW---- 122
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD-DKFSAKVSDFGISRSIPNDKTHLTT 386
               +V  AV + H+     + HRDIK  NIL+D ++   K+ DFG S ++  D  +  T
Sbjct: 123 ----QVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVY--T 172
Query: 387 TIQGTFGYLDPEYFQSSQFTDKS-DVYSFGVVLLELLTGKKPICFARVEEERNLVACFIS 445
              GT  Y  PE+ +  ++  +S  V+S G++L +++ G  P      E +  ++   + 
Sbjct: 173 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQVF 227
Query: 446 LAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQV 493
             +          RV+ E +         L   CL L    RPT +++
Sbjct: 228 FRQ----------RVSSECQ--------HLIRWCLALRPSDRPTFEEI 257

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 70/288 (24%), Positives = 120/288 (41%), Gaps = 51/288 (17%)
Query: 217 NYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQFIN------EVVILSQI 269
            Y     LG GGFG+VY G+ + D   VA+K  ++   +   +  N      EVV+L ++
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 270 NH--RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
           +     +++LL      +  VL+ E          + D              S  W    
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEP---VQDLFDFITERGALQEELARSFFW---- 117
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD-DKFSAKVSDFGISRSIPNDKTHLTT 386
               +V  AV + H+     + HRDIK  NIL+D ++   K+ DFG S ++  D  +  T
Sbjct: 118 ----QVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVY--T 167
Query: 387 TIQGTFGYLDPEYFQSSQFTDKS-DVYSFGVVLLELLTGKKPICFARVEEERNLVACFIS 445
              GT  Y  PE+ +  ++  +S  V+S G++L +++ G  P      E +  ++   + 
Sbjct: 168 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQVF 222
Query: 446 LAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQV 493
             +          RV+ E +         L   CL L    RPT +++
Sbjct: 223 FRQ----------RVSSECQ--------HLIRWCLALRPSDRPTFEEI 252

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 70/288 (24%), Positives = 120/288 (41%), Gaps = 51/288 (17%)
Query: 217 NYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQFIN------EVVILSQI 269
            Y     LG GGFG+VY G+ + D   VA+K  ++   +   +  N      EVV+L ++
Sbjct: 10  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 69
Query: 270 NH--RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
           +     +++LL      +  VL+ E          + D              S  W    
Sbjct: 70  SSGFSGVIRLLDWFERPDSFVLILERPEP---VQDLFDFITERGALQEELARSFFW---- 122
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD-DKFSAKVSDFGISRSIPNDKTHLTT 386
               +V  AV + H+     + HRDIK  NIL+D ++   K+ DFG S ++  D  +  T
Sbjct: 123 ----QVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVY--T 172
Query: 387 TIQGTFGYLDPEYFQSSQFTDKS-DVYSFGVVLLELLTGKKPICFARVEEERNLVACFIS 445
              GT  Y  PE+ +  ++  +S  V+S G++L +++ G  P      E +  ++   + 
Sbjct: 173 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQVF 227
Query: 446 LAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQV 493
             +          RV+ E +         L   CL L    RPT +++
Sbjct: 228 FRQ----------RVSSECQ--------HLIRWCLALRPSDRPTFEEI 257

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 70/288 (24%), Positives = 120/288 (41%), Gaps = 51/288 (17%)
Query: 217 NYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQFIN------EVVILSQI 269
            Y     LG GGFG+VY G+ + D   VA+K  ++   +   +  N      EVV+L ++
Sbjct: 9   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 68
Query: 270 NH--RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
           +     +++LL      +  VL+ E          + D              S  W    
Sbjct: 69  SSGFSGVIRLLDWFERPDSFVLILERPEP---VQDLFDFITERGALQEELARSFFW---- 121
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD-DKFSAKVSDFGISRSIPNDKTHLTT 386
               +V  AV + H+     + HRDIK  NIL+D ++   K+ DFG S ++  D  +  T
Sbjct: 122 ----QVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVY--T 171
Query: 387 TIQGTFGYLDPEYFQSSQFTDKS-DVYSFGVVLLELLTGKKPICFARVEEERNLVACFIS 445
              GT  Y  PE+ +  ++  +S  V+S G++L +++ G  P      E +  ++   + 
Sbjct: 172 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQVF 226
Query: 446 LAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQV 493
             +          RV+ E +         L   CL L    RPT +++
Sbjct: 227 FRQ----------RVSSECQ--------HLIRWCLALRPSDRPTFEEI 256

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 70/288 (24%), Positives = 120/288 (41%), Gaps = 51/288 (17%)
Query: 217 NYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQFIN------EVVILSQI 269
            Y     LG GGFG+VY G+ + D   VA+K  ++   +   +  N      EVV+L ++
Sbjct: 10  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 69
Query: 270 NH--RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
           +     +++LL      +  VL+ E          + D              S  W    
Sbjct: 70  SSGFSGVIRLLDWFERPDSFVLILERPEP---VQDLFDFITERGALQEELARSFFW---- 122
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD-DKFSAKVSDFGISRSIPNDKTHLTT 386
               +V  AV + H+     + HRDIK  NIL+D ++   K+ DFG S ++  D  +  T
Sbjct: 123 ----QVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVY--T 172
Query: 387 TIQGTFGYLDPEYFQSSQFTDKS-DVYSFGVVLLELLTGKKPICFARVEEERNLVACFIS 445
              GT  Y  PE+ +  ++  +S  V+S G++L +++ G  P      E +  ++   + 
Sbjct: 173 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQVF 227
Query: 446 LAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQV 493
             +          RV+ E +         L   CL L    RPT +++
Sbjct: 228 FRQ----------RVSSECQ--------HLIRWCLALRPSDRPTFEEI 257

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/213 (22%), Positives = 97/213 (45%), Gaps = 17/213 (7%)
Query: 218 YNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEID-KTQIHQFINEVVILSQINHRHIV 275
           Y Q +++G+G +G V         + VA+K+    + +T   + + E+ IL +  H +++
Sbjct: 45  YTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVI 104
Query: 276 KLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAG 335
            +      + +  +   YI    +   ++                LS ++      ++  
Sbjct: 105 GIRDILRASTLEAMRDVYIVQDLMETDLYKLLKS---------QQLSNDHICYFLYQILR 155
Query: 336 AVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISR--SIPNDKTHLTTTIQGTFG 393
            + Y+HS+    + HRD+K SN+L++     K+ DFG++R     +D T   T    T  
Sbjct: 156 GLKYIHSAN---VLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRW 212
Query: 394 YLDPEYFQSSQ-FTDKSDVYSFGVVLLELLTGK 425
           Y  PE   +S+ +T   D++S G +L E+L+ +
Sbjct: 213 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/215 (23%), Positives = 95/215 (44%), Gaps = 21/215 (9%)
Query: 218 YNQSRFLGQGGFGTV---YKGMLPDGSIVAVKRSKEID-KTQIHQFINEVVILSQINHRH 273
           Y    ++G+G +G V   Y  +  +   VA+K+    + +T   + + E+ IL +  H +
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 86
Query: 274 IVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEV 333
           I+ +        +  +   YI    +   ++                LS ++      ++
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDLMETDLY---------KLLKTQHLSNDHICYFLYQI 137
Query: 334 AGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTH--LTTTIQGT 391
              + Y+HS+    + HRD+K SN+LL+     K+ DFG++R    D  H    T    T
Sbjct: 138 LRGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVAT 194
Query: 392 FGYLDPEYFQSSQ-FTDKSDVYSFGVVLLELLTGK 425
             Y  PE   +S+ +T   D++S G +L E+L+ +
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 95/229 (41%), Gaps = 28/229 (12%)
Query: 212 QRATDNYNQSRFLGQGGFGTVYK------GMLPDGSIVAVKRSKEIDKTQIHQFIN-EVV 264
           +   D Y+    LG G F  V K      G+      +  +R+K   +    + I  EV 
Sbjct: 6   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 65
Query: 265 ILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWE 324
           IL +I H +++ L          +L+ E ++ G L   + +              SL+ E
Sbjct: 66  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK------------ESLTEE 113
Query: 325 NRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD----KFSAKVSDFGISRSIPND 380
                  ++   V Y+HS   + I H D+K  NI+L D    K   K+ DFG++  I  D
Sbjct: 114 EATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--D 168
Query: 381 KTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPIC 429
             +    I GT  ++ PE         ++D++S GV+   LL+G  P  
Sbjct: 169 FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 217

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 70/288 (24%), Positives = 120/288 (41%), Gaps = 51/288 (17%)
Query: 217 NYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQFIN------EVVILSQI 269
            Y     LG GGFG+VY G+ + D   VA+K  ++   +   +  N      EVV+L ++
Sbjct: 32  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 91
Query: 270 NH--RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
           +     +++LL      +  VL+ E          + D              S  W    
Sbjct: 92  SSGFSGVIRLLDWFERPDSFVLILERPEP---VQDLFDFITERGALQEELARSFFW---- 144
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD-DKFSAKVSDFGISRSIPNDKTHLTT 386
               +V  AV + H+     + HRDIK  NIL+D ++   K+ DFG S ++  D  +  T
Sbjct: 145 ----QVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVY--T 194
Query: 387 TIQGTFGYLDPEYFQSSQFTDKS-DVYSFGVVLLELLTGKKPICFARVEEERNLVACFIS 445
              GT  Y  PE+ +  ++  +S  V+S G++L +++ G  P      E +  ++   + 
Sbjct: 195 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQVF 249
Query: 446 LAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQV 493
             +          RV+ E +         L   CL L    RPT +++
Sbjct: 250 FRQ----------RVSXECQ--------HLIRWCLALRPSDRPTFEEI 279

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 95/229 (41%), Gaps = 28/229 (12%)
Query: 212 QRATDNYNQSRFLGQGGFGTVYK------GMLPDGSIVAVKRSKEIDKTQIHQFIN-EVV 264
           +   D Y+    LG G F  V K      G+      +  +R+K   +    + I  EV 
Sbjct: 6   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 65
Query: 265 ILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWE 324
           IL +I H +++ L          +L+ E ++ G L   + +              SL+ E
Sbjct: 66  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK------------ESLTEE 113
Query: 325 NRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD----KFSAKVSDFGISRSIPND 380
                  ++   V Y+HS   + I H D+K  NI+L D    K   K+ DFG++  I  D
Sbjct: 114 EATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--D 168
Query: 381 KTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPIC 429
             +    I GT  ++ PE         ++D++S GV+   LL+G  P  
Sbjct: 169 FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 217

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/258 (22%), Positives = 109/258 (42%), Gaps = 35/258 (13%)
Query: 218 YNQSRFLGQGGFGTV---YKGMLPDGSIVAVKRSKEID-KTQIHQFINEVVILSQINHRH 273
           Y    ++G+G +G V   Y  +  +   VA+K+    + +T   + + E+ IL +  H +
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 80
Query: 274 IVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEV 333
           I+ +        +  +   YI    +   ++                LS ++      ++
Sbjct: 81  IIGINDIIRAPTIEQMKDVYIVQDLMETDLY---------KLLKTQHLSNDHICYFLYQI 131
Query: 334 AGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTH--LTTTIQGT 391
              + Y+HS+    + HRD+K SN+LL+     K+ DFG++R    D  H    T    T
Sbjct: 132 LRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 188
Query: 392 FGYLDPEYFQSSQ-FTDKSDVYSFGVVLLELLTGKKPICFARV-------------EEER 437
             Y  PE   +S+ +T   D++S G +L E+L+  +PI   +                E+
Sbjct: 189 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPIFPGKHYLDQLNHILGILGSPEQ 247
Query: 438 NLVACFISLAKENQLLEI 455
             + C I+L   N LL +
Sbjct: 248 EDLNCIINLKARNYLLSL 265

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/213 (23%), Positives = 93/213 (43%), Gaps = 17/213 (7%)
Query: 218 YNQSRFLGQGGFGTVYKGMLPDGSI-VAVKRSKEID-KTQIHQFINEVVILSQINHRHIV 275
           Y    ++G+G +G V         + VA+K+    + +T   + + E+ IL +  H +I+
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 276 KLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAG 335
            +        +  +   YI    +   ++                LS ++      ++  
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETDLY---------KLLKTQHLSNDHICYFLYQILR 135
Query: 336 AVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTH--LTTTIQGTFG 393
            + Y+HS+    + HRD+K SN+LL+     K+ DFG++R    D  H    T    T  
Sbjct: 136 GLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRW 192
Query: 394 YLDPEYFQSSQ-FTDKSDVYSFGVVLLELLTGK 425
           Y  PE   +S+ +T   D++S G +L E+L+ +
Sbjct: 193 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/79 (41%), Positives = 45/79 (56%), Gaps = 2/79 (2%)
Query: 350 HRDIKSSNILLDDKFSAKVSDFGISRSIPNDK-THLTTTIQGTFGYLDPEYFQSSQFTDK 408
           HRD+K  NIL+     A + DFGI+ +  ++K T L  T+ GT  Y  PE F  S  T +
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV-GTLYYXAPERFSESHATYR 215
Query: 409 SDVYSFGVVLLELLTGKKP 427
           +D+Y+   VL E LTG  P
Sbjct: 216 ADIYALTCVLYECLTGSPP 234

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/215 (23%), Positives = 95/215 (44%), Gaps = 21/215 (9%)
Query: 218 YNQSRFLGQGGFGTV---YKGMLPDGSIVAVKRSKEID-KTQIHQFINEVVILSQINHRH 273
           Y    ++G+G +G V   Y  +  +   VA+K+    + +T   + + E+ IL +  H +
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 86
Query: 274 IVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEV 333
           I+ +        +  +   YI    +   ++                LS ++      ++
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDLMETDLY---------KLLKCQHLSNDHICYFLYQI 137
Query: 334 AGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTH--LTTTIQGT 391
              + Y+HS+    + HRD+K SN+LL+     K+ DFG++R    D  H    T    T
Sbjct: 138 LRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 194
Query: 392 FGYLDPEYFQSSQ-FTDKSDVYSFGVVLLELLTGK 425
             Y  PE   +S+ +T   D++S G +L E+L+ +
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 103/235 (43%), Gaps = 28/235 (11%)
Query: 216 DNYNQSRFLGQGGFGTVYK-GMLPDGSIVAVK---RSKEIDKTQIHQFINEVVILSQINH 271
           D+Y+    LG G FG V++      G+  A K      E DK  + +   E+  +S + H
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRK---EIQTMSVLRH 213
Query: 272 RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVAC 331
             +V L     +    V++YE++S G L   + D             + +S +  V    
Sbjct: 214 PTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEH-----------NKMSEDEAVEYMR 262
Query: 332 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA--KVSDFGISRSI-PNDKTHLTTTI 388
           +V   + +MH +  +   H D+K  NI+   K S   K+ DFG++  + P     +TT  
Sbjct: 263 QVCKGLCHMHENNYV---HLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT-- 317
Query: 389 QGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEE-RNLVAC 442
            GT  +  PE  +       +D++S GV+   LL+G  P      +E  RN+ +C
Sbjct: 318 -GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSC 371

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 95/229 (41%), Gaps = 28/229 (12%)
Query: 212 QRATDNYNQSRFLGQGGFGTVYK------GMLPDGSIVAVKRSKEIDKTQIHQFIN-EVV 264
           +   D Y+    LG G F  V K      G+      +  +R+K   +    + I  EV 
Sbjct: 7   ENVDDYYDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 265 ILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWE 324
           IL +I H +++ L          +L+ E ++ G L   + +              SL+ E
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK------------ESLTEE 114
Query: 325 NRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD----KFSAKVSDFGISRSIPND 380
                  ++   V Y+HS   + I H D+K  NI+L D    K   K+ DFG++  I  D
Sbjct: 115 EATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--D 169
Query: 381 KTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPIC 429
             +    I GT  ++ PE         ++D++S GV+   LL+G  P  
Sbjct: 170 FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 218

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 103/235 (43%), Gaps = 28/235 (11%)
Query: 216 DNYNQSRFLGQGGFGTVYK-GMLPDGSIVAVK---RSKEIDKTQIHQFINEVVILSQINH 271
           D+Y+    LG G FG V++      G+  A K      E DK  + +   E+  +S + H
Sbjct: 51  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRK---EIQTMSVLRH 107
Query: 272 RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVAC 331
             +V L     +    V++YE++S G L   + D             + +S +  V    
Sbjct: 108 PTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEH-----------NKMSEDEAVEYMR 156
Query: 332 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA--KVSDFGISRSI-PNDKTHLTTTI 388
           +V   + +MH +  +   H D+K  NI+   K S   K+ DFG++  + P     +TT  
Sbjct: 157 QVCKGLCHMHENNYV---HLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT-- 211
Query: 389 QGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEE-RNLVAC 442
            GT  +  PE  +       +D++S GV+   LL+G  P      +E  RN+ +C
Sbjct: 212 -GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSC 265

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 93/226 (41%), Gaps = 28/226 (12%)
Query: 215 TDNYNQSRFLGQGGFGTVYKGMLPDGS----IVAVKRSK-----EIDKTQIHQFINEVVI 265
           +  Y+    LG G FG V+  +  + +    +  +K+ K      I+  ++ +   E+ I
Sbjct: 23  SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAI 82
Query: 266 LSQINHRHIVKLLGCCLETEVPVLVYEYISSG-TLSHHIHDHXXXXXXXXXXXLSSLSWE 324
           LS++ H +I+K+L          LV E   SG  L   I  H              L   
Sbjct: 83  LSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQL--- 139
Query: 325 NRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHL 384
                      AV Y+       I HRDIK  NI++ + F+ K+ DFG +  +  ++  L
Sbjct: 140 ---------VSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYL--ERGKL 185
Query: 385 TTTIQGTFGYLDPEYFQSSQFTDKS-DVYSFGVVLLELLTGKKPIC 429
             T  GT  Y  PE    + +     +++S GV L  L+  + P C
Sbjct: 186 FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFC 231

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/215 (23%), Positives = 95/215 (44%), Gaps = 21/215 (9%)
Query: 218 YNQSRFLGQGGFGTV---YKGMLPDGSIVAVKRSKEID-KTQIHQFINEVVILSQINHRH 273
           Y    ++G+G +G V   Y  +  +   VA+K+    + +T   + + E+ IL +  H +
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 87
Query: 274 IVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEV 333
           I+ +        +  +   YI    +   ++                LS ++      ++
Sbjct: 88  IIGINDIIRAPTIEQMKDVYIVQDLMETDLY---------KLLKTQHLSNDHICYFLYQI 138
Query: 334 AGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTH--LTTTIQGT 391
              + Y+HS+    + HRD+K SN+LL+     K+ DFG++R    D  H    T    T
Sbjct: 139 LRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 195
Query: 392 FGYLDPEYFQSSQ-FTDKSDVYSFGVVLLELLTGK 425
             Y  PE   +S+ +T   D++S G +L E+L+ +
Sbjct: 196 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/215 (23%), Positives = 95/215 (44%), Gaps = 21/215 (9%)
Query: 218 YNQSRFLGQGGFGTV---YKGMLPDGSIVAVKRSKEID-KTQIHQFINEVVILSQINHRH 273
           Y    ++G+G +G V   Y  +  +   VA+K+    + +T   + + E+ IL +  H +
Sbjct: 31  YTNLSYIGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 88
Query: 274 IVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEV 333
           I+ +        +  +   YI    +   ++                LS ++      ++
Sbjct: 89  IIGINDIIRAPTIEQMKDVYIVQDLMETDLY---------KLLKTQHLSNDHICYFLYQI 139
Query: 334 AGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTH--LTTTIQGT 391
              + Y+HS+    + HRD+K SN+LL+     K+ DFG++R    D  H    T    T
Sbjct: 140 LRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 196
Query: 392 FGYLDPEYFQSSQ-FTDKSDVYSFGVVLLELLTGK 425
             Y  PE   +S+ +T   D++S G +L E+L+ +
Sbjct: 197 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/215 (23%), Positives = 95/215 (44%), Gaps = 21/215 (9%)
Query: 218 YNQSRFLGQGGFGTV---YKGMLPDGSIVAVKRSKEID-KTQIHQFINEVVILSQINHRH 273
           Y    ++G+G +G V   Y  +  +   VA+K+    + +T   + + E+ IL +  H +
Sbjct: 22  YTNLSYIGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 79
Query: 274 IVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEV 333
           I+ +        +  +   YI    +   ++                LS ++      ++
Sbjct: 80  IIGINDIIRAPTIEQMKDVYIVQDLMETDLY---------KLLKTQHLSNDHICYFLYQI 130
Query: 334 AGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTH--LTTTIQGT 391
              + Y+HS+    + HRD+K SN+LL+     K+ DFG++R    D  H    T    T
Sbjct: 131 LRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 187
Query: 392 FGYLDPEYFQSSQ-FTDKSDVYSFGVVLLELLTGK 425
             Y  PE   +S+ +T   D++S G +L E+L+ +
Sbjct: 188 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/215 (23%), Positives = 95/215 (44%), Gaps = 21/215 (9%)
Query: 218 YNQSRFLGQGGFGTV---YKGMLPDGSIVAVKRSKEID-KTQIHQFINEVVILSQINHRH 273
           Y    ++G+G +G V   Y  +  +   VA+K+    + +T   + + E+ IL +  H +
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 86
Query: 274 IVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEV 333
           I+ +        +  +   YI    +   ++                LS ++      ++
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDLMETDLY---------KLLKTQHLSNDHICYFLYQI 137
Query: 334 AGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTH--LTTTIQGT 391
              + Y+HS+    + HRD+K SN+LL+     K+ DFG++R    D  H    T    T
Sbjct: 138 LRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 194
Query: 392 FGYLDPEYFQSSQ-FTDKSDVYSFGVVLLELLTGK 425
             Y  PE   +S+ +T   D++S G +L E+L+ +
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/215 (23%), Positives = 95/215 (44%), Gaps = 21/215 (9%)
Query: 218 YNQSRFLGQGGFGTV---YKGMLPDGSIVAVKRSKEID-KTQIHQFINEVVILSQINHRH 273
           Y    ++G+G +G V   Y  +  +   VA+K+    + +T   + + E+ IL +  H +
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 80
Query: 274 IVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEV 333
           I+ +        +  +   YI    +   ++                LS ++      ++
Sbjct: 81  IIGINDIIRAPTIEQMKDVYIVQDLMETDLY---------KLLKTQHLSNDHICYFLYQI 131
Query: 334 AGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTH--LTTTIQGT 391
              + Y+HS+    + HRD+K SN+LL+     K+ DFG++R    D  H    T    T
Sbjct: 132 LRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 188
Query: 392 FGYLDPEYFQSSQ-FTDKSDVYSFGVVLLELLTGK 425
             Y  PE   +S+ +T   D++S G +L E+L+ +
Sbjct: 189 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/213 (23%), Positives = 93/213 (43%), Gaps = 17/213 (7%)
Query: 218 YNQSRFLGQGGFGTVYKGMLPDGSI-VAVKRSKEID-KTQIHQFINEVVILSQINHRHIV 275
           Y    ++G+G +G V         + VA+K+    + +T   + + E+ IL +  H +I+
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 276 KLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAG 335
            +        +  +   YI    +   ++                LS ++      ++  
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETDLY---------KLLKTQHLSNDHICYFLYQILR 135
Query: 336 AVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTH--LTTTIQGTFG 393
            + Y+HS+    + HRD+K SN+LL+     K+ DFG++R    D  H    T    T  
Sbjct: 136 GLKYIHSAN---VLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRW 192
Query: 394 YLDPEYFQSSQ-FTDKSDVYSFGVVLLELLTGK 425
           Y  PE   +S+ +T   D++S G +L E+L+ +
Sbjct: 193 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 68/233 (29%), Positives = 100/233 (42%), Gaps = 32/233 (13%)
Query: 215 TDNYNQSRFLGQGGFGTVYKGMLPDGS--IVAVK---RSKEIDKTQIHQFINEVVILSQI 269
           +D Y   + +G G FG V + M    S  +VAVK   R ++ID+    + IN       +
Sbjct: 17  SDRYELVKDIGSGNFG-VARLMRDKQSNELVAVKYIERGEKIDENVKREIINH----RSL 71
Query: 270 NHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRV 329
            H +IV+     L      +V EY S G L   I +               L        
Sbjct: 72  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQL-------- 123
Query: 330 ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA--KVSDFGISRSIPNDKTHLTTT 387
              ++G V+Y H+   + + HRD+K  N LLD   +   K+ DFG S+S        +T 
Sbjct: 124 ---ISG-VSYCHA---MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV 176
Query: 388 IQGTFGYLDPEYFQSSQFTDK-SDVYSFGVVLLELLTGKKPICFARVEEERNL 439
             GT  Y+ PE     ++  K +DV+S GV L  +L G  P  F   EE +N 
Sbjct: 177 --GTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYP--FEDPEEPKNF 225

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/213 (23%), Positives = 93/213 (43%), Gaps = 17/213 (7%)
Query: 218 YNQSRFLGQGGFGTVYKGMLPDGSI-VAVKRSKEID-KTQIHQFINEVVILSQINHRHIV 275
           Y    ++G+G +G V         + VA+K+    + +T   + + E+ IL +  H +I+
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 276 KLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAG 335
            +        +  +   YI    +   ++                LS ++      ++  
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETDLY---------KLLKTQHLSNDHICYFLYQILR 135
Query: 336 AVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTH--LTTTIQGTFG 393
            + Y+HS+    + HRD+K SN+LL+     K+ DFG++R    D  H    T    T  
Sbjct: 136 GLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRW 192
Query: 394 YLDPEYFQSSQ-FTDKSDVYSFGVVLLELLTGK 425
           Y  PE   +S+ +T   D++S G +L E+L+ +
Sbjct: 193 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 70/250 (28%), Positives = 101/250 (40%), Gaps = 37/250 (14%)
Query: 201 ERAKVFTAD---ELQRATDNYNQSRFLGQGGFGTVYKGMLPDG---SIVAVK---RSKEI 251
           +RA V T      +   +D Y+  + +G G FG     ++ D     +VAVK   R   I
Sbjct: 2   DRAPVTTGPLDMPIMHDSDRYDFVKDIGSGNFGVAR--LMRDKLTKELVAVKYIERGAAI 59
Query: 252 DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXX 311
           D+    + IN       + H +IV+     L      ++ EY S G L   I +      
Sbjct: 60  DENVQREIINH----RSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSE 115
Query: 312 XXXXXXLSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA--KVS 369
                    L               V+Y HS   + I HRD+K  N LLD   +   K+ 
Sbjct: 116 DEARFFFQQL------------LSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKIC 160
Query: 370 DFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDK-SDVYSFGVVLLELLTGKKPI 428
           DFG S+S        +T   GT  Y+ PE     ++  K +DV+S GV L  +L G  P 
Sbjct: 161 DFGYSKSSVLHSQPKSTV--GTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYP- 217
Query: 429 CFARVEEERN 438
            F   EE R+
Sbjct: 218 -FEDPEEPRD 226

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/107 (29%), Positives = 52/107 (48%), Gaps = 14/107 (13%)
Query: 327 VRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTT 386
           + +  ++A AV ++HS     + HRD+K SNI        KV DFG+  ++  D+   T 
Sbjct: 167 LHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 223
Query: 387 TIQ-----------GTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELL 422
                         GT  Y+ PE    + ++ K D++S G++L ELL
Sbjct: 224 LTPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/213 (23%), Positives = 92/213 (43%), Gaps = 17/213 (7%)
Query: 218 YNQSRFLGQGGFGTVYKGMLPDGSI-VAVKRSKEID-KTQIHQFINEVVILSQINHRHIV 275
           Y    ++G+G +G V         + VA+K+    + +T   + + E+ IL +  H +I+
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 104
Query: 276 KLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAG 335
            +        +  +   Y+ +         H              LS ++      ++  
Sbjct: 105 GINDIIRAPTIEQMKDVYLVT---------HLMGADLYKLLKTQHLSNDHICYFLYQILR 155
Query: 336 AVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTH--LTTTIQGTFG 393
            + Y+HS+    + HRD+K SN+LL+     K+ DFG++R    D  H    T    T  
Sbjct: 156 GLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRW 212
Query: 394 YLDPEYFQSSQ-FTDKSDVYSFGVVLLELLTGK 425
           Y  PE   +S+ +T   D++S G +L E+L+ +
Sbjct: 213 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 95/229 (41%), Gaps = 28/229 (12%)
Query: 212 QRATDNYNQSRFLGQGGFGTVYK------GMLPDGSIVAVKRSKEIDKTQIHQFIN-EVV 264
           +   D Y+    LG G F  V K      G+      +  +R+K   +    + I  EV 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 265 ILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWE 324
           IL +I H +++ L          +L+ E ++ G L   + +              SL+ E
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFLAEK------------ESLTEE 114
Query: 325 NRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD----KFSAKVSDFGISRSIPND 380
                  ++   V Y+HS   + I H D+K  NI+L D    K   K+ DFG++  I  D
Sbjct: 115 EATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--D 169
Query: 381 KTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPIC 429
             +    I GT  ++ PE         ++D++S GV+   LL+G  P  
Sbjct: 170 FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 218

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/213 (23%), Positives = 93/213 (43%), Gaps = 17/213 (7%)
Query: 218 YNQSRFLGQGGFGTVYKGMLPDGSI-VAVKRSKEID-KTQIHQFINEVVILSQINHRHIV 275
           Y    ++G+G +G V         + VA+K+    + +T   + + E+ IL +  H +I+
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 276 KLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAG 335
            +        +  +   YI    +   ++                LS ++      ++  
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETDLY---------KLLKTQHLSNDHICYFLYQILR 135
Query: 336 AVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTH--LTTTIQGTFG 393
            + Y+HS+    + HRD+K SN+LL+     K+ DFG++R    D  H    T    T  
Sbjct: 136 GLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 192
Query: 394 YLDPEYFQSSQ-FTDKSDVYSFGVVLLELLTGK 425
           Y  PE   +S+ +T   D++S G +L E+L+ +
Sbjct: 193 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 98/230 (42%), Gaps = 31/230 (13%)
Query: 205 VFTADELQRATDNYNQSRFLGQGGFGTV---YKGMLPDGSIVAVKRSKEIDKTQIH--QF 259
           V  AD        Y Q + +G G  G V   +  +L  G  VAVK+     + Q H  + 
Sbjct: 11  VQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVL--GINVAVKKLSRPFQNQTHAKRA 68
Query: 260 INEVVILSQINHRHIVKLLGC-----CLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXX 314
             E+V+L  +NH++I+ LL        LE    V +   +    L   IH          
Sbjct: 69  YRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIH---------- 118
Query: 315 XXXLSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGIS 374
                 L  E    +  ++   + ++HS+    I HRD+K SNI++    + K+ DFG++
Sbjct: 119 ----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 171
Query: 375 RSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTG 424
           R+   +   + T    T  Y  PE      + +  D++S G ++ EL+ G
Sbjct: 172 RTASTN--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 219

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/213 (23%), Positives = 93/213 (43%), Gaps = 17/213 (7%)
Query: 218 YNQSRFLGQGGFGTVYKGMLPDGSI-VAVKRSKEID-KTQIHQFINEVVILSQINHRHIV 275
           Y    ++G+G +G V         + VA+K+    + +T   + + E+ IL +  H +I+
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 86
Query: 276 KLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAG 335
            +        +  +   YI    +   ++                LS ++      ++  
Sbjct: 87  GINDIIRAPTIEQMKDVYIVQDLMETDLY---------KLLKTQHLSNDHICYFLYQILR 137
Query: 336 AVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTH--LTTTIQGTFG 393
            + Y+HS+    + HRD+K SN+LL+     K+ DFG++R    D  H    T    T  
Sbjct: 138 GLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 194
Query: 394 YLDPEYFQSSQ-FTDKSDVYSFGVVLLELLTGK 425
           Y  PE   +S+ +T   D++S G +L E+L+ +
Sbjct: 195 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/213 (23%), Positives = 93/213 (43%), Gaps = 17/213 (7%)
Query: 218 YNQSRFLGQGGFGTVYKGMLPDGSI-VAVKRSKEID-KTQIHQFINEVVILSQINHRHIV 275
           Y    ++G+G +G V         + VA+K+    + +T   + + E+ IL +  H +I+
Sbjct: 33  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 92
Query: 276 KLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAG 335
            +        +  +   YI    +   ++                LS ++      ++  
Sbjct: 93  GINDIIRAPTIEQMKDVYIVQDLMETDLY---------KLLKTQHLSNDHICYFLYQILR 143
Query: 336 AVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTH--LTTTIQGTFG 393
            + Y+HS+    + HRD+K SN+LL+     K+ DFG++R    D  H    T    T  
Sbjct: 144 GLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 200
Query: 394 YLDPEYFQSSQ-FTDKSDVYSFGVVLLELLTGK 425
           Y  PE   +S+ +T   D++S G +L E+L+ +
Sbjct: 201 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/213 (23%), Positives = 93/213 (43%), Gaps = 17/213 (7%)
Query: 218 YNQSRFLGQGGFGTVYKGMLPDGSI-VAVKRSKEID-KTQIHQFINEVVILSQINHRHIV 275
           Y    ++G+G +G V         + VA+K+    + +T   + + E+ IL +  H +I+
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 276 KLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAG 335
            +        +  +   YI    +   ++                LS ++      ++  
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETDLY---------KLLKTQHLSNDHICYFLYQILR 135
Query: 336 AVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTH--LTTTIQGTFG 393
            + Y+HS+    + HRD+K SN+LL+     K+ DFG++R    D  H    T    T  
Sbjct: 136 GLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 192
Query: 394 YLDPEYFQSSQ-FTDKSDVYSFGVVLLELLTGK 425
           Y  PE   +S+ +T   D++S G +L E+L+ +
Sbjct: 193 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/213 (23%), Positives = 93/213 (43%), Gaps = 17/213 (7%)
Query: 218 YNQSRFLGQGGFGTVYKGMLPDGSI-VAVKRSKEID-KTQIHQFINEVVILSQINHRHIV 275
           Y    ++G+G +G V         + VA+K+    + +T   + + E+ IL +  H +I+
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 104
Query: 276 KLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAG 335
            +        +  +   YI    +   ++                LS ++      ++  
Sbjct: 105 GINDIIRAPTIEQMKDVYIVQDLMETDLY---------KLLKTQHLSNDHICYFLYQILR 155
Query: 336 AVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTH--LTTTIQGTFG 393
            + Y+HS+    + HRD+K SN+LL+     K+ DFG++R    D  H    T    T  
Sbjct: 156 GLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 212
Query: 394 YLDPEYFQSSQ-FTDKSDVYSFGVVLLELLTGK 425
           Y  PE   +S+ +T   D++S G +L E+L+ +
Sbjct: 213 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/278 (22%), Positives = 116/278 (41%), Gaps = 36/278 (12%)
Query: 224 LGQGGFGTVYK-GMLPDGSIVAVKRSKEIDKTQIHQ--FINEVVILSQINHRHIVKLLGC 280
           LG+G +G V K   +P G I+AVKR +    +Q  +   ++  + +  ++    V   G 
Sbjct: 59  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 118
Query: 281 CLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYM 340
               E  V +   +   +L                  L         ++A  +  A+ ++
Sbjct: 119 LFR-EGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILG--------KIAVSIVKALEHL 169
Query: 341 HSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEY- 399
           HS  S+   HRD+K SN+L++     K+ DFGIS  + +  +   T   G   Y+ PE  
Sbjct: 170 HSKLSV--IHRDVKPSNVLINALGQVKMCDFGISGYLVD--SVAKTIDAGCKPYMAPERI 225
Query: 400 ---FQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKE-NQLLEI 455
                   ++ KSD++S G+ ++EL   + P               + S      QL ++
Sbjct: 226 NPELNQKGYSVKSDIWSLGITMIELAILRFP---------------YDSWGTPFQQLKQV 270
Query: 456 LDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQV 493
           ++    +   ++      +   +CL+ NSK+RPT  ++
Sbjct: 271 VEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPEL 308

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/278 (22%), Positives = 115/278 (41%), Gaps = 36/278 (12%)
Query: 224 LGQGGFGTVYK-GMLPDGSIVAVKRSKEIDKTQIHQ--FINEVVILSQINHRHIVKLLGC 280
           LG+G +G V K   +P G I+AVKR +    +Q  +   ++  + +  ++    V   G 
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 281 CLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYM 340
               E  V +   +   +L                  L         ++A  +  A+ ++
Sbjct: 75  LFR-EGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILG--------KIAVSIVKALEHL 125
Query: 341 HSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEY- 399
           HS  S+   HRD+K SN+L++     K+ DFGIS  + +D         G   Y+ PE  
Sbjct: 126 HSKLSV--IHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA--GCKPYMAPERI 181
Query: 400 ---FQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKE-NQLLEI 455
                   ++ KSD++S G+ ++EL   + P               + S      QL ++
Sbjct: 182 NPELNQKGYSVKSDIWSLGITMIELAILRFP---------------YDSWGTPFQQLKQV 226
Query: 456 LDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQV 493
           ++    +   ++      +   +CL+ NSK+RPT  ++
Sbjct: 227 VEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPEL 264

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 102/235 (43%), Gaps = 36/235 (15%)
Query: 215 TDNYNQSRFLGQGGFGTVYKGMLPD---GSIVAVK---RSKEIDKTQIHQFINEVVILSQ 268
           +D Y   + +G G FG     ++ D     +VAVK   R ++ID+    + IN       
Sbjct: 18  SDRYELVKDIGAGNFGVAR--LMRDKQANELVAVKYIERGEKIDENVKREIINH----RS 71
Query: 269 INHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVR 328
           + H +IV+     L      +V EY S G L   I +               L       
Sbjct: 72  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQL------- 124
Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA--KVSDFGISR-SIPNDKTHLT 385
               ++G V+Y H+   + + HRD+K  N LLD   +   K++DFG S+ S+ + +    
Sbjct: 125 ----ISG-VSYAHA---MQVAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQ---P 173
Query: 386 TTIQGTFGYLDPEYFQSSQFTDK-SDVYSFGVVLLELLTGKKPICFARVEEERNL 439
            +  GT  Y+ PE     ++  K +DV+S GV L  +L G  P  F   EE +N 
Sbjct: 174 KSAVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYP--FEDPEEPKNF 226

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/241 (24%), Positives = 99/241 (41%), Gaps = 47/241 (19%)
Query: 216 DNYNQSRFLGQGGFGTV---YKGMLPDGSIVAVKRSKEI--DKTQIHQFINEVVILSQIN 270
           D Y     +G G +G V   Y  +  +  +VA+K+   +  D     + + E+ IL+++N
Sbjct: 53  DRYEIRHLIGTGSYGHVCEAYDKL--EKRVVAIKKILRVFEDLIDCKRILREIAILNRLN 110
Query: 271 HRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVA 330
           H H+VK+L   +  +V     E      +   I D            L+ L  +    + 
Sbjct: 111 HDHVVKVLDIVIPKDV-----EKFDELYVVLEIADSDFKKLFRTPVYLTELHIKT---LL 162
Query: 331 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI------------- 377
             +   V Y+HS+    I HRD+K +N L++   S KV DFG++R++             
Sbjct: 163 YNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPIS 219
Query: 378 -----------PNDKTHLTTTIQG---TFGYLDPEY-FQSSQFTDKSDVYSFGVVLLELL 422
                      P+ K  L   + G   T  Y  PE       +T+  DV+S G +  ELL
Sbjct: 220 PREDDMNLVTFPHTKN-LKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELL 278
Query: 423 T 423
Sbjct: 279 N 279

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/215 (22%), Positives = 95/215 (44%), Gaps = 21/215 (9%)
Query: 218 YNQSRFLGQGGFGTV---YKGMLPDGSIVAVKRSKEID-KTQIHQFINEVVILSQINHRH 273
           Y    ++G+G +G V   Y  +  +   VA+++    + +T   + + E+ IL +  H +
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNL--NKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHEN 86
Query: 274 IVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEV 333
           I+ +        +  +   YI    +   ++                LS ++      ++
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDLMETDLY---------KLLKTQHLSNDHICYFLYQI 137
Query: 334 AGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTH--LTTTIQGT 391
              + Y+HS+    + HRD+K SN+LL+     K+ DFG++R    D  H    T    T
Sbjct: 138 LRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 194
Query: 392 FGYLDPEYFQSSQ-FTDKSDVYSFGVVLLELLTGK 425
             Y  PE   +S+ +T   D++S G +L E+L+ +
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/213 (23%), Positives = 92/213 (43%), Gaps = 17/213 (7%)
Query: 218 YNQSRFLGQGGFGTVYKGMLPDGSI-VAVKRSKEID-KTQIHQFINEVVILSQINHRHIV 275
           Y    ++G+G +G V         + VA+K+    + +T   + + E+ IL    H +I+
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENII 86
Query: 276 KLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAG 335
            +        +  +   YI    +   ++                LS ++      ++  
Sbjct: 87  GINDIIRAPTIEQMKDVYIVQDLMETDLY---------KLLKTQHLSNDHICYFLYQILR 137
Query: 336 AVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTH--LTTTIQGTFG 393
            + Y+HS+    + HRD+K SN+LL+     K+ DFG++R    D  H    T    T  
Sbjct: 138 GLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 194
Query: 394 YLDPEYFQSSQ-FTDKSDVYSFGVVLLELLTGK 425
           Y  PE   +S+ +T   D++S G +L E+L+ +
Sbjct: 195 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 97/223 (43%), Gaps = 30/223 (13%)
Query: 221 SRFLGQGGFGTVYKGMLPD-GSIVAVKRSKEIDKTQ-IHQFINEVVILSQINHRHIVKLL 278
           S  LGQG    V++G     G + A+K    I   + +   + E  +L ++NH++IVKL 
Sbjct: 14  SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF 73
Query: 279 GCCLETEV--PVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGA 336
               ET     VL+ E+   G+L   + +            L  L          +V G 
Sbjct: 74  AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLR---------DVVGG 124
Query: 337 VAYMHSSASIPIFHRDIKSSNILL----DDKFSAKVSDFGISRSIPNDKTHLTTTIQGTF 392
           + ++  +    I HR+IK  NI+     D +   K++DFG +R + +D+  +   + GT 
Sbjct: 125 MNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFV--XLYGTE 179
Query: 393 GYLDPEYFQSS--------QFTDKSDVYSFGVVLLELLTGKKP 427
            YL P+ ++ +        ++    D++S GV      TG  P
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 98/223 (43%), Gaps = 30/223 (13%)
Query: 221 SRFLGQGGFGTVYKGMLPD-GSIVAVKRSKEIDKTQ-IHQFINEVVILSQINHRHIVKLL 278
           S  LGQG    V++G     G + A+K    I   + +   + E  +L ++NH++IVKL 
Sbjct: 14  SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF 73
Query: 279 GCCLETEV--PVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGA 336
               ET     VL+ E+   G+L   + +            L  L          +V G 
Sbjct: 74  AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLR---------DVVGG 124
Query: 337 VAYMHSSASIPIFHRDIKSSNILL----DDKFSAKVSDFGISRSIPNDKTHLTTTIQGTF 392
           + ++  +    I HR+IK  NI+     D +   K++DFG +R + +D+  +  ++ GT 
Sbjct: 125 MNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFV--SLYGTE 179
Query: 393 GYLDPEYFQSS--------QFTDKSDVYSFGVVLLELLTGKKP 427
            YL P+ ++ +        ++    D++S GV      TG  P
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 97/230 (42%), Gaps = 31/230 (13%)
Query: 205 VFTADELQRATDNYNQSRFLGQGGFGTV---YKGMLPDGSIVAVKRSKEIDKTQIH--QF 259
           V  AD        Y Q + +G G  G V   +  +L  G  VAVK+     + Q H  + 
Sbjct: 13  VEVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVL--GINVAVKKLSRPFQNQTHAKRA 70
Query: 260 INEVVILSQINHRHIVKLLGC-----CLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXX 314
             E+V+L  +NH++I+ LL        LE    V +   +    L   IH          
Sbjct: 71  YRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIH---------- 120
Query: 315 XXXLSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGIS 374
                 L  E    +  ++   + ++HS+    I HRD+K SNI++    + K+ DFG++
Sbjct: 121 ----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 173
Query: 375 RSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTG 424
           R+   +   + T    T  Y  PE      +    D++S G ++ EL+ G
Sbjct: 174 RTACTN--FMMTPYVVTRYYRAPEVILGMGYAANVDIWSVGCIMGELVKG 221

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/213 (23%), Positives = 92/213 (43%), Gaps = 17/213 (7%)
Query: 218 YNQSRFLGQGGFGTVYKGMLPDGSI-VAVKRSKEID-KTQIHQFINEVVILSQINHRHIV 275
           Y    ++G+G +G V         + VA+K+    + +T   + + E+ IL    H +I+
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENII 86
Query: 276 KLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAG 335
            +        +  +   YI    +   ++                LS ++      ++  
Sbjct: 87  GINDIIRAPTIEQMKDVYIVQDLMETDLY---------KLLKTQHLSNDHICYFLYQILR 137
Query: 336 AVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTH--LTTTIQGTFG 393
            + Y+HS+    + HRD+K SN+LL+     K+ DFG++R    D  H    T    T  
Sbjct: 138 GLKYIHSAN---VLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRW 194
Query: 394 YLDPEYFQSSQ-FTDKSDVYSFGVVLLELLTGK 425
           Y  PE   +S+ +T   D++S G +L E+L+ +
Sbjct: 195 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 82/176 (46%), Gaps = 26/176 (14%)
Query: 260 INEVVILSQIN-HRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXL 318
           + EV IL +++ H +I++L           LV++ +  G L  ++ +            L
Sbjct: 71  LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE---------KVTL 121
Query: 319 SSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI- 377
           S       +R   EV  A+  ++      I HRD+K  NILLDD  + K++DFG S  + 
Sbjct: 122 SEKETRKIMRALLEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQLD 175
Query: 378 PNDKTHLTTTIQGTFGYLDPEYFQSSQ------FTDKSDVYSFGVVLLELLTGKKP 427
           P +K     ++ GT  YL PE  + S       +  + D++S GV++  LL G  P
Sbjct: 176 PGEKLR---SVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 81/176 (46%), Gaps = 26/176 (14%)
Query: 260 INEVVILSQIN-HRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXL 318
           + EV IL +++ H +I++L           LV++ +  G L  ++ +            L
Sbjct: 58  LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE---------KVTL 108
Query: 319 SSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI- 377
           S       +R   EV  A+  ++      I HRD+K  NILLDD  + K++DFG S  + 
Sbjct: 109 SEKETRKIMRALLEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQLD 162
Query: 378 PNDKTHLTTTIQGTFGYLDPEYFQSSQ------FTDKSDVYSFGVVLLELLTGKKP 427
           P +K      + GT  YL PE  + S       +  + D++S GV++  LL G  P
Sbjct: 163 PGEKLR---EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 215

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 94/217 (43%), Gaps = 31/217 (14%)
Query: 218 YNQSRFLGQGGFGTV---YKGMLPDGSIVAVKRSKEIDKTQIH--QFINEVVILSQINHR 272
           Y   + +G G  G V   Y  +L     VA+K+     + Q H  +   E+V++  +NH+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHK 83
Query: 273 HIVKLLGC-----CLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
           +I+ LL        LE    V +   +    LS  I                 L  E   
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ--------------MELDHERMS 129
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
            +  ++   + ++HS+    I HRD+K SNI++    + K+ DFG++R+     + + T 
Sbjct: 130 YLLYQMLVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTA--GTSFMMTP 184
Query: 388 IQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTG 424
              T  Y  PE      + +  D++S GV++ E++ G
Sbjct: 185 YVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 45/180 (25%), Positives = 83/180 (46%), Gaps = 17/180 (9%)
Query: 253 KTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXX 312
           K++   F NE+ I++ I + + +   G     +   ++YEY+ + ++     D       
Sbjct: 84  KSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKF--DEYFFVLD 141
Query: 313 XXXXXLSSLSWENRVRVAC---EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVS 369
                   +       + C    V  + +Y+H+  +I   HRD+K SNIL+D     K+S
Sbjct: 142 KNYTCFIPIQ-----VIKCIIKSVLNSFSYIHNEKNIC--HRDVKPSNILMDKNGRVKLS 194
Query: 370 DFGISRSIPNDKTHLTTTIQGTFGYLDPEYF--QSSQFTDKSDVYSFGVVLLELLTGKKP 427
           DFG S  + + K   +   +GT+ ++ PE+F  +SS    K D++S G+ L  +     P
Sbjct: 195 DFGESEYMVDKKIKGS---RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 66/272 (24%), Positives = 107/272 (39%), Gaps = 37/272 (13%)
Query: 210 ELQRATDNYNQSRFLGQGGFGTV-YKGMLPDGSIVAVKRSKEID---KTQIHQFINEVVI 265
           E++   D++   + +G+G F  V    M   G + A+K   + D   + ++  F  E  +
Sbjct: 55  EVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDV 114
Query: 266 LSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWEN 325
           L   + R I +L     +     LV EY   G L                  LS      
Sbjct: 115 LVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDL---------------LTLLSKFGERI 159
Query: 326 RVRVA----CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDK 381
              +A     E+  A+  +H    +   HRDIK  NILLD     +++DFG    +  D 
Sbjct: 160 PAEMARFYLAEIVMAIDSVHRLGYV---HRDIKPDNILLDRCGHIRLADFGSCLKLRADG 216
Query: 382 THLTTTIQGTFGYLDPEYFQS-------SQFTDKSDVYSFGVVLLELLTGKKPICFARVE 434
           T  +    GT  YL PE  Q+         +  + D ++ GV   E+  G+ P       
Sbjct: 217 TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA 276
Query: 435 EERNLVACFISLAKENQLLEILDARVAKEARE 466
           E    +  +    KE+  L ++D  V +EAR+
Sbjct: 277 ETYGKIVHY----KEHLSLPLVDEGVPEEARD 304

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 103/233 (44%), Gaps = 31/233 (13%)
Query: 209 DELQRATDNYNQSRFLGQGGFGTVYKG--MLPDGSIVAVKRSK--EIDKTQIHQFINEVV 264
           D L RA   Y     +G+G +G V+K   +   G  VA+KR +    ++      I EV 
Sbjct: 4   DGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVA 63
Query: 265 ILSQIN---HRHIVKLLGCCL------ETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXX 315
           +L  +    H ++V+L   C       ET++  LV+E++     ++              
Sbjct: 64  VLRHLETFEHPNVVRLFDVCTVSRTDRETKL-TLVFEHVDQDLTTY-----------LDK 111
Query: 316 XXLSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISR 375
                +  E    +  ++   + ++HS     + HRD+K  NIL+      K++DFG++R
Sbjct: 112 VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR 168
Query: 376 SIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
            I + +  LT+ +  T  Y  PE    S +    D++S G +  E+   +KP+
Sbjct: 169 -IYSFQMALTSVVV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 218

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 95/230 (41%), Gaps = 34/230 (14%)
Query: 212 QRATDNYNQSRFLGQGGFGTVYK------GMLPDGSIVAVKRSKE----IDKTQIHQFIN 261
           Q+  D Y+    LG G F  V K      G+      +  ++S+     + + +I +   
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIER--- 64
Query: 262 EVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSL 321
           EV IL Q+ H +++ L          VL+ E +S G L   +                SL
Sbjct: 65  EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQK------------ESL 112
Query: 322 SWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF----SAKVSDFGISRSI 377
           S E       ++   V Y+H+     I H D+K  NI+L DK       K+ DFG++  I
Sbjct: 113 SEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169
Query: 378 PNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
            +        I GT  ++ PE         ++D++S GV+   LL+G  P
Sbjct: 170 EDGVEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 94/217 (43%), Gaps = 31/217 (14%)
Query: 218 YNQSRFLGQGGFGTV---YKGMLPDGSIVAVKRSKEIDKTQIH--QFINEVVILSQINHR 272
           Y   + +G G  G V   Y  +L     VA+K+     + Q H  +   E+V++  +NH+
Sbjct: 26  YQNLKPIGSGAQGIVVAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHK 83
Query: 273 HIVKLLGC-----CLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
           +I+ LL        LE    V +   +    LS  I                 L  E   
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ--------------MELDHERMS 129
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
            +  ++   + ++HS+    I HRD+K SNI++    + K+ DFG++R+     + + T 
Sbjct: 130 YLLYQMLVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTA--GTSFMMTP 184
Query: 388 IQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTG 424
              T  Y  PE      + +  D++S GV++ E++ G
Sbjct: 185 YVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 49/215 (22%), Positives = 95/215 (44%), Gaps = 21/215 (9%)
Query: 218 YNQSRFLGQGGFGTV---YKGMLPDGSIVAVKRSKEID-KTQIHQFINEVVILSQINHRH 273
           Y    ++G+G +G V   Y  +  +   VA+K+    + +T   + + E+ IL +  H +
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 86
Query: 274 IVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEV 333
           I+ +        +  +   YI    +   ++                LS ++      ++
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDLMETDLY---------KLLKTQHLSNDHICYFLYQI 137
Query: 334 AGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQ--GT 391
              + Y+HS+    + HRD+K SN+LL+     K+ DFG++R    D  H     +   T
Sbjct: 138 LRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVAT 194
Query: 392 FGYLDPEYFQSSQ-FTDKSDVYSFGVVLLELLTGK 425
             Y  PE   +S+ +T   D++S G +L E+L+ +
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 49/215 (22%), Positives = 95/215 (44%), Gaps = 21/215 (9%)
Query: 218 YNQSRFLGQGGFGTV---YKGMLPDGSIVAVKRSKEID-KTQIHQFINEVVILSQINHRH 273
           Y    ++G+G +G V   Y  +  +   VA+K+    + +T   + + E+ IL +  H +
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 87
Query: 274 IVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEV 333
           I+ +        +  +   YI    +   ++                LS ++      ++
Sbjct: 88  IIGINDIIRAPTIEQMKDVYIVQDLMETDLY---------KLLKTQHLSNDHICYFLYQI 138
Query: 334 AGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQ--GT 391
              + Y+HS+    + HRD+K SN+LL+     K+ DFG++R    D  H     +   T
Sbjct: 139 LRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVAT 195
Query: 392 FGYLDPEYFQSSQ-FTDKSDVYSFGVVLLELLTGK 425
             Y  PE   +S+ +T   D++S G +L E+L+ +
Sbjct: 196 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 95/230 (41%), Gaps = 34/230 (14%)
Query: 212 QRATDNYNQSRFLGQGGFGTVYK------GMLPDGSIVAVKRSKE----IDKTQIHQFIN 261
           Q+  D Y+    LG G F  V K      G+      +  ++S+     + + +I +   
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIER--- 64
Query: 262 EVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSL 321
           EV IL Q+ H +++ L          VL+ E +S G L   +                SL
Sbjct: 65  EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQK------------ESL 112
Query: 322 SWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF----SAKVSDFGISRSI 377
           S E       ++   V Y+H+     I H D+K  NI+L DK       K+ DFG++  I
Sbjct: 113 SEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169
Query: 378 PNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
            +        I GT  ++ PE         ++D++S GV+   LL+G  P
Sbjct: 170 EDGVEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 103/233 (44%), Gaps = 31/233 (13%)
Query: 209 DELQRATDNYNQSRFLGQGGFGTVYKG--MLPDGSIVAVKRSK--EIDKTQIHQFINEVV 264
           D L RA   Y     +G+G +G V+K   +   G  VA+KR +    ++      I EV 
Sbjct: 4   DGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVA 63
Query: 265 ILSQIN---HRHIVKLLGCCL------ETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXX 315
           +L  +    H ++V+L   C       ET++  LV+E++     ++              
Sbjct: 64  VLRHLETFEHPNVVRLFDVCTVSRTDRETKL-TLVFEHVDQDLTTY-----------LDK 111
Query: 316 XXLSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISR 375
                +  E    +  ++   + ++HS     + HRD+K  NIL+      K++DFG++R
Sbjct: 112 VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR 168
Query: 376 SIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
            I + +  LT+ +  T  Y  PE    S +    D++S G +  E+   +KP+
Sbjct: 169 -IYSFQMALTSVVV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 218

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 103/233 (44%), Gaps = 31/233 (13%)
Query: 209 DELQRATDNYNQSRFLGQGGFGTVYKG--MLPDGSIVAVKRSK--EIDKTQIHQFINEVV 264
           D L RA   Y     +G+G +G V+K   +   G  VA+KR +    ++      I EV 
Sbjct: 4   DGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVA 63
Query: 265 ILSQIN---HRHIVKLLGCCL------ETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXX 315
           +L  +    H ++V+L   C       ET++  LV+E++     ++              
Sbjct: 64  VLRHLETFEHPNVVRLFDVCTVSRTDRETKL-TLVFEHVDQDLTTY-----------LDK 111
Query: 316 XXLSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISR 375
                +  E    +  ++   + ++HS     + HRD+K  NIL+      K++DFG++R
Sbjct: 112 VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR 168
Query: 376 SIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
            I + +  LT+ +  T  Y  PE    S +    D++S G +  E+   +KP+
Sbjct: 169 -IYSFQMALTSVVV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 218

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 81/176 (46%), Gaps = 26/176 (14%)
Query: 260 INEVVILSQIN-HRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXL 318
           + EV IL +++ H +I++L           LV++ +  G L  ++ +            L
Sbjct: 71  LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE---------KVTL 121
Query: 319 SSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI- 377
           S       +R   EV  A+  ++      I HRD+K  NILLDD  + K++DFG S  + 
Sbjct: 122 SEKETRKIMRALLEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQLD 175
Query: 378 PNDKTHLTTTIQGTFGYLDPEYFQSSQ------FTDKSDVYSFGVVLLELLTGKKP 427
           P +K      + GT  YL PE  + S       +  + D++S GV++  LL G  P
Sbjct: 176 PGEKLR---EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 95/230 (41%), Gaps = 34/230 (14%)
Query: 212 QRATDNYNQSRFLGQGGFGTVYK------GMLPDGSIVAVKRSKE----IDKTQIHQFIN 261
           Q+  D Y+    LG G F  V K      G+      +  ++S+     + + +I +   
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIER--- 64
Query: 262 EVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSL 321
           EV IL Q+ H +++ L          VL+ E +S G L   +                SL
Sbjct: 65  EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQK------------ESL 112
Query: 322 SWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF----SAKVSDFGISRSI 377
           S E       ++   V Y+H+     I H D+K  NI+L DK       K+ DFG++  I
Sbjct: 113 SEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169
Query: 378 PNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
            +        I GT  ++ PE         ++D++S GV+   LL+G  P
Sbjct: 170 EDGVEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 59/258 (22%), Positives = 108/258 (41%), Gaps = 36/258 (13%)
Query: 218 YNQSRFLGQGGFGTVYKGMLPD-GSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVK 276
           Y   + LG GG G V+  +  D    VA+K+    D   +   + E+ I+ +++H +IVK
Sbjct: 13  YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 72
Query: 277 L--------------LGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLS 322
           +              +G   E     +V EY+ +   +                    L 
Sbjct: 73  VFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLAN--------------VLEQGPLL 118
Query: 323 WENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD-DKFSAKVSDFGISRSIPNDK 381
            E+      ++   + Y+HS+    + HRD+K +N+ ++ +    K+ DFG++R +    
Sbjct: 119 EEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHY 175
Query: 382 THLTTTIQG--TFGYLDPEYFQS-SQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERN 438
           +H     +G  T  Y  P    S + +T   D+++ G +  E+LTGK     A   E+  
Sbjct: 176 SHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQ 235
Query: 439 LVACFISLAKENQLLEIL 456
           L+   I +  E    E+L
Sbjct: 236 LILESIPVVHEEDRQELL 253

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 43/182 (23%), Positives = 86/182 (47%), Gaps = 20/182 (10%)
Query: 321 LSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPND 380
           ++ E+ +  + +VA  + ++ S   I   HRD+ + NILL +    K+ DFG++R I  +
Sbjct: 196 ITMEDLISYSFQVARGMEFLSSRKCI---HRDLAARNILLSENNVVKICDFGLARDIYKN 252
Query: 381 KTHLTT-TIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERN 438
             ++     +    ++ PE      ++ KSDV+S+GV+L E+ + G  P    +++E+  
Sbjct: 253 PDYVRKGDTRLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSPYPGVQMDED-- 310
Query: 439 LVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELE 498
               F S  +E   +          A E     + ++ + C   + K+RP   ++  +L 
Sbjct: 311 ----FCSRLREGMRM---------RAPEYSTPEIYQIMLDCWHRDPKERPRFAELVEKLG 357
Query: 499 GL 500
            L
Sbjct: 358 DL 359

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 93/227 (40%), Gaps = 28/227 (12%)
Query: 212 QRATDNYNQSRFLGQGGFGTVYK------GMLPDGSIVAVKRSKEIDKTQIHQFIN-EVV 264
           Q+  D Y+    LG G F  V K      G+      +  ++S+   +    + I  EV 
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVS 67
Query: 265 ILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWE 324
           IL Q+ H +I+ L          VL+ E +S G L   +                SLS E
Sbjct: 68  ILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQK------------ESLSEE 115
Query: 325 NRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF----SAKVSDFGISRSIPND 380
                  ++   V Y+H+     I H D+K  NI+L DK       K+ DFG++  I + 
Sbjct: 116 EATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG 172
Query: 381 KTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
                  I GT  ++ PE         ++D++S GV+   LL+G  P
Sbjct: 173 VEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 95/230 (41%), Gaps = 34/230 (14%)
Query: 212 QRATDNYNQSRFLGQGGFGTVYK------GMLPDGSIVAVKRSKE----IDKTQIHQFIN 261
           Q+  D Y+    LG G F  V K      G+      +  ++S+     + + +I +   
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIER--- 64
Query: 262 EVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSL 321
           EV IL Q+ H +++ L          VL+ E +S G L   +                SL
Sbjct: 65  EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQK------------ESL 112
Query: 322 SWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF----SAKVSDFGISRSI 377
           S E       ++   V Y+H+     I H D+K  NI+L DK       K+ DFG++  I
Sbjct: 113 SEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169
Query: 378 PNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
            +        I GT  ++ PE         ++D++S GV+   LL+G  P
Sbjct: 170 EDGVEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 95/230 (41%), Gaps = 34/230 (14%)
Query: 212 QRATDNYNQSRFLGQGGFGTVYK------GMLPDGSIVAVKRSKE----IDKTQIHQFIN 261
           Q+  D Y+    LG G F  V K      G+      +  ++S+     + + +I +   
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIER--- 64
Query: 262 EVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSL 321
           EV IL Q+ H +++ L          VL+ E +S G L   +                SL
Sbjct: 65  EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQK------------ESL 112
Query: 322 SWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF----SAKVSDFGISRSI 377
           S E       ++   V Y+H+     I H D+K  NI+L DK       K+ DFG++  I
Sbjct: 113 SEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169
Query: 378 PNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
            +        I GT  ++ PE         ++D++S GV+   LL+G  P
Sbjct: 170 EDGVEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 101/224 (45%), Gaps = 31/224 (13%)
Query: 221 SRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQFINEVVILSQI-NHRHIVKLL 278
           S  LG+G +  V   + L +G   AVK  ++       +   EV  L Q   +++I++L+
Sbjct: 18  SELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELI 77
Query: 279 GCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVA 338
               +     LV+E +  G++  HI                  +     RV  +VA A+ 
Sbjct: 78  EFFEDDTRFYLVFEKLQGGSILAHIQKQ------------KHFNEREASRVVRDVAAALD 125
Query: 339 YMHSSASIPIFHRDIKSSNILLD--DKFS-AKVSDF--GISRSIPNDKTHLTT----TIQ 389
           ++H+     I HRD+K  NIL +  +K S  K+ DF  G    + N  T +TT    T  
Sbjct: 126 FLHTKG---IAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPC 182
Query: 390 GTFGYLDPEYF-----QSSQFTDKSDVYSFGVVLLELLTGKKPI 428
           G+  Y+ PE       Q++ +  + D++S GVVL  +L+G  P 
Sbjct: 183 GSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPF 226

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 101/244 (41%), Gaps = 35/244 (14%)
Query: 201 ERAKVFT--ADELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQ 258
           E AK FT    E+Q   +++   + +G+G FG V           AV + K  ++    +
Sbjct: 57  EWAKPFTQLVKEMQLHREDFEIIKVIGRGAFGEV-----------AVVKMKNTERIYAMK 105
Query: 259 FINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHI-----HDHXXXXXXX 313
            +N+  +L +            C   E  VLV       T  H+      H +       
Sbjct: 106 ILNKWEMLKRAE--------TACFREERDVLVNGDCQWITALHYAFQDENHLYLVMDYYV 157
Query: 314 XXXXLSSLS-WENRV---RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVS 369
               L+ LS +E+++        +   V  + S   +   HRDIK  N+LLD     +++
Sbjct: 158 GGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHYVHRDIKPDNVLLDVNGHIRLA 217
Query: 370 DFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQS-----SQFTDKSDVYSFGVVLLELLTG 424
           DFG    + +D T  ++   GT  Y+ PE  Q+      ++  + D +S GV + E+L G
Sbjct: 218 DFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYG 277
Query: 425 KKPI 428
           + P 
Sbjct: 278 ETPF 281

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 94/220 (42%), Gaps = 21/220 (9%)
Query: 216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKR-SKEIDK-TQIHQFINEVVILSQINHR 272
           D Y     +G G +G V        G  VA+K+     D  T   + + E+ IL    H 
Sbjct: 55  DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHD 114
Query: 273 HIVKLLGCCLETEVPVLVYE--YISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVA 330
           +I+ +    L   VP   ++  Y+    +   +H                L+ E+     
Sbjct: 115 NIIAIKDI-LRPTVPYGEFKSVYVVLDLMESDLHQ--------IIHSSQPLTLEHVRYFL 165
Query: 331 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI---PNDKTHLTTT 387
            ++   + YMHS+    + HRD+K SN+L+++    K+ DFG++R +   P +  +  T 
Sbjct: 166 YQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTE 222
Query: 388 IQGTFGYLDPEYFQS-SQFTDKSDVYSFGVVLLELLTGKK 426
              T  Y  PE   S  ++T   D++S G +  E+L  ++
Sbjct: 223 YVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/246 (25%), Positives = 106/246 (43%), Gaps = 39/246 (15%)
Query: 201 ERAKVFTAD--ELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQ 258
           E AK FT+   +++   +++   + +G+G FG V           AV + K  DK    +
Sbjct: 57  EWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEV-----------AVVKLKNADKVFAMK 105
Query: 259 FINEVVILSQINHRHIVKLLGCCLETEVPVLV---YEYISSGTLSHHIHD----HXXXXX 311
            +N+  +L +            C   E  VLV    ++I+  TL +   D    +     
Sbjct: 106 ILNKWEMLKRAE--------TACFREERDVLVNGDSKWIT--TLHYAFQDDNNLYLVMDY 155
Query: 312 XXXXXXLSSLS-WENRV---RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK 367
                 L+ LS +E+R+        +A  V  + S   +   HRDIK  NIL+D     +
Sbjct: 156 YVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIR 215
Query: 368 VSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQS-----SQFTDKSDVYSFGVVLLELL 422
           ++DFG    +  D T  ++   GT  Y+ PE  Q+      ++  + D +S GV + E+L
Sbjct: 216 LADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEML 275
Query: 423 TGKKPI 428
            G+ P 
Sbjct: 276 YGETPF 281

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 94/220 (42%), Gaps = 21/220 (9%)
Query: 216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKR-SKEIDK-TQIHQFINEVVILSQINHR 272
           D Y     +G G +G V        G  VA+K+     D  T   + + E+ IL    H 
Sbjct: 54  DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHD 113
Query: 273 HIVKLLGCCLETEVPVLVYE--YISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVA 330
           +I+ +    L   VP   ++  Y+    +   +H                L+ E+     
Sbjct: 114 NIIAIKDI-LRPTVPYGEFKSVYVVLDLMESDLHQ--------IIHSSQPLTLEHVRYFL 164
Query: 331 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI---PNDKTHLTTT 387
            ++   + YMHS+    + HRD+K SN+L+++    K+ DFG++R +   P +  +  T 
Sbjct: 165 YQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTE 221
Query: 388 IQGTFGYLDPEYFQS-SQFTDKSDVYSFGVVLLELLTGKK 426
              T  Y  PE   S  ++T   D++S G +  E+L  ++
Sbjct: 222 YVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 101/244 (41%), Gaps = 35/244 (14%)
Query: 201 ERAKVFT--ADELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQ 258
           E AK FT    E+Q   +++   + +G+G FG V           AV + K  ++    +
Sbjct: 73  EWAKPFTQLVKEMQLHREDFEIIKVIGRGAFGEV-----------AVVKMKNTERIYAMK 121
Query: 259 FINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHI-----HDHXXXXXXX 313
            +N+  +L +            C   E  VLV       T  H+      H +       
Sbjct: 122 ILNKWEMLKRAE--------TACFREERDVLVNGDCQWITALHYAFQDENHLYLVMDYYV 173
Query: 314 XXXXLSSLS-WENRV---RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVS 369
               L+ LS +E+++        +   V  + S   +   HRDIK  N+LLD     +++
Sbjct: 174 GGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHYVHRDIKPDNVLLDVNGHIRLA 233
Query: 370 DFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQS-----SQFTDKSDVYSFGVVLLELLTG 424
           DFG    + +D T  ++   GT  Y+ PE  Q+      ++  + D +S GV + E+L G
Sbjct: 234 DFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYG 293
Query: 425 KKPI 428
           + P 
Sbjct: 294 ETPF 297

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 79/308 (25%), Positives = 126/308 (40%), Gaps = 59/308 (19%)
Query: 216 DNYNQSRFLGQGGFGTVYK------GMLPDGSIVAVKR----SKEIDKTQIHQFINEVVI 265
           D+Y     LG G F  V K      G       +  +R     + + + +I +   EV I
Sbjct: 5   DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIER---EVNI 61
Query: 266 LSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWEN 325
           L +I H +I+ L          VL+ E +S G L   + +              SL+ + 
Sbjct: 62  LREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEK------------ESLTEDE 109
Query: 326 RVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF----SAKVSDFGISRSIPNDK 381
             +   ++   V Y+HS     I H D+K  NI+L DK       K+ DFGI+  I  + 
Sbjct: 110 ATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI--EA 164
Query: 382 THLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVA 441
            +    I GT  ++ PE         ++D++S GV+   LL+G  P              
Sbjct: 165 GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP-------------- 210
Query: 442 CFISLAKENQLLEILDARVAKEAREEDIGAMAELA----MRCLRLNSKKRPTMKQVSME- 496
            F+   K+  L  I  + V  +  EE     +ELA     R L  + K+R T+ Q S+E 
Sbjct: 211 -FLGETKQETLTNI--SAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQ-SLEH 266
Query: 497 --LEGLRR 502
             ++ +RR
Sbjct: 267 SWIKAIRR 274

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 94/226 (41%), Gaps = 34/226 (15%)
Query: 216 DNYNQSRFLGQGGFGTVYK------GMLPDGSIVAVKR----SKEIDKTQIHQFINEVVI 265
           D+Y     LG G F  V K      G       +  +R     + + + +I +   EV I
Sbjct: 12  DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIER---EVNI 68
Query: 266 LSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWEN 325
           L +I H +I+ L          VL+ E +S G L   + +              SL+ + 
Sbjct: 69  LREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEK------------ESLTEDE 116
Query: 326 RVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF----SAKVSDFGISRSIPNDK 381
             +   ++   V Y+HS     I H D+K  NI+L DK       K+ DFGI+  I  + 
Sbjct: 117 ATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI--EA 171
Query: 382 THLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
            +    I GT  ++ PE         ++D++S GV+   LL+G  P
Sbjct: 172 GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 99/233 (42%), Gaps = 32/233 (13%)
Query: 215 TDNYNQSRFLGQGGFGTVYKGMLPDGS--IVAVK---RSKEIDKTQIHQFINEVVILSQI 269
           +D Y   + +G G FG V + M    S  +VAVK   R ++ID+    + IN       +
Sbjct: 18  SDRYELVKDIGSGNFG-VARLMRDKQSNELVAVKYIERGEKIDENVKREIINH----RSL 72
Query: 270 NHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRV 329
            H +IV+     L      +V EY S G L   I +                S +     
Sbjct: 73  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN------------AGRFSEDEARFF 120
Query: 330 ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA--KVSDFGISRSIPNDKTHLTTT 387
             ++   V+Y H+   + + HRD+K  N LLD   +   K+  FG S+S        +T 
Sbjct: 121 FQQLISGVSYCHA---MQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKSTV 177
Query: 388 IQGTFGYLDPEYFQSSQFTDK-SDVYSFGVVLLELLTGKKPICFARVEEERNL 439
             GT  Y+ PE     ++  K +DV+S GV L  +L G  P  F   EE +N 
Sbjct: 178 --GTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYP--FEDPEEPKNF 226

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 94/226 (41%), Gaps = 34/226 (15%)
Query: 216 DNYNQSRFLGQGGFGTVYK------GMLPDGSIVAVKR----SKEIDKTQIHQFINEVVI 265
           D+Y     LG G F  V K      G       +  +R     + + + +I +   EV I
Sbjct: 26  DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIER---EVNI 82
Query: 266 LSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWEN 325
           L +I H +I+ L          VL+ E +S G L   + +              SL+ + 
Sbjct: 83  LREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEK------------ESLTEDE 130
Query: 326 RVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF----SAKVSDFGISRSIPNDK 381
             +   ++   V Y+HS     I H D+K  NI+L DK       K+ DFGI+  I  + 
Sbjct: 131 ATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI--EA 185
Query: 382 THLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
            +    I GT  ++ PE         ++D++S GV+   LL+G  P
Sbjct: 186 GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 231

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 75/170 (44%), Gaps = 29/170 (17%)
Query: 327 VRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF---SAKVSDFGISRSIPNDKTH 383
           +R+  ++   V Y+H +    I H D+K  NILL   +     K+ DFG+SR I +    
Sbjct: 134 IRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE- 189
Query: 384 LTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACF 443
               I GT  YL PE       T  +D+++ G++   LLT   P                
Sbjct: 190 -LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPF--------------- 233
Query: 444 ISLAKENQLLEILDARVAKEAREEDIGAMAELAM----RCLRLNSKKRPT 489
             + ++NQ   +  ++V  +  EE   ++++LA       L  N +KRPT
Sbjct: 234 --VGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPT 281

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 99/238 (41%), Gaps = 42/238 (17%)
Query: 215 TDNYNQSRFLGQGGFGTVYKGMLPDGS--IVAVK---RSKEIDKTQIHQFINEVVILSQI 269
           +D Y   + +G G FG V + M    S  +VAVK   R ++ID+    + IN       +
Sbjct: 18  SDRYELVKDIGSGNFG-VARLMRDKQSNELVAVKYIERGEKIDENVKREIINH----RSL 72
Query: 270 NHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRV 329
            H +IV+     L      +V EY S G L   I +                S +     
Sbjct: 73  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN------------AGRFSEDEARFF 120
Query: 330 ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA--KVSDFGISRSI-----PNDKT 382
             ++   V+Y H+   + + HRD+K  N LLD   +   K+  FG S+S      P D  
Sbjct: 121 FQQLISGVSYCHA---MQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDTV 177
Query: 383 HLTTTIQGTFGYLDPEYFQSSQFTDK-SDVYSFGVVLLELLTGKKPICFARVEEERNL 439
                  GT  Y+ PE     ++  K +DV+S GV L  +L G  P  F   EE +N 
Sbjct: 178 -------GTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYP--FEDPEEPKNF 226

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/217 (23%), Positives = 93/217 (42%), Gaps = 31/217 (14%)
Query: 218 YNQSRFLGQGGFGTV---YKGMLPDGSIVAVKRSKEIDKTQIH--QFINEVVILSQINHR 272
           Y   + +G G  G V   Y  +L     VA+K+     + Q H  +   E+V++  +NH+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHK 83
Query: 273 HIVKLLGC-----CLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
           +I+ LL        LE    V +   +    LS  I                 L  E   
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ--------------MELDHERMS 129
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
            +  ++   + ++HS+    I HRD+K SNI++    + K+ DFG++R+     + + T 
Sbjct: 130 YLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTA--GTSFMMTP 184
Query: 388 IQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTG 424
              T  Y  PE      + +  D++S G ++ E++ G
Sbjct: 185 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/217 (23%), Positives = 93/217 (42%), Gaps = 31/217 (14%)
Query: 218 YNQSRFLGQGGFGTV---YKGMLPDGSIVAVKRSKEIDKTQIH--QFINEVVILSQINHR 272
           Y   + +G G  G V   Y  +L     VA+K+     + Q H  +   E+V++  +NH+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHK 83
Query: 273 HIVKLLGC-----CLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
           +I+ LL        LE    V +   +    LS  I                 L  E   
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ--------------MELDHERMS 129
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
            +  ++   + ++HS+    I HRD+K SNI++    + K+ DFG++R+     + + T 
Sbjct: 130 YLLYQMLVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTA--GTSFMMTP 184
Query: 388 IQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTG 424
              T  Y  PE      + +  D++S G ++ E++ G
Sbjct: 185 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/171 (24%), Positives = 76/171 (44%), Gaps = 24/171 (14%)
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
           ++A  +  A+ ++HS  S+   HRD+K SN+L++     K  DFGIS  + +D       
Sbjct: 140 KIAVSIVKALEHLHSKLSV--IHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDIDA 197
Query: 388 IQGTFGYLDPEY----FQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACF 443
             G   Y  PE          ++ KSD++S G+  +EL   + P               +
Sbjct: 198 --GCKPYXAPERINPELNQKGYSVKSDIWSLGITXIELAILRFP---------------Y 240
Query: 444 ISLAKE-NQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQV 493
            S      QL ++++    +   ++      +   +CL+ NSK+RPT  ++
Sbjct: 241 DSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPEL 291

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 98/233 (42%), Gaps = 32/233 (13%)
Query: 215 TDNYNQSRFLGQGGFGTVYKGMLPDGS--IVAVK---RSKEIDKTQIHQFINEVVILSQI 269
           +D Y   + +G G FG V + M    S  +VAVK   R ++I      + IN       +
Sbjct: 18  SDRYELVKDIGSGNFG-VARLMRDKQSNELVAVKYIERGEKIAANVKREIINH----RSL 72
Query: 270 NHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRV 329
            H +IV+     L      +V EY S G L   I +                S +     
Sbjct: 73  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN------------AGRFSEDEARFF 120
Query: 330 ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA--KVSDFGISRSIPNDKTHLTTT 387
             ++   V+Y H+   + + HRD+K  N LLD   +   K+ DFG S+S        +T 
Sbjct: 121 FQQLISGVSYCHA---MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV 177
Query: 388 IQGTFGYLDPEYFQSSQFTDK-SDVYSFGVVLLELLTGKKPICFARVEEERNL 439
             GT  Y+ PE     ++  K +DV+S GV L  +L G  P  F   EE +N 
Sbjct: 178 --GTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYP--FEDPEEPKNF 226

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/224 (23%), Positives = 92/224 (41%), Gaps = 28/224 (12%)
Query: 213 RATDNYNQSRFLGQGGFGTVYK------GMLPDGSIVAVKRSKEIDKTQIHQFINEVVIL 266
           R T+ Y     LG+G F  V +      G      I+  K+    D  ++ +   E  I 
Sbjct: 8   RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLER---EARIC 64
Query: 267 SQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENR 326
             + H +IV+L     E     L+++ ++ G L   I                  S  + 
Sbjct: 65  RLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDI------------VAREYYSEADA 112
Query: 327 VRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF---SAKVSDFGISRSIPNDKTH 383
                ++  AV + H    + + HR++K  N+LL  K    + K++DFG++  +  ++  
Sbjct: 113 SHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ-Q 168
Query: 384 LTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
                 GT GYL PE  +   +    D+++ GV+L  LL G  P
Sbjct: 169 AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPP 212

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/229 (24%), Positives = 95/229 (41%), Gaps = 34/229 (14%)
Query: 214 ATDN-YNQSRF-----LGQGGFGTVYK------GMLPDGSIVAVKRSKEIDKTQIHQFIN 261
            T+N Y QS +     LG+G F  V +      G      I+  K+    D  ++ +   
Sbjct: 14  GTENLYFQSMYQLFEELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLER--- 70
Query: 262 EVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSL 321
           E  I   + H +IV+L     E     L+++ ++ G L   I                  
Sbjct: 71  EARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDI------------VAREYY 118
Query: 322 SWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF---SAKVSDFGISRSIP 378
           S  +      ++  AV + H    + + HRD+K  N+LL  K    + K++DFG++  + 
Sbjct: 119 SEADASHCIQQILEAVLHCHQ---MGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVE 175
Query: 379 NDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
            ++        GT GYL PE  +   +    D+++ GV+L  LL G  P
Sbjct: 176 GEQ-QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPP 223

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/217 (23%), Positives = 93/217 (42%), Gaps = 31/217 (14%)
Query: 218 YNQSRFLGQGGFGTV---YKGMLPDGSIVAVKRSKEIDKTQIH--QFINEVVILSQINHR 272
           Y   + +G G  G V   Y  +L     VA+K+     + Q H  +   E+V++  +NH+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 273 HIVKLLGC-----CLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
           +I+ LL        LE    V +   +    LS  I                 L  E   
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ--------------MELDHERMS 129
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
            +  ++   + ++HS+    I HRD+K SNI++    + K+ DFG++R+     + + T 
Sbjct: 130 YLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTA--GTSFMMTP 184
Query: 388 IQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTG 424
              T  Y  PE      + +  D++S G ++ E++ G
Sbjct: 185 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 96/217 (44%), Gaps = 28/217 (12%)
Query: 218 YNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFIN-EVVILSQINHRHIVK 276
           Y   + +G G FG V++  L +   VA+K+       Q  +F N E+ I+  + H ++V 
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESDEVAIKKV-----LQDKRFKNRELQIMRIVKHPNVVD 96
Query: 277 LLGCCLET-----EVPV-LVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVA 330
           L            EV + LV EY+      +    H           L  L     +R  
Sbjct: 97  LKAFFYSNGDKKDEVFLNLVLEYVPETV--YRASRHYAKLKQTMPMLLIKLYMYQLLR-- 152
Query: 331 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA-KVSDFGISRSIPNDKTHLTTTIQ 389
                ++AY+HS   I I HRDIK  N+LLD      K+ DFG ++ +   + +++    
Sbjct: 153 -----SLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXICS 204
Query: 390 GTFGYLDPEY-FQSSQFTDKSDVYSFGVVLLELLTGK 425
               Y  PE  F ++ +T   D++S G V+ EL+ G+
Sbjct: 205 RY--YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/217 (23%), Positives = 93/217 (42%), Gaps = 31/217 (14%)
Query: 218 YNQSRFLGQGGFGTV---YKGMLPDGSIVAVKRSKEIDKTQIH--QFINEVVILSQINHR 272
           Y   + +G G  G V   Y  +L     VA+K+     + Q H  +   E+V++  +NH+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 273 HIVKLLGC-----CLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
           +I+ LL        LE    V +   +    LS  I                 L  E   
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ--------------MELDHERMS 129
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
            +  ++   + ++HS+    I HRD+K SNI++    + K+ DFG++R+     + + T 
Sbjct: 130 YLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTP 184
Query: 388 IQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTG 424
              T  Y  PE      + +  D++S G ++ E++ G
Sbjct: 185 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 49/212 (23%), Positives = 93/212 (43%), Gaps = 19/212 (8%)
Query: 218 YNQSRFLGQGGFGTV---YKGMLPDGSIVAVKRSKEI-DKTQIHQFINEVVILSQINHRH 273
           Y   + +G G  G V   Y  +L D ++   K S+   ++T   +   E+V++  +NH++
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVL-DRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKN 84
Query: 274 IVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEV 333
           I+ LL        P    E      L   + D               +S+     +  ++
Sbjct: 85  IISLLNVF----TPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSY-----LLYQM 135
Query: 334 AGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFG 393
              + ++HS+    I HRD+K SNI++    + K+ DFG++R+     + + T    T  
Sbjct: 136 LXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTA--GTSFMMTPYVVTRY 190
Query: 394 YLDPEYFQSSQFTDKSDVYSFGVVLLELLTGK 425
           Y  PE      + +  D++S G ++ E++  K
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 36/105 (34%), Positives = 53/105 (50%), Gaps = 11/105 (10%)
Query: 336 AVAYMHSSASIPIFHRDIKSSNILLDDKFS---AKVSDFGISRSIPNDKTHLTTTIQGTF 392
           AV Y+H +    I HRD+K  N+LL  +      K++DFG S+ +   +T L  T+ GT 
Sbjct: 126 AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCGTP 180
Query: 393 GYLDPEYFQS---SQFTDKSDVYSFGVVLLELLTGKKPICFARVE 434
            YL PE   S   + +    D +S GV+L   L+G  P    R +
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ 225

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 49/217 (22%), Positives = 96/217 (44%), Gaps = 24/217 (11%)
Query: 218 YNQSRFLGQGGFGTVYKGMLPDG-SIVAVKRSK--EIDKTQIHQFINEVVILSQINHRHI 274
           Y +   +G+G +GTV+K    +   IVA+KR +  + D+      + E+ +L ++ H++I
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 275 VKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVA 334
           V+L       +   LV+E+       +    +              L  E       ++ 
Sbjct: 64  VRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN------------GDLDPEIVKSFLFQLL 111
Query: 335 GAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS--IPNDKTHLTTTIQGTF 392
             + + HS     + HRD+K  N+L++     K++DFG++R+  IP       +    T 
Sbjct: 112 KGLGFCHSRN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIP---VRCYSAEVVTL 165
Query: 393 GYLDPE-YFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
            Y  P+  F +  ++   D++S G +  EL    +P+
Sbjct: 166 WYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAARPL 202

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 36/105 (34%), Positives = 53/105 (50%), Gaps = 11/105 (10%)
Query: 336 AVAYMHSSASIPIFHRDIKSSNILLDDKFS---AKVSDFGISRSIPNDKTHLTTTIQGTF 392
           AV Y+H +    I HRD+K  N+LL  +      K++DFG S+ +   +T L  T+ GT 
Sbjct: 126 AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCGTP 180
Query: 393 GYLDPEYFQS---SQFTDKSDVYSFGVVLLELLTGKKPICFARVE 434
            YL PE   S   + +    D +S GV+L   L+G  P    R +
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ 225

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 36/105 (34%), Positives = 53/105 (50%), Gaps = 11/105 (10%)
Query: 336 AVAYMHSSASIPIFHRDIKSSNILLDDKFS---AKVSDFGISRSIPNDKTHLTTTIQGTF 392
           AV Y+H +    I HRD+K  N+LL  +      K++DFG S+ +   +T L  T+ GT 
Sbjct: 126 AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCGTP 180
Query: 393 GYLDPEYFQS---SQFTDKSDVYSFGVVLLELLTGKKPICFARVE 434
            YL PE   S   + +    D +S GV+L   L+G  P    R +
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ 225

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 36/105 (34%), Positives = 53/105 (50%), Gaps = 11/105 (10%)
Query: 336 AVAYMHSSASIPIFHRDIKSSNILLDDKFS---AKVSDFGISRSIPNDKTHLTTTIQGTF 392
           AV Y+H +    I HRD+K  N+LL  +      K++DFG S+ +   +T L  T+ GT 
Sbjct: 132 AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCGTP 186
Query: 393 GYLDPEYFQS---SQFTDKSDVYSFGVVLLELLTGKKPICFARVE 434
            YL PE   S   + +    D +S GV+L   L+G  P    R +
Sbjct: 187 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ 231

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 36/105 (34%), Positives = 53/105 (50%), Gaps = 11/105 (10%)
Query: 336 AVAYMHSSASIPIFHRDIKSSNILLDDKFS---AKVSDFGISRSIPNDKTHLTTTIQGTF 392
           AV Y+H +    I HRD+K  N+LL  +      K++DFG S+ +   +T L  T+ GT 
Sbjct: 125 AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCGTP 179
Query: 393 GYLDPEYFQS---SQFTDKSDVYSFGVVLLELLTGKKPICFARVE 434
            YL PE   S   + +    D +S GV+L   L+G  P    R +
Sbjct: 180 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ 224

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 51/222 (22%), Positives = 94/222 (42%), Gaps = 19/222 (8%)
Query: 208 ADELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIH--QFINEVV 264
           A  +    + Y     +G G +G+V        G  VAVK+     ++ IH  +   E+ 
Sbjct: 10  AKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELR 69
Query: 265 ILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWE 324
           +L  + H +++ LL        P    E  +   L  H+               + L+ +
Sbjct: 70  LLKHMKHENVIGLLDVF----TPARSLEEFNDVYLVTHL----MGADLNNIVKCAKLTDD 121
Query: 325 NRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHL 384
           +   +  ++   + Y+HS+    I HRD+K SN+ +++    K+ DFG++R   ++ T  
Sbjct: 122 HVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY 178
Query: 385 TTTIQGTFGYLDPE-YFQSSQFTDKSDVYSFGVVLLELLTGK 425
                 T  Y  PE       +    D++S G ++ ELLTG+
Sbjct: 179 V----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 49/212 (23%), Positives = 93/212 (43%), Gaps = 19/212 (8%)
Query: 218 YNQSRFLGQGGFGTV---YKGMLPDGSIVAVKRSKEI-DKTQIHQFINEVVILSQINHRH 273
           Y   + +G G  G V   Y  +L D ++   K S+   ++T   +   E+V++  +NH++
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVL-DRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKN 84
Query: 274 IVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEV 333
           I+ LL        P    E      L   + D               +S+     +  ++
Sbjct: 85  IISLLNVF----TPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSY-----LLYQM 135
Query: 334 AGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFG 393
              + ++HS+    I HRD+K SNI++    + K+ DFG++R+     + + T    T  
Sbjct: 136 LCGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTA--GTSFMMTPYVVTRY 190
Query: 394 YLDPEYFQSSQFTDKSDVYSFGVVLLELLTGK 425
           Y  PE      + +  D++S G ++ E++  K
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 36/105 (34%), Positives = 54/105 (51%), Gaps = 11/105 (10%)
Query: 336 AVAYMHSSASIPIFHRDIKSSNILL---DDKFSAKVSDFGISRSIPNDKTHLTTTIQGTF 392
           AV Y+H +    I HRD+K  N+LL   ++    K++DFG S+ +   +T L  T+ GT 
Sbjct: 251 AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCGTP 305
Query: 393 GYLDPEYFQS---SQFTDKSDVYSFGVVLLELLTGKKPICFARVE 434
            YL PE   S   + +    D +S GV+L   L+G  P    R +
Sbjct: 306 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ 350

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/212 (23%), Positives = 93/212 (43%), Gaps = 19/212 (8%)
Query: 218 YNQSRFLGQGGFGTV---YKGMLPDGSIVAVKRSKEI-DKTQIHQFINEVVILSQINHRH 273
           Y   + +G G  G V   Y  +L D ++   K S+   ++T   +   E+V++  +NH++
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVL-DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 84
Query: 274 IVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEV 333
           I+ LL        P    E      L   + D               +S+     +  ++
Sbjct: 85  IISLLNVF----TPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSY-----LLYQM 135
Query: 334 AGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFG 393
              + ++HS+    I HRD+K SNI++    + K+ DFG++R+     + + T    T  
Sbjct: 136 LXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTA--GTSFMMTPYVVTRY 190
Query: 394 YLDPEYFQSSQFTDKSDVYSFGVVLLELLTGK 425
           Y  PE      + +  D++S G ++ E++  K
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/105 (34%), Positives = 54/105 (51%), Gaps = 11/105 (10%)
Query: 336 AVAYMHSSASIPIFHRDIKSSNILL---DDKFSAKVSDFGISRSIPNDKTHLTTTIQGTF 392
           AV Y+H +    I HRD+K  N+LL   ++    K++DFG S+ +   +T L  T+ GT 
Sbjct: 265 AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCGTP 319
Query: 393 GYLDPEYFQS---SQFTDKSDVYSFGVVLLELLTGKKPICFARVE 434
            YL PE   S   + +    D +S GV+L   L+G  P    R +
Sbjct: 320 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ 364

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/212 (23%), Positives = 93/212 (43%), Gaps = 19/212 (8%)
Query: 218 YNQSRFLGQGGFGTV---YKGMLPDGSIVAVKRSKEI-DKTQIHQFINEVVILSQINHRH 273
           Y   + +G G  G V   Y  +L D ++   K S+   ++T   +   E+V++  +NH++
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVL-DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 77
Query: 274 IVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEV 333
           I+ LL        P    E      L   + D               +S+     +  ++
Sbjct: 78  IISLLNVF----TPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSY-----LLYQM 128
Query: 334 AGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFG 393
              + ++HS+    I HRD+K SNI++    + K+ DFG++R+     + + T    T  
Sbjct: 129 LXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTA--GTSFMMTPYVVTRY 183
Query: 394 YLDPEYFQSSQFTDKSDVYSFGVVLLELLTGK 425
           Y  PE      + +  D++S G ++ E++  K
Sbjct: 184 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/212 (22%), Positives = 92/212 (43%), Gaps = 19/212 (8%)
Query: 218 YNQSRFLGQGGFGTV---YKGMLPDGSIVAVKRSKEI-DKTQIHQFINEVVILSQINHRH 273
           Y   + +G G  G V   Y  +L D ++   K S+   ++T   +   E+V++  +NH++
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVL-DRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKN 84
Query: 274 IVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEV 333
           I+ LL        P    E      L   + D               +S+     +  ++
Sbjct: 85  IISLLNVF----TPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSY-----LLYQM 135
Query: 334 AGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFG 393
              + ++HS+    I HRD+K SNI++    + K+ DFG++R+     + + T    T  
Sbjct: 136 LCGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTA--GTSFMMTPYVVTRY 190
Query: 394 YLDPEYFQSSQFTDKSDVYSFGVVLLELLTGK 425
           Y  PE      + +  D++S G ++ E++  K
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 92/217 (42%), Gaps = 31/217 (14%)
Query: 218 YNQSRFLGQGGFGTV---YKGMLPDGSIVAVKRSKEIDKTQIH--QFINEVVILSQINHR 272
           Y   + +G G  G V   Y  +L     VA+K+     + Q H  +   E+V++  +NH+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 273 HIVKLLGC-----CLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
           +I+ LL        LE    V +   +    L   I                 L  E   
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--------------MELDHERMS 129
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
            +  ++   + ++HS+    I HRD+K SNI++    + K+ DFG++R+     + + T 
Sbjct: 130 YLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTP 184
Query: 388 IQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTG 424
              T  Y  PE      + +  D++S G ++ E++ G
Sbjct: 185 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 92/217 (42%), Gaps = 31/217 (14%)
Query: 218 YNQSRFLGQGGFGTV---YKGMLPDGSIVAVKRSKEIDKTQIH--QFINEVVILSQINHR 272
           Y   + +G G  G V   Y  +L     VA+K+     + Q H  +   E+V++  +NH+
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 84
Query: 273 HIVKLLGC-----CLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
           +I+ LL        LE    V +   +    L   I                 L  E   
Sbjct: 85  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--------------MELDHERMS 130
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
            +  ++   + ++HS+    I HRD+K SNI++    + K+ DFG++R+     + + T 
Sbjct: 131 YLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTP 185
Query: 388 IQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTG 424
              T  Y  PE      + +  D++S G ++ E++ G
Sbjct: 186 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/219 (22%), Positives = 93/219 (42%), Gaps = 19/219 (8%)
Query: 211 LQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIH--QFINEVVILS 267
           +    + Y     +G G +G+V        G  VAVK+     ++ IH  +   E+ +L 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 268 QINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
            + H +++ LL        P    E  +   L  H+                 L+ ++  
Sbjct: 77  HMKHENVIGLLDVF----TPARSLEEFNDVYLVTHL----MGADLNNIVKCQKLTDDHVQ 128
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
            +  ++   + Y+HS+    I HRD+K SN+ +++    K+ DFG++R   ++ T     
Sbjct: 129 FLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-- 183
Query: 388 IQGTFGYLDPE-YFQSSQFTDKSDVYSFGVVLLELLTGK 425
              T  Y  PE    +  +    D++S G ++ ELLTG+
Sbjct: 184 --ATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 92/217 (42%), Gaps = 31/217 (14%)
Query: 218 YNQSRFLGQGGFGTV---YKGMLPDGSIVAVKRSKEIDKTQIH--QFINEVVILSQINHR 272
           Y   + +G G  G V   Y  +L     VA+K+     + Q H  +   E+V++  +NH+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 273 HIVKLLGC-----CLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
           +I+ LL        LE    V +   +    L   I                 L  E   
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--------------MELDHERMS 129
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
            +  ++   + ++HS+    I HRD+K SNI++    + K+ DFG++R+     + + T 
Sbjct: 130 YLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTP 184
Query: 388 IQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTG 424
              T  Y  PE      + +  D++S G ++ E++ G
Sbjct: 185 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/219 (22%), Positives = 92/219 (42%), Gaps = 19/219 (8%)
Query: 211 LQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIH--QFINEVVILS 267
           +    + Y     +G G +G+V        G  VAVK+     ++ IH  +   E+ +L 
Sbjct: 22  IWEVPERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 81
Query: 268 QINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
            + H +++ LL        P    E  +   L  H+                 L+ ++  
Sbjct: 82  HMKHENVIGLLDVF----TPARSLEEFNDVYLVTHL----MGADLNNIVKCQKLTDDHVQ 133
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
            +  ++   + Y+HS+    I HRD+K SN+ +++    K+ DFG++R   ++ T     
Sbjct: 134 FLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYV-- 188
Query: 388 IQGTFGYLDPE-YFQSSQFTDKSDVYSFGVVLLELLTGK 425
              T  Y  PE       +    D++S G ++ ELLTG+
Sbjct: 189 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 92/217 (42%), Gaps = 31/217 (14%)
Query: 218 YNQSRFLGQGGFGTV---YKGMLPDGSIVAVKRSKEIDKTQIH--QFINEVVILSQINHR 272
           Y   + +G G  G V   Y  +L     VA+K+     + Q H  +   E+V++  +NH+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 273 HIVKLLGC-----CLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
           +I+ LL        LE    V +   +    L   I                 L  E   
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--------------MELDHERMS 129
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
            +  ++   + ++HS+    I HRD+K SNI++    + K+ DFG++R+     + + T 
Sbjct: 130 YLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTP 184
Query: 388 IQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTG 424
              T  Y  PE      + +  D++S G ++ E++ G
Sbjct: 185 EVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 94/215 (43%), Gaps = 20/215 (9%)
Query: 216 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIV 275
           + Y  +  LG+G FG V++ +        + +  ++  T       E+ IL+   HR+I+
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNIL 64
Query: 276 KLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAG 335
            L       E  V+++E+IS   +   I+             L+     + V   CE   
Sbjct: 65  HLHESFESMEELVMIFEFISGLDIFERIN--------TSAFELNEREIVSYVHQVCE--- 113
Query: 336 AVAYMHSSASIPIFHRDIKSSNILLDDKFSA--KVSDFGISRSI-PNDKTHLTTTIQGTF 392
           A+ ++HS     I H DI+  NI+   + S+  K+ +FG +R + P D   L  T     
Sbjct: 114 ALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPE-- 168
Query: 393 GYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
            Y  PE  Q    +  +D++S G ++  LL+G  P
Sbjct: 169 -YYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP 202

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/219 (22%), Positives = 92/219 (42%), Gaps = 19/219 (8%)
Query: 211 LQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIH--QFINEVVILS 267
           +    + Y     +G G +G+V        G  VAVK+     ++ IH  +   E+ +L 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 268 QINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
            + H +++ LL        P    E  +   L  H+                 L+ ++  
Sbjct: 77  HMKHENVIGLLDVF----TPARSLEEFNDVYLVTHL----MGADLNNIVKXQKLTDDHVQ 128
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
            +  ++   + Y+HS+    I HRD+K SN+ +++    K+ DFG++R   ++ T     
Sbjct: 129 FLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYV-- 183
Query: 388 IQGTFGYLDPE-YFQSSQFTDKSDVYSFGVVLLELLTGK 425
              T  Y  PE       +    D++S G ++ ELLTG+
Sbjct: 184 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/101 (29%), Positives = 50/101 (49%), Gaps = 8/101 (7%)
Query: 333 VAGAVAYMHSSASIPIFHRDIKSSNILLDDKF----SAKVSDFGISRSIPNDKTHLTTTI 388
           +   V Y+H+     + HRD+K SNIL  D+     S ++ DFG ++ +  +   L T  
Sbjct: 125 ITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC 181
Query: 389 QGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPIC 429
             T  ++ PE  +   +    D++S GV+L  +LTG  P  
Sbjct: 182 Y-TANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFA 221

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/235 (23%), Positives = 90/235 (38%), Gaps = 38/235 (16%)
Query: 210 ELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEI-----------DKTQIHQ 258
           EL      Y   RF+  G +G V  G+  +G  VA+KR               D     +
Sbjct: 16  ELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKR 75
Query: 259 FINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXL 318
            + E+ +L+  +H +I+ L    +  E P +   Y+ +  +                  L
Sbjct: 76  VLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR---------------TDL 120
Query: 319 SSLSWENRVRVACEVAGAVAY-----MHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGI 373
           + +  + R+ ++ +      Y     +H      + HRD+   NILL D     + DF +
Sbjct: 121 AQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNL 180
Query: 374 SRSIPND--KTHLTTTIQGTFGYLDPE-YFQSSQFTDKSDVYSFGVVLLELLTGK 425
           +R    D  KTH  T       Y  PE   Q   FT   D++S G V+ E+   K
Sbjct: 181 AREDTADANKTHYVTHR----WYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/240 (23%), Positives = 101/240 (42%), Gaps = 41/240 (17%)
Query: 218 YNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQF----INEVVILSQINHR 272
           Y +   +GQG FG V+K      G  VA+K  K + + +   F    + E+ IL  + H 
Sbjct: 19  YEKLAKIGQGTFGEVFKARHRKTGQKVALK--KVLMENEKEGFPITALREIKILQLLKHE 76
Query: 273 HIVKLLGCCLETEVPV--------LVYEYIS---SGTLSHHIHDHXXXXXXXXXXXLSSL 321
           ++V L+  C     P         LV+++     +G LS+                L   
Sbjct: 77  NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN---------------VLVKF 121
Query: 322 SWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIP--- 378
           +     RV   +   + Y+H +    I HRD+K++N+L+      K++DFG++R+     
Sbjct: 122 TLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAK 178
Query: 379 NDKTHLTTTIQGTFGYLDPEYFQSSQ-FTDKSDVYSFGVVLLELLTGKKPICFARVEEER 437
           N + +       T  Y  PE     + +    D++  G ++ E+ T + PI     E+ +
Sbjct: 179 NSQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNTEQHQ 237

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/219 (22%), Positives = 92/219 (42%), Gaps = 19/219 (8%)
Query: 211 LQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIH--QFINEVVILS 267
           +    + Y     +G G +G+V        G  VAVK+     ++ IH  +   E+ +L 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 268 QINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
            + H +++ LL        P    E  +   L  H+                 L+ ++  
Sbjct: 77  HMKHENVIGLLDVF----TPARSLEEFNDVYLVTHL----MGADLNNIVKCQKLTDDHVQ 128
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
            +  ++   + Y+HS+    I HRD+K SN+ +++    K+ DFG++R   ++ T     
Sbjct: 129 FLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-- 183
Query: 388 IQGTFGYLDPE-YFQSSQFTDKSDVYSFGVVLLELLTGK 425
              T  Y  PE       +    D++S G ++ ELLTG+
Sbjct: 184 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/235 (23%), Positives = 90/235 (38%), Gaps = 38/235 (16%)
Query: 210 ELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEI-----------DKTQIHQ 258
           EL      Y   RF+  G +G V  G+  +G  VA+KR               D     +
Sbjct: 16  ELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKR 75
Query: 259 FINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXL 318
            + E+ +L+  +H +I+ L    +  E P +   Y+ +  +                  L
Sbjct: 76  VLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR---------------TDL 120
Query: 319 SSLSWENRVRVACEVAGAVAY-----MHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGI 373
           + +  + R+ ++ +      Y     +H      + HRD+   NILL D     + DF +
Sbjct: 121 AQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNL 180
Query: 374 SRSIPND--KTHLTTTIQGTFGYLDPE-YFQSSQFTDKSDVYSFGVVLLELLTGK 425
           +R    D  KTH  T       Y  PE   Q   FT   D++S G V+ E+   K
Sbjct: 181 AREDTADANKTHYVTHRW----YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/219 (22%), Positives = 92/219 (42%), Gaps = 19/219 (8%)
Query: 211 LQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIH--QFINEVVILS 267
           +    + Y     +G G +G+V        G  VAVK+     ++ IH  +   E+ +L 
Sbjct: 37  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 96
Query: 268 QINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
            + H +++ LL        P    E  +   L  H+                 L+ ++  
Sbjct: 97  HMKHENVIGLLDVF----TPARSLEEFNDVYLVTHL----MGADLNNIVKCQKLTDDHVQ 148
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
            +  ++   + Y+HS+    I HRD+K SN+ +++    K+ DFG++R   ++ T     
Sbjct: 149 FLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-- 203
Query: 388 IQGTFGYLDPE-YFQSSQFTDKSDVYSFGVVLLELLTGK 425
              T  Y  PE       +    D++S G ++ ELLTG+
Sbjct: 204 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/219 (22%), Positives = 92/219 (42%), Gaps = 19/219 (8%)
Query: 211 LQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIH--QFINEVVILS 267
           +    + Y     +G G +G+V        G  VAVK+     ++ IH  +   E+ +L 
Sbjct: 13  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 72
Query: 268 QINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
            + H +++ LL        P    E  +   L  H+                 L+ ++  
Sbjct: 73  HMKHENVIGLLDVF----TPARSLEEFNDVYLVTHL----MGADLNNIVKCQKLTDDHVQ 124
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
            +  ++   + Y+HS+    I HRD+K SN+ +++    K+ DFG++R   ++ T     
Sbjct: 125 FLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-- 179
Query: 388 IQGTFGYLDPE-YFQSSQFTDKSDVYSFGVVLLELLTGK 425
              T  Y  PE       +    D++S G ++ ELLTG+
Sbjct: 180 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/219 (22%), Positives = 92/219 (42%), Gaps = 19/219 (8%)
Query: 211 LQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIH--QFINEVVILS 267
           +    + Y     +G G +G+V        G  VAVK+     ++ IH  +   E+ +L 
Sbjct: 22  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 81
Query: 268 QINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
            + H +++ LL        P    E  +   L  H+                 L+ ++  
Sbjct: 82  HMKHENVIGLLDVF----TPARSLEEFNDVYLVTHL----MGADLNNIVKCQKLTDDHVQ 133
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
            +  ++   + Y+HS+    I HRD+K SN+ +++    K+ DFG++R   ++ T     
Sbjct: 134 FLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYV-- 188
Query: 388 IQGTFGYLDPE-YFQSSQFTDKSDVYSFGVVLLELLTGK 425
              T  Y  PE       +    D++S G ++ ELLTG+
Sbjct: 189 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/219 (22%), Positives = 92/219 (42%), Gaps = 19/219 (8%)
Query: 211 LQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIH--QFINEVVILS 267
           +    + Y     +G G +G+V        G  VAVK+     ++ IH  +   E+ +L 
Sbjct: 36  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 95
Query: 268 QINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
            + H +++ LL        P    E  +   L  H+                 L+ ++  
Sbjct: 96  HMKHENVIGLLDVF----TPARSLEEFNDVYLVTHL----MGADLNNIVKCQKLTDDHVQ 147
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
            +  ++   + Y+HS+    I HRD+K SN+ +++    K+ DFG++R   ++ T     
Sbjct: 148 FLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-- 202
Query: 388 IQGTFGYLDPE-YFQSSQFTDKSDVYSFGVVLLELLTGK 425
              T  Y  PE       +    D++S G ++ ELLTG+
Sbjct: 203 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/212 (22%), Positives = 92/212 (43%), Gaps = 19/212 (8%)
Query: 218 YNQSRFLGQGGFGTV---YKGMLPDGSIVAVKRSKEI-DKTQIHQFINEVVILSQINHRH 273
           Y   + +G G  G V   Y  +L D ++   K S+   ++T   +   E+V++  +NH++
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVL-DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 77
Query: 274 IVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEV 333
           I+ LL        P    E      L   + D               +S+     +  ++
Sbjct: 78  IISLLNVF----TPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSY-----LLYQM 128
Query: 334 AGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFG 393
              + ++HS+    I HRD+K SNI++    + K+ DFG++R+     + + T    T  
Sbjct: 129 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY 183
Query: 394 YLDPEYFQSSQFTDKSDVYSFGVVLLELLTGK 425
           Y  PE      + +  D++S G ++ E++  K
Sbjct: 184 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/240 (23%), Positives = 101/240 (42%), Gaps = 41/240 (17%)
Query: 218 YNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQF----INEVVILSQINHR 272
           Y +   +GQG FG V+K      G  VA+K  K + + +   F    + E+ IL  + H 
Sbjct: 20  YEKLAKIGQGTFGEVFKARHRKTGQKVALK--KVLMENEKEGFPITALREIKILQLLKHE 77
Query: 273 HIVKLLGCCLETEVPV--------LVYEYIS---SGTLSHHIHDHXXXXXXXXXXXLSSL 321
           ++V L+  C     P         LV+++     +G LS+                L   
Sbjct: 78  NVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSN---------------VLVKF 122
Query: 322 SWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIP--- 378
           +     RV   +   + Y+H +    I HRD+K++N+L+      K++DFG++R+     
Sbjct: 123 TLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAK 179
Query: 379 NDKTHLTTTIQGTFGYLDPEYFQSSQ-FTDKSDVYSFGVVLLELLTGKKPICFARVEEER 437
           N + +       T  Y  PE     + +    D++  G ++ E+ T + PI     E+ +
Sbjct: 180 NSQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNTEQHQ 238

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/212 (22%), Positives = 92/212 (43%), Gaps = 19/212 (8%)
Query: 218 YNQSRFLGQGGFGTV---YKGMLPDGSIVAVKRSKEI-DKTQIHQFINEVVILSQINHRH 273
           Y   + +G G  G V   Y  +L D ++   K S+   ++T   +   E+V++  +NH++
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAVL-DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 78
Query: 274 IVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEV 333
           I+ LL        P    E      L   + D               +S+     +  ++
Sbjct: 79  IISLLNVF----TPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSY-----LLYQM 129
Query: 334 AGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFG 393
              + ++HS+    I HRD+K SNI++    + K+ DFG++R+     + + T    T  
Sbjct: 130 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY 184
Query: 394 YLDPEYFQSSQFTDKSDVYSFGVVLLELLTGK 425
           Y  PE      + +  D++S G ++ E++  K
Sbjct: 185 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/240 (23%), Positives = 101/240 (42%), Gaps = 41/240 (17%)
Query: 218 YNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQF----INEVVILSQINHR 272
           Y +   +GQG FG V+K      G  VA+K  K + + +   F    + E+ IL  + H 
Sbjct: 20  YEKLAKIGQGTFGEVFKARHRKTGQKVALK--KVLMENEKEGFPITALREIKILQLLKHE 77
Query: 273 HIVKLLGCCLETEVPV--------LVYEYIS---SGTLSHHIHDHXXXXXXXXXXXLSSL 321
           ++V L+  C     P         LV+++     +G LS+                L   
Sbjct: 78  NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN---------------VLVKF 122
Query: 322 SWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIP--- 378
           +     RV   +   + Y+H +    I HRD+K++N+L+      K++DFG++R+     
Sbjct: 123 TLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAK 179
Query: 379 NDKTHLTTTIQGTFGYLDPEYFQSSQ-FTDKSDVYSFGVVLLELLTGKKPICFARVEEER 437
           N + +       T  Y  PE     + +    D++  G ++ E+ T + PI     E+ +
Sbjct: 180 NSQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNTEQHQ 238

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/219 (22%), Positives = 92/219 (42%), Gaps = 19/219 (8%)
Query: 211 LQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIH--QFINEVVILS 267
           +    + Y     +G G +G+V        G  VAVK+     ++ IH  +   E+ +L 
Sbjct: 28  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 87
Query: 268 QINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
            + H +++ LL        P    E  +   L  H+                 L+ ++  
Sbjct: 88  HMKHENVIGLLDVF----TPARSLEEFNDVYLVTHL----MGADLNNIVKCQKLTDDHVQ 139
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
            +  ++   + Y+HS+    I HRD+K SN+ +++    K+ DFG++R   ++ T     
Sbjct: 140 FLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYV-- 194
Query: 388 IQGTFGYLDPE-YFQSSQFTDKSDVYSFGVVLLELLTGK 425
              T  Y  PE       +    D++S G ++ ELLTG+
Sbjct: 195 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/219 (22%), Positives = 92/219 (42%), Gaps = 19/219 (8%)
Query: 211 LQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIH--QFINEVVILS 267
           +    + Y     +G G +G+V        G  VAVK+     ++ IH  +   E+ +L 
Sbjct: 24  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 83
Query: 268 QINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
            + H +++ LL        P    E  +   L  H+                 L+ ++  
Sbjct: 84  HMKHENVIGLLDVF----TPARSLEEFNDVYLVTHL----MGADLNNIVKCQKLTDDHVQ 135
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
            +  ++   + Y+HS+    I HRD+K SN+ +++    K+ DFG++R   ++ T     
Sbjct: 136 FLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYV-- 190
Query: 388 IQGTFGYLDPE-YFQSSQFTDKSDVYSFGVVLLELLTGK 425
              T  Y  PE       +    D++S G ++ ELLTG+
Sbjct: 191 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/219 (22%), Positives = 92/219 (42%), Gaps = 19/219 (8%)
Query: 211 LQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIH--QFINEVVILS 267
           +    + Y     +G G +G+V        G  VAVK+     ++ IH  +   E+ +L 
Sbjct: 24  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 83
Query: 268 QINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
            + H +++ LL        P    E  +   L  H+                 L+ ++  
Sbjct: 84  HMKHENVIGLLDVF----TPARSLEEFNDVYLVTHL----MGADLNNIVKCQKLTDDHVQ 135
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
            +  ++   + Y+HS+    I HRD+K SN+ +++    K+ DFG++R   ++ T     
Sbjct: 136 FLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYV-- 190
Query: 388 IQGTFGYLDPE-YFQSSQFTDKSDVYSFGVVLLELLTGK 425
              T  Y  PE       +    D++S G ++ ELLTG+
Sbjct: 191 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/212 (22%), Positives = 92/212 (43%), Gaps = 19/212 (8%)
Query: 218 YNQSRFLGQGGFGTV---YKGMLPDGSIVAVKRSKEI-DKTQIHQFINEVVILSQINHRH 273
           Y   + +G G  G V   Y  +L D ++   K S+   ++T   +   E+V++  +NH++
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAVL-DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 78
Query: 274 IVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEV 333
           I+ LL        P    E      L   + D               +S+     +  ++
Sbjct: 79  IISLLNVF----TPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSY-----LLYQM 129
Query: 334 AGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFG 393
              + ++HS+    I HRD+K SNI++    + K+ DFG++R+     + + T    T  
Sbjct: 130 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY 184
Query: 394 YLDPEYFQSSQFTDKSDVYSFGVVLLELLTGK 425
           Y  PE      + +  D++S G ++ E++  K
Sbjct: 185 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 89/206 (43%), Gaps = 19/206 (9%)
Query: 224 LGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIH--QFINEVVILSQINHRHIVKLLGC 280
           +G G +G+V        G  VAVK+     ++ IH  +   E+ +L  + H +++ LL  
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 99
Query: 281 CLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYM 340
                 P    E  +   L  H+                 L+ ++   +  ++   + Y+
Sbjct: 100 F----TPARSLEEFNDVYLVTHL----MGADLNNIVKCQKLTDDHVQFLIYQILRGLKYI 151
Query: 341 HSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPE-Y 399
           HS+    I HRD+K SN+ +++    K+ DFG++R   ++ T        T  Y  PE  
Sbjct: 152 HSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYRAPEIM 204
Query: 400 FQSSQFTDKSDVYSFGVVLLELLTGK 425
                +    D++S G ++ ELLTG+
Sbjct: 205 LNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/219 (22%), Positives = 92/219 (42%), Gaps = 19/219 (8%)
Query: 211 LQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIH--QFINEVVILS 267
           +    + Y     +G G +G+V        G  VAVK+     ++ IH  +   E+ +L 
Sbjct: 24  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 83
Query: 268 QINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
            + H +++ LL        P    E  +   L  H+                 L+ ++  
Sbjct: 84  HMKHENVIGLLDVF----TPARSLEEFNDVYLVTHL----MGADLNNIVKCQKLTDDHVQ 135
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
            +  ++   + Y+HS+    I HRD+K SN+ +++    K+ DFG++R   ++ T     
Sbjct: 136 FLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYV-- 190
Query: 388 IQGTFGYLDPE-YFQSSQFTDKSDVYSFGVVLLELLTGK 425
              T  Y  PE       +    D++S G ++ ELLTG+
Sbjct: 191 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/217 (22%), Positives = 96/217 (44%), Gaps = 24/217 (11%)
Query: 218 YNQSRFLGQGGFGTVYKGMLPDG-SIVAVKRSK--EIDKTQIHQFINEVVILSQINHRHI 274
           Y +   +G+G +GTV+K    +   IVA+KR +  + D+      + E+ +L ++ H++I
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 275 VKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVA 334
           V+L       +   LV+E+       +    +              L  E       ++ 
Sbjct: 64  VRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN------------GDLDPEIVKSFLFQLL 111
Query: 335 GAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS--IPNDKTHLTTTIQGTF 392
             + + HS     + HRD+K  N+L++     K+++FG++R+  IP       +    T 
Sbjct: 112 KGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP---VRCYSAEVVTL 165
Query: 393 GYLDPE-YFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
            Y  P+  F +  ++   D++S G +  EL    +P+
Sbjct: 166 WYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/212 (22%), Positives = 92/212 (43%), Gaps = 19/212 (8%)
Query: 218 YNQSRFLGQGGFGTV---YKGMLPDGSIVAVKRSKEI-DKTQIHQFINEVVILSQINHRH 273
           Y   + +G G  G V   Y  +L D ++   K S+   ++T   +   E+V++  +NH++
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAVL-DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 85
Query: 274 IVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEV 333
           I+ LL        P    E      L   + D               +S+     +  ++
Sbjct: 86  IISLLNVF----TPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSY-----LLYQM 136
Query: 334 AGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFG 393
              + ++HS+    I HRD+K SNI++    + K+ DFG++R+     + + T    T  
Sbjct: 137 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY 191
Query: 394 YLDPEYFQSSQFTDKSDVYSFGVVLLELLTGK 425
           Y  PE      + +  D++S G ++ E++  K
Sbjct: 192 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/219 (22%), Positives = 93/219 (42%), Gaps = 19/219 (8%)
Query: 211 LQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIH--QFINEVVILS 267
           +    + Y     +G G +G+V        G  VAVK+  +  ++ IH  +   E+ +L 
Sbjct: 29  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLLK 88
Query: 268 QINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
            + H +++ LL        P    E  +   L  H+                 L+ ++  
Sbjct: 89  HMKHENVIGLLDVF----TPARSLEEFNDVYLVTHL----MGADLNNIVKCQKLTDDHVQ 140
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
            +  ++   + Y+HS+    I HRD+K SN+ +++    K+ DFG++R   ++ T     
Sbjct: 141 FLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-- 195
Query: 388 IQGTFGYLDPE-YFQSSQFTDKSDVYSFGVVLLELLTGK 425
              T  Y  PE       +    D++S G ++ ELLTG+
Sbjct: 196 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/219 (22%), Positives = 92/219 (42%), Gaps = 19/219 (8%)
Query: 211 LQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIH--QFINEVVILS 267
           +    + Y     +G G +G+V        G  VAVK+     ++ IH  +   E+ +L 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 268 QINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
            + H +++ LL        P    E  +   L  H+                 L+ ++  
Sbjct: 77  HMKHENVIGLLDVF----TPARSLEEFNDVYLVTHL----MGADLNNIVKXQKLTDDHVQ 128
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
            +  ++   + Y+HS+    I HRD+K SN+ +++    K+ DFG++R   ++ T     
Sbjct: 129 FLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-- 183
Query: 388 IQGTFGYLDPE-YFQSSQFTDKSDVYSFGVVLLELLTGK 425
              T  Y  PE       +    D++S G ++ ELLTG+
Sbjct: 184 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/219 (22%), Positives = 92/219 (42%), Gaps = 19/219 (8%)
Query: 211 LQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIH--QFINEVVILS 267
           +    + Y     +G G +G+V        G  VAVK+     ++ IH  +   E+ +L 
Sbjct: 23  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 82
Query: 268 QINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
            + H +++ LL        P    E  +   L  H+                 L+ ++  
Sbjct: 83  HMKHENVIGLLDVF----TPARSLEEFNDVYLVTHL----MGADLNNIVKCQKLTDDHVQ 134
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
            +  ++   + Y+HS+    I HRD+K SN+ +++    K+ DFG++R   ++ T     
Sbjct: 135 FLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-- 189
Query: 388 IQGTFGYLDPE-YFQSSQFTDKSDVYSFGVVLLELLTGK 425
              T  Y  PE       +    D++S G ++ ELLTG+
Sbjct: 190 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/240 (23%), Positives = 101/240 (42%), Gaps = 41/240 (17%)
Query: 218 YNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQF----INEVVILSQINHR 272
           Y +   +GQG FG V+K      G  VA+K  K + + +   F    + E+ IL  + H 
Sbjct: 20  YEKLAKIGQGTFGEVFKARHRKTGQKVALK--KVLMENEKEGFPITALREIKILQLLKHE 77
Query: 273 HIVKLLGCCLETEVPV--------LVYEYIS---SGTLSHHIHDHXXXXXXXXXXXLSSL 321
           ++V L+  C     P         LV+++     +G LS+                L   
Sbjct: 78  NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN---------------VLVKF 122
Query: 322 SWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIP--- 378
           +     RV   +   + Y+H +    I HRD+K++N+L+      K++DFG++R+     
Sbjct: 123 TLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAK 179
Query: 379 NDKTHLTTTIQGTFGYLDPEYFQSSQ-FTDKSDVYSFGVVLLELLTGKKPICFARVEEER 437
           N + +       T  Y  PE     + +    D++  G ++ E+ T + PI     E+ +
Sbjct: 180 NSQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNTEQHQ 238

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/212 (22%), Positives = 92/212 (43%), Gaps = 19/212 (8%)
Query: 218 YNQSRFLGQGGFGTV---YKGMLPDGSIVAVKRSKEI-DKTQIHQFINEVVILSQINHRH 273
           Y   + +G G  G V   Y  +L D ++   K S+   ++T   +   E+V++  +NH++
Sbjct: 25  YQNLKPIGSGAQGIVCAAYDAVL-DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 83
Query: 274 IVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEV 333
           I+ LL        P    E      L   + D               +S+     +  ++
Sbjct: 84  IISLLNVF----TPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSY-----LLYQM 134
Query: 334 AGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFG 393
              + ++HS+    I HRD+K SNI++    + K+ DFG++R+     + + T    T  
Sbjct: 135 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY 189
Query: 394 YLDPEYFQSSQFTDKSDVYSFGVVLLELLTGK 425
           Y  PE      + +  D++S G ++ E++  K
Sbjct: 190 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 221

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/212 (22%), Positives = 92/212 (43%), Gaps = 19/212 (8%)
Query: 218 YNQSRFLGQGGFGTV---YKGMLPDGSIVAVKRSKEI-DKTQIHQFINEVVILSQINHRH 273
           Y   + +G G  G V   Y  +L D ++   K S+   ++T   +   E+V++  +NH++
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVL-DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 84
Query: 274 IVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEV 333
           I+ LL        P    E      L   + D               +S+     +  ++
Sbjct: 85  IISLLNVF----TPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSY-----LLYQM 135
Query: 334 AGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFG 393
              + ++HS+    I HRD+K SNI++    + K+ DFG++R+     + + T    T  
Sbjct: 136 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY 190
Query: 394 YLDPEYFQSSQFTDKSDVYSFGVVLLELLTGK 425
           Y  PE      + +  D++S G ++ E++  K
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/212 (22%), Positives = 92/212 (43%), Gaps = 19/212 (8%)
Query: 218 YNQSRFLGQGGFGTV---YKGMLPDGSIVAVKRSKEI-DKTQIHQFINEVVILSQINHRH 273
           Y   + +G G  G V   Y  +L D ++   K S+   ++T   +   E+V++  +NH++
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVL-DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 84
Query: 274 IVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEV 333
           I+ LL        P    E      L   + D               +S+     +  ++
Sbjct: 85  IISLLNVF----TPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSY-----LLYQM 135
Query: 334 AGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFG 393
              + ++HS+    I HRD+K SNI++    + K+ DFG++R+     + + T    T  
Sbjct: 136 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY 190
Query: 394 YLDPEYFQSSQFTDKSDVYSFGVVLLELLTGK 425
           Y  PE      + +  D++S G ++ E++  K
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/219 (22%), Positives = 92/219 (42%), Gaps = 19/219 (8%)
Query: 211 LQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIH--QFINEVVILS 267
           +    + Y     +G G +G+V        G  VAVK+     ++ IH  +   E+ +L 
Sbjct: 24  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 83
Query: 268 QINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
            + H +++ LL        P    E  +   L  H+                 L+ ++  
Sbjct: 84  HMKHENVIGLLDVF----TPARSLEEFNDVYLVTHL----MGADLNNIVKCQKLTDDHVQ 135
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
            +  ++   + Y+HS+    I HRD+K SN+ +++    K+ DFG++R   ++ T     
Sbjct: 136 FLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-- 190
Query: 388 IQGTFGYLDPE-YFQSSQFTDKSDVYSFGVVLLELLTGK 425
              T  Y  PE       +    D++S G ++ ELLTG+
Sbjct: 191 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 53/103 (51%), Gaps = 10/103 (9%)
Query: 332 EVAGAVAYMHSSASIPIFHRDIKSSNILL--DDKFSAKVSDFGISRS---IPNDKTHLTT 386
           ++  A+ Y+H+     I HRDIK  N L   +  F  K+ DFG+S+    + N + +  T
Sbjct: 176 QIFSALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMT 232
Query: 387 TIQGTFGYLDPEYFQSSQ--FTDKSDVYSFGVVLLELLTGKKP 427
           T  GT  ++ PE   ++   +  K D +S GV+L  LL G  P
Sbjct: 233 TKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVP 275

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/212 (22%), Positives = 92/212 (43%), Gaps = 19/212 (8%)
Query: 218 YNQSRFLGQGGFGTV---YKGMLPDGSIVAVKRSKEI-DKTQIHQFINEVVILSQINHRH 273
           Y   + +G G  G V   Y  +L D ++   K S+   ++T   +   E+V++  +NH++
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAVL-DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 85
Query: 274 IVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEV 333
           I+ LL        P    E      L   + D               +S+     +  ++
Sbjct: 86  IISLLNVF----TPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSY-----LLYQM 136
Query: 334 AGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFG 393
              + ++HS+    I HRD+K SNI++    + K+ DFG++R+     + + T    T  
Sbjct: 137 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY 191
Query: 394 YLDPEYFQSSQFTDKSDVYSFGVVLLELLTGK 425
           Y  PE      + +  D++S G ++ E++  K
Sbjct: 192 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 40/146 (27%), Positives = 69/146 (47%), Gaps = 28/146 (19%)
Query: 325 NRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILL--DDKFSAK-----------VSDF 371
           N + +  ++A  VA++HS   + I HRD+K  NIL+    +F+A            +SDF
Sbjct: 116 NPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDF 172
Query: 372 GISRSIPNDKTHLTTTIQ---GTFGYLDPEYFQSS-------QFTDKSDVYSFGVVLLEL 421
           G+ + + + ++   T +    GT G+  PE  + S       + T   D++S G V   +
Sbjct: 173 GLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYI 232
Query: 422 LT-GKKPICFARVEEERNLVACFISL 446
           L+ GK P    +   E N++    SL
Sbjct: 233 LSKGKHPFG-DKYSRESNIIRGIFSL 257

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/219 (22%), Positives = 92/219 (42%), Gaps = 19/219 (8%)
Query: 211 LQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIH--QFINEVVILS 267
           +    + Y     +G G +G+V        G  VAVK+     ++ IH  +   E+ +L 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 268 QINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
            + H +++ LL        P    E  +   L  H+                 L+ ++  
Sbjct: 77  HMKHENVIGLLDVF----TPARSLEEFNDVYLVTHL----MGADLNNIVKCQKLTDDHVQ 128
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
            +  ++   + Y+HS+    I HRD+K SN+ +++    K+ DFG++R   ++ T     
Sbjct: 129 FLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-- 183
Query: 388 IQGTFGYLDPE-YFQSSQFTDKSDVYSFGVVLLELLTGK 425
              T  Y  PE       +    D++S G ++ ELLTG+
Sbjct: 184 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/219 (22%), Positives = 92/219 (42%), Gaps = 19/219 (8%)
Query: 211 LQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIH--QFINEVVILS 267
           +    + Y     +G G +G+V        G  VAVK+     ++ IH  +   E+ +L 
Sbjct: 19  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 78
Query: 268 QINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
            + H +++ LL        P    E  +   L  H+                 L+ ++  
Sbjct: 79  HMKHENVIGLLDVF----TPARSLEEFNDVYLVTHL----MGADLNNIVKCQKLTDDHVQ 130
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
            +  ++   + Y+HS+    I HRD+K SN+ +++    K+ DFG++R   ++ T     
Sbjct: 131 FLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-- 185
Query: 388 IQGTFGYLDPE-YFQSSQFTDKSDVYSFGVVLLELLTGK 425
              T  Y  PE       +    D++S G ++ ELLTG+
Sbjct: 186 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/219 (22%), Positives = 92/219 (42%), Gaps = 19/219 (8%)
Query: 211 LQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIH--QFINEVVILS 267
           +    + Y     +G G +G+V        G  VAVK+     ++ IH  +   E+ +L 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 268 QINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
            + H +++ LL        P    E  +   L  H+                 L+ ++  
Sbjct: 77  HMKHENVIGLLDVF----TPARSLEEFNDVYLVTHL----MGADLNNIVKCQKLTDDHVQ 128
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
            +  ++   + Y+HS+    I HRD+K SN+ +++    K+ DFG++R   ++ T     
Sbjct: 129 FLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-- 183
Query: 388 IQGTFGYLDPE-YFQSSQFTDKSDVYSFGVVLLELLTGK 425
              T  Y  PE       +    D++S G ++ ELLTG+
Sbjct: 184 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/219 (22%), Positives = 92/219 (42%), Gaps = 19/219 (8%)
Query: 211 LQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIH--QFINEVVILS 267
           +    + Y     +G G +G+V        G  VAVK+     ++ IH  +   E+ +L 
Sbjct: 28  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 87
Query: 268 QINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
            + H +++ LL        P    E  +   L  H+                 L+ ++  
Sbjct: 88  HMKHENVIGLLDVF----TPARSLEEFNDVYLVTHL----MGADLNNIVKCQKLTDDHVQ 139
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
            +  ++   + Y+HS+    I HRD+K SN+ +++    K+ DFG++R   ++ T     
Sbjct: 140 FLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-- 194
Query: 388 IQGTFGYLDPE-YFQSSQFTDKSDVYSFGVVLLELLTGK 425
              T  Y  PE       +    D++S G ++ ELLTG+
Sbjct: 195 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/219 (22%), Positives = 92/219 (42%), Gaps = 19/219 (8%)
Query: 211 LQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIH--QFINEVVILS 267
           +    + Y     +G G +G+V        G  VAVK+     ++ IH  +   E+ +L 
Sbjct: 22  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 81
Query: 268 QINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
            + H +++ LL        P    E  +   L  H+                 L+ ++  
Sbjct: 82  HMKHENVIGLLDVF----TPARSLEEFNDVYLVTHL----MGADLNNIVKCQKLTDDHVQ 133
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
            +  ++   + Y+HS+    I HRD+K SN+ +++    K+ DFG++R   ++ T     
Sbjct: 134 FLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-- 188
Query: 388 IQGTFGYLDPE-YFQSSQFTDKSDVYSFGVVLLELLTGK 425
              T  Y  PE       +    D++S G ++ ELLTG+
Sbjct: 189 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/219 (22%), Positives = 92/219 (42%), Gaps = 19/219 (8%)
Query: 211 LQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIH--QFINEVVILS 267
           +    + Y     +G G +G+V        G  VAVK+     ++ IH  +   E+ +L 
Sbjct: 23  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 82
Query: 268 QINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
            + H +++ LL        P    E  +   L  H+                 L+ ++  
Sbjct: 83  HMKHENVIGLLDVF----TPARSLEEFNDVYLVTHL----MGADLNNIVKCQKLTDDHVQ 134
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
            +  ++   + Y+HS+    I HRD+K SN+ +++    K+ DFG++R   ++ T     
Sbjct: 135 FLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-- 189
Query: 388 IQGTFGYLDPE-YFQSSQFTDKSDVYSFGVVLLELLTGK 425
              T  Y  PE       +    D++S G ++ ELLTG+
Sbjct: 190 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/219 (22%), Positives = 92/219 (42%), Gaps = 19/219 (8%)
Query: 211 LQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIH--QFINEVVILS 267
           +    + Y     +G G +G+V        G  VAVK+     ++ IH  +   E+ +L 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 268 QINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
            + H +++ LL        P    E  +   L  H+                 L+ ++  
Sbjct: 77  HMKHENVIGLLDVF----TPARSLEEFNDVYLVTHL----MGADLNNIVKCQKLTDDHVQ 128
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
            +  ++   + Y+HS+    I HRD+K SN+ +++    K+ DFG++R   ++ T     
Sbjct: 129 FLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-- 183
Query: 388 IQGTFGYLDPE-YFQSSQFTDKSDVYSFGVVLLELLTGK 425
              T  Y  PE       +    D++S G ++ ELLTG+
Sbjct: 184 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/219 (22%), Positives = 92/219 (42%), Gaps = 19/219 (8%)
Query: 211 LQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIH--QFINEVVILS 267
           +    + Y     +G G +G+V        G  VAVK+     ++ IH  +   E+ +L 
Sbjct: 16  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 75
Query: 268 QINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
            + H +++ LL        P    E  +   L  H+                 L+ ++  
Sbjct: 76  HMKHENVIGLLDVF----TPARSLEEFNDVYLVTHL----MGADLNNIVKCQKLTDDHVQ 127
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
            +  ++   + Y+HS+    I HRD+K SN+ +++    K+ DFG++R   ++ T     
Sbjct: 128 FLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-- 182
Query: 388 IQGTFGYLDPE-YFQSSQFTDKSDVYSFGVVLLELLTGK 425
              T  Y  PE       +    D++S G ++ ELLTG+
Sbjct: 183 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 72/313 (23%), Positives = 135/313 (43%), Gaps = 56/313 (17%)
Query: 224 LGQGGFGTVYKGMLPDGSIVAVK------RSKEIDKTQIHQFINEVVILSQINHRHIVKL 277
           +G+G +G V+ G    G  VAVK       +    +T+I+Q +        + H +I+  
Sbjct: 45  IGKGRYGEVWMGKW-RGEKVAVKVFFTTEEASWFRETEIYQTV-------LMRHENILGF 96
Query: 278 L-----GCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACE 332
           +     G    T++  L+ +Y  +G+L  ++               ++L  ++ +++A  
Sbjct: 97  IAADIKGTGSWTQL-YLITDYHENGSLYDYLKS-------------TTLDAKSMLKLAYS 142
Query: 333 VAGAVAYMH----SSASIP-IFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHL--- 384
               + ++H    S+   P I HRD+KS NIL+    +  ++D G++    +D   +   
Sbjct: 143 SVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIP 202
Query: 385 TTTIQGTFGYLDPEYFQSS------QFTDKSDVYSFGVVLLELLTGKKPICFARVEEER- 437
             T  GT  Y+ PE    S      Q    +D+YSFG++L E+   ++ +    VEE + 
Sbjct: 203 PNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEV--ARRCVSGGIVEEYQL 260
Query: 438 ---NLVACFISLAKENQLLEILDARVA---KEAREEDIGAMAELAMRCLRLNSKKRPTMK 491
              +LV    S     +++ I   R +   + + +E +  M +L   C   N   R T  
Sbjct: 261 PYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTAL 320
Query: 492 QVSMELEGLRRSQ 504
           +V   L  +  SQ
Sbjct: 321 RVKKTLAKMSESQ 333

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/219 (22%), Positives = 92/219 (42%), Gaps = 19/219 (8%)
Query: 211 LQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIH--QFINEVVILS 267
           +    + Y     +G G +G+V        G  VAVK+     ++ IH  +   E+ +L 
Sbjct: 40  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 99
Query: 268 QINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
            + H +++ LL        P    E  +   L  H+                 L+ ++  
Sbjct: 100 HMKHENVIGLLDVF----TPARSLEEFNDVYLVTHL----MGADLNNIVKCQKLTDDHVQ 151
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
            +  ++   + Y+HS+    I HRD+K SN+ +++    K+ DFG++R   ++ T     
Sbjct: 152 FLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-- 206
Query: 388 IQGTFGYLDPE-YFQSSQFTDKSDVYSFGVVLLELLTGK 425
              T  Y  PE       +    D++S G ++ ELLTG+
Sbjct: 207 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/219 (22%), Positives = 92/219 (42%), Gaps = 19/219 (8%)
Query: 211 LQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIH--QFINEVVILS 267
           +    + Y     +G G +G+V        G  VAVK+     ++ IH  +   E+ +L 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 268 QINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
            + H +++ LL        P    E  +   L  H+                 L+ ++  
Sbjct: 77  HMKHENVIGLLDVF----TPARSLEEFNDVYLVTHL----MGADLNNIVKCQKLTDDHVQ 128
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
            +  ++   + Y+HS+    I HRD+K SN+ +++    K+ DFG++R   ++ T     
Sbjct: 129 FLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-- 183
Query: 388 IQGTFGYLDPE-YFQSSQFTDKSDVYSFGVVLLELLTGK 425
              T  Y  PE       +    D++S G ++ ELLTG+
Sbjct: 184 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/219 (22%), Positives = 92/219 (42%), Gaps = 19/219 (8%)
Query: 211 LQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIH--QFINEVVILS 267
           +    + Y     +G G +G+V        G  VAVK+     ++ IH  +   E+ +L 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 268 QINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
            + H +++ LL        P    E  +   L  H+                 L+ ++  
Sbjct: 77  HMKHENVIGLLDVF----TPARSLEEFNDVYLVTHL----MGADLNNIVKCQKLTDDHVQ 128
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
            +  ++   + Y+HS+    I HRD+K SN+ +++    K+ DFG++R   ++ T     
Sbjct: 129 FLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGXV-- 183
Query: 388 IQGTFGYLDPE-YFQSSQFTDKSDVYSFGVVLLELLTGK 425
              T  Y  PE       +    D++S G ++ ELLTG+
Sbjct: 184 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/219 (22%), Positives = 92/219 (42%), Gaps = 19/219 (8%)
Query: 211 LQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIH--QFINEVVILS 267
           +    + Y     +G G +G+V        G  VAVK+     ++ IH  +   E+ +L 
Sbjct: 14  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 73
Query: 268 QINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
            + H +++ LL        P    E  +   L  H+                 L+ ++  
Sbjct: 74  HMKHENVIGLLDVF----TPARSLEEFNDVYLVTHL----MGADLNNIVKCQKLTDDHVQ 125
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
            +  ++   + Y+HS+    I HRD+K SN+ +++    K+ DFG++R   ++ T     
Sbjct: 126 FLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-- 180
Query: 388 IQGTFGYLDPE-YFQSSQFTDKSDVYSFGVVLLELLTGK 425
              T  Y  PE       +    D++S G ++ ELLTG+
Sbjct: 181 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/219 (22%), Positives = 92/219 (42%), Gaps = 19/219 (8%)
Query: 211 LQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIH--QFINEVVILS 267
           +    + Y     +G G +G+V        G  VAVK+     ++ IH  +   E+ +L 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 268 QINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
            + H +++ LL        P    E  +   L  H+                 L+ ++  
Sbjct: 77  HMKHENVIGLLDVF----TPARSLEEFNDVYLVTHL----MGADLNNIVKCQKLTDDHVQ 128
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
            +  ++   + Y+HS+    I HRD+K SN+ +++    K+ DFG++R   ++ T     
Sbjct: 129 FLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-- 183
Query: 388 IQGTFGYLDPE-YFQSSQFTDKSDVYSFGVVLLELLTGK 425
              T  Y  PE       +    D++S G ++ ELLTG+
Sbjct: 184 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/219 (22%), Positives = 92/219 (42%), Gaps = 19/219 (8%)
Query: 211 LQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIH--QFINEVVILS 267
           +    + Y     +G G +G+V        G  VAVK+     ++ IH  +   E+ +L 
Sbjct: 19  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 78
Query: 268 QINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
            + H +++ LL        P    E  +   L  H+                 L+ ++  
Sbjct: 79  HMKHENVIGLLDVF----TPARSLEEFNDVYLVTHL----MGADLNNIVKCQKLTDDHVQ 130
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
            +  ++   + Y+HS+    I HRD+K SN+ +++    K+ DFG++R   ++ T     
Sbjct: 131 FLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-- 185
Query: 388 IQGTFGYLDPE-YFQSSQFTDKSDVYSFGVVLLELLTGK 425
              T  Y  PE       +    D++S G ++ ELLTG+
Sbjct: 186 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 93/211 (44%), Gaps = 25/211 (11%)
Query: 222 RFLGQGGFGTV---YKGMLPDGSIVAVKRSKEIDKTQIH--QFINEVVILSQINHRHIVK 276
           R +G G +G+V   Y   L     VAVK+     ++ IH  +   E+ +L  + H +++ 
Sbjct: 26  RPVGSGAYGSVCSAYDARLRQK--VAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIG 83
Query: 277 LLGC-CLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAG 335
           LL      T +      Y+ +  +   +++              +LS E+   +  ++  
Sbjct: 84  LLDVFTPATSIEDFSEVYLVTTLMGADLNN---------IVKCQALSDEHVQFLVYQLLR 134
Query: 336 AVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYL 395
            + Y+HS+    I HRD+K SN+ +++    ++ DFG++R    + T        T  Y 
Sbjct: 135 GLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADEEMTGYV----ATRWYR 187
Query: 396 DPE-YFQSSQFTDKSDVYSFGVVLLELLTGK 425
            PE       +    D++S G ++ ELL GK
Sbjct: 188 APEIMLNWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/219 (22%), Positives = 92/219 (42%), Gaps = 19/219 (8%)
Query: 211 LQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIH--QFINEVVILS 267
           +    + Y     +G G +G+V        G  VAVK+     ++ IH  +   E+ +L 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 268 QINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
            + H +++ LL        P    E  +   L  H+                 L+ ++  
Sbjct: 77  HMKHENVIGLLDVF----TPARSLEEFNDVYLVTHL----MGADLNNIVKCQKLTDDHVQ 128
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
            +  ++   + Y+HS+    I HRD+K SN+ +++    K+ DFG++R   ++ T     
Sbjct: 129 FLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-- 183
Query: 388 IQGTFGYLDPE-YFQSSQFTDKSDVYSFGVVLLELLTGK 425
              T  Y  PE       +    D++S G ++ ELLTG+
Sbjct: 184 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/219 (22%), Positives = 92/219 (42%), Gaps = 19/219 (8%)
Query: 211 LQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIH--QFINEVVILS 267
           +    + Y     +G G +G+V        G  VAVK+     ++ IH  +   E+ +L 
Sbjct: 22  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 81
Query: 268 QINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
            + H +++ LL        P    E  +   L  H+                 L+ ++  
Sbjct: 82  HMKHENVIGLLDVF----TPARSLEEFNDVYLVTHL----MGADLNNIVKCQKLTDDHVQ 133
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
            +  ++   + Y+HS+    I HRD+K SN+ +++    K+ DFG++R   ++ T     
Sbjct: 134 FLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-- 188
Query: 388 IQGTFGYLDPE-YFQSSQFTDKSDVYSFGVVLLELLTGK 425
              T  Y  PE       +    D++S G ++ ELLTG+
Sbjct: 189 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/219 (22%), Positives = 92/219 (42%), Gaps = 19/219 (8%)
Query: 211 LQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIH--QFINEVVILS 267
           +    + Y     +G G +G+V        G  VAVK+     ++ IH  +   E+ +L 
Sbjct: 29  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 88
Query: 268 QINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
            + H +++ LL        P    E  +   L  H+                 L+ ++  
Sbjct: 89  HMKHENVIGLLDVF----TPARSLEEFNDVYLVTHL----MGADLNNIVKCQKLTDDHVQ 140
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
            +  ++   + Y+HS+    I HRD+K SN+ +++    K+ DFG++R   ++ T     
Sbjct: 141 FLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-- 195
Query: 388 IQGTFGYLDPE-YFQSSQFTDKSDVYSFGVVLLELLTGK 425
              T  Y  PE       +    D++S G ++ ELLTG+
Sbjct: 196 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/219 (22%), Positives = 92/219 (42%), Gaps = 19/219 (8%)
Query: 211 LQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIH--QFINEVVILS 267
           +    + Y     +G G +G+V        G  VAVK+     ++ IH  +   E+ +L 
Sbjct: 19  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 78
Query: 268 QINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
            + H +++ LL        P    E  +   L  H+                 L+ ++  
Sbjct: 79  HMKHENVIGLLDVF----TPARSLEEFNDVYLVTHL----MGADLNNIVKCQKLTDDHVQ 130
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
            +  ++   + Y+HS+    I HRD+K SN+ +++    K+ DFG++R   ++ T     
Sbjct: 131 FLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYV-- 185
Query: 388 IQGTFGYLDPE-YFQSSQFTDKSDVYSFGVVLLELLTGK 425
              T  Y  PE       +    D++S G ++ ELLTG+
Sbjct: 186 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/217 (23%), Positives = 91/217 (41%), Gaps = 31/217 (14%)
Query: 218 YNQSRFLGQGGFGTV---YKGMLPDGSIVAVKRSKEIDKTQIH--QFINEVVILSQINHR 272
           Y   + +G G  G V   Y  +L     VA+K+     + Q H  +   E+V++  +NH+
Sbjct: 28  YQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 85
Query: 273 HIVKLLGC-----CLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
           +I+ LL        LE    V +   +    L   I                 L  E   
Sbjct: 86  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--------------MELDHERMS 131
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
            +  ++   + ++HS+    I HRD+K SNI++    + K+ DFG++R+     + +   
Sbjct: 132 YLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMVP 186
Query: 388 IQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTG 424
              T  Y  PE      + +  D++S G ++ E++ G
Sbjct: 187 FVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/219 (22%), Positives = 92/219 (42%), Gaps = 19/219 (8%)
Query: 211 LQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIH--QFINEVVILS 267
           +    + Y     +G G +G+V        G  VAVK+     ++ IH  +   E+ +L 
Sbjct: 29  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 88
Query: 268 QINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
            + H +++ LL        P    E  +   L  H+                 L+ ++  
Sbjct: 89  HMKHENVIGLLDVF----TPARSLEEFNDVYLVTHL----MGADLNNIVKCQKLTDDHVQ 140
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
            +  ++   + Y+HS+    I HRD+K SN+ +++    K+ DFG++R   ++ T     
Sbjct: 141 FLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-- 195
Query: 388 IQGTFGYLDPE-YFQSSQFTDKSDVYSFGVVLLELLTGK 425
              T  Y  PE       +    D++S G ++ ELLTG+
Sbjct: 196 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/219 (22%), Positives = 92/219 (42%), Gaps = 19/219 (8%)
Query: 211 LQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIH--QFINEVVILS 267
           +    + Y     +G G +G+V        G  VAVK+     ++ IH  +   E+ +L 
Sbjct: 37  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 96
Query: 268 QINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
            + H +++ LL        P    E  +   L  H+                 L+ ++  
Sbjct: 97  HMKHENVIGLLDVF----TPARSLEEFNDVYLVTHL----MGADLNNIVKCQKLTDDHVQ 148
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
            +  ++   + Y+HS+    I HRD+K SN+ +++    K+ DFG++R   ++ T     
Sbjct: 149 FLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-- 203
Query: 388 IQGTFGYLDPE-YFQSSQFTDKSDVYSFGVVLLELLTGK 425
              T  Y  PE       +    D++S G ++ ELLTG+
Sbjct: 204 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/219 (22%), Positives = 92/219 (42%), Gaps = 19/219 (8%)
Query: 211 LQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIH--QFINEVVILS 267
           +    + Y     +G G +G+V        G  VAVK+     ++ IH  +   E+ +L 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 268 QINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
            + H +++ LL        P    E  +   L  H+                 L+ ++  
Sbjct: 77  HMKHENVIGLLDVF----TPARSLEEFNDVYLVTHL----MGADLNNIVKCQKLTDDHVQ 128
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
            +  ++   + Y+HS+    I HRD+K SN+ +++    K+ DFG++R   ++ T     
Sbjct: 129 FLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-- 183
Query: 388 IQGTFGYLDPE-YFQSSQFTDKSDVYSFGVVLLELLTGK 425
              T  Y  PE       +    D++S G ++ ELLTG+
Sbjct: 184 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/219 (22%), Positives = 92/219 (42%), Gaps = 19/219 (8%)
Query: 211 LQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIH--QFINEVVILS 267
           +    + Y     +G G +G+V        G  VAVK+     ++ IH  +   E+ +L 
Sbjct: 23  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 82
Query: 268 QINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
            + H +++ LL        P    E  +   L  H+                 L+ ++  
Sbjct: 83  HMKHENVIGLLDVF----TPARSLEEFNDVYLVTHL----MGADLNNIVKCQKLTDDHVQ 134
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
            +  ++   + Y+HS+    I HRD+K SN+ +++    K+ DFG++R   ++ T     
Sbjct: 135 FLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYV-- 189
Query: 388 IQGTFGYLDPE-YFQSSQFTDKSDVYSFGVVLLELLTGK 425
              T  Y  PE       +    D++S G ++ ELLTG+
Sbjct: 190 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/219 (22%), Positives = 92/219 (42%), Gaps = 19/219 (8%)
Query: 211 LQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIH--QFINEVVILS 267
           +    + Y     +G G +G+V        G  VAVK+     ++ IH  +   E+ +L 
Sbjct: 36  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 95
Query: 268 QINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
            + H +++ LL        P    E  +   L  H+                 L+ ++  
Sbjct: 96  HMKHENVIGLLDVF----TPARSLEEFNDVYLVTHL----MGADLNNIVKCQKLTDDHVQ 147
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
            +  ++   + Y+HS+    I HRD+K SN+ +++    K+ DFG++R   ++ T     
Sbjct: 148 FLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-- 202
Query: 388 IQGTFGYLDPE-YFQSSQFTDKSDVYSFGVVLLELLTGK 425
              T  Y  PE       +    D++S G ++ ELLTG+
Sbjct: 203 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/212 (22%), Positives = 92/212 (43%), Gaps = 19/212 (8%)
Query: 218 YNQSRFLGQGGFGTV---YKGMLPDGSIVAVKRSKEI-DKTQIHQFINEVVILSQINHRH 273
           Y   + +G G  G V   Y  +L D ++   K S+   ++T   +   E+V++  +NH++
Sbjct: 64  YQNLKPIGSGAQGIVCAAYDAVL-DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 122
Query: 274 IVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEV 333
           I+ LL        P    E      L   + D               +S+     +  ++
Sbjct: 123 IISLLNVF----TPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSY-----LLYQM 173
Query: 334 AGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFG 393
              + ++HS+    I HRD+K SNI++    + K+ DFG++R+     + + T    T  
Sbjct: 174 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY 228
Query: 394 YLDPEYFQSSQFTDKSDVYSFGVVLLELLTGK 425
           Y  PE      + +  D++S G ++ E++  K
Sbjct: 229 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/219 (22%), Positives = 92/219 (42%), Gaps = 19/219 (8%)
Query: 211 LQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIH--QFINEVVILS 267
           +    + Y     +G G +G+V        G  VAVK+     ++ IH  +   E+ +L 
Sbjct: 14  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 73
Query: 268 QINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
            + H +++ LL        P    E  +   L  H+                 L+ ++  
Sbjct: 74  HMKHENVIGLLDVF----TPARSLEEFNDVYLVTHL----MGADLNNIVKCQKLTDDHVQ 125
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
            +  ++   + Y+HS+    I HRD+K SN+ +++    K+ DFG++R   ++ T     
Sbjct: 126 FLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-- 180
Query: 388 IQGTFGYLDPE-YFQSSQFTDKSDVYSFGVVLLELLTGK 425
              T  Y  PE       +    D++S G ++ ELLTG+
Sbjct: 181 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/219 (22%), Positives = 92/219 (42%), Gaps = 19/219 (8%)
Query: 211 LQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIH--QFINEVVILS 267
           +    + Y     +G G +G+V        G  VAVK+     ++ IH  +   E+ +L 
Sbjct: 13  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 72
Query: 268 QINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
            + H +++ LL        P    E  +   L  H+                 L+ ++  
Sbjct: 73  HMKHENVIGLLDVF----TPARSLEEFNDVYLVTHL----MGADLNNIVKCQKLTDDHVQ 124
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
            +  ++   + Y+HS+    I HRD+K SN+ +++    K+ DFG++R   ++ T     
Sbjct: 125 FLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-- 179
Query: 388 IQGTFGYLDPE-YFQSSQFTDKSDVYSFGVVLLELLTGK 425
              T  Y  PE       +    D++S G ++ ELLTG+
Sbjct: 180 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 93/211 (44%), Gaps = 25/211 (11%)
Query: 222 RFLGQGGFGTV---YKGMLPDGSIVAVKRSKEIDKTQIH--QFINEVVILSQINHRHIVK 276
           R +G G +G+V   Y   L     VAVK+     ++ IH  +   E+ +L  + H +++ 
Sbjct: 34  RPVGSGAYGSVCSAYDARLRQK--VAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIG 91
Query: 277 LLGC-CLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAG 335
           LL      T +      Y+ +  +   +++              +LS E+   +  ++  
Sbjct: 92  LLDVFTPATSIEDFSEVYLVTTLMGADLNN---------IVKCQALSDEHVQFLVYQLLR 142
Query: 336 AVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYL 395
            + Y+HS+    I HRD+K SN+ +++    ++ DFG++R    + T        T  Y 
Sbjct: 143 GLKYIHSAG---IIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYV----ATRWYR 195
Query: 396 DPE-YFQSSQFTDKSDVYSFGVVLLELLTGK 425
            PE       +    D++S G ++ ELL GK
Sbjct: 196 APEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/212 (22%), Positives = 92/212 (43%), Gaps = 19/212 (8%)
Query: 218 YNQSRFLGQGGFGTV---YKGMLPDGSIVAVKRSKEI-DKTQIHQFINEVVILSQINHRH 273
           Y   + +G G  G V   Y  +L D ++   K S+   ++T   +   E+V++  +NH++
Sbjct: 64  YQNLKPIGSGAQGIVCAAYDAVL-DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 122
Query: 274 IVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEV 333
           I+ LL        P    E      L   + D               +S+     +  ++
Sbjct: 123 IISLLNVF----TPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSY-----LLYQM 173
Query: 334 AGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFG 393
              + ++HS+    I HRD+K SNI++    + K+ DFG++R+     + + T    T  
Sbjct: 174 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY 228
Query: 394 YLDPEYFQSSQFTDKSDVYSFGVVLLELLTGK 425
           Y  PE      + +  D++S G ++ E++  K
Sbjct: 229 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 50/219 (22%), Positives = 92/219 (42%), Gaps = 19/219 (8%)
Query: 211 LQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIH--QFINEVVILS 267
           +    + Y     +G G +G+V        G  VAVK+     ++ IH  +   E+ +L 
Sbjct: 19  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 78
Query: 268 QINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
            + H +++ LL        P    E  +   L  H+                 L+ ++  
Sbjct: 79  HMKHENVIGLLDVF----TPARSLEEFNDVYLVTHL----MGADLNNIVKCQKLTDDHVQ 130
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
            +  ++   + Y+HS+    I HRD+K SN+ +++    K+ DFG++R   ++ T     
Sbjct: 131 FLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-- 185
Query: 388 IQGTFGYLDPE-YFQSSQFTDKSDVYSFGVVLLELLTGK 425
              T  Y  PE       +    D++S G ++ ELLTG+
Sbjct: 186 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 50/219 (22%), Positives = 92/219 (42%), Gaps = 19/219 (8%)
Query: 211 LQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIH--QFINEVVILS 267
           +    + Y     +G G +G+V        G  VAVK+     ++ IH  +   E+ +L 
Sbjct: 15  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 74
Query: 268 QINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
            + H +++ LL        P    E  +   L  H+                 L+ ++  
Sbjct: 75  HMKHENVIGLLDVF----TPARSLEEFNDVYLVTHL----MGADLNNIVKCQKLTDDHVQ 126
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
            +  ++   + Y+HS+    I HRD+K SN+ +++    K+ DFG++R   ++ T     
Sbjct: 127 FLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-- 181
Query: 388 IQGTFGYLDPE-YFQSSQFTDKSDVYSFGVVLLELLTGK 425
              T  Y  PE       +    D++S G ++ ELLTG+
Sbjct: 182 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 50/98 (51%), Gaps = 8/98 (8%)
Query: 333 VAGAVAYMHSSASIPIFHRDIKSSNILLDDKFS---AKVSDFGISRSIPNDKTHLTTTIQ 389
           +  A+ Y+HS   I I HRD+K  N+L   K      K++DFG ++   +  + LTT   
Sbjct: 124 IGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LTTPCY 179
Query: 390 GTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
             + Y+ PE     ++    D++S GV++  LL G  P
Sbjct: 180 TPY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 216

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 50/98 (51%), Gaps = 8/98 (8%)
Query: 333 VAGAVAYMHSSASIPIFHRDIKSSNILLDDKFS---AKVSDFGISRSIPNDKTHLTTTIQ 389
           +  A+ Y+HS   I I HRD+K  N+L   K      K++DFG ++   +  + LTT   
Sbjct: 125 IGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LTTPCY 180
Query: 390 GTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
             + Y+ PE     ++    D++S GV++  LL G  P
Sbjct: 181 TPY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 217

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 50/98 (51%), Gaps = 8/98 (8%)
Query: 333 VAGAVAYMHSSASIPIFHRDIKSSNILLDDKFS---AKVSDFGISRSIPNDKTHLTTTIQ 389
           +  A+ Y+HS   I I HRD+K  N+L   K      K++DFG ++   +  + LTT   
Sbjct: 131 IGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LTTPCY 186
Query: 390 GTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
             + Y+ PE     ++    D++S GV++  LL G  P
Sbjct: 187 TPY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 223

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 50/98 (51%), Gaps = 8/98 (8%)
Query: 333 VAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA---KVSDFGISRSIPNDKTHLTTTIQ 389
           +  A+ Y+HS   I I HRD+K  N+L   K      K++DFG ++   +  + LTT   
Sbjct: 176 IGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LTTPCY 231
Query: 390 GTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
             + Y+ PE     ++    D++S GV++  LL G  P
Sbjct: 232 TPY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 268

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 50/98 (51%), Gaps = 8/98 (8%)
Query: 333 VAGAVAYMHSSASIPIFHRDIKSSNILLDDKFS---AKVSDFGISRSIPNDKTHLTTTIQ 389
           +  A+ Y+HS   I I HRD+K  N+L   K      K++DFG ++   +  + LTT   
Sbjct: 140 IGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LTTPCY 195
Query: 390 GTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
             + Y+ PE     ++    D++S GV++  LL G  P
Sbjct: 196 TPY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 232

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 73/295 (24%), Positives = 126/295 (42%), Gaps = 43/295 (14%)
Query: 224 LGQGGFGTV--YKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCC 281
           LG+GGF  V   +G L DG   A+KR    ++    +   E  +    NH +I++L+  C
Sbjct: 37  LGEGGFSYVDLVEG-LHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 282 LE----TEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAV 337
           L          L+  +   GTL + I               + L+ +  + +   +   +
Sbjct: 96  LRERGAKHEAWLLLPFFKRGTLWNEI--------ERLKDKGNFLTEDQILWLLLGICRGL 147
Query: 338 AYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS--IPNDKTHLTTTIQG----- 390
             +H+       HRD+K +NILL D+    + D G      I  + +    T+Q      
Sbjct: 148 EAIHAKGYA---HRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQR 204
Query: 391 -TFGYLDPEYF--QSSQFTD-KSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISL 446
            T  Y  PE F  QS    D ++DV+S G VL  ++ G+ P  +  V ++ + VA    L
Sbjct: 205 CTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP--YDMVFQKGDSVA----L 258
Query: 447 AKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLR 501
           A +NQL       + +  R     A+ +L    + ++  +RP +  +  +LE L+
Sbjct: 259 AVQNQL------SIPQSPRHSS--ALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 50/219 (22%), Positives = 92/219 (42%), Gaps = 19/219 (8%)
Query: 211 LQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIH--QFINEVVILS 267
           +    + Y     +G G +G+V        G  VAVK+     ++ IH  +   E+ +L 
Sbjct: 23  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 82
Query: 268 QINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
            + H +++ LL        P    E  +   L  H+                 L+ ++  
Sbjct: 83  HMKHENVIGLLDVF----TPARSLEEFNDVYLVTHL----MGADLNNIVKCQKLTDDHVQ 134
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
            +  ++   + Y+HS+    I HRD+K SN+ +++    K+ DFG++R   ++ T     
Sbjct: 135 FLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-- 189
Query: 388 IQGTFGYLDPE-YFQSSQFTDKSDVYSFGVVLLELLTGK 425
              T  Y  PE       +    D++S G ++ ELLTG+
Sbjct: 190 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 50/98 (51%), Gaps = 8/98 (8%)
Query: 333 VAGAVAYMHSSASIPIFHRDIKSSNILLDDKFS---AKVSDFGISRSIPNDKTHLTTTIQ 389
           +  A+ Y+HS   I I HRD+K  N+L   K      K++DFG ++   +  + LTT   
Sbjct: 130 IGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LTTPCY 185
Query: 390 GTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
             + Y+ PE     ++    D++S GV++  LL G  P
Sbjct: 186 TPY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 222

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 50/98 (51%), Gaps = 8/98 (8%)
Query: 333 VAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA---KVSDFGISRSIPNDKTHLTTTIQ 389
           +  A+ Y+HS   I I HRD+K  N+L   K      K++DFG ++   +  + LTT   
Sbjct: 126 IGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LTTPCY 181
Query: 390 GTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
             + Y+ PE     ++    D++S GV++  LL G  P
Sbjct: 182 TPY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 218

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 50/98 (51%), Gaps = 8/98 (8%)
Query: 333 VAGAVAYMHSSASIPIFHRDIKSSNILLDDKFS---AKVSDFGISRSIPNDKTHLTTTIQ 389
           +  A+ Y+HS   I I HRD+K  N+L   K      K++DFG ++   +  + LTT   
Sbjct: 132 IGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LTTPCY 187
Query: 390 GTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
             + Y+ PE     ++    D++S GV++  LL G  P
Sbjct: 188 TPY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 224

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 50/98 (51%), Gaps = 8/98 (8%)
Query: 333 VAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA---KVSDFGISRSIPNDKTHLTTTIQ 389
           +  A+ Y+HS   I I HRD+K  N+L   K      K++DFG ++   +  + LTT   
Sbjct: 170 IGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LTTPCY 225
Query: 390 GTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
             + Y+ PE     ++    D++S GV++  LL G  P
Sbjct: 226 TPY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 262

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 50/98 (51%), Gaps = 8/98 (8%)
Query: 333 VAGAVAYMHSSASIPIFHRDIKSSNILLDDKFS---AKVSDFGISRSIPNDKTHLTTTIQ 389
           +  A+ Y+HS   I I HRD+K  N+L   K      K++DFG ++   +  + LTT   
Sbjct: 126 IGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LTTPCY 181
Query: 390 GTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
             + Y+ PE     ++    D++S GV++  LL G  P
Sbjct: 182 TPY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 218

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 49/219 (22%), Positives = 91/219 (41%), Gaps = 19/219 (8%)
Query: 211 LQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIH--QFINEVVILS 267
           +    + Y     +G G +G+V        G  VAVK+     ++ IH  +   E+ +L 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 268 QINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
            + H +++ LL        P    E  +   L  H+                 L+ ++  
Sbjct: 77  HMKHENVIGLLDVF----TPARSLEEFNDVYLVTHL----MGADLNNIVKCQKLTDDHVQ 128
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
            +  ++   + Y+HS+    I HRD+K SN+ +++    K+ DFG++R   ++       
Sbjct: 129 FLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFV-- 183
Query: 388 IQGTFGYLDPE-YFQSSQFTDKSDVYSFGVVLLELLTGK 425
              T  Y  PE       +    D++S G ++ ELLTG+
Sbjct: 184 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 93/215 (43%), Gaps = 33/215 (15%)
Query: 222 RFLGQGGFGTV---YKGMLPDGSIVAVKRSKEIDKTQIH--QFINEVVILSQINHRHIVK 276
           R +G G +G+V   Y   L     VAVK+     ++ IH  +   E+ +L  + H +++ 
Sbjct: 34  RPVGSGAYGSVCSAYDARLRQK--VAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIG 91
Query: 277 LL-----GCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVAC 331
           LL        +E    V +   +    L++ +                +LS E+   +  
Sbjct: 92  LLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQ-------------ALSDEHVQFLVY 138
Query: 332 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGT 391
           ++   + Y+HS+    I HRD+K SN+ +++    ++ DFG++R    + T        T
Sbjct: 139 QLLRGLKYIHSAG---IIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYV----AT 191
Query: 392 FGYLDPE-YFQSSQFTDKSDVYSFGVVLLELLTGK 425
             Y  PE       +    D++S G ++ ELL GK
Sbjct: 192 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 89/197 (45%), Gaps = 33/197 (16%)
Query: 249 KEIDKTQIH---QFINEVVILSQI-NHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIH 304
           K I+K   H   +   EV +L Q   HR++++L+    E +   LV+E +  G++  HIH
Sbjct: 44  KIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIH 103
Query: 305 DHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK- 363
                                   V  +VA A+ ++H+     I HRD+K  NIL +   
Sbjct: 104 KRRHFNELEASV------------VVQDVASALDFLHNKG---IAHRDLKPENILCEHPN 148
Query: 364 --FSAKVSDFGISRSIP--NDKTHLTT----TIQGTFGYLDPEYF-----QSSQFTDKSD 410
                K+ DFG+   I    D + ++T    T  G+  Y+ PE       ++S +  + D
Sbjct: 149 QVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCD 208
Query: 411 VYSFGVVLLELLTGKKP 427
           ++S GV+L  LL+G  P
Sbjct: 209 LWSLGVILYILLSGYPP 225

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 30/101 (29%), Positives = 49/101 (48%), Gaps = 8/101 (7%)
Query: 333 VAGAVAYMHSSASIPIFHRDIKSSNILLDDKF----SAKVSDFGISRSIPNDKTHLTTTI 388
           +   V Y+H+     + HRD+K SNIL  D+     S ++ DFG ++ +  +   L T  
Sbjct: 125 ITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPC 181
Query: 389 QGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPIC 429
             T  ++ PE  +   +    D++S GV+L   LTG  P  
Sbjct: 182 Y-TANFVAPEVLERQGYDAACDIWSLGVLLYTXLTGYTPFA 221

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 49/219 (22%), Positives = 91/219 (41%), Gaps = 19/219 (8%)
Query: 211 LQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIH--QFINEVVILS 267
           +    + Y     +G G +G+V        G  VAVK+     ++ IH  +   E+ +L 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 268 QINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
            + H +++ LL        P    E  +   L  H+                 L+ ++  
Sbjct: 77  HMKHENVIGLLDVF----TPARSLEEFNDVYLVTHL----MGADLNNIVKCQKLTDDHVQ 128
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
            +  ++   + Y+HS+    I HRD+K SN+ +++    K+ DFG++R   ++       
Sbjct: 129 FLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFV-- 183
Query: 388 IQGTFGYLDPE-YFQSSQFTDKSDVYSFGVVLLELLTGK 425
              T  Y  PE       +    D++S G ++ ELLTG+
Sbjct: 184 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 92/218 (42%), Gaps = 31/218 (14%)
Query: 218 YNQSRFLGQGGFGTV---YKGMLPDGSIVAVKRSKEIDKTQIH--QFINEVVILSQINHR 272
           Y   + +G G  G V   Y  +L     VA+K+     + Q H  +   E+V++  +NH+
Sbjct: 31  YQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 88
Query: 273 HIVKLLGC-----CLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
           +I+ LL        LE    V +   +    L   I                 L  E   
Sbjct: 89  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--------------MELDHERMS 134
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
            +  ++   + ++HS+    I HRD+K SNI++    + K+ DFG++R+     + + T 
Sbjct: 135 YLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTP 189
Query: 388 IQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGK 425
              T  Y  PE      + +  D++S G ++ E++  K
Sbjct: 190 YVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 227

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 92/218 (42%), Gaps = 31/218 (14%)
Query: 218 YNQSRFLGQGGFGTV---YKGMLPDGSIVAVKRSKEIDKTQIH--QFINEVVILSQINHR 272
           Y   + +G G  G V   Y  +L     VA+K+     + Q H  +   E+V++  +NH+
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 77
Query: 273 HIVKLLGC-----CLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
           +I+ LL        LE    V +   +    L   I                 L  E   
Sbjct: 78  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--------------MELDHERMS 123
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
            +  ++   + ++HS+    I HRD+K SNI++    + K+ DFG++R+     + + T 
Sbjct: 124 YLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTP 178
Query: 388 IQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGK 425
              T  Y  PE      + +  D++S G ++ E++  K
Sbjct: 179 YVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 216

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 56/243 (23%), Positives = 99/243 (40%), Gaps = 41/243 (16%)
Query: 213 RATDNYNQSRFLGQGGFGTVYKGMLPDGSI-VAVKRSKEI--DKTQIHQFINEVVILSQI 269
           +  DNY     +G+G +G VY     + +  VA+K+   +  D     + + E+ IL+++
Sbjct: 25  KVPDNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRL 84
Query: 270 NHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVR- 328
              +I++L    +  ++      YI        I D            L+    E  V+ 
Sbjct: 85  KSDYIIRLHDLIIPEDLLKFDELYIVL-----EIADSDLKKLFKTPIFLT----EQHVKT 135
Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDK-THLTTT 387
           +   +     ++H S    I HRD+K +N LL+   S K+ DFG++R+I +DK  H+   
Sbjct: 136 ILYNLLLGEKFIHESG---IIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVND 192
Query: 388 IQG-----------------------TFGYLDPEY-FQSSQFTDKSDVYSFGVVLLELLT 423
           ++                        T  Y  PE       +T+  D++S G +  ELL 
Sbjct: 193 LEEKEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLN 252
Query: 424 GKK 426
             K
Sbjct: 253 MMK 255

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 49/219 (22%), Positives = 91/219 (41%), Gaps = 19/219 (8%)
Query: 211 LQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIH--QFINEVVILS 267
           +    + Y     +G G +G+V        G  VAVK+     ++ IH  +   E+ +L 
Sbjct: 13  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 72
Query: 268 QINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
            + H +++ LL        P    E  +   L  H+                 L+ ++  
Sbjct: 73  HMKHENVIGLLDVF----TPARSLEEFNDVYLVTHL----MGADLNNIVKCQKLTDDHVQ 124
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
            +  ++   + Y+HS+    I HRD+K SN+ +++    K+ DFG++R   ++       
Sbjct: 125 FLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFV-- 179
Query: 388 IQGTFGYLDPE-YFQSSQFTDKSDVYSFGVVLLELLTGK 425
              T  Y  PE       +    D++S G ++ ELLTG+
Sbjct: 180 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 48/206 (23%), Positives = 90/206 (43%), Gaps = 19/206 (9%)
Query: 224 LGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIH--QFINEVVILSQINHRHIVKLLGC 280
           +G G +G+V     +  G  +AVK+     ++ IH  +   E+ +L  + H +++ LL  
Sbjct: 59  VGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 118
Query: 281 CLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYM 340
                 P    E  +   L  H+                 L+ ++   +  ++   + Y+
Sbjct: 119 F----TPATSLEEFNDVYLVTHL----MGADLNNIVKCQKLTDDHVQFLIYQILRGLKYI 170
Query: 341 HSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPE-Y 399
           HS+    I HRD+K SN+ +++    K+ DFG++R   ++ T        T  Y  PE  
Sbjct: 171 HSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYRAPEIM 223
Query: 400 FQSSQFTDKSDVYSFGVVLLELLTGK 425
                +    D++S G ++ ELLTG+
Sbjct: 224 LNWMHYNMTVDIWSVGCIMAELLTGR 249

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 39/142 (27%), Positives = 67/142 (47%), Gaps = 24/142 (16%)
Query: 325 NRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILL--DDKFSAK-----------VSDF 371
           N + +  ++A  VA++HS   + I HRD+K  NIL+    +F+A            +SDF
Sbjct: 134 NPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDF 190
Query: 372 GISRSIPNDKTHLTTTIQ---GTFGYLDPEYFQSS---QFTDKSDVYSFGVVLLELLT-G 424
           G+ + + + +      +    GT G+  PE  + S   + T   D++S G V   +L+ G
Sbjct: 191 GLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKG 250
Query: 425 KKPICFARVEEERNLVACFISL 446
           K P    +   E N++    SL
Sbjct: 251 KHPFG-DKYSRESNIIRGIFSL 271

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 55/229 (24%), Positives = 90/229 (39%), Gaps = 21/229 (9%)
Query: 208 ADELQRATDNYNQSRFLGQGGFGTVYK------GMLPDGSIVAVKRSKEIDKTQIHQFIN 261
           AD+     D Y     +G+G F  V +      G      IV V +              
Sbjct: 16  ADDDVLFEDVYELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKR 75
Query: 262 EVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSL 321
           E  I   + H HIV+LL       +  +V+E++    L   I               S  
Sbjct: 76  EASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEI-----VKRADAGFVYSEA 130
Query: 322 SWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA---KVSDFGISRSIP 378
              + +R   ++  A+ Y H +    I HRD+K  N+LL  K ++   K+ DFG++  + 
Sbjct: 131 VASHYMR---QILEALRYCHDNN---IIHRDVKPENVLLASKENSAPVKLGDFGVAIQL- 183
Query: 379 NDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
            +   +     GT  ++ PE  +   +    DV+  GV+L  LL+G  P
Sbjct: 184 GESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP 232

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 28/101 (27%), Positives = 49/101 (48%), Gaps = 8/101 (7%)
Query: 333 VAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA----KVSDFGISRSIPNDKTHLTTTI 388
           +   V Y+HS     + HRD+K SNIL  D+       ++ DFG ++ +  +   L T  
Sbjct: 130 IGKTVEYLHSQG---VVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPC 186
Query: 389 QGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPIC 429
             T  ++ PE  +   + +  D++S G++L  +L G  P  
Sbjct: 187 Y-TANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPFA 226

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 39/142 (27%), Positives = 67/142 (47%), Gaps = 24/142 (16%)
Query: 325 NRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILL--DDKFSAK-----------VSDF 371
           N + +  ++A  VA++HS   + I HRD+K  NIL+    +F+A            +SDF
Sbjct: 134 NPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDF 190
Query: 372 GISRSIPNDKTHLTTTIQ---GTFGYLDPEYFQSS---QFTDKSDVYSFGVVLLELLT-G 424
           G+ + + + +      +    GT G+  PE  + S   + T   D++S G V   +L+ G
Sbjct: 191 GLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKG 250
Query: 425 KKPICFARVEEERNLVACFISL 446
           K P    +   E N++    SL
Sbjct: 251 KHPFG-DKYSRESNIIRGIFSL 271

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 96/224 (42%), Gaps = 27/224 (12%)
Query: 214 ATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSK-EIDKTQIH-QFINEVVILSQIN 270
           + D Y +   LG+G +G VYK +       VA+KR + E ++  +    I EV +L ++ 
Sbjct: 32  SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQ 91
Query: 271 HRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVA 330
           HR+I++L           L++EY +   L  ++  +           L  L         
Sbjct: 92  HRNIIELKSVIHHNHRLHLIFEY-AENDLKKYMDKNPDVSMRVIKSFLYQL--------- 141
Query: 331 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA-----KVSDFGISRSIPNDKTHLT 385
                 V + HS   +   HRD+K  N+LL    ++     K+ DFG++R+        T
Sbjct: 142 ---INGVNFCHSRRCL---HRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFT 195
Query: 386 TTIQGTFGYLDPEYFQSSQ-FTDKSDVYSFGVVLLELLTGKKPI 428
             I  T  Y  PE    S+ ++   D++S   +  E+L  K P+
Sbjct: 196 HEII-TLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLM-KTPL 237

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 49/219 (22%), Positives = 92/219 (42%), Gaps = 19/219 (8%)
Query: 211 LQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIH--QFINEVVILS 267
           +    + Y     +G G +G+V        G  VAVK+     ++ IH  +   E+ +L 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 268 QINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
            + H +++ LL        P    E  +   L  H+                 L+ ++  
Sbjct: 77  HMKHENVIGLLDVF----TPARSLEEFNDVYLVTHL----MGADLNNIVKCQKLTDDHVQ 128
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
            +  ++   + Y+HS+    I HRD+K SN+ +++    K+ D+G++R   ++ T     
Sbjct: 129 FLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDYGLARHTDDEMTGYV-- 183
Query: 388 IQGTFGYLDPE-YFQSSQFTDKSDVYSFGVVLLELLTGK 425
              T  Y  PE       +    D++S G ++ ELLTG+
Sbjct: 184 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 28/101 (27%), Positives = 49/101 (48%), Gaps = 8/101 (7%)
Query: 333 VAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA----KVSDFGISRSIPNDKTHLTTTI 388
           +   V Y+HS     + HRD+K SNIL  D+       ++ DFG ++ +  +   L T  
Sbjct: 130 IGKTVEYLHSQG---VVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPC 186
Query: 389 QGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPIC 429
             T  ++ PE  +   + +  D++S G++L  +L G  P  
Sbjct: 187 Y-TANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPFA 226

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 49/219 (22%), Positives = 91/219 (41%), Gaps = 19/219 (8%)
Query: 211 LQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIH--QFINEVVILS 267
           +    + Y     +G G +G+V        G  VAVK+     ++ IH  +   E+ +L 
Sbjct: 37  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 96
Query: 268 QINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
            + H +++ LL        P    E  +   L  H+                 L+ ++  
Sbjct: 97  HMKHENVIGLLDVF----TPARSLEEFNDVYLVTHL----MGADLNNIVKCQKLTDDHVQ 148
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
            +  ++   + Y+HS+    I HRD+K SN+ +++    K+ DFG++R   ++       
Sbjct: 149 FLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGXV-- 203
Query: 388 IQGTFGYLDPE-YFQSSQFTDKSDVYSFGVVLLELLTGK 425
              T  Y  PE       +    D++S G ++ ELLTG+
Sbjct: 204 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 50/219 (22%), Positives = 91/219 (41%), Gaps = 19/219 (8%)
Query: 211 LQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIH--QFINEVVILS 267
           +    + Y     +G G +G+V        G  VAVK+     ++ IH  +   E+ +L 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 268 QINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
            + H +++ LL        P    E  +   L  H+                 L+ ++  
Sbjct: 77  HMKHENVIGLLDVF----TPARSLEEFNDVYLVTHL----MGADLNNIVKSQKLTDDHVQ 128
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
            +  ++   + Y+HS+    I HRD+K SN+ +++    K+ DFG+ R   ++ T     
Sbjct: 129 FLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLCRHTDDEMTGYV-- 183
Query: 388 IQGTFGYLDPE-YFQSSQFTDKSDVYSFGVVLLELLTGK 425
              T  Y  PE       +    D++S G ++ ELLTG+
Sbjct: 184 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 73/159 (45%), Gaps = 19/159 (11%)
Query: 208 ADELQRATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKE-----IDKTQIHQFIN 261
           A+   R T  +++   +G G FG+V+K +   DG I A+KRSK+     +D+    + + 
Sbjct: 1   AEMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVY 60
Query: 262 EVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSL 321
              +L Q  H H+V+      E +  ++  EY + G+L+  I ++           L  L
Sbjct: 61  AHAVLGQ--HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDL 118
Query: 322 SWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILL 360
                     +V   + Y+H   S+ + H DIK SNI +
Sbjct: 119 --------LLQVGRGLRYIH---SMSLVHMDIKPSNIFI 146

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/154 (26%), Positives = 71/154 (46%), Gaps = 19/154 (12%)
Query: 213 RATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKE-----IDKTQIHQFINEVVIL 266
           R T  +++   +G G FG+V+K +   DG I A+KRSK+     +D+    + +    +L
Sbjct: 8   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 67
Query: 267 SQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENR 326
            Q  H H+V+      E +  ++  EY + G+L+  I ++           L  L     
Sbjct: 68  GQ--HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDL----- 120
Query: 327 VRVACEVAGAVAYMHSSASIPIFHRDIKSSNILL 360
                +V   + Y+H   S+ + H DIK SNI +
Sbjct: 121 ---LLQVGRGLRYIH---SMSLVHMDIKPSNIFI 148

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/154 (26%), Positives = 71/154 (46%), Gaps = 19/154 (12%)
Query: 213 RATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKE-----IDKTQIHQFINEVVIL 266
           R T  +++   +G G FG+V+K +   DG I A+KRSK+     +D+    + +    +L
Sbjct: 6   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 65
Query: 267 SQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENR 326
            Q  H H+V+      E +  ++  EY + G+L+  I ++           L  L     
Sbjct: 66  GQ--HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDL----- 118
Query: 327 VRVACEVAGAVAYMHSSASIPIFHRDIKSSNILL 360
                +V   + Y+H   S+ + H DIK SNI +
Sbjct: 119 ---LLQVGRGLRYIH---SMSLVHMDIKPSNIFI 146

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/230 (23%), Positives = 96/230 (41%), Gaps = 31/230 (13%)
Query: 224 LGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRH--IVKLLGCC 281
           +G+G +G V++G+   G  VAVK     D+     +  E  I + +  RH  I+  +   
Sbjct: 16  VGKGRYGEVWRGLW-HGESVAVKIFSSRDE---QSWFRETEIYNTVLLRHDNILGFIASD 71
Query: 282 LETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYMH 341
           + +         I+      H H+H           L        +R+A   A  +A++H
Sbjct: 72  MTSRNSSTQLWLIT------HYHEHGSLYDFLQRQTLEP---HLALRLAVSAACGLAHLH 122
Query: 342 -----SSASIPIFHRDIKSSNILLDDKFSAKVSDFGIS--RSIPNDKTHLTTTIQ-GTFG 393
                +     I HRD KS N+L+       ++D G++   S  +D   +    + GT  
Sbjct: 123 VEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKR 182
Query: 394 YLDPEYFQSSQFTD------KSDVYSFGVVLLELLTGKKPICFARVEEER 437
           Y+ PE       TD       +D+++FG+VL E+   ++ I    VE+ R
Sbjct: 183 YMAPEVLDEQIRTDCFESYKWTDIWAFGLVLWEI--ARRTIVNGIVEDYR 230

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/154 (26%), Positives = 71/154 (46%), Gaps = 19/154 (12%)
Query: 213 RATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKE-----IDKTQIHQFINEVVIL 266
           R T  +++   +G G FG+V+K +   DG I A+KRSK+     +D+    + +    +L
Sbjct: 4   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 63
Query: 267 SQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENR 326
            Q  H H+V+      E +  ++  EY + G+L+  I ++           L  L     
Sbjct: 64  GQ--HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDL----- 116
Query: 327 VRVACEVAGAVAYMHSSASIPIFHRDIKSSNILL 360
                +V   + Y+H   S+ + H DIK SNI +
Sbjct: 117 ---LLQVGRGLRYIH---SMSLVHMDIKPSNIFI 144

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/219 (22%), Positives = 91/219 (41%), Gaps = 19/219 (8%)
Query: 211 LQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIH--QFINEVVILS 267
           +    + Y     +G G +G+V        G  VAVK+     ++ IH  +   E+ +L 
Sbjct: 40  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 99
Query: 268 QINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
            + H +++ LL        P    E  +   L  H+                 L+ ++  
Sbjct: 100 HMKHENVIGLLDVF----TPARSLEEFNDVYLVTHL----MGADLNNIVKCQKLTDDHVQ 151
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
            +  ++   + Y+HS+    I HRD+K SN+ +++    K+ DFG++R   ++       
Sbjct: 152 FLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGYV-- 206
Query: 388 IQGTFGYLDPE-YFQSSQFTDKSDVYSFGVVLLELLTGK 425
              T  Y  PE       +    D++S G ++ ELLTG+
Sbjct: 207 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 99/221 (44%), Gaps = 43/221 (19%)
Query: 224 LGQGGFGTVYKGMLPDGSIVAVK--RSKEIDKTQIHQFINEVVILSQINHRHIVKLLGC- 280
           +G+G FG V++G    G  VAVK   S+E         I + V+L    H +I+  +   
Sbjct: 50  IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVML---RHENILGFIAAD 105
Query: 281 ----CLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGA 336
                  T++  LV +Y   G+L  +++ +             +++ E  +++A   A  
Sbjct: 106 NKDNGTWTQL-WLVSDYHEHGSLFDYLNRY-------------TVTVEGMIKLALSTASG 151
Query: 337 VAYMH-----SSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQ-- 389
           +A++H     +     I HRD+KS NIL+    +  ++D G+  ++ +D    T  I   
Sbjct: 152 LAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL--AVRHDSATDTIDIAPN 209
Query: 390 ---GTFGYLDPEYFQSS------QFTDKSDVYSFGVVLLEL 421
              GT  Y+ PE    S      +   ++D+Y+ G+V  E+
Sbjct: 210 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 250

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/121 (28%), Positives = 56/121 (46%), Gaps = 12/121 (9%)
Query: 331 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI-PNDKTHLTTTIQ 389
           C++   + Y+HS     I H+DIK  N+LL    + K+S  G++ ++ P        T Q
Sbjct: 116 CQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ 172
Query: 390 GTFGYLDPEYFQS-SQFTD-KSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLA 447
           G+  +  PE       F+  K D++S GV L  + TG  P       E  N+   F ++ 
Sbjct: 173 GSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPF------EGDNIYKLFENIG 226
Query: 448 K 448
           K
Sbjct: 227 K 227

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 99/221 (44%), Gaps = 43/221 (19%)
Query: 224 LGQGGFGTVYKGMLPDGSIVAVK--RSKEIDKTQIHQFINEVVILSQINHRHIVKLLGC- 280
           +G+G FG V++G    G  VAVK   S+E         I + V+L    H +I+  +   
Sbjct: 11  IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVML---RHENILGFIAAD 66
Query: 281 ----CLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGA 336
                  T++  LV +Y   G+L  +++ +             +++ E  +++A   A  
Sbjct: 67  NKDNGTWTQL-WLVSDYHEHGSLFDYLNRY-------------TVTVEGMIKLALSTASG 112
Query: 337 VAYMH-----SSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQ-- 389
           +A++H     +     I HRD+KS NIL+    +  ++D G+  ++ +D    T  I   
Sbjct: 113 LAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL--AVRHDSATDTIDIAPN 170
Query: 390 ---GTFGYLDPEYFQSS------QFTDKSDVYSFGVVLLEL 421
              GT  Y+ PE    S      +   ++D+Y+ G+V  E+
Sbjct: 171 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 99/221 (44%), Gaps = 43/221 (19%)
Query: 224 LGQGGFGTVYKGMLPDGSIVAVK--RSKEIDKTQIHQFINEVVILSQINHRHIVKLLGC- 280
           +G+G FG V++G    G  VAVK   S+E         I + V+L    H +I+  +   
Sbjct: 14  IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVML---RHENILGFIAAD 69
Query: 281 ----CLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGA 336
                  T++  LV +Y   G+L  +++ +             +++ E  +++A   A  
Sbjct: 70  NKDNGTWTQL-WLVSDYHEHGSLFDYLNRY-------------TVTVEGMIKLALSTASG 115
Query: 337 VAYMH-----SSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQ-- 389
           +A++H     +     I HRD+KS NIL+    +  ++D G+  ++ +D    T  I   
Sbjct: 116 LAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL--AVRHDSATDTIDIAPN 173
Query: 390 ---GTFGYLDPEYFQSS------QFTDKSDVYSFGVVLLEL 421
              GT  Y+ PE    S      +   ++D+Y+ G+V  E+
Sbjct: 174 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 214

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 99/221 (44%), Gaps = 43/221 (19%)
Query: 224 LGQGGFGTVYKGMLPDGSIVAVK--RSKEIDKTQIHQFINEVVILSQINHRHIVKLLGC- 280
           +G+G FG V++G    G  VAVK   S+E         I + V+L    H +I+  +   
Sbjct: 12  IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVML---RHENILGFIAAD 67
Query: 281 ----CLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGA 336
                  T++  LV +Y   G+L  +++ +             +++ E  +++A   A  
Sbjct: 68  NKDNGTWTQL-WLVSDYHEHGSLFDYLNRY-------------TVTVEGMIKLALSTASG 113
Query: 337 VAYMH-----SSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQ-- 389
           +A++H     +     I HRD+KS NIL+    +  ++D G+  ++ +D    T  I   
Sbjct: 114 LAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL--AVRHDSATDTIDIAPN 171
Query: 390 ---GTFGYLDPEYFQSS------QFTDKSDVYSFGVVLLEL 421
              GT  Y+ PE    S      +   ++D+Y+ G+V  E+
Sbjct: 172 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 212

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 99/221 (44%), Gaps = 43/221 (19%)
Query: 224 LGQGGFGTVYKGMLPDGSIVAVK--RSKEIDKTQIHQFINEVVILSQINHRHIVKLLGC- 280
           +G+G FG V++G    G  VAVK   S+E         I + V+L    H +I+  +   
Sbjct: 17  IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVML---RHENILGFIAAD 72
Query: 281 ----CLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGA 336
                  T++  LV +Y   G+L  +++ +             +++ E  +++A   A  
Sbjct: 73  NKDNGTWTQL-WLVSDYHEHGSLFDYLNRY-------------TVTVEGMIKLALSTASG 118
Query: 337 VAYMH-----SSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQ-- 389
           +A++H     +     I HRD+KS NIL+    +  ++D G+  ++ +D    T  I   
Sbjct: 119 LAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL--AVRHDSATDTIDIAPN 176
Query: 390 ---GTFGYLDPEYFQSS------QFTDKSDVYSFGVVLLEL 421
              GT  Y+ PE    S      +   ++D+Y+ G+V  E+
Sbjct: 177 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 217

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 49/98 (50%), Gaps = 8/98 (8%)
Query: 333 VAGAVAYMHSSASIPIFHRDIKSSNILLDDKFS---AKVSDFGISRSIPNDKTHLTTTIQ 389
           +  A+ Y+HS   I I HRD+K  N+L   K      K++DFG ++   +  + LT    
Sbjct: 124 IGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LTEPCY 179
Query: 390 GTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
             + Y+ PE     ++    D++S GV++  LL G  P
Sbjct: 180 TPY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 216

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/146 (26%), Positives = 67/146 (45%), Gaps = 28/146 (19%)
Query: 325 NRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILL--DDKFSAK-----------VSDF 371
           N + +  ++A  VA++HS   + I HRD+K  NIL+    +F+A            +SDF
Sbjct: 116 NPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDF 172
Query: 372 GISRSIPNDKTHLTTTIQ---GTFGYLDPEYFQSS-------QFTDKSDVYSFGVVLLEL 421
           G+ + + + +      +    GT G+  PE  + S       + T   D++S G V   +
Sbjct: 173 GLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYI 232
Query: 422 LT-GKKPICFARVEEERNLVACFISL 446
           L+ GK P    +   E N++    SL
Sbjct: 233 LSKGKHPFG-DKYSRESNIIRGIFSL 257

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 99/221 (44%), Gaps = 43/221 (19%)
Query: 224 LGQGGFGTVYKGMLPDGSIVAVK--RSKEIDKTQIHQFINEVVILSQINHRHIVKLLGC- 280
           +G+G FG V++G    G  VAVK   S+E         I + V+L    H +I+  +   
Sbjct: 37  IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVML---RHENILGFIAAD 92
Query: 281 ----CLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGA 336
                  T++  LV +Y   G+L  +++ +             +++ E  +++A   A  
Sbjct: 93  NKDNGTWTQL-WLVSDYHEHGSLFDYLNRY-------------TVTVEGMIKLALSTASG 138
Query: 337 VAYMH-----SSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQ-- 389
           +A++H     +     I HRD+KS NIL+    +  ++D G+  ++ +D    T  I   
Sbjct: 139 LAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL--AVRHDSATDTIDIAPN 196
Query: 390 ---GTFGYLDPEYFQSS------QFTDKSDVYSFGVVLLEL 421
              GT  Y+ PE    S      +   ++D+Y+ G+V  E+
Sbjct: 197 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 237

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 48/98 (48%), Gaps = 8/98 (8%)
Query: 333 VAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA---KVSDFGISRSIPNDKTHLTTTIQ 389
           +  A+ Y+HS   I I HRD+K  N+L   K      K++DFG ++   +  + LTT   
Sbjct: 170 IGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LTTPCY 225
Query: 390 GTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
             + Y+ PE     ++    D +S GV+   LL G  P
Sbjct: 226 TPY-YVAPEVLGPEKYDKSCDXWSLGVIXYILLCGYPP 262

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/219 (22%), Positives = 91/219 (41%), Gaps = 19/219 (8%)
Query: 211 LQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIH--QFINEVVILS 267
           +    + Y     +G G +G+V        G  VAVK+     ++ IH  +   E+ +L 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 268 QINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
            + H +++ LL        P    E  +   L  H+                 L+ ++  
Sbjct: 77  HMKHENVIGLLDVF----TPARSLEEFNDVYLVTHL----MGADLNNIVKCQKLTDDHVQ 128
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
            +  ++   + Y+HS+    I HRD+K SN+ +++    K+ DF ++R   ++ T     
Sbjct: 129 FLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFYLARHTDDEMTGYV-- 183
Query: 388 IQGTFGYLDPE-YFQSSQFTDKSDVYSFGVVLLELLTGK 425
              T  Y  PE       +    D++S G ++ ELLTG+
Sbjct: 184 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/218 (22%), Positives = 91/218 (41%), Gaps = 31/218 (14%)
Query: 218 YNQSRFLGQGGFGTV---YKGMLPDGSIVAVKRSKEIDKTQIH--QFINEVVILSQINHR 272
           Y   + +G G  G V   Y  +L     VA+K+     + Q H  +   E+V++  +NH+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 273 HIVKLLGC-----CLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
           +I+ LL        LE    V +   +    L   I                 L  E   
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--------------MELDHERMS 129
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
            +  ++   + ++HS+    I HRD+K SNI++    + K+ DFG++R+     + +   
Sbjct: 130 YLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMEP 184
Query: 388 IQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGK 425
              T  Y  PE      + +  D++S G ++ E++  K
Sbjct: 185 EVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVCHK 222

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/219 (22%), Positives = 91/219 (41%), Gaps = 19/219 (8%)
Query: 211 LQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIH--QFINEVVILS 267
           +    + Y     +G G +G+V        G  VAVK+     ++ IH  +   E+ +L 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 268 QINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
            + H +++ LL        P    E  +   L  H+                 L+ ++  
Sbjct: 77  HMKHENVIGLLDVF----TPARSLEEFNDVYLVTHL----MGADLNNIVKCQKLTDDHVQ 128
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
            +  ++   + Y+HS+    I HRD+K SN+ +++    K+  FG++R   ++ T     
Sbjct: 129 FLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILGFGLARHTDDEMTGYV-- 183
Query: 388 IQGTFGYLDPE-YFQSSQFTDKSDVYSFGVVLLELLTGK 425
              T  Y  PE       +    D++S G ++ ELLTG+
Sbjct: 184 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 72/287 (25%), Positives = 121/287 (42%), Gaps = 54/287 (18%)
Query: 224 LGQGGFGT-VYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCL 282
           LG G  GT VY+GM  D   VAVKR       +   F +  V L + +  H   +   C 
Sbjct: 32  LGHGAEGTIVYRGMF-DNRDVAVKRIL----PECFSFADREVQLLRESDEHPNVIRYFCT 86
Query: 283 ETEVPVLVYEYIS----SGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVA 338
           E +     ++YI+    + TL  ++               + L  E  + +  +    +A
Sbjct: 87  EKD---RQFQYIAIELCAATLQEYVEQ----------KDFAHLGLEP-ITLLQQTTSGLA 132
Query: 339 YMHSSASIPIFHRDIKSSNILLD-----DKFSAKVSDFGISRSIPNDKTHLT--TTIQGT 391
           ++HS   + I HRD+K  NIL+       K  A +SDFG+ + +   +   +  + + GT
Sbjct: 133 HLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGT 189
Query: 392 FGYLDPEYFQS---SQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLA 447
            G++ PE          T   D++S G V   +++ G  P  F +            SL 
Sbjct: 190 EGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHP--FGK------------SLQ 235
Query: 448 KE-NQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQV 493
           ++ N LL           + ED+ A  EL  + + ++ +KRP+ K V
Sbjct: 236 RQANILLGACSLDCLHPEKHEDVIA-RELIEKMIAMDPQKRPSAKHV 281

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/219 (22%), Positives = 91/219 (41%), Gaps = 19/219 (8%)
Query: 211 LQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIH--QFINEVVILS 267
           +    + Y     +G G +G+V        G  VAVK+     ++ IH  +   E+ +L 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 268 QINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
            + H +++ LL        P    E  +   L  H+                 L+ ++  
Sbjct: 77  HMKHENVIGLLDVF----TPARSLEEFNDVYLVTHL----MGADLNNIVKCQKLTDDHVQ 128
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
            +  ++   + Y+HS+    I HRD+K SN+ +++    K+ D G++R   ++ T     
Sbjct: 129 FLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDAGLARHTDDEMTGYV-- 183
Query: 388 IQGTFGYLDPE-YFQSSQFTDKSDVYSFGVVLLELLTGK 425
              T  Y  PE       +    D++S G ++ ELLTG+
Sbjct: 184 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/219 (22%), Positives = 91/219 (41%), Gaps = 19/219 (8%)
Query: 211 LQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIH--QFINEVVILS 267
           +    + Y     +G G +G+V        G  VAVK+     ++ IH  +   E+ +L 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 268 QINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRV 327
            + H +++ LL        P    E  +   L  H+                 L+ ++  
Sbjct: 77  HMKHENVIGLLDVF----TPARSLEEFNDVYLVTHL----MGADLNNIVKCQKLTDDHVQ 128
Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
            +  ++   + Y+HS+    I HRD+K SN+ +++    K+ D G++R   ++ T     
Sbjct: 129 FLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDRGLARHTDDEMTGYV-- 183
Query: 388 IQGTFGYLDPE-YFQSSQFTDKSDVYSFGVVLLELLTGK 425
              T  Y  PE       +    D++S G ++ ELLTG+
Sbjct: 184 --ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 60/244 (24%), Positives = 108/244 (44%), Gaps = 21/244 (8%)
Query: 204 KVFTADELQRATDNYN-QSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFI-N 261
           KV  + E +R  D +  +   +G+G +G VYK    DG        K+I+ T I      
Sbjct: 8   KVKLSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACR 67
Query: 262 EVVILSQINHRHIVKLLGCCLE--TEVPVLVYEYISSGTLSHHIHDHXXXXXXXXXXXLS 319
           E+ +L ++ H +++ L    L        L+++Y +   L H I  H           L 
Sbjct: 68  EIALLRELKHPNVISLQKVFLSHADRKVWLLFDY-AEHDLWHIIKFHRASKANKKPVQLP 126
Query: 320 SLSWENRVR-VACEVAGAVAYMHSSASIPIFHRDIKSSNILL----DDKFSAKVSDFGIS 374
                  V+ +  ++   + Y+H++    + HRD+K +NIL+     ++   K++D G +
Sbjct: 127 ----RGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 179
Query: 375 R--SIPNDKTHLTTTIQGTFGYLDPEYFQSSQ-FTDKSDVYSFGVVLLELLTGKKPICFA 431
           R  + P         +  TF Y  PE    ++ +T   D+++ G +  ELLT  +PI   
Sbjct: 180 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPIFHC 238
Query: 432 RVEE 435
           R E+
Sbjct: 239 RQED 242

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 41/153 (26%), Positives = 67/153 (43%), Gaps = 29/153 (18%)
Query: 289 LVYEYISSGTLSHHIHDHXXXXXXXXXXXLSSLSWENRVRVACEVAGAVAYMHSSASIPI 348
           LV+E +  G++  HIH                        V  +VA A+ ++H+     I
Sbjct: 88  LVFEKMRGGSILSHIHKRRHFNELEASV------------VVQDVASALDFLHNKG---I 132
Query: 349 FHRDIKSSNILLDDK---FSAKVSDFGISRSIP--NDKTHLTT----TIQGTFGYLDPEY 399
            HRD+K  NIL +        K+ DF +   I    D + ++T    T  G+  Y+ PE 
Sbjct: 133 AHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEV 192
Query: 400 F-----QSSQFTDKSDVYSFGVVLLELLTGKKP 427
                 ++S +  + D++S GV+L  LL+G  P
Sbjct: 193 VEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	537
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-127
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-118
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-110
3soc_A	322	Activin receptor type-2A; structural genomics cons	4e-76
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	4e-69
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	2e-67
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	3e-65
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	4e-64
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-61
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-61
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	9e-60
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	2e-59
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	3e-59
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	3e-58
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	5e-54
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	3e-53
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-52
3q4u_A	301	Activin receptor type-1; structural genomics conso	5e-52
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	1e-48
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	1e-47
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	3e-47
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-45
2a19_B	284	Interferon-induced, double-stranded RNA-activated	3e-45
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	4e-44
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	5e-44
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	7e-44
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	4e-43
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	3e-42
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	4e-42
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	3e-41
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	4e-41
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	4e-41
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	5e-41
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	4e-40
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	8e-40
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	9e-40
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-39
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-39
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-39
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	4e-39
4aoj_A	329	High affinity nerve growth factor receptor; transf	5e-39
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	5e-39
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	9e-39
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	9e-39
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	9e-39
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-38
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	2e-38
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	6e-38
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	7e-38
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	8e-38
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	9e-38
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	9e-38
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	1e-37
3pls_A	298	Macrophage-stimulating protein receptor; protein k	1e-37
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-37
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	2e-37
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	2e-37
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-37
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-37
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-37
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	2e-37
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	3e-37
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	4e-37
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	4e-37
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	5e-37
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	6e-37
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	6e-37
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	7e-37
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	9e-37
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-36
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-36
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	1e-36
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	1e-36
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-36
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-36
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-36
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-36
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-36
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	3e-36
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	3e-36
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	3e-36
3ork_A	311	Serine/threonine protein kinase; structural genomi	3e-36
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	4e-36
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	5e-36
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	5e-36
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	6e-36
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	6e-36
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	7e-36
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	1e-35
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	1e-35
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-35
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-35
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	3e-35
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	3e-35
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	3e-35
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	3e-35
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	5e-35
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	6e-35
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	1e-34
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	1e-34
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	3e-34
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	4e-34
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	6e-34
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	7e-34
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-33
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	3e-33
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	5e-33
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	1e-32
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-32
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	3e-32
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	3e-31
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	3e-31
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	5e-31
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	5e-31
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	6e-31
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-30
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	4e-30
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	5e-30
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	5e-30
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	5e-30
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	8e-30
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	9e-30
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-29
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	1e-29
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-29
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	2e-29
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	3e-29
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	4e-29
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	6e-29
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	8e-29
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	9e-29
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-28
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-28
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-28
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-28
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-28
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	3e-28
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	4e-28
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	4e-28
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	4e-28
3an0_A	340	Dual specificity mitogen-activated protein kinase;	6e-28
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	9e-28
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	1e-27
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-27
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	1e-27
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-27
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-27
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-27
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	3e-27
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	3e-27
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	4e-27
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	6e-27
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	7e-27
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-26
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	1e-26
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-26
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-26
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	3e-26
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	3e-26
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	6e-26
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	7e-26
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-25
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-25
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-25
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-25
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-25
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	6e-25
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	1e-24
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	3e-24
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	3e-24
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	4e-24
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	4e-24
3uqc_A	286	Probable conserved transmembrane protein; structur	7e-24
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-23
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	5e-23
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	6e-23
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	8e-23
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	1e-22
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-22
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	2e-22
3niz_A	311	Rhodanese family protein; structural genomics, str	2e-22
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-22
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-21
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	3e-21
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	4e-21
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	4e-21
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	4e-21
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	5e-21
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	5e-21
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	5e-21
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	6e-21
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	9e-21
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	1e-20
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-20
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	2e-20
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-20
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-20
4eby_A	212	Chitin elicitor receptor kinase 1; pathogen-associ	3e-20
4eby_A	212	Chitin elicitor receptor kinase 1; pathogen-associ	6e-04
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	3e-20
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	3e-20
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	5e-20
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-19
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-19
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	4e-19
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	4e-19
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	7e-19
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	7e-19
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	3e-18
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-16
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	2e-16
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-16
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	4e-16
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	1e-15
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-15
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	3e-15
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-14
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	1e-14
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-14
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	3e-14
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	3e-14
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	3e-14
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	5e-14
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	5e-14
3rp9_A	458	Mitogen-activated protein kinase; structural genom	9e-14
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	5e-12
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	1e-11
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	2e-11
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	2e-11
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	3e-11
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	8e-11
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	1e-09
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	1e-09
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	1e-09
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	7e-09
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	2e-08
2l9y_A	167	CVNH-LYSM lectin; carbohydrate, sugar binding prot	2e-07
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-07
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-06
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	3e-07
2djp_A	77	Hypothetical protein SB145; LYSM, structural genom	4e-07
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	1e-06

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  373 bits (960), Expect = e-127
 Identities = 117/311 (37%), Positives = 172/311 (55%), Gaps = 12/311 (3%)

Query: 195 SSCGSSERAKVFTADELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKT 254
           SS      +      +L+ AT+N++    +G G FG VYKG+L DG+ VA+KR       
Sbjct: 18  SSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQ 77

Query: 255 QIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQ 314
            I +F  E+  LS   H H+V L+G C E    +L+Y+Y+ +G L  H++          
Sbjct: 78  GIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTM--- 134

Query: 315 KQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGIS 374
                S+SWE R+ +    A  + Y+H+     I HRD+KS NILLD+ F  K++DFGIS
Sbjct: 135 -----SMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGIS 186

Query: 375 RSIPN-DKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARV 433
           +     D+THL+T ++GT GY+DPEYF   + T+KSDVYSFGVVL E+L  +  I  +  
Sbjct: 187 KKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLP 246

Query: 434 EEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQV 493
            E  NL    +      QL +I+D  +A + R E +    + A++CL L+S+ RP+M  V
Sbjct: 247 REMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDV 306

Query: 494 SMELEGLRRSQ 504
             +LE   R Q
Sbjct: 307 LWKLEYALRLQ 317

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  351 bits (903), Expect = e-118
 Identities = 107/301 (35%), Positives = 183/301 (60%), Gaps = 11/301 (3%)

Query: 202 RAKVFTADELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKR-SKEIDKTQIHQFI 260
           + K F+  ELQ A+DN++    LG+GGFG VYKG L DG++VAVKR  +E  +    QF 
Sbjct: 16  QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQ 75

Query: 261 NEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSS 320
            EV ++S   HR++++L G C+     +LVY Y+++G+++  + +  + Q          
Sbjct: 76  TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQ--------PP 127

Query: 321 LSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPND 380
           L W  R R+A   A  +AY+H      I HRD+K++NILLD++F A V DFG+++ +   
Sbjct: 128 LDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 187

Query: 381 KTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARV--EEERN 438
            TH+TT ++GT G++ PEY  + + ++K+DV+ +GV+LLEL+TG++    AR+  +++  
Sbjct: 188 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM 247

Query: 439 LVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELE 498
           L+     L KE +L  ++D  +    ++E++  + ++A+ C + +  +RP M +V   LE
Sbjct: 248 LLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307

Query: 499 G 499
           G
Sbjct: 308 G 308

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  329 bits (846), Expect = e-110
 Identities = 102/324 (31%), Positives = 170/324 (52%), Gaps = 29/324 (8%)

Query: 192 QQLSSCGSSERAKVFTADELQRATDNYNQ------SRFLGQGGFGTVYKGMLPDGSIVAV 245
           +  S   S  R   F+  EL+  T+N+++         +G+GGFG VYKG + + + VAV
Sbjct: 1   ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAV 59

Query: 246 KRSKEIDKTQIHQ----FINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSH 301
           K+   +      +    F  E+ ++++  H ++V+LLG   + +   LVY Y+ +G+L  
Sbjct: 60  KKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLD 119

Query: 302 HIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD 361
            +                 LSW  R ++A   A  + ++H +  I   HRDIKS+NILLD
Sbjct: 120 RLSCLDGTP---------PLSWHMRCKIAQGAANGINFLHENHHI---HRDIKSANILLD 167

Query: 362 DKFSAKVSDFGISRSIP-NDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLE 420
           + F+AK+SDFG++R+     +T +T+ I GT  Y+ PE     + T KSD+YSFGVVLLE
Sbjct: 168 EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLE 226

Query: 421 LLTGKKPICFARVEEERNLVACFISLAKENQ-LLEILDARVAKEAREEDIGAMAELAMRC 479
           ++TG   +   R  E + L+     +  E + + + +D ++  +A    + AM  +A +C
Sbjct: 227 IITGLPAVDEHR--EPQLLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQC 283

Query: 480 LRLNSKKRPTMKQVSMELEGLRRS 503
           L     KRP +K+V   L+ +  S
Sbjct: 284 LHEKKNKRPDIKKVQQLLQEMTAS 307

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  242 bits (619), Expect = 4e-76
 Identities = 71/341 (20%), Positives = 122/341 (35%), Gaps = 47/341 (13%)

Query: 190 LQQQLSSCGSSERAKVFTADELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSK 249
           +        S         + L   +          +G FG V+K        VAVK   
Sbjct: 1   MGHHHHHHSSGVD---LGTENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFP 56

Query: 250 EIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPV----LVYEYISSGTLSHHIHD 305
             DK Q  Q   EV  L  + H +I++ +G             L+  +   G+LS  +  
Sbjct: 57  IQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA 115

Query: 306 HQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASI-------PIFHRDIKSSNI 358
           +              +SW     +A  +A  +AY+H             I HRDIKS N+
Sbjct: 116 NV-------------VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNV 162

Query: 359 LLDDKFSAKVSDFGISRSIPNDKTHLTTTIQ-GTFGYLDPEYFQSS-----QFTDKSDVY 412
           LL +  +A ++DFG++      K+   T  Q GT  Y+ PE  + +         + D+Y
Sbjct: 163 LLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMY 222

Query: 413 SFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEILDARVAKEAR------- 465
           + G+VL EL +          E           + +   L ++ +  V K+ R       
Sbjct: 223 AMGLVLWELASRCTAADGPVDEYMLPFEEE---IGQHPSLEDMQEVVVHKKKRPVLRDYW 279

Query: 466 --EEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRSQ 504
                +  + E    C   +++ R +   V   +  ++R  
Sbjct: 280 QKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLT 320

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  223 bits (571), Expect = 4e-69
 Identities = 81/282 (28%), Positives = 137/282 (48%), Gaps = 29/282 (10%)

Query: 224 LGQGGFGTVYKGMLPDGSIVAVK--RSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCC 281
           +G G FGTV++     GS VAVK    ++    ++++F+ EV I+ ++ H +IV  +G  
Sbjct: 45  IGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103

Query: 282 LETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMH 341
            +     +V EY+S G+L   +H    +++         L    R+ +A +VA  + Y+H
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQ---------LDERRRLSMAYDVAKGMNYLH 154

Query: 342 SSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQ 401
           +  + PI HR++KS N+L+D K++ KV DFG+SR   +      +   GT  ++ PE  +
Sbjct: 155 NR-NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAA-GTPEWMAPEVLR 212

Query: 402 SSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEILDARVA 461
                +KSDVYSFGV+L EL T ++P  +       N      ++  + + LEI      
Sbjct: 213 DEPSNEKSDVYSFGVILWELATLQQP--W----GNLNPAQVVAAVGFKCKRLEI------ 260

Query: 462 KEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRS 503
                     +A +   C      KRP+   +   L  L +S
Sbjct: 261 ---PRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  219 bits (559), Expect = 2e-67
 Identities = 74/282 (26%), Positives = 131/282 (46%), Gaps = 35/282 (12%)

Query: 224 LGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLE 283
           +G+G FG V K        VA+K+ +   + +   FI E+  LS++NH +IVKL G CL 
Sbjct: 16  VGRGAFGVVCKAKW-RAKDVAIKQIESESERK--AFIVELRQLSRVNHPNIVKLYGACLN 72

Query: 284 TEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSS 343
                LV EY   G+L + +H           + L   +  + +    + +  VAY+HS 
Sbjct: 73  P--VCLVMEYAEGGSLYNVLHG---------AEPLPYYTAAHAMSWCLQCSQGVAYLHSM 121

Query: 344 ASIPIFHRDIKSSNILLDDKFS-AKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQS 402
               + HRD+K  N+LL    +  K+ DFG +     D     T  +G+  ++ PE F+ 
Sbjct: 122 QPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC----DIQTHMTNNKGSAAWMAPEVFEG 177

Query: 403 SQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEILDARVAK 462
           S +++K DV+S+G++L E++T +KP  F   +E        +          ++      
Sbjct: 178 SNYSEKCDVFSWGIILWEVITRRKP--F---DEIGGPAFRIMWAVHNGTRPPLI------ 226

Query: 463 EAREEDI-GAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRS 503
               +++   +  L  RC   +  +RP+M+++   +  L R 
Sbjct: 227 ----KNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRY 264

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  212 bits (543), Expect = 3e-65
 Identities = 82/293 (27%), Positives = 132/293 (45%), Gaps = 48/293 (16%)

Query: 224 LGQGGFGTVYKGM-LPDGSIVAVKR-------SKEIDKTQIHQFINEVVILSQINHRHIV 275
           +G+GGFG V+KG  + D S+VA+K         +     +  +F  EV I+S +NH +IV
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86

Query: 276 KLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAG 335
           KL G       P +V E++  G L H + D               + W  ++R+  ++A 
Sbjct: 87  KLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAHP-----------IKWSVKLRLMLDIAL 133

Query: 336 AVAYMHSSASIPIFHRDIKSSNILLDDK-----FSAKVSDFGISRSIPNDKTHLTTTIQG 390
            + YM +  + PI HRD++S NI L          AKV+DFG+S+       H  + + G
Sbjct: 134 GIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ----QSVHSVSGLLG 188

Query: 391 TFGYLDPEYF--QSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAK 448
            F ++ PE    +   +T+K+D YSF ++L  +LTG+ P  F      +  +     + +
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP--FDEYSYGK--IKFINMIRE 244

Query: 449 ENQLLEILDARVAKEAREEDI-GAMAELAMRCLRLNSKKRPTMKQVSMELEGL 500
           E     I           ED    +  +   C   + KKRP    +  EL  L
Sbjct: 245 EGLRPTIP----------EDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  209 bits (533), Expect = 4e-64
 Identities = 78/289 (26%), Positives = 125/289 (43%), Gaps = 44/289 (15%)

Query: 224 LGQGGFGTVYKGMLPDGSIVAVKRSKEID----KTQIHQFINEVVILSQINHRHIVKLLG 279
           +G GGFG VY+     G  VAVK ++          I     E  + + + H +I+ L G
Sbjct: 15  IGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73

Query: 280 CCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAY 339
            CL+     LV E+   G L+  +   +             +  +  V  A ++A  + Y
Sbjct: 74  VCLKEPNLCLVMEFARGGPLNRVLSGKR-------------IPPDILVNWAVQIARGMNY 120

Query: 340 MHSSASIPIFHRDIKSSNILLDDKFS--------AKVSDFGISRSIPNDKTHLTTTIQGT 391
           +H  A +PI HRD+KSSNIL+  K           K++DFG++R           +  G 
Sbjct: 121 LHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK---MSAAGA 177

Query: 392 FGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQ 451
           + ++ PE  ++S F+  SDV+S+GV+L ELLTG+ P  F       + +A    +A    
Sbjct: 178 YAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP--F----RGIDGLAVAYGVAMNKL 231

Query: 452 LLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGL 500
            L I          E      A+L   C   +   RP+   +  +L  +
Sbjct: 232 ALPI-----PSTCPEP----FAKLMEDCWNPDPHSRPSFTNILDQLTTI 271

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  205 bits (522), Expect = 1e-61
 Identities = 70/337 (20%), Positives = 125/337 (37%), Gaps = 57/337 (16%)

Query: 206 FTADELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVI 265
             A E     DN      +G+G +G VYKG L D   VAVK     ++     FINE  I
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR---QNFINEKNI 58

Query: 266 --LSQINHRHIVKLLGCCLETEVPV-----LVYEYISSGTLSHHIHDHQQQQEQKQKQEL 318
             +  + H +I + +               LV EY  +G+L  ++  H            
Sbjct: 59  YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH------------ 106

Query: 319 SSLSWENRVRVACEVAGAVAYMHSSASI------PIFHRDIKSSNILLDDKFSAKVSDFG 372
            +  W +  R+A  V   +AY+H+           I HRD+ S N+L+ +  +  +SDFG
Sbjct: 107 -TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFG 165

Query: 373 ISR-------SIPNDKTHLTTTIQGTFGYLDPEYFQSS-------QFTDKSDVYSFGVVL 418
           +S          P ++ +   +  GT  Y+ PE  + +           + D+Y+ G++ 
Sbjct: 166 LSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIY 225

Query: 419 LELLTGKKPICFARVEEERNLVACFISLAKENQLLEILDARVAKE-----------AREE 467
            E+      +       E  +   F +    +   E +   V++E               
Sbjct: 226 WEIFMRCTDLFPGESVPEYQMA--FQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSL 283

Query: 468 DIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRSQ 504
            + ++ E    C   +++ R T +     +  L    
Sbjct: 284 AVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIW 320

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  202 bits (516), Expect = 2e-61
 Identities = 54/287 (18%), Positives = 115/287 (40%), Gaps = 42/287 (14%)

Query: 224 LGQGGFGTVYKGMLPDGSIVAVK--RSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCC 281
           L +   G ++KG    G+ + VK  + ++    +   F  E   L   +H +++ +LG C
Sbjct: 18  LNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76

Query: 282 LETEVP--VLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAY 339
                P   L+  ++  G+L + +H+               +     V+ A ++A  +A+
Sbjct: 77  QSPPAPHPTLITHWMPYGSLYNVLHEGTNFV----------VDQSQAVKFALDMARGMAF 126

Query: 340 MHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEY 399
           +H+     I    + S ++++D+  +A++S   +  S        +        ++ PE 
Sbjct: 127 LHTL-EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ------SPGRMYAPAWVAPEA 179

Query: 400 FQSSQ---FTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEIL 456
            Q          +D++SF V+L EL+T + P  F     + + +   + +A E     I 
Sbjct: 180 LQKKPEDTNRRSADMWSFAVLLWELVTREVP--F----ADLSNMEIGMKVALEGLRPTI- 232

Query: 457 DARVAKEAREEDI-GAMAELAMRCLRLNSKKRPTMKQVSMELEGLRR 502
                       I   +++L   C+  +  KRP    +   LE ++ 
Sbjct: 233 ---------PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  199 bits (507), Expect = 9e-60
 Identities = 70/295 (23%), Positives = 120/295 (40%), Gaps = 44/295 (14%)

Query: 224 LGQGGFGTVYKGML-PDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCL 282
           LG+G FG   K      G ++ +K     D+     F+ EV ++  + H +++K +G   
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77

Query: 283 ETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHS 342
           + +    + EYI  GTL   I     Q             W  RV  A ++A  +AY+HS
Sbjct: 78  KDKRLNFITEYIKGGTLRGIIKSMDSQ-----------YPWSQRVSFAKDIASGMAYLHS 126

Query: 343 SASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLT-------------TTIQ 389
                I HRD+ S N L+ +  +  V+DFG++R + ++KT                 T+ 
Sbjct: 127 M---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVV 183

Query: 390 GTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKE 449
           G   ++ PE      + +K DV+SFG+VL E++            +       F    + 
Sbjct: 184 GNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA-----DPDYLPRTMDFGLNVRG 238

Query: 450 NQLLEILDARVAKEAREEDI-GAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRS 503
                             +   +   + +RC  L+ +KRP+  ++   LE LR  
Sbjct: 239 FLDRYC----------PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  198 bits (505), Expect = 2e-59
 Identities = 60/304 (19%), Positives = 111/304 (36%), Gaps = 57/304 (18%)

Query: 224 LGQGGFGTVYKGMLPDGSIVAVK--RSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCC 281
           +G+G FG VY G    G  VA++    +  ++ Q+  F  EV+   Q  H ++V  +G C
Sbjct: 41  IGKGRFGQVYHGRW-HGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGAC 98

Query: 282 LETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMH 341
           +      ++       TL   + D +             L      ++A E+   + Y+H
Sbjct: 99  MSPPHLAIITSLCKGRTLYSVVRDAKIV-----------LDVNKTRQIAQEIVKGMGYLH 147

Query: 342 SSASIPIFHRDIKSSNILLDDKFSAKVSDFGISR----SIPNDKTHLTTTIQGTFGYLDP 397
           +     I H+D+KS N+  D+     ++DFG+           +        G   +L P
Sbjct: 148 AK---GILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAP 203

Query: 398 EYFQSSQ---------FTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAK 448
           E  +            F+  SDV++ G +  EL   + P                    K
Sbjct: 204 EIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPF-------------------K 244

Query: 449 ENQLLEILDARVAKEAREEDIG-----AMAELAMRCLRLNSKKRPTMKQVSMELEGLRRS 503
                 I+   +    +           ++++ + C     ++RPT  ++   LE L + 
Sbjct: 245 TQPAEAIIWQ-MGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR 303

Query: 504 QRCL 507
            R L
Sbjct: 304 NRRL 307

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  194 bits (495), Expect = 3e-58
 Identities = 76/286 (26%), Positives = 130/286 (45%), Gaps = 36/286 (12%)

Query: 224 LGQGGFGTVYKGMLPDGSIVAVK--RSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCC 281
           +G G FGTVYKG    G  VAVK          Q+  F NEV +L +  H +I+  +G  
Sbjct: 32  IGSGSFGTVYKGKW-HGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89

Query: 282 LETEVPV-LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYM 340
             T   + +V ++    +L HH+H  + +              +  + +A + A  + Y+
Sbjct: 90  --TAPQLAIVTQWCEGSSLYHHLHASETK-----------FEMKKLIDIARQTARGMDYL 136

Query: 341 HSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPN-DKTHLTTTIQGTFGYLDPE- 398
           H+     I HRD+KS+NI L +  + K+ DFG++        +H    + G+  ++ PE 
Sbjct: 137 HAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEV 193

Query: 399 --YFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEIL 456
                S+ ++ +SDVY+FG+VL EL+TG+ P          N       + + +   ++ 
Sbjct: 194 IRMQDSNPYSFQSDVYAFGIVLYELMTGQLPY-----SNINNRDQIIEMVGRGSLSPDLS 248

Query: 457 DARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRR 502
                 + R      M  L   CL+    +RP+  ++  E+E L R
Sbjct: 249 ------KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  184 bits (470), Expect = 5e-54
 Identities = 64/311 (20%), Positives = 119/311 (38%), Gaps = 52/311 (16%)

Query: 224 LGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINE--VVILSQINHRHIVKLLGCC 281
           +G+G +G V+ G    G  VAVK       T+   +  E  +     + H +I+  +   
Sbjct: 45  IGKGRYGEVWMGKW-RGEKVAVKV---FFTTEEASWFRETEIYQTVLMRHENILGFIAAD 100

Query: 282 LETEVPV----LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAV 337
           ++         L+ +Y  +G+L  ++                +L  ++ +++A      +
Sbjct: 101 IKGTGSWTQLYLITDYHENGSLYDYLKST-------------TLDAKSMLKLAYSSVSGL 147

Query: 338 AYMHSSASI-----PIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHL---TTTIQ 389
            ++H+          I HRD+KS NIL+    +  ++D G++    +D   +     T  
Sbjct: 148 CHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRV 207

Query: 390 GTFGYLDPE------YFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACF 443
           GT  Y+ PE           Q    +D+YSFG++L E+           VEE +     +
Sbjct: 208 GTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVS--GGIVEEYQ---LPY 262

Query: 444 ISLAKENQLLEILDARVAKE----------AREEDIGAMAELAMRCLRLNSKKRPTMKQV 493
             L   +   E +   V  +          + +E +  M +L   C   N   R T  +V
Sbjct: 263 HDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRV 322

Query: 494 SMELEGLRRSQ 504
              L  +  SQ
Sbjct: 323 KKTLAKMSESQ 333

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  180 bits (459), Expect = 2e-52
 Identities = 59/311 (18%), Positives = 118/311 (37%), Gaps = 52/311 (16%)

Query: 224 LGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINE--VVILSQINHRHIVKLLGCC 281
           +G+G FG V++G    G  VAVK        +   +  E  +     + H +I+  +   
Sbjct: 50  IGKGRFGEVWRGKW-RGEEVAVKI---FSSREERSWFREAEIYQTVMLRHENILGFIAAD 105

Query: 282 LETEVPV----LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAV 337
            +         LV +Y   G+L  +++ +             +++ E  +++A   A  +
Sbjct: 106 NKDNGTWTQLWLVSDYHEHGSLFDYLNRY-------------TVTVEGMIKLALSTASGL 152

Query: 338 AYMHSSAS-----IPIFHRDIKSSNILLDDKFSAKVSDFGISR---SIPNDKTHLTTTIQ 389
           A++H           I HRD+KS NIL+    +  ++D G++    S  +          
Sbjct: 153 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV 212

Query: 390 GTFGYLDPE------YFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACF 443
           GT  Y+ PE        +  +   ++D+Y+ G+V  E+            E+ +     +
Sbjct: 213 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI--GGIHEDYQ---LPY 267

Query: 444 ISLAKENQLLEILDARVAKE----------AREEDIGAMAELAMRCLRLNSKKRPTMKQV 493
             L   +  +E +   V ++             E +  MA++   C   N   R T  ++
Sbjct: 268 YDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRI 327

Query: 494 SMELEGLRRSQ 504
              L  L + +
Sbjct: 328 KKTLSQLSQQE 338

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  178 bits (453), Expect = 5e-52
 Identities = 58/307 (18%), Positives = 111/307 (36%), Gaps = 52/307 (16%)

Query: 224 LGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVI--LSQINHRHIVKLLGCC 281
           +G+G +G V++G    G  VAVK     D+     +  E  +     + H +I+  +   
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVKIFSSRDEKS---WFRETELYNTVMLRHENILGFIASD 71

Query: 282 LETEVPV----LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAV 337
           + +        L+  Y   G+L  ++                +L   + +R+   +A  +
Sbjct: 72  MTSRHSSTQLWLITHYHEMGSLYDYLQLT-------------TLDTVSCLRIVLSIASGL 118

Query: 338 AYMHSSASI-----PIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHL---TTTIQ 389
           A++H           I HRD+KS NIL+       ++D G++         L        
Sbjct: 119 AHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV 178

Query: 390 GTFGYLDPE------YFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACF 443
           GT  Y+ PE               + D+++FG+VL E+           VE+ +     F
Sbjct: 179 GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVS--NGIVEDYK---PPF 233

Query: 444 ISLAKENQLLEILDARVAKE----------AREEDIGAMAELAMRCLRLNSKKRPTMKQV 493
             +   +   E +   V  +            +  + ++A+L   C   N   R T  ++
Sbjct: 234 YDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRI 293

Query: 494 SMELEGL 500
              L  +
Sbjct: 294 KKTLTKI 300

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  169 bits (430), Expect = 1e-48
 Identities = 71/283 (25%), Positives = 127/283 (44%), Gaps = 31/283 (10%)

Query: 216 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKR---SKEIDKTQIHQFINEVVILSQINH 271
            N+   + +G+G F  VY+   L DG  VA+K+      +D       I E+ +L Q+NH
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91

Query: 272 RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRV-RVA 330
            +++K     +E     +V E   +G LS  I      +  K+++ L     E  V +  
Sbjct: 92  PNVIKYYASFIEDNELNIVLELADAGDLSRMI------KHFKKQKRLIP---ERTVWKYF 142

Query: 331 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQG 390
            ++  A+ +MHS     + HRDIK +N+ +      K+ D G+ R   + KT    ++ G
Sbjct: 143 VQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFF-SSKTTAAHSLVG 198

Query: 391 TFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKEN 450
           T  Y+ PE    + +  KSD++S G +L E+   + P  F    ++ NL +      ++ 
Sbjct: 199 TPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP--FY--GDKMNLYS-LCKKIEQC 253

Query: 451 QLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQV 493
               +     ++E R        +L   C+  + +KRP +  V
Sbjct: 254 DYPPLPSDHYSEELR--------QLVNMCINPDPEKRPDVTYV 288

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  166 bits (422), Expect = 1e-47
 Identities = 72/289 (24%), Positives = 122/289 (42%), Gaps = 40/289 (13%)

Query: 216 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQI-----HQFINEVVILSQI 269
           ++Y     +G G +G   K     DG I+  K   E+D   +        ++EV +L ++
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWK---ELDYGSMTEAEKQMLVSEVNLLREL 62

Query: 270 NHRHIVKLLGCCLETEVPVL--VYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRV 327
            H +IV+     ++     L  V EY   G L+  I      +  K++Q L     E  V
Sbjct: 63  KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVI-----TKGTKERQYLD----EEFV 113

Query: 328 -RVACEVAGAVAYMHS--SASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHL 384
            RV  ++  A+   H        + HRD+K +N+ LD K + K+ DFG++R + +D T  
Sbjct: 114 LRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD-TSF 172

Query: 385 TTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFI 444
             T  GT  Y+ PE      + +KSD++S G +L EL     P  F       +      
Sbjct: 173 AKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP--F----TAFSQKELAG 226

Query: 445 SLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQV 493
            + +       +  R + E          E+  R L L    RP+++++
Sbjct: 227 KIREGK--FRRIPYRYSDELN--------EIITRMLNLKDYHRPSVEEI 265

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  167 bits (424), Expect = 3e-47
 Identities = 73/313 (23%), Positives = 128/313 (40%), Gaps = 43/313 (13%)

Query: 216 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK--RSKEIDKTQIHQFINEVVILSQINHR 272
           + Y + + +G+G FG         DG    +K      +   +  +   EV +L+ + H 
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83

Query: 273 HIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRV-RVAC 331
           +IV+      E     +V +Y   G L   I          QK  L     E+++     
Sbjct: 84  NIVQYRESFEENGSLYIVMDYCEGGDLFKRI--------NAQKGVLFQ---EDQILDWFV 132

Query: 332 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGT 391
           ++  A+ ++H      I HRDIKS NI L    + ++ DFGI+R + N    L     GT
Sbjct: 133 QICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVL-NSTVELARACIGT 188

Query: 392 FGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQ 451
             YL PE  ++  + +KSD+++ G VL EL T K    F    E  ++    + +   + 
Sbjct: 189 PYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHA--F----EAGSMKNLVLKIISGS- 241

Query: 452 LLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRS--QRCLEM 509
               +    + + R         L  +  + N + RP++  +      L +    + +E 
Sbjct: 242 -FPPVSLHYSYDLR--------SLVSQLFKRNPRDRPSVNSI------LEKGFIAKRIEK 286

Query: 510 CQVNQLLADEISL 522
               QL+A+E  L
Sbjct: 287 FLSPQLIAEEFCL 299

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  161 bits (410), Expect = 1e-45
 Identities = 64/320 (20%), Positives = 125/320 (39%), Gaps = 49/320 (15%)

Query: 191 QQQLSSCGSSERAKVFTADELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKR--S 248
                S G     +      +      Y+  + +G GG   V++ +     I A+K    
Sbjct: 3   HHHHHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNL 62

Query: 249 KEIDKTQIHQFINEVVILSQINH--RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDH 306
           +E D   +  + NE+  L+++      I++L    +  +   +V E   +  L+  +   
Sbjct: 63  EEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL--- 118

Query: 307 QQQQEQKQKQELSSLSWENRVRV-ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFS 365
                 K+K+ +         +     +  AV  +H      I H D+K +N L+ D   
Sbjct: 119 ------KKKKSID----PWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDG-M 164

Query: 366 AKVSDFGISRSIPNDKTHLT-TTIQGTFGYLDPEYFQSSQFTD-----------KSDVYS 413
            K+ DFGI+  +  D T +   +  GT  Y+ PE  +    +            KSDV+S
Sbjct: 165 LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWS 224

Query: 414 FGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMA 473
            G +L  +  GK P  F    +  N ++   ++   N  +E  D    K+ +        
Sbjct: 225 LGCILYYMTYGKTP--FQ---QIINQISKLHAIIDPNHEIEFPD-IPEKDLQ-------- 270

Query: 474 ELAMRCLRLNSKKRPTMKQV 493
           ++   CL+ + K+R ++ ++
Sbjct: 271 DVLKCCLKRDPKQRISIPEL 290

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  160 bits (406), Expect = 3e-45
 Identities = 65/299 (21%), Positives = 117/299 (39%), Gaps = 57/299 (19%)

Query: 212 QRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQFINEVVILSQIN 270
           +R   ++ +   +G GGFG V+K     DG    +K    +      +   EV  L++++
Sbjct: 7   KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIK---RVKYNN-EKAEREVKALAKLD 62

Query: 271 HRHIVKLLGCCLETEVPV----------------LVYEYISSGTLSHHIHDHQQQQEQKQ 314
           H +IV   GC    +                   +  E+   GTL   I    +++  ++
Sbjct: 63  HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI----EKRRGEK 118

Query: 315 KQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGIS 374
             ++ +L          ++   V Y+HS     + +RD+K SNI L D    K+ DFG+ 
Sbjct: 119 LDKVLALEL------FEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLV 169

Query: 375 RSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVE 434
            S+ ND     T  +GT  Y+ PE   S  +  + D+Y+ G++L ELL            
Sbjct: 170 TSLKNDGKR--TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT-----AF 222

Query: 435 EERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQV 493
           E         +  ++     I+     K+ +         L  + L    + RP   ++
Sbjct: 223 ETSKF----FTDLRDG----IISDIFDKKEKT--------LLQKLLSKKPEDRPNTSEI 265

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  157 bits (398), Expect = 4e-44
 Identities = 62/277 (22%), Positives = 117/277 (42%), Gaps = 39/277 (14%)

Query: 224 LGQGGFGTVYKGM-LPDGSIVAVK--RSKEIDKTQIHQFINEVVILSQINHRHIVKLLGC 280
           +G+G F TVYKG+       VA    + +++ K++  +F  E  +L  + H +IV+    
Sbjct: 34  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 93

Query: 281 CLETEVP----VLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGA 336
              T       VLV E ++SGTL  ++   +  + +  +                ++   
Sbjct: 94  WESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLR------------SWCRQILKG 141

Query: 337 VAYMHSSASIPIFHRDIKSSNILLDDKF-SAKVSDFGISRSIPNDKTHLTTTIQGTFGYL 395
           + ++H+  + PI HRD+K  NI +     S K+ D G++             + GT  ++
Sbjct: 142 LQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK---AVIGTPEFM 197

Query: 396 DPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEI 455
            PE ++  ++ +  DVY+FG+ +LE+ T + P       E +N    +            
Sbjct: 198 APEMYE-EKYDESVDVYAFGMCMLEMATSEYPYS-----ECQNAAQIY-RRVTSGVKPAS 250

Query: 456 LDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQ 492
            D     E +        E+   C+R N  +R ++K 
Sbjct: 251 FDKVAIPEVK--------EIIEGCIRQNKDERYSIKD 279

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  158 bits (401), Expect = 5e-44
 Identities = 63/294 (21%), Positives = 123/294 (41%), Gaps = 49/294 (16%)

Query: 217 NYNQSRFLGQGGFGTVYKGMLPDGSIVAVKR--SKEIDKTQIHQFINEVVILSQINH--R 272
            Y+  + +G GG   V++ +     I A+K    +E D   +  + NE+  L+++     
Sbjct: 10  IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69

Query: 273 HIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRV-AC 331
            I++L    +  +   +V E   +  L+  +         K+K+ +         +    
Sbjct: 70  KIIRLYDYEITDQYIYMVMEC-GNIDLNSWL---------KKKKSID----PWERKSYWK 115

Query: 332 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTH-LTTTIQG 390
            +  AV  +H      I H D+K +N L+ D    K+ DFGI+  +  D T  +  +  G
Sbjct: 116 NMLEAVHTIHQHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVG 171

Query: 391 TFGYLDPEYFQ-----------SSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNL 439
           T  Y+ PE  +            S+ + KSDV+S G +L  +  GK P  F    +  N 
Sbjct: 172 TVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP--FQ---QIINQ 226

Query: 440 VACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQV 493
           ++   ++   N  +E  D    K+ +        ++   CL+ + K+R ++ ++
Sbjct: 227 ISKLHAIIDPNHEIEFPD-IPEKDLQ--------DVLKCCLKRDPKQRISIPEL 271

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  159 bits (403), Expect = 7e-44
 Identities = 61/294 (20%), Positives = 120/294 (40%), Gaps = 49/294 (16%)

Query: 217 NYNQSRFLGQGGFGTVYKGMLPDGSIVAVKR--SKEIDKTQIHQFINEVVILSQINH--R 272
            Y+  + +G GG   V++ +     I A+K    +E D   +  + NE+  L+++     
Sbjct: 57  IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 116

Query: 273 HIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRV-AC 331
            I++L    +  +   +V E   +  L+  +         K+K+ +         +    
Sbjct: 117 KIIRLYDYEITDQYIYMVMEC-GNIDLNSWL---------KKKKSID----PWERKSYWK 162

Query: 332 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLT-TTIQG 390
            +  AV  +H      I H D+K +N L+ D    K+ DFGI+  +  D T +   +  G
Sbjct: 163 NMLEAVHTIHQHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVG 218

Query: 391 TFGYLDPEYFQSSQFTD-----------KSDVYSFGVVLLELLTGKKPICFARVEEERNL 439
              Y+ PE  +    +            KSDV+S G +L  +  GK P  F    +  N 
Sbjct: 219 AVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP--FQ---QIINQ 273

Query: 440 VACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQV 493
           ++   ++   N  +E  D    K+ +        ++   CL+ + K+R ++ ++
Sbjct: 274 ISKLHAIIDPNHEIEFPD-IPEKDLQ--------DVLKCCLKRDPKQRISIPEL 318

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  155 bits (393), Expect = 4e-43
 Identities = 67/302 (22%), Positives = 124/302 (41%), Gaps = 43/302 (14%)

Query: 217 NYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIV 275
           +Y   + LG+GGF  V     L DG   A+KR    ++    +   E  +    NH +I+
Sbjct: 30  HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNIL 89

Query: 276 KLLGCCLETEVPV----LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRV-RVA 330
           +L+  CL          L+  +   GTL + I     ++ + +   L+    E+++  + 
Sbjct: 90  RLVAYCLRERGAKHEAWLLLPFFKRGTLWNEI-----ERLKDKGNFLT----EDQILWLL 140

Query: 331 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISR--SIPNDKTHLTTTI 388
             +   +  +H+       HRD+K +NILL D+    + D G      I  + +    T+
Sbjct: 141 LGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTL 197

Query: 389 Q------GTFGYLDPEYFQS---SQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNL 439
           Q       T  Y  PE F         +++DV+S G VL  ++ G+ P  +    +    
Sbjct: 198 QDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP--Y----DMVFQ 251

Query: 440 VACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEG 499
               ++LA +NQL      R +            +L    + ++  +RP +  +  +LE 
Sbjct: 252 KGDSVALAVQNQLSIPQSPRHSSALW--------QLLNSMMTVDPHQRPHIPLLLSQLEA 303

Query: 500 LR 501
           L+
Sbjct: 304 LQ 305

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  152 bits (385), Expect = 3e-42
 Identities = 62/306 (20%), Positives = 115/306 (37%), Gaps = 55/306 (17%)

Query: 213 RATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKT-QIHQFINEVVILSQIN 270
           R   ++   + LG+GGFG V++     D    A+KR +  ++     + + EV  L+++ 
Sbjct: 2   RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 61

Query: 271 HRHIVKLLGCCLE---------TEVPVLVY---EYISSGTLSHHIHDHQQQQEQKQKQEL 318
           H  IV+     LE         +   V +Y   +      L   +     +   ++++  
Sbjct: 62  HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWM---NGRCTIEERERS 118

Query: 319 SSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIP 378
             L          ++A AV ++HS     + HRD+K SNI        KV DFG+  ++ 
Sbjct: 119 VCLHI------FLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMD 169

Query: 379 NDKTHLTTTIQ-----------GTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
            D+   T               GT  Y+ PE    + ++ K D++S G++L ELL     
Sbjct: 170 QDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---- 225

Query: 428 ICFARVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKR 487
                 + ER      +   +  +   +   +   E           +    L  +  +R
Sbjct: 226 PFST--QMERVRTLTDV---RNLKFPPLFTQKYPCE---------YVMVQDMLSPSPMER 271

Query: 488 PTMKQV 493
           P    +
Sbjct: 272 PEAINI 277

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  152 bits (385), Expect = 4e-42
 Identities = 69/312 (22%), Positives = 126/312 (40%), Gaps = 64/312 (20%)

Query: 213 RATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKT--QIHQFINEVVILSQI 269
           R   ++ +   LGQG FG V K     D    A+K   +I  T  ++   ++EV++L+ +
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIK---KIRHTEEKLSTILSEVMLLASL 59

Query: 270 NHRHIVKLLGCCLETEVPV-------------LVYEYISSGTLSHHIHDHQQQQEQKQKQ 316
           NH+++V+     LE    V             +  EY  +GTL   IH     Q++ +  
Sbjct: 60  NHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDE-- 117

Query: 317 ELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS 376
                 W    R+  ++  A++Y+HS     I HRD+K  NI +D+  + K+ DFG++++
Sbjct: 118 -----YW----RLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKN 165

Query: 377 IPND--------------KTHLTTTIQGTFGYLDPEYFQSSQFTD-KSDVYSFGVVLLEL 421
           +                   +LT+ I GT  Y+  E    +   + K D+YS G++  E+
Sbjct: 166 VHRSLDILKLDSQNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM 224

Query: 422 LTGKKPICFARVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLR 481
           +             ER  +   +            D    K  +        ++    + 
Sbjct: 225 IYP----FST--GMERVNILKKLRSVSIE-FPPDFDDNKMKVEK--------KIIRLLID 269

Query: 482 LNSKKRPTMKQV 493
            +  KRP  + +
Sbjct: 270 HDPNKRPGARTL 281

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  149 bits (378), Expect = 3e-41
 Identities = 64/286 (22%), Positives = 113/286 (39%), Gaps = 45/286 (15%)

Query: 216 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK---RSKEIDKTQIHQFINEVVILSQINH 271
             Y + RFLG+GGF   ++        + A K   +S  +   Q  +   E+ I   + H
Sbjct: 15  RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74

Query: 272 RHIVKLLGCCLETEVPV-LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRV- 329
           +H+V   G   E    V +V E     +L             K+++ L+    E   R  
Sbjct: 75  QHVVGFHGF-FEDNDFVFVVLELCRRRSLLELH---------KRRKALT----EPEARYY 120

Query: 330 ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQ 389
             ++     Y+H +    + HRD+K  N+ L++    K+ DFG++  +  D       + 
Sbjct: 121 LRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD-GERKKVLC 176

Query: 390 GTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACF--ISLA 447
           GT  Y+ PE       + + DV+S G ++  LL GK P  F    E   L   +  I   
Sbjct: 177 GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP--F----ETSCLKETYLRIKKN 230

Query: 448 KENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQV 493
           + +     +   +   A          L  + L+ +   RPT+ ++
Sbjct: 231 EYS-----IPKHINPVAA--------SLIQKMLQTDPTARPTINEL 263

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  149 bits (378), Expect = 4e-41
 Identities = 61/286 (21%), Positives = 106/286 (37%), Gaps = 42/286 (14%)

Query: 213 RATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSK--EIDKTQIHQFINEVVILSQI 269
               ++ +   LG G +G V+K     DG + AVKRS           + + EV    ++
Sbjct: 54  FFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKV 113

Query: 270 -NHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVR 328
             H   V+L     E  +  L  E     +L  H         +     L     E +V 
Sbjct: 114 GQHPCCVRLEQAWEEGGILYLQTEL-CGPSLQQHC--------EAWGASLP----EAQVW 160

Query: 329 -VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
               +   A+A++HS     + H D+K +NI L  +   K+ DFG+   +          
Sbjct: 161 GYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVEL--GTAGAGEV 215

Query: 388 IQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLA 447
            +G   Y+ PE  Q   +   +DV+S G+ +LE+    +       E  + L        
Sbjct: 216 QEGDPRYMAPELLQ-GSYGTAADVFSLGLTILEVACNMEL--PHGGEGWQQL-------- 264

Query: 448 KENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQV 493
           ++  L     A ++ E R         + +  L  + K R T + +
Sbjct: 265 RQGYLPPEFTAGLSSELR--------SVLVMMLEPDPKLRATAEAL 302

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  150 bits (380), Expect = 4e-41
 Identities = 64/286 (22%), Positives = 113/286 (39%), Gaps = 45/286 (15%)

Query: 216 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK---RSKEIDKTQIHQFINEVVILSQINH 271
             Y + RFLG+GGF   ++        + A K   +S  +   Q  +   E+ I   + H
Sbjct: 41  RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100

Query: 272 RHIVKLLGCCLETEVPV-LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRV- 329
           +H+V   G   E    V +V E     +L             K+++ L+    E   R  
Sbjct: 101 QHVVGFHGF-FEDNDFVFVVLELCRRRSLLELH---------KRRKALT----EPEARYY 146

Query: 330 ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQ 389
             ++     Y+H +    + HRD+K  N+ L++    K+ DFG++  +  D       + 
Sbjct: 147 LRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG-ERKKVLC 202

Query: 390 GTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACF--ISLA 447
           GT  Y+ PE       + + DV+S G ++  LL GK P  F    E   L   +  I   
Sbjct: 203 GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP--F----ETSCLKETYLRIKKN 256

Query: 448 KENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQV 493
           + +     +   +   A          L  + L+ +   RPT+ ++
Sbjct: 257 EYS-----IPKHINPVAA--------SLIQKMLQTDPTARPTINEL 289

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  150 bits (382), Expect = 5e-41
 Identities = 71/294 (24%), Positives = 125/294 (42%), Gaps = 46/294 (15%)

Query: 222 RFLGQGGFGTVYKGMLPDGSI-VAVKRSKE-IDKTQIHQFINEVVILSQINHRHIVKLLG 279
             +G+G FG V+ G L   +  VAVK  +E +      +F+ E  IL Q +H +IV+L+G
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179

Query: 280 CCLETEVPV-LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVA 338
            C + + P+ +V E +  G     +     +           L  +  +++  + A  + 
Sbjct: 180 VCTQKQ-PIYIVMELVQGGDFLTFLRTEGAR-----------LRVKTLLQMVGDAAAGME 227

Query: 339 YMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYL--- 395
           Y+ S   I   HRD+ + N L+ +K   K+SDFG+SR   +          G    +   
Sbjct: 228 YLESKCCI---HRDLAARNCLVTEKNVLKISDFGMSREEADG----VYAASGGLRQVPVK 280

Query: 396 --DPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQL 452
              PE     +++ +SDV+SFG++L E  + G  P      ++ R  V       ++   
Sbjct: 281 WTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFV-------EKGGR 333

Query: 453 LEILDARVAKEAREEDI-GAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRSQR 505
           L             E    A+  L  +C      +RP+   +  EL+ +R+  R
Sbjct: 334 LP----------CPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKRHR 377

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  146 bits (370), Expect = 4e-40
 Identities = 71/295 (24%), Positives = 133/295 (45%), Gaps = 31/295 (10%)

Query: 222 RFLGQGGFGTVYKGMLP-----DGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVK 276
           + LG+G FG+V            G +VAVK+ +   +  +  F  E+ IL  + H +IVK
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75

Query: 277 LLGCCLET-EVPV-LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVA 334
             G C       + L+ EY+  G+L  ++  H+++           +     ++   ++ 
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-----------IDHIKLLQYTSQIC 124

Query: 335 GAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTF-- 392
             + Y+ +   I   HRD+ + NIL++++   K+ DFG+++ +P DK        G    
Sbjct: 125 KGMEYLGTKRYI---HRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPI 181

Query: 393 GYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQL 452
            +  PE    S+F+  SDV+SFGVVL EL T  +       E  R +            L
Sbjct: 182 FWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL 241

Query: 453 LEILDA--RVAK--EAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRS 503
           +E+L    R+ +     +E    +  +   C   N  +RP+ + +++ ++ +R +
Sbjct: 242 IELLKNNGRLPRPDGCPDE----IYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  146 bits (370), Expect = 8e-40
 Identities = 79/299 (26%), Positives = 135/299 (45%), Gaps = 34/299 (11%)

Query: 224 LGQGGFGTVYKGMLP-----DGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLL 278
           LG+G FG+V            G++VAVK+ +     Q   F  E+ IL  ++   IVK  
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90

Query: 279 GCCLET-EVPV-LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGA 336
           G         + LV EY+ SG L   +  H+ + +  +   L  L +      + ++   
Sbjct: 91  GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASR---L--LLY------SSQICKG 139

Query: 337 VAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTF--GY 394
           + Y+ S   +   HRD+ + NIL++ +   K++DFG+++ +P DK +      G     +
Sbjct: 140 MEYLGSRRCV---HRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFW 196

Query: 395 LDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQLL 453
             PE    + F+ +SDV+SFGVVL EL T   K    +   E   ++ C   +   ++LL
Sbjct: 197 YAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKS--CSPSAEFLRMMGCERDVPALSRLL 254

Query: 454 EILDA--RVAK--EAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRSQRCLE 508
           E+L+   R+        E    + EL   C   + + RP+   +  +L+ L    R  E
Sbjct: 255 ELLEEGQRLPAPPACPAE----VHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCE 309

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  145 bits (367), Expect = 9e-40
 Identities = 70/303 (23%), Positives = 116/303 (38%), Gaps = 33/303 (10%)

Query: 195 SSCGSSERAKVFTADELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDK 253
           S   + E        E     D       LG+G +G VY G  L +   +A+K   E D 
Sbjct: 1   SMRSTEEGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS 60

Query: 254 TQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQK 313
                   E+ +   + H++IV+ LG   E     +  E +  G+LS  +       +  
Sbjct: 61  RYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDN 120

Query: 314 QKQELSSLSWENRVRV-ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF-SAKVSDF 371
                     E  +     ++   + Y+H +    I HRDIK  N+L++      K+SDF
Sbjct: 121 ----------EQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDF 167

Query: 372 GISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQ--FTDKSDVYSFGVVLLELLTGKKPIC 429
           G S+ +       T T  GT  Y+ PE        +   +D++S G  ++E+ TGK P  
Sbjct: 168 GTSKRLAGINPC-TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP-- 224

Query: 430 FARVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPT 489
           F  + E     A F  +       EI +  ++ EA+           ++C   +  KR  
Sbjct: 225 FYELGEP--QAAMF-KVGMFKVHPEIPE-SMSAEAK--------AFILKCFEPDPDKRAC 272

Query: 490 MKQ 492
              
Sbjct: 273 AND 275

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  144 bits (366), Expect = 1e-39
 Identities = 78/290 (26%), Positives = 120/290 (41%), Gaps = 55/290 (18%)

Query: 216 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK---RSKEIDKTQIHQFINEVVILSQINH 271
           +++   R LG+G FG VY         I+A+K   +++       HQ   EV I S + H
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68

Query: 272 RHIVKLLGCCLETEVPV-LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVA 330
            +I++L G        V L+ EY   GT+   +    +  EQ+                 
Sbjct: 69  PNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA------------TYI 115

Query: 331 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQG 390
            E+A A++Y HS     + HRDIK  N+LL      K++DFG S   P+ +      + G
Sbjct: 116 TELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---DLCG 169

Query: 391 TFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKEN 450
           T  YL PE  +     +K D++S GV+  E L GK P  F    E               
Sbjct: 170 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP--F----EANTY----------Q 213

Query: 451 QLLE-ILDAR------VAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQV 493
           +  + I          V + AR        +L  R L+ N  +RP +++V
Sbjct: 214 ETYKRISRVEFTFPDFVTEGAR--------DLISRLLKHNPSQRPMLREV 255

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  144 bits (366), Expect = 1e-39
 Identities = 72/293 (24%), Positives = 121/293 (41%), Gaps = 58/293 (19%)

Query: 216 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQI------HQFINEVVILSQ 268
           +++     LG+G F  VY+   +  G  VA+K    IDK  +       +  NEV I  Q
Sbjct: 11  EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIK---MIDKKAMYKAGMVQRVQNEVKIHCQ 67

Query: 269 INHRHIVKLLGCCLETEVPV-LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRV 327
           + H  I++L     E    V LV E   +G ++ ++          + +  S    EN  
Sbjct: 68  LKHPSILELYNY-FEDSNYVYLVLEMCHNGEMNRYLK--------NRVKPFS----ENEA 114

Query: 328 RV-ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTT 386
           R    ++   + Y+HS     I HRD+  SN+LL    + K++DFG++ +          
Sbjct: 115 RHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLA-TQLKMPHEKHY 170

Query: 387 TIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISL 446
           T+ GT  Y+ PE    S    +SDV+S G +   LL G+ P  F    +   +       
Sbjct: 171 TLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPP--F----DTDTVKNTL--- 221

Query: 447 AKENQLLEILDAR------VAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQV 493
                  +++ A       ++ EA+        +L  + LR N   R ++  V
Sbjct: 222 ------NKVVLADYEMPSFLSIEAK--------DLIHQLLRRNPADRLSLSSV 260

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  145 bits (367), Expect = 2e-39
 Identities = 71/295 (24%), Positives = 133/295 (45%), Gaps = 31/295 (10%)

Query: 222 RFLGQGGFGTVYKGMLP-----DGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVK 276
           + LG+G FG+V            G +VAVK+ +   +  +  F  E+ IL  + H +IVK
Sbjct: 47  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106

Query: 277 LLGCCLET-EVPV-LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVA 334
             G C       + L+ EY+  G+L  ++  H+++           +     ++   ++ 
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-----------IDHIKLLQYTSQIC 155

Query: 335 GAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTF-- 392
             + Y+ +   I   HRD+ + NIL++++   K+ DFG+++ +P DK +      G    
Sbjct: 156 KGMEYLGTKRYI---HRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPI 212

Query: 393 GYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQL 452
            +  PE    S+F+  SDV+SFGVVL EL T  +       E  R +            L
Sbjct: 213 FWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL 272

Query: 453 LEILDA--RVAK--EAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRS 503
           +E+L    R+ +     +E    +  +   C   N  +RP+ + +++ ++ +R  
Sbjct: 273 IELLKNNGRLPRPDGCPDE----IYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  144 bits (366), Expect = 4e-39
 Identities = 52/216 (24%), Positives = 104/216 (48%), Gaps = 27/216 (12%)

Query: 222 RFLGQGGFGTVYKGML--PDGSI---VAVKRSKE-IDKTQIHQFINEVVILSQINHRHIV 275
           + LG G FGTVYKG+       +   VA+K  +E        + ++E  +++ +++ H+ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 276 KLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAG 335
           +LLG CL + V  L+ + +  G L  ++ +H+             +  +  +    ++A 
Sbjct: 81  RLLGICLTSTV-QLITQLMPFGCLLDYVREHKDN-----------IGSQYLLNWCVQIAK 128

Query: 336 AVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGT---F 392
            + Y+     +   HRD+ + N+L+      K++DFG+++ +  ++        G     
Sbjct: 129 GMNYLEDRRLV---HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE--GGKVPI 183

Query: 393 GYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
            ++  E      +T +SDV+S+GV + EL+T G KP
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  143 bits (364), Expect = 5e-39
 Identities = 78/298 (26%), Positives = 126/298 (42%), Gaps = 40/298 (13%)

Query: 222 RFLGQGGFGTVYKGMLPDGS------IVAVKRSKEIDKTQIHQFINEVVILSQINHRHIV 275
             LG+G FG V+     +        +VAVK  KE  ++    F  E  +L+ + H+HIV
Sbjct: 47  WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106

Query: 276 KLLGCCLETEVPVLVYEYISSGTLSHHIHDH---QQQQEQKQKQELSSLSWENRVRVACE 332
           +  G C E    ++V+EY+  G L+  +  H    +     +      L     + VA +
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166

Query: 333 VAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTF 392
           VA  + Y+   A +   HRD+ + N L+      K+ DFG+SR I +        + G  
Sbjct: 167 VAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD---YYRVGGR- 219

Query: 393 GYL-----DPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISL 446
             L      PE     +FT +SDV+SFGVVL E+ T GK+P       E        I  
Sbjct: 220 TMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE-------AIDC 272

Query: 447 AKENQLLEILDARVAKEAREEDI-GAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRS 503
             + + LE          R       +  +   C +   ++R ++K V   L+ L ++
Sbjct: 273 ITQGRELE----------RPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  144 bits (365), Expect = 5e-39
 Identities = 59/290 (20%), Positives = 100/290 (34%), Gaps = 42/290 (14%)

Query: 210 ELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQFINEVVILSQ 268
           E +           +G+G FG V++      G   AVK   ++          E+V  + 
Sbjct: 52  EYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVK---KVRLEVFRV--EELVACAG 106

Query: 269 INHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVR 328
           ++   IV L G   E     +  E +  G+L   I         KQ   L     E+R  
Sbjct: 107 LSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI---------KQMGCLP----EDRAL 153

Query: 329 VAC-EVAGAVAYMHSSASIPIFHRDIKSSNILLDDK-FSAKVSDFGISRSIPNDKTHLTT 386
               +    + Y+H+     I H D+K+ N+LL      A + DFG +  +  D    + 
Sbjct: 154 YYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSL 210

Query: 387 ----TIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVAC 442
                I GT  ++ PE         K D++S   ++L +L G  P  + +         C
Sbjct: 211 LTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP--WTQYFRGP---LC 265

Query: 443 FISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQ 492
              +A E   +  +    A            +     LR     R +  +
Sbjct: 266 LK-IASEPPPIREIPPSCAPLTA--------QAIQEGLRKEPVHRASAME 306

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  142 bits (361), Expect = 9e-39
 Identities = 71/218 (32%), Positives = 107/218 (49%), Gaps = 28/218 (12%)

Query: 222 RFLGQGGFGTVYKGMLPDGS----IVAVKRSKEI-DKTQIHQFINEVVILSQINHRHIVK 276
             +G+G FG VY G L D        AVK    I D  ++ QF+ E +I+   +H +++ 
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90

Query: 277 LLGCCLETEVPVL-VYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAG 335
           LLG CL +E   L V  Y+  G L + I +       K             +    +VA 
Sbjct: 91  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD-----------LIGFGLQVAK 139

Query: 336 AVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYL 395
            + Y+   AS    HRD+ + N +LD+KF+ KV+DFG++R + + + +      G    L
Sbjct: 140 GMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTG--AKL 194

Query: 396 -----DPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
                  E  Q+ +FT KSDV+SFGV+L EL+T G  P
Sbjct: 195 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 232

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  143 bits (362), Expect = 9e-39
 Identities = 79/302 (26%), Positives = 135/302 (44%), Gaps = 40/302 (13%)

Query: 210 ELQRATDNYNQSRFLGQGGFGTVYKGMLPDGS------IVAVKRSKEI-DKTQIHQFINE 262
           E+ R  +    SR LGQG FG VY+G+            VA+K   E     +  +F+NE
Sbjct: 21  EVAR--EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 78

Query: 263 VVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLS 322
             ++ + N  H+V+LLG   + +  +++ E ++ G L  ++   +          L+  S
Sbjct: 79  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMA--NNPVLAPPS 136

Query: 323 WENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKT 382
               +++A E+A  +AY+    +    HRD+ + N ++ + F+ K+ DFG++R I     
Sbjct: 137 LSKMIQMAGEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD- 192

Query: 383 HLTTTIQGTFGYL-----DPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEE 436
                 +G  G L      PE  +   FT  SDV+SFGVVL E+ T  ++P      E+ 
Sbjct: 193 ---YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV 249

Query: 437 RNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSME 496
              V        E  LL+  D        +     + EL   C + N K RP+  ++   
Sbjct: 250 LRFV-------MEGGLLDKPD-----NCPDM----LFELMRMCWQYNPKMRPSFLEIISS 293

Query: 497 LE 498
           ++
Sbjct: 294 IK 295

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  144 bits (365), Expect = 9e-39
 Identities = 70/218 (32%), Positives = 106/218 (48%), Gaps = 28/218 (12%)

Query: 222 RFLGQGGFGTVYKGMLPDGS----IVAVKRSKEI-DKTQIHQFINEVVILSQINHRHIVK 276
             +G+G FG VY G L D        AVK    I D  ++ QF+ E +I+   +H +++ 
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154

Query: 277 LLGCCLETEVPVL-VYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAG 335
           LLG CL +E   L V  Y+  G L + I +       K             +    +VA 
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD-----------LIGFGLQVAK 203

Query: 336 AVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYL 395
            + ++   AS    HRD+ + N +LD+KF+ KV+DFG++R + + +         T   L
Sbjct: 204 GMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHN--KTGAKL 258

Query: 396 -----DPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
                  E  Q+ +FT KSDV+SFGV+L EL+T G  P
Sbjct: 259 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  146 bits (370), Expect = 2e-38
 Identities = 70/284 (24%), Positives = 135/284 (47%), Gaps = 32/284 (11%)

Query: 222 RFLGQGGFGTVYKGMLPDGSI-VAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGC 280
             LG G +G VY+G+    S+ VAVK  KE D  ++ +F+ E  ++ +I H ++V+LLG 
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGV 284

Query: 281 CLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYM 340
           C       ++ E+++ G L  ++ +  +Q+          +S    + +A +++ A+ Y+
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRECNRQE----------VSAVVLLYMATQISSAMEYL 334

Query: 341 HSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYF 400
                I   HR++ + N L+ +    KV+DFG+SR +  D        +    +  PE  
Sbjct: 335 EKKNFI---HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL 391

Query: 401 QSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQLLEILDAR 459
             ++F+ KSDV++FGV+L E+ T G  P     + +   L+       +++  +E  +  
Sbjct: 392 AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-------EKDYRMERPE-- 442

Query: 460 VAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRS 503
                 E+    + EL   C + N   RP+  ++    E + + 
Sbjct: 443 ---GCPEK----VYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  141 bits (358), Expect = 2e-38
 Identities = 77/299 (25%), Positives = 130/299 (43%), Gaps = 41/299 (13%)

Query: 222 RFLGQGGFGTVYKGMLPDGS------IVAVKRSKEIDKTQIHQFINEVVILSQINHRHIV 275
           R LG+G FG V+     + S      +VAVK  K+        F  E  +L+ + H HIV
Sbjct: 21  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80

Query: 276 KLLGCCLETEVPVLVYEYISSGT----LSHHIHDHQQQQEQKQKQELSSLSWENRVRVAC 331
           K  G C + +  ++V+EY+  G     L  H  D     + + +Q    L     + +A 
Sbjct: 81  KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140

Query: 332 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGT 391
           ++A  + Y+   AS    HRD+ + N L+      K+ DFG+SR + +   +    + G 
Sbjct: 141 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYY---RVGGH 194

Query: 392 FGYL-----DPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFIS 445
              L      PE     +FT +SDV+SFGV+L E+ T GK+P       E        I 
Sbjct: 195 -TMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE-------VIE 246

Query: 446 LAKENQLLEILDARVAKEAREEDI-GAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRS 503
              + ++LE          R       + ++ + C +   ++R  +K++   L  L ++
Sbjct: 247 CITQGRVLE----------RPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKILHALGKA 295

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  140 bits (354), Expect = 6e-38
 Identities = 69/289 (23%), Positives = 120/289 (41%), Gaps = 53/289 (18%)

Query: 216 DNYNQSRFLGQGGFGTVYKG-MLPDGSIVAVK---RSKEIDKTQIHQFINEVVILSQINH 271
           D+++  R LG+G FG VY      +  I+A+K   +S+   +   HQ   E+ I S + H
Sbjct: 14  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73

Query: 272 RHIVKLLGCCLETEVPV-LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVA 330
            +I+++          + L+ E+   G L   +  H +  EQ+                 
Sbjct: 74  PNILRMYNY-FHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSA------------TFM 120

Query: 331 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQG 390
            E+A A+ Y H      + HRDIK  N+L+  K   K++DFG S   P+ +     T+ G
Sbjct: 121 EELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR---TMCG 174

Query: 391 TFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKEN 450
           T  YL PE  +     +K D++  GV+  E L G  P  F    +  +         +  
Sbjct: 175 TLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPP--F----DSPSHTETH---RR-- 223

Query: 451 QLLEILDAR------VAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQV 493
               I++        ++  ++        +L  + LR +  +R  +K V
Sbjct: 224 ----IVNVDLKFPPFLSDGSK--------DLISKLLRYHPPQRLPLKGV 260

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  141 bits (356), Expect = 7e-38
 Identities = 64/311 (20%), Positives = 113/311 (36%), Gaps = 52/311 (16%)

Query: 216 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQI----HQFINEVVILSQIN 270
             +  S  LGQG    V++G     G + A+K     +           + E  +L ++N
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIK---VFNNISFLRPVDVQMREFEVLKKLN 65

Query: 271 HRHIVKLLGC--CLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVR 328
           H++IVKL        T   VL+ E+   G+L   + +        + + L          
Sbjct: 66  HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFL---------I 116

Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILL----DDKFSAKVSDFGISRSIPNDKTHL 384
           V  +V G + ++  +    I HR+IK  NI+     D +   K++DFG +R + +D    
Sbjct: 117 VLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD--EQ 171

Query: 385 TTTIQGTFGYLDPEYFQSS--------QFTDKSDVYSFGVVLLELLTGKKPICFARVEEE 436
             ++ GT  YL P+ ++ +        ++    D++S GV      TG  P  F   E  
Sbjct: 172 FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP--FRPFEGP 229

Query: 437 RNLVACFISLAKENQLLEILDARVAKEAREEDIGAM--------------AELAMRCLRL 482
           R        +        I   + A+    +  G M                +    L  
Sbjct: 230 RRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEA 289

Query: 483 NSKKRPTMKQV 493
           + +K     Q 
Sbjct: 290 DQEKCWGFDQF 300

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  140 bits (355), Expect = 8e-38
 Identities = 59/224 (26%), Positives = 104/224 (46%), Gaps = 31/224 (13%)

Query: 222 RFLGQGGFGTVYKGMLPDGS----IVAVKRSKE--IDKTQIHQFINEVVILSQINHRHIV 275
           R LG+G FG+V +  L         VAVK  K   I  + I +F+ E   + + +H H+ 
Sbjct: 29  RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88

Query: 276 KLLGCCLETE------VPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRV 329
           KL+G  L +       +P+++  ++  G L   +         +  +   +L  +  VR 
Sbjct: 89  KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFL------LASRIGENPFNLPLQTLVRF 142

Query: 330 ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQ 389
             ++A  + Y+   +S    HRD+ + N +L +  +  V+DFG+SR I +   +     Q
Sbjct: 143 MVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYR----Q 195

Query: 390 GTFGYL-----DPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
           G    L       E    + +T  SDV++FGV + E++T G+ P
Sbjct: 196 GCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  140 bits (354), Expect = 9e-38
 Identities = 68/292 (23%), Positives = 121/292 (41%), Gaps = 27/292 (9%)

Query: 222 RFLGQGGFGTVYKGMLP-----DGSIVAVKRSKEI-DKTQIHQFINEVVILSQINHRHIV 275
           R LG+G FG V            G  VAVK  K       I     E+ IL  + H +IV
Sbjct: 27  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86

Query: 276 KLLGCCLETEV-PV-LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEV 333
           K  G C E     + L+ E++ SG+L  ++  ++ +           ++ + +++ A ++
Sbjct: 87  KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK-----------INLKQQLKYAVQI 135

Query: 334 AGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTF- 392
              + Y+ S   +   HRD+ + N+L++ +   K+ DFG++++I  DK + T        
Sbjct: 136 CKGMDYLGSRQYV---HRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSP 192

Query: 393 -GYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKEN 450
             +  PE    S+F   SDV+SFGV L ELLT        + +     ++          
Sbjct: 193 VFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSD--SSPMALFLKMIGPTHGQMTVT 250

Query: 451 QLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRR 502
           +L+  L               + +L  +C       R + + +    E L +
Sbjct: 251 RLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 302

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  138 bits (351), Expect = 9e-38
 Identities = 61/209 (29%), Positives = 102/209 (48%), Gaps = 20/209 (9%)

Query: 222 RFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCC 281
           + LG G FG V  G       VAVK  KE       +F  E   + +++H  +VK  G C
Sbjct: 14  KELGSGQFGVVKLGKWKGQYDVAVKMIKE-GSMSEDEFFQEAQTMMKLSHPKLVKFYGVC 72

Query: 282 LETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMH 341
            +     +V EYIS+G L +++  H +            L     + +  +V   +A++ 
Sbjct: 73  SKEYPIYIVTEYISNGCLLNYLRSHGKG-----------LEPSQLLEMCYDVCEGMAFLE 121

Query: 342 SSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGY--LDPEY 399
           S   I   HRD+ + N L+D     KVSDFG++R + +D+    +++   F      PE 
Sbjct: 122 SHQFI---HRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY--VSSVGTKFPVKWSAPEV 176

Query: 400 FQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
           F   +++ KSDV++FG+++ E+ + GK P
Sbjct: 177 FHYFKYSSKSDVWAFGILMWEVFSLGKMP 205

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  139 bits (353), Expect = 1e-37
 Identities = 67/212 (31%), Positives = 101/212 (47%), Gaps = 27/212 (12%)

Query: 224 LGQGGFGTVYKGMLPD---GSIVAVKRSKE---IDKTQIHQFINEVVILSQINHRHIVKL 277
           LG GG  TVY     D      VA+K         +  + +F  EV   SQ++H++IV +
Sbjct: 19  LGGGGMSTVYLAE--DTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76

Query: 278 LGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAV 337
           +    E +   LV EYI   TLS +I  H              LS +  +    ++   +
Sbjct: 77  IDVDEEDDCYYLVMEYIEGPTLSEYIESHGP------------LSVDTAINFTNQILDGI 124

Query: 338 AYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT--IQGTFGYL 395
            + H      I HRDIK  NIL+D   + K+ DFGI++++   +T LT T  + GT  Y 
Sbjct: 125 KHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKAL--SETSLTQTNHVLGTVQYF 179

Query: 396 DPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
            PE  +     + +D+YS G+VL E+L G+ P
Sbjct: 180 SPEQAKGEATDECTDIYSIGIVLYEMLVGEPP 211

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  139 bits (353), Expect = 1e-37
 Identities = 66/230 (28%), Positives = 106/230 (46%), Gaps = 28/230 (12%)

Query: 210 ELQRATDNYNQSRFLGQGGFGTVYKGMLPDGS----IVAVKRSKEI-DKTQIHQFINEVV 264
            +       +  R +G+G FG VY G   D +      A+K    I +  Q+  F+ E +
Sbjct: 15  LIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGL 74

Query: 265 ILSQINHRHIVKLLGCCLETE-VPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSW 323
           ++  +NH +++ L+G  L  E +P ++  Y+  G L   I   Q+    K          
Sbjct: 75  LMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDL-------- 126

Query: 324 ENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTH 383
              +    +VA  + Y+     +   HRD+ + N +LD+ F+ KV+DFG++R I      
Sbjct: 127 ---ISFGLQVARGMEYLAEQKFV---HRDLAARNCMLDESFTVKVADFGLARDI--LDRE 178

Query: 384 LTTTIQGTFGYL-----DPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
             +  Q     L       E  Q+ +FT KSDV+SFGV+L ELLT G  P
Sbjct: 179 YYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  138 bits (350), Expect = 2e-37
 Identities = 61/211 (28%), Positives = 107/211 (50%), Gaps = 24/211 (11%)

Query: 222 RFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCC 281
             LG G FG V+ G     + VAVK  K+        F+ E  ++ Q+ H+ +V+L    
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77

Query: 282 LETEVPVL-VYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYM 340
             T+ P+  + EY+ +G+L   +      +          L+    + +A ++A  +A++
Sbjct: 78  --TQEPIYIITEYMENGSLVDFLKTPSGIK----------LTINKLLDMAAQIAEGMAFI 125

Query: 341 HSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGT---FGYLDP 397
                I   HRD++++NIL+ D  S K++DFG++R I +++    T  +G      +  P
Sbjct: 126 EERNYI---HRDLRAANILVSDTLSCKIADFGLARLIEDNE---YTAREGAKFPIKWTAP 179

Query: 398 EYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
           E      FT KSDV+SFG++L E++T G+ P
Sbjct: 180 EAINYGTFTIKSDVWSFGILLTEIVTHGRIP 210

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  138 bits (351), Expect = 2e-37
 Identities = 63/210 (30%), Positives = 109/210 (51%), Gaps = 20/210 (9%)

Query: 222 RFLGQGGFGTVYKGMLPDGSI-VAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGC 280
             LG G +G VY+G+    S+ VAVK  KE D  ++ +F+ E  ++ +I H ++V+LLG 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77

Query: 281 CLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYM 340
           C       ++ E+++ G L  ++ +  +Q+          +S    + +A +++ A+ Y+
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLRECNRQE----------VSAVVLLYMATQISSAMEYL 127

Query: 341 HSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGY--LDPE 398
                I   HRD+ + N L+ +    KV+DFG+SR +  D    T      F      PE
Sbjct: 128 EKKNFI---HRDLAARNCLVGENHLVKVADFGLSRLMTGD--TYTAHAGAKFPIKWTAPE 182

Query: 399 YFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
               ++F+ KSDV++FGV+L E+ T G  P
Sbjct: 183 SLAYNKFSIKSDVWAFGVLLWEIATYGMSP 212

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  139 bits (353), Expect = 2e-37
 Identities = 76/319 (23%), Positives = 130/319 (40%), Gaps = 48/319 (15%)

Query: 210 ELQRATDNYNQSRFLGQGGFGTVYKGMLPDGS------IVAVKRSKEI-DKTQIHQFINE 262
           E+ R   N    R LG G FG VY+G +           VAVK   E+  +     F+ E
Sbjct: 26  EVPR--KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLME 83

Query: 263 VVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLS 322
            +I+S+ NH++IV+ +G  L++    ++ E ++ G L   + + + +  Q      SSL+
Sbjct: 84  ALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQP-----SSLA 138

Query: 323 WENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD---DKFSAKVSDFGISRSIPN 379
             + + VA ++A    Y+         HRDI + N LL        AK+ DFG++R I  
Sbjct: 139 MLDLLHVARDIACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR 195

Query: 380 DKTHLTTTIQGTFGYL-----DPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARV 433
                +   +G    L      PE F    FT K+D +SFGV+L E+ + G  P      
Sbjct: 196 A----SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN 251

Query: 434 EEERNLVACFISLAKENQLLEILDARVAKEAREEDI-GAMAELAMRCLRLNSKKRPTMKQ 492
           +E    V            ++            ++  G +  +  +C +   + RP    
Sbjct: 252 QEVLEFV-------TSGGRMD----------PPKNCPGPVYRIMTQCWQHQPEDRPNFAI 294

Query: 493 VSMELEGLRRSQRCLEMCQ 511
           +   +E   +    +    
Sbjct: 295 ILERIEYCTQDPDVINTAL 313

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  142 bits (361), Expect = 2e-37
 Identities = 61/208 (29%), Positives = 103/208 (49%), Gaps = 18/208 (8%)

Query: 222 RFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCC 281
             LGQG FG V+ G     + VA+K  K         F+ E  ++ ++ H  +V+L    
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 248

Query: 282 LETEVPV-LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYM 340
             +E P+ +V EY+S G+L   +     +           L     V +A ++A  +AY+
Sbjct: 249 --SEEPIYIVTEYMSKGSLLDFLKGETGK----------YLRLPQLVDMAAQIASGMAYV 296

Query: 341 HSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYF 400
                +   HRD++++NIL+ +    KV+DFG++R I +++       +    +  PE  
Sbjct: 297 ERMNYV---HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 353

Query: 401 QSSQFTDKSDVYSFGVVLLELLT-GKKP 427
              +FT KSDV+SFG++L EL T G+ P
Sbjct: 354 LYGRFTIKSDVWSFGILLTELTTKGRVP 381

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  142 bits (361), Expect = 2e-37
 Identities = 63/250 (25%), Positives = 118/250 (47%), Gaps = 24/250 (9%)

Query: 183 KQNGGYLLQQQLSSCGSSERAKVFTADELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSI 242
           K+    L Q+    C SS+  K +  D  +   ++    + LG G FG V+       + 
Sbjct: 155 KKGNDGLCQKLSVPCMSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTK 214

Query: 243 VAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPV-LVYEYISSGTLSH 301
           VAVK  K      +  F+ E  ++  + H  +VKL      T+ P+ ++ E+++ G+L  
Sbjct: 215 VAVKTMKP-GSMSVEAFLAEANVMKTLQHDKLVKLHAVV--TKEPIYIITEFMAKGSLLD 271

Query: 302 HIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD 361
            +   +  +                +  + ++A  +A++     I   HRD++++NIL+ 
Sbjct: 272 FLKSDEGSK----------QPLPKLIDFSAQIAEGMAFIEQRNYI---HRDLRAANILVS 318

Query: 362 DKFSAKVSDFGISRSIPNDKTHLTTTIQGT---FGYLDPEYFQSSQFTDKSDVYSFGVVL 418
                K++DFG++R I +++    T  +G      +  PE      FT KSDV+SFG++L
Sbjct: 319 ASLVCKIADFGLARVIEDNE---YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILL 375

Query: 419 LELLT-GKKP 427
           +E++T G+ P
Sbjct: 376 MEIVTYGRIP 385

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  144 bits (364), Expect = 2e-37
 Identities = 61/208 (29%), Positives = 103/208 (49%), Gaps = 18/208 (8%)

Query: 222 RFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCC 281
             LGQG FG V+ G     + VA+K  K         F+ E  ++ ++ H  +V+L    
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 331

Query: 282 LETEVPV-LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYM 340
             +E P+ +V EY+S G+L   +     +           L     V +A ++A  +AY+
Sbjct: 332 --SEEPIYIVTEYMSKGSLLDFLKGETGK----------YLRLPQLVDMAAQIASGMAYV 379

Query: 341 HSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYF 400
                +   HRD++++NIL+ +    KV+DFG++R I +++       +    +  PE  
Sbjct: 380 ERMNYV---HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 436

Query: 401 QSSQFTDKSDVYSFGVVLLELLT-GKKP 427
              +FT KSDV+SFG++L EL T G+ P
Sbjct: 437 LYGRFTIKSDVWSFGILLTELTTKGRVP 464

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  142 bits (359), Expect = 2e-37
 Identities = 66/307 (21%), Positives = 122/307 (39%), Gaps = 49/307 (15%)

Query: 212 QRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQI-N 270
           Q   +     + LG G  GTV       G  VAVKR   +        + E+ +L++  +
Sbjct: 11  QSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKR---MLIDFCDIALMEIKLLTESDD 67

Query: 271 HRHIVKLLGCCLETEVPV-LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRV 329
           H ++++   C   T+  + +  E   +  L   +     + +    + L      N + +
Sbjct: 68  HPNVIRYY-CSETTDRFLYIALELC-NLNLQDLV-----ESKNVSDENLKLQKEYNPISL 120

Query: 330 ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK-------------FSAKVSDFGISRS 376
             ++A  VA++HS     I HRD+K  NIL+                    +SDFG+ + 
Sbjct: 121 LRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKK 177

Query: 377 IPNDKTHLTTTIQ---GTFGYLDPEYFQSSQF-------TDKSDVYSFGVVLLELLTGKK 426
           + + ++   T +    GT G+  PE  + S         T   D++S G V   +L+  K
Sbjct: 178 LDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK 237

Query: 427 PICFARVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKK 486
                +   E N++    SL   +++  + D  +  EA         +L  + +  +  K
Sbjct: 238 HPFGDKYSRESNIIRGIFSL---DEMKCLHDRSLIAEAT--------DLISQMIDHDPLK 286

Query: 487 RPTMKQV 493
           RPT  +V
Sbjct: 287 RPTAMKV 293

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  140 bits (354), Expect = 3e-37
 Identities = 73/307 (23%), Positives = 125/307 (40%), Gaps = 46/307 (14%)

Query: 222 RFLGQGGFGTVYKGMLPDGS------IVAVKRSKEI-DKTQIHQFINEVVILSQINHRHI 274
           R LG G FG VY+G +           VAVK   E+  +     F+ E +I+S+ NH++I
Sbjct: 77  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136

Query: 275 VKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVA 334
           V+ +G  L++    ++ E ++ G L   + + + +  Q      SSL+  + + VA ++A
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQP-----SSLAMLDLLHVARDIA 191

Query: 335 GAVAYMHSSASIPIFHRDIKSSNILLD---DKFSAKVSDFGISRSIPNDKTHLTTTIQGT 391
               Y+         HRDI + N LL        AK+ DFG++R I           +G 
Sbjct: 192 CGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA----GYYRKGG 244

Query: 392 FGYL-----DPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFIS 445
              L      PE F    FT K+D +SFGV+L E+ + G  P      +E    V     
Sbjct: 245 CAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV----- 299

Query: 446 LAKENQLLEILDARVAKEAREEDI-GAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRSQ 504
                  ++            ++  G +  +  +C +   + RP    +   +E   +  
Sbjct: 300 --TSGGRMD----------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 347

Query: 505 RCLEMCQ 511
             +    
Sbjct: 348 DVINTAL 354

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  139 bits (352), Expect = 4e-37
 Identities = 62/306 (20%), Positives = 112/306 (36%), Gaps = 44/306 (14%)

Query: 216 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVK-----------------RSKEIDKTQIHQ 258
           ++Y   R L QG F  +      D    A+K                   K   K++   
Sbjct: 31  NDYRIIRTLNQGKFNKIILC-EKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89

Query: 259 FINEVVILSQINHRHIVKLLGCCLETEVPV-LVYEYISSGTLSHHIHDHQQQQEQKQKQE 317
           F NE+ I++ I + + +   G  +     V ++YEY+ + ++           +      
Sbjct: 90  FKNELQIITDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCF- 147

Query: 318 LSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI 377
              +  +    +   V  + +Y+H+  +I   HRD+K SNIL+D     K+SDFG S  +
Sbjct: 148 ---IPIQVIKCIIKSVLNSFSYIHNEKNI--CHRDVKPSNILMDKNGRVKLSDFGESEYM 202

Query: 378 PNDKTHLTTTIQGTFGYLDPEYFQSSQFTD--KSDVYSFGVVLLELLTGKKPICFARVEE 435
            + K       +GT+ ++ PE+F +    +  K D++S G+ L  +     P  F     
Sbjct: 203 VDKKIK---GSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP--F---SL 254

Query: 436 ERNLVACF--ISLAK-----ENQLLEILDARVAKEAREEDIGAMAE-LAMRCLRLNSKKR 487
           + +LV  F  I         +                   +           LR N  +R
Sbjct: 255 KISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAER 314

Query: 488 PTMKQV 493
            T +  
Sbjct: 315 ITSEDA 320

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  137 bits (348), Expect = 4e-37
 Identities = 59/212 (27%), Positives = 106/212 (50%), Gaps = 26/212 (12%)

Query: 222 RFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCC 281
           + LG G FG V  G       VA+K  KE       +FI E  ++  ++H  +V+L G C
Sbjct: 30  KELGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 88

Query: 282 LETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMH 341
            +     ++ EY+++G L +++ + + +              +  + +  +V  A+ Y+ 
Sbjct: 89  TKQRPIFIITEYMANGCLLNYLREMRHR-----------FQTQQLLEMCKDVCEAMEYLE 137

Query: 342 SSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYL-----D 396
           S   +   HRD+ + N L++D+   KVSDFG+SR + +D+    T+  G           
Sbjct: 138 SKQFL---HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE---YTSSVG--SKFPVRWSP 189

Query: 397 PEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
           PE    S+F+ KSD+++FGV++ E+ + GK P
Sbjct: 190 PEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP 221

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  138 bits (349), Expect = 5e-37
 Identities = 75/303 (24%), Positives = 119/303 (39%), Gaps = 45/303 (14%)

Query: 222 RFLGQGGFGTVYKGML-----PDGSIVAVKRSKE-IDKTQIHQFINEVVILSQINHRHIV 275
           R LG+G FG V            G +VAVK  K          +  E+ IL  + H HI+
Sbjct: 37  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96

Query: 276 KLLGCCLET-EVPV-LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEV 333
           K  GCC +     + LV EY+  G+L  ++  H             S+     +  A ++
Sbjct: 97  KYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH-------------SIGLAQLLLFAQQI 143

Query: 334 AGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTF- 392
              +AY+H+   I   HRD+ + N+LLD+    K+ DFG+++++P    +      G   
Sbjct: 144 CEGMAYLHAQHYI---HRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP 200

Query: 393 -GYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNL-------VACF 443
             +  PE  +  +F   SDV+SFGV L ELLT             E          V   
Sbjct: 201 VFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRL 260

Query: 444 ISLAKENQLLEILDARVAKEAREEDI-GAMAELAMRCLRLNSKKRPTMKQVSMELEGLRR 502
             L +  + L           R +     +  L   C    +  RPT + +   L+ +  
Sbjct: 261 TELLERGERLP----------RPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHE 310

Query: 503 SQR 505
             +
Sbjct: 311 KYQ 313

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  138 bits (349), Expect = 6e-37
 Identities = 78/298 (26%), Positives = 129/298 (43%), Gaps = 41/298 (13%)

Query: 222 RFLGQGGFGTVYKGML------PDGSIVAVKRSKEI-DKTQIHQFINEVVILSQI-NHRH 273
           + LG+G FG V +              VAVK  KE    ++    ++E+ IL  I +H +
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92

Query: 274 IVKLLGCCLETEVPVLV-YEYISSGTLSH----HIHDHQQQQEQKQKQELSSLSWENRVR 328
           +V LLG C +   P++V  E+   G LS       ++    +   +      L+ E+ + 
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152

Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTI 388
            + +VA  + ++   AS    HRD+ + NILL +K   K+ DFG++R I  D  +    +
Sbjct: 153 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY----V 205

Query: 389 QGTFGYL-----DPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVAC 442
           +     L      PE      +T +SDV+SFGV+L E+ + G  P    +++EE      
Sbjct: 206 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE------ 259

Query: 443 FISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGL 500
           F    KE   +   D         E    M +  + C      +RPT  ++   L  L
Sbjct: 260 FCRRLKEGTRMRAPD-----YTTPE----MYQTMLDCWHGEPSQRPTFSELVEHLGNL 308

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  138 bits (350), Expect = 6e-37
 Identities = 51/216 (23%), Positives = 102/216 (47%), Gaps = 27/216 (12%)

Query: 222 RFLGQGGFGTVYKGML--PDGSI---VAVKRSKEI-DKTQIHQFINEVVILSQINHRHIV 275
           + LG G FGTVYKG+       +   VA+K  +E        + ++E  +++ +++ H+ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 276 KLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAG 335
           +LLG CL      L+ + +  G L  ++ +H+             +  +  +    ++A 
Sbjct: 81  RLLGICLT-STVQLITQLMPFGCLLDYVREHKDN-----------IGSQYLLNWCVQIAK 128

Query: 336 AVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGT---F 392
            + Y+     +   HRD+ + N+L+      K++DFG+++ +  ++        G     
Sbjct: 129 GMNYLEDRRLV---HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE--GGKVPI 183

Query: 393 GYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
            ++  E      +T +SDV+S+GV + EL+T G KP
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  136 bits (345), Expect = 7e-37
 Identities = 62/209 (29%), Positives = 106/209 (50%), Gaps = 20/209 (9%)

Query: 222 RFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCC 281
           + +G G FG V+ G   +   VA+K  +E        FI E  ++ +++H  +V+L G C
Sbjct: 14  QEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 72

Query: 282 LETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMH 341
           LE     LV E++  G LS ++   +              + E  + +  +V   +AY+ 
Sbjct: 73  LEQAPICLVTEFMEHGCLSDYLRTQRGL-----------FAAETLLGMCLDVCEGMAYLE 121

Query: 342 SSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGY--LDPEY 399
            +  I   HRD+ + N L+ +    KVSDFG++R + +D+   T++    F      PE 
Sbjct: 122 EACVI---HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY--TSSTGTKFPVKWASPEV 176

Query: 400 FQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
           F  S+++ KSDV+SFGV++ E+ + GK P
Sbjct: 177 FSFSRYSSKSDVWSFGVLMWEVFSEGKIP 205

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  137 bits (347), Expect = 9e-37
 Identities = 65/289 (22%), Positives = 105/289 (36%), Gaps = 45/289 (15%)

Query: 222 RFLGQGGFGTVYKGMLPD---GSIVAVKRSKE---IDKTQIHQFINEVVILSQINHRHIV 275
           R +G+GG G VY+    D     IVA+K   E    D     +   E     ++   H+V
Sbjct: 40  RLVGRGGMGDVYEAE--DTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVV 97

Query: 276 KLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAG 335
            +           +    I+   L+  +                 L+    V +  ++  
Sbjct: 98  PIHDFGEIDGQLYVDMRLINGVDLAAMLRRQ------------GPLAPPRAVAIVRQIGS 145

Query: 336 AVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT--IQGTFG 393
           A+   H++      HRD+K  NIL+     A + DFGI+ +       LT      GT  
Sbjct: 146 ALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASAT--TDEKLTQLGNTVGTLY 200

Query: 394 YLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP-------ICFARVEEERNLVACFISL 446
           Y+ PE F  S  T ++D+Y+   VL E LTG  P       +  A + +     +     
Sbjct: 201 YMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRP- 259

Query: 447 AKENQLLEILDARVAK------EAREEDIGAMAELAMRCLRLNSKKRPT 489
                +    DA +A+      E R    G ++  A   L    + R T
Sbjct: 260 ----GIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQDRAT 304

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  140 bits (354), Expect = 1e-36
 Identities = 61/288 (21%), Positives = 112/288 (38%), Gaps = 42/288 (14%)

Query: 217 NYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQIN-HRHIV 275
           ++     LG G  GT+    + D   VAVKR   I          EV +L + + H +++
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKR---ILPECFSFADREVQLLRESDEHPNVI 81

Query: 276 KLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAG 335
           +      + +   +  E   + TL  ++       EQK    L        + +  +   
Sbjct: 82  RYFCTEKDRQFQYIAIELC-AATLQEYV-------EQKDFAHLG----LEPITLLQQTTS 129

Query: 336 AVAYMHSSASIPIFHRDIKSSNILLDDK-----FSAKVSDFGISRSIPNDKTHLT--TTI 388
            +A++HS     I HRD+K  NIL+          A +SDFG+ + +   +   +  + +
Sbjct: 130 GLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGV 186

Query: 389 QGTFGYLDPEYFQSSQF---TDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFIS 445
            GT G++ PE          T   D++S G V   +++         ++ + N     I 
Sbjct: 187 PGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN-----IL 241

Query: 446 LAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQV 493
           L   +      +      AR        EL  + + ++ +KRP+ K V
Sbjct: 242 LGACSLDCLHPEKHEDVIAR--------ELIEKMIAMDPQKRPSAKHV 281

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  137 bits (348), Expect = 1e-36
 Identities = 72/299 (24%), Positives = 125/299 (41%), Gaps = 43/299 (14%)

Query: 222 RFLGQGGFGTVYKGMLPD--------GSIVAVKRSKEI-DKTQIHQFINEVVILSQI-NH 271
           + LG+G FG V                  VAVK  K+   +  +   ++E+ ++  I  H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100

Query: 272 RHIVKLLGCCLETEVPVLVYEYISSGTLSH----HIHDHQQQQEQKQKQELSSLSWENRV 327
           ++I+ LLG C +     ++ EY S G L            +      +     +++++ V
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160

Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
               ++A  + Y+   AS    HRD+ + N+L+ +    K++DFG++R I N   +    
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY---- 213

Query: 388 IQGTFGYL-----DPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVA 441
            + T G L      PE      +T +SDV+SFGV++ E+ T G  P     VEE      
Sbjct: 214 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE------ 267

Query: 442 CFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGL 500
               L KE   ++            E    +  +   C      +RPT KQ+  +L+ +
Sbjct: 268 -LFKLLKEGHRMDKPA-----NCTNE----LYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  136 bits (344), Expect = 1e-36
 Identities = 59/212 (27%), Positives = 108/212 (50%), Gaps = 24/212 (11%)

Query: 224 LGQGGFGTVYKGML--PDGSI-VAVKRSKE-IDKTQIHQFINEVVILSQINHRHIVKLLG 279
           LG G FG+V +G+       I VA+K  K+  +K    + + E  I+ Q+++ +IV+L+G
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77

Query: 280 CCLETEVPV-LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVA 338
            C      + LV E    G L   +   +++           +   N   +  +V+  + 
Sbjct: 78  VC--QAEALMLVMEMAGGGPLHKFLVGKREE-----------IPVSNVAELLHQVSMGMK 124

Query: 339 YMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTF--GYLD 396
           Y+     +   HRD+ + N+LL ++  AK+SDFG+S+++  D ++ T    G +   +  
Sbjct: 125 YLEEKNFV---HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA 181

Query: 397 PEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
           PE     +F+ +SDV+S+GV + E L+ G+KP
Sbjct: 182 PECINFRKFSSRSDVWSYGVTMWEALSYGQKP 213

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  139 bits (351), Expect = 1e-36
 Identities = 68/340 (20%), Positives = 126/340 (37%), Gaps = 53/340 (15%)

Query: 216 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQI----HQFINEVVILSQIN 270
             +  S  LGQG    V++G     G + A+K     +           + E  +L ++N
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIK---VFNNISFLRPVDVQMREFEVLKKLN 65

Query: 271 HRHIVKLLGC--CLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVR 328
           H++IVKL        T   VL+ E+   G+L   + +        + + L          
Sbjct: 66  HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFL---------I 116

Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILL----DDKFSAKVSDFGISRSIPNDKTHL 384
           V  +V G + ++  +    I HR+IK  NI+     D +   K++DFG +R + +D+   
Sbjct: 117 VLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE--Q 171

Query: 385 TTTIQGTFGYLDPEYFQSS--------QFTDKSDVYSFGVVLLELLTGKKPICFARVEEE 436
             ++ GT  YL P+ ++ +        ++    D++S GV      TG  P  F   E  
Sbjct: 172 FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP--FRPFEGP 229

Query: 437 RNLVACFISLAKENQLLEILDARVAKEAREEDIGAM--------------AELAMRCLRL 482
           R        +        I   + A+    +  G M                +    L  
Sbjct: 230 RRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEA 289

Query: 483 NSKKRPTMKQVSMELEGLRRSQRCLEMCQVNQLLADEISL 522
           + +K     Q   E   +   +  + +  + Q+ A +I +
Sbjct: 290 DQEKCWGFDQFFAETSDI-LHRMVIHVFSLQQMTAHKIYI 328

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  137 bits (346), Expect = 2e-36
 Identities = 62/214 (28%), Positives = 98/214 (45%), Gaps = 22/214 (10%)

Query: 222 RFLGQGGFGTVYKGMLPDGS----IVAVKRSKE-IDKTQIHQFINEVVILSQINHRHIVK 276
           + +G G  G V  G L         VA+K  K    + Q   F++E  I+ Q +H +I++
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114

Query: 277 LLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGA 336
           L G      + ++V EY+ +G+L   +  H  Q            +    V +   V   
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ-----------FTIMQLVGMLRGVGAG 163

Query: 337 VAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYL- 395
           + Y+     +   HRD+ + N+L+D     KVSDFG+SR + +D     TT  G      
Sbjct: 164 MRYLSDLGYV---HRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRW 220

Query: 396 -DPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
             PE      F+  SDV+SFGVV+ E+L  G++P
Sbjct: 221 TAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  137 bits (346), Expect = 2e-36
 Identities = 54/216 (25%), Positives = 100/216 (46%), Gaps = 27/216 (12%)

Query: 222 RFLGQGGFGTVYKGMLPDGS-----IVAVKRSKEI-DKTQIHQFINEVVILSQINHRHIV 275
           + LG G FGTV+KG+           V +K  ++   +       + ++ +  ++H HIV
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78

Query: 276 KLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAG 335
           +LLG C       LV +Y+  G+L  H+  H+             L  +  +    ++A 
Sbjct: 79  RLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGA-----------LGPQLLLNWGVQIAK 126

Query: 336 AVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGT---F 392
            + Y+     +   HR++ + N+LL      +V+DFG++  +P D   L  +        
Sbjct: 127 GMYYLEEHGMV---HRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYS--EAKTPI 181

Query: 393 GYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
            ++  E     ++T +SDV+S+GV + EL+T G +P
Sbjct: 182 KWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP 217

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  137 bits (346), Expect = 2e-36
 Identities = 62/329 (18%), Positives = 126/329 (38%), Gaps = 54/329 (16%)

Query: 217 NYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQFINEVVILSQI-NHRHI 274
                R L +GGF  VY+   +  G   A+KR    ++ +    I EV  + ++  H +I
Sbjct: 29  RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNI 88

Query: 275 VKLLGCCLETEVP-------VLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRV 327
           V+        +          L+   +  G L   +      ++ + +  LS     + V
Sbjct: 89  VQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFL------KKMESRGPLS----CDTV 138

Query: 328 -RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTT 386
            ++  +   AV +MH     PI HRD+K  N+LL ++ + K+ DFG + +I +   +  +
Sbjct: 139 LKIFYQTCRAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWS 197

Query: 387 TIQ-----------GTFGYLDPEYFQSSQ---FTDKSDVYSFGVVLLELLTGKKPICFAR 432
             +            T  Y  PE           +K D+++ G +L  L   + P  F  
Sbjct: 198 AQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP--F-- 253

Query: 433 VEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQ 492
             E+   +              I++ + +    +        L    L++N ++R ++ +
Sbjct: 254 --EDGAKLR-------------IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAE 298

Query: 493 VSMELEGLRRSQRCLEMCQVNQLLADEIS 521
           V  +L+ +  ++       + +LL     
Sbjct: 299 VVHQLQEIAAARNVNPKSPITELLEQNGG 327

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  136 bits (344), Expect = 2e-36
 Identities = 53/223 (23%), Positives = 104/223 (46%), Gaps = 30/223 (13%)

Query: 222 RFLGQGGFGTVYKGMLPDGS----IVAVK--RSKEIDKTQIHQFINEVVILSQINHRHIV 275
           + LG+G FG+V +G L         VAVK  +     + +I +F++E   +   +H +++
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99

Query: 276 KLLGCCLETE-----VPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVA 330
           +LLG C+E        P+++  ++  G L  ++         + +     +  +  ++  
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYL------LYSRLETGPKHIPLQTLLKFM 153

Query: 331 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQG 390
            ++A  + Y+   ++    HRD+ + N +L D  +  V+DFG+S+ I +   +     QG
Sbjct: 154 VDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYR----QG 206

Query: 391 TFGYL-----DPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
               +       E      +T KSDV++FGV + E+ T G  P
Sbjct: 207 RIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  135 bits (343), Expect = 2e-36
 Identities = 60/217 (27%), Positives = 108/217 (49%), Gaps = 26/217 (11%)

Query: 220 QSRFLGQGGFGTVYKGMLPDGSI---VAVKRSKE--IDKTQIHQFINEVVILSQINHRHI 274
           + + LG G FGTV KG      +   VAVK  K    D     + + E  ++ Q+++ +I
Sbjct: 21  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80

Query: 275 VKLLGCCLETEVPV-LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEV 333
           V+++G C        LV E    G L+ ++  ++             +  +N + +  +V
Sbjct: 81  VRMIGIC--EAESWMLVMEMAELGPLNKYLQQNRH------------VKDKNIIELVHQV 126

Query: 334 AGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTF- 392
           +  + Y+  S  +   HRD+ + N+LL  +  AK+SDFG+S+++  D+ +      G + 
Sbjct: 127 SMGMKYLEESNFV---HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 183

Query: 393 -GYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
             +  PE     +F+ KSDV+SFGV++ E  + G+KP
Sbjct: 184 VKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 220

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  137 bits (346), Expect = 3e-36
 Identities = 65/215 (30%), Positives = 106/215 (49%), Gaps = 23/215 (10%)

Query: 222 RFLGQGGFGTVYKGML--PDGSI---VAVKRSKE-IDKTQIHQFINEVVILSQINHRHIV 275
           + +G G FG VYKGML    G     VA+K  K    + Q   F+ E  I+ Q +H +I+
Sbjct: 50  KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNII 109

Query: 276 KLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAG 335
           +L G   + +  +++ EY+ +G L   + +   +            S    V +   +A 
Sbjct: 110 RLEGVISKYKPMMIITEYMENGALDKFLREKDGE-----------FSVLQLVGMLRGIAA 158

Query: 336 AVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGY- 394
            + Y+ +   +   HRD+ + NIL++     KVSDFG+SR + +D     TT  G     
Sbjct: 159 GMKYLANMNYV---HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR 215

Query: 395 -LDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
              PE     +FT  SDV+SFG+V+ E++T G++P
Sbjct: 216 WTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP 250

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  135 bits (343), Expect = 3e-36
 Identities = 64/217 (29%), Positives = 97/217 (44%), Gaps = 27/217 (12%)

Query: 222 RFLGQGGFGTVYKGML--PDGSI--VAVKRSKEIDKTQIHQ---FINEVVILSQINHRHI 274
             LG G FG V +G    P G    VAVK  K    +Q      FI EV  +  ++HR++
Sbjct: 24  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83

Query: 275 VKLLGCCLETEVPV-LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEV 333
           ++L G  L    P+ +V E    G+L   +  HQ                    R A +V
Sbjct: 84  IRLYGVVLTP--PMKMVTELAPLGSLLDRLRKHQGH-----------FLLGTLSRYAVQV 130

Query: 334 AGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFG 393
           A  + Y+ S   I   HRD+ + N+LL  +   K+ DFG+ R++P +  H          
Sbjct: 131 AEGMGYLESKRFI---HRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVP 187

Query: 394 Y--LDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
           +    PE  ++  F+  SD + FGV L E+ T G++P
Sbjct: 188 FAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  137 bits (347), Expect = 3e-36
 Identities = 28/325 (8%), Positives = 73/325 (22%), Gaps = 53/325 (16%)

Query: 201 ERAKVFTADELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK---RSKEIDKTQI 256
           + A+      L +          L  G    V+    +      A+K      E  ++++
Sbjct: 47  QNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSEL 106

Query: 257 HQFINEVVILSQINHRHIVKLLGCCLETEVP--------------------------VLV 290
            +        +++      +                                     +L+
Sbjct: 107 ERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLL 166

Query: 291 YEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFH 350
               S   L             +               +  ++    A + S     + H
Sbjct: 167 MPAAS-VDLELLFSTLDFVYVFR-----GDEGILALHILTAQLIRLAANLQSKG---LVH 217

Query: 351 RDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSS--QFTDK 408
                 N+ +       + D      +                Y   E+  +S   FT  
Sbjct: 218 GHFTPDNLFIMPDGRLMLGDVSALWKVGT----RGPASSVPVTYAPREFLNASTATFTHA 273

Query: 409 SDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEILDARVAKEAREED 468
            + +  G+ +  +     P        + +     + +   + L       +    +   
Sbjct: 274 LNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVK--- 330

Query: 469 IGAMAELAMRCLRLNSKKRPTMKQV 493
                 L  R L  + ++R    + 
Sbjct: 331 -----TLIGRFLNFDRRRRLLPLEA 350

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  135 bits (343), Expect = 3e-36
 Identities = 79/299 (26%), Positives = 120/299 (40%), Gaps = 50/299 (16%)

Query: 218 YNQSRFLGQGGFGTVYKGMLPD---GSIVAVKRSKE---IDKTQIHQFINEVVILSQINH 271
           Y     LG GG   V+     D      VAVK  +     D +   +F  E    + +NH
Sbjct: 14  YELGEILGFGGMSEVHLAR--DLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 71

Query: 272 RHIVKLL--GC--CLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRV 327
             IV +   G        +P +V EY+   TL   +H                ++ +  +
Sbjct: 72  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP------------MTPKRAI 119

Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
            V  +   A+ + H +    I HRD+K +NI++    + KV DFGI+R+I +    +T T
Sbjct: 120 EVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 176

Query: 388 --IQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP--------ICFARVEEER 437
             + GT  YL PE  +      +SDVYS G VL E+LTG+ P        + +  V E+ 
Sbjct: 177 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRED- 235

Query: 438 NLVACFISLAKEN-QLLEILDARVAK------EAREEDIGAMAELAMRCLRLNSKKRPT 489
                 I  +  +  L   LDA V K      E R +    M    +R       + P 
Sbjct: 236 -----PIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEAPK 289

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  135 bits (343), Expect = 4e-36
 Identities = 77/309 (24%), Positives = 136/309 (44%), Gaps = 48/309 (15%)

Query: 222 RFLGQGGFGTVYKGMLPDG------SIVAVKRSKEI-DKTQIHQFINEVVILSQINHRHI 274
           + LG+G FG V K            + VAVK  KE    +++   ++E  +L Q+NH H+
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88

Query: 275 VKLLGCCLETEVPVLVYEYISSGTL------------SHHIHDHQQQQEQKQKQELSSLS 322
           +KL G C +    +L+ EY   G+L             +      +        +  +L+
Sbjct: 89  IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148

Query: 323 WENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKT 382
             + +  A +++  + Y+   A + + HRD+ + NIL+ +    K+SDFG+SR +  + +
Sbjct: 149 MGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS 205

Query: 383 HLTTTIQGTFGYL-----DPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEE 436
           +    ++ + G +       E      +T +SDV+SFGV+L E++T G  P      E  
Sbjct: 206 Y----VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPER- 260

Query: 437 RNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSME 496
                   +L K    +E  D        EE    M  L ++C +    KRP    +S +
Sbjct: 261 ------LFNLLKTGHRMERPD-----NCSEE----MYRLMLQCWKQEPDKRPVFADISKD 305

Query: 497 LEGLRRSQR 505
           LE +   +R
Sbjct: 306 LEKMMVKRR 314

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  137 bits (346), Expect = 5e-36
 Identities = 72/299 (24%), Positives = 126/299 (42%), Gaps = 43/299 (14%)

Query: 222 RFLGQGGFGTVYKGML--------PDGSIVAVKRSKEI-DKTQIHQFINEVVILSQI-NH 271
           + LG+G FG V              +   VAVK  K+   +  +   ++E+ ++  I  H
Sbjct: 87  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146

Query: 272 RHIVKLLGCCLETEVPVLVYEYISSGTLSH----HIHDHQQQQEQKQKQELSSLSWENRV 327
           ++I+ LLG C +     ++ EY S G L            +      +     +++++ V
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206

Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
               ++A  + Y+   AS    HRD+ + N+L+ +    K++DFG++R I N   +    
Sbjct: 207 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY---- 259

Query: 388 IQGTFGYL-----DPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVA 441
            + T G L      PE      +T +SDV+SFGV++ E+ T G  P     VEE      
Sbjct: 260 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE------ 313

Query: 442 CFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGL 500
               L KE   ++            E    +  +   C      +RPT KQ+  +L+ +
Sbjct: 314 -LFKLLKEGHRMDKPA-----NCTNE----LYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  137 bits (346), Expect = 5e-36
 Identities = 62/214 (28%), Positives = 103/214 (48%), Gaps = 22/214 (10%)

Query: 222 RFLGQGGFGTVYKGMLPDGS----IVAVKRSKE-IDKTQIHQFINEVVILSQINHRHIVK 276
           + +G G FG V  G L   S     VA+K  K    + Q   F+ E  I+ Q +H +I++
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110

Query: 277 LLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGA 336
           L G   +++  ++V EY+ +G+L   +  H  Q            +    V +   +A  
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ-----------FTVIQLVGMLRGIASG 159

Query: 337 VAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYL- 395
           + Y+     +   HRD+ + NIL++     KVSDFG+ R + +D     TT  G      
Sbjct: 160 MKYLSDMGYV---HRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRW 216

Query: 396 -DPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
             PE     +FT  SDV+S+G+VL E+++ G++P
Sbjct: 217 TSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  135 bits (343), Expect = 6e-36
 Identities = 73/295 (24%), Positives = 122/295 (41%), Gaps = 38/295 (12%)

Query: 222 RFLGQGGFGTVYKGMLPD------GSIVAVKRSKE-IDKTQIHQFINEVVILSQI-NHRH 273
           + LG G FG V +              VAVK  K      +    ++E+ I+S +  H +
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111

Query: 274 IVKLLGCCLETEVPVLVYEYISSGTLSHHIHDH--QQQQEQKQKQELSSLSWENRVRVAC 331
           IV LLG C      +++ EY   G L + +       + +       S+ S  + +  + 
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171

Query: 332 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGT 391
           +VA  +A++   AS    HRD+ + N+LL +   AK+ DFG++R I ND  +    I   
Sbjct: 172 QVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY----IVKG 224

Query: 392 FGYL-----DPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFIS 445
              L      PE      +T +SDV+S+G++L E+ + G  P     V  +      F  
Sbjct: 225 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK------FYK 278

Query: 446 LAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGL 500
           L K+   +          A +     +  +   C  L    RPT +Q+   L+  
Sbjct: 279 LVKDGYQMAQPA-----FAPKN----IYSIMQACWALEPTHRPTFQQICSFLQEQ 324

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  136 bits (344), Expect = 6e-36
 Identities = 71/314 (22%), Positives = 131/314 (41%), Gaps = 49/314 (15%)

Query: 222 RFLGQGGFGTVYKGMLPDG------SIVAVKRSKEI-DKTQIHQFINEVVILSQINHRHI 274
           R +G+G FG V++   P        ++VAVK  KE         F  E  ++++ ++ +I
Sbjct: 53  RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112

Query: 275 VKLLGCCLETEVPVLVYEYISSGTL------------SHHIHDHQQQQEQKQKQELSSLS 322
           VKLLG C   +   L++EY++ G L                H     + +        LS
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172

Query: 323 WENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKT 382
              ++ +A +VA  +AY+   +     HRD+ + N L+ +    K++DFG+SR+I +   
Sbjct: 173 CAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 229

Query: 383 HLTTTIQGTFGYL-----DPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEE 436
           +           +      PE    +++T +SDV+++GVVL E+ + G +P      EE 
Sbjct: 230 YK----ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE- 284

Query: 437 RNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSME 496
                  I   ++  +L   +         E    +  L   C       RP+   +   
Sbjct: 285 ------VIYYVRDGNILACPE-----NCPLE----LYNLMRLCWSKLPADRPSFCSIHRI 329

Query: 497 LEG-LRRSQRCLEM 509
           L+    R++  + +
Sbjct: 330 LQRMCERAEGTVGV 343

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  140 bits (355), Expect = 7e-36
 Identities = 57/229 (24%), Positives = 101/229 (44%), Gaps = 27/229 (11%)

Query: 212 QRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKR-SKEIDKTQIHQFINEVVILSQI 269
            +    +     LG GGFG V + +    G  VA+K+  +E+      ++  E+ I+ ++
Sbjct: 10  TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL 69

Query: 270 NHRHIVKLLGCCLETE-------VPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLS 322
           NH ++V       +         +P+L  EY   G L  +++  +     K+    + LS
Sbjct: 70  NHPNVVSAR-EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLS 128

Query: 323 WENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA---KVSDFGISRSIPN 379
                    +++ A+ Y+H +    I HRD+K  NI+L         K+ D G ++ +  
Sbjct: 129 ---------DISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ 176

Query: 380 DKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
               L T   GT  YL PE  +  ++T   D +SFG +  E +TG +P 
Sbjct: 177 G--ELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPF 223

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  133 bits (338), Expect = 1e-35
 Identities = 58/210 (27%), Positives = 107/210 (50%), Gaps = 26/210 (12%)

Query: 222 RFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCC 281
           + +G+G FG V  G    G+ VAVK  K         F+ E  +++Q+ H ++V+LLG  
Sbjct: 27  QTIGKGEFGDVMLGDY-RGNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQLLGVI 83

Query: 282 LETEVPV-LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYM 340
           +E +  + +V EY++ G+L  ++    +            L  +  ++ + +V  A+ Y+
Sbjct: 84  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSV----------LGGDCLLKFSLDVCEAMEYL 133

Query: 341 HSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGY--LDPE 398
             +  +   HRD+ + N+L+ +   AKVSDFG+++         +T   G        PE
Sbjct: 134 EGNNFV---HRDLAARNVLVSEDNVAKVSDFGLTKEA------SSTQDTGKLPVKWTAPE 184

Query: 399 YFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
             +  +F+ KSDV+SFG++L E+ + G+ P
Sbjct: 185 ALREKKFSTKSDVWSFGILLWEIYSFGRVP 214

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  137 bits (348), Expect = 1e-35
 Identities = 71/288 (24%), Positives = 139/288 (48%), Gaps = 38/288 (13%)

Query: 222 RFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCC 281
           + +G+G FG V  G    G+ VAVK  K  D T    F+ E  +++Q+ H ++V+LLG  
Sbjct: 199 QTIGKGEFGDVMLGDY-RGNKVAVKCIKN-DATA-QAFLAEASVMTQLRHSNLVQLLGVI 255

Query: 282 LETEVPV-LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYM 340
           +E +  + +V EY++ G+L  ++    +            L  +  ++ + +V  A+ Y+
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSV----------LGGDCLLKFSLDVCEAMEYL 305

Query: 341 HSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYF 400
             +  +   HRD+ + N+L+ +   AKVSDFG+++   + +      ++ T     PE  
Sbjct: 306 EGNNFV---HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEAL 358

Query: 401 QSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQLLEILDAR 459
           +  +F+ KSDV+SFG++L E+ + G+ P     +++    V       ++   ++  D  
Sbjct: 359 REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV-------EKGYKMDAPD-- 409

Query: 460 VAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRSQRCL 507
                       + ++   C  L++  RPT  Q+  +LE +R  +  L
Sbjct: 410 ---GCPPA----VYDVMKNCWHLDAATRPTFLQLREQLEHIRTHELHL 450

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  133 bits (337), Expect = 2e-35
 Identities = 66/298 (22%), Positives = 124/298 (41%), Gaps = 42/298 (14%)

Query: 222 RFLGQGGFGTVYKGMLPDGS------IVAVKRSKEI-DKTQIHQFINEVVILSQINHRHI 274
             LG+  FG VYKG L   +       VA+K  K+  +     +F +E ++ +++ H ++
Sbjct: 15  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74

Query: 275 VKLLGCCLETEVPVLVYEYISSGT----LSHHIHDHQQQQEQKQKQELSSLSWENRVRVA 330
           V LLG   + +   +++ Y S G     L               +   S+L   + V + 
Sbjct: 75  VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134

Query: 331 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQG 390
            ++A  + Y+   +S  + H+D+ + N+L+ DK + K+SD G+ R +          + G
Sbjct: 135 AQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAAD---YYKLLG 188

Query: 391 TFGYL-----DPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFI 444
               L      PE     +F+  SD++S+GVVL E+ + G +P C    ++        +
Sbjct: 189 N-SLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD-------VV 240

Query: 445 SLAKENQLLEILDARVAKEAREEDI-GAMAELAMRCLRLNSKKRPTMKQVSMELEGLR 501
            + +  Q+L             +D    +  L + C      +RP  K +   L    
Sbjct: 241 EMIRNRQVLP----------CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 288

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  133 bits (336), Expect = 2e-35
 Identities = 66/216 (30%), Positives = 103/216 (47%), Gaps = 29/216 (13%)

Query: 222 RFLGQGGFGTVYKGMLPDGSI----VAVKRSKEI-DKTQIHQFINEVVILSQINHRHIVK 276
           R LG+G FG VY+G+  +       VAVK  K+        +F++E VI+  ++H HIVK
Sbjct: 18  RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 77

Query: 277 LLGCCLETEVPV-LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAG 335
           L+G     E P  ++ E    G L H++  ++             L     V  + ++  
Sbjct: 78  LIGII--EEEPTWIIMELYPYGELGHYLERNKNS-----------LKVLTLVLYSLQICK 124

Query: 336 AVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGT---F 392
           A+AY+ S   +   HRDI   NIL+      K+ DFG+SR I ++          T    
Sbjct: 125 AMAYLESINCV---HRDIAVRNILVASPECVKLGDFGLSRYIEDED---YYKASVTRLPI 178

Query: 393 GYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
            ++ PE     +FT  SDV+ F V + E+L+ GK+P
Sbjct: 179 KWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQP 214

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  132 bits (335), Expect = 3e-35
 Identities = 63/215 (29%), Positives = 104/215 (48%), Gaps = 27/215 (12%)

Query: 222 RFLGQGGFGTVYKGML--PDGSI--VAVKRSKE-IDKTQIHQFINEVVILSQINHRHIVK 276
           R +G+G FG V++G+   P+     VA+K  K     +   +F+ E + + Q +H HIVK
Sbjct: 21  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 80

Query: 277 LLGCCLETEVPV-LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAG 335
           L+G    TE PV ++ E  + G L   +   +             L   + +  A +++ 
Sbjct: 81  LIGVI--TENPVWIIMELCTLGELRSFLQVRKYS-----------LDLASLILYAYQLST 127

Query: 336 AVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTF--G 393
           A+AY+ S   +   HRDI + N+L+      K+ DFG+SR + +         +G     
Sbjct: 128 ALAYLESKRFV---HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY--YKASKGKLPIK 182

Query: 394 YLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
           ++ PE     +FT  SDV+ FGV + E+L  G KP
Sbjct: 183 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 217

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  133 bits (337), Expect = 3e-35
 Identities = 78/299 (26%), Positives = 126/299 (42%), Gaps = 42/299 (14%)

Query: 222 RFLGQGGFGTVYKGMLPD------GSIVAVKRSKEI-DKTQIHQFINEVVILSQI-NHRH 273
           + LG G FG V +              VAVK  K     T+    ++E+ +LS + NH +
Sbjct: 29  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88

Query: 274 IVKLLGCCLETEVPVLVYEYISSGTLSH------HIHDHQQQQEQKQKQELSSLSWENRV 327
           IV LLG C      +++ EY   G L +            +      + +  +L  E+ +
Sbjct: 89  IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148

Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
             + +VA  +A++   AS    HRD+ + NILL      K+ DFG++R I ND  +    
Sbjct: 149 SFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY---- 201

Query: 388 IQGTFGYL-----DPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVA 441
           +      L      PE   +  +T +SDV+S+G+ L EL + G  P     V+ +     
Sbjct: 202 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK----- 256

Query: 442 CFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGL 500
            F  + KE   +   +      A  E    M ++   C   +  KRPT KQ+   +E  
Sbjct: 257 -FYKMIKEGFRMLSPE-----HAPAE----MYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  138 bits (349), Expect = 3e-35
 Identities = 58/211 (27%), Positives = 108/211 (51%), Gaps = 22/211 (10%)

Query: 224 LGQGGFGTVYKGML--PDGSI-VAVKRSKE-IDKTQIHQFINEVVILSQINHRHIVKLLG 279
           LG G FG+V +G+       I VA+K  K+  +K    + + E  I+ Q+++ +IV+L+G
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403

Query: 280 CCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAY 339
            C    + +LV E    G L   +   +++           +   N   +  +V+  + Y
Sbjct: 404 VCQAEAL-MLVMEMAGGGPLHKFLVGKREE-----------IPVSNVAELLHQVSMGMKY 451

Query: 340 MHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGY--LDP 397
           +     +   HR++ + N+LL ++  AK+SDFG+S+++  D ++ T    G +      P
Sbjct: 452 LEEKNFV---HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAP 508

Query: 398 EYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
           E     +F+ +SDV+S+GV + E L+ G+KP
Sbjct: 509 ECINFRKFSSRSDVWSYGVTMWEALSYGQKP 539

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  134 bits (340), Expect = 3e-35
 Identities = 77/299 (25%), Positives = 124/299 (41%), Gaps = 43/299 (14%)

Query: 222 RFLGQGGFGTVYKGMLPD--------GSIVAVKRSKEI-DKTQIHQFINEVVILSQI-NH 271
           + LG+G FG V                + VAVK  K    +  +   I+E+ ++  I  H
Sbjct: 75  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134

Query: 272 RHIVKLLGCCLETEVPVLVYEYISSGTLSH----HIHDHQQQQEQKQKQELSSLSWENRV 327
           ++I+ LLG C +     ++ EY S G L            +            LS ++ V
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194

Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
             A +VA  + Y+   AS    HRD+ + N+L+ +    K++DFG++R I +   +    
Sbjct: 195 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY---- 247

Query: 388 IQGTFGYL-----DPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVA 441
            + T G L      PE      +T +SDV+SFGV+L E+ T G  P     VEE      
Sbjct: 248 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE------ 301

Query: 442 CFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGL 500
               L KE   ++            E    +  +   C      +RPT KQ+  +L+ +
Sbjct: 302 -LFKLLKEGHRMDKPS-----NCTNE----LYMMMRDCWHAVPSQRPTFKQLVEDLDRI 350

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  132 bits (333), Expect = 5e-35
 Identities = 50/240 (20%), Positives = 93/240 (38%), Gaps = 42/240 (17%)

Query: 213 RATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSK--EIDKTQIHQFINEVVILSQI 269
           R T  +++   +G G FG+V+K +   DG I A+KRSK            + EV   + +
Sbjct: 8   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 67

Query: 270 -NHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVR 328
             H H+V+      E +  ++  EY + G+L+  I      +  +          E  ++
Sbjct: 68  GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAI-----SENYRIMSYFK----EAELK 118

Query: 329 V-ACEVAGAVAYMHSSASIPIFHRDIKSSNILLD-------------------DKFSAKV 368
               +V   + Y+HS +   + H DIK SNI +                    +K   K+
Sbjct: 119 DLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKI 175

Query: 369 SDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQ-FTDKSDVYSFGVVLLELLTGKKP 427
            D G    I +         +G   +L  E  Q +     K+D+++  + ++     +  
Sbjct: 176 GDLGHVTRISS-----PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL 230

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  132 bits (335), Expect = 6e-35
 Identities = 74/297 (24%), Positives = 121/297 (40%), Gaps = 41/297 (13%)

Query: 222 RFLGQGGFGTVYKGMLPDGS---IVAVKRSKEI-DKTQIHQFINEVVILSQI-NHRHIVK 276
             +G+G FG V K  +         A+KR KE   K     F  E+ +L ++ +H +I+ 
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90

Query: 277 LLGCCLETEVPVLVYEYISSGTLSHHIHDH----QQQQEQKQKQELSSLSWENRVRVACE 332
           LLG C       L  EY   G L   +                   S+LS +  +  A +
Sbjct: 91  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150

Query: 333 VAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTF 392
           VA  + Y+   +     HRD+ + NIL+ + + AK++DFG+SR            ++ T 
Sbjct: 151 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQE-------VYVKKTM 200

Query: 393 GYL-----DPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISL 446
           G L       E    S +T  SDV+S+GV+L E+++ G  P C     E    +      
Sbjct: 201 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL------ 254

Query: 447 AKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRS 503
             +   LE           +E    + +L  +C R    +RP+  Q+ + L  +   
Sbjct: 255 -PQGYRLEKPL-----NCDDE----VYDLMRQCWREKPYERPSFAQILVSLNRMLEE 301

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  137 bits (347), Expect = 1e-34
 Identities = 51/277 (18%), Positives = 91/277 (32%), Gaps = 55/277 (19%)

Query: 224 LGQGGFGTVYKG--MLPDGSIVAVK--RSKEIDKTQIHQFINEVVILSQINHRHIVKLL- 278
           +  GG G +Y       +G  V +K       D       + E   L+++ H  IV++  
Sbjct: 88  IAHGGLGWIYLALDRNVNGRPVVLKGLVHSG-DAEAQAMAMAERQFLAEVVHPSIVQIFN 146

Query: 279 ----GCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVA 334
                      V  +V EY+   +L                     L     +    E+ 
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK--------------LPVAEAIAYLLEIL 192

Query: 335 GAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGY 394
            A++Y+HS   I + + D+K  NI+L ++   K+ D G    I          + GT G+
Sbjct: 193 PALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI----NS-FGYLYGTPGF 243

Query: 395 LDPEYFQ-SSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLL 453
             PE     +  T  +D+Y+ G  L  L              +         L +++ +L
Sbjct: 244 QAPE--IVRTGPTVATDIYTVGRTLAALTLDLPT--RNGRYVD--------GLPEDDPVL 291

Query: 454 EI---LDARVAK------EAREEDIGAMAELAMRCLR 481
           +        + +        R      M+      LR
Sbjct: 292 KTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLR 328

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  135 bits (341), Expect = 1e-34
 Identities = 73/289 (25%), Positives = 117/289 (40%), Gaps = 44/289 (15%)

Query: 215 TDNYNQSRFLGQGGFGTVYKG-MLPDGSIVAVK---RSKEIDKTQIHQFINEVVILSQIN 270
           +D Y   R LG+G FG V        G   AVK   + +   KT     + EV +L Q++
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84

Query: 271 HRHIVKLLGCCLETEVPV-LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRV 329
           H +I+KL     E +    LV E  + G L   I   ++  E                R+
Sbjct: 85  HPNIMKLYEFF-EDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA------------RI 131

Query: 330 ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK---FSAKVSDFGISRSIPNDKTHLTT 386
             +V   + YMH +    I HRD+K  N+LL+ K    + ++ DFG+S      K     
Sbjct: 132 IRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM--K 186

Query: 387 TIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISL 446
              GT  Y+ PE    + + +K DV+S GV+L  LL+G  P               F   
Sbjct: 187 DKIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPP---------------FNGA 230

Query: 447 AKENQLLEILDARVAKEARE-EDIGAMA-ELAMRCLRLNSKKRPTMKQV 493
            + + L ++   +   E  + + +   A +L  + L      R + +  
Sbjct: 231 NEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDA 279

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  131 bits (330), Expect = 3e-34
 Identities = 64/342 (18%), Positives = 113/342 (33%), Gaps = 82/342 (23%)

Query: 213 RATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQFI-NEVVILSQIN 270
           R   ++   + +G+GGFG V++     D    A+KR +  ++    + +  EV  L+++ 
Sbjct: 3   RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 62

Query: 271 HRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQK-----QELSSLSWEN 325
           H  IV+     LET       E                            + +   S +N
Sbjct: 63  HPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKN 122

Query: 326 RVRVA---------------CE----------------------------VAGAVAYMHS 342
            V                  C                             +A AV ++HS
Sbjct: 123 TVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS 182

Query: 343 SASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQ-----------GT 391
                + HRD+K SNI        KV DFG+  ++  D+   T               GT
Sbjct: 183 KG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239

Query: 392 FGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQ 451
             Y+ PE    + ++ K D++S G++L ELL           + ER  +   I+  +  +
Sbjct: 240 KLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFST------QMERVRI---ITDVRNLK 290

Query: 452 LLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQV 493
              +   +  +E           +    L  +  +RP    +
Sbjct: 291 FPLLFTQKYPQE---------HMMVQDMLSPSPTERPEATDI 323

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  131 bits (331), Expect = 4e-34
 Identities = 73/304 (24%), Positives = 135/304 (44%), Gaps = 47/304 (15%)

Query: 222 RFLGQGGFGTVYKGMLPDGS------IVAVKRSKEI-DKTQIHQFINEVVILSQI-NHRH 273
           + LG G FG V        S       VAVK  KE  D ++    ++E+ +++Q+ +H +
Sbjct: 51  KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110

Query: 274 IVKLLGCCLETEVPVLVYEYISSGTLSHHIHDH-----------QQQQEQKQKQELSSLS 322
           IV LLG C  +    L++EY   G L +++              + Q+  +++++L+ L+
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170

Query: 323 WENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKT 382
           +E+ +  A +VA  + ++         HRD+ + N+L+      K+ DFG++R I +D  
Sbjct: 171 FEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN 227

Query: 383 HLTTTIQGTFGYL-----DPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEE 436
           ++          L      PE      +T KSDV+S+G++L E+ + G  P     V+  
Sbjct: 228 YV----VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN 283

Query: 437 RNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSME 496
                 F  L +    ++         A EE    +  +   C   +S+KRP+   ++  
Sbjct: 284 ------FYKLIQNGFKMDQPF-----YATEE----IYIIMQSCWAFDSRKRPSFPNLTSF 328

Query: 497 LEGL 500
           L   
Sbjct: 329 LGCQ 332

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  133 bits (337), Expect = 6e-34
 Identities = 69/288 (23%), Positives = 116/288 (40%), Gaps = 43/288 (14%)

Query: 215 TDNYNQSRFLGQGGFGTVYKG-MLPDGSIVAVK--RSKEIDKTQIHQFINEVVILSQINH 271
           ++ Y + + LG G +G V            A+K  R   +  +   + + EV +L  ++H
Sbjct: 36  SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95

Query: 272 RHIVKLLGCCLETEVPV-LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVA 330
            +I+KL     E +    LV E    G L   I    +  E                 + 
Sbjct: 96  PNIMKLYDFF-EDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAA------------VII 142

Query: 331 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK---FSAKVSDFGISRSIPNDKTHLTTT 387
            +V   V Y+H      I HRD+K  N+LL+ K      K+ DFG+S    N K      
Sbjct: 143 KQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM--KE 197

Query: 388 IQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEE--RNLVACFIS 445
             GT  Y+ PE  +   + +K DV+S GV+L  LL G  P    + ++E  R +     +
Sbjct: 198 RLGTAYYIAPEVLRKK-YDEKCDVWSIGVILFILLAGYPP-FGGQTDQEILRKVEKGKYT 255

Query: 446 LAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQV 493
                         V++ A+        +L  + L+ +S++R + +Q 
Sbjct: 256 FDSPEW------KNVSEGAK--------DLIKQMLQFDSQRRISAQQA 289

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  130 bits (329), Expect = 7e-34
 Identities = 46/236 (19%), Positives = 77/236 (32%), Gaps = 28/236 (11%)

Query: 210 ELQRATDNYNQSRFLGQGGFGTVYKGM------LPDGSIVAVKRSKEIDKTQIHQFINEV 263
           E Q  +        LG+G F  VY+          +     +K  K  +  + +     +
Sbjct: 59  EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLM 118

Query: 264 VILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSW 323
             L        +K     L     VLV E  S GTL + I+ ++   E+   Q L     
Sbjct: 119 ERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGL----- 173

Query: 324 ENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA-----------KVSDFG 372
              +  A  +   +  +H      I H DIK  N +L + F              + D G
Sbjct: 174 --VISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLG 228

Query: 373 ISRSIPN-DKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
            S  +    K  + T    T G+   E   +  +  + D +     +  +L G   
Sbjct: 229 QSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  127 bits (322), Expect = 2e-33
 Identities = 50/231 (21%), Positives = 93/231 (40%), Gaps = 51/231 (22%)

Query: 222 RFLGQGGFGTVYKGMLPDGSI--------VAVKRSKEIDKTQIHQFINEVVILSQINHRH 273
             LGQG F  ++KG+  +           V +K   +  +     F     ++S+++H+H
Sbjct: 14  ESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKH 73

Query: 274 IVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEV 333
           +V   G C+  +  +LV E++  G+L  ++  ++       K           + VA ++
Sbjct: 74  LVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWK-----------LEVAKQL 122

Query: 334 AGAVAYMHSSASIPIFHRDIKSSNILLDDKFS--------AKVSDFGISRSIPNDKTHLT 385
           A A+ ++  +  I   H ++ + NILL  +           K+SD GIS ++        
Sbjct: 123 AAAMHFLEENTLI---HGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK----- 174

Query: 386 TTIQGTFGYLD-------PEYFQ-SSQFTDKSDVYSFGVVLLELLT-GKKP 427
                    L        PE  +        +D +SFG  L E+ + G KP
Sbjct: 175 -------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  133 bits (336), Expect = 3e-33
 Identities = 61/213 (28%), Positives = 103/213 (48%), Gaps = 23/213 (10%)

Query: 222 RFLGQGGFGTVYKGMLPDGS----IVAVKRSKE-IDKTQIHQFINEVVILSQINHRHIVK 276
           R +G+G FG V++G+          VA+K  K     +   +F+ E + + Q +H HIVK
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 455

Query: 277 LLGCCLETEVPV-LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAG 335
           L+G    TE PV ++ E  + G L   +   +             L   + +  A +++ 
Sbjct: 456 LIGVI--TENPVWIIMELCTLGELRSFLQVRKFS-----------LDLASLILYAYQLST 502

Query: 336 AVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYL 395
           A+AY+ S   +   HRDI + N+L+      K+ DFG+SR + +   +  +  +    ++
Sbjct: 503 ALAYLESKRFV---HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM 559

Query: 396 DPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKP 427
            PE     +FT  SDV+ FGV + E+L  G KP
Sbjct: 560 APESINFRRFTSASDVWMFGVCMWEILMHGVKP 592

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  130 bits (330), Expect = 5e-33
 Identities = 68/299 (22%), Positives = 116/299 (38%), Gaps = 54/299 (18%)

Query: 215 TDNYNQSRFLGQGGFGTVYKG-MLPDGSIVAVK-------------RSKEIDKTQIHQFI 260
            ++Y + R LG G +G V         S  A+K                +  +    +  
Sbjct: 35  GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94

Query: 261 NEVVILSQINHRHIVKLLGCCLETEVPV-LVYEYISSGTLSHHIHDHQQQQEQKQKQELS 319
           NE+ +L  ++H +I+KL     E +    LV E+   G L   I +  +  E        
Sbjct: 95  NEISLLKSLDHPNIIKLFDVF-EDKKYFYLVTEFYEGGELFEQIINRHKFDECDAA---- 149

Query: 320 SLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK---FSAKVSDFGISRS 376
                    +  ++   + Y+H      I HRDIK  NILL++K    + K+ DFG+S  
Sbjct: 150 --------NIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSF 198

Query: 377 IPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEE 436
              D         GT  Y+ PE  +   + +K DV+S GV++  LL G  P         
Sbjct: 199 FSKDYKL--RDRLGTAYYIAPEVLKKK-YNEKCDVWSCGVIMYILLCGYPP--------- 246

Query: 437 RNLVACFISLAKENQLLEILDARVAKEARE-EDIGAMA-ELAMRCLRLNSKKRPTMKQV 493
                 F     ++ + ++   +   +  + ++I   A EL    L  +  KR T ++ 
Sbjct: 247 ------FGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEA 299

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  127 bits (320), Expect = 1e-32
 Identities = 69/298 (23%), Positives = 113/298 (37%), Gaps = 46/298 (15%)

Query: 224 LGQGGFGTVYKGML-PDGSIVAVKR-SKEIDKTQIHQFINEVVILSQINHRHIVKLLGCC 281
           LG G  G V+K    P G ++A K    EI     +Q I E+ +L + N  +IV   G  
Sbjct: 41  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 100

Query: 282 LETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMH 341
                  +  E++  G+L   +    +  EQ     L         +V+  V   + Y+ 
Sbjct: 101 YSDGEISICMEHMDGGSLDQVLKKAGRIPEQ----ILG--------KVSIAVIKGLTYLR 148

Query: 342 SSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQ 401
               I   HRD+K SNIL++ +   K+ DFG+S  + +   +   +  GT  Y+ PE  Q
Sbjct: 149 EKHKI--MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN---SFVGTRSYMSPERLQ 203

Query: 402 SSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEILDARVA 461
            + ++ +SD++S G+ L+E+  G+ PI     +E   +  C +                 
Sbjct: 204 GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 263

Query: 462 KEAREEDIGAMA---ELAMR------------------------CLRLNSKKRPTMKQ 492
                 D        EL                           CL  N  +R  +KQ
Sbjct: 264 LNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 321

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  126 bits (318), Expect = 1e-32
 Identities = 77/323 (23%), Positives = 128/323 (39%), Gaps = 73/323 (22%)

Query: 193 QLSSCGSSERAKVFTADELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEI 251
            ++ C      K+    E +     Y     LG GGFG+VY G+ + D   VA+K    +
Sbjct: 20  HMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKH---V 76

Query: 252 DKTQIHQFIN---------EVVILSQINHR--HIVKLLGCCLETEVP-VLVYEYIS-SGT 298
           +K +I  +           EVV+L +++     +++LL    E     VL+ E       
Sbjct: 77  EKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW-FERPDSFVLILERPEPVQD 135

Query: 299 LSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNI 358
           L   I +    QE+             R     +V  AV + H+     + HRDIK  NI
Sbjct: 136 LFDFITERGALQEE-----------LAR-SFFWQVLEAVRHCHNCG---VLHRDIKDENI 180

Query: 359 LLD-DKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFT-DKSDVYSFGV 416
           L+D ++   K+ DFG    + +  T  T    GT  Y  PE+ +  ++    + V+S G+
Sbjct: 181 LIDLNRGELKLIDFGSGALLKD--TVYTDF-DGTRVYSPPEWIRYHRYHGRSAAVWSLGI 237

Query: 417 VLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEILDAR------VAKEAREEDIG 470
           +L +++ G  P  F   E +                 EI+  +      V+ E +     
Sbjct: 238 LLYDMVCGDIP--F---EHDE----------------EIIRGQVFFRQRVSSECQ----- 271

Query: 471 AMAELAMRCLRLNSKKRPTMKQV 493
               L   CL L    RPT +++
Sbjct: 272 ---HLIRWCLALRPSDRPTFEEI 291

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  128 bits (323), Expect = 3e-32
 Identities = 70/289 (24%), Positives = 111/289 (38%), Gaps = 45/289 (15%)

Query: 215 TDNYNQSRFLGQGGFGTVYKG-MLPDGSIVAVK--RSKEIDKTQIHQFINEVVILSQINH 271
            + YN    LG+G FG V K          AVK               + EV +L +++H
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80

Query: 272 RHIVKLLGCCLETEVPV-LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVA 330
            +I+KL     E      +V E  + G L   I   ++  E                R+ 
Sbjct: 81  PNIMKLFEIL-EDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA------------RII 127

Query: 331 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK---FSAKVSDFGISRSIPNDKTHLTTT 387
            +V   + YMH      I HRD+K  NILL+ K      K+ DFG+S     +       
Sbjct: 128 KQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM--KD 182

Query: 388 IQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICF-ARVEEE--RNLVACFI 444
             GT  Y+ PE  + + + +K DV+S GV+L  LL+G  P  F  + E +  + +     
Sbjct: 183 RIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPP--FYGKNEYDILKRVETGKY 239

Query: 445 SLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQV 493
           +              ++ +A+        +L  + L  +   R T  Q 
Sbjct: 240 AFDLPQW------RTISDDAK--------DLIRKMLTFHPSLRITATQC 274

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  123 bits (310), Expect = 3e-31
 Identities = 41/328 (12%), Positives = 86/328 (26%), Gaps = 81/328 (24%)

Query: 210 ELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK---RSKEIDKTQIHQFINEVVI 265
           EL        +   LGQ       +      G    V     ++      I Q   EV+ 
Sbjct: 67  ELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLR 126

Query: 266 LSQI-------------------------NHRHIVKLLGCCLETEVP--VLVYE--YISS 296
           L  +                           + ++++     +  V     +Y     + 
Sbjct: 127 LRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNL 186

Query: 297 GTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSS 356
            T    +  H    +        SL    R+++  +V   +A +H      + H  ++  
Sbjct: 187 QTFGEVLLSHSSTHK--------SLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPV 235

Query: 357 NILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQ-----------F 405
           +I+LD +    ++ F         +         + G+  PE                  
Sbjct: 236 DIVLDQRGGVFLTGFEHLV-----RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLM 290

Query: 406 TDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEILDARVAKEAR 465
           T   D ++ G+V+  +     P        +   +     + +           + +  R
Sbjct: 291 TFSFDAWALGLVIYWIWCADLP--I----TKDAALGGSEWIFRS-------CKNIPQPVR 337

Query: 466 EEDIGAMAELAMRCLRLNSKKRPTMKQV 493
                    L    LR   + R    Q 
Sbjct: 338 --------ALLEGFLRYPKEDRLLPLQA 357

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  123 bits (309), Expect = 3e-31
 Identities = 64/324 (19%), Positives = 116/324 (35%), Gaps = 65/324 (20%)

Query: 215 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK-----RSKEIDKTQIHQFINEVVILSQ 268
              Y+    +GQG +G V   +     +I A+K     + ++I+   + +   EV ++ +
Sbjct: 25  QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84

Query: 269 INHRHIVKLLGCCLETEVPV-LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRV 327
           ++H +I +L     E E  + LV E    G L   ++        K   ++         
Sbjct: 85  LHHPNIARLYE-VYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCP 143

Query: 328 ----------------------------RVACEVAGAVAYMHSSASIPIFHRDIKSSNIL 359
                                        +  ++  A+ Y+H+     I HRDIK  N L
Sbjct: 144 ECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG---ICHRDIKPENFL 200

Query: 360 LDDKFSA--KVSDFGISRSIPNDKT---HLTTTIQGTFGYLDPEYFQSSQ--FTDKSDVY 412
                S   K+ DFG+S+          +  TT  GT  ++ PE   ++   +  K D +
Sbjct: 201 FSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAW 260

Query: 413 SFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLE-ILDARVAKEARE-EDIG 470
           S GV+L  LL G  P               F     +   +  +L+ ++  E      + 
Sbjct: 261 SAGVLLHLLLMGAVP---------------FPG-VNDADTISQVLNKKLCFENPNYNVLS 304

Query: 471 AMA-ELAMRCLRLNSKKRPTMKQV 493
            +A +L    L  N  +R    + 
Sbjct: 305 PLARDLLSNLLNRNVDERFDAMRA 328

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  124 bits (311), Expect = 5e-31
 Identities = 39/325 (12%), Positives = 79/325 (24%), Gaps = 71/325 (21%)

Query: 222 RFLGQGGFGTVYKGM-LPDGSIVAVK---RSKEIDKTQIHQFINEVVILSQI-------- 269
             LGQ       +      G    V     ++      I Q   EV+ L  +        
Sbjct: 84  TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143

Query: 270 -----------------NHRHIVKLLGC----CLETEVPVLVYEYISSGTLSHHIHDHQQ 308
                              + ++++        + +   +      +  T    +  H  
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203

Query: 309 QQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKV 368
             +        SL    R+++  +V   +A +H      + H  ++  +I+LD +    +
Sbjct: 204 THK--------SLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFL 252

Query: 369 SDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQ-----FTDKSDVYSFGVVLLELLT 423
           + F                                Q      T   D ++ G+ +  +  
Sbjct: 253 TGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC 312

Query: 424 GKKPICFARVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLN 483
              P               F S              + +  R         L    LR  
Sbjct: 313 ADLP--NTDDAALGGSEWIFRS-----------CKNIPQPVR--------ALLEGFLRYP 351

Query: 484 SKKRPTMKQVSMELEGLRRSQRCLE 508
            + R    Q  ME     + +  L 
Sbjct: 352 KEDRLLPLQA-METPEYEQLRTELS 375

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  123 bits (311), Expect = 5e-31
 Identities = 68/297 (22%), Positives = 112/297 (37%), Gaps = 51/297 (17%)

Query: 215 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK--------RSKEIDKTQIHQFINEVVI 265
            D Y  S+ LG G  G V           VA++             +         E+ I
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193

Query: 266 LSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWEN 325
           L ++NH  I+K+     + E   +V E +  G L   +  +++ +E   K          
Sbjct: 194 LKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCK---------- 242

Query: 326 RVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILL---DDKFSAKVSDFGISRSIPNDKT 382
                 ++  AV Y+H +    I HRD+K  N+LL   ++    K++DFG S+ +   +T
Sbjct: 243 --LYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GET 295

Query: 383 HLTTTIQGTFGYLDPEYFQSSQF---TDKSDVYSFGVVLLELLTGKKPICFARVEEERNL 439
            L  T+ GT  YL PE   S          D +S GV+L   L+G  P            
Sbjct: 296 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP------------ 343

Query: 440 VACFISLAKENQLLE-ILDARVAKEAREED-IGAMA-ELAMRCLRLNSKKRPTMKQV 493
              F     +  L + I   +          +   A +L  + L ++ K R T ++ 
Sbjct: 344 ---FSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEA 397

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  121 bits (305), Expect = 6e-31
 Identities = 75/302 (24%), Positives = 121/302 (40%), Gaps = 75/302 (24%)

Query: 216 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQFIN---------EVVI 265
             Y     LG+GGFGTV+ G  L D   VA+K    I + ++  +           EV +
Sbjct: 31  AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKV---IPRNRVLGWSPLSDSVTCPLEVAL 87

Query: 266 LSQIN----HRHIVKLLGCCLETEVP-VLVYEYISSGT-LSHHIHDHQQQQEQKQKQELS 319
           L ++     H  +++LL    ET+   +LV E       L  +I +     E        
Sbjct: 88  LWKVGAGGGHPGVIRLLDW-FETQEGFMLVLERPLPAQDLFDYITEKGPLGEG------- 139

Query: 320 SLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD-DKFSAKVSDFGISRSIP 378
                +R     +V  A+ + HS     + HRDIK  NIL+D  +  AK+ DFG    + 
Sbjct: 140 ----PSR-CFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLH 191

Query: 379 NDKTHLTTTIQGTFGYLDPEYFQSSQFT-DKSDVYSFGVVLLELLTGKKPICFARVEEER 437
           +     T    GT  Y  PE+    Q+    + V+S G++L +++ G  P  F   E ++
Sbjct: 192 D--EPYTDF-DGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIP--F---ERDQ 243

Query: 438 NLVACFISLAKENQLLEILDAR------VAKEAREEDIGAMAELAMRCLRLNSKKRPTMK 491
                           EIL+A       V+ +           L  RCL      RP+++
Sbjct: 244 ----------------EILEAELHFPAHVSPDCC--------ALIRRCLAPKPSSRPSLE 279

Query: 492 QV 493
           ++
Sbjct: 280 EI 281

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  120 bits (304), Expect = 1e-30
 Identities = 82/300 (27%), Positives = 135/300 (45%), Gaps = 56/300 (18%)

Query: 207 TADELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK---RSKEIDKTQIHQFINE 262
           +  + Q    NY   + +G+G F  V     +  G  VA+K   +++ ++ T + +   E
Sbjct: 6   SCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQ-LNPTSLQKLFRE 64

Query: 263 VVILSQINHRHIVKLLGCCLETEVPV-LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSL 321
           V I+  +NH +IVKL    +ETE  + L+ EY S G +  ++  H + +E+         
Sbjct: 65  VRIMKILNHPNIVKLFEV-IETEKTLYLIMEYASGGEVFDYLVAHGRMKEK--------- 114

Query: 322 SWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDK 381
             E R     ++  AV Y H      I HRD+K+ N+LLD   + K++DFG S +     
Sbjct: 115 --EAR-SKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFS-NEFTVG 167

Query: 382 THLTTTIQGTFGYLDPEYFQSSQFT-DKSDVYSFGVVLLELLTGKKPICFARVEEERNLV 440
             L     G   Y  PE FQ  ++   + DV+S GV+L  L++G  P  F    + +NL 
Sbjct: 168 GKLDAFC-GAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP--F----DGQNL- 219

Query: 441 ACFISLAKENQLLE-ILDAR------VAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQV 493
                     +L E +L  +      ++ +           L  R L LN  KR T++Q+
Sbjct: 220 ---------KELRERVLRGKYRIPFYMSTDCE--------NLLKRFLVLNPIKRGTLEQI 262

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  118 bits (298), Expect = 4e-30
 Identities = 72/288 (25%), Positives = 110/288 (38%), Gaps = 43/288 (14%)

Query: 215 TDNYNQSRFLGQGGFGTVYKG-MLPDGSIVAVK--RSKEIDKTQIHQFINEVVILSQINH 271
            + YN    LG+G FG V K          AVK               + EV +L +++H
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80

Query: 272 RHIVKLLGCCLETEVPV-LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVA 330
            +I+KL     E      +V E  + G L   I   ++  E                R+ 
Sbjct: 81  PNIMKLFEIL-EDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA------------RII 127

Query: 331 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK---FSAKVSDFGISRSIPNDKTHLTTT 387
            +V   + YMH      I HRD+K  NILL+ K      K+ DFG+S     +       
Sbjct: 128 KQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM--KD 182

Query: 388 IQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLA 447
             GT  Y+ PE  + + + +K DV+S GV+L  LL+G  P               F    
Sbjct: 183 RIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPP---------------FYGKN 226

Query: 448 KENQLLEILDARVAKEARE-EDIGAMA-ELAMRCLRLNSKKRPTMKQV 493
           + + L  +   + A +  +   I   A +L  + L  +   R T  Q 
Sbjct: 227 EYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQC 274

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  118 bits (297), Expect = 5e-30
 Identities = 73/287 (25%), Positives = 117/287 (40%), Gaps = 39/287 (13%)

Query: 215 TDNYNQSRFLGQGGFGTVYKG-MLPDGSIVAVKR-SKEIDKTQIHQFINEVVILSQINHR 272
            D +   R LG G FG V+       G    +K  +K+  +  + Q   E+ +L  ++H 
Sbjct: 21  DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80

Query: 273 HIVKLLGCCLETEVPV-LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVAC 331
           +I+K+     E    + +V E    G L   I   Q + +        +LS E  V    
Sbjct: 81  NIIKIFEVF-EDYHNMYIVMETCEGGELLERIVSAQARGK--------ALS-EGYVAELM 130

Query: 332 -EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA---KVSDFGISRSIPNDKTHLTTT 387
            ++  A+AY HS     + H+D+K  NIL  D       K+ DFG++    +D+    T 
Sbjct: 131 KQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS--TN 185

Query: 388 IQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLA 447
             GT  Y+ PE F+    T K D++S GVV+  LLTG  P               F   +
Sbjct: 186 AAGTALYMAPEVFKRD-VTFKCDIWSAGVVMYFLLTGCLP---------------FTGTS 229

Query: 448 KENQLLEILDARVAKEAREEDIGAMA-ELAMRCLRLNSKKRPTMKQV 493
            E    +              +   A +L  + L  + ++RP+  QV
Sbjct: 230 LEEVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQV 276

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  118 bits (299), Expect = 5e-30
 Identities = 67/290 (23%), Positives = 112/290 (38%), Gaps = 39/290 (13%)

Query: 215 TDNYN---QSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQFINEVVILSQI- 269
             +Y+   + + LG+G F    K +        AVK    I K        E+  L    
Sbjct: 7   YQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKI---ISKRMEANTQKEITALKLCE 63

Query: 270 NHRHIVKLLGCCLETEVPV-LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVR 328
            H +IVKL       ++   LV E ++ G L   I   +   E +               
Sbjct: 64  GHPNIVKLHEVF-HDQLHTFLVMELLNGGELFERIKKKKHFSETEAS------------Y 110

Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA---KVSDFGISRSIPNDKTHLT 385
           +  ++  AV++MH      + HRD+K  N+L  D+      K+ DFG +R  P D   L 
Sbjct: 111 IMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLK 167

Query: 386 TTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFIS 445
           T    T  Y  PE    + + +  D++S GV+L  +L+G+ P  F   +      +    
Sbjct: 168 TPC-FTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVP--FQSHDRSLTCTSAVEI 224

Query: 446 LAKENQLLEILDARVAKEARE-EDIGAMA-ELAMRCLRLNSKKRPTMKQV 493
           + K      I     + E    +++   A +L    L ++  KR  M  +
Sbjct: 225 MKK------IKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGL 268

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  118 bits (298), Expect = 5e-30
 Identities = 68/289 (23%), Positives = 109/289 (37%), Gaps = 47/289 (16%)

Query: 215 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQI---HQFINEVVILSQIN 270
              +     LG G F  V+       G + A+K    I K+         NE+ +L +I 
Sbjct: 8   RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKC---IKKSPAFRDSSLENEIAVLKKIK 64

Query: 271 HRHIVKLLGCCLETEVPV-LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRV 329
           H +IV L     E+     LV + +S G L   I +     E+                V
Sbjct: 65  HENIVTLEDIY-ESTTHYYLVMQLVSGGELFDRILERGVYTEKDASL------------V 111

Query: 330 ACEVAGAVAYMHSSASIPIFHRDIKSSNILL---DDKFSAKVSDFGISRSIPNDKTHLTT 386
             +V  AV Y+H +    I HRD+K  N+L    ++     ++DFG+S+   N      +
Sbjct: 112 IQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM---S 165

Query: 387 TIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISL 446
           T  GT GY+ PE      ++   D +S GV+   LL G  P               F   
Sbjct: 166 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPP---------------FYEE 210

Query: 447 AKENQLLEILDARVAKEARE-EDIGAMA-ELAMRCLRLNSKKRPTMKQV 493
            +     +I +     E+   +DI   A +     L  +  +R T ++ 
Sbjct: 211 TESKLFEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKA 259

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  119 bits (300), Expect = 8e-30
 Identities = 71/312 (22%), Positives = 120/312 (38%), Gaps = 50/312 (16%)

Query: 195 SSCGSSERAKVFTADELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK--RSKEI 251
           +      R   F  +   + +DNY+    LG+G F  V + +    G   A K   +K++
Sbjct: 8   TGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL 67

Query: 252 DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPV-LVYEYISSGTLSHHIHDHQQQQ 310
                 +   E  I  ++ H +IV+L     + E    LV++ ++ G L   I   +   
Sbjct: 68  SARDFQKLEREARICRKLQHPNIVRLHDSI-QEESFHYLVFDLVTGGELFEDIVAREFYS 126

Query: 311 EQKQKQELSSLSWENRVRVACE----VAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA 366
           E                  A      +  ++AY HS+    I HR++K  N+LL  K   
Sbjct: 127 E----------------ADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKG 167

Query: 367 ---KVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT 423
              K++DFG++  + + +        GT GYL PE  +   ++   D+++ GV+L  LL 
Sbjct: 168 AAVKLADFGLAIEVNDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLV 225

Query: 424 GKKPICFARVEEERNLVACFISLAKENQLLEILDARVAKEARE-EDIGAMA-ELAMRCLR 481
           G  P               F    +     +I        + E + +   A  L    L 
Sbjct: 226 GYPP---------------FWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLT 270

Query: 482 LNSKKRPTMKQV 493
           +N KKR T  Q 
Sbjct: 271 VNPKKRITADQA 282

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  118 bits (299), Expect = 9e-30
 Identities = 67/288 (23%), Positives = 117/288 (40%), Gaps = 45/288 (15%)

Query: 215 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQ-IHQFINEVVILSQINHR 272
           +D +     LG+G    VY+          A+K    + KT        E+ +L +++H 
Sbjct: 52  SDFFEVESELGRGATSIVYRCKQKGTQKPYALKV---LKKTVDKKIVRTEIGVLLRLSHP 108

Query: 273 HIVKLLGCCLETEVPV-LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVAC 331
           +I+KL     ET   + LV E ++ G L   I +     E+                   
Sbjct: 109 NIIKLKEIF-ETPTEISLVLELVTGGELFDRIVEKGYYSERDA------------ADAVK 155

Query: 332 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA---KVSDFGISRSIPNDKTHLTTTI 388
           ++  AVAY+H +    I HRD+K  N+L          K++DFG+S+ + +       T+
Sbjct: 156 QILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL--MKTV 210

Query: 389 QGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAK 448
            GT GY  PE  +   +  + D++S G++   LL G +P               F     
Sbjct: 211 CGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEP---------------FYDERG 255

Query: 449 ENQLLE-ILDARVAKEARE-EDIGAMA-ELAMRCLRLNSKKRPTMKQV 493
           +  +   IL+      +   +++   A +L  + + L+ KKR T  Q 
Sbjct: 256 DQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQA 303

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  116 bits (294), Expect = 1e-29
 Identities = 64/289 (22%), Positives = 106/289 (36%), Gaps = 47/289 (16%)

Query: 215 TDNYNQSRFLGQGGFGTVYKG-MLPDGSIVAVKRSKEIDKTQIHQ---FINEVVILSQIN 270
              Y     +G+G +G V            A K+   I K  +     F  E+ I+  ++
Sbjct: 8   NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKK---IPKYFVEDVDRFKQEIEIMKSLD 64

Query: 271 HRHIVKLLGCCLETEVPV-LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRV 329
           H +I++L     E    + LV E  + G L   +   +  +E                R+
Sbjct: 65  HPNIIRLYETF-EDNTDIYLVMELCTGGELFERVVHKRVFRESDAA------------RI 111

Query: 330 ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK---FSAKVSDFGISRSIPNDKTHLTT 386
             +V  AVAY H      + HRD+K  N L          K+ DFG++      K     
Sbjct: 112 MKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM--R 166

Query: 387 TIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISL 446
           T  GT  Y+ P+  +   +  + D +S GV++  LL G  P               F + 
Sbjct: 167 TKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPP---------------FSAP 210

Query: 447 AKENQLLEILDARVAKEARE-EDIGAMA-ELAMRCLRLNSKKRPTMKQV 493
                +L+I +       ++  ++   A  L  R L  + K+R T  Q 
Sbjct: 211 TDSEVMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQA 259

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  117 bits (295), Expect = 1e-29
 Identities = 54/218 (24%), Positives = 103/218 (47%), Gaps = 21/218 (9%)

Query: 215 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSK-EIDKTQIHQFINEVVILSQINHR 272
            + + +   +G+G FG V+KG+      +VA+K    E  + +I     E+ +LSQ +  
Sbjct: 21  EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80

Query: 273 HIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVAC- 331
           ++ K  G  L+     ++ EY+  G+    +      + Q              +     
Sbjct: 81  YVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQ--------------IATILR 126

Query: 332 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGT 391
           E+   + Y+HS   I   HRDIK++N+LL +    K++DFG++  + + +    T + GT
Sbjct: 127 EILKGLDYLHSEKKI---HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GT 182

Query: 392 FGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPIC 429
             ++ PE  + S +  K+D++S G+  +EL  G+ P  
Sbjct: 183 PFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHS 220

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  117 bits (294), Expect = 1e-29
 Identities = 61/217 (28%), Positives = 107/217 (49%), Gaps = 24/217 (11%)

Query: 215 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKR---SKEIDKTQIHQFINEVVILSQIN 270
              Y +   +GQG  GTVY  M +  G  VA+++    ++  K  I   INE++++ +  
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI---INEILVMRENK 75

Query: 271 HRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVA 330
           + +IV  L   L  +   +V EY++ G+L+  + +    + Q                V 
Sbjct: 76  NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIA-------------AVC 122

Query: 331 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQG 390
            E   A+ ++HS+  I   HRDIKS NILL    S K++DFG    I  +++  +T + G
Sbjct: 123 RECLQALEFLHSNQVI---HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-G 178

Query: 391 TFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
           T  ++ PE      +  K D++S G++ +E++ G+ P
Sbjct: 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  117 bits (294), Expect = 2e-29
 Identities = 60/222 (27%), Positives = 103/222 (46%), Gaps = 16/222 (7%)

Query: 216 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSK-EIDKTQIHQFINEVVILSQINHRH 273
           D+Y     +G G    V      P    VA+KR   E  +T + + + E+  +SQ +H +
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74

Query: 274 IVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVAC-E 332
           IV      +  +   LV + +S G++   I  H   + + +   L     E+ +     E
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLD-IIKHIVAKGEHKSGVLD----ESTIATILRE 129

Query: 333 VAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTF 392
           V   + Y+H +  I   HRD+K+ NILL +  S +++DFG+S  +          ++ TF
Sbjct: 130 VLEGLEYLHKNGQI---HRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTF 186

Query: 393 -G---YLDPEYF-QSSQFTDKSDVYSFGVVLLELLTGKKPIC 429
            G   ++ PE   Q   +  K+D++SFG+  +EL TG  P  
Sbjct: 187 VGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYH 228

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  118 bits (299), Expect = 3e-29
 Identities = 62/292 (21%), Positives = 108/292 (36%), Gaps = 49/292 (16%)

Query: 215 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK--RSKEIDKTQIHQFINEVVILSQINH 271
           T+ Y     LG+G F  V + + +  G   A     +K++      +   E  I   + H
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69

Query: 272 RHIVKLLGCCLETEVPV-LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVA 330
            +IV+L       E    L+++ ++ G L   I   +   E                  A
Sbjct: 70  PNIVRLHDSI-SEEGHHYLIFDLVTGGELFEDIVAREYYSE----------------ADA 112

Query: 331 CE----VAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA---KVSDFGISRSIPNDKTH 383
                 +  AV + H      + HR++K  N+LL  K      K++DFG++  +  ++  
Sbjct: 113 SHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQA 169

Query: 384 LTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACF 443
                 GT GYL PE  +   +    D+++ GV+L  LL G  P               F
Sbjct: 170 WFGFA-GTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPP---------------F 213

Query: 444 ISLAKENQLLEILDARVAKEARE-EDIGAMA-ELAMRCLRLNSKKRPTMKQV 493
               +     +I        + E + +   A +L  + L +N  KR T  + 
Sbjct: 214 WDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEA 265

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  117 bits (294), Expect = 4e-29
 Identities = 65/295 (22%), Positives = 111/295 (37%), Gaps = 49/295 (16%)

Query: 215 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQ--------IHQFINEVVI 265
            D Y     +G+G F  V + +    G   AVK    +D  +              E  I
Sbjct: 23  EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKI---VDVAKFTSSPGLSTEDLKREASI 79

Query: 266 LSQINHRHIVKLLGCCLETEVPV-LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWE 324
              + H HIV+LL     ++  + +V+E++    L   I         K+       S  
Sbjct: 80  CHMLKHPHIVELLETY-SSDGMLYMVFEFMDGADLCFEI--------VKRADAGFVYSEA 130

Query: 325 NRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA---KVSDFGISRSIPNDK 381
                  ++  A+ Y H +    I HRD+K   +LL  K ++   K+  FG++  +    
Sbjct: 131 VASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG 187

Query: 382 THLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVA 441
                 + GT  ++ PE  +   +    DV+  GV+L  LL+G  P  F           
Sbjct: 188 LVAGGRV-GTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP--F----------- 233

Query: 442 CFISLAKENQLLE-ILDARVAKEARE-EDIGAMA-ELAMRCLRLNSKKRPTMKQV 493
                  + +L E I+  +     R+   I   A +L  R L L+  +R T+ + 
Sbjct: 234 ----YGTKERLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEA 284

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  114 bits (289), Expect = 6e-29
 Identities = 68/288 (23%), Positives = 115/288 (39%), Gaps = 42/288 (14%)

Query: 215 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK--RSKEIDKTQIHQFINEVVILSQINH 271
           +DNY+    LG+G F  V + +    G   A K   +K++      +   E  I  ++ H
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64

Query: 272 RHIVKLLGCCLETEVPV-LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVA 330
            +IV+L     + E    LV++ ++ G L   I   +   E                   
Sbjct: 65  PNIVRLHDSI-QEESFHYLVFDLVTGGELFEDIVAREFYSEADAS------------HCI 111

Query: 331 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA---KVSDFGISRSIPNDKTHLTTT 387
            ++  ++AY HS+    I HR++K  N+LL  K      K++DFG++  + + +      
Sbjct: 112 QQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA--WHG 166

Query: 388 IQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLA 447
             GT GYL PE  +   ++   D+++ GV+L  LL G  P               F    
Sbjct: 167 FAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP---------------FWDED 211

Query: 448 KENQLLEILDARVAKEARE-EDIGAMA-ELAMRCLRLNSKKRPTMKQV 493
           +     +I        + E + +   A  L    L +N KKR T  Q 
Sbjct: 212 QHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQA 259

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  115 bits (290), Expect = 8e-29
 Identities = 69/297 (23%), Positives = 113/297 (38%), Gaps = 51/297 (17%)

Query: 215 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK--------RSKEIDKTQIHQFINEVVI 265
            D Y  S+ LG G  G V           VA+K             +         E+ I
Sbjct: 9   RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68

Query: 266 LSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWEN 325
           L ++NH  I+K+     + E   +V E +  G L   +  +++ +E   K          
Sbjct: 69  LKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCK---------- 117

Query: 326 RVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK---FSAKVSDFGISRSIPNDKT 382
                 ++  AV Y+H +    I HRD+K  N+LL  +      K++DFG S+ +   +T
Sbjct: 118 --LYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GET 170

Query: 383 HLTTTIQGTFGYLDPEYFQSSQ---FTDKSDVYSFGVVLLELLTGKKPICFARVEEERNL 439
            L  T+ GT  YL PE   S     +    D +S GV+L   L+G  P            
Sbjct: 171 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP------------ 218

Query: 440 VACFISLAKENQLLE-ILDARVAKEARE-EDIGAMA-ELAMRCLRLNSKKRPTMKQV 493
              F     +  L + I   +         ++   A +L  + L ++ K R T ++ 
Sbjct: 219 ---FSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEA 272

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  115 bits (290), Expect = 9e-29
 Identities = 57/216 (26%), Positives = 104/216 (48%), Gaps = 22/216 (10%)

Query: 215 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEID-KTQIHQFINEVVILSQINHR 272
            + ++    LG+G +G+VYK +    G IVA+K   ++  ++ + + I E+ I+ Q +  
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIK---QVPVESDLQEIIKEISIMQQCDSP 84

Query: 273 HIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVAC- 331
           H+VK  G   +     +V EY  +G++S  I    +   + +            +     
Sbjct: 85  HVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDE------------IATILQ 132

Query: 332 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGT 391
                + Y+H    I   HRDIK+ NILL+ +  AK++DFG++  + +      T I GT
Sbjct: 133 STLKGLEYLHFMRKI---HRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GT 188

Query: 392 FGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
             ++ PE  Q   +   +D++S G+  +E+  GK P
Sbjct: 189 PFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPP 224

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  114 bits (287), Expect = 1e-28
 Identities = 53/219 (24%), Positives = 95/219 (43%), Gaps = 36/219 (16%)

Query: 224 LGQGGFGTVYKGM-LPDGSIVAVKR-SKEIDKTQIHQFINEV-VILSQINHRHIVKLLGC 280
           LG+G +G V K   +P G I+AVKR    ++  +  + + ++ + +  ++    V   G 
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74

Query: 281 CL-ETEVPVLVYEY--ISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAV 337
              E +V  +  E    S       + D  Q   +        L      ++A  +  A+
Sbjct: 75  LFREGDV-WICMELMDTSLDKFYKQVIDKGQTIPEDI------LG-----KIAVSIVKAL 122

Query: 338 AYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQ-----GTF 392
            ++HS  S+   HRD+K SN+L++     K+ DFGIS        +L   +      G  
Sbjct: 123 EHLHSKLSV--IHRDVKPSNVLINALGQVKMCDFGISG-------YLVDDVAKDIDAGCK 173

Query: 393 GYLDPE----YFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
            Y+ PE          ++ KSD++S G+ ++EL   + P
Sbjct: 174 PYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFP 212

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  116 bits (291), Expect = 2e-28
 Identities = 46/227 (20%), Positives = 78/227 (34%), Gaps = 28/227 (12%)

Query: 215 TDNYNQSRFLGQG--GFGTVYKGM-LPDGSIVAVKRSK--EIDKTQIHQFINEVVILSQI 269
              Y     +G+G     TV      P G  V V+R          +     E+ +    
Sbjct: 24  GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83

Query: 270 NHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRV 329
           NH +IV      +      +V  +++ G+    I  H              ++ E  +  
Sbjct: 84  NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMD----------GMN-ELAIAY 132

Query: 330 AC-EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTI 388
               V  A+ Y+H    +   HR +K+S+IL+       +S    + S+ +         
Sbjct: 133 ILQGVLKALDYIHHMGYV---HRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVH 189

Query: 389 Q------GTFGYLDPEYFQSSQ--FTDKSDVYSFGVVLLELLTGKKP 427
                      +L PE  Q +   +  KSD+YS G+   EL  G  P
Sbjct: 190 DFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score =  115 bits (289), Expect = 2e-28
 Identities = 81/345 (23%), Positives = 129/345 (37%), Gaps = 85/345 (24%)

Query: 222 RFLGQGGFGTVYKGML------PDGSIVAVKRSKEI-DKTQIHQFINEVVILSQI-NHRH 273
           + LG+G FG V +              VAVK  KE    ++    ++E+ IL  I +H +
Sbjct: 28  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87

Query: 274 IVKLLGCCLETEVPVLV-YEYISSGTLSHHIHDHQQQ--------------------QEQ 312
           +V LLG C +   P++V  E+   G LS ++   + +                       
Sbjct: 88  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPV 147

Query: 313 KQKQELSSLSWENRVRVACEV------------------------------AGAVAY-MH 341
             K+ L S++       +  V                              +  VA  M 
Sbjct: 148 DLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGME 207

Query: 342 SSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLD----- 396
             AS    HRD+ + NILL +K   K+ DFG++R I  D  +    ++     L      
Sbjct: 208 FLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY----VRKGDARLPLKWMA 263

Query: 397 PEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQLLEI 455
           PE      +T +SDV+SFGV+L E+ + G  P    +++EE      F    KE   +  
Sbjct: 264 PETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE------FCRRLKEGTRMRA 317

Query: 456 LDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGL 500
            D         E    M +  + C      +RPT  ++   L  L
Sbjct: 318 PD-----YTTPE----MYQTMLDCWHGEPSQRPTFSELVEHLGNL 353

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  114 bits (287), Expect = 2e-28
 Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 24/208 (11%)

Query: 224 LGQGGFGTVYKGM-LPDGSIVAVKR---SKEIDKTQIHQFINEVVILSQINHRHIVKLLG 279
           +G+G  G V        G  VAVK     K+  +  +    NEVVI+    H ++V++  
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELL---FNEVVIMRDYQHFNVVEMYK 109

Query: 280 CCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAY 339
             L  E   ++ E++  G L+  +   +  +EQ                V   V  A+AY
Sbjct: 110 SYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIA-------------TVCEAVLQALAY 156

Query: 340 MHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEY 399
           +H+   I   HRDIKS +ILL      K+SDFG    I  D     + + GT  ++ PE 
Sbjct: 157 LHAQGVI---HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEV 212

Query: 400 FQSSQFTDKSDVYSFGVVLLELLTGKKP 427
              S +  + D++S G++++E++ G+ P
Sbjct: 213 ISRSLYATEVDIWSLGIMVIEMVDGEPP 240

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  114 bits (287), Expect = 2e-28
 Identities = 61/239 (25%), Positives = 107/239 (44%), Gaps = 21/239 (8%)

Query: 199 SSERAKVFTADELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKR-SKEIDKTQI 256
           SS + K+          ++      +G+G +G+V K +  P G I+AVKR    +D+ + 
Sbjct: 5   SSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQ 64

Query: 257 HQFINEV-VILSQINHRHIVKLLGCCL-ETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQ 314
            Q + ++ V++   +  +IV+  G    E +   +  E +S+     + + +    +   
Sbjct: 65  KQLLMDLDVVMRSSDCPYIVQFYGALFREGDC-WICMELMSTSFDKFYKYVYSVLDDVIP 123

Query: 315 KQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGIS 374
           ++ L         ++      A+ ++  +  I   HRDIK SNILLD   + K+ DFGIS
Sbjct: 124 EEILG--------KITLATVKALNHLKENLKI--IHRDIKPSNILLDRSGNIKLCDFGIS 173

Query: 375 RSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTD----KSDVYSFGVVLLELLTGKKPIC 429
             + +     T    G   Y+ PE    S        +SDV+S G+ L EL TG+ P  
Sbjct: 174 GQLVDSIAK-TRDA-GCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYP 230

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  113 bits (284), Expect = 3e-28
 Identities = 67/289 (23%), Positives = 115/289 (39%), Gaps = 47/289 (16%)

Query: 216 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQFIN----EVVILSQIN 270
           ++++  + LG+G +G V   +       VAVK    +D  +          E+ I   +N
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVK---IVDMKRAVDCPENIKKEICINKMLN 63

Query: 271 HRHIVKLLGCCLETEVPV-LVYEYISSGTLSHHIHDHQQQQE---QKQKQELSSLSWENR 326
           H ++VK  G          L  EY S G L   I       E   Q+   +L +      
Sbjct: 64  HENVVKFYGH-RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA------ 116

Query: 327 VRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISR-SIPNDKTHLT 385
                     V Y+H      I HRDIK  N+LLD++ + K+SDFG++     N++  L 
Sbjct: 117 ---------GVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 164

Query: 386 TTIQGTFGYLDPEYFQSSQFT-DKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFI 444
             + GT  Y+ PE  +  +F  +  DV+S G+VL  +L G+ P  +   ++  +    + 
Sbjct: 165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP--W---DQPSDSCQEYS 219

Query: 445 SLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQV 493
              +  +       ++              L  + L  N   R T+  +
Sbjct: 220 DWKE-KKTYLNPWKKIDSAPL--------ALLHKILVENPSARITIPDI 259

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  113 bits (284), Expect = 4e-28
 Identities = 72/303 (23%), Positives = 119/303 (39%), Gaps = 61/303 (20%)

Query: 215 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQI------------HQFIN 261
            +NY     LG+G    V + +  P     AVK    ID T                 + 
Sbjct: 16  YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKI---IDVTGGGSFSAEEVQELREATLK 72

Query: 262 EVVILSQIN-HRHIVKLLGCCLETEVPV-LVYEYISSGTLSHHIHDHQQQQEQKQKQELS 319
           EV IL +++ H +I++L     ET     LV++ +  G L  ++ +     E++ +    
Sbjct: 73  EVDILRKVSGHPNIIQLKDTY-ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETR---- 127

Query: 320 SLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPN 379
                   ++   +   +  +H      I HRD+K  NILLDD  + K++DFG S  +  
Sbjct: 128 --------KIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQL-- 174

Query: 380 DKTHLTTTIQGTFGYLDPEYFQSSQFTDKS------DVYSFGVVLLELLTGKKPICFARV 433
           D       + GT  YL PE  + S   +        D++S GV++  LL G  P  F   
Sbjct: 175 DPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP--FWH- 231

Query: 434 EEERNLVACFISLAKENQLLE-ILDARVAKEARE-EDIGAMA-ELAMRCLRLNSKKRPTM 490
                         K+  +L  I+       + E +D      +L  R L +  +KR T 
Sbjct: 232 -------------RKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTA 278

Query: 491 KQV 493
           ++ 
Sbjct: 279 EEA 281

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  112 bits (282), Expect = 4e-28
 Identities = 69/217 (31%), Positives = 100/217 (46%), Gaps = 24/217 (11%)

Query: 217 NYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK---RSKEIDKTQIHQFINEVVILSQINHR 272
           +Y     LG G FG V  G     G  VAVK   R K      + +   E+  L    H 
Sbjct: 12  HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 71

Query: 273 HIVKLLGCCLETEVPV-LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVAC 331
           HI+KL    + T     +V EY+S G L  +I  H + +E            E R R+  
Sbjct: 72  HIIKLYQV-ISTPTDFFMVMEYVSGGELFDYICKHGRVEEM-----------EAR-RLFQ 118

Query: 332 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGT 391
           ++  AV Y H      + HRD+K  N+LLD   +AK++DFG+S ++ +D   L T+  G+
Sbjct: 119 QILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLS-NMMSDGEFLRTSC-GS 173

Query: 392 FGYLDPEYFQSSQFT-DKSDVYSFGVVLLELLTGKKP 427
             Y  PE      +   + D++S GV+L  LL G  P
Sbjct: 174 PNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLP 210

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  114 bits (288), Expect = 4e-28
 Identities = 59/284 (20%), Positives = 106/284 (37%), Gaps = 36/284 (12%)

Query: 215 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRH 273
            D Y+    LG G FG V++ +    G +   K          +   NE+ I++Q++H  
Sbjct: 50  YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 109

Query: 274 IVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEV 333
           ++ L     +    VL+ E++S G L   I     +  + +            +R ACE 
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINY--------MRQACE- 160

Query: 334 AGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA--KVSDFGISRSIPNDKTHLTTTIQGT 391
              + +MH  +   I H DIK  NI+ + K ++  K+ DFG++  +  D+         T
Sbjct: 161 --GLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV--KVTTAT 213

Query: 392 FGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQ 451
             +  PE          +D+++ GV+   LL+G  P               F        
Sbjct: 214 AEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP---------------FAGEDDLET 258

Query: 452 LLEILDARVAKEARE-EDIGAMA-ELAMRCLRLNSKKRPTMKQV 493
           L  +       +      +   A +     L+   +KR T+   
Sbjct: 259 LQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDA 302

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  112 bits (283), Expect = 9e-28
 Identities = 62/289 (21%), Positives = 113/289 (39%), Gaps = 41/289 (14%)

Query: 212 QRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK--RSKEIDKTQIHQFINEVVILSQ 268
           +   + Y  +  LG+G FG V++ +          K  + K  D+  +     E+ IL+ 
Sbjct: 1   KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVK---KEISILNI 57

Query: 269 INHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVR 328
             HR+I+ L       E  V+++E+IS   +   I+                L+    V 
Sbjct: 58  ARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSA-----------FELNEREIVS 106

Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA--KVSDFGISRSIPNDKTHLTT 386
              +V  A+ ++HS     I H DI+  NI+   + S+  K+ +FG +R +         
Sbjct: 107 YVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF--R 161

Query: 387 TIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISL 446
            +     Y  PE  Q    +  +D++S G ++  LL+G  P  F   E  + +       
Sbjct: 162 LLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP--FLA-ETNQQI------- 211

Query: 447 AKENQLLEILDARVAKEARE-EDIGAMA-ELAMRCLRLNSKKRPTMKQV 493
                +  I++A    +    ++I   A +   R L    K R T  + 
Sbjct: 212 -----IENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEA 255

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  115 bits (290), Expect = 1e-27
 Identities = 65/225 (28%), Positives = 105/225 (46%), Gaps = 24/225 (10%)

Query: 210 ELQRAT-DNYNQSRFLGQGGFGTVYKGMLPD-GSIVAVKR-SKE--IDKTQIHQFINEVV 264
           E Q  T + + Q R LG+GGFG V    +   G + A K+  K+    +      +NE  
Sbjct: 177 ERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQ 236

Query: 265 ILSQINHRHIVKLLGCCLETEVPV-LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSW 323
           IL ++N R +V L     ET+  + LV   ++ G L  HI+          +        
Sbjct: 237 ILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIY-------HMGQAGFP---- 284

Query: 324 ENRVRV-ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKT 382
           E R    A E+   +  +H      I +RD+K  NILLDD    ++SD G++  +P  +T
Sbjct: 285 EARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 341

Query: 383 HLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
                  GT GY+ PE  ++ ++T   D ++ G +L E++ G+ P
Sbjct: 342 --IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  115 bits (290), Expect = 1e-27
 Identities = 59/284 (20%), Positives = 105/284 (36%), Gaps = 36/284 (12%)

Query: 215 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRH 273
            D+Y+    LG G FG V++      G+  A K      ++       E+  +S + H  
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 215

Query: 274 IVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEV 333
           +V L     +    V++YE++S G L   + D           E + +S +  V    +V
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVAD-----------EHNKMSEDEAVEYMRQV 264

Query: 334 AGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA--KVSDFGISRSIPNDKTHLTTTIQGT 391
              + +MH +      H D+K  NI+   K S   K+ DFG++  +   ++       GT
Sbjct: 265 CKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS--VKVTTGT 319

Query: 392 FGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQ 451
             +  PE  +       +D++S GV+   LL+G  P               F     +  
Sbjct: 320 AEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP---------------FGGENDDET 364

Query: 452 LLEILDARVAKEARE-EDIGAMA-ELAMRCLRLNSKKRPTMKQV 493
           L  +       +      I     +   + L  +   R T+ Q 
Sbjct: 365 LRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQA 408

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  112 bits (282), Expect = 1e-27
 Identities = 64/289 (22%), Positives = 112/289 (38%), Gaps = 44/289 (15%)

Query: 215 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQFINEVVILSQ-INHR 272
           TD Y     +G G +    + +        AVK    IDK++      E+ IL +   H 
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKI---IDKSKRDPT-EEIEILLRYGQHP 76

Query: 273 HIVKLLGCCLETEVPV-LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVAC 331
           +I+ L     +    V +V E +  G L   I   +   E++               V  
Sbjct: 77  NIITLKDVY-DDGKYVYVVTELMKGGELLDKILRQKFFSEREAS------------AVLF 123

Query: 332 EVAGAVAYMHSSASIPIFHRDIKSSNILL----DDKFSAKVSDFGISRSIPNDKTHLTTT 387
            +   V Y+H+     + HRD+K SNIL      +  S ++ DFG ++ +  +   L T 
Sbjct: 124 TITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTP 180

Query: 388 IQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLA 447
              T  ++ PE  +   +    D++S GV+L  +LTG  P  FA   ++           
Sbjct: 181 C-YTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTP--FANGPDD----------- 226

Query: 448 KENQLLE-ILDARVAKEARE-EDIGAMA-ELAMRCLRLNSKKRPTMKQV 493
              ++L  I   + +        +   A +L  + L ++  +R T   V
Sbjct: 227 TPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALV 275

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  111 bits (280), Expect = 2e-27
 Identities = 50/228 (21%), Positives = 91/228 (39%), Gaps = 38/228 (16%)

Query: 217 NYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQFIN-------EVVILSQ 268
            Y     LG+G +G V + +        AVK    + K ++ +  N       E+ +L +
Sbjct: 6   KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKI---LKKKKLRRIPNGEANVKKEIQLLRR 62

Query: 269 INHRHIVKLLG-CCLETEVPV-LVYEYISSGT--LSHHIHDHQQQQEQKQK--QELSSLS 322
           + H+++++L+     E +  + +V EY   G   +   + + +    Q      +L    
Sbjct: 63  LRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLID-- 120

Query: 323 WENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKT 382
                         + Y+HS     I H+DIK  N+LL    + K+S  G++ ++     
Sbjct: 121 -------------GLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAA 164

Query: 383 -HLTTTIQGTFGYLDPEYFQSSQFTD--KSDVYSFGVVLLELLTGKKP 427
                T QG+  +  PE           K D++S GV L  + TG  P
Sbjct: 165 DDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  111 bits (280), Expect = 2e-27
 Identities = 67/289 (23%), Positives = 115/289 (39%), Gaps = 47/289 (16%)

Query: 216 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQFIN----EVVILSQIN 270
           ++++  + LG+G +G V   +       VAVK    +D  +          E+ I   +N
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVK---IVDMKRAVDCPENIKKEICINKMLN 63

Query: 271 HRHIVKLLGCCLETEVPV-LVYEYISSGTLSHHIHDHQQQQE---QKQKQELSSLSWENR 326
           H ++VK  G          L  EY S G L   I       E   Q+   +L +      
Sbjct: 64  HENVVKFYGH-RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA------ 116

Query: 327 VRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISR-SIPNDKTHLT 385
                     V Y+H      I HRDIK  N+LLD++ + K+SDFG++     N++  L 
Sbjct: 117 ---------GVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 164

Query: 386 TTIQGTFGYLDPEYFQSSQFT-DKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFI 444
             + GT  Y+ PE  +  +F  +  DV+S G+VL  +L G+ P  +   ++  +    + 
Sbjct: 165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP--W---DQPSDSCQEYS 219

Query: 445 SLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQV 493
              +  +       ++              L  + L  N   R T+  +
Sbjct: 220 DWKE-KKTYLNPWKKIDSAPL--------ALLHKILVENPSARITIPDI 259

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  111 bits (279), Expect = 2e-27
 Identities = 64/283 (22%), Positives = 113/283 (39%), Gaps = 49/283 (17%)

Query: 224 LGQGGFGTVYKGM-LPDGSIVAVKR-SKEIDKTQIHQFINEV-VILSQINHRHIVKLLGC 280
           +G G  G V+K      G ++AVK+  +  +K +  + + ++ V+L   +  +IV+  G 
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92

Query: 281 CL-ETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAY 339
            +  T+V  +  E + +              E+     L         ++   +  A+ Y
Sbjct: 93  FITNTDV-FIAMELMGTCAEKLKKRMQGPIPER----ILG--------KMTVAIVKALYY 139

Query: 340 MHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEY 399
           +     +   HRD+K SNILLD++   K+ DFGIS  + +DK     +  G   Y+ PE 
Sbjct: 140 LKEKHGV--IHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK-DRSA-GCAAYMAPER 195

Query: 400 FQSSQFTD-----KSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLE 454
                 T      ++DV+S G+ L+EL TG+ P                          E
Sbjct: 196 IDPPDPTKPDYDIRADVWSLGISLVELATGQFP------------------YKNCKTDFE 237

Query: 455 ILDARVAKEAR--EEDIG---AMAELAMRCLRLNSKKRPTMKQ 492
           +L   + +E       +G           CL  + +KRP   +
Sbjct: 238 VLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNK 280

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  110 bits (278), Expect = 3e-27
 Identities = 53/220 (24%), Positives = 103/220 (46%), Gaps = 23/220 (10%)

Query: 215 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRH 273
            + +     LG G FG VYK      G++ A K  +   + ++  +I E+ IL+  +H +
Sbjct: 18  NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77

Query: 274 IVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVAC-E 332
           IVKLLG         ++ E+   G +   + +  +               E +++V C +
Sbjct: 78  IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLT------------EPQIQVVCRQ 125

Query: 333 VAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTF 392
           +  A+ ++HS   I   HRD+K+ N+L+  +   +++DFG+S           + I GT 
Sbjct: 126 MLEALNFLHSKRII---HRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-GTP 181

Query: 393 GYLDPE-----YFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
            ++ PE       + + +  K+D++S G+ L+E+   + P
Sbjct: 182 YWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  112 bits (281), Expect = 3e-27
 Identities = 70/299 (23%), Positives = 124/299 (41%), Gaps = 54/299 (18%)

Query: 215 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK--------RSKEIDKTQIHQFINEVVI 265
              Y+    +G+G    V + +    G   AVK         S E  +        E  I
Sbjct: 93  YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHI 152

Query: 266 LSQI-NHRHIVKLLGCCLETEVPV-LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSW 323
           L Q+  H HI+ L+    E+   + LV++ +  G L  ++ +     E++ +        
Sbjct: 153 LRQVAGHPHIITLIDSY-ESSSFMFLVFDLMRKGELFDYLTEKVALSEKETR-------- 203

Query: 324 ENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTH 383
                +   +  AV+++H++    I HRD+K  NILLDD    ++SDFG S  +  +   
Sbjct: 204 ----SIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHL--EPGE 254

Query: 384 LTTTIQGTFGYLDPEYFQSSQFTD------KSDVYSFGVVLLELLTGKKPICFARVEEER 437
               + GT GYL PE  + S          + D+++ GV+L  LL G  P  F       
Sbjct: 255 KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP--FWH----- 307

Query: 438 NLVACFISLAKENQLLE-ILDARVAKEARE-EDIGAMA-ELAMRCLRLNSKKRPTMKQV 493
                     ++  +L  I++ +    + E +D  +   +L  R L+++ + R T +Q 
Sbjct: 308 ---------RRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQA 357

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  110 bits (277), Expect = 4e-27
 Identities = 78/304 (25%), Positives = 124/304 (40%), Gaps = 46/304 (15%)

Query: 215 TDNYN-QSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIH---QFINEVVILSQI 269
            D Y  Q   LG+G    V   + L      AVK    I+K   H   +   EV +L Q 
Sbjct: 11  EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKI---IEKQPGHIRSRVFREVEMLYQC 67

Query: 270 -NHRHIVKLLGCCLETEVPV-LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRV 327
             HR++++L+    E E    LV+E +  G++  HIH  +   E +              
Sbjct: 68  QGHRNVLELIEFF-EEEDRFYLVFEKMRGGSILSHIHKRRHFNELEA------------S 114

Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK---FSAKVSDFGISRSIPNDK--- 381
            V  +VA A+ ++H+     I HRD+K  NIL +        K+ DF +   I  +    
Sbjct: 115 VVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCS 171

Query: 382 ---THLTTTIQGTFGYLDPEYFQSSQFTDKS-----DVYSFGVVLLELLTGKKPICF-AR 432
              T    T  G+  Y+ PE  ++            D++S GV+L  LL+G  P  F  R
Sbjct: 172 PISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP--FVGR 229

Query: 433 VEEERNLVACFISLAKENQLLE-ILDARVAKEARE-EDIGAMA-ELAMRCLRLNSKKRPT 489
              +          A +N L E I + +     ++   I   A +L  + L  ++K+R +
Sbjct: 230 CGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLS 289

Query: 490 MKQV 493
             QV
Sbjct: 290 AAQV 293

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  111 bits (280), Expect = 6e-27
 Identities = 61/214 (28%), Positives = 101/214 (47%), Gaps = 26/214 (12%)

Query: 222 RFLGQGGFGTVYKGMLPD-GSIVAVK---RSKEIDKTQIHQFINEVVILSQINHRHIVKL 277
           R +G+G FG V      D   + A+K   + K +++ ++     E+ I+  + H  +V L
Sbjct: 21  RAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNL 80

Query: 278 LGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRV-ACEVAGA 336
                + E   +V + +  G L +H+     QQ    K        E  V++  CE+  A
Sbjct: 81  WYSFQDEEDMFMVVDLLLGGDLRYHL-----QQNVHFK--------EETVKLFICELVMA 127

Query: 337 VAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLD 396
           + Y+ +     I HRD+K  NILLD+     ++DF I+  +P +     TT+ GT  Y+ 
Sbjct: 128 LDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ--ITTMAGTKPYMA 182

Query: 397 PEYFQSSQFT--DKS-DVYSFGVVLLELLTGKKP 427
           PE F S +      + D +S GV   ELL G++P
Sbjct: 183 PEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  113 bits (284), Expect = 7e-27
 Identities = 58/225 (25%), Positives = 105/225 (46%), Gaps = 21/225 (9%)

Query: 210 ELQRAT-DNYNQSRFLGQGGFGTVYKGMLPD-GSIVAVKR-SKE--IDKTQIHQFINEVV 264
           E Q    D +   R LG+GGFG V+   +   G + A K+ +K+    +      + E  
Sbjct: 178 EAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKK 237

Query: 265 ILSQINHRHIVKLLGCCLETEVPV-LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSW 323
           IL++++ R IV L     ET+  + LV   ++ G + +HI++  +     Q         
Sbjct: 238 ILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQ--------- 287

Query: 324 ENRVRV-ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKT 382
           E R      ++   + ++H      I +RD+K  N+LLDD  + ++SD G++  +   +T
Sbjct: 288 EPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT 344

Query: 383 HLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
             T    GT G++ PE     ++    D ++ GV L E++  + P
Sbjct: 345 -KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  108 bits (272), Expect = 1e-26
 Identities = 71/293 (24%), Positives = 108/293 (36%), Gaps = 47/293 (16%)

Query: 215 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK------RSKEIDKTQIHQFINEVVILS 267
            D+Y     LG G F  V K      G   A K       S         +   EV IL 
Sbjct: 4   EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63

Query: 268 QINHRHIVKLLGCCLETEVPV-LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENR 326
           +I H +I+ L     E +  V L+ E +S G L   + + +   E +             
Sbjct: 64  EIRHPNIITLHDIF-ENKTDVVLILELVSGGELFDFLAEKESLTEDEA------------ 110

Query: 327 VRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA----KVSDFGISRSIPNDKT 382
            +   ++   V Y+HS     I H D+K  NI+L DK       K+ DFGI+  I     
Sbjct: 111 TQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE 167

Query: 383 HLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVAC 442
                I GT  ++ PE         ++D++S GV+   LL+G  P               
Sbjct: 168 F--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP--------------- 210

Query: 443 FISLAKENQLLEILDARVAKEARE-EDIGAMA-ELAMRCLRLNSKKRPTMKQV 493
           F+   K+  L  I       +     +   +A +   R L  + K+R T+ Q 
Sbjct: 211 FLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQS 263

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  109 bits (275), Expect = 1e-26
 Identities = 70/298 (23%), Positives = 114/298 (38%), Gaps = 71/298 (23%)

Query: 217 NYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQFIN-----------EVV 264
            Y+    LG G FG V+  +       V VK    I K ++ +              E+ 
Sbjct: 25  KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKF---IKKEKVLEDCWIEDPKLGKVTLEIA 81

Query: 265 ILSQINHRHIVKLLGCCLETEVPV-LVYEYISSGT-LSHHIHDHQQQQEQKQKQELSSLS 322
           ILS++ H +I+K+L    E +    LV E   SG  L   I  H +  E           
Sbjct: 82  ILSRVEHANIIKVLDI-FENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEP---------- 130

Query: 323 WENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKT 382
                 +  ++  AV Y+       I HRDIK  NI++ + F+ K+ DFG +  +   K 
Sbjct: 131 -LAS-YIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK- 184

Query: 383 HLTTTIQGTFGYLDPEYFQSSQFT-DKSDVYSFGVVLLELLTGKKPICFARVEEERNLVA 441
              T   GT  Y  PE    + +   + +++S GV L  L+  + P C            
Sbjct: 185 LFYTFC-GTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFC------------ 231

Query: 442 CFISLAKENQLLEILDAR------VAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQV 493
                    +L E ++A       V+KE           L    L+   ++R T++++
Sbjct: 232 ---------ELEETVEAAIHPPYLVSKELM--------SLVSGLLQPVPERRTTLEKL 272

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  109 bits (274), Expect = 1e-26
 Identities = 68/293 (23%), Positives = 107/293 (36%), Gaps = 47/293 (16%)

Query: 215 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK------RSKEIDKTQIHQFINEVVILS 267
            D Y+    LG G F  V K      G   A K                 +   EV IL 
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70

Query: 268 QINHRHIVKLLGCCLETEVPV-LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENR 326
           Q+ H +++ L     E    V L+ E +S G L   +   +            SLS E  
Sbjct: 71  QVLHHNVITLHDVY-ENRTDVVLILELVSGGELFDFLAQKE------------SLSEEEA 117

Query: 327 VRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA----KVSDFGISRSIPNDKT 382
                ++   V Y+H+     I H D+K  NI+L DK       K+ DFG++  I +   
Sbjct: 118 TSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE 174

Query: 383 HLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVAC 442
                I GT  ++ PE         ++D++S GV+   LL+G  P               
Sbjct: 175 --FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP--------------- 217

Query: 443 FISLAKENQLLEILDARVAKEARE-EDIGAMA-ELAMRCLRLNSKKRPTMKQV 493
           F+   K+  L  I       +         +A +   + L   ++KR T+++ 
Sbjct: 218 FLGDTKQETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEA 270

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  109 bits (274), Expect = 1e-26
 Identities = 67/293 (22%), Positives = 107/293 (36%), Gaps = 47/293 (16%)

Query: 215 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK------RSKEIDKTQIHQFINEVVILS 267
            D Y+    LG G F  V K      G   A K                     EV IL 
Sbjct: 10  DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69

Query: 268 QINHRHIVKLLGCCLETEVPV-LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENR 326
           +I H +++ L     E +  V L+ E ++ G L   + + +   E++             
Sbjct: 70  EIQHPNVITLHEVY-ENKTDVILILELVAGGELFDFLAEKESLTEEEA------------ 116

Query: 327 VRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA----KVSDFGISRSIPNDKT 382
                ++   V Y+HS     I H D+K  NI+L D+       K+ DFG++  I     
Sbjct: 117 TEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE 173

Query: 383 HLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVAC 442
                I GT  ++ PE         ++D++S GV+   LL+G  P               
Sbjct: 174 F--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP--------------- 216

Query: 443 FISLAKENQLLEILDARVAKEARE-EDIGAMA-ELAMRCLRLNSKKRPTMKQV 493
           F+   K+  L  +       E     +  A+A +   R L  + KKR T++  
Sbjct: 217 FLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDS 269

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  108 bits (271), Expect = 3e-26
 Identities = 59/250 (23%), Positives = 107/250 (42%), Gaps = 30/250 (12%)

Query: 194 LSSCGSSERAKVFTADELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEID 252
           ++S   +          L+     +     +G G +G VYKG  +  G + A+K    + 
Sbjct: 2   MASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD-VT 60

Query: 253 KTQIHQFINEVVILSQI-NHRHIVKLLGCCLETEVPV------LVYEYISSGTLSHHIHD 305
             +  +   E+ +L +  +HR+I    G  ++   P       LV E+  +G+++  I +
Sbjct: 61  GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKN 120

Query: 306 HQQQQEQKQKQELSSLSWENRVRVAC-EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF 364
            +            +L  E  +   C E+   ++++H    I   HRDIK  N+LL +  
Sbjct: 121 TKGN----------TLK-EEWIAYICREILRGLSHLHQHKVI---HRDIKGQNVLLTENA 166

Query: 365 SAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTD-----KSDVYSFGVVLL 419
             K+ DFG+S  +        T I GT  ++ PE     +  D     KSD++S G+  +
Sbjct: 167 EVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAI 225

Query: 420 ELLTGKKPIC 429
           E+  G  P+C
Sbjct: 226 EMAEGAPPLC 235

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  109 bits (273), Expect = 3e-26
 Identities = 70/287 (24%), Positives = 115/287 (40%), Gaps = 40/287 (13%)

Query: 215 TDNYN--QSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINH 271
              Y   ++  LG G FG V+K      G  +A K  K        +  NE+ +++Q++H
Sbjct: 86  NSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDH 145

Query: 272 RHIVKLLGCCLETEVPV-LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVA 330
            ++++L     E++  + LV EY+  G L   I D        +   L+ L     ++  
Sbjct: 146 ANLIQLYD-AFESKNDIVLVMEYVDGGELFDRIID--------ESYNLTELDTILFMKQI 196

Query: 331 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA--KVSDFGISRSIPNDKTHLTTTI 388
           CE    + +MH      I H D+K  NIL  ++ +   K+ DFG++R     +       
Sbjct: 197 CE---GIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--LKVN 248

Query: 389 QGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAK 448
            GT  +L PE       +  +D++S GV+   LL+G  P               F+    
Sbjct: 249 FGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP---------------FLGDND 293

Query: 449 ENQLLEILDARVAKEARE-EDIGAMA-ELAMRCLRLNSKKRPTMKQV 493
              L  IL  R   E  E +DI   A E   + L      R +  + 
Sbjct: 294 AETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEA 340

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  107 bits (270), Expect = 6e-26
 Identities = 65/291 (22%), Positives = 109/291 (37%), Gaps = 44/291 (15%)

Query: 215 TDNYN-QSRFLGQGGFGTVYKGM-LPDGSIVAVK--RSKEIDKTQIHQFINEVVILSQIN 270
            + Y   S+ LG+G F  V + +    G   A K  + +   +    + ++E+ +L    
Sbjct: 27  NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAK 86

Query: 271 HR-HIVKLLGCCLETEVPV-LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVR 328
               ++ L     E    + L+ EY + G +             +  + +S    EN V 
Sbjct: 87  SCPRVINLHEVY-ENTSEIILILEYAAGGEIFSLCLP-------ELAEMVS----ENDVI 134

Query: 329 VAC-EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA---KVSDFGISRSIPNDKTHL 384
               ++   V Y+H +    I H D+K  NILL   +     K+ DFG+SR I +     
Sbjct: 135 RLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE-- 189

Query: 385 TTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFI 444
              I GT  YL PE       T  +D+++ G++   LLT   P               F+
Sbjct: 190 LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSP---------------FV 234

Query: 445 SLAKENQLLEILDARVAKEARE-EDIGAMA-ELAMRCLRLNSKKRPTMKQV 493
               +   L I    V         +  +A +     L  N +KRPT +  
Sbjct: 235 GEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEIC 285

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  107 bits (270), Expect = 7e-26
 Identities = 68/292 (23%), Positives = 106/292 (36%), Gaps = 45/292 (15%)

Query: 215 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK------RSKEIDKTQIHQFINEVVILS 267
            D Y+    LG G F  V K      G   A K                 +   EV IL 
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70

Query: 268 QINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRV 327
           Q+ H +I+ L          VL+ E +S G L   +   +            SLS E   
Sbjct: 71  QVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKE------------SLSEEEAT 118

Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA----KVSDFGISRSIPNDKTH 383
               ++   V Y+H+     I H D+K  NI+L DK       K+ DFG++  I +    
Sbjct: 119 SFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE- 174

Query: 384 LTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACF 443
               I GT  ++ PE         ++D++S GV+   LL+G  P               F
Sbjct: 175 -FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP---------------F 218

Query: 444 ISLAKENQLLEILDARVAKEARE-EDIGAMA-ELAMRCLRLNSKKRPTMKQV 493
           +   K+  L  I       +         +A +   + L   ++KR T+++ 
Sbjct: 219 LGDTKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEA 270

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  109 bits (273), Expect = 1e-25
 Identities = 77/289 (26%), Positives = 122/289 (42%), Gaps = 53/289 (18%)

Query: 217 NYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK---RSKEIDKTQIHQFINEVVILSQINHR 272
           +Y     LG G FG V  G     G  VAVK   R K      + +   E+  L    H 
Sbjct: 17  HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHP 76

Query: 273 HIVKLLGCCLETEVPV-LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVAC 331
           HI+KL    + T   + +V EY+S G L  +I  + +  E+           E+R R+  
Sbjct: 77  HIIKLYQV-ISTPSDIFMVMEYVSGGELFDYICKNGRLDEK-----------ESR-RLFQ 123

Query: 332 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGT 391
           ++   V Y H      + HRD+K  N+LLD   +AK++DFG+S ++ +D   L T+  G+
Sbjct: 124 QILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLS-NMMSDGEFLRTSC-GS 178

Query: 392 FGYLDPEYFQSSQFT-DKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKEN 450
             Y  PE      +   + D++S GV+L  LL G  P  F    ++ ++   F       
Sbjct: 179 PNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLP--F----DDDHVPTLF------- 225

Query: 451 QLLEILDAR------VAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQV 493
              +I D        +              L    L+++  KR T+K +
Sbjct: 226 --KKICDGIFYTPQYLNPSVI--------SLLKHMLQVDPMKRATIKDI 264

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  109 bits (275), Expect = 1e-25
 Identities = 61/222 (27%), Positives = 101/222 (45%), Gaps = 30/222 (13%)

Query: 216 DNYNQSRFLGQGGFGTVYKGMLPD-GSIVAVKR-SKE--IDKTQIHQFINEVVILSQIN- 270
           ++++  R +G+GGFG VY     D G + A+K   K+    K      +NE ++LS ++ 
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248

Query: 271 --HRHIVKLLGCCLETEVPV-LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRV 327
                IV +      T   +  + + ++ G L +H+  H    E               +
Sbjct: 249 GDCPFIVCM-SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSE-------------ADM 294

Query: 328 RV-ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTT 386
           R  A E+   + +MH+     + +RD+K +NILLD+    ++SD G++      K H   
Sbjct: 295 RFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH--- 348

Query: 387 TIQGTFGYLDPEYFQSSQFTDKS-DVYSFGVVLLELLTGKKP 427
              GT GY+ PE  Q     D S D +S G +L +LL G  P
Sbjct: 349 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  106 bits (266), Expect = 1e-25
 Identities = 53/218 (24%), Positives = 93/218 (42%), Gaps = 22/218 (10%)

Query: 216 DNYNQSRFLGQGGFGTVYKG-MLPDGSIVAVKR-SKE--IDKTQIHQFINEVVILSQINH 271
           +++   + LG+G F TV     L      A+K   K   I + ++     E  ++S+++H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89

Query: 272 RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRV-A 330
              VKL     + E       Y  +G L  +I        +K      S   E   R   
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--------RKIG----SFD-ETCTRFYT 136

Query: 331 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTT-TIQ 389
            E+  A+ Y+H      I HRD+K  NILL++    +++DFG ++ +  +       +  
Sbjct: 137 AEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV 193

Query: 390 GTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
           GT  Y+ PE          SD+++ G ++ +L+ G  P
Sbjct: 194 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  106 bits (266), Expect = 2e-25
 Identities = 58/223 (26%), Positives = 95/223 (42%), Gaps = 33/223 (14%)

Query: 215 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKR---SKEIDKTQIHQFINEVVILSQIN 270
              ++  R +G G FG VY    + +  +VA+K+   S +    +    I EV  L ++ 
Sbjct: 53  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112

Query: 271 HRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVA 330
           H + ++  GC L      LV EY   G+ S  +  H++  +            E  +   
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQ------------EVEIAAV 159

Query: 331 C-EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLT--TT 387
                  +AY+HS   I   HRD+K+ NILL +    K+ DFG +       + +    +
Sbjct: 160 THGALQGLAYLHSHNMI---HRDVKAGNILLSEPGLVKLGDFGSA-------SIMAPANS 209

Query: 388 IQGTFGYLDPE---YFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
             GT  ++ PE        Q+  K DV+S G+  +EL   K P
Sbjct: 210 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 252

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  105 bits (265), Expect = 6e-25
 Identities = 56/228 (24%), Positives = 89/228 (39%), Gaps = 35/228 (15%)

Query: 216 DNYNQSRFLGQGGFGTVY----KGMLPDGSIVAVKR-SKE--IDKTQIHQFINEVVILSQ 268
           D++   + +G+G F  V     K     G + A+K  +K   + + ++  F  E  +L  
Sbjct: 61  DDFEILKVIGRGAFSEVAVVKMKQ---TGQVYAMKIMNKWDMLKRGEVSCFREERDVLVN 117

Query: 269 INHRHIVKLLGCCLETEVPV-LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRV 327
            + R I +L     + E  + LV EY   G L   +         K  + +         
Sbjct: 118 GDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLL--------SKFGERIP----AEMA 164

Query: 328 RV-ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTT 386
           R    E+  A+  +H        HRDIK  NILLD     +++DFG    +  D T  + 
Sbjct: 165 RFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSL 221

Query: 387 TIQGTFGYLDPEYFQSSQFTDKSDVY-------SFGVVLLELLTGKKP 427
              GT  YL PE  Q+      +  Y       + GV   E+  G+ P
Sbjct: 222 VAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  104 bits (261), Expect = 1e-24
 Identities = 68/301 (22%), Positives = 112/301 (37%), Gaps = 59/301 (19%)

Query: 210 ELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQI--HQFINEVVIL 266
            +   +D Y+  + +G G FG            +VAVK    I++          E++  
Sbjct: 14  PIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKY---IERGAAIDENVQREIINH 70

Query: 267 SQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQK---QELSSLSW 323
             + H +IV+     L      ++ EY S G L   I +  +  E + +   Q+L S   
Sbjct: 71  RSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLS--- 127

Query: 324 ENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA--KVSDFGISRSIPNDK 381
                        V+Y HS     I HRD+K  N LLD   +   K+ DFG S+S     
Sbjct: 128 ------------GVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 172

Query: 382 THLTTTIQGTFGYLDPEYFQSSQFT-DKSDVYSFGVVLLELLTGKKPICFARVEEERNLV 440
               +T+ GT  Y+ PE     ++    +DV+S GV L  +L G  P  F    E+    
Sbjct: 173 -QPKSTV-GTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYP--F----EDPEEP 224

Query: 441 ACFISLAKENQLLEILDAR--------VAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQ 492
             +        +  IL  +        ++ E           L  R    +   R ++ +
Sbjct: 225 RDY-----RKTIQRILSVKYSIPDDIRISPECC--------HLISRIFVADPATRISIPE 271

Query: 493 V 493
           +
Sbjct: 272 I 272

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  104 bits (261), Expect = 3e-24
 Identities = 54/226 (23%), Positives = 92/226 (40%), Gaps = 33/226 (14%)

Query: 216 DNYNQSRFLGQGGFGTVY----KGMLPDGSIVAVKR-SKE--IDKTQIHQFINEVVILSQ 268
           +++   + +G+G FG V     K       + A+K  +K   + + +   F  E  +L  
Sbjct: 74  EDFEILKVIGRGAFGEVAVVKLKN---ADKVFAMKILNKWEMLKRAETACFREERDVLVN 130

Query: 269 INHRHIVKLLGCCLETEVPV-LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRV 327
            + + I  L     + +  + LV +Y   G L   +         K +  L     E   
Sbjct: 131 GDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLL--------SKFEDRLP----EEMA 177

Query: 328 RV-ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTT 386
           R    E+  A+  +H        HRDIK  NIL+D     +++DFG    +  D T  ++
Sbjct: 178 RFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSS 234

Query: 387 TIQGTFGYLDPEYFQSSQFTDKS-----DVYSFGVVLLELLTGKKP 427
              GT  Y+ PE  Q+ +          D +S GV + E+L G+ P
Sbjct: 235 VAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  102 bits (257), Expect = 3e-24
 Identities = 64/217 (29%), Positives = 95/217 (43%), Gaps = 25/217 (11%)

Query: 217 NYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK---RSKEIDKTQIHQFINEVVILSQINHR 272
            Y     LG+G FG V           VA+K   R          +   E+  L  + H 
Sbjct: 10  PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHP 69

Query: 273 HIVKLLGCCLETEVPV-LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVAC 331
           HI+KL    + T   + +V EY   G L  +I + ++  E            E R R   
Sbjct: 70  HIIKLYDV-ITTPTDIVMVIEYAG-GELFDYIVEKKRMTED-----------EGR-RFFQ 115

Query: 332 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGT 391
           ++  A+ Y H      I HRD+K  N+LLDD  + K++DFG+S +I  D   L T+  G+
Sbjct: 116 QIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLS-NIMTDGNFLKTSC-GS 170

Query: 392 FGYLDPEYFQSSQFT-DKSDVYSFGVVLLELLTGKKP 427
             Y  PE      +   + DV+S G+VL  +L G+ P
Sbjct: 171 PNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLP 207

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  102 bits (256), Expect = 4e-24
 Identities = 61/291 (20%), Positives = 105/291 (36%), Gaps = 44/291 (15%)

Query: 215 TDNYNQSR-FLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQFINEVVILSQI-NH 271
           TD+Y  S+  LG G  G V +      G   A+K    +  +   +   EV    Q    
Sbjct: 27  TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKL---LYDSPKAR--QEVDHHWQASGG 81

Query: 272 RHIVKLLGCCLETEVPV----LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRV 327
            HIV +L              ++ E +  G L   I          Q++   + +     
Sbjct: 82  PHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRI----------QERGDQAFTEREAA 131

Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK---FSAKVSDFGISRSIPNDKTHL 384
            +  ++  A+ ++HS     I HRD+K  N+L   K      K++DFG ++    +    
Sbjct: 132 EIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNAL-- 186

Query: 385 TTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFI 444
             T   T  Y+ PE     ++    D++S GV++  LL G  P  F     +        
Sbjct: 187 -QTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP--FYSNTGQAISPGMKR 243

Query: 445 SLAKENQLLEILDARVAKEARE-EDIGAMA-ELAMRCLRLNSKKRPTMKQV 493
                     I   +      E  ++   A +L    L+ +  +R T+ Q 
Sbjct: 244 R---------IRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQF 285

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  103 bits (259), Expect = 4e-24
 Identities = 66/289 (22%), Positives = 107/289 (37%), Gaps = 51/289 (17%)

Query: 165 LYRFFKDKRNRMLKEKLFKQNGGYLLQQQLSSCGSSE-RAKVFTADELQRATDNYNQSR- 222
           +    +D ++ +  + L        L   +        R      + L R  D  N+ R 
Sbjct: 9   MDNLLRDPKSEVNSDCLLD-----GLDALVYDLDFPALRKNKNIDNFLSRYKDTINKIRD 63

Query: 223 -------F-----LGQGGFGTVY----KGMLPDGSIVAVKR-SKE--IDKTQIHQFINEV 263
                  +     +G+G FG V     K       + A+K  SK   I ++    F  E 
Sbjct: 64  LRMKAEDYEVVKVIGRGAFGEVQLVRHKS---TRKVYAMKLLSKFEMIKRSDSAFFWEER 120

Query: 264 VILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSW 323
            I++  N   +V+L     +     +V EY+  G L + +             ++     
Sbjct: 121 DIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM----------SNYDVP---- 166

Query: 324 ENRVRV-ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKT 382
           E   R    EV  A+  +HS   +   HRD+K  N+LLD     K++DFG    +  +  
Sbjct: 167 EKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM 223

Query: 383 HLTTTIQGTFGYLDPEYFQSSQFT---DKS-DVYSFGVVLLELLTGKKP 427
               T  GT  Y+ PE  +S        +  D +S GV L E+L G  P
Sbjct: 224 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  100 bits (251), Expect = 7e-24
 Identities = 32/288 (11%), Positives = 76/288 (26%), Gaps = 63/288 (21%)

Query: 224 LGQGGFGTVYKGMLPD---GSIVAVK---RSKEIDKTQIHQFINEVVILSQINHRHIVKL 277
            G       ++ +  D      VA+        +    + + ++  + LS+I+   + ++
Sbjct: 39  HGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96

Query: 278 LGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAV 337
           L         ++V E+I  G+L                      S    +R    +A A 
Sbjct: 97  LDVVHTRAGGLVVAEWIRGGSLQEVADTS--------------PSPVGAIRAMQSLAAAA 142

Query: 338 AYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDP 397
              H +    +       S + +       +                          +  
Sbjct: 143 DAAHRA---GVALSIDHPSRVRVSIDGDVVL---------------------AYPATMPD 178

Query: 398 EYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEILD 457
                     + D+   G  L  LL  + P           L       A +      +D
Sbjct: 179 A-------NPQDDIRGIGASLYALLVNRWP--LPEAGVRSGLAPAERDTAGQPIEPADID 229

Query: 458 ARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRSQR 505
             +           ++ +A R ++ +   R     +++  +    + R
Sbjct: 230 RDIP--------FQISAVAARSVQGDGGIRSASTLLNLMQQATAVADR 269

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  100 bits (251), Expect = 2e-23
 Identities = 67/214 (31%), Positives = 105/214 (49%), Gaps = 30/214 (14%)

Query: 224 LGQGGFGTVY---KGMLPD-GSIVAVKR-SKE--IDKTQIHQFINEVVILSQINHRHIVK 276
           LGQG FG V+   K    D   + A+K   K     + ++     E  IL ++NH  IVK
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRT-KMERDILVEVNHPFIVK 90

Query: 277 LLGCCLETEVPV-LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRV-ACEVA 334
           L     +TE  + L+ +++  G L   +      +E            E  V+    E+A
Sbjct: 91  LH-YAFQTEGKLYLILDFLRGGDLFTRL-----SKEVMFT--------EEDVKFYLAELA 136

Query: 335 GAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISR-SIPNDKTHLTTTIQGTFG 393
            A+ ++HS     I +RD+K  NILLD++   K++DFG+S+ SI ++K     +  GT  
Sbjct: 137 LALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK--AYSFCGTVE 191

Query: 394 YLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
           Y+ PE       T  +D +SFGV++ E+LTG  P
Sbjct: 192 YMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 98.5 bits (246), Expect = 5e-23
 Identities = 52/249 (20%), Positives = 94/249 (37%), Gaps = 61/249 (24%)

Query: 217 NYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQFIN-------------- 261
            Y     +G+G +G V       D +  A+K    + K ++ +                 
Sbjct: 14  QYTLKDEIGKGSYGVVKLAYNENDNTYYAMK---VLSKKKLIRQAGFPRRPPPRGTRPAP 70

Query: 262 ---------------EVVILSQINHRHIVKL---LGCCLETEVPVLVYEYISSGTLSHHI 303
                          E+ IL +++H ++VKL   L    E  +  +V+E ++ G +    
Sbjct: 71  GGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHL-YMVFELVNQGPVMEVP 129

Query: 304 HDHQQQQEQKQK--QELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD 361
                 ++Q +   Q+L                  + Y+H      I HRDIK SN+L+ 
Sbjct: 130 TLKPLSEDQARFYFQDLIK---------------GIEYLHYQK---IIHRDIKPSNLLVG 171

Query: 362 DKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFT---DKSDVYSFGVVL 418
           +    K++DFG+S         L +   GT  ++ PE    ++        DV++ GV L
Sbjct: 172 EDGHIKIADFGVSN-EFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230

Query: 419 LELLTGKKP 427
              + G+ P
Sbjct: 231 YCFVFGQCP 239

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  100 bits (251), Expect = 6e-23
 Identities = 58/219 (26%), Positives = 98/219 (44%), Gaps = 25/219 (11%)

Query: 216 DNYNQSRFLGQGGFGTVYKGMLPD-GSIVAVKR-SKE--IDKTQIHQFINEVVILSQINH 271
           + +   + LG+G FG V        G   A+K   KE  + K ++   + E  +L    H
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207

Query: 272 RHIVKLLGCCLETEVPV-LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRV- 329
             +  L     +T   +  V EY + G L  H+      +E+           E+R R  
Sbjct: 208 PFLTALK-YSFQTHDRLCFVMEYANGGELFFHL-----SRERVFS--------EDRARFY 253

Query: 330 ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISR-SIPNDKTHLTTTI 388
             E+  A+ Y+HS  ++   +RD+K  N++LD     K++DFG+ +  I +  T    T 
Sbjct: 254 GAEIVSALDYLHSEKNV--VYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKTF 309

Query: 389 QGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
            GT  YL PE  + + +    D +  GVV+ E++ G+ P
Sbjct: 310 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 99.4 bits (248), Expect = 8e-23
 Identities = 65/298 (21%), Positives = 107/298 (35%), Gaps = 57/298 (19%)

Query: 215 TDNYN-QSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQFINEVVILSQI-NH 271
            D+Y   S+ LG G  G V +          A+K    +      +   EV +  +    
Sbjct: 60  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKM---LQDCPKAR--REVELHWRASQC 114

Query: 272 RHIVKLLGCCLETEVPV-----LVYEYISSGTLSHHIHDHQQQQ--EQKQKQELSSLSWE 324
            HIV+++    E          +V E +  G L   I D   Q   E++           
Sbjct: 115 PHIVRIVDVY-ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS--------- 164

Query: 325 NRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA---KVSDFGISRSIPNDK 381
               +   +  A+ Y+HS   I I HRD+K  N+L   K      K++DFG ++   +  
Sbjct: 165 ---EIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN 218

Query: 382 THLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVA 441
           +   TT   T  Y+ PE     ++    D++S GV++  LL G  P              
Sbjct: 219 SL--TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP-------------- 262

Query: 442 CFIS---LAKENQLLE-ILDARVAKEARE-EDIGAMA-ELAMRCLRLNSKKRPTMKQV 493
            F S   LA    +   I   +      E  ++      L    L+    +R T+ + 
Sbjct: 263 -FYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEF 319

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 98.0 bits (245), Expect = 1e-22
 Identities = 60/220 (27%), Positives = 99/220 (45%), Gaps = 40/220 (18%)

Query: 224 LGQGGFGTVY---KGMLPD-GSIVAVK---------RSKEIDKTQIHQFINEVVILSQIN 270
           LG+GG+G V+   K    + G I A+K          +K+   T       E  IL ++ 
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHT-----KAERNILEEVK 79

Query: 271 HRHIVKLLGCCLETEVPV-LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRV 329
           H  IV L+    +T   + L+ EY+S G L   +     ++E            E+    
Sbjct: 80  HPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQL-----EREGIFM--------EDTACF 125

Query: 330 -ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISR-SIPNDKTHLTTT 387
              E++ A+ ++H      I +RD+K  NI+L+ +   K++DFG+ + SI +     T T
Sbjct: 126 YLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTV--THT 180

Query: 388 IQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
             GT  Y+ PE    S      D +S G ++ ++LTG  P
Sbjct: 181 FCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 98.0 bits (245), Expect = 1e-22
 Identities = 60/233 (25%), Positives = 100/233 (42%), Gaps = 39/233 (16%)

Query: 208 ADELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQFIN----- 261
           A +++     Y +  FLG+G F TVYK        IVA+K+ K   +++    IN     
Sbjct: 2   ALDVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALR 61

Query: 262 EVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQ-----KQ 316
           E+ +L +++H +I+ LL          LV++++ +  L   I D+               
Sbjct: 62  EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETD-LEVIIKDNSLVLTPSHIKAYMLM 120

Query: 317 ELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISR- 375
            L                  + Y+H      I HRD+K +N+LLD+    K++DFG+++ 
Sbjct: 121 TLQ----------------GLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKS 161

Query: 376 -SIPNDK-THLTTTIQGTFGYLDPEY-FQSSQFTDKSDVYSFGVVLLELLTGK 425
              PN   TH   T      Y  PE  F +  +    D+++ G +L ELL   
Sbjct: 162 FGSPNRAYTHQVVTRW----YRAPELLFGARMYGVGVDMWAVGCILAELLLRV 210

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 98.1 bits (245), Expect = 2e-22
 Identities = 58/220 (26%), Positives = 99/220 (45%), Gaps = 31/220 (14%)

Query: 216 DNYNQSRFLGQGGFGTVYKGML----PDGSIVAVKR-SKE--IDKTQIHQFINEVVILSQ 268
           D +++ + LG G FG V   ML      G+  A+K   K+  +   QI   +NE  IL  
Sbjct: 41  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97

Query: 269 INHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVR 328
           +N   +VKL     +     +V EY++ G +  H+     ++  +          E   R
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL-----RRIGRFS--------EPHAR 144

Query: 329 V-ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
             A ++     Y+HS     + +RD+K  N+L+D +   +V+DFG ++ +       T T
Sbjct: 145 FYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWT 197

Query: 388 IQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
           + GT   L PE   S  +    D ++ GV++ E+  G  P
Sbjct: 198 LCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 96.9 bits (242), Expect = 2e-22
 Identities = 61/229 (26%), Positives = 102/229 (44%), Gaps = 43/229 (18%)

Query: 212 QRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKR-----SKE-IDKTQIHQFINEVVI 265
           Q   + Y +   +G+G +G VYK     G IVA+KR       E I  T I     E+ +
Sbjct: 17  QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIR----EISL 72

Query: 266 LSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQ-----KQELSS 320
           L +++H +IV L+          LV+E++    L   + +++   +  Q      Q L  
Sbjct: 73  LKELHHPNIVSLIDVIHSERCLTLVFEFMEKD-LKKVLDENKTGLQDSQIKIYLYQLLR- 130

Query: 321 LSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISR--SIP 378
                           VA+ H      I HRD+K  N+L++   + K++DFG++R   IP
Sbjct: 131 ---------------GVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172

Query: 379 NDK-THLTTTIQGTFGYLDPEY-FQSSQFTDKSDVYSFGVVLLELLTGK 425
               TH   T+     Y  P+    S +++   D++S G +  E++TGK
Sbjct: 173 VRSYTHEVVTL----WYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 96.4 bits (241), Expect = 2e-22
 Identities = 49/229 (21%), Positives = 95/229 (41%), Gaps = 44/229 (19%)

Query: 216 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSK-EIDK-----TQIHQFINEVVILSQ 268
             Y +   +G+G +GTV+K        IVA+KR + + D      + +     E+ +L +
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR----EICLLKE 57

Query: 269 INHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQ-----KQELSSLSW 323
           + H++IV+L       +   LV+E+     L  +        + +       Q L     
Sbjct: 58  LKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLK---- 112

Query: 324 ENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISR--SIPNDK 381
                        + + HS     + HRD+K  N+L++     K+++FG++R   IP   
Sbjct: 113 ------------GLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC 157

Query: 382 -THLTTTIQGTFGYLDPEY-FQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
            +    T+     Y  P+  F +  ++   D++S G +  EL    +P+
Sbjct: 158 YSAEVVTL----WYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 95.0 bits (237), Expect = 1e-21
 Identities = 61/222 (27%), Positives = 100/222 (45%), Gaps = 32/222 (14%)

Query: 216 DNYNQSRFLGQGGFGTVYKGML----PDGSIVAVKR-SKE--IDKTQIHQFINEVVILSQ 268
           ++++  + LG+G FG V   +L      G   A+K   KE  I K ++   + E  +L  
Sbjct: 5   NDFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61

Query: 269 INHRHIVKLLGCCLETEVPV-LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRV 327
             H  +  L     +T   +  V EY + G L  H+      +E+           E R 
Sbjct: 62  TRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHL-----SRERVFT--------EERA 107

Query: 328 RV-ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISR-SIPNDKTHLT 385
           R    E+  A+ Y+HS     + +RDIK  N++LD     K++DFG+ +  I +  T   
Sbjct: 108 RFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--M 162

Query: 386 TTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
            T  GT  YL PE  + + +    D +  GVV+ E++ G+ P
Sbjct: 163 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 93.0 bits (232), Expect = 3e-21
 Identities = 57/225 (25%), Positives = 98/225 (43%), Gaps = 43/225 (19%)

Query: 216 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSK-EIDK-----TQIHQFINEVVILSQI 269
           + Y+    +G+G +G VYK     G   A+K+ + E +      T I     E+ IL ++
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR----EISILKEL 57

Query: 270 NHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQ-----KQELSSLSWE 324
            H +IVKL       +  VLV+E++    L   +   +   E         Q L+     
Sbjct: 58  KHSNIVKLYDVIHTKKRLVLVFEHLDQD-LKKLLDVCEGGLESVTAKSFLLQLLN----- 111

Query: 325 NRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISR--SIPNDK- 381
                       +AY H      + HRD+K  N+L++ +   K++DFG++R   IP  K 
Sbjct: 112 -----------GIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY 157

Query: 382 THLTTTIQGTFGYLDPEY-FQSSQFTDKSDVYSFGVVLLELLTGK 425
           TH   T+     Y  P+    S +++   D++S G +  E++ G 
Sbjct: 158 THEIVTL----WYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 93.4 bits (233), Expect = 4e-21
 Identities = 61/220 (27%), Positives = 104/220 (47%), Gaps = 31/220 (14%)

Query: 216 DNYNQSRFLGQGGFGTVYKGML----PDGSIVAVKR-SKE--IDKTQIHQFINEVVILSQ 268
            ++   R LG G FG V    L     +G   A+K   KE  +   Q+    +E ++LS 
Sbjct: 6   QDFQILRTLGTGSFGRV---HLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSI 62

Query: 269 INHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVR 328
           + H  I+++ G   + +   ++ +YI  G L   +     ++ Q+              +
Sbjct: 63  VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLL-----RKSQRFP--------NPVAK 109

Query: 329 V-ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
             A EV  A+ Y+HS     I +RD+K  NILLD     K++DFG ++ +P+    +T T
Sbjct: 110 FYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD----VTYT 162

Query: 388 IQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
           + GT  Y+ PE   +  +    D +SFG+++ E+L G  P
Sbjct: 163 LCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 94.5 bits (235), Expect = 4e-21
 Identities = 65/273 (23%), Positives = 118/273 (43%), Gaps = 44/273 (16%)

Query: 204 KVFTADELQRATDNYNQSRF-LGQGGFGTVYKGM---LPDGSIVAVKRSKE--IDKTQIH 257
           KV  + E +R  D +      +G+G +G VYK       D    A+K+ +   I  +   
Sbjct: 8   KVKLSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSAC- 66

Query: 258 QFINEVVILSQINHRHIVKLLGCCLE-TEVPV-LVYEYISSGTLSHHIHDHQQQQEQKQK 315
               E+ +L ++ H +++ L    L   +  V L+++Y     L H I  H+  +  K+ 
Sbjct: 67  ---REIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKP 122

Query: 316 QELS-----SLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA---- 366
            +L      SL ++        +   + Y+H++    + HRD+K +NIL+  +       
Sbjct: 123 VQLPRGMVKSLLYQ--------ILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRV 171

Query: 367 KVSDFGISR--SIPNDK-THLTTTIQGTFGYLDPEY-FQSSQFTDKSDVYSFGVVLLELL 422
           K++D G +R  + P      L   +  TF Y  PE    +  +T   D+++ G +  ELL
Sbjct: 172 KIADMGFARLFNSPLKPLADLDPVVV-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 230

Query: 423 TGKKPICFARVEEERNLVACFISLAKENQLLEI 455
           T  +PI F   +E+      +      +QL  I
Sbjct: 231 T-SEPI-FHCRQEDIKTSNPY----HHDQLDRI 257

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 94.8 bits (236), Expect = 4e-21
 Identities = 69/225 (30%), Positives = 113/225 (50%), Gaps = 32/225 (14%)

Query: 215 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEIDKTQIHQFIN-EVVILSQINHR 272
             +Y  ++ +G G FG VY+  L   G +VA+K+  + DK    +F N E+ I+ +++H 
Sbjct: 53  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-DK----RFKNRELQIMRKLDHC 107

Query: 273 HIVKLLGCCLET-----EVPV-LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENR 326
           +IV+L      +     EV + LV +Y+   T+      +      + KQ L        
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYS-----RAKQTLP----VIY 157

Query: 327 VRVAC-EVAGAVAYMHSSASIPIFHRDIKSSNILLD-DKFSAKVSDFGISRSIPNDKTHL 384
           V++   ++  ++AY+HS     I HRDIK  N+LLD D    K+ DFG ++ +   +   
Sbjct: 158 VKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP-N 213

Query: 385 TTTIQGTFGYLDPEY-FQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
            + I  +  Y  PE  F ++ +T   DV+S G VL ELL G +PI
Sbjct: 214 VSYI-CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI 256

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 93.9 bits (234), Expect = 5e-21
 Identities = 66/241 (27%), Positives = 109/241 (45%), Gaps = 42/241 (17%)

Query: 216 DNYNQSRFLGQGGFGTVY---KGMLPD-GSIVAVK---------RSKEIDKTQIHQFINE 262
           +N+   + LG G +G V+   K    D G + A+K         ++K  + T+      E
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTR-----TE 108

Query: 263 VVILSQINHRH-IVKLLGCCLETEVPV-LVYEYISSGTLSHHIHDHQQQQEQKQKQELSS 320
             +L  I     +V L     +TE  + L+ +YI+ G L  H+      Q ++       
Sbjct: 109 RQVLEHIRQSPFLVTLH-YAFQTETKLHLILDYINGGELFTHL-----SQRERFT----- 157

Query: 321 LSWENRVRV-ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPN 379
              E+ V++   E+  A+ ++H      I +RDIK  NILLD      ++DFG+S+    
Sbjct: 158 ---EHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVA 211

Query: 380 DKTHLTTTIQGTFGYLDPEYFQSSQF-TDKS-DVYSFGVVLLELLTGKKPICFARVEEER 437
           D+T       GT  Y+ P+  +      DK+ D +S GV++ ELLTG  P  F    E+ 
Sbjct: 212 DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP--FTVDGEKN 269

Query: 438 N 438
           +
Sbjct: 270 S 270

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 93.1 bits (232), Expect = 5e-21
 Identities = 56/225 (24%), Positives = 96/225 (42%), Gaps = 43/225 (19%)

Query: 216 DNYNQSRFLGQGGFGTVYKGMLPD-GSIVAVKR----SKE-IDKTQIHQFINEVVILSQI 269
           + Y +   LG+G + TVYKG      ++VA+K      +E    T     I EV +L  +
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCT----AIREVSLLKDL 57

Query: 270 NHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQ-----KQELSSLSWE 324
            H +IV L       +   LV+EY+    L  ++ D               Q L      
Sbjct: 58  KHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLR----- 111

Query: 325 NRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISR--SIPNDK- 381
                       +AY H      + HRD+K  N+L++++   K++DFG++R  SIP    
Sbjct: 112 -----------GLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY 157

Query: 382 THLTTTIQGTFGYLDPEY-FQSSQFTDKSDVYSFGVVLLELLTGK 425
            +   T+     Y  P+    S+ ++ + D++  G +  E+ TG+
Sbjct: 158 DNEVVTL----WYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 94.3 bits (235), Expect = 5e-21
 Identities = 60/238 (25%), Positives = 105/238 (44%), Gaps = 30/238 (12%)

Query: 198 GSSERAKVFTADELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIH 257
               +         ++    Y   + +G G FG V++  L +   VA+K+    DK    
Sbjct: 22  NKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVL-QDK---- 76

Query: 258 QFIN-EVVILSQINHRHIVKLLGCCLET-----EVPV-LVYEYISSGTLSHHIHDHQQQQ 310
           +F N E+ I+  + H ++V L            EV + LV EY+   T+      +    
Sbjct: 77  RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHY---- 131

Query: 311 EQKQKQELSSLSWENRVRV-ACEVAGAVAYMHSSASIPIFHRDIKSSNILLD-DKFSAKV 368
             K KQ +        +++   ++  ++AY+HS     I HRDIK  N+LLD      K+
Sbjct: 132 -AKLKQTMP----MLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKL 183

Query: 369 SDFGISRSIPNDKTHLTTTIQGTFGYLDPE-YFQSSQFTDKSDVYSFGVVLLELLTGK 425
            DFG ++ +   +    + I  +  Y  PE  F ++ +T   D++S G V+ EL+ G+
Sbjct: 184 IDFGSAKILIAGEP-NVSYI-CSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 92.6 bits (231), Expect = 6e-21
 Identities = 60/226 (26%), Positives = 92/226 (40%), Gaps = 44/226 (19%)

Query: 216 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKE------IDKTQIHQFINEVVILSQ 268
           + Y +   +G+G +G V+K      G IVA+K+  E      I K  +     E+ +L Q
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALR----EIRMLKQ 58

Query: 269 INHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQ-----KQELSSLSW 323
           + H ++V LL          LV+EY    T+ H +  +Q+   +        Q L     
Sbjct: 59  LKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQ---- 113

Query: 324 ENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISR--SIPNDK 381
                       AV + H        HRD+K  NIL+      K+ DFG +R  + P+D 
Sbjct: 114 ------------AVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY 158

Query: 382 -THLTTTIQGTFGYLDPEY-FQSSQFTDKSDVYSFGVVLLELLTGK 425
                 T      Y  PE     +Q+    DV++ G V  ELL+G 
Sbjct: 159 YDDEVATRW----YRSPELLVGDTQYGPPVDVWAIGCVFAELLSGV 200

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 92.7 bits (231), Expect = 9e-21
 Identities = 59/215 (27%), Positives = 100/215 (46%), Gaps = 33/215 (15%)

Query: 224 LGQGGFGTVYKGML----PDGSIVAVKR-SKE--IDKTQIHQFINEVVILSQI-NHRHIV 275
           +G+G +  V   +L        I A+K   KE   D   I     E  +  Q  NH  +V
Sbjct: 17  IGRGSYAKV---LLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLV 73

Query: 276 KLLGCCLETEVPV-LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRV-ACEV 333
            L   C +TE  +  V EY++ G L  H+     Q+++K          E   R  + E+
Sbjct: 74  GLH-SCFQTESRLFFVIEYVNGGDLMFHM-----QRQRKLP--------EEHARFYSAEI 119

Query: 334 AGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISR-SIPNDKTHLTTTIQGTF 392
           + A+ Y+H      I +RD+K  N+LLD +   K++D+G+ +  +    T  T+T  GT 
Sbjct: 120 SLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCGTP 174

Query: 393 GYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
            Y+ PE  +   +    D ++ GV++ E++ G+ P
Sbjct: 175 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 209

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 92.7 bits (231), Expect = 1e-20
 Identities = 65/215 (30%), Positives = 102/215 (47%), Gaps = 33/215 (15%)

Query: 224 LGQGGFGTVYKGML----PDGSIVAVKR-SKE--IDKTQIHQFINEVVILSQ-INHRHIV 275
           +G+G FG V   +L     +    AVK   K+  + K +    ++E  +L + + H  +V
Sbjct: 46  IGKGSFGKV---LLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 102

Query: 276 KLLGCCLETEVPV-LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRV-ACEV 333
            L     +T   +  V +YI+ G L +H+     Q+E+           E R R  A E+
Sbjct: 103 GLH-FSFQTADKLYFVLDYINGGELFYHL-----QRERCFL--------EPRARFYAAEI 148

Query: 334 AGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGIS-RSIPNDKTHLTTTIQGTF 392
           A A+ Y+HS     I +RD+K  NILLD +    ++DFG+   +I ++ T  T+T  GT 
Sbjct: 149 ASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST--TSTFCGTP 203

Query: 393 GYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
            YL PE      +    D +  G VL E+L G  P
Sbjct: 204 EYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 91.5 bits (228), Expect = 1e-20
 Identities = 52/229 (22%), Positives = 92/229 (40%), Gaps = 34/229 (14%)

Query: 213 RATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSK-EIDKTQIHQF----INEVVIL 266
            AT  Y     +G G +GTVYK      G  VA+K  +               + EV +L
Sbjct: 6   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65

Query: 267 SQIN---HRHIVKLLGCCLETEVPV-----LVYEYISSGTLSHHIHDHQQQQEQKQKQEL 318
            ++    H ++V+L+  C  +         LV+E++    L  ++            + +
Sbjct: 66  RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPP--GLPAETI 122

Query: 319 SSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISR--S 376
             L          +    + ++H++    I HRD+K  NIL+    + K++DFG++R  S
Sbjct: 123 KDLMR--------QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYS 171

Query: 377 IPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGK 425
                T +  T+     Y  PE    S +    D++S G +  E+   K
Sbjct: 172 YQMALTPVVVTLW----YRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 91.5 bits (228), Expect = 2e-20
 Identities = 57/233 (24%), Positives = 97/233 (41%), Gaps = 48/233 (20%)

Query: 213 RATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSK-EIDK-----TQIHQFINEVVI 265
            + D Y +   LG+G +G VYK +       VA+KR + E ++     T I     EV +
Sbjct: 31  TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIR----EVSL 86

Query: 266 LSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQK----QELSSL 321
           L ++ HR+I++L           L++EY  +  L  ++  +     +  K    Q ++  
Sbjct: 87  LKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLIN-- 143

Query: 322 SWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA-----KVSDFGISR- 375
                          V + HS       HRD+K  N+LL    ++     K+ DFG++R 
Sbjct: 144 --------------GVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA 186

Query: 376 -SIPNDK-THLTTTIQGTFGYLDPEY-FQSSQFTDKSDVYSFGVVLLELLTGK 425
             IP  + TH   T+     Y  PE    S  ++   D++S   +  E+L   
Sbjct: 187 FGIPIRQFTHEIITLW----YRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 91.1 bits (227), Expect = 2e-20
 Identities = 55/224 (24%), Positives = 102/224 (45%), Gaps = 32/224 (14%)

Query: 214 ATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKR----SKE-IDKTQIHQFINEVVILS 267
           ++  + Q   LG G + TVYKG+    G  VA+K     S+E    T I     E+ ++ 
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR----EISLMK 58

Query: 268 QINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQK--QKQELSSLSWEN 325
           ++ H +IV+L           LV+E++ +  L  ++         +  +   +    W+ 
Sbjct: 59  ELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQ- 116

Query: 326 RVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISR--SIPNDK-T 382
                 +    +A+ H +    I HRD+K  N+L++ +   K+ DFG++R   IP +  +
Sbjct: 117 ----LLQ---GLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFS 166

Query: 383 HLTTTIQGTFGYLDPEY-FQSSQFTDKSDVYSFGVVLLELLTGK 425
               T+     Y  P+    S  ++   D++S G +L E++TGK
Sbjct: 167 SEVVTL----WYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 92.4 bits (230), Expect = 2e-20
 Identities = 58/215 (26%), Positives = 99/215 (46%), Gaps = 33/215 (15%)

Query: 224 LGQGGFGTVY----KGMLPDGSIVAVKR-SKE--IDKTQIHQFINEVVILSQI-NHRHIV 275
           +G+G +  V     K       I A++   KE   D   I     E  +  Q  NH  +V
Sbjct: 60  IGRGSYAKVLLVRLKK---TDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLV 116

Query: 276 KLLGCCLETEVPV-LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRV-ACEV 333
            L   C +TE  +  V EY++ G L  H+     Q+++K          E   R  + E+
Sbjct: 117 GLH-SCFQTESRLFFVIEYVNGGDLMFHM-----QRQRKLP--------EEHARFYSAEI 162

Query: 334 AGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISR-SIPNDKTHLTTTIQGTF 392
           + A+ Y+H      I +RD+K  N+LLD +   K++D+G+ +  +    T  T+T  GT 
Sbjct: 163 SLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCGTP 217

Query: 393 GYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
            Y+ PE  +   +    D ++ GV++ E++ G+ P
Sbjct: 218 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 252

>4eby_A Chitin elicitor receptor kinase 1; pathogen-associated molecular patterns, pattern recognition receptors, LYSM, lysine chitin oligomer; HET: NAG BMA; 1.65A {Arabidopsis thaliana} PDB: 4ebz_A* Length = 212

 Score = 88.6 bits (219), Expect = 3e-20
 Identities = 25/109 (22%), Positives = 46/109 (42%), Gaps = 3/109 (2%)

Query: 2   LARYTYQGLTTCQALLGQNYFDAPNITIGAQVMIPLRCACPTANQIDKGVSYLLAYMAAK 61
           +A   Y  LTT ++L  +N F A NI + A + + + C+C   +   K     + Y    
Sbjct: 92  VAISNYANLTTMESLQARNPFPATNIPLSATLNVLVNCSCGDESV-SKDFGLFVTYPLRP 150

Query: 62  GDTISSIGYKFGVDQQSILEANMLSKADSIFPFAPLLIPLKNGSCSANP 110
            D++SSI    GV    +   N     +       + +P ++ + +  P
Sbjct: 151 EDSLSSIARSSGVSADILQRYNPGV--NFNSGNGIVYVPGRDPNGAFPP 197

>4eby_A Chitin elicitor receptor kinase 1; pathogen-associated molecular patterns, pattern recognition receptors, LYSM, lysine chitin oligomer; HET: NAG BMA; 1.65A {Arabidopsis thaliana} PDB: 4ebz_A* Length = 212

 Score = 40.5 bits (94), Expect = 6e-04
 Identities = 17/93 (18%), Positives = 33/93 (35%), Gaps = 8/93 (8%)

Query: 23  DAPNITIGAQVMIPLRCACPTANQIDKGVSYLLAYMAAKGDTISSIGYKF---GVDQQSI 79
           D   I +G++V++P  C C   + +    SY +     + DT   +           +S+
Sbjct: 51  DKDRIQMGSRVLVPFPCECQPGDFLGHNFSYSV----RQEDTYERVAISNYANLTTMESL 106

Query: 80  LEANMLSKADSIFPFAPLLIPLKNGSCSANPEN 112
              N    A +I   A L + +       +   
Sbjct: 107 QARNPFP-ATNIPLSATLNVLVNCSCGDESVSK 138

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 91.1 bits (227), Expect = 3e-20
 Identities = 70/223 (31%), Positives = 105/223 (47%), Gaps = 33/223 (14%)

Query: 216 DNYNQSRFLGQGGFGTVY----KGMLPDGSIVAVKR-SKE--IDKTQIHQFINEVVILSQ 268
           DN+   R LG+G FG V     K     G + AVK   K+  +    +   + E  ILS 
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKE---TGDLYAVKVLKKDVILQDDDVECTMTEKRILSL 79

Query: 269 I-NHRHIVKLLGCCLETEVPV-LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENR 326
             NH  + +L  CC +T   +  V E+++ G L  HI     Q+ ++          E R
Sbjct: 80  ARNHPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHI-----QKSRRFD--------EAR 125

Query: 327 VRV-ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISR-SIPNDKTHL 384
            R  A E+  A+ ++H      I +RD+K  N+LLD +   K++DFG+ +  I N  T  
Sbjct: 126 ARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT-- 180

Query: 385 TTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
           T T  GT  Y+ PE  Q   +    D ++ GV+L E+L G  P
Sbjct: 181 TATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 90.4 bits (225), Expect = 5e-20
 Identities = 52/229 (22%), Positives = 93/229 (40%), Gaps = 44/229 (19%)

Query: 213 RATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKE------IDKTQIHQFINEVVI 265
           ++ + Y     +G+G +G V K      G IVA+K+  E      + K  +     E+ +
Sbjct: 22  QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMR----EIKL 77

Query: 266 LSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQ-----KQELSS 320
           L Q+ H ++V LL  C + +   LV+E++   T+   +       + +       Q ++ 
Sbjct: 78  LKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIIN- 135

Query: 321 LSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISR--SIP 378
                           + + HS     I HRDIK  NIL+      K+ DFG +R  + P
Sbjct: 136 ---------------GIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177

Query: 379 NDK-THLTTTIQGTFGYLDPEY-FQSSQFTDKSDVYSFGVVLLELLTGK 425
            +       T      Y  PE      ++    DV++ G ++ E+  G+
Sbjct: 178 GEVYDDEVATRW----YRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 89.2 bits (222), Expect = 1e-19
 Identities = 63/223 (28%), Positives = 102/223 (45%), Gaps = 33/223 (14%)

Query: 216 DNYNQSRFLGQGGFGTV----YKGMLPDGSIVAVKR-SKE--IDKTQIHQFINEVVILSQ 268
            ++N    LG+G FG V     KG      + AVK   K+  I    +   + E  +L+ 
Sbjct: 20  TDFNFLMVLGKGSFGKVMLSERKG---TDELYAVKILKKDVVIQDDDVECTMVEKRVLAL 76

Query: 269 I-NHRHIVKLLGCCLETEVPV-LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENR 326
                 + +L   C +T   +  V EY++ G L +HI     QQ  + K        E  
Sbjct: 77  PGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHI-----QQVGRFK--------EPH 122

Query: 327 VRV-ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISR-SIPNDKTHL 384
               A E+A  + ++ S     I +RD+K  N++LD +   K++DFG+ + +I +  T  
Sbjct: 123 AVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT-- 177

Query: 385 TTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
           T T  GT  Y+ PE      +    D ++FGV+L E+L G+ P
Sbjct: 178 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 90.9 bits (225), Expect = 2e-19
 Identities = 61/220 (27%), Positives = 100/220 (45%), Gaps = 27/220 (12%)

Query: 216 DNYNQSRFLGQGGFGTVYKGMLPD-GSIVAVKR-SKE--IDKTQIHQFINEVVILSQIN- 270
            ++N    LG+G FG V          + AVK   K+  I    +   + E  +L+    
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 400

Query: 271 HRHIVKLLGCCLETEVPV-LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRV 329
              + +L   C +T   +  V EY++ G L +HI     QQ  + K        E     
Sbjct: 401 PPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHI-----QQVGRFK--------EPHAVF 446

Query: 330 -ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISR-SIPNDKTHLTTT 387
            A E+A  + ++ S     I +RD+K  N++LD +   K++DFG+ + +I +  T  T T
Sbjct: 447 YAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT--TKT 501

Query: 388 IQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
             GT  Y+ PE      +    D ++FGV+L E+L G+ P
Sbjct: 502 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 88.1 bits (219), Expect = 4e-19
 Identities = 58/256 (22%), Positives = 103/256 (40%), Gaps = 59/256 (23%)

Query: 203 AKVFTADELQ--RATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSK-EIDK----- 253
           AK + + E         Y +   +GQG FG V+K      G  VA+K+   E +K     
Sbjct: 2   AKQYDSVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPI 61

Query: 254 TQIHQFINEVVILSQINHRHIVKLLGCCLETEVPV--------LVYEYISSGTLSHHIHD 305
           T +     E+ IL  + H ++V L+  C     P         LV+++     L+  + +
Sbjct: 62  TALR----EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSN 116

Query: 306 HQQQQEQKQ-----KQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILL 360
              +    +     +  L+                 + Y+H +    I HRD+K++N+L+
Sbjct: 117 VLVKFTLSEIKRVMQMLLN----------------GLYYIHRNK---ILHRDMKAANVLI 157

Query: 361 DDKFSAKVSDFGISR-------SIPNDKTHLTTTIQGTFGYLDPEY-FQSSQFTDKSDVY 412
                 K++DFG++R       S PN  T+   T+     Y  PE       +    D++
Sbjct: 158 TRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW----YRPPELLLGERDYGPPIDLW 213

Query: 413 SFGVVLLELLTGKKPI 428
             G ++ E+ T + PI
Sbjct: 214 GAGCIMAEMWT-RSPI 228

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 87.7 bits (218), Expect = 4e-19
 Identities = 61/215 (28%), Positives = 97/215 (45%), Gaps = 33/215 (15%)

Query: 224 LGQGGFGTV----YKGMLPDGSIVAVKR-SKE--IDKTQIHQFINEVVILSQ-INHRHIV 275
           LG+G FG V    +K         A+K   K+  +    +   + E  +LS    H  + 
Sbjct: 25  LGKGSFGKVFLAEFKK---TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 81

Query: 276 KLLGCCLETEVPV-LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRV-ACEV 333
            +  C  +T+  +  V EY++ G L +HI     Q   K           +R    A E+
Sbjct: 82  HMF-CTFQTKENLFFVMEYLNGGDLMYHI-----QSCHKFD--------LSRATFYAAEI 127

Query: 334 AGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISR-SIPNDKTHLTTTIQGTF 392
              + ++HS     I +RD+K  NILLD     K++DFG+ + ++  D    T T  GT 
Sbjct: 128 ILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TNTFCGTP 182

Query: 393 GYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
            Y+ PE     ++    D +SFGV+L E+L G+ P
Sbjct: 183 DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 86.9 bits (216), Expect = 7e-19
 Identities = 54/236 (22%), Positives = 92/236 (38%), Gaps = 50/236 (21%)

Query: 213 RATDNYNQSRFLGQGGFGTVYKG--MLPDGSIVAVKRSK-EIDK-----TQIHQFINEVV 264
           RA   Y     +G+G +G V+K   +   G  VA+KR + +  +     + I     EV 
Sbjct: 8   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR----EVA 63

Query: 265 ILSQIN---HRHIVKLLGCCLETEVP-----VLVYEYIS---SGTLSHHIHDHQQQQEQK 313
           +L  +    H ++V+L   C  +         LV+E++    +  L          +  K
Sbjct: 64  VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK 123

Query: 314 Q--KQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF 371
               Q L                  + ++HS     + HRD+K  NIL+      K++DF
Sbjct: 124 DMMFQLLR----------------GLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 164

Query: 372 GISR--SIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGK 425
           G++R  S     T +  T+     Y  PE    S +    D++S G +  E+   K
Sbjct: 165 GLARIYSFQMALTSVVVTLW----YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 87.3 bits (217), Expect = 7e-19
 Identities = 52/230 (22%), Positives = 101/230 (43%), Gaps = 30/230 (13%)

Query: 212 QRATDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKR--SKEIDKTQIHQFINEVVILSQ 268
           ++  D +   R  GQG FGTV  G     G  VA+K+       + +  Q + +   L+ 
Sbjct: 19  RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQD---LAV 75

Query: 269 INHRHIVKLLGCCLETEVP-------VLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSL 321
           ++H +IV+L                  +V EY+   TL     ++      +++      
Sbjct: 76  LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYY-----RRQVAPP-- 127

Query: 322 SWENRVRV-ACEVAGAVAYMHSSASIPIFHRDIKSSNILLD-DKFSAKVSDFGISRSIPN 379
                ++V   ++  ++  +H   S+ + HRDIK  N+L++    + K+ DFG ++ +  
Sbjct: 128 --PILIKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSP 184

Query: 380 DKTHLTTTIQGTFGYLDPEY-FQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
            + +    I   + Y  PE  F +  +T   D++S G +  E++ G +PI
Sbjct: 185 SEPN-VAYICSRY-YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG-EPI 231

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 84.6 bits (210), Expect = 3e-18
 Identities = 50/221 (22%), Positives = 95/221 (42%), Gaps = 31/221 (14%)

Query: 215 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQFINEVVILSQI-NHR 272
            D+Y   R LG+G +  V++ + + +   V VK  K + K +I     E+ IL  +    
Sbjct: 35  QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKI---KREIKILENLRGGP 91

Query: 273 HIVKLLGCCL--ETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVR-V 329
           +I+ L        +  P LV+E++++                   Q L+    +  +R  
Sbjct: 92  NIITLADIVKDPVSRTPALVFEHVNNTDFKQLY------------QTLT----DYDIRFY 135

Query: 330 ACEVAGAVAYMHSSASIPIFHRDIKSSNILLD-DKFSAKVSDFGISRSIPNDKTHLTTTI 388
             E+  A+ Y HS     I HRD+K  N+++D +    ++ D+G++      + +     
Sbjct: 136 MYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVR 190

Query: 389 QGTFGYLDPEYFQSSQFTDKS-DVYSFGVVLLELLTGKKPI 428
             +  +  PE     Q  D S D++S G +L  ++  K+P 
Sbjct: 191 VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 80.5 bits (199), Expect = 1e-16
 Identities = 52/255 (20%), Positives = 98/255 (38%), Gaps = 65/255 (25%)

Query: 215 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIH-QFIN-EVVILSQINH 271
           +  Y+  + LG G FG V +   +  G   A+K      K     ++ N E+ I+  ++H
Sbjct: 6   SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALK------KVLQDPRYKNRELDIMKVLDH 59

Query: 272 RHIVKLLGC-------------------------------------CLETEVPV-LVYEY 293
            +I+KL+                                              + ++ EY
Sbjct: 60  VNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEY 119

Query: 294 ISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRV-ACEVAGAVAYMHSSASIPIFHRD 352
           +   TL   +         +  + +      N + +   ++  AV ++HS     I HRD
Sbjct: 120 VPD-TLHKVLKSFI-----RSGRSIP----MNLISIYIYQLFRAVGFIHSLG---ICHRD 166

Query: 353 IKSSNILLD-DKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPE-YFQSSQFTDKSD 410
           IK  N+L++    + K+ DFG ++ +   +      I  +  Y  PE    ++++T   D
Sbjct: 167 IKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPS-VAYI-CSRFYRAPELMLGATEYTPSID 224

Query: 411 VYSFGVVLLELLTGK 425
           ++S G V  EL+ GK
Sbjct: 225 LWSIGCVFGELILGK 239

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 79.3 bits (196), Expect = 2e-16
 Identities = 58/293 (19%), Positives = 95/293 (32%), Gaps = 75/293 (25%)

Query: 218 YNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQFINEVVILSQI-NHRHIV 275
              S+ LG G  G V +          A+K    +      +   EV +  +     HIV
Sbjct: 20  KVTSQVLGLGINGKVLQIFNKRTQEKFALKM---LQDCPKAR--REVELHWRASQCPHIV 74

Query: 276 KLLGCCLETEVPV-----LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVA 330
           +++    E          +V E +  G L   I       + +  Q  +    E      
Sbjct: 75  RIVDVY-ENLYAGRKCLLIVMECLDGGELFSRI-------QDRGDQAFT----EREASEI 122

Query: 331 C-EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA---KVSDFGISRSIPNDKTHLTT 386
              +  A+ Y+HS     I HRD+K  N+L   K      K++DFG ++    +K     
Sbjct: 123 MKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGEK----- 174

Query: 387 TIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFIS- 445
                  Y D             D++S GV++  LL G  P               F S 
Sbjct: 175 -------Y-DKS----------CDMWSLGVIMYILLCGYPP---------------FYSN 201

Query: 446 --LAKENQLLE-ILDARVAKEARE-EDIGAMA-ELAMRCLRLNSKKRPTMKQV 493
             LA    +   I   +      E  ++      L    L+    +R T+ + 
Sbjct: 202 HGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEF 254

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 80.0 bits (198), Expect = 2e-16
 Identities = 54/228 (23%), Positives = 90/228 (39%), Gaps = 34/228 (14%)

Query: 215 TDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKR--SKEIDKTQIHQFIN---------EV 263
              Y   RF+  G +G V  G+  +G  VA+KR  +   D   ++   +         E+
Sbjct: 21  QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80

Query: 264 VILSQINHRHIVKLLGCCLETEVPV-----LVYEYISSGTLSHHIHDHQQQQEQKQKQEL 318
            +L+  +H +I+ L    +  E P      LV E + +  L+  IHD +     +  Q  
Sbjct: 81  RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYF 139

Query: 319 SSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIP 378
                         +   +  +H +    + HRD+   NILL D     + DF ++R   
Sbjct: 140 -----------MYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDT 185

Query: 379 NDKTHLTTTIQGTFGYLDPEY-FQSSQFTDKSDVYSFGVVLLELLTGK 425
            D  + T  +     Y  PE   Q   FT   D++S G V+ E+   K
Sbjct: 186 AD-ANKTHYVT-HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 79.0 bits (195), Expect = 4e-16
 Identities = 62/345 (17%), Positives = 123/345 (35%), Gaps = 96/345 (27%)

Query: 216 DNYNQSRF-----LGQGGFGTVYKGM-LPDGSIVAVK--RSKEIDKTQIHQFINEVVILS 267
           + Y  +R+     LG G F TV+    + + + VA+K  R  ++         +E+ +L 
Sbjct: 14  EPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT---EAAEDEIKLLQ 70

Query: 268 QIN-----------HRHIVKLLGC-----------CLETEVPVLVYEYISSGTLSHHIHD 305
           ++N             HI+KLL              +  EV            L  ++  
Sbjct: 71  RVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEV------------LGENLLA 118

Query: 306 HQQQQEQKQKQELSSLSWENRVR-VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD-- 362
             ++ E    + +        V+ ++ ++   + YMH    I I H DIK  N+L++   
Sbjct: 119 LIKKYEH---RGIPL----IYVKQISKQLLLGLDYMHRRCGI-I-HTDIKPENVLMEIVD 169

Query: 363 ----KFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVL 418
                   K++D G +        H T +IQ    Y  PE    + +   +D++S   ++
Sbjct: 170 SPENLIQIKIADLGNACWYDE---HYTNSIQTRE-YRSPEVLLGAPWGCGADIWSTACLI 225

Query: 419 LELLTGK---KPICFARVEEERNLVACFISL--------------AKE--NQLLEILDAR 459
            EL+TG    +P       ++ + +A  I L               +   N    + +  
Sbjct: 226 FELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNIS 285

Query: 460 VAKEAR------------EEDIGAMAELAMRCLRLNSKKRPTMKQ 492
             K               +++   +++     L+L+ +KR     
Sbjct: 286 KLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 330

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 77.8 bits (192), Expect = 1e-15
 Identities = 50/220 (22%), Positives = 93/220 (42%), Gaps = 29/220 (13%)

Query: 215 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIH--QFINEVVILSQINH 271
              Y   + +G G  G V           VA+K+     + Q H  +   E+V++  +NH
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 83

Query: 272 RHIVKLL-----GCCLETEVPV-LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWEN 325
           ++I+ LL        LE    V +V E + +  L   I     + + ++   L       
Sbjct: 84  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQ---MELDHERMSYL------- 132

Query: 326 RVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLT 385
                 ++   + ++HS+    I HRD+K SNI++    + K+ DFG++R+       + 
Sbjct: 133 ----LYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMM 183

Query: 386 TTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGK 425
           T    T  Y  PE      + +  D++S G ++ E++ G 
Sbjct: 184 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 76.6 bits (189), Expect = 2e-15
 Identities = 50/224 (22%), Positives = 90/224 (40%), Gaps = 38/224 (16%)

Query: 215 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIH--QFINEVVILSQINH 271
              Y     +G G +G+V   +    G  VA+K+     +++I   +   E+++L  + H
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQH 82

Query: 272 RHIVKLLGCCLETEVPV------LVYEYISSGTLSHHIHDHQQQQEQKQK---QELSSLS 322
            +++ LL                LV  ++   T    I   +  +E+ Q    Q L  L 
Sbjct: 83  ENVIGLLDVFTPASSLRNFYDFYLVMPFM--QTDLQKIMGLKFSEEKIQYLVYQMLKGL- 139

Query: 323 WENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKT 382
                           Y+HS+    + HRD+K  N+ +++    K+ DFG++R    + T
Sbjct: 140 ---------------KYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMT 181

Query: 383 HLTTTIQGTFGYLDPE-YFQSSQFTDKSDVYSFGVVLLELLTGK 425
               T      Y  PE       +    D++S G ++ E+LTGK
Sbjct: 182 GYVVTRW----YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 77.2 bits (190), Expect = 3e-15
 Identities = 51/221 (23%), Positives = 92/221 (41%), Gaps = 31/221 (14%)

Query: 215 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIH--QFINEVVILSQINH 271
              Y   + +G G  G V           VA+K+     + Q H  +   E+V++  +NH
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 120

Query: 272 RHIVKLL-----GCCLETEVPV-LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWEN 325
           ++I+ LL        LE    V LV E +        +           + EL       
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELM--DANLCQV----------IQMELD----HE 164

Query: 326 RVR-VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHL 384
           R+  +  ++   + ++HS+    I HRD+K SNI++    + K+ DFG++R+       +
Sbjct: 165 RMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FM 219

Query: 385 TTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGK 425
            T    T  Y  PE      + +  D++S G ++ E++  K
Sbjct: 220 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 74.3 bits (183), Expect = 1e-14
 Identities = 50/225 (22%), Positives = 96/225 (42%), Gaps = 39/225 (17%)

Query: 215 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIH--QFINEVVILSQINH 271
              Y   + +G G +G V   +    G+ VA+K+     ++++   +   E+ +L  + H
Sbjct: 24  RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRH 83

Query: 272 RHIVKLLGCCLETEVPV------LVYEYISSGTLSHHIHDHQQQQEQKQK----QELSSL 321
            +++ LL      E         LV  ++  GT    +  H++  E + +    Q L  L
Sbjct: 84  ENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGL 141

Query: 322 SWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDK 381
                            Y+H++    I HRD+K  N+ +++    K+ DFG++R   ++ 
Sbjct: 142 ----------------RYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEM 182

Query: 382 THLTTTIQGTFGYLDPEY-FQSSQFTDKSDVYSFGVVLLELLTGK 425
           T    T      Y  PE      ++T   D++S G ++ E++TGK
Sbjct: 183 TGYVVTRW----YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 74.2 bits (183), Expect = 1e-14
 Identities = 56/243 (23%), Positives = 89/243 (36%), Gaps = 64/243 (26%)

Query: 215 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKR----SKEIDKTQIHQFINEVVILSQI 269
           + ++     LG+G +G V      P G IVA+K+     K +   +    + E+ IL   
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRT---LREIKILKHF 66

Query: 270 NHRHIVKLLGCCLETEVPV-----LVYEY--------ISSGTLSHHIHDHQQ----QQEQ 312
            H +I+ +                ++ E         IS+  LS    DH Q    Q   
Sbjct: 67  KHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSD---DHIQYFIYQ--- 120

Query: 313 KQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG 372
                                  AV  +H S    + HRD+K SN+L++     KV DFG
Sbjct: 121 ----------------TLR----AVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFG 157

Query: 373 ISRSIPNDKTHLTTTIQGTFG---------YLDPEY-FQSSQFTDKSDVYSFGVVLLELL 422
           ++R I       +       G         Y  PE    S++++   DV+S G +L EL 
Sbjct: 158 LARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF 217

Query: 423 TGK 425
             +
Sbjct: 218 LRR 220

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 74.2 bits (183), Expect = 1e-14
 Identities = 50/252 (19%), Positives = 95/252 (37%), Gaps = 43/252 (17%)

Query: 191 QQQLSSCGSSERAKVFTAD-ELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKR- 247
              +++  ++    V     ++      Y    ++G+G +G V       +   VA+K+ 
Sbjct: 4   HHHMAAAAAAGPEMVRGQVFDV---GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI 60

Query: 248 ---SKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPV-----LVYEYISSGTL 299
                +    +    + E+ IL +  H +I+ +        +       +V + + +  L
Sbjct: 61  SPFEHQTYCQRT---LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DL 116

Query: 300 SHHIHDHQQQQEQKQK---QELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSS 356
              +       +       Q L  L                 Y+HS+    + HRD+K S
Sbjct: 117 YKLLKTQHLSNDHICYFLYQILRGL----------------KYIHSAN---VLHRDLKPS 157

Query: 357 NILLDDKFSAKVSDFGISRSIPNDKTHLT--TTIQGTFGYLDPEY-FQSSQFTDKSDVYS 413
           N+LL+     K+ DFG++R    D  H    T    T  Y  PE    S  +T   D++S
Sbjct: 158 NLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWS 217

Query: 414 FGVVLLELLTGK 425
            G +L E+L+ +
Sbjct: 218 VGCILAEMLSNR 229

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 73.6 bits (181), Expect = 3e-14
 Identities = 59/252 (23%), Positives = 98/252 (38%), Gaps = 51/252 (20%)

Query: 215 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHR- 272
            D Y     +G+G FG V K     +   VA+K  K       +Q   EV +L  +N   
Sbjct: 53  MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFL-NQAQIEVRLLELMNKHD 111

Query: 273 -----HIVKLLGC-------CLETEVPVL---VYEYISSGTLSHHIHDHQQQQEQKQKQE 317
                +IV L          CL  E+  L   +Y+ +                     + 
Sbjct: 112 TEMKYYIVHLKRHFMFRNHLCLVFEM--LSYNLYDLL----------------RNTNFRG 153

Query: 318 LSSLSWENRVR-VACEVAGAVAYMHSSASIPIFHRDIKSSNILL--DDKFSAKVSDFGIS 374
           +S     N  R  A ++  A+ ++ +   + I H D+K  NILL    + + K+ DFG S
Sbjct: 154 VSL----NLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFG-S 207

Query: 375 RSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVE 434
                    +   IQ  F Y  PE      +    D++S G +L+E+ TG +P+ F+   
Sbjct: 208 SCQLGQ--RIYQYIQSRF-YRSPEVLLGMPYDLAIDMWSLGCILVEMHTG-EPL-FSG-A 261

Query: 435 EERNLVACFISL 446
            E + +   + +
Sbjct: 262 NEVDQMNKIVEV 273

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 73.6 bits (181), Expect = 3e-14
 Identities = 53/250 (21%), Positives = 88/250 (35%), Gaps = 60/250 (24%)

Query: 215 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKR-----SKEIDKTQIHQFINEVVILSQ 268
            DNY     +G+G +G VY          VA+K+        ID  +I   + E+ IL++
Sbjct: 25  PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRI---LREITILNR 81

Query: 269 INHRHIVKLLGCCLETEVPV-----LVYEYISSGTLSHHIHDHQQQQEQKQK----QELS 319
           +   +I++L    +  ++       +V E   S  L           E+  K      L 
Sbjct: 82  LKSDYIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLL 140

Query: 320 SLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPN 379
                              ++H S    I HRD+K +N LL+   S KV DFG++R+I +
Sbjct: 141 ----------------GENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINS 181

Query: 380 DKTHLTTTIQGTFGYLDP----------EY------------FQSSQFTDKSDVYSFGVV 417
           +K               P           +                 +T   D++S G +
Sbjct: 182 EKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCI 241

Query: 418 LLELLTGKKP 427
             ELL   + 
Sbjct: 242 FAELLNMLQS 251

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 73.6 bits (181), Expect = 3e-14
 Identities = 72/331 (21%), Positives = 121/331 (36%), Gaps = 73/331 (22%)

Query: 218 YNQSRFLGQGGFGTVYKGM-LPDGSIVAVK--RSKEIDKTQIHQFINEVVILSQINHR-- 272
           Y   + +G+G FG V K         VA+K  R+++       Q   E+ IL  +  +  
Sbjct: 99  YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFH---RQAAEEIRILEHLRKQDK 155

Query: 273 ----HIVKLLGC-------CLETEVPVL---VYEYISSGTLSHHIHDHQQQQEQKQKQEL 318
               +++ +L         C+  E+  L   +YE I                   +K + 
Sbjct: 156 DNTMNVIHMLENFTFRNHICMTFEL--LSMNLYELI-------------------KKNKF 194

Query: 319 SSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA--KVSDFGISRS 376
              S     + A  +   +  +H +    I H D+K  NILL  +  +  KV DFG S  
Sbjct: 195 QGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFG-SSC 250

Query: 377 IPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEE 436
             +    + T IQ  F Y  PE    +++    D++S G +L ELLTG  P+     E+E
Sbjct: 251 YEHQ--RVYTYIQSRF-YRAPEVILGARYGMPIDMWSLGCILAELLTG-YPL-LP-GEDE 304

Query: 437 RNLVACFISL------------AKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNS 484
            + +AC I L             +    +                G++     R  R   
Sbjct: 305 GDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKL 364

Query: 485 KKRPTMKQVSMELEGLRRS------QRCLEM 509
           +  P  ++    L+G          ++CLE 
Sbjct: 365 RGPPESREWGNALKGCDDPLFLDFLKQCLEW 395

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 72.8 bits (179), Expect = 5e-14
 Identities = 57/245 (23%), Positives = 97/245 (39%), Gaps = 43/245 (17%)

Query: 199 SSERAKVFTADELQRA----TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDK 253
            S+    F   EL +      + Y     +G G +G+V        G  VAVK+     +
Sbjct: 8   HSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 67

Query: 254 TQIH--QFINEVVILSQINHRHIVKLLGCCLETEVPV------LVYEYISSGTLSHHIHD 305
           + IH  +   E+ +L  + H +++ LL                LV   +  G   ++I  
Sbjct: 68  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK 125

Query: 306 HQQQQEQKQK----QELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD 361
            Q+  +   +    Q L  L                 Y+HS+    I HRD+K SN+ ++
Sbjct: 126 CQKLTDDHVQFLIYQILRGL----------------KYIHSAD---IIHRDLKPSNLAVN 166

Query: 362 DKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPE-YFQSSQFTDKSDVYSFGVVLLE 420
           +    K+ DFG++R   ++ T    T      Y  PE       +    D++S G ++ E
Sbjct: 167 EDCELKILDFGLARHTADEMTGYVATRW----YRAPEIMLNWMHYNQTVDIWSVGCIMAE 222

Query: 421 LLTGK 425
           LLTG+
Sbjct: 223 LLTGR 227

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 71.9 bits (177), Expect = 5e-14
 Identities = 52/246 (21%), Positives = 96/246 (39%), Gaps = 68/246 (27%)

Query: 215 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKR---SKEIDKTQIHQFINEVVILSQIN 270
              Y   + LG GG G V+  +       VA+K+   +           + E+ I+ +++
Sbjct: 10  GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHA---LREIKIIRRLD 66

Query: 271 HRHIVKLL------GCCLETEVPV--------LVYEY--------ISSGTLSHHIHDHQQ 308
           H +IVK+       G  L  +V          +V EY        +  G L     +H +
Sbjct: 67  HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLE---EHAR 123

Query: 309 ----QQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF 364
               Q                       +   + Y+HS+    + HRD+K +N+ ++ + 
Sbjct: 124 LFMYQ-----------------------LLRGLKYIHSAN---VLHRDLKPANLFINTED 157

Query: 365 -SAKVSDFGISRSIPNDKTH---LTTTIQGTFGYLDPE-YFQSSQFTDKSDVYSFGVVLL 419
              K+ DFG++R +    +H   L+  +  T  Y  P      + +T   D+++ G +  
Sbjct: 158 LVLKIGDFGLARIMDPHYSHKGHLSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFA 216

Query: 420 ELLTGK 425
           E+LTGK
Sbjct: 217 EMLTGK 222

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 72.5 bits (178), Expect = 9e-14
 Identities = 70/333 (21%), Positives = 117/333 (35%), Gaps = 84/333 (25%)

Query: 215 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKR-----SKEIDKTQIHQFINEVVILSQ 268
            D Y     +G G +G V +     +  +VA+K+        ID  +I   + E+ IL++
Sbjct: 52  PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRI---LREIAILNR 108

Query: 269 INHRHIVKLLGCCLETEVPV-----LVYEYISSGTLSHHIHDHQQQQEQKQK----QELS 319
           +NH H+VK+L   +  +V       +V E   S              E   K      L 
Sbjct: 109 LNHDHVVKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVYLTELHIKTLLYNLLV 167

Query: 320 SLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPN 379
                            V Y+HS+    I HRD+K +N L++   S KV DFG++R++  
Sbjct: 168 ----------------GVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDY 208

Query: 380 DKTHLTTTIQGTFGYLDP---------------EY------------FQSSQFTDKSDVY 412
            +   +                            +                 +T+  DV+
Sbjct: 209 PENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVW 268

Query: 413 SFGVVLLELLT----------GKKPI-----CFARVEEERNLVACFISLAKE-NQLLEIL 456
           S G +  ELL            + P+     CF    +++             +QL  I 
Sbjct: 269 SIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIF 328

Query: 457 DARVAKEAREEDIGAMA-ELAMRCLRLNSKKRP 488
           +  +     EEDI A+  E A R +R+  K+  
Sbjct: 329 N--ILGTPSEEDIEALEKEDAKRYIRIFPKREG 359

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 66.6 bits (163), Expect = 5e-12
 Identities = 62/254 (24%), Positives = 101/254 (39%), Gaps = 76/254 (29%)

Query: 215 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKR-----SKEIDKTQIHQFINEVVILSQ 268
              Y   + LG+G +G V+K +    G +VAVK+         D  +      E++IL++
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRT---FREIMILTE 64

Query: 269 IN-HRHIVKLLGCCLE---TEVPVLVYEY--------ISSGTLSHHIHDHQQ----QQEQ 312
           ++ H +IV LL         +V  LV++Y        I +  L      H+Q    Q   
Sbjct: 65  LSGHENIVNLLNVLRADNDRDV-YLVFDYMETDLHAVIRANILEP---VHKQYVVYQ--- 117

Query: 313 KQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG 372
                           +       + Y+HS     + HRD+K SNILL+ +   KV+DFG
Sbjct: 118 ----------------LIK----VIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFG 154

Query: 373 ISRSIPNDKTHLTTTIQGTFGYLDP---------EY------------FQSSQFTDKSDV 411
           +SRS  N +              +          +Y              S+++T   D+
Sbjct: 155 LSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDM 214

Query: 412 YSFGVVLLELLTGK 425
           +S G +L E+L GK
Sbjct: 215 WSLGCILGEILCGK 228

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 64.7 bits (158), Expect = 1e-11
 Identities = 57/229 (24%), Positives = 88/229 (38%), Gaps = 40/229 (17%)

Query: 216 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINH-RH 273
           + Y   R +G G FG +Y G  +  G  VA+K   E  KT+  Q   E  I   +     
Sbjct: 9   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL--ECVKTKHPQLHIESKIYKMMQGGVG 66

Query: 274 IVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEV 333
           I  +  C  E +  V+V E      L   + D      +K        S +  + +A ++
Sbjct: 67  IPTIRWCGAEGDYNVMVMEL-----LGPSLEDLFNFCSRK-------FSLKTVLLLADQM 114

Query: 334 AGAVAYMHSSASIPIFHRDIKSSNILL---DDKFSAKVSDFGISRSIPNDKTHL------ 384
              + Y+HS       HRD+K  N L+          + DFG+++   + +TH       
Sbjct: 115 ISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRE 171

Query: 385 TTTIQGTFGY------LDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
              + GT  Y      L  E  QS     + D+ S G VL+    G  P
Sbjct: 172 NKNLTGTARYASINTHLGIE--QSR----RDDLESLGYVLMYFNLGSLP 214

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 65.4 bits (159), Expect = 2e-11
 Identities = 58/229 (25%), Positives = 91/229 (39%), Gaps = 40/229 (17%)

Query: 216 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQFINEVVILSQIN-HRH 273
           + +   R +G G FG +Y G  +     VA+K   E  KT+  Q + E  I   +     
Sbjct: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL--ENVKTKHPQLLYESKIYRILQGGTG 64

Query: 274 IVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEV 333
           I  +    +E +  VLV +      L   + D      +K       LS +  + +A ++
Sbjct: 65  IPNVRWFGVEGDYNVLVMDL-----LGPSLEDLFNFCSRK-------LSLKTVLMLADQM 112

Query: 334 AGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK---VSDFGISRSIPNDKTHL------ 384
              V ++HS +     HRDIK  N L+     A    + DFG+++   +  TH       
Sbjct: 113 INRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRE 169

Query: 385 TTTIQGTFGY------LDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
              + GT  Y      L  E  QS     + D+ S G VL+  L G  P
Sbjct: 170 NKNLTGTARYASVNTHLGIE--QSR----RDDLESLGYVLMYFLRGSLP 212

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 64.5 bits (157), Expect = 2e-11
 Identities = 69/377 (18%), Positives = 116/377 (30%), Gaps = 121/377 (32%)

Query: 215 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK--RSKEIDKTQIHQFINEVVILSQI-- 269
              Y+  R LG G F TV+    +     VA+K  +S    +      ++E+ +L  +  
Sbjct: 36  NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS---AEHYTETALDEIRLLKSVRN 92

Query: 270 ------NHRHIVKLLGCCLETEVP-----VLVYEYISSGTLSHHIHDHQQQQEQKQKQEL 318
                 N   +V+LL    +          +V+E      L HH+     +   +     
Sbjct: 93  SDPNDPNREMVVQLLDD-FKISGVNGTHICMVFE-----VLGHHLLKWIIKSNYQ----- 141

Query: 319 SSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILL------------------ 360
             L      ++  +V   + Y+H+   I   H DIK  NILL                  
Sbjct: 142 -GLPLPCVKKIIQQVLQGLDYLHTKCRI--IHTDIKPENILLSVNEQYIRRLAAEATEWQ 198

Query: 361 -------------------------------DDKFSAKVSDFGISRSIPNDKTHLTTTIQ 389
                                           +K   K++D G +  +     H T  IQ
Sbjct: 199 RSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK---HFTEDIQ 255

Query: 390 GTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGK---KPICFARVEEERNLVACFISL 446
            T  Y   E    S +   +D++S   +  EL TG    +P        + + +A  I L
Sbjct: 256 -TRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIEL 314

Query: 447 ------------------------------AKENQLLEILDARVAKEAREEDIGAMAELA 476
                                          K   L E+L  +   E  +E+     +  
Sbjct: 315 LGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKY--EWSQEEAAGFTDFL 372

Query: 477 MRCLRLNSKKRPTMKQV 493
           +  L L  +KR T  + 
Sbjct: 373 LPMLELIPEKRATAAEC 389

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 63.1 bits (154), Expect = 3e-11
 Identities = 51/231 (22%), Positives = 83/231 (35%), Gaps = 42/231 (18%)

Query: 216 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQFINEVVILSQI-NHRH 273
            +Y   R +G+G FG +++G  L +   VA+K   E  ++   Q  +E      +     
Sbjct: 10  VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKF--EPRRSDAPQLRDEYRTYKLLAGCTG 67

Query: 274 IVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEV 333
           I  +     E    VLV +      L   + D      +K        S +     A ++
Sbjct: 68  IPNVYYFGQEGLHNVLVIDL-----LGPSLEDLLDLCGRK-------FSVKTVAMAAKQM 115

Query: 334 AGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK-----VSDFGISRSIPNDKTHL---- 384
              V  +H  + +   +RDIK  N L+    S       V DFG+ +   +  T      
Sbjct: 116 LARVQSIHEKSLV---YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPY 172

Query: 385 --TTTIQGTFGY------LDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
                + GT  Y      L  E  QS     + D+ + G V +  L G  P
Sbjct: 173 REKKNLSGTARYMSINTHLGRE--QSR----RDDLEALGHVFMYFLRGSLP 217

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 62.6 bits (151), Expect = 8e-11
 Identities = 32/270 (11%), Positives = 77/270 (28%), Gaps = 58/270 (21%)

Query: 194 LSSCGSSERAKVFTADELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVK------- 246
           +  C                 T+   +   +G+G FG V++ +  D + VA+K       
Sbjct: 2   MGECSQKG---PVPFSHC-LPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGP 56

Query: 247 -RSKEIDKTQIHQFINEVVILSQI---------NHRHIVKLLGCCL----ETEVPVLVYE 292
                  +    + + E++I  ++              + L            + +  ++
Sbjct: 57  DLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWD 116

Query: 293 YISSGTLSHHIHDHQQQQEQK-------------QKQELSSLSWENRVRVACEVAGAVAY 339
           + +S   S +      + +Q              ++      S      +  ++  ++A 
Sbjct: 117 HYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAV 176

Query: 340 MHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFG------ 393
             +S      HRD+   N+LL      K+      +S     +         +       
Sbjct: 177 AEASLR--FEHRDLHWGNVLLKKTSLKKLHYTLNGKSS-TIPSCGLQVSIIDYTLSRLER 233

Query: 394 ---------YLDPEYFQSSQFTDKSDVYSF 414
                     +D + F       + D+Y  
Sbjct: 234 DGIVVFCDVSMDEDLFT-GDGDYQFDIYRL 262

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 58.9 bits (143), Expect = 1e-09
 Identities = 60/348 (17%), Positives = 113/348 (32%), Gaps = 105/348 (30%)

Query: 215 TDNYNQSRFLGQGGFGTVYKGM--LPDGSIVAVK--RSKEIDKTQIHQFINEVVILSQIN 270
            + Y     LG+G FG V + +      S VA+K  R+             E+ +L +I 
Sbjct: 18  QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV---GKYREAARLEINVLKKIK 74

Query: 271 HR------HIVKLLGC-------CLETEVPVL---VYEYISSGTLSHHIHDHQQQQEQKQ 314
            +        V +          C+  E+  L    +E++                ++  
Sbjct: 75  EKDKENKFLCVLMSDWFNFHGHMCIAFEL--LGKNTFEFL----------------KENN 116

Query: 315 KQELSSLSWENRVR-VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA------- 366
            Q          VR +A ++  A+ ++H +    + H D+K  NIL  +           
Sbjct: 117 FQPYPL----PHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHK 169

Query: 367 ------------KVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSF 414
                       +V+DFG S +  ++  H TT +     Y  PE      +    DV+S 
Sbjct: 170 SCEEKSVKNTSIRVADFG-SATFDHE--HHTTIVATRH-YRPPEVILELGWAQPCDVWSI 225

Query: 415 GVVLLELLTGKKPICFARVEEERNLVACFISLA-----------------KENQLLEILD 457
           G +L E   G   + F    E R  +     +                   +  L+   +
Sbjct: 226 GCILFEYYRG-FTL-FQ-THENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDEN 282

Query: 458 ARVAKEARE-------------EDIGAMAELAMRCLRLNSKKRPTMKQ 492
           +   +  +E              +   + +L  R L  +  +R T+ +
Sbjct: 283 SSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAE 330

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 58.9 bits (143), Expect = 1e-09
 Identities = 67/351 (19%), Positives = 107/351 (30%), Gaps = 111/351 (31%)

Query: 218 YNQSRFLGQGGFGTVYKGM-LPDGSIVAVK--RSKEIDKTQIHQFINEVVILSQINHR-- 272
           +   R +G G FG V     + +    AVK  R+    K        E  IL +I +   
Sbjct: 37  FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI---KKYTRSAKIEADILKKIQNDDI 93

Query: 273 ---HIVKLLGC-------CLETEVPVL---VYEYISSGTLSHHIHDHQQQQEQKQKQELS 319
              +IVK  G        CL  E   L   +YE I                 +       
Sbjct: 94  NNNNIVKYHGKFMYYDHMCLIFE--PLGPSLYEII----------------TRNNYNGFH 135

Query: 320 SLSWENRVR-VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA------------ 366
                  ++    E+  A+ Y+     + + H D+K  NILLDD +              
Sbjct: 136 I----EDIKLYCIEILKALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDG 188

Query: 367 -------------KVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYS 413
                        K+ DFG   +      H  + I     Y  PE   +  +   SD++S
Sbjct: 189 KKIQIYRTKSTGIKLIDFG-C-ATFKSDYH-GSIINTRQ-YRAPEVILNLGWDVSSDMWS 244

Query: 414 FGVVLLELLTGKKPICFARVEEERNLVACFISL---------------------AKENQL 452
           FG VL EL TG   + F    E    +A   S+                      K+   
Sbjct: 245 FGCVLAELYTG-SLL-FR-THEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELK 301

Query: 453 LEILDARVAKEARE-----------EDIGAMAELAMRCLRLNSKKRPTMKQ 492
           L   +   +  + +                  +     L+++   RP+  +
Sbjct: 302 LAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAE 352

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 58.5 bits (142), Expect = 1e-09
 Identities = 46/230 (20%), Positives = 85/230 (36%), Gaps = 42/230 (18%)

Query: 217 NYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQFINEVVILSQI-NHRHI 274
           N+   + +G G FG +  G  L     VA+K   E  K++  Q   E     Q+ +   I
Sbjct: 10  NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKL--EPMKSRAPQLHLEYRFYKQLGSGDGI 67

Query: 275 VKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVA 334
            ++       +   +V E      L   + D     ++         S +  + +A ++ 
Sbjct: 68  PQVYYFGPCGKYNAMVLEL-----LGPSLEDLFDLCDRT-------FSLKTVLMIAIQLI 115

Query: 335 GAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVS-----DFGISRSIPNDKTHL----- 384
             + Y+HS   I   +RD+K  N L+    +         DF +++   + +T       
Sbjct: 116 SRMEYVHSKNLI---YRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYR 172

Query: 385 -TTTIQGTFGY------LDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
              ++ GT  Y      L  E  QS     + D+ + G + +  L G  P
Sbjct: 173 EHKSLTGTARYMSINTHLGKE--QSR----RDDLEALGHMFMYFLRGSLP 216

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 56.5 bits (137), Expect = 7e-09
 Identities = 63/349 (18%), Positives = 118/349 (33%), Gaps = 113/349 (32%)

Query: 218 YNQSRFLGQGGFGTVYKG--MLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHR--- 272
           Y     LG+G FG V +       G  VAVK  K +D+       +E+ +L  +N     
Sbjct: 16  YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYC-EAARSEIQVLEHLNTTDPN 74

Query: 273 ---HIVKLLGC-------CLETEVPVL---VYEYISSGTLSHHIHDHQQQQEQKQKQELS 319
                V++L         C+  E+  L    Y++I                ++       
Sbjct: 75  STFRCVQMLEWFEHHGHICIVFEL--LGLSTYDFI----------------KENGFLPFR 116

Query: 320 SLSWENRVR-VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD---------------- 362
                + +R +A ++  +V ++HS     + H D+K  NIL                   
Sbjct: 117 L----DHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDER 169

Query: 363 ---KFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLL 419
                  KV DFG S +  ++  H +T +     Y  PE   +  ++   DV+S G +L+
Sbjct: 170 TLINPDIKVVDFG-SATYDDE--HHSTLVSTRH-YRAPEVILALGWSQPCDVWSIGCILI 225

Query: 420 ELLTGKKPICFARVEEERNLVACFISLAKENQLLEILDARVAKEAR-------------- 465
           E   G   + F    + +  +A         ++L  L   + ++ R              
Sbjct: 226 EYYLG-FTV-FP-THDSKEHLAMME------RILGPLPKHMIQKTRKRKYFHHDRLDWDE 276

Query: 466 ----------------------EEDIGAMAELAMRCLRLNSKKRPTMKQ 492
                                 + +   + +L  + L  +  KR T+++
Sbjct: 277 HSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLRE 325

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 55.5 bits (134), Expect = 2e-08
 Identities = 31/175 (17%), Positives = 70/175 (40%), Gaps = 21/175 (12%)

Query: 222 RFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGC 280
           + +G GGFG +Y           A    K ++  +     +E+    ++  +  +K    
Sbjct: 43  KKIGSGGFGLIYLAFPTNKPEKDARHVVK-VEYQENGPLFSELKFYQRVAKKDCIKKWIE 101

Query: 281 CLETE---VPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENR-------VRVA 330
             + +   +P+       SG        ++    ++   +L  +S +N        +++ 
Sbjct: 102 RKQLDYLGIPLFYG----SGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLG 157

Query: 331 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKV--SDFGISRSIPNDKTH 383
             +   + Y+H +  +   H DIK++N+LL  K   +V  +D+G+S     +  H
Sbjct: 158 IRMLDVLEYIHENEYV---HGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNH 209

>2l9y_A CVNH-LYSM lectin; carbohydrate, sugar binding protein; NMR {Magnaporthe oryzae 70-15} Length = 167

 Score = 50.4 bits (120), Expect = 2e-07
 Identities = 17/54 (31%), Positives = 23/54 (42%)

Query: 57  YMAAKGDTISSIGYKFGVDQQSILEANMLSKADSIFPFAPLLIPLKNGSCSANP 110
               +GDT+  IG +F  D   I   N +   D I+P   L +P K GS     
Sbjct: 65  VTVQQGDTLRDIGRRFDCDFHEIARRNNIQNEDLIYPGQVLQVPTKGGSGGGAG 118

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 52.9 bits (126), Expect = 2e-07
 Identities = 67/475 (14%), Positives = 131/475 (27%), Gaps = 140/475 (29%)

Query: 48  DKGVSYLLAYMAAKG--------DTISSIGYKFGVD-------QQSILEANMLSKADSIF 92
             G   L   + +K         + +  I YKF +        Q S++    + + D ++
Sbjct: 61  VSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLY 120

Query: 93  ----PFAPLLIP-------LKNGSCSANPENF-FCHCKNGFLVDGK--LEGLHCKPDG-- 136
                FA   +        L+       P          G    GK  +    C      
Sbjct: 121 NDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGS---GKTWVALDVCLSYKVQ 177

Query: 137 KKFPVKLVALLGLGIGLGFLSVVVVGCYLYRFFKDKRNRMLKEKLFKQNGGYLLQQQLSS 196
            K   K +  L L                           + E L  Q   Y +    +S
Sbjct: 178 CKMDFK-IFWLNLK-------------------NCNSPETVLEML--QKLLYQIDPNWTS 215

Query: 197 CGSSERAKVFTADELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQI 256
                         +Q         R L                              + 
Sbjct: 216 RSDHSSNIKLRIHSIQAEL-----RRLL------------------------------KS 240

Query: 257 HQFINEVVILSQINHRHIVKL--LGC-CLETEVPVLVYEYISSGTLSHHIHDHQQQQ-EQ 312
             + N +++L  + +        L C  L T     V +++S+ T +H   DH       
Sbjct: 241 KPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTP 300

Query: 313 KQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG 372
            + + L    + +                    +P   R++ ++N       +  + D  
Sbjct: 301 DEVKSLLL-KYLD---------------CRPQDLP---REVLTTNPRRLSIIAESIRDG- 340

Query: 373 ISRS-----IPNDKTHLTTTIQGTFGYLDP----EYFQS-SQFTDKSDVYSFGVVLLELL 422
           ++       +  DK  LTT I+ +   L+P    + F   S F   + + +   +LL L+
Sbjct: 341 LATWDNWKHVNCDK--LTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPT---ILLSLI 395

Query: 423 TGKKPICFARVEEERNLVACFI--SLAKENQ---LLEILDARVAKEAREEDIGAM 472
                       +   +V      SL ++      + I    +  + + E+  A+
Sbjct: 396 WFDVI-----KSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYAL 445

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 49.1 bits (116), Expect = 3e-06
 Identities = 64/491 (13%), Positives = 132/491 (26%), Gaps = 144/491 (29%)

Query: 14  QALLGQNYFDAPNITI------GAQVMIPLRC-ACPTANQIDKGVSYLLAYMAAKGDTIS 66
           QALL      A N+ I      G   +    C +     ++D  + +L            
Sbjct: 142 QALLELR--PAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWL------------ 187

Query: 67  SIGYKFGVDQQSILEANMLSKADSIF---PFAPLLIPLKNGSCSANPENFFCH--CKNGF 121
           ++      +    +   +L + D  +         I L+  S  A           +N  
Sbjct: 188 NLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCL 247

Query: 122 LV-----DGK-LE--GLHCK--------------PDGKKFPVKLV------------ALL 147
           LV     + K      L CK                     + L             +LL
Sbjct: 248 LVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLL 307

Query: 148 G--LGIGLGFLSVVVVGC--------------------YLYRFFKDKRNRMLKEKLFKQN 185
              L      L   V+                             DK   +++  L    
Sbjct: 308 LKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLE 367

Query: 186 GGYLLQQQLSSCGSSERAKVFTAD------------------ELQRATDNYNQSRFLGQG 227
                ++            VF                     ++    +  ++   + + 
Sbjct: 368 P-AEYRKMFDRLS------VFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQ 420

Query: 228 GFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVP 287
              +     +P   I    + K  ++  +H+ I        ++H +I K      +  +P
Sbjct: 421 PKESTIS--IPS--IYLELKVKLENEYALHRSI--------VDHYNIPKTF--DSDDLIP 466

Query: 288 VLVYEYISSGTLSHHIHDHQQQQEQKQKQELSS-----LSW-ENRVRVACEVAGAVAYMH 341
             + +Y  S     HI  H +  E  ++  L         + E ++R       A   + 
Sbjct: 467 PYLDQYFYS-----HIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSIL 521

Query: 342 SSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQ 401
           ++     F++     N   D K+   V+   I   +P  + +L  +      Y D    +
Sbjct: 522 NTLQQLKFYKPYICDN---DPKYERLVNA--ILDFLPKIEENLICS-----KYTD--LLR 569

Query: 402 SSQFTDKSDVY 412
            +   +   ++
Sbjct: 570 IALMAEDEAIF 580

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 51.7 bits (124), Expect = 3e-07
 Identities = 38/233 (16%), Positives = 79/233 (33%), Gaps = 40/233 (17%)

Query: 222 RFLGQGGFGTVYKGMLPDGSIVAVKRSKEI--DKTQIHQFINEVVILSQINHRHIVKLLG 279
             +GQGGFG +Y   +     V       +  + +       E+    +      ++   
Sbjct: 41  LPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWI 100

Query: 280 CCLETE---VPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSL-SWENR-------VR 328
              + +   VP        SG    +   ++     +   +L  +     +       ++
Sbjct: 101 RTRKLKYLGVPKYWG----SGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQ 156

Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKV--SDFGISRSIPNDKTHL-- 384
           ++  +   + Y+H    +   H DIK+SN+LL+ K   +V   D+G++     +  H   
Sbjct: 157 LSLRILDILEYIHEHEYV---HGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAY 213

Query: 385 ----TTTIQGTFGY------LDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
                    GT  +             S     + D+   G  +++ LTG  P
Sbjct: 214 AADPKRCHDGTIEFTSIDAHNGVA--PSR----RGDLEILGYCMIQWLTGHLP 260

>2djp_A Hypothetical protein SB145; LYSM, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} Length = 77

 Score = 46.7 bits (111), Expect = 4e-07
 Identities = 17/42 (40%), Positives = 23/42 (54%)

Query: 61  KGDTISSIGYKFGVDQQSILEANMLSKADSIFPFAPLLIPLK 102
            GDT++ +  K+GV  + I  AN L   DSIF    L IP+ 
Sbjct: 22  PGDTLAGLALKYGVTMEQIKRANRLYTNDSIFLKKTLYIPIL 63

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 49.4 bits (118), Expect = 1e-06
 Identities = 26/184 (14%), Positives = 58/184 (31%), Gaps = 36/184 (19%)

Query: 222 RFLGQGGFGTVYKGM---------LPDGSIVAVK----------RSKEIDKTQIHQFINE 262
            F  +   G +Y+            P     ++K                +      +N+
Sbjct: 48  SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNK 107

Query: 263 VVILSQINHRHIVKLLGC-CLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSL 321
              L       I   +G    + +   LV        L   +        +        L
Sbjct: 108 WKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPS-----LGRSLQSALDVSPKH------VL 156

Query: 322 SWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKV--SDFGISRSIPN 379
           S  + ++VAC +  A+ ++H +  +   H ++ + NI +D +  ++V  + +G +     
Sbjct: 157 SERSVLQVACRLLDALEFLHENEYV---HGNVTAENIFVDPEDQSQVTLAGYGFAFRYCP 213

Query: 380 DKTH 383
              H
Sbjct: 214 SGKH 217

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	537
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.96
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.94
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.9
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.8
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.66
4eby_A	212	Chitin elicitor receptor kinase 1; pathogen-associ	99.65
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.34
4eby_A	212	Chitin elicitor receptor kinase 1; pathogen-associ	99.3
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.19
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.06
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.98
2djp_A	77	Hypothetical protein SB145; LYSM, structural genom	98.9
1e0g_A	48	Membrane-bound lytic murein transglycosylase D; ce	98.77
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.72
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.6
2l9y_A	167	CVNH-LYSM lectin; carbohydrate, sugar binding prot	98.57
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.49
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.41
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.29
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.19
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.02
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.92
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.91
2l9y_A	167	CVNH-LYSM lectin; carbohydrate, sugar binding prot	97.84
4a1k_A	165	Putative L, D-transpeptidase YKUD; transferase, pe	97.5
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.48
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.47
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.34
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.27
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.22
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.14
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.1
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.01
2gu1_A	361	Zinc peptidase; alpha/beta, beta barrel, structura	97.01
2gu1_A	361	Zinc peptidase; alpha/beta, beta barrel, structura	96.93
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.81
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	96.72
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.63
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.5
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.94
3mes_A	424	Choline kinase; malaria, structural genomics, stru	94.44
1e0g_A	48	Membrane-bound lytic murein transglycosylase D; ce	92.23
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	91.65
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	86.98
2jwa_A	44	Receptor tyrosine-protein kinase ERBB-2; transmemb	86.26
3slu_A	371	M23 peptidase domain protein; outer membrane, hydr	85.95
2djp_A	77	Hypothetical protein SB145; LYSM, structural genom	85.51
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	84.22
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	83.65

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=3.8e-58  Score=454.87  Aligned_cols=268  Identities=27%  Similarity=0.455  Sum_probs=220.0

Q ss_pred             cCCccccccCcCCceEEEEEEcC------CCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP------DGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVL  289 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  289 (537)
                      ++|...+.||+|+||.||+|++.      ++..||||+++..+....++|.+|+++|++++|||||+++|+|.+.+..+|
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l   92 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   92 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            56778899999999999999864      477899999998777778899999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhhhhhhhHHHHh-hhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEE
Q 009340          290 VYEYISSGTLSHHIHDHQQQQEQKQ-KQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKV  368 (537)
Q Consensus       290 V~e~~~~gsL~~~l~~~~~~~~~~~-~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki  368 (537)
                      ||||+++|+|.++|+.......... ......++|.++++|+.|||+||+|||+++   |+||||||+||||++++.+||
T Consensus        93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki  169 (299)
T 4asz_A           93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI  169 (299)
T ss_dssp             EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence            9999999999999987543211100 112346999999999999999999999998   999999999999999999999


Q ss_pred             eeccCccccCCCCCce-eeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHHHH
Q 009340          369 SDFGISRSIPNDKTHL-TTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISL  446 (537)
Q Consensus       369 ~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~  446 (537)
                      +|||+|+......... .....||+.|||||++.++.|+.|+|||||||+||||+| |+.||......+       +...
T Consensus       170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~-------~~~~  242 (299)
T 4asz_A          170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE-------VIEC  242 (299)
T ss_dssp             CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-------HHHH
T ss_pred             CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHH
Confidence            9999998765443332 234568999999999999999999999999999999999 899987543322       1111


Q ss_pred             HhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHH
Q 009340          447 AKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRR  502 (537)
Q Consensus       447 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~  502 (537)
                      ...+         ...+.+..++.++.+|+.+||+.||++||||.+|++.|+.+.+
T Consensus       243 i~~~---------~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~  289 (299)
T 4asz_A          243 ITQG---------RVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK  289 (299)
T ss_dssp             HHHT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHcC---------CCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            1111         1223445566789999999999999999999999999998765

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.2e-57  Score=457.37  Aligned_cols=269  Identities=28%  Similarity=0.452  Sum_probs=213.7

Q ss_pred             cCCccccccCcCCceEEEEEEcC------CCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP------DGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVL  289 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  289 (537)
                      ++|...++||+|+||.||+|+++      +++.||||+++..+....++|.+|+++|++++|||||+++|+|.+.+..+|
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l  120 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM  120 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            46677789999999999999864      478899999998877788899999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhhhhhhhHHHH---hhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcE
Q 009340          290 VYEYISSGTLSHHIHDHQQQQEQK---QKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA  366 (537)
Q Consensus       290 V~e~~~~gsL~~~l~~~~~~~~~~---~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~  366 (537)
                      ||||+++|+|.++++.........   ......+++|.++++|+.|||+||+|||+.+   ||||||||+||||++++.+
T Consensus       121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~  197 (329)
T 4aoj_A          121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV  197 (329)
T ss_dssp             EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence            999999999999998754321100   0111346999999999999999999999998   9999999999999999999


Q ss_pred             EEeeccCccccCCCCC-ceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHH
Q 009340          367 KVSDFGISRSIPNDKT-HLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFI  444 (537)
Q Consensus       367 ki~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~  444 (537)
                      ||+|||+++....... ...+...||+.|||||++.+..++.++|||||||+||||+| |+.||......+       ..
T Consensus       198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~-------~~  270 (329)
T 4aoj_A          198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE-------AI  270 (329)
T ss_dssp             EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH-------HH
T ss_pred             EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH-------HH
Confidence            9999999987644332 23345679999999999999999999999999999999999 899987543322       11


Q ss_pred             HHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHHh
Q 009340          445 SLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRS  503 (537)
Q Consensus       445 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~  503 (537)
                      .....         ....+.+..++.++.+|+.+||+.||++||||.||+++|+.+.+.
T Consensus       271 ~~i~~---------g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~  320 (329)
T 4aoj_A          271 DCITQ---------GRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA  320 (329)
T ss_dssp             HHHHH---------TCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             HHHHc---------CCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence            11111         112234455667899999999999999999999999999988763

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.3e-57  Score=452.87  Aligned_cols=265  Identities=24%  Similarity=0.428  Sum_probs=214.4

Q ss_pred             CCccccccCcCCceEEEEEEcC------CCCEEEEEEccCC-ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEE
Q 009340          217 NYNQSRFLGQGGFGTVYKGMLP------DGSIVAVKRSKEI-DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVL  289 (537)
Q Consensus       217 ~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  289 (537)
                      ++...++||+|+||+||+|.+.      +++.||||+++.. .....++|.+|+.++++++|||||+++|+|.+.+..+|
T Consensus        27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l  106 (308)
T 4gt4_A           27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM  106 (308)
T ss_dssp             GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence            4556788999999999999963      4678999999753 33446789999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhhhhhhhH----HHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCc
Q 009340          290 VYEYISSGTLSHHIHDHQQQQ----EQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFS  365 (537)
Q Consensus       290 V~e~~~~gsL~~~l~~~~~~~----~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~  365 (537)
                      ||||+++|+|.++|+......    ....+.....++|.++++|+.|||+||+|||+++   ||||||||+||||+++++
T Consensus       107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~  183 (308)
T 4gt4_A          107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLN  183 (308)
T ss_dssp             EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGC
T ss_pred             EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCCC
Confidence            999999999999997643210    0001111346999999999999999999999999   999999999999999999


Q ss_pred             EEEeeccCccccCCCCC-ceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHH
Q 009340          366 AKVSDFGISRSIPNDKT-HLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACF  443 (537)
Q Consensus       366 ~ki~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~  443 (537)
                      +||+|||+++....... ...+...||++|||||++.++.|+.++|||||||+||||+| |+.||......+       +
T Consensus       184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~-------~  256 (308)
T 4gt4_A          184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD-------V  256 (308)
T ss_dssp             EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH-------H
T ss_pred             EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH-------H
Confidence            99999999987643332 23445679999999999999999999999999999999999 899986543322       1


Q ss_pred             HHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHH
Q 009340          444 ISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGL  500 (537)
Q Consensus       444 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i  500 (537)
                      ......         ....+.+..++..+.+|+.+||+.||++||||.||++.|+.+
T Consensus       257 ~~~i~~---------~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          257 VEMIRN---------RQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             HHHHHT---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             HHHHHc---------CCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            111111         222234556677899999999999999999999999999864

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.6e-56  Score=443.43  Aligned_cols=260  Identities=28%  Similarity=0.459  Sum_probs=207.3

Q ss_pred             hcCCccccccCcCCceEEEEEEcCCCCEEEEEEccC--CChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEe
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKE--IDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE  292 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e  292 (537)
                      .+++...++||+|+||+||+|++++  .||||.++.  .+....++|.+|+.+|++++|||||+++|+|.+ +..+||||
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE  111 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ  111 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence            3567788999999999999999853  599999874  345667889999999999999999999999865 56899999


Q ss_pred             cCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeecc
Q 009340          293 YISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG  372 (537)
Q Consensus       293 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfg  372 (537)
                      |+++|+|.++|+...           ..++|.++++|+.|||+||+|||+++   ||||||||+||||++++.+||+|||
T Consensus       112 y~~gGsL~~~l~~~~-----------~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFG  177 (307)
T 3omv_A          112 WCEGSSLYKHLHVQE-----------TKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFG  177 (307)
T ss_dssp             CCSSCBHHHHHHTSC-----------CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCS
T ss_pred             cCCCCCHHHHHhhcC-----------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeecc
Confidence            999999999997542           36999999999999999999999998   9999999999999999999999999


Q ss_pred             CccccCCCC-CceeeeccccccccCccccc---CCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHh
Q 009340          373 ISRSIPNDK-THLTTTIQGTFGYLDPEYFQ---SSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAK  448 (537)
Q Consensus       373 la~~~~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  448 (537)
                      +|+...... ........||+.|||||++.   ++.|+.|+|||||||+||||+||+.||.......      .+.....
T Consensus       178 la~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~------~~~~~~~  251 (307)
T 3omv_A          178 LATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD------QIIFMVG  251 (307)
T ss_dssp             SCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH------HHHHHHH
T ss_pred             CceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH------HHHHHHh
Confidence            998764332 23345568999999999985   3569999999999999999999999996533221      1111111


Q ss_pred             hchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHH
Q 009340          449 ENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRR  502 (537)
Q Consensus       449 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~  502 (537)
                      .+.    ..+.+ ...+..++..+.+|+.+||+.||++||||.||++.|+.++.
T Consensus       252 ~~~----~~p~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~  300 (307)
T 3omv_A          252 RGY----ASPDL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQH  300 (307)
T ss_dssp             TTC----CCCCS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred             cCC----CCCCc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence            111    11111 12234556788999999999999999999999999998865

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=8.7e-55  Score=440.14  Aligned_cols=281  Identities=26%  Similarity=0.401  Sum_probs=226.3

Q ss_pred             ccCHHHHHHHhcCCccccccCcCCceEEEEEEcCC------CCEEEEEEccCC-ChHHHHHHHHHHHHHHhcCC-CCcce
Q 009340          205 VFTADELQRATDNYNQSRFLGQGGFGTVYKGMLPD------GSIVAVKRSKEI-DKTQIHQFINEVVILSQINH-RHIVK  276 (537)
Q Consensus       205 ~~~~~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~~------g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H-~niv~  276 (537)
                      .++.++++...++|+..+.||+|+||.||+|.+..      ++.||||+++.. .....++|.+|+.+|.+++| ||||+
T Consensus        53 p~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~  132 (353)
T 4ase_A           53 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN  132 (353)
T ss_dssp             CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             CCCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEE
Confidence            35666777777899999999999999999998542      357999999764 34556789999999999965 89999


Q ss_pred             EeeEEeeC-CccEEEEecCCCCChhhhhhhhhhhHH----HHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 009340          277 LLGCCLET-EVPVLVYEYISSGTLSHHIHDHQQQQE----QKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHR  351 (537)
Q Consensus       277 l~g~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~----~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~  351 (537)
                      ++|+|.+. +..++|||||++|+|.++|+.......    .........++|.+++.++.|||+||+|||+++   ||||
T Consensus       133 l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHR  209 (353)
T 4ase_A          133 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHR  209 (353)
T ss_dssp             EEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred             EEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecC
Confidence            99999775 468999999999999999986543110    000011245899999999999999999999999   9999


Q ss_pred             CCCCCCEEECCCCcEEEeeccCccccCCCCCc-eeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 009340          352 DIKSSNILLDDKFSAKVSDFGISRSIPNDKTH-LTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPIC  429 (537)
Q Consensus       352 Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~  429 (537)
                      ||||+|||+++++.+||+|||+|+....+... ..+...||+.|||||++.+..|+.++|||||||+||||+| |+.||.
T Consensus       210 DLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~  289 (353)
T 4ase_A          210 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP  289 (353)
T ss_dssp             CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             ccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCC
Confidence            99999999999999999999999987554443 3445679999999999999999999999999999999998 899986


Q ss_pred             ccchhhhccHHHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHHh
Q 009340          430 FARVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRS  503 (537)
Q Consensus       430 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~  503 (537)
                      .....+      .+.....         ...+...+..+++++.+++.+||+.||++||||.||++.|+.+.++
T Consensus       290 ~~~~~~------~~~~~i~---------~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~  348 (353)
T 4ase_A          290 GVKIDE------EFCRRLK---------EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  348 (353)
T ss_dssp             TCCCSH------HHHHHHH---------HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCHHH------HHHHHHH---------cCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence            543221      1222222         1222334455667899999999999999999999999999988764

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=7.6e-54  Score=426.40  Aligned_cols=269  Identities=22%  Similarity=0.293  Sum_probs=202.7

Q ss_pred             cCCccccccCcCCceEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCC----ccEEEE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETE----VPVLVY  291 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~~~lV~  291 (537)
                      ++|...++||+|+||+||+|++ +|+.||||+++..... ...+..|+..+.+++|||||+++|+|.+.+    ..+|||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~   80 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence            3566788999999999999998 5899999998753321 222335666667889999999999998764    469999


Q ss_pred             ecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhc-----CCCCeeecCCCCCCEEECCCCcE
Q 009340          292 EYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSS-----ASIPIFHRDIKSSNILLDDKFSA  366 (537)
Q Consensus       292 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~-----~~~~ivH~Dlk~~NIll~~~~~~  366 (537)
                      ||+++|+|.++|+.             ..++|..+++++.|+|+||+|||++     ..++|+||||||+|||||.++++
T Consensus        81 Ey~~~gsL~~~l~~-------------~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~  147 (303)
T 3hmm_A           81 DYHEHGSLFDYLNR-------------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC  147 (303)
T ss_dssp             ECCTTCBHHHHHHH-------------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCE
T ss_pred             cCCCCCcHHHHHHh-------------CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCE
Confidence            99999999999964             2599999999999999999999987     23459999999999999999999


Q ss_pred             EEeeccCccccCCCCCc---eeeeccccccccCcccccCC------CCCcchhHHHHHHHHHHHHhCCCCCCccchhhh-
Q 009340          367 KVSDFGISRSIPNDKTH---LTTTIQGTFGYLDPEYFQSS------QFTDKSDVYSFGVVLLELLTGKKPICFARVEEE-  436 (537)
Q Consensus       367 ki~Dfgla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~-  436 (537)
                      ||+|||+++........   ......||+.|||||++.+.      .++.|+|||||||+||||+||+.|+........ 
T Consensus       148 Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p  227 (303)
T 3hmm_A          148 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP  227 (303)
T ss_dssp             EECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCT
T ss_pred             EEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCcccccccc
Confidence            99999999876443322   12345799999999999754      467899999999999999999887643221110 


Q ss_pred             -------ccHHHHHHHHHhhchhhhhhcHHhhc-cccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHHh
Q 009340          437 -------RNLVACFISLAKENQLLEILDARVAK-EAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRS  503 (537)
Q Consensus       437 -------~~~~~~~~~~~~~~~~~~~~d~~~~~-~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~  503 (537)
                             ...............    +++.+.. ..+.++...+.+|+.+||+.||++||||.||+++|++|.+.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~----~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~  298 (303)
T 3hmm_A          228 YYDLVPSDPSVEEMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             TTTTSCSSCCHHHHHHHHTTSC----CCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             chhcccccchHHHHHHHHhccc----CCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence                   001111111111111    1111111 11235667899999999999999999999999999998764

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=9.8e-54  Score=429.50  Aligned_cols=250  Identities=23%  Similarity=0.366  Sum_probs=204.8

Q ss_pred             cCCccccccCcCCceEEEEEEc-CCCCEEEEEEccC--CChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEe
Q 009340          216 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKE--IDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE  292 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e  292 (537)
                      ++|...+.||+|+||.||+|+. .+|+.||||+++.  ......+.|.+|+.+|++++|||||++++++.+.+..|||||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            6899999999999999999995 4799999999864  345567789999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeecc
Q 009340          293 YISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG  372 (537)
Q Consensus       293 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfg  372 (537)
                      |+++|+|.+++....          ...+++.+++.++.||+.||+|||+++   |+||||||+||||+.++.+||+|||
T Consensus       104 y~~gg~L~~~i~~~~----------~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFG  170 (350)
T 4b9d_A          104 YCEGGDLFKRINAQK----------GVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFG  170 (350)
T ss_dssp             CCTTCBHHHHHHHTT----------TCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTT
T ss_pred             CCCCCcHHHHHHHcC----------CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccc
Confidence            999999999997543          235799999999999999999999999   9999999999999999999999999


Q ss_pred             CccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchh
Q 009340          373 ISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQL  452 (537)
Q Consensus       373 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  452 (537)
                      +|+...... ...+..+||+.|||||++.+..|+.++|||||||+||||++|+.||......+      .+..... +..
T Consensus       171 la~~~~~~~-~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~------~~~~i~~-~~~  242 (350)
T 4b9d_A          171 IARVLNSTV-ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN------LVLKIIS-GSF  242 (350)
T ss_dssp             EESCCCHHH-HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHH-TCC
T ss_pred             cceeecCCc-ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH------HHHHHHc-CCC
Confidence            998764321 22345679999999999999999999999999999999999999997543322      1111111 110


Q ss_pred             hhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          453 LEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       453 ~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                               ...+...+.++.+|+.+||+.||++|||+.|+++
T Consensus       243 ---------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          243 ---------PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             ---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---------CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                     1223344567889999999999999999999975

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=7.5e-53  Score=414.14  Aligned_cols=246  Identities=24%  Similarity=0.405  Sum_probs=198.2

Q ss_pred             ccccccCcCCceEEEEEEcC-CCCEEEEEEccC--CChHHHHHHHHHHHHHHhcCCCCcceEeeEEee----CCccEEEE
Q 009340          219 NQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKE--IDKTQIHQFINEVVILSQINHRHIVKLLGCCLE----TEVPVLVY  291 (537)
Q Consensus       219 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lV~  291 (537)
                      ...++||+|+||.||+|... ++..||+|++..  ......+.|.+|+.+|++++|||||++++++.+    ....+|||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            45678999999999999964 688999999854  345567789999999999999999999999875    24579999


Q ss_pred             ecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECC-CCcEEEee
Q 009340          292 EYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD-KFSAKVSD  370 (537)
Q Consensus       292 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~-~~~~ki~D  370 (537)
                      ||+++|+|.+++...            ..+++..+..++.||++||+|||+++ ++|+||||||+||||+. ++.+||+|
T Consensus       109 Ey~~gg~L~~~l~~~------------~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~D  175 (290)
T 3fpq_A          109 ELMTSGTLKTYLKRF------------KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGD  175 (290)
T ss_dssp             ECCCSCBHHHHHHHH------------SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECC
T ss_pred             eCCCCCCHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEe
Confidence            999999999999753            36999999999999999999999986 35999999999999984 78999999


Q ss_pred             ccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhc
Q 009340          371 FGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKEN  450 (537)
Q Consensus       371 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  450 (537)
                      ||+|+.....   ......||+.|||||++.+ .|+.++|||||||+||||+||+.||.......     . +......+
T Consensus       176 FGla~~~~~~---~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~-----~-~~~~i~~~  245 (290)
T 3fpq_A          176 LGLATLKRAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA-----Q-IYRRVTSG  245 (290)
T ss_dssp             TTGGGGCCTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-----H-HHHHHTTT
T ss_pred             CcCCEeCCCC---ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHH-----H-HHHHHHcC
Confidence            9999864332   3456789999999998865 69999999999999999999999996432211     1 11111111


Q ss_pred             hhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          451 QLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       451 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      ...        ...+...++++.+|+.+||+.||++|||+.|+++
T Consensus       246 ~~~--------~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          246 VKP--------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             CCC--------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCC--------CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            100        0112223356889999999999999999999864

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=3.9e-53  Score=424.48  Aligned_cols=249  Identities=23%  Similarity=0.389  Sum_probs=208.3

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecC
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI  294 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  294 (537)
                      ..|+..++||+|+||.||+|+.. +|+.||||+++.......+.+.+|+.+|++++|||||++++++.+.+..||||||+
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            56888899999999999999964 79999999986544444567889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCc
Q 009340          295 SSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGIS  374 (537)
Q Consensus       295 ~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla  374 (537)
                      ++|+|.+++..             ..+++.++..++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+|
T Consensus       154 ~gg~L~~~l~~-------------~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla  217 (346)
T 4fih_A          154 EGGALTDIVTH-------------TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFC  217 (346)
T ss_dssp             TTEEHHHHHHH-------------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred             CCCcHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCc
Confidence            99999998863             25999999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchhhh
Q 009340          375 RSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLE  454 (537)
Q Consensus       375 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  454 (537)
                      +.+..... .....+||+.|||||++.+..|+.++|||||||++|||++|+.||......+      .+.. ....    
T Consensus       218 ~~~~~~~~-~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~------~~~~-i~~~----  285 (346)
T 4fih_A          218 AQVSKEVP-RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK------AMKM-IRDN----  285 (346)
T ss_dssp             EECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHH-HHHS----
T ss_pred             eecCCCCC-cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH------HHHH-HHcC----
Confidence            87754432 3456789999999999999999999999999999999999999997543222      1111 1111    


Q ss_pred             hhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          455 ILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       455 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                       ..+.+  ......+.++.+|+.+||+.||++|||+.|+++
T Consensus       286 -~~~~~--~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          286 -LPPRL--KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             -SCCCC--SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -CCCCC--CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence             00111  112334567889999999999999999999864

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=5.8e-53  Score=421.99  Aligned_cols=256  Identities=21%  Similarity=0.258  Sum_probs=208.9

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecC
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI  294 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  294 (537)
                      +.|...++||+|+||.||+|+.. +|+.||||+++....     +.+|+.++++++|||||++++++.+.+..||||||+
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  132 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL  132 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence            46777889999999999999964 689999999875321     247999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCC-cEEEeeccC
Q 009340          295 SSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF-SAKVSDFGI  373 (537)
Q Consensus       295 ~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~-~~ki~Dfgl  373 (537)
                      ++|+|.+++...            ..+++..+..++.||+.||+|||+++   |+||||||+||||+.++ .+||+|||+
T Consensus       133 ~gg~L~~~l~~~------------~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGl  197 (336)
T 4g3f_A          133 EGGSLGQLIKQM------------GCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGH  197 (336)
T ss_dssp             TTCBHHHHHHHH------------SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTT
T ss_pred             CCCcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCC
Confidence            999999999753            36999999999999999999999999   99999999999999987 699999999


Q ss_pred             ccccCCCCCc----eeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhh
Q 009340          374 SRSIPNDKTH----LTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKE  449 (537)
Q Consensus       374 a~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  449 (537)
                      |+.+..+...    .....+||+.|||||++.+..|+.++|||||||++|||++|+.||......+   +..   .....
T Consensus       198 a~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~---~~~---~i~~~  271 (336)
T 4g3f_A          198 ALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP---LCL---KIASE  271 (336)
T ss_dssp             CEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC---CHH---HHHHS
T ss_pred             CeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH---HHH---HHHcC
Confidence            9877543221    1234579999999999999999999999999999999999999996543322   111   11111


Q ss_pred             chhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHHhhH
Q 009340          450 NQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRSQR  505 (537)
Q Consensus       450 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~~  505 (537)
                      ..        .....+...+..+.+++.+||+.||++|||+.|+++.|........
T Consensus       272 ~~--------~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~  319 (336)
T 4g3f_A          272 PP--------PIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVG  319 (336)
T ss_dssp             CC--------GGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred             CC--------CchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhh
Confidence            10        0112344556788999999999999999999999999987776543

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=2e-52  Score=413.17  Aligned_cols=247  Identities=22%  Similarity=0.378  Sum_probs=208.9

Q ss_pred             cCCccccccCcCCceEEEEEEc-CCCCEEEEEEccCC---ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEI---DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY  291 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  291 (537)
                      ++|+..+.||+|+||+||+++. .+|+.||||.+...   .....+.+.+|+++|++++|||||++++++.+.+..|+||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            5799999999999999999995 47999999998642   2233567899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeec
Q 009340          292 EYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF  371 (537)
Q Consensus       292 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Df  371 (537)
                      ||+++|+|.+++...            ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+||
T Consensus       112 Ey~~gG~L~~~i~~~------------~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DF  176 (311)
T 4aw0_A          112 SYAKNGELLKYIRKI------------GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDF  176 (311)
T ss_dssp             CCCTTEEHHHHHHHH------------SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCC
T ss_pred             ecCCCCCHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEc
Confidence            999999999999753            36999999999999999999999999   999999999999999999999999


Q ss_pred             cCccccCCCC-CceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhc
Q 009340          372 GISRSIPNDK-THLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKEN  450 (537)
Q Consensus       372 gla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  450 (537)
                      |+|+.+.... .......+||+.|||||++.+..|+.++||||+||++|||++|+.||...+..+      .+..... .
T Consensus       177 Gla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~------~~~~i~~-~  249 (311)
T 4aw0_A          177 GTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGL------IFAKIIK-L  249 (311)
T ss_dssp             TTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHH-T
T ss_pred             CCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHc-C
Confidence            9999875433 233456789999999999999999999999999999999999999997543322      1111111 1


Q ss_pred             hhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHH
Q 009340          451 QLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVS  494 (537)
Q Consensus       451 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~  494 (537)
                      .          ...+...+.++.+|+.+||+.||++|||+.|++
T Consensus       250 ~----------~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          250 E----------YDFPEKFFPKARDLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             C----------CCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred             C----------CCCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence            1          112334456788999999999999999999974

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=7.3e-52  Score=425.32  Aligned_cols=249  Identities=23%  Similarity=0.388  Sum_probs=209.1

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecC
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI  294 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  294 (537)
                      +.|+..++||+|+||.||+|+.. +|+.||||++........+.+.+|+.+|++++|||||++++++.+.+..|||||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~  230 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  230 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence            57889999999999999999964 69999999987655555567899999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCc
Q 009340          295 SSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGIS  374 (537)
Q Consensus       295 ~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla  374 (537)
                      ++|+|.+++..             ..+++.++..++.||++||+|||+++   ||||||||+||||+.++.+||+|||+|
T Consensus       231 ~gG~L~~~i~~-------------~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla  294 (423)
T 4fie_A          231 EGGALTDIVTH-------------TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFC  294 (423)
T ss_dssp             TTEEHHHHHHH-------------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTC
T ss_pred             CCCcHHHHHhc-------------cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccc
Confidence            99999998853             25999999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchhhh
Q 009340          375 RSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLE  454 (537)
Q Consensus       375 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  454 (537)
                      +.+..... .....+||+.|||||++.+..|+.++|||||||++|||++|+.||......+.      +.. ....    
T Consensus       295 ~~~~~~~~-~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~------~~~-i~~~----  362 (423)
T 4fie_A          295 AQVSKEVP-RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA------MKM-IRDN----  362 (423)
T ss_dssp             EECCSSCC-CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHH-HHHS----
T ss_pred             eECCCCCc-cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH------HHH-HHcC----
Confidence            87754432 34567899999999999999999999999999999999999999965432211      111 1111    


Q ss_pred             hhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          455 ILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       455 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                       ..+.+  ......+.++.+|+.+||+.||++|||+.|+++
T Consensus       363 -~~~~~--~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          363 -LPPRL--KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             -CCCCC--SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -CCCCC--cccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence             01111  112234567889999999999999999999864

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=2.3e-51  Score=400.13  Aligned_cols=245  Identities=26%  Similarity=0.392  Sum_probs=191.2

Q ss_pred             cCCccccccCcCCceEEEEEEc-CCCCEEEEEEccCC---ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEI---DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY  291 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  291 (537)
                      ++|+..+.||+|+||.||+|+. .+|+.||||.++..   .....+.+.+|+.++++++|||||++++++.+.+..|+||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            6899999999999999999995 47999999998642   2233567899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeec
Q 009340          292 EYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF  371 (537)
Q Consensus       292 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Df  371 (537)
                      ||+ +|+|.+++...            ..+++.++..++.||+.||+|||+++   |+||||||+|||+++++.+||+||
T Consensus        93 Ey~-~g~L~~~l~~~------------~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DF  156 (275)
T 3hyh_A           93 EYA-GNELFDYIVQR------------DKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADF  156 (275)
T ss_dssp             ECC-CEEHHHHHHHS------------CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCS
T ss_pred             eCC-CCCHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeec
Confidence            999 67999998653            46999999999999999999999999   999999999999999999999999


Q ss_pred             cCccccCCCCCceeeeccccccccCcccccCCCC-CcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhc
Q 009340          372 GISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQF-TDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKEN  450 (537)
Q Consensus       372 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  450 (537)
                      |+|+......  ......||+.|||||++.+..+ +.++||||+||++|||++|+.||.......      .+... ..+
T Consensus       157 Gla~~~~~~~--~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~------~~~~i-~~~  227 (275)
T 3hyh_A          157 GLSNIMTDGN--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPV------LFKNI-SNG  227 (275)
T ss_dssp             SCC-----------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHH-HHT
T ss_pred             CCCeecCCCC--ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHH------HHHHH-HcC
Confidence            9998764332  2345689999999999998776 579999999999999999999997543221      11111 111


Q ss_pred             hhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          451 QLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       451 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      .          ...+...+.++.+|+.+||+.||++|||+.|+++
T Consensus       228 ~----------~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          228 V----------YTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             C----------CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             C----------CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            1          1123334567889999999999999999999865

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.2e-51  Score=407.51  Aligned_cols=243  Identities=26%  Similarity=0.332  Sum_probs=195.3

Q ss_pred             cCCccccccCcCCceEEEEEEc----CCCCEEEEEEccCCC--hHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGML----PDGSIVAVKRSKEID--KTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVL  289 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~----~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  289 (537)
                      ++|+..+.||+|+||.||+++.    ..++.||||.++...  ......+.+|+.+|++++|||||++++++.+.+..|+
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            5799999999999999999984    247899999886421  2223467889999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEe
Q 009340          290 VYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVS  369 (537)
Q Consensus       290 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~  369 (537)
                      ||||+++|+|.+++...            ..+++.++..++.|++.||+|||+++   |+||||||+|||++.++.+||+
T Consensus       104 vmEy~~gg~L~~~l~~~------------~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~  168 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKE------------VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLT  168 (304)
T ss_dssp             EECCCTTCEEHHHHHHH------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEE
T ss_pred             EEEcCCCCCHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEec
Confidence            99999999999999753            36999999999999999999999999   9999999999999999999999


Q ss_pred             eccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhh
Q 009340          370 DFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKE  449 (537)
Q Consensus       370 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  449 (537)
                      |||+|+...... .......||+.|||||++.+..|+.++|||||||++|||+||+.||...+..+.      +..... 
T Consensus       169 DFGla~~~~~~~-~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~------~~~i~~-  240 (304)
T 3ubd_A          169 DFGLSKESIDHE-KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKET------MTMILK-  240 (304)
T ss_dssp             SSEEEEC------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHH-
T ss_pred             ccccceeccCCC-ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHH------HHHHHc-
Confidence            999998654332 223456799999999999999999999999999999999999999975433221      111111 


Q ss_pred             chhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHh
Q 009340          450 NQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMK  491 (537)
Q Consensus       450 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~  491 (537)
                      ..          ...+...++++.+|+.+||+.||++|||+.
T Consensus       241 ~~----------~~~p~~~s~~~~~li~~~L~~dP~~R~ta~  272 (304)
T 3ubd_A          241 AK----------LGMPQFLSPEAQSLLRMLFKRNPANRLGAG  272 (304)
T ss_dssp             CC----------CCCCTTSCHHHHHHHHHHTCSSGGGSTTCS
T ss_pred             CC----------CCCCCcCCHHHHHHHHHHcccCHHHCCCCC
Confidence            11          122334556788999999999999999964

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.2e-50  Score=401.80  Aligned_cols=250  Identities=23%  Similarity=0.387  Sum_probs=189.9

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCC-ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCc-------
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI-DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEV-------  286 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-------  286 (537)
                      ++|+..+.||+|+||.||+|+.. +|+.||||+++.. .....+.+.+|+.+|++++|||||++++++.+.+.       
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            46888999999999999999954 7899999998653 34456779999999999999999999999876543       


Q ss_pred             -----cEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEC
Q 009340          287 -----PVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD  361 (537)
Q Consensus       287 -----~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~  361 (537)
                           .|+||||+++|+|.+++.....         ....++..++.++.||++||+|||+++   |+||||||+|||++
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~---------~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~  152 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCT---------IEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFT  152 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCS---------GGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCC---------CChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEEC
Confidence                 6899999999999999976543         234677888999999999999999999   99999999999999


Q ss_pred             CCCcEEEeeccCccccCCCCCc-----------eeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCc
Q 009340          362 DKFSAKVSDFGISRSIPNDKTH-----------LTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICF  430 (537)
Q Consensus       362 ~~~~~ki~Dfgla~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~  430 (537)
                      .++.+||+|||+|+........           ..+..+||+.|||||++.+..|+.++|||||||++|||++   ||..
T Consensus       153 ~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~  229 (299)
T 4g31_A          153 MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFST  229 (299)
T ss_dssp             TTCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSS
T ss_pred             CCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCC
Confidence            9999999999999876443221           1234579999999999999999999999999999999996   6642


Q ss_pred             cchhhhccHHHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          431 ARVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       431 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      ..  +.   ..... .......         .+......+.+.+|+.+||+.||++|||+.|+++
T Consensus       230 ~~--~~---~~~~~-~~~~~~~---------p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          230 QM--ER---VRTLT-DVRNLKF---------PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             HH--HH---HHHHH-HHHTTCC---------CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             cc--HH---HHHHH-HHhcCCC---------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            21  10   00000 0111110         0112233456678999999999999999999875

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.8e-48  Score=391.68  Aligned_cols=288  Identities=40%  Similarity=0.675  Sum_probs=246.9

Q ss_pred             ccCHHHHHHHhcCCccccccCcCCceEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeC
Q 009340          205 VFTADELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLET  284 (537)
Q Consensus       205 ~~~~~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~  284 (537)
                      .++..++..++++|...+.||+|+||.||+|+.++|+.||||++........+.+.+|+.+++.++||||+++++++.+.
T Consensus        28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  107 (321)
T 2qkw_B           28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDER  107 (321)
T ss_dssp             --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT
T ss_pred             eecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence            34555666788999999999999999999999888999999998876666778899999999999999999999999999


Q ss_pred             CccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCC
Q 009340          285 EVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF  364 (537)
Q Consensus       285 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~  364 (537)
                      +..++||||+++|+|.+++......        ...++|..++.++.|+++||.|||+.+   |+||||||+|||++.++
T Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~~~~--------~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~  176 (321)
T 2qkw_B          108 NEMILIYKYMENGNLKRHLYGSDLP--------TMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENF  176 (321)
T ss_dssp             TCCEEEEECCTTCBTGGGSSSSCCC--------SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTC
T ss_pred             CeEEEEEEcCCCCcHHHHHhccCCC--------ccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCC
Confidence            9999999999999999999764321        235999999999999999999999998   99999999999999999


Q ss_pred             cEEEeeccCccccCCCC-CceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHH
Q 009340          365 SAKVSDFGISRSIPNDK-THLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACF  443 (537)
Q Consensus       365 ~~ki~Dfgla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~  443 (537)
                      .+||+|||+++...... ........||+.|+|||.+.+..++.++||||||+++|||++|+.||......+......+.
T Consensus       177 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~  256 (321)
T 2qkw_B          177 VPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWA  256 (321)
T ss_dssp             CEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHT
T ss_pred             CEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHh
Confidence            99999999998654322 22234456899999999999899999999999999999999999999876655555555555


Q ss_pred             HHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHHh
Q 009340          444 ISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRS  503 (537)
Q Consensus       444 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~  503 (537)
                      ......+.+...+++.+....+...+..+.+++.+||+.||++|||+.++++.|+.+.+.
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~  316 (321)
T 2qkw_B          257 VESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL  316 (321)
T ss_dssp             HHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             hhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence            555555666667777766677888899999999999999999999999999999988764

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=6e-48  Score=388.62  Aligned_cols=291  Identities=37%  Similarity=0.684  Sum_probs=247.2

Q ss_pred             cccccCHHHHHHHhcCCccccccCcCCceEEEEEEcCCCCEEEEEEccCCChH-HHHHHHHHHHHHHhcCCCCcceEeeE
Q 009340          202 RAKVFTADELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKT-QIHQFINEVVILSQINHRHIVKLLGC  280 (537)
Q Consensus       202 ~~~~~~~~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~  280 (537)
                      ....|+..++..+.++|...+.||+|+||.||+|...+|+.||||++...... ....+.+|+.+++.++||||++++++
T Consensus        16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~   95 (326)
T 3uim_A           16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF   95 (326)
T ss_dssp             CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred             ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence            45679999999999999999999999999999999888999999998754322 22368899999999999999999999


Q ss_pred             EeeCCccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEE
Q 009340          281 CLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILL  360 (537)
Q Consensus       281 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll  360 (537)
                      +.+.+..++||||+++|+|.+++......        ...++|..++.++.|+++||.|||+...++|+||||||+|||+
T Consensus        96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~--------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~  167 (326)
T 3uim_A           96 CMTPTERLLVYPYMANGSVASCLRERPES--------QPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILL  167 (326)
T ss_dssp             ECCSSCCEEEEECCTTCBHHHHHHCCSTT--------CCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEE
T ss_pred             EecCCceEEEEEeccCCCHHHHHHhcccc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEE
Confidence            99999999999999999999999765431        3459999999999999999999999932239999999999999


Q ss_pred             CCCCcEEEeeccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccch--hhhcc
Q 009340          361 DDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARV--EEERN  438 (537)
Q Consensus       361 ~~~~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~--~~~~~  438 (537)
                      +.++.+||+|||++...............||+.|+|||.+.+..++.++||||||+++|||++|+.||.....  .....
T Consensus       168 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~  247 (326)
T 3uim_A          168 DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM  247 (326)
T ss_dssp             CTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSB
T ss_pred             CCCCCEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchh
Confidence            9999999999999988765555555666799999999999888899999999999999999999999964322  22233


Q ss_pred             HHHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHH
Q 009340          439 LVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGL  500 (537)
Q Consensus       439 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i  500 (537)
                      ...+..............+.......+...+..+.+++.+||+.||++|||+.+|+++|+..
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  309 (326)
T 3uim_A          248 LLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD  309 (326)
T ss_dssp             HHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred             HHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence            44455555555566677777777778888999999999999999999999999999999863

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=9.6e-48  Score=395.19  Aligned_cols=261  Identities=22%  Similarity=0.324  Sum_probs=201.8

Q ss_pred             cCCccccccCcCCceEEEEEEc-CCCCEEEEEEccCC--ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeC------Cc
Q 009340          216 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEI--DKTQIHQFINEVVILSQINHRHIVKLLGCCLET------EV  286 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~  286 (537)
                      ++|...+.||+|+||.||+|+. .+|+.||||+++..  .....+.+.+|+.+|++++|||||++++++...      +.
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            5799999999999999999995 47999999998643  345567789999999999999999999998643      56


Q ss_pred             cEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcE
Q 009340          287 PVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA  366 (537)
Q Consensus       287 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~  366 (537)
                      .||||||++ |+|.+++...            ..+++..+..++.||+.||.|||+++   ||||||||+|||++.++.+
T Consensus       134 ~~ivmE~~~-g~L~~~i~~~------------~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~  197 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHSS------------QPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCEL  197 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTSS------------SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCE
T ss_pred             EEEEEeCCC-CCHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCE
Confidence            799999996 6899998753            46999999999999999999999999   9999999999999999999


Q ss_pred             EEeeccCccccCCCC---CceeeeccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHH
Q 009340          367 KVSDFGISRSIPNDK---THLTTTIQGTFGYLDPEYFQSS-QFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVAC  442 (537)
Q Consensus       367 ki~Dfgla~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~  442 (537)
                      ||+|||+|+.+....   .......+||+.|||||++.+. .++.++||||+||++|||++|+.||......+..   ..
T Consensus       198 Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l---~~  274 (398)
T 4b99_A          198 KIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQL---QL  274 (398)
T ss_dssp             EECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHH---HH
T ss_pred             EEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHH---HH
Confidence            999999998764322   2234557899999999998775 5699999999999999999999999765433211   11


Q ss_pred             HHHHHhhch-----------hhhhhc---HHh---hccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          443 FISLAKENQ-----------LLEILD---ARV---AKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       443 ~~~~~~~~~-----------~~~~~d---~~~---~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      .........           ....+.   +..   ........+.++.+|+.+||+.||++|||+.|+++
T Consensus       275 I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  344 (398)
T 4b99_A          275 IMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR  344 (398)
T ss_dssp             HHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             HHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            111110000           000000   000   00001123457889999999999999999999865

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=8.8e-47  Score=383.88  Aligned_cols=200  Identities=23%  Similarity=0.381  Sum_probs=171.1

Q ss_pred             HHhcCCccccccCcCCceEEEEEEcC----CCCEEEEEEccCCChHHHHHHHHHHHHHHhc-CCCCcceEeeEEeeCCcc
Q 009340          213 RATDNYNQSRFLGQGGFGTVYKGMLP----DGSIVAVKRSKEIDKTQIHQFINEVVILSQI-NHRHIVKLLGCCLETEVP  287 (537)
Q Consensus       213 ~~~~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~  287 (537)
                      ...+.|+..++||+|+||+||+|+.+    .++.||||++....  ...++.+|+++|+.+ +||||+++++++.+.+..
T Consensus        18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~   95 (361)
T 4f9c_A           18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV   95 (361)
T ss_dssp             GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred             CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence            34578999999999999999999742    46789999886543  235678999999998 699999999999999999


Q ss_pred             EEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCC-CcE
Q 009340          288 VLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK-FSA  366 (537)
Q Consensus       288 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~-~~~  366 (537)
                      ++||||+++|+|.+++.               .+++.++..++.|+++||+|||+++   |+||||||+|||++.+ +.+
T Consensus        96 ~lvmE~~~g~~L~~~~~---------------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~  157 (361)
T 4f9c_A           96 VIAMPYLEHESFLDILN---------------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKY  157 (361)
T ss_dssp             EEEEECCCCCCHHHHHT---------------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEE
T ss_pred             EEEEeCCCcccHHHHHc---------------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeE
Confidence            99999999999999883               4889999999999999999999999   9999999999999877 799


Q ss_pred             EEeeccCccccCCCCC---------------------------ceeeeccccccccCcccccCC-CCCcchhHHHHHHHH
Q 009340          367 KVSDFGISRSIPNDKT---------------------------HLTTTIQGTFGYLDPEYFQSS-QFTDKSDVYSFGVVL  418 (537)
Q Consensus       367 ki~Dfgla~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvll  418 (537)
                      ||+|||+|+.......                           ...+..+||+.|+|||++.+. .++.++||||+||++
T Consensus       158 kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il  237 (361)
T 4f9c_A          158 ALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIF  237 (361)
T ss_dssp             EECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHH
T ss_pred             EECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHH
Confidence            9999999986533211                           112345799999999999775 589999999999999


Q ss_pred             HHHHhCCCCCCccc
Q 009340          419 LELLTGKKPICFAR  432 (537)
Q Consensus       419 ~el~tg~~p~~~~~  432 (537)
                      |||++|+.||....
T Consensus       238 ~ell~G~~Pf~~~~  251 (361)
T 4f9c_A          238 LSLLSGRYPFYKAS  251 (361)
T ss_dssp             HHHHHTCSSSSCCS
T ss_pred             HHHHHCCCCCCCCC
Confidence            99999999996543

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.2e-45  Score=369.11  Aligned_cols=261  Identities=27%  Similarity=0.445  Sum_probs=215.9

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecC
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI  294 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  294 (537)
                      ++|...++||+|+||.||++... +++.||+|++...+....+.|.+|+.++++++||||+++++++.+.+..++||||+
T Consensus        10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~   89 (310)
T 3s95_A           10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI   89 (310)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence            57888899999999999999964 68999999998777788889999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCc
Q 009340          295 SSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGIS  374 (537)
Q Consensus       295 ~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla  374 (537)
                      ++|+|.+++....           ..++|..++.++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        90 ~~~~L~~~l~~~~-----------~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~  155 (310)
T 3s95_A           90 KGGTLRGIIKSMD-----------SQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLA  155 (310)
T ss_dssp             TTCBHHHHHHHCC-----------TTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTC
T ss_pred             CCCcHHHHHHhcc-----------CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccc
Confidence            9999999997632           36999999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCCce-------------eeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHH
Q 009340          375 RSIPNDKTHL-------------TTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVA  441 (537)
Q Consensus       375 ~~~~~~~~~~-------------~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~  441 (537)
                      +.........             .....||+.|+|||.+.+..++.++||||||+++|||++|..|+...........  
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~--  233 (310)
T 3s95_A          156 RLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG--  233 (310)
T ss_dssp             EECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSS--
T ss_pred             eecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHh--
Confidence            8764332211             1145689999999999999999999999999999999999999764322211000  


Q ss_pred             HHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHHhh
Q 009340          442 CFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRSQ  504 (537)
Q Consensus       442 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~  504 (537)
                              .......    ....+..++..+.+++.+||+.||++|||+.++++.|+.++...
T Consensus       234 --------~~~~~~~----~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~  284 (310)
T 3s95_A          234 --------LNVRGFL----DRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL  284 (310)
T ss_dssp             --------BCHHHHH----HHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             --------hhhhccc----cccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence                    0000111    11122334456889999999999999999999999999998743

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=4.9e-46  Score=400.64  Aligned_cols=252  Identities=22%  Similarity=0.314  Sum_probs=210.9

Q ss_pred             hcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEec
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY  293 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  293 (537)
                      .++|+..+.||+|+||.||+++.+ +|+.||+|.+........+.+.+|+.+|+.++|||||++++++.+.+..++||||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~  235 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  235 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence            368999999999999999999964 7999999999876666677899999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCC--CcEEEeec
Q 009340          294 ISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK--FSAKVSDF  371 (537)
Q Consensus       294 ~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~--~~~ki~Df  371 (537)
                      +++|+|.+++....           ..+++.++..++.||++||.|||+++   |+||||||+|||++.+  +.+||+||
T Consensus       236 ~~gg~L~~~i~~~~-----------~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DF  301 (573)
T 3uto_A          236 MSGGELFEKVADEH-----------NKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDF  301 (573)
T ss_dssp             CCCCBHHHHHTCTT-----------SCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCC
T ss_pred             cCCCcHHHHHHHhC-----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeec
Confidence            99999999986532           36899999999999999999999999   9999999999999854  89999999


Q ss_pred             cCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhch
Q 009340          372 GISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQ  451 (537)
Q Consensus       372 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  451 (537)
                      |+++.+....  .....+||+.|||||++.+..|+.++||||+||++|||++|+.||......+.      +...... .
T Consensus       302 G~a~~~~~~~--~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~------~~~i~~~-~  372 (573)
T 3uto_A          302 GLTAHLDPKQ--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET------LRNVKSC-D  372 (573)
T ss_dssp             SSCEECCTTS--EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH------HHHHHTT-C
T ss_pred             cceeEccCCC--ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH------HHHHHhC-C
Confidence            9999875433  34556799999999999999999999999999999999999999975443221      1111110 0


Q ss_pred             hhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          452 LLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       452 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                            ..+........+..+.+|+.+||+.||++|||+.|+++
T Consensus       373 ------~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          373 ------WNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             ------CCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ------CCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                  00111112234467889999999999999999999976

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=1.2e-44  Score=361.25  Aligned_cols=284  Identities=34%  Similarity=0.601  Sum_probs=231.8

Q ss_pred             cccccCHHHHHHHhcCCccc------cccCcCCceEEEEEEcCCCCEEEEEEccCC----ChHHHHHHHHHHHHHHhcCC
Q 009340          202 RAKVFTADELQRATDNYNQS------RFLGQGGFGTVYKGMLPDGSIVAVKRSKEI----DKTQIHQFINEVVILSQINH  271 (537)
Q Consensus       202 ~~~~~~~~el~~~~~~~~~~------~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~H  271 (537)
                      ....|++.++..++++|...      +.||+|+||.||+|.. +++.||||++...    .....+.+.+|+.++++++|
T Consensus        11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h   89 (307)
T 2nru_A           11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH   89 (307)
T ss_dssp             CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred             CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence            34679999999999999988      8899999999999998 5889999988642    23456789999999999999


Q ss_pred             CCcceEeeEEeeCCccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 009340          272 RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHR  351 (537)
Q Consensus       272 ~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~  351 (537)
                      |||+++++++.+.+..++||||+++|+|.+++.....         ...++|..++.++.|+++||.|||+.+   |+||
T Consensus        90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~  157 (307)
T 2nru_A           90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG---------TPPLSWHMRCKIAQGAANGINFLHENH---HIHR  157 (307)
T ss_dssp             TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGG---------CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECS
T ss_pred             CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccC---------CCCCCHHHHHHHHHHHHHHHHHHhcCC---eecC
Confidence            9999999999999999999999999999999975433         346999999999999999999999999   9999


Q ss_pred             CCCCCCEEECCCCcEEEeeccCccccCCCCCc-eeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCc
Q 009340          352 DIKSSNILLDDKFSAKVSDFGISRSIPNDKTH-LTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICF  430 (537)
Q Consensus       352 Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~  430 (537)
                      ||||+||+++.++.+||+|||++......... ......||+.|+|||.+.+ .++.++||||||+++|||++|+.||..
T Consensus       158 dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~  236 (307)
T 2nru_A          158 DIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDE  236 (307)
T ss_dssp             CCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCT
T ss_pred             CCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCccc
Confidence            99999999999999999999999876443322 2334568999999998864 588999999999999999999999875


Q ss_pred             cchhhhccHHHHHHHHHh-hchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHH
Q 009340          431 ARVEEERNLVACFISLAK-ENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRR  502 (537)
Q Consensus       431 ~~~~~~~~~~~~~~~~~~-~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~  502 (537)
                      ......  .......... ...+.+.+++.+ ...+...+..+.+++.+||+.||.+|||+.+|++.|+++..
T Consensus       237 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~  306 (307)
T 2nru_A          237 HREPQL--LLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA  306 (307)
T ss_dssp             TBSSSB--TTHHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred             CcchHH--HHHHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence            433221  1111111111 122333444333 23466778899999999999999999999999999998865

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=5.2e-46  Score=382.34  Aligned_cols=260  Identities=25%  Similarity=0.449  Sum_probs=215.5

Q ss_pred             hcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCC-ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEe
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI-DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE  292 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e  292 (537)
                      .++|...+.||+|+||.||+|.+. +++.||||.++.. .....++|.+|+.++++++||||+++++++.+.+..++|||
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  192 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME  192 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence            467888999999999999999976 7899999998754 34455678999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeecc
Q 009340          293 YISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG  372 (537)
Q Consensus       293 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfg  372 (537)
                      |+++|+|.+++....           ..+++..++.++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||
T Consensus       193 ~~~~g~L~~~l~~~~-----------~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG  258 (377)
T 3cbl_A          193 LVQGGDFLTFLRTEG-----------ARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFG  258 (377)
T ss_dssp             CCTTCBHHHHHHHHG-----------GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGG
T ss_pred             cCCCCCHHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCC
Confidence            999999999997543           25899999999999999999999999   9999999999999999999999999


Q ss_pred             CccccCCCCCcee-eeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHHHHHhhc
Q 009340          373 ISRSIPNDKTHLT-TTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKEN  450 (537)
Q Consensus       373 la~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  450 (537)
                      +++.......... ....++..|+|||.+.++.++.++||||||+++|||++ |+.||......+       ....    
T Consensus       259 ~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~-------~~~~----  327 (377)
T 3cbl_A          259 MSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ-------TREF----  327 (377)
T ss_dssp             GCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH-------HHHH----
T ss_pred             CceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHH----
Confidence            9986543322111 12335788999999998899999999999999999998 999986543221       1111    


Q ss_pred             hhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHHhh
Q 009340          451 QLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRSQ  504 (537)
Q Consensus       451 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~  504 (537)
                           +......+.+..++..+.+|+.+||+.||++|||+.+|++.|+.+.+..
T Consensus       328 -----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~~  376 (377)
T 3cbl_A          328 -----VEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKRH  376 (377)
T ss_dssp             -----HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             -----HHcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhhc
Confidence                 1111122334445567899999999999999999999999999998754

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.2e-45  Score=395.69  Aligned_cols=247  Identities=23%  Similarity=0.354  Sum_probs=199.5

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCC------ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI------DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPV  288 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~------~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  288 (537)
                      ++|+..++||+|+||.||+++.. +|+.||||+++..      ..........++.+++.++|||||++++++.+.+..|
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly  268 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS  268 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence            67999999999999999999964 6999999998531      1122223344567777889999999999999999999


Q ss_pred             EEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEE
Q 009340          289 LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKV  368 (537)
Q Consensus       289 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki  368 (537)
                      +||||+++|+|.++|...            ..+++..+..++.||+.||+|||+++   ||||||||+||||+.+|.+||
T Consensus       269 lVmEy~~GGdL~~~l~~~------------~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL  333 (689)
T 3v5w_A          269 FILDLMNGGDLHYHLSQH------------GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRI  333 (689)
T ss_dssp             EEECCCCSCBHHHHHHHH------------CCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEE
T ss_pred             EEEecCCCCcHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEe
Confidence            999999999999999753            36999999999999999999999999   999999999999999999999


Q ss_pred             eeccCccccCCCCCceeeeccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHH
Q 009340          369 SDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQS-SQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLA  447 (537)
Q Consensus       369 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~  447 (537)
                      +|||+|+......   ..+.+||+.|||||++.. ..|+.++||||+||++|||++|+.||......+.   ........
T Consensus       334 ~DFGlA~~~~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~---~~i~~~i~  407 (689)
T 3v5w_A          334 SDLGLACDFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK---HEIDRMTL  407 (689)
T ss_dssp             CCCTTCEECSSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH---HHHHHHHH
T ss_pred             cccceeeecCCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHhhc
Confidence            9999998765432   345689999999999975 5799999999999999999999999975432221   11111111


Q ss_pred             hhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCC-----HhhHH
Q 009340          448 KENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPT-----MKQVS  494 (537)
Q Consensus       448 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~ev~  494 (537)
                      .           .....+...+.++.+|+.+||+.||++|++     +.||+
T Consensus       408 ~-----------~~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~  448 (689)
T 3v5w_A          408 T-----------MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVK  448 (689)
T ss_dssp             H-----------CCCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHT
T ss_pred             C-----------CCCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHh
Confidence            1           011233445567889999999999999998     45554

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=5.3e-46  Score=369.01  Aligned_cols=267  Identities=25%  Similarity=0.480  Sum_probs=213.2

Q ss_pred             hcCCccccccCcCCceEEEEEEc-----CCCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeC--Ccc
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGML-----PDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLET--EVP  287 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~  287 (537)
                      .++|+..+.||+|+||.||++++     .+++.||||++........+.|.+|+.++++++||||+++++++...  ...
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   88 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence            36788899999999999999984     36889999999887777788899999999999999999999998654  458


Q ss_pred             EEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEE
Q 009340          288 VLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK  367 (537)
Q Consensus       288 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~k  367 (537)
                      ++||||+++|+|.+++.....           .+++..++.++.|+++||.|||+.+   |+||||||+|||++.++.+|
T Consensus        89 ~lv~e~~~~~~L~~~l~~~~~-----------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~k  154 (295)
T 3ugc_A           89 KLIMEYLPYGSLRDYLQKHKE-----------RIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVK  154 (295)
T ss_dssp             EEEEECCTTCBHHHHHHHCGG-----------GCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEE
T ss_pred             EEEEEeCCCCCHHHHHHhccc-----------ccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEE
Confidence            999999999999999976432           4999999999999999999999999   99999999999999999999


Q ss_pred             EeeccCccccCCCCCc--eeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHH
Q 009340          368 VSDFGISRSIPNDKTH--LTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFIS  445 (537)
Q Consensus       368 i~Dfgla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~  445 (537)
                      |+|||++.........  ......++..|+|||.+.+..++.++||||||+++|||++|..|+......        +..
T Consensus       155 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~--------~~~  226 (295)
T 3ugc_A          155 IGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE--------FMR  226 (295)
T ss_dssp             ECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH--------HHH
T ss_pred             EccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHH--------HHh
Confidence            9999999876443322  223345778899999999999999999999999999999999997543211        111


Q ss_pred             HHhhc--------hhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHHh
Q 009340          446 LAKEN--------QLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRS  503 (537)
Q Consensus       446 ~~~~~--------~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~  503 (537)
                      .....        ...+.+......+.+..++..+.+++.+||+.||++|||+.|+++.|+.++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~  292 (295)
T 3ugc_A          227 MIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN  292 (295)
T ss_dssp             HHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             hhcCccccchhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence            10000        11111222222233455667899999999999999999999999999999874

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=2.3e-45  Score=369.81  Aligned_cols=259  Identities=28%  Similarity=0.453  Sum_probs=212.4

Q ss_pred             cCCccccccCcCCceEEEEEEcC----CCCEEEEEEccCC-ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP----DGSIVAVKRSKEI-DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLV  290 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  290 (537)
                      ++|...+.||+|+||.||+|...    .+..||||.++.. .....+.|.+|+.++++++||||+++++++.+.+..++|
T Consensus        49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  128 (325)
T 3kul_A           49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV  128 (325)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred             hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence            56777899999999999999974    3446999999764 455567899999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEee
Q 009340          291 YEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSD  370 (537)
Q Consensus       291 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~D  370 (537)
                      |||+++|+|.+++....           ..+++..++.++.|+++||.|||+.+   |+||||||+|||++.++.+||+|
T Consensus       129 ~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~D  194 (325)
T 3kul_A          129 TEYMENGSLDTFLRTHD-----------GQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSD  194 (325)
T ss_dssp             EECCTTCBHHHHHHTTT-----------TCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECC
T ss_pred             eeCCCCCcHHHHHHhcc-----------cCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECC
Confidence            99999999999996542           36999999999999999999999999   99999999999999999999999


Q ss_pred             ccCccccCCCCCc--eeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHHHHH
Q 009340          371 FGISRSIPNDKTH--LTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLA  447 (537)
Q Consensus       371 fgla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~  447 (537)
                      ||+++........  ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+       .....
T Consensus       195 fg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-------~~~~~  267 (325)
T 3kul_A          195 FGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD-------VISSV  267 (325)
T ss_dssp             CSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH-------HHHHH
T ss_pred             CCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH-------HHHHH
Confidence            9999877543322  2233456788999999998899999999999999999999 999986543322       11111


Q ss_pred             hhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHHhh
Q 009340          448 KENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRSQ  504 (537)
Q Consensus       448 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~  504 (537)
                      .         .....+.+..++..+.+|+.+||+.||++|||+.+|++.|+.+..+.
T Consensus       268 ~---------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~  315 (325)
T 3kul_A          268 E---------EGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP  315 (325)
T ss_dssp             H---------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred             H---------cCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence            1         11122233445567899999999999999999999999999988754

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=2.4e-45  Score=376.59  Aligned_cols=260  Identities=27%  Similarity=0.469  Sum_probs=204.5

Q ss_pred             cCCccccccCcCCceEEEEEEcC----CCCEEEEEEccCC-ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP----DGSIVAVKRSKEI-DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLV  290 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  290 (537)
                      ++|...+.||+|+||.||+|+..    ++..||||+++.. .....++|.+|+.++++++||||+++++++.+.+..++|
T Consensus        45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (373)
T 2qol_A           45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV  124 (373)
T ss_dssp             GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence            57888999999999999999864    5778999998754 445567899999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEee
Q 009340          291 YEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSD  370 (537)
Q Consensus       291 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~D  370 (537)
                      |||+++|+|.+++....           ..+++..++.++.|+++||.|||+.+   |+||||||+|||++.++.+||+|
T Consensus       125 ~e~~~~~sL~~~l~~~~-----------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~D  190 (373)
T 2qol_A          125 TEYMENGSLDSFLRKHD-----------AQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSD  190 (373)
T ss_dssp             EECCTTCBHHHHHHTTT-----------TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECC
T ss_pred             EeCCCCCcHHHHHHhCC-----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECc
Confidence            99999999999997542           36999999999999999999999999   99999999999999999999999


Q ss_pred             ccCccccCCCCCce--eeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHHHHH
Q 009340          371 FGISRSIPNDKTHL--TTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLA  447 (537)
Q Consensus       371 fgla~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~  447 (537)
                      ||+++.........  .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+       ...  
T Consensus       191 fg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~-------~~~--  261 (373)
T 2qol_A          191 FGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD-------VIK--  261 (373)
T ss_dssp             C----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH-------HHH--
T ss_pred             CccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHH--
Confidence            99998765432221  222345788999999999999999999999999999998 999986543221       111  


Q ss_pred             hhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHHhhH
Q 009340          448 KENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRSQR  505 (537)
Q Consensus       448 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~~  505 (537)
                             .+......+.+..++..+.+++.+||+.||++||++.+|+++|+.+.....
T Consensus       262 -------~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~~  312 (373)
T 2qol_A          262 -------AVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPG  312 (373)
T ss_dssp             -------HHHTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCGG
T ss_pred             -------HHHcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCcc
Confidence                   111112222334455678999999999999999999999999999987554

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=7.9e-45  Score=372.48  Aligned_cols=270  Identities=26%  Similarity=0.435  Sum_probs=216.5

Q ss_pred             hcCCccccccCcCCceEEEEEEc--------CCCCEEEEEEccCC-ChHHHHHHHHHHHHHHhc-CCCCcceEeeEEeeC
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGML--------PDGSIVAVKRSKEI-DKTQIHQFINEVVILSQI-NHRHIVKLLGCCLET  284 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~--------~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~  284 (537)
                      .++|...+.||+|+||.||+|..        .++..||||.++.. .....+.+.+|+.+++++ +||||+++++++.+.
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            36788899999999999999985        23557999999764 344567899999999999 899999999999999


Q ss_pred             CccEEEEecCCCCChhhhhhhhhhhHHHH----hhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEE
Q 009340          285 EVPVLVYEYISSGTLSHHIHDHQQQQEQK----QKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILL  360 (537)
Q Consensus       285 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~----~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll  360 (537)
                      +..++||||+++|+|.+++..........    .......+++..++.++.|+++||.|||+.+   |+||||||+|||+
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll  236 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV  236 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence            99999999999999999998653210000    0011235899999999999999999999999   9999999999999


Q ss_pred             CCCCcEEEeeccCccccCCCCCc-eeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhcc
Q 009340          361 DDKFSAKVSDFGISRSIPNDKTH-LTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERN  438 (537)
Q Consensus       361 ~~~~~~ki~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~  438 (537)
                      +.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||......+   
T Consensus       237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~---  313 (370)
T 2psq_A          237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---  313 (370)
T ss_dssp             CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---
T ss_pred             CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---
Confidence            99999999999999876443322 2233457889999999999999999999999999999999 999986543322   


Q ss_pred             HHHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHHh
Q 009340          439 LVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRS  503 (537)
Q Consensus       439 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~  503 (537)
                          .......         ......+..++..+.+++.+||+.||++|||+.|+++.|+++...
T Consensus       314 ----~~~~~~~---------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~  365 (370)
T 2psq_A          314 ----LFKLLKE---------GHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL  365 (370)
T ss_dssp             ----HHHHHHT---------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----HHHHHhc---------CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence                1111111         111223444556789999999999999999999999999998763

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=2.5e-45  Score=366.96  Aligned_cols=270  Identities=30%  Similarity=0.447  Sum_probs=209.5

Q ss_pred             CHHHHHHHhcCCccccccCcCCceEEEEEEcCCCCEEEEEEccCC--ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeC
Q 009340          207 TADELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEI--DKTQIHQFINEVVILSQINHRHIVKLLGCCLET  284 (537)
Q Consensus       207 ~~~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~  284 (537)
                      +..++....++|+..+.||+|+||.||+|.. +|+.||||.+...  .....++|.+|+.++++++||||+++++++.+.
T Consensus        28 ~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~  106 (309)
T 3p86_A           28 DGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQP  106 (309)
T ss_dssp             ----CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred             CcccccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence            3344444567889999999999999999987 5889999998653  345567899999999999999999999999999


Q ss_pred             CccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCC
Q 009340          285 EVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF  364 (537)
Q Consensus       285 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~  364 (537)
                      +..++||||+++|+|.+++.....         ...+++..++.++.|+++||+|||+.+ ++|+||||||+|||++.++
T Consensus       107 ~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~  176 (309)
T 3p86_A          107 PNLSIVTEYLSRGSLYRLLHKSGA---------REQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKY  176 (309)
T ss_dssp             TCCEEEEECCTTCBHHHHHHSTTH---------HHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTC
T ss_pred             CceEEEEecCCCCcHHHHHhhcCC---------CCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCC
Confidence            999999999999999999976432         124899999999999999999999987 3499999999999999999


Q ss_pred             cEEEeeccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHH
Q 009340          365 SAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFI  444 (537)
Q Consensus       365 ~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~  444 (537)
                      .+||+|||+++...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+.      ..
T Consensus       177 ~~kL~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~------~~  249 (309)
T 3p86_A          177 TVKVCDFGLSRLKASTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQV------VA  249 (309)
T ss_dssp             CEEECCCC------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHH------HH
T ss_pred             cEEECCCCCCccccccc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HH
Confidence            99999999998653322 223445789999999999999999999999999999999999999865433221      11


Q ss_pred             HHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHHh
Q 009340          445 SLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRS  503 (537)
Q Consensus       445 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~  503 (537)
                      .....         ......+...+..+.+|+.+||+.||++|||+.++++.|+.+.++
T Consensus       250 ~~~~~---------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~  299 (309)
T 3p86_A          250 AVGFK---------CKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS  299 (309)
T ss_dssp             HHHHS---------CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred             HHHhc---------CCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            10000         011122334456788999999999999999999999999988874

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.4e-45  Score=359.32  Aligned_cols=257  Identities=26%  Similarity=0.442  Sum_probs=214.9

Q ss_pred             cCCccccccCcCCceEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecCC
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYIS  295 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  295 (537)
                      ++|...+.||+|+||.||++...+++.||+|++..... ..+++.+|+.++++++||||+++++++.+.+..++||||++
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   88 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   88 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred             hhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence            57888899999999999999988889999999876432 23678999999999999999999999999999999999999


Q ss_pred             CCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCcc
Q 009340          296 SGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISR  375 (537)
Q Consensus       296 ~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~  375 (537)
                      +|+|.+++....           ..+++..++.++.|+++||.|||+.+   |+||||||+||+++.++.+||+|||++.
T Consensus        89 ~~~L~~~l~~~~-----------~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~  154 (269)
T 4hcu_A           89 HGCLSDYLRTQR-----------GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTR  154 (269)
T ss_dssp             TCBHHHHHHTTT-----------TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGG
T ss_pred             CCcHHHHHHhcC-----------cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccc
Confidence            999999996542           36899999999999999999999999   9999999999999999999999999998


Q ss_pred             ccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHHHHHhhchhhh
Q 009340          376 SIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQLLE  454 (537)
Q Consensus       376 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  454 (537)
                      ..............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+       .......     
T Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~-------~~~~~~~-----  222 (269)
T 4hcu_A          155 FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE-------VVEDIST-----  222 (269)
T ss_dssp             GBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HHHHHHT-----
T ss_pred             cccccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH-------HHHHHhc-----
Confidence            765443333344557888999999998999999999999999999999 999986543322       1111111     


Q ss_pred             hhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHHh
Q 009340          455 ILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRS  503 (537)
Q Consensus       455 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~  503 (537)
                          ......+...+..+.+++.+||+.||++|||+.++++.|+++.++
T Consensus       223 ----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~  267 (269)
T 4hcu_A          223 ----GFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  267 (269)
T ss_dssp             ----TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             ----CccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence                111112233356788999999999999999999999999998874

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1e-45  Score=389.36  Aligned_cols=264  Identities=24%  Similarity=0.430  Sum_probs=218.2

Q ss_pred             HHHHHHHhcCCccccccCcCCceEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCcc
Q 009340          208 ADELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVP  287 (537)
Q Consensus       208 ~~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~  287 (537)
                      .++++...++|...+.||+|+||.||+|.++++..||||+++... ...+.|.+|+.+|++++||||+++++++. .+..
T Consensus       180 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~  257 (454)
T 1qcf_A          180 KDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPI  257 (454)
T ss_dssp             TTCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSC
T ss_pred             ccceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCcc
Confidence            334445567888999999999999999999888899999998643 34678999999999999999999999986 5678


Q ss_pred             EEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEE
Q 009340          288 VLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK  367 (537)
Q Consensus       288 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~k  367 (537)
                      ++||||+++|+|.+++.....          ..+++..++.++.|+++||+|||+++   |+||||||+|||++.++.+|
T Consensus       258 ~lv~e~~~~g~L~~~l~~~~~----------~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~k  324 (454)
T 1qcf_A          258 YIITEFMAKGSLLDFLKSDEG----------SKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCK  324 (454)
T ss_dssp             EEEECCCTTCBHHHHHHSHHH----------HTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEE
T ss_pred             EEEEeecCCCcHHHHHHhccC----------CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEE
Confidence            999999999999999976432          25899999999999999999999999   99999999999999999999


Q ss_pred             EeeccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHHHH
Q 009340          368 VSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISL  446 (537)
Q Consensus       368 i~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~  446 (537)
                      |+|||+++..............+|..|+|||.+..+.++.++||||||+++|||++ |+.||......+       ....
T Consensus       325 l~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~-------~~~~  397 (454)
T 1qcf_A          325 IADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE-------VIRA  397 (454)
T ss_dssp             ECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-------HHHH
T ss_pred             EeeCCCceEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH-------HHHH
Confidence            99999998764432222334456789999999998999999999999999999999 999986543221       1111


Q ss_pred             HhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHH
Q 009340          447 AKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRR  502 (537)
Q Consensus       447 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~  502 (537)
                               +......+.+..++..+.+|+.+||+.||++|||+.+|+++|+.+..
T Consensus       398 ---------i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~  444 (454)
T 1qcf_A          398 ---------LERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT  444 (454)
T ss_dssp             ---------HHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred             ---------HHcCCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence                     11112223344556789999999999999999999999999998754

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=4.1e-45  Score=357.35  Aligned_cols=259  Identities=27%  Similarity=0.428  Sum_probs=215.0

Q ss_pred             hcCCccccccCcCCceEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecC
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI  294 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  294 (537)
                      .++|...+.||+|+||.||++...++..||||.++.... ..+++.+|+.++.+++||||+++++++.+....++||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI   85 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence            467888999999999999999998888999999876432 2467899999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCc
Q 009340          295 SSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGIS  374 (537)
Q Consensus       295 ~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla  374 (537)
                      ++|+|.+++....           ..+++..++.++.|+++||.|||+.+   |+||||||+||+++.++.+||+|||++
T Consensus        86 ~~~~L~~~l~~~~-----------~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~  151 (268)
T 3sxs_A           86 SNGCLLNYLRSHG-----------KGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMT  151 (268)
T ss_dssp             TTCBHHHHHHHHG-----------GGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCE
T ss_pred             CCCcHHHHHHHcC-----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccc
Confidence            9999999997643           25999999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHHHHHhhchhh
Q 009340          375 RSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQLL  453 (537)
Q Consensus       375 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  453 (537)
                      ...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+.      ... ....   
T Consensus       152 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~------~~~-~~~~---  221 (268)
T 3sxs_A          152 RYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEV------VLK-VSQG---  221 (268)
T ss_dssp             EECCTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHH------HHH-HHTT---
T ss_pred             eecchhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHH------HHH-HHcC---
Confidence            8775554444444557788999999998889999999999999999999 9999865433221      111 1110   


Q ss_pred             hhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHHhh
Q 009340          454 EILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRSQ  504 (537)
Q Consensus       454 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~  504 (537)
                            .....+...+..+.+++.+||+.||++|||+.++++.|+.+++..
T Consensus       222 ------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~  266 (268)
T 3sxs_A          222 ------HRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKD  266 (268)
T ss_dssp             ------CCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC--
T ss_pred             ------CCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhcc
Confidence                  011112233457889999999999999999999999999987654

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=3.4e-45  Score=368.16  Aligned_cols=269  Identities=25%  Similarity=0.332  Sum_probs=210.1

Q ss_pred             hcCCccccccCcCCceEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCc----cEEE
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEV----PVLV  290 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~----~~lV  290 (537)
                      .++|...++||+|+||.||+|+.. ++.||||+++... .....+..|+.++++++||||+++++++.+...    .++|
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv  100 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI  100 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence            368889999999999999999985 7899999987543 334456679999999999999999999987543    6999


Q ss_pred             EecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhc----------CCCCeeecCCCCCCEEE
Q 009340          291 YEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSS----------ASIPIFHRDIKSSNILL  360 (537)
Q Consensus       291 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~----------~~~~ivH~Dlk~~NIll  360 (537)
                      |||+++|+|.+++..             ..++|..++.++.|+++||.|||+.          +   |+||||||+|||+
T Consensus       101 ~e~~~~g~L~~~l~~-------------~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill  164 (322)
T 3soc_A          101 TAFHEKGSLSDFLKA-------------NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLL  164 (322)
T ss_dssp             EECCTTCBHHHHHHH-------------CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEE
T ss_pred             EecCCCCCHHHHHHh-------------cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEE
Confidence            999999999999964             2589999999999999999999998          7   9999999999999


Q ss_pred             CCCCcEEEeeccCccccCCCCCc-eeeeccccccccCcccccCC-----CCCcchhHHHHHHHHHHHHhCCCCCCccchh
Q 009340          361 DDKFSAKVSDFGISRSIPNDKTH-LTTTIQGTFGYLDPEYFQSS-----QFTDKSDVYSFGVVLLELLTGKKPICFARVE  434 (537)
Q Consensus       361 ~~~~~~ki~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-----~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~  434 (537)
                      +.++.+||+|||+++........ ......||+.|+|||.+.+.     .++.++||||||+++|||++|+.||......
T Consensus       165 ~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~  244 (322)
T 3soc_A          165 KNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDE  244 (322)
T ss_dssp             CTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCC
T ss_pred             CCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcch
Confidence            99999999999999876543322 22345789999999999863     4567899999999999999999998754332


Q ss_pred             hhccHHH---------HHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHHhh
Q 009340          435 EERNLVA---------CFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRSQ  504 (537)
Q Consensus       435 ~~~~~~~---------~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~  504 (537)
                      .......         ..............+...   .........+.+|+.+||+.||++|||+.+|++.|++|.+..
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~~  320 (322)
T 3soc_A          245 YMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDY---WQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLT  320 (322)
T ss_dssp             CCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGG---GGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             hccchhhhhccCCchhhhhhhhhcccCCCCcccc---ccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence            2111111         011111111111111100   012345677999999999999999999999999999998743

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=2.9e-44  Score=357.15  Aligned_cols=250  Identities=26%  Similarity=0.445  Sum_probs=208.1

Q ss_pred             hcCCccccccCcCCceEEEEEEc-CCCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEec
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY  293 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  293 (537)
                      .++|...+.||+|+||+||+|.. .+|+.||||++........+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   98 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence            36899999999999999999984 57899999998754444567789999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccC
Q 009340          294 ISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGI  373 (537)
Q Consensus       294 ~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgl  373 (537)
                      +++|+|.+++..             ..+++..+..++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        99 ~~~~~L~~~~~~-------------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~  162 (297)
T 3fxz_A           99 LAGGSLTDVVTE-------------TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGF  162 (297)
T ss_dssp             CTTCBHHHHHHH-------------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTT
T ss_pred             CCCCCHHHHHhh-------------cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCC
Confidence            999999999864             25899999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchhh
Q 009340          374 SRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLL  453 (537)
Q Consensus       374 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  453 (537)
                      +........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.||........      .........  
T Consensus       163 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~------~~~~~~~~~--  233 (297)
T 3fxz_A          163 CAQITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA------LYLIATNGT--  233 (297)
T ss_dssp             CEECCSTTC-CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHHCS--
T ss_pred             ceecCCccc-ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhCCC--
Confidence            987654332 23456799999999999999999999999999999999999999965432211      111111110  


Q ss_pred             hhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          454 EILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       454 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                            .....+...+..+.+++.+||+.||++|||+.|+++
T Consensus       234 ------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          234 ------PELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             ------CCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ------CCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence                  001112334567889999999999999999999975

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1.1e-43  Score=357.09  Aligned_cols=261  Identities=24%  Similarity=0.373  Sum_probs=215.5

Q ss_pred             cccCHHHHHHHhcC----------CccccccCcCCceEEEEEEcC-CCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCC
Q 009340          204 KVFTADELQRATDN----------YNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKTQIHQFINEVVILSQINHR  272 (537)
Q Consensus       204 ~~~~~~el~~~~~~----------~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~  272 (537)
                      ..++.++++.+++.          |+..+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++|+
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~  102 (321)
T 2c30_A           23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF  102 (321)
T ss_dssp             --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred             CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence            45889999888865          666779999999999999975 7999999998765555667899999999999999


Q ss_pred             CcceEeeEEeeCCccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecC
Q 009340          273 HIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRD  352 (537)
Q Consensus       273 niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~D  352 (537)
                      ||+++++++...+..++||||+++|+|.+++..             ..++|..+..++.|+++||.|||+.+   |+|||
T Consensus       103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-------------~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~D  166 (321)
T 2c30_A          103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-------------VRLNEEQIATVCEAVLQALAYLHAQG---VIHRD  166 (321)
T ss_dssp             TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT-------------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred             CcceEEEEEEECCEEEEEEecCCCCCHHHHHHh-------------cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCC
Confidence            999999999999999999999999999998853             25999999999999999999999998   99999


Q ss_pred             CCCCCEEECCCCcEEEeeccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccc
Q 009340          353 IKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFAR  432 (537)
Q Consensus       353 lk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~  432 (537)
                      |||+|||++.++.+||+|||++........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus       167 lkp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~  245 (321)
T 2c30_A          167 IKSDSILLTLDGRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDS  245 (321)
T ss_dssp             CSGGGEEECTTCCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred             CCHHHEEECCCCcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            999999999999999999999987654322 2345579999999999999999999999999999999999999986543


Q ss_pred             hhhhccHHHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          433 VEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       433 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      ....      ... ....     ..+.+  ......+..+.+++.+||+.||++|||+.++++
T Consensus       246 ~~~~------~~~-~~~~-----~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  294 (321)
T 2c30_A          246 PVQA------MKR-LRDS-----PPPKL--KNSHKVSPVLRDFLERMLVRDPQERATAQELLD  294 (321)
T ss_dssp             HHHH------HHH-HHHS-----SCCCC--TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHH------HHH-HhcC-----CCCCc--CccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            2211      111 1110     00000  011223456889999999999999999999976

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=9.2e-45  Score=370.25  Aligned_cols=283  Identities=27%  Similarity=0.419  Sum_probs=223.5

Q ss_pred             cccCHHHHHHHhcCCccccccCcCCceEEEEEEc------CCCCEEEEEEccCC-ChHHHHHHHHHHHHHHhc-CCCCcc
Q 009340          204 KVFTADELQRATDNYNQSRFLGQGGFGTVYKGML------PDGSIVAVKRSKEI-DKTQIHQFINEVVILSQI-NHRHIV  275 (537)
Q Consensus       204 ~~~~~~el~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv  275 (537)
                      ..+...++....++|...+.||+|+||.||+|.+      .+++.||||+++.. .....+.+.+|+.++.++ +||||+
T Consensus        10 ~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv   89 (359)
T 3vhe_A           10 LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV   89 (359)
T ss_dssp             SCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             CCCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCccee
Confidence            3466777777889999999999999999999973      34678999999763 445567899999999999 799999


Q ss_pred             eEeeEEeeCCc-cEEEEecCCCCChhhhhhhhhhhH--------------------------------------------
Q 009340          276 KLLGCCLETEV-PVLVYEYISSGTLSHHIHDHQQQQ--------------------------------------------  310 (537)
Q Consensus       276 ~l~g~~~~~~~-~~lV~e~~~~gsL~~~l~~~~~~~--------------------------------------------  310 (537)
                      ++++++.+.+. .++||||+++|+|.+++.......                                            
T Consensus        90 ~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  169 (359)
T 3vhe_A           90 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVE  169 (359)
T ss_dssp             CEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------
T ss_pred             eeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccc
Confidence            99999987654 899999999999999998754210                                            


Q ss_pred             ----------HHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCccccCCC
Q 009340          311 ----------EQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPND  380 (537)
Q Consensus       311 ----------~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~  380 (537)
                                ..........+++..++.++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~  246 (359)
T 3vhe_A          170 EKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKD  246 (359)
T ss_dssp             --------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSC
T ss_pred             ccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeeccc
Confidence                      0000000123899999999999999999999999   999999999999999999999999999876443


Q ss_pred             CC-ceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHHHHHhhchhhhhhcH
Q 009340          381 KT-HLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQLLEILDA  458 (537)
Q Consensus       381 ~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  458 (537)
                      .. .......||+.|+|||.+.+..++.++||||||+++|||++ |+.||......+.      +......         
T Consensus       247 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~------~~~~~~~---------  311 (359)
T 3vhe_A          247 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE------FCRRLKE---------  311 (359)
T ss_dssp             TTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH------HHHHHHH---------
T ss_pred             ccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH------HHHHHHc---------
Confidence            32 23345668999999999999999999999999999999998 9999865432221      1111111         


Q ss_pred             HhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHHhh
Q 009340          459 RVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRSQ  504 (537)
Q Consensus       459 ~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~  504 (537)
                      ......+...+..+.+++.+||+.||++|||+.++++.|+.+....
T Consensus       312 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~  357 (359)
T 3vhe_A          312 GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  357 (359)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             CCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence            1111223334567889999999999999999999999999988653

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1.6e-44  Score=356.03  Aligned_cols=258  Identities=24%  Similarity=0.396  Sum_probs=212.1

Q ss_pred             hcCCccccccCcCCceEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecC
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI  294 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  294 (537)
                      .++|...+.||+|+||.||++...++..||||+++.... ..+++.+|+.++.+++|+||+++++++.+.+..++||||+
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  101 (283)
T 3gen_A           23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM  101 (283)
T ss_dssp             GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred             HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence            467888999999999999999998888999999976432 2367899999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCc
Q 009340          295 SSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGIS  374 (537)
Q Consensus       295 ~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla  374 (537)
                      ++|+|.+++....           ..+++..++.++.|+++||.|||+.+   |+||||||+||+++.++.+||+|||++
T Consensus       102 ~~~~L~~~l~~~~-----------~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~  167 (283)
T 3gen_A          102 ANGCLLNYLREMR-----------HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLS  167 (283)
T ss_dssp             TTCBHHHHHHCGG-----------GCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGG
T ss_pred             CCCcHHHHHHHhc-----------cCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccc
Confidence            9999999997643           25999999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHHHHHhhchhh
Q 009340          375 RSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQLL  453 (537)
Q Consensus       375 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  453 (537)
                      ...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+.       ......    
T Consensus       168 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~-------~~~~~~----  236 (283)
T 3gen_A          168 RYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET-------AEHIAQ----  236 (283)
T ss_dssp             GGBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH-------HHHHHT----
T ss_pred             ccccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHH-------HHHHhc----
Confidence            8765433333334456788999999998899999999999999999998 9999865433221       111111    


Q ss_pred             hhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHHh
Q 009340          454 EILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRS  503 (537)
Q Consensus       454 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~  503 (537)
                           ......+...+..+.+++.+||+.||++|||+.++++.|+.+...
T Consensus       237 -----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~  281 (283)
T 3gen_A          237 -----GLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE  281 (283)
T ss_dssp             -----TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -----ccCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence                 111112233346788999999999999999999999999988764

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=8.8e-45  Score=386.13  Aligned_cols=259  Identities=26%  Similarity=0.453  Sum_probs=217.1

Q ss_pred             HhcCCccccccCcCCceEEEEEEcCC-CCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEe
Q 009340          214 ATDNYNQSRFLGQGGFGTVYKGMLPD-GSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE  292 (537)
Q Consensus       214 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e  292 (537)
                      ...+|...++||+|+||.||+|.+.. +..||||.++.... ..++|.+|+.+|++++||||++++++|.+.+..++|||
T Consensus       218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E  296 (495)
T 1opk_A          218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE  296 (495)
T ss_dssp             CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence            35678888999999999999999764 78999999976432 35789999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeecc
Q 009340          293 YISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG  372 (537)
Q Consensus       293 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfg  372 (537)
                      |+++|+|.+++....          ...+++..++.++.|+++||+|||+++   |+||||||+|||++.++.+||+|||
T Consensus       297 ~~~~g~L~~~l~~~~----------~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG  363 (495)
T 1opk_A          297 FMTYGNLLDYLRECN----------RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFG  363 (495)
T ss_dssp             CCTTCBHHHHHHHSC----------TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTT
T ss_pred             ccCCCCHHHHHHhcC----------cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecc
Confidence            999999999997533          235899999999999999999999999   9999999999999999999999999


Q ss_pred             CccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHHHHHhhch
Q 009340          373 ISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQ  451 (537)
Q Consensus       373 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  451 (537)
                      +++..............++..|+|||.+....++.++|||||||++|||++ |+.||......+       .        
T Consensus       364 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~-------~--------  428 (495)
T 1opk_A          364 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------V--------  428 (495)
T ss_dssp             CEECCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-------H--------
T ss_pred             cceeccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH-------H--------
Confidence            998775443333334456789999999998999999999999999999999 899986543322       1        


Q ss_pred             hhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHH
Q 009340          452 LLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRR  502 (537)
Q Consensus       452 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~  502 (537)
                       .+.+........+..++..+.+|+.+||+.||++|||+.+|+++|+.+..
T Consensus       429 -~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~  478 (495)
T 1opk_A          429 -YELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  478 (495)
T ss_dssp             -HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred             -HHHHHcCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence             11112222233344556788999999999999999999999999998754

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=3.2e-44  Score=353.69  Aligned_cols=260  Identities=25%  Similarity=0.428  Sum_probs=201.8

Q ss_pred             hcCCccccccCcCCceEEEEEEcCC----CCEEEEEEccCC-ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEE
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLPD----GSIVAVKRSKEI-DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVL  289 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  289 (537)
                      .++|...+.||+|+||.||+|....    +..||+|..+.. .....+.+.+|+.++++++||||+++++++. .+..++
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l   92 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   92 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence            4678889999999999999998642    457999998753 4455678999999999999999999999984 456799


Q ss_pred             EEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEe
Q 009340          290 VYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVS  369 (537)
Q Consensus       290 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~  369 (537)
                      ||||+++|+|.+++....           ..+++..++.++.|+++||.|||+.+   |+||||||+|||++.++.+||+
T Consensus        93 v~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~  158 (281)
T 1mp8_A           93 IMELCTLGELRSFLQVRK-----------YSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLG  158 (281)
T ss_dssp             EEECCTTEEHHHHHHHTT-----------TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEEC
T ss_pred             EEecCCCCCHHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEEC
Confidence            999999999999997532           25899999999999999999999999   9999999999999999999999


Q ss_pred             eccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHHHHHh
Q 009340          370 DFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAK  448 (537)
Q Consensus       370 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~  448 (537)
                      |||+++..............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+.       .....
T Consensus       159 Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~-------~~~i~  231 (281)
T 1mp8_A          159 DFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV-------IGRIE  231 (281)
T ss_dssp             C-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH-------HHHHH
T ss_pred             ccccccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHH-------HHHHH
Confidence            999998775444333344557889999999998899999999999999999997 9999865433221       11111


Q ss_pred             hchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHHhhH
Q 009340          449 ENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRSQR  505 (537)
Q Consensus       449 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~~  505 (537)
                      ..         .....+...+..+.+++.+||+.||++|||+.++++.|+.+....+
T Consensus       232 ~~---------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~  279 (281)
T 1mp8_A          232 NG---------ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEK  279 (281)
T ss_dssp             TT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             cC---------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhc
Confidence            11         1112233455678899999999999999999999999999987653

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=4.5e-44  Score=376.37  Aligned_cols=253  Identities=27%  Similarity=0.474  Sum_probs=211.0

Q ss_pred             hcCCccccccCcCCceEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCC-ccEEEEec
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETE-VPVLVYEY  293 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lV~e~  293 (537)
                      .++|...+.||+|+||.||+|.+. |+.||||.++...  ..+.|.+|+.+|++++||||+++++++.+.. ..++||||
T Consensus       192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~  268 (450)
T 1k9a_A          192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY  268 (450)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred             hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence            467888899999999999999985 7899999998643  4568999999999999999999999988765 68999999


Q ss_pred             CCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccC
Q 009340          294 ISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGI  373 (537)
Q Consensus       294 ~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgl  373 (537)
                      +++|+|.+++.....          ..+++..++.++.|+++||+|||+++   |+||||||+|||++.++.+||+|||+
T Consensus       269 ~~~g~L~~~l~~~~~----------~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~  335 (450)
T 1k9a_A          269 MAKGSLVDYLRSRGR----------SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGL  335 (450)
T ss_dssp             CTTCBHHHHHHHHCT----------TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTT
T ss_pred             cCCCcHHHHHHhcCC----------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCC
Confidence            999999999976432          34799999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHHHHHhhchh
Q 009340          374 SRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQL  452 (537)
Q Consensus       374 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  452 (537)
                      ++.....    .....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+.       .....    
T Consensus       336 a~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~-------~~~i~----  400 (450)
T 1k9a_A          336 TKEASST----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV-------VPRVE----  400 (450)
T ss_dssp             CEECC----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTH-------HHHHH----
T ss_pred             ccccccc----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH-------HHHHH----
Confidence            9864322    122357889999999999999999999999999999999 9999865433221       11111    


Q ss_pred             hhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHHh
Q 009340          453 LEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRS  503 (537)
Q Consensus       453 ~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~  503 (537)
                           .....+.+..++..+.+|+.+||+.||++|||+.++++.|+.+...
T Consensus       401 -----~~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~  446 (450)
T 1k9a_A          401 -----KGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH  446 (450)
T ss_dssp             -----TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             -----cCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence                 1122234455667899999999999999999999999999998764

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1e-44  Score=371.23  Aligned_cols=268  Identities=26%  Similarity=0.428  Sum_probs=215.5

Q ss_pred             hcCCccccccCcCCceEEEEEEcC------CCCEEEEEEccCC-ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCcc
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLP------DGSIVAVKRSKEI-DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVP  287 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~  287 (537)
                      .++|...+.||+|+||.||+|.+.      +++.||||+++.. .......+.+|+.++++++||||+++++++.+....
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  149 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  149 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            367888999999999999999953      4668999998753 455566799999999999999999999999999999


Q ss_pred             EEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCC---
Q 009340          288 VLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF---  364 (537)
Q Consensus       288 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~---  364 (537)
                      ++||||+++|+|.+++.......     .....+++..++.++.|+++||+|||+.+   |+||||||+|||++.++   
T Consensus       150 ~lv~e~~~~g~L~~~l~~~~~~~-----~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~  221 (367)
T 3l9p_A          150 FILLELMAGGDLKSFLRETRPRP-----SQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGR  221 (367)
T ss_dssp             EEEEECCTTEEHHHHHHHHSCCS-----SSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTC
T ss_pred             EEEEEeCCCCCHHHHHHhhcccc-----CccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCc
Confidence            99999999999999998654210     01235999999999999999999999999   99999999999999554   


Q ss_pred             cEEEeeccCccccCCCC-CceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHH
Q 009340          365 SAKVSDFGISRSIPNDK-THLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVAC  442 (537)
Q Consensus       365 ~~ki~Dfgla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~  442 (537)
                      .+||+|||+++...... ........+|+.|+|||.+.+..++.++|||||||++|||++ |+.||......+       
T Consensus       222 ~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~-------  294 (367)
T 3l9p_A          222 VAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE-------  294 (367)
T ss_dssp             CEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-------
T ss_pred             eEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------
Confidence            59999999997542221 122334567899999999999999999999999999999998 999986543322       


Q ss_pred             HHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHHhhHH
Q 009340          443 FISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRSQRC  506 (537)
Q Consensus       443 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~~~  506 (537)
                      .......         ......+..++..+.+|+.+||+.||++|||+.+|++.|+.+......
T Consensus       295 ~~~~i~~---------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~~  349 (367)
T 3l9p_A          295 VLEFVTS---------GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV  349 (367)
T ss_dssp             HHHHHHT---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHH
T ss_pred             HHHHHHc---------CCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChhh
Confidence            1111111         111122334456788999999999999999999999999998876543

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.8e-44  Score=363.69  Aligned_cols=258  Identities=23%  Similarity=0.468  Sum_probs=205.5

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCC----EEEEEEccCC-ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGS----IVAVKRSKEI-DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVL  289 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  289 (537)
                      ++|+..++||+|+||.||+|+.. +++    .||+|.++.. .....++|.+|+.++++++||||++++++|.+.. .++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~   93 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   93 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence            57888999999999999999954 444    3688887643 3345678999999999999999999999998754 689


Q ss_pred             EEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEe
Q 009340          290 VYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVS  369 (537)
Q Consensus       290 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~  369 (537)
                      |+||+++|+|.+++....           ..+++..++.++.|+++||.|||+.+   |+||||||+|||++.++.+||+
T Consensus        94 v~e~~~~g~L~~~l~~~~-----------~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~  159 (327)
T 3poz_A           94 ITQLMPFGCLLDYVREHK-----------DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKIT  159 (327)
T ss_dssp             EEECCTTCBHHHHHHHST-----------TSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEEC
T ss_pred             EEEecCCCcHHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEc
Confidence            999999999999997643           36999999999999999999999999   9999999999999999999999


Q ss_pred             eccCccccCCCCCc-eeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHHHHH
Q 009340          370 DFGISRSIPNDKTH-LTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLA  447 (537)
Q Consensus       370 Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~  447 (537)
                      |||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.......       ..   
T Consensus       160 Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-------~~---  229 (327)
T 3poz_A          160 DFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-------IS---  229 (327)
T ss_dssp             CTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-------HH---
T ss_pred             cCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH-------HH---
Confidence            99999876443322 2234557889999999999999999999999999999999 999986543322       11   


Q ss_pred             hhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHHhh
Q 009340          448 KENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRSQ  504 (537)
Q Consensus       448 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~  504 (537)
                            ..+........+..++..+.+++.+||+.||++|||+.++++.|+.+....
T Consensus       230 ------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~  280 (327)
T 3poz_A          230 ------SILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP  280 (327)
T ss_dssp             ------HHHHTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTSH
T ss_pred             ------HHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhhh
Confidence                  111111122233445567889999999999999999999999999987654

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.6e-44  Score=379.97  Aligned_cols=259  Identities=27%  Similarity=0.416  Sum_probs=208.9

Q ss_pred             HHhcCCccccccCcCCceEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEe
Q 009340          213 RATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE  292 (537)
Q Consensus       213 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e  292 (537)
                      ...++|...++||+|+||.||+|.+.++..||||+++.... ..++|.+|+.+|++++||||+++++++.+ +..++|||
T Consensus       181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e  258 (452)
T 1fmk_A          181 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE  258 (452)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred             cChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEeh
Confidence            34567888999999999999999998778899999986432 34679999999999999999999999976 67899999


Q ss_pred             cCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeecc
Q 009340          293 YISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG  372 (537)
Q Consensus       293 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfg  372 (537)
                      |+++|+|.+++.....          ..+++..++.++.|+++||+|||+++   |+||||||+|||++.++.+||+|||
T Consensus       259 ~~~~gsL~~~l~~~~~----------~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG  325 (452)
T 1fmk_A          259 YMSKGSLLDFLKGETG----------KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFG  325 (452)
T ss_dssp             CCTTCBHHHHHSHHHH----------TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCC
T ss_pred             hhcCCCHHHHHHhcCC----------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCc
Confidence            9999999999975432          35899999999999999999999999   9999999999999999999999999


Q ss_pred             CccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHHHHHhhch
Q 009340          373 ISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQ  451 (537)
Q Consensus       373 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  451 (537)
                      +++..............+|..|+|||.+.++.++.++||||||+++|||++ |+.||......+       ......   
T Consensus       326 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~-------~~~~i~---  395 (452)
T 1fmk_A          326 LARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-------VLDQVE---  395 (452)
T ss_dssp             TTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHH---
T ss_pred             cceecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHH---
Confidence            998765443333344557889999999999999999999999999999999 999986543221       111111   


Q ss_pred             hhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHH
Q 009340          452 LLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRR  502 (537)
Q Consensus       452 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~  502 (537)
                            .....+.+..++..+.+|+.+||+.||++|||+.+|++.|+.+..
T Consensus       396 ------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~  440 (452)
T 1fmk_A          396 ------RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  440 (452)
T ss_dssp             ------TTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred             ------cCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence                  112223344556788999999999999999999999999997754

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=6.6e-44  Score=354.06  Aligned_cols=261  Identities=27%  Similarity=0.416  Sum_probs=208.3

Q ss_pred             hcCCccccccCcCCceEEEEEEc-CCCCEEEEEEccC---CChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEE
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKE---IDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLV  290 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  290 (537)
                      .++|...+.||+|+||.||++.. .+++.||+|.+..   ......+.|.+|+.++++++||||+++++++.+.+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            35788999999999999999995 4689999998743   3445567899999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEee
Q 009340          291 YEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSD  370 (537)
Q Consensus       291 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~D  370 (537)
                      |||+++|+|.+++...            ..+++..++.++.|+++||.|||+.+   |+||||||+|||++.++.+||+|
T Consensus        90 ~e~~~g~~L~~~l~~~------------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~D  154 (294)
T 4eqm_A           90 MEYIEGPTLSEYIESH------------GPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFD  154 (294)
T ss_dssp             EECCCSCBHHHHHHHH------------CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECC
T ss_pred             EeCCCCCCHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEe
Confidence            9999999999999653            35999999999999999999999999   99999999999999999999999


Q ss_pred             ccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhc
Q 009340          371 FGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKEN  450 (537)
Q Consensus       371 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  450 (537)
                      ||++...............||+.|+|||.+.+..++.++||||||+++|||++|+.||........      ....... 
T Consensus       155 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~------~~~~~~~-  227 (294)
T 4eqm_A          155 FGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI------AIKHIQD-  227 (294)
T ss_dssp             CSSSTTC-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHH------HHHHHSS-
T ss_pred             CCCccccccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHhhc-
Confidence            999987754443444556799999999999999999999999999999999999999975433211      1111111 


Q ss_pred             hhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCC-CHhhHHHHHHHHHH
Q 009340          451 QLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRP-TMKQVSMELEGLRR  502 (537)
Q Consensus       451 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-s~~ev~~~L~~i~~  502 (537)
                      ..     +......+...+..+.+++.+||+.||++|| ++.++.+.|+.+..
T Consensus       228 ~~-----~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~  275 (294)
T 4eqm_A          228 SV-----PNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH  275 (294)
T ss_dssp             CC-----CCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred             cC-----CCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence            00     0011112233446788999999999999998 89999999987654

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=9.5e-44  Score=358.26  Aligned_cols=247  Identities=28%  Similarity=0.412  Sum_probs=207.7

Q ss_pred             hcCCccccccCcCCceEEEEEEc-CCCCEEEEEEccC--CChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEE
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKE--IDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY  291 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  291 (537)
                      .++|...+.||+|+||.||+|.. .+|+.||||++..  ......+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   93 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM   93 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            46899999999999999999996 5799999999864  34556778999999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeec
Q 009340          292 EYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF  371 (537)
Q Consensus       292 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Df  371 (537)
                      ||+++|+|.+++...            ..+++..+..++.|+++||.|||+.+   |+||||||+|||++.++.+||+||
T Consensus        94 e~~~~~~L~~~l~~~------------~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DF  158 (328)
T 3fe3_A           94 EYASGGEVFDYLVAH------------GRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADF  158 (328)
T ss_dssp             CCCTTCBHHHHHHHH------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECST
T ss_pred             ECCCCCcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeec
Confidence            999999999999753            35999999999999999999999999   999999999999999999999999


Q ss_pred             cCccccCCCCCceeeeccccccccCcccccCCCCC-cchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhc
Q 009340          372 GISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFT-DKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKEN  450 (537)
Q Consensus       372 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t-~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  450 (537)
                      |++.......  ......||+.|+|||.+.+..++ .++|||||||++|||++|+.||......+       .......+
T Consensus       159 G~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-------~~~~i~~~  229 (328)
T 3fe3_A          159 GFSNEFTVGG--KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE-------LRERVLRG  229 (328)
T ss_dssp             TCCGGGSSSC--GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHC
T ss_pred             cCceecCCCC--ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhC
Confidence            9998764332  23456799999999999888775 79999999999999999999997543322       11111111


Q ss_pred             hhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          451 QLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       451 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      .          ...+...+..+.+|+.+||+.||.+|||+.|+++
T Consensus       230 ~----------~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~  264 (328)
T 3fe3_A          230 K----------YRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK  264 (328)
T ss_dssp             C----------CCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred             C----------CCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            0          1122334567889999999999999999999975

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=3.3e-44  Score=350.45  Aligned_cols=257  Identities=26%  Similarity=0.435  Sum_probs=213.7

Q ss_pred             cCCccccccCcCCceEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecCC
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYIS  295 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  295 (537)
                      ++|...+.||+|+||.||++...+++.||+|.+..... ..+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   86 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME   86 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred             hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence            57888899999999999999988888999999876433 23678999999999999999999999999999999999999


Q ss_pred             CCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCcc
Q 009340          296 SGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISR  375 (537)
Q Consensus       296 ~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~  375 (537)
                      +|+|.+++....           ..+++..++.++.|+++||.|||+.+   ++||||||+||+++.++.+||+|||++.
T Consensus        87 ~~~L~~~~~~~~-----------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~  152 (267)
T 3t9t_A           87 HGCLSDYLRTQR-----------GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTR  152 (267)
T ss_dssp             TCBHHHHHHHTT-----------TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGG
T ss_pred             CCcHHHHHhhCc-----------ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccc
Confidence            999999997542           36899999999999999999999999   9999999999999999999999999998


Q ss_pred             ccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHHHHHhhchhhh
Q 009340          376 SIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQLLE  454 (537)
Q Consensus       376 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  454 (537)
                      ..............++..|+|||.+.+..++.++||||||+++|||++ |+.||......+       .......+    
T Consensus       153 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~i~~~----  221 (267)
T 3t9t_A          153 FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE-------VVEDISTG----  221 (267)
T ss_dssp             GBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HHHHHHTT----
T ss_pred             ccccccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH-------HHHHHhcC----
Confidence            764432222334557789999999998899999999999999999999 899986543221       11111111    


Q ss_pred             hhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHHh
Q 009340          455 ILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRS  503 (537)
Q Consensus       455 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~  503 (537)
                           .....+...+..+.+++.+||+.||++|||+.++++.|+.+.++
T Consensus       222 -----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (267)
T 3t9t_A          222 -----FRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  265 (267)
T ss_dssp             -----CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             -----CcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence                 11112223446788999999999999999999999999998864

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-43  Score=365.73  Aligned_cols=271  Identities=28%  Similarity=0.421  Sum_probs=217.0

Q ss_pred             hcCCccccccCcCCceEEEEEEcC--------CCCEEEEEEccCC-ChHHHHHHHHHHHHHHhc-CCCCcceEeeEEeeC
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLP--------DGSIVAVKRSKEI-DKTQIHQFINEVVILSQI-NHRHIVKLLGCCLET  284 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~  284 (537)
                      .++|...+.||+|+||.||+|...        .+..||||+++.. .....+++.+|+.+++++ +||||+++++++.+.
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  147 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD  147 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence            468888999999999999999852        3457999998753 445567899999999999 999999999999999


Q ss_pred             CccEEEEecCCCCChhhhhhhhhhhHHHH----hhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEE
Q 009340          285 EVPVLVYEYISSGTLSHHIHDHQQQQEQK----QKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILL  360 (537)
Q Consensus       285 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~----~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll  360 (537)
                      +..++||||+++|+|.+++..........    .......+++..++.++.|+++||.|||+.+   |+||||||+|||+
T Consensus       148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll  224 (382)
T 3tt0_A          148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV  224 (382)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred             CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEEE
Confidence            99999999999999999998653200000    0000135999999999999999999999999   9999999999999


Q ss_pred             CCCCcEEEeeccCccccCCCCC-ceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhcc
Q 009340          361 DDKFSAKVSDFGISRSIPNDKT-HLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERN  438 (537)
Q Consensus       361 ~~~~~~ki~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~  438 (537)
                      +.++.+||+|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+   
T Consensus       225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~---  301 (382)
T 3tt0_A          225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---  301 (382)
T ss_dssp             CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---
T ss_pred             cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---
Confidence            9999999999999987644332 22334557889999999999999999999999999999999 999986543222   


Q ss_pred             HHHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHHhh
Q 009340          439 LVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRSQ  504 (537)
Q Consensus       439 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~  504 (537)
                          ........         .....+..++..+.+++.+||+.||++|||+.+|++.|+++....
T Consensus       302 ----~~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~  354 (382)
T 3tt0_A          302 ----LFKLLKEG---------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT  354 (382)
T ss_dssp             ----HHHHHHTT---------CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred             ----HHHHHHcC---------CCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence                11111111         111223344567899999999999999999999999999998643

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1.5e-43  Score=348.74  Aligned_cols=262  Identities=28%  Similarity=0.456  Sum_probs=211.0

Q ss_pred             hcCCccccccCcCCceEEEEEEcCC----CCEEEEEEccCC-ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEE
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLPD----GSIVAVKRSKEI-DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVL  289 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  289 (537)
                      .++|...+.||+|+||.||+|...+    +..||+|.++.. .....+.|.+|+.++++++||||+++++++.+ +..++
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~   89 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI   89 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence            4688889999999999999998542    336999998764 44566789999999999999999999999865 45699


Q ss_pred             EEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEe
Q 009340          290 VYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVS  369 (537)
Q Consensus       290 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~  369 (537)
                      ||||+++++|.+++....           ..+++..++.++.|+++||.|||+.+   |+||||||+||+++.++.+||+
T Consensus        90 v~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~  155 (281)
T 3cc6_A           90 IMELYPYGELGHYLERNK-----------NSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLG  155 (281)
T ss_dssp             EEECCTTCBHHHHHHHHT-----------TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEEC
T ss_pred             EEecCCCCCHHHHHHhcc-----------ccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeC
Confidence            999999999999997542           35899999999999999999999999   9999999999999999999999


Q ss_pred             eccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHHHHHh
Q 009340          370 DFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAK  448 (537)
Q Consensus       370 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~  448 (537)
                      |||++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+.       .....
T Consensus       156 Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~-------~~~~~  228 (281)
T 3cc6_A          156 DFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDV-------IGVLE  228 (281)
T ss_dssp             CCCGGGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGH-------HHHHH
T ss_pred             ccCCCcccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHH-------HHHHh
Confidence            999998775544333444567889999999998899999999999999999998 9999865433221       11111


Q ss_pred             hchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHHhhHHH
Q 009340          449 ENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRSQRCL  507 (537)
Q Consensus       449 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~~~~  507 (537)
                      ..         .....+...+..+.+++.+||+.||++|||+.++++.|+.+.+..+.+
T Consensus       229 ~~---------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~i  278 (281)
T 3cc6_A          229 KG---------DRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEKDI  278 (281)
T ss_dssp             HT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHHH
T ss_pred             cC---------CCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhhhhh
Confidence            11         111122334467889999999999999999999999999998876554

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.2e-43  Score=354.93  Aligned_cols=271  Identities=27%  Similarity=0.452  Sum_probs=216.9

Q ss_pred             HhcCCccccccCcCCceEEEEEEc------CCCCEEEEEEccCC-ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCc
Q 009340          214 ATDNYNQSRFLGQGGFGTVYKGML------PDGSIVAVKRSKEI-DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEV  286 (537)
Q Consensus       214 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~  286 (537)
                      ..++|...+.||+|+||.||++..      .+++.||||.++.. .....+.+.+|+.++++++||||+++++++.+.+.
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  100 (314)
T 2ivs_A           21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP  100 (314)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence            356888899999999999999985      24578999998753 45566789999999999999999999999999999


Q ss_pred             cEEEEecCCCCChhhhhhhhhhhHH------------HHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCC
Q 009340          287 PVLVYEYISSGTLSHHIHDHQQQQE------------QKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIK  354 (537)
Q Consensus       287 ~~lV~e~~~~gsL~~~l~~~~~~~~------------~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk  354 (537)
                      .++||||+++|+|.+++........            .........+++..++.++.|+++||.|||+++   |+|||||
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dik  177 (314)
T 2ivs_A          101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLA  177 (314)
T ss_dssp             CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCS
T ss_pred             eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccc
Confidence            9999999999999999986532100            000001234899999999999999999999999   9999999


Q ss_pred             CCCEEECCCCcEEEeeccCccccCCCCCce-eeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccc
Q 009340          355 SSNILLDDKFSAKVSDFGISRSIPNDKTHL-TTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFAR  432 (537)
Q Consensus       355 ~~NIll~~~~~~ki~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~  432 (537)
                      |+|||++.++.+||+|||++.......... .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus       178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  257 (314)
T 2ivs_A          178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP  257 (314)
T ss_dssp             GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence            999999999999999999998765443322 233457889999999998889999999999999999999 999986543


Q ss_pred             hhhhccHHHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHHh
Q 009340          433 VEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRS  503 (537)
Q Consensus       433 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~  503 (537)
                      ...       .......         ......+...+..+.+++.+||+.||++|||+.++++.|+++...
T Consensus       258 ~~~-------~~~~~~~---------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  312 (314)
T 2ivs_A          258 PER-------LFNLLKT---------GHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK  312 (314)
T ss_dssp             GGG-------HHHHHHT---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             HHH-------HHHHhhc---------CCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence            322       1111111         111122334456789999999999999999999999999998764

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=4.6e-44  Score=373.34  Aligned_cols=261  Identities=21%  Similarity=0.304  Sum_probs=212.1

Q ss_pred             cCHHHHHHHhcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCCh---HHHHHHHHHHHHHHhcCCCCcceEeeEE
Q 009340          206 FTADELQRATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDK---TQIHQFINEVVILSQINHRHIVKLLGCC  281 (537)
Q Consensus       206 ~~~~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~  281 (537)
                      +.+.+++..+++|+..++||+|+||.||+++.. +++.||+|+++....   .....+.+|..++..++||||+++++++
T Consensus        64 ~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~  143 (437)
T 4aw2_A           64 SKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF  143 (437)
T ss_dssp             HHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred             chhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            345566667789999999999999999999975 578999999864211   1123488999999999999999999999


Q ss_pred             eeCCccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEC
Q 009340          282 LETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD  361 (537)
Q Consensus       282 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~  361 (537)
                      .+.+..++||||+++|+|.+++....           ..+++..+..++.|++.||.|||+.+   |+||||||+|||++
T Consensus       144 ~~~~~~~lV~Ey~~gg~L~~~l~~~~-----------~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~  209 (437)
T 4aw2_A          144 QDDNNLYLVMDYYVGGDLLTLLSKFE-----------DRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMD  209 (437)
T ss_dssp             ECSSEEEEEECCCTTCBHHHHHHTTT-----------TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEC
T ss_pred             eeCCEEEEEEecCCCCcHHHHHHHcc-----------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEc
Confidence            99999999999999999999997632           36999999999999999999999999   99999999999999


Q ss_pred             CCCcEEEeeccCccccCCCCCceeeeccccccccCccccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhh
Q 009340          362 DKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQ-----SSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEE  436 (537)
Q Consensus       362 ~~~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~  436 (537)
                      .++.+||+|||+++..............||+.|+|||++.     .+.++.++|||||||++|||++|+.||......+.
T Consensus       210 ~~g~vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~  289 (437)
T 4aw2_A          210 MNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET  289 (437)
T ss_dssp             TTSCEEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred             CCCCEEEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHH
Confidence            9999999999999877655554455578999999999987     56789999999999999999999999975443221


Q ss_pred             ccHHHHHHHHHhhchhhhhhcHHhhcccc---HHHHHHHHHHHHHhcccCCCC--CCCHhhHHH
Q 009340          437 RNLVACFISLAKENQLLEILDARVAKEAR---EEDIGAMAELAMRCLRLNSKK--RPTMKQVSM  495 (537)
Q Consensus       437 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~---~~~~~~l~~l~~~cl~~~p~~--RPs~~ev~~  495 (537)
                            +.....         .......+   ...+..+.+|+.+||..+|++  ||++.|+++
T Consensus       290 ------~~~i~~---------~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~  338 (437)
T 4aw2_A          290 ------YGKIMN---------HKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK  338 (437)
T ss_dssp             ------HHHHHT---------HHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred             ------HHhhhh---------ccccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence                  111111         11000111   124567889999999888888  999999865

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1.3e-43  Score=356.41  Aligned_cols=269  Identities=25%  Similarity=0.431  Sum_probs=199.8

Q ss_pred             HhcCCccccccCcCCceEEEEEEcCCCC----EEEEEEccCC--ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCcc
Q 009340          214 ATDNYNQSRFLGQGGFGTVYKGMLPDGS----IVAVKRSKEI--DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVP  287 (537)
Q Consensus       214 ~~~~~~~~~~lg~G~~g~Vy~~~~~~g~----~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~  287 (537)
                      ..++|...+.||+|+||.||+|......    .||||.++..  .....+.+.+|+.++++++||||+++++++......
T Consensus        21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  100 (323)
T 3qup_A           21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK  100 (323)
T ss_dssp             C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred             ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence            3468999999999999999999975432    7999998753  345567899999999999999999999999877655


Q ss_pred             ------EEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEC
Q 009340          288 ------VLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD  361 (537)
Q Consensus       288 ------~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~  361 (537)
                            ++||||+++|+|.+++.......      ....+++..++.++.|+++||.|||+.+   |+||||||+|||++
T Consensus       101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~------~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~  171 (323)
T 3qup_A          101 GRLPIPMVILPFMKHGDLHAFLLASRIGE------NPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLA  171 (323)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHHHC---------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEC
T ss_pred             cCCCccEEEEEeccCCcHHHHHHhhhccc------cccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEc
Confidence                  99999999999999997643210      1235999999999999999999999999   99999999999999


Q ss_pred             CCCcEEEeeccCccccCCCCCc-eeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccH
Q 009340          362 DKFSAKVSDFGISRSIPNDKTH-LTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNL  439 (537)
Q Consensus       362 ~~~~~ki~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~  439 (537)
                      .++.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+.   
T Consensus       172 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~---  248 (323)
T 3qup_A          172 EDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI---  248 (323)
T ss_dssp             TTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---
T ss_pred             CCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHH---
Confidence            9999999999999876443322 2234456889999999999999999999999999999999 8999865433221   


Q ss_pred             HHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHHhhHHH
Q 009340          440 VACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRSQRCL  507 (537)
Q Consensus       440 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~~~~  507 (537)
                          ......         ......+...+..+.+++.+||+.||++|||+.++++.|+++.......
T Consensus       249 ----~~~~~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~  303 (323)
T 3qup_A          249 ----YNYLIG---------GNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVL  303 (323)
T ss_dssp             ----HHHHHT---------TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC----
T ss_pred             ----HHHHhc---------CCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhc
Confidence                111111         0111223344567899999999999999999999999999998755333

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=2e-43  Score=351.15  Aligned_cols=261  Identities=21%  Similarity=0.347  Sum_probs=203.2

Q ss_pred             hcCCccccccCcCCceEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHHHHh--cCCCCcceEeeEEeeC----CccE
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQ--INHRHIVKLLGCCLET----EVPV  288 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~g~~~~~----~~~~  288 (537)
                      .++|...+.||+|+||.||+|+. +|+.||||++...   ....+..|.+++..  ++||||+++++++.+.    ...+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~   82 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW   82 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence            46889999999999999999998 6899999998753   34556677777776  7999999999997653    3579


Q ss_pred             EEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh--------hcCCCCeeecCCCCCCEEE
Q 009340          289 LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMH--------SSASIPIFHRDIKSSNILL  360 (537)
Q Consensus       289 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH--------~~~~~~ivH~Dlk~~NIll  360 (537)
                      +||||+++|+|.+++..             ..+++..++.++.|+++||+|||        +.+   |+||||||+|||+
T Consensus        83 lv~e~~~~g~L~~~l~~-------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill  146 (301)
T 3q4u_A           83 LITHYHEMGSLYDYLQL-------------TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILV  146 (301)
T ss_dssp             EEECCCTTCBHHHHHTT-------------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEE
T ss_pred             EehhhccCCCHHHHHhh-------------cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEE
Confidence            99999999999999953             36999999999999999999999        777   9999999999999


Q ss_pred             CCCCcEEEeeccCccccCCCCCce---eeeccccccccCcccccCC------CCCcchhHHHHHHHHHHHHhC-------
Q 009340          361 DDKFSAKVSDFGISRSIPNDKTHL---TTTIQGTFGYLDPEYFQSS------QFTDKSDVYSFGVVLLELLTG-------  424 (537)
Q Consensus       361 ~~~~~~ki~Dfgla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~t~ksDV~S~Gvll~el~tg-------  424 (537)
                      +.++.+||+|||+++.........   .....||+.|+|||.+.+.      .++.++||||||+++|||++|       
T Consensus       147 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~  226 (301)
T 3q4u_A          147 KKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIV  226 (301)
T ss_dssp             CTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred             cCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccc
Confidence            999999999999997664433322   2234799999999999876      455799999999999999999       


Q ss_pred             ---CCCCCccchhhhccHHHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHH
Q 009340          425 ---KKPICFARVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGL  500 (537)
Q Consensus       425 ---~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i  500 (537)
                         +.||........  .................+.   ....+...+..+.+|+.+||+.||++|||+.+|+++|++|
T Consensus       227 ~~~~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          227 EDYKPPFYDVVPNDP--SFEDMRKVVCVDQQRPNIP---NRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             CCCCCTTTTTSCSSC--CHHHHHHHHTTSCCCCCCC---GGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccccccccccCCCCc--chhhhhHHHhccCCCCCCC---hhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence               777754322211  1111111111111110010   0112345678899999999999999999999999999976

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=2.4e-43  Score=356.37  Aligned_cols=274  Identities=26%  Similarity=0.428  Sum_probs=215.7

Q ss_pred             hcCCccccccCcCCceEEEEEEc--------CCCCEEEEEEccCC-ChHHHHHHHHHHHHHHhc-CCCCcceEeeEEeeC
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGML--------PDGSIVAVKRSKEI-DKTQIHQFINEVVILSQI-NHRHIVKLLGCCLET  284 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~--------~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~  284 (537)
                      .++|...+.||+|+||.||+|..        .++..||||+++.. .....+.+.+|+.+++++ +||||+++++++.+.
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  113 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  113 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence            46888999999999999999985        24678999998754 345567899999999999 899999999999999


Q ss_pred             CccEEEEecCCCCChhhhhhhhhhhHHH----HhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEE
Q 009340          285 EVPVLVYEYISSGTLSHHIHDHQQQQEQ----KQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILL  360 (537)
Q Consensus       285 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~----~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll  360 (537)
                      +..++||||+++|+|.+++.........    ........+++..++.++.|+++||.|||+.+   |+||||||+|||+
T Consensus       114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll  190 (334)
T 2pvf_A          114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV  190 (334)
T ss_dssp             SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred             CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEEE
Confidence            9999999999999999999764321000    00000235899999999999999999999999   9999999999999


Q ss_pred             CCCCcEEEeeccCccccCCCCCce-eeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhcc
Q 009340          361 DDKFSAKVSDFGISRSIPNDKTHL-TTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERN  438 (537)
Q Consensus       361 ~~~~~~ki~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~  438 (537)
                      +.++.+||+|||++.......... .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+   
T Consensus       191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---  267 (334)
T 2pvf_A          191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---  267 (334)
T ss_dssp             CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---
T ss_pred             cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH---
Confidence            999999999999998765443222 233457889999999988889999999999999999999 999986543222   


Q ss_pred             HHHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHHhhHHH
Q 009340          439 LVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRSQRCL  507 (537)
Q Consensus       439 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~~~~  507 (537)
                          ........         .....+..++..+.+++.+||+.||++|||+.++++.|+++.......
T Consensus       268 ----~~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~~  323 (334)
T 2pvf_A          268 ----LFKLLKEG---------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNE  323 (334)
T ss_dssp             ----HHHHHHHT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC--
T ss_pred             ----HHHHHhcC---------CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccccC
Confidence                11111111         111223344567899999999999999999999999999998755433

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=6.9e-44  Score=350.76  Aligned_cols=260  Identities=25%  Similarity=0.422  Sum_probs=213.9

Q ss_pred             HhcCCccccccCcCCceEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEec
Q 009340          214 ATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY  293 (537)
Q Consensus       214 ~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  293 (537)
                      ..++|...+.||+|+||.||+|...++..||||.++.... ..+.+.+|+.++++++||||+++++++.+ +..++||||
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~   88 (279)
T 1qpc_A           11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY   88 (279)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc-cHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEec
Confidence            3467888999999999999999988888999999875432 35678999999999999999999999864 567999999


Q ss_pred             CCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccC
Q 009340          294 ISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGI  373 (537)
Q Consensus       294 ~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgl  373 (537)
                      +++++|.+++.....          ..+++..++.++.|+++||.|||+.+   |+||||||+||++++++.+||+|||+
T Consensus        89 ~~~~~L~~~l~~~~~----------~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~  155 (279)
T 1qpc_A           89 MENGSLVDFLKTPSG----------IKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGL  155 (279)
T ss_dssp             CTTCBHHHHTTSHHH----------HTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTT
T ss_pred             CCCCCHHHHHhcCCC----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcc
Confidence            999999999976432          25999999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHHHHHhhchh
Q 009340          374 SRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQL  452 (537)
Q Consensus       374 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  452 (537)
                      +...............++..|+|||.+.+..++.++||||||+++|||++ |+.||......+       ........  
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-------~~~~~~~~--  226 (279)
T 1qpc_A          156 ARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-------VIQNLERG--  226 (279)
T ss_dssp             CEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTT--
T ss_pred             cccccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH-------HHHHHhcc--
Confidence            98775443333334557889999999988889999999999999999999 899986543221       11111111  


Q ss_pred             hhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHHhh
Q 009340          453 LEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRSQ  504 (537)
Q Consensus       453 ~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~  504 (537)
                             .....+...+..+.+++.+||+.||++|||+.++++.|+.+....
T Consensus       227 -------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  271 (279)
T 1qpc_A          227 -------YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT  271 (279)
T ss_dssp             -------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             -------cCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhc
Confidence                   111223344567899999999999999999999999999987653

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=9.6e-44  Score=360.27  Aligned_cols=273  Identities=25%  Similarity=0.423  Sum_probs=215.7

Q ss_pred             HHhcCCccccccCcCCceEEEEEEcC------CCCEEEEEEccCC-ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCC
Q 009340          213 RATDNYNQSRFLGQGGFGTVYKGMLP------DGSIVAVKRSKEI-DKTQIHQFINEVVILSQINHRHIVKLLGCCLETE  285 (537)
Q Consensus       213 ~~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~  285 (537)
                      ...++|...+.||+|+||.||+|...      +++.||||.++.. .....+.|.+|+.++++++||||+++++++.+.+
T Consensus        44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~  123 (343)
T 1luf_A           44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK  123 (343)
T ss_dssp             CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC
Confidence            34578999999999999999999964      3478999999764 4455678999999999999999999999999999


Q ss_pred             ccEEEEecCCCCChhhhhhhhhhhHH------------HHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCC
Q 009340          286 VPVLVYEYISSGTLSHHIHDHQQQQE------------QKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDI  353 (537)
Q Consensus       286 ~~~lV~e~~~~gsL~~~l~~~~~~~~------------~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dl  353 (537)
                      ..++||||+++|+|.+++........            .........+++..++.++.|+++||.|||+++   |+||||
T Consensus       124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dl  200 (343)
T 1luf_A          124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDL  200 (343)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred             ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence            99999999999999999986432110            000001246999999999999999999999999   999999


Q ss_pred             CCCCEEECCCCcEEEeeccCccccCCCCC-ceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCcc
Q 009340          354 KSSNILLDDKFSAKVSDFGISRSIPNDKT-HLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFA  431 (537)
Q Consensus       354 k~~NIll~~~~~~ki~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~  431 (537)
                      ||+|||++.++.+||+|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus       201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~  280 (343)
T 1luf_A          201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM  280 (343)
T ss_dssp             SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred             CcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCC
Confidence            99999999999999999999986643322 12234567899999999998899999999999999999999 99998654


Q ss_pred             chhhhccHHHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHHhh
Q 009340          432 RVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRSQ  504 (537)
Q Consensus       432 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~  504 (537)
                      ...+       .......+..         ...+...+..+.+++.+||+.||++|||+.++++.|+++....
T Consensus       281 ~~~~-------~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~  337 (343)
T 1luf_A          281 AHEE-------VIYYVRDGNI---------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA  337 (343)
T ss_dssp             CHHH-------HHHHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred             ChHH-------HHHHHhCCCc---------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence            3222       1111111111         1223344567899999999999999999999999999887643

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1.2e-43  Score=347.40  Aligned_cols=253  Identities=28%  Similarity=0.485  Sum_probs=198.6

Q ss_pred             cCCccccccCcCCceEEEEEEcCCCCEEEEEEccCCCh----HHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDK----TQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY  291 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  291 (537)
                      ++|...+.||+|+||.||+|... |+.||||.++....    ...+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         7 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (271)
T 3dtc_A            7 AELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM   85 (271)
T ss_dssp             TSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred             hheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence            57888999999999999999984 88999999865322    23567889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECC--------C
Q 009340          292 EYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD--------K  363 (537)
Q Consensus       292 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~--------~  363 (537)
                      ||+++++|.+++..             ..+++..++.++.|+++||.|||+.+..+|+||||||+|||++.        +
T Consensus        86 e~~~~~~L~~~~~~-------------~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~  152 (271)
T 3dtc_A           86 EFARGGPLNRVLSG-------------KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSN  152 (271)
T ss_dssp             ECCTTEEHHHHHTS-------------SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSS
T ss_pred             EcCCCCCHHHHhhc-------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccC
Confidence            99999999998853             36999999999999999999999998667899999999999986        7


Q ss_pred             CcEEEeeccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHH
Q 009340          364 FSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACF  443 (537)
Q Consensus       364 ~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~  443 (537)
                      +.+||+|||++.......   .....||+.|+|||.+.+..++.++||||||+++|||++|+.||........      .
T Consensus       153 ~~~kl~Dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~------~  223 (271)
T 3dtc_A          153 KILKITDFGLAREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAV------A  223 (271)
T ss_dssp             CCEEECCCCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHH------H
T ss_pred             cceEEccCCccccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------H
Confidence            789999999998654322   2245689999999999999999999999999999999999999865432211      0


Q ss_pred             HHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHH
Q 009340          444 ISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGL  500 (537)
Q Consensus       444 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i  500 (537)
                      ...         .........+...+..+.+++.+||+.||++|||+.|+++.|+.|
T Consensus       224 ~~~---------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          224 YGV---------AMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             HHH---------HTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             Hhh---------hcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence            111         111111223344456789999999999999999999999999864

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=5.1e-44  Score=360.23  Aligned_cols=280  Identities=28%  Similarity=0.422  Sum_probs=216.3

Q ss_pred             cCCccccccCcCCceEEEEEEc-----CCCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEee--CCccE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGML-----PDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLE--TEVPV  288 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~  288 (537)
                      ++|...+.||+|+||.||++++     .+++.||||++........+.+.+|+.++++++|+||+++++++..  ....+
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~  102 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR  102 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence            5788899999999999999984     3688999999988777777889999999999999999999999874  45689


Q ss_pred             EEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEE
Q 009340          289 LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKV  368 (537)
Q Consensus       289 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki  368 (537)
                      +||||+++|+|.+++.....           .+++..++.++.|+++||+|||+.+   |+||||||+|||++.++.+||
T Consensus       103 lv~e~~~~~~L~~~l~~~~~-----------~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl  168 (327)
T 3lxl_A          103 LVMEYLPSGCLRDFLQRHRA-----------RLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKI  168 (327)
T ss_dssp             EEEECCTTCBHHHHHHHHGG-----------GCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEE
T ss_pred             EEEeecCCCCHHHHHHhccc-----------CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEE
Confidence            99999999999999976432           5999999999999999999999999   999999999999999999999


Q ss_pred             eeccCccccCCCCCc--eeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHH
Q 009340          369 SDFGISRSIPNDKTH--LTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISL  446 (537)
Q Consensus       369 ~Dfgla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~  446 (537)
                      +|||++.........  ......+|..|+|||.+.+..++.++||||||+++|||++|+.||........... ......
T Consensus       169 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~-~~~~~~  247 (327)
T 3lxl_A          169 ADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMM-GCERDV  247 (327)
T ss_dssp             CCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHC-C----C
T ss_pred             cccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhc-cccccc
Confidence            999999877544332  22345678889999999988899999999999999999999999864322110000 000000


Q ss_pred             HhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHHhhHHHhhh
Q 009340          447 AKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRSQRCLEMC  510 (537)
Q Consensus       447 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~~~~~~~  510 (537)
                      .....+.+.+........+...+..+.+|+.+||+.||++|||+.++++.|+.+..........
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~  311 (327)
T 3lxl_A          248 PALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETH  311 (327)
T ss_dssp             CHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----------
T ss_pred             ccHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCcccc
Confidence            0001112222222223344556678999999999999999999999999999998766544433

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.6e-43  Score=349.67  Aligned_cols=261  Identities=26%  Similarity=0.446  Sum_probs=219.4

Q ss_pred             HhcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEe
Q 009340          214 ATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE  292 (537)
Q Consensus       214 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e  292 (537)
                      ..++|...+.||+|+||.||+|... ++..||+|.+.... ...+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   89 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   89 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence            4578888999999999999999975 48899999987643 346789999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeecc
Q 009340          293 YISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG  372 (537)
Q Consensus       293 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfg  372 (537)
                      |+++|+|.+++....          ...+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||
T Consensus        90 ~~~~~~L~~~~~~~~----------~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg  156 (288)
T 3kfa_A           90 FMTYGNLLDYLRECN----------RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFG  156 (288)
T ss_dssp             CCTTEEHHHHHHHCC----------TTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCC
T ss_pred             cCCCCcHHHHHHhcc----------cCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCc
Confidence            999999999997633          235999999999999999999999999   9999999999999999999999999


Q ss_pred             CccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHHHHHhhch
Q 009340          373 ISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQ  451 (537)
Q Consensus       373 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  451 (537)
                      ++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||........       .       
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~-------~-------  222 (288)
T 3kfa_A          157 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV-------Y-------  222 (288)
T ss_dssp             GGGTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH-------H-------
T ss_pred             cceeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH-------H-------
Confidence            998876555444455667889999999998999999999999999999999 8999865433221       1       


Q ss_pred             hhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHHhh
Q 009340          452 LLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRSQ  504 (537)
Q Consensus       452 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~  504 (537)
                        +.+........+...+..+.+++.+||+.||++|||+.++++.|+.+....
T Consensus       223 --~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~  273 (288)
T 3kfa_A          223 --ELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES  273 (288)
T ss_dssp             --HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             --HHHhccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence              111111122233444567899999999999999999999999999888754

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=2.6e-43  Score=352.33  Aligned_cols=271  Identities=27%  Similarity=0.422  Sum_probs=216.5

Q ss_pred             hcCCccccccCcCCceEEEEEEc------CCCCEEEEEEccCCC-hHHHHHHHHHHHHHHhc-CCCCcceEeeEEeeCCc
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGML------PDGSIVAVKRSKEID-KTQIHQFINEVVILSQI-NHRHIVKLLGCCLETEV  286 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~  286 (537)
                      .++|...+.||+|+||.||+|..      .+++.||||.++... ....+.+.+|+.+++++ +||||+++++++.+.+.
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  101 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence            46788899999999999999984      356789999987543 34567899999999999 99999999999999999


Q ss_pred             cEEEEecCCCCChhhhhhhhhhhHH------HHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEE
Q 009340          287 PVLVYEYISSGTLSHHIHDHQQQQE------QKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILL  360 (537)
Q Consensus       287 ~~lV~e~~~~gsL~~~l~~~~~~~~------~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll  360 (537)
                      .++||||+++|+|.+++........      .........+++..++.++.|+++||.|||+.+   |+||||||+||++
T Consensus       102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~  178 (313)
T 1t46_A          102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL  178 (313)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred             cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEE
Confidence            9999999999999999986542100      000011235999999999999999999999999   9999999999999


Q ss_pred             CCCCcEEEeeccCccccCCCCCc-eeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhcc
Q 009340          361 DDKFSAKVSDFGISRSIPNDKTH-LTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERN  438 (537)
Q Consensus       361 ~~~~~~ki~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~  438 (537)
                      +.++.+||+|||++......... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||........  
T Consensus       179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--  256 (313)
T 1t46_A          179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK--  256 (313)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH--
T ss_pred             cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH--
Confidence            99999999999999877544332 2334557889999999999999999999999999999999 9999865432211  


Q ss_pred             HHHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHHh
Q 009340          439 LVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRS  503 (537)
Q Consensus       439 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~  503 (537)
                          +.....         .......+...+..+.+++.+||+.||++|||+.++++.|+++..+
T Consensus       257 ----~~~~~~---------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  308 (313)
T 1t46_A          257 ----FYKMIK---------EGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE  308 (313)
T ss_dssp             ----HHHHHH---------HTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----HHHHhc---------cCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence                111111         1111122333456789999999999999999999999999988764

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=5.9e-43  Score=347.22  Aligned_cols=264  Identities=17%  Similarity=0.198  Sum_probs=212.3

Q ss_pred             hcCCccccccCcCCceEEEEEEc-CCCCEEEEEEccCCChHHHHHHHHHHHHHHhc-CCCCcceEeeEEeeCCccEEEEe
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEIDKTQIHQFINEVVILSQI-NHRHIVKLLGCCLETEVPVLVYE  292 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e  292 (537)
                      .++|...+.||+|+||.||+|.. .+|+.||||.+....  ..+.+.+|+.++..+ +|+|++++++++.+....++|||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e   86 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   86 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence            35789999999999999999994 578999999886532  234578899999999 79999999999999999999999


Q ss_pred             cCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCc-----EE
Q 009340          293 YISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFS-----AK  367 (537)
Q Consensus       293 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~-----~k  367 (537)
                      |+ +++|.+++....           ..+++..++.++.|+++||.|||+.+   |+||||||+|||++.++.     +|
T Consensus        87 ~~-~~~L~~~l~~~~-----------~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~k  151 (298)
T 1csn_A           87 LL-GPSLEDLLDLCG-----------RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIY  151 (298)
T ss_dssp             CC-CCBHHHHHHHTT-----------TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEE
T ss_pred             ec-CCCHHHHHHHhc-----------cCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEE
Confidence            99 999999997542           35999999999999999999999999   999999999999987776     99


Q ss_pred             EeeccCccccCCCCCc------eeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHH
Q 009340          368 VSDFGISRSIPNDKTH------LTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVA  441 (537)
Q Consensus       368 i~Dfgla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~  441 (537)
                      |+|||+++........      ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.............
T Consensus       152 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~  231 (298)
T 1csn_A          152 VVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYE  231 (298)
T ss_dssp             ECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHH
T ss_pred             EEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHH
Confidence            9999999876443221      2345579999999999999999999999999999999999999997643322211111


Q ss_pred             HHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHHhh
Q 009340          442 CFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRSQ  504 (537)
Q Consensus       442 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~  504 (537)
                      ...........     +.    .....+..+.+++.+||+.||++|||+.+|++.|+.+....
T Consensus       232 ~~~~~~~~~~~-----~~----~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~  285 (298)
T 1csn_A          232 RIGEKKQSTPL-----RE----LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL  285 (298)
T ss_dssp             HHHHHHHHSCH-----HH----HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             HHHhhccCccH-----HH----HHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhc
Confidence            11111110100     00    11123467889999999999999999999999999987743

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=5.5e-44  Score=383.47  Aligned_cols=260  Identities=27%  Similarity=0.417  Sum_probs=214.3

Q ss_pred             HHHhcCCccccccCcCCceEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEE
Q 009340          212 QRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY  291 (537)
Q Consensus       212 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  291 (537)
                      +...++|...++||+|+||.||+|.+.++..||||+++.... ..++|.+|+.+|++++|+||+++++++.+ +..++||
T Consensus       263 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~  340 (535)
T 2h8h_A          263 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT  340 (535)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             ecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEee
Confidence            334567888899999999999999998888899999976432 34679999999999999999999999976 6789999


Q ss_pred             ecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeec
Q 009340          292 EYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF  371 (537)
Q Consensus       292 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Df  371 (537)
                      ||+++|+|.+++.....          ..+++..++.|+.||++||+|||+++   |+||||||+|||++.++.+||+||
T Consensus       341 e~~~~gsL~~~l~~~~~----------~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DF  407 (535)
T 2h8h_A          341 EYMSKGSLLDFLKGETG----------KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADF  407 (535)
T ss_dssp             CCCTTEEHHHHHSHHHH----------TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCT
T ss_pred             ehhcCCcHHHHHhhcCC----------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEccc
Confidence            99999999999975432          35899999999999999999999999   999999999999999999999999


Q ss_pred             cCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHHHHHhhc
Q 009340          372 GISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKEN  450 (537)
Q Consensus       372 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  450 (537)
                      |+++..............++..|+|||.+..+.++.++|||||||++|||++ |+.||......+       ......  
T Consensus       408 G~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~-------~~~~i~--  478 (535)
T 2h8h_A          408 GLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-------VLDQVE--  478 (535)
T ss_dssp             TSTTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH-------HHHHHH--
T ss_pred             ccceecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHH--
Confidence            9998764332222234456789999999999999999999999999999999 899986543221       111111  


Q ss_pred             hhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHH
Q 009340          451 QLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRR  502 (537)
Q Consensus       451 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~  502 (537)
                             .......+..++..+.+|+.+||+.||++|||+.+|+++|+.+..
T Consensus       479 -------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~  523 (535)
T 2h8h_A          479 -------RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  523 (535)
T ss_dssp             -------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred             -------cCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence                   111222344556778999999999999999999999999997654

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=4.9e-43  Score=353.00  Aligned_cols=251  Identities=23%  Similarity=0.356  Sum_probs=200.1

Q ss_pred             hcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCC-ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCc------
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI-DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEV------  286 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~------  286 (537)
                      .++|+..+.||+|+||.||+|+.. +|+.||||+++.. .....+.+.+|+.++++++||||+++++++.+...      
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            467889999999999999999975 7999999998643 33456789999999999999999999999876542      


Q ss_pred             ---------------------------------------------------cEEEEecCCCCChhhhhhhhhhhHHHHhh
Q 009340          287 ---------------------------------------------------PVLVYEYISSGTLSHHIHDHQQQQEQKQK  315 (537)
Q Consensus       287 ---------------------------------------------------~~lV~e~~~~gsL~~~l~~~~~~~~~~~~  315 (537)
                                                                         .++||||+++|+|.+++.....       
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-------  157 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS-------  157 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS-------
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC-------
Confidence                                                               7999999999999999987543       


Q ss_pred             hccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCccccCCCCC-----------ce
Q 009340          316 QELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKT-----------HL  384 (537)
Q Consensus       316 ~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~-----------~~  384 (537)
                        ....++..++.++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||+++.......           ..
T Consensus       158 --~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~  232 (332)
T 3qd2_B          158 --LEDREHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYAT  232 (332)
T ss_dssp             --GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------C
T ss_pred             --ccchhhHHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhcccccccccccc
Confidence              235678889999999999999999999   99999999999999999999999999987754421           12


Q ss_pred             eeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchhhhhhcHHhhccc
Q 009340          385 TTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEILDARVAKEA  464 (537)
Q Consensus       385 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  464 (537)
                      .....||+.|+|||.+.+..++.++||||||+++|||++|..|+...     .   . .........         ....
T Consensus       233 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~-----~---~-~~~~~~~~~---------~~~~  294 (332)
T 3qd2_B          233 HTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER-----V---R-IITDVRNLK---------FPLL  294 (332)
T ss_dssp             CCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH-----H---H-HHHHHHTTC---------CCHH
T ss_pred             ccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH-----H---H-HHHHhhccC---------CCcc
Confidence            23456999999999999999999999999999999999987763210     0   0 000011100         0111


Q ss_pred             cHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          465 REEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       465 ~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      .......+.+++.+||+.||++|||+.|+++
T Consensus       295 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          295 FTQKYPQEHMMVQDMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             HHHHCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred             cccCChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence            2334466789999999999999999999975

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=4.5e-43  Score=353.79  Aligned_cols=262  Identities=17%  Similarity=0.217  Sum_probs=210.3

Q ss_pred             cCCccccccCcCCceEEEEEEc-CCCCEEEEEEccCCChHHHHHHHHHHHHHHhc-CCCCcceEeeEEeeCCccEEEEec
Q 009340          216 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEIDKTQIHQFINEVVILSQI-NHRHIVKLLGCCLETEVPVLVYEY  293 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~  293 (537)
                      ++|...+.||+|+||.||+|.. .+|+.||||.+.....  .+.+.+|+.+++++ +|+||+++++++.+.+..++||||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~   86 (330)
T 2izr_A            9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLEL   86 (330)
T ss_dssp             TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEEC
T ss_pred             CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEe
Confidence            6788999999999999999995 5789999999865322  24578999999999 999999999999999999999999


Q ss_pred             CCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCc-----EEE
Q 009340          294 ISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFS-----AKV  368 (537)
Q Consensus       294 ~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~-----~ki  368 (537)
                      + +++|.+++....           ..+++..++.++.|+++||+|||+.+   |+||||||+|||++.++.     +||
T Consensus        87 ~-~~~L~~~~~~~~-----------~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl  151 (330)
T 2izr_A           87 L-GPSLEDLFDLCD-----------RTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHI  151 (330)
T ss_dssp             C-CCBHHHHHHHTT-----------TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEE
T ss_pred             C-CCCHHHHHHHcC-----------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEE
Confidence            9 999999997542           36999999999999999999999999   999999999999999887     999


Q ss_pred             eeccCccccCCCCCc------eeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHH
Q 009340          369 SDFGISRSIPNDKTH------LTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVAC  442 (537)
Q Consensus       369 ~Dfgla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~  442 (537)
                      +|||+++........      ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..............
T Consensus       152 ~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~  231 (330)
T 2izr_A          152 IDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQK  231 (330)
T ss_dssp             CCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHH
T ss_pred             EEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHH
Confidence            999999876433221      12456799999999999999999999999999999999999999976433221111111


Q ss_pred             HHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHHhh
Q 009340          443 FISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRSQ  504 (537)
Q Consensus       443 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~  504 (537)
                      ........     ....+.    ...+ .+.+++.+||+.||.+||++.+|.+.|+.+....
T Consensus       232 i~~~~~~~-----~~~~~~----~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~  283 (330)
T 2izr_A          232 IGDTKRAT-----PIEVLC----ENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK  283 (330)
T ss_dssp             HHHHHHHS-----CHHHHT----TTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             HHhhhccC-----CHHHHh----ccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence            11000000     000000    1122 7899999999999999999999999999887754

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-43  Score=358.39  Aligned_cols=274  Identities=25%  Similarity=0.436  Sum_probs=212.9

Q ss_pred             HHhcCCccccccCcCCceEEEEEEc------CCCCEEEEEEccCC-ChHHHHHHHHHHHHHHhc-CCCCcceEeeEEeeC
Q 009340          213 RATDNYNQSRFLGQGGFGTVYKGML------PDGSIVAVKRSKEI-DKTQIHQFINEVVILSQI-NHRHIVKLLGCCLET  284 (537)
Q Consensus       213 ~~~~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~  284 (537)
                      ...++|...+.||+|+||.||+|..      .++..||||.++.. .....+.+.+|+.++.++ +||||+++++++.+.
T Consensus        42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  121 (344)
T 1rjb_A           42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS  121 (344)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence            3457889999999999999999995      24568999998753 233456789999999999 899999999999999


Q ss_pred             CccEEEEecCCCCChhhhhhhhhhhHHH-----------HhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCC
Q 009340          285 EVPVLVYEYISSGTLSHHIHDHQQQQEQ-----------KQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDI  353 (537)
Q Consensus       285 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~-----------~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dl  353 (537)
                      +..++||||+++|+|.+++.........           ........+++..++.++.|+++||.|||+.+   |+||||
T Consensus       122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Di  198 (344)
T 1rjb_A          122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDL  198 (344)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTC
T ss_pred             CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCC
Confidence            9999999999999999999765321000           00011235899999999999999999999999   999999


Q ss_pred             CCCCEEECCCCcEEEeeccCccccCCCCCc-eeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCcc
Q 009340          354 KSSNILLDDKFSAKVSDFGISRSIPNDKTH-LTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFA  431 (537)
Q Consensus       354 k~~NIll~~~~~~ki~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~  431 (537)
                      ||+|||++.++.+||+|||++......... ......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||...
T Consensus       199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~  278 (344)
T 1rjb_A          199 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI  278 (344)
T ss_dssp             SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             ChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence            999999999999999999999876443322 2334567889999999999999999999999999999998 99998654


Q ss_pred             chhhhccHHHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHHhh
Q 009340          432 RVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRSQ  504 (537)
Q Consensus       432 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~  504 (537)
                      .....      +......         ......+...+..+.+|+.+||+.||++|||+.++++.|+.+....
T Consensus       279 ~~~~~------~~~~~~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~  336 (344)
T 1rjb_A          279 PVDAN------FYKLIQN---------GFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA  336 (344)
T ss_dssp             CCSHH------HHHHHHT---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred             CcHHH------HHHHHhc---------CCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence            32211      1111111         1112223344567899999999999999999999999999887654

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.2e-43  Score=357.40  Aligned_cols=267  Identities=25%  Similarity=0.465  Sum_probs=215.1

Q ss_pred             hcCCccccccCcCCceEEEEEEc-----CCCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCC--cc
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGML-----PDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETE--VP  287 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~  287 (537)
                      .++|...+.||+|+||.||++.+     .+|+.||||++........+.+.+|+.++++++|+||+++++++...+  ..
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  119 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL  119 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence            35688889999999999999983     368899999998777777788999999999999999999999987654  68


Q ss_pred             EEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEE
Q 009340          288 VLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK  367 (537)
Q Consensus       288 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~k  367 (537)
                      ++||||+++|+|.+++....           ..+++..++.++.|+++||.|||+.+   |+||||||+||+++.++.+|
T Consensus       120 ~lv~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~k  185 (326)
T 2w1i_A          120 KLIMEYLPYGSLRDYLQKHK-----------ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVK  185 (326)
T ss_dssp             EEEECCCTTCBHHHHHHHST-----------TSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEE
T ss_pred             EEEEECCCCCCHHHHHHhcc-----------cCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEE
Confidence            99999999999999997642           35899999999999999999999999   99999999999999999999


Q ss_pred             EeeccCccccCCCCCce--eeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHH
Q 009340          368 VSDFGISRSIPNDKTHL--TTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFIS  445 (537)
Q Consensus       368 i~Dfgla~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~  445 (537)
                      |+|||++..........  .....++..|+|||.+.+..++.++||||||+++|||++|..|+......        +..
T Consensus       186 L~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~--------~~~  257 (326)
T 2w1i_A          186 IGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE--------FMR  257 (326)
T ss_dssp             ECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHH--------HHH
T ss_pred             EecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHH--------HHH
Confidence            99999998775443321  22345678899999998888999999999999999999999987532110        111


Q ss_pred             HHhh--------chhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHHh
Q 009340          446 LAKE--------NQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRS  503 (537)
Q Consensus       446 ~~~~--------~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~  503 (537)
                      ....        ..+.+.+......+.+..++..+.+++.+||+.||++|||+.+|++.|+.+++.
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~  323 (326)
T 2w1i_A          258 MIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ  323 (326)
T ss_dssp             HHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             hhccccchhhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence            0000        011111211112223445567899999999999999999999999999999875

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=5.5e-43  Score=350.29  Aligned_cols=263  Identities=21%  Similarity=0.338  Sum_probs=204.0

Q ss_pred             HhcCCccccccCcCCceEEEEEEcCCCCEEEEEEccCCC--hHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEE
Q 009340          214 ATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEID--KTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY  291 (537)
Q Consensus       214 ~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  291 (537)
                      ..++|...++||+|+||+||+++..+|+.||+|+++...  ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   98 (311)
T 3niz_A           19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF   98 (311)
T ss_dssp             SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred             hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence            347899999999999999999998889999999986432  233567889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeec
Q 009340          292 EYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF  371 (537)
Q Consensus       292 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Df  371 (537)
                      ||+++ +|.+++....           ..+++..+..++.|+++||.|||+.+   |+||||||+|||++.++.+||+||
T Consensus        99 e~~~~-~l~~~~~~~~-----------~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Df  163 (311)
T 3niz_A           99 EFMEK-DLKKVLDENK-----------TGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADF  163 (311)
T ss_dssp             ECCSE-EHHHHHHTCT-----------TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCC
T ss_pred             cCCCC-CHHHHHHhcc-----------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccC
Confidence            99985 8888876532           35999999999999999999999999   999999999999999999999999


Q ss_pred             cCccccCCCCCceeeeccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhc
Q 009340          372 GISRSIPNDKTHLTTTIQGTFGYLDPEYFQS-SQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKEN  450 (537)
Q Consensus       372 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  450 (537)
                      |+++....... ......+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+.   ...........
T Consensus       164 g~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~i~~~~~~~  239 (311)
T 3niz_A          164 GLARAFGIPVR-SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ---LPKIFSILGTP  239 (311)
T ss_dssp             TTCEETTSCCC----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH---HHHHHHHHCCC
T ss_pred             cCceecCCCcc-cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHHCCC
Confidence            99987643322 2334568999999999876 5689999999999999999999999975543322   11111111111


Q ss_pred             h---hhhh-------------hcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          451 Q---LLEI-------------LDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       451 ~---~~~~-------------~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      .   ....             .+...........+.++.+|+.+||+.||++|||+.|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          240 NPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             CTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             ChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            0   0000             0000000111223457889999999999999999999875

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.8e-43  Score=353.76  Aligned_cols=244  Identities=23%  Similarity=0.285  Sum_probs=195.4

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCC--ChHHHHHHHHHHHHHHhc-CCCCcceEeeEEeeCCccEEEE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI--DKTQIHQFINEVVILSQI-NHRHIVKLLGCCLETEVPVLVY  291 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~  291 (537)
                      ++|+..++||+|+||+||+|+.. +|+.||||++...  ......++..|+..+.++ +|+||+++++++.+.+..++||
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~  136 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT  136 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence            67999999999999999999975 7999999987642  334455666777766666 8999999999999999999999


Q ss_pred             ecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeec
Q 009340          292 EYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF  371 (537)
Q Consensus       292 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Df  371 (537)
                      ||+ +++|.+++....           ..++|..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+||
T Consensus       137 e~~-~~~L~~~~~~~~-----------~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DF  201 (311)
T 3p1a_A          137 ELC-GPSLQQHCEAWG-----------ASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDF  201 (311)
T ss_dssp             ECC-CCBHHHHHHHHC-----------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCC
T ss_pred             ecc-CCCHHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccc
Confidence            999 679998886542           36999999999999999999999998   999999999999999999999999


Q ss_pred             cCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhch
Q 009340          372 GISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQ  451 (537)
Q Consensus       372 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  451 (537)
                      |++.......  ......||+.|+|||++.+ .++.++||||||+++|||++|..|+.....          +.......
T Consensus       202 G~a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~----------~~~~~~~~  268 (311)
T 3p1a_A          202 GLLVELGTAG--AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG----------WQQLRQGY  268 (311)
T ss_dssp             TTCEECC--------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH----------HHHHTTTC
T ss_pred             eeeeecccCC--CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH----------HHHHhccC
Confidence            9998764332  2344568999999999875 789999999999999999999777643211          11111111


Q ss_pred             hhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          452 LLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       452 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                          ..+.    .+...+..+.+++.+||+.||++|||+.|+++
T Consensus       269 ----~~~~----~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          269 ----LPPE----FTAGLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             ----CCHH----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ----CCcc----cccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence                1111    11223467889999999999999999999975

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=3.5e-43  Score=352.81  Aligned_cols=270  Identities=26%  Similarity=0.400  Sum_probs=214.1

Q ss_pred             CccccccCcCCceEEEEEEcC-----CCCEEEEEEccCC-ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeC--CccEE
Q 009340          218 YNQSRFLGQGGFGTVYKGMLP-----DGSIVAVKRSKEI-DKTQIHQFINEVVILSQINHRHIVKLLGCCLET--EVPVL  289 (537)
Q Consensus       218 ~~~~~~lg~G~~g~Vy~~~~~-----~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~l  289 (537)
                      |...+.||+|+||.||++.+.     +++.||||+++.. .....+.+.+|+.++++++||||+++++++.+.  ...++
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  112 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL  112 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence            488899999999999998753     6789999998764 345567899999999999999999999999885  56799


Q ss_pred             EEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEe
Q 009340          290 VYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVS  369 (537)
Q Consensus       290 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~  369 (537)
                      ||||+++|+|.+++..             ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+
T Consensus       113 v~e~~~~~~L~~~l~~-------------~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~  176 (318)
T 3lxp_A          113 VMEYVPLGSLRDYLPR-------------HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIG  176 (318)
T ss_dssp             EECCCTTCBHHHHGGG-------------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEEC
T ss_pred             EEecccCCcHHHHHhh-------------CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEEC
Confidence            9999999999999964             25899999999999999999999999   9999999999999999999999


Q ss_pred             eccCccccCCCCCc--eeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHH
Q 009340          370 DFGISRSIPNDKTH--LTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLA  447 (537)
Q Consensus       370 Dfgla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~  447 (537)
                      |||++.........  ......+|..|+|||.+.+..++.++||||||+++|||++|+.||........ ..........
T Consensus       177 Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~-~~~~~~~~~~  255 (318)
T 3lxp_A          177 DFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFL-ELIGIAQGQM  255 (318)
T ss_dssp             CGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH-HHHCSCCHHH
T ss_pred             CccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhh-hhhcccccch
Confidence            99999877544322  22345578889999999988999999999999999999999999864322110 0000000001


Q ss_pred             hhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHHhh
Q 009340          448 KENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRSQ  504 (537)
Q Consensus       448 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~  504 (537)
                      ....+.+.+........+..++..+.+|+.+||+.||++|||+.++++.|+.+.+..
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~  312 (318)
T 3lxp_A          256 TVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKY  312 (318)
T ss_dssp             HHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhh
Confidence            111122223333333344556678999999999999999999999999999998754

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=9.8e-43  Score=351.97  Aligned_cols=247  Identities=24%  Similarity=0.365  Sum_probs=205.3

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCC---ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI---DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY  291 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  291 (537)
                      ++|+..+.||+|+||.||+++.. +|+.||+|.++..   .......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~   84 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence            57889999999999999999964 6899999998642   2234567889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeec
Q 009340          292 EYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF  371 (537)
Q Consensus       292 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Df  371 (537)
                      ||+++|+|.+++...            ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+||
T Consensus        85 E~~~gg~L~~~l~~~------------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DF  149 (337)
T 1o6l_A           85 EYANGGELFFHLSRE------------RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDF  149 (337)
T ss_dssp             ECCTTCBHHHHHHHH------------SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCC
T ss_pred             eCCCCCcHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeec
Confidence            999999999998653            35899999999999999999999999   999999999999999999999999


Q ss_pred             cCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhch
Q 009340          372 GISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQ  451 (537)
Q Consensus       372 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  451 (537)
                      |+++...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.......      .+..... ..
T Consensus       150 G~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~------~~~~i~~-~~  221 (337)
T 1o6l_A          150 GLCKEGISDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER------LFELILM-EE  221 (337)
T ss_dssp             TTCBCSCCTT-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHH-CC
T ss_pred             cchhhcccCC-CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHH------HHHHHHc-CC
Confidence            9998643322 22345679999999999999999999999999999999999999997543221      1111111 10


Q ss_pred             hhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCC-----CHhhHHH
Q 009340          452 LLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRP-----TMKQVSM  495 (537)
Q Consensus       452 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~  495 (537)
                                ...+...+..+.+|+.+||+.||++||     ++.||++
T Consensus       222 ----------~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~  260 (337)
T 1o6l_A          222 ----------IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             ----------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             ----------CCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence                      112333456788999999999999999     8888865

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.9e-43  Score=352.57  Aligned_cols=261  Identities=28%  Similarity=0.470  Sum_probs=206.2

Q ss_pred             cCCccccccCcCCceEEEEEEcCC-----CCEEEEEEccCC-ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLPD-----GSIVAVKRSKEI-DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVL  289 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~~-----g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  289 (537)
                      .+|...+.||+|+||.||+|....     +..||||.++.. .......+.+|+.++++++||||+++++++.+.+..++
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  123 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI  123 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence            456667899999999999998642     235999998754 34456679999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEe
Q 009340          290 VYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVS  369 (537)
Q Consensus       290 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~  369 (537)
                      ||||+++|+|.+++....           ..+++..++.++.|+++||.|||+.+   |+||||||+|||++.++.+||+
T Consensus       124 v~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~  189 (333)
T 1mqb_A          124 ITEYMENGALDKFLREKD-----------GEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVS  189 (333)
T ss_dssp             EEECCTTEEHHHHHHHTT-----------TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEEC
T ss_pred             EEeCCCCCcHHHHHHhCC-----------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEEC
Confidence            999999999999997532           36999999999999999999999999   9999999999999999999999


Q ss_pred             eccCccccCCCCCc--eeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHHHH
Q 009340          370 DFGISRSIPNDKTH--LTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISL  446 (537)
Q Consensus       370 Dfgla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~  446 (537)
                      |||+++........  ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+       ....
T Consensus       190 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~-------~~~~  262 (333)
T 1mqb_A          190 DFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE-------VMKA  262 (333)
T ss_dssp             CCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HHHH
T ss_pred             CCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH-------HHHH
Confidence            99999876433221  1223446789999999999999999999999999999999 999986543221       1111


Q ss_pred             HhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHHhhHH
Q 009340          447 AKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRSQRC  506 (537)
Q Consensus       447 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~~~  506 (537)
                      ...+         ...+.+...+..+.+++.+||+.||++||++.++++.|+.+......
T Consensus       263 ~~~~---------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~  313 (333)
T 1mqb_A          263 INDG---------FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDS  313 (333)
T ss_dssp             HHTT---------CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGG
T ss_pred             HHCC---------CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchh
Confidence            1111         11122334456789999999999999999999999999998875433

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.1e-43  Score=353.33  Aligned_cols=264  Identities=26%  Similarity=0.414  Sum_probs=209.7

Q ss_pred             cCCccccccCcCCceEEEEEEc-----CCCCEEEEEEccCC-ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeC--Ccc
Q 009340          216 DNYNQSRFLGQGGFGTVYKGML-----PDGSIVAVKRSKEI-DKTQIHQFINEVVILSQINHRHIVKLLGCCLET--EVP  287 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~  287 (537)
                      +.|...+.||+|+||.||++++     .+++.||||+++.. .....+.+.+|+.++++++|+||+++++++.+.  ...
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  100 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI  100 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence            4588889999999999999983     36889999998753 233457789999999999999999999999876  567


Q ss_pred             EEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEE
Q 009340          288 VLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK  367 (537)
Q Consensus       288 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~k  367 (537)
                      ++||||+++|+|.+++....           ..+++..++.++.|+++||+|||+.+   |+||||||+|||++.++.+|
T Consensus       101 ~lv~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~k  166 (302)
T 4e5w_A          101 KLIMEFLPSGSLKEYLPKNK-----------NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVK  166 (302)
T ss_dssp             EEEEECCTTCBHHHHHHHHT-----------TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEE
T ss_pred             EEEEEeCCCCcHHHHHHhcc-----------ccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEE
Confidence            99999999999999996542           36999999999999999999999999   99999999999999999999


Q ss_pred             EeeccCccccCCCCCc--eeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHH
Q 009340          368 VSDFGISRSIPNDKTH--LTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFIS  445 (537)
Q Consensus       368 i~Dfgla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~  445 (537)
                      |+|||++.........  ......+|..|+|||.+.+..++.++||||||+++|||++|+.|+......        +..
T Consensus       167 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~  238 (302)
T 4e5w_A          167 IGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMAL--------FLK  238 (302)
T ss_dssp             ECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH--------HHH
T ss_pred             ECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhH--------Hhh
Confidence            9999999877544332  233456888999999999999999999999999999999999985422110        000


Q ss_pred             HH-------hhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHH
Q 009340          446 LA-------KENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLR  501 (537)
Q Consensus       446 ~~-------~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~  501 (537)
                      ..       ........+........+...+..+.+|+.+||+.||++|||+.+++++|+.+.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          239 MIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             HHCSCCGGGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ccCCcccccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            00       000111111111222234455678999999999999999999999999999875

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=4.2e-43  Score=359.00  Aligned_cols=271  Identities=16%  Similarity=0.237  Sum_probs=209.2

Q ss_pred             hcCCccccccCcCCceEEEEEEcCC------CCEEEEEEccCCChHHH-----------HHHHHHHHHHHhcCCCCcceE
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLPD------GSIVAVKRSKEIDKTQI-----------HQFINEVVILSQINHRHIVKL  277 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~~------g~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~H~niv~l  277 (537)
                      .++|...+.||+|+||.||+|...+      ++.||||.+........           ..+..|+..+..++|+||+++
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~  113 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY  113 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence            4689999999999999999998754      47899999876443211           123456667778889999999


Q ss_pred             eeEEeeC----CccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCC
Q 009340          278 LGCCLET----EVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDI  353 (537)
Q Consensus       278 ~g~~~~~----~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dl  353 (537)
                      ++++...    ...++||||+ +|+|.+++...           ...+++..++.++.|+++||.|||+.+   |+||||
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~-----------~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDl  178 (364)
T 3op5_A          114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN-----------AKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDI  178 (364)
T ss_dssp             EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT-----------TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred             EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc-----------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecC
Confidence            9999875    3479999999 99999999753           236999999999999999999999998   999999


Q ss_pred             CCCCEEEC--CCCcEEEeeccCccccCCCCCce------eeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCC
Q 009340          354 KSSNILLD--DKFSAKVSDFGISRSIPNDKTHL------TTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGK  425 (537)
Q Consensus       354 k~~NIll~--~~~~~ki~Dfgla~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~  425 (537)
                      ||+|||++  .++.+||+|||+++.........      .....||+.|+|||.+.+..++.++|||||||++|||++|+
T Consensus       179 kp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~  258 (364)
T 3op5_A          179 KASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGH  258 (364)
T ss_dssp             CGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSC
T ss_pred             CHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCC
Confidence            99999999  88999999999998764322111      13345999999999999999999999999999999999999


Q ss_pred             CCCCccchhhhccHHHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHHhhH
Q 009340          426 KPICFARVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRSQR  505 (537)
Q Consensus       426 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~~  505 (537)
                      .||........  ....... .....+.+++++.+.   ....+..+.+++..||+.||++||++.+|++.|+.+.....
T Consensus       259 ~Pf~~~~~~~~--~~~~~~~-~~~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~  332 (364)
T 3op5_A          259 LPWEDNLKDPK--YVRDSKI-RYRENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIG  332 (364)
T ss_dssp             CTTGGGTTCHH--HHHHHHH-HHHHCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             CCccccccCHH--HHHHHHH-HhhhhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Confidence            99974322211  1111111 111223333333321   12234678899999999999999999999999999887543


Q ss_pred             H
Q 009340          506 C  506 (537)
Q Consensus       506 ~  506 (537)
                      .
T Consensus       333 ~  333 (364)
T 3op5_A          333 S  333 (364)
T ss_dssp             C
T ss_pred             C
Confidence            3

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.7e-43  Score=344.91  Aligned_cols=259  Identities=26%  Similarity=0.435  Sum_probs=212.5

Q ss_pred             cCCcccc-ccCcCCceEEEEEEcC---CCCEEEEEEccCC-ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEE
Q 009340          216 DNYNQSR-FLGQGGFGTVYKGMLP---DGSIVAVKRSKEI-DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLV  290 (537)
Q Consensus       216 ~~~~~~~-~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  290 (537)
                      ++|...+ .||+|+||.||+|...   ++..||||.++.. .....+.+.+|+.++++++||||+++++++ ..+..++|
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv   87 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV   87 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence            4555555 8999999999999853   5778999999764 455677899999999999999999999999 55678999


Q ss_pred             EecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEee
Q 009340          291 YEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSD  370 (537)
Q Consensus       291 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~D  370 (537)
                      |||+++++|.+++....           ..+++..++.++.|+++||.|||+.+   |+||||||+||+++.++.+||+|
T Consensus        88 ~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~D  153 (287)
T 1u59_A           88 MEMAGGGPLHKFLVGKR-----------EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISD  153 (287)
T ss_dssp             EECCTTEEHHHHHTTCT-----------TTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECC
T ss_pred             EEeCCCCCHHHHHHhCC-----------ccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECc
Confidence            99999999999996532           36999999999999999999999999   99999999999999999999999


Q ss_pred             ccCccccCCCCCce--eeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHHHHH
Q 009340          371 FGISRSIPNDKTHL--TTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLA  447 (537)
Q Consensus       371 fgla~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~  447 (537)
                      ||++..........  .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+       .....
T Consensus       154 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-------~~~~i  226 (287)
T 1u59_A          154 FGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-------VMAFI  226 (287)
T ss_dssp             CTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH-------HHHHH
T ss_pred             ccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH-------HHHHH
Confidence            99998775443322  223456889999999988889999999999999999998 999986543322       11111


Q ss_pred             hhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHHhhH
Q 009340          448 KENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRSQR  505 (537)
Q Consensus       448 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~~  505 (537)
                      ...         .....+...+..+.+++.+||+.||++|||+.++++.|+.+..+..
T Consensus       227 ~~~---------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~  275 (287)
T 1u59_A          227 EQG---------KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA  275 (287)
T ss_dssp             HTT---------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             hcC---------CcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence            111         1112334455688999999999999999999999999999987653

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.8e-42  Score=346.27  Aligned_cols=269  Identities=23%  Similarity=0.350  Sum_probs=212.2

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCC-hHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCC--ccEEEE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEID-KTQIHQFINEVVILSQINHRHIVKLLGCCLETE--VPVLVY  291 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lV~  291 (537)
                      ++|...++||+|+||.||+|... +|+.||||+++... ....+.+.+|+.++++++||||+++++++....  ..++||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (319)
T 4euu_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (319)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence            57888999999999999999965 58999999987532 233567889999999999999999999998765  679999


Q ss_pred             ecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEE----CCCCcEE
Q 009340          292 EYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILL----DDKFSAK  367 (537)
Q Consensus       292 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll----~~~~~~k  367 (537)
                      ||+++|+|.+++.....         ...+++..++.++.|+++||.|||+.+   |+||||||+|||+    +.++.+|
T Consensus        89 e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~k  156 (319)
T 4euu_A           89 EFCPCGSLYTVLEEPSN---------AYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYK  156 (319)
T ss_dssp             ECCTTCBHHHHHHSGGG---------TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEE
T ss_pred             eCCCCCCHHHHHHHhcc---------ccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEE
Confidence            99999999999986543         234999999999999999999999999   9999999999999    8888999


Q ss_pred             EeeccCccccCCCCCceeeeccccccccCccccc--------CCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccH
Q 009340          368 VSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQ--------SSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNL  439 (537)
Q Consensus       368 i~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~  439 (537)
                      |+|||+++.......  .....||+.|+|||.+.        +..++.++||||||+++|||++|+.||........  .
T Consensus       157 L~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~  232 (319)
T 4euu_A          157 LTDFGAARELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR--N  232 (319)
T ss_dssp             ECCCTTCEECCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGG--C
T ss_pred             EccCCCceecCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccch--h
Confidence            999999987654432  23456899999999986        57789999999999999999999999864332211  1


Q ss_pred             HHHHHHHHhhc---hhhhhh-----------cHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHH
Q 009340          440 VACFISLAKEN---QLLEIL-----------DARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGL  500 (537)
Q Consensus       440 ~~~~~~~~~~~---~~~~~~-----------d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i  500 (537)
                      ...........   ....+.           +.......+......+.+++.+||+.||++|||+.|+++.....
T Consensus       233 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~  307 (319)
T 4euu_A          233 KEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI  307 (319)
T ss_dssp             HHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred             HHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence            11111111110   000000           00011134567778899999999999999999999999887643

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=3.6e-43  Score=343.55  Aligned_cols=254  Identities=21%  Similarity=0.323  Sum_probs=208.0

Q ss_pred             cCCccccccCcCCceEEEEEEcCCCCEEEEEEccCC--ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeC--CccEEEE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEI--DKTQIHQFINEVVILSQINHRHIVKLLGCCLET--EVPVLVY  291 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~  291 (537)
                      ++|...+.||+|+||.||+|+.+ ++.||||.++..  .....+.|.+|+.++++++||||+++++++.+.  ...++||
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (271)
T 3kmu_A           10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT   88 (271)
T ss_dssp             GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred             HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence            57888999999999999999985 889999998753  455567899999999999999999999999877  6789999


Q ss_pred             ecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeec
Q 009340          292 EYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF  371 (537)
Q Consensus       292 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Df  371 (537)
                      ||+++|+|.+++.....          ..+++..++.++.|+++||.|||+.+. +++||||||+||+++.++.++|+||
T Consensus        89 e~~~~~~L~~~l~~~~~----------~~~~~~~~~~i~~qi~~~l~~lH~~~~-~i~H~dikp~Nil~~~~~~~~l~~~  157 (271)
T 3kmu_A           89 HWMPYGSLYNVLHEGTN----------FVVDQSQAVKFALDMARGMAFLHTLEP-LIPRHALNSRSVMIDEDMTARISMA  157 (271)
T ss_dssp             ECCTTCBHHHHHHSCSS----------CCCCHHHHHHHHHHHHHHHHHHTTSSS-CCTTCCCSGGGEEECTTSCEEEEGG
T ss_pred             cccCCCcHHHHHhhccc----------CCCCHHHHHHHHHHHHHHHHHHhcCCC-ceecCCCccceEEEcCCcceeEEec
Confidence            99999999999976422          358999999999999999999999763 4999999999999999999999999


Q ss_pred             cCccccCCCCCceeeeccccccccCcccccCCCCCc---chhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHh
Q 009340          372 GISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTD---KSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAK  448 (537)
Q Consensus       372 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~---ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  448 (537)
                      |++.....      ....||+.|+|||.+.+..++.   ++||||||+++|||++|+.||......+.      ......
T Consensus       158 ~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~~~~~~  225 (271)
T 3kmu_A          158 DVKFSFQS------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI------GMKVAL  225 (271)
T ss_dssp             GSCCTTSC------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHH------HHHHHH
T ss_pred             cceeeecc------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHH------HHHHHh
Confidence            98765322      2345799999999998765444   89999999999999999999865432221      111111


Q ss_pred             hchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHH
Q 009340          449 ENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRR  502 (537)
Q Consensus       449 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~  502 (537)
                      .         ......+...+..+.+++.+||+.||++|||+.++++.|+.+.+
T Consensus       226 ~---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          226 E---------GLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             S---------CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             c---------CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence            1         11112333445678999999999999999999999999998753

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=5.5e-43  Score=349.60  Aligned_cols=256  Identities=28%  Similarity=0.471  Sum_probs=200.6

Q ss_pred             cCCccccccCcCCceEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecCC
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYIS  295 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  295 (537)
                      ++|+..+.||+|+||.||++... ++.||||++...  ...+.|.+|+.++++++||||+++++++.  +..++||||++
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~   82 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAE   82 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCT
T ss_pred             hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCC
Confidence            56788899999999999999985 788999998753  34578999999999999999999999987  45799999999


Q ss_pred             CCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCc-EEEeeccCc
Q 009340          296 SGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFS-AKVSDFGIS  374 (537)
Q Consensus       296 ~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~-~ki~Dfgla  374 (537)
                      +|+|.+++.....         ...+++..++.++.|+++||+|||+.+...|+||||||+|||++.++. +||+|||++
T Consensus        83 ~~~L~~~l~~~~~---------~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~  153 (307)
T 2eva_A           83 GGSLYNVLHGAEP---------LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA  153 (307)
T ss_dssp             TCBHHHHHHCSSS---------EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-
T ss_pred             CCCHHHHHhccCC---------CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccc
Confidence            9999999976432         235889999999999999999999933223999999999999988876 799999999


Q ss_pred             cccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchhhh
Q 009340          375 RSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLE  454 (537)
Q Consensus       375 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  454 (537)
                      ......    .....||+.|+|||.+.+..++.++||||||+++|||++|+.||........    ...+.. ...    
T Consensus       154 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~----~~~~~~-~~~----  220 (307)
T 2eva_A          154 CDIQTH----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF----RIMWAV-HNG----  220 (307)
T ss_dssp             ---------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH----HHHHHH-HTT----
T ss_pred             cccccc----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH----HHHHHH-hcC----
Confidence            765332    2234589999999999999999999999999999999999999864322110    111111 111    


Q ss_pred             hhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHHh
Q 009340          455 ILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRS  503 (537)
Q Consensus       455 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~  503 (537)
                           .....+...+..+.+++.+||+.||++|||+.++++.|+.+.+.
T Consensus       221 -----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  264 (307)
T 2eva_A          221 -----TRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRY  264 (307)
T ss_dssp             -----CCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGG
T ss_pred             -----CCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence                 01112233445788999999999999999999999999988763

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=3.6e-43  Score=353.54  Aligned_cols=252  Identities=26%  Similarity=0.390  Sum_probs=202.0

Q ss_pred             hcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCC-hHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEe
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEID-KTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE  292 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e  292 (537)
                      .++|...+.||+|+||.||+++.. +++.||||.+.... ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            368899999999999999999965 78999999986432 2334668899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeecc
Q 009340          293 YISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG  372 (537)
Q Consensus       293 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfg  372 (537)
                      |+++|+|.+++...            ..+++..++.++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        86 ~~~~~~L~~~l~~~------------~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg  150 (323)
T 3tki_A           86 YCSGGELFDRIEPD------------IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFG  150 (323)
T ss_dssp             CCTTEEGGGGSBTT------------TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred             cCCCCcHHHHHhhc------------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEee
Confidence            99999999999753            35999999999999999999999999   9999999999999999999999999


Q ss_pred             CccccCCCC-CceeeeccccccccCcccccCCCC-CcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhc
Q 009340          373 ISRSIPNDK-THLTTTIQGTFGYLDPEYFQSSQF-TDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKEN  450 (537)
Q Consensus       373 la~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  450 (537)
                      ++....... ........||+.|+|||.+.+..+ +.++||||||+++|||++|+.||........     .+.......
T Consensus       151 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-----~~~~~~~~~  225 (323)
T 3tki_A          151 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-----EYSDWKEKK  225 (323)
T ss_dssp             TCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH-----HHHHHHTTC
T ss_pred             ccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH-----HHHHHhccc
Confidence            998653222 222345679999999999987765 7799999999999999999999975433211     011111110


Q ss_pred             hhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          451 QLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       451 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      .         ........+..+.+|+.+||+.||++|||+.|+++
T Consensus       226 ~---------~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~  261 (323)
T 3tki_A          226 T---------YLNPWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (323)
T ss_dssp             T---------TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             c---------cCCccccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            0         00111223456789999999999999999999975

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.6e-43  Score=356.38  Aligned_cols=258  Identities=25%  Similarity=0.480  Sum_probs=205.4

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCCE----EEEEEccCCC-hHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGSI----VAVKRSKEID-KTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVL  289 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  289 (537)
                      ++|...+.||+|+||.||+|... +++.    ||+|.+.... ....+.+.+|+.++++++||||+++++++. .+..++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~   91 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL   91 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence            57888899999999999999964 4443    8888775422 233456778999999999999999999986 456799


Q ss_pred             EEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEe
Q 009340          290 VYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVS  369 (537)
Q Consensus       290 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~  369 (537)
                      ||||+++|+|.+++....           ..+++..++.++.|+++||.|||+.+   |+||||||+|||++.++.+||+
T Consensus        92 v~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~  157 (325)
T 3kex_A           92 VTQYLPLGSLLDHVRQHR-----------GALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVA  157 (325)
T ss_dssp             EEECCTTCBSHHHHHSSG-----------GGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEEC
T ss_pred             EEEeCCCCCHHHHHHHcc-----------ccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEEC
Confidence            999999999999997643           25889999999999999999999999   9999999999999999999999


Q ss_pred             eccCccccCCCCCc-eeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHHHHH
Q 009340          370 DFGISRSIPNDKTH-LTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLA  447 (537)
Q Consensus       370 Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~  447 (537)
                      |||+++........ ......+|..|+|||.+.+..++.++||||||+++|||++ |+.||......+       .....
T Consensus       158 Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~  230 (325)
T 3kex_A          158 DFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE-------VPDLL  230 (325)
T ss_dssp             SCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH-------HHHHH
T ss_pred             CCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH-------HHHHH
Confidence            99999887544332 2345567889999999999999999999999999999999 999987543322       11111


Q ss_pred             hhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHHhh
Q 009340          448 KENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRSQ  504 (537)
Q Consensus       448 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~  504 (537)
                      ...         .....+..++..+.+++.+||+.||++|||+.++++.|+.+....
T Consensus       231 ~~~---------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~  278 (325)
T 3kex_A          231 EKG---------ERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDP  278 (325)
T ss_dssp             HTT---------CBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSH
T ss_pred             HcC---------CCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence            111         111122233446789999999999999999999999999886643

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.3e-43  Score=346.54  Aligned_cols=259  Identities=25%  Similarity=0.416  Sum_probs=207.4

Q ss_pred             CCccccccCcCCceEEEEEEcC-CC---CEEEEEEccCC-ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCcc-EEE
Q 009340          217 NYNQSRFLGQGGFGTVYKGMLP-DG---SIVAVKRSKEI-DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVP-VLV  290 (537)
Q Consensus       217 ~~~~~~~lg~G~~g~Vy~~~~~-~g---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~-~lV  290 (537)
                      .|...++||+|+||.||+|... ++   ..||+|.+... .....+.+.+|+.++++++||||+++++++.+.+.. ++|
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            4555688999999999999853 22   37999998753 345567899999999999999999999999876655 999


Q ss_pred             EecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEee
Q 009340          291 YEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSD  370 (537)
Q Consensus       291 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~D  370 (537)
                      +||+.+|+|.+++...           ...+++..++.++.|+++||.|||+.+   |+||||||+|||++.++.+||+|
T Consensus       102 ~e~~~~~~L~~~~~~~-----------~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~D  167 (298)
T 3pls_A          102 LPYMCHGDLLQFIRSP-----------QRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVAD  167 (298)
T ss_dssp             ECCCTTCBHHHHHHCT-----------TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECC
T ss_pred             EecccCCCHHHHHhcc-----------ccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCc
Confidence            9999999999999763           236899999999999999999999999   99999999999999999999999


Q ss_pred             ccCccccCCCCC---ceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHH
Q 009340          371 FGISRSIPNDKT---HLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLA  447 (537)
Q Consensus       371 fgla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~  447 (537)
                      ||+++.......   .......+|..|+|||.+.+..++.++||||||+++|||++|+.|+.......  .    .....
T Consensus       168 fg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~--~----~~~~~  241 (298)
T 3pls_A          168 FGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF--D----LTHFL  241 (298)
T ss_dssp             TTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGG--G----HHHHH
T ss_pred             CCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHH--H----HHHHh
Confidence            999986643321   12234567899999999999999999999999999999999666654322211  1    11111


Q ss_pred             hhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHHhh
Q 009340          448 KENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRSQ  504 (537)
Q Consensus       448 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~  504 (537)
                      ..         ......+...+..+.+++.+||+.||.+|||+.+++++|+++....
T Consensus       242 ~~---------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l  289 (298)
T 3pls_A          242 AQ---------GRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSAL  289 (298)
T ss_dssp             HT---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             hc---------CCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHH
Confidence            11         1111223334467889999999999999999999999999988754

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.8e-42  Score=353.18  Aligned_cols=251  Identities=26%  Similarity=0.337  Sum_probs=205.7

Q ss_pred             hcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCChH------HHHHHHHHHHHHHhcCCCCcceEeeEEeeCCcc
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKT------QIHQFINEVVILSQINHRHIVKLLGCCLETEVP  287 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~  287 (537)
                      .++|...+.||+|+||.||+++.. +|+.||+|.++.....      ..+.+.+|+.++++++||||+++++++.+.+..
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            468899999999999999999965 6899999988653221      346789999999999999999999999999999


Q ss_pred             EEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCC---
Q 009340          288 VLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF---  364 (537)
Q Consensus       288 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~---  364 (537)
                      ++||||+++|+|.+++...            ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++   
T Consensus        91 ~lv~e~~~gg~L~~~l~~~------------~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~  155 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQK------------ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPI  155 (361)
T ss_dssp             EEEEECCCSCBHHHHHTTC------------SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSS
T ss_pred             EEEEEcCCCCcHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCc
Confidence            9999999999999999652            36999999999999999999999999   99999999999998877   


Q ss_pred             -cEEEeeccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHH
Q 009340          365 -SAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACF  443 (537)
Q Consensus       365 -~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~  443 (537)
                       .+||+|||++.......  ......||+.|+|||.+.+..++.++|||||||++|||++|+.||......+.      +
T Consensus       156 ~~vkl~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~------~  227 (361)
T 2yab_A          156 PHIKLIDFGLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET------L  227 (361)
T ss_dssp             CCEEECCCSSCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH------H
T ss_pred             cCEEEEecCCceEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH------H
Confidence             79999999998765432  23455799999999999999999999999999999999999999975433221      1


Q ss_pred             HHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          444 ISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       444 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      ... .....  .+++..    ....+..+.+|+.+||..||++|||+.|+++
T Consensus       228 ~~i-~~~~~--~~~~~~----~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          228 ANI-TAVSY--DFDEEF----FSQTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             HHH-HTTCC--CCCHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHH-HhcCC--CCCchh----ccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            111 11100  001111    1123456889999999999999999999874

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-42  Score=349.18  Aligned_cols=251  Identities=23%  Similarity=0.293  Sum_probs=206.8

Q ss_pred             hcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEec
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY  293 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  293 (537)
                      .++|...+.||+|+||.||++... +++.||+|.++... .....+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   82 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence            468899999999999999999965 68899999987543 3456788999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECC--CCcEEEeec
Q 009340          294 ISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD--KFSAKVSDF  371 (537)
Q Consensus       294 ~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~--~~~~ki~Df  371 (537)
                      +++|+|.+++....           ..+++..++.++.|+++||.|||+.+   |+||||||+|||++.  ++.+||+||
T Consensus        83 ~~g~~L~~~l~~~~-----------~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Df  148 (321)
T 1tki_A           83 ISGLDIFERINTSA-----------FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEF  148 (321)
T ss_dssp             CCCCBHHHHHTSSS-----------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCC
T ss_pred             CCCCCHHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEEC
Confidence            99999999996532           36999999999999999999999999   999999999999987  789999999


Q ss_pred             cCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhch
Q 009340          372 GISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQ  451 (537)
Q Consensus       372 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  451 (537)
                      |++.......  ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+.      +....... 
T Consensus       149 g~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~------~~~i~~~~-  219 (321)
T 1tki_A          149 GQARQLKPGD--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI------IENIMNAE-  219 (321)
T ss_dssp             TTCEECCTTC--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHHHTC-
T ss_pred             CCCeECCCCC--ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHH------HHHHHcCC-
Confidence            9998775432  23456789999999999988899999999999999999999999975433221      11111110 


Q ss_pred             hhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          452 LLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       452 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      .  ..+...    ....+..+.+++.+||+.||++|||+.|+++
T Consensus       220 ~--~~~~~~----~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~  257 (321)
T 1tki_A          220 Y--TFDEEA----FKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             C--CCCHHH----HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             C--CCChhh----hccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            0  001111    1123457889999999999999999999987

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.5e-42  Score=349.50  Aligned_cols=251  Identities=25%  Similarity=0.342  Sum_probs=205.0

Q ss_pred             hcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCCh------HHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCcc
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDK------TQIHQFINEVVILSQINHRHIVKLLGCCLETEVP  287 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~  287 (537)
                      .++|...+.||+|+||.||++... +|+.||+|.++....      ...+.+.+|+.++++++||||+++++++.+....
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   89 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   89 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            357888999999999999999964 689999998864321      1356789999999999999999999999999999


Q ss_pred             EEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCC---
Q 009340          288 VLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF---  364 (537)
Q Consensus       288 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~---  364 (537)
                      ++||||+++|+|.+++...            ..+++..++.++.|+++||.|||+.+   |+||||||+|||++.++   
T Consensus        90 ~lv~e~~~~~~L~~~l~~~------------~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~  154 (326)
T 2y0a_A           90 ILILELVAGGELFDFLAEK------------ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPK  154 (326)
T ss_dssp             EEEEECCCSCBHHHHHTTS------------SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSS
T ss_pred             EEEEEcCCCCCHHHHHHhc------------CCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCC
Confidence            9999999999999999652            36999999999999999999999999   99999999999999887   


Q ss_pred             -cEEEeeccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHH
Q 009340          365 -SAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACF  443 (537)
Q Consensus       365 -~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~  443 (537)
                       .+||+|||+++.......  .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......+.      .
T Consensus       155 ~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~------~  226 (326)
T 2y0a_A          155 PRIKIIDFGLAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET------L  226 (326)
T ss_dssp             CCEEECCCTTCEECCTTSC--CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH------H
T ss_pred             CCEEEEECCCCeECCCCCc--cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH------H
Confidence             899999999987643322  3345699999999999999999999999999999999999999965432221      1


Q ss_pred             HHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          444 ISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       444 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      ..... ...  .....    .....+..+.+++.+||+.||++|||+.++++
T Consensus       227 ~~~~~-~~~--~~~~~----~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          227 ANVSA-VNY--EFEDE----YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             HHHHH-TCC--CCCHH----HHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHh-cCC--CcCcc----ccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            11110 000  00011    11123456889999999999999999999986

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1e-42  Score=351.52  Aligned_cols=275  Identities=26%  Similarity=0.404  Sum_probs=216.6

Q ss_pred             HHHhcCCccccccCcCCceEEEEEEcCC------CCEEEEEEccCC-ChHHHHHHHHHHHHHHhc-CCCCcceEeeEEee
Q 009340          212 QRATDNYNQSRFLGQGGFGTVYKGMLPD------GSIVAVKRSKEI-DKTQIHQFINEVVILSQI-NHRHIVKLLGCCLE  283 (537)
Q Consensus       212 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~------g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~  283 (537)
                      +...++|...+.||+|+||.||+|....      +..||+|.++.. .....+.+.+|+.+++++ +||||+++++++.+
T Consensus        42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~  121 (333)
T 2i1m_A           42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH  121 (333)
T ss_dssp             BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence            3345789999999999999999999532      247999998764 345567899999999999 89999999999999


Q ss_pred             CCccEEEEecCCCCChhhhhhhhhhhHHHH--hhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEC
Q 009340          284 TEVPVLVYEYISSGTLSHHIHDHQQQQEQK--QKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD  361 (537)
Q Consensus       284 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~--~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~  361 (537)
                      .+..++||||+++|+|.+++..........  .......+++..++.++.|+++||.|||+.+   |+||||||+|||++
T Consensus       122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~  198 (333)
T 2i1m_A          122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLT  198 (333)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEE
T ss_pred             CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEEC
Confidence            999999999999999999997654211000  0001235899999999999999999999998   99999999999999


Q ss_pred             CCCcEEEeeccCccccCCCCCc-eeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccH
Q 009340          362 DKFSAKVSDFGISRSIPNDKTH-LTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNL  439 (537)
Q Consensus       362 ~~~~~ki~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~  439 (537)
                      .++.+||+|||++......... ......+|+.|+|||.+.+..++.++||||||+++|||++ |..||........   
T Consensus       199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~---  275 (333)
T 2i1m_A          199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK---  275 (333)
T ss_dssp             GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH---
T ss_pred             CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH---
Confidence            9999999999999866433322 2334557889999999999999999999999999999999 8889865432211   


Q ss_pred             HHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHHhh
Q 009340          440 VACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRSQ  504 (537)
Q Consensus       440 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~  504 (537)
                         +.....         .......+...+..+.+++.+||+.||++|||+.+|++.|+.+....
T Consensus       276 ---~~~~~~---------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~  328 (333)
T 2i1m_A          276 ---FYKLVK---------DGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQED  328 (333)
T ss_dssp             ---HHHHHH---------HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             ---HHHHHh---------cCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhh
Confidence               111111         11111222333467889999999999999999999999999887654

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=4.8e-43  Score=353.23  Aligned_cols=258  Identities=23%  Similarity=0.467  Sum_probs=203.9

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCCE----EEEEEccCC-ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGSI----VAVKRSKEI-DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVL  289 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  289 (537)
                      ++|...++||+|+||.||+|... +++.    ||+|.+... .....+.+.+|+.++++++||||+++++++.+.. .++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~   93 (327)
T 3lzb_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   93 (327)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred             hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence            67889999999999999999954 4443    578877542 3345678999999999999999999999998755 789


Q ss_pred             EEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEe
Q 009340          290 VYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVS  369 (537)
Q Consensus       290 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~  369 (537)
                      |+||+++|+|.+++....           ..+++..++.++.|+++||.|||+.+   |+||||||+|||++.++.+||+
T Consensus        94 v~~~~~~g~L~~~l~~~~-----------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~  159 (327)
T 3lzb_A           94 ITQLMPFGCLLDYVREHK-----------DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKIT  159 (327)
T ss_dssp             EECCCSSCBHHHHHHHTT-----------TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEEC
T ss_pred             EEEecCCCcHHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEc
Confidence            999999999999997643           36999999999999999999999999   9999999999999999999999


Q ss_pred             eccCccccCCCCCc-eeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHHHHH
Q 009340          370 DFGISRSIPNDKTH-LTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLA  447 (537)
Q Consensus       370 Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~  447 (537)
                      |||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+       ...  
T Consensus       160 DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-------~~~--  230 (327)
T 3lzb_A          160 DFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-------ISS--  230 (327)
T ss_dssp             CTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-------HHH--
T ss_pred             cCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH-------HHH--
Confidence            99999876433222 2234456889999999999999999999999999999999 999986543322       111  


Q ss_pred             hhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHHhh
Q 009340          448 KENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRSQ  504 (537)
Q Consensus       448 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~  504 (537)
                             .+........+...+..+.+++.+||+.||++|||+.|+++.|+.+....
T Consensus       231 -------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  280 (327)
T 3lzb_A          231 -------ILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDP  280 (327)
T ss_dssp             -------HHHTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSH
T ss_pred             -------HHHcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCc
Confidence                   11111122223344567889999999999999999999999999988654

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=6e-43  Score=380.85  Aligned_cols=250  Identities=26%  Similarity=0.438  Sum_probs=203.2

Q ss_pred             ccCcCCceEEEEEEcC---CCCEEEEEEccCC-ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecCCCCC
Q 009340          223 FLGQGGFGTVYKGMLP---DGSIVAVKRSKEI-DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGT  298 (537)
Q Consensus       223 ~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs  298 (537)
                      .||+|+||.||+|.+.   ++..||||+++.. .....++|.+|+.+|++++||||++++++|.+ +..++||||+++|+
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~  421 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP  421 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence            7999999999999864   4667999999764 33456789999999999999999999999976 56899999999999


Q ss_pred             hhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCccccC
Q 009340          299 LSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIP  378 (537)
Q Consensus       299 L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~  378 (537)
                      |.+++....           ..+++..++.++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus       422 L~~~l~~~~-----------~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~  487 (613)
T 2ozo_A          422 LHKFLVGKR-----------EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALG  487 (613)
T ss_dssp             HHHHHTTCT-----------TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC
T ss_pred             HHHHHhhcc-----------CCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCccccc
Confidence            999997542           36999999999999999999999999   9999999999999999999999999998765


Q ss_pred             CCCCcee--eeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHHHHHhhchhhhh
Q 009340          379 NDKTHLT--TTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQLLEI  455 (537)
Q Consensus       379 ~~~~~~~--~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  455 (537)
                      .......  ....+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+       ......       
T Consensus       488 ~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-------~~~~i~-------  553 (613)
T 2ozo_A          488 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-------VMAFIE-------  553 (613)
T ss_dssp             --------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH-------HHHHHH-------
T ss_pred             CCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH-------HHHHHH-------
Confidence            4332222  23345789999999999999999999999999999998 999986543322       111111       


Q ss_pred             hcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHHh
Q 009340          456 LDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRS  503 (537)
Q Consensus       456 ~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~  503 (537)
                        .......+..++..+.+|+.+||+.||++||++.+|++.|+.+..+
T Consensus       554 --~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~  599 (613)
T 2ozo_A          554 --QGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  599 (613)
T ss_dssp             --TTCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             --cCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence              1112233445667899999999999999999999999999988764

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=3.2e-43  Score=353.38  Aligned_cols=277  Identities=27%  Similarity=0.454  Sum_probs=220.5

Q ss_pred             ccCHHHHHHHhcCCccccccCcCCceEEEEEEcC------CCCEEEEEEccCC-ChHHHHHHHHHHHHHHhcCCCCcceE
Q 009340          205 VFTADELQRATDNYNQSRFLGQGGFGTVYKGMLP------DGSIVAVKRSKEI-DKTQIHQFINEVVILSQINHRHIVKL  277 (537)
Q Consensus       205 ~~~~~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l  277 (537)
                      .+..++++...++|...+.||+|+||.||+|+..      +++.||||.+... .......+.+|+.++++++|+||+++
T Consensus        14 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~   93 (322)
T 1p4o_A           14 VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRL   93 (322)
T ss_dssp             CCCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCE
T ss_pred             ccChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeee
Confidence            3445555666789999999999999999999854      3678999998753 34456679999999999999999999


Q ss_pred             eeEEeeCCccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCC
Q 009340          278 LGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSN  357 (537)
Q Consensus       278 ~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~N  357 (537)
                      ++++.+.+..++||||+++|+|.+++.........  ......+++..++.++.|+++||.|||+.+   |+||||||+|
T Consensus        94 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~N  168 (322)
T 1p4o_A           94 LGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMAN--NPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARN  168 (322)
T ss_dssp             EEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHH--CTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGG
T ss_pred             EEEEccCCccEEEEEeCCCCcHHHHHHHhchhhcc--CCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccce
Confidence            99999999999999999999999999865432111  111246799999999999999999999999   9999999999


Q ss_pred             EEECCCCcEEEeeccCccccCCCCCce-eeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhh
Q 009340          358 ILLDDKFSAKVSDFGISRSIPNDKTHL-TTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEE  435 (537)
Q Consensus       358 Ill~~~~~~ki~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~  435 (537)
                      |+++.++.+||+|||++.......... .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.......
T Consensus       169 Ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~  248 (322)
T 1p4o_A          169 CMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ  248 (322)
T ss_dssp             EEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH
T ss_pred             EEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHH
Confidence            999999999999999998654332221 223456889999999999999999999999999999999 888886543221


Q ss_pred             hccHHHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHH
Q 009340          436 ERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRR  502 (537)
Q Consensus       436 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~  502 (537)
                             .........         ....+...+..+.+++.+||+.||++|||+.++++.|+.+..
T Consensus       249 -------~~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          249 -------VLRFVMEGG---------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             -------HHHHHHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             -------HHHHHHcCC---------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence                   111111111         111233445678899999999999999999999999987654

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1.4e-42  Score=343.46  Aligned_cols=260  Identities=29%  Similarity=0.518  Sum_probs=198.6

Q ss_pred             hcCCccccccCcCCceEEEEEEcCCCCEEEEEEccC--CChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEe
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKE--IDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE  292 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e  292 (537)
                      .++|...++||+|+||.||+|+..  ..||||.++.  ......+.|.+|+.++++++|+||+++++++ .....++|||
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e   99 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ   99 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred             ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence            468999999999999999999874  3599998864  3455667899999999999999999999976 4556799999


Q ss_pred             cCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeecc
Q 009340          293 YISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG  372 (537)
Q Consensus       293 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfg  372 (537)
                      |+++++|.+++....           ..+++..++.++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus       100 ~~~~~~L~~~l~~~~-----------~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg  165 (289)
T 3og7_A          100 WCEGSSLYHHLHASE-----------TKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFG  165 (289)
T ss_dssp             CCCEEEHHHHHTTC--------------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC
T ss_pred             ecCCCcHHHHHhhcc-----------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccce
Confidence            999999999996542           36999999999999999999999999   9999999999999999999999999


Q ss_pred             CccccCCCC-CceeeeccccccccCccccc---CCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHh
Q 009340          373 ISRSIPNDK-THLTTTIQGTFGYLDPEYFQ---SSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAK  448 (537)
Q Consensus       373 la~~~~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  448 (537)
                      ++....... ........||+.|+|||.+.   +..++.++||||||+++|||++|+.||......+.      ......
T Consensus       166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~~~~~~  239 (289)
T 3og7_A          166 LATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ------IIEMVG  239 (289)
T ss_dssp             ------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH------HHHHHH
T ss_pred             eccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH------HHHHhc
Confidence            997654321 22234456899999999986   56788999999999999999999999865432211      112221


Q ss_pred             hchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHH
Q 009340          449 ENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRR  502 (537)
Q Consensus       449 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~  502 (537)
                      ......    .. ......++..+.+|+.+||+.||++|||+.+++++|+.+.+
T Consensus       240 ~~~~~~----~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          240 RGSLSP----DL-SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             HTSCCC----CT-TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             ccccCc----ch-hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence            111110    00 11223445678999999999999999999999999998753

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=8.1e-43  Score=345.48  Aligned_cols=261  Identities=27%  Similarity=0.404  Sum_probs=210.6

Q ss_pred             hcCCcccc-ccCcCCceEEEEEEc---CCCCEEEEEEccCC--ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccE
Q 009340          215 TDNYNQSR-FLGQGGFGTVYKGML---PDGSIVAVKRSKEI--DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPV  288 (537)
Q Consensus       215 ~~~~~~~~-~lg~G~~g~Vy~~~~---~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  288 (537)
                      .++|...+ .||+|+||.||+|.+   .+++.||||.++..  .....+++.+|+.+++.++||||+++++++ +.+..+
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~   93 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM   93 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence            35677777 899999999999964   24678999998753  233467899999999999999999999999 566789


Q ss_pred             EEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEE
Q 009340          289 LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKV  368 (537)
Q Consensus       289 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki  368 (537)
                      +||||+++++|.+++...            ..+++..++.++.|+++||.|||+.+   |+||||||+||+++.++.+||
T Consensus        94 lv~e~~~~~~L~~~l~~~------------~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl  158 (291)
T 1xbb_A           94 LVMEMAELGPLNKYLQQN------------RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKI  158 (291)
T ss_dssp             EEEECCTTEEHHHHHHHC------------TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEE
T ss_pred             EEEEeCCCCCHHHHHHhC------------cCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEE
Confidence            999999999999999753            35899999999999999999999999   999999999999999999999


Q ss_pred             eeccCccccCCCCCcee--eeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHHH
Q 009340          369 SDFGISRSIPNDKTHLT--TTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFIS  445 (537)
Q Consensus       369 ~Dfgla~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~  445 (537)
                      +|||++...........  ....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+       ...
T Consensus       159 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~  231 (291)
T 1xbb_A          159 SDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-------VTA  231 (291)
T ss_dssp             CCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHH
T ss_pred             ccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH-------HHH
Confidence            99999987754443222  23346789999999988889999999999999999999 999986543322       111


Q ss_pred             HHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHHhhHHH
Q 009340          446 LAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRSQRCL  507 (537)
Q Consensus       446 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~~~~  507 (537)
                      .....         .....+...+..+.+++.+||+.||++|||+.++++.|+.+..+....
T Consensus       232 ~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~  284 (291)
T 1xbb_A          232 MLEKG---------ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNE  284 (291)
T ss_dssp             HHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHcC---------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhhc
Confidence            11111         111223345567899999999999999999999999999988765433

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=8.6e-43  Score=349.01  Aligned_cols=282  Identities=27%  Similarity=0.419  Sum_probs=221.5

Q ss_pred             ccCHHHHHHHhcCCccccccCcCCceEEEEEEc------CCCCEEEEEEccCC-ChHHHHHHHHHHHHHHhc-CCCCcce
Q 009340          205 VFTADELQRATDNYNQSRFLGQGGFGTVYKGML------PDGSIVAVKRSKEI-DKTQIHQFINEVVILSQI-NHRHIVK  276 (537)
Q Consensus       205 ~~~~~el~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~  276 (537)
                      .+...++....++|...+.||+|+||.||+|..      .+++.||||.++.. .....+.+.+|+.++.++ +||||++
T Consensus        16 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~   95 (316)
T 2xir_A           16 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN   95 (316)
T ss_dssp             CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             cccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeee
Confidence            355666666778999999999999999999973      35688999998763 344567899999999999 7999999


Q ss_pred             EeeEEeeCC-ccEEEEecCCCCChhhhhhhhhhhHH----HHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 009340          277 LLGCCLETE-VPVLVYEYISSGTLSHHIHDHQQQQE----QKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHR  351 (537)
Q Consensus       277 l~g~~~~~~-~~~lV~e~~~~gsL~~~l~~~~~~~~----~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~  351 (537)
                      +++++...+ ..++||||+++|+|.+++........    .........+++..++.++.|+++||.|||+.+   |+||
T Consensus        96 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~  172 (316)
T 2xir_A           96 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHR  172 (316)
T ss_dssp             EEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred             EEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccc
Confidence            999998765 48999999999999999976432100    000000123899999999999999999999999   9999


Q ss_pred             CCCCCCEEECCCCcEEEeeccCccccCCCCCc-eeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 009340          352 DIKSSNILLDDKFSAKVSDFGISRSIPNDKTH-LTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPIC  429 (537)
Q Consensus       352 Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~  429 (537)
                      ||||+||+++.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus       173 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~  252 (316)
T 2xir_A          173 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP  252 (316)
T ss_dssp             CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             cCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCc
Confidence            99999999999999999999999876444332 2334567899999999999999999999999999999998 999986


Q ss_pred             ccchhhhccHHHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHHhh
Q 009340          430 FARVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRSQ  504 (537)
Q Consensus       430 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~  504 (537)
                      .....+.      +......+         .....+...+..+.+++.+||+.||++|||+.++++.|+.+.+..
T Consensus       253 ~~~~~~~------~~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  312 (316)
T 2xir_A          253 GVKIDEE------FCRRLKEG---------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  312 (316)
T ss_dssp             TCCCSHH------HHHHHHHT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             ccchhHH------HHHHhccC---------ccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence            5432211      11111111         111122334567889999999999999999999999999988754

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.3e-42  Score=343.05  Aligned_cols=254  Identities=31%  Similarity=0.543  Sum_probs=203.8

Q ss_pred             cCCccccccCcCCceEEEEEEc-CCCCEEEEEEccCCChH---H----HHHHHHHHHHHHhcCCCCcceEeeEEeeCCcc
Q 009340          216 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEIDKT---Q----IHQFINEVVILSQINHRHIVKLLGCCLETEVP  287 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~---~----~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~  287 (537)
                      ++|...+.||+|+||.||+|+. .+++.||||++......   .    .+.+.+|+.++++++||||+++++++.+..  
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--   96 (287)
T 4f0f_A           19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--   96 (287)
T ss_dssp             TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred             ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence            6888899999999999999996 47899999998642211   1    167899999999999999999999986544  


Q ss_pred             EEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCc--
Q 009340          288 VLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFS--  365 (537)
Q Consensus       288 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~--  365 (537)
                      ++||||+++|+|.+++....           ..+++..++.++.|+++||+|||+.+ ++|+||||||+|||++.++.  
T Consensus        97 ~lv~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~  164 (287)
T 4f0f_A           97 RMVMEFVPCGDLYHRLLDKA-----------HPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENA  164 (287)
T ss_dssp             EEEEECCTTCBHHHHHHCTT-----------SCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTC
T ss_pred             eEEEEecCCCCHHHHHhccc-----------CCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCC
Confidence            79999999999999886542           36999999999999999999999987 34999999999999988776  


Q ss_pred             ---EEEeeccCccccCCCCCceeeeccccccccCcccc--cCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHH
Q 009340          366 ---AKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYF--QSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLV  440 (537)
Q Consensus       366 ---~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~  440 (537)
                         +||+|||+++....    ......||+.|+|||.+  ....++.++||||||+++|||++|+.||........    
T Consensus       165 ~~~~kl~Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~----  236 (287)
T 4f0f_A          165 PVCAKVADFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI----  236 (287)
T ss_dssp             SCCEEECCCTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH----
T ss_pred             ceeEEeCCCCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH----
Confidence               99999999975432    23446789999999998  445678999999999999999999999865433221    


Q ss_pred             HHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHH
Q 009340          441 ACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGL  500 (537)
Q Consensus       441 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i  500 (537)
                      ... .....        .......+...+..+.+++.+||+.||++|||+.++++.|+++
T Consensus       237 ~~~-~~~~~--------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          237 KFI-NMIRE--------EGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             HHH-HHHHH--------SCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             HHH-HHHhc--------cCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence            001 11111        1111223344556789999999999999999999999999864

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.4e-43  Score=358.94  Aligned_cols=258  Identities=28%  Similarity=0.497  Sum_probs=197.5

Q ss_pred             CCccccccCcCCceEEEEEEcC--CC--CEEEEEEccC-CChHHHHHHHHHHHHHHhcCCCCcceEeeEEee-CCccEEE
Q 009340          217 NYNQSRFLGQGGFGTVYKGMLP--DG--SIVAVKRSKE-IDKTQIHQFINEVVILSQINHRHIVKLLGCCLE-TEVPVLV  290 (537)
Q Consensus       217 ~~~~~~~lg~G~~g~Vy~~~~~--~g--~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lV  290 (537)
                      .|...+.||+|+||.||+|.+.  ++  ..||||.++. ......++|.+|+.++++++||||++++++|.+ .+..++|
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            4566789999999999999863  22  3689999865 344567889999999999999999999999765 4578999


Q ss_pred             EecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEee
Q 009340          291 YEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSD  370 (537)
Q Consensus       291 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~D  370 (537)
                      |||+++|+|.+++....           ..+++..++.++.|+++||.|||+.+   |+||||||+|||++.++.+||+|
T Consensus       170 ~e~~~~g~L~~~l~~~~-----------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~D  235 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRNET-----------HNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVAD  235 (373)
T ss_dssp             EECCTTCBHHHHHHCTT-----------CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECC
T ss_pred             EECCCCCCHHHHHhhcc-----------cCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEee
Confidence            99999999999997532           36899999999999999999999999   99999999999999999999999


Q ss_pred             ccCccccCCCCCc---eeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHHHH
Q 009340          371 FGISRSIPNDKTH---LTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISL  446 (537)
Q Consensus       371 fgla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~  446 (537)
                      ||+++........   ......+|+.|+|||.+.+..++.++||||||+++|||++ |..||......+   ...    .
T Consensus       236 FG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~---~~~----~  308 (373)
T 3c1x_A          236 FGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITV----Y  308 (373)
T ss_dssp             C---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC---HHH----H
T ss_pred             ccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH---HHH----H
Confidence            9999866433221   1234457889999999999999999999999999999999 566664432221   111    1


Q ss_pred             HhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHHhh
Q 009340          447 AKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRSQ  504 (537)
Q Consensus       447 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~  504 (537)
                      ...+.         ....+..++..+.+++.+||+.||++|||+.++++.|+.+....
T Consensus       309 ~~~~~---------~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~  357 (373)
T 3c1x_A          309 LLQGR---------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF  357 (373)
T ss_dssp             HHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred             HHcCC---------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence            11110         11122334567899999999999999999999999999988643

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=3.4e-43  Score=363.99  Aligned_cols=259  Identities=22%  Similarity=0.336  Sum_probs=209.3

Q ss_pred             HHHHHHHhcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCC---hHHHHHHHHHHHHHHhcCCCCcceEeeEEee
Q 009340          208 ADELQRATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEID---KTQIHQFINEVVILSQINHRHIVKLLGCCLE  283 (537)
Q Consensus       208 ~~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~  283 (537)
                      ..+++...++|...++||+|+||.||+++.. +++.||+|+++...   ....+.+.+|+.+++.++||||+++++++.+
T Consensus        61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~  140 (410)
T 3v8s_A           61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  140 (410)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence            4455556789999999999999999999965 58899999986421   1122347899999999999999999999999


Q ss_pred             CCccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCC
Q 009340          284 TEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK  363 (537)
Q Consensus       284 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~  363 (537)
                      .+..++||||+++|+|.+++..             ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.+
T Consensus       141 ~~~~~lV~E~~~gg~L~~~l~~-------------~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~  204 (410)
T 3v8s_A          141 DRYLYMVMEYMPGGDLVNLMSN-------------YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKS  204 (410)
T ss_dssp             SSEEEEEECCCTTEEHHHHHHH-------------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTT
T ss_pred             CCEEEEEEeCCCCCcHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCC
Confidence            9999999999999999998854             25899999999999999999999999   9999999999999999


Q ss_pred             CcEEEeeccCccccCCCCCceeeeccccccccCcccccCCC----CCcchhHHHHHHHHHHHHhCCCCCCccchhhhccH
Q 009340          364 FSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQ----FTDKSDVYSFGVVLLELLTGKKPICFARVEEERNL  439 (537)
Q Consensus       364 ~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~  439 (537)
                      +.+||+|||+++..............||+.|+|||++.+..    ++.++|||||||++|||++|+.||......+.   
T Consensus       205 g~ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~---  281 (410)
T 3v8s_A          205 GHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT---  281 (410)
T ss_dssp             SCEEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHH---
T ss_pred             CCEEEeccceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhH---
Confidence            99999999999887655444445678999999999997655    78999999999999999999999975433221   


Q ss_pred             HHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCC--CCCHhhHHH
Q 009340          440 VACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKK--RPTMKQVSM  495 (537)
Q Consensus       440 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~--RPs~~ev~~  495 (537)
                         +........       .+..+.....+..+.+|+.+||+.+|.+  ||++.||++
T Consensus       282 ---~~~i~~~~~-------~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~  329 (410)
T 3v8s_A          282 ---YSKIMNHKN-------SLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR  329 (410)
T ss_dssp             ---HHHHHTHHH-------HCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred             ---HHHHHhccc-------cccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence               111111000       0111111134467889999999999988  999999875

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.6e-42  Score=344.55  Aligned_cols=249  Identities=23%  Similarity=0.370  Sum_probs=196.8

Q ss_pred             hcCCccccccCcCCceEEEEEEc-CCCCEEEEEEccCCCh--------------------------HHHHHHHHHHHHHH
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEIDK--------------------------TQIHQFINEVVILS  267 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~  267 (537)
                      .++|...+.||+|+||.||+|+. .+++.||||.+.....                          ...+.+.+|+.+++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            36899999999999999999985 4688999998864321                          12356889999999


Q ss_pred             hcCCCCcceEeeEEee--CCccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 009340          268 QINHRHIVKLLGCCLE--TEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSAS  345 (537)
Q Consensus       268 ~l~H~niv~l~g~~~~--~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~  345 (537)
                      +++||||+++++++.+  .+..++||||+++|+|.+++..             ..+++..++.++.|+++||.|||+.+ 
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-------------~~~~~~~~~~~~~qi~~~l~~lH~~~-  157 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL-------------KPLSEDQARFYFQDLIKGIEYLHYQK-  157 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS-------------SCCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc-------------CCCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence            9999999999999986  4578999999999999887542             36999999999999999999999999 


Q ss_pred             CCeeecCCCCCCEEECCCCcEEEeeccCccccCCCCCceeeeccccccccCcccccCCC---CCcchhHHHHHHHHHHHH
Q 009340          346 IPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQ---FTDKSDVYSFGVVLLELL  422 (537)
Q Consensus       346 ~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~t~ksDV~S~Gvll~el~  422 (537)
                        |+||||||+|||++.++.+||+|||++........ ......||+.|+|||.+.+..   ++.++||||||+++|||+
T Consensus       158 --ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~  234 (298)
T 2zv2_A          158 --IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFV  234 (298)
T ss_dssp             --EECCCCCGGGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHH
T ss_pred             --eeccCCCHHHEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHH
Confidence              99999999999999999999999999987654322 234457999999999997765   378999999999999999


Q ss_pred             hCCCCCCccchhhhccHHHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          423 TGKKPICFARVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       423 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      +|+.||.......       .........        ...+.....+..+.+++.+||+.||++|||+.|+++
T Consensus       235 ~g~~pf~~~~~~~-------~~~~~~~~~--------~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          235 FGQCPFMDERIMC-------LHSKIKSQA--------LEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             HSSCSSCCSSHHH-------HHHHHHHCC--------CCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             HCCCCCCCccHHH-------HHHHHhccc--------CCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            9999986543211       111111110        000111233457889999999999999999999864

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.4e-42  Score=352.25  Aligned_cols=251  Identities=24%  Similarity=0.363  Sum_probs=199.2

Q ss_pred             hcCCccccccCcCCceEEEEEEcCCCCEEEEEEccC--CChHHHHHHHHHHHHHHhcCC--CCcceEeeEEeeCCccEEE
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKE--IDKTQIHQFINEVVILSQINH--RHIVKLLGCCLETEVPVLV  290 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lV  290 (537)
                      .++|...+.||+|+||.||++...+++.||||++..  ......+.+.+|+.++.+++|  +||+++++++.+....++|
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv   87 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV   87 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence            356888999999999999999988899999998864  345566789999999999976  9999999999999999999


Q ss_pred             EecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEee
Q 009340          291 YEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSD  370 (537)
Q Consensus       291 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~D  370 (537)
                      || +.+|+|.+++...            ..+++..+..++.|+++||.|||+.+   |+||||||+|||++ ++.+||+|
T Consensus        88 ~e-~~~~~L~~~l~~~------------~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~D  150 (343)
T 3dbq_A           88 ME-CGNIDLNSWLKKK------------KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLID  150 (343)
T ss_dssp             EC-CCSEEHHHHHHHS------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECC
T ss_pred             Ee-CCCCCHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEee
Confidence            99 5678999999753            36999999999999999999999999   99999999999997 56899999


Q ss_pred             ccCccccCCCCCc-eeeeccccccccCcccccC-----------CCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhcc
Q 009340          371 FGISRSIPNDKTH-LTTTIQGTFGYLDPEYFQS-----------SQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERN  438 (537)
Q Consensus       371 fgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~  438 (537)
                      ||+++........ ......||+.|+|||++.+           ..++.++|||||||++|||++|+.||......    
T Consensus       151 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~----  226 (343)
T 3dbq_A          151 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ----  226 (343)
T ss_dssp             CSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH----
T ss_pred             cccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH----
Confidence            9999876543322 2345679999999999864           67899999999999999999999998643211    


Q ss_pred             HHHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHH
Q 009340          439 LVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSME  496 (537)
Q Consensus       439 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~  496 (537)
                       ...         +...+++......+......+.+|+.+||+.||++|||+.|+++.
T Consensus       227 -~~~---------~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h  274 (343)
T 3dbq_A          227 -ISK---------LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  274 (343)
T ss_dssp             -HHH---------HHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             -HHH---------HHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence             111         112222222222333334578899999999999999999999764

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.7e-42  Score=346.23  Aligned_cols=273  Identities=23%  Similarity=0.346  Sum_probs=207.8

Q ss_pred             CHHHHHHHhcCCccccccCcCCceEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHHHHhc--CCCCcceEeeEEeeC
Q 009340          207 TADELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQI--NHRHIVKLLGCCLET  284 (537)
Q Consensus       207 ~~~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~H~niv~l~g~~~~~  284 (537)
                      ....-....++|...+.||+|+||.||+|+.. |+.||||++....   ...+..|.+++..+  +|+||+++++++.+.
T Consensus        28 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~  103 (337)
T 3mdy_A           28 PLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKG  103 (337)
T ss_dssp             CHHHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEES
T ss_pred             CcccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccC
Confidence            34444555679999999999999999999985 8999999986432   34455566666655  899999999999887


Q ss_pred             ----CccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhc--------CCCCeeecC
Q 009340          285 ----EVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSS--------ASIPIFHRD  352 (537)
Q Consensus       285 ----~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~--------~~~~ivH~D  352 (537)
                          ...++||||+++|+|.+++..             ..+++..++.++.|++.||.|||+.        +   |+|||
T Consensus       104 ~~~~~~~~lv~e~~~~g~L~~~l~~-------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~D  167 (337)
T 3mdy_A          104 TGSWTQLYLITDYHENGSLYDYLKS-------------TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRD  167 (337)
T ss_dssp             CGGGCEEEEEECCCTTCBHHHHHHH-------------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSC
T ss_pred             CCCCCceEEEEeccCCCcHHHHhhc-------------cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecc
Confidence                678999999999999999954             2589999999999999999999998        6   99999


Q ss_pred             CCCCCEEECCCCcEEEeeccCccccCCCCCce---eeeccccccccCcccccCCCCCcc------hhHHHHHHHHHHHHh
Q 009340          353 IKSSNILLDDKFSAKVSDFGISRSIPNDKTHL---TTTIQGTFGYLDPEYFQSSQFTDK------SDVYSFGVVLLELLT  423 (537)
Q Consensus       353 lk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~t~k------sDV~S~Gvll~el~t  423 (537)
                      |||+|||++.++.+||+|||++..........   .....||+.|+|||.+.+...+.+      +|||||||++|||++
T Consensus       168 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~t  247 (337)
T 3mdy_A          168 LKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVAR  247 (337)
T ss_dssp             CCGGGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHT
T ss_pred             cchHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHh
Confidence            99999999999999999999997764433221   124579999999999988776655      999999999999999


Q ss_pred             C----------CCCCCccchhhhccHHHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhH
Q 009340          424 G----------KKPICFARVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQV  493 (537)
Q Consensus       424 g----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev  493 (537)
                      |          +.||........  .................+...   .....++..+.+++.+||+.||++|||+.+|
T Consensus       248 g~~~~~~~~~~~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~el  322 (337)
T 3mdy_A          248 RCVSGGIVEEYQLPYHDLVPSDP--SYEDMREIVCIKKLRPSFPNR---WSSDECLRQMGKLMTECWAHNPASRLTALRV  322 (337)
T ss_dssp             TBCBTTBCCCCCCTTTTTSCSSC--CHHHHHHHHTTSCCCCCCCGG---GGGSHHHHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             ccCcccccccccccHhhhcCCCC--chhhhHHHHhhhccCcccccc---chhhHHHHHHHHHHHHhhhhChhhCCCHHHH
Confidence            9          555543221111  111111111111111111100   1123677889999999999999999999999


Q ss_pred             HHHHHHHHHhh
Q 009340          494 SMELEGLRRSQ  504 (537)
Q Consensus       494 ~~~L~~i~~~~  504 (537)
                      ++.|+.+.++.
T Consensus       323 l~~L~~l~~~~  333 (337)
T 3mdy_A          323 KKTLAKMSESQ  333 (337)
T ss_dssp             HHHHHHHHHTT
T ss_pred             HHHHHHHHhhc
Confidence            99999998764

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=3.8e-42  Score=351.44  Aligned_cols=253  Identities=25%  Similarity=0.384  Sum_probs=206.5

Q ss_pred             HHhcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCC--ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEE
Q 009340          213 RATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI--DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVL  289 (537)
Q Consensus       213 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  289 (537)
                      ...++|...+.||+|+||.||++... +|+.||+|.+...  .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus        26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l  105 (362)
T 2bdw_A           26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL  105 (362)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            34578999999999999999999964 6899999998643  44556789999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCC---CcE
Q 009340          290 VYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK---FSA  366 (537)
Q Consensus       290 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~---~~~  366 (537)
                      ||||+++|+|.+++...            ..+++..+..++.|+++||.|||+.+   |+||||||+|||++.+   +.+
T Consensus       106 v~e~~~gg~L~~~l~~~------------~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~  170 (362)
T 2bdw_A          106 VFDLVTGGELFEDIVAR------------EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAV  170 (362)
T ss_dssp             EECCCCSCBHHHHHTTC------------SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCE
T ss_pred             EEecCCCCCHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCE
Confidence            99999999999998652            36899999999999999999999999   9999999999999865   459


Q ss_pred             EEeeccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHH
Q 009340          367 KVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISL  446 (537)
Q Consensus       367 ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~  446 (537)
                      ||+|||++.......  ......||+.|+|||.+.+..++.++|||||||++|||++|+.||......+       ....
T Consensus       171 kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~-------~~~~  241 (362)
T 2bdw_A          171 KLADFGLAIEVNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR-------LYAQ  241 (362)
T ss_dssp             EECCCTTCBCCTTCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHH
T ss_pred             EEeecCcceEecCCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH-------HHHH
Confidence            999999998765332  2344679999999999999999999999999999999999999997543221       1111


Q ss_pred             HhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          447 AKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       447 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      ...+... .     ........+..+.+|+.+||+.||++|||+.++++
T Consensus       242 i~~~~~~-~-----~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  284 (362)
T 2bdw_A          242 IKAGAYD-Y-----PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK  284 (362)
T ss_dssp             HHHTCCC-C-----CTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             HHhCCCC-C-----CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            1111100 0     00011223457889999999999999999999875

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=4.7e-43  Score=346.52  Aligned_cols=252  Identities=22%  Similarity=0.413  Sum_probs=205.0

Q ss_pred             cCCccccccCcCCceEEEEEEcCC-C-------CEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCcc
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLPD-G-------SIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVP  287 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~~-g-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~  287 (537)
                      ++|...+.||+|+||.||+|.... +       ..||+|.+........+.+.+|+.++++++||||+++++++.+.+..
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   87 (289)
T 4fvq_A            8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN   87 (289)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred             hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence            578889999999999999998642 3       47999999776666778899999999999999999999999999999


Q ss_pred             EEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCc--
Q 009340          288 VLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFS--  365 (537)
Q Consensus       288 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~--  365 (537)
                      ++||||+++|+|.+++.....           .+++..++.++.|+++||.|||+.+   |+||||||+|||++.++.  
T Consensus        88 ~lv~e~~~~~~L~~~l~~~~~-----------~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~  153 (289)
T 4fvq_A           88 ILVQEFVKFGSLDTYLKKNKN-----------CINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRK  153 (289)
T ss_dssp             EEEEECCTTCBHHHHHHHTGG-----------GCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGG
T ss_pred             EEEEECCCCCCHHHHHHhCCC-----------CCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCccc
Confidence            999999999999999976432           4899999999999999999999999   999999999999998887  


Q ss_pred             ------EEEeeccCccccCCCCCceeeeccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhcc
Q 009340          366 ------AKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQS-SQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERN  438 (537)
Q Consensus       366 ------~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~  438 (537)
                            +||+|||++......     ....+|+.|+|||.+.+ ..++.++||||||+++|||++|..|+........  
T Consensus       154 ~~~~~~~kl~Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~--  226 (289)
T 4fvq_A          154 TGNPPFIKLSDPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR--  226 (289)
T ss_dssp             GTBCCEEEECCCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH--
T ss_pred             ccccceeeeccCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH--
Confidence                  999999998754321     23457899999999987 7799999999999999999996655433221110  


Q ss_pred             HHHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHHh
Q 009340          439 LVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRS  503 (537)
Q Consensus       439 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~  503 (537)
                          .......           ....+...+..+.+++.+||+.||++|||+.++++.|+.+...
T Consensus       227 ----~~~~~~~-----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p  276 (289)
T 4fvq_A          227 ----KLQFYED-----------RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP  276 (289)
T ss_dssp             ----HHHHHHT-----------TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred             ----HHHHhhc-----------cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence                0011110           0011112234678999999999999999999999999987653

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=4.4e-42  Score=343.25  Aligned_cols=265  Identities=23%  Similarity=0.382  Sum_probs=203.7

Q ss_pred             hcCCccccccCcCCceEEEEEEc-CCCCEEEEEEccC---CChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEE
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKE---IDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLV  290 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  290 (537)
                      .++|...+.||+|+||.||+|.. .+|+.||||+++.   ......+.+.+|+.++++++|+||+++++++.+.+..++|
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv  110 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV  110 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence            35788999999999999999995 4789999999864   3455667899999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEee
Q 009340          291 YEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSD  370 (537)
Q Consensus       291 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~D  370 (537)
                      |||+++|+|.+++......        ...+++..++.++.|+++||.|||+.+   ++||||||+||+++.++.+||+|
T Consensus       111 ~e~~~~~~L~~~l~~~~~~--------~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~D  179 (310)
T 2wqm_A          111 LELADAGDLSRMIKHFKKQ--------KRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGD  179 (310)
T ss_dssp             EECCCSCBHHHHHHHHHHT--------TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECC
T ss_pred             EecCCCCCHHHHHHHhccc--------ccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEe
Confidence            9999999999999754321        346899999999999999999999999   99999999999999999999999


Q ss_pred             ccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhc
Q 009340          371 FGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKEN  450 (537)
Q Consensus       371 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  450 (537)
                      ||++........ ......|++.|+|||.+.+..++.++||||||+++|||++|+.||.......    .. ........
T Consensus       180 fg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----~~-~~~~~~~~  253 (310)
T 2wqm_A          180 LGLGRFFSSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL----YS-LCKKIEQC  253 (310)
T ss_dssp             C-------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCH----HH-HHHHHHTT
T ss_pred             ccceeeecCCCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhH----HH-HHHHhhcc
Confidence            999986643322 2234568999999999999999999999999999999999999986432211    11 11111111


Q ss_pred             hhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHHhh
Q 009340          451 QLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRSQ  504 (537)
Q Consensus       451 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~  504 (537)
                      ...        .......+..+.+++.+||+.||++|||+.+|++.|+++....
T Consensus       254 ~~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~  299 (310)
T 2wqm_A          254 DYP--------PLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACT  299 (310)
T ss_dssp             CSC--------CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             cCC--------CCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhh
Confidence            110        0011233457889999999999999999999999999998754

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1e-42  Score=351.38  Aligned_cols=277  Identities=22%  Similarity=0.333  Sum_probs=203.2

Q ss_pred             hcCCccccccCcCCceEEEEEEc-CCCCEEEEEEccCCChHHHHHHHHHHHHHHhcC-CCCcceEeeEEee--------C
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEIDKTQIHQFINEVVILSQIN-HRHIVKLLGCCLE--------T  284 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~--------~  284 (537)
                      ..+|...++||+|+||.||++.. .+|+.||||++........+.+.+|+.++.++. ||||+++++++..        .
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~  106 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ  106 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred             CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence            45888999999999999999995 478999999987766777788999999999996 9999999999942        3


Q ss_pred             CccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCC
Q 009340          285 EVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF  364 (537)
Q Consensus       285 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~  364 (537)
                      ...++|+||+. |+|.+++.....         ...+++..++.++.|+++||.|||+.+ ++|+||||||+|||++.++
T Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~---------~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~  175 (337)
T 3ll6_A          107 AEFLLLTELCK-GQLVEFLKKMES---------RGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQG  175 (337)
T ss_dssp             EEEEEEEECCS-EEHHHHHHHHHT---------TCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTS
T ss_pred             ceEEEEEEecC-CCHHHHHHHhhc---------cCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCC
Confidence            34799999996 799999876432         346999999999999999999999976 3499999999999999999


Q ss_pred             cEEEeeccCccccCCCCCce-----------eeeccccccccCcccc---cCCCCCcchhHHHHHHHHHHHHhCCCCCCc
Q 009340          365 SAKVSDFGISRSIPNDKTHL-----------TTTIQGTFGYLDPEYF---QSSQFTDKSDVYSFGVVLLELLTGKKPICF  430 (537)
Q Consensus       365 ~~ki~Dfgla~~~~~~~~~~-----------~~~~~gt~~y~aPE~~---~~~~~t~ksDV~S~Gvll~el~tg~~p~~~  430 (537)
                      .+||+|||++..........           .....||+.|+|||.+   .+..++.++||||||+++|||++|+.||..
T Consensus       176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~  255 (337)
T 3ll6_A          176 TIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED  255 (337)
T ss_dssp             CEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--
T ss_pred             CEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcc
Confidence            99999999998764432211           1134589999999998   567789999999999999999999999853


Q ss_pred             cchhhhccHHHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHHhhHHHhhh
Q 009340          431 ARVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRSQRCLEMC  510 (537)
Q Consensus       431 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~~~~~~~  510 (537)
                      .....                   ++...............+.+|+.+||+.||++|||+.|+++.|+.+..........
T Consensus       256 ~~~~~-------------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~~~~  316 (337)
T 3ll6_A          256 GAKLR-------------------IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKS  316 (337)
T ss_dssp             -----------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCCTTS
T ss_pred             hhHHH-------------------hhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCCCCc
Confidence            22110                   01111111111122234778999999999999999999999999998876555555


Q ss_pred             hhhhhhccchh
Q 009340          511 QVNQLLADEIS  521 (537)
Q Consensus       511 ~~~~~l~~~~~  521 (537)
                      +..+++++...
T Consensus       317 ~~~~~~~~~~~  327 (337)
T 3ll6_A          317 PITELLEQNGG  327 (337)
T ss_dssp             CCHHHHTCC--
T ss_pred             cHHHHHHHcCC
Confidence            55555554443

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=2.3e-42  Score=351.78  Aligned_cols=255  Identities=23%  Similarity=0.336  Sum_probs=204.7

Q ss_pred             hcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCC-----ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccE
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI-----DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPV  288 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  288 (537)
                      .+.|...+.||+|+||.||++... +|+.||||.+...     .....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            357889999999999999999854 6899999987531     1123567899999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCc---
Q 009340          289 LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFS---  365 (537)
Q Consensus       289 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~---  365 (537)
                      +||||+++|+|.+++......        ...+++..+..++.|+++||.|||+++   |+||||||+|||++.++.   
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~--------~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~  171 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADA--------GFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAP  171 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHT--------TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCC
T ss_pred             EEEeCCCCCCHHHHHHHhccc--------CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCc
Confidence            999999999999888654321        235899999999999999999999999   999999999999987654   


Q ss_pred             EEEeeccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHH
Q 009340          366 AKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFIS  445 (537)
Q Consensus       366 ~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~  445 (537)
                      +||+|||++........ ......||+.|+|||.+.+..++.++|||||||++|||++|+.||......       .+..
T Consensus       172 vkl~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-------~~~~  243 (351)
T 3c0i_A          172 VKLGGFGVAIQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER-------LFEG  243 (351)
T ss_dssp             EEECCCTTCEECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHH-------HHHH
T ss_pred             EEEecCcceeEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHH-------HHHH
Confidence            99999999987754322 234557999999999999999999999999999999999999999653210       0111


Q ss_pred             HHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          446 LAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       446 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      ... ...  ...+...    ...+..+.+|+.+||+.||++|||+.++++
T Consensus       244 i~~-~~~--~~~~~~~----~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          244 IIK-GKY--KMNPRQW----SHISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             HHH-TCC--CCCHHHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHc-CCC--CCCcccc----ccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            111 100  0011111    123457889999999999999999999975

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=5.3e-42  Score=339.86  Aligned_cols=266  Identities=20%  Similarity=0.276  Sum_probs=206.9

Q ss_pred             HhcCCccccccCcCCceEEEEEEc-CCCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEE-eeCCccEEEE
Q 009340          214 ATDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCC-LETEVPVLVY  291 (537)
Q Consensus       214 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~-~~~~~~~lV~  291 (537)
                      ..++|...+.||+|+||.||+|+. .+++.||||......  ....+.+|+.+++.++|++++..++.+ .+.+..++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence            457899999999999999999995 578999999865422  223578899999999988877776666 5666789999


Q ss_pred             ecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEE---CCCCcEEE
Q 009340          292 EYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILL---DDKFSAKV  368 (537)
Q Consensus       292 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll---~~~~~~ki  368 (537)
                      ||+ +|+|.+++....           ..+++..++.++.|+++||.|||+.+   |+||||||+|||+   +.++.+||
T Consensus        85 e~~-~~~L~~~~~~~~-----------~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL  149 (296)
T 4hgt_A           85 ELL-GPSLEDLFNFCS-----------RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYI  149 (296)
T ss_dssp             ECC-CCBHHHHHHHTT-----------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEE
T ss_pred             Ecc-CCCHHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEE
Confidence            999 999999987532           36999999999999999999999999   9999999999999   78999999


Q ss_pred             eeccCccccCCCCC------ceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHH
Q 009340          369 SDFGISRSIPNDKT------HLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVAC  442 (537)
Q Consensus       369 ~Dfgla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~  442 (537)
                      +|||+++.......      .......||+.|+|||.+.+..++.++||||||+++|||++|+.||..............
T Consensus       150 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~  229 (296)
T 4hgt_A          150 IDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYER  229 (296)
T ss_dssp             CCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHH
T ss_pred             ecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhh
Confidence            99999987644332      122345789999999999999999999999999999999999999976443332222221


Q ss_pred             HHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHHhhH
Q 009340          443 FISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRSQR  505 (537)
Q Consensus       443 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~~  505 (537)
                      ..........     +.    .....+..+.+++.+||+.||++|||+.+|++.|+.+.....
T Consensus       230 ~~~~~~~~~~-----~~----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~  283 (296)
T 4hgt_A          230 ISEKKMSTPI-----EV----LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG  283 (296)
T ss_dssp             HHHHHHHSCH-----HH----HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred             hhcccccchh-----hh----hhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhC
Confidence            1111110000     00    011224578899999999999999999999999999887553

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.2e-42  Score=341.85  Aligned_cols=254  Identities=27%  Similarity=0.467  Sum_probs=203.6

Q ss_pred             hcCCccccccCcCCceEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeC-CccEEEEec
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLET-EVPVLVYEY  293 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-~~~~lV~e~  293 (537)
                      .++|...+.||+|+||.||++.. .|+.||||.++...  ..+.+.+|+.++++++||||+++++++.+. +..++||||
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~   96 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   96 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence            46788899999999999999998 48899999987643  456789999999999999999999997655 478999999


Q ss_pred             CCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccC
Q 009340          294 ISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGI  373 (537)
Q Consensus       294 ~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgl  373 (537)
                      +++|+|.+++.....          ..+++..++.++.|+++||.|||+.+   ++||||||+||+++.++.+||+|||+
T Consensus        97 ~~~~~L~~~l~~~~~----------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~  163 (278)
T 1byg_A           97 MAKGSLVDYLRSRGR----------SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGL  163 (278)
T ss_dssp             CTTEEHHHHHHHHHH----------HHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC
T ss_pred             CCCCCHHHHHHhccc----------ccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccc
Confidence            999999999976432          24889999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHHHHHhhchh
Q 009340          374 SRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQL  452 (537)
Q Consensus       374 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  452 (537)
                      +......    .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+.       .....    
T Consensus       164 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~-------~~~~~----  228 (278)
T 1byg_A          164 TKEASST----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV-------VPRVE----  228 (278)
T ss_dssp             ----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH-------HHHHT----
T ss_pred             ccccccc----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH-------HHHHh----
Confidence            8765332    123357889999999998999999999999999999998 9999865433221       11111    


Q ss_pred             hhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHHhh
Q 009340          453 LEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRSQ  504 (537)
Q Consensus       453 ~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~  504 (537)
                           .......+...+..+.+++.+||+.||++|||+.++++.|+.+....
T Consensus       229 -----~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~  275 (278)
T 1byg_A          229 -----KGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE  275 (278)
T ss_dssp             -----TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             -----cCCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence                 11112233345567899999999999999999999999999998743

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=3.1e-42  Score=354.66  Aligned_cols=252  Identities=22%  Similarity=0.308  Sum_probs=208.7

Q ss_pred             hcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEec
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY  293 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  293 (537)
                      .++|...+.||+|+||.||+|... +|+.||+|.+..........+.+|+.++++++||||+++++++.+....++||||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~  129 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  129 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence            468999999999999999999964 6899999999876666667899999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECC--CCcEEEeec
Q 009340          294 ISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD--KFSAKVSDF  371 (537)
Q Consensus       294 ~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~--~~~~ki~Df  371 (537)
                      +++|+|.+++....           ..+++..++.++.|+++||.|||+.+   |+||||||+|||++.  ++.+||+||
T Consensus       130 ~~gg~L~~~l~~~~-----------~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DF  195 (387)
T 1kob_A          130 LSGGELFDRIAAED-----------YKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDF  195 (387)
T ss_dssp             CCCCBHHHHTTCTT-----------CCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCC
T ss_pred             CCCCcHHHHHHhhc-----------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEec
Confidence            99999999987532           35899999999999999999999999   999999999999974  578999999


Q ss_pred             cCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhch
Q 009340          372 GISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQ  451 (537)
Q Consensus       372 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  451 (537)
                      |+++.......  .....||+.|+|||.+.+..++.++|||||||++|||++|+.||......+.      +..... ..
T Consensus       196 G~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~------~~~i~~-~~  266 (387)
T 1kob_A          196 GLATKLNPDEI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET------LQNVKR-CD  266 (387)
T ss_dssp             TTCEECCTTSC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH------HHHHHH-CC
T ss_pred             ccceecCCCcc--eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHH------HHHHHh-CC
Confidence            99987754332  3445799999999999999999999999999999999999999975432211      111111 00


Q ss_pred             hhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          452 LLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       452 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      .      ..........+..+.+++.+||+.||++|||+.++++
T Consensus       267 ~------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  304 (387)
T 1kob_A          267 W------EFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  304 (387)
T ss_dssp             C------CCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             C------CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence            0      0011112234467889999999999999999999986

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=2.8e-42  Score=353.77  Aligned_cols=251  Identities=24%  Similarity=0.308  Sum_probs=201.2

Q ss_pred             ccccCcCCceEEEEEEc-CCCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecCCCCCh
Q 009340          221 SRFLGQGGFGTVYKGML-PDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTL  299 (537)
Q Consensus       221 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL  299 (537)
                      .+.||+|+||.||+|.. .+|+.||+|+++.......+++.+|+.++++++||||+++++++.+.+..++||||+++|+|
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L  173 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL  173 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence            56799999999999985 46899999999876666778899999999999999999999999999999999999999999


Q ss_pred             hhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEE--CCCCcEEEeeccCcccc
Q 009340          300 SHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILL--DDKFSAKVSDFGISRSI  377 (537)
Q Consensus       300 ~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll--~~~~~~ki~Dfgla~~~  377 (537)
                      .+++....           ..+++..++.++.|+++||.|||+.+   |+||||||+|||+  +.++.+||+|||+++..
T Consensus       174 ~~~l~~~~-----------~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~  239 (373)
T 2x4f_A          174 FDRIIDES-----------YNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRY  239 (373)
T ss_dssp             HHHHHHTG-----------GGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEEC
T ss_pred             HHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceec
Confidence            99886542           25899999999999999999999999   9999999999999  67789999999999876


Q ss_pred             CCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchhhhhhc
Q 009340          378 PNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEILD  457 (537)
Q Consensus       378 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  457 (537)
                      .....  .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+.      +........  .   
T Consensus       240 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~------~~~i~~~~~--~---  306 (373)
T 2x4f_A          240 KPREK--LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAET------LNNILACRW--D---  306 (373)
T ss_dssp             CTTCB--CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHHHTCC--C---
T ss_pred             CCccc--cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhccC--C---
Confidence            44322  2345689999999999999999999999999999999999999975433221      111111100  0   


Q ss_pred             HHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH--HHHHH
Q 009340          458 ARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM--ELEGL  500 (537)
Q Consensus       458 ~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~--~L~~i  500 (537)
                        .........+..+.+|+.+||+.||++|||+.|+++  .+...
T Consensus       307 --~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~  349 (373)
T 2x4f_A          307 --LEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDH  349 (373)
T ss_dssp             --SCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred             --CChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence              000111233467889999999999999999999987  55544

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=6.9e-42  Score=358.08  Aligned_cols=253  Identities=22%  Similarity=0.327  Sum_probs=205.4

Q ss_pred             HhcCCccccccCcCCceEEEEEEc-CCCCEEEEEEccCC--ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEE
Q 009340          214 ATDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEI--DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLV  290 (537)
Q Consensus       214 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  290 (537)
                      ..++|...+.||+|+||.||++.. .+|+.||+|.+...  .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv   88 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI   88 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence            457899999999999999999985 47899999988653  234456789999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEC---CCCcEE
Q 009340          291 YEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD---DKFSAK  367 (537)
Q Consensus       291 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~---~~~~~k  367 (537)
                      |||+++|+|.+++...            ..+++..+..++.|+++||.|||+.+   |+||||||+|||++   .++.+|
T Consensus        89 ~E~~~gg~L~~~i~~~------------~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vk  153 (444)
T 3soa_A           89 FDLVTGGELFEDIVAR------------EYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVK  153 (444)
T ss_dssp             ECCCBCCBHHHHHHHC------------SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEE
T ss_pred             EEeCCCCCHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEE
Confidence            9999999999998753            46999999999999999999999999   99999999999998   567899


Q ss_pred             EeeccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHH
Q 009340          368 VSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLA  447 (537)
Q Consensus       368 i~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~  447 (537)
                      |+|||++........ ......||+.|+|||.+.+..++.++|||||||++|||++|+.||......+       .....
T Consensus       154 L~DFG~a~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~-------~~~~i  225 (444)
T 3soa_A          154 LADFGLAIEVEGEQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHR-------LYQQI  225 (444)
T ss_dssp             ECCCSSCBCCCTTCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-------HHHHH
T ss_pred             EccCceeEEecCCCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHH-------HHHHH
Confidence            999999987654332 2345679999999999999999999999999999999999999996543222       11111


Q ss_pred             hhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          448 KENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       448 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      ..+.. .     ...+.....+..+.+|+.+||+.||++|||+.|+++
T Consensus       226 ~~~~~-~-----~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          226 KAGAY-D-----FPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             HHTCC-C-----CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HhCCC-C-----CCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            11110 0     000111233467889999999999999999999976

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=3.5e-42  Score=354.54  Aligned_cols=251  Identities=24%  Similarity=0.381  Sum_probs=200.7

Q ss_pred             hcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCC---ChHHHHHHHHHHHHHHhc-CCCCcceEeeEEeeCCccEE
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI---DKTQIHQFINEVVILSQI-NHRHIVKLLGCCLETEVPVL  289 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l  289 (537)
                      .++|...++||+|+||.||+++.. +++.||+|+++..   .....+.+.+|..++.++ +||||+++++++.+.+..++
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            367899999999999999999965 5789999998642   233345678899999887 89999999999999999999


Q ss_pred             EEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEe
Q 009340          290 VYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVS  369 (537)
Q Consensus       290 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~  369 (537)
                      ||||+++|+|.+++...            ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+
T Consensus       131 V~E~~~gg~L~~~l~~~------------~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~  195 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQRQ------------RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLT  195 (396)
T ss_dssp             EEECCTTCBHHHHHHHH------------SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEEC
T ss_pred             EEEcCCCCcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEe
Confidence            99999999999998753            35999999999999999999999999   9999999999999999999999


Q ss_pred             eccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhh--ccHHHHHHHHH
Q 009340          370 DFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEE--RNLVACFISLA  447 (537)
Q Consensus       370 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~--~~~~~~~~~~~  447 (537)
                      |||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.  ...........
T Consensus       196 DFGla~~~~~~~-~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i  274 (396)
T 4dc2_A          196 DYGMCKEGLRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI  274 (396)
T ss_dssp             CCTTCBCCCCTT-CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHH
T ss_pred             ecceeeecccCC-CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHH
Confidence            999998643222 234556799999999999999999999999999999999999999964322111  11111111111


Q ss_pred             hhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHh
Q 009340          448 KENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMK  491 (537)
Q Consensus       448 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~  491 (537)
                      ...          ....+...+..+.+|+.+||+.||++||++.
T Consensus       275 ~~~----------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~  308 (396)
T 4dc2_A          275 LEK----------QIRIPRSLSVKAASVLKSFLNKDPKERLGCH  308 (396)
T ss_dssp             HHC----------CCCCCTTSCHHHHHHHHHHTCSCTTTSTTCS
T ss_pred             hcc----------ccCCCCcCCHHHHHHHHHHhcCCHhHcCCCC
Confidence            111          1123334556788999999999999999963

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.2e-43  Score=362.28  Aligned_cols=262  Identities=23%  Similarity=0.314  Sum_probs=209.8

Q ss_pred             cCHHHHHHHhcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCC---hHHHHHHHHHHHHHHhcCCCCcceEeeEE
Q 009340          206 FTADELQRATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEID---KTQIHQFINEVVILSQINHRHIVKLLGCC  281 (537)
Q Consensus       206 ~~~~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~  281 (537)
                      +.+.++....++|+..+.||+|+||.||+++.+ +|+.||||+++...   ....+.+.+|..++..++|+||+++++++
T Consensus        51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~  130 (412)
T 2vd5_A           51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF  130 (412)
T ss_dssp             HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred             hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence            445566666789999999999999999999964 78999999986421   12234578999999999999999999999


Q ss_pred             eeCCccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEC
Q 009340          282 LETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD  361 (537)
Q Consensus       282 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~  361 (537)
                      .+.+..++||||+++|+|.+++....           ..+++..+..++.||+.||.|||+.+   |+||||||+|||++
T Consensus       131 ~~~~~~~lVmE~~~gg~L~~~l~~~~-----------~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld  196 (412)
T 2vd5_A          131 QDENYLYLVMEYYVGGDLLTLLSKFG-----------ERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLD  196 (412)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHHHS-----------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEC
T ss_pred             eeCCEEEEEEcCCCCCcHHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeec
Confidence            99999999999999999999997532           36999999999999999999999999   99999999999999


Q ss_pred             CCCcEEEeeccCccccCCCCCceeeeccccccccCccccc-------CCCCCcchhHHHHHHHHHHHHhCCCCCCccchh
Q 009340          362 DKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQ-------SSQFTDKSDVYSFGVVLLELLTGKKPICFARVE  434 (537)
Q Consensus       362 ~~~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~  434 (537)
                      .++.+||+|||+++..............||+.|+|||++.       ...++.++|||||||++|||++|+.||......
T Consensus       197 ~~g~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~  276 (412)
T 2vd5_A          197 RCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA  276 (412)
T ss_dssp             TTSCEEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH
T ss_pred             CCCCEEEeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHH
Confidence            9999999999999887655443444567999999999987       457899999999999999999999999754432


Q ss_pred             hhccHHHHHHHHHhhchhhhhhcHHhh-ccccHHHHHHHHHHHHHhcccCCCCC---CCHhhHHH
Q 009340          435 EERNLVACFISLAKENQLLEILDARVA-KEAREEDIGAMAELAMRCLRLNSKKR---PTMKQVSM  495 (537)
Q Consensus       435 ~~~~~~~~~~~~~~~~~~~~~~d~~~~-~~~~~~~~~~l~~l~~~cl~~~p~~R---Ps~~ev~~  495 (537)
                      +.      +.......       ..+. ...+...+.++.+|+.+||+ +|.+|   |++.||++
T Consensus       277 ~~------~~~i~~~~-------~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~  327 (412)
T 2vd5_A          277 ET------YGKIVHYK-------EHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT  327 (412)
T ss_dssp             HH------HHHHHTHH-------HHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred             HH------HHHHHhcc-------cCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence            21      11111100       0000 00112345678899999999 99998   57887753

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1.7e-42  Score=378.23  Aligned_cols=250  Identities=28%  Similarity=0.423  Sum_probs=202.7

Q ss_pred             cccCcCCceEEEEEEcC---CCCEEEEEEccCC--ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecCCC
Q 009340          222 RFLGQGGFGTVYKGMLP---DGSIVAVKRSKEI--DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISS  296 (537)
Q Consensus       222 ~~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  296 (537)
                      ++||+|+||.||+|.+.   .++.||||+++..  .....++|.+|+.++++++||||+++++++.+ +..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            47999999999999753   4678999998753  33446789999999999999999999999964 557999999999


Q ss_pred             CChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCccc
Q 009340          297 GTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS  376 (537)
Q Consensus       297 gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~  376 (537)
                      |+|.+++..            ...+++..++.|+.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus       454 g~L~~~l~~------------~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~  518 (635)
T 4fl3_A          454 GPLNKYLQQ------------NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKA  518 (635)
T ss_dssp             EEHHHHHHH------------CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHH
T ss_pred             CCHHHHHhh------------CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccc
Confidence            999999965            236999999999999999999999999   99999999999999999999999999987


Q ss_pred             cCCCCCc--eeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHHHHHhhchhh
Q 009340          377 IPNDKTH--LTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQLL  453 (537)
Q Consensus       377 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  453 (537)
                      .......  ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+       .....      
T Consensus       519 ~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-------~~~~i------  585 (635)
T 4fl3_A          519 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-------VTAML------  585 (635)
T ss_dssp             TTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHH------
T ss_pred             cccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHH------
Confidence            7544322  2233456889999999999999999999999999999998 999986543322       11111      


Q ss_pred             hhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHHh
Q 009340          454 EILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRS  503 (537)
Q Consensus       454 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~  503 (537)
                         ........+..++..+.+|+.+||+.||++|||+.+|+++|+.+...
T Consensus       586 ---~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~  632 (635)
T 4fl3_A          586 ---EKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  632 (635)
T ss_dssp             ---HTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             ---HcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence               11222233445567899999999999999999999999999987653

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.3e-42  Score=353.43  Aligned_cols=243  Identities=26%  Similarity=0.390  Sum_probs=198.0

Q ss_pred             hcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCC---ChHHHHHHHHHHHHHHhc-CCCCcceEeeEEeeCCccEE
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI---DKTQIHQFINEVVILSQI-NHRHIVKLLGCCLETEVPVL  289 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l  289 (537)
                      .++|+..+.||+|+||.||+++.. +|+.||||+++..   .....+.+.+|..++..+ +||||+++++++.+.+..++
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  101 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF  101 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence            478999999999999999999964 6899999998742   223456688999999998 79999999999999999999


Q ss_pred             EEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEe
Q 009340          290 VYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVS  369 (537)
Q Consensus       290 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~  369 (537)
                      ||||+++|+|.+++...            ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+
T Consensus       102 v~E~~~gg~L~~~l~~~------------~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~  166 (353)
T 3txo_A          102 VMEFVNGGDLMFHIQKS------------RRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLA  166 (353)
T ss_dssp             EEECCCSCBHHHHHHHH------------SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEEC
T ss_pred             EEeCCCCCcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEc
Confidence            99999999999999753            35999999999999999999999999   9999999999999999999999


Q ss_pred             eccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhh
Q 009340          370 DFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKE  449 (537)
Q Consensus       370 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  449 (537)
                      |||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.      +..... 
T Consensus       167 DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~------~~~i~~-  238 (353)
T 3txo_A          167 DFGMCKEGICNG-VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDL------FEAILN-  238 (353)
T ss_dssp             CCTTCBCSCC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHH-
T ss_pred             cccceeecccCC-ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHH------HHHHHc-
Confidence            999998643222 224456799999999999988899999999999999999999999975543221      111111 


Q ss_pred             chhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCH
Q 009340          450 NQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTM  490 (537)
Q Consensus       450 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~  490 (537)
                      ..          ...+...+..+.+|+.+||+.||++||++
T Consensus       239 ~~----------~~~p~~~~~~~~~li~~lL~~dP~~R~~~  269 (353)
T 3txo_A          239 DE----------VVYPTWLHEDATGILKSFMTKNPTMRLGS  269 (353)
T ss_dssp             CC----------CCCCTTSCHHHHHHHHHHTCSSGGGSTTS
T ss_pred             CC----------CCCCCCCCHHHHHHHHHHhhhCHHHccCC
Confidence            10          11233344678899999999999999998

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=3.1e-42  Score=342.31  Aligned_cols=258  Identities=27%  Similarity=0.467  Sum_probs=204.4

Q ss_pred             cCCccccccCcCCceEEEEEEcCC----CCEEEEEEccC-CChHHHHHHHHHHHHHHhcCCCCcceEeeEEee-CCccEE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLPD----GSIVAVKRSKE-IDKTQIHQFINEVVILSQINHRHIVKLLGCCLE-TEVPVL  289 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~l  289 (537)
                      .+|...+.||+|+||.||+|...+    +..||+|.+.. ......+.+.+|+.++++++||||+++++++.+ .+..++
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  104 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  104 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence            467788999999999999999642    23689999875 344556789999999999999999999999754 457899


Q ss_pred             EEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEe
Q 009340          290 VYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVS  369 (537)
Q Consensus       290 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~  369 (537)
                      ||||+++|+|.+++...           ...+++..++.++.|+++||.|||+.+   |+||||||+||+++.++.+||+
T Consensus       105 v~e~~~~~~L~~~l~~~-----------~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~  170 (298)
T 3f66_A          105 VLPYMKHGDLRNFIRNE-----------THNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVA  170 (298)
T ss_dssp             EEECCTTCBHHHHHHCT-----------TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEEC
T ss_pred             EEeCCCCCCHHHHHHhc-----------ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEEC
Confidence            99999999999999653           236899999999999999999999999   9999999999999999999999


Q ss_pred             eccCccccCCCCCc---eeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCC-CCCccchhhhccHHHHHHH
Q 009340          370 DFGISRSIPNDKTH---LTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKK-PICFARVEEERNLVACFIS  445 (537)
Q Consensus       370 Dfgla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~-p~~~~~~~~~~~~~~~~~~  445 (537)
                      |||+++........   ......+|+.|+|||.+.+..++.++||||||+++|||++|.. |+......+   .    ..
T Consensus       171 Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~---~----~~  243 (298)
T 3f66_A          171 DFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---I----TV  243 (298)
T ss_dssp             SCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT---H----HH
T ss_pred             cccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH---H----HH
Confidence            99999876433221   2234557889999999999999999999999999999999554 443322211   1    01


Q ss_pred             HHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHHh
Q 009340          446 LAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRS  503 (537)
Q Consensus       446 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~  503 (537)
                      .....         .....+...+..+.+++.+||+.||++|||+.+++++|+.+...
T Consensus       244 ~~~~~---------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~  292 (298)
T 3f66_A          244 YLLQG---------RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  292 (298)
T ss_dssp             HHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             HHhcC---------CCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence            11111         01111223345788999999999999999999999999998764

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1.5e-42  Score=342.99  Aligned_cols=261  Identities=21%  Similarity=0.324  Sum_probs=200.3

Q ss_pred             cCCccccccCcCCceEEEEEEcCCCCEEEEEEccCCCh--HHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEec
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDK--TQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY  293 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  293 (537)
                      ++|...+.||+|+||.||+|...+|+.||+|++.....  ...+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            47888999999999999999988899999999865332  2246788999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccC
Q 009340          294 ISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGI  373 (537)
Q Consensus       294 ~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgl  373 (537)
                      +++ +|.+++....           ..+++..+..++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        82 ~~~-~l~~~~~~~~-----------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~  146 (288)
T 1ob3_A           82 LDQ-DLKKLLDVCE-----------GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGL  146 (288)
T ss_dssp             CSE-EHHHHHHTST-----------TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTH
T ss_pred             cCC-CHHHHHHhcc-----------cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECcc
Confidence            985 8988886532           36899999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCCceeeeccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchh
Q 009340          374 SRSIPNDKTHLTTTIQGTFGYLDPEYFQS-SQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQL  452 (537)
Q Consensus       374 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  452 (537)
                      +........ ......+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+.   .............
T Consensus       147 ~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~  222 (288)
T 1ob3_A          147 ARAFGIPVR-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ---LMRIFRILGTPNS  222 (288)
T ss_dssp             HHHHCC----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCCT
T ss_pred             ccccCcccc-ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHHCCCCh
Confidence            987643221 2234568999999999876 4589999999999999999999999975433221   1111111111000


Q ss_pred             h--------hhhcHHhh-------ccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          453 L--------EILDARVA-------KEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       453 ~--------~~~d~~~~-------~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      .        ...++...       .......+..+.+|+.+||+.||++|||+.|+++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          223 KNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             TTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            0        00010000       0111224467889999999999999999999864

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=2.9e-42  Score=345.62  Aligned_cols=263  Identities=22%  Similarity=0.323  Sum_probs=207.9

Q ss_pred             hcCCccccccCcCCceEEEEEEc-CCCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEee----CCccEE
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLE----TEVPVL  289 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~l  289 (537)
                      .++|...+.||+|+||.||++.. .+|+.||||++........+.+.+|+.+++.++||||+++++++..    ....++
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  107 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL  107 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence            46899999999999999999995 5789999999877667777889999999999999999999999973    346799


Q ss_pred             EEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEe
Q 009340          290 VYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVS  369 (537)
Q Consensus       290 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~  369 (537)
                      ||||+++|+|.+++.....        ....+++..++.++.|+++||.|||+.+   |+||||||+|||++.++.+||+
T Consensus       108 v~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~  176 (317)
T 2buj_A          108 LLPFFKRGTLWNEIERLKD--------KGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLM  176 (317)
T ss_dssp             EEECCTTCBHHHHHHHHHT--------TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEEC
T ss_pred             EEEeCCCCcHHHHHHHHHh--------cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEE
Confidence            9999999999999976432        1346999999999999999999999999   9999999999999999999999


Q ss_pred             eccCccccCCCCCc--------eeeeccccccccCcccccCCC---CCcchhHHHHHHHHHHHHhCCCCCCccchhhhcc
Q 009340          370 DFGISRSIPNDKTH--------LTTTIQGTFGYLDPEYFQSSQ---FTDKSDVYSFGVVLLELLTGKKPICFARVEEERN  438 (537)
Q Consensus       370 Dfgla~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~  438 (537)
                      |||++.........        ......||+.|+|||.+....   ++.++||||||+++|||++|+.||........ .
T Consensus       177 dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~  255 (317)
T 2buj_A          177 DLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD-S  255 (317)
T ss_dssp             CCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS-C
T ss_pred             ecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc-h
Confidence            99998765321110        012234799999999987554   68999999999999999999999853211110 0


Q ss_pred             HHHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHH
Q 009340          439 LVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRR  502 (537)
Q Consensus       439 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~  502 (537)
                      ..             ..+......+.+...+..+.+++.+||+.||++|||+.++++.|+.+..
T Consensus       256 ~~-------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~  306 (317)
T 2buj_A          256 VA-------------LAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP  306 (317)
T ss_dssp             HH-------------HHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred             hh-------------HHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence            00             0000011111223345678999999999999999999999999998764

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=3.3e-42  Score=344.63  Aligned_cols=265  Identities=24%  Similarity=0.434  Sum_probs=202.2

Q ss_pred             HhcCCccccccCcCCceEEEEEEcC----CCCEEEEEEccCC--ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCc-
Q 009340          214 ATDNYNQSRFLGQGGFGTVYKGMLP----DGSIVAVKRSKEI--DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEV-  286 (537)
Q Consensus       214 ~~~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-  286 (537)
                      ..++|...+.||+|+||.||+|...    .+..||||.++..  .....+.+.+|+.++++++||||+++++++.+.+. 
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  111 (313)
T 3brb_A           32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ  111 (313)
T ss_dssp             CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred             CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence            3467888899999999999999854    3458999998743  45556789999999999999999999999987653 


Q ss_pred             ----cEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECC
Q 009340          287 ----PVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD  362 (537)
Q Consensus       287 ----~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~  362 (537)
                          .++||||+++|+|.+++......      .....+++..++.++.|+++||.|||+.+   |+||||||+|||++.
T Consensus       112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~  182 (313)
T 3brb_A          112 GIPKPMVILPFMKYGDLHTYLLYSRLE------TGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRD  182 (313)
T ss_dssp             ---CEEEEEECCTTCBHHHHHHHTTBT------TSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECT
T ss_pred             CCcccEEEEecccCCCHHHHHHHhhhh------cCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcC
Confidence                49999999999999998643210      11346999999999999999999999999   999999999999999


Q ss_pred             CCcEEEeeccCccccCCCCCc-eeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHH
Q 009340          363 KFSAKVSDFGISRSIPNDKTH-LTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLV  440 (537)
Q Consensus       363 ~~~~ki~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~  440 (537)
                      ++.+||+|||++......... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+.    
T Consensus       183 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~----  258 (313)
T 3brb_A          183 DMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM----  258 (313)
T ss_dssp             TSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH----
T ss_pred             CCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHH----
Confidence            999999999999876443322 2234457889999999999999999999999999999999 8888865433221    


Q ss_pred             HHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHHh
Q 009340          441 ACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRS  503 (537)
Q Consensus       441 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~  503 (537)
                         .......         .....+...+..+.+++.+||+.||++|||+.++++.|+.+..+
T Consensus       259 ---~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~  309 (313)
T 3brb_A          259 ---YDYLLHG---------HRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES  309 (313)
T ss_dssp             ---HHHHHTT---------CCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---HHHHHcC---------CCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence               1111111         11122334456789999999999999999999999999998874

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=2.2e-42  Score=351.28  Aligned_cols=246  Identities=26%  Similarity=0.409  Sum_probs=201.0

Q ss_pred             cCCccccccCcCCceEEEEEEc-CCCCEEEEEEccCC---ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEI---DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY  291 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  291 (537)
                      +.|...+.||+|+||.||+|+. .+|+.||||++...   .....+++.+|+.++++++||||+++++++.+.+..++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            4588889999999999999995 57899999998643   2334567899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeec
Q 009340          292 EYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF  371 (537)
Q Consensus       292 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Df  371 (537)
                      ||+. |+|.+++...           ...+++..+..++.|+++||.|||+.+   |+||||||+|||++.++.+||+||
T Consensus       134 e~~~-g~l~~~l~~~-----------~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Df  198 (348)
T 1u5q_A          134 EYCL-GSASDLLEVH-----------KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDF  198 (348)
T ss_dssp             ECCS-EEHHHHHHHH-----------TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCC
T ss_pred             ecCC-CCHHHHHHHh-----------cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeec
Confidence            9997 6888888643           236999999999999999999999999   999999999999999999999999


Q ss_pred             cCccccCCCCCceeeeccccccccCccccc---CCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHh
Q 009340          372 GISRSIPNDKTHLTTTIQGTFGYLDPEYFQ---SSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAK  448 (537)
Q Consensus       372 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  448 (537)
                      |++......     ....||+.|+|||.+.   ++.++.++||||||+++|||++|+.||.......      .......
T Consensus       199 G~a~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~------~~~~~~~  267 (348)
T 1u5q_A          199 GSASIMAPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHIAQ  267 (348)
T ss_dssp             TTCBSSSSB-----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHH
T ss_pred             cCceecCCC-----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHHh
Confidence            999865432     2356899999999984   5778999999999999999999999986543221      1111111


Q ss_pred             hchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHH
Q 009340          449 ENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSME  496 (537)
Q Consensus       449 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~  496 (537)
                      .. .     +.   ..+...+..+.+++.+||+.||++|||+.++++.
T Consensus       268 ~~-~-----~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h  306 (348)
T 1u5q_A          268 NE-S-----PA---LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  306 (348)
T ss_dssp             SC-C-----CC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             cC-C-----CC---CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence            11 0     00   0112234568899999999999999999999864

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=9.5e-42  Score=338.20  Aligned_cols=264  Identities=21%  Similarity=0.279  Sum_probs=209.1

Q ss_pred             hcCCccccccCcCCceEEEEEEc-CCCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEE-eeCCccEEEEe
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCC-LETEVPVLVYE  292 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~-~~~~~~~lV~e  292 (537)
                      .++|...+.||+|+||.||+|+. .+|+.||||.+.....  .+++.+|+.+++.++|++++..++++ .+.+..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence            46899999999999999999995 5789999998765332  24688999999999988877666665 55667899999


Q ss_pred             cCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEE---CCCCcEEEe
Q 009340          293 YISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILL---DDKFSAKVS  369 (537)
Q Consensus       293 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll---~~~~~~ki~  369 (537)
                      |+ +++|.+++....           ..+++..++.++.|+++||.|||+++   |+||||||+|||+   +.++.+||+
T Consensus        86 ~~-~~~L~~~~~~~~-----------~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~  150 (296)
T 3uzp_A           86 LL-GPSLEDLFNFCS-----------RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYII  150 (296)
T ss_dssp             CC-CCBHHHHHHHTT-----------TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEEC
T ss_pred             ec-CCCHHHHHHhhc-----------cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEe
Confidence            99 899999997432           36999999999999999999999999   9999999999999   488899999


Q ss_pred             eccCccccCCCCCc------eeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHH
Q 009340          370 DFGISRSIPNDKTH------LTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACF  443 (537)
Q Consensus       370 Dfgla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~  443 (537)
                      |||++.........      ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...............
T Consensus       151 Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~  230 (296)
T 3uzp_A          151 DFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI  230 (296)
T ss_dssp             CCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHH
T ss_pred             eCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhh
Confidence            99999876543321      124557899999999999999999999999999999999999999764333222222211


Q ss_pred             HHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHHhh
Q 009340          444 ISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRSQ  504 (537)
Q Consensus       444 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~  504 (537)
                      ........     .+.    .....+..+.+++.+||+.||++|||+.+|++.|+.+....
T Consensus       231 ~~~~~~~~-----~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~  282 (296)
T 3uzp_A          231 SEKKMSTP-----IEV----LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ  282 (296)
T ss_dssp             HHHHHHSC-----HHH----HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             cccccCCc-----hHH----HHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhc
Confidence            11110000     000    11223457889999999999999999999999999988754

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=3.7e-42  Score=355.08  Aligned_cols=250  Identities=23%  Similarity=0.361  Sum_probs=199.7

Q ss_pred             cCCccccccCcCCceEEEEEEcCCCCEEEEEEccC--CChHHHHHHHHHHHHHHhcC--CCCcceEeeEEeeCCccEEEE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKE--IDKTQIHQFINEVVILSQIN--HRHIVKLLGCCLETEVPVLVY  291 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~~~~~lV~  291 (537)
                      ++|...+.||+|+||.||++...+++.||||++..  ......+.+.+|+.++.+++  |+||+++++++...+..++||
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~  135 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM  135 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence            46889999999999999999988899999998864  34556778999999999996  599999999999999999999


Q ss_pred             ecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeec
Q 009340          292 EYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF  371 (537)
Q Consensus       292 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Df  371 (537)
                      | +.+++|.+++...            ..+++..+..++.||++||.|||+.+   |+||||||+|||++ ++.+||+||
T Consensus       136 E-~~~~~L~~~l~~~------------~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DF  198 (390)
T 2zmd_A          136 E-CGNIDLNSWLKKK------------KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDF  198 (390)
T ss_dssp             E-CCSEEHHHHHHHC------------SSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCC
T ss_pred             e-cCCCCHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEec
Confidence            9 5688999999753            36899999999999999999999999   99999999999996 578999999


Q ss_pred             cCccccCCCCCc-eeeeccccccccCcccccC-----------CCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccH
Q 009340          372 GISRSIPNDKTH-LTTTIQGTFGYLDPEYFQS-----------SQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNL  439 (537)
Q Consensus       372 gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~  439 (537)
                      |+++........ ......||+.|+|||++.+           ..++.++|||||||++|||++|+.||......     
T Consensus       199 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-----  273 (390)
T 2zmd_A          199 GIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----  273 (390)
T ss_dssp             SSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-----
T ss_pred             CccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH-----
Confidence            999876443322 2345679999999999865           46899999999999999999999998643211     


Q ss_pred             HHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHH
Q 009340          440 VACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSME  496 (537)
Q Consensus       440 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~  496 (537)
                      ...         +..++++......+...+..+.+|+.+||+.||++|||+.|+++.
T Consensus       274 ~~~---------~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  321 (390)
T 2zmd_A          274 ISK---------LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  321 (390)
T ss_dssp             HHH---------HHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHH---------HHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence            111         112222222222232334578899999999999999999999753

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=9e-42  Score=346.25  Aligned_cols=249  Identities=24%  Similarity=0.382  Sum_probs=201.8

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCC---ChHHHHHHHHHHHHHHhc-CCCCcceEeeEEeeCCccEEE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI---DKTQIHQFINEVVILSQI-NHRHIVKLLGCCLETEVPVLV  290 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV  290 (537)
                      ++|...+.||+|+||.||+++.. +++.||+|+++..   .....+.+.+|..++.++ +||||+++++++.+.+..++|
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   88 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   88 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence            57888999999999999999965 6889999998642   345566788999999998 899999999999999999999


Q ss_pred             EecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEee
Q 009340          291 YEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSD  370 (537)
Q Consensus       291 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~D  370 (537)
                      |||+++|+|.+++...            ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|
T Consensus        89 ~e~~~gg~L~~~l~~~------------~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~D  153 (345)
T 3a8x_A           89 IEYVNGGDLMFHMQRQ------------RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTD  153 (345)
T ss_dssp             ECCCCSCBHHHHHHHH------------SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECC
T ss_pred             EeCCCCCcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEe
Confidence            9999999999998653            35999999999999999999999999   99999999999999999999999


Q ss_pred             ccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhc--cHHHHHHHHHh
Q 009340          371 FGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEER--NLVACFISLAK  448 (537)
Q Consensus       371 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~--~~~~~~~~~~~  448 (537)
                      ||+++...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||......+..  ...........
T Consensus       154 FG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~  232 (345)
T 3a8x_A          154 YGMCKEGLRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL  232 (345)
T ss_dssp             GGGCBCSCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHH
T ss_pred             ccccccccCCC-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHH
Confidence            99998643222 2234567999999999999999999999999999999999999999643221110  00111111111


Q ss_pred             hchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCH
Q 009340          449 ENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTM  490 (537)
Q Consensus       449 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~  490 (537)
                      ..          ....+...+..+.+|+.+||+.||++||++
T Consensus       233 ~~----------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          233 EK----------QIRIPRSLSVKAASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             HC----------CCCCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred             cC----------CCCCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence            11          011233445678899999999999999996

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=5.3e-42  Score=344.09  Aligned_cols=267  Identities=23%  Similarity=0.365  Sum_probs=191.9

Q ss_pred             hcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCC-hHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEe
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEID-KTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE  292 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e  292 (537)
                      .++|...+.||+|+||.||+|... +|+.||+|+++... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            467888999999999999999964 68999999986532 2334678899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeecc
Q 009340          293 YISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG  372 (537)
Q Consensus       293 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfg  372 (537)
                      |++ |+|.+++......      .....+++..+..++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        84 ~~~-~~L~~~l~~~~~~------~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg  153 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVG------NTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFG  153 (317)
T ss_dssp             CCC-CBHHHHHHHHHSS------SCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCS
T ss_pred             ecC-CCHHHHHHhcccc------ccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCc
Confidence            998 5999998754321      01235899999999999999999999999   9999999999999999999999999


Q ss_pred             CccccCCCCCceeeeccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhc-
Q 009340          373 ISRSIPNDKTHLTTTIQGTFGYLDPEYFQS-SQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKEN-  450 (537)
Q Consensus       373 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-  450 (537)
                      +++....... ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||......+.   ........... 
T Consensus       154 ~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~i~~~~~~~~  229 (317)
T 2pmi_A          154 LARAFGIPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQ---LKLIFDIMGTPN  229 (317)
T ss_dssp             SCEETTSCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCSCC
T ss_pred             cceecCCCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCC
Confidence            9987643322 2234568999999999876 4689999999999999999999999976543321   11111111100 


Q ss_pred             -hhhhh------------------hcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          451 -QLLEI------------------LDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       451 -~~~~~------------------~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                       .....                  +...+........+..+.+|+.+||+.||++|||+.|+++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          230 ESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             TTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence             00000                  0000011111123457899999999999999999999864

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=7.9e-42  Score=346.06  Aligned_cols=275  Identities=23%  Similarity=0.325  Sum_probs=214.7

Q ss_pred             ccCHHHHHHHhcCCccccccCcCCceEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHHHHh--cCCCCcceEeeEEe
Q 009340          205 VFTADELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQ--INHRHIVKLLGCCL  282 (537)
Q Consensus       205 ~~~~~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~g~~~  282 (537)
                      ......-....++|...+.||+|+||.||+|+. +|+.||||.+...   ....+.+|++++..  ++||||+++++++.
T Consensus        31 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~  106 (342)
T 1b6c_B           31 GLPLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADN  106 (342)
T ss_dssp             SSCHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEE
T ss_pred             CCceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeec
Confidence            445555566678999999999999999999998 5899999998643   34567889999888  78999999999998


Q ss_pred             eCC----ccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh--------hcCCCCeee
Q 009340          283 ETE----VPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMH--------SSASIPIFH  350 (537)
Q Consensus       283 ~~~----~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH--------~~~~~~ivH  350 (537)
                      ...    ..++||||+++|+|.+++..             ..+++..++.++.|+++||.|||        +.+   |+|
T Consensus       107 ~~~~~~~~~~lv~e~~~~g~L~~~l~~-------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH  170 (342)
T 1b6c_B          107 KDNGTWTQLWLVSDYHEHGSLFDYLNR-------------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAH  170 (342)
T ss_dssp             CCCSSCCCEEEEECCCTTCBHHHHHHH-------------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EEC
T ss_pred             ccCCccceeEEEEeecCCCcHHHHHhc-------------cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eee
Confidence            776    78999999999999999964             25899999999999999999999        677   999


Q ss_pred             cCCCCCCEEECCCCcEEEeeccCccccCCCCCc---eeeeccccccccCcccccCCC------CCcchhHHHHHHHHHHH
Q 009340          351 RDIKSSNILLDDKFSAKVSDFGISRSIPNDKTH---LTTTIQGTFGYLDPEYFQSSQ------FTDKSDVYSFGVVLLEL  421 (537)
Q Consensus       351 ~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~t~ksDV~S~Gvll~el  421 (537)
                      |||||+|||++.++.+||+|||++.........   ......||+.|+|||.+.+..      ++.++||||||+++|||
T Consensus       171 ~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el  250 (342)
T 1b6c_B          171 RDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI  250 (342)
T ss_dssp             SCCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHH
T ss_pred             CCCCHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHH
Confidence            999999999999999999999999876443322   123456899999999997652      34689999999999999


Q ss_pred             HhC----------CCCCCccchhhhccHHHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHh
Q 009340          422 LTG----------KKPICFARVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMK  491 (537)
Q Consensus       422 ~tg----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~  491 (537)
                      ++|          +.||........ . ................+....   ....+...+.+|+.+||+.||++|||+.
T Consensus       251 ~tg~~~~~~~~~~~~p~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~Rps~~  325 (342)
T 1b6c_B          251 ARRCSIGGIHEDYQLPYYDLVPSDP-S-VEEMRKVVCEQKLRPNIPNRW---QSCEALRVMAKIMRECWYANGAARLTAL  325 (342)
T ss_dssp             HTTBCBTTBCCCCCCTTTTTSCSSC-C-HHHHHHHHTTSCCCCCCCGGG---GTSHHHHHHHHHHHHHCCSSGGGSCCHH
T ss_pred             HhccCcCCcccccccCccccCcCcc-c-HHHHHHHHHHHHhCCCCcccc---cchhHHHHHHHHHHHHhccChhhCCCHH
Confidence            999          667754322111 1 111111111111111111110   1235677899999999999999999999


Q ss_pred             hHHHHHHHHHHhh
Q 009340          492 QVSMELEGLRRSQ  504 (537)
Q Consensus       492 ev~~~L~~i~~~~  504 (537)
                      +|++.|+.+.+..
T Consensus       326 ~i~~~L~~i~~~~  338 (342)
T 1b6c_B          326 RIKKTLSQLSQQE  338 (342)
T ss_dssp             HHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHh
Confidence            9999999998754

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=3.9e-42  Score=340.74  Aligned_cols=262  Identities=20%  Similarity=0.305  Sum_probs=201.8

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCC--ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEe
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI--DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE  292 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e  292 (537)
                      ++|...++||+|+||+||+|... +|+.||||+++..  .....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            57888999999999999999964 6899999998642  33445778899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeecc
Q 009340          293 YISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG  372 (537)
Q Consensus       293 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfg  372 (537)
                      |+++ +|.+++...           ...+++..+..++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        82 ~~~~-~l~~~~~~~-----------~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg  146 (292)
T 3o0g_A           82 FCDQ-DLKKYFDSC-----------NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFG  146 (292)
T ss_dssp             CCSE-EHHHHHHHT-----------TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred             cCCC-CHHHHHHhC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecc
Confidence            9986 666665432           236999999999999999999999999   9999999999999999999999999


Q ss_pred             CccccCCCCCceeeeccccccccCcccccCCC-CCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhch
Q 009340          373 ISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQ-FTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQ  451 (537)
Q Consensus       373 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  451 (537)
                      +++....... ......||+.|+|||.+.+.. ++.++||||||+++|||++|+.|+.......  ..............
T Consensus       147 ~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~--~~~~~i~~~~~~~~  223 (292)
T 3o0g_A          147 LARAFGIPVR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPT  223 (292)
T ss_dssp             TCEECCSCCS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH--HHHHHHHHHHCCCC
T ss_pred             cceecCCccc-cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHH--HHHHHHHHHhCCCC
Confidence            9987643322 234456899999999997765 8999999999999999999988865432211  11111111111110


Q ss_pred             hhhh---h---c---------HHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          452 LLEI---L---D---------ARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       452 ~~~~---~---d---------~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      ....   .   +         ...........+..+.+|+.+||+.||++|||+.|+++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          224 EEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             TTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence            0000   0   0         00000111234567889999999999999999999875

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=6.5e-42  Score=342.08  Aligned_cols=264  Identities=24%  Similarity=0.313  Sum_probs=199.6

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCC--ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEe
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI--DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE  292 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e  292 (537)
                      ++|...+.||+|+||.||++... +|+.||||++...  .....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            57889999999999999999965 5899999988543  33445678899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeecc
Q 009340          293 YISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG  372 (537)
Q Consensus       293 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfg  372 (537)
                      |+++++|.+++..            ...+++..+..++.|+++||.|||+.+   |+||||||+||+++.++.+||+|||
T Consensus        83 ~~~~~~l~~~~~~------------~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg  147 (311)
T 4agu_A           83 YCDHTVLHELDRY------------QRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFG  147 (311)
T ss_dssp             CCSEEHHHHHHHT------------SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred             eCCCchHHHHHhh------------hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCC
Confidence            9999999888764            235999999999999999999999999   9999999999999999999999999


Q ss_pred             CccccCCCCCceeeeccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHH--------
Q 009340          373 ISRSIPNDKTHLTTTIQGTFGYLDPEYFQS-SQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACF--------  443 (537)
Q Consensus       373 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~--------  443 (537)
                      ++........ ......||..|+|||.+.+ ..++.++||||||+++|||++|+.||......+........        
T Consensus       148 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  226 (311)
T 4agu_A          148 FARLLTGPSD-YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRH  226 (311)
T ss_dssp             TCEECC-------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred             CchhccCccc-ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccc
Confidence            9987643322 2334568999999999876 67899999999999999999999999765443321111100        


Q ss_pred             HHHHhhchhhh---hhcHHhh---ccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          444 ISLAKENQLLE---ILDARVA---KEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       444 ~~~~~~~~~~~---~~d~~~~---~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      ...........   ..++...   .......+..+.+|+.+||+.||++|||+.|+++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          227 QQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             HHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             ccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            00000000000   0000000   0001123456889999999999999999999974

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=8.9e-42  Score=352.33  Aligned_cols=266  Identities=19%  Similarity=0.254  Sum_probs=204.1

Q ss_pred             hcCCccccccCcC--CceEEEEEEcC-CCCEEEEEEccC--CChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEE
Q 009340          215 TDNYNQSRFLGQG--GFGTVYKGMLP-DGSIVAVKRSKE--IDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVL  289 (537)
Q Consensus       215 ~~~~~~~~~lg~G--~~g~Vy~~~~~-~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  289 (537)
                      .++|...++||+|  +||.||+++.. +|+.||||+++.  ......+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  103 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV  103 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence            3688999999999  99999999965 699999999864  334556778899999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEe
Q 009340          290 VYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVS  369 (537)
Q Consensus       290 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~  369 (537)
                      ||||+++|+|.+++.....          ..+++..+..++.|+++||.|||+.+   |+||||||+|||++.++.+||+
T Consensus       104 v~e~~~~~~L~~~l~~~~~----------~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~  170 (389)
T 3gni_B          104 VTSFMAYGSAKDLICTHFM----------DGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLS  170 (389)
T ss_dssp             EEECCTTCBHHHHHHHTCT----------TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEEC
T ss_pred             EEEccCCCCHHHHHhhhcc----------cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEc
Confidence            9999999999999976422          36999999999999999999999999   9999999999999999999999


Q ss_pred             eccCccccCCCCC------ceeeeccccccccCcccccC--CCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHH
Q 009340          370 DFGISRSIPNDKT------HLTTTIQGTFGYLDPEYFQS--SQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVA  441 (537)
Q Consensus       370 Dfgla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~--~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~  441 (537)
                      |||++........      .......||+.|+|||.+.+  ..++.++|||||||++|||++|+.||.........  ..
T Consensus       171 dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~  248 (389)
T 3gni_B          171 GLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML--LE  248 (389)
T ss_dssp             CGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHH--HH
T ss_pred             ccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHH--HH
Confidence            9999865422111      11123468999999999987  57899999999999999999999999654322110  00


Q ss_pred             HHHHHH----h-----hc-------------hhhhhhc---------HHhhccccHHHHHHHHHHHHHhcccCCCCCCCH
Q 009340          442 CFISLA----K-----EN-------------QLLEILD---------ARVAKEAREEDIGAMAELAMRCLRLNSKKRPTM  490 (537)
Q Consensus       442 ~~~~~~----~-----~~-------------~~~~~~d---------~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~  490 (537)
                      ......    .     ..             ...+.+.         .....+.+...+..+.+|+.+||+.||++|||+
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta  328 (389)
T 3gni_B          249 KLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSA  328 (389)
T ss_dssp             C--------------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCH
T ss_pred             HhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCH
Confidence            000000    0     00             0000000         000011223345678999999999999999999


Q ss_pred             hhHHH
Q 009340          491 KQVSM  495 (537)
Q Consensus       491 ~ev~~  495 (537)
                      .|+++
T Consensus       329 ~ell~  333 (389)
T 3gni_B          329 STLLN  333 (389)
T ss_dssp             HHHTT
T ss_pred             HHHhc
Confidence            99985

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=3.2e-42  Score=353.68  Aligned_cols=248  Identities=25%  Similarity=0.428  Sum_probs=203.0

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCC---ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI---DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY  291 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  291 (537)
                      ++|...+.||+|+||.||++... +++.||+|.+...   .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   94 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV   94 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            67888999999999999999964 6889999988642   1223567889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeec
Q 009340          292 EYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF  371 (537)
Q Consensus       292 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Df  371 (537)
                      ||+++|+|.+++...            ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+||
T Consensus        95 e~~~gg~L~~~l~~~------------~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DF  159 (384)
T 4fr4_A           95 DLLLGGDLRYHLQQN------------VHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDF  159 (384)
T ss_dssp             CCCTTEEHHHHHHTT------------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred             ecCCCCcHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEecc
Confidence            999999999999752            36999999999999999999999999   999999999999999999999999


Q ss_pred             cCccccCCCCCceeeeccccccccCcccccC---CCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHh
Q 009340          372 GISRSIPNDKTHLTTTIQGTFGYLDPEYFQS---SQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAK  448 (537)
Q Consensus       372 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  448 (537)
                      |+++......  ......||+.|+|||++.+   ..++.++|||||||++|||++|+.||...........    .....
T Consensus       160 G~a~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~----~~~~~  233 (384)
T 4fr4_A          160 NIAAMLPRET--QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEI----VHTFE  233 (384)
T ss_dssp             TTCEECCTTC--CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHH----HHHHH
T ss_pred             ceeeeccCCC--ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHH----HHHHh
Confidence            9998764332  2345679999999999864   4589999999999999999999999975433221111    11111


Q ss_pred             hchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCC-HhhHH
Q 009340          449 ENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPT-MKQVS  494 (537)
Q Consensus       449 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-~~ev~  494 (537)
                      .          .....+...+..+.+|+.+||+.||++||+ +.+|.
T Consensus       234 ~----------~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~  270 (384)
T 4fr4_A          234 T----------TVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQ  270 (384)
T ss_dssp             H----------CCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHH
T ss_pred             h----------cccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHH
Confidence            0          011223344567899999999999999998 55554

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=3.4e-42  Score=346.93  Aligned_cols=269  Identities=26%  Similarity=0.444  Sum_probs=211.4

Q ss_pred             hcCCccccccCcCCceEEEEEEc------CCCCEEEEEEccCC-ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCcc
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGML------PDGSIVAVKRSKEI-DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVP  287 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~  287 (537)
                      .++|...+.||+|+||.||+|++      .++..||||.+... ......++.+|+.++++++||||+++++++.+....
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  108 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence            46899999999999999999984      24678999998753 455567899999999999999999999999999999


Q ss_pred             EEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECC---CC
Q 009340          288 VLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD---KF  364 (537)
Q Consensus       288 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~---~~  364 (537)
                      ++||||+++|+|.+++.......     .....+++..++.++.|+++||.|||+.+   |+||||||+|||++.   +.
T Consensus       109 ~lv~e~~~~~~L~~~l~~~~~~~-----~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~  180 (327)
T 2yfx_A          109 FILMELMAGGDLKSFLRETRPRP-----SQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGR  180 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHTSCCS-----SSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTC
T ss_pred             EEEEecCCCCcHHHHHHhhcccc-----cccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcc
Confidence            99999999999999998653210     01135899999999999999999999999   999999999999984   45


Q ss_pred             cEEEeeccCccccCCCCC-ceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHH
Q 009340          365 SAKVSDFGISRSIPNDKT-HLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVAC  442 (537)
Q Consensus       365 ~~ki~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~  442 (537)
                      .+||+|||++........ .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+       
T Consensus       181 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-------  253 (327)
T 2yfx_A          181 VAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE-------  253 (327)
T ss_dssp             CEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-------
T ss_pred             eEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHH-------
Confidence            699999999976533222 22234567899999999998999999999999999999998 889986543221       


Q ss_pred             HHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHHhhHHH
Q 009340          443 FISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRSQRCL  507 (537)
Q Consensus       443 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~~~~  507 (537)
                      ........         .....+...+..+.+++.+||+.||++|||+.++++.|+.+.......
T Consensus       254 ~~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~~  309 (327)
T 2yfx_A          254 VLEFVTSG---------GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVI  309 (327)
T ss_dssp             HHHHHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHHH
T ss_pred             HHHHHhcC---------CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHHHh
Confidence            11111111         111123334567889999999999999999999999999888755433

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=2.7e-42  Score=349.75  Aligned_cols=249  Identities=25%  Similarity=0.376  Sum_probs=204.5

Q ss_pred             HHhcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCC---hHHHHHHHHHHHHHHhc-CCCCcceEeeEEeeCCcc
Q 009340          213 RATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEID---KTQIHQFINEVVILSQI-NHRHIVKLLGCCLETEVP  287 (537)
Q Consensus       213 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~  287 (537)
                      ...++|...+.||+|+||.||+++.+ +|+.||||+++...   ....+.+..|..++..+ +||||+++++++.+.+..
T Consensus        14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~   93 (345)
T 1xjd_A           14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL   93 (345)
T ss_dssp             --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence            34578999999999999999999965 68899999986421   22345678899999987 899999999999999999


Q ss_pred             EEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEE
Q 009340          288 VLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK  367 (537)
Q Consensus       288 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~k  367 (537)
                      ++||||+++|+|.+++...            ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+|
T Consensus        94 ~lv~E~~~gg~L~~~l~~~------------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vk  158 (345)
T 1xjd_A           94 FFVMEYLNGGDLMYHIQSC------------HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIK  158 (345)
T ss_dssp             EEEEECCTTCBHHHHHHHH------------SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEE
T ss_pred             EEEEeCCCCCcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEE
Confidence            9999999999999999753            35999999999999999999999999   99999999999999999999


Q ss_pred             EeeccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHH
Q 009340          368 VSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLA  447 (537)
Q Consensus       368 i~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~  447 (537)
                      |+|||+++...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||......+.      +....
T Consensus       159 L~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~------~~~i~  231 (345)
T 1xjd_A          159 IADFGMCKENMLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL------FHSIR  231 (345)
T ss_dssp             ECCCTTCBCCCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHH
T ss_pred             EeEChhhhhcccCC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHH------HHHHH
Confidence            99999998653222 224456799999999999999999999999999999999999999975433221      11111


Q ss_pred             hhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHh-hHH
Q 009340          448 KENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMK-QVS  494 (537)
Q Consensus       448 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~-ev~  494 (537)
                      . ..          ...+...+..+.+|+.+||+.||++||++. +|+
T Consensus       232 ~-~~----------~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          232 M-DN----------PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             H-CC----------CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             h-CC----------CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence            1 10          112233456788999999999999999998 664

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=2.7e-42  Score=350.39  Aligned_cols=263  Identities=19%  Similarity=0.257  Sum_probs=198.9

Q ss_pred             cCCccccccCcCCceEEEEEEcC----CCCEEEEEEccCCChHH-----------HHHHHHHHHHHHhcCCCCcceEeeE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP----DGSIVAVKRSKEIDKTQ-----------IHQFINEVVILSQINHRHIVKLLGC  280 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~H~niv~l~g~  280 (537)
                      ++|...+.||+|+||.||+|...    ++..||||.........           ...+.+|+..++.++|+||++++++
T Consensus        37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~  116 (345)
T 2v62_A           37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS  116 (345)
T ss_dssp             CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred             ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence            57889999999999999999975    57889999887543211           1246678899999999999999999


Q ss_pred             Eee----CCccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCC
Q 009340          281 CLE----TEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSS  356 (537)
Q Consensus       281 ~~~----~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~  356 (537)
                      +.+    ....++||||+ +++|.+++....            .+++..++.++.|+++||.|||+.+   |+||||||+
T Consensus       117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~------------~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~  180 (345)
T 2v62_A          117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNG------------TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAA  180 (345)
T ss_dssp             EEEESSSCEEEEEEEECE-EEEHHHHCBGGG------------BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGG
T ss_pred             cccccCCCcEEEEEEecc-CCCHHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHH
Confidence            988    67889999999 999999997632            5999999999999999999999998   999999999


Q ss_pred             CEEECCCC--cEEEeeccCccccCCCCCc------eeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 009340          357 NILLDDKF--SAKVSDFGISRSIPNDKTH------LTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI  428 (537)
Q Consensus       357 NIll~~~~--~~ki~Dfgla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~  428 (537)
                      |||++.++  .+||+|||+++........      ......||+.|+|||.+.+..++.++||||||+++|||++|+.||
T Consensus       181 NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf  260 (345)
T 2v62_A          181 NLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPW  260 (345)
T ss_dssp             GEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred             HEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence            99999887  9999999999876432211      113457899999999999999999999999999999999999999


Q ss_pred             CccchhhhccHHHHHHHHHhhchhhhhhcHHhhccc-cHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHH
Q 009340          429 CFARVEEERNLVACFISLAKENQLLEILDARVAKEA-REEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLR  501 (537)
Q Consensus       429 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~-~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~  501 (537)
                      ........  .........     ...+...+.... ....+..+.+++.+||+.||++|||+.+|++.|+.+.
T Consensus       261 ~~~~~~~~--~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~  327 (345)
T 2v62_A          261 EQNLKDPV--AVQTAKTNL-----LDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG  327 (345)
T ss_dssp             GGGTTCHH--HHHHHHHHH-----HHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred             cccccccH--HHHHHHHhh-----cccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence            54222111  000011100     011111111000 1134457899999999999999999999999998754

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=4.3e-42  Score=345.93  Aligned_cols=250  Identities=24%  Similarity=0.338  Sum_probs=180.2

Q ss_pred             ccccCcCCceEEEEEEcC-CCCEEEEEEccCCChHHHHHHHHHHHHHHhcC-CCCcceEeeEEeeCCccEEEEecCCCCC
Q 009340          221 SRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKTQIHQFINEVVILSQIN-HRHIVKLLGCCLETEVPVLVYEYISSGT  298 (537)
Q Consensus       221 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~~gs  298 (537)
                      .+.||+|+||.||++... +|+.||||++...   ....+.+|+.++..+. ||||+++++++.+....++||||+++|+
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~   92 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE   92 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence            478999999999999964 6899999998653   3456778999999997 9999999999999999999999999999


Q ss_pred             hhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCC---cEEEeeccCcc
Q 009340          299 LSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF---SAKVSDFGISR  375 (537)
Q Consensus       299 L~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~---~~ki~Dfgla~  375 (537)
                      |.+++...            ..+++..+..++.|+++||.|||+.+   |+||||||+|||++.++   .+||+|||+++
T Consensus        93 L~~~l~~~------------~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~  157 (325)
T 3kn6_A           93 LFERIKKK------------KHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFAR  157 (325)
T ss_dssp             HHHHHHHC------------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCE
T ss_pred             HHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccce
Confidence            99999753            46999999999999999999999999   99999999999997665   89999999998


Q ss_pred             ccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchhhhh
Q 009340          376 SIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEI  455 (537)
Q Consensus       376 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  455 (537)
                      ....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.....................+..   
T Consensus       158 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~---  233 (325)
T 3kn6_A          158 LKPPDNQ-PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDF---  233 (325)
T ss_dssp             ECCC-----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCC---
T ss_pred             ecCCCCC-cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCC---
Confidence            7644322 234456899999999999999999999999999999999999999754322111111111111111110   


Q ss_pred             hcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          456 LDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       456 ~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                         ....+.....+..+.+|+.+||+.||++|||+.++++
T Consensus       234 ---~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  270 (325)
T 3kn6_A          234 ---SFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY  270 (325)
T ss_dssp             ---CCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred             ---CCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence               0001111234567889999999999999999999863

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=8.1e-42  Score=342.65  Aligned_cols=244  Identities=25%  Similarity=0.387  Sum_probs=203.7

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCC---hHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEID---KTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY  291 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  291 (537)
                      ++|...+.||+|+||.||+++.. +|+.||+|.++...   ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~   85 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   85 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence            57888999999999999999964 68999999986421   123566789999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeec
Q 009340          292 EYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF  371 (537)
Q Consensus       292 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Df  371 (537)
                      ||+++|+|.+++...            ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+||
T Consensus        86 e~~~gg~L~~~l~~~------------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Df  150 (318)
T 1fot_A           86 DYIEGGELFSLLRKS------------QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDF  150 (318)
T ss_dssp             CCCCSCBHHHHHHHT------------SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCC
T ss_pred             eCCCCCCHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeec
Confidence            999999999999753            35899999999999999999999999   999999999999999999999999


Q ss_pred             cCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhch
Q 009340          372 GISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQ  451 (537)
Q Consensus       372 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  451 (537)
                      |+++.....    .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......+      .+......  
T Consensus       151 g~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~~~~i~~~--  218 (318)
T 1fot_A          151 GFAKYVPDV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK------TYEKILNA--  218 (318)
T ss_dssp             SSCEECSSC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHHC--
T ss_pred             CcceecCCc----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH------HHHHHHhC--
Confidence            999875432    234579999999999999999999999999999999999999996543221      11111111  


Q ss_pred             hhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCC-----CHhhHHH
Q 009340          452 LLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRP-----TMKQVSM  495 (537)
Q Consensus       452 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~  495 (537)
                             .  ...+...+..+.+++.+||+.||++||     ++.++++
T Consensus       219 -------~--~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          219 -------E--LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             -------C--CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             -------C--CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence                   0  012233446788999999999999999     7777763

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=4.6e-42  Score=338.20  Aligned_cols=251  Identities=27%  Similarity=0.426  Sum_probs=206.4

Q ss_pred             HhcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEee---------
Q 009340          214 ATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLE---------  283 (537)
Q Consensus       214 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~---------  283 (537)
                      ...+|...+.||+|+||.||++... +|+.||+|+++...    +.+.+|+.++++++||||+++++++..         
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   84 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS   84 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence            3467889999999999999999975 78999999987643    356789999999999999999999864         


Q ss_pred             -------CCccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCC
Q 009340          284 -------TEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSS  356 (537)
Q Consensus       284 -------~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~  356 (537)
                             ....++||||+++|+|.+++....          ...+++..++.++.|+++||.|||+.+   |+||||||+
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~  151 (284)
T 2a19_B           85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR----------GEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPS  151 (284)
T ss_dssp             ----CCEEEEEEEEECCCCSCBHHHHHHHGG----------GSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGG
T ss_pred             ccccccCcceEEEEEeccCCCCHHHHHhhcc----------CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHH
Confidence                   345799999999999999997543          246999999999999999999999999   999999999


Q ss_pred             CEEECCCCcEEEeeccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhh
Q 009340          357 NILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEE  436 (537)
Q Consensus       357 NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~  436 (537)
                      |||++.++.+||+|||++........  .....||+.|+|||.+.+..++.++||||||+++|||++|..|+....    
T Consensus       152 Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~----  225 (284)
T 2a19_B          152 NIFLVDTKQVKIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS----  225 (284)
T ss_dssp             GEEEEETTEEEECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH----
T ss_pred             HEEEcCCCCEEECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH----
Confidence            99999999999999999987654322  234568999999999999999999999999999999999998853110    


Q ss_pred             ccHHHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHHhh
Q 009340          437 RNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRSQ  504 (537)
Q Consensus       437 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~  504 (537)
                           ..........            .+...+..+.+++.+||+.||++|||+.++++.|+.+..+.
T Consensus       226 -----~~~~~~~~~~------------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~  276 (284)
T 2a19_B          226 -----KFFTDLRDGI------------ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP  276 (284)
T ss_dssp             -----HHHHHHHTTC------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC--
T ss_pred             -----HHHHHhhccc------------ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCC
Confidence                 0111111111            11223346789999999999999999999999999887654

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=4.3e-42  Score=349.40  Aligned_cols=251  Identities=25%  Similarity=0.348  Sum_probs=190.2

Q ss_pred             HhcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEe
Q 009340          214 ATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE  292 (537)
Q Consensus       214 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e  292 (537)
                      ..++|...+.||+|+||.||+|+.. +++.||||.++...  ..+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  128 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE  128 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence            4578999999999999999999975 57899999987642  34568899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECC---CCcEEEe
Q 009340          293 YISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD---KFSAKVS  369 (537)
Q Consensus       293 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~---~~~~ki~  369 (537)
                      |+++|+|.+++...            ..+++..++.++.|+++||.|||+.+   |+||||||+|||++.   ++.+||+
T Consensus       129 ~~~~~~L~~~l~~~------------~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~  193 (349)
T 2w4o_A          129 LVTGGELFDRIVEK------------GYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIA  193 (349)
T ss_dssp             CCCSCBHHHHHTTC------------SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEEC
T ss_pred             eCCCCCHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEc
Confidence            99999999998753            35899999999999999999999999   999999999999975   8899999


Q ss_pred             eccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhh
Q 009340          370 DFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKE  449 (537)
Q Consensus       370 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  449 (537)
                      |||+++......  ......||+.|+|||.+.+..++.++|||||||++|||++|+.||........     .+......
T Consensus       194 Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-----~~~~i~~~  266 (349)
T 2w4o_A          194 DFGLSKIVEHQV--LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF-----MFRRILNC  266 (349)
T ss_dssp             CCC------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH-----HHHHHHTT
T ss_pred             cCccccccCccc--ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH-----HHHHHHhC
Confidence            999998764322  23445689999999999999999999999999999999999999865432210     01111111


Q ss_pred             chhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          450 NQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       450 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      . .      ....+.....+..+.+|+.+||+.||++|||+.++++
T Consensus       267 ~-~------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          267 E-Y------YFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             C-C------CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             C-C------ccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0 0      0001111234467889999999999999999999875

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.7e-42  Score=349.97  Aligned_cols=245  Identities=25%  Similarity=0.349  Sum_probs=202.0

Q ss_pred             cCCccccccCcCCceEEEEEEc-CCCCEEEEEEccCCC---hHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEID---KTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY  291 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  291 (537)
                      ++|...+.||+|+||.||+|.. .+|+.||||.+....   ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   88 (336)
T 3h4j_B            9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI   88 (336)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            6888999999999999999995 578999999886421   112356889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeec
Q 009340          292 EYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF  371 (537)
Q Consensus       292 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Df  371 (537)
                      ||+ +|+|.+++...            ..+++..+..++.|+++||.|||+.+   |+||||||+|||+++++.+||+||
T Consensus        89 E~~-~g~l~~~l~~~------------~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DF  152 (336)
T 3h4j_B           89 EYA-GGELFDYIVEK------------KRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADF  152 (336)
T ss_dssp             CCC-CEEHHHHHHHH------------CSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCS
T ss_pred             ECC-CCcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEe
Confidence            999 78999988653            35999999999999999999999999   999999999999999999999999


Q ss_pred             cCccccCCCCCceeeeccccccccCcccccCCCC-CcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhc
Q 009340          372 GISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQF-TDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKEN  450 (537)
Q Consensus       372 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  450 (537)
                      |++........  .....||+.|+|||.+.+..+ +.++||||||+++|||++|+.||.........             
T Consensus       153 G~s~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~-------------  217 (336)
T 3h4j_B          153 GLSNIMTDGNF--LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF-------------  217 (336)
T ss_dssp             SCTBTTTTSBT--TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB-------------
T ss_pred             ccceeccCCcc--cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH-------------
Confidence            99987644322  344579999999999988776 68999999999999999999999654322110             


Q ss_pred             hhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          451 QLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       451 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                         ..+... ....+...+..+.+|+.+||+.||.+|||+.|+++
T Consensus       218 ---~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~  258 (336)
T 3h4j_B          218 ---KKVNSC-VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR  258 (336)
T ss_dssp             ---CCCCSS-CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred             ---HHHHcC-CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence               000000 01123334567889999999999999999999975

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=3.9e-42  Score=351.07  Aligned_cols=273  Identities=23%  Similarity=0.277  Sum_probs=210.7

Q ss_pred             cccCHHHHHHHhcCCccccccCcCCceEEEEEEc-CCCCEEEEEEccCCChHHHHHHHHHHHHHHhcC-----CCCcceE
Q 009340          204 KVFTADELQRATDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEIDKTQIHQFINEVVILSQIN-----HRHIVKL  277 (537)
Q Consensus       204 ~~~~~~el~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----H~niv~l  277 (537)
                      ..++..+.....++|...++||+|+||.||+|+. .+++.||||+++.. ....+.+..|+.+++.++     |+||+++
T Consensus        23 ~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~  101 (360)
T 3llt_A           23 VHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKY  101 (360)
T ss_dssp             GSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCE
T ss_pred             eeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecc
Confidence            4455555566678999999999999999999996 46889999998753 345567788999999996     9999999


Q ss_pred             eeEEeeCCccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCC
Q 009340          278 LGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSN  357 (537)
Q Consensus       278 ~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~N  357 (537)
                      ++++...+..++||||+ +++|.+++.....          ..+++..+..++.|++.||+|||+.+   |+||||||+|
T Consensus       102 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~----------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~N  167 (360)
T 3llt_A          102 HGKFMYYDHMCLIFEPL-GPSLYEIITRNNY----------NGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPEN  167 (360)
T ss_dssp             EEEEEETTEEEEEECCC-CCBHHHHHHHTTT----------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred             cceeeECCeeEEEEcCC-CCCHHHHHHhcCC----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCccc
Confidence            99999999999999999 8899999976432          35999999999999999999999999   9999999999


Q ss_pred             EEECC-------------------------CCcEEEeeccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHH
Q 009340          358 ILLDD-------------------------KFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVY  412 (537)
Q Consensus       358 Ill~~-------------------------~~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~  412 (537)
                      ||++.                         ++.+||+|||++......    .....||+.|+|||.+.+..++.++|||
T Consensus       168 Ill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Diw  243 (360)
T 3llt_A          168 ILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMW  243 (360)
T ss_dssp             EEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHH
T ss_pred             EEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchH
Confidence            99975                         789999999999865432    2345689999999999999999999999


Q ss_pred             HHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhch--------hhhhhcHH-hh--------------------cc
Q 009340          413 SFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQ--------LLEILDAR-VA--------------------KE  463 (537)
Q Consensus       413 S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~d~~-~~--------------------~~  463 (537)
                      ||||++|||++|+.||......+................        ....++.. ..                    ..
T Consensus       244 slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~  323 (360)
T 3llt_A          244 SFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPL  323 (360)
T ss_dssp             HHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCH
T ss_pred             HHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccc
Confidence            999999999999999976543322111111000000000        00000000 00                    00


Q ss_pred             ccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          464 AREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       464 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      ........+.+|+.+||+.||++|||+.|+++
T Consensus       324 ~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~  355 (360)
T 3llt_A          324 YKIIKHELFCDFLYSILQIDPTLRPSPAELLK  355 (360)
T ss_dssp             HHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             cccchHHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence            00111256889999999999999999999874

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=9.6e-42  Score=343.72  Aligned_cols=248  Identities=25%  Similarity=0.365  Sum_probs=194.0

Q ss_pred             hcCCccccccCcCCceEEEEEEc----CCCCEEEEEEccCCC----hHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCc
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGML----PDGSIVAVKRSKEID----KTQIHQFINEVVILSQINHRHIVKLLGCCLETEV  286 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~----~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~  286 (537)
                      .++|...+.||+|+||.||+++.    .+|+.||+|.++...    ......+.+|+.++++++||||+++++++.+.+.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            36889999999999999999986    478999999987532    2334567899999999999999999999999999


Q ss_pred             cEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcE
Q 009340          287 PVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA  366 (537)
Q Consensus       287 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~  366 (537)
                      .++||||+++|+|.+++...            ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~------------~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~  160 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLERE------------GIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHV  160 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHHH------------SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCE
T ss_pred             EEEEEeCCCCCcHHHHHHhC------------CCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcE
Confidence            99999999999999999653            35899999999999999999999999   9999999999999999999


Q ss_pred             EEeeccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHH
Q 009340          367 KVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISL  446 (537)
Q Consensus       367 ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~  446 (537)
                      ||+|||+++....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+.      ....
T Consensus       161 kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~------~~~i  233 (327)
T 3a62_A          161 KLTDFGLCKESIHDGT-VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKT------IDKI  233 (327)
T ss_dssp             EECCCSCC-----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHHH
T ss_pred             EEEeCCcccccccCCc-cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHH------HHHH
Confidence            9999999976432221 23445789999999999999999999999999999999999999975432211      1111


Q ss_pred             HhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCC-----CHhhHHH
Q 009340          447 AKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRP-----TMKQVSM  495 (537)
Q Consensus       447 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~  495 (537)
                      ...           ....+...+..+.+++.+||+.||++||     ++.++++
T Consensus       234 ~~~-----------~~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          234 LKC-----------KLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             HHT-----------CCCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             HhC-----------CCCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence            110           0112233456788999999999999999     5556543

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=8.3e-42  Score=347.12  Aligned_cols=244  Identities=24%  Similarity=0.356  Sum_probs=204.0

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCC---hHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEID---KTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY  291 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  291 (537)
                      ++|...+.||+|+||.||+++.. +|+.||||.++...   ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  120 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            67889999999999999999965 68999999986421   223567889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeec
Q 009340          292 EYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF  371 (537)
Q Consensus       292 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Df  371 (537)
                      ||+++|+|.+++...            ..+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+||
T Consensus       121 e~~~gg~L~~~l~~~------------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DF  185 (350)
T 1rdq_E          121 EYVAGGEMFSHLRRI------------GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDF  185 (350)
T ss_dssp             ECCTTCBHHHHHHHH------------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred             cCCCCCcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEccc
Confidence            999999999999753            35899999999999999999999999   999999999999999999999999


Q ss_pred             cCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhch
Q 009340          372 GISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQ  451 (537)
Q Consensus       372 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  451 (537)
                      |+++.....    .....||+.|+|||.+.+..++.++|||||||++|||++|+.||......+      .+.... .+.
T Consensus       186 g~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~------~~~~i~-~~~  254 (350)
T 1rdq_E          186 GFAKRVKGR----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ------IYEKIV-SGK  254 (350)
T ss_dssp             TTCEECSSC----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHH-HCC
T ss_pred             ccceeccCC----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHH------HHHHHH-cCC
Confidence            999876432    234578999999999999999999999999999999999999997543221      111111 111


Q ss_pred             hhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCC-----HhhHHH
Q 009340          452 LLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPT-----MKQVSM  495 (537)
Q Consensus       452 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~ev~~  495 (537)
                                ...+...+..+.+++.+||+.||++||+     +.+|++
T Consensus       255 ----------~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          255 ----------VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             ----------CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             ----------CCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence                      1123334567889999999999999998     666653

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=3.2e-42  Score=344.62  Aligned_cols=258  Identities=27%  Similarity=0.392  Sum_probs=198.6

Q ss_pred             hcCCccccccCcCCceEEEEEEc-CCCCEEEEEEccCC---ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCcc---
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEI---DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVP---  287 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~---  287 (537)
                      .++|...+.||+|+||.||++.. .+++.||||+++..   .......+.+|+.++++++||||+++++++......   
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            46899999999999999999995 57899999998753   344566789999999999999999999999876544   


Q ss_pred             -EEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcE
Q 009340          288 -VLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA  366 (537)
Q Consensus       288 -~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~  366 (537)
                       ++||||+++|+|.+++...            ..+++..++.++.|+++||+|||+.+   |+||||||+|||++.++.+
T Consensus        91 ~~lv~e~~~g~~L~~~l~~~------------~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~  155 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHTE------------GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAV  155 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHHH------------CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCE
T ss_pred             cEEEEecCCCCCHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCE
Confidence             9999999999999999753            35999999999999999999999999   9999999999999999999


Q ss_pred             EEeeccCccccCCCCCc--eeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHH
Q 009340          367 KVSDFGISRSIPNDKTH--LTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFI  444 (537)
Q Consensus       367 ki~Dfgla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~  444 (537)
                      ||+|||++.........  ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+.      ..
T Consensus       156 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~------~~  229 (311)
T 3ork_A          156 KVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV------AY  229 (311)
T ss_dssp             EECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HH
T ss_pred             EEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH------HH
Confidence            99999999876443222  22345689999999999999999999999999999999999999965433221      11


Q ss_pred             HHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHH-HHHHHH
Q 009340          445 SLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVS-MELEGL  500 (537)
Q Consensus       445 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~-~~L~~i  500 (537)
                      ........    .+.   ......+..+.+++.+||+.||++||++.+++ +.|.++
T Consensus       230 ~~~~~~~~----~~~---~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  279 (311)
T 3ork_A          230 QHVREDPI----PPS---ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  279 (311)
T ss_dssp             HHHHCCCC----CHH---HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             HHhcCCCC----Ccc---cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence            11111100    000   01122346788999999999999999766554 455444

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=8.9e-42  Score=341.15  Aligned_cols=261  Identities=23%  Similarity=0.292  Sum_probs=201.9

Q ss_pred             hcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCC---ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEE
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI---DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLV  290 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  290 (537)
                      .++|...+.||+|+||.||++... +++.||||.+...   .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD  112 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence            478999999999999999999964 6889999998653   334457899999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEee
Q 009340          291 YEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSD  370 (537)
Q Consensus       291 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~D  370 (537)
                      |||+++++|.+++...            ..+++..++.++.|+++||.|||+.+   |+||||||+|||++.++.+||+|
T Consensus       113 ~e~~~~~~L~~~l~~~------------~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~D  177 (309)
T 2h34_A          113 MRLINGVDLAAMLRRQ------------GPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVD  177 (309)
T ss_dssp             EECCCCEEHHHHHHHH------------CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECS
T ss_pred             EEecCCCCHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEec
Confidence            9999999999999753            35999999999999999999999999   99999999999999999999999


Q ss_pred             ccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhc
Q 009340          371 FGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKEN  450 (537)
Q Consensus       371 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  450 (537)
                      ||++...............||+.|+|||.+.+..++.++||||||+++|||++|+.||.......       ........
T Consensus       178 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-------~~~~~~~~  250 (309)
T 2h34_A          178 FGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSV-------MGAHINQA  250 (309)
T ss_dssp             CCC----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHH-------HHHHHHSC
T ss_pred             CccCccccccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHH-------HHHHhccC
Confidence            99998765443333445678999999999999999999999999999999999999986543211       11111110


Q ss_pred             hhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCC-CHhhHHHHHHHHHHhh
Q 009340          451 QLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRP-TMKQVSMELEGLRRSQ  504 (537)
Q Consensus       451 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-s~~ev~~~L~~i~~~~  504 (537)
                      .    ..   ....+...+..+.+++.+||+.||++|| |+.++++.|+.+....
T Consensus       251 ~----~~---~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~  298 (309)
T 2h34_A          251 I----PR---PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA  298 (309)
T ss_dssp             C----CC---GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred             C----CC---ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence            0    00   0112233445788999999999999999 9999999999776543

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=5e-42  Score=350.46  Aligned_cols=252  Identities=23%  Similarity=0.314  Sum_probs=193.7

Q ss_pred             hcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEec
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY  293 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  293 (537)
                      .++|...+.||+|+||.||+++.. +++.||||++..... ..+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   97 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY   97 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence            468999999999999999999965 789999999875332 235678999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCc--EEEeec
Q 009340          294 ISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFS--AKVSDF  371 (537)
Q Consensus       294 ~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~--~ki~Df  371 (537)
                      +++|+|.+++...            ..+++..++.++.|+++||.|||+.+   |+||||||+|||++.++.  +||+||
T Consensus        98 ~~~~~L~~~l~~~------------~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Df  162 (361)
T 3uc3_A           98 ASGGELYERICNA------------GRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDF  162 (361)
T ss_dssp             CCSCBHHHHHHHH------------SSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCC
T ss_pred             CCCCCHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeec
Confidence            9999999998653            35999999999999999999999999   999999999999987765  999999


Q ss_pred             cCccccCCCCCceeeeccccccccCcccccCCCCCcc-hhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhc
Q 009340          372 GISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDK-SDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKEN  450 (537)
Q Consensus       372 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k-sDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  450 (537)
                      |+++......  ......||+.|+|||.+.+..++.+ +||||||+++|||++|+.||.......  ...........  
T Consensus       163 g~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~~~~~~~~~~~--  236 (361)
T 3uc3_A          163 GYSKSSVLHS--QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR--DYRKTIQRILS--  236 (361)
T ss_dssp             CCC-----------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CC--CHHHHHHHHHT--
T ss_pred             CccccccccC--CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHH--HHHHHHHHHhc--
Confidence            9997542221  2334569999999999988887665 899999999999999999986533211  11111111111  


Q ss_pred             hhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          451 QLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       451 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                             .....+.....+..+.+|+.+||+.||++|||+.|+++
T Consensus       237 -------~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~  274 (361)
T 3uc3_A          237 -------VKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKT  274 (361)
T ss_dssp             -------TCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             -------CCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence                   11111111123467889999999999999999999976

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=6.5e-42  Score=342.90  Aligned_cols=259  Identities=25%  Similarity=0.329  Sum_probs=197.4

Q ss_pred             cCCccc-cccCcCCceEEEEEEc-CCCCEEEEEEccCCChHHHHHHHHHHHHHHhc-CCCCcceEeeEEeeCCccEEEEe
Q 009340          216 DNYNQS-RFLGQGGFGTVYKGML-PDGSIVAVKRSKEIDKTQIHQFINEVVILSQI-NHRHIVKLLGCCLETEVPVLVYE  292 (537)
Q Consensus       216 ~~~~~~-~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e  292 (537)
                      +.|... +.||+|+||.||++.. .+++.||||++........+.+.+|+.++.++ +||||+++++++.+.+..++|||
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   91 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE   91 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence            567664 7899999999999995 47899999998765555567889999999995 79999999999999999999999


Q ss_pred             cCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCc---EEEe
Q 009340          293 YISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFS---AKVS  369 (537)
Q Consensus       293 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~---~ki~  369 (537)
                      |+++|+|.+++...            ..+++..+..++.|+++||+|||+.+   |+||||||+|||++.++.   +||+
T Consensus        92 ~~~~~~L~~~l~~~------------~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~  156 (316)
T 2ac3_A           92 KMRGGSILSHIHKR------------RHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKIC  156 (316)
T ss_dssp             CCTTCBHHHHHHHH------------SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEEC
T ss_pred             cCCCCcHHHHHhcc------------CCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEE
Confidence            99999999999753            35899999999999999999999999   999999999999998776   9999


Q ss_pred             eccCccccCCCCC------ceeeeccccccccCcccccC-----CCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhcc
Q 009340          370 DFGISRSIPNDKT------HLTTTIQGTFGYLDPEYFQS-----SQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERN  438 (537)
Q Consensus       370 Dfgla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~  438 (537)
                      |||++........      .......||+.|+|||.+..     ..++.++||||||+++|||++|+.||......+...
T Consensus       157 Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~  236 (316)
T 2ac3_A          157 DFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGW  236 (316)
T ss_dssp             CTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC
T ss_pred             EccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccc
Confidence            9999976532211      11223458999999999875     557899999999999999999999997543221100


Q ss_pred             H--------HHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          439 L--------VACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       439 ~--------~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      .        ............. .. ....    ....+..+.+|+.+||+.||++|||+.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~i~~~~~-~~-~~~~----~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          237 DRGEACPACQNMLFESIQEGKY-EF-PDKD----WAHISCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             ----CCHHHHHHHHHHHHHCCC-CC-CHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             cccccchhHHHHHHHHHhccCc-cc-Cchh----cccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence            0        0001111111100 00 0000    0123457889999999999999999999976

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=8.2e-42  Score=346.46  Aligned_cols=269  Identities=21%  Similarity=0.272  Sum_probs=202.6

Q ss_pred             HHHHhcCCccccccCcCCceEEEEEEc-CCCCEEEEEEccCC-----ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeC
Q 009340          211 LQRATDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEI-----DKTQIHQFINEVVILSQINHRHIVKLLGCCLET  284 (537)
Q Consensus       211 l~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~  284 (537)
                      +....++|...+.||+|+||.||+|.. .+++.||+|.+...     .....+.+.+|+.++++++||||+++++++.+.
T Consensus        21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  100 (345)
T 3hko_A           21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE  100 (345)
T ss_dssp             HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence            456678999999999999999999996 46889999987542     334567899999999999999999999999999


Q ss_pred             CccEEEEecCCCCChhhhhhhhhhhHH--------------------HHh--------hhccCCCCHHHHHHHHHHHHHH
Q 009340          285 EVPVLVYEYISSGTLSHHIHDHQQQQE--------------------QKQ--------KQELSSLSWENRVRVACEVAGA  336 (537)
Q Consensus       285 ~~~~lV~e~~~~gsL~~~l~~~~~~~~--------------------~~~--------~~~~~~l~~~~~~~i~~~ia~g  336 (537)
                      +..++||||+++|+|.+++........                    ...        ......+++..++.++.|+++|
T Consensus       101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~  180 (345)
T 3hko_A          101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA  180 (345)
T ss_dssp             SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred             CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence            999999999999999999863211000                    000        0001124677888999999999


Q ss_pred             HHHHhhcCCCCeeecCCCCCCEEECCCC--cEEEeeccCccccCC---CCCceeeeccccccccCcccccC--CCCCcch
Q 009340          337 VAYMHSSASIPIFHRDIKSSNILLDDKF--SAKVSDFGISRSIPN---DKTHLTTTIQGTFGYLDPEYFQS--SQFTDKS  409 (537)
Q Consensus       337 l~yLH~~~~~~ivH~Dlk~~NIll~~~~--~~ki~Dfgla~~~~~---~~~~~~~~~~gt~~y~aPE~~~~--~~~t~ks  409 (537)
                      |+|||+.+   |+||||||+|||++.++  .+||+|||++.....   ..........||+.|+|||.+.+  ..++.++
T Consensus       181 l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~  257 (345)
T 3hko_A          181 LHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC  257 (345)
T ss_dssp             HHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred             HHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence            99999999   99999999999998776  899999999986532   22222345679999999999865  6789999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCC
Q 009340          410 DVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPT  489 (537)
Q Consensus       410 DV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs  489 (537)
                      ||||||+++|||++|+.||......+.      ..........       ...+.....+..+.+|+.+||+.||++|||
T Consensus       258 DiwslG~il~el~~g~~pf~~~~~~~~------~~~~~~~~~~-------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps  324 (345)
T 3hko_A          258 DAWSAGVLLHLLLMGAVPFPGVNDADT------ISQVLNKKLC-------FENPNYNVLSPLARDLLSNLLNRNVDERFD  324 (345)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHHCCCC-------TTSGGGGGSCHHHHHHHHHHSCSCTTTSCC
T ss_pred             HHHHHHHHHHHHHHCCCCCCCCChHHH------HHHHHhcccc-------cCCcccccCCHHHHHHHHHHcCCChhHCCC
Confidence            999999999999999999965433221      1111111100       000111123457889999999999999999


Q ss_pred             HhhHHH
Q 009340          490 MKQVSM  495 (537)
Q Consensus       490 ~~ev~~  495 (537)
                      +.++++
T Consensus       325 ~~~~l~  330 (345)
T 3hko_A          325 AMRALQ  330 (345)
T ss_dssp             HHHHHH
T ss_pred             HHHHhc
Confidence            999975

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.6e-41  Score=350.21  Aligned_cols=264  Identities=26%  Similarity=0.407  Sum_probs=194.3

Q ss_pred             HHhcCCccccccCcCCceEEEEEEc-CCCCEEEEEEccC--CChHHHHHHHHHHHHHHhcC-CCCcceEeeEEeeCC--c
Q 009340          213 RATDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKE--IDKTQIHQFINEVVILSQIN-HRHIVKLLGCCLETE--V  286 (537)
Q Consensus       213 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~--~  286 (537)
                      ...++|...+.||+|+||.||+|.. .+|+.||||++..  ......+.+.+|+.++.++. |+||+++++++...+  .
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~   85 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD   85 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence            3457899999999999999999985 4789999999854  34556677889999999997 999999999997554  6


Q ss_pred             cEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcE
Q 009340          287 PVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA  366 (537)
Q Consensus       287 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~  366 (537)
                      .++||||++ |+|.+++..             ..+++..+..++.|+++||.|||+.+   |+||||||+|||++.++.+
T Consensus        86 ~~lv~e~~~-~~L~~~~~~-------------~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~  148 (388)
T 3oz6_A           86 VYLVFDYME-TDLHAVIRA-------------NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHV  148 (388)
T ss_dssp             EEEEEECCS-EEHHHHHHH-------------TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCE
T ss_pred             EEEEecccC-cCHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCE
Confidence            799999998 589888864             25899999999999999999999999   9999999999999999999


Q ss_pred             EEeeccCccccCCC--------------------CCceeeeccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCC
Q 009340          367 KVSDFGISRSIPND--------------------KTHLTTTIQGTFGYLDPEYFQS-SQFTDKSDVYSFGVVLLELLTGK  425 (537)
Q Consensus       367 ki~Dfgla~~~~~~--------------------~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~el~tg~  425 (537)
                      ||+|||+++.....                    .....+...||+.|+|||.+.+ ..++.++|||||||++|||++|+
T Consensus       149 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~  228 (388)
T 3oz6_A          149 KVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK  228 (388)
T ss_dssp             EECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred             EecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCC
Confidence            99999999865321                    1112344579999999999876 67899999999999999999999


Q ss_pred             CCCCccchhhhccHHHHHHHHHhhchhh-----------hhhc---------------------HHh-hccccHHHHHHH
Q 009340          426 KPICFARVEEERNLVACFISLAKENQLL-----------EILD---------------------ARV-AKEAREEDIGAM  472 (537)
Q Consensus       426 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~d---------------------~~~-~~~~~~~~~~~l  472 (537)
                      .||......+...   ............           ..+.                     ... ........+..+
T Consensus       229 ~pf~~~~~~~~~~---~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (388)
T 3oz6_A          229 PIFPGSSTMNQLE---RIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEA  305 (388)
T ss_dssp             CSCCCSSHHHHHH---HHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHH
T ss_pred             CCCCCCCHHHHHH---HHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHH
Confidence            9997654322111   111111000000           0000                     000 000001234578


Q ss_pred             HHHHHHhcccCCCCCCCHhhHHHH
Q 009340          473 AELAMRCLRLNSKKRPTMKQVSME  496 (537)
Q Consensus       473 ~~l~~~cl~~~p~~RPs~~ev~~~  496 (537)
                      .+|+.+||+.||++|||+.|+++-
T Consensus       306 ~dll~~~L~~dP~~R~t~~e~l~H  329 (388)
T 3oz6_A          306 LDLLDKLLQFNPNKRISANDALKH  329 (388)
T ss_dssp             HHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             HHHHHHhhccCcccCCCHHHHhCC
Confidence            899999999999999999999753

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1.7e-41  Score=333.36  Aligned_cols=250  Identities=23%  Similarity=0.329  Sum_probs=204.3

Q ss_pred             hcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEec
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY  293 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  293 (537)
                      .++|...+.||+|+||.||+|... ++..||+|++........+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL   87 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence            467889999999999999999965 5778999998765445567899999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEE---CCCCcEEEee
Q 009340          294 ISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILL---DDKFSAKVSD  370 (537)
Q Consensus       294 ~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll---~~~~~~ki~D  370 (537)
                      +++++|.+++...            ..+++..++.++.|+++||.|||+.+   |+||||||+||++   +.++.+||+|
T Consensus        88 ~~~~~L~~~~~~~------------~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~D  152 (277)
T 3f3z_A           88 CTGGELFERVVHK------------RVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLID  152 (277)
T ss_dssp             CCSCBHHHHHHHH------------CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECC
T ss_pred             cCCCcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEe
Confidence            9999999988653            35899999999999999999999999   9999999999999   8889999999


Q ss_pred             ccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhc
Q 009340          371 FGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKEN  450 (537)
Q Consensus       371 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  450 (537)
                      ||++.......  ......||+.|+|||.+.+ .++.++||||||+++|||++|+.||......+       ........
T Consensus       153 fg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-------~~~~~~~~  222 (277)
T 3f3z_A          153 FGLAARFKPGK--MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSE-------VMLKIREG  222 (277)
T ss_dssp             CTTCEECCTTS--CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHC
T ss_pred             cccceeccCcc--chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHhC
Confidence            99998764433  2344568999999999865 48999999999999999999999997543322       11111111


Q ss_pred             hhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          451 QLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       451 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      ...  .....    ....+..+.+++.+||+.||++|||+.++++
T Consensus       223 ~~~--~~~~~----~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          223 TFT--FPEKD----WLNVSPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             CCC--CCHHH----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             CCC--CCchh----hhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            000  00000    0123467889999999999999999999975

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=4.1e-42  Score=347.40  Aligned_cols=268  Identities=24%  Similarity=0.376  Sum_probs=199.5

Q ss_pred             hcCCccccccCcCCceEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHH--HHhcCCCCcceEeeEEee-----CCcc
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVI--LSQINHRHIVKLLGCCLE-----TEVP  287 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~H~niv~l~g~~~~-----~~~~  287 (537)
                      .++|...+.||+|+||.||+|+. +++.||||++....   ...+..|.++  +..++|+||+++++++..     ....
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   87 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY   87 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence            36888999999999999999987 68999999987533   2344445444  445899999999986543     2256


Q ss_pred             EEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhc---------CCCCeeecCCCCCCE
Q 009340          288 VLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSS---------ASIPIFHRDIKSSNI  358 (537)
Q Consensus       288 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~---------~~~~ivH~Dlk~~NI  358 (537)
                      ++||||+++|+|.+++..             ...+|..++.++.|+++||.|||+.         +   |+||||||+||
T Consensus        88 ~lv~e~~~~g~L~~~l~~-------------~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Ni  151 (336)
T 3g2f_A           88 LLVMEYYPNGSLXKYLSL-------------HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNV  151 (336)
T ss_dssp             EEEECCCTTCBHHHHHHH-------------CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGE
T ss_pred             EEEEecCCCCcHHHHHhh-------------cccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceE
Confidence            899999999999999964             2468999999999999999999998         7   99999999999


Q ss_pred             EECCCCcEEEeeccCccccCCCCC-------ceeeeccccccccCcccccC-------CCCCcchhHHHHHHHHHHHHhC
Q 009340          359 LLDDKFSAKVSDFGISRSIPNDKT-------HLTTTIQGTFGYLDPEYFQS-------SQFTDKSDVYSFGVVLLELLTG  424 (537)
Q Consensus       359 ll~~~~~~ki~Dfgla~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~-------~~~t~ksDV~S~Gvll~el~tg  424 (537)
                      |++.++.+||+|||+++.......       .......||+.|+|||.+.+       ..++.++||||||+++|||++|
T Consensus       152 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g  231 (336)
T 3g2f_A          152 LVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMR  231 (336)
T ss_dssp             EECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhc
Confidence            999999999999999987643221       11234569999999999976       3566799999999999999999


Q ss_pred             CCCCCccchhhhc-cH----------HHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhH
Q 009340          425 KKPICFARVEEER-NL----------VACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQV  493 (537)
Q Consensus       425 ~~p~~~~~~~~~~-~~----------~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev  493 (537)
                      +.|+......... ..          ................+....  ......+..+.+|+.+||+.||++|||+.|+
T Consensus       232 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~  309 (336)
T 3g2f_A          232 CTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAW--KENSLAVRSLKETIEDCWDQDAEARLTAQXA  309 (336)
T ss_dssp             BGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTC--CCCSHHHHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             CCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCccc--ccccchHHHHHHHHHHHhcCChhhCcchHHH
Confidence            8876543221110 00          000011111110000000000  1123466789999999999999999999999


Q ss_pred             HHHHHHHHHhh
Q 009340          494 SMELEGLRRSQ  504 (537)
Q Consensus       494 ~~~L~~i~~~~  504 (537)
                      ++.|+.+....
T Consensus       310 l~~L~~ll~~~  320 (336)
T 3g2f_A          310 EERMAELMMIW  320 (336)
T ss_dssp             HHHHHHHHHCC
T ss_pred             HHHHHHHHHHH
Confidence            99999988654

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=5.1e-42  Score=360.56  Aligned_cols=248  Identities=24%  Similarity=0.353  Sum_probs=195.8

Q ss_pred             hcCCccccccCcCCceEEEEEEc-CCCCEEEEEEccCC---ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEE
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEI---DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLV  290 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  290 (537)
                      .++|...++||+|+||.||++.. .+|+.||||.++..   .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            46799999999999999999995 46899999998642   334456788999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeecCCCCCCEEECCCCcEEEe
Q 009340          291 YEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHS-SASIPIFHRDIKSSNILLDDKFSAKVS  369 (537)
Q Consensus       291 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-~~~~~ivH~Dlk~~NIll~~~~~~ki~  369 (537)
                      |||+++|+|.+++...            ..+++..+..++.|+++||+|||+ .+   |+||||||+|||++.++.+||+
T Consensus       227 ~e~~~~~~L~~~l~~~------------~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~  291 (446)
T 4ejn_A          227 MEYANGGELFFHLSRE------------RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKIT  291 (446)
T ss_dssp             ECCCSSCBHHHHHHHH------------SCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEEC
T ss_pred             EeeCCCCcHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEc
Confidence            9999999999998653            369999999999999999999998 88   9999999999999999999999


Q ss_pred             eccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhh
Q 009340          370 DFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKE  449 (537)
Q Consensus       370 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  449 (537)
                      |||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........      +..... 
T Consensus       292 DFG~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~------~~~i~~-  363 (446)
T 4ejn_A          292 DFGLCKEGIKDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL------FELILM-  363 (446)
T ss_dssp             CCCCCCTTCC------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHH-
T ss_pred             cCCCceeccCCCc-ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH------HHHHHh-
Confidence            9999986433322 23456799999999999999999999999999999999999999965433221      111111 


Q ss_pred             chhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCC-----CHhhHHH
Q 009340          450 NQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRP-----TMKQVSM  495 (537)
Q Consensus       450 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~  495 (537)
                      ..          ...+...+..+.+|+.+||+.||++||     ++.|+++
T Consensus       364 ~~----------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          364 EE----------IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             CC----------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             CC----------CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence            10          112233446788999999999999999     9998875

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=3.9e-41  Score=331.88  Aligned_cols=251  Identities=25%  Similarity=0.394  Sum_probs=205.6

Q ss_pred             hcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccC--CChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEE
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKE--IDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY  291 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  291 (537)
                      .++|...+.||+|+||.||+|... +|+.||+|.+..  ......+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            478999999999999999999964 689999999854  34555678899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCc---EEE
Q 009340          292 EYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFS---AKV  368 (537)
Q Consensus       292 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~---~ki  368 (537)
                      ||+++|+|.+++...            ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.   +||
T Consensus        85 e~~~~~~l~~~~~~~------------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl  149 (284)
T 3kk8_A           85 DLVTGGELFEDIVAR------------EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKL  149 (284)
T ss_dssp             CCCCSCBHHHHHHHH------------SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEE
T ss_pred             ecCCCCCHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEE
Confidence            999999999888653            35999999999999999999999999   999999999999986655   999


Q ss_pred             eeccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHh
Q 009340          369 SDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAK  448 (537)
Q Consensus       369 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  448 (537)
                      +|||++........  .....||+.|+|||.+.+..++.++||||||+++|||++|+.||.......       ......
T Consensus       150 ~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-------~~~~~~  220 (284)
T 3kk8_A          150 ADFGLAIEVNDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR-------LYAQIK  220 (284)
T ss_dssp             CCCTTCEECCSSCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHH
T ss_pred             eeceeeEEcccCcc--ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhH-------HHHHHH
Confidence            99999987643322  234568999999999999999999999999999999999999986543322       111111


Q ss_pred             hchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          449 ENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       449 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      .....      .........+..+.+++.+||+.||++|||+.|+++
T Consensus       221 ~~~~~------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (284)
T 3kk8_A          221 AGAYD------YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK  261 (284)
T ss_dssp             HTCCC------CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             hcccc------CCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            11000      000111233457889999999999999999999976

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=6.7e-42  Score=344.75  Aligned_cols=268  Identities=27%  Similarity=0.450  Sum_probs=209.5

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCCE--EEEEEccCC-ChHHHHHHHHHHHHHHhc-CCCCcceEeeEEeeCCccEEE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGSI--VAVKRSKEI-DKTQIHQFINEVVILSQI-NHRHIVKLLGCCLETEVPVLV  290 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~--vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV  290 (537)
                      ++|...+.||+|+||.||+++.. +|..  ||+|.++.. .....+.+.+|+.+++++ +||||+++++++.+.+..++|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            57888999999999999999964 4554  599988753 334456789999999999 899999999999999999999


Q ss_pred             EecCCCCChhhhhhhhhhhHHH----HhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcE
Q 009340          291 YEYISSGTLSHHIHDHQQQQEQ----KQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA  366 (537)
Q Consensus       291 ~e~~~~gsL~~~l~~~~~~~~~----~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~  366 (537)
                      |||+++|+|.+++.........    ........+++..++.++.|+++||.|||+.+   |+||||||+|||++.++.+
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~  181 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  181 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence            9999999999999765421100    00112346999999999999999999999999   9999999999999999999


Q ss_pred             EEeeccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHHH
Q 009340          367 KVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFIS  445 (537)
Q Consensus       367 ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~  445 (537)
                      ||+|||+++.....  .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+       ...
T Consensus       182 kL~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~-------~~~  252 (327)
T 1fvr_A          182 KIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-------LYE  252 (327)
T ss_dssp             EECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HHH
T ss_pred             EEcccCcCcccccc--ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH-------HHH
Confidence            99999999753221  11233456889999999988889999999999999999998 999986543221       111


Q ss_pred             HHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHHhh
Q 009340          446 LAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRSQ  504 (537)
Q Consensus       446 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~  504 (537)
                      ...         .......+...+..+.+|+.+||+.||++|||+.++++.|+.+....
T Consensus       253 ~~~---------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  302 (327)
T 1fvr_A          253 KLP---------QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER  302 (327)
T ss_dssp             HGG---------GTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred             Hhh---------cCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence            111         11111223344567899999999999999999999999999988754

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.8e-42  Score=351.27  Aligned_cols=264  Identities=15%  Similarity=0.235  Sum_probs=206.5

Q ss_pred             cCCccccccCcCCceEEEEEEcCC---------CCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcce----------
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLPD---------GSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVK----------  276 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~~---------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~----------  276 (537)
                      ++|...+.||+|+||.||+|....         ++.||||.+...     +.+.+|+.++++++|||+++          
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  116 (352)
T 2jii_A           42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL  116 (352)
T ss_dssp             CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred             CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence            688999999999999999999753         789999998753     36789999999999999998          


Q ss_pred             -----EeeEEee-CCccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeee
Q 009340          277 -----LLGCCLE-TEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFH  350 (537)
Q Consensus       277 -----l~g~~~~-~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH  350 (537)
                           +++++.. ....++||||+ +|+|.+++....          ...+++..++.++.|+++||.|||+.+   |+|
T Consensus       117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~----------~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH  182 (352)
T 2jii_A          117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP----------KHVLSERSVLQVACRLLDALEFLHENE---YVH  182 (352)
T ss_dssp             CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG----------GGCCCHHHHHHHHHHHHHHHHHHHHTT---CBC
T ss_pred             cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC----------cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccC
Confidence                 6777776 66789999999 999999997642          136999999999999999999999999   999


Q ss_pred             cCCCCCCEEECCCC--cEEEeeccCccccCCCCCc------eeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHH
Q 009340          351 RDIKSSNILLDDKF--SAKVSDFGISRSIPNDKTH------LTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELL  422 (537)
Q Consensus       351 ~Dlk~~NIll~~~~--~~ki~Dfgla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~  422 (537)
                      |||||+|||++.++  .+||+|||+++........      ......||+.|+|||.+.+..++.++||||||+++|||+
T Consensus       183 ~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~  262 (352)
T 2jii_A          183 GNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWL  262 (352)
T ss_dssp             SCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred             CCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHH
Confidence            99999999999998  9999999999876432211      113347899999999999999999999999999999999


Q ss_pred             hCCCCCCccchhhhccHHHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHH
Q 009340          423 TGKKPICFARVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRR  502 (537)
Q Consensus       423 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~  502 (537)
                      +|+.||........ ...........  ......+....   ....+..+.+++.+||+.||++|||+.+|+++|+.+..
T Consensus       263 ~g~~pf~~~~~~~~-~~~~~~~~~~~--~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  336 (352)
T 2jii_A          263 YGFLPWTNCLPNTE-DIMKQKQKFVD--KPGPFVGPCGH---WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQ  336 (352)
T ss_dssp             HSCCTTGGGTTCHH-HHHHHHHHHHH--SCCCEECTTSC---EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred             hCCCCcccCCcCHH-HHHHHHHhccC--Chhhhhhhccc---cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHH
Confidence            99999975432111 11111111000  00111110000   01224678899999999999999999999999999887


Q ss_pred             hh
Q 009340          503 SQ  504 (537)
Q Consensus       503 ~~  504 (537)
                      ..
T Consensus       337 ~~  338 (352)
T 2jii_A          337 DL  338 (352)
T ss_dssp             HT
T ss_pred             hc
Confidence            54

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=7.1e-42  Score=341.51  Aligned_cols=263  Identities=23%  Similarity=0.353  Sum_probs=198.7

Q ss_pred             HhcCCccccccCcCCceEEEEEEc-CCCCEEEEEEccCCC-----hHHHHHHHHHHHHHHhc---CCCCcceEeeEEeeC
Q 009340          214 ATDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEID-----KTQIHQFINEVVILSQI---NHRHIVKLLGCCLET  284 (537)
Q Consensus       214 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~~  284 (537)
                      ..++|...++||+|+||+||+|+. .+|+.||||+++...     ......+.+|+.+++++   +||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            457999999999999999999995 478999999876321     11123556677776666   499999999999876


Q ss_pred             C-----ccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEE
Q 009340          285 E-----VPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNIL  359 (537)
Q Consensus       285 ~-----~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIl  359 (537)
                      .     ..++||||++ |+|.+++.....          ..+++..++.++.|+++||+|||+.+   |+||||||+|||
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~----------~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil  152 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAPP----------PGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENIL  152 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCCT----------TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEE
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhccC----------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEE
Confidence            5     4799999997 599999976432          34999999999999999999999999   999999999999


Q ss_pred             ECCCCcEEEeeccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccH
Q 009340          360 LDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNL  439 (537)
Q Consensus       360 l~~~~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~  439 (537)
                      ++.++.+||+|||+++......  ......||+.|+|||.+.+..++.++|||||||++|||++|+.||......+.   
T Consensus       153 ~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---  227 (308)
T 3g33_A          153 VTSGGTVKLADFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ---  227 (308)
T ss_dssp             ECTTSCEEECSCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHH---
T ss_pred             EcCCCCEEEeeCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH---
Confidence            9999999999999998764332  23456789999999999999999999999999999999999999975543321   


Q ss_pred             HHHHHHHHhhchhhhh------hcHHh-------hccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          440 VACFISLAKENQLLEI------LDARV-------AKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       440 ~~~~~~~~~~~~~~~~------~d~~~-------~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      ...............+      ....+       ........+..+.+|+.+||+.||++|||+.|+++
T Consensus       228 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          228 LGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             HHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence            1111111110000000      00000       00011233467889999999999999999999875

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.3e-41  Score=372.60  Aligned_cols=260  Identities=25%  Similarity=0.425  Sum_probs=209.4

Q ss_pred             HhcCCccccccCcCCceEEEEEEcCC----CCEEEEEEccCC-ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccE
Q 009340          214 ATDNYNQSRFLGQGGFGTVYKGMLPD----GSIVAVKRSKEI-DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPV  288 (537)
Q Consensus       214 ~~~~~~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  288 (537)
                      ..++|...+.||+|+||.||+|.+..    +..||||+++.. .....+.|.+|+.++++++||||+++++++. .+..+
T Consensus       388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~  466 (656)
T 2j0j_A          388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW  466 (656)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred             ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceE
Confidence            34678888999999999999998642    457999998753 4455678999999999999999999999985 45689


Q ss_pred             EEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEE
Q 009340          289 LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKV  368 (537)
Q Consensus       289 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki  368 (537)
                      +||||+++|+|.+++....           ..+++..++.++.|+++||.|||+.+   |+||||||+|||++.++.+||
T Consensus       467 lv~E~~~~g~L~~~l~~~~-----------~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL  532 (656)
T 2j0j_A          467 IIMELCTLGELRSFLQVRK-----------FSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKL  532 (656)
T ss_dssp             EEEECCTTCBHHHHHHHTT-----------TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEE
T ss_pred             EEEEcCCCCcHHHHHHhcc-----------CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEE
Confidence            9999999999999997532           25899999999999999999999999   999999999999999999999


Q ss_pred             eeccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHHHHH
Q 009340          369 SDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLA  447 (537)
Q Consensus       369 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~  447 (537)
                      +|||+++..............+|+.|+|||.+.+..++.++||||||+++|||++ |..||......+       .....
T Consensus       533 ~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~-------~~~~i  605 (656)
T 2j0j_A          533 GDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-------VIGRI  605 (656)
T ss_dssp             CCCCCCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HHHHH
T ss_pred             EecCCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH-------HHHHH
Confidence            9999998775544443444567889999999998999999999999999999997 999986543322       11111


Q ss_pred             hhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHHhh
Q 009340          448 KENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRSQ  504 (537)
Q Consensus       448 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~  504 (537)
                      ..         ......+..++..+.+++.+||+.||++|||+.++++.|+.+....
T Consensus       606 ~~---------~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~  653 (656)
T 2j0j_A          606 EN---------GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE  653 (656)
T ss_dssp             HH---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             Hc---------CCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence            11         1111233445567899999999999999999999999999987654

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.4e-41  Score=345.70  Aligned_cols=243  Identities=25%  Similarity=0.351  Sum_probs=201.4

Q ss_pred             hcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCC---ChHHHHHHHHHHHHHHhc-CCCCcceEeeEEeeCCccEE
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI---DKTQIHQFINEVVILSQI-NHRHIVKLLGCCLETEVPVL  289 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l  289 (537)
                      .++|...+.||+|+||.||+++.. +|+.||||.++..   .....+.+..|..++..+ +||||+++++++.+.+..++
T Consensus        19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   98 (353)
T 2i0e_A           19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF   98 (353)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence            478999999999999999999975 4789999998642   123356688999999988 79999999999999999999


Q ss_pred             EEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEe
Q 009340          290 VYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVS  369 (537)
Q Consensus       290 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~  369 (537)
                      ||||+++|+|.+++...            ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+
T Consensus        99 v~E~~~gg~L~~~l~~~------------~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~  163 (353)
T 2i0e_A           99 VMEYVNGGDLMYHIQQV------------GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIA  163 (353)
T ss_dssp             EEECCCSCBHHHHHHHH------------SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEEC
T ss_pred             EEeCCCCCcHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEE
Confidence            99999999999999753            35999999999999999999999999   9999999999999999999999


Q ss_pred             eccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhh
Q 009340          370 DFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKE  449 (537)
Q Consensus       370 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  449 (537)
                      |||+++...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||......+      .+..... 
T Consensus       164 DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~------~~~~i~~-  235 (353)
T 2i0e_A          164 DFGMCKENIWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE------LFQSIME-  235 (353)
T ss_dssp             CCTTCBCCCCTT-CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHH-
T ss_pred             eCCcccccccCC-cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHH------HHHHHHh-
Confidence            999998643222 22345679999999999999999999999999999999999999997543221      1111111 


Q ss_pred             chhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCH
Q 009340          450 NQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTM  490 (537)
Q Consensus       450 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~  490 (537)
                      ..          ...+...+..+.+|+.+||+.||++||++
T Consensus       236 ~~----------~~~p~~~s~~~~~li~~lL~~dP~~R~~~  266 (353)
T 2i0e_A          236 HN----------VAYPKSMSKEAVAICKGLMTKHPGKRLGC  266 (353)
T ss_dssp             CC----------CCCCTTSCHHHHHHHHHHTCSCTTSCTTC
T ss_pred             CC----------CCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence            10          11233445678899999999999999965

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.1e-41  Score=352.32  Aligned_cols=272  Identities=23%  Similarity=0.340  Sum_probs=214.0

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCC-hHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCC--ccEEEE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEID-KTQIHQFINEVVILSQINHRHIVKLLGCCLETE--VPVLVY  291 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lV~  291 (537)
                      ++|...++||+|+||.||+|... +|+.||||+++... ....+.+.+|+.++++++||||+++++++.+.+  ..++||
T Consensus         9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~   88 (396)
T 4eut_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (396)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence            57888999999999999999965 58999999987532 233567889999999999999999999998765  679999


Q ss_pred             ecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEE----CCCCcEE
Q 009340          292 EYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILL----DDKFSAK  367 (537)
Q Consensus       292 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll----~~~~~~k  367 (537)
                      ||+++|+|.+++.....         ...+++..++.++.|++.||+|||+.+   |+||||||+|||+    +.++.+|
T Consensus        89 e~~~~g~L~~~l~~~~~---------~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~k  156 (396)
T 4eut_A           89 EFCPCGSLYTVLEEPSN---------AYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYK  156 (396)
T ss_dssp             CCCTTEEHHHHTTSGGG---------TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEE
T ss_pred             ecCCCCCHHHHHHhhhc---------ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEE
Confidence            99999999999986543         234999999999999999999999999   9999999999999    8888899


Q ss_pred             EeeccCccccCCCCCceeeeccccccccCcccccC--------CCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccH
Q 009340          368 VSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQS--------SQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNL  439 (537)
Q Consensus       368 i~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~  439 (537)
                      |+|||+++......  ......||+.|+|||.+.+        ..++.++||||||+++|||++|+.||........  .
T Consensus       157 L~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~--~  232 (396)
T 4eut_A          157 LTDFGAARELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR--N  232 (396)
T ss_dssp             ECCGGGCEECCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTT--C
T ss_pred             EecCCCceEccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccc--h
Confidence            99999998764432  2234568999999999864        4677899999999999999999999864322111  1


Q ss_pred             HHHHHHHHhhch---hhhh---h--------cHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHHh
Q 009340          440 VACFISLAKENQ---LLEI---L--------DARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRS  503 (537)
Q Consensus       440 ~~~~~~~~~~~~---~~~~---~--------d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~  503 (537)
                      ............   ....   .        +.......+......+.+++.+||+.||++|||+.++++.++.+...
T Consensus       233 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~  310 (396)
T 4eut_A          233 KEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR  310 (396)
T ss_dssp             HHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred             HHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence            111112111110   0000   0        00011123467778899999999999999999999999999888763

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=5.7e-42  Score=338.93  Aligned_cols=258  Identities=27%  Similarity=0.445  Sum_probs=199.7

Q ss_pred             cCCccccccCcCCceEEEEEEcC--CCC--EEEEEEccCC---ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP--DGS--IVAVKRSKEI---DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPV  288 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~--~g~--~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  288 (537)
                      ++|...+.||+|+||.||+|.+.  +++  .||||.++..   .....+.+.+|+.++++++||||+++++++.+.. .+
T Consensus        18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~   96 (291)
T 1u46_A           18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK   96 (291)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred             hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence            57888999999999999999853  333  6999988653   3345678999999999999999999999998765 79


Q ss_pred             EEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEE
Q 009340          289 LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKV  368 (537)
Q Consensus       289 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki  368 (537)
                      +|+||+++|+|.+++....           ..+++..++.++.|+++||.|||+.+   ++||||||+||+++.++.+||
T Consensus        97 ~v~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl  162 (291)
T 1u46_A           97 MVTELAPLGSLLDRLRKHQ-----------GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKI  162 (291)
T ss_dssp             EEEECCTTCBHHHHHHHHG-----------GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEE
T ss_pred             eeEecccCCCHHHHHHhcc-----------CCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEE
Confidence            9999999999999997643           25899999999999999999999999   999999999999999999999


Q ss_pred             eeccCccccCCCCCce--eeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHHH
Q 009340          369 SDFGISRSIPNDKTHL--TTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFIS  445 (537)
Q Consensus       369 ~Dfgla~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~  445 (537)
                      +|||++..........  .....+|..|+|||.+.+..++.++||||||+++|||++ |+.||......+      ....
T Consensus       163 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------~~~~  236 (291)
T 1u46_A          163 GDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ------ILHK  236 (291)
T ss_dssp             CCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHHH
T ss_pred             ccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHH------HHHH
Confidence            9999998775443321  234457889999999988889999999999999999999 999986543221      1111


Q ss_pred             HHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHHh
Q 009340          446 LAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRS  503 (537)
Q Consensus       446 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~  503 (537)
                      ....         ......+...+..+.+++.+||+.||++|||+.++++.|+++...
T Consensus       237 ~~~~---------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  285 (291)
T 1u46_A          237 IDKE---------GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT  285 (291)
T ss_dssp             HHTS---------CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred             HHcc---------CCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence            1111         011112234456789999999999999999999999999987653

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1.5e-41  Score=334.17  Aligned_cols=247  Identities=30%  Similarity=0.456  Sum_probs=201.5

Q ss_pred             hcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCC---hHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEE
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEID---KTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLV  290 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  290 (537)
                      .++|...+.||+|+||.||++... +++.||||.+....   ......+.+|+.++++++||||+++++++.+.+..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   87 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence            467889999999999999999864 57799999885421   12245688999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEee
Q 009340          291 YEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSD  370 (537)
Q Consensus       291 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~D  370 (537)
                      |||+++|+|.+++...            ..+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|
T Consensus        88 ~e~~~~~~l~~~l~~~------------~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~D  152 (279)
T 3fdn_A           88 LEYAPLGTVYRELQKL------------SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIAD  152 (279)
T ss_dssp             ECCCTTEEHHHHHHHH------------SSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECS
T ss_pred             EecCCCCcHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEe
Confidence            9999999999998653            35999999999999999999999998   99999999999999999999999


Q ss_pred             ccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhc
Q 009340          371 FGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKEN  450 (537)
Q Consensus       371 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  450 (537)
                      ||++.......   .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......+.      ... ... 
T Consensus       153 fg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~-~~~-  221 (279)
T 3fdn_A          153 FGWSVHAPSSR---RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET------YKR-ISR-  221 (279)
T ss_dssp             CCEESCC-----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHH-HHH-
T ss_pred             ccccccCCccc---ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHH------HHH-HHh-
Confidence            99986543322   2345689999999999999999999999999999999999999875433221      111 110 


Q ss_pred             hhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHH
Q 009340          451 QLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSME  496 (537)
Q Consensus       451 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~  496 (537)
                               .....+...+..+.+|+.+||+.||++|||+.|+++.
T Consensus       222 ---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h  258 (279)
T 3fdn_A          222 ---------VEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH  258 (279)
T ss_dssp             ---------TCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred             ---------CCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence                     1111233344678899999999999999999999863

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.9e-41  Score=334.23  Aligned_cols=247  Identities=21%  Similarity=0.344  Sum_probs=201.7

Q ss_pred             HhcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCC--ChHHHHHHHHHHHHHHhc-CCCCcceEeeEEeeCCccEE
Q 009340          214 ATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI--DKTQIHQFINEVVILSQI-NHRHIVKLLGCCLETEVPVL  289 (537)
Q Consensus       214 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l  289 (537)
                      ..++|...+.||+|+||.||++... +++.||||.++..  ......++.+|+..+..+ +||||+++++++.+.+..++
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l   88 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI   88 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence            3568889999999999999999975 7899999998752  344567788999999999 99999999999999999999


Q ss_pred             EEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECC-------
Q 009340          290 VYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD-------  362 (537)
Q Consensus       290 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~-------  362 (537)
                      ||||+++|+|.+++......        ...+++..++.++.|+++||.|||+++   |+||||||+|||++.       
T Consensus        89 v~e~~~~~~L~~~l~~~~~~--------~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~  157 (289)
T 1x8b_A           89 QNEYCNGGSLADAISENYRI--------MSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAA  157 (289)
T ss_dssp             EEECCTTCBHHHHHHHHHHH--------TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC--------
T ss_pred             EEEecCCCcHHHHHHhhccc--------ccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccc
Confidence            99999999999999764321        246999999999999999999999999   999999999999984       


Q ss_pred             ------------CCcEEEeeccCccccCCCCCceeeeccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCC
Q 009340          363 ------------KFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSS-QFTDKSDVYSFGVVLLELLTGKKPIC  429 (537)
Q Consensus       363 ------------~~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvll~el~tg~~p~~  429 (537)
                                  ...+||+|||++.......     ...||+.|+|||.+.+. .++.++||||||+++|||++|..++.
T Consensus       158 ~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~  232 (289)
T 1x8b_A          158 SEEGDEDDWASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPR  232 (289)
T ss_dssp             ------------CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCS
T ss_pred             ccccccccccCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCc
Confidence                        4589999999998764432     23489999999999766 56789999999999999999988754


Q ss_pred             ccchhhhccHHHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          430 FARVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       430 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      ....          ........         ....+...+..+.+++.+||+.||++|||+.++++
T Consensus       233 ~~~~----------~~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          233 NGDQ----------WHEIRQGR---------LPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             SSHH----------HHHHHTTC---------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             chhH----------HHHHHcCC---------CCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence            3211          11111111         11223334567889999999999999999999875

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=7.7e-42  Score=335.99  Aligned_cols=259  Identities=25%  Similarity=0.409  Sum_probs=206.1

Q ss_pred             hcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCC--ChHHHHHHHHHHHHHHhcCCCCcceEeeEEee--CCccEE
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI--DKTQIHQFINEVVILSQINHRHIVKLLGCCLE--TEVPVL  289 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~l  289 (537)
                      .++|...+.||+|+||.||++... +|+.||+|.+...  .....+.+.+|+.++++++||||+++++++.+  ....++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            367888999999999999999965 6899999998643  44556789999999999999999999998864  457899


Q ss_pred             EEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcC--CCCeeecCCCCCCEEECCCCcEE
Q 009340          290 VYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSA--SIPIFHRDIKSSNILLDDKFSAK  367 (537)
Q Consensus       290 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~--~~~ivH~Dlk~~NIll~~~~~~k  367 (537)
                      ||||+++|+|.+++......        ...+++..++.++.|+++||.|||+.+  ..+|+||||||+||+++.++.+|
T Consensus        85 v~e~~~~~~L~~~l~~~~~~--------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~k  156 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKE--------RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVK  156 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHT--------TCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEE
T ss_pred             EEeCCCCCCHHHHHHhhccc--------CCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEE
Confidence            99999999999999764321        345999999999999999999999977  23499999999999999999999


Q ss_pred             EeeccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHH
Q 009340          368 VSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLA  447 (537)
Q Consensus       368 i~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~  447 (537)
                      |+|||++........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+       .....
T Consensus       157 l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~i  228 (279)
T 2w5a_A          157 LGDFGLARILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE-------LAGKI  228 (279)
T ss_dssp             ECCCCHHHHC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHH
T ss_pred             EecCchheeeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHH-------HHHHH
Confidence            999999987643322 1234568999999999999999999999999999999999999987543221       11111


Q ss_pred             hhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHH
Q 009340          448 KENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELE  498 (537)
Q Consensus       448 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~  498 (537)
                      ..+..         ...+...+..+.+++.+||+.||++|||+.||++.+.
T Consensus       229 ~~~~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~  270 (279)
T 2w5a_A          229 REGKF---------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL  270 (279)
T ss_dssp             HHTCC---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred             hhccc---------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence            11111         1223344567899999999999999999999987653

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=2.7e-41  Score=345.64  Aligned_cols=257  Identities=18%  Similarity=0.216  Sum_probs=207.2

Q ss_pred             HHhcCCccccccCcCCceEEEEEE------cCCCCEEEEEEccCCChHHHHHHHHHHHHHHhcC---CCCcceEeeEEee
Q 009340          213 RATDNYNQSRFLGQGGFGTVYKGM------LPDGSIVAVKRSKEIDKTQIHQFINEVVILSQIN---HRHIVKLLGCCLE  283 (537)
Q Consensus       213 ~~~~~~~~~~~lg~G~~g~Vy~~~------~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~  283 (537)
                      ...++|...++||+|+||.||+|.      ..+++.||||+++....   .++..|+.++..++   |+|++++++++..
T Consensus        62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~  138 (365)
T 3e7e_A           62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP---WEFYIGTQLMERLKPSMQHMFMKFYSAHLF  138 (365)
T ss_dssp             CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCH---HHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred             ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCCh---hHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence            345788899999999999999994      44688999999986543   46677888887776   9999999999999


Q ss_pred             CCccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECC-
Q 009340          284 TEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD-  362 (537)
Q Consensus       284 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~-  362 (537)
                      .+..++||||+++|+|.+++......       ....++|..++.++.|+++||+|||+.+   |+||||||+|||++. 
T Consensus       139 ~~~~~lv~e~~~~g~L~~~l~~~~~~-------~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~  208 (365)
T 3e7e_A          139 QNGSVLVGELYSYGTLLNAINLYKNT-------PEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNG  208 (365)
T ss_dssp             SSCEEEEECCCCSCBHHHHHHHHHTS-------TTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGG
T ss_pred             CCCcEEEEeccCCCcHHHHHHHhhcc-------cccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEeccc
Confidence            99999999999999999999764321       1346999999999999999999999999   999999999999998 


Q ss_pred             ----------CCcEEEeeccCccccCC-CCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCcc
Q 009340          363 ----------KFSAKVSDFGISRSIPN-DKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFA  431 (537)
Q Consensus       363 ----------~~~~ki~Dfgla~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~  431 (537)
                                ++.+||+|||+++.... ..........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       209 ~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~  288 (365)
T 3e7e_A          209 FLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKN  288 (365)
T ss_dssp             GTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEE
T ss_pred             ccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccC
Confidence                      89999999999976532 2223345567999999999999999999999999999999999999998543


Q ss_pred             chhhhccHHHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCC-CCHhhHHHHHHHHHHh
Q 009340          432 RVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKR-PTMKQVSMELEGLRRS  503 (537)
Q Consensus       432 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~R-Ps~~ev~~~L~~i~~~  503 (537)
                      .....              .....    +.. .  .....+.+++..|++.+|.+| |++.++.+.|+.+...
T Consensus       289 ~~~~~--------------~~~~~----~~~-~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~  340 (365)
T 3e7e_A          289 EGGEC--------------KPEGL----FRR-L--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ  340 (365)
T ss_dssp             ETTEE--------------EECSC----CTT-C--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             CCCce--------------eechh----ccc-c--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence            22110              00000    000 0  113456789999999999998 7888999999887764

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=2.1e-41  Score=340.26  Aligned_cols=251  Identities=26%  Similarity=0.338  Sum_probs=205.0

Q ss_pred             hcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCCh------HHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCcc
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDK------TQIHQFINEVVILSQINHRHIVKLLGCCLETEVP  287 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~  287 (537)
                      .++|...+.||+|+||.||++... +|+.||||.++....      ...+++.+|+.++++++||||+++++++.+.+..
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            467889999999999999999964 689999998864321      1356789999999999999999999999999999


Q ss_pred             EEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCC---
Q 009340          288 VLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF---  364 (537)
Q Consensus       288 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~---  364 (537)
                      ++||||+++++|.+++...            ..+++..++.++.|+++||.|||+.+   |+||||||+|||++.++   
T Consensus        91 ~lv~e~~~~~~L~~~l~~~------------~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~  155 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQK------------ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPI  155 (321)
T ss_dssp             EEEECCCCSCBHHHHHHTC------------SCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSS
T ss_pred             EEEEEcCCCCcHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCc
Confidence            9999999999999999652            35899999999999999999999999   99999999999999888   


Q ss_pred             -cEEEeeccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHH
Q 009340          365 -SAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACF  443 (537)
Q Consensus       365 -~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~  443 (537)
                       .+||+|||++........  .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......+.      .
T Consensus       156 ~~~kl~Dfg~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------~  227 (321)
T 2a2a_A          156 PHIKLIDFGLAHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET------L  227 (321)
T ss_dssp             CCEEECCCTTCEECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH------H
T ss_pred             CCEEEccCccceecCcccc--ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHH------H
Confidence             799999999987654322  2345689999999999999999999999999999999999999965432221      1


Q ss_pred             HHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          444 ISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       444 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      .. ......  ..++..    ....+..+.+++.+||+.||++|||+.|+++
T Consensus       228 ~~-i~~~~~--~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          228 AN-ITSVSY--DFDEEF----FSHTSELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             HH-HHTTCC--CCCHHH----HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             HH-HHhccc--ccChhh----hcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            11 111000  011111    1123356889999999999999999999986

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=2.4e-41  Score=335.11  Aligned_cols=252  Identities=23%  Similarity=0.406  Sum_probs=200.3

Q ss_pred             CCccccccCcCCceEEEEEEc-CCCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecCC
Q 009340          217 NYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYIS  295 (537)
Q Consensus       217 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  295 (537)
                      +|.....||+|+||.||+|.. .+++.||||.+........+.+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  102 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP  102 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence            444556899999999999995 4688999999887666667789999999999999999999999999999999999999


Q ss_pred             CCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECC-CCcEEEeeccCc
Q 009340          296 SGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD-KFSAKVSDFGIS  374 (537)
Q Consensus       296 ~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~-~~~~ki~Dfgla  374 (537)
                      +++|.+++.....         ...+++..+..++.|+++||.|||+.+   ++||||||+||+++. ++.+||+|||++
T Consensus       103 ~~~L~~~l~~~~~---------~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~  170 (295)
T 2clq_A          103 GGSLSALLRSKWG---------PLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTS  170 (295)
T ss_dssp             EEEHHHHHHHTTC---------CCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTC
T ss_pred             CCCHHHHHHhhcc---------CCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccc
Confidence            9999999976432         235779999999999999999999999   999999999999987 899999999999


Q ss_pred             cccCCCCCceeeeccccccccCcccccCCC--CCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchh
Q 009340          375 RSIPNDKTHLTTTIQGTFGYLDPEYFQSSQ--FTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQL  452 (537)
Q Consensus       375 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  452 (537)
                      ........ ......||+.|+|||.+.+..  ++.++||||||+++|||++|+.||........     .......    
T Consensus       171 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----~~~~~~~----  240 (295)
T 2clq_A          171 KRLAGINP-CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA-----AMFKVGM----  240 (295)
T ss_dssp             EESCC------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH-----HHHHHHH----
T ss_pred             cccCCCCC-cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH-----HHHhhcc----
Confidence            87643221 233456899999999987643  88999999999999999999999864322110     0000000    


Q ss_pred             hhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          453 LEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       453 ~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                           .......+...+..+.+++.+||+.||++|||+.++++
T Consensus       241 -----~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          241 -----FKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             -----HCCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             -----ccccccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                 00111223344567889999999999999999999974

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.1e-42  Score=345.93  Aligned_cols=261  Identities=22%  Similarity=0.354  Sum_probs=196.4

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCChHH-HHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEec
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKTQ-IHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY  293 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  293 (537)
                      ++|...+.||+|+||.||+|... +++.||||+++...... ...+.+|+.++++++||||+++++++.+.+..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            57888999999999999999965 78999999987533221 22456799999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccC
Q 009340          294 ISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGI  373 (537)
Q Consensus       294 ~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgl  373 (537)
                      ++ |+|.+++....           ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        82 ~~-~~l~~~~~~~~-----------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~  146 (324)
T 3mtl_A           82 LD-KDLKQYLDDCG-----------NIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGL  146 (324)
T ss_dssp             CS-EEHHHHHHHTT-----------TCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSE
T ss_pred             cc-cCHHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcc
Confidence            97 58988887542           36999999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCCceeeeccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhh---
Q 009340          374 SRSIPNDKTHLTTTIQGTFGYLDPEYFQS-SQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKE---  449 (537)
Q Consensus       374 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---  449 (537)
                      +........ ......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+.   ..........   
T Consensus       147 a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~i~~~~~~~~~  222 (324)
T 3mtl_A          147 ARAKSIPTK-TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQ---LHFIFRILGTPTE  222 (324)
T ss_dssp             EECC-------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCCT
T ss_pred             cccccCCcc-ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCCh
Confidence            986543322 2334568999999999876 5689999999999999999999999976544332   1111111111   


Q ss_pred             chhhhhhcHHh-------------hccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          450 NQLLEILDARV-------------AKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       450 ~~~~~~~d~~~-------------~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      ...........             ...........+.+|+.+||+.||++|||+.|+++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  281 (324)
T 3mtl_A          223 ETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK  281 (324)
T ss_dssp             TTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             HhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence            01111110000             00011223467889999999999999999999976

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=2.4e-41  Score=331.85  Aligned_cols=252  Identities=26%  Similarity=0.398  Sum_probs=203.8

Q ss_pred             hcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCC-ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEe
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI-DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE  292 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e  292 (537)
                      .++|...+.||+|+||.||++... +++.||||.+... .....+.+.+|+.+++.++|+||+++++++.+.+..++|||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence            467888999999999999999965 6899999998642 23456788999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeecc
Q 009340          293 YISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG  372 (537)
Q Consensus       293 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfg  372 (537)
                      |+++++|.+++...            ..+++..++.++.|+++||.|||+.+   ++||||||+||+++.++.+||+|||
T Consensus        86 ~~~~~~L~~~l~~~------------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg  150 (276)
T 2yex_A           86 YCSGGELFDRIEPD------------IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFG  150 (276)
T ss_dssp             CCTTEEGGGGSBTT------------TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred             ecCCCcHHHHHhhc------------cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCC
Confidence            99999999998653            35899999999999999999999999   9999999999999999999999999


Q ss_pred             CccccCCCCC-ceeeeccccccccCcccccCCCC-CcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhc
Q 009340          373 ISRSIPNDKT-HLTTTIQGTFGYLDPEYFQSSQF-TDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKEN  450 (537)
Q Consensus       373 la~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  450 (537)
                      ++........ .......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||........ .    +.......
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~----~~~~~~~~  225 (276)
T 2yex_A          151 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-E----YSDWKEKK  225 (276)
T ss_dssp             TCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-H----HHHHHTTC
T ss_pred             CccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-H----HHHhhhcc
Confidence            9986532221 22344568999999999987665 7899999999999999999999975433211 0    11111100


Q ss_pred             hhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          451 QLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       451 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      ..         .......+..+.+++.+||+.||++|||+.|+++
T Consensus       226 ~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          226 TY---------LNPWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             TT---------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             cc---------cCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence            00         0011223456789999999999999999999865

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=5.7e-41  Score=353.59  Aligned_cols=258  Identities=21%  Similarity=0.306  Sum_probs=196.4

Q ss_pred             hcCCccccccCcCCceEEEEEEc-CCCCEEEEEEccCC--ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCC------
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEI--DKTQIHQFINEVVILSQINHRHIVKLLGCCLETE------  285 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------  285 (537)
                      .++|...+.||+|+||.||++.. .+|+.||||++...  .....+++.+|+.+++.++||||+++++++....      
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            46899999999999999999985 46889999998753  4556778899999999999999999999997553      


Q ss_pred             ccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCc
Q 009340          286 VPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFS  365 (537)
Q Consensus       286 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~  365 (537)
                      ..++||||++++ |.+.+.              ..+++..+..++.|+++||.|||+.+   |+||||||+|||++.++.
T Consensus       141 ~~~lv~E~~~~~-l~~~~~--------------~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~  202 (464)
T 3ttj_A          141 DVYLVMELMDAN-LCQVIQ--------------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCT  202 (464)
T ss_dssp             EEEEEEECCSEE-HHHHHT--------------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSC
T ss_pred             eEEEEEeCCCCC-HHHHHh--------------hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCC
Confidence            469999999864 666553              24899999999999999999999999   999999999999999999


Q ss_pred             EEEeeccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHH
Q 009340          366 AKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFIS  445 (537)
Q Consensus       366 ~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~  445 (537)
                      +||+|||+++.....  .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+..   .....
T Consensus       203 ~kl~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~---~~i~~  277 (464)
T 3ttj_A          203 LKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQW---NKVIE  277 (464)
T ss_dssp             EEECCCCCC-----C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHHH
T ss_pred             EEEEEEEeeeecCCC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHH
Confidence            999999999876432  2234567999999999999999999999999999999999999999765432211   11111


Q ss_pred             HHhhc----------hhh---------------hhhcHHhh---ccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          446 LAKEN----------QLL---------------EILDARVA---KEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       446 ~~~~~----------~~~---------------~~~d~~~~---~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      .....          ...               ..+.....   ..........+.+|+.+||+.||++|||+.|+++
T Consensus       278 ~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  355 (464)
T 3ttj_A          278 QLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  355 (464)
T ss_dssp             HHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            10000          000               00000000   0011223567899999999999999999999876

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=3.7e-41  Score=331.86  Aligned_cols=257  Identities=27%  Similarity=0.353  Sum_probs=204.6

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCCh------HHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDK------TQIHQFINEVVILSQINHRHIVKLLGCCLETEVPV  288 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  288 (537)
                      ++|...+.||+|+||.||++... +|+.||+|.++....      ...+.+.+|+.++++++||||+++++++.+....+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            56888999999999999999975 689999998764321      13577899999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCC----
Q 009340          289 LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF----  364 (537)
Q Consensus       289 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~----  364 (537)
                      +||||+++++|.+++...            ..+++..++.++.|+++||.|||+.+   ++||||||+||+++.++    
T Consensus        85 lv~e~~~~~~L~~~l~~~------------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~  149 (283)
T 3bhy_A           85 LILELVSGGELFDFLAEK------------ESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNP  149 (283)
T ss_dssp             EEEECCCSCBHHHHHHHH------------SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSC
T ss_pred             EEEeecCCCcHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCC
Confidence            999999999999999652            35999999999999999999999999   99999999999998877    


Q ss_pred             cEEEeeccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHH
Q 009340          365 SAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFI  444 (537)
Q Consensus       365 ~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~  444 (537)
                      .+||+|||++........  .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......+.      . 
T Consensus       150 ~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~-  220 (283)
T 3bhy_A          150 RIKLIDFGIAHKIEAGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQET------L-  220 (283)
T ss_dssp             CEEECCCTTCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------H-
T ss_pred             ceEEEecccceeccCCCc--ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHH------H-
Confidence            899999999987643322  2345689999999999999999999999999999999999999865432211      1 


Q ss_pred             HHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH--HHHHHHH
Q 009340          445 SLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM--ELEGLRR  502 (537)
Q Consensus       445 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~--~L~~i~~  502 (537)
                      ........  ......    ....+..+.+++.+||+.||++|||+.++++  .++.++.
T Consensus       221 ~~~~~~~~--~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~  274 (283)
T 3bhy_A          221 TNISAVNY--DFDEEY----FSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRR  274 (283)
T ss_dssp             HHHHTTCC--CCCHHH----HTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHH
T ss_pred             HHhHhccc--CCcchh----cccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHH
Confidence            11111000  001111    1123456889999999999999999999987  4555443

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=2.5e-41  Score=333.85  Aligned_cols=252  Identities=27%  Similarity=0.359  Sum_probs=198.2

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCC-ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEec
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI-DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY  293 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  293 (537)
                      ++|...++||+|+||.||++... ++..||+|++... .....+.+.+|+.++++++||||+++++++.+....++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  101 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET  101 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence            57888999999999999999964 6889999988653 233457789999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEE---CCCCcEEEee
Q 009340          294 ISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILL---DDKFSAKVSD  370 (537)
Q Consensus       294 ~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll---~~~~~~ki~D  370 (537)
                      +++|+|.+++......        ...+++..++.++.|+++||.|||+.+   |+||||||+|||+   +.++.+||+|
T Consensus       102 ~~~~~L~~~l~~~~~~--------~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~D  170 (285)
T 3is5_A          102 CEGGELLERIVSAQAR--------GKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIID  170 (285)
T ss_dssp             CSCCBHHHHHHHHHHH--------TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECC
T ss_pred             CCCCcHHHHHHhhhhc--------ccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEe
Confidence            9999999999764321        357999999999999999999999999   9999999999999   5568899999


Q ss_pred             ccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhc
Q 009340          371 FGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKEN  450 (537)
Q Consensus       371 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  450 (537)
                      ||++.......  ......||+.|+|||.+. +.++.++||||||+++|||++|+.||......+.       .......
T Consensus       171 fg~a~~~~~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~-------~~~~~~~  240 (285)
T 3is5_A          171 FGLAELFKSDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEV-------QQKATYK  240 (285)
T ss_dssp             CCCCCC------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHC
T ss_pred             eecceecCCcc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHH-------HhhhccC
Confidence            99998764332  234456899999999985 5689999999999999999999999975433221       1111000


Q ss_pred             hhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          451 QLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       451 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      .      +.... .....+..+.+++.+||+.||++|||+.|+++
T Consensus       241 ~------~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          241 E------PNYAV-ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             C------CCCCC---CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             C------ccccc-ccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0      00000 00112356789999999999999999999974

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=7.9e-42  Score=345.47  Aligned_cols=243  Identities=26%  Similarity=0.391  Sum_probs=202.6

Q ss_pred             HhcCCccccccCcCCceEEEEEEc-CCCCEEEEEEccCCCh--------HHHHHHHHHHHHHHhcCCCCcceEeeEEeeC
Q 009340          214 ATDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEIDK--------TQIHQFINEVVILSQINHRHIVKLLGCCLET  284 (537)
Q Consensus       214 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~  284 (537)
                      ..++|...+.||+|+||.||+|+. .+++.||||.++....        ...+.+.+|+.++++++||||+++++++.+.
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            457899999999999999999984 4788999998865321        1234577899999999999999999999999


Q ss_pred             CccEEEEecCCCC-ChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCC
Q 009340          285 EVPVLVYEYISSG-TLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK  363 (537)
Q Consensus       285 ~~~~lV~e~~~~g-sL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~  363 (537)
                      +..++||||+..| +|.+++...            ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.+
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~~~------------~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~  166 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFIDRH------------PRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAED  166 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHHTC------------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTT
T ss_pred             CEEEEEEEeCCCCccHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCC
Confidence            9999999999877 999998653            36999999999999999999999999   9999999999999999


Q ss_pred             CcEEEeeccCccccCCCCCceeeeccccccccCcccccCCCC-CcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHH
Q 009340          364 FSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQF-TDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVAC  442 (537)
Q Consensus       364 ~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~  442 (537)
                      +.+||+|||++........  .....||+.|+|||.+.+..+ +.++||||||+++|||++|+.||......        
T Consensus       167 ~~~kL~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------  236 (335)
T 3dls_A          167 FTIKLIDFGSAAYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET--------  236 (335)
T ss_dssp             SCEEECCCTTCEECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG--------
T ss_pred             CcEEEeecccceECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH--------
Confidence            9999999999987654332  344568999999999988776 78999999999999999999998642110        


Q ss_pred             HHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHH
Q 009340          443 FISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSME  496 (537)
Q Consensus       443 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~  496 (537)
                                   .....  ..+...+..+.+|+.+||+.||++|||+.++++.
T Consensus       237 -------------~~~~~--~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          237 -------------VEAAI--HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             -------------TTTCC--CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             -------------Hhhcc--CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                         00000  1122234568899999999999999999999874

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=3.5e-41  Score=355.17  Aligned_cols=246  Identities=28%  Similarity=0.399  Sum_probs=204.7

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCC---hHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEID---KTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY  291 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  291 (537)
                      ++|...+.||+|+||.||+|+.. +|+.||||++....   ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~   95 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM   95 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            67888999999999999999965 79999999986422   123467889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeec
Q 009340          292 EYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF  371 (537)
Q Consensus       292 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Df  371 (537)
                      ||+++|+|.+++...            ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+||
T Consensus        96 E~~~gg~L~~~l~~~------------~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DF  160 (476)
T 2y94_A           96 EYVSGGELFDYICKN------------GRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADF  160 (476)
T ss_dssp             ECCSSEEHHHHTTSS------------SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCC
T ss_pred             eCCCCCcHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEec
Confidence            999999999999752            35999999999999999999999999   999999999999999999999999


Q ss_pred             cCccccCCCCCceeeeccccccccCcccccCCCC-CcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhc
Q 009340          372 GISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQF-TDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKEN  450 (537)
Q Consensus       372 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  450 (537)
                      |++.......  ......||+.|+|||.+.+..+ +.++|||||||++|||++|+.||.......      .+... ..+
T Consensus       161 G~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~------~~~~i-~~~  231 (476)
T 2y94_A          161 GLSNMMSDGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT------LFKKI-CDG  231 (476)
T ss_dssp             SSCEECCTTC--CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH------HHHHH-HTT
T ss_pred             cchhhccccc--cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH------HHHHH-hcC
Confidence            9998765432  2344579999999999988765 689999999999999999999997543221      11111 111


Q ss_pred             hhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          451 QLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       451 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      .          ...+...+..+.+|+.+||+.||++|||+.++++
T Consensus       232 ~----------~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~  266 (476)
T 2y94_A          232 I----------FYTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE  266 (476)
T ss_dssp             C----------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             C----------cCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence            0          0112233457889999999999999999999986

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.4e-41  Score=334.11  Aligned_cols=249  Identities=25%  Similarity=0.388  Sum_probs=183.9

Q ss_pred             hcCCccccccCcCCceEEEEEEc-CCCCEEEEEEccCCCh---HHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEE
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEIDK---TQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLV  290 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  290 (537)
                      .++|...+.||+|+||.||+|.. .+|+.||||.+.....   ...+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            35788899999999999999995 4789999999864211   2246788999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEee
Q 009340          291 YEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSD  370 (537)
Q Consensus       291 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~D  370 (537)
                      |||+++++|.+++...           ...+++..++.++.|+++||.|||+.+   ++||||||+||+++.++.+||+|
T Consensus        90 ~e~~~~~~L~~~l~~~-----------~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~d  155 (278)
T 3cok_A           90 LEMCHNGEMNRYLKNR-----------VKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIAD  155 (278)
T ss_dssp             EECCTTEEHHHHHHTC-----------SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECC
T ss_pred             EecCCCCcHHHHHhhc-----------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEe
Confidence            9999999999998753           236999999999999999999999999   99999999999999999999999


Q ss_pred             ccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhc
Q 009340          371 FGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKEN  450 (537)
Q Consensus       371 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  450 (537)
                      ||++........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+.      .       
T Consensus       156 fg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~-------  221 (278)
T 3cok_A          156 FGLATQLKMPHE-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT------L-------  221 (278)
T ss_dssp             CTTCEECC-----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC----------------
T ss_pred             ecceeeccCCCC-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH------H-------
Confidence            999987643222 12345689999999999998999999999999999999999999865432211      0       


Q ss_pred             hhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          451 QLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       451 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                        .......  ...+...+..+.+++.+||+.||++|||+.++++
T Consensus       222 --~~~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          222 --NKVVLAD--YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             ----CCSSC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             --HHHhhcc--cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence              0000000  0122234467889999999999999999999875

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=4.3e-41  Score=334.94  Aligned_cols=251  Identities=24%  Similarity=0.414  Sum_probs=207.3

Q ss_pred             hcCCccccccCcCCceEEEEEEc-CCCCEEEEEEccCCC-hHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEe
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEID-KTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE  292 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e  292 (537)
                      .+.|...+.||+|+||.||+|.. .+++.||||.+.... ....+.+.+|+.++++++|+||+++++++.+....++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  100 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME  100 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence            35788899999999999999985 468999999986432 3446789999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeecc
Q 009340          293 YISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG  372 (537)
Q Consensus       293 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfg  372 (537)
                      |+++++|.+++..             ..+++..++.++.|+++||.|||+.+   |+||||||+||+++.++.+||+|||
T Consensus       101 ~~~~~~L~~~~~~-------------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg  164 (303)
T 3a7i_A          101 YLGGGSALDLLEP-------------GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFG  164 (303)
T ss_dssp             CCTTEEHHHHHTT-------------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred             eCCCCcHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecc
Confidence            9999999999853             36899999999999999999999999   9999999999999999999999999


Q ss_pred             CccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchh
Q 009340          373 ISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQL  452 (537)
Q Consensus       373 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  452 (537)
                      ++........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.||........       .......  
T Consensus       165 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-------~~~~~~~--  234 (303)
T 3a7i_A          165 VAGQLTDTQI-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKV-------LFLIPKN--  234 (303)
T ss_dssp             TCEECBTTBC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-------HHHHHHS--
T ss_pred             cceecCcccc-ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHH-------HHHhhcC--
Confidence            9987643322 23445689999999999999999999999999999999999999865432211       1111111  


Q ss_pred             hhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHH
Q 009340          453 LEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELE  498 (537)
Q Consensus       453 ~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~  498 (537)
                             .....+...+..+.+++.+||+.||++|||+.++++..-
T Consensus       235 -------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~  273 (303)
T 3a7i_A          235 -------NPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKF  273 (303)
T ss_dssp             -------CCCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHH
T ss_pred             -------CCCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChh
Confidence                   011122233456889999999999999999999987543

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=5.4e-42  Score=352.46  Aligned_cols=253  Identities=17%  Similarity=0.157  Sum_probs=196.3

Q ss_pred             hcCCccccccCcCCceEEEEEEc-CCCCEEEEEEccC---CChHHHHHHHHHH---HHHHhcCCCCcceEe-------eE
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKE---IDKTQIHQFINEV---VILSQINHRHIVKLL-------GC  280 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~---~~~~~~~~~~~E~---~~l~~l~H~niv~l~-------g~  280 (537)
                      .++|...+.||+|+||.||+|+. .+|+.||||++..   ......+.|.+|+   .++++++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            46788899999999999999996 4699999999863   3344567899999   555566899999998       55


Q ss_pred             EeeCC-----------------ccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhc
Q 009340          281 CLETE-----------------VPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSS  343 (537)
Q Consensus       281 ~~~~~-----------------~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~  343 (537)
                      +.+.+                 ..++||||+ +|+|.+++........     ....++|..++.|+.|+++||+|||++
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~-----~~~~l~~~~~~~i~~qi~~aL~~LH~~  225 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSS-----THKSLVHHARLQLTLQVIRLLASLHHY  225 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTT-----TTHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhcccccc-----ccccccHHHHHHHHHHHHHHHHHHHhC
Confidence            55443                 278999999 6899999986532110     012356789999999999999999999


Q ss_pred             CCCCeeecCCCCCCEEECCCCcEEEeeccCccccCCCCCceeeeccccccccCcccccCC-----------CCCcchhHH
Q 009340          344 ASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSS-----------QFTDKSDVY  412 (537)
Q Consensus       344 ~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~t~ksDV~  412 (537)
                      +   |+||||||+|||++.++.+||+|||+++....    ......| +.|+|||++.+.           .++.++|||
T Consensus       226 ~---ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Dvw  297 (377)
T 3byv_A          226 G---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAW  297 (377)
T ss_dssp             T---EECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHH
T ss_pred             C---eecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHH
Confidence            9   99999999999999999999999999986432    2344567 999999999877           899999999


Q ss_pred             HHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhh
Q 009340          413 SFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQ  492 (537)
Q Consensus       413 S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  492 (537)
                      ||||++|||++|+.||........               ...+..      .....+..+.+|+.+||+.||++|||+.+
T Consensus       298 SlG~il~elltg~~Pf~~~~~~~~---------------~~~~~~------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e  356 (377)
T 3byv_A          298 ALGLVIYWIWCADLPITKDAALGG---------------SEWIFR------SCKNIPQPVRALLEGFLRYPKEDRLLPLQ  356 (377)
T ss_dssp             HHHHHHHHHHHSSCCC------CC---------------SGGGGS------SCCCCCHHHHHHHHHHTCSSGGGCCCHHH
T ss_pred             HHHHHHHHHHHCCCCCcccccccc---------------hhhhhh------hccCCCHHHHHHHHHHcCCCchhCCCHHH
Confidence            999999999999999854322110               001110      01123456889999999999999999999


Q ss_pred             HHH--HHHHHHH
Q 009340          493 VSM--ELEGLRR  502 (537)
Q Consensus       493 v~~--~L~~i~~  502 (537)
                      +++  .++.+..
T Consensus       357 ~l~hp~f~~~~~  368 (377)
T 3byv_A          357 AMETPEYEQLRT  368 (377)
T ss_dssp             HHTSHHHHHHHH
T ss_pred             HhhChHHHHHHH
Confidence            986  5555554

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=6.3e-41  Score=332.31  Aligned_cols=248  Identities=23%  Similarity=0.398  Sum_probs=206.3

Q ss_pred             hcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCC---ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEE
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI---DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLV  290 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  290 (537)
                      .++|...+.||+|+||.||++... +++.||+|.+...   .....+.+.+|+.+++.++|+||+++++++.+.+..++|
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            367888999999999999999965 5789999987542   345567889999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEee
Q 009340          291 YEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSD  370 (537)
Q Consensus       291 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~D  370 (537)
                      |||+++++|.+++...            ..+++..++.++.|+++||.|||+.+   ++||||||+||+++.++.+||+|
T Consensus        94 ~e~~~~~~L~~~~~~~------------~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~d  158 (294)
T 2rku_A           94 LELCRRRSLLELHKRR------------KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGD  158 (294)
T ss_dssp             EECCTTCBHHHHHHHH------------CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECC
T ss_pred             EecCCCCCHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEe
Confidence            9999999999988652            36999999999999999999999999   99999999999999999999999


Q ss_pred             ccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhc
Q 009340          371 FGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKEN  450 (537)
Q Consensus       371 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  450 (537)
                      ||++........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+.      ...... .
T Consensus       159 fg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~------~~~~~~-~  230 (294)
T 2rku_A          159 FGLATKVEYDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET------YLRIKK-N  230 (294)
T ss_dssp             CTTCEECCSTTC-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHHT-T
T ss_pred             ccCceecccCcc-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHhh-c
Confidence            999987643322 23345689999999999998899999999999999999999999875433221      111111 0


Q ss_pred             hhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          451 QLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       451 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      .          ...+......+.+++.+||+.||++|||+.++++
T Consensus       231 ~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  265 (294)
T 2rku_A          231 E----------YSIPKHINPVAASLIQKMLQTDPTARPTINELLN  265 (294)
T ss_dssp             C----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             c----------CCCccccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence            0          0122233457889999999999999999999976

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1.9e-41  Score=346.11  Aligned_cols=262  Identities=25%  Similarity=0.408  Sum_probs=204.9

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCC-ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEec
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI-DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY  293 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  293 (537)
                      ++|...+.||+|+||.||++... +++.||+|.+... .....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus        33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  112 (360)
T 3eqc_A           33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH  112 (360)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence            57888999999999999999965 6899999998754 455567899999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeeecCCCCCCEEECCCCcEEEeecc
Q 009340          294 ISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSS-ASIPIFHRDIKSSNILLDDKFSAKVSDFG  372 (537)
Q Consensus       294 ~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~-~~~~ivH~Dlk~~NIll~~~~~~ki~Dfg  372 (537)
                      +++|+|.+++...            ..+++..+..++.+++.||.|||+. +   |+||||||+|||++.++.+||+|||
T Consensus       113 ~~~~~L~~~l~~~------------~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg  177 (360)
T 3eqc_A          113 MDGGSLDQVLKKA------------GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFG  177 (360)
T ss_dssp             CTTCBHHHHHHHH------------SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCC
T ss_pred             CCCCCHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECC
Confidence            9999999999753            3589999999999999999999996 7   9999999999999999999999999


Q ss_pred             CccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHH---------
Q 009340          373 ISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACF---------  443 (537)
Q Consensus       373 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~---------  443 (537)
                      ++......   ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+........         
T Consensus       178 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  254 (360)
T 3eqc_A          178 VSGQLIDS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETP  254 (360)
T ss_dssp             CCHHHHHH---C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------
T ss_pred             CCcccccc---cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCC
Confidence            98754221   123456899999999999999999999999999999999999999754433211000000         


Q ss_pred             --------------HHHHhhchhhhhhcHHhhc---c-ccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          444 --------------ISLAKENQLLEILDARVAK---E-AREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       444 --------------~~~~~~~~~~~~~d~~~~~---~-~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                                    ..........+.++.....   . .....+..+.+|+.+||+.||++|||+.|+++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  324 (360)
T 3eqc_A          255 PRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  324 (360)
T ss_dssp             -------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             CCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence                          0000000011111111110   0 11123457899999999999999999999976

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=2.3e-41  Score=346.45  Aligned_cols=250  Identities=25%  Similarity=0.379  Sum_probs=195.3

Q ss_pred             hcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCC---ChHHHHHHHHHHHH-HHhcCCCCcceEeeEEeeCCccEE
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI---DKTQIHQFINEVVI-LSQINHRHIVKLLGCCLETEVPVL  289 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~-l~~l~H~niv~l~g~~~~~~~~~l  289 (537)
                      .++|...+.||+|+||.||+++.. +++.||||+++..   .......+.+|..+ ++.++||||+++++++.+.+..++
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            367899999999999999999965 5889999998642   22334556777776 567899999999999999999999


Q ss_pred             EEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEe
Q 009340          290 VYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVS  369 (537)
Q Consensus       290 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~  369 (537)
                      ||||+++|+|.+++...            ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+
T Consensus       117 v~E~~~gg~L~~~l~~~------------~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~  181 (373)
T 2r5t_A          117 VLDYINGGELFYHLQRE------------RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLT  181 (373)
T ss_dssp             EEECCCSCBHHHHHHHH------------SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEEC
T ss_pred             EEeCCCCCcHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEe
Confidence            99999999999999753            35889999999999999999999999   9999999999999999999999


Q ss_pred             eccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhh
Q 009340          370 DFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKE  449 (537)
Q Consensus       370 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  449 (537)
                      |||+++...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||......+      .+......
T Consensus       182 DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~------~~~~i~~~  254 (373)
T 2r5t_A          182 DFGLCKENIEHN-STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE------MYDNILNK  254 (373)
T ss_dssp             CCCBCGGGBCCC-CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHH------HHHHHHHS
T ss_pred             eCccccccccCC-CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH------HHHHHHhc
Confidence            999998643222 22445679999999999999999999999999999999999999997543322      11111111


Q ss_pred             chhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHH
Q 009340          450 NQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMEL  497 (537)
Q Consensus       450 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L  497 (537)
                               ..  ..+...+..+.+|+.+||+.||.+||++.+.++.+
T Consensus       255 ---------~~--~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i  291 (373)
T 2r5t_A          255 ---------PL--QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEI  291 (373)
T ss_dssp             ---------CC--CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHH
T ss_pred             ---------cc--CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHH
Confidence                     00  11223445788999999999999999997544443

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=5.2e-41  Score=334.59  Aligned_cols=250  Identities=25%  Similarity=0.371  Sum_probs=202.9

Q ss_pred             hcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEec
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY  293 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  293 (537)
                      .++|...+.||+|+||.||++... +|+.||+|.++.......+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL   87 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence            467888999999999999999964 7899999999865554556788999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEE---CCCCcEEEee
Q 009340          294 ISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILL---DDKFSAKVSD  370 (537)
Q Consensus       294 ~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll---~~~~~~ki~D  370 (537)
                      +++|+|.+++...            ..+++..+..++.|++.||.|||+.+   |+||||||+||++   +.++.+||+|
T Consensus        88 ~~~~~L~~~l~~~------------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~D  152 (304)
T 2jam_A           88 VSGGELFDRILER------------GVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITD  152 (304)
T ss_dssp             CCSCBHHHHHHHH------------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCS
T ss_pred             CCCccHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEcc
Confidence            9999999998653            35899999999999999999999999   9999999999999   7889999999


Q ss_pred             ccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhc
Q 009340          371 FGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKEN  450 (537)
Q Consensus       371 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  450 (537)
                      ||++......   ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.......       .......+
T Consensus       153 fg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-------~~~~i~~~  222 (304)
T 2jam_A          153 FGLSKMEQNG---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK-------LFEKIKEG  222 (304)
T ss_dssp             CSTTCCCCCB---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH-------HHHHHHHC
T ss_pred             CCcceecCCC---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHcC
Confidence            9999764332   1234568999999999999999999999999999999999999986543221       11111111


Q ss_pred             hhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          451 QLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       451 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      ..      ..........+..+.+++.+||+.||++|||+.++++
T Consensus       223 ~~------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (304)
T 2jam_A          223 YY------EFESPFWDDISESAKDFICHLLEKDPNERYTCEKALS  261 (304)
T ss_dssp             CC------CCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             CC------CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            10      0001112234467889999999999999999999976

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.3e-42  Score=347.79  Aligned_cols=255  Identities=25%  Similarity=0.352  Sum_probs=204.0

Q ss_pred             hcCCccccccCcCCceEEEEEEc----CCCCEEEEEEccCCC----hHHHHHHHHHHHHHHhc-CCCCcceEeeEEeeCC
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGML----PDGSIVAVKRSKEID----KTQIHQFINEVVILSQI-NHRHIVKLLGCCLETE  285 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~----~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~  285 (537)
                      .++|...+.||+|+||.||+++.    .+|+.||||+++...    ....+.+.+|+.+++++ +|+||+++++++.+.+
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            36899999999999999999986    368999999886421    12335577899999999 6999999999999999


Q ss_pred             ccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCc
Q 009340          286 VPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFS  365 (537)
Q Consensus       286 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~  365 (537)
                      ..++||||+++|+|.+++...            ..+++..+..++.|+++||.|||+.+   |+||||||+|||++.++.
T Consensus       133 ~~~lv~e~~~~~~L~~~l~~~------------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~  197 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLSQR------------ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGH  197 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHHHH------------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSC
T ss_pred             eEEEEeecCCCCCHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCc
Confidence            999999999999999999753            35999999999999999999999999   999999999999999999


Q ss_pred             EEEeeccCccccCCCCCceeeeccccccccCcccccC--CCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHH
Q 009340          366 AKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQS--SQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACF  443 (537)
Q Consensus       366 ~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~  443 (537)
                      +||+|||+++..............||+.|+|||++.+  ..++.++||||||+++|||++|+.||........  .....
T Consensus       198 ~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~--~~~~~  275 (355)
T 1vzo_A          198 VVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS--QAEIS  275 (355)
T ss_dssp             EEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC--HHHHH
T ss_pred             EEEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch--HHHHH
Confidence            9999999998765444444455679999999999985  3478999999999999999999999965432211  11111


Q ss_pred             HHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCC-----CHhhHHHHH
Q 009340          444 ISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRP-----TMKQVSMEL  497 (537)
Q Consensus       444 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~~L  497 (537)
                      .....           .....+...+..+.+|+.+||+.||++||     |+.++++..
T Consensus       276 ~~~~~-----------~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~  323 (355)
T 1vzo_A          276 RRILK-----------SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL  323 (355)
T ss_dssp             HHHHH-----------CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred             HHHhc-----------cCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence            11110           01122334456788999999999999999     888887643

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.7e-41  Score=342.35  Aligned_cols=265  Identities=23%  Similarity=0.367  Sum_probs=200.5

Q ss_pred             hcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccC--CChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEE
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKE--IDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY  291 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  291 (537)
                      .++|...+.||+|+||.||++... +|+.||||++..  ......+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  103 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF  103 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence            367888999999999999999965 589999998754  33444567889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeec
Q 009340          292 EYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF  371 (537)
Q Consensus       292 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Df  371 (537)
                      ||+++++|.+++..            ...+++..+..++.|+++||.|||+.+   |+||||||+|||++.++.+||+||
T Consensus       104 e~~~~~~l~~~~~~------------~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Df  168 (331)
T 4aaa_A          104 EFVDHTILDDLELF------------PNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDF  168 (331)
T ss_dssp             ECCSEEHHHHHHHS------------TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC
T ss_pred             ecCCcchHHHHHhh------------ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeC
Confidence            99999999887654            235999999999999999999999999   999999999999999999999999


Q ss_pred             cCccccCCCCCceeeeccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHH--------
Q 009340          372 GISRSIPNDKTHLTTTIQGTFGYLDPEYFQSS-QFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVAC--------  442 (537)
Q Consensus       372 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~--------  442 (537)
                      |++........ ......||+.|+|||.+.+. .++.++||||||+++|||++|+.||......+.......        
T Consensus       169 g~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  247 (331)
T 4aaa_A          169 GFARTLAAPGE-VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPR  247 (331)
T ss_dssp             TTC-------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHH
T ss_pred             CCceeecCCcc-ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChh
Confidence            99986643322 23345689999999999775 789999999999999999999999976543321110000        


Q ss_pred             HHHHHhh-chhhhhhcHHhhc-----cccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          443 FISLAKE-NQLLEILDARVAK-----EAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       443 ~~~~~~~-~~~~~~~d~~~~~-----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      ....+.. ........+....     ......+..+.+|+.+||+.||++|||+.|+++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          248 HQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             HHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             hhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            0000000 0000000000000     011234567899999999999999999999976

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=6.4e-41  Score=338.83  Aligned_cols=248  Identities=23%  Similarity=0.398  Sum_probs=206.5

Q ss_pred             hcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCC---ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEE
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI---DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLV  290 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  290 (537)
                      .++|...+.||+|+||.||++... +++.||+|.+...   .....+.+.+|+.+++.++|+||+++++++.+.+..++|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            367888999999999999999965 5789999987642   345567889999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEee
Q 009340          291 YEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSD  370 (537)
Q Consensus       291 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~D  370 (537)
                      |||+++++|.+++...            ..+++..++.++.|+++||.|||+.+   |+||||||+|||++.++.+||+|
T Consensus       120 ~e~~~~~~L~~~~~~~------------~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~D  184 (335)
T 2owb_A          120 LELCRRRSLLELHKRR------------KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGD  184 (335)
T ss_dssp             ECCCTTCBHHHHHHHH------------CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECC
T ss_pred             EecCCCCCHHHHHhcc------------CCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEee
Confidence            9999999999988652            35999999999999999999999999   99999999999999999999999


Q ss_pred             ccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhc
Q 009340          371 FGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKEN  450 (537)
Q Consensus       371 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  450 (537)
                      ||++........ ......||..|+|||.+.+..++.++||||||+++|||++|+.||......+.      ...... .
T Consensus       185 fg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------~~~~~~-~  256 (335)
T 2owb_A          185 FGLATKVEYDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET------YLRIKK-N  256 (335)
T ss_dssp             CTTCEECCSTTC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHHH-T
T ss_pred             ccCceecccCcc-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHH------HHHHhc-C
Confidence            999987643322 23445689999999999998999999999999999999999999865433221      111111 0


Q ss_pred             hhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          451 QLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       451 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      .          ...+......+.+|+.+||+.||++|||+.|+++
T Consensus       257 ~----------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  291 (335)
T 2owb_A          257 E----------YSIPKHINPVAASLIQKMLQTDPTARPTINELLN  291 (335)
T ss_dssp             C----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             C----------CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0          0122233456889999999999999999999976

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=9.4e-41  Score=352.49  Aligned_cols=264  Identities=20%  Similarity=0.292  Sum_probs=208.8

Q ss_pred             hcCCccccccCcCCceEEEEEEc-CCCCEEEEEEccCCChHHHHHHHHHHHHHHhcCC-CCcceEeeEEeeCCccEEEEe
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEIDKTQIHQFINEVVILSQINH-RHIVKLLGCCLETEVPVLVYE  292 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~e  292 (537)
                      .++|...++||+|+||.||+|.. .+++.||||.+.....  ..++.+|+.++..++| +++..+..++.+.+..++|||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme   83 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD   83 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence            36899999999999999999995 5789999998764322  2357889999999976 566666677777888899999


Q ss_pred             cCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEE---CCCCcEEEe
Q 009340          293 YISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILL---DDKFSAKVS  369 (537)
Q Consensus       293 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll---~~~~~~ki~  369 (537)
                      |+ +++|.+++....           ..+++..++.|+.||+.||.|||+.+   |+||||||+||||   +.++.+||+
T Consensus        84 ~~-g~sL~~ll~~~~-----------~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~  148 (483)
T 3sv0_A           84 LL-GPSLEDLFNFCS-----------RKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYII  148 (483)
T ss_dssp             CC-CCBHHHHHHHTT-----------TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEEC
T ss_pred             CC-CCCHHHHHHhhc-----------CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEE
Confidence            99 999999997532           36999999999999999999999999   9999999999999   688999999


Q ss_pred             eccCccccCCCCCc------eeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHH
Q 009340          370 DFGISRSIPNDKTH------LTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACF  443 (537)
Q Consensus       370 Dfgla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~  443 (537)
                      |||+++........      ......||+.|+|||.+.+..++.++|||||||+||||++|+.||...............
T Consensus       149 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i  228 (483)
T 3sv0_A          149 DFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI  228 (483)
T ss_dssp             CCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHH
T ss_pred             eCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHH
Confidence            99999876443321      123567999999999999999999999999999999999999999764432221111111


Q ss_pred             HHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHHhh
Q 009340          444 ISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRSQ  504 (537)
Q Consensus       444 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~  504 (537)
                      ...    .....+. .+    ...++.++.+|+.+||+.+|++||++.+|+++|+.+....
T Consensus       229 ~~~----~~~~~~~-~l----~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~  280 (483)
T 3sv0_A          229 SEK----KVATSIE-AL----CRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE  280 (483)
T ss_dssp             HHH----HHHSCHH-HH----HTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             hhc----cccccHH-HH----hcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence            111    1111111 11    1123457899999999999999999999999999987644

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=4.5e-41  Score=343.53  Aligned_cols=270  Identities=22%  Similarity=0.315  Sum_probs=202.4

Q ss_pred             cCHHHHHHHhcCCccccccCcCCceEEEEEEcCCCCEEEEEEccCC-----------ChHHHHHHHHHHHHHHhcCCCCc
Q 009340          206 FTADELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEI-----------DKTQIHQFINEVVILSQINHRHI  274 (537)
Q Consensus       206 ~~~~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~-----------~~~~~~~~~~E~~~l~~l~H~ni  274 (537)
                      ....++....++|...+.||+|+||.||+|...+|+.||||++...           .....+.+.+|+.++++++||||
T Consensus        12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i   91 (362)
T 3pg1_A           12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI   91 (362)
T ss_dssp             HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred             HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence            4467788889999999999999999999999888999999987532           22334789999999999999999


Q ss_pred             ceEeeEEeeCC-----ccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCee
Q 009340          275 VKLLGCCLETE-----VPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIF  349 (537)
Q Consensus       275 v~l~g~~~~~~-----~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iv  349 (537)
                      +++++++...+     ..++||||++ |+|.+++....           ..+++..+..++.|+++||.|||+.+   |+
T Consensus        92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-----------~~~~~~~~~~~~~qi~~~l~~lH~~~---iv  156 (362)
T 3pg1_A           92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR-----------IVISPQHIQYFMYHILLGLHVLHEAG---VV  156 (362)
T ss_dssp             CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT-----------SCCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred             cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc-----------cCCCHHHHHHHHHHHHHHHHHHHHCc---CE
Confidence            99999986533     4699999998 68888886532           36999999999999999999999999   99


Q ss_pred             ecCCCCCCEEECCCCcEEEeeccCccccCCCCCceeeeccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCC
Q 009340          350 HRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQS-SQFTDKSDVYSFGVVLLELLTGKKPI  428 (537)
Q Consensus       350 H~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~el~tg~~p~  428 (537)
                      ||||||+|||++.++.+||+|||++.......  ......+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||
T Consensus       157 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf  234 (362)
T 3pg1_A          157 HRDLHPGNILLADNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALF  234 (362)
T ss_dssp             CCCCCGGGEEECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred             ecCCChHHEEEcCCCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCC
Confidence            99999999999999999999999997553322  2344568999999999877 67899999999999999999999999


Q ss_pred             CccchhhhccHHHHHHHHHhhchhh-----------hhhcHHh-------hccccHHHHHHHHHHHHHhcccCCCCCCCH
Q 009340          429 CFARVEEERNLVACFISLAKENQLL-----------EILDARV-------AKEAREEDIGAMAELAMRCLRLNSKKRPTM  490 (537)
Q Consensus       429 ~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~d~~~-------~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~  490 (537)
                      ......+.   ..............           +.+....       ...........+.+|+.+||+.||++|||+
T Consensus       235 ~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~  311 (362)
T 3pg1_A          235 RGSTFYNQ---LNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRIST  311 (362)
T ss_dssp             CCSSHHHH---HHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             CCCCHHHH---HHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCH
Confidence            76543221   11111111111000           0000000       001112234678899999999999999999


Q ss_pred             hhHHH
Q 009340          491 KQVSM  495 (537)
Q Consensus       491 ~ev~~  495 (537)
                      .|+++
T Consensus       312 ~ell~  316 (362)
T 3pg1_A          312 EQALR  316 (362)
T ss_dssp             HHHHT
T ss_pred             HHHHc
Confidence            99875

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=2.1e-40  Score=339.01  Aligned_cols=256  Identities=25%  Similarity=0.416  Sum_probs=205.3

Q ss_pred             HHHHHhcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCC--------hHHHHHHHHHHHHHHhc-CCCCcceEee
Q 009340          210 ELQRATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEID--------KTQIHQFINEVVILSQI-NHRHIVKLLG  279 (537)
Q Consensus       210 el~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l-~H~niv~l~g  279 (537)
                      ......++|...+.||+|+||.||+|+.. +|+.||||+++...        ....+.+.+|+.++.++ +||||+++++
T Consensus        88 ~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~  167 (365)
T 2y7j_A           88 AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID  167 (365)
T ss_dssp             HHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred             hhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence            34455678999999999999999999975 79999999876432        12245678999999999 7999999999


Q ss_pred             EEeeCCccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEE
Q 009340          280 CCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNIL  359 (537)
Q Consensus       280 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIl  359 (537)
                      ++......++||||+++|+|.+++...            ..+++..+..++.|++.||.|||+.+   |+||||||+|||
T Consensus       168 ~~~~~~~~~lv~e~~~g~~L~~~l~~~------------~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl  232 (365)
T 2y7j_A          168 SYESSSFMFLVFDLMRKGELFDYLTEK------------VALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENIL  232 (365)
T ss_dssp             EEEBSSEEEEEECCCTTCBHHHHHHHH------------SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred             EEeeCCEEEEEEEeCCCCcHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEE
Confidence            999999999999999999999999752            35999999999999999999999999   999999999999


Q ss_pred             ECCCCcEEEeeccCccccCCCCCceeeeccccccccCcccccC------CCCCcchhHHHHHHHHHHHHhCCCCCCccch
Q 009340          360 LDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQS------SQFTDKSDVYSFGVVLLELLTGKKPICFARV  433 (537)
Q Consensus       360 l~~~~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~  433 (537)
                      ++.++.+||+|||++........  .....||+.|+|||++.+      ..++.++||||||+++|||++|+.||.....
T Consensus       233 ~~~~~~ikl~DfG~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~  310 (365)
T 2y7j_A          233 LDDNMQIRLSDFGFSCHLEPGEK--LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ  310 (365)
T ss_dssp             ECTTCCEEECCCTTCEECCTTCC--BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             ECCCCCEEEEecCcccccCCCcc--cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH
Confidence            99999999999999987654322  344678999999999853      3588999999999999999999999865432


Q ss_pred             hhhccHHHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          434 EEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       434 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      ..       ........... ...+ .    ....+..+.+++.+||+.||++|||+.++++
T Consensus       311 ~~-------~~~~i~~~~~~-~~~~-~----~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          311 IL-------MLRMIMEGQYQ-FSSP-E----WDDRSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             HH-------HHHHHHHTCCC-CCHH-H----HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HH-------HHHHHHhCCCC-CCCc-c----cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            21       11111111000 0000 0    0122356889999999999999999999975

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.6e-40  Score=328.73  Aligned_cols=248  Identities=23%  Similarity=0.399  Sum_probs=198.4

Q ss_pred             CCccccccCcCCceEEEEEEcC-CCCEEEEEEccC--CChHHHHHHHHHHHHHHhcCCCCcceEeeEEee----CCccEE
Q 009340          217 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKE--IDKTQIHQFINEVVILSQINHRHIVKLLGCCLE----TEVPVL  289 (537)
Q Consensus       217 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~l  289 (537)
                      .|...+.||+|+||.||+|... ++..||+|.+..  ......+.+.+|+.++++++||||+++++++..    ....++
T Consensus        27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  106 (290)
T 1t4h_A           27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL  106 (290)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred             eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence            4667788999999999999864 678999998764  345567789999999999999999999999875    345799


Q ss_pred             EEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEC-CCCcEEE
Q 009340          290 VYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD-DKFSAKV  368 (537)
Q Consensus       290 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~-~~~~~ki  368 (537)
                      ||||+++|+|.+++...            ..+++..++.++.|+++||.|||+.+ ++|+||||||+|||++ .++.+||
T Consensus       107 v~e~~~~~~L~~~l~~~------------~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl  173 (290)
T 1t4h_A          107 VTELMTSGTLKTYLKRF------------KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKI  173 (290)
T ss_dssp             EEECCCSCBHHHHHHHH------------SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEE
T ss_pred             EEEecCCCCHHHHHHHc------------cCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEE
Confidence            99999999999999653            35899999999999999999999986 3499999999999998 7899999


Q ss_pred             eeccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHh
Q 009340          369 SDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAK  448 (537)
Q Consensus       369 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  448 (537)
                      +|||++......   ......||+.|+|||.+. +.++.++||||||+++|||++|+.||........      ......
T Consensus       174 ~Dfg~~~~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~------~~~~~~  243 (290)
T 1t4h_A          174 GDLGLATLKRAS---FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ------IYRRVT  243 (290)
T ss_dssp             CCTTGGGGCCTT---SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH------HHHHHT
T ss_pred             eeCCCccccccc---ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHH------HHHHHh
Confidence            999999765433   234456899999999886 4589999999999999999999999864322111      111111


Q ss_pred             hchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          449 ENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       449 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      .....        ...+...+..+.+++.+||+.||++|||+.++++
T Consensus       244 ~~~~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          244 SGVKP--------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             TTCCC--------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccCCc--------cccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            11100        0111222356889999999999999999999875

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.7e-41  Score=342.27  Aligned_cols=263  Identities=21%  Similarity=0.283  Sum_probs=193.9

Q ss_pred             HHhcCCccccccCcCCceEEEEEEc-CCCCEEEEEEccCCC--hHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEE
Q 009340          213 RATDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEID--KTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVL  289 (537)
Q Consensus       213 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  289 (537)
                      ...++|...++||+|+||.||++.. .+++.||||+++...  ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  110 (329)
T 3gbz_A           31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL  110 (329)
T ss_dssp             -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred             cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence            3457899999999999999999984 478999999987533  2334568899999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEE-----CCCC
Q 009340          290 VYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILL-----DDKF  364 (537)
Q Consensus       290 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll-----~~~~  364 (537)
                      ||||++ |+|.+++...            ..+++..+..++.|+++||.|||+.+   |+||||||+|||+     +.++
T Consensus       111 v~e~~~-~~L~~~~~~~------------~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~  174 (329)
T 3gbz_A          111 IFEYAE-NDLKKYMDKN------------PDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETP  174 (329)
T ss_dssp             EEECCS-EEHHHHHHHC------------TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CC
T ss_pred             EEecCC-CCHHHHHhhc------------CCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccc
Confidence            999998 5999998653            35999999999999999999999999   9999999999999     5556


Q ss_pred             cEEEeeccCccccCCCCCceeeeccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHH
Q 009340          365 SAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSS-QFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACF  443 (537)
Q Consensus       365 ~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~  443 (537)
                      .+||+|||+++....... ......||+.|+|||.+.+. .++.++|||||||++|||++|+.||......+.   ....
T Consensus       175 ~~kl~Dfg~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---~~~~  250 (329)
T 3gbz_A          175 VLKIGDFGLARAFGIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQ---LFKI  250 (329)
T ss_dssp             EEEECCTTHHHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHH
T ss_pred             eEEECcCCCccccCCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHH---HHHH
Confidence            699999999987643322 23445689999999999874 489999999999999999999999975433221   1111


Q ss_pred             HHHHhhc---hhhh-------------hhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          444 ISLAKEN---QLLE-------------ILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       444 ~~~~~~~---~~~~-------------~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      .......   ....             .....+....+......+.+|+.+||+.||++|||+.|+++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          251 FEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             HHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence            1111000   0000             00000000011113467889999999999999999999875

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=4.7e-41  Score=347.89  Aligned_cols=252  Identities=22%  Similarity=0.300  Sum_probs=191.4

Q ss_pred             cCCccc-cccCcCCceEEEEEEcC-CCCEEEEEEccCCChHHHHHHHHHHHHHHhc-CCCCcceEeeEEee----CCccE
Q 009340          216 DNYNQS-RFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKTQIHQFINEVVILSQI-NHRHIVKLLGCCLE----TEVPV  288 (537)
Q Consensus       216 ~~~~~~-~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~----~~~~~  288 (537)
                      ++|... +.||+|+||.||++... +|+.||||+++..     ..+.+|+.++.++ +|+||+++++++..    ....+
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~  135 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL  135 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence            456655 68999999999999964 6899999998742     3566788887554 89999999999875    55689


Q ss_pred             EEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECC---CCc
Q 009340          289 LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD---KFS  365 (537)
Q Consensus       289 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~---~~~  365 (537)
                      +||||+++|+|.+++.....          ..+++..+..++.|+++||.|||+.+   |+||||||+|||++.   ++.
T Consensus       136 lv~E~~~gg~L~~~l~~~~~----------~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~  202 (400)
T 1nxk_A          136 IVMECLDGGELFSRIQDRGD----------QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAI  202 (400)
T ss_dssp             EEEECCCSEEHHHHHHCC-------------CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCC
T ss_pred             EEEEeCCCCcHHHHHHHhCC----------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCcc
Confidence            99999999999999976422          35999999999999999999999999   999999999999998   789


Q ss_pred             EEEeeccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHH
Q 009340          366 AKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFIS  445 (537)
Q Consensus       366 ~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~  445 (537)
                      +||+|||+++......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........   ...
T Consensus       203 ~kl~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~---~~~  277 (400)
T 1nxk_A          203 LKLTDFGFAKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG---MKT  277 (400)
T ss_dssp             EEECCCTTCEECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCS---HHH
T ss_pred             EEEEecccccccCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHH---HHH
Confidence            9999999998764322  23456789999999999999999999999999999999999999975433221100   000


Q ss_pred             HHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHH
Q 009340          446 LAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSME  496 (537)
Q Consensus       446 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~  496 (537)
                      ....+...      .........+..+.+|+.+||+.||++|||+.++++.
T Consensus       278 ~i~~~~~~------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  322 (400)
T 1nxk_A          278 RIRMGQYE------FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  322 (400)
T ss_dssp             HHHHTCCC------CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             HHHcCccc------CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            11111000      0000112344678899999999999999999999863

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.1e-41  Score=341.90  Aligned_cols=257  Identities=19%  Similarity=0.313  Sum_probs=196.2

Q ss_pred             hcCCccccccCcCCceEEEEEEc-CCCCEEEEEEccC--CChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCC------
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKE--IDKTQIHQFINEVVILSQINHRHIVKLLGCCLETE------  285 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------  285 (537)
                      .++|...+.||+|+||.||+|.. .+|+.||||++..  ......+.+.+|+.++++++||||+++++++....      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            46889999999999999999996 4789999999854  33445678899999999999999999999998653      


Q ss_pred             ccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCc
Q 009340          286 VPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFS  365 (537)
Q Consensus       286 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~  365 (537)
                      ..++||||+ +++|.+++..             ..+++..+..++.|+++||.|||+.+   |+||||||+|||++.++.
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~-------------~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~  166 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKH-------------EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCE  166 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHH-------------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCC
T ss_pred             eEEEEEecC-CCCHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCC
Confidence            359999999 7899998864             25899999999999999999999999   999999999999999999


Q ss_pred             EEEeeccCccccCCCCCceeeeccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHH
Q 009340          366 AKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQS-SQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFI  444 (537)
Q Consensus       366 ~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~  444 (537)
                      +||+|||+++.....    .....+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||......+..   ....
T Consensus       167 ~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l---~~i~  239 (367)
T 1cm8_A          167 LKILDFGLARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQL---KEIM  239 (367)
T ss_dssp             EEECCCTTCEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHH
T ss_pred             EEEEeeecccccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHH
Confidence            999999999875432    234568999999999877 67999999999999999999999999755432211   1111


Q ss_pred             HHHhhc-----------hhhhhhc------HHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          445 SLAKEN-----------QLLEILD------ARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       445 ~~~~~~-----------~~~~~~d------~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      ......           .....+.      +..........+..+.+|+.+||+.||++|||+.++++
T Consensus       240 ~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~  307 (367)
T 1cm8_A          240 KVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  307 (367)
T ss_dssp             HHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence            110000           0000000      00000112234567889999999999999999999976

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=3.5e-41  Score=333.10  Aligned_cols=253  Identities=23%  Similarity=0.364  Sum_probs=188.7

Q ss_pred             hcCCccccccCcCCceEEEEEEc-CCCCEEEEEEccCC-ChH-HHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEE
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEI-DKT-QIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY  291 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~-~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  291 (537)
                      .++|+..+.||+|+||.||++.. .+|+.||||+++.. ... ..+.+.++...++.++||||+++++++.+.+..++||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~   85 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM   85 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence            46788999999999999999996 47899999998753 222 2334455556688889999999999999999999999


Q ss_pred             ecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeeecCCCCCCEEECCCCcEEEee
Q 009340          292 EYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSS-ASIPIFHRDIKSSNILLDDKFSAKVSD  370 (537)
Q Consensus       292 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~-~~~~ivH~Dlk~~NIll~~~~~~ki~D  370 (537)
                      ||++ |+|.+++......        ...+++..++.++.|++.||.|||+. +   |+||||||+||+++.++.+||+|
T Consensus        86 e~~~-~~l~~~l~~~~~~--------~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~D  153 (290)
T 3fme_A           86 ELMD-TSLDKFYKQVIDK--------GQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCD  153 (290)
T ss_dssp             ECCS-EEHHHHHHHHHHT--------TCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCC
T ss_pred             ehhc-cchHHHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEee
Confidence            9997 5898888653321        34799999999999999999999998 8   99999999999999999999999


Q ss_pred             ccCccccCCCCCceeeeccccccccCcccc----cCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHH
Q 009340          371 FGISRSIPNDKTHLTTTIQGTFGYLDPEYF----QSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISL  446 (537)
Q Consensus       371 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~  446 (537)
                      ||++........  .....||+.|+|||.+    .+..++.++||||||+++|||++|+.||.......     ......
T Consensus       154 fg~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~  226 (290)
T 3fme_A          154 FGISGYLVDDVA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF-----QQLKQV  226 (290)
T ss_dssp             C-----------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHH-----HHHHHH
T ss_pred             cCCccccccccc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchH-----HHHHHH
Confidence            999987643322  2334689999999996    55678999999999999999999999986432211     111111


Q ss_pred             HhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          447 AKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       447 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      ....         .........+..+.+++.+||+.||++|||+.|+++
T Consensus       227 ~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          227 VEEP---------SPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             HHSC---------CCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             hccC---------CCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence            1111         011111233467889999999999999999999987

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=3.2e-40  Score=332.60  Aligned_cols=255  Identities=20%  Similarity=0.343  Sum_probs=200.1

Q ss_pred             cCCccccccCcCCceEEEEEEc-CCCCEEEEEEccCCChHHHHHHHHHHHHHHhcC-CCCcceEeeEEee--CCccEEEE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEIDKTQIHQFINEVVILSQIN-HRHIVKLLGCCLE--TEVPVLVY  291 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~--~~~~~lV~  291 (537)
                      ++|...+.||+|+||.||+|+. .+++.||||.++...   .+.+.+|+.++++++ |+||+++++++.+  ....++||
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~  112 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  112 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence            6788899999999999999984 578999999987543   357889999999997 9999999999987  55789999


Q ss_pred             ecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCC-cEEEee
Q 009340          292 EYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF-SAKVSD  370 (537)
Q Consensus       292 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~-~~ki~D  370 (537)
                      ||+++++|.+++.               .+++..+..++.|+++||+|||+.+   |+||||||+|||++.++ .+||+|
T Consensus       113 e~~~~~~l~~~~~---------------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~D  174 (330)
T 3nsz_A          113 EHVNNTDFKQLYQ---------------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLID  174 (330)
T ss_dssp             ECCCCCCHHHHGG---------------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECC
T ss_pred             eccCchhHHHHHH---------------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEe
Confidence            9999999998874               3888999999999999999999999   99999999999999776 899999


Q ss_pred             ccCccccCCCCCceeeeccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhh
Q 009340          371 FGISRSIPNDKTHLTTTIQGTFGYLDPEYFQS-SQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKE  449 (537)
Q Consensus       371 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  449 (537)
                      ||+++.......  .....+|..|+|||.+.+ ..++.++||||||+++|||++|+.||........  ...........
T Consensus       175 fg~a~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~--~l~~~~~~~~~  250 (330)
T 3nsz_A          175 WGLAEFYHPGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD--QLVRIAKVLGT  250 (330)
T ss_dssp             CTTCEECCTTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH--HHHHHHHHHCH
T ss_pred             CCCceEcCCCCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHH--HHHHHHHhcCC
Confidence            999987644332  334568999999999877 6789999999999999999999999854432211  11111111111


Q ss_pred             chhhhhhcHH-----------------------hhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          450 NQLLEILDAR-----------------------VAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       450 ~~~~~~~d~~-----------------------~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      ....+.++..                       .........+..+.+|+.+||+.||++|||+.|+++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          251 EDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             HHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             chhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            1111111100                       000111124567899999999999999999999975

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=4.3e-41  Score=350.44  Aligned_cols=253  Identities=26%  Similarity=0.346  Sum_probs=191.8

Q ss_pred             HHhcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCC--------hHHHHHHHHHHHHHHhcCCCCcceEeeEEee
Q 009340          213 RATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEID--------KTQIHQFINEVVILSQINHRHIVKLLGCCLE  283 (537)
Q Consensus       213 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~  283 (537)
                      ...++|...+.||+|+||.||+|... +++.||||.+....        ......+.+|+.++++++||||+++++++. 
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-  210 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-  210 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence            44679999999999999999999854 68999999876421        122235789999999999999999999975 


Q ss_pred             CCccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCC
Q 009340          284 TEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK  363 (537)
Q Consensus       284 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~  363 (537)
                      .+..++||||+++|+|.+++...            ..+++..+..++.|+++||+|||+.+   |+||||||+|||++.+
T Consensus       211 ~~~~~lv~e~~~~g~L~~~l~~~------------~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~  275 (419)
T 3i6u_A          211 AEDYYIVLELMEGGELFDKVVGN------------KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQ  275 (419)
T ss_dssp             SSEEEEEEECCTTCBGGGGTSSS------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSS
T ss_pred             cCceEEEEEcCCCCcHHHHHhcc------------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecC
Confidence            45579999999999999998753            36999999999999999999999999   9999999999999754


Q ss_pred             ---CcEEEeeccCccccCCCCCceeeeccccccccCcccccC---CCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhc
Q 009340          364 ---FSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQS---SQFTDKSDVYSFGVVLLELLTGKKPICFARVEEER  437 (537)
Q Consensus       364 ---~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~  437 (537)
                         +.+||+|||+++.....  .......||+.|+|||++.+   ..++.++||||||+++|||++|+.||.......  
T Consensus       276 ~~~~~~kl~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~--  351 (419)
T 3i6u_A          276 EEDCLIKITDFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--  351 (419)
T ss_dssp             SSSCCEEECCSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC--
T ss_pred             CCcceEEEeecccceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH--
Confidence               45999999999876432  22345679999999999853   678899999999999999999999996532221  


Q ss_pred             cHHHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          438 NLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       438 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      .+    ..........  ..+..    ....+..+.+|+.+||+.||++|||+.|+++
T Consensus       352 ~~----~~~i~~~~~~--~~~~~----~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          352 SL----KDQITSGKYN--FIPEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             CH----HHHHHTTCCC--CCHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HH----HHHHhcCCCC--CCchh----hcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            11    1111111100  00111    1123457889999999999999999999875

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1.1e-40  Score=351.71  Aligned_cols=194  Identities=27%  Similarity=0.450  Sum_probs=155.2

Q ss_pred             hcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccC--CChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeC-----Cc
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKE--IDKTQIHQFINEVVILSQINHRHIVKLLGCCLET-----EV  286 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~  286 (537)
                      .++|...+.||+|+||.||+|+.. +|+.||||++..  ......+.+.+|+.+|++++|+||+++++++...     ..
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            368999999999999999999854 789999999865  3445567899999999999999999999999543     46


Q ss_pred             cEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcE
Q 009340          287 PVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA  366 (537)
Q Consensus       287 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~  366 (537)
                      .|+||||+. |+|.+++..            ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+
T Consensus       132 ~~lv~e~~~-~~L~~~~~~------------~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~  195 (458)
T 3rp9_A          132 LYVVLEIAD-SDFKKLFRT------------PVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSV  195 (458)
T ss_dssp             EEEEECCCS-EEHHHHHHS------------SCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCE
T ss_pred             EEEEEeccc-cchhhhccc------------CCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCE
Confidence            899999985 689888865            236999999999999999999999999   9999999999999999999


Q ss_pred             EEeeccCccccCCCCC--------------------------ceeeeccccccccCcccc-cCCCCCcchhHHHHHHHHH
Q 009340          367 KVSDFGISRSIPNDKT--------------------------HLTTTIQGTFGYLDPEYF-QSSQFTDKSDVYSFGVVLL  419 (537)
Q Consensus       367 ki~Dfgla~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~t~ksDV~S~Gvll~  419 (537)
                      ||+|||+++.......                          ...+...||+.|+|||++ ....++.++|||||||++|
T Consensus       196 kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~  275 (458)
T 3rp9_A          196 KVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFA  275 (458)
T ss_dssp             EECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHH
T ss_pred             eecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHH
Confidence            9999999987642221                          122445789999999986 5667999999999999999


Q ss_pred             HHHhC
Q 009340          420 ELLTG  424 (537)
Q Consensus       420 el~tg  424 (537)
                      ||++|
T Consensus       276 elltg  280 (458)
T 3rp9_A          276 ELLNM  280 (458)
T ss_dssp             HHHTT
T ss_pred             HHHHh
Confidence            99994

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=5e-41  Score=359.10  Aligned_cols=253  Identities=27%  Similarity=0.420  Sum_probs=206.1

Q ss_pred             hcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCC---hHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEE
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEID---KTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLV  290 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  290 (537)
                      .++|...+.||+|+||.||+++.. +|+.||||++....   ......+.+|+.++++++||||+++++++.+.+..++|
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  262 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV  262 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence            367888999999999999999964 79999999986421   22345688999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEee
Q 009340          291 YEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSD  370 (537)
Q Consensus       291 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~D  370 (537)
                      |||+++|+|.+++....          ...+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|
T Consensus       263 mEy~~gg~L~~~l~~~~----------~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~D  329 (576)
T 2acx_A          263 LTLMNGGDLKFHIYHMG----------QAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISD  329 (576)
T ss_dssp             ECCCCSCBHHHHHHSSS----------SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECC
T ss_pred             EEcCCCCcHHHHHHhcC----------CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEe
Confidence            99999999999987532          135999999999999999999999999   99999999999999999999999


Q ss_pred             ccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhc
Q 009340          371 FGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKEN  450 (537)
Q Consensus       371 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  450 (537)
                      ||+++.......  .....||+.|+|||++.+..++.++|||||||++|||++|+.||.........   ......... 
T Consensus       330 FGla~~~~~~~~--~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~---~~i~~~i~~-  403 (576)
T 2acx_A          330 LGLAVHVPEGQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR---EEVERLVKE-  403 (576)
T ss_dssp             CTTCEECCTTCC--EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCH---HHHHHHHHH-
T ss_pred             cccceecccCcc--ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhH---HHHHHHhhc-
Confidence            999987654332  34457999999999999989999999999999999999999999754321110   001111110 


Q ss_pred             hhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCC-----CHhhHHH
Q 009340          451 QLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRP-----TMKQVSM  495 (537)
Q Consensus       451 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~  495 (537)
                               .....+...+..+.+|+.+||+.||++||     ++.||++
T Consensus       404 ---------~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          404 ---------VPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             ---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             ---------ccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence                     01122334456788999999999999999     6677753

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=6.6e-41  Score=340.85  Aligned_cols=266  Identities=20%  Similarity=0.299  Sum_probs=200.0

Q ss_pred             hcCCccccccCcCCceEEEEEEc-CCCCEEEEEEccCCC--hHHHHHHHHHHHHHHhcCCCCcceEeeEEeeC-------
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEID--KTQIHQFINEVVILSQINHRHIVKLLGCCLET-------  284 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-------  284 (537)
                      .++|...+.||+|+||.||+|+. .+|+.||||++....  ......+.+|+.+++.++|+||+++++++.+.       
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            36889999999999999999996 478999999875432  22345678999999999999999999999874       


Q ss_pred             -CccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCC
Q 009340          285 -EVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK  363 (537)
Q Consensus       285 -~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~  363 (537)
                       +..++||||+++ +|.+.+....           ..+++..++.++.|+++||+|||+.+   |+||||||+|||++.+
T Consensus        96 ~~~~~lv~e~~~~-~l~~~l~~~~-----------~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~  160 (351)
T 3mi9_A           96 KGSIYLVFDFCEH-DLAGLLSNVL-----------VKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRD  160 (351)
T ss_dssp             -CEEEEEEECCSE-EHHHHHHCTT-----------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTT
T ss_pred             CceEEEEEeccCC-CHHHHHhhcc-----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCC
Confidence             457999999985 7777775532           36999999999999999999999999   9999999999999999


Q ss_pred             CcEEEeeccCccccCCCCC---ceeeeccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccH
Q 009340          364 FSAKVSDFGISRSIPNDKT---HLTTTIQGTFGYLDPEYFQS-SQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNL  439 (537)
Q Consensus       364 ~~~ki~Dfgla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~  439 (537)
                      +.+||+|||+++.......   .......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||...........
T Consensus       161 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~  240 (351)
T 3mi9_A          161 GVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLAL  240 (351)
T ss_dssp             SCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred             CCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence            9999999999987643221   22344568999999999876 4589999999999999999999999976543322111


Q ss_pred             HHHHHHHHhhchhhhhhcHHhh----------cccc-----HHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          440 VACFISLAKENQLLEILDARVA----------KEAR-----EEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       440 ~~~~~~~~~~~~~~~~~d~~~~----------~~~~-----~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      ................-.....          ....     ......+.+|+.+||+.||++|||+.|+++
T Consensus       241 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  311 (351)
T 3mi9_A          241 ISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  311 (351)
T ss_dssp             HHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence            1110000000000000000000          0000     011356889999999999999999999876

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=1.2e-40  Score=328.53  Aligned_cols=245  Identities=27%  Similarity=0.399  Sum_probs=203.4

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCC---hHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEID---KTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY  291 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  291 (537)
                      ++|...+.||+|+||.||++... +++.||||.+....   ....+.+.+|+.++++++|+||+++++++.+.+..++||
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   93 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML   93 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence            57888999999999999999965 57889999886421   122457889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeec
Q 009340          292 EYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF  371 (537)
Q Consensus       292 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Df  371 (537)
                      ||+++|+|.+++...            ..+++..++.++.|+++||.|||+.+   ++||||||+||+++.++.+||+||
T Consensus        94 e~~~~~~L~~~l~~~------------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Df  158 (284)
T 2vgo_A           94 EFAPRGELYKELQKH------------GRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADF  158 (284)
T ss_dssp             CCCTTEEHHHHHHHH------------SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCC
T ss_pred             EeCCCCcHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecc
Confidence            999999999999753            35899999999999999999999999   999999999999999999999999


Q ss_pred             cCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhch
Q 009340          372 GISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQ  451 (537)
Q Consensus       372 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  451 (537)
                      |++.......   .....|++.|+|||.+.+..++.++||||||+++|||++|+.||......+.      ...... . 
T Consensus       159 g~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------~~~~~~-~-  227 (284)
T 2vgo_A          159 GWSVHAPSLR---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTET------HRRIVN-V-  227 (284)
T ss_dssp             TTCEECSSSC---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHHT-T-
T ss_pred             cccccCcccc---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHH------HHHHhc-c-
Confidence            9997654322   2345689999999999999999999999999999999999999865432221      111111 0 


Q ss_pred             hhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          452 LLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       452 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                               ....+...+..+.+++.+||+.||++|||+.++++
T Consensus       228 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          228 ---------DLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             ---------CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ---------ccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence                     01122334467889999999999999999999975

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.6e-41  Score=340.81  Aligned_cols=265  Identities=23%  Similarity=0.283  Sum_probs=198.2

Q ss_pred             HHhcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCChH-----HHHHHHHHHHHHHhcCCCCcceEeeEEeeCCc
Q 009340          213 RATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKT-----QIHQFINEVVILSQINHRHIVKLLGCCLETEV  286 (537)
Q Consensus       213 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~  286 (537)
                      ...++|...+.||+|+||.||+|... +|+.||||++......     ..+.+.+|+.++++++||||+++++++.+.+.
T Consensus         7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (346)
T 1ua2_A            7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN   86 (346)
T ss_dssp             ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred             HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence            34578999999999999999999975 6899999998643221     12467899999999999999999999999999


Q ss_pred             cEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcE
Q 009340          287 PVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA  366 (537)
Q Consensus       287 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~  366 (537)
                      .++||||+++ +|.+++....           ..+++..+..++.|+++||.|||+.+   |+||||||+|||++.++.+
T Consensus        87 ~~lv~e~~~~-~l~~~~~~~~-----------~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~  151 (346)
T 1ua2_A           87 ISLVFDFMET-DLEVIIKDNS-----------LVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVL  151 (346)
T ss_dssp             CEEEEECCSE-EHHHHHTTCC-----------SSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCE
T ss_pred             eEEEEEcCCC-CHHHHHHhcC-----------cCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCE
Confidence            9999999986 8888886532           35889999999999999999999999   9999999999999999999


Q ss_pred             EEeeccCccccCCCCCceeeeccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHH
Q 009340          367 KVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSS-QFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFIS  445 (537)
Q Consensus       367 ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~  445 (537)
                      ||+|||+++...... .......||+.|+|||.+.+. .++.++||||||+++|||++|..||......+.   ......
T Consensus       152 kl~Dfg~a~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~---~~~i~~  227 (346)
T 1ua2_A          152 KLADFGLAKSFGSPN-RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ---LTRIFE  227 (346)
T ss_dssp             EECCCGGGSTTTSCC-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHH
T ss_pred             EEEecccceeccCCc-ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH---HHHHHH
Confidence            999999998764332 223445689999999998764 589999999999999999999999865433221   111111


Q ss_pred             HHhhchhhhhhc---------HHhhc-----cccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHH
Q 009340          446 LAKENQLLEILD---------ARVAK-----EAREEDIGAMAELAMRCLRLNSKKRPTMKQVSME  496 (537)
Q Consensus       446 ~~~~~~~~~~~d---------~~~~~-----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~  496 (537)
                      .........+.+         .....     ......+..+.+|+.+||+.||++|||+.|+++.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  292 (346)
T 1ua2_A          228 TLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  292 (346)
T ss_dssp             HHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             HcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            111000000000         00000     0112334678999999999999999999999763

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.4e-40  Score=326.39  Aligned_cols=247  Identities=29%  Similarity=0.406  Sum_probs=195.9

Q ss_pred             hcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCC---hHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEE
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEID---KTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLV  290 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  290 (537)
                      .++|...+.||+|+||.||+|... +|+.||||.+....   ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV   89 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence            367888999999999999999965 78999999986422   12346788999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEee
Q 009340          291 YEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSD  370 (537)
Q Consensus       291 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~D  370 (537)
                      |||+++++|.+++...            ..+++..++.++.|+++||.|||+.+   ++||||||+||+++.++.+||+|
T Consensus        90 ~e~~~~~~L~~~l~~~------------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d  154 (276)
T 2h6d_A           90 MEYVSGGELFDYICKH------------GRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIAD  154 (276)
T ss_dssp             EECCCSCBHHHHHHHH------------CSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECC
T ss_pred             EeccCCCcHHHHHhcc------------CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEee
Confidence            9999999999999753            35899999999999999999999999   99999999999999999999999


Q ss_pred             ccCccccCCCCCceeeeccccccccCcccccCCCC-CcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhh
Q 009340          371 FGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQF-TDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKE  449 (537)
Q Consensus       371 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  449 (537)
                      ||++.......  ......+|+.|+|||.+.+..+ +.++||||||+++|||++|+.||.......       .......
T Consensus       155 fg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-------~~~~~~~  225 (276)
T 2h6d_A          155 FGLSNMMSDGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT-------LFKKIRG  225 (276)
T ss_dssp             CCGGGCCCC---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHH
T ss_pred             cccccccCCCc--ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH-------HHHHhhc
Confidence            99998764432  2234568999999999987765 689999999999999999999986543221       1111111


Q ss_pred             chhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          450 NQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       450 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      ..          ...+......+.+++.+||+.||++|||+.++++
T Consensus       226 ~~----------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~  261 (276)
T 2h6d_A          226 GV----------FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIRE  261 (276)
T ss_dssp             CC----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             Cc----------ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence            10          0112233456889999999999999999999976

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=2.6e-41  Score=336.03  Aligned_cols=268  Identities=23%  Similarity=0.362  Sum_probs=188.4

Q ss_pred             HhcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCC-hHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEE
Q 009340          214 ATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEID-KTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY  291 (537)
Q Consensus       214 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  291 (537)
                      ..++|...+.||+|+||.||++... +++.||||++.... ....+++.+|+.++++++||||+++++++...+..++||
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   92 (303)
T 2vwi_A           13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM   92 (303)
T ss_dssp             CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred             chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence            3578999999999999999999954 68899999886432 334567889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeec
Q 009340          292 EYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF  371 (537)
Q Consensus       292 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Df  371 (537)
                      ||+++|+|.+++.......    ......+++..++.++.|+++||.|||+.+   ++||||||+||+++.++.+||+||
T Consensus        93 e~~~~~~L~~~l~~~~~~~----~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~df  165 (303)
T 2vwi_A           93 KLLSGGSVLDIIKHIVAKG----EHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADF  165 (303)
T ss_dssp             ECCTTCBHHHHHHHHHHTT----TTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCC
T ss_pred             hhccCCchHHHHHHHhhcc----ccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEec
Confidence            9999999999997532210    001245899999999999999999999999   999999999999999999999999


Q ss_pred             cCccccCCCCC----ceeeeccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHH
Q 009340          372 GISRSIPNDKT----HLTTTIQGTFGYLDPEYFQS-SQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISL  446 (537)
Q Consensus       372 gla~~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~  446 (537)
                      |++........    .......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||........      ....
T Consensus       166 g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------~~~~  239 (303)
T 2vwi_A          166 GVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV------LMLT  239 (303)
T ss_dssp             HHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH------HHHH
T ss_pred             cchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH------HHHH
Confidence            99976643321    11234568999999999875 5689999999999999999999999875433221      1111


Q ss_pred             HhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          447 AKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       447 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      .... .................+..+.+++.+||+.||++|||+.++++
T Consensus       240 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          240 LQND-PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             HTSS-CCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             hccC-CCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            1110 00000000001111223457889999999999999999999976

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=2.2e-41  Score=347.17  Aligned_cols=254  Identities=10%  Similarity=0.053  Sum_probs=184.2

Q ss_pred             hcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCC---hHHHHHHHHHHHHHHhc--CCCCcceEe-------eEE
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEID---KTQIHQFINEVVILSQI--NHRHIVKLL-------GCC  281 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l--~H~niv~l~-------g~~  281 (537)
                      ..+|...+.||+|+||.||+|... +|+.||||+++...   ....+.+.+|+.+++.+  +|||+++++       +++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            346888999999999999999954 78999999987643   23456677885555444  699988755       444


Q ss_pred             eeC-----------------CccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHH------HHHHHHHHHHHH
Q 009340          282 LET-----------------EVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENR------VRVACEVAGAVA  338 (537)
Q Consensus       282 ~~~-----------------~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~------~~i~~~ia~gl~  338 (537)
                      ...                 ...++||||++ |+|.+++.....           .+.+..+      +.++.|+++||+
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-----------~~~~~~~~~~~vk~~i~~qi~~aL~  208 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF-----------VYVFRGDEGILALHILTAQLIRLAA  208 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH-----------SCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc-----------ccchhhhhhhhhHHHHHHHHHHHHH
Confidence            333                 23799999999 899999987532           3566666      788899999999


Q ss_pred             HHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCccccCCCCCceeeeccccccccCcccccC--CCCCcchhHHHHHH
Q 009340          339 YMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQS--SQFTDKSDVYSFGV  416 (537)
Q Consensus       339 yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~ksDV~S~Gv  416 (537)
                      |||+++   |+||||||+|||++.++.+||+|||+++.....    .....+|+.|+|||.+.+  ..++.++|||||||
T Consensus       209 ~LH~~~---ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~  281 (371)
T 3q60_A          209 NLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGL  281 (371)
T ss_dssp             HHHHTT---EEETTCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHH
T ss_pred             HHHHCC---CccCcCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHH
Confidence            999999   999999999999999999999999999866321    224557799999999987  67999999999999


Q ss_pred             HHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          417 VLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       417 ll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      ++|||++|+.||..........        +...............+.....+..+.+|+.+||+.||++|||+.++++
T Consensus       282 il~elltg~~Pf~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          282 SIYRVWCLFLPFGLVTPGIKGS--------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             HHHHHHHSSCSTTBCCTTCTTC--------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             HHHHHHhCCCCCCCcCcccccc--------hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            9999999999997553221100        0000000000111111112234567889999999999999999999975

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=4.3e-41  Score=340.82  Aligned_cols=252  Identities=22%  Similarity=0.340  Sum_probs=200.2

Q ss_pred             HhcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCChHHHHHHHHHHHHHHhc-CCCCcceEeeEEeeCCccEEEE
Q 009340          214 ATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKTQIHQFINEVVILSQI-NHRHIVKLLGCCLETEVPVLVY  291 (537)
Q Consensus       214 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~  291 (537)
                      ..++|...+.||+|+||.||++... +|+.||||.++....    .+.+|++++.++ +||||+++++++.+.+..++||
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~   95 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT   95 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence            3467899999999999999999965 688999999875432    234688888888 7999999999999999999999


Q ss_pred             ecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCC----CcEE
Q 009340          292 EYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK----FSAK  367 (537)
Q Consensus       292 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~----~~~k  367 (537)
                      ||+++|+|.+++...            ..+++..+..++.|++.||.|||+.+   |+||||||+|||+.++    +.+|
T Consensus        96 E~~~gg~L~~~i~~~------------~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~k  160 (342)
T 2qr7_A           96 ELMKGGELLDKILRQ------------KFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIR  160 (342)
T ss_dssp             CCCCSCBHHHHHHTC------------TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEE
T ss_pred             eCCCCCcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEE
Confidence            999999999998653            35999999999999999999999999   9999999999998543    3599


Q ss_pred             EeeccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHH
Q 009340          368 VSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLA  447 (537)
Q Consensus       368 i~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~  447 (537)
                      |+|||+++....... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.........   . .....
T Consensus       161 l~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~---~-~~~~i  235 (342)
T 2qr7_A          161 ICDFGFAKQLRAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPE---E-ILARI  235 (342)
T ss_dssp             ECCCTTCEECBCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHH---H-HHHHH
T ss_pred             EEECCCcccCcCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHH---H-HHHHH
Confidence            999999987644322 234457899999999998888899999999999999999999999753221111   1 11111


Q ss_pred             hhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          448 KENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       448 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      ..+...      +........+..+.+|+.+||+.||++|||+.++++
T Consensus       236 ~~~~~~------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          236 GSGKFS------LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             HHCCCC------CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             ccCCcc------cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            111110      011112234567889999999999999999999875

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.9e-40  Score=331.95  Aligned_cols=252  Identities=25%  Similarity=0.425  Sum_probs=200.3

Q ss_pred             HHhcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEE
Q 009340          213 RATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY  291 (537)
Q Consensus       213 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  291 (537)
                      ...++|...+.||+|+||.||+|... +|+.||||.+....  ..+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  103 (314)
T 3com_A           26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM  103 (314)
T ss_dssp             ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence            34578999999999999999999965 58999999987532  3467889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeec
Q 009340          292 EYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF  371 (537)
Q Consensus       292 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Df  371 (537)
                      ||+++|+|.+++...           ...+++..++.++.|+++||.|||+.+   ++||||||+||+++.++.+||+||
T Consensus       104 e~~~~~~L~~~~~~~-----------~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~df  169 (314)
T 3com_A          104 EYCGAGSVSDIIRLR-----------NKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADF  169 (314)
T ss_dssp             ECCTTEEHHHHHHHH-----------TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCC
T ss_pred             ecCCCCCHHHHHHhc-----------CCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeec
Confidence            999999999998643           236999999999999999999999999   999999999999999999999999


Q ss_pred             cCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhch
Q 009340          372 GISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQ  451 (537)
Q Consensus       372 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  451 (537)
                      |++........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.||........      ...... ..
T Consensus       170 g~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~~~~-~~  241 (314)
T 3com_A          170 GVAGQLTDTMA-KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRA------IFMIPT-NP  241 (314)
T ss_dssp             TTCEECBTTBS-CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHH-SC
T ss_pred             ccchhhhhhcc-ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHhc-CC
Confidence            99987643322 23345689999999999999999999999999999999999999865432110      111100 00


Q ss_pred             hhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          452 LLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       452 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                           .+..  ..+...+..+.+++.+||+.||++|||+.++++
T Consensus       242 -----~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          242 -----PPTF--RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             -----CCCC--SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             -----Cccc--CCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence                 0000  112223457889999999999999999999976

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.8e-41  Score=338.83  Aligned_cols=261  Identities=23%  Similarity=0.421  Sum_probs=200.2

Q ss_pred             ccCHHHHHHHhcCCccccccCcCCceEEEEEEc-CCCCEEEEEEccCCChHHHHHHHHHHHHHHhc-CCCCcceEeeEEe
Q 009340          205 VFTADELQRATDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEIDKTQIHQFINEVVILSQI-NHRHIVKLLGCCL  282 (537)
Q Consensus       205 ~~~~~el~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~  282 (537)
                      .++..++....++|...+.||+|+||.||+|.. .+|+.||||.+.... ...+.+.+|+.+++++ +||||+++++++.
T Consensus        13 ~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   91 (326)
T 2x7f_A           13 EIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFI   91 (326)
T ss_dssp             ---CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred             hccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEe
Confidence            344455556678999999999999999999996 478999999986533 2346788999999999 8999999999998


Q ss_pred             e------CCccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCC
Q 009340          283 E------TEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSS  356 (537)
Q Consensus       283 ~------~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~  356 (537)
                      .      .+..++||||+++|+|.+++.....          ..+++..++.++.|++.||.|||+.+   |+||||||+
T Consensus        92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~----------~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~  158 (326)
T 2x7f_A           92 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG----------NTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQ  158 (326)
T ss_dssp             ECC--CCCCEEEEEEECCTTEEHHHHHHHSGG----------GCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGG
T ss_pred             eccCccccceEEEEEEcCCCCcHHHHHHhccc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHH
Confidence            7      4578999999999999999976432          36899999999999999999999999   999999999


Q ss_pred             CEEECCCCcEEEeeccCccccCCCCCceeeeccccccccCccccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCcc
Q 009340          357 NILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQ-----SSQFTDKSDVYSFGVVLLELLTGKKPICFA  431 (537)
Q Consensus       357 NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~S~Gvll~el~tg~~p~~~~  431 (537)
                      |||++.++.+||+|||++........ ......||+.|+|||.+.     +..++.++||||||+++|||++|+.||...
T Consensus       159 NIl~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~  237 (326)
T 2x7f_A          159 NVLLTENAEVKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM  237 (326)
T ss_dssp             GEEECTTCCEEECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred             HEEEcCCCCEEEeeCcCceecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCC
Confidence            99999999999999999986643221 223456899999999987     567899999999999999999999998644


Q ss_pred             chhhhccHHHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          432 RVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       432 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      .....      ....... ..     +.   ..+...+..+.+++.+||+.||++|||+.++++
T Consensus       238 ~~~~~------~~~~~~~-~~-----~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          238 HPMRA------LFLIPRN-PA-----PR---LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             CHHHH------HHHHHHS-CC-----CC---CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             cHHHH------HHHhhcC-cc-----cc---CCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            32211      1111110 00     00   011223457889999999999999999999987

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.7e-40  Score=347.30  Aligned_cols=198  Identities=27%  Similarity=0.412  Sum_probs=167.5

Q ss_pred             hcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccC--CChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeC-----Cc
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKE--IDKTQIHQFINEVVILSQINHRHIVKLLGCCLET-----EV  286 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~  286 (537)
                      .++|...+.||+|+||.||+|+.. +|+.||||+++.  ......+.+.+|+.++++++|+||+++++++...     ..
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            468999999999999999999954 688999999875  3445567899999999999999999999999876     56


Q ss_pred             cEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcE
Q 009340          287 PVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA  366 (537)
Q Consensus       287 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~  366 (537)
                      .++||||++ |+|.+++..            ...+++..++.++.||++||.|||+.+   |+||||||+|||++.++.+
T Consensus       105 ~~lv~e~~~-~~L~~~~~~------------~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~  168 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKT------------PIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSV  168 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHS------------SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCE
T ss_pred             EEEEEecCC-cCHHHHHhc------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCE
Confidence            899999987 599999865            235999999999999999999999999   9999999999999999999


Q ss_pred             EEeeccCccccCCCCCc---------------------eeeeccccccccCcccc-cCCCCCcchhHHHHHHHHHHHHhC
Q 009340          367 KVSDFGISRSIPNDKTH---------------------LTTTIQGTFGYLDPEYF-QSSQFTDKSDVYSFGVVLLELLTG  424 (537)
Q Consensus       367 ki~Dfgla~~~~~~~~~---------------------~~~~~~gt~~y~aPE~~-~~~~~t~ksDV~S~Gvll~el~tg  424 (537)
                      ||+|||+++........                     ..+...||+.|+|||.+ ....++.++|||||||++|||++|
T Consensus       169 kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g  248 (432)
T 3n9x_A          169 KVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNM  248 (432)
T ss_dssp             EECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTT
T ss_pred             EEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhc
Confidence            99999999876433211                     23456789999999986 566799999999999999999986


Q ss_pred             CCCC
Q 009340          425 KKPI  428 (537)
Q Consensus       425 ~~p~  428 (537)
                      ..|+
T Consensus       249 ~~p~  252 (432)
T 3n9x_A          249 LQSH  252 (432)
T ss_dssp             CTTT
T ss_pred             cccc
Confidence            5554

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.1e-40  Score=331.60  Aligned_cols=252  Identities=23%  Similarity=0.363  Sum_probs=199.5

Q ss_pred             hcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEec
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY  293 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  293 (537)
                      .++|+..+.||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   97 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF   97 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence            468889999999999999999975 5899999998776556678899999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccC
Q 009340          294 ISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGI  373 (537)
Q Consensus       294 ~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgl  373 (537)
                      +++++|.+++....           ..+++..++.++.|+++||.|||+.+   ++||||||+||+++.++.+||+|||+
T Consensus        98 ~~~~~l~~~~~~~~-----------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~  163 (302)
T 2j7t_A           98 CPGGAVDAIMLELD-----------RGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGV  163 (302)
T ss_dssp             CTTEEHHHHHHHHT-----------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHH
T ss_pred             CCCCcHHHHHHhhc-----------cCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCC
Confidence            99999999986532           36999999999999999999999999   99999999999999999999999998


Q ss_pred             ccccCCCCCceeeeccccccccCcccc-----cCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHh
Q 009340          374 SRSIPNDKTHLTTTIQGTFGYLDPEYF-----QSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAK  448 (537)
Q Consensus       374 a~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  448 (537)
                      +...... ........||+.|+|||.+     .+..++.++||||||+++|||++|+.||.......      .......
T Consensus       164 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~  236 (302)
T 2j7t_A          164 SAKNLKT-LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR------VLLKIAK  236 (302)
T ss_dssp             HHHHHHH-HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHH
T ss_pred             Ccccccc-ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH------HHHHHhc
Confidence            7543111 0112334689999999998     46778999999999999999999999986543221      1111111


Q ss_pred             hchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          449 ENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       449 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      .. ...       ...+...+..+.+++.+||+.||++|||+.++++
T Consensus       237 ~~-~~~-------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          237 SD-PPT-------LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             SC-CCC-------CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             cC-Ccc-------cCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            10 000       0112233457889999999999999999999875

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.5e-40  Score=354.34  Aligned_cols=252  Identities=22%  Similarity=0.348  Sum_probs=204.6

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCC---hHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEID---KTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY  291 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  291 (537)
                      ++|...+.||+|+||.||+++.. +|+.||+|++....   ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm  264 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM  264 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence            67888899999999999999975 69999999986421   123467889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeec
Q 009340          292 EYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF  371 (537)
Q Consensus       292 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Df  371 (537)
                      ||+++|+|.+++......        ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+||
T Consensus       265 E~~~gg~L~~~l~~~~~~--------~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DF  333 (543)
T 3c4z_A          265 TIMNGGDIRYHIYNVDED--------NPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDL  333 (543)
T ss_dssp             CCCTTCBHHHHHHTSSTT--------SCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCC
T ss_pred             EeccCCCHHHHHHHhhcc--------cccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeec
Confidence            999999999998764321        236999999999999999999999999   999999999999999999999999


Q ss_pred             cCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhch
Q 009340          372 GISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQ  451 (537)
Q Consensus       372 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  451 (537)
                      |+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......  ........... . 
T Consensus       334 Gla~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~--~~~~~~~~i~~-~-  408 (543)
T 3c4z_A          334 GLAVELKAGQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV--ENKELKQRVLE-Q-  408 (543)
T ss_dssp             TTCEECCTTCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC--CHHHHHHHHHH-C-
T ss_pred             ceeeeccCCCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccch--hHHHHHHHHhh-c-
Confidence            99987654332 2334579999999999999999999999999999999999999997543211  11111111111 0 


Q ss_pred             hhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhh
Q 009340          452 LLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQ  492 (537)
Q Consensus       452 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  492 (537)
                               ....+...+..+.+|+.+||+.||++||++.+
T Consensus       409 ---------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~  440 (543)
T 3c4z_A          409 ---------AVTYPDKFSPASKDFCEALLQKDPEKRLGFRD  440 (543)
T ss_dssp             ---------CCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBT
T ss_pred             ---------ccCCCcccCHHHHHHHHHhccCCHhHCCCCcc
Confidence                     01223344567889999999999999998743

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=2.4e-40  Score=338.57  Aligned_cols=261  Identities=21%  Similarity=0.342  Sum_probs=201.9

Q ss_pred             hcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCC-ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeC-----Ccc
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI-DKTQIHQFINEVVILSQINHRHIVKLLGCCLET-----EVP  287 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~  287 (537)
                      .++|...+.||+|+||.||++... +++.||||++... .....+.+.+|+.++++++||||+++++++...     ...
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            468999999999999999999854 6889999998753 344567899999999999999999999999765     357


Q ss_pred             EEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEE
Q 009340          288 VLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK  367 (537)
Q Consensus       288 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~k  367 (537)
                      ++|+||++ |+|.+++..             ..+++..++.++.|+++||.|||+.+   |+||||||+|||++.++.+|
T Consensus       106 ~iv~e~~~-~~L~~~l~~-------------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~k  168 (364)
T 3qyz_A          106 YIVQDLME-TDLYKLLKT-------------QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLK  168 (364)
T ss_dssp             EEEEECCS-EEHHHHHHH-------------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEE
T ss_pred             EEEEcccC-cCHHHHHHh-------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEE
Confidence            99999997 589888853             35999999999999999999999999   99999999999999999999


Q ss_pred             EeeccCccccCCCCCce--eeeccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHH
Q 009340          368 VSDFGISRSIPNDKTHL--TTTIQGTFGYLDPEYFQS-SQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFI  444 (537)
Q Consensus       368 i~Dfgla~~~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~  444 (537)
                      |+|||++..........  .....||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+.   .....
T Consensus       169 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---~~~i~  245 (364)
T 3qyz_A          169 ICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ---LNHIL  245 (364)
T ss_dssp             ECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGH---HHHHH
T ss_pred             EEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHH---HHHHH
Confidence            99999998764332221  234578999999998754 4589999999999999999999999976543322   11111


Q ss_pred             HHHhhc---hhhhhhcHH---h-----------hccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          445 SLAKEN---QLLEILDAR---V-----------AKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       445 ~~~~~~---~~~~~~d~~---~-----------~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      ......   .+....+..   .           ........+..+.+|+.+||+.||++|||+.|+++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  313 (364)
T 3qyz_A          246 GILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  313 (364)
T ss_dssp             HHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            111100   000000000   0           00011223467889999999999999999999975

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=2.3e-40  Score=345.86  Aligned_cols=200  Identities=26%  Similarity=0.304  Sum_probs=173.6

Q ss_pred             hcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCChHHHHHHHHHHHHHHhc------CCCCcceEeeEEeeCCcc
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKTQIHQFINEVVILSQI------NHRHIVKLLGCCLETEVP  287 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~H~niv~l~g~~~~~~~~  287 (537)
                      ..+|...++||+|+||.||+|... +++.||||+++.. ....+.+.+|+.+++.+      +|+||+++++++......
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~  174 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI  174 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence            357889999999999999999854 5889999999753 34456778899888887      577999999999999999


Q ss_pred             EEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCc--
Q 009340          288 VLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFS--  365 (537)
Q Consensus       288 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~--  365 (537)
                      ++||||+. ++|.+++.....          ..+++..++.++.|+++||+|||+.+   |+||||||+|||++.++.  
T Consensus       175 ~lv~e~~~-~~L~~~l~~~~~----------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~  240 (429)
T 3kvw_A          175 CMTFELLS-MNLYELIKKNKF----------QGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSG  240 (429)
T ss_dssp             EEEECCCC-CBHHHHHHHTTT----------CCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCC
T ss_pred             EEEEeccC-CCHHHHHHhccC----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcc
Confidence            99999996 699999876432          35999999999999999999999999   999999999999999887  


Q ss_pred             EEEeeccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccch
Q 009340          366 AKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARV  433 (537)
Q Consensus       366 ~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~  433 (537)
                      +||+|||++......    .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus       241 vkL~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~  304 (429)
T 3kvw_A          241 IKVIDFGSSCYEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDE  304 (429)
T ss_dssp             EEECCCTTCEETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             eEEeecccceecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCH
Confidence            999999999765332    2345689999999999999999999999999999999999999976543

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.1e-40  Score=343.29  Aligned_cols=270  Identities=22%  Similarity=0.306  Sum_probs=201.7

Q ss_pred             HHHhcCCccccccCcCCceEEEEEEc-CCCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCC-----
Q 009340          212 QRATDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETE-----  285 (537)
Q Consensus       212 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----  285 (537)
                      ....++|...+.||+|+||.||+|.. .+|+.||||++.....    ...+|+.+++.++|+||+++++++....     
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~   78 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK   78 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence            45567899999999999999999985 5789999998865322    2237999999999999999999985432     


Q ss_pred             ---------------------------------ccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHH
Q 009340          286 ---------------------------------VPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACE  332 (537)
Q Consensus       286 ---------------------------------~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~  332 (537)
                                                       ..++||||++ |+|.+.+......        ...+++..+..++.|
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~--------~~~l~~~~~~~i~~q  149 (383)
T 3eb0_A           79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRS--------GRSIPMNLISIYIYQ  149 (383)
T ss_dssp             -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHT--------TCCCCHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhc--------CCCCCHHHHHHHHHH
Confidence                                             3789999998 5888888653321        347999999999999


Q ss_pred             HHHHHHHHhhcCCCCeeecCCCCCCEEEC-CCCcEEEeeccCccccCCCCCceeeeccccccccCcccccCC-CCCcchh
Q 009340          333 VAGAVAYMHSSASIPIFHRDIKSSNILLD-DKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSS-QFTDKSD  410 (537)
Q Consensus       333 ia~gl~yLH~~~~~~ivH~Dlk~~NIll~-~~~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksD  410 (537)
                      +++||.|||+.+   |+||||||+|||++ .++.+||+|||+++.......  .....+|+.|+|||.+.+. .++.++|
T Consensus       150 i~~aL~~LH~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~D  224 (383)
T 3eb0_A          150 LFRAVGFIHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSID  224 (383)
T ss_dssp             HHHHHHHHHTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHH
T ss_pred             HHHHHHHHHHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchh
Confidence            999999999999   99999999999998 688999999999987644332  3345689999999998765 5899999


Q ss_pred             HHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchhhhhh---------------cHHhhccccHHHHHHHHHH
Q 009340          411 VYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEIL---------------DARVAKEAREEDIGAMAEL  475 (537)
Q Consensus       411 V~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------d~~~~~~~~~~~~~~l~~l  475 (537)
                      ||||||++|||++|+.||......+.   ...............+.               ........+...+..+.+|
T Consensus       225 iwslG~il~ell~g~~pf~~~~~~~~---~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  301 (383)
T 3eb0_A          225 LWSIGCVFGELILGKPLFSGETSIDQ---LVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDL  301 (383)
T ss_dssp             HHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHH
T ss_pred             hhhHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHH
Confidence            99999999999999999976543321   11111111111000000               0011111223345678999


Q ss_pred             HHHhcccCCCCCCCHhhHHH--HHHHHHH
Q 009340          476 AMRCLRLNSKKRPTMKQVSM--ELEGLRR  502 (537)
Q Consensus       476 ~~~cl~~~p~~RPs~~ev~~--~L~~i~~  502 (537)
                      +.+||+.||++|||+.|+++  .++.++.
T Consensus       302 i~~~L~~dP~~R~t~~e~l~hp~f~~~~~  330 (383)
T 3eb0_A          302 LEQILRYEPDLRINPYEAMAHPFFDHLRN  330 (383)
T ss_dssp             HHHHCCSSGGGSCCHHHHHTSGGGHHHHH
T ss_pred             HHHHccCChhhCCCHHHHhcCHHHHHHHh
Confidence            99999999999999999984  4455443

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=4.9e-40  Score=337.12  Aligned_cols=261  Identities=21%  Similarity=0.316  Sum_probs=193.2

Q ss_pred             hcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccC--CChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCC------
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKE--IDKTQIHQFINEVVILSQINHRHIVKLLGCCLETE------  285 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------  285 (537)
                      .++|...+.||+|+||.||+|... +++.||||++..  ......+.+.+|+.+++.++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            368999999999999999999854 688999999864  34455677899999999999999999999997665      


Q ss_pred             ccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCc
Q 009340          286 VPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFS  365 (537)
Q Consensus       286 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~  365 (537)
                      ..++||||+++ +|.+++..              .+++..+..++.|+++||.|||+.+   |+||||||+|||++.++.
T Consensus       104 ~~~lv~e~~~~-~l~~~~~~--------------~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~  165 (371)
T 2xrw_A          104 DVYIVMELMDA-NLCQVIQM--------------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCT  165 (371)
T ss_dssp             EEEEEEECCSE-EHHHHHHS--------------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSC
T ss_pred             ceEEEEEcCCC-CHHHHHhh--------------ccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCC
Confidence            67999999975 78777742              5899999999999999999999999   999999999999999999


Q ss_pred             EEEeeccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHH-----
Q 009340          366 AKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLV-----  440 (537)
Q Consensus       366 ~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~-----  440 (537)
                      +||+|||+++......  ......||+.|+|||.+.+..++.++|||||||++|||++|+.||......+.....     
T Consensus       166 ~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~  243 (371)
T 2xrw_A          166 LKILDFGLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLG  243 (371)
T ss_dssp             EEECCCCC------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CC
T ss_pred             EEEEEeeccccccccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            9999999998654321  234457899999999999999999999999999999999999999754432210000     


Q ss_pred             -----------HHHHHHHhhc------hhhhhhcHHhh---ccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          441 -----------ACFISLAKEN------QLLEILDARVA---KEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       441 -----------~~~~~~~~~~------~~~~~~d~~~~---~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                                 ..........      .+...+.....   ..........+.+|+.+||+.||++|||+.|+++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  318 (371)
T 2xrw_A          244 TPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  318 (371)
T ss_dssp             CCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence                       0000000000      00000000000   0012234678999999999999999999999976

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=2.3e-40  Score=331.38  Aligned_cols=252  Identities=23%  Similarity=0.351  Sum_probs=198.5

Q ss_pred             HHhcCCccccccCcCCceEEEEEEcCCCCEEEEEEccC--CChHHHHHHHHHHHHHHhcC--CCCcceEeeEEeeCCccE
Q 009340          213 RATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKE--IDKTQIHQFINEVVILSQIN--HRHIVKLLGCCLETEVPV  288 (537)
Q Consensus       213 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~~~~~  288 (537)
                      ...++|...+.||+|+||.||++...+++.||||.+..  ......+.+.+|+.++.+++  |+||+++++++.+.+..+
T Consensus        25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~  104 (313)
T 3cek_A           25 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY  104 (313)
T ss_dssp             ETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEE
T ss_pred             eccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEE
Confidence            33567899999999999999999988899999999864  34556778999999999997  599999999999999999


Q ss_pred             EEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEE
Q 009340          289 LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKV  368 (537)
Q Consensus       289 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki  368 (537)
                      +||| +.+++|.+++...            ..+++..++.++.|+++||.|||+.+   |+||||||+|||+++ +.+||
T Consensus       105 lv~e-~~~~~L~~~l~~~------------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL  167 (313)
T 3cek_A          105 MVME-CGNIDLNSWLKKK------------KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKL  167 (313)
T ss_dssp             EEEC-CCSEEHHHHHHHC------------SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEE
T ss_pred             EEEe-cCCCcHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEE
Confidence            9999 6688999999753            36899999999999999999999999   999999999999975 79999


Q ss_pred             eeccCccccCCCCCc-eeeeccccccccCcccccC-----------CCCCcchhHHHHHHHHHHHHhCCCCCCccchhhh
Q 009340          369 SDFGISRSIPNDKTH-LTTTIQGTFGYLDPEYFQS-----------SQFTDKSDVYSFGVVLLELLTGKKPICFARVEEE  436 (537)
Q Consensus       369 ~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~  436 (537)
                      +|||++......... ......||+.|+|||.+.+           ..++.++||||||+++|||++|+.||....... 
T Consensus       168 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-  246 (313)
T 3cek_A          168 IDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-  246 (313)
T ss_dssp             CCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH-
T ss_pred             eeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH-
Confidence            999999876443222 2234568999999999875           478889999999999999999999986432211 


Q ss_pred             ccHHHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          437 RNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       437 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                          ..+         ...+++......+......+.+++.+||+.||++|||+.++++
T Consensus       247 ----~~~---------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  292 (313)
T 3cek_A          247 ----SKL---------HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  292 (313)
T ss_dssp             ----HHH---------HHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ----HHH---------HHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence                111         1122222222222233457889999999999999999999976

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.6e-40  Score=334.75  Aligned_cols=256  Identities=23%  Similarity=0.340  Sum_probs=202.6

Q ss_pred             HHHhcCCccc-cccCcCCceEEEEEEcC-CCCEEEEEEccCC--ChHHHHHHHHHHHHHHhc-CCCCcceEeeEEeeCCc
Q 009340          212 QRATDNYNQS-RFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI--DKTQIHQFINEVVILSQI-NHRHIVKLLGCCLETEV  286 (537)
Q Consensus       212 ~~~~~~~~~~-~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~  286 (537)
                      +...+.|... +.||+|+||.||++... +|+.||||.++..  .......+.+|+.++..+ +||||+++++++.+.+.
T Consensus        24 ~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~  103 (327)
T 3lm5_A           24 ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSE  103 (327)
T ss_dssp             HHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             HhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCe
Confidence            3445667666 88999999999999965 6899999988652  233457789999999999 56999999999999999


Q ss_pred             cEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECC---C
Q 009340          287 PVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD---K  363 (537)
Q Consensus       287 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~---~  363 (537)
                      .++||||+++|+|.+++....          ...+++..++.++.|++.||+|||+.+   |+||||||+|||++.   +
T Consensus       104 ~~lv~e~~~~~~L~~~~~~~~----------~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~  170 (327)
T 3lm5_A          104 IILILEYAAGGEIFSLCLPEL----------AEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPL  170 (327)
T ss_dssp             EEEEEECCTTEEGGGGGSSCC-----------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTB
T ss_pred             EEEEEEecCCCcHHHHHHHhc----------ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCC
Confidence            999999999999999986532          246999999999999999999999999   999999999999998   7


Q ss_pred             CcEEEeeccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHH
Q 009340          364 FSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACF  443 (537)
Q Consensus       364 ~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~  443 (537)
                      +.+||+|||+++......  ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+.      .
T Consensus       171 ~~~kL~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~------~  242 (327)
T 3lm5_A          171 GDIKIVDFGMSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQET------Y  242 (327)
T ss_dssp             CCEEECCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------H
T ss_pred             CcEEEeeCccccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH------H
Confidence            899999999998764332  23345789999999999999999999999999999999999999965433221      1


Q ss_pred             HHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          444 ISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       444 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      ......       ......+.....+..+.+++.+||+.||++|||+.++++
T Consensus       243 ~~i~~~-------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~  287 (327)
T 3lm5_A          243 LNISQV-------NVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS  287 (327)
T ss_dssp             HHHHHT-------CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             HHHHhc-------ccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence            111100       000111112234467889999999999999999999875

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=4.3e-40  Score=339.99  Aligned_cols=262  Identities=23%  Similarity=0.282  Sum_probs=202.8

Q ss_pred             hcCCccccccCcCCceEEEEEEc-CCCCEEEEEEccCCChHHHHHHHHHHHHHHhcC--------CCCcceEeeEEe---
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEIDKTQIHQFINEVVILSQIN--------HRHIVKLLGCCL---  282 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------H~niv~l~g~~~---  282 (537)
                      .++|...++||+|+||.||+++. .+++.||||+++.. ....+.+.+|+.+++.++        |+||+++++++.   
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~  114 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG  114 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence            36899999999999999999985 46889999998753 445677899999999985        788999999987   


Q ss_pred             -eCCccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeeecCCCCCCEEE
Q 009340          283 -ETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSS-ASIPIFHRDIKSSNILL  360 (537)
Q Consensus       283 -~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~-~~~~ivH~Dlk~~NIll  360 (537)
                       +....++||||+ +++|.+++....          ...+++..++.++.|+++||.|||++ +   |+||||||+|||+
T Consensus       115 ~~~~~~~lv~e~~-~~~l~~~~~~~~----------~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll  180 (397)
T 1wak_A          115 VNGTHICMVFEVL-GHHLLKWIIKSN----------YQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILL  180 (397)
T ss_dssp             TTEEEEEEEECCC-CCBHHHHHHHTT----------TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEE
T ss_pred             CCCceEEEEEecc-CccHHHHHHhcc----------cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeE
Confidence             445789999999 567776665432          23699999999999999999999998 8   9999999999999


Q ss_pred             CCCC-------------------------------------------------cEEEeeccCccccCCCCCceeeecccc
Q 009340          361 DDKF-------------------------------------------------SAKVSDFGISRSIPNDKTHLTTTIQGT  391 (537)
Q Consensus       361 ~~~~-------------------------------------------------~~ki~Dfgla~~~~~~~~~~~~~~~gt  391 (537)
                      +.++                                                 .+||+|||++......    .....||
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt  256 (397)
T 1wak_A          181 SVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQT  256 (397)
T ss_dssp             CCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSC
T ss_pred             eccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCC
Confidence            9775                                                 7999999999876432    2344689


Q ss_pred             ccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhc---cHHHHHHHHHhhc--------h-hhhhhcH-
Q 009340          392 FGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEER---NLVACFISLAKEN--------Q-LLEILDA-  458 (537)
Q Consensus       392 ~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~---~~~~~~~~~~~~~--------~-~~~~~d~-  458 (537)
                      +.|+|||.+.+..++.++|||||||++|||++|+.||......+..   .............        . ..+.+.. 
T Consensus       257 ~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~  336 (397)
T 1wak_A          257 RQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKK  336 (397)
T ss_dssp             GGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTT
T ss_pred             CcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCc
Confidence            9999999999999999999999999999999999999754432211   1111111111100        0 0000000 


Q ss_pred             ----------------H--hhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          459 ----------------R--VAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       459 ----------------~--~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                                      .  -....+......+.+|+.+||+.||++|||+.|+++
T Consensus       337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          337 GDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             SSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             cccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence                            0  011235677788999999999999999999999975

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=3.4e-40  Score=350.44  Aligned_cols=250  Identities=26%  Similarity=0.386  Sum_probs=201.6

Q ss_pred             hcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCC--ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEE
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI--DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY  291 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  291 (537)
                      .++|...++||+|+||+||++... +++.||||++...  .......+.+|+.++++++||||+++++++.+....++||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  100 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence            467899999999999999999964 7899999998532  1223567889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEC---CCCcEEE
Q 009340          292 EYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD---DKFSAKV  368 (537)
Q Consensus       292 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~---~~~~~ki  368 (537)
                      ||+++|+|.+++...            ..+++..+..++.|+++||.|||+.+   |+||||||+|||++   .++.+||
T Consensus       101 e~~~~~~L~~~~~~~------------~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl  165 (486)
T 3mwu_A          101 ELYTGGELFDEIIKR------------KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKI  165 (486)
T ss_dssp             CCCCSCBHHHHHHHH------------SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEE
T ss_pred             EcCCCCcHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEE
Confidence            999999999988653            35999999999999999999999999   99999999999995   5567999


Q ss_pred             eeccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHh
Q 009340          369 SDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAK  448 (537)
Q Consensus       369 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  448 (537)
                      +|||++.......  ......||+.|+|||.+.+ .++.++|||||||++|+|++|+.||......+       ......
T Consensus       166 ~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------~~~~i~  235 (486)
T 3mwu_A          166 IDFGLSTCFQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD-------ILKRVE  235 (486)
T ss_dssp             CSCSCTTTBCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHH
T ss_pred             EECCcCeECCCCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHH
Confidence            9999998764332  2345579999999999875 58999999999999999999999997543322       111111


Q ss_pred             hchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          449 ENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       449 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      .+...      ...+.....+..+.+|+.+||+.||++|||+.++++
T Consensus       236 ~~~~~------~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~  276 (486)
T 3mwu_A          236 TGKYA------FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (486)
T ss_dssp             HTCCC------SCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             hCCCC------CCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            11100      000111233467889999999999999999999986

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=5.3e-40  Score=326.08  Aligned_cols=252  Identities=23%  Similarity=0.371  Sum_probs=203.9

Q ss_pred             HhcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCC---------hHHHHHHHHHHHHHHhcC-CCCcceEeeEEe
Q 009340          214 ATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEID---------KTQIHQFINEVVILSQIN-HRHIVKLLGCCL  282 (537)
Q Consensus       214 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~  282 (537)
                      ..++|...+.||+|+||.||++... +|+.||||.++...         ....+.+.+|+.+++++. ||||+++++++.
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   94 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence            3478999999999999999999964 68899999986432         223467889999999995 999999999999


Q ss_pred             eCCccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECC
Q 009340          283 ETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD  362 (537)
Q Consensus       283 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~  362 (537)
                      +.+..++||||+++|+|.+++...            ..+++..++.++.|+++||.|||+.+   ++||||||+||+++.
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~l~~~------------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~  159 (298)
T 1phk_A           95 TNTFFFLVFDLMKKGELFDYLTEK------------VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDD  159 (298)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHH------------SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECT
T ss_pred             cCCeEEEEEeccCCCcHHHHHhcc------------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcC
Confidence            999999999999999999999753            35999999999999999999999999   999999999999999


Q ss_pred             CCcEEEeeccCccccCCCCCceeeeccccccccCccccc------CCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhh
Q 009340          363 KFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQ------SSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEE  436 (537)
Q Consensus       363 ~~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~  436 (537)
                      ++.+||+|||++.......  ......+|+.|+|||.+.      ...++.++||||||+++|||++|+.||....... 
T Consensus       160 ~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-  236 (298)
T 1phk_A          160 DMNIKLTDFGFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML-  236 (298)
T ss_dssp             TCCEEECCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-
T ss_pred             CCcEEEecccchhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH-
Confidence            9999999999998764432  233456899999999884      4568899999999999999999999986543221 


Q ss_pred             ccHHHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          437 RNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       437 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                            ...........      ...+.....+..+.+++.+||+.||++|||+.++++
T Consensus       237 ------~~~~~~~~~~~------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          237 ------MLRMIMSGNYQ------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             ------HHHHHHHTCCC------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             ------HHHHHhcCCcc------cCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence                  11111111000      000111234467889999999999999999999875

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=1.1e-40  Score=341.12  Aligned_cols=257  Identities=23%  Similarity=0.339  Sum_probs=184.3

Q ss_pred             hcCCccccccCcCCceEEEEEEc-CCCCEEEEEEccC--CChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeC------C
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKE--IDKTQIHQFINEVVILSQINHRHIVKLLGCCLET------E  285 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~  285 (537)
                      .++|...+.||+|+||.||+|.. .+|+.||||++..  ......+.+.+|+.+++.++||||+++++++...      .
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            46899999999999999999984 4789999999865  3345567889999999999999999999998754      4


Q ss_pred             ccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCc
Q 009340          286 VPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFS  365 (537)
Q Consensus       286 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~  365 (537)
                      ..++|+||+ +++|.+++..             ..+++..+..++.|+++||.|||+.+   |+||||||+|||++.++.
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~-------------~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~  170 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKC-------------QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCE  170 (367)
T ss_dssp             CCEEEEECC-CEECC------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCC
T ss_pred             eEEEEeccc-CCCHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCC
Confidence            579999999 6799888853             25999999999999999999999999   999999999999999999


Q ss_pred             EEEeeccCccccCCCCCceeeeccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHH
Q 009340          366 AKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQS-SQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFI  444 (537)
Q Consensus       366 ~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~  444 (537)
                      +||+|||+++.....    .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||......+..   ....
T Consensus       171 ~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l---~~i~  243 (367)
T 2fst_X          171 LKILDFGLARHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL---KLIL  243 (367)
T ss_dssp             EEECC-------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHH
T ss_pred             EEEeecccccccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHH
Confidence            999999999865432    234578999999999877 67899999999999999999999999755432211   1111


Q ss_pred             HHHhhc---hhhhhhcH-------Hhh-------ccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          445 SLAKEN---QLLEILDA-------RVA-------KEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       445 ~~~~~~---~~~~~~d~-------~~~-------~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      ......   .+..+...       .+.       ..........+.+|+.+||+.||++|||+.++++
T Consensus       244 ~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~  311 (367)
T 2fst_X          244 RLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  311 (367)
T ss_dssp             HHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence            111100   00000000       000       0001122467889999999999999999999975

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=3.4e-40  Score=351.07  Aligned_cols=250  Identities=26%  Similarity=0.398  Sum_probs=198.9

Q ss_pred             hcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCC--hHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEE
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEID--KTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY  291 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  291 (537)
                      .++|...++||+|+||.||+++.. ++..||+|.+....  ......+.+|+.+++.++||||+++++++.+....++||
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  115 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM  115 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            457889999999999999999965 68899999986532  233567889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCC---CcEEE
Q 009340          292 EYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK---FSAKV  368 (537)
Q Consensus       292 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~---~~~ki  368 (537)
                      ||+++|+|.+++...            ..+++..+..++.|+++||.|||+.+   |+||||||+|||++.+   +.+||
T Consensus       116 e~~~~g~L~~~~~~~------------~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl  180 (494)
T 3lij_A          116 ECYKGGELFDEIIHR------------MKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKI  180 (494)
T ss_dssp             ECCCSCBHHHHHHHH------------SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEE
T ss_pred             ecCCCCcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEE
Confidence            999999999988653            35999999999999999999999999   9999999999999764   55999


Q ss_pred             eeccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHh
Q 009340          369 SDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAK  448 (537)
Q Consensus       369 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  448 (537)
                      +|||++.......  ......||+.|+|||++. +.++.++|||||||++|||++|+.||......+       ......
T Consensus       181 ~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------~~~~i~  250 (494)
T 3lij_A          181 VDFGLSAVFENQK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE-------ILRKVE  250 (494)
T ss_dssp             CCCTTCEECBTTB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHH
T ss_pred             EECCCCeECCCCc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHH
Confidence            9999998764432  234457999999999986 568999999999999999999999997544322       111111


Q ss_pred             hchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          449 ENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       449 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      .+...  .+    .+.....+..+.+|+.+||+.||.+|||+.++++
T Consensus       251 ~~~~~--~~----~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  291 (494)
T 3lij_A          251 KGKYT--FD----SPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE  291 (494)
T ss_dssp             HTCCC--CC----SGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hCCCC--CC----chhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence            11100  00    0111223457889999999999999999999985

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.6e-41  Score=340.30  Aligned_cols=264  Identities=22%  Similarity=0.378  Sum_probs=201.3

Q ss_pred             HHHhcCCccccccCcCCceEEEEEEcCCCCEEEEEEccCC--ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEE
Q 009340          212 QRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEI--DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVL  289 (537)
Q Consensus       212 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  289 (537)
                      ....++|...+.||+|+||.||+|...+  .||+|.++..  .....+.+.+|+.++++++|+||+++++++.+.+..++
T Consensus        29 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i  106 (319)
T 2y4i_B           29 DIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAI  106 (319)
T ss_dssp             SSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEE
T ss_pred             cCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEE
Confidence            3345788999999999999999999753  4999988642  22334567789999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEe
Q 009340          290 VYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVS  369 (537)
Q Consensus       290 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~  369 (537)
                      ||||+++++|.+++....           ..+++..++.++.|+++||.|||+.+   ++||||||+|||++ ++.+||+
T Consensus       107 v~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~  171 (319)
T 2y4i_B          107 ITSLCKGRTLYSVVRDAK-----------IVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVIT  171 (319)
T ss_dssp             ECBCCCSEEHHHHTTSSC-----------CCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEEC
T ss_pred             EeecccCCcHHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEe
Confidence            999999999999997632           36899999999999999999999999   99999999999998 6799999


Q ss_pred             eccCccccCCCC----CceeeeccccccccCcccccC---------CCCCcchhHHHHHHHHHHHHhCCCCCCccchhhh
Q 009340          370 DFGISRSIPNDK----THLTTTIQGTFGYLDPEYFQS---------SQFTDKSDVYSFGVVLLELLTGKKPICFARVEEE  436 (537)
Q Consensus       370 Dfgla~~~~~~~----~~~~~~~~gt~~y~aPE~~~~---------~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~  436 (537)
                      |||++.......    ........||+.|+|||.+..         ..++.++||||||+++|||++|+.||....... 
T Consensus       172 Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-  250 (319)
T 2y4i_B          172 DFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA-  250 (319)
T ss_dssp             CCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHH-
T ss_pred             ecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-
Confidence            999987653211    112233458999999999864         457899999999999999999999987543322 


Q ss_pred             ccHHHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHHhhHHH
Q 009340          437 RNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRSQRCL  507 (537)
Q Consensus       437 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~~~~  507 (537)
                            ..........     +..   .....+..+.+++.+||+.||++|||+.+++++|+.+....+..
T Consensus       251 ------~~~~~~~~~~-----~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~  307 (319)
T 2y4i_B          251 ------IIWQMGTGMK-----PNL---SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRL  307 (319)
T ss_dssp             ------HHHHHHTTCC-----CCC---CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-------
T ss_pred             ------HHHHhccCCC-----CCC---CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccC
Confidence                  1111111110     000   01123346889999999999999999999999999998865443

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=3.9e-40  Score=327.25  Aligned_cols=252  Identities=23%  Similarity=0.446  Sum_probs=193.5

Q ss_pred             HhcCCccccccCcCCceEEEEEEc-CCCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEee---------
Q 009340          214 ATDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLE---------  283 (537)
Q Consensus       214 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~---------  283 (537)
                      ..++|+..+.||+|+||.||+|+. .+|+.||||++... ....+.+.+|+.++++++||||+++++++.+         
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT   82 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence            346788999999999999999995 47899999998653 3456789999999999999999999999865         


Q ss_pred             ----CCccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEE
Q 009340          284 ----TEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNIL  359 (537)
Q Consensus       284 ----~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIl  359 (537)
                          .+..++||||+++|+|.+++....           ..+++..++.++.|+++||+|||+.+   |+||||||+|||
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil  148 (303)
T 1zy4_A           83 AVKKKSTLFIQMEYCENGTLYDLIHSEN-----------LNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIF  148 (303)
T ss_dssp             ---CEEEEEEEEECCCSCBHHHHHHHSC-----------GGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred             ccccCCceEEEEecCCCCCHHHhhhccc-----------cccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEE
Confidence                346799999999999999997532           25788999999999999999999999   999999999999


Q ss_pred             ECCCCcEEEeeccCccccCCCC-------------CceeeeccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCC
Q 009340          360 LDDKFSAKVSDFGISRSIPNDK-------------THLTTTIQGTFGYLDPEYFQSS-QFTDKSDVYSFGVVLLELLTGK  425 (537)
Q Consensus       360 l~~~~~~ki~Dfgla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvll~el~tg~  425 (537)
                      ++.++.+||+|||++.......             ........||+.|+|||.+.+. .++.++||||||+++|||++  
T Consensus       149 ~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~--  226 (303)
T 1zy4_A          149 IDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY--  226 (303)
T ss_dssp             ECTTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS--
T ss_pred             EcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh--
Confidence            9999999999999998664321             1122345689999999999764 78999999999999999998  


Q ss_pred             CCCCccchhhhccHHHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          426 KPICFARVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       426 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                       |+......  .   . ........      ........+...+..+.+++.+||+.||++|||+.++++
T Consensus       227 -p~~~~~~~--~---~-~~~~~~~~------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          227 -PFSTGMER--V---N-ILKKLRSV------SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             -CCSSHHHH--H---H-HHHHHHST------TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -ccCCchhH--H---H-HHHhcccc------ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence             44321110  0   0 11111110      011112233344567889999999999999999999975

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=6.4e-40  Score=349.88  Aligned_cols=251  Identities=26%  Similarity=0.382  Sum_probs=201.4

Q ss_pred             HhcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCCh-------------HHHHHHHHHHHHHHhcCCCCcceEee
Q 009340          214 ATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDK-------------TQIHQFINEVVILSQINHRHIVKLLG  279 (537)
Q Consensus       214 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~H~niv~l~g  279 (537)
                      ..++|...++||+|+||+||++... +++.||||.+.....             ...+.+.+|+.++++++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            3578999999999999999999964 688999999865321             23467889999999999999999999


Q ss_pred             EEeeCCccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEE
Q 009340          280 CCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNIL  359 (537)
Q Consensus       280 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIl  359 (537)
                      ++.+....++||||+++|+|.+++...            ..+++..++.++.|++.||.|||+.+   |+||||||+|||
T Consensus       114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~------------~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil  178 (504)
T 3q5i_A          114 VFEDKKYFYLVTEFYEGGELFEQIINR------------HKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENIL  178 (504)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHHH------------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred             EEEcCCEEEEEEecCCCCcHHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEE
Confidence            999999999999999999999998653            35999999999999999999999999   999999999999


Q ss_pred             ECCCC---cEEEeeccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhh
Q 009340          360 LDDKF---SAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEE  436 (537)
Q Consensus       360 l~~~~---~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~  436 (537)
                      ++.++   .+||+|||++.......  ......||+.|+|||.+. +.++.++|||||||++|+|++|+.||......+ 
T Consensus       179 ~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-  254 (504)
T 3q5i_A          179 LENKNSLLNIKIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD-  254 (504)
T ss_dssp             ESSTTCCSSEEECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-
T ss_pred             EecCCCCccEEEEECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-
Confidence            98776   69999999998765432  234556999999999986 568999999999999999999999997544322 


Q ss_pred             ccHHHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          437 RNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       437 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                            .......+...  .+...    ....+..+.+|+.+||+.||.+|||+.|+++
T Consensus       255 ------~~~~i~~~~~~--~~~~~----~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~  301 (504)
T 3q5i_A          255 ------IIKKVEKGKYY--FDFND----WKNISDEAKELIKLMLTYDYNKRCTAEEALN  301 (504)
T ss_dssp             ------HHHHHHHCCCC--CCHHH----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ------HHHHHHcCCCC--CCccc----cCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence                  11111111100  00000    1123457889999999999999999999975

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.4e-40  Score=333.35  Aligned_cols=261  Identities=22%  Similarity=0.337  Sum_probs=195.6

Q ss_pred             hcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEe-----------
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCL-----------  282 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~-----------  282 (537)
                      .++|...+.||+|+||.||+|... +|+.||||++...+....+++.+|+.++++++||||+++++++.           
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            367888999999999999999975 48999999998777777888999999999999999999999874           


Q ss_pred             ---eCCccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEE
Q 009340          283 ---ETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNIL  359 (537)
Q Consensus       283 ---~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIl  359 (537)
                         +....++||||++ |+|.+++..             ..+++..++.++.|+++||+|||+.+   |+||||||+|||
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~~-------------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil  152 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLEQ-------------GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLF  152 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHTT-------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEE
T ss_pred             cccccCceeEEeeccC-CCHHHHhhc-------------CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEE
Confidence               3456799999998 699998853             35899999999999999999999999   999999999999


Q ss_pred             EC-CCCcEEEeeccCccccCCCCCc--eeeeccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCccchhh
Q 009340          360 LD-DKFSAKVSDFGISRSIPNDKTH--LTTTIQGTFGYLDPEYFQS-SQFTDKSDVYSFGVVLLELLTGKKPICFARVEE  435 (537)
Q Consensus       360 l~-~~~~~ki~Dfgla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~  435 (537)
                      ++ +++.+||+|||+++........  ......+|..|+|||.+.+ ..++.++||||||+++|||++|+.||......+
T Consensus       153 ~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~  232 (320)
T 2i6l_A          153 INTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE  232 (320)
T ss_dssp             EETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred             EcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHH
Confidence            97 5779999999999876432211  1234457899999998865 678999999999999999999999997654322


Q ss_pred             hccHHHHHHHHHhh---c---hhh----hhhcHHhhc------cccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          436 ERNLVACFISLAKE---N---QLL----EILDARVAK------EAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       436 ~~~~~~~~~~~~~~---~---~~~----~~~d~~~~~------~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      ..   .........   .   .+.    ..+......      ......+..+.+++.+||+.||++|||+.++++
T Consensus       233 ~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (320)
T 2i6l_A          233 QM---QLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS  305 (320)
T ss_dssp             HH---HHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             HH---HHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence            11   111000000   0   000    000000000      011224567899999999999999999999975

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1.9e-40  Score=352.28  Aligned_cols=250  Identities=27%  Similarity=0.395  Sum_probs=204.4

Q ss_pred             hcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCC---ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEE
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI---DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLV  290 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  290 (537)
                      .++|...++||+|+||.||++... +|+.||||++...   .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  104 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV  104 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            467888999999999999999965 7899999998542   133467789999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEE---CCCCcEE
Q 009340          291 YEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILL---DDKFSAK  367 (537)
Q Consensus       291 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll---~~~~~~k  367 (537)
                      |||+.+|+|.+++...            ..+++..+..++.|+++||.|||+++   |+||||||+|||+   +.++.+|
T Consensus       105 ~e~~~~~~L~~~~~~~------------~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~k  169 (484)
T 3nyv_A          105 GEVYTGGELFDEIISR------------KRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIR  169 (484)
T ss_dssp             ECCCCSCBHHHHHHTC------------SCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEE
T ss_pred             EecCCCCCHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEE
Confidence            9999999999998653            46999999999999999999999999   9999999999999   5678999


Q ss_pred             EeeccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHH
Q 009340          368 VSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLA  447 (537)
Q Consensus       368 i~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~  447 (537)
                      |+|||++........  .....||+.|+|||.+.+ .++.++|||||||++|||++|+.||......+       .....
T Consensus       170 l~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------~~~~i  239 (484)
T 3nyv_A          170 IIDFGLSTHFEASKK--MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD-------ILKKV  239 (484)
T ss_dssp             ECCTTHHHHBCCCCS--HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHH
T ss_pred             EEeeeeeEEcccccc--cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH-------HHHHH
Confidence            999999987644332  344569999999999865 68999999999999999999999997543322       11111


Q ss_pred             hhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          448 KENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       448 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      ..+...      ...+.....+..+.+|+.+||+.||++|||+.++++
T Consensus       240 ~~~~~~------~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  281 (484)
T 3nyv_A          240 EKGKYT------FELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD  281 (484)
T ss_dssp             HHCCCC------CCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HcCCCC------CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence            111100      000111234467889999999999999999999975

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=3.2e-40  Score=362.68  Aligned_cols=244  Identities=25%  Similarity=0.346  Sum_probs=202.8

Q ss_pred             HhcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCC---ChHHHHHHHHHHHHHHhc-CCCCcceEeeEEeeCCccE
Q 009340          214 ATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI---DKTQIHQFINEVVILSQI-NHRHIVKLLGCCLETEVPV  288 (537)
Q Consensus       214 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~  288 (537)
                      ..++|+..++||+|+||.||++... +++.||||+++..   .....+.+..|..++..+ +|+||+++++++.+.+..|
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~  418 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY  418 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence            3468999999999999999999965 6889999998742   123346678899999988 7999999999999999999


Q ss_pred             EEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEE
Q 009340          289 LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKV  368 (537)
Q Consensus       289 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki  368 (537)
                      +||||+++|+|.+++...            ..+++..++.++.||+.||+|||+.+   |+||||||+||||+.++.+||
T Consensus       419 lV~E~~~gg~L~~~l~~~------------~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL  483 (674)
T 3pfq_A          419 FVMEYVNGGDLMYHIQQV------------GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKI  483 (674)
T ss_dssp             EEEECCCSCBHHHHHHHH------------SSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEE
T ss_pred             EEEeCcCCCcHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEE
Confidence            999999999999999753            35999999999999999999999999   999999999999999999999


Q ss_pred             eeccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHh
Q 009340          369 SDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAK  448 (537)
Q Consensus       369 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  448 (537)
                      +|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+      .+.....
T Consensus       484 ~DFGla~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~------~~~~i~~  556 (674)
T 3pfq_A          484 ADFGMCKENIWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE------LFQSIME  556 (674)
T ss_dssp             CCCTTCEECCCTT-CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHS
T ss_pred             eecceeeccccCC-cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHH------HHHHHHh
Confidence            9999998643332 22455679999999999999999999999999999999999999997543322      1111111


Q ss_pred             hchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCH
Q 009340          449 ENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTM  490 (537)
Q Consensus       449 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~  490 (537)
                               ..  ..++...+.++.+|+.+||+.||++||++
T Consensus       557 ---------~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~  587 (674)
T 3pfq_A          557 ---------HN--VAYPKSMSKEAVAICKGLMTKHPGKRLGC  587 (674)
T ss_dssp             ---------SC--CCCCTTSCHHHHHHHHHHSCSSSTTCTTC
T ss_pred             ---------CC--CCCCccCCHHHHHHHHHHccCCHHHCCCC
Confidence                     11  12233455678999999999999999998

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=9.1e-40  Score=329.88  Aligned_cols=262  Identities=21%  Similarity=0.322  Sum_probs=204.0

Q ss_pred             hcCCccccccCcCCceEEEEEEc--CCCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCC------cceEeeEEeeCCc
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGML--PDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRH------IVKLLGCCLETEV  286 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~--~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n------iv~l~g~~~~~~~  286 (537)
                      .++|...+.||+|+||.||++..  .+++.||||.++.. ....+.+.+|+.+++.++|+|      ++++++++.+.+.
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~   91 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH   91 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence            36889999999999999999985  36889999998753 344677889999999987654      9999999999999


Q ss_pred             cEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECC----
Q 009340          287 PVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD----  362 (537)
Q Consensus       287 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~----  362 (537)
                      .++||||+ +++|.+++....          ...+++..+..++.|+++||+|||+.+   |+||||||+|||++.    
T Consensus        92 ~~lv~e~~-~~~l~~~l~~~~----------~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~  157 (339)
T 1z57_A           92 ICIVFELL-GLSTYDFIKENG----------FLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYT  157 (339)
T ss_dssp             EEEEEECC-CCBHHHHHHHTT----------TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEE
T ss_pred             EEEEEcCC-CCCHHHHHHhcC----------CCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccc
Confidence            99999999 889999987643          236899999999999999999999999   999999999999987    


Q ss_pred             ---------------CCcEEEeeccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCC
Q 009340          363 ---------------KFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP  427 (537)
Q Consensus       363 ---------------~~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p  427 (537)
                                     ++.+||+|||++......    .....||+.|+|||.+.+..++.++||||||+++|||++|+.|
T Consensus       158 ~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p  233 (339)
T 1z57_A          158 EAYNPKIKRDERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTV  233 (339)
T ss_dssp             EEEC----CEEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             cccCCccccccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCC
Confidence                           678999999999865432    2345689999999999999999999999999999999999999


Q ss_pred             CCccchhhhccHHHHHHH-----HHhhchhhhh-----------------hcHH-----hhccccHHHHHHHHHHHHHhc
Q 009340          428 ICFARVEEERNLVACFIS-----LAKENQLLEI-----------------LDAR-----VAKEAREEDIGAMAELAMRCL  480 (537)
Q Consensus       428 ~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~-----------------~d~~-----~~~~~~~~~~~~l~~l~~~cl  480 (537)
                      |......+..........     ..........                 +...     ............+.+|+.+||
T Consensus       234 f~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L  313 (339)
T 1z57_A          234 FPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKML  313 (339)
T ss_dssp             CCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHT
T ss_pred             CCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHh
Confidence            976544332111111000     0000000000                 0000     001123355678999999999


Q ss_pred             ccCCCCCCCHhhHHH
Q 009340          481 RLNSKKRPTMKQVSM  495 (537)
Q Consensus       481 ~~~p~~RPs~~ev~~  495 (537)
                      +.||++|||+.|+++
T Consensus       314 ~~dP~~Rpt~~ell~  328 (339)
T 1z57_A          314 EYDPAKRITLREALK  328 (339)
T ss_dssp             CSSTTTSCCHHHHTT
T ss_pred             CcCcccccCHHHHhc
Confidence            999999999999874

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1.1e-39  Score=324.78  Aligned_cols=251  Identities=21%  Similarity=0.310  Sum_probs=199.1

Q ss_pred             hcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCC----hHHHHHHHHHHHHHHhcCCCCcceEeeEEe--eCCcc
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEID----KTQIHQFINEVVILSQINHRHIVKLLGCCL--ETEVP  287 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~--~~~~~  287 (537)
                      .++|...+.||+|+||.||++... +++.||+|.++...    ....+.+.+|+.++++++|+||+++++++.  +....
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            478999999999999999999964 68899999986422    234577999999999999999999999985  44578


Q ss_pred             EEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEE
Q 009340          288 VLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK  367 (537)
Q Consensus       288 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~k  367 (537)
                      ++||||+++| |.+++....          ...+++..++.++.|+++||.|||+++   |+||||||+||+++.++.+|
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~----------~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~k  149 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVP----------EKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLK  149 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHST----------TCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEE
T ss_pred             EEEehhccCC-HHHHHHhCc----------ccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEE
Confidence            9999999886 777775432          236999999999999999999999999   99999999999999999999


Q ss_pred             EeeccCccccCCCC-CceeeeccccccccCcccccCCC--CCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHH
Q 009340          368 VSDFGISRSIPNDK-THLTTTIQGTFGYLDPEYFQSSQ--FTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFI  444 (537)
Q Consensus       368 i~Dfgla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~--~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~  444 (537)
                      |+|||++....... ........||+.|+|||.+.+..  ++.++||||||+++|||++|+.||......+       ..
T Consensus       150 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~  222 (305)
T 2wtk_C          150 ISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYK-------LF  222 (305)
T ss_dssp             ECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-------HH
T ss_pred             eeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHH-------HH
Confidence            99999998764322 22234556899999999987644  3789999999999999999999987543221       11


Q ss_pred             HHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHH
Q 009340          445 SLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSME  496 (537)
Q Consensus       445 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~  496 (537)
                      .......          ...+......+.+++.+||+.||++|||+.++++.
T Consensus       223 ~~i~~~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          223 ENIGKGS----------YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             HHHHHCC----------CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             HHHhcCC----------CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            1111111          11223344678899999999999999999999863

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=4.1e-40  Score=335.99  Aligned_cols=269  Identities=20%  Similarity=0.271  Sum_probs=192.5

Q ss_pred             HHHHHHhcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCc-
Q 009340          209 DELQRATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEV-  286 (537)
Q Consensus       209 ~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-  286 (537)
                      .+.....++|...+.||+|+||.||+|... +|+.||||++.... .....+.+++..++.++||||+++++++..... 
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~   94 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER   94 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence            455667789999999999999999999964 68999999886532 223456778888999999999999999976443 


Q ss_pred             ------cEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh--hcCCCCeeecCCCCCCE
Q 009340          287 ------PVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMH--SSASIPIFHRDIKSSNI  358 (537)
Q Consensus       287 ------~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH--~~~~~~ivH~Dlk~~NI  358 (537)
                            .++||||+++ +|.+.+.....        ....+++..+..++.|++.||.|||  +.+   |+||||||+||
T Consensus        95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~--------~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NI  162 (360)
T 3e3p_A           95 DRRDIYLNVVMEYVPD-TLHRCCRNYYR--------RQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNV  162 (360)
T ss_dssp             CTTCEEEEEEEECCSC-BHHHHHHHHHT--------TTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGE
T ss_pred             cccceeEEEEeecccc-cHHHHHHHHhh--------cccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHE
Confidence                  7899999986 55555543211        1346899999999999999999999  888   99999999999


Q ss_pred             EECC-CCcEEEeeccCccccCCCCCceeeeccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCccchhhh
Q 009340          359 LLDD-KFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSS-QFTDKSDVYSFGVVLLELLTGKKPICFARVEEE  436 (537)
Q Consensus       359 ll~~-~~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~  436 (537)
                      |++. ++.+||+|||+++.......  .....||+.|+|||.+.+. .++.++||||||+++|||++|+.||........
T Consensus       163 ll~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~  240 (360)
T 3e3p_A          163 LVNEADGTLKLCDFGSAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQ  240 (360)
T ss_dssp             EEETTTTEEEECCCTTCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             EEeCCCCcEEEeeCCCceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHH
Confidence            9996 89999999999987654332  3345689999999998665 489999999999999999999999976543321


Q ss_pred             ccHHHHHHHHHhhc--hhhhhhcH----------------HhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          437 RNLVACFISLAKEN--QLLEILDA----------------RVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       437 ~~~~~~~~~~~~~~--~~~~~~d~----------------~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                         ...........  .....+++                ..........+..+.+|+.+||+.||++|||+.|+++
T Consensus       241 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  314 (360)
T 3e3p_A          241 ---LHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC  314 (360)
T ss_dssp             ---HHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             ---HHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence               11111111000  00000000                0111112224678999999999999999999999975

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=3.9e-40  Score=331.09  Aligned_cols=252  Identities=26%  Similarity=0.348  Sum_probs=196.6

Q ss_pred             HhcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCC--------hHHHHHHHHHHHHHHhcCCCCcceEeeEEeeC
Q 009340          214 ATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEID--------KTQIHQFINEVVILSQINHRHIVKLLGCCLET  284 (537)
Q Consensus       214 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~  284 (537)
                      ..++|...+.||+|+||.||+|... +++.||||.+....        ......+.+|+.++++++||||+++++++...
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   87 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE   87 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence            3468999999999999999999964 68899999886421        12234588999999999999999999998765


Q ss_pred             CccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCC
Q 009340          285 EVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF  364 (537)
Q Consensus       285 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~  364 (537)
                      + .++||||+++|+|.+++...            ..+++..++.++.|+++||.|||+.+   |+||||||+|||++.++
T Consensus        88 ~-~~lv~e~~~~~~L~~~~~~~------------~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~  151 (322)
T 2ycf_A           88 D-YYIVLELMEGGELFDKVVGN------------KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQE  151 (322)
T ss_dssp             S-EEEEEECCTTEETHHHHSTT------------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSS
T ss_pred             c-eEEEEecCCCCcHHHHHhcc------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCC
Confidence            5 79999999999999988653            36999999999999999999999999   99999999999998765


Q ss_pred             c---EEEeeccCccccCCCCCceeeeccccccccCccccc---CCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhcc
Q 009340          365 S---AKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQ---SSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERN  438 (537)
Q Consensus       365 ~---~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~  438 (537)
                      .   +||+|||++.......  ......||+.|+|||.+.   ...++.++||||||+++|||++|+.||.......  .
T Consensus       152 ~~~~~kl~Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~  227 (322)
T 2ycf_A          152 EDCLIKITDFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--S  227 (322)
T ss_dssp             SSCCEEECCCTTCEECCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS--C
T ss_pred             CCCeEEEccCccceeccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH--H
Confidence            4   9999999998764322  223456899999999973   5678999999999999999999999986543221  1


Q ss_pred             HHHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          439 LVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       439 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      +..    ....+...  ..+..    ....+..+.+++.+||+.||++|||+.++++
T Consensus       228 ~~~----~~~~~~~~--~~~~~----~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          228 LKD----QITSGKYN--FIPEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             HHH----HHHHTCCC--CCHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHH----HHHhCccc--cCchh----hhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence            111    11111100  00111    1123457889999999999999999999985

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=6.8e-40  Score=336.07  Aligned_cols=256  Identities=21%  Similarity=0.354  Sum_probs=197.0

Q ss_pred             hcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCC--ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCcc----
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI--DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVP----  287 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~----  287 (537)
                      .++|...+.||+|+||.||+|... +|+.||||++...  .....+.+.+|+.+++.++||||+++++++...+..    
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            468888999999999999999854 6899999998753  444567889999999999999999999999877654    


Q ss_pred             --EEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCc
Q 009340          288 --VLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFS  365 (537)
Q Consensus       288 --~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~  365 (537)
                        ++||||++ |+|.+++.              ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.
T Consensus       121 ~~~lv~e~~~-~~l~~~~~--------------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~  182 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMG--------------MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCE  182 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTT--------------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCC
T ss_pred             eEEEEEcccc-ccHHHHhh--------------cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCC
Confidence              99999997 58887773              25999999999999999999999999   999999999999999999


Q ss_pred             EEEeeccCccccCCCCCceeeeccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHH
Q 009340          366 AKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQS-SQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFI  444 (537)
Q Consensus       366 ~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~  444 (537)
                      +||+|||+++.....    .....||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+..   ....
T Consensus       183 ~kL~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~---~~i~  255 (371)
T 4exu_A          183 LKILDFGLARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQL---TQIL  255 (371)
T ss_dssp             EEECSTTCC------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHH
T ss_pred             EEEEecCcccccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHH
Confidence            999999999865332    234568999999999887 68899999999999999999999999754432211   1111


Q ss_pred             HHHhhc--hhhhhhc--------HHhh-------ccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          445 SLAKEN--QLLEILD--------ARVA-------KEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       445 ~~~~~~--~~~~~~d--------~~~~-------~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      ......  .....+.        ....       .......+..+.+|+.+||+.||++|||+.|+++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  323 (371)
T 4exu_A          256 KVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  323 (371)
T ss_dssp             HHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence            100000  0000000        0000       0011223567899999999999999999999875

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=1.4e-40  Score=337.73  Aligned_cols=258  Identities=21%  Similarity=0.333  Sum_probs=203.6

Q ss_pred             hcCCccccccCcCCceEEEEEEcCCCCEEEEEEccCCChH-----------------HHHHHHHHHHHHHhcCCCCcceE
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKT-----------------QIHQFINEVVILSQINHRHIVKL  277 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~-----------------~~~~~~~E~~~l~~l~H~niv~l  277 (537)
                      .++|...+.||+|+||.||++.. +|+.||||.+......                 ..+.+.+|+.++++++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            46899999999999999999999 8999999987642111                 12789999999999999999999


Q ss_pred             eeEEeeCCccEEEEecCCCCChhhh------hhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeee
Q 009340          278 LGCCLETEVPVLVYEYISSGTLSHH------IHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHS-SASIPIFH  350 (537)
Q Consensus       278 ~g~~~~~~~~~lV~e~~~~gsL~~~------l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-~~~~~ivH  350 (537)
                      ++++.+.+..++||||+++|+|.++      +....          ...+++..++.++.|+++||.|||+ .+   |+|
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~----------~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H  175 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNY----------TCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICH  175 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSS----------CCCCCHHHHHHHHHHHHHHHHHHHHTSC---EEC
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhcc----------ccCCCHHHHHHHHHHHHHHHHHHhccCC---Eee
Confidence            9999999999999999999999999      54321          2469999999999999999999999 88   999


Q ss_pred             cCCCCCCEEECCCCcEEEeeccCccccCCCCCceeeeccccccccCcccccCC-CCCc-chhHHHHHHHHHHHHhCCCCC
Q 009340          351 RDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSS-QFTD-KSDVYSFGVVLLELLTGKKPI  428 (537)
Q Consensus       351 ~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~-ksDV~S~Gvll~el~tg~~p~  428 (537)
                      |||||+||+++.++.+||+|||++......   ......||..|+|||.+.+. .++. ++||||||+++|||++|+.||
T Consensus       176 ~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf  252 (348)
T 2pml_X          176 RDVKPSNILMDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPF  252 (348)
T ss_dssp             CCCCGGGEEECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSS
T ss_pred             cCCChHhEEEcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCC
Confidence            999999999999999999999999876433   33456789999999999887 6666 999999999999999999999


Q ss_pred             CccchhhhccHHHHHHHHHhhchhhhh------h---cHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          429 CFARVEEERNLVACFISLAKENQLLEI------L---DARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       429 ~~~~~~~~~~~~~~~~~~~~~~~~~~~------~---d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      .......     . ...........-.      .   ............+..+.+|+.+||+.||++|||+.|+++
T Consensus       253 ~~~~~~~-----~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          253 SLKISLV-----E-LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             CCSSCSH-----H-HHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             CCCCcHH-----H-HHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            7543311     0 1111111110000      0   000000011334567899999999999999999999986

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=5.3e-40  Score=334.23  Aligned_cols=261  Identities=22%  Similarity=0.314  Sum_probs=200.1

Q ss_pred             hcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCC-ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeC-----Ccc
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI-DKTQIHQFINEVVILSQINHRHIVKLLGCCLET-----EVP  287 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~  287 (537)
                      .++|...+.||+|+||.||+|... +|+.||||++... .......+.+|+.++++++||||+++++++...     ...
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            468899999999999999999965 6889999998753 344566788999999999999999999998764     567


Q ss_pred             EEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEE
Q 009340          288 VLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK  367 (537)
Q Consensus       288 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~k  367 (537)
                      ++||||++ |+|.+++..             ..+++..+..++.|+++||.|||+.+   |+||||||+|||++.++.+|
T Consensus        90 ~lv~e~~~-~~L~~~~~~-------------~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~k  152 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVIST-------------QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLK  152 (353)
T ss_dssp             EEEECCCS-EEHHHHHHH-------------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEE
T ss_pred             EEEEeccC-ccHHHHHhh-------------cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEE
Confidence            99999997 589888854             25999999999999999999999999   99999999999999999999


Q ss_pred             EeeccCccccCCCCCc---------eeeeccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhc
Q 009340          368 VSDFGISRSIPNDKTH---------LTTTIQGTFGYLDPEYFQS-SQFTDKSDVYSFGVVLLELLTGKKPICFARVEEER  437 (537)
Q Consensus       368 i~Dfgla~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~  437 (537)
                      |+|||++.........         ......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+..
T Consensus       153 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~  232 (353)
T 2b9h_A          153 VCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQL  232 (353)
T ss_dssp             ECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred             EEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH
Confidence            9999999876432211         1123468999999998754 77899999999999999999999999765432211


Q ss_pred             cHHHHHHHHHhhch------------hhhhhcH------HhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          438 NLVACFISLAKENQ------------LLEILDA------RVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       438 ~~~~~~~~~~~~~~------------~~~~~d~------~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                         ...........            ..+.+..      ..........+..+.+|+.+||+.||++|||+.++++
T Consensus       233 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (353)
T 2b9h_A          233 ---LLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE  305 (353)
T ss_dssp             ---HHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ---HHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence               11111110000            0000000      0000011234567889999999999999999999976

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.9e-40  Score=344.22  Aligned_cols=271  Identities=20%  Similarity=0.318  Sum_probs=183.8

Q ss_pred             cCCcc-ccccCcCCceEEEEEEcC---CCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEee--CCccEE
Q 009340          216 DNYNQ-SRFLGQGGFGTVYKGMLP---DGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLE--TEVPVL  289 (537)
Q Consensus       216 ~~~~~-~~~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~l  289 (537)
                      +.|.. .++||+|+||.||+|+..   +++.||||++.....  ...+.+|+.++++++||||+++++++..  ....++
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l   97 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWL   97 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence            34544 458999999999999965   578999999875432  2467899999999999999999999965  567899


Q ss_pred             EEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEE----CCCCc
Q 009340          290 VYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILL----DDKFS  365 (537)
Q Consensus       290 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll----~~~~~  365 (537)
                      ||||+++ +|.+++.........   .....+++..++.++.|++.||.|||+.+   |+||||||+|||+    +.++.
T Consensus        98 v~e~~~~-~l~~~~~~~~~~~~~---~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~  170 (405)
T 3rgf_A           98 LFDYAEH-DLWHIIKFHRASKAN---KKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGR  170 (405)
T ss_dssp             EEECCSE-EHHHHHHHHHHHC----------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTC
T ss_pred             EEeCCCC-CHHHHHHHhcccccc---ccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCc
Confidence            9999974 888888654321100   01225999999999999999999999999   9999999999999    77899


Q ss_pred             EEEeeccCccccCCCCC--ceeeeccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCccchhhh------
Q 009340          366 AKVSDFGISRSIPNDKT--HLTTTIQGTFGYLDPEYFQS-SQFTDKSDVYSFGVVLLELLTGKKPICFARVEEE------  436 (537)
Q Consensus       366 ~ki~Dfgla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~------  436 (537)
                      +||+|||+++.......  .......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||........      
T Consensus       171 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~  250 (405)
T 3rgf_A          171 VKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYH  250 (405)
T ss_dssp             EEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCC
T ss_pred             EEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccch
Confidence            99999999987643322  22345678999999999987 4589999999999999999999999965432110      


Q ss_pred             ccHHHHHHHHHhhch---hhhh------------hcHHhhccc---------cHHHHHHHHHHHHHhcccCCCCCCCHhh
Q 009340          437 RNLVACFISLAKENQ---LLEI------------LDARVAKEA---------REEDIGAMAELAMRCLRLNSKKRPTMKQ  492 (537)
Q Consensus       437 ~~~~~~~~~~~~~~~---~~~~------------~d~~~~~~~---------~~~~~~~l~~l~~~cl~~~p~~RPs~~e  492 (537)
                      ...............   ...+            +........         .......+.+|+.+||+.||++|||+.|
T Consensus       251 ~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e  330 (405)
T 3rgf_A          251 HDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQ  330 (405)
T ss_dssp             HHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             HHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHH
Confidence            011111111111000   0000            000000000         0011356789999999999999999999


Q ss_pred             HHH
Q 009340          493 VSM  495 (537)
Q Consensus       493 v~~  495 (537)
                      +++
T Consensus       331 ~L~  333 (405)
T 3rgf_A          331 AMQ  333 (405)
T ss_dssp             HHT
T ss_pred             Hhc
Confidence            875

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=3.7e-40  Score=340.66  Aligned_cols=259  Identities=22%  Similarity=0.289  Sum_probs=194.2

Q ss_pred             cCCccccccCcCCceEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCc------cEE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEV------PVL  289 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~------~~l  289 (537)
                      .+|...++||+|+||.||+|+...+..||+|++.....    ...+|+.+++.++||||+++++++.....      .++
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l  115 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL  115 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence            57888999999999999999987777799998764322    12369999999999999999999965443      789


Q ss_pred             EEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEC-CCCcEEE
Q 009340          290 VYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD-DKFSAKV  368 (537)
Q Consensus       290 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~-~~~~~ki  368 (537)
                      ||||++++.+ +.+.....        ....+++..+..++.|+++||+|||+.+   |+||||||+|||++ .++.+||
T Consensus       116 v~e~~~~~l~-~~~~~~~~--------~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL  183 (394)
T 4e7w_A          116 VLEYVPETVY-RASRHYAK--------LKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKL  183 (394)
T ss_dssp             EEECCSEEHH-HHHHHHHH--------TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEE
T ss_pred             EeeccCccHH-HHHHHHHh--------hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEE
Confidence            9999987544 33332211        1346999999999999999999999999   99999999999999 7999999


Q ss_pred             eeccCccccCCCCCceeeeccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHH
Q 009340          369 SDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSS-QFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLA  447 (537)
Q Consensus       369 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~  447 (537)
                      +|||+++.......  .....+|+.|+|||.+.+. .++.++|||||||++|||++|+.||......+.   ........
T Consensus       184 ~DFG~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~---l~~i~~~~  258 (394)
T 4e7w_A          184 IDFGSAKILIAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQ---LVEIIKVL  258 (394)
T ss_dssp             CCCTTCEECCTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHH
T ss_pred             eeCCCcccccCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHh
Confidence            99999987643322  2345689999999998764 589999999999999999999999976543221   11111111


Q ss_pred             hhchhh--hhhcHHh-------------hccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          448 KENQLL--EILDARV-------------AKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       448 ~~~~~~--~~~d~~~-------------~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      ......  ....+..             ....+...+.++.+|+.+||+.||++|||+.|+++
T Consensus       259 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  321 (394)
T 4e7w_A          259 GTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC  321 (394)
T ss_dssp             CCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             CCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence            100000  0001100             01112224567899999999999999999999976

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1.3e-39  Score=331.66  Aligned_cols=256  Identities=22%  Similarity=0.359  Sum_probs=197.0

Q ss_pred             hcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccC--CChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCc-----
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKE--IDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEV-----  286 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-----  286 (537)
                      .++|...+.||+|+||.||+|... +|+.||||++..  ......+.+.+|+.++++++||||+++++++...+.     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            367888999999999999999964 689999999865  234456788999999999999999999999987654     


Q ss_pred             -cEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCc
Q 009340          287 -PVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFS  365 (537)
Q Consensus       287 -~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~  365 (537)
                       .++||||++ |+|.+++.              ..+++..+..++.|+++||.|||+++   |+||||||+|||++.++.
T Consensus       103 ~~~lv~e~~~-~~l~~~~~--------------~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~  164 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMG--------------LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCE  164 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTT--------------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCC
T ss_pred             eEEEEecccc-CCHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCc
Confidence             499999997 58888773              25899999999999999999999999   999999999999999999


Q ss_pred             EEEeeccCccccCCCCCceeeeccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHH
Q 009340          366 AKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQS-SQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFI  444 (537)
Q Consensus       366 ~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~  444 (537)
                      +||+|||++......    .....+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+.   .....
T Consensus       165 ~kl~Dfg~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~---~~~i~  237 (353)
T 3coi_A          165 LKILDFGLARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ---LTQIL  237 (353)
T ss_dssp             EEECSTTCTTC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHH---HHHHH
T ss_pred             EEEeecccccCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHH
Confidence            999999999865332    234568999999999877 6789999999999999999999999975543221   11111


Q ss_pred             HHHhhc--hhhhhh-cH-------Hh----h---ccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          445 SLAKEN--QLLEIL-DA-------RV----A---KEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       445 ~~~~~~--~~~~~~-d~-------~~----~---~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      ......  .....+ +.       .+    .   .......+..+.+|+.+||+.||++|||+.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          238 KVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             HHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            110000  000000 00       00    0   0112234578899999999999999999999875

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=4.8e-40  Score=330.66  Aligned_cols=263  Identities=22%  Similarity=0.347  Sum_probs=200.4

Q ss_pred             HhcCCccccccCcCCceEEEEEEc--CCCCEEEEEEccCCC--hHHHHHHHHHHHHHHhc---CCCCcceEeeEEe----
Q 009340          214 ATDNYNQSRFLGQGGFGTVYKGML--PDGSIVAVKRSKEID--KTQIHQFINEVVILSQI---NHRHIVKLLGCCL----  282 (537)
Q Consensus       214 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~----  282 (537)
                      +.++|...+.||+|+||.||++..  .+|+.||||+++...  ......+.+|+.+++.+   +||||+++++++.    
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            457899999999999999999996  468899999876421  11223456777777766   8999999999997    


Q ss_pred             -eCCccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEC
Q 009340          283 -ETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD  361 (537)
Q Consensus       283 -~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~  361 (537)
                       .....++||||++ |+|.+++.....          ..+++..++.++.|+++||.|||+.+   |+||||||+||+++
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~----------~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~  154 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVPE----------PGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVT  154 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSCT----------TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEC
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhccc----------CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEc
Confidence             4557899999998 699999876432          35899999999999999999999999   99999999999999


Q ss_pred             CCCcEEEeeccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHH
Q 009340          362 DKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVA  441 (537)
Q Consensus       362 ~~~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~  441 (537)
                      .++.+||+|||++.......  ......||..|+|||.+.+..++.++||||||+++|||++|+.||......+.   ..
T Consensus       155 ~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~  229 (326)
T 1blx_A          155 SSGQIKLADFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ---LG  229 (326)
T ss_dssp             TTCCEEECSCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HH
T ss_pred             CCCCEEEecCcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHH---HH
Confidence            99999999999998654322  23445689999999999999999999999999999999999999875443221   11


Q ss_pred             HHHHHHhhchhhhh----------hc---HHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          442 CFISLAKENQLLEI----------LD---ARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       442 ~~~~~~~~~~~~~~----------~d---~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      .............+          +.   ...........+..+.+|+.+||+.||++|||+.++++
T Consensus       230 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          230 KILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             HHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            11111110000000          00   00001112234567889999999999999999999974

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=2.4e-39  Score=319.89  Aligned_cols=251  Identities=27%  Similarity=0.397  Sum_probs=202.3

Q ss_pred             HhcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCC--ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEE
Q 009340          214 ATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI--DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLV  290 (537)
Q Consensus       214 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  290 (537)
                      ..++|...+.||+|+||.||++... +++.||||.+...  .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   99 (287)
T 2wei_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (287)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence            3468999999999999999999965 6899999997542  233467789999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCC---CcEE
Q 009340          291 YEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK---FSAK  367 (537)
Q Consensus       291 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~---~~~k  367 (537)
                      +||+++++|.+++...            ..+++..++.++.|+++||.|||+.+   ++||||||+||+++.+   +.+|
T Consensus       100 ~e~~~~~~L~~~l~~~------------~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~k  164 (287)
T 2wei_A          100 GELYTGGELFDEIIKR------------KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIK  164 (287)
T ss_dssp             ECCCCSCBHHHHHHHH------------SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEE
T ss_pred             EEccCCCCHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEE
Confidence            9999999999988653            35899999999999999999999999   9999999999999764   4799


Q ss_pred             EeeccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHH
Q 009340          368 VSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLA  447 (537)
Q Consensus       368 i~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~  447 (537)
                      |+|||++........  .....+|+.|+|||.+.+ .++.++||||||+++|||++|+.||......+       .....
T Consensus       165 L~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-------~~~~~  234 (287)
T 2wei_A          165 IIDFGLSTCFQQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD-------ILKRV  234 (287)
T ss_dssp             ECSTTGGGTBCCCSS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHH
T ss_pred             EeccCcceeecCCCc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHH-------HHHHH
Confidence            999999987643322  233458999999999865 48999999999999999999999987543221       11111


Q ss_pred             hhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          448 KENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       448 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      ..+...  .+    .+.....+..+.+++.+||+.||++|||+.++++
T Consensus       235 ~~~~~~--~~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          235 ETGKYA--FD----LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             HHCCCC--CC----SGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HcCCCC--CC----chhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence            111110  00    0011223457889999999999999999999986

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=7.5e-40  Score=341.15  Aligned_cols=259  Identities=25%  Similarity=0.336  Sum_probs=194.0

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCC------ccE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETE------VPV  288 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------~~~  288 (537)
                      .+|...+.||+|+||.||+|+.. +|+.||||++.....    .+.+|+.++++++|+||+++++++....      ..+
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~  129 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN  129 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence            46888999999999999999975 689999999865321    2347999999999999999999986432      257


Q ss_pred             EEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCC-CcEE
Q 009340          289 LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK-FSAK  367 (537)
Q Consensus       289 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~-~~~k  367 (537)
                      +||||+++ +|.+.+.....        ....+++..+..++.|+++||.|||+.+   |+||||||+|||++.+ +.+|
T Consensus       130 lv~e~~~~-~l~~~~~~~~~--------~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~k  197 (420)
T 1j1b_A          130 LVLDYVPE-TVYRVARHYSR--------AKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLK  197 (420)
T ss_dssp             EEEECCCE-EHHHHHHHHHH--------TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEE
T ss_pred             eehhcccc-cHHHHHHHHhh--------ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEE
Confidence            89999986 67666654221        1346999999999999999999999999   9999999999999955 6789


Q ss_pred             EeeccCccccCCCCCceeeeccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHH
Q 009340          368 VSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSS-QFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISL  446 (537)
Q Consensus       368 i~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~  446 (537)
                      |+|||+++.......  .....||+.|+|||++.+. .++.++|||||||++|||++|+.||......+.   .......
T Consensus       198 l~DFG~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~---l~~i~~~  272 (420)
T 1j1b_A          198 LCDFGSAKQLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ---LVEIIKV  272 (420)
T ss_dssp             ECCCTTCEECCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHH
T ss_pred             eccchhhhhcccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHH
Confidence            999999987643322  2345689999999998764 799999999999999999999999976433221   1111111


Q ss_pred             Hhhchhhhh--hcHH-------------hhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          447 AKENQLLEI--LDAR-------------VAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       447 ~~~~~~~~~--~d~~-------------~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      ........+  +.+.             .....+...+..+.+|+.+||+.||++|||+.|+++
T Consensus       273 lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~  336 (420)
T 1j1b_A          273 LGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  336 (420)
T ss_dssp             HCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence            111100000  0000             000011233467899999999999999999999975

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=7.8e-39  Score=329.50  Aligned_cols=202  Identities=27%  Similarity=0.359  Sum_probs=172.5

Q ss_pred             HHhcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCChHHHHHHHHHHHHHHhcC-CC-----CcceEeeEEeeCC
Q 009340          213 RATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKTQIHQFINEVVILSQIN-HR-----HIVKLLGCCLETE  285 (537)
Q Consensus       213 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~-----niv~l~g~~~~~~  285 (537)
                      ...++|...+.||+|+||.||+|... +++.||||+++.. .....++..|+.++..++ |+     +++++++++...+
T Consensus        51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~  129 (382)
T 2vx3_A           51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN  129 (382)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred             EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence            34578999999999999999999854 6889999999753 344567788999988885 45     4999999999999


Q ss_pred             ccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh--cCCCCeeecCCCCCCEEEC--
Q 009340          286 VPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHS--SASIPIFHRDIKSSNILLD--  361 (537)
Q Consensus       286 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~--~~~~~ivH~Dlk~~NIll~--  361 (537)
                      ..++||||++ |+|.+++....          ...+++..+..++.|++.||.|||+  .+   |+||||||+|||++  
T Consensus       130 ~~~lv~e~~~-~~L~~~l~~~~----------~~~~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~NIll~~~  195 (382)
T 2vx3_A          130 HLCLVFEMLS-YNLYDLLRNTN----------FRGVSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPENILLCNP  195 (382)
T ss_dssp             EEEEEEECCC-CBHHHHHHHTT----------TSCCCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGGGEEESST
T ss_pred             ceEEEEecCC-CCHHHHHhhcC----------cCCCCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcccEEEecC
Confidence            9999999996 59999997643          2359999999999999999999995  45   99999999999994  


Q ss_pred             CCCcEEEeeccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccch
Q 009340          362 DKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARV  433 (537)
Q Consensus       362 ~~~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~  433 (537)
                      .++.+||+|||+++.....    .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus       196 ~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~  263 (382)
T 2vx3_A          196 KRSAIKIVDFGSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE  263 (382)
T ss_dssp             TSCCEEECCCTTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             CCCcEEEEeccCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            5788999999999876432    2345689999999999999999999999999999999999999976543

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=5.4e-39  Score=329.15  Aligned_cols=259  Identities=22%  Similarity=0.302  Sum_probs=200.4

Q ss_pred             cCCccccccCcCCceEEEEEEc-CCCCEEEEEEccCCChHHHHHHHHHHHHHHhcC-----------CCCcceEeeEEee
Q 009340          216 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEIDKTQIHQFINEVVILSQIN-----------HRHIVKLLGCCLE  283 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~g~~~~  283 (537)
                      ++|...+.||+|+||.||+|.. .+++.||||.+.. .....+.+.+|+.++++++           |+||+++++++..
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~   97 (373)
T 1q8y_A           19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   97 (373)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC-CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence            5889999999999999999995 4789999999875 3344567889999999886           8999999999986


Q ss_pred             CC----ccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeeecCCCCCCE
Q 009340          284 TE----VPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSS-ASIPIFHRDIKSSNI  358 (537)
Q Consensus       284 ~~----~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~-~~~~ivH~Dlk~~NI  358 (537)
                      .+    ..++||||+ +++|.+++.....          ..+++..++.++.|++.||.|||++ +   |+||||||+||
T Consensus        98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~----------~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NI  163 (373)
T 1q8y_A           98 KGPNGVHVVMVFEVL-GENLLALIKKYEH----------RGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENV  163 (373)
T ss_dssp             EETTEEEEEEEECCC-CEEHHHHHHHTTT----------SCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGE
T ss_pred             cCCCCceEEEEEecC-CCCHHHHHHHhhc----------cCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHe
Confidence            54    679999999 8899999976432          3599999999999999999999998 8   99999999999


Q ss_pred             EEC------CCCcEEEeeccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccc
Q 009340          359 LLD------DKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFAR  432 (537)
Q Consensus       359 ll~------~~~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~  432 (537)
                      |++      ..+.+||+|||++......    .....||+.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus       164 ll~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  239 (373)
T 1q8y_A          164 LMEIVDSPENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE  239 (373)
T ss_dssp             EEEEEETTTTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred             EEeccCCCcCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCc
Confidence            994      4558999999999876432    233468999999999999999999999999999999999999997543


Q ss_pred             hhhhccHHHHHHHH---Hhh--------ch----------------------hhhhhcHHhhccccHHHHHHHHHHHHHh
Q 009340          433 VEEERNLVACFISL---AKE--------NQ----------------------LLEILDARVAKEAREEDIGAMAELAMRC  479 (537)
Q Consensus       433 ~~~~~~~~~~~~~~---~~~--------~~----------------------~~~~~d~~~~~~~~~~~~~~l~~l~~~c  479 (537)
                      ..............   ...        ..                      +.+.+.  .....+...+..+.+|+.+|
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~  317 (373)
T 1q8y_A          240 GHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLT--EKYKFSKDEAKEISDFLSPM  317 (373)
T ss_dssp             -----CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHH--HTTCCCHHHHHHHHHHHGGG
T ss_pred             ccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhh--hcccCCcchHHHHHHHHHHH
Confidence            22111111111111   100        00                      000000  01124567788999999999


Q ss_pred             cccCCCCCCCHhhHHH
Q 009340          480 LRLNSKKRPTMKQVSM  495 (537)
Q Consensus       480 l~~~p~~RPs~~ev~~  495 (537)
                      |+.||++|||+.|+++
T Consensus       318 L~~dP~~Rpt~~ell~  333 (373)
T 1q8y_A          318 LQLDPRKRADAGGLVN  333 (373)
T ss_dssp             GCSSTTTCBCHHHHHT
T ss_pred             hccCccccCCHHHHhh
Confidence            9999999999999976

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=4.3e-39  Score=327.27  Aligned_cols=259  Identities=20%  Similarity=0.267  Sum_probs=200.9

Q ss_pred             hcCCccccccCcCCceEEEEEEcC-CC-CEEEEEEccCCChHHHHHHHHHHHHHHhcCCCC------cceEeeEEeeCCc
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLP-DG-SIVAVKRSKEIDKTQIHQFINEVVILSQINHRH------IVKLLGCCLETEV  286 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n------iv~l~g~~~~~~~  286 (537)
                      .++|...+.||+|+||.||++... ++ +.||||.++.. ....+.+.+|+.++++++|++      ++.+.+++...+.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~   96 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH   96 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence            368999999999999999999954 34 68999998753 344567889999999997766      8999999999999


Q ss_pred             cEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEE------
Q 009340          287 PVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILL------  360 (537)
Q Consensus       287 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll------  360 (537)
                      .++||||+ +++|.+++....          ...+++..++.++.|+++||.|||+.+   |+||||||+|||+      
T Consensus        97 ~~lv~e~~-~~~l~~~l~~~~----------~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~  162 (355)
T 2eu9_A           97 MCIAFELL-GKNTFEFLKENN----------FQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFE  162 (355)
T ss_dssp             EEEEEECC-CCBHHHHHHHTT----------TCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEE
T ss_pred             EEEEEecc-CCChHHHHHhcc----------CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeccccc
Confidence            99999999 667777776532          236999999999999999999999998   9999999999999      


Q ss_pred             -------------CCCCcEEEeeccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCC
Q 009340          361 -------------DDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP  427 (537)
Q Consensus       361 -------------~~~~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p  427 (537)
                                   +.++.+||+|||+++.....    .....||+.|+|||.+.+..++.++||||||+++|||++|+.|
T Consensus       163 ~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p  238 (355)
T 2eu9_A          163 TLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTL  238 (355)
T ss_dssp             EEECCC-CCCEEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             ccccccccccccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCC
Confidence                         66889999999999865332    2345689999999999999999999999999999999999999


Q ss_pred             CCccchhhhccHHHHHHHHHhh--------chhhhh-----------------hcHH-----hhccccHHHHHHHHHHHH
Q 009340          428 ICFARVEEERNLVACFISLAKE--------NQLLEI-----------------LDAR-----VAKEAREEDIGAMAELAM  477 (537)
Q Consensus       428 ~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~-----------------~d~~-----~~~~~~~~~~~~l~~l~~  477 (537)
                      |......+...   ........        ......                 +...     ............+.+|+.
T Consensus       239 f~~~~~~~~~~---~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  315 (355)
T 2eu9_A          239 FQTHENREHLV---MMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMR  315 (355)
T ss_dssp             CCCSSHHHHHH---HHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHH
T ss_pred             CCCCCHHHHHH---HHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHH
Confidence            97654332111   11111100        000000                 0000     000112344568999999


Q ss_pred             HhcccCCCCCCCHhhHHH
Q 009340          478 RCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       478 ~cl~~~p~~RPs~~ev~~  495 (537)
                      +||+.||++|||+.|+++
T Consensus       316 ~~L~~dP~~Rpt~~e~l~  333 (355)
T 2eu9_A          316 RMLEFDPAQRITLAEALL  333 (355)
T ss_dssp             HHTCSSTTTSCCHHHHTT
T ss_pred             HHhcCChhhCcCHHHHhc
Confidence            999999999999999973

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.6e-39  Score=327.26  Aligned_cols=257  Identities=24%  Similarity=0.343  Sum_probs=180.5

Q ss_pred             hcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCC-ChHHHHHHHHHHH-HHHhcCCCCcceEeeEEeeCCccEEEE
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI-DKTQIHQFINEVV-ILSQINHRHIVKLLGCCLETEVPVLVY  291 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~  291 (537)
                      .++|...+.||+|+||.||++... +|+.||||+++.. ......++..|+. +++.++||||+++++++.+.+..++||
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~  100 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM  100 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence            368888999999999999999974 6899999998754 3344556666666 677789999999999999999999999


Q ss_pred             ecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeeecCCCCCCEEECCCCcEEEee
Q 009340          292 EYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSS-ASIPIFHRDIKSSNILLDDKFSAKVSD  370 (537)
Q Consensus       292 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~-~~~~ivH~Dlk~~NIll~~~~~~ki~D  370 (537)
                      ||+++ +|.+++.....       .....+++..+..++.|+++||.|||+. +   |+||||||+|||++.++.+||+|
T Consensus       101 e~~~~-~l~~~~~~~~~-------~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~D  169 (327)
T 3aln_A          101 ELMST-SFDKFYKYVYS-------VLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCD  169 (327)
T ss_dssp             CCCSE-EHHHHHHHHHH-------TTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECC
T ss_pred             eecCC-ChHHHHHHHHh-------hhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEcc
Confidence            99985 88887764221       0134689999999999999999999998 8   99999999999999999999999


Q ss_pred             ccCccccCCCCCceeeeccccccccCcccc----cCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHH
Q 009340          371 FGISRSIPNDKTHLTTTIQGTFGYLDPEYF----QSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISL  446 (537)
Q Consensus       371 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~  446 (537)
                      ||+++.......  .....||+.|+|||.+    .+..++.++||||||+++|||++|+.||........         .
T Consensus       170 fg~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---------~  238 (327)
T 3aln_A          170 FGISGQLVDSIA--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD---------Q  238 (327)
T ss_dssp             CSSSCC--------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC---------------
T ss_pred             CCCceecccccc--cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH---------H
Confidence            999987643322  2334689999999998    456789999999999999999999999864321100         0


Q ss_pred             HhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          447 AKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       447 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      ..  .......+.+........+..+.+|+.+||+.||++|||+.++++
T Consensus       239 ~~--~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          239 LT--QVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             -C--CCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HH--HHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence            00  000000001111111234467889999999999999999999976

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=2.6e-39  Score=338.56  Aligned_cols=255  Identities=23%  Similarity=0.300  Sum_probs=187.4

Q ss_pred             CCccccccCcCCceEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHHHHhc-CCCCcceEeeEEeeCCccEEEEecCC
Q 009340          217 NYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQI-NHRHIVKLLGCCLETEVPVLVYEYIS  295 (537)
Q Consensus       217 ~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~  295 (537)
                      .|...+.||+|+||+||.+...+|+.||||++...   ..+.+.+|+.+++++ +||||+++++++.+.+..++||||++
T Consensus        16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~   92 (434)
T 2rio_A           16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN   92 (434)
T ss_dssp             CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred             eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence            44456789999999997666667999999998653   235678999999987 89999999999999999999999996


Q ss_pred             CCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCC------------
Q 009340          296 SGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK------------  363 (537)
Q Consensus       296 ~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~------------  363 (537)
                       |+|.+++.........     ....++..++.++.||++||+|||+.+   |+||||||+|||++.+            
T Consensus        93 -gsL~~~l~~~~~~~~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~  163 (434)
T 2rio_A           93 -LNLQDLVESKNVSDEN-----LKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAE  163 (434)
T ss_dssp             -EEHHHHHHTC-----------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCC
T ss_pred             -CCHHHHHhccCCCchh-----hhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCC
Confidence             6999999765431100     011244567889999999999999999   9999999999999654            


Q ss_pred             -CcEEEeeccCccccCCCCCc---eeeeccccccccCcccccC-------CCCCcchhHHHHHHHHHHHHh-CCCCCCcc
Q 009340          364 -FSAKVSDFGISRSIPNDKTH---LTTTIQGTFGYLDPEYFQS-------SQFTDKSDVYSFGVVLLELLT-GKKPICFA  431 (537)
Q Consensus       364 -~~~ki~Dfgla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~t~ksDV~S~Gvll~el~t-g~~p~~~~  431 (537)
                       +.+||+|||+++........   ......||+.|+|||++.+       ..++.++|||||||++|||++ |+.||...
T Consensus       164 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~  243 (434)
T 2rio_A          164 NLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK  243 (434)
T ss_dssp             SCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCST
T ss_pred             ceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCc
Confidence             58999999999887544322   1234579999999999865       678999999999999999999 99998643


Q ss_pred             chhhhccHHHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          432 RVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       432 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      ....        .........    .+..........+..+.+|+.+||+.||++|||+.+|++
T Consensus       244 ~~~~--------~~i~~~~~~----~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          244 YSRE--------SNIIRGIFS----LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             TTHH--------HHHHHTCCC----CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hhhH--------HHHhcCCCC----cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence            2211        001110000    000111123456778999999999999999999999975

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.7e-39  Score=324.75  Aligned_cols=245  Identities=26%  Similarity=0.390  Sum_probs=191.5

Q ss_pred             HHHHHhcCCccccccCcCCceEEEEEEc-CCCCEEEEEEccCCCh------HHHHHHHHHHHHHHhc----CCCCcceEe
Q 009340          210 ELQRATDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEIDK------TQIHQFINEVVILSQI----NHRHIVKLL  278 (537)
Q Consensus       210 el~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~------~~~~~~~~E~~~l~~l----~H~niv~l~  278 (537)
                      +.....++|...+.||+|+||.||+|.. .+++.||||.+.....      .....+.+|+.++.++    +|+||++++
T Consensus        25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~  104 (312)
T 2iwi_A           25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL  104 (312)
T ss_dssp             --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred             chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence            3345568899999999999999999985 4688999999865322      1233466799999999    899999999


Q ss_pred             eEEeeCCccEEEEec-CCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCC
Q 009340          279 GCCLETEVPVLVYEY-ISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSN  357 (537)
Q Consensus       279 g~~~~~~~~~lV~e~-~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~N  357 (537)
                      +++.+.+..++|+|| +.+++|.+++...            ..+++..++.++.|+++||.|||+.+   |+||||||+|
T Consensus       105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~------------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~N  169 (312)
T 2iwi_A          105 DWFETQEGFMLVLERPLPAQDLFDYITEK------------GPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDEN  169 (312)
T ss_dssp             EEC-----CEEEEECCSSEEEHHHHHHHH------------CSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGG
T ss_pred             EEEecCCeEEEEEEecCCCCCHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhh
Confidence            999999999999999 7899999999753            35999999999999999999999999   9999999999


Q ss_pred             EEEC-CCCcEEEeeccCccccCCCCCceeeeccccccccCcccccCCCCC-cchhHHHHHHHHHHHHhCCCCCCccchhh
Q 009340          358 ILLD-DKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFT-DKSDVYSFGVVLLELLTGKKPICFARVEE  435 (537)
Q Consensus       358 Ill~-~~~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t-~ksDV~S~Gvll~el~tg~~p~~~~~~~~  435 (537)
                      |+++ .++.+||+|||++.......   .....||..|+|||.+.+..+. .++||||||+++|||++|+.||.....  
T Consensus       170 il~~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--  244 (312)
T 2iwi_A          170 ILIDLRRGCAKLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE--  244 (312)
T ss_dssp             EEEETTTTEEEECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--
T ss_pred             EEEeCCCCeEEEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH--
Confidence            9999 88999999999998765432   2345689999999998776664 599999999999999999999853210  


Q ss_pred             hccHHHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          436 ERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       436 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                                ....           ....+......+.+++.+||+.||++|||+.|+++
T Consensus       245 ----------~~~~-----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          245 ----------ILEA-----------ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             ----------HHHT-----------CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ----------Hhhh-----------ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                      0000           01122234457889999999999999999999976

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=7.1e-40  Score=329.01  Aligned_cols=247  Identities=27%  Similarity=0.422  Sum_probs=198.6

Q ss_pred             HHHHHHHhcCCccccccCcCCceEEEEEEc-CCCCEEEEEEccCCCh------HHHHHHHHHHHHHHhcC--CCCcceEe
Q 009340          208 ADELQRATDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEIDK------TQIHQFINEVVILSQIN--HRHIVKLL  278 (537)
Q Consensus       208 ~~el~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--H~niv~l~  278 (537)
                      ..+.....++|...+.||+|+||.||+|+. .+++.||||.++....      ...+.+.+|+.++++++  |+|+++++
T Consensus        35 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~  114 (320)
T 3a99_A           35 GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLL  114 (320)
T ss_dssp             -----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEE
T ss_pred             ccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEE
Confidence            344445567899999999999999999985 4788999998864211      12245678999999996  59999999


Q ss_pred             eEEeeCCccEEEEecCCC-CChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCC
Q 009340          279 GCCLETEVPVLVYEYISS-GTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSN  357 (537)
Q Consensus       279 g~~~~~~~~~lV~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~N  357 (537)
                      +++.+.+..++|+|++.. ++|.+++...            ..+++..++.++.|+++||.|||+.+   |+||||||+|
T Consensus       115 ~~~~~~~~~~lv~e~~~~~~~L~~~l~~~------------~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~N  179 (320)
T 3a99_A          115 DWFERPDSFVLILERPEPVQDLFDFITER------------GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDEN  179 (320)
T ss_dssp             EEEECSSEEEEEEECCSSEEEHHHHHHHH------------CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGG
T ss_pred             EEEecCCcEEEEEEcCCCCccHHHHHhcc------------CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHH
Confidence            999999999999999986 8999998753            35899999999999999999999999   9999999999


Q ss_pred             EEEC-CCCcEEEeeccCccccCCCCCceeeeccccccccCcccccCCCC-CcchhHHHHHHHHHHHHhCCCCCCccchhh
Q 009340          358 ILLD-DKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQF-TDKSDVYSFGVVLLELLTGKKPICFARVEE  435 (537)
Q Consensus       358 Ill~-~~~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~S~Gvll~el~tg~~p~~~~~~~~  435 (537)
                      ||++ +++.+||+|||++.......   .....||+.|+|||.+.+..+ +.++||||||+++|||++|+.||.....  
T Consensus       180 Ill~~~~~~~kL~Dfg~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--  254 (320)
T 3a99_A          180 ILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--  254 (320)
T ss_dssp             EEEETTTTEEEECCCTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--
T ss_pred             EEEeCCCCCEEEeeCcccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh--
Confidence            9999 78999999999998764332   234568999999999877665 6789999999999999999999853211  


Q ss_pred             hccHHHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          436 ERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       436 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                                ... ..          ...+...+..+.+++.+||+.||++|||+.++++
T Consensus       255 ----------~~~-~~----------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          255 ----------IIR-GQ----------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             ----------HHH-CC----------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ----------hhc-cc----------ccccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                      000 00          0011223456889999999999999999999976

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=5.7e-39  Score=324.68  Aligned_cols=252  Identities=21%  Similarity=0.286  Sum_probs=173.0

Q ss_pred             hcCCcccc-ccCcCCceEEEEEEcC-CCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEee----CCccE
Q 009340          215 TDNYNQSR-FLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLE----TEVPV  288 (537)
Q Consensus       215 ~~~~~~~~-~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~  288 (537)
                      .++|...+ .||+|+||.||++... +|+.||||++.... ...   .+....++.++|+||+++++++..    ....+
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~---~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~  102 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-KAR---QEVDHHWQASGGPHIVCILDVYENMHHGKRCLL  102 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-HHH---HHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-HHH---HHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence            56888854 6999999999999965 68999999987532 111   122334566799999999999976    34579


Q ss_pred             EEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECC---CCc
Q 009340          289 LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD---KFS  365 (537)
Q Consensus       289 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~---~~~  365 (537)
                      +||||+++|+|.+++....          ...+++..++.++.|+++||.|||+.+   |+||||||+|||++.   ++.
T Consensus       103 lv~e~~~gg~L~~~l~~~~----------~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~  169 (336)
T 3fhr_A          103 IIMECMEGGELFSRIQERG----------DQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAV  169 (336)
T ss_dssp             EEEECCTTEEHHHHHHTC-----------CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCC
T ss_pred             EEEeccCCCCHHHHHHhcC----------CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCce
Confidence            9999999999999997643          236999999999999999999999999   999999999999976   455


Q ss_pred             EEEeeccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHH
Q 009340          366 AKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFIS  445 (537)
Q Consensus       366 ~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~  445 (537)
                      +||+|||++.......   .....+|+.|+|||.+.+..++.++||||||+++|||++|+.||..........   ....
T Consensus       170 ~kl~Dfg~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---~~~~  243 (336)
T 3fhr_A          170 LKLTDFGFAKETTQNA---LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP---GMKR  243 (336)
T ss_dssp             EEECCCTTCEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----------------
T ss_pred             EEEeccccceeccccc---cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh---hHHH
Confidence            9999999998654322   234568999999999988889999999999999999999999986543221100   0000


Q ss_pred             HHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          446 LAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       446 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      ......      ...........+..+.+|+.+||+.||++|||+.|+++
T Consensus       244 ~~~~~~------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  287 (336)
T 3fhr_A          244 RIRLGQ------YGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN  287 (336)
T ss_dssp             -------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             hhhccc------cccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            000000      00011111234567889999999999999999999987

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1.4e-38  Score=318.74  Aligned_cols=251  Identities=23%  Similarity=0.385  Sum_probs=178.6

Q ss_pred             hcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCC-hHHH-HHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEE
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEID-KTQI-HQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY  291 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~-~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  291 (537)
                      .++|...+.||+|+||.||++... +|+.||||.+.... .... +.+.++..+++.++||||+++++++.+.+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~  103 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM  103 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence            467888999999999999999975 78999999987532 2333 33445556788889999999999999999999999


Q ss_pred             ecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeeecCCCCCCEEECCCCcEEEee
Q 009340          292 EYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSS-ASIPIFHRDIKSSNILLDDKFSAKVSD  370 (537)
Q Consensus       292 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~-~~~~ivH~Dlk~~NIll~~~~~~ki~D  370 (537)
                      ||+ ++.+..+....           ...+++..++.++.|+++||.|||+. +   |+||||||+||+++.++.+||+|
T Consensus       104 e~~-~~~~~~l~~~~-----------~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~d  168 (318)
T 2dyl_A          104 ELM-GTCAEKLKKRM-----------QGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCD  168 (318)
T ss_dssp             CCC-SEEHHHHHHHH-----------TSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECC
T ss_pred             ecc-CCcHHHHHHHh-----------ccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEE
Confidence            999 44444444321           24699999999999999999999995 8   99999999999999999999999


Q ss_pred             ccCccccCCCCCceeeeccccccccCccccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHH
Q 009340          371 FGISRSIPNDKTHLTTTIQGTFGYLDPEYFQ-----SSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFIS  445 (537)
Q Consensus       371 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~  445 (537)
                      ||++.......  ......+|+.|+|||.+.     ...++.++||||||+++|||++|+.||.......     .....
T Consensus       169 fg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~~~  241 (318)
T 2dyl_A          169 FGISGRLVDDK--AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF-----EVLTK  241 (318)
T ss_dssp             CTTC----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHH-----HHHHH
T ss_pred             CCCchhccCCc--cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccH-----HHHHH
Confidence            99997664332  223456899999999984     5578899999999999999999999986432211     11111


Q ss_pred             HHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          446 LAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       446 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      ......      +..  +.....+..+.+++.+||+.||.+|||+.++++
T Consensus       242 ~~~~~~------~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          242 VLQEEP------PLL--PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             HHHSCC------CCC--CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             HhccCC------CCC--CccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            111100      000  011123457889999999999999999999976

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=1e-38  Score=333.39  Aligned_cols=249  Identities=23%  Similarity=0.324  Sum_probs=186.7

Q ss_pred             hcCCccccccCcCCceEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHHHHhc-CCCCcceEeeEEeeCCccEEEEec
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQI-NHRHIVKLLGCCLETEVPVLVYEY  293 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~  293 (537)
                      ..+|...++||+|+||+||.....+|+.||||++.....   ..+.+|+.+++++ +||||+++++++.+....++||||
T Consensus        23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~   99 (432)
T 3p23_A           23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL   99 (432)
T ss_dssp             TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence            356888899999999996554445789999999865332   2356899999999 799999999999999999999999


Q ss_pred             CCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEC-----CCCcEEE
Q 009340          294 ISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD-----DKFSAKV  368 (537)
Q Consensus       294 ~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~-----~~~~~ki  368 (537)
                      ++ |+|.+++.....           .+.+..++.++.|+++||.|||+.+   |+||||||+|||++     ....+||
T Consensus       100 ~~-g~L~~~l~~~~~-----------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL  164 (432)
T 3p23_A          100 CA-ATLQEYVEQKDF-----------AHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMI  164 (432)
T ss_dssp             CS-EEHHHHHHSSSC-----------CCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEE
T ss_pred             CC-CCHHHHHHhcCC-----------CccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEE
Confidence            96 599999976432           3555567899999999999999999   99999999999994     3346889


Q ss_pred             eeccCccccCCCCC--ceeeeccccccccCccccc---CCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHH
Q 009340          369 SDFGISRSIPNDKT--HLTTTIQGTFGYLDPEYFQ---SSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVAC  442 (537)
Q Consensus       369 ~Dfgla~~~~~~~~--~~~~~~~gt~~y~aPE~~~---~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~  442 (537)
                      +|||+++.......  .......||+.|+|||.+.   ...++.++|||||||++|||++ |+.||.......       
T Consensus       165 ~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~-------  237 (432)
T 3p23_A          165 SDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ-------  237 (432)
T ss_dssp             CCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH-------
T ss_pred             ecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH-------
Confidence            99999987653322  2234567999999999997   4567889999999999999999 888885332211       


Q ss_pred             HHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          443 FISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       443 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      .......... ...      .........+.+|+.+||+.||++|||+.+|++
T Consensus       238 ~~~~~~~~~~-~~~------~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          238 ANILLGACSL-DCL------HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             HHHHTTCCCC-TTS------CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHhccCCc-ccc------CccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence            0000110000 000      112234456789999999999999999999983

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=5e-38  Score=346.97  Aligned_cols=240  Identities=23%  Similarity=0.340  Sum_probs=196.0

Q ss_pred             cCCccccccCcCCceEEEEEEcC--CCCEEEEEEccC-CChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCc-----c
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP--DGSIVAVKRSKE-IDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEV-----P  287 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~--~g~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-----~  287 (537)
                      ++|...+.||+|+||.||++...  +|+.||||++.. ........|.+|+.++++++||||+++++++.+.+.     .
T Consensus        80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~  159 (681)
T 2pzi_A           80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG  159 (681)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence            68999999999999999999964  689999999864 344556778999999999999999999999987765     6


Q ss_pred             EEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEE
Q 009340          288 VLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK  367 (537)
Q Consensus       288 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~k  367 (537)
                      |+||||+++++|.+++..              .++|.+++.++.||++||.|||+++   |+||||||+|||++.+ .+|
T Consensus       160 ~lv~E~~~g~~L~~~~~~--------------~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~k  221 (681)
T 2pzi_A          160 YIVMEYVGGQSLKRSKGQ--------------KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLK  221 (681)
T ss_dssp             EEEEECCCCEECC----C--------------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEE
T ss_pred             EEEEEeCCCCcHHHHHhC--------------CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEE
Confidence            999999999999887642              5999999999999999999999999   9999999999999986 899


Q ss_pred             EeeccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHH
Q 009340          368 VSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLA  447 (537)
Q Consensus       368 i~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~  447 (537)
                      |+|||+++.....     ....||++|+|||++.++. +.++|||||||++|||++|..|+........           
T Consensus       222 l~DFG~a~~~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~-----------  284 (681)
T 2pzi_A          222 LIDLGAVSRINSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL-----------  284 (681)
T ss_dssp             ECCCTTCEETTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC-----------
T ss_pred             EEecccchhcccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc-----------
Confidence            9999999876433     3456899999999987654 8999999999999999999888653211110           


Q ss_pred             hhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCC-CHhhHHHHHHHHHH
Q 009340          448 KENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRP-TMKQVSMELEGLRR  502 (537)
Q Consensus       448 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-s~~ev~~~L~~i~~  502 (537)
                           .   .    ..........+.+++.+||+.||++|| ++.++.+.|..+..
T Consensus       285 -----~---~----~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~  328 (681)
T 2pzi_A          285 -----P---E----DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLR  328 (681)
T ss_dssp             -----C---T----TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHH
T ss_pred             -----c---c----cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHH
Confidence                 0   0    000112335688999999999999999 56677777776654

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=2e-38  Score=342.41  Aligned_cols=272  Identities=22%  Similarity=0.362  Sum_probs=205.3

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCC-ChHHHHHHHHHHHHHHhcCCCCcceEeeEEee------CCcc
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI-DKTQIHQFINEVVILSQINHRHIVKLLGCCLE------TEVP  287 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~------~~~~  287 (537)
                      ++|...+.||+|+||.||+|... +|+.||||+++.. .....+.+.+|+.++++++||||+++++++..      .+..
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~   93 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP   93 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence            68999999999999999999964 6899999998753 45566789999999999999999999999765      5678


Q ss_pred             EEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCc--
Q 009340          288 VLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFS--  365 (537)
Q Consensus       288 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~--  365 (537)
                      ++||||+++|+|.+++.....         ...+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.  
T Consensus        94 ~LVmEy~~ggsL~~~L~~~~~---------~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~  161 (676)
T 3qa8_A           94 LLAMEYCEGGDLRKYLNQFEN---------CCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRL  161 (676)
T ss_dssp             CCEEECCSSCBHHHHHHSSSC---------TTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSC
T ss_pred             EEEEEeCCCCCHHHHHHhccc---------CCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCce
Confidence            999999999999999976432         235899999999999999999999999   999999999999997664  


Q ss_pred             -EEEeeccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHH
Q 009340          366 -AKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFI  444 (537)
Q Consensus       366 -~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~  444 (537)
                       +||+|||++.......  ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..........  ....
T Consensus       162 ~vKL~DFG~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~--~~i~  237 (676)
T 3qa8_A          162 IHKIIDLGYAKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWH--GKVR  237 (676)
T ss_dssp             EEEECSCCCCCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSS--TTCC
T ss_pred             eEEEccccccccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhh--hhhh
Confidence             9999999998764432  2344678999999999999999999999999999999999999986432111000  0000


Q ss_pred             -HHHhhchhhhhhcH------H--hhccccHHHHHHHHHHHHHhcccCCCCCCCHhh-----HHHHHHHHHHh
Q 009340          445 -SLAKENQLLEILDA------R--VAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQ-----VSMELEGLRRS  503 (537)
Q Consensus       445 -~~~~~~~~~~~~d~------~--~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e-----v~~~L~~i~~~  503 (537)
                       .........+....      .  .........+..+.+++.+||+.||++|||+.+     ..+.++.+...
T Consensus       238 ~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~  310 (676)
T 3qa8_A          238 EKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSL  310 (676)
T ss_dssp             ------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCC
T ss_pred             cccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhc
Confidence             00000000000000      0  011233446778999999999999999999988     55666666553

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.3e-37  Score=307.33  Aligned_cols=234  Identities=14%  Similarity=0.099  Sum_probs=184.9

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCC---ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI---DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY  291 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  291 (537)
                      ++|...+.||+|+||.||+|... +|+.||||.+...   .....+.|.+|+.++.+++|+||+++++++.+.+..++||
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  110 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA  110 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence            57999999999999999999975 5899999998753   2445678999999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeec
Q 009340          292 EYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF  371 (537)
Q Consensus       292 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Df  371 (537)
                      ||+++++|.+++..              .....++.+++.|+++||.|||+++   |+||||||+|||++.++.+||+++
T Consensus       111 e~~~g~~L~~~l~~--------------~~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~  173 (286)
T 3uqc_A          111 EWIRGGSLQEVADT--------------SPSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYP  173 (286)
T ss_dssp             ECCCEEEHHHHHTT--------------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSC
T ss_pred             EecCCCCHHHHHhc--------------CCChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEec
Confidence            99999999999853              1345568899999999999999999   999999999999999999999854


Q ss_pred             cCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhch
Q 009340          372 GISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQ  451 (537)
Q Consensus       372 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  451 (537)
                      |                     |++|       ++.++||||||+++|||++|+.||......+.....        ...
T Consensus       174 ~---------------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~--------~~~  217 (286)
T 3uqc_A          174 A---------------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA--------ERD  217 (286)
T ss_dssp             C---------------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC--------CBC
T ss_pred             c---------------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH--------HHH
Confidence            3                     3333       688999999999999999999999754332110000        000


Q ss_pred             hhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHHhhH
Q 009340          452 LLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRSQR  505 (537)
Q Consensus       452 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~~  505 (537)
                      ......  .........+..+.+++.+||+.||++| |+.|+++.|+++.....
T Consensus       218 ~~~~~~--~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~  268 (286)
T 3uqc_A          218 TAGQPI--EPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD  268 (286)
T ss_dssp             TTSCBC--CHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred             hccCCC--ChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence            000000  0001112334568899999999999999 99999999999887543

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.2e-37  Score=323.79  Aligned_cols=247  Identities=15%  Similarity=0.146  Sum_probs=182.2

Q ss_pred             HhcCCccccccCcCCceEEEEEE-cCCCCEEEEEEccCCCh---HHHHHHHHHHHHHHhcCC-CCcceE---------e-
Q 009340          214 ATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDK---TQIHQFINEVVILSQINH-RHIVKL---------L-  278 (537)
Q Consensus       214 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H-~niv~l---------~-  278 (537)
                      .+.+|...+.||+|+||.||+|. ..+|+.||||+++....   ...+.|.+|+.++..++| +|....         . 
T Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~  155 (413)
T 3dzo_A           76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD  155 (413)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred             CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence            34567788899999999999999 45799999999874222   235678999999999987 322111         1 


Q ss_pred             -----------eEEee-----CCccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh
Q 009340          279 -----------GCCLE-----TEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHS  342 (537)
Q Consensus       279 -----------g~~~~-----~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~  342 (537)
                                 .++..     ....+++|+++ .++|.+++.......     .....++|..++.++.|+++||+|||+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~-----~~~~~l~~~~~~~i~~qi~~aL~~LH~  229 (413)
T 3dzo_A          156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHS-----STHKSLVHHARLQLTLQVIRLLASLHH  229 (413)
T ss_dssp             EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHT-----TTSHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhccc-----ccCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence                       11111     12346666655 679999885432110     012358899999999999999999999


Q ss_pred             cCCCCeeecCCCCCCEEECCCCcEEEeeccCccccCCCCCceeeeccccccccCcccc----------cCCCCCcchhHH
Q 009340          343 SASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYF----------QSSQFTDKSDVY  412 (537)
Q Consensus       343 ~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~t~ksDV~  412 (537)
                      ++   |+||||||+|||++.++.+||+|||+++.....    .....| +.|+|||++          ....++.++|||
T Consensus       230 ~~---iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~Dvw  301 (413)
T 3dzo_A          230 YG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTW  301 (413)
T ss_dssp             TT---EECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHH
T ss_pred             CC---cccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHH
Confidence            99   999999999999999999999999999865332    344567 999999999          556688999999


Q ss_pred             HHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhh
Q 009340          413 SFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQ  492 (537)
Q Consensus       413 S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  492 (537)
                      ||||++|||++|+.||......+.               ...++..      ....+..+.+|+.+||+.||++|||+.+
T Consensus       302 SlGvil~elltg~~Pf~~~~~~~~---------------~~~~~~~------~~~~~~~~~~li~~~l~~dP~~Rpt~~~  360 (413)
T 3dzo_A          302 TLGLAIYWIWCADLPNTDDAALGG---------------SEWIFRS------CKNIPQPVRALLEGFLRYPKEDRLLPLQ  360 (413)
T ss_dssp             HHHHHHHHHHHSSCCCCTTGGGSC---------------SGGGGSS------CCCCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             HHHHHHHHHHHCCCCCCCcchhhh---------------HHHHHhh------cccCCHHHHHHHHHHccCChhhCcCHHH
Confidence            999999999999999965432211               0011110      0122356889999999999999999988


Q ss_pred             HHH
Q 009340          493 VSM  495 (537)
Q Consensus       493 v~~  495 (537)
                      +++
T Consensus       361 ~l~  363 (413)
T 3dzo_A          361 AME  363 (413)
T ss_dssp             HTT
T ss_pred             HHh
Confidence            865

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=1.5e-36  Score=301.74  Aligned_cols=228  Identities=21%  Similarity=0.319  Sum_probs=177.6

Q ss_pred             cCCccc-cccCcCCceEEEEEEc-CCCCEEEEEEccCCChHHHHHHHHHHHHH-HhcCCCCcceEeeEEee----CCccE
Q 009340          216 DNYNQS-RFLGQGGFGTVYKGML-PDGSIVAVKRSKEIDKTQIHQFINEVVIL-SQINHRHIVKLLGCCLE----TEVPV  288 (537)
Q Consensus       216 ~~~~~~-~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~H~niv~l~g~~~~----~~~~~  288 (537)
                      ++|... +.||+|+||.||++.. .+++.||+|.++..     ..+.+|+.++ +..+||||+++++++..    ....+
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   91 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   91 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence            567666 7799999999999996 47899999998752     3566888888 55589999999999987    66789


Q ss_pred             EEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECC---CCc
Q 009340          289 LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD---KFS  365 (537)
Q Consensus       289 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~---~~~  365 (537)
                      +||||+++|+|.+++.....          ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.   ++.
T Consensus        92 lv~e~~~~~~L~~~l~~~~~----------~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~  158 (299)
T 3m2w_A           92 IVMECLDGGELFSRIQDRGD----------QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAI  158 (299)
T ss_dssp             EEECCCCSCBHHHHHHHCTT----------CCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCC
T ss_pred             EEEeecCCCcHHHHHHhccC----------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCc
Confidence            99999999999999976432          36999999999999999999999999   999999999999998   789


Q ss_pred             EEEeeccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHH
Q 009340          366 AKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFIS  445 (537)
Q Consensus       366 ~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~  445 (537)
                      +||+|||++....                       +..++.++||||||+++|||++|+.||........         
T Consensus       159 ~kl~Dfg~a~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~---------  206 (299)
T 3m2w_A          159 LKLTDFGFAKETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI---------  206 (299)
T ss_dssp             EEECCCTTCEECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC---------------
T ss_pred             EEEeccccccccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh---------
Confidence            9999999986542                       23457799999999999999999999864322110         


Q ss_pred             HHhhchhhhhhcHHhh--ccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          446 LAKENQLLEILDARVA--KEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       446 ~~~~~~~~~~~d~~~~--~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                        .......+......  .......+..+.+++.+||+.||++|||+.|+++
T Consensus       207 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~  256 (299)
T 3m2w_A          207 --SPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  256 (299)
T ss_dssp             ---CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             --hHHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence              00000000000000  0000223567889999999999999999999986

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=7.4e-37  Score=309.08  Aligned_cols=242  Identities=15%  Similarity=0.198  Sum_probs=182.7

Q ss_pred             hcCCccccccCcCCceEEEEEEcCCCCEEEEEEccCCC--------hHHHHHHHHHHHHHHhcC---------CCCcceE
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEID--------KTQIHQFINEVVILSQIN---------HRHIVKL  277 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------H~niv~l  277 (537)
                      .++|...+.||+|+||.||+|+. +|+.||||+++...        ....+.+.+|+.+++.++         |+|++++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            35678889999999999999998 68999999986532        223467889999999886         7777766


Q ss_pred             eeEEe-----------------e-------------CCccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHH
Q 009340          278 LGCCL-----------------E-------------TEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRV  327 (537)
Q Consensus       278 ~g~~~-----------------~-------------~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~  327 (537)
                      .+++.                 +             .+..++||||+++|++.+.+..             ..+++..+.
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-------------~~~~~~~~~  164 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-------------KLSSLATAK  164 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-------------TCCCHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-------------cCCCHHHHH
Confidence            66542                 2             6788999999999987776643             258999999


Q ss_pred             HHHHHHHHHHHHHh-hcCCCCeeecCCCCCCEEECCCC--------------------cEEEeeccCccccCCCCCceee
Q 009340          328 RVACEVAGAVAYMH-SSASIPIFHRDIKSSNILLDDKF--------------------SAKVSDFGISRSIPNDKTHLTT  386 (537)
Q Consensus       328 ~i~~~ia~gl~yLH-~~~~~~ivH~Dlk~~NIll~~~~--------------------~~ki~Dfgla~~~~~~~~~~~~  386 (537)
                      .++.|++.||+||| +.+   |+||||||+|||++.++                    .+||+|||+++.....      
T Consensus       165 ~i~~qi~~aL~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------  235 (336)
T 2vuw_A          165 SILHQLTASLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------  235 (336)
T ss_dssp             HHHHHHHHHHHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------
T ss_pred             HHHHHHHHHHHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------
Confidence            99999999999999 899   99999999999999887                    9999999999876432      


Q ss_pred             eccccccccCcccccCCCCCcchhHHHHHHH-HHHHHhCCCCCCccchhhhccHHHHHHHHHhhchhhhhhcHHhhcccc
Q 009340          387 TIQGTFGYLDPEYFQSSQFTDKSDVYSFGVV-LLELLTGKKPICFARVEEERNLVACFISLAKENQLLEILDARVAKEAR  465 (537)
Q Consensus       387 ~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvl-l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  465 (537)
                      ...||+.|+|||.+.+.. +.++||||+|++ .+++++|..||.....      ............   ...........
T Consensus       236 ~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~------~~~~~~~~~~~~---~~~~~~~~~~~  305 (336)
T 2vuw_A          236 IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLW------LHYLTDKMLKQM---TFKTKCNTPAM  305 (336)
T ss_dssp             EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHH------HHHHHHHHHHTC---CCSSCCCSHHH
T ss_pred             cEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhh------hhHHHHhhhhhh---ccCcccchhhh
Confidence            346899999999998666 899999998776 7788889998632100      000000000000   00011111234


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHhhHH
Q 009340          466 EEDIGAMAELAMRCLRLNSKKRPTMKQVS  494 (537)
Q Consensus       466 ~~~~~~l~~l~~~cl~~~p~~RPs~~ev~  494 (537)
                      ...+.++.+|+.+||+.|     |+.|++
T Consensus       306 ~~~s~~~~dli~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          306 KQIKRKIQEFHRTMLNFS-----SATDLL  329 (336)
T ss_dssp             HHHHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred             hhcCHHHHHHHHHHhccC-----CHHHHH
Confidence            467788999999999966     888876

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.96  E-value=3.8e-30  Score=276.88  Aligned_cols=184  Identities=17%  Similarity=0.125  Sum_probs=130.2

Q ss_pred             cCcCCceEEEEEE-cCCCCEEEEEEccCC----------ChHHHHHHHHHHHHHHhc-CCCCcceEeeEEeeCCccEEEE
Q 009340          224 LGQGGFGTVYKGM-LPDGSIVAVKRSKEI----------DKTQIHQFINEVVILSQI-NHRHIVKLLGCCLETEVPVLVY  291 (537)
Q Consensus       224 lg~G~~g~Vy~~~-~~~g~~vavK~~~~~----------~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~  291 (537)
                      .+.|++|.+..++ +-.|+.+|+|.+...          .....++|.+|+++|+++ .|+||+++++++.+++..||||
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM  321 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM  321 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence            4566666555443 225888999988542          123456799999999999 7999999999999999999999


Q ss_pred             ecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeec
Q 009340          292 EYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF  371 (537)
Q Consensus       292 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Df  371 (537)
                      ||+++++|.++|...            .+++..   +|+.||++||+|||+++   ||||||||+||||++++.+||+||
T Consensus       322 Eyv~G~~L~d~i~~~------------~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DF  383 (569)
T 4azs_A          322 EKLPGRLLSDMLAAG------------EEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDF  383 (569)
T ss_dssp             ECCCSEEHHHHHHTT------------CCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCC
T ss_pred             ecCCCCcHHHHHHhC------------CCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeec
Confidence            999999999999763            346553   58999999999999999   999999999999999999999999


Q ss_pred             cCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCC
Q 009340          372 GISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP  427 (537)
Q Consensus       372 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p  427 (537)
                      |+|+....+.. ......||++|||||++.+ .+..++|+||+|++++++.++..+
T Consensus       384 GlAr~~~~~~~-~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          384 GSIVTTPQDCS-WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             TTEESCC---C-CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             ccCeeCCCCCc-cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence            99987754432 3445679999999999865 467789999999998887666544

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.94  E-value=3.1e-27  Score=252.77  Aligned_cols=184  Identities=15%  Similarity=0.218  Sum_probs=146.0

Q ss_pred             ccccccCcCCceEEEEEEcCCCCEEEEEEccCCC---h-----HHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEE
Q 009340          219 NQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEID---K-----TQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLV  290 (537)
Q Consensus       219 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~---~-----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  290 (537)
                      ...++||+|+||.||++.. .++.+++|+.....   .     ...+.|.+|++++++++||||+++..++...+..++|
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            3456899999999999976 57889999753311   1     1245689999999999999999777777788888999


Q ss_pred             EecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEee
Q 009340          291 YEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSD  370 (537)
Q Consensus       291 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~D  370 (537)
                      |||+++|+|.+++..                    ++.++.|+++||.|||+++   |+||||||+|||++.  .+||+|
T Consensus       418 mE~~~ggsL~~~l~~--------------------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~D  472 (540)
T 3en9_A          418 MSYINGKLAKDVIED--------------------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIID  472 (540)
T ss_dssp             EECCCSEEHHHHSTT--------------------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECC
T ss_pred             EECCCCCCHHHHHHH--------------------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEE
Confidence            999999999999853                    3579999999999999999   999999999999999  999999


Q ss_pred             ccCccccCCCCCce------eeeccccccccCcccccC--CCCCcchhHHHHHHHHHHHHhCCCCC
Q 009340          371 FGISRSIPNDKTHL------TTTIQGTFGYLDPEYFQS--SQFTDKSDVYSFGVVLLELLTGKKPI  428 (537)
Q Consensus       371 fgla~~~~~~~~~~------~~~~~gt~~y~aPE~~~~--~~~t~ksDV~S~Gvll~el~tg~~p~  428 (537)
                      ||+++.........      .....||+.|||||++..  ..|+.++|+||..+-.++.+.++.++
T Consensus       473 FGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          473 FGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             CTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             CccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            99999875432211      235679999999999976  56788899999999988888776654

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.90  E-value=8e-24  Score=207.83  Aligned_cols=151  Identities=20%  Similarity=0.139  Sum_probs=121.7

Q ss_pred             HHHHHhcCCccccccCcCCceEEEEEEcCCCCEEEEEEccCCCh------------------HHHHHHHHHHHHHHhcCC
Q 009340          210 ELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDK------------------TQIHQFINEVVILSQINH  271 (537)
Q Consensus       210 el~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~H  271 (537)
                      .+......|...+.||+|+||.||+|...+|+.||||.++....                  .....+.+|+.++++++ 
T Consensus        84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~-  162 (282)
T 1zar_A           84 RLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-  162 (282)
T ss_dssp             HHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-
T ss_pred             HHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-
Confidence            34444456667799999999999999997799999999864221                  23567899999999999 


Q ss_pred             CCcceEeeEEeeCCccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 009340          272 RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHR  351 (537)
Q Consensus       272 ~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~  351 (537)
                       | +++.+++. .+..++||||+++|+|.+ +..                  .....++.|+++||.|||+.+   |+||
T Consensus       163 -~-~~v~~~~~-~~~~~lvmE~~~g~~L~~-l~~------------------~~~~~i~~qi~~~l~~lH~~g---iiHr  217 (282)
T 1zar_A          163 -G-LAVPKVYA-WEGNAVLMELIDAKELYR-VRV------------------ENPDEVLDMILEEVAKFYHRG---IVHG  217 (282)
T ss_dssp             -T-SSSCCEEE-EETTEEEEECCCCEEGGG-CCC------------------SCHHHHHHHHHHHHHHHHHTT---EECS
T ss_pred             -C-CCcCeEEe-ccceEEEEEecCCCcHHH-cch------------------hhHHHHHHHHHHHHHHHHHCC---CEeC
Confidence             5 66666554 356799999999999988 421                  123469999999999999999   9999


Q ss_pred             CCCCCCEEECCCCcEEEeeccCccccCCCCCceeeeccccccccCccccc
Q 009340          352 DIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQ  401 (537)
Q Consensus       352 Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~  401 (537)
                      ||||+|||++ ++.+||+|||+++.              +..|+|||++.
T Consensus       218 Dlkp~NILl~-~~~vkl~DFG~a~~--------------~~~~~a~e~l~  252 (282)
T 1zar_A          218 DLSQYNVLVS-EEGIWIIDFPQSVE--------------VGEEGWREILE  252 (282)
T ss_dssp             CCSTTSEEEE-TTEEEECCCTTCEE--------------TTSTTHHHHHH
T ss_pred             CCCHHHEEEE-CCcEEEEECCCCeE--------------CCCCCHHHHHH
Confidence            9999999999 99999999999963              34478999874

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.80  E-value=1.2e-19  Score=175.87  Aligned_cols=136  Identities=18%  Similarity=0.150  Sum_probs=105.8

Q ss_pred             CccccccCcCCceEEEEEEc-CCCCE--EEEEEccCCCh------------------------HHHHHHHHHHHHHHhcC
Q 009340          218 YNQSRFLGQGGFGTVYKGML-PDGSI--VAVKRSKEIDK------------------------TQIHQFINEVVILSQIN  270 (537)
Q Consensus       218 ~~~~~~lg~G~~g~Vy~~~~-~~g~~--vavK~~~~~~~------------------------~~~~~~~~E~~~l~~l~  270 (537)
                      |...+.||+|+||.||+|.. .+|+.  ||||.++....                        .....+.+|+.++.+++
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            55678999999999999997 67888  99998653211                        11236789999999998


Q ss_pred             CCCc--ceEeeEEeeCCccEEEEecCCC-C----ChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh-h
Q 009340          271 HRHI--VKLLGCCLETEVPVLVYEYISS-G----TLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMH-S  342 (537)
Q Consensus       271 H~ni--v~l~g~~~~~~~~~lV~e~~~~-g----sL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH-~  342 (537)
                      |+++  ..++++    +..+|||||+.+ |    +|.++...               .++..+..++.|+++||.||| +
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---------------~~~~~~~~i~~qi~~~l~~lH~~  189 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---------------LKELDVEGIFNDVVENVKRLYQE  189 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---------------GGGSCHHHHHHHHHHHHHHHHHT
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---------------cChHHHHHHHHHHHHHHHHHHHH
Confidence            8764  444432    367999999952 5    55544321               224456789999999999999 8


Q ss_pred             cCCCCeeecCCCCCCEEECCCCcEEEeeccCcccc
Q 009340          343 SASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI  377 (537)
Q Consensus       343 ~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~  377 (537)
                      .+   |+||||||+|||++.  .++|+|||++...
T Consensus       190 ~g---ivHrDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          190 AE---LVHADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             SC---EECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             CC---EEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence            88   999999999999998  9999999999764

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.66  E-value=4.9e-17  Score=164.11  Aligned_cols=136  Identities=11%  Similarity=0.137  Sum_probs=98.6

Q ss_pred             CCccccccCcCCceEEEEEEcCCCCEEEEEEccCCC--------------hHHHHH--------HHHHHHHHHhcCCCCc
Q 009340          217 NYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEID--------------KTQIHQ--------FINEVVILSQINHRHI  274 (537)
Q Consensus       217 ~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~--------------~~~~~~--------~~~E~~~l~~l~H~ni  274 (537)
                      -|...+.||+|+||.||+|...+|+.||||.++...              ......        ..+|...|.++.+.++
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            388889999999999999998899999999764210              000111        1245556666644433


Q ss_pred             c--eEeeEEeeCCccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecC
Q 009340          275 V--KLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRD  352 (537)
Q Consensus       275 v--~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~D  352 (537)
                      .  ..+++    ...+|||||+++++|.++...                  .....++.|++.+|.|||+.+   |||||
T Consensus       176 ~vp~p~~~----~~~~LVME~i~G~~L~~l~~~------------------~~~~~l~~qll~~l~~lH~~g---IVHrD  230 (397)
T 4gyi_A          176 PVPEPIAQ----SRHTIVMSLVDALPMRQVSSV------------------PDPASLYADLIALILRLAKHG---LIHGD  230 (397)
T ss_dssp             SCCCEEEE----ETTEEEEECCSCEEGGGCCCC------------------SCHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred             CCCeeeec----cCceEEEEecCCccHhhhccc------------------HHHHHHHHHHHHHHHHHHHCC---CcCCC
Confidence            2  22221    234799999999888655421                  123568899999999999999   99999


Q ss_pred             CCCCCEEECCCC----------cEEEeeccCcccc
Q 009340          353 IKSSNILLDDKF----------SAKVSDFGISRSI  377 (537)
Q Consensus       353 lk~~NIll~~~~----------~~ki~Dfgla~~~  377 (537)
                      |||.|||+++++          .+.|+||+-+...
T Consensus       231 LKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          231 FNEFNILIREEKDAEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             CSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred             CCHHHEEEeCCCCcccccccccceEEEEeCCcccC
Confidence            999999998876          4899999977543

>4eby_A Chitin elicitor receptor kinase 1; pathogen-associated molecular patterns, pattern recognition receptors, LYSM, lysine chitin oligomer; HET: NAG BMA; 1.65A {Arabidopsis thaliana} PDB: 4ebz_A*

Probab=99.65  E-value=9e-17  Score=148.61  Aligned_cols=100  Identities=24%  Similarity=0.331  Sum_probs=84.7

Q ss_pred             ccccccCCcccHHHHhhCCCCCCCCCCCCceeeecccccCCCCccccchhhhhhhhhcccccchhhhHhhhcCChHHHHH
Q 009340            2 LARYTYQGLTTCQALLGQNYFDAPNITIGAQVMIPLRCACPTANQIDKGVSYLLAYMAAKGDTISSIGYKFGVDQQSILE   81 (537)
Q Consensus         2 ia~~~~~~l~t~~~l~~~N~~~~~~i~~g~~l~vp~~c~c~~~~~~~~~~~~~~~y~v~~gdtl~~ia~~f~~~~~~l~~   81 (537)
                      ||+..|+||+|+++|+++|.++++.|++||+|.||..|+|++. +...+...+.+|+|++||||++||++||+++++|++
T Consensus        92 IA~~~y~~lvt~~~L~~~N~~~~~~l~~Gq~L~IP~~~~~~~~-~~~~~~~~~~~Y~V~~GDTL~~IA~~fgvsv~~L~~  170 (212)
T 4eby_A           92 VAISNYANLTTMESLQARNPFPATNIPLSATLNVLVNCSCGDE-SVSKDFGLFVTYPLRPEDSLSSIARSSGVSADILQR  170 (212)
T ss_dssp             HHHTTTTTSSCHHHHHHHCCSCTTCCCTTCEEEEEEECCCCCT-TTCSSCCCEEEEECCTTCCHHHHHHHHTSCHHHHHH
T ss_pred             HHHHhcCCCCCHHHHHHhcCCCcccCCCCCEEEEcCCCcCCCc-ccccCCCCeEEEEECCCCcHHHHHHHHCcCHHHHHH
Confidence            6756899999999999999988899999999999999999765 344445556789999999999999999999999999


Q ss_pred             hhccCCCCcccccccccCCcCCC
Q 009340           82 ANMLSKADSIFPFAPLLIPLKNG  104 (537)
Q Consensus        82 ~n~~~~~~~i~~~~~l~vp~~~~  104 (537)
                      +|+..+ ..+.++. ++||.+..
T Consensus       171 ~N~~~~-~~~~~g~-l~IP~~~~  191 (212)
T 4eby_A          171 YNPGVN-FNSGNGI-VYVPGRDP  191 (212)
T ss_dssp             HSTTCC-TTSCSSE-EEEECCCT
T ss_pred             hcCCCc-cCCCCCE-EEecCCCC
Confidence            999754 3444454 88998753

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.34  E-value=4.4e-12  Score=122.53  Aligned_cols=146  Identities=16%  Similarity=0.107  Sum_probs=112.8

Q ss_pred             HHHhcCCccccccCcCCceEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHHHHhcC-CCCcceEeeEEeeCCccEEE
Q 009340          212 QRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQIN-HRHIVKLLGCCLETEVPVLV  290 (537)
Q Consensus       212 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV  290 (537)
                      ......|.....++.|+.+.||+.... ++.+++|............+.+|+.+++.+. |..+.++++++.+.+..|+|
T Consensus        10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv   88 (263)
T 3tm0_A           10 KKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL   88 (263)
T ss_dssp             HHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred             HHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence            344567877888888889999999864 6889999986421122345788999999984 67788999999988889999


Q ss_pred             EecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcC--------------------------
Q 009340          291 YEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSA--------------------------  344 (537)
Q Consensus       291 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~--------------------------  344 (537)
                      |||+++.+|.+.+..                 ......++.+++++|..||+..                          
T Consensus        89 ~e~i~G~~l~~~~~~-----------------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (263)
T 3tm0_A           89 MSEADGVLCSEEYED-----------------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLA  151 (263)
T ss_dssp             EECCSSEEHHHHCCT-----------------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCS
T ss_pred             EEecCCeehhhccCC-----------------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccc
Confidence            999999998765321                 1123467889999999999811                          


Q ss_pred             ------------------------------CCCeeecCCCCCCEEECCCCcEEEeeccCcc
Q 009340          345 ------------------------------SIPIFHRDIKSSNILLDDKFSAKVSDFGISR  375 (537)
Q Consensus       345 ------------------------------~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~  375 (537)
                                                    .+.++|+|+++.||+++++..+.|.||+.+.
T Consensus       152 ~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          152 DVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             CCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             ccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                          1348999999999999876666799998764

>4eby_A Chitin elicitor receptor kinase 1; pathogen-associated molecular patterns, pattern recognition receptors, LYSM, lysine chitin oligomer; HET: NAG BMA; 1.65A {Arabidopsis thaliana} PDB: 4ebz_A*

Probab=99.30  E-value=1e-12  Score=121.42  Aligned_cols=86  Identities=21%  Similarity=0.387  Sum_probs=73.2

Q ss_pred             HHHHhhCC-CC-CCCCCCCCceeeecccccCCCCccccchhhhhhhhhcccccchhhhH-hhhc--CChHHHHHhhccCC
Q 009340           13 CQALLGQN-YF-DAPNITIGAQVMIPLRCACPTANQIDKGVSYLLAYMAAKGDTISSIG-YKFG--VDQQSILEANMLSK   87 (537)
Q Consensus        13 ~~~l~~~N-~~-~~~~i~~g~~l~vp~~c~c~~~~~~~~~~~~~~~y~v~~gdtl~~ia-~~f~--~~~~~l~~~n~~~~   87 (537)
                      +++|+++| .+ +++.|.+||.|.||..|.|.+...    .....+|+|++||||++|| ++|+  +++++|+++|++ .
T Consensus        39 ~~~I~~~Np~l~~~~~l~~Gq~L~IP~~~~~~~~~~----~~~~~~Y~V~~GDTL~~IA~~~y~~lvt~~~L~~~N~~-~  113 (212)
T 4eby_A           39 FDPILRYNSNIKDKDRIQMGSRVLVPFPCECQPGDF----LGHNFSYSVRQEDTYERVAISNYANLTTMESLQARNPF-P  113 (212)
T ss_dssp             CHHHHTTCTTCSCTTSCCTTCEEEEEECCEEETTTE----EEEEEEEECCTTCCHHHHHHTTTTTSSCHHHHHHHCCS-C
T ss_pred             HHHHHHhccCCCCcCccCCCCEEEEeccccccCCcc----ccCceEEEecCCCcHHHHHHHhcCCCCCHHHHHHhcCC-C
Confidence            49999999 77 578999999999999999964321    1123479999999999999 7999  999999999995 5


Q ss_pred             CCcccccccccCCcCC
Q 009340           88 ADSIFPFAPLLIPLKN  103 (537)
Q Consensus        88 ~~~i~~~~~l~vp~~~  103 (537)
                      .+.|++|+.+.||..+
T Consensus       114 ~~~l~~Gq~L~IP~~~  129 (212)
T 4eby_A          114 ATNIPLSATLNVLVNC  129 (212)
T ss_dssp             TTCCCTTCEEEEEEEC
T ss_pred             cccCCCCCEEEEcCCC
Confidence            5789999999999874

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.19  E-value=3e-11  Score=116.15  Aligned_cols=136  Identities=15%  Similarity=0.142  Sum_probs=97.3

Q ss_pred             CCccccccCcCCceEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCC--cceEeeEEeeCCccEEEEecC
Q 009340          217 NYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRH--IVKLLGCCLETEVPVLVYEYI  294 (537)
Q Consensus       217 ~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~~~~~~~~~lV~e~~  294 (537)
                      ++......+.|..+.||+....+|+.+++|.....   ....+.+|+.+++.+.+.+  +.+++++..+.+..++||||+
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i   97 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV   97 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred             CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEec
Confidence            44433333455669999998877888999987653   2245678999999986544  556888888777889999999


Q ss_pred             CCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcC------------------------------
Q 009340          295 SSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSA------------------------------  344 (537)
Q Consensus       295 ~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~------------------------------  344 (537)
                      ++.+|.  ...               .+   ...++.++++.|..||+..                              
T Consensus        98 ~G~~l~--~~~---------------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (264)
T 1nd4_A           98 PGQDLL--SSH---------------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDD  157 (264)
T ss_dssp             SSEETT--TSC---------------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTS
T ss_pred             CCcccC--cCc---------------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchh
Confidence            998884  211               11   1245556666666666532                              


Q ss_pred             -------------------------CCCeeecCCCCCCEEECCCCcEEEeeccCcc
Q 009340          345 -------------------------SIPIFHRDIKSSNILLDDKFSAKVSDFGISR  375 (537)
Q Consensus       345 -------------------------~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~  375 (537)
                                               ...++|+|++|.||+++++..+.|.||+.+.
T Consensus       158 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          158 LDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             CCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                                     1229999999999999887667799999875

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.06  E-value=6.2e-10  Score=112.63  Aligned_cols=141  Identities=17%  Similarity=0.263  Sum_probs=106.7

Q ss_pred             ccccCcCCceEEEEEEcCCCCEEEEEEcc--CCC-hHHHHHHHHHHHHHHhcC--CCCcceEeeEEeeC---CccEEEEe
Q 009340          221 SRFLGQGGFGTVYKGMLPDGSIVAVKRSK--EID-KTQIHQFINEVVILSQIN--HRHIVKLLGCCLET---EVPVLVYE  292 (537)
Q Consensus       221 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~---~~~~lV~e  292 (537)
                      .+.|+.|.++.||+....+ ..+++|+..  ... ......+.+|..+++.+.  +..+.++++++.+.   +..++|||
T Consensus        43 ~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme  121 (359)
T 3dxp_A           43 VEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME  121 (359)
T ss_dssp             EEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred             EEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence            5678999999999998754 678888776  322 122346778999999996  45688899998776   34799999


Q ss_pred             cCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcC----------------------------
Q 009340          293 YISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSA----------------------------  344 (537)
Q Consensus       293 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~----------------------------  344 (537)
                      |+++.++.+..              ...++..++..++.++++.|..||+..                            
T Consensus       122 ~v~G~~l~~~~--------------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  187 (359)
T 3dxp_A          122 FVSGRVLWDQS--------------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYK  187 (359)
T ss_dssp             CCCCBCCCCTT--------------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHH
T ss_pred             ecCCeecCCCc--------------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHH
Confidence            99998875422              124778888899999999999999731                            


Q ss_pred             ---------------------------CCCeeecCCCCCCEEECCCCc--EEEeeccCccc
Q 009340          345 ---------------------------SIPIFHRDIKSSNILLDDKFS--AKVSDFGISRS  376 (537)
Q Consensus       345 ---------------------------~~~ivH~Dlk~~NIll~~~~~--~ki~Dfgla~~  376 (537)
                                                 .+.++|||+++.|||++.++.  +.|.||+.+..
T Consensus       188 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          188 LSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             hcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                       245999999999999997753  68999998864

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.98  E-value=5.8e-10  Score=110.09  Aligned_cols=185  Identities=20%  Similarity=0.239  Sum_probs=119.3

Q ss_pred             ccccCcCCceEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHHHHhcC-CCC--cceEeeEEeeCC---ccEEEEecC
Q 009340          221 SRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQIN-HRH--IVKLLGCCLETE---VPVLVYEYI  294 (537)
Q Consensus       221 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~n--iv~l~g~~~~~~---~~~lV~e~~  294 (537)
                      .+.++.|....||+..    ..+++|....  ......+.+|..+++.+. +..  +.+++......+   ..|+|||++
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~--~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i   98 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKH--SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI   98 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESS--HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCC--cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence            4568999999999853    4588998654  234567889999999883 333  445555544333   358999999


Q ss_pred             CCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhc-------------------------------
Q 009340          295 SSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSS-------------------------------  343 (537)
Q Consensus       295 ~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~-------------------------------  343 (537)
                      ++.+|.+....              .++..++..++.++++.|..||+.                               
T Consensus        99 ~G~~l~~~~~~--------------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (304)
T 3sg8_A           99 KGVPLTPLLLN--------------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRE  164 (304)
T ss_dssp             CCEECCHHHHH--------------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTT
T ss_pred             CCeECCccccc--------------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhccc
Confidence            99888653321              355666667777777777777751                               


Q ss_pred             ------------------------CCCCeeecCCCCCCEEECC--CCcEEEeeccCccccCCCCCceeee----------
Q 009340          344 ------------------------ASIPIFHRDIKSSNILLDD--KFSAKVSDFGISRSIPNDKTHLTTT----------  387 (537)
Q Consensus       344 ------------------------~~~~ivH~Dlk~~NIll~~--~~~~ki~Dfgla~~~~~~~~~~~~~----------  387 (537)
                                              ..+.++|+|+++.||++++  +..+.|.||+.+..-.... .....          
T Consensus       165 ~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~-Dl~~~~~~~~~~~~~  243 (304)
T 3sg8_A          165 LKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN-DFISLMEDDEEYGME  243 (304)
T ss_dssp             SCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH-HHHTTCCTTTSCCHH
T ss_pred             CCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH-HHHHHHhhccccCHH
Confidence                                    1244899999999999998  5568899999886432110 00000          


Q ss_pred             ----ccccccccC-cccccCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 009340          388 ----IQGTFGYLD-PEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI  428 (537)
Q Consensus       388 ----~~gt~~y~a-PE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~  428 (537)
                          .....+... |+....  .....+.|+++.++|++.+|..++
T Consensus       244 ~~~~~l~~Y~~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          244 FVSKILNHYKHKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHHHHHHHTCSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HHHHHHHHcCCCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence                000001111 221110  011368999999999999998775

>2djp_A Hypothetical protein SB145; LYSM, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens}

Probab=98.90  E-value=6e-10  Score=85.74  Aligned_cols=62  Identities=34%  Similarity=0.471  Sum_probs=53.7

Q ss_pred             CCceeeecccccCCCCccccchhhhhhhhhcccccchhhhHhhhcCChHHHHHhhccCCCCcccccccccCCcCC
Q 009340           29 IGAQVMIPLRCACPTANQIDKGVSYLLAYMAAKGDTISSIGYKFGVDQQSILEANMLSKADSIFPFAPLLIPLKN  103 (537)
Q Consensus        29 ~g~~l~vp~~c~c~~~~~~~~~~~~~~~y~v~~gdtl~~ia~~f~~~~~~l~~~n~~~~~~~i~~~~~l~vp~~~  103 (537)
                      .||.+.+|..             ..+.+|+|++|||||+||++|++++.+|+++|++...+.+++|+.+.+|...
T Consensus         3 ~Gq~l~ip~~-------------~~~~~y~V~~GDTL~~IA~~~~~~~~~l~~~N~l~~~~~l~~Gq~l~iP~~~   64 (77)
T 2djp_A            3 SGSSGCSPVR-------------ERRLEHQLEPGDTLAGLALKYGVTMEQIKRANRLYTNDSIFLKKTLYIPILT   64 (77)
T ss_dssp             CCCCCCCCCC-------------EEEEEECCCTTCCHHHHHHHHTCCHHHHHHHHTCCCSSCGGGSSCEEEEEEC
T ss_pred             CCcEeeccCC-------------CCcEEEEECCCCcHHHHHHHHCcCHHHHHHHcCCCCccccCCCCEEEECCCC
Confidence            6888888842             1245799999999999999999999999999998767899999999999863

>1e0g_A Membrane-bound lytic murein transglycosylase D; cell WALL, hydrolase, glycosidase, lipoprotein, outer membrane, multigene family; NMR {Escherichia coli} SCOP: d.7.1.1

Probab=98.77  E-value=2.1e-09  Score=74.45  Aligned_cols=45  Identities=29%  Similarity=0.459  Sum_probs=41.8

Q ss_pred             hhhcccccchhhhHhhhcCChHHHHHhhccCCCCcccccccccCCcC
Q 009340           56 AYMAAKGDTISSIGYKFGVDQQSILEANMLSKADSIFPFAPLLIPLK  102 (537)
Q Consensus        56 ~y~v~~gdtl~~ia~~f~~~~~~l~~~n~~~~~~~i~~~~~l~vp~~  102 (537)
                      +|+|++||||++||++|+++..+|.++|+  ..+.+++|+.+.+|++
T Consensus         4 ~y~V~~GDtl~~Ia~~~~~~~~~l~~~N~--~~~~l~~G~~l~ip~~   48 (48)
T 1e0g_A            4 TYRVRKGDSLSSIAKRHGVNIKDVMRWNS--DTANLQPGDKLTLFVK   48 (48)
T ss_dssp             EEEECTTCCHHHHHHHHTCCHHHHHHHCS--CGGGCCTTEEEECCCC
T ss_pred             EEEEcCCCcHHHHHHHHCcCHHHHHHhCC--CCCcCCcCCEEEEecC
Confidence            69999999999999999999999999998  6678999999999863

>2l9y_A CVNH-LYSM lectin; carbohydrate, sugar binding protein; NMR {Magnaporthe oryzae 70-15}

Probab=98.57  E-value=1.6e-08  Score=89.50  Aligned_cols=49  Identities=31%  Similarity=0.502  Sum_probs=46.0

Q ss_pred             hhhhcccccchhhhHhhhcCChHHHHHhhccCCCCcccccccccCCcCC
Q 009340           55 LAYMAAKGDTISSIGYKFGVDQQSILEANMLSKADSIFPFAPLLIPLKN  103 (537)
Q Consensus        55 ~~y~v~~gdtl~~ia~~f~~~~~~l~~~n~~~~~~~i~~~~~l~vp~~~  103 (537)
                      .+|+|++|||||+||++|++++.+|+++|++.+++.|+|||.+.+|...
T Consensus        63 ~~y~V~~GDTL~~IA~~~~~~~~~l~~~N~~~~~~~i~~Gq~L~ip~~~  111 (167)
T 2l9y_A           63 ATVTVQQGDTLRDIGRRFDCDFHEIARRNNIQNEDLIYPGQVLQVPTKG  111 (167)
T ss_dssp             EEEEECTTCCHHHHHHHTTCCHHHHHHHHTCCGGGCCCTTEEEEESCCC
T ss_pred             ceEEECCCCcHHHHHHHcCCCHHHHHHHcCCCCcccccCCCEEEEcCCC
Confidence            3799999999999999999999999999999888999999999999753

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.49  E-value=1.4e-06  Score=85.88  Aligned_cols=75  Identities=13%  Similarity=0.096  Sum_probs=55.8

Q ss_pred             ccccCcCCceEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCC---CcceEeeEEe-eCCccEEEEecCCC
Q 009340          221 SRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHR---HIVKLLGCCL-ETEVPVLVYEYISS  296 (537)
Q Consensus       221 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~---niv~l~g~~~-~~~~~~lV~e~~~~  296 (537)
                      .+.++.|....||+.    |..+++|.-..  ......+.+|..+|+.+.+.   .+.+++.++. ..+..++||||+++
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G   97 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG   97 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence            356788888899987    46688888532  34456788999999999653   3566777764 34567899999999


Q ss_pred             CChhh
Q 009340          297 GTLSH  301 (537)
Q Consensus       297 gsL~~  301 (537)
                      .+|.+
T Consensus        98 ~~l~~  102 (306)
T 3tdw_A           98 QILGE  102 (306)
T ss_dssp             EECHH
T ss_pred             eECch
Confidence            88865

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.41  E-value=1.7e-06  Score=83.33  Aligned_cols=134  Identities=16%  Similarity=0.136  Sum_probs=93.4

Q ss_pred             ccCcCCce-EEEEEEcC-CCCEEEEEEccCCChHHHHHHHHHHHHHHhcC-CCCcceEeeEEeeCCccEEEEecCCCCCh
Q 009340          223 FLGQGGFG-TVYKGMLP-DGSIVAVKRSKEIDKTQIHQFINEVVILSQIN-HRHIVKLLGCCLETEVPVLVYEYISSGTL  299 (537)
Q Consensus       223 ~lg~G~~g-~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~~gsL  299 (537)
                      .+..|..| .||+.... ++..+.+|+....   ....+.+|...|+.+. +--+.++++++.+.+..++|||++++.++
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~  107 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA  107 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence            34445544 68987754 4667999987642   3456788999998884 44477889999999999999999999888


Q ss_pred             hhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhc------------------------------------
Q 009340          300 SHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSS------------------------------------  343 (537)
Q Consensus       300 ~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~------------------------------------  343 (537)
                      .+.......                ....++.++++.|.-||..                                    
T Consensus       108 ~~~~~~~~~----------------~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (272)
T 4gkh_A          108 FQVLEEYPD----------------SGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDER  171 (272)
T ss_dssp             HHHHHHCGG----------------GHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGG
T ss_pred             cccccCCHH----------------HHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccc
Confidence            765432111                1223444444555555531                                    


Q ss_pred             -------------------CCCCeeecCCCCCCEEECCCCcEEEeeccCcc
Q 009340          344 -------------------ASIPIFHRDIKSSNILLDDKFSAKVSDFGISR  375 (537)
Q Consensus       344 -------------------~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~  375 (537)
                                         ..+.++|+|+.+.|||+++++.+-|.||+.+.
T Consensus       172 ~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          172 NGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             TTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                               11237999999999999988777799998775

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.19  E-value=2.5e-06  Score=85.76  Aligned_cols=81  Identities=4%  Similarity=-0.016  Sum_probs=56.3

Q ss_pred             cccc-CcCCceEEEEEEcC-------CCCEEEEEEccCCC---hHHHHHHHHHHHHHHhcC-C--CCcceEeeEEeeC--
Q 009340          221 SRFL-GQGGFGTVYKGMLP-------DGSIVAVKRSKEID---KTQIHQFINEVVILSQIN-H--RHIVKLLGCCLET--  284 (537)
Q Consensus       221 ~~~l-g~G~~g~Vy~~~~~-------~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-H--~niv~l~g~~~~~--  284 (537)
                      .+.| +.|....+|+....       ++..+++|......   ......+.+|+.+++.+. +  -.+.++++++.+.  
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            3567 88888999988764       26678899765421   001134667888888884 3  3577888887665  


Q ss_pred             -CccEEEEecCCCCChhh
Q 009340          285 -EVPVLVYEYISSGTLSH  301 (537)
Q Consensus       285 -~~~~lV~e~~~~gsL~~  301 (537)
                       +..++||||+++.++.+
T Consensus       105 ~g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          105 LGTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             TSSCEEEEECCCCBCCCB
T ss_pred             cCCceEEEEecCCCChhh
Confidence             35689999999877764

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.02  E-value=3.3e-05  Score=76.78  Aligned_cols=149  Identities=14%  Similarity=0.157  Sum_probs=80.1

Q ss_pred             cccCcCCceEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHHHHhcCC--CCcceEee------EEeeCCccEEEEec
Q 009340          222 RFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINH--RHIVKLLG------CCLETEVPVLVYEY  293 (537)
Q Consensus       222 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~g------~~~~~~~~~lV~e~  293 (537)
                      +.|+.|..+.||+....+| .+++|+.... .   .++..|..++..+..  -.+.+++.      +....+..+++|+|
T Consensus        38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~-~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~  112 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP-E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW  112 (346)
T ss_dssp             EECC----CEEEEEEETTE-EEEEEEECSC-H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred             eeccccccCcEEEEEeCCC-CEEEEecCCC-H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence            4566677889999887655 4889988752 2   223345555555431  13344443      12245667899999


Q ss_pred             CCCCChhh--------------hhhhhhhhHH-HHhh-hccCCCCHHHHH------------------------------
Q 009340          294 ISSGTLSH--------------HIHDHQQQQE-QKQK-QELSSLSWENRV------------------------------  327 (537)
Q Consensus       294 ~~~gsL~~--------------~l~~~~~~~~-~~~~-~~~~~l~~~~~~------------------------------  327 (537)
                      +++.++..              .+|....... .... .....-.|...+                              
T Consensus       113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  192 (346)
T 2q83_A          113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI  192 (346)
T ss_dssp             CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred             ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence            99876531              1111100000 0000 000012342211                              


Q ss_pred             -HHHHHHHHHHHHHhh----------cCCCCeeecCCCCCCEEECCCCcEEEeeccCcc
Q 009340          328 -RVACEVAGAVAYMHS----------SASIPIFHRDIKSSNILLDDKFSAKVSDFGISR  375 (537)
Q Consensus       328 -~i~~~ia~gl~yLH~----------~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~  375 (537)
                       .+...+.+++.+|+.          .....++|+|+++.|||++.++.+.|.||+.+.
T Consensus       193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence             111223446667763          123459999999999999888899999999764

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.92  E-value=5.6e-05  Score=73.40  Aligned_cols=80  Identities=16%  Similarity=0.154  Sum_probs=58.2

Q ss_pred             CCccccccCcCCceEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCC---CcceEeeEEeeCCccEEEEec
Q 009340          217 NYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHR---HIVKLLGCCLETEVPVLVYEY  293 (537)
Q Consensus       217 ~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~---niv~l~g~~~~~~~~~lV~e~  293 (537)
                      .....+.+|.|..+.||+..+.||+.|.+|+...........|..|...|+.+.-.   -+.+++++    +..++||||
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e~   91 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAMEW   91 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEEC
T ss_pred             CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEEe
Confidence            34456779999999999999999999999987654333334577899999888422   34455554    234899999


Q ss_pred             CCCCChh
Q 009340          294 ISSGTLS  300 (537)
Q Consensus       294 ~~~gsL~  300 (537)
                      ++.+...
T Consensus        92 l~~~~~~   98 (288)
T 3f7w_A           92 VDERPPT   98 (288)
T ss_dssp             CCCCCCC
T ss_pred             ecccCCC
Confidence            9887654

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.91  E-value=3.1e-05  Score=79.03  Aligned_cols=75  Identities=20%  Similarity=0.232  Sum_probs=49.7

Q ss_pred             ccccCcCCceEEEEEEcC-CCCEEEEEEccCCCh-------HHHHHHHHHHHHHHhcCC--CC-cceEeeEEeeCCccEE
Q 009340          221 SRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDK-------TQIHQFINEVVILSQINH--RH-IVKLLGCCLETEVPVL  289 (537)
Q Consensus       221 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~H--~n-iv~l~g~~~~~~~~~l  289 (537)
                      .+.||.|.++.||++... +++.++||.......       .....+..|.++++.+..  +. +.+++.+  +.+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            457999999999999754 468899997643211       112456778888888742  33 4456544  4556789


Q ss_pred             EEecCCCC
Q 009340          290 VYEYISSG  297 (537)
Q Consensus       290 V~e~~~~g  297 (537)
                      ||||+++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999764

>2l9y_A CVNH-LYSM lectin; carbohydrate, sugar binding protein; NMR {Magnaporthe oryzae 70-15}

Probab=97.84  E-value=8.1e-07  Score=78.55  Aligned_cols=74  Identities=11%  Similarity=-0.038  Sum_probs=53.3

Q ss_pred             cccHHHHhhCCC-CCCCCCCCCceeeecccccCCCCccccchhhhhhhhhcccccchhhhHhhhcCChHHHHHhhc
Q 009340           10 LTTCQALLGQNY-FDAPNITIGAQVMIPLRCACPTANQIDKGVSYLLAYMAAKGDTISSIGYKFGVDQQSILEANM   84 (537)
Q Consensus        10 l~t~~~l~~~N~-~~~~~i~~g~~l~vp~~c~c~~~~~~~~~~~~~~~y~v~~gdtl~~ia~~f~~~~~~l~~~n~   84 (537)
                      -+++.+|+++|. .+++.|+|||+|+||..-.-+.... ......-..|+|+.||+|++||++||.++.....+|.
T Consensus        81 ~~~~~~l~~~N~~~~~~~i~~Gq~L~ip~~~~~~~~~~-~~~~~~~~~~~v~~GdtL~aIA~r~G~~v~s~i~Ln~  155 (167)
T 2l9y_A           81 DCDFHEIARRNNIQNEDLIYPGQVLQVPTKGGSGGGAG-NFWDSARDVRLVDGGKVLEAELRYSGGWNRSRIYLDE  155 (167)
T ss_dssp             TCCHHHHHHHHTCCGGGCCCTTEEEEESCCCCCSSSSC-CGGGGEEEEEEETTTTEEEEEEEETTEEEEEEECGGG
T ss_pred             CCCHHHHHHHcCCCCcccccCCCEEEEcCCCCcccccc-ccccccceEEEeCCcCChHHHHHHcCCceEEEEEccc
Confidence            689999999995 5678999999999997533211100 0011112369999999999999999988877666664

>4a1k_A Putative L, D-transpeptidase YKUD; transferase, peptidoglycan synthesis; HET: CME; 1.75A {Bacillus subtilis} PDB: 4a1j_A 4a1i_A* 1y7m_A 3zqd_A 4a52_A*

Probab=97.50  E-value=2.5e-05  Score=68.98  Aligned_cols=46  Identities=28%  Similarity=0.509  Sum_probs=38.9

Q ss_pred             hhhhhcccccchhhhHhhhcCChHHHHHhhccCCCCcccccccccCC
Q 009340           54 LLAYMAAKGDTISSIGYKFGVDQQSILEANMLSKADSIFPFAPLLIP  100 (537)
Q Consensus        54 ~~~y~v~~gdtl~~ia~~f~~~~~~l~~~n~~~~~~~i~~~~~l~vp  100 (537)
                      +++|+|++||||+.||++|+++...|+++|+... ..+.+|+.+.+|
T Consensus         2 ~~~y~V~~GdtL~~IA~~f~~g~~~l~~aNp~vd-~~l~~g~~i~ip   47 (165)
T 4a1k_A            2 MLTYQVKQGDTLNSIAADFRISTAALLQANPSLQ-AGLTAGQSIVIP   47 (165)
T ss_dssp             CEEEECCTTCCHHHHHHHTTCCHHHHHHHCGGGG-GCCCTTCEEEET
T ss_pred             CEEEEECCCCCHHHHHHHhCCCHHHHHHhCccCC-CccCCCccccCc
Confidence            4689999999999999999999999999997533 335678888877

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.48  E-value=0.0021  Score=62.93  Aligned_cols=76  Identities=14%  Similarity=0.068  Sum_probs=60.9

Q ss_pred             ccccCcCCceEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHHHHhcC---CCCcceEeeEEeeCCccEEEEecCCCC
Q 009340          221 SRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQIN---HRHIVKLLGCCLETEVPVLVYEYISSG  297 (537)
Q Consensus       221 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV~e~~~~g  297 (537)
                      .+.|+.|....+|+... ++..+++|.....   ....|..|...|+.+.   ...+.++++++...+..++||||+++.
T Consensus        41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~  116 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS  116 (312)
T ss_dssp             EEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred             eEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence            45789999999999887 4677889987642   2456788999998884   356888999988878899999999988


Q ss_pred             Chh
Q 009340          298 TLS  300 (537)
Q Consensus       298 sL~  300 (537)
                      .+.
T Consensus       117 ~~~  119 (312)
T 3jr1_A          117 KNK  119 (312)
T ss_dssp             CCC
T ss_pred             CCC
Confidence            763

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.47  E-value=0.00046  Score=70.81  Aligned_cols=78  Identities=10%  Similarity=0.104  Sum_probs=47.6

Q ss_pred             CCCeeecCCCCCCEEECCCCcEEEeeccCccccCCCCCceeeec-cccccccCcccccCC---CCCcchhHHHHHHHHHH
Q 009340          345 SIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTI-QGTFGYLDPEYFQSS---QFTDKSDVYSFGVVLLE  420 (537)
Q Consensus       345 ~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~---~~t~ksDV~S~Gvll~e  420 (537)
                      .+.++|||+++.|||++.++ ++|.||+.+..-..... ..... .-...|++|+.....   .-....++.+....+|+
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~D-la~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFD-IGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN  308 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHH-HHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHH-HHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence            34499999999999999876 99999998864321100 00000 012346676655321   11223556678888888


Q ss_pred             HHhC
Q 009340          421 LLTG  424 (537)
Q Consensus       421 l~tg  424 (537)
                      .+++
T Consensus       309 ~y~~  312 (420)
T 2pyw_A          309 LFNK  312 (420)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            7765

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.34  E-value=0.00028  Score=69.47  Aligned_cols=168  Identities=13%  Similarity=0.135  Sum_probs=89.9

Q ss_pred             ccCHHHHHHHhcCCcc-----ccccCcCCceEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCC--cceE
Q 009340          205 VFTADELQRATDNYNQ-----SRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRH--IVKL  277 (537)
Q Consensus       205 ~~~~~el~~~~~~~~~-----~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l  277 (537)
                      .++.+++......|..     .+.|+.|....+|+....+| .+++|.....  ...+.+..|+.++..+...+  +.++
T Consensus         6 ~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~   82 (322)
T 2ppq_A            6 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLP   82 (322)
T ss_dssp             CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred             cCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcc
Confidence            3666777777766754     23466788889999887666 5788987652  11234456777777774222  3333


Q ss_pred             eeE------EeeCCccEEEEecCCCCChhhh--------------hhhhhhhHHHHhhhccCCCCHHHHHH---------
Q 009340          278 LGC------CLETEVPVLVYEYISSGTLSHH--------------IHDHQQQQEQKQKQELSSLSWENRVR---------  328 (537)
Q Consensus       278 ~g~------~~~~~~~~lV~e~~~~gsL~~~--------------l~~~~~~~~~~~~~~~~~l~~~~~~~---------  328 (537)
                      +..      ....+..+++++|+++..+...              +|..................|...+.         
T Consensus        83 ~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~  162 (322)
T 2ppq_A           83 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV  162 (322)
T ss_dssp             CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred             cCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhh
Confidence            321      1223456899999998664321              11100000000000000012322111         


Q ss_pred             ---HHHHHHHHHHHHhhc----CCCCeeecCCCCCCEEECCCCcEEEeeccCcc
Q 009340          329 ---VACEVAGAVAYMHSS----ASIPIFHRDIKSSNILLDDKFSAKVSDFGISR  375 (537)
Q Consensus       329 ---i~~~ia~gl~yLH~~----~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~  375 (537)
                         +...+.+.+..++..    ....++|+|+.+.|||++++..+.|.||+.+.
T Consensus       163 ~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          163 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence               011244455555532    23348999999999999987666899998764

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.27  E-value=0.0025  Score=62.69  Aligned_cols=95  Identities=13%  Similarity=0.018  Sum_probs=58.8

Q ss_pred             ccccCHHHHHHHhcCCcc-----ccccCcCCceEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCC--Ccc
Q 009340          203 AKVFTADELQRATDNYNQ-----SRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHR--HIV  275 (537)
Q Consensus       203 ~~~~~~~el~~~~~~~~~-----~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~--niv  275 (537)
                      ...++.+++......|..     ...++ |....||+....+|+.+++|....... ....+..|..++..+...  .+.
T Consensus         8 ~~~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~-~~~~~~~E~~~~~~L~~~g~~vp   85 (328)
T 1zyl_A            8 FQTLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVA   85 (328)
T ss_dssp             CCCCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBC
T ss_pred             CCCCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCCC-CHHHHHHHHHHHHHHHHcCCeec
Confidence            344666666666555532     23466 777899998877787899999863211 234556688888777422  244


Q ss_pred             eEeeE-----EeeCCccEEEEecCCCCCh
Q 009340          276 KLLGC-----CLETEVPVLVYEYISSGTL  299 (537)
Q Consensus       276 ~l~g~-----~~~~~~~~lV~e~~~~gsL  299 (537)
                      +++..     ....+..+++|+|+++.++
T Consensus        86 ~~~~~~g~~~~~~~g~~~~l~~~i~G~~~  114 (328)
T 1zyl_A           86 APVAFNGQTLLNHQGFYFAVFPSVGGRQF  114 (328)
T ss_dssp             CCCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred             ceeecCCcEEEEECCEEEEEEEecCCCCC
Confidence            44443     1123455789999987654

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.22  E-value=0.0019  Score=63.78  Aligned_cols=150  Identities=14%  Similarity=0.088  Sum_probs=75.4

Q ss_pred             cccCcCCceE-EEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHHHHhcCC--CCcceEeeEEeeCCccEEEEecCCCCC
Q 009340          222 RFLGQGGFGT-VYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINH--RHIVKLLGCCLETEVPVLVYEYISSGT  298 (537)
Q Consensus       222 ~~lg~G~~g~-Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lV~e~~~~gs  298 (537)
                      +.|+.|+... +|+....+|..+++|.......   ..+..|+.++..+..  -.+.+++.+..+  .-+++||++.+.+
T Consensus        24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~--~g~ll~e~l~~~~   98 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHA--RGLLLIEDLGDAL   98 (333)
T ss_dssp             CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETT--TTEEEECCCCSCB
T ss_pred             eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCC--CCEEEEeeCCCcc
Confidence            3465555444 6677654467788886544221   223456666666632  235567766433  3378999998777


Q ss_pred             hhhhhhhhhhh--HHHH---------hhh---ccCCCCHHHHH--------------------HHHHHHHHHHHHHh---
Q 009340          299 LSHHIHDHQQQ--QEQK---------QKQ---ELSSLSWENRV--------------------RVACEVAGAVAYMH---  341 (537)
Q Consensus       299 L~~~l~~~~~~--~~~~---------~~~---~~~~l~~~~~~--------------------~i~~~ia~gl~yLH---  341 (537)
                      +.+++......  ....         ...   ....++.....                    .....+.+.+..+.   
T Consensus        99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~  178 (333)
T 3csv_A           99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ  178 (333)
T ss_dssp             HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence            77665432210  0000         000   00111111000                    00011112222221   


Q ss_pred             hcCCCCeeecCCCCCCEEECCC----CcEEEeeccCccc
Q 009340          342 SSASIPIFHRDIKSSNILLDDK----FSAKVSDFGISRS  376 (537)
Q Consensus       342 ~~~~~~ivH~Dlk~~NIll~~~----~~~ki~Dfgla~~  376 (537)
                      ......++|||+.+.||+++.+    ..+.|.||+.+..
T Consensus       179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            1223459999999999999874    6899999998764

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.14  E-value=0.0011  Score=64.48  Aligned_cols=72  Identities=17%  Similarity=0.129  Sum_probs=44.7

Q ss_pred             ccccCcCCceEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCc-ceEeeEEeeCCccEEEEecC-CCCC
Q 009340          221 SRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHI-VKLLGCCLETEVPVLVYEYI-SSGT  298 (537)
Q Consensus       221 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~e~~-~~gs  298 (537)
                      .+.|+.|....+|+.     ..+++|........ .....+|+.+++.+...++ .++++++  .+.-++++||+ ++.+
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~   94 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQT   94 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEE
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCcc
Confidence            567888999999998     45888877542111 1122457777777743333 4566543  34457999999 5555


Q ss_pred             hh
Q 009340          299 LS  300 (537)
Q Consensus       299 L~  300 (537)
                      |.
T Consensus        95 l~   96 (301)
T 3dxq_A           95 MS   96 (301)
T ss_dssp             CC
T ss_pred             CC
Confidence            53

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.10  E-value=0.00089  Score=68.88  Aligned_cols=74  Identities=23%  Similarity=0.264  Sum_probs=50.2

Q ss_pred             ccccCcCCceEEEEEEcCC--------CCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCc-ceEeeEEeeCCccEEEE
Q 009340          221 SRFLGQGGFGTVYKGMLPD--------GSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHI-VKLLGCCLETEVPVLVY  291 (537)
Q Consensus       221 ~~~lg~G~~g~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~  291 (537)
                      .+.|+.|....+|+....+        +..+.+|+......  ...+.+|..++..+...++ .++++.+.+    .+|+
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~  151 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET--ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  151 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC--HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc--HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence            3567888889999998653        47899998744211  1455579988888853333 567776532    3899


Q ss_pred             ecCCCCChh
Q 009340          292 EYISSGTLS  300 (537)
Q Consensus       292 e~~~~gsL~  300 (537)
                      ||+++.+|.
T Consensus       152 e~l~G~~l~  160 (429)
T 1nw1_A          152 EYIPSRPLS  160 (429)
T ss_dssp             CCCCEEECC
T ss_pred             EEeCCcccC
Confidence            999865553

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.01  E-value=0.002  Score=64.89  Aligned_cols=149  Identities=18%  Similarity=0.212  Sum_probs=82.4

Q ss_pred             cccCcCCceEEEEEEcC--------CCCEEEEEEccCCChHHHHHHHHHHHHHHhcC-CCCcceEeeEEeeCCccEEEEe
Q 009340          222 RFLGQGGFGTVYKGMLP--------DGSIVAVKRSKEIDKTQIHQFINEVVILSQIN-HRHIVKLLGCCLETEVPVLVYE  292 (537)
Q Consensus       222 ~~lg~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e  292 (537)
                      +.|..|-...+|+....        +++.+.+|+..... .......+|..+++.+. +.-..++++++.+    .+|+|
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~-~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e  130 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL-QGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ  130 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc-chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence            45666777888998864        24789999864321 22445668999998884 3223567766643    39999


Q ss_pred             cCCCCChhhh-hhhh-----hhhHHHHhhh----ccCCCC--HHHHHHHHHHHHH-------------------HHHHHh
Q 009340          293 YISSGTLSHH-IHDH-----QQQQEQKQKQ----ELSSLS--WENRVRVACEVAG-------------------AVAYMH  341 (537)
Q Consensus       293 ~~~~gsL~~~-l~~~-----~~~~~~~~~~----~~~~l~--~~~~~~i~~~ia~-------------------gl~yLH  341 (537)
                      |+++.+|..- +...     ..........    ......  |.+..++..++..                   .+..|.
T Consensus       131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~  210 (379)
T 3feg_A          131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR  210 (379)
T ss_dssp             CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred             EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence            9998666421 1110     0000000000    011122  4455555443321                   233332


Q ss_pred             ----hc-CCCCeeecCCCCCCEEECCC----CcEEEeeccCcc
Q 009340          342 ----SS-ASIPIFHRDIKSSNILLDDK----FSAKVSDFGISR  375 (537)
Q Consensus       342 ----~~-~~~~ivH~Dlk~~NIll~~~----~~~ki~Dfgla~  375 (537)
                          .. ....++|+|+.+.||+++.+    +.+.|.||..+.
T Consensus       211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence                22 22348999999999999876    789999998875

>2gu1_A Zinc peptidase; alpha/beta, beta barrel, structural genomics, PSI, protein structure initiative; 1.90A {Vibrio cholerae}

Probab=97.01  E-value=0.00011  Score=73.63  Aligned_cols=92  Identities=13%  Similarity=0.064  Sum_probs=63.3

Q ss_pred             ccHHHHhhCCCCC-----CCCCCCCceeeecccccCCC--------Cc------cc-cc----------hhhhhhhhhcc
Q 009340           11 TTCQALLGQNYFD-----APNITIGAQVMIPLRCACPT--------AN------QI-DK----------GVSYLLAYMAA   60 (537)
Q Consensus        11 ~t~~~l~~~N~~~-----~~~i~~g~~l~vp~~c~c~~--------~~------~~-~~----------~~~~~~~y~v~   60 (537)
                      ++.++|.++|..+     .+.|.+||+|.||..-.-..        ..      .. ++          ......+|.|+
T Consensus        27 vs~~~l~~~n~~~~~~~~~~~L~~Gq~L~i~~~~~~~l~~l~~~~~~~~~~~~~~~~~g~f~~~~~~~~~~~~~~~~~v~  106 (361)
T 2gu1_A           27 VPYSILQKILSVDLDHLQLDMIQPGEELELMMDDMGQLSRLIYHMSIVEKAIYTRENDGSFSYDFQEISGEWREILFSGE  106 (361)
T ss_dssp             CCHHHHHHHHHHGGGTCCGGGCCTTCEEEEEECTTSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECCCEEEEEEEEEE
T ss_pred             CCHHHHHHHHhhcccccchhcCCCCCEEEEEECCCCcceEEEEEcCccceEEEEecCCCcceeeecccCceEEEEEEEEE
Confidence            7888888887433     56899999999996421000        00      00 00          00012358889


Q ss_pred             cccchhhhHhhhcCChHHHHHhhccCCC-----CcccccccccCCcC
Q 009340           61 KGDTISSIGYKFGVDQQSILEANMLSKA-----DSIFPFAPLLIPLK  102 (537)
Q Consensus        61 ~gdtl~~ia~~f~~~~~~l~~~n~~~~~-----~~i~~~~~l~vp~~  102 (537)
                      .||||++||++||+++..|+++|++.+.     ..|.+|+.+.++..
T Consensus       107 igdSL~~iA~~~Gvs~~~i~~ln~i~~~~idf~~~Lr~GD~l~V~~~  153 (361)
T 2gu1_A          107 INGSFSVSARRVGLTSSQVANITQVMKDKIDFSRSLRAGDRFDILVK  153 (361)
T ss_dssp             SSSCHHHHHHHTTCCHHHHHHHHHHHTTTCCTTTCCCC-CEEEEEEE
T ss_pred             ECCcHHHHHHHcCCCHHHHHHHHHhhcccccccccCCCCCEEEEEEE
Confidence            9999999999999999999999987432     35889988888764

>2gu1_A Zinc peptidase; alpha/beta, beta barrel, structural genomics, PSI, protein structure initiative; 1.90A {Vibrio cholerae}

Probab=96.93  E-value=0.00019  Score=71.98  Aligned_cols=48  Identities=27%  Similarity=0.315  Sum_probs=43.0

Q ss_pred             hhhhcccccchhhhHhhhcCChHHHHHhhccCC----CCcccccccccCCcC
Q 009340           55 LAYMAAKGDTISSIGYKFGVDQQSILEANMLSK----ADSIFPFAPLLIPLK  102 (537)
Q Consensus        55 ~~y~v~~gdtl~~ia~~f~~~~~~l~~~n~~~~----~~~i~~~~~l~vp~~  102 (537)
                      .+|+|++||||++||++||+++.+|.++|++..    .+.|.+|+.+.+|..
T Consensus         8 ~~~~Vk~GDTL~~Ia~r~gvs~~~l~~~n~~~~~~~~~~~L~~Gq~L~i~~~   59 (361)
T 2gu1_A            8 IHYMVKVGDTLSGIFAQLGVPYSILQKILSVDLDHLQLDMIQPGEELELMMD   59 (361)
T ss_dssp             EEEECCTTCCHHHHHHHTTCCHHHHHHHHHHGGGTCCGGGCCTTCEEEEEEC
T ss_pred             eEEEECCCCcHHHHHHHcCCCHHHHHHHHhhcccccchhcCCCCCEEEEEEC
Confidence            369999999999999999999999999998743    468999999999975

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.81  E-value=0.005  Score=63.70  Aligned_cols=75  Identities=12%  Similarity=0.002  Sum_probs=47.7

Q ss_pred             ccccCcCCceEEEEEEcCC-CCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCc-ceEeeEEeeCCccEEEEecCCCCC
Q 009340          221 SRFLGQGGFGTVYKGMLPD-GSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHI-VKLLGCCLETEVPVLVYEYISSGT  298 (537)
Q Consensus       221 ~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~e~~~~gs  298 (537)
                      .+.|+.|-...+|+....+ +..+++|+........ -...+|..++..+...++ .++++++.  +  .+|+||+++.+
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~  187 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA  187 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence            3568888889999998764 4678888764321110 011478888888865444 56777763  2  35999998755


Q ss_pred             hh
Q 009340          299 LS  300 (537)
Q Consensus       299 L~  300 (537)
                      |.
T Consensus       188 l~  189 (458)
T 2qg7_A          188 LS  189 (458)
T ss_dssp             CC
T ss_pred             CC
Confidence            53

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=96.72  E-value=0.01  Score=54.16  Aligned_cols=103  Identities=13%  Similarity=0.065  Sum_probs=66.7

Q ss_pred             CChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCccc
Q 009340          297 GTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS  376 (537)
Q Consensus       297 gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~  376 (537)
                      -||.+.|....           .+++++++|.++.|.+++|.-+-....+  ..+=+.|..|++..+|.+.+.+ ..+. 
T Consensus        33 vSL~eIL~~~~-----------~PlsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~~dG~V~f~~-~~s~-   97 (229)
T 2yle_A           33 LSLEEILRLYN-----------QPINEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVWRDGAVTLAP-AADD-   97 (229)
T ss_dssp             EEHHHHHHHHT-----------SCCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEETTSCEEECC-C----
T ss_pred             ccHHHHHHHcC-----------CCcCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEecCCceeccc-cccc-
Confidence            37888887653           4899999999999999998776221111  1223456899999999988774 1111 


Q ss_pred             cCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCC
Q 009340          377 IPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP  427 (537)
Q Consensus       377 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p  427 (537)
                                  .....+.|||... ...+.+.-|||+|+++|.-+--..|
T Consensus        98 ------------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~  135 (229)
T 2yle_A           98 ------------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK  135 (229)
T ss_dssp             ---------------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             ------------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence                        1123466888763 3456899999999999998864333

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.63  E-value=0.0038  Score=62.61  Aligned_cols=73  Identities=12%  Similarity=0.114  Sum_probs=43.7

Q ss_pred             cccCcCCceEEEEEEcCC---------CCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCC-cceEeeEEeeCCccEEEE
Q 009340          222 RFLGQGGFGTVYKGMLPD---------GSIVAVKRSKEIDKTQIHQFINEVVILSQINHRH-IVKLLGCCLETEVPVLVY  291 (537)
Q Consensus       222 ~~lg~G~~g~Vy~~~~~~---------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~lV~  291 (537)
                      +.|+.|....+|+....+         +..+++|....... .......|..+++.+...+ ..++++..    .-++||
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~----~~~~v~  113 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF----NGGRIE  113 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec----CCcEEE
Confidence            457777778899988653         26788887654221 1112356888888775334 34666544    237899


Q ss_pred             ecCCCCCh
Q 009340          292 EYISSGTL  299 (537)
Q Consensus       292 e~~~~gsL  299 (537)
                      ||+++.++
T Consensus       114 e~i~G~~l  121 (369)
T 3c5i_A          114 EWLYGDPL  121 (369)
T ss_dssp             ECCCSEEC
T ss_pred             EEecCCcC
Confidence            99987554

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.50  E-value=0.012  Score=58.31  Aligned_cols=67  Identities=9%  Similarity=0.069  Sum_probs=42.8

Q ss_pred             cCCceEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHHHHhcC---CCCcceEeeE------EeeCCccEEEEecCCC
Q 009340          226 QGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQIN---HRHIVKLLGC------CLETEVPVLVYEYISS  296 (537)
Q Consensus       226 ~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~------~~~~~~~~lV~e~~~~  296 (537)
                      .|....||+....+| .+++|+......      ..|+..+..+.   -+.+.+++..      ....+..+++|+|+++
T Consensus        33 ~g~~N~vy~v~~~~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G  105 (339)
T 3i1a_A           33 ADTNAFAYQADSESK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHA  105 (339)
T ss_dssp             SCSSCEEEEEECSSC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCC
T ss_pred             CccccceEEEEeCCC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCC
Confidence            333678999988777 899998765432      24555665552   1224555432      2234567899999998


Q ss_pred             CCh
Q 009340          297 GTL  299 (537)
Q Consensus       297 gsL  299 (537)
                      ..+
T Consensus       106 ~~~  108 (339)
T 3i1a_A          106 PNG  108 (339)
T ss_dssp             CBT
T ss_pred             CcC
Confidence            766

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=94.44  E-value=0.18  Score=51.39  Aligned_cols=75  Identities=7%  Similarity=0.024  Sum_probs=47.6

Q ss_pred             ccccCcCCceEEEEEEcCC--------CCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCC-cceEeeEEeeCCccEEEE
Q 009340          221 SRFLGQGGFGTVYKGMLPD--------GSIVAVKRSKEIDKTQIHQFINEVVILSQINHRH-IVKLLGCCLETEVPVLVY  291 (537)
Q Consensus       221 ~~~lg~G~~g~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~lV~  291 (537)
                      .+.+..|-...+|+....+        +..+++|+....... .-...+|..+++.+.-.+ ..++++.+.    -++|+
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~  149 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADFP----EGRIE  149 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence            3467777788899988753        578999986542211 112246888887774323 455665432    37899


Q ss_pred             ecCCCCChh
Q 009340          292 EYISSGTLS  300 (537)
Q Consensus       292 e~~~~gsL~  300 (537)
                      ||+++.+|.
T Consensus       150 efI~G~~l~  158 (424)
T 3mes_A          150 EFIDGEPLT  158 (424)
T ss_dssp             ECCCSEECC
T ss_pred             EEeCCccCC
Confidence            999987653

>1e0g_A Membrane-bound lytic murein transglycosylase D; cell WALL, hydrolase, glycosidase, lipoprotein, outer membrane, multigene family; NMR {Escherichia coli} SCOP: d.7.1.1

Probab=92.23  E-value=0.047  Score=36.61  Aligned_cols=27  Identities=15%  Similarity=0.229  Sum_probs=23.9

Q ss_pred             cccHHHHhhCCCCCCCCCCCCceeeecc
Q 009340           10 LTTCQALLGQNYFDAPNITIGAQVMIPL   37 (537)
Q Consensus        10 l~t~~~l~~~N~~~~~~i~~g~~l~vp~   37 (537)
                      -+++++|+++|. +++.|++||+|.||+
T Consensus        21 ~~~~~~l~~~N~-~~~~l~~G~~l~ip~   47 (48)
T 1e0g_A           21 GVNIKDVMRWNS-DTANLQPGDKLTLFV   47 (48)
T ss_dssp             TCCHHHHHHHCS-CGGGCCTTEEEECCC
T ss_pred             CcCHHHHHHhCC-CCCcCCcCCEEEEec
Confidence            357999999999 888899999999995

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=91.65  E-value=0.66  Score=46.74  Aligned_cols=28  Identities=36%  Similarity=0.495  Sum_probs=24.3

Q ss_pred             eeecCCCCCCEEE------CCCCcEEEeeccCcc
Q 009340          348 IFHRDIKSSNILL------DDKFSAKVSDFGISR  375 (537)
Q Consensus       348 ivH~Dlk~~NIll------~~~~~~ki~Dfgla~  375 (537)
                      ++|+|+.+.|||+      +++..+.++||.+|.
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~  279 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS  279 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence            5799999999999      456789999998875

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=86.98  E-value=0.089  Score=54.34  Aligned_cols=60  Identities=7%  Similarity=0.072  Sum_probs=18.2

Q ss_pred             ccccCcCCceEEEEEEcCC-CCEEEE------EEccCC--ChHHHHHHHHHHHHHHhcCCCCcceEeeEEee
Q 009340          221 SRFLGQGGFGTVYKGMLPD-GSIVAV------KRSKEI--DKTQIHQFINEVVILSQINHRHIVKLLGCCLE  283 (537)
Q Consensus       221 ~~~lg~G~~g~Vy~~~~~~-g~~vav------K~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~  283 (537)
                      .+.||   ||.||+|.+.. ..+|||      |..+..  ..+....|.+|..++...+|+|+++..++...
T Consensus       147 ~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~  215 (463)
T 3cxl_A          147 YEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH  215 (463)
T ss_dssp             TTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred             cccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence            45676   99999999864 357899      766542  23345678899999999999999999888754

>2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A

Probab=86.26  E-value=0.56  Score=30.57  Aligned_cols=14  Identities=29%  Similarity=0.043  Sum_probs=7.3

Q ss_pred             HHHHHHHHHHhhhh
Q 009340          160 VVGCYLYRFFKDKR  173 (537)
Q Consensus       160 ~~~~~~~~~~~~~r  173 (537)
                      ++.+++++.++.++
T Consensus        29 l~~~~~~RRR~~~~   42 (44)
T 2jwa_A           29 VVFGILIKRRQQKI   42 (44)
T ss_dssp             HHHHHHHHHHCSCC
T ss_pred             HHHHhheehhhhhc
Confidence            33444556666553

>3slu_A M23 peptidase domain protein; outer membrane, hydrolase; 2.41A {Neisseria meningitidis}

Probab=85.95  E-value=0.25  Score=49.09  Aligned_cols=49  Identities=8%  Similarity=0.095  Sum_probs=40.3

Q ss_pred             hhhhhcccccchhhhHhhhcCChHHHHHhhccC----CCCcccccccccCCcC
Q 009340           54 LLAYMAAKGDTISSIGYKFGVDQQSILEANMLS----KADSIFPFAPLLIPLK  102 (537)
Q Consensus        54 ~~~y~v~~gdtl~~ia~~f~~~~~~l~~~n~~~----~~~~i~~~~~l~vp~~  102 (537)
                      -.+|+|++||||++|-+++|++..++.+++...    ....+.||+++.+.+.
T Consensus        14 W~~~~V~~GDTL~~IL~r~Gls~~di~~i~~~~~~~~~l~~LrpGq~l~i~~~   66 (371)
T 3slu_A           14 WVQEAVQPGDSLADVLARSGMARDEIARITEKYGGEADLRHLRADQSVHVLVG   66 (371)
T ss_dssp             EEEEECCTTCCHHHHHHHTTCCHHHHHHHHTTC------CCBCSSSEEEEEEC
T ss_pred             eEEEEECCCCcHHHHHHHcCCCHHHHHHHHHhccccCchhhCCCCCEEEEEEC
Confidence            457999999999999999999999998887542    3467999999988765

>2djp_A Hypothetical protein SB145; LYSM, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens}

Probab=85.51  E-value=0.35  Score=36.04  Aligned_cols=29  Identities=17%  Similarity=0.220  Sum_probs=24.9

Q ss_pred             cccHHHHhhCCCC-CCCCCCCCceeeeccc
Q 009340           10 LTTCQALLGQNYF-DAPNITIGAQVMIPLR   38 (537)
Q Consensus        10 l~t~~~l~~~N~~-~~~~i~~g~~l~vp~~   38 (537)
                      -+++++|+++|.+ +++.|++||+|.||..
T Consensus        34 ~~~~~~l~~~N~l~~~~~l~~Gq~l~iP~~   63 (77)
T 2djp_A           34 GVTMEQIKRANRLYTNDSIFLKKTLYIPIL   63 (77)
T ss_dssp             TCCHHHHHHHHTCCCSSCGGGSSCEEEEEE
T ss_pred             CcCHHHHHHHcCCCCccccCCCCEEEECCC
Confidence            3789999999965 4678999999999974

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=84.22  E-value=2.5  Score=38.39  Aligned_cols=113  Identities=14%  Similarity=0.133  Sum_probs=74.9

Q ss_pred             CCCCcceEeeEEeeCCccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHH-HHhhcCCCCe
Q 009340          270 NHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVA-YMHSSASIPI  348 (537)
Q Consensus       270 ~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~-yLH~~~~~~i  348 (537)
                      .||.+  -..+-.+++...+.|+--+++.=...+               ..++...+++++..++.... +++.     -
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i---------------~~~~~~eKlrll~nl~~L~~~~~~~-----r  105 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI---------------RKTTLLSRIRAAIHLVSKVKHHSAR-----R  105 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH---------------HTSCHHHHHHHHHHHHHHHSSCCSS-----S
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH---------------HhcCHHHHHHHHHHHHHHHHHhhhC-----c
Confidence            57777  344445666666666655443222222               24888999999999887666 5544     4


Q ss_pred             eecCCCCCCEEECCCCcEEEeeccCccccCCCCCceeeeccccccccCcccccCCCCCcchhH-HHHHHHHHHHHhCCCC
Q 009340          349 FHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDV-YSFGVVLLELLTGKKP  427 (537)
Q Consensus       349 vH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV-~S~Gvll~el~tg~~p  427 (537)
                      +|--|.|+||++|.++.++|.-.|+-..+                  +|.-+     + ..|. -++=+++..++.++..
T Consensus       106 ~tf~l~P~NL~f~~~~~p~i~hRGi~~~l------------------pP~e~-----~-ee~fl~qyKali~all~~K~~  161 (219)
T 4ano_A          106 LIFIVCPENLMFNRALEPFFLHVGVKESL------------------PPDEW-----D-DERLLREVKATVLALTEGEYR  161 (219)
T ss_dssp             EECCCCGGGEEECTTCCEEESCCEETTTB------------------SSCSC-----C-HHHHHHHHHHHHHHHTTCSSC
T ss_pred             eeEEEeCceEEEeCCCcEEEEEcCCcccC------------------CCCCC-----C-HHHHHHHHHHHHHHHHcCCCC
Confidence            58889999999999999999988765432                  22211     1 2233 3677788888888877


Q ss_pred             C
Q 009340          428 I  428 (537)
Q Consensus       428 ~  428 (537)
                      |
T Consensus       162 F  162 (219)
T 4ano_A          162 F  162 (219)
T ss_dssp             H
T ss_pred             H
Confidence            5

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=83.65  E-value=1.7  Score=39.44  Aligned_cols=116  Identities=5%  Similarity=0.080  Sum_probs=77.6

Q ss_pred             CCCCcceEeeEEeeCCccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCee
Q 009340          270 NHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIF  349 (537)
Q Consensus       270 ~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iv  349 (537)
                      .||+++.. .+-.+.+...+.|+.-+  +...|-.             ...++...+++++..|+....++++     =+
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~--~~~~f~~-------------ik~~~~~eKlr~l~ni~~l~~~~~~-----r~  101 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDIND--NHTPFDN-------------IKSFTKNEKLRYLLNIKNLEEVNRT-----RY  101 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCT--TSEEGGG-------------GGGSCHHHHHHHHHHGGGGGGGGGS-----SE
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCc--ccCCHHH-------------HHhcCHHHHHHHHHHHHHHHHHhcC-----ce
Confidence            57888866 45555565555555433  2322221             2248889999999999988766654     35


Q ss_pred             ecCCCCCCEEECCCCcEEEeeccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 009340          350 HRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPIC  429 (537)
Q Consensus       350 H~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~  429 (537)
                      |--|.|+||++|.++.++|.-.|+-..++                  |.     ..+...=.-.+=+++..+++++..|.
T Consensus       102 tf~L~P~NL~f~~~~~p~i~~RGik~~l~------------------P~-----~~~ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          102 TFVLAPDELFFTRDGLPIAKTRGLQNVVD------------------PL-----PVSEAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             ECCCSGGGEEECTTSCEEESCCEETTTBS------------------CC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             EEEEecceEEEcCCCCEEEEEccCccCCC------------------CC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            88899999999999999999887654321                  21     11222223467788889999988864

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	537
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	4e-76
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	7e-70
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-69
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	3e-69
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	5e-67
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	5e-66
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	7e-66
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	3e-65
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	6e-65
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	8e-65
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	1e-64
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-64
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	7e-64
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	4e-63
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	6e-63
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	1e-62
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	1e-61
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	1e-61
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-61
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-61
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	3e-61
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	6e-61
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	7e-61
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	1e-60
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-60
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-60
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	5e-59
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-58
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-56
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	3e-56
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	5e-56
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-55
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-55
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-53
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	1e-52
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	1e-52
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	3e-52
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-51
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-49
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	5e-49
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	6e-49
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	1e-48
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	1e-47
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	4e-47
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	6e-47
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	1e-46
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	7e-46
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-45
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	4e-45
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	6e-45
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	6e-45
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	1e-44
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-42
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-42
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	7e-42
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-40
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	3e-40
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-38
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-37
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	9e-36
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	3e-35
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	8e-31
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-20
d1e0ga_	48	d.7.1.1 (A:) Membrane-bound lytic murein transclyc	3e-05
d1y7ma2	48	d.7.1.1 (A:1-48) Hypothetical protein YkuD, N-term	2e-04

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  239 bits (611), Expect = 4e-76
 Identities = 76/299 (25%), Positives = 128/299 (42%), Gaps = 30/299 (10%)

Query: 209 DELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQ 268
           D+ +         + +G G FGTVYKG       V +         Q+  F NEV +L +
Sbjct: 1   DDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRK 60

Query: 269 INHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVR 328
             H +I+  +G     ++  +V ++    +L HH+H  +           +       + 
Sbjct: 61  TRHVNILLFMGYSTAPQL-AIVTQWCEGSSLYHHLHIIE-----------TKFEMIKLID 108

Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPN-DKTHLTTT 387
           +A + A  + Y+H+     I HRD+KS+NI L +  + K+ DFG++        +H    
Sbjct: 109 IARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ 165

Query: 388 IQGTFGYLDPEYFQSSQ---FTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFI 444
           + G+  ++ PE  +      ++ +SDVY+FG+VL EL+TG+ P          N     I
Sbjct: 166 LSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPY------SNINNRDQII 219

Query: 445 SLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRS 503
            +     L   L      + R     AM  L   CL+    +RP   Q+   +E L RS
Sbjct: 220 FMVGRGYLSPDLS-----KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  223 bits (568), Expect = 7e-70
 Identities = 66/288 (22%), Positives = 125/288 (43%), Gaps = 30/288 (10%)

Query: 216 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIV 275
                 + +G G FG V+ G   +   VA+K  +E        FI E  ++ +++H  +V
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLV 63

Query: 276 KLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAG 335
           +L G CLE     LV+E++  G LS ++   +              + E  + +  +V  
Sbjct: 64  QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLF-----------AAETLLGMCLDVCE 112

Query: 336 AVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYL 395
            +AY+  +    + HRD+ + N L+ +    KVSDFG++R + +D+   +T  +    + 
Sbjct: 113 GMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA 169

Query: 396 DPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEI 455
            PE F  S+++ KSDV+SFGV++ E+ +  K     R   E               ++E 
Sbjct: 170 SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---------------VVED 214

Query: 456 LDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRS 503
           +               + ++   C +   + RP   ++  +L  +  S
Sbjct: 215 ISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  222 bits (566), Expect = 2e-69
 Identities = 63/283 (22%), Positives = 121/283 (42%), Gaps = 30/283 (10%)

Query: 216 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIV 275
           +       LG G FG V+ G     + VAVK  K+        F+ E  ++ Q+ H+ +V
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLV 71

Query: 276 KLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAG 335
           +L     +  +  ++ EY+ +G+L   +      +          L+    + +A ++A 
Sbjct: 72  RLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIK----------LTINKLLDMAAQIAE 120

Query: 336 AVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYL 395
            +A++         HRD++++NIL+ D  S K++DFG++R I +++       +    + 
Sbjct: 121 GMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWT 177

Query: 396 DPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEI 455
            PE      FT KSDV+SFG++L E++T  +         E               +++ 
Sbjct: 178 APEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---------------VIQN 222

Query: 456 LDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELE 498
           L+        +     + +L   C +   + RPT   +   LE
Sbjct: 223 LERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  223 bits (569), Expect = 3e-69
 Identities = 69/312 (22%), Positives = 126/312 (40%), Gaps = 46/312 (14%)

Query: 211 LQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKR-SKEIDKTQIHQFINEVVILSQ 268
           ++   D++ +   LG G  G V+K    P G ++A K    EI     +Q I E+ +L +
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60

Query: 269 INHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVR 328
            N  +IV   G         +  E++  G+L   +    +            +  +   +
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR------------IPEQILGK 108

Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTI 388
           V+  V   + Y+     I   HRD+K SNIL++ +   K+ DFG+S  + +       + 
Sbjct: 109 VSIAVIKGLTYLREKHKI--MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA---NSF 163

Query: 389 QGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFI---- 444
            GT  Y+ PE  Q + ++ +SD++S G+ L+E+  G+ PI     +E   +  C +    
Sbjct: 164 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDA 223

Query: 445 -------------------SLAKENQLLEILDARVAKEAREEDIGAM----AELAMRCLR 481
                                     + E+LD  V +   +   G       +   +CL 
Sbjct: 224 AETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLI 283

Query: 482 LNSKKRPTMKQV 493
            N  +R  +KQ+
Sbjct: 284 KNPAERADLKQL 295

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  216 bits (551), Expect = 5e-67
 Identities = 70/297 (23%), Positives = 131/297 (44%), Gaps = 30/297 (10%)

Query: 209 DELQRATDNYNQSRFLGQGGFGTVYKGMLPD-GSIVAVKRSKEIDKTQIHQFINEVVILS 267
           D+ +    +      LG G +G VY+G+       VAVK  KE D  ++ +F+ E  ++ 
Sbjct: 10  DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMK 68

Query: 268 QINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRV 327
           +I H ++V+LLG C       ++ E+++ G L  ++ +  +Q+          +S    +
Sbjct: 69  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE----------VSAVVLL 118

Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTT 387
            +A +++ A+ Y+         HRD+ + N L+ +    KV+DFG+SR +  D       
Sbjct: 119 YMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG 175

Query: 388 IQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLA 447
            +    +  PE    ++F+ KSDV++FGV+L E+ T                        
Sbjct: 176 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS---------------PYPGI 220

Query: 448 KENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRSQ 504
             +Q+ E+L+     E  E     + EL   C + N   RP+  ++    E + +  
Sbjct: 221 DLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 277

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  214 bits (545), Expect = 5e-66
 Identities = 66/321 (20%), Positives = 135/321 (42%), Gaps = 47/321 (14%)

Query: 206 FTADELQRATDNYNQS---------RFLGQGGFGTVYKGMLP----DGSIVAVKR-SKEI 251
           FT ++   A   + +          + +G G FG V  G L         VA+K      
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 252 DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQE 311
            + Q   F++E  I+ Q +H +++ L G   ++   +++ E++ +G+L   +  +  Q  
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125

Query: 312 QKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF 371
                     +    V +   +A  + Y+     +   HRD+ + NIL++     KVSDF
Sbjct: 126 ----------TVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDF 172

Query: 372 GISRSIPNDKTHLTTT----IQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP 427
           G+SR + +D +  T T     +    +  PE  Q  +FT  SDV+S+G+V+ E+++  + 
Sbjct: 173 GLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER 232

Query: 428 ICFARVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKR 487
             +    ++               ++  ++         +   A+ +L + C + +   R
Sbjct: 233 PYWDMTNQD---------------VINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHR 277

Query: 488 PTMKQVSMELEGLRRSQRCLE 508
           P   Q+   L+ + R+   L+
Sbjct: 278 PKFGQIVNTLDKMIRNPNSLK 298

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  213 bits (543), Expect = 7e-66
 Identities = 71/298 (23%), Positives = 127/298 (42%), Gaps = 30/298 (10%)

Query: 206 FTADELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVI 265
              D  +   ++      LGQG FG V+ G     + VA+K  K         F+ E  +
Sbjct: 7   LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQV 65

Query: 266 LSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWEN 325
           + ++ H  +V+L     E  +  +V EY+S G+L   +     +  +             
Sbjct: 66  MKKLRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGETGKYLR----------LPQ 114

Query: 326 RVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLT 385
            V +A ++A  +AY+         HRD++++NIL+ +    KV+DFG++R I +++    
Sbjct: 115 LVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 171

Query: 386 TTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFIS 445
              +    +  PE     +FT KSDV+SFG++L EL T  +      V  E         
Sbjct: 172 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--------- 222

Query: 446 LAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRS 503
                 +L+ ++         E   ++ +L  +C R   ++RPT + +   LE    S
Sbjct: 223 ------VLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  212 bits (540), Expect = 3e-65
 Identities = 69/312 (22%), Positives = 128/312 (41%), Gaps = 38/312 (12%)

Query: 209 DELQRATDNYNQSRFLGQGGFGTVYKGMLP------DGSIVAVKR-SKEIDKTQIHQFIN 261
             L+   +N    R +G+G FG V++   P        ++VAVK   +E        F  
Sbjct: 6   LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQR 65

Query: 262 EVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSS- 320
           E  ++++ ++ +IVKLLG C   +   L++EY++ G L+  +                S 
Sbjct: 66  EAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLST 125

Query: 321 -----------LSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVS 369
                      LS   ++ +A +VA  +AY+         HRD+ + N L+ +    K++
Sbjct: 126 RARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIA 182

Query: 370 DFGISRSIPN-DKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPI 428
           DFG+SR+I + D             ++ PE    +++T +SDV+++GVVL E+ +     
Sbjct: 183 DFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ- 241

Query: 429 CFARVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRP 488
                         +  +A E  +  + D  +     E     +  L   C       RP
Sbjct: 242 -------------PYYGMAHEEVIYYVRDGNI-LACPENCPLELYNLMRLCWSKLPADRP 287

Query: 489 TMKQVSMELEGL 500
           +   +   L+ +
Sbjct: 288 SFCSIHRILQRM 299

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  210 bits (536), Expect = 6e-65
 Identities = 72/301 (23%), Positives = 132/301 (43%), Gaps = 37/301 (12%)

Query: 216 DNYNQSRFLGQGGFGTVYKGMLPDGS-----IVAVKR-SKEIDKTQIHQFINEVVILSQI 269
               + + +G G FG VYKGML   S      VA+K       + Q   F+ E  I+ Q 
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66

Query: 270 NHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRV 329
           +H +I++L G   + +  +++ EY+ +G L   + +   +            S    V +
Sbjct: 67  SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE-----------FSVLQLVGM 115

Query: 330 ACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPND--KTHLTTT 387
              +A  + Y+ +       HRD+ + NIL++     KVSDFG+SR + +D   T+ T+ 
Sbjct: 116 LRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSG 172

Query: 388 IQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLA 447
            +    +  PE     +FT  SDV+SFG+V+ E++T  +   +     E           
Sbjct: 173 GKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE----------- 221

Query: 448 KENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRSQRCL 507
               +++ ++         +   A+ +L M+C +    +RP    +   L+ L R+   L
Sbjct: 222 ----VMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSL 277

Query: 508 E 508
           +
Sbjct: 278 K 278

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  210 bits (535), Expect = 8e-65
 Identities = 68/285 (23%), Positives = 122/285 (42%), Gaps = 32/285 (11%)

Query: 216 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK--RSKEIDKTQIHQFINEVVILSQINHR 272
           ++Y     +G G +G   K     DG I+  K      + + +    ++EV +L ++ H 
Sbjct: 4   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63

Query: 273 HIVKLLGCCLETE--VPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVA 330
           +IV+     ++       +V EY   G L+  I    ++++         L  E  +RV 
Sbjct: 64  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQ--------YLDEEFVLRVM 115

Query: 331 CEVAGAVAYMH--SSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTI 388
            ++  A+   H  S     + HRD+K +N+ LD K + K+ DFG++R + +D T      
Sbjct: 116 TQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD-TSFAKAF 174

Query: 389 QGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAK 448
            GT  Y+ PE      + +KSD++S G +L EL     P      +E    +       +
Sbjct: 175 VGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI-------R 227

Query: 449 ENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQV 493
           E +   I   R + E          E+  R L L    RP+++++
Sbjct: 228 EGKFRRI-PYRYSDELN--------EIITRMLNLKDYHRPSVEEI 263

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  209 bits (532), Expect = 1e-64
 Identities = 66/290 (22%), Positives = 134/290 (46%), Gaps = 36/290 (12%)

Query: 216 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIV 275
                 + +G+G FG V  G    G+ VAVK  K  +      F+ E  +++Q+ H ++V
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLV 63

Query: 276 KLLGCCLETEVPV-LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVA 334
           +LLG  +E +  + +V EY++ G+L  ++    +          S L  +  ++ + +V 
Sbjct: 64  QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR----------SVLGGDCLLKFSLDVC 113

Query: 335 GAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGY 394
            A+ Y+  +      HRD+ + N+L+ +   AKVSDFG+++   +       T +    +
Sbjct: 114 EAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----QDTGKLPVKW 166

Query: 395 LDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLE 454
             PE  +  +F+ KSDV+SFG++L E+ +  +        ++       +   ++   ++
Sbjct: 167 TAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD------VVPRVEKGYKMD 220

Query: 455 ILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRSQ 504
             D             A+ E+   C  L++  RP+  Q+  +LE ++  +
Sbjct: 221 APDGCPP---------AVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 261

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  208 bits (530), Expect = 2e-64
 Identities = 62/283 (21%), Positives = 119/283 (42%), Gaps = 30/283 (10%)

Query: 216 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIV 275
            +    + LG G FG V  G       VA+K  KE       +FI E  ++  ++H  +V
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLV 62

Query: 276 KLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAG 335
           +L G C +     ++ EY+++G L +++ + + +              +  + +  +V  
Sbjct: 63  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR-----------FQTQQLLEMCKDVCE 111

Query: 336 AVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYL 395
           A+ Y+ S       HRD+ + N L++D+   KVSDFG+SR + +D+   +   +    + 
Sbjct: 112 AMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS 168

Query: 396 DPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEI 455
            PE    S+F+ KSD+++FGV++ E+ +  K         E                 E 
Sbjct: 169 PPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE---------------TAEH 213

Query: 456 LDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELE 498
           +   +           +  +   C    + +RPT K +   + 
Sbjct: 214 IAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  208 bits (531), Expect = 7e-64
 Identities = 68/300 (22%), Positives = 127/300 (42%), Gaps = 32/300 (10%)

Query: 216 DNYNQSRFLGQGGFGTVYKGML------PDGSIVAVKR-SKEIDKTQIHQFINEVVILSQ 268
           +  +  + LG G FG V +              VAVK        T+    ++E+ +LS 
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 269 I-NHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQ------KQELSSL 321
           + NH +IV LLG C      +++ EY   G L + +   +      +      + +  +L
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 322 SWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDK 381
             E+ +  + +VA  +A++ S       HRD+ + NILL      K+ DFG++R I ND 
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199

Query: 382 THLTTT-IQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLV 440
            ++     +    ++ PE   +  +T +SDV+S+G+ L EL +                 
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS------------- 246

Query: 441 ACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGL 500
             +  +  +++  +++       + E     M ++   C   +  KRPT KQ+   +E  
Sbjct: 247 -PYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (522), Expect = 4e-63
 Identities = 74/282 (26%), Positives = 119/282 (42%), Gaps = 39/282 (13%)

Query: 216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVK---RSKEIDKTQIHQFINEVVILSQINH 271
           +++   R LG+G FG VY         I+A+K   +++       HQ   EV I S + H
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 272 RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVAC 331
            +I++L G   +     L+ EY   GT+   +    +               +       
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK------------FDEQRTATYIT 113

Query: 332 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGT 391
           E+A A++Y HS     + HRDIK  N+LL      K++DFG S   P+ +     T+ GT
Sbjct: 114 ELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---TLCGT 167

Query: 392 FGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQ 451
             YL PE  +     +K D++S GV+  E L GK P       E       +  +++   
Sbjct: 168 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF------EANTYQETYKRISRVEF 221

Query: 452 LLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQV 493
                   V + AR        +L  R L+ N  +RP +++V
Sbjct: 222 ---TFPDFVTEGAR--------DLISRLLKHNPSQRPMLREV 252

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (525), Expect = 6e-63
 Identities = 80/331 (24%), Positives = 151/331 (45%), Gaps = 39/331 (11%)

Query: 193 QLSSCGSSERAKVFTADELQRATDNYNQSRFLGQGGFGTVYKGMLPDGS----IVAVKR- 247
            LS+  + E  +      +  ++   + +  +G+G FG VY G L D        AVK  
Sbjct: 5   DLSAL-NPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL 63

Query: 248 SKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETE-VPVLVYEYISSGTLSHHIHDH 306
           ++  D  ++ QF+ E +I+   +H +++ LLG CL +E  P++V  Y+  G L + I + 
Sbjct: 64  NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE 123

Query: 307 QQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA 366
                          + ++ +    +VA  + ++ S       HRD+ + N +LD+KF+ 
Sbjct: 124 THN-----------PTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTV 169

Query: 367 KVSDFGISRSIPNDK---THLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT 423
           KV+DFG++R + + +    H  T  +    ++  E  Q+ +FT KSDV+SFGV+L EL+T
Sbjct: 170 KVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 229

Query: 424 GKKPICFARVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLN 483
              P        + N     + L +  +LL+           E     + E+ ++C    
Sbjct: 230 RGAPP-----YPDVNTFDITVYLLQGRRLLQP----------EYCPDPLYEVMLKCWHPK 274

Query: 484 SKKRPTMKQVSMELEGLRRSQRCLEMCQVNQ 514
           ++ RP+  ++   +  +  +        VN 
Sbjct: 275 AEMRPSFSELVSRISAIFSTFIGEHYVHVNA 305

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (524), Expect = 1e-62
 Identities = 63/303 (20%), Positives = 135/303 (44%), Gaps = 37/303 (12%)

Query: 216 DNYNQSRFLGQGGFGTVYKGMLPDGS------IVAVKR-SKEIDKTQIHQFINEVVILSQ 268
           +N    + LG G FG V        S       VAVK   ++ D ++    ++E+ +++Q
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96

Query: 269 I-NHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQ-----------QQEQKQKQ 316
           + +H +IV LLG C  +    L++EY   G L +++   ++           Q+  ++++
Sbjct: 97  LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156

Query: 317 ELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS 376
           +L+ L++E+ +  A +VA  + ++         HRD+ + N+L+      K+ DFG++R 
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARD 213

Query: 377 IPNDKTHLT-TTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEE 435
           I +D  ++     +    ++ PE      +T KSDV+S+G++L E+ +            
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP------- 266

Query: 436 ERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM 495
                  +  +  +    +++      +        +  +   C   +S+KRP+   ++ 
Sbjct: 267 -------YPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS 319

Query: 496 ELE 498
            L 
Sbjct: 320 FLG 322

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (516), Expect = 1e-61
 Identities = 56/306 (18%), Positives = 115/306 (37%), Gaps = 38/306 (12%)

Query: 222 RFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCC 281
             +G+G FG V++G    G  VAVK     ++        E+     + H +I+  +   
Sbjct: 9   ESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSW-FREAEIYQTVMLRHENILGFIAAD 66

Query: 282 LETEVPV----LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAV 337
            +         LV +Y   G+L  +++ +             +++ E  +++A   A  +
Sbjct: 67  NKDNGTWTQLWLVSDYHEHGSLFDYLNRY-------------TVTVEGMIKLALSTASGL 113

Query: 338 AYMHSSA-----SIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHL---TTTIQ 389
           A++H           I HRD+KS NIL+    +  ++D G++    +    +        
Sbjct: 114 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV 173

Query: 390 GTFGYLDPEYFQSS------QFTDKSDVYSFGVVLLELLTGKKPICFARVEE----ERNL 439
           GT  Y+ PE    S      +   ++D+Y+ G+V  E+             +    +   
Sbjct: 174 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233

Query: 440 VACFISLAKENQLLEILDARVAKEARE-EDIGAMAELAMRCLRLNSKKRPTMKQVSMELE 498
               +   ++    + L   +    +  E +  MA++   C   N   R T  ++   L 
Sbjct: 234 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293

Query: 499 GLRRSQ 504
            L + +
Sbjct: 294 QLSQQE 299

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (513), Expect = 1e-61
 Identities = 62/278 (22%), Positives = 118/278 (42%), Gaps = 39/278 (14%)

Query: 224 LGQGGFGTVYKGMLPD-GSIVAVK--RSKEIDKTQIHQFINEVVILSQINHRHIVKLLGC 280
           +G+G F TVYKG+  +    VA    + +++ K++  +F  E  +L  + H +IV+    
Sbjct: 17  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76

Query: 281 CLET----EVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGA 336
              T    +  VLV E ++SGTL  ++   +             +  +       ++   
Sbjct: 77  WESTVKGKKCIVLVTELMTSGTLKTYLKRFKV------------MKIKVLRSWCRQILKG 124

Query: 337 VAYMHSSASIPIFHRDIKSSNILLDDK-FSAKVSDFGISRSIPNDKTHLTTTIQGTFGYL 395
           + ++H+  + PI HRD+K  NI +     S K+ D G++      +      + GT  ++
Sbjct: 125 LQFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL---KRASFAKAVIGTPEFM 180

Query: 396 DPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEI 455
            PE ++  ++ +  DVY+FG+ +LE+ T + P        E    A              
Sbjct: 181 APEMYEE-KYDESVDVYAFGMCMLEMATSEYPY------SECQNAAQIYRRVTSGVKPAS 233

Query: 456 LDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQV 493
            D     E +        E+   C+R N  +R ++K +
Sbjct: 234 FDKVAIPEVK--------EIIEGCIRQNKDERYSIKDL 263

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (515), Expect = 2e-61
 Identities = 67/299 (22%), Positives = 119/299 (39%), Gaps = 29/299 (9%)

Query: 216 DNYNQSRFLGQGGFGTVYKGMLPDGS---IVAVKR-SKEIDKTQIHQFINEVVILSQI-N 270
           ++      +G+G FG V K  +         A+KR  +   K     F  E+ +L ++ +
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 271 HRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQK----QKQELSSLSWENR 326
           H +I+ LLG C       L  EY   G L   +   +  +            S+LS +  
Sbjct: 70  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 327 VRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTT 386
           +  A +VA  + Y+         HRD+ + NIL+ + + AK++DFG+SR          T
Sbjct: 130 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK--KT 184

Query: 387 TIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISL 446
             +    ++  E    S +T  SDV+S+GV+L E+++                       
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT---------------PYCG 229

Query: 447 AKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRSQR 505
               +L E L      E        + +L  +C R    +RP+  Q+ + L  +   ++
Sbjct: 230 MTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 288

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (513), Expect = 2e-61
 Identities = 67/281 (23%), Positives = 126/281 (44%), Gaps = 34/281 (12%)

Query: 215 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRH 273
              Y +   +GQG  GTVY  M +  G  VA+++     + +    INE++++ +  + +
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 274 IVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEV 333
           IV  L   L  +   +V EY++ G+L+  + +                       V  E 
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM-------------DEGQIAAVCREC 125

Query: 334 AGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFG 393
             A+ ++HS+    + HRDIKS NILL    S K++DFG    I  +++   +T+ GT  
Sbjct: 126 LQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSTMVGTPY 181

Query: 394 YLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLL 453
           ++ PE      +  K D++S G++ +E++ G+ P               +++      L 
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP---------------YLNENPLRALY 226

Query: 454 EILDARVAKEAREEDIGAMA-ELAMRCLRLNSKKRPTMKQV 493
            I      +    E + A+  +   RCL ++ +KR + K++
Sbjct: 227 LIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKEL 267

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (512), Expect = 3e-61
 Identities = 63/285 (22%), Positives = 113/285 (39%), Gaps = 35/285 (12%)

Query: 215 TDNYNQSRFLGQGGFGTVYKGMLPD-GSIVAVKRSKEIDKTQIHQFINEVVILSQINHRH 273
            D +     LG G FG VYK    +   + A K      + ++  ++ E+ IL+  +H +
Sbjct: 11  EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70

Query: 274 IVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEV 333
           IVKLL          ++ E+ + G +   + + ++            L+      V  + 
Sbjct: 71  IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER-----------PLTESQIQVVCKQT 119

Query: 334 AGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFG 393
             A+ Y+H +    I HRD+K+ NIL       K++DFG+S            +  GT  
Sbjct: 120 LDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR-RDSFIGTPY 175

Query: 394 YLDPEYFQSSQ-----FTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAK 448
           ++ PE           +  K+DV+S G+ L+E+   + P        E N +   + +AK
Sbjct: 176 WMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPH------HELNPMRVLLKIAK 229

Query: 449 ENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQV 493
                    +R +   +        +   +CL  N   R T  Q+
Sbjct: 230 SEPPTLAQPSRWSSNFK--------DFLKKCLEKNVDARWTTSQL 266

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (509), Expect = 6e-61
 Identities = 66/286 (23%), Positives = 124/286 (43%), Gaps = 38/286 (13%)

Query: 220 QSRFLGQGGFGTVYKGMLPD---GSIVAVK--RSKEIDKTQIHQFINEVVILSQINHRHI 274
           + + LG G FGTV KG          VAVK  +++  D     + + E  ++ Q+++ +I
Sbjct: 11  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70

Query: 275 VKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVA 334
           V+++G C E E  +LV E    G L+ ++  ++             +  +N + +  +V+
Sbjct: 71  VRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRH------------VKDKNIIELVHQVS 117

Query: 335 GAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQ--GTF 392
             + Y+  S      HRD+ + N+LL  +  AK+SDFG+S+++  D+ +           
Sbjct: 118 MGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV 174

Query: 393 GYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQL 452
            +  PE     +F+ KSDV+SFGV++ E  +  +                     K +++
Sbjct: 175 KWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM---------------KGSEV 219

Query: 453 LEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELE 498
             +L+              M +L   C   + + RP    V + L 
Sbjct: 220 TAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (509), Expect = 7e-61
 Identities = 65/296 (21%), Positives = 125/296 (42%), Gaps = 37/296 (12%)

Query: 210 ELQRATDNYNQSRF-LGQGGFGTVYKGML---PDGSIVAVKR-SKEIDKTQIHQFINEVV 264
           +L    DN   +   LG G FG+V +G+         VA+K   +  +K    + + E  
Sbjct: 2   KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 61

Query: 265 ILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWE 324
           I+ Q+++ +IV+L+G C + E  +LV E    G L   +   +++           +   
Sbjct: 62  IMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE-----------IPVS 109

Query: 325 NRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHL 384
           N   +  +V+  + Y+         HRD+ + N+LL ++  AK+SDFG+S+++  D ++ 
Sbjct: 110 NVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY 166

Query: 385 T--TTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVAC 442
           T  +  +    +  PE     +F+ +SDV+S+GV + E L+  +                
Sbjct: 167 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM---------- 216

Query: 443 FISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELE 498
                K  +++  ++     E   E    +  L   C     + RP    V   + 
Sbjct: 217 -----KGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 267

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  200 bits (509), Expect = 1e-60
 Identities = 66/300 (22%), Positives = 114/300 (38%), Gaps = 45/300 (15%)

Query: 201 ERAKVFTADELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKR---SKEIDKTQI 256
           + A++F  D+       ++  R +G G FG VY    + +  +VA+K+   S +    + 
Sbjct: 3   DVAELFFKDDP---EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKW 59

Query: 257 HQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQ 316
              I EV  L ++ H + ++  GC L      LV EY             +         
Sbjct: 60  QDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK--------- 110

Query: 317 ELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS 376
               L       V       +AY+HS     + HRD+K+ NILL +    K+ DFG +  
Sbjct: 111 ---PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASI 164

Query: 377 IPNDKTHLTTTIQGTFGYLDPEYFQSS---QFTDKSDVYSFGVVLLELLTGKKPICFARV 433
           +         +  GT  ++ PE   +    Q+  K DV+S G+  +EL   K P+     
Sbjct: 165 MAP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 219

Query: 434 EEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQV 493
                 +A       +N+   +     ++  R             CL+   + RPT + +
Sbjct: 220 MSALYHIA-------QNESPALQSGHWSEYFR--------NFVDSCLQKIPQDRPTSEVL 264

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (505), Expect = 2e-60
 Identities = 67/301 (22%), Positives = 123/301 (40%), Gaps = 37/301 (12%)

Query: 210 ELQRATDNYNQSRFLGQGGFGTVYKGMLPD----GSIVAVKRSKEI-DKTQIHQFINEVV 264
           E+QR  +     R +G+G FG V++G+          VA+K  K     +   +F+ E +
Sbjct: 3   EIQR--ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 60

Query: 265 ILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWE 324
            + Q +H HIVKL+G   E  V  ++ E  + G L   +   +            SL   
Sbjct: 61  TMRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQVRKY-----------SLDLA 108

Query: 325 NRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHL 384
           + +  A +++ A+AY+ S       HRDI + N+L+      K+ DFG+SR + +   + 
Sbjct: 109 SLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK 165

Query: 385 TTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFI 444
            +  +    ++ PE     +FT  SDV+ FGV + E+L             +       I
Sbjct: 166 ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND------VI 219

Query: 445 SLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRSQ 504
              +  + L +                   L  +C   +  +RP   ++  +L  +   +
Sbjct: 220 GRIENGERLPMPP-NCPPTLY--------SLMTKCWAYDPSRRPRFTELKAQLSTILEEE 270

Query: 505 R 505
           +
Sbjct: 271 K 271

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (505), Expect = 2e-60
 Identities = 69/282 (24%), Positives = 113/282 (40%), Gaps = 33/282 (11%)

Query: 216 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKR-SKEIDKTQIHQFINEVVILSQINHRH 273
           ++++  + LG+G +G V   +       VAVK    +           E+ I   +NH +
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 274 IVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEV 333
           +VK  G   E  +  L  EY S G L   I                 +   +  R   ++
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI------------GMPEPDAQRFFHQL 112

Query: 334 AGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI-PNDKTHLTTTIQGTF 392
              V Y+H    I I HRDIK  N+LLD++ + K+SDFG++     N++  L   + GT 
Sbjct: 113 MAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 169

Query: 393 GYLDPEYFQSSQF-TDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQ 451
            Y+ PE  +  +F  +  DV+S G+VL  +L G+ P        +        S  KE +
Sbjct: 170 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ------EYSDWKEKK 223

Query: 452 LLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQV 493
                  ++              L  + L  N   R T+  +
Sbjct: 224 TYLNPWKKIDSAPL--------ALLHKILVENPSARITIPDI 257

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (499), Expect = 5e-59
 Identities = 63/332 (18%), Positives = 145/332 (43%), Gaps = 42/332 (12%)

Query: 213 RATDNYNQSRFLGQGGFGTVYKGM-LPDGS----IVAVKR-SKEIDKTQIHQFINEVVIL 266
           + T+ + + + LG G FGTVYKG+ +P+G      VA+K   +        + ++E  ++
Sbjct: 7   KETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 65

Query: 267 SQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENR 326
           + +++ H+ +LLG CL + V  L+ + +  G L  ++ +H+                +  
Sbjct: 66  ASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNI-----------GSQYL 113

Query: 327 VRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI-PNDKTHLT 385
           +    ++A  + Y+       + HRD+ + N+L+      K++DFG+++ +   +K +  
Sbjct: 114 LNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 170

Query: 386 TTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFIS 445
              +    ++  E      +T +SDV+S+GV + EL+T                      
Sbjct: 171 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK---------------PYD 215

Query: 446 LAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRSQR 505
               +++  IL+              +  + ++C  +++  RP  +++ +E   + R  +
Sbjct: 216 GIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ 275

Query: 506 CLEMCQVNQLL----ADEISLADNLMQERNLD 533
              + Q ++ +      + +    LM E ++D
Sbjct: 276 RYLVIQGDERMHLPSPTDSNFYRALMDEEDMD 307

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (494), Expect = 2e-58
 Identities = 77/306 (25%), Positives = 139/306 (45%), Gaps = 28/306 (9%)

Query: 203 AKVFTADELQRATDNYNQSRFLGQGGFGTVYKGML------PDGSIVAVKR-SKEIDKTQ 255
           A V+  DE + A +    SR LGQG FG VY+G+          + VA+K  ++     +
Sbjct: 7   ADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRE 66

Query: 256 IHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQK 315
             +F+NE  ++ + N  H+V+LLG   + +  +++ E ++ G L  ++   +        
Sbjct: 67  RIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPV 126

Query: 316 QELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISR 375
             L+  S    +++A E+A  +AY++++      HRD+ + N ++ + F+ K+ DFG++R
Sbjct: 127 --LAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 181

Query: 376 SIP-NDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVE 434
            I   D             ++ PE  +   FT  SDV+SFGVVL E+ T  +        
Sbjct: 182 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN 241

Query: 435 EERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVS 494
           E+       +    E  LL+  D              + EL   C + N K RP+  ++ 
Sbjct: 242 EQ------VLRFVMEGGLLDKPDNCPDM---------LFELMRMCWQYNPKMRPSFLEII 286

Query: 495 MELEGL 500
             ++  
Sbjct: 287 SSIKEE 292

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  190 bits (483), Expect = 2e-56
 Identities = 58/281 (20%), Positives = 110/281 (39%), Gaps = 32/281 (11%)

Query: 216 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHI 274
           D+Y+    LG G FG V++      G+  A K      ++       E+  +S + H  +
Sbjct: 26  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85

Query: 275 VKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVA 334
           V L     +    V++YE++S G L   + D   +           +S +  V    +V 
Sbjct: 86  VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK-----------MSEDEAVEYMRQVC 134

Query: 335 GAVAYMHSSASIPIFHRDIKSSNILLDDKFS--AKVSDFGISRSIPNDKTHLTTTIQGTF 392
             + +MH +      H D+K  NI+   K S   K+ DFG++  +  D         GT 
Sbjct: 135 KGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL--DPKQSVKVTTGTA 189

Query: 393 GYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQL 452
            +  PE  +       +D++S GV+   LL+G  P      +E    V      + +  +
Sbjct: 190 EFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV-----KSCDWNM 244

Query: 453 LEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQV 493
            +   + ++++ +        +   + L  +   R T+ Q 
Sbjct: 245 DDSAFSGISEDGK--------DFIRKLLLADPNTRMTIHQA 277

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (476), Expect = 3e-56
 Identities = 67/292 (22%), Positives = 111/292 (38%), Gaps = 38/292 (13%)

Query: 216 DNYNQSRFLGQGGFGTVYKGMLP----DGSIVAVKR---SKEIDKTQIHQFINEVVILSQ 268
            +      LG G FG V +G           VAVK            +  FI EV  +  
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67

Query: 269 INHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVR 328
           ++HR++++L G  L   +  +V E    G+L   +  HQ                    R
Sbjct: 68  LDHRNLIRLYGVVLTPPM-KMVTELAPLGSLLDRLRKHQ-----------GHFLLGTLSR 115

Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTH--LTT 386
            A +VA  + Y+ S       HRD+ + N+LL  +   K+ DFG+ R++P +  H  +  
Sbjct: 116 YAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE 172

Query: 387 TIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISL 446
             +  F +  PE  ++  F+  SD + FGV L E+ T  +                +I L
Sbjct: 173 HRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP--------------WIGL 218

Query: 447 AKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELE 498
                L +I          E+    +  + ++C     + RPT   +   L 
Sbjct: 219 NGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (476), Expect = 5e-56
 Identities = 59/295 (20%), Positives = 113/295 (38%), Gaps = 37/295 (12%)

Query: 212 QRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK---RSKEIDKTQIHQFINEVVILS 267
           ++  +++   + LG+G F TV     L      A+K   +   I + ++     E  ++S
Sbjct: 4   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63

Query: 268 QINHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRV 327
           +++H   VKL     + E       Y  +G L  +I                S       
Sbjct: 64  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG------------SFDETCTR 111

Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI-PNDKTHLTT 386
               E+  A+ Y+H      I HRD+K  NILL++    +++DFG ++ + P  K     
Sbjct: 112 FYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN 168

Query: 387 TIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISL 446
           +  GT  Y+ PE          SD+++ G ++ +L+ G  P               F + 
Sbjct: 169 SFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP---------------FRAG 213

Query: 447 AKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLR 501
            +     +I+      +  E+      +L  + L L++ KR   +++        
Sbjct: 214 NEYLIFQKIIKLEY--DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKA 266

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (472), Expect = 2e-55
 Identities = 67/302 (22%), Positives = 124/302 (41%), Gaps = 31/302 (10%)

Query: 216 DNYNQSRFLGQGGFGTVYKGM------LPDGSIVAVKR-SKEIDKTQIHQFINEVVILSQ 268
           D     + LG+G FG V +              VAVK   +    ++    ++E+ IL  
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 269 INHRH-IVKLLGCCLETEVPV-LVYEYISSGTLSHHIHDHQQQQEQKQKQELSS----LS 322
           I H   +V LLG C +   P+ ++ E+   G LS ++   + +    +          L+
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 323 WENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKT 382
            E+ +  + +VA  + ++ S       HRD+ + NILL +K   K+ DFG++R I  D  
Sbjct: 133 LEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189

Query: 383 HL-TTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVA 441
           ++     +    ++ PE      +T +SDV+SFGV+L E+ +                  
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-------------- 235

Query: 442 CFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLR 501
            +  +  + +    L       A +     M +  + C      +RPT  ++   L  L 
Sbjct: 236 PYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295

Query: 502 RS 503
           ++
Sbjct: 296 QA 297

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (472), Expect = 2e-55
 Identities = 72/306 (23%), Positives = 126/306 (41%), Gaps = 35/306 (11%)

Query: 210 ELQRATDNYNQSRFLGQGGFGTVYKGMLP--------DGSIVAVKR-SKEIDKTQIHQFI 260
           EL R  D     + LG+G FG V                + VAVK    +  +  +   I
Sbjct: 9   ELPR--DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLI 66

Query: 261 NEVVILSQI-NHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQ----QQQEQKQK 315
           +E+ ++  I  H++I+ LLG C +     ++ EY S G L  ++   +    +       
Sbjct: 67  SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSH 126

Query: 316 QELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISR 375
                LS ++ V  A +VA  + Y+ S       HRD+ + N+L+ +    K++DFG++R
Sbjct: 127 NPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR 183

Query: 376 SIPNDKTHLTT-TIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVE 434
            I +   +  T   +    ++ PE      +T +SDV+SFGV+L E+ T           
Sbjct: 184 DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 243

Query: 435 EERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVS 494
           EE               L ++L      +        +  +   C      +RPT KQ+ 
Sbjct: 244 EE---------------LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLV 288

Query: 495 MELEGL 500
            +L+ +
Sbjct: 289 EDLDRI 294

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  180 bits (458), Expect = 1e-53
 Identities = 69/299 (23%), Positives = 119/299 (39%), Gaps = 39/299 (13%)

Query: 215 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKR---SKEIDKTQIHQFINEVVILSQIN 270
           +D Y     LG GG   V+    L     VAVK        D +   +F  E    + +N
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 271 HRHIVKLLGCCLETE----VPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENR 326
           H  IV +            +P +V EY+   TL   +H                ++ +  
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP------------MTPKRA 113

Query: 327 VRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHL-- 384
           + V  +   A+ + H +    I HRD+K +NI++    + KV DFGI+R+I +    +  
Sbjct: 114 IEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ 170

Query: 385 TTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFI 444
           T  + GT  YL PE  +      +SDVYS G VL E+LTG+ P        +  +   + 
Sbjct: 171 TAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPF-----TGDSPVSVAYQ 225

Query: 445 SLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRP-TMKQVSMELEGLRR 502
            + ++          ++ +           + ++ L  N + R  T  ++  +L  +  
Sbjct: 226 HVREDPIPPSARHEGLSADLD--------AVVLKALAKNPENRYQTAAEMRADLVRVHN 276

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (456), Expect = 1e-52
 Identities = 60/281 (21%), Positives = 107/281 (38%), Gaps = 33/281 (11%)

Query: 216 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHI 274
           + Y  +  LG+G FG V++ +          K  K +  T       E+ IL+   HR+I
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK-VKGTDQVLVKKEISILNIARHRNI 63

Query: 275 VKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVA 334
           + L       E  V+++E+IS   +   I+    +           L+    V    +V 
Sbjct: 64  LHLHESFESMEELVMIFEFISGLDIFERINTSAFE-----------LNEREIVSYVHQVC 112

Query: 335 GAVAYMHSSASIPIFHRDIKSSNILLDDKFSA--KVSDFGISRSIPNDKTHLTTTIQGTF 392
            A+ ++HS     I H DI+  NI+   + S+  K+ +FG +R +          +    
Sbjct: 113 EALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN--FRLLFTAP 167

Query: 393 GYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQL 452
            Y  PE  Q    +  +D++S G ++  LL+G  P      ++    +     +  E   
Sbjct: 168 EYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENI-----MNAEYTF 222

Query: 453 LEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQV 493
            E     ++ EA         +   R L    K R T  + 
Sbjct: 223 DEEAFKEISIEAM--------DFVDRLLVKERKSRMTASEA 255

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  180 bits (458), Expect = 1e-52
 Identities = 62/281 (22%), Positives = 112/281 (39%), Gaps = 32/281 (11%)

Query: 216 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHI 274
           D Y+    LG G FG V++ +    G +   K          +   NE+ I++Q++H  +
Sbjct: 29  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88

Query: 275 VKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVA 334
           + L     +    VL+ E++S G L   I     +           +S    +    +  
Sbjct: 89  INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK-----------MSEAEVINYMRQAC 137

Query: 335 GAVAYMHSSASIPIFHRDIKSSNILLDDKFSA--KVSDFGISRSIPNDKTHLTTTIQGTF 392
             + +MH      I H DIK  NI+ + K ++  K+ DFG++  +  D+    TT   T 
Sbjct: 138 EGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT--ATA 192

Query: 393 GYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQL 452
            +  PE          +D+++ GV+   LL+G  P  FA  ++   L         + + 
Sbjct: 193 EFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP--FAGEDDLETLQNV---KRCDWEF 247

Query: 453 LEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQV 493
            E   + V+ EA+        +     L+   +KR T+   
Sbjct: 248 DEDAFSSVSPEAK--------DFIKNLLQKEPRKRLTVHDA 280

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  177 bits (451), Expect = 3e-52
 Identities = 60/281 (21%), Positives = 104/281 (37%), Gaps = 29/281 (10%)

Query: 215 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKR-SKEIDKTQIHQFINEVVILSQINHR 272
            D Y+    LG G F  V          +VA+K  +K+  + +     NE+ +L +I H 
Sbjct: 8   RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67

Query: 273 HIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACE 332
           +IV L           L+ + +S G L   I +                +  +  R+  +
Sbjct: 68  NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF------------YTERDASRLIFQ 115

Query: 333 VAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTF 392
           V  AV Y+H    +    +        LD+     +SDFG+S+    D   + +T  GT 
Sbjct: 116 VLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME--DPGSVLSTACGTP 173

Query: 393 GYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQL 452
           GY+ PE      ++   D +S GV+   LL G  P       +    +     L  E + 
Sbjct: 174 GYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQI-----LKAEYEF 228

Query: 453 LEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQV 493
                  ++  A+        +     +  + +KR T +Q 
Sbjct: 229 DSPYWDDISDSAK--------DFIRHLMEKDPEKRFTCEQA 261

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  174 bits (443), Expect = 2e-51
 Identities = 65/295 (22%), Positives = 115/295 (38%), Gaps = 47/295 (15%)

Query: 216 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKR---------SKEIDKTQIHQFINEVVI 265
           +NY     LG+G    V + +  P     AVK          S E  +      + EV I
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 266 LSQIN-HRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWE 324
           L +++ H +I++L           LV++ +  G L  ++ +               LS +
Sbjct: 63  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT------------LSEK 110

Query: 325 NRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHL 384
              ++   +   +  +H      I HRD+K  NILLDD  + K++DFG S  +  D    
Sbjct: 111 ETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQL--DPGEK 165

Query: 385 TTTIQGTFGYLDPEYFQSSQ------FTDKSDVYSFGVVLLELLTGKKPICFARVEEERN 438
              + GT  YL PE  + S       +  + D++S GV++  LL G  P         + 
Sbjct: 166 LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF-----WHRKQ 220

Query: 439 LVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQV 493
           ++   + ++   Q         +   +        +L  R L +  +KR T ++ 
Sbjct: 221 MLMLRMIMSGNYQFGSPEWDDYSDTVK--------DLVSRFLVVQPQKRYTAEEA 267

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (432), Expect = 2e-49
 Identities = 60/300 (20%), Positives = 113/300 (37%), Gaps = 28/300 (9%)

Query: 211 LQRATDNYNQSRFLGQGGFGTVYKG--MLPDGSIVAVK--RSKEIDKTQIHQFINEVVIL 266
           L RA   Y     +G+G +G V+K   +   G  VA+K  R +  ++      I EV +L
Sbjct: 2   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 61

Query: 267 SQI---NHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSW 323
             +    H ++V+L   C  +         +    +   +  +  +  +        +  
Sbjct: 62  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEP------GVPT 115

Query: 324 ENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTH 383
           E    +  ++   + ++HS     + HRD+K  NIL+      K++DFG++R        
Sbjct: 116 ETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL 172

Query: 384 LTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACF 443
             T++  T  Y  PE    S +    D++S G +  E+   K     +   ++   +   
Sbjct: 173 --TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDV 230

Query: 444 ISLAKENQLLEILD---------ARVAKEAREEDIGAMA-ELAMRCLRLNSKKRPTMKQV 493
           I L  E      +          +    E    DI  +  +L ++CL  N  KR +    
Sbjct: 231 IGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  169 bits (430), Expect = 5e-49
 Identities = 67/285 (23%), Positives = 117/285 (41%), Gaps = 40/285 (14%)

Query: 216 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK---RSKEIDKTQIHQFINEVVILSQINH 271
            ++   R LG G FG V+      +G   A+K   +   +   Q+    +E ++LS + H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 272 RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVAC 331
             I+++ G   + +   ++ +YI  G L   +   Q+      K              A 
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAK------------FYAA 111

Query: 332 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGT 391
           EV  A+ Y+HS     I +RD+K  NILLD     K++DFG ++ +P+       T+ GT
Sbjct: 112 EVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT----YTLCGT 164

Query: 392 FGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQ 451
             Y+ PE   +  +    D +SFG+++ E+L G  P               F        
Sbjct: 165 PDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP---------------FYDSNTMKT 209

Query: 452 LLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSME 496
             +IL+A +       +   + +L  R +  +  +R    Q   E
Sbjct: 210 YEKILNAELRFPPFFNE--DVKDLLSRLITRDLSQRLGNLQNGTE 252

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  168 bits (427), Expect = 6e-49
 Identities = 58/292 (19%), Positives = 109/292 (37%), Gaps = 29/292 (9%)

Query: 216 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVK--RSKEIDKTQIHQFINEVVILSQINHRH 273
           + Y+    +G+G +G VYK     G   A+K  R ++ D+      I E+ IL ++ H +
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61

Query: 274 IVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEV 333
           IVKL       +  VLV+E++                          L          ++
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG------------LESVTAKSFLLQL 109

Query: 334 AGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFG 393
              +AY H      + HRD+K  N+L++ +   K++DFG++R+        T  I   + 
Sbjct: 110 LNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWY 166

Query: 394 YLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP------------ICFARVEEERNLVA 441
                   S +++   D++S G +  E++ G               I             
Sbjct: 167 RAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWP 226

Query: 442 CFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQV 493
               L K +    + +    +   +    +  +L  + L+L+  +R T KQ 
Sbjct: 227 NVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  170 bits (431), Expect = 1e-48
 Identities = 61/289 (21%), Positives = 117/289 (40%), Gaps = 40/289 (13%)

Query: 216 DNYNQSRFLGQGGFGTVYKGMLPD-GSIVAVKR------SKEIDKTQIHQFINEVVILSQ 268
           ++++  R +G+GGFG VY     D G + A+K         +  +T        + ++S 
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 269 INHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVR 328
            +   IV +       +    + + ++ G L +H+  H    E             +   
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSE------------ADMRF 111

Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTI 388
            A E+   + +MH+     + +RD+K +NILLD+    ++SD G++      K H +   
Sbjct: 112 YAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS--- 165

Query: 389 QGTFGYLDPEYFQSSQ-FTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLA 447
            GT GY+ PE  Q    +   +D +S G +L +LL G  P    + +++  +    +++A
Sbjct: 166 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA 225

Query: 448 KENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSME 496
            E      L    + E R         L    L+ +  +R        +
Sbjct: 226 VE------LPDSFSPELR--------SLLEGLLQRDVNRRLGCLGRGAQ 260

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (422), Expect = 1e-47
 Identities = 60/298 (20%), Positives = 117/298 (39%), Gaps = 31/298 (10%)

Query: 215 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKR-SKEIDKTQIHQFINEVVILSQINHR 272
              Y    ++G+G +G V       +   VA+K+ S    +T   + + E+ IL +  H 
Sbjct: 7   GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66

Query: 273 HIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACE 332
           +I+ +        +  +   Y+ +  +   ++   + Q          LS ++      +
Sbjct: 67  NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ---------HLSNDHICYFLYQ 117

Query: 333 VAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLT--TTIQG 390
           +   + Y+HS+    + HRD+K SN+LL+     K+ DFG++R    D  H    T    
Sbjct: 118 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 174

Query: 391 TFGYLDPEYFQSSQFTDKS-DVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKE 449
           T  Y  PE   +S+   KS D++S G +L E+L+ +         ++ N +   +    +
Sbjct: 175 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 234

Query: 450 NQLLEILDARVAKEAREEDIG--------------AMAELAMRCLRLNSKKRPTMKQV 493
             L  I++ +                            +L  + L  N  KR  ++Q 
Sbjct: 235 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (415), Expect = 4e-47
 Identities = 52/293 (17%), Positives = 104/293 (35%), Gaps = 29/293 (9%)

Query: 216 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK--RSKEIDKTQIHQFINEVVILSQINHR 272
           +N+ +   +G+G +G VYK      G +VA+K  R     +      I E+ +L ++NH 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61

Query: 273 HIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACE 332
           +IVKLL          LV+E++                          +          +
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALT-----------GIPLPLIKSYLFQ 110

Query: 333 VAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTF 392
           +   +A+ HS     + HRD+K  N+L++ + + K++DFG++R+        T  +   +
Sbjct: 111 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLW 167

Query: 393 GYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP------------ICFARVEEERNLV 440
                       ++   D++S G +  E++T +              I       +  + 
Sbjct: 168 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVW 227

Query: 441 ACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQV 493
               S+            +   +           L  + L  +  KR + K  
Sbjct: 228 PGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (415), Expect = 6e-47
 Identities = 63/282 (22%), Positives = 110/282 (39%), Gaps = 38/282 (13%)

Query: 216 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK---RSKEIDKTQIHQFINEVVILS-QIN 270
           +++   + LG+G FG V+           A+K   +   +    +   + E  +LS    
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 271 HRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVA 330
           H  +  +       E    V EY++ G L +HI    +                     A
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK------------FDLSRATFYA 109

Query: 331 CEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQG 390
            E+   + ++HS     I +RD+K  NILLD     K++DFG+ +         T T  G
Sbjct: 110 AEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK-TNTFCG 165

Query: 391 TFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKEN 450
           T  Y+ PE     ++    D +SFGV+L E+L G+ P         ++    F S+  +N
Sbjct: 166 TPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF------HGQDEEELFHSIRMDN 219

Query: 451 QLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQ 492
                    + KEA+        +L ++      +KR  ++ 
Sbjct: 220 ---PFYPRWLEKEAK--------DLLVKLFVREPEKRLGVRG 250

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (411), Expect = 1e-46
 Identities = 67/289 (23%), Positives = 108/289 (37%), Gaps = 41/289 (14%)

Query: 216 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKR------SKEIDKTQIHQFINEVVILSQ 268
           D Y+    LG G F  V K      G   A K                     EV IL +
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69

Query: 269 INHRHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVR 328
           I H +++ L          +L+ E ++ G L   + + +            SL+ E    
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE------------SLTEEEATE 117

Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD----KFSAKVSDFGISRSIPNDKTHL 384
              ++   V Y+HS   + I H D+K  NI+L D    K   K+ DFG++  I  D  + 
Sbjct: 118 FLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNE 172

Query: 385 TTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFI 444
              I GT  ++ PE         ++D++S GV+   LL+G  P      +E    V    
Sbjct: 173 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV---- 228

Query: 445 SLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQV 493
             A   +  +   +  +  A+        +   R L  + KKR T++  
Sbjct: 229 -SAVNYEFEDEYFSNTSALAK--------DFIRRLLVKDPKKRMTIQDS 268

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  160 bits (406), Expect = 7e-46
 Identities = 60/303 (19%), Positives = 101/303 (33%), Gaps = 37/303 (12%)

Query: 213 RATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINH 271
           R  + Y   R +G G FG +Y G  +  G  VA+K   E  KT+  Q   E  I   +  
Sbjct: 4   RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIK--LECVKTKHPQLHIESKIYKMMQG 61

Query: 272 RHIVKLLG-CCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVA 330
              +  +  C  E +  V+V E +            ++             S +  + +A
Sbjct: 62  GVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK------------FSLKTVLLLA 109

Query: 331 CEVAGAVAYMHSSASIPIFHRDIKSSNIL---LDDKFSAKVSDFGISRSIPNDKTH---- 383
            ++   + Y+HS       HRD+K  N L           + DFG+++   + +TH    
Sbjct: 110 DQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIP 166

Query: 384 --LTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVA 441
                 + GT  Y         + + + D+ S G VL+    G  P    +   +R    
Sbjct: 167 YRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYE 226

Query: 442 CFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLR 501
                 K +  +E+L      E               C  L    +P    +      L 
Sbjct: 227 RISE-KKMSTPIEVLCKGYPSEFA--------TYLNFCRSLRFDDKPDYSYLRQLFRNLF 277

Query: 502 RSQ 504
             Q
Sbjct: 278 HRQ 280

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (402), Expect = 2e-45
 Identities = 47/294 (15%), Positives = 103/294 (35%), Gaps = 31/294 (10%)

Query: 216 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK--RSKEIDKTQIHQFINEVVILSQINHR 272
             Y +   +G+G +GTV+K        IVA+K  R  + D+      + E+ +L ++ H+
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 273 HIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACE 332
           +IV+L       +   LV+E+       +    +                 E       +
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLD------------PEIVKSFLFQ 109

Query: 333 VAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTF 392
           +   + + HS     + HRD+K  N+L++     K+++FG++R+        +  +   +
Sbjct: 110 LLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLW 166

Query: 393 GYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEE-------------RNL 439
                  F +  ++   D++S G +  EL    +P+      ++                
Sbjct: 167 YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQ 226

Query: 440 VACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQV 493
                 L                    +      +L    L+ N  +R + ++ 
Sbjct: 227 WPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (399), Expect = 4e-45
 Identities = 67/289 (23%), Positives = 112/289 (38%), Gaps = 51/289 (17%)

Query: 216 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKR------SKEIDKTQIHQFINEVVILSQ 268
             Y     LG GGFG+VY G+ + D   VA+K       S   +     +   EVV+L +
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63

Query: 269 INHRH--IVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENR 326
           ++     +++LL      +  VL+ E              +            +L  E  
Sbjct: 64  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG-----------ALQEELA 112

Query: 327 VRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD-DKFSAKVSDFGISRSIPNDKTHLT 385
                +V  AV + H+     + HRDIK  NIL+D ++   K+ DFG    + +      
Sbjct: 113 RSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---Y 166

Query: 386 TTIQGTFGYLDPEYFQSSQFTDKS-DVYSFGVVLLELLTGKKPICFARVEEERNLVACFI 444
           T   GT  Y  PE+ +  ++  +S  V+S G++L +++ G  P               F 
Sbjct: 167 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP---------------FE 211

Query: 445 SLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQV 493
              +  +       RV+ E +         L   CL L    RPT +++
Sbjct: 212 HDEEIIRGQVFFRQRVSSECQ--------HLIRWCLALRPSDRPTFEEI 252

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (404), Expect = 6e-45
 Identities = 68/298 (22%), Positives = 114/298 (38%), Gaps = 37/298 (12%)

Query: 216 DNYNQSRFLGQGGFGTVYKGMLPD-GSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHI 274
            +Y  ++ +G G FG VY+  L D G +VA+K+  +  +        E+ I+ +++H +I
Sbjct: 20  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNI 75

Query: 275 VKLLGCCLETEVP------VLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVR 328
           V+L      +          LV +Y+         H  + +Q         +L       
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ---------TLPVIYVKL 126

Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLD-DKFSAKVSDFGISRSIPNDKTHLTTT 387
              ++  ++AY+HS     I HRDIK  N+LLD D    K+ DFG ++ +   + +  + 
Sbjct: 127 YMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN-VSY 182

Query: 388 IQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP------------ICFARVEE 435
           I   +       F ++ +T   DV+S G VL ELL G+              I       
Sbjct: 183 ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTP 242

Query: 436 ERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQV 493
            R  +        E +  +I      K  R         L  R L      R T  + 
Sbjct: 243 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (400), Expect = 6e-45
 Identities = 58/290 (20%), Positives = 105/290 (36%), Gaps = 34/290 (11%)

Query: 222 RFLGQGGFGTVYKGM-LPDGSIVAVKRSK-----EIDKTQIHQFINEVVILSQINHRHIV 275
            FLG+G F TVYK        IVA+K+ K     E         + E+ +L +++H +I+
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 276 KLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAG 335
            LL          LV++++ +        +               L+  +          
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLV------------LTPSHIKAYMLMTLQ 111

Query: 336 AVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYL 395
            + Y+H      I HRD+K +N+LLD+    K++DFG+++S  +     T  +  T  Y 
Sbjct: 112 GLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWYR 167

Query: 396 DPEYFQSSQFTD-KSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLE 454
            PE    ++      D+++ G +L ELL     +      ++   +   +    E Q  +
Sbjct: 168 APELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPD 227

Query: 455 ILDARVAKEAREEDIGAMAE-----------LAMRCLRLNSKKRPTMKQV 493
           +         +      +             L       N   R T  Q 
Sbjct: 228 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (400), Expect = 1e-44
 Identities = 60/288 (20%), Positives = 107/288 (37%), Gaps = 39/288 (13%)

Query: 216 DNYN-QSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQFINEVVILSQI-NHR 272
           D+Y   S+ LG G  G V +          A+K  ++  K        EV +  +     
Sbjct: 11  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-----ARREVELHWRASQCP 65

Query: 273 HIVKLLGCC----LETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVR 328
           HIV+++          +  ++V E +  G L   I D   Q          + +      
Sbjct: 66  HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ----------AFTEREASE 115

Query: 329 VACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF---SAKVSDFGISRSIPNDKTHLT 385
           +   +  A+ Y+HS     I HRD+K  N+L   K      K++DFG ++   +  +   
Sbjct: 116 IMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL-- 170

Query: 386 TTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFIS 445
           TT   T  Y+ PE     ++    D++S GV++  LL G  P            +   I 
Sbjct: 171 TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI- 229

Query: 446 LAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQV 493
              + +      + V++E +         L    L+    +R T+ + 
Sbjct: 230 RMGQYEFPNPEWSEVSEEVK--------MLIRNLLKTEPTQRMTITEF 269

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (383), Expect = 2e-42
 Identities = 57/311 (18%), Positives = 112/311 (36%), Gaps = 45/311 (14%)

Query: 213 RATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK--RSKEIDKTQIHQFINEVVILSQI 269
                Y +   +GQG FG V+K      G  VA+K    +   +      + E+ IL  +
Sbjct: 7   DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL 66

Query: 270 NHRHIVKLLGCCLETEVPV--------LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSL 321
            H ++V L+  C     P         LV+++          +   +             
Sbjct: 67  KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK------------F 114

Query: 322 SWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDK 381
           +     RV   +   + Y+H      I HRD+K++N+L+      K++DFG++R+    K
Sbjct: 115 TLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAK 171

Query: 382 T---HLTTTIQGTFGYLDPEYFQSSQ-FTDKSDVYSFGVVLLELLTGKKPICFARVEEER 437
               +  T    T  Y  PE     + +    D++  G ++ E+ T    +     + + 
Sbjct: 172 NSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQL 231

Query: 438 NLVACFI--------------SLAKENQLLEILDARVAKEAREEDIGAMA-ELAMRCLRL 482
            L++                  L ++ +L++    +V    +       A +L  + L L
Sbjct: 232 ALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVL 291

Query: 483 NSKKRPTMKQV 493
           +  +R      
Sbjct: 292 DPAQRIDSDDA 302

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (384), Expect = 2e-42
 Identities = 65/285 (22%), Positives = 112/285 (39%), Gaps = 37/285 (12%)

Query: 216 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK---RSKEIDKTQIHQFINEVVILSQINH 271
           ++++  + LG+G FG V        G   A+K   +   I K ++   + E  +L    H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 272 RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVAC 331
             +  L       +    V EY + G L  H+   +              + E       
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV------------FTEERARFYGA 112

Query: 332 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGT 391
           E+  A+ Y+HS     + +RDIK  N++LD     K++DFG+ +   +D      T  GT
Sbjct: 113 EIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKTFCGT 168

Query: 392 FGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQ 451
             YL PE  + + +    D +  GVV+ E++ G+ P  F   + ER      + L +E +
Sbjct: 169 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDHERLF---ELILMEEIR 223

Query: 452 LLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSME 496
               L      EA+         L    L+ + K+R        +
Sbjct: 224 FPRTLS----PEAK--------SLLAGLLKKDPKQRLGGGPSDAK 256

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  149 bits (378), Expect = 7e-42
 Identities = 52/306 (16%), Positives = 95/306 (31%), Gaps = 39/306 (12%)

Query: 216 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHR-H 273
            +Y   R +G+G FG +++G  L +   VA+K      ++   Q  +E      +     
Sbjct: 5   VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR--RSDAPQLRDEYRTYKLLAGCTG 62

Query: 274 IVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEV 333
           I  +     E    VLV + +            ++             S +     A ++
Sbjct: 63  IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRK------------FSVKTVAMAAKQM 110

Query: 334 AGAVAYMHSSASIPIFHRDIKSSNILLDDKFS-----AKVSDFGISRSIPNDKT------ 382
              V  +H      + +RDIK  N L+    S       V DFG+ +   +  T      
Sbjct: 111 LARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPY 167

Query: 383 HLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVAC 442
                + GT  Y+        + + + D+ + G V +  L G  P    +    +     
Sbjct: 168 REKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYE- 226

Query: 443 FISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRR 502
            I   K++  L  L A   +E          +       L     P    +      +  
Sbjct: 227 RIGEKKQSTPLRELCAGFPEE--------FYKYMHYARNLAFDATPDYDYLQGLFSKVLE 278

Query: 503 SQRCLE 508
                E
Sbjct: 279 RLNTTE 284

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (371), Expect = 2e-40
 Identities = 54/315 (17%), Positives = 120/315 (38%), Gaps = 47/315 (14%)

Query: 206 FTADELQRAT----DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK--RSKEIDKTQIHQ 258
           F   E+ +        Y   + +G G +G V   +    G+ VA+K        +    +
Sbjct: 4   FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63

Query: 259 FINEVVILSQINHRHIVKLLGCCLETEVP------VLVYEYISSGTLSHHIHDHQQQQEQ 312
              E+ +L  + H +++ LL      E         LV  ++  GT    +  H++    
Sbjct: 64  AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEK---- 117

Query: 313 KQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG 372
                   L  +    +  ++   + Y+H++    I HRD+K  N+ +++    K+ DFG
Sbjct: 118 --------LGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFG 166

Query: 373 ISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP----- 427
           ++R   +    +T  +   +           ++T   D++S G ++ E++TGK       
Sbjct: 167 LARQADS---EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD 223

Query: 428 ---ICFARVEEERNLVACFISLAKENQLLEILDARVAKEARE-----EDIGAMA-ELAMR 478
                   ++      A F+   + ++    +      E ++      +   +A  L  +
Sbjct: 224 HLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEK 283

Query: 479 CLRLNSKKRPTMKQV 493
            L L++++R T  + 
Sbjct: 284 MLVLDAEQRVTAGEA 298

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  147 bits (371), Expect = 3e-40
 Identities = 59/285 (20%), Positives = 114/285 (40%), Gaps = 40/285 (14%)

Query: 216 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK---RSKEIDKTQIHQFINEVVILSQINH 271
           D +++ + LG G FG V        G+  A+K   + K +   QI   +NE  IL  +N 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 272 RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVAC 331
             +VKL     +     +V EY++ G +  H+    +             S  +    A 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR------------FSEPHARFYAA 148

Query: 332 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGT 391
           ++     Y+H   S+ + +RD+K  N+L+D +   +V+DFG ++ +         T+ GT
Sbjct: 149 QIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT----WTLCGT 201

Query: 392 FGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQ 451
              L PE   S  +    D ++ GV++ E+  G  P      ++   +    +S      
Sbjct: 202 PEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF---FADQPIQIYEKIVSGKVR-- 256

Query: 452 LLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSME 496
                 +  + + +        +L    L+++  KR    +  + 
Sbjct: 257 ----FPSHFSSDLK--------DLLRNLLQVDLTKRFGNLKNGVN 289

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  141 bits (356), Expect = 2e-38
 Identities = 52/305 (17%), Positives = 117/305 (38%), Gaps = 50/305 (16%)

Query: 216 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQFINEVVILSQIN-HRH 273
           D+Y   R LG+G +  V++ + + +   V VK    +   +  +   E+ IL  +    +
Sbjct: 35  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKI---LKPVKKKKIKREIKILENLRGGPN 91

Query: 274 IVKLLGCCLE--TEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVAC 331
           I+ L     +  +  P LV+E++++                       +L+  +      
Sbjct: 92  IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ---------------TLTDYDIRFYMY 136

Query: 332 EVAGAVAYMHSSASIPIFHRDIKSSNILLD-DKFSAKVSDFGISRSIPNDKTHLTTTIQG 390
           E+  A+ Y HS   + I HRD+K  N+++D +    ++ D+G++      + +       
Sbjct: 137 EILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVA 191

Query: 391 TFGYLDPEYFQSSQFTD-KSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFI----- 444
           +  +  PE     Q  D   D++S G +L  ++  K+P        ++ +    +     
Sbjct: 192 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED 251

Query: 445 --------SLAKENQLLEILD-------ARVAKEAREEDIGAMA-ELAMRCLRLNSKKRP 488
                   ++  + +  +IL         R      +  +   A +   + LR + + R 
Sbjct: 252 LYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRL 311

Query: 489 TMKQV 493
           T ++ 
Sbjct: 312 TAREA 316

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 2e-37
 Identities = 67/294 (22%), Positives = 111/294 (37%), Gaps = 43/294 (14%)

Query: 216 DNYNQSRFLGQGGFGTVYKGML----PDGSIVAVKRSKEI----DKTQIHQFINEVVILS 267
           +N+   + LG G +G V+          G + A+K  K+               E  +L 
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 268 QINHR-HIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENR 326
            I     +V L           L+ +YI+ G L  H+   ++             +    
Sbjct: 84  HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER------------FTEHEV 131

Query: 327 VRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTT 386
                E+  A+ ++H    + I +RDIK  NILLD      ++DFG+S+    D+T    
Sbjct: 132 QIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAY 188

Query: 387 TIQGTFGYLDPEYFQSSQ--FTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFI 444
              GT  Y+ P+  +          D +S GV++ ELLTG  P               F 
Sbjct: 189 DFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP---------------FT 233

Query: 445 SLAKENQLLEILDARVAKEARE-EDIGAMA-ELAMRCLRLNSKKRPTMKQVSME 496
              ++N   EI    +  E    +++ A+A +L  R L  + KKR        +
Sbjct: 234 VDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDAD 287

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (338), Expect = 9e-36
 Identities = 56/312 (17%), Positives = 109/312 (34%), Gaps = 54/312 (17%)

Query: 216 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK--RSKEIDKTQIHQFINEVVILSQINHR 272
             Y   + +G G  G V           VA+K       ++T   +   E+V++  +NH+
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76

Query: 273 HIVKLLGCCL------ETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENR 326
           +I+ LL          E +   LV E + +        +                  E  
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL---------------DHERM 121

Query: 327 VRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTT 386
             +  ++   + ++HS     I HRD+K SNI++    + K+ DFG++R+     + + T
Sbjct: 122 SYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMT 176

Query: 387 TIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEE---------- 436
               T  Y  PE      + +  D++S G ++ E++  K         ++          
Sbjct: 177 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGT 236

Query: 437 -------------RNLVACFISLAKENQLLEILDARVAKEAREEDIGAMA--ELAMRCLR 481
                        RN V      A         D+    ++    + A    +L  + L 
Sbjct: 237 PCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLV 296

Query: 482 LNSKKRPTMKQV 493
           ++  KR ++   
Sbjct: 297 IDPAKRISVDDA 308

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (334), Expect = 3e-35
 Identities = 55/297 (18%), Positives = 108/297 (36%), Gaps = 33/297 (11%)

Query: 215 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK--RSKEIDKTQIHQFINEVVILSQINH 271
            + Y     +G G +G+V        G  VAVK             +   E+ +L  + H
Sbjct: 17  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76

Query: 272 RHIVKLLGCCLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVAC 331
            +++ LL             +      L  H+         K ++    L+ ++   +  
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVY----LVTHLMGADLNNIVKCQK----LTDDHVQFLIY 128

Query: 332 EVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSIPNDKTHLTTTIQGT 391
           ++   + Y+HS+    I HRD+K SN+ +++    K+ DFG++R   +    +T  +   
Sbjct: 129 QILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYVATR 182

Query: 392 FGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP---------------ICFARVEEE 436
           +            +    D++S G ++ ELLTG+                 +      E 
Sbjct: 183 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL 242

Query: 437 RNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQV 493
              ++   +      L ++     A      +  A+ +L  + L L+S KR T  Q 
Sbjct: 243 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAV-DLLEKMLVLDSDKRITAAQA 298

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  120 bits (302), Expect = 8e-31
 Identities = 55/320 (17%), Positives = 111/320 (34%), Gaps = 53/320 (16%)

Query: 218 YNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVK 276
           Y   R LG G F TV+    + + + VA+K  +  DK       +E+ +L ++N     K
Sbjct: 15  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTK 73

Query: 277 LLGCCLETEVPVLVYEYISSGTLSHHIHDH----QQQQEQKQKQELSSLSWENRVRVACE 332
                    + +L +         H +       +      +K E   +      +++ +
Sbjct: 74  EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133

Query: 333 VAGAVAYMHSSASIPIFHRDIKSSNILLD------DKFSAKVSDFGISRSIPNDKTHLTT 386
           +   + YMH    I   H DIK  N+L++      +    K++D G +       T+   
Sbjct: 134 LLLGLDYMHRRCGII--HTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTN--- 188

Query: 387 TIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP------------------- 427
               T  Y  PE    + +   +D++S   ++ EL+TG                      
Sbjct: 189 -SIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 247

Query: 428 --------------ICFARVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMA 473
                           + R       +   IS  K   L ++L  +   +  +++   ++
Sbjct: 248 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKY--KFSKDEAKEIS 305

Query: 474 ELAMRCLRLNSKKRPTMKQV 493
           +     L+L+ +KR     +
Sbjct: 306 DFLSPMLQLDPRKRADAGGL 325

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 87.5 bits (216), Expect = 1e-20
 Identities = 33/215 (15%), Positives = 63/215 (29%), Gaps = 45/215 (20%)

Query: 222 RFLGQGGFGTVYKGMLPDGSIVAVK----------RSKEIDKTQIHQFINEVVILSQINH 271
           + +G+G    V+           VK          + KE        F    +  ++   
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 272 RHIVKLLGCC----LETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRV 327
           R + KL G         E   ++ E I +  L     ++                     
Sbjct: 66  RALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPD------------------- 106

Query: 328 RVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRSI--PNDKTHLT 385
            V   +   VA  +      I H D+   N+L+ +     + DF  S  +     +  L 
Sbjct: 107 EVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSE-EGIWIIDFPQSVEVGEEGWREILE 162

Query: 386 TTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLE 420
             ++         YF    +  + D+ S    +L+
Sbjct: 163 RDVRNI-----ITYFS-RTYRTEKDINSAIDRILQ 191

>d1e0ga_ d.7.1.1 (A:) Membrane-bound lytic murein transclycosylase D, MltD {Escherichia coli [TaxId: 562]} Length = 48

class: Alpha and beta proteins (a+b)
fold: LysM domain
superfamily: LysM domain
family: LysM domain
domain: Membrane-bound lytic murein transclycosylase D, MltD
species: Escherichia coli [TaxId: 562]

 Score = 39.2 bits (92), Expect = 3e-05
 Identities = 13/46 (28%), Positives = 25/46 (54%), Gaps = 2/46 (4%)

Query: 57  YMAAKGDTISSIGYKFGVDQQSILEANMLSKADSIFPFAPLLIPLK 102
           Y   KGD++SSI  + GV+ + ++  N  +   ++ P   L + +K
Sbjct: 5   YRVRKGDSLSSIAKRHGVNIKDVMRWNSDT--ANLQPGDKLTLFVK 48

>d1y7ma2 d.7.1.1 (A:1-48) Hypothetical protein YkuD, N-terminal domain {Bacillus subtilis [TaxId: 1423]} Length = 48

class: Alpha and beta proteins (a+b)
fold: LysM domain
superfamily: LysM domain
family: LysM domain
domain: Hypothetical protein YkuD, N-terminal domain
species: Bacillus subtilis [TaxId: 1423]

 Score = 37.1 bits (86), Expect = 2e-04
 Identities = 13/47 (27%), Positives = 25/47 (53%), Gaps = 1/47 (2%)

Query: 54  LLAYMAAKGDTISSIGYKFGVDQQSILEANMLSKADSIFPFAPLLIP 100
           +L Y   +GDT++SI   F +   ++L+AN   +   +     ++IP
Sbjct: 1   MLTYQVKQGDTLNSIAADFRISTAALLQANPSLQ-AGLTAGQSIVIP 46

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	537
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.88
d1e0ga_	48	Membrane-bound lytic murein transclycosylase D, Ml	99.11
d1y7ma2	48	Hypothetical protein YkuD, N-terminal domain {Baci	99.06
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.6
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.02
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.5
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.49
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.33
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.05
d1y7ma2	48	Hypothetical protein YkuD, N-terminal domain {Baci	94.94
d1e0ga_	48	Membrane-bound lytic murein transclycosylase D, Ml	94.86
d1emoa1	43	Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}	83.2

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.2e-56  Score=429.38  Aligned_cols=258  Identities=25%  Similarity=0.423  Sum_probs=204.7

Q ss_pred             cCCccccccCcCCceEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecCC
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYIS  295 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  295 (537)
                      ++|+..+.||+|+||+||+|++.+++.||||+++... ...++|.+|+.++++++||||++++|+|.+.+..++||||++
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~   83 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   83 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence            4688889999999999999999888999999997643 334689999999999999999999999999999999999999


Q ss_pred             CCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCcc
Q 009340          296 SGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISR  375 (537)
Q Consensus       296 ~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~  375 (537)
                      +|+|.+++....           ..++|..++.++.|+|+||.|||+.+   |+||||||+|||+|+++.+||+|||+++
T Consensus        84 ~g~L~~~l~~~~-----------~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~  149 (263)
T d1sm2a_          84 HGCLSDYLRTQR-----------GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTR  149 (263)
T ss_dssp             TCBHHHHHHTTT-----------TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC---
T ss_pred             CCcHHHHhhccc-----------cCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchhe
Confidence            999999987643           36899999999999999999999999   9999999999999999999999999998


Q ss_pred             ccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchhhhh
Q 009340          376 SIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEI  455 (537)
Q Consensus       376 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  455 (537)
                      ..............||+.|+|||.+.+..++.|+|||||||++|||+|++.|+.......     . .....        
T Consensus       150 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~-----~-~~~~i--------  215 (263)
T d1sm2a_         150 FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-----E-VVEDI--------  215 (263)
T ss_dssp             ---------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHH-----H-HHHHH--------
T ss_pred             eccCCCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHH-----H-HHHHH--------
Confidence            876554444455678999999999999999999999999999999999655543222111     0 11111        


Q ss_pred             hcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHHh
Q 009340          456 LDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRS  503 (537)
Q Consensus       456 ~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~  503 (537)
                       ........+..++.++.+|+.+||+.||++||||+||++.|++|.++
T Consensus       216 -~~~~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es  262 (263)
T d1sm2a_         216 -STGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES  262 (263)
T ss_dssp             -HHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -HhcCCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence             11122223444556889999999999999999999999999999775

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=8.9e-55  Score=429.90  Aligned_cols=258  Identities=25%  Similarity=0.466  Sum_probs=203.1

Q ss_pred             CCccccccCcCCceEEEEEEcC-CC---CEEEEEEccC-CChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEE
Q 009340          217 NYNQSRFLGQGGFGTVYKGMLP-DG---SIVAVKRSKE-IDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY  291 (537)
Q Consensus       217 ~~~~~~~lg~G~~g~Vy~~~~~-~g---~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  291 (537)
                      +|+..++||+|+||+||+|.++ ++   ..||||++.. ......++|.+|+.+|++++|||||+++|+|.+.+..++||
T Consensus        27 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~  106 (299)
T d1jpaa_          27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIIT  106 (299)
T ss_dssp             GEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             hcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEE
Confidence            4555689999999999999974 23   2699998865 45566778999999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeec
Q 009340          292 EYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF  371 (537)
Q Consensus       292 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Df  371 (537)
                      ||+++|+|.+++....           ..++|.+++.++.|||+||.|||+++   |+||||||+||||+.++.+||+||
T Consensus       107 Ey~~~g~L~~~~~~~~-----------~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DF  172 (299)
T d1jpaa_         107 EFMENGSLDSFLRQND-----------GQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDF  172 (299)
T ss_dssp             ECCTTEEHHHHHHTTT-----------TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC
T ss_pred             EecCCCcceeeecccc-----------CCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCc
Confidence            9999999999887542           36999999999999999999999998   999999999999999999999999


Q ss_pred             cCccccCCCCCce----eeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHHHH
Q 009340          372 GISRSIPNDKTHL----TTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISL  446 (537)
Q Consensus       372 gla~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~  446 (537)
                      |+++.........    .....||+.|||||.+.++.++.++|||||||++|||+| |+.||......+       ....
T Consensus       173 Gla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~-------~~~~  245 (299)
T d1jpaa_         173 GLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD-------VINA  245 (299)
T ss_dssp             -----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HHHH
T ss_pred             ccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHH-------HHHH
Confidence            9998775433221    123457999999999999999999999999999999998 899986543322       1111


Q ss_pred             HhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHHhh
Q 009340          447 AKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRSQ  504 (537)
Q Consensus       447 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~  504 (537)
                               +......+.+..++..+.+|+.+||+.||++||||.||++.|+++.++.
T Consensus       246 ---------i~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~p  294 (299)
T d1jpaa_         246 ---------IEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNP  294 (299)
T ss_dssp             ---------HHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred             ---------HHcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcCh
Confidence                     1112222344556678999999999999999999999999999887643

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-54  Score=420.94  Aligned_cols=258  Identities=25%  Similarity=0.406  Sum_probs=213.9

Q ss_pred             hcCCccccccCcCCceEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecC
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI  294 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  294 (537)
                      .++|+..+.||+|+||.||+|.+++++.||||+++... ...++|.+|+.++++++|||||+++|++.+ +..++||||+
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~   89 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM   89 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred             HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence            46788889999999999999999888899999997543 234679999999999999999999998864 5679999999


Q ss_pred             CCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCc
Q 009340          295 SSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGIS  374 (537)
Q Consensus       295 ~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla  374 (537)
                      ++|+|.+++.....          ..++|..+++|+.||++||.|||+++   |+||||||+||||++++.+||+|||+|
T Consensus        90 ~~g~L~~~~~~~~~----------~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla  156 (272)
T d1qpca_          90 ENGSLVDFLKTPSG----------IKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLA  156 (272)
T ss_dssp             TTCBHHHHTTSHHH----------HTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CCCcHHHHHhhcCC----------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccce
Confidence            99999998876443          25999999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchhhh
Q 009340          375 RSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLE  454 (537)
Q Consensus       375 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  454 (537)
                      +..............||+.|+|||.+.++.++.++|||||||++|||+||+.|+........      ......      
T Consensus       157 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~------~~~~i~------  224 (272)
T d1qpca_         157 RLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE------VIQNLE------  224 (272)
T ss_dssp             EECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH------HHHHHH------
T ss_pred             EEccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHH------HHHHHH------
Confidence            98765554445566789999999999999999999999999999999997666543222110      111111      


Q ss_pred             hhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHH
Q 009340          455 ILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRR  502 (537)
Q Consensus       455 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~  502 (537)
                         .......+...+..+.+|+.+||+.||++||||.+|+++|+.+-.
T Consensus       225 ---~~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft  269 (272)
T d1qpca_         225 ---RGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT  269 (272)
T ss_dssp             ---TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---hcCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence               111222334455678999999999999999999999999997654

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-54  Score=419.16  Aligned_cols=261  Identities=29%  Similarity=0.489  Sum_probs=207.7

Q ss_pred             hcCCccccccCcCCceEEEEEEcCCCCEEEEEEccC--CChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEe
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKE--IDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE  292 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e  292 (537)
                      .++|...+.||+|+||+||+|++++  .||||+++.  .+....+.|.+|+.++++++|||||+++|++.+ +..++|||
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E   83 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ   83 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence            4678889999999999999999753  599999864  345567889999999999999999999999864 56799999


Q ss_pred             cCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeecc
Q 009340          293 YISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG  372 (537)
Q Consensus       293 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfg  372 (537)
                      |+++|+|.+++....           ..++|..++.++.|||+||+|||+++   ||||||||+||||+.++.+||+|||
T Consensus        84 y~~~g~L~~~l~~~~-----------~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFG  149 (276)
T d1uwha_          84 WCEGSSLYHHLHIIE-----------TKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFG  149 (276)
T ss_dssp             CCCEEEHHHHHHTSC-----------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCC
T ss_pred             cCCCCCHHHHHhhcc-----------CCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEcccc
Confidence            999999999997542           36999999999999999999999998   9999999999999999999999999


Q ss_pred             CccccCCCCC-ceeeeccccccccCcccccC---CCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHh
Q 009340          373 ISRSIPNDKT-HLTTTIQGTFGYLDPEYFQS---SQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAK  448 (537)
Q Consensus       373 la~~~~~~~~-~~~~~~~gt~~y~aPE~~~~---~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  448 (537)
                      +|+....... .......||+.|||||.+.+   +.++.++|||||||++|||+||+.||........      ......
T Consensus       150 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~------~~~~~~  223 (276)
T d1uwha_         150 LATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ------IIFMVG  223 (276)
T ss_dssp             CSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH------HHHHHH
T ss_pred             ceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH------HHHHHh
Confidence            9987644322 23455679999999999864   4589999999999999999999999865432211      111111


Q ss_pred             hchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHHh
Q 009340          449 ENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRS  503 (537)
Q Consensus       449 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~  503 (537)
                      .+..    .+. ....+..++..+.+|+.+||+.||++||||.||++.|+.+.++
T Consensus       224 ~~~~----~p~-~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~  273 (276)
T d1uwha_         224 RGYL----SPD-LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS  273 (276)
T ss_dssp             HTSC----CCC-GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             cCCC----CCc-chhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence            1110    111 1122344556889999999999999999999999999988864

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.8e-54  Score=425.15  Aligned_cols=259  Identities=25%  Similarity=0.420  Sum_probs=218.8

Q ss_pred             hcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEec
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY  293 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  293 (537)
                      .++|+..+.||+|+||+||+|++. +|+.||||+++... ...++|.+|+.+|++++|||||+++|+|.+.+..++||||
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~   94 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF   94 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence            467888999999999999999975 58899999987543 3456899999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccC
Q 009340          294 ISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGI  373 (537)
Q Consensus       294 ~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgl  373 (537)
                      +++|+|.+++....          ...++|..++.++.||++||+|||+++   |+||||||+||||++++.+||+|||+
T Consensus        95 ~~~g~l~~~l~~~~----------~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~  161 (287)
T d1opja_          95 MTYGNLLDYLRECN----------RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGL  161 (287)
T ss_dssp             CTTCBHHHHHHHSC----------TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCC
T ss_pred             ccCcchHHHhhhcc----------ccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccc
Confidence            99999999997543          246999999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchhh
Q 009340          374 SRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLL  453 (537)
Q Consensus       374 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  453 (537)
                      ++....+.........||+.|+|||.+.++.++.|+|||||||++|||++|+.|+........      .         .
T Consensus       162 a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~------~---------~  226 (287)
T d1opja_         162 SRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ------V---------Y  226 (287)
T ss_dssp             TTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH------H---------H
T ss_pred             eeecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHH------H---------H
Confidence            998766555555556789999999999999999999999999999999998777643322110      1         1


Q ss_pred             hhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHH
Q 009340          454 EILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRR  502 (537)
Q Consensus       454 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~  502 (537)
                      +.+......+.+...+..+.+|+.+||+.||++||||.||++.|+.+.+
T Consensus       227 ~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~  275 (287)
T d1opja_         227 ELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  275 (287)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred             HHHhcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            1222222333445566789999999999999999999999999987754

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-53  Score=411.43  Aligned_cols=253  Identities=25%  Similarity=0.403  Sum_probs=216.2

Q ss_pred             cCCccccccCcCCceEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecCC
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYIS  295 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  295 (537)
                      ++|+..++||+|+||+||+|++++++.||||+++.... ..++|.+|+.++++++||||++++|+|.+.+..++||||++
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~   82 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA   82 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence            57889999999999999999998888999999876433 34689999999999999999999999999999999999999


Q ss_pred             CCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCcc
Q 009340          296 SGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISR  375 (537)
Q Consensus       296 ~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~  375 (537)
                      +|+|.+++.....           .++|..+++++.|+|+||.|||+.+   |+||||||+|||+++++.+||+|||+++
T Consensus        83 ~g~l~~~~~~~~~-----------~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~  148 (258)
T d1k2pa_          83 NGCLLNYLREMRH-----------RFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSR  148 (258)
T ss_dssp             TEEHHHHHHSGGG-----------CCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCC
T ss_pred             CCcHHHhhhcccc-----------CCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhhe
Confidence            9999999866533           6899999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHHHHHhhchhhh
Q 009340          376 SIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQLLE  454 (537)
Q Consensus       376 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  454 (537)
                      ..............||+.|+|||.+.+..++.|+|||||||++|||+| |+.||......+       .......     
T Consensus       149 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~-------~~~~i~~-----  216 (258)
T d1k2pa_         149 YVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE-------TAEHIAQ-----  216 (258)
T ss_dssp             BCSSSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH-------HHHHHHT-----
T ss_pred             eccCCCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH-------HHHHHHh-----
Confidence            776555444555678999999999999999999999999999999998 898986554332       1111111     


Q ss_pred             hhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHH
Q 009340          455 ILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEG  499 (537)
Q Consensus       455 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  499 (537)
                          ......+...+.++.+|+.+||+.||++||||.+|++.|..
T Consensus       217 ----~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         217 ----GLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             ----TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             ----CCCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence                11223344455789999999999999999999999998864

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-53  Score=416.67  Aligned_cols=260  Identities=27%  Similarity=0.460  Sum_probs=207.2

Q ss_pred             cCCccccccCcCCceEEEEEEcCCC-----CEEEEEEccC-CChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLPDG-----SIVAVKRSKE-IDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVL  289 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~~g-----~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  289 (537)
                      ..|+..++||+|+||.||+|.+++.     ..||||+++. .......+|.+|+.++++++|||||+++|++.+.+..++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            4677889999999999999997532     3699999865 344556679999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEe
Q 009340          290 VYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVS  369 (537)
Q Consensus       290 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~  369 (537)
                      ||||+.+|+|.+++....           ..++|.+++.++.|+++||+|||+.+   |+||||||+||||+.++.+||+
T Consensus        87 v~e~~~~~~l~~~~~~~~-----------~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~  152 (283)
T d1mqba_          87 ITEYMENGALDKFLREKD-----------GEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVS  152 (283)
T ss_dssp             EEECCTTEEHHHHHHHTT-----------TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEEC
T ss_pred             EEEecccCcchhhhhccc-----------ccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEc
Confidence            999999999998876542           36999999999999999999999999   9999999999999999999999


Q ss_pred             eccCccccCCCCC--ceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHH
Q 009340          370 DFGISRSIPNDKT--HLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLA  447 (537)
Q Consensus       370 Dfgla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~  447 (537)
                      |||+++.......  .......||+.|||||.+.++.++.++|||||||++|||++|+.|+........      ..   
T Consensus       153 DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~------~~---  223 (283)
T d1mqba_         153 DFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE------VM---  223 (283)
T ss_dssp             CCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HH---
T ss_pred             ccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHH------HH---
Confidence            9999987644332  223345689999999999999999999999999999999997666543322110      11   


Q ss_pred             hhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHHhh
Q 009340          448 KENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRSQ  504 (537)
Q Consensus       448 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~  504 (537)
                            ..+......+.+..++..+.+|+.+||+.||++||||.||+++|+.+.+..
T Consensus       224 ------~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p  274 (283)
T d1mqba_         224 ------KAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP  274 (283)
T ss_dssp             ------HHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred             ------HHHhccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCc
Confidence                  112222233444556678999999999999999999999999999887643

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-53  Score=413.87  Aligned_cols=256  Identities=26%  Similarity=0.438  Sum_probs=211.3

Q ss_pred             cCCcccc-ccCcCCceEEEEEEcC---CCCEEEEEEccC-CChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEE
Q 009340          216 DNYNQSR-FLGQGGFGTVYKGMLP---DGSIVAVKRSKE-IDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLV  290 (537)
Q Consensus       216 ~~~~~~~-~lg~G~~g~Vy~~~~~---~g~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  290 (537)
                      ++|...+ +||+|+||.||+|.++   ++..||||.++. ......++|.+|+++|++++|||||+++|+|.+ +..++|
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv   86 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV   86 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence            4566666 4999999999999864   345799999875 345567889999999999999999999999864 567999


Q ss_pred             EecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEee
Q 009340          291 YEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSD  370 (537)
Q Consensus       291 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~D  370 (537)
                      |||+++|+|.+++....           ..++|..+++++.|+++||+|||+++   |+||||||+|||++.++.+||+|
T Consensus        87 mE~~~~g~L~~~l~~~~-----------~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~D  152 (285)
T d1u59a_          87 MEMAGGGPLHKFLVGKR-----------EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISD  152 (285)
T ss_dssp             EECCTTEEHHHHHTTCT-----------TTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECC
T ss_pred             EEeCCCCcHHHHhhccc-----------cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeecc
Confidence            99999999999986543           36999999999999999999999999   99999999999999999999999


Q ss_pred             ccCccccCCCCCce--eeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHHHHH
Q 009340          371 FGISRSIPNDKTHL--TTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLA  447 (537)
Q Consensus       371 fgla~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~  447 (537)
                      ||+++.........  .....||+.|+|||.+.++.++.++|||||||++|||+| |+.||......+       +....
T Consensus       153 FGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~-------~~~~i  225 (285)
T d1u59a_         153 FGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-------VMAFI  225 (285)
T ss_dssp             CTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH-------HHHHH
T ss_pred             chhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH-------HHHHH
Confidence            99999875543322  234568999999999999999999999999999999998 899986543322       11111


Q ss_pred             hhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHH
Q 009340          448 KENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRR  502 (537)
Q Consensus       448 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~  502 (537)
                      ..         ....+.+..++.++.+|+.+||+.||++||||.+|++.|+.+..
T Consensus       226 ~~---------~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~  271 (285)
T d1u59a_         226 EQ---------GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY  271 (285)
T ss_dssp             HT---------TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             Hc---------CCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            11         11223445566789999999999999999999999999987654

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-52  Score=408.39  Aligned_cols=249  Identities=28%  Similarity=0.431  Sum_probs=203.7

Q ss_pred             cccCcCCceEEEEEEcCC---CCEEEEEEccC--CChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecCCC
Q 009340          222 RFLGQGGFGTVYKGMLPD---GSIVAVKRSKE--IDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISS  296 (537)
Q Consensus       222 ~~lg~G~~g~Vy~~~~~~---g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  296 (537)
                      ++||+|+||+||+|.+++   ++.||||+++.  .+....++|.+|+.+|++++|||||+++|+|.+ +..++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            579999999999998643   46799999864  233456789999999999999999999999964 567999999999


Q ss_pred             CChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCccc
Q 009340          297 GTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISRS  376 (537)
Q Consensus       297 gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~  376 (537)
                      |+|.+++...            ..++|..+++++.||++||+|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus        92 g~L~~~l~~~------------~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~  156 (277)
T d1xbba_          92 GPLNKYLQQN------------RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKA  156 (277)
T ss_dssp             EEHHHHHHHC------------TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             CcHHHHHhhc------------cCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhh
Confidence            9999998753            36999999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCCCcee--eeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHHHHHhhchhh
Q 009340          377 IPNDKTHLT--TTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQLL  453 (537)
Q Consensus       377 ~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  453 (537)
                      .........  ....||+.|+|||.+.++.++.++|||||||++|||+| |+.||......+       .......    
T Consensus       157 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~-------~~~~i~~----  225 (277)
T d1xbba_         157 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-------VTAMLEK----  225 (277)
T ss_dssp             CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHT----
T ss_pred             ccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHH-------HHHHHHc----
Confidence            754443322  34568999999999999999999999999999999998 899986543222       1111111    


Q ss_pred             hhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHH
Q 009340          454 EILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRR  502 (537)
Q Consensus       454 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~  502 (537)
                           ....+.+..++.++.+|+.+||+.||++||||.+|+++|+..-.
T Consensus       226 -----~~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~  269 (277)
T d1xbba_         226 -----GERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY  269 (277)
T ss_dssp             -----TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             -----CCCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence                 12223444556789999999999999999999999999887643

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-53  Score=413.95  Aligned_cols=257  Identities=27%  Similarity=0.417  Sum_probs=206.9

Q ss_pred             cCCccccccCcCCceEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecCC
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYIS  295 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  295 (537)
                      ++|+..+.||+|+||.||+|++++++.||||+++... ...+.|.+|+.++++++|+|||+++|+|.+ +..++||||++
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~   94 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS   94 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred             HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecC
Confidence            5788999999999999999999888899999997543 234679999999999999999999999854 56799999999


Q ss_pred             CCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCcc
Q 009340          296 SGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGISR  375 (537)
Q Consensus       296 ~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~  375 (537)
                      +|+|..++.....          ..++|.+++.++.||++||+|||+.+   |+||||||+|||||.++++||+|||+++
T Consensus        95 ~g~l~~~~~~~~~----------~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~  161 (285)
T d1fmka3          95 KGSLLDFLKGETG----------KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLAR  161 (285)
T ss_dssp             TCBHHHHHSHHHH----------TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC
T ss_pred             CCchhhhhhhccc----------ccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhh
Confidence            9999999876532          36999999999999999999999999   9999999999999999999999999998


Q ss_pred             ccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchhhhh
Q 009340          376 SIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLEI  455 (537)
Q Consensus       376 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  455 (537)
                      ..............||+.|+|||++.++.++.++|||||||++|||++|+.|+........      .....        
T Consensus       162 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~------~~~~i--------  227 (285)
T d1fmka3         162 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE------VLDQV--------  227 (285)
T ss_dssp             --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH------HHHHH--------
T ss_pred             hccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHH------HHHHH--------
Confidence            8755554445556799999999999999999999999999999999997777644322111      11111        


Q ss_pred             hcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHH
Q 009340          456 LDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRR  502 (537)
Q Consensus       456 ~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~  502 (537)
                       ......+.+..++.++.+++.+||+.||++||||.+|+++|+....
T Consensus       228 -~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~  273 (285)
T d1fmka3         228 -ERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  273 (285)
T ss_dssp             -HTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred             -HhcCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence             1122223445556789999999999999999999999999987554

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-52  Score=406.49  Aligned_cols=255  Identities=25%  Similarity=0.418  Sum_probs=198.0

Q ss_pred             cCCccccccCcCCceEEEEEEc-CCCCEEEEEEccCC--ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeC--CccEEE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEI--DKTQIHQFINEVVILSQINHRHIVKLLGCCLET--EVPVLV  290 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV  290 (537)
                      ++|+..+.||+|+||+||+|+. .+|+.||||.++..  .....+.+.+|++++++++||||+++++++.+.  +..|+|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            5789999999999999999985 47899999998643  455567799999999999999999999999753  457999


Q ss_pred             EecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCC--CCeeecCCCCCCEEECCCCcEEE
Q 009340          291 YEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSAS--IPIFHRDIKSSNILLDDKFSAKV  368 (537)
Q Consensus       291 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~--~~ivH~Dlk~~NIll~~~~~~ki  368 (537)
                      |||+++|+|.+++......        ...+++..++.++.|+++||.|||+.+.  .+|+||||||+|||++.++.+||
T Consensus        84 mEy~~~g~L~~~i~~~~~~--------~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl  155 (269)
T d2java1          84 MEYCEGGDLASVITKGTKE--------RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKL  155 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHH--------TCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEE
T ss_pred             EecCCCCcHHHHHHhcccc--------CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEE
Confidence            9999999999999764331        3579999999999999999999998652  34999999999999999999999


Q ss_pred             eeccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHh
Q 009340          369 SDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAK  448 (537)
Q Consensus       369 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  448 (537)
                      +|||+++....+.. ......||+.|||||.+.+..++.++|||||||++|||+||+.||......+       ......
T Consensus       156 ~DFG~a~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~-------~~~~i~  227 (269)
T d2java1         156 GDFGLARILNHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE-------LAGKIR  227 (269)
T ss_dssp             CCHHHHHHC------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-------HHHHHH
T ss_pred             eeccceeecccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH-------HHHHHH
Confidence            99999988754332 2345679999999999999999999999999999999999999997543322       111111


Q ss_pred             hchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          449 ENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       449 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      .+..         ...+...+.++.+|+.+||+.||++|||+.|+++
T Consensus       228 ~~~~---------~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         228 EGKF---------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             HTCC---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             cCCC---------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence            1111         1223345567899999999999999999999864

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-52  Score=405.81  Aligned_cols=251  Identities=26%  Similarity=0.392  Sum_probs=202.8

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCC-hHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEec
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEID-KTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY  293 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  293 (537)
                      ++|+..+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy   84 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   84 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence            57889999999999999999964 68999999986532 33456789999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccC
Q 009340          294 ISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGI  373 (537)
Q Consensus       294 ~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgl  373 (537)
                      +++|+|.+++...            ..+++..+..++.|+++||+|||+++   |+||||||+|||+++++.+||+|||+
T Consensus        85 ~~gg~L~~~l~~~------------~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~  149 (271)
T d1nvra_          85 CSGGELFDRIEPD------------IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGL  149 (271)
T ss_dssp             CTTEEGGGGSBTT------------TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTT
T ss_pred             cCCCcHHHHHhcC------------CCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchh
Confidence            9999999999653            35999999999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCC-CceeeeccccccccCcccccCCCC-CcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhch
Q 009340          374 SRSIPNDK-THLTTTIQGTFGYLDPEYFQSSQF-TDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQ  451 (537)
Q Consensus       374 a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  451 (537)
                      |+...... ........||+.|||||++.+..+ +.++|||||||++|||++|+.||........     .+........
T Consensus       150 a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~-----~~~~~~~~~~  224 (271)
T d1nvra_         150 ATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-----EYSDWKEKKT  224 (271)
T ss_dssp             CEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH-----HHHHHHTTCT
T ss_pred             heeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHH-----HHHHHhcCCC
Confidence            98764332 223455679999999999988776 5789999999999999999999965432211     0111111110


Q ss_pred             hhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          452 LLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       452 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                               ........+.++.+|+.+||+.||++|||+.|+++
T Consensus       225 ---------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         225 ---------YLNPWKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             ---------TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ---------CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                     01111223456789999999999999999999854

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-51  Score=404.04  Aligned_cols=249  Identities=26%  Similarity=0.446  Sum_probs=207.8

Q ss_pred             cCCccccccCcCCceEEEEEEc-CCCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecC
Q 009340          216 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI  294 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  294 (537)
                      ++|+..++||+|+||+||+|+. .+|+.||||+++.......+.+.+|+.++++++||||+++++++.+.+..|+||||+
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            4799999999999999999995 479999999987544445677999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCc
Q 009340          295 SSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGIS  374 (537)
Q Consensus       295 ~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla  374 (537)
                      ++|+|.+++..             ..+++.++..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++
T Consensus       100 ~gg~L~~~~~~-------------~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a  163 (293)
T d1yhwa1         100 AGGSLTDVVTE-------------TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFC  163 (293)
T ss_dssp             TTCBHHHHHHH-------------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred             CCCcHHHHhhc-------------cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhh
Confidence            99999987753             25999999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchhhh
Q 009340          375 RSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLLE  454 (537)
Q Consensus       375 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  454 (537)
                      +.+..... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||......+      ..........   
T Consensus       164 ~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~------~~~~~~~~~~---  233 (293)
T d1yhwa1         164 AQITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR------ALYLIATNGT---  233 (293)
T ss_dssp             EECCSTTC-CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHHCS---
T ss_pred             eeeccccc-cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH------HHHHHHhCCC---
Confidence            88754332 2345679999999999999999999999999999999999999996543221      1111111110   


Q ss_pred             hhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          455 ILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       455 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                           .....+...+..+.+|+.+||+.||++|||+.|+++
T Consensus       234 -----~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         234 -----PELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             -----CCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             -----CCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                 001122334567889999999999999999999864

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-51  Score=398.75  Aligned_cols=245  Identities=30%  Similarity=0.456  Sum_probs=206.7

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCC---ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI---DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY  291 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  291 (537)
                      ++|+..+.||+|+||.||+|+.+ +|+.||+|++...   .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            56888999999999999999964 6899999988642   1223567889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeec
Q 009340          292 EYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF  371 (537)
Q Consensus       292 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Df  371 (537)
                      ||+++|+|.+++...            ..+++..+..++.||++||+|||+++   |+||||||+|||++.++.+||+||
T Consensus        86 Ey~~~g~L~~~l~~~------------~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DF  150 (263)
T d2j4za1          86 EYAPLGTVYRELQKL------------SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADF  150 (263)
T ss_dssp             ECCTTCBHHHHHHHH------------SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC
T ss_pred             eecCCCcHHHHHhhc------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeeccc
Confidence            999999999999753            36999999999999999999999999   999999999999999999999999


Q ss_pred             cCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhch
Q 009340          372 GISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQ  451 (537)
Q Consensus       372 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  451 (537)
                      |+++......   .....||+.|||||++.+..++.++|||||||++|||++|+.||......+.      +.. .... 
T Consensus       151 G~a~~~~~~~---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~------~~~-i~~~-  219 (263)
T d2j4za1         151 GWSVHAPSSR---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET------YKR-ISRV-  219 (263)
T ss_dssp             CSCSCCCCCC---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHH-HHTT-
T ss_pred             ceeeecCCCc---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHH------HHH-HHcC-
Confidence            9998764432   3456799999999999999999999999999999999999999965433221      111 1111 


Q ss_pred             hhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          452 LLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       452 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                               ....+...+.++.+|+.+||+.||++|||+.|+++
T Consensus       220 ---------~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         220 ---------EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             ---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---------CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence                     01123334567889999999999999999999975

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-52  Score=414.15  Aligned_cols=266  Identities=26%  Similarity=0.464  Sum_probs=210.3

Q ss_pred             hcCCccccccCcCCceEEEEEEcCC-C-----CEEEEEEccCC-ChHHHHHHHHHHHHHHhc-CCCCcceEeeEEeeCCc
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLPD-G-----SIVAVKRSKEI-DKTQIHQFINEVVILSQI-NHRHIVKLLGCCLETEV  286 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~~-g-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~  286 (537)
                      .++|+..++||+|+||+||+|++.. +     ..||||.+... .......|.+|+.++.++ +|||||+++|++.+.+.
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~  115 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP  115 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence            3678889999999999999998642 2     26999988653 334456789999999998 89999999999999999


Q ss_pred             cEEEEecCCCCChhhhhhhhhhhHHH-----------HhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCC
Q 009340          287 PVLVYEYISSGTLSHHIHDHQQQQEQ-----------KQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKS  355 (537)
Q Consensus       287 ~~lV~e~~~~gsL~~~l~~~~~~~~~-----------~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~  355 (537)
                      .++||||+++|+|.++++........           ........++|..++.++.||++||+|||+++   |+||||||
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp  192 (325)
T d1rjba_         116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA  192 (325)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred             EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCch
Confidence            99999999999999999765421100           00111346999999999999999999999998   99999999


Q ss_pred             CCEEECCCCcEEEeeccCccccCCCCCc-eeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccch
Q 009340          356 SNILLDDKFSAKVSDFGISRSIPNDKTH-LTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARV  433 (537)
Q Consensus       356 ~NIll~~~~~~ki~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~  433 (537)
                      +|||++.++.+||+|||+|+........ ......||+.|||||.+.++.++.++|||||||++|||+| |+.||.....
T Consensus       193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~  272 (325)
T d1rjba_         193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV  272 (325)
T ss_dssp             GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence            9999999999999999999876544333 2345668999999999999999999999999999999998 8999865432


Q ss_pred             hhhccHHHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHH
Q 009340          434 EEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELE  498 (537)
Q Consensus       434 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~  498 (537)
                      ...      +...         +......+.+..++.++.+|+.+||+.||++||||.||++.|.
T Consensus       273 ~~~------~~~~---------~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         273 DAN------FYKL---------IQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             SHH------HHHH---------HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHH------HHHH---------HhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            211      1111         1122223344555678999999999999999999999999985

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1e-51  Score=408.91  Aligned_cols=273  Identities=25%  Similarity=0.411  Sum_probs=216.2

Q ss_pred             HHHHHhcCCccccccCcCCceEEEEEEcC------CCCEEEEEEccCC-ChHHHHHHHHHHHHHHhcCCCCcceEeeEEe
Q 009340          210 ELQRATDNYNQSRFLGQGGFGTVYKGMLP------DGSIVAVKRSKEI-DKTQIHQFINEVVILSQINHRHIVKLLGCCL  282 (537)
Q Consensus       210 el~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~  282 (537)
                      +++...++|+..+.||+|+||+||+|+++      +++.||||+++.. .....++|.+|+.++++++||||++++++|.
T Consensus         7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~   86 (301)
T d1lufa_           7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA   86 (301)
T ss_dssp             HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence            34445678999999999999999999853      4578999998753 3445678999999999999999999999999


Q ss_pred             eCCccEEEEecCCCCChhhhhhhhhhhHHHH------------hhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeee
Q 009340          283 ETEVPVLVYEYISSGTLSHHIHDHQQQQEQK------------QKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFH  350 (537)
Q Consensus       283 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~------------~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH  350 (537)
                      +.+..++||||+++|+|.++++.........            .......++|..++.|+.|+++||+|||+.+   |||
T Consensus        87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivH  163 (301)
T d1lufa_          87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVH  163 (301)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEe
Confidence            9999999999999999999997643211100            0111345899999999999999999999999   999


Q ss_pred             cCCCCCCEEECCCCcEEEeeccCccccCCCCC-ceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCC-CCC
Q 009340          351 RDIKSSNILLDDKFSAKVSDFGISRSIPNDKT-HLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGK-KPI  428 (537)
Q Consensus       351 ~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~-~p~  428 (537)
                      |||||+|||+|.++.+||+|||+++....... ...+...||+.|+|||.+.+..+|.|+|||||||++|||++|. .||
T Consensus       164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~  243 (301)
T d1lufa_         164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY  243 (301)
T ss_dssp             SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             eEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCC
Confidence            99999999999999999999999986643332 2334567899999999999999999999999999999999986 456


Q ss_pred             CccchhhhccHHHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHH
Q 009340          429 CFARVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLR  501 (537)
Q Consensus       429 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~  501 (537)
                      ......+       .......+.         ..+.+...+.++.+|+.+||+.||++||||.||+++|++|.
T Consensus       244 ~~~~~~e-------~~~~v~~~~---------~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         244 YGMAHEE-------VIYYVRDGN---------ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             TTSCHHH-------HHHHHHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CCCCHHH-------HHHHHHcCC---------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            5433222       111122221         12234445567899999999999999999999999999874

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-51  Score=400.38  Aligned_cols=259  Identities=25%  Similarity=0.431  Sum_probs=202.5

Q ss_pred             hcCCccccccCcCCceEEEEEEcCC----CCEEEEEEccCC-ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEE
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLPD----GSIVAVKRSKEI-DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVL  289 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  289 (537)
                      .++|+..+.||+|+||.||+|++..    +..||||.++.. .....+.|.+|+.++++++||||++++|++. .+..++
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i   84 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   84 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence            3678889999999999999998642    346999998753 4455678999999999999999999999996 467899


Q ss_pred             EEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEe
Q 009340          290 VYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVS  369 (537)
Q Consensus       290 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~  369 (537)
                      ||||+++|+|.+++....           ..+++..++.++.||++||.|||+.+   |+||||||+||+++.++.+||+
T Consensus        85 v~E~~~~g~l~~~~~~~~-----------~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~  150 (273)
T d1mp8a_          85 IMELCTLGELRSFLQVRK-----------YSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLG  150 (273)
T ss_dssp             EEECCTTEEHHHHHHHTT-----------TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEEC
T ss_pred             EEEeccCCcHHhhhhccC-----------CCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEc
Confidence            999999999999876542           36999999999999999999999999   9999999999999999999999


Q ss_pred             eccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHHHHHh
Q 009340          370 DFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAK  448 (537)
Q Consensus       370 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~  448 (537)
                      |||+++..............||+.|+|||.+.+..++.++|||||||++|||++ |..||......+   +    .....
T Consensus       151 DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~---~----~~~i~  223 (273)
T d1mp8a_         151 DFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---V----IGRIE  223 (273)
T ss_dssp             C-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---H----HHHHH
T ss_pred             cchhheeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH---H----HHHHH
Confidence            999998876555555556678999999999999999999999999999999998 888886544322   1    11111


Q ss_pred             hchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHHhh
Q 009340          449 ENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRSQ  504 (537)
Q Consensus       449 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~  504 (537)
                      .+         ...+.+...+..+.+|+.+||+.||++|||+.||++.|+.|.+..
T Consensus       224 ~~---------~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~  270 (273)
T d1mp8a_         224 NG---------ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE  270 (273)
T ss_dssp             TT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             cC---------CCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence            11         112234455678999999999999999999999999999887654

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-51  Score=403.40  Aligned_cols=251  Identities=24%  Similarity=0.352  Sum_probs=207.4

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecC
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI  294 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  294 (537)
                      +.|+..+.||+|+||.||+|+.. +|+.||||+++.......+.|.+|+++|++++|||||++++++.+.+..++||||+
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            56888999999999999999964 68999999998766666788999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCc
Q 009340          295 SSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGIS  374 (537)
Q Consensus       295 ~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla  374 (537)
                      ++|+|.+++....           ..+++.++..++.||++||.|||+++   |+||||||+|||++.++++||+|||+|
T Consensus        92 ~~g~L~~~~~~~~-----------~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a  157 (288)
T d2jfla1          92 AGGAVDAVMLELE-----------RPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVS  157 (288)
T ss_dssp             TTEEHHHHHHHHT-----------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CCCcHHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhh
Confidence            9999999986532           36999999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCCceeeeccccccccCccccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhh
Q 009340          375 RSIPNDKTHLTTTIQGTFGYLDPEYFQ-----SSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKE  449 (537)
Q Consensus       375 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  449 (537)
                      +...... .......||+.|+|||++.     +..++.++|||||||++|||++|+.||......+.      +......
T Consensus       158 ~~~~~~~-~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~------~~~i~~~  230 (288)
T d2jfla1         158 AKNTRTI-QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV------LLKIAKS  230 (288)
T ss_dssp             EECHHHH-HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH------HHHHHHS
T ss_pred             hccCCCc-ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH------HHHHHcC
Confidence            7653221 1233567999999999984     45689999999999999999999999975433221      1111111


Q ss_pred             chhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          450 NQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       450 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      . .       .....+...+.++.+|+.+||+.||++|||+.|+++
T Consensus       231 ~-~-------~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         231 E-P-------PTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             C-C-------CCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             C-C-------CCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            1 0       001122344567889999999999999999999865

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-51  Score=407.94  Aligned_cols=258  Identities=23%  Similarity=0.471  Sum_probs=207.8

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCC----EEEEEEccC-CChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGS----IVAVKRSKE-IDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVL  289 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~----~vavK~~~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  289 (537)
                      .+|+..++||+|+||+||+|.+. +|+    .||||+++. .+....++|.+|+.++++++|||||+++|+|.+. ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            46889999999999999999964 444    589998865 3344567899999999999999999999999865 5688


Q ss_pred             EEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEe
Q 009340          290 VYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVS  369 (537)
Q Consensus       290 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~  369 (537)
                      ++||+.+|+|.+++....           ..++|..+++++.|||+||+|||+++   |+||||||+|||++.++.+||+
T Consensus        88 v~e~~~~~~l~~~~~~~~-----------~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~  153 (317)
T d1xkka_          88 ITQLMPFGCLLDYVREHK-----------DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKIT  153 (317)
T ss_dssp             EEECCTTCBHHHHHHHTS-----------SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEEC
T ss_pred             EEEeccCCcccccccccc-----------cCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEee
Confidence            999999999999887643           46999999999999999999999998   9999999999999999999999


Q ss_pred             eccCccccCCCCCc-eeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHHHHH
Q 009340          370 DFGISRSIPNDKTH-LTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLA  447 (537)
Q Consensus       370 Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~  447 (537)
                      |||+++........ ......||+.|+|||.+.++.++.++|||||||++|||+| |+.||......+            
T Consensus       154 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~------------  221 (317)
T d1xkka_         154 DFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE------------  221 (317)
T ss_dssp             CCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG------------
T ss_pred             ccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH------------
Confidence            99999987544333 2344568999999999999999999999999999999999 788876443322            


Q ss_pred             hhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHHhh
Q 009340          448 KENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRSQ  504 (537)
Q Consensus       448 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~  504 (537)
                          +...+......+.+..++..+.+|+.+||+.||++|||+.||++.|+.+....
T Consensus       222 ----~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~~  274 (317)
T d1xkka_         222 ----ISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP  274 (317)
T ss_dssp             ----HHHHHHHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSH
T ss_pred             ----HHHHHHcCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhCh
Confidence                11112222223344556678899999999999999999999999999886543

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-51  Score=396.83  Aligned_cols=251  Identities=27%  Similarity=0.480  Sum_probs=202.4

Q ss_pred             cCCccccccCcCCceEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeC-CccEEEEecC
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLET-EVPVLVYEYI  294 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-~~~~lV~e~~  294 (537)
                      ++|+..+.||+|+||.||+|+++ |+.||||+++...  ..+.|.+|++++++++||||++++|+|.+. +..++||||+
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~   83 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   83 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred             HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence            46778899999999999999994 7899999997643  356799999999999999999999999754 5679999999


Q ss_pred             CCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCc
Q 009340          295 SSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGIS  374 (537)
Q Consensus       295 ~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla  374 (537)
                      ++|+|.+++.....          ..++|..+++++.||++||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        84 ~~g~L~~~l~~~~~----------~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s  150 (262)
T d1byga_          84 AKGSLVDYLRSRGR----------SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLT  150 (262)
T ss_dssp             TTEEHHHHHHHHHH----------HHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-
T ss_pred             CCCCHHHHHHhcCC----------CCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccc
Confidence            99999999976432          24899999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHHHHHhhchhh
Q 009340          375 RSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFISLAKENQLL  453 (537)
Q Consensus       375 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  453 (537)
                      +.....    .....+|..|+|||.+.++.+|.++||||||+++|||+| |+.|+......+   +.    .        
T Consensus       151 ~~~~~~----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~---~~----~--------  211 (262)
T d1byga_         151 KEASST----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VV----P--------  211 (262)
T ss_dssp             ---------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HH----H--------
T ss_pred             eecCCC----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH---HH----H--------
Confidence            865332    233457899999999999999999999999999999998 677765443322   11    1        


Q ss_pred             hhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHH
Q 009340          454 EILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRR  502 (537)
Q Consensus       454 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~  502 (537)
                       .+......+.+...+.++.+|+.+||+.||++||||.+|+++|++|+.
T Consensus       212 -~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~  259 (262)
T d1byga_         212 -RVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT  259 (262)
T ss_dssp             -HHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -HHHcCCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence             111122233444555788999999999999999999999999999875

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-50  Score=392.00  Aligned_cols=246  Identities=24%  Similarity=0.408  Sum_probs=197.5

Q ss_pred             ccccccCcCCceEEEEEEcC-CCCEEEEEEccC--CChHHHHHHHHHHHHHHhcCCCCcceEeeEEee----CCccEEEE
Q 009340          219 NQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKE--IDKTQIHQFINEVVILSQINHRHIVKLLGCCLE----TEVPVLVY  291 (537)
Q Consensus       219 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lV~  291 (537)
                      ...++||+|+||+||+|+.. +++.||+|.+..  ......+.|.+|+++|++++|||||++++++.+    ....++||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            45668999999999999964 688999998764  345567789999999999999999999999875    34579999


Q ss_pred             ecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEC-CCCcEEEee
Q 009340          292 EYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD-DKFSAKVSD  370 (537)
Q Consensus       292 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~-~~~~~ki~D  370 (537)
                      ||+++|+|.+++...            ..+++..+..++.||++||+|||+++ ++|+||||||+|||++ +++.+||+|
T Consensus        92 E~~~~g~L~~~l~~~------------~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~D  158 (270)
T d1t4ha_          92 ELMTSGTLKTYLKRF------------KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGD  158 (270)
T ss_dssp             ECCCSCBHHHHHHHH------------SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECC
T ss_pred             eCCCCCcHHHHHhcc------------ccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEee
Confidence            999999999999753            36999999999999999999999976 3499999999999996 578999999


Q ss_pred             ccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhc
Q 009340          371 FGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKEN  450 (537)
Q Consensus       371 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  450 (537)
                      ||+++.....   ......||+.|||||.+.+ .++.++|||||||++|||++|+.||.......     . .......+
T Consensus       159 FGla~~~~~~---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~-----~-~~~~i~~~  228 (270)
T d1t4ha_         159 LGLATLKRAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA-----Q-IYRRVTSG  228 (270)
T ss_dssp             TTGGGGCCTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-----H-HHHHHTTT
T ss_pred             cCcceeccCC---ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHH-----H-HHHHHHcC
Confidence            9999865332   2345679999999999865 59999999999999999999999986432211     1 11111111


Q ss_pred             hhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          451 QLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       451 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      ...    .    ..+...++++.+|+.+||+.||++|||+.|+++
T Consensus       229 ~~~----~----~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         229 VKP----A----SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             CCC----G----GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCC----c----ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence            100    0    112223456889999999999999999999975

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.4e-50  Score=400.86  Aligned_cols=245  Identities=24%  Similarity=0.381  Sum_probs=201.6

Q ss_pred             cCCccccccCcCCceEEEEEEc-CCCCEEEEEEccCCC---hHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEID---KTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY  291 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  291 (537)
                      ..|+..+.||+|+||.||+|+. .+|+.||||+++...   ....+.+.+|+.+|++++|||||++++++.+.+..++||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            4588899999999999999995 478899999986432   344567999999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeec
Q 009340          292 EYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF  371 (537)
Q Consensus       292 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Df  371 (537)
                      ||+++|+|..++..            ...+++.+++.++.||++||.|||+++   |+||||||+|||++.++.+||+||
T Consensus        95 E~~~~g~l~~~~~~------------~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DF  159 (309)
T d1u5ra_          95 EYCLGSASDLLEVH------------KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDF  159 (309)
T ss_dssp             ECCSEEHHHHHHHH------------TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCC
T ss_pred             EecCCCchHHHHHh------------CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeec
Confidence            99999998766543            246999999999999999999999999   999999999999999999999999


Q ss_pred             cCccccCCCCCceeeeccccccccCcccccC---CCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHh
Q 009340          372 GISRSIPNDKTHLTTTIQGTFGYLDPEYFQS---SQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAK  448 (537)
Q Consensus       372 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  448 (537)
                      |+++.....     ....||+.|||||++.+   +.|+.++|||||||++|||++|+.||......+      .+.....
T Consensus       160 G~a~~~~~~-----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~------~~~~i~~  228 (309)
T d1u5ra_         160 GSASIMAPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHIAQ  228 (309)
T ss_dssp             TTCBSSSSB-----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHH
T ss_pred             ccccccCCC-----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHH------HHHHHHh
Confidence            999865432     34569999999999863   568999999999999999999999986443221      1111111


Q ss_pred             hchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          449 ENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       449 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      .. .        ....+...+..+.+|+.+||+.||++|||+.|+++
T Consensus       229 ~~-~--------~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         229 NE-S--------PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             SC-C--------CCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CC-C--------CCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence            10 0        00112233467889999999999999999999976

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-50  Score=404.91  Aligned_cols=267  Identities=25%  Similarity=0.402  Sum_probs=207.6

Q ss_pred             hcCCccccccCcCCceEEEEEEc-CCCCEEEEEEccCC-ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEe
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEI-DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE  292 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e  292 (537)
                      .++|+..++||+|+||+||+|+. .+|+.||+|+++.. .....+.+.+|+.+|++++|||||++++++.+.+..++|||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE   84 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   84 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            47899999999999999999995 47899999998653 34446789999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeeecCCCCCCEEECCCCcEEEeec
Q 009340          293 YISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSS-ASIPIFHRDIKSSNILLDDKFSAKVSDF  371 (537)
Q Consensus       293 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~-~~~~ivH~Dlk~~NIll~~~~~~ki~Df  371 (537)
                      |+++|+|.+++...            ..+++..+..++.|+++||.|||+. +   |+||||||+|||++.++.+||+||
T Consensus        85 y~~gg~L~~~l~~~------------~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DF  149 (322)
T d1s9ja_          85 HMDGGSLDQVLKKA------------GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDF  149 (322)
T ss_dssp             CCTTEEHHHHHHHH------------SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCC
T ss_pred             cCCCCcHHHHHhhc------------CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeC
Confidence            99999999999753            3599999999999999999999974 7   999999999999999999999999


Q ss_pred             cCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHH-HH------
Q 009340          372 GISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVAC-FI------  444 (537)
Q Consensus       372 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~-~~------  444 (537)
                      |+|+.....   ......||+.|+|||++.+..|+.++||||+||++|||++|+.||......+....... ..      
T Consensus       150 Gla~~~~~~---~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~  226 (322)
T d1s9ja_         150 GVSGQLIDS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAET  226 (322)
T ss_dssp             CCCHHHHHH---TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------
T ss_pred             CCccccCCC---ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccC
Confidence            999865322   23456799999999999999999999999999999999999999975433221000000 00      


Q ss_pred             ----------------HHHhhchhhhhhcHHhhcc---c-cHHHHHHHHHHHHHhcccCCCCCCCHhhHHH--HHHH
Q 009340          445 ----------------SLAKENQLLEILDARVAKE---A-REEDIGAMAELAMRCLRLNSKKRPTMKQVSM--ELEG  499 (537)
Q Consensus       445 ----------------~~~~~~~~~~~~d~~~~~~---~-~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~--~L~~  499 (537)
                                      .........+..+......   . ....+.++.+|+.+||+.||++|||+.|+++  .+++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~  303 (322)
T d1s9ja_         227 PPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR  303 (322)
T ss_dssp             -------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred             CcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence                            0000000001111000000   0 0112457889999999999999999999987  4544

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-50  Score=394.56  Aligned_cols=255  Identities=27%  Similarity=0.446  Sum_probs=199.9

Q ss_pred             cCCccccccCcCCceEEEEEEcC--CC--CEEEEEEccCC---ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP--DG--SIVAVKRSKEI---DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPV  288 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~--~g--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  288 (537)
                      ++|+..+.||+|+||.||+|++.  ++  ..||||+++..   .....++|.+|+.+|++++||||++++|+|.+ ...+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence            56888999999999999999863  22  36899988642   34456789999999999999999999999965 4678


Q ss_pred             EEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEE
Q 009340          289 LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKV  368 (537)
Q Consensus       289 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki  368 (537)
                      +||||+++|+|.+++....           ..++|..++.++.|+|+||.|||+++   |+||||||+|||++.++.+||
T Consensus        87 lv~e~~~~~~l~~~~~~~~-----------~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl  152 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKHQ-----------GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKI  152 (273)
T ss_dssp             EEEECCTTCBHHHHHHHHG-----------GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEE
T ss_pred             eeeeeecCcchhhhhhccc-----------CCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceee
Confidence            9999999999999887643           35999999999999999999999998   999999999999999999999


Q ss_pred             eeccCccccCCCCCce--eeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhccHHHHHHH
Q 009340          369 SDFGISRSIPNDKTHL--TTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERNLVACFIS  445 (537)
Q Consensus       369 ~Dfgla~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~~~~~~~~  445 (537)
                      +|||+++.........  .....||..|+|||.+.+..++.++|||||||++|||+| |+.||......+      ....
T Consensus       153 ~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~------~~~~  226 (273)
T d1u46a_         153 GDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ------ILHK  226 (273)
T ss_dssp             CCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHHH
T ss_pred             ccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH------HHHH
Confidence            9999999875443322  234567889999999999999999999999999999998 899986543322      1111


Q ss_pred             HHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHH
Q 009340          446 LAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGL  500 (537)
Q Consensus       446 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i  500 (537)
                      ....+         ...+.+...+..+.+|+.+||+.||++||||.+|.+.|++.
T Consensus       227 i~~~~---------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         227 IDKEG---------ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             HHTSC---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHhCC---------CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            11111         11223344456789999999999999999999999998864

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-50  Score=397.47  Aligned_cols=253  Identities=27%  Similarity=0.492  Sum_probs=206.0

Q ss_pred             ccccCcCCceEEEEEEcCCC----CEEEEEEccC-CChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeC-CccEEEEecC
Q 009340          221 SRFLGQGGFGTVYKGMLPDG----SIVAVKRSKE-IDKTQIHQFINEVVILSQINHRHIVKLLGCCLET-EVPVLVYEYI  294 (537)
Q Consensus       221 ~~~lg~G~~g~Vy~~~~~~g----~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-~~~~lV~e~~  294 (537)
                      .++||+|+||+||+|++.++    ..||||+++. .+....++|.+|+++|++++||||++++|+|.+. ...++||||+
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            46899999999999997532    2699999875 4566678899999999999999999999998765 5789999999


Q ss_pred             CCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCc
Q 009340          295 SSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGIS  374 (537)
Q Consensus       295 ~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla  374 (537)
                      ++|+|.+++....           ..+++..+++++.|+|+||.|||+.+   |+||||||+|||+++++.+||+|||++
T Consensus       112 ~~g~l~~~~~~~~-----------~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~  177 (311)
T d1r0pa_         112 KHGDLRNFIRNET-----------HNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLA  177 (311)
T ss_dssp             TTCBHHHHHHCTT-----------CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGG
T ss_pred             ecCchhhhhcccc-----------ccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccch
Confidence            9999999987643           36889999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCCc---eeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhch
Q 009340          375 RSIPNDKTH---LTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQ  451 (537)
Q Consensus       375 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  451 (537)
                      +........   ......||+.|+|||.+.++.++.++||||||+++|||+||+.|+.......  ...    .....+.
T Consensus       178 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~--~~~----~~i~~g~  251 (311)
T d1r0pa_         178 RDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DIT----VYLLQGR  251 (311)
T ss_dssp             CCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CH----HHHHTTC
T ss_pred             hhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH--HHH----HHHHcCC
Confidence            876543322   2234568999999999999999999999999999999999888875432111  111    1111111


Q ss_pred             hhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHH
Q 009340          452 LLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRR  502 (537)
Q Consensus       452 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~  502 (537)
                               ....+..++..+.+|+.+||+.||++||||.||++.|+.+..
T Consensus       252 ---------~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~  293 (311)
T d1r0pa_         252 ---------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS  293 (311)
T ss_dssp             ---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---------CCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence                     112233445678999999999999999999999999998875

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-50  Score=396.24  Aligned_cols=249  Identities=22%  Similarity=0.363  Sum_probs=204.9

Q ss_pred             cCCccccccCcCCceEEEEEEc-CCCCEEEEEEccCC---ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEI---DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY  291 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  291 (537)
                      ++|+..+.||+|+||+||+|+. .+|+.||||+++..   .....+.+.+|+.++++++||||+++++++.+.+..|+||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            5789999999999999999996 47899999998642   1233567899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeec
Q 009340          292 EYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF  371 (537)
Q Consensus       292 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Df  371 (537)
                      ||+++|+|.+++...            ..+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+||
T Consensus        88 Ey~~gg~L~~~~~~~------------~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DF  152 (288)
T d1uu3a_          88 SYAKNGELLKYIRKI------------GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDF  152 (288)
T ss_dssp             CCCTTEEHHHHHHHH------------SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCC
T ss_pred             EccCCCCHHHhhhcc------------CCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEeccc
Confidence            999999999988753            36999999999999999999999999   999999999999999999999999


Q ss_pred             cCccccCCCC-CceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhc
Q 009340          372 GISRSIPNDK-THLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKEN  450 (537)
Q Consensus       372 gla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  450 (537)
                      |+++.+.... ........||+.|+|||++.+..++.++|||||||++|||++|+.||......+      .+..... .
T Consensus       153 G~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~------~~~~i~~-~  225 (288)
T d1uu3a_         153 GTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL------IFQKIIK-L  225 (288)
T ss_dssp             TTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHT-T
T ss_pred             ccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH------HHHHHHc-C
Confidence            9998875433 223445679999999999999999999999999999999999999997543221      1111111 1


Q ss_pred             hhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHH
Q 009340          451 QLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSME  496 (537)
Q Consensus       451 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~  496 (537)
                      .          ...+...+..+.+|+.+||+.||++|||+.|++..
T Consensus       226 ~----------~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~  261 (288)
T d1uu3a_         226 E----------YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY  261 (288)
T ss_dssp             C----------CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred             C----------CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence            0          11233445678899999999999999999998553

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-50  Score=397.62  Aligned_cols=279  Identities=26%  Similarity=0.395  Sum_probs=209.2

Q ss_pred             CHHHHHHHhcCCccccccCcCCceEEEEEEcC------CCCEEEEEEccC-CChHHHHHHHHHHHHHHhc-CCCCcceEe
Q 009340          207 TADELQRATDNYNQSRFLGQGGFGTVYKGMLP------DGSIVAVKRSKE-IDKTQIHQFINEVVILSQI-NHRHIVKLL  278 (537)
Q Consensus       207 ~~~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~-~~~~~~~~~~~E~~~l~~l-~H~niv~l~  278 (537)
                      +.++++...++|+..++||+|+||.||+|.+.      +++.||||+++. ......+.+.+|..++.++ +|+||++++
T Consensus         4 ~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~   83 (299)
T d1ywna1           4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL   83 (299)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEee
Confidence            33444444578999999999999999999853      346899999875 3445567788999888887 689999999


Q ss_pred             eEEeeCC-ccEEEEecCCCCChhhhhhhhhhhHHH----HhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCC
Q 009340          279 GCCLETE-VPVLVYEYISSGTLSHHIHDHQQQQEQ----KQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDI  353 (537)
Q Consensus       279 g~~~~~~-~~~lV~e~~~~gsL~~~l~~~~~~~~~----~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dl  353 (537)
                      +++.+.+ ..++||||+++|+|.++++........    ........++|.+++.++.||++||.|||+++   |+||||
T Consensus        84 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDl  160 (299)
T d1ywna1          84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL  160 (299)
T ss_dssp             EEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred             eeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcC
Confidence            9987654 689999999999999999865431100    00001235899999999999999999999999   999999


Q ss_pred             CCCCEEECCCCcEEEeeccCccccCCCCCc-eeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCC-CCCCcc
Q 009340          354 KSSNILLDDKFSAKVSDFGISRSIPNDKTH-LTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGK-KPICFA  431 (537)
Q Consensus       354 k~~NIll~~~~~~ki~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~-~p~~~~  431 (537)
                      ||+||||++++.+||+|||+|+........ ......||+.|+|||.+.++.++.++|||||||++|||+||. .||...
T Consensus       161 Kp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~  240 (299)
T d1ywna1         161 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV  240 (299)
T ss_dssp             CGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             CccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCC
Confidence            999999999999999999999876444332 334567999999999999999999999999999999999975 466433


Q ss_pred             chhhhccHHHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHHh
Q 009340          432 RVEEERNLVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRS  503 (537)
Q Consensus       432 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~  503 (537)
                      ...+      .+......         ....+.+...++++.+|+.+||+.||++||||.||++.|+.|.++
T Consensus       241 ~~~~------~~~~~~~~---------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~  297 (299)
T d1ywna1         241 KIDE------EFCRRLKE---------GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  297 (299)
T ss_dssp             CCSH------HHHHHHHH---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CHHH------HHHHHHhc---------CCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence            2221      12222221         112233444556789999999999999999999999999988754

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.6e-49  Score=399.89  Aligned_cols=252  Identities=22%  Similarity=0.313  Sum_probs=210.5

Q ss_pred             hcCCccccccCcCCceEEEEEEc-CCCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEec
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY  293 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  293 (537)
                      .++|+..+.||+|+||.||+|+. .+|+.||||++........+.+.+|+.+|++++|||||++++++.+.+..++||||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  104 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  104 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            36899999999999999999996 47899999999877677778899999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEC--CCCcEEEeec
Q 009340          294 ISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD--DKFSAKVSDF  371 (537)
Q Consensus       294 ~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~--~~~~~ki~Df  371 (537)
                      +++|+|.+++....           ..+++..+..++.||+.||.|||+++   |+||||||+|||++  .++.+||+||
T Consensus       105 ~~gg~L~~~l~~~~-----------~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DF  170 (350)
T d1koaa2         105 MSGGELFEKVADEH-----------NKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDF  170 (350)
T ss_dssp             CCSCBHHHHHTCTT-----------SCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCC
T ss_pred             CCCCCHHHHHHhhc-----------CCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeec
Confidence            99999999986532           36999999999999999999999999   99999999999995  4678999999


Q ss_pred             cCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhch
Q 009340          372 GISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQ  451 (537)
Q Consensus       372 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  451 (537)
                      |+++......  ......||+.|||||++.+..++.++|||||||++|||++|+.||......+      .+........
T Consensus       171 G~a~~~~~~~--~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~------~~~~i~~~~~  242 (350)
T d1koaa2         171 GLTAHLDPKQ--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE------TLRNVKSCDW  242 (350)
T ss_dssp             TTCEECCTTS--CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHTCC
T ss_pred             chheeccccc--ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHH------HHHHHHhCCC
Confidence            9998875443  2455679999999999999999999999999999999999999996543322      1111111100


Q ss_pred             hhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          452 LLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       452 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                             ..........+..+.+|+.+||+.||++|||+.|+++
T Consensus       243 -------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  279 (350)
T d1koaa2         243 -------NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE  279 (350)
T ss_dssp             -------CSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             -------CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                   0011111233457889999999999999999999976

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=9.9e-50  Score=394.69  Aligned_cols=251  Identities=25%  Similarity=0.349  Sum_probs=191.3

Q ss_pred             hcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCC-hHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEe
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEID-KTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE  292 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e  292 (537)
                      .+.|+..+.||+|+||+||+|+.. +|+.||||.+.... ......+.+|+.+|++++||||+++++++.+.+..|+|||
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE   87 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ   87 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            467999999999999999999964 68999999986532 2334568899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEC---CCCcEEEe
Q 009340          293 YISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD---DKFSAKVS  369 (537)
Q Consensus       293 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~---~~~~~ki~  369 (537)
                      |+++|+|.+++...            ..+++..+..++.|++.||+|||+.+   |+||||||+|||++   +++.+||+
T Consensus        88 ~~~gg~L~~~l~~~------------~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~  152 (307)
T d1a06a_          88 LVSGGELFDRIVEK------------GFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMIS  152 (307)
T ss_dssp             CCCSCBHHHHHHTC------------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEEC
T ss_pred             ccCCCcHHHhhhcc------------cCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEe
Confidence            99999999999752            46999999999999999999999999   99999999999994   57899999


Q ss_pred             eccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhh
Q 009340          370 DFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKE  449 (537)
Q Consensus       370 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  449 (537)
                      |||+++......  ......||+.|||||.+.+..++.++|||||||++|||++|+.||......+.      .......
T Consensus       153 DFG~a~~~~~~~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~------~~~i~~~  224 (307)
T d1a06a_         153 DFGLSKMEDPGS--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKL------FEQILKA  224 (307)
T ss_dssp             CC--------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHHHHTT
T ss_pred             ccceeEEccCCC--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHH------HHHHhcc
Confidence            999998764332  23456799999999999999999999999999999999999999975433221      1111111


Q ss_pred             chhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          450 NQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       450 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      . .      ....+.....++.+.+|+.+||+.||++|||+.|+++
T Consensus       225 ~-~------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         225 E-Y------EFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             C-C------CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             C-C------CCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            0 0      0111122334567889999999999999999999976

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-50  Score=397.29  Aligned_cols=267  Identities=27%  Similarity=0.433  Sum_probs=210.4

Q ss_pred             cCCccccccCcCCceEEEEEEcCC-CC--EEEEEEccCC-ChHHHHHHHHHHHHHHhc-CCCCcceEeeEEeeCCccEEE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLPD-GS--IVAVKRSKEI-DKTQIHQFINEVVILSQI-NHRHIVKLLGCCLETEVPVLV  290 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~~-g~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV  290 (537)
                      ++|+..++||+|+||.||+|++++ |.  .||||+++.. .....++|.+|+++|+++ +||||++++|+|.+.+..++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            678888999999999999999753 33  5889988643 444567899999999999 799999999999999999999


Q ss_pred             EecCCCCChhhhhhhhhhhHH----HHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcE
Q 009340          291 YEYISSGTLSHHIHDHQQQQE----QKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA  366 (537)
Q Consensus       291 ~e~~~~gsL~~~l~~~~~~~~----~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~  366 (537)
                      |||+++|+|.++++.......    .........++|..+++++.|||+||.|||+.+   |+||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence            999999999999986532111    111223457999999999999999999999998   9999999999999999999


Q ss_pred             EEeeccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCC-CCCccchhhhccHHHHHHH
Q 009340          367 KVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKK-PICFARVEEERNLVACFIS  445 (537)
Q Consensus       367 ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~-p~~~~~~~~~~~~~~~~~~  445 (537)
                      ||+|||+++......  ......||..|+|||.+.++.++.++|||||||++|||++|.. ||......+       +..
T Consensus       167 kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~-------~~~  237 (309)
T d1fvra_         167 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-------LYE  237 (309)
T ss_dssp             EECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HHH
T ss_pred             EEccccccccccccc--cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH-------HHH
Confidence            999999998653222  2234568999999999999999999999999999999999765 554332211       111


Q ss_pred             HHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHHh
Q 009340          446 LAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRS  503 (537)
Q Consensus       446 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~  503 (537)
                      .         +......+.+...+.++.+|+.+||+.||++||||.||++.|+++.+.
T Consensus       238 ~---------i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~  286 (309)
T d1fvra_         238 K---------LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  286 (309)
T ss_dssp             H---------GGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             H---------HHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence            1         111122233445567899999999999999999999999999998764

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-49  Score=393.88  Aligned_cols=270  Identities=26%  Similarity=0.402  Sum_probs=216.6

Q ss_pred             hcCCccccccCcCCceEEEEEEc------CCCCEEEEEEccCC-ChHHHHHHHHHHHHHHhc-CCCCcceEeeEEeeCCc
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGML------PDGSIVAVKRSKEI-DKTQIHQFINEVVILSQI-NHRHIVKLLGCCLETEV  286 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~  286 (537)
                      .++|+..++||+|+||.||+|++      .+++.||||+++.. ......+|.+|+.+++++ +|||||+++|+|.+.+.
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~  101 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence            46888899999999999999985      24568999999753 445566899999999999 79999999999999999


Q ss_pred             cEEEEecCCCCChhhhhhhhhhhHHHH------hhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEE
Q 009340          287 PVLVYEYISSGTLSHHIHDHQQQQEQK------QKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILL  360 (537)
Q Consensus       287 ~~lV~e~~~~gsL~~~l~~~~~~~~~~------~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll  360 (537)
                      .++||||+++|+|.++++.........      .......+++..+++++.||++||+|||+++   ++||||||+|||+
T Consensus       102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~  178 (311)
T d1t46a_         102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL  178 (311)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred             EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccccc
Confidence            999999999999999998754321110      1112346999999999999999999999999   9999999999999


Q ss_pred             CCCCcEEEeeccCccccCCCCCc-eeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCC-CCccchhhhcc
Q 009340          361 DDKFSAKVSDFGISRSIPNDKTH-LTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKP-ICFARVEEERN  438 (537)
Q Consensus       361 ~~~~~~ki~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p-~~~~~~~~~~~  438 (537)
                      +.++.+||+|||+++........ ..+...||+.|+|||.+.++.++.++|||||||++|||+|++.| +......+.  
T Consensus       179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~--  256 (311)
T d1t46a_         179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK--  256 (311)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH--
T ss_pred             cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH--
Confidence            99999999999999987554433 33456789999999999999999999999999999999995555 433222111  


Q ss_pred             HHHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHH
Q 009340          439 LVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRR  502 (537)
Q Consensus       439 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~  502 (537)
                          +.         .++........+...+..+.+|+.+||+.||++||||.+|+++|+++..
T Consensus       257 ----~~---------~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~  307 (311)
T d1t46a_         257 ----FY---------KMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS  307 (311)
T ss_dssp             ----HH---------HHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----HH---------HHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence                11         1222223333344456789999999999999999999999999987654

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-49  Score=394.62  Aligned_cols=267  Identities=26%  Similarity=0.427  Sum_probs=215.7

Q ss_pred             hcCCccccccCcCCceEEEEEEcC------CCCEEEEEEccC-CChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCcc
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLP------DGSIVAVKRSKE-IDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVP  287 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~  287 (537)
                      .++|...++||+|+||+||+|.+.      +++.||||+++. ........|.+|+.++++++||||++++|+|...+..
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~   98 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT   98 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence            468888999999999999999863      357899999975 3445566799999999999999999999999999999


Q ss_pred             EEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEE
Q 009340          288 VLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAK  367 (537)
Q Consensus       288 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~k  367 (537)
                      ++||||+++|+|.+++..........  .....++|..+.+++.|+|+||.|||+++   |+||||||+|||+|+++++|
T Consensus        99 ~lv~e~~~~g~l~~~~~~~~~~~~~~--~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~K  173 (308)
T d1p4oa_          99 LVIMELMTRGDLKSYLRSLRPAMANN--PVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVK  173 (308)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHHHHHC--TTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEE
T ss_pred             eEEEeecCCCCHHHHHHhcccccccc--cccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEE
Confidence            99999999999999998754432211  12345899999999999999999999998   99999999999999999999


Q ss_pred             EeeccCccccCCCCCce-eeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCC-CCCCccchhhhccHHHHHHH
Q 009340          368 VSDFGISRSIPNDKTHL-TTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGK-KPICFARVEEERNLVACFIS  445 (537)
Q Consensus       368 i~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~-~p~~~~~~~~~~~~~~~~~~  445 (537)
                      |+|||+++......... .....||+.|+|||.+.++.++.++||||||+++|||+||. .|+......+      .+..
T Consensus       174 l~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~------~~~~  247 (308)
T d1p4oa_         174 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ------VLRF  247 (308)
T ss_dssp             ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH------HHHH
T ss_pred             EeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHH------HHHH
Confidence            99999998764433322 23446899999999999999999999999999999999985 5554332221      1111


Q ss_pred             HHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHH
Q 009340          446 LAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRR  502 (537)
Q Consensus       446 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~  502 (537)
                       ...+         ...+.+..++..+.+|+.+||+.||++||||.+|+++|++..+
T Consensus       248 -i~~~---------~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~  294 (308)
T d1p4oa_         248 -VMEG---------GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  294 (308)
T ss_dssp             -HHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             -HHhC---------CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence             1111         1122344455789999999999999999999999999986644

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-49  Score=391.17  Aligned_cols=269  Identities=28%  Similarity=0.418  Sum_probs=210.7

Q ss_pred             hcCCccccccCcCCceEEEEEEcC--------CCCEEEEEEccCC-ChHHHHHHHHHHHHHHhc-CCCCcceEeeEEeeC
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLP--------DGSIVAVKRSKEI-DKTQIHQFINEVVILSQI-NHRHIVKLLGCCLET  284 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~  284 (537)
                      .++|...+.||+|+||.||+|+..        ++..||||+++.. ......++.+|...+.++ +|||||+++++|.+.
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~   91 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   91 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence            357888899999999999999853        2347999998754 345567899999999998 899999999999999


Q ss_pred             CccEEEEecCCCCChhhhhhhhhhhHH----HHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEE
Q 009340          285 EVPVLVYEYISSGTLSHHIHDHQQQQE----QKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILL  360 (537)
Q Consensus       285 ~~~~lV~e~~~~gsL~~~l~~~~~~~~----~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll  360 (537)
                      +..++||||+++|+|.+++........    .........+++.++++++.|++.||+|||+.+   ||||||||+|||+
T Consensus        92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl  168 (299)
T d1fgka_          92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV  168 (299)
T ss_dssp             SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred             CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceee
Confidence            999999999999999999976542110    001112346999999999999999999999999   9999999999999


Q ss_pred             CCCCcEEEeeccCccccCCCCCc-eeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccchhhhcc
Q 009340          361 DDKFSAKVSDFGISRSIPNDKTH-LTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLT-GKKPICFARVEEERN  438 (537)
Q Consensus       361 ~~~~~~ki~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~t-g~~p~~~~~~~~~~~  438 (537)
                      +.++.+||+|||+++........ ......+|+.|+|||.+.++.++.|+|||||||++|||++ |+.||.......   
T Consensus       169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~---  245 (299)
T d1fgka_         169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---  245 (299)
T ss_dssp             CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---
T ss_pred             cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH---
Confidence            99999999999999877543332 2344568999999999999999999999999999999998 677775433221   


Q ss_pred             HHHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHH
Q 009340          439 LVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRR  502 (537)
Q Consensus       439 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~  502 (537)
                          ....+.         .....+.+...+.++.+|+.+||+.||++||||.||+++|++|..
T Consensus       246 ----~~~~i~---------~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a  296 (299)
T d1fgka_         246 ----LFKLLK---------EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA  296 (299)
T ss_dssp             ----HHHHHH---------TTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----HHHHHH---------cCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence                111111         122223344455679999999999999999999999999998865

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=4.1e-49  Score=397.30  Aligned_cols=252  Identities=22%  Similarity=0.310  Sum_probs=210.6

Q ss_pred             hcCCccccccCcCCceEEEEEEc-CCCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEec
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY  293 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  293 (537)
                      .++|+..+.||+|+||.||+|+. .+|+.||||+++.......+.+.+|+.+|++++|||||++++++.+.+..|+||||
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  107 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  107 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            35799999999999999999995 47999999999876666667889999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEC--CCCcEEEeec
Q 009340          294 ISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD--DKFSAKVSDF  371 (537)
Q Consensus       294 ~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~--~~~~~ki~Df  371 (537)
                      +++|+|.+++....           ..+++.+++.|+.||++||.|||+.+   |+||||||+||||+  .++.+||+||
T Consensus       108 ~~gg~L~~~~~~~~-----------~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DF  173 (352)
T d1koba_         108 LSGGELFDRIAAED-----------YKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDF  173 (352)
T ss_dssp             CCCCBHHHHTTCTT-----------CCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCC
T ss_pred             CCCChHHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeec
Confidence            99999998876532           36999999999999999999999999   99999999999998  6789999999


Q ss_pred             cCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhch
Q 009340          372 GISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQ  451 (537)
Q Consensus       372 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  451 (537)
                      |+++......  ......||+.|+|||++.+..++.++|||||||++|||+||+.||......+.      +..... ..
T Consensus       174 Gla~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~------~~~i~~-~~  244 (352)
T d1koba_         174 GLATKLNPDE--IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET------LQNVKR-CD  244 (352)
T ss_dssp             TTCEECCTTS--CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH------HHHHHH-CC
T ss_pred             ccceecCCCC--ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHh-CC
Confidence            9999875443  24556799999999999999999999999999999999999999965433221      111111 10


Q ss_pred             hhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          452 LLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       452 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                            ...........+.++.+|+.+||+.||++|||+.|+++
T Consensus       245 ------~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  282 (352)
T d1koba_         245 ------WEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  282 (352)
T ss_dssp             ------CCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             ------CCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                  00111122334567889999999999999999999976

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-49  Score=390.34  Aligned_cols=268  Identities=22%  Similarity=0.313  Sum_probs=202.1

Q ss_pred             cCCccccccCcCCceEEEEEEcCCCCEEEEEEccCCChHHHHHHHH--HHHHHHhcCCCCcceEeeEEeeCC----ccEE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFIN--EVVILSQINHRHIVKLLGCCLETE----VPVL  289 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~--E~~~l~~l~H~niv~l~g~~~~~~----~~~l  289 (537)
                      +.|...+.||+|+||.||+|++ +|+.||||+++...   .+++..  |+..+.+++||||++++|+|.+.+    ..++
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l   78 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL   78 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence            4566778999999999999998 58899999987532   234444  455556789999999999998754    4689


Q ss_pred             EEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcC-----CCCeeecCCCCCCEEECCCC
Q 009340          290 VYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSA-----SIPIFHRDIKSSNILLDDKF  364 (537)
Q Consensus       290 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~-----~~~ivH~Dlk~~NIll~~~~  364 (537)
                      ||||+++|+|.++++.             ..++|..+++++.|+|.||+|||+..     ..+|+||||||+||||+.++
T Consensus        79 v~Ey~~~g~L~~~l~~-------------~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~  145 (303)
T d1vjya_          79 VSDYHEHGSLFDYLNR-------------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG  145 (303)
T ss_dssp             EEECCTTCBHHHHHHH-------------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTS
T ss_pred             EEecccCCCHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCC
Confidence            9999999999999964             25999999999999999999999741     23499999999999999999


Q ss_pred             cEEEeeccCccccCCCCCc---eeeeccccccccCcccccCCC------CCcchhHHHHHHHHHHHHhCCCCCCccchhh
Q 009340          365 SAKVSDFGISRSIPNDKTH---LTTTIQGTFGYLDPEYFQSSQ------FTDKSDVYSFGVVLLELLTGKKPICFARVEE  435 (537)
Q Consensus       365 ~~ki~Dfgla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~  435 (537)
                      .+||+|||+++........   ......||+.|+|||++.+..      ++.|+|||||||+||||+||..|+.......
T Consensus       146 ~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~  225 (303)
T d1vjya_         146 TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ  225 (303)
T ss_dssp             CEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCC
T ss_pred             CeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccc
Confidence            9999999999877443322   234567999999999987643      5779999999999999999988874332111


Q ss_pred             h--------ccHHHHHHHHHhhchhhhhhcHHhhcc-ccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHHhh
Q 009340          436 E--------RNLVACFISLAKENQLLEILDARVAKE-AREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRSQ  504 (537)
Q Consensus       436 ~--------~~~~~~~~~~~~~~~~~~~~d~~~~~~-~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~  504 (537)
                      .        ...............    +++.+... .+.+....+.+|+.+||+.||++||||.||++.|++|.+..
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~----~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~  299 (303)
T d1vjya_         226 LPYYDLVPSDPSVEEMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE  299 (303)
T ss_dssp             CTTTTTSCSSCCHHHHHHHHTTSC----CCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             cchhhcccccchHHHHHHHHhccc----cCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhc
Confidence            0        011111111111111    11111111 13345677999999999999999999999999999988643

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-49  Score=387.79  Aligned_cols=251  Identities=25%  Similarity=0.342  Sum_probs=205.8

Q ss_pred             hcCCccccccCcCCceEEEEEEc-CCCCEEEEEEccCC------ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCcc
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEI------DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVP  287 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~------~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~  287 (537)
                      .++|+..+.||+|+||+||+|+. .+|+.||||+++..      .....+.|.+|+.+|++++|||||++++++.+.+..
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            36799999999999999999996 47999999987532      112357899999999999999999999999999999


Q ss_pred             EEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCC---
Q 009340          288 VLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF---  364 (537)
Q Consensus       288 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~---  364 (537)
                      ++||||+++|+|.+++...            ..+++..++.++.|+++||+|||+.+   |+||||||+|||++.++   
T Consensus        89 ~iv~E~~~gg~L~~~i~~~------------~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~  153 (293)
T d1jksa_          89 ILILELVAGGELFDFLAEK------------ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPK  153 (293)
T ss_dssp             EEEEECCCSCBHHHHHHHH------------SSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSS
T ss_pred             EEEEEcCCCccccchhccc------------cccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcc
Confidence            9999999999999999753            36999999999999999999999999   99999999999998776   


Q ss_pred             -cEEEeeccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHH
Q 009340          365 -SAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACF  443 (537)
Q Consensus       365 -~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~  443 (537)
                       .+||+|||++.......  ......||+.|+|||.+.+..++.++|||||||++|||++|+.||......+.      +
T Consensus       154 ~~vkl~DfG~a~~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~------~  225 (293)
T d1jksa_         154 PRIKIIDFGLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET------L  225 (293)
T ss_dssp             CCEEECCCTTCEECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------H
T ss_pred             cceEecchhhhhhcCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHH------H
Confidence             49999999998764432  23455789999999999999999999999999999999999999975433221      1


Q ss_pred             HHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          444 ISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       444 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      ..... ...      ......+...+..+.+|+.+||+.||++|||+.|+++
T Consensus       226 ~~i~~-~~~------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         226 ANVSA-VNY------EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             HHHHT-TCC------CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHHHh-cCC------CCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            11111 100      0001111223457889999999999999999999865

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.8e-48  Score=380.94  Aligned_cols=259  Identities=27%  Similarity=0.406  Sum_probs=204.7

Q ss_pred             hcCCccccccCcCCceEEEEEEc-CCCCEEEEEEccCC---ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCC----c
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEI---DKTQIHQFINEVVILSQINHRHIVKLLGCCLETE----V  286 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~  286 (537)
                      .++|...+.||+|+||.||+|+. .+|+.||||.++..   +....+.|.+|+.++++++||||+++++++...+    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            46799999999999999999995 47999999998642   3455678999999999999999999999998654    3


Q ss_pred             cEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcE
Q 009340          287 PVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA  366 (537)
Q Consensus       287 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~  366 (537)
                      .|+||||+++|+|.+++...            ..+++.+++.++.||++||+|||+++   |+||||||+|||++.++..
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~------------~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~  150 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTE------------GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAV  150 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHH------------CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCE
T ss_pred             EEEEEECCCCCEehhhhccc------------CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccc
Confidence            78999999999999888653            36999999999999999999999999   9999999999999999999


Q ss_pred             EEeeccCccccCCCCC--ceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHH
Q 009340          367 KVSDFGISRSIPNDKT--HLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFI  444 (537)
Q Consensus       367 ki~Dfgla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~  444 (537)
                      +|+|||.+........  .......||+.|+|||++.+..++.++|||||||++|||+||+.||......+      .+.
T Consensus       151 ~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~------~~~  224 (277)
T d1o6ya_         151 KVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS------VAY  224 (277)
T ss_dssp             EECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHH
T ss_pred             eeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHH------HHH
Confidence            9999999876533322  23345679999999999999999999999999999999999999997543221      122


Q ss_pred             HHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCC-CHhhHHHHHHHHH
Q 009340          445 SLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRP-TMKQVSMELEGLR  501 (537)
Q Consensus       445 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-s~~ev~~~L~~i~  501 (537)
                      .........       ........+..+.+++.+||+.||++|| |+.++++.|.+++
T Consensus       225 ~~~~~~~~~-------~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~  275 (277)
T d1o6ya_         225 QHVREDPIP-------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  275 (277)
T ss_dssp             HHHHCCCCC-------GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             HHHhcCCCC-------CchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence            222211110       0111223446788999999999999999 8999999998875

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-48  Score=387.16  Aligned_cols=247  Identities=24%  Similarity=0.369  Sum_probs=207.1

Q ss_pred             cCCccccccCcCCceEEEEEEc-CCCCEEEEEEccCC---ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEI---DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY  291 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  291 (537)
                      ++|+..+.||+|+||.||+++. .+|+.||||+++..   .....+.+.+|+.+|++++||||+++++++.+.+..|+||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~   84 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence            5789999999999999999995 47999999998642   2234567889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeec
Q 009340          292 EYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF  371 (537)
Q Consensus       292 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Df  371 (537)
                      ||+++|+|.+++...            ..+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+||
T Consensus        85 ey~~gg~L~~~~~~~------------~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DF  149 (337)
T d1o6la_          85 EYANGGELFFHLSRE------------RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDF  149 (337)
T ss_dssp             ECCTTCBHHHHHHHH------------SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCC
T ss_pred             eccCCCchhhhhhcc------------cCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeec
Confidence            999999999998763            35899999999999999999999999   999999999999999999999999


Q ss_pred             cCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhch
Q 009340          372 GISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQ  451 (537)
Q Consensus       372 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  451 (537)
                      |+|+....... ......||+.|+|||++.+..|+.++||||+||++|||++|+.||......+       .........
T Consensus       150 G~a~~~~~~~~-~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~-------~~~~i~~~~  221 (337)
T d1o6la_         150 GLCKEGISDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-------LFELILMEE  221 (337)
T ss_dssp             TTCBCSCCTTC-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCC
T ss_pred             ccccccccCCc-ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH-------HHHHHhcCC
Confidence            99987643332 3445679999999999999999999999999999999999999997654322       111111111


Q ss_pred             hhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCC-----HhhHHH
Q 009340          452 LLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPT-----MKQVSM  495 (537)
Q Consensus       452 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~ev~~  495 (537)
                                ...+...+.++.+|+.+||+.||++||+     +.|+++
T Consensus       222 ----------~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         222 ----------IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             ----------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             ----------CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence                      1223445567889999999999999995     666654

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=7.3e-48  Score=382.78  Aligned_cols=244  Identities=25%  Similarity=0.394  Sum_probs=204.9

Q ss_pred             cCCccccccCcCCceEEEEEEc-CCCCEEEEEEccCC---ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEI---DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY  291 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  291 (537)
                      ++|+..+.||+|+||+||+|+. .+|+.||||+++..   .....+.+.+|+.++++++||||+++++++.+.+..|+||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            5788899999999999999996 46999999998642   2233567899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeec
Q 009340          292 EYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF  371 (537)
Q Consensus       292 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Df  371 (537)
                      ||+++|+|..++...            ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+||
T Consensus        84 E~~~gg~l~~~~~~~------------~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DF  148 (316)
T d1fota_          84 DYIEGGELFSLLRKS------------QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDF  148 (316)
T ss_dssp             CCCCSCBHHHHHHHT------------SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCC
T ss_pred             eecCCcccccccccc------------ccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecC
Confidence            999999999888763            45889999999999999999999999   999999999999999999999999


Q ss_pred             cCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhch
Q 009340          372 GISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQ  451 (537)
Q Consensus       372 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  451 (537)
                      |+++.....    .....||+.|||||++.+..++.++|||||||++|||++|+.||......+.      ....... .
T Consensus       149 G~a~~~~~~----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~------~~~i~~~-~  217 (316)
T d1fota_         149 GFAKYVPDV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT------YEKILNA-E  217 (316)
T ss_dssp             SSCEECSSC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHHHC-C
T ss_pred             ccceEeccc----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHH------HHHHHcC-C
Confidence            999876433    2356799999999999999999999999999999999999999975433221      1111111 0


Q ss_pred             hhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCC-----CHhhHHH
Q 009340          452 LLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRP-----TMKQVSM  495 (537)
Q Consensus       452 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~  495 (537)
                                ...+...+..+.+++.+||+.||.+||     |+.++++
T Consensus       218 ----------~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         218 ----------LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             ----------CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             ----------CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence                      112333446788999999999999996     8888875

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.2e-47  Score=373.97  Aligned_cols=250  Identities=24%  Similarity=0.386  Sum_probs=204.5

Q ss_pred             cCCccccccCcCCceEEEEEEc-CCCCEEEEEEccCCC---------hHHHHHHHHHHHHHHhcC-CCCcceEeeEEeeC
Q 009340          216 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEID---------KTQIHQFINEVVILSQIN-HRHIVKLLGCCLET  284 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~  284 (537)
                      ++|+..+.||+|+||+||+++. .+|+.||||+++...         +...+.+.+|+.++++++ ||||+++++++.+.
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            5789999999999999999995 478999999976421         123456889999999997 99999999999999


Q ss_pred             CccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCC
Q 009340          285 EVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF  364 (537)
Q Consensus       285 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~  364 (537)
                      +..|+||||+++|+|.+++...            ..+++.++..++.||++||+|||+++   |+||||||+|||++.++
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~~------------~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~  147 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTEK------------VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDM  147 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHH------------SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTC
T ss_pred             cceEEEEEcCCCchHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCC
Confidence            9999999999999999999753            36999999999999999999999999   99999999999999999


Q ss_pred             cEEEeeccCccccCCCCCceeeeccccccccCccccc------CCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhcc
Q 009340          365 SAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQ------SSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERN  438 (537)
Q Consensus       365 ~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~  438 (537)
                      .+||+|||+++......  ......||+.|+|||++.      ...++.++||||+||++|||++|+.||......+.  
T Consensus       148 ~~kl~DFG~a~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~--  223 (277)
T d1phka_         148 NIKLTDFGFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM--  223 (277)
T ss_dssp             CEEECCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--
T ss_pred             CeEEccchheeEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHH--
Confidence            99999999998875433  234567999999999985      34578899999999999999999999976543221  


Q ss_pred             HHHHHHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          439 LVACFISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       439 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                          ...... +..      ....+.....++++.+|+.+||+.||++|||+.||++
T Consensus       224 ----~~~i~~-~~~------~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         224 ----LRMIMS-GNY------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             ----HHHHHH-TCC------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             ----HHHHHh-CCC------CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence                111111 110      0011112234567889999999999999999999854

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=3.4e-47  Score=385.22  Aligned_cols=248  Identities=23%  Similarity=0.375  Sum_probs=198.4

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCC------ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI------DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPV  288 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~------~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  288 (537)
                      ++|+..+.||+|+||.||+|+.. +|+.||||++...      .........+|+.+++.++|||||++++++.+.+..|
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            67999999999999999999964 6999999987531      1111222334577777888999999999999999999


Q ss_pred             EEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEE
Q 009340          289 LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKV  368 (537)
Q Consensus       289 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki  368 (537)
                      +||||+++|+|.+++...            ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||
T Consensus        84 ivmE~~~gg~L~~~l~~~------------~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl  148 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQH------------GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRI  148 (364)
T ss_dssp             EEECCCCSCBHHHHHHHH------------CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEE
T ss_pred             EEEEecCCCcHHHHHHhc------------ccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEE
Confidence            999999999999999753            35899999999999999999999999   999999999999999999999


Q ss_pred             eeccCccccCCCCCceeeeccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHH
Q 009340          369 SDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQS-SQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLA  447 (537)
Q Consensus       369 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~  447 (537)
                      +|||+|+......   .....||+.|+|||++.. ..++.++|||||||++|||+||+.||......+..   . .....
T Consensus       149 ~DFGla~~~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~---~-~~~~~  221 (364)
T d1omwa3         149 SDLGLACDFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH---E-IDRMT  221 (364)
T ss_dssp             CCCTTCEECSSSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHH---H-HHHHS
T ss_pred             eeeceeeecCCCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHH---H-HHHhc
Confidence            9999998765432   344579999999999975 46899999999999999999999999754332210   0 10000


Q ss_pred             hhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCC-----HhhHHH
Q 009340          448 KENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPT-----MKQVSM  495 (537)
Q Consensus       448 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~ev~~  495 (537)
                              ..  .....+...++++.+|+.+||+.||++|||     +.|+++
T Consensus       222 --------~~--~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         222 --------LT--MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             --------SS--CCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             --------cc--CCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence                    00  011123344567889999999999999999     466653

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-47  Score=380.75  Aligned_cols=247  Identities=24%  Similarity=0.377  Sum_probs=204.0

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCC---ChHHHHHHHHHHHHHH-hcCCCCcceEeeEEeeCCccEEE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI---DKTQIHQFINEVVILS-QINHRHIVKLLGCCLETEVPVLV  290 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~-~l~H~niv~l~g~~~~~~~~~lV  290 (537)
                      ++|...+.||+|+||+||+|+.. +|+.||||+++..   .....+.+..|..++. .++||||+++++++.+.+..|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            57889999999999999999964 6899999998642   1223456777777765 68999999999999999999999


Q ss_pred             EecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEee
Q 009340          291 YEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSD  370 (537)
Q Consensus       291 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~D  370 (537)
                      |||+++|+|.+++...            ..+++.++..++.||+.||+|||+++   |+||||||+|||+++++.+||+|
T Consensus        82 mEy~~~g~L~~~i~~~------------~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~D  146 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSC------------HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIAD  146 (320)
T ss_dssp             EECCTTCBHHHHHHHH------------SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECC
T ss_pred             EeecCCCcHHHHhhcc------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccc
Confidence            9999999999999763            35899999999999999999999999   99999999999999999999999


Q ss_pred             ccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhc
Q 009340          371 FGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKEN  450 (537)
Q Consensus       371 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  450 (537)
                      ||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......       ........
T Consensus       147 FG~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~-------~~~~i~~~  218 (320)
T d1xjda_         147 FGMCKENMLGDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE-------LFHSIRMD  218 (320)
T ss_dssp             CTTCBCCCCTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHC
T ss_pred             cchhhhcccccc-cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH-------HHHHHHcC
Confidence            999987644332 3445679999999999999999999999999999999999999997544322       11111111


Q ss_pred             hhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHh-hHHH
Q 009340          451 QLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMK-QVSM  495 (537)
Q Consensus       451 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~-ev~~  495 (537)
                                ....+...+.++.+|+.+||+.||++|||+. ++++
T Consensus       219 ----------~~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         219 ----------NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             ----------CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             ----------CCCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence                      0122334456788999999999999999996 6753

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.9e-47  Score=382.68  Aligned_cols=244  Identities=24%  Similarity=0.356  Sum_probs=205.1

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCC---ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEI---DKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY  291 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  291 (537)
                      ++|+..+.||+|+||.||+|+.+ +|+.||||+++..   .....+.+.+|+.+|+.++||||+++++++.+....++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            57999999999999999999964 7999999998632   1233567899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeec
Q 009340          292 EYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDF  371 (537)
Q Consensus       292 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Df  371 (537)
                      ||+.+|+|.+++...            ..+++..+..++.||+.||.|||+++   ||||||||+|||++.++.+||+||
T Consensus       121 e~~~~g~l~~~l~~~------------~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DF  185 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRI------------GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDF  185 (350)
T ss_dssp             ECCTTCBHHHHHHHH------------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred             ccccccchhhhHhhc------------CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeec
Confidence            999999999998753            36999999999999999999999999   999999999999999999999999


Q ss_pred             cCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhch
Q 009340          372 GISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQ  451 (537)
Q Consensus       372 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  451 (537)
                      |+++.....    .....||+.|||||++.+..++.++|||||||++|||+||+.||.......      .+..... ..
T Consensus       186 G~a~~~~~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~------~~~~i~~-~~  254 (350)
T d1rdqe_         186 GFAKRVKGR----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ------IYEKIVS-GK  254 (350)
T ss_dssp             TTCEECSSC----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHH-CC
T ss_pred             eeeeecccc----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHH------HHHHHhc-CC
Confidence            999876432    234679999999999999999999999999999999999999997543221      1111111 10


Q ss_pred             hhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCC-----CHhhHHH
Q 009340          452 LLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRP-----TMKQVSM  495 (537)
Q Consensus       452 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~  495 (537)
                                ...+...+..+.+|+.+||+.||.+|+     |+.++++
T Consensus       255 ----------~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         255 ----------VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             ----------CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             ----------CCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence                      112333456788999999999999994     8888875

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-47  Score=377.39  Aligned_cols=251  Identities=22%  Similarity=0.291  Sum_probs=206.2

Q ss_pred             hcCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEec
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY  293 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  293 (537)
                      .++|...+.||+|+||+||+|+.. +|+.||||.++.... ....+.+|+++|++++||||+++++++.+.+..|+||||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~   82 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence            467899999999999999999964 688999999976543 345688999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECC--CCcEEEeec
Q 009340          294 ISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD--KFSAKVSDF  371 (537)
Q Consensus       294 ~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~--~~~~ki~Df  371 (537)
                      +++|+|.+++....           ..+++.++..++.||++||.|||+++   |+||||||+|||++.  ...+||+||
T Consensus        83 ~~gg~L~~~i~~~~-----------~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DF  148 (321)
T d1tkia_          83 ISGLDIFERINTSA-----------FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEF  148 (321)
T ss_dssp             CCCCBHHHHHTSSS-----------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCC
T ss_pred             CCCCcHHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEccc
Confidence            99999999997532           26999999999999999999999999   999999999999985  458999999


Q ss_pred             cCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhch
Q 009340          372 GISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQ  451 (537)
Q Consensus       372 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  451 (537)
                      |+++......  ......+|+.|+|||.+.+..++.++||||+||++|||++|+.||......+      .+....... 
T Consensus       149 G~~~~~~~~~--~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~------~~~~i~~~~-  219 (321)
T d1tkia_         149 GQARQLKPGD--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ------IIENIMNAE-  219 (321)
T ss_dssp             TTCEECCTTC--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHHTC-
T ss_pred             chhhccccCC--cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhCC-
Confidence            9998764432  2345678999999999999999999999999999999999999997654322      111111110 


Q ss_pred             hhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          452 LLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       452 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      .  .++...    ....+.++.+|+.+||+.||++|||+.|+++
T Consensus       220 ~--~~~~~~----~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         220 Y--TFDEEA----FKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             C--CCCHHH----HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             C--CCChhh----ccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0  001111    1123456889999999999999999999986

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-47  Score=374.95  Aligned_cols=256  Identities=22%  Similarity=0.253  Sum_probs=194.9

Q ss_pred             ccccCcCCceEEEEEEcC-CCCEEEEEEccCCChH-----HHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEecC
Q 009340          221 SRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKT-----QIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI  294 (537)
Q Consensus       221 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  294 (537)
                      .++||+|+||+||+|+.. +|+.||||+++.....     ..+.+.+|+.++++++|||||++++++.+.+..++||||+
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~   82 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM   82 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence            578999999999999964 6899999998653222     1346889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccCc
Q 009340          295 SSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGIS  374 (537)
Q Consensus       295 ~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla  374 (537)
                      .++++..+...            ...+++..+..++.||++||+|||+++   |+||||||+|||++.++.+||+|||++
T Consensus        83 ~~~~~~~~~~~------------~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a  147 (299)
T d1ua2a_          83 ETDLEVIIKDN------------SLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLA  147 (299)
T ss_dssp             SEEHHHHHTTC------------CSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGG
T ss_pred             cchHHhhhhhc------------ccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccc
Confidence            98877666543            236889999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCCceeeeccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchhh
Q 009340          375 RSIPNDKTHLTTTIQGTFGYLDPEYFQSS-QFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQLL  453 (537)
Q Consensus       375 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  453 (537)
                      +....... ......||+.|+|||.+... .++.++|||||||++|||++|+.||......+.   ..............
T Consensus       148 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~---l~~i~~~~~~~~~~  223 (299)
T d1ua2a_         148 KSFGSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ---LTRIFETLGTPTEE  223 (299)
T ss_dssp             STTTSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHHCCCCTT
T ss_pred             cccCCCcc-cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHH---HHHHHHhcCCCChh
Confidence            87654332 23345789999999998654 579999999999999999999999875543221   11111111100000


Q ss_pred             hhhcH---------Hhhcc-----ccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          454 EILDA---------RVAKE-----AREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       454 ~~~d~---------~~~~~-----~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      ...+.         .....     .....+..+.+|+.+||+.||++|||+.|+++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         224 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             TSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             hccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence            00000         00000     01123467889999999999999999999864

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-47  Score=379.25  Aligned_cols=252  Identities=22%  Similarity=0.300  Sum_probs=198.4

Q ss_pred             hcCCcccc-ccCcCCceEEEEEEc-CCCCEEEEEEccCCChHHHHHHHHHHHHHHhc-CCCCcceEeeEEee----CCcc
Q 009340          215 TDNYNQSR-FLGQGGFGTVYKGML-PDGSIVAVKRSKEIDKTQIHQFINEVVILSQI-NHRHIVKLLGCCLE----TEVP  287 (537)
Q Consensus       215 ~~~~~~~~-~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~----~~~~  287 (537)
                      .++|.... .||+|+||.||+|+. .+|+.||||+++..     ..+.+|+.++.++ +||||+++++++.+    ....
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~   84 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   84 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence            36788765 599999999999995 57899999998752     3566899987665 89999999999875    3568


Q ss_pred             EEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECC---CC
Q 009340          288 VLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD---KF  364 (537)
Q Consensus       288 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~---~~  364 (537)
                      |+||||+++|+|.+++....          ...+++.++..++.|+++||+|||+.+   |+||||||+|||++.   ++
T Consensus        85 ~ivmEy~~gg~L~~~i~~~~----------~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~  151 (335)
T d2ozaa1          85 LIVMECLDGGELFSRIQDRG----------DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNA  151 (335)
T ss_dssp             EEEEECCCSEEHHHHHHSCS----------CCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTC
T ss_pred             EEEEECCCCCcHHHHHHhcC----------CCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccc
Confidence            99999999999999997532          236999999999999999999999999   999999999999985   56


Q ss_pred             cEEEeeccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHH
Q 009340          365 SAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFI  444 (537)
Q Consensus       365 ~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~  444 (537)
                      .+||+|||+++.......  .....||+.|+|||++.+..|+.++|||||||++|||+||+.||.........   ....
T Consensus       152 ~~Kl~DFG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~---~~~~  226 (335)
T d2ozaa1         152 ILKLTDFGFAKETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS---PGMK  226 (335)
T ss_dssp             CEEECCCTTCEECCCCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC----------
T ss_pred             cccccccceeeeccCCCc--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHH---HHHH
Confidence            799999999987654332  34567999999999999999999999999999999999999999654322110   0000


Q ss_pred             HHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          445 SLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       445 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      .......      ..+........+.++.+|+.+||+.||++|||+.|+++
T Consensus       227 ~~i~~~~------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         227 TRIRMGQ------YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             -CCCSCS------SSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHhcCC------CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            0000000      00001112344577899999999999999999999976

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-46  Score=370.23  Aligned_cols=262  Identities=21%  Similarity=0.322  Sum_probs=199.4

Q ss_pred             cCCccccccCcCCceEEEEEEc-CCCCEEEEEEccCCC--hHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEe
Q 009340          216 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEID--KTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE  292 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e  292 (537)
                      ++|+..++||+|+||+||+|+. .+|+.||||+++...  ....+.+.+|+.+|++++||||+++++++.+.+..++|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            5899999999999999999995 579999999986432  2235678999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeecc
Q 009340          293 YISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG  372 (537)
Q Consensus       293 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfg  372 (537)
                      |+.++ +.+++....          ...+++..+..++.|++.||+|||+.+   ||||||||+|||++.++.+||+|||
T Consensus        82 ~~~~~-~~~~~~~~~----------~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG  147 (298)
T d1gz8a_          82 FLHQD-LKKFMDASA----------LTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFG  147 (298)
T ss_dssp             CCSEE-HHHHHHHTT----------TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTT
T ss_pred             ecCCc-hhhhhhhhc----------ccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCC
Confidence            99764 444443321          246999999999999999999999999   9999999999999999999999999


Q ss_pred             CccccCCCCCceeeeccccccccCcccccCCC-CCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhc-
Q 009340          373 ISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQ-FTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKEN-  450 (537)
Q Consensus       373 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-  450 (537)
                      +++...... .......||+.|+|||.+.... ++.++|||||||++|||++|+.||......+.  +.. ........ 
T Consensus       148 ~a~~~~~~~-~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~--~~~-i~~~~~~~~  223 (298)
T d1gz8a_         148 LARAFGVPV-RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ--LFR-IFRTLGTPD  223 (298)
T ss_dssp             HHHHHCCCS-BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHH-HHHHHCCCC
T ss_pred             cceeccCCc-ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHH--HHH-HHHhcCCCc
Confidence            998765433 2334557999999999877655 57899999999999999999999975433221  111 11111000 


Q ss_pred             --hhhhhh-cHHhhc-----------cccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          451 --QLLEIL-DARVAK-----------EAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       451 --~~~~~~-d~~~~~-----------~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                        ...... .+....           ......+..+.+|+.+||+.||++|||+.|+++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~  282 (298)
T d1gz8a_         224 EVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA  282 (298)
T ss_dssp             TTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence              000000 000000           001123467889999999999999999999975

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=2.2e-46  Score=367.99  Aligned_cols=261  Identities=21%  Similarity=0.286  Sum_probs=200.8

Q ss_pred             cCCccccccCcCCceEEEEEEcCCCCEEEEEEccCCC--hHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEec
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEID--KTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY  293 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  293 (537)
                      ++|...++||+|+||+||+|+.++|+.||||+++...  ....+.+.+|+.+|++++||||+++++++.+.+..++++||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            5788999999999999999999899999999986532  22356899999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeeccC
Q 009340          294 ISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFGI  373 (537)
Q Consensus       294 ~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgl  373 (537)
                      +.++.+..+...            ...+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+|++|||+
T Consensus        82 ~~~~~~~~~~~~------------~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~  146 (286)
T d1ob3a_          82 LDQDLKKLLDVC------------EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGL  146 (286)
T ss_dssp             CSEEHHHHHHTS------------TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTH
T ss_pred             ehhhhHHHHHhh------------cCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEeccccc
Confidence            988766666543            236999999999999999999999998   99999999999999999999999999


Q ss_pred             ccccCCCCCceeeeccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhchh
Q 009340          374 SRSIPNDKTHLTTTIQGTFGYLDPEYFQSS-QFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQL  452 (537)
Q Consensus       374 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  452 (537)
                      +........ ......+++.|+|||.+.+. .++.++|||||||++|||++|+.||......+.   .............
T Consensus       147 a~~~~~~~~-~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~---~~~i~~~~~~~~~  222 (286)
T d1ob3a_         147 ARAFGIPVR-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ---LMRIFRILGTPNS  222 (286)
T ss_dssp             HHHHCC----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCCT
T ss_pred             ceecccCcc-ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHH---HHHHHHhhCCCCh
Confidence            987644332 23445689999999998754 578999999999999999999999975433221   1111111111000


Q ss_pred             hhhh--------c-------HHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          453 LEIL--------D-------ARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       453 ~~~~--------d-------~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      ....        +       +..........+..+.+|+.+||+.||++|||+.|+++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         223 KNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             TTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0000        0       00001112233467889999999999999999999863

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-46  Score=367.22  Aligned_cols=239  Identities=27%  Similarity=0.428  Sum_probs=194.8

Q ss_pred             cCCccccccCcCCceEEEEEEc-CCCCEEEEEEccCCC------hHHHHHHHHHHHHHHhcC--CCCcceEeeEEeeCCc
Q 009340          216 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEID------KTQIHQFINEVVILSQIN--HRHIVKLLGCCLETEV  286 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~~~  286 (537)
                      ++|...++||+|+||+||+|+. .+|+.||||+++...      .....++.+|+.++++++  ||||+++++++.+.+.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            5788999999999999999995 478999999876321      011234678999999996  8999999999999999


Q ss_pred             cEEEEecCCC-CChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECC-CC
Q 009340          287 PVLVYEYISS-GTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD-KF  364 (537)
Q Consensus       287 ~~lV~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~-~~  364 (537)
                      .++||||+.+ +++.+++...            ..+++..+..++.|+++||+|||+.+   |+||||||+|||++. ++
T Consensus        84 ~~lv~e~~~~~~~l~~~~~~~------------~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~  148 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFITER------------GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRG  148 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHHHH------------CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTT
T ss_pred             EEEEEEeccCcchHHHHHhcc------------CCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCC
Confidence            9999999976 5777777542            36999999999999999999999999   999999999999985 47


Q ss_pred             cEEEeeccCccccCCCCCceeeeccccccccCcccccCCCC-CcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHH
Q 009340          365 SAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQF-TDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACF  443 (537)
Q Consensus       365 ~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~  443 (537)
                      .+||+|||+++.....   ..+...||+.|+|||++.+..+ +.++|||||||++|||++|+.||.....          
T Consensus       149 ~vkl~DFG~a~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~----------  215 (273)
T d1xwsa_         149 ELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----------  215 (273)
T ss_dssp             EEEECCCTTCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH----------
T ss_pred             eEEECccccceecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH----------
Confidence            9999999999875432   2345679999999999987765 5679999999999999999999864210          


Q ss_pred             HHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          444 ISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       444 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                        .... .          ...+...+.++.+|+.+||+.||++|||+.|+++
T Consensus       216 --i~~~-~----------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         216 --IIRG-Q----------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             --HHHC-C----------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             --Hhhc-c----------cCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence              0110 0          0112233467889999999999999999999865

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-46  Score=367.58  Aligned_cols=262  Identities=21%  Similarity=0.325  Sum_probs=196.5

Q ss_pred             hcCCccccccCcCCceEEEEEEc-CC-CCEEEEEEccCC--ChHHHHHHHHHHHHHHhc---CCCCcceEeeEEeeC---
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGML-PD-GSIVAVKRSKEI--DKTQIHQFINEVVILSQI---NHRHIVKLLGCCLET---  284 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~-~~-g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~~---  284 (537)
                      .++|+..++||+|+||+||+|+. .+ ++.||||+++..  .......+.+|+.+++.+   +||||+++++++...   
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            46899999999999999999985 33 667999987532  222233456777776665   799999999998632   


Q ss_pred             --CccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECC
Q 009340          285 --EVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD  362 (537)
Q Consensus       285 --~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~  362 (537)
                        ...++++||+++|++.......           ...+++..+..++.|+++||+|||+++   |+||||||+|||++.
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~  151 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKVP-----------EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTS  151 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSC-----------TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECT
T ss_pred             cCceEEEEEEeccCCchhhhhhcc-----------CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcC
Confidence              3579999999988775544332           246899999999999999999999999   999999999999999


Q ss_pred             CCcEEEeeccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHH
Q 009340          363 KFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVAC  442 (537)
Q Consensus       363 ~~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~  442 (537)
                      ++.+||+|||+++.....  .......||+.|+|||++.+..++.++||||+||++|||++|+.||......+.   ...
T Consensus       152 ~~~~kl~dfg~~~~~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~---~~~  226 (305)
T d1blxa_         152 SGQIKLADFGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ---LGK  226 (305)
T ss_dssp             TCCEEECSCCSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHH
T ss_pred             CCCeeecchhhhhhhccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHH---HHH
Confidence            999999999999865332  234556799999999999999999999999999999999999999976543321   111


Q ss_pred             HHHHHhhchhhhh----------h---cHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          443 FISLAKENQLLEI----------L---DARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       443 ~~~~~~~~~~~~~----------~---d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      ............+          .   ............+..+.+|+.+||+.||++|||+.|+++
T Consensus       227 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         227 ILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             HHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            1111110000000          0   000001112233467889999999999999999999864

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.1e-44  Score=354.83  Aligned_cols=262  Identities=21%  Similarity=0.269  Sum_probs=198.8

Q ss_pred             cCCccccccCcCCceEEEEEEc-CCCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceE-eeEEeeCCccEEEEec
Q 009340          216 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKL-LGCCLETEVPVLVYEY  293 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l-~g~~~~~~~~~lV~e~  293 (537)
                      ++|+..+.||+|+||.||+|+. .+|+.||||.+.....  .+++..|+++++.++|+|++.. .++..+.+..++||||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~   84 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL   84 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence            5699999999999999999995 4689999998765322  2457889999999987765554 5555677788999999


Q ss_pred             CCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEEC---CCCcEEEee
Q 009340          294 ISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLD---DKFSAKVSD  370 (537)
Q Consensus       294 ~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~---~~~~~ki~D  370 (537)
                      +. |+|.+.+...           ...+++..++.++.|+++||+|||+++   |+||||||+|||++   .+..+||+|
T Consensus        85 ~~-~~l~~~~~~~-----------~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~D  149 (299)
T d1ckia_          85 LG-PSLEDLFNFC-----------SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIID  149 (299)
T ss_dssp             CC-CBHHHHHHHT-----------TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECC
T ss_pred             cC-Cchhhhhhhc-----------cCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeec
Confidence            94 5666665443           236999999999999999999999999   99999999999985   456799999


Q ss_pred             ccCccccCCCCCc------eeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHH
Q 009340          371 FGISRSIPNDKTH------LTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFI  444 (537)
Q Consensus       371 fgla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~  444 (537)
                      ||+|+........      ......||+.|+|||.+.+..++.++|||||||++|||++|+.||................
T Consensus       150 FG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~  229 (299)
T d1ckia_         150 FGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS  229 (299)
T ss_dssp             CSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHH
T ss_pred             cCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhh
Confidence            9999877443321      2345679999999999999999999999999999999999999997544332211111110


Q ss_pred             HHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHHh
Q 009340          445 SLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRS  503 (537)
Q Consensus       445 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~  503 (537)
                      ..    ... ...+.+    ...++.++.+++.+||+.+|++||++.++.+.|+.+..+
T Consensus       230 ~~----~~~-~~~~~~----~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~  279 (299)
T d1ckia_         230 EK----KMS-TPIEVL----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR  279 (299)
T ss_dssp             HH----HHH-SCHHHH----TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred             cc----cCC-CChhHh----ccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence            00    000 000111    122346788999999999999999999999999887653

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-44  Score=359.94  Aligned_cols=262  Identities=21%  Similarity=0.297  Sum_probs=195.1

Q ss_pred             hcCCccccccCcCCceEEEEEEc-CCCCEEEEEEccCC--ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeC-------
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEI--DKTQIHQFINEVVILSQINHRHIVKLLGCCLET-------  284 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-------  284 (537)
                      .++|+..++||+|+||+||+|+. .+|+.||||++...  .....+++.+|+.+|++++|+|++++++++...       
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            36899999999999999999996 47999999987542  233456788999999999999999999998653       


Q ss_pred             -CccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCC
Q 009340          285 -EVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDK  363 (537)
Q Consensus       285 -~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~  363 (537)
                       ...++||||+.++++..+...            ...++...+..++.|+++||.|||+.+   |+||||||+|||++.+
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~~~------------~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~  153 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLSNV------------LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRD  153 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHTCT------------TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTT
T ss_pred             CceEEEEEeccCCCccchhhhc------------ccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCC
Confidence             357999999988776655433            346889999999999999999999999   9999999999999999


Q ss_pred             CcEEEeeccCccccCCCCCc---eeeeccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccH
Q 009340          364 FSAKVSDFGISRSIPNDKTH---LTTTIQGTFGYLDPEYFQSS-QFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNL  439 (537)
Q Consensus       364 ~~~ki~Dfgla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~  439 (537)
                      +.+||+|||+++........   ......||+.|+|||.+.+. .++.++|||||||++|||++|+.||......+....
T Consensus       154 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~  233 (318)
T d3blha1         154 GVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLAL  233 (318)
T ss_dssp             SCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred             CcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHH
Confidence            99999999999876533222   22335699999999998765 689999999999999999999999975443221111


Q ss_pred             HHHHHHHHhh---chhhhh--------hcHHhhccc-------cHHHHHHHHHHHHHhcccCCCCCCCHhhHH
Q 009340          440 VACFISLAKE---NQLLEI--------LDARVAKEA-------REEDIGAMAELAMRCLRLNSKKRPTMKQVS  494 (537)
Q Consensus       440 ~~~~~~~~~~---~~~~~~--------~d~~~~~~~-------~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~  494 (537)
                         .......   ......        +........       .......+.+|+.+||+.||++|||+.|++
T Consensus       234 ---i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL  303 (318)
T d3blha1         234 ---ISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL  303 (318)
T ss_dssp             ---HHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred             ---HHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHH
Confidence               1111100   000000        000000000       011234677899999999999999999987

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-44  Score=361.99  Aligned_cols=262  Identities=22%  Similarity=0.350  Sum_probs=197.5

Q ss_pred             hcCCccccccCcCCceEEEEEEc-CCCCEEEEEEccCC-ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCC----ccE
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEI-DKTQIHQFINEVVILSQINHRHIVKLLGCCLETE----VPV  288 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~~~  288 (537)
                      +++|+..++||+|+||+||+|+. .+|+.||||+++.. .....+.+.+|+.+|++++|||++++++++....    ..+
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            45789999999999999999985 57999999998753 3455678999999999999999999999997654    235


Q ss_pred             EEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEE
Q 009340          289 LVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKV  368 (537)
Q Consensus       289 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki  368 (537)
                      ++++|+.+|+|.+++..             ..+++..+..++.|+++||+|||+++   |+||||||+|||+++++.+||
T Consensus        87 ~l~~~~~~g~L~~~l~~-------------~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl  150 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKT-------------QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKI  150 (345)
T ss_dssp             EEEEECCCEEHHHHHHH-------------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEE
T ss_pred             EEEEeecCCchhhhhhc-------------CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEE
Confidence            56677789999999853             25999999999999999999999999   999999999999999999999


Q ss_pred             eeccCccccCCCCCc--eeeeccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHH
Q 009340          369 SDFGISRSIPNDKTH--LTTTIQGTFGYLDPEYFQS-SQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFIS  445 (537)
Q Consensus       369 ~Dfgla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~  445 (537)
                      +|||+++........  ......||+.|+|||.+.. ..++.++||||+||++|||++|+.||......+.....   ..
T Consensus       151 ~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~---~~  227 (345)
T d1pmea_         151 CDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI---LG  227 (345)
T ss_dssp             CCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---HH
T ss_pred             cccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHH---hh
Confidence            999999876433222  2345678999999999854 56789999999999999999999999765433211111   00


Q ss_pred             HHhhch---hhhhhcHH-------h--hcc-----ccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          446 LAKENQ---LLEILDAR-------V--AKE-----AREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       446 ~~~~~~---~~~~~d~~-------~--~~~-----~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      ......   ........       .  ...     .....+.++.+|+.+||+.||++|||+.|+++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~  294 (345)
T d1pmea_         228 ILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  294 (345)
T ss_dssp             HHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            000000   00000000       0  000     01122356889999999999999999999985

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=9.2e-44  Score=350.03  Aligned_cols=263  Identities=17%  Similarity=0.198  Sum_probs=206.6

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCChHHHHHHHHHHHHHHhcCC-CCcceEeeEEeeCCccEEEEec
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKTQIHQFINEVVILSQINH-RHIVKLLGCCLETEVPVLVYEY  293 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~e~  293 (537)
                      ++|...++||+|+||.||+|+.. +|+.||||.++....  ...+.+|++.++.++| +|++.+++++.+....++||||
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~   82 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL   82 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence            57899999999999999999954 689999998764322  2356788999999965 8999999999999999999999


Q ss_pred             CCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECC-----CCcEEE
Q 009340          294 ISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDD-----KFSAKV  368 (537)
Q Consensus       294 ~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~-----~~~~ki  368 (537)
                      + +|+|.+++....           ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.     ++.+||
T Consensus        83 ~-~~~l~~~~~~~~-----------~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl  147 (293)
T d1csna_          83 L-GPSLEDLLDLCG-----------RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYV  147 (293)
T ss_dssp             C-CCBHHHHHHHTT-----------TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEE
T ss_pred             c-CCCHHHHHHhhc-----------cchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEE
Confidence            9 679999886543           36999999999999999999999999   999999999999974     578999


Q ss_pred             eeccCccccCCCCC------ceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHH
Q 009340          369 SDFGISRSIPNDKT------HLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVAC  442 (537)
Q Consensus       369 ~Dfgla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~  442 (537)
                      +|||+|+.......      .......||+.|||||.+.+..++.++||||||+++|||++|+.||..............
T Consensus       148 ~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~  227 (293)
T d1csna_         148 VDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYER  227 (293)
T ss_dssp             CCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHH
T ss_pred             cccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHH
Confidence            99999987643221      123346799999999999999999999999999999999999999975433222111111


Q ss_pred             HHHHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHHHHHHHHhh
Q 009340          443 FISLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSMELEGLRRSQ  504 (537)
Q Consensus       443 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~i~~~~  504 (537)
                      ..........     +.+    ....++++.+++..|++.+|++||++..+.+.|+.+.+..
T Consensus       228 i~~~~~~~~~-----~~l----~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~  280 (293)
T d1csna_         228 IGEKKQSTPL-----REL----CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL  280 (293)
T ss_dssp             HHHHHHHSCH-----HHH----TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             HHhccCCCCh-----HHh----cCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence            1110000000     111    1223357889999999999999999999999888876543

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-44  Score=363.52  Aligned_cols=263  Identities=25%  Similarity=0.336  Sum_probs=194.8

Q ss_pred             CCccccccCcCCceEEEEEEcC-CCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCC------ccEE
Q 009340          217 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHIVKLLGCCLETE------VPVL  289 (537)
Q Consensus       217 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------~~~l  289 (537)
                      +|+..++||+|+||+||+|+.. +|+.||||+++....    .+.+|+.+|++++|+||+++++++....      ..++
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            5778889999999999999964 699999999875432    2347999999999999999999986432      3689


Q ss_pred             EEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCC-cEEE
Q 009340          290 VYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF-SAKV  368 (537)
Q Consensus       290 V~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~-~~ki  368 (537)
                      ||||+++|.+..+......         ...+++.++..++.||++||+|||+++   |+||||||+|||++.++ .+||
T Consensus        97 v~Ey~~~~~~~~l~~~~~~---------~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl  164 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYSRA---------KQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKL  164 (350)
T ss_dssp             EEECCSEEHHHHHHHHHHT---------TCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEE
T ss_pred             EEeccCCccHHHHHhhhhc---------cCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeE
Confidence            9999987644433322211         346999999999999999999999999   99999999999999775 8999


Q ss_pred             eeccCccccCCCCCceeeeccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHH
Q 009340          369 SDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQS-SQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLA  447 (537)
Q Consensus       369 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~  447 (537)
                      +|||+++.......  .....||..|+|||.+.+ ..++.++||||+||++|||++|+.||......+..  .. .....
T Consensus       165 ~DFG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l--~~-i~~~~  239 (350)
T d1q5ka_         165 CDFGSAKQLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL--VE-IIKVL  239 (350)
T ss_dssp             CCCTTCEECCTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHH--HH-HHHHH
T ss_pred             ecccchhhccCCcc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHH--HH-HHHHh
Confidence            99999987654332  334578999999998765 57899999999999999999999999755432211  11 11100


Q ss_pred             hhc---hhhhhhc------------HHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH--HHHHH
Q 009340          448 KEN---QLLEILD------------ARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM--ELEGL  500 (537)
Q Consensus       448 ~~~---~~~~~~d------------~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~--~L~~i  500 (537)
                      ...   .......            ...........++.+.+|+.+||+.||++|||+.|+++  .++.+
T Consensus       240 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~  309 (350)
T d1q5ka_         240 GTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL  309 (350)
T ss_dssp             CCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred             CCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence            000   0000000            00000112234567889999999999999999999985  34444

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-43  Score=357.43  Aligned_cols=266  Identities=20%  Similarity=0.305  Sum_probs=196.4

Q ss_pred             hcCCccccccCcCCceEEEEEEc-CCCCEEEEEEccC--CChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCC------
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKE--IDKTQIHQFINEVVILSQINHRHIVKLLGCCLETE------  285 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------  285 (537)
                      .++|+..++||+|+||+||+|.. .+|+.||||+++.  ......+.+.+|+.+|++++|||||++++++...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            46899999999999999999995 4699999999874  34455678999999999999999999999998655      


Q ss_pred             ccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCc
Q 009340          286 VPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFS  365 (537)
Q Consensus       286 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~  365 (537)
                      ..++||||+ +++|..+...             ..+++..++.++.|++.||.|||+++   |+||||||+|||++.++.
T Consensus        97 ~~~lv~e~~-~~~l~~~~~~-------------~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~  159 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMKH-------------EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCE  159 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHHH-------------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCC
T ss_pred             eEEEEEecc-cccHHHHHHh-------------ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccc
Confidence            469999999 4567666542             36999999999999999999999999   999999999999999999


Q ss_pred             EEEeeccCccccCCCCCceeeeccccccccCcccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHH
Q 009340          366 AKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQS-SQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFI  444 (537)
Q Consensus       366 ~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~  444 (537)
                      +|++|||+++.....    .+...||+.|+|||.+.+ ..++.++||||+||++|||++|+.||................
T Consensus       160 ~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~  235 (346)
T d1cm8a_         160 LKILDFGLARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVT  235 (346)
T ss_dssp             EEECCCTTCEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred             cccccccceeccCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhcc
Confidence            999999999876433    244678999999999876 457899999999999999999999997654322111000000


Q ss_pred             -----HHHhhch--hhhhhcHHh-------hccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHHH--HHHHH
Q 009340          445 -----SLAKENQ--LLEILDARV-------AKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSME--LEGLR  501 (537)
Q Consensus       445 -----~~~~~~~--~~~~~d~~~-------~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~--L~~i~  501 (537)
                           .......  ........+       ........+..+.+|+.+||+.||++|||+.|+++-  ++.+.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~  308 (346)
T d1cm8a_         236 GTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  308 (346)
T ss_dssp             CCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             CCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence                 0000000  000000000       001112334567899999999999999999999862  55443

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-43  Score=348.05  Aligned_cols=262  Identities=19%  Similarity=0.297  Sum_probs=204.4

Q ss_pred             cCCccccccCcCCceEEEEEEc-CCCCEEEEEEccC--CChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeCCccEEEEe
Q 009340          216 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKE--IDKTQIHQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE  292 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e  292 (537)
                      ++|+..++||+|+||+||+|+. .+|+.||||+++.  ......+++.+|+.++++++||||+++++++.+....++|+|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            5788999999999999999995 5789999999854  334456789999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcEEEeecc
Q 009340          293 YISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSAKVSDFG  372 (537)
Q Consensus       293 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfg  372 (537)
                      ++.+++|..++...            ..+++..+..++.|+++||+|||+++   |+||||||+|||++.++.+||+|||
T Consensus        82 ~~~~~~l~~~~~~~------------~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG  146 (292)
T d1unla_          82 FCDQDLKKYFDSCN------------GDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFG  146 (292)
T ss_dssp             CCSEEHHHHHHHTT------------TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCT
T ss_pred             eccccccccccccc------------cccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecc
Confidence            99999888777643            36899999999999999999999999   9999999999999999999999999


Q ss_pred             CccccCCCCCceeeeccccccccCcccccCCC-CCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhhch
Q 009340          373 ISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQ-FTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKENQ  451 (537)
Q Consensus       373 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  451 (537)
                      .++....... ......++..|+|||.+.... ++.++|||||||++|||++|+.||.......  .....+........
T Consensus       147 ~a~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~--~~~~~~~~~~~~~~  223 (292)
T d1unla_         147 LARAFGIPVR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPT  223 (292)
T ss_dssp             TCEECCSCCS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH--HHHHHHHHHHCCCC
T ss_pred             hhhcccCCCc-cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHH--HHHHHHHhhcCCCC
Confidence            9987754332 233445788899999987654 6899999999999999999999975433221  11111111111100


Q ss_pred             h------hhhhc---------HHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          452 L------LEILD---------ARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       452 ~------~~~~d---------~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      .      ....+         ...........+..+.+|+.+||+.||.+|||+.|+++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         224 EEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             TTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0      00000         00001112233467889999999999999999999864

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-44  Score=356.90  Aligned_cols=252  Identities=25%  Similarity=0.347  Sum_probs=203.1

Q ss_pred             cCCccccccCcCCceEEEEEEc----CCCCEEEEEEccCC----ChHHHHHHHHHHHHHHhcCC-CCcceEeeEEeeCCc
Q 009340          216 DNYNQSRFLGQGGFGTVYKGML----PDGSIVAVKRSKEI----DKTQIHQFINEVVILSQINH-RHIVKLLGCCLETEV  286 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~----~~g~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~  286 (537)
                      ++|+..+.||+|+||+||+|+.    .+|+.||||.++..    +....+.+.+|+.++++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            6799999999999999999984    25889999987532    12234567899999999966 899999999999999


Q ss_pred             cEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcE
Q 009340          287 PVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA  366 (537)
Q Consensus       287 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~  366 (537)
                      .++||||+.+|+|.+++...            ..++......++.|++.||.|||+.+   |+||||||+|||++.++.+
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~------------~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~v  168 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQR------------ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHV  168 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHH------------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCE
T ss_pred             eeeeeecccccHHHHHHHhc------------ccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCE
Confidence            99999999999999998764            35788899999999999999999999   9999999999999999999


Q ss_pred             EEeeccCccccCCCCCceeeeccccccccCcccccCC--CCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHH
Q 009340          367 KVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSS--QFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFI  444 (537)
Q Consensus       367 ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~  444 (537)
                      ||+|||+++..............|++.|+|||.+.+.  .++.++|||||||+||||++|+.||......+.   .....
T Consensus       169 kL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~---~~~i~  245 (322)
T d1vzoa_         169 VLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS---QAEIS  245 (322)
T ss_dssp             EESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC---HHHHH
T ss_pred             EEeeccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHH
Confidence            9999999987755555445567899999999998754  468899999999999999999999975533221   11111


Q ss_pred             HHHhhchhhhhhcHHhhccccHHHHHHHHHHHHHhcccCCCCCCC-----HhhHHH
Q 009340          445 SLAKENQLLEILDARVAKEAREEDIGAMAELAMRCLRLNSKKRPT-----MKQVSM  495 (537)
Q Consensus       445 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~ev~~  495 (537)
                      ....          ......+...+.++.+|+.+||+.||++|||     +.|+++
T Consensus       246 ~~~~----------~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         246 RRIL----------KSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             HHHH----------HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             Hhcc----------cCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence            1110          0111233455678999999999999999995     677754

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.1e-42  Score=348.16  Aligned_cols=255  Identities=20%  Similarity=0.336  Sum_probs=196.7

Q ss_pred             cCCccccccCcCCceEEEEEEc-CCCCEEEEEEccCCChHHHHHHHHHHHHHHhcC-CCCcceEeeEEeeC--CccEEEE
Q 009340          216 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEIDKTQIHQFINEVVILSQIN-HRHIVKLLGCCLET--EVPVLVY  291 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~--~~~~lV~  291 (537)
                      ++|+..++||+|+||+||+|+. .+|+.||||+++...   .+++.+|+.+|++++ ||||+++++++...  ...++||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~  111 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  111 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence            5799999999999999999995 478999999987643   456889999999995 99999999999754  4589999


Q ss_pred             ecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCC-cEEEee
Q 009340          292 EYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKF-SAKVSD  370 (537)
Q Consensus       292 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~-~~ki~D  370 (537)
                      ||+++|+|..+..               .+++..+..++.||++||.|||+++   |+||||||+|||++.++ .+||+|
T Consensus       112 e~~~~~~L~~~~~---------------~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~D  173 (328)
T d3bqca1         112 EHVNNTDFKQLYQ---------------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLID  173 (328)
T ss_dssp             ECCCSCBGGGTTT---------------SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECC
T ss_pred             eecCCCcHHHHhc---------------CCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecc
Confidence            9999999976642               5899999999999999999999999   99999999999998654 699999


Q ss_pred             ccCccccCCCCCceeeeccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHHHHhh
Q 009340          371 FGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSS-QFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFISLAKE  449 (537)
Q Consensus       371 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  449 (537)
                      ||+++.......  .....+|+.|+|||.+.+. .++.++||||+||+++||++|+.||.........  ..........
T Consensus       174 FG~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~--~~~i~~~~g~  249 (328)
T d3bqca1         174 WGLAEFYHPGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ--LVRIAKVLGT  249 (328)
T ss_dssp             GGGCEECCTTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHH--HHHHHHHHCH
T ss_pred             cccceeccCCCc--ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHH--HHHHHHHHCC
Confidence            999987654332  3455689999999998765 4799999999999999999999998754332211  0001110000


Q ss_pred             c---------------hhhhhhc--------HHhhccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          450 N---------------QLLEILD--------ARVAKEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       450 ~---------------~~~~~~d--------~~~~~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      .               .......        ...........+.++.+|+.+||+.||++|||+.|+++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         250 EDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             HHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             chhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0               0000000        00000111223467889999999999999999999875

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-42  Score=350.25  Aligned_cols=260  Identities=21%  Similarity=0.307  Sum_probs=190.5

Q ss_pred             cCCccccccCcCCceEEEEEEcC-CCCEEEEEEccC--CChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeC------Cc
Q 009340          216 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSKE--IDKTQIHQFINEVVILSQINHRHIVKLLGCCLET------EV  286 (537)
Q Consensus       216 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~  286 (537)
                      ++|+..++||+|+||+||+|+.. +|+.||||+++.  ......+++.+|+.++++++||||+++++++...      ..
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            57999999999999999999964 699999999864  3455567789999999999999999999999643      56


Q ss_pred             cEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcE
Q 009340          287 PVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA  366 (537)
Q Consensus       287 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~  366 (537)
                      .|+||||+.++.+ +.+.              ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+
T Consensus        97 ~~iv~Ey~~~~l~-~~~~--------------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~  158 (355)
T d2b1pa1          97 VYLVMELMDANLC-QVIQ--------------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTL  158 (355)
T ss_dssp             EEEEEECCSEEHH-HHHT--------------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCE
T ss_pred             eEEEEeccchHHH-Hhhh--------------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccce
Confidence            7999999976544 4442              25899999999999999999999999   9999999999999999999


Q ss_pred             EEeeccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHH-----
Q 009340          367 KVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVA-----  441 (537)
Q Consensus       367 ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~-----  441 (537)
                      |++|||+++......  ......+|+.|+|||.+.+..++.++||||+||+++||++|+.||.............     
T Consensus       159 kl~df~~~~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~  236 (355)
T d2b1pa1         159 KILDFGLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGT  236 (355)
T ss_dssp             EECCCCC-----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred             eeechhhhhcccccc--ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccC
Confidence            999999988764332  2345578999999999999999999999999999999999999996543221100000     


Q ss_pred             -----------HHHHHHhhc------hhhhhhcHHhh---ccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          442 -----------CFISLAKEN------QLLEILDARVA---KEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       442 -----------~~~~~~~~~------~~~~~~d~~~~---~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                                 .........      ...........   .......+..+.+|+.+||+.||++|||++|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~  310 (355)
T d2b1pa1         237 PCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  310 (355)
T ss_dssp             CCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                       000000000      00000100000   1112345678899999999999999999999974

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-42  Score=348.49  Aligned_cols=258  Identities=22%  Similarity=0.325  Sum_probs=195.3

Q ss_pred             hcCCccccccCcCCceEEEEEEc-CCCCEEEEEEccCC--ChHHHHHHHHHHHHHHhcCCCCcceEeeEEeeC-----Cc
Q 009340          215 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEI--DKTQIHQFINEVVILSQINHRHIVKLLGCCLET-----EV  286 (537)
Q Consensus       215 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~  286 (537)
                      .++|+..++||+|+||+||+|+. .+|+.||||+++..  +....+++.+|+.+|++++|+|++++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            46799999999999999999994 57999999998743  345567789999999999999999999998643     34


Q ss_pred             cEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEECCCCcE
Q 009340          287 PVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILLDDKFSA  366 (537)
Q Consensus       287 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll~~~~~~  366 (537)
                      .+++++|+.+|+|.+++..             ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+
T Consensus        97 ~~~i~~~~~gg~L~~~~~~-------------~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~  160 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKC-------------QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCEL  160 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTT-------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCE
T ss_pred             eEEEEEeecCCchhhhccc-------------ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccc
Confidence            5777888899999999853             35999999999999999999999999   9999999999999999999


Q ss_pred             EEeeccCccccCCCCCceeeeccccccccCcccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCccchhhhccHHHHHHH
Q 009340          367 KVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSS-QFTDKSDVYSFGVVLLELLTGKKPICFARVEEERNLVACFIS  445 (537)
Q Consensus       367 ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~~~~~~~~~~~  445 (537)
                      |++|||++.....    ......||+.|+|||.+.+. .++.++|||||||++|||++|+.||...........   ...
T Consensus       161 kl~dfg~a~~~~~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~---i~~  233 (348)
T d2gfsa1         161 KILDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL---ILR  233 (348)
T ss_dssp             EECCC----CCTG----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHH
T ss_pred             cccccchhcccCc----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHH---HHH
Confidence            9999999976432    23445689999999987665 468899999999999999999999975433221110   100


Q ss_pred             HHhhc--hh---------hhhhcHHhh------ccccHHHHHHHHHHHHHhcccCCCCCCCHhhHHH
Q 009340          446 LAKEN--QL---------LEILDARVA------KEAREEDIGAMAELAMRCLRLNSKKRPTMKQVSM  495 (537)
Q Consensus       446 ~~~~~--~~---------~~~~d~~~~------~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  495 (537)
                      .....  ..         .........      .......+..+.+|+.+||+.||++|||+.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~  300 (348)
T d2gfsa1         234 LVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  300 (348)
T ss_dssp             HHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence            00000  00         000000000      0001123456889999999999999999999976

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.2e-37  Score=313.82  Aligned_cols=262  Identities=20%  Similarity=0.226  Sum_probs=190.0

Q ss_pred             CCccccccCcCCceEEEEEEc-CCCCEEEEEEccCCChHHHHHHHHHHHHHHhcC-----------CCCcceEeeEEeeC
Q 009340          217 NYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSKEIDKTQIHQFINEVVILSQIN-----------HRHIVKLLGCCLET  284 (537)
Q Consensus       217 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~g~~~~~  284 (537)
                      +|...++||+|+||+||+|+. .+|+.||||+++.. ....+.+.+|+.+++.++           |+||+++++++...
T Consensus        14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~-~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~   92 (362)
T d1q8ya_          14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK   92 (362)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred             cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc-ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence            488999999999999999995 57999999999753 334567788999988875           57899999988654


Q ss_pred             --CccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeecCCCCCCEEEC
Q 009340          285 --EVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHS-SASIPIFHRDIKSSNILLD  361 (537)
Q Consensus       285 --~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-~~~~~ivH~Dlk~~NIll~  361 (537)
                        ...+++++++..+...........         ...+++..+..++.|+++||+|||+ .+   |+||||||+|||++
T Consensus        93 ~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~  160 (362)
T d1q8ya_          93 GPNGVHVVMVFEVLGENLLALIKKYE---------HRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLME  160 (362)
T ss_dssp             ETTEEEEEEEECCCCEEHHHHHHHTT---------TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEE
T ss_pred             cccceeeeeeeccccccccccccccc---------ccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeee
Confidence              455677777666544333322221         3578999999999999999999998 77   99999999999998


Q ss_pred             CCC------cEEEeeccCccccCCCCCceeeeccccccccCcccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccchhh
Q 009340          362 DKF------SAKVSDFGISRSIPNDKTHLTTTIQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLLELLTGKKPICFARVEE  435 (537)
Q Consensus       362 ~~~------~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~el~tg~~p~~~~~~~~  435 (537)
                      .++      .++++|||.+......    .....||+.|+|||.+....++.++||||+||+++||++|+.||.......
T Consensus       161 ~~~~~~~~~~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~  236 (362)
T d1q8ya_         161 IVDSPENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHS  236 (362)
T ss_dssp             EEETTTTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred             ccCcccccceeeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCcccc
Confidence            665      3999999999865332    234568999999999999999999999999999999999999986443221


Q ss_pred             hccHHHHHH---HHHhh--------c-hhhhhhc-------------------HHhhccccHHHHHHHHHHHHHhcccCC
Q 009340          436 ERNLVACFI---SLAKE--------N-QLLEILD-------------------ARVAKEAREEDIGAMAELAMRCLRLNS  484 (537)
Q Consensus       436 ~~~~~~~~~---~~~~~--------~-~~~~~~d-------------------~~~~~~~~~~~~~~l~~l~~~cl~~~p  484 (537)
                      .........   .....        . ......+                   ...........+..+.+|+.+||+.||
T Consensus       237 ~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP  316 (362)
T d1q8ya_         237 YTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDP  316 (362)
T ss_dssp             --CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSST
T ss_pred             ccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCCh
Confidence            111111111   11000        0 0000000                   001112345677889999999999999


Q ss_pred             CCCCCHhhHHH
Q 009340          485 KKRPTMKQVSM  495 (537)
Q Consensus       485 ~~RPs~~ev~~  495 (537)
                      .+|||++|+++
T Consensus       317 ~~Rpta~e~L~  327 (362)
T d1q8ya_         317 RKRADAGGLVN  327 (362)
T ss_dssp             TTCBCHHHHHT
T ss_pred             hHCcCHHHHhc
Confidence            99999999864

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.88  E-value=1.4e-23  Score=191.71  Aligned_cols=163  Identities=20%  Similarity=0.211  Sum_probs=120.1

Q ss_pred             ccccccCcCCceEEEEEEcCCCCEEEEEEccCCC------------------hHHHHHHHHHHHHHHhcCCCCcceEeeE
Q 009340          219 NQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEID------------------KTQIHQFINEVVILSQINHRHIVKLLGC  280 (537)
Q Consensus       219 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~------------------~~~~~~~~~E~~~l~~l~H~niv~l~g~  280 (537)
                      ...++||+|+||.||+|+..+|+.||||.++...                  ......+..|...+.++.|.+++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            3467899999999999998889999999764311                  0112335568889999999999988765


Q ss_pred             EeeCCccEEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCCEEE
Q 009340          281 CLETEVPVLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSASIPIFHRDIKSSNILL  360 (537)
Q Consensus       281 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH~Dlk~~NIll  360 (537)
                      .    ..+++|||++++.+.+                   +++.....++.|++++|.|||+++   |+||||||+|||+
T Consensus        83 ~----~~~lvme~~~~~~~~~-------------------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv  136 (191)
T d1zara2          83 E----GNAVLMELIDAKELYR-------------------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLV  136 (191)
T ss_dssp             E----TTEEEEECCCCEEGGG-------------------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEE
T ss_pred             c----CCEEEEEeeccccccc-------------------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheee
Confidence            3    3479999998765422                   344445789999999999999999   9999999999999


Q ss_pred             CCCCcEEEeeccCccccCCCCCceeeeccccccccC------cccccCCCCCcchhHHHHHHHH
Q 009340          361 DDKFSAKVSDFGISRSIPNDKTHLTTTIQGTFGYLD------PEYFQSSQFTDKSDVYSFGVVL  418 (537)
Q Consensus       361 ~~~~~~ki~Dfgla~~~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~t~ksDV~S~Gvll  418 (537)
                      +++ .++|+|||+|.........         .|..      .+.+ ...|+.++|+||..--+
T Consensus       137 ~~~-~~~liDFG~a~~~~~~~~~---------~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         137 SEE-GIWIIDFPQSVEVGEEGWR---------EILERDVRNIITYF-SRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             ETT-EEEECCCTTCEETTSTTHH---------HHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred             eCC-CEEEEECCCcccCCCCCcH---------HHHHHHHHHHHHHH-cCCCCCcccHHHHHHHH
Confidence            976 5899999999765432211         1111      1111 35567889999976433

>d1e0ga_ d.7.1.1 (A:) Membrane-bound lytic murein transclycosylase D, MltD {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: LysM domain
superfamily: LysM domain
family: LysM domain
domain: Membrane-bound lytic murein transclycosylase D, MltD
species: Escherichia coli [TaxId: 562]

Probab=99.11  E-value=9e-12  Score=83.58  Aligned_cols=46  Identities=28%  Similarity=0.444  Sum_probs=42.2

Q ss_pred             hhhhcccccchhhhHhhhcCChHHHHHhhccCCCCcccccccccCCcC
Q 009340           55 LAYMAAKGDTISSIGYKFGVDQQSILEANMLSKADSIFPFAPLLIPLK  102 (537)
Q Consensus        55 ~~y~v~~gdtl~~ia~~f~~~~~~l~~~n~~~~~~~i~~~~~l~vp~~  102 (537)
                      ++|+|++||||++||++|++++++|+++|++.  +.++||+.+.+|++
T Consensus         3 v~y~V~~GDTl~~IA~~y~vs~~~i~~~N~l~--~~l~~Gq~L~i~vk   48 (48)
T d1e0ga_           3 ITYRVRKGDSLSSIAKRHGVNIKDVMRWNSDT--ANLQPGDKLTLFVK   48 (48)
T ss_dssp             CEEEECTTCCHHHHHHHHTCCHHHHHHHCSCG--GGCCTTEEEECCCC
T ss_pred             EEEEECCCCCHHHHHHHHCCCHHHHHHHcCCc--ccCcCCCEEEEEeC
Confidence            47999999999999999999999999999984  46999999999874

>d1y7ma2 d.7.1.1 (A:1-48) Hypothetical protein YkuD, N-terminal domain {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: LysM domain
superfamily: LysM domain
family: LysM domain
domain: Hypothetical protein YkuD, N-terminal domain
species: Bacillus subtilis [TaxId: 1423]

Probab=99.06  E-value=4.4e-12  Score=85.53  Aligned_cols=46  Identities=28%  Similarity=0.457  Sum_probs=42.5

Q ss_pred             hhhhcccccchhhhHhhhcCChHHHHHhhccCCCCcccccccccCCc
Q 009340           55 LAYMAAKGDTISSIGYKFGVDQQSILEANMLSKADSIFPFAPLLIPL  101 (537)
Q Consensus        55 ~~y~v~~gdtl~~ia~~f~~~~~~l~~~n~~~~~~~i~~~~~l~vp~  101 (537)
                      ++|+|++|||||+||++|++++++|+++|++.+ +.+++|+.+.+|.
T Consensus         2 i~y~V~~GDTL~~IA~~y~v~~~~i~~~N~~~~-~~l~~Gq~L~IPg   47 (48)
T d1y7ma2           2 LTYQVKQGDTLNSIAADFRISTAALLQANPSLQ-AGLTAGQSIVIPG   47 (48)
T ss_dssp             EEEECCTTCCHHHHHHHTTSCCCCCCCTSCTTC-SSCCTTCEEEETT
T ss_pred             EEEEECCCCCHHHHHHHhCCCHHHHHHHcCCCC-CCCCCCCEEEeCC
Confidence            579999999999999999999999999999865 5799999999984

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.60  E-value=1.4e-07  Score=88.24  Aligned_cols=149  Identities=18%  Similarity=0.140  Sum_probs=99.3

Q ss_pred             HHHHHHhcCCccccccCcCCceEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHHHHhcC-CCCcceEeeEEeeCCcc
Q 009340          209 DELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQIN-HRHIVKLLGCCLETEVP  287 (537)
Q Consensus       209 ~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~  287 (537)
                      .|+.+....|...+..+.+....||+... +++.+.+|+...........+.+|...+..+. +--+.+++.+..+.+..
T Consensus         7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~   85 (263)
T d1j7la_           7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS   85 (263)
T ss_dssp             HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred             HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence            35566667777666555455578998876 45667888876533333345667888888774 44467788888888889


Q ss_pred             EEEEecCCCCChhhhhhhhhhhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhcC-----------------------
Q 009340          288 VLVYEYISSGTLSHHIHDHQQQQEQKQKQELSSLSWENRVRVACEVAGAVAYMHSSA-----------------------  344 (537)
Q Consensus       288 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~-----------------------  344 (537)
                      ++||+++++.++.+......                 ....++.++++.+..||+..                       
T Consensus        86 ~lv~~~l~G~~~~~~~~~~~-----------------~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~  148 (263)
T d1j7la_          86 NLLMSEADGVLCSEEYEDEQ-----------------SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNN  148 (263)
T ss_dssp             EEEEECCSSEEHHHHTTTCS-----------------CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHT
T ss_pred             EEEEEecccccccccccccc-----------------cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHH
Confidence            99999999988765442211                 11223344444444444311                       


Q ss_pred             ---------------------------------CCCeeecCCCCCCEEECCCCcEEEeeccCcc
Q 009340          345 ---------------------------------SIPIFHRDIKSSNILLDDKFSAKVSDFGISR  375 (537)
Q Consensus       345 ---------------------------------~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~  375 (537)
                                                       .+.++|+|+.+.|||++++..+-|.||+.+.
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         149 DLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             TCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                                             1227899999999999987667799998775

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.02  E-value=1.3e-05  Score=73.99  Aligned_cols=75  Identities=15%  Similarity=0.091  Sum_probs=54.3

Q ss_pred             cCcCCc-eEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHHHHhcCC--CCcceEeeEEeeCCccEEEEecCCCCChh
Q 009340          224 LGQGGF-GTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINH--RHIVKLLGCCLETEVPVLVYEYISSGTLS  300 (537)
Q Consensus       224 lg~G~~-g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lV~e~~~~gsL~  300 (537)
                      +..|.. ..||+...+++..+.+|.......   ..+..|...++.+..  -.+.++++++.+.+..++||+|+++.++.
T Consensus        18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~   94 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL   94 (255)
T ss_dssp             CSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred             cCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence            444443 679999988888899998765433   235567777777643  34677888888888889999999887664


Q ss_pred             h
Q 009340          301 H  301 (537)
Q Consensus       301 ~  301 (537)
                      +
T Consensus        95 ~   95 (255)
T d1nd4a_          95 S   95 (255)
T ss_dssp             T
T ss_pred             c
Confidence            3

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.50  E-value=0.00026  Score=69.53  Aligned_cols=77  Identities=18%  Similarity=0.207  Sum_probs=48.4

Q ss_pred             ccccCcCCceEEEEEEcCC-CCEEEEEEccCC-------ChHHHHHHHHHHHHHHhcC-C--CCcceEeeEEeeCCccEE
Q 009340          221 SRFLGQGGFGTVYKGMLPD-GSIVAVKRSKEI-------DKTQIHQFINEVVILSQIN-H--RHIVKLLGCCLETEVPVL  289 (537)
Q Consensus       221 ~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l~-H--~niv~l~g~~~~~~~~~l  289 (537)
                      .+.||.|....||+....+ ++.|+||.-...       ......+...|...|+.+. +  ..+.+++.+  +.+..++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            3468999999999998654 678999964321       1111233446777777662 2  345556654  4566789


Q ss_pred             EEecCCCCCh
Q 009340          290 VYEYISSGTL  299 (537)
Q Consensus       290 V~e~~~~gsL  299 (537)
                      |||++++..+
T Consensus       109 vmE~L~~~~~  118 (392)
T d2pula1         109 VMEDLSHLKI  118 (392)
T ss_dssp             EECCCTTSEE
T ss_pred             EEeccCCccc
Confidence            9999987543

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.49  E-value=0.005  Score=58.26  Aligned_cols=69  Identities=13%  Similarity=0.067  Sum_probs=44.7

Q ss_pred             eEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCc--ceEee-----EEeeCCccEEEEecCCCCCh
Q 009340          230 GTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHI--VKLLG-----CCLETEVPVLVYEYISSGTL  299 (537)
Q Consensus       230 g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni--v~l~g-----~~~~~~~~~lV~e~~~~gsL  299 (537)
                      -.||+....+|+.+++|..+.... ..+++..|...+..+...++  +..+.     .....+..+.+++++++..+
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~~~-s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~  111 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQF  111 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred             ceeEEEEcCCCCEEEEEEeCCCCC-CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCC
Confidence            589999999999999998765321 23556778888888743222  11111     12234556889999876443

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.33  E-value=0.0049  Score=60.10  Aligned_cols=74  Identities=20%  Similarity=0.178  Sum_probs=48.8

Q ss_pred             ccccCcCCceEEEEEEcCC--------CCEEEEEEccCCChHHHHHHHHHHHHHHhcC-CCCcceEeeEEeeCCccEEEE
Q 009340          221 SRFLGQGGFGTVYKGMLPD--------GSIVAVKRSKEIDKTQIHQFINEVVILSQIN-HRHIVKLLGCCLETEVPVLVY  291 (537)
Q Consensus       221 ~~~lg~G~~g~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~  291 (537)
                      .+.|+.|---.+|+....+        .+.|.++.......  .-...+|..+++.+. +.=..++++++.+    .+|+
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~--~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~  120 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET--ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  120 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC--HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcch--hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence            3568778888899988643        34566666543222  234457888888884 4334578887743    6899


Q ss_pred             ecCCCCChh
Q 009340          292 EYISSGTLS  300 (537)
Q Consensus       292 e~~~~gsL~  300 (537)
                      ||+++.+|.
T Consensus       121 efi~g~~l~  129 (395)
T d1nw1a_         121 EYIPSRPLS  129 (395)
T ss_dssp             CCCCEEECC
T ss_pred             EEeccccCC
Confidence            999875553

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.05  E-value=0.014  Score=54.66  Aligned_cols=168  Identities=10%  Similarity=0.065  Sum_probs=85.0

Q ss_pred             ccCHHHHHHHhcCCccccc-----cCcCCceEEEEEEcCCCCEEEEEEccCCChHHHHHHHHHHHHHHhcCCCCc--ceE
Q 009340          205 VFTADELQRATDNYNQSRF-----LGQGGFGTVYKGMLPDGSIVAVKRSKEIDKTQIHQFINEVVILSQINHRHI--VKL  277 (537)
Q Consensus       205 ~~~~~el~~~~~~~~~~~~-----lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni--v~l  277 (537)
                      .++.+|++....+|...+.     |..|---+.|+....+|+ +++|+.....  ..++...|+.++..+...++  ...
T Consensus         2 ~ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~p   78 (316)
T d2ppqa1           2 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLP   78 (316)
T ss_dssp             CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred             CCCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCC--CHHHHHHHHHHHHhhhhcccccccc
Confidence            3677888888888877543     345666788998887665 8889875421  12334456667776643222  111


Q ss_pred             eeE------EeeCCccEEEEecCCCCChhhhhhhhhhhH----HH-------------------------HhhhccCCCC
Q 009340          278 LGC------CLETEVPVLVYEYISSGTLSHHIHDHQQQQ----EQ-------------------------KQKQELSSLS  322 (537)
Q Consensus       278 ~g~------~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~----~~-------------------------~~~~~~~~l~  322 (537)
                      +-.      .........++.+..+......-.......    ..                         ..........
T Consensus        79 i~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (316)
T d2ppqa1          79 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV  158 (316)
T ss_dssp             CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred             ceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhc
Confidence            111      112334456666665543321111000000    00                         0000000011


Q ss_pred             HHHHHHHHHHHHHHHHHHhhc-CCCCeeecCCCCCCEEECCCCcEEEeeccCcc
Q 009340          323 WENRVRVACEVAGAVAYMHSS-ASIPIFHRDIKSSNILLDDKFSAKVSDFGISR  375 (537)
Q Consensus       323 ~~~~~~i~~~ia~gl~yLH~~-~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~  375 (537)
                      .......+..+...+.-.+.. -+..+||+|+.+.||+++++...-|.||+.+.
T Consensus       159 ~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         159 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             chhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence            111222233333333333321 12338999999999999998777899999875

>d1y7ma2 d.7.1.1 (A:1-48) Hypothetical protein YkuD, N-terminal domain {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: LysM domain
superfamily: LysM domain
family: LysM domain
domain: Hypothetical protein YkuD, N-terminal domain
species: Bacillus subtilis [TaxId: 1423]

Probab=94.94  E-value=0.0027  Score=41.45  Aligned_cols=27  Identities=30%  Similarity=0.332  Sum_probs=23.9

Q ss_pred             ccHHHHhhCCCCCCCCCCCCceeeecc
Q 009340           11 TTCQALLGQNYFDAPNITIGAQVMIPL   37 (537)
Q Consensus        11 ~t~~~l~~~N~~~~~~i~~g~~l~vp~   37 (537)
                      +|+++|+++|++..+.|++||+|.||.
T Consensus        21 v~~~~i~~~N~~~~~~l~~Gq~L~IPg   47 (48)
T d1y7ma2          21 ISTAALLQANPSLQAGLTAGQSIVIPG   47 (48)
T ss_dssp             SCCCCCCCTSCTTCSSCCTTCEEEETT
T ss_pred             CCHHHHHHHcCCCCCCCCCCCEEEeCC
Confidence            789999999977667899999999994

>d1e0ga_ d.7.1.1 (A:) Membrane-bound lytic murein transclycosylase D, MltD {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: LysM domain
superfamily: LysM domain
family: LysM domain
domain: Membrane-bound lytic murein transclycosylase D, MltD
species: Escherichia coli [TaxId: 562]

Probab=94.86  E-value=0.0041  Score=40.44  Aligned_cols=27  Identities=11%  Similarity=0.108  Sum_probs=23.6

Q ss_pred             cccHHHHhhCCCCCCCCCCCCceeeecc
Q 009340           10 LTTCQALLGQNYFDAPNITIGAQVMIPL   37 (537)
Q Consensus        10 l~t~~~l~~~N~~~~~~i~~g~~l~vp~   37 (537)
                      -+++++|+++|.++ +.|+|||+|.||+
T Consensus        21 ~vs~~~i~~~N~l~-~~l~~Gq~L~i~v   47 (48)
T d1e0ga_          21 GVNIKDVMRWNSDT-ANLQPGDKLTLFV   47 (48)
T ss_dssp             TCCHHHHHHHCSCG-GGCCTTEEEECCC
T ss_pred             CCCHHHHHHHcCCc-ccCcCCCEEEEEe
Confidence            37899999999875 4699999999996

>d1emoa1 g.3.11.1 (A:2124-2166) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Fibrillin-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=83.20  E-value=0.31  Score=30.27  Aligned_cols=23  Identities=26%  Similarity=0.891  Sum_probs=19.8

Q ss_pred             CCCCCCCCCCccccCCCCcccCC
Q 009340          103 NGSCSANPENFFCHCKNGFLVDG  125 (537)
Q Consensus       103 ~~~c~~~~~~~~c~~~~~~~~~~  125 (537)
                      ...|.+.+++|.|.|++|+..+|
T Consensus        16 ~~~C~Nt~Gsy~C~C~~Gy~~~g   38 (43)
T d1emoa1          16 HGQCINTDGSYRCECPFGYILAG   38 (43)
T ss_dssp             SSCCCCCSSCCCCCCCTTEEESS
T ss_pred             CCEeECCCCCeEeECCCCcccCC
Confidence            45799999999999999997654